<SEC-DOCUMENT>0000868278-24-000004.txt : 20240329
<SEC-HEADER>0000868278-24-000004.hdr.sgml : 20240329
<ACCEPTANCE-DATETIME>20240328192719
ACCESSION NUMBER:		0000868278-24-000004
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		108
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240329
DATE AS OF CHANGE:		20240328

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ProPhase Labs, Inc.
		CENTRAL INDEX KEY:			0000868278
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				232577138
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21617
		FILM NUMBER:		24801392

	BUSINESS ADDRESS:	
		STREET 1:		711 STEWART AVE, SUITE 200
		STREET 2:		GARDEN CITY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			11530
		BUSINESS PHONE:		(215) 345-0919

	MAIL ADDRESS:	
		STREET 1:		711 STEWART AVE, SUITE 200
		STREET 2:		GARDEN CITY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			11530

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QUIGLEY CORP
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>prph-20231231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:7788277e-a48e-4763-84b1-a7c7849f902f,g:9ac615ab-2322-4dd1-8a91-31a5eca0bd4d,d:940cc81906cc4cdfbb1f3b7467688c8d-->
<html xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:prph="http://prophaselabs.com/20231231" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>prph-20231231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-33">0000868278</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-34">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-35">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-36">false</ix:nonNumeric><ix:nonNumeric contextRef="c-41" name="prph:DebtSecuritiesAvailableForSaleMaturityPeriod" id="f-378">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="c-49" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="f-443">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="c-51" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="f-445">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-53" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="f-447">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-72" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="f-513">1</ix:nonNumeric><ix:nonNumeric contextRef="c-74" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="f-514">1</ix:nonNumeric><ix:nonNumeric contextRef="c-76" xsi:nil="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="f-515"/><ix:nonNumeric contextRef="c-73" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="f-516">1</ix:nonNumeric><ix:nonNumeric contextRef="c-75" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="f-517">1</ix:nonNumeric><ix:nonNumeric contextRef="c-77" xsi:nil="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="f-518"/><ix:nonNumeric contextRef="c-163" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="f-688">P7Y</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-939">http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="c-199" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="f-968">10 years, 7 months</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="prph-20231231.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:SeptemberTwoThousandAndTwentyNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:SeptemberTwoThousandAndTwentyNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:A2023NoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:A2023NoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prph:CPMMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:OldBridgeNewJerseyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prph:CPMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="numberoflicensedcompound"><xbrli:measure>prph:numberOfLicensedCompound</xbrli:measure></xbrli:unit><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="inhibitor"><xbrli:measure>prph:inhibitor</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>prph:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="test"><xbrli:measure>prph:test</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:MarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:MarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:CorporateStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:USGovernmentObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:CorporateObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">prph:UncollectibleTradeReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">prph:UncollectibleTradeReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">prph:FullyReservedTradeReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:CorporateStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:CorporateStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:CorporateStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:USGovernmentObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:USGovernmentObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:USGovernmentObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:CorporateObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:CorporateObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:CorporateObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prph:PersonalGenomicsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:DiagnosticServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:DiagnosticServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:ContractManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:ContractManufacturingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:RetailAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:RetailAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:GenomicProductsAndServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:GenomicProductsAndServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">prph:CooperativeIncentivePromotionCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">prph:CooperativeIncentivePromotionCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">prph:StellaPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-03</xbrli:startDate><xbrli:endDate>2023-01-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-01-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-03</xbrli:startDate><xbrli:endDate>2023-01-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-03</xbrli:startDate><xbrli:endDate>2023-01-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:A2023SecuredMortgageLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:A2023SecuredMortgageLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-20</xbrli:startDate><xbrli:endDate>2023-12-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:A2023SecuredMortgageLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:A2023NoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">prph:A2023NotesWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">prph:A2023NotesWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-26</xbrli:startDate><xbrli:endDate>2023-01-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">prph:BlackScholesOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">prph:A2023NotesWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-26</xbrli:startDate><xbrli:endDate>2023-01-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">prph:A2023NotesWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:A2023NoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:SeptemberTwoThousandAndTwentyNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="debt"><xbrli:measure>prph:debt</xbrli:measure></xbrli:unit><xbrli:unit id="investor"><xbrli:measure>prph:investor</xbrli:measure></xbrli:unit><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">prph:LetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-28</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-28</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:SeptemberTwoThousandAndTwentyNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-10</xbrli:startDate><xbrli:endDate>2023-09-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:SeptemberTwoThousandAndTwentyNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:SeptemberTwoThousandAndTwentyNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-09</xbrli:startDate><xbrli:endDate>2022-05-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-14</xbrli:startDate><xbrli:endDate>2022-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-15</xbrli:startDate><xbrli:endDate>2023-03-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-26</xbrli:startDate><xbrli:endDate>2022-07-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:A2022DirectorsPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:Amended2022DirectorsPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:A2022DirectorsPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:A2022DirectorsPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:A2022DirectorsPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:Amended2010DirectorsPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:A2022PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:Amended2022PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:A2022PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:AmendedTwoThousandTenPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-20</xbrli:startDate><xbrli:endDate>2021-05-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-12</xbrli:startDate><xbrli:endDate>2018-04-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:CEOOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-03</xbrli:startDate><xbrli:endDate>2022-06-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">prph:MrKamalObbadMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:InducementOptionAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prph:InducementOptionAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-09</xbrli:startDate><xbrli:endDate>2022-05-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:CFOAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-12</xbrli:startDate><xbrli:endDate>2019-12-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:CFOAwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-12</xbrli:startDate><xbrli:endDate>2019-12-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:CFOAwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-03</xbrli:startDate><xbrli:endDate>2022-06-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:CFOAwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-04</xbrli:startDate><xbrli:endDate>2022-10-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:InducementOptionAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:InducementOptionAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:InducementOptionAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:InducementOptionAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:InducementOptionAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">prph:ShareBasedCompensationAwardTrancheFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:InducementOptionAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">prph:CertainHoldersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-01-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-12</xbrli:startDate><xbrli:endDate>2023-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-12</xbrli:startDate><xbrli:endDate>2023-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">prph:A2023NotesWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-06</xbrli:startDate><xbrli:endDate>2023-04-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="period"><xbrli:measure>prph:period</xbrli:measure></xbrli:unit><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-11-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">prph:LinebackerLicenseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-19</xbrli:startDate><xbrli:endDate>2022-07-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">prph:LinebackerLicenseAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:PhaseThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-19</xbrli:startDate><xbrli:endDate>2022-07-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">prph:LinebackerLicenseAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:NewDrugApplicationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-19</xbrli:startDate><xbrli:endDate>2022-07-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">prph:LinebackerLicenseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">prph:LinebackerLicenseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="site"><xbrli:measure>prph:site</xbrli:measure></xbrli:unit><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">prph:EquivirLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">prph:BESmartLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prph:CPMMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:OldBridgeNewJerseyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-23</xbrli:startDate><xbrli:endDate>2020-10-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:NewYorkSecondFloorLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="option"><xbrli:measure>prph:option</xbrli:measure></xbrli:unit><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:NewYorkSecondFloorLeaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-08</xbrli:startDate><xbrli:endDate>2020-12-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:NewYorkSecondFloorLeaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-08</xbrli:startDate><xbrli:endDate>2020-12-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:NewYorkFirstFloorLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:NewYorkFirstFloorLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-10</xbrli:startDate><xbrli:endDate>2022-06-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:NewYorkFirstFloorLeaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-10</xbrli:startDate><xbrli:endDate>2022-06-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:NewYorkFirstFloorLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-10</xbrli:startDate><xbrli:endDate>2022-06-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:NewYorkFirstFloorLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-07-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">prph:SegmentConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:DiagnosticServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">prph:SegmentConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:DiagnosticServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:GovernmentAgenciesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:InsuranceProvidersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:GovernmentAgenciesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:InsuranceProvidersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:ReimbursementReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:DiagnosticServicesClientsOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:ReimbursementReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:DiagnosticServicesClientsTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:ReimbursementReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:DiagnosticServicesClientsThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:ReimbursementReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:DiagnosticServicesClientsOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:ReimbursementReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:DiagnosticServicesClientsTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:DiagnosticServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:DiagnosticServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:ConsumerProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:ConsumerProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:UnallocatedCorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:UnallocatedCorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:DiagnosticServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:DiagnosticServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:ConsumerProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:ConsumerProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:UnallocatedCorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:UnallocatedCorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">prph:CommonStockPurchaseWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">prph:CommonStockPurchaseWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-16</xbrli:startDate><xbrli:endDate>2024-02-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-14</xbrli:startDate><xbrli:endDate>2024-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-14</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Mark One)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-2">x</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-4">December 31</ix:nonNumeric>, 2023</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-5">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from ______ to ______</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">000-21617</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">ProPhase Labs, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">23-2577138</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">711 Stewart Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-11">Suite 200</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-12">Garden City</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-13">New York</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-14">11530</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-15">(215)</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-16">345-0919</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, $0.0005 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">PRPH</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">Nasdaq</ix:nonNumeric> Capital Market</span></div></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-20">No</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-21">No</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-22">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;229.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-23">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.993%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-24">Accelerated filer</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-25">x</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-26">o</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="f-27">x</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-28">o</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-29">No</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of the registrant&#8217;s voting and non-voting common stock held by non-affiliates was $<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="f-30">100,240,301</ix:nonFraction> as of June 30, 2023, based on the closing price of the common stock on The Nasdaq Capital Market on such date. </span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;15, 2024, there were  <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-31">18,045,209</ix:nonFraction> shares outstanding of the registrant&#8217;s common stock, par value $0.0005 per share.</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-32" escape="true">Portions of the Registrant&#8217;s definitive proxy statement relating to its 2024 annual meeting of stockholders (the &#8220;2024 Proxy Statement&#8221;) are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. The 2024 Proxy Statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates</ix:nonNumeric>.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:78.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_13">PART I</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_16">Item 1.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_16">Business</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_16">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_19">Item 1A.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_19">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_19">21</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_22">Item 1B.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_22">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_22">50</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_22">Item 1</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_22">C</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_22">.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_1649267442142">Cybersecurity</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_22">50</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_25">Item 2.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_25">Properties</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_25">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_28">Item 3.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_28">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_28">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_31">Item 4.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_31">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_31">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_34">PART II</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_37">Item 5.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_37">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_37">52</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_40">Item 6.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_40">[Reserved]</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_40">52</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_43">Item 7.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_43">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_43">52</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_73">Item 7A.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_73">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_73">60</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_76">Item 8.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_76">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_76">62</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_160">Item 9.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_160">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_160">98</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_163">Item 9A.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_163">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_163">98</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_166">Item 9B.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_166">Other Information</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_166">100</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_169">Item 9C.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_169">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_169">100</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_172">PART III</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_175">Item 10.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_175">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_175">101</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_178">Item 11.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_178">Executive Compensation</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_178">101</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_181">Item 12.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_181">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_181">101</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_184">Item 13.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_184">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_184">101</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_187">Item 14.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_187">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_187">101</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_190">PART IV</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_193">Item 15.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_193">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_193">102</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_196">Item 16.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_196">Form 10-K Summary</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_196">104</a></span></div></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_199">Signatures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_199">105</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2</span></div></div></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K (&#8220;Annual Report&#8221;) contains &#8220;forward looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). All statements, other than statements of historical facts, included in this Annual Report, including statements related to future events and our future financial performance are forward-looking statements. Forward-looking statements typically are identified by use of terms such as &#8220;anticipate&#8221;, &#8220;believe&#8221;, &#8220;plan&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;may&#8221;, &#8220;will&#8221;, &#8220;should&#8221;, &#8220;estimate&#8221;, &#8220;predict&#8221;, &#8220;potential&#8221;, &#8220;continue&#8221; and similar words although some forward-looking statements are expressed differently. Forward-looking statements include, but are not limited to, statements concerning:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our anticipated expenses, ability to obtain funding for our operations and the sufficiency of our cash resources; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our strategic plans for our businesses, product candidates and research programs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">our anticipated timelines for clinical trials, regulatory filings and regulatory approvals for our product candidates, dietary supplements and diagnostics;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the beneficial characteristics, therapeutic effects, and potential advantages of our product candidates, dietary supplements and diagnostics;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our efforts to augment internal manufacturing capabilities and operation of our manufacturing facility;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">anticipated developments related to our competitors and our industry; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">estimates regarding the sufficiency of our existing capital resources to fund our future operating expenses and capital expenditure requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You are cautioned that forward-looking statements are not guarantees of performance and are subject to known and unknown risks, uncertainties and other factors that may cause our or our industry&#8217;s actual results, levels of activity, performance, achievements or prospects to be materially different from any future results, levels of activity, performance or achievements expressed or implied by the forward-looking statements. Many of these factors are beyond our ability to predict.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should also consider carefully the statements under other sections of this Annual Report, including the Risk Factors included in Item 1A, which are summarized below, which address risks that could cause our actual results to differ from those set forth in any forward-looking statements. Our forward-looking statements speak only as of the date of this Annual Report. We undertake no obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or otherwise except as otherwise required by law.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY OF RISK FACTORS</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should consider carefully the risks described under the "Risk Factors" section and elsewhere in this Annual Report. These risks, which include the following, could materially and adversely affect our business, financial condition, operating results, cash flow, and prospects, and cause the trading price of our common stock to decline:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business Generally</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">We have incurred significant net losses and accounts receivable that could materially, adversely affect our results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have limited cash on hand and may need substantial additional funding by incurring indebtedness or issuing common stock or other securities to finance our operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our failure to manage our growth successfully could harm our growth and operating results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Our businesses are subject to significant competitive pressures.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Unfavorable global economic conditions could adversely affect our business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Disruptions to our supply chain or increases in the price of materials could materially, adversely affect our results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">The adulteration of materials could materially and adversely affect our business. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">We may be subject to product liability claims.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Additional capital to support our businesses may not be available.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">System failures, security breaches or cyberattacks could adversely affect our business. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">We may not be successful without our key personnel.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">We may not be successful in executing our growth strategy.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">We may not be successful with our expansion in the Middle East and North Africa ("MENA") region.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Diagnostics Business</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">We may be unable to substitute the revenues from our lab diagnostic services or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tests with new business segments.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Our ability to reduce our accounts receivable depends on our collection of payment for the diagnostic tests we delivered, which we may not be able to do successfully as the process is complex and time-consuming, and any delay in  collecting claims could have an adverse effect on our revenue.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Personal Genomics Business</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">We may not successfully establish our presence in the personal genetics market. Our estimate of total market for personal genomic services may be inaccurate </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Concerns regarding privacy and use of genetic information may decrease consumer demand for our product.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">If we lose a significant or sole supplier, our business and operations could be materially adversely affected.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Any significant disruption in service could harm our reputation and may result in a loss of customers.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Our personal genomics business is subject to seasonal fluctuations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Contract Manufacturing and Dietary Supplement Business</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Disruptions at the manufacturing facilities, loss of certifications or other problems between customers and, our wholly owned subsidiary, Pharmaloz Manufacturing, Inc. (&#8220;PMI&#8221;) could adversely affect our business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Our PMI manufacturing business is subject to seasonal fluctuations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Our contract manufacturing and dietary supplement businesses are subject to extensive governmental regulation. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Our product development and commercialization efforts may be unsuccessful.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">If our products do not have the effects intended or cause undesirable side effects, our business may suffer.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">We may fail to meet market demand, and regulatory authorities may not accept our facilities.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Risks Related to Our Drug Development Operations</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Our product candidates are still in pre-clinical development, and it will be many years before our wholly owned subsidiary, ProPhase BioPharma, Inc. (&#8220;PBIO&#8221;), is able to commercialize a product candidate, if ever.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">We may expend our resources to pursue particular product candidates while failing to capitalize on other candidates or indications that may be more profitable or have a greater likelihood of commercial success.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">If we experience delays or enrollment difficulties in clinical trials, our ability to advance our product candidates through development and the regulatory process could be delayed or prevented.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Clinical trials are expensive, time consuming, and subject to uncertainty. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">We may fail to demonstrate the safety and efficacy of our product candidates.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">If our product candidates cause serious adverse events or undesirable side effects, including injury and death, their commercial potential may be limited or extinguished.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Even if we complete the necessary preclinical studies and clinical trials, we may be unable to obtain the regulatory approvals necessary for the commercialization of our product candidates or may face delays.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">If we are unable to establish marketing and sales capabilities or enter into agreements with third parties to market and sell our product candidates, we may not be able to generate product revenue.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Our products may not gain market acceptance and the market may be smaller than we believe.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Even if we are able to commercialize our product candidates, such products may be subject to unfavorable pricing regulations, third-party reimbursement practices, or healthcare reform initiatives, which could harm our business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Risks Related to Our Intellectual Property</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Failure to protect our trademarks and other intellectual property could impact our business. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">With sufficient IP rights we may not be able to compete effectively in our markets.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Claims of IP infringement may expose us to substantial liability and prevent our business efforts.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Share our trade secrets or confidential information, which increases the possibility that our trade secrets or other confidential information will be misappropriated or disclosed.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Governmental Regulation</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Laws and regulations regarding direct selling may prohibit or restrict our ability to sell our products in some markets or require us to make changes to our business model in some markets.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">We depend on third party service providers to comply with laws and regulations. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">We must comply with complex laws protecting privacy and security of health information and personal data.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Common Stock, Internal Controls and Governance Matters</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">We have identified material weaknesses in our internal controls over financial reporting, which may adversely affect investor confidence in us, our business, results of operations and financial condition, and the trading price of our common stock.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Sales of our common stock could adversely affect its trading price of and our ability to raise funds.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">If analysts don&#8217;t publish reports about us or they issue an adverse opinion, our stock price could decline.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Our CEO and Chairman owns a substantial amount of our common stock.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Our Certificate of Incorporation and amended and restated bylaws ("Bylaws") contain certain provisions that may be barriers to a takeover.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Our Bylaws provides that the Delaware Court of Chancery and the federal district courts are the exclusive forums for substantially all disputes with our stockholders.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">We have agreed to indemnify our officers and directors from liability.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5</span></div></div></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_16"></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Business</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a growth oriented and diversified next generation biotech, genomics and diagnostics company that develops and commercializes novel drugs, dietary supplements, and compounds, and contract manufacturing.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offered a broad array of COVID-19 related clinical diagnostic and testing services including polymerase chain reaction (&#8220;PCR&#8221;) testing for COVID-19 and Influenza A and B and rapid antigen testing for COVID-19 through our wholly-owned subsidiary, ProPhase Diagnostics, Inc. (&#8220;ProPhase Diagnostics&#8221;) up until August 2023.  </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer whole genome sequencing and related services through our wholly-owned subsidiary, Nebula Genomics, Inc. (&#8220;Nebula&#8221;). </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our wholly owned subsidiary, PBIO is focused on the licensing, development and commercialization of novel drugs, dietary supplements, and compounds. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our wholly-owned subsidiary, PMI, is a full-service contract manufacturer and private label developer of a broad range of non-GMO, organic and natural-based cough drops and lozenges and over-the-counter (&#8220;OTC&#8221;) drug and dietary supplement products. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also develop and market dietary supplements under the TK Supplements&#174; brand.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">ProPhase Diagnostics</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our wholly-owned subsidiary, ProPhase Diagnostics, which was formed in October 2020, offered a broad array of COVID-19 related clinical diagnostic and testing services including PCR testing for COVID-19 and Influenza A and B at its two Clinical Laboratory Improvement Amendments (&#8220;CLIA&#8221;) certified laboratories, located in Old Bridge, New Jersey and Garden City, New York. We also offered rapid antigen testing for COVID-19. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2020, the CARES Act was enacted, providing for reimbursement to healthcare providers for COVID-19 tests provided to uninsured individuals, subject to continued available funding. On March 22, 2022, the Health Resources &amp; Services Administrations (&#8220;HRSA&#8221;) uninsured program stopped accepting claims for COVID-19 testing and treatment due to the lack of sufficient funds. Despite requests from the Acting Director of the Office of Management and Budget and the White House Coordinator for COVID-19 Response for additional emergency funding for the uninsured program, emergency funding has not been allocated to the HRSA uninsured program. The expiration of the federal Public Health Emergency on May 11, 2023 changed regulatory guidelines around COVID-19 testing including billing codes and reimbursement rates of in and out of network laboratories.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Due to the significant decrease in demand and reimbursement rate for our diagnostic testing service, we have reduced the amount of diagnostic testing services that we provide since the second half of 2023. Nonetheless we are prepared to provide an increased volume of our diagnostic testing service if diagnostic testing is required due to a new COVID-19 outbreak. We have continued to ship COVID-19 antigen kits under an existing contract to our customer. In addition, in order to maintain licenses in certain states in which we operate, we currently perform several diagnostic tests each quarter to maintain our certified lab status, and we currently plan to do so for the foreseeable future.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Nebula Genomics</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nebula focuses on genomics testing technologies, a comprehensive method for analyzing entire genomes, including the genes and chromosomes in deoxyribonucleic acid (&#8220;DNA&#8221;). The data obtained from genomic sequencing may help to identify inherited disorders and tendencies, help predict disease risk, help identify expected drug response, and characterize genetic mutations, including those that drive cancer progression. We currently offer Nebula  whole genome sequencing products direct-to-consumers online with plans to sell in food, drug and mass (&#8220;FDM&#8221;) retail stores and to provide testing for universities conducting genomic research.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nebula provides consumers access to affordable and secure whole genome sequencing. It also provides customers with access to over 300 personalized reports based on their genomic profile. These reports are created utilizing the latest scientific research and provide individual genetic commentary on a broad range of traits and characteristics. Customers can </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">access their reports via Nebula&#8217;s secure online portal. As new scientific discoveries are made, customers receive new reports, as well as regular updates to their existing reports, through Nebula&#8217;s subscription model. In addition to the personalized reports, Nebula provides customers with access to a suite of exploration tools including a gene browser and a gene analysis tool. These tools allow customers to browse their data, search for genetic variants, and analyze their genes.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nebula&#8217;s solution was initially powered by the innovations of George Church, Ph.D., Professor of Genetics at Harvard Medical School and Chairman of Nebula&#8217;s Scientific Advisory Board. Dr. Church has pioneered the development of multiple DNA sequencing methods, including molecular multiplexing approaches that enable next generation sequencing as well as nanopore sequencing.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nebula&#8217;s whole genome sequencing DNA test decodes approximately 6.4 billion base pairs of the human genome, generating significant amounts of data, which exceeds the amount and quality of data widely offered by most competing services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through the use of additional tools, the data that is generated can help identify rare genetic mutations and provide consumers other valuable insights into their genes and overall health and wellness. Nebula also provides consumers with weekly educational content to further their knowledge about the use of their genetic data.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Based on our internal research, Nebula was the first company to bring the cost of sequencing a human genome below $300 and became one of the largest direct-to-consumer whole genome sequencing companies. Our goal is to dramatically increase Nebula&#8217;s sales by decreasing price, decreasing turnaround times and increasing distribution to both businesses and consumers, including universities conducting genetic research. We plan to accomplish this by integrating Nebula&#8217; genomic sequencing into our CLIA-certified labs. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nebula is currently in ongoing negotiations with numerous businesses to expand from direct to consumer to business to business (&#8220;B2B&#8221;) operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nebula plans to utilize its state of the art in house clinical lab to receive and process thousands of B2B samples every year. The Company is currently working with other labs, doctors&#8217; offices, health clinics, longevity clinics, and many other potential business consumers.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also actively collaborating with G42 Healthcare, a leading Abu Dhabi-based artificial intelligence (&#8220;AI&#8221;) health-tech company, to explore genomic sequencing and other potential opportunities. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ProPhase BioPharma</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We formed PBIO in June 2022 for the licensing, development and commercialization of novel drugs, dietary supplements and compounds. Licensed compounds under development currently include Equivir (a dietary supplement candidate) and Equivir G (prescription drug (&#8220;Rx&#8221;) candidate), two broad-based anti-viral candidates, and Linebacker LB-1 and LB-2, two small molecule proviral integration site for moloney murine leukemia virus (&#8220;PIM&#8221;) kinase inhibitors product candidates. We also own the exclusive rights to the BE-Smart Esophageal Pre-Cancer Diagnostic Screening test, which is in development, and related intellectual property (&#8220;IP&#8221;) assets. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Equivir (dietary supplement candidate) and Equivir G (Rx candidate)</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have exclusive worldwide rights to develop and commercialize Equivir (a dietary supplement candidate) and Equivir G (a Rx candidate) pursuant to a license agreement with Global BioLife, Inc. (&#8220;Global BioLife&#8221;), a wholly-owned subsidiary of DSS, Inc. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Equivir is a blend of polyphenols, which</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> are substances found in many nuts, vegetables and berries. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The composition, which contains polyphenols that we believe are generally recognized as safe, is projected to come in capsule form and be taken much like a multivitamin. The composition is believed to work by helping to improve proper immune function. We plan to pursue commercialization of Equivir as a dietary supplement, leveraging our distribution in over 40,000 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">FDM retail stores</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and online direct to consumers. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">               </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2023, we commenced patient enrollment in a randomized, placebo-controlled clinical trial of Equivir to evaluate its effect on upper respiratory tract infections. Vedic Lifesciences, a leading clinical research organization, was contracted to run the multi-arm trial.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Vedic produced interim results in February of 2024 which showed enough data to continue the trial to completion.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The trial is expected to be completed by the end of the second quarter 2024. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Equivir G is a blend of polyphenols similar to Equivir (dietary supplement) with the addition of Gallic acid. We are in the process of formulating its composition and preparing clinical studies. We are pursuing the development of Equivir G as a prescription based antiviral treatment based on data related to the polyphenol formulation in Equivir.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Evidence suggests that the blend of polyphenols in Equivir has the potential to block the entry of a virus into host cells, thereby preventing infection and replication in those host cells. Through our development of Equivir G, we believe a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">similar polyphenol formulation can be developed for the treatment of infection caused by various serotypes of influenza and Rhinovirus, a common viral infectious agent predominantly associated with the common cold in humans.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We believe this formulation may also have the potential to block the entry of Ebola virus into host cells, which could prevent Ebola Virus Disease</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and Ebola Hemorrhagic fever. These diseases are rare, but severe and often fatal in humans, particularly in sub-Saharan Africa. Ebola has a 90% death rate, according to the World Health Organization. Equivir has also shown in in-vitro studies to combat SARS-COV2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We plan to apply for an Investigational New Drug Application (&#8220;IND&#8221;) for Equivir G as a prescription-based antiviral treatment. Planned antiviral applications include SARS-COV2, Influenza and Ebola, among others. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Linebacker (LB-1 and LB-2)</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have exclusive worldwide rights to develop and commercialize LB-1 and LB-2 for the treatment of cancer, inflammatory diseases or symptoms and memory-related syndromes, diseases or symptoms, including dementia and Alzheimer&#8217;s disease, pursuant to a license agreement with Global BioLife.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LB-1 and LB-2 were initially developed by Global BioLife in partnership with Global Research and Development Group Sciences (&#8220;GRDG&#8221;). GRDG and Global BioLife created Linebacker, a multi-faceted therapeutic platform targeting metabolic, neurologic, cancer, and infectious diseases, to mirror the Panacea Project, a U.S. Defense Advanced Research Projects Agency program that provides novel, multi-target therapeutics for unmet physiological needs. Linebacker is a modified polyphenol. Linebacker compounds are modified Myricetin, which is a common plant-derived flavonoid. Myricetin exhibits a wide range of activities that include strong antioxidant, anticancer, antidiabetic and anti-inflammatory activities. It displays activities that are related to the central nervous system. Anecdotal evidence suggests that it may be beneficial to protect against diseases such as Parkinson&#8217;s and Alzheimer&#8217;s.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LB-1 is being developed as a potential co-therapy to down-regulate PIM (proviral integration site for moloney murine leukemia virus) kinase, which plays a key role as an oncogene in various cancers including myeloma, leukemia, prostate and breast cancers. In preclinical laboratory studies, LB-1 inhibited PIM, which could potentially slow the growth of the cancer and allow for better efficacy of the co-therapy drug or treatment being used. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Chemotherapy drugs alone, like TAXOL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (paclitaxel) injection, kill healthy cells alongside tumorous ones. LB-1 is being developed to focus directly on the PIM expressions potentially rendering the cancer cell transcription and replication significantly less effective, so that chemotherapy drugs such as paclitaxel can effectively kill the existing tumor cells. LB-1 may also be developed as a potential standalone post therapy to ensure cancer cells do not regenerate. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our initial focus for LB-1 is as a potential co-therapy for the following four drugs:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:13.8pt">Paclitaxel</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: a drug </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">used to treat breast, ovarian, lung, bladder, prostate, melanoma, esophageal, as well as other types of solid tumor cancers.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:13.8pt">Doxorubicin</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: a drug used to treat used to treat various forms of cancer, including breast cancer, bladder cancer, Kaposi's sarcoma, lymphoma, and acute lymphocytic leukemia.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:13.8pt">Topotecan</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: a drug used to treat ovarian cancer.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:13.8pt">Cisplatin</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: a drug used to treat testicular, ovarian, bladder, head and neck, lung and cervical cancer.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In vitro studies completed in the fourth quarter of 2023 from the initial LB-1 cell line demonstrated the following findings:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:13.8pt">LB-1 Co-Therapy with Paclitaxel </span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.75pt">LB-1 alone inhibited cell proliferation at 69.94% at 100uM</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.75pt">TAXOL alone inhibited cell proliferation at 41.96% at 200nM</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.75pt">LB-1 and TAXOL combined inhibited cell proliferation at 75.5% (100uM of LB1 + 200nM Taxol)</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:13.8pt">LB-1 Co-Therapy with Doxorubicin</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.75pt">LB-1 alone inhibited cell proliferation at 69.66% at 100uM</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.75pt">Doxorubicin alone inhibited cell proliferation at 51.6% at 2000nM</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.75pt">LB-1 and Doxorubicin combined inhibited cell proliferation at 86.95% (100uM of LB1 + 2000nM Doxorubicin)</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:13.8pt">LB-1 Co-Therapy with Topotecan</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.75pt">LB-1 alone inhibited cell proliferation at 69.54% at 100uM</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.75pt">Topotecan alone inhibited cell proliferation at 58.27% at 2000nM</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.75pt">LB-1 and Topotecan combined inhibited cell proliferation at 97.18% (100uM of LB1 + 2000nM Topotecan)</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:13.8pt">LB-1 Co-Therapy with Cisplatin</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.75pt">LB-1 alone inhibited cell proliferation at 72.33% at 100uM</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.75pt">Cisplatin alone inhibited cell proliferation at 22.74% at 30uM</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#9702;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.75pt">LB-1 and Cisplatin combined inhibited cell proliferation at 82.48% (100uM of LB1 + 30uM Cisplatin)</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In January 2023, REPROCELL completed an independent review of LB-1, which included testing of 25 cell lines with LB-1, and confirmed previous </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">in vitro</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> studies conducted by Charles River. These cell lines confirmed efficacy of LB-1 on ovarian, kidney, colon and lung adenocarcinoma/small cells.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2022 PBIO entered into a two-year collaborative agreement with Dana-Farber Cancer Institute and Harvard Medical School to further the research LB-1. This collaboration provides for year 1 and year 2 research plans, which were initiated in the first and second quarter of 2023. The ongoing studies are focused on identifying the most effective combination of cancer cell lines and agents with LB-1. Initial focus areas include hepatic, colon and breast cancer, and initial therapy agents include Topotecan and Doxorubicin. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2023, we teamed up with Certis oncology to use their proprietary CertisAI Predictive Oncology Intelligence to determine what, if any,cancers Linebacker would be most effective against. The Company has generated significant data and continues to administer testing models in the first and second quarter of 2024 to pinpoint the best cancers to target. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">BE-Smart Esophageal Pre-Cancer Diagnostics Screening Test </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We  own the worldwide exclusive rights to the BE-Smart Esophageal Pre-Cancer diagnostics screening test and related intellectual property assets. The BE-Smart test is aimed at early detection of esophageal cancer. It remains under development but has already been tested by an independent test lab, mProbe, Inc. (&#8220;mProbe&#8221;), on over 200 human samples and has shown greater than 99% sensitivity and specificity to detect protein expressions in cells that are at high risk of becoming cancerous. mProbe, a precision health and medicine company utilizing clinical proteomics in the oncology space in conjunction with Dr. Christopher Hartley of the prestigious Mayo Clinic, has been utilizing a small sample of tissue collected during endoscopies to help us confirm and optimize the BE-Smart Test. The initial data appears to demonstrate accuracy and reproducibility as well as identification of potential biomarkers for therapeutic drug discovery to treat esophageal cancer. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2023, we announced a collaboration with mProbe and Dr. Christopher Hartley of Mayo Clinic for the continued development of its BE-Smart Esophageal Pre-Cancer diagnostic screening test. We plan to commercialize the BE-Smart test as a Laboratory Developed Test (&#8220;LDT&#8221;) in the second half of 2024 with full commercialization backed by insurance expected by the end of 2024. We may, in certain cases, provide the BE-Smart test for research-use only (&#8220;RUO&#8221;) purposes, in which case the test may not be subject to certain regulatory requirements of the U.S. Food and Drug Administration (the "FDA"), provided that the test, its labels, and labeling are done in accordance with FDA&#8217;s regulatory requirements.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">According to the National Institute of Health Chapter 24: Indications and Outcomes of Gastrointestinal Endoscopy, over 20 million endoscopies are performed every year in the United States; approximately 2 million of these procedures are done on patients with Barret&#8217;s Esophagus, which is a condition in which the flat pink lining of the swallowing tube that connects the mouth to the stomach (esophagus) becomes damaged by acid reflux, which causes the lining to thicken and become red. In patients with Barrett&#8217;s Esophagus, one in two hundred will develop esophageal adenocarcinoma. Esophageal cancer is highly lethal and deemed as the sixth cause of cancer death worldwide according to Cancer State Facts, the overall five-year survival rate was less than 20%.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The BE-Smart test is being developed to provide health care providers and patients with data to help determine treatment options, including whether patients not believed to be at risk for esophageal cancer should continue to be monitored or, alternatively, to provide patients who might otherwise have been undiagnosed early treatment before esophageal cells become cancerous. The goal of widespread adoption of the BE-Smart test would allow health care providers to initiate potentially lifesaving early treatment processes such as an ablation procedure to remove the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">precancerous cells. This diagnostic test, once fully validated, could also significantly reduce unnecessary endoscopies as well as offer peace of mind to patients who are suffering with Barret&#8217;s syndrome who are at greater risk of esophageal cancer.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmaloz Contract Manufacturing </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMI is a full-service contract manufacturer and private label developer of a broad range of non-GMO, organic and natural-based cough drops and lozenges and OTC drug and dietary supplement products. PMI provides product development, pre-commercialization services, production, warehousing and distribution services for its customers. Our manufacturing facility, which is located in Lebanon, Pennsylvania, is registered with the FDA and is certified organic and kosher.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the sale of our former Cold-EEZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> business in March 2017, PMI entered into a manufacturing agreement with Mylan Consumer Healthcare Inc. and Mylan Inc. (collectively, &#8220;Mylan&#8221;) to supply various Cold-EEZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lozenge products to Mylan following the sale for a period of five years with annual renewal options. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the manufacturing agreement, PMI agreed to manufacture certain products for Mylan, as described in the manufacturing agreement, at prices that reflect current market conditions for such products and include an agreed upon mark-up on our costs. On May 1, 2021, the manufacturing agreement was assigned by Mylan to Meda Consumer Healthcare, Inc. (&#8220;Meda&#8221;) in connection with Meda&#8217;s acquisitions of certain assets from Mylan, including the Cold-EEZE&#174; brand and product line. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Meda is currently within Vespyr Brands and the manufacturing contract with PMI is expected to be renewed by the end of the second quarter of 2024.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In February 2023, we acquired new equipment and doubled the capacity for pouch packaging, to meet the growing demand for our products and services. PMI also acquired new automation equipment that is expected to double capacity in the second half of 2024. PMI is also planning for expansion of its lozenge manufacturing business and is projected to add a second line that should be operational by the beginning of the third quarter of 2024. PMI added multiple new customers throughout the second half of 2023 and remains positioned for growth.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TK Supplements</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our TK Supplements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">product line is dedicated to supporting better health, energy and sexual vitality. Each of our herbal supplements is researched to determine the optimum blend of ingredients to ensure our customers receive premium quality products. To achieve this, we formulate with the highest quality ingredients derived from nature and ingredients enhanced by science. Our TK Supplements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">product line includes Legendz XL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a male sexual enhancement and Triple Edge XL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an energy and stamina booster.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legendz XL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has distribution in Rite Aid, Walgreens, CVS, Walmart and other retailers, and via ecommerce.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we restaged Triple Edge XL from a 56 count (&#8220;ct&#8221;) to a 20 ct at CVS, making the retail price more in line with competition. The result was a double digit increase in consumer sales and a 40% expansion increase in the number of stores carrying the item between the restaging of the product in September 2022 and January 2023. In January 2024, Triple Edge XL was reviewed by CVS and, based on its 2022 and 2023 sales, CVS has determined to maintain authorization for its fiscal year ending December 31, 2024. We also presented and marketed Triple Edge XL 20 ct to Walgreens and other major pharmacies, and we are waiting on final decisions on whether those pharmacies will agree to carry Triple Edge XL 20 ct.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event all of the pharmacies at which we presented Triple Edge XL 20 ct accept the same of such product, we believe that such acceptances will increase demand for product inventory by over 100% in the 12 month period following all of the acceptances.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fluctuations in our Business</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our diagnostic services revenues were subject to fluctuations in COVID-19 testing demand. The demand for COVID-19 tests was highly volatile, primarily driven by the emergence and severity of new variants. The demand for COVID-19 tests significantly decreased in 2023 and as a result,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> we have reduced the amount of diagnostic testing services that we provide since the second half of 2023. Nonetheless we are prepared to provide an increased volume of our diagnostic testing service if diagnostic testing is required due to a new COVID-19 outbreak. We have continued to ship COVID-19 antigen kits under an existing contract to our customer. In addition, in order to maintain licenses in certain states in which we operate, we currently perform several diagnostic tests each quarter to maintain our certified lab status, and we currently plan to do so for the foreseeable future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our personal genomics kit sales are impacted by seasonal holiday demand. We expect to generate greater revenues from this business during the first quarter of our fiscal year. While kits sales increase during the holiday season (fourth quarter), we will generally recognize revenue when the customer sends in their kit to our laboratory for processing and a genetic report is delivered, which we expect will occur in the following fiscal quarter.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contract manufacturing revenues are subject to seasonal fluctuations. As the majority of products that we manufacture for our customers are OTC healthcare and cold remedy products, our revenues tend to be higher in the first, third and fourth quarters during the cold season. Generally, a cold season is defined as the period from September to March when the incidence of the common cold rises as a consequence of the change in weather and other factors. Revenues are generally at their lowest levels during the second quarter when contract manufacturing demand generally declines.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently own any patents. We maintain various trademarks for our TK Supplements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products including Legendz XL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Triple Edge XL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We maintain a trademark for our genomic testing, Nebula Genomics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Licensing Agreements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensing Agreement with Global BioLife, Inc. for Equivir and Equivir G</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to a license agreement with Global BioLife, dated March 17, 2022 (&#8220;Equivir License Agreement&#8221;), pursuant to which we acquired from Global BioLife a worldwide exclusive right and license under certain patents identified in the license agreement and know-how (collectively, the &#8220;Equivir Licensed IP&#8221;) to exploit any product comprising or containing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equivir Licensed Compound (as defined in the license agreement) (&#8220;Equivir Licensed Products&#8221;) for all uses (the &#8220;Equivir Field&#8221;). </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the terms of the Equivir License Agreement, Global BioLife reserves the right, solely for itself to use the Equivir Licensed IP to research and develop, including modify, enhance, improve, Equivir Licensed Products in the Equivir Field. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Subject to certain conditions set forth in the license agreement, we may grant sublicenses to our rights under the license agreement to any of our affiliates or any third party. We may assign our rights under the license agreement without consent (i) to our affiliates or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b) to an acquirer of all or substantially all of our assets to which this agreement relates. Under the terms of the license agreement, we or our affiliates have a fully-paid up, irrevocable, exclusive right of first refusal to obtain exclusive global rights to certain patents identified in the license agreement. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensing Agreement with BioLife, Inc. for Linebacker LB-1 and LB-2</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also party to a license agreement with Global BioLife, dated July 19, 2022 (&#8220;Linebacker License Agreement&#8221;), pursuant to which we acquired from Global BioLife a worldwide exclusive right and license under certain patents identified in the License Agreement (the &#8220;Linebacker Licensed Patents&#8221;) and know-how (collectively, the &#8220;Linebacker Licensed IP&#8221;) to exploit any compound covered by the Linebacker Licensed Patents (the &#8220;Linebacker Licensed Compound&#8221;), including Linebacker LB-1 and LB-2, and any product comprising or containing a Linebacker Licensed Compound (&#8220;Linebacker Licensed Products&#8221;) in the treatment of cancer, inflammatory diseases or symptoms, memory-related syndromes, diseases or symptoms including dementia and Alzheimer&#8217;s Disease (the &#8220;Linebacker Field&#8221;). Under the terms of the Linebacker License Agreement, Global BioLife reserves the right, solely for itself and for GRDG Sciences, LLC  to use the Linebacker Licensed Compound and Linebacker Licensed IP solely for research purposes inside the Linebacker Field and for any purpose outside the Linebacker Field.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain conditions set forth in the license agreement, we may grant sublicenses (including the right to grant further sublicenses) to our rights under the license agreement to any of our affiliates or any third party with the prior written consent of Global BioLife, which consent may not be unreasonably withheld. Either party to the license agreement may assign its rights under the license agreement (i) in connection with the sale or transfer of all or substantially all of our assets to a third party, (b) in the event of a merger or consolidation with a third party or (iii) to an affiliate; in each case contingent upon the assignee assuming in writing all of the obligations of its assignor under the license agreement.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Linebacker License Agreement, we were required to pay to Licensor a one-time upfront license fee of $50,000 within 10 days of the effective date and must pay an additional $900,000 following the achievement </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of a first Phase 3 study which may be required by the FDA for the first Linebacker Licensed Product and an additional $1 million upon the receipt of regulatory approval of a New Drug Application ("NDA") for the first Licensed Product.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the term of the Linebacker License Agreement, we are also required to pay to Global BioLife 3% royalties on Net Revenue (as defined in the license agreement) of each Linebacker Licensed Product, but no less than the minimum royalty of $250,000 of net revenue per year minus any royalty payments for any required third party licenses.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Linebacker License Agreement, the development of the Linebacker Licensed Compound and the first Linebacker Licensed Product for the United States will be governed by a clinical development plan, including anticipated timeline goals in connection with the clinical trials for the first Linebacker Licensed Product (the &#8220;Linebacker Development Plan&#8221;). The Linebacker Development Plan may be amended by the mutual written agreement of the parties to the Linebacker License Agreement based upon results of preclinical studies or clinical trials, including safety and effectiveness, guidance by the FDA, or upon the agreement of the parties.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Linebacker License Agreement will expire automatically on a country-by-country basis upon the last to occur of the expiration of the last to expire Linebacker Licensed Patents (the &#8220;Term&#8221;). Following the expiration of the Term, and on a country-by-country basis, the license will become non-exclusive, perpetual, fully-paid, unrestricted, royalty-free and irrevocable.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Linebacker License Agreement may be terminated by us for any reason or for convenience in our sole discretion: (i) on a Linebacker Licensed Product-by-Linebacker Licensed Product or a country-by-country basis or (ii) in its entirety, in either case ((i) or (ii)) for convenience upon 180 days prior written notice to Global BioLife. Global BioLife may terminate the license agreement solely for a material breach of the license agreement by us, which is not cured within 60 days&#8217; of written notice to us of such breach.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to extensive governmental regulation by various federal, state, and local agencies as described below.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Food and Drug Administration</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diagnostic Testing Services</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has regulatory responsibility for diagnostic testing instruments, test kits, reagents and other devices used by clinical laboratories. The FDA enforces laws and regulations that govern the development, testing, manufacturing, performance, labeling, advertising, marketing, distribution and surveillance of diagnostic products, including COVID-19 diagnostics authorized by the FDA under and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emergency Use Authorizations (&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EUA&#8221;), and it regularly inspects and reviews the manufacturing processes and product performance of diagnostic products.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 2014, there have been ongoing discussions and advocacy between stakeholders, including the clinical laboratory industry, the FDA, and Congress, about potential FDA regulation of LDTs, which are assays developed and performed in-house by clinical laboratories that can be made available to the public without pre-market review by the FDA (although COVID-19 LDTs are currently subject to FDA pre-market requirements, as a consequence of the national health emergency). Various regulatory and legislative proposals are under consideration, including some that could increase general FDA oversight of clinical laboratories and LDTs. The outcome and ultimate impact of such proposals on our business is difficult to predict at this time.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmaceutical Regulation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacturing and distribution of pharmaceutical products are subject to extensive regulation by the federal government, primarily through the FDA and the Drug Enforcement Administration, and to a lesser extent by state and local government agencies. The Food, Drug, and Cosmetic Act (&#8220;FFDCA&#8221;) and other federal statutes and regulations govern or influence the manufacture, labeling, testing, storage, record keeping, approval, advertising and promotion of OTC pharmaceutical products.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facilities used in the manufacture, packaging, labeling and repackaging of drug products, including OTC drug products, must be registered with the FDA and are subject to FDA inspection to ensure that drug products are manufactured in accordance with current Good Manufacturing Practice (&#8220;cGMPs&#8221;).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA approval is required before any &#8220;new drug&#8221; may be marketed, including new formulations, strengths, dosage forms and generic versions of previously approved drugs. Generally, to obtain FDA approval of a &#8220;new drug&#8221; a company must file a NDA or Abbreviated New Drug Application (&#8220;ANDA&#8221;).</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the OTC monograph system, selected OTC drugs are generally recognized as safe and effective and do not require the submission and approval of an NDA or ANDA prior to marketing.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA OTC monographs include well-known ingredients and specify requirements for permitted indications, required warnings and precautions, allowable combinations of ingredients and dosage levels. Drug products marketed under the OTC monograph system must conform to specific quality, formula and labeling requirements; however, these products can be developed and marketed without prior FDA approval unlike products requiring a submission and approval of an ANDA or NDA. In general, it is less costly to develop and bring to market a product regulated under the OTC monograph system. From time to time, adequate information may become available to the FDA regarding certain prescription drug products that will allow the reclassification of those products as no longer requiring the approval of an ANDA or NDA prior to marketing. For this reason, there may be increased competition and lower profitability related to a particular OTC-switch product should it be reclassified to the OTC monograph system.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncompliance with applicable requirements can result in product recalls, seizure of products, injunctions, suspension of production and/or distribution, refusal of the government or third parties to enter into contracts with us, withdrawal or suspension of the applicable regulator&#8217;s review of our drug applications, civil penalties and criminal fines, and disgorgement of profits.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dietary Supplement Regulation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA regulates dietary supplements under a different set of regulations than those covering &#8220;conventional&#8221; foods and drug products (prescription and OTC). Under the Dietary Supplement Health and Education Act (the &#8220;DSHEA&#8221;), which was passed in 1994, dietary supplements that were in commerce prior to 1994 are broadly presumed safe. For these supplements, manufacturers do not need to register their products with the FDA nor get FDA approval before producing or selling them. Manufacturers must make sure that product label information is truthful and not misleading. For these products, the FDA is responsible for taking action against any unsafe or misbranded dietary supplement product after it reaches the market. All new ingredients marketed within dietary supplements after 1994 that are not found in food must meet a stricter set of regulations and notification prior to release in the marketplace.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2007, pursuant to the authority granted by the FFDCA as amended by DSHEA, the FDA published detailed cGMP regulations that govern the manufacturing, packaging, labeling, and holding operations of dietary supplement manufacturers. The cGMP regulations, among other things, impose significant recordkeeping requirements on manufacturers. The cGMP requirements are in effect for all manufacturers, and the FDA is conducting inspections of dietary supplement manufacturers pursuant to these requirements. The failure of a manufacturing facility to comply with the cGMP regulations renders products manufactured in such facility &#8220;adulterated&#8221; and subjects such products and the manufacturer to a variety of potential FDA enforcement actions.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under the Food Safety Modernization Act, (the &#8220;FSMA&#8221;), which was enacted on January 2, 2011, the manufacturing of dietary ingredients contained in dietary supplements are subject to similar or even more burdensome manufacturing requirements. The FSMA requires importers of food, including dietary supplements and dietary ingredients, to conduct verification activities to ensure that the food they might import meets applicable domestic requirements. The FSMA also expands the reach and regulatory powers of the FDA with respect to the production and importation of food, including dietary supplements. The expanded reach and regulatory powers include the FDA&#8217;s ability to order mandatory recalls, administratively detain domestic products, require certification of compliance with domestic requirements for imported foods associated with safety issues and administratively revoke manufacturing facility registrations, effectively enjoining manufacturing of dietary ingredients and dietary supplements without judicial process. The regulation of dietary supplements may increase or become more restrictive in the future.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under FFDCA, dietary supplements are subject to both adulteration and misbranding provisions. Adulterated products are those that contain unlisted ingredients or are not prepared or packaged under the FDA cGMPs for dietary supplements and misbranded products are those with false or misleading labels. Adulterated or misbranded products are subject to the full range of civil and criminal enforcement measures under the FFDCA and all violations of FFDCA are subject to criminal enforcement at the FDA&#8217;s discretion.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to the Dietary Supplement and Nonprescription Drug Consumer Protection Act, which was passed in 2006 to amend the FFDCA with respect to serious adverse event reporting for dietary supplements and nonprescription drugs, among other things. The law requires that the manufacturer, packer or distributor of a dietary supplement or OTC drug notify the FDA of all serious adverse events it receives associated with their dietary supplement or OTC product within 15 business days. Serious adverse events are defined as those that result in death, a life-threatening experience, in-patient hospitalization, a persistent or significant disability or incapacity, congenital anomaly or birth defect, as well as situations where medical/surgical intervention is required to prevent the previously listed events.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consumer Product Safety Commission</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the Poison Prevention Packaging Act, the Consumer Product Safety Commission (&#8220;CPSC&#8221;) has authority to require that certain dietary supplements and certain pharmaceuticals have child-resistant packaging to help reduce the incidence of accidental poisonings. The CPSC has published regulations requiring iron-containing dietary supplements and various pharmaceuticals to have child resistant packaging and has established rules for testing the effectiveness of child-resistant packaging and for ensuring senior adult effectiveness. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The manufacturer of any product that is subject to any CPSC rule, ban, standard or regulation must also certify that, based on a reasonable testing program, the product complies with CPSC requirements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal Trade Commission</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising of our products in the United States is subject to regulation by the Federal Trade Commission (the &#8220;FTC&#8221;) under the Federal Trade Commission Act. Under the FTC&#8217;s Substantiation Doctrine, an advertiser is required to have a &#8220;reasonable basis&#8221; for all objective product claims before the claims are made. Failure to adequately substantiate claims may be considered either deceptive or unfair practices. Pursuant to this FTC requirement, we are required to have adequate substantiation for all material advertising claims that we make for any products sold in the United States.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, the FTC has initiated numerous investigations of and actions against companies that sell dietary supplements. The FTC has issued guidance to assist companies in understanding and complying with its substantiation requirement. We believe that we have adequate substantiation for all material advertising claims that we make for our products in the United States, and we believe that we have organized the documentation to support our advertising and promotional practices in compliance with these guidelines. However, no assurance can be given that the FTC would reach the same conclusion if it were to review or question our substantiation for our advertising claims in the United States.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FTC may enforce compliance with the law in a variety of ways, both administratively and judicially, using compulsory process, cease and desist orders, and injunctions. FTC enforcement can result in orders requiring, among other things, limits on advertising, corrective advertising, consumer redress, divestiture of assets, rescission of contracts, and such other relief as the agency deems necessary to protect the public. Violation of these orders could result in substantial financial or other penalties. Although we have not been the subject of any action by the FTC, no assurance can be given that the FTC will not question our advertising or other operations in the United States in the future. Any action in the future by the FTC could materially and adversely affect our ability to successfully market our products in the United States.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical Laboratory Improvement Act of 1967 and the Clinical Laboratory Improvement Amendments of 1988 (CLIA)</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The performance of laboratory diagnostic services is subject to extensive U.S. regulation, and many of these statutes and regulations have not been interpreted by the courts. CLIA extends federal oversight to virtually all physician practices performing clinical laboratory testing and to clinical laboratories operating in the United States by requiring that they be certified by the federal government or, in the case of clinical laboratories, by a federally approved accreditation agency. Standards for testing under CLIA are based on the complexity of the tests performed by the laboratory, with tests classified as &#8220;high complexity,&#8221; &#8220;moderate complexity,&#8221; or &#8220;waived.&#8221; Laboratories performing high-complexity testing are required to meet more stringent requirements than moderate-complexity laboratories. The sanction for failure to comply with CLIA requirements may be suspension, revocation or limitation of a laboratory&#8217;s CLIA certificate, which is necessary to conduct business, as well as significant fines and/or criminal penalties.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State and Laboratory Licensure </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to regulation under state law. State laws, including those of New Jersey and New York, require that laboratories and/or laboratory personnel meet certain qualifications, specify certain quality controls or require maintenance of certain records. For example, New York laws and regulations establish standards for: quality management systems; qualifications, responsibilities, and training; facility design and resource management; pre-analytic, analytic </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(including validation and quality control), and post-analytic systems; and quality assessments and improvements. The New York state laboratory laws and regulations are more stringent than CLIA. New York law mandates proficiency testing for laboratories licensed under New York law, regardless of whether such laboratories are located in New York. If a laboratory is out of compliance with New York statutory or regulatory standards, the New York State Department of Health(&#8220;NYSDOH&#8221;) may suspend, limit, revoke or annul the laboratory&#8217;s New York license, censure the holder of the license or assess civil money penalties. Statutory or regulatory noncompliance may result in a laboratory&#8217;s operator being found guilty of a misdemeanor under New York law. NYSDOH also must approve laboratory developed tests before the test is offered in New York. Should we be found out of compliance with New York or any other applicable laboratory standards of practice, we could be subject to such sanctions, which could harm our business. Applicable statutes and regulations could also be interpreted or applied by a prosecutorial, regulatory or judicial authority in a manner that would adversely affect our business. Potential sanctions for violation of these statutes and regulations include significant fines and the suspension or loss of various licenses, certificates and authorizations, which could have a material adverse effect on our business. In addition, compliance with future legislation could impose additional requirements on us, which may be costly.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Insurance Portability and Accountability Act</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Insurance Portability and Accountability Act (&#8220;HIPAA&#8221;) was designed to address issues related to the security and confidentiality of health information and to improve the efficiency and effectiveness of the healthcare system by facilitating the electronic exchange of information in certain financial and administrative transactions. These regulations apply to health plans and healthcare providers that conduct standard transactions electronically and healthcare clearinghouses (covered entities). Six such regulations include: (i) the Transactions and Code Sets Rule; (ii) the Privacy Rule; (iii) the Security Rule; (iv) the Standard Unique Employer Identifier Rule, which requires the use of a unique employer identifier in connection with certain electronic transactions; (v) the National Provider Identifier Rule, which requires the use of a unique healthcare provider identifier in connection with certain electronic transactions; and (vi) the Health Plan Identifier Rule, which required the use of a unique health plan identifier in connection with certain electronic transactions. We believe that we are in compliance in all material respects with each of the HIPAA Rules identified above.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Privacy Rule regulates the use and disclosure of protected health information (&#8220;PHI&#8221;) by covered entities. It also sets forth certain rights that an individual has with respect to his or her PHI maintained by a covered entity, such as the right to access or amend certain records containing PHI or to request restrictions on the use or disclosure of PHI. The Privacy Rule requires covered entities to contractually bind third parties, known as business associates, in the event that they perform an activity or service for or on behalf of the covered entity that involves the creation, receipt, maintenance, or transmission of PHI. We believe that we are in compliance in all material respects with the requirements of the HIPAA Privacy Rule.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 12, 2018, the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) issued a request for information (&#8220;RFI&#8221;) seeking input from the public on how the HIPAA regulations and the Privacy Rule, in particular, could be modified to amend existing, or impose additional, obligations relating to the processing of PHI. Subsequent to the RFI, on January 21, 2021, HHS published a notice of proposed rulemaking (&#8220;NPRM&#8221;) containing potential modifications to the Privacy Rule addressing standards that may impede the transition to value-based health care. We are monitoring the NPRM process. If modifications to the Privacy Rule are adopted, they may impact our compliance obligations under HIPAA.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Health Information Technology for Economic and Clinical Health Act (&#8220;HITECH&#8221;), which was enacted in February 2009, with regulations effective on September 23, 2013, strengthened and expanded the HIPAA Privacy and Security Rules and their restrictions on use and disclosure of PHI. HITECH includes, but is not limited to, prohibitions on exchanging PHI for remuneration and additional restrictions on the use of PHI for marketing. HITECH also fundamentally changes a business associate&#8217;s obligations by imposing a number of Privacy Rule requirements and a majority of Security Rule provisions directly on business associates that were previously only directly applicable to covered entities. Moreover, HITECH requires covered entities to provide notice to individuals, HHS, and, as applicable, the media when unsecured PHI is breached, as that term is defined by HITECH. Business associates are similarly required to notify covered entities of a breach. We believe our policies and procedures are fully compliant with HIPAA as modified by the HITECH requirements.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The administrative simplification provisions of HIPAA mandate the adoption of standard unique identifiers for healthcare providers. The intent of these provisions is to improve the efficiency and effectiveness of the electronic transmission of health information. The National Provider Identifier Rule requires that all HIPAA-covered healthcare providers, whether they are individuals or organizations, must obtain a National Provider Identifier (&#8220;NPI&#8221;) to identify themselves in standard HIPAA transactions. NPI replaces the unique provider identification number and other provider </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">numbers previously assigned by payers and other entities for the purpose of identifying healthcare providers in standard electronic transactions. The Company believes that it is in compliance with the HIPAA National Provider Identifier Rule in all material respects.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Health Plan Identifier (&#8220;HPID&#8221;) is a unique identifier designed to furnish a standard way to identify health plans in electronic transactions. The Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;) published the final rule adopting the HPID for health plans required by HIPAA on September 12, 2012. Effective October 31, 2014, CMS announced a delay, until further notice, in enforcement of regulations pertaining to health plan enumeration and use of the HPID in HIPAA transactions adopted in the HPID final rule. On October 28, 2019, CMS published a final rule rescinding the adopted standard unique HPID and implementation specifications and requirements for its use and other entity identifier and implementation specifications for its use, effective December 27, 2019. This delay remains in effect. We will continue to monitor future developments related to the HPID and respond accordingly.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of the HIPAA provisions could result in civil and/or criminal penalties, including significant fines and up to 10 years in prison. HITECH also significantly strengthened HIPAA enforcement by increasing the civil penalty amounts that may be imposed, requiring HHS to conduct periodic audits to confirm compliance and authorizing state attorneys general to bring civil actions seeking either injunctions or damages in response to violations of the HIPAA privacy and security regulations that affect the privacy of state residents.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total cost associated with meeting the ongoing requirements of HIPAA and HITECH is not expected to be material to our operations or cash flows. However, future regulations and interpretations of HIPAA and HITECH could impose significant costs on us.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the HIPAA regulations described above, numerous other data protection, privacy and similar laws govern the confidentiality, security, use, and disclosure of personal information. These laws vary by jurisdiction, but they most commonly regulate or restrict the collection, use, and disclosure of medical and financial information and other personal information. In the U.S., some state laws are more restrictive and, therefore, are not preempted by HIPAA. Penalties for violation of these laws may include sanctions against a laboratory&#8217;s licensure, as well as civil and/or criminal penalties.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Congress and state legislatures also have been considering new legislation relating to privacy and data protection. For example, on June 28, 2018, the California legislature passed the California Consumer Privacy Act (&#8220;CCPA&#8221;), which became effective January 1, 2020. The CCPA created new transparency requirements and granted California residents several new rights with regard to their personal information. In addition, in November 2020, California voters approved the California Privacy Rights Act (&#8220;CPRA&#8221;) ballot initiative, which introduced significant amendments to the CCPA and established and funded a dedicated California privacy regulator, the CPPA. The amendments introduced by the CPRA went into effect on January 1, 2023, and new implementing regulations are expected to be introduced by the CPPA. Failure to comply with the CCPA may result in, among other things, significant civil penalties and injunctive relief, or potential statutory or actual damages. In addition, California residents have the right to bring a private right of action in connection with certain types of incidents. These claims may result in significant liability and potential damages. We have implemented processes to manage compliance with the CCPA and continue to assess the impact of the CPRA on our business as additional information and guidance becomes available.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective August 14, 2020, the Substance Abuse and Mental Health Services Administration of HHS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">announced the finalization of proposed changes to the Confidentiality of Substance Use Disorder Patient Records regulation, 42 Code of Federal Regulations Part 2. This regulation protects the confidentiality of patient records relating to the identity, diagnosis, prognosis, or treatment that are maintained in connection with the performance of any federally assisted program or activity relating to substance use disorder education, prevention, training, treatment, rehabilitation, or research. Under the regulation, patient identifying information may only be released with the individual&#8217;s written consent, subject to certain limited exceptions. The latest changes to this regulation seek to better facilitate care coordination, while maintaining more stringent confidentiality of substance use disorder information. We have adopted changes to our policies and procedures necessary for compliance.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Genetic Privacy and Testing Laws</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to myriad laws designed to establish safeguards regarding the conduct of genomic testing and analysis and to protect against the misuse of genetic information and human biological specimens, collectively, &#8220;samples&#8221;, from which genetic information can be derived. These laws vary in their scope and in the nature of their requirements and restrictions. For example, certain genetic privacy laws prohibit the retention of samples after performing a genomic </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">analysis in addition to prohibiting the use or disclosure of genetic information for certain purposes, such as research, without appropriate informed consent from the individual or without sufficient anonymization. The applicability of such informed consent requirements may also depend on the identifiability of the genetic information or sample and the purposes of which it is used. Other laws may impose additional requirements, including requirements regarding institutional review board review and approval for certain research uses of genetic information or samples requirements to implement certain security controls in connection with the transfer of genetic information. We must comply with such genetic privacy and testing laws in our collection, use, disclosure, and retention of genetic information and samples.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Regulatory Oversight</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to regulation under various state, local, and international laws that include provisions governing, among other things, the formulation, manufacturing, packaging, labeling, advertising, and distribution of dietary supplements and OTC drugs. For example, Proposition 65 in the State of California is a list of substances deemed to pose a risk of carcinogenicity or birth defects at or above certain levels. If any such ingredient exceeds the permissible levels in a dietary supplement, cosmetic, or drug, the product may be lawfully sold in California only if accompanied by a prominent warning label alerting consumers that the product contains an ingredient linked to cancer or birth defect risk. Private attorney general actions as well as California attorney general actions may be brought against non-compliant parties and can result in substantial costs and fines.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reimbursement </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Billing for diagnostic services is complex and subject to extensive and non-uniform rules and administrative requirements. Depending on the billing arrangement and applicable law, we bill various payers, such as patients, insurance companies, Medicare, Medicaid, other government agencies and employer groups. Failure to accurately bill for our services could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We bill third-party payors, both commercial and government, using Current Procedural Terminology (&#8220;CPT&#8221;) codes, which are published by the American Medical Association. In April 2014, Congress passed the Protecting Access to Medicare Act of 2014 (&#8220;PAMA&#8221;), which included substantial changes to the way in which clinical laboratory services are priced and paid under Medicare. On June 23, 2016, CMS published the final rule implementing the reporting and rate-setting requirements. Under PAMA, laboratories that receive the majority of their Medicare revenue from payments made under the CLFS or the Physician Fee Schedule are required to report to CMS, beginning in 2017 and every three years thereafter (or annually for an advanced diagnostic laboratory test (&#8220;ADLT")), private payor payment rates and volumes for clinical diagnostic laboratory tests, or CDLTs. Laboratories that fail to report the required payment information may be subject to substantial civil monetary penalties. We do not believe that any of our tests meet the current definition of ADLTs. We therefore report private payor rates for our tests every three years.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required under PAMA, CMS uses the data reported by laboratories to develop Medicare payment rates for laboratory tests equal to the volume-weighted median of the private payor payment rates. For tests furnished on or after January 1, 2019, Medicare payments for CDLTs are based upon reported private payor rates. For a CDLT that is assigned a new or substantially revised CPT code, the initial payment rate is assigned using the gap-fill methodology, as under prior law.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On December 20, 2019, President Trump signed the Further Consolidated Appropriations Act, which included the Laboratory Access for Beneficiaries Act (&#8220;LAB Act&#8221;). The LAB Act delayed by one year the reporting of payment data under PAMA for CDLTs that are not ADLTs until the first quarter of 2021. The Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;), which was signed into law on March 27, 2020, delayed the reporting period by an additional year, until the first quarter of 2022. On December 10, 2021, the Protecting Medicare and American Farmers from Sequester Cuts Act (S. 610) further delayed the reporting requirement. On December 29, 2022, Section 4114 of Consolidated Appropriations Act, 2023 again delayed the next data reporting period for CDLTs that are not ADLTs. The next data reporting period of January 1, 2024 through March 31, 2024, will be based on the original data collection period of January 1, 2019 through June 30, 2019.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under PAMA, as amended by the LAB Act, any reduction to a particular payment rate resulting from the new methodology is limited to 10% per test per year in 2020 and to 15% per test per year in each of the years 2021 through 2023. The CARES Act delayed the 15% cut scheduled to take effect on January 1, 2021, for one year.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fraud and Abuse Laws and Regulations</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Existing U.S. laws governing federal healthcare programs, including Medicare and Medicaid, as well as similar state laws, impose a variety of broadly described fraud and abuse prohibitions on healthcare providers, including clinical laboratories. These laws are interpreted liberally and enforced aggressively by multiple government agencies, including the U.S. Department of Justice, OIG and various state agencies. Historically, the clinical laboratory industry has been the focus of major governmental enforcement initiatives. The U.S. government&#8217;s enforcement efforts have been conducted under regulations such as HIPAA, which includes several provisions related to fraud and abuse enforcement, including the establishment of a program to coordinate and fund U.S., state and local law enforcement efforts, and the Deficit Reduction Act of 2005, which includes requirements directed at Medicaid fraud, including increased spending on enforcement and financial incentives for states to adopt false claims act provisions similar to the U.S. False Claims Act. Amendments to the False Claims Act, and other enhancements to the U.S. fraud and abuse laws enacted as part of the ACA, have further increased fraud and abuse enforcement efforts and compliance risks. For example, the ACA established an obligation to report and refund overpayments from Medicare or Medicaid within 60 days of identification (whether or not paid through any fault of the recipient); failure to comply with this requirement can give rise to additional liability under the False Claims Act and Civil Monetary Penalties statute.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Anti-Kickback Statute prohibits knowingly providing anything of value in return for, or to induce the referral of, Medicare, Medicaid or other U.S. healthcare program business. Violations can result in imprisonment, fines, penalties, and/or exclusion from participation in U.S. healthcare programs. The OIG has published &#8220;safe harbor&#8221; regulations that specify certain arrangements that are protected from prosecution under the Anti-Kickback Statute if all conditions of the relevant safe harbor are met. Failure to fit within a safe harbor does not necessarily constitute a violation of the Anti-Kickback Statute; rather, the arrangement would be subject to scrutiny by regulators and prosecutors and would be evaluated on a case-by-case basis. Many states have their own Medicaid anti-kickback laws, and several states also have anti-kickback laws that apply to all payers (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., not just government healthcare programs).</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the OIG issues alerts and other guidance on certain practices in the healthcare industry that implicate the Anti-Kickback Statute or other fraud and abuse laws. OIG Special Fraud Alerts and Advisory Opinions relevant to the Company set forth a number of practices allegedly engaged in by some clinical laboratories and healthcare providers that raise issues under the U.S. fraud and abuse laws, including the Anti-Kickback Statute. These practices include: (i) providing employees to furnish valuable services for physicians (other than collecting patient specimens for testing) that are typically the responsibility of the physicians&#8217; staff; (ii) offering certain laboratory services at prices below fair market value in return for referrals of other tests that are billed to Medicare at higher rates; (iii) providing free testing to physicians&#8217; managed care patients in situations where the referring physicians benefit from such reduced laboratory utilization; (iv) providing free pickup and disposal of biohazardous waste for physicians for items unrelated to a laboratory&#8217;s testing services; (v) providing general-use facsimile machines or computers to physicians that are not exclusively used in connection with the laboratory services; (vi) providing free testing for healthcare providers, their families and their employees (i.e., so-called &#8220;professional courtesy&#8221; testing); (vii) compensation paid by laboratories to physicians for blood specimen processing and for submitting patient data to registries; and (viii) the provision of discounts on laboratory services billed to customers in return for the referral of U.S. healthcare program business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Anti-Kickback Statute, in October 2018, the U.S. enacted the Eliminating Kickbacks in Recovery Act of 2018 (&#8220;EKRA&#8221;), as part of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (the &#8220;SUPPORT Act&#8221;). EKRA is an all-payer anti-kickback law that makes it a criminal offense to pay any remuneration to induce referrals to, or in exchange for, patients using the services of a recovery home, a substance use clinical treatment facility, or laboratory. Although it appears that EKRA was intended to reach patient brokering and similar arrangements to induce patronage of substance use recovery and treatment, the language in EKRA is broadly written. As drafted, an EKRA prohibition on incentive compensation to sales employees is inconsistent with the federal anti-kickback statute and regulations, which permit payment of employee incentive compensation, a practice that is common in the industry. Only one court has addressed the application of EKRA. That case was decided by the United States District Court of Hawaii and involved a lawsuit between a laboratory and an employee. The Court ruled that the commission-based compensation provisions of the laboratory employee&#8217;s contract did not violate EKRA. Although this may be a favorable interpretation of EKRA for laboratory compensation structures, we cannot be assured that courts in our jurisdiction will reach the same conclusion or that the decision will not be overturned if there is an appeal. Significantly, EKRA permits the U.S. Department of Justice to issue regulations clarifying EKRA&#8217;s exceptions or adding additional exceptions, but such regulations have not yet been issued. We are working through our trade association to address the scope of EKRA and are seeking clarification or correction.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enrollment and re-enrollment in U.S. healthcare programs, including Medicare and Medicaid, are subject to certain program integrity requirements intended to protect the programs from fraud, waste, and abuse. In September 2019, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS published a final rule implementing program integrity enhancements to provider enrollment requiring Medicare, Medicaid, and Children&#8217;s Health Insurance Program (&#8220;CHIP&#8221;) providers and suppliers to disclose on an enrollment application or a revalidation application any current or previous direct or indirect affiliation with a provider or supplier that (1) has uncollected debt; (2) has been or is subject to a payment suspension under a federal health care program; (3) has been or is excluded by the OIG from Medicare, Medicaid, or CHIP; or (4) has had its Medicare, Medicaid, or CHIP billing privileges denied or revoked. This rule permits CMS to deny enrollment based on such an affiliation when CMS determines that the affiliation poses an undue risk of fraud, waste, or abuse. CMS is phasing in this new affiliation disclosure requirement.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under another U.S. statute, known as the Stark Law or &#8220;physician self-referral&#8221; prohibition, physicians who have a financial or a compensation relationship with a commercial laboratory may not, unless an exception applies, refer Medicare or Medicaid patients for testing to the laboratory, regardless of the intent of the parties. Similarly, laboratories may not bill Medicare or Medicaid for services furnished pursuant to a prohibited self-referral. There are several Stark Law exceptions that are relevant to arrangements involving clinical laboratories, including: (i) fair market value compensation for the provision of items or services; (ii) payments by physicians to a laboratory for commercial laboratory services; (iii) ancillary services (including laboratory services) provided within the referring physician&#8217;s own office, if certain criteria are satisfied; (iv) physician investment in a company whose stock is traded on a public exchange and has stockholder equity exceeding $75.0 million; and (v) certain space and equipment rental arrangements that are set at a fair market value rate and satisfy other requirements. Many states have their own self-referral laws as well, which in some cases apply to all patient referrals, not just government reimbursement programs.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the OIG and CMS published final rules to amend the regulations implementing the Anti-Kickback Statute and the Stark Law, respectively. The amendments are primarily intended to alleviate perceived impediments to coordinated care and value-based compensation arrangements through new safe harbors to the Anti-Kickback Statute and new exceptions to the Stark Law and have varying degrees of applicability to laboratories. The CMS final rule incorporates laboratories and permits support for value-based arrangements, under certain conditions for purposes of the Stark Law. However, the OIG final rule excludes laboratories from protection under the Anti-Kickback Statute safe harbors for value-based arrangements.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a variety of other types of U.S. and state fraud and abuse laws, including laws prohibiting submission of false or fraudulent claims. We seek to conduct our business in compliance with all U.S. and state fraud and abuse laws. We are unable to predict how these laws will be applied in the future, and no assurances can be given that our arrangements will not be subject to scrutiny under such laws. Sanctions for violations of these laws may include exclusion from participation in Medicare, Medicaid, and other U.S. or state healthcare programs, significant criminal and civil fines and penalties, and loss of licensure. Any exclusion from participation in a U.S. healthcare program, or material loss of licensure, arising from any action by any federal or state regulatory or enforcement authority, would likely have a material adverse effect on our business. In addition, any significant criminal or civil penalty resulting from such proceedings could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal competition for our lab diagnostic services are commercial laboratories, such as Quest Diagnostics Incorporated and Laboratory Corporation of America Holdings, both of which have significant infrastructures and resources to support their diagnostic processing services. In addition, we compete with large, multispecialty group medical clinics and health systems. Academic medical university-based clinics may also provide in-house clinical laboratories offering COVID-19 and other RPP Molecular tests. Additionally, we compete against regional clinical laboratories providing diagnostic services, including Interpace Biosciences, Inc. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of companies entering the personal genomics market has increased in recent years. We face competition from other companies attempting to capitalize on the same, or similar, opportunities as we are, including those with existing diagnostic, laboratory services and other companies entering the personal genetics market with new offerings such as direct access and/or consumer self-pay tests and genetic interpretation services. Some of our current and potential competitors have longer operating histories and greater financial, technical, marketing and other resources than we do. These factors may allow our competitors to respond more quickly or efficiently than we can to new or emerging technologies. These competitors may engage in more extensive research and development efforts, undertake more far-reaching marketing campaigns and adopt more aggressive pricing policies, which may allow them to build larger customer bases than we will be able to achieve. Our competitors may develop products or services that are similar to our products </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and services or that achieve greater market acceptance than our products and services. This could attract customers away from our services and reduce our market share.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pharmaceutical industry is characterized by intense competition and rapid innovation. Our potential competitors include major multi-national pharmaceutical established biotechnology companies, specialty pharmaceutical companies, and universities and other research institutions. Many of our competitors have substantially greater financial, technical, and other resources, such as larger research and development staffs, established manufacturing capabilities and facilities, and experienced marketing organizations with well-established sales forces. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large, established companies that have greater resources. Mergers and acquisitions in the biotechnology and pharmaceutical industries may result in even more resources being concentrated on our competitors. Competition may increase further as a result of advances in the commercial applicability of genome editing or other new technologies and greater availability of capital for investment in these industries. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient enrollment for participation in clinical trials, as well as in acquiring technologies complementary to, or necessary for, our development programs. Our commercial opportunities could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient to administer, have broader acceptance and higher rates of reimbursement by third-party payors, or are less expensive than any product candidates that we may develop. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market. Additionally, new technologies developed by our competitors may render our product candidates uneconomical or obsolete, and we may not be successful in marketing any product candidates we may develop against competitor products. The key competitive factors affecting the success of our product candidates are likely to be their efficacy, safety, and availability of reimbursement.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete with other contract manufacturers of OTC drug and dietary supplement products. These suppliers range widely in size. We compete primarily on the basis of price, quality and service. Management believes that our manufacturing capacity and abilities offer a significant advantage over many of our competitors in the full-service contract development and manufacturing industry. We have over 20 years of manufacturing experience and industry know how in large scale batch production of OTC lozenge products. To the extent that any of our competitors are able to offer better prices, quality and/or services, however, we could lose customers and our sales and margins may decline.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The OTC healthcare products and dietary supplements industries are highly competitive. Many of the participants in these industries have substantially greater capital resources, technical staffs, facilities, marketing resources, product development, and distribution experience than we do. We believe that our ability to continue to compete in these industries will depend on a number of factors, including product quality and price, availability, speed to market, consumer marketing, reliability, credit terms, brand name recognition, delivery time and post-sale service and support. However, our failure to appropriately and timely respond to consumer preferences and demand for new products could significantly harm our business, financial condition and results of operations. Furthermore, unfavorable publicity or consumer perception of products we develop and commercialize could have a material adverse effect on our business and operations. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Management</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider talent attraction, development, engagement and retention a key driver to our business success. We are committed to developing a comprehensive, cohesive and positive company culture and employee experience. At December 31, 2023, we employed 113 full-time employees, of which 47 were engaged in our contract manufacturing operations and 82 employees were providing diagnostic services.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We emphasize a number of measures and objectives in managing our human capital assets, including, among others, employee safety and wellness, talent acquisition and retention, employee engagement, development and training, diversity and inclusion, and compensation. None of our employees are represented by a labor organization or under any collective-bargaining arrangements. We consider our employee relations to be good.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to fostering an environment where all employees can grow and thrive. A diverse workforce results in a broader range of perspectives, helping drive our commitment to innovation. Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and new employees, advisors and consultants. The principal purposes of our cash and equity incentive plans are to attract, retain and reward personnel through the granting of cash-based and stock-based compensation awards, in order to increase </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stockholder value and the success of our Company by motivating such individuals to perform to the best of their abilities and achieve our objectives.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our business is fundamentally connected to the well-being of our employees. We understand that good health leads to better performance. We provide our employees and their families with access to a variety of flexible and convenient health and wellness programs, health reimbursement accounts and retirement savings plan Our health and wellness programs include benefits that provide support to manage events that may require time away from work or that impact their financial well-being and that support their physical and mental health by providing tools and resources to help them improve or maintain their health status and encourage engagement in healthy behaviors. We regularly evaluate our benefits package to make modifications that are aligned with the competitive landscape, legislative changes, and the unique needs of our business and culture.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Information</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were initially organized in Nevada in July 1989. Effective June 18, 2015, we changed our state of incorporation from the State of Nevada to the State of Delaware. Our principal executive offices are located at 711 Stewart Avenue, Suite 200, Garden City, New York 11530 and our telephone number is 215-345-0919.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Where You Can Find Other Information</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file periodic and current reports, proxy statements and other information with the Securities and Exchange Commission (the &#8220;SEC&#8221;). We make available on our website (www.ProPhaseLabs.com) free of charge our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to or exhibits included in those reports as soon as reasonably practical after we electronically file such materials with or furnish them to the SEC. Information appearing on our website is not part of this Annual Report. In addition, the SEC maintains an Internet site (www.sec.gov) that contains reports, proxy and information statements regarding issuers that file electronically with the SEC, including the Company.</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_19"></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.&#160;&#160;&#160;&#160;Risk Factors</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion addresses risks and uncertainties that could cause, or contribute to causing, actual results to differ from our expectations in material ways. In evaluating our business, investors should pay particular attention to the risks and uncertainties described below and in other sections of this Annual Report and in our subsequent filings with the SEC. These risks and uncertainties, or other events that we do not currently anticipate or that we currently deem immaterial, may also affect our results of operations, cash flows and financial condition. The trading price of our common stock could also decline due to any of these risks. The following information should be read in conjunction with Part II, Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and the financial statements and related notes included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8221; of this Annual Report.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business Generally</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have incurred significant losses and accounts receivable, have limited cash on hand, and anticipate that we may continue to incur losses for the foreseeable future.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have had limited history of profitability. While we were profitable for years ended December 31, 2022 and 2021 due to the diagnostic services that we provided, there is no certainty that we will be profitable in future years. We incurred net losses of approximately $16.8 million as of December 31, 2023 and expect to continue to incur signif</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">icant operating and capital expenditures. We anticipate that our expenses will increase substantially if, and as we: </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">continue our current research programs and our preclinical and clinical development of product candidates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">initiate preclinical studies and clinical trials for any other product candidates we identify and choose to develop; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">expand, maintain, enforce and/or defend our intellectual property; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">seek marketing approvals for any of our product candidates that successfully complete clinical trials; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">hire additional clinical, quality control and scientific personnel; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">establish, expand or contract for manufacturing capabilities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">add operational, financial and management information systems and personnel, including personnel to support our product candidate development; and</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">acquire or in-license other technologies</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Because of the numerous risks and uncertainties associated with our business, we are unable to predict the extent of any future losses or when we will become profitable, if at all. Even if we do become profitable, we may not be able to sustain or increase our profitability on a quarterly or annual basis. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">With the significant reduction of our diagnostic services and as we fund capital expenditures, we also expect to experience limited cash flow for the foreseeable future. We cannot guarantee that revenues from the genomics business and the contract manufacturing business will be sufficient to supplant the reduction in the diagnostic services revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If these revenues are not sufficient to replace the revenues from our diagnostic services, then the Company may continue to suffer yearly losses. As a result, we will need to generate significant revenues in order to achieve profitability or raise significant capital. We may not be able to generate these revenues or raise capital in the future. Our failure to achieve or maintain profitability could negatively impact the value of our common stock. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Refer to risk factors under the section titled "Risks Related to Our Diagnostic Business" for more information relating to risks associated with our diagnostic services and the significant reduction of such services. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have limited cash on hand, and we will need substantial additional funding and if we are unable to raise additional capital when needed, we may need to incur indebtedness or issue common stock or other securities to finance our operations.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of December 31, 2023, year-to-date cash used by operating activities was approximately $11.3 million and cash and cash equivalents and marketable securities available for sale were approximately $4.7 million. The Company believes that it has sufficient cash on hand to fund its operations into March of 2025. The exact duration that our liquidity will be sufficient to fund operations depends upon many factors, some of which are outside the control of the Company and is difficult to predict. Our future capital requirements will depend on, and could increase significantly as a result of, many factors, including: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">the scope, progress, results and costs of clinical trials, drug discovery, preclinical development, and laboratory testing for our wholly owned and partnered product candidates; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">the scope, prioritization and number of our research and development programs; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">the costs, timing and outcome of regulatory review of our products or product candidates; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">the costs of establishing and maintaining a supply chain for the development and manufacture of our customer's  or our product candidates; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">the success of our collaborations with our third-party collaborators; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">our ability to establish and maintain additional collaborations on favorable terms, if at all; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">the achievement of milestones or occurrence of other developments that trigger payments under any additional collaboration agreements we obtain; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">the extent to which we are obligated to reimburse, or entitled to reimbursement of, clinical trial costs under future collaboration agreements, if any; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending intellectual property-related claims; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">the costs of fulfilling our obligations under licensing agreements; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">the extent to which we acquire or in-license other product candidates and technologies; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">the costs of expanding our manufacturing capabilities; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">the costs of establishing or contracting for sales and marketing capabilities if we obtain regulatory approvals to market our product candidates; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">our ability to establish and maintain healthcare coverage and adequate reimbursement. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, as of December 31, 2023, we had a total of approximately $36.3 million in accounts receivable. These accounts receivable consist primarily of amounts due from government agencies and healthcare insurers, and there is no guarantee we will ever collect the balances.  To the extent that we do not generate sufficient cash from operations or do not collect our accounts receivable, our cash balances will decline. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the event our available cash is insufficient to support such initiatives, we may need to incur indebtedness or issue common stock or other securities to finance our operations. Any additional fundraising efforts may divert our management from their day-to-day activities, which may adversely affect our ability to develop and commercialize our products or product candidates or expand our manufacturing capabilities. We cannot guarantee that future financing will be available in sufficient amounts or on terms acceptable to us, if at all. Moreover, the terms of any financing may adversely affect the holdings or the rights of our stockholders and the issuance of additional securities, whether equity or debt, by us, or the possibility of such issuance, may cause the market price of our shares to decline. The sale of additional equity or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">convertible securities would dilute all of our stockholders and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a stockholder. The incurrence of indebtedness would result in increased fixed payment obligations and we may be required to agree to certain restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. We could also be required to seek funds through arrangements with collaborators or otherwise at an earlier stage than otherwise would be desirable and we may be required to relinquish rights to some of our technologies or product candidates or otherwise agree to terms unfavorable to us, any of which may have a material adverse effect on our business, operating results and prospects. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If we are unable to obtain funding on a timely basis, we may be required to significantly curtail, delay or discontinue one or more of our research or development programs or the commercialization of any product or product candidate, or be unable to expand our manufacturing capabilities or operations or otherwise capitalize on our business opportunities, as desired, which could materially affect our business, financial condition and results of operations. </span></div><div style="text-indent:27.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will face legal, reputational, and financial risks if we fail to protect our customer data from security breaches or cyberattacks. Changes in laws or regulations relating to privacy or the protection or transfer of data relating to individuals, or any actual or perceived failure by us to comply with such laws and regulations or any other obligations relating to privacy or the protection or transfer of data relating to individuals, could adversely affect our business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive and store a large volume of personally identifiable information, genetic information, and other data relating to our customers, as well as other personally identifiable information and other data relating to individuals such as our employees. Security breaches, employee malfeasance, or human or technological error could lead to potential unauthorized disclosure of our customers&#8217; personal information. Even the perception that the privacy of personal information is not satisfactorily protected or does not meet regulatory requirements could inhibit sales of our solutions and any failure to comply with such laws and regulations could lead to significant fines, penalties or other liabilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increased global information technology security threats and more sophisticated and targeted computer crime pose a risk to the security of our systems and networks and the confidentiality, availability, and integrity of our data. There have been several recent, highly publicized cases in which organizations of various types and sizes have reported the unauthorized disclosure of customer or other confidential information, as well as cyberattacks involving the dissemination, theft, and destruction of corporate information, IP, cash, or other valuable assets. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have also been several highly publicized cases in which hackers have requested &#8220;ransom&#8221; payments in exchange for not disclosing customer or other confidential information or for not disabling the target company&#8217;s computer or other systems. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A security compromise of our information systems or of those of businesses with whom we interact that results in confidential information being accessed by unauthorized or improper persons could harm our reputation and expose us to regulatory actions, customer attrition, remediation expenses, disruption of our business, and claims brought by our customers or others for breaching contractual confidentiality and security provisions or data protection laws. Breaches of health information and/or personal data may be extremely expensive to remediate, may prompt federal or state investigation, fines, civil and/or criminal sanctions and significant reputational damage. Monetary damages imposed on us could be significant and not covered by our liability insurance. Techniques used by bad actors to obtain unauthorized access, disable or degrade service, or sabotage systems evolve frequently and may not immediately produce signs of intrusion, and we may be unable to anticipate these techniques or to implement adequate preventative measures. In addition, a security breach could require that we expend substantial additional resources related to the security of our information systems and providing required breach notifications, diverting resources from other projects and disrupting our businesses. If we experience a data security breach, it could result in increased costs or loss of revenue; our reputation could be damaged; and we could be subject to additional litigation, regulatory risks and other business losses.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A security breach or privacy violation that leads to unauthorized disclosure or loss of unauthorized use or modification of, or that prevents access to or otherwise impacts the confidentiality, security, or integrity of, sensitive, confidential, or proprietary information we or our third-party service providers maintain or otherwise process, could require us to comply with breach notification laws, and cause us to incur significant costs for remediation, fines, penalties, notification to individuals, media and governmental authorities, implementation of measures intended to repair or replace systems or technology, and to prevent future occurrences, potential increases in insurance premiums, and forensic security audits or investigations. Our failure, or the failure by our third-party providers on our platform, to comply with applicable laws or regulations or any other obligations relating to privacy, data protection, or information security, or any compromise of security that results in unauthorized access to, or use or release of personally identifiable information or other data </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">relating to our customers, or other individuals, or the perception that any of the foregoing types of failure or compromise have occurred, could damage our reputation, discourage new and existing customers from using our platform, or result in fines, investigations, or proceedings by governmental agencies and private claims and litigation, any of which could adversely affect our business, financial condition, and results of operations. Even if not subject to legal challenge, the perception of privacy concerns, whether or not valid, may harm our reputation and brand and adversely affect our business, financial condition, and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our failure to manage our growth successfully could harm our growth and operating results.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our sale of the Cold-EEZE&#8482; business in March 2017, we have actively explored and pursued new product technologies, applications, product line extensions and other new product and business opportunities. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, we purchased our first CLIA licensed laboratory in Old Bridge, New Jersey, where we offered a variety of important medical tests, including, among others, COVID-19 diagnostic testing and Influenza A and B. In December 2020, we expanded our diagnostic services to a second location in Garden City, New York. In August 2021, we acquired Nebula, a privately-owned personal genomics company. We have transitioned Nebula&#8217;s whole genome sequencing services into the area where clinical diagnostic services were offered at our CLIA-certified molecular testing laboratories. In March 2022, we formed ProPhase Biopharma, Inc. for the licensing, development and commercialization of novel drugs, dietary supplements, and compounds. We may in the future consider and pursue investments and acquisitions in other sectors and industries.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have and will continue to incur significant expenses as we grow our new businesses. In order for us to be profitable, we must generate sufficient revenue to cover our expenses. There can be no assurance that our different business lines will succeed or that we will be successful in initiating or acquiring any new lines of business in the future, or that any such new business lines will achieve profitability.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our businesses are subject to significant competitive pressures.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of companies entering the personal genomics market has increased in recent years. We face competition from other companies attempting to capitalize on the same, or similar, opportunities as we are, including those with existing diagnostic, laboratory services and other companies entering the personal genetics market with new offerings such as direct access and/or consumer self-pay tests and genetic interpretation services. Some of our current and potential competitors have longer operating histories and greater financial, technical, marketing and other resources than we do. These factors may allow our competitors to respond more quickly or efficiently than we can to new or emerging technologies. These competitors may engage in more extensive research and development efforts, undertake more far-reaching marketing campaigns and adopt more aggressive pricing policies, which may allow them to build larger customer bases than we will be able to achieve. Our competitors may develop products or services that are similar to our products and services or that achieve greater market acceptance than our products and services. This could attract customers away from our services and reduce our market share.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pharmaceutical industry is characterized by intense competition and rapid innovation. Our potential competitors include major multi-national pharmaceutical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">companies, established biotechnology companies, specialty pharmaceutical companies, and universities and other research institutions. Many of our competitors have substantially greater financial, technical, and other resources, such as larger research and development staffs, established manufacturing capabilities and facilities, and experienced marketing organizations with well-established sales forces. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large, established companies that have greater resources. Mergers and acquisitions in the biotechnology and pharmaceutical industries may result in even more resources being concentrated on our competitors. Competition may increase further as a result of advances in the commercial applicability of genome editing or other new technologies and greater availability of capital for investment in these industries. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient enrollment for participation in clinical trials, as well as in acquiring technologies complementary to, or necessary for, our development programs. Our commercial opportunities could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient to administer, have broader acceptance and higher rates of reimbursement by third-party payors, or are less expensive than any product candidates that we may develop. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, new technologies developed by our competitors may render our product candidates uneconomical or obsolete, and we may not be successful in marketing any product candidates we may develop against competitor products. The key competitive factors affecting the success of our product candidates are likely to be their efficacy, safety, and availability of reimbursement.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete with other contract manufacturers of OTC drug and dietary supplement products. These suppliers range widely in size. We compete primarily on the basis of price, quality and service. Management believes that our manufacturing capacity and abilities offer a significant advantage over many of our competitors in the full-service contract development and manufacturing industry. We have over 20 years of manufacturing experience and industry know how in large scale batch production of OTC lozenge products. To the extent that any of our competitors are able to offer better prices, quality and/or services, however, we could lose customers and our sales and margins may decline.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The OTC healthcare products and dietary supplements industries are highly competitive. Many of the participants in these industries have substantially greater capital resources, technical staffs, facilities, marketing resources, product development, and distribution experience than we do. We believe that our ability to continue to compete in these industries will depend on a number of factors, including product quality and price, availability, speed to market, consumer marketing, reliability, credit terms, brand name recognition, delivery time and post-sale service and support. However, our failure to appropriately and timely respond to consumer preferences and demand for new products could significantly harm our business, financial condition and results of operations. Furthermore, unfavorable publicity or consumer perception of products we develop and commercialize could have a material adverse effect on our business and operations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unfavorable global economic conditions, including any adverse macroeconomic conditions or geopolitical events, including a pandemic, epidemic or infectious disease outbreak, the conflict in Ukraine or Gaza Strip, and bank failures affecting the financial services industry, could adversely affect our business, financial condition, results of operations or liquidity, either directly or through adverse impacts on certain of the third parties that we rely upon for our business operations.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results of operations could be adversely affected by general conditions in the global economy and in the global financial markets, including but not limited to a pandemic, epidemic or infectious disease outbreak such as COVID-19 pandemic, the conflict in Ukraine or Gaza Strip, and bank failures affecting the financial services industry. Global economic and business activities continue to face widespread uncertainties, and global credit and financial markets have experienced extreme volatility and disruptions in the past several years, including severely diminished liquidity and credit availability, rising inflation and monetary supply shifts, rising interest rates, labor shortages, declines in consumer confidence, declines in economic growth, increases in unemployment rates, recession risks, and uncertainty about economic and geopolitical stability. A severe or prolonged economic downturn, or additional global financial or political crises, could result in a variety of risks to our business, including delayed clinical trials or preclinical studies, delayed approval of our product candidates, delayed ability to obtain patents and other intellectual property protection, weakened demand for our product or product candidates, if approved, or our ability to raise additional capital when needed on acceptable terms, if at all. The extent of the impact of these conditions on our operational and financial performance, including our ability to execute our business strategies and initiatives in the expected timeframe, as well as that of third parties upon whom we rely, will depend on future developments which are uncertain and cannot be predicted. A weak or declining economy also could strain our suppliers, possibly resulting in supply disruption. Any of the foregoing could harm our business and we cannot anticipate all of the ways in which the current economic climate and financial market conditions could adversely impact our business. Furthermore, our stock price may decline due in part to the volatility of the stock market and the general economic downturn.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disruptions to our supply chain could materially and adversely affect our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disruptions to our supply chain, including our access to testing supplies and personal protective equipment for our diagnostic services business, materials and equipment (such as our saliva collections kits) necessary for our personal genomics business, and raw materials and product components necessary for our manufacturing operations, could have a material impact on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have long-term contracts with most of our suppliers. Although we maintain relationships with suppliers with the objective of ensuring that we have adequate supply for the delivery of our products and services, increases in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">demand for such items and services can result in shortages and higher costs. Our suppliers may not be able to meet our delivery schedules. Further, we may experience shortages in certain items as a result of limited availability, increased demand, pandemics (such as the COVID-19 pandemic), epidemics or other infectious disease outbreaks, weather conditions and natural disasters, global economic conditions, as well as other factors outside of our control.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic adversely impacted, and it or another pandemic, epidemic or infectious disease outbreak may in the future adversely impact, third parties that are critical to our businesses, including vendors, suppliers, and business partners. While our businesses have not been significantly negatively impacted up to this point by the COVID-19 pandemic,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">it is difficult if not impossible to predict whether and how we could be impacted by the COVID-19 pandemic, or another pandemic, epidemic or infectious disease outbreak, in the future.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increases in the price of testing supplies, equipment and raw materials needed for our businesses and costs associated with doing business could materially and adversely affect our business, financial condition and results of operation</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">s. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase certain materials and equipment (such as our saliva collections kits) for our personal genomics business and certain key raw materials and product components for our manufacturing operations.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the price of these supplies, equipment, raw materials, and components were to increase significantly, we may not be able to pass on such increases to customers who use our services or purchase our products, which could have a material adverse impact on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our freight costs may also increase due to factors such as limited carrier availability, increased fuel costs, increased compliance costs associated with new or changing government regulations, pandemics (such as the COVID-19 pandemic), epidemics or other infectious disease outbreaks, or inflation. Higher prices for natural gas, propane, electricity and fuel may also increase our production and delivery costs. The prices charged for our products may not reflect changes in our packaging material, freight, tariff and energy costs at the time they occur, or at all.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The adulteration of key testing materials and raw materials needed for our businesses could materially and adversely affect our business, financial condition and results of operations. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are reliant upon the supply of genomics testing materials and raw materials that meet our specifications and the specifications of third parties for whom we manufacture. If any genomics testing material or raw material is adulterated and does not meet our specifications or third parties&#8217; specifications, it could significantly impact our ability to perform genomic services or manufacture products and could materially and adversely impact our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to product liability claims.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a direct marketer and manufacturer of products designed for human consumption, we are subject to product liability claims if the use of our products or the products that we manufacture for third parties are alleged to have resulted in injury or to include inadequate instructions for use or inadequate warnings concerning possible side effects and interactions with other substances. Our current products and the products that we currently manufacture for third parties are not subject to pre-market regulatory approval in the United States and could contain contaminated substances.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we currently maintain product liability insurance, a successful claim brought against us related to our branded products or products that we manufacture for third parties in excess of, or outside of, our existing insurance coverage, could result in increased costs and could adversely affect our reputation with customers, which could in turn materially adversely affect our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may require additional capital to support our growing personal genomics business, product development and commercialization programs, and biopharmaceutical business, but additional funding may not be available to us on acceptable terms, or at all.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of capital that may be needed to support our various businesses will depend on many factors which may include, but are not limited to (i) the revenue we generate from our personal genomics products and services, drug and dietary supplement lines, and contract manufacturing services; (ii) the expenses we incur in growing these businesses and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">services;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) the cost involved in applying for and obtaining FDA, international regulatory or other technical approvals, if required; and (iv) whether we elect to establish partnering or other strategic arrangements for the development, sales, manufacturing and marketing of our products and services.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from our various businesses may not generate all the funds we need to support the growth of these businesses. To the extent that we do not generate sufficient cash from operations, we may, in the short and long-term, seek to raise capital through the issuance of equity securities or through other financing sources. To the extent that we seek to raise additional funds by issuing equity securities, our stockholders may experience significant dilution. Any debt financing, if available, may include financial and other covenants that could restrict our use of the proceeds from such financing or impose other business and financial restrictions on us. In addition, we may consider alternative approaches such as licensing, joint venture, or partnership arrangements to provide long-term capital. Additional funding may not be available to us on acceptable terms, or at all. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adverse credit market conditions may significantly affect our access to capital, cost of capital and ability to meet liquidity needs.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disruptions, uncertainty or volatility in the credit markets could adversely impact the availability and cost of credit to us in the future. For example, the credit and financial markets may be adversely affected by the war in Ukraine and measures taken in response thereto. If the credit markets are not favorable, we may be forced to delay raising capital or pay unattractive interest rates, which could increase our interest expense, decrease our profitability and significantly reduce our financial flexibility. Longer-term disruptions in the capital and credit markets as a result of uncertainty, changing or increased regulation, reduced alternatives or failures of significant financial institutions could adversely affect our access to liquidity needed for our business. Any disruption could require us to take measures to conserve cash until the markets stabilize or until alternative credit arrangements or other funding for our business needs can be arranged. Such measures could include deferring capital expenditures or other discretionary uses of cash. Overall, our results of operations, financial condition and cash flows could be materially adversely affected by disruptions in the credit markets.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">System failures could adversely affect our results of operations and financial condition.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Like many companies, our business is highly dependent upon our information technology infrastructure (websites, accounting and manufacturing applications, and product and customer information databases) to manage effectively and efficiently our operations, including order entry, customer billing, accurate tracking of purchases and volume incentives and managing accounting, finance and manufacturing operations. The occurrence of a natural disaster, security breach or other unanticipated problem could result in interruptions in our day-to-day operations that could adversely affect our business. A long-term failure or impairment of any of our information systems could have a material adverse effect on our results of operations and financial condition.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be successful without our key personnel.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends, in part, upon the continued service of key personnel, such as Mr. Ted Karkus, Chairman and Chief Executive Officer, and certain managers and strategists within the Company. The loss of the services of any one of them could have a material adverse effect on us.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to be successful, we must retain and motivate executives and other key employees, including those in managerial, technical, marketing and health product positions. In particular, our product generation efforts depend on hiring and retaining qualified health and science professionals. Competition for skilled employees who can perform the services that we require is intense and hiring, training, motivating, retaining and managing employees with the skills required is time-consuming and expensive. If we are not able to hire sufficient professional staff to support our operations, or to train, motivate, retain and manage the employees we do hire, it could have a material adverse effect on our business operations or financial results.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be successful in executing our growth strategy to identify, discover, develop, in-license or acquire additional product candidates or technologies, and our growth strategy may not deliver the anticipated results or we may refine or otherwise alter our growth strategy. We may seek to acquire businesses or undertake business combinations, collaborations or other strategic transactions which may not be successful or on favorable terms, if at all, and we may not realize the intended benefits of such transactions.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have acquired or in-licensed certain of our existing diagnostic tests, such as BE-Smart Esophageal Pre-Cancer diagnostic screening test, and product candidates, such as Linebacker LB-1 and LB-2. As part of our strategy, we plan to continue to identify products, diagnostic tests, product candidates or technologies that we believe are complementary to our existing products, diagnostic tests, and product candidates. We may do this through our internal discovery program, or by acquiring the rights to products, diagnostic tests, product candidates, and technologies through a variety of transaction types, including in-licensing, strategic transactions, mergers or acquisitions. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research programs and business development efforts to identify new products, diagnostic tests, product candidates, and technologies require substantial technical, financial, and human resources. We may focus our efforts and resources on potential products, diagnostic tests, product candidates, technologies or businesses that ultimately prove to be unsuccessful. Our research programs and business development efforts, including businesses or technology acquisitions, collaborations or licensing attempts, may fail to yield additional complementary or successful products, diagnostic tests, and product candidates for clinical development and commercialization or successful business combinations for a number of reasons, including, but not limited to, the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">our research or business development methodology or search criteria and process may be unsuccessful in identifying potential product candidates or businesses with a high probability of success for development progression;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">we may not be able or willing to assemble sufficient resources or expertise to in-license, acquire or discover additional products, diagnostic tests, and product candidates, acquire businesses or undertake business combinations, collaborations, or other strategic transactions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">we may not be able to agree to acceptable terms with potential licensors or other partners or with respect to business acquisitions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">we may incur substantial liabilities as part of an acquisition or merger that may not be offset by the benefits of the acquired assets or the synergies we hope to realize; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">any product candidates or technologies to which we acquire the rights or that we discover may not allow us to leverage our expertise and our development and commercial infrastructure as currently expected.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we cannot be certain that such discovery of, or transaction related to, targeted products, diagnostic tests product candidates or technologies will be on favorable terms; or that, following any such discovery or transaction, we will be able to realize the intended benefits of it. The consummation or performance of any acquisition, business combination, collaboration or other strategic transaction we may undertake in furtherance of our growth strategy or any refined or otherwise altered strategy, may involve additional risks, such as difficulties in assimilating different workplace cultures, retaining personnel and integrating operations, which may be geographically dispersed, increased costs, exposure to liabilities, incurrence of indebtedness, or use a substantial portion of our available cash for all or a portion of the consideration or cause dilution to our existing stockholders if we issue equity securities for all or a portion of the consideration. If any of these events occurs or we are unable to meet our strategic objectives for any such transaction, we may not be able to achieve the expected benefits from the transaction and our business may be materially harmed.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, in-licensing and acquisitions of products, diagnostic tests, product candidates, technologies or businesses often require significant payments and expenses and consume additional resources. We will need to continue to devote a substantial amount of time and personnel to research, develop and commercialize any such in-licensed or acquired products, diagnostic tests, product candidate or technologies, or integrate any new business, including extensive nonclinical or clinical testing, or both, and approval by the FDA and applicable foreign regulatory authorities, if any. All such products are prone to risks of failure inherent in pharmaceutical product development, including the possibility that the diagnostic tests, product candidate, or product developed based on in-licensed technology, will not be shown to be effective or sufficiently safe for approval by regulatory authorities. If intellectual property related to products, diagnostic tests, product candidates or technologies we in-license or acquire is not adequate, we may not be able to commercialize the affected products even after expending resources on their development. In addition, we may not be able to economically manufacture or successfully commercialize any product, diagnostic test or product candidate that we develop based on acquired or in-licensed technology that is granted regulatory approval, and such products may not gain wide acceptance or be competitive in the marketplace. Moreover, integrating any newly acquired or in-licensed product candidates could be expensive and time-consuming. If we cannot effectively manage these aspects of our business strategy, we may ultimately decide to reprioritize our efforts even after having expended resources on a particular prospect, and our business may be materially harmed.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to identify, discover, develop (in-license or otherwise acquire), and integrate new products, diagnostic tests or product candidates, or their related companies, in accordance with this strategy, our growth strategy or strategic transactions may not deliver the anticipated results, our ability to pursue this component of our growth strategy would be limited, and we may need to refine or otherwise alter this strategy. We cannot be certain that we will be successful in such efforts. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to successfully develop and commercialize our business units in the MENA region in accordance with our expansion strategy; regulatory requirements vary from country to country, including those in the MENA region; and changes in the value of the relevant currencies used in our operations, including those used in the MENA region, may adversely impact our operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">               </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, we announced our intention to develop our business units in the MENA region</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in particular, the Gulf Cooperation Council, an alliance of six Arab states in the Persian Gulf region, which includes Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates. Our entry into new markets may place a significant strain on our resources and increase demands on our executive management, personnel and operational systems, and our human, administrative and financial resources may be inadequate to meet these demands. Conducting and launching operations on an international scale requires close coordination of activities across multiple jurisdictions and time zones and consumes significant management resources. If we fail to coordinate and manage these activities effectively, our business, financial condition or results of operations could be adversely affected. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each jurisdiction in the MENA region that we target for commercialization of our products requires regulatory approvals and compliance with numerous and sometimes varying regulatory requirements. The approval procedures vary among countries and may involve requirements for additional testing, and the time required to obtain approval may differ from country to country in the MENA region and from that required to obtain clearance or approval in the United States. Approval or clearance in the United States does not ensure approval or certification by regulatory authorities in other countries or jurisdictions, and approval or certification by one regulatory authority in the MENA region does not ensure approval or certification by regulatory authorities in other countries in the MENA region or the United States. Any non-U.S. regulatory approval or certification process may include similar risks associated with obtaining clearance or approval in the United States. In addition, some countries only approve or certify a product for a certain period of time, in which case we will be required to re-approve or re-certify our products in a timely manner prior to the expiration of our prior approval or certification. We may not obtain regulatory approvals that we seek on a timely basis, if at all. We may not be able to file for regulatory approvals or certifications and may not receive or maintain necessary approvals to commercialize our products in any MENA market. If we fail to receive or maintain necessary approvals or certifications to commercialize our products in any MENA jurisdiction on a timely basis, or at all, or if we fail to have our products re-approved or re-certified, our business, results of operations and financial condition could be materially and adversely affected.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we successfully receive regulatory approvals and can commercialize our products, diagnostic tests, and product candidates in one or more of the jurisdictions in the MENA region, international sales entail a variety of risks, including longer payment cycles and difficulties in collecting accounts receivable outside of the United States, currency exchange fluctuations, challenges in staffing and managing foreign operations, tariffs and other trade barriers, unexpected changes in legislative or regulatory requirements of foreign countries into which we sell our products, difficulties in obtaining export licenses or in overcoming other trade barriers, laws and business practices favoring local companies, political instability, including conflicts and tensions involving the Israel-Hamas war, economic instability, difficulties protecting or procuring intellectual property rights, and restrictions resulting in delivery delays and significant taxes or other burdens of complying with a variety of foreign laws. In addition, expansion into the MENA markets may be affected by local economic and market as well as geopolitical conditions of each MENA country.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the value of the relevant currencies in the MENA region may affect the cost of certain items required in our operations. Changes in currency exchange rates may also affect the relative prices at which we are able to sell products in the same market. Our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenue from customers in the MENA region may be negatively impacted as increases in the U.S. dollar relative to such customers&#8217; local currency could make our products more expensive, impacting our ability to compete. Our costs of materials from international suppliers may increase if in order to continue doing business with us they raise their prices as the value of the U.S. dollar decreases relative to their local currency. Foreign policies and actions regarding currency valuation could result in actions by the United States and other countries to offset the effects of such fluctuations. The recent global financial downturn has led to a high level of volatility in foreign currency exchange rates </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and that level of volatility may continue, which could adversely affect our business, financial condition or results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Risks Related to Our Diagnostics Business</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to substitute the revenues from our lab diagnostic services or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">tests with new business  segments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During years end December 31, 2023 and 2022,  the net revenue from diagnostic services was $24.8 million and $108.3 million, respectively, which were 54.9% and 88.3% of our net revenue, respectively. By significantly decreasing our diagnostic services in 2023 and beyond, we will no longer generate the same level of revenues as we did in previous years for this business segment. Unless we are able to increase our revenues from existing or new line of businesses, our overall revenue will be lower than they have been for these historical periods and could adversely impact our business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to reduce our accounts receivable depends on our collection of payment for the diagnostic tests we delivered, which we may not be able to do successfully as the process is complex and time-consuming, and any delay in  collecting claims could have an adverse effect on our revenue. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Billing for our diagnostic tests was complex, time-consuming and expensive. Depending on the billing arrangement and applicable law, we were required to bill different parties for our tests. This included billing customers directly, as in the case of our hospital and other medical institution customers, as well as billing through Medicare, Medicaid, insurance companies and patients, all of which may have different billing requirements. Collection of receivables from third-party payors and patients is our primary source of cash from our diagnostic testing service and is critical to our results of operations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary collection risks relate to uninsured patients and the portion of the bill that is the patient&#8217;s responsibility, which primarily includes co-payments and deductibles. We faced and continue to face increased risk in our collection efforts due to the complexities of billing requirements, long collection cycles and lower collection rates, which adversely affected and could continue to affect our business, results of operations and financial condition. Our collection risks also include the potential for default or bankruptcy by the party responsible for payment and other risks associated with payment collection generally. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have substantial receivables due to us from certain government-based funding programs. Our payor base</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for our COVID-19 and influenza tests were principally comprised of governmental bodies, municipalities, and large corporations who paid us directly or through third-party pa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">yors. In March 2020, the CARES Act was enacted, providing for reimbursement to healthcare providers for COVID-19 tests provided to uninsured individuals, subject to continued available funding. On March 22, 2022, the Health Resources &amp; Services Administrations (&#8220;HRSA&#8221;) uninsured program stopped accepting claims for COVID-19 testing and treatment due to the lack of sufficient funds. Despite requests from the Acting Director of the Office of Management and Budget and the White House Coordinator for COVID-19 Response for additional emergency funding for the uninsured program, additional emergency funding were not allocated to the HRSA uninsured program. The expiration of the federal Public Health Emergency on May 11, 2023 also changed regulatory guidelines around COVID-19 testing including billing codes and reimbursement rates of in and out of network laboratories. Approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.0%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of our diagnostic services revenue for the year ended December 31, 2022 was generated from the HRSA program for the uninsured. None of our diagnostic revenues for the year ended December 31, 2023 was generated from  the HRSA program for the uninsured. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2023, insurers had significantly aged balances that we are continuing to work to collect. For the years ended December 31, 2023 and 2022, our accounts receivable were approximately 89.3% and 95.2%, respectively, from diagnostic testing services. We estimate our provisions for doubtful accounts based on a number of factors such as payer mix, the agings of the receivables, historical collection experience and assessment of probability of future collections. We routinely review accounts receivable balances in conjunction with these factors and other economic conditions that might ultimately affect the collectability of the patient accounts and make adjustments to our allowances as warranted. In addition, in determination of our year-end reserve balance, our management considered the specific facts and circumstances related to each of the individual payors. However, there will inevitably be billings that are rejected by the insurance carriers and associated receivables that will not be collected. While past history is helpful in informing the determination of an appropriate reserve, its utility is somewhat limited by the circumstances underlying a significant portion of these aged balances; specifically, an unprecedented volume of activity related COVID-19 diagnostic testing. Accordingly, the determination of an appropriate year-end reserve balance required significant management judgment, and the year-end reserve balance established may not be sufficient due to the changes in the facts and circumstances set forth </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">above overtime. We have hired third-party collection providers to assist us with our collection efforts. However, we cannot ensure that we or our third-party collection provider will be successful in collecting outstanding balances. Our inability to collect outstanding balances and reduce our accounts receivable could cause our revenue and ability to achieve profitability to decline and adversely affect our business, prospects and financial condition.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Personal Genomics Business</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prior to our acquisition of Nebula, we had no specific experience operating a personal genomics business. Our success in this industry will depend, in large part, on our ability to establish our presence in the personal genetics market, provide customers with a high level of service at a competitive price, achieve sufficient sales volume to realize economies of scale, and create innovative new features, products, and services to offer to our customers. Our failure to achieve any of these outcomes could adversely affect our business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to our acquisition of Nebula in 2021, we had no specific experience operating a personal genomics business. Our success in this industry will depend, in large part, on our ability to establish and maintain our presence in this market, provide customers with a high level of service at competitive prices, achieve sufficient sales volume to realize economies of scale, and create innovative new features, products and services to offer to our customers. If customers do not perceive our personal genomic reports to be reliable and of high quality, if we fail to introduce new and improved products and services, or if we introduce new products or services that are not favorably received by the market, we may not be able to attract or retain customers.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The growth and expansion of our genomics business and service offerings will place a continuous strain on our management, operational and financial resources. We will be required to manage multiple relationships with various strategic suppliers, customers and other third parties, including regulatory agencies. To effectively manage our growth, we must continue to implement and improve our operational, financial and management information systems and to expand, train and manage our employee base. In the event of further growth of our operations or in the number of our third-party relationships, our supply, systems, procedures or internal controls may not be adequate to support our operations and our management may not be able to manage any such growth effectively.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our estimates of the total addressable market for personal genomic services and the potential for market growth prove to be inaccurate, our business, financial condition, results of operations and prospects may be negatively affected.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimates and forecasts for the personal genomic service market are based on a number of complex assumptions, internal and third-party estimates, and other business data, including assumptions and estimates relating to our ability to leverage our diagnostic testing facilities to generate revenue from personal genomic services. While we believe our assumptions and the data underlying our estimates are reasonable, there are inherent challenges in measuring or forecasting such information. As a result, these assumptions and estimates may not be correct and the conditions supporting our assumptions or estimates may change at any time, thereby reducing the predictive accuracy of these underlying factors and indicators. Consequently, our estimates of the total addressable market and our forecasts of market growth and future revenue from our products and services may prove to be incorrect. For example, if the annual total addressable market or the potential market growth for our products and services is smaller than we have estimated or if the key business metrics we utilize to forecast revenue are inaccurate, it may impair our sales growth and have an adverse impact on our business, financial condition, results of operations and prospects.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Media reports have in the past reported on consumer privacy concerns and the use of genetic information accessed from other genetic databases by law enforcement and governmental agencies. These reports may decrease the overall consumer demand for personal genetic products and services, including ours.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Companies offering personal genomic services and products have received a high degree of media coverage in recent years. Unfavorable publicity or consumer perception of our product and service offerings, including consumer privacy concerns related to any of our existing or future collaborations, could adversely affect our reputation, resulting in a negative impact on the size of our customer base, the loyalty of our customers, the percentage of our customers that consent to participate in any future research programs, and our ability to attract new customers.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we lose a significant or sole supplier, our business and operations could be materially adversely affected.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, we rely on a two suppliers to manufacture our saliva collection kits and tubes used by customers who purchase our personal genomics services. Change in the supplier or design of certain of the materials that we rely on, in particular the saliva collection kit, could result in a requirement for additional premarket review from the FDA before making such a change.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any new laboratory or laboratories that are engaged to support our personal genomics business must first be validated in accordance with certain governmental standards before we are able to utilize their services for our U.S. customers. We cannot be certain that we will be able to secure alternative laboratory processing services, materials and equipment, and bring such alternative materials and equipment online and revalidate them without experiencing interruptions in our workflow, or that any alternative materials will meet our quality control and performance requirements of our current contracted laboratories that support our personal genomics business. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any significant disruption in service on our website, mobile applications, or in our computer or logistics systems, whether due to a failure with our information technology systems or that of a third-party vendor, could harm our reputation and may result in a loss of customers.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers purchase our personal genomics testing services and access Nebula offerings through our website or our mobile applications. Our reputation and ability to attract, retain and serve our customers is dependent upon the reliable performance of our and our partners' websites, mobile applications, network infrastructure and content delivery processes. Interruptions to any of these systems, whether due to system failures, computer viruses or physical or electronic break-ins, could affect the security or availability of our or our partner websites or mobile applications, including our databases, and prevent our customers from accessing and using our services.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our systems and operations are also vulnerable to damage or interruption from fire, flood, power loss, telecommunications failure, terrorist attacks, acts of war, electronic and physical break-ins, earthquake and similar events. In the event of any catastrophic failure involving our or our partner websites, we may be unable to serve our customer web traffic. The occurrence of any of the foregoing risks could result in damage to our systems or could cause them to fail completely, and our insurance may not cover such risks or may be insufficient to compensate us for losses that may occur.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, our business model is dependent on our ability to deliver testing kits to customers and have kits processed and returned to us. This requires coordination between our logistics providers and third-party shipping services. Operational disruptions may be caused by factors outside of our control such as hostilities, political unrest, terrorist attacks, natural disasters, pandemics, epidemics and other infectious disease outbreaks affecting the geographies where our operations and customers are located. We may not be effective at preventing or mitigating the effects of such disruptions, particularly in the case of a catastrophic event which could cause failure to deliver pre-implantation genetic screening (PGS) kits. Any such disruption may result in lost revenues, a loss of customers and reputational damage, which would have an adverse effect on our business, results of operations and financial condition.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our personal genomics business is subject to seasonal fluctuations.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our personal genomics kit sales are impacted by seasonal holiday demand. We expect to generate greater revenues from this business during the first quarter of our fiscal year, due to seasonal holiday demand and the fact that kits that are ordered during the holiday season (which occurs during the fourth quarter of our fiscal year) will generally be recognized as revenue when the customer sends in their kit to the laboratory to be processed and genetic reports are delivered to the customer, which for holiday purchases we expect will occur in the following fiscal quarter. Purchasing patterns of kit sales may also align with other gift-giving and family-oriented holidays such as Mother&#8217;s Day and Father&#8217;s Day. This seasonality could cause our operating results to vary considerably from quarter to quarter.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also experience an increase in lab processing times and costs associated with shipping orders due to freight surcharges due to peak capacity constraints and additional long-zone shipments necessary to ensure timely delivery for the holiday season. Such delays could lead to an inability to meet advertised estimated lab processing times, resulting in customer dissatisfaction or reputational damage. If too many customers access our website within a short period of time, we may experience system interruptions that make our website unavailable or prevent us from efficiently fulfilling orders, which may reduce the volume of kits sold. Also, third-party delivery and direct ship vendors may be unable to deliver merchandise on a timely basis.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We have integrated, and may continue to integrate in the future, machine learning and AI to help us in relation to production and other areas of our business. Machine learning and AI technology present various operational, compliance and reputational risks and if any such risks were to materialize, our business and results of operations may be adversely affected. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have integrated AI into our production processes and may continue to integrate machine learning and AI. We may continue to integrate machine learning and AI technology into other aspects of our business. Given that machine learning and AI is a new and rapidly developing technology that is in its early stages of business use, it presents a number of operational, compliance and reputational risks. AI algorithms are currently known to sometimes produce unexpected results and behave in unpredictable ways that can generate irrelevant, nonsensical, deficient or incorrect content and results. We expect that there will continue to be new laws or regulations concerning the use of machine learning and AI technology, which might be burdensome for us to comply with and may limit our use of new tools and features based on machine learning and AI technology. Further, the use of machine learning and AI technology involves complexities and may require specialized expertise. We may not be able to attract and retain top talent to support any machine learning and AI technology initiatives and maintain our systems and infrastructure. A disruption or failure in any machine learning and AI systems or infrastructure could result in delays and operational challenges. If any of the operational, compliance or reputational risks were to materialize, our business and results of operations may be adversely affected.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Contract Manufacturing and Dietary Supplement Business</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disruptions at our the manufacturing facilities of, or any loss of manufacturing certifications by, or termination or other problems under manufacturing and supply agreements between customers and, our wholly owned subsidiary, PMI, could materially and adversely affect our business, financial condition, results of operations and customer relationships.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any significant disruption at our manufacturing facility for any reason, including regulatory requirements, an FDA determination that the facility is not in compliance with the applicable cGMP regulations, the loss of certifications, power interruptions, destruction or damage to the facility or disruptions related to the COVID-19 pandemic or another pandemic, epidemic or infectious disease outbreak, could disrupt our ability to manufacture products for our contract manufacturing customers and any of our own branded products. Any such disruption could have a material adverse effect on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our PMI manufacturing business is subject to seasonal fluctuations and may fluctuate from cold season to cold season.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the majority of sales from our PMI manufacturing facility are from cold remedy products, our sales are subject to seasonal fluctuations and influenced by the timing, length and severity of each cold season. Our revenues tend to be higher in the first, third and fourth quarters during the cold season. Generally, a cold season is defined as the period of September to March, when the incidence of the common cold rises as a consequence of the change in weather and other factors.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our contract manufacturing and dietary supplement businesses are subject to extensive governmental regulation. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contract manufacturing and dietary supplement businesses are subject to laws and regulations that cover:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the formulation, manufacturing, packaging, labeling, distribution, importation, sale and storage of our products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the health and safety of our products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">trade practice and direct selling laws; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">product claims and advertising.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with these laws and regulations is time consuming and expensive. Moreover, new regulations could be adopted that would severely restrict the products we sell or manufacture or our ability to continue our business. We are unable to predict the nature of any future laws, regulations, interpretations or applications, nor can we predict what effect additional governmental regulations or administrative orders, when and if promulgated, would have on our business in the future. These future changes could, however, require the reformulation or elimination of certain products; imposition of additional record keeping and documentation requirements; imposition of new federal reporting and application requirements; modified methods of importing, manufacturing, storing or distributing certain products; and expanded or different labeling and substantiation requirements for certain products and ingredients. Any or all of these requirements could harm our business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2011, the FDA issued draft guidance governing the notification of new dietary ingredients (&#8220;NDIs&#8221;) and in August 2016, the FDA issued revised draft guidance. Although FDA guidance is not mandatory, it is a strong indication of the FDA&#8217;s current views, including its position on enforcement. We believe that the draft guidance, if implemented as proposed, could have a material impact on our operations. FDA enforcement of the NDI guidance as written could require us to incur additional expenses, which could be significant, and negatively affect our business in several ways, including, but not limited to, the detention and refusal of admission of imported products, the injunction of manufacturing of any dietary ingredients or dietary supplements until the FDA determines that those ingredients or products are in compliance, and the potential imposition of penalties for non-compliance.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our failure to comply with FTC regulations could result in substantial monetary penalties and could adversely affect our operating results.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FTC exercises jurisdiction over the advertising of dietary supplements and has instituted numerous enforcement actions against OTC drug companies for failure to have adequate substantiation for claims made in advertising or for the use of false or misleading advertising claims. Failure by us to comply with applicable regulations could result in substantial monetary penalties, which could have a material adverse effect on our financial condition or results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our product development and commercialization efforts may be unsuccessful.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous risks associated with</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dietary supplement product development and commercialization. We may be subject to delays and/or be unable to successfully implement our business plan and strategy to develop and commercialize one or more dietary supplements, including Equivir. The successful commercialization and market acceptance of any products we develop will be subject to, among other things, consumer purchasing trends, health and wellness trends, regulatory factors, retail acceptance and overall economic and market conditions. As a consequence, we may suspend or abandon some or all of our proposed new products before they ever become commercially viable. Even if we successfully develop a new product, if we cannot successfully commercialize it in a timely manner, our business and financial condition may be materially adversely affected.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our products do not have the effects intended or cause undesirable side effects, our business may suffer.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although many of the ingredients in our current dietary supplement products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are vitamins, minerals, and other substances for which there is a long history of human consumption, they also contain innovative ingredients or combinations of ingredients. While we believe that all of these products and the combinations of ingredients in them are safe when taken as directed, the products could have certain undesirable side effects if not taken as directed or if taken by a consumer who has certain medical conditions. In addition, these products may not have the effect intended if they are not taken in accordance with certain instructions, which include certain dietary restrictions. Furthermore, there can be no assurance that any of the products, even when used as directed, will have the effects intended or will not have harmful side effects in an unforeseen way or on an unforeseen cohort. If any of our products or products we develop or commercialize in the future are shown to be harmful or generate negative publicity from perceived harmful effects, our business, financial condition, results of operations, and prospects could be harmed significantly.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may fail to expand our growing and manufacturing capability in time to meet market demand for our manufacturing service, and regulatory authorities may refuse to accept our facilities. Any problems in our growing or manufacturing process could have a material adverse effect on our business, results of operations, and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our current plan is to build capacity at the manufacturing facilities owned by PMI to meet market demand of large lozenge manufacturing and production. Such build-out requires a successful FDA inspection of the manufacturing facilities. PMI successfully cleared its extensive multi-year FDA inspection in August, 2023. However, due to the complexity of the processes used to manufacture products, we may be unable to continue to pass federal, or state regulatory inspections in a cost-effective manner</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The manufacturing of products necessitates compliance with GMPs and other regulatory requirements. Our ability to successfully manufacture products will involve manufacture of finished products and labeling and packaging, which includes product information, tamper proof evidence and anti-counterfeit features, under tightly controlled processes and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">procedures. In addition, we will have to ensure chemical consistency among the batches, including clinical trial batches and, if approved, marketing batches. Demonstrating such consistency may require typical manufacturing controls as well as clinical data. We will also have to ensure that the batches conform to complex release specifications. The FDA or other foreign regulatory authorities may not accept our facilities if there are issues with our manufacturing facilities or processes. If we are unable to manufacture products in the future in accordance with regulatory specifications, or if there are disruptions in our manufacturing process due to damage, loss or otherwise, or generally, failure to pass regulatory inspections of our manufacturing facilities, we may not be able to expand the manufacturing facilities and meet demand or supply sufficient product to our customers, and this may also harm our ability to compete with other manufacturing facilities on a timely or cost-competitive basis. In addition, if we are unable to comply with manufacturing regulations, we may be subject to fines, unanticipated compliance expenses, recall or seizure of any approved products, total or partial suspension of production, and/or enforcement actions, including injunctions and criminal or civil prosecution. Any problems in our manufacturing process or facilities or any possible sanctions could adversely affect our business, the results of operations, and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Risks Related to Our Drug Development Operations</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our product candidates are still in pre-clinical development and it will be many years before our wholly owned subsidiary, PBIO, is able to commercialize a product candidate, if ever.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Equivir G (Rx) product candidate and Linebacker portfolio (LB-1 and LB-2) product candidates are still in pre-clinical development. Our ability to generate revenue from our product candidates, which we do not expect will occur for several years, if ever, will be a result of the successful development and eventual commercialization of these product candidates, which may never occur. Our product candidates may have adverse side effects or fail to demonstrate safety and efficacy. Additionally, our product candidates may have other characteristics that may make them impractical or prohibitively expensive for large-scale manufacturing. Furthermore, our product candidates may not receive regulatory approval or, if they do, they may not be accepted by the medical community or patients or may not be competitive with other products that become available.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We must submit IND applications to the FDA to initiate clinical trials in the United States. The filing of IND applications is subject to additional preclinical research, research-scale and clinical-scale manufacturing, and other factors yet to be identified. In addition, commencing any new clinical trial is subject to review by the FDA based on the acceptability and sufficiency of our chemistry, manufacturing, and controls,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and preclinical information provided to support our IND applications. If the FDA or foreign regulatory authorities require us to complete additional preclinical studies or we are required to satisfy other requests for additional data or information, our clinical trials may be delayed. Even after we receive and incorporate guidance from the FDA or foreign regulatory authorities, these regulatory authorities could disagree that we have satisfied all requirements to initiate our clinical trials or they may change their position on the acceptability of our trial design or the clinical endpoints selected. They could impose a clinical hold, which may require us to complete additional preclinical studies or clinical trials. The success of our product candidates will depend on several factors, including the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">sufficiency of our financial and other resources;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">completion of preclinical studies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">clearance of IND applications to initiate clinical trials;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">successful enrollment in, and completion of, our clinical trials;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">data from our clinical trials and support an acceptable risk-benefit profile of our product candidates for our intended patient population and indications and demonstrate safety and efficacy;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">establishment of agreements with contract manufacturing organizations (&#8220;CMOs&#8221;) for clinical and commercial supplies and scaling up of manufacturing processes and capabilities to support our clinical trials;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">successful development of our internal process development and transfer to larger-scale facilities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">receipt of regulatory and marketing approvals from applicable regulatory authorities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">receiving regulatory exclusivity for our product candidates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">establishment, maintenance, enforcement, and defense of patent and trade secret protection and other intellectual property rights;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">not infringing, misappropriating, or otherwise violating third-party intellectual property rights;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">establishing sales, marketing, and distribution capabilities for commercialization of our product candidates, if and when approved, whether by us or in collaboration with third parties;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">maintenance of a continued acceptable safety profile of products post-approval;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">acceptance of product candidates, if and when approved, by patients, the medical community, and third-party payors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">effective competition with other therapies and treatment options;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">establishment and maintenance of healthcare coverage and adequate reimbursement; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">expanding indications and patient populations for our products post-approval.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We may not be successful in our efforts to identify and successfully research and develop additional product candidates and may expend our resources to pursue particular product candidates or indications while failing to capitalize on other product candidates or indications that may be more profitable, or for which there is a greater likelihood of commercial success.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Part of our business strategy involves identifying and developing new product candidates. The process by which we identify product candidates may fail to yield successful product candidates for a number of reasons, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">we may not be able to assemble sufficient resources to identify or acquire additional product candidates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">competitors may develop alternative therapies that render new product candidates obsolete or less attractive;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">product candidates we develop or acquire may be covered by third-party intellectual property rights;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">new product candidates may, on further study, be shown to have adverse side effects, toxicities, or other characteristics that indicate that they are unlikely to receive marketing approval or achieve market acceptance;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">new product candidates may not be safe or effective;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the market for a new product candidate may change so that the continued development of that product candidate is no longer reasonable; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">we may not be able to produce new product candidates in commercial quantities at an acceptable cost, or at all.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are focused initially on Equivir G (Rx) and] our Linebacker portfolio (LB-1 and LB-2) product candidates and, as a result, we may forego or delay pursuit of opportunities with other product candidates or for other indications that later prove to have greater commercial potential. At anytime, we may choose to divert our attention and financial resources to a certain product candidate within our portfolio at the expense of another if we deem that our resources would be better allocated to pursue such product candidate. Our resource allocation decisions may cause us to fail to timely capitalize on viable commercial products or profitable market opportunities. Our spending on current and future product candidates for specific indications may not yield any commercially viable products. If we do not accurately evaluate the commercial potential or target market for a particular product candidate, we may relinquish valuable rights to that product candidate through collaboration, licensing, or other royalty arrangements when it would have been more advantageous for us to retain sole development and commercialization rights to that product candidate.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If we experience delays or difficulties enrolling patients in the clinical trials for our product candidates, our ability to advance our product candidates through clinical development and the regulatory process could be delayed or prevented.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The timely completion of clinical trials depends, among other things, on our ability to enroll a sufficient number of patients who remain in the trial until its conclusion. We may encounter delays in enrolling or be unable to enroll a sufficient number of patients to complete any of our clinical trials and, even if patients are enrolled, they may withdraw from our clinical trials before completion. Any clinical trials for our other product candidates will compete for enrollment of patients with other clinical trials for product candidates that are intended for the same or similar study populations as our product candidates. This competition will reduce the number and types of patients available to us because some patients who might opt to enroll in our trials may instead opt to enroll in a trial being conducted by one of our competitors. Additionally, since the number of qualified and experienced clinical investigators for therapeutic areas is limited, some of our clinical trial sites may be also conducting clinical trials for some of our competitors, which may reduce the number of patients who are available for our clinical trials at that clinical trial site.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In addition, the enrollment of patients depends on many factors, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">size of the patient population and process for identifying patients;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">design of the clinical trial protocol;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">regulatory hold on clinical trial recruitment because of unexpected safety events;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">design of the clinical trial protocol;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">availability of eligible prospective patients who may also be eligible patients for competitive clinical trials;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">availability and efficacy of approved alternative treatments for the disease under investigation;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">ability to obtain and maintain patient consent;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">risk that enrolled patients will drop out before completion of the trial;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">eligibility and exclusion criteria for the trial in question;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">perceived risks and benefits of our product candidates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">efforts by clinical sites and investigators to facilitate timely enrollment in clinical trials;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">patient referral practices of physicians;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">physicians&#8217; ability to monitor patients adequately during and after treatment because of patient healthcare access issues, including those caused by COVID-19, other pandemics, epidemics or infectious disease outbreaks;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">proximity and availability of clinical trial sites for prospective patients; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">interruptions, delays, or staffing shortages resulting from the COVID-19 pandemic, other pandemics, epidemics or infectious disease outbreaks.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Enrollment delays in our clinical trials may result in increased development costs for any product candidates we may develop, which may cause our stock price to decline and limit our ability to obtain additional financing. If we have difficulty enrolling a sufficient number of patients to conduct our clinical trials as planned, we may need to delay, limit, or terminate ongoing or future clinical trials, and postpone or forgo seeking marketing approval, any of which would have an adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Clinical trials are expensive, time consuming, and subject to uncertainty. We cannot guarantee that any of our clinical trials will be conducted as planned or completed on schedule, if at all. Issues may arise that could suspend or terminate our clinical trials. A failure of one or more of our clinical trials may occur at any stage of testing, and our future clinical trials may not be successful.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Events that may prevent successful or timely completion of clinical development include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">FDA or comparable foreign regulatory authorities disagreeing as to the design or implementation of our clinical trials;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">delays or failure to obtain regulatory clearance to initiate our clinical trials, as well as delays or failures to obtain any necessary approvals by the clinical sites;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">delays, suspension, or termination of our clinical trials by the clinical sites;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">modification of clinical trial protocols;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">delays in reaching agreement on acceptable terms with prospective contract research organizations (&#8220;CROs&#8221;) and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and clinical trial sites, as well as possible future breaches of such agreements;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">failure to manufacture sufficient quantities of our product candidates for use in our clinical trials;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">failure by third-party suppliers, CMOs, CROs, and clinical trial sites to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">imposition of a temporary or permanent clinical hold by us, IRBs for the institutions at which such trials are being conducted, or by the FDA or other regulatory authorities for safety or other reasons, such as a result of a new safety finding in a clinical trial on a similar product by one of our competitors, that presents unreasonable risk to clinical trial participants;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">changes in regulatory requirements and guidance that require amending or submitting new clinical protocols;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">changes in the standard of care on which we developed our clinical development plan, which may require new or additional trials;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the cost of clinical trials of our product candidates being greater than we anticipated;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">insufficient funding to continue clinical trials with our product candidates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the emergence of unforeseen safety issues or undesirable side effects;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">clinical trials of our product candidates producing negative or inconclusive results, which may result in our deciding, or regulators requiring us, to conduct additional clinical trials or abandon development of our product candidates;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">inability to establish clinical trial endpoints that applicable regulatory authorities consider clinically meaningful, or, if we seek accelerated approval, that applicable regulatory authorities consider likely to predict clinical benefit;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">regulators withdrawing their approval of a product or imposing restrictions on its distribution; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">interruptions, delays, or staffing shortages resulting from the COVID-19 pandemic, other pandemics, epidemics or infectious disease outbreaks.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">If (i) we are required to extend the duration of any clinical trials or to conduct additional preclinical studies or clinical trials or other testing of our product candidates beyond those that we currently contemplate; (ii) we are unable to successfully complete preclinical studies or clinical trials of our product candidates or other testing; (iii) the results of these trials, studies, or tests are negative or produce inconclusive results; (iv) there are safety concerns; or (v) we determine that the observed safety or efficacy profile would not be competitive in the marketplace, we may:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">abandon the development of one or more product candidates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">incur unplanned costs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">be delayed in obtaining marketing approval for our product candidates or not obtain marketing approval at all;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">obtain marketing approval in some jurisdictions and not in others;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">obtain marketing approval with labeling that includes significant use restrictions or safety warnings, including black box warnings;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">be subject to additional post-marketing requirements; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">have regulatory agencies remove the product from the market or we voluntarily withdraw the product from the market after obtaining marketing approval.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our preclinical studies or clinical trials may fail to adequately demonstrate the safety and efficacy of our product candidates and the development of our product candidates may be delayed or unsuccessful, which could prevent or delay regulatory approval and commercialization.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If we encounter safety or efficacy problems in our preclinical studies or clinical trials, our developmental plans could be delayed or prevented. Product candidates in later stages of clinical trials may fail to show the desired safety profiles and efficacy results despite having progressed through initial preclinical studies and clinical trials. A number of companies in the pharmaceutical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">industry have suffered significant setbacks in advanced clinical trials due to lack of efficacy or adverse safety profiles, notwithstanding promising results in earlier trials. Based upon negative or inconclusive results, we may decide, or regulatory agencies may require us, to conduct additional clinical trials or preclinical studies. In addition, data obtained from clinical trials are susceptible to varying interpretations, and regulatory agencies may not interpret our data as favorably as we do, which may delay, limit, or prevent regulatory approval.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, the design of a clinical trial can determine whether its results will support approval of our product candidates, and flaws in the design of a clinical trial may not be apparent until the clinical trial is well advanced. We have limited experience designing clinical trials and may be unable to design and execute a clinical trial that will support regulatory approval.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, we may publish initial, interim, or preliminary data from our clinical trials. Initial, interim, or preliminary data from clinical trials are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available. We also make assumptions, estimations, calculations, and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully evaluate all data at the time of publishing initial, interim, or preliminary data. These data also remain subject to audit and verification procedures that may result in the final data being materially different from the data we previously published. As a result, initial, interim, and preliminary data should be viewed with caution until the final data are available. Moreover, initial, interim, and preliminary data are subject to the risk that one or more of the clinical outcomes may materially change as more patient data become available when patients mature on study, patient enrollment continues, or, for final data, as other ongoing or future clinical trials with a product candidate further develop. Past results of clinical trials may not be predictive of future results. Unfavorable differences between initial, interim, or preliminary data and final data could significantly harm our business prospects and may cause the trading price of our common stock to decline significantly.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If our product candidates cause serious adverse events or undesirable side effects, including injury and death, or have other properties that could delay or prevent regulatory approval, their commercial potential may be limited or extinguished.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Product candidates we develop may be associated with undesirable or unacceptable side effects, unexpected characteristics, or other serious adverse events, including death. Inadequate recognition or management of the potential side effects of our product candidates could result in patient injury or death. If any undesirable or unacceptable side effects, unexpected characteristics, or other serious adverse events occur, our clinical trials could be suspended or terminated, and our business and reputation could suffer substantial harm.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There can be no assurance that we will resolve any adverse event related to any of our products to the satisfaction of the FDA or any regulatory agency in a timely manner or at all. If in the future we are unable to demonstrate that such adverse events were caused by factors other than our product candidates, the FDA or other regulatory authorities could order us to cease further clinical trials of, or deny approval of, our product candidates. Even if we demonstrate that such serious adverse events are not product candidate-related, such occurrences could affect patient recruitment or the ability of enrolled patients to complete our clinical trials. Moreover, if we elect, or are required, to delay, suspend, or terminate any clinical trial of any of our product candidates, the commercial prospects of such product candidates may be harmed and our ability to generate product revenues from these product candidates may be delayed or eliminated.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">The FDA or other regulatory agencies may disagree with our regulatory plans and we may fail to obtain regulatory approval of our product candidates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Although the FDA has found substantial evidence to support approval outside of the traditional phase 1, phase 2, and phase 3 framework for certain therapies, the general approach for FDA approval of a new drug is for the sponsor to provide dispositive data from at least two adequate and well-controlled clinical trials of the relevant biologic in the applicable patient population. Such clinical trials typically involve hundreds of patients, have significant costs, and take years to complete. We do not have agreement or guidance from the FDA that our regulatory development plans will be sufficient for submission of a NDA.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, the standard of care may change with the approval of new products in the same indications to which our product candidates are directed. This may result in the FDA or other regulatory authorities requesting additional studies to show that our product candidate is comparable or superior to the new products.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our clinical trial results may also not support marketing approval. In addition, our product candidates could fail to receive regulatory approval for many reasons, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the FDA or other regulatory authorities may disagree with the design or implementation of our clinical trials;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">we may be unable to demonstrate to the satisfaction of the FDA or other regulatory authorities that our product candidates are safe and effective for their proposed indications;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the results of clinical trials may not meet the level of statistical significance required by the FDA or other regulatory authorities for approval, including due to heterogeneity of patient populations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">we may be unable to demonstrate that the clinical and other benefits of our product candidates outweigh the safety risks;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the data collected from clinical trials of our product candidates may not be sufficient to the satisfaction of the FDA or other regulatory authorities to support the submission of a NDA or a similar filing in a foreign jurisdiction or to support commercial reimbursement;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the FDA or other authorities will review our manufacturing processes and inspect our CMOs&#8217; facilities and may not approve our manufacturing processes or CMOs&#8217; facilities; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the approval policies or regulations of the FDA or other regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Even if we comply with all FDA requests, we may still fail to obtain regulatory approval. We cannot be sure that we will ever obtain regulatory clearance for our product candidates.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Even if we complete the necessary preclinical studies and clinical trials, the regulatory approval process is expensive, time-consuming, and uncertain, and we may be unable to obtain the regulatory approvals necessary for the commercialization of our product candidates; furthermore, if there are delays in obtaining regulatory approvals, we may not be able to commercialize our products, may lose competitive lead time, and our ability to generate revenues from such products will be materially impaired</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The process of obtaining marketing approvals, both in the United States and in other jurisdictions, is expensive, may take many years, if approval is obtained at all, and can vary substantially based upon a variety of factors, including the type, complexity, and novelty of the product candidates involved. It is impossible to predict if or when any of our product candidates will prove to be safe and effective in humans or if we will receive regulatory approval for such product candidates. The risk of failure through the development process is high. Any product candidates we may develop, and the activities associated with their development and commercialization, including their manufacture, preclinical and clinical development, safety, efficacy, recordkeeping, labeling, storage, advertising, promotion, sale, and distribution, are subject to comprehensive regulation by the FDA and other regulatory authorities.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Failure to obtain marketing approval for a product candidate will prevent us from commercializing the product candidate in a given jurisdiction. PBIO has not received approval or authorization to market any product candidates from regulatory authorities in any jurisdiction and it is possible that none of its product candidates or any product candidates it may seek to develop in the future will ever obtain marketing approval or commercialization. PBIO has have not previously submitted a NDA to the FDA or made a similar submission to any foreign regulatory authority. ANDA must include extensive preclinical and clinical data and supporting information to establish a drug product candidate&#8217;s safety and efficacy for each desired indication. The NDA must also include significant information regarding the chemistry, manufacturing, and controls for our product. Any drug product candidates we develop may not be effective; may be only moderately effective; or may prove to have undesirable or unintended side effects, toxicities, or other characteristics that may preclude our obtaining marketing approval or prevent or limit commercial use. The FDA and other regulatory authorities have substantial discretion in the approval process and may refuse to accept our NDA applications and decide that our data are insufficient and require additional preclinical studies or clinical trials. The same may happen with review of our drug product candidates by foreign regulatory authorities. In addition, varying interpretations of the data obtained from preclinical studies and clinical trials could delay, limit, or prevent marketing approval of our drug product candidates. Any marketing approval we ultimately obtain may be limited or subject to restrictions or post-approval commitments that render our approved product not commercially viable. If we experience delays in obtaining approval or if we fail to obtain approval of any drug product candidates we may develop, the commercial prospects for those drug product candidates and our ability to generate revenues will be materially impaired and we may lose competitive lead time as similar products enter the market.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If ProPhase Biopharma, Inc. (PBIO) is unable to establish marketing and sales capabilities or enter into agreements with third parties to market and sell our product candidates, we may not be able to generate product revenue.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To achieve commercial success for any approved product for which PBIO retains sales and marketing responsibilities, PBIO must develop and build a sales and marketing team or make arrangements with third parties to perform these services. There are risks involved with both establishing internal sales and marketing capabilities and entering into arrangements with third parties to perform these services. For example, recruiting and training a sales force is expensive and time consuming and could delay product launch. PBIO will have to compete with other supplement, pharmaceutical and biotechnology companies to recruit, hire, train, and retain marketing and sales personnel. If the commercial launch of a product for which we have recruited a sales force and established marketing capabilities is delayed or does not occur for any reason, we would have prematurely or unnecessarily incurred these commercialization expenses, which may be costly and our investment will be lost if we cannot retain or reposition our sales and marketing personnel.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Factors that may inhibit our efforts to commercialize our products on our own include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our inability to recruit, hire, train, and retain adequate numbers of effective sales, marketing, customer service, medical affairs, and other support personnel;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our inability to equip sales personnel with effective materials, including sales literature, to help them educate physicians and other healthcare providers regarding our product candidates and their approved indications;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">our inability to effectively manage a geographically dispersed sales and marketing team;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the inability of medical affairs personnel to negotiate arrangements for reimbursement and other acceptance by payors;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the inability to price our products at a sufficient price point to ensure an adequate and attractive level of profitability; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">unforeseen costs and expenses associated with creating an independent sales and marketing organization.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If we are unable or decide not to establish internal sales, marketing, and distribution capabilities, we will need to enter into arrangements with third parties to perform sales, marketing, and distribution services. In such cases, our product revenue or the profitability to us from these revenue streams is likely to be lower than if we were to market and sell any product candidates that we develop ourselves. In addition, we may not be successful in entering into arrangements with </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">third parties to sell and market our product candidates or may be unable to do so on terms that are favorable to us. We likely will have little control over those third parties and they may fail to devote the necessary resources and attention to sell and market our product candidates effectively. If we do not establish sales and marketing capabilities successfully, either on our own or in collaboration with third parties, we may not be successful in commercializing our product candidates, and our business, financial condition, results of operations, and prospects will be materially adversely affected.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our products may not gain market acceptance among physicians, patients, hospitals, cancer treatment centers, and others in the medical community.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The use of Equivir G (Rx) for antiviral applications and/or the Linebacker portfolio (LB-1 and LB-2) as potential cancer co-therapies may not become broadly accepted by physicians, patients, hospitals, cancer treatment centers, and others in the medical community. Even with the requisite approvals from the FDA and other regulatory authorities internationally, the commercial success of any product candidates we develop will depend, in significant part, on the acceptance of physicians, patients, and healthcare payors of products as medically necessary, cost-effective, safe, and effective therapies.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Additional factors will influence whether our product candidates are accepted in the market, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the clinical indications for which our product candidates are approved;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">physicians, hospitals, cancer treatment centers, and patients considering our product candidates as safe and effective treatments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the potential and perceived advantages of our product candidates over alternative treatments;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the prevalence, identification, or severity of any side effects;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">product labeling or product insert requirements of the FDA or other regulatory authorities, including limitations or warnings contained in the product labeling;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the timing of market introduction of our product candidates as well as competitive products;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the cost of treatment of our product candidates in relation to alternative treatments;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the availability of coverage and adequate reimbursement by third-party payors and government authorities;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the willingness of patients to pay out-of-pocket for our product candidates in the absence of coverage;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">relative convenience and ease of administration, including as compared to alternative treatments and competitive therapies; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">the effectiveness of our sales and marketing efforts.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">If our product candidates are approved but fail to achieve market acceptance among physicians, patients, hospitals, cancer treatment centers, or others in the medical community, we will not be able to generate significant revenue. Even if our products achieve market acceptance, we may not be able to maintain that market acceptance over time if new products or technologies, or other therapeutic approaches, are introduced that are more favorably received than our products, are more cost effective, or render our products obsolete.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">The market opportunities for our product candidates may be smaller than we currently believe and limited to those patients who are ineligible for or have failed prior treatment, which may adversely affect our business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our projections of both the number of patients who have the indications we are targeting, and who have the potential to benefit from treatment with our product candidates, are based on our beliefs and estimates. New studies may change the estimated incidence or prevalence of these cancers. The number of eligible patients may turn out to be lower than we expected. Additionally, the potentially addressable patient population for our product candidates may be limited or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">may not be amenable to treatment with our product candidates. The effort to identify patients with diseases we seek to treat is in early stages, and we cannot accurately predict the number of patients for whom treatment might be possible. Additionally, the potentially addressable patient population for each of our product candidates may be limited or may not be amenable to treatment with our product candidates, and new patients may become increasingly difficult to identify or gain access to, which would adversely affect our business, financial condition, results of operations, and prospects. Even if we obtain significant market share for our product candidates, because the potential target populations are small, we may never achieve profitability without obtaining regulatory approval for additional indications.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Even if we are able to commercialize our product candidates, such products may be subject to unfavorable pricing regulations, third-party reimbursement practices, or healthcare reform initiatives, which could harm our business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The regulations that govern marketing approvals, pricing, and reimbursement for new products vary widely from country to country. Some countries require approval of the sale price of a product before it can be marketed. In many countries, the pricing review period begins after marketing approval is granted. In some non-U.S. markets, prescription pharmaceutical pricing remains subject to continuing governmental control even after initial marketing approval is granted. As a result, we might obtain marketing approval for our product candidates in a particular country, but then be subject to price regulations that delay our commercial launch of such product candidates, possibly for lengthy time periods, and such delays would negatively impact the revenues we are able to generate from the sale of our product candidates in that country. Pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if any product candidates we may develop obtain marketing approval.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Uncertainty exists as to the coverage and reimbursement status of any of our products candidates for which we obtain regulatory approval. Additionally, reimbursement coverage may be more limited than the indications for which our products are approved. The marketability of our products may suffer if government and other third-party payors fail to provide coverage and adequate reimbursement. Furthermore, coverage policies and third-party reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more of our product candidates for which we receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Moreover, eligibility for reimbursement does not imply that our product candidates will be paid for in all cases or at a rate that will cover our costs, including research, development, manufacture, sale, and distribution. Interim reimbursement levels for new products, if applicable, may also not be sufficient to cover our costs and may not be made permanent. Reimbursement rates may vary according to the use of our product candidate and the clinical setting in which it is used, may be based on reimbursement levels already set for lower cost products, and may be incorporated into existing payments for other services. Net prices for our product candidates may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of products from countries where our product candidates may be sold at lower prices than in the United States.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Third-party payors, whether domestic or foreign, governmental or commercial, are developing increasingly sophisticated methods of controlling healthcare costs. In both the United States and certain foreign jurisdictions, there have been a number of legislative and regulatory changes to healthcare systems that could impact our ability to sell our product candidates, if approved, profitably. There have been, and likely will continue to be, legislative and regulatory proposals at the federal and state levels directed at broadening the availability of, and containing or lowering the cost of, healthcare. The implementation of cost containment measures that third-party payors and healthcare providers are instituting and any other healthcare reforms may prevent us from being able to generate, or may reduce, our revenues from the sale of our product candidates, if approved, and our product candidates may not be profitable. Such reforms could have an adverse effect on anticipated revenue from product candidates for which we may obtain regulatory approval and may affect our overall financial condition and ability to develop product candidates. Even if our product candidates are successful in clinical trials and receive marketing approval, we cannot provide any assurances that we will be able to obtain and maintain third-party payor coverage or adequate reimbursement for our product candidates in whole or in part.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Enacted and future healthcare legislation may increase the difficulty and cost for us to obtain approval of and commercialize our product candidates and could adversely affect our business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Affordable Care Act brought significant changes to the way healthcare is financed by both the government and private insurers, and significantly impacted the U.S. pharmaceutical industry, including expanding the list of covered entities eligible to participate in the 340B drug pricing program and establishing a new Medicare Part D coverage gap discount program. We expect that these and other healthcare reform measures in the future, may result in more rigorous coverage criteria and lower reimbursement, and in addition, exert downward pressure on the price that we receive for any approved product. Any reduction in reimbursement from Medicare or other government-funded programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">reforms may hinder us in generating revenue, attaining profitability, or commercializing our products once, and if, marketing approval is obtained.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the European Union (&#8220;EU&#8221;), coverage and reimbursement status of any product candidates for which we obtain regulatory approval are provided for by the national laws of EU member states. The requirements may differ across the EU member states. In markets outside the United States and the EU, reimbursement and healthcare payment systems vary significantly by country, and many countries have instituted price ceilings or other price controls on specific products and therapies.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We cannot predict the likelihood, nature, or extent of government regulation that may arise from future legislation or administrative action in the United States, the EU, or any other jurisdiction. If we or any third parties we may engage are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we or those third parties are not able to maintain regulatory compliance, our product candidates may lose any regulatory approval that we may have obtained and we may not achieve or sustain profitability.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Risks Related to Our Intellectual Property</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to protect our trademarks and other intellectual property could impact our business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will rely on trademark laws to protect our proprietary rights in any products we develop and commercialize. Monitoring the unauthorized use of our intellectual property will be difficult. Litigation may be necessary to enforce our intellectual property rights or to determine the validity and scope of the proprietary rights of others. Litigation of this type could result in substantial costs and diversion of resources, may result in counterclaims or other claims against us and could significantly harm our results of operations. In addition, the laws of some foreign countries do not protect our proprietary rights to the same extent as do the laws of the United States. From time to time, we may apply to have certain trademarks registered. There is no guarantee that such trademark registrations will be granted. The unauthorized reproduction of our trademarks could diminish the value of our brand and its market acceptance, competitive advantages or goodwill, which could adversely affect our business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If we, or our licensors are unable to maintain effective patents or we are unable to maintain our license rights for our approved products, product candidates or any future product candidates, or if the scope of the patent or license rights obtained is not sufficiently broad, we may not be able to compete effectively in our markets.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have traditionally in-licensed all patent rights protecting our products and/or our product candidates. Commensurate with our purchase of the Stella Purchased Assets, we became the owner of certain patents, patent applications and their foreign counter-parts. Our success depends in large part on our, and our licensors&#8217; ability to obtain and maintain patents and other intellectual property protection in the United States and in other countries, as well as our license rights, with respect to our proprietary technology, products and product candidates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain and involves complex legal and factual questions for which legal principles remain unsolved. The patent applications that we own, acquire (previously, or in the future), or in-license may fail to result in issued patents with claims that cover our products or product candidates in the United States or in foreign countries. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions remain confidential for a period of time after filing, and some remain so until issued. Therefore, we cannot be certain that we, our predecessors (as to patents and patent applications acquired), or our licensors were the first to file any patent application related to our products or product candidates, or whether we, or they, were the first to make the inventions claimed in the patents or pending patent applications that we own, in-license or acquire. As a result, the issuance, scope, validity, enforceability and commercial value of our owned, acquired, or licensed patent rights are highly uncertain. There is no assurance that all potentially relevant prior art relating to such patents and patent applications has been found, which can invalidate a patent or prevent a patent from issuing from a pending patent application. Even if patents do successfully issue, and even if such patents cover our products or product candidates, third parties may challenge their validity, enforceability or scope, which may result in such patents being narrowed, found unenforceable or invalidated, which could allow third parties to commercialize our technology or products and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize products without infringing third-party patent rights. Furthermore, even if they are unchallenged, such patents and patent applications may not adequately protect our intellectual property, provide exclusivity for our products or product candidates, prevent others from designing around our claims or provide us with a competitive advantage. Any of these outcomes could impair our ability to prevent competition from third parties.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any successful opposition to any patents owned, acquired, or licensed to us after patent issuance, or the loss or other impairment of any owned, acquired, or licensed rights relating to our products or product candidates, could deprive us of rights necessary for the successful commercialization of any products or product candidates that we may develop. Further, if we, or our licensors, encounter delays in regulatory approvals, the period of time during which we could market a product or product candidate under patent protection could be reduced. In addition, our, or our licensors' patent positions might not protect us against competitors with similar products or technologies because competing products or technologies may not infringe our owned, acquired, or licensed patents.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We, our licensors may not have sufficient patent terms to effectively protect our products and business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Patents have a limited lifespan. In the United States, the natural expiration of a patent is generally 20 years after it is first filed. Although various extensions may be available, the life of a patent, and the protection it affords, is limited. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such product candidates are commercialized. As a result, our owned, acquired, or licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours or otherwise provide us with a competitive advantage. Even if patents covering our products or product candidates are obtained, once the patent life has expired for a product, we may be open to competition from generic medications.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Third-party claims of intellectual property infringement may expose us to substantial liability or prevent or delay our development and commercialization efforts.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our commercial success depends in part on our ability to develop, manufacture, market and sell our products that have been approved for sale, and to use our proprietary technology without alleged or actual infringement, misappropriation or other violation of the patents and proprietary rights of third parties. There have been many lawsuits and other proceedings involving patent and other intellectual property rights in the biotechnology and pharmaceutical industries, including patent infringement lawsuits, interferences, oppositions and reexamination proceedings before the USPTO, and corresponding foreign patent offices. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we will market products and are developing product candidates. Some claimants may have substantially greater resources than we do and may be able to sustain the costs of complex intellectual property litigation to a greater degree and for longer periods of time than we could. In addition, patent holding companies that focus solely on extracting royalties and settlements by enforcing patent rights may target us. As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that our products and product candidates may be subject to claims of infringement of the intellectual property rights of third parties.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Third parties may assert that we are employing their proprietary technology without authorization. There may be third-party patents or patent applications with claims to compositions, formulations, methods of manufacture or methods of treatment related to the use or manufacture of our products or our product candidates. We cannot be sure that we know of each and every patent and pending application in the United States and abroad that is relevant or necessary to the commercialization of our products or our product candidates. Because patent applications can take many years to issue, there may be currently pending patent applications that may later result in issued patents upon which our products or product candidates may infringe. In addition, third parties may obtain patents in the future and claim that use of our technologies infringes upon these patents. If any third-party patents were held by a court of competent jurisdiction to cover the manufacturing process of any of our products or product candidates, any compositions formed during the manufacturing process or any final product itself, the holders of any such patents may be able to block our ability to commercialize such product or product candidate unless we obtained a license under the applicable patents, or until such patents expire or are finally determined to be invalid or unenforceable. Similarly, if any third-party patents were held by a court of competent jurisdiction to cover aspects of our compositions, formulations, or methods of treatment, prevention or use, the holders of any such patents may be able to block our ability to develop and commercialize the applicable product or product candidate unless we obtained a license or until such patent expires or is finally determined to be invalid or unenforceable. In either case, such a license may not be available on commercially reasonable terms, or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our reliance on third parties requires us to share our trade secrets or confidential proprietary information, which increases the possibility that a competitor will discover them or that our trade secrets confidential proprietary information will be misappropriated or disclosed.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Because we rely on third parties to develop and manufacture our product candidates, we must, at times, share trade secrets or confidential proprietary information with them. We seek to protect our proprietary technology in part by entering into confidentiality agreements and, if applicable, material transfer agreements, collaborative research agreements, consulting agreements or other similar agreements with our collaborators, advisors, employees, and consultants prior to beginning research or disclosing proprietary information. These agreements typically limit the rights of the third parties to use or disclose our confidential information, such as trade secrets. Despite the contractual provisions employed when working with third parties, the need to share trade secrets and other confidential information increases the risk that such trade secrets become known by our competitors, are inadvertently incorporated into the technology of others, or are disclosed or used in violation of these agreements. Given that our proprietary position is based, in part, on our know-how and trade secrets, a competitor&#8217;s discovery of our trade secrets or other unauthorized use or disclosure would impair our competitive position and may harm our business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Protecting and enforcing our intellectual property rights could consume monetary funds needed for other company objectives</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Protecting and enforcing our intellectual property rights and combating unlicensed copying and use of our intellectual property can be difficult and expensive. Litigation filed by Company and excessive legal costs could result in insufficient cash available to continue our business objective. Similarly, reductions in the legal protection of our intellectual property.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We may not be able to prevent disclosure of confidential and proprietary information</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We receive confidential and proprietary information from collaborators, prospective licensors and licensees and other third parties. In addition, we employ individuals who were previously employed at other biotechnology or pharmaceutical companies. We may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed confidential information of these third parties or our employees&#8217; former employers. Litigation may be necessary to defend against these claims, which can result in significant costs if we are found to have improperly used the confidential or proprietary information of others. Even if we are successful in defending against these claims, litigation could result in substantial costs and diversion of personnel and resources.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Governmental Regulation</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and regulations regarding direct selling may prohibit or restrict our ability to sell our products in some markets or require us to make changes to our business model in some markets.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct selling companies are subject to laws and regulations by various government agencies. These laws and regulations are generally intended to prevent fraudulent or deceptive practices and to protect consumers. The FTC periodically investigates and brings enforcement actions against direct selling companies based on alleged pyramid selling activity and/or false and misleading claims made by the direct selling company or its independent distributors. Direct selling companies that have been the subject of an FTC enforcement action have generally been required to make significant changes to their business model and pay significant monetary fines. Being the target of an investigation or enforcement action by the FTC could have a material adverse effect on our results of operations and financial condition.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on third parties to provide services critical to our businesses and we depend on them to comply with applicable laws and regulations. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on third parties to provide services critical to our businesses, including laboratory service providers, raw material and equipment suppliers, ground and air transport of clinical and diagnostic services supplies and specimens, research services (including ancestry report generation), and people, among other services. Third parties that provide services to us are subject to similar risks related to security of customer-related information and compliance with U.S., state, local, or international environmental, health and safety, and privacy and security laws and regulations as we are. Any failure by third parties to comply with applicable laws, or any failure of third parties to provide services more generally, could have a material impact on us, whether because of the loss of the ability to receive services from the third parties, our legal liability for the actions or inactions of third parties, or otherwise.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We must comply with complex and overlapping laws protecting the privacy and security of health information and personal data.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of state, federal and international laws protecting the privacy and security of health information and personal data.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the administrative simplification provisions of HIPAA, HHS has issued regulations which establish uniform standards governing the conduct of certain electronic health care transactions and protecting the privacy and security of PHI used or disclosed by health care providers and other covered entities.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The privacy regulations regulate the use and disclosure of PHI by health care providers engaging in certain electronic transactions or &#8220;standard transactions.&#8221; They also set forth certain rights that an individual has with respect to his or her PHI maintained by a covered health care provider, including the right to access or amend certain records containing PHI or to request restrictions on the use or disclosure of PHI. The HIPAA security regulations establish administrative, physical, and technical standards for maintaining the integrity and availability of PHI in electronic form. These standards apply to covered health care providers and also to &#8220;business associates&#8221; or third parties providing services involving the use or disclosure of PHI. The HIPAA privacy and security regulations establish a uniform federal &#8220;floor&#8221; and do not supersede state laws that are more stringent or provide individuals with greater rights with respect to the privacy or security of, and access to, their records containing PHI. As a result, we may be required to comply with both HIPAA privacy regulations and varying state privacy and security laws.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, HITECH, among other things, established certain health information security breach notification requirements. In the event of a breach of unsecured PHI, a covered entity must notify each individual whose PHI is breached, federal regulators and in some cases, must publicize the breach in local or national media. Breaches affecting 500 individuals or more are publicized by federal regulators who publicly identify the breaching entity, the circumstances of the breach and the number of individuals affected.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws contain significant fines and other penalties for wrongful use or disclosure of PHI. Given the complexity of HIPAA and HITECH and their overlap with state privacy and security laws, and the fact that these laws are rapidly evolving and are subject to changing and potentially conflicting interpretation, our ability to comply with the HIPAA, HITECH and state privacy requirements is uncertain and the costs of compliance are significant. Adding to the complexity is that our planned operations are currently evolving, and the requirements of these laws will apply differently depending on such things as whether or not we bill electronically for our services or provide services involving the use or disclosure of PHI and incur compliance obligations as a business associate. The costs of complying with any changes to the HIPAA, HITECH and state privacy restrictions may have a negative impact on our operations. Noncompliance could subject us to criminal penalties, civil sanctions and significant monetary penalties as well as reputational damage.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also required to collect and maintain personal information about our employees as well as receive and transfer certain payment information, to accept payments from our customers, including credit card information. Most states have adopted laws requiring notification of affected individuals and state regulators in the event of a breach of personal information, which is a broader class of information than the health information protected by HIPAA. Many state laws impose significant data security requirements, such as encryption or mandatory contractual terms to ensure ongoing protection of personal information. Activities outside of the United States implicate local and national data protection standards, impose additional compliance requirements, and generate additional risks of enforcement for non-compliance. The collection and use of such information may be subject to contractual obligations as well. If the security and information systems that we or our outsourced third-party providers use to store or process such information are compromised or if we, or such third parties, otherwise fail to comply with these laws, regulations, and contractual obligations, we could face litigation and the imposition of penalties that could adversely affect our financial performance.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerous additional local, municipal, state, federal, and international laws and regulations address privacy and the collection, storing, sharing, use, disclosure, and protection of certain types of data, including the California Online Privacy Protection Act, the Personal Information Protection and Electronic Documents Act, the Telephone Consumer Protection Act of 1991, Section 5 of the Federal Trade Commission Act, and effective as of January 1, 2020, the CCPA. These laws, rules, and regulations evolve frequently, and their scope may continually change, through new legislation, amendments to existing legislation, and changes in enforcement, and may be inconsistent from one jurisdiction to another. For example, the CCPA, which went into effect on January 1, 2020, among other things, requires new disclosures to California consumers and affords such consumers new abilities to opt out of certain sales of personal information. The CCPA provides for fines of up to $7,500 per violation. Aspects of the CCPA and its interpretation and enforcement remain uncertain. The effects of this legislation potentially are far-reaching and may require us to modify our data processing practices and policies and incur substantial compliance-related costs and expenses. The CCPA has been amended on </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">multiple occasions, resulting in further uncertainty and requiring us to incur additional costs and expenses in an effort to comply. The CPRA became operative on January 1, 2023 (and applies to consumer data collected on or after January 1, 2022, (the &#8220;lookback period&#8221;), with enforcement beginning July 1, 2023. While the CCPA will remain operative and enforceable from now until July 1, 2023, we will continue to monitor developments related to the CPRA. The effects of this legislation potentially are far-reaching, however, and may require us to modify our data processing practices and policies and incur substantial compliance-related costs and expenses. Additionally, many laws and regulations relating to privacy and the collection, storing, sharing, use, disclosure, and protection of certain types of data are subject to varying degrees of enforcement and new and changing interpretations by courts. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">New laws governing the privacy of consumer health data, including information concerning genetic information, individual health conditions, and treatment have also passed in the United States. For example, Washington&#8217;s My Health My Data Act which broadly defines consumer health data, places restrictions on processing consumer health data (including imposing stringent requirements for obtaining consumer consent), provides consumers certain rights with respect to their health data, and creates a private right of action to allow individuals to sue for violations of the law. Other states, including California, could adopt similar laws.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the General Data Protection Regulation ('GDPR") imposes stringent requirements on the processing of "personal data", including health and sensitive data, by business who target EU consumers or operate in the EU. The GDPR is wide-ranging in scope and imposes numerous requirements on companies that process personal data, including requirements relating to certain health data, obtaining consent of the individuals to whom the personal data relates, providing information to individuals regarding data processing activities, implementing safeguards to protect the security and confidentiality of the personal data, providing notification of data breaches, and taking specific measures when disclosing the personal data to third parties. Penalties for businesses who are not compliant with the GDPR can reach up to 4% of global revenues. Additionally, post-Brexit, the UK has adopted its version of the GDPR (UK GDPR) alongside amendments to its Data Protection Act 2018, creating a separate regulatory environment that may impact global economic conditions and market operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in laws or regulations relating to privacy, data protection, breach notifications, and information security, particularly any new or modified laws or regulations, or changes to the interpretation or enforcement of such laws or regulations, that require enhanced protection of certain types of data or new obligations with regard to data retention, transfer, or disclosure, could greatly increase the cost of providing our platform, require significant changes to our operations, or even prevent us from providing our platform in jurisdictions in which we currently operate and in which we may operate in the future.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may face audits or investigations by one or more domestic government agencies or our customers pursuant to our contractual obligations relating to our compliance with these regulations. Complying with changing regulatory requirements requires us to incur substantial costs, exposes us to potential regulatory action or litigation, and may require changes to our business practices in certain jurisdictions, any of which could materially adversely affect our business operations and operating results. Despite our efforts to comply with applicable laws, regulations, and other obligations relating to privacy, data protection, and information security, it is possible that our interpretations of the law, practices, or platform could be inconsistent with, or fail or be alleged to fail to meet all requirements of, such laws, regulations, or obligations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Common Stock, Internal Controls and Governance Matters</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have identified material weaknesses in our internal controls over financial reporting. If we fail to properly remediate these material weaknesses or if we are otherwise unable to develop and maintain an effective system of internal controls over financial reporting, material misstatements in our financial statements could occur and we may not be able to accurately or timely report our financial results, which may adversely affect investor confidence in us, our business, results of operations and financial condition, and the trading price of our common stock.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in Item 9A. Controls and Procedures of this Annual Report, and Note 2 to the financial statements included under Item 8 of this Annual Report, we have identified material weaknesses in our internal controls over financial reporting, which include (i) inadequate review of certain account reconciliation or controls over financial statement closing process; (ii) errors made related to recording and calculating revenue and following our policy regarding principal versus agent consideration, and ineffective controls to identify exceptions; and (iii) inadequate controls over identifying discrepancies relating to the calculation and recording of deferred costs and cost of sales, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as of December 31, 2023.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A material weakness is a deficiency, or a combination of deficiencies, in our internal controls over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected and corrected on a timely basis.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective internal controls are necessary for us to provide reliable financial reports and prevent fraud. We are evaluating and intend to implement steps to remediate the material weaknesses. These remediation measures may be time consuming and costly and there is no assurance that these initiatives will ultimately have the intended effects. The material weaknesses in our internal control over financial reporting will not be considered remediated until the controls operate for a sufficient period of time and management has concluded, through testing that these controls operate effectively. If we do not successfully remediate the material weaknesses, or if other material weaknesses or other deficiencies arise in the future, we may be unable to accurately report our financial results, which could cause our financial results to be materially misstated and require restatement. In such case, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports, in addition to applicable stock exchange listing requirements and requirements under certain of our agreements, which could adversely affect investor confidence in us, our business, results of operations and financial condition, and the trading price of our common stock. Investors relying upon misinformation could make an uninformed investment decision, and we could be subject to sanctions or investigations by the SEC or other regulatory authorities or to stockholder class action securities litigation. In addition, these material weaknesses may also have the effect of heightening other risks described in this &#8220;Risk Factors&#8221; section.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future sales of shares of our common stock in the public market could adversely affect the trading price of shares of our common stock and our ability to raise funds in future offerings.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future sales of substantial amounts of shares of our common stock in the public market, or the perception that such sales are likely to occur, could adversely affect the prevailing trading prices of our common stock. Moreover, the perceived risk of potential dilution could cause stockholders to attempt to sell their shares and investors to &#8220;short&#8221; our stock, a practice in which an investor sells shares that he or she does not own at prevailing market prices, hoping to purchase shares later at a lower price to cover the sale. All of these events could combine to make it difficult for us to sell equity or equity-related securities in the future at a time and price that we deem appropriate.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts do not publish research or reports about our business or if they issue an adverse or misleading opinion regarding our stock, our stock price and trading volume could decline.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our common stock may be influenced by the research and reports that industry or securities analysts publish about us or our business. If any of the analysts who cover us issue an adverse or misleading opinion regarding us, our business model, products or stock performance, our stock price could decline. If one or more of these analysts cease coverage of us or fail to publish reports on us regularly, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline. Moreover, the unpredictability of our financial results likely reduces the certainty, and therefore reliability, of the forecasts by securities or industry analysts of our future financial results, adding to the potential volatility of our stock price.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Chief Executive Officer and Chairman of the Board of Directors owns a substantial amount of our common stock any may be able to exert significant influence over the outcome of matters submitted to stockholders for approval.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 12, 2024, our Chief Executive O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fficer and Chairman of the Board of Directors beneficially owned approximately 20.2% of our common stock. As such, our Chief Executive Officer may exert significant influence over the outcome of matters submitted to stockholders for approval. Consequently, he exercises substantial influence over major decisions including major corporate actions such as mergers and other business combinations transactions which could result in or prevent a change of control of the Company. Circumstances may occur in which the interests of our Chief Executive Officer could be in conflict with the interests of other stockholders. Accordingly, a stockholder&#8217;s ability to influence us through voting their shares may be limited.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Certificate of Incorporation and Bylaws contain certain provisions that may be barriers to a takeover.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Certificate of Incorporation and Bylaws contain certain provisions which may deter, discourage, or make it difficult for another person or entity to gain control of the Company through a tender offer, merger, proxy contest or similar transaction or series of transactions, including provisions that:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">authorize our board of directors autho</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rize &#8220;blank check&#8221; preferred stock without stockholder approval, which may provide for voting, liquidation, dividend, and other rights superior to our common stock; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">specify that special meetings of our stockholders can be called only by our chairman or the board of directors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">prohibit stockholder action by written consent;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">establish an advance notice procedure for stockholder matters to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to our board of directors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">provide that vacancies on our board of directors may be filled only by a majority of directors then in office, even though less than a quorum; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">expressly authorized our board of directors to make, alter, amend, or repeal our amended and restated bylaws.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions may deter a future tender offer or other takeover attempt which could include a premium over the market price of our common stock at the time. Such provisions could depress the trading price of our common stock.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Bylaws provides that the Court of Chancery of the State of Delaware and the federal district courts of the United States of America will be the exclusive forums for substantially all disputes between us and our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, executive officers, or employees.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated bylaws provide that the Court of Chancery of the State of Delaware is the exclusive forum for the following types of actions or proceedings under Delaware statutory or common law: for (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Corporation to the Corporation or the Corporation&#8217;s stockholders, (iii) any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law or the Certificate of Incorporation or Bylaws (as either may be amended from time to time), or (iv) any action asserting a claim governed by the internal affairs doctrine shall be the Court of Chancery in the State of Delaware (or, if the Court of Chancery does not have jurisdiction, the federal district court for the District of Delaware). This provision would not apply to suits brought to enforce a duty or liability created by the Securities Act of 1933 or the Exchange Act. Furthermore, Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both state and federal courts have jurisdiction to entertain such claims.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the exclusive forum provisions. In such instance, we would expect to vigorously assert the validity and enforceability of the exclusive forum provisions of our Certificate of Incorporation. This may require significant additional costs associated with resolving such action in other jurisdictions and there can be no assurance that the provisions will be enforced by a court in those other jurisdictions.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This exclusive forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, executive officers, or other employees, which may discourage lawsuits against us and our directors, executive officers, and other employees. If a court were to find the exclusive forum provision in our Certificate of Incorporation to be inapplicable or unenforceable in an action, we may incur further significant additional costs associated with resolving the dispute in other jurisdictions, all of which could seriously harm our business. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have agreed to indemnify our officers and directors from liability.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Certificate of Incorporation and our Bylaws provide that we will indemnify, to the fullest extent permitted by the Delaware General Corporation Law, any person who is or was made a party to, or is or was threatened to be made a party to, any pending, completed, or threatened action, suit or proceeding because he or she is or was a director, officer, employee or agent of the Company or is or was serving at the Company&#8217;s request as a director, officer, employee or agent of any corporation, partnership, joint venture, trust or other enterprise. These provisions permit us to advance expenses to an indemnified party in connection with defending any such proceeding, upon receipt of an undertaking by the indemnified party to repay those amounts if it is later determined that the party is not entitled to indemnification. We entered into indemnity agreements with each member of our board of directors. These agreements provide, among other things, that we will indemnify each officer and director in the event they become a party or otherwise a participant in any action or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">proceeding on account of their service as a director or officer of the Company (or service for another corporation or entity in any capacity at the request of the Company) to the fullest extent permitted by applicable law. The indemnification provisions may reduce the likelihood of derivative litigation against directors and officers and discourage or deter stockholders from suing directors or officers for breaches of their duties to the Company, even though such an action, if successful, might otherwise benefit the Company or its stockholders. In addition, to the extent that we expend funds to indemnify directors and officers, funds will be unavailable for operational purposes.</span></div><div><span><br/></span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_22"></div><div style="margin-top:10pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B.&#160;&#160;&#160;&#160;Unresolved Staff Comments </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_1649267442142"></div><div style="margin-top:10pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">tem 1C.&#160;&#160;&#160;&#160;Cybersecurity</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk management and strategy </span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybersecurity is an integral part of risk management at the Company. Our Board and management appreciate the evolving nature of threats presented by cybersecurity incidents and is committed to the prevention, timely detection, and mitigation of the effect any such incidents may have on the Company. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established policies and processes for assessing, identifying, and managing material risk from cybersecurity threats, and have integrated these processes into our overall risk management systems and processes. We routinely assess material risks from cybersecurity threats, including any potential unauthorized occurrence on or conducted through our information systems that may result in adverse effects on the confidentiality, integrity, or availability of our information systems or any information residing therein. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct periodic risk assessments to identify cybersecurity threats, as well as assessments in the event of a material change in our business practices that may affect information systems that are vulnerable to such cybersecurity threats. These risk assessments include identification of reasonably foreseeable internal and external risks, the likelihood and potential damage that could result from such risks, and the sufficiency of existing policies, procedures, systems, and safeguards in place to manage such risks. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following these risk assessments, we re-design, implement, and maintain reasonable safeguards to minimize identified risks; reasonably address any identified gaps in existing safeguards; and regularly monitor the effectiveness of our safeguards. Primary responsibility for assessing, monitoring and managing our cybersecurity risks rests with an IT consultant who reports to our Chief Operating Officer, to manage the risk assessment and mitigation process. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our overall risk management system, we monitor and test our safeguards and train our employees on these safeguards, in collaboration with IT and management. Personnel at all levels and departments are made aware of our cybersecurity policies through trainings. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We engage consultants, or other third parties in connection with our risk assessment processes. These service providers assist us to design and implement our cybersecurity policies and procedures, as well as to monitor and test our safeguards. We require each third-party service provider to certify that it has the ability to implement and maintain appropriate security measures, consistent with all applicable laws, to implement and maintain reasonable security measures in connection with their work with us, and to promptly report any suspected breach of its security measures that may affect our company. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not encountered cybersecurity challenges that have materially impaired our operations or financial standing. For additional information regarding risks from cybersecurity threats, please refer to Item 1A, &#8220;Risk Factors,&#8221; in this Annual Report.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Governance</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One of the key functions of our board of directors is informed oversight of our risk management process, including risks from cybersecurity threats. Our board of directors is responsible for monitoring and assessing strategic risk exposure, and our executive officers are responsible for the day-to-day management of the material risks we face. Our board of directors administers its cybersecurity risk oversight through the audit committee. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Information Officer and Chief Operating Officer are primarily responsible to assess and manage our material risks from cybersecurity threats with assistance from third-party service providers. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Information Officer and Chief Operating Officer oversee our cybersecurity policies and processes, including those described in &#8220;Risk Management and Strategy&#8221; above. The cybersecurity risk management program includes tools and activities to prevent, detect, and analyze current and emerging cybersecurity threats, and plans and strategies to address threats and incidents.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Chief Information Officer and IT consultant provide periodic briefings to the audit committee regarding our company&#8217;s cybersecurity risks and activities, including any recent cybersecurity incidents and related responses.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_25"></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Properties</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters are located in Garden City, New York. We leased this property commencing in December 2020 and leased additional space at this property commencing in November 2022 . O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ur headquarters are approximately 30,000 square feet and are comprised of lab diagnostic area with storage area and office space. Our second location is approximately 4,000 square feet and is comprised of lab diagnostic area with storage area and office space in Old Bridge, NJ. We leased additional administrative office space of approximately 2,000 square feet in Fort Washington, PA. Our principal manufacturing facility is located in Lebanon, Pennsylvania. The facility was purchased in October 2004. The facility has a total area of approximately 57,500 square feet and is comprised of manufacturing, w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">arehousing and office space. We are currently exploring opportunities to expand our Genomics lab operations.</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_28"></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we have been and may again become involved in legal proceedings arising in the ordinary course of business. Except as provided below, we are not presently a party to any other material litigation.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">TK Supplements, Inc., was the defendant in Aviles v. TK Supplements, Inc., a purported class action pending in the Superior Court for the State of California, County of Los Angeles. In the complaint that was filed on April 27, 2023, the plaintiff alleged that TK Supplements falsely advertised its Legendz XL male enhancement supplement in violation of California&#8217;s Consumer Legal Remedies Act. We believed the lawsuit and the allegations contained therein were without merit, and on February 6, 2024, the matter was voluntarily dismissed as a result of a negotiated resolution.</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_31"></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Mine Safety Disclosures</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">51</span></div></div></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_37"></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is currently traded on The Nasdaq Capital Market under the trading symbol &#8220;PRPH.&#8221;</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 12, 2024, there were approximately 162 holders of record.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">               </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">While we have paid dividends to holders of our common stock in 2021 and 2022, the declaration and payment of future dividends will depend on many factors, including, but not limited to, our earnings, financial condition, business development needs and regulatory considerations, and is at the sole discretion of our Board of Directors. At this time, we do not expect to pay any regular, quarterly cash dividend on our common stock in the foreseeable future</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Authorized Under Equity Compensation Plans</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Part III, Item 12. &#8220;Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters&#8221; for information relating to our equity compensation plans.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Sales of Unregistered Securities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchases of Equity Securities by the Issuer and Affiliated Purchasers </span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total number of shares purchased (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Average Price Paid per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Maximum Number (or approximate dollar value) of Shares that May Yet Be Purchased Under the Plans or Programs (1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1 through October 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,411,119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1 through November 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,411,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1 through December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,411,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,411,119&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">There was no other purchases of equity securities for the three months ended December 31, 2023.</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_40"></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;[Reserved]</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_43"></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.&#160;&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis should be read together with our financial statements and the related notes appearing elsewhere in this Annual Report. This discussion contains forward-looking statements reflecting our current expectations that involve risks and uncertainties. See &#8220;Special Note Regarding Forward-Looking Statements&#8221; for a discussion of the uncertainties, risks and assumptions associated with these statements. Actual results and the timing of events could differ materially from those discussed in our forward-looking statements as a result of many factors, including those set forth under &#8220;Risk Factors&#8221; and elsewhere in this Annual Report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">52</span></div></div></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_46"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a diversified company that offers a range of services including genomics testing, diagnostic testing and contract manufacturing. We are also focused on licensing, developing and commercializing novel drugs, dietary supplements, compounds and diagnostics.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We conduct our operations through two operating segments: diagnostic services and consumer products. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Until late fiscal year 2020, we were engaged primarily in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States. This includes the development and marketing of dietary supplements under the TK Supplements&#174; brand. However, commencing in December 2020, we also began offering COVID-19 diagnostic testing and were prepared to validate other Respiratory Pathology Panel Molecular tests through our diagnostic service business. In August 2021, we began offering personal genomics products and services, and in July 2022 we began focusing on the licensing, development and commercialization of novel drugs, dietary supplements, compounds and diagnostics.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our wholly owned subsidiary, ProPhase Diagnostics, Inc. (&#8220;ProPhase Diagnostics&#8221;), which was formed on October 9, 2020, offers a broad array of clinical diagnostic and testing services at its Clinical Labotary Improvement Amendments (&#8220;CLIA&#8221;) certified laboratories including polymerase chain reaction (&#8220;PCR&#8221;) testing for COVID-19. Critical to COVID-19 testing, we provide fast turnaround times for results. We also offer best-in-class rapid antigen testing for COVID-19. On October 23, 2020, we completed the acquisition of all of the issued and outstanding shares of capital stock of Confucius Plaza Medical Laboratory Corp. (&#8220;CPM&#8221;), which owned a 4,000 square foot CLIA accredited laboratory located in Old Bridge, New Jersey for approximately $2.5 million. In December 2020, we expanded our diagnostic service business with the build-out of a second, larger CLIA accredited laboratory in Garden City, New York. Operations at this second facility commenced in January 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On August 10, 2021, we acquired Nebula, a privately owned personal genomics company, through our new wholly owned subsidiary, ProPhase Precision Medicine Inc. (&#8220;PPM&#8221;). Subsequently in 2022, PPM legal name was changed to Nebula Genomics ("Nebula"). Nebula focuses on genomics sequencing technologies, a comprehensive method for analyzing entire genomes, including the genes and chromosomes in DNA. The data obtained from genomic sequencing can be used to help identify inherited disorders and tendencies, help predict disease risk, help identify expected drug response, and characterize genetic mutations, including those that drive cancer progression.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our wholly owned subsidiary, PBIO, was formed on June 28, 2022, for the licensing, development and commercialization of novel drugs, dietary supplements and compounds, beginning with Equivir and Equivir G. PBIO announced a second licensing agreement for two small molecule PIM kinase inhibitors, Linebacker LB-1 and LB-2, in July 2022, with plans to pursue development and commercialization of LB-1 as a cancer co-therapy.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In January 2023, we acquired exclusive rights to the BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test and related intellectual property assets.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our wholly owned subsidiary, PMI, is a full-service contract manufacturer and private label developer of a broad range of non-GMO, organic and natural-based cough drops and lozenges and OTC drug and dietary supplement products.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our diagnostic service business continued to be impacted by the level of demand for COVID-19 and other diagnostic testing and our ability to collect payment or reimbursement for our testing services for the years ended December 31, 2023 and 2022. Due to the significant decrease in demand and reimbursement rate for our diagnostic testing service, we have reduced the amount of diagnostic testing services that we provide since the second half of 2023. Nonetheless we are prepared to provide an increased volume of our diagnostic testing service if diagnostic testing is required due to a new COVID-19 outbreak. We have continued to ship COVID-19 antigen kits under an existing contract to our customer. In addition, in order to maintain licenses in certain states in which we operate, we currently perform several diagnostic tests each quarter to maintain our certified lab status, and we currently plan to do so for the foreseeable future.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our personal genomics business is and will continue to be impacted by demand for our genetic sequencing products and services, our marketing and service capabilities, and our ability to comply with applicable regulatory requirements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our consumer sales are and will continue to be impacted by (i) the timing of acceptance of our TK Supplements&#174; consumer products in the marketplace, and (ii) fluctuations in the timing of purchase and the ultimate level of demand for the OTC healthcare and cold remedy products that we manufacture, which is largely a function of the timing, length and severity of each cold season. Generally, a cold season is defined as the period from September to March when the incidence of the common cold rises as a result of the change in weather and other factors. We generally experience in the first, third and fourth quarter higher levels of net revenues from our contract manufacturing business. Revenues are generally at their lowest levels in the second quarter when customer demand generally declines.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, we continue to actively pursue acquisition opportunities for other companies, technologies and products within and outside the consumer products industry.</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_49"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations from Operations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">December&#160;31, 2023 compared with December&#160;31, 2022 </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Net revenue for the year ended December&#160;31, 2023, decreased $78.3 million, or 63.8%, to $44.4 million compared to $122.6 million for the year ended December&#160;31, 2022. The decrease in net revenue was the result of an $83.5 million decrease from diagnostic services, and a $5.2 million increase from consumer products. The decrease in net revenue for diagnostic services was due to decreased COVID-19 testing volumes compared to the 2022 period as a result of the highly contagious Omicron variant, which emerged in early 2022. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Overall diagnostic testing volume decreased from approximately 1,000,000 tests for the year ended December&#160;31, 2022 to approximately 480,000  tests for the year ended December&#160;31, 2023, of which 29%  were reimbursed by the HRSA uninsured program for the year ended December 31, 2022, and none were reimbursed from the HRSA uninsured program for the year ended December 31, 2023. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Cost of revenues for the year ended December&#160;31, 2023 was $28.1 million, comprised of $11.8 million for diagnostic services and $16.4 million for consumer products. Cost of revenues for the year ended December&#160;31, 2022 were $52.0 million comprised of $39.9 million for diagnostic services and $12.1 million for consumer products. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We realized a gross profit of $16.2 million for the year ended December&#160;31, 2023, as compared to $70.7 million for the year ended December&#160;31, 2022. The decrease of $54.4 million was comprised of a decrease of $55.4 million in diagnostic services, partially offset by an increase of $1.0 million in consumer products. For the year ended December&#160;31, 2023 and 2022 we realized an overall gross margin of 36.6% and 57.6%, respectively. Gross margin for diagnostic services was 52.6% and 63.2% for the year ended December&#160;31, 2023 and 2022, respectively. Gross margin for consumer products was 16.3% and 15.5% for the year ended December&#160;31, 2023 and 2022, respectively. Gross margin for consumer products have historically been influenced by fluctuations in quarter-to-quarter production volume, fixed production costs and related overhead absorption, raw ingredient costs, inventory mark to market write-downs and timing of shipments to customers.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Diagnostic expenses for the year ended December&#160;31, 2023 were $1.9 million as compared to $12.0 million of diagnostic expenses for the year ended December&#160;31, 2022. The decrease in diagnostic expenses of $10.1 million was primarily due to was due to decreased COVID-19 testing volumes for the year ended December&#160;31, 2023 compared to the year ended December 31, 2022 as a result of the Omicron variant, which emerged in early 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">General and administration expenses increased $0.1 million for the year ended December&#160;31, 2023 to $34.5 million, as compared to $34.4 million for the year ended December&#160;31, 2022. The increase in general and administration expenses for the year ended December&#160;31, 2023 as compared to the year ended December&#160;31, 2022 was principally related to an increase in personnel expenses, marketing and professional fees associated with the Company's strategic initiatives.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Research and development costs for the year ended December&#160;31, 2023 and 2022 were $1.4 million and $0.7 million, respectively. The increase in research and development costs for the year ended December&#160;31, 2023 as compared to the year ended December&#160;31, 2022 was principally due to increased activities at ProPhase BioPharma. These activities include product research and field testing.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Interest and other income for the years ended December&#160;31, 2023 and 2022 was $0.1 million and $0.2 million, respectively. The decrease in interest income for the year ended December&#160;31, 2023 as compared to the year ended December&#160;31, 2022 was primarily due to the lower account balance of our investment account that bears interest.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the years ended December&#160;31, 2023 and 2022 was $1.3 million and $0.8 million, respectively. The increase in interest expense for the year ended December&#160;31, 2023 as compared to the year ended December&#160;31, 2022 was principally due to higher balance of our outstanding debt that bears interest and leased manufacturing equipment.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As a result of the effects described above, net loss for the year ended December&#160;31, 2023 was $16.8 million, or $(0.98) per share, as compared to a net income of $18.5 million, or $1.17 per share, for the year ended December&#160;31, 2022. Diluted earnings per share for the years ended December&#160;31, 2023 and 2022 were $(0.98) and $1.02, respectively.</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_52"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measure and Reconciliation</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In an effort to provide investors with additional information regarding our results of operations as determined by accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;), we disclose certain non-GAAP financial measures. The primary non-GAAP financial measures we disclose are EBITDA and Adjusted EBITDA.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We define EBITDA as net income (loss) before net interest expense, income taxes, depreciation and amortization. Adjusted EBITDA further adjusts EBITDA by excluding acquisition costs, other non-cash items, and other unusual or non-recurring charges (as described in the table below).</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. These non-GAAP financial measures do not reflect a comprehensive system of accounting, differ from GAAP measures with the same names and may differ from non-GAAP financial measures with the same or similar names that are used by other companies. We compute non-GAAP financial measures using the same consistent method from quarter to quarter and year to year. We may consider whether other significant items that arise in the future should be excluded from the non-GAAP financial measures.</span></div><div style="text-align:justify;text-indent:29.15pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We use EBITDA and Adjusted EBITDA internally to evaluate and manage the Company&#8217;s operations because we believe they provide useful supplemental information regarding the Company&#8217;s ongoing economic performance. We believe that these non-GAAP financial measures provide meaningful supplemental information regarding our operating results primarily because they exclude amounts that are not considered part of ongoing operating results when planning and forecasting and when assessing the performance of the organization. In addition, we believe that non-GAAP financial information is used by analysts and others in the investment community to analyze our historical results and in providing estimates of future performance and that failure to report these non-GAAP measures could result in confusion among analysts and others and create a misplaced perception that our results have underperformed or exceeded expectations.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table sets forth the reconciliations of EBITDA and Adjusted EBITDA excluding other costs to the most comparable GAAP financial measures (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"/><td style="width:60.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">GAAP net income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16,782)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18,463&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income Tax Expense (Benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,018)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">EBITDA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(15,326)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">28,237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Non-cash rent expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Credit loss expense </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(10,435)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">We believe that net income is the financial measure calculated and presented in accordance with GAAP that is most directly comparable to EBITDA and Adjusted EBITDA. EBITDA and Adjusted EBITDA measure the Company&#8217;s operating performance without regard to certain expenses. EBITDA and Adjusted EBITDA are not presentations made in accordance with GAAP and the Company&#8217;s computation of EBITDA and Adjusted EBITDA may vary from others in the industry. EBITDA and Adjusted EBITDA have important limitations as analytical tools and should not be considered in isolation or as substitutes for analysis of the Company&#8217;s results as reported under GAAP.</span></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The non-cash portion of rent, which reflects the extent to which our GAAP rent expense recognized exceeds (or is less than) our cash rent payments. For newer leases, our rent expense recognized typically exceeds our cash rent payments, while for more mature leases, rent expense recognized is typically less than our cash rent payments.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">55</span></div></div></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_55"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our aggregate cash, cash equivalents and restricted cash as of December&#160;31, 2023 were $2.1 million as compared to $9.1 million at December&#160;31, 2022. Our working capital was $26.7 million and $44.8 million as of December&#160;31, 2023 and 2022, respectively. The decrease of $7.0 million in our cash, cash equivalents and restricted cash for the year ended December&#160;31, 2023 was primarily due to (a) the proceeds from the sale of marketable debt securities of $3.8 million, (b) the proceeds from the maturities of marketable debt securities of $4.2 million, (c) the proceeds for issuance of notes payable and mortgage loan of $10.5 million, and (d) the proceeds from warrant exercise of $1.2 million, offset by (i) $11.3 million cash used in operating activities, (ii) the asset purchase of Stella of $2.9 million, (iii) repurchase of common shares for payment of statutory taxes due on cashless exercise of options for $5.4 million, (iv) repurchase of common shares for $0.6 million, (v) purchase marketable debt securities of $3.8 million, and (vi) capital expenditures of $3.2 million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To date the principal sources of capital to fund our operations have been from diagnostic services, genomics sequencing, product sales, net proceeds from the offering of equity securities, and issuances of promissory notes. Based on management&#8217;s current business plans, the Company estimates it will have enough cash and liquidity to finance its operating requirements for at least 12 months from the date of filing these audited condensed consolidated financial statements. However, due to the nature of early-stage ventures and accounts receivables collections, there are inherent uncertainties associated with managements&#8217; business plan and cash flow projections, particularly if the Company is unable to grow its business lines, including replacing the revenues from our lab diagnostic services or tests with new business lines, or collect on its accounts receivables in a timely manner or at all. If we were to experience a cash shortfall, we believe our access to existing and other financing sources, including our at-the-market facility, and the established relationships with our investment banks will enable us to continue to meet our obligations and fund ongoing operations.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also use our cash to explore and/or acquire new product technologies, applications, product line extensions, new contract manufacturing applications and other new product opportunities. In the event that our available cash is insufficient to support such initiatives, we may need to incur indebtedness or issue common stock or other securities to finance our plans for growth. Volatility in the credit markets and the liquidity of major financial institutions, including as a result of inflation, the COVID-19 pandemic and/or the war in Ukraine and measures taken in response thereto, may have an adverse impact on our ability to fund our business strategy through future borrowings, under either existing or newly created instruments in the public or private markets on terms that we believe to be reasonable, if at all. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We anticipate that we will continue to incur losses for foreseeable future. We expect to continue to incur research and development costs and general and administrative expenses, as well as expenses related to potential commercialization of our product candidates, consistent with costs associated with research and development at companies of our size and stage of development, and, as a result, we will need additional capital to fund our operations, which we may raise through public or private equity or debt financings, strategic collaborations, or other sources.</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_58"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations and Commitments </span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Manufacturing Agreement</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Company and its wholly owned subsidiary, PMI, entered into a manufacturing agreement (the &#8220;Manufacturing Agreement&#8221;) with Mylan Consumer Healthcare Inc. (&#8220;MCH&#8221;) and Mylan Inc. (together with MCH, &#8220;Mylan&#8221;) in connection with the asset purchase agreement we entered into with Mylan in 2017. Pursuant to the terms of the Manufacturing Agreement, Mylan (or an affiliate or designee) purchased the inventory of the Company&#8217;s Cold-EEZE&#174; brand and product line, and PMI agreed to manufacture certain products for Mylan, as described in the Manufacturing Agreement, at prices that reflect current market conditions for such products and include an agreed upon mark-up on our costs. On May 1, 2021, the Manufacturing Agreement was assigned by Mylan to Nurya Brands, Inc. (&#8220;Nurya&#8221;) in connection with Nurya&#8217;s acquisitions of certain assets from Mylan, including the Cold-EEZE&#174; brand and product line. Unless terminated sooner by the parties, the Manufacturing Agreement was to remain in effect until March 29, 2023. Thereafter, the Manufacturing Agreement could be renewed by Nurya for up to four successive one-year periods by providing notice of its intent to renew not less than 90 days prior to the expiration of the then-current term.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> November 15, 2022, the Company was notified by Nurya of its election to renew the Manufacturing agreement for one year. As a result, the Manufacturing Agreement will remain in effect until March 29, 2024.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equivir License Agreement</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the terms of our Equivir License Agreement with Global BioLife for the worldwide exclusive right and license to Equivir and Equivir G, we are required to pay to Global BioLife a royalty of 5.5% after the date of first commercial sale and during the royalty term.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the event that no valid claim of Equivir Licensed Patents cover a Equivir </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Licensed Product in a particular jurisdiction, the royalty rate for such Equivir Licensed Product will be reduced by 50%.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">See Part I, Item 1, "Business - Licensing Agreements" for additional details regarding this agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Linebacker License Agreement</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of our Linebacker License Agreement with Global BioLife for the worldwise exclusive right and license to Linebacker (LB-1 and LB-2), we must pay Global BioLife $900,000 following the achievement of a first Phase 3 study which may be required by the FDA for the first Linebacker Licensed Product and an additional $1 million upon the receipt of regulatory approval of a NDA for the first Linebacker Licensed Product. During the term of the license agreement, we are also required to pay to Global BioLife 3% royalties on Net Revenue (as defined in the license agreement) of each Linebacker Licensed Product, but no less than the minimum royalty of $250,000 of Net Revenue per year minus any royalty payments for any required third party licenses. See Part I, Item 1, "Business - Licensing Agreements" for additional details regarding this agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stella Asset Purchase Agreement</span></div><div style="text-align:justify;text-indent:28.8pt"><span><br/></span></div><div style="text-align:justify;text-indent:28.8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 15, 2022, we entered into an Asset Purchase Agreement (the &#8220;Stella Purchase Agreement&#8221;) with Stella Diagnostics Inc. (&#8220;Stella&#8221;) and Stella DX, LLC (&#8220;Stella DX&#8221; and, together with Stella, the &#8220;Stella Sellers&#8221;), pursuant to which, on January 3, 2023, we purchased all of the assets, rights and interests of the Stella Sellers and their affiliates pertaining to the Stella Sellers&#8217; BE-Smart Esophageal Pre-Cancer diagnostic screening test and certain clinical assets, including all intellectual property rights (the &#8220;Stella Purchased Assets&#8221;). As consideration for the Stella Purchased Assets, we (i) paid to the Stella Sellers $3.5 million in cash, minus (a) the Secured Note Amount</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $0.5 million, (b) the Liability Payoff Amount of $0.4 million and (c) the Promissory Note Payoff Amounts of $0.4 million (each as defined in the Stella Purchase Agreement) in 2022, and (ii) issued to Stella DX 100,000 shares of our common stock. (See Footnote 11 to the Consolidated Financial Statements).</span></div><div style="text-align:justify;text-indent:28.8pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to pay to the Stella Sellers for each of the seven calendar years (each, an &#8220;Annual Period&#8221;) during the seven year period commencing on the first day of the calendar year following the date of the Commercialization Event (as defined in the Stella Purchase Agreement), a non-refundable, non-creditable royalty of 5% of the Adjusted Gross Margin (as defined in the Stella Purchase Agreement) for such Annual Period. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">JXVII Trust Promissory Note</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 26, 2023, we issued an unsecured promissory note and guaranty for an aggregate principal amount of $7.6 million (the "JXVII Note") to JXVII Trust (&#8220;JXVII&#8221;). The JXVII Note is due and payable on January 27, 2026, the third anniversary of the date on which the JXVII Note was funded (the &#8220;Note Closing Date&#8221;), and accrues interest at a rate of 10% per year from the Note Closing Date, payable on a quarterly basis, until the JXVII Note is repaid in full. We have the right to prepay the JXVII Note at any time after the Note Closing Date and prior to the maturity date without premium or penalty upon providing seven days&#8217; written notice to JXVII. Repayment of the JXVII Note has been guaranteed by the Company&#8217;s wholly-owned subsidiary, PMI.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The JXVII Note contains customary events of default. If a default occurs and is not cured within the applicable cure period or is not waived, any outstanding obligations under the JXVII Note may be accelerated. The JXVII Note also contains certain restrictive covenants which, among other things, restrict our ability to create, incur, assume or permit to exist, directly or indirectly, any lien (other than certain permitted liens described in the JXVII Note) securing any indebtedness of the Company, and prohibits us from distributing or reinvesting the proceeds from any divestment of assets (other than in the ordinary course) without the prior approval of JXVII. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(See Footnote 11 to the Consolidated Financial Statements).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Previously, we experienced higher than normal net revenue for the years ended December 31, 2021 and 2022, primarily as a result of increased revenue from our diagnostic services business. The increase in net revenue from diagnostic services was due to increased COVID-19 testing volumes performed as a result of the spread of the Omicron variant, which emerged in early 2022. The demand for our COVID-19 testing services significantly decreased starting in the second half of 2022, partly due to the widespread and effective vaccination of a majority of Americans against COVID-19 and successful containment efforts. For the year ended December 31, 2023, revenue from our diagnostic services significantly decreased. As a result, we have reduced the amount of diagnostic testing services that we provide </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">since the second half of 2023. Nonetheless we are prepared to provide an increased volume of our diagnostic testing service if diagnostic testing is required due to a new COVID-19 outbreak. We have continued to ship COVID-19 antigen kits under an existing contract to our customer. In addition, in order to maintain licenses in certain states in which we operate, we currently perform several diagnostic tests each quarter to maintain our certified lab status, and we currently plan to do so for the foreseeable future.</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_61"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HRSA Funding</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2020, the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") was enacted, providing for reimbursement to healthcare providers for COVID-19 tests provided to uninsured individuals, subject to continued available funding. Approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">28.0%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of our diagnostic services revenue for the year ended December 31, 2022 was generated from this program for the uninsured. None of our diagnostic revenues for the year ended December 31, 2023 was generated from this program for the uninsured. On March 22, 2022, the HRSA uninsured program stopped accepting claims for COVID-19 testing and treatment due to lack of sufficient funds. Despite requests from the Acting Director of the Office of Management and Budget and the White House Coordinator for COVID-19 Response for additional emergency funding for the uninsured program, additional emergency funding were allocated to the HRSA uninsured program. For years ended December 31, 2023 and 2022, we continued to perform testing for uninsured persons and were incurring the accompanying costs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 30, 2023, the Administration announced that effective May 11, 2023, the federal Public Health Emergency would expire related to the COVID-19 pandemic. This expiration changes regulatory guidelines around COVID-19 testing including billing codes and reimbursement rates of in and out of network laboratories. As a result of the Public Health Emergency ending and the significant decrease in demand of COVID-19 testing, we have reduced the amount of diagnostic testing services that we provide since the second half of 2023. </span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_64"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">At-the-Market Facility</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 28, 2021, we entered into a Sales Agreement (the &#8220;Sales Agreement&#8221;) with ThinkEquity LLC (the &#8220;Sales Agent&#8221;), pursuant to which we may offer and sell, from time to time through the Sales Agent, shares of our common stock having an aggregate offering price of up to $100,000,000, subject to the terms and conditions of the Sales Agreement. We are not obligated to make any sales of shares under the Sales Agreement.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will pay the Sales Agent a fixed commission rate of 2.0% of the aggregate gross proceeds from the sale of any shares pursuant to the Sales Agreement and have agreed to provide the Sales Agent with customary indemnification and contribution rights. We also agreed to reimburse the actual out-of-pocket accountable expenses of the Sales Agent up to $60,000 (of which a $25,000 advance was paid on December 7, 2021), which amount includes the fees and expenses of legal counsel to the Sales Agent up to $50,000, and to pay the costs associated with bound volumes of the public offering materials as well as commemorative mementos and lucite tombstones, in an amount not to exceed $3,000.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We will pay the Sales Agent a fixed commission rate of 2.0% of the aggregate gross proceeds from the sale of any shares pursuant to the Sales Agreement and have agreed to provide the Sales Agent with customary indemnification and contribution rights. We also agreed to reimburse the actual out-of-pocket accountable expenses of the Sales Agent up to $60,000 (of which a $25,000 advance was paid on December 7, 2021)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:107%">.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we will pay to H.C. Wainwright &amp; Co. (&#8220;Wainwright&#8221;), a fee equal to 1.0% of the gross proceeds of the sales price of all the shares sold under the Sales Agreement, pursuant to a separate financial services agreement with Wainwright. Wainwright is not a sales agent under the Sales Agreement.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2023 and 2022, we did not have any sales under the at-the-market facility.</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_67"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of Inflation</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to normal inflationary trends and anticipate that any increased costs for our contract manufacturing and retail operations would be passed on to our customers; however, any increased costs related to diagnostic services would be absorbed by the Company. Inflation could have a material effect to our business in the future..</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_70"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant accounting policies are described in Note 2 of the Notes to Consolidated Financial Statements included under Item 8 of this Part II. However, certain accounting policies are deemed &#8220;critical&#8221;, as they require management&#8217;s highest degree of judgment, estimates and assumptions. These accounting policies, estimates and disclosures have been discussed with the Audit Committee of our Board of Directors. A discussion of our critical </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounting policies and estimates, the judgments and uncertainties affecting their application and the likelihood that materially different amounts would be reported under different conditions or using different assumptions are as follows:</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements and the accompanying notes thereto, in conformity with GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the respective reporting periods. Examples include revenue recognition and the estimation of the variable consideration associated with the diagnostic reimbursement rates, the provision for bad debt and billing discrepancies, sales returns and allowances, inventory obsolescence, useful lives of property and equipment, impairment of goodwill, intangibles and property and equipment, income tax valuations and assumptions related to accrued advertising. The estimates and assumptions are based on historical experience, current trends and other factors that management believes to be relevant at the time the financial statements are prepared. Management reviews the accounting policies, assumptions, estimates and judgments on a quarterly basis. Actual results could differ from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition and Accounts Receivables</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue principally through four types of revenue streams: diagnostic services, genomic products and services,&#8239;contract manufacturing, and retail and other. The process for estimating revenues and the ultimate collection of receivables involves assumptions and judgments.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue from our diagnostic services is recognized when the lab test is complete, and the diagnostic test result is provided to the customer. Revenue from our genomics services is recognized when the sequencing report is provided to the customer. Revenue from our consumer products is recognized when the shipments to contract manufacturing and retailer customers are recognized at the time ownership is transferred to the customer. We bill the providers at standard price and take into consideration for negotiated discounts and an anticipated reimbursement remittance adjustments based on the payer portfolio, when revenue is recorded. We use the most expected value method to estimate the transaction price for reimbursements that may vary from the standard price.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carry our accounts receivable at cost less an allowance for credit losses. Allowances for credit losses are based upon our judgment regarding collectability. On a periodic basis, we evaluate our receivables and establish an allowance for credit losses, based on a history of past write-offs, collections, current credit conditions or generally accepted future trends in the industry and/or local economy. Accounts are written off as uncollectible at the time we determine that collections are unlikely. The reserve is not intended to address return activity or disputed balances with ongoing customers, as this should be addressed in a reserve for credit memos with a corresponding charge to revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Long-lived Assets</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review our goodwill at least annually for impairment as well as the carrying value of goodwill and our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be fully recoverable. When it is determined that the carrying amount of long-lived assets or goodwill is impaired, impairment is measured by comparing an asset&#8217;s estimated fair value to its carrying value. The determination of fair value is based on quoted market prices in active markets, if available, or independent appraisals; sales price negotiations; or projected future cash flows discounted at a rate determined by management to be commensurate with our business risk. The estimation of fair value utilizing discounted forecasted cash flows includes significant judgments regarding assumptions of revenue, operating and marketing costs; selling and administrative expenses; interest rates; property and equipment additions and retirements; and industry competition, general economic and business conditions, among other factors.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting for income taxes requires recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities. These deferred taxes are measured by applying the provisions of tax laws in effect at the balance sheet date, including the impact of the Tax Cuts and Jobs Act (&#8220;TCJA&#8221;) enacted on December 22, 2017. The TCJA made broad and significant changes to the U.S. tax code that affects the year ended December 31, 2017, including, but not limited to, a change in the federal rate from 35% to 21% effective January 1, 2018.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize in income the effect of a change in tax rates on deferred tax assets and liabilities in the period that includes the TCJA enactment date. We utilize the asset and liability approach which requires the recognition of deferred tax assets and liabilities for the future tax consequences of events that have been recognized in our financial statements or tax returns. In estimating future tax consequences, we generally consider all expected future events other than enactments of changes in the tax law or rates. Until sufficient taxable income to offset the temporary timing differences attributable to operations and the tax deductions attributable to option, warrant and stock activities are assured, a valuation allowance equaling the total net current and non-current deferred tax asset is being provided.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is valued at the lower of cost, determined on a first-in, first-out basis (&#8220;FIFO&#8221;), or net realizable value. We regularly review inventory quantities on hand and record a provision for excess and obsolete inventory based primarily on current and anticipated customer demand, production and laboratory requirements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 1, 2023, the Company adopted ASU 2016-13, &#8220;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&#8221; (&#8220;ASU 2016-13&#8221;)  ASU 2016-13 requires an impairment model (known as the current expected credit loss (&#8220;CECL&#8221;) model) that is based on expected losses rather than incurred losses. Under the new guidance, each reporting entity should estimate an allowance for expected credit losses, which is intended to result in more timely recognition of losses. This model replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost, accounts receivable and available for sale debt securities and applies to some off-balance sheet credit exposures. In February 2020, the FASB issued ASU 2020-02, Financial Instruments - Credit Losses (Topic 326), which amends the effective date of the original pronouncement for smaller reporting companies. ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022.  The adoption of ASU 2016-13 did not have a material impact on the Company's consolidated financial statements. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2023, the Financial Accounting Standards Board (FASB) issued ASU 2023-05, "Business Combinations - Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement." The new guidance applies to the formation of a joint venture and requires a joint venture to initially measure all contributions received upon its formation at fair value. The guidance is intended to reduce diversity in practice and is applicable to joint venture entities with a formation date on or after January 1, 2025 on a prospective basis. The Company currently does not have any transactions that fall under the scope of ASU 2023-05; therefore, the adoption of ASU 2023-05 is not expected to have an impact on the Company's consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), which requires an enhanced disclosure of significant segment expenses on an annual and interim basis. This guidance will be effective for the annual periods beginning the year ended December 31, 2024, and for interim periods beginning January 1, 2025. Early adoption is permitted. Upon adoption, the guidance should be applied retrospectively to all prior periods presented in the financial statements. We do not expect the adoption of this guidance to have a material impact on our consolidated financial statements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which improves the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the effective tax rate reconciliation and income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. This guidance will be effective for the annual periods beginning the year ended December 31, 2025. Early adoption is permitted. Upon adoption, the guidance can be applied prospectively or retrospectively. We do not expect the adoption of this guidance to have a material impact on our consolidated financial statements.</span></div><div><span><br/></span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_73"></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7A.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Like virtually all commercial enterprises, we may be exposed to the risk (&#8220;market risk&#8221;) that the cash flows to be received or paid relating to certain financial instruments could change as a result of changes in interest rate, exchange rates, commodity prices, equity prices and other market changes.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are not subject to risks of material foreign currency fluctuations, nor do we use derivative financial instruments in our investment practices. We place our marketable investments in instruments that meet high credit quality </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">standards. We do not expect material losses with respect to our investment portfolio or excessive exposure to market risks associated with interest rates. The impact on our results of one percentage point change in short-term interest rates would not have a material impact on our future earnings, fair value, or cash flows related to investments in cash equivalents or interest-earning marketable securities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current economic conditions may cause a decline in business and consumer spending which could adversely affect our business and financial performance including the collection of accounts receivables, realization of inventory and recoverability of assets. In addition, our business and financial performance may be adversely affected by current and future economic conditions, including a reduction in the availability of credit, financial market volatility and recession.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">61</span></div></div></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.&#160;&#160;&#160;&#160;Financial Statements and Supplementary Data</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO FINANCIAL STATEMENTS</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.052%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Page</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline">Reports of Independent Registered Public Accounting Firms</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> (PCAOB ID: <ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-37">536</ix:nonNumeric>)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">62</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Financial Statements:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_85">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">67</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_88">Consolidated Statements of Operations and Other Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">69</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_91">Consolidated Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_91">70</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_94">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_94">71</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_97">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_97">72</a></span></div></td></tr></table></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_79"></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">To the Board of Directors and Members of ProPhase Labs, Inc. and Subsidiaries</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Opinion on the Financial Statements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">We have audited the accompanying consolidated balance sheets of ProPhase Labs, Inc. and Subsidiaries (the Company) as of December 31, 2023 and 2022, and the related consolidated statements of operations and comprehensive income, stockholders&#8217; equity, and cash flows for each of the two years in the period ended December 31, 2023, and the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December, 2023 and 2022, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Basis for Opinion</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Critical Audit Matters</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Diagnostic Service Revenue, Accounts Receivable, and Allowances</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">As described in Note 2 to the consolidated financial statements, the Company&#8217;s diagnostic service revenue is derived from third party insurers and government agencies. Management estimates the amount of consideration it expects to receive for providing diagnostic services based on historical billing and collection information. Management takes into consideration expected reimbursements from insurance providers (including uncollectible billings) and government agency programs, including those for uninsured patients. Revenue and accounts receivable are billed based on standard test rates. Revenue and accounts receivable are recognized based on finalized tests and historical reimbursement rate based on the type of service performed and billing code requirements. Given the nature of these estimates, performing audit procedures to evaluate appropriate revenue recognition and allowances associated with diagnostic services with billing discrepancies required a high degree of auditor judgment and an increased extent of effort.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. The procedures included the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.68pt">Gaining an understanding of diagnostic services&#8217; billing and collection process.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Testing the completeness and accuracy of the Company&#8217;s billing system, which included, among other things, performing transaction testing on a sample of diagnostic tests performed, which included review of patient information including insurance carrier as estimated reimbursement rate is based on historical payments by insurance carrier, review of finalization of test results, and an analysis of the historical reimbursements rate to date for each payer. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.68pt">Performing an analysis of the collections compared to the estimated rate used to record revenue based on historical collections. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Performing a cash reconciliation to ensure the revenue and accounts receivable recognized were reasonable, based on deposits received through December 31, 2023. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.68pt">Reviewing management&#8217;s estimated allowances as compared to historical collection rates, current and future economic conditions and events, and specific allowances for credit loss items based on longevity of the outstanding balance and specific reserve by type and payer for probability of payment through December 31, 2023. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Genomics Revenue and Deferred Revenue</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">As described in Note 2 to the consolidated financial statements, the Company&#8217;s genomics revenue is derived from DNA kit sales direct to the consumer sales via website or through online retailers with upfront payments. Management estimates the breakout of the consideration it expects to receive for providing the kit sales and subscriptions. Management takes into consideration the standard price of kits and subscriptions when breaking out the recognition of revenue. Management satisfies product performance obligation at a point in time when the genetic testing results are provided to the customer. For subscriptions services associated with its genomic testing, we satisfy our performance obligation ratably over the subscription period. If the customer does not return the test kit, services cannot be completed by the Company, potentially resulting in unexercised rights (&#8220;breakage&#8221;) revenue, including lifetime subscription services. Management estimates breakage for the portion of test kits not expected to be returned using an analysis of historical data and consider other factors that could influence customer test kit return behavior. When breakage revenue is recognized on a kit, the company recognize breakage on any associated subscription services ratably over the term of the subscription. Given the nature of these estimates, performing audit procedures to evaluate appropriate revenue recognition and allowances associated with genomics services required a high degree of auditor judgement and an increased extent of effort.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. The procedures included the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.68pt">Gaining an understanding of the genomics&#8217; billing and standard pricing of kits and subscriptions.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.68pt">Testing the completeness and accuracy of the Company&#8217;s genomics revenue reports, which included, among other things, performing transaction testing on a sample of genomics tests performed, which included review of payment information as invoices were not available for all selections. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Performing a cash reconciliation for online retailers used to ensure the revenue and accounts receivable recognized were reasonable, based on deposits received through December 31, 2023. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.68pt">Performing a cash reconciliation for all business to business customers to ensure the revenue and accounts receivable recognized were reasonable, based on collections through December 31, 2023. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Obtaining accounts receivable confirmation for business to business customers with outstanding balances as of December 31, 2023. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.68pt">Reviewing management&#8217;s estimated pricing assumptions based on type of kit and quantity of kit ordered through online retailers. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">f.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:11.01pt">Reviewing calculation of management estimate regarding timing of breakage for kit recognition as of December 31, 2023. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Reviewing calculation of estimate regarding useful life of subscription revenue. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">/s/ <ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-38">Morison Cogen LLP</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">We have served as the Company&#8217;s auditor since 2022.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-39">Blue Bell, Pennsylvania</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">March 28, 2024</span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">To the Board of Directors and Members of ProPhase Labs, Inc. and Subsidiaries</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Adverse Opinion on Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">We have audited ProPhase Labs, Inc. and Subsidiaries&#8217; (the Company&#8217;s) internal control over financial reporting as of December 31, 2023, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Internal Control&#8212;Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, because of the effect of the material weakness described in the following paragraph on the achievement of the objectives of the control criteria, the Company has not maintained effective internal control over financial reporting as of December 31, 2023, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Internal Control&#8212;Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> issued by COSO.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">A material weakness is a control deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company&#8217;s annual or interim consolidated financial statements will not be prevented or detected on a timely basis. The following material weaknesses have been identified and included in management&#8217;s assessment:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Certain account reconciliations contained misstatements, resulting in several proposed journal entries. In addition, it does not appear there was adequate review of the reconciliations or controls over the financial statement closing process. This reduces the likelihood of the Company achieving the objectives of the above-mentioned control criteria.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Several errors were made related to recording revenue in the proper period, calculating current period revenue, and following Company policy regarding principal versus agent considerations, resulting in misstatements in accounts receivable, deferred revenue, and revenue for multiple subsidiaries. The Company relies heavily on the manual input process for these areas and it does not appear there are controls in place to identify exceptions. In addition, in certain instances where revenue is recorded based on an estimation of rates, it appears the rates were not updated accordingly throughout the year. This reduces the likelihood of the Company achieving the objectives of the above-mentioned control criteria.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">The Company relies heavily on the manual input process for calculating and recording deferred costs and cost of sales, resulting in misstatements in those areas. In addition, it does not appear there are adequate controls in place to identify discrepancies. This reduces the likelihood of the Company achieving the objectives of the above-mentioned control criteria.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">These material weaknesses were considered in determining the nature, timing, and extent of audit tests applied in our audit of the 2023 consolidated financial statements, and this report does not affect our report dated March 28, 2024, on those consolidated financial statements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets and the related consolidated statements of operations and comprehensive income, stockholders&#8217; equity, and cash flows of the Company, and our report dated March 28, 2024, expressed an unqualified opinion.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Basis for Opinion</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">/s/ Morison Cogen LLP</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">We have served as the Company&#8217;s auditor since 2022.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Blue Bell, Pennsylvania</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">March 28, 2024</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">66</span></div></div></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPHASE LABS, INC AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share amounts)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-40">1,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-41">9,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCash" scale="3" id="f-42">540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestrictedCash" format="ixt:fixed-zero" scale="3" id="f-43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Marketable securities, available for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-44">3,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-45">8,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-46">36,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-47">37,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Inventory, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-48">3,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-49">3,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-50">2,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-51">2,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-52">47,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-53">60,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-54">12,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-55">7,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Prepaid expenses, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseNoncurrent" scale="3" id="f-56">832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidExpenseNoncurrent" scale="3" id="f-57">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Operating lease right-of-use asset, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-58">4,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-59">4,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-60">12,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-61">8,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-62">5,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-63">5,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Deferred tax asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-64">7,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:fixed-zero" scale="3" id="f-65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-66">1,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-67">1,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">TOTAL ASSETS</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-68">91,927</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-69">87,648</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-70">9,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-71">5,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accrued diagnostic services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="f-72">314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-73">1,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accrued advertising and other allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedMarketingCostsCurrent" scale="3" id="f-74">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedMarketingCostsCurrent" scale="3" id="f-75">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-76">1,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" format="ixt:fixed-zero" scale="3" id="f-77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-78">953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-79">301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredRevenueCurrent" format="ixt:num-dot-decimal" scale="3" id="f-80">2,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredRevenueCurrent" format="ixt:num-dot-decimal" scale="3" id="f-81">2,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Income tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-82">3,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-83">4,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-84">2,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-85">2,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-86">20,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-87">16,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPHASE LABS, INC AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Continued</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Non-current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Long-term debt, net of discount of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent" scale="3" id="f-88">341</ix:nonFraction></span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-89">2,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="3" id="f-90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Unsecured convertible promissory notes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnsecuredLongTermDebt" format="ixt:fixed-zero" scale="3" id="f-91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-92">2,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Unsecured promissory notes, net of discount of $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent" scale="3" id="f-93">266</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent" scale="3" id="f-94">0</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-95">7,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:UnsecuredLongTermDebt" format="ixt:fixed-zero" scale="3" id="f-96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Due to sellers (see Note 3)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetAcquisitionContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-97">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetAcquisitionContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="f-98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Deferred revenue, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-99">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-100">1,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Deferred tax liability, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="f-101">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="f-102">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Finance lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-103">4,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="f-104">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-105">4,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-106">4,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-107">21,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-108">7,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-109">42,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-110">24,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">COMMITMENTS AND CONTINGENCIES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-111"/></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-112"/>&#160;</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Preferred stock authorized <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-113"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-114">1,000,000</ix:nonFraction></ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="4" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-115"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-116">0.0005</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-117"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-118"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-119"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-120">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-121">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-122">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common stock authorized <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-123"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-124">50,000,000</ix:nonFraction></ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-125"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-126">0.0005</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-127">18,045,029</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-128">16,210,776</ix:nonFraction> shares outstanding, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-129">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-130">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-131">118,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-132">109,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Retained earnings (accumulated deficit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-133">5,029</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-134">11,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury stock, at cost, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-135">18,940,967</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-136">18,126,790</ix:nonFraction> shares, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="f-137">64,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="f-138">58,033</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-139">300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-140">757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-141">49,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-142">63,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-143">91,927</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-144">87,648</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">68</span></div></div></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPHASE LABS, INC &amp; SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS AND</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share amounts)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenues, net</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-145">44,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-146">122,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-147">28,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-148">51,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-149">16,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-150">70,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfessionalFees" format="ixt:num-dot-decimal" scale="3" id="f-151">1,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ProfessionalFees" format="ixt:num-dot-decimal" scale="3" id="f-152">12,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">General and administration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-153">34,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-154">34,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-155">1,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-156">652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-157">37,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-158">47,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Loss) income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-159">21,613</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-160">23,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestIncomeOther" scale="3" id="f-161">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:InterestIncomeOther" scale="3" id="f-162">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-163">1,275</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="f-164">764</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in fair value of investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:fixed-zero" scale="3" id="f-165">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" scale="3" id="f-166">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-167">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="f-168">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Loss) income from operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-169">22,800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-170">22,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-171">6,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-172">4,445</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Loss (income)  from operations after income taxes</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-173">16,782</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-174">18,463</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other comprehensive (loss) income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unrealized (loss) income on marketable  securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-175">1,057</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-176">932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total comprehensive (loss) income</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-177">17,839</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-178">19,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Earnings (loss)  per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-179">0.98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-180">1.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-181">0.98</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-182">1.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average common shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-183">17,207</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-184">15,845</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-185">17,207</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-186">18,651</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">69</span></div></div></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPHASE LABS, INC &amp; SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share data)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Common Stock<br/>Shares<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Par<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Additional Paid in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated<br/>(Deficit) Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Treasury<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Balance as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-187">15,485,900</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-188">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-189">104,552</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-190">2,642</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-191">175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-192">48,407</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-193">58,628</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Issuance of common stock for debt conversion</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-194">200,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="f-195">600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="f-196">600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Issuance of common stock upon stock options cashless exercise</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-197">828,021</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Repurchase of common shares</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-198">303,145</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-199">2,152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-200">2,152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Cash dividends</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-201">9,352</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-202">9,352</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury shares repurchased to satisfy tax withholding obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-203">7,474</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-204">7,474</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrealized gain on marketable debt securities, net of taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-205">932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="f-206">932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Cashless warrants exercise</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-207">3,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-208">3,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-209">18,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-210">18,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-211">16,210,776</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-212">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-213">109,138</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-214">11,753</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-215">757</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-216">58,033</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-217">63,631</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Issuance of common stock in asset acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-218">100,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="f-219">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="f-220">999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-221">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Repurchases of common shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="c-27" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-222">69,628</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="f-223">588</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="f-224">588</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Issuance of common stock to convert outstanding convertible notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-225">800,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="f-226">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-227">2,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-228">2,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Issuance of common stock upon exercise of warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="INF" name="prph:IssuanceOfCommonStockSharesExerciseOfWarrant" format="ixt:num-dot-decimal" scale="0" id="f-229">400,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="prph:IssuanceOfCommonStockUponExerciseOfWarrantAmount" format="ixt:num-dot-decimal" scale="3" id="f-230">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="prph:IssuanceOfCommonStockUponExerciseOfWarrantAmount" format="ixt:num-dot-decimal" scale="3" id="f-231">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Issuance of common stock upon stock options cashless exercise</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-232">603,881</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Issuance of warrants with unsecured promissory note</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" id="f-233">398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" id="f-234">398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury shares repurchased to satisfy tax withholding obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-235">5,379</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-236">5,379</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrealized loss on marketable securities, net of taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-237">1,057</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-238">1,057</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Stock-based compensation (including $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="prph:PrepaidShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-239">1,024</ix:nonFraction> in prepaid expense)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-240">4,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-241">4,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-242">16,782</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-243">16,782</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Balance as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-32" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-244">18,045,029</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-245">18</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-246">118,694</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-247">5,029</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-248">300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-249">64,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-250">49,383</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">70</span></div></div></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPHASE LABS, INC &amp; SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-251">16,782</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-252">18,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Realized loss on marketable debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" scale="3" id="f-253">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" scale="3" id="f-254">354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-255">6,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-256">4,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortization of debt discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="f-257">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="f-258">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortization on right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="f-259">421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="f-260">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gain on sales of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainLossOnSaleOfProperties" scale="3" id="f-261">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:GainLossOnSaleOfProperties" scale="3" id="f-262">127</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-263">3,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-264">3,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in fair value of investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="prph:ChangeInFairValueOfInvestmentSecurities" format="ixt:fixed-zero" scale="3" id="f-265">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="prph:ChangeInFairValueOfInvestmentSecurities" scale="3" id="f-266">174</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts receivable allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-267">718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-268">761</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventory valuation reserve</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="prph:InventoryValuationReserve" format="ixt:fixed-zero" scale="3" id="f-269">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="prph:InventoryValuationReserve" scale="3" id="f-270">78</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Credit loss expense, direct write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProvisionForLoanLeaseAndOtherLosses" scale="3" id="f-271">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ProvisionForLoanLeaseAndOtherLosses" format="ixt:num-dot-decimal" scale="3" id="f-272">6,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="f-273">68</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-274">4,498</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="f-275">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="f-276">702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-277">376</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-278">617</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Deferred tax asset </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="prph:IncreaseDecreaseInDeferredIncomeTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-279">7,313</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="prph:IncreaseDecreaseInDeferredIncomeTaxAssets" format="ixt:fixed-zero" scale="3" id="f-280">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:fixed-zero" scale="3" id="f-281">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="f-282">555</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-283">3,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-284">1,121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued diagnostic services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="prph:IncreaseDecreaseInAccruedDiagnosticServices" scale="3" id="f-285">695</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="prph:IncreaseDecreaseInAccruedDiagnosticServices" scale="3" id="f-286">881</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued advertising and other allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="prph:IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances" scale="3" id="f-287">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="prph:IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances" scale="3" id="f-288">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="f-289">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="f-290">619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="prph:IncreaseDecreaseInDeferredIncomeTaxLiabilities" scale="3" id="f-291">224</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="prph:IncreaseDecreaseInDeferredIncomeTaxLiabilities" scale="3" id="f-292">138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="f-293">181</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="f-294">301</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="f-295">912</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="f-296">2,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" scale="3" id="f-297">611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" scale="3" id="f-298">423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;Net cash (used in) provided by operating activities </span></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-299">11,348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-300">28,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;Business acquisitions, escrow received </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EscrowDepositsRelatedToPropertySales" scale="3" id="f-301">478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:EscrowDepositsRelatedToPropertySales" format="ixt:fixed-zero" scale="3" id="f-302">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;Business acquisitions, net of cash acquired </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="f-303">2,904</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="f-304">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;Issuance of secured promissory note receivable </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="prph:IssuanceOfSecuredPromissoryNoteReceivable" format="ixt:fixed-zero" scale="3" id="f-305">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="prph:IssuanceOfSecuredPromissoryNoteReceivable" format="ixt:fixed-zero" scale="3" id="f-306">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;Purchase of marketable securities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-307">3,819</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-308">6,777</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;Proceeds from sales of marketable securities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-309">3,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-310">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;Proceeds from maturities of marketable securities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-311">4,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-312">7,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;Proceeds from dispositions of property and other assets, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleOfOtherPropertyPlantAndEquipment" scale="3" id="f-313">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ProceedsFromSaleOfOtherPropertyPlantAndEquipment" scale="3" id="f-314">452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;Proceeds from promissory note </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable" format="ixt:fixed-zero" scale="3" id="f-315">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable" format="ixt:fixed-zero" scale="3" id="f-316">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;Capital expenditures </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-317">3,155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-318">3,919</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net cash used in investing activities </span></td><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-319">1,369</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-320">2,077</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Proceeds from issuance of note payable </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromNotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-321">10,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ProceedsFromNotesPayable" format="ixt:fixed-zero" scale="3" id="f-322">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Proceeds from exercise of warrants </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="f-323">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:fixed-zero" scale="3" id="f-324">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Repayment of common stock for payment of statutory taxes on cashless exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-325">5,379</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-326">7,474</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Repayment of note payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:fixed-zero" scale="3" id="f-327">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-328">7,044</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Repurchases of common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="f-329">588</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-330">2,152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Payment of dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:fixed-zero" scale="3" id="f-331">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="f-332">9,353</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net cash  provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-333">5,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-334">26,023</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Decrease) increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-335">6,960</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="f-336">451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash, cash equivalents and restricted cash, at the beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-337">9,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-338">8,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cash, cash equivalents and restricted cash, at the end of the year</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-339">2,149</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-340">9,109</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Supplemental disclosures:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash paid for income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-341">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-342">1,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest payment on the promissory notes</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="f-343">932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="f-344">763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Supplemental disclosure of non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;Stock-based compensation included in the prepaid expense </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-345">1,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="f-346">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;Issuance of common shares for debt conversion</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="prph:IssuanceOfCommonSharesForDebtConversion" format="ixt:num-dot-decimal" scale="3" id="f-347">2,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="prph:IssuanceOfCommonSharesForDebtConversion" scale="3" id="f-348">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;Net unrealized loss, investments in marketable securities</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="prph:NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-349">1,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="prph:NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-350">1,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;Assets obtained in exchange for new finance lease obligations </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-351">5,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-352">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;Issuance of warrants with unsecured promissory note </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="prph:IssuanceOfWarrantsWithUnsecuredPromissoryNote" scale="3" id="f-353">398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="prph:IssuanceOfWarrantsWithUnsecuredPromissoryNote" format="ixt:fixed-zero" scale="3" id="f-354">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;Common stock issued in asset acquisition </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssued1" format="ixt:num-dot-decimal" scale="3" id="f-355">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:StockIssued1" format="ixt:fixed-zero" scale="3" id="f-356">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statement</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">71</span></div></div></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_100"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-357" continuedAt="f-357-1" escape="true">Organization and Business</ix:nonNumeric></span></div><ix:continuation id="f-357-1" continuedAt="f-357-2"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ProPhase Labs, Inc. (&#8220;ProPhase&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221;) is a diversified company that offers a range of services including genomics testing, diagnostic testing and contract manufacturing. We are also focused on licensing, developing and commercializing novel drugs, dietary supplements, compounds and diagnostics.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until late fiscal year 2020, the Company was engaged primarily in the research, development, manufacture, distribution, marketing and sale of over-the-counter ("OTC") consumer healthcare products and dietary supplements in the United States. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In October 2020, the Company completed the acquisition of all of the issued and outstanding shares of capital stock of Confucius Plaza Medical Laboratory Corp. (&#8220;CPM&#8221;), which owned a <ix:nonFraction unitRef="sqft" contextRef="c-37" decimals="0" name="us-gaap:AreaOfRealEstateProperty" format="ixt:num-dot-decimal" scale="0" id="f-358">4,000</ix:nonFraction> square foot </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Clinical Laboratory Improvement Amendments (&#8220;CLIA&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> accredited laboratory located in Old Bridge, New Jersey for approximately $<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="f-359">2.5</ix:nonFraction> million, and began offering COVID-19 diagnostic tests through our wholly-owned subsidiary, ProPhase Diagnostics, Inc. ("ProPhase Diagnostics") in December 2020. Also in December 2020, we expanded our diagnostic service business with the build-out of a second, larger CLIA accredited laboratory in Garden City, New York. Operations at this second facility commenced in January 2021. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We offered a broad array of COVID-19 related clinical diagnostic and testing services including polymerase chain reaction (&#8220;PCR&#8221;) testing for COVID-19 and Influenza A and B through ProPhase Diagnostics, as well as rapid antigen and antibody/immunity testing for COVID-19. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Due to the significant decrease in demand and reimbursement rate for our diagnostic testing service, we have reduced the amount of diagnostic testing services that we provide since the second half of 2023. Nonetheless we are prepared to provide an increased volume of our diagnostic testing service if diagnostic testing is required due to a new COVID-19 outbreak. We have continued to ship COVID-19 antigen kits under an existing contract to our customer. In addition, in order to maintain licenses in certain states in which we operate, we currently perform several diagnostic tests each quarter to maintain our certified lab status, and we currently plan to do so for the foreseeable future.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2021, the Company acquired Nebula Genomics, Inc. (&#8220;Nebula&#8221;), a privately owned personal genomics company, through our wholly-owned subsidiary, ProPhase Precision Medicine Inc. Nebula focuses on genomics sequencing technologies, a comprehensive method for analyzing entire genomes, including the genes and chromosomes in deoxyribonucleic acidDNA. The data obtained from genomic sequencing can be used to help identify inherited disorders and tendencies, help predict disease risk, help identify expected drug response, and characterize genetic mutations, including those that drive cancer progression. </span></div><div style="text-align:justify;text-indent:29.15pt"><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's wholly owned subsidiary, ProPhase BioPharma, Inc. (&#8220;PBIO&#8221;), was formed in June 2022, for the licensing, development and commercialization of novel drugs, dietary supplements and compounds. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Licensed compounds currently include Equivir (a OTC, dietary supplement candidate) and Equivir G (prescription drug (&#8220;Rx&#8221;) candidate), <ix:nonFraction unitRef="numberoflicensedcompound" contextRef="c-39" decimals="INF" name="prph:NumberOfLicensedCompounds" format="ixt-sec:numwordsen" scale="0" id="f-360">two</ix:nonFraction> broad-based anti-virals, and Linebacker LB-1 and LB-2, <ix:nonFraction unitRef="inhibitor" contextRef="c-40" decimals="INF" name="prph:NumberOfInhibitors" format="ixt-sec:numwordsen" scale="0" id="f-361">two</ix:nonFraction> small molecule proviral integration site for moloney murine leukemia virus (&#8220;PIM&#8221;) kinase inhibitors. The Company also own the exclusive rights to the BE-Smart Esophageal Pre-Cancer Diagnostic Screening test and related intellectual property (&#8220;IP&#8221;) assets. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the activities of PBIO, in January 2023, the Company acquired exclusive rights to BE-Smart Esophageal Pre-Cancer Diagnostic Screening test and related IP assets. The BE-Smart test is focused on the early detection of esophageal cancer, and is intended to provide health care providers and patients with data to help determine treatment options. The development of these novel drugs and compounds is highly dependent on how each performs during the testing and development stage, the demand for these product and services once entered into the marketplace, our marketing and service capabilities and our ability to comply with applicable regulatory requirements. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's wholly-owned subsidiary, Pharmaloz Manufacturing, Inc. (&#8220;PMI&#8221;), is a full-service contract manufacturer and private label developer of a broad range of non-GMO, organic and natural-based cough drops and lozenges and OTC drug and dietary supplement products. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also develops and markets dietary supplements under the TK Supplements&#174; brand. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The TK Supplements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">product line includes Legendz XL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a male sexual enhancement and Triple Edge XL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an energy and stamina booster. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's wholly owned subsidiary, Pharmaloz Real Estate Holdings, Inc. (&#8220;PREH&#8221;), was formed in November 2023, for the purpose to receive additional investment to expand its current facility. There was no operation for PREH as of December 31, 2023. </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-357-2"><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company continues to actively pursue acquisition opportunities for other companies, technologies and products within and outside the consumer products industry.</span></div></ix:continuation><div id="i940cc81906cc4cdfbb1f3b7467688c8d_103"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-362" continuedAt="f-362-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="f-362-1" continuedAt="f-362-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-363" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no effect on the reported results of operations.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="f-364" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification ("ASC") 280, &#8220;Segment Reporting&#8221; (&#8220;ASC 280&#8221;), the Company discloses financial and descriptive information about its reportable operating segments. Operating segments are components of an enterprise about which separate financial information is available and regularly evaluated by the chief operating decision maker in deciding how to allocate resources and in assessing performance.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows ASC 280, which establishes standards for reporting information about operating segments in annual and interim financial statements, and requires that companies report financial and descriptive information about their reportable segments based on a management approach. ASC 280 also establishes standards for related disclosures about products and services, geographic areas and major customers.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are defined as components of an enterprise that engage in business activities for which separate financial information is available and is evaluated by the Chief Operating Decision Maker (&#8220;CODM&#8221;), which for the Company is its Chief Executive Officer, in deciding how to allocate resources and assess performance. We maintain <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" id="f-365">two</ix:nonFraction> operating segments: diagnostic services (which includes our COVID-19 and other diagnostic testing services) and consumer products (which includes our contract manufacturing, retail customers, biopharma and personal genomics products and services). See Note 15 Segment Information.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-366" continuedAt="f-366-1" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business and Liquidity Risks and Uncertainties</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our diagnostic service business continued to be impacted by the level of demand for COVID-19 and other diagnostic testing, the prices we are able to receive for performing our testing services, our ability to collect payment or reimbursement for our testing services in December 31, 2023 and ultimately led to our revenues decreasing significantly for the year ended December 31, 2023. On March 22, 2022, the Health Resources &amp; Services Administration ("HRSA") program stopped accepting claims for COVID-19 testing and treatment provided to uninsured individuals due to lack of sufficient funds. We recognized approximately <ix:nonFraction unitRef="test" contextRef="c-10" decimals="INF" name="prph:NumberOfTestsRecognized" format="ixt:num-dot-decimal" scale="0" id="f-367">1,000,000</ix:nonFraction> tests for the year ended December 31, 2022 and approximately <ix:nonFraction unitRef="test" contextRef="c-1" decimals="INF" name="prph:NumberOfTestsRecognized" format="ixt:num-dot-decimal" scale="0" id="f-368">480,000</ix:nonFraction>  tests for the year ended December 31, 2023, of which <ix:nonFraction unitRef="number" contextRef="c-10" decimals="2" name="prph:NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage" scale="-2" id="f-369">28</ix:nonFraction>%  were reimbursed by the HRSA uninsured program for the year ended December 31, 2022, and <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="prph:NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage" format="ixt-sec:numwordsen" id="f-370">none</ix:nonFraction> were reimbursed from the HRSA uninsured program for the year ended December 31, 2023. As a result, we have reduced the amount of diagnostic testing services that we provide since the second half of 2023. Nonetheless we are prepared to provide an increased volume of our diagnostic testing service if diagnostic testing is required due to a new COVID-19 outbreak. We have continued to ship COVID-19 antigen kits under an existing contract to our customer. In addition, in order to maintain licenses in certain states in which we operate, we currently perform several diagnostic tests each quarter to maintain our certified lab status, and we currently plan to do so for the foreseeable future. There is no guarantee that the demand of our diagnostic testing services will increase or meet the level of demand that we experienced during the COVID-19 pandemic, and there is no guarantee that we will be able to substitute the revenues previously generated from this line of business from our other business lines.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our personal genomics business is and will continue to be influenced by demand for our genetic sequencing products and services, our marketing and service capabilities, and our ability to comply with applicable regulatory requirements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our contracting manufacturing business is and will continue to be impacted by demand for our services, which is largely a function of the timing, length and severity of each cold season. Generally, a cold season is defined as the period from September to March when the incidence of the common cold rises as a result of the change in weather and other factors. We generally experience in the first, third and fourth quarter higher levels of net revenues from our contract manufacturing business. Revenues are generally at their lowest levels in the second quarter when customer demand generally declines. This line of business is also impacted by our ability to meet such demands. The building of our manufacturing facilities and manufacturing of products necessitates compliance with applicable regulatory requirements.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-362-2" continuedAt="f-362-3"><ix:continuation id="f-366-1" continuedAt="f-366-2"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consumer sales are and will continue to be impacted by (i) the timing of acceptance of our TK Supplements</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consumer products in the marketplace, and (ii) fluctuations in the timing of purchase and the ultimate level of demand for these products. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="f-371">11.3</ix:nonFraction>&#160;million was used by operating activities.  The Company had cash, cash equivalents, restricted cash and marketable securities of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="f-372">5.3</ix:nonFraction> million as of December&#160;31, 2023. Based on management&#8217;s current business plans, the Company estimates that it will have enough cash and liquidity to finance its operating requirements for at least one year from the date of filing these financial statements. However, due to the nature of the diagnostic business and the Company's focus thus far on COVID-19, there are inherent uncertainties associated with managements&#8217; business plan and cash flow projections if the Company is unable to grow its diagnostic testing business beyond COVID-19 testing services and to grow its other businesses.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-366-2" continuedAt="f-366-3">As such, the Company&#8217;s future capital needs and the adequacy of its available funds will depend on many factors. These include, but not necessarily limited to, the actual cost and time necessary to achieve sustained profitability from diagnostic services, the ability to successfully diversify the diagnostic services revenue streams and the ability to market and grow the personal genomics, biopharma, manufacturing and supplement businesses. The Company may be required to raise additional funds through equity or debt securities offerings or strategic collaboration and/or licensing agreements in order to fund operations until it is able to generate enough revenues. Such financing may not be available on acceptable terms, or at all, and the Company&#8217;s failure to raise capital when needed could have a material adverse effect on its strategic objectives, results of operations and financial condition.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-373" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements and the accompanying notes thereto, in conformity with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;), requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the respective reporting periods. Examples include revenue recognition and the impact of the variable consideration around diagnostic test reimbursement rates, the provision for uncollectible receivables and billing errors, sales returns and allowances, rates, slow moving, dated inventory and associated provisions, the estimated useful lives and potential impairment of long-lived assets, stock based compensation valuation, income tax asset valuations and assumptions related to accrued advertising.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimates and assumptions are based on historical experience, current trends and other factors that management believes to be relevant at the time the financial statements are prepared. Management reviews the accounting policies, assumptions, estimates and judgments on a quarterly basis. Actual results could differ from those estimates.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-374" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all highly liquid investments with a maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents include cash on hand and monies invested in money market funds. The carrying amount approximates the fair market value due to the short-term maturity of these securities.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="f-375" continuedAt="f-375-1" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-375-1">Restricted cash as of December&#160;31, 2023 includes approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EscrowDeposit" format="ixt:num-dot-decimal" scale="0" id="f-376">540,000</ix:nonFraction> held in escrow related to the Company's mortgage loan. There was no restricted cash as of December 31, 2022.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:MarketableSecuritiesPolicy" id="f-377" continuedAt="f-377-1" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have classified our investments in marketable debt and equity securities as available-for-sale and as a current asset. Our investments in marketable securities are carried at fair value, with unrealized gains and as a separate component of stockholders&#8217; equity. Realized gains and losses from our marketable securities are recorded as interest income (expense). Marketable debt securities carry maturity dates between <span style="-sec-ix-hidden:f-378">one</span> and <ix:nonNumeric contextRef="c-42" name="prph:DebtSecuritiesAvailableForSaleMaturityPeriod" format="ixt-sec:durwordsen" id="f-379">three years</ix:nonNumeric> from date of purchase and interest rates of <ix:nonFraction unitRef="number" contextRef="c-41" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="f-380">1.40</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-42" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="f-381">4.90</ix:nonFraction>% during fiscal 2022. </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-362-3" continuedAt="f-362-4"><ix:continuation id="f-377-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:MarketableSecuritiesTextBlock" id="f-382" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the components of our marketable securities and the underlying fair value input level tier hierarchy (see fair value of financial instruments) (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Unrealized <br/>Losses </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate stock</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-383">3,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-384">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-385">401</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-386">3,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-387">3,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-388">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-389">401</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-390">3,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrealized <br/>Losses </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">U.S. government obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-391">1,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-392">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-393">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-394">1,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-395">5,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-396">1,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-397">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-398">6,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-399">7,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-400">1,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-401">92</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-402">8,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the unrealized gains or losses generally are the result of a change in the risk premiums required by market participants rather than an adverse change in cash flows or a fundamental weakness in the credit quality of the issuer or underlying assets.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ReceivablesPolicyTextBlock" id="f-403" continuedAt="f-403-1" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable, net</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable consists primarily of amounts due from government agencies and healthcare insurers. Unbilled accounts receivable relates to the delivery of our diagnostic testing services for which the related billings will occur in a future period, after a patient&#8217;s insurance information has been validated, and represent amounts we have an unconditional right to receive payment. Unbilled accounts receivable is classified as accounts receivable on the consolidated balance sheet. We carry our accounts receivable at the amount of consideration for which we expect to be entitled less allowances. When estimating the allowances for our diagnostics business, the Company pools its trade receivables based on the following payer types: healthcare insurers and government payers. The Company principally estimates the allowance for credit losses by pool based on historical collection experience, current economic conditions, expectations of future economic conditions, other credits and the period of time that the receivables have been outstanding. To the extent that any individual payers are identified that have deteriorated in credit quality, the Company removes the payers from their respective pools and establishes allowances based on the individual risk characteristics of such payers. On a periodic basis, we evaluate our receivables and establish an allowance, based on a history of past write-offs, government and healthcare insurer payment trends, collections, current credit conditions or generally accepted future trends. Accounts receivable are stated at the net amount expected to be collected, using an expected loss methodology that is referred to as the current expected credit loss ("CECL") model.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="f-404" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts are written off as uncollectible at the time we determine that collections are unlikely. Accounts receivable, net is comprised of the following (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableTradeCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-405">40,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableTradeCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-406">37,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unbilled accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:UnbilledContractsReceivable" format="ixt:fixed-zero" scale="3" id="f-407">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-408">2,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-409">40,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-410">40,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-411">3,864</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-412">3,140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total accounts receivable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="f-413">36,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="f-414">37,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="f-415" continuedAt="f-415-1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The table below presents a roll forward of the Company's allowance for credit losses (amount in thousands).</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-362-4" continuedAt="f-362-5"><ix:continuation id="f-415-1"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.212%"><tr><td style="width:1.0%"/><td style="width:83.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.190%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance as of January 1, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-416">3,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period provision for expected credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" scale="3" id="f-417">724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-418">3,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For Fiscal 2023, we recorded  $<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" format="ixt:num-dot-decimal" scale="6" id="f-419">0.3</ix:nonFraction>&#160;million to credit losses in operating expenses representing a write-off of trade receivables we have determined to be uncollectible and increased the allowance for credit losses as a reduction of revenue by $<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="f-420">0.4</ix:nonFraction>&#160;million. The results of these adjustments and our current year allowances, resulted in an allowance of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="f-421">3.9</ix:nonFraction>&#160;million at December&#160;31, 2023. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-403-1">At December 31, 2023, within the diagnostic services business, insurers had significantly aged balances that we are continuing to work to collect.  The specific facts and circumstances related to each of these individual payors have been considered by our management, which informed the determination of the year-end reserve balance. We continue to pursue collection of amounts due. However, there will inevitably be billings that are rejected by the insurance carriers and associated receivables that will not be collected. We believe that the reserve established at December 31, 2023 is adequate to capture this collectability risk. While past history is helpful informing the determination of an appropriate reserve, its utility is somewhat limited by the circumstances underlying a significant portion of these aged balances; specifically, an unprecedented volume of activity related COVID 19 diagnostic testing.  Accordingly, the determination of an appropriate reserve required significant management judgment and was informed by the unique facts and circumstances related to each of the three significant insurers.</ix:continuation> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For Fiscal 2022, we recorded $<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" format="ixt:num-dot-decimal" scale="6" id="f-422">5.9</ix:nonFraction>&#160;million to credit loss expense in operating expenses representing a write-off of trade receivables we have determined to be uncollectible. Additionally, we wrote off $<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" format="ixt:num-dot-decimal" scale="6" id="f-423">2.9</ix:nonFraction>&#160;million of trade receivables and related allowances at December 31, 2022, that were fully reserved for in 2021 and did not impact the result of operations for the year ended December 31, 2022. The Company also increased its allowance for credit losses in Fiscal 2022 by $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="f-424">5.5</ix:nonFraction>&#160;million. The results of these adjustments and our current year allowances, resulted in an allowance of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="f-425">3.1</ix:nonFraction>&#160;million at December 31, 2022. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:InventoryPolicyTextBlock" id="f-426" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory, net</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is valued at the lower of cost, determined on a first-in, first-out basis (&#8220;FIFO&#8221;), or net realizable value. Inventory items are analyzed to determine cost and the net realizable value and appropriate valuation adjustments are established.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="f-427" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2023 and 2022, the components of inventory are as follows (in thousands): </span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services testing material</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="prph:InventoryLabMaterial" scale="3" id="f-428">623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="prph:InventoryLabMaterial" format="ixt:num-dot-decimal" scale="3" id="f-429">1,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="f-430">1,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="f-431">1,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InventoryWorkInProcess" scale="3" id="f-432">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InventoryWorkInProcess" scale="3" id="f-433">754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Finished goods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="f-434">1,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InventoryFinishedGoods" scale="3" id="f-435">356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventory</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InventoryGross" format="ixt:num-dot-decimal" scale="3" id="f-436">4,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InventoryGross" format="ixt:num-dot-decimal" scale="3" id="f-437">4,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventory valuation reserve</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InventoryValuationReserves" scale="3" id="f-438">258</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InventoryValuationReserves" scale="3" id="f-439">512</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventory, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-440">3,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-441">3,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-442" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are recorded at cost. We use the straight-line method in computing depreciation for financial reporting purposes. Depreciation expense is computed in accordance with the following ranges of estimated asset lives: building and improvements - <span style="-sec-ix-hidden:f-443">ten</span> to <ix:nonNumeric contextRef="c-50" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-444">thirty-nine years</ix:nonNumeric>; leasehold improvements - lesser of lease term or estimated useful life; machinery and equipment including lab equipment - <span style="-sec-ix-hidden:f-445">three</span> to <ix:nonNumeric contextRef="c-52" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-446">seven years</ix:nonNumeric>; computer equipment and software - <span style="-sec-ix-hidden:f-447">three</span> to <ix:nonNumeric contextRef="c-54" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-448">five years</ix:nonNumeric>; and furniture and fixtures - <ix:nonNumeric contextRef="c-55" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-449">five years</ix:nonNumeric>.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-362-5" continuedAt="f-362-6"><ix:continuation id="f-366-3"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Financial Risks</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash investments, marketable debt securities, and trade accounts receivable. Our marketable securities are fixed income investments, which are highly liquid and can be readily purchased or sold through established markets.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain cash and cash equivalents with certain major financial institutions. As of December&#160;31, 2023, our cash and cash equivalents and restricted cash balance was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-450">2.1</ix:nonFraction> million. Of the total bank balance, $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashFDICInsuredAmount" format="ixt:num-dot-decimal" scale="6" id="f-451">1.0</ix:nonFraction> million was covered by federal depository insurance and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashUninsuredAmount" format="ixt:num-dot-decimal" scale="6" id="f-452">1.1</ix:nonFraction> million was uninsured at December&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable subject us to credit risk concentrations from time-to-time. We extend credit to our consumer healthcare product customers based upon an evaluation of the customer&#8217;s financial condition and credit history and generally do not require collateral. Our diagnostic services receivable credit risk is based on payer reimbursement experience, which includes government agencies and healthcare insurers, the period the receivables have been outstanding and the historical collection rates. The collectability of the diagnostic services receivables is also directly linked to the quality of our billing processes, which depend on information provided and billing services of third parties. These credit concentrations impact our overall exposure to credit risk, which could be further affected by changes in economic, regulatory or other conditions that may impact the timing and collectability of trade receivables and diagnostic test receivables. Additionally, the reimbursement receivables from the diagnostic service business are subject to billing errors and related disputes.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, see Note 13 - Significant Customers Concentrations.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-453" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the inception of an arrangement, we determine whether the arrangement is or contains a lease based on the unique facts and circumstances present in the arrangement. Most leases with a term greater than one year are recognized on the balance sheet as right-of-use assets and short-term and long-term lease liabilities, as applicable. We have elected not to recognize on the balance sheet leases with terms of 12 months or less. We typically only include an initial lease term in its assessment of a lease arrangement. Options to renew a lease are not included in our assessment unless there is reasonable certainty that we will renew.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected remaining lease term. Certain adjustments to the right-of-use asset may be required for items such as incentives received. The interest rate implicit in our leases is typically not readily determinable. As a result, we utilize our incremental borrowing rate, which reflects the fixed rate at which we could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term and in a similar economic environment (see Note 12, Leases).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of a lease should be allocated between lease components (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., land, building, etc.) and non-lease components (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., common area maintenance, consumables, etc.). The fixed and in-substance fixed contract consideration (including any consideration related to non-components) must be allocated based on the respective relative fair values to the lease components and non-lease components.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="f-454" continuedAt="f-454-1" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the fair value of the consideration transferred over the fair value of the underlying identifiable assets and liabilities acquired in a business combination. Goodwill and intangible assets deemed to have an indefinite life are not amortized, but instead are assessed for impairment annually. Additionally, if an event or change in circumstances occurs that would more likely than not reduce the fair value of the reporting unit below its carrying value, we would evaluate goodwill and other intangibles at that time.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In testing for goodwill impairment, we have the option to first assess qualitative factors to determine whether the existence of events or circumstances lead to a determination that it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If, after assessing the totality of events and circumstances, we conclude that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is not required. If we conclude otherwise, we are required to perform the two-step impairment test. The goodwill impairment test is performed at the reporting unit level by comparing the estimated fair value of a reporting unit with its respective carrying value. If the estimated fair value exceeds the carrying value, goodwill at the reporting unit level is not impaired. If the estimated fair value is less than the carrying value, an impairment charge will be recorded to </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-362-6" continuedAt="f-362-7"><ix:continuation id="f-454-1"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reduce the reporting unit to fair value. Management completed a qualitative assessment of Goodwill and it was not deemed impaired at December 31, 2023. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets deemed to have finite lives are amortized on a straight-line basis over their estimated useful lives, where the useful life is the period over which the asset is expected to contribute directly, or indirectly, to our future cash flows.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="f-455" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews long-lived assets, including property and equipment and finite-lived intangible assets, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. An impairment loss is recognized when the asset&#8217;s carrying value exceeds the total undiscounted cash flows expected from its use and eventual disposition. The amount of the impairment loss is determined as the excess of the carrying value of the asset over its fair value. For the fiscal years ended December&#160;31, 2023 and 2022, the Company did <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="f-456"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="INF" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="f-457">no</ix:nonFraction></ix:nonFraction>t have an impairment of the long-lived assets.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="f-458" continuedAt="f-458-1" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure assets and liabilities at fair value based on expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale date of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the hierarchical levels of inputs to measure fair value:</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Level 1: Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Level 2: Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Level 3: Unobservable inputs reflecting the Company&#8217;s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of our financial assets and liabilities, such as cash, accounts receivable, accounts payable, and unsecured note payable, approximate their fair values because of the short-term nature of these instruments.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for our marketable securities at fair value, with the net unrealized gains or losses of marketable debt securities reported as a component of accumulated other comprehensive income or loss and marketable equity securities change in fair value reported on the condensed consolidated statement of operations. The components of marketable securities are as follows (in thousands):</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="f-459" escape="true"><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-460">3,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-57" xsi:nil="true" name="us-gaap:MarketableSecurities" id="f-461"/></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-58" xsi:nil="true" name="us-gaap:MarketableSecurities" id="f-462"/></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-463">3,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-464">3,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="3" id="f-465">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="3" id="f-466">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-467">3,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">U.S. government obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="3" id="f-468">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-469">1,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="3" id="f-470">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-471">1,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-472">5,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-473">1,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="3" id="f-474">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-475">6,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-476">5,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-477">2,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="3" id="f-478">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-479">8,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-362-7" continuedAt="f-362-8"><ix:continuation id="f-458-1"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers of marketable debt securities between Levels 1, 2 or 3 for the years ended December&#160;31, 2023 and 2022.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-480" continuedAt="f-480-1" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue that represents the transfer of promised goods or services to customers at an amount that reflects the consideration that is expected to be received in exchange for those goods or services. We recognize revenue when performance obligations with our customers have been satisfied. At contract inception, we evaluate the contract to determine if revenue should be recognized using the following five steps: (1) identify the contract with the customer; (2) identify the performance obligations; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations; and (5) recognize revenue when (or as) the entity satisfies a performance obligation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract with Customers and Performance Obligations</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account. A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Sales from product shipments to contract manufacturing and retailer customers are recognized at the time ownership is transferred to the customer. Revenue from diagnostic services is recognized when the results are made available to the customer. Revenue from our personal genomics business is recognized when the genetic testing results are provided to the customer. For subscription services associated with our genomic testing, we recognize revenue ratably over the term of the subscription.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s performance obligation for contract manufacturing and retail customers is to provide the goods ordered by the customer. The Company has one performance obligation for its diagnostic services, which is to provide the results of the laboratory test to the customer. Our personal genomics business has separate performance obligations to provide initial testing and genome results and subscriptions services to our customers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction Price </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our diagnostic services business, a revenue transaction is initiated when we receive a requisition order to perform a diagnostic test. The information provided on the requisition form is used to determine the party that will be billed for the testing performed and the expected reimbursement. We provide diagnostic services to a range of customers. In many cases, the customer that orders our services is not responsible for paying for these services. Depending on the billing arrangement and applicable law, the payer may be the patient or a third party, such as a health plan, Medicare or Medicaid program and other government reimbursement programs. We bill the providers at standard price and take into consideration negotiated discounts and anticipated reimbursement remittance adjustments based on the payer portfolio, when revenue is recorded. We use the most expected value method to estimate the transaction price for reimbursements that vary from the listed contract price.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our personal genomics business, a revenue transaction is initiated by a DNA test kit sale direct to the consumer sales via our website or through online retailers. The kit sales and subscriptions are billed at a standard price and take into consideration any discounts when revenue is recorded. We also contract with third party B2B partners and universities and sell DNA test kits directly to them.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contract manufacturing and retail customers, the transaction price is fixed based upon either (i) the terms of a combined master agreement and each related purchase order, or (ii) if there is no master agreement, the price per individual purchase order received from each customer. The customers are invoiced at an agreed upon contractual price for each unit ordered and delivered by the Company.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from retail customers is reduced for trade promotions, estimated sales returns and other allowances in the same period as the related sales are recorded. No such allowance is applicable to our contract manufacturing customers. We estimate potential future product returns and other allowances related to current period revenue. We analyze historical returns, current trends, and changes in customer and consumer demand when evaluating the adequacy of the sales returns and other allowances.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not accept returns from our contract manufacturing customers. Our return policy for retail customers accommodates returns for (i) discontinued products, (ii) store closings and (iii) products that have reached or exceeded their designated expiration date. We do not impose a period of time during which product may be returned. All requests for product returns must be submitted to us for pre-approval. We will not accept return requests pertaining to customer inventory &#8220;Overstocking&#8221; or &#8220;Resets&#8221;. We will accept return requests only for products in their intended package </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-480-1" continuedAt="f-480-2"><ix:continuation id="f-362-8" continuedAt="f-362-9"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">configuration. We reserve the right to terminate shipment of product to customers who have made unauthorized deductions contrary to our return policy or pursue other methods of reimbursement. We compensate the customer for authorized returns by means of a credit applied to amounts owed.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our diagnostic services business, a revenue transaction is initiated when we receive a requisition order to perform a diagnostic test. The information provided on the requisition form is used to determine the party that will be billed for the testing performed and the expected reimbursement. We provide diagnostic services to a range of customers. In many cases, the customer that orders our services is not responsible for paying for these services. Depending on the billing arrangement and applicable law, the payer may be the patient or a third party, such as a health plan, Medicare or Medicaid program and other government reimbursement programs. We bill the providers at standard price and take into consideration negotiated discounts and anticipated reimbursement remittance adjustments based on the payer portfolio, when revenue is recorded. We use the most expected value method to estimate the transaction price for reimbursements that vary from the listed contract price.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our personal genomics business, a revenue transaction is initiated by a DNA test kit sale direct to the consumer sales via our website or through online retailers. The kit sales and subscriptions are billed at a standard price and take into consideration any discounts when revenue is recorded. We also contract with third party B2B partners and universities and sell DNA test kits directly to them.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recognize Revenue When the Company Satisfies a Performance Obligation </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For diagnostic services, the Company satisfies its performance obligation at the point in time that the results are made available to the customer, which is when the customer benefits from the information contained in the results and obtains control.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For genomic services, we satisfy our product performance obligation at a point in time when the genetic testing results are provided to the customer. For subscriptions services associated with its genomic testing, we satisfy our performance obligation ratably over the subscription period. If the customer does not return the test kit, services cannot be completed by us, potentially resulting in unexercised rights (&#8220;breakage&#8221;) revenue, including lifetime subscription services. We estimate breakage for the portion of test kits not expected to be returned using an analysis of historical data and consider other factors that could influence customer test kit return behavior. When breakage revenue is recognized on a kit, we recognize breakage on any associated subscription services ratably over the term of the subscription</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance obligations related to contract manufacturing and retail customers are satisfied at a point in time when the goods are shipped to the customer as (i) we have transferred control of the assets to the customers upon shipping, and (ii) the customer obtains title and assumes the risks and rewards of ownership after the goods are shipped.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and December&#160;31, 2022, we have deferred revenue of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="f-481">3.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="f-482">3.6</ix:nonFraction> million, respectively. Our new personal genomics business comprised $<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="f-483">3.4</ix:nonFraction> million of the deferred revenue as of December&#160;31, 2023. The remainder of deferred revenue relates to research and development (&#8220;R&amp;D&#8221;) stability and release testing programs recognized as contract manufacturing revenue. Deferred revenues primarily consist of amounts that have been billed to or received from customers in advance of revenue recognition and prepayments received from customers in advance of services performed for the R&amp;D work. We recognize deferred revenues as revenues when the services are performed and the corresponding revenue recognition criteria are met. Customer prepayments are generally applied against invoices issued to customers when services are performed and billed.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-484" continuedAt="f-484-1" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates our deferred revenue by recognition period (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Recognition Period</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0-12 Months</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="f-485">2,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="f-486">2,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13-24 Months</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="f-487">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="f-488">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Over 24 Months</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="f-489">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="f-490">376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="f-491">3,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="f-492">3,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-362-9" continuedAt="f-362-10"><ix:continuation id="f-480-2"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We disaggregate revenue from contracts with customers into four categories: contract manufacturing, retail and others, diagnostic services and genomic products and services. We determined that disaggregating revenue into these categories achieves the disclosure objective to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.</span></div><ix:continuation id="f-484-1"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company&#8217;s revenue by revenue source for Fiscal 2023 and 2022 (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.263%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.142%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue by Customer Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-493">24,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-494">108,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Contract manufacturing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-495">9,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-496">8,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Retail and others</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-497">2,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-498">1,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Genomic products and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-499">7,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-500">4,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-501">44,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-502">122,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer Consideration</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes payments to certain diagnostic services customers for distinct services that approximate fair value for those services. Such services include specimen collection, the collection and delivery of insurance and patient information necessary for billing and collection, and logistics services. Consideration associated with specimen collection services is classified in cost of revenues and the remaining costs are classified as diagnostic expenses within operating expenses in the accompanying statement of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales Tax Exclusion from the Transaction Price</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from the customer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shipping and Handling Activities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for shipping and handling activities that we perform as activities to fulfill the promise to transfer the good.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="f-503" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising and Incentive Promotions</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising and incentive promotion costs are expensed within the period in which they are utilized. Advertising and incentive promotion expense is comprised of (i) media advertising, presented as part of general and administrative expense, (ii) cooperative incentive </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">promotions and coupon program expenses, which are accounted for as part of net revenue, and (iii) free product, which is accounted for as part of cost of revenues. Advertising and incentive promotion expenses incurred from continuing operations for Fiscal 2023 and 2022 were $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="f-504">1.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="f-505">0.4</ix:nonFraction> million, respectively.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="f-506" continuedAt="f-506-1" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for stock-based compensation in accordance with FASB ASC 718, &#8220;Compensation &#8211; Stock Compensation.&#8221; Under the fair value recognition provision of the ASC, stock-based compensation cost is estimated at the grant date based on the fair value of the award. The Company estimates the fair value of stock options and warrants granted using the Black-Scholes-Merton option pricing model and stock grants at their closing reported market value. We recognize all stock-based payments to employees and directors, including grants of stock options, as compensation expense in the financial statements based on their grant date fair values. The grant date fair values of stock options are determined through the use of the Black-Scholes option pricing model. The compensation cost is recognized as an expense over the requisite service period of the award, which usually coincides with the vesting period. We account for forfeitures as they occur.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-362-10" continuedAt="f-362-11"><ix:continuation id="f-506-1"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock and stock options to purchase our common stock have been granted to employees pursuant to the terms of certain agreements and stock option plans (see Note 7, Stockholders' Equity). Stock options are exercisable during a period determined by us, but in no event later than <ix:nonNumeric contextRef="c-88" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="f-507">seven years</ix:nonNumeric> from the date granted.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="f-508" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D costs are charged to operations in the period incurred, R&amp;D costs incurred for the years ended December&#160;31, 2023 and 2022 were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-509">1.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-510">0.7</ix:nonFraction> million, respectively. R&amp;D costs are principally related to personnel expenses and new product development initiatives and costs associated with the OTC health care products, dietary supplements and validation costs associated with the diagnostic services business.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-511" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes in accordance with accounting guidance now codified as FASB ASC 740, &#8220;Income Taxes,&#8221; which requires that the Company recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for, or benefit from, income taxes includes deferred taxes resulting from the temporary differences in income for financial and tax purposes using the liability method. Such temporary differences result primarily from the differences in the carrying value of assets and liabilities. Future realization of deferred income tax assets requires sufficient taxable income within the carry-back, carryforward period available under tax law. We evaluate, on a quarterly basis whether, based on all available evidence, it is probable that the deferred income tax assets are realizable. Valuation allowances are established when it is more likely than not that the tax benefit of the deferred tax asset will not be realized. The evaluation, as prescribed by ASC 740- 10, &#8220;Income Taxes,&#8221; includes the consideration of all available evidence, both positive and negative, regarding historical operating results including recent years with reported losses, the estimated timing of future reversals of existing taxable temporary differences, estimated future taxable income exclusive of reversing temporary differences and carryforwards, and potential tax planning strategies which may be employed to prevent an operating loss or tax credit carryforward from expiring unused.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under ASU No. 2019-12, &#8220;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (&#8220;ASU 2019-12&#8221;), which simplifies various aspects related to accounting for income taxes. This standard became effective for the Company January 1, 2021. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for uncertainties in income taxes under the provisions of FASB ASC 740-10-05 (the &#8220;Subtopic&#8221;). The Subtopic clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements. The Subtopic prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The Subtopic provides guidance on the de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-512" continuedAt="f-512-1" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards, Adopted</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2023, the Company adopted Accounting Standards Update ("ASU") 2016-13, &#8220;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&#8221; (&#8220;ASU 2016-13&#8221;) ASU 2016-13 requires an impairment model (known as the CECL model) that is based on expected losses rather than incurred losses. Under the new guidance, each reporting entity should estimate an allowance for expected credit losses, which is intended to result in more timely recognition of losses. This model replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost, accounts receivable and available for sale debt securities and applies to some off-balance sheet credit exposures. In February 2020, the FASB issued ASU 2020-02, Financial Instruments - Credit Losses (Topic 326), which amends the effective date of the original pronouncement for smaller reporting companies. ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022. The adoption of ASU 2016-13 did not have a material impact on the Company's consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2023, the FASB issued ASU 2023-05, "Business Combinations - Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement." The new guidance applies to the formation of a joint venture and requires a joint venture to initially measure all contributions received upon its formation at fair value. The guidance is intended to reduce diversity in practice and is applicable to joint venture entities with a formation date on or after January 1, 2025 on a </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-512-1"><ix:continuation id="f-362-11"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prospective basis. The Company currently does not have any transactions that fall under the scope of ASU 2023-05; therefore, the adoption of ASU 2023-05 is not expected to have an impact on the Company's consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards, Not Yet Adopted</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), which requires an enhanced disclosure of significant segment expenses on an annual and interim basis. This guidance will be effective for the annual periods beginning the year ended December 31, 2024, and for interim periods beginning January 1, 2025. Early adoption is permitted. Upon adoption, the guidance should be applied retrospectively to all prior periods presented in the financial statements. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which improves the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the effective tax rate reconciliation and income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. This guidance will be effective for the annual periods beginning the year ended December 31, 2025. Early adoption is permitted. Upon adoption, the guidance can be applied prospectively or retrospectively. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.</span></div></ix:continuation></ix:continuation><div id="i940cc81906cc4cdfbb1f3b7467688c8d_109"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="f-519" continuedAt="f-519-1" escape="true">Asset Acquisition</ix:nonNumeric></span></div><ix:continuation id="f-519-1"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stella Diagnostics - Asset Purchase Agreement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 15, 2022, the Company entered into an Asset Purchase Agreement (the &#8220;Stella Purchase Agreement&#8221;), with Stella Diagnostics Inc. (&#8220;Stella&#8221;) and Stella DX, LLC (&#8220;Stella DX&#8221; and, together with Stella, the &#8220;Stella Sellers&#8221;), pursuant to which, on January 3, 2023, the Company purchased all of the assets, rights and interests of the Stella Sellers and their affiliates pertaining to the Stella Sellers&#8217; BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test and certain clinical assets, including all intellectual property rights (the &#8220;Stella Purchased Assets&#8221;). All capitalized terms used in this section to describe this transaction but not defined herein shall have the meanings set forth in the Stella Purchase Agreement, </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As consideration for the Stella Purchased Assets, at closing, the Company (i) paid to the Stella Sellers $<ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="prph:PaymentsForAssetAcquisition" format="ixt:num-dot-decimal" scale="6" id="f-520">3.5</ix:nonFraction> million in cash, minus (a) the Secured Note Amount of $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:AssetAcquisitionContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-521">0.5</ix:nonFraction> million, (b) the Liability Payoff Amount of $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="prph:AssetAcquisitionConsiderationTransferredLiabilityPayoff" format="ixt:num-dot-decimal" scale="6" id="f-522">1.6</ix:nonFraction> million and (c) the Promissory Note Payoff Amount of $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="prph:AssetAcquisitionConsiderationTransferredPromissoryNotePayoff" format="ixt:num-dot-decimal" scale="0" id="f-523">400,000</ix:nonFraction>, and (ii) issued to Stella DX <ix:nonFraction unitRef="shares" contextRef="c-89" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets" format="ixt:num-dot-decimal" scale="0" id="f-524">100,000</ix:nonFraction> shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-90" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-525">0.0005</ix:nonFraction> per share, of the Company at a value of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-90" decimals="2" name="prph:AssetAcquisitionSharesIssuedAndIssuableValuePerShare" scale="0" id="f-526">10.00</ix:nonFraction> per share. Total consideration paid was $<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:AssetAcquisitionConsiderationTransferred" format="ixt:num-dot-decimal" scale="6" id="f-527">4.6</ix:nonFraction> million. The Secured Note Amount of $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:AssetAcquisitionContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-528">0.5</ix:nonFraction> million and the Promissory Note Payoff of $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="prph:AssetAcquisitionConsiderationTransferredPromissoryNotePayoff" format="ixt:num-dot-decimal" scale="0" id="f-529">400,000</ix:nonFraction> were paid in 2022. The balance of the consideration was paid at closing during the year ended December&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition to the consideration paid at closing, the Company will issue shares of common stock valued at $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:AssetAcquisitionContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-530">2.0</ix:nonFraction> million (the &#8220;Milestone Stock&#8221;) to the Stella Sellers upon a Commercialization Event (as defined in the Stella Purchase Agreement). The Milestone Stock was recorded at closing as a non-current liability at its fair value of $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:AssetAcquisitionContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-531">2.0</ix:nonFraction> million. Also, the Company is required to pay to the Stella Sellers for each of the seven calendar years during the <ix:nonNumeric contextRef="c-90" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="f-532">seven years</ix:nonNumeric> period commencing on the first day of the calendar year following the date of the Commercialization Event, a non-refundable, non-creditable royalty of <ix:nonFraction unitRef="number" contextRef="c-89" decimals="INF" name="prph:PurchaseAgreementRoyaltyPercent" scale="-2" id="f-533">5</ix:nonFraction>% of the Adjusted Gross Margin for such Annual Period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The asset purchase does not qualify as a business combination under FASB ASC 805, Business Combinations, and has therefore been accounted for as an asset acquisition. In connection with the Stella Purchased Assets, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="prph:AssetAcquisitionTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="f-534">0.2</ix:nonFraction> million in transaction costs, which were capitalized into the purchase price of the Stella Purchased Assets. The total purchase price for the Stella Purchased Assets was $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="f-535">6.8</ix:nonFraction>&#160;million, which was allocated to the proprietary technology intangible asset acquired. The Company is amortizing the acquired intangible asset on a straight-line basis over its estimated useful life of five years.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_112"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="f-536" continuedAt="f-536-1" escape="true">Intangible Assets, Net</ix:nonNumeric></span></div><ix:continuation id="f-536-1" continuedAt="f-536-2"><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, the Company acquired intangible assets of $<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="f-537">6.8</ix:nonFraction> million included with proprietary intellectual property, in connection with the acquisition of the Stella Purchased Assets. See Note 3.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-536-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" id="f-538" escape="true"><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets as of December&#160;31, 2023 and 2022 consisted of the following (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Estimated Useful<br/>Life (in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Trade names</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-539">5,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-540">5,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-94" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-541">15</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Proprietary intellectual property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-542">11,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-543">4,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-96" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-544">5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-545">1,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-546">1,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-98" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-547">1</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">CLIA license</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-548">1,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-549">1,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-100" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-550">3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-551">19,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-552">12,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-553">6,768</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-554">3,822</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-555">12,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-556">8,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for acquired intangible assets was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-557">2.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-558">2.4</ix:nonFraction> million during the years ended December&#160;31, 2023 and 2022, respectively. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="f-559" continuedAt="f-559-1" escape="true">The estimated future amortization expense of acquired intangible assets as of December&#160;31, 2023 is as follows (in thousands):</ix:nonNumeric></span></div><ix:continuation id="f-559-1"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year ended December 31, 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-560">2,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year ended December 31, 2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-561">2,583</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year ended December 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="f-562">2,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year ended December 31, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="f-563">1,731</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year ended December 31, 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="f-564">370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-565">2,815</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-566">12,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div id="i940cc81906cc4cdfbb1f3b7467688c8d_115"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-567" continuedAt="f-567-1" escape="true">Property, Plant and Equipment</ix:nonNumeric></span></div><ix:continuation id="f-567-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-568" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of property, plant and equipment are as follows (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="f-569">352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="f-570">352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="f-571">374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="f-572">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lesser of lease term or estimated useful life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Building improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-573">1,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-574">1,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-108" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-575">10</ix:nonNumeric>-<ix:nonNumeric contextRef="c-109" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-576">39</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Machinery</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-577">6,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-578">5,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-51" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-579">3</ix:nonNumeric>-<ix:nonNumeric contextRef="c-52" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-580">7</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lab equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-581">12,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-582">5,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-114" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-583">3</ix:nonNumeric>-<ix:nonNumeric contextRef="c-115" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-584">7</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-585">2,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-586">2,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-53" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-587">3</ix:nonNumeric>-<ix:nonNumeric contextRef="c-54" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-588">5</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="f-589">446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="f-590">461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-55" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-591">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-592">24,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-593">15,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-594">11,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-595">8,440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-596">12,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-597">7,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for Fiscal 2023 and 2022 were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="f-598">3.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="f-599">2.3</ix:nonFraction> million, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">84</span></div></div></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 - <ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-600" continuedAt="f-600-1" escape="true">Outstanding Debt</ix:nonNumeric></span></div><ix:continuation id="f-600-1"><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Secured Mortgage Loan</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On December 20, 2023, the Company's wholly-owned subsidiary PREH entered into an Open-End Mortgage Agreement (the "Mortgage Agreement"). The Mortgage provided for a loan of $<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-601">3.3</ix:nonFraction> million (the "Mortgage Loan") with stated maturity date on January 6, 2034, bore a fixed interest rate of <ix:nonFraction unitRef="number" contextRef="c-119" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-602">8.25</ix:nonFraction>% per annum and required monthly mortgage payments of principal and interest of $<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPayment" format="ixt:num-dot-decimal" scale="0" id="f-603">25,000</ix:nonFraction>. The obligations under the Mortgage Agreement were secured by PREH's  certain real property in Pennsylvania. The Company incurred $<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="0" id="f-604">341,000</ix:nonFraction> issuance cost, which was recognized as a debt discount and will be amortized using the effective interest method over the term of the Mortgage Loan. The Company retains $<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:EscrowDeposit" format="ixt:num-dot-decimal" scale="0" id="f-605">540,000</ix:nonFraction> cash in an escrow account which was recognized as a restricted cash on the Company's consolidated balance sheet as of December 31, 2023. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Unsecured Promissory Note Payable</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 26, 2023, the Company issued an unsecured promissory note (the &#8220;2023 Note&#8221;) and guaranty for an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-606">7.6</ix:nonFraction> million. The 2023 Note is due and payable on January 27, 2026, the third anniversary of the date on which the 2023 Note was funded (the &#8220;Closing Date&#8221;), and accrues interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-122" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-607">10</ix:nonFraction>% per year from the Closing Date, payable on a quarterly basis, until the 2023 Note is repaid in full. The Company has the right to prepay the 2023 Note at any time after the Closing Date and prior to the maturity date without premium or penalty upon providing seven days&#8217; written notice to the note holder. Repayment of the 2023 Note has been guaranteed by the Company&#8217;s wholly-owned subsidiary, Pharmaloz Manufacturing, Inc. In addition to the 2023 Note, the Company issued warrants to purchase <ix:nonFraction unitRef="shares" contextRef="c-123" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-608">76,000</ix:nonFraction> shares of the Company's common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-123" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="f-609">9.00</ix:nonFraction> for a term of <ix:nonNumeric contextRef="c-124" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-610">5</ix:nonNumeric> years, vesting immediately. The warrants were valued at $<ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" format="ixt:num-dot-decimal" scale="6" id="f-611">0.4</ix:nonFraction> million fair value, using the Black-Scholes option pricing model to calculate the grant date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of <ix:nonFraction unitRef="number" contextRef="c-124" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-612">81.5</ix:nonFraction>%, risk free interest rate of <ix:nonFraction unitRef="number" contextRef="c-124" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-613">3.62</ix:nonFraction>% and expected warrant life of <ix:nonNumeric contextRef="c-123" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="f-614">5</ix:nonNumeric> years. The relative fair value of the warrant was $<ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-615">0.4</ix:nonFraction> million and was recorded as a discount to the note payable in accordance with FASB ASC 835-30-25, Recognition, and is being accreted over the term of the note payable for financial statement purposes. As of December&#160;31, 2023, the unpaid principal balance of the 2023 Note was $<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-616">7.3</ix:nonFraction> million, net of debt discount of $<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="6" id="f-617">0.3</ix:nonFraction> million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Unsecured Convertible Notes Payable</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;15, 2020, the Company issued <ix:nonFraction unitRef="debt" contextRef="c-127" decimals="INF" name="prph:NumberOfDebtInstruments" format="ixt-sec:numwordsen" id="f-618">two</ix:nonFraction> unsecured, partially convertible, promissory notes (the &#8220;September 2020 Notes&#8221;) for an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-619">10.0</ix:nonFraction> million to <ix:nonFraction unitRef="investor" contextRef="c-127" decimals="INF" name="prph:NumberOfInvestors" format="ixt-sec:numwordsen" id="f-620">two</ix:nonFraction> investors (collectively, the &#8220;Lenders&#8221;).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;28, 2022, the Company entered into a letter agreement (the &#8220;Letter Agreement&#8221;) with one of the Lenders providing for the payoff of its September 2020 Note in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-621">2.0</ix:nonFraction> million.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the Letter Agreement, (i) the Lender converted $<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-622">0.6</ix:nonFraction> million of the principal amount due to him under his September 2020 Note into <ix:nonFraction unitRef="shares" contextRef="c-130" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-623">200,000</ix:nonFraction> shares of Company common stock (the &#8220;Conversion Shares&#8221;) at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-129" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-624">3.00</ix:nonFraction> per share as provided for under the terms of the September 2020 Note (the &#8220;Conversion&#8221;), (ii) the Company paid to the Lender $<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="6" id="f-625">1.4</ix:nonFraction> million in cash, representing $<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" format="ixt:num-dot-decimal" scale="6" id="f-626">1.4</ix:nonFraction> million of the remaining principal under the September 2020 Note following the Conversion plus $<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:InterestPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-627">41,000</ix:nonFraction> in accrued and outstanding interest under the September 2020 Note, and (iii) the Company repurchased the Conversion Shares at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-131" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-628">5.75</ix:nonFraction> per share for an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:DebtConversionConvertedInstrumentAmount1" format="ixt:num-dot-decimal" scale="6" id="f-629">1.2</ix:nonFraction> million (for a total aggregate payment to the Lender of $<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPayment" format="ixt:num-dot-decimal" scale="6" id="f-630">2.6</ix:nonFraction> million).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, the Company paid the remaining Lender </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-631">5.6</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in principal on the remaining September 2020 Note. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 10, 2023, the Lender converted the remaining </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-5" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="6" id="f-632">2.4</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> principal into <ix:nonFraction unitRef="shares" contextRef="c-134" decimals="INF" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="f-633">800,000</ix:nonFraction> shares of the Company's common stock. The September 2020 Note was settled in full as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2023 and 2022, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:InterestExpenseOther" format="ixt:num-dot-decimal" scale="6" id="f-634">0.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:InterestExpenseOther" format="ixt:num-dot-decimal" scale="6" id="f-635">0.8</ix:nonFraction> million, respectively, in interest expense under the September 2020 Notes.</span></div></ix:continuation><div id="i940cc81906cc4cdfbb1f3b7467688c8d_121"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-636" continuedAt="f-636-1" escape="true">Stockholders&#8217; Equity</ix:nonNumeric></span></div><ix:continuation id="f-636-1" continuedAt="f-636-2"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our authorized capital stock consists of <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-637">50</ix:nonFraction> million shares of common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-638">0.0005</ix:nonFraction> par value, and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt-sec:numwordsen" scale="6" id="f-639"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt-sec:numwordsen" scale="6" id="f-640">one</ix:nonFraction></ix:nonFraction> million shares of preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-641">0.0005</ix:nonFraction> par value.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-636-2" continuedAt="f-636-3"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preferred stock authorized under the Company's certificate of incorporation may be issued from time to time in one or more series. As of December&#160;31, 2023, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-642">no</ix:nonFraction> shares of preferred stock have been issued. The Company's board of directors have the full authority permitted by law to establish, without further stockholder approval, one or more series of preferred stock and the number of shares constituting each such series and to fix by resolution voting powers, preferences and relative, participating, optional and other special rights of each series of preferred stock, and the qualifications, limitations or restrictions thereof, if any. Subject to the limitation on the total number of shares of preferred stock that the Company has authority to issue under its certificate of incorporation, the board of directors is also authorized to increase or decrease the number of shares of any series, subsequent to the issue of that series, but not below the number of shares of such series then-outstanding. In case the number of shares of any series is so decreased, the shares constituting such decrease will resume the status that they had prior to the adoption of the resolution originally fixing the number of shares of such series. The Company may, subject to any required stockholder approval, amend from time to time its certificate of incorporation to increase the number of authorized shares of preferred stock or common stock or to make other changes or additions to our capital structure or the terms of our capital stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Dividends </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:DividendsCommonStock" format="ixt:fixed-zero" scale="0" id="f-643">No</ix:nonFraction> dividends have been declared during the year ended December&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 9, 2022, the board of directors of the Company declared a special cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-137" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-644">0.30</ix:nonFraction> per share on the Company&#8217;s common stock, paid on June 4, 2022, in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-645">4.7</ix:nonFraction> million to holders of record of the Company&#8217;s common stock as of May 25, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2022, the board of directors of the Company declared a special cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-138" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-646">0.30</ix:nonFraction> per share on the Company&#8217;s common stock, paid on March 10, 2022, in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-647">4.6</ix:nonFraction> million to holders of record of the Company&#8217;s common stock on March 1, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Repurchase Program</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 15, 2023, the Company announced that its board of directors had approved a new stock repurchase program. Under the stock repurchase program, the Company is authorized to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="f-648">6.0</ix:nonFraction> million of its outstanding shares of common stock from time to time, over a <ix:nonNumeric contextRef="c-140" name="us-gaap:StockRepurchaseProgramPeriodInForce1" format="ixt-sec:durwordsen" id="f-649">nine-month</ix:nonNumeric> period. The number of shares to be repurchased and the timing of the repurchases, if any, will depend on a number of factors, including, but not limited to, price, trading volume and general market conditions, along with the Company&#8217;s working capital requirements and general business conditions. The board of directors will re-evaluate the program from time to time and may authorize adjustments to its terms.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Commencement Date (as defined in the stock repurchase agreement), and for a period of <ix:nonNumeric contextRef="c-140" name="us-gaap:StockRepurchaseProgramPeriodInForce1" format="ixt-sec:durwordsen" id="f-650">nine months</ix:nonNumeric> thereafter, repurchases may be made through open market transactions (based on prevailing market prices), privately negotiated transactions, block trades, or any combination thereof, in accordance with applicable federal securities laws, including Rule 10b-18 of the Securities Exchange Act of 1934, as amended.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 26, 2022, the Company announced that its board of directors had approved new stock repurchase programs. Under each of the stock repurchase programs, the Company was authorized to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="f-651">6.0</ix:nonFraction> million of its outstanding shares of common stock from time to time, over a <ix:nonNumeric contextRef="c-142" name="us-gaap:StockRepurchaseProgramPeriodInForce1" format="ixt-sec:durwordsen" id="f-652">six-month</ix:nonNumeric> period. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company repurchased <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-653">69,628</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-654">303,145</ix:nonFraction> shares during the years ended December&#160;31, 2023 and 2022, respectively, pursuant to the stock repurchase programs for an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="f-655">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="f-656">2.2</ix:nonFraction> million respectively, including commissions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The 2022 Directors' Equity Compensation Plan</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On May 19, 2022, the stockholders of the Company approved the 2022 Directors&#8217; Equity Compensation Plan (the &#8220;2022 Directors&#8217; Plan&#8221;) at the 2022 Annual Meeting of Stockholders of the Company (the &#8220;2022 Annual Meeting&#8221;). The 2022 Directors&#8217; Plan amended and restated the Company&#8217;s Amended and Restated 2010 Directors&#8217; Equity Compensation Plan and provided for an increase in the number of shares reserved for issuance under the plan by <ix:nonFraction unitRef="shares" contextRef="c-143" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-657">300,000</ix:nonFraction> shares and for the adjustment of the per share exercise price of stock options granted under the 2022 Plan in the event of any change in the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-636-3" continuedAt="f-636-4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">outstanding shares of common stock of the Company as a result of, among other things, any distribution or special dividend to stockholders of shares, cash or other property (other than regular cash dividends).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 16, 2023, the stockholders of the Company approved the Amended and Restated 2022 Directors&#8217; Equity Compensation Plan (the &#8220;Amended 2022 Directors&#8217; Plan&#8221;) at the 2023 Annual Meeting of Stockholders of the Company. The Amended 2022 Directors&#8217; Plan provides for an increase in the number of shares reserved for issuance under such plan by <ix:nonFraction unitRef="shares" contextRef="c-144" decimals="INF" name="prph:CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-658">150,000</ix:nonFraction> shares.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company issued <ix:nonFraction unitRef="shares" contextRef="c-145" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-659">120,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-146" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-660">120,000</ix:nonFraction> options issued under this plan during the year ended December&#160;31, 2023 and 2022, respectively. As of December&#160;31, 2023, there were <ix:nonFraction unitRef="shares" contextRef="c-147" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-661">210,000</ix:nonFraction> shares of common stock available to be issued under the 2022 Directors&#8217; Plan. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The 2010 Directors&#8217; Equity Compensation Plan</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 20, 2021, the stockholders of the Company approved the Amended and Restated 2010 Directors&#8217; Equity Compensation Plan (the &#8220;Amended 2010 Directors&#8217; Plan&#8221;) at the 2021 annual meeting of stockholders of the Company (the "2021 Annual Meeting"). The Amended 2010 Directors&#8217; Plan authorizes the issuance of up to <ix:nonFraction unitRef="shares" contextRef="c-148" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-662">775,000</ix:nonFraction> shares of common stock. This plan was amended and restated on April 11, 2022 (to become the 2022 Directors' Plan), subject to stockholder approval, which was obtained at the 2022 Annual Meeting.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The 2022 Equity Compensation Plan</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 19, 2022, the stockholders of the Company approved the 2022 Equity Compensation Plan (the &#8220;2022 Plan&#8221;) at the 2022 Annual Meeting. The 2022 Plan amended and restated the Company&#8217;s Amended and Restated 2010 Equity Compensation Plan and provides for an increase in the number of shares reserved for issuance under the plan by <ix:nonFraction unitRef="shares" contextRef="c-149" decimals="INF" name="prph:CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-663">1,000,000</ix:nonFraction> shares and provides for the adjustment of the per share exercise price of stock options granted under the 2022 Plan in the event of any change in the outstanding shares of common stock of the Company as a result of, among other things, any distribution or special dividend to stockholders of shares, cash or other property (other than regular cash dividends).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 16, 2023, the stockholders of the Company approved the Amended and Restated 2022 Equity Compensation Plan (the &#8220;Amended 2022 Plan&#8221;) at the 2023 Annual Meeting of Stockholders of the Company. The Amended 2022 Plan provides for an increase in the number of shares reserved for issuance under such plan by <ix:nonFraction unitRef="shares" contextRef="c-150" decimals="INF" name="prph:CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-664">700,000</ix:nonFraction> shares.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, there were <ix:nonFraction unitRef="shares" contextRef="c-151" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-665">1,093,285</ix:nonFraction> shares of common stock available to be issued under the 2022 Plan. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The 2010 Equity Compensation Plan</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 20, 2021, the stockholders of the Company approved the Amended and Restated 2010 Equity Compensation Plan (the &#8220;Amended 2010 Plan&#8221;) at the 2021 Annual Meeting. The Amended 2010 Plan authorized the issuance of up to <ix:nonFraction unitRef="shares" contextRef="c-152" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-666">4,900,000</ix:nonFraction> shares of common stock. This plan was amended and restated on April 11, 2022 (to become the 2022 Plan), subject to stockholder approval, which was obtained at the 2022 Annual Meeting.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The 2018 Stock Incentive Plan</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2018, the Company's stockholders approved the 2018 Stock Incentive Plan (the &#8220;2018 Stock Plan&#8221;). The 2018 Stock Plan provides for the grant of incentive stock options to eligible employees of the Company, and for the grant of non-statutory stock options to eligible employees, directors and consultants. The purpose of the 2018 Stock Plan is to advance the interests of the Company and its stockholders by providing an incentive to attract, retain, and reward persons performing services for the Company and by motivating such persons to contribute to the growth and profitability of the Company. The 2018 Stock Plan provides that the total number of shares that may be issued pursuant to the 2018 Stock Plan is <ix:nonFraction unitRef="shares" contextRef="c-153" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" format="ixt:num-dot-decimal" scale="0" id="f-667">2,300,000</ix:nonFraction> shares. At April 12, 2018, all <ix:nonFraction unitRef="shares" contextRef="c-153" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-668">2,300,000</ix:nonFraction> shares had been granted in the form of stock options to Ted Karkus (the &#8220;CEO Option&#8221;), the Company's Chief Executive Officer.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Stock Plan required certain proportionate adjustments to be made to the stock options granted under the 2018 Stock Plan upon the occurrence of certain events, including a special distribution (whether in the form of cash, shares, other securities, or other property) in order to maintain parity. Accordingly, the Compensation Committee of the board of directors, as required by the terms of the 2018 Stock Plan, adjusted the exercise price of the CEO Option in connection </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-636-4" continuedAt="f-636-5"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with each special cash dividend paid by the Company proportionately to the amount of the dividend paid. The final exercise price of the CEO Option was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-154" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-669">0.60</ix:nonFraction> per share after the latest special cash dividend paid on June 3, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023 and 2022, <ix:nonFraction unitRef="shares" contextRef="c-155" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-670">1,100,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-156" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-671">1,200,000</ix:nonFraction> stock options were exercised under the 2018 Stock Plan. No share based compensation expense will be recognized in forward periods related to the 2018 Stock Plan.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inducement Option Awards</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no issuances of inducements awards during the year ended December&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 9, 2022, the Company issued a non-qualified stock option to the prospective Chief Financial Officer of the Company (the &#8220;CFO&#8221;), as an inducement to his employment with the Company, effective May 23, 2022 (the &#8220;CFO Award&#8221;). The CFO Award entitled the CFO to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-157" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-672">400,000</ix:nonFraction> shares of the Company&#8217;s common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-158" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-673">6.74</ix:nonFraction> per share, the closing price of the Company&#8217;s common stock on May 9, 2022. The CFO Award provided for certain proportionate adjustments to be made in the event of any change in the outstanding shares of common stock of the Company as a result of, among other things, any distribution or special dividend to stockholders of shares, cash or other property (other than regular cash dividends) in order to maintain parity. The exercise price of the CFO Award was reduced from $<ix:nonFraction unitRef="usdPerShare" contextRef="c-159" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-674">6.74</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-160" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-675">6.44</ix:nonFraction> per share, effective as of June 3, 2022, the date $<ix:nonFraction unitRef="usdPerShare" contextRef="c-161" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-676">0.30</ix:nonFraction> special cash dividend was paid to Company&#8217;s stockholders. The grant date fair value of the CFO Award was approximately $<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" format="ixt:num-dot-decimal" scale="6" id="f-677">1.6</ix:nonFraction> million. In connection with CFO&#8217;s separation from service on October 4, 2022, these options were forfeited on October 4, 2022.  The Company reversed $<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="prph:ShareBasedPaymentArrangementExpenseReversal" format="ixt:num-dot-decimal" scale="0" id="f-678">149,000</ix:nonFraction> of stock based compensation expense previously recognized for the unvested options at the time of forfeiture.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year ended December 31, 2022, the Company issued an inducement award to a prospective employee to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-163" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" format="ixt:num-dot-decimal" scale="0" id="f-679">250,000</ix:nonFraction> shares of the Company&#8217;s common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-164" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="f-680">13.00</ix:nonFraction>, the closing price of the common stock on the date of grant. The award vested <ix:nonFraction unitRef="number" contextRef="c-165" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-681">50</ix:nonFraction>% on the date of grant and the remaining portion will vest <ix:nonFraction unitRef="number" contextRef="c-166" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-682"><ix:nonFraction unitRef="number" contextRef="c-167" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-683"><ix:nonFraction unitRef="number" contextRef="c-168" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-684">25</ix:nonFraction></ix:nonFraction></ix:nonFraction>% per year for the next <ix:nonNumeric contextRef="c-167" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-685"><ix:nonNumeric contextRef="c-166" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-686"><ix:nonNumeric contextRef="c-168" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-687">two years</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric>. The award expires on the <span style="-sec-ix-hidden:f-688">seven</span>th anniversary of the grant date.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All inducement awards have been granted outside of the Company&#8217;s equity compensation plans pursuant to Nasdaq Listing Rule 5635(c)(4).</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of all option grants  </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-689" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock options activity during Fiscal 2023 and 2022 (in thousands, except per share data).</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Number of Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Weighted Average Remaining Contractual Life (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-690">5,110</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-16" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-691">3.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-169" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-692">3.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-693">20,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="3" id="f-694">1,095</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-695">9.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-10" name="prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" format="ixt-sec:duryear" id="f-696">7.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-697">1,833</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-698">1.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="f-699">420</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-700">1.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-701">3,952</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-702">5.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-10" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-703">3.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-704">20,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="3" id="f-705">1,135</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-706">8.65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" format="ixt-sec:duryear" id="f-707">5.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-708">1,348</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-709">0.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="f-710">788</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-711">0.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-712">2,951</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-713">7.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-714">4.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="f-715">693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Options vested and exercisable</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="f-716">1,880</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="f-717">6.69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-718">4.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="3" id="f-719">693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-636-5" continuedAt="f-636-6"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the closing stock price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-720">4.52</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-721">9.63</ix:nonFraction> for the Company&#8217;s common stock on December&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2023, certain holders of stock options elected to exercise their stock options pursuant to a cashless exercise provision resulting in the net issuance of <ix:nonFraction unitRef="shares" contextRef="c-27" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-722">603,881</ix:nonFraction> shares of common stock and the return of <ix:nonFraction unitRef="shares" contextRef="c-170" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-723">744,369</ix:nonFraction> shares to the Company. The Company also made a cash payment of approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="f-724">5.4</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to repurchase <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-725">603,881</ix:nonFraction> shares of treasury stock to satisfy tax withholding obligations related to the cashless exercise of these stock options.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December 31, 2022, we issued <ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-726">828,021</ix:nonFraction> shares of common stock through a cashless exercise of <ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-727">1,833,000</ix:nonFraction> options.  In connection with the cashless exercise, the company repurchased <ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-728">1,103,000</ix:nonFraction> common stock at a cost of $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="f-729">7.5</ix:nonFraction> million to satisfy tax withholding.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023 and 2022, the Company granted options to purchase <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-730">1,135,000</ix:nonFraction> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-731">1,095,000</ix:nonFraction> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares of the Company&#8217;s common stock to various employees and consultants, respectively. The options grant date fair value was valued at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" format="ixt:num-dot-decimal" scale="6" id="f-732">4.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" format="ixt:num-dot-decimal" scale="6" id="f-733">6.1</ix:nonFraction> million during the year ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2023 and 2022, using the Black-Scholes option pricing model to calculate the grant-date fair value of the options. The fair value of stock options for employees are expensed over the vesting term in accordance with the terms of the related stock option agreements and are expensed over the terms of the consulting agreement for consultants.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-734" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes weighted average assumptions used in determining the fair value of the stock options at the date of grant during Fiscal 2023 and 2022:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercise price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="f-735">8.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="f-736">10.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-737">4.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-10" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-738">4.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-739">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-740">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Risk-free rate of interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-741">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-742">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected dividend yield (per share)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-743">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-744">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected stock price volatility is based on the Company&#8217;s historical common stock trading prices and the expected term is based on the period that the Company&#8217;s stock-based awards are expected to be outstanding based on the simplified method.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on Stock Warrants </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2023, the Company issued warrants to an advisory firm to purchase <ix:nonFraction unitRef="shares" contextRef="c-171" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-745">50,000</ix:nonFraction> shares of the Company's common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-172" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="f-746">10.00</ix:nonFraction> for a term of <ix:nonNumeric contextRef="c-173" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="f-747">5</ix:nonNumeric> years, vesting immediately. The warrants were valued at $<ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-748">0.3</ix:nonFraction>&#160;million fair value, using the Black-Scholes option pricing model to calculate the grant date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of <ix:nonFraction unitRef="number" contextRef="c-174" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-749">80.9</ix:nonFraction>%, risk free interest rate of <ix:nonFraction unitRef="number" contextRef="c-174" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-750">3.5</ix:nonFraction>% and expected warrant life of <ix:nonNumeric contextRef="c-174" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-751">5</ix:nonNumeric> years. These warrants were expensed over the <ix:nonNumeric contextRef="c-4" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="f-752">1</ix:nonNumeric> year term of the engagement which ended on December 31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 27, 2023, the Company issued <ix:nonNumeric contextRef="c-175" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-753">five-year</ix:nonNumeric> warrants to purchase <ix:nonFraction unitRef="shares" contextRef="c-176" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-754">76,000</ix:nonFraction> shares of the Company's common stock with the unsecured promissory note (see Note 6).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2023, the Company issued warrants to a consultant to purchase <ix:nonFraction unitRef="shares" contextRef="c-177" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-755">250,000</ix:nonFraction> shares of the Company's common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-177" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="f-756">9.00</ix:nonFraction> for a term of <ix:nonNumeric contextRef="c-177" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="f-757">5</ix:nonNumeric> years, vesting immediately.  The warrants were valued at $<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-758">1.4</ix:nonFraction>&#160;million, using the Black-Scholes option pricing model to calculate the grant date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of <ix:nonFraction unitRef="number" contextRef="c-178" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-759">80.4</ix:nonFraction>%, risk free interest rate of <ix:nonFraction unitRef="number" contextRef="c-178" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-760">3.6</ix:nonFraction>% and expected warrant life of <ix:nonNumeric contextRef="c-178" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-761">5</ix:nonNumeric> years, which was initially recognized as a prepaid expense and to be expensed over the term of the consulting agreement. As of December 31, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="f-762">5.1</ix:nonFraction>&#160;million was remained in the prepaid expense and other current assets on the consolidated balance sheet.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-636-6"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between August and September 2023, the Company received $<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="6" id="f-763">1.2</ix:nonFraction>&#160;million from the exercise of outstanding warrants with an exercise price at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-180" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-764">3.00</ix:nonFraction> per share. The Company issued approximately <ix:nonFraction unitRef="shares" contextRef="c-181" decimals="-3" name="prph:IssuanceOfCommonStockSharesExerciseOfWarrant" format="ixt:num-dot-decimal" scale="0" id="f-765">400,000</ix:nonFraction> shares of common stock upon these warrant exercises.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, there were <ix:nonFraction unitRef="usd" contextRef="c-10" decimals="INF" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" format="ixt-sec:numwordsen" id="f-766">no</ix:nonFraction> stock warrants issued.</span></div><ix:nonNumeric contextRef="c-1" name="prph:ScheduleOfWarrantActivityTableTextBlock" id="f-767" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes warrant activities during Fiscal 2023 and 2022 (in thousands, except per share data):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Number of Shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average<br/>Remaining Contractual<br/>Life <br/>(in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-182" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="f-768">855</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-182" decimals="INF" name="prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1" scale="0" id="f-769">8.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-183" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-770">1.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-184" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="f-771">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-184" decimals="INF" name="prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1" format="ixt:fixed-zero" scale="0" id="f-772">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-185" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="f-773">855</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-185" decimals="2" name="prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1" scale="0" id="f-774">8.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-184" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-775">1.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-186" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="3" id="f-776">376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-186" decimals="2" name="prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1" scale="0" id="f-777">9.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-186" name="prph:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-778">4.2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="c-186" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" scale="3" id="f-779">400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-186" decimals="2" name="prph:WeightedAverageExercisePriceWarrantsExercised" scale="0" id="f-780">3.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-187" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="f-781">831</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-187" decimals="2" name="prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1" scale="0" id="f-782">11.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-186" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-783">1.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants vested and exercisable</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-187" decimals="-3" name="prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber" scale="3" id="f-784">831</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-186" decimals="2" name="prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1" scale="0" id="f-785">11.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-186" name="prph:WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable" format="ixt-sec:duryear" id="f-786">1.9</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-787">3.5</ix:nonFraction>&#160;million of share-based compensation expense during the year ended December&#160;31, 2023. The Company will recognize an aggregate of approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="f-788">5.1</ix:nonFraction>&#160;million of remaining share-based compensation expense related to outstanding stock options and warrants over a weighted average period of <ix:nonNumeric contextRef="c-1" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-789">4.3</ix:nonNumeric> years.</span></div></ix:continuation><div id="i940cc81906cc4cdfbb1f3b7467688c8d_124"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="f-790" continuedAt="f-790-1" escape="true">Defined Contribution Plans</ix:nonNumeric></span></div><ix:continuation id="f-790-1"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains the ProPhase Labs, Inc. 401(k) Savings and Retirement Plan, a defined contribution plan for its employees. The Company's contributions to the plan are based on the amount of the employee plan contributions and compensation. The Company's contributions to the plan for the years ended December&#160;31, 2023 and 2022 were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="f-791">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="f-792">0.2</ix:nonFraction> million, respectively.</span></div></ix:continuation><div id="i940cc81906cc4cdfbb1f3b7467688c8d_127"></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-793" continuedAt="f-793-1" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-794" escape="true"><ix:continuation id="f-793-1" continuedAt="f-793-2"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the provision (benefit) for income taxes, in the consolidated statements of operations are as follows (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.818%"><tr><td style="width:1.0%"/><td style="width:65.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.018%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.334%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Continuing Operations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="f-795">772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-796">1,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="f-797">284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-798">3,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-799">1,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-800">4,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-801">5,459</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="f-802">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-803">1,615</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="f-804">210</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-805">7,074</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="f-806">138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income taxes from continuing operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-807">6,018</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-808">4,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-793-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-809" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the statutory federal income tax expense (benefit) to the effective tax is as follows (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.507%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Statutory Rate - federal</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-810">4,788</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-811">4,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">State taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="f-812">1,133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="f-813">2,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research &amp; development tax credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="3" id="f-814">350</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="f-815">1,200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Permanent differences and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="f-816">510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="f-817">601</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income taxes from continuing operations before valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="prph:IncomeTaxesFromContinuingOperationsBeforeValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-818">5,761</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="prph:IncomeTaxesFromContinuingOperationsBeforeValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-819">5,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="f-820">257</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-821">1,354</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income tax expense (benefit)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-822">6,018</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-823">4,445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-824">6,018</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-825">4,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-826" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of the primary &#8220;temporary differences&#8221; between values recorded for assets and liabilities for financial reporting purposes and values utilized for measurement in accordance with tax laws giving rise to our deferred tax assets are as follows (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net operating loss and capital loss carryforward</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-827">4,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-828">1,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Right of use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-829">1,464</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-830">1,466</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="f-831">4,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="f-832">2,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Capital lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="prph:DeferredTaxAssetsCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-833">1,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="prph:DeferredTaxAssetsCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-834">1,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="prph:DeferredTaxLiabilitiesDepreciation" scale="3" id="f-835">479</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="prph:DeferredTaxLiabilitiesDepreciation" scale="3" id="f-836">705</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="prph:DeferredTaxLiabilitiesAmortization" format="ixt:num-dot-decimal" scale="3" id="f-837">1,612</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="prph:DeferredTaxLiabilitiesAmortization" format="ixt:num-dot-decimal" scale="3" id="f-838">2,703</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Tax credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="3" id="f-839">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:fixed-zero" scale="3" id="f-840">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="f-841">567</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="f-842">824</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-843">7,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilities" scale="3" id="f-844">224</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes tax assets and liabilities for the future tax consequences related to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and for net operating loss carryforwards. Management evaluated the deferred tax assets for recoverability using a consistent approach that considers the relative impact of negative and positive evidence, including historical profitability and projections of future reversals of temporary differences and future taxable income. The Company is required to establish a valuation allowance for deferred tax assets if management determines, based on available evidence at the time the determination is made, that it is not more likely than not that some portion or all of the deferred tax assets will be realized.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As of December&#160;31, 2023, the Company is in a net deferred tax asset position for federal and state jurisdictions. Based on a three-year cumulative income position and anticipated future taxable income, the Company concluded that the federal and combined state deferred tax assets will be realized and there is no need for a valuation allowance at this time. The Company will continue to monitor the need for any valuation allowance changes on a quarterly basis.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company continues to maintain a valuation allowance against some of the separate company state net operating loss ("NOL") carryforwards. As of December 31, 2023 there is a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="f-845">0.6</ix:nonFraction>&#160;million compared to $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="f-846">0.8</ix:nonFraction>&#160;million as of December 31, 2022. As of December 31, 2023, the Company has state NOL carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" format="ixt:num-dot-decimal" scale="6" id="f-847">1.5</ix:nonFraction>&#160;million, which begin to expire in 2024 and federal NOL carryforwards of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" format="ixt:num-dot-decimal" scale="6" id="f-848">3.1</ix:nonFraction>&#160;million as well as an R&amp;D tax credit carryforward of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="6" id="f-849">0.3</ix:nonFraction>&#160;million which can be carried forward indefinitely. A portion of the federal NOL is attributable to 2021 Nebula acquisition, and it is Section 382 limited with an annual limitation of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="prph:TaxCreditCarryforwardLimitationAmount" format="ixt:num-dot-decimal" scale="6" id="f-850">0.3</ix:nonFraction>&#160;million.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files a consolidated federal income tax return and separate company state returns as well as combined state returns where applicable.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">91</span></div></div></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_130"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10 - <ix:nonNumeric contextRef="c-1" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="f-851" continuedAt="f-851-1" escape="true">Other Current Liabilities</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="f-852" escape="true"><ix:continuation id="f-851-1"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of other current liabilities at December&#160;31, 2023 and 2022, respectively (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued diagnostic services commissions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesForCommissionsExpenseAndTaxes" format="ixt:fixed-zero" scale="3" id="f-853">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedLiabilitiesForCommissionsExpenseAndTaxes" format="ixt:num-dot-decimal" scale="3" id="f-854">1,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued payroll</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedPayrollTaxesCurrent" scale="3" id="f-855">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedPayrollTaxesCurrent" scale="3" id="f-856">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued bonus</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedBonusesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-857">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedBonusesCurrent" format="ixt:fixed-zero" scale="3" id="f-858">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-859">1,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="f-860">714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="prph:AccruedReturns" scale="3" id="f-861">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="prph:AccruedReturns" scale="3" id="f-862">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued benefits and vacation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrent" scale="3" id="f-863">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrent" scale="3" id="f-864">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total other current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-865">2,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-866">2,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="i940cc81906cc4cdfbb1f3b7467688c8d_133"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-867" continuedAt="f-867-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-867-1" continuedAt="f-867-2"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Manufacturing Agreement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its wholly owned subsidiary, PMI, entered into a manufacturing agreement (the &#8220;Manufacturing Agreement&#8221;) with Mylan Consumer Healthcare Inc. (&#8220;MCH&#8221;) and Mylan Inc. (together with MCH, &#8220;Mylan&#8221; in connection with the asset purchase agreement we entered into with Mylan in 2017. Pursuant to the terms of the Manufacturing Agreement, Mylan (or an affiliate or designee) purchased the inventory of the Company&#8217;s Cold-EEZE&#174; brand and product line, and PMI agreed to manufacture certain products for Mylan, as described in the Manufacturing Agreement, at prices that reflect current market conditions for such products and include an agreed upon mark-up on our costs. On May 1, 2021, the Manufacturing Agreement was assigned by Mylan to Nurya Brands, Inc. (&#8220;Nurya&#8221;) in connection with Nurya&#8217;s acquisitions of certain assets from Mylan, including the Cold-EEZE&#174; brand and product line. Unless terminated sooner by the parties, the Manufacturing Agreement was to remain in effect until March 29, 2023. Thereafter, the Manufacturing Agreement could be renewed by Nurya for up to <ix:nonFraction unitRef="period" contextRef="c-188" decimals="INF" name="prph:ManufacturingAgreementRenewalOptions" format="ixt-sec:numwordsen" scale="0" id="f-868">four</ix:nonFraction> successive <ix:nonNumeric contextRef="c-188" name="prph:ManufacturingAgreementRenewalPeriod" format="ixt-sec:durwordsen" id="f-869">one-year</ix:nonNumeric> periods by providing notice of its intent to renew not less than <ix:nonNumeric contextRef="c-188" name="prph:AgreementTerm" format="ixt-sec:durday" id="f-870">90</ix:nonNumeric> days prior to the expiration of the then-current term.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On November 15, 2022, the Company was notified by Nurya of its election to renew the Manufacturing agreement for <ix:nonNumeric contextRef="c-189" name="prph:ManufacturingAgreementRenewalPeriod" format="ixt-sec:durwordsen" id="f-871">one year</ix:nonNumeric>. As a result, the Manufacturing Agreement will remain in effect until March 29, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">License Agreements</span></div><div style="text-align:justify;text-indent:32.39pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Linebacker LB1 and LB2</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:32.39pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In July 19, 2022, the Company through its wholly-owned subsidiary ProPhase BioPharma entered into a License Agreement (the &#8220;Linebacker License Agreement&#8221;) with Global BioLife, Inc. (the &#8220;Licensor&#8221;), with an effective date of July 18, 2022 (the &#8220;Linebacker Effective Date&#8221;), pursuant to which it acquired from Licensor a worldwide exclusive right and license under certain patents identified in the Linebacker License Agreement (the &#8220;Licensed Patents&#8221;) and know-how (collectively, the &#8220;Licensed IP&#8221;) to exploit any compound covered by the Licensed Patents (the &#8220;Licensed Compound&#8221;), including Linebacker LB1 and LB2, and any product comprising or containing a Licensed Compound (&#8220;Licensed Products&#8221;) in the treatment of cancer, inflammatory diseases or symptoms, memory-related syndromes, diseases or symptoms including dementia and Alzheimer&#8217;s Disease (the &#8220;Field&#8221;). Under the terms of the Linebacker License Agreement, the Licensor reserves the right, solely for itself and for GRDG Sciences, LLC (&#8220;GRDG&#8221;) to use the Licensed Compound and Licensed IP solely for research purposes inside the Field and for any purpose outside the Field.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:32.39pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Subject to certain conditions set forth in the Linebacker License Agreement, the Company may grant sublicenses (including the right to grant further sublicenses) to its rights under the Linebacker License Agreement to any of its affiliates or any third party with the prior written consent of Licensor, which consent may not be unreasonably withheld. Either party to the Linebacker License Agreement may assign its rights under the Linebacker License Agreement (i) in connection with the sale or transfer of all or substantially all of its assets to a third party, (b) in the event of a merger or consolidation with a third party or (iii) to an affiliate; in each case contingent upon the assignee assuming in writing all of the obligations of its assignor under the Linebacker License Agreement.</span></div></ix:continuation><div style="text-align:justify;text-indent:32.39pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-867-2"><div style="text-align:justify;text-indent:32.39pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the terms of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Linebacker </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">License Agreement, the Company is required to pay to Licensor a one-time upfront license fee of $<ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="prph:UpfrontLicenseFee" format="ixt:num-dot-decimal" scale="0" id="f-872">50,000</ix:nonFraction> within <ix:nonNumeric contextRef="c-190" name="prph:LicenseAgreementTerm" format="ixt-sec:durwordsen" id="f-873">ten days</ix:nonNumeric> of the Linebacker Effective Date and must pay an additional $<ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="prph:AdditionalPaymentOfFee" format="ixt:num-dot-decimal" scale="0" id="f-874">900,000</ix:nonFraction> following the achievement of a first Phase 3 study which may be required by FDA for the first Licensed Product and an additional </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-5" name="prph:AdditionalPaymentOfFee" format="ixt:num-dot-decimal" scale="6" id="f-875">1.0</ix:nonFraction>&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> upon the receipt of regulatory approval of a New Drug Application for the first Licensed Product.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:32.39pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the term of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Linebacker </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">License Agreement, the Company is also required to pay to Licensor <ix:nonFraction unitRef="number" contextRef="c-190" decimals="INF" name="prph:LicenseOrRoyaltyNetRevenuePercentage" scale="-2" id="f-876">3</ix:nonFraction>% royalties on Net Revenue (as defined in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Linebacker</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> License Agreement) of each Licensed Product, but no less than the minimum royalty of $<ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:RoyaltyExpense" format="ixt:num-dot-decimal" scale="0" id="f-877">250,000</ix:nonFraction> of Net Revenue per year minus any royalty payments for any required third party licenses.</span></div><div><span><br/></span></div><div style="text-indent:32.39pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In connection with the Linebacker License Agreement, the Company has incurred approximately $<ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-878">0.6</ix:nonFraction>&#160;million and  $<ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-879">0.5</ix:nonFraction>&#160;million  in general and administrative expenses that are included in the Consolidated Statements of Operations and Comprehensive Income (Loss) for the year ended December 31, 2023 and 2022, respectively. No clinical studies have begun under this agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Equivir</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In March 2023, we commenced patient enrollment in a randomized, placebo-controlled clinical trial of Equivir to evaluate its effect on upper respiratory tract infections. Vedic Lifesciences, a leading clinical research organization, is contracted to conduct the combination prophylactic and therapeutic study, which will be conducted at <ix:nonFraction unitRef="site" contextRef="c-195" decimals="INF" name="prph:NumberOfSites" scale="0" id="f-880">8</ix:nonFraction> sites. We currently anticipate trial completion in the third quarter of 2024 and anticipate launching Equivir (dietary supplement) in the United States toward the end of 2024.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the license agreement relating to Equivir, for the year ended December 31, 2023, the Company has incurred approximately and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$<ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-881">0.4</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in general and administrative expenses that are included in the Consolidated Statements of Operations and Comprehensive Income (Loss) for the year ended ended December 31, 2023. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">BE-Smart Esophageal Pre-Cancer Diagnostics Screening Test</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In March 2023, and in connection with the Asset acquisition of Stella,, we announced a collaboration for the continued development of its BE-Smart Esophageal Pre-Cancer diagnostic screening test. We are pursuing initial commercialization of the BE-Smart test as an LDT (Laboratory Developed Test) and RUO (Research Use Only) for the third quarter of 2025 with full commercialization backed by insurance expected by the third quarter of 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the license agreement relating to BE-Smart License Agreement, for the year ended December 31, 2023, the Company has incurred approximately and $<ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-882">0.3</ix:nonFraction>&#160;million in general and administrative expenses that are included in the Consolidated Statements of Operations and Comprehensive Income (Loss) for the year ended ended December 31, 2023. No clinical studies have begun under this agreement.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of our business, we may be named as a defendant in legal proceedings. It is our policy to vigorously defend litigation or to enter into a reasonable settlement where management deems it appropriate.</span></div></ix:continuation><div id="i940cc81906cc4cdfbb1f3b7467688c8d_136"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeFinanceLeasesTextBlock" id="f-884" continuedAt="f-884-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-883" continuedAt="f-883-1" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="f-884-1" continuedAt="f-884-2"><ix:continuation id="f-883-1" continuedAt="f-883-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Jersey Laboratory Lease</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;23, 2020, the Company completed the acquisition of CPM, which included the acquisition of a <ix:nonFraction unitRef="sqft" contextRef="c-37" decimals="0" name="us-gaap:AreaOfRealEstateProperty" format="ixt:num-dot-decimal" scale="0" id="f-885">4,000</ix:nonFraction> square foot CLIA accredited laboratory located in Old Bridge, New Jersey, which was owned by CPM (which is now known as ProPhase Diagnostics NJ, Inc.). The lease was renewed in February 2023, for an additional <ix:nonNumeric contextRef="c-37" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durmonth" id="f-886">36</ix:nonNumeric> months until February 2026. The monthly base rent remains the same at $<ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-2" name="prph:LesseeOperatingLeaseMonthlyBaseRent" format="ixt:num-dot-decimal" scale="0" id="f-887">5,500</ix:nonFraction> per month. The lease renewal resulted in the recognition of an additional right-of-use asset and operating lease liability of $<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="0" id="f-888"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="0" id="f-889">170,000</ix:nonFraction></ix:nonFraction> during the year ended December&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New York Second Floor Lease</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 8, 2020, the Company entered into a Lease Agreement (the &#8220;NY Second Floor Lease&#8221;) with BRG Office L.L.C. and Unit 2 Associates L.L.C. (the &#8220;Landlord&#8221;), pursuant to which the Company leases certain premises located on the second floor (the &#8220;Second Floor Leased Premises&#8221;) of 711 Stewart Avenue, Garden City, New York (the &#8220;Building&#8221;). The Second Floor Leased Premises serve as the Company&#8217;s second location and corporate headquarters, </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-884-2" continuedAt="f-884-3"><ix:continuation id="f-883-2" continuedAt="f-883-3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">offering a wide range of laboratory testing services for diagnosis, screening and evaluation of diseases, including COVID-19 and Respiratory Pathogen Panel Molecular tests.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NY Second Floor Lease was effective as of December&#160;8, 2020, and commenced in January 2021 (the &#8220;Commencement Date&#8221;) when the facility was made available to us by the landlord. The initial term of the NY Lease is 10 years and 7 months (the &#8220;Initial Term&#8221;), unless sooner terminated as provided in the NY Lease. The Company may extend the term of the NY Lease for <ix:nonFraction unitRef="option" contextRef="c-199" decimals="INF" name="prph:LesseeOperatingLeaseNumberOfRenewalOptions" format="ixt-sec:numwordsen" id="f-890">one</ix:nonFraction> additional option period of <ix:nonNumeric contextRef="c-199" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="f-891">five years</ix:nonNumeric>. The Company has the option to terminate the NY Lease on the sixth anniversary of the Commencement Date, provided that it gives the landlord written notice not less than <ix:nonNumeric contextRef="c-200" name="prph:LesseeOperatingLeaseOptionToTerminateNoticePeriod" format="ixt-sec:durwordsen" id="f-892">nine months</ix:nonNumeric> and not more than <ix:nonNumeric contextRef="c-201" name="prph:LesseeOperatingLeaseOptionToTerminateNoticePeriod" format="ixt-sec:durmonth" id="f-893">12</ix:nonNumeric> months in advance and that we pay the landlord a termination fee.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2022, the Company entered into a First Amendment to the NY Second Floor Lease (the &#8220;Second Floor Lease Amendment&#8221;). The Second Floor Lease Amendment amends the NY Second Floor Lease to provide that any uncured default by the Company or any of its affiliate under the NY First Floor Lease (defined below) will constitute a default by the Company under the NY Second Floor Lease.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New York First Floor Lease</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;10, 2022, the Company entered into a second Lease Agreement (the &#8220;NY First Floor Lease&#8221;) with Landlord, pursuant to which the Company leases approximately <ix:nonFraction unitRef="sqft" contextRef="c-202" decimals="0" name="us-gaap:AreaOfRealEstateProperty" format="ixt:num-dot-decimal" scale="0" id="f-894">4,516</ix:nonFraction> sq. feet located on the first floor (the &#8220;NY First Floor Leased Premises&#8221;) of the building. As described above, the Company currently leases space on the second floor of the building. The First Floor Leased Premises will be used to expand the Company&#8217;s in-house lab capabilities to include traditional clinical testing across multiple specialty areas and Next Generation Sequencing (NGS) to perform Whole Genome Sequencing (WGS) and an array of genetic diagnostic test offerings for both clinical and research purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The NY First Floor Lease became effective as of June 10, 2022 and will commence upon the date of the Landlord&#8217;s substantial completion of certain improvements to the NY First Floor Leased Premises (the &#8220;First Floor Commencement Date&#8221;), as set forth in the NY First Floor Lease, targeted to be approximately five months from the execution of the NY First Floor Lease. The initial term of the NY First Floor Lease will expire on July 15, 2031, unless</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">sooner terminated as provided in the NY First Floor Lease. The Company may extend the term of the NY First Floor Lease for <ix:nonFraction unitRef="option" contextRef="c-202" decimals="INF" name="prph:LesseeOperatingLeaseNumberOfRenewalOptions" format="ixt-sec:numwordsen" id="f-895">one</ix:nonFraction> additional option period of <ix:nonNumeric contextRef="c-202" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="f-896">five years</ix:nonNumeric> pursuant to the terms described in the NY First Floor Lease. The Company has the option to terminate the NY First Floor Lease effective July 31, 2027 (the &#8220;Early Termination Date&#8221;), provided the Company gives the Landlord written notice not less than <ix:nonNumeric contextRef="c-203" name="prph:LesseeOperatingLeaseOptionToTerminateNoticePeriod" format="ixt-sec:durwordsen" id="f-897">nine months</ix:nonNumeric> and not more than <ix:nonNumeric contextRef="c-204" name="prph:LesseeOperatingLeaseOptionToTerminateNoticePeriod" format="ixt-sec:durmonth" id="f-898">12</ix:nonNumeric> months prior to the Early Termination Date and pays the Landlord a termination fee as more particularly described in the Lease.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the first year of the NY First Floor Lease, the Company will pay a base rent of $<ix:nonFraction unitRef="usd" contextRef="c-205" decimals="0" name="us-gaap:PaymentsForRent" format="ixt:num-dot-decimal" scale="0" id="f-899">11,290</ix:nonFraction> per month (subject to an <ix:nonNumeric contextRef="c-205" name="prph:LesseeOperatingLeaseAbatementPeriod" format="ixt-sec:durwordsen" id="f-900">eight month</ix:nonNumeric> abatement period), with a gradual rental rate increase of approximately <ix:nonFraction unitRef="number" contextRef="c-205" decimals="INF" name="prph:GradualRentalRateIncreasePercentage" scale="-2" id="f-901">2.75</ix:nonFraction>% for each twelve month period thereafter, culminating in a monthly base rent of $<ix:nonFraction unitRef="usd" contextRef="c-202" decimals="0" name="us-gaap:PrepaidRent" format="ixt:num-dot-decimal" scale="0" id="f-902">14,026</ix:nonFraction> during the final months of the initial term of the NY First Floor Lease. In addition to the monthly base rent, the Company is responsible for its proportionate share of real estate tax escalations in accordance with the terms of the NY First Floor Lease. The Landlord will provide a construction allowance to the Company in an aggregate amount not to exceed $<ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-3" name="prph:ConstructionAllowance" format="ixt:num-dot-decimal" scale="0" id="f-903">203,000</ix:nonFraction>, to reimburse the Company for the cost of certain improvements to be made by the Company to the First Floor Leased Premises. During the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">December&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, the Company recognized additional </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$<ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-5" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="f-904"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-905">0.8</ix:nonFraction></ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> right-of-use asset and operating lease liability for the NY First Floor Lease.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2023 and 2022, the Company had operating lease liabilities for the New York and New Jersey leases of approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="f-906">5.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="f-907">4.6</ix:nonFraction> million, respectively, and right of use assets of approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-908">4.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-909">4.1</ix:nonFraction> million, respectively, which were included in the consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finance Leases</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 19, 2023, the Company entered into a master lease agreement for a laboratory equipment (the "First Equipment Lease") with a vendor. The First Equipment Lease has a <ix:nonNumeric contextRef="c-207" name="us-gaap:LesseeFinanceLeaseTermOfContract1" format="ixt-sec:durwordsen" id="f-910">5-year</ix:nonNumeric> term and is recognized as a finance lease under ASC 842.  The present value of the minimum future obligations of $<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="f-911">1.5</ix:nonFraction> million was calculated based on an interest rate of <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-912">8.0</ix:nonFraction>%, which was recognized in finance lease liabilities in the consolidated balance sheet. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 21, 2023, the Company entered into a master lease agreement for a laboratory equipment (the "Second Equipment Lease") with a vendor. The Second Equipment Lease has a <ix:nonNumeric contextRef="c-208" name="us-gaap:LesseeFinanceLeaseTermOfContract1" format="ixt-sec:durwordsen" id="f-913">4-year</ix:nonNumeric> term and is recognized as a finance lease </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-884-3" continuedAt="f-884-4"><ix:continuation id="f-883-3" continuedAt="f-883-4"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">under ASC 842.  The present value of the minimum future obligations of $<ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="f-914">5.1</ix:nonFraction> million was calculated based on an interest rate of <ix:nonFraction unitRef="number" contextRef="c-208" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-915">7.4</ix:nonFraction>%, which was recognized in finance lease liabilities in the condensed consolidated balance sheet. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 26, 2023, the Company entered into a master lease agreement for a laboratory equipment (the "Third Equipment Lease") with a vendor. The Third Equipment Lease has a <ix:nonNumeric contextRef="c-209" name="us-gaap:LesseeFinanceLeaseTermOfContract1" format="ixt-sec:durwordsen" id="f-916">3-year</ix:nonNumeric> term starting on the commencement date. The commencement date is when the equipment is shipped and installed, then the Company will provide Final Acceptance Certificate to the vendor. As of December&#160;31, 2023, the commencement date was not established, therefore, there was no fixed assets or finance lease liability recognized in the condensed consolidated balance sheet. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Depreciation and interest expense related to the Equipment Lease was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="0" id="f-917">760,000</ix:nonFraction> for the year ended December 31, 2023.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-918" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes quantitative information about the Company's operating and finance leases (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="f-919">956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="f-920">816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Variable lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="f-921">956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="f-922">816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Finance leases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest lease cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="f-923">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" format="ixt:fixed-zero" scale="0" id="f-924">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-925">760</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:fixed-zero" scale="0" id="f-926">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total finance lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="prph:FinanceLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-927">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="prph:FinanceLeaseCost" format="ixt:fixed-zero" scale="3" id="f-928">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other information related to the Company&#8217;s leases is shown below (dollar amounts in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the Years Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating cash flows used in operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="f-929">839</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="f-930">774</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"/><td style="width:67.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.729%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted-average remaining lease term &#8211; operating leases (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-931">7.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-5" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-932">8.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term &#8211; finance leases (in years)</span></td><td colspan="3" style="padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-4" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-933">3.8</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;NA </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted-average discount rate &#8211; operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-934">10.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-935">10.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate &#8211; finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-936">7.56</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease asset (1)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-937">5,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">NA</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) As of December&#160;31, 2023, the Company had recorded accumulated depreciation of approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" format="ixt:num-dot-decimal" scale="0" id="f-938">760,000</ix:nonFraction> for the finance lease asset. Finance lease assets are recorded within <span style="-sec-ix-hidden:f-939">property and equipment, net</span> on the Company&#8217;s condensed consolidated balance sheets.</span></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-940" escape="true"><ix:continuation id="f-884-4"><ix:continuation id="f-883-4"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Minimum lease payments over the remaining lease periods as of December&#160;31, 2023 are as follows (amounts in thousands):</span></div></ix:continuation></ix:continuation><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.121%"><tr><td style="width:1.0%"/><td style="width:39.421%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.986%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.017%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.294%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Operating Lease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Finance Lease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year Ended December 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="f-941">952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-942">1,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="prph:LeaseLiabilityToBePaidYearOne" format="ixt:num-dot-decimal" scale="3" id="f-943">2,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year Ended December 31, 2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="f-944">977</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-945">1,840</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="prph:LeaseLiabilityToBePaidYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-946">2,817</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year Ended December 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="f-947">941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-948">1,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="prph:LeaseLiabilityToBePaidYearThree" format="ixt:num-dot-decimal" scale="3" id="f-949">2,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year Ended December 31, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="f-950">955</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-951">1,188</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="prph:LeaseLiabilityToBePaidYearFour" format="ixt:num-dot-decimal" scale="3" id="f-952">2,143</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year Ended December 31, 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="f-953">982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="3" id="f-954">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="prph:LeaseLiabilityToBePaidYearFive" format="ixt:num-dot-decimal" scale="3" id="f-955">1,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-956">2,667</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:fixed-zero" scale="3" id="f-957">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="prph:LeaseLiabilityToBePaidAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-958">2,667</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-959">7,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-960">6,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="prph:LeaseLiabilityToBePaid" format="ixt:num-dot-decimal" scale="3" id="f-961">14,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less present value discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-962">2,284</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="f-963">898</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="prph:LeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-964">3,182</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total   </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-965">5,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-966">5,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="prph:LeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-967">11,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div id="i940cc81906cc4cdfbb1f3b7467688c8d_145"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="f-969" continuedAt="f-969-1" escape="true">Significant Customers Concentrations</ix:nonNumeric></span></div><ix:continuation id="f-969-1"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue for years ended December 31, 2023 and 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-970">44.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-971">122.6</ix:nonFraction> million, respectively. Diagnostic Services accounted for <ix:nonFraction unitRef="number" contextRef="c-210" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-972">54.9</ix:nonFraction>%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and <ix:nonFraction unitRef="number" contextRef="c-211" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-973">88.3</ix:nonFraction>%, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our net revenue for the year ended December&#160;31, 2023 and 2022. The company decreased its diagnostic services business in the second half of 2023 due to the significant decrease in demand for our diagnostic testing services. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2023 &amp; 2022, there were no consumer products customers that accounted for 10% or more of our total revenues.. Collections of diagnostic services revenues are driven by payers, which are government agencies (primarily HRSA), insurance providers, and client payers. For the year ended December 31, 2022, requisitions from each payer group were approximately <ix:nonFraction unitRef="number" contextRef="c-212" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-974">29</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-213" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-975">66</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="c-214" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-976">5</ix:nonFraction>%, respectively. For the year ended December 31, 2023, requisitions from government agencies including Medicaid and Medicare were approximately <ix:nonFraction unitRef="number" contextRef="c-215" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-977">17</ix:nonFraction>% and insurance providers were <ix:nonFraction unitRef="number" contextRef="c-216" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-978">83</ix:nonFraction>%.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to account receivable credit concentrations from time-to-time as a result of the timing, payment pattern and ultimate purchase volumes or shipping schedules with our customers. These concentrations may impact its overall exposure to credit risk, either positively or negatively, in that our customers may be similarly affected by changes in economic, regulatory or other conditions that may impact the timing and collectability of amounts due to the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Three diagnostic services payers generated <ix:nonFraction unitRef="number" contextRef="c-217" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-979">32.6</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-218" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-980">18.7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-219" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-981">12.6</ix:nonFraction>% of our total reimbursement receivable balances from government agencies and healthcare issuers at December 31 2023. Two diagnostic services payers generated <ix:nonFraction unitRef="number" contextRef="c-220" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-982">68.8</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-221" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-983">16.0</ix:nonFraction>% of our total reimbursement receivable balances from government agencies and healthcare issuers at December 31, 2022. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, the Company relies on a sole supplier to manufacture its saliva collection kits used by customers who purchase its personal genomics services. Change in the supplier or design of certain of the materials that the Company relies on, in particular the saliva collection kit, could result in a requirement for additional premarket review from the FDA before making such a change.</span></div></ix:continuation><div id="i940cc81906cc4cdfbb1f3b7467688c8d_148"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-984" continuedAt="f-984-1" escape="true">Segment Information</ix:nonNumeric></span></div><ix:continuation id="f-984-1" continuedAt="f-984-2"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has identified <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-985">two</ix:nonFraction> operating segments, diagnostic services and consumer products, based on the manner in which the Company&#8217;s CEO as CODM assesses performance and allocates resources across the organization. The operating segments are organized in a manner that depicts the difference in revenue generating synergies that include the separate processes, profit generation and growth of each segment. The diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third party payers and government organizations. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provides personal genomics products and services. The unallocated corporate expenses mainly included professional fees associated with the public company.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-986" escape="true"><ix:continuation id="f-984-2"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of segment information for Fiscal 2023, 2022 and 2021 (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.939%"><tr><td style="width:1.0%"/><td style="width:65.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.592%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.981%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-987">24,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-988">108,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consumer products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-989">19,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-990">14,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consolidated net revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-991">44,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-992">122,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cost of revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-993">11,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-994">39,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consumer products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-995">16,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-996">12,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consolidated cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-997">28,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-998">51,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Depreciation and amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-999">3,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1000">2,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consumer products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1001">2,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1002">2,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total Depreciation and amortization expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1003">6,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1004">4,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Operating and other expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="prph:OperatingAndOtherExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1005">32,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="prph:OperatingAndOtherExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1006">43,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Income (loss) from operations, before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1007">1,804</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1008">56,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consumer products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1009">7,493</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1010">10,824</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unallocated corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1011">13,503</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1012">22,657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total income from operations, before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1013">22,800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1014">22,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1015">6,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1016">4,445</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Net Income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1017">16,782</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1018">18,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of segment information for Fiscal 2023 and Fiscal 2022 (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1019">44,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1020">50,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consumer products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1021">38,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1022">22,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unallocated corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1023">9,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1024">14,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1025">91,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1026">87,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="i940cc81906cc4cdfbb1f3b7467688c8d_151"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 15 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-1027" continuedAt="f-1027-1" escape="true">Earnings Per Share</ix:nonNumeric></span></div><ix:continuation id="f-1027-1" continuedAt="f-1027-2"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share (&#8220;EPS&#8221;) excludes dilution and is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or otherwise result in the issuance of common stock that shared in the earnings of the entity. Diluted EPS also utilizes the treasury stock method which prescribes a theoretical buy back of shares from the theoretical proceeds of all options outstanding during the period, and the if-converted method for convertible debt.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-1027-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-1028" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the weighted average number of common shares outstanding used in calculating basic and diluted net loss per share (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net (loss) income - basic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-1029">16,782</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-1030">18,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest on unsecured convertible promissory note</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="prph:InterestOnUnsecuredConvertiblePromissoryNote" format="ixt:fixed-zero" scale="3" id="f-1031">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="prph:InterestOnUnsecuredConvertiblePromissoryNote" scale="3" id="f-1032">632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net (loss) income - diluted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-1033">16,782</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-1034">19,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average shares outstanding - basic</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1035">17,207</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-1036">15,845</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diluted shares- Stock Options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-234" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="f-1037">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-235" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="f-1038">1,493</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diluted shares- Stock Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-236" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="f-1039">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-237" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="f-1040">1,073</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unsecured convertible promissory note</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-1041">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="3" id="f-1042">240</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average shares outstanding - diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1043">17,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-1044">18,651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-1045" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the number of securities excluded from the income per share computation as a result of their anti-dilutive effect (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.263%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.142%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Anti-dilutive securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Common stock purchase warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-238" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-1046">831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-239" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-1047">455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Stock Options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-240" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-1048">2,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-241" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-1049">770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Anti-dilutive securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-1050">3,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-1051">1,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i940cc81906cc4cdfbb1f3b7467688c8d_154"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 16 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="f-1052" continuedAt="f-1052-1" escape="true">Related Parties</ix:nonNumeric></span></div><ix:continuation id="f-1052-1"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Executive Vice President and Co-Chief Operations Officer of ProPhase Diagnostics, is a related party to the Company's Chairman and Chief Executive Officer. For the years ended December 31, 2023 and 2022, there were no payments made to the Executive Vice President outside compensation for the position held at the Company.</span></div></ix:continuation><div id="i940cc81906cc4cdfbb1f3b7467688c8d_157"></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 17 &#8211; <ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-1053" continuedAt="f-1053-1" escape="true">Subsequent Events</ix:nonNumeric></span></div><ix:continuation id="f-1053-1"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> February&#160;14, 2024, the Company entered into an agreement of sale of future receipts (&#8220;Future Receipts Financing Agreement&#8221;) with Libertas Funding, LLC (&#8220;Libertas&#8221;) by which Libertas purchases from the Company, its future accounts and contract rights arising from the sale of goods or rendition of services to the Company&#8217;s customers. The purchase price was approximate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-5" name="prph:ProceedsFromFinancingAgreement" format="ixt:num-dot-decimal" scale="6" id="f-1054">2.5</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which was paid to the Company on February 16, 2024, net of $<ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-3" name="prph:FinancingAgreementOriginationFee" format="ixt:num-dot-decimal" scale="0" id="f-1055">50,000</ix:nonFraction> origination fee. The Future Receipts Financing Agreement requires twelve equal payments of $<ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-3" name="prph:FinancingAgreementPeriodicPayment" format="ixt:num-dot-decimal" scale="0" id="f-1056">247,000</ix:nonFraction> to be paid monthly for a total repayment of approximate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-5" name="prph:FinancingArrangementAggregateRepaymentAmount" format="ixt:num-dot-decimal" scale="6" id="f-1057">3.0</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the term of the agreement. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated subsequent events through March 28, 2024, which is the date the consolidated financial statements were available to be issued. There were no additional subsequent events that required adjustment to or disclosure in the consolidated financial statements.</span></div></ix:continuation><div id="i940cc81906cc4cdfbb1f3b7467688c8d_160"></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.&#160;&#160;&#160;&#160;Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_163"></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A.&#160;&#160;&#160;&#160;Controls and Procedures </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed with or submitted to the SEC under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our reports filed under the Exchange Act is accumulated and communicated to management, including our principal executive officer and principal financial and accounting officer, to allow timely decisions regarding required disclosure.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of December 31, 2023. This evaluation was carried out under the supervision and with the participation of our principal executive officer and principal financial and accounting officer. Based on that review, our management, including our principal executive officer and principal financial and accounting officer, concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of December 31, 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control Over Financial Reporting </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining an adequate system of internal control over financial reporting. Our system of internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our internal control over financial reporting includes those policies and procedures that:</span></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect our transactions and dispositions of our assets;</span></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide reasonable assurance that our transactions are recorded as necessary to permit preparation of our financial statements in accordance with accounting principles generally accepted in the United States of America, and that our receipts and expenditures are being made only in accordance with authorizations of our management and our directors; and</span></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on the financial statements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, a system of internal control over financial reporting can provide only reasonable assurance and may not prevent or detect misstatements. Further, because of changes in conditions, effectiveness of internal controls over financial reporting may vary over time. Our system contains self-monitoring mechanisms, and actions are taken to correct deficiencies as they are identified.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management conducted an evaluation of our effectiveness of the system of internal control over financial reporting based on the framework in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework). Based upon our review, our management, including our principal executive officer and principal financial and accounting officer, concluded that the Company&#8217;s internal controls over financial reporting were not effective as of December 31, 2023 due to material weaknesses described below. </span></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We did not adequately review certain account reconciliations or controls over the financial statement closing process, which resulted in misstatements in account reconciliations and resulted in several proposed unadjusted journal entries.</span></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Several errors were made related to recording revenue in the proper period, calculating current period revenue, and following Company policy regarding principal versus agent considerations, resulting in misstatements in accounts receivable, deferred revenue, and revenue for multiple subsidiaries. We relied heavily on the manual input process for these areas and it did not properly design and maintain controls to identify exceptions. In certain instances where revenue is recorded based on an estimation of rates, process were not in place to properly update the rates accordingly throughout the year. </span></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We did not design and maintain adequate controls over the identification of discrepancies relating to the calculated and recorded deferred costs and cost of sales, which such calculation and recording relied heavily on the manual input process and resulted in misstatements in deferred costs and cost of sales.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Management is committed to remediating the material weaknesses. We have begun the process of implementing changes to our internal control over financial reporting to remediate the control deficiencies that gave rise to the material weaknesses, including implementing new automated financial systems related to recording transactions and account reconciliation preparation and review, which will significantly reduce the amount of processes that rely on manual inputs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will not consider the material weakness remediated until the remedial controls operate for a sufficient period of time and we have concluded, through testing, that these controls are effectively designed and operating effectively. We will continue to assess throughout 2024.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Morison Cogen LLP, the Company&#8217;s independent registered public accounting firm, was appointed by the Company&#8217;s Board of Directors and ratified by the Company&#8217;s stockholders. They were engaged to render an opinion regarding the fair presentation of the Company&#8217;s consolidated financial statements as well as conducting an audit of internal control over financial reporting for the period ending December 31, 2023. Their reports, that expressed the opinion that the Company has not maintained effective internal control over financial reporting as of December 31, 2023, based on criteria established in IInternal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework), because of the effect of the material weaknesses described above on the achievement of the objectives of the control criteria,, included at page 65 of this Form 10-K are based upon audits conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as described above in &#8220;Management&#8217;s Report on Internal Control Over Financial Reporting&#8221;, there was no change in our internal control over financial reporting identified in connection with evaluation required by paragraph (d) of Rules 13a-15 or 15d-15 under the Exchange Act that occurred during the fourth quarter of the fiscal year ended December 31, 2023 that has materially affected or is reasonably likely to materially affect our internal control over financial reporting.</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_166"></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B.&#160;&#160;&#160;&#160;Other Information</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On March 26, 2024, our board of directors amended and restated our Bylaws in order to make certain procedural changes consistent with the Delaware General Corporation Law. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The foregoing description of the Bylaws is qualified in its entirety by reference to the Bylaws, a copy of which is attached as Exhibit 3.2 to this Annual Report, and is incorporated herein by reference. Additionally, a copy of the Bylaws marked to show changes to the former Bylaws is included as Exhibit 3.2.1 to this Annual Report, and is incorporated herein by reference.</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_169"></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9C.&#160;&#160;&#160;&#160;Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">100</span></div></div></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_172"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_175"></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10.&#160;&#160;&#160;&#160;Directors, Executive Officers and Corporate Governance</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required under this item is incorporated by reference from the sections of the Company&#8217;s Proxy Statement for the 2024 Annual Meeting of Stockholders (the &#8220;2024 Proxy Statement&#8221;) titled &#8220;Proposal 1 &#8211; Election of Board of Directors,&#8221; &#8220;Executive Officers,&#8221; &#8220;Governance Policies and Procedures &#8211; Code of Conduct,&#8221; &#8220;Corporate Governance &#8211; Committees of the Board of Directors &#8211; Audit Committee.&#8221; The 2024 Proxy Statement will be filed with the Securities and Exchange Commission ("SEC") not later than 120 days after the close of our fiscal year ended December 31, 2023 and is hereby incorporated by reference</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_178"></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 11.&#160;&#160;&#160;&#160;Executive Compensation</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required under this item is incorporated by reference from the section of the 2024 Proxy Statement titled &#8220;Executive and Director Compensation.&#8221;</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_181"></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12.&#160;&#160;&#160;&#160;Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required under this item is incorporated by reference from the sections of the 2024 Proxy Statement titled &#8220;Equity Compensation Plan Information&#8221; and &#8220;Security Ownership.&#8221; </span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_184"></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13.&#160;&#160;&#160;&#160;Certain Relationships and Related Transactions and Director Independence</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required under this item is incorporated by reference from the sections of the 2024 Proxy Statement titled &#8220;Corporate Governance &#8211; Certain Relationships and Related Transactions,&#8221; and &#8220;Corporate Governance &#8211; Director Independence.&#8221;</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_187"></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14.&#160;&#160;&#160;&#160;Principal Accountant Fees and Services</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required under this item is incorporated by reference from the section of the 2024 Proxy Statement titled &#8220;Audit and Non-Audit Fees.&#8221;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">101</span></div></div></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_190"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_193"></div><div style="-sec-extract:summary;margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 15.&#160;&#160;&#160;&#160;Exhibits and Financial Statement Schedules</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)(1) Financial Statements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following consolidated financial statements of ProPhase Labs, Inc., together with the report thereon of Friedman LLP, independent registered public accounting firms, are included in this Annual Report.</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.052%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Page</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline">Reports of Independent Registered Public Accounting Firms</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_79">62</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Financial Statements:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_85">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_85">67</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_88">Consolidated Statements of Operations and Other Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_88">69</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_91">Consolidated Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_91">70</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_94">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_94">71</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_97">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i940cc81906cc4cdfbb1f3b7467688c8d_97">72</a></span></div></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)(2) Financial Statement Schedules.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All schedules have been omitted because they are not required or because the required information is given in the consolidated financial statements or Notes thereto set forth under Item 8 above.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)(3) Exhibits</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.143%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Description</span></td></tr><tr><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.1&#8224;+</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/868278/000149315217002984/ex2-2.htm">Manufacturing Agreement, dated March 29, 2017, by and between Meda Consumer Healthcare Inc., Pharmaloz Manufacturing, Inc. and Prophase Labs, Inc. (incorporated by reference to Exhibit 2.2 of the Current Report on Form 8-K (File No. 000-21617) filed on March 29, 2017).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/868278/000114420415038044/v413615_ex3-3.htm">Certificate of Incorporation of the Company, (incorporated by reference to Exhibit 3.3 of the Current Report on Form 8-K (File No. 000-21617) filed on June 19, 2015).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.2**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="prophase-bylaws2024.htm">Amended and Restated Bylaws of the Company (as of March 26, 2024).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.2.1**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="literacompareredline-pro.htm">Amended and Restated Bylaws of the Company (as of March 26, 2024, marked to show changes).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/868278/0000921895-97-000237.txt">Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.1 of Form 10-KSB/A (File No. 000-21617) filed on April 4, 1997).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/868278/000149315220004807/ex4-3.htm">Description of Common Stock (incorporated by reference to Exhibit 4.3 of the Annual Report on Form 10-K (File No. 000-21617) filed on March 26, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/868278/000114420409044702/v158614_ex10-1.htm">Form of Indemnification Agreement between the Company and each of its Officers and Directors, dated August 19, 2009 (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K (File No. 000-21617) filed on August 19, 2009).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.2*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/868278/000149315223021848/ex10-1.htm">Amended and Restated 2022 Equity Compensation Plan (incorporated by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K (File No. 000-21617) filed on June 20, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.3*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/868278/000149315223021848/ex10-2.htm">Amended and Restated 2022 Directors&#8217; Equity Compensation Plan (incorporated by reference to Exhibit 10.2 of the Company&#8217;s Current Report on Form 8-K (File No. 000-21617) filed on June 20, 2023).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.4*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="prophase-formof2022plannqo.htm">Form of Non-Qualified Stock Option Agreement pursuant to 2022 Equity Compensation Plan </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.5*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="prophase-formof2022planinc.htm">Form of Incentive Stock Option Agreement pursuant to 2022 Equity Compensation Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.6*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="prophase-director2022plano.htm">Form of Option Agreement pursuant to 2022 Directors&#8217; Equity Compensation Plan </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.7*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000f1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/868278/000149315218002422/ex10-1.htm">Amended and Restated 2015 Executive Employment Agreement with Ted Karkus, effective February 23, 2018 (incorporated by reference to Exhibit 10.2 of the Current Report on Form 8-K (File No. 000-21617) filed on April 16, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/868278/000149315221007538/ex10-18.htm">Lease agreement by and among ProPhase Diagnostics, Inc., BRG Office L.L.C. and Unit 2 Associates L.L.C. for the corporate headquarters and diagnostic lab facility located at 711 Stewart Avenue, Garden City, NY 11530 (incorporated by reference to Exhibit 10.18 of the Annual Report on Form 10-K (File No. 000-21617) filed on March 31, 2021).</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.143%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/868278/000149315221032692/ex10-1.htm">Sales Agreement, dated December 28, 2021, between ProPhase Labs, Inc. and ThinkEquity LLC (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K (File No. 000-21617) filed on December 29, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/868278/000149315222016524/ex10-1.htm">Lease Agreement by and between ProPhase Diagnostics, Inc. and BRG Office L.L.C. and Unit 2 Associates L.L.C., as tenants in common, dated June 10, 2022 (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K (File No. 000-21617) filed on June 13, 2022)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/868278/000149315222016524/ex10-2.htm">Guaranty dated June 10, 2022 (incorporated by reference to Exhibit 10.2 of the Current Report on Form 8-K (File No. 000-21617) filed on June 13, 2022)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/868278/000149315222016524/ex10-3.htm">First Amendment of Lease, dated June 10, 2022, by and between ProPhase Diagnostics, Inc. and BRG Office L.L.C. and Unit 2 Associates L.L.C., as tenants in common (incorporated by reference to Exhibit 10.3 of the Current Report on Form 8-K (File No. 000-21617) filed on June 13, 2022)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/868278/000149315222019965/ex10-1.htm">License Agreement by and between ProPhase BioPharma, Inc. and Global BioLife, Inc., dated July 19, 2022 (effective as of July 18, 2022) (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K (File No. 000-21617) filed on July 21, 2022)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/868278/000149315222035948/ex10-1.htm">Asset Purchase Agreement by and among Stella Diagnostics Inc., Stella DX, LLC and ProPhase Labs, Inc., dated December 15, 2022 (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K (File No. 000-21617) filed on December 20, 2022)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/868278/000149315223002940/ex10-1.htm">Unsecured Promissory Note and Guaranty issued to JXVII Trust, dated January 26, 2023 (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K (File No. 000-21617) filed on January 30, 2023)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/868278/000149315223002940/ex10-2.htm">Common Stock Purchase Warrant issued to JXVII Trust, dated January 27, 2023 (incorporated by reference to Exhibit 10.2 of the Current Report on Form 8-K (File No. 000-21617) filed on January 30, 2023)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17*&#8224;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/868278/000149315223002940/ex10-2.htm">Latkin Offer Letter, dated as of December 28, 2023, by and between the Company and Jed A. Latkin (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K (File No. 000-21617) filed on January 4, 2024.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="prophase-exhibit191.htm">Insider Trading Policy</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="prophase-exhibit211.htm">Subsidiaries of ProPhase Labs, Inc.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="prph-exhibit231consent.htm">Consent of Morison Cogen LLP, Independent Registered Public Accounting Firm </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="prophase-exhibit3111.htm">Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="prophase-exhibit3121.htm">Certification of Principal Finance Officer and Principal Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1***</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="prophase-exhibit3211.htm">Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2***</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="prophase-exhibit3221.htm">Certification of the Principal Finance Officer and Principal Accounting Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.1**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="prophase-exhibit971.htm">Compensation Recovery Policy</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101 INS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Instance Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101 SCH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101 CAL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101 DEF</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101 LAB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101 PRE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Indicates a management contract or compensatory plan or arrangement.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** Filed herewith.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*** Furnished herewith.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224; Confidential treatment granted as to portions of the exhibit. The Company agrees to furnish supplementally a copy of any omitted schedule or exhibit to the Securities and Exchange Commission upon request.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">+ Certain schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule or exhibit to the Securities and Exchange Commission upon request.</span></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_196"></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16&#160;&#160;&#160;&#160;Form 10-K Summary</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">104</span></div></div></div><div id="i940cc81906cc4cdfbb1f3b7467688c8d_199"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i940cc81906cc4cdfbb1f3b7467688c8d_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline">PROPHASE LABS, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">/s/ Ted Karkus</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Ted Karkus, Chairman of the Board,</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Chief Executive Officer and Director</span></div></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.142%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:49.203%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.143%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Signature</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Title</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Date</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">/s/ Ted Karkus</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chairman of the Board and Chief Executive Officer </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 28, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Ted Karkus</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">/s/ Jed Latkin</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Operating Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 28, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Jed Latkin</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">/s/ Jason Barr</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">March 28, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Jason Barr</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">/s/ Louis Gleckel</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Director </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">March 28, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Louis Gleckel</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">/s/ Warren Hirsch</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Director </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">March 28, 2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warren Hirsch</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">105</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>2
<FILENAME>prophase-bylaws2024.htm
<DESCRIPTION>EX-3.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i6a8a02e1c6904c1e892a8a3a8251190d_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">BYLAWS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">PROPHASE LABS, INC.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(As amended and restated March 26, 2024)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8211; OFFICES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The registered office of Prophase Labs, Inc. (the &#8220;Corporation&#8221;) in the State of Delaware is 874 Walker Road, Suite C, Dover, DE 19904. The name of its registered agent at such address is United Corporate Services, Inc.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Corporation may have such offices within or without the State of Delaware as the Board of Directors may designate or as the business of the Corporation may require from time to time.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8211; STOCKHOLDERS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ANNUAL MEETING&#58; The annual meeting of stockholders shall be held each year on a date and a time designated by the Board of Directors. At each annual meeting directors shall be elected and any other proper business may be transacted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SPECIAL MEETINGS&#58; In addition to the rights of the holders of any series of Preferred Stock, special meetings of the stockholders may be called at any time by (a) the Chairman or (b) the Board of Directors pursuant to a resolution approved by a majority of the whole Board of Directors. Business transacted at any special meeting of stockholders shall be limited to the purposes stated in the notice to stockholders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PLACE OF MEETING&#58; The Board of Directors may designate any place, either within or without the State of Delaware, as the place of meeting for any annual meeting or for any special meeting called by the Board of Directors. The Board of Directors may, in its sole discretion, determine that the meeting shall not be held at any place, but may instead be held solely by means of remote communication as provided under the Delaware General Corporation Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOTICE OF MEETING&#58; Whenever stockholders are required or permitted to take any action at a meeting, a written notice of any such meeting shall be given which notice shall state the place, date and hour of the meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting is called. The notice shall, unless otherwise prescribed by statute, be delivered not less than ten (10) nor more than sixty (60) days before the date of the meeting, either personally or by mail, by or at the direction of the Chairman, to each stockholder of record entitled to vote at such meeting. If mailed, such notice shall be deemed to be delivered when deposited in the United States mail, addressed to the stockholder at his address as it appears on the stock transfer books of the Corporation, with postage thereon prepaid. Notice of any meeting of the stockholders shall not be required to be given to any stockholder who shall attend such meeting in person or by proxy without protesting, prior to or at the commencement of the meeting, the lack of proper notice to such stockholder, or who shall waive notice thereof as provided in Article XI of these Bylaws. Notice of adjournment of a meeting of the stockholders need not be given if the date, time and place, if any, to which it is adjourned, and any means of remote communication for such adjourned meeting, are (i) announced at the meeting at which the adjournment is taken, (ii) displayed during the time scheduled for such meeting on the same electronic network used to enable stockholders and proxy holders to participate in such meeting by means of remote communication or (iii) set forth in the notice of such meeting given in accordance with the provisions of this Article 2.4&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that if the adjournment is for more than 30 days or, after adjournment, a new record date is fixed for the adjourned meeting, then a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOTICE BY ELECTRONIC TRANSMISSION&#58;  Any notice to stockholder given by the Corporation pursuant to any provision of these Bylaws, the Exchange Act (as defined in Article 2.15(b) below) or the Certificate of Incorporation shall be effective if given by a form of electronic </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">transmission consented to by the stockholder to whom the notice is given. The consent is revocable by the stockholder by written notice to the Corporation. The consent is revoked if&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Corporation is unable to deliver by electronic transmission two consecutive notices given by the Corporation in accordance with the consent&#59; and</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The inability to deliver by electronic transmission becomes known to the secretary, assistant secretary, transfer agent or other agent of the Corporation responsible for the giving of notice. However, the inadvertent failure to treat the inability to deliver notice by electronic transmission as a revocation does not invalidate any meeting or other action.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notice given pursuant to this Article 1.5 shall be deemed given if&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By facsimile machine, when directed to a number at which the stockholder has consented to receive notice&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By electronic mail, when directed to an electronic mail address at which the stockholder has consented to receive notice&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By posting on an electronic network together with separate notice to the stockholder of the specific posting, upon the later of&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:90pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Such posting&#59; and</font></div><div style="margin-top:12pt;text-align:justify;text-indent:90pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The giving of the separate notice&#59; and</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By any other form of electronic transmission, when directed to the stockholder.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As used in this Article 1.5, &#8220;electronic transmission&#8221; means any form of communication not directly involving the physical transmission of paper that&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Creates a record that may be retained, retrieved and reviewed by the recipient of the communication&#59; and</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">May be directly reproduced in paper form by the recipient through an automated process.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CLOSING OF TRANSFER BOOKS OR FIXING OF RECORD DATE&#58; For the purpose of determining stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment thereof, or stockholders entitled to receive payment of any dividend, or in order to make a determination of stockholders for any other proper purpose, the Board of Directors of the Corporation may provide that the stock transfer books shall be closed for a stated period but not to exceed, in any case, sixty (60) days. In lieu of closing the stock transfer books, the Board of Directors may fix in advance a date as the record date for any such determination of stockholders, such date in any case to be not more than sixty (60) days, and, in case of a meeting of stockholders, not less than ten (10) days prior to the date on which the particular action, requiring such determination of stockholders, is to be taken. If the stock transfer books are not closed and no record date is fixed for the determination of stockholders entitled to notice of or to vote at a meeting of stockholders, or stockholders entitled to receive payment of a dividend, the date on which notice of the meeting is mailed or the date on which the resolution of the board of directors declaring such dividend is adopted, as the case may be, shall be the record date for such determination of stockholders. But payment or allotment of dividends may not be made more than sixty days after the date on which the resolution is adopted. When a determination of stockholders entitled to vote at any meeting of stockholders has been made as provided in this Article 2.6, such determination shall apply to any adjournment thereof regardless of its length except where the determination has been made through the closing of the stock transfer books and the stated period of closing has expired.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BOOKS AND ACCOUNTS&#58; This Corporation shall keep and maintain at its principal office in this State&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A certified copy of its Certificate of Incorporation, and all amendments thereto.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A certified copy of its Bylaws, and all amendments thereto.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A stock ledger or a duplicate stock ledger, revised annually, containing the names, alphabetically arranged, of all persons who are stockholders of the Corporation, showing their places of residence, if known, and the number of shares held by them respectively&#59; or</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In lieu of the stock ledger or duplication stock ledger specified in paragraph (c), a statement setting out the name of the custodian of the stock ledger or duplicate stock ledger, and the present and complete post office address, including street and number, if any, where such stock ledger or duplicate stock ledger specified in this Article 1.7 is kept.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 8. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">QUORUM&#58; A majority of the outstanding shares of the Corporation entitled to vote, represented in person or by proxy, shall constitute a quorum at a meeting of stockholders&#59; provided, however, that in the case of any vote to be taken by classes or series, the holders of a majority of the votes entitled to be cast by the stockholders of a particular class or series, present in person or by proxy, shall constitute a quorum of such class or series.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ADJOURNMENTS&#59; POSTPONEMENTS&#58; In the absence of a quorum, holders of stock representing a majority of the voting power of all shares present in person or represented by proxy at the meeting, or the chairman of the meeting, may adjourn any meeting of stockholders (including an adjournment to address a technical failure to convene), from time to time, to reconvene at the same or some other place, and notice need not be given of any such adjourned meeting if the time and place thereof are announced at the meeting at which the adjournment is taken. Furthermore, after the meeting has been duly organized, the chairman of the meeting may adjourn any meeting of stockholders, from time to time, to reconvene at the same or some other place, and notice need not be given of any such adjourned meeting if the date, time and place, if any, thereof, and any means of remote communication for such meeting, are (i) announced at the meeting at which the adjournment is taken, (ii) displayed during the time scheduled for such meeting on the same electronic network used to enable stockholders and proxy holders to participate in such meeting by means of remote communication, or (iii) set forth in the notice of such meeting given in accordance with the provisions of Article 2.4. At the adjourned meeting, the Corporation may transact any business which might have been transacted at the original meeting. If the adjournment is for more than thirty (30) days, or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting. Any previously scheduled meeting of stockholders may be postponed by the Board of Directors prior to the date previously scheduled for such meeting and the Corporation shall publicly announce such postponement.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 10. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PROXIES&#58; At any meeting of stockholders, a stockholder may vote in person or by proxy executed in writing by the stockholder or by his duly authorized attorney in fact. Proxies for use at any meeting of stockholders shall be in writing and filed with the Secretary, or such other officer as the Board of Directors may from time to time determine by resolution, before or at the time of the meeting. All proxies shall be received and taken charge of and all ballots shall be received and canvassed by the secretary of the meeting who shall decide all questions touching upon the qualification of voters, the validity of the proxies and the acceptance or rejection of votes, unless an inspector or inspectors shall have been appointed by the Chairman, in which event such inspector or inspectors shall decide all such questions. Any stockholder directly or indirectly soliciting proxies from other stockholders must use a proxy card color other than white, which shall be reserved for the exclusive use by the Board of Directors.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A proxy shall not be valid after six months from the date of its execution, unless coupled with an interest, but no proxy shall be valid after seven years from the date of its execution, unless renewed or extended at any time before its expiration.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 11. LIST OF STOCKHOLDERS ENTITLED TO VOTE&#58; A complete list of stockholders entitled to vote at any meeting of stockholders, arranged in alphabetical order and showing the address of each stockholder and the number of shares registered in the name of each stockholder, shall be open to he examination of any stockholder, for any purpose germane to the meeting, for a period of ten (10) days ending on the day before the meeting date, (i) on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided with the notice of the meeting, or (ii) during ordinary business hours, at the principal place of business of the Corporation. In the event that the Corporation determines to make the list available on an electronic network, the Corporation may take reasonable steps to ensure that such information is available only to the stockholders of the Corporation.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 12. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VOTING AND ELECTIONS&#58; Each stockholder of record of any series of Preferred Stock shall be entitled at each meeting of the stockholders to such number of votes, if any, for each share of such stock as may be fixed in the Certificate of Incorporation or in the resolution or resolutions adopted by the Board of Directors provide for the issuance of such Preferred Stock, and each stockholder of record of Common Stock shall be entitled at each meeting of the stockholders to one vote for each share of such stock, in each case, registered in such stockholder&#8217;s name on the books of the Corporation&#58; (i) on the date fixed pursuant to Section 6 of Article II of these Bylaws as the record date for the determination of stockholders entitled to notice of and to vote at such meeting&#59; or (ii) if no such record date shall have been so fixed, then at the close of business on the day next preceding the day on which notice of such meeting is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">At each meeting of the stockholders, all corporate actions to be taken by vote of the stockholders (other than the election of directors) shall be authorized by a majority of the votes cast by the stockholders entitled to vote thereon who are present in person or represented by proxy, and where a separate vote by class or series is required, a majority of the votes cast by the stockholders of such class or series who are present in person or represented by proxy shall be the act of such class or series. Directors shall be elected by a plurality of the votes cast at a meeting of the stockholders by the holders of stock entitled to vote in the election of directors, provided a quorum is present.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 13. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VOTING OF SHARES BY CERTAIN HOLDERS&#58; Shares standing in the name of another corporation may be voted by such officer, agent or proxy as the bylaws or a resolution of the board of directors of such corporation may prescribe, and a certified copy of the by-law or resolution is presented at the meeting.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Shares held by an administrator, executor, guardian or conservator may be voted by him, either in person or by proxy, without a transfer of shares into his name. A stockholder whose shares are pledged shall be entitled to vote such shares until the shares have been transferred into the name of the pledgee, and thereafter the pledgee shall be entitled to vote the shares so transferred.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Neither treasury shares of its own stock held by the Corporation, nor shares held by another corporation if a majority of the shares entitled to vote for the election of directors of such other corporation are held by the corporation, shall be voted at any meeting or counted in determining the total number of outstanding shares at any given time for purposes of any meeting.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 14. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VOTING TRUST&#58; A stockholder, by agreement in writing, may transfer his stock to a voting trustee or trustees for the purpose of conferring the right to vote thereon for a period not exceeding 15 years upon the terms and conditions therein stated. The certificates of stock so transferred shall be surrendered and canceled and new certificates therefor issued to such trustee or trustees in which it shall appear that they are issued pursuant to such agreement, and in the entry of such ownership in the proper books of such corporation that fact shall also be noted, and thereupon such trustee or trustees may vote upon the stock so transferred during the terms of such agreement. A duplicate of every such agreement shall be filed in the principal office of the corporation and at all times during such terms be open to inspection by any stockholder or his attorney.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 15. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOMINATION OF DIRECTORS&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In addition to the rights of the holders of any series of Preferred Stock, nominations of any person for election to the Board of Directors at an annual meeting or at a special meeting (but only if the election of directors is a matter specified in the notice of meeting given by or at the direction of the person calling such special meeting) may be made at such meeting only (i) by or at the direction of the Board of Directors, including by any committee or persons appointed by the Board of Directors, or (ii) by a stockholder who (A) was a stockholder of record (and, with respect to any beneficial owner, if different, on whose behalf such nomination is proposed to be made, only if such beneficial owner was the beneficial owner of shares of the Corporation) both at the time of giving the notice provided for in this Article 2.15 and at the time of the meeting, (B) is entitled to vote at the meeting for the election of directors, and (C) has complied with this Article 2.15 as to such nomination. The foregoing clause (ii) shall be the exclusive means for a stockholder to make any nomination of a person or persons for election to the Board of Directors at an annual meeting or special meeting.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Without qualification, in addition to such stockholder complying with the provisions of Rule 14a-19 under the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (as so amended and inclusive of such rules and regulations, the &#8220;Exchange Act&#8221;), for a stockholder to make any nomination of a person or persons for election to the Board of Directors at an annual meeting, the stockholder must (i) provide Timely Notice (as defined in Article 2.16) thereof in writing and in proper form to the Secretary of the Corporation either by personal delivery or by United States mail, postage prepaid, and (ii) provide any updates or supplements to such notice at the times and in the forms required by this Article 2.15. Without qualification, if the election of directors is a matter specified in the notice of meeting given by or at the direction of the person calling such special meeting, then for a stockholder to make any nomination of a person or persons for election to the Board of Directors at a special meeting, the stockholder must (i) provide timely notice thereof in writing and in proper form to the Secretary of the Corporation at the principal executive offices of the Corporation either by personal delivery or by United States mail, postage prepaid, and (ii) provide any updates or supplements to such notice at the times and in the forms required by this Article 2.15.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To be timely, a stockholder&#8217;s notice for nominations to be made at a special meeting must be delivered to, or mailed and received at, the principal executive offices of the Corporation not earlier than the one hundred twentieth (120th) day prior to such special meeting and not later than the ninetieth (90th) day prior to such special meeting or, if such special meeting is announced later than the ninetieth day prior to the date of such special meeting, the tenth (10th) day following the day on which public disclosure (as defined in Article 2.15) of the date of such special meeting was first made.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In no event shall any adjournment of an annual meeting or special meeting or the announcement thereof commence a new time period for the giving of a stockholder&#8217;s notice as described above.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To be in proper form for purposes of this Article 2.15, a stockholder&#8217;s notice to the Secretary shall set forth&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:144pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As to each Nominating Person (as defined below), the Stockholder Information (as defined in Article 2.16(c)(i), except that for purposes of this Article 2.15 the term &#8220;Nominating Person&#8221; shall be substituted for the term &#8220;Proposing Person&#8221; in all places it appears in Article 2.16(c)(i))&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:144pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As to each Nominating Person, any Disclosable Interests (as defined in Article 2.16(c)(ii), except that for purposes of this Article 2.15 the term &#8220;Nominating Person&#8221; shall be substituted for the term &#8220;Proposing Person&#8221; in all places it appears in Article 2.16(c)(ii) and the disclosure in clause (L) of Article 2.16(c)(ii) shall be made with respect to the election of directors at the meeting)&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:144pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A representation that the Nominating Person is a holder or record or beneficial owner of shares of the Corporation entitled to vote at the meeting and intends to appear in person or by proxy at the meeting to nominate the person or persons specified in the notice&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv) A representation as to whether the Nominating Person intends to solicit proxies in support of such person&#8217;s nominee(s) in accordance with Rule 14a-19 under the Exchange Act&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)  A representation as to whether the Nominating Person intends or is part of a group that intends (x) to deliver a proxy statement and&#47;or a form of proxy to holders of at least the percentage of the Corporation&#8217;s outstanding stock reasonably believed by the Nominating Person to be sufficient to elect the nominee or nominees proposed to be nominating by the Nominating Person&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:144pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As to each person whom a Nominating Person proposes to nominate for election as a director, (A) all information with respect to such proposed nominee that would be required to be set forth in a stockholder&#8217;s notice pursuant to this Article 2.15 if such proposed nominee were a Nominating Person, (B) all information relating to such proposed nominee that is required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors in a contested election pursuant to Article 14(a) under the Exchange Act (including such proposed nominee&#8217;s written consent to being named in the proxy statement as a nominee and to serving as a director if elected), (C) a description of all direct and indirect compensation and other material monetary agreements, arrangements and understandings during the past three years, and any other material relationships, between or among any Nominating Person, on the one hand, and each proposed nominee, his or her respective affiliates and associates and any other persons with whom such proposed nominee (or any of his or her respective affiliates and associates) is Acting in Concert (as defined in Article 2.16(c)), on the other hand, including, without limitation, all information that would be required to be disclosed pursuant to Item 404 under Regulation S-K if such Nominating Person were the &#8220;registrant&#8221; for purposes of such rule and the proposed nominee were a director or executive officer of such registrant, and (D) a completed and signed questionnaire, representation and agreement as provided in Article 2.15(f)&#59; and</font></div><div style="margin-top:12pt;text-align:justify;text-indent:144pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Corporation may require any proposed nominee to furnish such other information (A) as may reasonably be required by the Corporation to determine the eligibility of such proposed nominee to serve as an independent director of the Corporation in accordance with the Corporation&#8217;s corporate governance guidelines or (B) that could be material to a reasonable stockholder&#8217;s understanding of the independence or lack of independence of such proposed nominee.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of this Article 2.15, the term &#8220;Nominating Person&#8221; shall mean (i) the stockholder providing the notice of the nomination proposed to be made at the meeting, (ii) the beneficial owner or beneficial owners, if different, on whose behalf the notice of the nomination proposed to be made at the meeting is made, (iii) any affiliate or associate of such stockholder or beneficial owner, and (iv) any other person with whom such stockholder or such beneficial owner (or any of their respective affiliates or associates) is Acting in Concert.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A stockholder providing notice of any nomination proposed to be made at a meeting shall further update and supplement such notice, if necessary, so that the information provided or required to be provided in such notice pursuant to this Article 2.15 shall be true and correct as of the record date for the meeting and as of the date that is ten (10) business days prior to the meeting or any adjournment or postponement thereof, and such update and supplement shall be delivered to, or mailed and received by, the Secretary at the principal executive offices of the Corporation not later than five (5) business days after the record date for the meeting (in the case of the update and supplement required to be made as of the record date), and not later than eight (8) business days prior to the date for the meeting, if practicable (or, if not practicable, on the first practicable date prior to) any adjournment or postponement thereof (in the case of the update and supplement required to be made as of ten (10) business days prior to the meeting or any adjournment or postponement thereof).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding anything in these Bylaws to the contrary, no person shall be eligible for election as a director of the Corporation unless nominated in accordance with this Article 2.15. The presiding officer at the meeting shall, if the facts warrant, determine that a nomination was not properly made in accordance with this Article 2.15, and if he or she should so determine, he or she shall so declare such determination to the meeting and the defective nomination shall be disregarded.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To be eligible to be a nominee for election as a director of the Corporation, the proposed nominee must deliver (in accordance with the time periods prescribed for delivery of notice under this Article 2.15) to the Secretary at the principal executive offices of the Corporation a written questionnaire with respect to the background and qualification of such proposed nominee (which questionnaire shall be provided by the Secretary upon written request) and a written representation and agreement (in form provided by the Secretary upon written request) that such proposed nominee (i) is not and will not become a party to (A) any agreement, arrangement or understanding with, and has not given any commitment or assurance to, any person or entity as to how such proposed nominee, if elected as a director of the Corporation, will act or vote on any issue or question (a &#8220;Voting Commitment&#8221;) that has not been disclosed to the Corporation or (B) any Voting Commitment that could limit or interfere with such proposed nominee&#8217;s ability to comply, if elected as a director of the Corporation, with such proposed nominee&#8217;s fiduciary duties under applicable law, (ii) is not, and will not become a party to, any agreement, arrangement or understanding with any person or entity other than the Corporation with respect to any direct or indirect compensation, reimbursement or indemnification in connection with service or action as a director that has not been disclosed to the Corporation and (iii) in such proposed nominee&#8217;s individual capacity and on behalf of the stockholder (or the beneficial owner, if different) on whose behalf the nomination is made, would be in compliance, if elected as a director of the Corporation, and will comply with applicable publicly disclosed corporate governance, conflict of interest, confidentiality and stock ownership and trading policies and guidelines of the Corporation.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In addition to the requirements of this Article 2.15 with respect to any nomination proposed to be made at a meeting, each Nominating Person shall comply with all applicable requirements of the Exchange Act with respect to any such nominations. Unless otherwise required by law, (i) no Nominating Person shall solicit proxies in support of director nominees other than the Corporation&#8217;s nominees unless such stockholder has complied with Rule 14a-19 under the Exchange Act in connection with the solicitation of such proxies, including the provision to the Corporation of notices required thereunder in a timely manner, and (ii) if such stockholder (1) provides notice pursuant to Rule 14a-19(b) under the Exchange Act and (2) subsequently fails to comply with all applicable requirements of Section 10 and this Article 2.15 and Rules 14a-19(a)(2) and 14a-19(a)(3) under the Exchange Act, then the Corporation shall disregard any proxies or votes solicited for such Nominating Person&#8217;s director nominees. Upon request by the Corporation, if any such Nominating Person provides notice pursuant to Rule 14a-19(b) under the Exchange Act, such Nominating Person shall deliver to the Corporation, no later than five (5) business days prior to the applicable meeting, reasonable evidence that it has met the requirements of Rule 14a-19(a)(3) under the Exchange Act. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 16. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOTICE OF BUSINESS AT ANNUAL MEETINGS&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">At an annual meeting of the stockholders, only such business shall be conducted as shall have been properly brought before the meeting. To be properly brought before an annual meeting, business must be (i) brought before the meeting by the Corporation and specified in the notice of meeting given by or at the direction of the Board of Directors, (ii) brought before the meeting by or at the direction of the Board of Directors, or (iii) otherwise properly brought before the meeting by a stockholder who (A) was a stockholder of record (and, with respect to any beneficial owner, if different, on whose behalf such business is proposed, only if such beneficial owner was the beneficial owner of shares of the Corporation) both at the time of giving the notice provided for in this Article 2.16 and at the time of the meeting, (B) is entitled to vote at the meeting, and (C) has complied with this Article 2.16 as to such business. Except for proposals properly made in accordance with Rule 14a-8 under the Exchange Act, and included in the notice of meeting given by or at the direction of the Board of Directors, the foregoing clause (iii) shall be the exclusive means for a stockholder to propose business to be brought before an annual meeting of the stockholders. Stockholders shall not be permitted to propose business to be brought before a special meeting of the stockholders, and the only matters that may be brought before a special meeting are the matters specified in the notice of meeting given by or at the direction of the person calling the meeting. Stockholders seeking to nominate persons for election to the Board must comply with Article 2.15 and this Article 2.16 shall not be applicable to nominations except as expressly provided in Article 2.15.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Without qualification, for business to be properly brought before an annual meeting by a stockholder, the stockholder must (i) provide Timely Notice (as defined below) thereof in writing and in proper form to the Secretary of the Corporation either by personal delivery or by United States </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">mail, postage prepaid, and (ii) provide any updates or supplements to such notice at the times and in the forms required by this Article 2.16. To be timely, a stockholder&#8217;s notice must be delivered to, or mailed and received at, the principal executive offices of the Corporation not less than ninety (90) days nor more than one hundred twenty (120) days prior to the one-year anniversary of the preceding year&#8217;s annual meeting&#59; provided, however, that if the date of the annual meeting is more than thirty (30) days before or more than sixty (60) days after such anniversary date, notice by the stockholder to be timely must be so delivered, or mailed and received, not later than the ninetieth (90th) day prior to such annual meeting or, if such annual meeting is announced later than the ninetieth day prior to the date of such annual meeting, the tenth (10th) day following the day on which public disclosure of the date of such annual meeting was first made (such notice within such time periods, &#8220;Timely Notice&#8221;). In no event shall any adjournment of an annual meeting or the announcement thereof commence a new time period for the giving of Timely Notice as described above.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To be in proper form for purposes of this Article 2.16, a stockholder&#8217;s notice to the Secretary shall set forth&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:144pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As to each Proposing Person (as defined below), (A) the name and address of such Proposing Person (including, if applicable, the name and address that appear on the Corporation&#8217;s books and records)&#59; and (B) the class or series and number of shares of the Corporation that are, directly or indirectly, owned of record or beneficially owned (within the meaning of Rule 13d-3 under the Exchange Act) by such Proposing Persons, except that such Proposing Person shall in all events be deemed to beneficially own any shares of any class or series of the Corporation as to which such Proposing Person has a right to acquire beneficial ownership at any time in the future (the disclosures to be made pursuant to the foregoing clauses (i) and (ii) are referred to as &#8220;Stockholder Information&#8221;)&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:144pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As to each Proposing Person, (A) any derivative, swap or other transaction or series of transactions engaged in, directly or indirectly, by such Proposing Person, the purpose or effect of which is to give such Proposing Person economic risk similar to ownership of shares of any class or series of the Corporation, including due to the fact that the value of such derivative, swap or other transactions are determined by reference to the price, value or volatility of any shares of any class or series of the Corporation, or which derivative, swap or other transactions provide, directly or indirectly, the opportunity to profit from any increase in the price or value of shares of any class or series of the Corporation (&#8220;Synthetic Equity Interests&#8221;), which Synthetic Equity Interests shall be disclosed without regard to whether (x) the derivative, swap or other transactions convey any voting rights in such shares to such Proposing Person, (y) the derivative, swap or other transactions are required to be, or are capable of being, settled through delivery of such shares or (z) such Proposing Person may have entered into other transactions that hedge or mitigate the economic effect of such derivative, swap or other transactions (B) any proxy (other than a revocable proxy or consent given in response to a solicitation made pursuant to, and in accordance with, Article 14(a) of the Exchange Act by way of a solicitation statement filed on Schedule 14A), agreement, arrangement, understanding or relationship pursuant to which such Proposing Person has or shares a right to vote any shares of any class or series of the Corporation, (C) any agreement, arrangement, understanding or relationship, including any repurchase or similar so-called &#8220;stock borrowing&#8221; agreement or arrangement, engaged in, directly or indirectly, by such Proposing Person, the purpose or effect of which is to mitigate loss to, reduce the economic risk (of ownership or otherwise) of shares of any class or series of the Corporation by, manage the risk of share price changes for, or increase or decrease the voting power of, such Proposing Person with respect to the shares of any class or series of the Corporation, or which provides, directly or indirectly, the opportunity to profit from any decrease in the price or value of the shares of any class or series of the Corporation (&#8220;Short Interests&#8221;), (D) any rights to dividends on the shares of any class or series of the Corporation owned beneficially by such Proposing Person that are separated or separable from the underlying shares of the Corporation, (E) any performance related fees (other than an asset based fee) that such Proposing Person is entitled to based on any increase or decrease in the price or value of shares of any class or series of the Corporation, or any Synthetic Equity Interests or Short Interests, if any, (F)(x) if such Proposing Person is not a natural person, the identity of the natural person or persons associated with such Proposing Person responsible for the formulation of and decision to propose the business to be brought before the meeting (such person or persons, the &#8220;Responsible Person&#8221;), the manner in which such Responsible Person was selected, any fiduciary duties owed by such Responsible Person to the equity holders or other beneficiaries of such Proposing Person, the qualifications and background of such Responsible Person </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and any material interests or relationships of such Responsible Person that are not shared generally by any other record or beneficial holder of the shares of any class or series of the Corporation and that reasonably could have influenced the decision of such Proposing Person to propose such business to be brought before the meeting, and (y) if such Proposing Person is a natural person, the qualifications and background of such natural person and any material interests or relationships of such natural person that are not shared generally by any other record or beneficial holder of the shares of any class or series of the Corporation and that reasonably could have influenced the decision of such Proposing Person to propose such business to be brought before the meeting, (G) any significant equity interests or any Synthetic Equity Interests or Short Interests in any principal competitor of the Corporation held by such Proposing Persons (H) any direct or indirect interest of such Proposing Person in any contract with the Corporation, any affiliate of the Corporation or any principal competitor of the Corporation (including, in any such case, any employment agreement, collective bargaining agreement or consulting agreement), (I) any pending or threatened litigation in which such Proposing Person is a party or material participant involving the Corporation or any of its officers or directors, or any affiliate of the Corporation, (J) any material transaction occurring during the prior twelve months between such Proposing Person, on the one hand, and the Corporation, any affiliate of the Corporation or any principal competitor of the Corporation, on the other hand, (K) a summary of any material discussions regarding the business proposed to be brought before the meeting (x) between or among any of the Proposing Persons or (y) between or among any Proposing Person and any other record or beneficial holder of the shares of any class or series of the Corporation (including their names), and (L) any other information relating to such Proposing Person that would be required to be disclosed in a proxy statement or other filing required to be made in connection with solicitations of proxies or consents by such Proposing Person in support of the business proposed to be brought before the meeting pursuant to Article 14(a) of the Exchange Act (the disclosures to be made pursuant to the foregoing clauses (A) through (L) are referred to as &#8220;Disclosable Interests&#8221;)&#59; provided, however, that Disclosable Interests shall not include any such disclosures with respect to the ordinary course business activities of any broker, dealer, commercial bank, trust company or other nominee who is a Proposing Person solely as a result of being the stockholder directed to prepare and submit the notice required by these Bylaws on behalf of a beneficial owner&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:144pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As to each item of business that the stockholder proposes to bring before the annual meeting, (A) a reasonably brief description of the business desired to be brought before the annual meeting, the reasons for conducting such business at the annual meeting and any material interest in such business of each Proposing Person, (B) the text of the proposal or business (including the text of any resolutions proposed for consideration), and (C) a reasonably detailed description of all agreements, arrangements and understandings (x) between or among any of the Proposing Persons or (y) between or among any Proposing Person and any other record or beneficial holder of the shares of any class or series of the Corporation (including their names) in connection with the proposal of such business by such stockholder&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:144pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A representation that the Proposing Person is a holder or record or beneficial owner of shares of the Corporation entitled to vote at the meeting and intends to appear in person or by proxy at the meeting to propose the business specified in the notice&#59; and</font></div><div style="margin-top:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v) A representation as to whether the Proposing Person intends to solicit proxies in support of such person&#8217;s proposal.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of this Article 2.16, the term &#8220;Proposing Person&#8221; shall mean (i) the stockholder providing the notice of business proposed to be brought before an annual meeting, (ii) the beneficial owner or beneficial owners, if different, on whose behalf the notice of the business proposed to be brought before the annual meeting is made, (iii) any affiliate or associate (each within the meaning of Rule 12b-2 under the Exchange Act for purposes of these Bylaws) of such stockholder or beneficial owner, and (iv) any other person with whom such stockholder or beneficial owner (or any of their respective affiliates or associates) is Acting in Concert (as defined below).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A person shall be deemed to be &#8220;Acting in Concert&#8221; with another person for purposes of these Bylaws if such person knowingly acts (whether or not pursuant to an express agreement, arrangement or understanding) in concert with, or towards a common goal relating to the management, governance or control of the Corporation in parallel with, such other person where (A) each person is conscious of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">other person&#8217;s conduct or intent and this awareness is an element in their decision-making processes and (B) at least one additional factor suggests that such persons intend to act in concert or in parallel, which such additional factors may include, without limitation, exchanging information (whether publicly or privately), attending meetings, conducting discussions, or making or soliciting invitations to act in concert or in parallel&#59; provided, that a person shall not be deemed to be Acting in Concert with any other person solely as a result of the solicitation or receipt of revocable proxies or consents from such other person in response to a solicitation made pursuant to, and in accordance with, Article 14(a) of the Exchange Act by way of a proxy or consent solicitation statement filed on Schedule 14A. A person Acting in Concert with another person shall be deemed to be Acting in Concert with any third party who is also Acting in Concert with such other person.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A stockholder providing notice of business proposed to be brought before an annual meeting shall further update and supplement such notice, if necessary, so that the information provided or required to be provided in such notice pursuant to this Article 2.16 shall be true and correct as of the record date for the meeting and as of the date that is ten (10) business days prior to the meeting or any adjournment or postponement thereof, and such update and supplement shall be delivered to, or mailed and received by, the Secretary at the principal executive offices of the Corporation not later than five (5) business days after the record date for the meeting (in the case of the update and supplement required to be made as of the record date), and not later than eight (8) business days prior to the date for the meeting, if practicable (or, if not practicable, on the first practicable date prior to) any adjournment or postponement thereof (in the case of the update and supplement required to be made as of ten (10) business days prior to the meeting or any adjournment or postponement thereof).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding anything in these Bylaws to the contrary, no business shall be conducted at an annual meeting except in accordance with this Article 2.16. The presiding officer of the meeting shall, if the facts warrant, determine that the business was not properly brought before the meeting in accordance with this Article 2.16, and if he or she should so determine, he or she shall so declare to the meeting and any such business not properly brought before the meeting shall not be transacted.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Article 2.16 is expressly intended to apply to any business proposed to be brought before an annual meeting of stockholders other than any proposal made pursuant to Rule 14a-8 under the Exchange Act. In addition to the requirements of this Article 2.16 with respect to any business proposed to be brought before an annual meeting, each Proposing Person shall comply with all applicable requirements of the Exchange Act with respect to any such business. Nothing in this Article 2.16 shall be deemed to affect the rights of stockholders to request inclusion of proposals in the Corporation&#8217;s proxy statement pursuant to Rule 14a-8 under the Exchange Act.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of these Bylaws, &#8220;public disclosure&#8221; shall mean disclosure in a press release reported by a national news service or in a document publicly filed by the Corporation with the Securities and Exchange Commission pursuant to Articles 13, 14 or 15(d) of the Exchange Act.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 17. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CONDUCT OF MEETINGS&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Meetings of stockholders shall be presided over by the Chairman or in the Chairman&#8217;s absence by the Chief Executive Officer, or in the Chief Executive Officer&#8217;s absence by the President (if the President shall be a different individual than the Chief Executive Officer), or in the President&#8217;s absence by a Vice President, or in the absence of all of the foregoing persons by a chairman designated by the Board of Directors, or in the absence of such designation by a chairman chosen by vote of the stockholders at the meeting. The Secretary shall act as secretary of the meeting, but in the Secretary&#8217;s absence the chairman of the meeting may appoint any person to act as secretary of the meeting.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Board of Directors of the Corporation may adopt by resolution such rules, regulations and procedures for the conduct of any meeting of stockholders of the Corporation as it shall deem appropriate including, without limitation, such guidelines and procedures as it may deem appropriate regarding the participation by means of remote communication of stockholders and proxyholders not physically present at a meeting. Except to the extent inconsistent with such rules, regulations and procedures as adopted by the Board of Directors, the chairman of any meeting of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">stockholders shall have the right and authority to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such chairman, are appropriate for the proper conduct of the meeting. Such rules, regulations or procedures, whether adopted by the Board of Directors or prescribed by the chairman of the meeting, may include, without limitation, the following&#58; (i) the establishment of an agenda or order of business for the meeting&#59; (ii) rules and procedures for maintaining order at the meeting and the safety of those present&#59; (iii) limitations on attendance at or participation in the meeting to stockholders of record of the Corporation, their duly authorized and constituted proxies or such other persons as shall be determined&#59; (iv) restrictions on entry to the meeting after the time fixed for the commencement thereof&#59; and (v) limitations on the time allotted to questions or comments by participants. Unless and to the extent determined by the Board of Directors or the chairman of the meeting, meetings of stockholders shall not be required to be held in accordance with the rules of parliamentary procedure.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The chairman of the meeting shall announce at the meeting when the polls for each matter to be voted upon at the meeting will be opened and closed. If no announcement is made, the polls shall be deemed to have opened when the meeting is convened and closed upon the final adjournment of the meeting. After the polls close, no ballots, proxies or votes or any revocations or changes thereto may be accepted.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In advance of any meeting of stockholders, the Board of Directors, the Chairman or the Chief Executive Officer shall appoint one or more inspectors of election to act at the meeting and make a written report thereof. One or more other persons may be designated as alternate inspectors to replace any inspector who fails to act. If no inspector or alternate is present, ready and willing to act at a meeting of stockholders, the chairman of the meeting shall appoint one or more inspectors to act at the meeting. Unless otherwise required by law, inspectors may be officers, employees or agents of the Corporation. Each inspector, before entering upon the discharge of such inspector&#8217;s duties, shall take and sign an oath faithfully to execute the duties of inspector with strict impartiality and according to the best of such inspector&#8217;s ability. The inspector shall have the duties prescribed by law and shall take charge of the polls and, when the vote is completed, shall make a certificate of the result of the vote taken and of such other facts as may be required by law.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8211; DIRECTORS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NUMBER AND TERM. The business of this Corporation shall be managed by a Board of Directors which shall consist of not less than three (3) directors nor more than nine (9) directors, who need not be residents of the State of Delaware or stockholders of the Corporation. The exact number of directors within the minimum and maximum limitations specified in the preceding sentence shall be fixed from time to time by the Board of Directors pursuant to a resolution adopted by a majority of the entire Board of Directors, which number shall initially be six (6). Except as otherwise provided in the Certificate of Incorporation, each director shall serve for a term ending on the date of the annual meeting of stockholders next following the annual meeting at which such director was elected. Notwithstanding the foregoing, each director shall hold office until such director&#8217;s successor shall have been duly elected and qualified or until such director&#8217;s earlier death, resignation or removal. Directors need not be stockholders.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">REGULAR MEETINGS&#58; Each newly elected Board of Directors may hold its first meeting for the purpose of organization and the transaction of business, if a quorum is present, immediately after and at the same place as the annual meeting of the stockholders. Notice of such meeting shall not be required. At the first meeting of the Board of Directors in each year at which a quorum shall be present, held next after the annual meeting of stockholders, the Board of Directors shall proceed to the election of the officers of the Corporation. Regular meetings of the Board of Directors shall be held at such times and places as shall be designated from time to time by resolution of the Board of Directors. Notice of such regular meetings shall not be required.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SPECIAL MEETINGS&#58; Special meetings of the Board of Directors may be called by the Chairman of the Board, or on the written request of any two directors, by the Secretary, in each case on at least twenty-four (24) hours personal, written, telegraphic, cable or wireless notice to each director. Such notice, or any waiver thereof pursuant to Article 3.4 hereof, shall state the time and place of the special meeting, but need not state the purpose or purposes of such meeting, except as may otherwise be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">required by law or provided for in the Certificate of Incorporation or these Bylaws. If the day or date, time and place of a meeting of the Board of Directors has been announced at a previous meeting of the board, no notice is required. Notice of an adjourned meeting of the Board of Directors need not be given other than by announcement at the meeting at which adjournment is taken.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOTICE WAIVER&#58; Notice of any meeting of the Board of Directors may be waived by any director either before, at or after such meeting orally or in a writing signed by such director. A director, by his or her attendance at any meeting of the Board of Directors, shall be deemed to have waived notice of such meeting, except where the director objects at the beginning of the meeting to the transaction of business because the meeting is not lawfully called or convened and does not participate thereafter in the meeting. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the Board of Directors need be specified in the notice or waiver of notice of such meeting.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">QUORUM AND MANNER OF ACTING&#58; Unless otherwise provided in the Certificate of Incorporation, a majority of the total number of directors then in office shall constitute a quorum for the transaction of business of the Board of Directors and the vote of a majority of the directors present at a meeting at which a quorum is present shall be the act of the Board of Directors.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">RESIGNATION. Any director may resign at any time by giving notice in writing or by electronic transmission to the Board of Directors or to the Secretary of the Corporation. The resignation of any director shall take effect upon receipt of notice thereof or at such later time as shall be specified in such notice&#59; and unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NEWLY CREATED DIRECTORSHIPS. A directorship to be filled by reason of any increase in the number of directors may be filled (i) by election at an annual or special meeting of stockholders called for that purpose or (ii) by the Board of Directors for a term of office continuing only until the next election of one or more directors by the stockholders.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 8. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VACANCIES IN THE BOARD OF DIRECTORS. Any vacancies in the Board of Directors resulting from death, resignation, retirement, disqualification, removal from office or other cause shall be filled by a majority vote of the directors then in office, and directors so chosen shall hold office for a term expiring at the annual meeting of stockholders at which the term of the class to which they have been elected expires. No decrease in the number of directors constituting the Board of Directors shall shorten the term of any incumbent director.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">REMOVAL OF DIRECTORS. Except as may otherwise be provided by law, any director or the entire Board of Directors may be removed, with or without cause, at an annual meeting or at a special meeting called for that purpose, by the affirmative vote of the holders of a majority of the shares then entitled to vote at an election of directors.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 10. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ACTION WITHOUT A MEETING&#59; TELEPHONE CONFERENCE MEETING&#58; Unless otherwise restricted by the Certificate of Incorporation, any action required or permitted to be taken at any meeting of the Board of Directors, or any committee designated by the Board of Directors, may be taken without a meeting if all members of the Board of Directors or committee, as the case may be, either originally or in counterparts, consent thereto in writing. Such consent shall have the same force and effect as a unanimous vote at a meeting, and may be stated as such in any document or instrument filed with the Secretary of State of Delaware.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unless otherwise restricted by the Certificate of Incorporation, subject to the requirement for notice of meetings, members of the Board of Directors, or members of any committee designated by the Board of Directors, may participate in a meeting of such Board of Directors or committee, as the case may be, by means of a conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other, and participation in such a meeting shall constitute presence in person at such meeting, except where a person participates in the meeting for the express purpose of objecting to the transaction of any business on the grounds that the meeting is not lawfully called or convened.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 10. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXECUTIVE AND OTHER COMMITTEES&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Board of Directors, by resolution adopted by a majority of the number of directors then in office may designate from among its members an executive committee and one or more other committees, each consisting of two or more directors, and each of which, to the extent provided in the resolution or in the charter or these Bylaws shall have and may exercise all of the authority of the Board of Directors except the power to&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:144pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Declare dividends or distributions on stock&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:144pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Issue stock other than as provided in subsection (b) of this Article.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:144pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Recommend to the stockholders any action which requires stockholder approving, including, but not limited to, adopting an agreement of merger or consolidation, the sale, lease or exchange of all or substantially all of the Corporation&#8217;s property and assets, a dissolution of the Corporation or a revocation of a dissolution of the Corporation&#59; or</font></div><div style="margin-top:12pt;text-align:justify;text-indent:144pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amend the Certificate of Incorporation or the Bylaws.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If the Board of Directors has given general authorization for the issuance of stock, a committee of the Board, in accordance with a general formula or method specified by the board by resolution or by adoption of a stock option or other plan, may fix the terms of stock subject to classification or reclassification and the terms on which any stock may be issued, including all terms and conditions required or permitted to be established or authorized by the Board of Directors under the Delaware General Corporation Law.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The appointment of any committee, the delegation of authority to it or action by it under that authority does not constitute of itself, compliance by any director not a member of the committee, with the standard provided by statute for the performance of duties of directors.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any committee designated pursuant to this Article 3.10 shall choose its own chairman, shall keep regular minutes of its proceedings and report the same to the Board of Directors when requested, shall fix its own rules or procedures, and shall meet at such times and at such place or places as may be provided by such rules, or by resolution of such committee or resolution of the Board of Directors. At every meeting of any such committee, the presence of a majority of all the members thereof shall constitute a quorum and the affirmative vote of a majority of the members present shall be necessary for the adoption by it of any resolution.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Board of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of such committee. In the absence or disqualification of a member of a committee, the member or members present at any meeting and not disqualified from voting, whether or not constituting a quorum, may unanimously appoint another member of the Board of Directors to act at the meeting in the place of the absent or disqualified member.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 11. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CHAIRMAN OF THE BOARD&#58; The Board shall elect from its members a Chairman, which Chairman shall preside at all meetings of the stockholders and the directors. The Chairman shall serve in such capacity until his or her successor is elected by the Board or until his or her earlier resignation or removal from the Board. He or she shall also perform such other duties the Board may assign to him or her from time to time.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 12. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">COMPENSATION&#58; By resolution of the Board of Directors, each director may be paid his expenses, if any, of attendance at each meeting of the Board of Directors, and may be paid a stated salary as director or a fixed sum for attendance at each meeting of the Board of Directors or both. No such payment shall preclude any director from serving the Corporation in any other capacity and receiving compensation therefor.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 13. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PRESUMPTION OF ASSENT&#58; A director of the Corporation who is present at a meeting of the board of Directors at which action on any corporate matter is taken unless he shall announce his dissent at the meeting and his dissent is entered in the minutes and he shall forward such dissent by registered mail to the secretary of the corporation immediately after the adjournment of the meeting. Such right to dissent shall not apply to a director who voted in favor of such action.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8211; OFFICERS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NUMBER, TITLES, AND TERM OF OFFICE&#58; The officers of the Corporation shall be chosen by the Board of Directors and shall include a Chief Executive Officer, President, Chief Operating Officer, Chief Financial Officer, President, one or more Vice Presidents (any one or more of whom may be designated Executive Vice President or Senior Vice President), a Treasurer, a Secretary, and such other officers as the Board of Directors may from time to time elect or appoint. Each officer shall hold office until his successor shall be duly elected and shall qualify or until his death or until he shall resign or shall have been removed in the manner hereinafter provided. Any number of offices may be held by the same person, unless the Certificate of Incorporation provides otherwise. Except for the Chairman of the Board, if any, no officers need be a director.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SALARIES&#58; The salaries or other compensation of the officers and agents of the Corporation shall be fixed from time to time by the Board of Directors.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">REMOVAL&#58; Any officer or agent elected or appointed by the Board of Directors may be removed, either with or without cause, by the vote of a majority of the whole Board of Directors at a special meeting called for the purpose, or at any regular meeting of the Board of Directors, provided the notice for such meeting shall specify that the matter of any such proposed removal will be considered at the meeting but such removal shall be without prejudice to the contract rights, if any, of the person so removed. Election or appointment of an officer or agent shall not of itself create contract rights.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VACANCIES&#58; Any vacancy occurring in any office of the Corporation may be filled by the Board of Directors.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CHIEF EXECUTIVE OFFICER&#58; The Chief Executive Officer shall, in the absence of the Chairman, preside at all meetings of the stockholders. Subject to the control of the Board of Directors and the executive committee (if any), the Chief Executive Officer shall have general executive charge, management and control of the properties, business and operations of the Corporation with all such powers as may be reasonably incident to such responsibilities&#59; he may agree upon and execute all leases, contracts, evidences of indebtedness and other obligations in the name of the Corporation and may sign all certificates for shares of capital stock of the Corporation and shall have such other powers and duties as designated in accordance with these Bylaws and as from time to time may be assigned to him by the Board of Directors.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PRESIDENT&#58; Subject to such supervisory powers, if any, as may be given by the Board to the Chief Executive Officer, the President shall have general supervision, direction, and control of the business and other officers of the corporation. The President shall have the general powers and duties of management usually vested in the office of President of a corporation and shall have such other powers and duties as may be prescribed by the Board or these Bylaws. If, for any reason, the Corporation does not have a Chairman or Chief Executive Officer, or such officers are unable to act, the President shall assume the duties of those officers.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CHIEF OPERATING OFFICER&#58; The Chief Operating Officer shall supervise the operation of the Corporation, subject to the policies and directions of the Board. He or she shall provide for the proper operation of the Corporation and oversee the internal interrelationship amongst any and all departments of the Corporation. He or she shall submit to the Chief Executive Officer, the President, the Chairman and the Board timely reports on the operations of the Corporation.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 8. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CHIEF FINANCIAL OFFICER&#58; The Chief Financial Officer shall have general supervision, direction and control of the financial affairs of the Corporation. He or she shall provide for the establishment of internal controls and see that adequate audits are currently and regularly made. He or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">she shall submit to the Chief Executive Officer, the President, the Chief Operating Officer, the Chairman and the Board timely statements of the accounts of the Corporation and the financial results of the operations thereof. The Chief Financial Officer shall perform such other duties and have such other powers as may be prescribed by the Board or these Bylaws, all in accordance with basic policies as established by and subject to the oversight of the Board and the Chief Executive Officer. In the absence of a named Treasurer, the Chief Financial Officer shall also have the powers and duties of the Treasurer as hereinafter set forth and shall be authorized and empowered to sign as Treasurer in any case where such officer&#8217;s signature is required.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">VICE PRESIDENTS&#58; In the absence of the President, or in the event of his inability or refusal to act, a Vice President designated by the Board of Directors shall perform the duties of the President, and when so acting shall have all the powers of and be subject to all the restrictions of the President. In the absence of a designation by the Board of Directors of a Vice President to perform the duties of the President, or in the event of his absence or inability or refusal to act, the Vice President who is present and who is senior in terms of time as a Vice President of the Corporation shall so act. The Vice Presidents shall perform such other duties and have such other powers as the chief executive officer or the Board of Directors may from time to time prescribe.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 10. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TREASURER&#58; The Treasurer shall have responsibility for the custody and control of all the funds and securities of the Corporation, and he shall have such other powers and duties as designated in these Bylaws and as from time to time may be assigned to him by the Board of Directors. He shall perform all acts incident to the position of Treasurer, subject to the control of the chief executive officer and the Board of Directors&#59; and he shall, if required by the Board of Directors, give such bond for the faithful discharge of his duties in such form as the Board of Directors may require.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 11. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ASSISTANT TREASURERS&#58; Each Assistant Treasurer shall have the usual powers and duties pertaining to his office, together with such other powers and duties as designated in these Bylaws and as from time to time may be assigned to him by the chief executive officer or the Board of Directors. The Assistant Treasurers shall exercise the powers of the Treasurer during that officer&#8217;s absence or inability or refusal to act.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 12. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECRETARY&#58; The Secretary shall keep the minutes of all meetings of the Board of Directors, committees of directors and the stockholders, in books provided for that purpose&#59; he shall attend to the giving and serving of all notices&#59; he may in the name of the Corporation affix the seal of the Corporation to all contracts of the Corporation and attest the affixation of the seal of the Corporation thereto&#59; he may sign with the other appointed officers all certificates for shares of capital stock of the Corporation&#59; he shall have charge of the certificate books, transfer books and stock ledgers, and such other books and papers as the Board of Directors may direct, all of which shall at all reasonable times be open to inspection of any director upon application at the office of the Corporation during business hours&#59; he shall have such other powers and duties as designated in these Bylaws and as from time to time may be assigned to him by the Board of Directors&#59; and he shall in general perform all acts incident to the office of Secretary, subject to the control of the chief executive officer and the Board of Directors.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 13. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ASSISTANT SECRETARIES&#58; Each Assistant Secretary shall have the usual powers and duties pertaining to his office, together with such other powers and duties as designated in these Bylaws and as from time to time may be assigned to him by the chief executive officer or the Board of Directors. The Assistant Secretaries shall exercise the powers of the Secretary during that officer&#8217;s absence or inability or refusal to act.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE V</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8211; INDEMNIFICATION OF OFFICERS, DIRECTORS,<br>EMPLOYEES AND AGENTS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">INDEMNIFICATION&#58; The Corporation shall indemnify and hold harmless, to the fullest extent authorized by the Delaware General Corporation Law, as the same exists or may hereafter be amended (but, in the case of any such amendment, only to the extent that such amendment permits the Corporation to provide broader indemnification rights than such law permitted the Corporation to provide prior to such amendment), any person who was or is a party or threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">investigative (other than action by or in the right of the Corporation) by reason of the fact that he is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise (an &#8220;indemnitee&#8221;), against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by an indemnitee in connection with such action, suit or proceeding if such indemnitee acted in good faith and in a manner such indemnitee reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe such conduct was unlawful&#59; provided, however, that, except as provided in Article 5.3 with respect to proceedings to enforce rights to indemnification, the Corporation shall indemnify any such indemnitee in connection with a proceeding (or part thereof) initiated by such indemnitee only if such proceeding (or part thereof) was authorized by the Board of Directors of the Corporation. The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the indemnitee did not act in good faith and in a manner which such indemnitee reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that such conduct was unlawful. The right to indemnification conferred by this Article 5.1 shall vest at the time an individual becomes an indemnitee.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">RIGHT TO ADVANCEMENT OF EXPENSES&#58; The right to indemnification conferred in Article 5.1 shall include the right to be paid by the Corporation the expenses incurred in defending any such proceeding in advance of its final disposition (hereinafter an &#8220;advancement of expenses&#8221;)&#59; provided, however, that, if the Delaware General Corporation Law requires, an advancement of expenses incurred by an indemnitee in his or her capacity as a director or officer (and not in any other capacity in which service was or is rendered by such indemnitee, including, without limitation, service to an employee benefit plan) shall be made only upon delivery to the Corporation of an undertaking (hereinafter an &#8220;undertaking&#8221;), by or on behalf of such indemnitee, to repay all amounts so advanced if it shall ultimately be determined by final judicial decision from which there is no further right to appeal (hereinafter a &#8220;final adjudication&#8221;) that such indemnitee is not entitled to be indemnified for such expenses under this Article 5.2 or otherwise. The rights to indemnification and to the advancement of expenses conferred in Articles 5.1 and 5.2 shall be contract rights and such rights shall continue as to an indemnitee who has ceased to be a director, officer, employee, or agent and shall inure to the benefit of the indemnitee&#8217;s heirs, executors, and administrators.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">RIGHT OF INDEMNITEE TO BRING SUIT&#58; If a claim under Article 5.1 or 5.2 is not paid in full by the Corporation within sixty (60) days after a written claim has been received by the corporation, except in the case of a claim for an advancement of expenses, in which case the applicable period shall be twenty (20) days, the indemnitee may at any time thereafter bring suit against the Corporation to recover the unpaid amount of the claim. If successful in whole or in part in any such suit, or in a suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the indemnitee shall be entitled to be paid also the expense of prosecuting or defending such suit. In (i) any suit brought by the indemnitee to enforce a right to indemnification hereunder (but not in a suit brought by the indemnitee to enforce a right to an advancement of expenses) it shall be a defense that, and (ii) in any suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the Corporation shall be entitled to recover such expenses upon a final adjudication that, the indemnitee has not met any applicable standard for indemnification set forth in the Delaware General Corporation Law. Neither the failure of the Corporation (including its Board of Directors, independent legal counsel, or its stockholders) to have made a determination prior to the commencement of such suit that indemnification of the indemnitee is proper in the circumstances because the indemnitee has met the applicable standard of conduct set forth in the Delaware General Corporation Law, nor an actual determination by the Corporation (including its Board of Directors, independent legal counsel, or its stockholders) that the indemnitee has not met such applicable standard of conduct, shall create a presumption that the indemnitee has not met the applicable standard of conduct or, in the case of such a suit brought by the indemnitee, be a defense to such suit. In any suit brought by the indemnitee to enforce a right to indemnification or to an advancement of expenses hereunder, or brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the burden of proving that the indemnitee is not entitled to indemnification, or to such advancement of expenses, under this Article 5 or otherwise shall be on the Corporation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NON-EXCLUSIVITY OF RIGHTS&#58; The rights to indemnification and to the advancement of expenses conferred in this Article 5 shall not be exclusive of any other right which any person may have or hereafter acquire under any statute, the corporation&#8217;s Certificate of Incorporation, Bylaws, agreement, vote of stockholders, or disinterested directors or otherwise.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">INSURANCE&#58; The Corporation may maintain insurance, at its expense, to protect itself and any director, officer, employee, or agent of the Corporation or another corporation, partnership, joint venture, trust, or other enterprise against any expense, liability or loss, whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the Delaware General Corporation Law.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">INDEMNIFICATION OF EMPLOYEES AND AGENTS OF THE CORPORATION&#58; The Corporation may, to the extent authorized from time to time by the Board of Directors, grant rights to indemnification and to the advancement of expenses to any employee or agent of the Corporation to the fullest extent of the provisions of this Article 5 with respect to the indemnification and advancement of expenses of directors and officers of the Corporation.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AMENDMENT OR MODIFICATION&#58; This Article 5 may be altered or amended at any time as provided in these Bylaws, but no such amendment shall have the effect of diminishing the rights of any person who is or was an officer or director as to any acts or omissions taken or omitted to be taken prior to the effective date of such amendment.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8211; CONTRACTS, LOANS, CHECKS AND DEPOSITS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CONTRACTS&#58; The Board of Directors may authorize any officer or officers, agent or agents, to enter into any contract or execute and deliver any instrument in the name of on behalf of the corporation, and such authority may be general or confined to specific instances.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LOANS&#58; No loans shall be contracted on behalf of the Corporation and no evidences of indebtedness shall be issued in its name unless authorized by a resolution of the Board of Directors. Such authority may be general or confined to specific instances.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CHECKS, DRAFTS, ETC.&#58; All checks, drafts, or other orders for the payment of money, notes or other evidences of indebtedness issued in the name of the corporation, shall be signed by such officer or officers, agent or agents of the Corporation and in such manner as shall from time to time be determined by resolution of the Board of Directors.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DEPOSITS&#58; All funds of the Corporation not otherwise employed shall be deposited from time to time to the credit of the Corporation in such banks, trust companies or other depositories as the Board of Directors may select.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> CERTIFICATES FOR SHARES AND THEIR TRANSFER</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CERTIFICATES FOR SHARES&#58; Notwithstanding any other provision in these Bylaws, any or all classes and series of shares of the Corporation, or any part thereof, may be represented by uncertificated shares, except that shares represented by a certificate that is issued and outstanding shall continue to be represented thereby until the certificate is surrendered to the corporation. Within a reasonable time after the issuance or transfer of uncertificated shares, the Corporation shall send to the registered owner thereof, a written notice containing the information required to be set forth or stated on certificates. The rights and obligations of the holders of shares represented by certificates and the rights and obligations of the holders of uncertificated shares of the same class or series shall be identical. If certificates for the shares of the Corporation are issued, each will be in such form as shall be determined by the Board of Directors. Such certificates shall be signed by the president or vice president and countersigned by the secretary or an assistant secretary and sealed with the Corporation seal or a facsimile thereof. The signatures of such officers upon a certificate may be facsimile signatures if the certificate is manually signed on behalf of a transfer agent or a registrar other than the Corporation or an employee of the Corporation. Each certificate for shares shall be consecutively numbered or otherwise identified. The name and address of the person to whom the shares represented thereby are issued, with the number of shares and date of issue, shall be entered on the stock transfer books of the Corporation. All certificates </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">surrendered to the Corporation for transfer shall be cancelled and no new certificates shall be issued until the former certificates for a like number of shares shall have been surrendered and cancelled, except that in case of a lost, destroyed or mutilated certificate, a new one may be issued therefor upon such terms and indemnity to the Corporation as the Board of Directors may prescribe.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TRANSFER OF SHARES&#58; Transfer of shares of the Corporation shall be made only on the stock transfer books of the Corporation by the holder of record thereof or by his legal representative, who shall furnish proper evidence of authority to transfer, or by his attorney thereunto authorized by power of attorney duly executed and filed with the secretary of the corporation, and on surrender for cancellation of the certificate for such shares. The person in whose name shares stand on the books of the Corporation shall be deemed by the Corporation to be the owner thereof for all purposes.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8211; FISCAL YEAR</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The fiscal year of the Corporation shall be determined by the Board of Directors.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE IX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8211; DIVIDENDS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Board of Directors may, from time to time, declare and the Corporation may pay dividends on its outstanding shares in the manner, and upon the terms and conditions provided by law and its Certificate of Incorporation.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE X</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8211; CORPORATE SEAL</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Board of Directors shall provide a corporate seal which shall be circular in form and shall have inscribed thereon the name of the Corporation, the year of its incorporation and the words, &#8220;Corporate Seal,&#8221; and &#8220;Delaware.&#8221;</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE XI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8211; WAIVER OF NOTICE</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Whenever notice is required to be given by law, the Certificate of Incorporation or under any of the provisions of these Bylaws, a written waiver thereof, signed by the person entitled to notice, whether before or after the time stated therein, shall be deemed equivalent to notice. Attendance of a person at a meeting shall constitute a waiver of notice of such meeting, except when the person attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the stockholders, directors, or members of a committee of directors need be specified in any written waiver of notice unless so required by the Certificate of Incorporation or the Bylaws.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE XII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8211; FORUM FOR ADJUDICATION OF DISPUTES</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Corporation to the Corporation or the Corporation&#8217;s stockholders, (iii) any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law or the Certificate of Incorporation or Bylaws (as either may be amended from time to time), or (iv) any action asserting a claim governed by the internal affairs doctrine shall be the Court of Chancery in the State of Delaware (or, if the Court of Chancery does not have jurisdiction, the federal district court for the District of Delaware). If any action the subject matter of which is within the scope of the preceding sentence is filed in a court other than a court located within the State of Delaware (a &#8220;Foreign Action&#8221;) in the name of any stockholder, such stockholder shall be deemed to have consented to (i) the personal jurisdiction of the state and federal courts located within the State of Delaware in connection with any action brought in any such court to enforce the preceding sentence and (ii) having service of process made upon such stockholder in any such action by service upon such stockholder&#8217;s counsel in the Foreign Action as agent for such stockholder.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE XIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8211; AMENDMENTS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stockholders of the Corporation holding at least 66 2&#47;3% of the Corporation&#8217;s outstanding voting stock shall have the power to adopt, amend or repeal the Bylaws. To the extent provided in the Corporation&#8217;s Certificate of Incorporation, the Board of Directors of the Corporation shall also have the power to adopt, amend or repeal the Bylaws of the Corporation.</font></div><div style="margin-top:6pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2 1
<SEQUENCE>3
<FILENAME>literacompareredline-pro.htm
<DESCRIPTION>EX-3.2 1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>literacompareredline-pro</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- literacompareredline-pro001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="literacompareredline-pro001.jpg" title="slide1" width="1055" height="5460">
<DIV><FONT size="1" style="font-size:1pt;color:white">BYLAWS OF PROPHASE LABS, INC. (As amended and restated June 16March 26, 20232024) ARTICLE I &#8211; OFFICES Section 1. The registered office of Prophase Labs, Inc. (the &#8220;Corporation&#8221;) in the State of Delaware is 874 Walker Road, Suite C, Dover, DE 19904. The name of its registered agent at such address is United Corporate Services, Inc. Section 2. The Corporation may have such offices within or without the State of Delaware as the Board of Directors may designate or as the business of the Corporation may require from time to time. ARTICLE II &#8211; STOCKHOLDERS Section 1. ANNUAL MEETING: The annual meeting of stockholders shall be held each year on a date and a time designated by the Board of Directors. At each annual meeting directors shall be elected and any other proper business may be transacted. Section 2. SPECIAL MEETINGS: In addition to the rights of the holders of any series of Preferred Stock, special meetings of the stockholders may be called at any time by (a) the Chairman or (b) the Board of Directors pursuant to a resolution approved by a majority of the whole Board of Directors. Business transacted at any special meeting of stockholders shall be limited to the purposes stated in the notice to stockholders. Section 3. PLACE OF MEETING: The Board of Directors may designate any place, either within or without the State of Delaware, as the place of meeting for any annual meeting or for any special meeting called by the Board of Directors. The Board of Directors may, in its sole discretion, determine that the meeting shall not be held at any place, but may instead be held solely by means of remote communication as provided under the Delaware General Corporation Law. Section 4. NOTICE OF MEETING: Whenever stockholders are required or permitted to take any action at a meeting, a written notice of any such meeting shall be given which notice shall state the place, date and hour of the meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting is called. The notice shall, unless otherwise prescribed by statute, be delivered not less than ten (10) nor more than sixty (60) days before the date of the meeting, either personally or by mail, by or at the direction of the Chairman, to each stockholder of record entitled to vote at such meeting. If mailed, such notice shall be deemed to be delivered when deposited in the United States mail, addressed to the stockholder at his address as it appears on the stock transfer books of the Corporation, with postage thereon prepaid. Notice of any meeting of the stockholders shall not be required to be given to any stockholder who shall attend such meeting in person or by proxy without protesting, prior to or at the commencement of the meeting, the lack of proper notice to such stockholder, or who shall waive notice thereof as provided in Article XI of these Bylaws. Notice of adjournment of a meeting of the stockholders need not be given if the date, time and place, if any, to which it is adjourned, and any means of remote communication for such adjourned meeting, are (i) announced at the meeting at which the adjournment is taken, (ii) displayed during the time scheduled for such meeting on the same electronic network used to enable stockholders and proxy holders to participate in such meeting by means of remote communication or (iii) set forth in the notice of such meeting given in accordance with the provisions of this Article 2.4; provided, however, that if the adjournment is for more than 30 days or, after 1 adjournment, a new record date is fixed for the adjourned meeting, then a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting. Section 5. NOTICE BY ELECTRONIC TRANSMISSION:  Any notice to stockholder given by the Corporation pursuant to any provision of these Bylaws, the Exchange Act (as defined in Article 2.162.15(b) below) or the Certificate of Incorporation shall be effective if given by a form of electronic transmission consented to by the stockholder to whom the notice is given. The consent is revocable by the stockholder by written notice to the Corporation. The consent is revoked if: (a) The Corporation is unable to deliver by electronic transmission two consecutive notices given by the Corporation in accordance with the consent; and (b) The inability to deliver by electronic transmission becomes known to the secretary, assistant secretary, transfer agent or other agent of the Corporation responsible for the giving of notice. However, the inadvertent failure to treat the inability to deliver notice by electronic transmission as a revocation does not invalidate any meeting or other action. Notice given pursuant to this Article 1.5 shall be deemed given if: (a) By facsimile machine, when directed to a number at which the stockholder has consented to receive notice; (b) By electronic mail, when directed to an electronic mail address at which the stockholder has consented to receive notice; (c) By posting on an electronic network together with separate notice to the stockholder of the specific posting, upon the later of: (1) Such posting; and (2) The giving of the separate notice; and (d) By any other form of electronic transmission, when directed to the stockholder. As used in this Article 1.5, &#8220;electronic transmission&#8221; means any form of communication not directly involving the physical transmission of paper that: (a) Creates a record that may be retained, retrieved and reviewed by the recipient of the communication; and (b) May be directly reproduced in paper form by the recipient through an automated process. Section 6. CLOSING OF TRANSFER BOOKS OR FIXING OF RECORD DATE: For the purpose of determining stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment thereof, or stockholders entitled to receive payment of any dividend, or in order to make a determination of stockholders for any other proper purpose, the Board of Directors of the Corporation may provide that the stock transfer books shall be closed for a stated period but not to exceed, in any case, sixty (60) days. In lieu of closing the stock transfer books, the Board of Directors may fix in advance a date as the record date for any such determination of stockholders, such date in any case to be not more than sixty (60) days, and, in case of a meeting of stockholders, not less than ten (10) days prior to the date on which the particular action, requiring such determination of stockholders, is to be taken. If 2 the stock transfer books are not closed and no record date is fixed for the determination of stockholders entitled to notice of or to vote at a meeting of stockholders, or stockholders entitled to receive payment of a dividend, the date on which notice of the meeting is mailed or the date on which the resolution of the board of directors declaring such dividend is adopted, as the case may be, shall be the record date for such determination of stockholders. But payment or allotment of dividends may not be made more than sixty days after the date on which the resolution is adopted. When a determination of stockholders entitled to vote at any meeting of stockholders has been made as provided in this Article 2.6, such determination shall apply to any adjournment thereof regardless of its length except where the determination has been made through the closing of the stock transfer books and the stated period of closing has expired. Section 7. BOOKS AND ACCOUNTS: This Corporation shall keep and maintain at its principal office in this State: (a) A certified copy of its Certificate of Incorporation, and all amendments thereto. (b) A certified copy of its Bylaws, and all amendments thereto. (c) A stock ledger or a duplicate stock ledger, revised annually, containing the names, alphabetically arranged, of all persons who are stockholders of the Corporation, showing their places of residence, if known, and the number of shares held by them respectively; or (d) In lieu of the stock ledger or duplication stock ledger specified in paragraph (c), a statement setting out the name of the custodian of the stock ledger or duplicate stock ledger, and the present and complete post office address, including street and number, if any, where such stock ledger or duplicate stock ledger specified in this Article 1.7 is kept. Section 8. QUORUM: A majority of the outstanding shares of the Corporation entitled to vote, represented in person or by proxy, shall constitute a quorum at a meeting of stockholders; provided, however, that in the case of any vote to be taken by classes or series, the holders of a majority of the votes entitled to be cast by the stockholders of a particular class or series, present in person or by proxy, shall constitute a quorum of such class or series. Section 9. ADJOURNMENTS; POSTPONEMENTS: In the absence of a quorum, holders of stock representing a majority of the voting power of all shares present in person or represented by proxy at the meeting, or the chairman of the meeting, may adjourn any meeting of stockholders (including an adjournment to address a technical failure to convene), from time to time, to reconvene at the same or some other place, and notice need not be given of any such adjourned meeting if the time and place thereof are announced at the meeting at which the adjournment is taken. Furthermore, after the meeting has been duly organized, the chairman of the meeting may adjourn any meeting of stockholders, from time to time, to reconvene at the same or some other place, and notice need not be given of any such adjourned meeting if the date, time and place, if any, thereof, and any means of remote communication for such meeting, are (i) announced at the meeting at which the adjournment is taken, (ii) displayed during the time scheduled for such meeting on the same electronic network used to enable stockholders and proxy holders to participate in such meeting by means of remote communication, or (iii) set forth in the notice of such meeting given in accordance with the provisions of Article 2.4. At the adjourned meeting, the Corporation may transact any business which might have been transacted at the original meeting. If the adjournment is for more than thirty (30) days, or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting. Any previously scheduled meeting of stockholders 3 may be postponed by the Board of Directors prior to the date previously scheduled for such meeting and the Corporation shall publicly announce such postponement. Section 10. PROXIES: At any meeting of stockholders, a stockholder may vote in person or by proxy executed in writing by the stockholder or by his duly authorized attorney in fact. Proxies for use at any meeting of stockholders shall be in writing and filed with the Secretary, or such other officer as the Board of Directors may from time to time determine by resolution, before or at the time of the meeting. All proxies shall be received and taken charge of and all ballots shall be received and canvassed by the secretary of the meeting who shall decide all questions touching upon the qualification of voters, the validity of the proxies and the acceptance or rejection of votes, unless an inspector or inspectors shall have been appointed by the Chairman, in which event such inspector or inspectors shall decide all such questions. Any stockholder directly or indirectly soliciting proxies from other stockholders must use a proxy card color other than white, which shall be reserved for the exclusive use by the Board of Directors. A proxy shall not be valid after six months from the date of its execution, unless coupled with an interest, but no proxy shall be valid after seven years from the date of its execution, unless renewed or extended at any time before its expiration. Section 11. LIST OF STOCKHOLDERS ENTITLED TO VOTE: A complete list of stockholders entitled to vote at any meeting of stockholders, arranged in alphabetical order and showing the address of each stockholder and the number of shares registered in the name of each stockholder, shall be open to he examination of any stockholder, for any purpose germane to the meeting, for a period of ten (10) days ending on the day before the meeting date, (i) on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided with the notice of the meeting, or (ii) during ordinary business hours, at the principal place of business of the Corporation. In the event that the Corporation determines to make the list available on an electronic network, the Corporation may take reasonable steps to ensure that such information is available only to the stockholders of the Corporation. Section 12. VOTING AND ELECTIONS: Each stockholder of record of any series of Preferred Stock shall be entitled at each meeting of the stockholders to such number of votes, if any, for each share of such stock as may be fixed in the Certificate of Incorporation or in the resolution or resolutions adopted by the Board of Directors provide for the issuance of such Preferred Stock, and each stockholder of record of Common Stock shall be entitled at each meeting of the stockholders to one vote for each share of such stock, in each case, registered in such stockholder&#8217;s name on the books of the Corporation: (i) on the date fixed pursuant to Section 6 of Article II of these Bylaws as the record date for the determination of stockholders entitled to notice of and to vote at such meeting; or (ii) if no such record date shall have been so fixed, then at the close of business on the day next preceding the day on which notice of such meeting is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held. At each meeting of the stockholders, all corporate actions to be taken by vote of the stockholders (other than the election of directors) shall be authorized by a majority of the votes cast by the stockholders entitled to vote thereon who are present in person or represented by proxy, and where a separate vote by class or series is required, a majority of the votes cast by the stockholders of such class or series who are present in person or represented by proxy shall be the act of such class or series. Directors shall be elected by a plurality of the votes cast at a meeting of the stockholders by the holders of stock entitled to vote in the election of directors, provided a quorum is present. 4 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- literacompareredline-pro002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="literacompareredline-pro002.jpg" title="slide2" width="1055" height="5460">
<DIV><FONT size="1" style="font-size:1pt;color:white">Section 13. VOTING OF SHARES BY CERTAIN HOLDERS: Shares standing in the name of another corporation may be voted by such officer, agent or proxy as the bylaws or a resolution of the board of directors of such corporation may prescribe, and a certified copy of the by-law or resolution is presented at the meeting. Shares held by an administrator, executor, guardian or conservator may be voted by him, either in person or by proxy, without a transfer of shares into his name. A stockholder whose shares are pledged shall be entitled to vote such shares until the shares have been transferred into the name of the pledgee, and thereafter the pledgee shall be entitled to vote the shares so transferred. Neither treasury shares of its own stock held by the Corporation, nor shares held by another corporation if a majority of the shares entitled to vote for the election of directors of such other corporation are held by the corporation, shall be voted at any meeting or counted in determining the total number of outstanding shares at any given time for purposes of any meeting. Section 14. VOTING TRUST: A stockholder, by agreement in writing, may transfer his stock to a voting trustee or trustees for the purpose of conferring the right to vote thereon for a period not exceeding 15 years upon the terms and conditions therein stated. The certificates of stock so transferred shall be surrendered and canceled and new certificates therefor issued to such trustee or trustees in which it shall appear that they are issued pursuant to such agreement, and in the entry of such ownership in the proper books of such corporation that fact shall also be noted, and thereupon such trustee or trustees may vote upon the stock so transferred during the terms of such agreement. A duplicate of every such agreement shall be filed in the principal office of the corporation and at all times during such terms be open to inspection by any stockholder or his attorney. Section 15. ACTION WITHOUT MEETING: Any action required or permitted to be taken by the stockholders of the Corporation must be effected at an annual or special meeting of stockholders of the Corporation and may not be effected by any consent in writing by such stockholders. Section 1615. NOMINATION OF DIRECTORS: (a) In addition to the rights of the holders of any series of Preferred Stock, nominations of any person for election to the Board of Directors at an annual meeting or at a special meeting (but only if the election of directors is a matter specified in the notice of meeting given by or at the direction of the person calling such special meeting) may be made at such meeting only (i) by or at the direction of the Board of Directors, including by any committee or persons appointed by the Board of Directors, or (ii) by a stockholder who (A) was a stockholder of record (and, with respect to any beneficial owner, if different, on whose behalf such nomination is proposed to be made, only if such beneficial owner was the beneficial owner of shares of the Corporation) both at the time of giving the notice provided for in this Article 2.162.15 and at the time of the meeting, (B) is entitled to vote at the meeting for the election of directors, and (C) has complied with this Article 2.162.15 as to such nomination. The foregoing clause (ii) shall be the exclusive means for a stockholder to make any nomination of a person or persons for election to the Board of Directors at an annual meeting or special meeting. (b) Without qualification, in addition to such stockholder complying with the provisions of Rule 14a-19 under the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (as so amended and inclusive of such rules and regulations, the &#8220;Exchange Act&#8221;), for a stockholder to make any nomination of a person or persons for election to the Board of Directors at an annual meeting, the stockholder must (i) provide Timely Notice (as defined in Article 2.172.16) thereof in writing and in proper form to the Secretary of the Corporation either by personal delivery or by United 5 States mail, postage prepaid, and (ii) provide any updates or supplements to such notice at the times and in the forms required by this Article 2.162.15. Without qualification, if the election of directors is a matter specified in the notice of meeting given by or at the direction of the person calling such special meeting, then for a stockholder to make any nomination of a person or persons for election to the Board of Directors at a special meeting, the stockholder must (i) provide timely notice thereof in writing and in proper form to the Secretary of the Corporation at the principal executive offices of the Corporation either by personal delivery or by United States mail, postage prepaid, and (ii) provide any updates or supplements to such notice at the times and in the forms required by this Article 2.162.15. To be timely, a stockholder&#8217;s notice for nominations to be made at a special meeting must be delivered to, or mailed and received at, the principal executive offices of the Corporation not earlier than the one hundred twentieth (120th) day prior to such special meeting and not later than the ninetieth (90th) day prior to such special meeting or, if such special meeting is announced later than the ninetieth day prior to the date of such special meeting, the tenth (10th) day following the day on which public disclosure (as defined in Article 2.162.15) of the date of such special meeting was first made. In no event shall any adjournment of an annual meeting or special meeting or the announcement thereof commence a new time period for the giving of a stockholder&#8217;s notice as described above. (c) To be in proper form for purposes of this Article 2.162.15, a stockholder&#8217;s notice to the Secretary shall set forth: (i) As to each Nominating Person (as defined below), the Stockholder Information (as defined in Article 2.172.16(c)(i), except that for purposes of this Article 2.162.15 the term &#8220;Nominating Person&#8221; shall be substituted for the term &#8220;Proposing Person&#8221; in all places it appears in Article 2.172.16(c)(i)); (ii) As to each Nominating Person, any Disclosable Interests (as defined in Article 2.172.16(c)(ii), except that for purposes of this Article 2.162.15 the term &#8220;Nominating Person&#8221; shall be substituted for the term &#8220;Proposing Person&#8221; in all places it appears in Article 2.172.16(c)(ii) and the disclosure in clause (L) of Article 2.172.16(c)(ii) shall be made with respect to the election of directors at the meeting); (iii) A representation that the Nominating Person is a holder or record or beneficial owner of shares of the Corporation entitled to vote at the meeting and intends to appear in person or by proxy at the meeting to nominate the person or persons specified in the notice; (iv) A representation as to whether the Nominating Person intends to solicit proxies in support of such person&#8217;s nominee(s) in accordance with Rule 14a-19 under the Exchange Act; (v)  A representation as to whether the Nominating Person intends or is part of a group that intends (x) to deliver a proxy statement and/or a form of proxy to holders of at least the percentage of the Corporation&#8217;s outstanding stock reasonably believed by the Nominating Person to be sufficient to elect the nominee or nominees proposed to be nominating by the Nominating Person; (vi) As to each person whom a Nominating Person proposes to nominate for election as a director, (A) all information with respect to such proposed nominee that would be required to be set forth in a stockholder&#8217;s notice pursuant to this Article 2.162.15 if such proposed nominee were a Nominating Person, (B) all information relating to such proposed nominee that is 6 required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors in a contested election pursuant to Article 14(a) under the Exchange Act (including such proposed nominee&#8217;s written consent to being named in the proxy statement as a nominee and to serving as a director if elected), (C) a description of all direct and indirect compensation and other material monetary agreements, arrangements and understandings during the past three years, and any other material relationships, between or among any Nominating Person, on the one hand, and each proposed nominee, his or her respective affiliates and associates and any other persons with whom such proposed nominee (or any of his or her respective affiliates and associates) is Acting in Concert (as defined in Article 2.172.16(c)), on the other hand, including, without limitation, all information that would be required to be disclosed pursuant to Item 404 under Regulation S-K if such Nominating Person were the &#8220;registrant&#8221; for purposes of such rule and the proposed nominee were a director or executive officer of such registrant, and (D) a completed and signed questionnaire, representation and agreement as provided in Article 2.162.15(f); and (vi) The Corporation may require any proposed nominee to furnish such other information (A) as may reasonably be required by the Corporation to determine the eligibility of such proposed nominee to serve as an independent director of the Corporation in accordance with the Corporation&#8217;s corporate governance guidelines or (B) that could be material to a reasonable stockholder&#8217;s understanding of the independence or lack of independence of such proposed nominee. For purposes of this Article 2.162.15, the term &#8220;Nominating Person&#8221; shall mean (i) the stockholder providing the notice of the nomination proposed to be made at the meeting, (ii) the beneficial owner or beneficial owners, if different, on whose behalf the notice of the nomination proposed to be made at the meeting is made, (iii) any affiliate or associate of such stockholder or beneficial owner, and (iv) any other person with whom such stockholder or such beneficial owner (or any of their respective affiliates or associates) is Acting in Concert. (d) A stockholder providing notice of any nomination proposed to be made at a meeting shall further update and supplement such notice, if necessary, so that the information provided or required to be provided in such notice pursuant to this Article 2.162.15 shall be true and correct as of the record date for the meeting and as of the date that is ten (10) business days prior to the meeting or any adjournment or postponement thereof, and such update and supplement shall be delivered to, or mailed and received by, the Secretary at the principal executive offices of the Corporation not later than five (5) business days after the record date for the meeting (in the case of the update and supplement required to be made as of the record date), and not later than eight (8) business days prior to the date for the meeting, if practicable (or, if not practicable, on the first practicable date prior to) any adjournment or postponement thereof (in the case of the update and supplement required to be made as of ten (10) business days prior to the meeting or any adjournment or postponement thereof). (e) Notwithstanding anything in these Bylaws to the contrary, no person shall be eligible for election as a director of the Corporation unless nominated in accordance with this Article 2.162.15. The presiding officer at the meeting shall, if the facts warrant, determine that a nomination was not properly made in accordance with this Article 2.162.15, and if he or she should so determine, he or she shall so declare such determination to the meeting and the defective nomination shall be disregarded. (f) To be eligible to be a nominee for election as a director of the Corporation, the proposed nominee must deliver (in accordance with the time periods prescribed for delivery of notice under this Article 2.162.15) to the Secretary at the principal executive offices of the Corporation a written questionnaire with respect to the background and qualification of such proposed nominee (which questionnaire shall be provided by the Secretary upon written request) and a written representation and agreement (in form provided by the Secretary upon written request) that such proposed nominee (i) is not 7 and will not become a party to (A) any agreement, arrangement or understanding with, and has not given any commitment or assurance to, any person or entity as to how such proposed nominee, if elected as a director of the Corporation, will act or vote on any issue or question (a &#8220;Voting Commitment&#8221;) that has not been disclosed to the Corporation or (B) any Voting Commitment that could limit or interfere with such proposed nominee&#8217;s ability to comply, if elected as a director of the Corporation, with such proposed nominee&#8217;s fiduciary duties under applicable law, (ii) is not, and will not become a party to, any agreement, arrangement or understanding with any person or entity other than the Corporation with respect to any direct or indirect compensation, reimbursement or indemnification in connection with service or action as a director that has not been disclosed to the Corporation and (iii) in such proposed nominee&#8217;s individual capacity and on behalf of the stockholder (or the beneficial owner, if different) on whose behalf the nomination is made, would be in compliance, if elected as a director of the Corporation, and will comply with applicable publicly disclosed corporate governance, conflict of interest, confidentiality and stock ownership and trading policies and guidelines of the Corporation. (g) In addition to the requirements of this Article 2.162.15 with respect to any nomination proposed to be made at a meeting, each Nominating Person shall comply with all applicable requirements of the Exchange Act with respect to any such nominations. Unless otherwise required by law, (i) no Nominating Person shall solicit proxies in support of director nominees other than the Corporation&#8217;s nominees unless such stockholder has complied with Rule 14a-19 under the Exchange Act in connection with the solicitation of such proxies, including the provision to the Corporation of notices required thereunder in a timely manner, and (ii) if such stockholder (1) provides notice pursuant to Rule 14a-19(b) under the Exchange Act and (2) subsequently fails to comply with all applicable requirements of Section 10 and this Article 2.162.15 and Rules 14a-19(a)(2) and 14a-19(a)(3) under the Exchange Act, then the Corporation shall disregard any proxies or votes solicited for such Nominating Person&#8217;s director nominees. Upon request by the Corporation, if any such Nominating Person provides notice pursuant to Rule 14a-19(b) under the Exchange Act, such Nominating Person shall deliver to the Corporation, no later than five (5) business days prior to the applicable meeting, reasonable evidence that it has met the requirements of Rule 14a-19(a)(3) under the Exchange Act. Section 1716. NOTICE OF BUSINESS AT ANNUAL MEETINGS: (a) At an annual meeting of the stockholders, only such business shall be conducted as shall have been properly brought before the meeting. To be properly brought before an annual meeting, business must be (i) brought before the meeting by the Corporation and specified in the notice of meeting given by or at the direction of the Board of Directors, (ii) brought before the meeting by or at the direction of the Board of Directors, or (iii) otherwise properly brought before the meeting by a stockholder who (A) was a stockholder of record (and, with respect to any beneficial owner, if different, on whose behalf such business is proposed, only if such beneficial owner was the beneficial owner of shares of the Corporation) both at the time of giving the notice provided for in this Article 2.172.16 and at the time of the meeting, (B) is entitled to vote at the meeting, and (C) has complied with this Article 2.172.16 as to such business. Except for proposals properly made in accordance with Rule 14a-8 under the Exchange Act, and included in the notice of meeting given by or at the direction of the Board of Directors, the foregoing clause (iii) shall be the exclusive means for a stockholder to propose business to be brought before an annual meeting of the stockholders. Stockholders shall not be permitted to propose business to be brought before a special meeting of the stockholders, and the only matters that may be brought before a special meeting are the matters specified in the notice of meeting given by or at the direction of the person calling the meeting. Stockholders seeking to nominate persons for election to the Board must comply with Article 2.162.15 and this Article 2.172.16 shall not be applicable to nominations except as expressly provided in Article 2.162.15. 8 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- literacompareredline-pro003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="literacompareredline-pro003.jpg" title="slide3" width="1055" height="5460">
<DIV><FONT size="1" style="font-size:1pt;color:white">(b) Without qualification, for business to be properly brought before an annual meeting by a stockholder, the stockholder must (i) provide Timely Notice (as defined below) thereof in writing and in proper form to the Secretary of the Corporation either by personal delivery or by United States mail, postage prepaid, and (ii) provide any updates or supplements to such notice at the times and in the forms required by this Article 2.172.16. To be timely, a stockholder&#8217;s notice must be delivered to, or mailed and received at, the principal executive offices of the Corporation not less than ninety (90) days nor more than one hundred twenty (120) days prior to the one-year anniversary of the preceding year&#8217;s annual meeting; provided, however, that if the date of the annual meeting is more than thirty (30) days before or more than sixty (60) days after such anniversary date, notice by the stockholder to be timely must be so delivered, or mailed and received, not later than the ninetieth (90th) day prior to such annual meeting or, if such annual meeting is announced later than the ninetieth day prior to the date of such annual meeting, the tenth (10th) day following the day on which public disclosure of the date of such annual meeting was first made (such notice within such time periods, &#8220;Timely Notice&#8221;). In no event shall any adjournment of an annual meeting or the announcement thereof commence a new time period for the giving of Timely Notice as described above. (c) To be in proper form for purposes of this Article 2.172.16, a stockholder&#8217;s notice to the Secretary shall set forth: (i) As to each Proposing Person (as defined below), (A) the name and address of such Proposing Person (including, if applicable, the name and address that appear on the Corporation&#8217;s books and records); and (B) the class or series and number of shares of the Corporation that are, directly or indirectly, owned of record or beneficially owned (within the meaning of Rule 13d-3 under the Exchange Act) by such Proposing Persons, except that such Proposing Person shall in all events be deemed to beneficially own any shares of any class or series of the Corporation as to which such Proposing Person has a right to acquire beneficial ownership at any time in the future (the disclosures to be made pursuant to the foregoing clauses (i) and (ii) are referred to as &#8220;Stockholder Information&#8221;); (ii) As to each Proposing Person, (A) any derivative, swap or other transaction or series of transactions engaged in, directly or indirectly, by such Proposing Person, the purpose or effect of which is to give such Proposing Person economic risk similar to ownership of shares of any class or series of the Corporation, including due to the fact that the value of such derivative, swap or other transactions are determined by reference to the price, value or volatility of any shares of any class or series of the Corporation, or which derivative, swap or other transactions provide, directly or indirectly, the opportunity to profit from any increase in the price or value of shares of any class or series of the Corporation (&#8220;Synthetic Equity Interests&#8221;), which Synthetic Equity Interests shall be disclosed without regard to whether (x) the derivative, swap or other transactions convey any voting rights in such shares to such Proposing Person, (y) the derivative, swap or other transactions are required to be, or are capable of being, settled through delivery of such shares or (z) such Proposing Person may have entered into other transactions that hedge or mitigate the economic effect of such derivative, swap or other transactions (B) any proxy (other than a revocable proxy or consent given in response to a solicitation made pursuant to, and in accordance with, Article 14(a) of the Exchange Act by way of a solicitation statement filed on Schedule 14A), agreement, arrangement, understanding or relationship pursuant to which such Proposing Person has or shares a right to vote any shares of any class or series of the Corporation, (C) any agreement, arrangement, understanding or relationship, including any repurchase or similar so-called &#8220;stock borrowing&#8221; agreement or arrangement, engaged in, directly or indirectly, by such Proposing Person, the purpose or effect of which is to mitigate loss to, reduce the economic risk (of ownership or otherwise) of shares of any class or series of the Corporation by, manage the risk of share price changes for, or increase or decrease the voting power of, such Proposing Person with respect to the 9 shares of any class or series of the Corporation, or which provides, directly or indirectly, the opportunity to profit from any decrease in the price or value of the shares of any class or series of the Corporation (&#8220;Short Interests&#8221;), (D) any rights to dividends on the shares of any class or series of the Corporation owned beneficially by such Proposing Person that are separated or separable from the underlying shares of the Corporation, (E) any performance related fees (other than an asset based fee) that such Proposing Person is entitled to based on any increase or decrease in the price or value of shares of any class or series of the Corporation, or any Synthetic Equity Interests or Short Interests, if any, (F)(x) if such Proposing Person is not a natural person, the identity of the natural person or persons associated with such Proposing Person responsible for the formulation of and decision to propose the business to be brought before the meeting (such person or persons, the &#8220;Responsible Person&#8221;), the manner in which such Responsible Person was selected, any fiduciary duties owed by such Responsible Person to the equity holders or other beneficiaries of such Proposing Person, the qualifications and background of such Responsible Person and any material interests or relationships of such Responsible Person that are not shared generally by any other record or beneficial holder of the shares of any class or series of the Corporation and that reasonably could have influenced the decision of such Proposing Person to propose such business to be brought before the meeting, and (y) if such Proposing Person is a natural person, the qualifications and background of such natural person and any material interests or relationships of such natural person that are not shared generally by any other record or beneficial holder of the shares of any class or series of the Corporation and that reasonably could have influenced the decision of such Proposing Person to propose such business to be brought before the meeting, (G) any significant equity interests or any Synthetic Equity Interests or Short Interests in any principal competitor of the Corporation held by such Proposing Persons (H) any direct or indirect interest of such Proposing Person in any contract with the Corporation, any affiliate of the Corporation or any principal competitor of the Corporation (including, in any such case, any employment agreement, collective bargaining agreement or consulting agreement), (I) any pending or threatened litigation in which such Proposing Person is a party or material participant involving the Corporation or any of its officers or directors, or any affiliate of the Corporation, (J) any material transaction occurring during the prior twelve months between such Proposing Person, on the one hand, and the Corporation, any affiliate of the Corporation or any principal competitor of the Corporation, on the other hand, (K) a summary of any material discussions regarding the business proposed to be brought before the meeting (x) between or among any of the Proposing Persons or (y) between or among any Proposing Person and any other record or beneficial holder of the shares of any class or series of the Corporation (including their names), and (L) any other information relating to such Proposing Person that would be required to be disclosed in a proxy statement or other filing required to be made in connection with solicitations of proxies or consents by such Proposing Person in support of the business proposed to be brought before the meeting pursuant to Article 14(a) of the Exchange Act (the disclosures to be made pursuant to the foregoing clauses (A) through (L) are referred to as &#8220;Disclosable Interests&#8221;); provided, however, that Disclosable Interests shall not include any such disclosures with respect to the ordinary course business activities of any broker, dealer, commercial bank, trust company or other nominee who is a Proposing Person solely as a result of being the stockholder directed to prepare and submit the notice required by these Bylaws on behalf of a beneficial owner; (iii) As to each item of business that the stockholder proposes to bring before the annual meeting, (A) a reasonably brief description of the business desired to be brought before the annual meeting, the reasons for conducting such business at the annual meeting and any material interest in such business of each Proposing Person, (B) the text of the proposal or business (including the text of any resolutions proposed for consideration), and (C) a reasonably detailed description of all agreements, arrangements and understandings (x) between or among any of the Proposing Persons or (y) between or among any Proposing Person and any other record or beneficial holder of the shares of any class or series of the Corporation (including their names) in connection with the proposal of such business by such stockholder; 10 (iv) A representation that the Proposing Person is a holder or record or beneficial owner of shares of the Corporation entitled to vote at the meeting and intends to appear in person or by proxy at the meeting to propose the business specified in the notice; and (v) A representation as to whether the Proposing Person intends to solicit proxies in support of such person&#8217;s proposal. For purposes of this Article 2.172.16, the term &#8220;Proposing Person&#8221; shall mean (i) the stockholder providing the notice of business proposed to be brought before an annual meeting, (ii) the beneficial owner or beneficial owners, if different, on whose behalf the notice of the business proposed to be brought before the annual meeting is made, (iii) any affiliate or associate (each within the meaning of Rule 12b-2 under the Exchange Act for purposes of these Bylaws) of such stockholder or beneficial owner, and (iv) any other person with whom such stockholder or beneficial owner (or any of their respective affiliates or associates) is Acting in Concert (as defined below). A person shall be deemed to be &#8220;Acting in Concert&#8221; with another person for purposes of these Bylaws if such person knowingly acts (whether or not pursuant to an express agreement, arrangement or understanding) in concert with, or towards a common goal relating to the management, governance or control of the Corporation in parallel with, such other person where (A) each person is conscious of the other person&#8217;s conduct or intent and this awareness is an element in their decision-making processes and (B) at least one additional factor suggests that such persons intend to act in concert or in parallel, which such additional factors may include, without limitation, exchanging information (whether publicly or privately), attending meetings, conducting discussions, or making or soliciting invitations to act in concert or in parallel; provided, that a person shall not be deemed to be Acting in Concert with any other person solely as a result of the solicitation or receipt of revocable proxies or consents from such other person in response to a solicitation made pursuant to, and in accordance with, Article 14(a) of the Exchange Act by way of a proxy or consent solicitation statement filed on Schedule 14A. A person Acting in Concert with another person shall be deemed to be Acting in Concert with any third party who is also Acting in Concert with such other person. (d) A stockholder providing notice of business proposed to be brought before an annual meeting shall further update and supplement such notice, if necessary, so that the information provided or required to be provided in such notice pursuant to this Article 2.172.16 shall be true and correct as of the record date for the meeting and as of the date that is ten (10) business days prior to the meeting or any adjournment or postponement thereof, and such update and supplement shall be delivered to, or mailed and received by, the Secretary at the principal executive offices of the Corporation not later than five (5) business days after the record date for the meeting (in the case of the update and supplement required to be made as of the record date), and not later than eight (8) business days prior to the date for the meeting, if practicable (or, if not practicable, on the first practicable date prior to) any adjournment or postponement thereof (in the case of the update and supplement required to be made as of ten (10) business days prior to the meeting or any adjournment or postponement thereof). (e) Notwithstanding anything in these Bylaws to the contrary, no business shall be conducted at an annual meeting except in accordance with this Article 2.172.16. The presiding officer of the meeting shall, if the facts warrant, determine that the business was not properly brought before the meeting in accordance with this Article 2.172.16, and if he or she should so determine, he or she shall so declare to the meeting and any such business not properly brought before the meeting shall not be transacted. 11 (f) This Article 2.172.16 is expressly intended to apply to any business proposed to be brought before an annual meeting of stockholders other than any proposal made pursuant to Rule 14a-8 under the Exchange Act. In addition to the requirements of this Article 2.172.16 with respect to any business proposed to be brought before an annual meeting, each Proposing Person shall comply with all applicable requirements of the Exchange Act with respect to any such business. Nothing in this Article 2.172.16 shall be deemed to affect the rights of stockholders to request inclusion of proposals in the Corporation&#8217;s proxy statement pursuant to Rule 14a-8 under the Exchange Act. (g) For purposes of these Bylaws, &#8220;public disclosure&#8221; shall mean disclosure in a press release reported by a national news service or in a document publicly filed by the Corporation with the Securities and Exchange Commission pursuant to Articles 13, 14 or 15(d) of the Exchange Act. Section 1817. CONDUCT OF MEETINGS: (a) Meetings of stockholders shall be presided over by the Chairman or in the Chairman&#8217;s absence by the Chief Executive Officer, or in the Chief Executive Officer&#8217;s absence by the President (if the President shall be a different individual than the Chief Executive Officer), or in the President&#8217;s absence by a Vice President, or in the absence of all of the foregoing persons by a chairman designated by the Board of Directors, or in the absence of such designation by a chairman chosen by vote of the stockholders at the meeting. The Secretary shall act as secretary of the meeting, but in the Secretary&#8217;s absence the chairman of the meeting may appoint any person to act as secretary of the meeting. (b) The Board of Directors of the Corporation may adopt by resolution such rules, regulations and procedures for the conduct of any meeting of stockholders of the Corporation as it shall deem appropriate including, without limitation, such guidelines and procedures as it may deem appropriate regarding the participation by means of remote communication of stockholders and proxyholders not physically present at a meeting. Except to the extent inconsistent with such rules, regulations and procedures as adopted by the Board of Directors, the chairman of any meeting of stockholders shall have the right and authority to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such chairman, are appropriate for the proper conduct of the meeting. Such rules, regulations or procedures, whether adopted by the Board of Directors or prescribed by the chairman of the meeting, may include, without limitation, the following: (i) the establishment of an agenda or order of business for the meeting; (ii) rules and procedures for maintaining order at the meeting and the safety of those present; (iii) limitations on attendance at or participation in the meeting to stockholders of record of the Corporation, their duly authorized and constituted proxies or such other persons as shall be determined; (iv) restrictions on entry to the meeting after the time fixed for the commencement thereof; and (v) limitations on the time allotted to questions or comments by participants. Unless and to the extent determined by the Board of Directors or the chairman of the meeting, meetings of stockholders shall not be required to be held in accordance with the rules of parliamentary procedure. (c) The chairman of the meeting shall announce at the meeting when the polls for each matter to be voted upon at the meeting will be opened and closed. If no announcement is made, the polls shall be deemed to have opened when the meeting is convened and closed upon the final adjournment of the meeting. After the polls close, no ballots, proxies or votes or any revocations or changes thereto may be accepted. (d) In advance of any meeting of stockholders, the Board of Directors, the Chairman or the Chief Executive Officer shall appoint one or more inspectors of election to act at the meeting and make a written report thereof. One or more other persons may be designated as alternate inspectors to 12 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- literacompareredline-pro004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="literacompareredline-pro004.jpg" title="slide4" width="1055" height="5460">
<DIV><FONT size="1" style="font-size:1pt;color:white">replace any inspector who fails to act. If no inspector or alternate is present, ready and willing to act at a meeting of stockholders, the chairman of the meeting shall appoint one or more inspectors to act at the meeting. Unless otherwise required by law, inspectors may be officers, employees or agents of the Corporation. Each inspector, before entering upon the discharge of such inspector&#8217;s duties, shall take and sign an oath faithfully to execute the duties of inspector with strict impartiality and according to the best of such inspector&#8217;s ability. The inspector shall have the duties prescribed by law and shall take charge of the polls and, when the vote is completed, shall make a certificate of the result of the vote taken and of such other facts as may be required by law. ARTICLE III &#8211; DIRECTORS Section 1. NUMBER AND TERM. The business of this Corporation shall be managed by a Board of Directors which shall consist of not less than three (3) directors nor more than nine (9) directors, who need not be residents of the State of Delaware or stockholders of the Corporation. The exact number of directors within the minimum and maximum limitations specified in the preceding sentence shall be fixed from time to time by the Board of Directors pursuant to a resolution adopted by a majority of the entire Board of Directors, which number shall initially be six (6). Except as otherwise provided in the Certificate of Incorporation, each director shall serve for a term ending on the date of the annual meeting of stockholders next following the annual meeting at which such director was elected. Notwithstanding the foregoing, each director shall hold office until such director&#8217;s successor shall have been duly elected and qualified or until such director&#8217;s earlier death, resignation or removal. Directors need not be stockholders. Section 2. REGULAR MEETINGS: Each newly elected Board of Directors may hold its first meeting for the purpose of organization and the transaction of business, if a quorum is present, immediately after and at the same place as the annual meeting of the stockholders. Notice of such meeting shall not be required. At the first meeting of the Board of Directors in each year at which a quorum shall be present, held next after the annual meeting of stockholders, the Board of Directors shall proceed to the election of the officers of the Corporation. Regular meetings of the Board of Directors shall be held at such times and places as shall be designated from time to time by resolution of the Board of Directors. Notice of such regular meetings shall not be required. Section 3. SPECIAL MEETINGS: Special meetings of the Board of Directors may be called by the Chairman of the Board, or on the written request of any two directors, by the Secretary, in each case on at least twenty-four (24) hours personal, written, telegraphic, cable or wireless notice to each director. Such notice, or any waiver thereof pursuant to Article 3.4 hereof, shall state the time and place of the special meeting, but need not state the purpose or purposes of such meeting, except as may otherwise be required by law or provided for in the Certificate of Incorporation or these Bylaws. If the day or date, time and place of a meeting of the Board of Directors has been announced at a previous meeting of the board, no notice is required. Notice of an adjourned meeting of the Board of Directors need not be given other than by announcement at the meeting at which adjournment is taken. Section 4. NOTICE WAIVER: Notice of any meeting of the Board of Directors may be waived by any director either before, at or after such meeting orally or in a writing signed by such director. A director, by his or her attendance at any meeting of the Board of Directors, shall be deemed to have waived notice of such meeting, except where the director objects at the beginning of the meeting to the transaction of business because the meeting is not lawfully called or convened and does not participate thereafter in the meeting. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the Board of Directors need be specified in the notice or waiver of notice of such meeting. 13 Section 5. QUORUM AND MANNER OF ACTING: Unless otherwise provided in the Certificate of Incorporation, a majority of the total number of directors then in office shall constitute a quorum for the transaction of business of the Board of Directors and the vote of a majority of the directors present at a meeting at which a quorum is present shall be the act of the Board of Directors. Section 6. RESIGNATION. Any director may resign at any time by giving notice in writing or by electronic transmission to the Board of Directors or to the Secretary of the Corporation. The resignation of any director shall take effect upon receipt of notice thereof or at such later time as shall be specified in such notice; and unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective. Section 7. NEWLY CREATED DIRECTORSHIPS. A directorship to be filled by reason of any increase in the number of directors may be filled (i) by election at an annual or special meeting of stockholders called for that purpose or (ii) by the Board of Directors for a term of office continuing only until the next election of one or more directors by the stockholders. Section 8. VACANCIES IN THE BOARD OF DIRECTORS. Any vacancies in the Board of Directors resulting from death, resignation, retirement, disqualification, removal from office or other cause shall be filled by a majority vote of the directors then in office, and directors so chosen shall hold office for a term expiring at the annual meeting of stockholders at which the term of the class to which they have been elected expires. No decrease in the number of directors constituting the Board of Directors shall shorten the term of any incumbent director. Section 9. REMOVAL OF DIRECTORS. Except as may otherwise be provided by law, any director or the entire Board of Directors may be removed, with or without cause, at an annual meeting or at a special meeting called for that purpose, by the affirmative vote of the holders of a majority of the shares then entitled to vote at an election of directors. Section 10. ACTION WITHOUT A MEETING; TELEPHONE CONFERENCE MEETING: Unless otherwise restricted by the Certificate of Incorporation, any action required or permitted to be taken at any meeting of the Board of Directors, or any committee designated by the Board of Directors, may be taken without a meeting if all members of the Board of Directors or committee, as the case may be, either originally or in counterparts, consent thereto in writing. Such consent shall have the same force and effect as a unanimous vote at a meeting, and may be stated as such in any document or instrument filed with the Secretary of State of Delaware. Unless otherwise restricted by the Certificate of Incorporation, subject to the requirement for notice of meetings, members of the Board of Directors, or members of any committee designated by the Board of Directors, may participate in a meeting of such Board of Directors or committee, as the case may be, by means of a conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other, and participation in such a meeting shall constitute presence in person at such meeting, except where a person participates in the meeting for the express purpose of objecting to the transaction of any business on the grounds that the meeting is not lawfully called or convened. Section 10. EXECUTIVE AND OTHER COMMITTEES: (a) The Board of Directors, by resolution adopted by a majority of the number of directors then in office may designate from among its members an executive committee and one or more other committees, each consisting of two or more directors, and each of which, to the extent provided in 14 the resolution or in the charter or these Bylaws shall have and may exercise all of the authority of the Board of Directors except the power to: (i) Declare dividends or distributions on stock; (ii) Issue stock other than as provided in subsection (b) of this Article. (iii) Recommend to the stockholders any action which requires stockholder approving, including, but not limited to, adopting an agreement of merger or consolidation, the sale, lease or exchange of all or substantially all of the Corporation&#8217;s property and assets, a dissolution of the Corporation or a revocation of a dissolution of the Corporation; or (iv) Amend the Certificate of Incorporation or the Bylaws. (b) If the Board of Directors has given general authorization for the issuance of stock, a committee of the Board, in accordance with a general formula or method specified by the board by resolution or by adoption of a stock option or other plan, may fix the terms of stock subject to classification or reclassification and the terms on which any stock may be issued, including all terms and conditions required or permitted to be established or authorized by the Board of Directors under the Delaware General Corporation Law. (c) The appointment of any committee, the delegation of authority to it or action by it under that authority does not constitute of itself, compliance by any director not a member of the committee, with the standard provided by statute for the performance of duties of directors. (d) Any committee designated pursuant to this Article 3.10 shall choose its own chairman, shall keep regular minutes of its proceedings and report the same to the Board of Directors when requested, shall fix its own rules or procedures, and shall meet at such times and at such place or places as may be provided by such rules, or by resolution of such committee or resolution of the Board of Directors. At every meeting of any such committee, the presence of a majority of all the members thereof shall constitute a quorum and the affirmative vote of a majority of the members present shall be necessary for the adoption by it of any resolution. (e) The Board of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of such committee. In the absence or disqualification of a member of a committee, the member or members present at any meeting and not disqualified from voting, whether or not constituting a quorum, may unanimously appoint another member of the Board of Directors to act at the meeting in the place of the absent or disqualified member. Section 11. CHAIRMAN OF THE BOARD: The Board shall elect from its members a Chairman, which Chairman shall preside at all meetings of the stockholders and the directors. The Chairman shall serve in such capacity until his or her successor is elected by the Board or until his or her earlier resignation or removal from the Board. He or she shall also perform such other duties the Board may assign to him or her from time to time. Section 12. COMPENSATION: By resolution of the Board of Directors, each director may be paid his expenses, if any, of attendance at each meeting of the Board of Directors, and may be paid a stated salary as director or a fixed sum for attendance at each meeting of the Board of Directors or both. No such payment shall preclude any director from serving the Corporation in any other capacity and receiving compensation therefor. 15 Section 13. PRESUMPTION OF ASSENT: A director of the Corporation who is present at a meeting of the board of Directors at which action on any corporate matter is taken unless he shall announce his dissent at the meeting and his dissent is entered in the minutes and he shall forward such dissent by registered mail to the secretary of the corporation immediately after the adjournment of the meeting. Such right to dissent shall not apply to a director who voted in favor of such action. ARTICLE IV &#8211; OFFICERS Section 1. NUMBER, TITLES, AND TERM OF OFFICE: The officers of the Corporation shall be chosen by the Board of Directors and shall include a Chief Executive Officer, President, Chief Operating Officer, Chief Financial Officer, President, one or more Vice Presidents (any one or more of whom may be designated Executive Vice President or Senior Vice President), a Treasurer, a Secretary, and such other officers as the Board of Directors may from time to time elect or appoint. Each officer shall hold office until his successor shall be duly elected and shall qualify or until his death or until he shall resign or shall have been removed in the manner hereinafter provided. Any number of offices may be held by the same person, unless the Certificate of Incorporation provides otherwise. Except for the Chairman of the Board, if any, no officers need be a director. Section 2. SALARIES: The salaries or other compensation of the officers and agents of the Corporation shall be fixed from time to time by the Board of Directors. Section 3. REMOVAL: Any officer or agent elected or appointed by the Board of Directors may be removed, either with or without cause, by the vote of a majority of the whole Board of Directors at a special meeting called for the purpose, or at any regular meeting of the Board of Directors, provided the notice for such meeting shall specify that the matter of any such proposed removal will be considered at the meeting but such removal shall be without prejudice to the contract rights, if any, of the person so removed. Election or appointment of an officer or agent shall not of itself create contract rights. Section 4. VACANCIES: Any vacancy occurring in any office of the Corporation may be filled by the Board of Directors. Section 5. CHIEF EXECUTIVE OFFICER: The Chief Executive Officer shall, in the absence of the Chairman, preside at all meetings of the stockholders. Subject to the control of the Board of Directors and the executive committee (if any), the Chief Executive Officer shall have general executive charge, management and control of the properties, business and operations of the Corporation with all such powers as may be reasonably incident to such responsibilities; he may agree upon and execute all leases, contracts, evidences of indebtedness and other obligations in the name of the Corporation and may sign all certificates for shares of capital stock of the Corporation and shall have such other powers and duties as designated in accordance with these Bylaws and as from time to time may be assigned to him by the Board of Directors. Section 6. PRESIDENT: Subject to such supervisory powers, if any, as may be given by the Board to the Chief Executive Officer, the President shall have general supervision, direction, and control of the business and other officers of the corporation. The President shall have the general powers and duties of management usually vested in the office of President of a corporation and shall have such other powers and duties as may be prescribed by the Board or these Bylaws. If, for any reason, the Corporation does not have a Chairman or Chief Executive Officer, or such officers are unable to act, the President shall assume the duties of those officers. 16 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- literacompareredline-pro005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="literacompareredline-pro005.jpg" title="slide5" width="1055" height="5460">
<DIV><FONT size="1" style="font-size:1pt;color:white">Section 7. CHIEF OPERATING OFFICER: The Chief Operating Officer shall supervise the operation of the Corporation, subject to the policies and directions of the Board. He or she shall provide for the proper operation of the Corporation and oversee the internal interrelationship amongst any and all departments of the Corporation. He or she shall submit to the Chief Executive Officer, the President, the Chairman and the Board timely reports on the operations of the Corporation. Section 8. CHIEF FINANCIAL OFFICER: The Chief Financial Officer shall have general supervision, direction and control of the financial affairs of the Corporation. He or she shall provide for the establishment of internal controls and see that adequate audits are currently and regularly made. He or she shall submit to the Chief Executive Officer, the President, the Chief Operating Officer, the Chairman and the Board timely statements of the accounts of the Corporation and the financial results of the operations thereof. The Chief Financial Officer shall perform such other duties and have such other powers as may be prescribed by the Board or these Bylaws, all in accordance with basic policies as established by and subject to the oversight of the Board and the Chief Executive Officer. In the absence of a named Treasurer, the Chief Financial Officer shall also have the powers and duties of the Treasurer as hereinafter set forth and shall be authorized and empowered to sign as Treasurer in any case where such officer&#8217;s signature is required. Section 9. VICE PRESIDENTS: In the absence of the President, or in the event of his inability or refusal to act, a Vice President designated by the Board of Directors shall perform the duties of the President, and when so acting shall have all the powers of and be subject to all the restrictions of the President. In the absence of a designation by the Board of Directors of a Vice President to perform the duties of the President, or in the event of his absence or inability or refusal to act, the Vice President who is present and who is senior in terms of time as a Vice President of the Corporation shall so act. The Vice Presidents shall perform such other duties and have such other powers as the chief executive officer or the Board of Directors may from time to time prescribe. Section 10. TREASURER: The Treasurer shall have responsibility for the custody and control of all the funds and securities of the Corporation, and he shall have such other powers and duties as designated in these Bylaws and as from time to time may be assigned to him by the Board of Directors. He shall perform all acts incident to the position of Treasurer, subject to the control of the chief executive officer and the Board of Directors; and he shall, if required by the Board of Directors, give such bond for the faithful discharge of his duties in such form as the Board of Directors may require. Section 11. ASSISTANT TREASURERS: Each Assistant Treasurer shall have the usual powers and duties pertaining to his office, together with such other powers and duties as designated in these Bylaws and as from time to time may be assigned to him by the chief executive officer or the Board of Directors. The Assistant Treasurers shall exercise the powers of the Treasurer during that officer&#8217;s absence or inability or refusal to act. Section 12. SECRETARY: The Secretary shall keep the minutes of all meetings of the Board of Directors, committees of directors and the stockholders, in books provided for that purpose; he shall attend to the giving and serving of all notices; he may in the name of the Corporation affix the seal of the Corporation to all contracts of the Corporation and attest the affixation of the seal of the Corporation thereto; he may sign with the other appointed officers all certificates for shares of capital stock of the Corporation; he shall have charge of the certificate books, transfer books and stock ledgers, and such other books and papers as the Board of Directors may direct, all of which shall at all reasonable times be open to inspection of any director upon application at the office of the Corporation during business hours; he shall have such other powers and duties as designated in these Bylaws and as from time to time 17 may be assigned to him by the Board of Directors; and he shall in general perform all acts incident to the office of Secretary, subject to the control of the chief executive officer and the Board of Directors. Section 13. ASSISTANT SECRETARIES: Each Assistant Secretary shall have the usual powers and duties pertaining to his office, together with such other powers and duties as designated in these Bylaws and as from time to time may be assigned to him by the chief executive officer or the Board of Directors. The Assistant Secretaries shall exercise the powers of the Secretary during that officer&#8217;s absence or inability or refusal to act. ARTICLE V &#8211; INDEMNIFICATION OF OFFICERS, DIRECTORS, EMPLOYEES AND AGENTS Section 1. INDEMNIFICATION: The Corporation shall indemnify and hold harmless, to the fullest extent authorized by the Delaware General Corporation Law, as the same exists or may hereafter be amended (but, in the case of any such amendment, only to the extent that such amendment permits the Corporation to provide broader indemnification rights than such law permitted the Corporation to provide prior to such amendment), any person who was or is a party or threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than action by or in the right of the Corporation) by reason of the fact that he is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise (an &#8220;indemnitee&#8221;), against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by an indemnitee in connection with such action, suit or proceeding if such indemnitee acted in good faith and in a manner such indemnitee reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe such conduct was unlawful; provided, however, that, except as provided in Article 5.3 with respect to proceedings to enforce rights to indemnification, the Corporation shall indemnify any such indemnitee in connection with a proceeding (or part thereof) initiated by such indemnitee only if such proceeding (or part thereof) was authorized by the Board of Directors of the Corporation. The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the indemnitee did not act in good faith and in a manner which such indemnitee reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that such conduct was unlawful. The right to indemnification conferred by this Article 5.1 shall vest at the time an individual becomes an indemnitee. Section 2. RIGHT TO ADVANCEMENT OF EXPENSES: The right to indemnification conferred in Article 5.1 shall include the right to be paid by the Corporation the expenses incurred in defending any such proceeding in advance of its final disposition (hereinafter an &#8220;advancement of expenses&#8221;); provided, however, that, if the Delaware General Corporation Law requires, an advancement of expenses incurred by an indemnitee in his or her capacity as a director or officer (and not in any other capacity in which service was or is rendered by such indemnitee, including, without limitation, service to an employee benefit plan) shall be made only upon delivery to the Corporation of an undertaking (hereinafter an &#8220;undertaking&#8221;), by or on behalf of such indemnitee, to repay all amounts so advanced if it shall ultimately be determined by final judicial decision from which there is no further right to appeal (hereinafter a &#8220;final adjudication&#8221;) that such indemnitee is not entitled to be indemnified for such expenses under this Article 5.2 or otherwise. The rights to indemnification and to the advancement of expenses conferred in Articles 5.1 and 5.2 shall be contract rights and such rights shall continue as to an indemnitee who has ceased to be a director, officer, employee, or agent and shall inure to the benefit of the indemnitee&#8217;s heirs, executors, and administrators. 18 Section 3. RIGHT OF INDEMNITEE TO BRING SUIT: If a claim under Article 5.1 or 5.2 is not paid in full by the Corporation within sixty (60) days after a written claim has been received by the corporation, except in the case of a claim for an advancement of expenses, in which case the applicable period shall be twenty (20) days, the indemnitee may at any time thereafter bring suit against the Corporation to recover the unpaid amount of the claim. If successful in whole or in part in any such suit, or in a suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the indemnitee shall be entitled to be paid also the expense of prosecuting or defending such suit. In (i) any suit brought by the indemnitee to enforce a right to indemnification hereunder (but not in a suit brought by the indemnitee to enforce a right to an advancement of expenses) it shall be a defense that, and (ii) in any suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the Corporation shall be entitled to recover such expenses upon a final adjudication that, the indemnitee has not met any applicable standard for indemnification set forth in the Delaware General Corporation Law. Neither the failure of the Corporation (including its Board of Directors, independent legal counsel, or its stockholders) to have made a determination prior to the commencement of such suit that indemnification of the indemnitee is proper in the circumstances because the indemnitee has met the applicable standard of conduct set forth in the Delaware General Corporation Law, nor an actual determination by the Corporation (including its Board of Directors, independent legal counsel, or its stockholders) that the indemnitee has not met such applicable standard of conduct, shall create a presumption that the indemnitee has not met the applicable standard of conduct or, in the case of such a suit brought by the indemnitee, be a defense to such suit. In any suit brought by the indemnitee to enforce a right to indemnification or to an advancement of expenses hereunder, or brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the burden of proving that the indemnitee is not entitled to indemnification, or to such advancement of expenses, under this Article 5 or otherwise shall be on the Corporation. Section 4. NON-EXCLUSIVITY OF RIGHTS: The rights to indemnification and to the advancement of expenses conferred in this Article 5 shall not be exclusive of any other right which any person may have or hereafter acquire under any statute, the corporation&#8217;s Certificate of Incorporation, Bylaws, agreement, vote of stockholders, or disinterested directors or otherwise. Section 5. INSURANCE: The Corporation may maintain insurance, at its expense, to protect itself and any director, officer, employee, or agent of the Corporation or another corporation, partnership, joint venture, trust, or other enterprise against any expense, liability or loss, whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the Delaware General Corporation Law. Section 6. INDEMNIFICATION OF EMPLOYEES AND AGENTS OF THE CORPORATION: The Corporation may, to the extent authorized from time to time by the Board of Directors, grant rights to indemnification and to the advancement of expenses to any employee or agent of the Corporation to the fullest extent of the provisions of this Article 5 with respect to the indemnification and advancement of expenses of directors and officers of the Corporation. Section 7. AMENDMENT OR MODIFICATION: This Article 5 may be altered or amended at any time as provided in these Bylaws, but no such amendment shall have the effect of diminishing the rights of any person who is or was an officer or director as to any acts or omissions taken or omitted to be taken prior to the effective date of such amendment. ARTICLE VI &#8211; CONTRACTS, LOANS, CHECKS AND DEPOSITS 19 Section 1. CONTRACTS: The Board of Directors may authorize any officer or officers, agent or agents, to enter into any contract or execute and deliver any instrument in the name of on behalf of the corporation, and such authority may be general or confined to specific instances. Section 2. LOANS: No loans shall be contracted on behalf of the Corporation and no evidences of indebtedness shall be issued in its name unless authorized by a resolution of the Board of Directors. Such authority may be general or confined to specific instances. Section 3. CHECKS, DRAFTS, ETC.: All checks, drafts, or other orders for the payment of money, notes or other evidences of indebtedness issued in the name of the corporation, shall be signed by such officer or officers, agent or agents of the Corporation and in such manner as shall from time to time be determined by resolution of the Board of Directors. Section 4. DEPOSITS: All funds of the Corporation not otherwise employed shall be deposited from time to time to the credit of the Corporation in such banks, trust companies or other depositories as the Board of Directors may select. ARTICLE VII CERTIFICATES FOR SHARES AND THEIR TRANSFER Section 1. CERTIFICATES FOR SHARES: Notwithstanding any other provision in these Bylaws, any or all classes and series of shares of the Corporation, or any part thereof, may be represented by uncertificated shares, except that shares represented by a certificate that is issued and outstanding shall continue to be represented thereby until the certificate is surrendered to the corporation. Within a reasonable time after the issuance or transfer of uncertificated shares, the Corporation shall send to the registered owner thereof, a written notice containing the information required to be set forth or stated on certificates. The rights and obligations of the holders of shares represented by certificates and the rights and obligations of the holders of uncertificated shares of the same class or series shall be identical. If certificates for the shares of the Corporation are issued, each will be in such form as shall be determined by the Board of Directors. Such certificates shall be signed by the president or vice president and countersigned by the secretary or an assistant secretary and sealed with the Corporation seal or a facsimile thereof. The signatures of such officers upon a certificate may be facsimile signatures if the certificate is manually signed on behalf of a transfer agent or a registrar other than the Corporation or an employee of the Corporation. Each certificate for shares shall be consecutively numbered or otherwise identified. The name and address of the person to whom the shares represented thereby are issued, with the number of shares and date of issue, shall be entered on the stock transfer books of the Corporation. All certificates surrendered to the Corporation for transfer shall be cancelled and no new certificates shall be issued until the former certificates for a like number of shares shall have been surrendered and cancelled, except that in case of a lost, destroyed or mutilated certificate, a new one may be issued therefor upon such terms and indemnity to the Corporation as the Board of Directors may prescribe. Section 2. TRANSFER OF SHARES: Transfer of shares of the Corporation shall be made only on the stock transfer books of the Corporation by the holder of record thereof or by his legal representative, who shall furnish proper evidence of authority to transfer, or by his attorney thereunto authorized by power of attorney duly executed and filed with the secretary of the corporation, and on surrender for cancellation of the certificate for such shares. The person in whose name shares stand on the books of the Corporation shall be deemed by the Corporation to be the owner thereof for all purposes. ARTICLE VIII &#8211; FISCAL YEAR Section 1. The fiscal year of the Corporation shall be determined by the Board of Directors. 20 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- literacompareredline-pro006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="literacompareredline-pro006.jpg" title="slide6" width="1055" height="4095">
<DIV><FONT size="1" style="font-size:1pt;color:white">ARTICLE IX &#8211; DIVIDENDS Section 1. The Board of Directors may, from time to time, declare and the Corporation may pay dividends on its outstanding shares in the manner, and upon the terms and conditions provided by law and its Certificate of Incorporation. ARTICLE X &#8211; CORPORATE SEAL Section 1. The Board of Directors shall provide a corporate seal which shall be circular in form and shall have inscribed thereon the name of the Corporation, the year of its incorporation and the words, &#8220;Corporate Seal,&#8221; and &#8220;Delaware.&#8221; ARTICLE XI &#8211; WAIVER OF NOTICE Section 1. Whenever notice is required to be given by law, the Certificate of Incorporation or under any of the provisions of these Bylaws, a written waiver thereof, signed by the person entitled to notice, whether before or after the time stated therein, shall be deemed equivalent to notice. Attendance of a person at a meeting shall constitute a waiver of notice of such meeting, except when the person attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the stockholders, directors, or members of a committee of directors need be specified in any written waiver of notice unless so required by the Certificate of Incorporation or the Bylaws. ARTICLE XII &#8211; FORUM FOR ADJUDICATION OF DISPUTES Section 1. Unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Corporation to the Corporation or the Corporation&#8217;s stockholders, (iii) any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law or the Certificate of Incorporation or Bylaws (as either may be amended from time to time), or (iv) any action asserting a claim governed by the internal affairs doctrine shall be the Court of Chancery in the State of Delaware (or, if the Court of Chancery does not have jurisdiction, the federal district court for the District of Delaware). If any action the subject matter of which is within the scope of the preceding sentence is filed in a court other than a court located within the State of Delaware (a &#8220;Foreign Action&#8221;) in the name of any stockholder, such stockholder shall be deemed to have consented to (i) the personal jurisdiction of the state and federal courts located within the State of Delaware in connection with any action brought in any such court to enforce the preceding sentence and (ii) having service of process made upon such stockholder in any such action by service upon such stockholder&#8217;s counsel in the Foreign Action as agent for such stockholder. ARTICLE XIII &#8211; AMENDMENTS Section 1. Stockholders of the Corporation holding at least 66 2/3% of the Corporation&#8217;s outstanding voting stock shall have the power to adopt, amend or repeal the Bylaws. To the extent provided in the Corporation&#8217;s Certificate of Incorporation, the Board of Directors of the Corporation shall also have the power to adopt, amend or repeal the Bylaws of the Corporation. 21 22 0 Table Insert Changes: 0 Table Delete 0 Add Intelligent Table Comparison: Active Table moves to 44 0 Summary report: Litera Compare for Word 11.3.0.46 Document comparison done on 3/25/2024 2:21:46 PM Table moves from 0 Delete Embedded Graphics (Visio, ChemDraw, Images etc.) 45 0 Original DMS: iw://us-digitalfile.reedsmith.com/US_ACTIVE/177079042/1 Embedded Excel 0 Move From Format changes 0 0 Total Changes: Modified DMS: iw://us-digitalfile.reedsmith.com/US_ACTIVE/177079042/4 89 Move To Style name: ReedSmith Standard </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>prophase-director2022plano.htm
<DESCRIPTION>EX-10.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ief024bfb59644ceb99bb2771d609a911_1"></div><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.6</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">PROPHASE LABS, INC.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">DIRECTORS&#8217; EQUITY COMPENSATION PLAN</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">OPTION AWARD AGREEMENT</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">THIS AGREEMENT (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), is made effective as of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">____</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">th day of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">_______</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Date of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">_____________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">RECITALS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, the Company has adopted 2022 Directors&#8217; Equity Compensation Plan (as amended from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), which Plan is incorporated herein by reference and made a part of this Agreement.&#160;&#160;Capitalized terms not otherwise defined herein shall have the same meanings as in the Plan&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, the Committee has determined that it would be in the best interests of the Company and its shareholders to grant the option provided for herein to the Participant pursuant to the Plan and the terms set forth herein.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOW THEREFORE, in consideration of the mutual covenants hereinafter set forth, the parties agree as follows&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Grant of the Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.&#160;&#160;The Company hereby grants to the Participant the right and option (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) to purchase, on the terms and conditions hereinafter set forth, all or any part of an aggregate of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">__________ </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares, subject to adjustment as set forth in the Plan.&#160;&#160;The purchase price of the Shares subject to the Option shall be $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">_________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> per Share (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Option Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).&#160;&#160;The Option is intended to be a non-qualified stock option, and is not intended to be treated as an option that complies with Section 422 of the Internal Revenue Code of 1986, as amended.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;All Options granted pursuant to the Plan shall vest and become exercisable&#58; ________</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160; </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Period of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.&#160;&#160;Subject to the provisions of the Plan and this Agreement, the Participant may exercise all or any part of the vested portion of the Option at any time prior to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">earliest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> to occur of&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:18pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)&#160;&#160;the seventh anniversary of the Date of Grant&#59;</font></div><div style="padding-left:18pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:18pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)&#160;&#160;one year following the date of the Participant&#8217;s separation from service due to death or Disability&#59; and</font></div><div style="padding-left:18pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;</font></div><div style="padding-left:18pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)&#160;&#160;the date of the Participant&#8217;s separation from service by the Company for Cause.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For purposes of this agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; shall mean (i) the willful failure or refusal by such Participant to perform his or her duties to the Company or its Affiliates (other than any such failure resulting from such Participant&#8217;s incapacity due to physical or mental illness), which has not ceased within ten days after a written demand for substantial performance is delivered to such Participant by the Company, which demand identifies the manner in which the Company believes that such Participant has not performed such duties&#59; (ii) the willful engaging by such Participant in misconduct which is materially injurious to the Company or its Affiliates, monetarily or otherwise (including breach of any confidentiality or non-competition covenants to which such Participant is bound)&#59; (iii) the conviction of such Participant of, or the entering of a plea of nolo contendere by such Participant with respect to, a felony or to any crime which is materially injurious to the Company or its Affiliates&#59; or (iv) substantial or repeated acts of dishonesty by such Participant in the performance of his&#47;her duties to the Company or its Affiliates. The determination of the existence of Cause shall be made by the remainder of the Board in good faith.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:18pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)&#160;&#160;Subject to Section 3(a), the vested portion of the Option may be exercised by delivering to the Company at its principal office written notice of intent to so exercise&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> that, the Option may be exercised with respect to whole Shares only.&#160;&#160;Such notice shall specify the number of Shares for which the Option is being exercised and shall be accompanied by payment in full of the Option Price.&#160;&#160;The payment of the Option Price may be made at the election of the Participant (i) in cash or its equivalent (e.g., by check), (ii) to the extent permitted by the Committee, in Shares having a Fair Market Value equal to the aggregate Option Price for the Shares being purchased and satisfying such other requirements as may be imposed by the Committee&#59; provided, that such Shares have been held by the Participant for no less than six months (or such other period as established from time to time by the Committee in order to avoid adverse accounting treatment applying generally accepted accounting principles), (iii) partly in cash and, to the extent permitted by the Committee, partly in such Shares, (iv) if there is a public market for the Shares at such time, through the delivery of irrevocable instructions to a broker to sell Shares obtained upon the exercise of the Option and to deliver promptly to the Company an amount out of the proceeds of such Sale equal to the aggregate option price for the Shares being purchased, or (v) through a &#8220;net settlement&#8221; as described in Section 6(c) of the Plan.&#160;&#160;No Participant shall have any rights to dividends or other rights of a stockholder with respect to Shares subject to an Option until the Participant has given written notice of exercise of the Option, paid in full for such Shares and, if applicable, has satisfied any other conditions imposed by the Committee pursuant to the Plan.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160; </font></div><div style="padding-left:18pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)&#160;&#160;Notwithstanding any other provision of the Plan or this Agreement to the contrary, the Option may not be exercised prior to the completion of any registration or qualification of the Option or the Shares under applicable state and federal securities or other laws, or under any ruling or regulation of any governmental body or national securities exchange that the Committee shall in its sole discretion determine to be necessary or advisable.</font></div><div style="padding-left:18pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;</font></div><div style="padding-left:18pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)&#160;&#160;In the event of the Participant&#8217;s death, the vested portion of the Option shall remain exercisable by the Participant&#8217;s executor or administrator, or the person or persons to whom the Participant&#8217;s rights under this Agreement shall pass by will or by the laws of descent and distribution as the case may be, to the extent set forth in Section 3(a).&#160;&#160;Any heir or legatee of the Participant shall take rights herein granted subject to the terms and conditions hereof.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.&#160;&#160;Upon a Change of Control (as defined by the Plan), the terms of the Plan shall apply.&#160;&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Option Recovery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.&#160;&#160;If the Committee determines that the Participant (a) engaged in conduct that constituted Cause as defined in Section 3(a) of this Agreement at any prior to the Participant&#8217;s termination of services, (b) engaged in conduct during the 6 month period after the Participant&#8217;s termination of services that would have constituted Cause if the Participant had not ceased to provide services, or (c) violates the terms of any non-compete agreement, non-solicitation agreement, confidentiality agreement, or any other restriction on the Participant&#8217;s post-termination activities established under any agreement with the Company or other Company policy or arrangement during the 6 months after the Participant&#8217;s ceases to provide services to the Company, then (i) any Option held by the Participant shall immediately terminate, and the Participant shall automatically forfeit all Shares underlying any exercised portion of an Option for which the Company has not yet delivered the Share certificates, upon refund by the Company of the Exercise Price paid by the Participant for such Shares and (ii) the Participant shall return any Shares received upon exercise of this Option or repay to the Company any proceeds received from the sale of other disposition of the Shares transferred pursuant to this Option less the Exercise Price.&#160;&#160;&#160;Upon any exercise of an Option, the Company may withhold delivery of share certificates pending resolution of an inquiry that could lead to a finding resulting in a forfeiture under this Section.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.&#160;&#160;The Option may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Participant otherwise than by will or by the laws of descent and distribution, and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company or any Affiliate&#59; provided that the designation of a beneficiary shall not constitute an assignment, alienation, pledge, attachment, sale, transfer or encumbrance.&#160;&#160;No such permitted transfer of the Option to heirs or legatees of the Participant shall be effective to bind the Company unless the Committee shall have been furnished with written notice thereof and a copy of such evidence as the Committee may deem necessary to establish the validity of the transfer and the acceptance by the transferee or transferees of the terms and conditions hereof.&#160;&#160;During the Participant&#8217;s lifetime, the Option is exercisable only by the Participant.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The Participant may be required to pay to the Company or any Affiliate and the Company shall have the right and is hereby authorized to withhold, any applicable withholding taxes in respect of the Option, its exercise or any payment or transfer under or with respect to the Option and to take such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other action as may be necessary in the opinion of the Committee to satisfy all obligations for the payment of such withholding taxes.</font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.&#160;&#160;Upon the acquisition of any Shares pursuant to the exercise of the Option, the Participant will make or enter into such written representations, warranties and agreements as the Committee may reasonably request in order to comply with applicable securities laws or with this Agreement.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.&#160;&#160;Any notice necessary under this Agreement shall be addressed to the Company in care of its Secretary at the principal executive office of the Company and to the Participant at the address appearing in the personnel records of the Company for the Participant or to either party at such other address as either party hereto may hereafter designate in writing to the other.&#160;&#160;Any such notice shall be deemed effective upon receipt thereof by the addressee.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Choice of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.&#160;&#160;This Agreement shall be governed by and construed in accordance with the laws of the state of Delaware without regard to conflicts of laws.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Option Subject to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.&#160;&#160;By entering into this Agreement the Participant agrees and acknowledges that the Participant has received and read a copy of the Plan.&#160;&#160;The Option is subject to the Plan.&#160;&#160;The terms and provisions of the Plan, as they may be amended from time to time, are hereby incorporated herein by reference.&#160;&#160;In the event of a conflict between any term or provision contained herein and a term or provision of the Plan, the applicable terms and provisions of the Plan will govern and prevail.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160; 12.&#160;&#160;&#160;&#160;13. Section 409A. The Company intends that income realized by the Participant pursuant to the Plan and this Agreement will not be subject to taxation under Section 409A of the Code. The provisions of the Plan and this Agreement shall be interpreted and construed in favor of satisfying any applicable requirements of Section 409A of the Code. In the event that it is reasonably determined by the Committee that, as a result of Section 409A of the Code, any payment or delivery of Shares in respect of the Option may not be made at the time contemplated by the terms of the Plan or the this Agreement, as the case may be, without causing Participant to be subject to taxation under Section 409A of the Code, the Company shall use reasonably commercial efforts to make such payment or delivery of Shares on the first day that would not result in the Participant incurring any tax liability under Section 409A of the Code. If Participant is a &#8220;specified employee&#8221; (within the meaning of Section 409A(a)(2)(B)(i) of the Code), any payment and&#47;or delivery of Shares in respect of the Option that are linked to the date of the Participant&#8217;s separation from service shall not be made prior to the date which is six (6) months after the date of such Participant&#8217;s separation from service from the Company, determined in accordance with Section 409A of the Code and the regulations promulgated thereunder. The Company, in its reasonable discretion, may amend (including retroactively) the Plan and this Agreement in order to conform to the applicable requirements of Section 409A of the Code, including amendments to facilitate the Participant&#8217;s ability to avoid taxation under Section 409A of the Code. However, the preceding provisions shall not be construed as a guarantee by the Company of any particular tax result for income realized by the Participant pursuant to the Plan or this Agreement. In any event, the Company shall be responsible for the payment of any applicable taxes on income realized by the Participant pursuant to the Plan or this Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160; </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Signature in Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.&#160;&#160;This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Signatures on next page.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160; </font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160; </font></div><div><font><br></font></div><div style="text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div><hr style="page-break-after:always"><div style="background-color:#ffffff"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties have caused this Agreement to be effective as of the day and year first above written.</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.420%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPHASE LABS, INC.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;&#160;</font></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PARTICIPANT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;&#160;</font></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160; </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>prophase-formof2022planinc.htm
<DESCRIPTION>EX-10.4
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ibbfaa7b1d5214182958c9eb517d73b11_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.5</font></div><div style="margin-bottom:12pt;padding-right:-9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPHASE LABS, INC.</font></div><div style="margin-bottom:12pt;padding-right:-9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022 EQUITY COMPENSATION PLAN</font></div><div style="margin-bottom:12pt;padding-right:-9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPTIONS AWARD AGREEMENT</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProPhase Labs, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) has granted you an Incentive Stock Option (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) under the 2022 Equity Compensation Plan (as amended from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).  The terms of the Option are set forth in the Option Grant Agreement provided to you (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).  The following provides a summary of the key terms of the Option&#59; however, you should read the entire Agreement, along with the terms of the Plan, to fully understand the Option.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">SUMMARY OF STOCK OPTION GRANT</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Option Number&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Participant&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date of Grant&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vesting Schedule&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise Price Per Share&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Options Granted&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term&#47;Expiration Date&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div id="ibbfaa7b1d5214182958c9eb517d73b11_4"></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">PROPHASE LABS, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2022 EQUITY COMPENSATION PLAN </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">OPTION AWARD AGREEMENT<br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">THIS AGREEMENT (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), is made effective as of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">___</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">th day of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">______</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Date of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">_______________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)&#58;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">R E C I T A L S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, the Company has adopted The 2022 Equity Compensation Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), which Plan is incorporated herein by reference and made a part of this Agreement.  Capitalized terms not otherwise defined herein shall have the same meanings as in the Plan&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, the Committee has determined that it would be in the best interests of the Company and its shareholders to grant the option provided for herein to the Participant pursuant to the Plan and the terms set forth herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOW THEREFORE, in consideration of the mutual covenants hereinafter set forth, the parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Grant of the Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The Company hereby grants to the Participant the right and option (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) to purchase, on the terms and conditions hereinafter set forth, all or any part of an aggregate of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">_______ </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares, subject to adjustment as set forth in the Plan.  The purchase price of the Shares subject to the Option shall be </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$____</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> per Share (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Option Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).  The Option is intended to be an incentive stock option, and is not intended to be treated as an option that complies with Section 422 of the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">All Options granted pursuant to the Plan shall vest and become exercisable in accordance with the following schedule&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">________________________</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt;text-decoration:underline">Exercise of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt;text-decoration:underline">Period of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Subject to the provisions of the Plan and this Agreement, the Participant may exercise all or any part of the Vested portion of the Option at any time prior to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">earliest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> to occur of&#58;</font></div><div style="margin-bottom:12pt;padding-left:17.25pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:22.32pt">the seventh anniversary of the Date of Grant&#59;</font></div><div style="margin-bottom:12pt;padding-left:17.25pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:19.55pt">one year following the date of the Participant&#8217;s termination of Employment due to death or Disability&#59;</font></div><div style="margin-bottom:12pt;padding-left:17.25pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.78pt">three months following the date of the Participant&#8217;s termination of Employment by the Company without Cause&#59;</font></div><div style="margin-bottom:12pt;padding-left:17.25pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iv)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:17.32pt">the date of the Participant&#8217;s termination of Employment by the Company for Cause or by the Participant for any reason.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For purposes of this agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; shall mean &#8220;Cause&#8221; as defined in any employment agreement then in effect between the Participant and the Company or if not defined therein or, if there shall be no such agreement, (i) the willful failure or refusal by such Participant to perform his or her duties to the Company or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:100%">- 2 -&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">its Affiliates (other than any such failure resulting from such Participant&#8217;s incapacity due to physical or mental illness), which has not ceased within ten days after a written demand for substantial performance is delivered to such Participant by the Company, which demand identifies the manner in which the Company believes that such Participant has not performed such duties&#59; (ii) the willful engaging by such Participant in misconduct which is materially injurious to the Company or its Affiliates, monetarily or otherwise (including breach of any confidentiality or non-competition covenants to which such Participant is bound)&#59; (iii) the conviction of such Participant of, or the entering of a plea of nolo contendere by such Participant with respect to, a felony or to any crime which is materially injurious to the Company or its Affiliates&#59; or (iv) substantial or repeated acts of dishonesty by such Participant in the performance of his&#47;her duties to the Company or its Affiliates.  The determination of the existence of Cause shall be made by the Committee in good faith.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:17.25pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:22.32pt">Subject to Section 3(a), the Vested Portion of the Option may be exercised by delivering to the Company at its principal office written notice of intent to so exercise&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> that, the Option may be exercised with respect to whole Shares only.  Such notice shall specify the number of Shares for which the Option is being exercised and shall be accompanied by payment in full of the Option Price.  The payment of the Option Price may be made at the election of the Participant (i) in cash or its equivalent (e.g., by check), (ii) to the extent permitted by the Committee, in Shares having a Fair Market Value equal to the aggregate Option Price for the Shares being purchased and satisfying such other requirements as may be imposed by the Committee&#59; provided, that such Shares have been held by the Participant for no less than six months (or such other period as established from time to time by the Committee in order to avoid adverse accounting treatment applying generally accepted accounting principles), (iii) partly in cash and, to the extent permitted by the Committee, partly in such Shares, or (iv) if there is a public market for the Shares at such time, through the delivery of irrevocable instructions to a broker to sell Shares obtained upon the exercise of the Option and to deliver promptly to the Company an amount out of the proceeds of such Sale equal to the aggregate option price for the Shares being purchased.  No Participant shall have any rights to dividends or other rights of a stockholder with respect to Shares subject to an Option until the Participant has given written notice of exercise of the Option, paid in full for such Shares and, if applicable, has satisfied any other conditions imposed by the Committee pursuant to the Plan.</font></div><div style="margin-bottom:12pt;padding-left:17.25pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:19.55pt">Notwithstanding any other provision of the Plan or this Agreement to the contrary, the Option may not be exercised prior to the completion of any registration or qualification of the Option or the Shares under applicable state and federal securities or other laws, or under any ruling or regulation of any governmental body or national securities exchange that the Committee shall in its sole discretion determine to be necessary or advisable.</font></div><div style="margin-bottom:12pt;padding-left:17.25pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.78pt">In the event of the Participant&#8217;s death, the Vested Portion of the Option shall remain exercisable by the Participant&#8217;s executor or administrator, or the person or persons to whom the Participant&#8217;s rights under this Agreement shall pass by will or by the laws of descent and distribution as the case may be, to the extent set forth in Section 3(a).  Any heir or legatee of the Participant shall take rights herein granted subject to the terms and conditions hereof.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Upon a Change of Control (as defined by the Plan), the terms of the Plan shall apply.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt;text-decoration:underline">Option Recovery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  If the Committee determines that the Participant (a) engaged in conduct that constituted Cause as defined in Section 3(a) of this Agreement at any time prior to the Participant&#8217;s termination of services, (b) engaged in conduct during the 6 month period after the Participant&#8217;s termination of services that would have constituted Cause if the Participant had not ceased to provide services, or (c) violates the terms of any non-compete agreement, non-solicitation agreement, confidentiality agreement, or any other restriction on the Participant&#8217;s post-termination activities established under any agreement with the Company or other Company policy or arrangement during the 6 months after the Participant&#8217;s ceases to provide services to the Company, then (i) any Option held by the Participant shall immediately terminate, and the Participant shall automatically forfeit all Shares underlying any exercised portion of an Option for which the Company has not yet delivered the Share certificates, upon refund by the Company of the Exercise Price paid by the Participant for such Shares and (ii) the Participant shall return any Shares received upon exercise of this Option or repay to the Company any proceeds received from the sale of other disposition of the Shares transferred pursuant to this Option less the Exercise Price.   Upon any exercise of an Option, the Company may withhold delivery of share certificates pending resolution of an inquiry that could lead to a finding resulting in a forfeiture under this Section.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt;text-decoration:underline">No Right to Continued Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The granting of the Option evidenced hereby and this Agreement shall impose no obligation on the Company or any Affiliate to continue the Employment of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:100%">- 3 -&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant and shall not lessen or affect the Company&#8217;s or its Affiliate&#8217;s right to terminate the Employment of such Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt;text-decoration:underline">Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The Option may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Participant otherwise than by will or by the laws of descent and distribution, and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company or any Affiliate&#59; provided that the designation of a beneficiary shall not constitute an assignment, alienation, pledge, attachment, sale, transfer or encumbrance.  No such permitted transfer of the Option to heirs or legatees of the Participant shall be effective to bind the Company unless the Committee shall have been furnished with written notice thereof and a copy of such evidence as the Committee may deem necessary to establish the validity of the transfer and the acceptance by the transferee or transferees of the terms and conditions hereof.  During the Participant&#8217;s lifetime, the Option is exercisable only by the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The Participant may be required to pay to the Company or any Affiliate and the Company shall have the right and is hereby authorized to withhold, any applicable withholding taxes in respect of the Option, its exercise or any payment or transfer under or with respect to the Option and to take such other action as may be necessary in the opinion of the Committee to satisfy all obligations for the payment of such withholding taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Upon the acquisition of any Shares pursuant to the exercise of the Option, the Participant will make or enter into such written representations, warranties and agreements as the Committee may reasonably request in order to comply with applicable securities laws or with this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.5pt"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Any notice necessary under this Agreement shall be addressed to the Company in care of its Secretary at the principal executive office of the Company and to the Participant at the address appearing in the personnel records of the Company for the Participant or to either party at such other address as either party hereto may hereafter designate in writing to the other.  Any such notice shall be deemed effective upon receipt thereof by the addressee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.5pt"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Choice of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  This Agreement shall be governed by and construed in accordance with the laws of the state of Delaware without regard to conflicts of laws.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.5pt"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Option Subject to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  By entering into this Agreement the Participant agrees and acknowledges that the Participant has received and read a copy of the Plan.  The Option is subject to the Plan.  The terms and provisions of the Plan, as they may be amended from time to time, are hereby incorporated herein by reference.  In the event of a conflict between any term or provision contained herein and a term or provision of the Plan, the applicable terms and provisions of the Plan will govern and prevail.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.5pt;text-decoration:underline">Section 409A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> The Company intends that income realized by the Participant pursuant to the Plan and this Agreement will not be subject to taxation under Section 409A of the Code. The provisions of the Plan and this Agreement shall be interpreted and construed in favor of satisfying any applicable requirements of Section 409A of the Code. In the event that it is reasonably determined by the Committee that, as a result of Section 409A of the Code, any payment or delivery of Shares in respect of the Option may not be made at the time contemplated by the terms of the Plan or this Agreement, as the case may be, without causing Participant to be subject to taxation under Section 409A of the Code, the Company shall use reasonably commercial efforts to make such payment or delivery of Shares on the first day that would not result in the Participant incurring any tax liability under Section 409A of the Code. If Participant is a &#8220;specified employee&#8221; (within the meaning of Section 409A(a)(2)(B)(i) of the Code), any payment and&#47;or delivery of Shares in respect of the Option that are linked to the date of the Participant&#8217;s separation from service shall not be made prior to the date which is six (6) months after the date of such Participant&#8217;s separation from service from the Company, determined in accordance with Section 409A of the Code and the regulations promulgated thereunder. The Company, in its reasonable discretion, may amend (including retroactively) the Plan or this Agreement in order to conform to the applicable requirements of Section 409A of the Code, including amendments to facilitate the Participant&#8217;s ability to avoid taxation under Section 409A of the Code. However, the preceding provisions shall not be construed as a guarantee by the Company of any particular tax result for income realized by the Participant pursuant to the Plan or this Agreement. In any event, the Company shall be responsible for the payment of any applicable taxes on income realized by the Participant pursuant to the Plan or this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.5pt;text-decoration:underline">Signature in Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Signatures on next page.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:100%">- 4 -&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:100%">- 5 -&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties have caused this Agreement to be effective as of the day and year first above written.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font><br></font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPHASE LABS, INC.</font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><br>____________________________________<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; </font></div><div style="margin-bottom:18pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:18pt;padding-left:252pt"><font><br></font></div><div style="margin-bottom:18pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PARTICIPANT<br><br></font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">____________________________________<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;  </font></div><div style="padding-left:252pt"><font><br></font></div><div style="margin-bottom:18pt;padding-left:252pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:100%">- 6 -&#160;&#160;&#160;&#160;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>prophase-formof2022plannqo.htm
<DESCRIPTION>EX-10.5
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i97e136914e0441299ead9918948ef461_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.4</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">PROPHASE LABS, INC.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2022 EQUITY COMPENSATION PLAN</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">OPTION AWARD AGREEMENT</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">THIS AGREEMENT (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), is made effective as of the __th day of ______ (hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Date of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">_______</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">RECITALS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, the Company has adopted The 2022 Equity Compensation Plan (as amended from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), which Plan is incorporated herein by reference and made a part of this Agreement. Capitalized terms not otherwise defined herein shall have the same meanings as in the Plan&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WHEREAS, the Committee has determined that it would be in the best interests of the Company and its shareholders to grant the option provided for herein to the Participant pursuant to the Plan and the terms set forth herein.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOW THEREFORE, in consideration of the mutual covenants hereinafter set forth, the parties agree as follows&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Grant of the Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The Company hereby grants to the Participant the right and option (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) to purchase, on the terms and conditions hereinafter set forth, all or any part of an aggregate of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">_____ </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares, subject to adjustment as set forth in the Plan. The purchase price of the Shares subject to the Option shall be $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">_______</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> per Share (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Option Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;). The Option is intended to be a non-qualified stock option, and is not intended to be treated as an option that complies with Section 422 of the Internal Revenue Code of 1986, as amended.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  All Options granted pursuant to the Plan shall vest and become exercisable in accordance with the following schedule&#58;  </font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">______________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Period of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Subject to the provisions of the Plan and this Agreement, the Participant may exercise all or any part of the Vested Portion of the Option at any time prior to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">earliest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> to occur of&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i) the seventh anniversary of the Date of Grant&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii) one year following the date of the Participant&#8217;s termination of service due to death or Disability&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii) three months following the date of the Participant&#8217;s termination of service by the Company without Cause&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iv) the date of the Participant&#8217;s termination of service by the Company for Cause or by the Participant for any reason.</font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For purposes of this agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; shall mean &#8220;Cause&#8221; as defined in any services agreement then in effect between the Participant and the Company or if not defined therein or, if there shall be no such agreement, (i) the willful failure or refusal by such Participant to perform his or her duties to the Company or its Affiliates (other than any such failure resulting from such Participant&#8217;s incapacity due to physical or mental illness), which has not ceased within ten days after a written demand for substantial performance is delivered to such Participant by the Company, which demand identifies the manner in which the Company believes that such Participant has not performed such duties&#59; (ii) the willful engaging by such Participant in misconduct which is materially injurious to the Company or its Affiliates, monetarily or otherwise (including breach of any confidentiality or non-competition covenants to which such Participant is bound)&#59; (iii) the conviction of such Participant of, or the entering of a plea of nolo contendere by such Participant with respect to, a felony or to any crime which is materially injurious to the Company or its Affiliates&#59; or (iv) substantial or repeated acts of dishonesty </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">by such Participant in the performance of his&#47;her duties to the Company or its Affiliates. The determination of the existence of Cause shall be made by the Committee in good faith.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:39.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i) Subject to Section 3(a), the Vested Portion of the Option may be exercised by delivering to the Company at its principal office written notice of intent to so exercise&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> that, the Option may be exercised with respect to whole Shares only. Such notice shall specify the number of Shares for which the Option is being exercised and shall be accompanied by payment in full of the Option Price. The payment of the Option Price may be made at the election of the Participant (i) in cash or its equivalent (e.g., by check), (ii) to the extent permitted by the Committee, in Shares having a Fair Market Value equal to the aggregate Option Price for the Shares being purchased and satisfying such other requirements as may be imposed by the Committee&#59; provided, that such Shares have been held by the Participant for no less than six months (or such other period as established from time to time by the Committee in order to avoid adverse accounting treatment applying generally accepted accounting principles), (iii) partly in cash and, to the extent permitted by the Committee, partly in such Shares, or (iv) if there is a public market for the Shares at such time, through the delivery of irrevocable instructions to a broker to sell Shares obtained upon the exercise of the Option and to deliver promptly to the Company an amount out of the proceeds of such Sale equal to the aggregate option price for the Shares being purchased. No Participant shall have any rights to dividends or other rights of a stockholder with respect to Shares subject to an Option until the Participant has given written notice of exercise of the Option, paid in full for such Shares and, if applicable, has satisfied any other conditions imposed by the Committee pursuant to the Plan.&#160;</font></div><div style="padding-left:39.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:39.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii) Notwithstanding any other provision of the Plan or this Agreement to the contrary, the Option may not be exercised prior to the completion of any registration or qualification of the Option or the Shares under applicable state and federal securities or other laws, or under any ruling or regulation of any governmental body or national securities exchange that the Committee shall in its sole discretion determine to be necessary or advisable.</font></div><div style="padding-left:39.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:39.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii) In the event of the Participant&#8217;s death, the Vested Portion of the Option shall remain exercisable by the Participant&#8217;s executor or administrator, or the person or persons to whom the Participant&#8217;s rights under this Agreement shall pass by will or by the laws of descent and distribution as the case may be, to the extent set forth in Section 3(a). Any heir or legatee of the Participant shall take rights herein granted subject to the terms and conditions hereof.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Upon a Change of Control (as defined by the Plan), the terms of the Plan shall apply.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Option Recovery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. If the Committee determines that the Participant (a) engaged in conduct that constituted Cause as defined in Section 3(a) of this Agreement at any prior to the Participant&#8217;s termination of services, (b) engaged in conduct during the 6 month period after the Participant&#8217;s termination of services that would have constituted Cause if the Participant had not ceased to provide services, or (c) violates the terms of any non-compete agreement, non-solicitation agreement, confidentiality agreement, or any other restriction on the Participant&#8217;s post-termination activities established under any agreement with the Company or other Company policy or arrangement during the 6 months after the Participant&#8217;s ceases to provide services to the Company, then (i) any Option held by the Participant shall immediately terminate, and the Participant shall automatically forfeit all Shares underlying any exercised portion of an Option for which the Company has not yet delivered the Share certificates, upon refund by the Company of the Exercise Price paid by the Participant for such Shares and (ii) the Participant shall return any Shares received upon exercise of this Option or repay to the Company any proceeds received from the sale of other disposition of the Shares transferred pursuant to this Option less the Exercise Price. Upon any exercise of an Option, the Company may withhold delivery of share certificates pending resolution of an inquiry that could lead to a finding resulting in a forfeiture under this Section.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">No Right to Continued Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The granting of the Option evidenced hereby and this Agreement shall impose no obligation on the Company or any Affiliate to continue the services of the Participant and shall not lessen or affect the Company&#8217;s or its Affiliate&#8217;s right to terminate the services of such Participant.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The Option may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Participant otherwise than by will or by the laws of descent and distribution, and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company or any Affiliate&#59; provided that the designation of a beneficiary shall not constitute an assignment, alienation, pledge, attachment, sale, transfer or encumbrance. No such permitted transfer of the Option to heirs or legatees of the Participant shall be effective to bind the Company unless the Committee shall have been furnished with written notice thereof and a copy of such evidence as the Committee may deem </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">necessary to establish the validity of the transfer and the acceptance by the transferee or transferees of the terms and conditions hereof. During the Participant&#8217;s lifetime, the Option is exercisable only by the Participant.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The Participant may be required to pay to the Company or any Affiliate and the Company shall have the right and is hereby authorized to withhold, any applicable withholding taxes in respect of the Option, its exercise or any payment or transfer under or with respect to the Option and to take such other action as may be necessary in the opinion of the Committee to satisfy all obligations for the payment of such withholding taxes.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Upon the acquisition of any Shares pursuant to the exercise of the Option, the Participant will make or enter into such written representations, warranties and agreements as the Committee may reasonably request in order to comply with applicable securities laws or with this Agreement.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Any notice necessary under this Agreement shall be addressed to the Company in care of its Secretary at the principal executive office of the Company and to the Participant at the address appearing in the personnel records of the Company for the Participant or to either party at such other address as either party hereto may hereafter designate in writing to the other. Any such notice shall be deemed effective upon receipt thereof by the addressee.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Choice of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. This Agreement shall be governed by and construed in accordance with the laws of the state of Delaware without regard to conflicts of laws.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Option Subject to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. By entering into this Agreement the Participant agrees and acknowledges that the Participant has received and read a copy of the Plan. The Option is subject to the Plan. The terms and provisions of the Plan, as they may be amended from time to time, are hereby incorporated herein by reference. In the event of a conflict between any term or provision contained herein and a term or provision of the Plan, the applicable terms and provisions of the Plan will govern and prevail.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The Company intends that income realized by the Participant pursuant to the Plan and this Agreement will not be subject to taxation under Section 409A of the Code. The provisions of the Plan and this Agreement shall be interpreted and construed in favor of satisfying any applicable requirements of Section 409A of the Code. In the event that it is reasonably determined by the Committee that, as a result of Section 409A of the Code, any payment or delivery of Shares in respect of the Option may not be made at the time contemplated by the terms of the Plan or the this Agreement, as the case may be, without causing Participant to be subject to taxation under Section 409A of the Code, the Company shall use reasonably commercial efforts to make such payment or delivery of Shares on the first day that would not result in the Participant incurring any tax liability under Section 409A of the Code. If Participant is a &#8220;specified employee&#8221; (within the meaning of Section 409A(a)(2)(B)(i) of the Code), any payment and&#47;or delivery of Shares in respect of the Option that are linked to the date of the Participant&#8217;s separation from service shall not be made prior to the date which is six (6) months after the date of such Participant&#8217;s separation from service from the Company, determined in accordance with Section 409A of the Code and the regulations promulgated thereunder. The Company, in its reasonable discretion, may amend (including retroactively) the Plan and this Agreement in order to conform to the applicable requirements of Section 409A of the Code, including amendments to facilitate the Participant&#8217;s ability to avoid taxation under Section 409A of the Code. However, the preceding provisions shall not be construed as a guarantee by the Company of any particular tax result for income realized by the Participant pursuant to the Plan or this Agreement. In any event, the Company shall be responsible for the payment of any applicable taxes on income realized by the Participant pursuant to the Plan or this Agreement.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Signature in Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Signatures on next page.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties have caused this Agreement to be effective as of the day and year first above written.</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.108%"><tr><td style="width:1.0%"></td><td style="width:45.027%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.645%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.028%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 34.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPHASE LABS, INC.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 34.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 34.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 34.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 34.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 34.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 34.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PARTICIPANT</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 34.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 34.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 34.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 34.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>7
<FILENAME>prophase-exhibit191.htm
<DESCRIPTION>EX-19.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="iefa2408ed8384171ac47bd4e701f6068_35"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 19.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:151%;text-decoration:underline">PROPHASE LABS, INC.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:151%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:151%;text-decoration:underline">INSIDER TRADING POLICY</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">The Need For A Policy Statement</font></div><div style="text-align:justify;text-indent:5pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Federal securities laws make it illegal for you-- the officers, directors and employees of ProPhase Labs, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;) and its subsidiaries-- to buy or sell or otherwise transact in the Company&#8217;s securities at a time when you possess material non-public information (also referred to hereafter as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Inside Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;) relating to the Company. This conduct is known as &#8220;insider trading.&#8221; Passing such material nonpublic information on to someone else who may buy or sell securities-- known as &#8220;tipping&#8221;-- is also illegal. These prohibitions apply to stock, options, debt securities or any other securities of the Company, as well as to securities of other</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">companies if you learn something in the course of your duties that may affect their value.</font></div><div style="text-align:justify;text-indent:5pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">We</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">are</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">adopting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">this</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">avoid</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">even</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">appearance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">improper</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">conduct</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">part of anyone employed by or associated with our Company (not just so-called insiders). We have all worked very hard over the years to establish our reputation vis-&#224;- vis our integrity and ethical conduct. We cannot afford to have it damaged.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">The Consequences</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">consequences</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">insider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">violations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">can</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">be</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> staggering&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">For individuals </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">who trade on Inside Information (or disclose Inside Information to others who </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">trade)&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:14.15pt">Disgorgement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">any</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">profit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">gained</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">loss</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> avoided&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:97%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%;padding-left:14.15pt">A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">civil</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">penalty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">(in</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">addition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">disgorgement)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">up</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">to greater</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">$1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">three times the profit gained or loss avoided&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:14.15pt">A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">criminal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">fine</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(no</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">matter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">how</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">small</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">profit)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">up</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">$5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">million&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:14.15pt">A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">jail term of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">up</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">to 20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> years.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">For the Company </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(as</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">well as possibly any</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">supervisory</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">person)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">that fails to take appropriate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">steps to prevent illegal trading&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:98%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%;padding-left:14.15pt">A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">civil</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">penalty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">greater</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">$1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">million</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">three</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">times</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">profit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">gained</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">loss avoided as a result of the violation&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:14.15pt">A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">criminal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">penalty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">up</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">$2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> million.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">For an officer, director or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">employee who violates this Company Policy Statement, Company- imposed</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">sanctions,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">including</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">dismissal for cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(as</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">defined</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">in</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">an officer&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">employee&#8217;s contract, if applicable), could result.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Needless to say, any of the above consequences-- even an investigation by the United States Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;) that does not result in prosecution-- can tarnish one&#8217;s reputation and irreparably damage a career.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 19.1</font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Designation of Certain Persons.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">Section 16 Individuals. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The Company has determined that those persons listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> attached hereto are the directors and executive officers of the Company who are subject to the reporting and penalty provisions of Section 16 of the Securities and Exchange Act of 1934, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;), and the rules and regulations promulgated thereunder (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Section 16 Individuals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;). </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> will be amended by the Company from time to time to reflect the election of new officers or directors, any change in function of current officers and the resignation or departure of current officers and directors.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">Other Restricted Persons and Trading Windows. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The Company has determined that those persons and&#47;or categories of personnel listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Restricted Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;) will have general access to the Company&#8217;s internal financial statements or Inside Information relating to the Company&#8217;s financial results during a given financial quarter. Restricted Persons may not execute transactions involving the purchase or sale (or otherwise make any transfer, gift, pledge or loan) of the Company&#8217;s securities without the express written permission of the Company&#8217;s Chief Executive Officer or Chief Financial Officer (or their designee) or at any time other than during the period (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Window</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;) commencing at the close of business on the second trading day following the date of public disclosure of the financial results for a particular fiscal quarter or year and ending one calendar month prior to the end of the next fiscal quarter. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> will be amended by the Company from time to time. These pre-clearance procedures will also apply to transactions by such Restricted Persons&#8217; family members.</font></div><div style="text-align:justify;text-indent:5pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Unless</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">revoked,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">has</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">been</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">approved</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Company&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Chief Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or Chief Financial Officer (or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">their designee) will normally remain valid until</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the close of trading two business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">days</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">following</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">which</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">it</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">was</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">granted.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">If</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">does</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">occur</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">during</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the two-day period, pre-clearance of the transaction must be re-requested.</font></div><div style="text-align:justify;text-indent:5pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Certain</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">listed</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">may</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">come</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">have</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">access</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Company&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">internal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">financial results</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">other</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Inside</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">for</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">time.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">During</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">period,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">such</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">should</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">also follow the Trading Window procedures and refrain from trading while in possession of Inside Information. The Company may impose special blackout periods during which such persons are prohibited from trading in the Company&#8217;s securities. If the Company imposes a special blackout period, it will notify the persons affected.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Company Policy on Insider Trading</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">If</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">an</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">officer,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">any</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">has</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">material</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">non-public</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">relating</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">our</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Company, including any of its subsidiaries, it is our policy that neither that person nor any related person (including</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">any</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">family</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">member)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">may</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">buy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">sell</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">otherwise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">transact</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">in</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Company or engage in any other action to take advantage of that information or (2) communicate that information to other persons not having a need to know the information for legitimate, Company- related</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">reasons.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">This</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">also</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">applies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">relating</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">any</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">other</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">company,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">including</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">our customers, financing sources or merger prospects, obtained in the course of employment.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Even transactions that may be necessary or justifiable for independent reasons (such as the need to raise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">money</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">for</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">an</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">emergency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">expenditure)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">are</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">no</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">exception.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Even</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">appearance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">an</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> improper </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">transaction must be avoided to preserve our reputation for adhering to the highest standards of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">conduct.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Material Information Defined. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Material information is any information that a reasonable investor would consider important in a decision to buy, hold or sell stock. In short, any information which could reasonably affect the price of the stock.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 19.1</font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Examples of Material Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> Common examples of information that will frequently be regarded as material are&#58; unpublished financial results&#59; non-public projections of future earnings or losses&#59; news of a pending or proposed merger, acquisition or tender offer&#59; news of a significant sale of assets or the disposition of a subsidiary&#59; changes in dividend policies or the declaration of a stock dividend or split&#59; the offering of additional securities&#59; changes in management&#59; changes in auditors or auditor notification that the Company may no longer rely on an audit report&#59; entry into or termination of material agreements&#59; results or material data from clinical trials or preclinical studies, or other significant research or development milestones&#59; significant intellectual property developments&#59; developments regarding significant litigation or government agency investigations or significant communications&#59; impending bankruptcy or financial liquidity problems&#59; and the gain or loss of a substantial customer. We emphasize that this list is merely illustrative. Either positive or negative information may be material.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Twenty-Twenty Hindsight. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Remember,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">if</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">your</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">become</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">subject</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">scrutiny, they</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">will</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">be viewed</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">after-the-fact</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">with the benefit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of hindsight.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">As a result,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">before</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">engaging in any transaction you should carefully consider how regulators and others might view</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">your transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">hindsight.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Transactions by Family Members. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The very same restrictions apply to your family members and others </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">living in your household. Officers, directors and employees are expected to be responsible for the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">compliance of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">their family members. Officers, directors and employees should not discuss material non- </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">public</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">with</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">family</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">members.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">To</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">avoid</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">appearance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">impropriety,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">during</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">times</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">when you</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">are</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">in</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">possession</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">material</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">non-public</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">information,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">family</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">members</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">should</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">be</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">prevented</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">from trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">without</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">revealing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">youpossess.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">For purposes of this policy, &#8220;family member&#8221; means a person's spouse, parents, children, siblings, mothers and fathers-in-law, sons and daughters-in-law, brothers and sisters-in-law, and anyone (other than domestic employees) who shares such person's home.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Disclosing Information to Others. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Whether information is proprietary information about our Company </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">could</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">have</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">an impact</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">on our</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">price,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">you</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">must</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">pass</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">others (including other persons within the Company, family members or friends) unless the person has a need to know the information for legitimate Company-related reasons. You should also not discuss such information in public places where it can be overheard, such as elevators, restaurants, taxis and airplanes. An officer, director or employee who improperly reveals Inside Information to another person can be held </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">liable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">for</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of his</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8220;tippee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">any</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">other</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">with</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">whom</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the tippee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">above</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">penalties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">apply</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">whether</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">you</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">benefit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">financially</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">from</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">such</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">trades</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">whether or not you knew or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">intended that another person would trade Company stock on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">the basis of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">revealed.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">In order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">to avoid</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">even</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">appearance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">impropriety,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">it</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">is recommended</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">that </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">officers, directors and employees refrain from providing advice or making recommendations regarding the purchase or sale of the Company&#8217;s stock, whether or not you are then in possession of material non- </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">public</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">information.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Trading in Securities of Customers, etc. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">penalties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">for</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">insider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Company&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">insider trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">apply</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">equally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">material</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">nonpublic</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">concerning</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">other</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">companies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">obtained through</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">your</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">association</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">with</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Company,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">including</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">concerning</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> our customers, borrowers, suppliers, merger prospects or others with whom we have business dealings. You must refrain from trading securities of another company while in possession of such material nonpublic information concerning it, and you must not disclose such information </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 19.1</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">to others unless the person has a need to know the information for legitimate, Company-related reasons.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">When Information Is Public. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If you are in possession of material information which has not previously been made public, it is also improper for you to enter a trade immediately after the Company has made a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">public</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">announcement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">information,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">including</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">earnings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">releases.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Before</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">entering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">into</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">trade,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the Company&#8217;s stockholders and the investing public must be afforded sufficient time to receive the information and act upon it. Although the amount of time you must wait varies with the type and complexity of the information released,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">a good general rule is to wait until the third business day following the Company&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">public release of the information before engaging in a trade.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Thus, if an announcement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">is</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">made</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Monday,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Thursday</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">would</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">be</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">which</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">you</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">should trade (assuming you have no knowledge of other material information that has not been publicly disclosed). If an announcement is made on a Friday, the following Wednesday generally would be the first day.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Rule 10b5-1 Trading Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">. Rule 10b5-l of the Exchange Act (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Rule 10b5-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;) provides an affirmative defense</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">insider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">for</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">anyone who</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">sells or purchases securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">at</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">time when such person is in possession of material nonpublic information, if such transaction was made pursuant to a &#8220;pre-established trading plan&#8221; complying with the Rule (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Rule 10b5-1 Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">in</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">this</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">do</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">apply</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">under</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Rule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">10b5-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:8.84pt">has been reviewed and approved at least one week in advance of the adoption of such Rule 10b5-1 Plan by the Chief Executive Officer or Chief Financial Officer of the Company (or their designee)&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:8.84pt">was entered into in good faith by the officer, director or employee at a time when such person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">was</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">in</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">possession</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">material</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">nonpublic</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">about</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(and for Restricted Persons, only during a Trading Window)&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:8.84pt">gives a third party the discretionary authority to execute such purchases and sales, outside the control of the officer, director or employee entering into such Rule 10b5-1 Plan, so long as such third party does not possess any material nonpublic information about the Company&#59; or explicitly specifies the security or securities to be purchased or sold,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">number</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">shares,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">prices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">and&#47;or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">dates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">transactions,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">other</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">formula(s) describing such transactions&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:8.84pt">does not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">permit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">direct or indirect exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of any</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">influence</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">over the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">timing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or terms of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">purchase</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">officer,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">entering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">into</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">10b5-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Plan&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:8.84pt">provides for a mandatory &#8220;cooling off&#8221; period between the time the 10b5-1 Plan is adopted,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">amended</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">modified</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">trade</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">under</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(as</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">described </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">below)&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:8.84pt">for any officer or director, includes a certification (i) that such person is not aware of any</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">material</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">nonpublic</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">such</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">is</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">adopting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">in</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">good faith</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">as</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">part</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">evade</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">prohibition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">against</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">illegal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">insider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">trading&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:8.84pt">otherwise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">complies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">with</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Rule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">10b5-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">1.</font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 19.1</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">For</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">officers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Company,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8220;cooling-off&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">shall</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">begin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">10b5- 1 Plan is adopted, amended or modified and end the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">later </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of (1) 90 days thereafter and (2) two business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">days</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">following</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">filing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Company&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">quarterly</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Form</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">10-Q</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">annual</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">report on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">10-K</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">covering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">financial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">reporting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">in</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">which</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">was</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">adopted,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">amended</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">modified, but in no event later than 120 days. For all other persons, the &#8220;cooling-off&#8221; period shall be 30 days after the 10b5-1 Plan is adopted, amended or modified.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Pre-clearance is not required for purchases and sales of securities under an approved 10b5-1 Plan. With respect to any purchase or sale under an approved 10b5-1 Plan, the third party effecting transactions on behalf of the officer, director or employee should be instructed to send duplicative confirmations of all such transactions to the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Rule 10b5-1 restricts the use of multiple overlapping Rule 10b5-1 Plans, subject to limited </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">exceptions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Once a Rule 10b5-1 plan is implemented, a Rule 10b5-1 Plan may not be amended, modified, suspended or terminated without the Company&#8217;s approval. Modification or termination of 10b5-1 Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">are</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">discouraged</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">absent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">compelling</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">circumstances.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Any</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">modification to a Rule 10b5-1 Plan (other than an amendment or modification that does not change the pricing, amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">timing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">trades)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">is</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">treated</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">as</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">entry</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">into</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">new</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">must</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">comply</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">with all of the above requirements.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Other Prohibited Activities. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Finally,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">it</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">is</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Company&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">officers,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">employees should not engage in any of the following activities with respect to the securities of the Company&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:98%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%;padding-left:8.84pt">Trading in securities on a short-term basis by directors and officers -- Any security of the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">purchased</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">an</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%;text-decoration:underline">must</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">be</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">held</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">for</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">minimum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">six</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">(6) months</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">prior</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">sale,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">unless</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">security</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">is</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">subject</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">forced</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">sale (e.g.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">as</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:98%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:98%">consequence of a merger or acquisition involving the Company)&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:8.84pt">Purchases</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> margin&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:8.84pt">Short</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> sales&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:97%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%;padding-left:8.84pt">Buying</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">selling</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">puts,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">calls</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">or options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">purchase</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">sell</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">any</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">Company&#8217;s securities, other than options granted by the Company or bona fide pledges&#59; or</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:97%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%;padding-left:8.84pt">Heading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">monetization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">similar</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">arrangements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">with</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">respect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:97%">the Company&#8217;s securities.</font></div><div style="text-indent:5pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Certification</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">You</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">will</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">be</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">required</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">certify</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">you</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">understand</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">will</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">comply</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">with</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">this</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Statement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Also, you</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">will</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">be</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">required</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">certify</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">an</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">annual</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">basis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">you</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">have</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">complied</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">with</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">this</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Statement during the preceding year.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Failure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">to comply with</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">this Policy Statement may constitute grounds for your dismissal from employment for cause or, if you are a director, your removal from the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Board.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Company Assistance</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Any</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">who</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">has</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">any</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">questions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">about</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">specific</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">general</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">questions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">about</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">this</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Policy Statement may obtain additional guidance from the Chief Executive Officer or Chief Financial Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Please</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">remember,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">ultimate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">responsibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">for</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">adhering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">this</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 19.1</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">avoiding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">improper</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">rests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">with</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">you.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">In</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">this</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">regard,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">it</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">is imperative that you use your best judgment.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Adopted November 1, 2009</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Updated June 16, 2023</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Read</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Acknowledged</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.224%"><tr><td style="width:1.0%"></td><td style="width:61.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.952%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-indent:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Name</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.224%"><tr><td style="width:1.0%"></td><td style="width:61.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.952%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-indent:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Date</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="iefa2408ed8384171ac47bd4e701f6068_40"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 19.1</font></div></div><div style="margin-top:3.95pt;padding-left:147.6pt;padding-right:107.15pt;text-indent:14.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:176%;text-decoration:underline">PROPHASE LABS, INC.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:176%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:176%;text-decoration:underline">INSIDER TRADING POLICY</font></div><div style="margin-top:10.75pt;padding-left:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">The Need For A Policy Statement</font></div><div style="margin-top:11.95pt;padding-left:5pt;padding-right:5.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Federal securities laws make it illegal for you-- the officers, directors and employees of ProPhase Labs, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and its subsidiaries-- to buy or sell or otherwise transact in the Company&#8217;s securities at a time when you possess material non-public information (also referred to hereafter as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Inside Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) relating to the Company. This conduct is known as &#8220;insider trading.&#8221; Passing such material nonpublic information on to someone else who may buy or sell securities-- known as &#8220;tipping&#8221;-- is also illegal. These prohibitions apply to stock, options, debt securities or any other securities of the Company, as well as to securities of other companies if you learn something in the course of your duties that may affect their value.</font></div><div style="margin-top:12.15pt;padding-left:5pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">We are adopting this Policy Statement to avoid even the appearance of improper conduct on the part of anyone employed by or associated with our Company (not just so-called insiders). We have all worked very hard over the years to establish our reputation vis-&#224;- vis our integrity and ethical conduct. We cannot afford to have it damaged.</font></div><div style="margin-top:5.3pt"><font><br></font></div><div style="padding-left:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">The Consequences</font></div><div style="margin-top:11.95pt;padding-left:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The consequences of insider trading violations can be staggering&#58;</font></div><div style="margin-top:12.1pt;padding-left:5pt;padding-right:10.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">For individuals </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">who trade on Inside Information (or disclose Inside Information to others who trade)&#58;</font></div><div style="margin-top:11.9pt;padding-left:59pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.8pt">Disgorgement of any profit gained or loss avoided&#59;</font></div><div style="margin-top:12.15pt;padding-left:59pt;padding-right:25.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:114%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%;padding-left:13.8pt">A civil penalty (in addition to disgorgement) of up to greater of $1 million or three times the profit gained or loss avoided&#59;</font></div><div style="margin-top:12pt;padding-left:59pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.8pt">A criminal fine (no matter how small the profit) of up to $5 million&#59; and</font></div><div style="margin-top:11.75pt;padding-left:59pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.8pt">A jail term of up to 20 years.</font></div><div style="margin-top:11.85pt;padding-left:5pt;padding-right:5.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">For the Company </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(as well as possibly any supervisory person) that fails to take appropriate steps to prevent illegal trading&#58;</font></div><div style="margin-top:12.05pt;padding-left:59pt;padding-right:32.65pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:13.8pt">A civil penalty of the greater of $1 million or three times the profit gained or loss avoided as a result of the violation&#59; and</font></div><div style="margin-top:12.05pt;padding-left:59pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.8pt">A criminal penalty of up to $2.5 million.</font></div><div style="margin-top:11.7pt;padding-left:5pt;padding-right:5.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">For an officer, director or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">employee who violates this Company Policy Statement, Company- imposed sanctions, including dismissal for cause (as defined in an officer&#8217;s or employee&#8217;s contract, if applicable), could result.</font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.842%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></td></tr></table></div></div></div><div id="iefa2408ed8384171ac47bd4e701f6068_43"></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 19.1</font></div></div><div style="margin-top:4pt;padding-left:5pt;padding-right:5.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Needless to say, any of the above consequences-- even an investigation by the United States Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) that does not result in prosecution-- can tarnish one&#8217;s reputation and irreparably damage a career.</font></div><div style="margin-top:12pt;padding-left:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Designation of Certain Persons.</font></div><div style="margin-top:11.95pt;padding-left:5pt;padding-right:5.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Section 16 Individuals. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company has determined that those persons listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto are the directors and executive officers of the Company who are subject to the reporting and penalty provisions of Section 16 of the Securities and Exchange Act of 1934, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and the rules and regulations promulgated thereunder (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 16 Individuals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> will be amended by the Company from time to time to reflect the election of new officers or directors, any change in function of current officers and the resignation or departure of current officers and directors.</font></div><div style="margin-top:12.05pt;padding-left:5pt;padding-right:5.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Other Restricted Persons and Trading Windows. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company has determined that those persons and&#47;or categories of personnel listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) will have general access to the Company&#8217;s internal financial statements or Inside Information relating to the Company&#8217;s financial results during a given financial quarter. Restricted Persons may not execute transactions involving the purchase or sale (or otherwise make any transfer, gift, pledge or loan) of the Company&#8217;s securities without the express written permission of the Company&#8217;s Chief Executive Officer or Chief Financial Officer (or their designee) or at any time other than during the period (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Trading</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Window</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) commencing at the close of business on the second trading day following the date of public disclosure of the financial results for a particular fiscal quarter or year and ending one calendar month prior to the end of the next fiscal quarter. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> will be amended by the Company from time to time. These pre-clearance procedures will also apply to transactions by such Restricted Persons&#8217; family members.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unless revoked, a transaction that has been approved by the Company&#8217;s Chief Executive Officer or Chief Financial Officer (or their designee) will normally remain valid until the close of trading two business days following the day on which it was granted. If the transaction does not occur during the two-day period, pre-clearance of the transaction must be re-requested.</font></div><div style="margin-top:11.95pt;padding-left:5pt;padding-right:5.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Certain persons not listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> may come to have access to the Company&#8217;s internal financial results or other Inside Information for a period of time. During that period, such persons should also follow the Trading Window procedures and refrain from trading while in possession of Inside Information. The Company may impose special blackout periods during which such persons are prohibited from trading in the Company&#8217;s securities. If the Company imposes a special blackout period, it will notify the persons affected.</font></div><div style="margin-top:12.1pt;padding-left:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Company Policy on Insider Trading</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If an officer, director or any employee has material non-public information relating to our Company, including any of its subsidiaries, it is our policy that neither that person nor any related person (including any family member) may (1) buy or sell or otherwise transact in securities of the Company or engage in any other action to take advantage of that information or (2) communicate that information to other persons not having a need to know the information for legitimate, Company- related reasons. This policy also applies to information relating to any other company, including our customers, financing sources or merger prospects, obtained in the course of employment.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Even transactions that may be necessary or justifiable for independent reasons (such as the need to raise money for an emergency expenditure) are no exception. Even the appearance of an improper</font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.842%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div></td></tr></table></div></div></div><div id="iefa2408ed8384171ac47bd4e701f6068_46"></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 19.1</font></div></div><div style="margin-top:3.95pt;padding-left:5pt;padding-right:5.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">transaction must be avoided to preserve our reputation for adhering to the highest standards of conduct.</font></div><div style="margin-top:11.95pt;padding-left:5pt;padding-right:5.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Material Information Defined. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Material information is any information that a reasonable investor would consider important in a decision to buy, hold or sell stock. In short, any information which could reasonably affect the price of the stock.</font></div><div style="margin-top:12.05pt;padding-left:5pt;padding-right:5.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:105%">Examples of Material Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">Common examples of information that will frequently be regarded as material are&#58; unpublished financial results&#59; non-public projections of future earnings or losses&#59; news of a pending or proposed merger, acquisition or tender offer&#59; news of a significant sale of assets or the disposition of a subsidiary&#59; changes in dividend policies or the declaration of a stock dividend or split&#59; the offering of additional securities&#59; changes in management&#59; changes in auditors or auditor notification that the Company may no longer rely on an audit report&#59; entry into or termination of material agreements&#59; results or material data from clinical trials or preclinical studies, or other significant research or development milestones&#59; significant intellectual property developments&#59; developments regarding significant litigation or government agency investigations or significant communications&#59; impending bankruptcy or financial liquidity problems&#59; and the gain or loss of a substantial customer. We emphasize that this list is merely illustrative. Either positive or negative information may bematerial.</font></div><div style="margin-top:11.8pt;padding-left:5pt;padding-right:5.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Twenty-Twenty Hindsight. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Remember, if your securities transactions become the subject of scrutiny, they will be viewed after-the-fact with the benefit of hindsight. As a result, before engaging in any transaction you should carefully consider how regulators and others might view your transaction in hindsight.</font></div><div style="margin-top:11.95pt;padding-left:5pt;padding-right:5.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Transactions by Family Members. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The very same restrictions apply to your family members and others living in your household. Officers, directors and employees are expected to be responsible for the compliance of their family members. Officers, directors and employees should not discuss material non- public information with family members. To avoid the appearance of impropriety, during times when you are in possession of material non-public information, family members should be prevented from trading without revealing the information youpossess.</font></div><div style="margin-top:12.05pt;padding-left:5pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of this policy, &#8220;family member&#8221; means a person's spouse, parents, children, siblings, mothers and fathers-in-law, sons and daughters-in-law, brothers and sisters-in-law, and anyone (other than domestic employees) who shares such person's home.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Disclosing Information to Others. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Whether information is proprietary information about our Company or information that could have an impact on our stock price, you must not pass the information on to others (including other persons within the Company, family members or friends) unless the person has a need to know the information for legitimate Company-related reasons. You should also not discuss such information in public places where it can be overheard, such as elevators, restaurants, taxis and airplanes. An officer, director or employee who improperly reveals Inside Information to another person can be held liable for the trading activities of his &#8220;tippee&#8221; and any other person with whom the tippee shares the information. The above penalties apply whether or not you benefit financially from such trades and whether or not you knew or intended that another person would trade Company stock on the basis of the information revealed. In order to avoid even the appearance of impropriety, it is recommended that officers, directors and employees refrain from providing advice or making recommendations regarding the purchase or sale of the Company&#8217;s stock, whether or not you are then in possession of material non- public information.</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Trading in Securities of Customers, etc. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The penalties for insider trading and the Company&#8217;s insider trading policy apply equally to material nonpublic information concerning other companies obtained through your employment or association with the Company, including information concerning our</font></div><div><font><br></font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.842%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 19.1</font></div></div><div><font><br></font></div><div style="margin-top:3.95pt;padding-left:5pt;padding-right:5.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">customers, borrowers, suppliers, merger prospects or others with whom we have business dealings. You must refrain from trading securities of another company while in possession of such material nonpublic information concerning it, and you must not disclose such information to others unless the person has a need to know the information for legitimate, Company-related reasons.</font></div><div style="margin-top:11.95pt;padding-left:5pt;padding-right:5.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">When Information Is Public. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If you are in possession of material information which has not previously been made public, it is also improper for you to enter a trade immediately after the Company has made a public announcement of the information, including earnings releases. Before entering into a trade, the Company&#8217;s stockholders and the investing public must be afforded sufficient time to receive the information and act upon it. Although the amount of time you must wait varies with the type and complexity of the information released, a good general rule is to wait until the third business day following the Company&#8217;s public release of the information before engaging in a trade. Thus, if an announcement is made on a Monday, Thursday generally would be the first day on which you should trade (assuming you have no knowledge of other material information that has not been publicly disclosed). If an announcement is made on a Friday, the following Wednesday generally would be the first day.</font></div><div style="margin-top:12.1pt;padding-left:5pt;padding-right:5.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Rule 10b5-1 Trading Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Rule 10b5-l of the Exchange Act (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Rule 10b5-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) provides an affirmative defense to insider trading liability for anyone who sells or purchases securities at a time when such person is in possession of material nonpublic information, if such transaction was made pursuant to a &#8220;pre-established trading plan&#8221; complying with the Rule (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Rule 10b5-1 Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:11.9pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The trading restrictions in this policy do not apply to transactions under a Rule 10b5-1 Plan that&#58;</font></div><div style="margin-top:12.1pt;padding-left:59pt;padding-right:5.7pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt">has been reviewed and approved at least one week in advance of the adoption of such Rule 10b5-1 Plan by the Chief Executive Officer or Chief Financial Officer of the Company (or their designee)&#59;</font></div><div style="margin-top:11.95pt;padding-left:59pt;padding-right:5.7pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt">was entered into in good faith by the officer, director or employee at a time when such person was not in possession of material nonpublic information about the Company (and for Restricted Persons, only during a Trading Window)&#59;</font></div><div style="margin-top:12pt;padding-left:59pt;padding-right:5.55pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt">gives a third party the discretionary authority to execute such purchases and sales, outside the control of the officer, director or employee entering into such Rule 10b5-1 Plan, so long as such third party does not possess any material nonpublic information about the Company&#59; or explicitly specifies the security or securities to be purchased or sold, the number of shares, the prices and&#47;or dates of the transactions, or other formula(s) describing such transactions&#59;</font></div><div style="margin-top:12.05pt;padding-left:59pt;padding-right:5.6pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt">does not permit the direct or indirect exercise of any influence over the timing or terms of the purchase or sale by the officer, director or employee entering into the 10b5-1 Plan&#59;</font></div><div style="margin-top:12.05pt;padding-left:59pt;padding-right:5.35pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt">provides for a mandatory &#8220;cooling off&#8221; period between the time the 10b5-1 Plan is adopted, amended or modified and the date of the first trade under the plan (as described below)&#59;</font></div><div style="margin-top:12pt;padding-left:59pt;padding-right:5.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt">for any officer or director, includes a certification (i) that such person is not aware of any material nonpublic information and (ii) that such person is adopting the plan in good faith and not as part of a plan to evade the prohibition against illegal insider trading&#59; and</font></div><div style="margin-top:11.95pt;padding-left:58.95pt;text-indent:-17.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.7pt">otherwise complies with the requirements of Rule 10b5-1.</font></div><div><font><br></font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.842%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 19.1</font></div></div><div><font><br></font></div><div style="margin-top:3.95pt;padding-left:5pt;padding-right:5.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For officers and directors of the Company, the &#8220;cooling-off&#8221; period shall begin on the date the 10b5- 1 Plan is adopted, amended or modified and end the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">later </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">of (1) 90 days thereafter and (2) two business days following the filing of the Company&#8217;s quarterly report on Form 10-Q or annual report on 10-K covering the financial reporting period in which the plan was adopted, amended or modified, but in no event later than 120 days. For all other persons, the &#8220;cooling-off&#8221; period shall be 30 days after the 10b5-1 Plan is adopted, amended or modified.</font></div><div style="margin-top:11.95pt;padding-left:5pt;padding-right:5.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pre-clearance is not required for purchases and sales of securities under an approved 10b5-1 Plan. With respect to any purchase or sale under an approved 10b5-1 Plan, the third party effecting transactions on behalf of the officer, director or employee should be instructed to send duplicative confirmations of all such transactions to the Company.</font></div><div style="margin-top:12.05pt;padding-left:5pt;padding-right:5.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Rule 10b5-1 restricts the use of multiple overlapping Rule 10b5-1 Plans, subject to limited exceptions.</font></div><div style="margin-top:12.05pt;padding-left:5pt;padding-right:5.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Once a Rule 10b5-1 plan is implemented, a Rule 10b5-1 Plan may not be amended, modified, suspended or terminated without the Company&#8217;s approval. Modification or termination of 10b5-1 Plans are generally discouraged absent compelling circumstances. Any amendment or modification to a Rule 10b5-1 Plan (other than an amendment or modification that does not change the pricing, amount of securities or timing of trades) is treated as the entry into a new plan and must comply with all of the above requirements.</font></div><div style="margin-top:11.95pt;padding-left:5pt;padding-right:5.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Other Prohibited Activities. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finally, it is the Company&#8217;s policy that officers, directors and employees should not engage in any of the following activities with respect to the securities of the Company&#58;</font></div><div style="margin-top:12.2pt;padding-left:59pt;padding-right:5.6pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:9pt">Trading in securities on a short-term basis by directors and officers -- Any security of the Company purchased by an officer or director </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">must</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> be held for a minimum of six (6) months prior to sale, unless the security is subject to forced sale (e.g., as a consequence of a merger or acquisition involving the Company)&#59;</font></div><div style="margin-top:12.15pt;padding-left:58.9pt;text-indent:-17.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.9pt">Purchases on margin&#59;</font></div><div style="margin-top:11.75pt;padding-left:58.9pt;text-indent:-17.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.9pt">Short sales&#59;</font></div><div style="margin-top:12.1pt;padding-left:59pt;padding-right:36.3pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:114%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%;padding-left:9pt">Buying or selling puts, calls or options to purchase or sell any of the Company&#8217;s securities, other than options granted by the Company or bona fide pledges&#59; or</font></div><div style="margin-top:12.25pt;padding-left:59pt;padding-right:34.45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:114%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%;padding-left:9pt">Heading or monetization transactions or similar arrangements with respect to the Company&#8217;s securities.</font></div><div style="margin-top:12.15pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Certification</font></div><div style="margin-top:12pt;padding-left:5pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">You will be required to certify that you understand and will comply with this Policy Statement. Also, you will be required to certify on an annual basis that you have complied with this Policy Statement during the preceding year. Failure to comply with this Policy Statement may constitute grounds for your dismissal from employment for cause or, if you are a director, your removal from the Board.</font></div><div style="margin-top:11.95pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Company Assistance</font></div><div style="margin-top:11.95pt;padding-left:5pt;padding-right:5.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any person who has any questions about specific transactions or general questions about this Policy Statement may obtain additional guidance from the Chief Executive Officer or Chief </font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.842%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 19.1</font></div></div><div style="margin-top:11.95pt;padding-left:5pt;padding-right:5.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Financial Officer of the Company. Please remember, however, that the ultimate responsibility for adhering to</font></div><div><font><br></font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.842%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:64.08pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 19.1</font></div></div><div><font><br></font></div><div style="margin-top:3.95pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">this Policy Statement and avoiding improper transactions rests with you. In this regard, it is imperative that you use your best judgment.</font></div><div><font><br></font></div><div style="margin-top:2.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Adopted November 1, 2009</font></div><div style="margin-top:0.05pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Updated June 16, 2023</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:10.35pt"><font><br></font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Read and Acknowledged</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:7.05pt"><img alt="image_3.jpg" src="image_3.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:240px"></div><div style="margin-top:0.05pt;padding-left:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:7.15pt"><img alt="image_3.jpg" src="image_3.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:240px"></div><div style="padding-left:11pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date</font></div><div style="height:59.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.842%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>8
<FILENAME>prophase-exhibit211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i77797f19d6ee446696278e62f2cb5245_35"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">EXHIBIT 21.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SUBSIDIARIES OF PROPHASE LABS, INC.</font></div><div style="text-align:center"><font><br></font></div><div><img alt="image.jpg" src="image.jpg" style="height:397px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The above subsidiaries are included in the consolidated financial statements for the year ended December 31, 2023.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>9
<FILENAME>prph-exhibit231consent.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i912b36ab1e2a40d4b98e4ab1f744d211_40"></div><div style="min-height:48.96pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 23.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consent of Independent Registered Public Accounting Firm</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We hereby consent to the incorporation by reference in the Registration Statements of ProPhase Labs, Inc. and Subsidiaries on Forms S-8 (No. 333-268353, No. 333-265304, No. 333-261447, No. 333-259009, No. 333-256747, No. 333-225496, No. 333-224369, No. 333-217484, No. 333-189875 and No. 333-169697), and Forms S-3 (No. 333-260848) of our report dated March 29, 2024, with respect to the consolidated financial statements and internal control over financial reporting of ProPhase Labs, Inc. and Subsidiaries included in this Annual Report (Form 10-K) for the years ended December 31, 2023.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Morison Cogen LLP</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 28, 2024</font></div><div style="height:48.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>10
<FILENAME>prophase-exhibit3111.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i2fac3725112744919e4322f8fb6a3a9a_1"></div><div style="min-height:50.4pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">OFFICER&#8217;S CERTIFICATION PURSUANT TO</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">RULE 13a-14(a)&#47;15d-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I, Ted Karkus, certify that&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Annual Report on Form 10-K of ProPhase Labs, Inc.&#59;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this Annual Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Annual Report&#59;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this Annual Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this Annual Report&#59;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 131-15(f) and 15d015(f) for the registrant and have&#58;</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Annual Report is being prepared&#59;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this Annual Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font><br></font></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 28, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Ted Karkus</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ted Karkus</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>11
<FILENAME>prophase-exhibit3121.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i81dbc9f01efc45f7ab181220740c2207_1"></div><div style="min-height:50.4pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">OFFICER&#8217;S CERTIFICATION PURSUANT TO</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">RULE 13a-14(a)&#47;15d-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I, Jed Latkin, certify that&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Annual Report on Form 10-K of ProPhase Labs, Inc.&#59;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this Annual Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Annual Report&#59;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this Annual Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this Annual Report&#59;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 131-15(f) and 15d015(f) for the registrant and have&#58;</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Annual Report is being prepared&#59;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this Annual Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font><br></font></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 28, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Jed Latkin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jed Latkin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Operating Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Finance and Principal Accounting Officer)</font></td></tr></table></div><div><font><br></font></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>12
<FILENAME>prophase-exhibit3211.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i4be92e92d2f344d7b6812ad9ea1c8af4_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPHASE LABS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PURSUANT TO RULE 13a-14(b) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AND 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I, Ted Karkus, Chief Executive Officer of ProPhase Labs, Inc., a Delaware corporation (the &#8220;Registrant&#8221;), in connection with the Registrant&#8217;s Annual Report on Form 10-K for the period ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), do hereby represent, warrant and certify, in compliance with Rule 13a-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</font></td></tr></table></div><div style="padding-left:180pt;text-indent:36pt"><font><br></font></div><div style="padding-left:216pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> Ted Karkus</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ted Karkus</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board and</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;  March 28, 2024</font></td></tr></table></div><div><font><br></font></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>13
<FILENAME>prophase-exhibit3221.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ib902c12ebfbe4748825ff006988b4aea_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPHASE LABS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PURSUANT TO RULE 13a-14(b) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AND 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I, Jed Latkin, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer of ProPhase Labs, Inc., a Delaware corporation (the &#8220;Registrant&#8221;), in connection with the Registrant&#8217;s Annual Report on Form 10-K for the period ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), do hereby represent, warrant and certify, in compliance with Rule 13a-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</font></td></tr></table></div><div style="padding-left:216pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Jed Latkin</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jed Latkin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Operating Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Principal Accounting Officer)</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;  March 28, 2024</font></td></tr></table></div><div><font><br></font></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>14
<FILENAME>prophase-exhibit971.htm
<DESCRIPTION>EX-97.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i24f04d2b730f48c1962f97686ded98b2_35"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 97.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">CLAWBACK POLICY</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Purpose</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ProPhase Labs, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) is establishing this policy to align the interests of executive officers of the Company with those of shareholders, to create and maintain a culture that emphasizes integrity and accountability and to enforce the Company&#8217;s pay-for-performance compensation philosophy.  This policy provides for the recoupment of certain executive compensation in the event of an accounting restatement resulting from material noncompliance with financial reporting requirements under the federal securities laws (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). This Policy is designed to comply with Section 10D of the Securities Exchange Act of 1934 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), Rule 10D-1 promulgated under the Exchange Act (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Rule 10D-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), and Nasdaq Listing Rule 5608 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Listing Standards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Administration</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Policy shall be administered by the Board of Directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) of the Company or, if so designated by the Board, a committee thereof including the Compensation Committee, in which case references herein to the Board shall be deemed references to such committee. The Board is authorized to interpret and construe this Policy and to make all determinations and rules as it deems to be necessary or advisable for its administration. It is intended that this Policy be interpreted in a manner that is consistent with the requirements of Section 10D of the Exchange Act and any applicable rules or standards adopted by the Securities and Exchange Commission or the Nasdaq Stock Market (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Nasdaq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;).  Any determinations made by the Board shall be final and binding on all affected individuals. The Board may delegate administrative duties with respect to this Policy to one or more directors or employees of the Company, as permitted under applicable law, including any Listing Standards.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Covered Executives</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Policy applies to the Company&#8217;s current and former executive officers, as determined by the Board in accordance with Section 10D of the Exchange Act, the definition of executive officer set forth in Rule 10D-1 and the Listing Standards (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Covered Executives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), and such other employees who may from time to time be deemed subject to the Policy by the Board. For this purpose, an &#8220;executive officer&#8221; includes the Company&#8217;s president, principal financial officer, principal accounting officer (or controller), any vice president in charge of a principal business unit, division or function or any other officer or person who performs a &#8220;policy-making&#8221; function for the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Recoupment&#59; Accounting Restatement</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">In the event that the Company is required to prepare an Accounting Restatement, as defined herein, the Board will promptly require reimbursement or forfeiture of any Excess Incentive Compensation, as defined herein, received by any Covered Executive during the three completed fiscal years immediately preceding the date on which the Company is required to prepare an Accounting Restatement, and including any transition period (that results from a change in the Company&#8217;s fiscal year) within or immediately following those three completed fiscal years, except that a transition period comprising a period of at least nine months shall count as a full fiscal year.  The Policy applies to all Incentive-Based Compensation received by a Covered </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 97.1</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Executive (i) after beginning service as an executive officer&#59; (ii) who served as an executive officer at any time during the performance period for that Incentive-Based Compensation&#59; and (iii) while the Company has a listed class of securities.  Recovery of amounts under this Policy with respect to a Covered Executive shall not require the finding of any misconduct by such Covered Executive or that such Covered Executive caused or contributed to any error associated with an Accounting Restatement. For clarity, the recovery of any executive compensation under this Policy will not give rise to any person&#8217;s right to voluntarily terminate employment for &#8220;good reason,&#8221; or due to a &#8220;constructive termination&#8221; (or any similar term of like effect) under any plan, program or policy of or agreement with the Company or any of its affiliates.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">For purposes of this Policy, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Accounting Restatement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means an accounting restatement of the Company&#8217;s financial statements due to the Company&#8217;s material noncompliance with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.  Also for purposes of this Policy, the date on which the Company is required to prepare an accounting restatement is the earlier of (i) the date the Board concludes, or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement&#59; or (ii) the date a court, regulator, or other legally authorized body directs the Company to prepare an Accounting Restatement, in each case regardless of whether or when the restated financial statements are filed.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Excess Incentive Compensation&#58; Amount Subject to Recovery</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The amount subject to recovery (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Excess Incentive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) is the excess of the Incentive-Based Compensation paid to the Covered Executive based on the erroneous data over the Incentive-Based Compensation that would have been paid to the Covered Executive had it been based on the restated results.  Excess Incentive Compensation shall be determined by the Board without regard to any taxes paid by the Covered Executive with respect to the Excess Incentive Compensation.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">For Incentive-Based Compensation based on stock price or total shareholder return&#58;  (i) the Board shall determine the amount of the Excess Incentive Compensation based on a reasonable estimate of the effect of the Accounting Restatement on the stock price or total shareholder return upon which the Incentive-Based Compensation was received&#59; and (ii) the Company shall maintain documentation of the determination of that reasonable estimate and provide such documentation to Nasdaq.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Incentive-Based Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a Financial Reporting Measure.  Incentive-Based Compensation is received for purposes of this Policy in the Company&#8217;s fiscal period during which the Financial Reporting Measure specified in the Incentive-Based Compensation award is attained, even if the payment or grant of the Incentive-Based Compensation occurs after the end of that period.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">A &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Financial Reporting Measure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; means any measure that is determined and presented in accordance with the accounting principles used in preparing the Company&#8217;s financial statements, and any measure that is derived in whole or in part from such measure.  For purposes of this Policy, Financial Reporting Measures include, but are not limited to, the following, and any measures derived from the following&#58;  revenues&#59; earnings before interest, taxes, depreciation and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 97.1</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">amortization&#59; net income&#59; Company stock price&#59; and total shareholder return.  A Financial Reporting Measure need not be presented within the Company&#8217;s financial statements or included in a filing with the Securities Exchange Commission.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Method of Recoupment</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Board shall determine, in its sole discretion, the timing and method for promptly recouping Excess Incentive Compensation, which may include without limitation&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a) seeking reimbursement of all or part of any cash or equity Incentive-Based Compensation previously paid, </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b) seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based awards,</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(c) cancelling prior cash or equity-based awards, whether vested or unvested or paid or unpaid, </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(d) cancelling or offsetting against any planned future cash or equity-based awards, </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(e) forfeiture of deferred compensation, subject to compliance with Section 409A of the Internal Revenue Code (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) and the regulations promulgated thereunder, and </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(f) any other method authorized by applicable law or contract. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Subject to compliance with any applicable law, the Board may recover amounts under this Policy from any amount otherwise payable to the Covered Executive.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Company is authorized and directed pursuant to this Policy to recoup Excess Incentive Compensation in compliance with this Policy unless the Compensation Committee of the Board has determined that recovery would be impracticable solely for the following limited reasons, and subject to the following procedural and disclosure requirements&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.68pt">The direct expense paid to a third party to assist in enforcing the Policy would exceed the amount to be recovered&#59; provided that prior to concluding that it would be impracticable to recover any amount of Excess Incentive Compensation based on expense of enforcement, the Board must make a reasonable attempt to recover such erroneously awarded compensation, document such reasonable attempt(s) to recover and provide that documentation to Nasdaq&#59; or</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.68pt">Recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and regulations thereunder.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">No Indemnification of Covered Executives&#59; No Liability</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Company shall not indemnify any Covered Executives against the loss of any incorrectly awarded Excess Incentive Compensation. The Company is prohibited from paying or reimbursing a Covered Executive for purchasing insurance to cover any such loss. None of the Company, an affiliate of the Company or any member of the Board shall have any liability to any person as a result of actions taken under this Policy.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Board Indemnification</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 97.1</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Any members of the Board or its delegates shall not be personally liable for any action, determination or interpretation made with respect to this Policy and shall be fully indemnified by the Company to the fullest extent under applicable law and Company organizational documents and policy with respect to any such action, determination or interpretation. The foregoing sentence shall not limit any other rights to indemnification of the members of the Board or its delegates under applicable law or Company organizational documents and policy. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Effective Date</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Policy shall be effective as of the effective date of the Listing Standards (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). The terms of this Policy shall apply to any Incentive-Based Compensation that is received by Covered Executives on or after the Effective Date, even if such Incentive-Based Compensation was approved, awarded, granted or paid to Covered Executives prior to the Effective Date. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Amendment and Termination</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Board may amend this Policy from time to time in its discretion and shall amend this Policy as it deems necessary to reflect final regulations adopted by the Securities and Exchange Commission under Section 10D of the Exchange Act, to comply with any rules or standards adopted by Nasdaq, and to comply with (or maintain an exemption from the application of) Section 409A of the Code.  The Board may terminate this Policy at any time. This Policy will terminate automatically when the Company does not have a class of securities listed on a national securities exchange or association.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Other Recoupment Rights</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Board intends that this Policy will be applied to the fullest extent of the law. The Board may require that any employment agreement, equity award agreement, or similar agreement entered into on or after the Effective Date shall, as a condition to the grant of any benefit thereunder, require a Covered Executive to agree to abide by the terms of this Policy. Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment that may be available to the Company pursuant to the terms of any similar policy in any employment agreement, equity award agreement, or similar agreement and any other legal remedies available to the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Severability</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The provisions in this Policy are intended to be applied to the fullest extent of the law. To the extent that any provision of this Policy is found to be unenforceable or invalid under any applicable law, such provision shall be applied to the maximum extent permitted, and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required under applicable law. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Governing Law</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Policy and all rights and obligations hereunder are governed by and construed in accordance with the internal laws of the State of Delaware, excluding any choice of law rules or principles that may direct the application of the laws of another jurisdiction. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 97.1</font></div></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Successors</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Policy shall be binding and enforceable against all Covered Executives and their beneficiaries, heirs, executors, administrators or other legal representatives.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Exhibit Filing Requirement</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">A copy of this Policy and any amendments thereto shall be posted on the Company&#8217;s website and filed as an exhibit to the Company&#8217;s annual report on Form 10-K. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#91;FOR SIGNATURE BY THE COMPANY&#8217;S COVERED EXECUTIVES&#93; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Clawback Policy Acknowledgment</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">I, the undersigned, agree and acknowledge that I am fully bound by, and subject to, all of the terms and conditions of the ProPhase Labs, Inc. Clawback Policy (as may be amended, restated, supplemented or otherwise modified from time to time, the &#8220;Policy&#8221;). In the event of any inconsistency between the Policy and the terms of any employment agreement to which I am a party, or the terms of any compensation plan, program or agreement under which any compensation has been granted, awarded, earned or paid, the terms of the Policy shall govern. In the event it is determined by the Board, or such committee thereof that is charged with administration of the Policy, that any amounts granted, awarded, earned or paid to me must be forfeited or reimbursed to the Company, I will promptly take any action necessary to effectuate such forfeiture and&#47;or reimbursement. Any capitalized terms used in this Acknowledgment without definition shall have the meaning set forth in the Policy.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">By&#58; _______________________________                           Date&#58; _________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Name&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Title&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>15
<FILENAME>prph-20231231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:7788277e-a48e-4763-84b1-a7c7849f902f,g:9ac615ab-2322-4dd1-8a91-31a5eca0bd4d-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:prph="http://prophaselabs.com/20231231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://prophaselabs.com/20231231">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prph-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prph-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prph-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="prph-20231231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://prophaselabs.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://prophaselabs.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://prophaselabs.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000003 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000004 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperationsandOtherComprehensiveIncome" roleURI="http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome">
        <link:definition>0000005 - Statement - Consolidated Statements of Operations and Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>0000006 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquityParenthetical" roleURI="http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical">
        <link:definition>0000007 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000008 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandBusiness" roleURI="http://prophaselabs.com/role/OrganizationandBusiness">
        <link:definition>0000009 - Disclosure - Organization and Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000010 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetAcquisition" roleURI="http://prophaselabs.com/role/AssetAcquisition">
        <link:definition>0000011 - Disclosure - Asset Acquisition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNet" roleURI="http://prophaselabs.com/role/IntangibleAssetsNet">
        <link:definition>0000012 - Disclosure - Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipment" roleURI="http://prophaselabs.com/role/PropertyPlantandEquipment">
        <link:definition>0000013 - Disclosure - Property, Plant and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OutstandingDebt" roleURI="http://prophaselabs.com/role/OutstandingDebt">
        <link:definition>0000014 - Disclosure - Outstanding Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://prophaselabs.com/role/StockholdersEquity">
        <link:definition>0000015 - Disclosure - Stockholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefinedContributionPlans" roleURI="http://prophaselabs.com/role/DefinedContributionPlans">
        <link:definition>0000016 - Disclosure - Defined Contribution Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://prophaselabs.com/role/IncomeTaxes">
        <link:definition>0000017 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilities" roleURI="http://prophaselabs.com/role/OtherCurrentLiabilities">
        <link:definition>0000018 - Disclosure - Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://prophaselabs.com/role/CommitmentsandContingencies">
        <link:definition>0000019 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://prophaselabs.com/role/Leases">
        <link:definition>0000020 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantCustomersConcentrations" roleURI="http://prophaselabs.com/role/SignificantCustomersConcentrations">
        <link:definition>0000021 - Disclosure - Significant Customers Concentrations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://prophaselabs.com/role/SegmentInformation">
        <link:definition>0000022 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://prophaselabs.com/role/EarningsPerShare">
        <link:definition>0000023 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedParties" roleURI="http://prophaselabs.com/role/RelatedParties">
        <link:definition>0000024 - Disclosure - Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://prophaselabs.com/role/SubsequentEvents">
        <link:definition>0000025 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>9954472 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetTables" roleURI="http://prophaselabs.com/role/IntangibleAssetsNetTables">
        <link:definition>9954473 - Disclosure - Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentTables" roleURI="http://prophaselabs.com/role/PropertyPlantandEquipmentTables">
        <link:definition>9954474 - Disclosure - Property, Plant and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://prophaselabs.com/role/StockholdersEquityTables">
        <link:definition>9954475 - Disclosure - Stockholders&#8217; Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://prophaselabs.com/role/IncomeTaxesTables">
        <link:definition>9954476 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilitiesTables" roleURI="http://prophaselabs.com/role/OtherCurrentLiabilitiesTables">
        <link:definition>9954477 - Disclosure - Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://prophaselabs.com/role/LeasesTables">
        <link:definition>9954478 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://prophaselabs.com/role/SegmentInformationTables">
        <link:definition>9954479 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://prophaselabs.com/role/EarningsPerShareTables">
        <link:definition>9954480 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandBusinessNarrativeDetails" roleURI="http://prophaselabs.com/role/OrganizationandBusinessNarrativeDetails">
        <link:definition>9954481 - Disclosure - Organization and Business - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>9954482 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails" roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails">
        <link:definition>9954483 - Disclosure - Summary of Significant Accounting Policies - Summary of Components of Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofAccountsReceivableNetDetails" roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofAccountsReceivableNetDetails">
        <link:definition>9954484 - Disclosure - Summary of Significant Accounting Policies - Schedule of Accounts Receivable Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAccountsReceivableAllowanceforCreditLossDetails" roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableAllowanceforCreditLossDetails">
        <link:definition>9954485 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable, Allowance for Credit Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails" roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails">
        <link:definition>9954486 - Disclosure - Summary of Significant Accounting Policies - Schedule of Components of Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails" roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails">
        <link:definition>9954487 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails" roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails">
        <link:definition>9954488 - Disclosure - Summary of Significant Accounting Policies - Schedule of Deferred Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails_1" roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails_1">
        <link:definition>9954488 - Disclosure - Summary of Significant Accounting Policies - Schedule of Deferred Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPerformanceObligationDetails" roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPerformanceObligationDetails">
        <link:definition>9954489 - Disclosure - Summary of Significant Accounting Policies - Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPerformanceObligationDetails_1" roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPerformanceObligationDetails_1">
        <link:definition>9954489 - Disclosure - Summary of Significant Accounting Policies - Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofDisaggregationbyRevenueDetails" roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDisaggregationbyRevenueDetails">
        <link:definition>9954490 - Disclosure - Summary of Significant Accounting Policies - Schedule of Disaggregation by Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetAcquisitionDetails" roleURI="http://prophaselabs.com/role/AssetAcquisitionDetails">
        <link:definition>9954491 - Disclosure - Asset Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetNarrativeDetails" roleURI="http://prophaselabs.com/role/IntangibleAssetsNetNarrativeDetails">
        <link:definition>9954492 - Disclosure - Intangible Assets, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetScheduleofIntangibleAssetsDetails" roleURI="http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails">
        <link:definition>9954493 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails" roleURI="http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails">
        <link:definition>9954494 - Disclosure - Intangible Assets, Net - Schedule Estimated Future Amortization Expense of Acquired Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" roleURI="http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails">
        <link:definition>9954495 - Disclosure - Property, Plant, and Equipment - Schedule of Property, Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNarrativeDetails" roleURI="http://prophaselabs.com/role/PropertyPlantandEquipmentNarrativeDetails">
        <link:definition>9954496 - Disclosure - Property, Plant and Equipment - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OutstandingDebtDetails" roleURI="http://prophaselabs.com/role/OutstandingDebtDetails">
        <link:definition>9954497 - Disclosure - Outstanding Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://prophaselabs.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>9954498 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofStockOptionsActivityDetails" roleURI="http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails">
        <link:definition>9954499 - Disclosure - Stockholders' Equity - Schedule of Stock Options Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquitySummaryofWeightedAverageAssumptionsUsedinDeterminingFairValueofOptionsDetails" roleURI="http://prophaselabs.com/role/StockholdersEquitySummaryofWeightedAverageAssumptionsUsedinDeterminingFairValueofOptionsDetails">
        <link:definition>9954500 - Disclosure - Stockholders' Equity - Summary of Weighted Average Assumptions Used in Determining Fair Value of Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofWarrantActivityDetails" roleURI="http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails">
        <link:definition>9954501 - Disclosure - Stockholders' Equity - Schedule of Warrant Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefinedContributionPlansDetailsNarrative" roleURI="http://prophaselabs.com/role/DefinedContributionPlansDetailsNarrative">
        <link:definition>9954502 - Disclosure - Defined Contribution Plans (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails" roleURI="http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails">
        <link:definition>9954503 - Disclosure - Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" roleURI="http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails">
        <link:definition>9954504 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>9954505 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://prophaselabs.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>9954506 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails" roleURI="http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails">
        <link:definition>9954507 - Disclosure - Other Current Liabilities - Schedule of Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNarrativeDetails" roleURI="http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails">
        <link:definition>9954508 - Disclosure - Commitments and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://prophaselabs.com/role/LeasesNarrativeDetails">
        <link:definition>9954509 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails" roleURI="http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails">
        <link:definition>9954510 - Disclosure - Leases - Schedule of Quantitative Information About Operating and Finance Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails" roleURI="http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails">
        <link:definition>9954511 - Disclosure - Leases - Schedule of Maturity of Operating and Finance Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1" roleURI="http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1">
        <link:definition>9954511 - Disclosure - Leases - Schedule of Maturity of Operating and Finance Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantCustomersConcentrationsNarrativeDetails" roleURI="http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails">
        <link:definition>9954512 - Disclosure - Significant Customers Concentrations - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDetailsNarrative" roleURI="http://prophaselabs.com/role/SegmentInformationDetailsNarrative">
        <link:definition>9954513 - Disclosure - Segment Information (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleofSegmentInformationDetails" roleURI="http://prophaselabs.com/role/ScheduleofSegmentInformationDetails">
        <link:definition>9954514 - Disclosure - Schedule of Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails" roleURI="http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails">
        <link:definition>9954515 - Disclosure - Earnings Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromtheIncomePerShareComputationDetails" roleURI="http://prophaselabs.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromtheIncomePerShareComputationDetails">
        <link:definition>9954516 - Disclosure - Earnings Per Share - Schedule of Anti-dilutive Securities Excluded from the Income Per Share Computation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://prophaselabs.com/role/SubsequentEventsDetails">
        <link:definition>9954517 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="prph_InventoryValuationReserve" abstract="false" name="InventoryValuationReserve" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_CFOAwardMember" abstract="true" name="CFOAwardMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_AgreementTerm" abstract="false" name="AgreementTerm" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prph_A2023NotesWarrantsMember" abstract="true" name="A2023NotesWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances" abstract="false" name="IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_NumberOfInhibitors" abstract="false" name="NumberOfInhibitors" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prph_LeaseLiabilityToBePaidYearThree" abstract="false" name="LeaseLiabilityToBePaidYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_Amended2010DirectorsPlanMember" abstract="true" name="Amended2010DirectorsPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_LeaseLiabilityToBePaidYearFive" abstract="false" name="LeaseLiabilityToBePaidYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_EquivirLicenseAgreementMember" abstract="true" name="EquivirLicenseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prph_PrepaidShareBasedCompensationExpense" abstract="false" name="PrepaidShareBasedCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_DeferredTaxLiabilitiesAmortization" abstract="false" name="DeferredTaxLiabilitiesAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_ArrangementTypeAxis" abstract="true" name="ArrangementTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="prph_AccruedReturns" abstract="false" name="AccruedReturns" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_ManufacturingAgreementRenewalPeriod" abstract="false" name="ManufacturingAgreementRenewalPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prph_InventoryLabMaterial" abstract="false" name="InventoryLabMaterial" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_LetterAgreementMember" abstract="false" name="LetterAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance" abstract="false" name="CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="prph_DiagnosticServicesClientsThreeMember" abstract="false" name="DiagnosticServicesClientsThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_LeasesLiabilityAbstract" abstract="true" name="LeasesLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prph_LeaseLiabilityToBePaid" abstract="false" name="LeaseLiabilityToBePaid" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_ConsumerProductsMember" abstract="false" name="ConsumerProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_CorporateObligationsMember" abstract="false" name="CorporateObligationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_GradualRentalRateIncreasePercentage" abstract="false" name="GradualRentalRateIncreasePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="prph_PersonalGenomicsBusinessMember" abstract="true" name="PersonalGenomicsBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_UncollectibleTradeReceivablesMember" abstract="true" name="UncollectibleTradeReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prph_A2023NoteMember" abstract="true" name="A2023NoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_DiagnosticServicesClientsOneMember" abstract="false" name="DiagnosticServicesClientsOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_ChangeInFairValueOfInvestmentSecurities" abstract="false" name="ChangeInFairValueOfInvestmentSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_LicenseOrRoyaltyNetRevenuePercentage" abstract="false" name="LicenseOrRoyaltyNetRevenuePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="prph_ConstructionAllowance" abstract="false" name="ConstructionAllowance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="prph_CPMMember" abstract="false" name="CPMMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_ClientPayersMember" abstract="false" name="ClientPayersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_LeaseLiabilityToBePaidYearTwo" abstract="false" name="LeaseLiabilityToBePaidYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_DeferredTaxAssetsCapitalLeaseObligations" abstract="false" name="DeferredTaxAssetsCapitalLeaseObligations" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_CooperativeIncentivePromotionCostsMember" abstract="false" name="CooperativeIncentivePromotionCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_ScheduleOfWarrantActivityTableTextBlock" abstract="false" name="ScheduleOfWarrantActivityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance" abstract="false" name="IncomeTaxesFromContinuingOperationsBeforeValuationAllowance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_Amended2022PlanMember" abstract="true" name="Amended2022PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prph_UnallocatedCorporateMember" abstract="false" name="UnallocatedCorporateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_LeaseLiabilityUndiscountedExcessAmount" abstract="false" name="LeaseLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_AssetAcquisitionTransactionCosts" abstract="false" name="AssetAcquisitionTransactionCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_AmendedTwoThousandTenPlanMember" abstract="false" name="AmendedTwoThousandTenPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_GovernmentAgenciesMember" abstract="false" name="GovernmentAgenciesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_StellaPurchaseAgreementMember" abstract="true" name="StellaPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage" abstract="false" name="NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="prph_TwoThousandEighteenStockIncentivePlanMember" abstract="false" name="TwoThousandEighteenStockIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_WeightedAverageExercisePriceWarrantsExercised" abstract="false" name="WeightedAverageExercisePriceWarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="prph_A2023SecuredMortgageLoanMember" abstract="true" name="A2023SecuredMortgageLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prph_IssuanceOfWarrantsWithUnsecuredPromissoryNote" abstract="false" name="IssuanceOfWarrantsWithUnsecuredPromissoryNote" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_MarketableSecuritiesMember" abstract="false" name="MarketableSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="prph_FinancingAgreementOriginationFee" abstract="false" name="FinancingAgreementOriginationFee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_USGovernmentObligationsMember" abstract="false" name="USGovernmentObligationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_IssuanceOfSecuredPromissoryNoteReceivable" abstract="false" name="IssuanceOfSecuredPromissoryNoteReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_FullyReservedTradeReceivablesMember" abstract="true" name="FullyReservedTradeReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prph_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_TypeOfArrangementDomain" abstract="true" name="TypeOfArrangementDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_A2022PlanMember" abstract="true" name="A2022PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_FinancingAgreementPeriodicPayment" abstract="false" name="FinancingAgreementPeriodicPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_DeferredTaxLiabilitiesDepreciation" abstract="false" name="DeferredTaxLiabilitiesDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_FinancingArrangementAggregateRepaymentAmount" abstract="false" name="FinancingArrangementAggregateRepaymentAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_SeptemberTwoThousandAndTwentyNoteMember" abstract="false" name="SeptemberTwoThousandAndTwentyNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff" abstract="false" name="AssetAcquisitionConsiderationTransferredPromissoryNotePayoff" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="prph_ContractManufacturingMember" abstract="false" name="ContractManufacturingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_DebtSecuritiesAvailableForSaleMaturityPeriod" abstract="false" name="DebtSecuritiesAvailableForSaleMaturityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2" abstract="false" name="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prph_InsuranceProvidersMember" abstract="false" name="InsuranceProvidersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_GenomicProductsAndServicesMember" abstract="false" name="GenomicProductsAndServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities" abstract="false" name="IncreaseDecreaseInDeferredIncomeTaxLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_CertainHoldersMember" abstract="true" name="CertainHoldersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare" abstract="false" name="AssetAcquisitionSharesIssuedAndIssuableValuePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="prph_A2022DirectorsPlanMember" abstract="true" name="A2022DirectorsPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_CommonStockPurchaseWarrantsMember" abstract="false" name="CommonStockPurchaseWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_TaxCreditCarryforwardLimitationAmount" abstract="false" name="TaxCreditCarryforwardLimitationAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_InterestOnUnsecuredConvertiblePromissoryNote" abstract="false" name="InterestOnUnsecuredConvertiblePromissoryNote" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_Amended2022DirectorsPlanMember" abstract="true" name="Amended2022DirectorsPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prph_LesseeOperatingLeaseAbatementPeriod" abstract="false" name="LesseeOperatingLeaseAbatementPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prph_ShareBasedPaymentArrangementExpenseReversal" abstract="false" name="ShareBasedPaymentArrangementExpenseReversal" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_IncreaseDecreaseInAccruedDiagnosticServices" abstract="false" name="IncreaseDecreaseInAccruedDiagnosticServices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_CorporateStockMember" abstract="true" name="CorporateStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable" abstract="false" name="WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prph_LinebackerLicenseAgreementsMember" abstract="true" name="LinebackerLicenseAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prph_BlackScholesOptionPricingModelMember" abstract="true" name="BlackScholesOptionPricingModelMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_PurchaseAgreementRoyaltyPercent" abstract="false" name="PurchaseAgreementRoyaltyPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="prph_UpfrontLicenseFee" abstract="false" name="UpfrontLicenseFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_DiagnosticServicesClientsTwoMember" abstract="false" name="DiagnosticServicesClientsTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_OldBridgeNewJerseyMember" abstract="false" name="OldBridgeNewJerseyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_RetailAndOtherMember" abstract="false" name="RetailAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_NumberOfInvestors" abstract="false" name="NumberOfInvestors" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prph_ManufacturingAgreementRenewalOptions" abstract="false" name="ManufacturingAgreementRenewalOptions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prph_LesseeOperatingLeaseNumberOfRenewalOptions" abstract="false" name="LesseeOperatingLeaseNumberOfRenewalOptions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prph_NumberOfSites" abstract="false" name="NumberOfSites" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prph_NewDrugApplicationMember" abstract="true" name="NewDrugApplicationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_NumberOfLicensedCompounds" abstract="false" name="NumberOfLicensedCompounds" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff" abstract="false" name="AssetAcquisitionConsiderationTransferredLiabilityPayoff" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_LeaseLiability" abstract="false" name="LeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_PaymentsForAssetAcquisition" abstract="false" name="PaymentsForAssetAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_DiagnosticServicesMember" abstract="false" name="DiagnosticServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_IssuanceOfCommonStockSharesExerciseOfWarrant" abstract="false" name="IssuanceOfCommonStockSharesExerciseOfWarrant" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="prph_ReimbursementReceivableMember" abstract="true" name="ReimbursementReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_NumberOfDebtInstruments" abstract="false" name="NumberOfDebtInstruments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prph_IssuanceOfCommonSharesForDebtConversion" abstract="false" name="IssuanceOfCommonSharesForDebtConversion" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_PhaseThreeMember" abstract="true" name="PhaseThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_NewYorkFirstFloorLeaseMember" abstract="true" name="NewYorkFirstFloorLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prph_OperatingAndOtherExpenses" abstract="false" name="OperatingAndOtherExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_LicenseAgreementTerm" abstract="false" name="LicenseAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prph_MrKamalObbadMember" abstract="false" name="MrKamalObbadMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_BESmartLicenseAgreementMember" abstract="true" name="BESmartLicenseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prph_NewYorkSecondFloorLeaseMember" abstract="true" name="NewYorkSecondFloorLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prph_LeaseLiabilityToBePaidYearOne" abstract="false" name="LeaseLiabilityToBePaidYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_InducementOptionAwardMember" abstract="false" name="InducementOptionAwardMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_AdditionalPaymentOfFee" abstract="false" name="AdditionalPaymentOfFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_LeaseLiabilityToBePaidYearFour" abstract="false" name="LeaseLiabilityToBePaidYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount" abstract="false" name="IssuanceOfCommonStockUponExerciseOfWarrantAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prph_SegmentConcentrationRiskMember" abstract="true" name="SegmentConcentrationRiskMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod" abstract="false" name="LesseeOperatingLeaseOptionToTerminateNoticePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="prph_LesseeOperatingLeaseMonthlyBaseRent" abstract="false" name="LesseeOperatingLeaseMonthlyBaseRent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_ShareBasedCompensationAwardTrancheFourMember" abstract="true" name="ShareBasedCompensationAwardTrancheFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="prph_LeaseLiabilityToBePaidAfterYearFive" abstract="false" name="LeaseLiabilityToBePaidAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_IncreaseDecreaseInDeferredIncomeTaxAssets" abstract="false" name="IncreaseDecreaseInDeferredIncomeTaxAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_CEOOptionsMember" abstract="false" name="CEOOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="prph_ProceedsFromFinancingAgreement" abstract="false" name="ProceedsFromFinancingAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="prph_NumberOfTestsRecognized" abstract="false" name="NumberOfTestsRecognized" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="prph_NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities" abstract="false" name="NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>16
<FILENAME>prph-20231231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:7788277e-a48e-4763-84b1-a7c7849f902f,g:9ac615ab-2322-4dd1-8a91-31a5eca0bd4d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://prophaselabs.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="prph-20231231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://prophaselabs.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e8fc20a3-28ad-4f1e-bcc3-9c7d5019246f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8c9101e6-500f-408b-a7e3-133bbb666cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e8fc20a3-28ad-4f1e-bcc3-9c7d5019246f" xlink:to="loc_us-gaap_AssetsCurrent_8c9101e6-500f-408b-a7e3-133bbb666cd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_b3ec2eeb-f865-41c6-b539-f842f3fee244" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e8fc20a3-28ad-4f1e-bcc3-9c7d5019246f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_b3ec2eeb-f865-41c6-b539-f842f3fee244" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent_348c8161-45af-4e1d-b7b6-1145e387e6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e8fc20a3-28ad-4f1e-bcc3-9c7d5019246f" xlink:to="loc_us-gaap_PrepaidExpenseNoncurrent_348c8161-45af-4e1d-b7b6-1145e387e6b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7f2ea2ca-ecc6-46ee-a5b7-6c28aff1a75a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e8fc20a3-28ad-4f1e-bcc3-9c7d5019246f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7f2ea2ca-ecc6-46ee-a5b7-6c28aff1a75a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8af3f626-1af3-4acd-b5a6-021c67d1e05d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e8fc20a3-28ad-4f1e-bcc3-9c7d5019246f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8af3f626-1af3-4acd-b5a6-021c67d1e05d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_4e4aee0d-62f8-43a5-9c5d-a86cc9881090" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e8fc20a3-28ad-4f1e-bcc3-9c7d5019246f" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_4e4aee0d-62f8-43a5-9c5d-a86cc9881090" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d407a281-ccdc-4534-844d-251b67918284" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e8fc20a3-28ad-4f1e-bcc3-9c7d5019246f" xlink:to="loc_us-gaap_Goodwill_d407a281-ccdc-4534-844d-251b67918284" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b2c70171-ca39-4ab9-96ec-571b0ba31817" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e8fc20a3-28ad-4f1e-bcc3-9c7d5019246f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b2c70171-ca39-4ab9-96ec-571b0ba31817" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0bf571f5-17e7-4591-8db1-fe28565fb0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_38b23968-cefc-49d7-8c6b-80080eea2a93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0bf571f5-17e7-4591-8db1-fe28565fb0ea" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_38b23968-cefc-49d7-8c6b-80080eea2a93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_ce89b735-06fe-4e8d-ab82-7045b16652a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0bf571f5-17e7-4591-8db1-fe28565fb0ea" xlink:to="loc_us-gaap_RestrictedCash_ce89b735-06fe-4e8d-ab82-7045b16652a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_002ad991-2c58-4bf9-a4d6-fbd26cac1d39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0bf571f5-17e7-4591-8db1-fe28565fb0ea" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_002ad991-2c58-4bf9-a4d6-fbd26cac1d39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_38ec1367-617d-4fba-90a1-baf6135c5a61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0bf571f5-17e7-4591-8db1-fe28565fb0ea" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_38ec1367-617d-4fba-90a1-baf6135c5a61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_7380cfa7-ba30-4734-973a-4be1799d4b03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0bf571f5-17e7-4591-8db1-fe28565fb0ea" xlink:to="loc_us-gaap_InventoryNet_7380cfa7-ba30-4734-973a-4be1799d4b03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3d83316a-1323-475b-873c-5f5a05a83746" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0bf571f5-17e7-4591-8db1-fe28565fb0ea" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3d83316a-1323-475b-873c-5f5a05a83746" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d2d4c32c-da23-4d25-b1e1-5aaafd42b334" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e8fca0a4-b1df-428b-9253-d119dad1da43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d2d4c32c-da23-4d25-b1e1-5aaafd42b334" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e8fca0a4-b1df-428b-9253-d119dad1da43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_42db72fc-5e17-4148-9848-9688c78a5658" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d2d4c32c-da23-4d25-b1e1-5aaafd42b334" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_42db72fc-5e17-4148-9848-9688c78a5658" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_c3a0c828-eed4-4df7-b05d-06b34cc21831" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d2d4c32c-da23-4d25-b1e1-5aaafd42b334" xlink:to="loc_us-gaap_AccountsPayableCurrent_c3a0c828-eed4-4df7-b05d-06b34cc21831" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_723017b7-7e8f-4378-b4bb-9cb83d2c6e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d2d4c32c-da23-4d25-b1e1-5aaafd42b334" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_723017b7-7e8f-4378-b4bb-9cb83d2c6e1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_18dec6f2-20fd-441c-bf20-15330e8484f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d2d4c32c-da23-4d25-b1e1-5aaafd42b334" xlink:to="loc_us-gaap_DeferredRevenueCurrent_18dec6f2-20fd-441c-bf20-15330e8484f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_e236ba43-ca75-4bd4-8cd3-6e45e680184e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d2d4c32c-da23-4d25-b1e1-5aaafd42b334" xlink:to="loc_us-gaap_TaxesPayableCurrent_e236ba43-ca75-4bd4-8cd3-6e45e680184e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_428c0a65-9d24-4a66-b920-8f5c17597d77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d2d4c32c-da23-4d25-b1e1-5aaafd42b334" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_428c0a65-9d24-4a66-b920-8f5c17597d77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_6272ce5e-c4fd-4612-a6c8-e07056b5dcb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d2d4c32c-da23-4d25-b1e1-5aaafd42b334" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_6272ce5e-c4fd-4612-a6c8-e07056b5dcb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_29a19aa0-bac1-4275-b10c-1f6e42812948" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d204c571-bd4e-4074-8ae8-592fe3d14c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_29a19aa0-bac1-4275-b10c-1f6e42812948" xlink:to="loc_us-gaap_LiabilitiesCurrent_d204c571-bd4e-4074-8ae8-592fe3d14c7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_f1534dfc-4ced-470b-9de7-12e071b075dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_29a19aa0-bac1-4275-b10c-1f6e42812948" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_f1534dfc-4ced-470b-9de7-12e071b075dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_a1ffce35-8c62-459f-9558-92e9b33adf79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_5ce6c7f5-7b08-4b49-99cb-218466366472" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_a1ffce35-8c62-459f-9558-92e9b33adf79" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_5ce6c7f5-7b08-4b49-99cb-218466366472" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_98f735fc-ab83-45b4-a244-28ce73ac601c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_a1ffce35-8c62-459f-9558-92e9b33adf79" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_98f735fc-ab83-45b4-a244-28ce73ac601c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_9077412d-c214-404c-ae5e-91384111ceb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_a1ffce35-8c62-459f-9558-92e9b33adf79" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_9077412d-c214-404c-ae5e-91384111ceb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredLongTermDebt_ae2b3404-92db-4676-a907-43731da2df68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredLongTermDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_a1ffce35-8c62-459f-9558-92e9b33adf79" xlink:to="loc_us-gaap_UnsecuredLongTermDebt_ae2b3404-92db-4676-a907-43731da2df68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c131c0e8-05ce-46d0-a617-4255045325fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_a1ffce35-8c62-459f-9558-92e9b33adf79" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c131c0e8-05ce-46d0-a617-4255045325fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent_681a7b92-244b-4b52-acb5-f2e9803772ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_a1ffce35-8c62-459f-9558-92e9b33adf79" xlink:to="loc_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent_681a7b92-244b-4b52-acb5-f2e9803772ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_651c4e9f-2683-4909-b720-637e7e308c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_a1ffce35-8c62-459f-9558-92e9b33adf79" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_651c4e9f-2683-4909-b720-637e7e308c2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6bb4c3ba-2d7e-4602-b4bc-78f2b82ec588" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_aee89b82-aea0-4e54-8668-7f1f4a1cd87f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6bb4c3ba-2d7e-4602-b4bc-78f2b82ec588" xlink:to="loc_us-gaap_PreferredStockValue_aee89b82-aea0-4e54-8668-7f1f4a1cd87f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_47e1b3e0-787a-4a9d-8e01-41d360bca461" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6bb4c3ba-2d7e-4602-b4bc-78f2b82ec588" xlink:to="loc_us-gaap_CommonStockValue_47e1b3e0-787a-4a9d-8e01-41d360bca461" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_1faf0f49-ecdf-4dba-bc1f-2c3b49798329" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6bb4c3ba-2d7e-4602-b4bc-78f2b82ec588" xlink:to="loc_us-gaap_AdditionalPaidInCapital_1faf0f49-ecdf-4dba-bc1f-2c3b49798329" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b84730c5-c786-4594-af3f-774aa6a61954" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6bb4c3ba-2d7e-4602-b4bc-78f2b82ec588" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b84730c5-c786-4594-af3f-774aa6a61954" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_866fb30d-83f0-4c6e-a5bd-e1ed0d842a75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6bb4c3ba-2d7e-4602-b4bc-78f2b82ec588" xlink:to="loc_us-gaap_TreasuryStockCommonValue_866fb30d-83f0-4c6e-a5bd-e1ed0d842a75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b1d9a066-4238-425d-a50f-e4f5605d7089" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6bb4c3ba-2d7e-4602-b4bc-78f2b82ec588" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b1d9a066-4238-425d-a50f-e4f5605d7089" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_15a08cd3-6187-4b6d-af4f-1c3f8e094b78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9b574a1e-93eb-497e-b71b-759a4948f9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_15a08cd3-6187-4b6d-af4f-1c3f8e094b78" xlink:to="loc_us-gaap_Liabilities_9b574a1e-93eb-497e-b71b-759a4948f9f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_c3034931-fde1-487f-a169-3a97ed47adb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_15a08cd3-6187-4b6d-af4f-1c3f8e094b78" xlink:to="loc_us-gaap_CommitmentsAndContingencies_c3034931-fde1-487f-a169-3a97ed47adb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7d809ed4-633f-49ed-9e62-9f03718bb30f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_15a08cd3-6187-4b6d-af4f-1c3f8e094b78" xlink:to="loc_us-gaap_StockholdersEquity_7d809ed4-633f-49ed-9e62-9f03718bb30f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome" xlink:type="simple" xlink:href="prph-20231231.xsd#ConsolidatedStatementsofOperationsandOtherComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3c3b13f9-82a7-4339-bf9b-fc707dcc14b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_24d8a5ab-d3bb-46d5-9834-d501bbf792dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_3c3b13f9-82a7-4339-bf9b-fc707dcc14b7" xlink:to="loc_us-gaap_NetIncomeLoss_24d8a5ab-d3bb-46d5-9834-d501bbf792dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_fc2a43b8-0da5-4562-b7e6-b2718bfa7752" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_3c3b13f9-82a7-4339-bf9b-fc707dcc14b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_fc2a43b8-0da5-4562-b7e6-b2718bfa7752" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_ece23ae3-221e-4f50-9cac-c3aadbbd14f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7cb25cf1-e9cb-43b2-89d9-8b3661f5196f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ece23ae3-221e-4f50-9cac-c3aadbbd14f2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7cb25cf1-e9cb-43b2-89d9-8b3661f5196f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_d6306b4d-2722-4dd8-9ada-76689a787db1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ece23ae3-221e-4f50-9cac-c3aadbbd14f2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_d6306b4d-2722-4dd8-9ada-76689a787db1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_3951caf7-6739-412a-be4b-f216bd12f29f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_026af86c-8a2a-49f4-bd6d-f3a02d0267c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3951caf7-6739-412a-be4b-f216bd12f29f" xlink:to="loc_us-gaap_ProfessionalFees_026af86c-8a2a-49f4-bd6d-f3a02d0267c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_645a3873-35ca-438d-94b5-c676011c0e45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3951caf7-6739-412a-be4b-f216bd12f29f" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_645a3873-35ca-438d-94b5-c676011c0e45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d6e2443e-ed3a-4aeb-ba68-1c7a32d66265" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3951caf7-6739-412a-be4b-f216bd12f29f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d6e2443e-ed3a-4aeb-ba68-1c7a32d66265" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_02ed3dbe-d552-4887-a74d-737ccb4524b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_979840e2-118a-4775-a8b3-e05921a06ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_02ed3dbe-d552-4887-a74d-737ccb4524b1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_979840e2-118a-4775-a8b3-e05921a06ca1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f8f9a265-ff37-47ae-98f3-18043e851245" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_02ed3dbe-d552-4887-a74d-737ccb4524b1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f8f9a265-ff37-47ae-98f3-18043e851245" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d739cff-1239-4cc3-8922-7eb568a01a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b4ac8737-b29e-44a5-a9b4-55daa10aa2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d739cff-1239-4cc3-8922-7eb568a01a6e" xlink:to="loc_us-gaap_OperatingIncomeLoss_b4ac8737-b29e-44a5-a9b4-55daa10aa2ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_3b8ae64e-ce35-499c-83cc-8fe9c1985717" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d739cff-1239-4cc3-8922-7eb568a01a6e" xlink:to="loc_us-gaap_InterestIncomeOther_3b8ae64e-ce35-499c-83cc-8fe9c1985717" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c92cca18-f084-459a-84b4-2241143f861e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d739cff-1239-4cc3-8922-7eb568a01a6e" xlink:to="loc_us-gaap_InterestExpense_c92cca18-f084-459a-84b4-2241143f861e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_06db81ba-0624-4867-9c18-d872d86f595d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d739cff-1239-4cc3-8922-7eb568a01a6e" xlink:to="loc_us-gaap_GainLossOnInvestments_06db81ba-0624-4867-9c18-d872d86f595d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_19a6c263-d4b5-4063-b9e5-c0083864a838" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d739cff-1239-4cc3-8922-7eb568a01a6e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_19a6c263-d4b5-4063-b9e5-c0083864a838" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c5389f9d-2c32-4606-8b22-332c38af1586" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_2181ec0d-be43-4a73-816b-2e2c4009a926" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c5389f9d-2c32-4606-8b22-332c38af1586" xlink:to="loc_us-gaap_GrossProfit_2181ec0d-be43-4a73-816b-2e2c4009a926" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_cb8420e3-9e0d-40d8-9421-ef9bd193595e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c5389f9d-2c32-4606-8b22-332c38af1586" xlink:to="loc_us-gaap_OperatingExpenses_cb8420e3-9e0d-40d8-9421-ef9bd193595e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="prph-20231231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_17e974a5-c7d5-4d71-b773-85383d333d00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_17e974a5-c7d5-4d71-b773-85383d333d00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_07d32652-7966-44f4-9b68-34f75d9ff1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_07d32652-7966-44f4-9b68-34f75d9ff1dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities_62937ccf-ed8e-4456-a2f6-899df9d587c3" xlink:href="prph-20231231.xsd#prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities_62937ccf-ed8e-4456-a2f6-899df9d587c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_InventoryValuationReserve_e42506da-bd9e-4935-b8c5-ec04211aecb9" xlink:href="prph-20231231.xsd#prph_InventoryValuationReserve"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_prph_InventoryValuationReserve_e42506da-bd9e-4935-b8c5-ec04211aecb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_e2fcffc2-c699-4922-a04c-ffc63ebc357c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_e2fcffc2-c699-4922-a04c-ffc63ebc357c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_05317478-79c8-497c-8314-00bbd3e7fe9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_us-gaap_ShareBasedCompensation_05317478-79c8-497c-8314-00bbd3e7fe9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_8b907457-677f-4446-bf6b-31bc6921753e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_8b907457-677f-4446-bf6b-31bc6921753e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_a1e15361-0398-438e-9ddc-ca0561943ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_a1e15361-0398-438e-9ddc-ca0561943ae9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_4e40f027-0342-456d-a95d-aeb7aa0322c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_4e40f027-0342-456d-a95d-aeb7aa0322c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ChangeInFairValueOfInvestmentSecurities_2fb2aa28-db5b-406a-8bf6-7137b43a4524" xlink:href="prph-20231231.xsd#prph_ChangeInFairValueOfInvestmentSecurities"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_prph_ChangeInFairValueOfInvestmentSecurities_2fb2aa28-db5b-406a-8bf6-7137b43a4524" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_eb1b2412-4038-4393-8bfd-ccb2933cde3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForLoanLeaseAndOtherLosses"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_eb1b2412-4038-4393-8bfd-ccb2933cde3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4103bb13-a9ca-4d40-a7ea-ae1d177f6361" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4103bb13-a9ca-4d40-a7ea-ae1d177f6361" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IncreaseDecreaseInDeferredIncomeTaxAssets_040cc3f9-b561-4835-a5e6-3a16345925e6" xlink:href="prph-20231231.xsd#prph_IncreaseDecreaseInDeferredIncomeTaxAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_prph_IncreaseDecreaseInDeferredIncomeTaxAssets_040cc3f9-b561-4835-a5e6-3a16345925e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bee98058-25ff-4b6f-99cf-43391debe663" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bee98058-25ff-4b6f-99cf-43391debe663" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IncreaseDecreaseInAccruedDiagnosticServices_e22157c2-4d69-4d34-b9a4-841f87874179" xlink:href="prph-20231231.xsd#prph_IncreaseDecreaseInAccruedDiagnosticServices"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_prph_IncreaseDecreaseInAccruedDiagnosticServices_e22157c2-4d69-4d34-b9a4-841f87874179" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2c420b8f-dc55-44cb-a2d8-253f8dbf232b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2c420b8f-dc55-44cb-a2d8-253f8dbf232b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_636e1b19-4e8b-4fff-a915-bb950989daa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_636e1b19-4e8b-4fff-a915-bb950989daa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2b7fff1e-d4d5-471c-8c30-260ef229757b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2b7fff1e-d4d5-471c-8c30-260ef229757b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cb636fb6-a006-49a5-ad02-08338d53c9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_us-gaap_NetIncomeLoss_cb636fb6-a006-49a5-ad02-08338d53c9ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_9ef0a5bf-cef0-4291-8f23-9e5a1d3a92fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="20" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_9ef0a5bf-cef0-4291-8f23-9e5a1d3a92fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfProperties_d465f378-fefa-4449-8c4c-2c536df35495" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfProperties"/>
    <link:calculationArc order="21" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_us-gaap_GainLossOnSaleOfProperties_d465f378-fefa-4449-8c4c-2c536df35495" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_35380c3a-22ea-4672-a017-ec4342f3b755" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="22" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_35380c3a-22ea-4672-a017-ec4342f3b755" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_a2568a48-96e7-4b6d-9afc-b5fcd35529b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="23" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_a2568a48-96e7-4b6d-9afc-b5fcd35529b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances_842e16e6-967e-4964-904f-e777415b8d84" xlink:href="prph-20231231.xsd#prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances"/>
    <link:calculationArc order="24" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a70e52bb-2891-4bbd-9ae9-fd2d55b4eda3" xlink:to="loc_prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances_842e16e6-967e-4964-904f-e777415b8d84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a757da7e-8a9f-4673-b111-6d63cda1a8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_6e13cc29-ed23-4623-b23f-0181ff20b25a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a757da7e-8a9f-4673-b111-6d63cda1a8a4" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_6e13cc29-ed23-4623-b23f-0181ff20b25a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ddaff2c6-3502-445f-a50d-35b30bd7aadf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a757da7e-8a9f-4673-b111-6d63cda1a8a4" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ddaff2c6-3502-445f-a50d-35b30bd7aadf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_be7d30bc-7577-4146-b071-ce324354df29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a757da7e-8a9f-4673-b111-6d63cda1a8a4" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_be7d30bc-7577-4146-b071-ce324354df29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_2b6cdca6-996d-4885-a196-706def149259" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a757da7e-8a9f-4673-b111-6d63cda1a8a4" xlink:to="loc_us-gaap_PaymentsOfDividends_2b6cdca6-996d-4885-a196-706def149259" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_238e30e2-13fa-4ca5-b3b4-c5b04dac926a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a757da7e-8a9f-4673-b111-6d63cda1a8a4" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_238e30e2-13fa-4ca5-b3b4-c5b04dac926a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_df012b99-1ebb-4610-aac1-350796095c41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a757da7e-8a9f-4673-b111-6d63cda1a8a4" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_df012b99-1ebb-4610-aac1-350796095c41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_546c5f28-0645-4446-b497-9cc77b4b853b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c22f9d3d-413c-4af9-9804-85b581cb02ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_546c5f28-0645-4446-b497-9cc77b4b853b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c22f9d3d-413c-4af9-9804-85b581cb02ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cb0e7db6-780a-4954-a7ba-7ff0a7074676" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_546c5f28-0645-4446-b497-9cc77b4b853b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cb0e7db6-780a-4954-a7ba-7ff0a7074676" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7bccf853-386b-4587-ae6e-e897f93d3ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_546c5f28-0645-4446-b497-9cc77b4b853b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7bccf853-386b-4587-ae6e-e897f93d3ab9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_40ed66da-c04d-4d74-b462-d11109b4b2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_5dd56392-9755-4337-a652-6284c9f3af4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_40ed66da-c04d-4d74-b462-d11109b4b2bb" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_5dd56392-9755-4337-a652-6284c9f3af4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDepositsRelatedToPropertySales_30b61dcb-c3f7-4a0e-80b2-c43cc6814681" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EscrowDepositsRelatedToPropertySales"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_40ed66da-c04d-4d74-b462-d11109b4b2bb" xlink:to="loc_us-gaap_EscrowDepositsRelatedToPropertySales_30b61dcb-c3f7-4a0e-80b2-c43cc6814681" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_93d60b18-4b9a-4021-95d4-dd11948d5878" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_40ed66da-c04d-4d74-b462-d11109b4b2bb" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_93d60b18-4b9a-4021-95d4-dd11948d5878" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_d8adb2e6-825b-4556-80d6-2f4dff94704b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_40ed66da-c04d-4d74-b462-d11109b4b2bb" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_d8adb2e6-825b-4556-80d6-2f4dff94704b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_486b527e-7a15-41eb-a977-ff99da3b12f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_40ed66da-c04d-4d74-b462-d11109b4b2bb" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_486b527e-7a15-41eb-a977-ff99da3b12f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment_1da78666-e01b-4f70-92cf-a189b4a7da4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_40ed66da-c04d-4d74-b462-d11109b4b2bb" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment_1da78666-e01b-4f70-92cf-a189b4a7da4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_86ed69d3-f05b-4c3b-9c0b-7b656dfa17ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_40ed66da-c04d-4d74-b462-d11109b4b2bb" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_86ed69d3-f05b-4c3b-9c0b-7b656dfa17ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IssuanceOfSecuredPromissoryNoteReceivable_88887d14-398c-46f3-840c-b8e85ae99ba6" xlink:href="prph-20231231.xsd#prph_IssuanceOfSecuredPromissoryNoteReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_40ed66da-c04d-4d74-b462-d11109b4b2bb" xlink:to="loc_prph_IssuanceOfSecuredPromissoryNoteReceivable_88887d14-398c-46f3-840c-b8e85ae99ba6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_b3739e65-fc9e-4d51-a4fd-cb82b32cdfca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_40ed66da-c04d-4d74-b462-d11109b4b2bb" xlink:to="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_b3739e65-fc9e-4d51-a4fd-cb82b32cdfca" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails"/>
  <link:calculationLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_7900168f-a32a-4d61-b0d9-500f67fef303" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_InventoryLabMaterial_1c9c5704-e4cc-4a42-baee-b04a85d5a983" xlink:href="prph-20231231.xsd#prph_InventoryLabMaterial"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_7900168f-a32a-4d61-b0d9-500f67fef303" xlink:to="loc_prph_InventoryLabMaterial_1c9c5704-e4cc-4a42-baee-b04a85d5a983" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_def702fe-c682-4f4a-a783-195a34147c52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_7900168f-a32a-4d61-b0d9-500f67fef303" xlink:to="loc_us-gaap_InventoryRawMaterials_def702fe-c682-4f4a-a783-195a34147c52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_fbdf12e8-1a57-42c7-9e6f-b990c4548f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_7900168f-a32a-4d61-b0d9-500f67fef303" xlink:to="loc_us-gaap_InventoryWorkInProcess_fbdf12e8-1a57-42c7-9e6f-b990c4548f9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_c2c85343-5d34-4e11-a654-d8a030b8f588" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_7900168f-a32a-4d61-b0d9-500f67fef303" xlink:to="loc_us-gaap_InventoryFinishedGoods_c2c85343-5d34-4e11-a654-d8a030b8f588" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1e96d1d2-d809-468c-8f4a-59d53d91ad22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_2f92279b-2cdf-41c2-bac2-be83625dc074" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_1e96d1d2-d809-468c-8f4a-59d53d91ad22" xlink:to="loc_us-gaap_InventoryGross_2f92279b-2cdf-41c2-bac2-be83625dc074" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_d4965840-3bde-4957-aba4-dd80c876bbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryValuationReserves"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_1e96d1d2-d809-468c-8f4a-59d53d91ad22" xlink:to="loc_us-gaap_InventoryValuationReserves_d4965840-3bde-4957-aba4-dd80c876bbbd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#IntangibleAssetsNetScheduleofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cabb36af-b5cc-4566-8574-fda102b0442a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_87537d9e-b590-4561-803d-95cede6c97f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cabb36af-b5cc-4566-8574-fda102b0442a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_87537d9e-b590-4561-803d-95cede6c97f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e7772d28-8c78-4f72-91bd-2515c5882cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cabb36af-b5cc-4566-8574-fda102b0442a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e7772d28-8c78-4f72-91bd-2515c5882cfe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_90619b92-9505-48c2-be12-5ee8da2d2434" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0f4220c1-b268-4036-b235-ac1023ea7584" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_90619b92-9505-48c2-be12-5ee8da2d2434" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0f4220c1-b268-4036-b235-ac1023ea7584" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_8a5f17e0-522b-41ba-b0e9-3537898805af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_90619b92-9505-48c2-be12-5ee8da2d2434" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_8a5f17e0-522b-41ba-b0e9-3537898805af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_cac822ec-c14a-40c7-bbbe-7d774d81cffe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_90619b92-9505-48c2-be12-5ee8da2d2434" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_cac822ec-c14a-40c7-bbbe-7d774d81cffe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_522a55f1-6f88-4428-b33d-c2c24ca56a21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_90619b92-9505-48c2-be12-5ee8da2d2434" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_522a55f1-6f88-4428-b33d-c2c24ca56a21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_feb93ee0-9bc1-409c-9cc2-917cb0dd7c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_90619b92-9505-48c2-be12-5ee8da2d2434" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_feb93ee0-9bc1-409c-9cc2-917cb0dd7c6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_76ebec65-ca63-4704-9606-471ac72889cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_90619b92-9505-48c2-be12-5ee8da2d2434" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_76ebec65-ca63-4704-9606-471ac72889cc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_2f786da1-e1e4-4339-b53a-330b81265d18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_866a6214-25b0-4411-9142-1a6d11383e56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_2f786da1-e1e4-4339-b53a-330b81265d18" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_866a6214-25b0-4411-9142-1a6d11383e56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_d60e77e0-8d17-4bb6-8896-16bfa36a18ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_2f786da1-e1e4-4339-b53a-330b81265d18" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_d60e77e0-8d17-4bb6-8896-16bfa36a18ab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"/>
  <link:calculationLink xlink:role="http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9487670c-cd73-4074-bedd-d1b7adf06a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_ace825c3-ba37-4b82-bae9-a9f203f8dd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9487670c-cd73-4074-bedd-d1b7adf06a6a" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_ace825c3-ba37-4b82-bae9-a9f203f8dd3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_d49f30b7-a18b-4259-9f53-1dfa592e58d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9487670c-cd73-4074-bedd-d1b7adf06a6a" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_d49f30b7-a18b-4259-9f53-1dfa592e58d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_0be72ec4-bf41-4fa2-83e8-f6445c077987" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_39d94b52-79d3-45b1-9020-0c4a9e4ea1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_0be72ec4-bf41-4fa2-83e8-f6445c077987" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_39d94b52-79d3-45b1-9020-0c4a9e4ea1a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_6ff486ba-3edc-4f3c-9e3f-5f17785214e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_0be72ec4-bf41-4fa2-83e8-f6445c077987" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_6ff486ba-3edc-4f3c-9e3f-5f17785214e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_19b81127-1a10-4313-ab6c-0bd946c37ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_78de4778-96ac-415d-bc77-d01311c55a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_19b81127-1a10-4313-ab6c-0bd946c37ae5" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_78de4778-96ac-415d-bc77-d01311c55a2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_34a65a04-611f-44dc-8121-e552948f6dff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_19b81127-1a10-4313-ab6c-0bd946c37ae5" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_34a65a04-611f-44dc-8121-e552948f6dff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance_9f96002b-ac06-4b35-8962-f155fe863971" xlink:href="prph-20231231.xsd#prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_f9977a10-a88e-410d-9d2b-d8bf95293dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance_9f96002b-ac06-4b35-8962-f155fe863971" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_f9977a10-a88e-410d-9d2b-d8bf95293dcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_dfb39499-4d8a-46fd-a2fa-d3e21189214b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance_9f96002b-ac06-4b35-8962-f155fe863971" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_dfb39499-4d8a-46fd-a2fa-d3e21189214b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_f098d110-b8e4-4a75-94b3-72465fe7928b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance_9f96002b-ac06-4b35-8962-f155fe863971" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_f098d110-b8e4-4a75-94b3-72465fe7928b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_3aa3b220-cadf-47f4-8a15-d9cac6e5578a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance_9f96002b-ac06-4b35-8962-f155fe863971" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_3aa3b220-cadf-47f4-8a15-d9cac6e5578a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6ff44b70-44b4-43ad-95c4-246a98752af3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance_1467938d-0c47-4148-b1d5-2263b74f6450" xlink:href="prph-20231231.xsd#prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_6ff44b70-44b4-43ad-95c4-246a98752af3" xlink:to="loc_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance_1467938d-0c47-4148-b1d5-2263b74f6450" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4e726159-a300-486b-944d-70fc38b27a21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_6ff44b70-44b4-43ad-95c4-246a98752af3" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4e726159-a300-486b-944d-70fc38b27a21" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_f437386e-6ad5-411f-b705-1f6ea3cd2dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DeferredTaxLiabilitiesDepreciation_78098f4f-8db0-4078-94ca-24bf3b692889" xlink:href="prph-20231231.xsd#prph_DeferredTaxLiabilitiesDepreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_f437386e-6ad5-411f-b705-1f6ea3cd2dc0" xlink:to="loc_prph_DeferredTaxLiabilitiesDepreciation_78098f4f-8db0-4078-94ca-24bf3b692889" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_4c73ccb8-e82d-48a5-b9e9-c09a857a9714" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_f437386e-6ad5-411f-b705-1f6ea3cd2dc0" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_4c73ccb8-e82d-48a5-b9e9-c09a857a9714" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DeferredTaxLiabilitiesAmortization_e283b60c-0b94-44c1-8be3-4666ee4c6bbf" xlink:href="prph-20231231.xsd#prph_DeferredTaxLiabilitiesAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_f437386e-6ad5-411f-b705-1f6ea3cd2dc0" xlink:to="loc_prph_DeferredTaxLiabilitiesAmortization_e283b60c-0b94-44c1-8be3-4666ee4c6bbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_6efdb9cb-7e40-46de-b365-ff064446c23f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_f437386e-6ad5-411f-b705-1f6ea3cd2dc0" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_6efdb9cb-7e40-46de-b365-ff064446c23f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DeferredTaxAssetsCapitalLeaseObligations_94827dab-f23f-4d9e-ab7d-57f64bc0c5df" xlink:href="prph-20231231.xsd#prph_DeferredTaxAssetsCapitalLeaseObligations"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_f437386e-6ad5-411f-b705-1f6ea3cd2dc0" xlink:to="loc_prph_DeferredTaxAssetsCapitalLeaseObligations_94827dab-f23f-4d9e-ab7d-57f64bc0c5df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_1d6606dd-13bf-4968-a427-d0fc2ad7609f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_f437386e-6ad5-411f-b705-1f6ea3cd2dc0" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_1d6606dd-13bf-4968-a427-d0fc2ad7609f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_592dfd9c-6870-436d-9db8-67c7881721cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_f437386e-6ad5-411f-b705-1f6ea3cd2dc0" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_592dfd9c-6870-436d-9db8-67c7881721cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_0d000088-724f-4d52-8b61-60ba255138e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_f437386e-6ad5-411f-b705-1f6ea3cd2dc0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_0d000088-724f-4d52-8b61-60ba255138e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_84931661-dd65-41c9-bca9-47042bcbeb99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DeferredTaxLiabilitiesAmortization_d8e4fc33-917c-49ac-bcaa-23668be42047" xlink:href="prph-20231231.xsd#prph_DeferredTaxLiabilitiesAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_84931661-dd65-41c9-bca9-47042bcbeb99" xlink:to="loc_prph_DeferredTaxLiabilitiesAmortization_d8e4fc33-917c-49ac-bcaa-23668be42047" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_9c5da336-fec4-4a92-9387-e0b110dbe775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_84931661-dd65-41c9-bca9-47042bcbeb99" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_9c5da336-fec4-4a92-9387-e0b110dbe775" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_faaf2edb-3784-4b84-aff6-1afd66fc2044" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_84931661-dd65-41c9-bca9-47042bcbeb99" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_faaf2edb-3784-4b84-aff6-1afd66fc2044" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_13d0f672-e61d-42da-b5a8-3354c80dad68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_84931661-dd65-41c9-bca9-47042bcbeb99" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_13d0f672-e61d-42da-b5a8-3354c80dad68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_b9667b1d-b197-421d-8b98-62d56bf6e05e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_84931661-dd65-41c9-bca9-47042bcbeb99" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_b9667b1d-b197-421d-8b98-62d56bf6e05e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DeferredTaxAssetsCapitalLeaseObligations_e057bf90-7a46-4189-beec-4325e7f155c9" xlink:href="prph-20231231.xsd#prph_DeferredTaxAssetsCapitalLeaseObligations"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_84931661-dd65-41c9-bca9-47042bcbeb99" xlink:to="loc_prph_DeferredTaxAssetsCapitalLeaseObligations_e057bf90-7a46-4189-beec-4325e7f155c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DeferredTaxLiabilitiesDepreciation_682b3494-6e54-448f-9a8f-84094d943310" xlink:href="prph-20231231.xsd#prph_DeferredTaxLiabilitiesDepreciation"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_84931661-dd65-41c9-bca9-47042bcbeb99" xlink:to="loc_prph_DeferredTaxLiabilitiesDepreciation_682b3494-6e54-448f-9a8f-84094d943310" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_eba8027f-3597-4558-a996-035a55269faf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_84931661-dd65-41c9-bca9-47042bcbeb99" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_eba8027f-3597-4558-a996-035a55269faf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_cc085e93-6358-428b-85bf-ec4ed809712c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesForCommissionsExpenseAndTaxes_fc02ff3a-0685-422d-9b65-d65d8d7f2144" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesForCommissionsExpenseAndTaxes"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_cc085e93-6358-428b-85bf-ec4ed809712c" xlink:to="loc_us-gaap_AccruedLiabilitiesForCommissionsExpenseAndTaxes_fc02ff3a-0685-422d-9b65-d65d8d7f2144" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AccruedReturns_660b2e12-aaf5-48c8-b56c-418f963c8396" xlink:href="prph-20231231.xsd#prph_AccruedReturns"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_cc085e93-6358-428b-85bf-ec4ed809712c" xlink:to="loc_prph_AccruedReturns_660b2e12-aaf5-48c8-b56c-418f963c8396" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrent_1448963c-fa93-41ad-ade4-6da55bdd1aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedPayrollTaxesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_cc085e93-6358-428b-85bf-ec4ed809712c" xlink:to="loc_us-gaap_AccruedPayrollTaxesCurrent_1448963c-fa93-41ad-ade4-6da55bdd1aa8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_65639769-e1bc-4f03-9fd5-61be853d266c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_cc085e93-6358-428b-85bf-ec4ed809712c" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_65639769-e1bc-4f03-9fd5-61be853d266c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrent_0ef6e9ab-e54f-46a6-bb43-151ac6b123b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedBonusesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_cc085e93-6358-428b-85bf-ec4ed809712c" xlink:to="loc_us-gaap_AccruedBonusesCurrent_0ef6e9ab-e54f-46a6-bb43-151ac6b123b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_e7bc89a6-7d45-4953-ab66-84f25960ccac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_cc085e93-6358-428b-85bf-ec4ed809712c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_e7bc89a6-7d45-4953-ab66-84f25960ccac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails"/>
  <link:calculationLink xlink:role="http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prph_FinanceLeaseCost_88a8e13b-0c0f-4c9e-bece-7acebc2c10d0" xlink:href="prph-20231231.xsd#prph_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_1ec8f4bc-2445-4c26-9b15-73bc9d5b198e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_FinanceLeaseCost_88a8e13b-0c0f-4c9e-bece-7acebc2c10d0" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_1ec8f4bc-2445-4c26-9b15-73bc9d5b198e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6aeabf71-ebad-4e60-9fc7-0dc53693eaad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_FinanceLeaseCost_88a8e13b-0c0f-4c9e-bece-7acebc2c10d0" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6aeabf71-ebad-4e60-9fc7-0dc53693eaad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_8bd2e591-7138-4dd5-9e8f-91d3f7132ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_bbe50831-58e9-4bec-8c81-9f41bf4eec49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_VariableLeaseCost_8bd2e591-7138-4dd5-9e8f-91d3f7132ad3" xlink:to="loc_us-gaap_OperatingLeaseCost_bbe50831-58e9-4bec-8c81-9f41bf4eec49" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"/>
  <link:calculationLink xlink:role="http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityUndiscountedExcessAmount_1bbf43d9-2047-407d-aef7-05b405fbdddc" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_c4741b14-3f98-4f4e-bbe7-e6895ae1d053" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityUndiscountedExcessAmount_1bbf43d9-2047-407d-aef7-05b405fbdddc" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_c4741b14-3f98-4f4e-bbe7-e6895ae1d053" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7d3a59e1-573b-4c0e-ad35-2f1df82c4e80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityUndiscountedExcessAmount_1bbf43d9-2047-407d-aef7-05b405fbdddc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7d3a59e1-573b-4c0e-ad35-2f1df82c4e80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_78c8e91d-774c-4656-aed2-998b9cc7b32f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1b24dfd4-c2ff-4386-8508-8a5b2acf984a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_78c8e91d-774c-4656-aed2-998b9cc7b32f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1b24dfd4-c2ff-4386-8508-8a5b2acf984a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_fe761301-4480-4e78-9e0f-864c0d57a7c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_78c8e91d-774c-4656-aed2-998b9cc7b32f" xlink:to="loc_us-gaap_FinanceLeaseLiability_fe761301-4480-4e78-9e0f-864c0d57a7c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearTwo_4900d4bc-c98a-40bf-9848-08c1b5e420cd" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearTwo"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_91a529f3-f236-45b7-852d-a9a004624af5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaidYearTwo_4900d4bc-c98a-40bf-9848-08c1b5e420cd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_91a529f3-f236-45b7-852d-a9a004624af5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_988a4976-de16-4d7a-a7dd-2fefab5751ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaidYearTwo_4900d4bc-c98a-40bf-9848-08c1b5e420cd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_988a4976-de16-4d7a-a7dd-2fefab5751ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearFour_09c163f7-76a0-49fe-8a80-e6203aa07b22" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearFour"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8797c2aa-b009-4268-90df-927d90fbd0cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaidYearFour_09c163f7-76a0-49fe-8a80-e6203aa07b22" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8797c2aa-b009-4268-90df-927d90fbd0cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_a38be246-0de5-4004-afe9-10f2e0c71ece" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaidYearFour_09c163f7-76a0-49fe-8a80-e6203aa07b22" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_a38be246-0de5-4004-afe9-10f2e0c71ece" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidAfterYearFive_eaf009d7-e7dc-43d0-bf49-faa4f44fe3ee" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_af360f13-aba5-4c3a-89f6-b4cd48b27e47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaidAfterYearFive_eaf009d7-e7dc-43d0-bf49-faa4f44fe3ee" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_af360f13-aba5-4c3a-89f6-b4cd48b27e47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_7d656892-7569-4f13-baf9-b71f378a276e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaidAfterYearFive_eaf009d7-e7dc-43d0-bf49-faa4f44fe3ee" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_7d656892-7569-4f13-baf9-b71f378a276e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiability_9a184b56-05d6-4853-9542-4c55df87044c" xlink:href="prph-20231231.xsd#prph_LeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c124f259-9c01-4d50-ab11-5d318de6f5bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiability_9a184b56-05d6-4853-9542-4c55df87044c" xlink:to="loc_us-gaap_OperatingLeaseLiability_c124f259-9c01-4d50-ab11-5d318de6f5bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_57f974c9-605e-43f1-abeb-aba4019ef962" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiability_9a184b56-05d6-4853-9542-4c55df87044c" xlink:to="loc_us-gaap_FinanceLeaseLiability_57f974c9-605e-43f1-abeb-aba4019ef962" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a20f57b5-c03e-439c-a573-d1c1d371ea02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_644ad912-336a-4523-a42e-5139c1f7da5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a20f57b5-c03e-439c-a573-d1c1d371ea02" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_644ad912-336a-4523-a42e-5139c1f7da5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d90d7c72-8aaa-4865-99c1-add4f7ae81a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a20f57b5-c03e-439c-a573-d1c1d371ea02" xlink:to="loc_us-gaap_OperatingLeaseLiability_d90d7c72-8aaa-4865-99c1-add4f7ae81a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearOne_0af849d4-ae77-4f8d-955d-2338ccee6de1" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearOne"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_512bd784-78b8-4e59-b264-95bbaf51a350" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaidYearOne_0af849d4-ae77-4f8d-955d-2338ccee6de1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_512bd784-78b8-4e59-b264-95bbaf51a350" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_cdabf942-c818-4e4b-881c-ea7d7bb05da4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaidYearOne_0af849d4-ae77-4f8d-955d-2338ccee6de1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_cdabf942-c818-4e4b-881c-ea7d7bb05da4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaid_5c6768e4-1876-4376-8b59-c0a49b51605b" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaid"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearFour_f8bcfb22-d00b-4ab5-83a6-746f00ec48b1" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaid_5c6768e4-1876-4376-8b59-c0a49b51605b" xlink:to="loc_prph_LeaseLiabilityToBePaidYearFour_f8bcfb22-d00b-4ab5-83a6-746f00ec48b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearFive_5e6091b6-65f5-480f-a782-e23f01b09e06" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaid_5c6768e4-1876-4376-8b59-c0a49b51605b" xlink:to="loc_prph_LeaseLiabilityToBePaidYearFive_5e6091b6-65f5-480f-a782-e23f01b09e06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidAfterYearFive_feb8f311-a88c-4c85-80b3-a140177b44e9" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidAfterYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaid_5c6768e4-1876-4376-8b59-c0a49b51605b" xlink:to="loc_prph_LeaseLiabilityToBePaidAfterYearFive_feb8f311-a88c-4c85-80b3-a140177b44e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearThree_54d20e64-88cd-4eb1-90f5-fb4f6b55001e" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaid_5c6768e4-1876-4376-8b59-c0a49b51605b" xlink:to="loc_prph_LeaseLiabilityToBePaidYearThree_54d20e64-88cd-4eb1-90f5-fb4f6b55001e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearOne_6a391f33-3987-414b-995c-4c039bef7b33" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearOne"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaid_5c6768e4-1876-4376-8b59-c0a49b51605b" xlink:to="loc_prph_LeaseLiabilityToBePaidYearOne_6a391f33-3987-414b-995c-4c039bef7b33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearTwo_146f1873-2adc-49fd-a1dd-6f6417fc3d36" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearTwo"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaid_5c6768e4-1876-4376-8b59-c0a49b51605b" xlink:to="loc_prph_LeaseLiabilityToBePaidYearTwo_146f1873-2adc-49fd-a1dd-6f6417fc3d36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearFive_1f45df23-ed8f-4c66-9fd2-c9a3255a19e3" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_04b170da-d6d9-4ac0-bdb4-139eb732a98a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaidYearFive_1f45df23-ed8f-4c66-9fd2-c9a3255a19e3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_04b170da-d6d9-4ac0-bdb4-139eb732a98a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b5da8866-0697-46cd-96f0-a76c03125d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaidYearFive_1f45df23-ed8f-4c66-9fd2-c9a3255a19e3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b5da8866-0697-46cd-96f0-a76c03125d8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearThree_fc447724-adfb-4088-a004-ce5c29568b2f" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearThree"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_4d103c0c-8c86-4bb4-87c0-8531b1e2ff33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaidYearThree_fc447724-adfb-4088-a004-ce5c29568b2f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_4d103c0c-8c86-4bb4-87c0-8531b1e2ff33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_81be25f4-d011-4ecc-a170-6c03786c15c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaidYearThree_fc447724-adfb-4088-a004-ce5c29568b2f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_81be25f4-d011-4ecc-a170-6c03786c15c0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1" xlink:type="simple" xlink:href="prph-20231231.xsd#LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1"/>
  <link:calculationLink xlink:role="http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaid_55c7df61-94c2-4c47-acd6-5a822f08a979" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaid"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiability_3d4cfcf0-f8ae-40fa-85ab-50ee21554c74" xlink:href="prph-20231231.xsd#prph_LeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaid_55c7df61-94c2-4c47-acd6-5a822f08a979" xlink:to="loc_prph_LeaseLiability_3d4cfcf0-f8ae-40fa-85ab-50ee21554c74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityUndiscountedExcessAmount_efe86231-6b59-4808-a84e-61fcded2a14c" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_prph_LeaseLiabilityToBePaid_55c7df61-94c2-4c47-acd6-5a822f08a979" xlink:to="loc_prph_LeaseLiabilityUndiscountedExcessAmount_efe86231-6b59-4808-a84e-61fcded2a14c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_4e726025-7102-4e4d-bbce-f3f7f0f6422b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_d0f797b4-69a1-44f0-8693-37ff7cf40b47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_4e726025-7102-4e4d-bbce-f3f7f0f6422b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_d0f797b4-69a1-44f0-8693-37ff7cf40b47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_23b4ee97-a303-4cd2-9076-3590d153bf9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_4e726025-7102-4e4d-bbce-f3f7f0f6422b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_23b4ee97-a303-4cd2-9076-3590d153bf9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_c976a82e-4989-4c56-bbe3-0cb3a1c51070" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_4e726025-7102-4e4d-bbce-f3f7f0f6422b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_c976a82e-4989-4c56-bbe3-0cb3a1c51070" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_173aed28-1a94-43e1-a9d8-ad2535dcf8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_4e726025-7102-4e4d-bbce-f3f7f0f6422b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_173aed28-1a94-43e1-a9d8-ad2535dcf8d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_0b875982-10bd-4779-9cb9-c76fa04f8cec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_4e726025-7102-4e4d-bbce-f3f7f0f6422b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_0b875982-10bd-4779-9cb9-c76fa04f8cec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_84f3abc7-df64-4d0f-bf48-f3889dd0e6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_4e726025-7102-4e4d-bbce-f3f7f0f6422b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_84f3abc7-df64-4d0f-bf48-f3889dd0e6fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_75a05064-8d19-4417-8184-4bd267bc21b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_eda9c337-36e5-4e10-bc6c-36cbe1b25d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_75a05064-8d19-4417-8184-4bd267bc21b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_eda9c337-36e5-4e10-bc6c-36cbe1b25d2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8f80bb80-a1be-47b4-8849-1dedbeb30121" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_75a05064-8d19-4417-8184-4bd267bc21b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8f80bb80-a1be-47b4-8849-1dedbeb30121" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f9e00120-f065-4c2a-9c98-c393d99545a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_75a05064-8d19-4417-8184-4bd267bc21b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f9e00120-f065-4c2a-9c98-c393d99545a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_edccb5f1-c55a-4811-b016-5d0756a7f5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_75a05064-8d19-4417-8184-4bd267bc21b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_edccb5f1-c55a-4811-b016-5d0756a7f5e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0b3791cc-0d0e-4313-86e1-9f7692d51671" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_75a05064-8d19-4417-8184-4bd267bc21b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0b3791cc-0d0e-4313-86e1-9f7692d51671" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e7074305-5176-4456-b530-72368110b802" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_75a05064-8d19-4417-8184-4bd267bc21b0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e7074305-5176-4456-b530-72368110b802" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d38c4cea-d410-4020-8dd0-b7c9c84d6938" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_680bec76-d242-47cd-accd-59b974c6ac30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d38c4cea-d410-4020-8dd0-b7c9c84d6938" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_680bec76-d242-47cd-accd-59b974c6ac30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_9f51a064-c2f3-49e9-ac6a-d724f0bd652f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d38c4cea-d410-4020-8dd0-b7c9c84d6938" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_9f51a064-c2f3-49e9-ac6a-d724f0bd652f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_68257f1f-7d66-474b-b3e8-21fa552601d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d38c4cea-d410-4020-8dd0-b7c9c84d6938" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_68257f1f-7d66-474b-b3e8-21fa552601d3" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>17
<FILENAME>prph-20231231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:7788277e-a48e-4763-84b1-a7c7849f902f,g:9ac615ab-2322-4dd1-8a91-31a5eca0bd4d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://prophaselabs.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="prph-20231231.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ed3132b4-5194-4109-8b08-9046e6a87b37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4b404e28-9cad-464f-a32c-2f3d67e50c75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ed3132b4-5194-4109-8b08-9046e6a87b37" xlink:to="loc_us-gaap_StatementTable_4b404e28-9cad-464f-a32c-2f3d67e50c75" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_88a23cc9-5506-4a84-b9ce-63c43c4d70c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4b404e28-9cad-464f-a32c-2f3d67e50c75" xlink:to="loc_us-gaap_DebtInstrumentAxis_88a23cc9-5506-4a84-b9ce-63c43c4d70c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_88a23cc9-5506-4a84-b9ce-63c43c4d70c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_88a23cc9-5506-4a84-b9ce-63c43c4d70c1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_88a23cc9-5506-4a84-b9ce-63c43c4d70c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a4c468e7-f39b-48ed-9499-dd439bc159e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_88a23cc9-5506-4a84-b9ce-63c43c4d70c1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a4c468e7-f39b-48ed-9499-dd439bc159e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2023NoteMember_c38d4d6e-a7d4-4754-8d16-ed4059d1d360" xlink:href="prph-20231231.xsd#prph_A2023NoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a4c468e7-f39b-48ed-9499-dd439bc159e5" xlink:to="loc_prph_A2023NoteMember_c38d4d6e-a7d4-4754-8d16-ed4059d1d360" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_SeptemberTwoThousandAndTwentyNoteMember_2726a95f-2f7f-4644-b9e4-43e7c0d2fc88" xlink:href="prph-20231231.xsd#prph_SeptemberTwoThousandAndTwentyNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a4c468e7-f39b-48ed-9499-dd439bc159e5" xlink:to="loc_prph_SeptemberTwoThousandAndTwentyNoteMember_2726a95f-2f7f-4644-b9e4-43e7c0d2fc88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ed3132b4-5194-4109-8b08-9046e6a87b37" xlink:to="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_669e3a0a-14ba-43e5-8062-c22ff35225b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:to="loc_us-gaap_AssetsCurrentAbstract_669e3a0a-14ba-43e5-8062-c22ff35225b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e1897e89-9990-42a0-89dc-f5e5caa7517d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_669e3a0a-14ba-43e5-8062-c22ff35225b6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e1897e89-9990-42a0-89dc-f5e5caa7517d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_c54d4320-ed8b-4659-bffc-27ed6ecd9086" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_669e3a0a-14ba-43e5-8062-c22ff35225b6" xlink:to="loc_us-gaap_RestrictedCash_c54d4320-ed8b-4659-bffc-27ed6ecd9086" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_e2d7c579-7a0e-4b31-97ce-5560ee813b85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_669e3a0a-14ba-43e5-8062-c22ff35225b6" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_e2d7c579-7a0e-4b31-97ce-5560ee813b85" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_673611af-5d6e-4fa1-92e6-9b36a854f7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_669e3a0a-14ba-43e5-8062-c22ff35225b6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_673611af-5d6e-4fa1-92e6-9b36a854f7f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_47c3f4b6-324f-4cc4-968f-c1f253bdd2be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_669e3a0a-14ba-43e5-8062-c22ff35225b6" xlink:to="loc_us-gaap_InventoryNet_47c3f4b6-324f-4cc4-968f-c1f253bdd2be" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d49668cf-fb4e-491f-a546-563dca6870b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_669e3a0a-14ba-43e5-8062-c22ff35225b6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d49668cf-fb4e-491f-a546-563dca6870b4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2cd89b2c-9342-456e-8db3-cf6e3d62ce3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_669e3a0a-14ba-43e5-8062-c22ff35225b6" xlink:to="loc_us-gaap_AssetsCurrent_2cd89b2c-9342-456e-8db3-cf6e3d62ce3b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a244feb1-2201-4396-ace6-cee657370b06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a244feb1-2201-4396-ace6-cee657370b06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent_bc0f6d3d-79f4-41e7-ae47-dc924a41073d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:to="loc_us-gaap_PrepaidExpenseNoncurrent_bc0f6d3d-79f4-41e7-ae47-dc924a41073d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ee92831e-5a51-4aae-b558-f77bd4d3a989" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ee92831e-5a51-4aae-b558-f77bd4d3a989" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cf1d1911-803b-4137-a1e8-f87e9eeaf913" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cf1d1911-803b-4137-a1e8-f87e9eeaf913" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cf3ac7bf-a87c-4bd6-a771-fcbe209cd7df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:to="loc_us-gaap_Goodwill_cf3ac7bf-a87c-4bd6-a771-fcbe209cd7df" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_8358ec2e-662e-4d00-a606-793d3e52a782" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_8358ec2e-662e-4d00-a606-793d3e52a782" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_640a30d3-afe2-4059-80f3-45b7d70372bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_640a30d3-afe2-4059-80f3-45b7d70372bb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c88285a5-96da-4632-ad09-086d2e043bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:to="loc_us-gaap_Assets_c88285a5-96da-4632-ad09-086d2e043bcd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3d18abf4-a052-43ab-8cd7-f55833011d36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ed3132b4-5194-4109-8b08-9046e6a87b37" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3d18abf4-a052-43ab-8cd7-f55833011d36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3d18abf4-a052-43ab-8cd7-f55833011d36" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_ce6e004c-baab-427b-9452-cd226e138fca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:to="loc_us-gaap_AccountsPayableCurrent_ce6e004c-baab-427b-9452-cd226e138fca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_f73742f7-e65a-4e91-95e2-add06aa22b82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_f73742f7-e65a-4e91-95e2-add06aa22b82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_0ac6212a-845e-4bee-b893-9b42cc72808f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_0ac6212a-845e-4bee-b893-9b42cc72808f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_866fa658-490a-46f7-afc0-ff6abf7f85c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_866fa658-490a-46f7-afc0-ff6abf7f85c0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e12ca579-5d98-44f8-bc17-c10c7dfb2507" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e12ca579-5d98-44f8-bc17-c10c7dfb2507" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_87911f1a-d1fb-49ed-ade8-f19c3a533e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:to="loc_us-gaap_DeferredRevenueCurrent_87911f1a-d1fb-49ed-ade8-f19c3a533e3f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_31d360d1-1f9b-4c81-a9bf-0a320146041b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:to="loc_us-gaap_TaxesPayableCurrent_31d360d1-1f9b-4c81-a9bf-0a320146041b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_f7ef6680-ee13-48ed-99f2-901df8efdee3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_f7ef6680-ee13-48ed-99f2-901df8efdee3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8c7af506-25fe-4d1a-84c7-e392c537c9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:to="loc_us-gaap_LiabilitiesCurrent_8c7af506-25fe-4d1a-84c7-e392c537c9e4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3d18abf4-a052-43ab-8cd7-f55833011d36" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_7dbd1276-4963-451a-966a-31df631a3f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_7dbd1276-4963-451a-966a-31df631a3f8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredLongTermDebt_be0c084f-4363-4e86-8b1c-f30da578ee30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:to="loc_us-gaap_UnsecuredLongTermDebt_be0c084f-4363-4e86-8b1c-f30da578ee30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent_50c25302-0f20-424e-a99c-17c01ba1eba1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:to="loc_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent_50c25302-0f20-424e-a99c-17c01ba1eba1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ec8aa7e7-7375-4cbe-a5ac-08cfb03e8ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ec8aa7e7-7375-4cbe-a5ac-08cfb03e8ebe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_99fe0d68-9a41-4aa4-808b-102e5a08a6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_99fe0d68-9a41-4aa4-808b-102e5a08a6c8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_77a39aa7-7907-46cb-baa1-a3ceafbf1c65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_77a39aa7-7907-46cb-baa1-a3ceafbf1c65" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_df1920e8-b13b-40fd-8bf1-b6b92ca89f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_df1920e8-b13b-40fd-8bf1-b6b92ca89f3b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_20d32826-4c80-4007-b52d-ad67c3d4904c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_20d32826-4c80-4007-b52d-ad67c3d4904c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d084c931-b07f-461f-9f4c-3d38c5a26c08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3d18abf4-a052-43ab-8cd7-f55833011d36" xlink:to="loc_us-gaap_Liabilities_d084c931-b07f-461f-9f4c-3d38c5a26c08" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8ff35786-7f2e-4544-bd44-b03c408641b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3d18abf4-a052-43ab-8cd7-f55833011d36" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_8ff35786-7f2e-4544-bd44-b03c408641b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_0112e1a2-9cf2-4190-81da-f4fea3f6e994" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ed3132b4-5194-4109-8b08-9046e6a87b37" xlink:to="loc_us-gaap_CommitmentsAndContingencies_0112e1a2-9cf2-4190-81da-f4fea3f6e994" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_b8ceafb9-0b04-4f3f-8357-86a92105fe3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ed3132b4-5194-4109-8b08-9046e6a87b37" xlink:to="loc_us-gaap_StockholdersEquityAbstract_b8ceafb9-0b04-4f3f-8357-86a92105fe3d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_07c46871-1e4d-46a5-aa5d-412baf510802" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b8ceafb9-0b04-4f3f-8357-86a92105fe3d" xlink:to="loc_us-gaap_PreferredStockValue_07c46871-1e4d-46a5-aa5d-412baf510802" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f7c24e2a-486d-4a6f-9249-72ed42050358" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b8ceafb9-0b04-4f3f-8357-86a92105fe3d" xlink:to="loc_us-gaap_CommonStockValue_f7c24e2a-486d-4a6f-9249-72ed42050358" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_ee0fdc73-048f-4c74-bad4-d3b4abd36ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b8ceafb9-0b04-4f3f-8357-86a92105fe3d" xlink:to="loc_us-gaap_AdditionalPaidInCapital_ee0fdc73-048f-4c74-bad4-d3b4abd36ab2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0890acc1-3d29-47ef-8622-fb29b7562a14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b8ceafb9-0b04-4f3f-8357-86a92105fe3d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0890acc1-3d29-47ef-8622-fb29b7562a14" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_58d14c62-48d3-4163-8b5f-3c3a468c2b21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b8ceafb9-0b04-4f3f-8357-86a92105fe3d" xlink:to="loc_us-gaap_TreasuryStockCommonValue_58d14c62-48d3-4163-8b5f-3c3a468c2b21" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_989102a4-0277-4065-81a4-fd60fd0682b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b8ceafb9-0b04-4f3f-8357-86a92105fe3d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_989102a4-0277-4065-81a4-fd60fd0682b1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_079493cb-d3b2-4469-984a-1542c06e4b14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b8ceafb9-0b04-4f3f-8357-86a92105fe3d" xlink:to="loc_us-gaap_StockholdersEquity_079493cb-d3b2-4469-984a-1542c06e4b14" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="prph-20231231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9c2b0c70-fdb4-433d-97df-731977db3ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:to="loc_us-gaap_StatementTable_9c2b0c70-fdb4-433d-97df-731977db3ff3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b8804ebb-6ee5-48a4-9715-eb5eed910735" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9c2b0c70-fdb4-433d-97df-731977db3ff3" xlink:to="loc_us-gaap_DebtInstrumentAxis_b8804ebb-6ee5-48a4-9715-eb5eed910735" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b8804ebb-6ee5-48a4-9715-eb5eed910735_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b8804ebb-6ee5-48a4-9715-eb5eed910735" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b8804ebb-6ee5-48a4-9715-eb5eed910735_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_615884a1-b33c-4aec-a612-c89c32d90ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b8804ebb-6ee5-48a4-9715-eb5eed910735" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_615884a1-b33c-4aec-a612-c89c32d90ea5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2023NoteMember_81e4672f-28cf-4670-a12b-ad61d0c8365f" xlink:href="prph-20231231.xsd#prph_A2023NoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_615884a1-b33c-4aec-a612-c89c32d90ea5" xlink:to="loc_prph_A2023NoteMember_81e4672f-28cf-4670-a12b-ad61d0c8365f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_674bea13-d861-4eb2-95ca-cfbcd917c32b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_674bea13-d861-4eb2-95ca-cfbcd917c32b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_2912e3f9-f450-4e7e-b333-e146a9b19006" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_2912e3f9-f450-4e7e-b333-e146a9b19006" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1503e5ee-0acc-49d3-a5f2-e06277466c37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1503e5ee-0acc-49d3-a5f2-e06277466c37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_9ab997ae-e4a9-4fff-9456-e51dab88d884" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:to="loc_us-gaap_PreferredStockSharesIssued_9ab997ae-e4a9-4fff-9456-e51dab88d884" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_9aa4add2-62cc-46d2-b445-f0a37ad75849" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_9aa4add2-62cc-46d2-b445-f0a37ad75849" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_9b8e0f96-6b43-4c40-a0bc-adb84b1aa826" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_9b8e0f96-6b43-4c40-a0bc-adb84b1aa826" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_50445d6a-9edf-442f-9e32-3a9dafb767ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_50445d6a-9edf-442f-9e32-3a9dafb767ac" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1c51ef4b-9338-4baf-8fa5-daf98540a17e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1c51ef4b-9338-4baf-8fa5-daf98540a17e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_6b55ae8b-255f-4b2a-ac06-ce70f5956e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:to="loc_us-gaap_TreasuryStockCommonShares_6b55ae8b-255f-4b2a-ac06-ce70f5956e5a" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="prph-20231231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_88293b5b-b51b-4e9f-82b1-3a97c6e1f599" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a426b96d-568d-4a65-ad7f-fe48e611d3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_88293b5b-b51b-4e9f-82b1-3a97c6e1f599" xlink:to="loc_us-gaap_StatementTable_a426b96d-568d-4a65-ad7f-fe48e611d3a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e0116a88-4b5f-4f87-98f1-35d55bf191a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a426b96d-568d-4a65-ad7f-fe48e611d3a2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e0116a88-4b5f-4f87-98f1-35d55bf191a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e0116a88-4b5f-4f87-98f1-35d55bf191a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e0116a88-4b5f-4f87-98f1-35d55bf191a1" xlink:to="loc_us-gaap_EquityComponentDomain_e0116a88-4b5f-4f87-98f1-35d55bf191a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_806e505a-cb84-4bd9-b467-325d261deff7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e0116a88-4b5f-4f87-98f1-35d55bf191a1" xlink:to="loc_us-gaap_EquityComponentDomain_806e505a-cb84-4bd9-b467-325d261deff7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8353e436-b4b6-4717-877f-57a4041066ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_806e505a-cb84-4bd9-b467-325d261deff7" xlink:to="loc_us-gaap_CommonStockMember_8353e436-b4b6-4717-877f-57a4041066ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_08f18f4b-e893-4a6e-b95c-5589c9ad2eff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_806e505a-cb84-4bd9-b467-325d261deff7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_08f18f4b-e893-4a6e-b95c-5589c9ad2eff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_36702055-fa1b-4327-b954-08aed233aa35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_806e505a-cb84-4bd9-b467-325d261deff7" xlink:to="loc_us-gaap_RetainedEarningsMember_36702055-fa1b-4327-b954-08aed233aa35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e7b0ca84-d01e-4058-bd50-4aaf5e56f201" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_806e505a-cb84-4bd9-b467-325d261deff7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e7b0ca84-d01e-4058-bd50-4aaf5e56f201" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_546e3702-fcf8-49d3-82fe-6d6968e54888" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_806e505a-cb84-4bd9-b467-325d261deff7" xlink:to="loc_us-gaap_TreasuryStockCommonMember_546e3702-fcf8-49d3-82fe-6d6968e54888" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_88293b5b-b51b-4e9f-82b1-3a97c6e1f599" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_517b28ab-fbd6-4b6c-aca4-a4d845dcd337" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_517b28ab-fbd6-4b6c-aca4-a4d845dcd337" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_45d1ce42-9821-40df-86d3-1e0517b0e716" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_StockholdersEquity_45d1ce42-9821-40df-86d3-1e0517b0e716" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_5355bef7-ab24-453f-b94d-a4c93a989ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_5355bef7-ab24-453f-b94d-a4c93a989ed3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_578d8dbf-7d9b-434f-a3b3-7c43e8dbe1af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_578d8dbf-7d9b-434f-a3b3-7c43e8dbe1af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_6d1c797f-7905-4c02-b5e3-05be00c8ff5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_6d1c797f-7905-4c02-b5e3-05be00c8ff5c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_34f53882-4bce-4330-9894-43d58759650c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_34f53882-4bce-4330-9894-43d58759650c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_aa3d43d1-b20e-4653-8e8d-03ca317d44e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_aa3d43d1-b20e-4653-8e8d-03ca317d44e0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_57302380-c2d2-4f8e-9a78-e9cb7a6ffbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_57302380-c2d2-4f8e-9a78-e9cb7a6ffbe5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_f0e75b49-e440-4445-b9f6-1a5a06bf1ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_DividendsCommonStockCash_f0e75b49-e440-4445-b9f6-1a5a06bf1ea5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IssuanceOfCommonStockSharesExerciseOfWarrant_9802c44b-6820-4d00-ab68-561efde3acad" xlink:href="prph-20231231.xsd#prph_IssuanceOfCommonStockSharesExerciseOfWarrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_prph_IssuanceOfCommonStockSharesExerciseOfWarrant_9802c44b-6820-4d00-ab68-561efde3acad" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount_e2adbe3f-0708-421c-8897-8bef3eea87ef" xlink:href="prph-20231231.xsd#prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount_e2adbe3f-0708-421c-8897-8bef3eea87ef" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f06738d0-44a3-4cf0-abaa-fb216dd21472" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f06738d0-44a3-4cf0-abaa-fb216dd21472" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_f16e5bc1-f338-4173-a230-96cb53cecaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_f16e5bc1-f338-4173-a230-96cb53cecaf4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_706771d1-7799-4b43-9459-1f780b3865f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_706771d1-7799-4b43-9459-1f780b3865f8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_92c4ee4d-d09d-443b-aaa7-f87bdef65bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_92c4ee4d-d09d-443b-aaa7-f87bdef65bdf" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7c609e9b-de28-40ac-86dc-e8775bbe695c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7c609e9b-de28-40ac-86dc-e8775bbe695c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a5116e0f-95f7-49b1-8aef-f5c2d58ed6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_NetIncomeLoss_a5116e0f-95f7-49b1-8aef-f5c2d58ed6d6" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_40ab16e3-5bea-46f7-b7c6-71a5f7bca3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_81608d0c-f1e9-48f4-a061-23f2150c52cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/OrganizationandBusinessNarrativeDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#OrganizationandBusinessNarrativeDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/OrganizationandBusinessNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a2446c90-4f0a-4f30-afd4-2b4b6afca15d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b365d673-0010-434d-84c8-0923114a8b55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2446c90-4f0a-4f30-afd4-2b4b6afca15d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b365d673-0010-434d-84c8-0923114a8b55" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1d028c80-4abc-4a8c-96e9-b96e7bcd1aea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b365d673-0010-434d-84c8-0923114a8b55" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1d028c80-4abc-4a8c-96e9-b96e7bcd1aea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d028c80-4abc-4a8c-96e9-b96e7bcd1aea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1d028c80-4abc-4a8c-96e9-b96e7bcd1aea" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d028c80-4abc-4a8c-96e9-b96e7bcd1aea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8750eb3c-8149-427a-923a-b27b1c1a40f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1d028c80-4abc-4a8c-96e9-b96e7bcd1aea" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8750eb3c-8149-427a-923a-b27b1c1a40f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CPMMember_fb84f36c-f24c-4ed7-b4a4-904628a64ad7" xlink:href="prph-20231231.xsd#prph_CPMMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8750eb3c-8149-427a-923a-b27b1c1a40f2" xlink:to="loc_prph_CPMMember_fb84f36c-f24c-4ed7-b4a4-904628a64ad7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_3a70b61d-8573-4c0c-9532-2842b297b419" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2446c90-4f0a-4f30-afd4-2b4b6afca15d" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_3a70b61d-8573-4c0c-9532-2842b297b419" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9b5cff34-33d2-4103-aa65-f31f0494e484" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2446c90-4f0a-4f30-afd4-2b4b6afca15d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9b5cff34-33d2-4103-aa65-f31f0494e484" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfLicensedCompounds_9207c197-0e77-48be-805f-6010fe8cfe7d" xlink:href="prph-20231231.xsd#prph_NumberOfLicensedCompounds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2446c90-4f0a-4f30-afd4-2b4b6afca15d" xlink:to="loc_prph_NumberOfLicensedCompounds_9207c197-0e77-48be-805f-6010fe8cfe7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfInhibitors_615312b0-8261-4e87-96cc-9a9742c6b86a" xlink:href="prph-20231231.xsd#prph_NumberOfInhibitors"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2446c90-4f0a-4f30-afd4-2b4b6afca15d" xlink:to="loc_prph_NumberOfInhibitors_615312b0-8261-4e87-96cc-9a9742c6b86a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beafc682-d6c5-4a58-8f07-20d261c0c672" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beafc682-d6c5-4a58-8f07-20d261c0c672" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0049a9ed-dfc8-42da-b70e-f781ae2047b6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beafc682-d6c5-4a58-8f07-20d261c0c672" xlink:to="loc_srt_RangeAxis_0049a9ed-dfc8-42da-b70e-f781ae2047b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0049a9ed-dfc8-42da-b70e-f781ae2047b6_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0049a9ed-dfc8-42da-b70e-f781ae2047b6" xlink:to="loc_srt_RangeMember_0049a9ed-dfc8-42da-b70e-f781ae2047b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_caa99b94-03ea-482f-b1cd-9c8dec69d5ca" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0049a9ed-dfc8-42da-b70e-f781ae2047b6" xlink:to="loc_srt_RangeMember_caa99b94-03ea-482f-b1cd-9c8dec69d5ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_31caf064-26c2-46d5-b93d-5485f71213a6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_caa99b94-03ea-482f-b1cd-9c8dec69d5ca" xlink:to="loc_srt_MinimumMember_31caf064-26c2-46d5-b93d-5485f71213a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_471ae9d4-f08c-400b-8a7d-b50e7f5652e3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_caa99b94-03ea-482f-b1cd-9c8dec69d5ca" xlink:to="loc_srt_MaximumMember_471ae9d4-f08c-400b-8a7d-b50e7f5652e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_1f4554ba-ddfe-47bd-a6e1-0d5355b99383" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beafc682-d6c5-4a58-8f07-20d261c0c672" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_1f4554ba-ddfe-47bd-a6e1-0d5355b99383" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_1f4554ba-ddfe-47bd-a6e1-0d5355b99383_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_1f4554ba-ddfe-47bd-a6e1-0d5355b99383" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_1f4554ba-ddfe-47bd-a6e1-0d5355b99383_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_fd302df9-be66-4d9c-be7a-08a830c4f7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_1f4554ba-ddfe-47bd-a6e1-0d5355b99383" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_fd302df9-be66-4d9c-be7a-08a830c4f7f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CooperativeIncentivePromotionCostsMember_420058c1-94ed-4c5a-8f14-dc314c95aafc" xlink:href="prph-20231231.xsd#prph_CooperativeIncentivePromotionCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_fd302df9-be66-4d9c-be7a-08a830c4f7f9" xlink:to="loc_prph_CooperativeIncentivePromotionCostsMember_420058c1-94ed-4c5a-8f14-dc314c95aafc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7274e0f3-82cd-4e16-94d8-35b1cffbe2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beafc682-d6c5-4a58-8f07-20d261c0c672" xlink:to="loc_us-gaap_DebtInstrumentAxis_7274e0f3-82cd-4e16-94d8-35b1cffbe2c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7274e0f3-82cd-4e16-94d8-35b1cffbe2c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7274e0f3-82cd-4e16-94d8-35b1cffbe2c1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7274e0f3-82cd-4e16-94d8-35b1cffbe2c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_11c99144-ddcc-4026-a9a1-f8c3e3b85309" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7274e0f3-82cd-4e16-94d8-35b1cffbe2c1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_11c99144-ddcc-4026-a9a1-f8c3e3b85309" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_MarketableSecuritiesMember_6f8b6afd-a2ee-476f-ab8b-1b2605005e83" xlink:href="prph-20231231.xsd#prph_MarketableSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_11c99144-ddcc-4026-a9a1-f8c3e3b85309" xlink:to="loc_prph_MarketableSecuritiesMember_6f8b6afd-a2ee-476f-ab8b-1b2605005e83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_20d22b3d-df0d-4045-a9e8-956dee992a87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beafc682-d6c5-4a58-8f07-20d261c0c672" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_20d22b3d-df0d-4045-a9e8-956dee992a87" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_20d22b3d-df0d-4045-a9e8-956dee992a87_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_20d22b3d-df0d-4045-a9e8-956dee992a87" xlink:to="loc_us-gaap_ReceivableTypeDomain_20d22b3d-df0d-4045-a9e8-956dee992a87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_0c442178-fc96-4d7f-b4e0-311c9d597181" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_20d22b3d-df0d-4045-a9e8-956dee992a87" xlink:to="loc_us-gaap_ReceivableTypeDomain_0c442178-fc96-4d7f-b4e0-311c9d597181" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_UncollectibleTradeReceivablesMember_950d1bab-e339-414a-ba3a-a1d2bc9741c4" xlink:href="prph-20231231.xsd#prph_UncollectibleTradeReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_0c442178-fc96-4d7f-b4e0-311c9d597181" xlink:to="loc_prph_UncollectibleTradeReceivablesMember_950d1bab-e339-414a-ba3a-a1d2bc9741c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_FullyReservedTradeReceivablesMember_1a7818b7-5d01-478a-8d5d-7671fe44f71c" xlink:href="prph-20231231.xsd#prph_FullyReservedTradeReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_0c442178-fc96-4d7f-b4e0-311c9d597181" xlink:to="loc_prph_FullyReservedTradeReceivablesMember_1a7818b7-5d01-478a-8d5d-7671fe44f71c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_938903c2-f484-4766-ac87-b5a5c488bea7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beafc682-d6c5-4a58-8f07-20d261c0c672" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_938903c2-f484-4766-ac87-b5a5c488bea7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_938903c2-f484-4766-ac87-b5a5c488bea7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_938903c2-f484-4766-ac87-b5a5c488bea7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_938903c2-f484-4766-ac87-b5a5c488bea7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_040164e3-804d-46a7-a920-576ff271bc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_938903c2-f484-4766-ac87-b5a5c488bea7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_040164e3-804d-46a7-a920-576ff271bc8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_7d2cfbb5-d2f1-40df-90e8-ae1d0b648752" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_040164e3-804d-46a7-a920-576ff271bc8e" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_7d2cfbb5-d2f1-40df-90e8-ae1d0b648752" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_448f9825-bade-4bf8-9803-962edf8f971e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_040164e3-804d-46a7-a920-576ff271bc8e" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_448f9825-bade-4bf8-9803-962edf8f971e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_fb41a272-58fe-40fe-ac71-ca51d083e761" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_040164e3-804d-46a7-a920-576ff271bc8e" xlink:to="loc_us-gaap_ComputerEquipmentMember_fb41a272-58fe-40fe-ac71-ca51d083e761" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_ce8dfd8e-abc0-4d19-813b-27e956450cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_040164e3-804d-46a7-a920-576ff271bc8e" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_ce8dfd8e-abc0-4d19-813b-27e956450cfe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_83a0deab-e6f8-4c80-9236-c3ff5310a387" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beafc682-d6c5-4a58-8f07-20d261c0c672" xlink:to="loc_srt_ProductOrServiceAxis_83a0deab-e6f8-4c80-9236-c3ff5310a387" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_83a0deab-e6f8-4c80-9236-c3ff5310a387_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_83a0deab-e6f8-4c80-9236-c3ff5310a387" xlink:to="loc_srt_ProductsAndServicesDomain_83a0deab-e6f8-4c80-9236-c3ff5310a387_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_31207ee4-5d5b-470e-afa9-0232ae2363d1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_83a0deab-e6f8-4c80-9236-c3ff5310a387" xlink:to="loc_srt_ProductsAndServicesDomain_31207ee4-5d5b-470e-afa9-0232ae2363d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_PersonalGenomicsBusinessMember_4bd0cc74-1477-4f34-8dc5-0f369baae26b" xlink:href="prph-20231231.xsd#prph_PersonalGenomicsBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_31207ee4-5d5b-470e-afa9-0232ae2363d1" xlink:to="loc_prph_PersonalGenomicsBusinessMember_4bd0cc74-1477-4f34-8dc5-0f369baae26b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f61ab50e-4ffc-494c-88a4-264118997e17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beafc682-d6c5-4a58-8f07-20d261c0c672" xlink:to="loc_us-gaap_AwardTypeAxis_f61ab50e-4ffc-494c-88a4-264118997e17" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f61ab50e-4ffc-494c-88a4-264118997e17_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f61ab50e-4ffc-494c-88a4-264118997e17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f61ab50e-4ffc-494c-88a4-264118997e17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ee03e0a-6a1f-4f20-8e60-857743f7c41d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f61ab50e-4ffc-494c-88a4-264118997e17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ee03e0a-6a1f-4f20-8e60-857743f7c41d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3d950196-4beb-435b-868e-86ee6475c92b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ee03e0a-6a1f-4f20-8e60-857743f7c41d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3d950196-4beb-435b-868e-86ee6475c92b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_d4c4a055-5f54-4ca7-afd1-646ac188b576" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_NumberOfOperatingSegments_d4c4a055-5f54-4ca7-afd1-646ac188b576" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfTestsRecognized_d465df90-57ba-4529-8d35-08d03e455e38" xlink:href="prph-20231231.xsd#prph_NumberOfTestsRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_prph_NumberOfTestsRecognized_d465df90-57ba-4529-8d35-08d03e455e38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage_743ee9ca-b093-4f89-8cc6-f8cc74e055c9" xlink:href="prph-20231231.xsd#prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage_743ee9ca-b093-4f89-8cc6-f8cc74e055c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d438595-1ac4-4675-ab13-afdf37ece21c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d438595-1ac4-4675-ab13-afdf37ece21c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_3eb9fc89-cd01-40f5-82a5-41b2c3f31d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_3eb9fc89-cd01-40f5-82a5-41b2c3f31d8f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit_a85bf443-3349-477d-9529-eedbdb977ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EscrowDeposit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_EscrowDeposit_a85bf443-3349-477d-9529-eedbdb977ea8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DebtSecuritiesAvailableForSaleMaturityPeriod_33cbaf9b-a316-4541-8e57-3b7810160f90" xlink:href="prph-20231231.xsd#prph_DebtSecuritiesAvailableForSaleMaturityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_prph_DebtSecuritiesAvailableForSaleMaturityPeriod_33cbaf9b-a316-4541-8e57-3b7810160f90" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_6cb95b33-51e5-4f09-b0a2-f81ca3bb40b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_6cb95b33-51e5-4f09-b0a2-f81ca3bb40b1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_b8317fbd-68ee-4d8d-8768-63e85c6836b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_b8317fbd-68ee-4d8d-8768-63e85c6836b6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_4b1c85f5-430f-42fd-b3b8-4c9e5dd5583c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_4b1c85f5-430f-42fd-b3b8-4c9e5dd5583c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_01d79fd2-73ad-4861-a96d-02bade255feb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_01d79fd2-73ad-4861-a96d-02bade255feb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_9ccadffc-d6a0-4158-93d7-3465055ef538" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_9ccadffc-d6a0-4158-93d7-3465055ef538" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8531d84c-dc89-4f40-baf7-73adab8f937f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8531d84c-dc89-4f40-baf7-73adab8f937f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7c82d3e7-578d-4e79-b2da-91e280068b79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7c82d3e7-578d-4e79-b2da-91e280068b79" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFDICInsuredAmount_fe5fa09c-4377-4ce4-9bab-df0562fb2b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFDICInsuredAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_CashFDICInsuredAmount_fe5fa09c-4377-4ce4-9bab-df0562fb2b1b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashUninsuredAmount_39e1cba7-f4fe-42d5-8d82-bf336bd6b65c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashUninsuredAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_CashUninsuredAmount_39e1cba7-f4fe-42d5-8d82-bf336bd6b65c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_b0ae003c-f202-461b-a27a-9c53f71263fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_AssetImpairmentCharges_b0ae003c-f202-461b-a27a-9c53f71263fd" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_78697611-6efb-4d86-9940-f423faed505f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_ContractWithCustomerLiability_78697611-6efb-4d86-9940-f423faed505f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_7adeec6f-1e57-49c9-93ce-38dab0b8736e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_AdvertisingExpense_7adeec6f-1e57-49c9-93ce-38dab0b8736e" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_701ab86b-0f40-40eb-b308-d9d7c9d40a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_701ab86b-0f40-40eb-b308-d9d7c9d40a2e" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_94134efc-0c51-4f0e-a214-29ccacc3143b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_94134efc-0c51-4f0e-a214-29ccacc3143b" xlink:type="arc" order="20"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_19cf9d0b-6781-476a-a3d8-3d5716218dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_d328b944-e0f4-41bf-be7d-05c660949d74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_19cf9d0b-6781-476a-a3d8-3d5716218dc4" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_d328b944-e0f4-41bf-be7d-05c660949d74" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_493a44e8-b12b-4185-aae2-7b87ffe65b67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_d328b944-e0f4-41bf-be7d-05c660949d74" xlink:to="loc_us-gaap_FinancialInstrumentAxis_493a44e8-b12b-4185-aae2-7b87ffe65b67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_493a44e8-b12b-4185-aae2-7b87ffe65b67_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_493a44e8-b12b-4185-aae2-7b87ffe65b67" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_493a44e8-b12b-4185-aae2-7b87ffe65b67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cab62d67-ecb0-4298-9cfa-f9c3d23ec6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_493a44e8-b12b-4185-aae2-7b87ffe65b67" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cab62d67-ecb0-4298-9cfa-f9c3d23ec6cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CorporateStockMember_b8eb377a-68e6-4d70-8895-faba050020c4" xlink:href="prph-20231231.xsd#prph_CorporateStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cab62d67-ecb0-4298-9cfa-f9c3d23ec6cf" xlink:to="loc_prph_CorporateStockMember_b8eb377a-68e6-4d70-8895-faba050020c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_USGovernmentObligationsMember_1b7d6cbc-156b-4da8-bfbb-a74630a880bc" xlink:href="prph-20231231.xsd#prph_USGovernmentObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cab62d67-ecb0-4298-9cfa-f9c3d23ec6cf" xlink:to="loc_prph_USGovernmentObligationsMember_1b7d6cbc-156b-4da8-bfbb-a74630a880bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CorporateObligationsMember_0a979990-17fd-40cc-a15c-69284c72fa67" xlink:href="prph-20231231.xsd#prph_CorporateObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cab62d67-ecb0-4298-9cfa-f9c3d23ec6cf" xlink:to="loc_prph_CorporateObligationsMember_0a979990-17fd-40cc-a15c-69284c72fa67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_06cc7d9c-31e3-450a-88d3-d33b678409c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_19cf9d0b-6781-476a-a3d8-3d5716218dc4" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_06cc7d9c-31e3-450a-88d3-d33b678409c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a8f640d5-115c-4f56-a772-e8abe659f175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_19cf9d0b-6781-476a-a3d8-3d5716218dc4" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a8f640d5-115c-4f56-a772-e8abe659f175" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_59336856-5807-4983-8d5c-4130fa501512" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_19cf9d0b-6781-476a-a3d8-3d5716218dc4" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_59336856-5807-4983-8d5c-4130fa501512" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_807c20da-3976-461e-9eda-95631650d800" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_19cf9d0b-6781-476a-a3d8-3d5716218dc4" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_807c20da-3976-461e-9eda-95631650d800" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_82966f65-c4d1-49b3-bf24-ab09e0dabcca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_4d6a74b2-b18a-4d19-8fe2-26b058681b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_82966f65-c4d1-49b3-bf24-ab09e0dabcca" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_4d6a74b2-b18a-4d19-8fe2-26b058681b3e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_27fca85e-e107-4073-b0d8-e72d6707684c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_4d6a74b2-b18a-4d19-8fe2-26b058681b3e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_27fca85e-e107-4073-b0d8-e72d6707684c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_27fca85e-e107-4073-b0d8-e72d6707684c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_27fca85e-e107-4073-b0d8-e72d6707684c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_27fca85e-e107-4073-b0d8-e72d6707684c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1ac0215b-c028-4d8d-9487-b7ed6beaed0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_27fca85e-e107-4073-b0d8-e72d6707684c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1ac0215b-c028-4d8d-9487-b7ed6beaed0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CorporateStockMember_577a5292-c094-47c6-be20-deedf0a98ebf" xlink:href="prph-20231231.xsd#prph_CorporateStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1ac0215b-c028-4d8d-9487-b7ed6beaed0b" xlink:to="loc_prph_CorporateStockMember_577a5292-c094-47c6-be20-deedf0a98ebf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_USGovernmentObligationsMember_fea81789-e6b1-4f10-be92-03c5646dfd5a" xlink:href="prph-20231231.xsd#prph_USGovernmentObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1ac0215b-c028-4d8d-9487-b7ed6beaed0b" xlink:to="loc_prph_USGovernmentObligationsMember_fea81789-e6b1-4f10-be92-03c5646dfd5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CorporateObligationsMember_d488f903-5445-4e85-951b-893387e0a1de" xlink:href="prph-20231231.xsd#prph_CorporateObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1ac0215b-c028-4d8d-9487-b7ed6beaed0b" xlink:to="loc_prph_CorporateObligationsMember_d488f903-5445-4e85-951b-893387e0a1de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b6c3bce2-9d84-4cef-83b2-740a358db6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_4d6a74b2-b18a-4d19-8fe2-26b058681b3e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b6c3bce2-9d84-4cef-83b2-740a358db6c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b6c3bce2-9d84-4cef-83b2-740a358db6c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b6c3bce2-9d84-4cef-83b2-740a358db6c4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b6c3bce2-9d84-4cef-83b2-740a358db6c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_66c5d8c5-6fef-459c-85dd-b34993185d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b6c3bce2-9d84-4cef-83b2-740a358db6c4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_66c5d8c5-6fef-459c-85dd-b34993185d7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_81153f38-bbd5-42cd-b050-05268b50ec83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_66c5d8c5-6fef-459c-85dd-b34993185d7b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_81153f38-bbd5-42cd-b050-05268b50ec83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3d71706f-c4a7-4e3d-96d0-99c53de2cc45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_66c5d8c5-6fef-459c-85dd-b34993185d7b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_3d71706f-c4a7-4e3d-96d0-99c53de2cc45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_cdd3a87a-c04b-45fd-84bb-f5d7ce08e502" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_66c5d8c5-6fef-459c-85dd-b34993185d7b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_cdd3a87a-c04b-45fd-84bb-f5d7ce08e502" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_c2790317-98e8-45c7-a57b-4edd004ededf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_82966f65-c4d1-49b3-bf24-ab09e0dabcca" xlink:to="loc_us-gaap_MarketableSecurities_c2790317-98e8-45c7-a57b-4edd004ededf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementLineItems_b184ba71-7cd9-4cca-9363-d60464c79825" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementByTypeTable_183afae6-c93d-4d6d-a0ff-be82d628ceb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementByTypeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_b184ba71-7cd9-4cca-9363-d60464c79825" xlink:to="loc_us-gaap_DeferredRevenueArrangementByTypeTable_183afae6-c93d-4d6d-a0ff-be82d628ceb7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b9dddb84-cf93-4ca8-b1af-069c584928d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_183afae6-c93d-4d6d-a0ff-be82d628ceb7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b9dddb84-cf93-4ca8-b1af-069c584928d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_5b2c49c2-6400-401c-9ed3-5b38459cc1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_b184ba71-7cd9-4cca-9363-d60464c79825" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_5b2c49c2-6400-401c-9ed3-5b38459cc1e8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails_1" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails_1"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementLineItems_b184ba71-7cd9-4cca-9363-d60464c79825" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementByTypeTable_183afae6-c93d-4d6d-a0ff-be82d628ceb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementByTypeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_b184ba71-7cd9-4cca-9363-d60464c79825" xlink:to="loc_us-gaap_DeferredRevenueArrangementByTypeTable_183afae6-c93d-4d6d-a0ff-be82d628ceb7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_5b2c49c2-6400-401c-9ed3-5b38459cc1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_b184ba71-7cd9-4cca-9363-d60464c79825" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_5b2c49c2-6400-401c-9ed3-5b38459cc1e8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPerformanceObligationDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesPerformanceObligationDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementLineItems_327d91cb-1ad9-41e9-b475-d883ccb1494e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementByTypeTable_a5c64e65-8a38-40a6-89f9-24bdc65fa344" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementByTypeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_327d91cb-1ad9-41e9-b475-d883ccb1494e" xlink:to="loc_us-gaap_DeferredRevenueArrangementByTypeTable_a5c64e65-8a38-40a6-89f9-24bdc65fa344" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_a46c2cd3-4745-44d7-b43d-25f15e49cb19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_a5c64e65-8a38-40a6-89f9-24bdc65fa344" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_a46c2cd3-4745-44d7-b43d-25f15e49cb19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_9b050fd2-fd01-4d37-8a1b-f2e389a82b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_327d91cb-1ad9-41e9-b475-d883ccb1494e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_9b050fd2-fd01-4d37-8a1b-f2e389a82b6b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPerformanceObligationDetails_1" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesPerformanceObligationDetails_1"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPerformanceObligationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementLineItems_327d91cb-1ad9-41e9-b475-d883ccb1494e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementByTypeTable_a5c64e65-8a38-40a6-89f9-24bdc65fa344" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementByTypeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_327d91cb-1ad9-41e9-b475-d883ccb1494e" xlink:to="loc_us-gaap_DeferredRevenueArrangementByTypeTable_a5c64e65-8a38-40a6-89f9-24bdc65fa344" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_9b050fd2-fd01-4d37-8a1b-f2e389a82b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_327d91cb-1ad9-41e9-b475-d883ccb1494e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_9b050fd2-fd01-4d37-8a1b-f2e389a82b6b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDisaggregationbyRevenueDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesScheduleofDisaggregationbyRevenueDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDisaggregationbyRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_8e157830-77ea-4123-a7d8-b047449b8991" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_e831eb63-42a7-48c7-adc7-1c7b8dd2d472" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_8e157830-77ea-4123-a7d8-b047449b8991" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_e831eb63-42a7-48c7-adc7-1c7b8dd2d472" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c381537f-d319-4640-9021-e9c66ab80fac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_e831eb63-42a7-48c7-adc7-1c7b8dd2d472" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c381537f-d319-4640-9021-e9c66ab80fac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c381537f-d319-4640-9021-e9c66ab80fac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c381537f-d319-4640-9021-e9c66ab80fac" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c381537f-d319-4640-9021-e9c66ab80fac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e3f1b6dd-f67c-4fa7-ae96-6b9f34612fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c381537f-d319-4640-9021-e9c66ab80fac" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e3f1b6dd-f67c-4fa7-ae96-6b9f34612fc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DiagnosticServicesMember_829962e5-2805-4ef1-91d3-b27eda3e2e52" xlink:href="prph-20231231.xsd#prph_DiagnosticServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e3f1b6dd-f67c-4fa7-ae96-6b9f34612fc8" xlink:to="loc_prph_DiagnosticServicesMember_829962e5-2805-4ef1-91d3-b27eda3e2e52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ContractManufacturingMember_2a57d14f-3203-4523-8d7b-0b922b8e3e36" xlink:href="prph-20231231.xsd#prph_ContractManufacturingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e3f1b6dd-f67c-4fa7-ae96-6b9f34612fc8" xlink:to="loc_prph_ContractManufacturingMember_2a57d14f-3203-4523-8d7b-0b922b8e3e36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_RetailAndOtherMember_502c0392-6abc-428b-bc91-910b7b1b61e1" xlink:href="prph-20231231.xsd#prph_RetailAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e3f1b6dd-f67c-4fa7-ae96-6b9f34612fc8" xlink:to="loc_prph_RetailAndOtherMember_502c0392-6abc-428b-bc91-910b7b1b61e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_GenomicProductsAndServicesMember_3ce2979c-aab5-4a94-99dd-98e30d5a3c7e" xlink:href="prph-20231231.xsd#prph_GenomicProductsAndServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e3f1b6dd-f67c-4fa7-ae96-6b9f34612fc8" xlink:to="loc_prph_GenomicProductsAndServicesMember_3ce2979c-aab5-4a94-99dd-98e30d5a3c7e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e57ca6d1-997e-4fad-9f74-2399a206cc68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_8e157830-77ea-4123-a7d8-b047449b8991" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e57ca6d1-997e-4fad-9f74-2399a206cc68" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/AssetAcquisitionDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#AssetAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/AssetAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTable_df69e758-583d-4edc-b4c6-d22e33ac06cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_us-gaap_AssetAcquisitionTable_df69e758-583d-4edc-b4c6-d22e33ac06cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_7c280581-29f7-4098-85c1-2c914a40e6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AssetAcquisitionTable_df69e758-583d-4edc-b4c6-d22e33ac06cf" xlink:to="loc_us-gaap_AssetAcquisitionAxis_7c280581-29f7-4098-85c1-2c914a40e6a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_7c280581-29f7-4098-85c1-2c914a40e6a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_7c280581-29f7-4098-85c1-2c914a40e6a6" xlink:to="loc_us-gaap_AssetAcquisitionDomain_7c280581-29f7-4098-85c1-2c914a40e6a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_443895e7-689a-4edf-adb4-20507d4283de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_7c280581-29f7-4098-85c1-2c914a40e6a6" xlink:to="loc_us-gaap_AssetAcquisitionDomain_443895e7-689a-4edf-adb4-20507d4283de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_StellaPurchaseAgreementMember_8ee4b0fe-3807-49ab-9854-a1a8ea427058" xlink:href="prph-20231231.xsd#prph_StellaPurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_443895e7-689a-4edf-adb4-20507d4283de" xlink:to="loc_prph_StellaPurchaseAgreementMember_8ee4b0fe-3807-49ab-9854-a1a8ea427058" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fe8f2780-ebbf-48cd-b5b5-475e59b5322d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AssetAcquisitionTable_df69e758-583d-4edc-b4c6-d22e33ac06cf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fe8f2780-ebbf-48cd-b5b5-475e59b5322d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fe8f2780-ebbf-48cd-b5b5-475e59b5322d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fe8f2780-ebbf-48cd-b5b5-475e59b5322d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fe8f2780-ebbf-48cd-b5b5-475e59b5322d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b0713839-58d6-4fbb-98f6-512a27ed926c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fe8f2780-ebbf-48cd-b5b5-475e59b5322d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b0713839-58d6-4fbb-98f6-512a27ed926c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_a3724298-e89d-4181-81f4-4375ef772a12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b0713839-58d6-4fbb-98f6-512a27ed926c" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_a3724298-e89d-4181-81f4-4375ef772a12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_PaymentsForAssetAcquisition_600eeeac-aaac-490b-ad09-545161c56d39" xlink:href="prph-20231231.xsd#prph_PaymentsForAssetAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_prph_PaymentsForAssetAcquisition_600eeeac-aaac-490b-ad09-545161c56d39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationLiability_31bc2a1f-1fca-4a52-97d3-8a80047e20bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_us-gaap_AssetAcquisitionContingentConsiderationLiability_31bc2a1f-1fca-4a52-97d3-8a80047e20bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff_3da6fa40-dec9-4b51-b1f6-80dd5f43b845" xlink:href="prph-20231231.xsd#prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff_3da6fa40-dec9-4b51-b1f6-80dd5f43b845" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff_e58bb753-2d17-4ba7-9d6d-ddd2775c8a35" xlink:href="prph-20231231.xsd#prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff_e58bb753-2d17-4ba7-9d6d-ddd2775c8a35" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_65a58223-82c1-4ee7-8e68-4dcec599e62d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_65a58223-82c1-4ee7-8e68-4dcec599e62d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_06a5f695-1976-4351-8c3b-eeb26d45fe87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_06a5f695-1976-4351-8c3b-eeb26d45fe87" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare_ea1635a0-4390-4352-bbd0-ddabd7c310f0" xlink:href="prph-20231231.xsd#prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare_ea1635a0-4390-4352-bbd0-ddabd7c310f0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_b66dfe60-a7d7-43ea-97a7-92a76d253ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_b66dfe60-a7d7-43ea-97a7-92a76d253ba5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent_09c48085-e53b-4373-ac30-e68dcb21e0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent_09c48085-e53b-4373-ac30-e68dcb21e0c1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7e2180e4-d41a-4407-8550-774d1e1c8126" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7e2180e4-d41a-4407-8550-774d1e1c8126" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_PurchaseAgreementRoyaltyPercent_ee806ae9-24e0-4af4-96fd-635c9dacf31f" xlink:href="prph-20231231.xsd#prph_PurchaseAgreementRoyaltyPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_prph_PurchaseAgreementRoyaltyPercent_ee806ae9-24e0-4af4-96fd-635c9dacf31f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AssetAcquisitionTransactionCosts_65eaad5a-a9ec-4c9d-a377-1e65b452c6d9" xlink:href="prph-20231231.xsd#prph_AssetAcquisitionTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_prph_AssetAcquisitionTransactionCosts_65eaad5a-a9ec-4c9d-a377-1e65b452c6d9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_4671364a-f12e-4ea6-8a74-405158f912c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_4671364a-f12e-4ea6-8a74-405158f912c6" xlink:type="arc" order="12"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/IntangibleAssetsNetNarrativeDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#IntangibleAssetsNetNarrativeDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/IntangibleAssetsNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f57d5778-2b09-4c5f-804d-60944f9a6bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8e261174-c9ad-4648-b7ef-a82d5afadb92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f57d5778-2b09-4c5f-804d-60944f9a6bdf" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8e261174-c9ad-4648-b7ef-a82d5afadb92" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f1d1b9b3-8421-44fb-8209-5decb4b68ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8e261174-c9ad-4648-b7ef-a82d5afadb92" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f1d1b9b3-8421-44fb-8209-5decb4b68ab0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f1d1b9b3-8421-44fb-8209-5decb4b68ab0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f1d1b9b3-8421-44fb-8209-5decb4b68ab0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f1d1b9b3-8421-44fb-8209-5decb4b68ab0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_34eb8507-95a3-420a-a79c-ba82bacbc728" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f1d1b9b3-8421-44fb-8209-5decb4b68ab0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_34eb8507-95a3-420a-a79c-ba82bacbc728" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_1f8be2a6-1a1f-44fa-97b7-9d0171c3ae50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_34eb8507-95a3-420a-a79c-ba82bacbc728" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_1f8be2a6-1a1f-44fa-97b7-9d0171c3ae50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_6f4e0d1e-50c1-45d3-91a6-d92883fdd0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f57d5778-2b09-4c5f-804d-60944f9a6bdf" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_6f4e0d1e-50c1-45d3-91a6-d92883fdd0f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2f0a810a-5a4c-4509-8940-2d64b05992ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f57d5778-2b09-4c5f-804d-60944f9a6bdf" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2f0a810a-5a4c-4509-8940-2d64b05992ea" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#IntangibleAssetsNetScheduleofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b0104c34-d339-4c7f-b791-73ef0c9ff216" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c0707f74-41cd-49ad-b999-717c9be6f89b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b0104c34-d339-4c7f-b791-73ef0c9ff216" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c0707f74-41cd-49ad-b999-717c9be6f89b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_229954c9-d3f4-49f0-a97f-be20836ea374" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c0707f74-41cd-49ad-b999-717c9be6f89b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_229954c9-d3f4-49f0-a97f-be20836ea374" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_229954c9-d3f4-49f0-a97f-be20836ea374_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_229954c9-d3f4-49f0-a97f-be20836ea374" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_229954c9-d3f4-49f0-a97f-be20836ea374_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91671369-fa34-4bb9-9bbd-134a067fbdfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_229954c9-d3f4-49f0-a97f-be20836ea374" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91671369-fa34-4bb9-9bbd-134a067fbdfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_c696aa67-9ad3-4156-a18b-ece3970694d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91671369-fa34-4bb9-9bbd-134a067fbdfc" xlink:to="loc_us-gaap_TradeNamesMember_c696aa67-9ad3-4156-a18b-ece3970694d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember_12c5a756-3e1b-4038-b674-702f74ea3453" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91671369-fa34-4bb9-9bbd-134a067fbdfc" xlink:to="loc_us-gaap_IntellectualPropertyMember_12c5a756-3e1b-4038-b674-702f74ea3453" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_56a2a19a-a04a-4488-b365-648956815a39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91671369-fa34-4bb9-9bbd-134a067fbdfc" xlink:to="loc_us-gaap_CustomerRelationshipsMember_56a2a19a-a04a-4488-b365-648956815a39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_38670244-13d6-4b97-866d-a93d8bc33a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91671369-fa34-4bb9-9bbd-134a067fbdfc" xlink:to="loc_us-gaap_LicenseMember_38670244-13d6-4b97-866d-a93d8bc33a7f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4060f662-09f9-48cd-be6b-ad03ac63d8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b0104c34-d339-4c7f-b791-73ef0c9ff216" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4060f662-09f9-48cd-be6b-ad03ac63d8bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_efa675cd-40d6-4490-aeed-4be708def853" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b0104c34-d339-4c7f-b791-73ef0c9ff216" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_efa675cd-40d6-4490-aeed-4be708def853" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1b7b8a93-efde-484a-9814-a94413f3b470" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b0104c34-d339-4c7f-b791-73ef0c9ff216" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1b7b8a93-efde-484a-9814-a94413f3b470" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8ccb5462-b863-4f90-9ab0-cd721d99ffe4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b0104c34-d339-4c7f-b791-73ef0c9ff216" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8ccb5462-b863-4f90-9ab0-cd721d99ffe4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0d6469f3-0846-4f89-bc42-61d16bf02d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_38e5e5cf-dc51-450f-85d0-50920413fa65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0d6469f3-0846-4f89-bc42-61d16bf02d0a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_38e5e5cf-dc51-450f-85d0-50920413fa65" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8f1ccd5a-d4e0-4ee3-9e6e-ced7950383c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_38e5e5cf-dc51-450f-85d0-50920413fa65" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8f1ccd5a-d4e0-4ee3-9e6e-ced7950383c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8f1ccd5a-d4e0-4ee3-9e6e-ced7950383c9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8f1ccd5a-d4e0-4ee3-9e6e-ced7950383c9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8f1ccd5a-d4e0-4ee3-9e6e-ced7950383c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44fa8acf-d8b3-436d-8735-c1bc9034b37c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8f1ccd5a-d4e0-4ee3-9e6e-ced7950383c9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44fa8acf-d8b3-436d-8735-c1bc9034b37c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_25a76398-8953-4567-8909-373c22233784" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44fa8acf-d8b3-436d-8735-c1bc9034b37c" xlink:to="loc_us-gaap_LandMember_25a76398-8953-4567-8909-373c22233784" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_a2fe45e9-5e32-4657-bf4e-28a3f311a34e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44fa8acf-d8b3-436d-8735-c1bc9034b37c" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_a2fe45e9-5e32-4657-bf4e-28a3f311a34e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember_af92853d-09e4-45c8-bacf-0af4c6b964c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44fa8acf-d8b3-436d-8735-c1bc9034b37c" xlink:to="loc_us-gaap_BuildingImprovementsMember_af92853d-09e4-45c8-bacf-0af4c6b964c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_633c4549-e708-4736-9bc5-51db51dd2ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44fa8acf-d8b3-436d-8735-c1bc9034b37c" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_633c4549-e708-4736-9bc5-51db51dd2ec4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_bc3a41fc-cf89-4447-b30c-49b051b7b8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44fa8acf-d8b3-436d-8735-c1bc9034b37c" xlink:to="loc_us-gaap_EquipmentMember_bc3a41fc-cf89-4447-b30c-49b051b7b8a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_11161a3e-be2f-4c3e-bb5d-bcc4626fd594" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44fa8acf-d8b3-436d-8735-c1bc9034b37c" xlink:to="loc_us-gaap_ComputerEquipmentMember_11161a3e-be2f-4c3e-bb5d-bcc4626fd594" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_dcdfefbe-e0da-4f35-bf61-9d0278f2dda1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44fa8acf-d8b3-436d-8735-c1bc9034b37c" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_dcdfefbe-e0da-4f35-bf61-9d0278f2dda1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a9c91424-e60f-48f7-a3fb-4d23b378d2ef" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_38e5e5cf-dc51-450f-85d0-50920413fa65" xlink:to="loc_srt_RangeAxis_a9c91424-e60f-48f7-a3fb-4d23b378d2ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a9c91424-e60f-48f7-a3fb-4d23b378d2ef_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a9c91424-e60f-48f7-a3fb-4d23b378d2ef" xlink:to="loc_srt_RangeMember_a9c91424-e60f-48f7-a3fb-4d23b378d2ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_87563278-b5b5-460a-8aea-62fe9e682fff" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a9c91424-e60f-48f7-a3fb-4d23b378d2ef" xlink:to="loc_srt_RangeMember_87563278-b5b5-460a-8aea-62fe9e682fff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_74f70403-7506-4bfa-83b6-58538301a513" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_87563278-b5b5-460a-8aea-62fe9e682fff" xlink:to="loc_srt_MinimumMember_74f70403-7506-4bfa-83b6-58538301a513" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_27e3d2b8-64b7-4c04-8aff-b5ff1ead66da" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_87563278-b5b5-460a-8aea-62fe9e682fff" xlink:to="loc_srt_MaximumMember_27e3d2b8-64b7-4c04-8aff-b5ff1ead66da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_ca3dee7a-0b5d-47c5-bc32-ee8a5e844b06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0d6469f3-0846-4f89-bc42-61d16bf02d0a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_ca3dee7a-0b5d-47c5-bc32-ee8a5e844b06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_184b9f66-c0ed-4366-9497-43f02c523379" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0d6469f3-0846-4f89-bc42-61d16bf02d0a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_184b9f66-c0ed-4366-9497-43f02c523379" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_29d11d98-9703-4b2d-8c22-5b3d55a420d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0d6469f3-0846-4f89-bc42-61d16bf02d0a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_29d11d98-9703-4b2d-8c22-5b3d55a420d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_8f7cb6f0-51c4-4de4-bc1a-64e5bb8be460" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0d6469f3-0846-4f89-bc42-61d16bf02d0a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_8f7cb6f0-51c4-4de4-bc1a-64e5bb8be460" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/OutstandingDebtDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#OutstandingDebtDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/OutstandingDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_67480303-ed7a-4b03-b3af-59cfb3b95b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_67480303-ed7a-4b03-b3af-59cfb3b95b9f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_39d60a7f-5c29-4acd-9649-5b7b47219747" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_67480303-ed7a-4b03-b3af-59cfb3b95b9f" xlink:to="loc_us-gaap_DebtInstrumentAxis_39d60a7f-5c29-4acd-9649-5b7b47219747" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_39d60a7f-5c29-4acd-9649-5b7b47219747_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_39d60a7f-5c29-4acd-9649-5b7b47219747" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_39d60a7f-5c29-4acd-9649-5b7b47219747_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_910ac623-cde6-478a-9cf3-41275913b13f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_39d60a7f-5c29-4acd-9649-5b7b47219747" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_910ac623-cde6-478a-9cf3-41275913b13f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2023SecuredMortgageLoanMember_a3d0206d-963d-465c-a6e3-5981ae20b787" xlink:href="prph-20231231.xsd#prph_A2023SecuredMortgageLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_910ac623-cde6-478a-9cf3-41275913b13f" xlink:to="loc_prph_A2023SecuredMortgageLoanMember_a3d0206d-963d-465c-a6e3-5981ae20b787" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2023NoteMember_8256b3e2-8d96-434e-9668-92b47876028c" xlink:href="prph-20231231.xsd#prph_A2023NoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_910ac623-cde6-478a-9cf3-41275913b13f" xlink:to="loc_prph_A2023NoteMember_8256b3e2-8d96-434e-9668-92b47876028c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_SeptemberTwoThousandAndTwentyNoteMember_aaf0346b-9e91-4abc-9d7b-1a1a8e46e34d" xlink:href="prph-20231231.xsd#prph_SeptemberTwoThousandAndTwentyNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_910ac623-cde6-478a-9cf3-41275913b13f" xlink:to="loc_prph_SeptemberTwoThousandAndTwentyNoteMember_aaf0346b-9e91-4abc-9d7b-1a1a8e46e34d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a81e90b4-82e1-485d-9cda-04f0a3f23bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_67480303-ed7a-4b03-b3af-59cfb3b95b9f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a81e90b4-82e1-485d-9cda-04f0a3f23bbd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a81e90b4-82e1-485d-9cda-04f0a3f23bbd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a81e90b4-82e1-485d-9cda-04f0a3f23bbd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a81e90b4-82e1-485d-9cda-04f0a3f23bbd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a2b28b4d-10d1-48ab-a51b-35ecc650ebe0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a81e90b4-82e1-485d-9cda-04f0a3f23bbd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a2b28b4d-10d1-48ab-a51b-35ecc650ebe0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_3b7361c5-ac9a-4ba6-978e-b9acde32ffa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a2b28b4d-10d1-48ab-a51b-35ecc650ebe0" xlink:to="loc_us-gaap_SecuredDebtMember_3b7361c5-ac9a-4ba6-978e-b9acde32ffa4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_9c72fa9d-fe1a-4153-b3e4-5b3ff4057159" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a2b28b4d-10d1-48ab-a51b-35ecc650ebe0" xlink:to="loc_us-gaap_UnsecuredDebtMember_9c72fa9d-fe1a-4153-b3e4-5b3ff4057159" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ArrangementTypeAxis_63839f80-e2f7-4d31-be9c-4c74d6fa1729" xlink:href="prph-20231231.xsd#prph_ArrangementTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_67480303-ed7a-4b03-b3af-59cfb3b95b9f" xlink:to="loc_prph_ArrangementTypeAxis_63839f80-e2f7-4d31-be9c-4c74d6fa1729" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_TypeOfArrangementDomain_63839f80-e2f7-4d31-be9c-4c74d6fa1729_default" xlink:href="prph-20231231.xsd#prph_TypeOfArrangementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_prph_ArrangementTypeAxis_63839f80-e2f7-4d31-be9c-4c74d6fa1729" xlink:to="loc_prph_TypeOfArrangementDomain_63839f80-e2f7-4d31-be9c-4c74d6fa1729_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_TypeOfArrangementDomain_50480ad7-3d64-4ef9-b6c9-3bb51cfa4351" xlink:href="prph-20231231.xsd#prph_TypeOfArrangementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_prph_ArrangementTypeAxis_63839f80-e2f7-4d31-be9c-4c74d6fa1729" xlink:to="loc_prph_TypeOfArrangementDomain_50480ad7-3d64-4ef9-b6c9-3bb51cfa4351" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LetterAgreementMember_cd57d5d9-c3b1-4c07-95b9-97640e7c5be7" xlink:href="prph-20231231.xsd#prph_LetterAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_prph_TypeOfArrangementDomain_50480ad7-3d64-4ef9-b6c9-3bb51cfa4351" xlink:to="loc_prph_LetterAgreementMember_cd57d5d9-c3b1-4c07-95b9-97640e7c5be7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_b1bf3681-193e-4de6-bf5b-801bf54c0f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_67480303-ed7a-4b03-b3af-59cfb3b95b9f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_b1bf3681-193e-4de6-bf5b-801bf54c0f0f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_b1bf3681-193e-4de6-bf5b-801bf54c0f0f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_b1bf3681-193e-4de6-bf5b-801bf54c0f0f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_b1bf3681-193e-4de6-bf5b-801bf54c0f0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_5437c89e-19d6-4fb7-a532-0ec405d0974d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_b1bf3681-193e-4de6-bf5b-801bf54c0f0f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_5437c89e-19d6-4fb7-a532-0ec405d0974d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2023NotesWarrantsMember_7365cab4-3805-42ba-955e-b8ec25f74b7c" xlink:href="prph-20231231.xsd#prph_A2023NotesWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_5437c89e-19d6-4fb7-a532-0ec405d0974d" xlink:to="loc_prph_A2023NotesWarrantsMember_7365cab4-3805-42ba-955e-b8ec25f74b7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_21e1089b-8e31-42fd-b905-963049038231" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_67480303-ed7a-4b03-b3af-59cfb3b95b9f" xlink:to="loc_us-gaap_ValuationTechniqueAxis_21e1089b-8e31-42fd-b905-963049038231" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_21e1089b-8e31-42fd-b905-963049038231_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_21e1089b-8e31-42fd-b905-963049038231" xlink:to="loc_us-gaap_ValuationTechniqueDomain_21e1089b-8e31-42fd-b905-963049038231_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_756984ce-43fb-447d-89ee-af6f47ae1800" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_21e1089b-8e31-42fd-b905-963049038231" xlink:to="loc_us-gaap_ValuationTechniqueDomain_756984ce-43fb-447d-89ee-af6f47ae1800" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_BlackScholesOptionPricingModelMember_a402fdf1-b51d-4919-8491-d2c9f7f67779" xlink:href="prph-20231231.xsd#prph_BlackScholesOptionPricingModelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_756984ce-43fb-447d-89ee-af6f47ae1800" xlink:to="loc_prph_BlackScholesOptionPricingModelMember_a402fdf1-b51d-4919-8491-d2c9f7f67779" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_76448e5c-73eb-4bd0-a920-17183a5a649b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_67480303-ed7a-4b03-b3af-59cfb3b95b9f" xlink:to="loc_us-gaap_TypeOfArrangementAxis_76448e5c-73eb-4bd0-a920-17183a5a649b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_76448e5c-73eb-4bd0-a920-17183a5a649b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_76448e5c-73eb-4bd0-a920-17183a5a649b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_76448e5c-73eb-4bd0-a920-17183a5a649b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e973a0aa-80ea-4843-8cb0-5e638c1a7000" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_76448e5c-73eb-4bd0-a920-17183a5a649b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e973a0aa-80ea-4843-8cb0-5e638c1a7000" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LetterAgreementMember_5ad5ed9d-ee5f-40c0-8417-cd90ce14742b" xlink:href="prph-20231231.xsd#prph_LetterAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e973a0aa-80ea-4843-8cb0-5e638c1a7000" xlink:to="loc_prph_LetterAgreementMember_5ad5ed9d-ee5f-40c0-8417-cd90ce14742b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c65adc82-7c42-4513-9b92-1693679cb0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c65adc82-7c42-4513-9b92-1693679cb0ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f7b17c53-ad3e-4a38-9568-bec6caf558e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f7b17c53-ad3e-4a38-9568-bec6caf558e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_622c7e9f-f2f4-47d2-8986-228cd1ff6a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_622c7e9f-f2f4-47d2-8986-228cd1ff6a1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_2c8d9183-27e7-4e8f-80ea-7fe733cf3255" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_2c8d9183-27e7-4e8f-80ea-7fe733cf3255" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit_7eb52cf9-4589-4fb1-bcdd-ffdc47c51ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EscrowDeposit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_EscrowDeposit_7eb52cf9-4589-4fb1-bcdd-ffdc47c51ae6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_6ef0c6de-dc62-4252-bbbd-7459d07f6220" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_6ef0c6de-dc62-4252-bbbd-7459d07f6220" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_6d0e7128-6619-4742-bfe5-d92c53063056" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_6d0e7128-6619-4742-bfe5-d92c53063056" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4a05fed3-4b74-4a91-a68f-1b56baf5c413" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4a05fed3-4b74-4a91-a68f-1b56baf5c413" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_22512226-891e-46a9-9cb1-02536115f472" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_22512226-891e-46a9-9cb1-02536115f472" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_4dfbe3cc-e49f-4e14-ba7d-1eb3d08a9f52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_4dfbe3cc-e49f-4e14-ba7d-1eb3d08a9f52" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d9921300-bc73-497b-8579-e9af35549838" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d9921300-bc73-497b-8579-e9af35549838" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_a78e31e2-03c1-457b-ac28-7f822807878f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_a78e31e2-03c1-457b-ac28-7f822807878f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_82dcac02-ba33-46f5-941c-d338d0a6d6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_82dcac02-ba33-46f5-941c-d338d0a6d6ab" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_56dde8b6-9954-49f7-8904-a0b49f9929fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_56dde8b6-9954-49f7-8904-a0b49f9929fd" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfDebtInstruments_eb30d33a-ce25-4ac3-a99a-a47d57782ced" xlink:href="prph-20231231.xsd#prph_NumberOfDebtInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_prph_NumberOfDebtInstruments_eb30d33a-ce25-4ac3-a99a-a47d57782ced" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfInvestors_30e78201-057e-48c7-ae86-1b011a9b4714" xlink:href="prph-20231231.xsd#prph_NumberOfInvestors"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_prph_NumberOfInvestors_30e78201-057e-48c7-ae86-1b011a9b4714" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6fcd1802-a34f-4a8d-ad5b-4525135ee37f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6fcd1802-a34f-4a8d-ad5b-4525135ee37f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_bbe829f6-74f5-4143-8004-74f1a934183b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_bbe829f6-74f5-4143-8004-74f1a934183b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_090c8264-dcb9-4b79-968e-a9e2253fe55b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_Cash_090c8264-dcb9-4b79-968e-a9e2253fe55b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalancePrincipalAmount_a7555b67-4516-475c-901b-2df5e5ec4655" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalancePrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_InvestmentOwnedBalancePrincipalAmount_a7555b67-4516-475c-901b-2df5e5ec4655" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_927684a8-b8c4-444d-bcf6-2910c2d63c96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_927684a8-b8c4-444d-bcf6-2910c2d63c96" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_2d0ea701-e611-4e8c-b9b5-36abb19eceef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_2d0ea701-e611-4e8c-b9b5-36abb19eceef" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_c66d9536-bc56-4a05-9182-f5f467dbbfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_c66d9536-bc56-4a05-9182-f5f467dbbfd4" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_aabd2b84-2240-48b2-8474-67ec572d7de5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_aabd2b84-2240-48b2-8474-67ec572d7de5" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_eff8942d-cb5b-49b6-9f57-b263f68f0629" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_eff8942d-cb5b-49b6-9f57-b263f68f0629" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseOther_fd412aa4-0fc1-4210-9b2a-12e0cf2d48c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_InterestExpenseOther_fd412aa4-0fc1-4210-9b2a-12e0cf2d48c0" xlink:type="arc" order="25"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#StockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3a7d91e9-2f80-4f5e-8a7c-139f2782158e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:to="loc_us-gaap_PlanNameAxis_3a7d91e9-2f80-4f5e-8a7c-139f2782158e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3a7d91e9-2f80-4f5e-8a7c-139f2782158e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_3a7d91e9-2f80-4f5e-8a7c-139f2782158e" xlink:to="loc_us-gaap_PlanNameDomain_3a7d91e9-2f80-4f5e-8a7c-139f2782158e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_9307b4b6-a466-41fd-a0ab-d29d3ac4d788" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_3a7d91e9-2f80-4f5e-8a7c-139f2782158e" xlink:to="loc_us-gaap_PlanNameDomain_9307b4b6-a466-41fd-a0ab-d29d3ac4d788" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2022DirectorsPlanMember_f17f8314-bfe6-4670-8ba2-1be13dad4e88" xlink:href="prph-20231231.xsd#prph_A2022DirectorsPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9307b4b6-a466-41fd-a0ab-d29d3ac4d788" xlink:to="loc_prph_A2022DirectorsPlanMember_f17f8314-bfe6-4670-8ba2-1be13dad4e88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_Amended2022DirectorsPlanMember_39efcc71-9cf8-4619-af89-d2be29dd8dc4" xlink:href="prph-20231231.xsd#prph_Amended2022DirectorsPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9307b4b6-a466-41fd-a0ab-d29d3ac4d788" xlink:to="loc_prph_Amended2022DirectorsPlanMember_39efcc71-9cf8-4619-af89-d2be29dd8dc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_Amended2010DirectorsPlanMember_913b0b5b-86d1-42a5-8cc5-21c183b0f5f5" xlink:href="prph-20231231.xsd#prph_Amended2010DirectorsPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9307b4b6-a466-41fd-a0ab-d29d3ac4d788" xlink:to="loc_prph_Amended2010DirectorsPlanMember_913b0b5b-86d1-42a5-8cc5-21c183b0f5f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_Amended2022PlanMember_37ee5918-e30d-4c32-9c06-cc74b5f81316" xlink:href="prph-20231231.xsd#prph_Amended2022PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9307b4b6-a466-41fd-a0ab-d29d3ac4d788" xlink:to="loc_prph_Amended2022PlanMember_37ee5918-e30d-4c32-9c06-cc74b5f81316" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2022PlanMember_36c076de-28ce-4b7d-82b3-6efb46092cb3" xlink:href="prph-20231231.xsd#prph_A2022PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9307b4b6-a466-41fd-a0ab-d29d3ac4d788" xlink:to="loc_prph_A2022PlanMember_36c076de-28ce-4b7d-82b3-6efb46092cb3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AmendedTwoThousandTenPlanMember_e26cdd81-147b-4e42-a3f9-c31f685462d1" xlink:href="prph-20231231.xsd#prph_AmendedTwoThousandTenPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9307b4b6-a466-41fd-a0ab-d29d3ac4d788" xlink:to="loc_prph_AmendedTwoThousandTenPlanMember_e26cdd81-147b-4e42-a3f9-c31f685462d1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_TwoThousandEighteenStockIncentivePlanMember_7d53f8c8-11c3-46b8-bd39-26a42bd3ab24" xlink:href="prph-20231231.xsd#prph_TwoThousandEighteenStockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9307b4b6-a466-41fd-a0ab-d29d3ac4d788" xlink:to="loc_prph_TwoThousandEighteenStockIncentivePlanMember_7d53f8c8-11c3-46b8-bd39-26a42bd3ab24" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_0e48fa6a-ce97-44ff-8e56-e0f092326820" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:to="loc_srt_TitleOfIndividualAxis_0e48fa6a-ce97-44ff-8e56-e0f092326820" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_0e48fa6a-ce97-44ff-8e56-e0f092326820_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_0e48fa6a-ce97-44ff-8e56-e0f092326820" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_0e48fa6a-ce97-44ff-8e56-e0f092326820_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ed32bef4-b5c5-43e6-a96b-7f72e50b53d1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_0e48fa6a-ce97-44ff-8e56-e0f092326820" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ed32bef4-b5c5-43e6-a96b-7f72e50b53d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_8e4af234-4906-4683-87a5-5642e73e4c28" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ed32bef4-b5c5-43e6-a96b-7f72e50b53d1" xlink:to="loc_srt_ChiefExecutiveOfficerMember_8e4af234-4906-4683-87a5-5642e73e4c28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_MrKamalObbadMember_d26dd85e-0a51-4ee1-bad0-bb8064e772fa" xlink:href="prph-20231231.xsd#prph_MrKamalObbadMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ed32bef4-b5c5-43e6-a96b-7f72e50b53d1" xlink:to="loc_prph_MrKamalObbadMember_d26dd85e-0a51-4ee1-bad0-bb8064e772fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefFinancialOfficerMember_9bee2e98-2bd0-40cf-8988-bd91c8472bc2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefFinancialOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ed32bef4-b5c5-43e6-a96b-7f72e50b53d1" xlink:to="loc_srt_ChiefFinancialOfficerMember_9bee2e98-2bd0-40cf-8988-bd91c8472bc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b4a4e56e-65d4-49e8-a8ac-0031e6c88ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:to="loc_us-gaap_AwardTypeAxis_b4a4e56e-65d4-49e8-a8ac-0031e6c88ff7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4a4e56e-65d4-49e8-a8ac-0031e6c88ff7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b4a4e56e-65d4-49e8-a8ac-0031e6c88ff7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4a4e56e-65d4-49e8-a8ac-0031e6c88ff7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c6507ee-1025-4ea4-864e-ccaf28b8fe8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b4a4e56e-65d4-49e8-a8ac-0031e6c88ff7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c6507ee-1025-4ea4-864e-ccaf28b8fe8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CEOOptionsMember_67215b71-4561-495c-aed4-36eeb6be7847" xlink:href="prph-20231231.xsd#prph_CEOOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c6507ee-1025-4ea4-864e-ccaf28b8fe8d" xlink:to="loc_prph_CEOOptionsMember_67215b71-4561-495c-aed4-36eeb6be7847" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_InducementOptionAwardMember_964c2b0f-3c49-4118-aaa2-1d479706d800" xlink:href="prph-20231231.xsd#prph_InducementOptionAwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c6507ee-1025-4ea4-864e-ccaf28b8fe8d" xlink:to="loc_prph_InducementOptionAwardMember_964c2b0f-3c49-4118-aaa2-1d479706d800" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CFOAwardMember_7ee9b969-90ce-4735-ad7f-5e8cce5bcc2c" xlink:href="prph-20231231.xsd#prph_CFOAwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c6507ee-1025-4ea4-864e-ccaf28b8fe8d" xlink:to="loc_prph_CFOAwardMember_7ee9b969-90ce-4735-ad7f-5e8cce5bcc2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_12317122-d6d1-4335-9178-0e0382416a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_12317122-d6d1-4335-9178-0e0382416a4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_12317122-d6d1-4335-9178-0e0382416a4d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_12317122-d6d1-4335-9178-0e0382416a4d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_12317122-d6d1-4335-9178-0e0382416a4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f32738a9-a06f-4592-81d0-9a7572af09e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_12317122-d6d1-4335-9178-0e0382416a4d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f32738a9-a06f-4592-81d0-9a7572af09e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_InducementOptionAwardMember_e2d312bf-dd1e-4b90-8b85-160f93de8a5e" xlink:href="prph-20231231.xsd#prph_InducementOptionAwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f32738a9-a06f-4592-81d0-9a7572af09e5" xlink:to="loc_prph_InducementOptionAwardMember_e2d312bf-dd1e-4b90-8b85-160f93de8a5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3f29156e-404f-45a7-b271-3895c9175c55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3f29156e-404f-45a7-b271-3895c9175c55" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3f29156e-404f-45a7-b271-3895c9175c55_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3f29156e-404f-45a7-b271-3895c9175c55" xlink:to="loc_us-gaap_EquityComponentDomain_3f29156e-404f-45a7-b271-3895c9175c55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_93d521b6-69d0-45ba-ae28-f6e01fb97390" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3f29156e-404f-45a7-b271-3895c9175c55" xlink:to="loc_us-gaap_EquityComponentDomain_93d521b6-69d0-45ba-ae28-f6e01fb97390" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0d65b3ee-50b4-4d70-9d3f-e3836f7bfdfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_93d521b6-69d0-45ba-ae28-f6e01fb97390" xlink:to="loc_us-gaap_CommonStockMember_0d65b3ee-50b4-4d70-9d3f-e3836f7bfdfa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_6fa2fb42-1c95-44da-b375-05f03baefab8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_93d521b6-69d0-45ba-ae28-f6e01fb97390" xlink:to="loc_us-gaap_WarrantMember_6fa2fb42-1c95-44da-b375-05f03baefab8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_7a5a7e7e-59ad-4634-95c9-34fc93f2d7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:to="loc_us-gaap_VestingAxis_7a5a7e7e-59ad-4634-95c9-34fc93f2d7e5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_7a5a7e7e-59ad-4634-95c9-34fc93f2d7e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_7a5a7e7e-59ad-4634-95c9-34fc93f2d7e5" xlink:to="loc_us-gaap_VestingDomain_7a5a7e7e-59ad-4634-95c9-34fc93f2d7e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_7e833228-6fbd-49b0-a82b-2f42b4b9706c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_7a5a7e7e-59ad-4634-95c9-34fc93f2d7e5" xlink:to="loc_us-gaap_VestingDomain_7e833228-6fbd-49b0-a82b-2f42b4b9706c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_c249dc84-2f8b-4285-8afe-7f1128d3591c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_7e833228-6fbd-49b0-a82b-2f42b4b9706c" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_c249dc84-2f8b-4285-8afe-7f1128d3591c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_a5c20f6f-df1a-4e0a-8207-6b8fd7b49e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_7e833228-6fbd-49b0-a82b-2f42b4b9706c" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_a5c20f6f-df1a-4e0a-8207-6b8fd7b49e6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_6a96587c-1a80-4d3a-9bb4-f6f69a499c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_7e833228-6fbd-49b0-a82b-2f42b4b9706c" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_6a96587c-1a80-4d3a-9bb4-f6f69a499c4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationAwardTrancheFourMember_381aadcf-2738-4216-a6ec-b874691c52e3" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationAwardTrancheFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_7e833228-6fbd-49b0-a82b-2f42b4b9706c" xlink:to="loc_prph_ShareBasedCompensationAwardTrancheFourMember_381aadcf-2738-4216-a6ec-b874691c52e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_a0bfe702-76b2-4ae0-a796-5afea9dfbc52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_a0bfe702-76b2-4ae0-a796-5afea9dfbc52" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_a0bfe702-76b2-4ae0-a796-5afea9dfbc52_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_a0bfe702-76b2-4ae0-a796-5afea9dfbc52" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_a0bfe702-76b2-4ae0-a796-5afea9dfbc52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_e38e249b-953d-4133-8295-efea19e7adc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_a0bfe702-76b2-4ae0-a796-5afea9dfbc52" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_e38e249b-953d-4133-8295-efea19e7adc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2023NotesWarrantsMember_673a5689-e071-448d-b798-82d240e737de" xlink:href="prph-20231231.xsd#prph_A2023NotesWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_e38e249b-953d-4133-8295-efea19e7adc5" xlink:to="loc_prph_A2023NotesWarrantsMember_673a5689-e071-448d-b798-82d240e737de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_07951270-3059-40a4-96b7-03e2791f5b7b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:to="loc_srt_RangeAxis_07951270-3059-40a4-96b7-03e2791f5b7b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_07951270-3059-40a4-96b7-03e2791f5b7b_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_07951270-3059-40a4-96b7-03e2791f5b7b" xlink:to="loc_srt_RangeMember_07951270-3059-40a4-96b7-03e2791f5b7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_42e10246-f9b4-447c-b624-d74acb8c5bca" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_07951270-3059-40a4-96b7-03e2791f5b7b" xlink:to="loc_srt_RangeMember_42e10246-f9b4-447c-b624-d74acb8c5bca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_eef6818e-5afa-4e9b-b1b0-8f248ca7991e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_42e10246-f9b4-447c-b624-d74acb8c5bca" xlink:to="loc_srt_MinimumMember_eef6818e-5afa-4e9b-b1b0-8f248ca7991e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_fdacc5c4-93e3-4081-a2a5-d70349747241" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_42e10246-f9b4-447c-b624-d74acb8c5bca" xlink:to="loc_srt_MaximumMember_fdacc5c4-93e3-4081-a2a5-d70349747241" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_0a9efee6-64f9-4c6e-b738-2f8f563df09d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:to="loc_us-gaap_GranteeStatusAxis_0a9efee6-64f9-4c6e-b738-2f8f563df09d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_0a9efee6-64f9-4c6e-b738-2f8f563df09d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_0a9efee6-64f9-4c6e-b738-2f8f563df09d" xlink:to="loc_us-gaap_GranteeStatusDomain_0a9efee6-64f9-4c6e-b738-2f8f563df09d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_2184cfad-7c81-4980-bf39-7ee916141443" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_0a9efee6-64f9-4c6e-b738-2f8f563df09d" xlink:to="loc_us-gaap_GranteeStatusDomain_2184cfad-7c81-4980-bf39-7ee916141443" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CertainHoldersMember_c65ee5db-5640-4e13-8ca1-7c0380a445b4" xlink:href="prph-20231231.xsd#prph_CertainHoldersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_2184cfad-7c81-4980-bf39-7ee916141443" xlink:to="loc_prph_CertainHoldersMember_c65ee5db-5640-4e13-8ca1-7c0380a445b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_f5d4dd90-b005-4745-9376-84f4c7c601af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_f5d4dd90-b005-4745-9376-84f4c7c601af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b991a17d-b649-4072-8789-850be7a9f76f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b991a17d-b649-4072-8789-850be7a9f76f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_6340d35d-0176-4c18-84cd-8e0372d07686" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_6340d35d-0176-4c18-84cd-8e0372d07686" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_08612308-0c0e-48ad-8b36-c6618d100df0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_08612308-0c0e-48ad-8b36-c6618d100df0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_3703f261-259e-4aeb-98bf-6ff369d19b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_PreferredStockSharesIssued_3703f261-259e-4aeb-98bf-6ff369d19b6f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_d86be7df-4fed-41c0-af99-253a5c73054d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_DividendsCommonStock_d86be7df-4fed-41c0-af99-253a5c73054d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_9b8644b3-a554-4e39-baf7-ffdc5f9eb966" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_9b8644b3-a554-4e39-baf7-ffdc5f9eb966" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_081a8968-bfda-456e-a964-e881088e643f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_081a8968-bfda-456e-a964-e881088e643f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_9e203021-0c83-42fa-9062-5a62dfd9e151" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_9e203021-0c83-42fa-9062-5a62dfd9e151" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_785fdf1c-1e43-4ff1-a6de-815551da1e85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_785fdf1c-1e43-4ff1-a6de-815551da1e85" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_9e47f39a-6ba4-45ae-951c-67efde128add" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_9e47f39a-6ba4-45ae-951c-67efde128add" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_eb4119e2-2b90-4b08-ba4c-56daa334e2f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_eb4119e2-2b90-4b08-ba4c-56daa334e2f4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_81ad91a6-bfcf-4949-937c-dcd8020ff038" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_81ad91a6-bfcf-4949-937c-dcd8020ff038" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance_e730a334-43a1-4a81-9748-99a96a1c974d" xlink:href="prph-20231231.xsd#prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance_e730a334-43a1-4a81-9748-99a96a1c974d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b8ecb36b-8c50-409c-b75c-ccaa78ddd17c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b8ecb36b-8c50-409c-b75c-ccaa78ddd17c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_66e1973f-8057-4b29-94c6-c1b8bca9c8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_66e1973f-8057-4b29-94c6-c1b8bca9c8d8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4bb7f5b0-54f5-4be7-8b93-3b6be2db9c38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4bb7f5b0-54f5-4be7-8b93-3b6be2db9c38" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_17ab15ce-0e6f-4cb0-a8b1-dac85e6c003a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_17ab15ce-0e6f-4cb0-a8b1-dac85e6c003a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_86e98873-c1f2-4f7b-a228-cbc3374272af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_86e98873-c1f2-4f7b-a228-cbc3374272af" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_90876515-7771-453b-8cdb-eda6c282dd45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_90876515-7771-453b-8cdb-eda6c282dd45" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_7d6a054d-90b0-482e-9005-8d169c09a15f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_7d6a054d-90b0-482e-9005-8d169c09a15f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_2de58a5d-a0a1-4a65-8f53-d1d6e429e146" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_2de58a5d-a0a1-4a65-8f53-d1d6e429e146" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedPaymentArrangementExpenseReversal_4b2e15f6-78b5-4ec4-973d-db4ba701557f" xlink:href="prph-20231231.xsd#prph_ShareBasedPaymentArrangementExpenseReversal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_prph_ShareBasedPaymentArrangementExpenseReversal_4b2e15f6-78b5-4ec4-973d-db4ba701557f" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_b1f98a48-0cbd-402a-a086-bc6411985fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_b1f98a48-0cbd-402a-a086-bc6411985fe2" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_92e41e57-64f4-4dbe-9e69-0c56ebf22836" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_92e41e57-64f4-4dbe-9e69-0c56ebf22836" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_d2165ddf-0295-48a6-ac84-3c196f0688a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_d2165ddf-0295-48a6-ac84-3c196f0688a1" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_419e4341-72d3-4b94-a333-e030dd024be0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_419e4341-72d3-4b94-a333-e030dd024be0" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_6f3daec7-d5a6-4f5c-b46f-a25a599294e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_6f3daec7-d5a6-4f5c-b46f-a25a599294e2" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_6d7e2557-d33c-4453-ad30-f22644067614" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_6d7e2557-d33c-4453-ad30-f22644067614" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_cacf220b-f650-4476-bdff-ba9a1ba36396" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_cacf220b-f650-4476-bdff-ba9a1ba36396" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_45807dbe-09db-4a31-a2ee-98253ab55714" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_45807dbe-09db-4a31-a2ee-98253ab55714" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_ac48728d-26d5-4d62-96d9-e65f016335b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_ac48728d-26d5-4d62-96d9-e65f016335b9" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_6e4f2c37-0d58-4d9b-96fa-adf15a090d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_6e4f2c37-0d58-4d9b-96fa-adf15a090d6a" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_d85975f2-f0ee-4a66-ad1f-61427cdc6cae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_d85975f2-f0ee-4a66-ad1f-61427cdc6cae" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_e0c754c0-48b7-4759-8afa-39422db221d4" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_e0c754c0-48b7-4759-8afa-39422db221d4" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_70e44976-88b0-4730-a7ca-e1cdaf409837" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_70e44976-88b0-4730-a7ca-e1cdaf409837" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_adfb807d-13e8-43a3-8a4a-d8ea1f38f279" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_adfb807d-13e8-43a3-8a4a-d8ea1f38f279" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_b24a405a-b990-46b7-968f-fa5489dee7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_b24a405a-b990-46b7-968f-fa5489dee7d5" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_22ddd560-627c-4fac-a41b-174d323c8d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_22ddd560-627c-4fac-a41b-174d323c8d4e" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_af7ed7a6-b8c2-4e6a-b372-d55e3f9c6c98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_af7ed7a6-b8c2-4e6a-b372-d55e3f9c6c98" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_855fc325-2344-4c37-823b-03909683f8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_855fc325-2344-4c37-823b-03909683f8ba" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_fcb1fef4-dafc-444e-b71d-f0ec7a6644d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_fcb1fef4-dafc-444e-b71d-f0ec7a6644d2" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_90d1937b-75f0-45a1-baa2-a76f26d43170" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_90d1937b-75f0-45a1-baa2-a76f26d43170" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_1993fd0e-49a6-4f08-bedb-169cfac0821f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_1993fd0e-49a6-4f08-bedb-169cfac0821f" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5b17f68b-efda-41a2-8573-d07bcb3bb622" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5b17f68b-efda-41a2-8573-d07bcb3bb622" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IssuanceOfCommonStockSharesExerciseOfWarrant_838a193f-4598-4a4b-98a7-18d41907a86c" xlink:href="prph-20231231.xsd#prph_IssuanceOfCommonStockSharesExerciseOfWarrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_prph_IssuanceOfCommonStockSharesExerciseOfWarrant_838a193f-4598-4a4b-98a7-18d41907a86c" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_20d2fd63-1bc0-458c-9a1f-260b978e9cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_20d2fd63-1bc0-458c-9a1f-260b978e9cd4" xlink:type="arc" order="46"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2de2c145-61b0-4253-92c7-affa1e107942" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2de2c145-61b0-4253-92c7-affa1e107942" xlink:type="arc" order="47"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cc6e70a0-13d5-4008-81f1-0a5b9e3f6549" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cc6e70a0-13d5-4008-81f1-0a5b9e3f6549" xlink:type="arc" order="48"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1f7ebd6b-3a4e-4c10-9e0c-189f917fe836" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1f7ebd6b-3a4e-4c10-9e0c-189f917fe836" xlink:type="arc" order="49"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#StockholdersEquityScheduleofWarrantActivityDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4623c548-9cbd-4498-aef7-fb51b0b86c69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_889ebce3-9129-463a-b358-bd88c3b5f9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4623c548-9cbd-4498-aef7-fb51b0b86c69" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_889ebce3-9129-463a-b358-bd88c3b5f9ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5ed6a7b3-0cb9-41c7-adbd-755dac3b3ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_889ebce3-9129-463a-b358-bd88c3b5f9ac" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5ed6a7b3-0cb9-41c7-adbd-755dac3b3ffb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5ed6a7b3-0cb9-41c7-adbd-755dac3b3ffb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5ed6a7b3-0cb9-41c7-adbd-755dac3b3ffb" xlink:to="loc_us-gaap_EquityComponentDomain_5ed6a7b3-0cb9-41c7-adbd-755dac3b3ffb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0f837e19-2eca-462d-aa8d-2f97dabdeffb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5ed6a7b3-0cb9-41c7-adbd-755dac3b3ffb" xlink:to="loc_us-gaap_EquityComponentDomain_0f837e19-2eca-462d-aa8d-2f97dabdeffb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_21579542-dec4-408d-a5d3-7902f834b263" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0f837e19-2eca-462d-aa8d-2f97dabdeffb" xlink:to="loc_us-gaap_WarrantMember_21579542-dec4-408d-a5d3-7902f834b263" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0adc45aa-f38b-4007-91d8-80a2c7347b12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4623c548-9cbd-4498-aef7-fb51b0b86c69" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0adc45aa-f38b-4007-91d8-80a2c7347b12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_909c40aa-7712-444c-b718-62fadf7ab2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0adc45aa-f38b-4007-91d8-80a2c7347b12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_909c40aa-7712-444c-b718-62fadf7ab2b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_f4ed064b-745e-4f7c-b7be-737801f10d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0adc45aa-f38b-4007-91d8-80a2c7347b12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_f4ed064b-745e-4f7c-b7be-737801f10d4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2098d78d-c89f-419b-ad30-c41ac61c1776" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0adc45aa-f38b-4007-91d8-80a2c7347b12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2098d78d-c89f-419b-ad30-c41ac61c1776" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3d1b3125-a602-4f4d-86eb-a21c13e9b987" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber_1d147009-e6b0-4ac9-9ce0-7582411da0b1" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0adc45aa-f38b-4007-91d8-80a2c7347b12" xlink:to="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber_1d147009-e6b0-4ac9-9ce0-7582411da0b1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_6cbe455a-459a-488a-8241-83b1b22cccc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4623c548-9cbd-4498-aef7-fb51b0b86c69" xlink:to="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_6cbe455a-459a-488a-8241-83b1b22cccc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1_9e1891cb-61bd-4b3f-979c-4b3313e3b1fb" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_6cbe455a-459a-488a-8241-83b1b22cccc2" xlink:to="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1_9e1891cb-61bd-4b3f-979c-4b3313e3b1fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1_d2fd4fb7-d801-4503-9bda-580d4578c10b" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_6cbe455a-459a-488a-8241-83b1b22cccc2" xlink:to="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1_d2fd4fb7-d801-4503-9bda-580d4578c10b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_WeightedAverageExercisePriceWarrantsExercised_bc1d261d-79c4-4c55-b7f5-03f34cb4210c" xlink:href="prph-20231231.xsd#prph_WeightedAverageExercisePriceWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_6cbe455a-459a-488a-8241-83b1b22cccc2" xlink:to="loc_prph_WeightedAverageExercisePriceWarrantsExercised_bc1d261d-79c4-4c55-b7f5-03f34cb4210c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1_0b391cff-6b84-4220-8437-52a547c7a989" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1_69320658-0f71-4c26-b087-35178e6ddbf5" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_6cbe455a-459a-488a-8241-83b1b22cccc2" xlink:to="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1_69320658-0f71-4c26-b087-35178e6ddbf5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_f6421c62-dc0d-422d-bdee-6803a6f89a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4623c548-9cbd-4498-aef7-fb51b0b86c69" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_f6421c62-dc0d-422d-bdee-6803a6f89a3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2_6497f090-ccb6-475a-8d22-5cdb90fbc956" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4623c548-9cbd-4498-aef7-fb51b0b86c69" xlink:to="loc_prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2_6497f090-ccb6-475a-8d22-5cdb90fbc956" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable_a3327d3f-8265-4734-a1b8-fb0840afde50" xlink:href="prph-20231231.xsd#prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4623c548-9cbd-4498-aef7-fb51b0b86c69" xlink:to="loc_prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable_a3327d3f-8265-4734-a1b8-fb0840afde50" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_152a9ad4-211a-4c7f-9ef4-ea5a1376869d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_us-gaap_OtherCommitmentsTable_152a9ad4-211a-4c7f-9ef4-ea5a1376869d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_dee4770a-74ea-4ed7-b5db-2aea99dc2e87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_152a9ad4-211a-4c7f-9ef4-ea5a1376869d" xlink:to="loc_us-gaap_AwardTypeAxis_dee4770a-74ea-4ed7-b5db-2aea99dc2e87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dee4770a-74ea-4ed7-b5db-2aea99dc2e87_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_dee4770a-74ea-4ed7-b5db-2aea99dc2e87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dee4770a-74ea-4ed7-b5db-2aea99dc2e87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_192ee536-f4a0-4b28-af0f-932d235be199" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_dee4770a-74ea-4ed7-b5db-2aea99dc2e87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_192ee536-f4a0-4b28-af0f-932d235be199" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_PhaseThreeMember_68dbc3dd-9da9-4cb2-8cc3-c44db041879b" xlink:href="prph-20231231.xsd#prph_PhaseThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_192ee536-f4a0-4b28-af0f-932d235be199" xlink:to="loc_prph_PhaseThreeMember_68dbc3dd-9da9-4cb2-8cc3-c44db041879b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NewDrugApplicationMember_f24c5aa2-406a-4a13-9242-ca4145a10dac" xlink:href="prph-20231231.xsd#prph_NewDrugApplicationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_192ee536-f4a0-4b28-af0f-932d235be199" xlink:to="loc_prph_NewDrugApplicationMember_f24c5aa2-406a-4a13-9242-ca4145a10dac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_bee795a4-3e65-4180-a109-315d33261a26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_152a9ad4-211a-4c7f-9ef4-ea5a1376869d" xlink:to="loc_us-gaap_TypeOfArrangementAxis_bee795a4-3e65-4180-a109-315d33261a26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_bee795a4-3e65-4180-a109-315d33261a26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_bee795a4-3e65-4180-a109-315d33261a26" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_bee795a4-3e65-4180-a109-315d33261a26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0833ea01-58d8-4ce2-866f-d8b522a4fdc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_bee795a4-3e65-4180-a109-315d33261a26" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0833ea01-58d8-4ce2-866f-d8b522a4fdc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LinebackerLicenseAgreementsMember_cebf4131-a13f-4cde-9890-8bcc89eca732" xlink:href="prph-20231231.xsd#prph_LinebackerLicenseAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0833ea01-58d8-4ce2-866f-d8b522a4fdc5" xlink:to="loc_prph_LinebackerLicenseAgreementsMember_cebf4131-a13f-4cde-9890-8bcc89eca732" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_EquivirLicenseAgreementMember_d40d4c7a-053f-4344-9a29-014fe56d5173" xlink:href="prph-20231231.xsd#prph_EquivirLicenseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0833ea01-58d8-4ce2-866f-d8b522a4fdc5" xlink:to="loc_prph_EquivirLicenseAgreementMember_d40d4c7a-053f-4344-9a29-014fe56d5173" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_BESmartLicenseAgreementMember_09eb8f59-5829-42d7-92fe-33b751a06f56" xlink:href="prph-20231231.xsd#prph_BESmartLicenseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0833ea01-58d8-4ce2-866f-d8b522a4fdc5" xlink:to="loc_prph_BESmartLicenseAgreementMember_09eb8f59-5829-42d7-92fe-33b751a06f56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ManufacturingAgreementRenewalOptions_9de28d1e-1b29-4d88-9c2e-05ad4ac52bac" xlink:href="prph-20231231.xsd#prph_ManufacturingAgreementRenewalOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_prph_ManufacturingAgreementRenewalOptions_9de28d1e-1b29-4d88-9c2e-05ad4ac52bac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ManufacturingAgreementRenewalPeriod_ba90c432-8468-409f-8133-ab8438994114" xlink:href="prph-20231231.xsd#prph_ManufacturingAgreementRenewalPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_prph_ManufacturingAgreementRenewalPeriod_ba90c432-8468-409f-8133-ab8438994114" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AgreementTerm_3cfb5c29-0753-46f7-9609-04f90633611e" xlink:href="prph-20231231.xsd#prph_AgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_prph_AgreementTerm_3cfb5c29-0753-46f7-9609-04f90633611e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_UpfrontLicenseFee_674088ce-4d01-4755-b165-71dc8e161982" xlink:href="prph-20231231.xsd#prph_UpfrontLicenseFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_prph_UpfrontLicenseFee_674088ce-4d01-4755-b165-71dc8e161982" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LicenseAgreementTerm_ac97e444-debe-41b5-991b-7bd91d11596f" xlink:href="prph-20231231.xsd#prph_LicenseAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_prph_LicenseAgreementTerm_ac97e444-debe-41b5-991b-7bd91d11596f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AdditionalPaymentOfFee_4f0f12d1-67d0-4f51-a911-5eeaa27ef100" xlink:href="prph-20231231.xsd#prph_AdditionalPaymentOfFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_prph_AdditionalPaymentOfFee_4f0f12d1-67d0-4f51-a911-5eeaa27ef100" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LicenseOrRoyaltyNetRevenuePercentage_1d6f5aed-5b64-4518-8ff1-3a07c276a816" xlink:href="prph-20231231.xsd#prph_LicenseOrRoyaltyNetRevenuePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_prph_LicenseOrRoyaltyNetRevenuePercentage_1d6f5aed-5b64-4518-8ff1-3a07c276a816" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_47d0ca51-bf38-4768-bd5f-d18aac6dbe59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_us-gaap_RoyaltyExpense_47d0ca51-bf38-4768-bd5f-d18aac6dbe59" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_7edfe703-7ac6-4426-ac6f-7417f84cc473" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_7edfe703-7ac6-4426-ac6f-7417f84cc473" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfSites_4b28b12e-0a34-4c9f-ab64-51cb03443434" xlink:href="prph-20231231.xsd#prph_NumberOfSites"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_prph_NumberOfSites_4b28b12e-0a34-4c9f-ab64-51cb03443434" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_da060538-470f-45b2-aabf-52697c492ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_da060538-470f-45b2-aabf-52697c492ecf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_402d40d7-f790-4b2e-a005-5861720cad96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_da060538-470f-45b2-aabf-52697c492ecf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_402d40d7-f790-4b2e-a005-5861720cad96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_402d40d7-f790-4b2e-a005-5861720cad96_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_402d40d7-f790-4b2e-a005-5861720cad96" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_402d40d7-f790-4b2e-a005-5861720cad96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6dd400a5-365c-45fa-83f6-97c99bb93b54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_402d40d7-f790-4b2e-a005-5861720cad96" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6dd400a5-365c-45fa-83f6-97c99bb93b54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CPMMember_4baacdc3-c2d8-4321-b9e4-0271b2498791" xlink:href="prph-20231231.xsd#prph_CPMMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6dd400a5-365c-45fa-83f6-97c99bb93b54" xlink:to="loc_prph_CPMMember_4baacdc3-c2d8-4321-b9e4-0271b2498791" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_b6eb1198-d254-49da-b025-365465624a44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_da060538-470f-45b2-aabf-52697c492ecf" xlink:to="loc_us-gaap_GeographicDistributionAxis_b6eb1198-d254-49da-b025-365465624a44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_b6eb1198-d254-49da-b025-365465624a44_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GeographicDistributionAxis_b6eb1198-d254-49da-b025-365465624a44" xlink:to="loc_us-gaap_GeographicDistributionDomain_b6eb1198-d254-49da-b025-365465624a44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_d5df5505-b951-4c5c-a63f-c174e9140bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GeographicDistributionAxis_b6eb1198-d254-49da-b025-365465624a44" xlink:to="loc_us-gaap_GeographicDistributionDomain_d5df5505-b951-4c5c-a63f-c174e9140bb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_OldBridgeNewJerseyMember_3103f0f6-5053-4c85-ad02-e9c9851a94c1" xlink:href="prph-20231231.xsd#prph_OldBridgeNewJerseyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_d5df5505-b951-4c5c-a63f-c174e9140bb5" xlink:to="loc_prph_OldBridgeNewJerseyMember_3103f0f6-5053-4c85-ad02-e9c9851a94c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NewYorkSecondFloorLeaseMember_cd6e9f6c-5bdb-4ae2-bd02-6b7d4937f9c2" xlink:href="prph-20231231.xsd#prph_NewYorkSecondFloorLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_d5df5505-b951-4c5c-a63f-c174e9140bb5" xlink:to="loc_prph_NewYorkSecondFloorLeaseMember_cd6e9f6c-5bdb-4ae2-bd02-6b7d4937f9c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NewYorkFirstFloorLeaseMember_c8e67f36-6819-4f92-ab9b-d64f2f1dcd76" xlink:href="prph-20231231.xsd#prph_NewYorkFirstFloorLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_d5df5505-b951-4c5c-a63f-c174e9140bb5" xlink:to="loc_prph_NewYorkFirstFloorLeaseMember_c8e67f36-6819-4f92-ab9b-d64f2f1dcd76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_226fb284-de52-4224-9cc0-327041244db6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_da060538-470f-45b2-aabf-52697c492ecf" xlink:to="loc_srt_RangeAxis_226fb284-de52-4224-9cc0-327041244db6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_226fb284-de52-4224-9cc0-327041244db6_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_226fb284-de52-4224-9cc0-327041244db6" xlink:to="loc_srt_RangeMember_226fb284-de52-4224-9cc0-327041244db6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fe8ce1b8-878d-4ff2-8a3b-f24da8164a66" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_226fb284-de52-4224-9cc0-327041244db6" xlink:to="loc_srt_RangeMember_fe8ce1b8-878d-4ff2-8a3b-f24da8164a66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_32eb7ba6-edf5-49dd-9ae5-19fb778b27a3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fe8ce1b8-878d-4ff2-8a3b-f24da8164a66" xlink:to="loc_srt_MinimumMember_32eb7ba6-edf5-49dd-9ae5-19fb778b27a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e29392ae-d6db-4423-b164-4e3b39a75831" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fe8ce1b8-878d-4ff2-8a3b-f24da8164a66" xlink:to="loc_srt_MaximumMember_e29392ae-d6db-4423-b164-4e3b39a75831" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_60b5ccc6-097d-477e-a8f7-9d47b587def0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_60b5ccc6-097d-477e-a8f7-9d47b587def0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_294aa2c3-d7bb-4884-908d-b3faf4674bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_294aa2c3-d7bb-4884-908d-b3faf4674bc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LesseeOperatingLeaseMonthlyBaseRent_63412c5b-39d1-436f-9bbc-af99e286f229" xlink:href="prph-20231231.xsd#prph_LesseeOperatingLeaseMonthlyBaseRent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_prph_LesseeOperatingLeaseMonthlyBaseRent_63412c5b-39d1-436f-9bbc-af99e286f229" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_97f55cd6-58bf-4ecb-847a-df69e498fa50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_OperatingLeaseLiability_97f55cd6-58bf-4ecb-847a-df69e498fa50" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LesseeOperatingLeaseNumberOfRenewalOptions_37164d4c-b1cc-4513-8e9d-486a94812048" xlink:href="prph-20231231.xsd#prph_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_prph_LesseeOperatingLeaseNumberOfRenewalOptions_37164d4c-b1cc-4513-8e9d-486a94812048" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod_ac9bb69d-d97a-453e-b2f0-c9efc5d8bd0f" xlink:href="prph-20231231.xsd#prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod_ac9bb69d-d97a-453e-b2f0-c9efc5d8bd0f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_7f61c045-ec3b-4ff3-88a1-a5700ca6e5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_7f61c045-ec3b-4ff3-88a1-a5700ca6e5c9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRent_607889fb-5f81-464c-8d53-4f90e928b47b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_PaymentsForRent_607889fb-5f81-464c-8d53-4f90e928b47b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LesseeOperatingLeaseAbatementPeriod_70b39316-b9e8-4b44-bf9d-23fac14d58c5" xlink:href="prph-20231231.xsd#prph_LesseeOperatingLeaseAbatementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_prph_LesseeOperatingLeaseAbatementPeriod_70b39316-b9e8-4b44-bf9d-23fac14d58c5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_GradualRentalRateIncreasePercentage_d98cec9e-abf5-4895-82e0-db7ec4574a51" xlink:href="prph-20231231.xsd#prph_GradualRentalRateIncreasePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_prph_GradualRentalRateIncreasePercentage_d98cec9e-abf5-4895-82e0-db7ec4574a51" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidRent_d3eeba5c-14e7-4762-89b4-179f7d10f8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidRent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_PrepaidRent_d3eeba5c-14e7-4762-89b4-179f7d10f8f9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ConstructionAllowance_afc7de07-448f-40d7-95d6-d6bed927880b" xlink:href="prph-20231231.xsd#prph_ConstructionAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_prph_ConstructionAllowance_afc7de07-448f-40d7-95d6-d6bed927880b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e2686926-170b-4016-9059-2438b4c72c43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e2686926-170b-4016-9059-2438b4c72c43" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_eaf27b69-8d65-4ac4-8897-ac26acb0a4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_eaf27b69-8d65-4ac4-8897-ac26acb0a4b6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e4bdaa4d-a673-4c5c-a7d7-ab538ae524b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e4bdaa4d-a673-4c5c-a7d7-ab538ae524b7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_571864f4-2b18-480a-ba3a-771b15a5269a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_571864f4-2b18-480a-ba3a-771b15a5269a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_8d62bb92-e7af-4e64-b7f4-44cae7810173" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_8d62bb92-e7af-4e64-b7f4-44cae7810173" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SignificantCustomersConcentrationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_17c3efb0-9cfb-47ff-a843-0b947bdf9269" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_d69e4c3f-abaf-442a-81cf-a2726b2e738c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_17c3efb0-9cfb-47ff-a843-0b947bdf9269" xlink:to="loc_us-gaap_ConcentrationRiskTable_d69e4c3f-abaf-442a-81cf-a2726b2e738c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_85f15dff-ab91-4cdb-b569-f2ba85c8958f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_d69e4c3f-abaf-442a-81cf-a2726b2e738c" xlink:to="loc_srt_MajorCustomersAxis_85f15dff-ab91-4cdb-b569-f2ba85c8958f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_85f15dff-ab91-4cdb-b569-f2ba85c8958f_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_85f15dff-ab91-4cdb-b569-f2ba85c8958f" xlink:to="loc_srt_NameOfMajorCustomerDomain_85f15dff-ab91-4cdb-b569-f2ba85c8958f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_6b62383b-74ca-4fb2-aaf2-f25e71d28212" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_85f15dff-ab91-4cdb-b569-f2ba85c8958f" xlink:to="loc_srt_NameOfMajorCustomerDomain_6b62383b-74ca-4fb2-aaf2-f25e71d28212" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_GovernmentAgenciesMember_ce0181e6-72df-4ad5-ac9a-74070c3c1b5c" xlink:href="prph-20231231.xsd#prph_GovernmentAgenciesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_6b62383b-74ca-4fb2-aaf2-f25e71d28212" xlink:to="loc_prph_GovernmentAgenciesMember_ce0181e6-72df-4ad5-ac9a-74070c3c1b5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_InsuranceProvidersMember_60269aa9-d920-4308-8131-2761408bae66" xlink:href="prph-20231231.xsd#prph_InsuranceProvidersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_6b62383b-74ca-4fb2-aaf2-f25e71d28212" xlink:to="loc_prph_InsuranceProvidersMember_60269aa9-d920-4308-8131-2761408bae66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ClientPayersMember_c9ea2a07-e469-453a-846c-4d1b931e117b" xlink:href="prph-20231231.xsd#prph_ClientPayersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_6b62383b-74ca-4fb2-aaf2-f25e71d28212" xlink:to="loc_prph_ClientPayersMember_c9ea2a07-e469-453a-846c-4d1b931e117b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DiagnosticServicesClientsOneMember_330f1321-b650-4d01-8887-8dec874391e4" xlink:href="prph-20231231.xsd#prph_DiagnosticServicesClientsOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_6b62383b-74ca-4fb2-aaf2-f25e71d28212" xlink:to="loc_prph_DiagnosticServicesClientsOneMember_330f1321-b650-4d01-8887-8dec874391e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DiagnosticServicesClientsTwoMember_b3ae4bb2-19ec-4f3a-b1b0-07056190dd83" xlink:href="prph-20231231.xsd#prph_DiagnosticServicesClientsTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_6b62383b-74ca-4fb2-aaf2-f25e71d28212" xlink:to="loc_prph_DiagnosticServicesClientsTwoMember_b3ae4bb2-19ec-4f3a-b1b0-07056190dd83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DiagnosticServicesClientsThreeMember_8ed8df16-f25a-481d-9849-15349f8b63cf" xlink:href="prph-20231231.xsd#prph_DiagnosticServicesClientsThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_6b62383b-74ca-4fb2-aaf2-f25e71d28212" xlink:to="loc_prph_DiagnosticServicesClientsThreeMember_8ed8df16-f25a-481d-9849-15349f8b63cf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e9bedbf6-c2c8-4c50-84ce-8100a7ee07e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_d69e4c3f-abaf-442a-81cf-a2726b2e738c" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e9bedbf6-c2c8-4c50-84ce-8100a7ee07e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e9bedbf6-c2c8-4c50-84ce-8100a7ee07e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e9bedbf6-c2c8-4c50-84ce-8100a7ee07e5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e9bedbf6-c2c8-4c50-84ce-8100a7ee07e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6f4da480-ddc8-4779-9d0e-f585e250c600" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e9bedbf6-c2c8-4c50-84ce-8100a7ee07e5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6f4da480-ddc8-4779-9d0e-f585e250c600" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_0c9311f2-d347-49b2-9dcb-3f8c770d5626" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6f4da480-ddc8-4779-9d0e-f585e250c600" xlink:to="loc_us-gaap_SalesRevenueNetMember_0c9311f2-d347-49b2-9dcb-3f8c770d5626" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ReimbursementReceivableMember_48e15ca6-56df-4ad6-9071-2ee472aaceea" xlink:href="prph-20231231.xsd#prph_ReimbursementReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6f4da480-ddc8-4779-9d0e-f585e250c600" xlink:to="loc_prph_ReimbursementReceivableMember_48e15ca6-56df-4ad6-9071-2ee472aaceea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_560c5063-1b06-407c-b837-338fcdbdceaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_d69e4c3f-abaf-442a-81cf-a2726b2e738c" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_560c5063-1b06-407c-b837-338fcdbdceaf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_560c5063-1b06-407c-b837-338fcdbdceaf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_560c5063-1b06-407c-b837-338fcdbdceaf" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_560c5063-1b06-407c-b837-338fcdbdceaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ba0b2a98-4ce0-4a31-b66e-3dbba98bebfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_560c5063-1b06-407c-b837-338fcdbdceaf" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ba0b2a98-4ce0-4a31-b66e-3dbba98bebfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_SegmentConcentrationRiskMember_e091533e-d1a9-4bce-b327-d0a93c5135fa" xlink:href="prph-20231231.xsd#prph_SegmentConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ba0b2a98-4ce0-4a31-b66e-3dbba98bebfb" xlink:to="loc_prph_SegmentConcentrationRiskMember_e091533e-d1a9-4bce-b327-d0a93c5135fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_c9b236b0-2241-41f7-912f-a7d833b04c77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ba0b2a98-4ce0-4a31-b66e-3dbba98bebfb" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_c9b236b0-2241-41f7-912f-a7d833b04c77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9f0a26a0-e5e3-4439-a4a6-58df83cad2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_d69e4c3f-abaf-442a-81cf-a2726b2e738c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9f0a26a0-e5e3-4439-a4a6-58df83cad2e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9f0a26a0-e5e3-4439-a4a6-58df83cad2e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9f0a26a0-e5e3-4439-a4a6-58df83cad2e3" xlink:to="loc_us-gaap_SegmentDomain_9f0a26a0-e5e3-4439-a4a6-58df83cad2e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_016c3895-4ffe-47a2-90d8-71346160aed3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9f0a26a0-e5e3-4439-a4a6-58df83cad2e3" xlink:to="loc_us-gaap_SegmentDomain_016c3895-4ffe-47a2-90d8-71346160aed3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DiagnosticServicesMember_600f71d1-0ef2-4d93-b8b0-a2e2df7d1a93" xlink:href="prph-20231231.xsd#prph_DiagnosticServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_016c3895-4ffe-47a2-90d8-71346160aed3" xlink:to="loc_prph_DiagnosticServicesMember_600f71d1-0ef2-4d93-b8b0-a2e2df7d1a93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c7f0e452-f39a-400d-a8f5-33b3c099859f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_17c3efb0-9cfb-47ff-a843-0b947bdf9269" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c7f0e452-f39a-400d-a8f5-33b3c099859f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_50370c39-b990-43bb-bfc0-c22aea988b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_17c3efb0-9cfb-47ff-a843-0b947bdf9269" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_50370c39-b990-43bb-bfc0-c22aea988b1b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/ScheduleofSegmentInformationDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#ScheduleofSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/ScheduleofSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_217c27a6-1d1d-45f9-87d5-9712d499d769" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_217c27a6-1d1d-45f9-87d5-9712d499d769" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cc7e7bc3-32ba-46ef-a3be-0c9a55aa456f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_217c27a6-1d1d-45f9-87d5-9712d499d769" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cc7e7bc3-32ba-46ef-a3be-0c9a55aa456f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cc7e7bc3-32ba-46ef-a3be-0c9a55aa456f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cc7e7bc3-32ba-46ef-a3be-0c9a55aa456f" xlink:to="loc_us-gaap_SegmentDomain_cc7e7bc3-32ba-46ef-a3be-0c9a55aa456f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9051aaba-5991-42cd-8228-992ee6e0f229" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cc7e7bc3-32ba-46ef-a3be-0c9a55aa456f" xlink:to="loc_us-gaap_SegmentDomain_9051aaba-5991-42cd-8228-992ee6e0f229" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DiagnosticServicesMember_27088c1a-c21d-4df9-902a-0bd857018bc6" xlink:href="prph-20231231.xsd#prph_DiagnosticServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9051aaba-5991-42cd-8228-992ee6e0f229" xlink:to="loc_prph_DiagnosticServicesMember_27088c1a-c21d-4df9-902a-0bd857018bc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ConsumerProductsMember_eb756ba3-56c7-4e70-9503-65717a952ee8" xlink:href="prph-20231231.xsd#prph_ConsumerProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9051aaba-5991-42cd-8228-992ee6e0f229" xlink:to="loc_prph_ConsumerProductsMember_eb756ba3-56c7-4e70-9503-65717a952ee8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_UnallocatedCorporateMember_90d66227-d232-4166-8e0b-0887a704018b" xlink:href="prph-20231231.xsd#prph_UnallocatedCorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9051aaba-5991-42cd-8228-992ee6e0f229" xlink:to="loc_prph_UnallocatedCorporateMember_90d66227-d232-4166-8e0b-0887a704018b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_10d69c15-4311-4b3e-a1ce-603ea31a6708" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_10d69c15-4311-4b3e-a1ce-603ea31a6708" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_980e789c-cf77-45bf-9c3d-2df201f0455a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_980e789c-cf77-45bf-9c3d-2df201f0455a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_ef2b07fa-867a-46d9-8f24-ae3317794e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:to="loc_us-gaap_DepreciationAndAmortization_ef2b07fa-867a-46d9-8f24-ae3317794e4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_OperatingAndOtherExpenses_caf18102-71b5-47b3-a4e8-e5db0f1a30eb" xlink:href="prph-20231231.xsd#prph_OperatingAndOtherExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:to="loc_prph_OperatingAndOtherExpenses_caf18102-71b5-47b3-a4e8-e5db0f1a30eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1f6b92b1-b957-4430-8093-f0a938a84be2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1f6b92b1-b957-4430-8093-f0a938a84be2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c6e8dd37-0f7e-48dd-a142-d97395784995" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c6e8dd37-0f7e-48dd-a142-d97395784995" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3123771f-ca2d-4479-83d2-3251538a2ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:to="loc_us-gaap_NetIncomeLoss_3123771f-ca2d-4479-83d2-3251538a2ecc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0349721c-efe6-47fa-bfb6-c18bd15fe506" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:to="loc_us-gaap_Assets_0349721c-efe6-47fa-bfb6-c18bd15fe506" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_44311b6b-bd5d-48fb-9a02-a20d5714cb45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_54e440e5-635d-47ff-b162-3188fb0f66c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_44311b6b-bd5d-48fb-9a02-a20d5714cb45" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_54e440e5-635d-47ff-b162-3188fb0f66c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9591e0fe-5b02-4a85-956e-eeca1b33e82f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_54e440e5-635d-47ff-b162-3188fb0f66c9" xlink:to="loc_us-gaap_AwardTypeAxis_9591e0fe-5b02-4a85-956e-eeca1b33e82f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9591e0fe-5b02-4a85-956e-eeca1b33e82f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9591e0fe-5b02-4a85-956e-eeca1b33e82f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9591e0fe-5b02-4a85-956e-eeca1b33e82f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dc7868c9-5e07-4558-a4c6-49af7fffbaad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9591e0fe-5b02-4a85-956e-eeca1b33e82f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dc7868c9-5e07-4558-a4c6-49af7fffbaad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2f89c01d-d012-4430-aae9-a25f12153b69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dc7868c9-5e07-4558-a4c6-49af7fffbaad" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2f89c01d-d012-4430-aae9-a25f12153b69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_84cb4a76-b4e9-431c-abc1-9009b744f676" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dc7868c9-5e07-4558-a4c6-49af7fffbaad" xlink:to="loc_us-gaap_WarrantMember_84cb4a76-b4e9-431c-abc1-9009b744f676" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_6a7fbbe9-3515-4c5a-b23e-5dc99de9017b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_44311b6b-bd5d-48fb-9a02-a20d5714cb45" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_6a7fbbe9-3515-4c5a-b23e-5dc99de9017b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_InterestOnUnsecuredConvertiblePromissoryNote_1015d47d-8407-4c24-9235-fe5d0a137593" xlink:href="prph-20231231.xsd#prph_InterestOnUnsecuredConvertiblePromissoryNote"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_44311b6b-bd5d-48fb-9a02-a20d5714cb45" xlink:to="loc_prph_InterestOnUnsecuredConvertiblePromissoryNote_1015d47d-8407-4c24-9235-fe5d0a137593" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_07360b7c-576d-4f04-b5eb-ad9f836f7aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_44311b6b-bd5d-48fb-9a02-a20d5714cb45" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_07360b7c-576d-4f04-b5eb-ad9f836f7aa9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cda6cd72-7c00-4ce8-9e7c-c534f1c2ea9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_44311b6b-bd5d-48fb-9a02-a20d5714cb45" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cda6cd72-7c00-4ce8-9e7c-c534f1c2ea9b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0fcb673d-aa85-4abe-9577-84b8ef0d66f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_44311b6b-bd5d-48fb-9a02-a20d5714cb45" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0fcb673d-aa85-4abe-9577-84b8ef0d66f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_6b2cdc17-844b-4200-94ad-18950e5bc679" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_44311b6b-bd5d-48fb-9a02-a20d5714cb45" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_6b2cdc17-844b-4200-94ad-18950e5bc679" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_efb7e6a2-0efd-4904-bab6-4489fbbb75b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_44311b6b-bd5d-48fb-9a02-a20d5714cb45" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_efb7e6a2-0efd-4904-bab6-4489fbbb75b1" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromtheIncomePerShareComputationDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromtheIncomePerShareComputationDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromtheIncomePerShareComputationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1cff186d-6127-4a3d-8a9f-70d9fb70a1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_eb33474c-96c5-46dd-952f-9c0841213b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1cff186d-6127-4a3d-8a9f-70d9fb70a1b3" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_eb33474c-96c5-46dd-952f-9c0841213b2d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_07861913-8b8d-4ba6-86b4-1b9cff230b80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_eb33474c-96c5-46dd-952f-9c0841213b2d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_07861913-8b8d-4ba6-86b4-1b9cff230b80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_07861913-8b8d-4ba6-86b4-1b9cff230b80_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_07861913-8b8d-4ba6-86b4-1b9cff230b80" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_07861913-8b8d-4ba6-86b4-1b9cff230b80_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f36a73a6-f3a9-4cbc-ba8c-2920f601ca1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_07861913-8b8d-4ba6-86b4-1b9cff230b80" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f36a73a6-f3a9-4cbc-ba8c-2920f601ca1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CommonStockPurchaseWarrantsMember_b2b4ac90-20ed-480e-aa89-f87272d44fbf" xlink:href="prph-20231231.xsd#prph_CommonStockPurchaseWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f36a73a6-f3a9-4cbc-ba8c-2920f601ca1a" xlink:to="loc_prph_CommonStockPurchaseWarrantsMember_b2b4ac90-20ed-480e-aa89-f87272d44fbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e2d33177-febf-4d91-92fd-9e03b856ef87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f36a73a6-f3a9-4cbc-ba8c-2920f601ca1a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e2d33177-febf-4d91-92fd-9e03b856ef87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0249dede-9970-4024-a7d7-b1643ee26485" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1cff186d-6127-4a3d-8a9f-70d9fb70a1b3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0249dede-9970-4024-a7d7-b1643ee26485" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://prophaselabs.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_85171fdb-caeb-42b5-81ca-7e7cdfad3120" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_a556c35a-556b-463a-b21c-fdb6d3c79657" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_85171fdb-caeb-42b5-81ca-7e7cdfad3120" xlink:to="loc_us-gaap_SubsequentEventTable_a556c35a-556b-463a-b21c-fdb6d3c79657" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b096aed7-3610-4254-82f0-97c44e92c24d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a556c35a-556b-463a-b21c-fdb6d3c79657" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b096aed7-3610-4254-82f0-97c44e92c24d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b096aed7-3610-4254-82f0-97c44e92c24d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b096aed7-3610-4254-82f0-97c44e92c24d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b096aed7-3610-4254-82f0-97c44e92c24d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a58783d0-a74d-4315-9aa7-80a92cbce2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b096aed7-3610-4254-82f0-97c44e92c24d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a58783d0-a74d-4315-9aa7-80a92cbce2bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_564c164f-2b38-47ef-8044-3e75ecfdd312" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a58783d0-a74d-4315-9aa7-80a92cbce2bb" xlink:to="loc_us-gaap_SubsequentEventMember_564c164f-2b38-47ef-8044-3e75ecfdd312" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ProceedsFromFinancingAgreement_7deec036-871b-466c-a595-84469740cc8c" xlink:href="prph-20231231.xsd#prph_ProceedsFromFinancingAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_85171fdb-caeb-42b5-81ca-7e7cdfad3120" xlink:to="loc_prph_ProceedsFromFinancingAgreement_7deec036-871b-466c-a595-84469740cc8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_FinancingAgreementOriginationFee_1264c3d6-8adc-443a-ba19-5e8381593ea0" xlink:href="prph-20231231.xsd#prph_FinancingAgreementOriginationFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_85171fdb-caeb-42b5-81ca-7e7cdfad3120" xlink:to="loc_prph_FinancingAgreementOriginationFee_1264c3d6-8adc-443a-ba19-5e8381593ea0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_FinancingAgreementPeriodicPayment_b0abc165-70d6-4669-bbf2-d074272bac44" xlink:href="prph-20231231.xsd#prph_FinancingAgreementPeriodicPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_85171fdb-caeb-42b5-81ca-7e7cdfad3120" xlink:to="loc_prph_FinancingAgreementPeriodicPayment_b0abc165-70d6-4669-bbf2-d074272bac44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_FinancingArrangementAggregateRepaymentAmount_0d442c24-7ff8-48f9-a2b4-c279746f92d9" xlink:href="prph-20231231.xsd#prph_FinancingArrangementAggregateRepaymentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_85171fdb-caeb-42b5-81ca-7e7cdfad3120" xlink:to="loc_prph_FinancingArrangementAggregateRepaymentAmount_0d442c24-7ff8-48f9-a2b4-c279746f92d9" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>18
<FILENAME>prph-20231231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:7788277e-a48e-4763-84b1-a7c7849f902f,g:9ac615ab-2322-4dd1-8a91-31a5eca0bd4d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityVoluntaryFilers_15ab94cf-b0e8-4667-aaf3-2e5643a2cc3f_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_d88ed84e-06ac-40f8-80f0-ef54bfd095ac_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_221b6d4e-896d-4f73-b51d-9de1d0648442_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_4cc102c0-a2ca-45a1-bb98-a8cac283dd3d_negatedLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Inventory valuation reserve</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_5e6ff961-b303-4698-9303-464c5495971f_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_PhaseThreeMember_64a8661b-ada7-4304-95a6-bf7b96fd3b51_terseLabel_en-US" xlink:label="lab_prph_PhaseThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Phase Three</link:label>
    <link:label id="lab_prph_PhaseThreeMember_label_en-US" xlink:label="lab_prph_PhaseThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Phase Three [Member]</link:label>
    <link:label id="lab_prph_PhaseThreeMember_documentation_en-US" xlink:label="lab_prph_PhaseThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Phase Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_PhaseThreeMember" xlink:href="prph-20231231.xsd#prph_PhaseThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_PhaseThreeMember" xlink:to="lab_prph_PhaseThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6b0d9532-496f-447d-b70c-f8c875cf2a66_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_9530daa9-e132-42d7-984e-a048e9785489_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award expiration period (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_LeaseLiabilityToBePaid_351fd30c-aa12-44cc-b3bc-ec20652c3fad_totalLabel_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaid" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_prph_LeaseLiabilityToBePaid_label_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Liability, To Be Paid</link:label>
    <link:label id="lab_prph_LeaseLiabilityToBePaid_documentation_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Liability, To Be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaid" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_LeaseLiabilityToBePaid" xlink:to="lab_prph_LeaseLiabilityToBePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOther_b41dd5ef-7929-4cb2-bf73-0f1c012063a9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOther_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOther" xlink:to="lab_us-gaap_InterestIncomeOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f509be7-9bbc-44ff-b5cd-d189edebdaa7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_fa236a08-f4fb-4cc2-a37d-c778526cde33_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected timing of satisfaction, period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_4e436ca3-dc9f-47c4-ad5c-07c50b2d2f11_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_8fcab823-6955-4a9b-a284-3db6a2d6fa21_terseLabel_en-US" xlink:label="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of stock options granted</link:label>
    <link:label id="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_label_en-US" xlink:label="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Fair Value</link:label>
    <link:label id="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_documentation_en-US" xlink:label="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:to="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_0bbd930a-d2a4-4cde-becb-dcd60676d877_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsTable" xlink:to="lab_us-gaap_OffsettingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_eec1be14-bb3b-4f2f-88e0-0cf6991b87cf_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_0fdba854-bd78-4887-bc1c-b0f1e03715fa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_130bbcd6-1436-4bf9-8e94-60456d267236_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contribution amount</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_InducementOptionAwardMember_59288f2c-0516-446e-9fb8-96005c410e72_terseLabel_en-US" xlink:label="lab_prph_InducementOptionAwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inducement Option Award</link:label>
    <link:label id="lab_prph_InducementOptionAwardMember_label_en-US" xlink:label="lab_prph_InducementOptionAwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inducement Option Award [Member]</link:label>
    <link:label id="lab_prph_InducementOptionAwardMember_documentation_en-US" xlink:label="lab_prph_InducementOptionAwardMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Inducement Option Award [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_InducementOptionAwardMember" xlink:href="prph-20231231.xsd#prph_InducementOptionAwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_InducementOptionAwardMember" xlink:to="lab_prph_InducementOptionAwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_4637c97b-304f-4ddb-96b3-0156cda8958c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liability, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_DeferredTaxAssetsCapitalLeaseObligations_648e4800-1162-46c8-8682-37124935e9a6_terseLabel_en-US" xlink:label="lab_prph_DeferredTaxAssetsCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital lease obligations</link:label>
    <link:label id="lab_prph_DeferredTaxAssetsCapitalLeaseObligations_label_en-US" xlink:label="lab_prph_DeferredTaxAssetsCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Capital Lease Obligations</link:label>
    <link:label id="lab_prph_DeferredTaxAssetsCapitalLeaseObligations_documentation_en-US" xlink:label="lab_prph_DeferredTaxAssetsCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred tax assets, capital lease obligations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DeferredTaxAssetsCapitalLeaseObligations" xlink:href="prph-20231231.xsd#prph_DeferredTaxAssetsCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_DeferredTaxAssetsCapitalLeaseObligations" xlink:to="lab_prph_DeferredTaxAssetsCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_5ee9e7b7-1254-454a-b6ad-7d0d33011834_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_c13d691f-677d-4e65-a452-0bb78d4b63ee_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_f9121084-7074-4ab5-a163-a7f21a100a59_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual life, options vested and exercisable (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_6f5a05d5-5171-4da8-9e04-86c0c17cfe34_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingImprovementsMember_419ae4d2-4bdc-4497-9041-34c659f3b14e_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Building improvements</link:label>
    <link:label id="lab_us-gaap_BuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment_e70c4a50-bf3b-414a-a0ec-5ce68ef2026e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from dispositions of property and other assets, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Other Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_524a7516-c6c8-470e-8e68-257a1e107663_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_578d01f2-0268-4b68-9804-ee0b567fff74_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b0fe4ba3-d986-4acc-9384-e1869610bcac_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year Ended December 31, 2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_a26530fe-660b-4d34-b450-ee2a29de684e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_StellaPurchaseAgreementMember_a13b5121-d75d-42ed-826a-906af853656a_terseLabel_en-US" xlink:label="lab_prph_StellaPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stella Purchase Agreement</link:label>
    <link:label id="lab_prph_StellaPurchaseAgreementMember_label_en-US" xlink:label="lab_prph_StellaPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stella Purchase Agreement [Member]</link:label>
    <link:label id="lab_prph_StellaPurchaseAgreementMember_documentation_en-US" xlink:label="lab_prph_StellaPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stella Purchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_StellaPurchaseAgreementMember" xlink:href="prph-20231231.xsd#prph_StellaPurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_StellaPurchaseAgreementMember" xlink:to="lab_prph_StellaPurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_668e56bc-0182-40bd-8014-34b3cbdc09aa_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_bc769015-a7a0-492b-93c0-4cb690f176a8_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_ad7e7761-1e1d-4db6-bbe0-5c2d4eec346f_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_d4170b2b-03fd-4c9e-9e0b-8906d792e0cd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_7e5e8d78-98e2-4aa5-a79c-a6873c546957_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend yield (per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_efb85aef-fd54-4594-81a7-3f44b006adaf_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inducement award (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_A2023NoteMember_7d2c91df-a8a9-4b64-b8b2-d5199825415e_terseLabel_en-US" xlink:label="lab_prph_A2023NoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023 Note</link:label>
    <link:label id="lab_prph_A2023NoteMember_label_en-US" xlink:label="lab_prph_A2023NoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2023 Note [Member]</link:label>
    <link:label id="lab_prph_A2023NoteMember_documentation_en-US" xlink:label="lab_prph_A2023NoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2023 Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2023NoteMember" xlink:href="prph-20231231.xsd#prph_A2023NoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_A2023NoteMember" xlink:to="lab_prph_A2023NoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_e9329afa-24c3-44e9-8878-4ea2d13ad81f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_853d7031-4baf-413e-9763-6cbe8f1b185c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_6e8680a6-7163-4d1b-8d55-056d637f5664_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_e62b6d85-65bf-4735-98bf-cc9bde5b4daf_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionDomain_cb761188-108d-4cde-aece-8c433ed67263_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographic Distribution [Domain]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionDomain_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographic Distribution [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionDomain" xlink:to="lab_us-gaap_GeographicDistributionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_8f824354-2b19-4bb6-ad5c-3f0a2e16bead_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_9c6345d3-86c2-41e5-bcb4-b4e41f7f49d2_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_SeptemberTwoThousandAndTwentyNoteMember_02682fd9-dad0-46a0-8d8c-56ecde3224e4_terseLabel_en-US" xlink:label="lab_prph_SeptemberTwoThousandAndTwentyNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">September 2020 Notes</link:label>
    <link:label id="lab_prph_SeptemberTwoThousandAndTwentyNoteMember_label_en-US" xlink:label="lab_prph_SeptemberTwoThousandAndTwentyNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">September 2020 Notes [Member]</link:label>
    <link:label id="lab_prph_SeptemberTwoThousandAndTwentyNoteMember_documentation_en-US" xlink:label="lab_prph_SeptemberTwoThousandAndTwentyNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">September 2020 Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_SeptemberTwoThousandAndTwentyNoteMember" xlink:href="prph-20231231.xsd#prph_SeptemberTwoThousandAndTwentyNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_SeptemberTwoThousandAndTwentyNoteMember" xlink:to="lab_prph_SeptemberTwoThousandAndTwentyNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1_1f96bdc0-bf6f-410d-bcc0-6c12f0462009_terseLabel_en-US" xlink:label="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, warrants vested and exercisable (in dollars per share)</link:label>
    <link:label id="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1_label_en-US" xlink:label="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price, Warrants Vested and Exercisable</link:label>
    <link:label id="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1_documentation_en-US" xlink:label="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share based compensation arrangement by share based payment award non options vested and exercisable weighted average exercise price 1.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1" xlink:to="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_af5a82e4-4c50-4c54-859d-9f0697cacf6d_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_1b7a2b53-a868-44f8-ae67-e15960bf2c6e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par or stated value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_894c7bf6-214b-49ab-833c-e8fbb14348ed_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock authorized 1,000,000, $0.0005 par value, no shares issued and outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_ac566522-7ff3-4c52-a663-6d7c5b34a4a1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_9ce7f8ad-9b49-41b6-82f0-8e48622edf13_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities_005c2616-d0d3-4e5b-b662-606df6b41580_terseLabel_en-US" xlink:label="lab_prph_NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net unrealized loss, investments in marketable securities</link:label>
    <link:label id="lab_prph_NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities_label_en-US" xlink:label="lab_prph_NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Unrealized Loss (Gain), Investments In Marketable Debt Securities</link:label>
    <link:label id="lab_prph_NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities_documentation_en-US" xlink:label="lab_prph_NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non cash investing and financing unrealized loss investments in marketable debt securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities" xlink:href="prph-20231231.xsd#prph_NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities" xlink:to="lab_prph_NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_be2e23c2-bdac-4b3a-9edb-610727c2aeeb_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment to stockholders</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_GenomicProductsAndServicesMember_a9057121-ef1f-4b5f-987a-f58346008419_terseLabel_en-US" xlink:label="lab_prph_GenomicProductsAndServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Genomic products and services</link:label>
    <link:label id="lab_prph_GenomicProductsAndServicesMember_label_en-US" xlink:label="lab_prph_GenomicProductsAndServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Genomic Products and Services [Member]</link:label>
    <link:label id="lab_prph_GenomicProductsAndServicesMember_documentation_en-US" xlink:label="lab_prph_GenomicProductsAndServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Genomic Products and Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_GenomicProductsAndServicesMember" xlink:href="prph-20231231.xsd#prph_GenomicProductsAndServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_GenomicProductsAndServicesMember" xlink:to="lab_prph_GenomicProductsAndServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_372ee4af-fc23-4e96-8095-68220621de09_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d15ef311-ed94-4400-8c2f-7b73c33e0361_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_8240e709-a596-477a-90cf-7859eecc7fc5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_68fb1e76-9991-46d2-91a3-b307419ab887_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_025855e0-b7a8-48de-afcc-ea9b818b5029_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_60e5a36c-31c8-4a39-b64b-728475b03643_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_AuditInformationAbstract_label_en-US" xlink:label="lab_prph_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_prph_AuditInformationAbstract_documentation_en-US" xlink:label="lab_prph_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AuditInformationAbstract" xlink:href="prph-20231231.xsd#prph_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_AuditInformationAbstract" xlink:to="lab_prph_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_e5707223-5953-4057-871f-76b7b7728031_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued benefits and vacation</link:label>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Employee Benefits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:to="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f1829fa0-3d21-4b64-899a-8c0fcb98f229_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Number of shares, outstanding, beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1692df1c-fd87-4b4b-825a-511a68c51f5c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Number of shares, outstanding, ending (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_fc4ea6dd-961b-49c4-a93e-3caa42005465_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Building and Building Improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_def10e84-476d-453e-b5ba-9cf215db036f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_NewYorkFirstFloorLeaseMember_a1499f2b-c605-46b2-89aa-fccb92660034_terseLabel_en-US" xlink:label="lab_prph_NewYorkFirstFloorLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New York First Floor Lease</link:label>
    <link:label id="lab_prph_NewYorkFirstFloorLeaseMember_label_en-US" xlink:label="lab_prph_NewYorkFirstFloorLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New York First Floor Lease [Member]</link:label>
    <link:label id="lab_prph_NewYorkFirstFloorLeaseMember_documentation_en-US" xlink:label="lab_prph_NewYorkFirstFloorLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">New York First Floor Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NewYorkFirstFloorLeaseMember" xlink:href="prph-20231231.xsd#prph_NewYorkFirstFloorLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_NewYorkFirstFloorLeaseMember" xlink:to="lab_prph_NewYorkFirstFloorLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1cd92508-2dd5-4659-ade0-e86eff8bcd9d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ArrangementTypeAxis_5155001a-57c6-4688-a627-6f22dccf05a1_terseLabel_en-US" xlink:label="lab_prph_ArrangementTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type Of Arrangement [Axis]</link:label>
    <link:label id="lab_prph_ArrangementTypeAxis_label_en-US" xlink:label="lab_prph_ArrangementTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Arrangement Type [Axis]</link:label>
    <link:label id="lab_prph_ArrangementTypeAxis_documentation_en-US" xlink:label="lab_prph_ArrangementTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Arrangement Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ArrangementTypeAxis" xlink:href="prph-20231231.xsd#prph_ArrangementTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ArrangementTypeAxis" xlink:to="lab_prph_ArrangementTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_7775f64a-411f-45c1-9098-c935e22d5724_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss (income) from operations after income taxes</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_2282f317-efd0-43fe-a491-d0f3abde6ec1_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_78e1cf83-0b1a-4089-83e6-e3a3aa244fcd_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_4a477f1a-a1bc-40d7-9b98-f4d9315c3298_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_30f892b4-fdd6-4ffd-8864-cd40b4d37596_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_6abe0888-04cb-4b19-9256-84c662fed9d0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year Ended December 31, 2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_TwoThousandEighteenStockIncentivePlanMember_68ba34de-34ab-4ea2-bf95-2aae5fe19966_terseLabel_en-US" xlink:label="lab_prph_TwoThousandEighteenStockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2018 Stock Incentive Plan</link:label>
    <link:label id="lab_prph_TwoThousandEighteenStockIncentivePlanMember_label_en-US" xlink:label="lab_prph_TwoThousandEighteenStockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2018 Stock Incentive Plan [Member]</link:label>
    <link:label id="lab_prph_TwoThousandEighteenStockIncentivePlanMember_documentation_en-US" xlink:label="lab_prph_TwoThousandEighteenStockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two Thousand Eighteen Stock Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_TwoThousandEighteenStockIncentivePlanMember" xlink:href="prph-20231231.xsd#prph_TwoThousandEighteenStockIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_TwoThousandEighteenStockIncentivePlanMember" xlink:to="lab_prph_TwoThousandEighteenStockIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_af9c4b27-59ec-4318-a257-24d27122e668_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Machinery</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_5e9beef1-9b3a-4676-8cdd-4027c709392a_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1d4677dc-bba8-4ec1-a679-ecf8bdc8080e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1c78cc6e-4129-4318-90a6-8a006e6e50d7_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6e885ab7-a378-4ea1-8f1d-a62177b26e73_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_ec781a2d-2eaa-45c9-b4e2-350c46de743d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_20d6c8ab-70cc-481f-87c8-549316f21c33_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_8c69c6ab-e09b-4058-8187-3dddd3b42453_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repurchase of common shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_f811011a-d95a-474f-b41a-27d6ade313ab_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_91a4792a-444a-4d04-bf1f-a839fc642940_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_ce8e8d9e-a79c-4124-b34b-54b177c101cf_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_787c05a3-cf6a-4d86-b329-3b10ac9d877f_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_7227d046-3109-4af9-8bcb-4fce6dae1385_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Contract balance, deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5d221ff4-274a-474c-a7f3-0e4ad0ed671f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon stock options cashless exercise (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_84af76fd-fcd7-48c3-ac45-1e083744e7c0_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Number of shares, exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2d98e83d-7540-4090-b3a0-506a55dc79be_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Number of shares options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryGross_f8926768-0267-42b8-bf0e-431acb66222c_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryGross_label_en-US" xlink:label="lab_us-gaap_InventoryGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryGross" xlink:to="lab_us-gaap_InventoryGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_37df0c43-6baf-48d9-83b8-a3da78b62148_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Basic and Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_e97d34f4-e3fb-472e-bd4e-552d650655fd_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_f61e731d-f3e4-45ff-bcec-d3d8539fa770_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenues</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_74e8ede0-ddb9-4f09-b369-3289de50598d_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7a9d346a-2037-4b52-a921-9cd93e5831bd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_SegmentConcentrationRiskMember_b6427bf1-9e68-4b97-8d6a-739e11e6d622_terseLabel_en-US" xlink:label="lab_prph_SegmentConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Concentration Risk</link:label>
    <link:label id="lab_prph_SegmentConcentrationRiskMember_label_en-US" xlink:label="lab_prph_SegmentConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Concentration Risk [Member]</link:label>
    <link:label id="lab_prph_SegmentConcentrationRiskMember_documentation_en-US" xlink:label="lab_prph_SegmentConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Segment Concentration Risk</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_SegmentConcentrationRiskMember" xlink:href="prph-20231231.xsd#prph_SegmentConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_SegmentConcentrationRiskMember" xlink:to="lab_prph_SegmentConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_UnallocatedCorporateMember_6d15c761-6bb7-4cdb-8908-8fb5a1ffd0fa_terseLabel_en-US" xlink:label="lab_prph_UnallocatedCorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unallocated corporate</link:label>
    <link:label id="lab_prph_UnallocatedCorporateMember_label_en-US" xlink:label="lab_prph_UnallocatedCorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unallocated Corporate [Member]</link:label>
    <link:label id="lab_prph_UnallocatedCorporateMember_documentation_en-US" xlink:label="lab_prph_UnallocatedCorporateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unallocated Corporate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_UnallocatedCorporateMember" xlink:href="prph-20231231.xsd#prph_UnallocatedCorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_UnallocatedCorporateMember" xlink:to="lab_prph_UnallocatedCorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_LicenseOrRoyaltyNetRevenuePercentage_6e724063-e775-47c0-a35a-f48faac7dfed_terseLabel_en-US" xlink:label="lab_prph_LicenseOrRoyaltyNetRevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License or royalty net revenue percentage</link:label>
    <link:label id="lab_prph_LicenseOrRoyaltyNetRevenuePercentage_label_en-US" xlink:label="lab_prph_LicenseOrRoyaltyNetRevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License or royalty net revenue percentage</link:label>
    <link:label id="lab_prph_LicenseOrRoyaltyNetRevenuePercentage_documentation_en-US" xlink:label="lab_prph_LicenseOrRoyaltyNetRevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Or royalty net revenue percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LicenseOrRoyaltyNetRevenuePercentage" xlink:href="prph-20231231.xsd#prph_LicenseOrRoyaltyNetRevenuePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_LicenseOrRoyaltyNetRevenuePercentage" xlink:to="lab_prph_LicenseOrRoyaltyNetRevenuePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_NumberOfInvestors_755f1933-808b-485d-969a-e3c29f5cdc0b_terseLabel_en-US" xlink:label="lab_prph_NumberOfInvestors" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of investors</link:label>
    <link:label id="lab_prph_NumberOfInvestors_label_en-US" xlink:label="lab_prph_NumberOfInvestors" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Investors</link:label>
    <link:label id="lab_prph_NumberOfInvestors_documentation_en-US" xlink:label="lab_prph_NumberOfInvestors" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Investors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfInvestors" xlink:href="prph-20231231.xsd#prph_NumberOfInvestors"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_NumberOfInvestors" xlink:to="lab_prph_NumberOfInvestors" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_deeafaf4-615c-4444-8020-e6e66701fe58_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_f8db7906-a625-470a-ba06-2821859e6fd1_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_83657a88-c861-4171-9061-ce510d9bc1e4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_334b5996-ed8b-4bb8-af86-1f2fd6eefc3d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_IssuanceOfWarrantsWithUnsecuredPromissoryNote_4f967f22-3152-4d68-b19f-af883c24e2c1_terseLabel_en-US" xlink:label="lab_prph_IssuanceOfWarrantsWithUnsecuredPromissoryNote" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of warrants with unsecured promissory note</link:label>
    <link:label id="lab_prph_IssuanceOfWarrantsWithUnsecuredPromissoryNote_label_en-US" xlink:label="lab_prph_IssuanceOfWarrantsWithUnsecuredPromissoryNote" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance Of Warrants With Unsecured Promissory Note</link:label>
    <link:label id="lab_prph_IssuanceOfWarrantsWithUnsecuredPromissoryNote_documentation_en-US" xlink:label="lab_prph_IssuanceOfWarrantsWithUnsecuredPromissoryNote" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Issuance Of Warrants With Unsecured Promissory Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IssuanceOfWarrantsWithUnsecuredPromissoryNote" xlink:href="prph-20231231.xsd#prph_IssuanceOfWarrantsWithUnsecuredPromissoryNote"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_IssuanceOfWarrantsWithUnsecuredPromissoryNote" xlink:to="lab_prph_IssuanceOfWarrantsWithUnsecuredPromissoryNote" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_LinebackerLicenseAgreementsMember_37c99c3f-64b2-47c5-b2ae-ccf62a61b3cd_terseLabel_en-US" xlink:label="lab_prph_LinebackerLicenseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Linebacker License Agreements</link:label>
    <link:label id="lab_prph_LinebackerLicenseAgreementsMember_label_en-US" xlink:label="lab_prph_LinebackerLicenseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Linebacker License Agreements [Member]</link:label>
    <link:label id="lab_prph_LinebackerLicenseAgreementsMember_documentation_en-US" xlink:label="lab_prph_LinebackerLicenseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Linebacker License Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LinebackerLicenseAgreementsMember" xlink:href="prph-20231231.xsd#prph_LinebackerLicenseAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_LinebackerLicenseAgreementsMember" xlink:to="lab_prph_LinebackerLicenseAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_13ce97ea-e48f-49a7-b0d8-e9cf8306a4e2_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities, available for sale</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_058814df-a0c7-412a-8dd1-fb995ad2f669_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_20f101cd-33a5-4bec-8cb3-04c839b1ea08_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of warrants with unsecured promissory note</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_ffd2c523-022e-4255-b440-d619a6a7efbe_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_f5708eb0-5577-4993-ad74-a85a024ffd74_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_cf488893-14f2-42dc-aa55-35be2644e440_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1ac84295-2150-4c92-88fb-1726540dee95_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6d545881-2655-41b1-ae70-68a0560e7ad9_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_023dad35-3820-4ff8-8165-e4c04e924460_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_dd1bc176-8b52-49c3-bfca-ce146681b192_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_38493204-1af6-454d-9920-3a18fe9c1226_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_953ef845-f6bb-4f63-95e9-b05cac24cc8b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Number of shares options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_Amended2022DirectorsPlanMember_3677111d-5e72-430f-b7b3-32a4a5764952_terseLabel_en-US" xlink:label="lab_prph_Amended2022DirectorsPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amended 2022 Directors' Plan</link:label>
    <link:label id="lab_prph_Amended2022DirectorsPlanMember_label_en-US" xlink:label="lab_prph_Amended2022DirectorsPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amended 2022 Directors' Plan [Member]</link:label>
    <link:label id="lab_prph_Amended2022DirectorsPlanMember_documentation_en-US" xlink:label="lab_prph_Amended2022DirectorsPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amended 2022 Directors' Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_Amended2022DirectorsPlanMember" xlink:href="prph-20231231.xsd#prph_Amended2022DirectorsPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_Amended2022DirectorsPlanMember" xlink:to="lab_prph_Amended2022DirectorsPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_dbc9f25e-63fa-4b65-9993-df1f66807cae_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e0d26754-e379-4c05-a859-4517467022aa_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year ended December 31, 2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_edefb211-fb52-446f-97e6-f13ccd0f9b93_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_69f15261-9db6-4399-a7a2-6f52fc531b28_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ReimbursementReceivableMember_4c2ef9bb-44b0-4208-94d9-582221e664db_terseLabel_en-US" xlink:label="lab_prph_ReimbursementReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reimbursement Receivable</link:label>
    <link:label id="lab_prph_ReimbursementReceivableMember_label_en-US" xlink:label="lab_prph_ReimbursementReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reimbursement Receivable [Member]</link:label>
    <link:label id="lab_prph_ReimbursementReceivableMember_documentation_en-US" xlink:label="lab_prph_ReimbursementReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reimbursement Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ReimbursementReceivableMember" xlink:href="prph-20231231.xsd#prph_ReimbursementReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ReimbursementReceivableMember" xlink:to="lab_prph_ReimbursementReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_InventoryValuationReserve_e37daa9f-d477-4d29-9d25-31612b6d5e78_terseLabel_en-US" xlink:label="lab_prph_InventoryValuationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory valuation reserve</link:label>
    <link:label id="lab_prph_InventoryValuationReserve_label_en-US" xlink:label="lab_prph_InventoryValuationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Valuation Reserve</link:label>
    <link:label id="lab_prph_InventoryValuationReserve_documentation_en-US" xlink:label="lab_prph_InventoryValuationReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Inventory valuation reserve.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_InventoryValuationReserve" xlink:href="prph-20231231.xsd#prph_InventoryValuationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_InventoryValuationReserve" xlink:to="lab_prph_InventoryValuationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_52048180-6706-4f75-ae73-a4a711cf1edc_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year Ended December 31, 2028</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_InterestOnUnsecuredConvertiblePromissoryNote_654e57b9-3a32-4e3a-927f-bbab53908ad1_terseLabel_en-US" xlink:label="lab_prph_InterestOnUnsecuredConvertiblePromissoryNote" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest on unsecured convertible promissory note</link:label>
    <link:label id="lab_prph_InterestOnUnsecuredConvertiblePromissoryNote_label_en-US" xlink:label="lab_prph_InterestOnUnsecuredConvertiblePromissoryNote" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest on unsecured convertible promissory note</link:label>
    <link:label id="lab_prph_InterestOnUnsecuredConvertiblePromissoryNote_documentation_en-US" xlink:label="lab_prph_InterestOnUnsecuredConvertiblePromissoryNote" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest on unsecured convertible promissory note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_InterestOnUnsecuredConvertiblePromissoryNote" xlink:href="prph-20231231.xsd#prph_InterestOnUnsecuredConvertiblePromissoryNote"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_InterestOnUnsecuredConvertiblePromissoryNote" xlink:to="lab_prph_InterestOnUnsecuredConvertiblePromissoryNote" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_LeaseLiability_5355f958-9137-488b-a48d-ba8db1d853bc_totalLabel_en-US" xlink:label="lab_prph_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_prph_LeaseLiability_label_en-US" xlink:label="lab_prph_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Liability</link:label>
    <link:label id="lab_prph_LeaseLiability_documentation_en-US" xlink:label="lab_prph_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiability" xlink:href="prph-20231231.xsd#prph_LeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_LeaseLiability" xlink:to="lab_prph_LeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_NewYorkSecondFloorLeaseMember_0e7c22ee-4dea-4287-b672-96960cf3e245_terseLabel_en-US" xlink:label="lab_prph_NewYorkSecondFloorLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New York Second Floor Lease</link:label>
    <link:label id="lab_prph_NewYorkSecondFloorLeaseMember_label_en-US" xlink:label="lab_prph_NewYorkSecondFloorLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New York Second Floor Lease [Member]</link:label>
    <link:label id="lab_prph_NewYorkSecondFloorLeaseMember_documentation_en-US" xlink:label="lab_prph_NewYorkSecondFloorLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">New York Second Floor Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NewYorkSecondFloorLeaseMember" xlink:href="prph-20231231.xsd#prph_NewYorkSecondFloorLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_NewYorkSecondFloorLeaseMember" xlink:to="lab_prph_NewYorkSecondFloorLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_fd810595-e51d-40ec-89df-ecd9f0e46551_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain on marketable debt securities, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_51080c3a-a397-48a3-947c-16b80cf15c76_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant</link:label>
    <link:label id="lab_us-gaap_WarrantMember_a64cf6f7-ceb7-40ad-bbbc-87fdd3137650_verboseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_AmendedTwoThousandTenPlanMember_e0aaf111-e327-44c5-8472-4db509cc30c6_terseLabel_en-US" xlink:label="lab_prph_AmendedTwoThousandTenPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amended 2010 Plan</link:label>
    <link:label id="lab_prph_AmendedTwoThousandTenPlanMember_label_en-US" xlink:label="lab_prph_AmendedTwoThousandTenPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amended 2010 Plan [Member]</link:label>
    <link:label id="lab_prph_AmendedTwoThousandTenPlanMember_documentation_en-US" xlink:label="lab_prph_AmendedTwoThousandTenPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amended 2010 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AmendedTwoThousandTenPlanMember" xlink:href="prph-20231231.xsd#prph_AmendedTwoThousandTenPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_AmendedTwoThousandTenPlanMember" xlink:to="lab_prph_AmendedTwoThousandTenPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_fe0fadaf-5759-4569-a756-9873d0c028ca_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_43fe0c03-ed83-4467-962b-4d9a09040a28_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating loss carryforwards, federal</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_a9c523d1-cb54-41fb-93e4-5a4cbafd2272_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating leases:</link:label>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases, Operating [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOperatingAbstract" xlink:to="lab_us-gaap_LeasesOperatingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_bf9d5991-547e-459e-a1e3-5297d39c60bd_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_c1213e13-c450-43e6-b1a3-b49054c7ab4f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_35a4c824-9c23-48d0-b7ce-984abca9c703_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock issued during period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Purchase of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_54637a7f-f80d-42bc-9bdc-9ef22b5d6606_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Components of Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_2344104b-6dcd-4e9f-b449-ee50204b1340_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_AgreementTerm_8adda000-d329-45e8-9bb0-426fecf22b6c_terseLabel_en-US" xlink:label="lab_prph_AgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Agreement term (in days)</link:label>
    <link:label id="lab_prph_AgreementTerm_label_en-US" xlink:label="lab_prph_AgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Agreement Term</link:label>
    <link:label id="lab_prph_AgreementTerm_documentation_en-US" xlink:label="lab_prph_AgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Agreement Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AgreementTerm" xlink:href="prph-20231231.xsd#prph_AgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_AgreementTerm" xlink:to="lab_prph_AgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d5064654-aa24-4f86-8ca0-3ac50d0f9f48_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_bf4ca117-e117-4c51-b777-d13e51ac8d24_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Treasury shares repurchased to satisfy tax withholding obligations</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_5963e6ef-ade5-4aa1-b8f3-0bc8e44285dc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Maturity of Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ShareBasedPaymentArrangementExpenseReversal_566cf2ac-be37-4e80-bc68-ef63dab1f8cb_terseLabel_en-US" xlink:label="lab_prph_ShareBasedPaymentArrangementExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reversal of stock based compensation expense</link:label>
    <link:label id="lab_prph_ShareBasedPaymentArrangementExpenseReversal_label_en-US" xlink:label="lab_prph_ShareBasedPaymentArrangementExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Reversal</link:label>
    <link:label id="lab_prph_ShareBasedPaymentArrangementExpenseReversal_documentation_en-US" xlink:label="lab_prph_ShareBasedPaymentArrangementExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Reversal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedPaymentArrangementExpenseReversal" xlink:href="prph-20231231.xsd#prph_ShareBasedPaymentArrangementExpenseReversal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ShareBasedPaymentArrangementExpenseReversal" xlink:to="lab_prph_ShareBasedPaymentArrangementExpenseReversal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseNoncurrent_b31dfdbf-6547-4b1b-8238-279ab7c0250c_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses, net of current portion</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseNoncurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseNoncurrent" xlink:to="lab_us-gaap_PrepaidExpenseNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashUninsuredAmount_cbfd0ae7-efb9-453d-8547-5b64871cc1c3_terseLabel_en-US" xlink:label="lab_us-gaap_CashUninsuredAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bank balance uninsured</link:label>
    <link:label id="lab_us-gaap_CashUninsuredAmount_label_en-US" xlink:label="lab_us-gaap_CashUninsuredAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Uninsured Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashUninsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashUninsuredAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashUninsuredAmount" xlink:to="lab_us-gaap_CashUninsuredAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_41eaf74e-e4ef-4394-a0c5-3352c7e73bc9_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_NumberOfInhibitors_7be69701-df50-497e-a70f-e199fbc5b0f9_terseLabel_en-US" xlink:label="lab_prph_NumberOfInhibitors" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of inhibitors</link:label>
    <link:label id="lab_prph_NumberOfInhibitors_label_en-US" xlink:label="lab_prph_NumberOfInhibitors" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Inhibitors</link:label>
    <link:label id="lab_prph_NumberOfInhibitors_documentation_en-US" xlink:label="lab_prph_NumberOfInhibitors" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Inhibitors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfInhibitors" xlink:href="prph-20231231.xsd#prph_NumberOfInhibitors"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_NumberOfInhibitors" xlink:to="lab_prph_NumberOfInhibitors" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_c23c24aa-984e-415f-b191-7847fce108de_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_08e5ad58-c16a-4691-80f7-6f4de8710b97_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Anti-dilutive Securities Excluded from the Income Per Share Computation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusAxis_42f1ac93-e53a-4537-8323-85d589bef9ab_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusAxis_label_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis" xlink:to="lab_us-gaap_GranteeStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_0c117d5e-17ef-49ee-8f85-0d41dce87573_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_CertainHoldersMember_9baedee7-8884-440f-b8f7-4a56d48a9a8b_terseLabel_en-US" xlink:label="lab_prph_CertainHoldersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Certain Holders</link:label>
    <link:label id="lab_prph_CertainHoldersMember_label_en-US" xlink:label="lab_prph_CertainHoldersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Certain Holders [Member]</link:label>
    <link:label id="lab_prph_CertainHoldersMember_documentation_en-US" xlink:label="lab_prph_CertainHoldersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Certain Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CertainHoldersMember" xlink:href="prph-20231231.xsd#prph_CertainHoldersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_CertainHoldersMember" xlink:to="lab_prph_CertainHoldersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_a02ca959-e14b-4370-b267-e8532a5190e5_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Quantitative Information About Operating and Finance Leases</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_8e267ed5-1025-438b-86f3-193e5617f158_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_48ec9e1f-2f03-4503-8eb1-e6e3f814c4f7_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_IssuanceOfCommonSharesForDebtConversion_84e12c71-44d5-4849-b20a-b21d79148fbd_terseLabel_en-US" xlink:label="lab_prph_IssuanceOfCommonSharesForDebtConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common shares for debt conversion</link:label>
    <link:label id="lab_prph_IssuanceOfCommonSharesForDebtConversion_label_en-US" xlink:label="lab_prph_IssuanceOfCommonSharesForDebtConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance Of Common Shares For Debt Conversion</link:label>
    <link:label id="lab_prph_IssuanceOfCommonSharesForDebtConversion_documentation_en-US" xlink:label="lab_prph_IssuanceOfCommonSharesForDebtConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Issuance Of Common Shares For Debt Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IssuanceOfCommonSharesForDebtConversion" xlink:href="prph-20231231.xsd#prph_IssuanceOfCommonSharesForDebtConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_IssuanceOfCommonSharesForDebtConversion" xlink:to="lab_prph_IssuanceOfCommonSharesForDebtConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities_a5258326-66ea-4379-87aa-b7e5d133f888_terseLabel_en-US" xlink:label="lab_prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Deferred Income Tax Liabilities</link:label>
    <link:label id="lab_prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities_documentation_en-US" xlink:label="lab_prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Deferred Income Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities" xlink:href="prph-20231231.xsd#prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities" xlink:to="lab_prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d6f9917c-3557-4f75-9695-9b0575a77ca8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share, amount</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_b772ddff-6da3-407d-a46b-68b7b8f19891_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_e8359873-137f-4f1b-b1ad-ef3c8776bb21_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_bb9794a1-4f21-48be-ad7c-63e67ed87252_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_1cd523f8-d437-4c7e-91be-d92ab656b402_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_7f66e343-8406-4be8-a0ab-8f4947e21d6e_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a958baff-21d8-4c0c-a6d8-5261b6007677_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_37314e19-091a-4670-a780-9db7991ad884_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_LeaseLiabilityToBePaidYearFive_1a65493e-db8c-406a-81d2-addf519d2b62_totalLabel_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaidYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Year Ended December 31, 2028</link:label>
    <link:label id="lab_prph_LeaseLiabilityToBePaidYearFive_label_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaidYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Liability, To Be Paid, Year Five</link:label>
    <link:label id="lab_prph_LeaseLiabilityToBePaidYearFive_documentation_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaidYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Liability, To Be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearFive" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_LeaseLiabilityToBePaidYearFive" xlink:to="lab_prph_LeaseLiabilityToBePaidYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4007d075-f6aa-410e-a64d-87f736d14373_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_034f4e96-7754-4ebe-8821-5dd3e6c8a60a_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase price</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_31188f29-7f9d-4b86-b8fe-2d5456782b93_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual life, outstanding shares (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_c02960ed-b16b-4c78-961b-9afe6bdb0d85_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_edcfc7c3-321d-4ccd-b188-366e8b2676db_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ad66db7d-8075-49a6-9b12-4fde25b97737_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less present value discount</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_6ad8b535-eac3-49a8-ab79-5b5e19e03747_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_8c60a0e3-a01a-484a-bf9a-1baef7fca96a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_e966ce48-69f8-4275-a898-eaa7fe06891c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_f87b5e11-f47d-42ce-b54e-c05f034ffb40_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_5d515513-a752-440d-a324-cf2ba244ca67_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_66db0cdd-bdea-418b-afda-be5fd9b2016b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_ab300bf4-fb90-4a27-83ce-041195707049_terseLabel_en-US" xlink:label="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant fair value</link:label>
    <link:label id="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_label_en-US" xlink:label="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:to="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_72584f53-d9f6-4df9-9895-b686f6db8477_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_36a182d4-2de0-458c-bb52-e950c50770ab_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_a84908fb-6a02-4693-b0a4-4786502e8a02_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicenseMember_4b7c52e2-bebb-497d-8e51-4ffd16a71e62_terseLabel_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CLIA license</link:label>
    <link:label id="lab_us-gaap_LicenseMember_label_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseMember" xlink:to="lab_us-gaap_LicenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_657da01f-d097-41be-ad61-cbfb4794351a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest lease cost</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_9dd0952e-24be-4eee-811b-73df3ef162bb_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_7dbd138b-6103-40c2-b830-453f7c6c9b06_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_3f73d62d-6bcc-482b-8545-25bf907ca6cf_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d5f1dfe7-012b-47c4-b972-7860eff3bab0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year Ended December 31, 2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_994379ee-40db-4438-ace5-280fee15e2c2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_CorporateObligationsMember_22e184dc-9f6c-488c-acb2-8bf426d8f4a0_terseLabel_en-US" xlink:label="lab_prph_CorporateObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate obligations</link:label>
    <link:label id="lab_prph_CorporateObligationsMember_label_en-US" xlink:label="lab_prph_CorporateObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Obligations [Member]</link:label>
    <link:label id="lab_prph_CorporateObligationsMember_documentation_en-US" xlink:label="lab_prph_CorporateObligationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Corporate Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CorporateObligationsMember" xlink:href="prph-20231231.xsd#prph_CorporateObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_CorporateObligationsMember" xlink:to="lab_prph_CorporateObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_a6fc63cb-f81f-4ee8-9f2b-9ee0987c8f6c_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_4400eb8a-2b33-497d-97a4-97fa735800d8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_7000145d-0e5e-49db-baa4-cc5e1624cf80_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently Issued Accounting Standards, Adopted and Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance_6dea12dd-483e-4bbe-9613-61e510e27631_terseLabel_en-US" xlink:label="lab_prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in shares for issuance (in shares)</link:label>
    <link:label id="lab_prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Increase (Decrease) In Capital Shares Reserved For Future Issuance</link:label>
    <link:label id="lab_prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance_documentation_en-US" xlink:label="lab_prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Increase (Decrease) In Capital Shares Reserved For Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance" xlink:href="prph-20231231.xsd#prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance" xlink:to="lab_prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_556172f6-92fc-40b0-8e9e-adabc1858d9a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_e278cf64-567d-477f-973c-98f5edde0c84_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_db80d316-85e0-4552-9b35-0f731dd2a6cc_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash, at the beginning of the year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_aafe8a4c-9c01-4d85-930c-2793b172d419_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash, at the end of the year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8f6c8cdb-3845-458a-9eca-f9c19f55d6eb_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance_f5290c56-8aaa-46d4-a67d-90e98f7e5cf4_totalLabel_en-US" xlink:label="lab_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income taxes from continuing operations before valuation allowance</link:label>
    <link:label id="lab_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance_label_en-US" xlink:label="lab_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IncomeTaxesFromContinuingOperationsBeforeValuationAllowance</link:label>
    <link:label id="lab_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance_documentation_en-US" xlink:label="lab_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income taxes from continuing operations before valuation allowance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance" xlink:href="prph-20231231.xsd#prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance" xlink:to="lab_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e01b9e1a-0a64-459a-81db-e4d786f40ebb_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9463fc05-9411-4498-a358-291f31b3ad1e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year Ended December 31, 2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGross_4a17fdfc-e0f7-4851-86e8-23496e575ac9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGross_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGross" xlink:to="lab_us-gaap_AccountsReceivableGross" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1_19e94fe7-eeee-4281-b299-83965bd2077b_terseLabel_en-US" xlink:label="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, warrants granted (in dollars per share)</link:label>
    <link:label id="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1_label_en-US" xlink:label="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price, Warrants Granted</link:label>
    <link:label id="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1_documentation_en-US" xlink:label="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share based compensation arrangement by share based payment award non options outstanding granted weighted average exercise price 1.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1" xlink:to="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber_820a1c09-ae0d-4a20-a706-c8c7d404151e_terseLabel_en-US" xlink:label="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares, warrants vested and exercisable (in shares)</link:label>
    <link:label id="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Shares Warrants Vested and Exercisable</link:label>
    <link:label id="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber_documentation_en-US" xlink:label="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share based compensation arrangement by share based payment award non options vested and expected to vest exercisable number.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_1294d4b0-ef18-4384-b3f9-10ba276e7223_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Closing stock price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_18f48efa-4325-4360-8660-7769d913063e_totalLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_48d1de84-7d92-411b-ba98-d34862abf383_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_a7672959-04b7-4d86-842a-92b427ae8c80_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_USGovernmentObligationsMember_535e9c42-9083-41f5-bcb2-5f7c65034d02_terseLabel_en-US" xlink:label="lab_prph_USGovernmentObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S. government obligations</link:label>
    <link:label id="lab_prph_USGovernmentObligationsMember_label_en-US" xlink:label="lab_prph_USGovernmentObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">U.S. Government Obligations [Member]</link:label>
    <link:label id="lab_prph_USGovernmentObligationsMember_documentation_en-US" xlink:label="lab_prph_USGovernmentObligationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">U.S. Government Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_USGovernmentObligationsMember" xlink:href="prph-20231231.xsd#prph_USGovernmentObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_USGovernmentObligationsMember" xlink:to="lab_prph_USGovernmentObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_1d3d209b-3f26-4b63-9bb3-dadc84d45e93_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_c477125a-765f-4ffc-9873-999180d5bde0_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_d61bda25-a708-4e9f-b72d-8b0af1b58eb2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Weighted Average Assumptions Used in Determining Fair Value of Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_6b897ca2-a6e2-4c4e-97e0-98682f59d975_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, at cost, 18,940,967 and 18,126,790 shares, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_a2c3308c-8d1a-4ce6-b18a-ed095a9b284e_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_b4551fc1-f28a-4810-b47a-ae72f094ef81_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Research &amp; development tax credit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a4bd3688-e213-4e72-9afe-d2a0b00c8ffd_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_507ef167-7b80-48ac-b2b0-763788132991_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award vesting rights (as a percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_a6561208-5095-4f9f-94af-cacd00ce815f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_UpfrontLicenseFee_a63ec6fb-f338-439c-b3cd-d589425b5812_terseLabel_en-US" xlink:label="lab_prph_UpfrontLicenseFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Upfront license fee</link:label>
    <link:label id="lab_prph_UpfrontLicenseFee_label_en-US" xlink:label="lab_prph_UpfrontLicenseFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Upfront License Fee</link:label>
    <link:label id="lab_prph_UpfrontLicenseFee_documentation_en-US" xlink:label="lab_prph_UpfrontLicenseFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Upfront License Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_UpfrontLicenseFee" xlink:href="prph-20231231.xsd#prph_UpfrontLicenseFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_UpfrontLicenseFee" xlink:to="lab_prph_UpfrontLicenseFee" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_FinancingAgreementOriginationFee_a88d9430-f30d-4d10-a143-745450061655_terseLabel_en-US" xlink:label="lab_prph_FinancingAgreementOriginationFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Origination fee</link:label>
    <link:label id="lab_prph_FinancingAgreementOriginationFee_label_en-US" xlink:label="lab_prph_FinancingAgreementOriginationFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Agreement, Origination Fee</link:label>
    <link:label id="lab_prph_FinancingAgreementOriginationFee_documentation_en-US" xlink:label="lab_prph_FinancingAgreementOriginationFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Agreement, Origination Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_FinancingAgreementOriginationFee" xlink:href="prph-20231231.xsd#prph_FinancingAgreementOriginationFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_FinancingAgreementOriginationFee" xlink:to="lab_prph_FinancingAgreementOriginationFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c27c2953-8e9f-4a59-8fac-94def1b72769_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average period (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionTable_66a5d348-f216-420c-a02d-bed97ce5e567_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionTable" xlink:to="lab_us-gaap_AssetAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_NumberOfTestsRecognized_11306256-a95e-42e7-829a-eac99b1d8373_terseLabel_en-US" xlink:label="lab_prph_NumberOfTestsRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of tests recognized</link:label>
    <link:label id="lab_prph_NumberOfTestsRecognized_label_en-US" xlink:label="lab_prph_NumberOfTestsRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Tests Recognized</link:label>
    <link:label id="lab_prph_NumberOfTestsRecognized_documentation_en-US" xlink:label="lab_prph_NumberOfTestsRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of tests recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfTestsRecognized" xlink:href="prph-20231231.xsd#prph_NumberOfTestsRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_NumberOfTestsRecognized" xlink:to="lab_prph_NumberOfTestsRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_43d0cf5c-513e-447a-87a5-5c5fe4ea48f2_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_536f1ada-ba31-433e-9841-75393ecd0157_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_8e701e29-d768-4f4f-aedb-d875235c03bd_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation, nonvested award, cost not yet recognized, amount</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_2a213964-f9e8-44ad-b1f9-647de2a774ba_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_6afca28a-0ca3-4d00-abc7-a954c51553ca_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Number of shares, warrants outstanding, beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_ca38e032-d333-410b-9b1d-2fa53a823241_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Number of shares, warrants outstanding, ending (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_DiagnosticServicesClientsOneMember_cb0ac4ed-f5c8-45bc-800e-94937e7ebe6f_terseLabel_en-US" xlink:label="lab_prph_DiagnosticServicesClientsOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diagnostic Services Clients One</link:label>
    <link:label id="lab_prph_DiagnosticServicesClientsOneMember_label_en-US" xlink:label="lab_prph_DiagnosticServicesClientsOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Diagnostic Services Clients One [Member]</link:label>
    <link:label id="lab_prph_DiagnosticServicesClientsOneMember_documentation_en-US" xlink:label="lab_prph_DiagnosticServicesClientsOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Diagnostic Services Clients One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DiagnosticServicesClientsOneMember" xlink:href="prph-20231231.xsd#prph_DiagnosticServicesClientsOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_DiagnosticServicesClientsOneMember" xlink:to="lab_prph_DiagnosticServicesClientsOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_35c61c04-58d6-4daa-b4d8-0ef00ee08d1b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock in asset acquisition</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_f172d54e-1ac2-4614-b706-065a308cfc2f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_9c5c8e06-bba4-4250-a15f-5fa13ee85c5c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_6806a634-b8ed-46ee-a3b6-c8467d367986_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedPayrollTaxesCurrent_5c8f9841-ba02-433c-94ad-8b76c797c98c_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedPayrollTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued payroll</link:label>
    <link:label id="lab_us-gaap_AccruedPayrollTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedPayrollTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Payroll Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedPayrollTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedPayrollTaxesCurrent" xlink:to="lab_us-gaap_AccruedPayrollTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_ee49f846-a552-44fb-83bb-ade79754fafb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_88e7276a-b3c3-4230-9c16-59b672ae7afd_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year Ended December 31, 2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_2d5f7ca4-83f9-4a17-a224-86114ee16ccb_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_0069c70d-2ebf-48b8-ab91-148c86274d8a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_DiagnosticServicesClientsThreeMember_a20ac838-25a7-4823-a1e1-dc40b865a35c_terseLabel_en-US" xlink:label="lab_prph_DiagnosticServicesClientsThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diagnostic Services Clients Three</link:label>
    <link:label id="lab_prph_DiagnosticServicesClientsThreeMember_label_en-US" xlink:label="lab_prph_DiagnosticServicesClientsThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Diagnostic Services Clients Three [Member]</link:label>
    <link:label id="lab_prph_DiagnosticServicesClientsThreeMember_documentation_en-US" xlink:label="lab_prph_DiagnosticServicesClientsThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Diagnostic Services Clients Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DiagnosticServicesClientsThreeMember" xlink:href="prph-20231231.xsd#prph_DiagnosticServicesClientsThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_DiagnosticServicesClientsThreeMember" xlink:to="lab_prph_DiagnosticServicesClientsThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ChangeInFairValueOfInvestmentSecurities_e2795b6d-a170-4858-b370-c6c19f49d636_negatedLabel_en-US" xlink:label="lab_prph_ChangeInFairValueOfInvestmentSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of investment securities</link:label>
    <link:label id="lab_prph_ChangeInFairValueOfInvestmentSecurities_label_en-US" xlink:label="lab_prph_ChangeInFairValueOfInvestmentSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in fair value of investment securities</link:label>
    <link:label id="lab_prph_ChangeInFairValueOfInvestmentSecurities_documentation_en-US" xlink:label="lab_prph_ChangeInFairValueOfInvestmentSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Change in fair value of investment securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ChangeInFairValueOfInvestmentSecurities" xlink:href="prph-20231231.xsd#prph_ChangeInFairValueOfInvestmentSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ChangeInFairValueOfInvestmentSecurities" xlink:to="lab_prph_ChangeInFairValueOfInvestmentSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_ed21d948-bced-4fef-b7f4-44915ffd59d4_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Chief Executive Officer</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_4fb7f424-10aa-4212-83b2-1a519cd14fd4_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d8d7bd8d-59b9-4241-8d64-3130e8ed7280_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueArrangementLineItems_83080cc6-a757-412e-8dcf-7c295e307908_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueArrangementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Revenue Arrangement [Line Items]</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueArrangementLineItems_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueArrangementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Revenue Arrangement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems" xlink:to="lab_us-gaap_DeferredRevenueArrangementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_bb3d3af7-48c5-49f2-8e75-12c2297c1468_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year Ended December 31, 2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_90a5a112-c262-489a-a505-4177fb0fb73f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_a3e49d25-67c7-411f-93e8-9855feacdd22_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent_4ff4876d-cc0e-44c2-8a8d-036ffe8bb53d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due to sellers (see Note 3)</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_96892e39-3d64-4c1c-9a2d-ac6d2af07423_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentOwnedBalancePrincipalAmount_9819a076-fb8f-4cfe-b3d4-5b6c8a5eaea7_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining principal amount</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedBalancePrincipalAmount_label_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Owned, Balance, Principal Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalancePrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:to="lab_us-gaap_InvestmentOwnedBalancePrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_45a3ce02-bfb8-4e95-969d-47fa54e6e128_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_AccruedReturns_8be73ec6-9646-4815-83a7-b0abd8834b39_terseLabel_en-US" xlink:label="lab_prph_AccruedReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued returns</link:label>
    <link:label id="lab_prph_AccruedReturns_label_en-US" xlink:label="lab_prph_AccruedReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Returns</link:label>
    <link:label id="lab_prph_AccruedReturns_documentation_en-US" xlink:label="lab_prph_AccruedReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued return.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AccruedReturns" xlink:href="prph-20231231.xsd#prph_AccruedReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_AccruedReturns" xlink:to="lab_prph_AccruedReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_5010ce4b-425c-4d2c-84f3-df57b0fd2385_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_91128090-6cc0-4154-aa99-12ba7683b299_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_2d092dd0-ec1d-47ce-ab88-499f4fa75e09_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a2399fd8-1d77-4a2b-bbe3-96c288940abf_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_LeasesLiabilityAbstract_1c233988-4d58-4792-8336-8860661b758f_terseLabel_en-US" xlink:label="lab_prph_LeasesLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_prph_LeasesLiabilityAbstract_label_en-US" xlink:label="lab_prph_LeasesLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases Liability [Abstract]</link:label>
    <link:label id="lab_prph_LeasesLiabilityAbstract_documentation_en-US" xlink:label="lab_prph_LeasesLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Leases Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeasesLiabilityAbstract" xlink:href="prph-20231231.xsd#prph_LeasesLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_LeasesLiabilityAbstract" xlink:to="lab_prph_LeasesLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare_bc1121d4-1b8b-43cd-8c55-7eaf304d1ab9_terseLabel_en-US" xlink:label="lab_prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued (in value per share)</link:label>
    <link:label id="lab_prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare_label_en-US" xlink:label="lab_prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Shares Issued and Issuable, Value Per Share</link:label>
    <link:label id="lab_prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare_documentation_en-US" xlink:label="lab_prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Shares Issued and Issuable, Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare" xlink:href="prph-20231231.xsd#prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare" xlink:to="lab_prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_00f2edaf-4ee3-4326-9113-4e9a419bacaa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_bfc6cde4-f397-4beb-9288-cb59becc7cc0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Periodic payment</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fcf2c0dc-f54b-4350-829c-c25fec9197b7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0aba7bb2-3c5b-4d30-afd4-cbf4e65b16f5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares, forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3d3209d5-bba0-4b71-9018-f641d619c276_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Number of shares options forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_309c532c-426e-4b18-9b74-80139e2a436d_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_81a93955-4517-4920-8994-05c0509f65b2_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_4587bacd-3aa5-4b07-881f-671662357f88_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants and Rights Note Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Note Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionLineItems_75a5ddcb-676c-45f3-a325-4e563977874a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionLineItems" xlink:to="lab_us-gaap_AssetAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_2d97f574-0576-4f66-8d44-f629999230b2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_47351b75-c062-4140-bb7a-b7976e5aba02_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inducement award amount</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Plan Modification, Incremental Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_UncollectibleTradeReceivablesMember_46a36cc7-9747-4e62-88b9-2519b2d528e4_terseLabel_en-US" xlink:label="lab_prph_UncollectibleTradeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Uncollectible Trade Receivables</link:label>
    <link:label id="lab_prph_UncollectibleTradeReceivablesMember_label_en-US" xlink:label="lab_prph_UncollectibleTradeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Uncollectible Trade Receivables [Member]</link:label>
    <link:label id="lab_prph_UncollectibleTradeReceivablesMember_documentation_en-US" xlink:label="lab_prph_UncollectibleTradeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Uncollectible Trade Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_UncollectibleTradeReceivablesMember" xlink:href="prph-20231231.xsd#prph_UncollectibleTradeReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_UncollectibleTradeReceivablesMember" xlink:to="lab_prph_UncollectibleTradeReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_NumberOfLicensedCompounds_21b0949a-a6e3-4143-8c8d-70b827a70b20_terseLabel_en-US" xlink:label="lab_prph_NumberOfLicensedCompounds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of licensed compounds</link:label>
    <link:label id="lab_prph_NumberOfLicensedCompounds_label_en-US" xlink:label="lab_prph_NumberOfLicensedCompounds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Licensed Compounds</link:label>
    <link:label id="lab_prph_NumberOfLicensedCompounds_documentation_en-US" xlink:label="lab_prph_NumberOfLicensedCompounds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Licensed Compounds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfLicensedCompounds" xlink:href="prph-20231231.xsd#prph_NumberOfLicensedCompounds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_NumberOfLicensedCompounds" xlink:to="lab_prph_NumberOfLicensedCompounds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseTermOfContract1_afdbb34d-a1e5-47b9-9fe0-09f7b32d8b07_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equipment lease, term (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Finance Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:to="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_90cc7432-4e7e-490c-8b67-e3853e506944_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_89e39219-7cfc-4d29-8701-2a13a5f6dba2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statutory Rate - federal</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_1b0daf8e-2fbb-4e3b-a6b1-bacaabb9b621_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt conversion, principal amount</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_660672d4-def6-4f46-8c2d-06c7839cdc57_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Receivable Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b2984da2-cc70-4edd-a398-c1d32a2a4440_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_13fcba8c-c267-41f4-81db-b7abae404c11_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_1944813b-e6d5-4e8f-8ed2-e913987e57a3_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_36909687-ee92-4774-9f2b-8b3456d19c09_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt conversion, common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_ecc6f537-ff6c-4d3e-a26c-7f4f24aa13f4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_15fb68be-8ae8-40f4-bb44-64681e37dce0_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_6b8359dd-4080-4963-9a5e-9597d524ac00_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_BESmartLicenseAgreementMember_d4b83da1-c589-4b6d-a46f-2d59c65193d4_terseLabel_en-US" xlink:label="lab_prph_BESmartLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BE-Smart License Agreement</link:label>
    <link:label id="lab_prph_BESmartLicenseAgreementMember_label_en-US" xlink:label="lab_prph_BESmartLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BE-Smart License Agreement [Member]</link:label>
    <link:label id="lab_prph_BESmartLicenseAgreementMember_documentation_en-US" xlink:label="lab_prph_BESmartLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BE-Smart License Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_BESmartLicenseAgreementMember" xlink:href="prph-20231231.xsd#prph_BESmartLicenseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_BESmartLicenseAgreementMember" xlink:to="lab_prph_BESmartLicenseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_9b6335ee-56be-41b5-8a9d-492a6b858863_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_MarketableSecuritiesMember_57997272-3fe4-4b2f-9745-1811e292b196_terseLabel_en-US" xlink:label="lab_prph_MarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_prph_MarketableSecuritiesMember_label_en-US" xlink:label="lab_prph_MarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities [Member]</link:label>
    <link:label id="lab_prph_MarketableSecuritiesMember_documentation_en-US" xlink:label="lab_prph_MarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Marketable Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_MarketableSecuritiesMember" xlink:href="prph-20231231.xsd#prph_MarketableSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_MarketableSecuritiesMember" xlink:to="lab_prph_MarketableSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_8e8ec448-8fac-44ba-bc78-1620b1b4b8f3_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_EquivirLicenseAgreementMember_ebd11c24-859a-433c-aef2-5c9845a7315b_terseLabel_en-US" xlink:label="lab_prph_EquivirLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equivir License Agreement</link:label>
    <link:label id="lab_prph_EquivirLicenseAgreementMember_label_en-US" xlink:label="lab_prph_EquivirLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equivir License Agreement [Member]</link:label>
    <link:label id="lab_prph_EquivirLicenseAgreementMember_documentation_en-US" xlink:label="lab_prph_EquivirLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equivir License Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_EquivirLicenseAgreementMember" xlink:href="prph-20231231.xsd#prph_EquivirLicenseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_EquivirLicenseAgreementMember" xlink:to="lab_prph_EquivirLicenseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_146c89b2-c615-4e6c-9f85-601c9e3b9125_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising and Incentive Promotions</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_7541e1eb-4ec9-4a18-bfa3-d78b441a8ee5_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repurchases of common shares</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_1a2cb17f-b6c3-4c83-9534-7fa7d829b55d_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_6537a269-75f7-45b5-a034-b6aafa82d891_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_0b520b2f-abef-4983-a1b8-664896548906_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_9558b9c6-65e2-4e7d-88a2-f52c85d2f755_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_97892171-7449-4361-897e-b8643c4d9391_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFDICInsuredAmount_8fd44e83-61cc-4406-84d7-4f9fe10bf1b8_terseLabel_en-US" xlink:label="lab_us-gaap_CashFDICInsuredAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal depository insurance</link:label>
    <link:label id="lab_us-gaap_CashFDICInsuredAmount_label_en-US" xlink:label="lab_us-gaap_CashFDICInsuredAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, FDIC Insured Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFDICInsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFDICInsuredAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFDICInsuredAmount" xlink:to="lab_us-gaap_CashFDICInsuredAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_09444a5a-60a9-4df9-9bd5-f0fd5fca99c9_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings (accumulated deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_LesseeOperatingLeaseAbatementPeriod_bda33000-0323-473f-b374-9a04d3680dd8_terseLabel_en-US" xlink:label="lab_prph_LesseeOperatingLeaseAbatementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, operating lease, abatement period</link:label>
    <link:label id="lab_prph_LesseeOperatingLeaseAbatementPeriod_label_en-US" xlink:label="lab_prph_LesseeOperatingLeaseAbatementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Abatement Period</link:label>
    <link:label id="lab_prph_LesseeOperatingLeaseAbatementPeriod_documentation_en-US" xlink:label="lab_prph_LesseeOperatingLeaseAbatementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, operating lease, abatement period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LesseeOperatingLeaseAbatementPeriod" xlink:href="prph-20231231.xsd#prph_LesseeOperatingLeaseAbatementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_LesseeOperatingLeaseAbatementPeriod" xlink:to="lab_prph_LesseeOperatingLeaseAbatementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_34165b29-c02b-4b09-9caf-34b6272091fc_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionContingentConsiderationLiability_6c1fec1c-3017-4798-b299-18d6e7130904_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Secured note amount</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionContingentConsiderationLiability" xlink:to="lab_us-gaap_AssetAcquisitionContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_3c25ba57-f13f-48d4-9ec5-0bb080914f70_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_InventoryLabMaterial_41d4a8b8-ebd7-4c18-b964-6ceaf4ece8c2_terseLabel_en-US" xlink:label="lab_prph_InventoryLabMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diagnostic services testing material</link:label>
    <link:label id="lab_prph_InventoryLabMaterial_label_en-US" xlink:label="lab_prph_InventoryLabMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Diagnostic services testing material</link:label>
    <link:label id="lab_prph_InventoryLabMaterial_documentation_en-US" xlink:label="lab_prph_InventoryLabMaterial" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Inventory lab material.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_InventoryLabMaterial" xlink:href="prph-20231231.xsd#prph_InventoryLabMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_InventoryLabMaterial" xlink:to="lab_prph_InventoryLabMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_d47ac83d-b6e3-4a7e-b90f-8da6df1abd05_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_5dc6830b-6eeb-4598-9563-7537a28b134e_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_f6f6f46a-ac46-489a-b2fa-ac088e9d3c1c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_47821f76-6b5a-4bdc-b48d-393e4b140060_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_77691943-53ab-4d0c-b32b-1a52114058db_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_51e26bf5-c621-4c2c-a0f2-f86888235ca6_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising expense</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_LesseeOperatingLeaseNumberOfRenewalOptions_7f86966a-bbd1-4a12-a9e1-0a069d0b8c23_terseLabel_en-US" xlink:label="lab_prph_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of renewal options</link:label>
    <link:label id="lab_prph_LesseeOperatingLeaseNumberOfRenewalOptions_label_en-US" xlink:label="lab_prph_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:label id="lab_prph_LesseeOperatingLeaseNumberOfRenewalOptions_documentation_en-US" xlink:label="lab_prph_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, operating lease, number of renewal options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:href="prph-20231231.xsd#prph_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:to="lab_prph_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_fac4d48f-9241-453b-ba43-6f7a8e29add3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_def30bf6-c63c-4e5d-a9d5-d140ccb41a1f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_A2022DirectorsPlanMember_6969b81e-eaf7-44d3-b8d3-9a9c8001fd37_terseLabel_en-US" xlink:label="lab_prph_A2022DirectorsPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022 Directors Plan</link:label>
    <link:label id="lab_prph_A2022DirectorsPlanMember_label_en-US" xlink:label="lab_prph_A2022DirectorsPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2022 Directors Plan [Member]</link:label>
    <link:label id="lab_prph_A2022DirectorsPlanMember_documentation_en-US" xlink:label="lab_prph_A2022DirectorsPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2022 Directors Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2022DirectorsPlanMember" xlink:href="prph-20231231.xsd#prph_A2022DirectorsPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_A2022DirectorsPlanMember" xlink:to="lab_prph_A2022DirectorsPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_8dc98b07-ecb5-4320-96db-422f74fe6b30_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Present value of minimum future obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_e6b53777-df5d-4e7d-b530-cdf4f8342201_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d7f404da-fc8c-436b-9259-62cfab5421d5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c94c1f05-47ff-4b69-9720-f3f3231d36ab_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_eb96d35b-c73d-4f12-a04b-e3c561450b54_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_a7e5ecde-7955-40d5-afd0-eab2634962b6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year ended December 31, 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_d1e795e0-38de-408a-99c0-da88bf2122d7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flows used in operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_1892c866-268b-4810-84ac-c23f6a464701_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_493641f8-fd89-492c-a1c9-ebe49bb8be6b_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_ed521586-b4fe-4a6a-9e30-21c6bac50eee_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_DeferredTaxLiabilitiesDepreciation_f5755cfd-9bd4-4a31-b768-7d1007565462_negatedTerseLabel_en-US" xlink:label="lab_prph_DeferredTaxLiabilitiesDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_prph_DeferredTaxLiabilitiesDepreciation_label_en-US" xlink:label="lab_prph_DeferredTaxLiabilitiesDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Depreciation</link:label>
    <link:label id="lab_prph_DeferredTaxLiabilitiesDepreciation_documentation_en-US" xlink:label="lab_prph_DeferredTaxLiabilitiesDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities, depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DeferredTaxLiabilitiesDepreciation" xlink:href="prph-20231231.xsd#prph_DeferredTaxLiabilitiesDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_DeferredTaxLiabilitiesDepreciation" xlink:to="lab_prph_DeferredTaxLiabilitiesDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_ee3d1afe-e06d-414d-a968-9b1f7a00e02d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_02926160-9e05-45f5-9d3a-13bc157692a6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from maturities of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_A2023SecuredMortgageLoanMember_8b230084-3afc-490a-b939-f074adf622ef_terseLabel_en-US" xlink:label="lab_prph_A2023SecuredMortgageLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023 Secured Mortgage Loan</link:label>
    <link:label id="lab_prph_A2023SecuredMortgageLoanMember_label_en-US" xlink:label="lab_prph_A2023SecuredMortgageLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2023 Secured Mortgage Loan [Member]</link:label>
    <link:label id="lab_prph_A2023SecuredMortgageLoanMember_documentation_en-US" xlink:label="lab_prph_A2023SecuredMortgageLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2023 Secured Mortgage Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2023SecuredMortgageLoanMember" xlink:href="prph-20231231.xsd#prph_A2023SecuredMortgageLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_A2023SecuredMortgageLoanMember" xlink:to="lab_prph_A2023SecuredMortgageLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_f352e48d-fe57-4bc7-a4a8-902f8a244452_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings (loss) per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_OldBridgeNewJerseyMember_b0137755-ba4c-4859-8a40-252015ba2c58_terseLabel_en-US" xlink:label="lab_prph_OldBridgeNewJerseyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Old Bridge New Jersey</link:label>
    <link:label id="lab_prph_OldBridgeNewJerseyMember_label_en-US" xlink:label="lab_prph_OldBridgeNewJerseyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Old Bridge New Jersey [Member]</link:label>
    <link:label id="lab_prph_OldBridgeNewJerseyMember_documentation_en-US" xlink:label="lab_prph_OldBridgeNewJerseyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Old Bridge New Jersey [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_OldBridgeNewJerseyMember" xlink:href="prph-20231231.xsd#prph_OldBridgeNewJerseyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_OldBridgeNewJerseyMember" xlink:to="lab_prph_OldBridgeNewJerseyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_2da6d81e-c2c8-4cd7-b11f-483cbebe22b8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business and Liquidity Risks and Uncertainties and Concentration of Financial Risks</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_a75f0aed-6e73-4c0e-9687-711f6774f8fb_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_62b0055b-ea1c-465d-bc96-9c1716c5d6cf_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Contribution Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3d970330-edb2-4ebe-b8f5-9f2d86a529a3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_e396b64a-f16d-4376-8923-58a78833a80f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_a7a9a544-7222-4c83-919f-5fa0379cc5e0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par or stated value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_b727854f-7b7b-4ba1-adf0-379474cfb2c4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_5e58b70c-ca7c-4003-8709-db5c822eea26_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_dcaf328d-8f45-417c-b0e2-ae7419ac0117_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_49a64034-4acd-437d-aeb1-4139df4c7c48_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income - basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_d5811a95-b300-4f4a-bea4-d4eabe6ba30e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfessionalFees_4bda0070-5bff-478d-859e-3240773eef89_terseLabel_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diagnostic expenses</link:label>
    <link:label id="lab_us-gaap_ProfessionalFees_label_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfessionalFees" xlink:to="lab_us-gaap_ProfessionalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_e5158145-a622-4808-a3c3-a030f6668136_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2_97e441b1-77a3-45f3-b44b-734d13c7fdcb_terseLabel_en-US" xlink:label="lab_prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual life, warrants granted (in years)</link:label>
    <link:label id="lab_prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Shares Authorized, Under Stock Option Plans, Exercise Price Range, Granted, Warrants, Weighted Average, Remaining Contractual Term 2</link:label>
    <link:label id="lab_prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2_documentation_en-US" xlink:label="lab_prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Shares Authorized, Under Stock Option Plans, Exercise Price Range, Granted, Warrants, Weighted Average, Remaining Contractual Term 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2" xlink:to="lab_prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_3f155223-5e0d-49d6-b15d-ff0025bc4a91_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_5e20bc2c-6a9d-45d4-9ed1-21c4325f704f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_CorporateStockMember_0b701bcf-98bd-42de-8a1a-c77382869011_terseLabel_en-US" xlink:label="lab_prph_CorporateStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate stock</link:label>
    <link:label id="lab_prph_CorporateStockMember_label_en-US" xlink:label="lab_prph_CorporateStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Stock [Member]</link:label>
    <link:label id="lab_prph_CorporateStockMember_documentation_en-US" xlink:label="lab_prph_CorporateStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Corporate Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CorporateStockMember" xlink:href="prph-20231231.xsd#prph_CorporateStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_CorporateStockMember" xlink:to="lab_prph_CorporateStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_GradualRentalRateIncreasePercentage_cb025479-02b5-4800-9400-c9e504086bba_terseLabel_en-US" xlink:label="lab_prph_GradualRentalRateIncreasePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gradual rental rate increase percentage</link:label>
    <link:label id="lab_prph_GradualRentalRateIncreasePercentage_label_en-US" xlink:label="lab_prph_GradualRentalRateIncreasePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gradual Rental Rate Increase Percentage</link:label>
    <link:label id="lab_prph_GradualRentalRateIncreasePercentage_documentation_en-US" xlink:label="lab_prph_GradualRentalRateIncreasePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gradual rental rate increase percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_GradualRentalRateIncreasePercentage" xlink:href="prph-20231231.xsd#prph_GradualRentalRateIncreasePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_GradualRentalRateIncreasePercentage" xlink:to="lab_prph_GradualRentalRateIncreasePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_c66505f7-2d33-43af-a88e-4b27c778e313_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total intrinsic value, options vested and exercisable</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_fd529a5e-4e0d-4bd5-92d2-e7d0578e53b2_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_FinanceLeaseCost_2532d9f0-087f-4c9c-a565-995fde260481_totalLabel_en-US" xlink:label="lab_prph_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total finance lease expense</link:label>
    <link:label id="lab_prph_FinanceLeaseCost_label_en-US" xlink:label="lab_prph_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:label id="lab_prph_FinanceLeaseCost_documentation_en-US" xlink:label="lab_prph_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_FinanceLeaseCost" xlink:href="prph-20231231.xsd#prph_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_FinanceLeaseCost" xlink:to="lab_prph_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_LicenseAgreementTerm_b7c04616-5dba-4c22-96a6-3730c8a9491d_terseLabel_en-US" xlink:label="lab_prph_LicenseAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License agreement term (in days)</link:label>
    <link:label id="lab_prph_LicenseAgreementTerm_label_en-US" xlink:label="lab_prph_LicenseAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement Term</link:label>
    <link:label id="lab_prph_LicenseAgreementTerm_documentation_en-US" xlink:label="lab_prph_LicenseAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LicenseAgreementTerm" xlink:href="prph-20231231.xsd#prph_LicenseAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_LicenseAgreementTerm" xlink:to="lab_prph_LicenseAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_a23c97a1-f93d-43af-b9f8-33e39c11b621_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Current Total</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_ae83dff0-c8ab-4780-9852-61da7fc3c930_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected stock price volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_9602aad0-f3fa-48a1-9bd9-9b2ac607a55e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_5f5eeaca-51fd-4ded-8f2d-cf28e77ec8a7_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization and Business</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_DeferredTaxLiabilitiesAmortization_ac573790-cacc-4248-a3ae-4fd999544c83_negatedTerseLabel_en-US" xlink:label="lab_prph_DeferredTaxLiabilitiesAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_prph_DeferredTaxLiabilitiesAmortization_label_en-US" xlink:label="lab_prph_DeferredTaxLiabilitiesAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Amortization</link:label>
    <link:label id="lab_prph_DeferredTaxLiabilitiesAmortization_documentation_en-US" xlink:label="lab_prph_DeferredTaxLiabilitiesAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities, amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DeferredTaxLiabilitiesAmortization" xlink:href="prph-20231231.xsd#prph_DeferredTaxLiabilitiesAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_DeferredTaxLiabilitiesAmortization" xlink:to="lab_prph_DeferredTaxLiabilitiesAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_9485bdd2-ee56-417d-a570-d5e13cfda37d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, options vested and exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_16ff15d3-a07d-4178-9178-2ee95f1cf810_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3cba32ca-d0fc-4bae-bc4e-7f6d76181e05_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e3b4d1c7-46b1-451c-9a0d-f32407e05049_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_c5603683-73f3-4717-8fbd-f8d12aafdf90_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_fd992556-884b-4430-b460-db392399f1ac_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents, restricted cash and marketable securities</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, and Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_DiagnosticServicesClientsTwoMember_d6dae96b-fdf5-4295-933b-17df2e2a63fc_terseLabel_en-US" xlink:label="lab_prph_DiagnosticServicesClientsTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diagnostic Services Clients Two</link:label>
    <link:label id="lab_prph_DiagnosticServicesClientsTwoMember_label_en-US" xlink:label="lab_prph_DiagnosticServicesClientsTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Diagnostic Services Clients Two [Member]</link:label>
    <link:label id="lab_prph_DiagnosticServicesClientsTwoMember_documentation_en-US" xlink:label="lab_prph_DiagnosticServicesClientsTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Diagnostic Services Clients Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DiagnosticServicesClientsTwoMember" xlink:href="prph-20231231.xsd#prph_DiagnosticServicesClientsTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_DiagnosticServicesClientsTwoMember" xlink:to="lab_prph_DiagnosticServicesClientsTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_32a91093-99a6-49f9-964a-d1855145d61a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_c3669323-1ebe-4410-8749-263eaab92edc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_a470a21e-38b2-4159-abdb-8553d3731cfa_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue, net of current portion</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_6f1943e2-b937-433e-8eda-7a6062a12194_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_416c033c-f85e-4bd6-b33f-37dbcfea575d_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedBonusesCurrent_ad181f0b-1210-4633-8e2e-dee646ebd9a7_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedBonusesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued bonus</link:label>
    <link:label id="lab_us-gaap_AccruedBonusesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedBonusesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Bonuses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedBonusesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedBonusesCurrent" xlink:to="lab_us-gaap_AccruedBonusesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_6eef7a9e-ca2d-4089-bd53-f14ffc549368_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_13814e9e-6448-470f-8041-c104066bd02c_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_00ccf843-4e1b-455c-bb34-2a2a77fe0fb7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_15795c2e-d833-4d7c-86ba-290bb7ac55bf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_90ba0bc9-3015-411e-b687-3ce92bb24ea5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_AdditionalPaymentOfFee_0700b53e-e5e4-4ef3-9005-1906185b49bc_terseLabel_en-US" xlink:label="lab_prph_AdditionalPaymentOfFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional payment of fee</link:label>
    <link:label id="lab_prph_AdditionalPaymentOfFee_label_en-US" xlink:label="lab_prph_AdditionalPaymentOfFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Payment Of Fee</link:label>
    <link:label id="lab_prph_AdditionalPaymentOfFee_documentation_en-US" xlink:label="lab_prph_AdditionalPaymentOfFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Additional Payment Of Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AdditionalPaymentOfFee" xlink:href="prph-20231231.xsd#prph_AdditionalPaymentOfFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_AdditionalPaymentOfFee" xlink:to="lab_prph_AdditionalPaymentOfFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_5aacb976-e735-4aa3-afbe-7437fdd7180a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_7035f9ac-87ac-41e9-a099-3f0fee041bc9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_773ea807-7f12-4eae-91a4-5e80881f8af4_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_6df232f5-8db9-40bb-9886-ee0f374c1230_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock authorized 50,000,000, $0.0005 par value, 18,045,029 and 16,210,776 shares outstanding, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation_6a711899-05e6-49c1-b93f-732091e2aa76_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation included in the prepaid expense</link:label>
    <link:label id="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Benefits and Share-Based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:to="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_b128b2ea-55b8-4ea3-857c-beb1edd975a8_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administration</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b2cf05ce-fa7b-440d-8354-0080e81767ce_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_96797e3a-6d88-474b-bb21-5ad02cf130f3_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_905c0e78-7099-45b5-ae04-8e70ea5ef578_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization on right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_75b4f598-d7d3-4b2f-b2d3-095d320749bf_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued diagnostic services</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_1d77ec9e-bd16-4656-8919-1495efbbeaef_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_DebtSecuritiesAvailableForSaleMaturityPeriod_a68e38e4-8cd7-4af5-9133-475a8f43554a_terseLabel_en-US" xlink:label="lab_prph_DebtSecuritiesAvailableForSaleMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt securities maturity (in years)</link:label>
    <link:label id="lab_prph_DebtSecuritiesAvailableForSaleMaturityPeriod_label_en-US" xlink:label="lab_prph_DebtSecuritiesAvailableForSaleMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity Period</link:label>
    <link:label id="lab_prph_DebtSecuritiesAvailableForSaleMaturityPeriod_documentation_en-US" xlink:label="lab_prph_DebtSecuritiesAvailableForSaleMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DebtSecuritiesAvailableForSaleMaturityPeriod" xlink:href="prph-20231231.xsd#prph_DebtSecuritiesAvailableForSaleMaturityPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_DebtSecuritiesAvailableForSaleMaturityPeriod" xlink:to="lab_prph_DebtSecuritiesAvailableForSaleMaturityPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_87ef73d3-f3d0-4238-8cac-813ea4a7a7fb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating loss carryforwards, state and local</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_4acb86f3-f5fa-42ba-a2fc-38a6283388c0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_bf905f6b-ad9b-4349-8337-697424156093_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bc1bbe46-e74f-4f3e-828d-a762641b4b71_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_ce3c1e42-65eb-4461-8243-3ae038eaf7dd_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest payable</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_FullyReservedTradeReceivablesMember_354bba2b-fcd7-4386-b288-5093122fc5e9_terseLabel_en-US" xlink:label="lab_prph_FullyReservedTradeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fully Reserved Trade Receivables</link:label>
    <link:label id="lab_prph_FullyReservedTradeReceivablesMember_label_en-US" xlink:label="lab_prph_FullyReservedTradeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fully Reserved Trade Receivables [Member]</link:label>
    <link:label id="lab_prph_FullyReservedTradeReceivablesMember_documentation_en-US" xlink:label="lab_prph_FullyReservedTradeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fully Reserved Trade Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_FullyReservedTradeReceivablesMember" xlink:href="prph-20231231.xsd#prph_FullyReservedTradeReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_FullyReservedTradeReceivablesMember" xlink:to="lab_prph_FullyReservedTradeReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRent_7286e5a6-4e45-483c-abb4-18efbc8181a9_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Base rent</link:label>
    <link:label id="lab_us-gaap_PaymentsForRent_label_en-US" xlink:label="lab_us-gaap_PaymentsForRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRent" xlink:to="lab_us-gaap_PaymentsForRent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_66986050-31bc-46e9-862b-7b2ea96e9619_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNet_cf653142-485d-49b6-8e1f-2bc6130e6290_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNet_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet" xlink:to="lab_us-gaap_AccountsReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_e3fc6d72-5565-497e-92df-de1ce93e2a95_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_00705465-606c-4bbc-88b1-5aadadd5688e_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosures:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_CooperativeIncentivePromotionCostsMember_3b12d946-b20a-4949-a22a-db8ad2647b93_terseLabel_en-US" xlink:label="lab_prph_CooperativeIncentivePromotionCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cooperative Incentive Promotion Costs</link:label>
    <link:label id="lab_prph_CooperativeIncentivePromotionCostsMember_label_en-US" xlink:label="lab_prph_CooperativeIncentivePromotionCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cooperative Incentive Promotion Costs [Member]</link:label>
    <link:label id="lab_prph_CooperativeIncentivePromotionCostsMember_documentation_en-US" xlink:label="lab_prph_CooperativeIncentivePromotionCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cooperative Incentive Promotion Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CooperativeIncentivePromotionCostsMember" xlink:href="prph-20231231.xsd#prph_CooperativeIncentivePromotionCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_CooperativeIncentivePromotionCostsMember" xlink:to="lab_prph_CooperativeIncentivePromotionCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_ac0a0dcb-bc0f-494c-9f17-cbcd957364fa_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_15a584ea-e16b-418a-b67d-30926585e105_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_b35fe2b3-78b9-4a01-9e38-01f11ef3b7a0_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_4498ca6d-f7d6-40ae-87c6-d9ad51c0bf5f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_a4f53422-0193-4291-9a8e-931930e107bb_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_31a02c96-1d3b-4155-b7fd-abdb82348e94_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EscrowDepositsRelatedToPropertySales_a8e1b311-0023-434d-8b4c-a23c778432fa_terseLabel_en-US" xlink:label="lab_us-gaap_EscrowDepositsRelatedToPropertySales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business acquisitions, escrow received</link:label>
    <link:label id="lab_us-gaap_EscrowDepositsRelatedToPropertySales_label_en-US" xlink:label="lab_us-gaap_EscrowDepositsRelatedToPropertySales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Escrow Deposits Related to Property Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDepositsRelatedToPropertySales" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EscrowDepositsRelatedToPropertySales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EscrowDepositsRelatedToPropertySales" xlink:to="lab_us-gaap_EscrowDepositsRelatedToPropertySales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_60f5b5c3-b2e9-4a16-8ca8-99090b18480c_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repurchases of common share (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_e424f7ba-4377-43fa-951a-93b282195c34_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_FinancingAgreementPeriodicPayment_8fd861ac-a059-4c11-8ba5-eaff4bd9f7e3_terseLabel_en-US" xlink:label="lab_prph_FinancingAgreementPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Periodic payment amount</link:label>
    <link:label id="lab_prph_FinancingAgreementPeriodicPayment_label_en-US" xlink:label="lab_prph_FinancingAgreementPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Agreement, Periodic Payment</link:label>
    <link:label id="lab_prph_FinancingAgreementPeriodicPayment_documentation_en-US" xlink:label="lab_prph_FinancingAgreementPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Agreement, Periodic Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_FinancingAgreementPeriodicPayment" xlink:href="prph-20231231.xsd#prph_FinancingAgreementPeriodicPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_FinancingAgreementPeriodicPayment" xlink:to="lab_prph_FinancingAgreementPeriodicPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_37200763-f8b7-4fea-b1be-aa0500797ec6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances_d0d8ccd7-aaf5-4e2e-a409-746c2b783c9f_terseLabel_en-US" xlink:label="lab_prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued advertising and other allowances</link:label>
    <link:label id="lab_prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances_label_en-US" xlink:label="lab_prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Decrease In Accrued Advertising And Other Allowances</link:label>
    <link:label id="lab_prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances_documentation_en-US" xlink:label="lab_prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase Decrease In Accrued Advertising And Other Allowances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances" xlink:href="prph-20231231.xsd#prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances" xlink:to="lab_prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_a2c9ae89-fe63-4ed9-afcc-3e9f2e115e4f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_1be6b255-af95-4d3f-81ec-1f9910d5b5c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_0c76d0d8-dc2f-4d2c-9429-1e7c39a2d7a4_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_afa23785-a633-4826-a49f-14b126385878_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_96c5fc23-5cfb-47c4-89d9-7ec3383ea954_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year ended December 31, 2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_616e9be8-4b0a-48dd-a714-a721a7211710_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_c35f0e9d-ed9e-4f76-ac33-06f41753d277_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credit</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_217fd6f1-0f82-4d93-b50b-1d37a3c357ad_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year Ended December 31, 2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_b21da75e-43b1-4dc5-b439-b79b8cfb1017_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash (used in) provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1ae6fd31-eca3-4658-8908-bad88786e8a3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash used by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_30f1b951-9b8b-4284-b145-3a6f24dd8e73_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Estimated Future Amortization Expense of Acquired Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseOther_41f696b7-679e-404a-8fdc-b17c48aee019_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseOther_label_en-US" xlink:label="lab_us-gaap_InterestExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseOther" xlink:to="lab_us-gaap_InterestExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_IssuanceOfCommonStockSharesExerciseOfWarrant_9ff3cee0-e5aa-4813-b8ea-b7d95f677b52_terseLabel_en-US" xlink:label="lab_prph_IssuanceOfCommonStockSharesExerciseOfWarrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon exercise of warrant (in shares)</link:label>
    <link:label id="lab_prph_IssuanceOfCommonStockSharesExerciseOfWarrant_label_en-US" xlink:label="lab_prph_IssuanceOfCommonStockSharesExerciseOfWarrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of Common Stock, Shares, Exercise of Warrant</link:label>
    <link:label id="lab_prph_IssuanceOfCommonStockSharesExerciseOfWarrant_documentation_en-US" xlink:label="lab_prph_IssuanceOfCommonStockSharesExerciseOfWarrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Issuance of Common Stock, Shares, Exercise of Warrant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IssuanceOfCommonStockSharesExerciseOfWarrant" xlink:href="prph-20231231.xsd#prph_IssuanceOfCommonStockSharesExerciseOfWarrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_IssuanceOfCommonStockSharesExerciseOfWarrant" xlink:to="lab_prph_IssuanceOfCommonStockSharesExerciseOfWarrant" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_IncreaseDecreaseInAccruedDiagnosticServices_dfa34c73-b9be-459f-a562-74073955cf7c_verboseLabel_en-US" xlink:label="lab_prph_IncreaseDecreaseInAccruedDiagnosticServices" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued diagnostic services</link:label>
    <link:label id="lab_prph_IncreaseDecreaseInAccruedDiagnosticServices_label_en-US" xlink:label="lab_prph_IncreaseDecreaseInAccruedDiagnosticServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Decrease In Accrued Diagnostic Services</link:label>
    <link:label id="lab_prph_IncreaseDecreaseInAccruedDiagnosticServices_documentation_en-US" xlink:label="lab_prph_IncreaseDecreaseInAccruedDiagnosticServices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase decrease in accrued diagnostic services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IncreaseDecreaseInAccruedDiagnosticServices" xlink:href="prph-20231231.xsd#prph_IncreaseDecreaseInAccruedDiagnosticServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_IncreaseDecreaseInAccruedDiagnosticServices" xlink:to="lab_prph_IncreaseDecreaseInAccruedDiagnosticServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_c3a893a2-e48a-4dc6-b603-29c86bd56f22_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unsecured convertible promissory note</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_21375889-25cd-4f06-b269-f7a09cf507c6_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_7e91018b-4502-4044-8462-dd8e4e33cdf7_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_0a42b1c4-de91-491b-8842-a94188f7e358_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_e7c3fc00-6b5e-474f-8481-bec61f6efb1f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_InsuranceProvidersMember_3da27b6a-105c-42d1-b256-81d57b871d3b_terseLabel_en-US" xlink:label="lab_prph_InsuranceProvidersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance Providers</link:label>
    <link:label id="lab_prph_InsuranceProvidersMember_label_en-US" xlink:label="lab_prph_InsuranceProvidersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance Providers [Member]</link:label>
    <link:label id="lab_prph_InsuranceProvidersMember_documentation_en-US" xlink:label="lab_prph_InsuranceProvidersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Insurance Providers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_InsuranceProvidersMember" xlink:href="prph-20231231.xsd#prph_InsuranceProvidersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_InsuranceProvidersMember" xlink:to="lab_prph_InsuranceProvidersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_c143ab87-ad46-4e9f-9430-670ac4329c97_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_label_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_IssuanceOfSecuredPromissoryNoteReceivable_bf95311b-d39e-4e36-b821-8079f6056366_negatedTerseLabel_en-US" xlink:label="lab_prph_IssuanceOfSecuredPromissoryNoteReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Issuance of secured promissory note receivable</link:label>
    <link:label id="lab_prph_IssuanceOfSecuredPromissoryNoteReceivable_label_en-US" xlink:label="lab_prph_IssuanceOfSecuredPromissoryNoteReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance Of Secured Promissory Note Receivable</link:label>
    <link:label id="lab_prph_IssuanceOfSecuredPromissoryNoteReceivable_documentation_en-US" xlink:label="lab_prph_IssuanceOfSecuredPromissoryNoteReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Issuance of secured promissory note receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IssuanceOfSecuredPromissoryNoteReceivable" xlink:href="prph-20231231.xsd#prph_IssuanceOfSecuredPromissoryNoteReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_IssuanceOfSecuredPromissoryNoteReceivable" xlink:to="lab_prph_IssuanceOfSecuredPromissoryNoteReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2a375176-938a-4840-b938-9e86085b7b8f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_d0a24293-1606-4344-867a-9595d625de25_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_218bec53-981f-4ff5-a8c0-c8ceb75e0140_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_d422c181-7e02-4e86-b796-676a4b5451ff_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_62e74232-9996-42d6-b29e-1f64e3d42609_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_PersonalGenomicsBusinessMember_8c000d40-1b1d-4100-ab58-1a3ed2644762_terseLabel_en-US" xlink:label="lab_prph_PersonalGenomicsBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Personal Genomics Business</link:label>
    <link:label id="lab_prph_PersonalGenomicsBusinessMember_label_en-US" xlink:label="lab_prph_PersonalGenomicsBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Personal Genomics Business [Member]</link:label>
    <link:label id="lab_prph_PersonalGenomicsBusinessMember_documentation_en-US" xlink:label="lab_prph_PersonalGenomicsBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Personal Genomics Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_PersonalGenomicsBusinessMember" xlink:href="prph-20231231.xsd#prph_PersonalGenomicsBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_PersonalGenomicsBusinessMember" xlink:to="lab_prph_PersonalGenomicsBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_e5a375b5-770e-406a-909b-92a90042302a_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_922be185-64fa-400c-9d16-2c02396a2212_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_33ef551f-bc99-4dc2-baaa-d0c3ad780ee4_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets, valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_d96b5649-f274-4c16-a0c4-f15a19e3680a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease, right-of-use asset, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b39da642-82d2-484b-aa11-4a68f8b2a900_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_f66e99e7-e8e4-4a3b-a147-8b5737fc1c13_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_beb8dc23-2d26-40be-bf1d-b552317986d7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_2f1cf2d0-2369-44e0-8563-0cb5f2f547c9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_42fdd917-7f08-449d-ac4c-ef67240643ef_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">(Loss) income from operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c814a68e-7348-482e-8e49-21db6a7418b2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total income from operations, before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesForCommissionsExpenseAndTaxes_3052f94f-fdb7-4c53-a2b5-16607ec56c91_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesForCommissionsExpenseAndTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued diagnostic services commissions</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesForCommissionsExpenseAndTaxes_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesForCommissionsExpenseAndTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities for Commissions, Expense and Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesForCommissionsExpenseAndTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesForCommissionsExpenseAndTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesForCommissionsExpenseAndTaxes" xlink:to="lab_us-gaap_AccruedLiabilitiesForCommissionsExpenseAndTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_1e627088-591c-4dcf-a877-a6b7c3afc7d0_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unbilled accounts receivable</link:label>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_label_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledContractsReceivable" xlink:to="lab_us-gaap_UnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionAxis_bc2a70c7-df33-4ce8-beb9-0f06075ad203_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographic Distribution [Axis]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionAxis_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographic Distribution [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionAxis" xlink:to="lab_us-gaap_GeographicDistributionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_f0d98b14-3958-45f6-9a81-0e393f2e368f_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ac62df0f-7780-4e60-bf08-bd94fa219a79_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_3f9ce9e0-f85a-43ea-9c76-11abc0e7fe97_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_f5c6e32f-294c-4682-ae4c-57c7f2e81c36_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock for debt conversion (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_008c673d-8941-4eab-9b75-8b3948490e84_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ClientPayersMember_15afcf05-4128-4976-aab5-46d7818dd829_terseLabel_en-US" xlink:label="lab_prph_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Client Payers</link:label>
    <link:label id="lab_prph_ClientPayersMember_label_en-US" xlink:label="lab_prph_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Client Payers [Member]</link:label>
    <link:label id="lab_prph_ClientPayersMember_documentation_en-US" xlink:label="lab_prph_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Client Payers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ClientPayersMember" xlink:href="prph-20231231.xsd#prph_ClientPayersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ClientPayersMember" xlink:to="lab_prph_ClientPayersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_543ef903-1421-403a-9ac3-f2cd239c4c94_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod_017b9a40-1e71-4fbc-bb37-e2fcafe8d565_terseLabel_en-US" xlink:label="lab_prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option to terminate, notice period</link:label>
    <link:label id="lab_prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod_label_en-US" xlink:label="lab_prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Option To Terminate, Notice Period</link:label>
    <link:label id="lab_prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod_documentation_en-US" xlink:label="lab_prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Option To Terminate, Notice Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod" xlink:href="prph-20231231.xsd#prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod" xlink:to="lab_prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_f90d907c-d428-4cb4-b1ea-c60a977f4219_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_2a89e076-2f51-4fa4-9898-44ab0b760bbe_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_58900623-6e6f-4d96-9e18-a98df0e06bef_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff_22044c1b-497f-4cd4-a0ee-3089e1135067_terseLabel_en-US" xlink:label="lab_prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Promissory note payoff amount</link:label>
    <link:label id="lab_prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff_label_en-US" xlink:label="lab_prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Promissory Note Payoff</link:label>
    <link:label id="lab_prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff_documentation_en-US" xlink:label="lab_prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Promissory Note Payoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff" xlink:href="prph-20231231.xsd#prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff" xlink:to="lab_prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b09ccf9-93c4-4f01-b745-fc490fa30173_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_64b5a9e4-8d02-4570-a1fc-d78dcf2e6920_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_81990e5e-a2e2-4b8a-b280-053f5bed8438_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="lab_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_09f5a2eb-44c4-4d67-87fd-e7339475bc63_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year Ended December 31, 2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7c702009-7199-4a98-9ad1-82e8bbdd4d89_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated Useful Life (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b43d8440-d400-40a9-8264-0f0bb253c679_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a5eb06a5-9278-43ba-9d28-e56bf6a9f2c4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year Ended December 31, 2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_72d9c303-e147-4741-b70e-9b5f07be28c7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares, warrants granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0cf82e5d-9940-4211-8632-82d1cb8abf34_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, outstanding, beginning (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2930d982-9fc2-4b02-b717-bd12548c94d1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, outstanding, ending (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_af72cccf-f9d9-4528-a298-56b2c3599d8d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ProceedsFromFinancingAgreement_04162be0-42c6-4e13-969f-e4d1fe3bd746_terseLabel_en-US" xlink:label="lab_prph_ProceedsFromFinancingAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from financing agreement</link:label>
    <link:label id="lab_prph_ProceedsFromFinancingAgreement_label_en-US" xlink:label="lab_prph_ProceedsFromFinancingAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Financing Agreement</link:label>
    <link:label id="lab_prph_ProceedsFromFinancingAgreement_documentation_en-US" xlink:label="lab_prph_ProceedsFromFinancingAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Financing Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ProceedsFromFinancingAgreement" xlink:href="prph-20231231.xsd#prph_ProceedsFromFinancingAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ProceedsFromFinancingAgreement" xlink:to="lab_prph_ProceedsFromFinancingAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_f03a33ea-9e43-4794-93c9-06fc30f62b4a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_LeaseLiabilityToBePaidYearThree_f7e49716-a06e-4233-9921-8b2f6976ce94_totalLabel_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaidYearThree" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Year Ended December 31, 2026</link:label>
    <link:label id="lab_prph_LeaseLiabilityToBePaidYearThree_label_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaidYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Liability, To Be Paid, Year Three</link:label>
    <link:label id="lab_prph_LeaseLiabilityToBePaidYearThree_documentation_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaidYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Liability, To Be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearThree" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_LeaseLiabilityToBePaidYearThree" xlink:to="lab_prph_LeaseLiabilityToBePaidYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_cdb742ae-21e9-4fcf-aec4-a557e62796aa_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase program, term (in months)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:to="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_20bd3afa-414d-4fa0-948b-ca4f9b497e6a_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_d512ad19-ade7-4542-a455-f3f4c07fe65a_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_8c76d04e-7d70-4800-9a45-67d26e33d322_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_e7fd2613-b547-42d6-9b07-71347d5de98c_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_9e4bc737-713c-4ea8-9247-2478109ab3cf_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_37b3413c-5f57-49ec-89e5-d16642c009ce_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_1f195c8f-ebbc-4744-b9af-1c489202a260_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of note payable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromNotesPayable" xlink:to="lab_us-gaap_ProceedsFromNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_e6c7f594-e490-4653-be66-04dd682529d1_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_d92c7f60-d4ca-4ab1-83aa-6f1ca45d2ab5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_TaxCreditCarryforwardLimitationAmount_572097b9-404a-4d36-a5f7-9c1eed82786d_terseLabel_en-US" xlink:label="lab_prph_TaxCreditCarryforwardLimitationAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Annual limitation amount</link:label>
    <link:label id="lab_prph_TaxCreditCarryforwardLimitationAmount_label_en-US" xlink:label="lab_prph_TaxCreditCarryforwardLimitationAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Limitation Amount</link:label>
    <link:label id="lab_prph_TaxCreditCarryforwardLimitationAmount_documentation_en-US" xlink:label="lab_prph_TaxCreditCarryforwardLimitationAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax credit carryforward limitation amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_TaxCreditCarryforwardLimitationAmount" xlink:href="prph-20231231.xsd#prph_TaxCreditCarryforwardLimitationAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_TaxCreditCarryforwardLimitationAmount" xlink:to="lab_prph_TaxCreditCarryforwardLimitationAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_d269a91a-0c1f-4c69-ba11-972b8e95ba82_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued advertising and other allowances</link:label>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Marketing Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:to="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_e730d619-a2cf-445a-9555-541576bd3590_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease term (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_596596a2-6ef7-4cb1-9344-847daa283375_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_LeaseLiabilityToBePaidYearFour_9a07ea84-25e0-4719-938c-26156000d1d4_totalLabel_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaidYearFour" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Year Ended December 31, 2027</link:label>
    <link:label id="lab_prph_LeaseLiabilityToBePaidYearFour_label_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaidYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Liability, To Be Paid, Year Four</link:label>
    <link:label id="lab_prph_LeaseLiabilityToBePaidYearFour_documentation_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaidYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Liability, To Be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearFour" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_LeaseLiabilityToBePaidYearFour" xlink:to="lab_prph_LeaseLiabilityToBePaidYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_CommonStockPurchaseWarrantsMember_4d5ac3e7-b62f-44b0-976e-622a533a23d6_terseLabel_en-US" xlink:label="lab_prph_CommonStockPurchaseWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock purchase warrants</link:label>
    <link:label id="lab_prph_CommonStockPurchaseWarrantsMember_label_en-US" xlink:label="lab_prph_CommonStockPurchaseWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock Purchase Warrants [Member]</link:label>
    <link:label id="lab_prph_CommonStockPurchaseWarrantsMember_documentation_en-US" xlink:label="lab_prph_CommonStockPurchaseWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock Purchase Warrants [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CommonStockPurchaseWarrantsMember" xlink:href="prph-20231231.xsd#prph_CommonStockPurchaseWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_CommonStockPurchaseWarrantsMember" xlink:to="lab_prph_CommonStockPurchaseWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_a6faa1cb-12ef-4053-9c0a-f52f57bc0d5e_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_84b1446a-ae54-403e-8659-3c9dbd40286c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_f69a726f-3dfc-4fd2-855f-109aee87eba0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price, lower range (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_f275170f-8c42-43a0-9db3-29c76f0faa5b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Options Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_3a78dbef-69a4-4b5a-bca0-93143816d892_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_f44bd6bc-abf2-4886-8aa2-294d021246d0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Special cash dividend (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6c658094-f3a1-4df8-819e-62af67eea834_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AreaOfRealEstateProperty_8d9935d1-8f90-4893-8837-922bfbfa805f_terseLabel_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Area of CLIA accredited laboratory (sq. ft.)</link:label>
    <link:label id="lab_us-gaap_AreaOfRealEstateProperty_label_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Area of Real Estate Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AreaOfRealEstateProperty" xlink:to="lab_us-gaap_AreaOfRealEstateProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ConsumerProductsMember_f7334447-c1df-4413-b473-23aff6e7bdfe_terseLabel_en-US" xlink:label="lab_prph_ConsumerProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consumer products</link:label>
    <link:label id="lab_prph_ConsumerProductsMember_label_en-US" xlink:label="lab_prph_ConsumerProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consumer Products [Member]</link:label>
    <link:label id="lab_prph_ConsumerProductsMember_documentation_en-US" xlink:label="lab_prph_ConsumerProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consumer Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ConsumerProductsMember" xlink:href="prph-20231231.xsd#prph_ConsumerProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ConsumerProductsMember" xlink:to="lab_prph_ConsumerProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_2fc543ab-eeca-4ae7-ac58-05467b6a8d1a_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredLongTermDebt_3279021a-508c-404e-a5f2-d859cdb3c9b8_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unsecured convertible promissory notes, net</link:label>
    <link:label id="lab_us-gaap_UnsecuredLongTermDebt_label_en-US" xlink:label="lab_us-gaap_UnsecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unsecured Long-Term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredLongTermDebt" xlink:to="lab_us-gaap_UnsecuredLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_NewDrugApplicationMember_879dec00-bff3-4bd8-848e-d141c409dfda_terseLabel_en-US" xlink:label="lab_prph_NewDrugApplicationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Drug Application</link:label>
    <link:label id="lab_prph_NewDrugApplicationMember_label_en-US" xlink:label="lab_prph_NewDrugApplicationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Drug Application [Member]</link:label>
    <link:label id="lab_prph_NewDrugApplicationMember_documentation_en-US" xlink:label="lab_prph_NewDrugApplicationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">New Drug Application</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NewDrugApplicationMember" xlink:href="prph-20231231.xsd#prph_NewDrugApplicationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_NewDrugApplicationMember" xlink:to="lab_prph_NewDrugApplicationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_499f6b04-e419-4684-90d5-d1b56a922c8f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_b9e255ca-3714-431c-b74c-11402eb6ec8d_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Cash dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_1b3238ee-53f6-40f6-be3b-7d46c0cc543d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_61c19328-19bb-4ddc-9bbe-19c37b4582f4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:to="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_16160291-54bc-48bf-9518-ba5cde2170fa_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_62ac5323-4358-4ab0-8297-f95ba2a93701_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_CFOAwardMember_921cb32d-ec61-4aac-9251-2e697b576657_terseLabel_en-US" xlink:label="lab_prph_CFOAwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CFO Award</link:label>
    <link:label id="lab_prph_CFOAwardMember_label_en-US" xlink:label="lab_prph_CFOAwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CFO Award [Member]</link:label>
    <link:label id="lab_prph_CFOAwardMember_documentation_en-US" xlink:label="lab_prph_CFOAwardMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CFO Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CFOAwardMember" xlink:href="prph-20231231.xsd#prph_CFOAwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_CFOAwardMember" xlink:to="lab_prph_CFOAwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_c8815791-cff5-4d2c-aee9-1fff54bbcf71_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_babd26f9-bd10-4440-8ba9-1090cce0ed04_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repayment of common stock for payment of statutory taxes on cashless exercise of stock options</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a676e794-3ebb-4d7e-a041-991384f1af16_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash payment for repurchase</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_f0f8cb0b-cd21-4ea1-8d93-92ea5e1f742a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_MrKamalObbadMember_522a726f-5528-41c4-b96d-fcda0333fabc_terseLabel_en-US" xlink:label="lab_prph_MrKamalObbadMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mr. Kamal Obbad</link:label>
    <link:label id="lab_prph_MrKamalObbadMember_label_en-US" xlink:label="lab_prph_MrKamalObbadMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mr. Kamal Obbad [Member]</link:label>
    <link:label id="lab_prph_MrKamalObbadMember_documentation_en-US" xlink:label="lab_prph_MrKamalObbadMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Mr. Kamal Obbad [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_MrKamalObbadMember" xlink:href="prph-20231231.xsd#prph_MrKamalObbadMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_MrKamalObbadMember" xlink:to="lab_prph_MrKamalObbadMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_Amended2022PlanMember_29f5bb94-9727-4945-b505-fc61626d24bc_terseLabel_en-US" xlink:label="lab_prph_Amended2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amended 2022 Plan</link:label>
    <link:label id="lab_prph_Amended2022PlanMember_label_en-US" xlink:label="lab_prph_Amended2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amended 2022 Plan [Member]</link:label>
    <link:label id="lab_prph_Amended2022PlanMember_documentation_en-US" xlink:label="lab_prph_Amended2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amended 2022 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_Amended2022PlanMember" xlink:href="prph-20231231.xsd#prph_Amended2022PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_Amended2022PlanMember" xlink:to="lab_prph_Amended2022PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_18b2aa62-d133-48b4-b282-372de11db604_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_f3490809-6290-4adf-8818-b8e62ecd339a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_abf43a7a-e862-4d38-b08c-a22f02346e07_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_760fac8f-4665-44c0-bbcc-5c4b4cf5c2db_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ManufacturingAgreementRenewalOptions_78aa290e-51cd-4502-b3ca-06ba6bf9cb47_terseLabel_en-US" xlink:label="lab_prph_ManufacturingAgreementRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of successive periods</link:label>
    <link:label id="lab_prph_ManufacturingAgreementRenewalOptions_label_en-US" xlink:label="lab_prph_ManufacturingAgreementRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Manufacturing Agreement, Renewal Options</link:label>
    <link:label id="lab_prph_ManufacturingAgreementRenewalOptions_documentation_en-US" xlink:label="lab_prph_ManufacturingAgreementRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Manufacturing Agreement, Renewal Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ManufacturingAgreementRenewalOptions" xlink:href="prph-20231231.xsd#prph_ManufacturingAgreementRenewalOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ManufacturingAgreementRenewalOptions" xlink:to="lab_prph_ManufacturingAgreementRenewalOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_dbf8a5e0-96c3-4c8b-aa55-1d7eafee3d36_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_412847b2-8413-484e-b7f0-14c09f53e4ac_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_e5e58c18-5846-465d-9143-ce219fe3d585_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated (Deficit) Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ContractManufacturingMember_cdec66b2-106f-4d92-b608-b941ae2741e6_terseLabel_en-US" xlink:label="lab_prph_ContractManufacturingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract manufacturing</link:label>
    <link:label id="lab_prph_ContractManufacturingMember_label_en-US" xlink:label="lab_prph_ContractManufacturingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract Manufacturing [Member]</link:label>
    <link:label id="lab_prph_ContractManufacturingMember_documentation_en-US" xlink:label="lab_prph_ContractManufacturingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract Manufacturing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ContractManufacturingMember" xlink:href="prph-20231231.xsd#prph_ContractManufacturingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ContractManufacturingMember" xlink:to="lab_prph_ContractManufacturingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_ffe6129a-f3c6-46e0-96e6-c7999db7678d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_f2a8057c-96ba-405a-b106-471af6dfe146_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_1e93fce1-0872-4474-b5ac-c828013b02f7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_9daf1ab2-9dfc-4deb-bbdf-eed90a5b2005_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable_597dd8e4-cc07-4fc0-b0f4-9a9be5fb7dd3_terseLabel_en-US" xlink:label="lab_prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual life, warrants vested and exercisable (in years)</link:label>
    <link:label id="lab_prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable_label_en-US" xlink:label="lab_prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Remaining Contractual Life Warrants, Vested And Exercisable</link:label>
    <link:label id="lab_prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable_documentation_en-US" xlink:label="lab_prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share based compensation arrangement by share based payment award non options vested and exercisable weighted average remaining contractual term 2.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable" xlink:href="prph-20231231.xsd#prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable" xlink:to="lab_prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueArrangementByTypeTable_b4b668b4-0d1b-4b4e-9bed-8b9a61dcfec1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueArrangementByTypeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueArrangementByTypeTable_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueArrangementByTypeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Revenue Arrangement, by Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementByTypeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementByTypeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable" xlink:to="lab_us-gaap_DeferredRevenueArrangementByTypeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_edbd7cc4-9520-4ad6-b214-3400e882fe4e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Trade</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2cdbf95e-af9f-4aa9-8b1a-87b8efe7ab22_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free rate of interest</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_f4dbc769-2143-4c3c-b6c6-69b731a0c29f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_4c0fd44d-827f-44fb-a4a5-a9db9518bd6b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use asset, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_02a11e7b-ba66-478e-a269-a3935c1db6af_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_8a6bf904-f109-4593-9d87-409abf259c73_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_A2022PlanMember_eecfadeb-1ac5-4d85-8cc4-9a775b319c99_terseLabel_en-US" xlink:label="lab_prph_A2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022 Plan</link:label>
    <link:label id="lab_prph_A2022PlanMember_label_en-US" xlink:label="lab_prph_A2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2022 Plan [Member]</link:label>
    <link:label id="lab_prph_A2022PlanMember_documentation_en-US" xlink:label="lab_prph_A2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2022 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2022PlanMember" xlink:href="prph-20231231.xsd#prph_A2022PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_A2022PlanMember" xlink:to="lab_prph_A2022PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_8a0056a9-1252-40ae-b86d-eff2c96331c4_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants outstanding, term (in years)</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_20017291-823a-4aec-b888-3eff9d6666e4_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtAmount1_65f94daf-6e45-4907-aca5-534ac1ffcd90_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt conversion, amount</link:label>
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion, Original Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionOriginalDebtAmount1" xlink:to="lab_us-gaap_DebtConversionOriginalDebtAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_60f11807-46a8-47b4-83fb-072c9b23d2fa_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_88a72bc7-2c02-4789-b004-4c96624c6247_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income - diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses_89b9fb90-e76e-491f-a591-6b44ed9f5a0b_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit loss expense, direct write-offs</link:label>
    <link:label id="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses_label_en-US" xlink:label="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provision for Loan, Lease, and Other Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForLoanLeaseAndOtherLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:to="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_3e4ec862-d083-485b-a30b-93227b1f1c83_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from promissory note</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale and Collection of Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:to="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_6e2165b1-2748-46f8-8b89-368af77f49de_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8e54421f-52f2-4b66-9fad-26525bd5d3c2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_LeaseLiabilityUndiscountedExcessAmount_60dc1c5c-508f-4ec3-acef-4163e244cab4_negatedTotalLabel_en-US" xlink:label="lab_prph_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Less present value discount</link:label>
    <link:label id="lab_prph_LeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_prph_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_prph_LeaseLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_prph_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityUndiscountedExcessAmount" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_LeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_prph_LeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssued1_61b3758d-c953-4c6d-8481-f3b2fbc712f4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued in asset acquisition</link:label>
    <link:label id="lab_us-gaap_StockIssued1_label_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssued1" xlink:to="lab_us-gaap_StockIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_4394573e-f078-4f48-a5fc-8f2d3d48a6ac_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Number of shares, options vested and exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_d91a67cb-5a47-45a2-a362-85827c9ea290_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total non-current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_494cf0f1-d18c-41e9-90af-36ef3d5a6713_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_f0674f42-7ec9-4206-b567-8f2a4bfb5ef8_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5d962bd8-f3fd-4fb5-935e-62034cc175c3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_b2705752-b810-4580-8918-6379db6f315c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_cefe6c8c-dfc1-442e-a98c-5094f6c56e19_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Technology-Based Intangible Assets</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_8db5a103-7fcf-45d8-a6ba-f18b77e6279d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sales of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_e790f1cd-925e-4337-be6a-4c202965d90e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_c4e284b6-8181-472c-8558-deca7bebebc3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_cc03aeaf-8596-45a6-8ee3-d152b9019f2e_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_21753170-7f9d-443e-86a2-a057f585e303_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Number of shares, warrants exercise (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_caefab51-a6da-428e-85b6-0f2b817a4e88_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_CPMMember_afc7277b-2c91-47f8-a5d7-530a01b3fe68_terseLabel_en-US" xlink:label="lab_prph_CPMMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CPM Acquisition</link:label>
    <link:label id="lab_prph_CPMMember_label_en-US" xlink:label="lab_prph_CPMMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CPM [Member]</link:label>
    <link:label id="lab_prph_CPMMember_documentation_en-US" xlink:label="lab_prph_CPMMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CPM acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CPMMember" xlink:href="prph-20231231.xsd#prph_CPMMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_CPMMember" xlink:to="lab_prph_CPMMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_9d457f49-095f-4c02-9614-13c3069e76d0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_553af294-48d5-4c13-954d-0f14c5432a3a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_LeaseLiabilityToBePaidYearTwo_edd8d3b2-9516-426e-9729-9c2341387e4b_totalLabel_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Year Ended December 31, 2025</link:label>
    <link:label id="lab_prph_LeaseLiabilityToBePaidYearTwo_label_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Liability, To Be Paid, Year Two</link:label>
    <link:label id="lab_prph_LeaseLiabilityToBePaidYearTwo_documentation_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Liability, To Be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearTwo" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_LeaseLiabilityToBePaidYearTwo" xlink:to="lab_prph_LeaseLiabilityToBePaidYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9ec59110-4e1e-4c5b-9f41-0085c2a83b92_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_38dc9ae7-02ee-4276-9108-072a512c62c1_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_TypeOfArrangementDomain_186017c7-3cbc-4b54-b05e-1ead3ae85e65_terseLabel_en-US" xlink:label="lab_prph_TypeOfArrangementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type Of Arrangement [Domain]</link:label>
    <link:label id="lab_prph_TypeOfArrangementDomain_label_en-US" xlink:label="lab_prph_TypeOfArrangementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type Of Arrangement [Domain]</link:label>
    <link:label id="lab_prph_TypeOfArrangementDomain_documentation_en-US" xlink:label="lab_prph_TypeOfArrangementDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Type Of Arrangement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_TypeOfArrangementDomain" xlink:href="prph-20231231.xsd#prph_TypeOfArrangementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_TypeOfArrangementDomain" xlink:to="lab_prph_TypeOfArrangementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_ee7538cf-fd5c-40d3-b1f8-20cbd7f6bcf7_negatedLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_f9d9fa88-9644-45e2-b058-845edd04c6db_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_49a1cea4-1054-452b-a941-5aae6b68dc03_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_PurchaseAgreementRoyaltyPercent_5b751117-6df3-4bb9-a64f-d227740e6a22_terseLabel_en-US" xlink:label="lab_prph_PurchaseAgreementRoyaltyPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty percent</link:label>
    <link:label id="lab_prph_PurchaseAgreementRoyaltyPercent_label_en-US" xlink:label="lab_prph_PurchaseAgreementRoyaltyPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Agreement, Royalty Percent</link:label>
    <link:label id="lab_prph_PurchaseAgreementRoyaltyPercent_documentation_en-US" xlink:label="lab_prph_PurchaseAgreementRoyaltyPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Purchase Agreement, Royalty Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_PurchaseAgreementRoyaltyPercent" xlink:href="prph-20231231.xsd#prph_PurchaseAgreementRoyaltyPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_PurchaseAgreementRoyaltyPercent" xlink:to="lab_prph_PurchaseAgreementRoyaltyPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyExpense_9794f4c8-0c92-4541-80d4-01d6312486ba_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum royalty</link:label>
    <link:label id="lab_us-gaap_RoyaltyExpense_label_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense" xlink:to="lab_us-gaap_RoyaltyExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_20f0ad01-e54d-41da-b89b-cc2324f1702d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated fair value of options at date of grant</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_a30dab12-209f-4b39-afd7-bb92ef3f7518_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of investment securities</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_OperatingAndOtherExpenses_d95afa22-2655-455e-ad0f-60a8d7252735_terseLabel_en-US" xlink:label="lab_prph_OperatingAndOtherExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating and other expenses</link:label>
    <link:label id="lab_prph_OperatingAndOtherExpenses_label_en-US" xlink:label="lab_prph_OperatingAndOtherExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating and other expenses</link:label>
    <link:label id="lab_prph_OperatingAndOtherExpenses_documentation_en-US" xlink:label="lab_prph_OperatingAndOtherExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating and other expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_OperatingAndOtherExpenses" xlink:href="prph-20231231.xsd#prph_OperatingAndOtherExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_OperatingAndOtherExpenses" xlink:to="lab_prph_OperatingAndOtherExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EscrowDeposit_8ef2bec9-88ab-49ec-b6e3-daf6a340902d_terseLabel_en-US" xlink:label="lab_us-gaap_EscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Escrow amount</link:label>
    <link:label id="lab_us-gaap_EscrowDeposit_label_en-US" xlink:label="lab_us-gaap_EscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Escrow Deposit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EscrowDeposit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EscrowDeposit" xlink:to="lab_us-gaap_EscrowDeposit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_98fc7071-aeeb-4485-b4e0-e9aae74691b5_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable allowances</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_956e4558-8fe3-4d7c-9956-3a2e2e87a3a0_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_NumberOfDebtInstruments_625ba342-55da-408c-a3ea-0af66a811332_terseLabel_en-US" xlink:label="lab_prph_NumberOfDebtInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of debt instruments</link:label>
    <link:label id="lab_prph_NumberOfDebtInstruments_label_en-US" xlink:label="lab_prph_NumberOfDebtInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Debt Instruments</link:label>
    <link:label id="lab_prph_NumberOfDebtInstruments_documentation_en-US" xlink:label="lab_prph_NumberOfDebtInstruments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Debt Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfDebtInstruments" xlink:href="prph-20231231.xsd#prph_NumberOfDebtInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_NumberOfDebtInstruments" xlink:to="lab_prph_NumberOfDebtInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_01c8471f-7b4a-4f69-9236-a57a27b63332_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Right of use asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_f29da654-ac5e-465d-9524-39d0aeba1d0d_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Deferred Total</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_a1eefd1a-de3b-4fbd-8ec7-33d1575ead16_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_d63354e2-a521-4d97-b1bd-01e58aee767f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Third Installment</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_62ed0304-3528-4460-8f2d-4c1078e7027f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_57eaed4f-5623-4e20-876d-505b69d97ef1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_582ddb67-0c4a-47cd-9220-3d1ff953391b_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3e4ffd17-9f0b-41d8-ae69-6cf5be40666e_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_5611adea-ae86-4edc-986a-ece6c7c4b595_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_ded8367f-88f0-46d8-b768-a6d9f414ad6a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year ended December 31, 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_efd7e19c-359d-4651-829a-cf7adb2c027c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_735153f8-57bb-4a73-8f02-ba12141bb351_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_52589948-caa4-4ddc-97b9-2e33cfc5149a_negatedLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less allowances</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_981deafb-5397-4a2a-96ca-39a8a0f8e0b1_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_3f4953bf-870f-4ed0-8361-3011a7cfcf5c_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ScheduleOfWarrantActivityTableTextBlock_0a1f81ef-f708-4cf9-8152-c6064049adf7_terseLabel_en-US" xlink:label="lab_prph_ScheduleOfWarrantActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Warrant Activity</link:label>
    <link:label id="lab_prph_ScheduleOfWarrantActivityTableTextBlock_label_en-US" xlink:label="lab_prph_ScheduleOfWarrantActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Warrant Activity [Table Text Block]</link:label>
    <link:label id="lab_prph_ScheduleOfWarrantActivityTableTextBlock_documentation_en-US" xlink:label="lab_prph_ScheduleOfWarrantActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Warrant Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ScheduleOfWarrantActivityTableTextBlock" xlink:href="prph-20231231.xsd#prph_ScheduleOfWarrantActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ScheduleOfWarrantActivityTableTextBlock" xlink:to="lab_prph_ScheduleOfWarrantActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_LeaseLiabilityToBePaidYearOne_61f58c9c-c1db-43b3-8c6e-7b16f9d27e26_totalLabel_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Year Ended December 31, 2024</link:label>
    <link:label id="lab_prph_LeaseLiabilityToBePaidYearOne_label_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Liability, To Be Paid, Year One</link:label>
    <link:label id="lab_prph_LeaseLiabilityToBePaidYearOne_documentation_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Liability, To Be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearOne" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_LeaseLiabilityToBePaidYearOne" xlink:to="lab_prph_LeaseLiabilityToBePaidYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfProperties_96185537-adff-4831-a2fa-362f25d9b7e6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfProperties" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gain on sales of assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfProperties_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfProperties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Sale of Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfProperties" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfProperties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfProperties" xlink:to="lab_us-gaap_GainLossOnSaleOfProperties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_edf6eb72-b8cd-4cec-8fed-6c79835cfe51_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Total intrinsic value, outstanding, beginning</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_b3176d52-3e53-49b0-9be5-eb1882e1c17e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Total intrinsic value, outstanding, ending</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8613048f-96a8-4854-b925-86d85659ddbd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_FinancingArrangementAggregateRepaymentAmount_5952ad32-defd-417c-8bf4-306ad143848c_terseLabel_en-US" xlink:label="lab_prph_FinancingArrangementAggregateRepaymentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate repayment amount</link:label>
    <link:label id="lab_prph_FinancingArrangementAggregateRepaymentAmount_label_en-US" xlink:label="lab_prph_FinancingArrangementAggregateRepaymentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Arrangement, Aggregate Repayment Amount</link:label>
    <link:label id="lab_prph_FinancingArrangementAggregateRepaymentAmount_documentation_en-US" xlink:label="lab_prph_FinancingArrangementAggregateRepaymentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Arrangement, Aggregate Repayment Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_FinancingArrangementAggregateRepaymentAmount" xlink:href="prph-20231231.xsd#prph_FinancingArrangementAggregateRepaymentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_FinancingArrangementAggregateRepaymentAmount" xlink:to="lab_prph_FinancingArrangementAggregateRepaymentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntellectualPropertyMember_c053059e-e7f6-4ec6-a3e5-eaa946eeb377_terseLabel_en-US" xlink:label="lab_us-gaap_IntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proprietary intellectual property</link:label>
    <link:label id="lab_us-gaap_IntellectualPropertyMember_label_en-US" xlink:label="lab_us-gaap_IntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intellectual Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntellectualPropertyMember" xlink:to="lab_us-gaap_IntellectualPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_54156d11-f39b-415f-b0c9-49c50d00052a_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4c6ea87f-ac1f-443e-8d6e-175ee8706f14_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted shares</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_AssetAcquisitionTransactionCosts_f267faa2-f8a4-4989-8514-60cafe0081a9_terseLabel_en-US" xlink:label="lab_prph_AssetAcquisitionTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_prph_AssetAcquisitionTransactionCosts_label_en-US" xlink:label="lab_prph_AssetAcquisitionTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Transaction Costs</link:label>
    <link:label id="lab_prph_AssetAcquisitionTransactionCosts_documentation_en-US" xlink:label="lab_prph_AssetAcquisitionTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AssetAcquisitionTransactionCosts" xlink:href="prph-20231231.xsd#prph_AssetAcquisitionTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_AssetAcquisitionTransactionCosts" xlink:to="lab_prph_AssetAcquisitionTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_9f08e338-51bc-4833-8971-8152dc41c520_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year ended December 31, 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_837ef3f6-c75c-4047-944c-114d2bf182bd_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant, fair value</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_cd41b587-c76e-4dae-bf42-3c5c4ca065c9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common shares related to business acquisition (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_8cb086e7-654d-4452-a62a-b9fecd93abdb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price, upper range (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_287ad68e-b899-4ba0-a763-5a0df47d36da_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Second Installment</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_15cfa838-71c9-493f-87da-f3e450234a29_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_A2023NotesWarrantsMember_4c02d53f-3d00-4aa8-a219-0b4219ca00dd_terseLabel_en-US" xlink:label="lab_prph_A2023NotesWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023 Notes Warrants</link:label>
    <link:label id="lab_prph_A2023NotesWarrantsMember_label_en-US" xlink:label="lab_prph_A2023NotesWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2023 Notes Warrants [Member]</link:label>
    <link:label id="lab_prph_A2023NotesWarrantsMember_documentation_en-US" xlink:label="lab_prph_A2023NotesWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2023 Notes Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2023NotesWarrantsMember" xlink:href="prph-20231231.xsd#prph_A2023NotesWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_A2023NotesWarrantsMember" xlink:to="lab_prph_A2023NotesWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_8d9367d5-737d-4a18-9d5f-f4de37abeb05_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_979a7ee3-c6fe-4743-884c-797849feed91_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Ownership Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_c7782d56-700b-4653-8c97-820e72345742_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1_be299e0a-ba12-4ed1-ab12-769c01a28eef_periodStartLabel_en-US" xlink:label="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, warrants outstanding, beginning (in dollars per share)</link:label>
    <link:label id="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1_c15165be-2737-4c12-a0d7-1cc66327ec3c_periodEndLabel_en-US" xlink:label="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, warrants outstanding, ending (in dollars per share)</link:label>
    <link:label id="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1_label_en-US" xlink:label="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1</link:label>
    <link:label id="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1_documentation_en-US" xlink:label="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share based compensation arrangement by share based payment award non options outstanding weighted average exercise price 1.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1" xlink:to="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_3e895713-c444-4aa9-8b43-eb99b9d14e67_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_bd20f158-e7cf-4a93-972f-20187ad0b7f1_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_5ba0e83c-707d-44a0-ba84-8bff1c15e7ea_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average discount rate &#8211; finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_47699fa0-7164-4dde-91e7-1b11159063a0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_c9b46929-93fa-4201-ac75-aa852b3bb783_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_e359c373-8dd2-4637-a589-6ae467a9b10e_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_d5ab01df-5507-4d38-be7f-63f920a4fbcd_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_5dcd3e82-394e-42a1-b09a-40299b1af97b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_97d46eea-cc55-49e9-aa1d-1474ecab0deb_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant Customers Concentrations</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_8f085c03-e382-496f-b5c4-cfae242d8db8_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_WeightedAverageExercisePriceWarrantsExercised_bbd12d8c-49bd-487b-9de6-bc7aa93c8f8a_verboseLabel_en-US" xlink:label="lab_prph_WeightedAverageExercisePriceWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price warrants, exercised (in dollars per share)</link:label>
    <link:label id="lab_prph_WeightedAverageExercisePriceWarrantsExercised_label_en-US" xlink:label="lab_prph_WeightedAverageExercisePriceWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price Warrants, Exercised</link:label>
    <link:label id="lab_prph_WeightedAverageExercisePriceWarrantsExercised_documentation_en-US" xlink:label="lab_prph_WeightedAverageExercisePriceWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price Warrants, Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_WeightedAverageExercisePriceWarrantsExercised" xlink:href="prph-20231231.xsd#prph_WeightedAverageExercisePriceWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_WeightedAverageExercisePriceWarrantsExercised" xlink:to="lab_prph_WeightedAverageExercisePriceWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_ecae2dc6-19c4-4c20-b412-ca6c9695715c_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_c5da4c2b-8219-442b-aa79-6fc638b40d57_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total intangible assets, gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_6f43c4b4-4154-4d64-ab87-b38915070b83_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_a585edb7-2a8d-4630-8fc0-3525359f5536_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income taxes from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_7d192ef7-83bd-4263-a112-72016e9c9d1f_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bad debt expense</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_d67c775e-9659-4f6b-b2dd-a3079312f77f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease asset</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_3cddf3d4-cb23-4f7a-91d1-ec4090bd3861_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_a502486b-5cd6-4a91-9701-dfb0e9053823_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_d4fe964d-b970-426a-bfc0-d4ee0cfd6e34_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_9456f40a-1e47-413c-add5-20e5d1b5311f_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ConstructionAllowance_2aefb439-0fd1-4129-ad3c-7984a9ed557d_terseLabel_en-US" xlink:label="lab_prph_ConstructionAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Construction allowance</link:label>
    <link:label id="lab_prph_ConstructionAllowance_label_en-US" xlink:label="lab_prph_ConstructionAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction Allowance</link:label>
    <link:label id="lab_prph_ConstructionAllowance_documentation_en-US" xlink:label="lab_prph_ConstructionAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Construction Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ConstructionAllowance" xlink:href="prph-20231231.xsd#prph_ConstructionAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ConstructionAllowance" xlink:to="lab_prph_ConstructionAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_0d54ff0b-ba73-4ff5-936d-cc52e0149c34_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Disaggregation of Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_a29bcfd0-6cae-43af-9c46-51898bbc8c76_terseLabel_en-US" xlink:label="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual life, granted shares (in years)</link:label>
    <link:label id="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_label_en-US" xlink:label="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Granted, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_documentation_en-US" xlink:label="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:to="lab_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_98be9b55-13ac-406a-9bb0-cb94524bd64c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_LetterAgreementMember_bc9f046b-f8b6-4a24-aa96-0c33053cdee9_terseLabel_en-US" xlink:label="lab_prph_LetterAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letter Agreement</link:label>
    <link:label id="lab_prph_LetterAgreementMember_label_en-US" xlink:label="lab_prph_LetterAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letter Agreement [Member]</link:label>
    <link:label id="lab_prph_LetterAgreementMember_documentation_en-US" xlink:label="lab_prph_LetterAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Letter agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LetterAgreementMember" xlink:href="prph-20231231.xsd#prph_LetterAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_LetterAgreementMember" xlink:to="lab_prph_LetterAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1a2ae65c-01a5-446e-ad9b-86b79c10aa3d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining lease term &#8211; operating leases (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_ceb5809b-e8a0-4c25-91f4-c771a2ab18a1_terseLabel_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_label_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:to="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_91fe0eb4-9b99-402a-a2d1-f91988c90636_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Permanent differences and other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b97dd52a-8cda-46ae-99e1-0ce34f3de0b2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues, net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7bc548bf-faa4-4ef3-9f31-d2a5dbba0547_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total revenue, net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_PrepaidShareBasedCompensationExpense_3501b257-753a-44dc-b413-2399a384eb3f_terseLabel_en-US" xlink:label="lab_prph_PrepaidShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expense</link:label>
    <link:label id="lab_prph_PrepaidShareBasedCompensationExpense_label_en-US" xlink:label="lab_prph_PrepaidShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Share-Based Compensation Expense</link:label>
    <link:label id="lab_prph_PrepaidShareBasedCompensationExpense_documentation_en-US" xlink:label="lab_prph_PrepaidShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prepaid Share-Based Compensation Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_PrepaidShareBasedCompensationExpense" xlink:href="prph-20231231.xsd#prph_PrepaidShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_PrepaidShareBasedCompensationExpense" xlink:to="lab_prph_PrepaidShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_376282aa-32cb-482c-84e2-01ad01ab9c04_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_11c8c5dd-444c-4df3-9083-0cd996249e4a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_9e5ac3fe-dc2f-41fd-99aa-8badba794329_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_Amended2010DirectorsPlanMember_6750ed04-7627-4e85-ad4d-0a0bd696d31d_terseLabel_en-US" xlink:label="lab_prph_Amended2010DirectorsPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amended 2010 Directors' Plan</link:label>
    <link:label id="lab_prph_Amended2010DirectorsPlanMember_label_en-US" xlink:label="lab_prph_Amended2010DirectorsPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amended 2010 Directors' Plan [Member]</link:label>
    <link:label id="lab_prph_Amended2010DirectorsPlanMember_documentation_en-US" xlink:label="lab_prph_Amended2010DirectorsPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amended 2010 Directors' Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_Amended2010DirectorsPlanMember" xlink:href="prph-20231231.xsd#prph_Amended2010DirectorsPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_Amended2010DirectorsPlanMember" xlink:to="lab_prph_Amended2010DirectorsPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_LeaseLiabilityToBePaidAfterYearFive_6b9dd223-1a3b-465b-adeb-5c657ac3fc0b_totalLabel_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaidAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_prph_LeaseLiabilityToBePaidAfterYearFive_label_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaidAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Liability, To Be Paid, After Year Five</link:label>
    <link:label id="lab_prph_LeaseLiabilityToBePaidAfterYearFive_documentation_en-US" xlink:label="lab_prph_LeaseLiabilityToBePaidAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease, Liability, To Be Paid, After Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidAfterYearFive" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_LeaseLiabilityToBePaidAfterYearFive" xlink:to="lab_prph_LeaseLiabilityToBePaidAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6d33be3d-0414-4556-bafa-50dfb2326dcb_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_8e09a37d-8525-41d0-8e2c-46dd8ea392c9_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares withheld for tax withholding obligation (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_5006b239-abaf-46fb-ada9-68daa8422e78_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repayment of note payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7c90e892-73fb-4ae7-b521-60a5d32a876b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_7128eb63-3f93-49c5-af81-39c39bb6d3a9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average discount rate &#8211; operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_997d8bc7-79b9-44fd-b6c2-1398760d6806_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest payment on the promissory notes</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_54f7e8a8-aea6-427e-9d29-5b2296d04b5d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_NumberOfSites_3d958722-c145-4687-b213-2e805d97eb01_terseLabel_en-US" xlink:label="lab_prph_NumberOfSites" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of sites</link:label>
    <link:label id="lab_prph_NumberOfSites_label_en-US" xlink:label="lab_prph_NumberOfSites" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Sites</link:label>
    <link:label id="lab_prph_NumberOfSites_documentation_en-US" xlink:label="lab_prph_NumberOfSites" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Sites</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfSites" xlink:href="prph-20231231.xsd#prph_NumberOfSites"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_NumberOfSites" xlink:to="lab_prph_NumberOfSites" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_8b87acb3-04db-41a8-8a7f-b23397864030_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-maturity, Allowance for Credit Loss [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="lab_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_06a56598-1e31-4b6b-a9ab-edfac4431a7d_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTaxAbstract_86962ca1-964f-40a7-b50d-2f40e13e3868_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive (loss) income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTaxAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_9a852158-0a3e-4f08-9de6-4f20a7365a06_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated useful life (in years)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage_031d9a59-06cd-4357-a187-dfe508c56514_terseLabel_en-US" xlink:label="lab_prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of tests recognized reimbursed by HRSA uninsured program (as a percent)</link:label>
    <link:label id="lab_prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage_label_en-US" xlink:label="lab_prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Tests Recognized Reimbursed By HRSA Uninsured Program, Percentage</link:label>
    <link:label id="lab_prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage_documentation_en-US" xlink:label="lab_prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of tests recognized reimbursed by HRSA uninsured program, percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage" xlink:href="prph-20231231.xsd#prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage" xlink:to="lab_prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_9038d542-6f83-4a9f-a78a-f8f86d293e98_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, net of discount of $341</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_5526094d-ce14-4bb2-9ba5-8090ff6c43a6_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining lease term &#8211; finance leases (in years)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_4bade183-e2c8-4dd4-95ed-65e91e9de1f8_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount_562a839b-f21f-414e-9d0d-a488f39e70ab_terseLabel_en-US" xlink:label="lab_prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon exercise of warrants</link:label>
    <link:label id="lab_prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount_label_en-US" xlink:label="lab_prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of Common Stock Upon Exercise of Warrant, Amount</link:label>
    <link:label id="lab_prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount_documentation_en-US" xlink:label="lab_prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Issuance of Common Stock Upon Exercise of Warrant, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount" xlink:href="prph-20231231.xsd#prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount" xlink:to="lab_prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_594dbc5a-af47-489b-84b8-7d665feeff31_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c01a6878-73c8-48ff-9a8f-fabef0f816e2_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9372d1a4-914e-4088-bc38-18d201706e43_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares outstanding - diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_CEOOptionsMember_e8e959fb-1908-4e58-8457-cfa1757252de_terseLabel_en-US" xlink:label="lab_prph_CEOOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CEO Options</link:label>
    <link:label id="lab_prph_CEOOptionsMember_label_en-US" xlink:label="lab_prph_CEOOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CEO Options [Member]</link:label>
    <link:label id="lab_prph_CEOOptionsMember_documentation_en-US" xlink:label="lab_prph_CEOOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CEO Options [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CEOOptionsMember" xlink:href="prph-20231231.xsd#prph_CEOOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_CEOOptionsMember" xlink:to="lab_prph_CEOOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusDomain_29494d6f-5371-4859-b658-a73dcf666180_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusDomain_label_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusDomain" xlink:to="lab_us-gaap_GranteeStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_0340633b-d46a-4e8b-b3c6-a5a1de67c5d3_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Realized loss on marketable debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_c2ad1e5e-c972-43f4-9c29-88703ea3057b_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets obtained in exchange for new finance lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_6129f970-3234-4a6b-bd47-7c9f7f37a99d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_5032f828-608c-407d-b903-5ad9db6ccc4d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less present value discount</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_c8653c1c-98cf-4943-9984-fc6d7bf58702_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_d401d43f-36ac-410b-83ed-9b12e09a14ba_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_PaymentsForAssetAcquisition_9c4e54e2-fe36-4a1f-b9d1-cd37b6f70db4_terseLabel_en-US" xlink:label="lab_prph_PaymentsForAssetAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid</link:label>
    <link:label id="lab_prph_PaymentsForAssetAcquisition_label_en-US" xlink:label="lab_prph_PaymentsForAssetAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Asset Acquisition</link:label>
    <link:label id="lab_prph_PaymentsForAssetAcquisition_documentation_en-US" xlink:label="lab_prph_PaymentsForAssetAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments for Asset Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_PaymentsForAssetAcquisition" xlink:href="prph-20231231.xsd#prph_PaymentsForAssetAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_PaymentsForAssetAcquisition" xlink:to="lab_prph_PaymentsForAssetAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_82d1286e-b940-4b6a-bfe7-a9e920304186_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance leases:</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_5ff1e86e-178a-400f-abd8-a09057aefd2b_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_3bcc1144-dfa7-4445-b825-7172a801b45d_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_IncreaseDecreaseInDeferredIncomeTaxAssets_69daedef-af6f-4002-88aa-7116658d1739_negatedTerseLabel_en-US" xlink:label="lab_prph_IncreaseDecreaseInDeferredIncomeTaxAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax asset</link:label>
    <link:label id="lab_prph_IncreaseDecreaseInDeferredIncomeTaxAssets_label_en-US" xlink:label="lab_prph_IncreaseDecreaseInDeferredIncomeTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Deferred Income Tax Assets</link:label>
    <link:label id="lab_prph_IncreaseDecreaseInDeferredIncomeTaxAssets_documentation_en-US" xlink:label="lab_prph_IncreaseDecreaseInDeferredIncomeTaxAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Deferred Income Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IncreaseDecreaseInDeferredIncomeTaxAssets" xlink:href="prph-20231231.xsd#prph_IncreaseDecreaseInDeferredIncomeTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_IncreaseDecreaseInDeferredIncomeTaxAssets" xlink:to="lab_prph_IncreaseDecreaseInDeferredIncomeTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_7ed28fe3-6a92-4c52-bcf6-7383a7192251_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_9eb0a727-6322-4c5b-ab5c-326b564fd2fe_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_DiagnosticServicesMember_ad1af64e-f5e7-413a-bc26-8f5ce2b59951_terseLabel_en-US" xlink:label="lab_prph_DiagnosticServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diagnostic services</link:label>
    <link:label id="lab_prph_DiagnosticServicesMember_3fefc891-a153-42a4-8787-de8f2de2786b_verboseLabel_en-US" xlink:label="lab_prph_DiagnosticServicesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diagnostic Services</link:label>
    <link:label id="lab_prph_DiagnosticServicesMember_label_en-US" xlink:label="lab_prph_DiagnosticServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Diagnostic Services [Member]</link:label>
    <link:label id="lab_prph_DiagnosticServicesMember_documentation_en-US" xlink:label="lab_prph_DiagnosticServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Diagnostic Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DiagnosticServicesMember" xlink:href="prph-20231231.xsd#prph_DiagnosticServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_DiagnosticServicesMember" xlink:to="lab_prph_DiagnosticServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_1624a6d7-8505-497f-bfa5-b79bbd8be43b_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lab equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_13343b71-808b-4a02-a4ae-27fa1d48801a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual life, options vested and exercisable (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_7a2e0fd4-c464-4339-a4f8-58a862a86246_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fb4d1bab-ccab-4acb-9aa2-c154b82399f5_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_LesseeOperatingLeaseMonthlyBaseRent_43dd9b41-ef3a-463a-8739-9f40537f44f5_terseLabel_en-US" xlink:label="lab_prph_LesseeOperatingLeaseMonthlyBaseRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Monthly base rent</link:label>
    <link:label id="lab_prph_LesseeOperatingLeaseMonthlyBaseRent_label_en-US" xlink:label="lab_prph_LesseeOperatingLeaseMonthlyBaseRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Monthly Base Rent</link:label>
    <link:label id="lab_prph_LesseeOperatingLeaseMonthlyBaseRent_documentation_en-US" xlink:label="lab_prph_LesseeOperatingLeaseMonthlyBaseRent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Monthly Base Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LesseeOperatingLeaseMonthlyBaseRent" xlink:href="prph-20231231.xsd#prph_LesseeOperatingLeaseMonthlyBaseRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_LesseeOperatingLeaseMonthlyBaseRent" xlink:to="lab_prph_LesseeOperatingLeaseMonthlyBaseRent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_6ed34960-1a1d-481d-b8e3-20a8d8cb8e99_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_895faecf-ac2d-44d6-8ddc-187a2188d36a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rates (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_45d1c5ac-6757-4a30-ba9f-265880cc94f8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_2ddd05b3-e2f9-4b96-b034-f97e9e7bcb86_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payment of dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ebac8ed4-cf70-41b5-abd0-1f55055d0971_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_d34dd2de-146b-4178-808e-640385a28a48_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityAbstract_4af8bf7a-7c7d-4308-a906-5d961d21500c_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_d25060b2-ffe0-477e-8585-e5eedbb93bdb_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_2614f4c1-e26d-4414-97b5-a2a5da9be3ce_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_3bc0e90a-5cf0-4280-850e-6ae4c4f55e46_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_d8cbeda6-a8c3-4a47-8e34-fcfa4d3927d8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0adfa8f6-e5ca-44cc-84cb-9134ebf0e8a6_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">(Decrease) increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d011ea56-0bb7-4f26-bdda-56248ca564fc_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_1dfea94d-a6cd-44f7-9882-f820761b43d7_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_61697179-1715-4f5c-8e91-2b0d1575ecc9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Renewal term (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_2a489576-ba95-48e3-8e4a-da0d73ef9c38_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_2d30f579-b0ea-4542-8ca8-5ac879370187_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_d09f23ef-3150-479b-8d7d-8c0d35a2ae22_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_RetailAndOtherMember_a1325aa8-1e9d-4efe-8c82-9dffdac318f8_terseLabel_en-US" xlink:label="lab_prph_RetailAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retail and others</link:label>
    <link:label id="lab_prph_RetailAndOtherMember_label_en-US" xlink:label="lab_prph_RetailAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retail and Other [Member]</link:label>
    <link:label id="lab_prph_RetailAndOtherMember_documentation_en-US" xlink:label="lab_prph_RetailAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Retail and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_RetailAndOtherMember" xlink:href="prph-20231231.xsd#prph_RetailAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_RetailAndOtherMember" xlink:to="lab_prph_RetailAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_5ed64a6b-f6ce-4d8b-907d-14c62f674a29_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credit carryforwards, research</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_085ca707-b8bb-4c37-9c28-65be953000da_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss and capital loss carryforward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fa3d349f-b908-4042-b827-3647e21d987a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a4dddf51-7e41-4f88-ab0c-3a2ae21ee2b6_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares outstanding - basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_2a67ca4e-a616-4590-8533-5e22fc0e927b_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_4824b415-d37a-43d8-8490-e44d9419ba2d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_0b23b659-61a1-45ec-a826-ba08cf96ffcc_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsLineItems" xlink:to="lab_us-gaap_OffsettingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_885bc4d9-77d2-4e73-8583-fa5d58ae1d10_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">(Loss) income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_cd1d4799-057c-4785-9323-61ea9bbd8d90_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_GovernmentAgenciesMember_5fa37d60-fcb5-465b-bff0-dd66b67d6f82_terseLabel_en-US" xlink:label="lab_prph_GovernmentAgenciesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government Agencies</link:label>
    <link:label id="lab_prph_GovernmentAgenciesMember_label_en-US" xlink:label="lab_prph_GovernmentAgenciesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Agencies [Member]</link:label>
    <link:label id="lab_prph_GovernmentAgenciesMember_documentation_en-US" xlink:label="lab_prph_GovernmentAgenciesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Government Agencies [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_GovernmentAgenciesMember" xlink:href="prph-20231231.xsd#prph_GovernmentAgenciesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_GovernmentAgenciesMember" xlink:to="lab_prph_GovernmentAgenciesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ManufacturingAgreementRenewalPeriod_3fb02e06-8bd5-4469-9a44-6cc83f154986_terseLabel_en-US" xlink:label="lab_prph_ManufacturingAgreementRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Agreement term, successive periods (in years)</link:label>
    <link:label id="lab_prph_ManufacturingAgreementRenewalPeriod_label_en-US" xlink:label="lab_prph_ManufacturingAgreementRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Manufacturing Agreement, Renewal Period</link:label>
    <link:label id="lab_prph_ManufacturingAgreementRenewalPeriod_documentation_en-US" xlink:label="lab_prph_ManufacturingAgreementRenewalPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Manufacturing Agreement, Renewal Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ManufacturingAgreementRenewalPeriod" xlink:href="prph-20231231.xsd#prph_ManufacturingAgreementRenewalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ManufacturingAgreementRenewalPeriod" xlink:to="lab_prph_ManufacturingAgreementRenewalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidRent_67970a9b-91e5-4ba5-9b2c-155ba3c29961_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rent total</link:label>
    <link:label id="lab_us-gaap_PrepaidRent_label_en-US" xlink:label="lab_us-gaap_PrepaidRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidRent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidRent" xlink:to="lab_us-gaap_PrepaidRent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_d7ce4598-9b69-4de9-88d6-525d3a11d297_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductInformationLineItems_34b76e8d-f995-4e29-b8d8-5e07a1f2c5d6_terseLabel_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductInformationLineItems_label_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_ShareBasedCompensationAwardTrancheFourMember_74b28ba7-e463-4039-a894-9ae75cdaded3_terseLabel_en-US" xlink:label="lab_prph_ShareBasedCompensationAwardTrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fourth Installment</link:label>
    <link:label id="lab_prph_ShareBasedCompensationAwardTrancheFourMember_label_en-US" xlink:label="lab_prph_ShareBasedCompensationAwardTrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Award Tranche Four [Member]</link:label>
    <link:label id="lab_prph_ShareBasedCompensationAwardTrancheFourMember_documentation_en-US" xlink:label="lab_prph_ShareBasedCompensationAwardTrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share based compensation award tranche four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationAwardTrancheFourMember" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationAwardTrancheFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_ShareBasedCompensationAwardTrancheFourMember" xlink:to="lab_prph_ShareBasedCompensationAwardTrancheFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff_3dc5821a-4c53-442b-984e-f179504d471a_terseLabel_en-US" xlink:label="lab_prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability payoff amount</link:label>
    <link:label id="lab_prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff_label_en-US" xlink:label="lab_prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Liability Payoff</link:label>
    <link:label id="lab_prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff_documentation_en-US" xlink:label="lab_prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Liability Payoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff" xlink:href="prph-20231231.xsd#prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff" xlink:to="lab_prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_7d7a94df-7bae-4c8c-918e-a38d19aacb64_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_badb35ba-63b4-408b-959e-bf905b4b462a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_60d6c7a2-f4a3-41c9-b711-0c02c2dfe99b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock for debt conversion</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_05cd241b-5499-4bff-9c8e-2fe05fd42350_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0eef40e0-a78c-42be-84ba-65c017b8fa32_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_c8457ab0-774e-4556-973d-d91cd47bfd25_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for doubtful accounts period increase</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_32802f55-d84e-42ec-8908-f3bb3579fe5d_verboseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current period provision for expected credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_41c1f13d-4d70-4f0f-a31c-d5ea2c1869d6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Remaining Contractual Life (in years) and Total Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_1031f848-85d1-4bc6-87b9-662ebd2a52fb_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_prph_BlackScholesOptionPricingModelMember_b3e05a47-e725-4a7e-9b2a-cf6d0eadd33b_terseLabel_en-US" xlink:label="lab_prph_BlackScholesOptionPricingModelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Black-Scholes Option Pricing Model</link:label>
    <link:label id="lab_prph_BlackScholesOptionPricingModelMember_label_en-US" xlink:label="lab_prph_BlackScholesOptionPricingModelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Black-Scholes Option Pricing Model [Member]</link:label>
    <link:label id="lab_prph_BlackScholesOptionPricingModelMember_documentation_en-US" xlink:label="lab_prph_BlackScholesOptionPricingModelMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Black-Scholes Option Pricing Model</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_prph_BlackScholesOptionPricingModelMember" xlink:href="prph-20231231.xsd#prph_BlackScholesOptionPricingModelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_prph_BlackScholesOptionPricingModelMember" xlink:to="lab_prph_BlackScholesOptionPricingModelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefFinancialOfficerMember_9a7ff523-d0fd-46c1-843f-8e6db41dd2a6_terseLabel_en-US" xlink:label="lab_srt_ChiefFinancialOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Chief Financial Officer</link:label>
    <link:label id="lab_srt_ChiefFinancialOfficerMember_label_en-US" xlink:label="lab_srt_ChiefFinancialOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Chief Financial Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefFinancialOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefFinancialOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefFinancialOfficerMember" xlink:to="lab_srt_ChiefFinancialOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_5ca48c88-5f88-413b-b663-baa0cf3634b1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">First Installment</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>19
<FILENAME>prph-20231231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:7788277e-a48e-4763-84b1-a7c7849f902f,g:9ac615ab-2322-4dd1-8a91-31a5eca0bd4d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://prophaselabs.com/role/Cover" xlink:type="simple" xlink:href="prph-20231231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_78426135-c27f-4016-b4b1-2c22485565b7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_DocumentType_78426135-c27f-4016-b4b1-2c22485565b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_7f220d49-bd1e-4da1-9592-9e7e99ef18b2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_DocumentAnnualReport_7f220d49-bd1e-4da1-9592-9e7e99ef18b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_154788cd-cde8-4401-b935-fe104e1ee5b6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_DocumentPeriodEndDate_154788cd-cde8-4401-b935-fe104e1ee5b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_be4a00fa-c281-4de3-91db-790a53f2c3cd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_CurrentFiscalYearEndDate_be4a00fa-c281-4de3-91db-790a53f2c3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_5fdbe617-83d8-4253-9565-ca3a70782a88" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_DocumentTransitionReport_5fdbe617-83d8-4253-9565-ca3a70782a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_698de83b-c9a1-4a56-ab5c-ff50289695c3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntityFileNumber_698de83b-c9a1-4a56-ab5c-ff50289695c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_258613c4-1df9-4117-befb-91b3e418eadf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntityRegistrantName_258613c4-1df9-4117-befb-91b3e418eadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8d8d8594-7b02-4175-b9f2-4be2d36b174e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8d8d8594-7b02-4175-b9f2-4be2d36b174e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_f480a89c-a889-4673-aa5e-45c971f25947" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntityTaxIdentificationNumber_f480a89c-a889-4673-aa5e-45c971f25947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_86a28945-06eb-4ba4-bae8-f34bc4f48ca5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntityAddressAddressLine1_86a28945-06eb-4ba4-bae8-f34bc4f48ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_fcb66a32-066c-404d-9e02-0cf218cf48fc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntityAddressAddressLine2_fcb66a32-066c-404d-9e02-0cf218cf48fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2b8e73c8-c469-443c-a8ae-a1b16a9b9efc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntityAddressCityOrTown_2b8e73c8-c469-443c-a8ae-a1b16a9b9efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_4c20d8d0-50ef-408c-89ee-c99729fa3b24" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntityAddressStateOrProvince_4c20d8d0-50ef-408c-89ee-c99729fa3b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_38140d07-d6f3-4950-9836-f0e8015b0f37" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntityAddressPostalZipCode_38140d07-d6f3-4950-9836-f0e8015b0f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_468427e2-1c15-44cb-bb5f-bd5aafddf1ee" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_CityAreaCode_468427e2-1c15-44cb-bb5f-bd5aafddf1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_c9af882b-5a0a-4f3d-8c1d-feaa1a5b2e83" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_LocalPhoneNumber_c9af882b-5a0a-4f3d-8c1d-feaa1a5b2e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_493a34d1-de6a-484d-970f-0a6f51ded4ef" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_Security12bTitle_493a34d1-de6a-484d-970f-0a6f51ded4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_4e977987-9aec-495f-a96e-a2736bae6953" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_TradingSymbol_4e977987-9aec-495f-a96e-a2736bae6953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_600f4323-30bc-45f4-9a14-7ff3b07ed69a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_SecurityExchangeName_600f4323-30bc-45f4-9a14-7ff3b07ed69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_d53d672d-e9eb-49ed-8577-9019d8f9b201" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_d53d672d-e9eb-49ed-8577-9019d8f9b201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_26da48f8-069b-4a7b-a419-e822fb714b1b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntityVoluntaryFilers_26da48f8-069b-4a7b-a419-e822fb714b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_33d6c454-2ea1-4b30-b04d-d1d326d9746e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntityCurrentReportingStatus_33d6c454-2ea1-4b30-b04d-d1d326d9746e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_3a716e17-e359-4c35-8cac-e5a1f048b903" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntityInteractiveDataCurrent_3a716e17-e359-4c35-8cac-e5a1f048b903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_e755f956-ffc0-498c-ae0c-dee6bf83a9ba" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntityFilerCategory_e755f956-ffc0-498c-ae0c-dee6bf83a9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_a0f038ca-277a-4280-9f7b-c3481046132f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntitySmallBusiness_a0f038ca-277a-4280-9f7b-c3481046132f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_0adfc263-6bd1-4b46-aa4f-2899c7d53ac4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntityEmergingGrowthCompany_0adfc263-6bd1-4b46-aa4f-2899c7d53ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_30dae6d5-8a58-4504-af91-dfa2c1a2d7d6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_IcfrAuditorAttestationFlag_30dae6d5-8a58-4504-af91-dfa2c1a2d7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_8240a322-c22a-4f0f-887e-6451fa0128b0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_8240a322-c22a-4f0f-887e-6451fa0128b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_3947974e-27e5-472d-9191-ba8165bc5972" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntityShellCompany_3947974e-27e5-472d-9191-ba8165bc5972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_a44ad10b-67cf-45f2-98e5-4393fe8794b8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntityPublicFloat_a44ad10b-67cf-45f2-98e5-4393fe8794b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_6c8b2224-0104-4bf4-9ed0-2cf327b59c01" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_6c8b2224-0104-4bf4-9ed0-2cf327b59c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_20e381c7-086c-4e20-a5a3-946b746382e1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_20e381c7-086c-4e20-a5a3-946b746382e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_9e0ab86e-4af4-4c6c-b1e1-3651c3e9751c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_EntityCentralIndexKey_9e0ab86e-4af4-4c6c-b1e1-3651c3e9751c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_3cf2545f-0e26-4320-98a8-623c579453b8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_DocumentFiscalYearFocus_3cf2545f-0e26-4320-98a8-623c579453b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_d616293c-6ad3-43ae-a22f-adf2d803c890" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_DocumentFiscalPeriodFocus_d616293c-6ad3-43ae-a22f-adf2d803c890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_998e089c-c85b-4c34-80f3-080383d03b53" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_74121b41-9494-4ea3-822e-a9cb3d3e8617" xlink:to="loc_dei_AmendmentFlag_998e089c-c85b-4c34-80f3-080383d03b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/AuditInformation" xlink:type="simple" xlink:href="prph-20231231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_prph_AuditInformationAbstract_a1138edb-4c11-4388-a337-a40ecb681bc3" xlink:href="prph-20231231.xsd#prph_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_4b1f5b54-2c75-4e8b-96c3-761924d15d1a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prph_AuditInformationAbstract_a1138edb-4c11-4388-a337-a40ecb681bc3" xlink:to="loc_dei_AuditorName_4b1f5b54-2c75-4e8b-96c3-761924d15d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_6c4ee0a9-31b1-4a85-95b5-ea15f2263eea" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prph_AuditInformationAbstract_a1138edb-4c11-4388-a337-a40ecb681bc3" xlink:to="loc_dei_AuditorFirmId_6c4ee0a9-31b1-4a85-95b5-ea15f2263eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_38f2a27b-c191-418a-9794-2fd98ea1602d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prph_AuditInformationAbstract_a1138edb-4c11-4388-a337-a40ecb681bc3" xlink:to="loc_dei_AuditorLocation_38f2a27b-c191-418a-9794-2fd98ea1602d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="prph-20231231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c435a718-92e2-425d-946e-5c8995f4d953" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4b404e28-9cad-464f-a32c-2f3d67e50c75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c435a718-92e2-425d-946e-5c8995f4d953" xlink:to="loc_us-gaap_StatementTable_4b404e28-9cad-464f-a32c-2f3d67e50c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_88a23cc9-5506-4a84-b9ce-63c43c4d70c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4b404e28-9cad-464f-a32c-2f3d67e50c75" xlink:to="loc_us-gaap_DebtInstrumentAxis_88a23cc9-5506-4a84-b9ce-63c43c4d70c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a4c468e7-f39b-48ed-9499-dd439bc159e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_88a23cc9-5506-4a84-b9ce-63c43c4d70c1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a4c468e7-f39b-48ed-9499-dd439bc159e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2023NoteMember_c38d4d6e-a7d4-4754-8d16-ed4059d1d360" xlink:href="prph-20231231.xsd#prph_A2023NoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a4c468e7-f39b-48ed-9499-dd439bc159e5" xlink:to="loc_prph_A2023NoteMember_c38d4d6e-a7d4-4754-8d16-ed4059d1d360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_SeptemberTwoThousandAndTwentyNoteMember_2726a95f-2f7f-4644-b9e4-43e7c0d2fc88" xlink:href="prph-20231231.xsd#prph_SeptemberTwoThousandAndTwentyNoteMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a4c468e7-f39b-48ed-9499-dd439bc159e5" xlink:to="loc_prph_SeptemberTwoThousandAndTwentyNoteMember_2726a95f-2f7f-4644-b9e4-43e7c0d2fc88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ed3132b4-5194-4109-8b08-9046e6a87b37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4b404e28-9cad-464f-a32c-2f3d67e50c75" xlink:to="loc_us-gaap_StatementLineItems_ed3132b4-5194-4109-8b08-9046e6a87b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ed3132b4-5194-4109-8b08-9046e6a87b37" xlink:to="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_669e3a0a-14ba-43e5-8062-c22ff35225b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:to="loc_us-gaap_AssetsCurrentAbstract_669e3a0a-14ba-43e5-8062-c22ff35225b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e1897e89-9990-42a0-89dc-f5e5caa7517d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_669e3a0a-14ba-43e5-8062-c22ff35225b6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e1897e89-9990-42a0-89dc-f5e5caa7517d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_c54d4320-ed8b-4659-bffc-27ed6ecd9086" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_669e3a0a-14ba-43e5-8062-c22ff35225b6" xlink:to="loc_us-gaap_RestrictedCash_c54d4320-ed8b-4659-bffc-27ed6ecd9086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_e2d7c579-7a0e-4b31-97ce-5560ee813b85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_669e3a0a-14ba-43e5-8062-c22ff35225b6" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_e2d7c579-7a0e-4b31-97ce-5560ee813b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_673611af-5d6e-4fa1-92e6-9b36a854f7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_669e3a0a-14ba-43e5-8062-c22ff35225b6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_673611af-5d6e-4fa1-92e6-9b36a854f7f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_47c3f4b6-324f-4cc4-968f-c1f253bdd2be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_669e3a0a-14ba-43e5-8062-c22ff35225b6" xlink:to="loc_us-gaap_InventoryNet_47c3f4b6-324f-4cc4-968f-c1f253bdd2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d49668cf-fb4e-491f-a546-563dca6870b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_669e3a0a-14ba-43e5-8062-c22ff35225b6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d49668cf-fb4e-491f-a546-563dca6870b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2cd89b2c-9342-456e-8db3-cf6e3d62ce3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_669e3a0a-14ba-43e5-8062-c22ff35225b6" xlink:to="loc_us-gaap_AssetsCurrent_2cd89b2c-9342-456e-8db3-cf6e3d62ce3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a244feb1-2201-4396-ace6-cee657370b06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a244feb1-2201-4396-ace6-cee657370b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent_bc0f6d3d-79f4-41e7-ae47-dc924a41073d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:to="loc_us-gaap_PrepaidExpenseNoncurrent_bc0f6d3d-79f4-41e7-ae47-dc924a41073d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ee92831e-5a51-4aae-b558-f77bd4d3a989" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ee92831e-5a51-4aae-b558-f77bd4d3a989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cf1d1911-803b-4137-a1e8-f87e9eeaf913" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cf1d1911-803b-4137-a1e8-f87e9eeaf913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cf3ac7bf-a87c-4bd6-a771-fcbe209cd7df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:to="loc_us-gaap_Goodwill_cf3ac7bf-a87c-4bd6-a771-fcbe209cd7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_8358ec2e-662e-4d00-a606-793d3e52a782" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_8358ec2e-662e-4d00-a606-793d3e52a782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_640a30d3-afe2-4059-80f3-45b7d70372bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_640a30d3-afe2-4059-80f3-45b7d70372bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c88285a5-96da-4632-ad09-086d2e043bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_25348349-1c8f-4784-9c1d-92a535ab20dc" xlink:to="loc_us-gaap_Assets_c88285a5-96da-4632-ad09-086d2e043bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3d18abf4-a052-43ab-8cd7-f55833011d36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ed3132b4-5194-4109-8b08-9046e6a87b37" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3d18abf4-a052-43ab-8cd7-f55833011d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3d18abf4-a052-43ab-8cd7-f55833011d36" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_ce6e004c-baab-427b-9452-cd226e138fca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:to="loc_us-gaap_AccountsPayableCurrent_ce6e004c-baab-427b-9452-cd226e138fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_f73742f7-e65a-4e91-95e2-add06aa22b82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_f73742f7-e65a-4e91-95e2-add06aa22b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_0ac6212a-845e-4bee-b893-9b42cc72808f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_0ac6212a-845e-4bee-b893-9b42cc72808f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_866fa658-490a-46f7-afc0-ff6abf7f85c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_866fa658-490a-46f7-afc0-ff6abf7f85c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e12ca579-5d98-44f8-bc17-c10c7dfb2507" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e12ca579-5d98-44f8-bc17-c10c7dfb2507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_87911f1a-d1fb-49ed-ade8-f19c3a533e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:to="loc_us-gaap_DeferredRevenueCurrent_87911f1a-d1fb-49ed-ade8-f19c3a533e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_31d360d1-1f9b-4c81-a9bf-0a320146041b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:to="loc_us-gaap_TaxesPayableCurrent_31d360d1-1f9b-4c81-a9bf-0a320146041b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_f7ef6680-ee13-48ed-99f2-901df8efdee3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_f7ef6680-ee13-48ed-99f2-901df8efdee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8c7af506-25fe-4d1a-84c7-e392c537c9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ab0f7f0d-0ca6-46d7-a908-58bda43d6703" xlink:to="loc_us-gaap_LiabilitiesCurrent_8c7af506-25fe-4d1a-84c7-e392c537c9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3d18abf4-a052-43ab-8cd7-f55833011d36" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_7dbd1276-4963-451a-966a-31df631a3f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_7dbd1276-4963-451a-966a-31df631a3f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredLongTermDebt_be0c084f-4363-4e86-8b1c-f30da578ee30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:to="loc_us-gaap_UnsecuredLongTermDebt_be0c084f-4363-4e86-8b1c-f30da578ee30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent_50c25302-0f20-424e-a99c-17c01ba1eba1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:to="loc_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent_50c25302-0f20-424e-a99c-17c01ba1eba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ec8aa7e7-7375-4cbe-a5ac-08cfb03e8ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ec8aa7e7-7375-4cbe-a5ac-08cfb03e8ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_99fe0d68-9a41-4aa4-808b-102e5a08a6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_99fe0d68-9a41-4aa4-808b-102e5a08a6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_77a39aa7-7907-46cb-baa1-a3ceafbf1c65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_77a39aa7-7907-46cb-baa1-a3ceafbf1c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_df1920e8-b13b-40fd-8bf1-b6b92ca89f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_df1920e8-b13b-40fd-8bf1-b6b92ca89f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_20d32826-4c80-4007-b52d-ad67c3d4904c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e3b5b977-c0fb-45f5-82d2-db2a32cc608b" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_20d32826-4c80-4007-b52d-ad67c3d4904c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d084c931-b07f-461f-9f4c-3d38c5a26c08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3d18abf4-a052-43ab-8cd7-f55833011d36" xlink:to="loc_us-gaap_Liabilities_d084c931-b07f-461f-9f4c-3d38c5a26c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8ff35786-7f2e-4544-bd44-b03c408641b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3d18abf4-a052-43ab-8cd7-f55833011d36" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_8ff35786-7f2e-4544-bd44-b03c408641b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_0112e1a2-9cf2-4190-81da-f4fea3f6e994" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ed3132b4-5194-4109-8b08-9046e6a87b37" xlink:to="loc_us-gaap_CommitmentsAndContingencies_0112e1a2-9cf2-4190-81da-f4fea3f6e994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_b8ceafb9-0b04-4f3f-8357-86a92105fe3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ed3132b4-5194-4109-8b08-9046e6a87b37" xlink:to="loc_us-gaap_StockholdersEquityAbstract_b8ceafb9-0b04-4f3f-8357-86a92105fe3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_07c46871-1e4d-46a5-aa5d-412baf510802" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b8ceafb9-0b04-4f3f-8357-86a92105fe3d" xlink:to="loc_us-gaap_PreferredStockValue_07c46871-1e4d-46a5-aa5d-412baf510802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f7c24e2a-486d-4a6f-9249-72ed42050358" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b8ceafb9-0b04-4f3f-8357-86a92105fe3d" xlink:to="loc_us-gaap_CommonStockValue_f7c24e2a-486d-4a6f-9249-72ed42050358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_ee0fdc73-048f-4c74-bad4-d3b4abd36ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b8ceafb9-0b04-4f3f-8357-86a92105fe3d" xlink:to="loc_us-gaap_AdditionalPaidInCapital_ee0fdc73-048f-4c74-bad4-d3b4abd36ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0890acc1-3d29-47ef-8622-fb29b7562a14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b8ceafb9-0b04-4f3f-8357-86a92105fe3d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0890acc1-3d29-47ef-8622-fb29b7562a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_58d14c62-48d3-4163-8b5f-3c3a468c2b21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b8ceafb9-0b04-4f3f-8357-86a92105fe3d" xlink:to="loc_us-gaap_TreasuryStockCommonValue_58d14c62-48d3-4163-8b5f-3c3a468c2b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_989102a4-0277-4065-81a4-fd60fd0682b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b8ceafb9-0b04-4f3f-8357-86a92105fe3d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_989102a4-0277-4065-81a4-fd60fd0682b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_079493cb-d3b2-4469-984a-1542c06e4b14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b8ceafb9-0b04-4f3f-8357-86a92105fe3d" xlink:to="loc_us-gaap_StockholdersEquity_079493cb-d3b2-4469-984a-1542c06e4b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="prph-20231231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e44bc433-85cf-4444-8288-7717e4b48487" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9c2b0c70-fdb4-433d-97df-731977db3ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e44bc433-85cf-4444-8288-7717e4b48487" xlink:to="loc_us-gaap_StatementTable_9c2b0c70-fdb4-433d-97df-731977db3ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b8804ebb-6ee5-48a4-9715-eb5eed910735" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9c2b0c70-fdb4-433d-97df-731977db3ff3" xlink:to="loc_us-gaap_DebtInstrumentAxis_b8804ebb-6ee5-48a4-9715-eb5eed910735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_615884a1-b33c-4aec-a612-c89c32d90ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b8804ebb-6ee5-48a4-9715-eb5eed910735" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_615884a1-b33c-4aec-a612-c89c32d90ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2023NoteMember_81e4672f-28cf-4670-a12b-ad61d0c8365f" xlink:href="prph-20231231.xsd#prph_A2023NoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_615884a1-b33c-4aec-a612-c89c32d90ea5" xlink:to="loc_prph_A2023NoteMember_81e4672f-28cf-4670-a12b-ad61d0c8365f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9c2b0c70-fdb4-433d-97df-731977db3ff3" xlink:to="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_674bea13-d861-4eb2-95ca-cfbcd917c32b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_674bea13-d861-4eb2-95ca-cfbcd917c32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_2912e3f9-f450-4e7e-b333-e146a9b19006" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_2912e3f9-f450-4e7e-b333-e146a9b19006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1503e5ee-0acc-49d3-a5f2-e06277466c37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1503e5ee-0acc-49d3-a5f2-e06277466c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_9ab997ae-e4a9-4fff-9456-e51dab88d884" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:to="loc_us-gaap_PreferredStockSharesIssued_9ab997ae-e4a9-4fff-9456-e51dab88d884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_9aa4add2-62cc-46d2-b445-f0a37ad75849" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_9aa4add2-62cc-46d2-b445-f0a37ad75849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_9b8e0f96-6b43-4c40-a0bc-adb84b1aa826" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_9b8e0f96-6b43-4c40-a0bc-adb84b1aa826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_50445d6a-9edf-442f-9e32-3a9dafb767ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_50445d6a-9edf-442f-9e32-3a9dafb767ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1c51ef4b-9338-4baf-8fa5-daf98540a17e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1c51ef4b-9338-4baf-8fa5-daf98540a17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_6b55ae8b-255f-4b2a-ac06-ce70f5956e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_27717821-b6d4-4e2f-9628-a2c613205737" xlink:to="loc_us-gaap_TreasuryStockCommonShares_6b55ae8b-255f-4b2a-ac06-ce70f5956e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome" xlink:type="simple" xlink:href="prph-20231231.xsd#ConsolidatedStatementsofOperationsandOtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_6b1f593e-9a8b-494a-9821-d9406f3d211c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e98f4777-a39a-4a8d-968b-f3998cfcedac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6b1f593e-9a8b-494a-9821-d9406f3d211c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e98f4777-a39a-4a8d-968b-f3998cfcedac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_305aa486-3d49-42fb-8e7b-11b60f1f55bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6b1f593e-9a8b-494a-9821-d9406f3d211c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_305aa486-3d49-42fb-8e7b-11b60f1f55bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f6ae6721-280b-4028-97db-6d5f28d508f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6b1f593e-9a8b-494a-9821-d9406f3d211c" xlink:to="loc_us-gaap_GrossProfit_f6ae6721-280b-4028-97db-6d5f28d508f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_5c7b61c7-6490-48dc-bb80-708db6e4be3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6b1f593e-9a8b-494a-9821-d9406f3d211c" xlink:to="loc_us-gaap_OperatingExpensesAbstract_5c7b61c7-6490-48dc-bb80-708db6e4be3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_ced5990c-7a78-4b09-b553-98a10bb8dba5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5c7b61c7-6490-48dc-bb80-708db6e4be3f" xlink:to="loc_us-gaap_ProfessionalFees_ced5990c-7a78-4b09-b553-98a10bb8dba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_ce3b8651-7fad-4ac3-989a-df8f06c66e30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5c7b61c7-6490-48dc-bb80-708db6e4be3f" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_ce3b8651-7fad-4ac3-989a-df8f06c66e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_83980cc8-8744-4e4f-847f-27a05840a962" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5c7b61c7-6490-48dc-bb80-708db6e4be3f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_83980cc8-8744-4e4f-847f-27a05840a962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7bbda816-f49d-4793-a03f-77dc96224aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5c7b61c7-6490-48dc-bb80-708db6e4be3f" xlink:to="loc_us-gaap_OperatingExpenses_7bbda816-f49d-4793-a03f-77dc96224aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7f8c7ca7-47e3-460c-805c-909f221d1aab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6b1f593e-9a8b-494a-9821-d9406f3d211c" xlink:to="loc_us-gaap_OperatingIncomeLoss_7f8c7ca7-47e3-460c-805c-909f221d1aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_9cea5907-957c-4154-a040-25673deca9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6b1f593e-9a8b-494a-9821-d9406f3d211c" xlink:to="loc_us-gaap_InterestIncomeOther_9cea5907-957c-4154-a040-25673deca9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_388c207c-d1d0-48a8-b156-072d1f17c658" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6b1f593e-9a8b-494a-9821-d9406f3d211c" xlink:to="loc_us-gaap_InterestExpense_388c207c-d1d0-48a8-b156-072d1f17c658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_aef200a1-3bca-42da-8ef1-0b8595bdeb70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6b1f593e-9a8b-494a-9821-d9406f3d211c" xlink:to="loc_us-gaap_GainLossOnInvestments_aef200a1-3bca-42da-8ef1-0b8595bdeb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8159870d-022f-426f-9f58-8c3fb95ba91b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6b1f593e-9a8b-494a-9821-d9406f3d211c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8159870d-022f-426f-9f58-8c3fb95ba91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5384a178-e59e-4bde-b439-5495cd2476f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6b1f593e-9a8b-494a-9821-d9406f3d211c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5384a178-e59e-4bde-b439-5495cd2476f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_642ec32b-69c9-415a-aa83-e1c2933ee2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6b1f593e-9a8b-494a-9821-d9406f3d211c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_642ec32b-69c9-415a-aa83-e1c2933ee2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_51255996-a772-42dc-ad7f-5afae1965949" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6b1f593e-9a8b-494a-9821-d9406f3d211c" xlink:to="loc_us-gaap_NetIncomeLoss_51255996-a772-42dc-ad7f-5afae1965949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTaxAbstract_4d62de48-3f47-4489-b2f8-e1a53366fef7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTaxAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6b1f593e-9a8b-494a-9821-d9406f3d211c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTaxAbstract_4d62de48-3f47-4489-b2f8-e1a53366fef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_591a1e9c-665c-4a3f-a8bf-dae1bdf22b63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTaxAbstract_4d62de48-3f47-4489-b2f8-e1a53366fef7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_591a1e9c-665c-4a3f-a8bf-dae1bdf22b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_fb23c0a1-0e35-4c4d-99c8-58e9ff22a1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6b1f593e-9a8b-494a-9821-d9406f3d211c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_fb23c0a1-0e35-4c4d-99c8-58e9ff22a1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_79e1aab7-c5c3-4d57-9658-fa080a4645d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6b1f593e-9a8b-494a-9821-d9406f3d211c" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_79e1aab7-c5c3-4d57-9658-fa080a4645d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a47f68c6-2c4a-4942-b808-5e35ee0d4fea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_79e1aab7-c5c3-4d57-9658-fa080a4645d6" xlink:to="loc_us-gaap_EarningsPerShareBasic_a47f68c6-2c4a-4942-b808-5e35ee0d4fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d1380b46-a597-40e1-b559-775ea34b873a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_79e1aab7-c5c3-4d57-9658-fa080a4645d6" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d1380b46-a597-40e1-b559-775ea34b873a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a49a23b2-ef2f-458d-91f5-eeced04cc067" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6b1f593e-9a8b-494a-9821-d9406f3d211c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a49a23b2-ef2f-458d-91f5-eeced04cc067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_83a813cb-d76d-42a0-ba12-a30e049aef05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a49a23b2-ef2f-458d-91f5-eeced04cc067" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_83a813cb-d76d-42a0-ba12-a30e049aef05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2f221de5-28c1-4810-8d47-2e164ea64b26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a49a23b2-ef2f-458d-91f5-eeced04cc067" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2f221de5-28c1-4810-8d47-2e164ea64b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="prph-20231231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_36e5fc96-a2cf-4b0f-956e-ea90bdcb6644" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a426b96d-568d-4a65-ad7f-fe48e611d3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_36e5fc96-a2cf-4b0f-956e-ea90bdcb6644" xlink:to="loc_us-gaap_StatementTable_a426b96d-568d-4a65-ad7f-fe48e611d3a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e0116a88-4b5f-4f87-98f1-35d55bf191a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a426b96d-568d-4a65-ad7f-fe48e611d3a2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e0116a88-4b5f-4f87-98f1-35d55bf191a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_806e505a-cb84-4bd9-b467-325d261deff7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e0116a88-4b5f-4f87-98f1-35d55bf191a1" xlink:to="loc_us-gaap_EquityComponentDomain_806e505a-cb84-4bd9-b467-325d261deff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8353e436-b4b6-4717-877f-57a4041066ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_806e505a-cb84-4bd9-b467-325d261deff7" xlink:to="loc_us-gaap_CommonStockMember_8353e436-b4b6-4717-877f-57a4041066ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_08f18f4b-e893-4a6e-b95c-5589c9ad2eff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_806e505a-cb84-4bd9-b467-325d261deff7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_08f18f4b-e893-4a6e-b95c-5589c9ad2eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_36702055-fa1b-4327-b954-08aed233aa35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_806e505a-cb84-4bd9-b467-325d261deff7" xlink:to="loc_us-gaap_RetainedEarningsMember_36702055-fa1b-4327-b954-08aed233aa35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e7b0ca84-d01e-4058-bd50-4aaf5e56f201" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_806e505a-cb84-4bd9-b467-325d261deff7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e7b0ca84-d01e-4058-bd50-4aaf5e56f201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_546e3702-fcf8-49d3-82fe-6d6968e54888" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_806e505a-cb84-4bd9-b467-325d261deff7" xlink:to="loc_us-gaap_TreasuryStockCommonMember_546e3702-fcf8-49d3-82fe-6d6968e54888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_88293b5b-b51b-4e9f-82b1-3a97c6e1f599" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a426b96d-568d-4a65-ad7f-fe48e611d3a2" xlink:to="loc_us-gaap_StatementLineItems_88293b5b-b51b-4e9f-82b1-3a97c6e1f599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_88293b5b-b51b-4e9f-82b1-3a97c6e1f599" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_517b28ab-fbd6-4b6c-aca4-a4d845dcd337" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_517b28ab-fbd6-4b6c-aca4-a4d845dcd337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_45d1ce42-9821-40df-86d3-1e0517b0e716" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_StockholdersEquity_45d1ce42-9821-40df-86d3-1e0517b0e716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_5355bef7-ab24-453f-b94d-a4c93a989ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_5355bef7-ab24-453f-b94d-a4c93a989ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_578d8dbf-7d9b-434f-a3b3-7c43e8dbe1af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_578d8dbf-7d9b-434f-a3b3-7c43e8dbe1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_6d1c797f-7905-4c02-b5e3-05be00c8ff5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_6d1c797f-7905-4c02-b5e3-05be00c8ff5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_34f53882-4bce-4330-9894-43d58759650c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_34f53882-4bce-4330-9894-43d58759650c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_aa3d43d1-b20e-4653-8e8d-03ca317d44e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_aa3d43d1-b20e-4653-8e8d-03ca317d44e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_57302380-c2d2-4f8e-9a78-e9cb7a6ffbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_57302380-c2d2-4f8e-9a78-e9cb7a6ffbe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_f0e75b49-e440-4445-b9f6-1a5a06bf1ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_DividendsCommonStockCash_f0e75b49-e440-4445-b9f6-1a5a06bf1ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IssuanceOfCommonStockSharesExerciseOfWarrant_9802c44b-6820-4d00-ab68-561efde3acad" xlink:href="prph-20231231.xsd#prph_IssuanceOfCommonStockSharesExerciseOfWarrant"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_prph_IssuanceOfCommonStockSharesExerciseOfWarrant_9802c44b-6820-4d00-ab68-561efde3acad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount_e2adbe3f-0708-421c-8897-8bef3eea87ef" xlink:href="prph-20231231.xsd#prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount_e2adbe3f-0708-421c-8897-8bef3eea87ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f06738d0-44a3-4cf0-abaa-fb216dd21472" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f06738d0-44a3-4cf0-abaa-fb216dd21472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_f16e5bc1-f338-4173-a230-96cb53cecaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_f16e5bc1-f338-4173-a230-96cb53cecaf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_706771d1-7799-4b43-9459-1f780b3865f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_706771d1-7799-4b43-9459-1f780b3865f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_92c4ee4d-d09d-443b-aaa7-f87bdef65bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_92c4ee4d-d09d-443b-aaa7-f87bdef65bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7c609e9b-de28-40ac-86dc-e8775bbe695c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7c609e9b-de28-40ac-86dc-e8775bbe695c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a5116e0f-95f7-49b1-8aef-f5c2d58ed6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_NetIncomeLoss_a5116e0f-95f7-49b1-8aef-f5c2d58ed6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_40ab16e3-5bea-46f7-b7c6-71a5f7bca3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_40ab16e3-5bea-46f7-b7c6-71a5f7bca3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_81608d0c-f1e9-48f4-a061-23f2150c52cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7685651d-c131-405c-879f-ccfc12671af9" xlink:to="loc_us-gaap_StockholdersEquity_81608d0c-f1e9-48f4-a061-23f2150c52cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="prph-20231231.xsd#ConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_28047fc4-b7f9-4314-95d4-86b5fee9ecce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_PrepaidShareBasedCompensationExpense_0f40a310-ab6a-4dbb-8af2-bd6285300091" xlink:href="prph-20231231.xsd#prph_PrepaidShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_28047fc4-b7f9-4314-95d4-86b5fee9ecce" xlink:to="loc_prph_PrepaidShareBasedCompensationExpense_0f40a310-ab6a-4dbb-8af2-bd6285300091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="prph-20231231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_e964def6-5ade-4452-bf74-e57420df0076" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88016107-098f-4cea-8690-8a2711f0f872" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e964def6-5ade-4452-bf74-e57420df0076" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88016107-098f-4cea-8690-8a2711f0f872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0a93f306-61b8-421d-a44d-2bc89664c095" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88016107-098f-4cea-8690-8a2711f0f872" xlink:to="loc_us-gaap_NetIncomeLoss_0a93f306-61b8-421d-a44d-2bc89664c095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_400a57e5-570f-4194-80d1-a8592cd9656f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88016107-098f-4cea-8690-8a2711f0f872" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_400a57e5-570f-4194-80d1-a8592cd9656f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_43149370-8951-40fc-bd86-4292b8b9d0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_400a57e5-570f-4194-80d1-a8592cd9656f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_43149370-8951-40fc-bd86-4292b8b9d0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f08708ee-478d-442e-a56f-6b9c3f312725" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_400a57e5-570f-4194-80d1-a8592cd9656f" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f08708ee-478d-442e-a56f-6b9c3f312725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_2e8fcbce-19d4-49c9-b166-c7045993b79e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_400a57e5-570f-4194-80d1-a8592cd9656f" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_2e8fcbce-19d4-49c9-b166-c7045993b79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_70641733-1e78-43ce-b18e-e4665a8b2dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_400a57e5-570f-4194-80d1-a8592cd9656f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_70641733-1e78-43ce-b18e-e4665a8b2dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfProperties_d4ac4d6f-26a2-4ca6-84cf-f8ab033b8ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSaleOfProperties"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_400a57e5-570f-4194-80d1-a8592cd9656f" xlink:to="loc_us-gaap_GainLossOnSaleOfProperties_d4ac4d6f-26a2-4ca6-84cf-f8ab033b8ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b484b716-9dbe-4a1d-8087-4a155329f118" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_400a57e5-570f-4194-80d1-a8592cd9656f" xlink:to="loc_us-gaap_ShareBasedCompensation_b484b716-9dbe-4a1d-8087-4a155329f118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ChangeInFairValueOfInvestmentSecurities_998b366a-56d2-4fd9-a3e9-81951c3c5342" xlink:href="prph-20231231.xsd#prph_ChangeInFairValueOfInvestmentSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_400a57e5-570f-4194-80d1-a8592cd9656f" xlink:to="loc_prph_ChangeInFairValueOfInvestmentSecurities_998b366a-56d2-4fd9-a3e9-81951c3c5342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_eb4462ed-ec43-4213-85b5-855e45da9b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_400a57e5-570f-4194-80d1-a8592cd9656f" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_eb4462ed-ec43-4213-85b5-855e45da9b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_InventoryValuationReserve_dd83134f-4615-46cc-8d7e-b7b1af336519" xlink:href="prph-20231231.xsd#prph_InventoryValuationReserve"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_400a57e5-570f-4194-80d1-a8592cd9656f" xlink:to="loc_prph_InventoryValuationReserve_dd83134f-4615-46cc-8d7e-b7b1af336519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_69e65172-b54d-4d9a-b658-edb5a7c7c127" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForLoanLeaseAndOtherLosses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_400a57e5-570f-4194-80d1-a8592cd9656f" xlink:to="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_69e65172-b54d-4d9a-b658-edb5a7c7c127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f197c1d-0310-40d7-b9bc-e8d13b0ba73d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_400a57e5-570f-4194-80d1-a8592cd9656f" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f197c1d-0310-40d7-b9bc-e8d13b0ba73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1ef0048a-ee10-4922-94b7-7afd3e1bec44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f197c1d-0310-40d7-b9bc-e8d13b0ba73d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1ef0048a-ee10-4922-94b7-7afd3e1bec44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_ca844e69-af73-489c-be0e-9f6a522b72fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f197c1d-0310-40d7-b9bc-e8d13b0ba73d" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_ca844e69-af73-489c-be0e-9f6a522b72fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_02f23fdf-7574-4d4e-b897-5fb0d99142c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f197c1d-0310-40d7-b9bc-e8d13b0ba73d" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_02f23fdf-7574-4d4e-b897-5fb0d99142c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IncreaseDecreaseInDeferredIncomeTaxAssets_c9dc6750-ef2f-45f5-a032-87e2a2f2c869" xlink:href="prph-20231231.xsd#prph_IncreaseDecreaseInDeferredIncomeTaxAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f197c1d-0310-40d7-b9bc-e8d13b0ba73d" xlink:to="loc_prph_IncreaseDecreaseInDeferredIncomeTaxAssets_c9dc6750-ef2f-45f5-a032-87e2a2f2c869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_ce618aa0-30bd-4df7-8253-a88ae0deff31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f197c1d-0310-40d7-b9bc-e8d13b0ba73d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_ce618aa0-30bd-4df7-8253-a88ae0deff31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2f857673-6c96-47c2-ac28-d1f40580f544" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f197c1d-0310-40d7-b9bc-e8d13b0ba73d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2f857673-6c96-47c2-ac28-d1f40580f544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IncreaseDecreaseInAccruedDiagnosticServices_6881ebb6-ec34-4c77-8430-e5c1eea445a1" xlink:href="prph-20231231.xsd#prph_IncreaseDecreaseInAccruedDiagnosticServices"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f197c1d-0310-40d7-b9bc-e8d13b0ba73d" xlink:to="loc_prph_IncreaseDecreaseInAccruedDiagnosticServices_6881ebb6-ec34-4c77-8430-e5c1eea445a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances_c0ac6171-4dbd-42ef-9fb7-888a42908fee" xlink:href="prph-20231231.xsd#prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f197c1d-0310-40d7-b9bc-e8d13b0ba73d" xlink:to="loc_prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances_c0ac6171-4dbd-42ef-9fb7-888a42908fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_fb475b06-ea93-4ac1-a49e-c07f2f25a8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f197c1d-0310-40d7-b9bc-e8d13b0ba73d" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_fb475b06-ea93-4ac1-a49e-c07f2f25a8b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities_942fe24e-a9b0-43c2-a4c1-c4df48873c99" xlink:href="prph-20231231.xsd#prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f197c1d-0310-40d7-b9bc-e8d13b0ba73d" xlink:to="loc_prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities_942fe24e-a9b0-43c2-a4c1-c4df48873c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_3af3aaf5-75ad-4d0a-b2b2-5fc01a831513" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f197c1d-0310-40d7-b9bc-e8d13b0ba73d" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_3af3aaf5-75ad-4d0a-b2b2-5fc01a831513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_b2e1ee02-dcec-4f64-87bd-e6b368b77710" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f197c1d-0310-40d7-b9bc-e8d13b0ba73d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_b2e1ee02-dcec-4f64-87bd-e6b368b77710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_8729a9ac-afef-488b-b869-8f3b502882e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f197c1d-0310-40d7-b9bc-e8d13b0ba73d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_8729a9ac-afef-488b-b869-8f3b502882e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05d56903-2c40-4dcc-8336-5ffd69a91475" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88016107-098f-4cea-8690-8a2711f0f872" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_05d56903-2c40-4dcc-8336-5ffd69a91475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2e7317d9-c73f-4919-8170-903eedb8087a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e964def6-5ade-4452-bf74-e57420df0076" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2e7317d9-c73f-4919-8170-903eedb8087a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDepositsRelatedToPropertySales_5594b5ab-1979-40b5-b84d-3529face8a02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EscrowDepositsRelatedToPropertySales"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2e7317d9-c73f-4919-8170-903eedb8087a" xlink:to="loc_us-gaap_EscrowDepositsRelatedToPropertySales_5594b5ab-1979-40b5-b84d-3529face8a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8cd191a1-1b27-421f-83bd-f891851aea4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2e7317d9-c73f-4919-8170-903eedb8087a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8cd191a1-1b27-421f-83bd-f891851aea4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IssuanceOfSecuredPromissoryNoteReceivable_5ae9a4fc-495f-4d7f-a5f6-cc7cf950aff2" xlink:href="prph-20231231.xsd#prph_IssuanceOfSecuredPromissoryNoteReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2e7317d9-c73f-4919-8170-903eedb8087a" xlink:to="loc_prph_IssuanceOfSecuredPromissoryNoteReceivable_5ae9a4fc-495f-4d7f-a5f6-cc7cf950aff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_aedfa026-f637-446d-a93e-2871de238034" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2e7317d9-c73f-4919-8170-903eedb8087a" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_aedfa026-f637-446d-a93e-2871de238034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_bef5121c-3041-4ce6-beee-5980ecf01e50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2e7317d9-c73f-4919-8170-903eedb8087a" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_bef5121c-3041-4ce6-beee-5980ecf01e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_28e6dd05-d3ab-4150-bbf5-4cdd959f454b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2e7317d9-c73f-4919-8170-903eedb8087a" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_28e6dd05-d3ab-4150-bbf5-4cdd959f454b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment_e334fd54-aa25-421e-b5e6-f2a575132693" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2e7317d9-c73f-4919-8170-903eedb8087a" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment_e334fd54-aa25-421e-b5e6-f2a575132693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_449dbe05-27ea-48df-b293-cded3e4bb238" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2e7317d9-c73f-4919-8170-903eedb8087a" xlink:to="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_449dbe05-27ea-48df-b293-cded3e4bb238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_39fa8b0c-0380-4f5a-887c-a8e99b371ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2e7317d9-c73f-4919-8170-903eedb8087a" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_39fa8b0c-0380-4f5a-887c-a8e99b371ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_87b95ebc-2982-4e30-a2a9-149cf2c5a133" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2e7317d9-c73f-4919-8170-903eedb8087a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_87b95ebc-2982-4e30-a2a9-149cf2c5a133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4ef2c0b9-143f-441e-9d5a-09502893cd14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e964def6-5ade-4452-bf74-e57420df0076" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4ef2c0b9-143f-441e-9d5a-09502893cd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_abc86634-a541-4b71-880e-f958b01cd30c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4ef2c0b9-143f-441e-9d5a-09502893cd14" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_abc86634-a541-4b71-880e-f958b01cd30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_1439238c-4ed7-409f-8989-ade1e1465afa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4ef2c0b9-143f-441e-9d5a-09502893cd14" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_1439238c-4ed7-409f-8989-ade1e1465afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_baa2ec8d-9d08-497a-8b0d-a75151c08efe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4ef2c0b9-143f-441e-9d5a-09502893cd14" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_baa2ec8d-9d08-497a-8b0d-a75151c08efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_a18e3cd6-9f8e-465d-8763-face5128f7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4ef2c0b9-143f-441e-9d5a-09502893cd14" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_a18e3cd6-9f8e-465d-8763-face5128f7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_78d1c835-d18a-4ee4-9adc-723530a5d577" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4ef2c0b9-143f-441e-9d5a-09502893cd14" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_78d1c835-d18a-4ee4-9adc-723530a5d577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_2691ec79-e933-41a2-8ffd-f539250a4853" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4ef2c0b9-143f-441e-9d5a-09502893cd14" xlink:to="loc_us-gaap_PaymentsOfDividends_2691ec79-e933-41a2-8ffd-f539250a4853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a12413f3-4d05-453a-a526-66213ad1ac38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4ef2c0b9-143f-441e-9d5a-09502893cd14" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a12413f3-4d05-453a-a526-66213ad1ac38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_811a27fa-6cd6-4110-9392-0876de4025a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e964def6-5ade-4452-bf74-e57420df0076" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_811a27fa-6cd6-4110-9392-0876de4025a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e80a9573-53d9-4725-bbcf-aff6d64c652c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e964def6-5ade-4452-bf74-e57420df0076" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e80a9573-53d9-4725-bbcf-aff6d64c652c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2574c3fe-f597-47dd-b47a-440877482cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e964def6-5ade-4452-bf74-e57420df0076" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2574c3fe-f597-47dd-b47a-440877482cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_492b75cd-0691-4dba-9875-224e60761866" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e964def6-5ade-4452-bf74-e57420df0076" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_492b75cd-0691-4dba-9875-224e60761866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_58d06844-b363-41d4-89ae-103b17f98d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_492b75cd-0691-4dba-9875-224e60761866" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_58d06844-b363-41d4-89ae-103b17f98d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_cea02290-0fca-49cc-8407-8762d6abbe18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_492b75cd-0691-4dba-9875-224e60761866" xlink:to="loc_us-gaap_InterestPaidNet_cea02290-0fca-49cc-8407-8762d6abbe18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_57d117cb-68f0-42a3-83d3-bba08ef1530e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_e964def6-5ade-4452-bf74-e57420df0076" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_57d117cb-68f0-42a3-83d3-bba08ef1530e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_f2a197e6-5d87-41a3-a17c-ddfb93ca1f77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_57d117cb-68f0-42a3-83d3-bba08ef1530e" xlink:to="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_f2a197e6-5d87-41a3-a17c-ddfb93ca1f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IssuanceOfCommonSharesForDebtConversion_ef6f2f0a-f029-414e-8fb4-1bd0741a5754" xlink:href="prph-20231231.xsd#prph_IssuanceOfCommonSharesForDebtConversion"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_57d117cb-68f0-42a3-83d3-bba08ef1530e" xlink:to="loc_prph_IssuanceOfCommonSharesForDebtConversion_ef6f2f0a-f029-414e-8fb4-1bd0741a5754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities_6a2f1650-386a-42ec-b0b2-5df602c8c4c4" xlink:href="prph-20231231.xsd#prph_NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_57d117cb-68f0-42a3-83d3-bba08ef1530e" xlink:to="loc_prph_NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities_6a2f1650-386a-42ec-b0b2-5df602c8c4c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_514b118e-3fa1-412a-914e-22b3a342fedd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_57d117cb-68f0-42a3-83d3-bba08ef1530e" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_514b118e-3fa1-412a-914e-22b3a342fedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IssuanceOfWarrantsWithUnsecuredPromissoryNote_523eca70-7d44-42ac-b26e-6393e6b8be09" xlink:href="prph-20231231.xsd#prph_IssuanceOfWarrantsWithUnsecuredPromissoryNote"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_57d117cb-68f0-42a3-83d3-bba08ef1530e" xlink:to="loc_prph_IssuanceOfWarrantsWithUnsecuredPromissoryNote_523eca70-7d44-42ac-b26e-6393e6b8be09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_204fed35-add1-4ae3-906f-fc9c9fca4e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssued1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_57d117cb-68f0-42a3-83d3-bba08ef1530e" xlink:to="loc_us-gaap_StockIssued1_204fed35-add1-4ae3-906f-fc9c9fca4e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/OrganizationandBusiness" xlink:type="simple" xlink:href="prph-20231231.xsd#OrganizationandBusiness"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/OrganizationandBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cdd97632-513f-40ad-9546-c5f721d937f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_fd7747b4-4a13-479f-b98d-3b2d644e6e35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cdd97632-513f-40ad-9546-c5f721d937f8" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_fd7747b4-4a13-479f-b98d-3b2d644e6e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b2b96bc9-4273-48ae-896d-97d602da7cec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_44ae0965-20a1-47b7-b42f-346aab29bbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b2b96bc9-4273-48ae-896d-97d602da7cec" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_44ae0965-20a1-47b7-b42f-346aab29bbdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/AssetAcquisition" xlink:type="simple" xlink:href="prph-20231231.xsd#AssetAcquisition"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/AssetAcquisition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_91782502-77fb-40e6-b3bb-6b9b9f717bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_6faf9901-e83d-4e79-8e18-e5ad9ad0f00c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_91782502-77fb-40e6-b3bb-6b9b9f717bb6" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_6faf9901-e83d-4e79-8e18-e5ad9ad0f00c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/IntangibleAssetsNet" xlink:type="simple" xlink:href="prph-20231231.xsd#IntangibleAssetsNet"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/IntangibleAssetsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a528ecfc-d7ad-4d71-8406-d1ecd7372fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_4c8b58c0-79e9-4423-92fa-1f6cebca9a01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a528ecfc-d7ad-4d71-8406-d1ecd7372fe8" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_4c8b58c0-79e9-4423-92fa-1f6cebca9a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/PropertyPlantandEquipment" xlink:type="simple" xlink:href="prph-20231231.xsd#PropertyPlantandEquipment"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/PropertyPlantandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5ee27e6b-42de-418f-a434-c8fda5366856" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_a5cad33c-efc7-415b-9df3-2e2cf527e28d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5ee27e6b-42de-418f-a434-c8fda5366856" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_a5cad33c-efc7-415b-9df3-2e2cf527e28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/OutstandingDebt" xlink:type="simple" xlink:href="prph-20231231.xsd#OutstandingDebt"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/OutstandingDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_22cb5d34-35ed-41fc-ac11-b5d870861e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_7d353504-ca08-4747-af2a-85ccab04a27e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_22cb5d34-35ed-41fc-ac11-b5d870861e6b" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_7d353504-ca08-4747-af2a-85ccab04a27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/StockholdersEquity" xlink:type="simple" xlink:href="prph-20231231.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1527fd3a-7897-4021-9e05-5e910d89fc16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f1cad613-161b-4ea8-891f-2dff0e298b61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1527fd3a-7897-4021-9e05-5e910d89fc16" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f1cad613-161b-4ea8-891f-2dff0e298b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/DefinedContributionPlans" xlink:type="simple" xlink:href="prph-20231231.xsd#DefinedContributionPlans"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/DefinedContributionPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1c48a43b-6255-45bf-a398-27e6d8951924" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_c4c43b7f-c225-4e93-a33f-206541f46b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1c48a43b-6255-45bf-a398-27e6d8951924" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_c4c43b7f-c225-4e93-a33f-206541f46b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/IncomeTaxes" xlink:type="simple" xlink:href="prph-20231231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_13b1e8ee-a188-4539-81b1-1062c439187c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_ad6fdc39-0c4c-4d06-b8ee-71e7389892e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_13b1e8ee-a188-4539-81b1-1062c439187c" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_ad6fdc39-0c4c-4d06-b8ee-71e7389892e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/OtherCurrentLiabilities" xlink:type="simple" xlink:href="prph-20231231.xsd#OtherCurrentLiabilities"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/OtherCurrentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_9d3b79b8-ab1f-453e-a258-5cfca6df139d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_28c7e16b-8ba9-4061-a311-d9bab80d6f85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_9d3b79b8-ab1f-453e-a258-5cfca6df139d" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_28c7e16b-8ba9-4061-a311-d9bab80d6f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="prph-20231231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_044764cb-6a86-4d90-a5fe-9fb4d1b4fc87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5e20da99-707c-4832-abb6-274c8acdc02d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_044764cb-6a86-4d90-a5fe-9fb4d1b4fc87" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5e20da99-707c-4832-abb6-274c8acdc02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/Leases" xlink:type="simple" xlink:href="prph-20231231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d279475e-d8a0-4797-b1e7-bc5ba32a75ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_14a287f0-1d64-41ba-9adb-0f5a7841016a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d279475e-d8a0-4797-b1e7-bc5ba32a75ba" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_14a287f0-1d64-41ba-9adb-0f5a7841016a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_20e41822-84c9-4c3e-870d-8dbb4cd65755" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d279475e-d8a0-4797-b1e7-bc5ba32a75ba" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_20e41822-84c9-4c3e-870d-8dbb4cd65755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SignificantCustomersConcentrations" xlink:type="simple" xlink:href="prph-20231231.xsd#SignificantCustomersConcentrations"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SignificantCustomersConcentrations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_d4c1359f-7aa6-4af1-a722-eff98ab496bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_0c838df7-e5a7-48ff-bcb4-38ea5498c362" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_d4c1359f-7aa6-4af1-a722-eff98ab496bf" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_0c838df7-e5a7-48ff-bcb4-38ea5498c362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SegmentInformation" xlink:type="simple" xlink:href="prph-20231231.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cf846419-aa5d-4526-8d56-d61b91ab0537" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_e500cee9-9428-4698-9b54-bc860ba1737b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cf846419-aa5d-4526-8d56-d61b91ab0537" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_e500cee9-9428-4698-9b54-bc860ba1737b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/EarningsPerShare" xlink:type="simple" xlink:href="prph-20231231.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2b9336c0-bfdf-4759-a82a-433e17a7daaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_20cd430a-f02f-4686-a373-54fb8a0f74b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2b9336c0-bfdf-4759-a82a-433e17a7daaa" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_20cd430a-f02f-4686-a373-54fb8a0f74b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/RelatedParties" xlink:type="simple" xlink:href="prph-20231231.xsd#RelatedParties"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/RelatedParties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_8e201eb1-3ef1-49a2-9b6c-4ceae1f71254" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_d629a9e0-6040-47eb-adac-373824e02d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_8e201eb1-3ef1-49a2-9b6c-4ceae1f71254" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_d629a9e0-6040-47eb-adac-373824e02d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SubsequentEvents" xlink:type="simple" xlink:href="prph-20231231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_a44c2640-b89f-4be9-b293-71035e8dd601" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_6f9d45ca-50ce-4b2b-be81-648d76eb7ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_a44c2640-b89f-4be9-b293-71035e8dd601" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_6f9d45ca-50ce-4b2b-be81-648d76eb7ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_69328880-b749-4b3b-a4ce-c586858d17e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_69328880-b749-4b3b-a4ce-c586858d17e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_411e6b7f-e462-4a6e-923d-5fc2af7a8813" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_411e6b7f-e462-4a6e-923d-5fc2af7a8813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_185c2ec7-a752-4fd5-9240-b9a896f6f434" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_185c2ec7-a752-4fd5-9240-b9a896f6f434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_48332336-c2c9-4c08-8b20-2031c527a46a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_UseOfEstimates_48332336-c2c9-4c08-8b20-2031c527a46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1721bab6-5c77-4fa7-a6ab-26d6ae575b61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1721bab6-5c77-4fa7-a6ab-26d6ae575b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_8e430d95-2c28-4d17-818a-3298abc7dc9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_8e430d95-2c28-4d17-818a-3298abc7dc9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_17000da6-21e5-4a45-b926-06d75b8dec62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_17000da6-21e5-4a45-b926-06d75b8dec62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_e62611a2-2b08-4b40-a974-704e2b9c519a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_e62611a2-2b08-4b40-a974-704e2b9c519a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_52bc5439-b847-4e51-90df-5d8b6911ce97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_52bc5439-b847-4e51-90df-5d8b6911ce97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_21db8946-3267-4df9-bef5-a7a22589022c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_21db8946-3267-4df9-bef5-a7a22589022c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_c8152ba6-45a3-4e15-b962-88d8c23791c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_c8152ba6-45a3-4e15-b962-88d8c23791c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_041aee56-4684-4065-b674-72f9dc2ebe32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_041aee56-4684-4065-b674-72f9dc2ebe32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_cd58e165-1b75-44e9-9c97-ac633eaac360" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_cd58e165-1b75-44e9-9c97-ac633eaac360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_804398b7-04fb-4f0c-92f6-961c759bf41e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_804398b7-04fb-4f0c-92f6-961c759bf41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_0e5a6ed3-0846-4802-9aa5-bd07395eb9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_0e5a6ed3-0846-4802-9aa5-bd07395eb9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_13b8621a-d07f-4836-a2ff-cf05ea44dbb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_13b8621a-d07f-4836-a2ff-cf05ea44dbb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_d83e9838-4ea8-4c2c-b5bd-fe900647c5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_d83e9838-4ea8-4c2c-b5bd-fe900647c5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_a287e07f-e409-4b12-92ce-b7bf036d856a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_a287e07f-e409-4b12-92ce-b7bf036d856a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_a351e411-0986-4afd-9a1d-16ddc64f9087" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_a351e411-0986-4afd-9a1d-16ddc64f9087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2f9897c3-d556-491b-8b8e-ef9cd2f011e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5342a6b1-79b9-4cdd-ab50-31033d911e00" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2f9897c3-d556-491b-8b8e-ef9cd2f011e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3ac53925-a4ce-4be1-a162-e2fcc9563977" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_8f96d29c-64b6-47b5-83d9-d73c40b31228" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ac53925-a4ce-4be1-a162-e2fcc9563977" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_8f96d29c-64b6-47b5-83d9-d73c40b31228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_7ab79be7-e1cd-4333-8a37-d69f5bdb07ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ac53925-a4ce-4be1-a162-e2fcc9563977" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_7ab79be7-e1cd-4333-8a37-d69f5bdb07ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_142024b1-754d-4bef-bb70-424c240a40f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ac53925-a4ce-4be1-a162-e2fcc9563977" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_142024b1-754d-4bef-bb70-424c240a40f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_5e5693a6-c732-4dd0-a064-48fe4f74115a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ac53925-a4ce-4be1-a162-e2fcc9563977" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_5e5693a6-c732-4dd0-a064-48fe4f74115a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_8c7da7fe-f5ea-4f77-b10d-b336ea2372b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ac53925-a4ce-4be1-a162-e2fcc9563977" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_8c7da7fe-f5ea-4f77-b10d-b336ea2372b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_6bbef1ab-25ee-4a01-a2aa-a40898c1ac5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ac53925-a4ce-4be1-a162-e2fcc9563977" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_6bbef1ab-25ee-4a01-a2aa-a40898c1ac5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/IntangibleAssetsNetTables" xlink:type="simple" xlink:href="prph-20231231.xsd#IntangibleAssetsNetTables"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/IntangibleAssetsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f2928cd4-eb02-4944-8bad-99deb7c65fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_65846fa9-5efe-4d45-83bc-8f95642eb7b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f2928cd4-eb02-4944-8bad-99deb7c65fcf" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_65846fa9-5efe-4d45-83bc-8f95642eb7b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_6bdece6e-d305-407c-a664-888bc14b6147" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f2928cd4-eb02-4944-8bad-99deb7c65fcf" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_6bdece6e-d305-407c-a664-888bc14b6147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/PropertyPlantandEquipmentTables" xlink:type="simple" xlink:href="prph-20231231.xsd#PropertyPlantandEquipmentTables"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/PropertyPlantandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ac687eff-80e7-4d5a-9229-0f705fd4cfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_d3aa9749-d6de-417d-b93b-aa1694249cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ac687eff-80e7-4d5a-9229-0f705fd4cfd4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_d3aa9749-d6de-417d-b93b-aa1694249cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="prph-20231231.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f0d7611a-ebaf-4fff-9fb9-2d8c1f2c090a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_377120ff-308f-4efc-ab3d-f0748d72fa71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f0d7611a-ebaf-4fff-9fb9-2d8c1f2c090a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_377120ff-308f-4efc-ab3d-f0748d72fa71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_a702ea6f-f100-43ac-bbef-8c4c3aeb8c44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f0d7611a-ebaf-4fff-9fb9-2d8c1f2c090a" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_a702ea6f-f100-43ac-bbef-8c4c3aeb8c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ScheduleOfWarrantActivityTableTextBlock_47623f49-aa3d-4b2a-9a1d-8098253ab3ab" xlink:href="prph-20231231.xsd#prph_ScheduleOfWarrantActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f0d7611a-ebaf-4fff-9fb9-2d8c1f2c090a" xlink:to="loc_prph_ScheduleOfWarrantActivityTableTextBlock_47623f49-aa3d-4b2a-9a1d-8098253ab3ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="prph-20231231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f4b89303-7b15-4985-9a7a-c72a264fc256" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_081c8f67-d78a-40d6-9607-9382051d7641" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f4b89303-7b15-4985-9a7a-c72a264fc256" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_081c8f67-d78a-40d6-9607-9382051d7641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8f7bfec1-a545-4a3c-81b4-0d187d12e3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f4b89303-7b15-4985-9a7a-c72a264fc256" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8f7bfec1-a545-4a3c-81b4-0d187d12e3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_dc4dc662-ae33-438f-b27a-e883bcb6cd2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f4b89303-7b15-4985-9a7a-c72a264fc256" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_dc4dc662-ae33-438f-b27a-e883bcb6cd2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/OtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="prph-20231231.xsd#OtherCurrentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/OtherCurrentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5476035b-f60f-4829-940c-d84eca2e9b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_c9c00cb4-96b8-49c1-a93d-7a2f71cc72de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5476035b-f60f-4829-940c-d84eca2e9b8d" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_c9c00cb4-96b8-49c1-a93d-7a2f71cc72de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/LeasesTables" xlink:type="simple" xlink:href="prph-20231231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4ad0a614-6c55-4722-b445-d4aae64378d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_53e3b357-0bb2-4b5a-b02f-e9b293b1145a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4ad0a614-6c55-4722-b445-d4aae64378d8" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_53e3b357-0bb2-4b5a-b02f-e9b293b1145a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_061f30b9-7233-43b4-968d-b3604264ed7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4ad0a614-6c55-4722-b445-d4aae64378d8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_061f30b9-7233-43b4-968d-b3604264ed7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="prph-20231231.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0db3fc73-5d8d-4ea4-b8e6-19adb2de59b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_64da6ea4-d263-4220-9f49-89a8ff212707" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0db3fc73-5d8d-4ea4-b8e6-19adb2de59b3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_64da6ea4-d263-4220-9f49-89a8ff212707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="prph-20231231.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_54d63efe-fa6d-4f22-b8e1-cf643953c664" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4f7def46-172e-490e-946d-2b79f3c2fa0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_54d63efe-fa6d-4f22-b8e1-cf643953c664" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4f7def46-172e-490e-946d-2b79f3c2fa0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_b9cca75b-9645-49a0-96f8-00395f1cae18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_54d63efe-fa6d-4f22-b8e1-cf643953c664" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_b9cca75b-9645-49a0-96f8-00395f1cae18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/OrganizationandBusinessNarrativeDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#OrganizationandBusinessNarrativeDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/OrganizationandBusinessNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aa30ec66-a97f-4c2c-9fe1-00ef8b5b9d57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b365d673-0010-434d-84c8-0923114a8b55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aa30ec66-a97f-4c2c-9fe1-00ef8b5b9d57" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b365d673-0010-434d-84c8-0923114a8b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1d028c80-4abc-4a8c-96e9-b96e7bcd1aea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b365d673-0010-434d-84c8-0923114a8b55" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1d028c80-4abc-4a8c-96e9-b96e7bcd1aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8750eb3c-8149-427a-923a-b27b1c1a40f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1d028c80-4abc-4a8c-96e9-b96e7bcd1aea" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8750eb3c-8149-427a-923a-b27b1c1a40f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CPMMember_fb84f36c-f24c-4ed7-b4a4-904628a64ad7" xlink:href="prph-20231231.xsd#prph_CPMMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8750eb3c-8149-427a-923a-b27b1c1a40f2" xlink:to="loc_prph_CPMMember_fb84f36c-f24c-4ed7-b4a4-904628a64ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a2446c90-4f0a-4f30-afd4-2b4b6afca15d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b365d673-0010-434d-84c8-0923114a8b55" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_a2446c90-4f0a-4f30-afd4-2b4b6afca15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_3a70b61d-8573-4c0c-9532-2842b297b419" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2446c90-4f0a-4f30-afd4-2b4b6afca15d" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_3a70b61d-8573-4c0c-9532-2842b297b419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9b5cff34-33d2-4103-aa65-f31f0494e484" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2446c90-4f0a-4f30-afd4-2b4b6afca15d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9b5cff34-33d2-4103-aa65-f31f0494e484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfLicensedCompounds_9207c197-0e77-48be-805f-6010fe8cfe7d" xlink:href="prph-20231231.xsd#prph_NumberOfLicensedCompounds"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2446c90-4f0a-4f30-afd4-2b4b6afca15d" xlink:to="loc_prph_NumberOfLicensedCompounds_9207c197-0e77-48be-805f-6010fe8cfe7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfInhibitors_615312b0-8261-4e87-96cc-9a9742c6b86a" xlink:href="prph-20231231.xsd#prph_NumberOfInhibitors"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2446c90-4f0a-4f30-afd4-2b4b6afca15d" xlink:to="loc_prph_NumberOfInhibitors_615312b0-8261-4e87-96cc-9a9742c6b86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_32556160-3e7f-4fcc-abf7-a4746fcd152a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beafc682-d6c5-4a58-8f07-20d261c0c672" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_32556160-3e7f-4fcc-abf7-a4746fcd152a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beafc682-d6c5-4a58-8f07-20d261c0c672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0049a9ed-dfc8-42da-b70e-f781ae2047b6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beafc682-d6c5-4a58-8f07-20d261c0c672" xlink:to="loc_srt_RangeAxis_0049a9ed-dfc8-42da-b70e-f781ae2047b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_caa99b94-03ea-482f-b1cd-9c8dec69d5ca" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0049a9ed-dfc8-42da-b70e-f781ae2047b6" xlink:to="loc_srt_RangeMember_caa99b94-03ea-482f-b1cd-9c8dec69d5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_31caf064-26c2-46d5-b93d-5485f71213a6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_caa99b94-03ea-482f-b1cd-9c8dec69d5ca" xlink:to="loc_srt_MinimumMember_31caf064-26c2-46d5-b93d-5485f71213a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_471ae9d4-f08c-400b-8a7d-b50e7f5652e3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_caa99b94-03ea-482f-b1cd-9c8dec69d5ca" xlink:to="loc_srt_MaximumMember_471ae9d4-f08c-400b-8a7d-b50e7f5652e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_1f4554ba-ddfe-47bd-a6e1-0d5355b99383" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beafc682-d6c5-4a58-8f07-20d261c0c672" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_1f4554ba-ddfe-47bd-a6e1-0d5355b99383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_fd302df9-be66-4d9c-be7a-08a830c4f7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_1f4554ba-ddfe-47bd-a6e1-0d5355b99383" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_fd302df9-be66-4d9c-be7a-08a830c4f7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CooperativeIncentivePromotionCostsMember_420058c1-94ed-4c5a-8f14-dc314c95aafc" xlink:href="prph-20231231.xsd#prph_CooperativeIncentivePromotionCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_fd302df9-be66-4d9c-be7a-08a830c4f7f9" xlink:to="loc_prph_CooperativeIncentivePromotionCostsMember_420058c1-94ed-4c5a-8f14-dc314c95aafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7274e0f3-82cd-4e16-94d8-35b1cffbe2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beafc682-d6c5-4a58-8f07-20d261c0c672" xlink:to="loc_us-gaap_DebtInstrumentAxis_7274e0f3-82cd-4e16-94d8-35b1cffbe2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_11c99144-ddcc-4026-a9a1-f8c3e3b85309" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7274e0f3-82cd-4e16-94d8-35b1cffbe2c1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_11c99144-ddcc-4026-a9a1-f8c3e3b85309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_MarketableSecuritiesMember_6f8b6afd-a2ee-476f-ab8b-1b2605005e83" xlink:href="prph-20231231.xsd#prph_MarketableSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_11c99144-ddcc-4026-a9a1-f8c3e3b85309" xlink:to="loc_prph_MarketableSecuritiesMember_6f8b6afd-a2ee-476f-ab8b-1b2605005e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_20d22b3d-df0d-4045-a9e8-956dee992a87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beafc682-d6c5-4a58-8f07-20d261c0c672" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_20d22b3d-df0d-4045-a9e8-956dee992a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_0c442178-fc96-4d7f-b4e0-311c9d597181" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_20d22b3d-df0d-4045-a9e8-956dee992a87" xlink:to="loc_us-gaap_ReceivableTypeDomain_0c442178-fc96-4d7f-b4e0-311c9d597181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_UncollectibleTradeReceivablesMember_950d1bab-e339-414a-ba3a-a1d2bc9741c4" xlink:href="prph-20231231.xsd#prph_UncollectibleTradeReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_0c442178-fc96-4d7f-b4e0-311c9d597181" xlink:to="loc_prph_UncollectibleTradeReceivablesMember_950d1bab-e339-414a-ba3a-a1d2bc9741c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_FullyReservedTradeReceivablesMember_1a7818b7-5d01-478a-8d5d-7671fe44f71c" xlink:href="prph-20231231.xsd#prph_FullyReservedTradeReceivablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_0c442178-fc96-4d7f-b4e0-311c9d597181" xlink:to="loc_prph_FullyReservedTradeReceivablesMember_1a7818b7-5d01-478a-8d5d-7671fe44f71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_938903c2-f484-4766-ac87-b5a5c488bea7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beafc682-d6c5-4a58-8f07-20d261c0c672" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_938903c2-f484-4766-ac87-b5a5c488bea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_040164e3-804d-46a7-a920-576ff271bc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_938903c2-f484-4766-ac87-b5a5c488bea7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_040164e3-804d-46a7-a920-576ff271bc8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_7d2cfbb5-d2f1-40df-90e8-ae1d0b648752" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_040164e3-804d-46a7-a920-576ff271bc8e" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_7d2cfbb5-d2f1-40df-90e8-ae1d0b648752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_448f9825-bade-4bf8-9803-962edf8f971e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_040164e3-804d-46a7-a920-576ff271bc8e" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_448f9825-bade-4bf8-9803-962edf8f971e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_fb41a272-58fe-40fe-ac71-ca51d083e761" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_040164e3-804d-46a7-a920-576ff271bc8e" xlink:to="loc_us-gaap_ComputerEquipmentMember_fb41a272-58fe-40fe-ac71-ca51d083e761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_ce8dfd8e-abc0-4d19-813b-27e956450cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_040164e3-804d-46a7-a920-576ff271bc8e" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_ce8dfd8e-abc0-4d19-813b-27e956450cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_83a0deab-e6f8-4c80-9236-c3ff5310a387" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beafc682-d6c5-4a58-8f07-20d261c0c672" xlink:to="loc_srt_ProductOrServiceAxis_83a0deab-e6f8-4c80-9236-c3ff5310a387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_31207ee4-5d5b-470e-afa9-0232ae2363d1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_83a0deab-e6f8-4c80-9236-c3ff5310a387" xlink:to="loc_srt_ProductsAndServicesDomain_31207ee4-5d5b-470e-afa9-0232ae2363d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_PersonalGenomicsBusinessMember_4bd0cc74-1477-4f34-8dc5-0f369baae26b" xlink:href="prph-20231231.xsd#prph_PersonalGenomicsBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_31207ee4-5d5b-470e-afa9-0232ae2363d1" xlink:to="loc_prph_PersonalGenomicsBusinessMember_4bd0cc74-1477-4f34-8dc5-0f369baae26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f61ab50e-4ffc-494c-88a4-264118997e17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beafc682-d6c5-4a58-8f07-20d261c0c672" xlink:to="loc_us-gaap_AwardTypeAxis_f61ab50e-4ffc-494c-88a4-264118997e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ee03e0a-6a1f-4f20-8e60-857743f7c41d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f61ab50e-4ffc-494c-88a4-264118997e17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ee03e0a-6a1f-4f20-8e60-857743f7c41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3d950196-4beb-435b-868e-86ee6475c92b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ee03e0a-6a1f-4f20-8e60-857743f7c41d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3d950196-4beb-435b-868e-86ee6475c92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_beafc682-d6c5-4a58-8f07-20d261c0c672" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_d4c4a055-5f54-4ca7-afd1-646ac188b576" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_NumberOfOperatingSegments_d4c4a055-5f54-4ca7-afd1-646ac188b576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfTestsRecognized_d465df90-57ba-4529-8d35-08d03e455e38" xlink:href="prph-20231231.xsd#prph_NumberOfTestsRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_prph_NumberOfTestsRecognized_d465df90-57ba-4529-8d35-08d03e455e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage_743ee9ca-b093-4f89-8cc6-f8cc74e055c9" xlink:href="prph-20231231.xsd#prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage_743ee9ca-b093-4f89-8cc6-f8cc74e055c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d438595-1ac4-4675-ab13-afdf37ece21c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0d438595-1ac4-4675-ab13-afdf37ece21c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_3eb9fc89-cd01-40f5-82a5-41b2c3f31d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_3eb9fc89-cd01-40f5-82a5-41b2c3f31d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit_a85bf443-3349-477d-9529-eedbdb977ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EscrowDeposit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_EscrowDeposit_a85bf443-3349-477d-9529-eedbdb977ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DebtSecuritiesAvailableForSaleMaturityPeriod_33cbaf9b-a316-4541-8e57-3b7810160f90" xlink:href="prph-20231231.xsd#prph_DebtSecuritiesAvailableForSaleMaturityPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_prph_DebtSecuritiesAvailableForSaleMaturityPeriod_33cbaf9b-a316-4541-8e57-3b7810160f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_6cb95b33-51e5-4f09-b0a2-f81ca3bb40b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_6cb95b33-51e5-4f09-b0a2-f81ca3bb40b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_b8317fbd-68ee-4d8d-8768-63e85c6836b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_b8317fbd-68ee-4d8d-8768-63e85c6836b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_4b1c85f5-430f-42fd-b3b8-4c9e5dd5583c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_4b1c85f5-430f-42fd-b3b8-4c9e5dd5583c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_01d79fd2-73ad-4861-a96d-02bade255feb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_01d79fd2-73ad-4861-a96d-02bade255feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_9ccadffc-d6a0-4158-93d7-3465055ef538" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_9ccadffc-d6a0-4158-93d7-3465055ef538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8531d84c-dc89-4f40-baf7-73adab8f937f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8531d84c-dc89-4f40-baf7-73adab8f937f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7c82d3e7-578d-4e79-b2da-91e280068b79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7c82d3e7-578d-4e79-b2da-91e280068b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFDICInsuredAmount_fe5fa09c-4377-4ce4-9bab-df0562fb2b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFDICInsuredAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_CashFDICInsuredAmount_fe5fa09c-4377-4ce4-9bab-df0562fb2b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashUninsuredAmount_39e1cba7-f4fe-42d5-8d82-bf336bd6b65c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashUninsuredAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_CashUninsuredAmount_39e1cba7-f4fe-42d5-8d82-bf336bd6b65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_b0ae003c-f202-461b-a27a-9c53f71263fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_AssetImpairmentCharges_b0ae003c-f202-461b-a27a-9c53f71263fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_78697611-6efb-4d86-9940-f423faed505f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_ContractWithCustomerLiability_78697611-6efb-4d86-9940-f423faed505f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_7adeec6f-1e57-49c9-93ce-38dab0b8736e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_AdvertisingExpense_7adeec6f-1e57-49c9-93ce-38dab0b8736e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_701ab86b-0f40-40eb-b308-d9d7c9d40a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_701ab86b-0f40-40eb-b308-d9d7c9d40a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_94134efc-0c51-4f0e-a214-29ccacc3143b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b91d62eb-7096-40b4-b6c8-21ffbbe3119b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_94134efc-0c51-4f0e-a214-29ccacc3143b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e9d3078b-7d37-4d59-8f51-44f4a10eb366" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_d328b944-e0f4-41bf-be7d-05c660949d74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e9d3078b-7d37-4d59-8f51-44f4a10eb366" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_d328b944-e0f4-41bf-be7d-05c660949d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_493a44e8-b12b-4185-aae2-7b87ffe65b67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_d328b944-e0f4-41bf-be7d-05c660949d74" xlink:to="loc_us-gaap_FinancialInstrumentAxis_493a44e8-b12b-4185-aae2-7b87ffe65b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cab62d67-ecb0-4298-9cfa-f9c3d23ec6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_493a44e8-b12b-4185-aae2-7b87ffe65b67" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cab62d67-ecb0-4298-9cfa-f9c3d23ec6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CorporateStockMember_b8eb377a-68e6-4d70-8895-faba050020c4" xlink:href="prph-20231231.xsd#prph_CorporateStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cab62d67-ecb0-4298-9cfa-f9c3d23ec6cf" xlink:to="loc_prph_CorporateStockMember_b8eb377a-68e6-4d70-8895-faba050020c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_USGovernmentObligationsMember_1b7d6cbc-156b-4da8-bfbb-a74630a880bc" xlink:href="prph-20231231.xsd#prph_USGovernmentObligationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cab62d67-ecb0-4298-9cfa-f9c3d23ec6cf" xlink:to="loc_prph_USGovernmentObligationsMember_1b7d6cbc-156b-4da8-bfbb-a74630a880bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CorporateObligationsMember_0a979990-17fd-40cc-a15c-69284c72fa67" xlink:href="prph-20231231.xsd#prph_CorporateObligationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cab62d67-ecb0-4298-9cfa-f9c3d23ec6cf" xlink:to="loc_prph_CorporateObligationsMember_0a979990-17fd-40cc-a15c-69284c72fa67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_19cf9d0b-6781-476a-a3d8-3d5716218dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_d328b944-e0f4-41bf-be7d-05c660949d74" xlink:to="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_19cf9d0b-6781-476a-a3d8-3d5716218dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_06cc7d9c-31e3-450a-88d3-d33b678409c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_19cf9d0b-6781-476a-a3d8-3d5716218dc4" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_06cc7d9c-31e3-450a-88d3-d33b678409c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a8f640d5-115c-4f56-a772-e8abe659f175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_19cf9d0b-6781-476a-a3d8-3d5716218dc4" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a8f640d5-115c-4f56-a772-e8abe659f175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_59336856-5807-4983-8d5c-4130fa501512" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_19cf9d0b-6781-476a-a3d8-3d5716218dc4" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_59336856-5807-4983-8d5c-4130fa501512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_807c20da-3976-461e-9eda-95631650d800" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_19cf9d0b-6781-476a-a3d8-3d5716218dc4" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_807c20da-3976-461e-9eda-95631650d800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofAccountsReceivableNetDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesScheduleofAccountsReceivableNetDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofAccountsReceivableNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a23515ff-1036-4f59-a748-987f37d9e705" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_8323e0ed-2753-4be7-9898-37d7e400fd34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a23515ff-1036-4f59-a748-987f37d9e705" xlink:to="loc_us-gaap_AccountsPayableTradeCurrentAndNoncurrent_8323e0ed-2753-4be7-9898-37d7e400fd34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_34ed47f0-2049-4c48-9703-1df8f5200be3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a23515ff-1036-4f59-a748-987f37d9e705" xlink:to="loc_us-gaap_UnbilledContractsReceivable_34ed47f0-2049-4c48-9703-1df8f5200be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_bf744f96-8fe4-4f68-9077-41b3ac541367" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a23515ff-1036-4f59-a748-987f37d9e705" xlink:to="loc_us-gaap_AccountsReceivableGross_bf744f96-8fe4-4f68-9077-41b3ac541367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_fa63b98b-f7c3-4667-9b69-e5a1c7540a30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a23515ff-1036-4f59-a748-987f37d9e705" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_fa63b98b-f7c3-4667-9b69-e5a1c7540a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_86a0068c-d55f-43cc-b013-28ebe780aa68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a23515ff-1036-4f59-a748-987f37d9e705" xlink:to="loc_us-gaap_AccountsReceivableNet_86a0068c-d55f-43cc-b013-28ebe780aa68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableAllowanceforCreditLossDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesAccountsReceivableAllowanceforCreditLossDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableAllowanceforCreditLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_815ebdfd-e419-4232-aa9d-c091226ab07f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_928cf06f-b456-42b9-923a-68bd3c285447" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_815ebdfd-e419-4232-aa9d-c091226ab07f" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_928cf06f-b456-42b9-923a-68bd3c285447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_7502e825-c450-4d19-8da1-8098f45dfd98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_928cf06f-b456-42b9-923a-68bd3c285447" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_7502e825-c450-4d19-8da1-8098f45dfd98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_5ab55a7f-1493-4961-9a38-344bea2358ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_928cf06f-b456-42b9-923a-68bd3c285447" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_5ab55a7f-1493-4961-9a38-344bea2358ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_e43212d2-ead2-41ec-9cc6-1bb5237b659f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_928cf06f-b456-42b9-923a-68bd3c285447" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_e43212d2-ead2-41ec-9cc6-1bb5237b659f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3ac4476a-95c6-4c72-be92-ff20ce1d6b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_InventoryLabMaterial_3fce9697-2ae7-4238-8bf5-5972ed453817" xlink:href="prph-20231231.xsd#prph_InventoryLabMaterial"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ac4476a-95c6-4c72-be92-ff20ce1d6b6d" xlink:to="loc_prph_InventoryLabMaterial_3fce9697-2ae7-4238-8bf5-5972ed453817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_4f806715-5237-4419-90a0-a018e098ba38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ac4476a-95c6-4c72-be92-ff20ce1d6b6d" xlink:to="loc_us-gaap_InventoryRawMaterials_4f806715-5237-4419-90a0-a018e098ba38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_a96136a0-a229-4558-a9e3-fcc9c6453733" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ac4476a-95c6-4c72-be92-ff20ce1d6b6d" xlink:to="loc_us-gaap_InventoryWorkInProcess_a96136a0-a229-4558-a9e3-fcc9c6453733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_501ac63a-7b62-4989-a45a-a7be14d68d99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ac4476a-95c6-4c72-be92-ff20ce1d6b6d" xlink:to="loc_us-gaap_InventoryFinishedGoods_501ac63a-7b62-4989-a45a-a7be14d68d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_5cde0fa4-6434-42f5-8f60-00606ef4e788" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ac4476a-95c6-4c72-be92-ff20ce1d6b6d" xlink:to="loc_us-gaap_InventoryGross_5cde0fa4-6434-42f5-8f60-00606ef4e788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_467aa96b-9ff6-4f33-a2dd-58be9d3af3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ac4476a-95c6-4c72-be92-ff20ce1d6b6d" xlink:to="loc_us-gaap_InventoryValuationReserves_467aa96b-9ff6-4f33-a2dd-58be9d3af3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f5cce72a-7b02-49ec-8e3f-09af657d81e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ac4476a-95c6-4c72-be92-ff20ce1d6b6d" xlink:to="loc_us-gaap_InventoryNet_f5cce72a-7b02-49ec-8e3f-09af657d81e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ee3c4cbd-4170-4891-8258-99b4329951a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_4d6a74b2-b18a-4d19-8fe2-26b058681b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ee3c4cbd-4170-4891-8258-99b4329951a6" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_4d6a74b2-b18a-4d19-8fe2-26b058681b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_27fca85e-e107-4073-b0d8-e72d6707684c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_4d6a74b2-b18a-4d19-8fe2-26b058681b3e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_27fca85e-e107-4073-b0d8-e72d6707684c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1ac0215b-c028-4d8d-9487-b7ed6beaed0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_27fca85e-e107-4073-b0d8-e72d6707684c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1ac0215b-c028-4d8d-9487-b7ed6beaed0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CorporateStockMember_577a5292-c094-47c6-be20-deedf0a98ebf" xlink:href="prph-20231231.xsd#prph_CorporateStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1ac0215b-c028-4d8d-9487-b7ed6beaed0b" xlink:to="loc_prph_CorporateStockMember_577a5292-c094-47c6-be20-deedf0a98ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_USGovernmentObligationsMember_fea81789-e6b1-4f10-be92-03c5646dfd5a" xlink:href="prph-20231231.xsd#prph_USGovernmentObligationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1ac0215b-c028-4d8d-9487-b7ed6beaed0b" xlink:to="loc_prph_USGovernmentObligationsMember_fea81789-e6b1-4f10-be92-03c5646dfd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CorporateObligationsMember_d488f903-5445-4e85-951b-893387e0a1de" xlink:href="prph-20231231.xsd#prph_CorporateObligationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1ac0215b-c028-4d8d-9487-b7ed6beaed0b" xlink:to="loc_prph_CorporateObligationsMember_d488f903-5445-4e85-951b-893387e0a1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b6c3bce2-9d84-4cef-83b2-740a358db6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_4d6a74b2-b18a-4d19-8fe2-26b058681b3e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b6c3bce2-9d84-4cef-83b2-740a358db6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_66c5d8c5-6fef-459c-85dd-b34993185d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b6c3bce2-9d84-4cef-83b2-740a358db6c4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_66c5d8c5-6fef-459c-85dd-b34993185d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_81153f38-bbd5-42cd-b050-05268b50ec83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_66c5d8c5-6fef-459c-85dd-b34993185d7b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_81153f38-bbd5-42cd-b050-05268b50ec83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3d71706f-c4a7-4e3d-96d0-99c53de2cc45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_66c5d8c5-6fef-459c-85dd-b34993185d7b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_3d71706f-c4a7-4e3d-96d0-99c53de2cc45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_cdd3a87a-c04b-45fd-84bb-f5d7ce08e502" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_66c5d8c5-6fef-459c-85dd-b34993185d7b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_cdd3a87a-c04b-45fd-84bb-f5d7ce08e502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_82966f65-c4d1-49b3-bf24-ab09e0dabcca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_4d6a74b2-b18a-4d19-8fe2-26b058681b3e" xlink:to="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_82966f65-c4d1-49b3-bf24-ab09e0dabcca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_c2790317-98e8-45c7-a57b-4edd004ededf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_82966f65-c4d1-49b3-bf24-ab09e0dabcca" xlink:to="loc_us-gaap_MarketableSecurities_c2790317-98e8-45c7-a57b-4edd004ededf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9440c70c-b657-4624-b89b-01142be8febf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementByTypeTable_183afae6-c93d-4d6d-a0ff-be82d628ceb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementByTypeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9440c70c-b657-4624-b89b-01142be8febf" xlink:to="loc_us-gaap_DeferredRevenueArrangementByTypeTable_183afae6-c93d-4d6d-a0ff-be82d628ceb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b9dddb84-cf93-4ca8-b1af-069c584928d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_183afae6-c93d-4d6d-a0ff-be82d628ceb7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b9dddb84-cf93-4ca8-b1af-069c584928d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementLineItems_b184ba71-7cd9-4cca-9363-d60464c79825" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_183afae6-c93d-4d6d-a0ff-be82d628ceb7" xlink:to="loc_us-gaap_DeferredRevenueArrangementLineItems_b184ba71-7cd9-4cca-9363-d60464c79825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_5b2c49c2-6400-401c-9ed3-5b38459cc1e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_b184ba71-7cd9-4cca-9363-d60464c79825" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_5b2c49c2-6400-401c-9ed3-5b38459cc1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails_1" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails_1"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPerformanceObligationDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesPerformanceObligationDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8c69e013-447f-4ee2-bdcf-9318c7077612" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementByTypeTable_a5c64e65-8a38-40a6-89f9-24bdc65fa344" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementByTypeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c69e013-447f-4ee2-bdcf-9318c7077612" xlink:to="loc_us-gaap_DeferredRevenueArrangementByTypeTable_a5c64e65-8a38-40a6-89f9-24bdc65fa344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_a46c2cd3-4745-44d7-b43d-25f15e49cb19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_a5c64e65-8a38-40a6-89f9-24bdc65fa344" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_a46c2cd3-4745-44d7-b43d-25f15e49cb19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueArrangementLineItems_327d91cb-1ad9-41e9-b475-d883ccb1494e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueArrangementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementByTypeTable_a5c64e65-8a38-40a6-89f9-24bdc65fa344" xlink:to="loc_us-gaap_DeferredRevenueArrangementLineItems_327d91cb-1ad9-41e9-b475-d883ccb1494e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_9b050fd2-fd01-4d37-8a1b-f2e389a82b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredRevenueArrangementLineItems_327d91cb-1ad9-41e9-b475-d883ccb1494e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_9b050fd2-fd01-4d37-8a1b-f2e389a82b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPerformanceObligationDetails_1" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesPerformanceObligationDetails_1"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDisaggregationbyRevenueDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SummaryofSignificantAccountingPoliciesScheduleofDisaggregationbyRevenueDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDisaggregationbyRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a46d4aab-46d7-416a-a52d-8fd38a55449a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_e831eb63-42a7-48c7-adc7-1c7b8dd2d472" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a46d4aab-46d7-416a-a52d-8fd38a55449a" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_e831eb63-42a7-48c7-adc7-1c7b8dd2d472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c381537f-d319-4640-9021-e9c66ab80fac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_e831eb63-42a7-48c7-adc7-1c7b8dd2d472" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c381537f-d319-4640-9021-e9c66ab80fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e3f1b6dd-f67c-4fa7-ae96-6b9f34612fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c381537f-d319-4640-9021-e9c66ab80fac" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e3f1b6dd-f67c-4fa7-ae96-6b9f34612fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DiagnosticServicesMember_829962e5-2805-4ef1-91d3-b27eda3e2e52" xlink:href="prph-20231231.xsd#prph_DiagnosticServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e3f1b6dd-f67c-4fa7-ae96-6b9f34612fc8" xlink:to="loc_prph_DiagnosticServicesMember_829962e5-2805-4ef1-91d3-b27eda3e2e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ContractManufacturingMember_2a57d14f-3203-4523-8d7b-0b922b8e3e36" xlink:href="prph-20231231.xsd#prph_ContractManufacturingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e3f1b6dd-f67c-4fa7-ae96-6b9f34612fc8" xlink:to="loc_prph_ContractManufacturingMember_2a57d14f-3203-4523-8d7b-0b922b8e3e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_RetailAndOtherMember_502c0392-6abc-428b-bc91-910b7b1b61e1" xlink:href="prph-20231231.xsd#prph_RetailAndOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e3f1b6dd-f67c-4fa7-ae96-6b9f34612fc8" xlink:to="loc_prph_RetailAndOtherMember_502c0392-6abc-428b-bc91-910b7b1b61e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_GenomicProductsAndServicesMember_3ce2979c-aab5-4a94-99dd-98e30d5a3c7e" xlink:href="prph-20231231.xsd#prph_GenomicProductsAndServicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e3f1b6dd-f67c-4fa7-ae96-6b9f34612fc8" xlink:to="loc_prph_GenomicProductsAndServicesMember_3ce2979c-aab5-4a94-99dd-98e30d5a3c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_8e157830-77ea-4123-a7d8-b047449b8991" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_e831eb63-42a7-48c7-adc7-1c7b8dd2d472" xlink:to="loc_us-gaap_ProductInformationLineItems_8e157830-77ea-4123-a7d8-b047449b8991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e57ca6d1-997e-4fad-9f74-2399a206cc68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_8e157830-77ea-4123-a7d8-b047449b8991" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e57ca6d1-997e-4fad-9f74-2399a206cc68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/AssetAcquisitionDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#AssetAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/AssetAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_db7a892e-44bc-461d-a7ba-3726eaa6a207" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTable_df69e758-583d-4edc-b4c6-d22e33ac06cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_db7a892e-44bc-461d-a7ba-3726eaa6a207" xlink:to="loc_us-gaap_AssetAcquisitionTable_df69e758-583d-4edc-b4c6-d22e33ac06cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_7c280581-29f7-4098-85c1-2c914a40e6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionTable_df69e758-583d-4edc-b4c6-d22e33ac06cf" xlink:to="loc_us-gaap_AssetAcquisitionAxis_7c280581-29f7-4098-85c1-2c914a40e6a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_443895e7-689a-4edf-adb4-20507d4283de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_7c280581-29f7-4098-85c1-2c914a40e6a6" xlink:to="loc_us-gaap_AssetAcquisitionDomain_443895e7-689a-4edf-adb4-20507d4283de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_StellaPurchaseAgreementMember_8ee4b0fe-3807-49ab-9854-a1a8ea427058" xlink:href="prph-20231231.xsd#prph_StellaPurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_443895e7-689a-4edf-adb4-20507d4283de" xlink:to="loc_prph_StellaPurchaseAgreementMember_8ee4b0fe-3807-49ab-9854-a1a8ea427058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fe8f2780-ebbf-48cd-b5b5-475e59b5322d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionTable_df69e758-583d-4edc-b4c6-d22e33ac06cf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fe8f2780-ebbf-48cd-b5b5-475e59b5322d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b0713839-58d6-4fbb-98f6-512a27ed926c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fe8f2780-ebbf-48cd-b5b5-475e59b5322d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b0713839-58d6-4fbb-98f6-512a27ed926c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_a3724298-e89d-4181-81f4-4375ef772a12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b0713839-58d6-4fbb-98f6-512a27ed926c" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_a3724298-e89d-4181-81f4-4375ef772a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionTable_df69e758-583d-4edc-b4c6-d22e33ac06cf" xlink:to="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_PaymentsForAssetAcquisition_600eeeac-aaac-490b-ad09-545161c56d39" xlink:href="prph-20231231.xsd#prph_PaymentsForAssetAcquisition"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_prph_PaymentsForAssetAcquisition_600eeeac-aaac-490b-ad09-545161c56d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationLiability_31bc2a1f-1fca-4a52-97d3-8a80047e20bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_us-gaap_AssetAcquisitionContingentConsiderationLiability_31bc2a1f-1fca-4a52-97d3-8a80047e20bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff_3da6fa40-dec9-4b51-b1f6-80dd5f43b845" xlink:href="prph-20231231.xsd#prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff_3da6fa40-dec9-4b51-b1f6-80dd5f43b845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff_e58bb753-2d17-4ba7-9d6d-ddd2775c8a35" xlink:href="prph-20231231.xsd#prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff_e58bb753-2d17-4ba7-9d6d-ddd2775c8a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_65a58223-82c1-4ee7-8e68-4dcec599e62d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_65a58223-82c1-4ee7-8e68-4dcec599e62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_06a5f695-1976-4351-8c3b-eeb26d45fe87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_06a5f695-1976-4351-8c3b-eeb26d45fe87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare_ea1635a0-4390-4352-bbd0-ddabd7c310f0" xlink:href="prph-20231231.xsd#prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare_ea1635a0-4390-4352-bbd0-ddabd7c310f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_b66dfe60-a7d7-43ea-97a7-92a76d253ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_b66dfe60-a7d7-43ea-97a7-92a76d253ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent_09c48085-e53b-4373-ac30-e68dcb21e0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent_09c48085-e53b-4373-ac30-e68dcb21e0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7e2180e4-d41a-4407-8550-774d1e1c8126" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7e2180e4-d41a-4407-8550-774d1e1c8126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_PurchaseAgreementRoyaltyPercent_ee806ae9-24e0-4af4-96fd-635c9dacf31f" xlink:href="prph-20231231.xsd#prph_PurchaseAgreementRoyaltyPercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_prph_PurchaseAgreementRoyaltyPercent_ee806ae9-24e0-4af4-96fd-635c9dacf31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AssetAcquisitionTransactionCosts_65eaad5a-a9ec-4c9d-a377-1e65b452c6d9" xlink:href="prph-20231231.xsd#prph_AssetAcquisitionTransactionCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_prph_AssetAcquisitionTransactionCosts_65eaad5a-a9ec-4c9d-a377-1e65b452c6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_4671364a-f12e-4ea6-8a74-405158f912c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionLineItems_be55b9fd-19a4-4ad2-b238-583cdc6d168e" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_4671364a-f12e-4ea6-8a74-405158f912c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/IntangibleAssetsNetNarrativeDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#IntangibleAssetsNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/IntangibleAssetsNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_56b325fc-fa5d-477f-aec4-eb3f106d3472" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8e261174-c9ad-4648-b7ef-a82d5afadb92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_56b325fc-fa5d-477f-aec4-eb3f106d3472" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8e261174-c9ad-4648-b7ef-a82d5afadb92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f1d1b9b3-8421-44fb-8209-5decb4b68ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8e261174-c9ad-4648-b7ef-a82d5afadb92" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f1d1b9b3-8421-44fb-8209-5decb4b68ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_34eb8507-95a3-420a-a79c-ba82bacbc728" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f1d1b9b3-8421-44fb-8209-5decb4b68ab0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_34eb8507-95a3-420a-a79c-ba82bacbc728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_1f8be2a6-1a1f-44fa-97b7-9d0171c3ae50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_34eb8507-95a3-420a-a79c-ba82bacbc728" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_1f8be2a6-1a1f-44fa-97b7-9d0171c3ae50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f57d5778-2b09-4c5f-804d-60944f9a6bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8e261174-c9ad-4648-b7ef-a82d5afadb92" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f57d5778-2b09-4c5f-804d-60944f9a6bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_6f4e0d1e-50c1-45d3-91a6-d92883fdd0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f57d5778-2b09-4c5f-804d-60944f9a6bdf" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_6f4e0d1e-50c1-45d3-91a6-d92883fdd0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2f0a810a-5a4c-4509-8940-2d64b05992ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f57d5778-2b09-4c5f-804d-60944f9a6bdf" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2f0a810a-5a4c-4509-8940-2d64b05992ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#IntangibleAssetsNetScheduleofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b4f517c8-2f13-4c1a-b96a-16a0a549c146" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c0707f74-41cd-49ad-b999-717c9be6f89b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b4f517c8-2f13-4c1a-b96a-16a0a549c146" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c0707f74-41cd-49ad-b999-717c9be6f89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_229954c9-d3f4-49f0-a97f-be20836ea374" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c0707f74-41cd-49ad-b999-717c9be6f89b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_229954c9-d3f4-49f0-a97f-be20836ea374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91671369-fa34-4bb9-9bbd-134a067fbdfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_229954c9-d3f4-49f0-a97f-be20836ea374" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91671369-fa34-4bb9-9bbd-134a067fbdfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_c696aa67-9ad3-4156-a18b-ece3970694d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91671369-fa34-4bb9-9bbd-134a067fbdfc" xlink:to="loc_us-gaap_TradeNamesMember_c696aa67-9ad3-4156-a18b-ece3970694d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember_12c5a756-3e1b-4038-b674-702f74ea3453" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91671369-fa34-4bb9-9bbd-134a067fbdfc" xlink:to="loc_us-gaap_IntellectualPropertyMember_12c5a756-3e1b-4038-b674-702f74ea3453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_56a2a19a-a04a-4488-b365-648956815a39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91671369-fa34-4bb9-9bbd-134a067fbdfc" xlink:to="loc_us-gaap_CustomerRelationshipsMember_56a2a19a-a04a-4488-b365-648956815a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_38670244-13d6-4b97-866d-a93d8bc33a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91671369-fa34-4bb9-9bbd-134a067fbdfc" xlink:to="loc_us-gaap_LicenseMember_38670244-13d6-4b97-866d-a93d8bc33a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b0104c34-d339-4c7f-b791-73ef0c9ff216" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c0707f74-41cd-49ad-b999-717c9be6f89b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b0104c34-d339-4c7f-b791-73ef0c9ff216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4060f662-09f9-48cd-be6b-ad03ac63d8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b0104c34-d339-4c7f-b791-73ef0c9ff216" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4060f662-09f9-48cd-be6b-ad03ac63d8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_efa675cd-40d6-4490-aeed-4be708def853" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b0104c34-d339-4c7f-b791-73ef0c9ff216" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_efa675cd-40d6-4490-aeed-4be708def853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1b7b8a93-efde-484a-9814-a94413f3b470" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b0104c34-d339-4c7f-b791-73ef0c9ff216" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1b7b8a93-efde-484a-9814-a94413f3b470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8ccb5462-b863-4f90-9ab0-cd721d99ffe4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b0104c34-d339-4c7f-b791-73ef0c9ff216" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8ccb5462-b863-4f90-9ab0-cd721d99ffe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dc505bf1-6b0a-4ff2-b968-8a7b4ca455d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4e54179b-ba79-42fc-9ccf-007845862189" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dc505bf1-6b0a-4ff2-b968-8a7b4ca455d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4e54179b-ba79-42fc-9ccf-007845862189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_acd4cea3-93cd-4022-88fa-65ce617354b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dc505bf1-6b0a-4ff2-b968-8a7b4ca455d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_acd4cea3-93cd-4022-88fa-65ce617354b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_21f171ed-8957-4409-a342-35860420a146" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dc505bf1-6b0a-4ff2-b968-8a7b4ca455d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_21f171ed-8957-4409-a342-35860420a146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_81625e09-854e-4925-8879-2c82d721b806" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dc505bf1-6b0a-4ff2-b968-8a7b4ca455d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_81625e09-854e-4925-8879-2c82d721b806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e8c38666-b60f-42f2-9658-02735e27329c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dc505bf1-6b0a-4ff2-b968-8a7b4ca455d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e8c38666-b60f-42f2-9658-02735e27329c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c6c0c4c5-5ec1-4972-94a2-d3234907dd5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dc505bf1-6b0a-4ff2-b968-8a7b4ca455d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c6c0c4c5-5ec1-4972-94a2-d3234907dd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3ca4626-45fa-45e1-b7f0-cdcdc4e82b48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dc505bf1-6b0a-4ff2-b968-8a7b4ca455d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3ca4626-45fa-45e1-b7f0-cdcdc4e82b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_557a1677-753e-456f-8df5-e82d587542c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_38e5e5cf-dc51-450f-85d0-50920413fa65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_557a1677-753e-456f-8df5-e82d587542c4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_38e5e5cf-dc51-450f-85d0-50920413fa65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8f1ccd5a-d4e0-4ee3-9e6e-ced7950383c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_38e5e5cf-dc51-450f-85d0-50920413fa65" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8f1ccd5a-d4e0-4ee3-9e6e-ced7950383c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44fa8acf-d8b3-436d-8735-c1bc9034b37c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8f1ccd5a-d4e0-4ee3-9e6e-ced7950383c9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44fa8acf-d8b3-436d-8735-c1bc9034b37c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_25a76398-8953-4567-8909-373c22233784" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44fa8acf-d8b3-436d-8735-c1bc9034b37c" xlink:to="loc_us-gaap_LandMember_25a76398-8953-4567-8909-373c22233784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_a2fe45e9-5e32-4657-bf4e-28a3f311a34e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44fa8acf-d8b3-436d-8735-c1bc9034b37c" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_a2fe45e9-5e32-4657-bf4e-28a3f311a34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember_af92853d-09e4-45c8-bacf-0af4c6b964c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44fa8acf-d8b3-436d-8735-c1bc9034b37c" xlink:to="loc_us-gaap_BuildingImprovementsMember_af92853d-09e4-45c8-bacf-0af4c6b964c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_633c4549-e708-4736-9bc5-51db51dd2ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44fa8acf-d8b3-436d-8735-c1bc9034b37c" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_633c4549-e708-4736-9bc5-51db51dd2ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_bc3a41fc-cf89-4447-b30c-49b051b7b8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44fa8acf-d8b3-436d-8735-c1bc9034b37c" xlink:to="loc_us-gaap_EquipmentMember_bc3a41fc-cf89-4447-b30c-49b051b7b8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_11161a3e-be2f-4c3e-bb5d-bcc4626fd594" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44fa8acf-d8b3-436d-8735-c1bc9034b37c" xlink:to="loc_us-gaap_ComputerEquipmentMember_11161a3e-be2f-4c3e-bb5d-bcc4626fd594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_dcdfefbe-e0da-4f35-bf61-9d0278f2dda1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_44fa8acf-d8b3-436d-8735-c1bc9034b37c" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_dcdfefbe-e0da-4f35-bf61-9d0278f2dda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a9c91424-e60f-48f7-a3fb-4d23b378d2ef" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_38e5e5cf-dc51-450f-85d0-50920413fa65" xlink:to="loc_srt_RangeAxis_a9c91424-e60f-48f7-a3fb-4d23b378d2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_87563278-b5b5-460a-8aea-62fe9e682fff" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a9c91424-e60f-48f7-a3fb-4d23b378d2ef" xlink:to="loc_srt_RangeMember_87563278-b5b5-460a-8aea-62fe9e682fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_74f70403-7506-4bfa-83b6-58538301a513" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_87563278-b5b5-460a-8aea-62fe9e682fff" xlink:to="loc_srt_MinimumMember_74f70403-7506-4bfa-83b6-58538301a513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_27e3d2b8-64b7-4c04-8aff-b5ff1ead66da" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_87563278-b5b5-460a-8aea-62fe9e682fff" xlink:to="loc_srt_MaximumMember_27e3d2b8-64b7-4c04-8aff-b5ff1ead66da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0d6469f3-0846-4f89-bc42-61d16bf02d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_38e5e5cf-dc51-450f-85d0-50920413fa65" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0d6469f3-0846-4f89-bc42-61d16bf02d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_ca3dee7a-0b5d-47c5-bc32-ee8a5e844b06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0d6469f3-0846-4f89-bc42-61d16bf02d0a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_ca3dee7a-0b5d-47c5-bc32-ee8a5e844b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_184b9f66-c0ed-4366-9497-43f02c523379" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0d6469f3-0846-4f89-bc42-61d16bf02d0a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_184b9f66-c0ed-4366-9497-43f02c523379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_29d11d98-9703-4b2d-8c22-5b3d55a420d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0d6469f3-0846-4f89-bc42-61d16bf02d0a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_29d11d98-9703-4b2d-8c22-5b3d55a420d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_8f7cb6f0-51c4-4de4-bc1a-64e5bb8be460" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0d6469f3-0846-4f89-bc42-61d16bf02d0a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_8f7cb6f0-51c4-4de4-bc1a-64e5bb8be460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/PropertyPlantandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#PropertyPlantandEquipmentNarrativeDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/PropertyPlantandEquipmentNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_91627d02-c16c-4fc9-bb58-7a2bdd019583" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_845be1be-30f8-4c35-818b-d527c5c5ed5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_91627d02-c16c-4fc9-bb58-7a2bdd019583" xlink:to="loc_us-gaap_Depreciation_845be1be-30f8-4c35-818b-d527c5c5ed5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/OutstandingDebtDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#OutstandingDebtDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/OutstandingDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_dce4592a-19f3-4692-b1cb-b381b11f9d12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_67480303-ed7a-4b03-b3af-59cfb3b95b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dce4592a-19f3-4692-b1cb-b381b11f9d12" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_67480303-ed7a-4b03-b3af-59cfb3b95b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_39d60a7f-5c29-4acd-9649-5b7b47219747" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_67480303-ed7a-4b03-b3af-59cfb3b95b9f" xlink:to="loc_us-gaap_DebtInstrumentAxis_39d60a7f-5c29-4acd-9649-5b7b47219747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_910ac623-cde6-478a-9cf3-41275913b13f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_39d60a7f-5c29-4acd-9649-5b7b47219747" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_910ac623-cde6-478a-9cf3-41275913b13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2023SecuredMortgageLoanMember_a3d0206d-963d-465c-a6e3-5981ae20b787" xlink:href="prph-20231231.xsd#prph_A2023SecuredMortgageLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_910ac623-cde6-478a-9cf3-41275913b13f" xlink:to="loc_prph_A2023SecuredMortgageLoanMember_a3d0206d-963d-465c-a6e3-5981ae20b787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2023NoteMember_8256b3e2-8d96-434e-9668-92b47876028c" xlink:href="prph-20231231.xsd#prph_A2023NoteMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_910ac623-cde6-478a-9cf3-41275913b13f" xlink:to="loc_prph_A2023NoteMember_8256b3e2-8d96-434e-9668-92b47876028c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_SeptemberTwoThousandAndTwentyNoteMember_aaf0346b-9e91-4abc-9d7b-1a1a8e46e34d" xlink:href="prph-20231231.xsd#prph_SeptemberTwoThousandAndTwentyNoteMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_910ac623-cde6-478a-9cf3-41275913b13f" xlink:to="loc_prph_SeptemberTwoThousandAndTwentyNoteMember_aaf0346b-9e91-4abc-9d7b-1a1a8e46e34d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a81e90b4-82e1-485d-9cda-04f0a3f23bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_67480303-ed7a-4b03-b3af-59cfb3b95b9f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a81e90b4-82e1-485d-9cda-04f0a3f23bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a2b28b4d-10d1-48ab-a51b-35ecc650ebe0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a81e90b4-82e1-485d-9cda-04f0a3f23bbd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a2b28b4d-10d1-48ab-a51b-35ecc650ebe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_3b7361c5-ac9a-4ba6-978e-b9acde32ffa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a2b28b4d-10d1-48ab-a51b-35ecc650ebe0" xlink:to="loc_us-gaap_SecuredDebtMember_3b7361c5-ac9a-4ba6-978e-b9acde32ffa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_9c72fa9d-fe1a-4153-b3e4-5b3ff4057159" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a2b28b4d-10d1-48ab-a51b-35ecc650ebe0" xlink:to="loc_us-gaap_UnsecuredDebtMember_9c72fa9d-fe1a-4153-b3e4-5b3ff4057159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ArrangementTypeAxis_63839f80-e2f7-4d31-be9c-4c74d6fa1729" xlink:href="prph-20231231.xsd#prph_ArrangementTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_67480303-ed7a-4b03-b3af-59cfb3b95b9f" xlink:to="loc_prph_ArrangementTypeAxis_63839f80-e2f7-4d31-be9c-4c74d6fa1729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_TypeOfArrangementDomain_50480ad7-3d64-4ef9-b6c9-3bb51cfa4351" xlink:href="prph-20231231.xsd#prph_TypeOfArrangementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prph_ArrangementTypeAxis_63839f80-e2f7-4d31-be9c-4c74d6fa1729" xlink:to="loc_prph_TypeOfArrangementDomain_50480ad7-3d64-4ef9-b6c9-3bb51cfa4351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LetterAgreementMember_cd57d5d9-c3b1-4c07-95b9-97640e7c5be7" xlink:href="prph-20231231.xsd#prph_LetterAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prph_TypeOfArrangementDomain_50480ad7-3d64-4ef9-b6c9-3bb51cfa4351" xlink:to="loc_prph_LetterAgreementMember_cd57d5d9-c3b1-4c07-95b9-97640e7c5be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_b1bf3681-193e-4de6-bf5b-801bf54c0f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_67480303-ed7a-4b03-b3af-59cfb3b95b9f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_b1bf3681-193e-4de6-bf5b-801bf54c0f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_5437c89e-19d6-4fb7-a532-0ec405d0974d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_b1bf3681-193e-4de6-bf5b-801bf54c0f0f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_5437c89e-19d6-4fb7-a532-0ec405d0974d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2023NotesWarrantsMember_7365cab4-3805-42ba-955e-b8ec25f74b7c" xlink:href="prph-20231231.xsd#prph_A2023NotesWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_5437c89e-19d6-4fb7-a532-0ec405d0974d" xlink:to="loc_prph_A2023NotesWarrantsMember_7365cab4-3805-42ba-955e-b8ec25f74b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_21e1089b-8e31-42fd-b905-963049038231" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_67480303-ed7a-4b03-b3af-59cfb3b95b9f" xlink:to="loc_us-gaap_ValuationTechniqueAxis_21e1089b-8e31-42fd-b905-963049038231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_756984ce-43fb-447d-89ee-af6f47ae1800" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_21e1089b-8e31-42fd-b905-963049038231" xlink:to="loc_us-gaap_ValuationTechniqueDomain_756984ce-43fb-447d-89ee-af6f47ae1800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_BlackScholesOptionPricingModelMember_a402fdf1-b51d-4919-8491-d2c9f7f67779" xlink:href="prph-20231231.xsd#prph_BlackScholesOptionPricingModelMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_756984ce-43fb-447d-89ee-af6f47ae1800" xlink:to="loc_prph_BlackScholesOptionPricingModelMember_a402fdf1-b51d-4919-8491-d2c9f7f67779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_76448e5c-73eb-4bd0-a920-17183a5a649b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_67480303-ed7a-4b03-b3af-59cfb3b95b9f" xlink:to="loc_us-gaap_TypeOfArrangementAxis_76448e5c-73eb-4bd0-a920-17183a5a649b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e973a0aa-80ea-4843-8cb0-5e638c1a7000" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_76448e5c-73eb-4bd0-a920-17183a5a649b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e973a0aa-80ea-4843-8cb0-5e638c1a7000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LetterAgreementMember_5ad5ed9d-ee5f-40c0-8417-cd90ce14742b" xlink:href="prph-20231231.xsd#prph_LetterAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e973a0aa-80ea-4843-8cb0-5e638c1a7000" xlink:to="loc_prph_LetterAgreementMember_5ad5ed9d-ee5f-40c0-8417-cd90ce14742b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_67480303-ed7a-4b03-b3af-59cfb3b95b9f" xlink:to="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c65adc82-7c42-4513-9b92-1693679cb0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c65adc82-7c42-4513-9b92-1693679cb0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f7b17c53-ad3e-4a38-9568-bec6caf558e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f7b17c53-ad3e-4a38-9568-bec6caf558e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_622c7e9f-f2f4-47d2-8986-228cd1ff6a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_622c7e9f-f2f4-47d2-8986-228cd1ff6a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_2c8d9183-27e7-4e8f-80ea-7fe733cf3255" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_2c8d9183-27e7-4e8f-80ea-7fe733cf3255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit_7eb52cf9-4589-4fb1-bcdd-ffdc47c51ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EscrowDeposit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_EscrowDeposit_7eb52cf9-4589-4fb1-bcdd-ffdc47c51ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_6ef0c6de-dc62-4252-bbbd-7459d07f6220" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_6ef0c6de-dc62-4252-bbbd-7459d07f6220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_6d0e7128-6619-4742-bfe5-d92c53063056" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_6d0e7128-6619-4742-bfe5-d92c53063056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4a05fed3-4b74-4a91-a68f-1b56baf5c413" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4a05fed3-4b74-4a91-a68f-1b56baf5c413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_22512226-891e-46a9-9cb1-02536115f472" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_22512226-891e-46a9-9cb1-02536115f472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_4dfbe3cc-e49f-4e14-ba7d-1eb3d08a9f52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_4dfbe3cc-e49f-4e14-ba7d-1eb3d08a9f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d9921300-bc73-497b-8579-e9af35549838" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d9921300-bc73-497b-8579-e9af35549838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_a78e31e2-03c1-457b-ac28-7f822807878f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_a78e31e2-03c1-457b-ac28-7f822807878f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_82dcac02-ba33-46f5-941c-d338d0a6d6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_82dcac02-ba33-46f5-941c-d338d0a6d6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_56dde8b6-9954-49f7-8904-a0b49f9929fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_56dde8b6-9954-49f7-8904-a0b49f9929fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfDebtInstruments_eb30d33a-ce25-4ac3-a99a-a47d57782ced" xlink:href="prph-20231231.xsd#prph_NumberOfDebtInstruments"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_prph_NumberOfDebtInstruments_eb30d33a-ce25-4ac3-a99a-a47d57782ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfInvestors_30e78201-057e-48c7-ae86-1b011a9b4714" xlink:href="prph-20231231.xsd#prph_NumberOfInvestors"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_prph_NumberOfInvestors_30e78201-057e-48c7-ae86-1b011a9b4714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6fcd1802-a34f-4a8d-ad5b-4525135ee37f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6fcd1802-a34f-4a8d-ad5b-4525135ee37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_bbe829f6-74f5-4143-8004-74f1a934183b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_bbe829f6-74f5-4143-8004-74f1a934183b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_090c8264-dcb9-4b79-968e-a9e2253fe55b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_Cash_090c8264-dcb9-4b79-968e-a9e2253fe55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalancePrincipalAmount_a7555b67-4516-475c-901b-2df5e5ec4655" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalancePrincipalAmount"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_InvestmentOwnedBalancePrincipalAmount_a7555b67-4516-475c-901b-2df5e5ec4655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_927684a8-b8c4-444d-bcf6-2910c2d63c96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_927684a8-b8c4-444d-bcf6-2910c2d63c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_2d0ea701-e611-4e8c-b9b5-36abb19eceef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_2d0ea701-e611-4e8c-b9b5-36abb19eceef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_c66d9536-bc56-4a05-9182-f5f467dbbfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_c66d9536-bc56-4a05-9182-f5f467dbbfd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_aabd2b84-2240-48b2-8474-67ec572d7de5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_aabd2b84-2240-48b2-8474-67ec572d7de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_eff8942d-cb5b-49b6-9f57-b263f68f0629" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_eff8942d-cb5b-49b6-9f57-b263f68f0629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseOther_fd412aa4-0fc1-4210-9b2a-12e0cf2d48c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseOther"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_6a102623-6854-4497-a3dc-3ec0821d9f1e" xlink:to="loc_us-gaap_InterestExpenseOther_fd412aa4-0fc1-4210-9b2a-12e0cf2d48c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_764b79fa-b750-4f79-97c6-5f5ba69e92eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_764b79fa-b750-4f79-97c6-5f5ba69e92eb" xlink:to="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3a7d91e9-2f80-4f5e-8a7c-139f2782158e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:to="loc_us-gaap_PlanNameAxis_3a7d91e9-2f80-4f5e-8a7c-139f2782158e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_9307b4b6-a466-41fd-a0ab-d29d3ac4d788" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3a7d91e9-2f80-4f5e-8a7c-139f2782158e" xlink:to="loc_us-gaap_PlanNameDomain_9307b4b6-a466-41fd-a0ab-d29d3ac4d788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2022DirectorsPlanMember_f17f8314-bfe6-4670-8ba2-1be13dad4e88" xlink:href="prph-20231231.xsd#prph_A2022DirectorsPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9307b4b6-a466-41fd-a0ab-d29d3ac4d788" xlink:to="loc_prph_A2022DirectorsPlanMember_f17f8314-bfe6-4670-8ba2-1be13dad4e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_Amended2022DirectorsPlanMember_39efcc71-9cf8-4619-af89-d2be29dd8dc4" xlink:href="prph-20231231.xsd#prph_Amended2022DirectorsPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9307b4b6-a466-41fd-a0ab-d29d3ac4d788" xlink:to="loc_prph_Amended2022DirectorsPlanMember_39efcc71-9cf8-4619-af89-d2be29dd8dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_Amended2010DirectorsPlanMember_913b0b5b-86d1-42a5-8cc5-21c183b0f5f5" xlink:href="prph-20231231.xsd#prph_Amended2010DirectorsPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9307b4b6-a466-41fd-a0ab-d29d3ac4d788" xlink:to="loc_prph_Amended2010DirectorsPlanMember_913b0b5b-86d1-42a5-8cc5-21c183b0f5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_Amended2022PlanMember_37ee5918-e30d-4c32-9c06-cc74b5f81316" xlink:href="prph-20231231.xsd#prph_Amended2022PlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9307b4b6-a466-41fd-a0ab-d29d3ac4d788" xlink:to="loc_prph_Amended2022PlanMember_37ee5918-e30d-4c32-9c06-cc74b5f81316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2022PlanMember_36c076de-28ce-4b7d-82b3-6efb46092cb3" xlink:href="prph-20231231.xsd#prph_A2022PlanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9307b4b6-a466-41fd-a0ab-d29d3ac4d788" xlink:to="loc_prph_A2022PlanMember_36c076de-28ce-4b7d-82b3-6efb46092cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AmendedTwoThousandTenPlanMember_e26cdd81-147b-4e42-a3f9-c31f685462d1" xlink:href="prph-20231231.xsd#prph_AmendedTwoThousandTenPlanMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9307b4b6-a466-41fd-a0ab-d29d3ac4d788" xlink:to="loc_prph_AmendedTwoThousandTenPlanMember_e26cdd81-147b-4e42-a3f9-c31f685462d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_TwoThousandEighteenStockIncentivePlanMember_7d53f8c8-11c3-46b8-bd39-26a42bd3ab24" xlink:href="prph-20231231.xsd#prph_TwoThousandEighteenStockIncentivePlanMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9307b4b6-a466-41fd-a0ab-d29d3ac4d788" xlink:to="loc_prph_TwoThousandEighteenStockIncentivePlanMember_7d53f8c8-11c3-46b8-bd39-26a42bd3ab24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_0e48fa6a-ce97-44ff-8e56-e0f092326820" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:to="loc_srt_TitleOfIndividualAxis_0e48fa6a-ce97-44ff-8e56-e0f092326820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ed32bef4-b5c5-43e6-a96b-7f72e50b53d1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_0e48fa6a-ce97-44ff-8e56-e0f092326820" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ed32bef4-b5c5-43e6-a96b-7f72e50b53d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_8e4af234-4906-4683-87a5-5642e73e4c28" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ed32bef4-b5c5-43e6-a96b-7f72e50b53d1" xlink:to="loc_srt_ChiefExecutiveOfficerMember_8e4af234-4906-4683-87a5-5642e73e4c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_MrKamalObbadMember_d26dd85e-0a51-4ee1-bad0-bb8064e772fa" xlink:href="prph-20231231.xsd#prph_MrKamalObbadMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ed32bef4-b5c5-43e6-a96b-7f72e50b53d1" xlink:to="loc_prph_MrKamalObbadMember_d26dd85e-0a51-4ee1-bad0-bb8064e772fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefFinancialOfficerMember_9bee2e98-2bd0-40cf-8988-bd91c8472bc2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefFinancialOfficerMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ed32bef4-b5c5-43e6-a96b-7f72e50b53d1" xlink:to="loc_srt_ChiefFinancialOfficerMember_9bee2e98-2bd0-40cf-8988-bd91c8472bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b4a4e56e-65d4-49e8-a8ac-0031e6c88ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:to="loc_us-gaap_AwardTypeAxis_b4a4e56e-65d4-49e8-a8ac-0031e6c88ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c6507ee-1025-4ea4-864e-ccaf28b8fe8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b4a4e56e-65d4-49e8-a8ac-0031e6c88ff7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c6507ee-1025-4ea4-864e-ccaf28b8fe8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CEOOptionsMember_67215b71-4561-495c-aed4-36eeb6be7847" xlink:href="prph-20231231.xsd#prph_CEOOptionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c6507ee-1025-4ea4-864e-ccaf28b8fe8d" xlink:to="loc_prph_CEOOptionsMember_67215b71-4561-495c-aed4-36eeb6be7847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_InducementOptionAwardMember_964c2b0f-3c49-4118-aaa2-1d479706d800" xlink:href="prph-20231231.xsd#prph_InducementOptionAwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c6507ee-1025-4ea4-864e-ccaf28b8fe8d" xlink:to="loc_prph_InducementOptionAwardMember_964c2b0f-3c49-4118-aaa2-1d479706d800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CFOAwardMember_7ee9b969-90ce-4735-ad7f-5e8cce5bcc2c" xlink:href="prph-20231231.xsd#prph_CFOAwardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c6507ee-1025-4ea4-864e-ccaf28b8fe8d" xlink:to="loc_prph_CFOAwardMember_7ee9b969-90ce-4735-ad7f-5e8cce5bcc2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_12317122-d6d1-4335-9178-0e0382416a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_12317122-d6d1-4335-9178-0e0382416a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f32738a9-a06f-4592-81d0-9a7572af09e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_12317122-d6d1-4335-9178-0e0382416a4d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f32738a9-a06f-4592-81d0-9a7572af09e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_InducementOptionAwardMember_e2d312bf-dd1e-4b90-8b85-160f93de8a5e" xlink:href="prph-20231231.xsd#prph_InducementOptionAwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f32738a9-a06f-4592-81d0-9a7572af09e5" xlink:to="loc_prph_InducementOptionAwardMember_e2d312bf-dd1e-4b90-8b85-160f93de8a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3f29156e-404f-45a7-b271-3895c9175c55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3f29156e-404f-45a7-b271-3895c9175c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_93d521b6-69d0-45ba-ae28-f6e01fb97390" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3f29156e-404f-45a7-b271-3895c9175c55" xlink:to="loc_us-gaap_EquityComponentDomain_93d521b6-69d0-45ba-ae28-f6e01fb97390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0d65b3ee-50b4-4d70-9d3f-e3836f7bfdfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_93d521b6-69d0-45ba-ae28-f6e01fb97390" xlink:to="loc_us-gaap_CommonStockMember_0d65b3ee-50b4-4d70-9d3f-e3836f7bfdfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_6fa2fb42-1c95-44da-b375-05f03baefab8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_93d521b6-69d0-45ba-ae28-f6e01fb97390" xlink:to="loc_us-gaap_WarrantMember_6fa2fb42-1c95-44da-b375-05f03baefab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_7a5a7e7e-59ad-4634-95c9-34fc93f2d7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:to="loc_us-gaap_VestingAxis_7a5a7e7e-59ad-4634-95c9-34fc93f2d7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_7e833228-6fbd-49b0-a82b-2f42b4b9706c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_7a5a7e7e-59ad-4634-95c9-34fc93f2d7e5" xlink:to="loc_us-gaap_VestingDomain_7e833228-6fbd-49b0-a82b-2f42b4b9706c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_c249dc84-2f8b-4285-8afe-7f1128d3591c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_7e833228-6fbd-49b0-a82b-2f42b4b9706c" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_c249dc84-2f8b-4285-8afe-7f1128d3591c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_a5c20f6f-df1a-4e0a-8207-6b8fd7b49e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_7e833228-6fbd-49b0-a82b-2f42b4b9706c" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_a5c20f6f-df1a-4e0a-8207-6b8fd7b49e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_6a96587c-1a80-4d3a-9bb4-f6f69a499c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_7e833228-6fbd-49b0-a82b-2f42b4b9706c" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_6a96587c-1a80-4d3a-9bb4-f6f69a499c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationAwardTrancheFourMember_381aadcf-2738-4216-a6ec-b874691c52e3" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationAwardTrancheFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_7e833228-6fbd-49b0-a82b-2f42b4b9706c" xlink:to="loc_prph_ShareBasedCompensationAwardTrancheFourMember_381aadcf-2738-4216-a6ec-b874691c52e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_a0bfe702-76b2-4ae0-a796-5afea9dfbc52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_a0bfe702-76b2-4ae0-a796-5afea9dfbc52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_e38e249b-953d-4133-8295-efea19e7adc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_a0bfe702-76b2-4ae0-a796-5afea9dfbc52" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_e38e249b-953d-4133-8295-efea19e7adc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_A2023NotesWarrantsMember_673a5689-e071-448d-b798-82d240e737de" xlink:href="prph-20231231.xsd#prph_A2023NotesWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_e38e249b-953d-4133-8295-efea19e7adc5" xlink:to="loc_prph_A2023NotesWarrantsMember_673a5689-e071-448d-b798-82d240e737de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_07951270-3059-40a4-96b7-03e2791f5b7b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:to="loc_srt_RangeAxis_07951270-3059-40a4-96b7-03e2791f5b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_42e10246-f9b4-447c-b624-d74acb8c5bca" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_07951270-3059-40a4-96b7-03e2791f5b7b" xlink:to="loc_srt_RangeMember_42e10246-f9b4-447c-b624-d74acb8c5bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_eef6818e-5afa-4e9b-b1b0-8f248ca7991e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_42e10246-f9b4-447c-b624-d74acb8c5bca" xlink:to="loc_srt_MinimumMember_eef6818e-5afa-4e9b-b1b0-8f248ca7991e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_fdacc5c4-93e3-4081-a2a5-d70349747241" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_42e10246-f9b4-447c-b624-d74acb8c5bca" xlink:to="loc_srt_MaximumMember_fdacc5c4-93e3-4081-a2a5-d70349747241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_0a9efee6-64f9-4c6e-b738-2f8f563df09d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:to="loc_us-gaap_GranteeStatusAxis_0a9efee6-64f9-4c6e-b738-2f8f563df09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_2184cfad-7c81-4980-bf39-7ee916141443" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_0a9efee6-64f9-4c6e-b738-2f8f563df09d" xlink:to="loc_us-gaap_GranteeStatusDomain_2184cfad-7c81-4980-bf39-7ee916141443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CertainHoldersMember_c65ee5db-5640-4e13-8ca1-7c0380a445b4" xlink:href="prph-20231231.xsd#prph_CertainHoldersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_2184cfad-7c81-4980-bf39-7ee916141443" xlink:to="loc_prph_CertainHoldersMember_c65ee5db-5640-4e13-8ca1-7c0380a445b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_7931abe4-6a96-4de3-9de6-e34ee9fc98bd" xlink:to="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_f5d4dd90-b005-4745-9376-84f4c7c601af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_f5d4dd90-b005-4745-9376-84f4c7c601af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b991a17d-b649-4072-8789-850be7a9f76f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b991a17d-b649-4072-8789-850be7a9f76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_6340d35d-0176-4c18-84cd-8e0372d07686" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_6340d35d-0176-4c18-84cd-8e0372d07686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_08612308-0c0e-48ad-8b36-c6618d100df0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_08612308-0c0e-48ad-8b36-c6618d100df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_3703f261-259e-4aeb-98bf-6ff369d19b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_PreferredStockSharesIssued_3703f261-259e-4aeb-98bf-6ff369d19b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_d86be7df-4fed-41c0-af99-253a5c73054d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_DividendsCommonStock_d86be7df-4fed-41c0-af99-253a5c73054d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_9b8644b3-a554-4e39-baf7-ffdc5f9eb966" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_9b8644b3-a554-4e39-baf7-ffdc5f9eb966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_081a8968-bfda-456e-a964-e881088e643f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_081a8968-bfda-456e-a964-e881088e643f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_9e203021-0c83-42fa-9062-5a62dfd9e151" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_9e203021-0c83-42fa-9062-5a62dfd9e151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_785fdf1c-1e43-4ff1-a6de-815551da1e85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_785fdf1c-1e43-4ff1-a6de-815551da1e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_9e47f39a-6ba4-45ae-951c-67efde128add" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_9e47f39a-6ba4-45ae-951c-67efde128add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_eb4119e2-2b90-4b08-ba4c-56daa334e2f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_eb4119e2-2b90-4b08-ba4c-56daa334e2f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_81ad91a6-bfcf-4949-937c-dcd8020ff038" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_81ad91a6-bfcf-4949-937c-dcd8020ff038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance_e730a334-43a1-4a81-9748-99a96a1c974d" xlink:href="prph-20231231.xsd#prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance_e730a334-43a1-4a81-9748-99a96a1c974d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b8ecb36b-8c50-409c-b75c-ccaa78ddd17c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b8ecb36b-8c50-409c-b75c-ccaa78ddd17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_66e1973f-8057-4b29-94c6-c1b8bca9c8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_66e1973f-8057-4b29-94c6-c1b8bca9c8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4bb7f5b0-54f5-4be7-8b93-3b6be2db9c38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4bb7f5b0-54f5-4be7-8b93-3b6be2db9c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_17ab15ce-0e6f-4cb0-a8b1-dac85e6c003a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_17ab15ce-0e6f-4cb0-a8b1-dac85e6c003a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_86e98873-c1f2-4f7b-a228-cbc3374272af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_86e98873-c1f2-4f7b-a228-cbc3374272af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_90876515-7771-453b-8cdb-eda6c282dd45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_90876515-7771-453b-8cdb-eda6c282dd45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_7d6a054d-90b0-482e-9005-8d169c09a15f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_7d6a054d-90b0-482e-9005-8d169c09a15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_2de58a5d-a0a1-4a65-8f53-d1d6e429e146" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_2de58a5d-a0a1-4a65-8f53-d1d6e429e146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedPaymentArrangementExpenseReversal_4b2e15f6-78b5-4ec4-973d-db4ba701557f" xlink:href="prph-20231231.xsd#prph_ShareBasedPaymentArrangementExpenseReversal"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_prph_ShareBasedPaymentArrangementExpenseReversal_4b2e15f6-78b5-4ec4-973d-db4ba701557f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_b1f98a48-0cbd-402a-a086-bc6411985fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_b1f98a48-0cbd-402a-a086-bc6411985fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_92e41e57-64f4-4dbe-9e69-0c56ebf22836" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_92e41e57-64f4-4dbe-9e69-0c56ebf22836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_d2165ddf-0295-48a6-ac84-3c196f0688a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_d2165ddf-0295-48a6-ac84-3c196f0688a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_419e4341-72d3-4b94-a333-e030dd024be0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_419e4341-72d3-4b94-a333-e030dd024be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_6f3daec7-d5a6-4f5c-b46f-a25a599294e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_6f3daec7-d5a6-4f5c-b46f-a25a599294e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_6d7e2557-d33c-4453-ad30-f22644067614" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_6d7e2557-d33c-4453-ad30-f22644067614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_cacf220b-f650-4476-bdff-ba9a1ba36396" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_cacf220b-f650-4476-bdff-ba9a1ba36396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_45807dbe-09db-4a31-a2ee-98253ab55714" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_45807dbe-09db-4a31-a2ee-98253ab55714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_ac48728d-26d5-4d62-96d9-e65f016335b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_ac48728d-26d5-4d62-96d9-e65f016335b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_6e4f2c37-0d58-4d9b-96fa-adf15a090d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_6e4f2c37-0d58-4d9b-96fa-adf15a090d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_d85975f2-f0ee-4a66-ad1f-61427cdc6cae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_d85975f2-f0ee-4a66-ad1f-61427cdc6cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_e0c754c0-48b7-4759-8afa-39422db221d4" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_e0c754c0-48b7-4759-8afa-39422db221d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_70e44976-88b0-4730-a7ca-e1cdaf409837" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_70e44976-88b0-4730-a7ca-e1cdaf409837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_adfb807d-13e8-43a3-8a4a-d8ea1f38f279" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_adfb807d-13e8-43a3-8a4a-d8ea1f38f279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_b24a405a-b990-46b7-968f-fa5489dee7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_b24a405a-b990-46b7-968f-fa5489dee7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_22ddd560-627c-4fac-a41b-174d323c8d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_22ddd560-627c-4fac-a41b-174d323c8d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_af7ed7a6-b8c2-4e6a-b372-d55e3f9c6c98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_af7ed7a6-b8c2-4e6a-b372-d55e3f9c6c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_855fc325-2344-4c37-823b-03909683f8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_855fc325-2344-4c37-823b-03909683f8ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_fcb1fef4-dafc-444e-b71d-f0ec7a6644d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_fcb1fef4-dafc-444e-b71d-f0ec7a6644d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_90d1937b-75f0-45a1-baa2-a76f26d43170" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_90d1937b-75f0-45a1-baa2-a76f26d43170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_1993fd0e-49a6-4f08-bedb-169cfac0821f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_1993fd0e-49a6-4f08-bedb-169cfac0821f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5b17f68b-efda-41a2-8573-d07bcb3bb622" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5b17f68b-efda-41a2-8573-d07bcb3bb622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IssuanceOfCommonStockSharesExerciseOfWarrant_838a193f-4598-4a4b-98a7-18d41907a86c" xlink:href="prph-20231231.xsd#prph_IssuanceOfCommonStockSharesExerciseOfWarrant"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_prph_IssuanceOfCommonStockSharesExerciseOfWarrant_838a193f-4598-4a4b-98a7-18d41907a86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_20d2fd63-1bc0-458c-9a1f-260b978e9cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants"/>
    <link:presentationArc order="47" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_20d2fd63-1bc0-458c-9a1f-260b978e9cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2de2c145-61b0-4253-92c7-affa1e107942" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="48" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2de2c145-61b0-4253-92c7-affa1e107942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cc6e70a0-13d5-4008-81f1-0a5b9e3f6549" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="49" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cc6e70a0-13d5-4008-81f1-0a5b9e3f6549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1f7ebd6b-3a4e-4c10-9e0c-189f917fe836" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_0a939fa8-e1a5-476f-a159-98cf5d186574" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1f7ebd6b-3a4e-4c10-9e0c-189f917fe836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#StockholdersEquityScheduleofStockOptionsActivityDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d77ee14b-7911-4574-85f7-0698e1a2b47d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a9f95d84-c1f2-4312-aa52-415675bc4afa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d77ee14b-7911-4574-85f7-0698e1a2b47d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a9f95d84-c1f2-4312-aa52-415675bc4afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ea5b17b5-4452-4046-8174-b80544e6557f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a9f95d84-c1f2-4312-aa52-415675bc4afa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ea5b17b5-4452-4046-8174-b80544e6557f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9f024c35-af51-4337-a431-d7540cd36f99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a9f95d84-c1f2-4312-aa52-415675bc4afa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9f024c35-af51-4337-a431-d7540cd36f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6374b706-f179-46be-992d-a35fd05038bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a9f95d84-c1f2-4312-aa52-415675bc4afa" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6374b706-f179-46be-992d-a35fd05038bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1cf6bd35-17a7-4d53-b72c-72ededddae26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a9f95d84-c1f2-4312-aa52-415675bc4afa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1cf6bd35-17a7-4d53-b72c-72ededddae26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6539b49f-5454-4b15-9631-1fe2655dc9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a9f95d84-c1f2-4312-aa52-415675bc4afa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6539b49f-5454-4b15-9631-1fe2655dc9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_b5706044-337d-4487-a15c-44e897b276eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a9f95d84-c1f2-4312-aa52-415675bc4afa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_b5706044-337d-4487-a15c-44e897b276eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_7d28800c-e1b3-48bb-ad9c-81f6be8135da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d77ee14b-7911-4574-85f7-0698e1a2b47d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_7d28800c-e1b3-48bb-ad9c-81f6be8135da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_df3c88ab-ae34-4a0a-b45c-a0fa14ae823c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_7d28800c-e1b3-48bb-ad9c-81f6be8135da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_df3c88ab-ae34-4a0a-b45c-a0fa14ae823c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_437a8b65-9d17-47cb-bad3-691bf012c9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_7d28800c-e1b3-48bb-ad9c-81f6be8135da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_437a8b65-9d17-47cb-bad3-691bf012c9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2ff1834f-93cc-483a-830e-6d696442ea7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_7d28800c-e1b3-48bb-ad9c-81f6be8135da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2ff1834f-93cc-483a-830e-6d696442ea7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2a31e7c8-9367-4112-90eb-3eaa2fdbf630" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_7d28800c-e1b3-48bb-ad9c-81f6be8135da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2a31e7c8-9367-4112-90eb-3eaa2fdbf630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f70ec89f-00e4-4b6d-a4cb-3969b2db6264" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_7d28800c-e1b3-48bb-ad9c-81f6be8135da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f70ec89f-00e4-4b6d-a4cb-3969b2db6264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_53d2291e-4d5d-4dfa-9a73-6ce741beb275" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_7d28800c-e1b3-48bb-ad9c-81f6be8135da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_53d2291e-4d5d-4dfa-9a73-6ce741beb275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_9ec07aa9-8528-4fc2-9bca-091e1d48c50f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d77ee14b-7911-4574-85f7-0698e1a2b47d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_9ec07aa9-8528-4fc2-9bca-091e1d48c50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c08f0239-f44f-4031-89c0-1b45c8ac07f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_9ec07aa9-8528-4fc2-9bca-091e1d48c50f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c08f0239-f44f-4031-89c0-1b45c8ac07f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_3c41eab1-7fef-4f78-8fc7-bc54c54da2bc" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_9ec07aa9-8528-4fc2-9bca-091e1d48c50f" xlink:to="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_3c41eab1-7fef-4f78-8fc7-bc54c54da2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_85735e34-4e43-43a5-baf9-eae62f092dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_9ec07aa9-8528-4fc2-9bca-091e1d48c50f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_85735e34-4e43-43a5-baf9-eae62f092dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_cd5d3b57-41ed-4b22-ab45-76f62beccc98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_9ec07aa9-8528-4fc2-9bca-091e1d48c50f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_cd5d3b57-41ed-4b22-ab45-76f62beccc98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2a63bb6c-081f-4246-8d9f-d2aacf662a53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_9ec07aa9-8528-4fc2-9bca-091e1d48c50f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2a63bb6c-081f-4246-8d9f-d2aacf662a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_8b93dfea-43f5-47b0-8a45-2491e7a20c45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_9ec07aa9-8528-4fc2-9bca-091e1d48c50f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_8b93dfea-43f5-47b0-8a45-2491e7a20c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/StockholdersEquitySummaryofWeightedAverageAssumptionsUsedinDeterminingFairValueofOptionsDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#StockholdersEquitySummaryofWeightedAverageAssumptionsUsedinDeterminingFairValueofOptionsDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/StockholdersEquitySummaryofWeightedAverageAssumptionsUsedinDeterminingFairValueofOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_10ce4424-dba2-4c03-b3d6-5e5f87bbb4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_d81ddfdf-4133-4348-af4d-a344f8052e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_10ce4424-dba2-4c03-b3d6-5e5f87bbb4f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_d81ddfdf-4133-4348-af4d-a344f8052e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_771ee0f2-cdc0-4b82-bec9-2b4e94724d94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_10ce4424-dba2-4c03-b3d6-5e5f87bbb4f4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_771ee0f2-cdc0-4b82-bec9-2b4e94724d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_febab412-73b9-496f-a489-eb032f7c9923" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_10ce4424-dba2-4c03-b3d6-5e5f87bbb4f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_febab412-73b9-496f-a489-eb032f7c9923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a9bba96e-2f31-4b2a-9d58-b179660fa19f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_10ce4424-dba2-4c03-b3d6-5e5f87bbb4f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a9bba96e-2f31-4b2a-9d58-b179660fa19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ce5d2889-1c70-4f8e-a5b4-cebe0a8bb65e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_10ce4424-dba2-4c03-b3d6-5e5f87bbb4f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ce5d2889-1c70-4f8e-a5b4-cebe0a8bb65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#StockholdersEquityScheduleofWarrantActivityDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_91396bb9-7bee-4fbb-bbc7-caa18b94a762" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_889ebce3-9129-463a-b358-bd88c3b5f9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_91396bb9-7bee-4fbb-bbc7-caa18b94a762" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_889ebce3-9129-463a-b358-bd88c3b5f9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5ed6a7b3-0cb9-41c7-adbd-755dac3b3ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_889ebce3-9129-463a-b358-bd88c3b5f9ac" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5ed6a7b3-0cb9-41c7-adbd-755dac3b3ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0f837e19-2eca-462d-aa8d-2f97dabdeffb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5ed6a7b3-0cb9-41c7-adbd-755dac3b3ffb" xlink:to="loc_us-gaap_EquityComponentDomain_0f837e19-2eca-462d-aa8d-2f97dabdeffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_21579542-dec4-408d-a5d3-7902f834b263" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0f837e19-2eca-462d-aa8d-2f97dabdeffb" xlink:to="loc_us-gaap_WarrantMember_21579542-dec4-408d-a5d3-7902f834b263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4623c548-9cbd-4498-aef7-fb51b0b86c69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_889ebce3-9129-463a-b358-bd88c3b5f9ac" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4623c548-9cbd-4498-aef7-fb51b0b86c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0adc45aa-f38b-4007-91d8-80a2c7347b12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4623c548-9cbd-4498-aef7-fb51b0b86c69" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0adc45aa-f38b-4007-91d8-80a2c7347b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_909c40aa-7712-444c-b718-62fadf7ab2b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0adc45aa-f38b-4007-91d8-80a2c7347b12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_909c40aa-7712-444c-b718-62fadf7ab2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_f4ed064b-745e-4f7c-b7be-737801f10d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0adc45aa-f38b-4007-91d8-80a2c7347b12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_f4ed064b-745e-4f7c-b7be-737801f10d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2098d78d-c89f-419b-ad30-c41ac61c1776" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0adc45aa-f38b-4007-91d8-80a2c7347b12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2098d78d-c89f-419b-ad30-c41ac61c1776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3d1b3125-a602-4f4d-86eb-a21c13e9b987" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0adc45aa-f38b-4007-91d8-80a2c7347b12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3d1b3125-a602-4f4d-86eb-a21c13e9b987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber_1d147009-e6b0-4ac9-9ce0-7582411da0b1" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0adc45aa-f38b-4007-91d8-80a2c7347b12" xlink:to="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber_1d147009-e6b0-4ac9-9ce0-7582411da0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_6cbe455a-459a-488a-8241-83b1b22cccc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4623c548-9cbd-4498-aef7-fb51b0b86c69" xlink:to="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_6cbe455a-459a-488a-8241-83b1b22cccc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1_9e1891cb-61bd-4b3f-979c-4b3313e3b1fb" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_6cbe455a-459a-488a-8241-83b1b22cccc2" xlink:to="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1_9e1891cb-61bd-4b3f-979c-4b3313e3b1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1_d2fd4fb7-d801-4503-9bda-580d4578c10b" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_6cbe455a-459a-488a-8241-83b1b22cccc2" xlink:to="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1_d2fd4fb7-d801-4503-9bda-580d4578c10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_WeightedAverageExercisePriceWarrantsExercised_bc1d261d-79c4-4c55-b7f5-03f34cb4210c" xlink:href="prph-20231231.xsd#prph_WeightedAverageExercisePriceWarrantsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_6cbe455a-459a-488a-8241-83b1b22cccc2" xlink:to="loc_prph_WeightedAverageExercisePriceWarrantsExercised_bc1d261d-79c4-4c55-b7f5-03f34cb4210c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1_0b391cff-6b84-4220-8437-52a547c7a989" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_6cbe455a-459a-488a-8241-83b1b22cccc2" xlink:to="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1_0b391cff-6b84-4220-8437-52a547c7a989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1_69320658-0f71-4c26-b087-35178e6ddbf5" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_6cbe455a-459a-488a-8241-83b1b22cccc2" xlink:to="loc_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1_69320658-0f71-4c26-b087-35178e6ddbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_f6421c62-dc0d-422d-bdee-6803a6f89a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4623c548-9cbd-4498-aef7-fb51b0b86c69" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_f6421c62-dc0d-422d-bdee-6803a6f89a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2_6497f090-ccb6-475a-8d22-5cdb90fbc956" xlink:href="prph-20231231.xsd#prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4623c548-9cbd-4498-aef7-fb51b0b86c69" xlink:to="loc_prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2_6497f090-ccb6-475a-8d22-5cdb90fbc956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable_a3327d3f-8265-4734-a1b8-fb0840afde50" xlink:href="prph-20231231.xsd#prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4623c548-9cbd-4498-aef7-fb51b0b86c69" xlink:to="loc_prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable_a3327d3f-8265-4734-a1b8-fb0840afde50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/DefinedContributionPlansDetailsNarrative" xlink:type="simple" xlink:href="prph-20231231.xsd#DefinedContributionPlansDetailsNarrative"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/DefinedContributionPlansDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f7a5af3a-1e45-41c2-a61f-432d644eae9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_6d7eca44-a0ac-417c-884c-be034a7fc469" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f7a5af3a-1e45-41c2-a61f-432d644eae9c" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_6d7eca44-a0ac-417c-884c-be034a7fc469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8e410d86-4a21-45bb-b999-c6d942807727" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1237aa9e-323a-4172-b462-3a579079e62d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8e410d86-4a21-45bb-b999-c6d942807727" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1237aa9e-323a-4172-b462-3a579079e62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_e537faf5-0623-430c-b0cb-4faf0be74483" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1237aa9e-323a-4172-b462-3a579079e62d" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_e537faf5-0623-430c-b0cb-4faf0be74483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9cbc2ad2-b06b-4860-8359-718e83cee3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1237aa9e-323a-4172-b462-3a579079e62d" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9cbc2ad2-b06b-4860-8359-718e83cee3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_8415f598-61bd-462b-95e0-d23b2b9f4392" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1237aa9e-323a-4172-b462-3a579079e62d" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_8415f598-61bd-462b-95e0-d23b2b9f4392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_52cb2e67-61aa-4eac-9d9a-9c6c3c884fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8e410d86-4a21-45bb-b999-c6d942807727" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_52cb2e67-61aa-4eac-9d9a-9c6c3c884fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7fc6d00d-c042-4bc4-a80d-9980804a3eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_52cb2e67-61aa-4eac-9d9a-9c6c3c884fe3" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7fc6d00d-c042-4bc4-a80d-9980804a3eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_1782459f-89d9-4c20-8df7-39fc5b59450b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_52cb2e67-61aa-4eac-9d9a-9c6c3c884fe3" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_1782459f-89d9-4c20-8df7-39fc5b59450b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_91b39f0f-3e92-47a9-9fbc-665ea7b1a1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_52cb2e67-61aa-4eac-9d9a-9c6c3c884fe3" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_91b39f0f-3e92-47a9-9fbc-665ea7b1a1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9b48df0f-451e-4235-bbf3-2cc384bcd896" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8e410d86-4a21-45bb-b999-c6d942807727" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9b48df0f-451e-4235-bbf3-2cc384bcd896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_89e2a97d-1aa3-4c90-9184-0fbfdc0002f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_9f15166d-20ef-4923-a973-03e13579b3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89e2a97d-1aa3-4c90-9184-0fbfdc0002f1" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_9f15166d-20ef-4923-a973-03e13579b3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_1e619745-4c84-494b-b92f-0a0f1211772b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89e2a97d-1aa3-4c90-9184-0fbfdc0002f1" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_1e619745-4c84-494b-b92f-0a0f1211772b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_f7ecdd4b-83f0-4e1b-9da8-2e1de1738384" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89e2a97d-1aa3-4c90-9184-0fbfdc0002f1" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_f7ecdd4b-83f0-4e1b-9da8-2e1de1738384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_f1e0dd8b-5b9f-4752-b829-c1d1f0dde9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89e2a97d-1aa3-4c90-9184-0fbfdc0002f1" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_f1e0dd8b-5b9f-4752-b829-c1d1f0dde9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance_89ad8a54-ba2f-48d8-ba67-dd50a05b0b95" xlink:href="prph-20231231.xsd#prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89e2a97d-1aa3-4c90-9184-0fbfdc0002f1" xlink:to="loc_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance_89ad8a54-ba2f-48d8-ba67-dd50a05b0b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_feea3bec-a348-46b4-a654-a16f31a55474" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89e2a97d-1aa3-4c90-9184-0fbfdc0002f1" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_feea3bec-a348-46b4-a654-a16f31a55474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a21c1e10-d514-45eb-a297-c15263b7a782" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_89e2a97d-1aa3-4c90-9184-0fbfdc0002f1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a21c1e10-d514-45eb-a297-c15263b7a782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6c62abe0-5841-445b-882f-359ed3f757bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_19e8994e-974f-40f1-98d3-1a6f0ebcca62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6c62abe0-5841-445b-882f-359ed3f757bf" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_19e8994e-974f-40f1-98d3-1a6f0ebcca62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_a9b09607-3e6f-406e-92f3-68b472c1eef0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6c62abe0-5841-445b-882f-359ed3f757bf" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_a9b09607-3e6f-406e-92f3-68b472c1eef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_19857ac7-ea36-45ef-bb23-bde7f3e5a446" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6c62abe0-5841-445b-882f-359ed3f757bf" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_19857ac7-ea36-45ef-bb23-bde7f3e5a446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DeferredTaxAssetsCapitalLeaseObligations_1da01c9b-f6ba-45fa-966a-24bcacf55412" xlink:href="prph-20231231.xsd#prph_DeferredTaxAssetsCapitalLeaseObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6c62abe0-5841-445b-882f-359ed3f757bf" xlink:to="loc_prph_DeferredTaxAssetsCapitalLeaseObligations_1da01c9b-f6ba-45fa-966a-24bcacf55412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DeferredTaxLiabilitiesDepreciation_677d899d-d4bb-430e-8a53-95662098316f" xlink:href="prph-20231231.xsd#prph_DeferredTaxLiabilitiesDepreciation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6c62abe0-5841-445b-882f-359ed3f757bf" xlink:to="loc_prph_DeferredTaxLiabilitiesDepreciation_677d899d-d4bb-430e-8a53-95662098316f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DeferredTaxLiabilitiesAmortization_f81f8e7e-7226-497a-a21b-3f20b8a1f186" xlink:href="prph-20231231.xsd#prph_DeferredTaxLiabilitiesAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6c62abe0-5841-445b-882f-359ed3f757bf" xlink:to="loc_prph_DeferredTaxLiabilitiesAmortization_f81f8e7e-7226-497a-a21b-3f20b8a1f186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_49d9447a-ce9d-470a-8143-895a3c6ae770" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6c62abe0-5841-445b-882f-359ed3f757bf" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_49d9447a-ce9d-470a-8143-895a3c6ae770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5638e338-bacb-459a-907f-73dba2ab7142" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6c62abe0-5841-445b-882f-359ed3f757bf" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5638e338-bacb-459a-907f-73dba2ab7142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c71d305a-baf6-4f55-9f21-bf0cc731db11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6c62abe0-5841-445b-882f-359ed3f757bf" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c71d305a-baf6-4f55-9f21-bf0cc731db11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_7ba2c905-c4ab-441b-b6dd-30133e369a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6c62abe0-5841-445b-882f-359ed3f757bf" xlink:to="loc_us-gaap_DeferredTaxLiabilities_7ba2c905-c4ab-441b-b6dd-30133e369a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b3b3def7-f309-4484-b37b-876fec2ca645" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_14f5ba7a-8f05-4a3f-9354-293aa3c08947" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b3b3def7-f309-4484-b37b-876fec2ca645" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_14f5ba7a-8f05-4a3f-9354-293aa3c08947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_09d336a2-db08-4183-a5ef-110b238de42b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b3b3def7-f309-4484-b37b-876fec2ca645" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_09d336a2-db08-4183-a5ef-110b238de42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_6e17c7f6-0f02-459d-98eb-bf40ea63d840" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b3b3def7-f309-4484-b37b-876fec2ca645" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_6e17c7f6-0f02-459d-98eb-bf40ea63d840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_7d189bcb-cff8-4d40-97bb-e5f3f1f62ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b3b3def7-f309-4484-b37b-876fec2ca645" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_7d189bcb-cff8-4d40-97bb-e5f3f1f62ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_TaxCreditCarryforwardLimitationAmount_734c3545-e1ee-4642-90df-21a8169fd3e6" xlink:href="prph-20231231.xsd#prph_TaxCreditCarryforwardLimitationAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b3b3def7-f309-4484-b37b-876fec2ca645" xlink:to="loc_prph_TaxCreditCarryforwardLimitationAmount_734c3545-e1ee-4642-90df-21a8169fd3e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_fa6b04cb-6df3-4b9a-8440-c81747186eec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesForCommissionsExpenseAndTaxes_4def9ff7-7eee-48f8-bfad-900810e0d4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesForCommissionsExpenseAndTaxes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_fa6b04cb-6df3-4b9a-8440-c81747186eec" xlink:to="loc_us-gaap_AccruedLiabilitiesForCommissionsExpenseAndTaxes_4def9ff7-7eee-48f8-bfad-900810e0d4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrent_bda82706-e2ea-4a95-813b-a8a7f7b175b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedPayrollTaxesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_fa6b04cb-6df3-4b9a-8440-c81747186eec" xlink:to="loc_us-gaap_AccruedPayrollTaxesCurrent_bda82706-e2ea-4a95-813b-a8a7f7b175b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrent_eb71a51d-5d0b-4894-8b47-e9b256509154" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedBonusesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_fa6b04cb-6df3-4b9a-8440-c81747186eec" xlink:to="loc_us-gaap_AccruedBonusesCurrent_eb71a51d-5d0b-4894-8b47-e9b256509154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_83772357-c61c-41c2-aa1b-b90cfe52779e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_fa6b04cb-6df3-4b9a-8440-c81747186eec" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_83772357-c61c-41c2-aa1b-b90cfe52779e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AccruedReturns_3e757419-f6a1-45c7-a6f8-796493a141ae" xlink:href="prph-20231231.xsd#prph_AccruedReturns"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_fa6b04cb-6df3-4b9a-8440-c81747186eec" xlink:to="loc_prph_AccruedReturns_3e757419-f6a1-45c7-a6f8-796493a141ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_369a0fac-ffc8-4e89-8028-f7200187ba25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_fa6b04cb-6df3-4b9a-8440-c81747186eec" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_369a0fac-ffc8-4e89-8028-f7200187ba25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_fb3c2ed6-2991-400a-ada0-02eb9c139c69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_fa6b04cb-6df3-4b9a-8440-c81747186eec" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_fb3c2ed6-2991-400a-ada0-02eb9c139c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_85a1d355-46f6-4f3f-b020-0e6694e64c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_152a9ad4-211a-4c7f-9ef4-ea5a1376869d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_85a1d355-46f6-4f3f-b020-0e6694e64c1f" xlink:to="loc_us-gaap_OtherCommitmentsTable_152a9ad4-211a-4c7f-9ef4-ea5a1376869d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_dee4770a-74ea-4ed7-b5db-2aea99dc2e87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_152a9ad4-211a-4c7f-9ef4-ea5a1376869d" xlink:to="loc_us-gaap_AwardTypeAxis_dee4770a-74ea-4ed7-b5db-2aea99dc2e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_192ee536-f4a0-4b28-af0f-932d235be199" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_dee4770a-74ea-4ed7-b5db-2aea99dc2e87" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_192ee536-f4a0-4b28-af0f-932d235be199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_PhaseThreeMember_68dbc3dd-9da9-4cb2-8cc3-c44db041879b" xlink:href="prph-20231231.xsd#prph_PhaseThreeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_192ee536-f4a0-4b28-af0f-932d235be199" xlink:to="loc_prph_PhaseThreeMember_68dbc3dd-9da9-4cb2-8cc3-c44db041879b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NewDrugApplicationMember_f24c5aa2-406a-4a13-9242-ca4145a10dac" xlink:href="prph-20231231.xsd#prph_NewDrugApplicationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_192ee536-f4a0-4b28-af0f-932d235be199" xlink:to="loc_prph_NewDrugApplicationMember_f24c5aa2-406a-4a13-9242-ca4145a10dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_bee795a4-3e65-4180-a109-315d33261a26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_152a9ad4-211a-4c7f-9ef4-ea5a1376869d" xlink:to="loc_us-gaap_TypeOfArrangementAxis_bee795a4-3e65-4180-a109-315d33261a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0833ea01-58d8-4ce2-866f-d8b522a4fdc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_bee795a4-3e65-4180-a109-315d33261a26" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0833ea01-58d8-4ce2-866f-d8b522a4fdc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LinebackerLicenseAgreementsMember_cebf4131-a13f-4cde-9890-8bcc89eca732" xlink:href="prph-20231231.xsd#prph_LinebackerLicenseAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0833ea01-58d8-4ce2-866f-d8b522a4fdc5" xlink:to="loc_prph_LinebackerLicenseAgreementsMember_cebf4131-a13f-4cde-9890-8bcc89eca732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_EquivirLicenseAgreementMember_d40d4c7a-053f-4344-9a29-014fe56d5173" xlink:href="prph-20231231.xsd#prph_EquivirLicenseAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0833ea01-58d8-4ce2-866f-d8b522a4fdc5" xlink:to="loc_prph_EquivirLicenseAgreementMember_d40d4c7a-053f-4344-9a29-014fe56d5173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_BESmartLicenseAgreementMember_09eb8f59-5829-42d7-92fe-33b751a06f56" xlink:href="prph-20231231.xsd#prph_BESmartLicenseAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0833ea01-58d8-4ce2-866f-d8b522a4fdc5" xlink:to="loc_prph_BESmartLicenseAgreementMember_09eb8f59-5829-42d7-92fe-33b751a06f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_152a9ad4-211a-4c7f-9ef4-ea5a1376869d" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ManufacturingAgreementRenewalOptions_9de28d1e-1b29-4d88-9c2e-05ad4ac52bac" xlink:href="prph-20231231.xsd#prph_ManufacturingAgreementRenewalOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_prph_ManufacturingAgreementRenewalOptions_9de28d1e-1b29-4d88-9c2e-05ad4ac52bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ManufacturingAgreementRenewalPeriod_ba90c432-8468-409f-8133-ab8438994114" xlink:href="prph-20231231.xsd#prph_ManufacturingAgreementRenewalPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_prph_ManufacturingAgreementRenewalPeriod_ba90c432-8468-409f-8133-ab8438994114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AgreementTerm_3cfb5c29-0753-46f7-9609-04f90633611e" xlink:href="prph-20231231.xsd#prph_AgreementTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_prph_AgreementTerm_3cfb5c29-0753-46f7-9609-04f90633611e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_UpfrontLicenseFee_674088ce-4d01-4755-b165-71dc8e161982" xlink:href="prph-20231231.xsd#prph_UpfrontLicenseFee"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_prph_UpfrontLicenseFee_674088ce-4d01-4755-b165-71dc8e161982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LicenseAgreementTerm_ac97e444-debe-41b5-991b-7bd91d11596f" xlink:href="prph-20231231.xsd#prph_LicenseAgreementTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_prph_LicenseAgreementTerm_ac97e444-debe-41b5-991b-7bd91d11596f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_AdditionalPaymentOfFee_4f0f12d1-67d0-4f51-a911-5eeaa27ef100" xlink:href="prph-20231231.xsd#prph_AdditionalPaymentOfFee"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_prph_AdditionalPaymentOfFee_4f0f12d1-67d0-4f51-a911-5eeaa27ef100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LicenseOrRoyaltyNetRevenuePercentage_1d6f5aed-5b64-4518-8ff1-3a07c276a816" xlink:href="prph-20231231.xsd#prph_LicenseOrRoyaltyNetRevenuePercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_prph_LicenseOrRoyaltyNetRevenuePercentage_1d6f5aed-5b64-4518-8ff1-3a07c276a816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_47d0ca51-bf38-4768-bd5f-d18aac6dbe59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_us-gaap_RoyaltyExpense_47d0ca51-bf38-4768-bd5f-d18aac6dbe59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_7edfe703-7ac6-4426-ac6f-7417f84cc473" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_7edfe703-7ac6-4426-ac6f-7417f84cc473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NumberOfSites_4b28b12e-0a34-4c9f-ab64-51cb03443434" xlink:href="prph-20231231.xsd#prph_NumberOfSites"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f901fad0-0784-4b37-bd0f-dfd0aaff730f" xlink:to="loc_prph_NumberOfSites_4b28b12e-0a34-4c9f-ab64-51cb03443434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_64276830-77a1-4460-9e06-175c1f40eb21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_da060538-470f-45b2-aabf-52697c492ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_64276830-77a1-4460-9e06-175c1f40eb21" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_da060538-470f-45b2-aabf-52697c492ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_402d40d7-f790-4b2e-a005-5861720cad96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_da060538-470f-45b2-aabf-52697c492ecf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_402d40d7-f790-4b2e-a005-5861720cad96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6dd400a5-365c-45fa-83f6-97c99bb93b54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_402d40d7-f790-4b2e-a005-5861720cad96" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6dd400a5-365c-45fa-83f6-97c99bb93b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CPMMember_4baacdc3-c2d8-4321-b9e4-0271b2498791" xlink:href="prph-20231231.xsd#prph_CPMMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6dd400a5-365c-45fa-83f6-97c99bb93b54" xlink:to="loc_prph_CPMMember_4baacdc3-c2d8-4321-b9e4-0271b2498791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_b6eb1198-d254-49da-b025-365465624a44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_da060538-470f-45b2-aabf-52697c492ecf" xlink:to="loc_us-gaap_GeographicDistributionAxis_b6eb1198-d254-49da-b025-365465624a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_d5df5505-b951-4c5c-a63f-c174e9140bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionAxis_b6eb1198-d254-49da-b025-365465624a44" xlink:to="loc_us-gaap_GeographicDistributionDomain_d5df5505-b951-4c5c-a63f-c174e9140bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_OldBridgeNewJerseyMember_3103f0f6-5053-4c85-ad02-e9c9851a94c1" xlink:href="prph-20231231.xsd#prph_OldBridgeNewJerseyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_d5df5505-b951-4c5c-a63f-c174e9140bb5" xlink:to="loc_prph_OldBridgeNewJerseyMember_3103f0f6-5053-4c85-ad02-e9c9851a94c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NewYorkSecondFloorLeaseMember_cd6e9f6c-5bdb-4ae2-bd02-6b7d4937f9c2" xlink:href="prph-20231231.xsd#prph_NewYorkSecondFloorLeaseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_d5df5505-b951-4c5c-a63f-c174e9140bb5" xlink:to="loc_prph_NewYorkSecondFloorLeaseMember_cd6e9f6c-5bdb-4ae2-bd02-6b7d4937f9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_NewYorkFirstFloorLeaseMember_c8e67f36-6819-4f92-ab9b-d64f2f1dcd76" xlink:href="prph-20231231.xsd#prph_NewYorkFirstFloorLeaseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_d5df5505-b951-4c5c-a63f-c174e9140bb5" xlink:to="loc_prph_NewYorkFirstFloorLeaseMember_c8e67f36-6819-4f92-ab9b-d64f2f1dcd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_226fb284-de52-4224-9cc0-327041244db6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_da060538-470f-45b2-aabf-52697c492ecf" xlink:to="loc_srt_RangeAxis_226fb284-de52-4224-9cc0-327041244db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fe8ce1b8-878d-4ff2-8a3b-f24da8164a66" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_226fb284-de52-4224-9cc0-327041244db6" xlink:to="loc_srt_RangeMember_fe8ce1b8-878d-4ff2-8a3b-f24da8164a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_32eb7ba6-edf5-49dd-9ae5-19fb778b27a3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fe8ce1b8-878d-4ff2-8a3b-f24da8164a66" xlink:to="loc_srt_MinimumMember_32eb7ba6-edf5-49dd-9ae5-19fb778b27a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e29392ae-d6db-4423-b164-4e3b39a75831" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fe8ce1b8-878d-4ff2-8a3b-f24da8164a66" xlink:to="loc_srt_MaximumMember_e29392ae-d6db-4423-b164-4e3b39a75831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_da060538-470f-45b2-aabf-52697c492ecf" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_60b5ccc6-097d-477e-a8f7-9d47b587def0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_60b5ccc6-097d-477e-a8f7-9d47b587def0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_294aa2c3-d7bb-4884-908d-b3faf4674bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_294aa2c3-d7bb-4884-908d-b3faf4674bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LesseeOperatingLeaseMonthlyBaseRent_63412c5b-39d1-436f-9bbc-af99e286f229" xlink:href="prph-20231231.xsd#prph_LesseeOperatingLeaseMonthlyBaseRent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_prph_LesseeOperatingLeaseMonthlyBaseRent_63412c5b-39d1-436f-9bbc-af99e286f229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_97f55cd6-58bf-4ecb-847a-df69e498fa50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_OperatingLeaseLiability_97f55cd6-58bf-4ecb-847a-df69e498fa50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LesseeOperatingLeaseNumberOfRenewalOptions_37164d4c-b1cc-4513-8e9d-486a94812048" xlink:href="prph-20231231.xsd#prph_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_prph_LesseeOperatingLeaseNumberOfRenewalOptions_37164d4c-b1cc-4513-8e9d-486a94812048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod_ac9bb69d-d97a-453e-b2f0-c9efc5d8bd0f" xlink:href="prph-20231231.xsd#prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod_ac9bb69d-d97a-453e-b2f0-c9efc5d8bd0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_7f61c045-ec3b-4ff3-88a1-a5700ca6e5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_7f61c045-ec3b-4ff3-88a1-a5700ca6e5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRent_607889fb-5f81-464c-8d53-4f90e928b47b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_PaymentsForRent_607889fb-5f81-464c-8d53-4f90e928b47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LesseeOperatingLeaseAbatementPeriod_70b39316-b9e8-4b44-bf9d-23fac14d58c5" xlink:href="prph-20231231.xsd#prph_LesseeOperatingLeaseAbatementPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_prph_LesseeOperatingLeaseAbatementPeriod_70b39316-b9e8-4b44-bf9d-23fac14d58c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_GradualRentalRateIncreasePercentage_d98cec9e-abf5-4895-82e0-db7ec4574a51" xlink:href="prph-20231231.xsd#prph_GradualRentalRateIncreasePercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_prph_GradualRentalRateIncreasePercentage_d98cec9e-abf5-4895-82e0-db7ec4574a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidRent_d3eeba5c-14e7-4762-89b4-179f7d10f8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidRent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_PrepaidRent_d3eeba5c-14e7-4762-89b4-179f7d10f8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ConstructionAllowance_afc7de07-448f-40d7-95d6-d6bed927880b" xlink:href="prph-20231231.xsd#prph_ConstructionAllowance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_prph_ConstructionAllowance_afc7de07-448f-40d7-95d6-d6bed927880b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e2686926-170b-4016-9059-2438b4c72c43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e2686926-170b-4016-9059-2438b4c72c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_eaf27b69-8d65-4ac4-8897-ac26acb0a4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_eaf27b69-8d65-4ac4-8897-ac26acb0a4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e4bdaa4d-a673-4c5c-a7d7-ab538ae524b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e4bdaa4d-a673-4c5c-a7d7-ab538ae524b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_571864f4-2b18-480a-ba3a-771b15a5269a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_571864f4-2b18-480a-ba3a-771b15a5269a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_8d62bb92-e7af-4e64-b7f4-44cae7810173" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_ce0bd95f-501d-454b-98e1-b440af0191eb" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_8d62bb92-e7af-4e64-b7f4-44cae7810173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3d2214d0-7691-4a95-86ae-e67513ed8649" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_1d8995b3-e475-4dd7-9e0a-d342ba8630f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3d2214d0-7691-4a95-86ae-e67513ed8649" xlink:to="loc_us-gaap_LeasesOperatingAbstract_1d8995b3-e475-4dd7-9e0a-d342ba8630f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_ab6e5181-f759-4560-bdcb-682fcea25415" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_1d8995b3-e475-4dd7-9e0a-d342ba8630f1" xlink:to="loc_us-gaap_OperatingLeaseCost_ab6e5181-f759-4560-bdcb-682fcea25415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_10a8fc87-19a2-4409-9c3d-4d33a34510dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_1d8995b3-e475-4dd7-9e0a-d342ba8630f1" xlink:to="loc_us-gaap_VariableLeaseCost_10a8fc87-19a2-4409-9c3d-4d33a34510dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_e58b871a-0cd6-468f-966b-712ede595c22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3d2214d0-7691-4a95-86ae-e67513ed8649" xlink:to="loc_us-gaap_LeaseCostAbstract_e58b871a-0cd6-468f-966b-712ede595c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_0eb337f1-8b3d-4d7b-beda-0f0ff33bd351" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_e58b871a-0cd6-468f-966b-712ede595c22" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_0eb337f1-8b3d-4d7b-beda-0f0ff33bd351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_7f1096da-6117-4ff8-ac12-bfd76a6f35fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_e58b871a-0cd6-468f-966b-712ede595c22" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_7f1096da-6117-4ff8-ac12-bfd76a6f35fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_FinanceLeaseCost_f6cadcd1-7ce5-460a-bf1f-63b32dcfadbe" xlink:href="prph-20231231.xsd#prph_FinanceLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_e58b871a-0cd6-468f-966b-712ede595c22" xlink:to="loc_prph_FinanceLeaseCost_f6cadcd1-7ce5-460a-bf1f-63b32dcfadbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_e566912c-da8b-4278-8a31-5faf191faa07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3d2214d0-7691-4a95-86ae-e67513ed8649" xlink:to="loc_us-gaap_OperatingLeasePayments_e566912c-da8b-4278-8a31-5faf191faa07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_159f3fda-90f7-4d1c-9531-773a7f26320a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3d2214d0-7691-4a95-86ae-e67513ed8649" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_159f3fda-90f7-4d1c-9531-773a7f26320a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_37f02f75-1480-41b1-a601-f16bc1cb2b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3d2214d0-7691-4a95-86ae-e67513ed8649" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_37f02f75-1480-41b1-a601-f16bc1cb2b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2796c696-b8b7-4692-b3e3-a7e4568ca578" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3d2214d0-7691-4a95-86ae-e67513ed8649" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2796c696-b8b7-4692-b3e3-a7e4568ca578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_477062f2-1f4b-4a80-a940-d2f071432435" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3d2214d0-7691-4a95-86ae-e67513ed8649" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_477062f2-1f4b-4a80-a940-d2f071432435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_1d48dba7-ec18-4fc7-940c-7811b1ba5d01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3d2214d0-7691-4a95-86ae-e67513ed8649" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_1d48dba7-ec18-4fc7-940c-7811b1ba5d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_c81d9833-5394-4115-8ce1-71f600fa4632" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3d2214d0-7691-4a95-86ae-e67513ed8649" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_c81d9833-5394-4115-8ce1-71f600fa4632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_b2a1058d-7b65-4af8-a7ca-46c73dc54e20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3d2214d0-7691-4a95-86ae-e67513ed8649" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_b2a1058d-7b65-4af8-a7ca-46c73dc54e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_10551159-46f8-4fbb-90e2-3b8683a6b7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityAbstract_0f8c2e84-edc9-4669-a0bb-4db6dac56446" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_10551159-46f8-4fbb-90e2-3b8683a6b7b3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityAbstract_0f8c2e84-edc9-4669-a0bb-4db6dac56446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f5d1459e-6cdb-431d-b632-178e5fccf154" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_0f8c2e84-edc9-4669-a0bb-4db6dac56446" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f5d1459e-6cdb-431d-b632-178e5fccf154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5905d868-aa6a-4d89-b4c1-85e90eafed80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_0f8c2e84-edc9-4669-a0bb-4db6dac56446" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5905d868-aa6a-4d89-b4c1-85e90eafed80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d3d20e3d-1f99-4ff8-ad48-82f827080c71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_0f8c2e84-edc9-4669-a0bb-4db6dac56446" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d3d20e3d-1f99-4ff8-ad48-82f827080c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b42eef90-007e-4ea0-b97c-e7722f43a7bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_0f8c2e84-edc9-4669-a0bb-4db6dac56446" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b42eef90-007e-4ea0-b97c-e7722f43a7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b724206a-9906-43ae-8ead-0d10b92e3a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_0f8c2e84-edc9-4669-a0bb-4db6dac56446" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b724206a-9906-43ae-8ead-0d10b92e3a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_4d0debe4-f5f0-405c-b492-1fc9b59bc72e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_0f8c2e84-edc9-4669-a0bb-4db6dac56446" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_4d0debe4-f5f0-405c-b492-1fc9b59bc72e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b185db05-f083-4f94-b5b6-5c050707b45e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_0f8c2e84-edc9-4669-a0bb-4db6dac56446" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b185db05-f083-4f94-b5b6-5c050707b45e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f6cabbe5-dc8d-47ff-a150-7ea9d94bd55a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_0f8c2e84-edc9-4669-a0bb-4db6dac56446" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f6cabbe5-dc8d-47ff-a150-7ea9d94bd55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_bf2512b1-6322-4fc6-a6b5-18922b62b4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_0f8c2e84-edc9-4669-a0bb-4db6dac56446" xlink:to="loc_us-gaap_OperatingLeaseLiability_bf2512b1-6322-4fc6-a6b5-18922b62b4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract_f4d08a4c-e531-4b16-8a98-ad4e9ff2eb8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_10551159-46f8-4fbb-90e2-3b8683a6b7b3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityAbstract_f4d08a4c-e531-4b16-8a98-ad4e9ff2eb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_95e7504a-8e54-4141-8747-1ea32a7141aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_f4d08a4c-e531-4b16-8a98-ad4e9ff2eb8b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_95e7504a-8e54-4141-8747-1ea32a7141aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_361f2843-df3b-4e9c-88c9-568743ade10f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_f4d08a4c-e531-4b16-8a98-ad4e9ff2eb8b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_361f2843-df3b-4e9c-88c9-568743ade10f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_86c67b3b-9d0c-45c0-b13b-0ec2c610ed09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_f4d08a4c-e531-4b16-8a98-ad4e9ff2eb8b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_86c67b3b-9d0c-45c0-b13b-0ec2c610ed09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_569905e8-c3e8-408f-a240-4cddab2912a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_f4d08a4c-e531-4b16-8a98-ad4e9ff2eb8b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_569905e8-c3e8-408f-a240-4cddab2912a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_ab09d2e0-563f-4c3e-bf0b-f3f12295a023" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_f4d08a4c-e531-4b16-8a98-ad4e9ff2eb8b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_ab09d2e0-563f-4c3e-bf0b-f3f12295a023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_cc92a403-5e3f-4216-ab80-985bf8e62602" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_f4d08a4c-e531-4b16-8a98-ad4e9ff2eb8b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_cc92a403-5e3f-4216-ab80-985bf8e62602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_391d334c-167b-4c12-ba4b-3dfa7e0c8382" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_f4d08a4c-e531-4b16-8a98-ad4e9ff2eb8b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_391d334c-167b-4c12-ba4b-3dfa7e0c8382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_b58c1e6c-43ca-4aa5-a583-e7030cc981a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_f4d08a4c-e531-4b16-8a98-ad4e9ff2eb8b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_b58c1e6c-43ca-4aa5-a583-e7030cc981a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_e267f500-e219-4121-a7eb-eca03c31ec39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_f4d08a4c-e531-4b16-8a98-ad4e9ff2eb8b" xlink:to="loc_us-gaap_FinanceLeaseLiability_e267f500-e219-4121-a7eb-eca03c31ec39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeasesLiabilityAbstract_3bfb6c91-4c18-4d74-9438-5f9ed1ea52d0" xlink:href="prph-20231231.xsd#prph_LeasesLiabilityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_10551159-46f8-4fbb-90e2-3b8683a6b7b3" xlink:to="loc_prph_LeasesLiabilityAbstract_3bfb6c91-4c18-4d74-9438-5f9ed1ea52d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearOne_898efaeb-18a4-4eab-8964-f023292ba963" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearOne"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prph_LeasesLiabilityAbstract_3bfb6c91-4c18-4d74-9438-5f9ed1ea52d0" xlink:to="loc_prph_LeaseLiabilityToBePaidYearOne_898efaeb-18a4-4eab-8964-f023292ba963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearTwo_679380f3-4e3c-4559-8b36-be575e411385" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prph_LeasesLiabilityAbstract_3bfb6c91-4c18-4d74-9438-5f9ed1ea52d0" xlink:to="loc_prph_LeaseLiabilityToBePaidYearTwo_679380f3-4e3c-4559-8b36-be575e411385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearThree_9f2a90d0-76e6-44e0-ba26-475828bf7ea7" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prph_LeasesLiabilityAbstract_3bfb6c91-4c18-4d74-9438-5f9ed1ea52d0" xlink:to="loc_prph_LeaseLiabilityToBePaidYearThree_9f2a90d0-76e6-44e0-ba26-475828bf7ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearFour_f3785bec-677b-4c0a-88c4-336fb4af7c08" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prph_LeasesLiabilityAbstract_3bfb6c91-4c18-4d74-9438-5f9ed1ea52d0" xlink:to="loc_prph_LeaseLiabilityToBePaidYearFour_f3785bec-677b-4c0a-88c4-336fb4af7c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidYearFive_4387a79c-e93f-4350-bd10-6924400fceaf" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prph_LeasesLiabilityAbstract_3bfb6c91-4c18-4d74-9438-5f9ed1ea52d0" xlink:to="loc_prph_LeaseLiabilityToBePaidYearFive_4387a79c-e93f-4350-bd10-6924400fceaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaidAfterYearFive_7e6ad5e1-1931-4924-ab86-a7032d5e324f" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaidAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prph_LeasesLiabilityAbstract_3bfb6c91-4c18-4d74-9438-5f9ed1ea52d0" xlink:to="loc_prph_LeaseLiabilityToBePaidAfterYearFive_7e6ad5e1-1931-4924-ab86-a7032d5e324f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityToBePaid_caf37674-5311-451c-b6e6-0010646f7a34" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityToBePaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prph_LeasesLiabilityAbstract_3bfb6c91-4c18-4d74-9438-5f9ed1ea52d0" xlink:to="loc_prph_LeaseLiabilityToBePaid_caf37674-5311-451c-b6e6-0010646f7a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiabilityUndiscountedExcessAmount_3dce393b-cac2-4f59-94e3-0be6849c24e5" xlink:href="prph-20231231.xsd#prph_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prph_LeasesLiabilityAbstract_3bfb6c91-4c18-4d74-9438-5f9ed1ea52d0" xlink:to="loc_prph_LeaseLiabilityUndiscountedExcessAmount_3dce393b-cac2-4f59-94e3-0be6849c24e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_LeaseLiability_075c397e-ed30-4d1f-8d20-50b58110cec2" xlink:href="prph-20231231.xsd#prph_LeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_prph_LeasesLiabilityAbstract_3bfb6c91-4c18-4d74-9438-5f9ed1ea52d0" xlink:to="loc_prph_LeaseLiability_075c397e-ed30-4d1f-8d20-50b58110cec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1" xlink:type="simple" xlink:href="prph-20231231.xsd#LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SignificantCustomersConcentrationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_ab3e13cb-55c3-4600-9255-b379afdb7477" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_d69e4c3f-abaf-442a-81cf-a2726b2e738c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_ab3e13cb-55c3-4600-9255-b379afdb7477" xlink:to="loc_us-gaap_ConcentrationRiskTable_d69e4c3f-abaf-442a-81cf-a2726b2e738c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_85f15dff-ab91-4cdb-b569-f2ba85c8958f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d69e4c3f-abaf-442a-81cf-a2726b2e738c" xlink:to="loc_srt_MajorCustomersAxis_85f15dff-ab91-4cdb-b569-f2ba85c8958f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_6b62383b-74ca-4fb2-aaf2-f25e71d28212" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_85f15dff-ab91-4cdb-b569-f2ba85c8958f" xlink:to="loc_srt_NameOfMajorCustomerDomain_6b62383b-74ca-4fb2-aaf2-f25e71d28212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_GovernmentAgenciesMember_ce0181e6-72df-4ad5-ac9a-74070c3c1b5c" xlink:href="prph-20231231.xsd#prph_GovernmentAgenciesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_6b62383b-74ca-4fb2-aaf2-f25e71d28212" xlink:to="loc_prph_GovernmentAgenciesMember_ce0181e6-72df-4ad5-ac9a-74070c3c1b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_InsuranceProvidersMember_60269aa9-d920-4308-8131-2761408bae66" xlink:href="prph-20231231.xsd#prph_InsuranceProvidersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_6b62383b-74ca-4fb2-aaf2-f25e71d28212" xlink:to="loc_prph_InsuranceProvidersMember_60269aa9-d920-4308-8131-2761408bae66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ClientPayersMember_c9ea2a07-e469-453a-846c-4d1b931e117b" xlink:href="prph-20231231.xsd#prph_ClientPayersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_6b62383b-74ca-4fb2-aaf2-f25e71d28212" xlink:to="loc_prph_ClientPayersMember_c9ea2a07-e469-453a-846c-4d1b931e117b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DiagnosticServicesClientsOneMember_330f1321-b650-4d01-8887-8dec874391e4" xlink:href="prph-20231231.xsd#prph_DiagnosticServicesClientsOneMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_6b62383b-74ca-4fb2-aaf2-f25e71d28212" xlink:to="loc_prph_DiagnosticServicesClientsOneMember_330f1321-b650-4d01-8887-8dec874391e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DiagnosticServicesClientsTwoMember_b3ae4bb2-19ec-4f3a-b1b0-07056190dd83" xlink:href="prph-20231231.xsd#prph_DiagnosticServicesClientsTwoMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_6b62383b-74ca-4fb2-aaf2-f25e71d28212" xlink:to="loc_prph_DiagnosticServicesClientsTwoMember_b3ae4bb2-19ec-4f3a-b1b0-07056190dd83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DiagnosticServicesClientsThreeMember_8ed8df16-f25a-481d-9849-15349f8b63cf" xlink:href="prph-20231231.xsd#prph_DiagnosticServicesClientsThreeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_6b62383b-74ca-4fb2-aaf2-f25e71d28212" xlink:to="loc_prph_DiagnosticServicesClientsThreeMember_8ed8df16-f25a-481d-9849-15349f8b63cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e9bedbf6-c2c8-4c50-84ce-8100a7ee07e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d69e4c3f-abaf-442a-81cf-a2726b2e738c" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e9bedbf6-c2c8-4c50-84ce-8100a7ee07e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6f4da480-ddc8-4779-9d0e-f585e250c600" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e9bedbf6-c2c8-4c50-84ce-8100a7ee07e5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6f4da480-ddc8-4779-9d0e-f585e250c600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_0c9311f2-d347-49b2-9dcb-3f8c770d5626" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6f4da480-ddc8-4779-9d0e-f585e250c600" xlink:to="loc_us-gaap_SalesRevenueNetMember_0c9311f2-d347-49b2-9dcb-3f8c770d5626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ReimbursementReceivableMember_48e15ca6-56df-4ad6-9071-2ee472aaceea" xlink:href="prph-20231231.xsd#prph_ReimbursementReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6f4da480-ddc8-4779-9d0e-f585e250c600" xlink:to="loc_prph_ReimbursementReceivableMember_48e15ca6-56df-4ad6-9071-2ee472aaceea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_560c5063-1b06-407c-b837-338fcdbdceaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d69e4c3f-abaf-442a-81cf-a2726b2e738c" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_560c5063-1b06-407c-b837-338fcdbdceaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ba0b2a98-4ce0-4a31-b66e-3dbba98bebfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_560c5063-1b06-407c-b837-338fcdbdceaf" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ba0b2a98-4ce0-4a31-b66e-3dbba98bebfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_SegmentConcentrationRiskMember_e091533e-d1a9-4bce-b327-d0a93c5135fa" xlink:href="prph-20231231.xsd#prph_SegmentConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ba0b2a98-4ce0-4a31-b66e-3dbba98bebfb" xlink:to="loc_prph_SegmentConcentrationRiskMember_e091533e-d1a9-4bce-b327-d0a93c5135fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_c9b236b0-2241-41f7-912f-a7d833b04c77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ba0b2a98-4ce0-4a31-b66e-3dbba98bebfb" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_c9b236b0-2241-41f7-912f-a7d833b04c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9f0a26a0-e5e3-4439-a4a6-58df83cad2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d69e4c3f-abaf-442a-81cf-a2726b2e738c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9f0a26a0-e5e3-4439-a4a6-58df83cad2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_016c3895-4ffe-47a2-90d8-71346160aed3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9f0a26a0-e5e3-4439-a4a6-58df83cad2e3" xlink:to="loc_us-gaap_SegmentDomain_016c3895-4ffe-47a2-90d8-71346160aed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DiagnosticServicesMember_600f71d1-0ef2-4d93-b8b0-a2e2df7d1a93" xlink:href="prph-20231231.xsd#prph_DiagnosticServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_016c3895-4ffe-47a2-90d8-71346160aed3" xlink:to="loc_prph_DiagnosticServicesMember_600f71d1-0ef2-4d93-b8b0-a2e2df7d1a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_17c3efb0-9cfb-47ff-a843-0b947bdf9269" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d69e4c3f-abaf-442a-81cf-a2726b2e738c" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_17c3efb0-9cfb-47ff-a843-0b947bdf9269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c7f0e452-f39a-400d-a8f5-33b3c099859f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_17c3efb0-9cfb-47ff-a843-0b947bdf9269" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c7f0e452-f39a-400d-a8f5-33b3c099859f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_50370c39-b990-43bb-bfc0-c22aea988b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_17c3efb0-9cfb-47ff-a843-0b947bdf9269" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_50370c39-b990-43bb-bfc0-c22aea988b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SegmentInformationDetailsNarrative" xlink:type="simple" xlink:href="prph-20231231.xsd#SegmentInformationDetailsNarrative"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SegmentInformationDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_66c40915-0375-42d9-9547-ee44772399d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_18f4fa67-8abb-4ed1-ad17-77503e20e0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_66c40915-0375-42d9-9547-ee44772399d1" xlink:to="loc_us-gaap_NumberOfOperatingSegments_18f4fa67-8abb-4ed1-ad17-77503e20e0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/ScheduleofSegmentInformationDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#ScheduleofSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/ScheduleofSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_44286d65-81d6-4cdb-b67b-2f7716e7b048" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_217c27a6-1d1d-45f9-87d5-9712d499d769" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_44286d65-81d6-4cdb-b67b-2f7716e7b048" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_217c27a6-1d1d-45f9-87d5-9712d499d769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cc7e7bc3-32ba-46ef-a3be-0c9a55aa456f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_217c27a6-1d1d-45f9-87d5-9712d499d769" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cc7e7bc3-32ba-46ef-a3be-0c9a55aa456f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9051aaba-5991-42cd-8228-992ee6e0f229" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cc7e7bc3-32ba-46ef-a3be-0c9a55aa456f" xlink:to="loc_us-gaap_SegmentDomain_9051aaba-5991-42cd-8228-992ee6e0f229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_DiagnosticServicesMember_27088c1a-c21d-4df9-902a-0bd857018bc6" xlink:href="prph-20231231.xsd#prph_DiagnosticServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9051aaba-5991-42cd-8228-992ee6e0f229" xlink:to="loc_prph_DiagnosticServicesMember_27088c1a-c21d-4df9-902a-0bd857018bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ConsumerProductsMember_eb756ba3-56c7-4e70-9503-65717a952ee8" xlink:href="prph-20231231.xsd#prph_ConsumerProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9051aaba-5991-42cd-8228-992ee6e0f229" xlink:to="loc_prph_ConsumerProductsMember_eb756ba3-56c7-4e70-9503-65717a952ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_UnallocatedCorporateMember_90d66227-d232-4166-8e0b-0887a704018b" xlink:href="prph-20231231.xsd#prph_UnallocatedCorporateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9051aaba-5991-42cd-8228-992ee6e0f229" xlink:to="loc_prph_UnallocatedCorporateMember_90d66227-d232-4166-8e0b-0887a704018b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_217c27a6-1d1d-45f9-87d5-9712d499d769" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_10d69c15-4311-4b3e-a1ce-603ea31a6708" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_10d69c15-4311-4b3e-a1ce-603ea31a6708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_980e789c-cf77-45bf-9c3d-2df201f0455a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_980e789c-cf77-45bf-9c3d-2df201f0455a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_ef2b07fa-867a-46d9-8f24-ae3317794e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:to="loc_us-gaap_DepreciationAndAmortization_ef2b07fa-867a-46d9-8f24-ae3317794e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_OperatingAndOtherExpenses_caf18102-71b5-47b3-a4e8-e5db0f1a30eb" xlink:href="prph-20231231.xsd#prph_OperatingAndOtherExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:to="loc_prph_OperatingAndOtherExpenses_caf18102-71b5-47b3-a4e8-e5db0f1a30eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1f6b92b1-b957-4430-8093-f0a938a84be2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1f6b92b1-b957-4430-8093-f0a938a84be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c6e8dd37-0f7e-48dd-a142-d97395784995" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c6e8dd37-0f7e-48dd-a142-d97395784995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3123771f-ca2d-4479-83d2-3251538a2ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:to="loc_us-gaap_NetIncomeLoss_3123771f-ca2d-4479-83d2-3251538a2ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0349721c-efe6-47fa-bfb6-c18bd15fe506" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_faf1d9f8-8508-4117-9109-26e73336bb3d" xlink:to="loc_us-gaap_Assets_0349721c-efe6-47fa-bfb6-c18bd15fe506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_54e440e5-635d-47ff-b162-3188fb0f66c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9591e0fe-5b02-4a85-956e-eeca1b33e82f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_54e440e5-635d-47ff-b162-3188fb0f66c9" xlink:to="loc_us-gaap_AwardTypeAxis_9591e0fe-5b02-4a85-956e-eeca1b33e82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dc7868c9-5e07-4558-a4c6-49af7fffbaad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9591e0fe-5b02-4a85-956e-eeca1b33e82f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dc7868c9-5e07-4558-a4c6-49af7fffbaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2f89c01d-d012-4430-aae9-a25f12153b69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dc7868c9-5e07-4558-a4c6-49af7fffbaad" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2f89c01d-d012-4430-aae9-a25f12153b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_84cb4a76-b4e9-431c-abc1-9009b744f676" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dc7868c9-5e07-4558-a4c6-49af7fffbaad" xlink:to="loc_us-gaap_WarrantMember_84cb4a76-b4e9-431c-abc1-9009b744f676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_44311b6b-bd5d-48fb-9a02-a20d5714cb45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_54e440e5-635d-47ff-b162-3188fb0f66c9" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_44311b6b-bd5d-48fb-9a02-a20d5714cb45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_6a7fbbe9-3515-4c5a-b23e-5dc99de9017b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_44311b6b-bd5d-48fb-9a02-a20d5714cb45" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_6a7fbbe9-3515-4c5a-b23e-5dc99de9017b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_InterestOnUnsecuredConvertiblePromissoryNote_1015d47d-8407-4c24-9235-fe5d0a137593" xlink:href="prph-20231231.xsd#prph_InterestOnUnsecuredConvertiblePromissoryNote"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_44311b6b-bd5d-48fb-9a02-a20d5714cb45" xlink:to="loc_prph_InterestOnUnsecuredConvertiblePromissoryNote_1015d47d-8407-4c24-9235-fe5d0a137593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_07360b7c-576d-4f04-b5eb-ad9f836f7aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_44311b6b-bd5d-48fb-9a02-a20d5714cb45" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_07360b7c-576d-4f04-b5eb-ad9f836f7aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cda6cd72-7c00-4ce8-9e7c-c534f1c2ea9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_44311b6b-bd5d-48fb-9a02-a20d5714cb45" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cda6cd72-7c00-4ce8-9e7c-c534f1c2ea9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0fcb673d-aa85-4abe-9577-84b8ef0d66f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_44311b6b-bd5d-48fb-9a02-a20d5714cb45" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0fcb673d-aa85-4abe-9577-84b8ef0d66f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_6b2cdc17-844b-4200-94ad-18950e5bc679" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_44311b6b-bd5d-48fb-9a02-a20d5714cb45" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_6b2cdc17-844b-4200-94ad-18950e5bc679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_efb7e6a2-0efd-4904-bab6-4489fbbb75b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_44311b6b-bd5d-48fb-9a02-a20d5714cb45" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_efb7e6a2-0efd-4904-bab6-4489fbbb75b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromtheIncomePerShareComputationDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromtheIncomePerShareComputationDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromtheIncomePerShareComputationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4736e645-e5cf-4068-9b60-46851910c7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_eb33474c-96c5-46dd-952f-9c0841213b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4736e645-e5cf-4068-9b60-46851910c7ad" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_eb33474c-96c5-46dd-952f-9c0841213b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_07861913-8b8d-4ba6-86b4-1b9cff230b80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_eb33474c-96c5-46dd-952f-9c0841213b2d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_07861913-8b8d-4ba6-86b4-1b9cff230b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f36a73a6-f3a9-4cbc-ba8c-2920f601ca1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_07861913-8b8d-4ba6-86b4-1b9cff230b80" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f36a73a6-f3a9-4cbc-ba8c-2920f601ca1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_CommonStockPurchaseWarrantsMember_b2b4ac90-20ed-480e-aa89-f87272d44fbf" xlink:href="prph-20231231.xsd#prph_CommonStockPurchaseWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f36a73a6-f3a9-4cbc-ba8c-2920f601ca1a" xlink:to="loc_prph_CommonStockPurchaseWarrantsMember_b2b4ac90-20ed-480e-aa89-f87272d44fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e2d33177-febf-4d91-92fd-9e03b856ef87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f36a73a6-f3a9-4cbc-ba8c-2920f601ca1a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e2d33177-febf-4d91-92fd-9e03b856ef87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1cff186d-6127-4a3d-8a9f-70d9fb70a1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_eb33474c-96c5-46dd-952f-9c0841213b2d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1cff186d-6127-4a3d-8a9f-70d9fb70a1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0249dede-9970-4024-a7d7-b1643ee26485" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1cff186d-6127-4a3d-8a9f-70d9fb70a1b3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0249dede-9970-4024-a7d7-b1643ee26485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://prophaselabs.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="prph-20231231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://prophaselabs.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_05be3e9e-769b-46aa-a9d5-71ffb8aef5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_a556c35a-556b-463a-b21c-fdb6d3c79657" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_05be3e9e-769b-46aa-a9d5-71ffb8aef5e8" xlink:to="loc_us-gaap_SubsequentEventTable_a556c35a-556b-463a-b21c-fdb6d3c79657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b096aed7-3610-4254-82f0-97c44e92c24d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a556c35a-556b-463a-b21c-fdb6d3c79657" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b096aed7-3610-4254-82f0-97c44e92c24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a58783d0-a74d-4315-9aa7-80a92cbce2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b096aed7-3610-4254-82f0-97c44e92c24d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a58783d0-a74d-4315-9aa7-80a92cbce2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_564c164f-2b38-47ef-8044-3e75ecfdd312" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a58783d0-a74d-4315-9aa7-80a92cbce2bb" xlink:to="loc_us-gaap_SubsequentEventMember_564c164f-2b38-47ef-8044-3e75ecfdd312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_85171fdb-caeb-42b5-81ca-7e7cdfad3120" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a556c35a-556b-463a-b21c-fdb6d3c79657" xlink:to="loc_us-gaap_SubsequentEventLineItems_85171fdb-caeb-42b5-81ca-7e7cdfad3120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_ProceedsFromFinancingAgreement_7deec036-871b-466c-a595-84469740cc8c" xlink:href="prph-20231231.xsd#prph_ProceedsFromFinancingAgreement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_85171fdb-caeb-42b5-81ca-7e7cdfad3120" xlink:to="loc_prph_ProceedsFromFinancingAgreement_7deec036-871b-466c-a595-84469740cc8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_FinancingAgreementOriginationFee_1264c3d6-8adc-443a-ba19-5e8381593ea0" xlink:href="prph-20231231.xsd#prph_FinancingAgreementOriginationFee"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_85171fdb-caeb-42b5-81ca-7e7cdfad3120" xlink:to="loc_prph_FinancingAgreementOriginationFee_1264c3d6-8adc-443a-ba19-5e8381593ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_FinancingAgreementPeriodicPayment_b0abc165-70d6-4669-bbf2-d074272bac44" xlink:href="prph-20231231.xsd#prph_FinancingAgreementPeriodicPayment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_85171fdb-caeb-42b5-81ca-7e7cdfad3120" xlink:to="loc_prph_FinancingAgreementPeriodicPayment_b0abc165-70d6-4669-bbf2-d074272bac44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_prph_FinancingArrangementAggregateRepaymentAmount_0d442c24-7ff8-48f9-a2b4-c279746f92d9" xlink:href="prph-20231231.xsd#prph_FinancingArrangementAggregateRepaymentAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_85171fdb-caeb-42b5-81ca-7e7cdfad3120" xlink:to="loc_prph_FinancingArrangementAggregateRepaymentAmount_0d442c24-7ff8-48f9-a2b4-c279746f92d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image.jpg
<TEXT>
begin 644 image.jpg
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MH @4@:T@T.)P*R?5.(M $2@"1: (%($B< $$6AQ> .2Z* )%H @4@2)0!(K
M5A!H<;B5DVJ<1: (%($B4 2*0!&X  (M#B\ <ET4@2)0!(I $2@"16 K"+0X
MW,I)-<XB4 2*0!$H D6@"%P @1:'%P"Y+HI $2@"1: (%($BL!4$6AQNY:0:
M9Q$H D6@"!2!(E $+H! B\,+@%P71: (%($B4 2*0!'8"@(M#K=R4HVS"!2!
M(E $BD 1* (70*#%X05 KHLB4 2*0!$H D6@"&P%@1:'6SFIQED$BD 1* )%
MH @4@0L@T.+P B#711$H D6@"!2!(E $MH) B\.MG%3C+ )%H @4@2)0!(K
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MGW$@RSRRMOJCU>;:&5H08E.[^O$<L;&EI\7AEDZKL1:!(E $[@0!/^A^Q/T
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M[=W%X7L#J'X1* )%H @4@2)0!(K [2#P[N+P+__U_-RW&)0#Y4 Y4 Z4 ^5
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MQ=I:,7>L?^RXQZF[;VW*OG7,?B07<1R[KT.3Z5OC.T:/6&XIGF-BKVP_-.7
M93F0N0_LS;=K'T#/Q^]2B\/+GI?XM_T?W/E>\_K]%A=XZ7<<+MNGE;-PV+YZ
MM-CR&XKM+""=3WG[%R\.<4Q ;H+^M8M#8DKP!>>M+0?&ON9!N'?6>-]J_S6]
M]^PER?::GTNLGQNK2^RA/OK!*0<NPX%9'(([.6WI@SO/Y-9RWXROX\MPZ-HX
M\_W.XG#RDC5_[/!]S/IIB?^L6V]D;8"=]#/W?97BD(MJL&Z.3>4\@;+&W)QW
M3,OFW#PM<]CRER#CK)09^P*Z@"1HS"E#JUS:=-U#T@XM\AZ@^W2=L:]SQHW-
MM&=,M*QATQB80U_</&3CHE5&?6TL^24&XD[]W_[^GW^,W8-KXHE=UIA'W]BT
M3VSBH(QKZFF3UK5L)U:,\:4^K?+XTE[.N][V,9)KS_EQS]F<,SG ?.:$S(G*
MDO_,F<R98\@IZJI'#N(UWY#[S#^TYL)<QV;F+GVIARSKQM/V,7D,+^"$YP\G
MX*_CY.F4A:>30]A2'X[!35XYK=W97JPX])+0>BD(Q@O(AG/37BYDLH]N7J)Y
ML935!Z (%JV 9!\?R..?/CK8H<]< NJAZ1>9^:+#NKJNXQ.[Q& <K&D_^\3
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MN*^V+WQX+_;HKSWO+@[7#'>^"!2!(E $BD 1* )%8'L(M#C<WIDUXB)0!(I
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MAR7#C@SO_:51_?Y:+0?*@7*@'"@'ML^!%H<M#EL<E@/E0#E0#I0#Y4 YL.-
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MLVD.1#_S<?K0=MO'04"NP)OD;?(SN0,RR37DUAYLSW5UC^7=28K#M4 [_X+
M/&P.,(GQ(GD;O5N/[S90:A1%H @4@2)0!.X/@1:'%SA3BD!_J>J.8G%6^*Y=
MNR7>8W]E7#OF^B\"1: (%($B4 1.@T"+P]/@^*H5_].M_QEC_B7Q50,5* )%
MH @4@2)0!(K !1!H<7@!D.NB"!2!(E $BD 1* );0:#%X59.JG$6@2)0!(I
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M*4=?V9S?=VYI[U)G;(QM;RMA]3QZ'FL<\)LP6_+'FD[.DZ<S/^5:^^7=I3@
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@+Y<  0($"! @$!084L42S EXHOL     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
MB5!.1PT*&@H    -24A$4@   S    0@" 8    Y>;D.   61TE$051X7NW7
M,0T , S L/(GW?Y#L$CV&0:9!0  B)@W    _,K     &08&  #(,#   $"&
M@0$  #(,#   D&%@  " # ,#  !D&!@  "##P    !D&!@  R# P  ! AH$!
M   R# P  )!A8   @ P# P  9!@8   @P\     9!@8  ,@P,   0(:! 0
M,@P,  "086   ( , P,  &08&   (,/     &08&  #(,#   $"&@0$  #(,
M#   D&%@  " # ,#  !D&!@  "##P    !D&!@  R# P  ! AH$!   R# P
M )!A8   @ P# P  9!@8   @P\     9!@8  ,@P,   0(:! 0  ,@P,  "0
M86   ( , P,  &08&   (,/     &08&  #(,#   $"&@0$  #(,#   D&%@
M  " # ,#  !D&!@  "##P    !D&!@  R# P  ! AH$!   R# P  )!A8
M@ P# P  9!@8   @P\     9!@8  ,@P,   0(:! 0  ,@P,  "086   ( ,
M P,  &08&   (,/     &08&  #(,#   $"&@0$  #(,#   D&%@  " # ,#
M  !D&!@  "##P    !D&!@  R# P  ! AH$!   R# P  )!A8   @ P# P
M9!@8   @P\     9!@8  ,@P,   0(:! 0  ,@P,  "086   ( , P,  &08
M&   (,/     &08&  #(,#   $"&@0$  #(,#   D&%@  " # ,#  !D&!@
M "##P    !D&!@  R# P  ! AH$!   R# P  )!A8   @ P# P  9!@8   @
MP\     9!@8  ,@P,   0(:! 0  ,@P,  "086   ( , P,  &08&   (,/
M    &08&  #(,#   $"&@0$  #(,#   D&%@  " # ,#  !D&!@  "##P
M !D&!@  R# P  ! AH$!   R# P  )!A8   @ P# P  9!@8   @P\     9
M!@8  ,@P,   0(:! 0  ,@P,  "086   ( , P,  &08&   (,/     &08&
M  #(,#   $"&@0$  #(,#   D&%@  " # ,#  !D&!@  "##P    !D&!@
MR# P  ! AH$!   R# P  )!A8   @ P# P  9!@8   @P\     9!@8  ,@P
M,   0(:! 0  ,@P,  "086   ( , P,  &08&   (,/     &08&  #(,#
M $"&@0$  #(,#   D&%@  " # ,#  !D&!@  "##P    !D&!@  R# P  !
MAH$!   R# P  )!A8   @ P# P  9!@8   @P\     9!@8  ,@P,   0(:!
M 0  ,@P,  "086   ( , P,  &08&   (,/     &08&  #(,#   $"&@0$
M #(,#   D&%@  " # ,#  !D&!@  "##P    !D&!@  R# P  ! AH$!   R
M# P  )!A8   @ P# P  9!@8   @P\     9!@8  ,@P,   0(:! 0  ,@P,
M  "086   ( , P,  &08&   (,/     &08&  #(,#   $"&@0$  #(,#
MD&%@  " # ,#  !D&!@  "##P    !D&!@  R# P  ! AH$!   R# P  )!A
M8   @ P# P  9!@8   @P\     9!@8  ,@P,   0(:! 0  ,@P,  "086
M ( , P,  &08&   (,/     &08&  #(,#   $"&@0$  #(,#   D&%@  "
M# ,#  !D&!@  "##P    !D&!@  R# P  ! AH$!   R# P  )!A8   @ P#
M P  9!@8   @P\     9!@8  ,@P,   0(:! 0  ,@P,  "086   ( , P,
M &08&   (,/     &08&  #(,#   $"&@0$  #(,#   D&%@  " # ,#  !D
M&!@  "##P    !D&!@  R# P  ! AH$!   R# P  )!A8   @ P# P  9!@8
M   @P\     9!@8  ,@P,   0(:! 0  ,@P,  "086   ( , P,  &08&
M(,/     &08&  #(,#   $"&@0$  #(,#   D&%@  " # ,#  !D&!@  "##
MP    !D&!@  R# P  ! AH$!   R# P  )!A8   @ P# P  9!@8   @P\
M   9!@8  ,@P,   0(:! 0  ,@P,  "086   ( , P,  &08&   (,/
M&08&  #(,#   $"&@0$  #(,#   D&%@  " # ,#  !D&!@  "##P    !D&
M!@  R# P  ! AH$!   R# P  )!A8   @ P# P  9!@8   @P\     9!@8
M ,@P,   0(:! 0  ,@P,  "086   ( , P,  &08&   (,/     &08&  #(
M,#   $"&@0$  #(,#   D&%@  " # ,#  !D&!@  "##P    !D&!@  R# P
M  ! AH$!   R# P  )!A8   @ P# P  9!@8   @P\     9!@8  ,@P,
M0(:! 0  ,@P,  "086   ( , P,  &08&   (,/     &08&  #(,#   $"&
M@0$  #(,#   D&%@  " # ,#  !D&!@  "##P    !D&!@  R# P  ! AH$!
M   R# P  )!A8   @ P# P  9!@8   @P\     9!@8  ,@P,   0(:! 0
M,@P,  "086   ( , P,  &08&   (,/     &08&  #(,#   $"&@0$  #(,
M#   D&%@  " # ,#  !D&!@  "##P    !D&!@  R# P  ! AH$!   R# P
M )!A8   @ P# P  9!@8   @P\     9!@8  ,@P,   0(:! 0  ,@P,  "0
M86   ( , P,  &08&   (,/     &08&  #(,#   $"&@0$  #(,#   D&%@
M  " # ,#  !D&!@  "##P    !D&!@  R# P  ! AH$!   R# P  )!A8
M@ P# P  9!@8   @P\     9!@8  ,@P,   0(:! 0  ,@P,  "086   ( ,
M P,  &08&   (,/     &08&  #(,#   $"&@0$  #(,#   D&%@  " # ,#
M  !D&!@  "##P    !D&!@  R# P  ! AH$!   R# P  )!A8   @ P# P
M9!@8   @P\     9!@8  ,@P,   0(:! 0  ,@P,  "086   ( , P,  &08
M&   (,/     &08&  #(,#   $"&@0$  #(,#   D&%@  " # ,#  !D&!@
M "##P    !D&!@  R# P  ! AH$!   R# P  )!A8   @ P# P  9!@8   @
MP\     9!@8  ,@P,   0(:! 0  ,@P,  "086   ( , P,  &08&   (,/
M    &08&  #(,#   $"&@0$  #(,#   D&%@  " # ,#  !D&!@  "##P
M !D&!@  R# P  ! AH$!   R# P  )!A8   @ P# P  9!@8   @P\     9
M!@8  ,@P,   0(:! 0  ,@P,  "086   ( , P,  &08&   (,/     &08&
M  #(,#   $"&@0$  #(,#   D&%@  " # ,#  !D&!@  "##P    !D&!@
MR# P  ! AH$!   R# P  )!A8   @ P# P  9!@8   @P\     9!@8  ,@P
M,   0(:! 0  ,@P,  "086   ( , P,  &08&   (,/     &08&  #(,#
M $"&@0$  #(,#   D&%@  " # ,#  !D&!@  "##P    !D&!@  R# P  !
MAH$!   R# P  )!A8   @ P# P  9!@8   @P\     9!@8  ,@P,   0(:!
M 0  ,@P,  "086   ( , P,  &08&   (,/     &08&  #(,#   $"&@0$
M #(,#   D&%@  " # ,#  !D&!@  "##P    !D&!@  R# P  ! AH$!   R
M# P  )!A8   @ P# P  9!@8   @P\     9!@8  ,@P,   0(:! 0  ,@P,
M  "086   ( , P,  &08&   (,/     &08&  #(,#   $"&@0$  #(,#
MD&%@  " # ,#  !D&!@  "##P    !D&!@  R# P  ! AH$!   R# P  )!A
M8   @ P# P  9!@8   @P\     9!@8  ,@P,   0(:! 0  ,@P,  "086
M ( , P,  &08&   (,/     &08&  #(,#   $"&@0$  #(,#   D&%@  "
M# ,#  !D&!@  "##P    !D&!@  R# P  ! AH$!   R# P  )!A8   @ P#
M P  9!@8   @P\     9!@8  ,@P,   0(:! 0  ,@P,  "086   ( , P,
M &08&   (,/     &08&  #(,#   $"&@0$  #(,#   D&%@  " # ,#  !D
M&!@  "##P    !D&!@  R# P  ! AH$!   R# P  )!A8   @ P# P  9!@8
M   @P\     9!@8  ,@P,   0(:! 0  ,@P,  "086   ( , P,  &08&
M(,/     &08&  #(,#   $"&@0$  #(,#   D&%@  " # ,#  !D&!@  "##
MP    !D&!@  R# P  ! AH$!   R# P  )!A8   @ P# P  9!@8   @P\
M   9!@8  ,@P,   0(:! 0  ,@P,  "086   ( , P,  &08&   (,/
M&08&  #(,#   $"&@0$  #(,#   D&%@  " # ,#  !D&!@  "##P    !D&
M!@  R# P  ! AH$!   R# P  )!A8   @ P# P  9!@8   @P\     9!@8
M ,@P,   0(:! 0  ,@P,  "086   ( , P,  &08&   (,/     &08&  #(
M,#   $"&@0$  #(,#   D&%@  " # ,#  !D&!@  "##P    !D&!@  R# P
M  ! AH$!   R# P  )!A8   @ P# P  9!@8   @P\     9!@8  ,@P,
M0(:! 0  ,@P,  "086   ( , P,  &08&   (,/     &08&  #(,#   $"&
M@0$  #(,#   D&%@  " # ,#  !D&!@  "##P    !D&!@  R# P  ! AH$!
M   R# P  )!A8   @ P# P  9!@8   @P\     9!@8  ,@P,   0(:! 0
M,@P,  "086   ( , P,  &08&   (,/     &08&  #(,#   $"&@0$  #(,
M#   D&%@  " # ,#  !D&!@  "##P    !D&!@  R# P  ! AH$!   R# P
M )!A8   @ P# P  9!@8   @P\     9!@8  ,@P,   0(:! 0  ,@P,  "0
M86   ( , P,  &08&   (,/     &08&  #(,#   $"&@0$  #(,#   D&%@
M  " # ,#  !D&!@  "##P    !D&!@  R# P  ! AH$!   R# P  )!A8
M@ P# P  9!@8   @P\     9!@8  ,@P,   0(:! 0  ,@P,  "086   ( ,
M P,  &08&   (,/     &08&  #(,#   $"&@0$  #(,#   D&%@  " # ,#
M  !D&!@  "##P    !D&!@  R# P  ! AH$!   R# P  )!A8   @ P# P
M9!@8   @P\     9!@8  ,@P,   0(:! 0  ,@P,  "086   ( , P,  &08
M&   (,/     &08&  #(,#   $"&@0$  #(,#   D&%@  " # ,#  !D&!@
M "##P    !D&!@  R# P  ! AH$!   R# P  )!A8   @ P# P  9!@8   @
MP\     9!@8  ,@P,   0(:! 0  ,@P,  "086   ( , P,  &08&   (,/
M    &08&  #(,#   $"&@0$  #(,#   D&%@  " # ,#  !D&!@  "##P
M !D&!@  R# P  ! AH$!   R# P  )!A8   @ P# P  9!@8   @P\     9
M!@8  ,@P,   0(:! 0  ,@P,  "086   ( , P,  &08&   (,/     &08&
M  #(,#   $"&@0$  #(,#   D&%@  " # ,#  !D&!@  "##P    !D&!@
MR# P  ! AH$!   R# P  )!A8   @ P# P  9!@8   @P\     9!@8  ,@P
M,   0(:! 0  ,@P,  "086   ( , P,  &08&   (,/     &08&  #(,#
M $"&@0$  #(,#   D&%@  " # ,#  !D&!@  "##P    !D&!@  R# P  !
MAH$!   R# P  )!A8   @ P# P  9!@8   @P\     9!@8  ,@P,   0(:!
M 0  ,@P,  "086   ( , P,  &08&   (,/     &08&  #(,#   $"&@0$
M #(,#   D&%@  " # ,#  !D&!@  "##P    !D&!@  R# P  ! AH$!   R
M# P  )!A8   @ P# P  9!@8   @P\     9!@8  ,@P,   0(:! 0  ,@P,
M  "086   ( , P,  &08&   (,/     &08&  #(,#   $"&@0$  #(,#
MD&%@  " # ,#  !D&!@  "##P    !D&!@  R# P  ! AH$!   R# P  )!A
M8   @ P# P  9!@8   @P\     9!@8  ,@P,   0(:! 0  ,@P,  "086
M ( , P,  &08&   (,/     &08&  #(,#   $"&@0$  #(,#   D&%@  "
M# ,#  !D&!@  "##P    !D&!@  R# P  ! AH$!   R# P  )!A8   @ P#
M P  9!@8   @P\     9!@8  ,@P,   0(:! 0  ,@P,  "086   ( , P,
M &08&   (,/     &08&  #(,#   $"&@0$  #(,#   D&%@  " # ,#  !D
M&!@  "##P    !D&!@  R# P  ! AH$!   R# P  )!A8   @ P# P  9!@8
M   @P\     9!@8  ,@P,   0(:! 0  ,@P,  "086   ( , P,  &08&
M(,/     &08&  #(,#   $"&@0$  #(,#   D&%@  " # ,#  !D&!@  "##
MP    !D&!@  R# P  ! AH$!   R# P  )!A8   @ P# P  9!@8   @P\
M   9!@8  ,@P,   0(:! 0  ,@P,  "086   ( , P,  &08&   (,/
M&08&  #(,#   $"&@0$  #(,#   D&%@  " # ,#  !D&!@  "##P    !D&
M!@  R# P  ! AH$!   R# P  )!A8   @ P# P  9!@8   @P\     9!@8
M ,@P,   0(:! 0  ,@P,  "086   (", W::>?NX<3S_     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_3.jpg
<TEXT>
begin 644 image_3.jpg
MB5!.1PT*&@H    -24A$4@  !.<    %" 8    .H8@K    "7!(67,  $SE
M  !,Y0%USO"5    /TE$051XG.W.L0T   C#L/[_-#S BABPI>Q)DI(D29(D
M29*TWNAZ2I(D29(D2?H0                  !<:'KYNL2%QD%>     $E%
&3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>literacompareredline-pro001.jpg
<TEXT>
begin 644 literacompareredline-pro001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"!54!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-U\*K'7(+^[L?$%E;+/>PVLQ59DQ\^54XW ?-QZ$>E;6B^(8/'^A:(=-N;F
MNJW%\8+AU> (<&,L#DEV! SU4,>N*TO!6CS^%/ 6GZ/?7*ZA<VT3!_+<$'+$
M[%W$< ' SC@?A7,_!KPYJOA'1]3LM9L5M7GO#/&RSQ.I7:H ^5B<\'M0!6O;
M_4$_:$T_0UU*_72Y;$SO:BZDV%]K\]?]D<=.*]9KRK4M%UO_ (7A9^*X=)DG
MTNWLS;,R7$ =FVN,A6D'&6'7%=1/K/B-Y]2GMM#D2*&TVV4$MU!NN)V)R6PY
M"JN%[YY- '/:MX^O-,^+VDZ=,"GA^\CDL4E/W9+D,,L/]UMJ>V6J7XS_ -MV
M'A--=T/4;RUEL)5-Q'!,RK)"QP<@'L<<^A-9_CSX?/K/@2WM]+>^FU>UD66V
M2>[C&UR?G));:"<D\$\XKN-.2XUSP:MCXEM5@NKBU-O>P^:C!B5VLRE21@\D
M>E 'F'Q"\6W%D/"/BS1]2U$:5<B.6_LXKE]GE$KC=@_*3\Z^Y7V->CW<]S>7
MVH:CH\LLYLM.(MXEF;RI[AUWKE<X.%V?]_/85R&@?#1K;X3ZKX9U.YCEOKH2
MK$Q<$1A'9H0/0;LOC_;-=+X?T:]\-_"Y-+M9E?6H]/;!:0$FX*?*,DXP#M4>
MRB@#C/!/C+3_ !-9V.GOKVI:=XLBGC-U#>7#A;DJX,B*K?( P! 50K#ITSGV
M:O*?&/A >-8K"7^P1I?B!)XFEU))HML:J06.Y6W2=/ERN<XZ<UZL#D9'- !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% $%[96FHVCVE]:PW5M)C?#/&'1L'(R#P>0#61_P@_A+
M_H6-%_\  "+_ .)K>HH P?\ A!_"7_0L:+_X 1?_ !-'_"#^$O\ H6-%_P#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHZCSO*$A4;8N@) S[G/TJ3X@>#]-\$? ?5-)TPRO&9X99)92"\CF5 2<8'0
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MQ@!V:4DC'3/2G:#X=\3>'-'BTNPN]"2VC>1U7['*,;W9R!B7@98X'IB@#DO
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:&8NP4GC/8<X- '=45XIX#URW\,ZA\3M6U*'[/!97JL\$)#!3ND 1.@Y) '
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MBSX?>+38:9$=,TRZ2U%X\^)#*LB99$V_=YQG=G#?A0![716/X5;'@W168_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3D=F&QU?#1E"D[7_ ,FOR?\ 3//]3^'TDNMZI<V$6EI:WUIY*I+%@V[[0-R
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M8@U+0+C5-/\ #]Y=ZY9S^(=(NS<^<V5BFR^XIP,J,!0"!VZ<UWG]F6WK<?\
M@3)_\51_9EMZW'_@3)_\550S!0C&,%;E\E?K>[W:=V')<\ZN=$U33--\3:QH
M>N65IKFI727#$)YJ1QJ3B-<KEG.3_#R3@#O7?PQ7=[X<A34+:VDOI+9#-#*,
MQ>;M!((YXW5;@M(K=BT9ER1CYY6?^9-3UPXFJZ\W-^7X*R_ N'N--'G>D^!=
M7M]0B.H-H<MEYQEF2*R7>W.< E>!G QGIQ4EW\-HI3?6D*6B6=Y=K<>=MQ-
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MBZ[9:]!<S6)E*6]S):R>;&4(D0X88//7UK2H ***:[B.-G(8A1G"@D_@!UH
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MKJ.UD>%64X8;PI'!X)Z \9S6]O7<%W#<02!GD@=?YC\Z '444@96+!6!*G#
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M*G2XMBTP9@Z+M3)(Z!>,=/7)YH R!K&K:[I_BJ^L-1>RETB\GM;6%8T9&,*
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M31176!@>8HZ\<<8XKG]8T^XD\77\LUOXHLE9(H;:;19@8IHU7(WCG:P9G&"
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M4Q_W Q&%')Z 'WH S)[[6].O=(T^35I;R;6G:13Y<41@5(@S1QG!')(.6R<
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MMX3U+Q1'<7LFJ16>D1ZE;B>-%*2,SH4^11\F5!YR0.];<?P^TN/0GT9;N_\
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M6ZQ^$-:9V"J+&?))P/\ 5FO+=+B31]%\#>)-5E?4?#T5C;QR)*V4TVX*@).
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M67@C6;B^AGFM5M7$L<#E'92,$!ATZ]>PS7#V%Q8W'CS4;9+K3;A+KPV@2*S
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M]Q/!-N@:3S8QA"#M#;0"<>HSS6QI]M8:;\8I[;3XH+>.?05EDCA 42,)R Q
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M_I-JARX4;B "<<D#I_,_G7+^//$5UX?T>TCT_8-2U.^AT^T=UW+&\A^^1WP
M3CUQ4U[X:N?['FCT_6=3CU(QG;=273.&;'=#\@!_V5&.V* .B550850HR3@#
M').3^M1"TM@21;Q E_,)"#E_[WU]ZR]0\3V=A+>HL%U=?8$$EX;9 WD*1N&<
MD$G;SA<G&..1FG?>.M'LY;&.-;R]>_M7NK46=NTGG(H!.WU."./SQ0!O&QLR
M6)M8"6Z_NQS2BSM0RL+:$,GW2$&5^E<M<?$?2+<7H%EJ\LEBL;W4:6+[H5==
M^Y@<8 '7],X.-?\ X2?3YDLOL'F:A)>V_P!J@BM@-S0\?.=Q  ^8#DCDX]:
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MNTG.[[P*[L;<\9J!/'.GSZE<6%K8:K=3V]S]FF$5FV(VV;@6)Q@$="?_ *]
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MZU-10!%+:V\\:1S012(A#*KH"%(Z$ ]*7[/#Y;Q^3'Y<A)==HPV>N1WS4E%
M$ LK46Z0"VA$*?=C\L;5^@Z"E2TMHY!(EO$K@8#! ".,=?I4U% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !7.>,!K)L[#^R+:6YC%XAO8K>18YF@P<^6S$ '.WN#C.".M='
M10!Y+)X4\1"QU<VFD"&:'Q##K5G ]PFVY5%C_=Y!.&^4Y)XSCD]:T-5T;6O%
M.OZG-_9%UIMM?^')-.66YDBS'*SLPW!')QSVS7I5% 'FRP^([]O!HN/#=U!+
MI%S_ *8?/A*$"%X]R'?DC)!Y /UJS8>&M3O_  IXST>[M9+"35;V\DMI)'1@
M4E'RD[&./<&O0** ."T.'59[4_:_ UAI]_;6\BR2MY++</L*[8]O(5CU+8P.
M.<Y%/3/#=_I3:A%INF7AT*?39 ^AZA.CH+@D8CB.X[5*[P>=O(Q[>DT4 <9X
M.T.^T35+V&W:_B\/M!&;:TOY1(\$N6W+&<D[ -O!)YZ59UBPU"X^(7AO4(+&
M22RLX;I)YPZ (9 @7@L&/W3G KJJ* //?#_A_4=/\2V-]IUG>:3:S^:VKZ?)
M,KVI<J</" QVL7P>,#&<X/!V_'FA7FO>'%BTX(U]:W4-Y!'(VU9&C<-M)[9&
M1GUQ73T4 <S>7%_X@MX+%=%O;)6FBDN);IHPL:HZN5&UV+,=N!CCG.>,&J+'
M4HOB#K.I_P!FSM93:7#;Q2J\?SR(TC$ %LC[XY('>NPHH \QTSP_KMMX?^']
MI+I$XFTBY#WH$L1\M1$Z9^_SRP/&>,U+?^%];O;;QMI<5F(_[2O$OK*[DD0Q
M2%5BPA&=WWHR#D8P>IKTFB@#SF;1-1\4^&-4L6\*6OAR[GL9(/-8Q,SR'&%4
MQY/E\<DXZC -/5?$.J:SX.N[GPW=6K:7)*+W=-"5!: Q[DP^67)ST!QV->AT
M4 <OX[\-7'B31;;[!)''J>G7D5_9-+]PRQGA6QV()'Y5<M-9U6]@6-O#]W97
M9&'-P\311GN=RN2P],#)[[>VY10!Q-E8:KX>\1>)&&FRZC9ZM(MW;R1.@VR>
M6$:-PS# ^4$'D8K.T3PIJ?A_5/!-LMK)<VVE6%S!=W2.@59)=AX!8,0"K=NF
M*]'HH \]L+NX@\?>.XX-,GO6D%H$$90*6^S_ '6W$8!]>G7\8- \)ZIX+U70
M[J.%]2MH]&73+M8&&Z*17,@=0Q&5)9E]>AQ7;6.@V&G:M?:G;K,+N_*FX9IG
M8/M&%^4G P..!6G0!YC<>%=7@M(9X=.EFGNO%*:S- DD8,$08<$E@"VU02 3
MR3SWK9\2VNNWVO2VZZ;+=Z1-IK1Q>5.D:I<DG/G98%EQMP &&<\$\CM:* /-
M=,T;7K.'X?W#Z-*7TFSEL[N$3Q;HRT2(')W8*Y0YP2<$<9XI-(T35-*O+S1;
MGPE9:A"]Y+/:ZO)Y101R2%_WJGYRREB, <X'0<UZ710!0UJ34(=*EDTJ 3WJ
MLACB9@H<;QN&3P,KGFN/O_#S:QXUT/7+'1)]*OK2<O?7DAC7S8=A!B.QCYA)
M*\]  >>@KOZ* /--!T35-)GFT.[\)65ZBW4DEOK+^4R&)I"X,BGY]ZYQ@#G
MY YKH/"ECJ%GK_BB:\L);>&]OUN+>1W0AU$2)T5B0<J>H'%=710!QVA^&KW3
M/%VIEMG]A^>=0LTSRMQ*I60>P&'/_;7VK&U7PMK>K/XZCAM6M6U&6TGT^:5T
M*2-"J<$*Q(!9,<@<&O2J* .)O8O$'C3PGJ>FW>CMHDD]F\0^T3)(6F.,8V$_
MNP0<D\G/2H=)BU.ZL9FN? =CI][!:R*Y8PLMS(4(V1E3D*QZEL<<<YR.\HH
M\_T#2-4\,W=]-I%CJ1T86!>+1[NX1BET#D)"Q9MJXR#SC)&,]NQT;46U;1;3
M4&MGMVGB#F%F#%#Z9'!]B.#UJ[)&DT;1RHKHPPRL,@CT(I54*H50 H& !VH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M59]BEG<(NYOX5RPR>PS4<&H:U%J]I:7UG9O;7".WVNVE;",H!"%2._.&SV/
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M64VR(VK3^8?-7+ H&*[?U'?%=AX,L;'3?"UI9Z9>7%Y81;Q;SW#!BZ;CC:0
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M$J"+((\Y$4%2#P,X/)]Z .^HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPVMU=,E_]EM+LVEU-]D<+ X(!+Y' RP]_;%7[7Q9IMSJUQIK"YMYX;<W0-S
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M/!.66"*/<Q#@'C=U!89'R^U20>+=-FNK"%UN($U$$V,\T>V.XXW84]02.0&
M)'3- &X(T!?"*-YR^!]XXQSZ\ #\*@73[)(9(4L[=8I/OH(E"M]1CFN<?XB:
M&D4\Q6_^SV]Y]CN)_LCA('W!?G)'RC+ >OMBNDOKR'3[&>\N-_DP(7?8A=L#
MK@ $F@!#IUDTAD:SMRY&TL8ESC&,9QZ<4?V=8FU>U-G;_9W.6B\I=C?48P:Y
MZ'X@Z+,VFD1WZQ:E#YEI*UH^R4[=^Q2!R^.PZ]!S4\/C;2)-+O;Z3[3;_8KA
M;6>">$K*LK%0B[>^[>N#TY^M &\EK;QVOV9((EM]NWRE0!,>F.F*;!8VEKM^
MSVL,.U-B^7&%PN<X&.V2>*Q)O&FFVUEJUS<0WD;:05^W0^5NDB4KN#84D%=I
MSD$]_2M :U;M)IJ+',QU!2\.U0<*%#$MSP,$<^X'<4 7H8(K="D,21J26*HH
M R>IXIDEG:S,[2VT+LZA7+1@E@#D ^HS6?KGB33_  \;(7YG!O)Q;P^5"S[G
M() X'4X.!U/8&JR^+K22Q6YCL=2>3R3/):_9BLT489EW.C$8R5; ZM@X!Q0!
MK#3;!3&196P,?W"(E^7G/'''-/%E:+>->+:PBZ9=IF$8WD>F[KBLR/Q3IEU;
M6,VGO)?F^A,]O%;+EGC&,L=Q 4 D#YB.3CKQ56#QQI$]K:7*BZ$5S?\ ]G*7
MA(*W&=NUAU'((STXH Z)T21=KJK#KAAFH+33K&P:1K.RM[<R'+F&)4W'WP.:
MR+WQ'IKQ:_9S/>0MI< -VT4;;T1U8JR%<DG )R.G?%5%\8Z/I.G:';[M3NFO
M[(36>8'FEG18PW) ^9R",CKDY/'- '1O8VDD<T;VL#),=TJM&")#ZL._XTX6
MMNOF;;>(>8H5\(/F & #ZC'%8=UXSTZTT][]X+YK>"%)KIE@.;564,/,4X((
M4@E0"0.2,$5N"ZCDLA=P9GB:/S$\KG>",C;ZYH 9-I]E<6J6LUG;R6Z8VQ/$
MI1<=, C%6  H    X ':O+],\2PR:./%VM7>M6@MM0G1A"6,$D?G-$D;)RH
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M^9_O**[B2-98GC<$JZE3@D<'W%9VAZ!IWAVQ^QZ;"T<1;<Q>1I'8XQRS$D\
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M-HW@<!OE&,UZ+10!YY+H.H)XK35=&M;[3+R34A]O3S UG>6P;!E*Y.'* 8P
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MZQ.I4C=P<N/4=>:2QTK5X;WX>L^E7(72K&2"];='^Y9H4C'\7/*GIGBO1**
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MA+[(US<QJ;*'RDE"$@&60J=O'H"3@=><#J*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>DB M.LY8R>:A9<+M&,8YYK'^(4#:YJ_A71+([[R+5X=1FV\F""(-N=O3)(
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI.UBIX(!'*GK0!?HK/T_6[#5+V_L[21VGL)%CN%:)DV,1N ^8#/&#D<<UH4
M%%!. 36?I&MV.N03S6$KR)!</;2;XV0K(G### '@\4 :%%%9[:W8)K\>B-*X
MOY(&N%C,;8,:D G=C;U8<9S0!H45GZMK=AH<=O)?R/&MQ.EO&5B9@9'(502
M<9)ZG K0H **** "BD=@B,YSA1DX!)_(=:HZ-K-CK^F)J.G2M+:N[HKLC(25
M8J>& (Y4]: +]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$7F)+OMBJN&4AE()4XY':I4T4C5K749-2O)9;>![<*PCVNK%2Q;" Y)1>A%
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M(!&86\PH5&.J]#R2?>I[_P $V&HZ/?Z?/=W@;4)TGN[E"@EE9"NW)*D #8H
M ' ]SFZGAV)/% U]KV[>Z%F+,QML\LINW= N<[N<YH V:*** "BBB@ HHHH
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MB.[.JJ@)9B<!<=<^E>5:DEC9:7K^M^%=9CN;F72?WEOI:(L04,/WI"'B3:6
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M'X 4 >A4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!88'!/K5BXMH+NW>WN88YH7&'CD4,K#W!X-9-CXLTF^M+ZX66:$6$GE7,=Q
M\<D;$ J-A&3N##&!SGCFH9/&FC6XU$73W-M+IT N;B&2V?>L)SB0  [EX/(Z
M8YQ0!K'2]/:=)S8VIF1=BR&%=RKC& <<#':H_P"P](\CR/[*L?)W;_+^SIMW
M>N,=:AT7Q%8:_P"<;$7!6)4;?+;O&KAQE2A8 ,/<9_E67J'Q"\/Z;+?Q327C
M/I[A;L164K^0"-VYL+PN"#NZ<\9H WTTVPBNOM4=E;)<;=OFK$H?'3&<9Q26
M6EZ?IGF?8+"UM/-;=)Y$*Q[SZG Y-8U_XZT*PEAB:>XGDGM#>0BVM9)?-B&/
MF0J,-]X'CH,DX%3W?B[2;.*XFD:X:"U56NI8X'9;<, PWX&0<$$CJ <G H U
M+W3[+4[?[/?V=O=PY#>7/$LBY'0X(Q21Z;8102P1V5LD,V?-C6)0K\8^88YX
M]:R+_P :Z+I]\+%Y;F>Z>V^UQQ6UK)*98\@ IM4A^O;. "3C%367BS1]2T>U
MU.QN&N(;MS' D<9\QW&<KMQD$;3G.,8R>* +L>C:7%IYT^/3;-+(G)MU@41Y
M]=N,4ITC3#9_9#IUH;;=N\DP+LW>NW&,UCOX\\/Q6*W<MS-&GVT6#JUN^Z*?
M(&QQCY>HY/!'3-:VFZG!K>G&YM1=0HS/'^^@:*12I*GY7&>H[B@#G-7\+7]S
MKDEU%:Z%J%B\4<4=KJ5L3]E"YSY9 (P<Y(P.W. *U=(\*Z9IMHD;V%@T@E:8
M".U5(XF.,^6O.P<#H>3D]ZY3P9X[LK7PYIT&N7U[)<SWD]N;R:!VBW^?($1I
M<;0< 8&>!CI76OXKTN--89WG']C@&]7R&S&"N_(&/F&WGC- %TZ+I31SQMIE
MF4N/]<I@7$G.?F&.>?6I$TVQB\SR[*W3S8Q%)MB4;T P%/'( XQ5";Q1IL4*
MRH9YU-HMZPAA9V2$YPY'7G!P.O!XX-0-JFGMXOA@^W:@+P:<\XLU1_)>+<O[
MS&WYG!( P2>2,4 :<VC:7<V,=C/IMG+9QXV6\D"M&N.F%(P*?=:987MF+.[L
M;:XM5QB&6)708Z?*1CBL&S^('A^^_L]H)KDPW\QMX)VM)%C,NXJ$+%<*Q*G
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MXIUUIUC>NCW=E;W#1_<,L2N5^F1Q6<OBC31#-/.9[:&*U-XTL\+(IA'\8/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME4/')&P974]""."* ,OQ!KRZ*+"%(5FN]0NEM;:-Y/+0N06RS8.  IZ DG
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M*/*DB4)Y;E1P3N;:#W!(Z4[X96-C!8ZW-;VMO'(-:O8M\<:@[!,<+D=AQ@4
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ME 4X')SG(H [&PTC3=+ADAT_3[2TBD.YTMX5C5CZD #-1_V#H_D0P?V38^5
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M$0GFC>TE5S$<X=%*Y=>#RH/2K$/B32[C3-.U&&65[;465;5E@<F0L"1QC(&
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M,3&0IORSKL;@X^X3D>M5=2\#2:EI&MJ][''JNJW,-TTXC)CC:$IY2!<Y*@(
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M-Y<HPZE67=D<.>A["EN/ 5[?6/BRWN]7A8Z^$.Y+8KY+K&JY^]RN5Z=<=R:
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M9L-%NM2DT/5;VYM9/[.MRUHL*G:\CQA?,;)X 4D!1GJ3GI0!D6/C_5G\+?\
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M)O*2,J8O+38.<G.0 >@H Z&BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M75?#<-S:7%W/&9)5/VP$31L)&S&X/.5^[^%8>K64<WQ@T5FEN5)TJY;"7#J
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MMKW#)F:)LX!']T 8#].* ._HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY/HL^D2Z>9+&:<W+1R3R,1*3DNK%MRMDDY!'4TZW\7:1J%[JUA:ZE;1SZ?\
M))))(N%;;DG!(R%R,GIGBKEEJ4-OH%E=ZAJUG.'B3-ZA"13L1]Y>2.>H )H
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MU2&>79<X:.)%<<.SAB1N&,'/%=%'X?TQ;:]@>U$Z7PQ=&X8RM,,8PQ8DD <
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M=W0[L5ZSXC>(^%=4:3'EM9R_?&.J' P?Y5JT4 >3:=]DDD^%"S")C#8LL@<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM^TNNQVIG6_33+@I<E<KY;C&TN4!(91C)8'F@#N[F]>WOK*V6RN9EN696FC
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M#<D\,Z1)H,NB?9"FG2JRRQ1RNAD#9W;F4AB3DY)/.>:N:=I]OI5A!8VBNMO
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M')4'(&3WJQ'J^F2Z@;"/4;1[T9)MUF4R#'7Y<YXH BT?0-.T#2$TK3(I(+)
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MI3X_$.BRS&&/5[!Y1"+@HMRA81$9WXS]W!!STQ0!I5B7'A/1[F\O+EX)%:]
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M<1<S64/Q;U2UU"[O$LO[*BG2)+B8(LA=@S (>#@"O0--6[6PC^W+"ERV6>.
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MI#'('/?FN>L/"7BG2=#\/W=O:6,VIZ1/=[[)[CY+B"XD+$;]N%8?+CJ./PH
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M5@I8JH&3P 2?PJ>.198DD0Y1U#*<8X->7Z?JVN:9X$\8ZRFIK<7=E?WVPW$
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MAAL8(!XSB@#L**Y[0)O$7]J:C!JULW]GKL>RN93$)6R/G1UC8C@XP<#@UT-
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MSQV(/!% $=GX06RU>PU)=4O))[*P-@GF+&0R$AB3A1SE5Z8'%9[VEIX/T :
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M.<5T-% '*^&=/MKO7-3\5)87%H^HI%%&ES&8Y"JJ,N4/*EC@8[B-3WKJJ**
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M9](A>")"J;9%=0K;_EZX4=,57L_ MG9V$>DB\N)-%AN!<16#A2J$/O5-V,E
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M5E:PV\9.XK$@4$^IQWJ1+>&(RF.)%,S;Y-J@;VP!D^IP /PH \?BU%M-\+I
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M]:] G\.:%=73W5QHNG37#_>EDM49V^I(R:O6UK;V<"P6L$4$*_=CB0*H^@%
M'G'A2'2]3F\-Z[9Z]:_:FA*20VL6);LLGSK/ER6*D$Y(X/UJCIUQ9IX9^SW1
ME8W7BVYBAA60)',_GR,$E)!_=_*21@DX KTJTT'2+"\N+RSTNRM[FX_UTT4"
MJ\GKN(&33&\.:&]E)9-HVG&UD?S'@-JFQG_O%<8)]Z /.-/TDZ_X9\;:-;3V
MYN;;5))-/6 X2)UCB<!!DX4N2".GS'UQ4</B)FU[3?%]GIX^PZW9_P!FK$4/
M_'YMWIGT!;?$3_L9/&*]4M=-L;&6:6TLK>WDFV^:\42J7VC R0.<#@4];*T6
M**);:$1Q/OC0(,(W/('8\G\Z //]5L-)M-4M= _=RRVFB2.RWK 6R(6 ,VS&
M6E+*>01@$\C(SAZ8D6NVOPO6^N);C[1;3Q7(\]OW@%L3AL'KZ]R#7J]UI6G7
MMW!=W=A:SW-N<PRRPJSQ_P"Z2,C\*AC\.Z)$+;R]'T]/LN3;[;9!Y63D[>/E
MY]* /.Y[/3+O6_$'A:^O[+3H+*W@CTX7:EI(;?R5_>0NSC#!]V6Y.0,DX%=S
M<65S?> Y;&VO))[J?3&ACNI1M:1VBP'8=B2<FKM_H6D:K<03ZAI=E=S0',4D
M\"NT?T)'%:% '%_"^\BN_AYIUBI:WO-/B^Q7<) $D$J<'(/0G[W/K7)1^)M4
MD\*6EWK&K>;:/XCDLKJ>XA01QP*9%0.$"?*7";B3CUX.*]1NM!TB^N3<W6F6
M<T[+M:62%2Q'H3C)'M4O]EZ?_9QT[[#;?82NPVWDKY97TVXQB@#RSQ1I5GI_
M@SQ,]CK"3Q23V<PM[+]W!:L954[ &(&X<E<]P<<U>U:.7PYXN\1+H"/'-)X8
M>\$:L7,EPLC!9""3EO?O7>IX=T2/3!IB:/IXL V\6WV9/+W>NW&,^]3II.FQ
M7JWL>GVB7:IY8G6%0X7^[NQG'M0!PGAVRT?4[_1=7L-<M29[5XY+>Q0H]VK)
MD^>=[,64C.XX()P3S6#H5CHUG\)+#6[YKS[9=HEF\\5RP:0-<\1DL2JH2 &.
M/NEO7GU.T\/Z+82W,EGI-C;O=<3M%;HIE_WL#G\:<NA:0NF/IBZ79+82??M1
M;H(F[\KC!H \]L)5M[_XC6 DM(XTL8I$MK5L11N8)-^T>ORC)P,XS@5VO@G_
M )$+P[_V#+;_ -%+5Q- T:-9%32;!5DA$#@6R -&.B'CE1Z=*MVMI;V5NEO:
M6\5O @PD42!%4>P' H X+X1G^S]"U#P_=L$U;3K^<7,;'#,&?<LF.ZL",'OB
MKOCK5Q%#I$<<G_$OEUF"UU*1>%$9S\K-_=+; W;G!ZFNFO\ 0=(U2>.>_P!+
ML[J:,822:!791Z D9Q5A]/LY+ V#VD#6938;<Q@QE?3;TQ[4 >;Z]9G3]=\5
M6&GAH=)D\-O=S0PL42&Y!<(R@?=+*IR!C.W)JCJ&@Z=9>#?"&H0&XAN;^^TE
M;J=;J0&0<#)^; P">@XX]!7J$>BZ5%92V4>FVBVLO^LA$*['[?,,8/0=:P?%
M?A:35-*TK3M*L]/CM;34(+J2"7]W&8XVW% JH1ST]* .)\16][X.U'Q<GA3S
MXK4Z$EW+$CLX@N#*5+KDG:QC#M_P'-=#>6MK9^*?"%QX<"I!J(ECNE@.%N+;
MRMPD?'4J=N&ZY;&>:[BTT^SL8FCM;2"!9#N=8D #'&,G Y]*AL]$TK3M_P!B
MTVSMO,!5_)A5-P/.#@=/:@#RS2=/T6S^&6HZ]J$E^DT4M[:_:;:Y82I&]TRA
M%+':,G;R1QDFK+1VZZ_XQTMX]/2WET&.4V-L0T0D E[< M@*<X' ''%>E1:)
MI,%E-90Z991VD^?-@2!0DF>NY0,'\:+70])LI$DM-+LH'2+R$:*!5*QYSL!
MX7))QTH \U6&SA\%_#62S\N-C?Z>)1"VT,S0$MN X).%///2KB+;Z[:^/3K1
M":AI]W,L$C';):0+$&A>,]4S@MD=3FN['AW1%MX;<:-IX@@<R0QBV3;&W]Y1
MC /N*DN=%TN\NUN[K3;2:Y4!5EDA5F !R!DC.,\T ><:3:2:YXN\.#Q!'))/
M=>%FDO(7=@KOYD.=RYQWY&,9^E=+\,'8^!;:-I&=8+FZ@C+,6(1)Y%49/H !
M]!72R:5ITUZ+V6PM7NPNP3M"IDV^F[&<>U.LM.L=-A,-A9V]K$6+%((E12?7
M '6@#CM$9?\ A<?BL9&?L%EQG_?JSXMU33+J?2].:1IY6U-85A$H2"241L^R
M8D'*@$-MQDG;6Y/X8\/W5P]Q<:%IDL[\O)):1LS?4D9-.;PYH;Z>-/;1M/-D
M)/-%N;9/+#_WMN,9]Z /-+#37UOP/XKLK.6"6\T[6;B;3TA^XA38X1%R<(QW
M+CI\QIT6NLWB2W\2:?9+]@\36?V*U#1DXNU *LP/0,3(I]?*S7J=KI]E8R32
M6EG;P/.P:5HHPID(& 6P.3CUIRV5HD5O&EM"L=N<PJ$ $9P1E1VX)''J: *V
MGQZ?I$%GHL$T2/'#B*%G'F.JX!;'4\GD^IK0J![&TDOH[U[:%KN)#&DY0%U4
MXR W4 X'%3T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML+76M-O+>XG@NXV2VSY^?E:' S\ZGE>.>0*SQXV\-M)'&-7MR\J[XU!.77U
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M;#G&2<CD8YHRZYXREU'PYI<J6&EWVIV5R]PCQ>=Y$L6WD$/AE.X$#/'<G&*
M/0:*R-7NM4TWPK<7-O +[4X+;=LBC.)) .2JYSZD+GGIFN#\0^*)M6^&WB6]
MTC7UF2"!%Y@$=Q"22)(Y%.-I.1@X'?'3- 'J=%<J=6OYO%">&(KQ$FBT_P"V
MW%V(1N;=(4154G Z$D\]NF<C)TSQQ?W\MKHLJ00ZN^K7.F33JA\O$$9D:1%)
MZLNT $\$D\@8(!V6J:SI^C10RZA<K DTJPQD@G<['"C@=R14U_?VNF6,U[>S
M+#;0(7DD;HJCJ:X#QLVKVWA*3^VG@E6'6[,VTT"G?)#Y\9!=0/O]1\O7'2M"
MXU2?7_ .O:REU$VFW6GW#6D*(-RH(V!WM_>R#\O\/0Y- '8VEU#?6<%W;/O@
MGC66-\$;E89!P>>AJ:O.O#VKZOI<O@RQN;BUET[5-,($20E6@,4".#OR=V1D
M'@43^-=43P'#XZB,+6!D$DE@8^?LQDV9#YSY@&&].HQWH [>WUC3[K5;K2X+
ME7O;1%>>( _(&SMR<8YP?RHN]9T^QU&RT^YN5CN[UF6WBP29"JECT'' /6N+
MN]7AT#QUXQU>="\5GHEK.47@MM,QQ^/2HM2_M27Q1\/[N_NX9?M%S+(\4<6T
M1N;9SA#G)7!(YR> >.E 'H]%<'9^(_$VL6^GZQI&GF>RGNRDD#B)5^S;RI<.
M9-V\8SC&.HQWHTS5_%FI7FNO%/I[Q:3J$UNMLMLP:Y40JR*&+_*=S#GG.3TQ
M@@'>45Q_@[Q/_P )#<2+_:(DEA@'VNQGM_(N+6;/(*G^#TZ].IS5SQ#J.H6N
MI06UO=16T$EM*X*1^=/)*I7:!'@_( 26;Z<CK0!TE%><6_B_Q!JMGX(DM)+"
MV?7HI?M&^!G".L+/N7YAQD9V_K5N76O%%P=4TW3@EQJ>DQ11O)%#&([BX:,2
M?,'D!5"&4<<]3GM0!WE%4K66_N-&AEGA2SU"2!6DB?\ >+%(1RIP1N /H>:X
M'2/%WB1_!^E^([Z:QE&J"&V@M(;<J4GDF"!RQ< C;D[>.0!GO0!Z717"7GB7
MQ'X>M]6N=3T\RV*)"+">8QH[32.(_+<(S< LIW #C/4U<DU'6K+QMI>BS7\,
M]O?V=Q,SBV"-')'L'R\D;?GZ')XZF@#KZJ6^IV=UJ-Y80S;KJSV>>FTC9O&5
MY(P<@=JX:R\8ZQ<>$/">KNUOY^I:I'9W2B+Y2C2.N5YR#A1Z]ZM7GB;6H+CQ
MU&DEGG1+6.XLR8&QS$\A#C?R?E R"/I0!W5%<%%X@\0V]IHS7<]M<S:Z8A;1
MV]N%-N!"TDG+. Y.T 9V\G.#TI9?$OB32;=K;5+)$GN]4AL-+NI0G[Q9,DM(
MB.>4"MT(W<=.: .NBUG3Y]8GTF*Y5K^"(320@'*H3@'.,=:O5PNEPW4'QAU)
M+JZ%R?[#MS&_EA&V^=)PV."<YY '&/J=C4M:G?Q?9^&K.0022V<E[-.4#%45
ME154'C)9LDG. O3G( .BHKS6\\;:];Z9?0J++^TM-UJ#3IG:)MD\<K)M<#=\
MA*OS][H<5W>F0ZI#8NFIWMO=76]RLL-N8UVD_*"NX]/K0!?HKRJ7QAXN@\&S
M>+&FTR2VT^\EBN;)+9E:>))S&65RYVD <#!Z9).<5N7WB'Q%J3:R?#=H9)--
MN?LT4;+'LG=51F#EG5ESNP,#C&<G.  =S17#?VKXJU'QA>Z/:W-A8I!9VMWB
M6V,K+O9@\9PX!/RGYACZ<Y&3=^+O%$'AG7=;%SIY_L?5I+4P"U8"XC214QG>
M2G#9[\T >GU4TS4[/6+".^L)O-MI"P5]I7)5BIX(!Z@BN=M-4UN#QU+H5[=6
MD\=QIK7L#I;E/(=9 A4_,=Z_,#U!X[5R\VOZYK?A#P?J#WT=O/>ZXL%P(8?D
M<++)MX)S@>6IQGGUH ]5HKSM-6U#2?&/C._O;\W%II6FVTY@$07*A)GVKSP<
M@G/.<^@%7X-;\2V]U:7]W9&719+22>^D*Q)]F*IO4Q[9"74\C!&>ASVH Z?4
M=9T_2I+2.^N5A>\G6WMU(),DC=%&!5ZO+M9O-3UG1_!&MW%Q$L-]K-E/]D6/
MB)7RR -U) .#G@GH!71?%"XN[7X;:Y/9736TJ6QRZKDE3P0/3(/6@#KZ*Y9M
M6OY?%4?AB*\1)X]/-]<78A&2#)L154D@="23GH/7(F\':]=:Y9:A%?QQK?:9
M?RV$[1 A)&3!#J"20"K XR<'- '1U'<7$5K;R3SN$BC4L['L!7!Z?>:U'XH\
M=2I?0SM8K$+:*Y CC&8-Z@MGY5!8Y/U-3Z5XCOKKQ'<Z//<+=VSZ.+Y9_(,7
MS[BC!>FY#P0<?B: .OT[4;35].M]0L9A-:W"!XI " RGO@\U:KS/X6ZO+JWA
MG1M.L+I(8M,LHEO4DCS([,H90H/1<9^;D'H.A-:$7B/Q-JUM#JNB:>;BV-\\
M1MF$2H\"2M&S;S(&#_*6Z8[8/4@'>45E^(KR[L-!NKJQ>TCN$"XDNWVQ("P#
M,Q]@20.Y '>N/E\7ZO%9^-5@E21]$LX[NUFNK1D9PT;N5=,KW0X.!UZ'N >B
M45P]EKFO)XBT*SO;JTD@UO3YID6*W*FVDC6-LY+'>#O]!T[4S2_$NL7.F7&F
MW4\"^)(-5^PN%APFTG>) I.=IA!?KU!% '=T4@X R<GUI: "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBH+V\M].L9[V[E6*W@C:221CPJ@9)H GHJG-<7HO;%;:TCEM)=W
MVB9I=K1#;E<+CYLGCJ,5<H **** "LB^T:>?5UU2TU.>TG6#R#&$5XG&XG+*
M>21G@@C'/K6O5>VOK:[FNHH)5D>UE\F8#^!]JMCZX9?SH YVX\!Z=?Z7JUM?
MW$\UUJLJ3W%XA$<BR1@",I@879M&.O?.<FC_ (0A+[0KW3-?U>]U@747DF68
M)&T:@@C8$ &[(4[CDDJ/3%=510!S>G^%)8M.N;35=;O]6,UL]H))PB&.)A@@
M;5&6/&6;)X%0#P3_ ,2S0K)]8NI!HUQ'<0.\:98HA15. !M"D^YZYKJZ* .8
MD\&QI<ZN;+4)[2TU@E[VW15(+E=K.A/W&8=>OJ,&IXO"L-KXAMM6L[EH!:Z?
M_9T-L$!C6+(8>^057OT%=!10!C^&= 3PUHRZ9%=27$2RR2*\B@-EW+D<<=6-
M2:_H<'B'3!8W$DD2">*?='C.8Y%<#GL2HI9M4EN='GN]#BAU">.1HDC:;RU=
MT?8XW8.,$-V[5IT 4C8SG6UO_P"T)Q;BW,/V+"^66W9\SIG=CCKC%1:KI<FI
M/9LEVUO]EG$X"H&WL 0 <]N3TY]ZTJ* ,?7?#.G>(9--FO(_](TZ[CN[:9?O
M(R,&Q]#C!']0*9>^'(Y=<76[&X>RU+RO(DD50R3QYR%D4]<'H001ZXXK;HH
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M:PVMNGW8H(PB+] .!0!Y1%?6WVWPIJ]A<8AN]<G0W=Q*/M-S&1-N$F, 1@@
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MVG]BZ=]F>3S6A^RIL9_[Q7&"?>ITTC38[\7Z:?:K>"/RA<+"HD"?W=V,X]J
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MKII5DNI,,-=B!1*>WWL9Z<4 >4:S90MX9^(VJ9E6\L=6DFM9$E9?*=8X2&4
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MY!(J_(O.1N4D#D9/I4.MV>J7^E_$98]%U)6U/R#9J8"3+B%%X SZ<^G0X/%
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MU)(QP2![YK2N]*TS4]'65= UC3(KN_247$".M[%(L;XN&4;F'.$Y&<-R,8H
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MVM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%8/BSQ!/X;TVVO(;);L2W<-LRF785\QP@(X(/
M7H2/K0!O45QR^)O$,FNZEH2:-8?VA;V\=W"YO6\EHG+##'R]V[*D8 Q[CNEG
MX]CU/2M$FM+79=ZI:/=>7)O=850JK9V*2?F8 <#/)XZ$ [*BN,M?',T]E9)<
M:5-9ZG<SS0^1,DFT"+&Z5?DW,AW+CY1G=VP367J7C+7I],TYH--%A<-KT.G3
M^?YB+,F\$-$2@)1QP21D<C!ZT >ABX@-R;831_: GF&+<-P7.-V.N,\9J2N4
M&KRKXWO+ Z-9?;XM(2Y6Z6;YI%,C#RBVS(4,&/?KG%9VE>/=1O;?PS?W.CP0
M:=KL@@1ENB\L<A1F7*[0"IV$9SGO@=* .\HKB-3\>SVFEZSJUKIT4]GI.H?8
M)4DF*2.VY%9AA2  SCCDD GC@5V<;3&V5I(T6<H"R*Y*AL<C=@9&>^/PH (+
MB"ZC,EO-'*@8J6C8, P.",CN",5)7 V'C2TL/"<.HOIUGI4<^K363X?$$+B1
MP9'8*."4ZX'+#)'6NPTF[N;VQ\ZZBAC<NP4P2^8CIGY7#8'!&#[9QS0!>HKF
MK[Q'?O<:Q!HFG1WLNDJOG(\I0S2%-_EIP>=I7D\9('J15\0>+K[1K.[O#I<<
M,%I8K=DWDXC,[X8F%, _. O)YY(X[T =6]Q!'/' \T:S29V1E@&?'7 [XHBN
M(+@R"&:.0Q/LD",#L; .#CH<$<>]<1J4L-[\1/ NHQ1!3<V=Z^2!NVF.,@$^
MV:I^'-5MO#=KXNG$ (;Q*T$,,8P&DD6%5' .!DY. > >#TH ]'J-KB!+A+=I
MHUFD!*1E@&8#J0.IKCV\=R:>NL/JVES)#80I-#<PQR".YWG:(P75</N(&.>H
M-4K@7Q^+?AN2_M+2&1].O#OMW+$_ZK*DD#.WL>^3P* /0:B:Y@1BK31JPZ@L
M :EKS7XK:#I=MX"U6\CL+?[7-=V\DEPT2F1B9XP?FQG&./I0!Z%)?6D,#SRW
M4"11C+R-( J_4]JL5YW\2_#VD6'P_P#$%W::=;02R0PAO*B502D@VG '4;FY
M]ZV!XON+'7]0T_6K&&UAM]-;5(Y89S(?)1MKAP5&&'!XR.>M '645R.G^+KZ
MZUK3+671Y?LFH1,XGB24_9F"[@LI9 N&' (/48YZU?\ %OB"X\-Z;;WD%BMV
M);N&V9#+L*^8X0$<$$Y/0D?6@#?HKC6\<2:7/X@B\064-K_9-K'>AK6<RB6)
M]P Y5<-E,>G(JU+XFOM.U?2;+5;"")-6W);R13%A%,%W"-\J.H!PP[CIWH Z
M2>XAM8'GN)HX84&7DD8*JCU)/2H-2TZUUG2[C3[Q/,M;F,QR*&*Y4^A'(KSV
M/Q1JC?#CQ#K&LZ9I^IQVUS<HUL\I".B2E-N"A&  ,>O?%=;<:[<OJ<VDZ1:0
MS7=M9I=2^;(41=^X1H, \G8WL !US0!)8>&8[*2-I]5U34$B(:..]N-ZJ1T/
M &XCJ-V>>>O-:\%M#;*RPIMWL78YR68]R3R3T_(5S,GBZY/V*T&FM:ZI/9_:
MYK>XWN+<9VA3Y:L22V1GC@$^U:OAK6)M>T&WU"YTZXTZ=]RR6MPI#(RD@]0"
M0<9!P,@B@#6J*&X@N/,\B:.7RW*/L8-M8=0<=#R./>N;L_%C:EKMWIUI':,]
MG>?9KBV>8K<(G_/;9CE3D8]N<]JY#2M=N_">F^*[^UTNWETRU\13_:,S>6RH
MQC4^6H4@D9SR1[4 >L55NA9W#K97+QLT@W"!GP7 Z_+GYAZ]JYKQ3XPN_#D6
MIW)T^$6MA"DJM<3^6;PG)9(N#RH'?N<8'6J]\(9?BQX<N4C4&;2;LLVT98;H
M<9_.@#LX;B"X#F":.4(Q1]C!MK#J#CH?:I*XOX<QI#:^(XXD5$7Q!>A548 &
MX=!78RF01,8@IDQ\H8X!/N: 'T5Q5IX[GNO#WA?5_P"S8U36KQ+1X_/),!8O
MA@=OS?<]NM5K[QYJ]K:>([N/0[5H=!N2EQNO2#)&$5R4^3[V&Z' Z<GL =T;
MB!;A;<S1B=E+K$6&XJ.I ZXY%25P]T8#\6M%NU55\W1+EF?&"1OB(R?8&GVG
MCFYO)]'GM](FGTS4Y BR11RF2!6&4D?Y-NT\9P?ER.30!VM%<KH7BU]?NR+2
M.U:*.>6&YA$Q^T6I3< 70C^(J/ID=>M+X6\6/XH6"YMDM&M)(F:41SDS6L@*
MXBD0CAL%N>/N]^M '4T5D:YKBZ3+IUK'$)KW4;C[/;1LVU<A2S,QP> JD]/0
M=ZYG7O&FIV.F>*+);:WM]:TFQ^V1/O+12PD'$B\9R"I!4]\<D4 =P]Q!'/'
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M3F0-&7*$-E1A@0.F1SUH Z.BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM;K5+;=KK)(C1P,/*=41><MTRG3KCN:MZCX;\2'6K/Q#I>IZ?%JPM?LE[#/
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MSO(%U)-;_MJ:26,^7)*2VY< Y VL .?X179@2K  2KS!>OW0S8_' S]:DHH
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M@M(=W+X?].M37?@C5+KPUXITG[59JVN7KW2R?,1"&" J1CYL;!SQU]N>]HH
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M#C)':NJM]6TZ[LY+RVU"UFM8R0\\<RLBXZY8' Q7%^.[VROG\)^=L^SOKT1
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MK<21C+K%,KE1[@'BO/O$-YIGBGPQX@U/P8K7>J3:9Y#W5N'&4#9\KG WE2_
M&1WQD58NKC3]?\0^#;[0)866W$INO+(Q#:&+!CD'\/S; %/<'T- ';P:OIES
M<+;V^HVDLSJS+'',K,0IPQ !S@'@^AKG[GQ47\=:)I&GWMA<V5Y%<M.(B'DC
M:-05Y#8 .>F.W6N%L;".;X/>(+C0[2"75DN+U5>! 9A$UP=RJ1R,QC@#KQBM
MMM=T#5O'_@>ZT>XMY(?LUY$/)'^K!2/;&V/ND<_*>E 'I3NL:,[L%11EF8X
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M3?9W]DDMK>.4FE&QP$3'RJQ 89.>.XY/;H/&VNW'AKP?J6KVML;B:WB+*NX
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MH>VGB6:.3! *,,@\].#WJ'2]7L-:M6NM.N%N(5D:(NH(&]3AAR.QH YO0/\
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M"4O]T'.,'&?7VYJ+1?"]UI?B[5+DR(='EE-[:0CJEQ*NV4^WW21_UU:NMHH
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MG!R#VJB/ HC\/V&E:CI/]HHTMS=SS6DXCEM+B1PZF)F*\#+#.1G:#CM7HU%
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M<<L3')!"KG\C^G%+H'@Z?0ECA/B'4;VUM5*V-O<A"MOP0,D ,^ <#)P!VZ8
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MT\BP,^DKJ4[E!(REGV!%SQ@%6))'3'3-:\GA,1ZMJ=]IVHSV0U10+R)$5@S
M;?,3/W'QP3R#@<9II\&6=I>Z;?:-,VG7-A:?84VJ'22WX(1U/7!&000<YZYH
M XG7/%4M[HFEW.K1JESHWBM+6[:WC8K(8E<[T7D\J0<<G/%=6^N:O_PA]SXB
MM-M\LP2:TM;6(2,D#,N3P?WCA"S8&!D;>>IFG\#VTEK8PQ7LT;6VI?VK)+L5
MFGN,DDOQC'S'@8X  QBBS\&'3+;4+73M7NK6UNKI;N*%$0K:N) Y$>1PK$<J
M<CDXQF@"SX2UR'7[.YNK;58=1M1*%B=8_+DC&T925>,,&SV'!'%.\3:[+I4N
MD6-ML%UJEZMK&\@RL8VEF;'&3A< >I%6-(T&+2[_ %'4"XDO=1='N'1 BG8N
MU<+SVSDDDDGZ 'B'P];>(;2WCEEEMY[6X2ZM;F'&^&5>C#(((Y((/!!- &-#
MK.J)XGU7PQ<W$;3)8K?V=ZL7)C+%&5USC<&'!&,@]..8_A9#+_PKG099Y5ES
M:*8OW>#&#U&<\_6MJ#P^8[J]U"6\,NIW4"VQN?+ $<:Y(5%[#+,>2<D^@ $G
MAK0U\-Z!::/'<O<06B".)Y% ;:.F<<&@#"\=2ZBFJ>%(K.^^SQ7&JK%(GEA@
M_P"[D8$\\@%>G^%8=Q+K%IXI^(%WI=W;036MK:3LTT!D\PI YVXW# ..3S7;
M>(/#Z:\NGM]LGM)["[6[@FA"DA@K*00P(((8]JI-X/!NO$$_]I39UN!()@8U
M/EJJ% 5]]I/7///M0!GQ^*M1UF6QL].A>*>;2(=2E>)$<J9<A5 =E& 5;/4]
M.E=%X<N=7N] M)M=LDLM4*D7$,;AE# D9!!/! !QDXSBL&?P  ND3Z=K=[I^
MI:9:+8I>0HA,T QA)$8%3TSTZ\UU.GV2Z?91VRRRS%<EI93EY&)R6/;)))X
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MH[]*R9_AU%-%=0)KFH16TVIC5(XE6,B&;S!(2"5)89' / SWH 9HTNKS>/\
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MVR0W,*"3R1:REY$)QNC&W,HSW3=5JW\3:1=Z5:ZE;71GMKHE8/*B=GD(SD!
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M8B,?(N%'!^\220,YR*H:CXIEB\3>$KDWES!IU]!=-<6K6[+O9(U*X4KO)RW
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M?E4N!M0J?E.XC  /2K&AZ3>:1XYT6&>&YFCL_#:V#W@A<QF8.AQNQCD*3_\
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M>&);?5]2@OSX5U+3KVWB9)9]25@8\]4C+,2X)YR.,#U(%=K10 4444 %%%%
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M?%<O/X&N(?#^BZ7I]S 6L=334IYI@1YT@D,C  9P"S'N<#'6NV7<5&X -CD
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MY\4I#.AV( F1]XY/ ')STR<5/XZDOKGPKI=WJ6FPP72:Q9-%#'*)&7,Z\;B
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M..R@#)SZ8 .BHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDX  (4N3SZ<UKZ])?^$].U;7+;5Y+NWBTMY([*Y_>$SKSYH;.0N",J!CN,4
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MWBG1759$#@.I5@",\@\@^QKB+2Q'_"YM2?[3<\:1;R;?-.#F:7Y<?W?:N[H
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M$A>9!LD8JI;!!()!_'%=*T]]!\3+725U*Z-E)HDLOEL5.V198U#YQR<$]<T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<PVY#;9-N"-H<JW0],CI7M5% ')^#ET2YO-6U;1+RXODOWC:>Z? BDD52OR
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M]B14(FM=:TKP"NALBZE8W<'FQ)Q);0K&5N$D'51QM(/4[?:O4J0  D@#)ZT
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M9!+N*$XSNVA@5+8QGVYHO_&5G90:A=+9W=S8Z;(8KRY@52L1 !?@L&8*"-V
M<<]2"!C^&-.\5>'1)X>%C;2Z8EU));ZH;@96%W+E3'C)<;B!VZ>G,<'A[6M,
MT[Q1H4%HMU;:M/<3VEWYJA8O/'S+*"=WRL2<J&R/2@#;G\96ZZS_ &59Z=?7
M]R]B+Z$VXCV31E@ 59G '7OCIWR*IVOQ$L+JUTJ]33=26PU&=;5;IXT58IF8
MJ$8;MWWAM) *Y[U#I7AR]T7Q?8S0VLDVFV6@)IB3;T#.Z.&!VD]"!C/K[<UD
M0>&-=B\!:-I+:<3>6>LI>RJ)H]OEK<F;@[N3@XQZ^W- '07OCVWM'UM$T;5+
MAM&*F\\M(QM0IOWC+C(V\X'/M5BV\9VMSJ]A8C3[^./487FL;F1$"7.U0Q &
M[<IP<C<%S61+H>KO-X\<:>V-9A5+/,L?)%OY7S?-QSS]/?BG1:)JXO\ P+*;
M!@FCP/'>'S4^4M!Y0V_-\W//T]^* -%?'>GG08-8^Q7PMI;[[ 5*Q[XY/-\K
M+#?C&[N">.U,O_'EO976M6Z:-JES)HZI)=>4D>!&RE]X+. 1M&<?>/8<'',R
M^&/$Z>')]"ATN!UAUL7T5RUTH6:(W/G<#&5(&0<^G&:V)-%UAM1\;S_V>=NK
MVD45IB9/F986C.>>!ELCV'8\4 :4^LZ1=^)?#),-Y)/>P33V%PC%8MAC#-O&
MX9.TKC*G&>U2_P#"8VADM'CLKV6QNKS[%%>QHK1F3)7. =P3<I&[&,^QS6+9
MZ%J\5_X$D>P(31[*2"\/FI\K-$L8V\_,,J3]"._%.\):=XJ\.VZ>&WL;9].M
MIV,&J_:!DP%RVTQ8SOP=OIWYQR :S>-;)+N%&L[P6TVHG3$NBJA#."1C&[=M
MR"N['7VYJE:^*Y[Z^\56MYI%VMGI9\HF)XRS+Y0<]'!W$-D8Z =0:PKWP[XJ
MOI+>:[TVWNKZSUU+Q;M[L#S+=9"56-<'RP%(!'&2,_,36U!H^LV>K>+V%C'+
M;:KME@D6< EO(6/9M.,<KG).,?E0!>TGQ!IL.@^'H--M[J4W]FLEE:LX:41*
MBDEV9L< J"23R1C-13_$#3+;2)[^2TO@UK>K8W5L(U,MO*S!1N ;!!W*05)R
M#Q6-IGAG6M('A#4X[3S;G2]-.FWUF)4#.A5?GC8G:2&0'!(R#VIFL>$=5N[#
M6[N"TS?:OJEI=?9_-4"&* QX#'."Q"$\9&6 SQF@#K-)\2Q:GK-[I,EA>6-Y
M:QI-Y=R$_>1.2%=2K-QE2,'!'I6CJEW)8Z7<W4-N]Q)%&66-"H)Q_O$#WZ]J
MPK73M0'Q(N]8>S9+&;3(K57,B$[UD=SD YQAP/J*W=56632;N."(RRO"RH@(
M&21@<D@4 <%X3O+:/1/#OB&^AU'^V=0MT@"+,I_M!W7S"Q4-C@!B"VW:,CT%
M;]SX[L+*QUJ:ZLKV.YT91)=VFU#($(RKJ=VUE(!YSV.0#6%;^%M;M_#G@R>*
MV4:IX<VK):M*NV=#'Y<FU@<9P<C./?%/U_PMJ>LP>*=1CLS'>:IIJ:=:VKR)
MN4#<2\A!*C);H">%]\  Z_1M9.L+._\ 9M[:1QE?+>Z0*)E900RX)XY[X/M2
MZCK45AJ%GIXADGO+M9'BA1E4LL>W<<L0/XEXZ\^@)%K3A*NFVRS1&*58E5T)
M!*D#!Y!(KG_&&AQZ\UG;W>C/?6B+(_GV\RQ7%M+\NQHV++C^+//8<&@"W#XJ
MMY-3TK3WL;V&?4[:2YA\Q4 4(%+*V&R&&X=L>]16WC/3[JP>X6WNEE&H/IJ6
MSJGF23H2"JX8KCACDD# )K!30O$UC/X0U&9!J][IL%S;7F9U1R)0NUMS<-MV
M $]3UYK/7PEXH@T]KV"VM!J=EXAGU6W@-Q\ES%(6#)NQ\I*L<$_B!0!;\=:Z
M-1\$ZN4AU"PO--OK:.5&)4G=+'R"A(=2K=.?IFNJTOQ-%J.N7>CRV%Y97EO"
MEPJW(3][$Q*AUVL>ZD8."/2L+Q+9>)/$O@RZMY-+CM[N>:W:*T%RK^6L<JNS
M._ R=I  ST'/)QH0Z=J!^)4FM-9LEB^DI:!VD3(D$K.<@$\8;&?4>G- &WK&
MJV^B:3<ZE=+*T,"[F6)-S-S@ #U)(%9T/BRR^T:M;W\4NGR:5 ES<^>5*B)@
MQ# J3G[K CKD5+XL@UBY\,7L6@R!-28+Y1+[,C<-P#?PDKN /8D&N(N_ ^K:
MM/XEA&GVVF6NL:5# CBYWM'*A<_/@98DL,G)XSR30!?U#5)[WXB^"I/L>H6<
M4ZW;@32#9(OD$C**Q 89SR,\^Q T])\1:+9Z;K=]%!>P+'JSV\\4[;WDNFV+
MMC&X@ EE  ('T%4%M/%&J:_X3U"^T6&U.F&<7C&\1@Q>+9N0#)(SS@X/;WK*
M@\/WNN:-XC%@R)?6GBM[^U$I(21XC&=I/H<$9]: .S'BR!-0NM.N;"[M[^"U
M-VMNWEDSQ X)1@VTD'@@D$?3FF0>,["X@\/3I:WGDZ]@6KE4^0E"X#C=D<*>
MF:JOHEWKOB>#6KRT?3UMM/FM8XI'1W9Y2-Q.PD;0%XYR23P,<\]IGA_Q1'I_
M@NSFTF"+^P;@+,YNU(D41/'O7 Z?,#@\^PZT =%;^/(;NXNXK?0M8E6SN9;:
MXD6*/;$\:;CD[^AZ#'MG&1DTWQ]9:E+HN--U&"VUE<VEU,B!&?87V$!BP. >
M<8..":B\/:7JFGVGBE;FP96O]0GN[91*AWJZ*H!YX.5Y[<]:RK+PYK5OHG@.
MT?3SYNBS*UWB9, ")X_EYYY8'Z"@#=O?'NE6$D;RI,;%KO[&;Q60HLF[9RN[
M?MW KNV]?;FLSQ[KZW'@SQ1#I]O?2_8;>2*6ZMI @BF"9QG<&.W*EL CG'."
M!%H6C>(]#N)]$_L?3[G3S=22VVK/,H:.)W+[6C(W,Z[B!V/'2JEUX<\26>C>
M,M M=.CO;;6)+JYL[O[2J;#,IS&ZGG(/0C(.>2* /0-().BV))))MX\D_P"Z
M*Q;SQG';ZIJFFP:/J=W=:=#'/*D*Q@.C[L%2S@?PG@X)[ \UM:3%/!H]G#=1
MI'/'"B.J/N ( '!P,USD>F:G#XS\1ZG]A=K6]L8((&61,L\?F9R"> =XQ]#0
M!+9^/+"]GT8I87Z66L86TO9$58V<H7V$;MX. >=N"1P3UI;CQ[I5M/:[TF-E
M<W?V*.\5D*>;N*C*[MX4L"-VW'?H0:P;3PWK<'AKP-8-IY,VBW4<MWB9,;5C
M=#M.[G[X/X&IO#6C>(]"(T&31]/GL(9V:#6#,N[R2Y8!H\9,@!QG..GIR ;&
MI>/=*TS,TR3-8I=?9);M&0I')NV'*[MQ4-\I('7VYJ&S\57-[K/B>QN=)NEM
M=+VQYB>,LP,>\G[X.2&&,=,<D&LW2=&\1Z)?7NDIH^GW>G37<MQ;:I),H:!)
M'+E7C()=E+'&#@\<BM"WTG5['Q)XLG6R2:TU01RP2+, VY81&4VGOD9SG&/R
MH 9IWB[2M.T7PO!9:=J<EOJL&+%>)' 6,N%<E\YP.N2/4@9-78/'.G/H>H:E
M<VUW:-877V.XM954RB8E0J#:Q4[MZX(..>M8&F>'-:M+/P##)IYW:(&%X1,F
M!F%HAMYYY;/TJMJVD7L&B^*H+O3XS)K6KQ26$<ERJ&1CY2C:RD[7'ELP[# S
MQF@#LK+Q-%=^(Y]">PNX+V")9W+["GEMG:P(8YR01TZCZ&MVN#TBXU6TUJZN
M+_PU=)JUY:E(;B:_@D$OE LL7R ; 2Q.[;C)Y/05U/A_4KC5]#MKZ[M!:7$@
M820B02!2&*Y5APRG&0>X(H K:OXFBTJ[FM5L;N[F@LVO91"% 6($CJQ +'!P
M!Z=N*I7?CNR@;2%M]/U&];5[1KNS%O&I\Q50.1RPP<,O7CGK5/Q-I.O:EKMQ
M$EG#>Z1-IS10I)<!$@N"6R[I@[\@K@X.,=LDU1TC0==MKKP(]SIJHNC6$MK=
ME+A&P6CC0$<C/*$G'0$8S0!LZAX\L=.LKBZDLKMDM(DDO4!C#VVY0Y5E+@EE
M5@2%SU[GBNEMKF&\M8;JW<20S(LD;CHRD9!_(UP\FD^(=&\6:M-8:+8ZOINJ
MRK<*\]PL3VLNQ4;=E260[0?EY%=S;H\5M%'(RLZH%9E7:"0.H';Z4 <[IVIM
MK?BW6(@6^Q:,T<"(IXDG9=[L?7:"H ]=Q],5]'-GK>AZN=%6]L;F/4+@![B0
MLR72GYB/F8;-W&WH1GCFF^&;-]'\9>*K24';?3QZC;$_\M%9 C@>ZLO/IN7U
MI?#,%SX:TCQ!=:O;FWC?4;K4%^=6S$YW#H3\W;'Y9H UO"FO)XG\*Z=K*1^6
M;J$,\?\ <<'#+^# BFZOXEBTN\EM%L;N[GALVO95A"@+$#CJQ +$@X ].U4_
MAYHUSH'@+2=/O%V72QM+,G]QY&+E?P+8_"J?B72M=U+7I8TLX;W1YM.:**.2
MX$:0W!)R[K@[^-N#@X([9S0!<E\<6*RZ+';V-_=G6;9KFS,,:X=0@;!RPVG#
M+UP.>2*@/Q!T]-#34Y;#4$']H?V;-!Y:M)!/O"88!B",D?=)SFLG1O#^NVL_
M@1KK3E1=%L9;:Z*7"-@M$B*1R,\H2<= 1UJK+X9UY]'O[<::?,G\3+JJ#SX\
M>0)5?GYOO84C'N.: .JMO&EBTFL1ZA;76EOI,2W%P+L)S"P8JZE&8$?*>.N>
M,5+'XKA&IV6GWFGWEG-?QM)9^<$Q,5&XID,=KXYPV/KP:YO7_!^H^(M6\41O
M$;:UU32X+6"=G4[9(V=OF4'.,L/R-:1TK5O$%_X<GU6P^PMI$IN9V\U'$TOE
ME (]I)VY8L2P!X QSP 6$\=Z>^@VNL?8KX6UQ??8-I6/?')YOE98;\8W#J">
M*9?^/+>RN=:MTT;5;F31E22Z\I(\"-E+[P6< C:,X^\>PX..9?PQXG3PXVA1
M:7 ZVVMB^CN6NE"S1?:?.X&,J0#@Y].,YK7ET36&U#QQ-_9YVZO:Q16F)D^9
MEA:,YYX&6S]/?B@#H'\36LAMH]/@GOY[FT%ZD4.T$0G&&)8@#). .I.?0D5X
MO&5A<V%A<6T%P\U]"T\5M(%AD5%(#%MY 7!('7DGC(R:YNTT3Q/X?OM%U;3]
M,BO6&C0Z7?V+W*QLC1$E9$<Y!&2PQUQC\+FM:3XDCUK2_$5KI]EJ=REM):WN
MGM*$&QG#J8W88RI&,D#([#/ !JV'CG2]4TZPN;&.XFGOI9((K3"B4/'GS V3
MM 7')SCD8SD9SO %Q+/J_B_S4NH]FJA5BN9-[1_N8\C.3QG)&#C!J+4=&\0+
MJV@>)+73[5[FR\^.YTR&95 BE"CY'( +KM!.< Y/M6CX2TW5K+6?$EWJ-E';
M1:A>+<0 3AVQY2)@@# ^[Z_XT ;6KZQ%I"V@>":>6[N%MH(H5!+.03R20  %
M)))[>O%<SK/CUH/"MWJ>G:=<-<6VH+IT\4I0&&0R*A/WL-]X8P><C..<:GBV
MVUJX33?[*B^T6Z78:^MEG\EIH=I& WH&VDCC(&.F17)-X/UX>%/$>FQZ=9PR
M7&LIJ-I%%<#8Z"2)R@^4;>(R,G'/8"@#TR"1I8$D>%X689,<A4LOL=I(_(FN
M7BU^ZU+QAKGAZ33[B.TM+:$B>.55.7$A+$A@P!V@#&3P2<9KI[=YI+>-[B(1
M2L,M&'W;3Z9[URZ:9JMCX[UG4XK)+BQU"S@0.LP5D>(2#;M/4G>.<@=>: ,3
MX?\ BT6_A/PE8W]I?G^T(O)COY IC>;#-M.6WY(4\[<'UK?U#Q[I6FL)94F:
MQ%W]CDO$9"B2;MARN[=M#?*2!U]N:YZP\,:Y:^%O ^G/IY,^C7J37>)DQM5'
M7*G//WP?P-6=&T;Q'H=Y=Z.NCZ?=Z=)=RSVVJO,H:&.1RY5XR"S,I8XP<'CD
M4 >@GI7&3?$>Q@L+R_;2-5^QV%ZUG>3>7'B!@P4L1ORPRW\.3CDXXKLZ\SO/
M#&NW'@?Q;I2:=B[U34Y;FV!FCQY;NK L<\$!3D>XZ]@#J8O&-F-6N]/OK.\T
MYK>S:_66Z50DD"G#.-K$C!QD, >>E,M_&^G2:S:Z9<0S6DEY \]M)*T9614&
M7!VL2K '.& X_*LGQ'X9U#Q%XDF<VSP6-UH-QIKS,Z$QR2LK [0W(&WG'?\
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M&?7VYKDUTC5=+\+^&-'.FI)KEMJ$]U'$EXD<@0-(Y>-B&7'[Q%8,,?,1CH0
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M/TRH ^1>IY.>@]: .HHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MRN?]9@;<'')SC Q0!JM;>&?"%LK21PVJ73K;!I-TC2%C@)DY)!)Z=*Z$
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M!WE9NK^']*UY(EU.QBN#"Q:)VR'C)ZE6&"/P-/URZO+'0K^ZTZU-U>PP.\,
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJNAZ?J)C$1N[:.<H#G;N4-C/?&:ELKZVU" SVLJRQ"1XMR]-R,58?@RD?A0
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M>AZ#@#-3>$M!M;&RU*Z%DT U:ZDN6MY1RB,3A2#]W.2Q7L785TDI=8G,2!Y
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M.FJ3^3IE\M]%(8UW,X<N W;&6/0 XQ78T4 <S+X+M+N]\02WUP]Q!KD,<-S
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MD]]I]M<2HI17EB#$*>JY/8^G2G3:/IES=V]W/I]K+<VPQ!*\*EXO]TD97\*
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M=UJ5N+V\@,ZS.@=!#(=G#'(4_+G.<#&:CMI;33M,UW29)KI;1?%$=I9VT<N
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MKGJ,<8R:[6]L;34K.2TOK:&YMI1AX9D#HPZ\@\&JMQH.D7:6Z7&F6DBVR[(
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MBQ1+!*MPZQM&Y1P#;(QPP.>3D^_-,T;4HG;P%I>LR+_9EWH D19S^[GN0L6
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M_P!4EN-+\327]]:1:GH]QJL*QW]N^VYT^7<B")U/WH]P'3^^3@Y%9&KS);^
M?B2AE$36^JR_9QOP8LQ0E=GIR3C'O7J8T/2A>M>#3K47+2>:THB&6?LQ]6]^
MM0W/AG0KR\GO+G1[&:YN$\N:62W5FD7T8D<CM0!R4D^GZWXTU_0]>G5(DT^W
M:P61PN(V5O,ECSQO#8&[J-H]ZA;3;'4?B!H-G+/<7UG_ ,(Y*!)-(=UPHEB
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M8-1T_P -7,44VI0-.S6*M=H@!W3B(@G<,*H)!8#)QC% &GK/CK2]-\,ZCK,
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M"VF6ENET\#!)'C,F_P";&,_,I]Z=\2[>1] T^^4$Q:;JUI>S@?\ /))!N/T
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M/A"'3+VQN;6XLYID?SH]H8F5V!4_Q#!!R..?K23)./BW;7?V2Z-HNC26QN!
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MO=E[<3&W(,3K()0<&/RR-^[/\.,TMMXFTB[M+FYBN\+:R^1.CQNDD<AQA2A
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M=F HP%/RY([=:W=-?_B3VC,DBD0+E70A@0.05(SFO,/[/U#_ (5M]B_LN_\
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M1927LMQY4+2);"97**64$<%@OX>G-;]F+O0/'?B2XOK.[N+'55@FM9[>W>8
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MVR(5*G(!(P< U;N_#U_-XE\/:F+J.6/2XITE,N0\QE506&!@8VYQ[XXKIJ*
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MND\U O&!@8QGW]NM=!10!QT?A"YN/$>EZS>BRCOK"1R][:AEENHRK*(Y!@#
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M0AF(52-N3\H&0>,]34&O>+-=T:Q\860O-]WHL4%W:7AB3,D<O&R1<;<@AAD
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MS/(6&%W!AL78<\9.X<C'+H-7UBX\1:=X7N[R&WOUTIKZ]N;)0P=A((PL>\$
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MP2VRVJJLL1N3#R>H(&",>G.:]3H **\]\:^)-8T6'7[NROT)TZ&*:"UMXED
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M>'==M-=N[W7M4O)(!IY=8%E 3)<%TB08&>X'7&:Z[>H!.X87J<]*5F"J68@
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M([>:9YE,4;E@-DK)P3C/W1VH O:)I,6A:+::7!//-%:Q+$CSL&<JHP,X '
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M\D X/<8XI)O 5@^NW6IV^HZG9QWK![VRMIPL%RV,$L,9!(X.TC-=510   #
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M(FN?]>8X54R_[V!\WXT >/:%865KX+^'>K0Q(NH/J\<!NLYD,;&4,F[KM/\
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M >"W*9[X]C7;_P!C:7B4?V;9XE_U@\A?G^O'-+/I&F7-M%;W&G6DL$)S'%)
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%1R6)X/8#KFD?6-?M;C1M OV235;F&XFN+C3@G*QLH7:)<*&(=2>#C!P.<@
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MZA':2":&&542/S!]UV"J-S#MG@'G&<54UKQ>MGHMCJFF10WMK<ZA'9&0RE0
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M6WD^9>6D=M.I/!" QJ=NWKN7TP>M=#JGA>QUGPTFA7[S36ZB/$A($F4(*G(
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M+IA@V2)(6,HD4MDY QT''/UK>S0 4444 %%%% !1110 4444 %%%% !1110
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ME@"+<K" RY4KC=U"X8_*.^#VK3H \1L8-/7X/:)' L$<[ZS;"X\G"/\ \?I
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MLJW=I)#'OWMY81H7_N$;1@MA<'J* -R[\8:):75G;-<R2RWL!N+400/+YZ
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M'O);FV?_ %#IR8B"<OQDA@!TZ"@#I*BNKJWLK62YNIXX+>)2TDLK!50#N2>
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MLI9XE=[:<8>)B.5/T-8(\1ZOJ$$]]HFG0WEI;WYLS"S[99E1]DDBL2%7:=V
M<Y"]1G% '0:GI\6K:;<6$\D\<4Z[6>"4QN/HPY%&FZ;;:381V=HKB),G,CEW
M8DY+,Q)+$DDDFN>G\3ZA=QZ[<:+;6TT6BRM!(DS,&N9$0.ZJ1]S 8 $@Y.>
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M!;M^XW*JD8W?-P@YXZU/=>%=<@\0-K.AZU;6<]W!'#?PSVIEBE*#"R*-P*L
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KB?B?;I/H.F[GF7&L60_=S,F09E!SM(S[>AY'-=M5'5M(L==T
M][#48/.MV96*AV0AE(92&4@@@@'(- '%76DB]^*EY9+>WUM&OAV ;X+AEE/[
M^7'[SEO?KSWS6?H/B75-9TWP9I]U<;Y-1TV>>61KE[=KB2,HH = 6S@LQ QG
M'7L>\B\,:3#J+:A%!,EVUN+4R+<R@^4,D+]['4DYZY)/6J4_@+PU<Z':Z-+I
MV;*T??;*)Y \+>J/NW+^!H L>%;74[#3)K/5=12^GAN'"2!B[)&<,B.Q +,
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M" <@T <O:2/K?C#Q#H,UW>V]OI5O:I;"&Z=')D1F:4L#ESD ?,2/E/')J_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,AGYXQE<[>N#G.>!1NO'-[:^&/$^JFPMVET*]>V,?F$+,JJC;LX^4_/TYZ4
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M8Y9B3QU'''/:44 <U_PC]^WBO2M:>XM@EE926CQ*K9?>4)8'MC8./>NEHHH
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MJ;N R$Q3K,P5HUC^ZI4MP5 /R\YYKO['2+:P?S$:XFEV[?-N9WF8#N 6)QG
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %,>6.+'F2*FXX&XXSQG^0/Y4^N/\ #ET/$>K>)KVZ19(;6]?2H(G&
M55(U7><>K.3GV51VH ZR"XANH5FMYHYHG^Z\;!E/T(IR2)*F^-U=3W4Y%>3>
M#/$^J>'? /A6:YTF%M"F\NU>Y2Y)FB9W*JY3;C9N('WL\YQVKKI;YM(^)=GI
MZ<6NM6<LI0=!/"5RP_WD;!_W10!U<DD<2[I'5%]6.!4/VZT/_+U!_P!_!4>H
M:79:K'#'?6\=Q%%*)5CD4,I8 @9!X.,Y^H%>?>&/#FC:EXG\>65SIEH\'VV*
M-1Y*_NP85^[Q\O//'>@#TB.Y@FEEBBGC>2(@2(K@E">F1VJ6O+AJ5_X>\2?$
M._TK3;6>.T:WNIUEF,0*K:JS!<*<L>3S@5T]UXO,DT5KI=N)+A[&.^/FI(RJ
MLF=BGRU8Y.UN>V.] '55$MS UR]LL\9N$4.T0<;E4YP2.H!P>?:J/A[59=<T
M"SU*?3[G3YITS):W*%9(F!((((!ZC@X&1@UC'6WC\7Z]:QZ/:?:[/3HKA;GS
M</<(2^$9MF5 *G^]UH ZRBN&TGQSJ5X?"]S=Z3;P6&O+MC9+DO)')Y9D&5V@
M;3M(ZYZ$XZ5/<>-+JRU:PM[RPAA2]U(V"0--_I"K\P28KTVL4Z>A!R>E '6P
MW,%PTJPSQR-$VR0(X)1L9P<=#@CCWH:Y@2Y2V:>-9Y%+)$7 9@,9('4@9'YU
MYAIVI:OH%SXWNM&T6UN[6UU9IYT:X\EBH@B+"-0I!;&3SCVR3QTMOXCM=3\5
M: L6F6[Q:EI<EY;7SD&5$_=DIC;P#N7/S=NE '3'4K%;::Y:]MQ! Q664RKM
MC(ZACG /(ZU9ZC(KRFTOXM!\ ^-KS^RK6_MK?7+TO9S$+&R;P,8VD'''&*Z:
M?5M9_P"%F6^DVZVOV#^R7N0C.RDGS8U+' /(Z >YYYQ0!V%%<?8>,;V[T74)
M9=.@BU:SU#^SS8^>2#(64*=VW.&#!LXZ?0UUCF86[&,(9MORAB0N['<]<9H
MDHKS[PUXRU$^"](OM2C@GU#5KUK:U5)" SM)(3NR/E554],\ #K70Z9XAFE\
M47GAS4;>.*^AMUNX9(6)2>$MM+ $94AA@CGL<T =!427,$D\L$<\;S1 &2-7
M!9,YQD=1G!_*LW7=<&DOI]K%$LU]J-Q]GMHF;:N=I9F8X. JJ3TYX'>N*T[5
M3X>\7^/-1U"VA5HH]/\ EMLXF9PZKVR"S, >OXT >ELRHI9F"J!DDG  JN-0
MLC%;RB[MS'<,%@?S!B4GD!3GDG!Z>E<Q'KUYJ5[J&C:AH[_9FL&GCNU@E$)/
M0Q-YB#YAP1ZCTQ6%X?U-=.\ _#Q)=,MKR.[DMK=))6^:WD,;$.HVGG"L,Y!&
M: /3:*Y:'Q7.FK^(=/O[2&W?2H%N8F64M]HB8,0X&T8P5*D#//X4R\\57\4S
MZ?#81MJD%G'<W,?[V2-&?=MC#(A.3L;YB!CC@YX .LH)P,GI7"MXWUFYN-%M
M;+PZ([K5;*:X2&^G:%H9(]NY'&S(&6X/?C@9S7:1!Y[-!=PQK(\8\V('>H)'
M*YQR.HZ<T +;W,%W")K::.:(D@/&P920<'D>A!'X5+7D7A/Q+J7A;X>Z5>OI
M$$F@1W4L-Q.MQB:(/<NH<1[<;02!][/L*[2'Q7-'K/B#3]2M8+0Z7;K=Q.)2
MWVB$ACOQM& "I4@9Y_"@#J:*K:=+=3Z=;37MNEO=21AI84?>(V(Y7.!G'3I7
M)7GCJZ5'O-.TB>_LH;TVKI##*TKA9/+>1,(5(5@>,\@9R.E '8I<P27$END\
M;31 &2-7!9 <XR.HS@_E4M>?6^H6?A_QQX]U29-L%O964\@C49<A93QZD]*T
M5\9W5IJ,B:II4L>GK927;7L,,VR QC<R.711G&2".N,8% '845S=GK.NW,^G
MO_8T7V._MGF659_^/5MH9%EXYW9QE<X([]:YG2O&VNVOP_LM<O;*VO9;K4#;
MD).4(WW+1\ KCC@ 9Z#DT >E45RT/B'5FU6#0[BPLH=8EBENF"7#211VZ.%5
ML[026+ 8P.A.>U9D_P 0KF'2I9AI*-?6FK1Z7>6_VC 1G=0'0[?F!# C.WK[
M4 =VS*BEF("@9))X ID$\-U!'/;RI+#(H9)(V#*P/0@C@BN6MO$NHRW^OZ5J
M&EV@N]/M4N8TCN6:.:-P_P I8H"""A!^4CFHM$\3K=:/X:M=-T^VMKG5+'[5
M';J=L-M$JKGH.<%U   SGMB@#LJ*S=$O=0OM/,FIZ<;"Z25XVB\P.K!3@.I_
MNL.1GFL.;5M:_P"%GKI,0MC8+I1N0C2,I8F55+'Y3R,8 ]">><4 ==17#:5X
MQ\0ZIH\^K0^&HI+>+[3'Y,-YNE>6.0HJJ"@&TXZ]>#QTS/%XTN#>:[9?9[*Z
MN-,L5O5>WN3Y<@.\%"=IVL"A]<Y[4 =E17%:5XSU*[O?#(O=*MX+37[8R0/'
M<%Y(W$7FD,NT#:1G&"3P,XS@6=!\72^(9B;&.S=$DEBG@,Y6>U9-P42+CC<1
MUQQGC=UH ZRD9E12S,%51DDG  KSZ#X@ZM+H6DZV^A6XL[V_^PR1K=DRJYF:
M)2N5 (R!G)!Y/ Q6I!XEU&2]U_2M0TJS^UZ?:I=(D=RS13QN'^4L4!!&P@_*
M0<T =5!/#<P1SP2I+#(H9)(V#*P/0@CJ*DKA;/QI:VVB>%56"QTM-7LO-@$S
M;+>(A4(A!  !._CIPIZ\"KMYXOGL[W3=-N(;*SU*\LOM*QW<Y6-Y> 84?'+9
M/7TQP<\ '4-<P+<I;-/&)W4ND1<;F48R0.I R/SJ6N5?6=OC72;*\TFV2:?3
M9K@7C/F2':4WQ_=X&6'?G'2J<OCR6'P[:^*6L8SH$\RHSB0^='$S[%F(Q@@D
M@E<Y /4]* .VHKAM0\::U!<^*(K31K.0:"B2R-)>,!+&8O,.W"?>QQ@\ ]S7
M8:?>)J.F6M]&I6.YA290W4!@",_G0!)%<P3O*D,\<C1-LD5'!*-C.#CH<&I:
M\LL-1U?0=0\<7.BZ-:W=O:ZGY\\;W'DL5%O&2(P%(+=3S@?7/'0OXZ%_"IT.
MU^T.;"*^Q+'(1B4$I'^[5L,0IR3TXZ\X .RHKE+'Q9=ZRUI:6.F-:ZC+8"]G
M@O\ =&;<%BBH1C))96].!GN!3K?Q1?7=QI>F?V6+/6;RT>[GMKB7(M41@I)*
M_>RS #&.,DXQ@@'4T5P=Q\0KF#3)Y/[)0W]GJL6F7EO]HP%+LH61#M^8$,",
M[?TJTOB;Q%)KNI:$NCZ?]OM[>.[A<WK>2T3EAACY>[=E2.!COD8Y .RHKC++
MQXNJ:7HDMI:%+O5+-KORW5Y%A52JMG8I)^9@!P.YXZ&%/'[I9::=3L1HUQ>7
M,ULSZAOCA5H^00S*"0^1M)QW[C! .YJ*.Y@EGE@CGC>:+'F1JX+)GID=LX/Y
M5%IT]S<Z?#->0)!<,/GC1]ZJ<]FP,CWP*X&SU./2?B1XPMK*&&74KPV7V6TW
M;/-81,68D X4#DM@_B2 0#TBBN4O?$>LP>*;?P_!I=E)<3V#W:S-=,J*5=5(
M(V9Q\W;)/' Y(KZ;XZ;4M+T7;9)'JNJ7,]JMN9<I&T)<2L6QDJ-G'&3N XY(
M .SHKB+[QOJ%C:^(H3I,4VJZ'&EQ) LY"7%NP+!T.TD$ -E2.HZG-78O&&_Q
M?8Z,4M?LM]IQO[>Z68Y?&/EV[>.,L#GH#Z4 =517&2>+]76]\/6J:/:L^M1S
M21$W;*$"+N7=\G&05)ZD<C!K5\*Z]/KUE>F\M8[:\L;V6RG2*0NA="/F4D X
M((/(H WJ*Y+5-6UB+XCZ/I5M]G^P364\[JSL&8JT8R< ] W ^N3TJO<^.9X_
M#EQXHMK".?0[>=T?$A$SQ)(8WE48QP02%)Y SD'B@#M:BN+F"TB,MS/'#&"
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M>E=310!P<_@?4KCPCXDT1KNT5]9O9KI90&(B$C!BI'\1&,9XSGMCG7GT&_\
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M,X'XC\Q0!S^J>'KN7Q-I_B33I88[^WMWM9X)B?+GA8AMNX#*D,,@X/TK+OO
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MVFX*L3"2*4$8RV<'<"W';';OL1PQ0AA%&B!F+$*H&2>I^M/H **** "BBB@
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M0RS#SG*%SC<P0G:I.!D@#.!0!C>,KW5+";3[BVLKR^TU!*;VWL)MER!\NR1
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M'^D2)Y9$R1G/E@[SA>.#RO%9=AJ6MIX4T#79==OIKAM>%E)&Y7RY(FNWB(8
M<G&,'M@8Q7;V?@/0;&;3YH8;KS=/1H[9WO)7,:, -O+?=&!A>@QQ3U\#Z$FD
MP:6L%P+."Y^UQ1_:Y?EEW;]V=V?O$G&<9H Y^]UJ\T[Q9Y&LF_MK6YU"-=/U
M&VD+VK+E1Y$J@_(Q8,,D<D]<#%5X2VC^,OB!JL4ES-)86-O<I$TI*R$0RMM(
M[CCCTKL3X7TUIVD<3NC7(NVA>=VC,P((?:3C@@''3(SC/-26WAW3K35[[5(H
MY?M5\%6Y+S.RR!00H*D[< $]!WH YK1X=?NYM#U>/5X5L;NW/VL-=M+]H+IE
M'B4QA48'G XQVXH^'$>I:CH=GKFHZY?W<K?:8&@D*>40)W 8@+G< N,YZ'&.
M*U]&\"Z#H%R\VFV\\6=WEQFYD:.#=][RT+$(3D\@9[=*TM$T.P\/:<+#34DC
MME9G5'E:3!8EC@L2>22?QH R_$=PYUG2+*.]N!YPF9K"U)26X 48;S PV*A.
M3SR2!ST/+:;X@UN?P!X;O+BXF<2ZJUKJ-PG,H@6:6,8(&>JH"P&<9/'4=QJO
MAO3=9OK*]NXYA=6>X0RP3O$P#8W*2A&5.!D'TKE=?\'06&GZ;8Z3H=U=Z5%>
M274\-I?-%<1.0VTQ%G4!<NY*AAUXZF@"E<ZQKFB:=K]^U]=-IQU*"TTZ2[VA
M8X9'C5Y-Q0L0I9P&;<.!P>]C78?$FB:1XEO%U<6]J-*EN+6%;IKB:*>,$EE:
M1 =A!&1S@XQC-:.B>%HY[6^MKZVU4:1>0^4^GZO>_:68YSN'SOLX]&R3S@8&
M;]IX#T&ST>[TM(KJ2VNXO)F\Z[E=S%T\L,6RJ\G@$"@##M)=2M?%GANWDUB]
MN8=9TN=KF.5QM1T6(JT> -I^<C^>3S5OX40>7X#M93//*TLUQN\V4OR)Y!D9
M[GOZFMY?#&F+?:;>A)S<:;$T-JQN)#L1@ 1C.&R .N>@J71M T[0(IHM.BDB
MCFD:0HTSNJDDL0H8D*,L3@8'- &+/?RZK\0KCP[)//;VEMIB70$$AC>5W<KN
MW#G"A1P#C+'.>*Y3^W?$%SIVE6TFK7$4\'BE]&EN(T0&ZA7?AR,?>X XXR#D
M&O1-0\/V&I:A;ZA(LL5];JR1W,$K1N$;JI(ZJ>N#GGGK4$_A+1KBVL+=K>18
MK"X^U6XCG=2LN2=Y(.6;+,26SG)SUH OZ78OINFPVDE[<WK1Y_TBZ8-(^23\
MQ  .,XZ=J\\DUS4]1^'FL^+K?4)[?4;*>YDB@W_NHTAD($3Q]&W*O)/S9;@C
M@5Z?6$WA#1FN;N7R)%CO)1/<VRS,(9I./F9,X).!GL<<YH YS0U:\^*>H7DD
MEU&SZ/9S^2TS;4+-)E<=,#T]<FN<\+2W^E>#O >H6^IW06ZU%;*6UR/),3M+
MGY<9W9 .<Y_#BO3I_#NFW&M_VPT<JWWD?9S)'.Z!D!)&5! )!)()&1GZ52C\
M$:%#IFG:='!<+:Z=.+FUC%U+^[D!)!SNR<9/!R.30!S2W?B'Q)9ZIJ&EZA;V
M5S8:G- K37;+%%'#)M*21!""&09))R-V00!BK>G0ZGJOC_Q%;2Z_J,=IIMS9
MRPP1% I#1[F1OEY0],<'W/&-F;P+X?FUZ363:2+=3,KSK'.Z13L.ADC!VL?J
M/K6A9:#86&KWVJVZ2B[O]OVAFF=@^T87Y2<# XX H K>+;MK3P_(R:B;"226
M*)95C\QV+2*-B+_>894>A.>U<I#J^OP+X\M;'SOM&GP13:?!=RB5XF>$L06)
M.>1G!)&>,XKM]:T2P\0::UAJ,320%U<;'9&5E.5964@@@CJ*YS7/!EM!H^LR
MZ-I[76H:C;I;SI/>2?OT'RMRS$;]A8!CWQDXS0!0M+S4SKEM>Z?>:G-HT6D-
M<W<<PR'N!C:I+J2&(W95<8P.F>5T)O$.KV?A[Q#%JL$=O=1J]\&NVD282+]U
M(RFV-E8@#![8.ZI/#V@31:K;7-I9^)-+CB8F:/4M4\^.1=I&P()9,\D<G;C'
M![5LZ5X$\/Z+J#WFGVLL+,S.D(N)##$S9W,D9.U2<GD#C/&* .'@U+6XO"=K
MKKZ]?RW$&OFT\MBHCDB-V8BK@+S\I_# QBNC\,6NWXE>,W-Q<MY<EIM5YF*_
M-#G&/0$G [5K_P#"#Z%_9/\ 9?D7'V/[3]K\O[7+_K=^_=G=G[W.,XS5Z'P]
MIUOKL^LQ12+?3HJ2MYS[7VC:I*9VE@"1G&<4 9?BS5Y[/4_#NEPR-!'JM\89
MIU."J+&S[0>Q8@#/7&<<X(R_/O8O$?B3PU+=W,VGKIL=];RM(3)!N+*8]_4@
ME,C))QD9KK=7T:PURS6UOX3(B2++&RL4>.13E75@058>HJ*+0+&*WO(\3,]Z
MH6XG:9C+( , ;\Y  S@# &3ZF@#&^&=N(/ASH+"65_,L86Q(Y8+\@X'H/:J:
M6N[XTW+&XN<#1(I0GG-MSY[KC'3&%''KS75Z1I%GH>F0:=8*Z6L"A(D>1GV*
M.@!8DXJ&Y\/:==ZW%K$D<HOHX?($D<SH"F=P#*" V"21D'!YH \PT&6_TOP=
MX9U.UU.Z02:^;1[8$>2T4EW(C KCD\YSGCM6\]SX@\2IKDVDZA#976G:E);0
MO)=LJ0K$1D21!"&##)R3GYN,8KHT\#Z$FE6NF+!<"TM;D7<,?VN7Y)0V\-G=
MG[Q)QG&33;OP)X?O-<?6);65;J7;YXCN'2.XV]/,0$*_XCGOF@#7U W3Z)=-
M:$?:S;N8BIXW[3C'XXKEOA$T+?"_11"?F5'$H[B3S&WY]\YKMJPAX1TN+4+B
M]M#=V4ER_F7"6ET\22MW8J#C<>[  GUH SM=U/R?%F@:#;2>1#JDMR]U)"VU
MF,40;9N'*DY!)&#A?>N5\1ZUKFEZ5XYTZWU.Z4:2MM<65WD-(JR]8F8@DX(.
M#][!'->A7WAO2]0L[:VFMR!:RB:WDCD99(I.?G#@YR<G)SSDYSFH;KPEH]]I
M-YIMU#++!>N'NF,[AYV& -S@Y/  QG   Z4 <SKEIJ^EZ_X>LX/$^J,FJ:A*
ML^_RSM7R&.$^3@ KD Y )Z&LBY\0ZWX7F\0:*^IW%Y%!?6$5KJ%SM:2WCN3A
M]QQ@E<'!([C/I72^+-&NK[6O"BVUK>36MC=O+//'-AHU\IE4[BP8G<1Z\9S6
MZ_AC2)M-OK"YM1<PW[;KLS,6:9L  ENN0 ,8QC QC% '/W<^H:1XYM='MKZ[
M>PU/3[B3]X_FO;2Q;?G5GR<$.!@Y&<8Q6)HD^I/\.]+U^]\57ZW6HPV\)1D5
MPS-*/EC4 'S'&5SGC.>,<=Y;>';&V+ONN99WA^S^?-<.\BQ]=H8G(]R.3@9S
M@55/@O0SX:A\/_9Y1IT#J\""XDWQ,IRI5\[@0>F#0!P>N7E_/X9^)&FW$]Y%
M!801R6T<EP7DC#P!BA<$D@GMD]2,D5T=W+>:;KW@:UM]0NOLMT\R3PNX82 6
M[.,DC/! XSCCI6RG@G04.IDVDDG]IP""\\VXD?SE"[<G+'YL?Q=?>I%\):2K
MZ6^RY:32R6M7>[E9E)&TDDM\W''S9XXH X]]:U/5/ OB#Q1;ZA/:ZAIUQ=-!
M"'_=QI Q C=.C;E7DGG+<$8%6(9]4U_QE-9/J^H6-I/H5O>^1 RJT,CNX(#;
M<C&![\=<<5T\GA#1Y+F\E,$BQWL@ENK=9F$,[C'S,@."3@9_O8YS5AO#VGG6
MIM7"SK?36XMGD6X<#RP20H&<#!).0,\T 4/ &J7>M> M%U"^D\VZFM@99,8W
MD$C)]SBL:TCU/4O'WB.VDU[48[339+.>&"$H =R,S(?EY4XQCK[\"NNT;1K+
M0-*ATS3HWCM(01'&TC/M&<XRQ)Q4=GH-A8ZS?:M DHO+X*+AFF=E?:,+\I.!
M@<<"@#C- N?$/B#3/#_B6VU&W@2>99+Q)+QVCDB8E6B$6S:KJ2 "#G(Y)S3]
M,UF]C\46VF:X^H65[<7$YMKJ.3S+._C(<HJ=51E7:<$#.WG.:Z"P\"^'],UB
M34[.TDBD>0S>2)W\@2'JXBSL#>^..V*LP>&M-L7@F1+B46CO-;Q23-(L;L""
M5#'KAF [#)QB@#S87_B.'X;P^,$\17\]]97KJ;5]GE7$8NFC*,H7DD=#VP
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MY/7&: +U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4M=#(=2PRB\CYB.![UA^#_[#O=0U36=$N[F^^W>5]HNW&(Y'4$ *-JC<!C)
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MRQ'Y&"LV\-VSWSQ7;^&+*UT[PU86=BEREG%'M@6Y)\P)D[<YY'&.#R!@'I0
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M3L<2JC8R-P5@?U%9?Q!2^D\"ZH-/BEFG"(QBB&6DC#J9% [DH&&.^:Q-&O\
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M<YXJ >/+%=0NK":SN4NH;-KY(T>*3SHE.&VE7(W#NI(]LT =716%X<\3#Q)
MES#I5_;6LMM%<0W%PBA)0XSA<,3D=\@>HR"":^L^-+313J3RV5Y+;Z6(C>3Q
MJH6,/R, D%L @G'3/<\4 :>M66I7]I'%I>KMI<RRJS3+;I-N09RN&X&>.>V*
MLV%E%IMA#9P;C'$NT,YRS'N2>Y)R2?4UFZEXDBLI[RWMK*YOY[*W%S<QVVW,
M:')4?,1EB%;"CT[9&<Q/%]Q=>,-*TVTTV=K&\TQK[S6VJV"T8!*L05"ACD=<
MG@<4 ==00#U&:Y#2?$>BV>G:U?16U[;A-7>VFAF;?)+=,47:@W$ $LH ! [\
M"KW_  EL$6H7>G75A=P7]O:F\6W.QC/$#@LA#8)!X()!_#F@#H:" >HKD],\
M>VFI3Z(/[,U"WMM9CW6ES,J!&?87V$!BP. ><8..">M=90 8H P,"BB@ HHH
MH ,#.<<T444 %%%% !@9SCFBBB@ HZ#%%%    , 8%%%% %'5[2^O-,DM],U
M(Z;=$KLN1 LNS!!(VMP<C(_&G:7IZZ98);"5YGW,\DTF-TCL2S,<<<DG@<#H
M.!5RB@ H  Z"BB@ (R,'I1CC':BB@ HHHH ,#.<<T444 %&!G..:** "BBB@
M HHHH *  !@#%%% !1110 8&<XYHP,YQS110 4  =!BBB@ HHHH *,#.<<T4
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7,>.=+O]7T>TM].M_.ECO[:Y8&14 6.1
M7/)/4@8%=/10!Q?B/2]<A\4V7B/1M.M]2!M#9W=A<3+$VW=O5T8@C()(/M^E
MG7=!O]=\$S6KI;VNKJ1=6@@.4MYT;?& V!G! !; SD\=JZNB@#C->\*ZA?>%
MM-2UEA.L6%]%JGS$K'-.K%G4GG"DLP'IQ5;6_"-UXPO;V\O(6TT2:/+IT*2.
MKOOD(8NVPD;1M4 9R<GIQ7>44 <AI4GC6YT=[2^LK+3KR"U:-+I;@3+<3;"J
M,%V_*N<,<\\8QUK'T;P]X@B\1^&]5NM*MXI+:TFM]0F>\\R61V\O]X3CYLE3
M@9XSC@5Z/10!YD_A7Q"/A=?>%_L,+7(NF,$BW VRJ;DS;CG&T;3C')SV%;T>
MF:II'C;4M<M;)[RSU>VA$T*RHLL$T0*K]XA2I4\X)((Z&NOHH \ZL?!VI:3+
MX4$<*S_8;ZZO;YTD 56F60;4!P2 9!Z<#/4XK>\*Z9?Z=JOB2>\MO*CO]0^U
M0'>K93RT3!P>#E"?QKIZ* .+&EZYHWCC6=1L;*._T_6HX2V9Q&UM+&FSG/5"
M,'(R1Z5B^'O"7B#0;;PEJ#6D4EWI=G)87EG'."7B<@AD8X7<& R"<$=Z].HH
M \XU/P5JUT-2URS%O'K$VJP:C!:3MF,K#'Y0C<CC+*7)(R 2!GC-:\EMK&K:
M#<+J?A>P1)VCC?2_/23S(]WSL7P%SCE1ZKUYX["B@#E_!>A7>@0:A;-)<KIK
M3AM/M;J;S9+>/:,J6R>-V<#)P,<Y)JJ=(U1/%7BF_%D6M]0L(;>W(E3+.@D!
MR"> =XQ]#7944 ><Z)X8UO09_#&JI:">:RT@:3?VBRIN*@JPDC)(4_,O()'!
MI=0\&ZI)I6HWEO#$VHWFN0:J;4RA0$B=,1[NF[:F2>F3C)QFO1:* (4DF%H)
M)(1YVS+11N#SZ G&?KQ7G.G>%M=M/"W@S3Y+ &?2-2%S=;9DQL D'RG/)_>#
MTZ'VSZ910!RNC:-=Q^*?%=S?68%CJKPF+<ZMN5(1&P8 \9Q^7I5?POX:U?0?
M#M]:-=QO>QQR6FFS/R(X$+>1N]QNY]@!VKLJ* /-]'\/>(8O$'AK5;K2;>.:
MTM9X-0F:]$DLKN(_WA..<E6P,\9Q\HJ.Y\+:[-\/O$.CK8 7M_JDMU"IF3;L
M><2C)SP0!@CUQ7IE% '%KINN:3XZU#6;&P6]L=8MX%FC:=8Y+66(%1G.05(;
MG&3GL>^-HOAWQ5IFA>&=.N+"VN+2U$ZWUD+S:K,S9C=CC#*,ME>>H/../3:*
M /,;+PEXAL_"6AV7V"U-SI.NM?")+D 2Q&24\'&%XE&![=NE:$>E^)M%\2ZG
M)9Z/I^IV&JS+=;Y;D1FTF**C@Y4ET^4$8&:[ZB@#-U2#4F\-W=OIEQ&FJ&U9
M+>9EPHEVX5L<X&?K7':-H6N6GBO3M:DT6&%5TJ2TNA]M$DS2ET;<S$?,3M(&
M3]2.E>AT4 >:6/A?7+;P=X.TQ[ &YTC4H[FY"S)MV+OSM.>2=XXXZ'\=36M#
M^V_$'3I[.Y18KJW9=5A'/FQPNK1GZ[SL.>JLP[5V]9VEZ!I.BR74FFZ?!:R7
M<AEG:-<&1B2<D_B>/<T 7;@LMO(4C,C[3A 0"Q].>*\YL_#&N6W@[P7IC6&;
MG1[^*>ZQ,F-B!P=ISR3O&!QT->E44 >=:OX1UC5K[Q>T2):G4#936$TCJR^9
M;X(#J"2 6 ]>,_2K=QI'B#Q7X8U+3]2TNRT.::V,49BF$Q>7(8/D*-J KTY)
MSVQSW5% '(Z1'XDU&SE@UC1M/TMQ;O$TD$XE\]R,94!1L3J>23T'UQ4\.^(/
M^$)\)Z5+IL8N=(OK.24)<JP:. C+ G')QP/S(KTBB@#AIM#U9M2\<3+8DIK%
MK'%:'S4Y986C.[G@9;/T]^*R9K35[2[\,6VGZ:LVKZ5H_E72PWL<4L:D(@!+
M*R,C&-R 1G*@\<@^GUDZKX8T76KF*YU#3H9KF)=J3<K(%ZXW*0<>W2@"EX+*
MPZ,^G#2)=+>RE,<D$DZS99@)"V]3R3OR<X.3TZ5DVVB:SHMQXGL[6S6]M-8G
MDN[:;S540R2(%=9 3G:" 05#'':NRL[*VT^V2VLX(X(4^ZD:X ]?QJ>@#A='
M\*WNA>)?#_D0F;3]-T9M.>X+J"SED;=MSG'R'\ZVO&V@3^)O"=YIEK.L-TQ2
M6!W^Z)$<.N[V)4 _6N@HH Y0:7J&N>)M"UG4+$Z?_9,4Y\MI5<R2RJ$.TJ3\
M@&[DX))' KG+?PMXB@\$Z-H;Z?$TNFZM%<%TN5(DB2<R%AG&,@@ >N<X[^G4
M4 >>ZSX2U36]5\6806L6J65K%:3LZG;+"S,-R@DX)*^O -:%FOB;4-(O(]2T
M"QT^?[+)$%M[A9#<2,N 1P B=3R2>GISV5% &+X0L;K3/!^D:=>P^5<V=I%;
MR*&# E%"D@CL<5Q_C#PUXEU]?$]D;*VO(+J%!IDTMR%6W 4;E"8X<MD[NX/4
M8Q7I5% '"?8/%.C>+;O6-/TNUOK?5[>%;JW:\\LVLT8*@ABOS*5/.!G(Z>MZ
M?2-:C\;Z/K*Q6]TBZ=)9W;"3R_+9G1]P&"2/E( Z],^M=;10!YI+X.UJ[TC5
MPL4=O?#Q#_;5@))04DVE2J.5S@G:0?3(ZUM76CW^KZ\-=FL'MGM=,FM(+9Y4
M+R22D9)*DJ% 4 <Y.3P,<]C10!YW9>&]:M])\!VKV/[S1'4W>)DQ@0M'\O//
M+9[<5V^G3ZA.;O[?91VOEW+I;[)O,\V(8VN>!M)Y^7MBKM% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBL"&V80G QQSR#CH/")T&_U?4]:T34;C46O$B6YNC@1,R@A0 %4%P.O<#&:
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M$J8FWE<]^G(YSCVJAH;2^&[GX>2^(IA:%=)NK=I;EMNUSY;)&Q/1MHQCV(H
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MDNA+JT2Q7>)>&105  _AP"1QZ^M:.EZ=!I&EVVG6Q?[/;1K%$';<0BC &>^
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MWS)ZX)&2*I>&KK0M=BT&:PU*[E\0:9;/''8E$1K9_+VNLH" [-PQ\QY..YH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM+!;WLTNCD"XB2W.]R4W@(O5B1C'KF@#<HID4GG0I*%=0ZAMKC##/8CL:?0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFFW)F=+-DDMIQ)B6)T^XRL.XZ>_?.34<_A.PN]/U*UN9;F9M3C$5Y<,X$DJ
M$!<@ *,$\*!U)ZDF@#!L;W5[/QCH-K<:O/=V^KZ9-++%)'&%BDC$9#1X7(^^
M1@DUGV'BK55T6VAN;]GN;WQ+-I(O'1 T<:O)C  V[B(]HXZMG!KL!X8M!J.F
MWYN+HW&G0-!;L77 1@ P(QSD*O)]*J/X#T6;0KK1YUN)K6YN6O"6EPZ3%MQD
M1A@J=W/_ -:@#0TBSU"RO=0CN]4^VVS.CVD;J/-A4C#!F'W@6!(.,]1DUJL"
MR$!BI(P&&,CWYK.T;1+?1+=HXI[NYD<@R7%Y.TTKXZ L>P[ 8')]36BP)4@$
MJ2.HZB@#R9-:\2+X*M=?/B"=KJ+63:&-H(O*EC-V8?G 4$G!'0KT'UK6N]4U
M;1=<\2:8WB',<>D1W\%WJ$:$6TC/(AX11E?E! P>?6M[_A!M+&AC1_.O/L8N
MOM87S1GS=_F9SC/W_FQ3M4\$:5K-U>W&H-<S/>VBV<P\P*#&K;EQ@#!#'<".
M_MQ0!EZ+J6I2^,M3T9[F^2U.EPW<#72Q^:CL[H6'!P#M!VL.#V'2L!M3O-8^
M'7@34-0G,]W/K=DTLA4#<?./88 KMK3P=I]GJO\ :D=SJ#WQM1:M/+=,Y902
M02#P2-QQQCVJ-/ ^EQZ)IFD)+=K::;<+<VJB4;D=3N4DXR0"2<'UYSQ0!TM%
M8EAHLMIXHU+51<W1ANXXU,,LY=-RC&Y5Z(,#MU)/M6W0!Y=J^M>(["U\4:1#
MJMU)KEK<1W&ED11;IK=UW!,;,'&R8$XS\OX5H:MJW_"0^"?$6IV=Y*^E_P!@
M2!(R%PTKP,[$\9R%9!P<9)XXKLGT6PDUZ+6V@!OXK=K9)?1&8,1^8_4^M4X_
M"FEP>&)_#MM$]OITZRHZ1-@E9"2XSVSN(]A0!RFE7NIZ-J_A&!]3GNK/4]*E
M:6U>- D1BBC93'@;A]X@Y)S4FB7OBC7;#P_XAM;VW2VNV22\AEG!C,+]511'
MD.I( ^;D@@YKID\*V27FD77GW1ETF)H;7+C 1@%8'CYLA0,GT]>:J:9X"T;1
M]2>[LFO8X3*9DL?M3FVCD/)=8L[0<\CL#T P* .-GUKQ%!X8UG6SK]R\NE:\
M]K'"88@DL0N%CVR87)^5C]W;ZUZS7,R>!M+ET>^TIYKPVE]=F\N%\T9:4N')
MSC(RP!P../K72HI5%4L6(&"QQD^_% '->(]8GA\2>'M MYFM_P"U))VDG0#<
M$B3<57/ +$CGL <<X(XYY+_18OBC<VFI3B\M/+GBN65&;Y;564$%<' P,XSQ
MZ\UZ!KWANP\11VPN_.CGM)1-;7-O(8Y87Z95AZC@@Y!JA_P@NDF'68WFOW_M
MA%2]9[EF,@"!._ R!U SV&!Q0!BW]SK=]XET#2[;7;BR@U#2)II3'%&S+(OE
MX92RGGYSG.1UQ@\AAN_%&O1ZS'HNH)%>:9>?8X7ED54+(J%FE3RSG?D]", C
M&""3U">%[--4T[4?M%T;C3X#;0$N,>6<9!&.<[5YZ\54OO FCWVNRZOOOK>>
MX"K=QVMT\4=T%& )54_-QQ[CK0!G0W^J^)[_ ,0V-IJO]G7.FK#%;^0%=/->
M(2>8V1EE); ' PI/4\5D^U#XJK+-J4\JQ^'EN&2';Y3GS<,%!!PK;0>N>G-;
MFH^"-)U'6O[6WWMI=/&L4YLKIX!<(.BR!2,@=.QQ5V7PUITFN6FKJLL5S;0?
M9E$,I1&C!W!64<$ \@4 <KH=[XHUNS\/>(;:\MUM;LI)>PRS@QF)Q]U%$>0Z
MD@#YN<$$FL+Q!J%WXH^$MSXBDOIHUGO4V6BA?+2);M8U0C&2?E#$YSGVXKM]
M*\!Z-HNHM=637J0^89DL3=.;6.0\EEBS@'//H.V.*@N/AQH=Q!?6HDOXK&]F
M%Q+9PW3)")-P8LJCIDCH#CT ., '75Q/CZ*:35O" BOKFW635UC81%<']U(<
MD$')&WC/'M7:(@CC5%+$*  68L?Q)Y-9NMZ#9:_%:I>&96M;A;F"2"4QNC@$
M9!'LQ'XT <W;ZAJ?B*?Q1':ZG/8R:3.;2T"*A^=8U;S) 5.X,S8QTP..>:W?
M!^M2^(_"&E:Q/"(IKNW621!T#=\>V>1[4R?PEI\FH75Y#+=6DEY$L-X+>7:+
MA5&!NR"00.-RD-CO6S;6T-G:Q6UM$L4$*"..-!@*H&  /3% &3XJO)K/1@\&
MH)8N]Q#'YACWNP9P"D:X.789 X/)KA]1\1:[:^'O'JQ7UU;3:.8Y+-YEB>6-
M6A5RK$ J1DG!Y//6O0-=T&R\16"6E[YJB.9)XI(9"CQ2(<JRL.A%9,W@#1IX
M]6C>2^*ZLB)>9NF;S H [YY( R>OI@4 5+*[U6Q^(-EIUQJLUY:ZAI<ERT4L
M:*L4B.@^3: 0I#D8)/3K7:5CCPY:C6K/5FN+E[NTMVMHRSC'EM@D$ <Y*CGK
MQ6Q0!P5Y?>(O$%]XBM=#NUM+C3+A;>VS*JJ'\M'W2*48LK%B.O0<<\TV2\EM
M_B3;7MRL;S1^%9995@;*,PFC)"GN,]#6UJ7@;2-2UUM8,E]:W<J+'<FSNWA6
MY4=!(%/S8''8XJ__ ,([9#Q!%K*F5;F*U^QHBD",0Y!V[<>H!SUX].* .8T2
MZ\4:E#X?U^.]MS974:RWT4DX*.DBY C41Y5E8@ ;N>A)/-2^';S5O$FA:+XE
M@UH6XN9S)<VKHK0F$LR^4O&0X.WYLYR#V.*TM&\":-H-]Y]BUZL"NTD-D]T[
M6T#'.62,G /)^F>,4NG>!='TK5)+RT-XD3S&X%C]I?[,DI.2XBSC.>?0'D 8
M% '$)<:II7@SX@ZG::U>K=VFIW7ENXC?E5CP3E/3CT  P!70W%YJNF:UH.D3
M:U<3G7IY)'F:*-3;I'#O:./"\;FQR<D#/.>:UKCP-I%S#K$#-=I!J[E[N))S
ML)8 ,0.Q;:,D<\=JNZAX;L=3L+.UNFG9[*19;:Y5]LL3KP&# =<<'(P>X- '
M#>(/$.NZ19>-M.AU*8R:5:17ME>&-#(JR!LQOE<'!4X.,X[\5N6EUJUGX_M=
M,GU>>ZMM0TJ6Y9)(XP(94= #'A>!ASPV[H.36M=^$-.OM+U&QNGN)?[2P+V<
MN!), , $@   #HH Z^IS-_PC=L=9M=5-S=&\M;=K:-RRX\ML$@C;@DE0<^U
M'&Z1XIU270=!M[J_8W6IZU<V,EZR(&6.-Y2  !M#$1JHX[GO7;:/::A8SW\-
M[J@O8C*)+4.H$L49'W6(^]\P;!QG'K68_@'1)?#K:)*+E[47!NXV,Q$D,Q8M
MO1Q@@[B3^)[5KZ/HUOHMJT,,US<.YW23W<S2RR'H,L?0=!T% %]U+QLJNR$@
M@,N,K[C.17D]IK7B1O!OAW7F\03O=7&K"REC:"+RI(WN7BRP"@[@,8P0.!QU
M->LN"R,H8J2,!AC(]^:YI/ VEQZ)9Z0DUX+.SNA=PKYHRL@<N#G&3AB3@^M
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M*^YOE5%R>I&20.>E<WH'BW4];L/!5A<71BN=6M9[B[N8U56<1 #:O& 6)!)
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MLM/:T\5B.[DC;-LQQ)OD5FZ(S'OWR#6O8W&FS:[XULO$;0(DZQO!Y^%#V)B
M79GL&WYQT8^M 'H-S=6]G"9KJ>*"('!>5PJ_F:PM6UZ[LO%7AO3[=;:2RU5Y
MEDD.2XV1,X*D'&#@>M<'X?U:?0+_ ,*GQM-]G@ET'RH9[TX1+C?EE<G@.8M@
MR>>".YIWB&&*T;P39>#Y8K-@]]_9WVIBPP87P1N.=K$_*3QR.".* .V\7^)9
MM%\/OJ&EO9W$D5S!%*KL6 $DJQ_PD<_-GGTKHH;JWN&D6">*5HFV2!'#%&]#
MCH:\IU[6]#U/X12_85CLW6^MH[NU>0>;%.+J,R!SG);(8ENIZU)K<1LO%GBJ
MT\,)#!>3>&$>**T 4M*'E ("_P 6TC'X4 >H0WMI<320P74,LL7$B)(&9/J!
MTK$\+:Y>:P^NI?);HVG:G)9H800"BHC G)//S'TKE'>RU)?A_=>&VB^U1SHK
MK"1NCM/*;SE<#H 0H(/\6.]8U]?M%X=\920-YMJGBE6U!8CN;[)^Y\S@<X(!
M!]MWO0!W]MXGDN_'XT2WELI]/.FO=B6%MSB19%3:2#C'S'C&>E=!%>VD]Q);
MPW4,DT7^LC20%D^H'(KS'4]0LKSX@W<_AN[M);V?PI<1VLEK(IWRAU,:@CJ1
MU ZXJ3PM+X4UZ;P_=PZK<3ZC8VSQ/8[8E,"%,2K.H0'8",?,<9QC.: /2HKV
MUGE$45S#)(5+!4D!. <$X],\?6L&X\0W-KX]31K@VL>FMI<EZ9F)#JRR(G))
MP%^8]JPOA)IND?\ "&6&HVUK:&]#7,)N$4%POGO\N[J!@+Q]*EU2+3KOXQV-
MO?+;S*NAS'RIL$9\Z,C(/MD_A0!VTE[:Q6HNI+F%+<@$3-( A!Z'/2AKVT2T
M%VUS"+8@'SC(-F/7=TKR'P[J^EV?AKPC#-+;1,NI7ZVMU<2XM[7:\H&X @,2
MC84$CKD'C!=H3QW/AI+6QUV"QU*T\2W9LVGC!B:3,Q$<B<;0R%B ,$'!':@#
MV"&:*XB$L$J2QMT=&# _B*CDO;6*YCMI+F%)Y/N1-( S?0=36#X%OI+[P\[3
M:?#8SQ7<\<J6[;H7D$AWO&>ZLQ)_,5R.G:CH%W_;^A>*"#K(UEYEMBQ2>X <
M-;M%@AB-H4#!X YP* /3)KVTMI8XI[J&*24XC220*7/L#UITUU;VYQ-/%&=I
M?YW ^4=3SV'K7G$4UE+-X_T[Q*8EN))6=!/@%[0Q 1;,]0"&Z=&)[FJ&C6*2
M>+?!T/B**"34CX=D^U+< %F<-%M#@]6 SU[@F@#U1[ZTCM!=O=0+;$ B8R (
M0>GS=*&O;1+0W;74*VPZS&0!.N.O2O)=!43>%M-ATK6;33[^TUN_.GK.H>WD
MP\H\I@#P"C$@CD=J?_PD"P?\(O?:K$=#TH37\$\EOMDMXKOS!M<,RD;&Q+M.
M.-QYQ0!ZP+NV:**47$1CE($;AQAR>F#WS5*_\0:5INBW6KW%]!]BME8R2I(&
M&1_",'[W;'7->9:GIOANWT[PV+"Y^UV-QXI61)K@IL8.CF018 'E;NP&,Y[8
MJ+78+..R^*UC91P+%';P2K!"!A&\CYF"CH>.30!ZU_:=BMBE[)=P1VS8Q*\J
MA<^F<XJ66ZMX+;[3+/%'!@'S7<!<'H<]*\UU'7=)MO%.CSW>J)9Z!<Z6T5I>
M1K&UOY^_]XI9E902NWGC[I&:KVLFE^&]:\'P"[G/A81W?V.YO6'E_:"P*$M@
M #:7"$XX/% ':>$M?NM>;6Q<BV*V.HO:PO;YVO&$1@Q))R?G/3BM%-?TV77Y
MM%2ZC:^AB662,,,J&)P/KP3CTY[URWPWGL'O/%\=C+ 8_P"W))56%AC:T<?S
M#'8G//2JEZXMOB7XCCMC#'JEQH<)T]6 #22@S<KZX.,_K0!Z E[:273VL=U"
M]P@R\2R NH]QU%22RQP1-+-(D<:C+.[  #W)KR>)[?4? W@C^R65==MKVV4J
M#B:.0<70D'WL8WEL]>_45TGQ=6W;X8:R;@1G:B%"^.&WKC&>_6@#KVO[-(9I
MFNX!%"Q25S(-J,.S'L>1UIPN[8VOVH7$1M]N[S=XV8]<],5YYXG_ +)\,ZYX
M=NT,>F:#</.;B[M8HS&+AD01.Y*L.5#C<1WZUFSRZ-X=&AW]I>7%SX5?6IY[
MNYDVM LCQG8R[5"B(2$]L!N>PH ]5CN[::U^U17$3V^"WFJX*8'4YZ53OKYY
MM#N;K1[S3S*$)BGG?= &']XJ>GT-<!XAN]%L=+@U;19)1H4NNI<ZI=VO[V,Y
M1@9%#!E*J_EDX!&1Z@XI>);;PY)\/O&^HZ7J+:E'>1)+),QC,'G@8'E[5 WX
MQNQST[YH ]72[@\U;=KB$W&!F,.,],\#K0;VT$,DQNH1%$<2/Y@VI]3VKB/%
M9&C7N@>-;. W M\65X(%W-+;S8"D>NV381]357Q*W_"-/X7GU.X>UT]KJ>34
M;J%%9([J1<J[;E8;=Q< D<9'I0!Z)#/#<PK-!*DL3C*O&P96'L14<U_9VV_S
M[N"+85#;Y NTMTSD\9QQ6!X*M-'MK34)=#O9[VSNKQYS,Q4Q-(P&[RMJ@;<]
M<#&<^]<9?6.BSZY\3_/@LG,=E"PWJIV,;=LL/0YQSUS0!ZI<W=M9P^==7$4$
M6<;Y7"C/U-4M5U_3-&@M);RZC1;N>."#YA^\9V &/4#.2?0&N!\/:D!XD\+2
M:I,AL+CPS&EG-*P*&Y^4RC)XWE OX ^]9$MO'8^'[::X,:Z+#XS5[*23'EQ6
MA?L3P(]V[';&.V* /64GNGUHH)[)M/:U#HBDF<ON.6ZXV8QVSFK$=[:S7,EM
M%<PO/']^)9 67ZCJ*\ZU!U/Q$ULZ&T*W\WA3=;^5@%I?,DV''K]W\,5)X7U'
MPSK>F:!)I91_$%A9/''"C$26KF/$GG+GIN&,L.201R: /04O;22[>T2ZA:Y0
M9:$2 NH]2.HI\4\4V_RI4DV,4;8P.UAU!]#[5Y3X/FT#6K;PTL^K7O\ PD6F
M2#S+ "-)HY@-LWF (&*'YBQ)Y]2:]!\/W.@7*ZC_ &"]J0M[)]L^SC'^D<;R
MWJQXY[T ;-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4R2*.9"DL:NAZJPR*?10 P0Q"(1"-!&N,)M&!CIQ2200RNCR1([(<H64
M$J?4>E244 ,EABG39-&DBYSM=01G\:5HXV8,R*2.A(IU% $?D0_\\H_^^12B
M*-6W"-0WJ!S3Z* (XX(8G=XXD1W.795 +'W]:58HUSMC49ZX'6GT4 1Q6\,
M AACC &!L4#CKCBA8(4:1EBC5I/OD* 6^OK4E% #51$&$55'L,4ABC9MQC4M
MZD<T^B@"/R(2 /*3 .X#:.OK0]O!(C(\,;(QRRLH()]ZDHH 1$5$"(H55&
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M+#$LK2K$@D<89PHR?J:KV6G06,MS+'S+<R>9*Q &3C ''8?XGJ:MT4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\2))]0NKG;?7D6V8H?NA #D*#G  QG&!P!7IU_H-MJ.M:;JLLUPMQIQ<P!&
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M8T9W8*JC)8G  KR#27T368/L&N:U=6WB.SU=Y6LH_*2X:<2L4,>4WLI4KSG
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M 32O%'(RL\:,RYVEE!(SUI]% $'V*TV[?LL..N/+%*]K;R2Q2O;Q-)%_JV*
ME/H>U344 (RJZE74,IX((R#47V2VVJOV>+:K;U&P8#>H]_>IJ* (S;P&-HS#
M&49MS+M&"<YR1ZYI);:WG>-Y8(Y'C.8V= 2A]1Z5+10!']G@\[SO)C\W^_M&
M?SJ0@$8(R#110!##:6UO"T,%O%%$V2R(@4'/7(%)]CM1&\?V:'8XPZ[!AA[C
MO4]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%5UO8)+V2T1M\L2AI-HX3/0$]B>N.N.: +%%9VFZ[IVL/>II]P+AK*
M7R9]JD;7P#@$X!X(Y'%6;.]M[^#SK=]RABC C!5@<%2#R"/0T 6**S]1UFST
MN6"&=I&N+C=Y4$,322.%QN(503@9&3T&1ZBETO6K'64N&LI'8VTODS+)$T;1
MOM#;2K $'##\Z +]%%-=@B,YR0HR=H)/X <F@!U%9VAZU9>(=*CU+3V=K:1W
M13(A0Y1RAX/(Y4]:T: "BBB@ HHJM>7L5E8W-VZR2+;(SND*%W.!G 4<DX[>
M] %FBHX)5GMXYE5U610P#J58 C/(/(/M4E !1110 4444 %%,FE6"!YG#E44
ML0B%CCV R3^%4]&U>TU[1[;5;!F>UN4WQ,R[21G'0].E %^BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(Y48(_\ KCG+SQK?MX*\4W<=E)H7B;2FC:]APDJEB%"L"00RLH^O'7N>^O\
M0H[[4X=12]O+2[AB:%)+=UQM)!(*L"K<@=0<8XQ51_!VESZ7JUE=F>Z.K#%[
M<2N/-DPNU>5 "[0!@  #TZT 9FL>(KW1_&EQ$TS2Z=%X?N-1:VVK_K(W0##8
MW<@G@DCFK.B'7+V+0=8.LQ2V=W;>;>VSQ*%)= R>20,C!./F)R/>IK3P58V^
MJPZG/>ZC>W<=JUF7NIPPDC8@D,  #T';''//--T+P/I_AYQ]CO=2:"+=]EMI
M[DR16N[(/EJ1Z$@;LXR?4T <+X>O=6T;P=H&HVNI,MM+KSV<EEY*%'CEO)$8
MEB"VX$Y!! XQ@]:[WQ[J-]I'@;5]2TVX^SW=K;M+')L#X(]CQ4"> ].CT2UT
MA;V_%K:WGVV+YTW"7>9 <[.1O)./?TIWQ$MKB\^'NM6=K!-<W-Q:M%%'%&79
MV/3@#_ZU &+=ZSK_ (:\4:0U_J9U+3=5M[AI+<6Z(;>2*(RYC*C)! (PQ/UJ
M&7Q+K5MX+T/QC]M,RW<MNUU8>6GE^5,P7:A W!EW#!).<'(].JTO0K<M9:A<
MS7=W/!;&* 7B@&%6 W +M4Y. "6R<#KR<Q6/@K3;"&"TCFNFTVVN/M-O82.I
MAB<-N&/EW8#'(4L0#CC@4 8O_"2WL'C#^RM6NKO3));[;9;H4:TO(>R+)M)$
MG<@D'/'0XK*TZXU73O"/C_4X-9NFNK.^OFB:9(W&8T4J?N^B@8Z = *[5O"M
MI+.C3W=Y/;I>_;TMI&4QI-N+@@[=V QR!NQ4#^"M.:WUNW6YOHX-9:1KF)9A
MM!D $A4$'!8#WQVQF@#&EU+7+KQ'X:T^'5WMH-2TF6><I!&S!U$?S*6! /SG
MJ"/:J=OXJUN+P?!-<7/F20Z\VF7FH>4H,=NLS(92,;0<!03C SG%=7'X4M8M
M2TR_%[>F?3;9K6#+)C8V,[AMY)VKS[5SFO\ AG^R=)M[.RCUNZLYM3:^NIK*
M5?M,#G<VY  -P+D9&#@=!TP 7M#GUO5-3\36R:P[6$.(=-O?(C8;VC#,P( #
M[&./0]#R#76V<4T%E!%<7!N)TC59)B@7S& P6P.!D\X%<9I&D7]Q:W\0U+Q,
M^GW%J\7_ !,)$CN%D)&&B.T,F!NSN[E<=#75:+9W&GZ)96=W<O<SPQ*CS.Q9
MF('=CR?J>O6@#B(_$>L1:QX?)U(WD-_J<]I<-#$@M2N)"BQL0')78H+9()W#
M)K/O]?\ $T'ASQ;JZ:ZP?0]5DB@B%M%MEC41'8_RYQACTP<G.3P!T]O\.-(M
MH;&".[U00V%T;JTC^U$+"3NRBX'W?G/7GT(J>;P)IT^DZQIDEY?&VU>X-S=C
M>F2YQG!V\ [5_+ZT 1)J=[KOBO7=(MK^2PBTF&!<Q(C-)+*A?<=P/R@;0 ,9
M.[)Z4SX5_P#)+_#_ /UZ_P#LQJ]/X.LY=:76(K[4+6]:%8+F2WE5/M2+T$@V
MXR.<,N".QJ]X>T&T\,Z';:18O.]M;KM0SOO;'U_PH U**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS:W45Y90QLTD$;QY^5VP"VX,P. ,<8S@DW!=>*XM!O;Z]BT>WU!(P+>W\]S
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M(E>9,6Q4JI_B^; P.^!UJK!J4>CZAH5]K/\ :":3=Z!;6J75LLC"&X0DNCA
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH **J7EY+:S6<<=E/<K/-Y;O%MQ"-I.]LD<<8XSUJW0 445&LT3S20K(IDC
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M21E^ZSH#M8CL2#0!OUY?!:FUN_B9=6MW>PW%NV^*1;ER5/V5'Z,2.O3C@<#
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MKJ;:VAL[6&UMXQ'#"BQQH.BJ!@#\A0!QWQ9MTF^'&J,S2 Q^61LE90?WB#D
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.Z[;^)="M]7M8IHH9R^U)@ XVN5.0"1U7UK4H **** "BJ@O9#JYL?L5P(Q
M)OM>!Y1.[&S.<[N_3&.]6Z "BBB@ HHK)?7X$\5Q>'VM[@7$MH]VLQ"^655E
M4C.<YRP[4 :U%9.NZ_!H L&N+>XE6]O(K-&B"D(\C!5+9(XY[9K6H ***9+-
M'!$TLSJD:]68X H ?162FOP-XL?P\;>X6Y2S^V>:P7RV3?LX(.<YSU Z5K4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*UCN;9\$H_8CH01R".Q'(J"QT"SL'C=9+R=H_P#5_:KN2?9VR-['G'?KSUH
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MD5=C,9"4^[]T[<$=_7@5SFK7<OB;X2+XEN+NY%Q<:A"Q@64B*-!>*BQ;.G
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MVXNI1YBJ" ,;L+@$XQCJ: .(TW4=5'_"O]7EU:\FEUE5CO(7<>2X:V9\A ,
MAE!R.>N:2TU>_&K^%KFWU.[O;;4-0N()[MW*PW2;)679#DA57: &^4G;GD'-
M=DG@_1(X=*A6VF$>E$&R7[7-^Y(&T8^;G@D<YXXJK!\/O#-L+98K"0):W!N+
M=/M4I6%CG(0;L*IW'*CY3W!H P#J%_I.KZ]X6GO[J6]OV271YY)F+"*3Y& _
MZY,&8]RN,YKT.&,0PI$&=@BA=SL68X[DGJ:YS3K:_P!7\01:OK&C1Z>VGI-!
M:*TZ3.^\C,F5^Z-J  =?F;/05TU 'BNA)J>C?#+POXBT_6+[S8YX(6T\L#!-
M')/Y90)C[WS9W9)Z^V.B^TZ]XEM=8O--U&&PN]/U2:!)9+QUCA2%\;9(0NU@
MR#)).?FR"  *ZVP\):-IA@%M;R"&WD,MO \[O%"YSRB,2JGDXP.,G&*@N/ W
MAVYUY]:DL"+V0JTI29U28KT+H#M<CW!H V;X.^G7 25X7,38DCQE3CJ,@C]*
M\PT[4M4L/A]H7B"?6[ZXNM6%I:3?:9PL,(>3EQ\I*L1\N[GKG'%>J3P)<V\D
M$F[9(I5MKE3@^A!!'X5E)X4T1/#)\.?81)I!3R_LTLCR +UP"Q)&#R.>.U '
M#^,-,U>R\(>+A>:C_H$NGF:VM!>RS2Q.HPW[Q@&*-D94Y';H<5LW:LM[INE6
M^HWTC?V;)+]BBG='R2H$SS;LA5Y4+SDGH<<;-CX,T+3]'N]+BM'DM;R/RIQ/
M.\K.F"-NYB2  3@ C&3BD_X0G0?/LY_LLQEM(C DANI=SQDY*2'=F1<]FR*
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MSHNG-=WUT;2,S7\*P73$?ZU%#  _@Q%1W'AW2;OP\- N+&.72Q"L MVS@(H
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MXP <[LC.3FKFDSW?BC2KK5QKD^G7=IJLR,%8F*&*&4KY3QY"G<@R6/(+9'
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MWE24M;@J\ES@<&,AN I#9X/X5Y9J3-<>&OB9;PM<W4CS0W"LUN5+IY466P%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"O/9Q7,\$DI9A V]$
MS\N[& Q]2,G';OU (L444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4451N-4AANVM$CEN+A(O.>.$ E$YP3D@#)! '?![ D %ZBLW0-;
MMO$>A6FKVB2I;W2;XUE # 9(Y )]/6I[348+N>XMUW)<6[ 2Q.,,H/W6]U(Z
M$>A'4$  MT4R5S'$SK&TA R$3&3[#) K)\,^*-,\6:8]_I<CM$DK0R+(FUT=
M>H(^A!_&@#9HK$_X2K3F\7-X8B\V;4DMQ<RJBC;$A(&6)(YY' YY%;= !111
M0 45DZ7K]OJNJZKIT4%Q%-IDB1S>:H 8NNX%<$Y&".N.M:U !112$X4G!..P
MH 6BN?L?%D.I:1+J%GINH2B*]:R>!8U\P,LFQFQNQM!R2<]!704 %%%% !14
M$UU'$LV 99(D$C11X+X.<<>^#CZ54T#6K;Q%H5GJ]HDJ6]W'YD:R@!@,]P"1
M^M &E1110 4444 %%%% !1162FOV[^*I/#WD7"W26@O/,91Y;(6V\'.<YSV[
M4 :U%%% !115/5M2CT?2;O4IHI98K6)II%B +%5&3@$CL/6@"Y15;3KV/4],
MM+^)66.YA29%?J R@@'WYILEZT>J060L[EUEC>0W*J/*CVD?*QSD$YXX[&@"
MW1110 4444 %%%% !1110 451U35;?2DM_.#O+<S"""),;I9""<#) Z GDC@
M&DTC4_[6LC<&QO+)UD:)X;N/8X93@]"01Z$$@T 7Z*** "BBFR.8XV<(SE03
MM7J?84 .HK,\/:Y;>)="MM7M(YHX+C=L68 .-K%3D GNI[UIT %%%127"1DI
MG?*$+B)2-S >@_(4 2T5E^'M=MO$NAV^K6D<T<$^_:LP <;6*G(!/=3WK4H
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M%W3<60?O ,<XQT.#78Z]X3TCQ)%:KJ,,K26C;K>XBF>.6(XP2'4@\]_6N?\
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MM)(RD%2S[MQP0,#.!@4 <_<F^M/$_B'1'U>_N+670A?*990'BEWR(=C*!M!
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MLK&/.=IW,01GU]* -VBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ.)"2JD?>;R<KQS\RBM2ZU/1O%VBZE?>$HGEUH:--:QRQHT9MP1E83T ?=C
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *PO%'A^;Q#:V4,5ZEK]EO8;S+0&3<8V#*/O+@9'-;M% "*"
M% .,]\# I:**    8%& .E%% !@>E& .U%% "8'I2T44 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MUW8*2/MD$.Z-L<$J,[W'NJD'MF@#=HK%;Q5I0TS3KY97D74E4V4*1DRSY&[
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO]JF+B(XQN Z;L?Q$$\GGFFS>&K-]0N[^&>]M;F[*F=[>Y90^U0H^7[HX Y
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M-H&I*XU'0YC93)+C<8P,Q,<$CE".Y^Z:ZFQT>VT^]O;N%IS+>.))O,E9P6
M& >G  P*K6OAG3K/Q'=Z]"+A;^[55G;SV*R!1A04SMX'3B@#GF_Y+M'_ -BT
MW_I2*@\81W!^)O@1;*2&&8C42K2Q&11^Z7.5#+GOWKJ3X;T\^)1X@_TC^T1!
M]G$GG-M\K=NV;<XQGGI3-4\+Z=J^K6>J7370N[(.+9XKEX_+WC#8"D=0.<T
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M!ZC<:SI=H7%SJ5G"4<1L))U7:QZ*<G@GL*JW/B;2;3Q%;Z%->PI?SQ-*L;2
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M5+K4Y+;09M*:WBOX45HDN,H2&+*P&5&,^JD>M=KX-L=-T_PY%#HYN&TXR/)
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MN9+*>(:' %:1E9?O2[L9XZ$9]C[UC>$]1-HGP^O=0G4:2-(DM5F=OW<-W\N
MYZ*2BLHSZD=Z .Z\9^(;C2/!-UKFC36DQBV,C./,C=6<*<%6'KG//2MS4+^U
ML(,W%]:VC/D1O<N I;Z$C/TS7DFOQBU\#^/9XI%71[K4HGL!GY78F(RLGJI?
M=T]":Z5-:LK#XGZL-<N8(K:]T^W72IIV'E21C=YJ*QX+%F4D=2 /04 ;?A'Q
M*VJ^!K#7=8FM+9Y@YE<-Y<2D.RC&X\=!U-;@U/3S;PW OK8P3D"&3S5VR$]
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M5D3>(K>'Q$VB&UNFNA9-?(RJI61%95('S9W98<$ >]<^/B=I[>'FUX:+K/\
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MOF90"Q+,S8P ,DEO0=2!0!U=&*\\\*ZXEC>^,+F^^V1HFKQPQ07$GF2!FCC
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M)+WQ?'=W4;P;;![&21;UXXE:WG7H @D;<I'3/0CDFI3X#BN[S4[G5]4N;_\
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MNQ<?\!ZYSGVK/L_ MO::;#HQOI9=#@N!<0V3H"5VOYBQE^IC#8(&,\ $D<4
M9%SKGC&[NO%46F7.E1G1)E\I9+5V^T#R5DV'Y_EZXW<Y]!4UEXRU'Q-%!'HU
MN\,K:7!?R$(DA5YMVU,.Z_*-AR1R<CIWKZ-8W&I^*_'$$6H/;6UY<Q*<1 ET
M\A$9HF/0YRN<,.!Q6O?^!(C?6%]H6J76B75G:K9!K9$D62W7[J,C@@X['WH
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M\#VUQX?@T>WO9K>..\%])-L5I)IA)YNYCTY?DX'L,"NH0,$4.P9L<D# )^E
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MMV!W(^^P4D \#DG!/(FT/P\VBW^JW7VYI_[2N?M,J-&%"/M5?EP>F%'!S]:
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M376EZ;.LUI;R(-RE<F-7?^)4XQP#P,DXJQ8Z&OA]=>O7OC*FH2M=RJZ!0C[
MORX[84<'- ')6?C'Q3'H7ACQ+>MITNFZG-!;W5I# RO%YIVB17+'/S8^7'3C
M)ZUIS^*]7N_#.M^)-,:W%OI<\ZQVDD9/GQP'#EFSD,=K%<=.,@U7\ Z ^H>
M_#":E=.\%@(YQ:-%L99DSM$A[A2<@8!X&2>^T?!$*)J]G;7\T.E:O(\MW:!
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M00O\. 1@' Q7<^&M+@T_7M0EM-8MYX;N&.0V-I%MAA(R!(HWL%+>G&=N>QH
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MU7@O;:ZGN8()5>2U<1S ?P,5#8/OA@?QI]O'## D5N%6)!M4+T&.,5Y%/(=
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M0-Q.1Z$^M:_@_4O^$LGM=5EM?LSZ9;&SEAV[0EV3B5<>B!!C_KH: .WHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ JI?Z78:K$D6H65O=1HP=4GC#@,.A />K=5[V^MM/MC<74
MHCCW!0<$EF)P% ')))P .30!!_8>E?:Y+O\ LZU^TRQ^5)-Y0WLG]TGJ1[57
M'A7P^([2,:)IVRS8O;+]F3$)/4J,<9XZ4U/%>B/:W5Q]MV+:3+!.DD;I(DC8
MVJ4(W9;(P,<YXS4D/B329[:\G6Z*K9R"&X22)T>-SC:I0@-D[EQQSD8S0!GZ
MAHM_!#'I7AVVTJPTJY$@O7"%)$+8RT:J-I8C=][OCKTKH8(8[:"."% D4:A$
M1>BJ!@ 51CU_3I+>YF\YXUM9%CE$L+QLKL 57:P!).Y<8!SD8I=-US3]6FNH
M+29C/:,%GADB:*2,D9&5< @$<@XP: ,;Q-X>NM:\2^';L6UK-8Z=+-).LTA#
M-OC*#:-IY!(.<CI6S+H&CW&G_P!GS:7:2V>_>8)(59"V<[B".3GG/K6C69J.
MOZ;I32K=S2 PQ>?+Y<#R>5'SAFV@[1\K=?0^AH GO-)T^_M8[6[LH)H(F#1H
MZ A".A7T(]14UK:6]E;K!:P1PQ*20D:A1DG)/'<GFLDZC:#Q=);#5IVN(K R
M/IJ1;EV[Q^]X7);G;@'\*=8^+-%U..UDLKMIENIG@AVP2<NGW@?EXQW)P* -
M);"T2S:T6VB6V?=NB"#:=Q);CW))/UJE+X9T*;2DTN32+%M/1MZ6WD+Y:-ZA
M<8!^E9=OX[TR2YUP7"7=O;Z1)Y<TSVDN.%5F8X7@#=W[#/3FMD:W8-%I\HE<
MIJ)"VI$+_O"5+#MQ\H)YQP#0 RW\.Z):Q7,5OI%C''=+MG5;=0)5QC#<<C'&
M#4FE:)I>A6S6VDZ?;64+-O9+>,("?4XZFK]<KI_BJ"?PY?\ BR[F,>D1"4P(
MHZQ1L5WGU9RI('H5'7)(!T&H:;8ZK:-::C9P7=NQ#&*>,.I(.0<&H/[ T?SY
MI_[+LQ--'Y4KB%=SI_=)QR/:L+PQXC75X&OKW6+47)A^TMI=O(C?9HB.-_\
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M"Z/#D;@2I ;!'(..:73_ !7HFJ:D-/L[WS+EH?/13$ZB1.,E6( ;&1G!..]
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MZ!I%_IL6G76F6DUE#M\J!X5*1XZ;1CC'M3]/T72]*>5]/TZUM&EQYC00JA?
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MV<;=[-*RKQ@," 3G/0UTMBM]X?\ 'FNW6I6]U<VFJ6]L\%S;6[RA7B0H\;!
M2N2=PSQR><UW%% 'EFBZ9JOANS\,:9=:7=&W,=V\D]E )9K=I)-Z0;Q_JT(.
M"P(Y4<@#-4])LM0@\+^";2?1]2CET_7'EN%:U=BB9G^<X!X^=>>^<C->OT4
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M0/"^P.OFAHA&,=>@&<]^F!5BQM[3PE::W)XEO].@L]7U*2=3)+M7]XH'E'<
M#PA^O/'% &[%JTEQKD=E;Q0RV_V07,MPLI^7<2$ &,$-ACG(^[[U2UOQ.FE:
MW8Z2#:QW%Y#))"]Y,8HY&4J/+5L'YCNS[ =#4'P_T/\ L3PQ$C23R-,Q>,SC
MYUA'RPH?3;&$&/7-3^)-"GUT/:S6FG7^FRP%'MKS<I63)PZL%.#@^QZ8(QR
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M=QD?* <[23TY-=!X>\07>IZKK&E:C8PVM[IDD8;R)S+&Z2)N4@E5.>H(QVK
MM?!&K6WA;PYI'VBR:32-26]>3+@2A6=@H&."=Y&>>GOQOZ1HE[8^+=>U>9[<
MP:F(-B(Q+1^4I7G(P<YS[>] #/$?B.\T5[CRK&$V\%FUR;FZG\J.1P3B%3@_
M.0"?;(X.>*3^-+N:Z\-PZ?I,<PUVR>ZA:6YV>6517VM\IX^<<C)X/%/UOPQJ
MNH>([F_M;ZT%K<Z:;$I<1,[6Y);+QX('S @'/]T=<8JMIGA'5[*Y\(R37-E*
M-"LY+638'7S0R(F1UZ! ??/:@".3Q[?P^%+G67T>$OI^H/9:C&+H[80CA&E4
M[,LHR&Q@'&?2NHBU.6?7Y+"*&)[>*V2:2X$IR&<D*H&,'A2<YXXXYKG;2UL/
M"FE:Q#XIO].BL]8U"XF >7:K"8$F+Y@,G /3KZ"K_@/19-#\*6L,\LTMQ*!(
M[SC$@7 6-6]"L:HI]P: +E]K4PUP:)IT$4UZ+7[7(9I"B1INVKT!)+$'Z!2?
M0&C_ ,))JAL--EET7^SY;F&22Y:^G"Q6A4@!68 Y+$\=.,GVJ/7?#NL-XIMO
M$?AZ]M(;P6WV.Y@O49HIHMVY3\IR&4D_7-)=^'-<DUO1]2CU.UG>TBE2=+J%
MBF^0@^9&H;@K@J 3]TXSU) *UO\ $.WN-"\/Z@\<%D=89T5KN;$43IG*EP.2
M2,+TSS]#H7'BBXMVL;*2SBBU2YADG:(R,\<2(P7.Y5);)9<<#(R>,8.7I/@[
M5--\+V6A79TK5+*'STGMKB-E257?<ASAL,.>V.?QJ"+P%JVC6>ASZ!JL":GI
M<<T!6[5GAF@D??Y1P=P"$*%/7Y: .I\,ZW-KVCB[N=.GL+A97BD@E!ZJ<;E)
M +*>"#@=:YNR\7WUC<^,K[6Q -.T>?:HAD)8*(D8* 5 ));KD<G'2NPTN"]@
MLA_:-S'<7;DO(T2%(U/]U 22 !ZG)Y/>N6NO TM_)XJL[J[A_LO7B),+&?.B
MD$:IUSC *!AQ0!?;Q->6&M:38:O8101ZMN2"6&8OY<H7=Y;Y4=1G##N,8[UG
M?$M ++P].MN)IXM>LC$. V?,Z GIFKL'A[4[^YT.779K60Z.QE1K?=FXEV%
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ML7$<F<L#MQNSZC.?PKF_&=NT?@'POH5HXBL[Z]L=/G;&0(2.0>G!*J/?..]
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M&IW1K(',9Z990<XS]*P_"'B@ZMX0T[5-8N+.WNKMI5P&\M&*R,H"ACGH!W-
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MC9(IX6<RVFT*P).( #CZ$$&NYHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L/7;#7
M-3E2#3-8.D0*FYYXX$EDD<GA0'R%48R>,G(Z8.=RN5\7>-=,\.20Z?/J$=K>
MW2DJ[HSB%.[D '/L.Y]@2  \ ZOJVJ:/?1:TT<M[IVH36+7,2;%N!&0/,"]!
MG."!W!KJJY[P?J>A7^DF#P]+)/96K;&F9&7?(?F8DL 68D[B?5JZ&@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/L?^/N^MK?Y#)^^F5/E'5N3T'K23:OIMO)!'/J-I$]QCR5>95,F>FT$\Y]J
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M5\TRV=Y;W#0OLE$,JOY;>C8/!]C3;;5-/O9Y(+6^MIYH^7CBF5F7G'(!XYH
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M) /N_,$7![XKTJD"@$D  GK[T >7>$-3T6]TG3] UR%Y/$VGZDTTEHRN)?M
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M?BNWU+58=.:RN[2>XLA?P"<)AXL@'[K'# LN0?6KVIKJD_AV[6P,5MJKVSB
ML=R1RE3MR<<@''./PKCM"T'6[?Q?I.L3Z/%;H-+DM+QWO!+*9"Z-O9L$MG:<
M<GWQTH ZG7?$EMH$^G0W%K=S'4+C[-$8$# /M+ 'D'D*?6L=_B##';ZJS:!K
M'VC26_TZV"1;H4VAP^?,VL"IR K$]>*M>+=,O]1O_#DEE:F9+'4UNYSO5<((
MW7C)&3EQ^1K+ET35VO/'<@L&*ZQ D=F?-3YBL'E'=\W'//T]^* -VY\5V4:6
M_P!DCDO99[47B11,B'RC]UB791SR .IP?0U7M?'.E:CIFGWFFB2Z-_"\T,(*
M1L%0[6W%V &&.WKUZ9 )'-QZ!XCT:ZT75+31;;4]ND0:;?6$TZ(T;19*R(YR
MI'S,"/3'X7-5T7Q#;:OI?B"RTJPU"9;:2UO-,$JQJJ,^]3&[#!*G@D@;O09X
M ))/B&MZWAR31]/N+B#5+N6"4$QJ\;1HY:/!8#=E>N<8'!.15U=?TNQUGQ5<
MK9:E]JTZW@EO06W*Z;7*F-2^!A0V>F?>JVJZ1KES+X:U.+3K3[18WSSS644P
M58T>)TP'QAB-P)..><=JBNM#UB35/&TZV!*:MI\5O:$2I\SK&Z'.3P,N#] ?
MI0!J:;XVM-1U+2[0Z=J%LNJVQN+*>=$"2[5#,O#%@0#W !P<$]V7'CW3X+6.
M]2SO9[&6^-A'<1*A5YMQ3 !8':6!7/J/3!K-@T35H[SP)*]@RIHUL\5X?-3Y
M2T C&/FY&1GZ>_%<_9)>Q6+7I\-37OA^/4)=5@^RZE#Y& [,LBHX#X_CVEL$
M\X P  >HW^I6NEZ7/J5])Y%K;Q&65G_A4#)Z=_85F1>*(?[7L],O+&\L;B^C
M:2T\\)B;:,L@*L<.!S@XX^AH\7Z&WBSP9J.D13>0]Y#^[=@1M8$,N1UQD#-9
MK:9JOB#5?#MYJFGFQ;27>XF_>HXEE,90"/:3\N26RV#P!CDX ,W0!)XMUK6Y
M=3M=0@DT_5]MK.DZ)Y"QI&?*^5R?F)8L,%3NZ],=5J/B&*QU!["*TN+R[CM?
MM;PP%-PCR5! 9ADD@\#TYQD9SO!^G:CIU[XA:^LV@2^U.2\@;S$;*,B* <$X
M/RD^GO5/QGX<DUZ[)72IFG@MLV&IV=RL,]O/EL@DL#L^X>_?B@"XGBFZE\=Q
MZ(NFS"U.FB\,VZ/^)PH)!;(488=R2>F!DO/C?3U@L[U[>Z72KR<6\&H$+Y18
MG:I(W;@K$8#$8Z= 0:SET#6U\66=[=+%=Q3Z$NFWMRDH0K*'W,X7&2#DXQWZ
MXK.@\*:S<^ K3P3?VJK';S0QMJ*2+Y;V\4H<%5SO#E5"X(P"2<T =-J/C"TT
M]+V=;*]NK6QF6"[GMD5A$YVY&W.YMNY2=H.,^H(&':ZHFD>/_&$LSW4\:V]B
M8;99"[.["7Y(U8XR<=!@5)IVG^*?#VMZS9V.GVUYINI7KWL%Z]R$^RM)C>KI
MC+ $9&.O0D=LW6?".N77B_6/$&GQ/#?Q);/I<YE3;(\:NLB2+N^XX?'MUXQ@
M@%_7K^>V^(7A6Y6UU O/9WNZQ60$LRB/:-N_RP?F/S9 YY-;-IXUTZ[T:*_$
M%U'++>-8+9.J^=]H5BIC^]MR-I.<XP,YJE<6>L:AXP\-:Q+I+P1V=M<I=+Y\
M;;'E" ;?F^8 H>>.HXK"C\(ZZML+V.U5+ZR\1SZM!;O,N+B&0ME-P)"OM8]>
M,_7- '27VOV^J:=X@TIH[NQU*SLVD>%GV/L925D1T;E<@C(.01@@5#X8UU+3
MP9X2MF2:[U"]TV%HX4(+L%B4N[%B  ,C))ZD=2:CN="OM0UC6=?:R>">?1_[
M,MK1Y$+M\SL68ABHY90.3P">^*R[+P]X@T9O".JVVGBYGTW2_P"R[ZR\]%8K
MA/GC8G:<,G0D9% $G@S7(["Q\2W%]]K4GQ#+;PP7$N^7<4C C!9B/7^+  SG
M%:=S\1]+L[#6;B>TO!+H[1B[MT$;L%D^XZD-M*GZY'<5S\GA+Q+-8:I<1V=I
M%?+X@_MBS@FG#I.NP(8W('&5W<^N/K6CKVE^(/$/@75K3^P+;3KR[2..&TCN
M$<@A@S,[@ 8XP ,_KP ;T?BU'NX[-M)U&&[FDD6WAG6.-IDC56:1<MC;\Z\=
M<YR!@XV=/O!J%A!=B"6#S5W>5, '3V8 D9_&N>\5:,GB&.P@O="EN[8*[L\,
MZ1W-I+\NQD;</]K.#V'6H=)NO$.A0>&])U.W_M%K@/%=7QN!YD; %D!7'SG:
M,,WL3]0#H=6U>VT>WBEN-[--,D$$48!>61CPJY(&>IY(  ))P*RI?&EG;#5H
M[JRO(;S2[?[5/:E4+O#@GS$(;:PX(ZY!&".E,\9Z)?:K!I5YIFQ[W2K^.]2&
M1MJS  JR9[$JQP?6LO5_#VHZQ>ZWK0L7@N+C0WTFUM9)$WL7+,6<ABH&2H')
M/!/H* .BT#Q"/$$331Z9?VL!BBEBFN8U59E=<_)@D\=\XZCUIK>)83?W%M;V
M=S<K;74=I<2Q;,12/MQD%@VT!UR0/7K@U8\.6]Q9^&M,M+N$PW%O:QPR(6#8
M95"G!!P1Q7)ZSX8OK[Q&=5T^PET[5X[N+9J=O<*L=Q; KN69-V6.W< -IZ+R
M!G !?T[QJ7N_$TFJ6<EE8:-.8S.S(P"B-6.<,26.[( ![#.>*TX?%$']LVFE
MWME=V%Q>Q-):_: FV7:,LH*L<, <D'''3/-<MJ7@S5M4@\:Z25BAMM9F2ZM;
MSS>CJD8"E ,_>CY/H>]:=QH^I>)]1T&YU:P;3QIOFRS_ +U'\R5XS'B,J3\O
MS,<M@\ 8ZX -"'QA:7,VG>797K66I2-#:WJH#&Y )!X.Y5(!PQ S[<&L'P;K
M']GVNJ6K)>7]Q)X@O8(84D$D@C63&XEV'R*, DGN!U(JSX.M?%FBZ=9^';[3
M[;[)IX$2:FEP#Y\*_= BQD,1A3D@#DY/2L72_"OB/1-8NO$&GV1%[/JMPUQ:
M/<)LN;.60NN3G"R(3D?4CD4 71K,NB>/_%LPLM2OT2QLYS;PN',8Q*7(WN%7
MH/E!Y[ \UU">*K*YCTS[!'->3:E:_;+>&/:&\G"G>VX@*/F4=<Y/UK'72M5_
MX2;Q1J']G2"#4=/@@MP98]Q=%D!!&[C_ %@_(UFZ)X9UO09_#&JK9&>6RT<:
M1?VBRINP"K"2,DA3\R\@D<'\* '>,]?M]<^'5_>V,EU;7%G?P6\T1<QR0R"X
MC5T<*<'AO4@@@BNIU/6X?M-WI5O:7E[<0VXEN5M'"-$K9VC<64[CM; !SQVX
MSRFK>#]4G\+^(%M[4/J.M:I%>>1YJ@0HDD9 +$X+;8R3C/+8Y S6E'IVNZ/X
MXU?5+33A?6&M10%P9UC>UEC39A@>JD8.5R0<\&@"IX%\0I9_#OPREPTMW?W=
MHTBH9%#N%/S,6=@, LHY.<D5?3XCZ5+8Z?<PV>H2_;;Q[ 1)&I:*X4$F-OFQ
MGY3R"1[XYKF=+\*>*-#T;PM>1:59WM[IEI+8WFG27"CS(W96#(Y&T,"H_#O6
M_JNE:W?GPW<?V3#$]IJHO9[>"5,0QB-TV[CC>WS ],=1G@9 -%/&<<D,Q71]
M2^TV]LMU<VC",30HQ8 %2_)^0GC/&.YQ707MY;Z?8SWMW*L5O;QM++(W1549
M)_*N+\9>&;K7+Z>XM=-EAU2"$#3-7M+E8GB?G*R_,"8\X.,-P6XSUZ+Q!HLN
MO>$;_1I+@)/=VC0F8+@!ROWL>F>U %&/QO9-JR:9+9W<-U-;/<VR$QMYZK]Y
M1M<X8 @X;'%0:;\0;#4CHLBZ;J4-GK!V6MW-&@0R;2P0@,6!(4\XQ[TS0?\
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M7]E:JFGWUR;1;DPH1'+O9 K*&+')7JH(Y SG(#/ FBRZ4NHDS_:K.SFEL]+
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\=N0D<ZL@/EMG$D?S\'GI]ZLSPMXBU6T\#:&\TYO;[5[^:"-C&H9#OF=V.6
M8X0X&0 2.O2@#TZBL#PY<^()+G4H-;L_+@BD4V5R?+#3H1DAE1F *GC/ ((X
MZU'?:U<3^,HO#5E*MO(+!K^:<IO8+O"*J@\<G<23G@8[Y !T=%>;2^-]>_L^
M.)%L5U"U\11Z-=EHFV3*S+AT^;Y,JPR#NQS70^'-6U67Q/K^B:I/;W)L!;S1
M3PPF+*RJQVE=S="AYSWH ZBBN:\4ZQJ&AWFBW4;PC2YKU+6^W1Y9!)D(X;.
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M'[N#MSUXSWKHO"&KZCJ+:U9:I)#-<Z9J#6HGBC\L2IL1U)7)P?GQU[4 =*2
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MUUB"]D5[:Q:Q2-UWAD9@Q9CU+%E!SFN@KF[[Q)>G4=1LM&TI=1FTWR?M,;7
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MPVJ-SCCYFS^ISU5% '+W/@BQU674)M9<7DU]9"PE9(Q%F(-NR<$Y?.#GH,#
M'>S9>&GCNM.N=1U&34)=-1DM&DC52I9=I=\?>?;QG@<GC)K?HH Y!O 4,GAW
M4](DU*<B^OCJ G5%#PS&0297L0& X/;/-3V_@T#6+O4[W5[R[FO+ 6,ZLL:*
MZ@L<@!>/O' 'XYKJ** .17P,5T/1-+;6;J1-'N8;B!WC3)\H;8T. !M Z]SZ
MU9D\(B/4-5N=/U&:SBU8 WL*HK OMVF2,G[C$<$\C@'&:Z.0NL3&-0[@':I;
M )],]JQ_">O'Q/X8LM8:V^S&Y#'R=^_9ARO7 ST]* *\7A*WM-:TS4+*<V\>
MFV+6-O;! 4$9V]3U)^1>_:K7AO0%\.:?-9I=/<))<2W&YU (:1B[#CMDG%:L
MI=8G,2!Y #M4MM!/IGG%9/A/7CXG\,6.LFV^S&Z5F\G?OV88C&<#/3TH @F\
M,E/$-UK6F7\EC<WL*17:B,2)+LX1\'HX!(!Y&.H-5[GP3:MINB:?9W4MK;:1
M<I=0@*',DB[N7)ZYW,3C&2>M=!=WMM8K$;F58_.E6&//5G8X '^>QJQ0 BY"
MC<03CD@8KC5^'T<?A^+14UB[^QP7JW< 9$)CVRF55S@9&X\D\D8Z5V=<W?\
MB2]_M'4;'1=*74;C35A:YC:X$+-YF2%3(()"C/) Y SZ #;OP7:ZEJ>KW5_<
M-/%JMDME<6X0*H1=Q!4]0<L3GZ5)X>\,W6BE/MOB"_U9($\NV6Z"#REZ9)4
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MK^+?'?VH2.B:7:2(JR,F&\N8AL CD8XSTIME=P:U8^&H+V4W=\_AI;J:.\D
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M7\* .,TJTT]_'.J^&+R/_0-,TZW_ +-M9Y&<%'WF20%B26!VKNSE<<8R:O\
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MKX0N5LKP06^F7$4TAMG"QLPBVJQ(X^XWY4 =I>7MMI]I)=7<RPP1C+.W0<X
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MQ3_,Q,$J!2",@'G'WO:@#9'B^S?Q;;Z#'#<NTME]K\X6\A7!90F#CIR<D\#
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MN4\3>/)FL;SRKNRMX[=Q;.1,RQ.K!3CG!8#\:H6MG>IIGPTB-A?+)IX5;O\
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MDYX1B?3&#@\5V<<<S_%G[<MI="T;1! )VMW5/,\[?M)(P#M.?TZT =A1110
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M6,,P!D<\X51DGCM7,GQ==ZIX>\4_8X[47FDAXQ-%<$Q./*#AU8+G(!Z>HZT
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MHKV*>6\*)*C[L=$)!^7@<CU([[_A[6(_$'AW3M7BB:)+RW281L<E-PSC/?%
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M8@V=NW)(W8S@GIP1!=^"M3NM"\6Z;]HLU.O7+3(^6/DAD1,$8^;A >W6N\)
M&2<"L+3?%%MJMY;16]E?&VNX6FMKTQ P2J#_ '@25SD$;@,CI0!L6RR):Q),
M%$BH VPY&<=JPKS0;YO&]KX@L[FW5%L6LIX94))4R!P5(/!XQSTSGGI714UY
M$CV[W5=S!5W'&2>@H X+_A!]5_X1(Z-]ILO,.K?VCYN6QCS_ #MF,>O&?QJV
M/#7B33/$&H7.AZK8PZ=JDHN+F"Z@:1[>7:%9XB" <@ X;C(KM** &QIY<2)N
M9MH W,<D^Y/K6!'HEZOC^;Q 9+?[+)IZ6/E G>-KL^[ICJQ&/QSVJY=Z_:V?
MB+3]$DBG^T7Z2O"X0>7B, MDYZ\CMWHUW7[7P_#:2W44[K<W45JAA0':\C!5
M+9(P,F@#G]+\+^(M$OKJRL-7LQX?N+E[A4DA8W-OO8LZ1L#MP23@D$C/0T_4
M?"%SJ^LV5[>"R6>RU 7-OJ$.Y;@0ABWDD8P00=I.<8[9YKLJ"<#- '#Q^";^
MVT;6?#EM=V_]BZG+*ZNV[SK9)3F2-1C#=6P21C/(.*TX?#D]MXVMM7@:!;"#
M2_[.2#+;P-X<-TQQM Q^.>U:&A:]:^(+>[FM8IXQ:W4EI(LRA6WH<-P">,T1
M:_:S>)[C0!%.MW#;+=,[( C(S%1@YR3D'MVH XZV\!Z];Z/HVD#4M/%KH^IK
M=V[^2Y>1%9V <9 S\V,#ZY[':B\,ZE:ZGXFF@NK5K;6,2(CHP=)/*6,Y.<;?
MESTSVKK** .&M/!6H:=;^%[FUNK8ZGH5J;)@VX174)4*03C*GY0P.#@^M&K>
M![O4M*UH+<6R:EK-Y;W-Q(=WEQK"4V(O&6XCQDXY8G':NYK*U_7[7P[917=W
M%/)%)/' /)0-M9V"J3DC R10!2BT2^'CQ_$$CVX@?35LC"K,6!#L^[. #RV,
M?C[5T#EPC% "^/E#' )]S3J* .*TCPGJ>E^$]/T.8:9?P0&9;J"=6\NX1V+#
MJIVD$^AZ>_&UX3T#_A&?#\6F"7>B22.B@DK$K.6$:D\[5!P,]<=NE;=4M6U*
M'1M(N]2N(Y7AM8FED6)=S;5&3@?04 97B/0]2U/5M%O]/NK9!I\LCR6]TC-'
M)N7:'P"/F7DCZGI7.)\/M7@T^!H=5M!J5AJTVI64A@8(PD9BZ2#.<$.1QTQW
MKO=/O(]1TVUOH0RQ7,*3(''(# $9]^:L4 <#=^ K_7)?$AUB]M4BUJUMXMEK
M&Q,+PY*L&8\X8@].<=JV(=!U&_U71]0UR2T:725D,?V;<1-*Z[#(<@;1MW?*
M,\MUXKIJ:Z)+&T<BJZ,,,K#((]"* /+_  7HUWXD^&.GZ7</;+I3W<DLKHQ,
MCHETS^7MQ@991EL].V>:W[SP1-J&H>*4GO(AIFOQQ[U6,^=$ZQ",$'.,?*&Z
M=>*ZVVL[6RC,=K;0P(3DK$@4$_05-0!Q]IX=\1ZCH]SI/BG5K.YM)+5[4-90
MM'),&4KOD+$C(!/ &,\]JHP^$?$SP>&[:\U/3'30[I9$F6%R\\:QM&-PR &P
MW8GUSV/?44 4M/34T>\_M&:VD5KAC:^0A4K#@;0^2<MG.2.*NU5U*_CTO3+F
M_F21XK>-I76)=S$ 9.!2:7J$6KZ19:E;JZPW<"3QJX 8*ZAAG'?!H PM,\%6
M6GZWXCOG/FP:TP+6Y^[&"@$F/]\\GZ#TJQX0\-GPEX4MM(2;[3-"IS*Y(\P_
MPY/8!0J^P45T%% ' 6_@?58/"FAZ/]ILVDTS5%OVERP$@65I=N,<?>QGGIGO
MQ:M_#'B/2M:U$:1J]G'HVI7+74L<\#//;2/_ *SRB" <G)&[H3T/?M:* .1?
MPQJ/]J>*KI);4IK5M';Q*S-F+8C)EN.<[L_ACWK;\.Z=-I'AO3=,N'C>6SMH
M[<O'G#;%"YYZ9QG%:=% '-:MH6J7/BVPUBRO+40P6TENT%U$SB,LP/FQ@$?/
M@;>>U3>"M"N_#/A.QT:\N8;A[52BR1(5!7/&<D\_E6_10!S/BCP[>ZGJ6C:S
MI-U#!J>E22&-;A28I8Y%"NC8Y&0 01G&.E8MQX"U34?^$ADN]4MK>XU*YMKR
MUDM8F)MIH50*?F/S#*=,<]>.@[Z1_+C9]K-M!.U1DGV%0:?>&_TZWNS;7%J9
MD#^1<IMDCSV89.#0!S<F@^(M:\,ZKIWB#4K'S[RSDM(_L,+K&FY<;VW$ECTX
M& .?6JESX5\1I-I&KZ=J>GQ:U96QLYTDA<VUQ"<':<'<""N0?>NCT;7[76Y]
M2AMXIXWT^Z-K,)D"Y<*K9')XPPZXK5H Y.]\.ZS>WWAZ]FO;6:XTZZ>ZG)5D
M5RR,FQ!SM4!N,DDXYZFK7]B7Z>.KCQ C6S0OIRV2PEF#95V<,3C');&/Q]JN
MMK]JGBB+P^8IQ=2VKW2R;!Y91652,YSG+#M6K0!P%OX'U6W\)>']&^TV;2:5
MJ*7K2Y8"4)(SA0,<$[L9YQCOGBY=>%-2N+OQA*LUH%UZU2WC!+9AVQM'D\<Y
MW$XXZ8]ZZC3;XZC9_:#:75H=[IY5R@1_E8KG&3P<9'L15N@#CT\+ZD+_ ,*7
M!FM571+:2"7:S9EWQK'N7CC&W.#GKCWK,TSP-K]G_P ([YNJ:=(VCW4LID%N
MY>Y$B.K.YW<N=WY\Y/2O0ZR+OQ'96FL:1II6:1]5W_9YHU!C^5"YRV?0<8SU
MH YY_!NJ#0_%>DQWMH;?6IKF6%F1@T1G'S;N>=O. .OJ*LKX7U&RUO3==L9;
M4WL.GC3KNWE9A'-&#N5E8 E6#9['(./>NDU.].FZ=/>"TN;LQ+N\BU3?(_LH
MR,FK8.0#C'UH X:X\#W7V2U^SW%N;HZZ-:NW<,%=P<[% S@8PN3_ '<XYK8T
MK1+RR\7ZYK$TD!@U)(%2-"=T?E*R\Y&#G=GVQWKH:@O+N"PL9[RYD$=O;QM+
M(YZ*JC)/Y"@"CXET&W\3^'+_ $6Z=DBNXMF]>J'.58?0@'\*S(= U._O]%NM
M=FM)'TC<\9M]W[^4IL\Q@1\F 6.T9Y/7CG?TZ_MM5TVUU"SD\RVN8EFB;U5A
MD?SJP2 "2< =2: .>\+Z)?:+<ZT]T]M(FHZA)?+Y1;,>Y478<CGA.O'7I6OJ
M<5Y/ITL>GS1171P8WE4LG!!(8#J",C\:;<:BL,MBL=M<7*7<FP2VZADC&TL'
M<YX4XQGGDBKM ' 3_#H7&F>)[>#[+IG]MVZ1_9K7+0QR+NS)C"\MD @ <+W)
MK2?PYJ\?B*Q\20W%D^IK9FRO8"&2&:/=O7:?F*E6[D'()Z5L6>OVM[XAU#18
MXIUN;".*61G0!&63=MVG.3]T]JU: .#O/ %U]ECO=.U"*WU^/5)-5$[QDPM(
MXVM&5SG9LPN>O&>]6]:\-Z]KWAS['?7MBU[)=03OY:.L,:Q.KA%!R3DKRQ/?
MIP!78,RHC.[!549))P *YJQ\=Z1>ZU;Z68K^UEN@QLY+NT>*.Z &3Y;,.>.>
M<<4 4+3PEJFF6.N:38SVBZ/?QO\ 9+9V;-FTBD.%..4W$D+QCUIUOX3U**;P
M<S36A70(6BEP6_?9A\K(XXX^;G/I[UV9( R3@"L[3=9MM7W26*RS6H) NPH$
M3D'!VDG+#_: (]Z .4M_ EY#X6G\'M=6[Z"\Q*2G=YZ0&3S#%C&"<Y7?GH?N
M\5=O_!TNJ:]K<]U)"-/U32UTTI&3YB ;SN'&/XSQ["NOHH X*'PGXFD'AN.^
MU+3'70[@.LJ0N6G01M&"PR K8;G!(SS[58T;POXBT*ZFTZSU>S_X1U[AYXU>
M%OM4*NQ9HE8';C).&()&?I7:T4 <QI.@:GIUQXEF^T6ZOJL[7$#1Y)A;RU09
MR.?N@U'H_A1[/Q6WB"6&RM+B2T-O<I8[@ETY8-YK@@8(P<=3\QR>*UO$6OVO
MAG1Y-3O(IY((V16$"!B-S!1U(XR16K0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S7C#5[G
M31H]K:LL;:EJ"VC2-)LV@H[8#8."Q0+G'\7&#@UTM9VN:%IOB/2Y--U2W$]L
MY#8W%2K#D,I'((]10!PGB1O%/A_PKXAG;6EC$<UM)8".;SIH4>14='9T!*DY
MVGKU&>*ONVH6OC35=$DUB^N+6XT0W@,C*'BE$A0F,J!M!&..V*V3X'T5]!FT
M>87D]M.ZO,\UW(\LI4@KND)W8! P,XJ^/#MA_;G]L,)GO?LWV0NTS%3%G.TK
MG'7G.,T >>:;<7^E_"SP3<V>I74;7%WI\<RE@P=)'563D9 QZ$5T&@VS'XK>
M+9&NKEA'!8E4:4E<,LW&/0=0/4FM1/ NAQZ/:Z4D=T+.UG2X@0W<A*.ARF"6
MSA3T7I[5>/AS3O[<EUE5F2^EA6&1TG=5<+D*2H.TL-S8)'&: ///"NK75KX,
M\&:3:LJ?VG/=J[M,8LA&D;8'"DJ2<<@9X(&,YK4NK_Q#X?2STC4-2A=M4UF.
MVMYXY?,EMK=U9BK,RC+?(55B">?45OR> ?#\OAN'0'M93802^= #._F0ODG<
MCYW Y)[]S4LG@K1)] .CSP330&03&66X=I_-'23S2=VX8&#G@#'3B@#&T&T^
MQ?%?Q%&)YYD.FV;+YSER@W2\;CR1G)Y)ZUO^,59O!6M[)98F6QF8/$Y5@0A/
M!'3I1IGA73=*U635(6O)+Z6%8))I[N20NJDD9!.#U/;Z5K7-M#>6LUK<()(9
MD:.1#T92,$?D: //M)OYK=/ WAU+JX2#4=.:YFD\S#L(X4Q$K=5'S9..<+UY
M-;7A34+\^(O$NA7D[W4.F3PFVN)/OF.6/?L8]RIXSU((S5Q?!>C)IEA8HEPH
MT]Q):3_:7,T) V_*Y).-OR[>F.,5J:?I=KIB3"W5M\\GFS2NQ9Y7P!N8GKP
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MIK&ZE*F2&25')!(7!7<@XQT)Q5GPOKLWB8:.$FGAELK=FU2(OR)P3'Y;_P#
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M>IQZ=J ,SP;K<EYK$NG:@-3L=7AM%:XT^^;>K'=@S1/R&4DXXX'& *WO&/\
MR)&O_P#8-N/_ $6U3V.A6EC>"\#3SW*P_9TEN)2[)'G.T$^X!)/)P,DX%7KJ
MVAO;2:UN8Q)!/&T<B'HRL,$?D: /-;$ZOH"^![V'6+N[M=4\BRN;"54\M5:
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M)+2WBA?;@B$,9&'\6XL1@Y&%X&<FJN@ZA?7UKX<\.VTGEHOAFUO#MNFMW<L
MF0RHQ^7:..!\PSFNJN_!&BW>H7-[LNH);J 070M[J2-;A -HW@'#$#C)^AS4
M5W\/_#]Y9:9;&&ZA.F)Y=G/!=R)-$F,;1(&W8P.F?I0!H^&(]6AT"V@UR\MK
MS4HMR33VY^5\,0,\#YL8SP.<U1\0W$C:YIEA%>S_ +V*9VL;0[)9L;0',F1L
M123GGDD#GI6[965OIUE%:6L?EPQ#"KDD^I))Y))R23R2<FJ&I^&M-U?4K34;
ME9UN[162.6"X>(E&QN1MI&5.!P?2@#A]/\0>(;KP)X=U62"[U1,SC4H[*0)<
MNB,R*Z@8+8(&0N"<CW%=MX5U"WU3PU9WMK?R7T,@;;<2KM=L,1AAQAAC!]Q5
M:Q\%:1I=O;0Z<;NT%JTK0F.Y<[/,(++@D@KD#Y2,#KUYK8T[3K72;&.RLHO+
M@C+$#)))8EF))Y))))/J: .6\53:F?&?AC3;/5KFRMK_ .U+.L*H<[(MP()4
MX//N.^*Y74-7\1Z5I'B73!KES)+I&J645M>NJ%Y(IVC.QSCDJ'ZC!YKJ_%.E
MW>H^-?"L\-O=FVLFN6GN8&V^47CVIWYYZC!&.O%:EUX/T>]TJ73KB.9H9[@7
M4["=E>64$$,S Y)!5<=AM '  H Q-]Y:>,[#PM+J]_/;W-M<:A)/*ZK*Y#(J
MPJR!<*,LW'/09QQ65/>^))]#\665I?W,E]X?O UK.N US#L67RGXP6VDKD8.
M=I]<]UJ7A^QU5[*:X$JW5DQ:VN8Y"LL9(PV&'4$=0<@^E6=/TRUTN!XK5"/,
MD:65V8LTCGJS$\D]/P '0"@#G[34O^$AM[K5M+O[B.Q6P40,C YE9/,+88$$
MJK(/J6!Y%8&A>(K_ %2T\#:5<WDP?5-.>\N[A6VR3%%7Y PZ9+9)&#A>,9KN
M+'0=.TW1/['L8/L]EAP$B8J1O)+8/4<DUFR>!M#DTK3=/6*XB32VS8RQW#K+
M;\8PKYSC'&#Q0!Q-EJ-SX>;Q)#;W+-)=>*(;,7$[X**\475MIYP-H8@]03DU
MIZUJ'B/PAI^JW$]_;FVNI+>*Q1YVGDM&=Q&[EF0;E&[<,YP>.AKH_P#A _#[
M6.J6<UK+<0:FXDNUGN9)-[  !N6X8;1R.>.M.M_!&APZ)=Z3-!/>6UVH2<WE
MP\SNH^Z-S$D =0!C!Y'- &(MA]A^,.F@7=S.KZ)<<3R;R")8LD$\\\<=!C@"
MN\=2R,H8J2,!AC(]^:P+#P9I6GZE:ZBLE_->6L+012W%[+(0A()4Y;!' X/I
MZUOL-RE<D9&,CJ* /*8M;UV7P%H5V-9N1=R^(A9S3%4)EC-VT>&&WI@#@8KJ
M/#4]];^-?$>C7&HW-[;6\5K<0M<E2Z&0/N&0!QE 0.U7%\#Z(FEV^FK'<BUM
M[O[;$GVE\K-NW[LYS]XDXZ9-:%KH-E9ZW=ZO%YWVR[1(YF:5B&5,[1MS@8R>
MGK0!2\=*S> ?$!2:6)DTZ=U>)RK K&Q'(^E<A<6<GVGX:P1WEPC2"4^<2&=,
MVASMR,?3@XKTF\M(+^RGL[J,26]Q&T4J'HRL,$?D:Q8/!ND6[:4R"[+:42;1
MGNI&*97:<Y//R_+ST' H XF_UG6K+X=^-C%K%W]IT;4)8+:Z;893&%C8*Q*\
M_?(SP>G-:_C36+_2-1GFN_[0CT1K152_TYMQL)LMN>:,<LI!3G! VGCG-;LW
M@C19]/U2QECN&MM5F\^\0W+_ +U^,G.<C[J\#'058N_"]A>O.9I;LK<P+;7"
M"X;;-&,\,/\ @1R1@G/6@#7BD2:))8W#QNH96!R"#T-<]XIF>YGL-'BLIKU)
MY/M%W%"4SY$9!P=[*,,Y08SRNZNBCC2*-8XU"H@"JJC  '0"J4.D6L&LW&JH
MTYNKB-8I-TS%=JDE0%)P,%FZ>IH XSX;S2Z:^M>#KB.>T?39C-8I*4+BTE)9
M.A93M.X=2.GTK#6+5M5^$NM:W?>(]3EECL]2C\I61$;9)(%)VJ#GY,<$#!QC
M'7T6;POIL_B1?$#?:%U)8/LXE2X=1Y><[=H.",\\CK267A72;#0;G0XH9&TZ
MY$HEAEF9\B3.\9)R,EB>O>@#FYY[[2V\!PVVHW7D7<XBN(F*D2+]G=ADXSP5
M'&<4_3[G4/%%AJ>I0:V^FW-EJLL"C&Z*&*&3#(Z9 ;<H))/(W#& *W5\'Z2L
M>EI_I;?V6_F6K/=2,RMMVY))RWRG'.1CBHG\#Z$VO2ZP()XYYW$D\4=PZPSN
M.C/&#M8_44 <WJ6JRZ%XM\=ZK!&));/0[:9$/0LHG(S[9K7TFVU]=:TR_P#[
M3MY-*N;=A<1R7;3&=RNY)(AY:A3P<@'&.W%;2^'--&KWVIM$[W%]"(+D22%D
MDC&<*4/&/F/;N:J:!X*T7PU,9-.CN0 "L4<UU)*D"GJ(U8D+GVYH WW19$9'
M4,C##*PR"/0USFH64?B#Q'IL@ -GHT[7#2_W[C:45 ?10S%O?:/7'131">"2
M%F=0ZE248JPR.Q'(/N*YBQ^'N@Z?/;RP_P!HD6[B2..74IY(PP.1\C.5///(
MH K?%2>ZA^'][':RM";F6&UDF'_+..2548_D2/QHM+G4O#_C;3/#K3K=:3>V
M,C0#R51K5H=HVC: "A# #.2#WK>_X1S36BU2&:%YX=4<O=13R,ZME0N "?E&
M .F*2+0+. 2R?Z1/.UN;82RSLTBQ_P!U6ZCMD]20"2<"@#6KE?&5]J>GOI]Q
M:V5Y>Z<GF&^@L)-MSC VN@R"P4YRH/<=:U/#6CG0-!M]-\UY!"7V[Y&D*J7+
M!=S<G:"!D^G0=*FO](@O[NVNVFN(;BV5TCD@E*_*^W<".C [5Z@XQ0!QVGZY
M)=:[X+^P:Q<7FGZC:79F=QCSC&%VEACY6!+ XQS5.U\3:C%!]AFOY<77BN;2
MEN7P6BA7<54''4[0H)Y^;/6NNN/!FC3VVFP)%/;_ -FLS6TEM</%(F[[_P X
M.3NSSD\U"W@'PX^DWVEO9.UK>W)NY5,[Y64G.]#GY"/5<>^: .<\>V-WI_@3
MQ)#+JS7<#S6LEK#,-TELIFC!!8G+@L"1GW&36OILU_8?$JZT>74[J\M)]*6]
MVW&T^7)YI0[=H&%(QQ[5??P3HTNA2Z/.+N>VG=7F>6[D>64J05W2$[B 0,#.
M.*O1Z!8QZ\-;_?M?BV^R^8TS$&/.=NW..O.<9H U**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*9++'!$\LTBQQH"S.YP%'J2>E/KBOB1=26-GH=W*K'2H-6@DU(JI8+"-V&8?
MW0^PGZ"@"YHWB675/&VKZ7'<V5SI]M:03P26W)R[.&#-N(.-G;%;(U[1S!=3
MKJMDT5HNZX=9U(B'JV#Q^->7ZU>1ZGK_ (W?PY-'=W%UH5LT;6C!O/VM('"L
M.&.WY>,^E;&DW7ASQ->'5M'U"]U#4(]-EMV38J"",C/ER!449W8PO)ZD< T
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M;2==T@ZI9WL+6@+;G,@&T!B 6_N@XSSV-:_6O%='OQ!\/?!<F[=8Z9J:C5U
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M]:O+"W2ROTM;9B?*\P-$K@?,QRWS=ORJIXSN(+'QGX+O;MQ%;)=7*-*PX#-
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MO((D+E8QECCTKDK+XDZ9=OH[MINJ6UEJY6.UO9X5$1D896,D,2">@.,$]":
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M0:5XD.JV6A6VJVNH6D$5S;3W"1R6TL8(#!B""I!Y YX_/T*B@"O81S16,*7
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MM5DO(&\Q6RC(B@'!.#\A_,5>\7Z3<:[X/U?2K0QBXN[62&,R'"[B,#)K:HH
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MM=W^DK<V]UITTZ!9XI7#91^0&!5>N._X^B:(MX+$R7ME;V,LCEQ;0,&$0P
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MT\]K-!.ES;74! D@E7[K#/'<C![&@#E_'*ZU'\./&$6JO;30) ?L<\0VN\9
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M%N2 !G  Z9YH [FBO.+WQ5-X)\3ZQI5S)->:?'H[ZM9^=(7DC*$JT1<Y+ D
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MQ(RI9@/X3UQ[9-30^+=.N[#2;FR6:Z?5H_-M((P [(!EB=Q 4+D9R>I Y)%
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ML;B55$=Q@;L##%E)7D!@N?KQ0!T-%4=3U:VTF.!I][R7$H@@AC +RR')"KG
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ML <'&1QUIGBO2=<N+_1-=MM*M-4FL3/'<:8SJ \4NW[K/\N]2BGG&<FNYHH
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MP]XCU+2?'4::)(DFLS0/:(UQ%DA8XU.[YL#&T]_IGK73S66I2?$:PU@:9/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\+Z5)\0]:L+"RMTT*[T5(M0M[= L/GF0[.!P'\O)XY&0>]2^"X[R\GM]&U2
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M\YZ9D+CW"*:PM(U33(M,^']O/+;07)T0F*ZNW_<(/+B5T"9 >0] ,C W=>E
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MRQ0X#?WL-NX/0@]Q0!ZVEQ#);BX2:-H2NX2!@5QZYZ8KGM&\1S:IXOUG2_\
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MM IN;B&$,<*9'"Y/H,UR/A66-_B#XY5)%9A<VF0#D_\ 'N@_G6;XRO\ 3?\
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M&OW4:,$#Z"K &!@=*** (FMH&W;H(SN;<<H.3Z_6E6W@1PZPQJXX#!0#4E%
M$*6EM'YNRWB7S3F3:@&\^I]:>D,4:%(XT13U"J #3Z* (H;:"WB\J"&.*/D[
M$0*.>O I)+2VEMQ;R6\3PC \MD!7CVZ5-10!&T$31K&T2%%(*J5&!CI@>U24
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDP67<,9 SQSGIS6E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*[E/R*>"1SGCC'/JU<G:_#[2[*#2([:ZOHGTEY&M)ED7S%#G+(QV_,IYX/\
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M</&NX!4R7V_*J\C.T;:T+'7-7>[\96)NKE!IUK#<6<EU%'YJ;XW)R%&",ID
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M)6=_;/<R2WNLSV,BIY2ZN4,P?G<1M (7&WAN<@].^EK?A^TUTV37$EQ#+97
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M)<_: 2)0XV;VC.6+<XQWXIB0:0O@3XE6IBLQ=17.I,(]JAT4+E#CJ!G&/TH
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M(8-OG2QQ[CM7>P&3Z#-25YIXDU#3[3QM?IJ%[I\T5]H:PQP7=U'"(BSOR-Y
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MM,O-<\,YFU**XO8Y9K2%0Z12*8MQ$HZ$@= >0:POB+XE!\&ZF^ER:@AMKB.
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M6.5&.@'/'>M]'61%=&#*PR".XJAJ>M6VF7%G:NDLUW>NR6]O$!ND*J6;DD
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M>I:7%?B&XMHY%+&.[B,4B8)!W*>G2LR+QAIDDNG[EN(K;4G\NRNY(\17#$9
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M M@ND7#76EW5E)>1B2+]VL2%7.=^#STQFNXUE9I] OHX('EFEMG1(E(#%BI
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR[ESZ$@9% 'LZ.DB[D=67.,J<UA>+M=NO#VFVMW;6\,PEO8+:3S&(VK)(J9
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MX'/W2Q!'(*YKB+F;3KS3_",U_H]IIJV_B*>VNHI"KPH^)RX5B,%"_([9X[4
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M'HV>#^--:XA2/S&FC5,[=Q8 9]*\0=K&Y\#ZE;M<6TOV;Q<HC,)V"-&N4Y0
MDHI!8C!]>:Z[5;/PWI'BJTT>WM;&Q9K"XG_TK M0KNH?;'D!I"1C@C"YZ]*
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M*[BXSAB<9SR>?>H;72EBU:XU6=A)>3(L*D#B*)22$7\223W..P &@2%4LQ
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M;FUA,"8*1&,;5QTP.@Q7$^$+BY\5'^V9[K5;6>WU"Y&Q9"L$D2R.BQ%#E3@
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M(W5O)")!U7<I&?PS7!Q:)J^K>$/#GAN]TV6UNM,N;4W-P2IB"6Y'SHP/)<*
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M>:\@B+Q$M$;A),Y#X& IZ^V,UZ;?ZE8Z5;&YU"\@M8 0OF32!!D]!D]_:K5
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MN R1ZUL>%_/O+N*XN?!4.AW,$96:=TA)9CP5B*$DKW)..@&#G(["B@ HHHH
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M-Q4EL[^/N#CGO60?AU<+I$$,.M^3J=IJ4NHV=[':X$;R,Q=&0N=RG<1U'&*
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M$[F5R1DD@Y&.>HJYXD\+W'B."_LKB\MFTZ\A$?D3VOF- X!'F1MN&&Y&.."
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M(D\MXY%8A"F<[LH1NSCH<=JR[G5KW7?$?@/5]-@MX[N^TJ[F5+ACLC+)"3G
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MH.J#4H(VTKS3Y?V4D2ETV'G?\HQT'-6O%6@MXD\/3Z8EXUH\C1NLP3> 4<.
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M[1"1)$[QHPQO.Q@78'D\#L3D=#_;6HW>OW.@V,MF+RQM(Y[JXEA8H6D+!$5
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MAKP_<:"VJF:^CNA?WTE[A(#'Y;/C*_>;(X'I0!O4444 %%%% !1110 4444
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MVD''"@#.!DUA>&9KVU^'_@V.&2=K%]2GCO5@)\Z5/,G(P%^9AN 9@O. >V:
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M Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?,*[@F><>N/3FG4 %%%% !115>&^M+FYN+:"YBDGMF"SQHX+1$C(##MD<\T
M6***9++'!"\TTBQQ1J6=V. H'))/84 /HJ*VN(+RVBN;:5)H)4#QR1L&5U(R
M"".H(J6@ HHHH **JW^IV&E6_GZA>06L7/SS2!!QR>M3PS17$*30R))%(H9'
M1@58'H01U% #Z*K2ZA907T%E+=P)=W&3# T@#R8!)VKU. #^56: "BBB@ HH
MHH **** "BBB@ HI&944LQ 4#))/ %45US27LH[Q=3M&M99A!',)E*/(6V[0
M<X)W<8]: +]%%% !1110 456BU"RGO9K**[@DNH%#2PI("\8/0L.HSCO5F@
MHHHH **** "BBJM_J=CI=OY^H7D%K%S\\T@0<<GK[4 6J*9#-%<0I-#(DL4B
MAD=&!5@>A!'45#+J%E!>P64MW EW<9\F!I 'DP"3M7J< '\J +-%%% !139)
M$AC:21U1%&69C@ >I-5+36-+OSBSU*SN#D#$,ZOSZ<'V/Y4 7:*** "BBB@
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M8+.^;4I[6%II V^,O#N#@'.7X;YLCKTK9LO#^LS:7=VFOZZM\TUJ]JK06WD
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MMH;B*6>1R'#ASA@ .?DQQT]^E5K#QMJMR/"M_/86D>F:\5B"+(S31.T3.#G
M4K\I&.O0Y[5K+X:O$\1:YJR:C!_Q,[6*W$36I/E>6' .=_S??.1@=JH0>!KR
M#2/"M@-7@(T"9)0YLS^_VHR 8\SY>&/KS0 W_A,=1M];TJTO;:TC^WW\EF]H
MC%IK8 .8W9PQ4[@@.W .&[X--E\9KI$GC*YO=/MXQH\D"C[.WS7+21J4W,0.
M<LJ]./>J$O@RZT31["2\\30QV6B7[ZBLSV7S%#YF[S#O^9OWA^8 >X/:2ST"
MT\73^.4ED\S2=7FMU@N86!#[+>/YT/0[6QSTRI':@#:F\0:GI/B/2]*U.*TE
M754D%M-;AD$<R+N,;Y)R",X88Z?=K+TGQ3XDU?PW=:U)IFDBRBBNU:(SON=X
MI&4?PD;2%.<\Y] :V8/#M]<7^EWVL7\%U<:6CBW:*W,8:1EV&1P6/.W/ P.3
M[8BT?PI=Z5X-O- .I0RM.;C9<"U*A/.9F.5WG."YQR.U &(==UB[NOA]]A>T
ML[?5+=IY;=8F*AA;%@O##Y!NX'J >U:L?BN]M[[Q+8ZE';Q7&EQ+/;"-6/VB
M)@=K $\G<"F!W'7D4B^"[N*S\*K!JT276@(8EE-KE9D,7E'Y=_RMC!!R1GL>
ME59X]&\7^.-/N=/N'FET5Y8[YXU94RK*4A?(&2)%#CTV'U% ':69N39PF\$8
MN2@,HBSM#8Y SVKB[CQQ>#PI-XOM;:WFT6&9PT&#YSP)(8VE#9P#D%@I'0?>
M!KNJXJ+P')!HE]X;CU%/^$?NIFD\DPGS8HW;>\2ONQM)S@D9 )Z]: *]Q)>W
MGQ<LT2:UDLVT.61$>-B#&TT0;O\ >.!STQVK<\4R3:!X"U271%M[1["QD>!1
M%\D81"0 HP!P..P]#TH;P[<CQM#X@COH$ABL#8BT^S'.PNKD[]_7*@?=K2UO
M3$UK0=0TIY#$E[;26Y<#)4.I7./;- '!7S:B=:^'4I-O/?,ESM9MR+S:]6/)
M/J?7VK4M/'%T-+G%_;0C4XM8;2 +=7>-W W[PH!;&S)V]<C&1G(M1>$M2^V>
M&;JXUBWDDT02 A;(J)@T?E\?O/EP.>_/MQ5.?X>SW%AJD3:UY5W<ZM_:]I<P
MVVTVLX 4<%R'&!C'&<F@#:\/:QJE_?ZE9ZC8/'';,AM[P6\D,=RK#)PC\JRD
M8/)[&GZGKDD7B&PT"Q$0O;J&2X:252RQ1)@9V@@L2S  9'<]L&?0[#5K2)Y-
M9U1+^[<!<PP>3$BC/1<GDYY.?3@8JKK7AR2^US3-=L+I;;4; /'F2,O'-$^-
MR, 0>H!!!X/8T 8-QX]OK6ROUEM+<:AIFJ06%W'\VR1)F0)(ASD95\X.>A'O
M5_5/$FIP:OX@TNV6U1[+2EO[>=D8\DN-K+GG&SU'6FZAX%^WZ-JT1OE35-1N
MXKU[L0_(LD13RU"9^Z!&!C.3DGO3X?"-_+KFH:IJ.K0S-?Z:MA-%#:^6JX+G
M<A+D@?/T.>_/8 &79>+KG1_"7A.35[VVA_M.UC+:C<1,8HSY2%5D^8?,Q)^8
MD#@\5/?ZMX@?Q1X/MEN+*&.]2YDG2-6='9(^"&##*X;(]\$^E7K#POJMEH6F
M:5+J=C>VUI;&TE@GL3Y4\85%3(WG# (<DY!W'@57MO 3Z=!X:73M4$4FB&<
MR0;UD2;.Y0-PVX_AY.,#.: $U#QCJ.FZK;17-M:)'/JR:>+7<6F$3G:DY96(
M4$\A2HX[YJOJ/C'Q##)XL%II^F[/#X64F65R9D\KS2!@##8[] ?7J"3X?ZFT
M+6Z:_$(4UD:M 7LMS[_,W[9&W_..PP%/ ^E7IO!EY+_PE@.K0_\ %01",DVA
MS!B+RL_?^;CGMS^5 %F/Q+-JVJV^F:4L,<K:>FH3RW"EUC63A$V@C).&).>
M.^>..\.:O<Z/\/-*D:PLYS/XA>VE61B5B+WC+N08Y()X/&,"NEB\&:CI^JZ=
MJNEZO;Q7L-@FGW8FM"\5Q&G*L%#@JPY_B/6J\7@"^C\-6ND?VU"3!JHU(2FS
M)R1,9=F/,'\1Z^G:@"2^\4>(/[8\2Z?86.FC^R+>*X22>5SYBLKM@@ <G9CV
M]ZM0>+Y=1D\,V]G!'!-K=BU\))P76)51&V@ C<V7'<< FI#X5O/[8\17XU.
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MF/(;D)M' K&T'7]3O++POH]S>R2?:WU&-IIKEXGG,$VR-#(OS9VDD]"=OUR
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M<D$\8Z<5T6LW-[X8\6:*-,GN[NTO[:Z%Q;3W#S F*+S$D4L25.?E..#N'&:
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M\6:Q=75TMS'<7$*P).RI"D<NU8R@.TY49.03EO88]B!&<9&: %HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ JAJVBV&N6\=OJ,+311R+*JB5DPZG*GY2.0>15^N9\;ZOJ&BZ78
MW5A-'&7U&V@EWQ[MR22JI YXX/7!H O:YX5T3Q)#;Q:O8BY^S-NA?S'22,^S
MJ0PS@9YYQ6!KOAAI=>\)QZ?I<G]E:7),TI@G$7EAHRJX.\,3N.21[]:ZC3M<
MTK5Q<'3M1M;L6[;9C#*&\L^^.E-MM>TF]E>*VU&VED2/S2JR G9_?'JON.*
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MR1/#;R PEVA#7$CK$6!#% 6(4D$C(P>3ZFHM2\6:3I>LZ9I=Q=1K<7X9HR7
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MXQ&RGX3:5I<]O,+BUUF);B&2!A@"\+-U'("\G' !&>M>ST4 >5>([:[O]?\
M&T&DH9)[G1+98E3@3LC2%D!Z$[2!_P "%;?AB[\/^(=<MM7T^VU5M1M[=H9G
MO!,GV96P3$V_Y6;=V&>A/'&>ZHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"N2=K+A@P(*D,>,>E7J* .7D\#:?(EL!=WD;PZD=5:2,Q@RW!R-S#9C&#C
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M2LK9 [@ $=>M/\.6/BH:7!HFNPV$=K:P&W>[MYR[W:A2JX0J-G&"3D\C@<\
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M->/<G3T9E<"WDP0#R.,$]ASV% 'J%%9>A&ZETU+NZU!+PW(\U#"%\M$;E0I
M!88(^8]<9P.E<[JE[XCNO'TV@:;JUM8VYTI;Q)&LQ*R/YNT@@L,Y ]NO3/(
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M0W.JM;7MW:VVK$M?6L)79(Q&UF!*DH6'!(//7@\U8O?"MK=ZGHU['=7-K_9
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MH;8PP2 >>G0D5Z/GG'>L\:FM[;ZDNE-#<7=F[0;'?"><$#!2PS@?,N?3GTH
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M')YKHJ,B@#E-"\"VV@2JEMJVJRZ?"Q:UL)IE:&W)_N_+D@9X#$@=>N#3?^$
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MCN2HP"002IQP2I!_'FNJ!R,BB@#%M?#5O9^)I]<BNKD2S6R6IM_D\I8T)*@
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M +!T?R8X?[*L?*B;?&GV=-J-Z@8X-.;1M+=[AVTVS+7*[9R8%S*/1N/F'UH
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MR;#RI&WO']F3:S>I&.3[U072]6N-=#7LU@-&M)!+96]O$PD+!-H\PD[<*22
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MQ=T[ZO>BY!ZEO-.<_ABNX P,#I65;Z-'::C?30A#:Z@WF7-NZY'F;0I<?[P
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M,J/@J&ST4C R?;'-8_\ 8VJ_\*!30O[,NO[56W6 VOE_-N$@;Z8QSG./QXH
M[BV\6Z3=7]W91O<K<6T/VAD>UD4R19QOC!7YUSQE<U3A^(7AR=+"1+F<0:@#
M]FN&M9!%(V"=@;;C<0#A>O;KQ5.YCN3\28]46QNVLAH<EN91 W^L,JN$QC.<
M ^W;K7/V.E:G!X(\ V,FF78N=-U&&6\C\HDQ(BR!F/K]Y>F<_A0!W-CXLTB_
MM[^99I8/[/<)=1W,#Q21D@%<HP!Y!&..<U&_C+1H3?I<R7%O+86_VJ>*6VD#
MB'G]X%QEEX.2.F.<5QVMZ#K&IW_C?[%8R;[E]/GLO/7;'<FWVLR9/3)7'.,Y
M]*MR1?VOX=UNXM?!=QI=[)I4]IF>!!/*[KQ&FTDE,\DG Z'UP =+8^,]&U&^
MM[."6X\VYMS<VY>VD59T !;8Q&'(!&0,]:/"?B=/%.GSW:6L]N([B6(++$R\
M([(.3P3\O(!XZ5ST%E??VQ\/Y387033[.6*[8Q'$+-"J '_@2D<9]>G-:G@"
MUOM-TJ]TZ^L)[=X;^ZD$C[=DJO,[J4P22,,.H% %S7O%,>B:YHNF-:7,S:C)
M(I>.%G"*D;-QCJV0.!VR3CBI[_Q7I6FFZ,\LIBLV"W<T<+/';D@'YV XX()]
M 03@5F>++6^_X23PKJ=K83WD-C=3>>L&W<H>%D4\D<9(R>U8]M8:GI5EXQT6
MXTVXNVU2YN;FQEC3='*)UQL9NB%3P=V!C&,T >AHZ21K)&P9& *LIR"#W%8D
MOB_1X;PV[SR86\6Q:81,8UN&QB,MC&>0/3)QG-6_#NF/HOAK2]+DE\V2SM(H
M&D_O%5"D_I7G6NV>OZBMZLNA7[SVVO0W$(MRBP/;),A#J-PWN5&26!(.>0.*
M .O\6^(8+/1-:@MKBZ6\M;-I'EM8BYMR5)4L<$#.,^H'/ YI=$UZ./PKX?6[
MFGN-1O-.BE"1H9)9/W:EW/MEADGC) ZD"N;,&LZ7+XTT^;1KZZ763)=6=Q J
MN,O"$,3G/RE2H [$=*9HUIK6@:QX>U6YT:]FM6\/PZ7<10A7DM9D.[)4'[K=
M,CI@9Q0!;\)>,[6T\,F\UO4;J5;C6;BSMIIH79C^]*HK87Y>.Q Z&NFB\6Z;
M/91W,,=](SJ[B 6<@F"HVUB4(R!D8YZ]LUP46EZP-#M(I-$ODD3Q<=09"BL?
M(\]G+_*3T!''?MFMSQ);7FG^.(M;;P_/K>EW5@EI)';(KRV\B.[*VUB,J0Y!
M],4 =)#XKTF[M;2YLIWO([N%KB(6T3.QC4@,V ,C!(&.N>,9%$WBG3(K=)PT
M\J&T6]80P,[)"V<.R@9&<'CKP>.#7*:IX>AFM].6#2[_ $"YMX)9+.YT=,_9
M69\^3(B95MWRDC!7(;GD$UM4TC6+VSL;RXAU'3_%-OI,82^TU-\4LV6W6\B#
M*%<@'G"C<<&@#TQ'$D:NOW6 (K$/B_1Q>I;>?)A[PV F$3>5]H'_ "SW8QGC
M'IGC.>*U=/\ M7]FVOVU8UN_)3SQ']T/@;L>V<UY?J5IX@OG@DN-!U!KJR\1
MQW)6 HL!MUER&1=P#L5P2S#.2<D# H ]6D<11/(0Q"@L0JEB<>@')-<UX>\:
M6FM>'5U>:&>U1YWB2-X6W/\ O61 O'S,0HR%S@YKIE)*@D8..GI7DT.B:]#X
M#TRV70Y9KO0]7DNI;25D O(S)-D1G//RR@@G'(XS0!W\'BS1YH;^1KAX'T^1
M8[J&:-EDC9L;!MQD[LC;C.[/&:PO%WBB.?P?XG32[VZLM5TRT,SIL\N6/*ED
M/S#H<=1^AK,U32[O5="DU70?"ITV\M[RTO%MKE$AGO3"^XJVTD 8/RY.<@]!
MC-[Q#<:CXF\"Z^+?P[?6<UU9-;Q17,:B>:0@X&%)PHSU)YR>F.0#<TKQ9IEY
M.FG"2Y-XEH+GY[:0"9!@,T9(_><D?=SU&,U%9>/_  ]J#:?]GN+AHM0E,-O.
MUK(L32 D!"Y7 8[3@'G\ZS6ANCXW\.:A]AN_LMMI4\,\GDM\CMY9"D=<_(W2
ML"RTG5(? 7A*QDTN\%U9:W'<W,7E$F.)9G<L>Q^5ATR>?8T =M9:OI:ZWXA<
MZK=$V2Q->0W(*0V@V,04W*.& +$Y(Z5-%XMTA[N:UEFDMIHK0WI6YB:+, X,
M@W#H._<=Q7':QX>U76;OQ_;VMO+"VHP6@LII4*I,T2G<N>PS@<]<]Q6RNLZY
MK6AWLT'A26SU&*QD79J*IMDF*\1IACN0GJ3@'CU. #9T_P 2Z;J]V+&VEGBN
M);47<0DA*%X2<"1=PP1DC@\C(R*SOAU>W=_X.BGOKJ6ZG^U72&64Y9@L\BC\
M@ *P="MM37QMI.K3:1JRP-HTEM/-=%<I+OC8_(&PB_*0 H&>P[UN_#JTNK#P
MFMK>VLUM<+=W+F.5<':\SNI_)A0 WQEK\FFZAH6FQK=!-0O/+G>")RWE"-V*
MJRC(8E1TY S]:6S\0:7X=M[BSO-6OKU+6X5)KFXB9_LWFD&..1P.VY1DY(R,
MD4GBZ"ZF\0^%9;>SN)XK._:>X>*,L(T,3ID^O+#@9-<OXOLM>U:T\469T2^D
MD-Q#)8_9MJ0RQ*8R6;Y@7D^5AA@<87&.30!W/VVRE\:R6"ZE?+?KI^\V>TB$
M)O \T97!?)QD$\ \5@^#O$RVOA.QEUN^N)IKO5)[&*>1&<LYN'2-25&%Z <X
M'%6DBNW^**:H]A=1VAT3R#(T>0LOF[]AQGG;Z9&>,YKFH='U:+X?V"_V5=M=
M:?XA&HR6H3]X\(NFDR@)P3M8'&?:@#N[CQ9I%H^K)/-,C:3&LUX/L\A\M&!(
M887YAA6.1G&.:CL_&6CW\4DEO)<E5,03=:R+YQD!91'D?/P#]W.,$GCFN1O;
M75KV\\=W T2^CCU71XH+3<J[G<1RKM(!R"2X^G?'2K6M:;J;^$_"E[:Z2][+
MI#1/=:9( KR)Y+1. #P67=D>N.* .QTG7;'6OM2VCOYUI+Y-Q#*A22)\9PRG
MU!!!Z'M5#7/%,>C>(-%TIK2YE;47DS)'"SA%2-FXQU;(7CL,DXXI?"\<#I=7
MUOX>.C+<E<I-$D<\I4$;G"D\#.!DYX/M5+Q5:WP\5>%=4M;">\@LI[@3K!MW
M+YD)53R1QGJ>U &E?^*])TXW+7$LODVCA+J>.%GCMV(!P[ 8'!!/H""<5M*R
MNBNC!E89!!R"*\Y@T[5--TGQAH$^FW%U)J=S=3V,R)NCF6=>%=NB%22#NQQT
MS7;Z#IS:/X>TS3'E\U[.UBMVD_O%$"Y_'% %._\ %NCZ;(XN9W6**=;::X6)
MC%%*V %9P, Y('MD9Q3]0\4:9IC70G>9ELP&NWAA:1;<$9!<J#CCG'4#DX'-
M<MHAUK0KO5M N/#]Q>K<:C-=V=\ C6Y25]^923E2I)R,$G'':I+.TU'0[WQ=
M8W&G7-[#JMP]Y92PIO60R1A#$QZ)@J!EL#!ZT =#=^,-&L[^&R:>:6YGMC=0
M);V\DOG1\<H5!#?>' SQSTJ)?&^A-INFWZW$QMM2G%M;L+:0YEW%=C#'RMN!
M'S8Z5S>@^'[[P_XA\+030SSPZ=H4EG/<I&602LT9"CN1\K8_"C2O#%UJGPWU
M;1KF":RO9+VZN+9I5VE',S2PN#]=I_,4 =M<:W8VMS=03R/&UK"L\K-&VT*Q
M(7#8P22I&!SQTK/?QGHT!U!;F2XMY;"#[5/%+;2!Q#S^\"XRR\')'3'.*P=2
MT77=9^'$\DEK$OB"[>"^DM7;"%XW1A"3V^6,+Z9)]:@EB_M?PWKD]IX+N-+O
M9=*GLP9X$$\KNO$:;224SR2<#H?7 !T^G>,-'U/4K>PMY9Q-=0&XMS);NB3(
M "VQB &(W#.#WI__  EFD"^M+5II%%Y*8;:=HF$4T@S\JOC!/!QZXXS7,+87
MSZMX#?[%=HEE8SPW<GE$>0SPH@!_X$IZ9]>G-5/!^FW%I;:;H&J^#,W^ER(!
MJ;QQM;%4/RS(V=V\KT &03SCG !UNF:M)%XHO_#EU(9)(8$O+61OO/ Q*D-Z
ME64C/<%<Y.2>@KAKD3#XIZCK%O;2W,>F:!Y#Q0@;I)7D,@C7/!;:@_[Z'K75
M:-J:ZSI%MJ"V\UOYRY,,P >-@2"IQQP0: .7UO67O/',7AII-1M[4Z=+.TEG
M'(K^:9$5&#*/NJ"Q_NY//3%7-$\9:-+##8?VE=7<L"R0SWD]H\:[X1^\,C;0
MJ'@G!Q_+,<T-ROQ7@O\ ['<FR71WM3<+$2@E,RL%]>@//3WK&L_#VI:IX!\8
M:-Y$UE=:A?7LMN9U*ATD<LASZ$<'N.XH Z^V\4Z7<WMM:!YHI;N,RVHF@=!<
M*!DE"1R0#G'7'.,5GGXA^'%@%P;FX%L+HVDDYM)1'#(&VXD8KA/FX^;'Y5F2
MVM]XEE\)M+IUU83:5<B[O3-'M$96)E\M#T?<S#E<C YYP*Q+G2=4E^'/B'3T
MTN\-Y=:V]S##Y1R\;72R!O0?*">?I0!Z!IOB;3=5U2XTVW:=+N"-93'/;O$7
MC)(#KN W+D$9%0>+?$B>%](2]:VFG:2XBMU6-"P!=PN6QVY^I. *ST@N9/BJ
MNHBTN!9-HOV?SVB(7S/-W[3GD?+^';KQ4OQ!L+S4/"I2QM9+J:&\M;CR8\;F
M6.9&;&<9. >* +#:MI\GBNVA^W:C'=_V?),+$PNL;Q[ERY!7EP<  '/)XJO%
M\0_#<L%E<K=3BUO)3#%<M:R+$) Q7:S%<*25. >>GJ*K3)=R_$G2]5;3KN.T
M329XI',>[8[.C*IVYYPIZ9&>*YJVTG5(_AQH&GOI=X+RVUQ+F:'RCE(ENVE+
M>GW"#Q]* .\L?%FD7QU$":6W;3E#W*7<#P,B$$J^' .T@'GVJ6R\1Z??:L^E
MJ9X;Y81<""XA:-GB)QO7<.1G@]QW KB?$>@ZKK6M^+%LK65/MFF6L=K+*A6.
M66*1W*$GH#D#GCDUN>%V34+Z.];P;)HMS#"8Y9[J*,/DXRD14DLN<DL<#@<'
M/ !I>+/$B>&-+ANFMIIVFN8K=1'&6"EW"Y./KTZDX%6+GQ%8VSB,K=23^1]H
M:"*W=I$CZ;F4#(Y!P#R<' .#69\0+&\OO#48L;62ZEM[ZUN3#%C>R1S*S;02
M,G /%4;5-0T?QYJFKW&GWDFGZQ:6^TQ1^8]M+$&'ELJY(R&SD9&<Y- '7:=J
M-IJVGP7]A<)<6LZ[XY4/##_/:L9/%<3^,[KP_P#9+H?9K5)VF\AR&+%NF!TP
MIY/4\#I3? NB7&@>%X[2Z7RYI)YK@P@@B$22,X3CC@$ XXSFJJVU]9_%&\OS
M87$ME=Z7#$MQ& 41HY)"P;G.<,,8!S0 NG>*]!T_0+6[;5KZZM;N_>VAN+J)
MRWFM*5V'Y1M4'(&[' J<^/=$'VY/]/-Q98,]M]@F\Y5(R'V;<[, _-T_2N-@
MTK5$\':3:-I=X+B#Q,+V2/RCE8!=-+O_ .^2..O;%=%%!=1^.?$U\UE=?9;G
M3K>*&00L1(Z>9N _[[6@#H3XBTYK.SNK>22Z6]A\^V2WC9WDCP"6  R!\PY.
M.2!U(%3Z1J]CKNF1:CITXFMI<[6P5((.""#R""""#7E^FZ3JVAV'A74+OPY=
M:G;VVE?V=?64:*9K=PP82*K$!AP0<'TKL[74D\/V^EV\?AF:QMM1N64I;1H%
MM"Q 4R[3C<Q89VYQSSQD@'0ZE?QZ7IES?RQRR1V\;2,D2;F8 9P!6-I'BZUO
M_#.DZK<QRPS:A''Y=N(7W/(T8<J@QE@!D[AQ@$YP*U]5MY+O1[ZVB ,DMO)&
M@)QDE2!7G=AIVM6VG> M3;2;Q?["@-G?6A"F4AH5C,J*"=P5EZ=2"<"@#T#2
MM:L=9%P+21O-MI##<0R(4DB?&<,IY'!R#T(Y&:@UCQ-I>@W-I;7\LR37A98%
MCMWDWE5+$#:#S@<#J>,"LWP]I<P\7>(?$#Q206^HBWBACD7:SB)""Y4\C);
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M'CC>V>/>664L3N#@'[H&<@=,Y'>>(M-EUGPSJFF02^5+>6DL"2'HI92 ?UH
MKV_BO2;FZLX%EE3[<";.22%D2XP,_(Q&#QR!W'(R*AL/&NBZGJ8T^TDNI)_M
M$ELW^B2A4D1=S*S%<+QG&<9QQ7.#3]1U_1?".FSZ;<V5YI-[;7%XTB82/R%(
M.Q^C[S@#;G@G.*U_ UM=6K^(A=6D]O\ :-9GNH3*A7S(G"[6'Y'@\^U '6T4
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 445A>*O$4?AK3K>[F*10S7*027,JEH[<,#\[@<[<@+
MU'+#F@#=JAJ>E1ZHMN'NKRW:"7S%:VG:,DX(PV.&'/0UB'Q1<J=(L@+*6_U:
M>9+:6%RT!AC4L9>#D_+M^4'JV,XYK*U?Q]J&C:;XF273[:35-#6*4CS&6*>&
M3[KKP2#U!7/4?>H [BRLK;3K&"RLX5AMH$$<4:]%4# %3UQ\OB'Q#'XL_L'^
MS].WW-F]W:R^>^(PCJK"3Y>3\P(V_3WJ#3_'<MYI&F^9:+%JEW=7%HR1H\R(
MT!8.X"C<P^48''WADC&: .WHK"\,ZQJ&K07BZEILMG-;7#1*YB=$N$ZK(@<
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MT_A^ZCME@LM4L-9M].O1DLK*\B -&>" RL.O(&1Z&N@?6Y+;QU;Z;?65D/\
MB4RW;7R$EP%= R@$<+SGJ<X% '545R^EZ]K6J1Z-J=OID,FDZF-Y"OB6VB*[
MHY&).&R,94#(SU.*H0^-K^\_LZ^T_2IKO3;RZ$++':S>9'$6*B;?MV$< E>P
M/4XH [>BD;<$)4 MC@$X!/UKSVW\>ZT^D66L3Z78QV+ZJ=.N%6=FD&9S"&3Y
M0, XZ]>>!0!Z'17%ZKXRU!/[3?1M->^_LVX\AK=;>9WN6 4N$=5*J1NP,YR0
M>@P2NI^,;XMJ:Z-ITEQ-IRIO@DMIF::0QB3R@4!"':RC)SR<8 &2 =D[K&C.
M[!549+$X %16MW;7ULES:7$5Q ^=LL3AE;!P<$<'D&N=@\1W>M:A+INFVL<,
MUO90W-VM\K9C:4$I"5&"&PIW'MQP<\5/A1G_ (5EHN5"G9)E1V_>OQ0!V=%<
MQK7B#5;/Q9INAV-C:2?;K:>5)IIF7:8]N<@+T^<=,Y]NM9]AXZGN=+LHYK2%
M-8N=4FTORE<F(21%M\F>I4*A..I) ]Z .WHK@->\7ZM86/BG3-EM#K&F::=0
MM[A5)CFAPWS!2<JP92,$D9P>>E=;H#W4F@6+WCH\S0(2R9YRHZYYS0!:%]:&
M^-B+J$W@C\PP>8/,V9 W;>N,D<^]6*\_UC^T8_BW"VCV]H]Z^@2#-TY1 //3
MD[02?3'O4VG>/Y;ZQM8);'[-K+WL]C/"JO.D3PC+L @W,N"N!Q][KQF@#NJ*
MP_#&L:AJUO>#4M-ELY[:X:%7:)T2X3@K(@< @'/0]".M+KVNOI5[H]A#&IN-
M4NC;QR29V1X1G)..IPN ,C)/6@#5N[NVL+62ZO+B*WMXANDEE<*JCU)/ J4$
M$ @@@]"*\[U/QIJ0\*^++FZT73KE=%F:V=))F*7& K%MA0@##+\NX\Y&>]=#
M<:_>6?C73='GA@2PU"VD>WG&=QE0 F+'0?*2P/H",=Z .DHKDW\5W")I\1CC
M-QJ3SO:M'!)(HMXR,2%5RQW!D(''W^O'.=+XWURWT^R>;0!'<3:RNF-YYDA6
M16/RRQAESM(]>A]: .]HKG/#NO7^H:UK>D:G;6T5UIKPG?;.S(Z2J67[P!R,
M$&K?B+74T&RMI!&);B[NXK.VC+;0TLC8&3V &2?84 ;%4QJVFG41IPU"U^W$
M$BV\Y?,P.ORYS6+#X@OXO%,OAN]CMOM<EF;RSN8PPCD4-M964DD$$@\$Y![=
M*R/AG:OJ'A*POM3AM;B:*ZNIK>8IF1)&FE#MD]"<D<=J .]HK)UW4KO3H[4V
MT4(CEFV3W5PX$5JFTG>PR"<D!0 1RW6N6/Q OSX974HM.MYIDUD:5,/-95;]
M\(]Z C/.0<$C'J: .V@L+>WMY(8T(64EI&W'<['J2>N?\ .U3QQQPQ)%$BI&
M@"JBC 4#H *Y&'Q'K[ZAK^DMI]BVIV%M%=VJQ2N8YE?=A"2 0V4(SC'(X%6-
M)\43:UI_AVXLU@9]21I;A"&'DH@_>8YZJY5.>[9[8H ZBBJVHW;6&F7=XD#S
MM!"\HAC^](54G:/<XQ7(V_C.XO/#&HZ[83Z9?VUK8-= PE@5D4%FB=225.!U
M/Y#'(!V]%<JOBJX_M;PQ;O;PB#6K22=VR=T)2-7QZ$'=CMTHTWQ#K&KVVE:K
M8Z;#/I.H2X*A]LL,)SMF8DX.<#* 9&[J<4 =':7UI?H[V=U#<+&YC=HI X5A
MU4XZ'D<5/7D^F:[J/AC2O$^I6ME:2:=;>)+@7 >0K(5>5%.P 8XW \GFO6*
M"F3316\+S3RI%$@RSNP55'J2>E<;K?C*^T6Z=I[2VC@74(;1+=WS/-$[*OGC
M!PJ[F( (YV]1G%.US6;K5['Q18Z;%:M!ID#0SM<9/G2F+>47'W<*5^8YY.,<
M9H ZA=4T]_L>V^MC]M&ZUQ*O[\;=V4Y^;Y>>.U6Z\\\/:JUGIGPUL#86TT=]
MIZJ+ESF2!EM=WRC'&0,$Y]>*NW/C6\_X1W4/$UC:03Z383RH\1)$LT43%9)%
M/08(8A2#D#J,X !VU%<O:>)KB^\17^F6Z0-%'IT-_;3X;YA(6 ##_@/4>M9%
MOX[U>_L?",MGI=F9/$$<AQ)<,!$ZQ,X'"_=^7D]>O% '?T5Q"^)/%,FMW.AC
M3-*2_M]-BO&<W,C1;F+*1]T'JAQ^>>Q?9>.SJNF:$]K;F*\U6R:\*F&2=8%7
M:#\J#+?,X Z#&3GH" =I5>"^M+J:>&WNH9I8&"S)'(&,9/0,!T/UKE++QEJ%
MS#I=E<:4UEK-_=36Z1W"NL82(;FF (#%"NW X.6QD8)J'P2MPGC/QNMTL*S"
M[ML^0"$;]PN" >F1@D<X/<]: .YJ.2WBEEBED0,\1)0G^$D8R/?'&?<^IK#\
M8:_=^'-*@O;6TBN2]W!;NLDA7 DD"9'')Y]168OB'Q-)XBU'0%L-+%[#;1WD
M$QGD\KRV9EVL-N2VY>V!@YXQ@@'9T5P^G>/7UG3=':TMO)O-0L6O) 89)UA"
ML$QMC&3ELX/' /? ,EKXUO9[33;>YTJ:PU:\\\O%+;RR"-8B 7"JH9E8LF,X
MZG)XY .TJ 7EJUZUD+F$W:QB5H XWA"<!BO7&01GVKS[4O%/B2XT[1B+,:9/
M+K\>GSB:*11.@)97CSA@C;><C/45NC6;I?&NH:8=,L3<P:3'=)<!R&ER[+L8
M[<JH*L<?-UH ZNBN TGQSJ]Y;^%M0N]-LXM/UUQ !',S2QR%&=3@C&WY",9S
MT/M4FJ>.[RUTG7-7L[*"6VTC41826\K,LDIRBEPPSMYD&!M.0,YYQ0!W=01W
MEK-=S6D=S$]S %,L2N"\8;.TL.HS@XSUQ4D)E,$9G1$F*C>J,64-W ) R/?
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME!)&R%%V;L[0$ ZYZGVJ])X:N[CQ9;:U=7MO+''ITEC- ("OF!V5F8'=P,J
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MM;H7<@9./0#N3T'UJKI^MO=:E<6%WIUU831[3&9MI2=2"<HRD@D8^8=N/44
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ME$=K/]HMXC=S%(7YY12V%'S'@ #VK<U+3;/6--N-.U"!9[2X0I+$W1A^% '
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MR1/)(I!3H3P"">1VXP*]+L_#^FZ?>7]W:Q2QSWY!N7^T2'>0, \MP0  ",8
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M-XR1@X9"#@C@CH: /,=5FNM4^">L-J-S/+/9W\L"M]H8DJET%4,W&_ XRP[
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M"@C61E:!H-NP';@9^]G!SS1'<:WXEL=4U"QU..PN[#5)HO->\D$<"0R$;)(
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M%<'KUC?Z;XQ(TR)_LGBF(6MTR<&WF0<S>Q,.\?[R+7?111P0I#$@2-%"JJC
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M+3#K]Q T$VJ[9UB?[T<6T"-?R^;ZN: -:[U.PL)(8[R]M[=YB1$LLH4N1R<
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MID(9AECT&%/KS@ 9-57\0S1QV<9TFZ%Y=7,ELD)(VJ4#$NSC("$+D'J<CCT
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M.WE@@MI[6X664H4#LC!Q@'=]P\<=1S7344 >;:CX2UV\\-^,M/CMK<3:U?\
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M0Y /'!'?M[UTU% '&?%4N/A[>F,*7^T6NT,< G[1'C)JZ-*O;[Q;;^(+JU$
ML+*2WMX/,#/(\A4L21P% 0 =SDD@8YL^)IM!:WL[+7D$L-[=);P1LCLCS%OE
M!V\#GGGT]JVT01HJ+G"C R23^9H \XTSPOXFTWPQX7TPV]I<1:>\JZA9-<E8
M[@-G8V[:<A2<E2.?0X%00^"O$MGI<<MHNGQZEIVMSZC9QB5O+GCD+[HV^7Y,
MJ^!UZ5ZA10!Q>MZ1XF\0:%%<D65AJ]I=Q7EG:^:98E:/.5D?:"=P9@<# X]S
M5I]0\50>'[W4KG3=,MKV-%\FS-V6CX/S.\FT8XZ*!VZG/'54A4,,, 1G/(H
MALIY+FPM[B:!H)98E=X6ZQD@$J?<=*\ZUGPIXGU+^T1);:?=3?VM%>6EW-<D
M-]G25&6$+L.S 4Y(/)YP2<UVC>*-(35(-/-P_G3S-;QN(7,;2J"6C\S&W<,'
MC/8CJ*V* .(.@ZR=5\8736L)75[.&"WVS?QI&Z'=QP,OD=>!T[52TWPSXAT+
M4- U6TMK:ZEM]%BTB_M&N-F/+(*R1M@@\YR#C@^M>B44 <QX)TC4]&L-2BU.
M*W1[C4KF[C\B8O\ +)(6&<J,=?\ ]72EU;2M0N?'6@ZM! C6=A!<QS$R ,3*
M$ P.^-G/(ZUT-S<Q6=K+<S$B*)2SE5+$ >PR34.F:E:ZQIEMJ-C)YMK<QB6)
MRI7<IZ'!Y% ' )X+UP6YNT2WCU"T\0S:O;1M-E)HI"=T;,!\K;6/.",XK5U#
MPK>:[=Z]J<Z):7-]HK:3;0L^[8#O8LY''+,.!GA?? [6B@#A9M#UZYL?!Z2V
M=JDND74<UPJ7.X;%B:/Y25&22V<<#WI=+TCQ5H&J:I86,=C/I-_>R7D-[).5
MDM/,.YU,>T[\')7D=>37<T4 </'I?BK0O$FJG2;?3KW2]5N/M0>YG:-[24JJ
MOD!3O4[00!CTR.M=M$K)$BNY=@H!<@#<?7 IU% 'FU]X2UVZ\(^,-*6V@%QK
M.H27-L3/\JHVS[YQP1L/3/45I3:;XHTGQ9?:KH]E8WMGJR1&XM[JY,36TR($
MW!@K;E*@9&,Y%=O10!P]WI/BG2/$_P#;6DQ6.J+>VD5O?V\\IM\21[MLB':V
M!\Q!7&>G6G7.B>(;+Q?9>)+5+6_DDL/L-_;&3R0O[PR*\9(.0"2N#R1CO7;4
M4 <QX)TC4]&T_48=3BMT>XU*YNH_(E+_ "R2%AG*C'7_ /5TI=5TK4+GQUH.
MK00(UG807,<Q,@#$RA,8'?&SGD=:Z:B@#S5/!>N+;?:T2WCU&T\0S:O;1--E
M)HI"=T;,!\K;6/.",XK4U/PI>Z]<>(-2F2.TNK_1&TBUB9]VP'>2SD<<LXX&
M<!?? Z?4M8L]*5/M+2&1U9DBAB:61PHRQ"J"2!D9/N/45-IVH6FK:=;ZA8S"
M:UN$$D4@!&Y3['D?C0!5\/17UOH%E!J,$,-S#"D;)%*9 -J@?>P/3/2LBXTS
M5;+QW<Z[:6D5W;W6GQVFSS_+:-T=V!.1@J=_4<C'0UU5% 'G(\&:YX>71]3T
M-K2]U&U-R+ZVF<Q1W"W$@D<(V#MVL!C(Y YKN-*_M%K+S-42"*YD;<88&W)$
M.,*&(!;IDG Y)[8J]10!P7BC^T+CQQ9MH5K;7-_96+F<"\^SS(DK *"2CJRG
M8QQC@@'(XS5&EW^I^'])TW3]#BTYM%UJ"::W-X)5VQD2,5DQEF;?W .<Y]^R
MU7PWH>M31W&J:7:74L0PDLL8+*/3=UQ[5?M;6WLK9+:T@B@@C&$CB0*JCV Z
M4 <WXC\+3ZMXBTG4[698557M-14_\MK5OFV?]]*!]':H-<TOQ#9>+X_$.@6]
MI?)/:+9WEE<S&'(5F9'5\'D;V!&.GZ=C10!R%SH^MW'BGPSJD\=O(MA'=?:C
M')@ S!0%0$?,%QC)P3UQVJUX.TF_TE-:%_%'']LU2>]BV2;ODD((!]",<_SK
MI:* .6UK1=07QCIGB;3$2=H+>2SNK5GV%XF(8%">-P8#@XR.XK(U7P=J5WX7
M\6QPQP_VIXADW>69<)"H144%L<G"Y.!U..@S7H%% $%F939Q>=%Y4H4!DW!L
M'Z]ZX'Q9X6\1:Y-XEMQ#8W5M?6BQZ=+/.0;0A,,H3:1EFR=V1P>>@%>BT4 <
M?9Z3K,?C:#6KBT@$*:,+)UBGW'S?,W\9 RO&,\<]L5E1>'UL/A+-X?\ $$T%
MI<)'/+')'+N(82-*CIT)*DKQCJ/>O1:QM6M]#EUK1SJ=C%/?^8XL9'MC(8V"
M[F(;!"<+G)QR!CF@!WAFPNK#0;==0</J,P\^\<#&Z9^6Q[ G:/8"J7BS1$UY
M;:TN]'AU+3MLAE7S!'-%)\NQXV.,'[^>1U'7I7244 >?Q^&?$>GCPC>!XM5O
M=)2XAN!/<E&9)0 IWE3N*A5!.,GK5(^#/$JZ?<7$)L(]4M_$,NL6:^:QCF5L
MAHW^7Y<JQP>>W2O2V=55B3]T9..3CZ57TW4+?5=.@O[0N;>= Z%XV1L>ZL 1
M^- ')>(],\3>)O!=]9SV=G;7MT\/E6JW.](@DBNS-)M&2<8P!@8'O6A'I>HM
M\1AKC6Z)8G2A9G,H+B3S-_3T[9SU[5T]% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6+XFO
M;JQL;9K:[@M1)=1QRR2 L_EDG(B7!W2'@ 8/4^E;58_B'P[#X@BLM]W<VD]E
M<K=6]Q;%=R. 1T964@AB,$4 <A!XWU*'2=1BF(>]7Q FC6<MQ$%($GEE7D5<
M#*AV.!C.!TYJS;6UY!\8)XWU!KAF\/9BDFB7*?O^A"!01GGMUJ])\.=*GLM6
MM9[W494U*Y6\9FF4-#.H4"2,A1AOD!YR!T  R*1M(B\/:]::_?:CKFIW;P#3
MBT=LLJ["2^72*/(&0/F'<\]: ,O1/&6IZCHGA"WGF1=1UV:X66Y6, 1I%O9M
MJ]-Q"J!G/4GFH==\6:WHMIXOL?M0>[T>UBOK.[,2YDC?(V2+C&05(R ,C'3O
MH^'_  3O\"Z!9:BTUIJ>G.;J&:$CS+>1F9L<@@\-M(((-;4_A"PO-/UBVOI)
MKF35XA%=W#%5<J%(4+@ *%R2..I).: *T^K:BOCVRTF*X06MUI4USM>('9(C
MQJ",8)'SG(S7)1^(O%[?"^Y\7MK-F)$LIF%L+$$!UE(#[MWH",8(Z=>IZZT\
M&"WU>SU6;7-4N;ZUM7M5ED,7S(Q!Y4)CC:.0,GOFFQ^!+&/P-+X2_M'4&L)%
M9#(6B\T*S%B =F.I/;- %$Z_J^C>*_LVI7D=Y93Z1-J'EQP",PM$5R%.<D$-
MW[CMTHTO5O$]X^B:LL+OIEY#YM\DODJD2LFY6A*L7.#@8;.1Z&MI_"MO+KEI
MJTU]>2RVUH]F(G\ORY(WP6W )G)VCH1TJGH/@6U\/S(D&JZI/IT+%K;3[B8-
M# 3Z<;B!G@,2!UZ@&@#D==U*_P#$?@'2/$+WGEV]YJMI(MF(UV)%]I4(-V-V
M_@$G..HQTKU:0.8F$;*KD':S+N /J1D9_.N+_P"%:V2::=*@UC5(=*6Z6Z@L
MT:,K ZN),(Q0MMW#H21R:[,HQA*"1@VW&\8R#Z],9_"@#R^R\4>*9/"WAG77
MU*U9[_45L9K<VH",'E>,-D'.1@' (X&#ZU>N/%NKZ!>>)+&]N8]0>S-B;24P
MK&0;ES'A@" 0I&>HXX)[UL1?#^RA\/Z7HR:IJ7V?3;Q;R!\Q;RZN7 8^7@C<
M3VJ:^\"Z9J=WK,]]<7=PFKP1P7$+,@11&24*X4,""2<Y/- &5J&O>(_#4.L:
MA>V\D^DPV0EMY+LPK*MQN"["(C@H<@YX(P15AY/%<=W=*SW":;)82-]IG6W$
MMO< 9&P(2"I&>&!((ZFKMEX*MH],NK#5=3U'6HKB!K8F_E#%(CU4;0.3@$L<
MG('/%/T/P?'H\1BGUC5-3B6,PP)?2JPA0C! VJ,G'&XY..!C)R <II>K:QI/
MPX\%74.H>:U]<V,,_GQ!F\N4J& /'OR<GGK5Z_U?Q+-K/C&TM=5M[:+2;:&X
MMB+0,WS1N^TY)R#M&3^6*U$\ VB:!IFC?VOJAM]-N8KBW8M%N'E',:G]WC:,
M>F3W)JVWA"W:^UR[_M*_$FLPI!< &+"*JE1L^3@X8]<]: ,E/%5[>OX3261=
M/M]8T\W4MTH7B7RT81*7! ^\QY!)"\=ZTO NIZMK'A[[=JTD3N\TB1-%#Y8>
M-7*J_4Y# !NW7CBN:UW2/[+NM#TO[3XD@T[3K PP7]A;"Z+ME5"2(L;8(5!A
MMG.[KUSUGA2/4H[*?[=>WEY"9 ;:6^@6&<I@9W*H7 SG&0#Z]J *]UJVHQ?$
M>PT<31_V?<:;/<%!'\P='C .[//WCQ@?C69\/K>X74?%KS7TLZKKDR%'1 &8
M10_,<#.<<8''M713^'H;CQ1:Z^;RZ6XMK=[=(5*>64<@MD%=V<J._:DT+PY%
MH-QJ4L-]>7']H737<RS^7@2,%!*[4! PH&.: ,3Q^;P7GA9+;4)K9)]9BBD6
M-5(;Y'8$Y!S@J..GZ5C3C58O&'CN;3-16UFMK"RE,K0+(798I2!@\ '!SQ],
M5VVO^'X/$$-FLMS<VLMG=)=P36Y7<DB@C^)6!&&(P15/_A#[<7NM70U+4 ^K
MVZ6\X+1D*J*57;E,YPS<DGK0!CVOBK4=<;2;.U2>&>ZT6'5)GM%B+ R<  2G
M&T$-G@GIT[]+X:EUF;0;9O$$$4.J#*S+"P*G!(##!.,C!QG@FL6?X>6;6VCB
MSU;5+*]TFW%I;WT$B"5H0 -CC9M8<#^'KS73:?8QZ;91VL<DL@7):29MSNQ.
M2S'N223_ "Q0!Q^I:K?>(+;QA!:7GV2WTI'M541JQFD\K>Y?<"=OS!0%P>"<
M\C%+2-0U"W\(^%[:VOEMXV\/12I';QB6Y>41Q[2592HB )RQQR0,BM^\\$6\
M^K:E?VFIW]A_:D7EWT%N4,<Y"[0V&4E6QQE2,_K4-M\/[.SET^2WU75(S::>
M--;$D?[^W4Y56^3@C^\NT^] '.IJVJ>(+KX;7S:A):-J,<TLT<"+L\P6S'=A
M@?4C!X&?7FM*;7O$VKP7]YX>@D>2SU"2UCMW\@02I%)L?>S-Y@8X8@C 'R\'
MDG1MO %E::=H=I#J>I(^BNQM;@.F_:R%"A^3&W:<< 'OG/-*W@*S76[N_M=4
MU.TMKZ3S;S3X9@()WZ$D$%AN_BVD9H ZP<@&N*\<&].N^$8K;49[:.?4S'(D
M:J0V(9&!.0<XQTZ<],@8VK#3;ZW\3ZG?/?7DEC<)&([:=U9(W P3& ,J,=<]
M2?;F37O#T&O?8'>ZN;6>QN1<P36Y7<K!2I'S*P((8CI0!S]SKVM0Z[XMLDNH
M-FG:9#=6A:#[K,)2=W/S?<'H/:LZUUWQ,S>"Y6U2V9?$%MMEC:T&(G^S^;O4
M@@D\'@\<]!72R^#[:74=7O?[1U!9-4M%LYE#1D*BA@-N4)S\S<DGK38_!=K&
MOAY5U+4,:"NVUR8OF'E^7\_R<_*<<8_.@#GX/%^K6,&HZ?=RB]O8=<CTN"Y6
M)$9ED17!*Y"[@"P'0$XKI/#\GB$:IJ,&JQ.VGC8]E/.8A,<CYU<1G;@'&#@=
M>:J7/P^TN]MM8@NKN_E&J7*W;MO16@F4 *\1505("KUST]S6KH6A-H\;F?5+
M[4[EP%-Q>.I8*.B@*  .?3)[D\8 *OB"]O8=4T^UM[X6T,\<I98$$ES(XV[0
MBE2NP9)9CP/EY&:Y6S\7>(=1T'P3=QW%K#-J]R]M=9M]P)59/F'S<?ZO.!^=
M=?J?AF'4=>L]9CO[VSN[:%[<FV90)8F()1MRGNH.1@^]9EE\/;&PL]'M8=4U
M/RM(N7N;8,\9^9MPP<IR,.P]>>M &1_PF.K:3:ZW8W=Q%>7]MJ]OIMI<O$$!
M\]8RI=5X^7>W3&<#IUJU:VUU;?&5%N+Y[L'P^Y5I$567]^F1\H (_#-:-W\/
M],OXM;CN[N^E&KS)<2DNBF&5 H1XRJ@J1M7KGI]:GT_PE]DU^#6[G6M1O;V*
MT-GF;R@KQE@W(5!SD YZT 1^.-6U31[+2I-+E@CDN=4MK2031%P5DD"GOQ^O
MMBL<:IKEGKVN^&M8O(=0B?1WU"UN4@$)09*-&P!(/."#Z>M7/B3#-<Z5H\-O
M'=LXUBTE9[6!I&B19 6?A2!@<\C%; \-PRO?W4]Y<RWE];"U:YPBM'$,X5!M
MP.6).022?8  ',>'[V\M_!?@FV@O5MH)]+3S!"@DN9&$2;1&I5AMY)8D8''(
MS2Z%XQU+6-*\*6TTB07^L-=":X1!E5MRP.U3D;FPO7('S<=*UH/ =K:?V(;7
M5M3@ETBV:SBE5H]TD!V_(_R8_A7D 'WJO_PK73$T.STZ'4=2BDL+E[FQO%E7
MSK=F))53MP5.XY!!SW/2@!;O5M>T86.F7TT5U=ZAJ4D%M/;*@D%N(VD!8-M3
MS<+M_N\YP>AU/#4FOF348=;B_<QS V4[F,2R1D<B18R5!!R,C&1CBJ]_X'L=
M3T--/N[[4)+E+A;I-1\T+<+.!@."!M&!Q@#&.U17_A:^7PU/9V>N:N^J2NC?
MVAYR+*2OW03M"B,=P!W/4DY .K.<'! /8D5Y=K&J:IK7PD\82WMX!/:S7UL6
MAB"AXXRR!<'. 1[Y]Z]0 ;8 6RV,%@._K7+_ /""6?\ PC>K:$=3U$VVJ3RS
M3OF+>#(<N%/EX )/I0!N:/#)!I-JLMP\[^6OSNJ@XQT^4 5Q?B7Q/J^D/J%U
M#>12?9-1MH5M8(@\0A=HU(F<C*R$N2 K<#:<8)-=W9VQL[.*W,TDWEJ%$DNW
M<P'KM 'Z5RM]\.[&]CU6'^U=3AM=2NEO7MXGCVQSAE;>N4)Y*#@DCVZ8 *E[
MJGB.Y\2^*--M-5@M8=/LH+FW86@=@6$AP<G!SL&3^0'6HX?%.J_9_!FN7,ZQ
MZ3J\445[&L:XBGD3,9#'D(6^4^F5YK?3PE FI:I?C4]0\[4K:.UFR8R%5 0I
M7*9S\S<G/6L35-)@@\.0?#Z"QU6]BEM$BCO9(08H4#8#-(H4!T"[@,9) ]:
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MN949X8F&"%^3!)P,LP)XJ2[\$Z?>^$;/P[/<WK0V0C^RW0=5GA:,81U95 W
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M \9K;TZ#2;+XS.FG+:0K-H"L4@VJK'SN#@<9VX_#% 'H-%%% !1110 4444
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M$9SQ0!JW=G:W]L]M>6T-S;O]Z*9 ZMWY!X-,BTRPA,IBL;:,RH(Y"L2C>@&
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M+@?-A>HQWSC!X/-8_P /-4N=5M=?DN+NYN5AUF>&$W*[71%5,+MP-N,GC H
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M2&W;3D\8^4Y.>,<\\5=3Q':?9K)G6X^TW:%X[98'\Q@N-QVD9"C(Y/'(YY%
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M=N%4C^(\'UX-7M/U^RU*XBAMQ< SP&YA:2%E62+*C<I(Q_$O'7GI0!J4444
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MY;SV^B;6MU@B*>;(B%$=\L<84DX'<YSQB@""R\7:A/I>L+<6MK%K.GWPLEM
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ171O=0N$$OVIT=8UCWQP/,%W;_F'S8!8 >IH ]#FFBMX_,FD5$R%W,<#)(
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MW^JSBXEBR#Y:*H1$XZD*HR?[Q/;% &IJ6HVVDZ=<7]Y)Y=O A=VQD_0#N3T
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MY^."Q)Q[9H [NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M 4P:SI36<-X-2LS:SL$BG$Z[)&)P K9P2?05;EEC@B>65U2-%+,[' 4#J2:
M,36_!N@^(;^"^U*Q\R[@78DT<SQ/MZ[24(++['(Y-6?^$<TH:I#J26S1W4-O
M]EB:.9T"1<?(%!"@<#MV%5-(\:Z!K&EIJ$6IVL<,DS0H)9E5B=[(O!.06VY
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MY>T8-=D&ZC29UCG(Z%XP=K<<'(Y'!S5J\UW2-/EDBO-4L[>2*+SI$EG52J9
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M>GTH Z6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK<0RQ,"O^F%F'(YPG)QT!YZUV&MW5A8^-+"VBM19?:+"9DU""W,AE+.I,,8
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MAA18XU'90, ?E4M 'C7B'489X-32.":R:U\2P2RVL5N[%P)H\W#N0>& RNW
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MS$CQJ2P"@[L,QVD@#MC)&1G)'@S4[*'1/(CAFFAUR76+[$NU09/,RB9'.-X
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MM[:>VN%EE*%!(4(88!W8V'CCJ.: "T\9176DZS>MIUQ#+I4[6\MJ[)YCN "
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MR_M(FQG&<X&.G7O0!NZ[X^T[1/M[%/M$>G,JW>R9%=20&.Q"07(# GIZ#)!
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MS>79BZEC03KLWE\[OE4#KGGH,9.*BT_Q_INHVCM%#)]M6_.G"T5E8O-C=\K
M[2FT%MV>@/?BH_$6CZY<QZ#J^D);C5=*9MUI<28CF1TVNF\#@\ @X[57UO1O
M$^L:?INJQI8VNM:=>B[@LO-+Q%-A1HVDV@EF#'G&!P/<@&I_PE\-O;7C7^GW
M=K<6UW'9K"5S]HDDQL\IN P.X<\8YSC%*?%T=O?WVFWNGW$6H6MH;U8$='%Q
M"#@F-B0,@\$'';K6;K>B>(?$VAP3W"6=AJEG>P7UG:+,98U:(D[7DV@G=DC@
M8''7FI+O0]0U;69M<GLUMYH]+EL;:V,P8L\A!9F8< #  ZGDG X% #K+Q['=
M:3#JDNC7]O:745NUFSF,FZDE.%C0;L@Y[G QSTYJEI,MP_QAU,7%K);/_8L+
M%#-YBL3,_P RGTP .@Y4_4Q3^$=9E^'GAS3X?L\6LZ#);3QH\A,4SPC;M+ 9
M 8$]N#6EIFG:[+X^DU^^L+6TM9=+CM#&+KS'5UD=^R@'[WKZ?0 '7T444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 445S_BK7)M)72K2U*K=:I?)9QR.,B($%F;'<A5.!ZD=J -"
MWUJPNM9N])AF9KVT1))HS&PVJV=IR1@YP>F>E:%>;(VH:7XZ\83)?V\US%HU
MM)!/?;8T3!FQYA4 8!SR ./SJW::]JD^N:GHXO[AX?[%6^@NY+98Y$DW,A*C
M:,KP"-RY^HH [X$$9!S17F?AK6M0M/"/@RP6XN;FZU>V\PR*(O,1$B#,%WX4
MDDCEL\9ZUU_AB37FM[R+7H@KQW#"UE)3?+#_  EU0E0W4''!QTH UKR[AL+&
MXO+@L(8(VED*H6(51DX Y/ Z"GV\\=U;17$1)CE0.I92IP1D9!Y'T-9?BN]N
M],\):OJ%A)''=6MG+/&TB;QE$+=,CTKF=6\6WFF66BW6H3W-EIMWIZR2ZE!;
M"5([@A<"48.U.2<@#GN* .D'@_PXNHM?KH=@+IG\QI! O+_WL=,^_6M*]O;?
M3[8W%U*(X@57."268A5  Y))(  Y)-)ITK3Z9:3//%.SPHQEB.4D)4'<OL>H
MKD?B3%/)!X=\J[DA4Z[9(555.29!AN0>F.G3UH W-*\6Z1K.J3:;9RSF\@#&
M:*2VDC,>T@$,64 'YE..X.1Q6W7*+J.IQ_$./07O%:S?1GN=PA42>:)$3<3T
M/!/& /8UF>']<UR[\5W?AK4M0B%WITS3RS1H@%U;,%\L*N,J03\WIQ_>! !W
MU5[Z]M]-L9[VZ<I;P(7D8(6VJ.IP 37%7&O>)M6BU*Z\/02/+8Z@]K% _DB"
M41N%<2,S;P3\Q!&,?+P>31J.K7WB*P\81VEW]CM]+CDM501JYED$.]R^0?E^
M8* N#P3GD8 .UL+VWU/3K:_M7+VUS$DT3$$;D8 @X/(X(I;R\M["TDNKJ58H
M(QEG;MV_$YX [UD>"/\ D0?#G_8+MO\ T4M8_P 4HYG\*P&*Z>%?[1LU9552
M&S<1XSD=CS_.@#I=+URPUB2[BM))/.LY!'/%+"\;QL1D9# '!'(/0UHUR::E
M>W_BN\\.6^H20&PLHYYKH11F2620L%&"I4* O.!DDCD8YYZ/QEXAOK+0TCEM
M+:\DUN71[X^065FC$F73)X'R X]>,T >A:CI=CJ]H;34+6*Y@+!]DBY 8'((
M]"#WJ:"""T@2""-(HE&$1  !]!4.F07MMIL$.HWBWEVBXDN%B$0D.>NT$XXQ
M7*^)_MK?$3PC;P:E/!!*+MFB15*[DC&&Y!R<,1[=J .ETO6[#66O%L9FD-G.
M;:<-&R;)  2/F SPPYZ5H5Y)-?ZQHUCX_P!9TN]B@^P:LTYB> /YV(8<J23P
M"/3G/>NGU#7-7U/5M6TW11<136%O$R-$L+!I9%++O\QA\F !\O/7F@#M**I:
M1+?3Z1:2:G!';W[1+]HBC;<JR8^8 ^F:S/$%]>6^HZ;;07JVT$XE\P0H)+F1
M@!M$:%6&WDEB1QQR,T =!60/$^E,NK%9Y&_LD?Z8H@?,?R[N!C+?+SQFN2T7
MQGJ6KZ3X3M9'2'4=:DN5FG5!\B6Y8,54Y&YL+Z@9)P<8JC#<ZGHDOQ.O8+U)
M+ZS\N>.:6$'=MM0P!48&< #/3OCM0!Z=!,EQ;QSQDE)%#KE2#@C(X/(J2N.M
MM?O=5UW3="CN3:R/HR:E<W$:*78LP154,"H&=Q/![ 8K&7QEK7V:WBEDC6\M
M/$T>BW3+$-EQ&Q'S@'E6*L.AX.?; !Z517!:IXCUFTN/'<5O=1?\2>PBN[0R
M0AMI:.1V4XQD?(,9Z>]5[_5?%FG:1HFH'6+.7^U;^QA\DV6!$LN XW!OFR3U
MP#UQCL >BT5YY-XMU;0)/%L&H7$5^VEI:26LIA$?,Y*A6 .,*P!ZYQU/>K5[
MKOB'PV-3U/4+>:XT6WT][@&Y,*2K<+T1?+)RC#N1D'N: .IN]:L+'5;#3+B9
MDN[]F6V3RV(<JI9OF P, 'J:T*\YU&/43XO^']U>Z@+@SS3O)&(E5$<VKGY"
M!G;R1\Q8].:]&H **\XU#7/$S?\ ";FWU6W@&@XEM]MH&WCR!+L;)/'.">OI
MCH;*^)=8LM:\/7%[=Q36&LV4\\EK' %^SF.)91M;.6X)!S]1CI0!WU%<+I&L
M>*-4&@ZO!;N^GWZK)>0R^2(XHW7*M$RMO)!(!#9SSPO2H]+U[Q-KEIH^MZ9;
MR/9W<X-Q;R^0L2VQ)&Y&#>9YB\'G@G/ H [>\O(;"QN+R=F$-O&TDA12Q"J,
MG &23CL*?;SI<VT4\1)CE0.NY2IP1D9!Y'T->:Z9?:S8>&O'VJQZL\UU8WUX
M8OM$2LN8HT*\#'90,=!Z5IRZUKUQKOAC3[>_@@BU32Y;B9S;!F5U6,[ASC^,
MX&,#WZ4 =W17G,'C#6(O"44UU)&]Q'KK:3=7XC"K'$LQ0S%>BG  YX!.>G%;
M?AK4]6O?$VOVD]W'=:7821QVTXA :1F0,P+J0I*9P<+W'>@#JZ**P/$-]=VU
M_IEO!>K;03F7S1$GF7,A"C:(D*L",DEB1P .F: -^BN=\"ZU>:_X/L]1OPOV
MIFECD*KM!*2LF<<X)VY..,U%X]U;4M#\+MJ&ERPQSI<V\9\V/>"KRHA YX^]
MUP: .GHKS^^\5ZIX7U;Q%#JEQ'J,%EI"ZI#LA$15BSH8^"?E)4<G)&>]6KO6
MM8T2Y\,W%S>+>6NL3I9W$8B5?)ED0LC1D#.W*D$,6.,<T =;?W]OINGW-]<L
MP@MT,DA1"Y  R?E )/X5-%(LT22IG8ZAER"#@^QZ5YAI^HZUIG@;QKJ\6K//
M=V5_?>6US"K#]TV <#'.% ]!Z5TL>LWNJZ[%H=O=FSD32H[Z6=$5G=Y&*J &
M! 4;23QW&,<T ;^EZ+IFB020Z786UG%(YD=8(P@9CW..IJ]7%'6=>%[IOA^[
M(.JM8275Y-I@C/*NJ#8)B!C)R<@]@/6MWPS+K<NBI_PD$$46H([(QC*X=0?E
M; ) )&,C/7- &KY,7G^?Y:^;MV;\<[<YQGTI]<]XIUR726TBSMBJ7&J7Z6BR
ML,B($%F;'<X4@>Y'7&*HVVJ:G'XQU#PM<WCR Z>NH6EZ(T$B+OV,C #:3D @
MX'!_&@#7@\4:1<ZK#IT5RQGN!(8"87$<VPX?8^-K$=\&M2.** .8T5 S%W(&
M,D]2:X[X412I\-M$DEN'F#VP**RJ/+Y/ (&3^.:E^*,MS!\-]9EM+J2VD6'E
MH\9920"O(X!![<T =!)K=A%KD.C/,POYHFFCC\ML,BXR=V,<9'&<\UH5Y_K-
MM??\+'\-6\.H;;DZ;>@W4D2LP&Z+D*,+GL.WL:CTSQCJL^EZ98SDS:G<ZI=Z
M>]Q B*66 R$NJL0H8A%X/').#C% 'H;*KH4=0RL,$$9!%4]+TC3M$LA9Z78V
M]G;!BWE01A%R>IX[UG>&I-?/V^'7(L)'/_H<S&,22Q$?QJA*A@<C(P#QQ5KQ
M'=W5CX>O+FRGM+>XC0%);QB(DY )./09P.YP* -2LZ?6=.LM8LM(DD*7EZ':
M",1MA]HW,=V,<?7O7%2^.KO1!XNDNO/N[;2;2WN;4W,(AE<R[UVL !A=RCJH
M(!/6I=1MM0@^(W@EKW4?M3/'>[AY2JJ/Y(SLP,[?8DGCK0!VUAJ5MJ0N3;-(
M?LT[V\F^-DPZ]<;@,CGJ.#5NO.HO&FJ6^DWWVF2"2]?Q+_8MK((MJ1J650Q7
M/.!N/7DX&:O7VM:MI'B6XT.6\:XBN-+EO;.Z:)!)%)&0&1@ %93D$' /4<]:
M .WHK@K/Q/JT]IX N7G3.MH!>)Y8VL3;M)E>X^8>O2H]*U+Q5J::Y=G6+.*+
M2]0N[80_8=PE5$&S)W@K@D'OGG/L >@T5YQHWB/Q"P\$7U[?P3P:['Y<]NMN
M$V,8#('#9SG*\CI@].]6;77_ !-K=I:ZSHUO(\#WK(]O)Y"PM;K(R,=V[S!)
MA<^F>,=Z .QU;5K+0]+GU+4)3%:0+OD<(S[1ZX4$U:BD6:%)4.4=0RGV->9>
M*=5OO$OP^\:7L%Y]GM;,W-G';B-6$BQ#:Y<D9R3NQ@C QG/->C:;_P @NT_Z
MX)_Z"* +5%<GXAU/6+?QEX?TJQNX(+;48[GS2T&]E,: @@Y]^GMSGI7+W7B;
MQ3:>$?$.JG5+=Y?#^H2VY'V11]L1"I^?GY?E?'R@<C- 'JE%<1J.MZ]JE[KU
MKH"2K<:6ZPP@+"8Y93&LG[W>P8*=X7Y<8P3D] V;7=?U6[U#3K"&:UO[&S@=
MU@\B11<2(6VN9&&4& /EY///2@#N<C.,\U4L=2MM1:Z6V:0FUG:WEWQLF' !
M.,@9'(Y&17$02ZY=?$70%U&Z>SF;1)9KBSAV/$LHDB#@'!R#ZYR!T(YS5O\
MQ9XAM_!OB[4$N[;[9I6KM:PM]G^7RAY0QC/7YSR<T >F45Q]MJNM67CFZT>[
MN8[^&32C?PHD(B,;K)L*#DY!R.N36/IGBG7=2;PG);7T#RZL9/[0M3;AOLFQ
M2QP 0R[6&P[B>2._! .Y?1-+DU8:J]A;M?A0OV@H-^!TY]LG'I5^BN%E\4W,
M/C!M'U"\ETN=[Q%LHYH!]GO8/ER$DP?WA^;C(YP,=Z .JTK6[#6OMGV"9I/L
M=P;:?=&R;9  2N& [,.:T*\BDU'6-$TOQ[K6F7L4(L-;DF:%X _GXBARI)/
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MJ" .,L>3D\]:=XCT"'Q+I)TZYN;BWA,L<I:WVAB4<.OWE/&Y0:UL@=Z,\XH
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M,3R064ENX5=S%DEW,AZG(ZD=:["70])GEN)9M+LI)+D 3N]NA,N""-Q(^;!
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M$LBM$ID9?0A2Y]C6Y>6=G;^,O"4WAZ*!;6_BG2[2!1Y=Q:B(,KN.APQ7!/\
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M7Z$C(J>>"*YA>&>))8G&&210RL/0@]: /']:5QX3\:Z5K&@V-IJD&DI.TMD
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 52U/5]-T:V%SJE_:V4!;:)+B58U)],D]:NUEZS#;);2W\FDMJ<\43*D*(
MKNRGJJAR!S@9]<#KB@#0M[B"[MX[BVFCF@D4,DD;!E8'H01P14E<5\*9-/;P
M';0Z?YR"">9)X)DV-;S%RS1;>P7=@>V*[6@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *R=1D\01ZC#_9MKIMQ8E")1<7#Q2*^>"I",",=N*UJ*
M ,CP_HHT6VN]SJ]S>W4EY<L@POF/CA1Z !1[XSWK7HHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M M%%% !112*P90RD%2,@@\$4 +1110 4444 %%%% !112!U8L%8$J<$ ]#0
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M033/Y>6*':S;048+$Q##)!QCG&=KPP^I6?B&:WU'3=,$]Y%YDEW9ZA)<N0F
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M7&]-P.,E<CJ.F0<8(!ZA17+>!]1O[RWUFTU&[:\DTW59K..X=%5Y(P%9=P4
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M'A"KD8)Z,3D>IYK T[7_ !)_PC/AO7KC6WF>YUD6$]O]GB6.6)KEXLG"[@P
M&""!QT/)(!ZJ&4L5##< "1GD _\ ZC2UQ'A2.Y_X3WQD9=1NIHX;J!5CDV%<
M&!&Q]W( +' !'OD\UV] $-W9VU_;/;7EO%<0.,/%*@=6'N#P:6VM;>RMH[>U
M@C@@C&U(XE"JH] !P*EHH **** "BBB@ HHHH *KWMA9ZE;-;7UK!=0,03%/
M&'4D'(X/'6K%% "*JHH50 H&  . *6BB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@""[L[6_MGMKRVAN8'^]%,@=
M6^H/!J+3]*T[2(3#IMA:V<1.2EM"L:D^N% JY10 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#*PV,J A<8 ((R>0?>N@HH YW3/!FG:?83V<]Q?ZG%- ;8_VC<&;;">#&O0
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M[1G(E##HPP,8& !C&.*?+X5M+FUU&.ZN;J>?4+?[+<73E!*8<$;!A0JCYFZ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444A(&,D#/ H 6BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BD!!) ()'7VI: "BBB@ HHI"RJ0"P!/ !/6@!:*** "
MBBB@ HI"0" 2,GI[T$@#)( ]Z %HHHH **0$'."#C@T9&<9&>N* %HHHH **
M** "BBB@ HHHH ***0D#J0.W- "T4$@#). *.M !1129&2,C([4 +12$@$ D
M9/3WI: "BBB@ HHHH **** "BBB@ HHHH ***0$$D C(ZCTH 6BBB@ HHHH
M**** "BBB@ HHHH ***0D#&2!G@4 +1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:.WDKGN,,Q![AA0!V-%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^;@PJ$V9\V,,,%3PV!D]>!@@<4 =_6;KNN6/AS29=3U%I%MHB S1Q,Y!)P.
M..2.3Q7(Z-K'BC7K+0M>L&Q:7<RO=6\S0B$6[$@A"!OWKQU."0>!P!A^*=3O
M?%'PGUK7!?R0V[7+1Q6:QIL\J.X$8W$C=N.W=D$8R!C'4 ]<Z54TS4(M5TZ&
M^@CGCCF!*K/$T;CG'*MR.E6)5=X76.3RW((5\9VGUQ7F5IXG\17?@KP3J*ZD
MB7>J:BEM=.;="'5O,[<8QL'3% 'J%%<IX5O]2;Q!XDT;4+]KY=.GA,%Q)&B.
M5DB#[2$ !P<X.*CUO5;W1_&EC'=:F\.B:C:31K\D>(+B-=^=Q7."@<@'/*_A
M0!U]'05Y]X2\0:OK6G65A=WT\>M07TJ:ANAC5A%&-P^7;@!@\(XY^8\\5-X8
MF\1ZU>ZK-/X@V0:?JMU9B%;./]XBJ N3U!4D'CKSG.> #K].U*#4]-@OXEFB
MBF'RK<1&)QSC!5L$'-*FHQ2:K-IPCG$T42RLYB81D,2  ^,$\=*\P_M/5M=\
M)_#_ %"ZU6YCN;W552X:!8U#\2D$@J1QL&!T]03@CISJFKKXQU_2AJ&8+;28
M;FWS"F8W8R D\<_<'M[4 =G17F>BZ_XA,'@74KS5_M,>M@0W5M]GC1,F%G#@
M@;@V5YYP<]!1J?B?7FMM9-I>F#6+76%M+73!$C>; 60!L$;CN1F?<#@8] :
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MP;-N   #CMG/OFKL/BO5M.L=6LKJ[:]NK?7HM+M[IXXT;9*(V!8 !-P#L <
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M@N84FC)&"58 CCZ&N(O]5U""[\6^&[ZX:\BCT9KZUN'15<(RNC(^T '#+D'
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M";2Q>Q,T"*8'\PH0NT#*]#AB3QU- '2Z9J,6JZ?%>P1SQQR9PL\31N,$CE6
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MD-_8W%G<+N@N(VBD7.,JPP1^1J2.:*7/ER(^#@[6!Q1)+'"NZ6147.,L<#-
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MMSJ,(@N+MRGFF, @*,*% &YNB]6)ZU2E\"Z>\&C"&]O[:ZT>/R;2\AD02B/
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M ?CGYN>,=<=.*UC<VX25S/%MBSYAWC"8ZY]*K:?J]EJ>E0ZG;3J;.9-Z2,0
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M8G'8$],],CG!.,=:O4 >5!+2YT'X?ZCH&P:BUW;H[Q_ZQXBA^TK)W/0EL_Q
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MC(+=R<<X7)QSCD5RWC'2-3\6Q:1;V&BW%A=V]Y%/_:=P\2FU1?O;=KEF)Z8
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MBSVDEPTZJ"!AD48YZ#<<GZ=><2>&(]T=Q>#P['H:S[1Y)2-9GVY^9_+)&.<
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M\MY=)N!+I,N;T;HSY0\ETS][GEATSQ0!T5Q\1-"MHKZ5UOS#87/V:[D%F^V
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MD$K.5QNST(YQC-<9I7A[7=%TSPY?W'ADZE]CANK.]TYS$TB+)-YB2QY.TG@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\O.W=OYQGG% ';4$X&37'3WNKM\68-.CO8%T]=(:X\DP$DYF16R=X^;C@XP
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M,8E_UD)7S/F1L#OVJ[<>$-6B\17.KZ/XB_L\WZI]O@^QK*DCJNT21[F^1MH
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M4I&TC;B"5#'H!DX/M755C0>($G\6W7A\VDT<MO:)=><S+M=68J, $GJIZXH
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MC29[B5HY=/N/-W1C_6(5*O&?]EN,CVK>HH YCQ%X6O-2UBRUO1]7.EZI;1M
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MH2,7:90?O'JP7.T,<GD#/)I4\'^'H]>?7$TJ!=1=M[3#/+?WMN=N[_:QGWH
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M$>E 'F6AWMY'XD\&M%>WDUIJ=I=-)/<W#%KT!%=9&BR5CY.1@Y ."!TJA?\
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MZNZ21@'#$Y;!QGKS6 =3U!OAGHOC&SO[F76))[=Y4$S&.<R3"-X?+SM &X@
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M]*CDSGSMC_/,/]\+&/8HU6OB-::A=^$)/[.@DN9(+F"XEMHQEIXXY%9D [G
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M;2]9AA-E-9K.\<J^5L>%A%T.<D C^(]*]!T>UBL=%L;6"V:UAA@1$@9RYB4
M *6).2!QU- $4WB#2;>]%G-?P)/YJPE2W D895">@8@C"DY.12ZAKVE:4Y2^
MOX;<@!FWM@(I. 6/\()XR<"O+_$US+<VNNP)I][:RV^NV\QM;:R=EF198O\
M2'<*=Q8+P%(X X.,UKQ:E!IOB+Q-I?B'2KVY@UF9+BS(LGF6YC,2)Y)P"%*E
M3PV ,YXH [K4-<TS2AF^O88!L\P[C]U/[YQT7_:/%%]KFF:= DUW>Q1QNAD5
MLYR@ZMQ_",CGH,UP_P!OC\/^,M;MM>TNY.GZQ:VRVGD6KW,9"QE'MSL4]R2
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MD*KY:*5AZ(X.?9C45W WASX@:/=RI(-#72'T^.;!9;>7>K9<_P .Y5 W'N*
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MS%Y4@,K!N,HPP0<9]JT[OQ3-:^(HM LM%FN+A]/-Y$PF1$(#*NW)Y ^;KCZ
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M"EF/.-V,D]!FN@LO&4EWIEW+_8UR+^UU$:;+:1MY@60E<,7 XCPX8MC@9XH
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MP<\]*ALOB%:2V%X=0LGT[4K.\6QFLIY5XE?E"'Z;"N6W>@/!XR =C17'V_Q
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M!(%.]4P=R@,"3D="!TKDHM6F\->+/'][9Z0]Y%;M;7,ZI*L85!;[G(SU;J<
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ME4*)"J<;SP% !.?0=,\5UGAWQ3%KU]J5B85CN=/9 [12B:&17&59' &>A!&
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MJQ4_*PSC(X]JMT </'X<UV#4]!UY$L?[0LK-K"[M%G;RY(3M(*R%?O!E#<J
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M_%R]HIV%L0J6Z$A1U8XX /'&*O\ C&*\7PEH;2ZJ+^XEUFP=;@QH(^9E(*A
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M4(KKS@(5=@8T4@@MW^8^W R#TK=TO1K?2I;R>-Y);F]E$UQ-)MW2,%"CA0
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M6ULFKZV]KXELM59Y+:-8ENC.)&P!E=[(5('IMXX X /7O-CP3O7CKS2231Q
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MBI+=?ZUU &&?@<D=>*Y3QE:65[X_\&VVHQQ2VL@OE:.;[CGRTPI!X.<=#UH
M[@31LBN)$*-R&##!IVY=VW<,GG&:\IM/!D.K:3XPTC3HXTTV+4%ET5B,I#<+
M&K/LST3S<J0./O#UKI_!MV/%#_\ "3W%C]FE6!;*)'3#1LO,V.^/,^3_ +9^
M] '7LRHI9B%4#)). !7*:KXQ$>FZ)J.D+!=6>HZG#9-([D81Y-FY0.O0D9([
M5U$T4<\#Q2QK)&ZE61QD,/0BO%=,&FO\*?!<,1MQ(VM6*70B(5MWG,,,1SG
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M1KC.SGKR.&VGFJ?A_P ;V^J^%K76KNVFM?M<OEP1%,M*S.P14P?F.!SVX)X
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M %8Z=8M(9&L[<R%=I8Q+G&,8SCICBD&F6 1$%C;!$?S$7REPK?WAQP?>K5%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !IG;QP<,>U$9FTOQ9;7$UO9ZOI=WK<R6][$-MW97#%U:-_[Z##+P<A0.P%
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MYHXA@22"<@.WJV"1N/)H [NBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M -J]N.WMFNS_ .$DT_[7JEH/.,^F1)-<H(CD(P8JR_WLA3T]* +=OI=C!:/
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M '4XXJ*+6[759-0TR,W5I?V\*R21R)L=4<':ZGD'[IZ=".<4 ;(10@0* H&
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M)'(S4.G^-=(U34_L%F+V247$EJ[?8Y%2.1%W$.Q7"^V<9Q0!T5%%% !1110
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MZ3>Z=!9^'M3\&PS7.GS#9J[QQ- \:ME9<YWB3'08SGDD<XLZ?HNH6?BJVO\
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M%?H5SA58[D8$$'.1G'8Y$FC^);_Q%X=N]9T\VT=I]FS;-+"VXS*OS[EW<*K
MKCJ2#VP3;CT37I-+DAO=?CDO)V19I8[4H@A!Y1%#Y5F!(+Y)YX P,1:;X0;2
M=8U:2RO(H='U)06TY+? BDV[2Z-NP-W&1MQP* ,?P]XHU"+PEX62[F2XU'5[
M82K*+>23:JQAF9E4DN<L!QM'S=L4ZX\:>(+/3+>2?1(TN'UF+3MTWF0I/&[
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ME@FGW#O9^9#=1)]W*;\JP))R&[XKK["VDM+*.&6Y>YE&2\S@ NQ.2<#@#)X
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *,<Y[T44 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4A (P0"/>EHH   !@# HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3_''@W2)-9NI(KN"Z^V8VCSVBC4JQ^7Y22<G&!0!WM%>=^*DUK19?#BIXCU
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M.IP2#@CC@@C\*GH \_O=(N_#WQ&TS6-+MM0O;6\MGM=4)=I=B@@Q/ECR0<C
MR<5Z!4%Y>VFG6KW5[<PVUN@RTLSA%7ZD\5,"&4$$$'D$4 8/C?1[O7_!>J:9
M8,JW<\/[G<< L"&"GV.,?C6/-)JWC7PSJ.GR:%<Z+<SZ?+;237FT?O&7&V,J
M22F>2QQQC .>.WHH \^-AJ/B'3O"-E/IMS8W6DWL%U>M*F$C\E&!"-T?<2 -
MN>"<XZ5E7VD:K/\ #_QE81Z7=F[O]7FGM8O+P9(WD1E;T'"GK@C\17IUW?V>
MGQ+)>74-NC,$5II @+'H!GN?2K% '$ZA!=2_$./4EL[G[$-"FMVG,9"K(TB.
M%.>>BGV[5SGAZQF\2?#CP1IT%I.C6LUI=RSR1E4C2([MRMT8MP !D_-SC!KU
M2Y@%S;2P&1XQ(I4LF,@'TR#531-'MM T>VTNS:4VMLFR(2-N*J.@SCG\: .
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MHV*LV"HP#QCD]_2N)U>Q_P"$=L?"OANXU_3K-M/A>2.\U"U*V\I4!% .\;9
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MX;(H)(V"#/WSAOD&3TYX ZTZR\#7$7A^/PW=W\,^C1W)G(6$K+*OFF41L=Q
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M?1WI8VI^S-L! C\O?G;SNR6)W#/I@ Y[Q'X@;Q'\+?&JSQPE].::U\R('9*
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MAO5[29=MQ+I4++)"JJ=A9O,<8S\H4X/S9' - 'H-%%% !1110 4444 %%%%
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M<9/;-<KI.M77B'Q#I.E7UQ/'#)X=AU)O(E:%II78*QW(0<+Z ]6YZ"L2_O\
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M&VW<-R@@\CZ5S$7BC6'T/P%?&:#.LRP1WH\GEM\+.2ISA>5].] &V? GAO\
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MO%02-!%.K.%(!!V@YQR/S% $]AIMKID4B6L97S9#+(S,6:1S@%F8DDG  Y[
M#M46J:)I^L?9S>P%I+:3S()4D:.2)L8RKJ01D<'!Y[TO]MZ5_:*Z?_:-K]L8
MD+!YHWDCD@#U ZBJ[>*O#RR1H=<T[=+,;=!]I3YI!C*#GD\CCW% "S>&M)N-
M'N-*EM6:SN6+3IYSAIB>I=L[FSWR:T+6UBLK6.V@#B*-0JAW9R /=B31=W<%
MC:2W5U*L4$*EY'8\*!WK+TCQ3I.L>'X=:BO(8[2158EY%&PMT5O1N1QUYH ;
MKGA#0O$=S;W.J6/FW%N"(IDE>)U!ZKN0@D>QXI;CPAH-U=VUU)IR"6VM_LL>
MQV1?)_YYLJD!E_V6!%:5EJ%GJ4+36-U#<1JQ1FB<-M8=0<="/2N;U+Q++I/C
MZ*QOKZTM]&.E2W;M* FQUEC0$N3T^8\<=>] %F;P#X9GT>STI],'V6R;?;;9
MI%DB/^S(&WCC Z] /05;?PKHSQZ=']C*IIS^9:A)G3RWYRW##).3DG).3ZFK
MJZMISZ;'J*WULUE( 4N!*"C ],'H<T^QU"SU.V%S874-S 25\R%PPR.",CN/
M2@""PT33]-OKV\M(72XO7#W#M,[^8P& <,2!P ..PIU_I-IJ4EO+<K+YENQ:
M)XIGC921@\J1U'8TE]K>EZ9*L=]J-K;.V,":4+U.!UZ9/ ]Z'UO28[R:S?4[
M-;J&,RRPM.H=$'5F7.0/<\4 59_">B7-G:VLMB#%:SFXAQ(ZLLASN8L#N).Y
MLY)SDYS1<>%-&NKRXNI+0B2Z14N5CF=$G4# $B*0K\<<@\<=*M2ZWI<-I!=2
M:C:B"<9AD\T$2#&?E/\ %QSQ2-KND)%:RMJED([L9MV,ZXF&,Y7GYN.>* *>
ML^$-"U^XMKC4;$//:@K%+'*\3JIZKE""5]CQ4Y\.:4=0LKX6I2>RB,-L4E=5
MB0@ J%!VX( [=A4)\8>&A8_;3K^F"U\TP^=]J3;O'5<YZU+=WJC7M-@CUBT@
M#I(SV3A6DN1M^5E.<@+@DG!S[4 4XO WAZ"P@L8K*5+6WN!=0Q+=S!8Y0<AE
M&_@YY^M71X:TC[9J%VUIYDNH1B*[\V5W69 " I5B1@ D=.YIH\5>'C-!$-<T
MXR3RF&)1<H3(XX*KSR<\?7BK%WKFE6%P+>[U&U@F^7Y))0I&XX7.>F3P,]:
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M>VLUU-:Q7,+W$&#+$K@O'GIN'49]ZAN=8TVRN!;W-_;0S$J DD@!RQPH^I/
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M\,37WBG4+O4/#$]\L[(+>[T_5#;;8U4 +(N]"6!W'(W<$#M7<G6=+!O =2M
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M^S/LDOV+S_M/E?:I<>9NW;L[LYW?-]>:EO\ Q3I6G>(++1+BZBCO+M'D4.X
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M3E2^DD\UV$C[&D_O^7G9N_VL9[U7A\3V>MZ3HM_I^MV5D+R:%C%,5=Y0P!,
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MU>ZO;F&VMT&7EF<(J_4GB@#,?PIHS0Z?&+:2,Z<GEVDD=Q(DD28QM#AMVW
MP3C@>E/N?"^CW>F0Z;-:$VD,HG2-973]X&W;R006;=\V22<\]:FL]?T?4+^:
MPL]4L[B\@&98(IE9T'N <BG)KFE/J'V!=2M3=_-^Y$J[CM^]@9YQW].] %*^
M\(:)J.I'4;BT?[6T/D221W$D?FQ_W9 K ./][-5[KP%X9O-)L=,FTP&VL/\
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MAW-P1U%<?X[O%N;/QM916T]I<JT#F**V9WO0HC_?,V" @ P N,%>3SBO8J*
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M9Z$"(;J]1YH$CA(1\99OF VY.&/7)P:Q/BHP_P"%=:I&,M))Y01%&68^:AX
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MUPD9!F5?4[1M./85ZW10!Y3J*Z;XHT36M5\+1ZG>ZJ^EFVDDF\U,H'5S!A@
M7(WCC..F>1F_I]QH/B=Y]4TF+5+C4X]-FMW:Y65/(5A_JF# !FW=AGH3Z9]'
MHH \C%W!-\/_ (=H X>TU#3TF#QLIC,:8<G(Z*>">@]:GOUM7N?BHQ2-FGM$
M2([>9/\ 1 N%_O?/QQW]Z]5HH \JEUJUT'5O"^KS7.#)H!MG6>.4Q]8SPR(V
M'W#!!'3N#C.QX1UKPWX9\'Z+90ZLMW%-<FT2XAA;;Y[,6*L,?(!N &['&*W=
M0\/7TVN/JVFZY/8RRPI!-$T*31LJEBI ;E3\S=#@^E78-$A2'9<32W+O.MQ,
M\F!YTBA0I8* ,#8N ./E&<T ,\42)'X4U<NP -G*H]R4( 'J2>U<'!/+::;\
M-=3DW-I-A;>3?D G[/*ULJ(SC^$*=RDGINYKU*B@#QWQ9:--I/Q$U&T&_3=1
MBM4M@@RMQ.H^=HP/O<;1D=2I]*]9L8K-+97LHX5BD 8&)0 W  /'7@ ?A5FB
M@#QK5]1CG!V6UQ9FT\5Q2SV<5J[8 G&9Y&VG)?J-I P<8.,UW?Q'VR?#/Q$V
MW@Z?*0&&"/E/8UU597B31CXA\.WVD?:/LZ7D30O)LWD*1@X&1S0!Q,MC;:MX
M@\(7/AT0K/8VL_VB:%<"*-H=JH^.A+D84\\,<<&J?A"71M2L] TO4;;51XAT
M9D\RUF$JK;R(-K2EL;=A&3UYR!R37J%E ]M8P022+(\:!"ZKM#8&,XR<?G4]
M 'G7@N*P'ASQ).\, D75-0DWL@#!'=MI!/.&7&#WK'T&6;3K#X<:C=!ETJUL
M9;:Z<@XM9VC4*TG]WHRY/3=SUKUVB@#Q[6[._C?Q'K6GP2SZ#+K>GW4D,*EO
M/BB"FX=%'W@6"Y(Z[#VKH=-U2QU3XN+?6#//;S:"(Q<)"^PL)R<%L8Z9_EUK
MT"B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ K.UC6;?1K>!YE>26YG2VMX4QNED;H!G@< D
MD] #6C7-^,=!O-9M],N=.>-;_2[Z.]A24D)+M!#(2 <95CS@X.* );7Q,9]4
MOM'DL'BU:TA6X%N9%*S1,<!T?C(R"#D @BN>^'%E'K.A:1XFO[1DU8Q2,;P2
MX-P'9L[P#\P'& W3 QBMFWTB]E\57'B>XM5BG&G"QM[7S021O+LS,.!D[0 ,
M\ GO@2> ](OM \&:=I&HQQ+<VD?EL8GWJW).0< ]_2@"/Q?K]_HDVAQ6-H)O
M[0U&.U=RX!4$,V #W(4C/:H=:\?6.C+?,T(F_L[;]L1;A%D4E0Q"*3ER%8$]
M!S@$G(%GQAH^H:HFC3Z:D$D^G:G%>&*:0QAU"NI&X X/SYZ=JRX]+\6:'XDU
M*;2K?3;W3M6E6X<7$[1M:3[%1SPIWH=H('!^G6@"Y+XW$FJ3Z=INC7M],EC'
M?1LCQHDL3DX(+-QT/!YSV[UN:%K%MX@T*RU>T#B"[A65%<890>Q]QTK#AT?5
MK?QQ>ZPT<<]O)I45FK>8%=Y$9V+%<8 ._P!?PJWX&TB\T#P7IFDZ@L8N;2+R
MG,3[E.">0<#^5 $.JZBUYXUTWPRA(A-K)J%Y@XWQJP1$^A9LGU"XZ$U4\8;X
M?$O@YXIYXP^IF)XTE8(Z^3(>5!P>0.2*DU&R>Q^)VEZZW_'M=:?)I<C=HY-X
MDCS_ +V'7ZX'4BK'BC2=1U+5_#MQ90QO%IU]]JF+R[25\MTPHQR?FSSCI0!2
MU&Y.K?$^V\/7 W:=;:2U_)"?NS2-+Y:[AW"@,0.F2#V%9>EWU]=>$O$@BG=M
M0\.:A=PV4[L69UC =$<_Q J0ASU SUP:Z34=%N8O%]IXEL(UFE6S>QN8&?:7
MC+!T92>,A@>#V8^F#F#29?#'@773)MGU/4I+FY=(N0]S/PD:9Y/5%!]L\4 =
M1HNJ1:WH5AJL *Q7ENDZJ>H#*#C\,U0U#6EEOKS2+.RDOI[>W66Z1)1&$5\[
M5![NP5B!P,#DC(S/X8TDZ#X6TK268,]G:QPNPZ%E4 G\\UB?V/KFD>.M4U?3
M8+:]L=8BA$Z2SF)K>6)=H8?*=RE>O?- &9\/]9EM/A]X4M(;.:ZNKNUD<,QV
MQH$.6+O@X)W #U/T-:T7CZUGTS0=1CT^Y^R:Q<?95E9E @EW%=K\]RI (SDX
M]16%HOA3Q1IFC^%["XM]/N[6P@EBN[-KIA&7)!CD/R'=M&X;2" 3D9[2P>'A
MIOPJNO#GB2XM+9U6X>&2"4ELB1I4D4$ [@2IP,]!SSB@#I=2\66^ER7PG@(B
MM98+?SC(JHTLI 523]W&Y22>@(Z]*U-.O9[Q;@7%FUM)#+Y>"X99!M5MRD=5
M^;'0=#7/PZ+J \%06E[9VFI7UTRRZG#<X"3%SF0#@CY>B_[J]*G\&>'IO#EM
M?VP:6/3Y+CS+&SEF,IM8]J@KN.>"P8@ D 'KUH T=:UZUT4VL4S1_:+MV2%)
M)5C4X&22QX  ^IY'!KGD^)5B^G1W*:?=R/\ VJNE31Q,C^7*S  @[OF4@Y!7
M.?:KOB[1]8N;[2-:T$V[ZAIDDG^C7+%8[B*10'7< =I^52#[53UK2O$>N:9I
M3SVUG'=0:M;WSV\<Y*111,&*ARH+L>>P'..V2 78/&]JBZ[_ &K9SZ:^C(DM
MPDK*^8W!*%2A().",>O%8M[<W4_Q3\*R7&G36A>SO& ,P?<-J84@' 89.>H^
M;@GG":[X*U/7[SQ<C&*VAU>UM8[67S-Q22 LP++C@$D=,\9JVFG^*-2\4^'-
M7U#3;"V&GPW,=RJ7A?<9%0;D&SIE<@$_4CN 1V?B[2M&\-WFIVFB7L4!UB2U
MGB#*SB=I@C.?F/!<]%S]*U[7QA";W5[34["XTV33+87K^<R/N@.[YQL)Y&QL
MC^=<W)X1UY_"E_IHM[87%QKQU)?](^41?:!-@G;][ QTQ[U?UBTN-/U[7_$=
M_%:)I<FBK:_OY-PW*7;#J!]T[P.#G\Z -&#QH)-0T2TDTFZ']M0F>S=)(SA
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MVMU#>6IESL,D;!@&QS@]*Q9M(\6:CXDFUE;:RTR9]#EL(S]J,K13,^Y7X3!
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MQBU"K;22C+R9!^;*@_+TW8[<5KMJ6LV_B^Y\+_;S)]JTUKVQO7B3?"ZN$9'
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M'3/XYJ_8^(=:.C:O#<:G:BYT[6Q8->RQ!6>$^6Q*HH(:7#E5 &"<<4 >@$@
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MW"A.<<GCIW73=;\07E]I/A[4_*T_5GL9;R^EM]KX"2"-1'G*@MG<<@XQCOD
M';4UW$:,[9VJ"3@9/Y5YJWBG7;?1+^=[Y9)[/Q*FF!C @$D!>)/F 'WL,3D8
MY]N*W_[7U,^,M>TF.Y3R;?38;JW\R('RW=I >F,CY!U- '2:=?P:IIUO?VI<
MP3H'0R1LC8/JK $?C5FO-;?Q/XBOM$\"3PWUO%-K>4NG:W#<^2[[AS@8*]/U
MJ\VI^([BYU+1+2[FGU'2K:(-=000(LT[J6!=)&X3&T87G[W/04 =VS!$9CG
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MUO$?XW X%<'=>-9Y/!WB/5=)UF=[K3;='^RWMJD=Q;2C=N65-H&"-N"/0\T
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M:P!1[&:<Q"8@CYU<1G;P<8( X/-4M;U'6AXZTK1;&_AMK2]LKB5B;<.Z,A0
M@DX/W_IZYH ZZBO.=,\9:I-8:3IMQ/&=2O-8N=,>\$0 V0%\N%Z!B%  Z9.<
M<8J'Q-KFL6EIXRT&2_E\VTT<ZE9WT:(LGED,"CX&W.Y3@@ X/8C- 'H%UJ=M
M9W%E!*9-]Y(8X=D;,"P4MR0,*, \G%7*X9M1U327\$VD5\);:_D\FX$D*[V4
M0,X (P  5';/O4UEJ>N^([*YU/2+ZWM_L^I26Z6LZ#RFABDV/O;!8.0&88(
M^48ZD@'9T5P=WKGB35_[8?P[')Y^G7QM88F$/D2E-N\2EFWC.3C;C QUKIM=
MUK^PO"M]K4T&XVEJTYA#9R0N=N?KQF@#6K'U;Q1I.B-(+ZX=1$$,S)"\@A#D
MA2Y4':"0>M8%SK>L:++X7O+F\6]M=8N([2YA\I5$4DB%E>(@9V@@@ABW!'-1
M^%K:Y'Q&\9&2_FD1);0,C(F'S ",X7C&>V/?- '=T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M 23U[GFK.F^'(M,UW5-6COKR6;4FC:>.4Q[ 47:NW" CCWK8R/44M !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7#_%*WM9O#NGR74,+I'JUD2TJ@A5,RAN3T!'!]J[BHKFU
MM[VW>WNH(IX'&'CE0,K?4'@T >?RZ1H^L?%*YLY[6VN=/_X1R + ,&(CSY0/
ME'!QV].U<YHNKC_A'_ ,&L7L,>EW-C<1F:\020M.I41J^X@9V!P,]_>O7/[(
MTPS--_9UIYK)Y9?R%W%<8VYQTQVICZ)I,FGG3WTNR:R)W&V:W0QD^NW&* ,O
MP5I]EIFC3VNG:DU_9BZD:)QCRXP<$QQXXV*20.3@Y':N4GT73-3\9^/X;ZUC
MN(A86<GER'<H8QS?-CH".QZCMUKTJ""&V@2"WB2*&,;4CC4*JCT '057;2--
M:6:5M/M#).,2N85S(/1CCG\: /+M*M8(+3X8ZPBXU*\*17-T6)DF1K5R59CR
M1D# /3'%)X<_LW7[+2KV_P!:AM?$5IJ.;B**-5O#.'(:)B3N9"#TQC:!T"\>
MH#1-*"PJ-,LL0',0^SK^[/\ L\<?A3ETG34U)M273[1;]AM:Z$*B4CT+8S^M
M 'EMA_9NOPW#:KK4-CX@LM7D+JD:B\5UF;RT0D[F5DVJ !@CBK^FV.DIJWQ%
MB-O:1W!F.P!55]IM48XQS@G)/O7H;:3IK:D-2;3[0WZC:+HPKYH'3&_&?UIT
MFF6$LTTTEC;/+.@CE=HE)D4=%8XY'L: /++"RM;V'X3)<)O66Q='7<0'46><
M'!Y'J.^2#UIA06'@GQ?9V=Q#9VEGXC\N*!I/+C,1:!C #T56+,.P^8YP,UZD
MNBZ4IA*Z99@P?ZDB!?W?^[QQ^%9.O^&3=Z;Y.C0Z;:R&X2>>*:U!BNE7)V2;
M<'&<'//(Z$9H Q_#UKIR>*M;\21R65IIWV:(+$MQ&1&5#>9*VQBJ C:.O.W)
MKMK6ZM[ZUBNK2>.>WE4/'+$P97!Z$$=17+:5X.CBN7O+G2= LIC!)!Y>GVOR
M2!\9\PD+O7C[N,>_IT>E:;;Z/IL-A:J%AB!P  .222<#@<D\#@=J /,G$&J^
M#?&]WJ@":[87EV4F/$UN4&;?RSU48"XQUR>N34]OH=MKWQ!AMO$5J)IIO#-M
M-=P,Q ,_FG<< ]01^E>C2Z3IL]\E[-I]K)=IC;.\*F1<=,,1FG_V=8B^^W?8
M[?[7C'G^4OF8_P![&: .6^+!G'PNU_[/NW>0-VWKLWKO_P#'=U1?$F.$^%M.
MD7&(]3L?+(.  9T'\J[*YMH;RUFM;B-98)D,<D;#(92,$'\*S[30X$TN'3K^
M."_AML+ UQ&';:!A=V1]X#C/?KQ0!@0QQQ_&FYV<%] 1V&>I\]AG\@/RI/#/
MF#XF^.0N?L^;$^WF>2=WX[=GZ5U1TZTCN&O(;&U%Z$VK,8P&QC &X#.*BTG2
M8]*BGPWF7%U,UQ<S$8,DAP,X[  !0.P4=>M '+ZK=03_ !5LM)U@1-I[:2\U
MG'< &.6X\S#\'@L$ QZ!F]:XFQ^P6_AW3GMW@6&T\;LH=6&(XC.X'/92,?7B
MO8[_ $O3]4C2/4+&VNT1MRK<0K(%;U (.#36T?3'LYK-M.M&M9F+RP&!2DC$
MY)9<8)SSS0!Y=K4EA<3?%5(9864:9#*HC<??6&7+#'<-C/O5OQ#H.E:;X%TN
M^M+=8[BYOM,DFEWDF1O,C&XY/)P37HO]BZ5Y;Q_V99;)%5'7R%PRJ,*",<@#
MH.U.DTG39;6.UDT^T>WBYCB:%2B?08P* //[S1-,U3Q[XRAOK5+B+^RK60QR
M$E=Y$WS8Z9&!@]NU4K/4/^)+\-[O4KJ&XMGL7\^UN)D4S-Y*@2_O"%8KTY.?
MGR,UZ8='TPRR2G3K0R2KMD8P+EU]"<<BN=UWPK<W%[9R:;::)/801/&=-O[;
M$09B#YBE0<-@8Y4\9Z9- #OA]HZZ5HMRX>!OM-Y-+&L,HD$,1<F.+<"0=JD#
MC@=.U4(4M=9^(GB?2]?@BFBBM+8V,5P 5\AE;S'3/0[^"PYX7T%=!X<\/1:&
MMS(EM8VLMT5,D-A#Y4*[00,#N>>6XSQQQ6C>Z5IVHM&U]86MTT>=AGA5]F>N
M,CB@#R/2[-]63X<QZX7N3,]_"6E<[I[<1R>7N]<IM^H//6MNR@T@^*?$^@ZI
M#;I;:;8V\>FV]P?ECM?*)9DW?[>06'/RJ,\"O0IM-L+F>*>>RMI98?\ 5R21
M*S)]"1Q3;O2=-O[B&XO-/M+B: YBDFA5VC_W21D?A0!Y3H9@?PW\*9D=6D6Y
M$1(;I^XDR#^(%0:OI&GR>'_B7=/ K3V5Z\MJY8DP.((F#)S\K9[CGM7K?]BZ
M4$MT_LRSV6_^H7R%Q%_N\<?A2'1-)*S*=+LBLQS*/LZ8D/JW'/XT >;>,+K3
MK]?$:N\+7UMH"-))?."J%ED9/(3@[R>KYX(3@FGBPTWQ)XJ\)I?[;V&\\/3?
M: 921*1Y/WL'G!)_$>HKT@Z-I;2)(VFV9DCC,*,8%RL9ZJ#CA>3QTYH31],C
MEAECTZS62!0L3K H,8'0*<<#Z4 <#J5I_P (7XLF32[)?LWB2V6UMP(]RPWB
M#"Y_V&0EC_US)[UZ#IFG6^DZ9;:?:($M[>-8T'L!U/N>I-9EOINL7&O-=ZO<
M6+V5K*[Z?#;1,&&X;0TA8D%@I8< #YB?3&[0!X?_ &)93?#.[U>T0CQ%;ZM<
M+I]Q'(?-6;[6P5%YZ'/*]#DGWK>OGLK75/B9;W+6\0DL8)$C<@!F-N_(!ZG=
M^OO7HR:1IL5^U_'I]HEXQRUPL*B0]N6QFBXTC3;NZ%U<Z?:37 C,0EDA5G"'
M.5R1G!R>/>@#S&5+JX\/:'J&GIIVLI;>'X?MFE7;89HBO,D3\A7RI!SZ#OBM
M6U>TO?'_ (3NK>.1(;OP_,P24X?8?)*AAZ@$_K7;2Z'I,XC$VEV4@B39'OMT
M.Q?09' ]JEDTVPFN5N9;*V>X5=JRM$I8#T!QG% 'C=GIUE;^!-)U:*)1?V_B
M7RXKG<2Z(;YE*@]E*DY'0YYK5O3IFO:GXITWQ!K-MIM];WH,+2HHGB@"H8G@
M<G(Z'[HZD^M>D_V%H_D"#^RK'R@V\1_9TV[O7&.OO3Y](TRYO(+N?3K26YM_
M]3-) K/'_NL1D?A0!YUX@^T:;JE[J\UO;ZWI236BWB.-E[82!8RI3C!4Y5BO
M'+''4U)J/G:9XF?49[6TU?2+G6(4^T1_+>:?/N1%4Y^_'N X&#ACU%>A/I.F
MR7OVU]/M&N\@^>T*E\CH=V,\4#2=-6]-ZNGV@NBVXSB%=^?7=C.: ,CQ^<?#
MOQ)_V#+C_P!%M7)P64.D>+O"D^E0(EW?:+=>>0>;ED2)DWG^+!)P37I5S:V]
MY T%U!%/"WWHY4#*?J#4"Z1IJ2PRIIUHLD Q$XA4&,>BG''X4 >5)_I7PMT/
M7;#_ )&E;V!3/C$\ERTP2:-SU(P7RIXP!Q@"I=7>QM;+XK6LK01$()(8F('S
M&T4JRCU+9.1WKU"/2=.BOGOH]/M4O'.6N%A42-VY;&327&CZ7=7+7-QIMG-<
M/$86ED@5F:,\%"2,[3D\=* /.$TG2O$'C;0K>^C2ZM;GPNYD3S#MDQ)"!G!Y
MQS^(!ZBI9$DTCQ+%<RVEGJNCW.L+##>1?+=V$^X1B-L_?C!&.#D*?I7H:Z5I
MRW,=RMA:B>-0J2B%=R@= #C(%":3IL=X;Q-/M%NBQ8SK"H<D]3NQG/- #[/4
M;'4#.+*\@N#;RF&;R9 WEN.JMCH1Z&O/?'$VF7>L:Y:R&$W=OH99C?,#%&K%
M]ODIP3(2,%LC&$ZGBNZTW1K73+F^N((HDEO9?-E\J,(">W ZGDDDY))/L!//
MIMA<W274]E;2W$:E$EDB5G53U )&0#Z4 >86C:;>Z]\.;^^^R3M+HLWFSS;6
MWR+' 1ECU8$L?49-=9\3X(I_AGX@$L22;+*1U#*#M8#((]QZUT0TK3A';1BP
MM0EJ=UNODKB$^J#'R_A5F2-)HGCE17C<%65AD,#U!% 'G&H66DWOBWP+9PQ6
MSV+6M_NBAP(V_=Q$@A>"#W'?O6#%?)HV@?96E2VT*#Q;<V<^Y-\4$'SE%89P
M(Q(4Z\=.U>LKHVEHT#+IMFK6XVPD0*#&/1>.!]*5-(TR.WGMTTZT6"?_ %T:
MP*%D_P!X8P?QH P?!VG:;87FKMI6JQWD%Q+'*T-L%%O Y7!"!20"V S#/<'O
M6'<Z#H^M_%37;'58%N+=](MI6ADD.TG?("V,]1QSVKO[.QM-.M5MK&U@M;=/
MNQ01A$'T XKFSX5>Z\=7VLZA::=<V,]G%;1QR_O'0HSG=@ICG?CKV[T <#I&
MG_;K3X=6^JM)<QO=7\"-*YS-;".;R]WJ"NWZ@^]=7:Z3I^F_%>VTZT@6*U7P
MV\8B#$@*)T ')].*[6;3+"YEBEGL;:62'_5/)$K%/]TD<?A1)IEA+=&ZDL;9
M[@KL,K1*7*XQC.,XQVH \<T;3[.V\$>!]7AC"ZA_;R0"YW$OY;7$JL@/]TCJ
MO3OUK<MYM!UJ3Q19^)KI8-5M=6;RV\P)<QQ*5,'DG[P! & O4L>[5Z#_ &%H
M_DI#_95CY2-O1/LZ;5;U QP?>I)-)TZ:_BOY=/M7O8AMCN&A4R(/0-C(H XF
MYMX6^)'B:,KQ+X?A=UW'D[Y1G]!7,Z9HMK#X5^'6N:4&76Y;BTA>9)"7FA*G
MSD;GE0H)QVVUZM?Z5!)%=SVME:#4)H6C$SH%8Y&.7 )Q6=X.\,Q^'?#^G6D]
MI8C4+6W6"2YMT&9, #.XJ#S@<4 >>7M_IK76DZI93PPY\5['FN)0;MQO=9 3
MQLC'0*<_+MSCI7:>'F5OB;XRVD']SIYX/_3.2ND.BZ49)7.F61>:02R,8%R[
MCD,>.2.Q-2Q:?907<EW%9V\=S+_K)DB4._U;&30!Q7B[3K*_^)/A*VO4WPW-
MO?))&7(64*L9"D9Y')X[\URFHV7]E?#SQYI]LS#1K;4XTL59B5C&^(R(I/\
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M?W))(E9E^A(R* .<^)X_XMCXBQ_SY/6,V@6&G_$'PW-HL(7[=;7!U55<NMQ
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M7_!FGZGIE_J-LUW?W6B".(V3ZDA%Q&WS;X\D!F0?+@MZD#.#0!J>+O$:^%M
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M0K:R6J,/.?=@12?*<*3D$''0U5L]5EL_'_BA;[49/[-M-/MKD+*PV0 ^:7(
M' PH]^*YBPTC6(/ ?A73I=&O$N=/UU)YTP&Q$L[N7X)XPP]SV%;5];:S'XH\
M7WNGZ8TSW&DPQ67GQ_NII4$F5.>WSCK@&@#H(_$=CJXGL+6>YMKMK+[7%NB*
M,T)X$B[ACK^(R,@5SO@?QY83>'?#=GJEY=-J-];HHN9X)/+FF(R4$I&TO[9Z
M\=>*K:/8ZH_C2SU)M(U5()]#DM99KQTRLWF*W*AL(.#@* /08YJ+3-"U&_\
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MAMUFD*SW3V44_E-Y3SKG=&&QC/RM[$@@&JEU\0?#UH+TR3716PF\F[9;.4B
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M]M;:(7^H/9&T#[IX!AS'(S E?F"9VX'#=3@T =E--%;P23SR)'%&I=W<X55
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M]2N1D>V17)W'P^AOHO$1EDM[276[-;65;.(K&&&[]Z03\S$L/3@8R<YKMJ*
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MA\FV\DOVWR'<=S8[# Y)Y.,=%10 4444 %%%% !1110 4444 %%%% !1110
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MT5PC ,!T&<X'% '%^%O$U[XMN]"L=6EFMOM.A?;V6"5H&N)3(4)W*00 J[L
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-QEQW8#Y0>V3CK6K>W>D0?$/3;=M/N!K,MM+Y5Q&B;9(>-X9MV< A>HSZ=:
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MW=Z39V<TD-I93R^?(8U.V.4D#:"2QQWH ],J&ZO+6RC$EW<PP(S! TKA06/
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M5U2ZAO!<VL>%MI80/**J3\V-N23C=D]*GNO">K^(?#5]IGB76(999XU2)["
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M/^%+'2'GAGFLH%@24*55PHP"1DX_.I+;7X+GQ/>:"+:XCN+6WCN&D<+L=')
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M&1U*LI[@]:=10!Q%KX%N8_#D'A:YOHI]#MYTD0F,B9XDD$BQ,<XX( +#J!C
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M$ZNH9D)4YPRD@C\""/PI] 'GP\ ZRMM;6XUNT9+36?[4BD>T9I)"68D2G?\
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M[5TMQICV9N;N'7+B>SN-,D3[)/(9?,D SYRL3\O!P0H"\CI6O#X?TV*&[B>
MW'VQ!'<M<NTK2H 0%8L2=N">.G)]35'2_!&@Z-:3VME:S)%/&86W74K,L9_@
M1BQ*+[*10!R/PQU(:M8:3I]U+=64NF:7;M#9B0H+J-HU_?G!PR@@J!VYW9R
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M34Y#/<6/B^*Q^TD &=8IF4.<<9XP<=P:TK^[E\3:5X],]W<P?V89[.W@AF9
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MS:ZI;77G7,[D+=E4#K*D1)$8YXZ<'D5VI\+:0]Y:7;V\KS6<#6\)>YE8+&P
M92"V&!P,Y!Z"J5IX!\-V36+064H:P9C:EKN9C$&&"JY8X7_9Z>U '%VNH:M8
M>"]<\42ZWJ-Q<Z;=7UO%%)(#%M$Q16==O)7J/IC&*ZW2K'5[;Q%;WAU*(Z5<
MVQ5K9[Y[HRR?>61"RC;QG('!':M?3_#>DZ987=A;6I^R7;N\\4TKRJY?._.\
MGKDY]<U7T#P=H?AAG;2K1XBR[!YD\DNQ<YVIO8[5SC@8Z#T% &[1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY@4#KD*XXZX(KI;B:SUOQ]X?UG2+F&6SMK&Z&HSH1L$3!?+C<]CNRVT\C::
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M>HJP-<TDZ?)J U.S^Q1DJ]QYZ^6I'4%LX!KRCP_-)9>%/ .H2 _V387]R+\
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M)(E)8 9+89CL8@ ],9(R,V+;QA8ZO#8+I$4M[+?VAO$C#"/RX<XRY)^4[CM
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MT]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %<[XOLM8O;.Q72 DJQWB/>6S3&+[1  <IOP<<E2
M1W ([X/144 >6R>!M?-CJRV\&G6LZZY#K.GHDQ,;,BH/*8!1@?*1GU[ 5H7O
MAK6_$VOWUSJ-C!I]G?Z"^F28NO,DC=G+9 "X.,^O^%>A5D0^)](GU6'38[HF
MXG\SR,Q.$E\LX<(Y&UBN.0#0!SL7A_6-6T_PUIVKVT4']C74-S-<1RAUN&A4
MA/+'4;B03N Q@CG.:Q='L=0UOPUXRT.WM5"7VM7\'VMI!LC5I,,2OWMP&<
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M9KK+NZ@L;26ZNI5B@B4L[L<!1533-=T_5[B\M[263S[-E2XAEA>)XRPRN5<
MX(Y!Z&@#@QX1\1PZ>UY9Q6R:I::]<ZI;0S2YCGBFW QL1]UMKGGH#^G<:&^K
M3P/<:M9V]C(^ EI!+YNP#J6?:,DYZ 8  ]ZGO]8L-,EBBNKC$\V?*AC1I)'Q
MU*HH+$#N0.*2QUK3M2N9K:UN0]Q"JM+ RE)(P<XW*P!7.#U% '.7NEZROQ,A
M\0VVGI-91:6UB0;A4<L9 ^X#TP,>M9D_@&^U[4_%.HZF\%@=9L%L8H+=S)M
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MJW>O6VMVU]/:7T-N]KN1497B9@Q4JP/=001CIWH Y+2_&NL7,=MHUW$&U?\
MM.ZT^:>U5 '$";RZ*Y"@D,O!) ^;CM75>&9=?>&]BUZ (8K@BUF)0/-">A=4
M) 8<@XP#Z52U#P%IE[I%O9QW%Y:W5O=->Q:A#(!.)V)+.3C!W9.1C&.,# QL
MZ/I1TJU9);ZYOKF0[I;FY(WN>@X4  #L  .O<DD RM:UJ['B2VT&Q6<226<E
MW));B(R!0RHH42$+U8Y//0<<Y&'+K?C*U_X1FTOQ96EY?7TMI<9B$F]1&[))
M\KX&0H)7/7N!70^(_"4.OW=E?Q7]YINIV6X07EHP#!6QN1@P(93@<$=J9+X/
M@FETB5]2OC-IMPURLC%&:>5E*EI"5]&(P, #&,8% '%^(]:UR3P)XSL[C4LW
M.E7B6XNH8E0S0N(SM(Y .)""1Z5UM]J>JZ?XS\.:0;R.:UOH;HS,T(#EHU4J
M<@XQ\W0 =*6Y\"65W9^(+:XOKUX]<D66?E 8W4*%*87C&Q>N>E6W\+K-K&CZ
MI/JE[+<Z6DJH6$>)?, #E\)[#&W % '!EKZ;X7_$"6]U"6[*SZC#^\10?DRH
M/ ] !CH,5TS:S?S7]OH.G"XC>'2H;MY8%B9LN2JC$C ;1L).,DY'([VW\"VC
MZ9KNFC4K];/6))9)8P8\1&4YDV97N?7..V*34O \5[<Z=?6NL:CI^IV4'V47
MML4#2Q==CJ5*D9YZ<&@"GI^OZ_>:AHWA_4HXM-U>:REO+]X=LFU4<(HCSN7+
M%@QSG !'7D+\-TFCB\3I<2B65=?N0T@7;N^5.<=JOWO@JVGFTR\M-0O;/4=.
M#K'>HRN\JN<N) P(8,>>G!Z8J[X>\.1^'O[0,=]=71OKI[N7[1LXD; )&U1U
MP/Z8H A\07U[;ZEI]M!>);03K*7\I/,N7<!=HC0J1MY)8D<8'(S7%'7-8\0Z
M)X!OY+XVDM[J317"0QKM=E67#$'/=,XSCGV&.YU3PS'J.O66LQ:A>65W:Q/
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M)H2Y)=?NX*G)R"#]:OW/@N*[L]/AGU?4'FM+U+\W),9>:91@%LK@#'&% XH
MP];\0ZOX9EBLM;U8P1R6Q,&LI8@6[7!=\),/FV +Y?0C.6Y%>@1-OB1MRMN4
M'<IR#[BL;5O#IU62[WZC<1V]Y:"TN+<(C(R_-\PR#AOG(STX''%:UI:Q65G!
M:6Z[88(UCC7.<*HP!^0H \U@\0WWART\?:Y=7DEZ+'4?*BAD554L8X0G(&0H
M+ <=LGKS7176K:KH/BK0K"\NEOK/5S) S&)4:"94W@KMZH0&&#DCCDU9D\$:
M=/+KJW$US-9:T=US9LR^6'*JI=2!N!PH[X!Y J>P\,K;W-A<7NH7.H2:=&T=
MHUP$!3<-I8[0-S[>,GL3QR: '>,-?_X1?PI?ZP(EE>W0"-&. 79@BY]LL,^U
M9EYJNKZ'XIT33;B[2]MM866$.\(4V\Z)O! 7&4(!&#R,#YJZ+5])L]<TBZTO
M4(O-M+F,QR)G&0?0]B.H/M6=9^&1#<65Q>:E=7T]A$\5I).J Q[@%+G &Y\#
M&3VSQR: .-T_Q5XF?P]X?UVYOK1TNM7_ +/N+9+7:'1KAXMV[.01@8 ].<UJ
M76O>)=5359_#ML[RV%^UK% PA$,WED!Q(S,'!/S8*XQQUJ['X M8O#]CHRZK
M?_9[*^%_$Y\K>9!(90"=F,;B3TI\O@2#^W+O4;/6-3LH;]@]]96\BB*X;&"W
M*DJ2!R5()]J .J4L\0)!1F7U!*G^5</IVOZO(NM:-=W:_P!N6NHI;6[+"H!A
MD :.3;W&P.6_W&QBNY50JA5   P .U93>';!_%,?B(HWVY+4VO7Y2N[()']X
M98 ^C&@# 36M7UJ/Q))I5XENVC7#6D"21*PGECC5V,G<*2VT;=N,$\]!E:=K
M=[XE\8>$M1AO)K6UOM&FNC:!5*JP:(,,D9.<D9].F,FNGE\(PC4M3N[*_NK)
M=44"]AAV%78#;O7<#L8C@D=>.,\T^3PA8C4-'N[.>XL?[*@:UBCMRNUX3MRC
M;@3CY%Y!!]Z ,&R\0>)M;M=/UG2+1Y+6:[*RV\GDK%]F#LI8-OW^8 ,\\9R,
M5WDBL\3JCE&*D!P,[3Z\UREAX#MM,U.:6TU;4H],EG-RVE"1?L_F$[CCY=P4
MGG:#@]^.*ZQ@2I 8J2.".U 'E.@ZQ=^'?!E_>_:!<3W&OSVD"S1C8LLETR>8
MV,$CDG&>V.*Z:YU?5](\7VVARW:74.I64TUK<2PC=#+%@L&"[0R$,".A![FI
MHO 6G#PW?:%<W=W=6EY.]R6D*+)'*S[]R,JC!#<C_"K\/AS%V+V[U&XN[]+9
MK6&X=$!B1B"Q"A<;CM7)([# '- &7X!OM?US0M/US5=0MI(;RS5A:Q6VPI)G
M[V_/.1VQQ_.[X@UJYMM;TO1;-)O.OHYIFDA$9=4CV A?,(7)+CKG@'CN+WAS
M0HO#6@6FCV]Q//!:KLC>?;OV]@=H /Y56\2^%;?Q)]BF^V75A?V,ADM;RT8"
M2(D88<@@J1U!'.* ,>/4_$]OIMM'K#V]C*VI/ 9@%>>>WVED:.--X\TG *\X
M 8X]*6F^--2GTRVMIR@OKC7IM(2=XPNU$+-O91QOVKC'3<0<8XK:G\$QSKIL
MW]L:DNHV-PUPM_NC:21G38VX%2F"N!@*,8%5I/AOILNEWMB^H:B?/U ZE#/Y
MJB2UN,YWQD+UR3USUH RO'T6LP> /$<6I7-O=0">V-E*!ME*&6/(D  7(;."
M.HK<TW4]7@\?76A:A=PW<#Z<M]$R0>48CYA0IU.1T.3S3KSP2FI>';G2M0UG
M4;F2Z:,SWC&,2L$8,J@;-JJ".@'<^M7X_#J)XJ'B!KZY>Y%F+(Q$((RF[=GA
M<YW<]: -JBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBN:\:VEW>Z=8PV%S9I>?;%:*WO5)AN
MRJ.3$^.Q + ^J"@"?Q'K\^AW.BQQVD<T6HZA'9.[2E3'N#'(&.?NGN.U;U>1
MW4\&I:)X=MSIDFER1>+%@NK19<B.7;(6$;KCY?FX(QC..U.N6TS0?^$_TYC<
M6NDQW%CL@M)!'M>9$! )R%5FQN/H30!ZU17D,ABBN/B/8"2TA0:1%.EO9.5C
MCD\J;.W!&6^5<D 9P,BI;JWL/#OAKPM?(4MK759+1-6NIRTD;@6[^7Y@+ ;=
MY7/0= >.* /6:*Y7P?IMEIUSJXT_5(KNWFE24P6R!;>V<KRL8!(&<!BN>,@]
MZSXDM];^(WB/2==@CGAAL[9K"&<97RF#>:Z ]]^ 6'/"T =-K^M1Z%I\=P\?
MF237$5K#'G&Z21PBY/89.2?0&GZ3/JLWVI-5LH;=HIBL,D,V]9TP"&QC*GD@
M@^GI7EDL3ZA\,_"LNLHEW*NN6\,,]RH=Y+?[3M4DGJ&0+]1@FO5[V*"UT2YC
MCD%E!';N \2X\E0IY4#TZ_A0!=HKRFQAFM$U#0]7TBS^VG0YGM]0L"##?1+M
M&YEQE9 2ISSG)P>E)IU[:O/\*'%S$9VM661MXW$?8VX;_@7KWH ]7K!\/Z_/
MK&H:Y:3VD=NVF7@MALE+[QY:ONR0,?>Z5QOAJ71->TFWO-8O/)\26FK.9]D@
M6Y$PF8+#ZF,J57:.-OT)K+US3;2ZTGXFWTL9:YL[HS6TF\@PR+;QD.O/#9'7
MKVH ]DIKR)%&TDCJB*"S,QP !U)-4))M_AQYY;EH-UH7>=1DQ_)DL/IUKS>T
MMWM8=0T+6]'L7N6T*=X-0LL-!?0KM^9T(R) 2ASR#DX/2@#U&QO8-1T^VOK5
M]]O<Q+-$V,;E8 @_D:L5Y+H\UI%8_#73A';KI%[:9O%0+LENA;(8UDQP2?F.
M#U('H*AU>\NO#LWBBWMWDB\-0:IIPE\HG;;QR8-RB8^ZN"N0.F\XQF@#TGQ3
MK$WA_P ,:CJ\%LER]G TQB>0H&"C)Y /\JT;28W-E!.0%,L:N0.V1FO//$]G
MH%OX1\97&B7*,;G26>:"UD4VZ81@K!5X5F'YA:M>"KN&[UFYAUNVBB\0VT"&
M#."C6>/W;Q$]N2&/7=D=,  '?U4@DOVU*ZCFMX4LE5#;RK*2\A.=X9<?+CC'
M)SFGV5]9ZE:K=6-U!=6[Y"RP2!T.#@X(XZUY]+#&?$WQ(C+/M.FVKD>8W!\N
M8\'/'/I0!Z317DVAV-M87?PPOK92EU?6317,N\EID^R;PK$GD!@"!VQQ74_$
M34FTS2]*DDF2'3Y=3BBOI9$+(D1#8W@$?)OV \XP<'@T =A17EU[;Z)H^F:O
MLUC[3::A>68^R:>5AMHI6< +G+!%? ,G^SSCD9RKS5)]&MOB%'8SPQB"2RD,
M.GG:L*,%$YC /!"[LL,<C/!H ]8UF^ETS1;V_@@2>2V@>81/)L#;03C=@XZ>
ME-T+46UCP]INIO&(VO+6*X* Y"ET#8S^-<G=6WAH6>LW^A741>XT24/!9R+Y
M!0 E9&5>CG. 3R0#Z&L30[&VT[4?AC=VJ&.XOM/>*YDW$F9!:!PK9/(# 8';
MM0!ZO17'?$'4AIMKHC7+^7I4VJQ1:@Y.%$15L!SV0N$!SQC@\&LK64\,Z7I>
MH)9W4SV]_J-HKVUK<*MNLK,H"9P51&VYD'/!]Q0!Z-17DUFOFS^.]'M]4L+$
MFYL_($0_T=)'6,%=F?NLV$;&,[CP,XJ*]UJXTS1M4@N]*BT6YMM1LEU8VO[R
MU-NYQYB 8(4A<,O!P>>M 'KU%<3H$6BZ)J>JZG!K]A]BF@CEGAMML5I!C@2?
M>(5F^HSC/:NR_=75OPP>*5>&5N&4CL10!)17BNEVD&E?!Z/Q+;++_:"[H)[H
M.[LMJ;S]Z, ] H)XP1R<@DFNB2QL(5US4="\2V,#W6C2';8H([:$@?)<-M9M
MK#)&>X!Z[: /2*J6$E_(+G[?;PPE9W6#RI2^^(?=9N!ACW'./6O/?#6FPZKK
M?AS4+:&&TBM--(O$2Y1C<2D)L.(V);:0YW-@_-[G%?3;.>Z\.^(+*QO;>"X_
MX2F=;=+S<\,Q5E80R=]I"X_+Z4 >F7VH6NFPI+=S+&DDL<*9_B=V"J![DD59
MKQS5&LK_ ,/6\=]H,.G75GXIM(KRW;;)"C,8]QC;&-C*5)'N<UHZ@=,U?Q/X
M@T'4[_3;*VCM8/[.^T1#"0&/F2!MP"D/NY _A7L!0!ZE17ERZ#I^L>/=/T[4
M9I]1M9?#&7::1T-QB9 '8 C!(P?KSU%4\6.OC78-4UJVTW5;#59 DGE?Z9 B
M/F'RF+9VL@4  8.X]2: /3M;OY=*T.^U"&!)Y+6!YA$\FP/M!)&[!QT]*71+
M]M5T'3M1>,1M=VL4Y0'(4NH;&?QKSFZEL]:A^(D>N+$]_8^9';QS8S!;B &-
MDS]W<VXY'4X]!7<>#&27P+H!5@RG3K<94_\ 3-: -&PDOY%N/M]O# 5G=81%
M*7WQ _*QR!@D=1SCUJW7B]_"@^&7BU0\@\GQ+(L9$C94?:8UQG/H<<UUVEV-
MMI'Q;O;.P3R8+G18[F:,,2))1,R[SD\MC@GJ: .ZHKC/&EIJ-QJ>G3:9%I^H
MS6\$S2:/?<+<QDH"Z,00KJ0 "1C#GIFL+2KW3I_$W@>\MHGM+.YT2YC"7! 8
MA!$ K'^(@!N?3)H ]0K!\7Z_/X:T!]3@M([D)-%&ZO*4P))%3(P#G!8<<?6O
M-]/UBWL]&L$FN$&AR^*KN"\8-^[$1:3RE;L(RP3VP,=#6KXQL=&L_ GB!-&N
M2\$VH6<DD<4@,,#F>+*QXX7@!B!_>![T >HT5PVDV5MI'Q:U&RL(_(M[C1H;
MJ6,,2'E\Z1=YSU8C )[U+XSM=1GU6QGTR&PU.6WMY6ET>].T7$9*9>-B" ZD
M8R1C#GIGD ZN74+6'4+>P>51=7".\<?<JN-Q^@R/SJS7E6GG0]0\7>"=06RC
MBMI="F,7VQ%+C880@+'JR\X/N2.M4F=M1^%6JZW+F/Q7:7DQ,ZC]_#<K.1'$
M#UQM**%Z$'IS0![%6%'K\[>.IO#SVD:Q)IZWJ3B4DMF39M*X&.A[GM7(>=I>
MMZ_XJTGQ=<0VUQ%'!]G,DBH883$I,D+-T(DWDL.X7/05G>*;R[L?&GGV44]U
M:+X<A^W9_P"/G[+Y[>8R@CE\<G/;=CG% 'H&M:_/I6O:#IZVD<D.J7#P-,92
M&C*QL_"XYSM]:W:\YUZVT>ZN_ ,6F"+^RY[YS%]G8JKH;:3N.>>_KWK!N;E]
M TGQ-96.ZWTBW\2VT4ZQL0+>UD$1E"_W5))!QTW&@#V*0N(F,2JT@!VJS;03
M[G!Q^1K&\(Z\_B;PM9:Q);K;/<AR8E?<%P[+C.!GIZ5AQ6@TOXI6<&CQI#87
M>ER27UO" L09741R;1P&.6&>X!]*Y'0+]8?"GP\L;Q@NCWMW<I=ESA'<&0Q1
MMV(+\X/4J* /2-'UZ?4O$>O:5-:1PC2WA5724OYHD3?D\#'&..?K6[7C>HW,
M/A^[^(3:44MX8KK36F6W&?+A(03$*I! VE\XQCGI6EJ.F:2ND>)K_3-9M9DN
M-"F=K33%$< **2DQVL</SCMD#V- '?>(M2O-(T*ZO['3UOYX%#^0TZP@KGYC
MO;@8&3^%7[:8W%K#,8WC,B!RCC#+D9P?<5SO@S0=,LO#UG>06X,]]9VSW,CN
MS^:RH-I()(!&>V.WH*R?&]O>G53>VEK8ZQ#:V!^UZ3<ML<1LS?O86Y ?Y2#_
M +HYSB@#O:*S-)DM=3\,V,L*RBTN;.-D60[7V,@(#8Z'!YKRC0+*WM?"/PXU
MF(,-1FU..WDN3(2[1N)MR9)^Z<#CUYH ]JHKQS4KVP>[LM4L9T0_\):D3W%S
M(#<O^]V2(,8V1 <!3G*XSBK&H:3I]_/\3S/'YZVT<<UN6D9A&_V0.'7G@[N0
M>U 'K=%>865M%:>)?A_J$&X7NIV4PO9BY+7/^C!QO)/S889'IVJEX8^Q:_8:
M'JMUK=M:Z];7H^TI%"%NWFW%9()"6)*')XQ@* 1@"@#URBN0^(U_/I_A^SD5
MFCLI-2M8M0D4XV6S2 /DCH#P#[$UEW]@ECX[N+/3(Q#IEWH<LM];P?)&KJP$
M<@"XPQ!89'4*?2@#T.JVH:A:Z582WMY*L4$0RS'ZX 'N20 /4UY/H-E;V6G?
M##5( RWUT5@GG+DM)&ULY*')Y7(! Z#'%=7\6;>WF^'MX]Q#$XBGMG4R*#L_
M?H"1GIP2/H30!L'7YU\=Q^'6M(Q!)ISWJW E)8E9$3:5QQ][.<FMZO/;O2]*
MU#XI6%@;>"33QH%P/(CP(F N(QM*C@C.>.F1[5S>EZJ;3PIX0M;V[BBTB34+
MVUEENU,D0V/*L"29897C R<95?2@#V:L+1]>GU+Q)KVDS6D<(TMX561)2_FB
M1-^3P,<8&.?K57P9IUIID&HP6&J+>VS71D"0J!#;,P!,<>"<+T.W/&:YB70=
M%UWQEX\36ES!"EH^XRL@A_T?_6#!P",<'M^= 'IU%>3^%;F_U+5_#.E^*HS-
M%+X=\^&.[7*S3^8 Q8'[SB+8>>1N;U-5;>[O;+['IEU([>&_^$JFLE=V)4P!
M3Y<1)ZQ^;E>>/E Z<4 >F>)M6FT'PSJ.KP6R7+V=N\YB>0H&"@D\X/8>E7K&
MX-WI]M<LH4S1+(5';(!Q7E_B.W?37^(%A8*(]'/A_P"T/"G$<-RRR A1T7<J
MAB!['O6IX-O(+G4;B'7($AUZVM$:V; *FSV_(\.1ZYW=3N]L  'HE%>:^#?/
MTGQ%INGZG96L\L^GR_8=:L6^6]B!C9C,IY$GW#NR02QQUK7\57)_X3;PIIUX
MH.D7;7(E5Q^[DG5 8D?L?XR >I [@4 =7?7D.G:?<WUP2(+:)II"!DA5!)_0
M5E:'JNKZG+!/<:;!%IMU9I<PSQS[F1FP?+=2!S@YW#C@CTKBKBR6+3OB5IGE
M(^B6EOYMG$ZAD@F:V+R*F?N@$JV!T+<5VW@ZUMK7P=I M8(H5DLX9&$2!0S&
M-<L<=2?6@!NM>)8]/T'7;^P2*\FT>-VGA,NP;EC$A7< >=I';OVK5TZZ-]IE
MI=LH5IX4E*@]-R@X_6O*A::;:^'_ (J"*WM8;D/>*NU%5PAM4) [[<\^F:T+
M*RATGQ=X.FTZ/9/J&CW N3O)-P4CB9-Q)YP2<>@XZ4 >G5G:[KEEX=T>?5-0
M=EMX0.$&YG8G"JH[L20 />O-O"@L-=L?#NKRZY;0:W!<*+I(80MW--RLL,N6
M)*DY)&.  1@"MWXM6T[^&M.OXXWE@TO5;:^NXT&284)W<=\9!^@H V;S7->L
M-%GU2;0(F2*(RFVCO=TX &<$;-N?4!CWQN[])50:G8OIJZ@EU%)9NH9)4;<K
M@],8ZY[ =:XNUBM/$'C'Q=IVOQ(XMT@%JDW_ "RMVCR9(R?NG?NRPY! YX%
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MB]0F>5_N\@]<UZ%10!YEX/L)H;72M"U7P=,-1TIT7^T)45K7$? F1\YW%1P
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M=% 'GWA&-[E],@U#P9/8ZGIJ[9KRX13$A"[2T+[B6+<=!P"<G@9] 9@JECG
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MUFB/<W$4"NZQH97"AG8X"C/4D\ 5-0!Y-?V^NWS6DD^@ZC]JLO$B7#QVZJD
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MV-TD1W6K*BQLIY^=65<$< YK930=3_X3&+Q#+<VA9--:Q:%$8!B7#[P<G R
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M^J12FSGA9MJS1KN,;@C.,<AAUP>!5=/ <,OP[?PK?7TL[RQ@27N/G+J1L?\
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M"#N^4\>]:/\ PD-[I_BC3=%U:WMP-4CD:UGMV; DC&YHV!_V>0W?!X%9VI>
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M0=JFTJ2_E\:7NAR7&I6]G/HD=PJS71>9)/,9/,!R=A( ^4$CCZB@#T"BO/\
MPEJ-[JUG8:+>7=P=5TJZF35)!,P+^6<+DYZ2;T8=L!@.E5M'NM>\2:3I_B&T
MU&&T<7K-<>9>.8S$)&5H##MV@XP <[LC.>: .^U2_32M*NM0DAEFCMHFE=(@
M"Q51DXR0.GO1I6H1ZMH]EJ4*,D5W;QSHK_> =0P!QWYJKXF_Y%36/^O&;_T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHLIU;?;S'^UAMOO]*E_?#;MQ][CY>.,<<5J65G#I]E#9VRLL$*".-6=G(4<
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MV=Y:%_,M;J(!/W. ?G(.TD'/(X(Q0!-J^AZ?KL-O'J$+R"WF6>%DE>-HY "
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M11@*H&  /2JEUK.EV-K'<W>HVD$$B[DEEF559<9R"3R,$<U<CD2:-9(W5XW
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M% !_9=E_:_\ :OV=/MWD?9O._B\O=NV_3/-4V\,:.WAP^'_L>W2F0QFWCD9
M5))(RI!P23WJW'JVG36!OX[^U>S&0;A95,8P<?>SCKQ1;ZMIUW8O>V]_:RVD
M>[?.DJE%V]<MG QW]* *@\,Z4+^ROO*G^TV4+06\ANI3L0XR,;L'.!UST%5F
M\$>'GT.YT9[ R6%Q,9Y(I)Y'/F$[BX8L2ISSD$50LO%37GCR_P!,BU"PFTN#
M3$NUDBQ^[<R,I#MN(. H/;@_C6MINKVT.D6!U'7-.N;B=3MN(G6-+@C))0;C
MD8'8GH: (#X*T%M"DT:2UFDLI7624/=2EY64@@L^[<V,#J<<"KL>@:='K:ZR
ML4QU 6_V;S6N)&_=YSMVEL'GGIG-36>KZ9J-B]]9:A:7-HA(:>&971<=<L#@
M8I+;6=+O)_(MM2M)IO\ GG',K-TST!STY^E %ZBBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N(
M^*"V[^']/2=8V!U:S.' /RB92WX;<Y]J[>B@#R;Q'!<7>N>.K/02HN[G0[98
MDA(!D93)N5<=6V$#\16K-<6OB/6O!5WH#+YMG([W(CX-M;F(AHY!_"2VQ=I[
MCV->B44 >-7<L/\ PJ#QEILBM]LBO;W,31G(9IV*8R.2001CM6_=Z[9:)X]F
MN-<8_P!DZGI4,-C=>6TD659S)%E0<%MRGWP/:O1J* /+K^\LO#'B+1Y[J.^T
MCPY)I1M;22.,D6\GF;MK@@E-Z;.O.5P>G':^$+#3]-\-VUMI4-Q%8!G:!;C=
MN*LQ.<-R <D@'L1TZ5N44 >0D^=\./$WAO45)\2-=W)2 \2W$KR%X98QU(Y3
M##@!>V*Z&:;[/\3O#4-W<HUQ'H]Q%,^>#(3%C\3M8@=\5WM% '-^-H;:?0XH
M[C49M-8W430WL8!\B53N1F!X*Y&#GCGMUKA]1OM0G\*-=:K%:R?V;XCLY;C4
M;%#Y-S$C1$S@<XP,*V,@%3Z5ZY10!Y#K5Q/K6I^//["$T\MUH]I]G,<; 3JI
MDWA3CG*G ]<\5TMEK_ACQ#&^K:;;G[5;Z=)#+.\31_98S@^4Q( W;AT'H3TZ
M]S10!X]H_P!DMM!^%I01131S@38 #)FW=6W>F6(!SWQ76_%<1M\.-31PK,QA
M"*1DD^:AX'K@'\C7:44 <"XTP?&&TD46GE+H#A6 7:#YRE0#TSL+$>V>U<=H
MVHIHVE>&M0NI;F'1;:ZU."XEMEW?97DG)B=@ <*5# '' ;WKV^B@#R:_.G:)
M;:1K>FC4QX=.K3W5Y<JK,P:6+:)PA7(3<6' [DCJ,KK4.D+X3GU?1?M<UE/K
M=E>W-U*K;9")4WR*I ^4 #) P2#Z5ZQ10!P;W=E)\7;2Y#QB*30)0SN-N<S(
MP!S_ +()P>PS7(::+*#X<^$&588YD\21R2$ !E N7RQ[@;".3V([5[710!X[
MXCOM*BU+QIH-[J]K:Q:M)#NEO$D#0DQ("4PI5U "E?F7!R.G)]7L'LFTFW>U
MFBELC"#'*K HZ8^]D<8(YK$A\-ZM9W]V]EXDECL[JX:X>&6U21T9NH1SV] P
M;  '05OV5G#8645K "(HEVKGJ?<^YZT >4Z*EK-\/=+C75VTB[AUNZ>TNU16
M2&0O.5\Q3QL9"1SC.X5W'@>]O;[09'U"VMHKA+N9&EM,^3<X8YF3/9B2?KFN
MEHH \;\0WFDQW?C/PY?ZQ;6D6J7D;O->)(LD)\N/=M 4JZ@*-IW+@Y[ $].\
MU@WQ3\/2V<L#POH]P$DC(*L&:(IR.#D D>O-:]OX:U:QN[K['XDF2RN9WG:&
M6U221"YR0LA[>FX-@8'05OV=I#864-I;KMAA0(@SG@4 <+I&FW5AXMU'PP+=
MO[&:Z7689,?(JL26A]CYRA@/[N:QKB?2WU3Q+X:\5OJ2S7U\TUO;Q1L5O82%
M\O8RJ?F&T+U&-H]\>M44 >8"+3U\6>._/2#/]DVT8,F&)/ER!QD]3RH/X9K:
M\&>(],M?#7A#1KFZ*ZC=Z9&(HRC')CC&\%L8!&#P3GBNUJO-9Q7%U!/*68P$
MM&N?E#$$;OK@D?C0!ROQ!:YMX] OPCR:=9ZM%-?JBEML0# .0.JJQ5CZ8SVK
M UZ.&\U?Q=J]A+%+I,WALP32QD-'/=?/LP>C,$P./[RBO4:* .,T75O#_A?P
M+HFHW1AM8KBVMK=YHX22S[.CE03P=V2>G.:Z?5S$NC7IG*"+R'W;^G0U)>V<
M5_;&WG+&%_\ 6(#@2+_=/L>X[].F:L4 >0FXAB^$7@='D57CO=.WJ3RNR12^
M1VV@'/I7J]Q) ;&261XS;F,L68C;MQUSTQ4]% 'B^CBSMO _PU*B&*>/58S-
M@!64;)0Q;N.J@Y]15\NA\&^-O#VKKG6Y[J[>&!A^\NB_,#Q#^(?< Q]W;SC%
M>LT4 >>:>9M+^(^G1ZL[-<2^&H;9I2I82S+*2_('OD^QS7.0W+VGA62^MX7G
ML+'Q?-=WL4"[C]F\UR'VCJH)1Q_NY[5[-10!YIXBN[#4_#VHZ]X9LY[F-KNS
MN+^>VC8-=QQ."RH&'S%5 Z#';D@BMGPG-X?U?6KK7=%N+R]EFMTAN+N4,J':
M<JF"J@L,GH,@<'J*[*B@#B?$CPI\3O!C$H'"WH8]QNC4+GTR<@>IK'T2XN+'
MQ+IMOI][#JVCW-[.PM)DQ=Z7(1(S-D=8\EERP_C7!.17IU% '-^.M*GU7PK<
M&R&=1LF6^LCCD31'>H'UP5_X%7(1KJMQXCAU&*UFCL_&-J(IH\8-J(P"K,>S
M- 9/^!8':O4Z* /+/&MY;?;/%NEQP-9W+:$%1DA:1[Y0DN$08*JB$D' S\W4
M8JQ;W5M/XJ^'<Z.,G3;E69E*G)CC"YSSR0V/7'%>ET4 >?6^FW5AXVU+P]';
ML='U65=6\P#Y8\$">/\ X$XC./21JR]0N],A\2>)]"\5RZA%%JDRR6JQ1,R7
M<)B1-B%5)W*RGC(Y.1ZUZK10!YMIE_;Z%XXUFRUU9+>*\L+2/3#<YD\R)(R'
MB#<[G#DDKU;.>:E^'7B+3--\!^$--O)WAN[Z$Q6Z/"X#,IY&<8'WAC/7/%>B
M57N+.*ZE@>8LRPOYBQY^4L.A/KCMVSSU P <YX^OH-/T>QGN;598_P"TK?\
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MN_L)K@1Y\OE9(WP1U+=1T/KT[S3ENUL(_MPB%T<LZ0_<3)R%!(&<# S@9QG
MZ4 <K+\1[>'3KK4FT34A8V5\UE>2GR_W#!PA. ^6&XC[N>/RK2M_%\!UJ\TW
M4+&YTY[>S-\LEP4*R0 [6?Y6.W!Z@X/-<Q=>%-=G\#^)=)6SC%WJ6JR7D&9U
MVB-YED^8]B N,8/)%:FL>&[[7/%=S<2P&'3KO09M+DD\Q2Z/(P;.T'D #'7K
M[<T 6[7Q]ID^LV&GRH8?[0B>6UE,L; [%W,KA6)0[>>?0]QBF0_$+3)M0TRW
M$3F+5,K9S++&V]MNY0RALIN'3/T.#4&@V7BJ;3DT;7K'3X((8#;RWUM/O:Z&
MTJ"J;1LZ@DD]L <\)X2LO%FF6UGHFIV6G"UL%6(:G%-EKB-!A0(MORL0 "2?
M7% &=)XN74_AWK>I^(M$NI+"*XGADAMIE!*)*4P&#*>-HR??C(KH[[Q7]C\0
MG0;?1[Z[O/L7VN,1F,(Z[@N-S,,<GG=CIQG-<S<>$_$#?#[Q%X;6UMFDN[JX
M>UE%QPZRS&0%@1\N <=\FM\:;J?_  L&+7#98LUT@V9'FKO\PR!^F<8XQG/7
MVYH EM?&VGWVCZ-?6\,YEU>4P6ULX"N)%W;PQS@!=C9//3C.15O0?$D>NW6H
MVRV%U;2Z?.;><RE"OF  X7#$D8(() X/KD5P8TC5=*\-^&-#-E:RZY;ZA<7D
M48O!&^P-(Y:-]I''FHK!E(()&.XZOP>]Q!<ZC97NB/IU[(XO)Y#=I<>>SY7<
M64#:?DP!@# XZ&@"S/?Z:OQ!@M);*Y&HKIDLL=V7_=>2'0,NT-R<D<E>W!J?
M1/$BZX+2:WLI197ENUS!<AU92H*C:V#E6.[./8\Y&*IWFE:D_P 1+7688%-G
M#IDUH7,@SYCNC@[?3Y,?C69X<\*W6F^)8-4MK'^QXI;=QJ=G#.&M[B<[=KQH
M#A<8;)PIY QR30 _QI*UKXP\&7")<2O]LG3R8F/[S_1Y,#!(7.>YQCN0*T+7
MQQ8RZ5>7=W;3V<]G>_8);65DW><=NT!@VT@AE.<X SGI3O$6E7]]XE\,WMK;
MK)!IUS)-.3(%.&B:,!0>IRV?PKG+KPAKUS%KL]LL%O>OK4>K:?YKAD?8B+LD
MQR,A6Z9ZB@"?Q!XJL]>\)>,=-0207^G:=)*PCG# @QLR.CH>1D<CC!'(K<L=
M:2"PT;2H()+K4)].2?RD<+LC"J"[,>F20!W)^A(IWUKXDU[P=K5K>:79V%U>
M64EK!:Q7(D^9E(+N^T #D8 SQGKD 5(]"U[2O$.D:[96<5UC24TR^LWG",FQ
MMRR(W(/.01QQCO0!/\+Y&E\.:@SI,A_M>\ CF;<Z 2D!2<GD=.IZ5VU<7X:T
M_P 2:#I=S$VG64DUSK4UPRB[.$@EE+,V=O) / [^W2NTH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ K/;0]+?6TUE]/MVU-(_*6Z,8,BKSP#VZG\ZT** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#.U;0=*UV*./5-/
MM[M8FW1^:F2A]5/4?A4VG:78Z3;?9]/M(K:(G<5C7&3ZGU/N:MT4 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVS %9GD 0@],-TYKG?$?B2:S7P]<Z3=6<]EJ&J16DL@'F!D;<248-@?=QT-
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M,O)(P55'J2>E $E%5K74;*^@>>TO+>XA1BKR12AU4CJ"0>"*IS>)M#ATZ[U
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M,H(ZC(]*@CUG2YK26[BU*S>VA.))EG4HA]VS@4 7J*I76L:99>7]KU&T@\T
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M!O+1BA 8.#D8R3QUXS74RZ[#!=0:99VLUW>-:BY\A&4%(LX!9F(')X'4G![
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MWFMTNHRX8RLR (4!?:HVD9^[[]*D3QQ9#5=1L+FQO+7^S;7[5>SR>6T4"XR
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M6-'M_%7B)Y8;FUN;&T@EO;B>3,318D*E0&(& &SP#4T?BZW%YID%W8W=FFJ
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M@D#CGK7)^+=%;5-?T.6TNHX;R8R6-^B'/F6;)OE7U&"%P>Q?WKMP H    X
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MV_/!&[( ';G.> #URBN&OM?\1ZD=9;PY:F273;LVL43+%Y<[*%+B1F<,N=Q
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M'7)R>:IR_#^QN=+UBPNKVZD34[W^T#(NU'@G^7#1D#C&Q<9S^M=<#D CO2T
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MN'8Q^)E12LIQM-\P .#R-N,9KHK30['5?B?XG2]$\R6R:?<PQFXD 23]X0P
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M.9_LJ99_[QXZ\GF@#SX&W\1KKHU#7+73=6T_590LODG[7;HDF8A&2X^5D"C
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M HHHH **** "BBB@ HHHH **** "JU]?VNFVQN+N41Q[E0'!)9F.%4 <DDD
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M"29@%W$#EB!P,]:Y6".<?%F]NS:70M'TB&V6X,#>69%E=BN[&.C#GI74WO\
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MX7M?B1K=K+<37-I>*(A+*SJ"T,6&*GJ%+9^@QTKT&;PQIL]Q/+*L[I/.EQ+
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MR1^>@Z+(%8;Q_O9ST- &5IVH7?B3Q%K>F7-^\(TNTM0IL92BO++&7:4'JR]
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJO>WL&G64UW<OLA
MB7<Q R?H!W)Z #J30!8HK"\'^(CXJ\.1:L;-K0R2S1^2S[BNR1DY/K\N?\:W
M: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KC_$5_JL?B.V5?#6
MH:EIUL@FC-J\(5Y\G!8.ZGY!R/=L]5%=A10!Y[\';V>Y\&-#+IUQ;)%=7!26
M4H5E+3R$A<$GY3P<@<],UZ%5/2]*LM&L5LM/@$%NKNX0,3\S,68\DGDDFKE
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
%44 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>literacompareredline-pro002.jpg
<TEXT>
begin 644 literacompareredline-pro002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"!54!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MVN2+V%=\EK-$\,JK_>V. V/?&*YK7W5_BUX*9&##[/J'(.?X$JKX\79X_P#
M<MGQJ37TD9V_>:VV?O<^P% '2P>,=(NKJ[MK?[=--9R>5<+'83MY;XS@X3TY
MI;OQEHMC96-W<2W*PWTXM[?%G*6:4D@(5"Y#94C! /%<KX8_M;_A*_'?]F&R
M#?VBF/M(;[WDKC[O:G>/3<+H_@P,D;7J^(+ RH6VCS2&)R0#C).<X/6@#LM-
M\1:7JU[<6-K<,+RV :6VFA>&5%/1MK@''N.*K77B[2;0W;.]R\%FQ2YN(K:2
M2*)@,D%E!''?'3OBN9\)J^L_$;6M:U;;::U80#31IJ<A("WF++O./,#]C@8Z
M8JG?6WB+P3+J>JZ(L.O>&;F>:YN].<[9[=F8F4Q-T89W$J?IZF@#TR&9+B".
M:,Y210ZG'8C(I+B>&UMY;BXD2*&)"\DCG"JH&22>P K'TUCJT&AZMI6H20Z2
M;7?]D,2GSU=!LW,>5*^W7/-6]>L+35- U#3[^0QVES;O#*X."JL,$@_C0!4@
M\6:9-/9PD7D1O6VVK36DB+,<%N"5P. 3@X.!5G2==LM:FU"*S\W=87!MIA)$
M4PX4-P#SC##FN&M=2\1>$=2TG1?%L,6JZ5-=1V]AK, VNDIXC69/4]-P_'/-
M9UY/JFFV?Q$UC3-4DLY-/U(W"QI$C+*5@B)5]P)VD<87:?<T >NT5P'BO7-4
M@BU>>QU*1'M-(%W#;6D:,T+X=B\Q<8VG: %!R0&P#C-,N=1U[5O$>B6%IK3Z
M?#J6B27<GE01N8Y 8\,NX'^^>#GC/0X( /0J*\];4/%.N0:N=#NPEWIM\;2+
MS&C$3F/;N\U=I;YLL>", KCH25U7Q-?:=XD-OJUS=:99SSV_V&]AC26T<$(7
MBD;:2K,V\ G'!4C'.0#T&BH;QITLIVM@AN!&QB$API;'&?;-><V7B*[U/3-7
ML;G4M5T_6;;2I)+BQNHHTD20#_6Q.%PR$Y&03C(Q@T >EJRNBNC!E89!!R"*
M6O.]$GO;3PCX+MTU>?;=V2,\"(C7,H$"[4C^7 52<EF]LMS5&'Q-XAN?"7AN
M[74C%=W&O'3KAV@C;S(Q+(GS # .$&=I'>@#U*LR;7;*'Q#;:&_F_;;F%YXQ
MY1V%4QGYNF?F' KAKSQ7JOAF+QC#/?-J+::]F+.:ZC0,IN,+\^P*"JL<]!QQ
MFKMS8W-K\5O#HEU*XNM^F7@!F5 58&+)&U1UXXZ#% '::=J":E;O-'!<0A)7
MB*W$1C8E6*D@'J#C(/<5;KRT^(_$)\%0WJZL1>KXB^P-*T$9#Q?:O*P5 '\/
MI@^]:\.J:]INM^*],2ZEU>6STZ.^L4GC16\QA(/+^15RI9!COSUH [NJ]]=K
M86%Q=O'-*L$;2%(4+NP SA5')/M7#:-J^K:GK?AP66L37=E=6#7.ICRHR(I
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M#<2!EM^"HV\ G"DJ"Q8@'BI],\/6^E:IJ.H0W-R\VH2+)<"1E*EE4*" %&,
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M-TL8+M&.@ DV@XXX85N>$KZ7Q'&WB'4K/[+<6EN;#9(H&R53_I!!_NEU5?\
MMF?6NCU>TU22PBAT*\M;"9)%RTUMYJ>6,Y4*&7!Z=^U3V&G0V&F16()E15.]
MI "9&)RS-VRQ))]S0!Y3X;U/3;?PI\/(KF2WBN'@N&@N;J3%O"54AMRY 9R&
MPH)&/F.>Q9I=LEY\*?MMCY=QJ/AW5+B^@10,J([AV,>/X0T><+[CVKU_[':A
M57[-#M5MZC8,!O4>_O3UBC1658T56)+ * "3U)H \KMUG;Q3=+#9E-/\:VXD
MCQ%M,0CPKEO0O =_/\7%3^*S)I.I:O?V(L=3TZ%;:/4='E79-"% \MK=A_O
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MTCQ[/+0JQR.22>!P/4XF\$V.HZ>^OC4-.EM!=ZO/=P%Y(V#1OMV_<8X/!X-
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MCD5)/+=E8.FX@$AD&1GI46KV&NW6K>'/$JZ?F73YIQ/IJ2J7$,R!<AB0K.N
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MZ\T =]17,:5K6K3^--3T.Z6S>WLH(9A/%&RLWF;L*06(!!4]^0173T %%%%
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MW$\M]JC7MO<++&(I(WDC; );.X8((( XSF@#M8O%#2^-[S0#8SK%:VL<[7!
MVDN6YZ\+\N,^N>W)DB\8:7)+89\^.VU%_+LKN2/$-PW) 4YR,@';N W=LUBW
MNC:G=^,M7D^PSQV6L:+':?:@Z?Z,X,FX,-V<X<8VY!/?O5"'0]8U3P?X>\-7
MVFR6MQIEQ:_:+G<IBV6Y&'C(.27"@ 8R-QSC% '2VGC73+[5GTVU@U"6:*Z-
MI*PLWV1.%W9<D?*".A/_ ->NCKD/"UKJ.GZAXKGN=,GC6ZU!KJURR?OE\I%
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M7L;=DAMY49]#G%7UU_Q#'J4T#6$=Q:FS>9+K[++;+%*O_+-PY)8$<AACIC%
M'845YY;^-/$">#[3Q/J-MI\>G74%N^8(Y9'MMY^>1U!Y0#!P#D=_6M(^+Y19
M:?Y-QIU]-JM^+6PN+8DPLFS<9&&XG*@,"N>2 .,YH [&BN&U+QCJFD2^(M.N
M+>SEU#3=,.J6TJADCGA&X$,N258,I'7G(/%3:=XFUH^(-"M-2@L?LNM64D\7
MV??OA=%1B&).&!#]@,>_6@#LZ*QO$^O+X>T@70C$L\T\5K;QDX#2R.%7)[ 9
MR?8&LR;Q#JFF^)X]"O4LYI+RSDN+&XB1HE+QXWQNI9CT(((/MCO0!UE5'U.Q
M34H]-:\@%](AD2WWCS"HZG;UQ[US_@C6M>\1Z39:QJ$.G0V-Y:++'' 7\U9"
M><YXVX_&L_Q5]N_X63X7_LT6WVLV-^%:YW;%_P!3R0O)^F1]10!W=%><R>.=
M?@\/:E=SV5BE[H=^+?5%17=#"=I,T7(/"MNVGT/(KL+74I[W7IX+=X'T^"WC
M9I%4EC*^2%#9Q@+M;I_&M &M17,>)M>U72]<T'3M.MK27^TY982UP[#85B9P
M>.WR\_E[USEYX^\0:9H_B2.\L-/;6-#FMPYC+B&:*8C8R@G(/7()[=: /2J*
MY(Z[KD&MVFA78TU=0O6FGBDA$CQQ6T87[P)!9RS8X(&.?:JJ^)_$%U9>(;*Q
ML[*37]$E :%E;RKI&7>A7YLJ67L2<$8SSD ';T5RFA^(-3\3Z#<:QI/V/[/+
M$/L*SQ,&>0#Y_,PW WAE]>,\C&8]$\57FN:1H$L"VZWUZ[B]A:-OW C!$HQN
MR"K[4YSRP.* .OHHKFK_ %O4++QI9Z1)]ECL=0M)7MIVC8L)X\$HWS 8VDMV
MZ$=LT :%EX<TO3]8N]6MX&^VW9)DD>5WQG&0H8D*#@9QC.!Z"KEKJ%G>RW,5
MK<Q3/;2>5.J,"8WP#M/H<$5R7AKQ??\ B'1+"9?L:ZC+?R6UQ$L3[8E3)8C+
M9Y4*03_?7BL?Q#XFUAO!'CJ:V^R6-UIET]NLL*%BZ>7&=V<CY\/C=VP.* /0
MVU.Q74TTUKR 7SH9%M]X\PJ.K;>N.>M6ZX#6EU-?B1X;6&2S>_.FWP\UHV6,
M?-%SMW$G'INY]14NG>.;RZTO3(9H+9=9O=3GTS"[C"K0E]\@&<D;4R%SG) S
MWH [JBN#U7QIJFCCQ)97$5F^H:38#4K>18V$5S#SP5W95@RD?>/8^U:DGB&_
M'B71-,1+81:I837&XHQ:-T"?[7(._IP>.M '445R/PVO=4U+PC'>ZI=Q7$DM
MS<X*Q%",7$H.?F(QP,  8 QSUJ;Q/KNIZ3/*+9;.&!+)YXY;@&5IYE_Y9+&K
M!N ,EL$<^U '445G:!J9UKP[IFJF+RC>VL5P8\YV[U#8S[9KC[;6M>M]3\=W
M+7-I<II17R('B9  (!(!D,<?>.>.3Z=  >@T5Q5IK_BB70+/5[F#1X[:]2UD
M5_,9?LJ.N9'DW, V/EPJG/S8YQDT+CQ]JD7A'7M3BM;26YTG4Q999)(TE0F/
M#["<@XE'!/;WH ]$HKCAXEUJR\0ZKI5]96MS)#I9U*T2SWAFPS+Y1W9W,2!A
M@!UZ5)X;\2W'B:UFGL-3TRX00J<I ZO;S9.Y)(R^[ITZ=_Q -Z/7-+EU/^S8
M]0MVO<,1 )!N.TX; [X/7'3O5^O+/!VJ/I_@'PE+=);7-]>NT5E+]D=W@)61
MY&."68D*?N[<Y&>,D:>I^,?$>E>']7O9M*@9[*Z@C@GDBDACNHI75<JC'<K*
M6P03CC/>@#T"HWABDDCD>-6>,DH6&2IZ9'IQ532O[6\B;^V/L7G><WE?8]^W
MR^-N[=SNZYQQ6%)XBU346U]M#2T*Z/*;<I<(Q-S*J!V4$,-@^8*#AN<G&.H!
MTUU=V]E 9KF9(HP0-SG')Z#W/M3-/U&RU6S2\L+J*YMGSMEB<,IP<$9'<&O/
M=3UJZ\27_P /M4TV>*"UOYWF2*:%G*/]GESNPXSC)&..><]J[]HTTS3KA[2S
M0NJO,88$">;)RQP!W8]_4T 3W5U;V5M)<W<\4$$8W/+*X55'J2>!1;7,-Y:0
MW5M*LL$R+)'(AR'4C((]B#7#6GBAO$_A;5I8[RPN(1IDQGABC:.:VFVG,<B,
MQ/KS@?=-5_">N:MIUGX%TVYBLVT[5--2.+R]WFQM';AP6)."& /  QZF@#T:
MBN''C#5(-<TFTO8;-?M]_+9RVL67DML!VC+2!BA)" E< X;V-1VGB[7I&UR]
MN;?3(M+T.\N(KO:9#*\4<0<%.V[)'7@@]L<@'>45Q]CXCUV;5-/#:9]IL+R!
MWE>*UEB-HX7<H+.<2!N5R .><8-+X/\ %DGB>1'6YL6"P$W=HL;1W%G/E<1N
MK,21RXW8'*^] '2ZA?66G6;7&H7$5O;95&DE;:N6(4#/N2!^-3Q11PQ+%$BQ
MQJ,*JC  ] *Y_P <:Q<Z#X;:_M[:VN-MQ!&Z7 )&'E1,@#J06!_"J5[KOB&3
MQAJ&@:;#IB>3I\=Y%-<;V^\[KA@",_<[$8SGGI0!?C\$Z)!<RRP)>0QRNTDE
MM%?3) [$Y),0?9SW&,'TKH%540(BA548  P *\W7Q1K&O2_#^]LYX+*+5O.D
MG@:)I!O6!SR0PRN<X'K@Y.,5K3^*M4NM,U[5=(BM'MM&N)8#!,K;[DP@&3#!
ML)SD#ANF3UX .S) &3P*JV&I6.J122V%W#=11R&)GA<.H<=1D=QFFZ3J4.L:
M/9:G;;O(NX$GC##D*R@C/OS7F6GZYJOAO2/$NJVL-D]A;^);@7$<NXR2*\RH
M=A! 4C=GG.?;N >H#4+,ZDVG"YB-ZL0G,&X;Q&3@-CTR,9JS7+2:]=P^.K_2
MOL,$J0Z0+V)H\^=(?,90A/3JIX]Z9X0\4OXFVS17EA/$(,W$,4;13VLV1^[=
M&8G^]S@?=H ZRBN;\7:[J&A#1S86]M,;[48K)Q.S+@/GD8^G7GZ&L^W\3:\&
M\3V$MG8W6I:1Y+PF%S#%(DJ[ANWL<;<-GGD#M0!VE%<&/&NH >*8HA8WCZ18
M)?6\Z1O%',K*Y(P2V>8SA@<'/M1%XI\2&_\ #D36^EF/7K5GB \P&"18A(2Q
MS\RD9^4 '.!GO0!WE%<+:>-[U=/N8=0AMSJ<6M'1U:WC=HW;8)/,V9+?<)^7
M/)&,C.1M>'M5U>]O]2M=3L=D5NR&VO5@>%+A6'(V.2RLI&#S@Y!% '04R2:*
M'9YLB)O8(NY@-S'H![T^O,_B5.FJFXM+;5(K2\T2-+^V5I0IENP=R+C/.$4C
M'_35?2@#TRBLSP]K5OXB\/6&L6O^JNX5E SG:3U4^X.1^%9/B?Q6N@:K86<]
MQ;:?;W<<A6^O(F>'S05VQDAE"D@DY)_AH ZFBN&;4=>E^(.@VCW=K%#+I$ES
M/ D1=?,#1!L,'YZG:>W/7-1S^.;\>#V\96\%M)HR3,6MMK>>UN)#&9 ^[&[C
M=MV].,YH [VJL>IV,VHRZ?%>0/>0H'E@5P713T+#M^-<[+X@U?5&UG_A'(+.
M8Z7(L(CN <W4NQ790VX!!AP 3GG/&!SA:CK8TKXK3[EC34;[1+:"T@D;Y6G:
M:8A2>.!@Y/H.,G (!WTVIV-O?VUA->01WESGR(&<!Y, DD+U( !JW7 ^)QJ2
M^+? VYK274//NQN"LD0)MVSQDG ^O..U.MO'-['IEQ%?06K:K'K@T2(P[EAD
MD;:5?!)( 5LD9/W<9YH [F::*WA>:>1(HD&YW=@JJ/4D]*CLKVVU&SBO+.>.
M>VE&Z.6-MRN/4'N*YV'7KV'Q7/X:U1+>1Y;$WEK<VZ%%=0VUT92S88$@YS@@
M]L5SW@C7);/P3X(T6S$7V[4K5F5Y062*.,9=B 02>5 &1USGB@#T"SU.QU"2
MXCL[R"X>V?RYA$X;RVQG:<=#[5:KS#2-9GT#4_&,UVL4MY-K5M:QB&-MC/)%
M$JMM&6Z'<0,G@@5I:EXM\1:5I?B&Z?389H]/M?M5K=O;RV\<N =R,C$MN&.H
M."#VQ0!U%EX<TO3]8N]6MX&^VW9)DD>5WQG&0H8D*#@9QC.!Z"M6LG0IM9N(
M9)]62Q1)-CVRVI<E5*@D/NX)![CBLJ^\0ZE9>*[S2)FL88&TUKVQGDC;#,AP
MZN=W\.5/'9O;D ZIF5$+NP55&22< "J]AJ-EJEH+NPNH;JW9F5987#*2I(."
M.#@@BN8\->*K[Q%I.A7"+;1W5VTIOH3$P\@1$JZ@%LA@Y5>?[V<<8KEO#&N:
MKH'A73[F*&R?3)==FLYD;=YI$MVZ;U(( P2."#GU% 'K-%<C)XDU34(_$$^B
M1VC1Z-,]N8[A6+7,J(KNH8,-@^8*#AN03TK.G^(L<RZ8]O-:Z='J>G+=6<VH
MQL8IIB2/)WAE",,#.<YW#'3D [^BN0U+Q/J)O=1T_2H8S>:?;QNZO:2SK+*Z
MEA&"A 08 ^8D_>Z<<]'I-W/?Z1:7=U9R6=Q+$KRVTART3$<J3WP: +;,J(SN
MP55&22< "J]AJ-EJEH+NPNH;JW9F5987#*2I(.".#@@BN7T'Q?-K>MO8K/91
M3P7$T=WITL;)<P(NX(X);#@X0Y"X^;VKE_#&N:KH'A73KF*&R?3)==FLY4;=
MYI$MVZ[U(( P2."#D=Q0!ZS4%Y:0W]E/9W 9H9XVBD"L5)5A@X(Y'!ZBN.\1
M^,-4T&2\G>&S6"VN[>)+8YDEGAD9%,NY6Q&-SD ,O.SW%3R:[XDNO&>IZ'IU
MOI:Q64=M/YMPTF6CD9@PX_BPIQV&.<YX .CTC1['0M/2QT^$QP*<_,[.S'U9
MF))/ Y)["KU<-;^,=6U!-.U'2]/-WI]U=>4\"VDHDCAW%?.$I.PXP&*X[XSQ
MFK&E>+YM4\2RZ6)[*"XM[N6*XT^>-DN!"H;9*A+8<-A#PN &Z\<@'8T5G:[>
M7EAHMQ<V%O%/<H!M6:0(@!8 LQ) PH)8\C.,5R9\;Z@MGXO,265U+H=JEU#,
ML;Q1SHT;/C:23QL/(.#D4 =[49AB,XG,:F4+M#XY ],^E<<GBC6[>#3FU&*P
M635VC%BMM'+*T0\II)#(HY;&W "^O)XS6OX;U35M0;4(=5L3";:;;!<K"T27
M,9&0P1R64CD$$GVZT ;U5;W4['3FMUO;R"W:XE6&%9'"F1R<!5!ZG)[5S>JZ
M[KX\:'P]I5OIPWZ:;Q)[HN=I$@3E5QD<]!ZYSQ@\UJ/B&X\2>&M#FO[5+;4+
M/Q7;65W%&24$L<V"5)YP<@_C0!ZG4<\\-K \]Q*D4,8W/)(P55'J2>E<=J?B
MS57;5CH5FMU)IMQ]G^S-:RN;EPJLX$B_+'][ SGD<X!J:77[_6I]:L=,CMX/
M[.MD\\7<;.6EDCW^7\K#;A2,GGENG'(!U%G>6VH6<5W9SI/;S*'CEC.5=3T(
M/<5/7F_@[7)[+PIX"T6V6-9=3L&;SYE+*@BC#$  C+'([] 35NQ\<ZA)IN^]
MM;=+F75I-)@,"2.K/&7WR;1R5Q&2 #UXR.M '>U574[%]3?34O(&ODC\U[=7
M!=4R!N(Z@<BN1?QCJVG07J:CIH,IO;>STVX\EX([MIC@95R678<[O4#CK3+)
M+Y/C+(+Z6VE;^P!L>")H\CS^A!9N<Y[]Z .[HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KAOB
MC,L>B:0OVF."5M9LRCR8(7$H);&1D#J:[FB@#EKSP;;ZXVI3ZS<+<R7]B+ &
MW3RUBAR6^7);YBQ!R3_"O''*:7X;UVVL9+?4_$[:B5A:&V9K,1[<C&Z3#9D;
M''4#DGD\C1UWQ NAW&DQ/:2S#4;U+-9$90L;,"03DYZ*>@_*MF@#F],\.:AI
M'A72M'M-6C$NG;$6=K8[98U!7:R;^X/7/49K-/PYMEM)#;72VE__ &H-5@EM
MX-L4,P4+@1YY4@?,,\DD\<8ZW4+O[!IUQ=^2\WD1M)Y<9 9L#.!D@?K7/IXU
MB?3_  Q>?V?/Y>OO&D9WKB$O&7 ;N> >@H 2_P#!\NJ0ZS+=W\7]HZG8?V<9
MTMR$AA^;(5"^2278Y+>GI3D\*70U3PW>MJ41_L6WD@V"U(\X.JJ3G?\ +P@]
M>];VI7G]G:9=7OD23^1$TACC(#, ,X&2!^M1:)J:ZWH.G:JD1B2]MH[A8V.2
MH=0V"?QH K^)O#]OXGT.73;B62$EEDBGC^]%(A#*X^A%5%\.W<^HQZIJ-_;S
MZA;VKVUL\=J4CCWXWN5+DDG:O<8 ]ZZ*B@#&\*Z&_AKPS8Z,]VMT+./RDE$7
ME[E'3(R>:BUCP_/?Z]I>LV=ZEO=Z>DT86:$RQR))MW @,I!^08.?PK>HH Y.
M?^Q/!^G7']LW#32:S=.9V%N[_:)77&P*H.!M4* >PZDGFYX)T'_A'/"EE8-Y
MGG; \OFON<$@84GOM4*@]E%:TEZIAO#:+]JN+7*M C $OL#A,G@$AEZ^HI(+
MX&WLC=I]DN;I0!;NP9E?869,C@D 'D<<4 <=XYGV^,?!4<5Y!;SB]G8-*-P
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MQ3_9<B1'1D8%2W!PW!SU[&K7_"&3VS:W;Z?J@M].UEWEN(7M][QR.NV1HVW
M#<.<$$ \^U=;10!!96<&GV%O96J".WMXEBB3^ZJC 'Y"N.G\ W4_AK6M&;6(
M@-4U!K]I19G,9,BR%0/,Y&5'/IFM^W\0+/XMN_#YM)8Y+>T2Z\YF7:ZLQ48
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MN+RVU[PMH]Y-=10ZP]W=70:X?=O"[T@W9R%4-T!&=GN<]S>V-KJ5J;:\@2>
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M.W6O+KD^DV[ZD"I\\@Y)7H2.A(XP2"1@5HZJDLNDWD<$1EE>%T1 0,DC Y)
MH \LLH]2LO#W@'Q';ZQJ<]_?36=M=Q3W321SQ2K\PV$X!4#.[&>"3D\U8N=7
MFT2W\=7D,OD#^WK:*6?IY,;K KOD=,*3SVZUU7@KPO%H_AO1HKZR9-1L;=8R
M'F,BH^W#,@W%5SSR #R?4UKQ^&](C&H*+)&7423=I(S.LQ(QE@Q(/''TH XC
MQ'+JW@W2==UJSUA7CEL%:&S#/,(G\Q4-PK.QX"N"1T) /K5N[TZVL?B7X-DM
M;BXF66TO1NEN&E#X2/#?,3R<\D=>/2NFTKPAX?T2QN;+3]*MX;:Y7;/&07$B
MX(VG=G*\GCIR:AM?!/A_3GMI['3(4N;-7%H\K/)Y.X=!DG X' Z<XQF@#CK.
M#7=8T_2E\_4AJRZS(-1N(9Y$A>U$CAMK@["NT(%"\@CI]ZIW_M#Q2WB18M;&
MF7FF:@T4<OFR VL:!2K% P5E89)+ YR?08KZ?X!E>%8;GPU;V.I<F35K34W5
M/,/)E2-<'.?F"D =LXKMK[P;X=U+6H]8O-)MYM03&)F!RV.FX#AL<8R#TH Y
M1SJ'BS4?$VGKJXL;RPDCCMW262-H$,*.LH16 (+%_O=A@\5WVG2F2PMO,N8[
MB8P(SR(-H?(^\%[ G)K-U7P=X=UO4XM1U+2;>XNXAM65P<E?1L'##V.13T\.
MVB>+G\0K$D=TUK]E9D)S(N5(W=N-O&/4^U &S1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5>]
MOK73H//NYTAC+! 6/WF)P% ZDD\ #DU8KE?'5V;.TTF3["9X_P"T8M]PMNTQ
MLQAOWH0 Y(^Z#@@;LD'H0#4;Q/H::<U_)JEK':I*8&>1PNV0'&P@\AO]GK4N
MGZ]I.K75S;:?J%O<S6V/.2)P2F>A^G!Y]J\FOXYF\&^.;(VFHRRW&M13Q":T
M<-,A-N=V-HSPC$@#@#D"M_Q';W=_XRUB/2%=9[CPJ]M;3*A5#,78JH?& V#D
M<\9S0!K:SXLQXG\,V>E:E$T%[>/#/&L8/FH(W.5<\$!E )7\ZW?$OB.R\+Z,
M^HWI8J&6-$4'+.Q  ]AD]:X%=5@U%/A^MOI]_'+I]VL=U ;&4&V(MW0J?EZ9
MQ^'-=3\3()KCP'>K!#+,Z36\I2)"[;5GC9B .3@ G\* *]SXL%CX]$-WJD$>
MAOH[7:AD"XD$RIG=U/&>/TKIAK6FMIL&HI>PO:3@&&5&W"3/0+CECP>!SQ7*
M+<PW'Q9MM0\J9;;^P759I8&4*QF5L9(X8J"<'G%<CI37.D^&?"6HW-CJ3:=8
MW-_%?1VR2K-!YLC&.3:N&V@>G9Z /4?^$JT 6=O=G6+-8+B7R(G:4#?)G!4
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MTDKA8UDQG87/RAL<[<YK@QJ]OJNK> );6POX_L4LD=S$;&4&U)MF3:WR\8;
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MMD<&@"[1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 ,F5WA=(W".1@,5SCWQ67X8T)/#/AZTT
M>*Y>XAM5*1R2* VW.><<=ZUZ* "BBB@ KE[#PA/IT7V.'Q'JATS+8M6$1(#$
MDKYNS?CD\YW>]=110 V.-(8DBC4(B *JJ,  = *=110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(^;GCCGMQTXH X3^W+W0]-UJP&H3M;0^)(K!+BZN'=H()%C8@R$E@,L1N)R
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M:GX)\.ZS]C.H:8D[V:;()#(X=5_N[@<D>Q)%;D,,=O#'##&L<4:A$1!@*HX
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MP6S32%BR?N%P"%)QN)(/"X&.M'PKWI\-](@EAFAE@C:*1)HF0A@Q[$#/U'%
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MQG'>N8D\17>O>)-7T;1=9M[&XT\0>1NC65;AV!9PP/.T  ?*00<G)Z5C*O\
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M$[ML;;" P!8Y)SC@<#O5*\NXKRS^'DL23;8;V,R%X64HHMW4D@C(&X@9/&:
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M.&0:G;&.94>-P^5(?[G/0;NWKVK5KS+Q&EQIFNZE=^'[G-R)+>.YT*YAS%?
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M9BO4GCE2.><]L<T =/D"BN)G\4:3K-CX/U.329IX]2O$-H[L!]FF*/RW.20
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M9$?#'9G/R8X!ZUOII&JKX^N=>\FU^S2:5'9JGGG?O61WR?EQCY\=>W2NHHH
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MGU2YB>_L)KB=(EC"&00J=V"IY.]A[#ICFM2R\37C^+ET?5;VZTR]:[F$5O-
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MOM/E 8[<?C[UVC>%K+^WK75X)KFVFM[068CA<"-X@VY58$$\'G@CT.1Q6?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>NP^)-"M]4@AD@64NK12XW1NC%&4XXX936%XDWQ_$/P6R3SJLL]VLD8E;RV
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M 'IE%4K&]N+JZOHIM/FM4MY?+BDD92)UV@[EP>!DXY]*;K6H-I>D3W4:"2<
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M)]Y0/[O7CW-4=/\ !=E806%H;R\N+#3I1-9VD[*5A89V\A0S!<G:&)QQUP,
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M4 +M.2,#N<YR:DMO"(ATR2VEUS5[FY=HF%]-*C3((W#J%^7:!D<_*<YYSQ@
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M,A)^1,?*H)R1V[UTZ>&[*YFN+O4))=0ENK0VC&Y55 @/+(%4#&XG)[\#T H
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M.D>R/Y%+PY7E3U[]_0BMK_A!]/":A:QW5W'IFH3&>YT]2OE.S$%\$KN56QR
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MZ;<RI;"R7 DC9B'W9]%(QC'(ZXYVK77[W5==TO0DNFMI)-%74[FXC1"[%F5
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MX]LB@#8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/H&LW'BNP\47*0:G;ZH?*)D"7"0KL,!@/49QP%ZDG^]R >H%@" 2 3TSWH)
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M<0!MZ@'KG/UK#T.\TP>(/ EU97%M%;7:78.^8-<R(T98&X<8RQ8 [<<,.IH
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M#(Q "LPX') ST!/)%03>-]&AU:?2\WLEW;S1PS1Q64K[&D^Z3A?NG^]TY'-
M&NFDZ='9R6::?:K:R??@$*A&^JXP:%TG34LC9+I]JMH3DP"%1&3_ +N,5QY\
M:V&L^!+_ %6_?5-(M5GDA,]M$XE0+,R*0P# $[0#V&<9JUXHUR2+Q7H6@[;Y
M;:\6X>X:V617<(@VA77GJV3M/89X/(!TPTC3%DBD73K0/"-L;"%<H/0''%+:
M:5IVGNSV5A:VS,,,8850D>^!7-^'+S3])&N13^(M2OWTUD%Y)J>5$ V9&WY5
MZK@DC.>O>M)?%VD"YN[>YEEM)K6T^W2)=1-&?L_(\P9'3(((ZCN* -BYM;>]
MMVM[J"*>%OO1RH&4]^0>*@.DZ:TSS'3[0RNNQW,*[F7I@G'(K.M_%FG7,LT"
M)="YCM!>K T#!Y83P&4=\D8QU'?%5M \8VVL>&;'5Y8)X6O3B&#RF+2$Y(5/
M[WR@DD<<$\ 4 ;$FBZ5+8?8)-,LWL\[OL[0*8\^NW&*=)I.FS)"DNGVCK  (
M5:%2(Q_L\<?A6=;>+M)N[9I(9)3*ET;)K8Q%9A/C.S:>^ 3GI@9SBM+3]0AU
M*W::!95"R-$RRQE&#*<$8/OW[]J "^TO3]3$8O["UNQ$VZ,3PK)L/J,C@TZ7
M3K*XN([B:SMY)XO]7(\2ED^A(R*X_4?%LFI6GC&QM([VRFTFW<1W C*G>(O,
MW9(('5<=R.:N>%/%ME>66AZ9/-<MJ%SIT<RRS0N$N&5%,FV0C#D9R<'O0!O?
MV'I'DO#_ &78^4[;V3[.FUF]2,<FKGDQ>1Y/EIY6W9LVC;MQC&/2L9_%NDQW
MEK!))*J7<YMK>X,3>3+*,_('QC)P<=CC@FJ]KXYT.]OGM();HM'-+!+(UI(D
M<3QKN8.Q4!.,]<9Q0!M6FF6%AO\ L=C;6V_AO)B5-WUP.>IJ/^QM+\B*#^S;
M/R87\R*/R%VHW]Y1C /N*I0>*],FU&*P_P!)CN)X&N+998&3[0B_>*9')&1Q
MUYZ5RNCZU_;(U#7+_4]2TY-,U2=3@,L#P1ML$3(1M+'KP-^3QZ4 =TVEZ<]M
M+;-86K02N9)(C"I5W)R6(Q@G/.:+K2M.O9H)KNPM;B6 YA>6%7:,_P"R2./P
MJE!XFT^6^FL7%Q!>10?:/L\L#!WBSC<H .X9X(&2#U J'0?&&D>)9$72VN94
M>#STF:VD2-EW;3AR "<]NOY' !J7>F:??R0R7EC;7+P-NB::)7,9]5)'!^E(
MFEZ?&END=C:HELV^!5A4")L$97CY3@GD>M9LM]8_\)M;61O[U+X64D@M &%N
M\>Y<N21@L#@#!XR>*DM?$^FW9C9&F6"6V>[BN'B*Q20KMRX;ICY@><$@YZ4
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M]C46I>(K'2Y+A)A/(UK +BX$$1D,49W88@>NQN!D\&@"X^F:?*UPTEC;.UP
M)RT2DRXZ;N.<>]1OHVER)"CZ;9LD/^J4P*1'_N\<?A4'_"0V']HW^G@S&ZL8
M5GFC$+9V-G!7CYL[3T]*CA\4:7<Z?I]Y:R27"ZBADM(XXR9)5 R3M/0 $9)P
M!D>HH T$TZRCNS=I9VZW)&TS")0^/3=C--M=+T^QGFGM+&VMYISF:2*%4:0^
MK$#G\:XK7O%<%T_A/5=+U.X6PN-5-M<1HI7?B.3*,F-Q8,@&WN>QKK-%U^QU
M^.Y:S,RO:S&">*>%HI(W !P58 \@@CZT 3PZ/I=N8S!IMG$8Y#*FR!5VN1@L
M,#@GUJ5;"S0W!2T@4W)S/B,#S>,?-_>X]:Q)O%:1>-O^$>^QW1VV1NGF6%F!
MRX50,=OO9/K@>M54^)'AV2SDO(WO7M(XI99)Q8R[$6-MKY.W@@\XZXP<<T ;
M\.C:7;V#V,.FV<=FYRUND"B-CZE0,'H*GM;*UL8C%:6T-O&3N*0QA!GUP*I_
M\)!IXU:TTUI'6YN[=KF#,;!71<;CNQCC<.#ZU7A\4V%Q&LD,5Y(DEJUW RV[
M$3Q+MY0]\[EP#@\YZ<T :5[IUCJ4:I?6=O=(C;E6>)7"GU&1UI+C3;"[@C@N
M+*VFAC^Y')$K*OT!&!6'H'C&VUCPS8:O+!/"U[@0P")BTC$%@J?WOE!)(XX)
MX JW:^*])O+.:XCFD#0W/V22!HF$JS?\\]F,Y[\<8YSCF@#9CC2*-8XT5$48
M"J, 55M=*TZRF::TT^UMY6!!>*%48@^X%0:3KUCK,EY#;-(MS92"*YMYD*21
M,1D9![$<@C(-)?Z_96%Q);LL\\\40GEBMHFD:.,Y 9@/7!P.IP< X- %I=-L
M5AGA6RMA%<,6F01+MD)ZEACDGWIUI86>GP>196D%M#G/EPQA%S]!6-<^-]!M
MH],D^U23)J:,]FUO;R2"8*I8@%0?FP/N]<\8K0_MFW;P_P#VRD5R]N8//$?D
ML)2,9QL."#]: 'V^C:7:PSPV^FV<,4YS,D<"JLA]6 '/XT?V+I6R)/[,LML)
M)B'D+A">Z\<?A7/:?\0=-D\/:+J6HQW-J^J!%BC%K(P9V3=M4@<\9QZXXS6E
MIGB[3-6NA:VZW:W)M3=B&:U>-S&&V9PP'.X8QUH U[FUM[V!H+JWBGA;K'*@
M93^!ID>GV4-HUI%9VZ6SYW0K$H1L]<KC'-9MKXKTN_T^QO+)YKA;XR"WC2(A
MWV$ASM., 8/7';U%4+SQO;0ZKH-I;V=Y*FJF4[_L[Y18T8D;<9W;@.,<#.<<
M4 =%9V%GIT/DV-I!:Q9SL@C"+GZ 4ZYM+:\C5+JWBG16#JLJ!@&'0C/<>M9-
M_P"+=)TUS]JDE6W6=;:2Z$3&&*0D *S]!R0,] 3@D&EU3Q7I6CB=[MYA!;.J
M7,Z0LT=N6QC>P''W@3Z @G&: -*'3K*VN9+F"SMXIY/ORI$JL_U(&3446C:7
M#M\K3;./;(95VP*,.1@L..I'?K5>X\1V%O<R0_OI1%+'#+)#$76-Y-NP,1ZA
MU/H 03BI];N;>ST.^N+N>>WMT@<R36ZLTD2X.67:"<CKG!QB@ _L/2/):'^R
MK'RF;>R?9TVEO4C'6G?V/IGVI;K^SK3[0N,3>0N\8&!SC/ Z5C1^+-&TVUT6
MTDNKV>2^LQ+:,]O)))<(J DDA>7(() YR>E:NB:Y8^(-/-Y8/(461X9$EC,;
MQR*<,K*>00>U $ZZ98)>&\6RMA=-UF$2[S_P+&:;%I.G0WLU[%I]K'=3#$LZ
M0J'D'HS8R?QK/E\6Z7%-J\+&Y\S2$62\46[DHC D,./F& 3\N>E31ZY97UOI
M_D/< :I$9+9TB.=NW.XY'R\$'GU% %F/2-,BMY;>/3K1()N9(U@4*_U&,&I!
MI]DMD;(6=N+0@J8!$/+(/4;<8Q7#> _&=N?#&A6VK7=Y-?7LLL(NI879'E\Q
M]J&3&W<0.!GM706>KZ4FM>(I#JEWFR$37D5UE(;4!"04W <$#<2"0>* -B#3
M+"VL38V]C;169!4V\<2K'@]1M QS3+/1],TYE:RTZTMBJ[%,$"IA<YP,#IDD
MXK'O/$MG>Q7^F6\]U9ZB+![N(/$8W,?(#KN'KQ@\C/05F^"?&%I=Z'X:L+VX
MNI-2OK!&6>:%]D\BQAG D(PS#DGGL>XH [>BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N<\9:
M=;ZKIEK:W=C>7$)NE8S63%9K0A6*S(5YR#@<9^\>#71U!>7MKI]JUS>W,-M;
MJ0&EF<(H)( R3QR2!^- 'G$FG>(FTOP_%?)=Z@UEXB6X6X:("4V:*X5Y0,?-
M\W3&XC'&<U)J-MK]OJ/C>\TS2II7NY+)K8O$I\U$55E*!N-RC) ;J0#S7I5%
M 'G&G6&HP:_XJNAHVII;:CID"P/<2"1V=5E!5OG)W$N..PZXZ5'%IFI)X;^'
M=LVFW7G:7<0->KY?^I"0/&Q/K\S#IFO0[F_L[)X4NKN"!YW$<*R2!3(YZ*H/
M4^PJQ0!S?C_2[S6O FKZ=I\/G7<\.(X]P7<0P.,GCM65J^CW'B_6M/NXK>XL
M(+*QNXC+<Q[',D\8C"A>N%Y8GIG;C/..VEFB@A>6:1(XT&6=V "CU)/2JHUG
M3#%:2#4;0I>$"U;SEQ.3TV<_-^% '$>#[6<KIEAJ7@A+/4M-4)+J,D41A^5=
MN^)@=Q9OH,9.3Q@[WC/3+;5K2RM[JSOI(Q<;Q=6#,LUFX5MLJ[>?]G@'[W2N
MFHH \SDL/$D.F>&K[4(+G4Y-+UB61C'&HN)+8K(B2,F0-V&4D=>>><U1UC2=
M<O="\?0KH=XLNJW4,EHF4/F 1Q CAN"-IR>G8$UZU10!Q_BB&ZO=:\)75M8W
M,L5K?FXN"(^8D,3IDCZL.!DUF:O976F>.-0O;GPO)K^EZI#"J-!'&[V\B J5
M97(&Q@0<YP.:]#HH X:VTZYL_'FD7*Z3]EL;?1I;9Q:Q?N89&D1Q&N.N IY
MQ],XKG;#1]=TRQ\/:HNDW4K:3JU]-<V( $CPSM(%D0$X8J'!QG/)KUNB@#RK
M4M$UW6Y_&<UKI$\)NWT^ZLA>;%6<P;6,;#<2,[<<\<\XZ5HO"=6\.ZU/:^"9
M-)O)=+FM 98(UGED=>(T*$DIGDEL#.#V-=Y-?V=O=06LUW!'<7!(AB>0!Y"
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M9[9I?#WS)PVV9?)$N#SP<''>FW?BG7YM;L=*TK3M/:6\TEK^.2YG<*K!D!#
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M# 93A%\Z252"H4DC !R7SCBL^'4+O5? /P^O+^=I[I]<MA)*YR6VM*H)/<X
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M0B2$YRORMC/(7&>>:MW/8Z]!X+GAN-5P->E@DCNIY8YX6V3,8WPV=R\*#DG
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M<@9..@-;/A;6AXNN+'4K=[B&"SL]ES!YKX^U,<-&XSR8PAZ_\] : .RHHHH
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M<5YGJ47B2^\.>)='M+R+7_\ B71-;:G"FR65!(2UM)CAGV;^G/S<CYJ]@HH
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M(8@CT-;/B2XFM=;U+4] OTN)I'MQ=:)=)N2_&U-KP,.0VT@9&1E><8KT^B@
MKADN_P"QOB;K4VLL(K+4+&W%C<2_ZL"/?YD6[H&)?=CO7<T4 >0&RGT?X?\
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M;=($^Z,<@;/;K0 ZV\=V,VC17DT+6MR][)IYM9Y479/&6WJ7SMV@(3GTZ9)
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M@G\N6W&!N#@#++G<0.0<XXZU-)X?U?\ MCQC=""!H]7M(H+4^=@[DC="7&.
M2^>,]* -*;Q8KPVLNGV$UTMQIYU$2.?*C$6%(!8@C>=PPOL<D5@:WJ5MKMQ\
M/M;M!(L5YJ"N@<X(1H)&P1G&<@?E1;^&?$<2:%:S06%S96FCI8R037#;(;A0
M!YX&T[\J !G!'J,FF6'A37[?0O!-E-!9F70[A9+C9<$AD6-H_ERO).[..!QC
M- &EX7C6+XA^-T7.WS;,X))P3#D]?<FH_B,1 WA:Z6*662/78 $B/S."KG:
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M+UYP-;P])XLF*#Q#;:=;"%-K-:3&0W+]-V"HV+WQR2<= .0#HJ*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ***Y[Q7KDVD#2+2V*I<:IJ$=DLK#(B!!9FQT)PI SQDCKC% &Q?
MZ=9:K9O::A:075L_WHIXPZG\#4&EZ%I.B(Z:7IUM9A\;_)C"EL=,D=:XW6O$
MFMZ%?^(M)%VEP]OHDFKV5U-"I9=A*M&X7:IY (.!P><TV+7/$NEZEX6O-0U"
M"]T[7 L$MNEL$-O(8BZLK#EONG.?P Z  ]$HK@-)USQ/KEIH>N:=$YL[V56N
MH)O($*6[9Y0@^9O7CKP>>!P*R[KQ-XH@\.Z[K1U2 _V/K+VH@6T4+/$LJ)M8
MDDCACC'.>YZ  ]3I 00"""#T(K.\0F9?#FI/;7$EM,EM(R31@;D(4G(R".WI
M7%>'M7O;;1/ >A)?2F;5].6=[ET0M%'' C%$^7!)+#E@QQGKQ0!Z/51M2MUU
M:/3#YOVEX6G7]TVS:" ?FQMSDCC.:PO#6LW\_B+7] U"07$FEO"\5UL"F6*5
M2RA@.-P*D$@ 'C@43ZKJ:_$F+1DN(A8S:1+<JAAR5E66-02<Y(PQX&* .HHK
MR[3?$_B9_#WAK7+K4X95O=7%A<6RVJJKHT[Q[MW4,,#&,#CG/6M8^*+J/Q@V
MCZC>3Z7</>A;.*:W7[->P<<))MSYA]"PYXQ0!W=%>67&O>,7\.^)=:M]6LP=
M"U"Y06QLQMN(H<$JQSE?ESC'.>_/&M)XCUKQ#)JD.@I<03V<$#0A%@96EDB$
MH$OF'.WYE7Y0#PQST  .]I"0" 2,GI7&VNKZWKNI7ND+<)I5_8:=;RS>4$D!
MN90YQE@08UV=N3GJ,<TI!K,GQ$\,PW^J%)CI5Q)<16@4P^:K1!MNY<X.2.>1
MVQSD [6RU*WU"2[C@\W=:S&"7?$R?, #QD#<,$<CBK=><GQIJMCI>OO<RPS7
M4.OII5F_E;4C#B( L <G&]CUYQC-:EUJNKZ1XPMM#>]^U0:E8S36T\T*[X)8
ML;@0@4,I##'?(ZF@#LJS]9UNPT"Q^VZC*\4&]8]ZQ,_S,0J@[0<9) R>.:X+
M1?$WB.33?!.L7FHQ31:U,MM<6JVRJ!NC=@X;KD%/I@].];?Q4W?\*\OMN-WV
MBTQGIG[3%0!V5%<-]L\2V'C%= N]7BN8M4L9I[2Y2T5&M98RN1MY#)\XZ\]L
M]Z3P_P"(=3UG3-*LI+IH]:2[EAU0"-/D\G_6<8Q@EH@#UQ(#S0!W5%8WB:\N
M;'2DEM;NWM6:XBC>68$D(S@,(U .Z0C(48.21Q7$:EXOUZT\*^-9H+DK=:+.
M@MIKFW7S#&T:/AE&%S\QP<=,9&: /4**XV.]UR'QW)H5QJB20WFEO=Q.ELJF
MVD614PO7<N'S\V3QUJKH7B#5M3TNTTRXO"GB"+47M;\K&F$6,[G8+C&UD*;3
MZR+UYH [RD) &20![UC>*K[4=.T&6ZTRUFN9DDCWI;H'E\K>/,**>&8+D@'O
MZ]*X;6]<?6_!T5WIOB.>>$ZY:0Y6)(Y44R1 Q2J4&&#;CT&1C.10!ZG17(P:
MCJ&K^)=9T&UU.6U_LBWMPUP(HV>:656;<P*XV@ < #))Y%9?A_QK?^)3HFG.
M5L+VYBNGO)8E!Y@D$9$>X$?,QW<@X (]P =EJ.MV&E75C;7DKI+?3"WMP(F8
M,Y!.,@8' )Y(Z4FN:Q8:#H]QJ.IR/%9Q+^\=(V<@'V4$_C7">,;K4M'TOPS<
MZ](EY/9Z^'+V49+21+%,5^7 ^<KC('&>E/\ %US<:E\'==U6744NH;VT,T"1
M!?+BC)!50P +$#@D_E0!WFF:5I^DP/'IUK';Q2N9&6,8!8\EL>I[FKM<++X@
MU30/%-Q;:C>+>V/]BS:D(T@"&)HF4%5(Y((;^+)R*AE\2:S8:!X:\22W2W$&
MJ36R7=F(U"1K/C:8B!NRI91\Q.1GI0!V&GZW8:G>W]G:2NT]A(L=PK1,FQF&
MX#Y@,\8.1QS1+K=A!KEMHTDKB^N8WEB3RFPRKC<=V-O&1QG/-<%/KY\,ZE\1
MM62-9)8KFR6)7^Z7>&-%S[98$^U6M32ZTOXE^';B]U"6]1-,OG.Z)%*E1$6Q
MM X/& <D8ZF@#T.J6HZ1I^K+"M_:QW"PR"6,/R$<=&'N.Q[5R.D:MXJU6/0=
M7M8V:QOT62\BG\@111NN5:(JV\E20,-UY^Z:F\%WGB+6GFO[_5X6M;:^N[1K
M9+0+YH20JC;LY7&.G.: .T P !T%+7,W^L7%SXWA\,VUPUH!IS7\T\:JSD>8
M(U5=P('.XDD'H*Y:?QAXB&G&W2XMDO[+Q'#I$\Q@RMQ&[+M;&?E)5AD#\,4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,UQ:/(/+20A<NF &#?(IY)P1QBK=KX;6&Z@N[G4;R]N[:!H+:>X\O=$K8W,
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDB:#PCP[I5).UV]E>Z2TWZJZ];=AGA2.YN-5\1KJ<CRS":/*,Y*Q;HPQ1?0
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MR:]/!>SE.FW=>6[:[WZ-/\-^O5T445N>2%%%% !1110 4444 %%%% !1110
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MMY]==+]NW?KH=U17)>)?%JVF@75QIIN8[J-05,VG3A>OJR@#ZFJ;^)[P:_\
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M0;,=LXS[YJ?;1;2CNSH67U8PE*M?EBKZ7[I/=:=]CMJ***W/)"BBB@ HHHH
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M;F]\R;;=0+!/;Y'ER*H(&>,]&(X.*CM/#D-K%9P/=7%Q;6+A[:&7:0A (7)
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MWEYW]!TZ8YJUXO;6FTVT>XM=/0+?6^TQW4A.[S%P"-@X]:Z\6-H)(9!:P!X
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO8+ALR*@"QN&/)/4XXHBL-37Q]J.M'3I/LD^EQ6L?[V/<9$=V((W<#YP,^U
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M-S&7 DE?>_E[R45V_B8+M!/J._6@"&_\6V]H-2DALKN]@TLXO9;<(1$=H9@
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MV^L>'XIXCYDK+8SJDME)\OEF-R4R<;LD8YQP10!UFGWGV^P@N_(E@\U=WE3
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M??.\@D<MDLQX&UVR6P /H*ENO'=A8V&M375E>QW.C*)+NT 0R!&&5=3NVLI
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MU[0K:WDISO4L2=AZ #(]><XH ]!HKD5UG5=<O?$,&CW$-L=(E%O$LL6\3S;
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MD^_*^=J^Y/8?6JMMXET6[N(;>'4K<S3C,,;-M:4=?E!QN_"LGXF?\DS\1_\
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MV#6&AW=[#);16S*]PL2_)ABQV?-CL>IK1?6_$NE7+7]_8M/HJ6,UQ=2$11M
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MXWEO- ^Y'A0 >,DGGC%-DU[7;[Q1I6FV5Q9VMOJ&CM?;GMS(T3AHQ_> ;[_
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M ^4Y)W8.>>,^E &C17 :IXKU;3M3AS-;2*^MQ6#6T,9=$@=@H+2?PR\AMN>
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MBW0B>-6C:79P[A,@X.<%AQ6B)K[^US";2/[!Y <7/F_,9=Q!39CIC!W9]L4
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M@,-RDHV."R\_CS1=^"%.O-JVD:Q?:1)/"D%W';!&6=$&$X=3M8#C<.<5U=%
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MK:.0/ 2R#:\1&/E8+G&.#G/)KE?']S;30^-);:4M>:=:0;IKB7'V23:706X
MR"V02V1S@<X('J-I8VEA&R6EO'"KMN;8N-QQC)]3@ ?A56Z\/:+?7DEW=Z38
MSW,L1ADFEMU9VC(P5)(R1CC% %B$I>Z8FYRRRQ89D<@].<$<C\*\>TNQC_X0
M;P#J@FN1?SZG#;27(N'#M$[2!DSG@$>G?GKS7LJ6EM'9K9I;Q+;*GEB%4 0+
MC&W;TQCM5$>&M"%M!;#1=.%O;OYD,7V5-L;_ -Y1C /N* //+M[#0+CX@6+7
M%Y9Z5''8LJ6DN'1Y@RML+<+N(4$_4TRXCC74/'NERQV4=NVB13"QMVW1)+LF
MZ# RV%4D@#.!QQFO2)/#^BRO=O)I-B[WB[+EFMT)F7T<X^8?6EM= T:RD$EK
MI-C ZP_9PT=NJD19SLX'W<DG'2@#S1=,T=O^%8LUK:%'1A,2HP2;,MS]3@_E
M4C&'Q+_PD*WVNVNF:EI^J2!)O*)NK:-&!B,9WCY60#@+AMS=2:]%'AO0Q8P6
M/]C:?]D@D\V&#[,FR-_[RKC /)YI9_#VC76JQ:K<:592ZA%CR[IX%,BXZ8;&
M>.U '':5HEGJGQ)\4?;6N9A9RV%Q AN9 (Y/+9L@!O7L>.2,<FMSQI;7]U::
M>FF26;W277F+97N1%>@1OF(D=\?,,Y&4![5MP:3IUK?37UO86L5W/_KIXX56
M23_>8#)_&G7NFV6I)&E[:0W"QOYD?FH&V-C&Y<]#R>1ZT >6236VJ0^$8DM[
M[2Q_;MS:7=F;EAY;[9F>,,I *[CA2.0, 8J'4'N/!\WBVSTVXFBT&"YTYG+,
M\@M%E<>>%YW8V8) ((#<8ZUVGB3PK)J-UX>CL+'3_P"S].O3<S0RML# HZX5
M0I!.7W9..172PZ98P6<EI%9P+;2[O,B$8VOGKN'?/?/6@#S371_PCNC>(-8T
M/6H'\ZQB=[33(ML42>8H:=<.VUMC-R,9VY_A-=19Z=X=?4)+O2+X@7FFE3;V
M<^(G0'(F.WG?\V-V<D?2MW3=!TC1[66UTW3+.SMY23)'!"J*Y/'( YIEAX=T
M32K:>VT_2;&U@N#F:.&!563_ '@!S0!Y>T$-]\&_!4]XBSR_;;!=\OS'#3KN
MY/KWKJ;J+[!\5-/CLE8*-!N2D <[,K)%MPN<#\*Z=O#>A/90V3:-IYM(6WQ0
M&V39&WJJXP#]*F_LC3?MT=]_9]K]KB3RXY_)7S$7T#8R![4 >;^%%M]=T_PU
MKQU^VAU1)5%TL,)%Q<2D8DAERY)&<G[ORA00 !61?36NN?""?7+_ &-K?]IH
M+EW/[R%Q=JOE>H4)C"],8/7FO6K?P]HUIJLNJV^E646H2Y\RY2!5D;/7+ 9Y
M[^M0W'A3P]=74]U<:'ITL]P09I'MD9I"""-Q(YY _*@"[JD:S:3=HS,%:%N4
M<J>G8CD5Y7IT7VW0_A8)I[G]^"DNV=UWC[,Y.<'KD=>M>M26T$ML;:2&-[<K
ML,3*"I7TQTQ[517P[HB+:JFCZ>JVA)MP+9 (3ZIQ\OX4 <]X!B6SOO%6FP%A
M9VFK%;>(L6$2M#&Q49Z#<2<>]5XK*P7XU7\TD$"RG1K>578 $N9I%W?7 4?E
M78VFEZ?833S6=C;6\L[;IGAB5&D/JQ Y/UI+C2=-N[V.]N+"UFNHT,:3R0JS
MJIZJ&(R <GCWH \AT2SBM/!G@;5X&E2^;7%MS*)6_P!4\\JLF,XVD=L=>:TG
M\KQ(?$2W^NVNF:GI^J2!9C"?M5M&C@Q&,[Q\K(!P%PVYNI->B#PUH*VT-L-%
MTX6\$GFQ1"U3;&_]Y1C /N*=/X>T:ZU6+59]*LI=0AQY=T\"F1<=,-C/';TH
M H^-U+> -?;?(CIIT\BO&Y0AEC8@Y!SU%<A86JZ5XE\$7%D9?/U#2K@76Z9F
M^T;88V3=DXX)./3/I7I-W:6U_:R6UY;Q7%O(,/%*@=6'H0>#55=!T=);65=*
MLEDM%VVSBW4&$>B''RCZ4 >7">>[^$MEXHM7;_A*4NHR9AQ*\YN CPMW*\E=
MAX QQQ6_H>FZ=_PL/QP##%'*QM=K(=CY> EL$8.3R3CWKLTT/2H[]K]--M5N
MV?S&F$2ABV,;LX^]CC/6G2:/IDM[)>R:=:/=R1>2\[0J7:/^Z6QDCVH \M\/
M:LJ>'_AS9ZK/_P 2N_@G\]IF^268+^[60GJ#ES@]2!Z5IZO+8^'UTG3[34Q_
M8ESK,J74EV?-@A9HV9(."O[K>1QG (P>,BNYD\.:)+I/]DOI%@=.SD6OV=?*
M!]0N, U(^B:5)I']DOIMHVG!=@M#"OE =<;<8H R/".FPZ4^J06VJQWD#W E
M6"%-L5H6'*)\S8!X;;GC/3FL>UCM_$7BWQAIVMKDVGDI:JYQY,#19\R,_P +
M%MQ+#G@#/ KM-/TVQTFS2STZT@M+9/NQ01A%'KP*BO=$TO4KA)[W3K6XF12B
MO+$&;:>JY/;VZ4 >7*LNM>&/AK>Z["D]]/J*1R22KEI8_*FVDYZY 5OJ:]%\
M5PHO@K6(T+Q+'83%#$Y0KM0D8(((Z"KUYH^F:@\#WNG6ER\!S"TT*N8SZKD<
M?A4]Q:6UY:O:W-O%-;R+M>*1 R,/0@\$4 >6VVE6RWOPYD5[A7U*R:*\9;AP
M9T%J'"MST# <?A59M0?0-(UNSAG^S:3;^*8[:1I-SI;6SI&S \@A-YP1D<,?
M6O4!H&C!K0C2;$&S&+8BW3]P/]CCY?PI4T+2(X[J./2K)4O,_:56W0";/7>,
M?-^- 'G6M!?#&EZQ?:=K<#6ES-9M=064)$%G$90LDBA7)7>N<@$9P2,=:3Q#
MHNGQ^&O%MQ;:I975O<Z+)-]@LH0+='125F WL%8^V,[<]J]&L="TC3-/?3['
M3+2VLY,[X(H55'SP<@#!R/6FZ?X?T;2K*:ST_2K*UMI\^;## JK)D8.X <\<
M<T <5<P6UKJ?P[%D1&C3LKI$Y"'-J[<J#C.<'.,USFJV$0\(?$#4?-N3=Z;J
M\KV<IN7)@94A(*Y/7G\N*]73P[HD:6B)H]@JV9S; 6R8A/\ L<?+^%!\-Z$T
M%Q VC:>8KE]\Z&V3;*WJPQ\Q]S0!R&O/YWC*\MKU5OK:715^SVRRH&@E+L"V
M&(P7XPXZ;#TKI_"&F76D>%--L[^X:XO4@7[1*96DWR8&X[F))YKG]9\'W-YK
MTUPV@^'-8L&BCBMXK\&)[15!RJD1N""23V/..PKIO#VBQ:#I*V4*11IO:010
M@B./<<[4!Z*/\3QG% 'G8L+O7(;FS242:LGB!F.I1W(7_1UE^9-P8. $S'L'
M<>G-;\%C!-\4-:TZ4R26LNB6^Z*25F',DBDC)XX Z>F:SXOA_<W'FP:MX?\
M"]W/*[L^L;6$[EF)WF/R_O<_\],#M7>6VC:=:W0O([.#[;Y8B:[,:^<Z@?Q/
MC)H X7P<CW(A\*WL9DG\.7<GVF1U_P!:HYMV/NZONSZQG/6L[1O+\16$&IW6
MNVMCK5GJC^?LA/VI9!*R^03OY1AA0NW&,<9KU5+>&.:69(D667'F.%P7P,#)
M[X%41X>T8:S_ &P-*LO[2QC[7Y"^;TQ][&>G% 'E&K6$7_")_$/4/-N3=:=J
MLDEG(;ER8&6.%@5YZY/Y<5ZWJ3%M!NV/4VSG_P =-1'PWH;0W$+:-IYBN6WS
MH;9-LK>K#'S'W-:$<,4,*PQ1HD2KM5%4!0/0#TH \?TO1X['PO\ #S6=+DN%
MU>XDLX)<3NPG@9/WJ%2<;54$].-M:LENVB>(=7\'QQOY/B%A<6$N"?+0X6X3
M/;RP"ZCMN KOK'0M)TV8RV.FVEM(<_-#"JD9.3C XR>3ZU0TFPUF75&U'7SI
M_G0K)#:1V6\JJ,P)9BW.XA4&!P,'DYX &^,;B[T;P%J\^C1[;FULG-N$&=F%
MZ@>PY_"N:NH8;2]\$:AX>8YU"80W/EN?]*MVA9V>0_Q,NT'<><GKS7HQ&1@U
MGV6A:3ISL]EIMI;LP()BA5>"<D<#@$\XH XWX=:+9RK>ZI*;B6\M=6OX(9)+
MF1MD?FE=N"<'@#KDU>\3-8WOBRVTV8K-.NFS3M!=.!:QQEE4RD8RT@(P,$8!
M;D=^IL-+T_2TD33[&VM%D;>XMXEC#-ZG Y/O3;O1],U"[M[J\T^UN+BV.8)9
MH5=HC_LDC(_"@#R;2A:ZOI_PMNM3\JZE83Q32SD,2!;N0&)^@/-=Q\3X(;GX
M8^(!)&LBK9O(N1G! R"/I6W_ ,(YH?V&&R_L?3_LD$GG10?9DV1O_>5<8!Y/
M-7YX(KF"2">))89%*/&ZAE93P00>HH \\U+3=.N/&7@FQCC06AL[[='"VT'*
M0D@[>QSR.]8EOJ;Z3H4-@]TL&CQ^*[K3Y)+C=)'% #)Y<;_,#LW[1R<8X/&0
M?4(O#NB0/:O%H]@C6BE+=EMD!A!ZA3CY1]*%\/Z*ME<V2Z38K:W3%IX1;H$E
M)[L,8)]S0!D^$M,@TN\U=+75HKN":1)A:V\>V&T)4@JGS-C=@,5SQG..:RDE
MMM<\=^*],UD(ZV-M;_8H9#@+$T99Y4_VMYP6'(V@9%=EIVEV&CV:V>FV4%G;
M*21%!&$4$]3@=ZBOM!TC5+N&ZO\ 3+.ZN(.(I9H5=D'H"10!Y=H1QX1^%<B2
MR F[6)@LA"D>3*<%<X/(%:>F:5'-K7C2^5;FYO=+U S6"-<2$))]F0CC=SDG
M&#D5W2>&]"CAM84T;3UCM&W6ZBV3$1]5XX/N*L6FDZ=87$]Q9V%K;S3G,TD,
M*HTA]6(&3^- 'G?AJ.UU.W\.>(;/7K4WWE%9(;>(B6]=D^>.<F0EB""<D<8S
MP*F\'MH^O:!X>UNYU&1-<6?_ $EHY LTTYRKPR#!)09SM[!01@"NXL_#VC:?
MJ,^H66E65O>3Y\V>*!5=\\G) SR:6W\/Z/::K+JEOI5E%J$V?,N4@42-GKE@
M,\T >7V]C8VOPZ^(;6R);W$5YJ>PP-Y;JJ'*CY2#@'''3FM^VG&H>-M)T;5$
M673F\/K<6\,HS'--N <D'AF5=N/0,3WKL7\/Z-(;PR:38N;T@W6ZW0^?CIOX
M^;\:6?0])N;:WMIM-M7AMCF!#$N(N,?+Q\O''% 'E<JW;:39VDUU=FUM?&B6
M5E(+APS6V_&W<#\VUMR@GD;>.E==X2MX]-\=^+M,M-R648LYDA+EE1W1]Y&3
MWV@FNGFT32;FWM[>?3+*6"V8-!&\"LL1'0J",*?I4D&E:=:WLU[;V%K%=S@"
M6>.)5>3'3<P&3^- '*W<J:C\4FT758EEL!I GM8)1F.60R$2-@\%@-H'< GU
MKC]3ADN/A=JT5_FYAL/$ M=/GG.]C;K=QJ/F/)Q\RY]%KUF_TK3]4\K[=907
M)A8M&98PQ0G@D'MQZ4VYT32KRRCLKK3+.>TBQY<$L"LB8Z84C H G2RMH[/[
M&D$:VVTIY07Y=IZC'XUXS8VEG'\'M$2!(XI9-:MQ*8L*V!?,!TZ8 ./I7M<<
M:11K'&BHBC 51@"LP^&=!:-XVT33BDDWGNIM4(:3^^1C[WOUH \\U:6?PQJ'
MCR/1#-$D>E6UVJ*[.4=C(LDBY/WMHR3W*@UT'AZQT_\ X2*TU;3-<LI(KJS*
MFTL(BJ7"\$2N-[?,,XW'GYL$\UU<>D:;#>R7L6GVJ74J[))UA4.Z^A;&2/:H
M]+T#1]$:9M*TNSLC.<RFW@6/>?? YH T:*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *SM7UW3-
M!AAEU2[2VCGE6&-G!(+L< <#CZGBM&N*^)KB+0])D*-(%UNQ8HB[BV)AP!W/
MM0!M:7XOT'6#?"SU!=U@-UTLT;PF)<9W$. =N!G=TI4\6:,]Q/;M<R130P?:
M6CGMY(F,6<;U#*-PSQQFN-\3>'-0\3ZMKNI:5!+!OT,6$1N(VA-Q+YOF8PP!
MP H7)P/G]C5S2YH-5CDOSX2U6PO[>TDCDEOHG+(67!CBR27!/<#&!ZT ;UGX
MY\.Z@NZTOVE!CCD4K;R?.)#A-OR_,2>,#)'.0,5>'B'3#9RW33ND<<PMV$D+
MJ_FG&$"$;B3N& !SGBN.L-+27X3^']+U33M4C>)((Y?LL;I<6DB#B50!GY6
MY /7OTJB^G^*!9Z=?70N-4CT?7!,K&W\JXN[7RMGF-'@$NA8@< L%SCID [D
M^+-$6SU"ZDO#$FG<W:RPNDD(QD%D(W8(Y!Q@]J33_%NB:IJ4>GVEX7N)8?/B
M#0NBRIQDHS*%;&1D DCO7(>(-+NM4N_%>MV=G=B"Y\/'388C;NLES,?,.=A
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MW^J;;J:,'(C!4!$_!0N??/K0!F>*-=ET/QMX;$VH2Q:;<Q7?VB (&#LB*4P
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MEG)DD&"S*25"$].@.: .QD\5VR>,X?#@@N6D>T-R9EMW9/OJJ@$#&.6RW08
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M<O<$<'J#6?H&BWVA>*/#,%U#<S)8>'7LY[E(7:,2[HR%# >BMCZ"LN*PU!?
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M9F8%5NS(S+C.5"X.>AS@9.: /1K#Q1H^I&_%O=[3IX#70GB>$Q*02&.\#Y2
M2&Z''6GV7B+3+_4FTZ&:1;Q8A.(9X)(F:/.-RAU&X9XR,XKAO$6C:GK.N^+X
MK"VN$:]T>WBMI9(F2.62-G8IN( Y# ?C[&MCPQ+;ZOJ4%^?"NI:;>V\3)+/J
M*L#&3U2,L27!/.1Q@>IQ0!VM%%% !1110 4444 %%%% !1110 4444 %%%%
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M78?+SNQD8( R.M7&\8WMQJVC66G:7#(NK:<U]!+-<E-F AVL IP/G'(S].]
M'7U&+B W)MA-&;@()#%N&X*3@-CKC(/-<%_PL#54\/OK,VB6R6]E?FQU "[)
M8.)A$6B&SY@"0?F*GJ/>M:75G7QQJ6GPZ59+?0Z2MS%>L_S2*78!&PN0H8,<
M9/7M0!U=%>6VWBGQ/+X*\'7_ /H9FU:_@CFD,K!G#9?'W?E!VD'K@<=^.@U7
MQI=VO]I#3M,^VRZ852>%!*6EDV*[)&50C(##!/4\8'6@#LJ*X[4/&TP%VNE:
M:\\]I;1SR03)*KLSIO$0"HVU]N.O0D#'7'16FJQ3Z#%JT\4MG$UN+B2.X0J\
M(V[B&'8CG/TH OT5QK>-KB#3-&UNZT]$T?598HU=9298!+_JG<8P0<C(!^7/
M\52Z7XFUO5=?O[&'1K5;;3[_ .RW,QO#G88PX91LY/S#(..W)YP =;17.>)/
M$=[HFI:-96FFQWC:G.\"EKCR]C"-G&?E/'R\GJ/0]*R;7X@30C5K/6=,6VU?
M3[F"W\B"8R1S^><1,K;<XZY^4D8/!/% '<T5PMYXZU+3[+7I9=#,ATRU^UQ3
M9DBAN$P=R[F3AUQTYSZBIKGQE?:;'9R:Q9V.FP:A.L=K<RW1:-5,9?\ >':
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MAX7./Y^IK7K-MM1GN=>O;)8(_LMK''NG#G<96R2FW'9=K9S_ !BL.]U75_\
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MSDA"0,C=QDXXZ&ENO *V_@VS\/Z/,JB&\BO);BZ)9YG202,S8')8CKVKMJ*
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M7PY8:+J.HZOI]O</?7Q#3J;EBLK#@$ACM&!W Z4 8_P\GD(\361),%EKUU%
M.RHVV3:/HSM6[XIL]0OO#5_#I-W+:ZCY+-;2Q'!$@&5!SQ@G@_6CPYH@T/3'
MA9Q)<W$\EU=2@8#S2,68CVYP/8"M>@#RVW\;K_;>@ZVUU<KH-Y8^3=(TA,<%
MX4+JI[EMJ,I'3+*>M;<GVZ.?1M.N-2O9+J>WFN)[""0B5F)7!,N1MCCW;>OS
M''WC6]_PBFB?V;_9_P!@C^R_;/MWE]O.\SS-W_?7;TXZ4[4_#6F:MJ=IJ5S'
M,MW:HT:20SO$2C8)1MI&Y20.#0!PVGZ_X@NO GAK5I8+O5(RLW]I1V,@CN7"
ML5610,%L8Y (R2*[CPM?V^I^&;&\M;Z2^AE0[;B5=KOAB#N'9@00?<&JUCX+
MT?2[>UATX7=J+0R^28[I\J)""R\D@KD#@C QD<UKZ=IUKI5A%9640B@CSM7)
M/)))))Y)))))ZDT 9/BFZ>'^R[>.^E@:XO AM[=?WUVH1B8T;(V= Q;(P%/(
MS5/P#J%]?:?J\5_+)(UEJUQ:Q>:P9UC4@JI;^(C.,^U;&M>'M/UX6AO4E\RT
ME\Z"6"9XI(VP0<,I!Y!(-)HWAW3- >\;3H7B^US&>8-*[@N>I 8G&<<XZ]Z
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M6#((PHW<#!(QZ<4 <_I%YXC\1Z7IWB*RU"WMLWC-<++=L8S )&5H3%Y>%8
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M"N6\8K8O\0/!(NEMRWGW.[S /N^0VW.>V[&/>N2OXM)/A7XH;4LR_P!KE,.
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MZ5K>UV[I$7_7!5Z$[ 01CV-6[FZ\+:]IFO:[8:E<:C.=$FMYIIE5(XUQN1'
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR$5BN"QX+8([X%=KX?\ $,/B"&\*VMQ:7%E<M:W%O<;=\;@ ]5)!!# @@]Z
M-<@'J :" >H!K(U3Q FG7ZV$5E=7=T;9[HI"% $:$ _,Q R2P '\JQ+GQR\U
MYX3.E:?/=6>N"27>"BMM6%G" ,PPV<$G., @9S0!V>,455U.\?3]+NKR.W:X
M>")I!$K!2^!G&3P*\XU#7KO5-!\ :[<6]W!/<ZE;F2*)\K,KP2/PBL002!C=
M@C':@#U  #. !GK2US5KXTL9;34Y;NUNK"?3;A+>XMKC87WN%\L JQ4[MZXY
M[\XJ?2?%=GJNMW>C&&6WO[:)9S&[(P>)C@,K(Q'!X(Z@T ;H  P!@>U  '0
M9KFO%'B.\T35-!L[73Y+D:C=F%W1D! ",VT!F')V]3@8SWQ4']NZ99^(/$DX
ML-1^VV%G!-=_,&62/#E?+7?MR &STS[T =;17(P^/[:6725.CZJJ:O;^;8R>
M6A$S; YCQORIP>K +P3G'-6;3QK87&G7=S/;7-I/:WGV&6TFV>9YQQM4$,5.
M0P.=V,9)(P: .EQ2$ ]0*Q-$\4V>MZEJ&FI%)!?6!0S12,K95QE65E)!!P>^
M01R*M:AK4-C?6M@D4ES?72N\4$6T'8F-S$L0 HRH^I&* -' QC'%5[ZQBU"T
M:UF+>0_$B+@!U[J?8]\8KCO$?C5G^'WB#4=)AN8K^P66WFC<()+24+]YOFP0
M,@@J6SD8SS6YX=T>VM"^HPV]W:2W42)+;S3!E)7_ ):8#,-QSR<Y/?F@#>I
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M0.RX#%@0IZD '!P3277CRPMK7[:MG>3V)OCIZW$00AIMVS@%@=N\;=WK[<T
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M.!UR1ZD#FMOP_P"(8?$$5YMM;BSN+*Y:VN+>XV[XW #=5)!!# @@T :X !)
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M7EE8+&@+,Q["J^F:G9:SIL.H:?.)[2<%HY0" PSC///44 <;<Z%J\EUX]=;
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M.,)^9K(UGPYXIU,W9GTZWN[B'68KNTN7NP!]F2566-%(^0A1\W3/7YJ].HH
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MXR1G')+9 ]!R<\5Z110!YOJOA'6]3NO%DL$4=O+=W=G>Z<\SJR,]NJ#:X!)
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MC&1ZU;U#Q!XBU"36E\.6ADETRY^S11LL92>0(CL'+.I4'?@8'&,Y.<#3O_"
MO]-L;675+II;:]COWN756>:5#E=W  ' & !P !BH+KP2S>(;G5M-UW4-,^W;
M?M]O;;"DY48W#<"4; P2O/X\T =*D["P6XN8F@;R@\L>=Q0XR1QUQ[5R&K7^
MBWLVCVEMYB+8W27!=;63]TB X'W<_,<#Z9/:NS2)88%AB&Q44*@'\( P*P(/
M#5[#(2?$>H,CR>9*FR(>9SR"P3/3C@\#@=*RJ*3T2_K[SNP4Z4&Y3E9K;5^?
MDRW_ ,)-I7_/6?\ \!9?_B:Y_P .>(-.M&U]W>;#ZG+*H6WD.1L3T7CH>M=;
M#:RQ7MU.UW+)'-MV0L!MAP,';WYZG-5]*TC^RY+YA<--]LN&N'#*!M<@ XQV
MPHI.,VT_Z_,N%3#0ISC9ZI=?G_+T_P"&.#T7Q8^FZ5#J]TJ3O?W >](BDWHK
M-A2K8VD*,#;^1YKI?%NEVNI>&[C1+:"-I]58[ 5SM)(+3'_='.?7:.X%7HO#
M5O%;)8B9SIT<XG2V(& 0VX+GNH;D#\,XXKGKJQO)-4N[V'Q'JMNTYP4C-D0B
MCHJELD ?7J2>IKMRRG.,^9S2Y;-;[KTOZDYE7H5I<U*.K;^[HNFVWW:L[J-!
M%$D8)(50N6.2<>M<KIP ^*.N8 &=-M"?^^Y:GANS#?6TPNKQH(;;R#;O/;E9
M&R/WC'?DMQZ]Z@M_*M_$UWK?F3,]S"D#PF2WVA4+%<'S,Y^8UTTJ;A&:;^*/
MXW3_ $/-;O8H^)[;6]!O;WQ3;7%MJ%@BJ]SIT]L RPH.3')G.1\S8/')KN48
M.BNO1AD5R+AKB:Z2]U"\N=/GD+_8W>U "G^#<&R4]O3@DC-=7!*)X$E (##.
M"0?U!(_6IQ3;IP4K-KJM-+*R>VJUU_%CCN<)_P )7JUOK6CQ3S6THO=4EL;B
M"",M%"H$A3;+WD 0;ASU(PN*H7_BSQ1;Z)XJU1+K3@N@Z@\0B^RM^_C58VVD
M[_EX8\\\^@'.O;_#F.VMM.M4UW41;Z;?&\LTVQ?N\[\J3MRWWVY/-6+CP''<
MZ/X@TU]3G\G7+AKBX81KN0L%!">@PJ]<UPE$XUF]UGQ+JND:=<1VBZ7!"TLC
MQ>87EE!95QG[@4#/<[N",<UOA5G_ (5AH6<9\ALX_P!]JM/X09/$']M6.KW-
ME=S0);WOE1HRW*I]UBK [6&< CMVJ_X7\/Q^%_#UKH\-W/<Q6X(628*&P3G'
MR@<9)]3[T <QXL\5ZMH7]JW44UL18S6XAM8XS+OB<H&,S#_5DEFVC(^[G!S5
MNTEU*3XMZG ^H9M(=-MY$@,0PH9Y 0#GKE02>_X4NI_#R'44UR :S?P6FKS+
M<RVZ",A9EV_,"5)Q\B\9QQ6M'X96+Q.NNIJ5WYS6B6L\9";9PC,RLWRY!RQ^
M[@&@#,^)L][;>"II;&[-LQN;>-R%R71YD0K[##<_E6?>P:F_Q6MX;6]@BNSX
M>D#7,D&X#_2$Y";AST[_ )UU?B30H?$FA3Z7/-+ LI1UEBQN1D<.I&01U454
MC\,R1^)(M<.J32W4=B;+$D:X92P<L< <[@.F!CC% '/:3XUU+5-%\.1F$?VE
MJ?VH2O;HO MW*,45V R3M/).!G@UTWABXUV>RN5U^S6">*Y=(9%*_OX>-KE5
M9@K=B,]1[UB?\*XMTT+3K"WU>]M[O3+B6XLK^(*)8C(Q9U(QM93N.01TQ73Z
M1IKZ9:&.>]GOKF1M\US.%#.V .B@*H    'ZY) .9>34W^+[6JZABT31A,D!
MB! W3;6[]3L'/X5ER>,?$">%KB_#V)NH/$!TQOW#!6C^T"+CYCM/.<G=777/
MAQ9O%</B"*^N()TM?LDD2!2DJ!]X!R,C!)Z$9K);P#&VCSZ:=5N/+FU/^U&?
MRTW"7S!)@<8V[@/?WH @34/%,GBS5/#HU.P5DLHKZ&[%D<QAF="FS?@\IG)/
M3C!SD5M'\;:EKVF^'XH8"E]J&GR7EPUNJ-L",J?('8#EFSSG &,<Y'2+X==/
M$]SKRW[_ &B>S6S,?E#8JJ68$=\Y8]ZQ%^&T-OI&CVUCK5]:7VC[UM+^)4W[
M'.61U(VNI^G8>^0#?\,7.MW.CY\06:6U^DKH=A7$J _*^ S;<CJ,\'-9PUC4
MM;US7M.TJYAM#I/EQ*TD7F>;,Z;_ )N1A "HXP2<\UNZ7IYTVS$+W4UW,QWR
MW$^-\K'N<  =      *S)?#'E^(+S6-,U"6QN+^)([Q5C5UDV#"N >C@'&>1
MC&0: .+U+7;SQ7H/@/68G%D;O6(TD@,>\)*JS*QSGD J<#Z5Z<(72V9$=%F9
M>9 G!?'WB*YZY\%6C6.A6-G<RVEMHMPEQ;HJAB[J&'SD]<[FST))SFNF&<#)
MR>YH \;\[4;KX.V-W>7@NYYM9B92Z;3N^WG.2/4^@XKI[GQ?JGAV^\30:K);
MWRZ=817]NT,)A^^77RSEFXW*.?0FK8^'L2^'QHB:Q>"S2]%W"K)&3%B4RA0<
M<C>>2<G&!Q5Z[\&VNHZKJEY?W#SQZE8K8SV^P*OE@L00>H.6/.: &:9=>*!X
MCCAO+,R:3+;EI)W6*-H9@>  LC%D(SUY&.IIWC76-2T33]/GTUK<--J-M:R"
M:,ME9) IP01@\]<&G^'?"]QHAC%UK^H:K';KLM4N@@$*].2J@NV.-S9XSC&3
M5KQ'H"^(K2UMWNY+=;>ZBN@8U!)>-@R@Y[9'- '/)J/BJ7Q)K6@#4]/#V]K%
M>0W?V(Y4/O&S9OP>4ZYZ=CG(@TCQIJ7B*RT:&V@:*\N]*&H7#VZ(Q4EM@"AV
M QN#$]3C [YKHU\-NGB*_P!:74'$]Y:I:LGE+M14+%2.^<L>IK$3X;1VECHZ
M:;KE]8W^DPM;P7L2H6>$G)212-K#/(XZT %MXD\1N=*T?4=.-IK-Q!//<_9_
M+?"1NJ*4#/M&[>#R3C!&.XS-4OO%DD/A>/5&73KF37?LTBHBLMQ&$=XY" QQ
M]T?+GK^%=#JG@>._ATZ:#5[^TU;3V=XM20JTKE_OAP1M8' XP , # &*EO/!
MZWNGZ?%)JU[]ML[U;X7Q"&1Y0I4DJ5VXVL1@# P/2@"G)K^LQ^(O$NG":S*Z
M?IL-W:L8&^\WF9WC?S]SL16?H_B?Q!)-X+N;^>SEM=?M\2P10%6B?R#*&#;N
M<D$$8 &?;)WG\)[M6U74!J,PDU&S2S=2BD(B[L$?[7SMUXYZ5#!X*2"'PU$N
MI3%= &+?,:YD'EF/Y_\ @)/3'/- &'>^,-;;3;R_LFMX[F#7/[+6PE@+Y0R!
M Q 96+D'S."!M_.O1(PXC02,K2 #<RKM!/<@9.!^)KR6R^VRZA=W5OK&MZ?K
M$UQ+)]@GT-9V0ECM3SC'RF, '?M [@"N]TZSUE/$L]Y=7TKV<MJBO:D+Y4<P
M"\Q?Q8^_G/\ >'IP 9WC2\=M9\*Z(#B'4=1W3^CI"ADV'V+!<_3'>J'C)[B/
MXE^ VM84FF!O\(\FP']RN><'^5;_ (IT:741IFH6B;[W2KQ;J),@&1<%9$!/
M )1CCW [5'JGAS^W=;TC78]2N+673A*;9%A7_EHH5MX89S@=.,4 <WI-Q,?C
M5>2:O;C3;Z;25AM+>)O,CNHU?<TA<8^<'C:0,"M?PQ=O!XY\7:(/^/6"2WO(
M%[(9D)D ]BZEOJQK0M?"]O:^(7\1W][<W^H);F"-Y0H2"/.2$1%')[DY/:CP
M[I$D&JZUKMRACN-5F0K&>L<,:;(P?<_,Q';=CM0 SQ)K&H:7KGANWMF@^S:A
M?&VN%>,E\>6[@JV<#[OH:S+;Q9/+XO?1;N[73[U;QECLKF#:MU;#.UX9/XF/
M!(SQR,<9K>UKP^-9O])NVNY(3IMS]IC5$!#OM*_-GMACTJK-X4%Y<VYOK^2Y
MM[;4#J$$;QKOCDW%@H?^X"W3&>,9QQ0!<\3ZU_PCWAR[U,1B1X0JHA. 79@B
MY]LL,UA2ZEXNLYM29[5#8)I[W$5U<QQ@QW"\["B2$LA'0]1W)KIM9TBSU[1K
MO2K]"]K=1F.0 X./4'L0<$?2L.P\(75OIMQ:7OB/4-1+V[6T,ERJ9A1A@GY0
M-SX_B;/ZG(!D:1XE\0/<^#)KZXLY+;Q!:DR0QVY4PN+?S0P;=SD@@C QGVR:
M&G:OKVG>"O&FLC48KBZL;^^\OS[?(/E' Z,/X5  [>]=/!X,6!?#2KJ4Q'A]
M-EOF-?W@\OR_G_X#Z8YYIC^!HCI?B#34U2[6TUF6:62/:A\DR\R;3C/)SC.<
M4 9\]WJEU\0_#2+J CMYM*FN&A\H%=P,63UZD,0/3\35#3=:?04\8W,,0DGF
M\2I:PJ>F^5($!/(X&[.,C.,9'6NIE\*+)J6C:@NI7,5SID#VVZ-4Q/&VW(8$
M''W%Y&#U_"I)X"LKK3M=L;R[N)H=8NOM<A4!&AEPN&C(Z8V*1G/2@"AJ'B?Q
M#X9M-;O]5T]IM,M[9)+.>4QQNTS,$\I@C-QEE.[ P,]:9?0:C#\4/"/VZ]CN
M=UI?'Y(=FU]L>['/W>F <D8.2<\:B^"%O-#O-,U_6+[65NH?(\R<(AC3(/RA
M0!NR%.XY)*BBU\&W":MH^I7OB&^O)]*26.+?%$N]7"@A\+DG"C)ZGV[@$?Q0
MN+RU^'NJ36-T;:0*BLRKDE&=59?;(;K4S:M?W'BK_A&8;Q(YK>P%Y<78A!+%
MG*HJJ3@#@DGGMC%:OB+0X/$GA^\TBYDDBBN4"F2/&Y2""",\=0*H2^%6.K6>
MLP:G.FK06[6TMR\:L+F(MNVN@ '#<C&,>] "^#M?N=>TZ]6_BC2^TZ^FL+DQ
M A'>,CYU!R0""#C/%5[S7;W2O'EO8:A<0IH][9RRVS^7AEFCP71FSTV98<#H
M?2MK1M'M]%LW@@+NTLSW$TKXW2RNVYF.,#DGH.  !VJOXA\-V/B6WM(;X-BV
MNDN4*G!)7@J?]EE+*1Z&@#%M]>U2XU?2M">98;R]M)=0FE,(#10AE5$"GC?\
MPR3D?*>.1CG/$'B36;OP]JVG2726]_I>LVMG/-#%\MQ%))&5."?ERK?, >W7
M!Q7=:QX<CU+5=/U:"Y>TU*PWK%,BA@R.,,CJ?O*< ]B",@U2O?!-G>Z)?V+W
M<ZW-]=)>S7BA=YF1E*D C&!L4 8Z#UYH J7^M:Y/J>I:1I(:2[TZVB9IEAC(
MDFD#%0P9QA, =.3D\C'/3://?W.CVDVJ6BVE^\2FX@5PPC?'(!!((S[U@7_@
MF2XUB+6+#Q!J.G:B8%M[J>%8V^U("2-RLI7<,G! XSTKIK2V2SM(K>,N5C7&
MYVW,WJ2>Y/4GUH X:_\ %>K6&K6:O-;2";7%TY[>&,O''"Y(4F3M+T8KGC.,
M=ZM^%9=2F\;^+ENM0\Z&WNH8DC,0&U3"K@ YX W'Z]::?AU'Y"VZ:[J*6T.I
M_P!IVT86(^3)O+D9*DL,LW7/7O6W8>'$T[Q'J6KPWUR5U QO-;-MV;U0(&SC
M=]T#C.,\T 8_C^;4(IO#,=E?&V2XUF&&51&&WC#,,\] 4!QWK'F.KP^-?&\V
MF7EM!<0:=8RM)- 9-Y5)B %W# ..3SCT[CL_$7A]/$%O9(;N:TFLKM+R":$*
M2KKD<A@01AC5,>$MNHZU>C4IC)JUM';2AHU.Q45E4CWP[9SW/2@#*M?%VH:T
MFCVUE \5S>:/%J<S0HCE-^ JJ'8#&=V3R>G3.:Z/PU<ZS=:#;R:_9)9ZG\RS
M1QL&4X) 88)QD8.,G&<5@R?#U$M=%.GZW>V&HZ1;"SAO850M)  !LD4@JPX!
MZ=>:ZK3K$:?9);^?+<.,EYIB"\C$Y+'  _   =  !0!Q%_K_ (F:Z\9Q6M[8
M0KH:)+ 3:,QD!A\W:WS\>A/Y 5+;^*-9CU7PQ<7LMHVGZ[:R2M;QPD-;E8?-
M!#ECNXR#P*UG\(![CQ'+_:,H.NQK'./+7]T!'Y8V?\!]<\\^U(G@Y5E\..=0
ME8:%&T<(,:XE!C\L[_\ @/ICGGVH S-*U_Q1JRZ%JUIIYET[4"KW,3>4H@A<
M95T;S-Q*\9!'/. *;9^(_$VL6^G:QI&GF>QN+O;) XB51;;RI<.9-V\8SC&.
MHQWJ_H7@8:#.L-OKFH/HT4AEM]+DV&.)LY WXWE0>0N<=,YI--\"+I.H2_9-
M;U!-'DG-P=)^0Q!R=Q ;&X)GG:#@]\@D4 8^C7^MV]IX]O\ ^T8IYK&^G\E9
MK?*@I!$RC 8<8XQ^.35G_A)-?N9_!4%O/91_VY8/-<-);LQ2185?(PPR,MTX
MZ=:U_P#A#D1O$ AU.ZC@UHN\L.U"L;NBHSJ<9R548!) ]*2#P<L%QX<F&HS$
MZ% T$ ,:XD5D"'?[[5'3'- &&GC/5K7PIJ%Q="WEO+'6O[*DNQ&5C5/,5?.9
M<\85^1G&16UHNJ:O<>,]:TF>X@GT[3XX62;R,2.TBD[68,%RN,X"]&'3OB^(
M-"?0M O(8[O4Y(=4U87=U<6EL)6M<D,Q\L*=\>45=N#][G(XJ[X.6_2]VP:Q
M<:CI/E,6^T:4MGLDR-NPA$W9&[/!''4=" )\2UNFT_1/(N1$K:U9*RF/=D^<
MN#U[$9QWJW#J=_J7B35M#L;N&VETRW@>>Y^SAC--*K%?ESPH51GN<X!&.=+Q
M'X?'B*"SA:\DMEM;N*[4QHI+/&VY0<]L]:BG\,G_ (2!M<L;][._FMUM[K;&
M'CG5>5)4]&&3@YZ'!S0!REMXVU[5X/# M!8VD^HW=S8WBR0M((Y8DDRR'<,K
ME,XZ]LBN_L8[Z/2X8[VYAEOA'B2:.(JC/CJ%ST]LUA#P1:PMH7V2[F@31YI)
MXQM5C-)(&#LY(YSO8\8Y-=10!XU/-J-S\&+RYO;W[7*^K@ N@4[AJ..2.QP.
M .*ZF\\6ZGX;U;Q#;ZO);WT5EI*ZK 8(3"1EG0QG+-D908/O5J3X?0MX?NM$
M75[Q;*:\^UHA1"83YOG;5.WD;^YSQQQ5^Z\(6^H:W>:C?W#3I>Z=_9L]ML 1
MHLLW!Z@Y9N<T 0:;>>*?^$@M4N;/S=*G@8SS,L49MY1RNT+(Q9&Y&""1QS5S
MQ+K<VE-IEI:Q%[K4;K[/&0 =@",[$!B 3A,#)ZD=<8,'AWPG/H1B2XU_4=3M
M[9=EI#=;,0C&.2J@N<<98\ GBK?B?PU;>)].BMIKB>UGMYEN+:ZMVVR02KG#
M#MW((/8T <5XQN/$$OPU\8P:W:;(8HQ]BN3L#3QG!.Y49@&4\9X!XXKHM3US
M5+G6[_1M&C=9K*TBF:18XWS))OV@AW7Y<)SCDYZC'+[SP8^I^%[[1]2UN\NY
MK]52XO'1%?8#D*JJ JCKV/4T:KX-DOM8M]9L=<O-+U1(!;3SVR(5N(P<@,C@
MKD$G![9H @L->UO4]1L]$NH8M)U0:8+V]V[9=C%RBJG)&,JQ)YXP.O(S=1F\
M3'Q#X&M]0O;:UNYGNOM,=JA>)I$A?##."1M/3L3WP*V-2\#QW%YI^HZ;J][I
MNIV<30?:X]LC31L=S+('!#9;+9QU)-6+SPA%<MH\L>I7L-UI<LDJ7 *,\ID4
MK)NW*1EMQZ 8[8H Q;_QO>Z))XVFOD@G@T1;<VJ1H4+&5,@,23_$0,^G:KUY
MK&KZ'XBT.QO;B"[MM7,D!=8=AMYU0N" #\R'!&#R,#FK,G@JRNKKQ"]]/)<P
M:ZB1W$#* $"+M7:1R#CN<\\\5+9^&&BGT^:^U*6_DTQ&2S:6-5*EEV[WQ]Y]
MN1G@<GC)S0!R5MXN\3?\(_8:Y<7&GM"=9_L^>WCMF'F(;DP[@Q8[2."!STY)
MS@>@:UJD6B:'?ZK,I>*SMY)V5>K!5)P/RKG!X!C'AV/11JMQY*7_ -O$GEIO
M\SS?-QTQC?[=.*ZJZM(;ZQFL[M%E@GC:*5".'5A@C\030!QTWB36-+@\,ZG>
M207%IK-Q!;7$$<6WR'F7*,C9R0#P<YSG(QTJ/PS;W;_$3QDMQ=I-"LEJKQF$
M8<& $#KQC/XUJZ?X.CM+?2[.YU">]L=*D$EE#*J@J5!5-[#[VT'CIV)R15S2
M_#QTSQ!JVK"^DE?4VC::)D 52B;%VXYZ=<YH VZ*** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M*X_X@:D]A#H4$DAAL+W5H;:]E#;0(B&.TGL&8*"?0D=Z -&W\07%QXKU;0Q8
MH&LK6*XCD\[_ %V\N "-OR\I[]:UM/ENYM/MY;ZV2VNWC!EA23S!&V.0&P,_
M6O/X-/L;3Q_XPM;1!;QOHUNY2!RFTYE^[M(V]CQCKGO659VZZAH_PLCN)K@I
M<Q-',%G=1(OV5R0<'N>_6@#UZBO+9K*QN?$.M>$[B]M;*VL[*!-.2\#2.D)0
MYEB=I!A@^06Y/RKS@58L9[.^\3_V!K^H"]MAH<#V,MSA!<Y+B68 \;^$P>H&
M2.IH ]"FOK:"\MK2255N+G=Y4?=@HRQ^@X_,>M6*\RETW24\;^"?WIOH5TZ\
M1;R[8.\RQ^5M8M@;NY!]\]ZH/,VJ?#;Q'KEQ(\7B2PN[IA,IQ+;RQR'RHE/4
M+MV#;T.X]<T >N45YK#H\6N_$>\M]8%P<Z-9W,ENMS(JK-YCY(PW&"HX'%)I
MDMQI?BO3AJ=I%>6U[?3G3];M'^=V99#Y-PAYX7< 1P-@X&* /2Z*AM;RVO8?
M.M+B&XBW%=\3AQD'!&1W!KA?&+V5YKNH6;,);FWT1YG2Z<""W1F;$J+C)E)7
M&01@ <C/(!Z!3/)B_P">:?\ ?(KRJR UF[^&AN[JXF^UZ3-]J N' E(@C/S8
M/7YCGN<\\55AU%]+TA-*,\D6C_\ "82Z=*S2'$5MDLL>[.0I; //0D=Z+@>A
M66L_:O%^IZ%)I\48LK>&X68/N\P2%Q]W:-N-GJ:T=3O++2;![RY1=BE5554%
MG=B%5%'=BQ 'N:Y/P_9V>G_%CQ'!9QQPHVG6;F*/A5.Z7.!T'8X'KGO4WCUI
M/[8\&1G/V9M;0R>A81N4!_']0*=V!JZGKL.F2Z?8M8+/J^H%A!9PL.BC+,SD
M#"J,9./8 U(=7U*UO[&RNM(C3[8[HDUO<^9%&RQL^'RBL,[<#"D>_0'F=5/]
ME_&_2-1OFV6-]I$EA;2MPJW DW[<] 67IZ]*[V6XACFAB=AYLI/EKC).!R?I
MCO[^]*X%72]4BU..<!3%<6TI@N(&.3&X ./<$$,#W!!JEX@U^70[S185LUFC
MU*^2R,AEVF(LK,#C!W<*>XK&T5I%^+?BI(\^0UE9/+Z"3#@?CM'Z"CXAQ+/+
MX2A=G57U^$$HQ4X\J7H1R/J* .UHKR>:2QT3_A.=+:>\MM,COK%8(K:7#*\R
M1DH&;(56;ANP!:I+59CJOCO1X=0L]++160@2%B8()9%<$ <=<*&( ]<4 >J4
M5QG@J[?^U=7T^^T5-)U6W2!IXK9P]M*IWA9(N!C.&R",\#OFCQ5J,,/C/PUI
MNI.J:3>+<[Q(<1RSJ%\M'SP1@N0#P3CN!0!V=%>:WWV32;[PYHUI>SW&@W>L
M3QW+22;D5S&S1VX(X\O><;>?N[3W%9?BB*?3[;X@Z=9R2QZ5!ID5U$D<C(MO
M.P;<J8/ (4,5Z<].: /7J*\VGT6S3X@:!;KY_DZEI=P;U/M#XN"AB*[^><;C
M^''3BL'8P\.V%D+NZB@M?&K6$.RX=2D G8!,YYP,8ST[4 >M:Q?2:9HU[?Q0
M"=[:%YA$7V;]HR1G!QT]*I:=J]]JFE:#J%OI\9AU"%)KG=/@VZM'N&./GY('
M;UKB7TP:#XA\7Z9ICS#2)-!^U20O*TBPW#>8O!8G&Y5)(]OI1;Y6T^%+K)(N
MZ-$91(0K#[&QY7.#R.N* /4*R_$>JR:%X<U'5HK87)LK=[@Q&39N5%+'G![#
MTKSNU\OQ':ZA<7FNVVG:Q8:M*&<0DW4&R8^7&I\P91DVJ%"X;)X)R:9J<MMK
M_A7XD3:J%?4=/DNX85<X:WB2+]UL_NAN3D?>R0<]* /4M/NC>Z;:W9389X4D
MVYSC< <?K5FL[0"&\.:6000;2+!'^X*\WUO2I$U3Q'X/MD(FUH1ZAI4N2/);
M&)1N_A"E,@=/WF.] 'J\A=8V,:AG )52< GTSVJA!J;16>G?VM'%9WUX1&+=
M9?, EVEBH; S@*3G':N2\/W47BS0Y=<DMFMO*T[[$$3,9CE"DS $8. V%'IM
M;U-<Y9VMI?:-\*9KZ*.9GRCO-SD&V<X)/N ?PH ]%T;7Y=4U[7=+ELU@.ERQ
M1AUEW^:'0.#T&."..:W*\CUC3;2^N?B?<2[V:U@BFMRDK*(W6S#*XP>H(&#_
M (FO3-"GDNO#VF7$SEY9;2)W8]R4!)H IZYXDBTS0=:U&SC2]ETA&:>'S=F"
MJ"0KNP>=I!Z=ZU+"Y-YIUM=%=AFB23;G.,@''ZUY3]BL+7PO\5&B@ABG$MZB
M[0 VTVR,1],\UJZ?90Z7XT\(&T:5#J6D7 NR96/G;%A*DY/49.,= <#B@#OM
M/FOIHI3?VD=LZS.L:I+YF^,'Y6)P,$CG':K=>5:5;7]WX2O;;3[N W2>)+H0
MP7[LT=TJ2.?)=N3@JN><_=%=;X%OHKW2;Q5TR73+BWO9(;JS=PZPR@*2$8<%
M,,",>N.U '0WMY#I]C<7ER^R""-I9&]%49/\JH>&=?M_$_AVRUBU5DCN4R8V
M/S1L#AE/N""/PJEXD>YO;RPT:RBAF=G%W<QRRF-?*C8$ L%8C<^WC'(5Q7/>
M$7N/#_CK6_#5]%%;Q:F#JUC'#,752QVS(&*J<[@&P!P": /0G=(XV=V"HH)9
MF.  .YJ@VHSW-GIUYI-O'=V]V\;.[2^7L@9<^8.#N/3Y>.O6O-=*\/:=?>#_
M !5?W:37-Q:W6JPPF:X=PJ!F 7:3@] >03^E3-!;6WA#X</9GRB^H6 E$,A"
MN6@).X X).%/- 'JM8<.ORR>-KGP\]FJ+%8I>+<"7.\,Y3&W'&"I[FN0A?2_
M$4WBVVU_4&L[^QU$K%,LHCFM8%"-$T1.=H;!.0.23UXJSJES<VWQ$UNYL4+7
M<?A420(1DEQ+*5&/KB@#T*J][<M:6K2I \\G 2*/&78G '/ ^IZ"O/O"T%CJ
M,OAO7[/Q!:^<\)26*VB(DO"R999B9"692"<D9!!KN]5O)["Q:YACMG"<R&XG
M,2JOKD*V3G'&*4G9%THN4TDKE+2M>FO-4GTN_P!.>QOHHA,J&02+)&3C<&'O
MP16AJ=[_ &;IES>^0\P@C:0HA ) &3U(]*YNQN]4GU>34?L>DM=7$*QQQ?VF
MVZ.-<DC B/.223]!VYFU:_UFY\-:A(MAIC6[VDO[V+46?Y=IR1^ZP?SK%5/=
M>OX'HU,)>O&T4EI=<RWZVUO^)NV^HPRZ/#J4Q6"%X%G<NW"*5W')]JAMM5:X
ML7U!K5XK,1F1"V?,=0,YV <9'09S["N*UM]9F^'5G%)8VB67E6OFR)>,6,65
MZCR^!TSR<#/6M6PDUJQ\916\J(MA/:-+-&;][A8MI #@N@*YSC;T.">U$:WO
M)-::?B7/+XJE*2:O>5M5M&WGOK_5RU:^++L>(+32M6T*?3OMX<V<IG24.5&X
MJVW[C8Y[CWKII&*1LRHSD#(5<9/L,X%<U%>:;K&NV>IO>VWD6NZ.Q3S!NED?
MY3)CKC'RKZ@L>A%='%<0W!D$,T<GEN8WV,#M8=5..A]J]+$QBG%QARZ:K6U[
MOOKM:^N]SQHF;X;UQ?$6BQZDML]L'DEC\IV!9=CLG)''\-5=-U_4-3U)5AT*
M0:4Y;R]2-S'M=1G#! =V"1Q]<U0\ &$>!<SLBPBYO/,+G "^?)G)[#%5[7P[
M:>'/&&E2>'";>SOEE^VV4;EHB@0E90N?E(;:N1UW5TRHT8U:U.VJYN6][:7Z
MW6O:]UW%=V3.WHK!\:WEK8>#-5N+RYN[:W$!5I;0@2KN(4;"> 22!D],]JXN
M+=:^*?$VFQWMKH\<OA^.0"UDREM*3*/,[98* 20!P!Z9KRRSU*J]W?6UCY/V
MB58S/*L,0/5W;H!^I^@-<=X,GGMO$-]I.J:-#IVK)9Q.SV3[K6YB#,!(@P"K
M9)!!YX'I1\0[*TN=2\'-<P12?\3M(B7 /RM%*2OT) _(4 =S17G5BEKXBU3Q
ME::L0KV4B1VAW8^S6YA!22,_PDG<VX>@]!72>!+S4=0\":)=ZMN-]-:(TK,,
M%N.&/N1@_C0!T-%>:7$EQIGBI+C4+.'4=+O-7$=OJEL^)[64ML$,JG[T88%>
M#@=<9Q6+JL\=O\./' ,PC>VU^5;?+X,7[R/ 3T^4G@=L]J /9:PQK\O_  G)
M\.M9J(_[/-\MR)<EOW@3;MQQU/.37,SRZ=KOC#Q7HNOW*PB"W@^PEY ABA:/
M+31$\!@Y.6'(VKZ5&=,L=6^)%C:7+SW=HWA@<RR$-,/.7!?&,D]3[]J /1J*
MY'X8SRW'P\TMII7E9#-$&=BQVI,ZJ"3Z!0/PK)N]'M-6^)7B"SO3/+;-H]O(
M83<.%W%Y1G&?8<=,\]: /1**\F\,:I<:G_P@.GZPYGL+S1Y9,3'<MS<)M #Y
M^]A-QP>YSU%5-92ZM]"\3V*7%P-.L->LX[!UF8; [PF2,'/*J7( .0,X[4 >
MR54OIKZ%K465I'<!YU2<O+L\J+!RXX.X@X^7C.>M<*GA[3F^)VHZ0T<ITZYT
M>*ZFMC.^R2;SI$WMSR<#^O7FL73KB>?P-\.;F6ZG>;^V8X"QE;YT!F ##.&X
M1>OI0!Z_17D.L:9;W*?$Z262Y=K +/:DW+_N9!:*X9>>H;IZ=!WJWKMU;ZI;
MW@DE\^]@\-I/,;J0"*WWAB)(UQDRDCJ", +SGB@#TN6^MH+RWM))5%Q<;C%'
MW8*,L?H,C\Q3+.:^EGO%N[2."..;;;NLN\RIM!W$8&TYR,<]*\ULTL]1\3?#
MZ_OA#//-H4SS32D$LZI P))[@LQ_$U6O]1N]'T3QQ);3W"Q)K\,4TWFLSPP,
ML D(8G(X+<]LYXQ0!Z]17!WEBFG_ !"TFUTE3%I^I:?<_;X+=BB;4V>7*-N,
M-E]NX<D'VKE- MUMO"WPXUF.6<ZA<:A';S3M,S%XG27<A!.,< X]>>M 'L]8
MVJZMJ-E<2)::4+F&&W\^29[CRE')^4?*<G"D_E6I%<P7#RK#/'(T3[) C@E&
MQG!QT."./>H-6_Y U]_U[R?^@F@# T+Q7J>NZ;IFHPZ"$M-1C+Q/]K!*':6
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MJ?B32M'FDBO+AUDC@-S(D4+RF.('&]@@.U>#R?0^AJ&[\6Z'97%K;S7X,MU
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M\(8$JX5U!(."00"#CO5:R\5:'I^DZ)'<:U)=&_MPUK<31-ON@$W;B O!('3
M)/'4T :A\/:*=/CT_P#LFR%G$^^.!8%5(V_O* , ^XITNA:1<6*6,^EV4MHC
M;U@DMU9%;.<A2,9SSFJEOXNT.YTE]3CO3]F2X^RMNA=9!-D+Y?ED!]^2/EQG
MD51UGQUIFF>&-6UB 3W)TXF.6 0.KI+@$*ZD J.0=QXP: -O^Q-)^V->?V99
M?:FC\IIOLZ;RG]TMC./;I4*^&=!6W@MUT331#;R>;#&+2/;$_P#>48P#[BJD
MVK6,_B'181JEW;3S+.T5BUNR"Y 7DN&3*[<9'(Z]\BIY_%.C6T_ES7A5?/\
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M=10!K/X?T622[>32+!GO!BY9K9"9QZ/Q\WXTAT#25:WDBTNPCGM$*VL@MDS
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MK)>ZE=&ZN&084' 557/8*H&>YR>,X !@)J6J:EXN\6Z3>16DFF6EG;A8RY)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH " 001D'M4%M96MF&%K;0P;CEO*C"Y/OBIZ*
M "BBB@ HZT44 5[:QL[,L;6U@@+_ 'C%&%W?7%6*** "BBB@ HHHH **** "
MBBB@ HHHH *@@L;2U=WM[6"%W^^T<84M]<=:GHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5]>17+M!82&&Y;R) 8W'52-N21D9QTS57^W+"#6=8E.K7-Q]CM(Y)M/2 MY
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MJ.K?\+(\C2;]/[2T^$6?FP%/.*P,,#/?)''7G! .17JE,>:*-T1Y$5G.%#,
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M@91NVRY0 9'0@D9&/>NJ(R"#W]#7+^&=*\5:>MO::UJMA<V=FNR*2WA=9K@
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MD#OFG:CX]GTJS\1)<:7&=2T2%;EX5N"(YX6!(=&VY[$$$<$=3UJK8^ M1LM
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M X=5OKDW6I0SG489%C +K!O"X50!M;TY]2: .N\1:]:^&=$N-6O8YWMX,%Q
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M;6[V"[FCN7$#QOO<0G!19#M7+@'KCD8- &K<7D5M+;Q.29+A]D:*,DG!)/T
M!)/]2!6=J7B6PTO2+S59Q,UE9LRS2QIN"[3AL#J<'@X[@^AJ76/#^F:]]C_M
M*V\XV=PMS 0[*4D7H<J1^1X-<GXZ\/Z9HWP^\9W=A;>3-J%N\]R0[$._K@G
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M"XOEB:15PPP$QM5F;CIU&<&BFOZ_+X5TN0:K/#<KXG_LR1RJ,9(?M!0!^.2
M ,C&<<YS0!ZM17GBZCK^FW7CC3K*\GU.XT^SANK#[4%+B21')7Y0 1E 0,>U
M.L-1U*77;&YL-2O[G1UTDW5ZK*I!G&-JDLI*LP+912N,#@=P#T&BN T&?Q+J
M]IX=\10ZC:K;72I)?1R7):.1)!]U$\L;&5B /F[8))YKOZ *&K:S8:';17&H
M3K#%+/';HQ[N[!5'ZY]@":OUP'C+3SXNN-1T@Z;=7=I:VK1)) 8P([MP&#'>
MZ\HNPC&?]8U00>.;L?"3^V9<1:M:NEA>>8 ?(G$JQ.S#IQG?CZ4 >C5S^H:C
MH%KKNE"XLTEN]1)%M>):^8H( QF4#Y<Y&.>:S-?TR_LM+UYUU^Y:SDTF5HX&
M;]\DR DR+)U"D%00!@'IBKW@[3HCX-\.R3/+.T=E#+'YKY"$Q*. ..!G&>F:
M )].\7Z7J=O]HC%S#$MT;-VN(#%Y<O&U6!Y&[<N#T.0.I K>KGO%&FVW_"$^
M((%3:)K.>1W+$L7V'#9/.1@8],#'058\)7\^J>#=$U"Z)-Q<V,,LA/=F0$G\
MZ -FL.Y\4VD%\UO':7MTD=TEG//;1!T@E8*0'&=V,,N2 0-PR1S6V1D$9(SW
M%>2VNI7'A3PUX_UNWN)YI[76)HXUF(9-S+ HD88Y(W9/L* /6Z*XK4+C4="\
M6>';2#4;F[L]7\ZVN%E*NRNL9=9DXXZ'(^[R.*C^'@U;5-)M]:U'7;RZ;S+N
M V[+&(V"SNJL<*#N 7L0,<8XY .YHK+\27;6/AK4;J._AL'CMW9;N9-Z0G'#
M%>^#V[^]<YX?U+4%\>W.DRR7OV)M)AO$2](,@D,C(6&"2H8 ?*3QCH.E ';T
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5GZUHMEK^FM87Z.T)=) 8Y"C*ZL&5E8<@@@&M"H[B
MX@M86FN)HX8E^\\C!5'XF@#)B\,6$&K/JD4ETMV]J+0R&=F_= D@<YYR2<]<
MD\UGS?#SP_-H5AI/E7*0Z<Y>RECN'6:W)Z[) =P_SZ"M#4?%>B:9%923ZC;%
M;V=8("LJD.Q/)SG&!U)[?E5^?5-/M3$+B^M83-CRO,F5=_\ NY//7M0!E2^#
MM*EMM/@)NMMA<"ZA?[0Y<S<CS'8DESR>N>M&N>#=)U_4+?4+D74%];H8TN;.
MY>"0H3DH60@E<]JV;N]M+"'SKRZAMHLXWS2!%S]36#JFO7=KXM\,V%JUM)I^
MJF<2-M)?Y(BZE6!Q@\=J +%[X2TJ];37VW%L^G*R6[VMP\3*C !E)4Y(.!GO
MQUJLG@+0XK..TB2ZCACO_P"T55;E\"?=N# 9X )Z#CU!IGBWQ-)I>A&_T>XL
M;AX[N""96/F8$DJH?NL,$;L\^G2NAMKZTO&E6UNH)VA;9*(I Q1O1L=#[&@#
M*E\(Z3<7>JW%S%)<'585@O$ED)21%!"C';&3@C!YJ"Q\#Z38WNG78EU":?3E
M=+5I[V1_+5@ 5QGD84#!_'/%;5OJ5C=SR06U[;S31?ZR..569.W(!XK&\*:Y
M>ZLNN_VB;=3I^J36:-"I13&BH03DGGYCGF@!FF> ]#T?4GO+&.YB4R-*EK]I
M<V\<AZNL1.T'D]N.V*T]%T&ST&.YCLC-MN9WN9!+(7S(YRS#/3)[=*R+/Q.]
M]\0'T:VN;&YTW^S#=K) =SB3S FTL&(Q@YZ#K700:E87-Q+;V][;2SP_ZV..
M569/]X Y'XT 3RQ1SPO#*@>-U*LIZ$'@BN7M/"$$OA>+PSJ:2R6EBZ&SN8Y2
MCA4;,1!!RKH ![XSW('0P:E8W4PAM[VVFE*>8$CE5CMSC=@'IGC/K5/5?$FE
M:+>V%I?WD4,]](4A5W Z*6+'/0#&,^I [T 4E\#Z,DU],OVT37HA\^3[9*69
MHB"C9+?>!4<]>*U-/TBVT^XN;E#)+=76WSYY3EW"C"C@   $\ =SW)J6?4K"
MUGB@N+VVAFEQY<<DJJS_ $!/-6J *FI:=!JMBUI<&58V9'W12%&5E8,I##D8
M*BLZ;PEI-W9W]O?0M=_VAL^TR3-\[[/N8*XV[>V,8//7FM"75M-A;;+J%I&W
MF^3AYE'[S .SK][!''7FI(K^SGNI;6&[@DN(<>;"D@+IGIN Y'XT 5;#1+:P
MNFN_,GN;LQ"'[1<2;W$8.0H]!GD]SWSBKUQ;Q7=M+;3H)(94,<B'HRD8(_*J
M\.I6=Z\T%E?VLMQ&#N5) Y0]/F .>OTK$\(>)VU;PC8ZIK$]G;7-Q+-'A6\M
M"4E= %#$GHH[T %EX"T2PETV:'[<9=-5DM7>]D8QHP V<G&T8&!TXI__  @V
MC_V+_9'^E_8OM/VO9]H;/F[_ #,YZ_?^;'3-;4NI6,%W':37MM'<R_ZN%Y5#
MO]%)R:M4 8S^&--FU:YU*=99Y[FT^Q3"5]R20\G85Z8RQ/XFJ>D>!='T.&6*
MR:^\MHVAC66\DD%NAZK$&)"#Z<^];<&I6%U<R6]O>VTT\?+Q1RJS+SCD Y'/
M%-&K::98HAJ%H9)F9(T$RY=EZ@#/)'?% &5%X+TF&TTBUC-T(=(<262^>?W9
M *CZ\$CG/6JMW\.] NUU&)DO([749/.N;6&[=(7DR"7V@X!.!G'UZ\UT4>H6
M4TLL<5Y;O)#GS%6524QUR,\?C4L%Q#=0K-;S1S1-]UXV#*?H10!SVH^!-$U+
M5(]2D%[#=K$(9);:\EB:>,=%D*MEQ]>?>I[OPAI-UJT&IHMQ:7<4(M]]G.T.
M^(=$;:1D#MW':M*35M-A<)+J%HC&7R<-,H/F8!V=?O8(XZ\T^\U"RT]%:]O+
M>V5CA3-*J GVR: *V@Z%8^&](ATO35E2UBSM625I",G)Y8G')/ XJ/6?#NGZ
MY-93W?GI<64ADMYK>=HG0L,,-RD'!'!%:$EW;0F,2W$2&7/E[G WX&3CUX&:
MK?VWI)MH[D:I9>1*_EQR_:$VN_\ =!S@GVH QQX!T)+9[>-+I(FOAJ&T73X$
MP;<&&3QAN<=,]<U;E\)Z5<7VHW=S')</J4"VUVDLA*21KG V]!C<>1SS5V>:
MY76[2)+JS2V:*0R0.#YSL,;2G/0<YX/44\:MIK2Q1+J%H9)F98D$RY<KPP49
MY([XZ4 8UCX%TBQN]-NEEU":730ZVAFO9'$2L "H&>1@8P>W7/%=+5674K""
M[2TFO;:.YDQLA>50[9Z84G)JG%XDTJ?Q#<:''>0M?6\:221[QD;MV%_WL*21
MV!'K0!1F\#Z/<:?JMC+]J:WU6;S[Q//;]X_&3GJ/NKP,=!5T^&[%]:BU:5IY
M;N.V-H"\F5,1()4KT.2 3]*DTN\E&BK=:G?V$K*7\RXMCMAP'('))Q@8!YZ@
MU9CU*QELFO8[VV>U7.9UE4H,=?FSB@#&T/P1HWAZ<R:>+M47=Y$$ET\D5ONZ
M^6C$A<Y/.,\D=":/^$(T8Z'=Z05N#:W5P;I\SMO68OOWJW53N&>*VX=0LKFX
MDMX+N"6>( R1)(&9 >A(!R,U.S*BEF("@9))X H YQ? ^C+/=SM]M>XN[=;:
M>9KR0NZJ202<_>R>O4=L59E\*Z?<P7Z7+W,\E];BTGF>3]XT(W?(",8'S-TY
M.>M:$&J:?=02SV]]:S0Q9\R2.965,#/)!P.*YK0/$FH^)YX[[3+G3#IRW<T,
M]J^3,L2,R+(&!(R2N<%0,-UXR0#;N/#FFW?AH^'[F)IM.,(@V2,2=@Z<]<C
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M+"?RKV?+!E+H&AC3.UI#@'G)P,8.:=\)[B.?X9:*$DWF&$Q/_LL&/'X<5V9
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M2.M=;CG/>D(!&" 1[T >%ZI=:>_@GQY!/=12R#7HIHV=0APQM_G4=LX<@CJ
M3SR:[>Q.F6OQC:WL#:1++H"DQP%5#$3$C@=3M/Y5WV ,\=:* "BBB@ HHHH
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MPUW2HK1KQ9 #"RI*K?)U.=X([>]11:#K.K:'X:T;5+#[*VD75O-<70E1HY1
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M,7.2Y)&>%Z#K7-OXCUK7M$\"Z@MU#:27^IF&YC2$E'9!+@X+9QF/.W/4]>*
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M +\@=,9)VJ[,1R3CC%=Q10!YUX36[BU.W&E:ZVHV+-BYB?1%M%5-IP=ZJGS
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MZTE=>F-A=&42"2W5I460DLD;\ #YB!N5B/6H;_P*AOM/OM"U6YT2[L[1;$-
MBRK);K]U&5P0<=CVS7744 <GJ7@C[1=:=J&G:S>:?JUE&\7VT*DIG1SN<2*P
MVG+?-T !/ Z8GG\)M+?:)=C4YC+I4LDP>5 S3O(I5RYX'(8X   [< "NEHH
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MJ11@EL*F3U8Y.2<X'0#%+X6T#_A&/#]MHZ737,-L"L<CH%;!)/..#U]JV:*
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M0D9(AY(Q+NC\L[N?[OIWY]JNW/AJRN?%=EXB?>+NUMW@ !^5PQ!!/KMR^/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !116;K>LPZ%I_VN6WNKEBXCCM[2/S)9
M6/9%[G )^@)H TJ*R]"UDZY8M='2]1TX+(4$6H0B*0X .0N3QS^AK4H ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "N?\4>$X?$Z6I;4]2T^XM&9
MX)K&?RV5B,9/'/''T)]:Z"LC5-#EU#4;>]@UO5-/>%"ACM9$\N0$Y^9'5AGW
MQF@#.\#7VKW&FW]AKDJW%]I=\]DUTJ[1<*%5U?'8E7&1ZBNHJM8V%OIUJ+>W
M4A=Q=F9BS.Q.2S$\DD]ZLT %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %5K_4+72[-[N]F6&!" 6.3DDX  ')))  '))JS7/>,M"?Q!HT5I;:
MA]@OXKF.XLI\!@)H\LN5/WA@'(_'M0!=L?$.FZAJ!L(995O!$9C!/;R0OL!
MW;74'&2!G_ UI@@C((/;BN!T'Q%J<_B5-!\5Z8-.\0?9)1:7]HP>&YCRI<Q[
M@<,"JG:P/3\*H>$[[4[?X;Z1=G6F$EW?.LTEPJO)M,TNX0JJ$O(QQP0>_3%
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M>,[C]W&!CKS3)]3\27WB3Q!IT&JQ6,=IIUO=0^7;)(T;N),KELAAE!DX^F*
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ML[>4O[R0*&Z?[( X^E>3WPNW^%'CV6ZU&YNV6_O(?WP3^"4*#\J@YP ,=..
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MUW=16EVUY;PS%"(Y#NZ$*&(&\X!/IUP*S;CX<Z?<6]Y:G5-4CLKF]%\+:.5
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M<Z39VTUE9ZD;"Y$LA23"@;Y%/3Y2<;>^.HZ5MZGJ=IH^G37]],L5O"N68_D
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M%0VYC&$:)\GY,;1@GY<'J.E9^A^&M1\/ZIX(M9()IXM+TVY@N[B-<HDDGED
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M.6PK9;(Z]*M7/BW4)],US5M*MK::TT>>6%X9=WF7/E#,I5@<)CY@,ALX[9H
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M>B7LVH:?]IFEM)E9V\J:T;='+'_"PY/7TSP?6@"Q?ZE8Z7;^?J%Y!:P_WYI
M@]>IJ>&:.XA2:&1)(I%#(Z,"K ]"".HKB+W^T)OC!:6_F6S6PT:9A')&Q&PS
M1!^^-QP.>F.U1+XODL/!0\2Z9I]H/#MK(8UM(D*R?9TD,9D4@[1T+!,=.^:
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MV[?ZJ.,=.]8UMX!O;?P]H>E#5X&_LK4_[0$ILS^]^=WV8\SCESSD]!Q7=44
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M2A5"6A'EL@=EZX1FR>..O:@#TP>(-':PGOO[3M!:P,5FE:956)AV8D_*?8U
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MF[S$,;[E7U)X^4<GCTK+\/QW.@6_AC1]3M;BTN_['E7[:MNTTOS2 BU7@JI
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M*JI)( <M]T>Q/;U[5H5Y-(VF-?\ B+PUXIM-6EGO=0DGMH81,8[V)B#'M9.
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ME=NX4J#R>&)7KD5H88>#/&?AO587?6;BYO&@A*$M=^;S"\?]X [1Q]W;SC%
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M<X]* .VHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZW8:?9M?"TM-UTRR[ I="RJO]Y]N&QP,$<\XJS\/R3\.O#9)R?[,M_\ T6M
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M5>@E1BCX]MRDCV-5]4\6RV/B,Z%::)>7UZ;(WD?EO&B.H<+C<S<<GJ<>V<T
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M/>N?M/B7%<6VC:A-H=_;:1JLBP17TC(521B0H90=P!(QNQC/MS0!TOAG1/\
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M+#(^\!G(YR..:T* //-/\':LW@RS\(:A';)9P7*R37<<Q;S8UF\T!5V@AB0
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MVD.68*.%!/4\^E7* .6\':==>&?#,EKK+6L&VZGF\Q9LIMEE9QDD#!^;%5/
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MA2'4+2*YB1PZI(,@,.AQZBH=(UG3]86[6PD=Q97!M9@\;(5D502,, 3PPYH
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MTN4\R)RI7<OK@\BBVU"VOKJ]M8Q(7M)%CEWQ,JY*AAM)&&&".10 W1;RYO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLH9&AV$L1GC#$\$=Z9\5HI7\!W+1W,D(6YM0RH%(?-Q$.<@].O&/?(J]X?\
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MAB,YQE@<=/2@#GKO4-<TW6+'1Y]0>\GU1I[A'MK>*-X(XU3,:;SM;YGSELG
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M[BROO.\WSF3</-)+X*J.I8GVH PEU#5-(M_ MM#?F2WOY4@N!+$FXKY#. "
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M!CN<TM/2WL7G=]:U6[>6$Q*;G4;<^4#U90" &X')STKU<+2DL.[RU>GRO?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG';F@#?HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBO1/$^I7.E6FG7NGZNZ7$B3W+1FTG"*C'.P[T(53C /':NT@21((TED\R15
M9]N-QQR<=JDK(U?Q-I6A"0W]PZB%%EF,<+R>2C$@.^T':I(/)]#Z&@#B]?\
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M!0!SD=UXFE\7:MX=_MR%52RBO8;H62[XM[.I0+G!&4!R<G''N*VA>+]6U1O
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MGX'%O?Z/=SZ_JMW)I D6U\XQ?=90I5L("W QD\^]=+>VD5_8W%G."8;B)HI
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M;)#:Q3K=ZC;V4A>0J8Q*X7<  <]>F16FDE^=6EC>" :>(5,<HD)D,F3N!7&
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M0DCGOF\,K<2-J#@VZHP0,^P\O+D8ZC )R>>:&B"#6;'X6&ZF-PSI/#/^^)+
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M Y(##CUR,BN&\-?V?K]CH^H7NMP6OB&UU#-S'%$JWC3[RKPN2VXH<],8"@=
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M4;5?.\*NT<[F/"R28VP.OJ&C)<_[6TUT'Q%0/\.?$).<I83.I#$8(0D'CWH
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M&P>7Y>-NW'&,<8Q7E:7=C;Z!XH2^:4Q3^+6@58Y1&KN7BPLC$$",X^;C[N:
M/4+V]MM.L)[Z[F2*V@C,DDC'A5 R34L<JRPI*I^1U##/H:\8U(6KZ+\4=/+6
M$D<4,<\5O;J/*C?R 69%R<$,!DC'(SQ6W>W>E1>(=#TJ>;2[719],=K<30H]
ML]QN7>",A=^T@C/J?7D ]/HKR6;0]-CNO VG)J$NIV/V^[A69W.'C\F0[ 0?
MF0'Y1[#'2O4=/T^UTO3H-/LH1%:P((XHP20JCH,GF@#"\1^+4TKPMK6KZ9'#
M?/I3,DL;2E%W* 6&0#DC<./7(R*Z.-_,C5NY )%>,7%MIMK\.?B0D$%I#<K?
MWR!8T57$89,#CG;R..G-=%+!8>'OB'%-;J]O#<>'KF>\:$DO*8WC(<_WG +8
M)YYH ](R#WHR/6O(= FL(O%?@UK66UAMK[2KA603!IY5(C*&=Q@/(22>G#;L
M$U0L=/L[?P)H>KQ)B_A\2B..X+DNB&^=2@)/"E2<CH<\T >VUR^M>+ULM$LM
M5TR*&]MKC4([(N92H&Z;RBRX!W8.>X]:Z66*.>)XI462-U*NCC(8'J".XKQ2
MQ@T]?@[H\<"01SOK%N+CR<(__'Z0NXCG@ X^G% 'MU&0:\EU@2>&]4\=Q:!$
M;<#2+:Z\JWR,.6D#R*/[VT9SU) -;WAJUT.;Q':ZOHVMVDIGLRC6NGQ*B2)D
M$/*H)(93QDX/.* .\HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ J.XMX+NW>WN88YH9!M>.10R
ML/0@\&I*S-:U_3O#UM#<:G,T,4TR0*XC9AO8X ) PO)ZG H D71-)33#IB:7
M9+IYZVHMU\H\Y^YC'7VH;0])=9%;2[)ED55<&W0AE484'CD#MZ50@\5:3J,6
MJ1QS7<,E@@-RKVLD<L:L"5=59<D$ X(!Z54LO%>AZ;H^@QOJ5[=+J$ ^QSSP
MN\ER F[+$+]\@=.I)X% &[+I&FSVT-O-I]I)!"<Q1/"I5/\ =!&!^%.33;"*
M\-Y'96R73#:9UB4.1Z;L9Q6?8^*M)U#3+C4(II$BMYS;3)+"Z2)+D#84(W;B
M67 QDY&*S=7\>Z;IVB:W>1Q7,EWI,8>:S:%ED4L,H2"/N'^]TX/?B@#>M]$T
MJTEN);;3+*&2YSY[QP*IES_>('S?C4UG86>G0F&RM(+:(G)2",(N?7 K#EUF
MQN=8\/)+>ZC:75R96@M1"\<=QB,[A)N7HH!(&1S@\U9NO%FD65Q''/-(L;W'
MV47'DL81-G&POC .>/3/&<\4 :EW96M_ 8+RVAN820WES1AUR.AP:A;1M+:6
M:5M-LS).-LSF!<R#T8XY'UKD]2\7/J6G^,;2R6]LI](@D$=P(2"76+?G)! Z
MC /)'-7O"WBVQOK31M-FN+AM1N-/CF#RPN%G(1=Y60C:Y!/.">M &X-$TE3;
M$:79 VI)MR+=/W)/79Q\OX4)H>D1^1LTJQ7[.28<6Z#R\G)V\<<\\57\3ZXG
MASP]=:FT?FO&%2&+./,E9@J+^+$?A6-J>H7EGK_AOP[)?2!]3%Q+<W285G,2
M [$_N@EL\<@+UR<T =/:Z=8V+RO:6=O;M*<R-%$J%SZG YIUU96EZ(Q=VL,X
MB<21^;&&V,.C#/0^]>=7OC34M&@\1Z/YWVC4++4+6RL;F5021<A2F\# )0%O
MKM&>YK:EUR;PWXO72;J>ZO;.YTV2[B+*'F$D3 .HP!D,&!QV(/0'@ Z,Z'I!
M$X.EV1$YS,#;I^\/^UQS^-)<Z%I%[!!!=:58SPVYS#'+;HRQ_P"Z"./PKA=0
M\8S:EH?@[78)[JPAO-4@2XAV%5>-T=MO(RW0?=.#776>LVOB:TOHM+NKBVN[
M23RW$T#120R8#+N1P"5((//4'\@#<  & , 53NM(TV]N8[F[T^TN)XQA)985
M9E&<X!(R.:I^%]=7Q%X?M]0\L13$M%/$#GRY48JZ_3<#CVQ4/B#7K6SM-0M8
MY[D7<-J9I&M83(T"D':S<$#H<#KP3CB@#4ETRPFNUNY;&VDN5&U9GB4N!Z!L
M9J,:)I*V4MD-,LA:S',L MUV.?\ :7&#^-<WX6\41)X-\.'4)[B[U.\TU;ED
MC1I99 JKO<X[98?4G S6JOC#1)#H_EW,DBZP,V+I Y67C.-V,*< G!P>#0!K
M6EG:Z?:I:V5M#;6\8PD4*!%7Z <"F3:;8W-U'=3V5M+<1?ZN9XE9T^A(R*2W
MU*VN;^[LHC(9K7:)<QL%!89 #$8)QSP>]9FJ>,-'TC4FTVYDN6OA!]H%O#:R
M2.Z9 RH53NY/;.,$G&* +XT321:W%J-+LA;W)S/$+=-DO^\,8/XT+H6D+&T:
MZ58A&C$3*+=,%!T4C'0>G2LH>/?#C:9IVHI?,]KJ,ODVSI!(VZ3GY" O#<'Y
M3R<<9IEKX@TK5M?TEH+_ %**>>VG>*RD@>*.50P#,X91\RD8'(Z].: -E=&T
MI'MW73;,/;#$#"!<Q#_9X^7\*C?P]HDMU+=2:/I[W$Q!EE:V0NY!R"3C)P0#
M^%57\6Z/%)&'G=8)+C[*ET8F\DRYV[-^,=01GIGC.>*BF\:Z)#K$VE&6Y:]A
MFBAEC2TE;8TGW22%QM_VNG(YH UX=,L+:[DNH+&VBN9?]9,D2J[_ %(&33(M
M(TR#49-1BTZTCOI!A[E(5$C#W;&35#Q?XB7PKX8O-7:WDG,*@(B*3EB<#=CH
MN2,G^N*L3:_90F!-MRUQ.C2);+;OYNQ3@L4QD#)')QG(QUH =-X>T6YNI;J?
M2+"6XE $DKVR,[@$$9)&3@@?D*T0 JA5  '  [54TK5;+6M/COM/G$UO)D!@
M"""#@@@\@@@@@\BJUSXAL+6ZDMW,SF&6.&5HH6=8GDV[58@<$[E/L""<9H O
M0V5I;3SSP6L,4TY#321QA6D(Z%B.I^M*+2V$:QBWB\M7\Q5V# ;.[<!ZYYSZ
MUE2>+-(B@U>5YI@ND?\ '\/L[YB&W?G&,D;><C/%2W/B/3K>*%P\LS36_P!J
M2.")G?RN/G( R!SWZ]!S0!<O],L-5M_L^HV5M>09W>7<1+(N?7!!&:;)I.FR
MFW,FGVCFV $&Z%3Y0'3;Q\OX5QVI^*8CXM\)WUEJ<\VCZC:7<GDP(7$Q54*$
M(!N+?,>/T&*ZW1M:L=?TX7VGR.\6]HV#QE'1U.&5E8 @@CH: 'KHVEJEPBZ;
M9A;D8G @7$H_VN/F_&E&D::LT$PTZT$MNH2%Q"NZ-1T"G' ^E5KWQ#86$\\4
MIF<VX4SF*%G$6[[N[ XS^@Y.!S6;J/C_ ,/Z7<7]O<3W336&W[4D5G*YB!&=
MQPOW<<[NG(YYH VDTC3(]3;4DTZT6_<;6NA"HE(]"^,_K1+HVESM<--IMG(U
MQCSR\"DRXZ;LCG';-5Y/$6G"UMIX)'NUNH?/@6UC:5I(^#N  Z<C\2!UJ.#Q
M3I%WI]E>V=R;J.^#&V6&-F>3;][Y<9&.ASC!X/- %U-(TV.XBN$T^T6:%=L<
MBPJ&0>@.,@5)?6-MJ5A<6-Y$LMM<1M%+&W1E(P17.WGB;1-2T_2+N+5[RWAN
M=2C@A:WC93),'V^3)E3M!.00<=.M7;WQ?H]A<3Q3SR!;::."XF6)FCADDQL5
MV P,[E^F1G&: +UKIY&E+I^H&.]C1?+W2H#YJ#H7!XW>O8XSQG <VCZ6UB+%
MM-LS9@Y%N8%\L'UVXQ6!'=WB_%B:P-Y,]D=%6X6W8C8C^<5)  ]!WS6SK.OZ
M=H$5M)J4S0I<SI;QL(V8;V. "0,+]3B@"6RT72M-F,UCIEE:RLNTO! J$CTR
M!TX%2Q:=8P7<EW%9V\=S)]^9(E#M]6QD]!6$?'FA@WJ?Z>;BRP9K;[!-YP4@
MD/LV[MN ?FQC]*T#XDTU[*TNK:22[2[@^T0+;1-([QX!W;0,@<CKW('7B@"S
M-H^F7$D\DVG6DCW "S,\"DR = Q(YQ[T@T?38WBFBTVS$UNNV!O)4&/V4XRH
M^E5(/%&DWFFV=_97#7<5X&:W6"-F>3;][Y<9&#P<XP>#R:RK[X@:;';://8Q
MW%W'J5[]DW) Y,3#)=67&0XVD;<9[]* -W2M)33GN[AF$EY>R^=<RXQN. J@
M#LJJ  /;/4FK5W9VNH6KVM[;0W-O(,/%,@=&^H/!K#CUK3(O$.K.VHZ@9;2S
MBDN+1X7\N%,L0ZKMR6/.<9^Z/2ET[QOH6J7>GV]K/.3J,1DM)'MI$CFPNXJK
MD;2P')&<C![B@#2BT'1X8)8(M*L4AE01R1K;H%=!T4C'(]JAN]*^R6,LGA^R
MTRVU)8!#;O+!B-5!R$.S!V]>!WJO>^,=%L!,\\\OD0W M)9XX'=$F./DRH/.
M2!QQDXZ\5MI,DD"S E8V4/EU*D#&>0>1^- %#1=/N+&VEDO98IK^ZD\ZYDB4
MJA; 4!023M"JH&?3/>H/%FEW6M^$]4TJS,*SWML\"M,Q55W*1DX!/&>E-@\6
M:1<7-G"LTBB^S]CFDA98[@@9PC$8/'(]1R,BH;/QKHFH:I_9UK+<R7 N7M6'
MV24*DB+N(8E<+QTSC.#CI0!<T;1;73=.BC.GV4-P85CG-N@P^!SD[02.IY'>
MK$6CZ9#9R6<6G6D=K+_K(4@4(_U7&#5VN?LM4L&\0:\L5]J%Q/:K!]HLVB8I
M!D-M\M=N3NP2<9S@4 :<FCZ9-8I8RZ=:/:1D%(&@4QJ1T(7&!1+I&F3VD=I-
MIUI);1<QPO I1/HI&!7)>!KNZ\46.G^(I-0U&&8F8W%J586\RLS!%4,,?( .
M5YX^;.:Z6_\ $-AITL\<QF<VT:R7!AA:01*V<%L#C.#] ,G YH U%540(BA5
M48  P *A:RM&O5O6M83=HGEK.8QO"_W0W7'M5 ^)-,%SJEMYDWG:6BR7:"!\
MHK E2./F!"G[N>E(OB73);*PN;>22X&H0_:+6.&)FDDCP#NVXR!AEY..2!U(
M% %N#2--M;R2[M]/M(;F0DO-'"JNQ/7+ 9.:M21I+&T<B*Z."K*PR"#U!%<%
MJ_BN"XU?P;JFF:K.VD7MQ<)+'$IQ+MADP"N-Q8.,;?4=,UUNBZ[8Z_:RW%B\
MA$,S031RQ-&\<BXRK*P!!Y!_&@">STO3]/W?8K&VMMX ;R853('0' ]S45MH
M.CV9C-KI-C 8W:1/*MT7:QZL,#@G YJ+4O$-AI;SI.9G:W@%Q.(86D,49W89
M@H[[6]_E/I5'4O'&AZ5>W5E<2W3W=K&LLL,-G+(P0YPP"J<KP<D<#N: -=-(
MTV/4GU*/3[1;]QM>Y6%1*P]"V,FH_P"P=',4L7]DV'ERMOD3[,F';U(QR:@B
M\3:5<Z=97UI.UW%>H7MA;H7:51U(4#(QWSC!P#R:9;>*]'O--M[ZVN6E2XE:
M"*-8V\UI5SN39C<&&TY!' !)XYH V(XTAC6.-%1%&%51@ >@%4XM(TZTG>ZM
M--LX[H[CYB1*C$GKE@,\]S6#J?BC1+_0&N?[5OK.%+]+222VB998YUD4>4XV
MG;DX4YX(;KS6AJ?B[1](FNX[J>3%DJ/=O'$SK;J_W2Y XSC/L.3Q0!G^#?"?
M]A:>5U&STY[X74\Z7,(WMB21GQN9000&Q6_<Z1IE[>07EUIUI/=0?ZF:6%6>
M/_=8C(_"L"ZO+R/XI:7:+>S&RGTNXE:WR-F]7C ;@<G#'KFMO6]=T_P[IYO]
M3E:*V#JA<1LX!8@#. <9) R>.: );S2--U">">]T^TN9H#F&2:%7:,^JDCC\
M*>^G6,EZEZ]G;M=H,+.T2EU'LV,BL4^.-%^UW5F/MQN[=!)]F%C-YLJ'(#QK
MMRZY!Y'%6X/%&E7>F65_:3/<Q7JE[9(8F9Y /O?+C(QT.<8/!Y- %F+0](@9
M6ATJQC*R^>I2W08D_OC ^][]:FM=.L;*262TL[>!Y3F1HHE0N?4D#FL^U\4Z
M3>Z;#?6L[S)-*T,<:1-YID7.Y-F-P88.<CC&3Q63J7Q TVVTRUN[..XN3-J<
M>G21B!PT$A<*X=<9# '@=2<8R.: .FNM.L;YXGN[.WN'B.8VEB5RA]1D<5$=
M%THM<,=,LBUP,3DP+^]_WN.?QK,75M/?Q:T8OM1%VFF^<U@87$?E[Q^\V[<E
M\G;P3W&,U%8^/O#VHOIPMKF=H]1<QVT[6LBQ.XS\F\K@,=I^4G/% &K<:!HU
MU;06UQI-A-!;G,,4ELC+&?\ 9!&!^%2W^E:=JMNL&H6%K=PJ=RQW$*R*#Z@$
M&L_4/%^C:6+Q[F>3R;)UCNYHX6=(&;!"L5!Y^9>F<9&<9K7AN([BU2XC$GEN
MNX;HV5L?[I (/MC- $<VG65S'!'/9V\J0,'A5XE81L.A4$<$>U1-HNE.UPS:
M99,UQ_KR8%)E_P![CG\:R-%UW2DT=[J#4KZ^BEOY8(S<(WFF7><Q*I4'"X(&
M1P%Y.!6UI^HP:E \L E 21HF66,HRLIP1@C/^/:@",Z+IH,3Q:?9QS0+M@D%
MNF8?]WCC\*XJW\ 7,]K]AU?3?#-P2I6355M3]JD)ZR8(^60]=VX@'G':NHU+
MQ=H^E37<=U/(!9^7]KD2)F2W\S[F\@<9Z^PY.!3;_P 8:1IVJ3:9*UU)?0P"
MX:WAM)9':,G *A5.X9!Z9Q@YQ0!N@8&.WO5"'0M'MQ&(-*L8O+=I$V6Z+M<C
M!88'!(ZFLY_&^@);Z5/]L=XM54M9LD$C"7"EB.%^]@?=ZYXQFIK/Q;H][I-U
MJ2W#Q06LQMYUFA>.2.4$#84(W;CN7 QDY&* +7]@:-Y!@_LBP\DOO,?V9-I;
MUQC&?>G76AZ1>W$=Q=Z793S1)LCDEMT9D7T!(R![553Q3IC27L+M/%<V<(N)
MK>2!Q((C_&JXRR\'E<X/'6B/Q3I$O]CE+ARNL)OL6\E\2C87ZX^4[03@XH U
M8((;6!(+>)(HD&$CC4*JCT '2JK:-I;O<.VFV9>X&)V,"YE'^UQ\WXUBGX@^
M'0'?[1<^5%=_8YI?L<H2&7(7$AVX3YB!\V*T-5\3Z9H_VG[5)*1:Q":Y,,+2
M"",YPS[0<#@GUP"<8H M2Z+I4]I%:2Z99R6T)W10M I1#ZJ,8'X5+-IMC<60
MLIK*WDM  ! \2F, =/E(QQ5"^\3:98P&8R2SHL NG-M"TNR$YPYV@X!P<=S@
MXS@TLGB/36AM3;7#W+7L!GMQ:(9&:/ ^< #@<CD]R!UXH U@     !P *H?V
M%I'V>>W_ +*L?(N#F:/[.FV4]<L,8/XU@_#;4KG5O" N[J[FNG-Y=*LLW#E%
MF<+D8&. .,#%)%J-Q;_$_4[6XOY/[.CT:*Z$4C )$QED#$<#L@Y- '21Z5IT
M/F^786J>;&(I-L*C>@& IXY '&.E1SZ'I%SI\>GSZ792V4>"EL]NC1KCT4C
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MVZRNKJX4':S$H-V#QGJ>M>CU!;7MI>^;]EN89_)<QR>5(&V. "5..AP1Q[T
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MHU544*JA548  P * /.4TW4M<\-^%-&N--N;.]TJ\M9;MY$Q'&+<<E'Z-NP
M-N?O<XQ6KX0CN]./BN:?3[M3-JLUY;H8\&>,H@&W/<E2,'':NRJO!=6NH0R&
MVN8YXU=HG:&0':P.&7(/!!_$4 5=!U<:YHT.H?9+BS9RZ/;W  >-E8JRG'NI
MK"TB&YM?'_BN_FL[E;6XAM!!+Y1(E,:N'"X]"P^O;-=9##';PK%#&L<:#"JH
MP *?0!R?PVM;K3_ >FV%]:S6MW;JZR12I@C+L1ST/!'2LCQ?I-[/J][J.B1Z
MG9:[%"B6TT"%[:_&,B*93\N 21EL8!ZG&*]#I"0 23@#J30!Y_>6^J6/BSQ)
M)_9-U=+J^F0)!+;*#&LD:R*RL21M^\"/4=,GBLS2;;7O#1\*ZO)H-]=01:&F
ME7MK $:>!U*L'"[N02,'G(XSZ5Z;:7MK?P>?9W,-Q%N*^9"X=<@X(R.X/%3T
M <-J<%_=:]X.O!I$UO%;7D\\\4:!OLZ/$Z+O*Y&XE@3C.,GKC)N>#K:ZMM6\
M4O<6L\"76J&X@:1"HDC,4:Y'XJ?>NMHH X#QII%Q=ZM<7VEIJEEK4%DHM+RT
M0O%='+GR)5Y4J#CEL ;^O%,LK^6R^*.IM>VTTD[:)9^;]EB:0"3?+D #)P3G
M!/'')%>A5E0:!;6_B.YUQ9[@W=Q"L$BLPV%%)*@#'&"QYZ\T ><6OAC5/"MK
MX=OI=#DU6WACNXKS3[?:\EL)YA*I120&VX"G!^E:E_87^FW.@^)-(\,/#;6M
MS<-<Z7;JBW!CF15\TJ#M,@*Y(!S@X]:]!N+VTLVA6YN886F<1Q"20*9&/15S
MU/L*GH X+Q8FH:UX+?[/H=S!+/J%M,EMY8\[8DL;L\@4D X5N,YQCOP,OQK:
M:YK$?BS3TT:^ECGLT_LY[8*D<WR?,93D,SAL@*<\8P.IKU!F"J68@*!DDG@"
MHS<0+$DK31B-RH1RPPQ;I@]\Y&* ..6&]F^(.@Z@VG7<5O'I,T$KNF1'([1E
M58@D9PAZ<"K?Q'M+K4/!=S9V5K-<W,D]NRQQ+DD).CL?;"J:Z>>>&UA::XEC
MBB099Y&"JOU)I8I8YXEEAD62-QE70Y##U!% ')>7<?\ "TFU3['=?8?[$$'G
M^2V/,\TOMQC.=OM[=>*XS2M(UC1M,\.:C<^';O4(K-;VUO;!4'G1K+/YB2(I
M(#= #@]_KCUP7UH;XV(NH3=A/,,'F#>$R!NV]<9(Y]ZD,L8E6(R*)&!8(3R0
M.IQ^(_.@#S;5M)N;==%UW3_"7^AV]S.]UI$2(L[)*JCS2H.TR KG&<X.,YSB
M;5],FN?#UI?:7X8DL0FM6E_)9I&BW$B(ZEG90<;O;.< 9]!Z-4%W>VFGP&>\
MN8;:$$#S)I BY/09- '**EW_ ,+/759-/NTM/[#\AI/++!9?-W[/ESD[?3(S
MQG-<UI^E:I!X#\$V,FEWBW6GZO%/=1>428HU:0ECV(PR],]?8UZO10!Y+J<>
M^_\ %.EG1]<FT?4KU6N#8VJ3J[!$$A1]X*DE=I4JV,'!!X'J-C>07VFV][;;
MC!-$LB90AMI&1E3R#[=:QH_!>G07<TUM=:G;13RM-+;07TB1,['+':#\N223
M@BM6YOM,T2TC^UW5I8VR@)'YLBQJ . !G XXH \^L=$,_A.>PU;2=359=>N+
ME7MPR3VRL\CQSIMYR,J.,GYCQVKJ_!<.L6^CSPZQ<2W+)=.MK<3QA)I8!C8T
M@X^;J.0"0 2,UT2LKJ&5@RL,@@Y!%5QJ-B9[B$7EN9;90TZ>:,Q YP6&?E!P
M>OI0!YKXWL==U>#Q=IRZ->R^;#'_ &>UKM2*90J[F<[@7?((VG/ &!U-;]LM
MV?B5)JTNG7D-HVAQP;VBSB42LY3Y<\[2.G';.:Z^VNK>]MDN;6>.>"0922)@
MRL/4$<&I: /*- TK5+33/A]#/I=Y')IEU<-> Q']R&215)]<EUZ9I;[0=:NA
MK]S9V$_G1>(K?5K>&1=@NXHEC!4$\9)4X!QT%>K5#->6UO/!!-<11S7#%88W
M<!I"!DA1WP!GB@#CKK2KCQ%XL76(+>>UMX=(GL\W,9B:224@A=IYPN"2>F2,
M9YK!TJVUEK3X?V[>']1C;17\J\,BHH4BW:/*_-RN2#GW&,GIZK10!Y1?:5JD
MW@+Q?8QZ7>&ZO=:DN+:+RB#)&TJ,&'8<*3S@_F*V$EU70?&.N.V@7VJZ;KAA
MGMY+=5/EN(EC:.4.1M'R@Y/'-=_3)IHK:%YIY4BB099W8*JCU)/2@#SO4+.^
MTGQ?<WE_X8EUK3]3M($_T%%<VTL:E60JQ'R'.<U)!9:AX:\:6VI+H4C:7=:4
MEGY&G('^PR+(SA=HQ\I#?>'&1V%=_!/#=6\=Q;RI+#*H>.1&#*ZD9!!'4$5)
M0!R7PZM;ZR\-S07]A/9R_;[J54FVY97F=@>">Q%5+ZWU1?'VM7]EISS!M 6W
MMFE3]U+<*\CA"?0[EYZ=>:[BH)+VTBNX;22YA2YFR8H6D =\#)P.IP : /.=
M#M=6;Q9X9U.;1M515TV:VNY+C8HBE/EGA V$0;6 "@9QP#5&'1=>@\":7;KH
M4TUUH>KR74MI(5 O(V>;(C.>3ME##..>F:];HH \Q\06#ZMX%UQ]*\(W&GW-
M]]G18G@1;FX*2 DN%)PH'3<?7VSZ9&XEB60!@&&<,I4CZ@]*=10!P$MGJ-KK
MGCL'3+J2+4X(WM9HU#(^+<1[>N=VX8QCWZ56LM/U"-OAKOT^[']EV[1WO[H_
MN";4Q<_\#XXSZ]*](HH \FBM?$%U/X;O+S0-16]LM7D>[CCV+!&A64#RE# %
M?F4ER,G)R33]1TG5+CP1X]L8],O#<ZCJDLUI'Y1!E1A& P]/N-UQ^HKU:H;J
M[MK&V>YN[B*W@09>65PBJ/<G@4 /A<20HX5EW*#AE((^H/2O*(=+UB+X;:9H
MLFC7JW=CJ\4C@(&#(MT9&9<$Y 7!SWS@9KUE'61%=&#*PR"#D$5%:WEM>QM)
M:7$4\:NT;-$X8!E.&&1W!X(H \[\0Z#JFMZYXMCL[>6,7VD6\-K-+&5CDEC=
MV*$GH#N Y]36OX79=2OH;N3P9)H]Y;Q%)KBZC0$$]4B8$EE)Y)X& .YXZR\O
M;33X#/>W,-M"" 9)I BY/09-3T %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<]XOU^[\.:=:
M75K9Q71FO8+9E>4H5$CA<CCD\]R*Z&L'Q7H-QXATZVM;>ZBMC#>0W1:2,OGR
MW#A< CJ1UH S[7Q)JK:EK^E7^GV1NK"UCNH1%,WERQN'^5B5R""A&<<YZ"J%
MGXPOAI?@L6&CV2)KD6!&)3&L!$)D"@!3\O'7T[5K-X:OCXCUC5EO;<?VA8QV
MBQ&%OW>S?AL[N?OGC Z#FJ-EX)OK.V\(PC4;=AX>R,^0P\\&,Q_WOEX;/?F@
M!+7QQ<1Z;J U&SB&I6FJKI:I;EWCE=@K*PX+8VODC!/RG%9_B'Q;XAM_#'BG
MR[(VTUA:B:VU%K66*.52#N 5\$.OU(Y!]JN7/@"YO+;6T?55AN+[4DU.TN((
M2&M9D"A>"Q##Y!GIU-7;CPQK.M>%]4TS7M9AFN+VV:W1[6V,<<0(^]M+$LQ.
M,\CI@8Y) "YU:[M-?\)V%Y8V4[WYF'VH$EX2L+-\@(XR  3GUXJK+XVOY4CO
MM,TJ:^L?MIMFBBM9C*8UD,;2JX79@$$[?3N#P+TWAK5+K4_#=_<ZC:M+I#2-
M($MF59B\9CPOSG: #GG.3Z=*JZ9X1UK1K^YM;#7D3P_<7#W'V5K;,\.]BSI'
M)NP%))Y()&>.>: ,B[O]6U*T^(UMJ#VTEI9PR0Q1JI^0?9@XQGC^+D^M7?#.
MOZE9MX2TB\L[9;/4M,'V:2.5C(C11(QW@C&"#VZ>]7;GP??-<^*?L^IP);:]
M'@H]N6:)S"(B=VX97 SC .>_J^'PE?1WWA2X:_MR-"@>%E$+?O\ =&(\CYOE
MX />@#9\1ZY#X<T*XU.:,RB/:J1*<&1V8*BY[99@,]NM<G,-1C^+>CO?16KN
M=(NF4VP(+'?%E#N/..,'(SGH*Z?Q5X>B\4^'+K2)9WM_.VM'.@RT3JP96 [X
M('%8A\*:_?:U9:GJ6M68FM[&>S8VEJR%A)M^<$N=K?*#Z>U !IWC"_GU_2]*
MO+>TCGU*VFE,4;EGLI(PI\N0@X8X;G&W!'3FG:?XNU"[T:_,UK:Q:U:ZB-/-
MF&8KO+*%.>I4JV_..F?0U5TSP3JNG3^&KBXUFS9-"AE@VQV13S8F5023O.'.
MW)/3D\4_18-(\2>.9/%6CW)N+-+5(W>/(BFN!N56Y'+)&S*?9P.U '7W]Q-:
M:9<7$4<<LT43.$9BBL0,XS@X_(UPUIX]UO[+X:U;4-(M(]'UMX8 \-PS30RR
MCY"P(QL)XZY'!/I7;:NZQZ+?.[!5%O(22< ?*:X;P5HL^N^ _!_VVYMVL;&.
M"[1(E.^1T7Y%8YP I.3CJ5'3D4 :NB>(_$>MW]^D6E:;':V&H3V4Q>[?<VQ
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M=L666VF4@J5)&1D E3C(XZ&LV;Q'J%[-KBZ);6TPT=_*D6=F!N)0@=D4C[F
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MP^7GYHLG8QSW9<-CMG':N3G^UW/Q9O+6Z^QR6 T-=\4JDKY33,&XZ9(49[8
MKO$18T5$4*B@!5 P /2N?'AZZ/CB?7GNK=K>:P6Q-MY1W;0Y?=NS_M$8Q0!B
M+XSDT[PA8>)8;"WC\-L\<0A3*RP6Y?RTD]#_  DI@8!ZG%2Z=#$?B9XP4QH5
M?3[(L,<-_KNM+:^ YX?#B^%9K^*;0(YU= 8CYQB602"$G.,9 &[&=O& >:U(
M/#U[;^*M:UE+RW*ZC;10)$8CF/R]V"3NYSO.1@4 <UX'UQK+P/X)T>U5&OM2
MM&,;29V1I&NYW(')ZJ ,C.>HQ5V^\;ZG9Z=XC0:=!)JGA\I)<1JS>7-;NNX2
M)W!VAB5.<%2,\YI;+P#=:=I/AE;?4HO[4\/[T@G,)$<T3C:Z.N[(R,<@\$ ^
MU;VF>'DMKS5K^]:.>[U4H+@*F$$:)M5 #R1@L23U+'ITH SU\7[?&<>C2R68
MLY],.H070)^< \J1G P/F^E12:]>C5?",5_I5F9-4>4^82=]L1"S@*"."0,$
MY[D8[U5B^&EK'H6DZ>]]*\NGW?F_:"/FDAVF,PG_ &3%M0_[N:W-:T&YU3Q!
MH.IPW442:7-)*8WC+&7?&4(SD8P&)Z&@#FKOQ[KEMI&NZK_9-@+;1-1:VN%^
MTL6DC79DI\H^;Y\\X';'>M[4?$EV->U#2-.A@\ZQT];YVN,XEW%@J+CI]PY;
MG&1P:RKOP)?W7AOQ-I!U.V7^W+Q[KS1;M^Y#;<KC=\WW!SQUK'\372W'C.XB
MFUW0=/GM;*.W:'5X&59@^6<QMYB%D.5!!+#*XQZ@'=^%M9F\0^&K#5YK5+4W
MD2S)$DIDVJPR,DJO/X?B:Y22_P!6U#4/'UE?/;265E;B*.,*?E5K<N,9XS\W
M)]O:NL\,W-Y=:'"][':K(I9$:T1DBD0'"LBMR%(Z#GV)!%94WA2^_M;Q)=6V
MI0)!K<**T4EN6:-UB\K.X,,KCG&,Y[T 8_A'7]2L+'P/I=U9VPL=4TU(X)$E
M8RH\=N'RPQC! / Z5=A\;7]X=.OK#2IKO3;RZ$)6*UF\R*(D@3[]NPKP"5'0
M'J:FMO!U];GPA_Q,+=AX>C,9_<-^_!A,7][Y>#GOS3="\(ZUH$W]G6VO(?#J
M3&6&V-M_I$:EMWE"3=C9D]<9QQQUH Z+7M9MO#VA7NKWF[R+2(RL%ZMCH![D
MX'XUQNH_VF_Q)\$3:C#:(9$O"!!G=&?)Y0D_> _O#'?@5V'B+0[?Q)X>OM&N
MV98;N(QLR=5/8CW! /X5ST/A7Q#-JOA^^U/6[*9]($J[HK-E:<.@3+9?AL<\
M< ]CV $M_&5^->T?3[VTMH7U.:>%K97W36916="Y!(.Y5SCC&>]/M?%VH-9^
M(HKNUMH]5TJX6"*V0L1-O \ELGM(6 'H0>N*HZ=X!U>RC\/QOKMM(-%NI)8V
M^QG=,KJZL7._E_GZ],\D&IK6+1O%?CVVU[2;LW$-C;O%=O'GRY) W[I6R.63
M,C>V5]10!VC3?9K)I[MT411EY64':,#)(]JXY_&UW;Z'I/B2XLX1HNH2Q(54
MGSK>.4XCD8]&ZKE0!C=P6Q79SPQW-O)!,H>*5"CJ>X(P17'6?@>YCT&R\-WF
MH17.C65Q')'F(B:2.-]\<;G., A06 Y Q@9S0!5U#QMKUO#XHG@TJP,?A^7,
MN^Y?,L8C60[<+][![\#@<]1W5O.+JTBN(^%EC#KGMD9%<A<^"[ZXM/%UO_:-
MNH\0YY\AOW ,0B_O?-P,]N:ZO3K>2TTVVMIG5Y(8EC9T7 ; QD#G% '#7WC[
M4=.\.ZU?W-I9K=:/J(M;FWW-S$2I$J]SE6WXQT!]*F\>7LE]X.\50*MO+90:
M2S^<H))E9"V!VX7:W_ Q6Q<>#K.Z\5W6LS.7ANK,6\UH1\DC@,HD/OY;LGT-
M4D\$20?#>X\*1:ANEGMVMWO)D+$@C:"1D9PH51ST44 &D^(-4AUW3=$OK*U2
M&\TUKBT>*9BP,>P%9,C'(<'(SCD<]:KZ1XO+:';LFF6MM>WNL3Z?#;PM^[\Q
M7?<[' )X1F/ )/'&<UI?\(U?'Q%HNJM>V_\ Q+;*2U:(0M^\W[,MG=Q]P<<]
M360?A[>'PZ+-=72+4;?59-5LKR. XCD9V8JRECN7YV'7I0!5\?SZK/X \0PZ
MMI\2?9;BV^S7,1&VY4RQG<%))0@Y4@G\:Z/3=?U)_&-UH&IVEK&PLEOK>2WE
M9_D+E"K9 ^8$#D<<U4U?PMK>O>%+S3=1UBV-[=M%NEBMF$,2QN' 5-^<DCDE
MN_L!6A'H-Y_PG \0R74'E_V<+%K=8CG[^_<&SZ\8Q^- '04444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO;T*F^46T(<1KZMD@=CP,GVJEX?L-5T[6-12\U!);*=4EMK1KA[B2W/(8[W
M8JQY /0@XJQJFL7MI+):VFBW,]Q(&$+B2$(Y"]3EPP X!)'IZBHF[(Z,-!3J
M6:O\[?B:.FW%G>:?#=V&PVTZB1&1=H(/MZU'-J]M!K%KI;K+]HN5=T.P[,*
M3\WXCIFLG1YKK2-)MM.@\/:@R6Z"/<9K?)/<G][W//XUGZGJ5ZWC#09#H=ZK
MI'<[8S+!E\JF<8DQQ[D=>,U#J-13ZZ=&=4,'&5:44TXVE;WHWT3:OK]YU5]J
M-O8"(2EFEF;9%$@R\C>@'\ST'?%5=3UQ=,@A9M.O[FYFR4M+:-7DP,9)^;:
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MW:XDC** '0%LX+,0,9QUXP0#U.LSQ!K47A[0;S5Y[>>>&TB,LB0;=VT=3\Q
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[&'RH5)/+%F8GJ69B2Q]R2:N44 8-_X,T+4M1N;^XM)!<747DW)AN)(A.F,
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MTA1IGD&YB23\Q.,DDFM&B@#(N_#.E7UQ<S7$,K_:MOVB/[1((YMH &Y VT\
M#IR.N:BU#P?H>J:A/?7=HS3W$'D3[9Y$65 " '16"L1DX)!([=JW** .<O/
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M@Y[>E-3PEJUI=^'[ZQO[-;K3=/.G3^="SI)&=GS* P(;* X)[]: ':?XOO\
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M..P '.>>, '14444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDYP?7%7;*Q6Q^,LB1SW$B/H 8">9I2O[_!PS$G'MF@#NZ*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *S=:T'3O$%O!#J,3N()EGA>.5XGCD&<,K(00>3T/>M*H;FZM[* SW4\4
M$*D R2N%49.!R?>@# D\ ^&Y+:^MVL9/)OI4FN$6ZE4.ZXPW#<'*J3CJ0"<X
MJY/X6TFYU&74)8KAKJ6U^QO)]KE&8>NW ;'7G/7/>LSQ;XFDLO"O]KZ%>64Z
MK=P0.X_>J0\JQL 0V PW=\].E;]CJ^F:H\Z:?J-I=M VR98)E<QMZ-@\'ZT
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M5WFEZA8036V@(TJ7L%C',8)0S,L7W!N?H3D8/.>]:]% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZM(+JX-_%#,([F>%9)5!0C'*G8=HQD#% 'IU4M7U6TT/1[O5+^3R[6UB,LC
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M$RR0SQJ^ P)3(!VMCHP!&17.7GBBYU/Q'J6@Z#J6F07MC#$\?VD[UGE8OF/
M8$!0G.,D%O;D V-.\):1I8MDMXIC#:,6M8)9WDCMR01E%8G'!('IDXQ4#>!=
M ;7Y=9%K*ES,XEF2.X=89G'1GC!VL?J.O/6M:WU6PGNOL:W]H]ZH.^".96<$
M=?ESG@U%/X@T6V9EGU>PC969"'N4!#*NYAC/4 @D=@: -!T$D;(2P##&5."/
MH:Y^+P/H4.FZ?I\<%PMKIUQ]JM4%U+^[DR3NSNR>6;@Y')K*OO'*W>G>']2T
M*YM9;2_U6&SG#KN<1N3R,-\IPN<$'K756^L:9=V<UY;:C:36L&X2S1SJR1[1
MD[F!P,#KF@"*RT*PT_5K_5+=)1=W^S[0S3.P?:,+\I.!@<< 5S_B;2;O4O'7
MA>YBM;LVEDMUYUS!($\II%4)WR>0<\$>M=?%+'/"DT,BR12*&1T.58'D$$=1
M3Z ,*Y\(:-=Z8=/G@E:!K@73D7#J\DP(8.S @DY ZGC [ 59U+0+#5);.>X6
M5;JR)-O<Q2,DL>1AOF'4$=0<@UJ44 <-XR\-E] L-.TG3[B<?VM;W=R8I<.5
M60-(Y=F!+8[YSTQTKI8= TX+=M-"UR][$(KA[IO,:2, @(<]%^8\#CDGJ36I
M10!S>D>!=#T2WF@LHKI8Y8S"!)=ROY49ZI'N8[!T^[CH/05KZ1I-IH>EP:;8
M(Z6ENNR)'D9]J]AEB3BKM% &7J/A^PU74;&_NEF-S8LSVS).Z!&(P3@$ Y!(
MYS4%UX4TJZO[N\:.:*6]01W8AG>-;A0,#> <$XXSUQQG%;=% &4WAS33K-KJ
MPBD2[M(3;P%)65$C.,KL!VXX';L*A;PGI+R:O(8Y]VKJ$O3]ID_>@+M Z_+\
MO'&.*VZ* ,1?">DI+I$BQS[M(4I9?Z3)^[!7:1U^;Y>.<\5?U72[76M,N-.O
ME=[6X0QRHDC(64C!&5(.#5RB@#&N/"VEW-G86[I,#I[!K299W$L) V\/G.,<
M$'((ZYIEWX0T>^TF;3;B"5[>>87$Y$[J\L@((9G!#$@JN.>-H'0"MRB@!J*$
M14!8A1C+')/U-<-I7AN6\\4^+9M2M;Z"SU&>+R\3[4N(EA5&!"MD<@^A(/I7
M=T4 8VH>%M*U&\LKJ2*6&:R0Q0M;3O#^[.,QG81E?E'!]*J1> ] @LK.SBM[
MA(+.[-Y BW4H"3$D[@ W^TW'3D\5TE% '%WNC7=Y\4H=0-O>Q6,>DM;"[AE"
M 2F4-M(SDC;GJ,9QWK:G\*:-/I=MIQM2D-K*)[=HY&62*7).\.#NW$DDG/.3
MG.:VJ* ,=O#.FO9W%NZSDW$R3S3^>XE>1"I1MX.>-JX X&,8J.Y\(:+?Z=?V
M5]:F[CORK733.2\A4 *=W48 &,8Q^)K<HH Y^U\&:/::6]A&+ME>2.1IGNY6
MF+(<I^\+;@%(X ..O')K3T_2K737N)80[3W+AYYI&+/(0 HR?8   <5=HH R
M]0\/V&HZC!J,BRQ7T"-&ES;RM&^P\E"1]Y<\X.<'D8-07GA/1K[1X=)EMY!9
M0R"58XYW3+AMP8L""QW?-DDY//6MNB@!J($15!8@#&6.3^=<]/X&T"YM=2M9
M+:?[/J4QGN8A=2A6<G<Q #?+D@$XQD@9KHZ* ,G_ (1W3_[935S]H-\EL;59
M?M#_ .J)R1C..H!SC.:K6O@_2;"QM+.R%U;QV<CRVY2ZDW(SYW<DG(.3P<CG
MI6_10!4T[3;72K3[-:1[(R[2,22Q=V8LS$GDDDDYJ.TT>TL=1O+^'SO/O"#,
M7F=P<# PI)"X'IBK]% &+_PBFE?V[<ZTJW*:A<Q>3-*EU(H9!T&T-CCMQQ38
MO".BQ>%F\-"V=M):,Q^0\SMA2<X#$[ASR.>*W** ,8>%],^VZ;>%;EKC35=;
M:1[J1BN_[^[+?,3W+9JM;>!]!L];EU6WMI8YI9?M#PK<.(#+_P ]/*SLW=\X
MZ\]:Z*B@#&7PMI N-5F>V:4ZL MZLLK.DH"[1\I.!\O'&*C\/^$=(\,AO[.C
MGY7RU,]S)-Y:==B;R=J\#@=<#/2MVB@#/U31;/6%A6\$Y$3;D\J=X\'IGY2,
M_P#US5>+PSID-C=VB+<>7=*%E9KF1G('0!BQ(ZGIZUL45+A%N[1M'$5HQ4%)
MV72^G?\ ,HZAI-IJ=HEK=+(T*,K!5E9>5(()(.3@@&I+O3[:^@CBN%9O*</&
MX8AD8=&!'.?\35JBGRKL2JLU9)O38Y_6M&LI=+EM)+::>.YE#S[9IE>0@<%F
MC!;' &.!P*S--TJTTFZ>YMM.NFF:,Q;I[J]EPIQG&^,X/ Y'-=G1752Q,J=/
MV:O;M=I?<9RO)\SW.36WC7P]_8?]GS&P\HPE3+=;F0YR"WE;N<GO1-;I/HL6
MDFQN4M8@@C,<]TKIM^[AQ%NXP.]=915?6M;V>]]WOW]2>4YRTMU>VN+#[%+M
MNHF265YK@R/\I',CQ@CVYXSQ6AX>TG^PM!M=-$C2" ,%+.7V@L2%W-R0H(4$
M]@*TZ*PJ3YY<W_!&CF;KP!X>O&OC-;7&V^G%S-&EW*J><"#YBJ&PK94?,,'\
MZWY;2&:Q>S=28'C,3+D_=(QC/7I4]%9C,BV\-Z=;2"0K-<.MNUJC7,S2E(CC
M* L>AP,D\G R>*JIX)T.+2;338X)UALI!+:O]ID,L# 8&QRVX #C&<8XQ70T
M4 8\OA;1[G2K[3KJT%S;WYW77G,6:9L  ELYR-HQCI@8QBJL'@C1(=%N]),=
MU-;7:>7.TUW*\CH,@)O+;@H!/ (')]37144 8B>$])BU2#4HTN$O(;86BRK<
MR F('(5OFPV/4Y-0)X'T*/2K+3$AN!:65R+NWC^UR_)*&+!L[LGYB3@\<UT5
M% &'<>$M(N;R\N6BF0WRA;R.*9D2Y &!O4'!XX)[C@Y%69?#^G3:S9ZLT4@N
M[.-HH"DK*J(V,C:#MP<#MV%:=% '*O\ #OPX\<T(@NDM9;@7)M8[R5(5E#!M
MRH& 4Y&>*FO_  )X?U'6?[5GMIA=.BI,8KF1%N%7H)5# ./][.1P<BNDHH S
M(- T^VUV?6HDE%]/$L,C^<Y4HN=HVYVC&3V[FK=_8P:E87%C=*S03QF.158J
M2I&#@CD?458HH S['1;2QNY+Q3++=/$L)GGD+OY:DD+D]LDGW[YIM]H5AJ6I
MV&HW*2FZL&9K9EF=0A8;6. <'(..<UI44 8!\&:&]GJ5I):O+!J4WVBY62=V
MW2\?."3E6^5<%<8P*N6N@V-JTTA66XFGB$$DUS(9':,9PF3T')X'7.3S6G10
M!SJ>!]#CTRQTY8;G[-83I<6RF\E)C=/N8.[.%[#H/2B]\#Z#J&MMJ\UM*+J5
M56?RKAXTN OW1*BD!P/<'T.17144 <]JW@G0M:U>/5+JWF2]5!$TMO<20F5/
M[K["-P^M;\<:11I'&BI&@"JJC  '0 4ZB@# '@O0?L>I6;61>UU&1I9X7F=D
MW,VXE 3\AW?-\N.<'L*O6&B6FGW#7*&::Y:,1&>XE:1]@.0H)Z#//N>N:T:*
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6",01L(H\/$1$&.22H!SD\8).WI7J]% 'B[W=O\ \*7N5\^/=_;A.-PSC^T
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M<.K ^G<=LC/6NHTJXTBU\9>/Q=&V&G+;VLL\>P,A00L)"5 .[@ $8/I7H=%
M%;3I+2;3+273P@LGA1K<(FU1&5&W XP,8XJS110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX;:)I76)=S;0,G ^E+IM_%JFE6>H0*ZPW4"3H'&&"LH89QWP:XZ^L]=L=/\
M$POKV!],GTJ5[>W:Y:::.0(0Y#,BDH01US@_6JN@ZI-<S>$/#0FEM[63PZE[
M*\3;6E95C14##D 99CCG@=LY /1:*\NNM6\0KH'B18[ZYEG\-:D&65,!KNU
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M-BEFW'/H/?K7#ZGKDGAOQ!\1M8AB$DMII]B\:GH6VR@9]LD9]JLWUE);>//
M<[ZC<W;2B[,C2N&5V^SD[U'1<^@P.G% 'HE%><Z'>>)?$6EZ)XDL[^U@CGN
M]W'+=L8VA+%6B$?EX5U. #G.1R3FKG@]-6U35-5N[S7[Z6/3M9N;:.WVQA)(
MPJ@!\+VSD8QT]S0!W5%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU9CU.PELFO8[ZV>T3.Z=95*#'7+9Q0!:HJM!J-C<W,EM;WEO+/$ TD4<JLR
M]"0#D9J6>>*UMY;B>18X8D+N[' 50,DG\* )**R=+U@7FBIK-VT5I9W"B6$2
MG:4B/W2Y)QD@@X[9QSC)N1ZE8RV1O8[VV>T7.9UE4H,=?FSB@"U14%K>6M]$
M9;2YAN(P=I>)PX!],CO3KBY@M(&GN9XX8E^])(X51^)H EHKE_"WB2;6+OQ"
MMS/9R6VGW@BAGM^$:,Q(^22Q!^\><XXK6DU_2DTNXU)-0M9;2W!\R6.964$?
MPY!QGV]Z -*BN%TKQ!KNMV>DZO::KH$6G7JPM/#,&,L+N5/E*0V&8JQ'.#N
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M]C-?6ZV"/';%;EF*(V,K\V=R_*, YQCC%-L]5U>W\0Q:5J\%FPN87E@FM-P
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MK2/*N187,WG/"+J3 ._?A>?E&\[L#'-;5OJFGW<TT5M?VLTL/^M2.96,?^\
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M,T]]5TZ.X%N]_:K,7$8C:90V\C(7&<YQSBFQZQIDMQ%;QZC://,I:*-9U+.
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M#X@TN34)8C%'"NGR-Y: ECTEP"<#/)Y  )[[,%UJ=Y8RW4&O:6T",Z.YT]U
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MWN]"N;=-/BU$2;5>TE("RH6&\9/&=N<>^* ,_4O%\.D:;>7U_I>H116DD22
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M!L*AHU RI.026QTQCGC(BT'Q8OA7P_X?ET:)I-%U&U?[4MV@BGAA?(91]X'
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M]DNX0B%XW^7!X;!4[U.0>]4M0M_%%SH]M-::/#8EKV-KK3;:Y597MP#N'FC
MW$D' /08SR:PKOPEX@/AOQ=IEOHUO'_:=_%<VJ0W*;0H$61R!C'EG\3P".:
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MXZ6/3]0;XEC66LG2P.D"T\QI$R)/-W\@,3C'&?7VYH ZFBBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBH+V\AT^QN+RY;;!!&TLC>BJ,F@!8KNWFN)[>.9'F@*B5 <E,C(R.V
M1S4U>2Z1?_V%\0--U*=KE1XFC,&H+-#(BQ7>2\(!8 '"DQ#']T&NHUG5?$;^
M-UT#2;G3X(Y=+>[26XMV<HZR(O.&&0<^V,]\8H Z^65((7ED;;&BEF/H!R:B
ML+ZVU.PM[ZSE$MM<1B2*0 C<I&0<'FN'T2\UU=7\;RR:E!-)93*L2R6QV#$"
M.  '!"C)XSDYSFK.C^*[_6+7PM9J\,-]JNEG4+B81Y"*H3(1<]2SCKG !ZT
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M4 %9^JZ)8:W'!'J$+2I!*LT8$KIM=3E6^4CD'D>E:%% " ;5 &<#CDYI:**
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ8;^G X&> #MZ*Y"W\1WM]JNE:'!=637=QIS:A<7D*[XB@947RQNYW%LY).
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M+ "2-U;AE.![' (..KM5TV\B\*7FD074U[JFI1O";F50/F==K2$* JJJ]AZ
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M.^.HJ>S\(O9:QI&H#5))3IMB;%4DA7,B';DDC'/R+C _.NGI&W!"5 +8X!.
M3]: /.M'M+C4_&/CJ"VU(6\%U/"A(B#,5^SHC-&V0 0<C)# $#CUZ#_A#;>R
MU+3]1T2<:?<6=D-/VM'YL<MN.55ER#D$9# @\G.:RU^)"II6H:M<:'=IIVG7
MDEG=S1R([1LC!6;;D$J"1R.<=J[:">*YMXYX7#Q2H'1QT92,@T 85MX8?3H8
MAIVH-%+Y\UQ<M-$)%NGE.7+J"._3!&, =.N5+\.;:.PT]=+U*?3=1L+B:X@O
M((U(4S,6D3RS\OEG(PO; YZY[:B@#!CT&_@BMF36Y9;I&=KB6XA5EN=P PR*
M5"@!1@+CIWR<VO#VA6WAS2$TZU.8Q))*<*%&YW+MM4<*N6.!V&*U** .2'@:
M..UU33(-0>/1=3F>:XL_+!92_P#K%C?/RJW.1@XR<$5?F\-L_BNQUN*\6(6=
MJ]I';"'*[&*D\YZ_*,>GH:FU'6IM/UW2[#^S+B:WOF=#=HR[8G"E@I7.3D*>
M1TQ2^'=:FURPEGN=-GTZXAG:&2WF96((P<@J<$8(_'([4 +XET*/Q+X?N=)E
MGD@$Q1A+& 2C(X=3@\'E1Q5./PU<IXGAUUM4,MQ'8-9;9(!A@SARQP1SN Z=
MN/>M>WGO)-1O(9K(16L6S[/<><&\_(RWRXRNT\<]:MT <7%X!:'P_IFD+JK>
M7I^HC4(Y#;C<SB0R!3\V,;F/OC'XW]2\)MJY>"_OQ-8M>1WB1- /,B9"K!4?
M/RJ2O/!.&8 C/'2UC^*M<;PUX9O]96T-V+2(R-$) F0/?!_E0!/KNFS:QHUS
MI\5X;3[0AC>54W,$/! YXR.,U7\0>'T\0^%KK0YY4CCN8A$[I%PO3E5SP00"
M.N*BN/$;6_B?1]'-D2NIP33+/Y@^3RPI(VXY^\.>*WJ .8_X12[>^\/WD^L-
M--HRNJ,UN,S[TV$O\W7;Z8YY]JM'PXR>+)]?MK^6)[BU2WFM_+5D?86*'/48
MWG(!&>*U[N9[>SFFCB\UXT+"/=MW8'3/:J'AK6AXB\-:?K @, O(5F$1;=LS
MVS@9H YW_A748\,V6E)JUQ%=:?>/>V5_%&HDAD9F8Y!R&4[V&.XQ5W4O!\^K
M^%KO2+_6IY[B\*&>\:%0V%((5$&%49'OU/<YKJJ* .4U/P?=7.O+KFF:]<:5
MJ$D"P7C00H\=PJY()1\@,,G!YP*Z.WM1:6*6T4CDHFT22'<Q/]YO4D\FK%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#07<\[0RQ1A0H1@(VSC'4'G/:NTT?2TTK18--W;TB0KU. "2=HR2=HS@9).
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M18N7!B;R';Y#G*C/.!Q4.D0&PUOX>W,-Q=&74]/D2\,EP[B8"W5UR"<#!'&
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M=:1:36$)!BMWB!6/'3:.WX5+-X?T>>TM+273;5K:S8-;1>6-L)'0J.@([$4
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MGU<'[Q]S4>G^%M!TJYCN;'2;."XCC\I)4B&]5] W6@#7HHHH **** "BBB@
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M@P&>CGOBM6W\4:-=7L-I#>AY9VD6 ^6X28IG>$?&UR,'(!/0^E<]<P3IX_\
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M+I^H^9I>II<M(D81DE"Q;D8-C/?L<=*V)O$ND6][%:37@226;[.CF-O+,O\
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MM"N=2A::Y\BX6U>%('#QRL0 KJ5RGWAU SQC)(STD$R7$*2H'"N,@.A1OQ#
M$?C7 >*M^N>!]4N]+T&[B,MS:SE3:&.XN?+FC9F,>-QPJX&>3@\8QGOK:<7-
MM'.(Y(PXW!94*L![@\CZ'GUQ0!C:AXIM=/\ %&GZ"\-RT]W$\N]('955<#J
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M2HUNB#:P&&.X$;1D^U '466L6-MH.E32ZD]Z+F!/(G\HF2Z^3=N$:C.2/F(
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MQ0W,MJ8)9;9T20)"%;:Q&#@C% '8T444 %%%% !1110 4444 %%%% !1110
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M-K?Z>=0ACS@),K[9 /0,"K?4,>YKH=*GOKK2[>?4K);&\=<RVRS"41G/3<
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MZVF@:-)>F/S92Z0V\.<>;*[!47/NQ&3V&35:\N19WFBVEUX@$%Y-.281$O\
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MCD;>@8JVQ"IP#NQC -=#X>A=/B/XKEDL[F..:.S6&:2W<))L1@P5R,'!([T
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M:IJ=S+;0K)/BX39OVN\1485MAP0QZKZU0NOB)>6VFZSJ/_"/$VFC7[6MVQO
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M[7S1EY#C)!QD [5X'I]: -?6U=M"OQ'/+ _V=RLL1 93M/(/8UYA#!<'P/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5--^R0ZME+699_,VR;=PCD&T;6(SC!89!&?7I'+B-C&H9P#M#' )[9.#C\J
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MY+$^IP.E/N/B']DMM=>33%FETJV%WFTNA+#/'SG$A4888Y7&>F,T =Q2,RH
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MSC([T 6Z*** "BBJFG:@FI6[S1P7$(25XBMQ$8V)5BI(!Z@XR#W% %NBBB@
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MQ]XCJ3QCBO1:J7NE:=J31-?6%K=&%M\9GA5]C>HR.#0!R6M>$-2UJ+Q'=O\
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M&9]_VJ!'<NT87&T\DX8GC.<'I5[1M#U?3M2\3W3M:)_:D_GVS1R,QC81*@W
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHGL8[EA;22]=[1]R2 3S@XY% &)J6I:K-<?$*P;4YTBL+"*6T,2HC0EHI'8
MA><E1R><="#S72>"XGA\%:*)+B6<M90,#(%!4&-?E&T#@>^3[T]?"UC_ &CK
M%Y))<2MJ\2PW<;L-C(JE5 P 1@,1U[\U;T72(-"TJ#3K>:XEAA4(C7$A=@H
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M,-P6SMXZXSCGFMV&-HHE1I7E(&"[XR?K@ ?I534M,74A;$W-Q;26TWG1R0,
M0VUEP0001ACP10!Q"^*)Y[/PQ>:7KLMW;WNMFSG\V!%8QE9&\MUV JZ[5'&.
MF><TFH>+M3TB[\6QO=B5+2^L;6T:6-<6XG5-S' &0I<GGT KH[KP5I=UIHM#
M)=1RB^_M$7<4@6;[1_STSC&<'&,8QVJ/_A M#>/68[E;FZ36%1;M;B=F#;%
M##T;@'/4'I@<4 4/$]EJEGX;\5_:-6^V:?+HLYBBF11,D@C;<<J "I!7C'!]
M*I:)>:KI>M>#[-]3DN;+5=,DWVSQ(J0M%'&RE"!NZ,0=Q-;UOX)L8=&O--EU
M#5+M;N VTD]U<^;((B,%%)&%!'7 R>.>!B=/"EFE[HUU]JNVDTB)H;7++C:R
MA6#?+SD*!^'K0!O5Y[*_B;6/$GBW3;+Q')9+IWV=K3;;1-AGB+[6)4Y7/7OT
MYXY]"K@M.T:XO?'GB^65]3LK2]%LB/''L2=5BVOAF4X(/&00>>#0!2T/Q?J_
MBR+2[6/S+6XFT=+^8V[(C,[.T>5WJPV@H3C'\0Y]7RW?B];[PCI5]K$5K>WP
MNX;Y[2*.128T)1UW+PV,$CIGMCBNAU3P+H^I?V<\+7>FSZ=%Y-K/ITQAD2+
M'EY[KP.#5AO"5A]LTBZ2>[232MYM\2ALEP0[.6!+%LG))[YZ\T <QJ6NZGH&
MKK8:WJ5];VI-O'::LMO&;>5L+YBSX4^6S-N'8 $8Q@YN)JNJ^((O%4UCJ4EA
M)I%W):6L2QHREHXU8M)N4DAF8C (X''/-;M]X6M-1DO1<W-V]K?2))<VA=3%
M(4"@=5W 81<X(SBF7'A*QFU"_O(9[NT.HH$OH[>0*EP -N3D$JV.-RE3CO0!
MRNG>(=:\2ZQX<6+49=.M=6T22\FBBAC8QR!HQE&93_>.,Y&.W<;G@ZYN?$?@
MUXM8F-S(ES<6DTH 0S+'*R<A< 9 &<>]:?\ PC%BFLV>IP2302V5J;2WCB*B
M-(CC*A=O^ROY5-H6A6WAZRDM+26=XI)GG/G,"0[L6;& .I)- ',^,]>OM"U'
M,TE]9:*UGA-0LH5E6UGW,,S*5)V8V8(&/O9[8[6VD6:UBE2194= RR*<A@1U
M'L:S-2\/0ZE<W,SWMY"MU;"UGBB==DD8+<$,IP?G89&#S6G;6\-I:PVUO&(X
M84$<:#HJ@8 _*@#E_&%]JEIK/AFWT[4#:QWU\UM./*1]R^4[9Y&005'MZYZ5
MS[^*]6T6TUVPFOVO)[?6K;3K:\GC0-&DZQG<X4!25W-CCGC-=QJN@VVKWNG7
M4\]PDFGS>? (F  ?!7)R#G@D?C5&7P3I-S'K,=V;BXCU=UEN4D<#YU "LI !
M4@*N,>@H S;O4-6TGQE!HG]HS7%IJ6GSS0RR(ADMI8MN2"% *D,."#@^W%<_
M8:WXED\/^"-8?7I&EUB>.UN86MHO+P\;MO "AMP*COCVQQ7>0>'(8I7N);V\
MN;PVYMDNIV0R1QDY(7"A>2 2<$G R3@52C\$:=#IFCZ='=7JV^CS+-:#>N59
M00N3MY #$<^M '/R:QK=AI_CZS_MB:>;1(!<6=W+%%Y@W6YDVL H4@,/[O0U
M/)J6MW>O^%+&+6);>#4])EGN"D,9;>BQ'<I93@_.>N1[5O3^#K&XDUUWNKS_
M (G<8BO '7!4+L 7Y?E^4D?_ %^:?%X4M(K_ $J]6[O#-IENUM;Y9<"-@ 01
MMY)"KS[4 <GIOBO6&T[3],FN6GO9M;N],-X0B.Z0^80>FT.0BCIZ\9JU<:MX
MFT*-;/4)XY#?ZK%:V,Q=#-'$ZLQ#_*$W90JIP<[AG.*U9OA]HUQH]QID\EX\
M<MZU^LOF[98;AB6,B,H&TY)]N:FF\#:3=^'YM(OI+V]69UD>ZN;AGN-Z_=8/
M_"5[8P.O')R <CXMG\2V'AW5;+4KE7L;^\M+:U=I%,\<4KA9E?:J@CJ >N&.
M:Z?QAJM_H;:?/#;WS:0HD%Z^G1J\T. NQMA!R@^;=@9'';(*W7@6TG\+WVD&
M_OKB>Y"D7M[,9I5=#NC.3V5AG QU/J36D=/FU1K*^GFN].O[:-XF6W=2IW;=
MWWE(9<HI!QGZ'(H Y/QAJF?A#%K]GJ*W\]F;:\@O54+YKK*H)P ,9!92,#J1
MBO1 <@&N6U#PK;W&C6'ABU@,>DQ31S7)8YWHC^9L]V9P"?;=ZBNJH Y;Q%J5
M_8^+O"EM;7;):7UU-%<P[%(D"PNXY(R.0.AKDM1UOQ)#X?\ &6J1Z_*KZ%J3
MK;1BWBVR(J1-L?Y>5^8],'DG)X ]!U/0+;5=3TW4)IKA)M.D:6 1L NYE*DD
M$'/RDC\:SIO ^G3Z;K-A)<WIM]8F,]X-ZY9B #@[> 0JCCTH Z1&WQJV,;@#
M6!XCO+F&_P!*MH+\P).\F^W@0-<7&$X$>00H!(+,< <<C/.[!%Y,$<7F-)L4
M+O?&3CUP *R]8\-6>LZAI]_+-=07=@7\F6VF,;;7 #J?4' ]^."* ..T3Q=J
ME_I?ANQNKHQWFI:A>6LMV40.$@,F  !MWML49QCKCM6GJ&H:SH!L]-NM6CG?
M4]86UMKDQJ)((&1G ;C:7RC*#CN"<XJR_P .=";13I8:^6-;MKV"9;EO-MI2
MQ;=&W\/+'USGG-6;KP1I-]H#Z1>/>7(:59S=RW#&X$J_=D$G4,,#&. .,4 9
M>N:EK/A:TF275$NA?ZE:VEC))&OF6J2L%8O@ -C#%<CTSFEO=2U;2?%_]B?V
MA-<6M]IDUS!-)&ADMI8B,]% *D,."#@^W%:W_"&:7+H5SI5\]Y?I<[3+<7=P
MSS,5.5(?C;M/(QC!R>YS8B\-P(\L\UY=W-Y);_91=3%/,2+.2JX4*,GDG&3@
M9)P* .'L=?U^V\&:!K5WK;SW.O&SLD1K>-8[:25OFE&!DG;G@\;NV.*MRQW.
ME_$[5)?[4#LGADR13WVT)"1,W+%0/E!&3WZ^U=(W@K2)/"$?AB83RZ?"JK"6
MDQ)%M.5*L ""I'!JN? .ESW$]Q?W>HW\MQ8-I\K7%S]^$DD@A0!GGK^/7F@#
M*T/6=6F\6VVE2:A=RVUWHC77GSPQJ3,KHOF1C:"%.\\,.PX]<G1M?\1-X?\
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M216INQ^\=EDA"#+<E]O_  *NQ\/RZ!*FH'0'M67[;(;O[.?^7@XWEO\ :Z4
M;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6BC=T=D5F3E6(R5^GI52PTR#3Y+J6)1YMU+YLK!0N3C'0?YZGO5VB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M HHJI?ZA%I_V;S8IW^T3K;KY,3/M9LX+8^ZO'+'@4 6Z*** "BD+*I ) +'
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLNI+I")P^#)G<N'4@K\Q/()S@YR!6MI.D6NC6CV]J&(DFDGE=R-TDCL69C@
M9)/8 >E '#C4;G1O%WC_ %:6]N[B'3;*WG6V;9M8"*5PGW<@ YQ@CJ<YJS<:
MWK.E6GA/5I-0-[#JUS;VUW;&) BF=<J\94!AM;'!+9'OS72-X7T]M>O=69IR
M]] L%U;F3]S,%#*"R]SM8CKCGIGFH-.\'V.G)80BYO+BTTY]]E;7#JR6YP5&
M"%#-M!(&XMC/L* +OB.+5)?#U\-%N3;ZDL+-;.$5@7 R%(8$8)X_&N)M?',L
MFM>&;UM1E&B:C98N@\<86&Y*ED#-MSD^7*"!C! ['%>E5SC>!M!;1IM*-I_H
MDU]_:#KGK+Y@D_ <;<?W>* .9U5-2N-<\"-/>R)=W-W=RAY(DW0*UO(0F  ,
MJI R0>1DY'%+;>*]6LM/OK&YNVN[N/Q$-'@NV2-'*,JN"0 $WX8J#C&<9!Z'
MLM2T"WU35],U*6XN8YM-=W@6,J%RRE6R"ISE216;-X"TBZL-6LKJ2ZGAU2Y^
MUS;W 9)@  Z%0"I&U?R^N0#E?&G_  D]MX'\7"^OI4LOLRR64F^(7&.DD;[%
M *<C!&#@X)K2UJSNV^(OABVBU.9)CIU\#=-'&9 -T/0;0F?JI'L:VT\$Z>V@
M7^DWMYJ6HI?1>3-<7ESYDNSL < #&2>!UZYJ9/"ENFJZ?J3:CJ$EU80O#&\D
MBMN5\;BV5Y)VCTQCC% '+:9XMU>32],T^>=I[^XUB[TYKM5C1V2#S"& (V!R
M$4=,=>,T:WJ/C'0_#E_--?QHZ:C;+9RR)&\K02RJA60* HP2<$<D>];DOP]T
MB?19M,EGOF1[UM0CG$H6:"X9BQ>-E48.2?7K4L_@>RNM$.F7&HZG,'FCFEN9
M9P\TC(P9,L5P " 0  /S.0#9TJTOK*UDCO\ 4WU"4RLZRO"D953T7"\''K7G
MRQW1/Q.,VHW4Z1*Z+')L*X-HK#HH(QD@ $#UR>:].0%452Q8@8+'&3[\5S]Q
MX.L)[O6;A;F]A_MB,)=1QR@(?D$98 @X)48_7KS0!S'A^_U;2KOP/;/J37%C
MJNF,KVIA15A,<".I0@;L]0<DYSQCI5C1]7\3Z]8Z'K]A(!:7<RO=6\[1"$6[
M$@A"!O\ ,7CJ>2#GL!OQ>$+.*XT*87EZ6T2,Q6@+)C:5V'=\O/R@#_Z_-5],
M\!:7I&I/<V=UJ*6IF-PNF_:3]E20G.X)CUYQG /..!0!LZ]_R+VI_P#7I+_Z
M :\^L=WPQN[6X&?^$/U3891VTVX8#YO:)SU[ ^G?TC4+-=1T^>S>66))T,;/
M%C< 1@XR".GM41TFVET4Z3=@WEJT/DN)P"73&,'  Z>U '&Z/K-P8/!/AVVG
M:V%YHXNI9T52VU(XP$7<".2V2<'@>^1G:MXJ\0Z?I/B:S6_'VW1=0M(H[PP(
M3-#.R8#+C;N <@D =!TKL9?!^G/9Z-##)<V\VC(L=C=1./-C4($()((8%0 0
M00:9>^"].O\ 2+K3YI[O%Y<)<W4ZLHEFD4J5+';@ ;$P  ,*!0!D;]?/CN[\
M/?\ "13BVFTU;Y9A;0^9 WF%"J?+C:>#\P8\=>]9UIXJURY\'^#M2:]5;B]U
M>.QO"L*XF3S)$)Z?*3L!XQU-=E_PCL/_  D1US[;=_;#:?8^J;?+SNZ;>N[G
M/].*SHO 6G0Z1INF1WM^+?3;S[;;_.FX2;BPR=G(RS''O]* .?U/5/$C7'CL
M6^O/;IHD:3VH2UB)/^C^;L8LIRN>/7IR.]S5->U6>SBN+;43 [Z(+U;6SB1Y
M1*1G>^]2JQC&!D@D[NN*W)?!UG+)KSM>WN=<01W8#)]T)L&WY>/EX_\ K\U7
M_P"$"TSSXI1>:BI6P73Y0DX03PKG:'P!R,GD8/KF@#GH[W4-:\1_#V]DU&X@
M-_I<US+%"$V>9Y49) 93UWD<YP.F.<IJOB37[70/'\\6IXN-'N +23R$^1?*
M1]N,8/+'DYKIH? VFV\&AQQW6H*VC(T=M+]H^<QLH4HQQT(5>F,8XQ27/@;3
M[NUURVEO+XQ:TX>\ =!D@!?E^7CY5 _"@"G9ZAK-EX]M=-NM2-[:W^ER77E-
M"B"&1'0?(0,[2'Z,6/'6L33_ !'X@U2#PV\&I,NHWMY)#JE@(8S]D1=Y8X*[
MEV%57+'G=ZD5UUSX>$6HPZW#-=W.HV-G);V\3.BK*#@[6^7C)5>>V*XO0-)U
M&.VM(+&[\8V5]$%W6]YL-I&V?F!+@[DSG[K%B.^>: /1]9_Y >H?]>TG_H)K
MS+P]X;U/Q5\/O ]L_P!DM=.L7M[YYEE9YG\L':JKM 7.>3N./>O4K^T%_83V
MC321+,A1GBQN (P<9!'Z55T#1(/#NBVVE6DT\EM;+LB\X@LJ]AD 9_&@#D%U
MCQ/KMG<:GH<@C:WU&6%;>9HA;M%%*48.2"X8JI;((P2.W6Q87'B'4_&GB"S7
M7?)L]*N[9HX1:QGS4>(.T;,1D#)ZCFM#_A M+37+G4H+K4;>.[E\ZZL8;DK;
M3R=V=,<D]\$ ]P:T;'PY;V&K:KJ27-T\NJ%3<+(5VY5=J[0%!&%&.OUYH XW
M2_&]U;1WC:S/>P:MIVF3W-WI-U B"5T ;S('5?F3AA]X\$9Z9JU/KVLZ;I7A
M37'OS>1:K<6T%W:F) BB<<-$0-PVL1P2<CKSS716OA*RADM'NKBYU VEN]M
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M9@X)CW*(QT/.<Y[5PM_;:"OACQOJ.B:R;\7>DR&Y\AHC;HPB8*1L4 .1U[X
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M*5W2.5'9#APK E3[^E>3_9WMM/\ B;+H%M"NIP7#+;FWC DC'V>/(3'(/WL
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MB30?[6\+ZGI5@EM;RWULUL9"N JE=H/ YP.@J[H^F1:;8Q1BVMHKC8JS- H
M=@,9)P"?Q]:HV/B_2M4TNUO]/-Q<QW;E+9! R/,0,G:'"\ 9RQXXQG-6]$UV
MRU^UFFLV<&"=[>>*5=KPRK]Y&'KT]N: -"6*.>)HI8UDC889'&01[BH6T^R:
M0R-9VY<C:6,2YQC&,X].*J7VNV]G>-9QPW%W=I#Y\D%L@9DCR0&.2!R0<#J<
M' .#7-^*/&"-X8TJ_P!$>:>WU.^MX!<0#!"-*JNO."KD;E]0<]"* .O&G6(1
M$%E;A4?S%41+A6_O#CK[TXV=JT+PFVA,3MO9#&,,V<Y([G/.:HZ+IPTVWN'6
MYU&:.XD\]8;V4RM!D#**3DXR,X).,\5PGB+Q==ZU\-_$&HV\=]I<ME=F&.1'
MV, DRQD%E/7[V1TY[]: /3V570HZAE88((R"*J_V7IVP)]@M=H.0ODK@'UZ>
MU9UGXKTV\U2[TXBXMI[: 7)^U0F(/#DCS%)ZJ",'.*+?Q7I\^K6>G/'<V\U]
M$TMDT\>U;E5 +;><@@$'# '':@#52QM(Y6E2U@61P0SK& 6!ZY--DT^RFM!:
M2V=N]L,8A:(%!CI\N,5A>//$DWACPTUU9QI)?W$\=I:+)]WS9#@$^PY/OBG7
M/AJ\.BS1VVO:DFK-"P6]:<D>81U\K_5@9[!1CL<\T ;DEC:2F,R6L#F,83=&
M#M'MZ4)8V<7F>7:0)Y@P^V,#</0^M9UYXCMK&2> P7-U/:0K-=I:Q[_)4@X)
MY&2<$[1EL#ITJI=^.M$M?[-V/<W?]IPO-9_9;=Y/.55W$+@<G';KZXH VH=-
ML;9-D%E;1+L*82)5&TG)' Z<GBGVUE:60<6MK# '.6$487<?4XZUS$OQ&T:,
M7*K:ZM)/:P13S0)I\GF1I(I8$J0,  <GIVYK43Q3IES:Z?/8R/>G48C-:Q6X
M&Z1  6;YB H&0#N(Y('4XH MZKI46J0PAF,<]M,L]O,!DQ2#.#[@@D$=P2*G
M6S@(=I;> RRJ%F8(/G]CZCZUA3>.]"@T<:G)+.(?M8LI%\AB\,VX*4D&/E()
M'7\,Y%.C\96,S)#'8ZD;MUF<6CVQCE\N(@,^'(^7++CG)SP.M %Z]T.VO4@M
M6CBCL(Y5G>WC0 2NI#+NQ_"" <=R!VR#JUR-YXZM_-\,MIMK/>VNMNQ2:-,8
M01,^,$@[L@<=AGVJW9ZQI*:]XC<WUZKV,<+WJW198(%VL08PW R 22.#Q0!O
M"UMUCEC$$024DR*$&')ZDCOFDMK2VLH1#:6\4$0.0D2!5_(5DP>*K"74+6RE
MBNK6:\B::T\^+:+A5&3MQD[@"#M.&QVJA%\0]#F2"5%OOL\MX;(W#6CK'%+O
MV .3]W+<>V1G&: .FN;6WO(3#=013Q'JDJ!E/X&DCM;>*-XX[>)$?[ZJ@ ;C
M'/KQQ66VG:A_PF*:C'J%T+#[(8Y;5F4PE]WRE5ZANN2>V!SSA]AXCM-2FMEM
MX;DPW2.]O<%!Y<JKU((.1UXR 3VH O)IUC%:_98[.W2VSGR5B4)GZ8Q0-.L0
MT;"SMP8_N'RE^7G/'''/--U+4K72;,W5W)LCW*B@ EG=B%55 Y))( %9G_"6
M6"/J$$\-U!>6$'VF:UD0>9Y//SK@D,O!Z$\C'7B@#<*(9!(54N 0&QR <9&?
MP'Y5%/96MU)%)<6T,LD1W1M)&&*'U!/2LN/Q5ILLNB(OG$:U$9;)O+X<"/S"
M#Z':,\UFZ-XWBU"SU*[N[*XM8[;4&L8E91EW#K&J<'&XN?H,]>": .F^QVOV
MG[3]FA\__GKY8W=,=>M2R1I+&T<B*Z,,,K#((]"*Y77_ !I_9.C2W<6F7C3Q
MWT5B\4B ;'<I\Q(;!&)!C!.3QZD6]0\8Z?IOVH30W;-9VJW=XJ1@FVB.<,_/
M^RQPN3@=* -N*TMH&5HK>*-E01J40#"C^$>WM6#XD\/7&MZOH=R@M6M].N'F
MEBGR?-#1LA7&".C9YJ6[\8Z7::G#IP6[N+J>U-W"EO;._F("!\IQ@GYA].^*
M=;>+M*N]#L]5@>5H[R7R((?+(E>4$@Q[3T8%6SG@!22<#- &I_9]E]F2V^QV
M_P!G0Y6+REVK]!C ZFGR6=K-:_99+:%[<C'E,@*8],=*\^L-;!U;X@-J5SJT
M%A:109C)8RVH,+%S&%SC^\"O'0YXKH%\6Z3IT6C6.=0GEOK/SK3,#R23(J*>
M6QR^",_7)P.: -_[#:?9X[?[+!Y$?*1^6-J_0=!4-]8EX;B:Q2UAU)HV$-S+
M"&VOC )Q@D?C6=;^,=(N=#&JAYDC-S]C\F2,K*+C?L\K;_>W<?KTJ?3O$MCJ
M6KWFDQQW45_9A3<12P,!&&&5^<90Y'(PWKZ&@"30]-NK&"6;4;J.ZU&Y8/<3
M11^6G  "HI)(4 =SU)/>M":"&YB,4\22QMU1U# _@:J7^JPV-S;VOERSW5P'
M:*"+&YE3&X_,0,#([]Q6'=>- FL^'[*VTZ[DCU5)9=YC *JBY*[200V2N<]!
M[T =&EC:1VAM([6!+8@@PK& ASU^7I2M96KR"1K:%G"&,,8P2$/5<^GM6/?>
M,-+L$N9Y1.UE:3>1=7D<>Z*!^,ACG/&1D@$#N1@XFU/Q-8Z;]H&R>Z:VM_M5
MP+90_E1<X8\CKM; &2<' H U/LMN/)_<1?N>(OD'[OC'R^G'I3196JWC7@MH
M1=,NTS",;R/3=UQ7&G6DD^(FG7D.I2MI%SH$UYM:4K"0)(MLFTX .TGD^M==
MIM^-2LH[M+>X@20;E6X38Y'J5ZC\<&@ _LO3]K+]@M=K')'DK@G\J<NGV22)
M(MG;K(@PK"( K]#CBL6Z\:Z9:ZU<:2(-0GO+<Q>:D%F[[5D) ;IRHQR>E23^
M+],MKBV683K;7-U]CBO/+_<M-DC9G.>H(SC;D=: -=+"SCFFF2T@6688E=8P
M&D_WCW_&F?V5IVS9]@M=N<[?)7&?7I64WC+2EO$A_?F)K_\ LT7(3]W]IZ>7
MUSG/&<8SQFK)\16GVMH8X;F6-+H6CSQH#&DIQ\IYR.HYQC/&<T ::V\*3><L
M,8EVA-X49VCH,^GM236T%QL\^&.78P=-ZAMK#H1GH:Q;WQAI=@ES/+Y[65K-
MY%S>)'F*%\@$,<YP"0"0"!W(P<-O?&>F66JW&F"&_N;V"W6Y,5M:LY:,D@%3
MT(X//3MG/% &P^G6,@P]E;L-Q?#1*?F/4].IIT=E:Q2M+';0I(V=SK& 3GKD
MUD)XOTNXM=*FLC+=MJL336<4*@/(B@%C\Q &,C.2.3BN;\0^)X+H>#M;TV]O
M!8W6I&.2.(.#*HCERC1CEB'3&,'D4 =O'I6G0ILBL+5%PPPL*@8;&[MWP,^N
M*LNB2QM'(JNC##*PR"/0BN(UKQ9:ZYX&\4OIDU]8ZAIEI*TL4B-!/ XC+(2.
MH!QD$=:U=,\1V\4FAZ/<BY-]>V*S1R,N5D"H"YW$\D9&1UYH VX].L8;0VD=
MG;I;$Y\E8E"9_P!W&*FAABMXQ'#$D<8Z*BA0/P%5K'4HM0DNTBCE7[-,8'9U
MP&8==ISR.1_+J#7&77B%]#^)&LI.=4O;8:9;S):6T;S[&+R!F5!PHPHR>* .
MYDL[:64RR6\+R%#&79 3M/5<^GM4B(L:*B*%11A548 'H*QK;Q5IE_IMC>Z<
M\E\M^C26T<"_.ZK]XX8@+M. <D8) ZD"N;\0^(XM6TSP[J.CWUU"C>(+:TGC
M5FB;_6;9(I%^HY!_D: .WAL;2VD,D%K!$YX+)&%)_$40:?96SRO!:6\33',I
MCC"E_P#>P.?QK%@U72U\5:RIO;U9[.TB>ZCG++;Q1_.0Z \9.#EAQP/2I$\6
MV+:C'I[V]Y#=3P-<VL<L6TW*+C=LYZC(.UL-STH U5TZQ2)XDL[=8WQO01*
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MC+$,I#$'D=!^-^_\):EJ>F6<-YKHEO(;^&^DG:T^5C$P945 XVKD<\DG)YH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+:^7//<&)IS% FYEC! +$?4XP,D]@:LPWD=QI\=[$'>*2(2H OS$$9''K[4
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MS#LN+B2UB$URMM$7,*'."WUP3@9; SB@#7HKGYO&>B13:9$D\UP=3A::S-O
M\@F55W'! P3@CCKS5,_$705T]KYA?+!#.8+HFT?_ $1PVTB7CY>2/SS0!UE%
M07M[;Z=87%]=RK%;6\;2RR-T55&2?R%9VF^)+'4]1.GHD\-U]F6[6.>/:7A8
MX#C&1C/&.H[B@#8HKCO'W]NP0Z9<^&[ITU$W806[O^YN%$;N48'IG9@$8Z]:
MC_X26#Q1X5L=4TZXN;.4:A;6US KE)(7:9$DB<>N"1^((Q0!VM%8M_XFT_3&
MNXV6YG%B@>[:",R?9U(R"W<G'.!DXYQ@BHKCQCH\%Y96JR3W$M];M<VHMX'D
M$T8 .5(&#]X=/7)P* -^BN47XB:"UE%>?Z:+<S_9YI&M'"VLF_9ME./D.[ _
M$'H0:M-JNG1>,+N$W>HF\M].$DEJ$<PB/><.JX^9R<C*YX&* .AHKF-/\>Z'
MJ<NF+;M=^5J>1:W#VSK$[ $[-Y&-V >/8CKQ5C_A,=)^V1P;IC')>G3UN1'^
MZ-P,YCSUSD$9QC(QF@#?HKD[;Q?%?WWB.SGM;VVM]*/EO,D3%O\ 5ABPVY(X
M88&,\9I;+Q;HNG:5X>@^U:C<C4K8-9R2PO++.JQ[LLP'+D=NI)Z4 =716!;>
M,='N-$N=5,LL,-M<&UFCFB994FR%\LIUW$LN .N14]EXEL;[6;C1U2ZBU&W5
M7EADMVPBL,J2X!3!P<?-V([4 ;%%<1XWN;RW\1^%+>VU&ZM(;^]>"Y$,F Z"
M,L.N<'(ZBH/#?B6Y@\1^*].O]1:^TC27A\B^=07#.OS0DH '8' &!NYP<DB@
M#OJ*YV7QKI-L=12\%U:SZ?;BZG@DMV+^2<_O%"YW+P<D=,<XI+3QKI=\$%O%
M?,TK1K;JULR?:"Z-(/++85@%1B3G QUY&0#HZ*R!XDL?L=O/MG$ES.]O#;&(
MB5Y$+!E"^VQCD\8&<XJE<>.=$M-'U#4KB2XC33I/*NX3 QEA<XP&4 X!R,-]
MTYZT =)16-I_B?3M2UJ?28A<QW<4(G"SP-&)8L[=Z$CYESQGW%+K/B?3-!N[
M*UOGG$UZ66!8[=Y-Y52Q V@\X' ZDD8% &Q17*+\1/#_ /8=[JTDEU#%8S""
MZBEM766!R0 '7&5!R.3Q[U>B\6:?.H"0WHF>X:WAMY+9HY)F50Q*!L97:<[C
M@>] &[17.3>.="MM(GU*>>:.&VN1:W"- V^"4D *XQ\O)')X.1@\T_3?&>CZ
MGJ5YIZO<6UU:Q?:'CO+=X"T/3S%W@93WH Z"BL.W\6:9<7=C;GSX1J"EK*6:
M(JER ,_*>QQR V"1R :EMO$5G=W4$4,=PT=Q+)##<"/]T[INW#/;&QNH&<<9
MH UZ*PO^$NTH7ME [3)'?2F&TNFC(AGD&?E5O4X."<!L<$U-:^(K.\N8(H8[
MAHKAY(X;CR_W<C)G=@]ONG&0,XXR* ->BN?\5>)3X<BTTK9S7#WU]#:#8N0F
MYADGWQG ]:GO/$UE9M,GE74TEO"L]RD$)=H$8$@L/7@_*,MQTH V:*KV=]:Z
MAI\-]9S+/:S1B2.2/D,I&017.I\0]!D5)%-[Y!O#9/.;201Q2[]@#DCY<MQS
MZC.,T =516-J'B:PTZ2[1DN)S9()+LV\1?[.I&06Q[#.!DXYQ@BH;CQEHT%U
M8VRRS7$E_;M<VOV>!Y!,@ .5(&">1P/7)P* -^BN37XB:";%+T_;5MQ/]GN'
M:T<"UDW[-LIQ\AW8'X@]#5M]4TZ/QE<P&[U$WL&G"62T".8?+W_?50/F?/&5
MSP,4 =#17,:?X^T/4Y-,%NUWY.IDK:W#VSK$[X)V;R,;L*>/;'7BK!\8Z2+Q
M(-TQC>^.G"X$?[K[2/\ EGGKG(QG&,\9H WZ*YC3_&,-WK6OVEQ;36EMI#*L
MEQ*N%QLWLQ/88(QW[U?L_$MC=ZS_ &2R7%M>M#]HBBN8BAECS@LOT.,@X(SR
M* -BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBD9@JEF(  R2>U "T52L=8TW5))H["_MKEX
M"!*L4@8ID9&0.F1T]:NT %%%% !156YU&QLY[>"YNX(9KE]D$<D@5I&]%!Y)
M^E6J "BBB@ HJO9W]IJ,!FLKF*XB#M&7B<, RG##([@@BK% !1110 4444 %
M%%% !1156_U*QTJU:ZU"[@M;=3@R3R!%SZ9/>@"U15?[?:?VC_9_VF+[;Y7G
M^1O&_P O.W=CKC/&:L4 %%%% !1110 4444 %%,>:*.2.-Y%5Y,A%)Y;')P.
M]#RQQO&CR*K2-M0$X+'!.!ZG )_ T /HICS11/&DDBHTAVH&.-QQG ]3@&GT
M <=\1[2271=,U! 3'I6K6NH3 ?\ /)'PY_!6+?A5SQQI%UJOA\7&F*'U73ID
MOK$9QND0YV?1EW+_ ,"KI&4,I5@"I&""."*H_:-,T5+6R>YAMA*XBMH9)0"Q
M/1$!.3[ =![4 <MXNT34)OAK<Z9:VKW>I7#QRR)$1\TAF620Y)  X;'M@5+X
MWMWU:]\)6$"MYIUB*^8$8*10JS,3Z<E%^K"NI@U&QNKRXL[>[@EN;;;Y\22!
MFBW9QN Z9P>OI3OL]O#<2WK "5DPTKG[JCG ST'?]: *GB"ZOK31+E],M9+F
M^9"D"1@<,> QR0,#J>>U<?XL\$@>#(1H*:C)JFG/#<Z<DEU(^V5"",J[;1D;
M@?J:[RSO+;4+.*[LYX[BVF4/'+&P96'J"*GH X#Q#I\WB$V=[)IFL:7J<5GN
MMKZR<>;!*3\T+@'#*2%Z_+UY&:[#1%U!="T]=6\O^T1;QBY\O&WS-HW8QQC.
M>E+9ZUI>H74MK9ZA;7%Q$H9XXI0S*IZ' [>]7J /*;7P[X@C\%:3:KI<JWN@
MZS]N\EI$Q>)YTI(C.[^Y("-V.>*ZNRTV?4/'_P#PDIMIK6VBTO["BSKM>5FD
MWD[>H"X YZDG' R>KHH X7Q987UMXNL->BT'^W;#[(UG<VJ*C2Q'>&61 Y /
M<$9%,N+?5;>YT1;7PVUKI,IG:YM--,4<L+MM\L.P90 ?F+;#UP"2!SWM% 'D
M>EZ)XET31O#E_'H<TD^B7UZ)[%94WS0SN_SQG."5!7 .">?QZ'Q+'J^N:+IL
ML>AW$+C6+6Z^S$IYJ11NK,\F&V[N#P"3T[Y [.UO[2]:X6UN8IFMY3#,(W#>
M6X )5L=#R./>K% ')Z39WL?Q'U_4)+.:.SNK2UCAF8#:[1^9N&,Y'WQU'K5+
M6[HVGQ9T&3R)IE.EW8;R5W%1OBYQU(Z#C/6NYK+FT&TG\06^MNT_VVWB:&,B
M3"A&(+#;T.2!^5 'GUUX3U>UB.O0:0E[*=>FU.32)"F7@DC\K'/R^9@;\9ZG
M'45=US3;K4O"4S:9X2.G2W%[:2BU2.))W6*579Y-K;1P" ,D\>^!Z14<\\5M
M;R7$\B10Q*7DD<X55 R23V % '(>+]'36;VTE^RZI;7$,#/:ZIIS8E@D)'[M
MES\RM@<$8X.2,U0TNQ\1:3XETW7=6M6O#=:-%97WV4!FMYT8MG:.JG<0=N<'
MVKOK>XAN[:*YMY4E@E0/'(ARKJ1D$'N"*AL]2L=1\[[%>07/D2>5+Y,@?8^
M=IQT.".* /.7\,:I:6MA*EA,\EQXK.LS0H5/V:$EA@\X)QM) SR3C.*Z70+.
M\@\>>*KR>SFBM;S[+]GF;&)/+C*MWR.3W S75T4 <IXPT?4[F]T;5M#"#4K.
M=H69NGD3#8Y/KM.Q\?[%4_"_A6[T'Q%?VW)T*WD-UIP9MS>9*H$G_?)5\?\
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M<C1O%(,X964@J1D\@]Z;IFA6FE,9(Y+NXF*[?.N[J2=POH"Y.T<#(&,X&>E
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M4L0A <8^^<G]!0!8T0 ?%7Q9@=;*PS_Y&KJKZ26&PN)8$C>5(V95D8A20.Y
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M &<^7-&4"LCINSS@'(;@BH-5\"2:II.L0G48XK_5[B&:YN?LQ90(BFQ%3>,
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MXST ##.#G([BM2;Q'>P:]XKMX]/LO,TRPAN8I-Q#3 B0X=L=MG  [GGFJX\
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MQT[YKN*XW3?!NIZ1?W$%CXA>/0)[A[@V!M@9(R[;F1)<_*A)/;(R<$'FNRH
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M'PW>R:5\/?!MO!/<0Q:MJ8M;J;SW)5-\I"J2?D+%0N5P>3WYH ]AI"0H))
MY)-<?I<MYIWQ*O\ 0XYYY]+DTR.^59Y6D-O*9&0J&8D[6 S@G@@XQ6GXWA6?
MP)KZ.7 &GSM\CE3D(2.00>W3OWH =>>)[>UU;0K)()9X]89A!<H5\L!8S)SS
MGD#CC'/6M+4KF>STZ>YMK*2]GC7<EO$RJTA] 6( KS>6P0I\,[>.>YC$I8LX
MG9G&;-LA68DJ.W&,=L56U"[U"R^'WC^"#5-0#:3?2)9SM<NTT:>7&X7S"=Q
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M"$88_*!Z=!BN%\-K/IO@WP)J=M?WJRSZJMI)%Y[>2T+O*"IC^Z>@.2,Y[]*
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MC::C;3649*O.L@V(1U!/8CWH KW_ (5T34A8_:+! ; 8M7A=H6A&,85D((&
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MIRP07*>7*%E<ED_N[BV0O)X! YJ5/"6B1R:=(EFR/IL9BLV6>0&%#P5!W=,
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M72X6U$E2TN6 <K]TLH.UB.Q()&!5U-#TZ/5KC5%MS]LN(Q%-(9&(=!T4J3C
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M2DU6S2R1S&\SS *KCJIST;VZU&WBSP\LEW&VM6(>S -POGKF/)QS^/'UXZT
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M6UA)8QBVM65[=8R8S"R]&1E(*GW!SR:Y[_A+TT_QIJD&JZK:0Z/%I]O<V[N
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M<>>[ AV(ZCOC(KM:* "O-/!YN['6M*L].NVU+0IH)66&ZBQ<Z3P"$9NZD_*
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MM% 'B<MY)'\*)O#]_:7A\06FHQM<Q"UD=I&-XKF52%.X,#G/?./2O:D8.BN
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H(!&",BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***BN+
MJWM$5[F>*%68(ID<*"Q. !GN3VH EHJ@VMZ2ME]M;5+(6FXIYYN$V;AU&[.,
MC!X]JGDO[.*S%Y)=P):D!A.T@"$'H=W3F@"Q15%-;TF2 3IJ=DT)<()%N$*E
MB 0,YZX(X]ZG%[:M<2VZW4)GB7=)&) 60>I'4"@">BLG3-1$>CV<FJ:KITT\
MN5\^W8)%*V3PF6/8>IZ&IY-<TB*SBO)-5L4M9O\ 53M<($?Z-G!_"@"_15:Z
MO[2SMA/<WEO;Q-PLDT@522,CDD9K$\%:[=^(-)O+F\:W=X=0N+97MU*HR1N5
M4C)/4#/6@#I**Q]5\3Z1HNIZ?I]]>PPW%\S"-7D"X559BQST'RXSZD5=GU33
M[6YCMKB^MH;B3 2*2959L], G)H MT45R=CXJ,7B?Q%I^LWNGVUK82VZ6TC'
MR=WF1E\$LQRW;C'3I0!UE%5KS4++3H!/>WEO;0DX$D\JHOYDU/'(DT:R1.KQ
MN RLIR&!Z$&@!U%5;^_M;"#?=7MM:;LA'N'"KNQ[D9^F:Y?PYXBU/7/"&DZG
M->Z9:W5Q?O%-O0A)46=TV1@MD.0HQR>>QH [*BJLNIZ?#=K:2WUM'<L0%A>9
M0Y)Z87.>:)M3L+>[CM)KZVCN9,!(7E4.^>F%)R: +5%<YIFLW]SXYUS1K@P&
MUL[>VF@,:%6_>>9D,23G[@Z8K8M]4T^[N9+:VOK::>,9>*.969><<@'(YH M
MT5534]/DO#9I?6S70)!A692X(Z_+G-(FJ:?)?M8)?6K7B@DVZS*9 !U^7.:
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ME+ YQTSZ\4Y-3T^2\-G'?6S70)!A652X(Z_+G/% %JBFNZ11M)(ZHBC+,QP
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M],E*NS!\'#)DE23@Y8=>,UO"%SHNL6GA[3M0O=1/B/2)E+Z>45)(9ER)'8A
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M\/[#Q'%;RWW]CW,=Q%<A68DB/RT<'J=N1@]P:]>BBC@B2*)%CC10J(@P% X
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M/:V30]+DG,2NFL6;(SXR )E+$?AG/M7; !0   !V%+0!YC)'HTOCWQLTZV3
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MBF #1R1L593@D'D=035+5/%MMIHU!H[*\O8]-"F\>U56\K(#8P6!8A2&( .
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M+U;">WG,8:WD+JN3AB&'SJ1@G.1T&2-K4/%<&G[XS8W,MU%;BYFME>(/&A)
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M.X#?C>5!Y"YQTSFFW7@*.[TCQ!ITFIS"+6[G[3<,L:[D.%!">V$7KGO7844
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MVHJ;BI'.<Y8]36,/AQ';Z9HL.GZU>V5_H\;0VM]$B%FB;JDBD;7' [=J[<Y
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MQK'$BA41!@*!T  Z"@#R2VOK?[?X1U6PN#Y%YJ]PAN[B8&YNHRLQ;S,  ("
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MQLKWQ7#ITI$TZ:9-.T%TX6VBC+*OFD8RT@((&,8&[D=^JLM+L=.W_8[2& N
M&** 2!T&?09.!VS3+S1M+U"[M[N]TZUN+FV.8)9859HS_LDCB@#$^&UY+?\
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MD$]UJ<8BF5TWQK$ 0L6#C<HW,3TR6/3@"[H^EV^BZ3;Z=:J%A@7"@*%')).
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M=7&/.FCB"O)CIN(Y/XT <KJ=U'>_%*ST+4@K:>=*>Y@@D^Y//YFUL@\,509
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M:RVS26FI)M7B3@JC#)4MD8VUMZ1#=67Q*\2-+8W7V>_BM'@N1'F(A(V5@6Z
MYP,=><].: .OHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&1^.!7?ZG=26.EW5W#"LTD$32"-GV!L#.,X./RH M4R66.")I9I%CC099W.
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M5PVY<>G(JSIGB:]NO$:Z7=:6RPRVYFCNX%D,:L#@QN61<'N#WYX% '3T444
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M*_[A6Q_$I,C>HPOJ*[E]P1B@!;' )P"?K3(8(;=2L$4<2EBQ"*%!)ZGCO4E
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M@/4+RWUO&H0VMW=:HFJV,\0+_9Y4554,"!N&%Y_WCQ73:%;Z\B/-K]W92W!
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M*ZA::@\>GS?*#'B&-E3 &-N6(Z=\]:ZFY\+Z3<W&F3M;O&^F*R6WDRO&%1@
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M;2YG6#5X+F=H&VF.-=V6SD'(R.G-;(\-Z8]O?Q7,!N_[10)=O<'<TJ@8"GT
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MCUR&Z>AH ]CNM5TZR,@N[^UMS&GF.)9E3:N<;CD\#) S3Y+^SALQ>2W<"6I
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M1V\9Z/*Q"HOT+$?A7._#S4[Z2QU'0=8N#<:MHMTUO-*W6:-OGBDQZ,I_\=H
M[*D"A0 H  ["N2B\>QW;WB66@:O<&TGFMIF$<:HDD:;L,Q?@'H#S[XR,Y\?B
MBWU7P=X;U/7-.OT-_=VGE?9Y JB5V!1B5?.S)Z'DXY% '?45S^J>+;731J#)
M97E['IH7[8]JJMY.0&Q@L"Q"D,0 < _A66)_^+NPNL\WV>7P^\Q1Y&V ^<@W
M;2<*<>PH [2D(# @@$'J#7,0^.M,EU#3+<Q3I#JA*V5TQ0I*V-P! 8LNX<C<
M!GV-=10 F!C&./2E    & *QM9T=-1$DMUJ-Y;11Q_)]GG:(1D9)<X/)^O Q
M]:?X8EOIO#.GRZD2;MX09"PP3Z$CUQC/O4\SYK6-W1C[+VBE?6S7K?[]M>Q8
MGTR.358=2B;RKJ-#$S 9$D1.=C#V/(/8Y[$@W=HW;L#.,9KG]3DFB\::"B7,
MPAF2YWPAL(=J+@X[GDU+K6D17+37]WJNHVT$$1.RUN6A554$DG'4^_H!2YWK
M9;%K#Q]SFE925]K]6K?@;E%<O9>'Y]0\.:=:ZAJ.HJGEF6=4NG65V8Y"M(#N
MPH)&,\\>E'@87R:7?07=W->6\&H30V5Q.VYW@4@#+?Q8;>,]\5TPI*5#VO-J
MK:>OGW.>K'DJ."=TF]3J*9,KO!(D4GER,I"OC.TXX..]<QXWEN+>/0I;>[G@
MW:S:1.L3[1(C2 %6QU'M2^+M>N+"[TO1K%I$O-3D<&6*(R-#"@R[*H!RW( R
M,9.3TK2GA)U%#E?Q7^5M_P #-RL:6@Z/=:;')-J6IMJ>HS!5ENC"L0*KG:H1
M> !N8]^6/T&O7$7WBNQL/"LDFARRO?27L>FHMWO,D=R[!!Y@?YN,[L=P*WY;
M^WT9[/2XH[B\O9T=TB5@9'5<;Y&9B !EEYSU8 "L*D'"3B^G?0I.YKA0O0 9
M.>*6N.U7Q";KP7/XITR*Z@GTX22O;W"[&98R?-B<<@Y"M@C.#@@U+J^NIIEQ
MH&M6\C-I^K7$5I,A/!$J_NI .Q#!5/J&YZ#$ =91110 A4$@D#(Z'TI:YFY\
M<:=:V9U)[>Z.D+<&V?45"F)6#["Q&[=L#_+NQC//3FF7WCBWM-0U>QBTC5+N
M?2XDFG$$<>#&P8[E+. <!3QU/8'G !U 4 D@ 9Y..]+5;3K^WU73+74+5BUO
M=0I-$Q&"58 CCZ&LKQIKMQX:\'ZEJ]K:FXFMH2RKN "GLQR>@]!R: -ZBO/]
M8U&Y@\?^%;K[)J.^>RO=UBL@8NR^5M^4/Y8/S'G(Z\FMVS\::=>:-#?B&XBD
MENGLA:2A5E$Z%@R'YMO&QCG=C ZT =$ %&%  '84M8N@>)K/Q!)?P0QRPW5A
M,(;F"7:2A(RI!4D$$<@@UM=!DT %(  20!D]3ZUS1\<:<MO9WSV]TNE7DXMX
M=0(7RBQ.U21NW!6(P&(QTZ @UDWWB*\U8>-M+DL;JUBTRV*1SQS*I#&$R!B5
M;<,Y7 &>!SC)% '<2HYBD$)1)6& S)N&?< C/YUC^$?#[^&/#5GH\ETEV;5"
MBSK#Y99<DC(W-Z^M8G@_Q5'_ &;X7T>ZL[Z.6]TR-K>[E5?+G9(E+@?-N!QS
MEE .#@FKTOCS2H;FR#QS?9+VZ^QPW@*&,RDD#(W;PI((#;<?@0: .HP,@X&1
MT-! )!(&1T-<UIGC.'5M5EL;72-4/D7DEG/.T2^7"Z(&RQW=#G QGGKC(STU
M !17G*:X_A_QOXVG-IJ>H0P0V<YB@</Y2>7(SD>8P '?:#D]A733^+K0"V^Q
M6EW?-<6!U%!"JC]QQ@Y<@9.X8'7Z4 =!T&!2  9P ,G)Q7,/XZTX_P!A?9[.
M_N1K<+369AB7G";]IRPP<8]O4@ FGVGC;3[G1IK^2WNK>6&].GO9R*OG?:=P
M41@!BI)R,$'&#DD#- '2T5PNBW=Q/\6M8CEAO+91I-NWD7$N]=QD?+( Q !
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M_NOL<-JR@2^>&960C.!C8Q)SC ^E6M'\2P:SJ6H:>EG=P7&GN([@3*NU6(!
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ME.UG")1<-]J;/S !<9?/!!SC'XU9U7PG97%O%!;V\N))D$S&ZD($0.6X+<Y
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MAI$%C::CHRVF6NA(Z2@R<N0"68[QDY/ ZD\5W=[?6VG6DEW>3+#;QC<\C=%
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M0U+Q9JVG:K;!Y;5UEUR/3VMH8RZ) [;59I!PLO(;;GH<8[T[2+G63XM\;_\
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MM\MC9ZB+^TA6./\ <L)#)MR5^8;B<9SQV- %";6XO#?BOXAZS-&9$L[&PEV
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MS/,Z$$%<]C0!UL8=8D61P\@4!F"X!/KCM7F>G>)-3T/0_%>JWEVE[+'KDEG
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M% !6'XK\02^&-$EU8:>U[;P%?.2.3;( 6 RH(PW7ID5N5B^*\#03G_GZM?\
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M5/9ZU<W'B6^TF?2YK>*"))H+II%99U;K\HY4@Y'/7!]*YKX:Z=IT6F:LB6T
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MNR6&EV7Q3\+R::L21SZ9=G,;9$@'E;6]R03\W4XZG% 'H+NL:,[L%51DL3@
M>M<]?>*EM[OPXMK;K<V>MR[([CS-NP&-I%.W'.0OJ.M6O%D$5SX/UF*:-9$-
ME,2K#(.$)'ZUY\ME9OH'PQMX@$26:%I?)<J2QLF)Y'()H ]9HKR"XOY/#EAX
MHL[:=[;2[;Q!:Q.S,SK;6\BQ&3N"%R3G!'#'&*[/PUIEOI^OW\UIK%M/#=P1
MR&QLXML$1' D WL%+#Z9VY[&@#K**XOXFAO[ T]EN)X#_:UFI>*4IPTR@YP<
M'CUS7/:GI(T/Q)XCL-+GNX]-N/#DMY/%]ID;RK@,0CABV06 ;OSM- 'JM%>3
M&WBT7PMX/O(GN%CUJ;3X-5N'N'8-'Y9*@Y.%!8JIQC(X/%3>)()M+U3Q?I^G
M/+!I9\,R7S102,BV]R"X4IM(V[@I) X.W- 'J=%>61:8=*U/P+JNDSW3WNHJ
M(KU&N&=;F+[.7+,"<#:0,8  R!Z51-S<WGPBA\4V[N/%45R&,H)$AG^T;# P
M_NX.W8>,8XH ]AHKS769KG2_$DVHWUI'J6C2ZG;A;VWDQ<Z=(#&HC93]Z,L!
MPO\ ?)(.:I#;XDCUU[S7K;3-4T[590)?))N;9$D_=!#Y@RC( ,!<-N/4F@#T
MC6]1DTC0K[4H[<7#6D#S^47V;PH)(S@XX'I3M(OSJFBV&H&/RS=6\<^S.=NY
M0V,]\9KSJ\EM]?T_XBC5L->Z<9H;>-VP;>!8 8W3^[N;<21UZ= !7<^$2#X+
MT(@Y']GV_P#Z+6@#9HKSB\TFUU7XA>*+2\:XEMO[)MY1";APH<F7D 'CH,#I
MGGK5#PUJEQJLW@73M8<SV-WH;S8E.5N;E=@P^?O$)N;![G/4"@#U:BO&]4%W
M!H^MV*W-R+"P\2VD-BXF8%4=XB\><\JI<@ YQT[5O1>'M.D^).L:,ZSMIL^E
M074EL;F38\QDD0N?FR3@#\>>N#0!W=[->Q2V@M+-+A))@MPS3;/*CP?G P=Q
MR ,<=:MUY%I=U<W/A'X97<UU<23OJ20NQE;]XHCF^\,X8_(O)YXJ'5]/BET?
MXDW3S7;3:=<M+:,;J3,+BWC<,O/7/Y=!0!['17F=U<#7_%%_HNJWUG;@Z7;R
MVBW41.X.&\R6/#J X; SU&!C'-0Q2K=:_:>'-3UJVO+7^QHWM+B_A)6\;>ZR
M2+AU!?:(\').,D=22 >I45C>%+8V?ABRM3JKZKY*M&+V08,H#$ ]3G@8SDYQ
MGO7,>*O*T#QG::I- \]CJ]K)ITL )P;@#?%CT9\,F?7;0!Z!17FO@B.XF$'A
MK4$\R\\-W,AN9>?WQ(_<-D]0RN6^L8S5+PT$\0Z7HFN3:_;6FK0WH^UB.$BX
M>0N5>WDS)RIS@#;P ", 4 >KT5Y/I]@8M(\:ZY;-=SZKI.HZ@=/+7,C^61",
M#:3ANO0YZ#T%:_ANTL;K4M"UW3_$%J1/;NCV]K$0;P%,YF)D8ED(SN(SDD'K
M0!Z#16'XQO+;3_!VK7-W=75K ELX>:TQYJ9& 4SP&R>#_*N9\.$V/Q-NM/46
M]K!)HL$QM+>7<HD\UP&/0%RN,D 9&.O6@#T*BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JU[I
M]EJ4 AOK2&YB!#;)D#KD'(.#[U9JO?7UMIMHUS=S"*%2!D@DDDX  ')))  '
M))H ?+:V\]HUK+#');NFQHF4%2O3!'I5>_TC3M3:)[ZR@N'A),32("R9X.#U
M&>_K7):?XD>X\;>)H)=3NDTVTT^"4+-!Y9MF8R;B%* G@*1D&M.U\5Z'IFC:
M,+K6WN?MMN&MKB6)M]T FXMA5ZD#I@$].M &Q-HFE7*VJS:;:2+:$&W#0J1"
M1TV<?+^%-.@:.SW;G2[,M>#%R3 N9QZ/Q\WXU3D\8:''IT>H?:Y&M7@%R7CM
MI7V1'.'<!24'!Y;'0^AJS=^(M*LX8Y7NC(LD!N%^SQM,3%_?P@)V\CGI0 ]?
M#^C)):2)I5DKV:[+9A H,*^B<?*/I49\,Z";22T.C6!MI)/->+[.FQGZ[B,8
M)]ZSIO&VFC6M&T^V$URFIPO<17$,+O&8U P05!SRPSZ#KC(J]<^*=&LYFCN+
MS8J3"!YO*<Q1R'&%:0#8IR0,$]2!0 Z?POH%U<37%QHNGRS3Q"&61[="SH!@
M*21R,8'X5.=$TIKJWNCIMI]HMHO)@E\E=T4?3:IQP/850U#QIX?TN_EL;O4
MEU#L,D2Q.Q4.=JGY0>,\9[=\5O4 90\,:"+9+8:+IX@27SEC^S)M63^^!C ;
MWZU4U[PU%>:9J?\ 9-M86VJ7L0B>XE@!\Q<C*.1R05ROMG(K5OM2M-.6(W,A
M5IGV11HC.\C8)PJJ"3P">!P 36=+XPT"'2)=4EU!4M(9O(E9HW#1R9 V,F-R
MMDC@@=10!@Z)X*C@U6UOY/#6@Z+-;/O$NF2L[R<$;?\ 5H%4YY^]GI[UV\T,
M=Q$T4T:R1N,,K#((]Q5/2M:T_6X9YM/G,T<$S02$HRX< $CY@,C!!R.#FKY(
M ))P!0!4T_2]/TBW^SZ;96]G!G/EV\01<_0<57N_#FBW^J0ZG=Z393WT&/*N
M)(%9UQTP2,\=O2HH?%.CW%]%9QW3^?/&TL :"11.B\DQL5Q)@8/RD\'/2F6?
MBW1-0CADM+MY5FN6M$VV\F?-4992-N1@ Y)X&#0!?BTG3H-1EU"*QMDO91B2
MX6("1QZ%NIJ.ST/2M/E$MGIUM ZY"F.,+MS]['IGOCKWJ#4/$^CZ5(R7MV8E
M218I)?*=HHF;&T.X&U"<C[Q'4>HHU/Q-I&CF87UT8Q %:=EB=UA#'@NR@A ?
M]K'KTH GAT+2;>^:]ATVUCN6<R&18@#O(P6_WB.IZFFMX>T5_M>[2;(_;/\
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M;>*-'N[^VLH;O,UTK/;;HG5;A5^\8W("O@'/RD\<]*0>*-'-_!9?:RLMPS+
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MVD>0@9.%4$G &3QQ6>_C+P_'IUE?OJ<:VM]+Y,$C*P#/D@J>,J000<XQ@YH
MT+'2-.TPDV-E!;DJ$S&@&%'11Z >@XJW)&DT3Q2HKQN"K(PR&!Z@CN*RK#Q/
MHVI6]]/;WH6.P)%UY\;0F'C=E@X! QSGH16 ?$<EW\2](L+2\NA93Z?<32VT
MML8@2"FQQN0,<Y;N1Q0!T]CHNEZ8C+8V%O;JRA"(XP/E'1?H,GCI3[#2-.TH
M2#3["VM!(Q=Q!$$W,>I..I]ZN5A:EJ[MXDL?#UH^R>>%[NXD'6.!2%X]V9@!
MZ -WQ0!J7VG66I1)%?6L-PB.)$65 VUAT8>A&3S5>?0=)N=+?3)]-M9;%VW-
M \0*,V<[B.YSSGKFN7CNM8O?B7JNB#7;N"QM["&YC2*& D,[,",M&21Q4FG:
M[JEOXSN?!^LW"RR36GVS3]0@01NZ [65UY7>IYR!@CMVH Z2VT'1[-I6MM+L
MHFFC$4A2!1O0# 4\<KCC'2HK/PQH.GV%Q8V>C6$%I<_Z^&.W4)+_ +PQS^-1
M>&]:?58[ZVN=HO\ 3;IK2Y"C 8@ JX'8,K*<=B2.<5MT 9RZ!HZ26CII=FKV
M8Q:L(%S /1./E_"KTL4<T312HKQN,,K#((]#62?%6C+?+:&\_>-<_8P_E/Y9
MGQ_J_,QMW>V>O'6MF@"C!HNEVVF/ID&G6D5@ZE6MDA41D'J"H&.:@M/#&A6#
M1-::/8PM%&8XV2!044]0#CC/?UJY>W]MIT FNI=B,P10 69V/1549+$^@&:H
MP>)]'N+&YNTO0(K6;R)PZ,CQR9 "%" VXDC QDY&,YH D_X1S1!I4FEC2+$:
M?(<O:B!1&QSG.W&,YYJSIVF6.D626>G6<%I;)G;% @11GKP*I)XHT=HKYVNS
M$;!0]TDT3QO$I&0Q1@&P>QQ@XJI'XZ\-RRVT:ZES=0^?;LT,@69< X1BN&;!
M'R@[NV,T :NHZ/IFKB$:EI]K>"!]\7VB)7V-ZC(XJN?#.@E=IT;3ROGFYQ]G
M3_7'K)T^][]:JKXV\/'29-4;41':13_9I&EB=&CER!L9"H8'D=1W%/T[Q3HO
MB"ZO-.TS4\WD";G41E753P'7>N&7W&1T]: +R:+I:7%S<+IUH)KI=EQ((5W3
M+TPYQ\P^M5;+PIX>TV:&:RT33X)8-QB>.W4&/.,[3CCH*Q_!'B%Y_A]HVI:Q
M=O/=W2L"PC+/*^YN%1!DG )P!P >PJ;4?'VDVNG65W:F>[6YU!-/VQV\FZ*0
MN%<.NW*L!GY2,DXP* .I95=2K*&4C!!&0167%X8T&&.VCBT73T2V<O JVR 1
M,>I7C@^XINH>)])TN)I;R>6-$C664BWD;R4;HTF%/ECK]['0^AIU_KFG6ZB(
MW<GF2P&9#:Q-,ZQ_\],*K<>A(P?>@"9-#TF/[7LTRS7[9_Q\XA7]_P#[_'S?
MC1I6B:7H5LUMI.GVUE"S;F2WB"!CZG'4UC?#K4[O6? .E:A?W+7-U.CL\S
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M6BW<UXPMC&DK3+!(R1HXRI<A<(""#\V*VU974,K!E(R"#D$4 +1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7'^/[;4&M]$U&QM)KU-,U2*[N;6 ;I)(@K*2J_Q$;@0/:NPHH
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M#1J;F?>UHOE\":-RV"2O0*,Y., 9->H44 <A\/X9[>TUQ;BTN+=I=9N[A!/
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M=?2EUC36\6>%=9ET3PYJ-CJ<MB(/-U16CEE D5S N]B2I"L">!DC&<G'J=%
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M03Z@_KR)G\+TN;8>WM5>7+Y]C(\-'3--U+6OLEW;0Z;).@MX1*H56"XD*C/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*KS6%G<3I//:02S)]R1XPS+]"1D58HH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ (!&",BJ]M86=D7-K:00%SEC%&%W?7'6K%% !1110 4444
M %%%% !1110 4444 1S017,+0SQ)+$W#(ZA@?J#26]M!:0B*VACAB'1(T"@?
M@*EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MHY[>*Y0)-&'4'.#ZU)133:U0%/\ LJP_Y]8_RH_LJP_Y]8_RJY15>TGW8K%/
M^RK#_GUC_*G1Z=9PR+)';HKKT('2K5%'M)OJ.PFT;MV!NQC/>C:N[=@;L8SC
MG%+14 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%9/B36UT#1GO/+$L[.D%O
M"3CS)I&"HOTR1GVS0-7M--O;'2+^^:34KP,8LPL!*0,MMP,  =L\#&?6@#6H
MKG?$&NZ=%I5^CZU+I36\L<,ETL))C<E6"C<I#$@@<9X8>U2ZCJ\FC>(--AN7
MW6.J2FVC) S#.%+*,]U8*W7H0.QX -VBJ6J6]]<VJ16%Y]CD,B[Y@BNRH.2
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M#-=!\0[:YG\/6LEM:SW)MM2M+F2.",R/L292Q"CDX'.!75.ZQHSNP55&2S'
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MA;7 WA%KB;3W;0BPD$9=1(#"8AC(/."6S^'O0!-:^.O^)7>R:A8I;W]IJ?\
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M+$@"5R^TY Z9QGO[55U*P;3_ (B:=XB/_'M/8OIEPW:,EQ)&Q]B0RY]67UH
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M/Y,;$_=A4[3\Y S[<=<U4N/"FJ3/XSQ)9@:_$(X<R-^YQ#Y66^7GCYN/I[U
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M>\2V7B276=!O=-C-_#%'?VMZKN@>,;5DC*X.<<8.,X_+KK6*2"UBBEF:>55
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&BO.VO?$_B*VU6]T6^M;2>PU.6WC%Q<E8D2%]K+(@C.=R@G.[(W#&,5Z&#D
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MOQ/X@TW0/$=IJ%I%!=2+)>1271,;0N2#&J>5\KJ< '=R1@DYH ]$HKR.YO\
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MG&N_$7B"+2[RS&J2K<:;XDM].%UY:'[1!(\9 <8^\ ^#MVY_&@#U:JFIW_\
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MLMAJ]XD$V\$O&&B:0=&PI 49!!ZUU,.H65Q:-=07EO+;+G=,DJL@QUR0<<4
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M;U8K.Y-S:Q_;)-L#'=E4&>%.X\5=;P?I1;6-HN475]WVM$N&",64*Y"YPI8
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MA5UM0LDLUO'N[=;5@")C( A!Z?-G%'V^S^Q_;/M<'V7_ )[^8-G7'WLXZ\4
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M1XA0%_E#!?MKY&>H&P_D:U/$5UHNDZ_XTC-I%-9-I%D9;2VD\H.?,=23LY
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M>.N!NQFNT\(W$$OCOQRL<T;M]LMCA6!.!;H#^H(^HKM-B#^%>N>G?UI0H!R
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M0)(Y_"EC;V6NQZ=JEGKMZ;1[F,&(R;YOW4BG&-R,W P1GCM5RUUBX-[X0O\
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MNSUZ<9K2T_3=:T#7?$$L>FF_M=7=;N(QS(/)F\L(Z/O*DK\H((!XSQ0!M_\
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M)'+# ^<8)]#6%HOAWQ'X>;PKJD>EM=2V6E'2K^R6>,.J[E821DMM/*\@D'%
M%_P3KBVNF:]/>&]+-X@GMK>"XDWS;L)MC!9B.,'^+  )SCFM.Y^(FDV5AJUQ
M=6U]'+I,L<=W;;%:1/,QL;*L5*G/4&N9D\*>))=-O[E-,MA>P^(WU>VM)YU9
M+F-DV&-B,A25+8)[XK1UW2M;USP-J=M#X:@TZ[NC"L5G'-$6^20,S.XPN,#
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ME4QN#D  YP!R<]JHS>&]>D\":II8TI_M=SKAOHT,T6/*-TLV2=W7:,8]?SH
MZ;Q/KT7]FZY8VD%]<36EHS7$EFX0VY*%E^;<IW8^;"Y.,>H!K^&=?6V\%^&H
M6CN+Z_FTB"<Q1LN\J(URS,[*.2<<G).?0XSSI7B#2]4\4Q6VE-?66N@W$$RS
MQHUO*8@C)(&/3@8*[JSK?PYXBT>/PWJ":!:ZH]MH\6EWVGO/&&0IRLB,WRGG
M<",]"/P .EA^(>CW46C26D%_<#5O-%N(H,D/&"61N>&!4CT[YQS5JR\9Z==Z
M5->M#=6\D-[]@>TE1?.^T9 $8 )!)W Y!Q@Y) !K+N=)U:7Q!X2OAI4445C+
M<RW4=M(@2 21LBJ,D;B,C) ]<>E8]QX6\1/:ZM=6EFL=]%XD&M644TR;;A!&
MJ&,E2=I(#=?;\ #L(_%UC_Q,DNK>[M)]/DBCEAF099I<>6$*DJVXD 8/!ZXJ
M32_$UIJ>L7FD&">UU"UC69H)]A+1MP'4HS C((ZY!K"UW3_$?BOPO-OTZWTV
M]AF@N;2SN)EF#O$X<B1E^7:V, #/J>N!J^&1J,S/<7WARUT/";/*CECE>1L\
MG<@P%&..YST&.0"_?:W%::BFG0V\]Y?-"9_L\&P%8P<;B690,G@<Y//H<<MX
MJ\9^=\/)]6T-;DL\R6KL-J26S&98W5@6!5^2!C.#@].:T+W2]2T_X@KXBL[5
M[ZTNK 65S!&Z+)$RN71UWD J=Q!&<]#S6'J7A'5E\#ZO9VMGYVH:MK']I/"L
MJ!809T?:6) )V(.G\1/;F@#L-'TRWTI;R]07ELER1+):W,X=8"H()4 L%SU.
M"14%MXKANK5+J+3KYK:6S:]AE C*RQC;T^?AL.#AL=^XQ6T[2O9NR1%92AVQ
MR8ZXX!P<?K7!:%X3O;'5'?3[.XT;3;NRE6^TZ2X62 7#8VM"JL=O\>>@QCCT
M .BA\8Z?/'X?E2"Z\K70#:.57"DQF3#_ #9!V@] :2;QC8Q/$XMKR6RDO?L(
MO8D5HA+N*8^]NP&!7<%QGO7):9H?B9++P1:S:(L/]@S!+AVNXR'40O'O7!/R
M\@\\^W>M/PO9>*?#JR>'?[,AET^.ZDDMM5-RN!"\A<AH_O%QN(]#QSZ@%#3O
M%">&=0\937D.J7EG:ZFI>1"91;1&&,DDNWW023A<D#MBO19KE(K1[D!Y$5-^
M(QN+#&>!WKSV^\/:W<:-X^M4TQ_,UF5FL\S1X8&%(\GYN.5)^E=W;+(FB1)+
M$T4BVX5D8@E2%Y&02* .:L_B5I%XVD/]BU."RU5ECMKV:W"PF1ONQD[L@GIT
MQGOP:M6OCFRO-1N+2+3M3VVMT]K=7#0 10%4#[G;=PI!Z_GC(SR'A73+WQ+\
M,?"&FFQ>"W@DM[J6Z=T*E(FW@( =VYL <@8R>>!GH-+\.W]Q9^--/O[:2SBU
MJZF>";>C?))"L><*QP1M)Q]* -6+QE8-)IAEMKNWM=48)97<J*(YF(W*.&+*
M6'(W 9^O%9MS\3-*M;>]N6TW5VM;"[:UO)TM04MRN,LWS9V\]@3QD@<9IQ:!
MK.J^'_#>AZG8?9GTFZMY;BZ$J-'*(/NF/!W98A>H7 +>V<W2X+_5-%\>Z+::
M>TC7VKWENMPSH(H]Z*I+ G=\N<\ YXH [BX\2VR7,MM8VUSJ4T,"W$J6FP[$
M;.SEF4$MM) &3Q[C,5OXPTV_@TV33!+?-J,,D]O'#M5BB%0Y.]E (+ 8ZYSZ
M'&-I6@ZCX2\3WUQ9V<NI:;?6=M%^[D19(9($\L9#LH*LN#D$D'MWK-7P)Y/A
M[2M)O]+FO#%]HN3>:?<+%-97$DF\>4S,OR_,P_X",CT .N;Q-!]GM&AL[N:Y
MNK47:VB[%D2,X^]O8*#DXQGKG'0D067C72M3T_3+K3A/=/J6_P"SVZ*%D^3B
M3=N("[3P23U( SD5RS:!XJTV\T;6+C3K;Q'<C35L=0MY)41P5<NDBL_RDC<0
MWKUJ_=:1KMCXAT3Q'::5!,8K>:UO--M940Q1R,'4QEMJL05 ;.,]J )_AQ=3
M74?B<RF[&S79T6.[D+O&HCB^7))X'/0D>E:%]XVM;/4]2TZ/2]4N[K3X4GE2
M"%<,C;N5+,!QM/7&>V:B\%:=JFGS>(7U*R%LM]JLEY /.5R49$49QT/R5!_9
MFJ1^,_$>HC3I'M;S3H;>!UDC^=T\S/!;(^^,9]#0!K)XJL+FWTN2Q2:\EU.W
M^TVT$04.8@ 2QW$!0-RCD]3BJ4OC[28=(.HM#>XCO183P"(&2WF+!=KC..K#
MD$Y!&,USN@^&M=T%_"NJ?8&FFL=*.E7]FLL>\+E6$D9+;3\R\@D'!_"EU3PE
MJTNFZI<P63/>:IK=M?M;B5!Y,431\$EL%B$)X)Y;&>,T ="/&\1O[W3ET36&
MU"UC6;[*(4WRQ-G#J=^W'RD88@YXQGBH;KQ+HFJVWA:_Q?M#J-VC63PDH!(4
M; EPPXP&R.1D4^*QU*/XC7VLG3IC92:5%;(PDCR9%D=R,;O1@,^OYUSFG>&=
M>M?"7@C3I-+?[1I&I+<78$T6%0+*,@[N?]8/R- '07OQ#T^R&KL=,U65-(D"
M7K1P+B)=H;?RPRN"#QS[8K5U#Q-:V1=8+>XOI([<73QVVS*QG.T_.R@YVM@#
MDX-<K>Z!K4]C\0(4TU]VM BR_?1X;,"Q<_-QR,\]O?BHY=%UW2]=@U6W\.V^
MKV]WI\%M=6DTT22VTL60&5FRI4ACD YXS0!T\7C'3KVQL[G3$FU W=M]JCB@
MV*WEYQD[V4 YXQG.0?0XT-"URQ\1Z+;:MITC/:W )7<NU@02"".Q!!!^E<=J
MFAZY8^(;'7+70;#5HY+$6=WIZ.D?D$2,ZM&7 ! WLIZ9ZX].GLY-5M!I=O\
MV/;K%.TANV@F54LQ@L@ P/,).%)&.<GI0!MT444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGI6C10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9G V@ EF)SP!_"?:JCA:DI1BENK_ "U^[8.9'2T5#:&Y-G";Q8EN2@,JPDE
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M2[@:Y49:$2 N![KUK,A\0VFK6VKQZ->VCW=BSP;I6S&)0BMEL')4%@"1Z$4
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MIPMK-;R%A(ASPV1PX !(''S"@#:HHJJ;Z"9YK>UN[9[M 1Y?F!BI_P!H YH
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M+!C@,I.T-@&L36=3FU7QY8Z";6]ETN;3);@FVG2/S"7C59-P<':H9O?)R <
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M&-YS@,,C(R1U&>(K+QKJ(TMH+R*WDU0:W)HZR01-Y;E 7\S86S]Q3\N[KWH
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MLTJPQ>8V"[L<!0.YR:N5XXUWJE]\(M,O;^ZBNYYM:A928RAW?;CG<<D8)Z8
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M<:8U^B+?PQ0I(LQ0;0Z[L[&QQGGZ5UE0RW<$%Q;P2RJLMPQ6)#U<@%CCZ 4
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MYM.\2ZOK!OEE_M/RO,A\G:$\M2J[3N]#SG]*U[F[@LUC:XE6,22+$F?XG8X
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M0:EXCNM62!-ELLL*1[!TRQ7EVQQD^IXR:L^*M!_X2?PY=:.;HVR7.T/*(]Y
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MQ 6\:2>'6LV4K8?;1<&088;]FW;]<\T ;5%%% !1110 4444 %%%% !1110
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M53&CZ &*;B0#Y^,@'IGV^O6NH_X1O1O*OHCIMNT=^<W:.NX3GU8'J?>H]/\
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M$*-!L"<@9)8KP.RD^F:?A&*&2RT;0]8\.:Q_;.CR1@O.9C;(T?'GHY.PY7.
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M(65MDB\J<=<8KC-4M=6U.7QM<:=I5\7DN].O;>*:!HQ=)"L;,@)'4A?N]>Q
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MG3]!NH(I]>M+IU6Q822JKJ7FD0+D<#JPR0/I0!VFE:_I>MM<IIUXD[VSA)E
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M-,U@SV+!-,.GWD>'Z;U?,?KT(YQZ^U==10!Q7ACP]XI\/QP:*^HZ?+H-H_\
MH\P1_M1B!RL3#[GMNYX[ \@@\(7<OB?3=<N8K"UO[1W^T7EF[![V,JRJDB;0
M.ZDDD\KQC/':T4 <[XJ\/7&LMI=]83QQ:CI=V+FW\W/ER#!5T;'(#*3R <5F
M:OX1O]8C\07LIM(M2U33/[+B02LT<$7SDDMM!8EG)^Z.@'O7:T4 4])@GM=(
ML[:Y$8GAA6-_*8LI(&,@D ]O2N&UCP3XAU&/7H$O--D6^OHKNWN)PYE5$=&$
M!P,*@V'!&>IX!.:]%HH XCQ!X/O_ !%<[[J/3EN(9X9;+4X6=+BU"["X "\@
MD/@%L?-STIVI^#[O5]<M-0N(K"&ZL[]9X-2@=EN/(#9\IE"@-D97EL8.<9Z]
MK10!PL?@W5+31M=\.VL]H=(U269XYG9A+;)-_K$";2'QEBIW#KSTI_\ PBNN
M:%XCEO\ PO<:>+.\MX8+FVOPY\LQ+L1T*]?EP"IQG'7T[>B@#E[G0-2E\6Z%
MJ@G@EATZUF@F>1B))6D"98 +@8*9QGOVQ6!8>"?$EO\ V"9[S2Y)M+OY+B6X
M(D,EV'5U+N?[^'''(X^\.E>CT4 <%/X%U*YT[Q'IQU"W@BO]1.I65Q&K&6&;
M<CKN!XP&3MG(/;'.K:VOC&;39SJ=SHXO0@2&*V60PR'<"S2%AGD C '&3R>,
M=110!R&@^'H/"5YK.K&.WTZQNDC<V-I(SQ(Z[MSJ"JX9LJ-JK_".I/%KP'HU
MQHOA:*.\3R[RZFEO+A/[CRN7V_4 @?45T;(KXW*&VG(R,X/K3J .0B\/ZW;:
MUXGU&!]/SJC6[0+([, (U"%7&WHR@].F?QJ;PKX5'A[4]5NX8;>QMK[RV&GV
MLC/#&ZAMSC*K@MD#  'RCUXZFB@#"NM(N-1\317-];V4^EP0,D,;L682,02Y
M4KMZ* .>,MZXK,7PM>Z?\04UW2(M/M]/ELQ:WEN&*&4ABRN %P&7)'N#VKL*
M* .)\->&O$GAT#1HM0L&\/Q3M);R;7^U+&6+^41]WJ2-V<X[=,.7PMJ\$'BZ
MTAFL7MM:DEF@+EPZ/)$L9#8!&!MSQG.>U=I10!Q=MX7U:&_\'SL;(IH=G);3
M@2OF0M&J97Y.VS//KCMFL+6=*NM&\/7^GW]QI,<NMZ^;BV,\C^4-S"0HSX4H
M0(SAASDC&#BO4:BN;6WO;=K>Z@BGA?[T<J!E/U!XH X_PG+J%OKES:WEKH[O
M<Q>?+=:?>RW#Y7:JB7S!D @G;S_"W'6M/7-%OM0\3^'=2MC;"#3)99)5D=@S
M[XRF%PI'&<\GV]ZVK*PL].@\BQM(+6'.?+@C"+GZ 58H \]O/!6M77A7Q5I(
MDL%EUJ_>ZC?S7*QJVS@_)R1L[>OM7<SVJ:AILMI?0HT=Q$8IHPQ*D,,,,X&1
MR>PJS10!R/A[2/$?AC3HM%A;3]1TZV&RUN)YWAF2/^%74(P8J.,@KD <"I-3
M\-ZB^NZ1K]E=0RZC8I+#/'/F..XBDY*@@,4VD KP>F#GK7544 <%JW@C4-0T
MO66CDM%U/6+^VNIRSMY<20&/8BG;EN(^N!RQ],59U?P==:]K^JW%XUO'8:AH
MPTQA'(S2(VYFW@%0#R_3/;\*[2B@#D=+T3Q+=:2^D^)KVPEM!;/:E[(.)+@,
MI3<^[A3@DX&>><C&"GAG2O%^EV]OIVJ:AIEQ8V*;(985=9KA5&$$F>%[9(SG
M'USU]% '$Z=X/U"/X:ZCX6NY[99[F.Z1)HF9E'G,[#((!X+X_"MK3X/$-M'H
M\,S:9Y$<;)?A/,+<*!'Y1/N#G<.G2MRB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6MI86B>51=&0KA@"=R ?7@5T<H_X2/QQX8U?3HKA(;"&Y:[>6%HB!(BJL1W
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M HHHH **** "BBL?Q#X@@\/6UI+/Y0^U7*VR--+Y<:LP)!=\':/E(Z=2!WH
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MJHI&W!&* %L< G )^M<?%X\\SPUINM?V;A+O4AI[Q>?S&QG,.X';\PR,]N*
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M:E4102^9(NYF #;<*"<D]ZT;KP;IE_8:I:WC7$[ZF8S<W!<+(3'CRR"H &W
M(P.O7-0-X"TB>XN;B\FO[R6ZL#I\[3W+'S(B6)R!@9^8^PP, &@#(T+6-6F\
M7V^DR7]W+:W6B&[$T\,:DS+(B^9&-H(4AS\K =!QZY.C:_XB;P_X+UVZUJ2X
M;4[];.ZMC!&L3H_F?-PNX,"HY! ]O7K[/P1I]E?VE_'?:F]Y:VS6J32W18F,
MD$ @\'!48XQZYI(? NFP:1I6EQW-ZMKI5R+FU'F*2K@DC)V\@;FX/K]* ,_P
M1%<_\)'XP>;4;J=4U7RQ'+L(_P!3$0>%R,=  0,=N]'B"*Y?XH^%TCU&ZAB>
MUO&,<>PKE?+YP5/)#$$]?3%=#8^'K+3M:O\ 5+=[A9;YA)-$93Y6\*%W!>F2
M% _"C5/#UEJVIZ?J,[W$=S8%_*>&4IE7 #*V.H.T?E0!QTGB+6-1\$ZYXJL=
M0:WET^>Y:&T,:&(Q0,04<$;B6"DD@C!(QTY[-KE]3\+_ &N-Y;1[FS\U2A&^
M/<F>,@C(SZ51?P7IC2:@J27,=GJ,OG7EBCCR9W.-Q(QD;L#<%(#=P<FN@:-&
MC,94;"-I7MCTH \@@CN6^''PZ<WTLDTVJ63*\RJWEDH_3 &?7DD^];ZZKK5G
M!X\L#J\\\NCPK<6=W+%%YB[H#)M("A2 P_N]#6S#X"TNWTS3=/BNM0%OIMRM
MS:AI]VQESL'(/R@$@#ISSFK4GA&REFUN5KF[W:U$L5WAUY4+L 7Y?E^4D?CZ
M\T <WJ'B35+'1?#^I7G]H'2YM-62]O-/B222&9E0B1T*GY,;SP,9ZCI7:Z-<
M"[T2PN%O$O!);QM]I086;*CYP.V>M4(O"\-O%:QVVHW\'V:U%FI1T.Z(= P9
M2"1V.,^_)SI6.FVVF:3!IM@IM[:WA$,(3DHH&!C.<GZYH \\\<6D_B?^U'L[
M2\DN=+55TJ>&+<JW2,)'8'/JJ1^VUO6K^N^+KJ^^$(\4Z+=&TN7BBD!"*^UB
MZHZ$,#T)8>O%=AI.DQ:/IHL8)YY(PSL'F8,^6)8G..>23SGK6"GP\TE/#]]H
M8NK_ /L^]G-Q-%YJ_?+!CM.WY06 .!@<>YH QM?TW5;;Q1X4BN/$E]/]HU2=
MEVQQ((Q]G<@ ;"#@@X+9X;UYJ34O%>I:%J/CJ:2<W<&DV-M<6D+HH",ZR9!*
M@$C(&<]A75ZMX<M-973S=S70FL)A-#/%+Y<@;:5.2H'4$@X_2HAX4TXZAJMW
M-YT_]JPK;W<,K QO&H(48QD8#,.O?F@!MA9ZM!JEK<OK@N]/FMMLD4T:!FFX
M(>,J!@8W9'/0>YKB/">L75EX*\)Z79DI+J=W>(9 RJP5'F<A2P(!) Z@\9QS
M@CM-!\'6/AY-MK>ZE,$C,5N+JY,HMD/\,8/ Z#J">,=*K/\ #[19/#,&@NUV
M;:VG-Q:S";;-;R%BVY' !!RS=<]: +GAF/7H!?P:Y/%.JS[K-]ZF7R2.!)M4
M#(((! Y'O4&N:NBVM[I\&F7LEU<J\:XMB5<XVEL]U Q^&!Z5J:/H\&BVAABG
MNKEW;=)<7<QEED.,<L?;C P!5:\\-0WNH27K:AJ<,LBA2(+IHU '0 #\?SJ*
MBDU:)U825*-3FJ[+\R#3M3AT[3;6QBTW5FCMXEB4FT;)"@#^E9<FM*?'MO/_
M &?J/&F2)L^S'<?WB'./3WKI8M(AA:P*7%UBS#!09B1+N&"9/[Q[Y/>E;287
MUI-5,LPN$B,( (V["02,8]0#GK4.$VDCHAB,/&<I--W3^]W_ .'.)&JZA>>*
MM;O+:"[2>VBC@M4>R:3RP5W'<,C;N./? 'I72Z1X@AOO#=OKDUJT4\\83RU7
MYI'!.%3/4$DX^OUK0GT>":]DNXY)K>::,13-"P'F*,XSD'D9.",'GK7/ZWHM
MI-=VL:7=Q9I91".".VU!K<("/15/..,YZ5O@Z#=6TWIK<G&8JC5I)0C9JWR2
M5FO.[U_X<U_"VC'0M#2UDV^=)+)<3!/NJ\CERJ^PS@?2LWQ=_P AWPC_ -A4
M_P#HB6J\5G##IR6:WLYQ<K<M,VJR-*[*1@,Q3)7@#'I5C4Q%JMW8W,TL2/8R
M^="([O #X(R<QG/!(].:].,6J[JR=[\WXIKOYGF=+%WQ'X=N-;:VN+/6;S3+
MRTW&!X K(68 9=6'S#CID=34GA34K[5-!CEU.-$OHI9;:?R_N,\<C(67V.W-
M9U\QOK^*\%_);,B&,QV^HLL;KG/*F,C/N,'WK;TAXOL8A@CACBB^55BD+C\2
M0.?YUC5YEAU"6MMM%IO=7ZWW&M[G(WGB.]L?%QT_5KF]TV*>^B73[A8D>SN8
M_ES$S;25D)WCDCG&#CBL"[N-4TVP^(>L:9JDEI)I^J-.L:1(RRE8820^X$[2
M.,+M/N>WH,WA:SN)7\^YNY;5[I;QK1W4Q>:K!@1\NX#< < XR.G)S6F\$:=/
M8ZU9R7-X8=9D,MX-Z_,2 IP=O'"@<>E<)1C>+-;U."/6)K#4I$>STC[7#;6D
M:,T+X=M\Q<8VG: %SD@-@'&:6[NGOO&7P]O)0!)/:7<K!>F6@C)Q^=:UUX$T
MJ\N;N:6XOP;VS6SNUCN"BW"*I52X7&2 Q'&!Z@U/#X0L8+G19TN;TOH\;16N
M^4-PP"MNR.<@ >V.,4 9W@7_ )"?C+_L.R?^B8:H:K97FH?%J2"SU.73G/A]
M<SPQH[@?:&X&\$#\C^'6NKTC0;;1;C4)K>:=VO[@W,XE8$&0@ D8 QPH&.G%
M,OO#MO>:U'K$5U=6=^D!MC-;NOSQ;MVTJP8=><XS[T <5I'B[7+R+2]%NI5?
M4I+Z^LYKN+;&9Q;'&5R"JEL@GC^%L8[=AX7378;6[@UZ>&>1+AOLTBL#(8#R
MHDVJ!N'(R!S@5#J7@?1-2T:TTPQSVR6<OG6T]M,R30R9)+A^NXDDDG.2<FM3
M2-)@T>S^SPRW$[,V^2>YE,DLK8 RS'KP /0  "@#B;5;^/QCX]FBU>[5K:"W
M:(,(V5<PLP&"O0$G &.ISFJ1U/Q+:_#W2O$S^(YY)[U-.W0?9H0B^9(BN?NY
M^8/^?(P, =K/X4L)M6U#4EFNX9]0A6&X$4V$;:I4-M((W!21_P#7YIK^$--E
M\()X8D>Y>PCC2.)O,Q)&$(*88#JI48/MWH P==\5:CH'B'Q*?.-Q:6&A)J$-
MLZ* LI>1>H ;'R#J3WK0TQ/$J:]8W$EXD^D3P,)UGDC+&3&4>+8@X/.03TYJ
MW;^"M+BU&>_GDO+R>YL_L4YNIRZRQY8G<O .=Q'IZ 4GA[P7IWAMU-K=:C/'
M$I6WAN[MI8[93VC4]..,\G'&>30 [Q'=W,.H:3;07[0K.\F^W@0-<7&$X"9!
M"J"<LQP!QR,\\=!XE\0W7A+PU=#4FBN[C7CIUP[01MYD8EE7Y@!@-A!G:0.M
M=UK'AJRUG4-/OYI;J"[L2XAEMIC&VUP ZG'4' ]^."*S8O &DV]I;6L,]^D-
MM?G4(5\_=LFW%A]X'@%FX[YYS0!SMYXKU;PS%XPMY[]]0;3I;-;.>ZC0,AN
M!\^P*"JL<]!QQ5^6RGL_BUH'G:C<78;2[O'G*@*L&BR1M4=>..V.*V[CP7I-
M[+K3WOG7*:RB)>12,-K!!A-N "I'8@^_6FV/@NRL]3L-1DU#5+NZL8GAA>YN
MBWR-C(. ,_='7KWSQ0 OB#5Y[?Q!H&B03FV_M22;?.H!8+%'NVKD$ DD<X/
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M;B2_@!ZS1RQ *%'\1WJ4P._'>@#JT\3V[#1[P%6TS5PBVTXX*R.NY%8?[0R
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M+8SQ"=AN$1<;B/7'6O(-#MM.L]+^%E];QV\5Y,XCEG7 =P;9P59NI&0HP>F
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M^ 1?LG]DRZ"$MF<CR_MFR/J>F[RPP&?5@.]8FLV<$/AS7%;RAHZ^)[8Z<20
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MN+)[6^(1-K1N=D78<'D'\1ZBN?BOH=+T-OWQ@T&S\7W4=T;=59;>'+^7E2"
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M =,0&!! (/!!J+[);90_9XOD "_(/E Z8JOI6I+JUE]I6TO+7YV3RKN$Q/\
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M8VRW<L$D09S$V<,NPL#RI'7(QS4&F^.=+U.\TJ"*"^B758?.LYIH-L<N$WE
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M:QHU_/\ 8[[5EC(21D61#'*2KKW(9!P>A%;VI^,=-TE);BYCN38P3K;W%ZB
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M;.FH6T(T02FUN9,IO\X#>H5F7IQQZ&@#N:*** "BBB@ HHHH **** "BBB@
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M[6""UMI74,WD@G+$$@%B2!SP ,XSQW'VO2='>PTD3VUJ\H\JTM0P4L%'15]
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M,%PZR*&(#<C!&<XQUKG[_P *ZO\ 8KJ[@TZ26YO_ !';ZFULLL8,,,;)U)8
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ME\)V6JVU[>RW5KJ<AB*QB5MQ656^<[23T!R/2N]U>P;4M#OM/23RFN;:2 2
M?<+*5S^&:FL[RWU"R@O+29)K:=!)%(AR'4C((J>@#R]+'Q-/H/A#3)_#DZ7&
MAZA;&XE6XA\J2.*-DWH=^3D$'! ZXJ;3=#U72M1U#29_"=EJ,$][-<6NK2&(
MJB2N7Q*K?.2I8] <\#CK7I5% '&VNGZG;^,_%E^VF3&UOK2VCMI!)'^\:-9
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MUUH7P\BTBSOIK6_2V -TL8N'64]2 ?O8Z#/8#TK>TI;U='LEU)U>^$""X90
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M9YAF,[BQ#@'"GA>N1Z5O'1YK^UG@UJZCO$FA>!HH83#%L88;Y2S$D@XR3QV
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<S0[3O"R0MGHV#D<<KSSFD\3/'=^)1IZ3SS3II<LS6?G&&&-2P G9EY+<%5
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M3W6F6T+;S.8DL7V[P(@O+,V03G P0,GH-/[-#+\88;IO,,I\/B7Y9F4%A.H
MP#C'MT]J /0**\P\-"]\0Z/X?\3#Q#';7/VE3>!1(QE9B5>V92^T<D ?+\N
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M *LH))(.[)SG'%Y+S^W;SQ@E_=2K+I2K';QQRO#Y2^0'$H ((+,6Y/0*!ZY
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M9%R3MW;L$#@XSUH [2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "JNHZ;9:M9M::A:QW,#$,4D
M7(!!R"/0@]".15JN6\<ZM>Z+9:3<VEXMLDFJVL%P612&B>0!@2W3C/- &Y:Z
M186<,T4-LNV?B8R$NTO&/F9LEN..3TK/LO!GAS3Y+62UT>U1[1F:W;;N,9.
M<9^G'IVQ4^E>)]$UM+I]-U.VN!:G$^U\>7WR<]!P>>G%2V.O:7J-X]G:W:O<
MI&)3$RE&,9. ZA@-R_[0R/>@!EEX=TK3FC-K:"/RE9(AO8B(-U" G"9[[<5"
M/"6A"SCLQIT8MHY_M*1!FVK+G.\#/WL\Y]>:LW^O:5I=U!:W^H6]O/<!C%'(
MX#,%!)('H #S6>?'7A<6:W9UJU$#2F(L21M8$ AAC*X)')QU'K0!H)H6F)>W
M5X+1#<7<8BN'<EO-0<!6R>1R>#ZU3T[P7X;TFUO+:PT:T@AO4,=PBIQ(ASE3
M_L\GCIS5K4?$&E:2[)>WBQ,D7G2 *S>7'G&]\ [5SGYC@<'TJ6\U:RLXXC+<
M@-< F$1J9&< 9)55!) &"2!B@"#_ (1K2#;SP/9++'.BQR>:[2$HIRJY8DA0
M>0!P*M66F6FGF5K:(B27'F2.[.[X& "S$D@=AGBN9\$^)7O_  K+J6J:@MQ_
MI]Q!%,$ \Q5E94"JHY) & !DUTNFZK8ZO;O/87*3HDAB?&04<=58'E2/0C-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOL.(P2"/GRK8SD8/6MCP[KNA:%X>\.:5937MW:RXLHKDVS@(ZX7$N0#&2Q
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MU;5-.2)[FVMWD7S6("X'7@')'7'&?45R^KR7:^.?!-Z=/ADU*2TOE*13</\
M)'C<Y4<<D]#C)P#W[#Q5H\GB#PIJND12K%+>6SPH[CA6(X)]LUC'0M=N-?\
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M*M'AN[\#;#_KL;MH&0#[9[<U9BU;59-:US2&OM02W&B)>P2SI&DR.6=2RX'
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M27.-SQ@':OR@!0,DC '))Z\TMCX:M[.6WF>\O+N>UA:"UEN75F@5L9VX49/
M^9LGCKR<ZT4\,X8PRI(%8JQ1@<$=0<=Z2&ZM[G?Y$\4NP[7V.&VGT..E '.1
M^!--BT6PTE+J^%K8W8O(!YB[EE#EP2=O(#$G!]?2B?P%I,VNW&JI/J%NUT0U
MY;6]TT<%TP&,R(.O'7IGOG)KHH;RUN$9X;F&14^\4<$#ZX^E+!<P72;[>>.5
M?[T;AA^E &0?"UI]OUB\6ZNUEU:)8KG#+C:H*KM&WC )'X^M0Q^#;"*'0XEN
M;P)HF/L8WK\N%V#/R\_*2.?Y\UM7ETEK 29H(Y&^6/SGVJS=A6+X3\2'6O!>
MG:YJ1MK5[E"S@-M13N( !8^U $-KX"TBRUF;4+::_BBFG^TR6"73"U:7.=YC
MZ9SSCID#BG3>!].GT[6;"2YO3;ZQ,9KP;URS$ '!V\ A5''I70FY@4(6GC <
M97+CYA[>M*9X59U:5 4&Y@6'RCU/I0!D_P#",V?]N6VL&:[^V06PM2PEVB6,
M-N <# ."2>W7G-;51P7$%S'YEO-'*G]Z-@P_,4V:ZM[<,9KB*,* 6+N!C/ S
MGUH YM? &DQZ2FEQW%^EI'=K=Q1^?D1NKF10N0<*&).._?-79/">G7&I:C>W
M1FN3J-LMI=12E=CQ#.!@ 8^\W(]:V9)X80#+*B @D%F S@9/Z<U4CFNWU@@2
MV3:<ULKQA6)F,FXY/ILQC'?- &1I/@>PT>UEMX;_ %29&A,$7VJZ,OV>,]5C
M##"\ #."<#K4K^"](F\(1^&+A9I].B14BWO^\C"\J58 $%<#!K<2ZMY)W@2>
M)IH_OQJX++]1VH^TP>:(O/C\PL5";QDD#)&/7!!H P8?!.EC1+O2KZ6]U.*[
M0)-+?W+2R,HY4!N-N#R,8YYZU<LO#\-I=)=RW=W>7<4!MX;BY96:)"02!A0,
MDA<D@DX&2:GO];T_3+ZPL[JX2.XOI&C@0L 6VHSD_0!>OJ1ZU;DNK>*:.&2>
M))9/N(S@,WT'>@#.T+P_;>'X+B&UGN)(YYWN'$S!OWCG<Q! '4\XZ4>)=#B\
M1^'KO2I)#$9E!CE R8Y%(9&Q[, :U7=8T9W8*BC)8G  ]:Y'5/&J_P!F:+J6
MBFVNK2_U2&R=W)R$>39N4 ^Q(S[<4 :5YHP\1VNFOJ@GM;FQN$N0D+C:)DZ,
M"0=R\G'L>1G@,D\(V4LNN2-<WF=:01W@#K@J$V +\OR_+Q_]?FMR*>&<,894
MD"L58HP.".H..])!=6]SO\B>*78=K>6X;:?0XZ&@"+3K&/3--MK"%Y'BMXUB
M0R$%MJC R0!GC%4[[P[9WVNVFL-)<Q7EK$T*M#*5#HQ#%6'<94''MSD5IO+'
M&5#R(I;. QQG R?TJ,7UH8XI!=0E)CMC;S!ASZ#U_"@#GF\"::^BW&DM=7QM
M;B\^VR#S%W&7>),YV]-X!Q_2EOO FEWVN/JXNM2M;J9%2[^QW30K=A1@>8%Z
M\<9&.*Z*>ZM[;9Y\\46\[5\QPNX^@SU-$]S;VJ![B>*%"<!I'"@GTYH >B+'
M&L:*%10 JJ,  =JYW4_!.F:EKIU@7&H65W)&(K@V5TT(N4'028ZXZ9&#[UJ7
M.MZ?::M::7-<HMY=JSQQ[AG:HY8^W('U-+:SW:RZ@U_+9""*7]R86.4CV@_O
M,\!LYZ<8Q0!DWO@71[V\O+@M=P+>V@L[F"WG,<<L:J57('<!B!VQU!IZ>#[2
M*V6VAU#48X?L2V,B^<'\V)=V-VY3@_.PR,<<#&*WDGADEDCCEC>2/&]58$KG
MID=J1+FWDG>!)XFE3[\:N"R_4=J .<O_  #H]Y>V=Y;2W^F7%K;K:K)IURT)
M>%?NQMCJ!V[^]=';6T5G:Q6T";(8E"(N<X ^M2U%!=6]TA>WGBF53@F-PP!]
M.* ,S4/#MK?:O!J\<]Q9ZE#$8!<VS*&:(G)1@P*L,\C(X/3%5[WP=IEYH46C
M[KB&T2<7!\J0;I)0_F;V8@DG?\Q]36W'<P3-MBGC=MH;"N"<>OTX-)-=VUN\
M:37$4;R'"*[A2Q]L]: )$4HBJSLY Y9L9/Y8%95WX=L[O7[?6S)<Q7L$)@W0
MRE5="P8!AW 89_GD<5IRW$,.?-FCCPI<[F PHZGZ<BD-U;@(3/$ XRAWCYA[
M>M '.#P)IHT5-)%U??94O/MH'F+N\W?YF<[>F_G']*+SP'I5WKLNK+<:C;37
M(47D5K=-%'=[1@>8HZ\<<8XKI1+&9#&)%,BC)4'D?A3)[NVMB@GN(HBYP@D<
M+N/H,]: )54*H50  , #M7/ZAX.T_4=6N=1:>]@DN[<6UU'!/L2=!G;N&.2-
MQ[]\'(K<N;B*UA,LTL42C@-*X5<]N37+Z%X@UC7/#C7R+IL%U'J4EJ_F%Q%Y
M:3%&P<YW%1QVR10!DW/ALV'C#PE9Z;_:<5AIEE<0?:D4R>7N$812S*5((4CI
M@8'3BNAO/!.CWVCG3IEGR;K[;]J23;.+C.?-#CHW;I@#C&.*W9KJWMR@GGBB
M,AVH'<+N/H,]:<9HA)Y9D0/C.W<,X^E '+S?#W2+O^TC?7&H7<FHVR6UR\UR
M<LJ$E2 H !!.>F/;K5FT\&:=;:K_ &F]QJ%S=-:?8Y'N+IF$L>2?F'0GYC[<
MYQGFMX7$!C$@FC*$A=VX8R> ,TT7EL4#BXA*G=@AQ@[>OY=Z .9E^'>BR^'[
M/2#+J 2Q<26=RMTPGMB!@;'[ #C&,?CS6[I.DP:/9?9X9;B=F;?)/<RF265L
M 99CUX 'H  !5H7,#0I,LT9B? 5PPVMG@8/?-,-]:"*24W4 CC;:[F085O0G
ML: *&M^'+/79;&:>6Y@N+&4RV\]M+L="0589]"#@BLL_#[2/L=S:I/J"PW%\
M-0=?M);]\&# C<#_ ! 'U/?-=/-<0V\)FFFCBB'5W8*H_$T>?%M1O-3;)]P[
MAAN,\>M &+/X2TV[U*_O;QIKDW]H+.YBD*['B&<#  Q]YCD'/-5++P'IUG<Z
M5.U_JMPVE%_L8GNB1&K+MV\ 9&..<G'7-:^IZ_IFDZ+/JUU=Q"SA!)D5P0QZ
M;1ZDG@#UK01TD0.C*RGH5.0: '5AZ?X6L[";3Y&N;N[.G1M%9_:75O)5@%."
M%!)P,98GBM<75NURUNL\1G49:(.-P'J1UH:Y@641M/&)"VT*7&<XSC'KCF@#
MEH?ASHT$%E;K<ZD;>PNQ=VD)NB%@8;OE7'.WYC[]LXXK+\.>'GU"X\60ZC_:
M5O9W^JR2&W9#''<P%$&<E<@'# X()'6O0&D1,;W5=QP,G&3Z4V&>&YC\R"6.
M6/.-R,&'YB@#B3I5S/\ %2YN83J%E:#1XK5+B"'$999'8IEE*\!E(/X ]16W
M-X/TR2TTFUB:>WATN<7-LL3C_6#/S,6!+$[FSGJ6)-;4%U;W08V\\4H4[6,;
MAL'T.*B?4[".&>9[VW$< 9IF\T8C ZEN>,4 8,_@+2)M=N-52:_MS=L&N[6W
MNF2"Z8<9D0=>.#TSWSDU;/A6T-]K%V+J[675XUBN<,N-JJ57;\O& 2/Q]>:O
MZ;J]EJNEVFH6TRF"ZC62,L0#AEW $>N.U6H9X;B(2PRI+&>CHP8'\10!@Q^#
MK"*/0XUN;S;HG_'F-Z_+\FSYOE^;Y21S_/FH;3P%I%CK,U_:S7\44T_VE[!;
MIA:F7.=_E],YYQTR!QQ71P75O=(7MYXIE!P6C<, ?3BD2[MI)%C2XB9V7>JJ
MX)*^H'I[T <_-X'TV?3-8T^2YO6M]8F,]V-ZY9B #@[> 0JCCTJ[_P (U9_V
M];ZT9KK[;%;"U9A+M65 Q9=X& <$D]NM:ANK=;E;9IXA.PW+$7&XCU ZTDEW
M;1$B2XB0A@AW.!\QZ#ZF@"1U+QLH=D)& RXR/<9XK!MO!FD6_A*3PQ(DMSI3
MJRF*=\D MNX8 '[QR#U!K<6XA:=X%EC,R %HPPW*#T)%(+JW:Y:V$\1G4;C$
M'&X#UQUH YZR\#:5;:5=:==SW^IP7,)MW.H733,L1_@4\;1T.1SP.>!C"/AI
MM$\;^$Q;/J]_;6J722W%TSS"%715C7=C &01Z^IZ5WIN[975#<1!V8HJEQDL
M.P]_:JL.MZ?/K=SH\5RC7MM&DDL88?*'W;1]?E)QZ8]: ,*3X=:/)%+ ;C41
M:M>B^2W6Y(CAEW[R4 '&6Y[XR<8S6@_A6T?4M1OQ=7:S:A;+:S8=2/+7.T#*
MG!&YN>O-7=1UO3]+NK&VN[A(YKZ4Q0(6 +$*6)^@ Z^X]:RM&\237>O>(+#4
M/LD$>G7,,,+JY&_S(PXR3U/S8XH DF\&:3<^$8O#-R)IM/A1$A+28DBV?<*L
M ""N!@_GFHQX&TJ30;O2;^6^U*.["B6>]N6DF.TY3#?P[3R,8YR>YKH)[FWM
M4#W$\<*$X#2.%!/IS2RW$$ S+-'&,%LNP' ZF@#!T_P?9V.LV^K/?ZG>7T%L
M;59;FYW9C)!P0  >0/RYR:Z%U5T9&&588(]143W=M&\227$2-+_JPS@%_IZT
ML]U;VVSSYXHMYVKYCA=Q]!GK0!SL7@/1X=#M-*22\\NRF6:SF,Y,MLR_=V$]
M  2,$$$'G-:^G:1!ITUS<AY9[NZ*F>YF(WR;1A1P   ,X  ')/4DU4\2>($T
M*&Q0&/[1?7D5I%YA^52Y.7(R"0 "<<9X&1G-5]+UK4H=572M?2S6>Y\Q["XM
M"WEW$:8)!5LE'PP.,D$9P>* -76-)L]=TBYTO4(S):W*;)%5BIQUX(Y'(%5[
M3P_;0W(NKJ>XU"Y$)MUENRK%8S@LH"J!S@9.,G R3BM:B@#F="\"Z7X=N1)9
M7&HM;QLS6]G-=L\%L3G/EH>G4]<XR<=:Z5@60@,5)& PQD>_-+10!RZ>!=-3
M0K71UNKX6EK=B\B'F+N$@?S <[>1O)./Z<4[5/ VEZS<:C->S7CMJ$$<$P60
M+A8VW(5P."K<@_GFNFHH YI/ VD?;+JZN7O;R2[LQ9W(N;EG69!N^\/7YCTX
M'8 \U%9> M.L[C2IC?ZK<'2BQLUFNB1$K+MV\ $C''.3CC.*ZJB@#E[#P%I&
MF:M)>VDU_' \QN/[/%TWV42YSO$?3.><=,X..!74444 <BOPYT5(H85GU)8+
M>]^W6\2W;!8),L2$ Z EF]^3@BM$>%;,SQM-<W<\$5ZU]';2NI1)BQ;<#MW8
M!8D#.!Z5NT4 %<XG@K2X_M,*/<KI]S<?:9M/#CR&DR&)QC< 6 )4,%/IR:Z.
MB@#(;P];MXG77_M-R+Q;?[*%#+L\K<&*XQZ@'/7WK7HHH YE_ 6ARZ9J>FS)
M<2V>H3-.\+SMMB=FWEH_[IW?-_\ 6XIH\"Z>V@WFDW-_JEW'>((II[JZ,DK1
MCH@8C@<GH!UKJ** ,8>&[8:W9:LUU=/=6=NUM'N9=I1L%@0%YR57GVK5G@BN
MK>6WF0/%*A1U/1E(P14E% &'X9TZXT?0XM$F9R+%/(@N!@^9$.$/LP7 (/<9
MZ&I]#T"UT"RFM+:6>6&69YF6<AOF=BS] .I).*U:* ,.P\*:=I\UFT9F>*QW
M?8H)&!CM=PP=@QGH2!N)P#@8%-L=)>;Q5=^(KE"DC6RV5K&>JQ!B[,?0LQ''
M8*N>20-ZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ KBOB<L+:#I1N"!;C6K(S,QVJJ>:,D
MGL,=Z[6FNB2(R2*K(PP589!% 'E.K:%9P:QXO7P_:0QZ;)X:D2ZAM4 B-U\W
MEX4<;]F<X[%3WI]GJ^E77B3X:M;WMK*RV$\3,C@X8P1X0GL<Y^7K7J,$$-M$
M(H(HXHUZ)&H4#\!38K.U@V^3;0Q[<[=B 8SUQCU[T >;>%7ELM9T6QF^PZSI
M5Y;W!T[4XAMGBCP&=)UY!!X!;^\!D9-<_;PZ=)\./#*,+?9'XKV)@@;%-Y)D
M ]AMQT[5[1%8VD+2-%:PQM(,.4C +#W]:/L-IMV_98,9SCRQ0!Y/JZC2[[XB
MVVAPK$$L]/E-M9J%.WYQ,54<9,8]/2KPC\(:M#J>JZ=XFGD\[19+>ZDM?)"6
M\!Z-(J(NUUR< \X#<8!KTQ+:".0R)#&KGJRJ 3^-)%9VT$;I%;PQI(275$ #
M$]SZT >8%[E[?7='UZ>PM+EK*T*Z[IZCRI8S*5B,B'A3N)R,X*D] *Z3P7=W
MTFJ:W9:K8V<6I6[0F:[L"?)N@RG:V#RK@ 9'^[VQ751V-I#"T,5K D3G+(L8
M"L?4BG06T%K%Y5O#'#&#G9&H4?D* .$_M&P3XF^(;/Q');QQO86XTX79 1X"
M&\X+NXR7(SW( ]*Y?PCJVDQ^'? EM)/:QW MKORKFZE_<18(#J5R TA!& 2,
M D^Q]CEMH)WC>:".1HSN1G0$J?49Z4?9;?9$GD1;8CF,;!A#[>E 'DFAZ8-8
M^$.GW6FB*XUC0;N:ZM%P"0T<[GRB.VY.-ONI]*W;A;;Q!X1O?$,MW_9+:O+;
M?9+F:,$Q1I(OD!P>"K/EB#VDQ74ZSI>J78MX-)U*'3K5BXNP+?>[JW=#D!6Z
M\D'DY[8.HEI;QV:6BPI]GC0(L17*A0, 8H Y?P1>7DMQKEIJ6GVEOJ-O=)]I
MGL6)@N6:-<.N>0=H4$'IQZUA'2/#M_\ $_Q9!K-K8R0MIUI*4N NW_EJ'DP>
MX&/FZC/49KT>"WAMHA%;PQQ1CHD:A0/P%<[;>&9!XSU36KM;.>WO(H(TB9-S
M1&+?ALD8R=Y],>] 'G6BZ5!*WPUM-<ACF>2&_CVW2C=)!M)B5@>HV[>#6]=V
MBZ9X]URT\/0007B>%%6UBA 7]XKR!!CU&$'Y5Z2]O!)()'AC9QT9E!(_&@6\
M(F\X0Q^;_?VC/YT >6(;6^\+> ;G0R@U:.\MD;9_K0NTBZ63OCAMV>X'?%:7
M@'1]%FUCQ-="RM'NK/Q!.8'"@M"#'&/E_NYRW3K^%=_':6T4\D\=O$DTGWY%
M0!F^I[TZ*W@A),4,<9/4HH&: .(\<?8(?&'@NZU 6Z6XN[A))9P HS;R;02>
M.O0>M8H>TO="^(-IKOEKJ27=PZB7B00[!]F://..!MQ_%GN:]3>..4*)$5]I
M##<,X(Z'ZU'):6TL\<\EO$\T?W)&0%E^A[4 9_A^*\?PIID6L+YEZ;*);L2#
M.9-@W9_'.:\ET^33'^%?@^V$EN)!KEI'=*K ,#Y[9#8Y!QZ\XKW"H39VK##6
MT)&2V"@ZGJ?K0!Y-JZ_V7??$:VT.$1".TT^8VUFH4[?G$Q51QDQCT]*Z3PL/
M#&H^)4UK0M<EU"Y>P$,L<'E")(]P*^:J(NUP> #SC/& :[9+:".0R)#&KGJR
MJ 3^-$%K;VH86\$409MS"- N3ZG'>@#B/%EI87/Q+\&)=0P2-(EZC+( =ZB(
M$ ^HSV-<7J.GZ3'\/OB'+';VHDLM6G%HP S;_P"J8"/^Y\Q)XQS7MCV\,D@D
M>&-G7HS*"1^-,^Q6FTK]EAP>2/+% 'FFKWVCS^,-<TWQ1JXT^TO;&$64DOE"
M.: H1(%>1" P<DX!!.1UQ4,D^E:=XBBTK7M7N;/2IM$ABTZXU$18E4%Q*KM(
MA <@QDC@D 9Z"O49+.UE$8DMH7$1S&&0'8?4>E.GMK>Z55N((IE4[E$B!@#Z
M\]Z /,(K/1M(\4^!8_.>6Q6PO8;>XU#:9)<&+R^<#)Q]T8SC%9&N16 \%_%&
M)4MPD>H[T4 85O*BY ['.?QS7M+11NR,Z*Q0Y4D9VGU'I47V*TP1]FAYY/[L
M<T <+#:Z?8?%BQCT]8+;[5H,QD,. 9")8RK'^\>6.3D]:YGPXNB:_:>#[";5
M-$FGTNYDDD>2ZC>2[!#  1$[]SDJS!@"".YKUNZTZ*>TFBAVVTSQ,B7$2+OB
M)& R\=1U%<Q9>#K]K>&RU:71;BUA"+YL&FE)Y N,$L7(4\#) SUQ@\@ ?\3)
MKFW\'/+"KM;)=0-?! 23:B1?-Z=MO7VS6=J%O9S_ !!M9]-^S2:?/HT_]J"/
M:87C!7R"V."<E\'T![5Z"1D8/2H(K*U@A:&&VACB8Y9$C 4GW H XKX3Z7I<
M7@/1-3MK6W%]+8K%+<JH,C '[K-U.#V[8 [5@>/[_399/&]FKP07L>DQB0W3
M;WGPCN@@0D;0,Y+#//88S7K$<4<*[8HT1<YPJ@"FO;P22&1X8V<J4+,H)VGJ
M,^GM0!YM:0Z/K/Q*TF6=+.\2?PT7<N%<2D2Q@%NS8YZYZ>U9^CZ0=3^$6GWN
MF1QS:GH=[<75@.&SY=Q)^Z^C(-H'^[Z5ZP;2V+;C;Q9QC.P=,8Q^59.L:3J5
MUY$&DZA!IMHV];P+;;I'4@ ;&R K#GD@]1Z8(!!X3DCU>";Q-Y!C;5-K0AUP
MZVZC$8/URS_\#]JY#QU?:;)J/BNR9K>"]70=KM=MN,ZD2E4@3(Y!ZL,\[>.,
MUZ=!#';6\<$*!(HE"(B]%4#  H>"%Y!(\4;2!2H8J"<'J,^E 'F&CZ[9OXK\
M/G5[N Z?+X=C-C-.X\I[C.)@&/&_:%'KC/J:Q+9=.D^&T2VHMW%KXK41!,'R
M@;T8QZ94_E7M$EG;31)%+;PO'&041D!"D=,#M6%JGAVZU:]2">XM5T:.XANT
M@C@*R^9&^_!;=@@L 3QGJ.^: ,"V>QN?&'C2P\3" *\<1A%S@*UGY>#L)[!]
MY..A/TK"T.:?3+GX;WGB.=;>8Z=>Q23W;!#R(S&KLW\6P=#SUKUF:TMKEHVG
MMXI6C.4+H&*GU&>E.FMX;@*)X8Y0K!E#J&P1T(SWH \1F?2KKPM=AFMRL?C?
M(R0K1HUR.G=<KGTXKJ=4\/\ AZT^)?A>R@TRPA@EM;YW@2)55SF,C*]",[B
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M_LQBQY9;G&,<8S5D6MNH<+;Q#>,-A!\P]#ZU*JJBA5 50,  8 % 'C\9CO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9Y8Y-BO@@9Z'(K&76=6T;Q9:PWVI/?65WI$]Z\/D(GE/$4/R%1G!#'AB>>]
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M;@$^V2"?:NBTQ?$L/B.,W,QFT>6W(<731>8DPY!3RU&5(SD'IC(H ZBBBB@
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M;G/[MMN%(Q@XVCMSCG-=(]S!&NYYHU7CDL .>GYTZ66.",R2R)&@ZLYP!^-
M',Q^ ].AT73M)2]OQ;:?=B]@^=-PD#EQD[.1N)./>HS /$WBFSN+K0[NUCT*
M>8QW-XBKYTA&P&/#'*$9;) Y5/?'5F1 @<NH4XP<\'/2HVN[9(A*]Q$L9.T.
M7 !/IGUH SKWP[:7NOVNM&:ZAO+>%H 89-HDC+!MK#'(W*#_ #R.*S/^$#T[
M^Q#I'VV_^RF\^W??3=YOF>9G.SIOYQ_2MR\UBQL+ZPLKBX1+B^=D@3(RVU"Y
M/T 7KZD>M.MGOCJ=\EQ]D^R+Y9MO*9C+@CYO,!X'/3':@#.?PK;2:KJ.HF]O
M!<7]JMK-ADQL7.,#;P?F;GWJ"'P78P0Z%$EY>[-$_P"/,%DX^0I\WR\_*2/_
M *_-=!'/%*SK'*CE#A@K [3Z'TH\^'>J>;'N8D*NX9)'7'TH \OM-.U&6YNR
M3XSTS4Y[F68V]M(C6@9G)!5W#+MQCJ1WX'2O2A;S3:6+:YG(G>$)++" /FQA
MBH(('.>U620H)8@ =2:;YL?R_.OS?=YZ_2@#G(/ ^GV]EH=I'>7PBT5]]H-Z
M$@[2HW?+S\K$?C6CI>@6^DZEJ5]#<7$DNHRK+.)2I7<%"@C"C'R@#\*T6GA0
MX>6-3N"X+ ?,>@^M8<^NW</CVST'R(?LEQ82W7F[B7W(R+C'0#Y_>@"Q=>'+
M2Y\11:X)[J&\CM_LQ\F3:KINW ,,<X;G]#D<5FIX#TZ/1+72%O;\6MK>?;HO
MG3<)?,,F<[.1O)./?TKIA/$9C")4,H&2@8;@/7% GA:5HA+&9%ZH&&1^% '-
M77@/3+C79]5CN]2M'NMOVR"UNC'#=$#&9% ZXX.",U;O?"EGJ#WB7%U=M9WD
MD<L]EN3RF*!0 /EW*/D7(!'3WK:2>&21HTEC9U.&56!(^HI[.J+N=@H]2<4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *S]3TV74FME6^N;6*-R\@MI-C2<$!2?3G/'H*T*1CM4G!.!G
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MMY7][GYO3/% '22^+],ANK1)1.EM>7/V2WO"G[F2;)&P'.>2" 2,''!-;Y.
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M[6;4=.OX+*#[-NCCG:=4,>0Q8KC?\W)X!Q1 FH)\9;87\MK*?[ EV/!$T?\
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M]3UAW@-WJ"1+,+:#R8SLW?,5W-ECN.3GH!]39U#2[J]UG3;L7D26MD[2&W:
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MSO\ 5CQZ?G659> KBRTGPSIZZO&RZ#/YR.;0YF^5E /S\<.?TKMJ* .+O/
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M%O)/)#ID,<D\ MY9%)#/'SP3G)ZG)ZG/)I__  BVC"#3X!9XBTY@UFHE?$!
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MJ=S-'<:1+(ME+(9%M\1."RDDD!O3.,J<=ZHAQ=Q:)IT5U<RSKX?$QLDG:"-
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MF]3R[EV7/FKC;A@>#QQ[BJ6F>"O#FCVUU;Z=I45M'=KLF$;,"R_W<YR%YZ#
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M17F12NXL2P/) /W>W:N_;PGH#^'SH3Z5;-I9Y-N5R,YSNSUW9YSG/O21>$M
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M@M)9LAFC!Z$Y(&3\HSV&!P*M:OH6F:];QP:G:)<)%()8R25:-QT96!!4^X-
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M1117LB"&1DE)*E2".1G'0]P<#'9+X9T=+V2[6R59))A<.@=A&THZ2&/.POD
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M--EE6%P)4,L:[E4G*9$@R"3WQU! !Z,]_:1W\=@]S$MW+&TB0%QO95(!('7
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MW?)>+=7LUZ%BMBC;Y6W%%&]MW/ [U-X+T.;0?#D=O=;?ML\LMW=;3D"65R[
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MP-@1LRDT0(RC'DMSP^#VQTEUX&\-7LM[)<:5'(;V02W"EWVNX(.[;G ;*C)
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M+<6Y97VDD$,IR"""""#W!JE#X0\/V[7K1Z5;YOHA#=;@6$J@8PV>ON>I[YH
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M\%7EYJ]O8:5?75U_:&A/+%JCBYDS)*I*1[B3\RN,R<\?*.U=U=6%I>R6TES
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M@>&7E?1]-CM6E&&(9FP,YP-Q.T9YP,"@#;HHHH **** "BBB@ HHHH ****
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M%90S;1WQCG Z'%SQ=+%IM]X:UM+6Y?1(3*EVU@KAXMZ*L<A5/F(&TJ?0-^%
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M!;6]W'%M(=MD86:(CKRF\8]<5;\46VH6WAC3M5-G=S.FJ1ZCJ5O;$^=Y9##
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M65U]MAY!]/6F:GX]CTNP\1W,NESR-H4J1S)%(OSAT5@P)QQAAGC/L: .PH)
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MZ)V=D!/8C*GOZ5)J7C0:9,[SZ;,EC'J,>G&:1]CL[[0'1"/F0%P,YSP< XH
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MS3NL<BH<JZ/MR""6ZKT->@*H50H& !@"EH X_6_#UYKUE;6FM:;I^J0&-VE
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M,4"@ 97< =BYPWY4 <7?-JEOX@^(]]I>I_89;.&VN 1 DAD9+7<%.X$!3CG
MSSU'?7U#7]4N;.UN+:_%NTVB_;5MK.)9)O-(!W-O4JL0'&202<CFMF7P=:2S
M:]*U]? ZY&(KH QX"A-@V?)Q\O'?\^:KCP%IZW%O,E_J2-'IZZ=($F51/ N=
MH?"]1D\KM- &%+J4VLR_##4[D*)[MS/($&!N:S<G'MDUK>%?^1Z\<_\ 7Y:_
M^DT=6;;P-8VMOH,,=_J.W0SFU+2(Q/R%/FRO3:<8&/SYK1TSP_!I>KZIJ45U
M<R3:E(LDZ2E=H95"KMPH(^4 =: .?\>)/+KG@Y+:98)FU1PLK)OV_P"CR\XR
M,UEMXLUW0+S6=%U&Z74;B"YL8[2]\E(VV7+E?G483<N&QT!XS7;:WH%OK9LI
M))[BWN+&?[1;3P,H:-]I4\,"I!#$8(/6JEUX-TF_TK4K&_66Z_M(JUU/(P$K
MLN-A!4 +MP,   >G)R ,T/\ X2*+7+R+46:72GB5[9[@Q"=),X92(@%*]"#U
M'2JOC#4M7LM7\.6NF7L5NFH7K6TV^ 2<>4[9Y/;;T_6M/0?#D>A(Q;4M2U*8
MJ$$^H3B1U0?PC   ]3C)P,DX%8GCFUN+S6O"@MTO@(-2,TL]K S^2OE.H8G:
M0.2!SZT <[JWB?Q3H>E>,K"75([B]T:.WN;6_-L@9XY<C:R@;<@J><<^E='<
M7^LZ?XETKP_<:QYTFK27%P+A+9$-O%&BGRD!R"2S9W,"<9'7!J_?^"=/U/2M
M4L;JZO&;5&4WER&02R!<!5^[@* .  ._<DFYJOANVU==/DGN;E+W3Y/,MKV(
MJ)48C#?P[2&'!!7!]* .4N-7\3R0^+]&L;TOJNB"*XL[KR4S<QR(7$;KMV[O
ME9<@#^$XZYWM(UB3Q(]G>:9?NMB=/69\HC;I)!\@/'!4!BP!'5:UM,T>WTR2
MZF1Y)KJ[D$EQ<2XWR$*%&<        ?B346C>'K'P_IT]CIBM!%-/+.2,$JS
ML2<9&,#@ 8Z =: .,T+Q?JNI:'X/M)[H+J6N2W/G7:Q*-B0[V.U<;=Q 51D'
MC)YJG'JEUX9UWQQ.;AKNY:^TVWCFE55(\U$0%@-J_*&]@<#.,UTP^'FEIH&G
M:5'>:A&=,G,]E>)(@G@8DDX.W!!R<@@@YIY\ :5.FM+?W%[?C64C6[^T2+R4
M4!64*H"D8!XZ'IB@#*U?7_$?A.RUO5+U3<Z9%:*]K]L,0E6X+A-I$0 ,?S*<
M]1R/2EOK.]M?B=X/-WJ<M[NMK[_61H@5@D>2NU1P>.#G&.M;%MX&T]-(N]-U
M&]U+6(;F$V[-J-QYC+'_ '5( QR <]<@<\"FV?@>WM=0TF^FUG5[R;2UD2V-
MQ,APC@ JVU!NX4<GGU)XH K_ !5_Y)CKO_7%?_0UJ"6Z\1Z5XVL-)N]9%W9Z
MU!<>4R6J1M9RQJ&RO7<I!QALG/>NIUO1[3Q!HUUI5^KM:W*;'"-M;KG(/KD"
MJ::1'ILCZO<S7VK7MK;.D1D"&0+]YE1455W,57GJ< 9Q0!SFA:_JVHZ=;Z/<
MWS)XA@U)[6^=8D^6.,[V<+MQL9"@!QUD'6NH\4-,GA35GM[F6VF2TE=)HL;E
M(4GC(([5F^'+&.^UR_\ %<FE3Z?<7L,5ND=T@2;8F26=03M)) QZ1K717=M%
M>V<]I.NZ&>-HW&<95A@_H: /+V@NAHGPP5+YVFDEB999D5O+S9OP H&0.V<G
MU)J_'XLU;3;?5["ZNC>W5OK<&FV]TT<:,4F6-@2!A-P#,!T!.,UOP>!K."WT
M2$:GJ;KHT@>U+R(QX38 ?DZ!3C QZ]>:+CP'I5Y;ZU!>2W=Q'J\JSSAW4%)%
M "LA505(VKZ]/K0!-H7_  D,>LWT6ILTNF,BO:27!B$ZMT=6$8"E>A!QGL<U
M!XRT&^U@Z=<Z-J4=CKFG2/<69F7='("NUU<==I# 9'3-:.A>'DT.-]VI:CJ4
M[ +]HU"82.%'11@  ?AD]R<"I=4T6/5+FSN?MEW:W%H7,4ELZ@_, #D,"&&!
MT((_2@#AXO'US86?B&36M#&G^)M-L4DDC#[X;B,,PC=&_N;G.1U&>O7&G=ZI
MXDT!KW5KD27>C0:=-/(ER85D$R*6'E^5U5@""&R1US6TOA+3Y7U"347FU*;4
M+<6D\EUMSY//[M0BJ%&6)X&<G.>E5]&\$6.D6[VTE_J>IVQB:".'4+CS4AC8
M8*J !VXR<G'&<9H 338_$$[:7?\ ]M036=U:%KF*2%0%D90R&': < YR&8\8
M[URVE^)?$<7@2W\4W^K1W!G/V1;46J(JR/=")92V1]T9^7@'CODGJM!\$VGA
M\*EMJ>JSPPJ5M(;FX$B6@(Q^[&WL#@;MV!QW-/M?!.E0>#Y?"TS7%WID@8%;
MAEW#<Q?@J!T8Y![4 8>LMXJMM,\1F6\N8].&DRSV]Q(8!<Q3H"2H\M=I0C'.
M-P.<'H:?87%_9Z%X4M8M7E"7-D&=$C1[J0B)-JQC9M"#)W,PX^7)YK8T[P9:
M66G75E=:EJFJ+<6[6I>_N/,9(F&"JD 8SQD]3@9/ J&+P'90MI,D>J:JMQID
M3013B==[Q,%!C;Y<;<*O0 \9SGF@#FH/%7B*]\)>#[U+Z*"ZU'53873&W4[E
M!F&['0']T#@=R>U:\E[K?AGQ+HD.M:XU]I=\DEL\S6T4(6Z^]'NVC@,H88S]
MX>AQ5J#X>Z=:Z?IUE!J&II!IU\;^W!E1MLA+''S*<@;WX]^<TOBF%/$LQ\*S
MZ+>RV[O#/+>O&!;JBN&(#YSO^7;@#^+TS0!K^'9KN[TE;V[G>3[4[30JZ*IC
MA8DQKP!SLVDYYR36*NK:DWBSQ1IGVUQ!:6$%S;$1INB=_,S@[>1\@ZYKKP H
M    X %8&H>$;2_UR751>W]K+/;"UN8[>152= 25W94D$;CRI'6@#E++Q#XD
MU5? \46J16[:WILLUU)]E5B'6-&W*#QGYCQT^O2H[;QCKEC)-X?U&YCGU)==
MATM-1$*INBD3S0Y0?+O"@C'3)'!P<SW7AHZ3XG\$Z;IKZL+/3(+J(W:Q&3RP
MR($#-L*8.".G'MUKIKCP7I5WI4UE.9WDFNA>M>;P)Q<#&V4,!@,, # Q@8QB
M@#"U77M;T;6-=T87WV@IHDFJV5W+"F^)D)5D8* K#."#@=3G--TK6M>CUCP<
M;W5!=0:[9.T\'V=$6-UA60,I SD\@Y..> .E='+X4MKB'4/M5[=SW5]:_8Y;
MM_+$@AY^10$"@?,Q^[G)]AB./P?:13Z#,+Z^+:)&8K4$QX*E-AW_ "<_*,=O
MSYH N^)4U1O#E\=$N/(U-(6>W.Q7#.!D*0P(P>GXUQMMXY>37O#MVVHR?V'J
M5AF;?'&%AN2A90S[<Y(23*CH0.QQ7H]<T? >@G19-)-L?LDE_P#V@5SSYGF;
M\>R_PX_N\>] &)>ZAXECU'PI91ZL8#K#W)F\VUC9XE$32(.@&5&!TY(YR.*O
M6EWK<7CE/#UYJYGA_L+SVFCMDC<S"0(9.A [G'3GH:V]3\/0:IK.EZI)=744
MVFN[P+$4VDNI5MV5).5)'6E/A^ ^*AXA^TW/VH6OV3RLKY?E[MV,;<YW<YS^
ME 'E]J=1D^%7ABY;6[_S+K6;<2_ZOG==G.3LR>?FY)YZ\<5U][JFN:AJ>M:/
MH]Q<I<Z5#"B2JL!\R5X]X:4./NG@80#HW/3%Q/ &F1^'O[$2\U 6J7*W-NWG
M#=;,LGF+L^7& Q/4$^IX&':AX$LKW5XM5AU/5K"^$*P3S6=SL-RB]!)D')Z\
MC!]^E &8NH>)[SQ?8:--J,-AY^B-=7"V\*2>7.LB*Q1FSGDG&01CL3R-CP'J
M][K?@^TO=1D66[\R:&214"AS'*\>[ X&0H/'K5A/"UI%KMOJT%S=0RV]D;&*
M)2A18B0>ZDDY4')/:I_#V@V_AO2AIUK/<30"1Y 9RI8%V+MRJC^)B?QH YV^
MN?$5[\0;S0['6TL;5--AO$86B2,K&5E(^;J"%_7BJT&M>)M<LEU?1=P5+^2,
MVTIA%NT$<K1L&/\ K ^%W9SC/&,5U*>'H$\4R^(!=W1N9+9;5HB4\ORPQ8#&
MW.<DG.>]9D7@'3;?6KF_MK[4X+>ZF-Q<:='<8M99#R6*8SR>H!P>XQQ0!DZC
MXAU6]\,^*]<L-1>S_L>6ZAMX$BC=7, ^8R;E).Y@>A&!BKVG:QJ=QXTM-,DO
M&-K<Z +TKY: I-O5=P./0G@Y%9_B_P %00:'XHO=+GU42ZE:S,^FVK%H9[AD
M(#; I;).,X(![BMBW\,P:DNBZO\ :=1L+VWL5MG$)\HR1G:3&X921\R]1@CL
M: ,'1?%^K:AHOAJWEEDDO]4EO1)/"D2OL@D8 *&^0$C;V/ ;C/(M7.J>+M'T
M4RZC;W%S'%J)$DUDD4EU]B*L5<Q@%"X;:&VC[N2!W%T_#?1_^$?M-(2ZU&+[
M%<-<VEW'.%GMW8DMM;&,'<>"#UK3B\+1P6ULD>JZF+F"<SM=M*KRS,5*'?N4
MJ1M.,  # QB@#CM1U*36K;P7=6/B2>Y@N=9>,S0)&F]=LS)O4IPZA5!! &<G
M&<$;GB"XDTWXB^$'B8G[<MU97'K(HC$BD_1E_P#'CZU=F\#Z9+96\"SW<,L&
MH-J2W,3JLAG;=N8_+MY#$8QC%2OH[:CXML=3F1UMM)AECM@Y.Z263"L_/. J
MX!/4LQZ $@%KQ/>7-CH$\]I>6UG,&C43W )5074'  .7P2%&#EL#%<9<^*-<
M@T[QTD5W*LFC6T=S9RW=O&)0&B9R&50%QE>,C(!Y%=MX@T&U\1Z6;"[DGB42
MI-'-;OMDCD1@RLI((R".X-8\O@#3YO[8,FHZHS:Q;K;WC&93O"J5R!MP"02.
M!@=@* ,Z'7=8TKQ'I"ZCJ7VRRU+2Y[J2$6Z)Y+Q+&V4(Y.0YR"3STQTK&U:[
MU'7/"W@_7KB_;;?:U8SFS6-/+C5I054'&[(&,DDY.>!QCM_^$3M3J6E7TE[>
M22:9;O;PJWE[61P VX;.<A5].E9<?PVTV&S@L(M4U9-.MKM+RUM!,FRW=6W
M*=F[;GL6- '5:A+);Z;=30R01RQPNR/<-B-2 2"Y[+Z^U<9X>U_5)?%]AIEQ
M>RWEI=:.UV998$C4RJZ*6BPJML.\_>'8$&NQU+3K?5=)NM-NU9[:ZA:"4!L$
MJPP>?7!K#T_P19Z?J>GZC_:>J7-S8VS6J-/."'B)4A6 4#@J.F,]\T 2^.+G
M5=/\*W>HZ/.\=Q9 7#HJ*WFQ*<R+\P.#MW$8[@5@'QD\'C&XC>_FGT>YTTW%
MB5CC ,RJKM&IVY8['C89]2.>W?NBR(R.H96&"",@BN=M_ VAVVF:+81V[>1H
MUP+FURV2' ;DGO\ >S^ ]* ,2[F\5?\ "3Z7X?3Q L$EQI$L\UQ]CC<K,K1C
M<!@ C+$8Z8]^:6?5-9?4/&NF2ZHX6PTV":UE@B1'C9DE+')!Y)0=>G;%=//X
M>@G\3VVO&ZNEN;>!K=(U*>648@L""N>2H[]JC3PO9C6-6U%[BYD?58%@N8F9
M=FQ0P4#"@C 9N_>@#@XX;X:%\,D76K]5N7AW "+C_1&8?P<XQQNSU.<G!&U<
M:OXEUK^VO^$?>1+C3KTVD",(?)D*!2WF[OG^;<?NXP,>]:J^!;%='TK3AJ&I
M?\2J99;2X\Y?-3:A0+G;C;M.,8]^O--N? 6G3:Y/JEOJ&JV37047EO:W6R*Z
MVC +C!.<<$@@F@#*GU'Q'?\ B;7M-@UA;&*UTVWNX?*MHY#&[^9D98$,,H,Y
M'TQ73>$=5GUSP?H^J7(47%W:1RR[1@;BH)P/3-1CPK;+J^H:E'>7<<U];):R
M(GE[$1<[=HV<8W-Z]:N:%H\'A_1+32;:6:6WM8Q'$9B"P4= 2 ,T <I:ZCX@
MNO%/B.-]:6*PT6ZA?R4M$8S1&$2-&2>1UZ]:-'U/Q5JT.@:S;-FROD62\AG\
MD1(DBY4Q%?GRI(&&///0UTFG>';?3=8U74DNKF674V5[B.4H4RJA5P H(^4
M=:S=&\":=X>N?,M+[5&L8W,L.FR7&^W@8\_(@&>#D@$D \@9Q0!Q\WB+QA#X
M)OO%2ZS!)_9=].DED;1 MS%'.4(+=5.T<8].<YKH;>\\0ZKXXUK3X=:6TL;
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MMW(1%&<]Z .AHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M10)$)(#J2!D@'MZUY3K&G^')O#OB[4=)U>*_%QHDC30VOE_9T95)C<A!Q)U
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MF)"V"R1;1C8#G@=#D=J $C\17^IZMJUGH]K9RC2I5AF%Q<%'DD*!L !3M7!
M#'.2#QQFMC2M0>^T.SU"ZA^R/- LLD3MGRB1DJ3[=*XG6O#VE^(M8U+5]"UE
M]#\3::QAN+F&0;6"J"OG(>&3!')_7&*R%\43ZE%X+OO%$D.GV=_:7 >22-3
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MB[2.VV07%S]^0 ?*QX&<C'/IB@!;75IM6AU"72TA>. R0022L0LTR9!Z=$#
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M/EC80>HV]*6UM+:Q@$%I;PV\(Y$<2!%'X"IJ* &"*-=^V-1YAR^!]XXQD^O
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "LWQ!9WFH>'[ZRL)4BN;F(
MPK(Q(V!N&88!Y )(]P*TJ* (K:WBM+6&V@0)#"BQQJ.BJ!@#\JEHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOR^Z/917/>)/">O:OJ&O^3-I\MIJ6FFTMGNF??9,496"J%(PY8$MD'CHV *
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M<"@'\(/&?2L_3?!4\&O2ZI]GLM+>YL9+>^BL)6:*ZE;;B0H54+MPW/4[O;)
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M9KN[BL[>,':&DD.!D]@.23SP.A/%8LOBMKEO$NFW>AM(=)M]URB3JR3(Z;@
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MCWSHIHVI'X@C7Y%M%M#I8LBBS,9 _F;\XV 8[=??VH Z6BBB@ HHHH ****
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M'+8 &,GM@8Z5Y]_;-YX9_P"%BZV;RYO&L+E1%!-M*$F&/;G"@@ MT! Q[\T
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MRF-)MQ8$';NP&)(&<5LBXA,@C$T9D.?E##/'7CVR*8M]:/#+*MU T46?,<2
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M'HK:&\<PZS!<2R6L3,8HU#9?(!'!(XYSZ&NAU75ET^6RM(U$E[?2F*WC)P.
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M?7;G5([C4+?[6P>[M(+IDM[ENF70=<]\$ ]\Y-7=/TBXM/$VJ:D;N[:VNUC
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MY5K;Q01YSLB0*,^N!0!X_8:KIMEX5^'TLEY';:/Y CO[F%8V2*Z\E/+\W*D
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ML4!W+_=SW'M0 ZVN(KJVCG@E26*10RNARK#U![BG[$P!M7@Y''0^M*    ,
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M0W!P7A8218VG^'\.M>UO%'(R,\:,R'*EE!VGU'I4/]GV6TK]CM\$Y(\I?\*
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M0>H'IFBWLK6U9VM[:&%I#ES'&%+'WQUH GHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K*U[Q#
M8^'+6"YU#SA'-.ENIBB+X9V"C..@R>]:M<MX\T^_U/1[*#3[.2ZECU*UN'5'
M1=J1RJ['YB.PH M6?B_2[I]42;[18MI<8FN1>1&(K$02)!G^$A6]^.0*?#XI
MLY-1MK&:WN[6>\B::S6>,+]H51DA<$X8 @[6P<=NM<GXC\*:KXBU;Q9"EM);
M0:GI,%M;7+NFTRQL[8(#%@#N SCUK3DL-3\2ZEX8N;W3)M.;2IFN;HR.AS)Y
M938A5CD$MG/ P/4XH T_!_B67Q/IT]Y)836@2YFB42;>0DC)C@GGY>>V>F:R
MO%>IRZ3X]\+R"6^>":*\$MI;[W$Q5$V?NQP2"QY[=^!5SP)8:CI.FWNG7]B\
M'EW]S+',9$99EDE9U*@$D<,,[@*/$EC??\)=X;UFVLI;NVL!=)<+"5WKYB*%
M8!B,C*\XY]J +6F^,])U32WO8#<*\=S]D>TEB*3K/_SS*'^+G/ICG. :?;^+
M],F_M!)1/;76GRQPW%K,G[U6DQY8 4D-OR,8)S7'ZOX0UBX6_P!>MK"&:^EU
MB'45TJ=UQ+%'"8=C'E0[ LW< XJQJFAZEKGAJ:XT_P +V>E7<5Q;W,-C.(@U
MT8FW%9"F5"D' R?7.,T ;]QX[TJRAU8WT5Y;3Z7$LUS;O#ND$;='&PD%>#R#
MQCG%6M/\6Z?J.LKI:17D,\EN;F!IX"B3Q@@$H3UP6'YY&1S7+ZEI^HZUX*UV
M.T\&QZ3=W=B]M' # )I78=V4A0@]SD^@QSH_V?J<GC7PU?\ ]FSK:VFFSP7$
MC/'^[=_+P,;LG[AZ9[4 =5J.H6NE:?-?7LHBMX5W.Q!/L  .22<  <DG%<=%
MJ]Q+\688734K:#^Q)IWM9CE&(EC =55F&[&1Z^W-:OCW1M0UOPM)!I81KZ">
M&ZAB=MJRF.17V$]LX_/%9EM_;%_\0-/UR3P]>VEHFE36T@FDAW)(TB,!@.<C
MY",_H!0!?T#Q!I2^'-.EL)=1O$O;F:*U6Y;=/*ZO(6!+D8 V/C)&  .O%:0\
M26AM;6007/VBZEDAAM"@$KO&6#C!. !M)R3CISR*XK3?#-R_@33-&USP_=N8
M[VXE=H)T6:U+22/'+&ROU^8# .>3P12#2/%^F#P_K313:Q<:7-=P26\DJ+<2
MVLI&QBV=ID 12>><^N: +WBKQ%'JOA>VO]*NKRVD@UNWM)T#&)U<3JDD;@'!
M&#ZD'-=1?^)+6QN+J!+>ZNY+.(2W2VR!C"IR1G)&20"=JY;';D9P/%%MKFN^
M&+;;H[K<G4K:X%JLL>^**.1&.]BP4M\I. 3U ]Z?96>J:!XO\07@TV>^L=7\
MJXA:%DW12K&$:-PS# . 0>G7- &T/%&GSI:-8>9J!N[8W<2VH4DPC +_ #$=
MV QUSVX-+)XDMA;P26]M=W<LMJ+L6\"#S%B(X9@Q 'H!G)(. <&N'B\"/9>&
M]%TBXL[XW=A:N\&JZ7,$EMIW<LT8RP+(<XY&/EYQFGRZ1XCT_5M-UC4M @\1
M/<:5#9ZA%&8@\,\99MZ[\*5.\@XQR,]* .P@\6Z5?66G7&G/)>G4HVDM8H%&
M]U7[Q.X@*%. <D<D#J<5E?#B^GO]/UQYIKN01ZU=11B[=FDC12H"'))&.F*I
M2:7K&C>*='U^TT-);7[!+8W.GV#1J;4/*)%902JMR &P1ZUJ>!;'4;&/7?[1
MT^2T-UJ]Q=PAY$;=&Y&/NL<'C_\ 70!9U/Q-+8^,M+T%-/GE6[AEF:9=N,)M
M&!DCIN!)^F,\X==^,M+LHYKF47!T^"X^S3WZH##%)NVD,<[L!C@L 5!ZG@U5
MURPU$>//#^K6EB]U;0V]S;3%)$7RC)Y95CN(ROR'.,GV-<]#X<UJW\#:UX*>
MP>4W$MPEI?[T,313.7WOSN#+N;(QS@8S0!Z6S80L 6P,X7O]*\OU_P 6WFM_
M#35M5BBO=+DM;\11NDNP[5N5C()5N3C.1TYXSUKTNTMUM+*"V5BRPQK&&;J0
M!C)KS&Y\/^(/^%>ZWH":+,]R^J/-"XFBVS(UT)@RY;@;>N[!SC@]@#M[/Q9I
MMUJ-]8R+<V<UG +E_M<1B#0G(\Q<_P .5.<X(]*6V\56,^L6NERPW5K<7D+3
M69N(PHN$7!;;@D@@$$JP!P>E<YK_ (=U/7O%.J[;26WL[[PX^G+=.Z829G9L
M$!BV,'KBK'A*'49)K1=1\&6FE75HA6>]'DL)&V[?W.SYANZG.,#(YH T?'GB
M2;POX8>[LXTDOIYH[6T63[OFR' )]AR?PI\_ABY;1I8H-=U-=5>$@7QN&(\P
MC[WE?ZL#/8*,=N>:3QUX9D\5>&)+&VF6"]BE2YM)7^ZLJ'*Y]CR/QJ6QUO5[
MFV6.?PY=VM_C#B22,P*WJ'#$E?H,^U $MSXBALGFMOL]S>7-I LUVEJ@<PJ0
M<$Y(R3@D*,M@=.E5+KQWHENNEF)KJ\&J1/+9FUMVD\T*NX@?[7MU'?%4;.RU
M7P_XTUZ^-C-J%EJZ02H]N4#12QIL*,&88! !!Z#D&L?2/">JZ#<>!K=;-[B+
M3/MCWDL3ILB:<,0HW,"0&;' Z"@#<D^(NDI]I1;#6)+BV@BN)K9+!_-1'!()
M4XQ@ Y_+FM2+Q7I=W::=<6#O?'4HS+:10 ;Y$4#<?F("@9 .XCD@=>*YVTO9
MK/XI^*3%87%WNL++B';PP\W .XCKSST&.<5GZ%X0U;PA=>&K^*W-ZEM93V=]
M;V[#,7FR^<&0,0& ;Y3WP 0#0!T\WCS1+?1CJ<CW(B2[%E,GD,7@FW!=KC^'
MDCV.1C.13X_&-I-)'!'IVIF]D$S):/;^7*4C(#/AR!MRRXYR<\#KCE-6\+:O
M)INL7=OITLEUJFMVMZ+59(P8HH6CY8E@NXA&. 3U ]:Z+74UF;Q-IVS39[O1
M6M7$J0S)&5G++M\TE@3'M!X7//4'B@".[\=P$^&9-+LY[VUUN1MDJ*!A1&SX
MPQ!W97ITP#[9N6>L:2GB'Q$YN[V.6QA@>]%TS+!"NUR&0'@< DD<' KC]'\/
M^(-.\->!A+HLK7&BW<@N;=)XMY1HY$#@E@N,L.,YQVJ]JOA75=<U#QS;M;/:
MPZO8VT-K<LZE&>-7R" =P&6 Y'3- '50>*K&2_M+.:&ZM9+Z-I;,SQX%PJC)
M"X)(;'.U@&QVZUG1_$319(XYEBU 6S7AL7N&M66.*7?L <GIEN/;(SC-5)-/
MU3Q'/X7>^TN:PDTFX%W=L[H076-D"1E6.X%FSG@8'KQ6++X?UY_ .HZ:-&N/
MMD^NF]CC\V+F(W8FSG?C[HZ9SF@#U*N>'C+2R;.5A.EC>S?9[:^9!Y,LA)
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M9CW)/)/UJ:N9GUV_T_QMIVE78M5TK4+9S;3!&W^>@!,9.['*Y8''.".V:TM
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MW#=75T+?(/E%"B*N[A0(U')/4^M:(\/W0\7MXA^WQ;VT\6/D_9CC 8ONSO\
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MUK0[/7OL^C:G*TWV=K02/;LS!F"/N'RD\X(R,]:[>RFFN+&WFN;8VT\D:M)
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MS&86_?;YI&1'NQM#D8^7.?:M.O'];GN+I;E?[+O[9[3Q-#.]I;6#E&C69?\
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M,5O?Q,WD_:!NRH>+IYBDX#)_M#(]ZKV_C'PY=SVD%OK-I+)>,5MPDF?,()&
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M4>GRI#,K1DR, LB.0-ZG=QP.00<5:7Q?JKZMJ6D)X;8ZE:0I<I&;U1')$^X
ME\?*V5(Q@\]\<T =?17)0>/+&]TO1[JU6%)]4M6NHHKRX$*HBX#;GP>=S #
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M&GV4FD^9?-83RP7NY<J@9-R >Y*]<4 :&AZ(NBVKH][=7]S(09;N[8-))@8
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MN05& I" 8R3C/% 'IE%8=SK\SZO>:5I5DEY=V4*37 DG\I5WYV(#M;+$*3T
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M<5WVF^))[KQ/=:%?:8UE/':K>0MYRR"2(L5YQ]U@1TR>O6@#H**** "BBB@
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M/;;Q&1LLP4' YP,Y)["@#E=8\/>)?$.@Q27=W86>M6MW%>620;WMXWCS@,2
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M)8897+.A3;AF&6 .X#D9 Q@]_6=KFM6?AW1[C5=0,HM;==TACC9R!] /UZ4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*Y_Q??:GINE07.FVMS<JMPOVI+15:?R,-N,:MP6SMXZXSCGFN@JCJ>F+J0MC
M]JN;:2VF\Z.2W8 [MK+@@@@C#'@B@#B[;Q<]]!HEKI>J2WQU.ZN5^T%$BFC6
M-2WE%64*KC(!RO0$]P:AU6_\8Z/I$"W.I1).^N6]O!(4CD=[:615"R@*!N'(
MRN,CWKH+[P%HVH:8;24W23&\-\+V&7RYUN#UD#*  <<8 Q@#BGS>"K&XTNWL
M9;W49#%=)>&XDG#RR2H049F8'I@8 P..E &7J$VN>%]6T"6^U^XOM+N;M[2[
M,EO"A5I,^02508&[Y3R.HZ5'X@UC6+/PD=:M-3D3[1J4'D*8HR!;/,L8 ^7^
M)3NR>1NQGBNLUK1;+Q!HMQI.HHTMM.H5\'#<$$$$="" :BUSP]::]I::=</-
M#;))'(%@(7E&#+U!X! /X4 8CWVJ^(-7\2Z=IFIG3IM*\J&WQ&C!I&C$F^0,
MI)7Y@N!C@'VQ7N-5UW5M5U+1]/NO)N;"R@;S;4QA7FD5FWD2*V4X& /?)/&-
M34/!&G:AKAUA;O4K.\DC6*Y:RN3"+I%Z"0#KCU&#[TFJ^!M+U+4[;48;B_TV
M\@A%OYNG7!A,D0Z1MCJ!V[CUH V-&?4'T:T.JB :@(P+G[.V8_,'#;?;-<?_
M &WJ^M:3XJU/3]1:SETB\N+:V@$:,C&!03YF02=YST(P",<\GN;6VBL[6*V@
M39%$H1%R3@#W/)^IK#G\':?+=ZC-%/=VT6I_\?UM X$=P<;23D$J2O!*E2?K
MS0!R]OK6O^)]>TRWL=7DTJVU+P\NH[%MXY&AD+H."PY'S=^V>AP1Z%<.T%C*
M_FQJZ1D^9+P@('5O0>M9J>&K./Q#!K44L\<\%I]CCB0J(A#D';MV^H!Z]O2M
M*\M(+^QN+.Y3?!<1M%(N<;E88(_(T <!I?B75+?7]&BN;V>^M+W2I[F:1H42
M.62/8=\. '"G<0-PY&",]:U- N-;US2= \0QZS&D-XHFN[1XT,81U^5(R!N#
M*Q R2<\Y["K5AX#TVPN]*N1>:G-+ID;0VYFNB1Y;!1L(  (&T?7'.:71O NE
M:#>>;97&H"U61I8;![DM;0.<DE$_$D D@$Y&#0!Q]C=ZMI?P\\::I;:S=&\M
M+^_,3S)&^#&Y /*]2 !Z#L!731ZS>:KXKAT!+R6T6+2([Z66)4\R5W;: -RD
M #!)P.21V&#<?P/ICV&LV(GO4M=7DDDN(EF^53(<R; 1QN/7OZ8JQ/X5M);N
MPOH[J[M]0LH#;QWD3)YCQ'&4<%2K#(!Y7@\C% '%GQ5XBFTVRA%^L5Y;^)_[
M%N9Q I6YC!.'V]B1C(4CG/3MTOA:^U(>)_$FBW^H27\=@]N\$TT:*X65"Q4[
M%4$ CCCO5N?P;ILUG8VRR7,2V=[]O5HW&Z2XR6\QR0=Q)8GTYZ<#%RQT"WT_
M7-1U>.>X>XU 1B=7*[/D!"X  Q@$CW[YH J>)+RYM[K2H(+_ .SK<3.LD4*!
M[B<!"0L8(('."Q.  .HKEK/Q/XAE\'0WQAO+QK;5;BVOC:QQFZ-O&TBAE4#:
M6!";MHZ9QZUV.M>&[36[S3[R6>ZM[JP=V@FMI=C .,.IX.00!^7&*I67@FPT
MV,)87VI6Y%Y)>*PN-^UWW;AAP05.]NH)S@YX% %KPEJD.L>'H;R#4SJ4;R2X
MG:,1OC>V%90!AE&%/ Z9[USOC/6M5L!KTMAJ;J^GZ9]JAM[2)&,3@.Q><N,;
M3M "@Y(#$ XS77Z5I-MH]K)#;!CYLSW$LCD;I)'.68X &2?0 5D:GX'TO5;_
M %*[EFOHO[3MA;7D4-P4290I521Z@$CKCU!H V]-N7O-+M+IP \T*2,!T!*@
M_P!:\Q\4ZE>^)_AGXPU,7\MO!!)<6T5JB(5,<3;3OR"VYL$\$8R,=\^G:;81
MZ7IMO8PO*\<"!%:9R[$#U)KG+WX>:3>?VM&MUJ%M::L2]Y:6\X6)Y#U< @D,
M>^#@]P: &KJ.HK\0;+25O66PGT22X\H1K\LJR1J&SC)X8\=*YO3?$/B&W\!'
MQ7?:V;EM\MJ+9K>-(]QN_*24D 'Y1VX!&/<GN%\,6L>M6VJI=W@N;>T-G'F0
M,/+)!.=P))R <D]O3BHK/P=I5KX7G\.2":ZTR?S-\5PP)^=BS8( /WB3['I0
M!@:MJ_B;PI;:SJ]TRW6EPZ>988[IXS*MR#CCRU7,9!!/<$<5LM8ZU%*9?^$B
M:6QFL65LQQB03XR'B(7 &,\'/0>YIVF>"=-T^PN+*>YU#4X9X#;$:C<F;9">
MJ+TP#@>_ YX%/T#P?8^'UV17FHW:)&8H4O;DRK!&?X4'8< 9Y.!C- ''>%M8
MOK3PGX#TM;^<S:X#ON9%1C"B1-(P7Y>2Q &6W'DU-KOB/7='B\9::FH.\VF:
M>FHV-XT2%PK!@8W&W:<,AP<9QUSUKHX? .D0:'::4DM[Y=E,LUE,9\R6S+G;
ML)&  "1@@@@\YJS=>$+"]TW4[2ZGNI7U1!'>7)91+*@& O"X4 $\ #J3U)-
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M7L#*KHR,,JPP1ZBN6A\ Z9;Z9ING17FHBWTVY6YM0TP8HRYV#E3\HR>/?G-
M&!-XHU;0/^$KM+B_:_;3[JRCM;BX2-607.T'=L"J0I8D<>QKI-&C\1P>(IUO
MI_-TB2V#1"X>,SI,&P0-BJ"A!!YY!]C3Y_!>E7DVMO>>?<IK*(EY%*PV$(,)
MMP 5('0@^_6IO#_A>V\/@[+_ %*^DV>6DE_<F9HT_NKT ' ]S@9)P* .;^)#
MN=<\$VTW&G2ZRGGY^ZT@4F)3_P "SQ[5W5U!!<VSQ7**T)P6#=.#D'VP1FJV
MLZ+8:_IDFGZE;B:WDP<9*E6!R&4CD$'H15:ST VXC2YU?4;^&,@I%=/&0".A
M)5%9\?[1/KUH Y@ZYJ^L:)XHU;3]1:TETB[N8+:W\M&C;R ,^9D%CO(/0C (
MQR,FO#K.O>)O$.G6UCK$FE6VH^'DU((MO'(T,A=!QN'/7'/;/3@CIIO!VGR7
M6I213W=O!JG-]:PN!%<'&TDY!*DC@E2N>]65\-VD?B*+6XI9XYXK7[&D2%1$
M(<@[=NWU .<YX].* .(EO?%MY8^+Y[7Q(89-$O)!;)]DB(E5(4DV/D?=.2.,
M'G.3P!J:'XEO?&&IFTCN9=,2+2;2\?R%0NTDZEOXU8;5 ';DGFH= T"34=2\
M7QWQU.UL]0U$MY)C,:7,)C13RRY&2&!VD''X5TUUX7LI=5@U2TEGT^]AM_LH
MEM-HWPYR$965E(!Y'&1V- '$0^*?$6HV/AU!?K:W4FM3Z3>O' A6;RUD_>*&
M!P?D!QTSGJ.*NZ_?Z[HUAJD*>(9KNZT[23<H;>VB$GF#S&\R?*[ I"J H()P
MQ .,UTDO@W37BTJ**2YMTTN<W, B<<RG=EV+ EB=S9SUW&FZEX)TS5-2U"]E
MFO8CJ-J+6\B@N"B3J 0I8#G(#$=<>H- '/I->:E\0_"]RVH7,*W&ARW+0Q[/
M+#;H20 5/7/)Z\<$5 WB_5M/TCQ T]T)[B/Q"NEVLKQ*!"C^4 2  #MWL>>I
MQFNIC\&Z=%-H\R3WPETJ%H(I/M!W21G;E7/<94=,=/3BF_\ "$Z2]AK%C<FX
MN;?5IS<W*2N/]:<?,I4 J1M7&.F!0!G76H:MI/C2TT0ZC-<VFJ6,\L,LL<?F
M6TL6TD_*H!4AAP0<'VXK!T77_$3:3X&UJ[UE[@:Q<+:W5J8(UC(:.1@X(7<&
M!0=\>PKN;?P[##,;F:^O+J\%N;:.ZG*%XHR02%PH7)(!)().!D\51A\#:=!I
MFC:?'=7HM]'F$]H-Z95@"!D[>0 S#GUH V=9N)+30[^XAN+:VEBMW=)KHXBC
M8*<,_P#L@]?:N/TC6=7E\5OI#7]V]O-H@O(YKF"-6\T2!"Z*%!"G/W7';I79
M:MI=KK>D7>EWR%[6ZB:*50<'!'8]C6+:^";&UU&'41J&J27L5H;/SY;G<6C)
M!&1C!(QZ8[D$\T <GHGB#Q"VD^!M:N]9>X&L7"VUU:F"-8R&CD8,"%W!@4'?
M'L*K>*]2O?$_PJ\4:N+^6"!)9H(K5$39Y<<FSY\C=N;!;@C&1COGM(? VG6^
MFZ-I\=U>BWT>83V@WIE6 (&3MY #,.?6J]Y\.M(NTU6 76HV]EJCF6ZLX)PL
M32'!+@8)!..<'!]* .N3[B_2N&^']S<:C\/[G5_.,=]J%S=W+R[02K"1D7@^
MBHH ]!7;01""!(E9V"*%!=BS'ZD]:P-%T-]'BU+1T\Q+"XFEN+:6+&8A(=SQ
M\YP0Q8@XQ@CN* .:M_$FMR^#O >IF_/GZG>VT-[^Z3]\KABW;Y?NCIBN@TC4
MM0F^(/B/3+BZ,MG;6UI+;QE%'EF3S-W(&3]T=:>O@C3TT?1]+2ZO5MM(G2>T
MPZ[@R9VY.WD#)X]^<U=BT2WT[6]0UZ-[N6ZNXDCEB!4JP3.P*,#&-QYSWYH
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M7!T2VE6"T4(=V9 S*J_Q;.XYZ5LW,>GW>O>"+WPV(-DJR+,( -K67E$D.!U
M;8!GHQ]: /0/M-OO5//CW.2JKO&6(Z@>XI5FCE$@AEC=T.U@&SM;T..E>(G3
M]*3X727R0VZ7,'B(K#<+@/$OV[&$8<J-I/ QU)KL+>PTNQ^*&KZ?;VUI!9S^
M'XI)[=$54=A+(-S*."=N.?2@#M-,GNCIEJVIR6?VQUQ(;5B8B_HF[DBK<4T4
MT?F12I)'S\R,"/SKQC2;:PN_"OPJ%Q'#)ON#$V[&67R9<J?49P".AZ&I;V:/
M1[3QC#9*8=*M=?M'NXK5 1%;E(C*0F",9'(Q@C.>] 'L,-Q#<Q^9!-'*F<;D
M8,,_A49NEFMIGLI(9Y$!  D&W<!T)&<5Y9K(TF'1/$&M^&M9N=3:>*V.H"S,
M31+"LJ[SA$ \PQ;\@Y^4<CI72>%8O#=WXEFUC0]<?4)9[%8IT@,7DJH8%"ZQ
MH,2<D#/. >.* -[P]J]U?^'8M0U>""RGRZR!)=T7RN5#*QQE3@$'WK721)4#
MQNKJ>C*<@US/C6WFN8=)2RU*VLM12]#V8NTWPSR"-_W;CK@J6((Y! (YIW@2
M\-YX<8/ID>G2PW=Q%-!"VZ(RB1B[1GNI8D^W([4 ;*R7W]M21NUI]@\A60 M
MY_F;CNR.FS&,=\YJPMS \BQI/&SLNY5#@DCU'M7"/!8GXK:_%)' 4F\/PM.K
M 8<^;*"6'?C;U]JY;0;33[/PS\+]1@B@COI;V.*2X&/,=3#*&4MU(R%&.W H
M ]%\<>))?#'A:^U&S%K+>6\?F+!.Y&Y<@$X')Z^WUK6:6]360K/9KIWV8L<L
M1-Y@8<XZ;-IZ]<XKQS6K_3[WX6>,8M7>V'B".^F,\<Q E#"7]UM!YVB/:%QQ
M@'WKME^P7'QE5XOL\JW7AQBQ7:PE'GK@G^\,?I0!V_VB'9O\V/9G&[<,9JM;
M27S:E?)<-:&U4I]F$1;S0"OS>8#P/FZ8[5P?AG3C::G=>!I+0&PTR]_M")BG
MR-;.3)$F?[PER/I$:R=;EN+!OBFVBJ5N5%F[+;\,%,0\UACH=I<Y]>: .ZO?
M$LEOXTTC1X?LDEI>17+2RB3+QM$%...!]X=?2NA\^+"GS4P_"_,.?I7FTMWX
M:G^(O@F;2)M/,,MC=Q+Y++RFR/8I _X%@'WKG+:_TRW^'GAFSEN;9+JR\3+Y
ML)8!X +UR2P_A&".3CJ* /:VN8$G6!IXUF896,N Q'L.M8EMKMW+X\OM!EA@
M6V@L(KN.122[;W9<'L/N?_7KS?Q3JNERVNO36L]M;36_B"V:43R;KAW22%3(
MI)'EQA>G7(SR,XKL["XAF^,.H-%*CAM!MF4JV<CSI3G\B/SH [1F5%+,P50,
MDDX %1K<P/;_ &A)HVAQGS P*X^O2N0^(&H+IDWARYOSC1%U(#4&(RB@HPC+
M_P"P)-I.>,@5DZS=>$[/36N=/*7%K?ZW;,TR7.+,7/!W,P)78-@+ <$D#.>@
M!Z*ES!)!YZ31M#C/F*P*X^M.2:*5W2.5':,X=58$J??TKP[6)K*;PE\1H&N;
M2X,>H07*>2H51E8<R(N3@$YYSSSS73:GINEZ)XYM=1T2W\NV.C7DVK+8\&6(
M!3$QQU=FW8;J<'GB@#TF*Y@F=TBGCD>,X=4<$J??TI1<0M.T FC,RC)C##<!
MZXZUY#HNH6B^)_";Z9=:>@FT.XAMX89 Q4XB,<<CY^=\\G@<YX[UJ>"KWPSK
M&C^&OM$H;Q+9.?-@$FVZ6XP5F:1<[BI.YB6XZ>PH [.XUHZ+IVJ:CKMQ91VM
MM,WE&!B3Y>!M5L_\M"3T''(K76XA=@JS1LQZ ,"37C.I6]F/AU\1HXHH?+AU
MZ1U55&(_]1D@=OXOUKJ?%*6&C3Z1XZTB"&6WL&-O=_9$#>9:2':2NWJ4?##'
M;=0!WZR(^=CJV#@X.<4R2Y@BE2*2>-))/N(S@%OH.]9WAS3VL-)#3Q+'>73M
M=704#B1SN(SWVY"CV45Y?\0-1TZ6T\<)!)!;WL!MA*+A]T\KJJ,IA7(V(HYR
M,Y.X\=2 >Q2W$,(8RS1QA5W'>P&!Z_2EDFBBA,TDB)$!DNS  #ZUYX;'0]8^
M+=\9H+*[MIM AE(8*Z2'SI!O(Z$[<<^F*YWPMJR0Z?\ #A=6G4:.UI<*LDS?
MN_M*G$88G@$+N"Y[_2@#T;PMK]SKD^N1W,=N@L-0-K$8&+!T\M'#$GJ?G[5O
M33PVT?F3RI$F<;G8*/S-</\ #B33QJ7C&"PDMS&-:>14A8$;6BCY '8D-^M2
MW<Z_\+:2UU94-E+I!^P"8 QM+YA\T#/&_;L]]H^M ':F1%"EG4!B "3U)Z4D
M4T4ZEHI$D4$@E&!&1U%>+_88AI&APW*H]@OC-HM,+G_ES/F *IZ[,@X[$8[8
MKL_!T%I8^._&EA8QPP6T<MG(MO" J(S0_,0HX&<#- &OJFOW6G^,M%TGRK?[
M%?PW,CS,QWH8E4_0#YAZ]*WEFB>$3)(C1$;@X8%<>N:X;QC:V-W\0O!T&I1P
MRVLD=\ICGP4=MD9"D'@].A]*Y*=5\/VFH26S26_@]?$L66A4.D4/E?O&4$$>
M6)]O8C*F@#T7QAXCFT/PA=:WI:VMT82GWW)0@N%/W>I&?45T*312.Z)(C-&<
M.JL"5/OZ5Y%XGMM!A\"^,+[1M9>_BO6M7G=)(C;K()%'R>6H <C!;O\ =)K4
MU%=+T#X@:LT%N(;5O"TMQ<Q66$>79*?F&.KX)PW7GK0!Z,ES#/YBV\T4LD?#
M*K@[3Z''2N0M/'3Q> -2\2ZG;Q+)92W,?DP,0',4C(H!/K@<^_2N;\,W^GKX
M\\-&VN]/6";09(8XK9]VW#1%(V?/SN!D]!W.!6?>_99?@/XF>3R7V7UZ49L'
M:QN6QCT.#^M 'JFE2ZR]Y<KJ'V"6SVHUO/:[E))SN5E)/0@<@\YZ"M%[B".9
M(7FC65_NH6 9OH.]-M8K>&W1+6.*.#&56)0%YYXQQ7E;&WOO!_CR'6 HUJ"\
MN6&[_7*0,VIC[XQL"8ZGWS0!W>MZ^]GK.FZ+:/;I>WZS.LLX+)&L:@G*@@DD
MLH'([GMBKEM?W%GX?%]X@^RV<T,9>Z,4A,28SDAB <8Y_''-<3/;))XZ\"+K
M$-L^I2:7<F[#HI+2A(<Y]>0V/QKJ_&T*S^!-?C:,2?\ $NN"JE<\B-B/QS0!
M4N_%<HUKPM#9QP/I^M&3?(Y/F(%A:48 X'09SGO]:Z:.:*:(2Q2H\9Y#JP(_
M.O*\:1?R?#."+[)+:N91*D978[?8SD''!Y(!'X&L^:YBTC1_$4<!,&CVGBQ/
MMB6R!A#;%(RQV8(V[\$C&.O% 'L<,\-S'YD$J2IG&Y&##\Q1+/# %,TL<88[
M5WL!D^@S7*>$;;0?[9U;4=#UA]2^V+$UR8GB:W5P"!CRU #D=>^,9[55\9PW
MAUN*ZTJXT^:\M["3SM*U$?N[FW9AN*M_"P*@$X(Y&: .I?6]/368-)-S&;R>
M!KA(PP^X"JY/U+#'K@^E7/M$'VC[/YT?G8W>7N&['KCK7F6G7&E3>.O"M_):
M164=WX=)MXKH#<)/,AV*"?O.!T[UD@M?_!]WX7QA;WYR>!<+?_:.!Z\J?IL/
MH* /8Y+B&%T26:-&D.$5F +'T'K6%:Z]=2>.-2T.>*W2UM;*&ZCE5CN.]G4[
ML\#[G_UZY WN@76L^,-%\93PPW,UPA@$S[&DMO+3RQ">I(<.<+SN/J:S_%%U
M<VWCK5)H(&GT^'1[-M4M W[][7?-O"G/4 @L.I&0",T =[JGB&XLO%GA_3(4
MMGLM2-P))BQ+(8XR_&./2N@CFBEB$L<B/&1D.K @CZUYYK)T35?%/@!+06DV
MES_:S%'&!Y;IY' V],>WX5SIG73M&U*&!431;;QILOHXP/+BM3L)! X";R,C
MIC/;- 'KL]YNTV>YL7@G9$8H=^4) Z$C-9WA;76UKP=IFMWHAMVNK99I IPB
M9'J3TKGO)6#XD:G-IK1IITFA[[X1$>7Y^\^6QQQNV;OP ]JYG0=2BM-*^&*Z
MC)&FBO9R!GD(\K[4$'E!R> ?OXSW]Q0!Z#X9\07.M7NNPW$=LB:=>BWB:!BP
M=#&CAB3U/S=JW8[JWE@,T<\3Q+G,BN"HQUYKQB:_LK&V\7-82H-.C\1VTUZ+
M0*^VV*1^8^W!!7=UX((R/6K?B>R\-3^#?&6IZ3J_]J?:;!6G*-"UNDB\(1L4
M 2X_'&,XXR >O)+'*6$<BN5.&VG.#Z&L^75@^O+H]J%>=(A<7+-TBC)(4>[,
M0V/923V!30M)TS3;/S--M8(1=!997B _>MM W$]SCOWKGO# D7XE>.1-G>S6
M+1Y[Q^20,>VX/^.: .Q-Q )Q 9HQ,1D1[AN(]<=:'N(8VVO-&K9 PS 'G@?G
M7CQ/V_X2ZG]H 7Q;;W\I8CBX6]\\F+;WY4H!CC;QTK=TO1=)U'XI>(X]1LK.
M>>.TT^?85! E'F$N!ZY"\]>?>@#NM8U>RT+2KC4M0F6*V@3<S$]?0#U)/ 'J
M:RKGQ%/!XWL='V6WV"YL9KHS[SN!C9!] /F]^E9_Q7B27X9ZR7C5_+C1P2N=
MN'7)]N,UG7T.BZI\2_#L$:65S8-I5X4C4*T3?O(NPX(R"?J,]J /0?.B\CS_
M #4\K;N\S<-N/7/I1%+'/&LD4BR1MRK(<@_C7B]AJ,.F>'-#%Q<M;:!;^(+Z
M">6-59(!OE\G<&! 0,1U&!\I["O0O!=EH]JNJ2Z'J<NH6MU=><\@:-H!*1\P
MBV*%]"<9&3ZYH FC\13IXXOM%NUMH;.#3XKQ)MY#'?(R88G@?=_7K7023111
M&621$C R79@ !]:\_P!2T_1M1^+=[#K<%I/;G0866.[ *'$TNX@-QD ]>V>V
M:YC2[@Z'9^%(]:O9K+P^TE^EK<3!66/,@^S>89%( ,>_:3V/:@#V<31%$<2)
ML?&UMPPV>F/6B*:*=2T4B2*"02C C(ZBO)-1TCP_;:=X9BTZ[:^L9?%*M'-*
MR%,.KETB* #RMW&!QG(J/5"NCGXAV^DQ>3:6]QITTUO9H!MB*IYY5 ,<H&SQ
MZT >N1W=M+&TD=Q$Z(<,RN"%/H37'V/B/Q'KVF66L:*FC?V==98K>.Z/ H?
M)*DABR@\87!(Y(J'P_;^%;_7+O5=+UD:F)]/6.ZC3R3;JBL"AD5$&).H&[G
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MW@B1'\0^-0KJ2-8Y /\ TPB']#^5 '83316\9DFE2.,=6=@ /Q-(9XE"DRH
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M Q ZG!/)YH [NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "HYK>"X $\,<H'0.H;'YU)67K>O6
MN@0VTUY'.8[BX2V5HU!"NYVKNY& 2<9Z4 7DM+:.7S8[>)9/[ZH ?SI(;&TM
MS*8+6"(RG,A2,+O/OCK6;%XDLY=5U331%<+<:;$LT^]552K E2I)YSM//;'.
M*YB;7Y(?B-9W"C5)+6ZT%YTL%#,2_FI@^7G"MM[G&.] ';_V?9;=OV.WVYSC
MREQG\J7[#9EBWV2#<1@GRQTQC'Y5E6WB[2[W1]/U&V:65=1<QVL 3$LCC=N7
M:<8*[6SD@#!YI(_%^EO;7LCF:&>RG2VN+650)4ED($:XS@[BRX(.TYZ\&@#5
M_L^RP!]CM\+R/W0X_2GI:6T1<QV\2%QABJ ;OK6</$-LMO<23V]S;R07"VQA
MD0;WD8*5"[20V=PY!QUSC!I=)\0VFKWE]8HDUO?6#*MS;3J Z;AE3P2"".A!
M/2@#1M[6WM(?*MH(H8LYV1H%&?H*2WM+:S0I;6\4"$[BL2!03Z\=ZX>_UV31
M/B=?JXU2]MSHT4RV5JCSX?S7#,J#A>%'/'YFNBM/%NEZEI5C?Z<TEXM\&^SP
MQ+B1]OWP0Q 7;T.2 #@=2,@&O<6UO=Q^7<P131_W9$##\C3XXXX8UCB14C48
M55& !Z 5Y[XC\4V^H6GAW4M-O+R!(_$$=E>0+O5P0'WQ2(/O'(''.>,9S70Q
M^-](.GZK=W NK3^RW5+J&XA*R*6 *849SNW#'UH W&LK5Y&D:VA9VX9C&"3]
M33?[/LL ?8[?"G('E#C]*Q;C78-4LM=T^,7=E?V-MOEC8A'0.C%&5D)'.T]#
MVYKE6\1:A:?#?P21]LGFU-K"&XN$;+LKA2XW$@[F (S[GD&@#T62PLYIFFEM
M('E9=I=HP6(],XZ4_P"RV_G^?Y$7G?\ /38-WIUK'M85\-Z'?7:MJ=Y'\UVM
MM<3"62(;03&I8]!@\%CC)YQ7(7_B>ZU#2_ FNN+VR^VW\0G@B9MLR/ [X"J3
MO&0,9&>.E 'I810Y<*-Q !;') S@?J?SJ-+6WBD:2."))&^\RH 3]36-8^+]
M,O;*^N&%S;-8SBWN(+B(K*LC;=JA1G.[<N,9SD5/IOB*TU'5;O2C%/:ZA:HL
MLEM<* QC;HZE201D$<'@]<4 7X+"SMB#!:01$$D&.,+C.,]!WP,_2E%C:"1Y
M!:P!W<.S",99AT)/<CUK*U+Q78:9K4>D20WLU]+;M<1Q06[-O52 0#T)^8>P
M[D4VU\7Z5>Z+9ZG TS+>3&W@@,>)FF!8&/:>A!5LYX !.<<T :[6=J[2,]M"
MS2X$A* E\=,^N*<+6W$_GB"(3'_EH$&[\ZP9O&VDVVGZM=7*W4+Z3@WMLT):
M6($9!PN05(Y# X]^*9_PG&F_VBEB;74A/- 9[53:M_I*C&1'ZD9&<X&.<XYH
M Z.6*.:)HI462-AAE89!'H14?V.U^RBU^S0_9P,"'8-@'TZ5RNI^*]$U'P@V
MHS3:I:VOVM;:3[.KQSPS+*%V-C[OS8!R<$'WJ_?^,].L=5O-,%MJ%S>VL"W#
MQ6]JS$H21E>@/W3ST[9SQ0 >,/#LGB'PS?:59-;VTMYL#S.IX"L".!U^[CK6
MU9VD-K$1';00,_S2+"H +=ST&?K62OB[3)[?2I+(37CZI"UQ:10J SQJ 68[
MB ,;E')SDXK-O?'D'V3P[=:79W%Y;ZS=>2D@4+L #%@02#N^0C'3@\],@'51
MV=K#L\JVA3R\[-J ;<]<>F:$M+:*XDN([>))Y!AY%0!F^IZFL*TU?2_^$GUO
M-U>QW%I:PR7:7+,L$2?.0R@\9X;)'' YJ:#Q9I\M[8VTL5U;?V@A>RDGCPMP
M -V%P20V.=K $CM0!K)9VL:NJ6T*K(,.%0 ,/0^M9-]H^I7VJPH;ZWCT%%C9
MK)+?]X[HVX#?G 3A<C'(&.]9_P#PL313&9O*U#[,EZ;&:X-JP2"7>$^<GH-Q
M ]1W R*Z:]FCM[&>:;S?+2,EO*4L^,=@O.?I0!/4+VEM([O);Q.[IL=F0$LO
MH?4>U<_HNO:<F@:(E@U_?"\M3+:K,X:>2-0,NS.P&1N7/.>16[8WT5_IT-]$
MDJQRQB0+(A#@>A7J#[4 .-E:,Y=K6$N1@L8QDC&*1K"S>W-N]I T#')C,8*D
M^N,8KF3\1M$%H+PQ:@+,79LY;EK5@D$@?9\Y/0;N/;C.,BK]OXPTR:\U"UG2
MZLY+&V^UR"[@,>Z#G]XO<K\I]#[4 ;D4,4((BB2,,<D(H&3ZTRYM+:\C$=U;
MQ3Q@YVRH&&?7!K)TSQ58ZG?QV2Q7-O--9B^A$Z "6 D#>""<<D9!P1D<5S'B
M;Q)]MN?"<^FMJ$5K=:U#&MRC%(;F,[LC .2#@$;@ 0,C(H [V2TMI@HEMXI
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M?V9[MH;=066%2 6.X@=2!C.3V%7=-U"VU;3+74;*3S+6ZB6:)\$95AD<'I0
M^2SM9C"9;:%S"<Q%HP=A_P!GT_"G-;6[S"9H(FE'1R@+#\:X'XA^)0_@^_DT
MM]03R+N*#[=:MLC602JKH2"&(Y92<%<\9S70G5-.C\9WD)FU(WT&G+)) %<P
M^5O.&5/XG)R,@'@8H VUL[5#E;:%3O\ ,X0#Y_[WU]Z=%:V\#L\4$4;-U*(
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M_LD&PG)7RQC/KC%<CI.HW'C#Q1KT;75Q!I&CW LHX;>5HFGF S(SNI#8!(
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M?4+BSB@U%C;7+6]Q+]D?RX&5-^YSCY5QW-36'C#3]1N;:"*"[1[RS-[9^9&
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M444 %%%% !1110 4444 %97B;14\1>&M0TEVV_:82J/_ ''ZHWX, ?PK5HH
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MN8755AD$C,Q*L=V,-Q@'GTZUF^#M*U.Q@T_1M2\'V45QIVV,ZP/*:.1$X5T
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MM,N;)-(@N&>.5D+R22HJ>6N&(( #$DD#.W&><<MJ.GW^D?L\7VGZE9O:W=O
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M>K7QCSY;*T<91W0@%CAMJC/U(Q6/-=ZM>6'Q*COKV&:WM8YH8XU@*E5^RA@
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M'(C%& 8D@_*01D]*Z*?Q#=)=1Z-IH5;F#3HKEY'M)+A?GW*B[4((^XQ))],
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MY@,D>N,=Z[.SUF34]7MDL);>;3S8K=32A#D^8?W6T[L $!R<@XP/6LRV2R\
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MC][&Y8*V>3@ X I;/P*;?1K70)]2^T:':7"S0V[08EVH^](VDW890P'\()
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M04;:3QCD'CFNHLK=K'XG7FE1WE\]G=Z,MU*DMU(_[T3%-ZDG*$@_PX' P.*
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M"WDIU>Y2XD2&6$;\E74A6!;9L"]!Z#-='\4)I[;X=:M<VMU/;3Q(C)+!*T;
M[U!Y!'&">* .OHKS365U#PAXQMY])O+^^2^TR]GN;2YN&F4R0HK(Z@GY<LP7
M"X'( %1-=W<'A/P;XDT^_N9]0O+FS2ZW3,RW0FP)%*9VC!)(P/EV\8% '96/
MB1]0O=?LX=-F^TZ0RH(VD4&=FCWJ <X&00.3WYQ6Q:2RSV<$L]N;>9XU:2%F
M#&-B.5)'!P>,BO/3O%]\47CEEAD18G22&0HZL+-2"&!!'(I=(U-[_4O"6BZC
M<RBVN?#RW8'FLINI\1@@L#EL*6;&>^3T% '>7US=6[6HMK%[H2SK'*5D5?)0
M@YD.>H& ,#GFK=>=ZO#-I%KX0MK?7+^\\O7DM9)WG;,J$2$H^#A]I"C)R?E]
M<U6;[?XI'B-DUY-+O=,U%XTEW2;K2.,@J=@<*5902<CG)]!@ ]-HKS;6;^^T
MKQ!+>:K'<7.C2WMMY6HV-PRM8L/+'E2Q9'R,W)//#\]JZKQG=16GA:Z>6^N;
M(.T<2RVHS*69U4*O(P6SMSD8SG(QF@#?HKRNXN+^W'Q%L_/N+1+32XKJVBAO
M78V\ABE)*MP0244D#C/KGFS9&XTKQ%X.GAO+^=M3TN<W<<UR\BS%(HW4A2=J
MD$G[H'6@#LO$GB!?#MI:7#VDMPMQ=PVN490$,CA0QSSC)[ ULUXY<R+KOPW\
M.>([BZFEO[G5[269A,VP,;D Q[,X"KT QQMSUR3Z9XJDOH?">KRZ;/'!>I:2
MM#+(P548*2"2>!CU/'K0!KT5P.DZ=>7WB32[N :M;Z6NF?Z9%<3S1[K@E=O!
M(+-C?N;D'CDG%85EJ5Z?A[X0NGU*\-R_B&.W>1KE]TB&[=2C'/S#: ,'/ H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P!I8,"1YF<[@,X'/) X)ZUT%% &='H.F17MW>+:)Y]X@CN6))$J@8"L"<$
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHK>%YIY4BB0;G=V"JH]23TH ?14%G>6VH6<5W9SQSVTHW1RQMN5QZ@CJ*GH
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M %%%% !1110 4444 %%%% !1110 5R'A+4&U?5_%.JS98VNHOIL"#G9'"JY
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MO:%G@<#!>)B_RGN,@X///.0#J:BN;B&SM9KFX<1PPH9)'/15 R3^5/1!'&J
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M9#<R!%=E61?ECX< $YYZ@#&;>J>%+W5-+T^WEU@-=6U_%?RW$EMN$KQL&"A
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M=&1LG![$KN7/^U7D&AA:!XPU#7-'#(;(:G_:C6+(L3^7L7YMXRV2#$-X/0Y
M]ZIZQXEU9=(\?_94L[*[T=,Q3QQERX, DR>1\V" #T&.AKI++PI96'BR[UZ
ME&N+6.#[.HPBE,C>/<J$7V"^]49/!3W \6)<:BK1^(4VL([?:8/W0B!!+'=P
M >@YH P]1_M+_A(OA\PDMI[YH;O:[(R(,P+R1EB<?7GVKJ/".N7FMV5^NH10
M)>6%_-8RFWR(W*8PR@DD9##@DU53PGJ!U'PY>W&L0RR:,DB$"SVB;>@0_P ?
MR\#WYSVX%[PWH$V@MJIEO4N?[0OY+WY8#'Y9< %?O'(^4>E &X<X. ">V37
M6?C77/[+U36[ZTTU-+TN>\@N$C=S-(T3%4V9XY(P<^M=^<X..#VS7*V'@I(O
M#NM:)J5XMW;:K/<3.8X?**><2S 99NA/!_G0!$GB/7X-2DCETE[VT-E).LL%
MI+ 8YD&1$?,SNW= PQSVYJG:>.+F^\,ZGK6GW.EWZ6=@]P\2!X7AF4$F.12S
M,. <<#.#6CI?AG7[6PEM=0\5RWFR!X;21;41-&2I42.0Q\Q@.G0=SDX(R?$W
MAU+#2/$?B*_NK3[;)H5Q9L\$'D++E2=SY9MS9  ].1SG@ EMO%^OV^H^')-6
ML;!=+UT+'$]LSF6"8Q[U#YX(;!Z=/4XR7V?C+5M2&D:CI^FM=:;?W 1XEM)5
MDAA8D+-YI^1@."5 [\$XR9/#6C/JVB^%KZ^OX+JWT^WCFMXX(MN9?*V!G.XY
M*AF& !R<^U/T'P7J.@3"RM_$4C>'XYC+!8&V'F1C=N$?FYR4![8SCC.* );/
MQ!K>LV<&K:/9VD^GR7S6Y@<E93"LAC:4.6V@@J6V;3D=\U'X3O=7O/$_BE+Z
M]@FM[2^6".-8"I5?*1A@[S@?,<\')R<CI1I7@N_T:^N(++7W309[EKG^S_LX
M+H6;<R++GA"<\;<X)P1UK3TKP]-I7B+6-1CO]]KJ4JSM;&$ I($5"=^>1A0<
M8'/>@#>K@H=?U#3_ !;XSNM2O8GTO2+:"7R4@(8)Y<CX4[\;L]20<\=*[VN8
MG\'+<Z[K=W->;]/UFU2WN[,P\G:C("'SP,-TQG('/:@"I)XJU/3O^$=O-2@M
M&L-:FCMML"L'M995W1@L21(,_*3A?7VKLJY2R\(7"VNC66IZFE[9Z/*LML!;
M[)'9%*QF1MQ!V@]@,D ^QZN@##UW4[^QN[*&V^RP6\PD\R[N!O"N -D:QAE9
MV;)Z?W3QS7-6_CO5KW0_"=_;:?9A]:N6M94DD<!& DY7CIF,]<GGI70:OX=N
M[[Q+IVM66J"UDM89;=XY+?S5='*DE?F&U_E'S<^X-8UA\/[NPTW0+(:VDB:-
M?/=QE[/E]V\;3AQCB1N?IP.E #'\5>)5T?Q.([33Y]7T*< I&CB.XB,:R?*-
MV0VUNF3DCWXW['7'U74--73Y;>:RFL1>3R[#G#8$>WYN-WSGG.-AJAY=IX*O
M=<U_6-5C%KJES$Q M6'E,$$:C(+$Y"CL.:E\":#!H>BS-!'+$EY<R7$44V=T
M,)8F./!Y4!3G;V+$4 =11110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !117'_$:2YAT/3Y+2]N;2
M0ZK:1E[>0H2KS*I![$8/0Y% '845Y5K.JZCX1N?'"Z;=7EPMMI=O>0)<SO/Y
M,KF16<;R3C #8Z<=*V;_ ,[2/$'A.32KZ\N+?5'>VNHY+EY1,AB+B4;B=K#;
MG(QD''I0!WE(Q(4D#) Z#O7CA:_C\ MK2ZUJO]H6FO-!#(;QR/+-[Y15E)VN
M-I_B!_+BNJLH);'XB:KHL5_J#V5QH\=V5FNY)&24RR(60L25R .!@<=* .PT
MVYN+S3H+BZLI+*>1<O;2.K-&?0E20?PJU7D>FW>HWWA;X;RR:MJ"RWUP8KJ1
M+E@TRF*5CN/<Y4<GD=JN1WCZ=;>*=)DUC4H[>WUFVM[-A*TUP?-6)C"KNV1N
M)89+?+N)SQ0!Z;++'!"\TKJD<:EG=C@*!R2:JS7LRW-@EO927%O<EO,N%=0L
M"[<@D$Y.3@<>M>6:XUU+X>^)FFW;S+!9V\4L$'VMY1$6@W$!C@D$C)7IG/6N
MCO%DT_Q+X"@M;R\6"=[A9HFNI'60"V=AN#$YP>1GI0!WM%>5OJ5[JGP[\0^)
MAJ%U:ZQ87-V\82=@L!A<[8C'G:054 @CG=GTJY'!=:YXTU*TO;[4[:"30[6Z
M:U@O)(A%*S2 [=I!7&T< X..<T >D45S?P_U"ZU3X?Z%>WLS37,MHADD8Y+G
M&,GWXKD)M.NM6G\=!_$&KVYTVYWV;17KH(6^SH^>#RN2?E/'7C/- 'J=%>5:
M=_:/BG7]#AU'4]3M1?\ A<75S%:W30_O=\0W #[IYSQ].A(-J.YN=;\/>,KZ
M34;RUU#2KRZAM6CN&06ZPH#&2H.&W8W'<#NW$=,8 /2Z*\PL#?>*/%6GP:CJ
M&I6D5[X9AO;BUMKIX0)F< XP<K^&.F#QD&GH.MZL\_A[P]J5]<S6LFJ:C9O?
M&0K)=);Y$8+C!Y.<D')V8YR<@'K=%>:R2:]'J'BS0=+O&DCM9;*>Q^UW# _O
M#NDM_-^\ P4@'.1O^E57\5-%I@MU6_TNXEUR"TU"WO[AF-F'BR DH)_=L4&&
M!'WSC'% 'JE8P\0)_P )C_PCIM)ED-B;T7!*[&4.J8 !SG+=\=.]<7KLNK>$
M+'42=:S;W]Y9QI&'=VTZ.1]DCAW).&P<9X!SBM&UT^'3_C+&L$DY5_#[G;+.
M\N")T&06)(SW_/KF@#MY[B&UC$D\BQHSK&"QZLS!5'U)('XU+7$?$NUCN;3P
M[YAE&->LE_=RLG#2 '[I'/H>H[8I+(G7O&'B71+JZO88-,AM8K18;J2-@KQE
MC+N!RS9XR2<;?<Y .XK&T3Q FM7VKVHM)K=]-N1;/YI4[R45\C:3QAAWJC\/
M=3U#6/ VG7FJ/YEV1)&\N,>:$D9 ^/\ :"@_C7(MH_\ :-[\0+D:KJ%A+:WG
MFPR6MRT2HZVT9W,%QN''1LC'IUH ]5HKR_2M5U7Q9=P:7J%Q]ENGT&TNUC$\
MD#/)(&\R0;""2"$X/W?QKO/#D=W#X>LX+[45U&ZB0QRW:+M$I4D9QZ\<^] &
MI17CNHF]3P9XVU1=8U47>DZO/]B<7L@$87RR%(SAEY(PV1CH!DUO7\S>'_&L
M@_MF^AM+G0;J[N9+B9IECDC9,2JA.%(#'Y5 !]* /1*QM>\0)H+Z6LEI-,+^
M^CLE="H$;.< MDYQUZ _A7$:=J>H:5XCLF1KR6VE\.37?E7-TTCW+QF/;(RD
MD(S;CPI/!YZ8JI< :GX5\ Z]+>W%Q>7FKV4T[F=BC.Y)9=F=H"G@ #C'N<@'
MK=%>9!]4\3VVNW-OK:Z9>Z;JDL8E,TF+9(G^4-$"%9609.1SN/H,=[KETEEX
M>U"ZFO#9)%;2.UT$W&'"GYPO?'7'>@#0J*WN(;J+S8)%DCW,NY3D94E3^H(K
MSW0GN_\ A-K3399;U;"\\/M,\<]Z[R2,)(U$K<GRW(9ONL>O7CC0^$MO'#\-
MM(D5I2TL1+!Y6<#YV' )(7\,4 =O17F7CJ^N!%XMGT_4+Q[G3;*)QLN&@CL7
M"EQMVG]X[9!((QC SSBO1K9VN+"%W)W21*21QR10!/17C;M?Q^ 9M:76M5^W
MV>O-!#(;QR!']M$6UE)VN-I_B!_+BM'Q!J5]X0UOQ*FG7M[+$N@I?!;F=Y_+
ME\YD:1=Y./EYP./EZ4 >IT5YUJ"ZIH-I>^(].UA)K<Z1/)%9^=)<+<2*A=)5
M+L<8[XX((]JM:5IMS=W>D:I'KV[3KVU>.:%;F63[9N3<K*2WR.N"<KCC(XP*
M .KNM2==/%UIUJVHGSA'LAD5?X]CG+$#Y>3^%:%>-::LFG_ _1+RSO+R"=KN
MVW%+J3!#700KC. ""<@<&NBO+.74_'?B:PFU34X[2/2[>>.*"\DC"2$R_,NT
M@C[HX!P>X- 'H=%>::;JVJ7^C> +B\GN9[.\M7-_Y!8RRR>4-C,$^9ESNSCC
M)7-=%X)M-1L=+NY-6N+MC->R_91>3,[K;[R(@=QX8KCWZ9YH ZFBL[7[V?3?
M#NIW]M'YD]M:2S1IC.YE0D#\Q7(:-%=R?V%XD3Q$BV4ULQN5::25;S='NSAC
MM1E*LWR@8 (Z"@#T"BO+]%OKR/Q%X-DAO;VXM-3MKHR3W-PVZ] C#K(8LE8^
M>5P<@'! Z5?\+2-XD\-Z+XDFUN[MKXWA:Z59F*.2[(;8QD[0,E0.,\ ]230!
MU'A[Q GB!=2*VDUL;&^DLG24J260*2?E)&/F]:UI7:.)G2)I6 R$0@%O89('
MYFO'+])K3PMXZUNUOKVWN[#7Y9;?R;AHT# PYW*I <$'!#9&.F.:]FH P?#/
MB[3O%4-X;)9H;FQG:WNK2X"B6%U)'(4D8.#@@D<>QJ[I6K#5?M1%E<VWV>=H
M#Y^SYF7J1M8\?7%<!-H-_:VJ^,/#<6[6;2ZO$N;4<#4+?[3(3&?]L=5/KQZ4
MQ?%@NO"UAJ&FRS06>L^(TMI9N4>*)V^89_A.5V9[9X/0T >IT5YUJKWNE>*-
M8TFSO+S^SY] EO@#<.S6TZ-M#(Y)*A@>F>JD^M9UG%=^7\.KG^V-5\W5[58K
MXF\<B5?LI?[I.%.5^\H#<DYSS0!Z9J-S/::=<7%K9O>SQH62WC=5:0^@+<#\
M:LH2R*64J2,E3V]J\FU"XO;'P5\0[2WU/4%&E7+?8Y3=.TL2F&-]OF$[B,L>
MI[UN74$VH?$FRT^74=02RGT&2:6"&[>-682QKGY2"IP>H(/O@D$ [ZHI[B&U
MC$D\BQHSI&"QZLS!5'U)('XUYGH&I7%[X:\,6EUJ=[<7<E[>PK;B4JUXD+RH
M/,ER"%0!6)Y)P.#FLN4SZGX1T9=0N+B62U\8+:(WVJ0L$%T5 WY!; X#'D=L
M4 >M?:KG^US:?89/LOD>;]LWKLW[L>7MSNSCG.,5;KBE65?BC-IJWM[]C;0%
M<1&Y<A7\XKN&3PV .>M<IH4]_%X:^'^N/JVI37M]?I:W)FNG9)8W67(*9VDY
M4'=C/O0![!2.2J,P4L0,A1C)]N:\QU8:_J$/B>VMI=0_MI-31--EMI)!"D)$
M9"EE.Q< N7#<\]_EKTN"(001Q!W<(H4-(Q9CCN2>IH XY/B7I_\ 9=QJMQI&
MK6^FVMTUI<7;I$RPNK;265)"VW/&0#79HZ2QK)&P9& 96!R"#WKR?PQX<NO%
M/A#7](?4DM=.N-<O!<+';[I6439(5RV%SCKM-:LT5WKNM^(O#MI?FP;3(H(;
M()<2QM"AA5A* I&[YB1SG[N.YR >BT5YK]AN]8\;6VEW?B#46@E\.QW$LEC<
MO LDHE \U #\N<9X_EG,D>H7NF>+H(=;2\:VN=3D6PU.UNF>"3.]5MYH\X4K
M]T'!!9<]<F@#T:BO)GU;4+_X5WWB^.^NH-<MIYI0@F;9&8YBH@,>=I78 ,$9
M).>O-7YK>YU7Q7XKMKG4=4@ACTNUN(X(;V2,0RL)22I4@C!4<#@]P>* /2J0
MG ) )]AWK"\$WUQJ?@;0KV[D,MS/80R2R'JS%!DGW-<O;ZC>Z=XOMH-;2\,-
MSJ4PL=3M;IGMYMV\+;RQYPA4<#@@E,^IH Z[PYKZ>(K.ZN$M9;;[/>36C1RD
M%MT;;3T)'4>IK8KQDI-8^$];URUOKV&[M/%,WE+'<,D>&O%1@R A7!#'[P/M
MBM/QQJ5S%9^*K_3-1O))]-:WPXG:&.R8!"8T4']X6W9;( PV,G&* .Z;Q"J^
M+_\ A'?L<WFFP:^6?<NUE5U3:!G.<MWQTIN@:Q;>*](DN7L6CC6YEMVAN K'
M=&Y4YQD=1[UD2?\ )9K3_L7IO_2B*E^&O_(N7W_87OO_ $H>A.VJ Z7^R=-_
MZ!]I_P!^5_PH_LG3?^@?:?\ ?E?\*Y624^(O&?B/0;F^N;3['9P?8UMYVB8>
M8K%IAM(W$-M'.0-ON<PV5U)J?C.+P]>:C<7-I;:)%<1RI*T)O'9RC2DH1G&T
M8 .,L3Z5?M)]V*QV']DZ;_T#[3_ORO\ A3DTS3XW5TL;974Y5EB4$'\J\L34
M-8FL-'MI]4O@;;Q;)I2W*3%6N;=?,P7[,<J!D]U]:MR:?*;OQWIHU;6!:Z;#
M'<V:C4)=T4CP%B=^[>1N7(4DKR>*/:3[L=CU*L;Q'X@3P[:VMQ):37"7%W#:
MYC*@(9'"@G)SC)[ UQ%F][X@U[PI#=ZMJ,<.H^&S<W4=O<M$))/W//R_=/S'
MD8/;.":S99K\>#KC3[Z[GO$TWQ;;V=M<SMNDDB6>(C<W\1!8KGVJ /8J*X#6
M-1F\'^-9;JXGO+G3M9M62U@>X=ECO$R1$@)POF \8[KQUKL-'L)-.T:ULY[F
M6YFCC EFED9V=\?,<L2>N<>E %^HKJ62"TFEA@:XE2-F2%2 9"!D*"> 3TYK
MR?5Y-7M8/$?AFTOM2EUFWNEU'3'-]*&>V*[RA;=DJ/+DC^K+T)S6_)J*^(/"
M6N>)=/O;V&V;2RMF8[EU"LL9=G !QN#$(3US&?4T =I#>J8+(W2?9;BZ48MW
M8%@^TL5R."0 >G'%4-!\0)KLVJQ+:36S:=>-9N)2I+$*K;AM)&/F'>N(^S+?
MZ]\-+BYFN6EFTR8R.+F12Q$$;9R&')).3W[YK+U.&6'0_B+JUM?7MM=6&JO-
M;FWN&C576*$Y8*0'STPV1CL* /9**B$RK:>?(P11'O9CT QDFO,]%O[Q/$/@
MN6&_O;BTU..Z\VXN)VS>@1[UD,.2J#."N#D XP.E '2/XZBC\.^(-8.E7>W1
M;F6WF@W)O;RU4EOO8Q\WJ3Q^%=3;RB>VBF P)$#8],C->577_)/?BC_V$;W_
M -%1UZAIW_(,M/\ KBG_ *"* +-%>5IJ5R+[PSJ-CJ-Y<VU[KDMN]Y+.RBYC
M(F^40Y*A%V  \'Y<XYS5>>ROKW0/'%__ ,)#J\%QH^HW3V3+>.%B\N)' (S\
MRGI@Y &< $G(!ZY6-KGB!-#N=)ADM)IAJ-ZEFLB%0L;,"06R<]%/0?E7%V<-
M[XE\7BSU'4]4M8KCP[:WDUO;73PA)G=@Q&#E>@X'7'.:S[:\U"\\+>#/[2N'
MNI[?Q2+9;F3[TZ1F=%<GN<#KWQ0!ZE!=7,FI75M)8R16\*H8KDNI68MG<  <
MC;@=>N:MUYEK&MZGHFI?$6ZM+F>5K+3[6:VCE<ND+,LFYE4\ =\>U;KV]GIL
M/]MP>)KN*SDTR0GS)6G1\+O^T88GE1GIP<@>@H ZV5VCB=UC:1E!(1<9;V&2
M!^9K,\,Z['XF\.V>L0P/!'<AF6.0@LN&*\XX[5QWAVZO8/&NB6_GWAL[W1))
M6%U<M(T[*T6)60DA&.X\ G@X/3%<UI%I>:9\+_#OB+3=3U!=0BNHHEM1<-Y,
MZ/<[#$8ONG(8G.-W'7T /4],\0)J7B#6=(%I-#)IGD[WD*D2>8"P*X)XP._/
M/2MFO+]5U6YT35_B5J5GQ/;VMBR,%SL_=L"V.^ 2?PKH='TV[M_$%KJ,6MH^
MG7=J5^R">2<3GAEE5G8X('!(X.1[4 =?1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5'5-'L-:
M@CAU" S1QR+*B[V7#J<JW!'(/(]*O53U#5=/TE(GU"]@M5ED$49FD"[W)P%&
M>IH A70-,74;B_\ LVZYN8A#,[R,_F1CHK D@CD\8[GUIFG^&])THH;.U*>4
MACBW2NXA0]5CW$[!P.%QT'I38_%&AS6 OH=4MIK9G=%>)M^XK]X #DX[_G5@
MZUIG]G0Z@+Z!K2?'DRHX82D] N/O'@\#TH I?\(?H1TQM.^PG[&TWVAH?.DV
MF3=NW?>Z[N?KSUJR?#^FMJ4FHF&3[9)!]G:;SY-QC_N_>Z9R?J<]:C3Q3H4E
MJUTNJVI@6<6S2>8,+*<80GLWS#@\\U9?6-.6YN;1K^WCN+:+S9D=P#&AZ,<]
M![]* *47A'0X;>P@BLBD6GN7M$6:0"%CW7YN.I_,^M)<>#] NX[Z.XT]95OI
M%EN=\CGS'7&UNO!&!@C!&*BL/$6F6.B:<^I>);*[DN$)2\)2(7.,DLJ@XP #
MTXXJRWBK0ETZ'4#JEL;2:,RI*K94H#@MQT4'@D\"@!D7A#P_ UXT>E6X-[#]
MGN203YJ8QAL]<CJ>I[T^/PKHL1T\QV6TZ=DVI65QY1(P2.>21P2>HXI]QXET
M.TE$4^K6:2&'[0%,RY,?&&QZ'(QZYXJ%/&'AR7[#LUJQ;[<0+;$P_>$D@ >^
M01]01UH D?PQHTE[-=M9#S)W6290[".5UQAGC!VL1@<D$\#TJ5M TUM2N-1,
M#B\N(A#+*LS@L@Z+P>@R?IDTNH:]I6E/LO[^"W/RD^8V @)P"QZ*"> 3C-0W
MOBK0-.EGBO-8LX9+=0TJ-*-R ],CKS@_E0!;TS2[/1M/BL-/A\BUB&(X@Q(4
M>@R3@>U<IH_A5IO$7B>ZU?3I5MM1N4DB!N/DEC6-4VR(CX;E2<,",'W(K7U#
MQEH^GWVCVKW22?VKN:&1#E/+",^_(XP< #US[&M$ZWIJWRV9O(Q.TGE*OJ^,
M[ >F['..N* $;0].;68]7-N?MT<7DI*)&&V/KMQG&,X.,=:AN?#&CW=[/>36
M0,UP%6XVR,JSA>@D0$*^.GS \<5K5G6NO:3>W:VMM?P23NI>- W^L4=63^\!
MW(SB@#GKOP_<7WQ,759K.==/32OLBW$5SY3"3S"_\#AMN./KV[UOW'AW2+G3
M(-.DL8OLMNRO B90Q,O1D88*MUY!SR:YE/$-YXB\1:OINCZS%92:=+"D(,*R
MI<90/)O!&<8.T;2I!&>:Z'Q+XCL?"^DF_OF.TR)$BCJSL0 /8<\F@"1O#NE/
M82636I:*659I"9'WO(I!5R^=Q8;5P<Y&!Z4DOAK1[C3KNPN+&.XMKP[KE9R9
M#*0  69B22 !@YXP,=*P+CQ:+'QYY%WJEO'H3:.;Q2RA<2>:$SNZGC/'OTKI
MO[9TTZ;#J"WL+VDX!AE1MPDR,C;C[QZ\#TH I6GA#P_8Z)/HT&E0#3[C_70N
M"XD_WBQ).,#'/&!BC3_"&@Z7>PWMIIZK=0Q>3'-)(\CJF<[06).*T=/U&SU6
MT6[L+F*Y@8D"2-LC(."/8@\$5S?BC5]5L/%?AK3+"ZBB@U66:*8O"'*;(RX*
M\CTP<YH Z'5-)L-:LC9ZC;+<0;U?:Q(PRG(((Y!![BJUSX:TBZN(KA[3RYHH
M?LZR02/$WE?W"4(ROL<BHHKBZTVXNYM3U6VFL880SL8A&T+9SEB"1@@Y]L>]
M6[77=*O7M5M;^"8W<;2V^QL^:@."R^H''/N/6@"Y!!%:V\=O;Q)%#$H1(T4!
M54<  #H*S)_"^C7-[/=RV0,MSC[0%D94GQP/,0':_ Q\P-3'7M*^WI8?;X!<
MNYC1"WWG R4!Z%AW7.:YGPWXRA#ZG;>(-8M$N4UF>RM0^V/<BE0H ^IZGN:
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MM636K(Z>LGE-<>:-BO\ W2>Q]CZUHMJ-HES;VS7"+/<J7AC/#.!R2![9'YT
M6J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2\VD^&O"&HWEGJ+:992W\%ZELLJRVQDE)CD*IAMH Q]']Z]H) QD@9X'O2T
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MIL8]ZZ'Q59#3X?!=JN^9[?6H99Y%0GCRY=\K8Z LV23W:N]I-RX)R,#KSTH
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MJ1UZC'6MU]6BT?QKK#:W87LNF:W9VZV<BV4LH8*K*\#*%+*26)P1_$:]'HH
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MQ6D&[RXQC+G+,2<EF/<DDDGN2: +-%%% !1110 4444 %%%% !1110 4444
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M\>5&'FNNY491R >0#WQTI^LZ-=WEY>Z_J$<4'V32+BVMX8Y"Y)<9=R<#CY0
M/<DXZ5F^&M&OM?\ !O@A+N*"&RT^.UOMZ2EFE*1?NP!@8Y()Y[8&<Y !L77C
MF*WTF?74L7FT*WN&@ENDD^<!7V-(L>/F0,#SG. 2 13I_&-TWB*[T;3M N;V
M6VC@F,BW$:*T<C$;P2>VTG'4\UDP^"]6MO">I^#D>V;2KJ6407AD/F0P2N69
M2FWEAN8 YP<C.,8K9TO0;[3_ !OJ.I^7;+IL]E;VL069C(OE%^2NW&#O]>U
M">"]=U374U:34;:&%;?49[5/+EW;?+;9M^Z,]"<]\]!6]JFI6NCZ7=:E>R>7
M:VL32RMC.% R?J:Q?"FBZEH<^LPW7V5K2YU&>]@DC=BY$K;L,I "XY'!.?;'
M.AXFT.+Q+X:U'1II#$EY"T7F 9*'L<=\'!Q0!07Q4]OJFEV>IZ<UFNJ@BTE$
MH<;PN[RY!@;6(SC&X'!&:Y[0[(^*?$?B0:[IL,HL]3C$$HN#OMC'%&RJA !
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MIMS)-,)92K,&B:/"@*<_>SR1TH KVWCJ!M,O9[VPEMKVTU!=-:S$BN9)VV[
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MHI;?!4NI4#!91T)XJ^UGXOU?PYJ=IJT>DP7,]E):Q1VTSE)'=<>8S%<J!V4
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M6N4'B/\ LR,0IMW6+LYN&Z;CN4;!WP,Y/< 8(!T5%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M1W%Q#:6TEQ<S)#!$I>221@JJHZDD]!4E>?\ Q8D?^S?#MK(<:?=:]:0WW]TQ
M;B<-[9 _(4 =&_C#1XK/[9-)=16A *W$MG*D;9Z88KCGC'KD8S6[4-W;07EG
M-;7**]O*A21&Z%2,$5R<6IZIXBU#Q+!IVHM8'2IA:VZK&C!Y/+#EI-RDE26
MP". ><G@ [*CI7F-IXIU_P 3R^$C8Z@NEIK>FW,TP6W60QR1[!N7=U&6. >U
M6$D\7ZEK'B;2;;Q*D$FEI;>1*+&,^8[0[B&!R I/7OTP1CD ]&IJQ1H[NB*K
M.<N0,%CC'/KQ7GOAKQE?^+[G1[$2MI[SZ*-2N7@52S.9/+ 7>& 7(8]">5YZ
MYI2^+/$3:;';K>11WUIXFCT:>X^SJ5N8V9<.5_A)5AD#OG&* /3TBCC9V1%5
MG.YB!@L>F3ZTI8 @$@$G R>IKAM2GUW2W^P2>(I+J9+&:=?L]K$+EWW_ "LZ
ME3&L:KQGY=Q_*LI-0U'7M5^&]]+J-Q;MJ%G-/-' $V>8( 2P#*>NYASG /&.
MM 'HEMJ,-W>WMI''.LEHRK(SQ,JL64,-K$8;@\XZ&K=><ZEXSU/0D\=3SS)<
MC29[6*S5HPJH9D3&[') :3)YZ"M6]U#5M#\7:'IKZA)?6FL+-"6EB0-!,B;P
MZ[%&5(!!!SCCF@#L:S(O$&F3>(9]!2YSJ<$(G>$HP^0XY!(P>HZ'C(KS[3O$
M?B4^'/#>NW.L"4W6LC3Y[86T:I)&UP\62<9## Q@@<<@\D^E26B"[:^ WW*Q
M&./>W"@D$@>F2%R?8>E %JBN%\'^);K4]833]5O+NUU>*T8WFEWENB9DW+^\
MA95^:/[X^\>"/K5WQ3J&K6WB;PS8Z??K;0:A/-#.#"KDA87<$$]""/\ '(XH
M ZVBO-8_%VK:=87]A<WGVJ\3Q'%HUO>R1*I5) C;V50%+*&8#@ D#(K2O=7U
MC2/%-QHAOWN8;K2I;VUN)8D\R"2,@,I"@!E(8$9&0?6@#N*KW]['IVGW%[,D
MKQP1F1EBC+N0!GA1R37G%GK?B9]/\#Z@^MASKBI!<PM:Q[%+0,XD7 !W KZ[
M>>@J>XU_7M/T#QW!_:IGN]"^>UO)8(]Y4P+*%95 4X)(SB@#T6*030I*H8*Z
MA@&4@@'U!Y!I]<+/J6N77BW1=+@U8VUM?:1)<RE+=&<.IC&Y2P(S\YZ@CV-4
M=*\7:O<:5HUA/*TVHW>HWEE)<Q)&CNMN9.5#?(&(5>V/O8'2@#TBD95=2K*&
M4C!!&017 R:UXET>."PU,[Y;_51;65P#%YP@,;O\X&(]_P A4'H<@X.,&2XO
M/&6F:=JKR037L4=S ]KY?E->&W)_?#:HV%EP=O'(/J* .GT_PSH.DW376G:+
MI]I<-G,L%LB,<]>0,UJ5SW@_68-=TRXNK;5'OXA<,@\Z(12P85<QR*%7# Y[
M="*R)-:U4:GXZM!?N$TRUAGLV\N/,1:)W(^[\PRHZYXH [BL[6]<L?#]@+W4
M'D2 R)$&2)G^9F"KG XR2!DX%<9!K>OZA?>"[=-5%NFL:0]Q=,MNC-YBQQ-N
M7(P#ESQC'L:R]8U2_P!2^%>K)J5P+FYL==2Q-QL"&41WT:AB%P <8Z4 >L45
MQ.I:MK>JZSKVEZ+)-!/IB1)$T?DE6E>/>#)YF3LY PN.C<],4->\3ZSI @_M
MF:;2H)M/C U"SA6>VAO#N#B4E6(3.S!X&,\YZ 'HM%<#XA\4W6EZ])#>WMSI
MFG3K#_9^H1PI):NQ^\LK;24)/ / Q@_7K=?FU&#0+Z7281-J"0L;>,D#<^.!
MSQGTSQF@#1HKR^^\9W$G@SQ+J>E:S>I?:;!&YM+ZUC2XM9,G*NNP JPQ@\]#
M@UOZGX@O=+\:1P-,TFG_ -B7%]);[%^_&R8P<9Y#'C- '8,P52QS@#/ R?RK
M/T76[+7[ WVGN[P"5XLO&4.Y&*MPP!'(/6L30I==U*TT#7/[7A:TO8!->VKQ
MJ$ D0,@B(&[*L0/F)R/>N,TF^U;1?"J:K9ZCLMU\22P26?DH5E22\9&W,06!
M^;(((Z<@T >OTC,%4LQ  &23VK.\0S:C;^'[Z;2(1-J"1$P1Y&6;T&>,^F>,
MXKS?Q%XB.M?#CQ5+9:WJ"2VT,:RVES D%S;,20R2 (/E8$<CT(S0!ZU17(G4
M;V;QA'X6CU*XC$.F?;I;K9%YLI:0HJCY-H P<X7GY??.-IOC+5+JXM=!NIEC
MOSK5SI<M^D8&](8S+O53E0[ JN,$ DG'04 =KK.N6.@6L5S?O(L<LR0*4B9_
MG=@J@X'')')P*LZA?V^EZ=<7]T76WMT,DA2-G(4<DX4$FN!\;Q:K9>#KM-4O
M4OE75[-[5D0"7R3/'A7  !;(8 @<C'>K\>IR^(?!&N:VM^[6MQ9W"Q6.Q1]F
MVH05<[=V_(.1G S@9QD@'8:??0ZGIMK?VQ)@NH4FC+#!*L 1D?0U8KS7PW?Z
MMI;^ ;9]1,]CJNF^6]J8458C';JZLK ;L\8.20<\ 4V7Q=K$GPW_ .$\MKL[
M5D,YTXQIY30"4H4SC<'VC.[/WNV.* .[@URQN=>NM%C>3[;;0K-*K1,H"L2
M02,'H>F>E&H:Y8Z9J&GV-TTBSZA*8K<")BK,%+$%L8' /4UQM_JR:+X^\3:P
M\;.EIX;AN#'T+;7F;'MTJOJ2ZA/J'P^U&\U)[AKJ^$LD(C18U=K>1ODP-V!D
MCDG/'>@#OY](TZYU"'4)[&WDO(,B*=XP7CSUVMU%7*\^M=:\3Z]8P:SHY*Q_
M;G5[>8PB VZ2LC G_6!\+G.<9[8JUH=QXAU;Q3K<4FN".STO4UC$"VB?O8S"
MK%"W4<MP1SU_  Z74M<L=)NM/MKMI%EOYQ;V^V)F5G()P6 P. >I[5I5Q7Q"
M65[CPDL,BQRG7H@KLNX*?*EYQD9JG%K>M6D/B_3IM:@:?2KF!;?4+R)5VI*B
M,051<,PW,%PO)(&#0!Z#17G]KKWB&2Z\7V%F)[JXL+:WFT];N...4F17R#M
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M?0(I)(I4#*[>?(-S*>"<8Y/3BM/X6RM-\,M"9I"^("@).>%9@!^  'X5TO\
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MBALF!3$SK"Z$#YN.6'7% '0:=XSTK4]1LK*%;M'OK<W%K)-;LB3* "P5CP2
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MNDO:FX&W:)#*K@8SG& ><5%XGM'U+QSX1MX1G['-/?3L/X$6/8,_5G _ ^E
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MZEIGC*^O;GPO'XAL=4AA&Z%8MUO,B;"I$A'R,,'.>*[O38#:Z;;0&WM[8I&
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !02 ,DX HIDL,<\3131I)&XPR.H((]P: &V]S!=P+/;31S1-G;)&P93
M@X."/<$4?:K?[6+3SXOM)C\WR=XW[,XW;>N,\9KA/ .J6F@_![3;^[=8[>".
M0<L%R3,P503P,D@<\<UGZ#J&GM\7?/;6+&ZN[S1?WC0W*NOF^?Q$G/\ "H
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M6FEJOA]RQ$AD;SHQ$)2.,8;!Z]/8]:OV_BG5%\1Z-;7UO9KI^LVLL\'E%C)
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M&K.L:ECU9B H^I) H XB\^'U]<P:G;1^( EO=ZFNJ1AK,.\<H=7VLV_YD^4
M#@CCD@8K1/A&\^V^)+G^UHB=;MHX"&M#F+8A0-PXW$AB>@YKH%NK@ZM):&QD
M6V6%9%NRZ[6<D@IMSG( !SC'-6F)"DA2Q Z#J: /*M?MTTFY\/:'>>(;+3QI
M>G!([K4=.#VUPW"#;EP%D"H<_-T?@<G&K#X?U#Q)H5MC5+:TN]*NA+I6IV%F
M8HRNS!'DLQ!0AF7@X../?J?#>OQ^)-*:^CMI;8+<2P&.4@L#&Y0YQD=1ZFMB
M@#-T:PO[*W8ZGJ7V^\D(WRK$(D '150$X'7J223UZ ,CTNZ'B:359KR*2'[.
M+>&W$!#1#=N8[]W)8A<\?P+^,>K>(1I;2;=-OKR.!=UQ);HI$0QGN1DXYP,\
M5IVEU#?6<-W;.'@F021L.ZD9%2I)NQK*C4C!3:T9S[^%;C_A.W\20:A%'%/:
M+:7-F;8L)E!)#%MX^89P#CIQS57PYX.U'P]Y>GIX@DFT*VD+VMF;<"5!G(1I
M<Y90>V 3P,XX/0-J\*Z]'I!BF\^2!IPY7";5(!&>Y^84^]U."RFA@*O+<SD^
M5!$ 68#J><  =R2!^=',@]C4NE;=7^7<SO#WAZ;0;K56%^)[6]O);Q(?)VF)
MI#E@6R=PSTX&,G.>,4-7\'76HZUJE[!K'V>#4]/%C<0M;"1E WX,;%AM^^<C
M!S['D:NJZY+IJ1)%I5Y?W;J7-O:A244=V9B /89R>< X-2Z#KEGXBTF/4++S
M%C9F1HY5VO&ZG#*P[$&MW1J*G[6WNF-];&)8^#KRTOO#ET^KQ2G1;-[0*;3'
MFAE52>'^7 1?7O5*3X=S/IDL0UD1WZZP^L6EU':X\F5V)*E2YWK\Q&,CBNGU
M77;?2;W3;6:&=VO[@6\3HGR*Q!/S$GT4],U)K&K)H]HLQM;F[D=PD5O:H&DD
M."3@$@< $GGH*%1F^6R^+8+HRM(\.:A9>*+S7;[5(;B6[M8K>2&&U,2#RRQ!
M&78_Q'@Y^O:FZUIKVWB_2/$L2EHX(9;*\"C)$3X97QZ*ZC/LQ/:MK2K]]3L$
MNI+"[L2Q(\F[55D&#C) )_G5VHE%Q;B]T,Y34O#_ (BO=<;4[+Q1;VT6S9!"
MVFB41+W(8R#)/<X]!4?B?2+K5O"L7A:2Z>[NKTQI=W10+B(.&D<@<+D JH]2
M.P)'7T5(%6_M9KG3+BUM+DVDSQ%(IU7=Y38X;&1G'I7-2^!8;V;6[B]GA2XU
M?3_L$[6=OY2D?-F0@LVY_FZD\ 8YK7\/>($\0)J+):36QL;Z2R=)2I)9 ,GY
M21CGUJI=>+5M_%#^'HM&U&YO5M/M@,1A"-%NV9!:0<[N,4 4K'PAJL>LZ'J=
M_KL5Q+I=O+;;(K+RUD1P@S]\D-\G)R0>P'=MEX%D@T.+P_<ZDEQHL5R;@1"W
MVRR#S3*$=]Q!&_KA1D#''?<\/>(K#Q-I\EW8&4>5,]O/#,FR2&5?O(P[$<5K
M'I0!RNI^$9M9N8?[0O8)H+>_6]MG^S8G@VN'\M9-W0D8)QT)'H17M/!>I:;J
MM[_9WB*2WT2]N&N9K VP9T=SEQ'+G**QSV.,G&#S6UX>\0)XAAOY$M9;8V=[
M+9.DI4L6C(!/RDCJ?4UL4 >;^*/#5UH>B^,+ZTUQ;?2=0MKBYGLI8 Q$[1$'
M9(6X#$#((/MC-7],T*?4K;POX@TG58;>:#2EM)-T'G))$P0D###:P9.O(]17
M<UD:UXAMM#N=-@N(+ASJ%VEI$T:957;.-Q)X& ?7I0!S*?#FXAT&TM;?7Y(=
M2L+Z6]LKY;<9C,C,61DSAU(<@]/Z5?U'PEJ>K:)%:7VO++>"[ANI+C[)A/W3
MAE1(PXVC(Y)))R?;'4W5S#96LMS<2".&)"[N>@ ZU0\.:[;^)=!MM7M8I8H+
MC=L24 ,-K%>1V^[0!F3>$I;K7=8U"?4$,6IZ<M@\*6Y4HHW_ #!BQY^<]O2J
MA\%W[Z-X=L)=:A=M%N8IUD^Q8$@C0HJX\SC@DDY//H.*[*L_7-7@T'1;O5+F
M*>6"UB:618$W-M49/' Z ]30!RU\FC^,?&>G"SDEDN-#N)1?.J,BJ!C$+$@!
MLR!& &1B,^M=P<[3@@'L2,UEW.OVEGH=MJDRR;+D1"&)0"\CR8"(!G&XD@=<
M>^.:;I^OQ7FK7.DS6\MIJ%O&LQAE*G?$Q(#J5)!&00>X(^F0#GW\!74GAG6M
M'?6E#:E?O?K-':;?+=I%DVE2YW+E<8XR#5RU\)ZC!K6J:K+K<<D^HV<=O*@L
M]J*R;P& WYVX<_+G.?XNU;^G:E%JD3SVP+6H8I'-GB7!()7_ &<C /?J.,$N
MU"]&GV;W;12211#=*(QEE3NP'?'7 YQG&3P0#EE\#7,?AWPUI*ZM%_Q([F*=
M93:$^=Y8(4$>9QPQR<G\*LZIX1FUJ>(:A?03007Z7MNWV;$\&UPVQ9-W )&,
MXZ$CT(W+K5K.UT^*],HEBF*+!Y1#&9GQL">N<CV[GCFLC7/%S:*'VZ'J>H"W
MC$EVUDB,MN,9P2S+N..<*"<8)QD4 :/B314\1^&]0T:29H5O(&B\U1DIGH<=
M_I65-X5O7U'2M9CU6,:S8PO;RS&V_=7$38)0H&R,$ @[C@]<UI0^([">TTV^
MC<M8:B$\BY_AW/\ =5NZD]![\<$C.O0!E:'HB:.+V5I1-=W]P;FYF";0SD!0
M ,G"A5  R>G7FL:X\(:C#XGO=6T37CIT6I!#?6[6JS!G4;0\9)&QMH Y!'?!
MKKJ* .:;PM-9^(VUK1[Y+>::U2UNHKF(S),$^X_#*0XR1G)R#^-5#X%$5OH4
M-GJ"Q#3+YK^1I(-[7$K[]Q.&&W)D8]\<>E;7B77$\-^';W6)+66YCM(S(\<1
M4-@=^2/\]JTXI/-A20# =0V/3- '*R^#[J23Q4_]J0C_ (2",1D?9#^XQ%Y7
M'[SYOE^G/Y5S]A;W&G?%"RTJVU6R:YM/#4=LQDA)$FV4X^4/D-@ ]3W]>.VT
M[Q#;:GKVJZ1%!<1SZ:(C*TJ;5;S Q7;SD\+W IFO^)K'PZ^G170D>:_NX[6&
M.,9.78+N/HH+#)]P.] &3/X%)TK3+.VU%8Y+35!JL\TEOO-Q-O+MP&&T$L?7
M P*K:JFC^,/%NFVUK)++=Z'=NUZR(Z*B;>8F)&&#/Y9QSD*?2NYHH *YJ?P5
MIUUKNL:C<,[QZI:"VFM_X0=I5G_WBFQ?;;[U>O?$-M8^(],T22"X-QJ E,4@
M3]V/+7<V3GKC'0'K1>Z\EOJ3Z;:6<]]>QP"XEBA*#8A)"Y+$#+$-@>QSB@#-
MD\'$_#M_"D>H$-+:FWEO)(M[.6'SOMW#DDD]>*?-X7NGUG1=4BU1(KC3[5[2
M4?9LK-&VPG +?(<H.?FZU>M_$^F77A^WUJ"5GM;G:L*A<.\A;:(]I_BW?+CL
M0<]*UHRS1JSIL<C)7.<'TS0!Q,_@&ZG\,ZSHS:S"!J>HM?M*+,_NR9%D*@>9
MR,J!G/2NGUK2CK7AZ^TJ6Y>$W=L\#30C!4LN"0,_IFI)=3BM]4@L9U,;7(/V
M=S]V1@,E/9@ 3CN 2.AP-J</]J'3XP9)DC$LV#Q"AR%+'U)!P/8T <[IOA#4
MK/7K#5[C7(IIK73VT]HX[$1HZ;E92!O.WE1GKGMMJLW@&Y;P-/X9.L18ENS<
M_:/L9R,S^=MV^9_>XSGI^=:=OXQBD\1VFCW6DZC9&^5VLKBX1 EQL&YA@,64
M[><, <>G2MBTU.*YO;FR93%=V^&>)NI1L[77U4X(SZ@CM0 :E8'4]%N]/DG:
M)KJW>!IH?E*[E*EEYX(SD5R^G>#KW3-1T74[S7X7&DV3V;*EFL2/$=F#RYVG
MY!D\@]@M=K10!Y=\/](;Q'\-M*M+C4+>33$N6FD@CB_>-LG9U1FW8QN"D_+D
MCCWJ?0XY]6\5>/;2PU6UBCN+J-'Q'YCJ#;HI9"& SU'((!'X5Z56/K?B!-%O
M=)MY+2:4:E=K:)*A4+&Q5FYR<]%/04 4!X06WUGP[=V5TD%GHEK):Q6QA+%T
M=44Y?<,$!!V/>J$OP^-UI&MV-SJIWZAJ/]IP7$$'EO:S#:5(RQW8V#T[_AVU
M% ''WWA#5M9\,WNFZQXB,]W<(B)<0V@CCC"N&_U>X[MQ4;LGD<#'.0>"[N?4
M]5O;_6A+_:FFBPN(X;41@8#@,F6; PYX.3GOCBNKGN(;94::14#NL:Y/5F.
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M7&/.B\QR9 .@9L[B/8G% '-QN^A>.;-/[4O!:7>ASW%S]HG:1%>-H\2*IX7
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MM_+9 ^5*\CEX\G[HDR&( P.3R ,UT-O:P6EI':6T2PV\:"-(XQM"J!@ 8Z4
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M;..W729&D@=78NF0 5'/(.%!)SP,#KD '2T444 %%%% !1110 4444 %%%%
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M,@;"#D]B* /4I]?TFVO19S:A D_F+$5+<"1N50GH&.1@'DY%9,6J:D_Q&O\
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M*(02V .>G7')H ZBD) ZG%<OI>NZI>^/]=TB6UA6QL8;8HPERWSB4[L;>2<
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MMRE@E\C-+\K*S%0IXRIRI]:IZ9XUAUC2]%GL[-C>:NDDD%M)(%")&<.SL <
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M7CJ"*TUM]5L);*YTB:.*6W6193(9 IBV$8!+;@,<8/6@#K*0D 9) 'O7/?\
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MUC(#.03R3@  <DDGH*OT </H_A?4O#?]N7.@VMI:+=1QFUTN2X9K>.8;M[Y
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MEE"JS9*C"A5..YW<XQSSR^#/$*_#6/PM_P 2TS6]S&T4OGN%>-)Q+N/R<$@
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MZ+:Z5:RSRP6L8CC:=]S;0, 9P!P !P!4.L^'X-;N=.GGNKJ%K"X%S"(2@'F
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M <AE.1O9"#SVVCL%XW/ FA:/-K7B2]-E;M=67B"X^SOCF',: [?3.3GU_ 4
M=OJ>JV>D6\<][,L:2S1P1Y/+.[!5 ]>3^6367%XAN#XXO-#GBMX[2#3X[Q)Q
M(2S;G9,'. /NGU^M9'Q0AM7T+2YKN*%HHM8LB[RJ"$0S*&R3T&.M4FTW1M8^
M*%W;3VUI=6 \.P&.(J&BV^=)@A>G Z'MGB@#T*26.)-\DBHG]YC@4XLH )88
M/0YZUX_X;U*PE\/> K>^EA^U'3[AH9KZ3_1T5<(<J2-[@8 &1@;N>QHZ4MC?
M^#?A_'*\,SQ:]);-AN53-QA.N0,!/E],4 >VHZ2+N1E89QE3FLGQ#KBZ+#9*
MJJT]]>1V<.[[JL^?F/J  QQWQC(SFN?\%6]MI_C#QKIUC%%;V<-Y;/';PJ%2
M,O;H6(4<#)IOQ&M;*:Y\)-<P6\C/KUO%F1%)*E9,KSVSCB@#=TBX\2-J$\>L
MP:7':(K"*6VE<O*0W#;#PJ[3TR2"/0UN;UQG<,>N:X5+"Q_X7#=6HMK?RI?#
MB+)#L&UAY[+R._  ^@%4/"6G"*YD\$W%H&MM!O6N5=X\K) WSV_/][+-S_TQ
MYZT >CF6,2B(NHD(R%SR1]*<2%!)( '))KR"Q.CZY%=6VMZVUGXAL]8D<PHL
M:W7F"4F+RR1N92FU1CC''2O1?&0N&\#Z\+3/V@Z=<>7MZ[O+;&/>@!L/B:V;
MP[<^(92L>E)&TL+D_-+&,X?G@!N-H]"#WP(=!U3Q'JD$TU[I6FVD1C#6TD%_
M]H64^A(08'N,]>AJ#29=$7X<:&NK-8C39K"UC"WFWRGRB[5(;@\XQ53PIHUI
MHOBW5XM!95T*6"*1[>-MT,5T6;<(^PRH4D#IE?44 =+H^K0ZS8FXB4QO'(\,
M\+'YHI4.UD/T(Z]Q@]ZSKC7[FW\=6VAO# MG-I\MWYY<[P4=%P1C 'S>_P"%
M9?@D2?\ "4>-RN?LAU5=GIYGDIO_ %Q5;Q!8:=J7Q6T:UU2"&>VDTBZ AGP4
MD821'!4\-W.#GIGM0!W@=2%(8$-R#GK2[E.>1QUYZ5XLEG#IFCZ=)\J:/:^-
M%_L^60Y6*UZ?*QZ)OW '.*TI)-,O]?\ B#;0:M;62W*Z>%N4VLNXC;N(Z,NX
MA6[8)S0!Z9?3W+:7<2:4UK)=B,F'SW(B+=MQ7)Q]*L+)MB4S-&K[=S8;CWQG
MM7DNLO++X'\>6&LZ/8VNIVEHDDTUGS;W!*-Y<B@C*M\N"#S]WUK7GTS3=0^)
MNAQW=K;W"3>'Y3(DBAEDQ)%MW#HPZXSGI[4 >B^8GE^9O79C.[/&/7-)YT7D
M^;YB>5C._<,8]<UXQIVHQ:;X7\-1W=R+;08]9OK>:5E#QPXDE$ <,"-@/3/
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MOWAW@$'MG->I6&JZ?JHG-A>07(MY6@F\IPVR1>JG'0B@"T\B1C+NJC!/S''
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW]^A!( ) () !%5KKQOI%O?7%E&M[=7,%NMT8[:U>0M&V<,IQ@C@\CCMG/%
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MPP[5Q&NS"+^ QQ[<5Q/@6:Y\36%AXCN+S5(+D/.98?-(MIU9W55V'*_( O(
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M\30OX4/BW5)GAM;H[X8@"1'$S[8E"CJ[94D^K8Z 4 6]4T74+R:&PM+FRM=
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M#DC(ZX R3@X% &FFG6,5D;*.SMTM""# L2A"#U^7&*?':6T+%HK>)&*",E4
M.T=%^@]*Q;CQIHUO/IL(>YGDU*W-S:""V=_.0 -\N!R<,..HSS@4ZW\8:1<Z
M(NJK)*D37/V00R1%9?/W[/*V==V[C'X].: -6UTZRL5D6TL[>W$ARXAB5-Q]
M3@<T1:?90Q2116=O''*,2(L2@./<8YK+@\7Z5+=ZC:RM<6UQIJ>9>+- P6%<
M9!+@%#D<@!B3^!J6R\265WK+:0T=Q;7_ )'VA(;B/89(LXW+UZ'J.",\B@#2
MM;2VL8!!:6\5O"O2.) BC\!Q22V5I-.D\MK#),GW9'C!9?H>U)?WL.FZ?<7M
MP2(;>-I'P,G &>!W-<IX$US5;NYUG1?$.U=7L;CSBJG(,$PWI@]PN63_ ("*
M .G_ +)TT(R?V?:;&(++Y*X)'<\4Z33+"5H&DL;9S;_ZDM$I\K_=XX_"LO5/
M%^E:0MU+<M,;:SD2.[N(X]T=NS8P&/7^)2< X!&<5%8>*#?>--4T$6-PJ644
M+>>4X9GWDGKPN% 'J<^U &W=6%G>F,W=I!<&)MT?FQA]A]1GH:DDMX998Y9(
M8WDB),;LH)3/7![5)10!3_LC3=C)_9UIM8[BODK@GUZ>YJOJ.BPW5A=16?EV
M%Y+ T45Y%"OF0DKM##Z5J44 <78^#KAY+8:I:>'E6VDCD6:QL"DK%"&7#,3L
MY SC/&1QUKI=.TFVTV6[FA1!+=R^;*40*"<8Z#^?4DDU?HH @>QM)+E;E[6!
MIUZ2F,%A^/6DEL+.>ZBNIK2"2XA_U<KQ@NGT)Y%6** *\EA9S2R2RVD#R2)Y
M;NT8)9/[I..1[4U],T^6>.>2QMGFCQLD:)2RXZ8...E6J* *USI]E>R1R75G
M;SO$<QM+$K%#[$CBG2V-I-.L\MK!),GW9&C!8?0U/10!3_LG3?)>'^S[3RG(
M9D\E=K$="1CG%3"TM@)@+>+$W^M&P?O.,?-Z\<<U-10!6@T^RM;5K6WL[>&W
M;.Z*.)50YZY &*3^S;#[(]I]BMOLS_?A\I=C?5<8-6J* &0PQ6\*0P1)%$@P
MJ(H55'H .E175A9WPC%W:07 C;<GG1A]I]1GH:L44 ->-)4*2(KH>JL,@U'<
M6=M=JJW-O#,%.0)4#8/XU-10!5FTVQN98I9[*VEDB&(WDB5B@] 2.*6;3;&Y
MM%M)[*WEMDQMA>)608Z8!&*LT4 5Y+"SE>-Y+2!WB $;-&"4 Z8]*2/3K&)9
M5CL[=%E&) L2@./0\<U9HH @M[.UM+86UM;0PP $"*- J\]>!Q1:65I80F&S
MM8;:(G=LAC"#/K@5/10!'-;PW"JL\,<JJP=0ZA@&'0C/>H#I>GDR$V%J3)_K
M"85^?G//'/-6Z* *PTZQ5HF%G;AH05C(B7* ]0.. :<+&T$<,8M8 D!S"OEC
M$9]5';\*GHH 9+#%/$T4T:21M]Y'4$'Z@U$+"S$4<0M(!'$V^-/+&$;U ['W
MJQ10 R:&*XB:*:-)(VZHZ@@_@:KC2]/5HV%C:@Q?ZLB%?DYSQQQS5NB@"LNG
M6*'*V=NI\WSLB)1^\_O=/O>_6B+3;&"Y:YALK>.=L[I4B4,<^I S5FB@"*XM
MH+N/R[F".9,YVR(&&?H:B_LRP$BR?8;;>HVJWE+D#&,9QTQ5JB@"I_9>G_9I
M+;[!:_9Y/OQ>2NUOJ,8-2&RM#:"T-K";8  0F,; !T&WI4]% !TJH^F:?(I5
M[&V92YD(,*D%CU;IU]ZMT4 5X[&SAG,\5K DQ&#(L8#8^M%K86=CYGV2T@M_
M,;=)Y483>?4XZFK%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !7*>/[*^U#1;.&PLI;N5-1
MM9V2,J,)'*KL?F('05U=% '">*;"_M_%UCK\7A_^W+![(V=Q:*(S+"=^]9%#
MD ]2",CM5:XT_5='US0M?L?#0^RI!<6USIECY:R6ZRLC*X&0C-E!NP>_4XS7
MHE% 'D:V&HZUX8\;QVEDS7H\1I<"UWKN/EBVD*YSMW84]\9[GK7262ZK-\0;
MO6Y-#O(+&;1HX$,C1[PZR2-M90W!(/;/;..@Z72=!L]&GOIK0S;[Z<W$_F2%
M@TA !;GIP ...*TZ /+-*T36K3PUX M)=(N1/I-WYEZH*'RE\N1<YW<\N.F>
M]:6L:=?:;XXO=1?PN/$&FZG!$G[L1&2VE0%<$2$#8P(.<\$5Z#10!Q$.EWUM
MXZT2[72%@LK;2I[>3[*%$4+NZ,$49!( 4C(&/IFL*;0];?X<ZGIBZ/<_;9];
M-W'#N3)B-V)MV=V/N@\9SFO5** /-Y--OM-\4ZR+CP>FNV&K3+<V]QB$F%C&
MJ-'+YAR%&T'(SP>A/%:=GI]_9^/+Z];3'%E_8T%I&\"J(S(C.Q5%SD###&1B
MNUHH \MT;0]<TS1_A_))H]Q)-HYFBO+=7CWIOB9 V2V"N2,X/2KZZ'J$/BR/
M4]'MK_3)Y=2;^TK=G#6=U!N(\[&2!(5"D8P<GD8R:]#HH Y;QUI.H:EIVF7.
MF1^?<Z7J4-^+;<%\]4R&0$\ X8D9[@5';V%Q>^.O^$G:SN+>WM]+-FD<B@23
M,T@<_+GHNT#GJ6/89/6T4 <I\.;*^TOP18Z?J-G+:7<!DWQR%3]Z1F&"I(/!
M%96J^'&UOXFW$VHZ/)/HD^AG3WF?;M\PS;N!G<.#]['6O0** ."LM/\ $7_"
M)ZUX1U&WEN&2UFM;#5&=2MS&T9";^<AQD*<C!QG-5-.MM;N=7\#3R>'[VWAT
MNVFM[LRO$"C&)$R 'Y7(Z]3Z5Z110!Y7+X<UV;0-6>'2=]U#XE?5H+.Y9 MY
M"6^[G) )4GKT(%=CX703-/?#PNFA;U5"LD<2S2D9SGRR1M';)R>>!WZ.B@#E
M/B!97NH^'X+:PLY;J87UM,5C*C"1S*['+$=@:NZQX;77+RUOAJVJZ?-#$R*+
M21$X8@G(96YX'Y5O44 >6:9X<\2^'/".IBU^WW=U-K#2-!))$S_9O/):2+("
MB1E.[)/7H 16EHGA^^EU_P 4)/9ZII=EJ0M9(+I+Q?.&Q,,"X9FW9'/48SS7
MH-% &&-);2?#5]9PW&HZC(Z2%3=3^;*2RX"ACCC_ .O5+POIYM_AQIFEZSIS
MDPV,=M<VLD8DW$*%(P,AA74T4 <%I_@6.;4;[4I+1=/1K!]/T^UW;VAC8?,[
MG)^8\  $A5'J3BMIAUI/@YIMMI5J9-3LTBM+B ;?,7RI DH7=\N\!21GV/I7
MHU01VD$-S-<1ILDFP9"IP'(& 2.F< #/7  ["@#CO">G7]EXT\07DNDW=K8W
M\%JT,MQ.LC917#!SO8[LL/48[]JY6STJ>&+3?$Y4_9)?%L]^<_PV\^84D/M]
MQL^C9KUVYMXKNW>"92T3C#*"1N'H<=O;O2O;PR6[6[Q(T#)L:,J"I7&,8Z8Q
MVH R]3U!TO#ITF@WM];30Y,L:Q-$QR08V#,,''J,<]:Y\:4?"7PAO=.D&Z2*
MSN D2$MAY"Y2)?7EP@]>*[2&%+>%(DW;$&!N8L<?4\FFS6D-S)"\R;S"V] 3
MP&[''0D=O2@#/\+:;+HWA/1],G.9K2RAADP<_,J ']17G5EI'B"#POX9T4^'
M[LS:/K4<T\GF1!)(UDD;=&2W(PP/./2O6Z* /-+[1]7GTKXB0)I5R9-69OL0
MRG[W,"Q_WN/F4]<<5:T^VUG0O%YU,Z/=WEEJ6FVUNXA9/,M9HMPVL&8#:=Q.
M0<9_.O0:* /(+'P_K^G>'_#-[-X;-Z^ES7J7>F2-$S213R%A)'DD97"\'!Y(
M]ZV]5TR]NM-T66P\+_80NN6]]+:P+$KI$GWGDVMM+GT!)QCO7HE%  #D UY3
M'HFO1?#VST-M$N?M5GK"3$AXRLD8NS*77YNFW'7!R<8KU:B@#SCQ!X;U77=<
M\5+;VLD$6H:1!;VUQ+MV-+&SMM(SD#Y@,X]:UO"PGO+N*XN?!4.AW,$96:=T
MA)9CP5B*$DKW)..PP<Y'8T4 <9\0;'4-0;PY_9^G3WGV+6;>]G\HH-L2;MWW
MF&3R.*U4U"Y;5!+#X?O(@T1-Q<2^6"RH&*(H#DEBS'&>,9YZ5O44 >>V&F:Q
MHOBZ+Q!;Z7))%KJG^UK2,1@V;C_5N#GYCCY7P3N/S#L*?H">(O#]UJ6@OH4E
MW#-?S75GJ0D3R!'*Y?\ >@MNW*2> #GVZUW]% 'G=YI6JR3?$79I=P1JUNL=
MB<I^^(MO*/\ %Q\WKCCFH)['Q#-!;Z;+HUW)9-H*6\8AECC"W04JPF.X$J.,
M 97D\$]/2Z* /-M%TS6(KWP"]QH]S"FEZ9+;799D/ENT<:KG#'.2AZ9P,9QT
M%"YTR_M_#>H1SZ3=_;IO%#7]A'')&)2#+YBN@+;6(56)4D<9S7K%9FLZ!I^O
MPPQW\4A,$GFPRPRO%)$^"-RNA!!P3WH X&>QF\0V/B6R73-3T_Q!J]NDPDU&
M%%AE$!4*B[&8!02,Y.?G)Y'3HO"PEO+M+J?P7#H5Q#$4EFD2$LS'&5B*$DKW
M)..W!ZC>TS1;32MS0M<S2L-IFNKF2>3'IN<D@>PP*T: .>\1V\^IWFG:4;.Z
M?3Y)A+=W$+[ H3E%R&##+A3D=E]ZP=5T&\T3QYHNNZ'8W]ZCQ26>IAKHRGR#
M@H097SE6YP.Q-=_10!P&F+X@\/:WKFG+H,NH6NI7SWMG>+(@BC\P#<DP)# *
M1V!)'05H65GJ>G_$36KUM.EGM+^SMA'<QN@4-$)-RD%L@DL,<$<]177T4 5-
M+NY[[3+>ZNK&6QGE3<]M*P9HSZ$CBK=%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFHO@ZP;X5:,001^_Z?\ 7>2@"WI/CE;C2-?U75K6'3[/1KR>TE=)S*7,1 )
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JMWIMC?J5O+*VN5(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6NO!6GW&D:9ID-S=VEOIUTEW%Y+(6>56+AG+*<Y8DGIDF@#H8D:.%4>0R.%
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M9);;24N+';;V;B(*\J(" <816;&XXZ$T >HZE=26FEW5W;QI-)#$TBHS[0Q
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M^28^(?\ KT;^8K(DT"QT[XB: ^BQ%!?VMR=55)&83PA!L>3DY.\@!CR<GTH
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M>*1'1O#LA5E8$$?:$Z4GQ4BCD\$,[Y#)>VFU@Q!&;B,'I[$T =ID<\CCK02
M,DX%>=+X;T9OBI?Z8UA";"YT6.YGM2/W<LOG.N]UZ,V.YR>_6N:\/:HG]E>#
M+/6+V"+2I[*[BBDO4$D+3I,%16W$#(C!"Y]Q0![7D 9SQ52^U*TTZ.![J98Q
M//';Q GEW=@J@>O7\@37F$K6.@GPYIG]M1S^')KN[3[5=1J]LLN%,<?7:4!,
MH7)(!'^R,1ZMHVBV6DZ,D-Y!J-B/%,)#NB&&!7Y>*,\@1Y[9P#D=J /4Q)?_
M -KO&T, T[R RRB0^89=QR-N,;<8YSUJUD9QD5P"VUDWQ1U&*%8_LLWAJ)ML
M;?(1YT@!&.,;0HX[ 5R^@6-I9^'/AEJT$834)[N.WEN=Q+O&T,N4)/\ #D#C
MH* /9\C.,\^E+7D&I6J:O_PDVD-=V4FIR:TK6^H/=1J;>,&,[,%@XV*&7 !!
MS[G'J5M>:='=?V1;W5N+FWA5OLJR R)'T!*YSCWH NT444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 57N[&TU"(17MK!<QJP<)-&' 8=\'OR:L5R'Q!U"XTO3](NX+Z:U0:O:1S^
M60 \32 ,&XSC&>E '1/HVER10Q/IMFT<!S$A@4B,]<J,<?A2-HVEL;@MIMF3
M<C;/F!?WH]&X^;\:R;?QWH5Q!J<GFW43:9'YMW#/:2QRQQX)W[&4,5P"<@5?
M7Q'IC7VF68F?S=3A:>T_=-B1%4,><8! (.#@\T 6%T?2T4JFFV:AHA 0(%&8
MQT3I]WVZ4AT32C'#&=,LMD!S$OV=<1GU48X_"JUKXDT^]EB2#[0R3H\D$H@;
M9*J]2IQSU&.YZC(K(T[Q9H.F^';2]?5KZYM+N^>WAN;N)V8R&5EVGY1M .0-
MP' H ZN:&*XA>&>-)8G&&1U#*P]"#UJH-$TE1"!IED! <Q 6Z?NS_L\<?A5*
MQ\6:1?IJ++-+ =-P;I+J!X6C4C<K%7 ." <'VI%\7:0+F[MKB:6TFM;8WDB7
M4+1GR!UD&1R!T/<'J!0!>&B:2'=QIEEODE$[M]G3+2#HYXY89//6K;11M*DK
M1H9$!"N1RH/7![9P*R_^$DL$2[:X%Q;?98XY9!- RG:Y(3''S$E2,#G/'6K5
MCJD-_+<0I'/'+;E1(DT10C(R,9X(QW&10 M[I.FZF\+W^GVETT)W1-/"KE#Z
MKD<?A5RL*^\7:58:K/I<ANY+Z& 7#6\-I)(S(3@%0%^;D'IG&.:KVWCSP_>-
MII@N9GAU%ECM[C[-((C(0<1E\8#G!^4G.: -G^R--_M#[?\ V?:?;?\ GX\E
M?,_[ZQFB\TG3=1FAFOM/M+F6 [HGGA5VC/JI(X_"L^3Q=H\5GJUT\TRQ:2^R
M]_T=\Q':&Z8R1M(.1FI+SQ/IMDDCL9Y5BMENYO)A9S%$V=K, ,\[6XZ\&@"Y
M?Z3INJ"(:AI]K=^4VZ/[1"LFP^HR#@TZ33;":Z6ZELK9[A1M65HE+@>@.,XK
M(A\4QS>-KGPZ+2X!M[9)FF,+;6+E@,'H%^4\GJ>G2L[QKJLVD:YX6F%[<0VD
MM^\5Q#$,B5?)D8#: 68Y P!U/;- '56EA9V",EG:06R,=S+#&$!/J<5SDGA5
M[SQ[=:UJ%IIUS82V,=HD<OSNI1W;=@ICG?CKVJ[IOC'1-4L;R[AN)(Q92"*Y
MBGA>.6)S]U3&PW9.1@8Y)P.:M:=X@L-3U"ZT^(RQ7MJJO+;SQ&-PK?=8 ]5.
M#R/I0!9FTS3[F2&2>QMI7AXB9X58Q_[I(X_"B]TK3M2:-KZPM;HQYV&>%7VY
MZXR.*R]2U9YO%-CX<MG*/);O>W4B\,L*L%"@]BS-C/8*V,'!#;2XLM0\0Z[9
M6VJ:C]KAC@6:!@52V)#;6CRO);!)^\#@?2@"#Q#X;N-8\2>'[P06,MAIK3--
M#<$Y?>FP +M(XZ\_IUKH$L;..S-FEK MJ05,"Q@(0>HV],&LOPOK;ZU87*W
M47MA=RV5T$&%,B'[P'8,I5@.V[':N93Q='H'C/Q;'JUY?W%G;BU>&..!YO(1
MHV9VPB_*N<9)]N30!V4>A:1#8?8(M*L4LBV[[.MN@CSZ[<8S4DNE:=/###-I
M]K)%#S$CPJ5C_P!T$<?A61>>.= LOL>ZZEF-[;-=6OV>VDE\Z-0"2FU3N.".
M!R.]37'B[2;>"2<M</'#"D]PT=L[?9T9=P+@#*G')'4#DC% "0Z;J]SKQN=4
MGL6T^TE:2PAMHF#Y*[0TA)() +  #'S9["MZLI/$6F2:G;:?'<&2>ZMC=V^Q
M&9)8AC+*P&T_>7OWJ*+Q9H\^EC48[EC ;HV:@Q,':</L\L*1DG<".G;/2@"\
M=(TUM0^WG3[0WO'^D&%?,XZ?-C-/73K%+TWJV5N+LC!G$2^81_O8S7)>)_%4
M%UX5\3PZ7=WEIJNEV4LLF(&1H75-R@L5V\\$8.2.16AHGBW3KL6NG-)<M?&Q
M6Y!>WD G4 ;C&Q&),$C[N>M &TVDZ:]^+]M/M6O!C%P85,G'3YL9I;C2M.N[
MN*ZN;"UFN8E*QS20JSH#U )&0#67X1\3)XJT4:BEK-;@RRJ%DC*_*LKHO)X)
MPHS@G!XKG%\6IH'C;Q9'JMY?W%G EI)#%' \WD*R.7;"+\JCC)/MS0!J:]X7
MNKJ]LGT^TT2XT^W@:$:9J%O^Z4D@[T*@@' QC:>.F,FK6C^#]-LH9C<Z7I0:
M=U=K>VM56",J" 0I'+<\M@9XXXJ\WB/36M+6XMI7O%NX3/ MK&9&DC&,L .W
M(Z]R!UXKG?$?C:W;0=&O-'FFFM]4U""V\^&%R5C,F) .,J^ 5Q]X'..10!UJ
M:7I\=P]PEC;+.Z[7D6%0S#T)QDBI;6TMK&W2WM+>*W@3[L<2!%7Z <5SMGJ-
MIH"W<$E_JFH?\OGDR1/-+:0L.%;C=C*M@-ENHYQ4]WXVT&T73F-W),NI1M)9
MFW@DE$P52QVE0<G ^[UR>E &K<Z1IMY=)=7.GVD]Q&,)++"K.O?@D9%+?Z7I
M^JPK#J-C;7D2MN"7$2R*#ZX8'FLN?QEI%OIWV]C=&W6!;F9EM9"8(V&0T@QE
M>.<=<<XQ6N;V'^SOMT1,\!B\U#"-YD7&1M ZY'2@!EQI>GW8B%S86LPAQY0D
MA5MG^[D<?A27>D:;?M$UYIUI<&$8C,T*OL'MD<5P&H>,YM6\-^%M>MIKO3X;
MG6+=)X]I57A9F^4DCYN ,[3@G-=A8^*](OX-0E6:6#^SF"W27,#PO'D94E6
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M[4+G! W$\CG.: ,H>"K^6ZN4U'3_  QJ:3322?;[RR+7&&8D!EQAMH(488<
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MI5R?^ GTJ;1;6ZB^(WB:\EM)TM;J"T2"9DPLAC#A\'VW#Z]JZ.XM;;4((_,
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ML9+$CY?E')S69#HVJ:GX"T/PG<Z=/:W^GW%JD\Y7]TD<#@^:C]&W*O '.6Y
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M1V;>4<3,L#(0/^!$#G'KTKJ_"L4MOX1T>WN(GAGALH8I(Y!@JRH 1^8-:]%
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4A 8$$
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M=\^OR\XYIHU.X,6F/_95WF\($JY3-IE"W[SGL1MXSS7()>:A]H^(L']IW?\
MH01K5M_,.;8/A>,#YCZ5$NHZC]A^&D_]HW6;WRENE\SB?-JSDOW8[@#R: .Z
MM-2AN[FYM0&CNK8CS8GZ@'.UAZJ<'!]B.""!<KB]5EDM?B[X=\DG%YIUW%<
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M=*@TV]M6FM[=E> F9Q)$R_=99 =X(]<YIY\2Z"+1KLZUIWV99/):;[4FP/\
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M@AHT^;A@<$XSC'2LO4?&MI<:=XECT6]MCJ&CP2-^\^<,ZQ[SA<@D#@9Z9^E
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MEQUVG/.,'IZ4 9>O6>H:M*/#RZ- =#GB3S[QYUPJAOFB$6,Y*@ 'H,Y[8/3
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MU:S7)*;E2($[F;C[HSR3Q72:1I@TNR\EKB6ZG=S)/<R@!YG/5B  !P   ,
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M([C3AI$EO>S1G='*6<&.,GH6 WDCJ ><9KE'T_6].T7]U;S$^"+UFM3MRUY
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MQR.N#57XKH&^&6ML2P*1*RE6(YW#TJ]X<?Q?)Y4/B"VT^W6W7:\]K.9#=MC
M(4J-@[]2<XZ"I_&NB7'B/P=J>D6CQI<746V-I20N00>2 3V]* *L'C2)?$!T
MG5-,O-+:2![BUFN2A2>-.7Y5CM('.T\XJ"V\?:9?:KING,F(]61OLLJ3HYR%
MW;9%4YC)'(_(X/%&H>';KQ5J5K=ZK;BPAM;.Y@2))1([/.@1FR. H7..Y)Y
MQRWPM!XQL+6UTK5K?3_LU@@C%]!.6>Z51A (RN$)P,DD]\#G( ,#P1XF_L+P
MMID$^G7<EG/JUQ9F]WJ51WN9%0$$[B,X!..,]^:ZC4_&D6EO=2RZ=<_8;2\B
MLIK@X4[Y-N"BG[R@NN3]< XKGHO".O)X*T_2#;6_VJWUH:@Y$_R&,7)FP#C.
M<''3KWIOB#PIXGU>+7(GMK"ZDFO8;BQNI[DAHX4>-O)"[3LQL;)!YSWH UHP
M8?C!J)B5W+:#%)Y>_P"\WG..,\#. *H^"K5?$AEUG5;&1;^UU6Z:&[$P# +(
MR"+Y3DH% &T\'&:VH-*U1?B#-KDMO#]E?28[/Y)LMYBNSG ('R_-@'K[4_P1
MI.HZ+I-U::C#$DDE]<7*F*3>I621G Z#D9Q0!HZMK<6F7=A9;5>[OW9($>01
MJ2J[CEC[=  2<_4BHOBD+JFC:?<Z;<V\VJ>>J!V4^4T0)8-@]P.",BF^*]&7
M7(;>SN](@U/3CO,\;.$EC;C8\9.,$?,.HZ]>QY^/PMXATZV\*7*.FIWFCS7
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M8(5QYH7.>W7)ZCC@TFF>!M0\,W'A_4-.:*[GLK>>VOH-VP2K-)YK&,G@%7/
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M/;LUS"UK':!=S),RJ^[.1@*1C'IWYJ]XCU;4-.\1^&+:VFC6UO[QX+A#'EF
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP"P$2&*59"9&?)W KC  &,'-6L@]Z ,SQ+G_ (1?555))':TE54C0NS$H0
M 23DUS_A#P]YWACPQ+J,]Y(^G6L316MQ$(_(F$6PDC:"2N6 STSW.#7:9&<9
MY]** .?T[PC8V.F:KITTUQ>VFJ3S3W$=SL^]+G>!M5< Y_"DT_PG!9'31<7]
MW?1Z8#]B2YV'RCM*@DJH+,%)4$]B>_-="2 ,DX%&1C.>* ,I_#U@_BB/Q"4/
MVY+4VH.?E*[L@X]1E@#Z,:K3>$[*YUS4-3N9IYOM]F+&>V?;Y1B&[CA=W\3=
M^];V0>E8.I:_/8^+M#T9;:)X-2$^Z?S#N0QINQMQCG(YS^% &9:_#Z&W72(V
MUW5IH=(G\VRCD:(^6-I4(3LRPPQ'))Q4MIX"L[#5KBYM=3U.&PN)S<RZ6LP^
MS-(3DG&-P!/)4'![\<5TM[>V^G6,][=RK%;6\;22R-T50,DUBZCXI32=(M+R
M[M)/M5_,D-E8H1YLCO\ =4YX!QRQZ+SR<<@&?>_#NRN5UJ"#5-1L[#62SW=G
M"T?EF1AAG7<A92>I ."?RKJ[2W^R6<-L)9)!$@0228W' QDX &?PK&N=5UNP
M2VENM(MI(YKB*%_LUVSF$.ZKN(9%W 9R<?EC)%VRU9;C4[O3)T$5[;*LA0'(
MDB;(61?;*D$=B#U&"0#,@\$Z<FGZU874]S>VFL323W44Y3&]P 2I501]T8],
M5/9^&$MY[.>ZU&[OIK&)HK22XV9BW *6^51N? QDYXSZG)XLUZX\.Z=:W<%K
M%<++>06S[Y"NP22!-P !SC/3(K>R#0!D>&_#\/AG21IMM=7-Q"LCR*;C:6!=
MB[?=4<98FC5_#\.L:EI=[+=W,+Z;,9X5BV;68J5.[*DD88C@CK6L"#T(- (/
M0T <M/X%L[C3]?LGU&_\K7)3+=8,>02H4A?DX&U0.<]*Z6V@^S6L4'F/)Y:!
M=[XRV.YP /TJ7I1G(SVH Y!OA[8G0Y]&74]26QEN_M:QAH_W3>;YNU<ITW\\
MY/;.*T_^$9C_ .$AN-;&H7@NI[-;)A^[VA 2P(&SKEB?QZ5N @C(.129![B@
M#G--\()HVG:79:?JU_$FFQ/#$6\MMZ,5.'&S!QM&",&M31-'M- TB#3;(,((
MMQ&[&268LQ.,#DDG@ <\5H9!&<\56U"YDM=-N;F"-)988V=8W?8&(&<$@''Y
M&@"MI>D#3+B_G^VW-R][/YSF?9\IVA0%VJ. % P<]*R%\#6T=UK\T>J:@@UQ
M2+J)3%L!V[-R#9P=O&><]\U9T;6M2UOPYH&K6UI; 7Z1S72/*1Y4;(2=G'S$
M' P<5OY&0,\F@#GKKPA:7?A*U\/27EX(;00^1<@H)4,14H?N[21M'5>:F'AB
M'_A(K?6WOKR6XALVL]DA0HZ,P9BWRYR2H/! [  <5<UW4)=)T&_U""&.>6UM
MWF6)Y-@?:I8C.#C@>E.T6_;5-"T[4'0(]U;1SLBG(4LH; _.@##T+P+:>'YU
M6UU/4I-.BD,EMILLH,$#$D\<;B 3D D@'GK@T/X"TR?2M9TZZN;RX@U:Z-Y+
MO95:*8[<-&548QL7&<]/K754R8R"&0PJK2A3L5C@$XX!/84 9.@^'VT96:?5
M=0U2X*A!/?2*S*@_A 4 #W.,G R>!B35=$.JW$$W]IWUKY&2BV[(!D_Q'<IY
MQQ_^LTZ+5/L\6E0:J8(-2OOW8AB?>ID"%V"D@$@!3SCT]:J:'K]QJFM:]I]Q
M:Q0?V7<QPJR2%_,#1JX)R!@_,./YTFDU9ETZDJ<N:.Y8CT1X[ VW]K:BSF99
M3<-*ID."/EZ8"\=,=S4NIZ1'JDUE))<3Q&TG$\8CVX+@$<Y![,:T:YGQ'XM3
M2_"VM:OID<-\^E,R2QM*47<H!89 .2-PX]<C(I<BM8OZQ4YN:^NO;J;FH62:
MC9/:2LPC<KOV_P 2@@E?H<8/L:R/%EO#>VD-I-?WEHA?S";6:",OCH#YO49Y
MP/QK>B?S(U;C)4$CTJMITE\]GOU.&WAN [C;!(77:&.TY(')7!/O6U*?LZBF
MMT9-MQY>ARMJ(;:VO8WUO5[B2YB,2S37UKN@Z\Q[6 !Y!R0>@J;5VT_6O#IT
M6ZNKL0LB)),MU;>9)M(.22Q&20">*["LWQ!K$>@:!>ZI)&TOV>,LL2_>D<\*
M@]V8@?C73]<]Y3Y=4[_,CE,?4[K3=6LH(+EI?-MY4GAN$N;821R+T8?/C/48
MQ@@D8JYHALVU*ZN%9YKVX1?-FDEA8[%X50$8X W$].I.36AHVJV^N:+9:I:-
MFWNX5F3V!&<'W'2I-0U"UTK3KB_O9EBMK>,R2NQX51UK-XB\'!*R]1VUN9NI
M>&(=0\06VM)?WMI=0P-;/]G=0)HF8,5;<IQR,Y7!]ZS;#X?66G6VAP0ZGJ)C
MT:9Y;4.T9Y8%2&^3IAB.,=<]:Z*>6^^VV(M88'LY"WVEY)"KH-N5V#&&R>N2
M,"KF1G&>:YAG)W7P_P!,O;;6(+F[O9!J=RMX[[T5H)E"A7C*J,$;5ZYZ>YJS
MIWA/['X@CURXUG4+V^6T^QDS>4%=-V[D*@YSW%2Z1KUQJ'BC7M(FM8XETPP;
M)$D+&42*6R<@8Z#CGZUO @YP>E !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7*^.;FQBM=(M
M[T.QN=3BCAC,HCBDD 9@)20<IP3C&20!7557O+&SU&W-O?6L%U"2"8YXPZY'
M0X/% 'BU_P#8Y?A]XWM7DLITM->22%8E'EQ*6M]Q123M7+/T/<^M>U6:VB6B
M)8K"MLN0BP !!SR!CCKFH_[*T[9<)]@M=ER )U\E<2@# W<?-QQS5B**."%(
M88TCB0!41%P% Z  =!0!XW+;:;:^!/B8D$-I#=+>7RA415<1[8\#CG;DCVYK
M;DLTT7QSITFC0".[O/#]T\@!R;B1#&8R^?O-DGD\\UW\NCZ9.T[2Z=:2-<8\
MXO I,N.F[CG';-*FDZ;'/%.FGVBS0KMCD$*AD'H#C@4 >;^$4T;6$\,:S#KL
M*ZM&NV:&WC5;B=RF)4GY+, 06)([9KH?BQ!%/\,-=\V))/+@WKN4':01R/0]
M>:Z>WTC3;2^FOK;3[2&[G_UL\<*K))_O,!D_C5F6&.XA>&:-)(G4JZ.H*L#U
M!!ZB@#@]4@TZ/Q[X%.GK D!-\BBW("8$))P%XZD_F:X^_P!,L4^'OBW45B O
M+#Q#/]DN-QWV^+E -AS\O'''7O7L7]CZ7NMV_LVSS;#; ?(7]T/1>/E'TIG]
MA:/Y#P?V58^3(V]X_LZ;6;U(QR?>@#S_ %FV;P_XTU@>'8/(NIO"UQ<A(N3-
M<)( CM_>?D\GDYJ?PK#H.HZGH&M:9KENUR;9T>VLXU5YU*9;[0,EB589R?XC
M[UWR:7I\=TETEA:K<(NQ91"H=5QC .,@8I+32--T^XFN++3[2VFG.9I(851I
M#_M$#)_&@#F_B/>S6.AZ>^YEL)-4M8]1<' 6V+_/D]E)V@^Q-58M-BM?B>]E
M86\(TF[T@R7]JJ#R?,$@6-BO3<PWCW"^U=O+%'/$\4T:R1N"K(XR&!Z@@]:K
MVNE:=96SVUI86L$#_?BBA55;C'( P>* .1^$MI:0^ ;.>WMX(Y)9;@221H 7
MQ/(!DCK@=*CUNVTT?%[0I[R"TR^F7.))D7EUDBV\GN,G'IFNUL]/LM/C,=E:
M6]LA.2L,80'\ *6>RM+J:&6XM89I8"6B>2,,8R>I4GH?I0!XUJ%C:#P9XKUG
MRU_M"R\3RO;7&3NA/VJ,':?X<@G..O>MG5FTW6O$_BK1O$.J6=@Z"(VC72*'
M2W,2D20NQ&")-Y)'0XST%>A_V#H_DO#_ &38^5(V]T^SIM9O4C')]Z=<Z-I=
MY+;RW6FV<\EMCR'E@5C%CIM)'R_A0 [3$QH]FC333_Z.@,LPVO)\H^9AV)ZG
MWKQRZTNQ3X<Z[J2Q 7MCXBD%K<ASO@'VU5^1LY7Y3CCK7MY (((R#U%9_P#8
M.C^0T']DV/DNV]H_LZ;2WJ1C&?>@#S?Q)"_ASQ/XB7PY";::3PP]TR09W/*L
MI'F>[A2?FZFIHTTUH)=?\*ZS;S:BVD7 @M-/B5?.(0LC2J"3N5\ $\Y..]>C
MII>GQW:W:6-LMRJ[!,L*APN,8SC.,=J2QTC3=,>9[#3[2T:8[I6@A5"Y]6P.
M?QH \]\,6OA[6;G0-5L]9M99WMGBEM+>)0]RK)\ZW(R2VTC.6_B/^USST%OI
MR? >)X$MTNH[R(RF+"N#]MVC=CGIN'/;->QVFD:;87,US9Z?:6\\YS-+#"J-
M(?\ :(&3^-,;1-)>&2%]+LFBDD,KH;="K.>K$8Y/OUH XFZT33-5^*6N6M_;
M)<0/HL#O%(24+&249*],@ 8].U8NE:@W_"*?#>ZO[J*>V\N19[2>9%,^(B%?
MYR%.S'0G^(8YQ7J7]CZ9YSS?V=:>:Z;&?R%W,N,8)QR/:N>U[PK/<7%DVEV>
MB2V%NCJVF7UMB$LQ'[Q2H.& !'*GACZT 5O!T.G^&=%U"_O;ZRM;>\U&1X2;
ME2D,;-^ZBW9VY&>@.!G SBNSN/,^S2^3_K=AV?7'%<K;>!;!M,OK:ZL-*MUO
M]@FM[.U A4+NP5!_Y:?,?GQV''%=:H"J% P , 4 >>^"R!\#+=B3N_LV<R%N
MN_Y]V??.:Y6^T]!\ ]+OIM;GV06,$RV,[(8+AA@B%E #,"< #=UQUKU:RT"V
MLUN[/RH9M,N)6G%M*@81NYRX /!4L2V.Q)[$ 30>']%M95EM](L(I$.5>.V1
M2#[$"@#CO'%S=7?@3P_=FV-KJ,FH:=(D ZQ2EURGX9(KOY8DFA>*1=R."K#U
M%4+S2EU'5+.YNBK063^=!$.\N"H=OH"V!ZG/7&-"2-)8VCD171AAE89!'H10
M!Y)X>M;V^^&WA :9/8R7L1GF2QU $PW@#.&4GLP#9!Y[^]=WX'O(+[PI;RV^
MGOIZK+-&]H[!O)=96#J"."H8'!';%:1T+1S;I;G2K'R(V+)']G3:K'J0,8!J
M[##%;PI#!&D42#:J(H55'H .E 'E>H'3==UGQ7I7B#5[73KJ"Y4V[SHHFB@\
MM#&\+L1CYMQ^7N3GK5E=$T[5/'NMVVHPF[B;0K5W6XS\SYE&]EZ!N!VX/3%>
MA7.D:;>WD-Y=:?:3W,'^IFEA5GC_ -UB,C\*'TG39+B6X?3[5II5VR2&%2SC
MT)QDB@#R;2ULKVU^%=YJR6TVZUG26:Z56W!;<[0Q;K@C//>M#4K6WDE^+$)B
M21!912!'&X!OLK," >^[GZUZ0-'TP6\, TVS$,+^9%'Y"[4?^\HQ@'W%/CTR
MPAGFGBLK9)IQB618E#2#_:..?QH \[G%BFE_#A;$6ZQ_VE 7$ 4#>;60G.._
M(_.J$G]G:_+XAM=:UJ#3M6L]5<QMY:B[B17!@,+$YP5V@!1SD]SSZ=_8FDB*
M"(:79>7;G,*?9TQ&<Y^48X_"GRZ1IL^H1ZA-I]I)>Q#$=R\*F1![,1D4 ><7
M$UEJ\GQ!@UX0M?6:,EM'<8!BMO(!1DSTR^XDCOCT%=IX&D27P#X>:-U8#3;<
M94YY$:Y%:-WHNE7]RES>:99W-PBE$EF@5V53U )&0.:M000VT*0P1)%$@PJ1
MJ%51Z #I0!X_=,NCZ)\2I]&AAAU6*_;RS BK,D)CA,A7'( !9N._-=+<VUI:
M>,_!]UX:2*."]CF6Y%N $FMA'N5VQUPQ7#'G+8[UW"6-I'=2W26L*W,P"RS+
M& [@= QZD#WJ*RTG3M-+FQL+6U+_ 'S!"J;N_.!S0!1\6>'X?%'AB^TF7 >:
M(^3(1S')CY6'T./PR*XVVU2_U[P;>^(;2Q\K5M,TJ6TAC$6&CNPO[[:/8JH7
M'^T*],ID4,<*E8HTC4L7(50 6)R3]222?K0!YF\-JMEX!U;P\$%W=W4,4TD?
MWKBW:)FF\SNV-NXELX8>IK'2:TT/PIXLFLH[>W>+Q'(ET8(QYB6?GQ^9PN#L
M"GIZ&O6[72=-L;B2XM-/M;>:3.^2*%49LG)R0,GFI$T^RCEN)4M+=9+G_7N(
MP#+QCYCCYN/6@#E/"UCH\7B.ZO\ 2-8MKE;JT3S;6P1%MQ@_+(0I.'()'N ?
M2G^+Y]//B#P]8W6UKB5KB2%+EP+7"H S2*1\Y ;Y5XY)Y%=+8:7I^E0M#IUC
M;6<3-N9+>)8U)]2% YIUWI]E?^5]LL[>Y\I]\?G1*^QO49'!]Z /&;46%YX&
M\++=-:7*VOBGR,L%98XC/* O.<(0!@9Q@#TKVE([:6R6.-(GM7C"JJ@%"A'0
M#IC%0-I&F/;2VS:=:-;RR&62(P*5=R<EB,8)SSFKH    P!T% 'B-M!I\?P8
M@BMTMXIVUB)9_)PKX&H$+NQR,#./3M6MK,<GAS6_&T7AV$V['08;ORK?@^;O
ME5I /[^T=>I(%>DOH>DR)(CZ79,LDAE=6MT(9S_$>.6]^M2QZ;80W1NHK*V2
MY*[3,L2AR/3.,XH XKPS;:!<^(+#6=&UNUD>:S9&M;"-466/@AIE!)RIP,G!
MR<=ZL_$V&.70]++E@1K%D RN5(S,H/(]JZJQTC3=,:9K#3[2T:8[I3!"L9<^
MK8'/XU)=V%G?HJ7EI!<JAW*LT8< ^HR* //8?#6B2?$3Q#I3Z? =.DTRWN7M
M,?NFE+2J9"G3=@#YNO?K6!X>U9+BQ\'66NWMLEA<Z(WD/J$8DAEG5PI4[B!N
M" 8SZD#K7KITC3#/),=.M/-D78[^0NYE]"<<CVJ.70='GL%L)=)L9+-6WBW:
MW0QAO7;C&: /-2UCHMQX9T>;6H[CP](EVD-W?1B2!Y@R%$))"D!?,523],X%
M,U'1M%L;+PO$EW#J5BGB7:DTR(8HT>.0F)#R/+#<8R>1CM7J5SI>GWMB+&[L
M;:>T  $$L*M& .GRD8XHDTO3Y;*.RDL;9[2/&R!H5*+CIA<8&.U '!206C>-
MO&$<>WR)-!MWPC?+_P MN1CH, =*R=!L+2QB^%NHVT8CO+N$0W$VXEI4-HS;
M6)Z@$# Z#'&*]2?2-,DFEF?3K1I9EVR.T"EG'H3CD?6FC1-)40@:99 0',.+
M=?W?^[QQ^% 'ELUHFM+JNEM=64FI_P#"0F1-1:ZC!2)9!E,%A)E4#1;0,'UQ
MS7JEO>Z?]KDTNWNH#<VL:E[99 7C4CY25SD ^]<5'X&O9C-;ZII_AC4!*[LV
MI3V1:X;<Q.60C&X9Q]X#@<=JZNR\/65CJHU&.-/M"VRVJR; '9!M^^W5S\B\
MGICCJ<@&1XSN+$:AX>LKL;YKB\<P1S2!+=F6)B3+D'< #E5ZEMO(ZUYZK6]S
MX)DMA<Q2"U\8+%%]GD*K'&;L8V ,=JXSCGCL:]FO-/LM1B6*^L[>ZC1@ZK/&
M' 8=" 1U]ZBDT3290XDTRR</)YS!K=3N?^\>.6]^M 'F&N&;PO?>/D\.1?9F
M72+:Y6. 8VR%I%>0#^]M&2?4 FM"6/P]#X\\!76D&S6.>"["R1,,RKY(VEC_
M !'.>3SDFO0X],L(KI[J.QMDN'7:TJQ*'8>A.,XJ"U\/Z+8R+)::186[JQ=6
MBMD0ACU(('4X% '-_%<R#X?W>W/E&XMA/C_GGYZ;OP]?;-4_B&K6'B?P;XAN
M,C2].O94NW_AB\U B2-Z*#U/;-=QJ%A;:IIUQ87D0EMKB-HI4/\ $I&#3+*T
MEBTY;.]D6ZVKY9D=>95QC+CIG'7L>O&<  DEOK:*.%S*K"9@L6T[O,)Z;<=?
M7V&3T%<EJ'F#XR:+Y&?FTBY%QC^YYD>W/_ JZ:PT/2-*D:33]+LK1V&&:WMT
MC)'U IEGI2Q:M=:K<%7O9T6$$=(HE)(1?Q8DGN3Z 4 <]\3U5_"UJC$@-JMD
M"0Q!_P!>G0CI7.:D-+\-:WXXA5;BSTQM&M[B:.P;8^]C*A=.P<C&6_$UZ==V
M%GJ"*E[:07**=RK-&' /J,BHCI&F&664Z=:>9*ACD?R%RZXQM)QR/:@#S2UD
MM+3QAK%HFH6&FV\_AD.QT]P5A8,XWY&-[JG.[ XQQ6UX,-SI_B2;2-4TJR@U
M!=/22.^TXX@NX5?:"5QE7R??.3C@5V$6B:3"JK%IEE&JQ&!0MN@ C/5!Q]T]
MQTJ2STVPTX,+*RMK8-C<(8E3..F<"@#E/&NI0V7B3PM#JCHFB7,\Z7+2\1&4
M1_N0^>,9W$ \9 /:L;5?[,TE-(M=+G:3P]=>("+\B3= A=25B7' B\S;D=,Y
M'J*]'O+*TU&U>UO;6&YMW^]%-&'5OJ#Q3?[.L?[/_L_[';_8MNS[/Y2^7M]-
MN,8]J /,/$UE]BN?'EE8H(](_P"$>^UR0Q_+'#=XDQM X4E55B!UX)ZU,=#T
MQ?%7@@+;(!J.G7"7N&/^E*L4;*).?G /8YXXZ5Z,FD:;'8M9)IUHMHQRT A4
M(3[KC%(-'TM9()!IMF'MQB%A N8QZ*<<?A0!Y#<6]O#X7O+16,%I9>-4@@6.
M0H((C-&2JX/R@;C]*Z&'1H- \>ZW;:-'Y&F3:"9[R!&)C6XWD(V.S,H?ZXS6
M[XI\(C4]-M[32+'38 +^"[N Z^6L@C<-@[5.2<8Y]>]=#!I=A!:/;1V%K%#+
MS+"D2A&.,<C'/XB@#S&T2/\ X1'X43?\M/M5LF<]C;R$C\P/RIC_ -G:_)X@
MMM9UJ#3M7L]5D\MO+47<2*^8#"Q.<%-H 4<Y/<UZ=_8FD^7#'_9=EL@.Z)?L
MZ8C/JHQQ^%/ETC39]1CU"73[22]B&([EX5,B#V;&10!YK>36.KVOQ%BUT0-J
M-GYJ6Z3XW16X@!B9,],MN;([GZ5W?@V1)?!&@M&ZNO\ 9\ RIR/]6M7;O1-*
MO[I;F\TRRN+A4*++- KL%/4 D9QR>*MPPQ6\*0P1I%$@PJ(H55'H .E 'DVM
M: ?[1\2>"[2UC5M9*:GITI3Y8& Q+D]@&1<#_IJ!T)K;T>>#Q5X8O?$-Q9+
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MK2M6LYH;^\FCO;)CYUHS2NR.NS+%2'((*_ACF@#L+_7=+N3H<C:AJ%I]IO\
MR[=(XG3SY%WJ8I,KP.&.#@_+[4V[\?\ A^R:_$LUV?[/D$=WLLI6\C(!W-A>
M%P0=W3TS7.S67B&;2/"*ZG!/=W=GK?VB>9(=K?9U$JK(ZC@,0R$@<\GCK27V
MFZC+9_$B--.NRVJ+MLAY1_?'[,L?'I\P[X]: .VO]?L=/4[C-.PA^T%+:)I6
M6/\ OD*.G!QZX.,X-0CQ5I,EM!<6LTEW'/;_ &M#;1-(?)_OD 9Z\8ZY!XX-
M<5):7VDZ[;:E=>&;K6-.O=+MK:1(8E::UFBW<%&(^4[SSGJ*L:SX?#QVALM.
MO]!U"ULBUC<:0FY(V9V/V>1%RK#[I.1MR6Y'< ZZZ\4:;:Q/*QGD2.V6[E\F
M%G,439VLP SSM;CKP:V:\QUK2-7NHHKY(+_3_%4&F0JMS8)OMKJ7!+02+RFT
M-GEL !NO&*[RSO[N34#87.GS(T=M'*]VN/)=SD,B\YR,9Z=#0!A?$_4;[1OA
M_J>J:;>26MY;!&CD0 ]9%4Y!!!X)JQ:R6\NK6<5EXIFNIANFDMO-BD$D8&TY
MVKD8+J<Y'-5?BC8WFJ_#W5--T^TFNKRY"+%%$N2<2*QR>@X!ZU?-ZCWUG)::
M#=BZ)\KSI+?RUAC8@N6.?11@#.3CZT /A\9Z+</<1Q2W!FM[I;.6'[+()%E8
M9 V[<D8&<CC'.<5/JOB?3-'^T_:I)2+2,371AA:00(<X9]HXZ$XZX&<8KD=1
MLM3A\46_C6PTJ=YC-]AN-/$.))+89 FR?^6@/(Y^X=O!S4Z2ZMH/C#76;0+W
M5=.ULQ3V\ENJ'RW$2QM'*'(VCY0<GCDT =/?>)M,L8#,7EG18!<N;:%I=D)S
MASM!X.#CN<'&<&J=QX[T"":&%;F:XEGM/MD"6UK)*9HB0 4VJ=WWAP.F"3C!
MKG-0L[[2?%]U>7_A>36]/U.U@3_0D20VTR*59-KD?(<YSGBEC9-'^)FC1G3?
ML\:^'IE-M90EUMQY\9P%49('3('4YP!T ->\^(6EC2]&U#35FO8-4O4M$>.%
MCY9R=P88R& #87&<^U=:L@:(2 -@KNP5(/Y=<^U>7R>&M4L=*M;Z/39Y&D\5
MG69+.+:9(H6W*.,XSC:Q /&3Z5Z@C%HE=T*,5!*'DJ?3B@#S[3M:/B"[UJ_N
MM4U'2X](U-@KA'CA%O$B%DD##:2V6)S\PR,8Q75V_B;39[\6)-Q#=/";B**>
MW=&FC'4H"/F(R,K]X9&17#2^'M6U?PAXXTN&VFM;N_U62\L_/0JLR Q%>>@W
M%",'!YYK<N(;GQ'XC\,ZL=/N[)=)$\]T)XBK*SQ[/*7^_P DDE<C"]>10!K:
M+XRT;Q!<1PZ;)<R^8DCK(;61$^1]C L5 #9['G!'K5G6/$NEZ#-:0ZC/)$]V
MQ2 +"[[V )P"H/.!P.I[ UD_#BTNM/\ !L%G?6DUK<QW%PS1RK@X>9W4^AX8
M54\=S_9O$'@N7RI)0NJME8UW-CR),D#OCK@<\<4 7T^(/AUM%OM5:YN(X+"0
M17:26LBRP,>@="NY<^I&/>KD/BW2IT8QM<E_M!MHXVMI%>9PN[Y 0"R[>=PX
MQSG%</XG\/:AJ.G^-]1L]/N&?6(K6VM;?RRLDOE=9&4_=!R0-V#A?<5T?B.U
MOCXF\,^)+2UGN+2R\^*ZMT0^:B3*H#A.IVE1D#G!X% &A-XVT&WTFZU*>ZDC
M@M)A;W(:!]\,A( 5UQE<Y&">#D<\T_3/&&BZMJMSIEO<2I=P1^<8[B!X=\6<
M>8F\#<F>XXK@?&6EW$7A_P <>(&@DCAU.73U@A<;781.BERI^Z6)( .#A1G%
M;WB#0+GQAKHN;6.>RCATB\L_M$\9C9I9U"JH!Y(7!)/3D8SS@ Z.W\6:3<75
ME"LTJ"_S]CEDA98[C S\C$8/'(]1R,BIH?$-A/>0VT7GMYT\EO',(6,;21AB
MZ[L8XV,.>"0<9KCETW4M=\/>$](N--N;*]TF\M9KQY$Q'&( 02C]&WX &W/#
M<XQ2V&DZA9^*K>]T2+4;*.XOI3J>G7*EK4H=^9XV/"LQVG"G)W<@ &@#J+7Q
M?H]Y>6EO#/(1>2216LQB81SO'G>JMC'&UOK@XS6/X?UJ2TU'Q>VJ7\TUM9ZF
MD,)D^8J'CCVHH4=V?  ')-<Y:VOB"YN_"U]>Z!J"WEEJ4K7B(46",,DBCRD#
M8V?,/FQD]R36D-+>9/&L6HZ)>75GJ&I0R1Q*I5I8ML2%T.0<J5+#H?E% '<V
M&IP:BUPD231R6[B.5)HBA5BH;OU&".1D52U;Q7I.B7\-A>RSB[GC>2&**VDD
M:4+C(7:IW'D<#GFL[P59ZM8'4[:\O+N]TU)4_L^XOTVW#+M^8/D D \ L 3S
MVQ5+Q-<BT^)_A"5HII%^RWX;RHR[*,0\[1R?P!ZT :2?$#PX^C0ZL+V06DMT
M+/)MY 8YL@;'&,H<G^+%6H/%FF7,,+0K=M+,TBQVS6LB3-Y9PYV, 0 2.3@<
M@=3BN'U'P]J(L[Z]ATZX9M1\26VH+;(F62"-H]SL.Q8(6QUY ZY Z/4[:^L/
MB)8>(TMI[K39=->PG6%"SV[>8)%?8/F(.-IP"1@4 :$OC?P_#IEMJ,E\5MKB
MY^R*QA?Y)L[2CC'R$'.0V.E.TSQGH>J?VB(KF2!].&^ZCNX'@>-",ARK@':0
M.M<%K.EW.D:>-2GMY5.H^,+:]CM0!O";E4<9QN;;NQ[@'G-:?B3PQJ'BC4M>
MU/3H6MS)H\=C;?:$,9N)5E\TY4X(7A5R0,[CV% '6#Q=I(NKBUF:Y@N(+;[6
M8I;617:'."ZKC+ 'J!R.X%<MXN\:VVI_#_5[SP]?WT$T-I%=1W*0/&&1V &U
MV7![@X.01CL:L:<1J5G<W7_"$3:3>Q6<D4DLT";R[#'EQ%22RD\EC@<#UXIW
MVE:E+\!HM$CTZY.IC3H;4VNSYO,7:#[8X)SG% ';+K]@?$/]@[Y1J(M_M.PP
MN%,>0-P?&T\D#@]:LZ?J5OJ<4LML9"D4SPL7C9/G1BK 9'(!!&1QQ7+>-[6\
M-OI'B'1E5=6L;A(XHY@5$L<Q$;1L/J5;V*UU.F6":9IEM91L66&,*7;JY[L?
M<G)/N: ,J]\9Z/8WU]9.UW)=6,:RSPPV<KL$;.& "\CY3R./?FDM?&VA7EWI
M\%O<RNNHC_19_L\@AE;;NVB0C;NP#QG/!'48K-BM[J'Q_P"([Y[*Y^RSZ=;P
MPRB(D2.ADW ?]]CZU@66E:G#X0^'UF^FW8N-,OH9+Q/*.856.123Z\L.F: .
MUB\7Z/->6]ND\A6YN'M8)_*;RI)DSN0-C&1M;V.TX)K"^(GB=;/P;KQTR\O(
MKNSC*M<VL1*Q2X!"%\$ \C..F1DC-8+VOB"\;0KF[T#4/MMCKQFN4B*+ D7[
MT Q+N (^927(SDG)IE[I^NVG@WQAX7?1;ZZNKN>YGL[J%5:.=)6W#+9X89((
M/IQF@#T*\\16.E6Q-R9Y6AMUGG$$+2F*/GYVV@X'#>YP< X-:=I=V]_9PWEI
M,DUO.@DBD0Y#J1D$?A7G5U;7NF^*KF^O_"=UJ^G:K:P*JPI')):RHI4HZEL;
M2"#G.*[_ $FV%GI5M;K:0682, 6T  2+_9&...G% &''XBT>PN?$E]+J>H21
MV#(;R*6%REIB//R*$S@CYB>1SG-7-/\ %VD:GJD6G6\LXGF@^T0F6W=$F08R
M49@ V-PS@GK7(ZCINHS+\2ECTZZ8ZI;K'9?NC^_/V81''I\WKCCGI5];2\?Q
M1X*N18W0AL]/GAN7,1 B=TC"@_BC=./PH Z_4]4L]'L6O+Z7RH594SM+%F8A
M54 <DDD  >M4X/$^E30ZC(\[6YTU@MXEPA1H<J&&0>H((((SFJWC1]330 VE
M6;74HN83*D:*\BQ!P7:-6X+@<C/?GM7"WGAW7+[_ (3*.PTN\A>[:QO+)KV8
M,)FAVL49BY.25(YX'&<4 >A0>*=*EN[NUDF>UGM+<74L=U&T16$Y_>?-_#P<
M^F.<46GBC2[O438>;+!<_9_M:I<1-%OAS@N-P' /7N.XKF]875?'/A#5K2#0
MKG2;F:S,:M?A%=Y00P1<$_)P02<#YACO4SS:MXT\.:A82Z#<Z-=S:?+;2SW@
M48D=<;8RI)9<\EN!@#J3P ;EOXKTFYNK.W665#?*6LY)861+@ 9.QB,$XY Z
MD<C(J"S\;Z'?Z@;*WFN6D6>6WD9K254C>-=S!V*@)QGKC.#7/?V?J.OZ1X1T
M^?3;FRN])O;>YO6E3"1^2A!"-T?<< ;<\$YQ26&AZE?^%?'.EB":SN-3O;R2
MU>9"H=)% 1L]@<$'N/2@"?5O$QN_%G@]-.NKZ.TO;F7<#$4BN8Q"[!@2.1D*
M1SR,$ ]:Z"+Q?H\UY!;I/(5N+E[2&?RF\J29,[D#8QGY6]C@X)KD5DUC4I_!
M)?PWJ5O+I=R1>JZH$C_</&2K%L,N3D$=O?BJ4MKX@O3HEQ=:!J'VVQ\0&>X2
M(HMNL7[T Q+N (PRDN1G).30!V%Q\0?#UJMXTD]ULLKC[/=.+.4B!L#E_E^5
M?F')X/.,X-:>I^(M/THRK.TLCPP&YE2")I#'%S\[8' X..YP<9P:X/4-*U.?
MPS\0[6/3;LSZI=.]DGE']\#%&@(].5/7%7XY-7\/^+KO4/["O]3TW6+.V0?9
MD4R6\L2E2CJ[+A2&SG.,T =7)XETU;2"Y@DENTGM_M48M8FE9HO[^ .!SQZ]
MLU<TS4K/6--M]1T^X6XM+A \4J]&']/I7":M::AI?BRWUBZ\,OJNGW>G16LM
MO8JLCV<J.[* K$ H1(1D8Y7/' KM="M4LM&MX(]-ATU &9;.$*%B!8G&%XSS
MSCC.<9H H3>--$@M=6N99KA8M)D$=Z?LLF8CC/3;DC!!R,C!S5Z36[))((C]
MHW7%NUPFRW=CY:XR> <'YEXZG-<UK/AF\N_&<A@CSHVM60AU;#8(,1^7_OM7
M*'V'M4_@?3-4TC1I#K8:2YM%^PP%1N:2WA9@CX_O-G/N M %>+QA8Z5H'AHV
M<VHZM;ZI.((;R>-G=E^8EFP 2V%.!C/MQ5>'Q6NB^,?%O]J7=_/96T=I+%$L
M#RF!&1V<[47Y5'&2?;)K)T[1M7LO 7@2-])NWN=(U&.2[ME4>8B[)5)&2 1E
MUZ'O[&M5[._;6?'D[:==A-0L((K7]V3YKK$ZLHQZ,P&>AZ].: .]M[B*[MHK
MF"19(94$D;KT92,@C\*\]2^O9/&/C&SNO%%UI]AID-K);N?)VP^9&S,3O0[A
MD#@UUOA&&:V\&Z);7,,D-Q!8PPRQR#!5U0*P_,&N*F\()XD\9>,1J6GW$%O?
MQVG]GWYAPT<D2'+H>JD-MZXSCO0!L^&/&4W_  K?3_$7BE&M9)!ME=(&P09-
MB.5 )4-\I].?2NC;5[*;69M"6>6/4!;?:,",C$9.W<K$;3S]?I7%:NOB37_A
MIJ6D:AI4W]N6^P$H!Y=YY<JMOC/3Y@N=IP<GI5ZRDO[OXDKK;:+J%OI[:+Y'
MF3(H97$I?!4$G..PR?:@"7P+KSGX?:1>:K=375W<O+&I(+RS.)'P !U^5?H
M.P%='H^N6&N03264C$V\S03QR(4>*1>JLIY!Y'YUYG9:)K-AX-\*73:%->2Z
M1<7'VW3&4"1XY2_S)DX9ERI SSDBO0/#$,/V:XNX-!&C)<N&\F2-$FDP,;Y
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M0C6TMLLZL;9U)-ME0<@E"5(_O,:[V]UFZEUZ71-*2#[7!:"[EDN 2JAF*H@
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MOY<OE2!MCX!VG'0X(X]ZL5Y1;ZWJ/AB#QUJEA8VDUI9:T\UPLDA5F7RH=P0
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M1110 4444 %%%% !1110 4444 %8?BO09?$6C+:072VUQ%<PW,4CQ[U#QN'
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M!R &&TY''4#I@@5<T1M9_M'5UU*XCGM!<9LV6 Q%%YRAR?FQ\OS=R3Z5MT4
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MB(/#E]V[=ZL1C'2K,6NA=/LKS4+&YT];E@C+/MS Y.%#X) R< 'IDC.,UKT
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<1\7O\
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M_P CABP*'.4P22-I&"3CK0!R&O7VJ:/>>+])M=1O/LL.@G5+69I2\EM*-Z[
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MA^R?91&!!L\O8. %QC'Y4 >>:!JEVEZ^DZ['J-GK*Z9*666X:>UOL;<S1-G
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MOB;58+C1M0N6L]LP" 1Q(X5QC#*>F#P,YQDFO4[.SM]/LXK2TA6&")=J1H,
M"N,\.>%&DN_$C:WIMS%%?:H]S'&]T#'-$50*&1'(/*G(8<C .>E &=;G4_$G
MB^WM+G6-4L(;GP[;W[PVDWEF.9I"#CCCI@_X<4Q]4U#5O _B;Q''J-U:ZGIM
MS=F!$E81PBW)VQM'G:V0O.X$_/[#'>C0M.77CK8AD_M P^09?.?'EYSMVYVX
MSSTZU6E\*:+->75RUHP-VP>YC69UBG8="\8.UCP,Y'/?- '(0?VEXF\8S65Q
MJ^J6%M/H5K>FWM9O+,4KLX(4XR,8'N<<G'%4O#7B/5]3D\+Z'JMW,1</?I-=
MQL8VN_L[E$ 9<$9&6.#D[?0FNBDT"ZO/B;=ZG<65W%8-I<=I'<PW8BRZR.S#
M".&P0PZCJ.W6MZY\,Z/<V%G9-9*D-DP>U\EFC:!@, HRD$>_//?- '%_;/$:
M3^)]"T^9[TZ;?6KV@GN3'+/%(@EDMQ*>=P (#$YP>3WJ)?%F^RL[:T>_MGO-
M;%E=V^IS.DMH3"6$7F?,0&95PP[.<8/([EO#>E/9&U,$@0SBY+K/()&E'1S(
M&W$\ 9)Z #H*CNO"6AWVE7>FWE@MQ;7<GFS^:[,\C@ !BY.[(  !SP  * *_
MAJQU33K[5(+_ %!+BW=TFM;<SO-);*00P,C@,REE)&>G(KGKG2#K/Q1UVV_M
M*_L5_LFT)>RF\IR=\V/FQGCT[]\UV6BZ%IWA^S-KIL!BC9MS%Y&D=STRS,23
MP,<FH[SPYIE]J1U"6*9+MHO)>6"XDA+QY)"ML8;@"3C/3- ' ^'=<UF[N? C
M7M],\EQ/J%K<L&*I=+"L@1RO3/R@YJU;W>O7&F>)8M.GDO+BU\0M%%;RW9C>
M6!4C=H4D)RI(W8Y]:[+4/"^CZE9V5I/:;(K%@]K]GD>!H2!M^1D((&#C -5X
MO!>@6\<R0630B:Y%TYBGD0^:!@,"&X./2@#B]2U]Y_ -]?:9>ZQ975MJUO#-
M;7;D36Y:6)6B9B22N&)!!Z-6K=P7FI?$+6]+?6=3@LUTJ"=([>?R]CL\@RI'
M(^Z/KWR.*Z2X\)Z+=Z?+8W%J\D$TXN)<SR!I)!C#,P;)(VKC)XVCT%2_\(YI
MG]ISZB(IA>7$ MY91<RY:,9P/O<8R>G/)H X/0_$>IZW9>#]/N9]TFH:1)<R
MN;I[9KB5"BX#H"V0"S$#&>O;!N7">*-)TJSB>=]>^R7,QNK:TNVCNG@P"F'^
M4NR;AD<;LKWKH;GP'X:N]$L](FT[-G9-NM0)Y \!_P!A]VX?0'%7%\+Z3'!9
M10P2P"R#B!H;B1&7?C=DALMDC)W9R>: .-EUJ[GT31M5TI-4UG1A#/\ :X(K
MAH;Y#O #D;@7*;70KGKSSQCM?#MU;:EX6TVXMKR6[@EM4VW,F5DD^7!9NX8]
M_>F#POI*"V\F&: VR/'&T%S)&=KG<V2K#=D\DG)SSUK1L[.WT^RAL[2%(;>%
M D<:# 51T% 'DVD7TOA_P"LEI<7,;7WB-["6X>=Y/)B:[=6<;B0&VY&[KD@G
M)KKXIKS2/B5;:3!<7,^F7^G27#13S-*8)(W4;@S$D!@X&,XR.*UE\(: MIJ-
MK_9R-;ZB[27,3NS*S,=Q(!.%YY^7'//6K>GZ+8Z;*TT"2O.R",S3SO,^P=%W
M.2<<YQZ\T :%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %<UXSUB_T6VTF>REA19]5M;6?S(]Q
M,<D@5L'/!QWP:Z6N-^)4(ET'3GDA,MM#J]G+<#RRX6)9079AC[H'6@#H]-UO
M2M8CFDTS4K2\2%MLK6\RN$/H<'BELM9TS4IY(++4+6YEB 9TBE#%0>AP.Q]:
M\V\2:3/JVI^(]4\+1++!+H(MI'ML!+N;S-VU2.&81AER,_? ]JW/"]YX=\1:
M[;:QIHU.;4(+9H97N5D06R$@F-L@*6W=AGH3]0#4\6:W>:)J7A[RKBWBL[R_
M^SW7FIR$\MWR&)PH&SGC\:THO$V@SZ7)JD6M:>]A&Q5[E;E#&I]"V< ^U<_\
M0HXO/\+7%U$&LK;64DN7=-R1)Y4@#/V W%>3QR*Y+Q7I\4FF_$#5-/B4:=?V
M,$,1C7Y;JY7=N9 /O<%1D=2#Z&@#U%-?T>2*XE35+-H[:7R9F6=2(Y/[AYX;
MVZT?V_HXL/MYU6R%GO\ +\\SJ$#9QMW9QG/&*Y#7A#IVN^#]9MX8UT**247<
ML*#9&[PA(I'QV'S+N/3=6#XETZXN],^(>HZ=&\VFWBVCPB$;EFDCP970#J,!
M02.I4^E 'JRZA9O?M8+=P&\1/,:W$@\P)TW%>N.1S57_ (2'1O/$']K60E8D
M*IG4%B#@@<\X/!QWXKC8]3LM9^*"7-F]Q)9S^'I(EN8H7P29@?E..N >?48Z
MUSWA;5-#O1X,LKO5[2%]'W+ CQ21RSLR&-$8,H5#@C(#-E@,'O0!V?AWQ@CS
M:K;Z_JEA#<1:S-8VBDB'S%54P I)).6]3UK83Q3I4GBB7P\MU%]NBA65U+@<
ML3A1ZG )('08KS'5!!)X!^(A1$:YFUF1HMJY>09B*%>Y&0V"/0UV-M<QQ?%R
M\=MYCOM'MQ;2(A99-LDI;# 8X# _C0!H^,M8O]%BT:6SEACCN-6MK6X\R/<3
M'(X!P<X7CO@_A6OINMZ5K$4LNF:E:7D<+;9'MYE<(?0D'BN;^),(DT;29)83
M+;0:S9S7/R%U6)9/F9A_= ZUS?B32;C5-2\3:KX7A$MO+HB6\C6W"7DPEW%5
M(X<B(%<C/WP/44 >C6^OZ/=>?Y&J6<GV=0\VV=3Y:GHQYX'OTKF?#WB:Z\11
M1:W!K&GPZ='-.MY9R;28X5=UC?>#E6.P$[N""<=.8O#=_P"&]=UN+7+!M1EO
M;>T:&>:[$D:VR$@F-]P"EMW89Q@GTSS%BUR?A5HLMM')-%I^N?:M0MT0ES;B
MZD<G9U/5'QCD#- 'JD.MZ5<07$\.I6CQ6_\ KW$RXB[_ #<_+QZU';^(M$NQ
M,;?5[&40Q)-*4N%.Q&&58\\ CD&N,U00:CXMU#6]/FCETP>'I;>ZGC(,<LA;
M,:YZ%@-WN,@=ZS#!]C^$_A+4+.RD=;(V4FI+:1_OO+13OX R2KL&QZ@F@#TZ
MPU.PU2-Y+"\@N5C<HYBD#;&'8XZ'V--O]7T[2POV^^M[;<I8>;(%RHZGGL,C
M)[5@>$3H5]J&I:UHAO)_MBQ+<7D_F*LS("% #@9*CJ0.X'4'&;XJOHH_&#V3
M026TTVCN$O8X&E>XRY_<(,%1C 8Y!.",8ZT =?<:YI-J8A<:G9Q&:,RQAYU&
M] ,EAD\J ,YZ5-I^HV6JV:7FGW<%W;/G;+!('4X.#R/>O*= >VN&^%@FCR;>
MSF23SHR-C"!5&=P_O# /<CCI75_#QX]WBA(R IUZYD0#H48)AA[$YYZ'F@#I
MK[6M+TQPE_J-K;,5W8FE5<+G&3GH,\9Z4V\U[2-/E:*\U2SMY$B,S++.JE8\
M@;B">F2!GW%>?>-[R.2^\7Z<MO+:W,FAX22.W:234/DEPH."JHA.#@9^;.1B
MI-*FL[GQOX3N7"[4\/2*7EC*[7S%C[PX. ^/49QQ0!WG]O:.;:TN?[4LO(O"
M!;2>>NV8_P"P<_-^%,B\2Z%-I\NH1:SI[V43^7)<"Y3RT;T+9P#7E-L+5O"O
MANWD6,I%XMD<QLO"1>;,=Q'9,,ISTY%7M?@:\_X6G;649DDFM+=HXXQGS"L.
M&V@=2",''? H ]3&H61OA8B\@-X8_-$'F#S"G][;UQR.:AM=;TN_N3;6>HVD
M]P%+>7'*K' ."< \@'C/K7!/KEGJ/CK2+^PBN+ZW&A72#RX7Q(VZ,[ <=>"/
M8\=:S-"U""?Q#X"N81*ENMI=0&VBM7$5FQCCQ#N*[B1@@EB?NY^4&@#NO!FK
MW^KVNKG49(GEM-5N;-&BCV+LC; XR?YFM6\UW2-/FDAO-4L[>6*+SI$EG561
M,@;B">!D@9]Q7.?#J1'@\1[6!W:]>2#W1GRK#V/8]ZBNS;#XRV<LHC&S0Y5W
ML!A7\U"!GL=NX^N,T =&GB;0I);.)-9L&DO1NM5%PA,P]4&>>AZ>E3W.M:79
M7<=K=:C:PW$C!4CDE56)/08)ZGMZUY)$MK#\+(%C2-)D\1B4*JX8*+W<&QUP
M(^<_W?:KS3:5->^(O#?B=-4>>]U"2XM8(5D*7T3$-$491C(PJ\D8VCG . #T
MV]UK2]-E2*^U&UMG?&U9I54\G ZGN>/K5+_A*](_X2>70/M<0O8H!-(&<#&3
MPHSU. 3CL,>M<)=SZ;;Z_P")=!\6#4UCU.99+40I(Z7<)B1/+4H"=RE2.W7-
M;-@8]+^)YBGBFACFT"VBAWAG&4DDW*7Y!*@C))]Z .ATW6;2+3(YK_Q!IUV)
M[IXH;B-EC1R7(6-?F.YAPO!Y(J]I^LZ7JRS-IVHVMVL#;)3!,KA&]#@\5Y(H
MMG^'>GP2(C >*@[1LN<1_;"Q)']W8<YZ8-;M]':S^)_'L!EDBM[G0X59[9=S
M$JDP;8!]Y@"O'N* .[A\0:-<3I!%JMD\TF"B"==S@]"HSR#ZBKL\\-K \]Q*
MD4*#+R2,%51ZDGI7E_A?5]&UGQ%X;FN-6L4O]/T]K2*VC613.[!,_P"L1<8"
M9"C/)//'/2?$1;M--TB\ABDFM++5K:YOHXU+$P*3D[1R0K;6Q_LY[4 =%#K6
MEW-O/<0ZC:O#;G$SB5<1'_:Y^7\:YKPEKVH>*TL]9M-3LS9.THNM/VAGB7<P
MB(8'(;Y03NX.3C%1VAANOB9<:_87$;:4NCB&ZN48>5)+YNY/FZ$JN[/H& [U
M)\*G4_#G2HLXEC$@=",,A\QR,CJ.* -B7Q1IB^)CX=6\A74?L_G8=AA22 JX
MR,DY)P#G ]Q63X,\80ZGHMBNLZG8KK%U/<HD =8VD"32(-J$YZ)[]*BN)TL?
MC LUP'2*XT-8HI-C%6=9V9AD# P""<]!S7&6GV>+X<:$0J+<)XG6=_EPX O&
M.\]\>60<_P!WVH ];N]:TNQN8[:[U&U@GD(58Y)54DGH,$]^WK5XD $DX [U
MY---I;ZEXD\.>*DU-I;^^:>VAA21DOH6"^7L91C*[0O)&-HYX./2-46%?#EX
MEU'*T M'$J1L2Y78<@'N<=Z (I?$^APVES=-JMH8K:+SI2DH8JG][ YP>@]>
MU)IWB72]1T"UU@7D$=M<(C9:5?D9E!V$Y^]STZUPFG'4_L^K:.E[#K]B-#F^
MQZA''MGBR-JP2XX+'J. ?E.14>GZAY*?#S59/,_L:TLFM+J5HV5;>X,**K/D
M<#ATW= 21GF@#TN#5+"YL#?07MO):*"6G64%!CKELX&._I7/^*_% MO!.M:I
MX?U"SENM/A+D\2A"!G! (P2.1G\C7%ZO:WT,_B+7M.MY;G0SK5A>-! N[[0D
M04SNB_Q MM.1P2AK2\5ZAH>M^!O%>J:+;M))>6 ADN_)=#<. 0D:A@"Q )Z#
MC('T .]74K=S'9"^M4U*2 2+"[ M@C[VS()&:Y_P1XQ@UGP_I/\ :FI60UJ]
MC=_LRNJ.X#L,JF<XPOZ50\(:P--U6^TK6I8WNY4%W;ZGT2YMSG:I/163E=O
MQR!R37+:4+>#X?> L(D<\6NQO,-N&0;Y S-W P5R3V(H ]:N=:TNSNEMKK4;
M6&=BJB.255.6^Z,$]^WK61<:OJ$/Q'L='\R(Z?<:=-<%!'\X='C49;/3#'C
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MM]K%A;-!M\T2W"*4W?=R">,X./I3Y]>T>U2![C5;*)9XS+"SW"@2(%+%EYY
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXV9WHQ5P-K'H01SBI;_6UMM5@TFV@-SJ$T+7 B#A%2-2 69CT!) '!)/L"0
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M6"ZA-+PB^4V2 A;[SX4G'';G)J"?Q5>/XQT;3;*R,MA?6$EYYN]0S % .#T
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M'7'RX 'U- %RWT"6#QC>:^;U6^TVT=L8/)QM5"S*=V[KECGBMRLSQ#K*>'M
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M"_+C:,8VX]_04_Q;H2:^;:UN]'BU'3PDA<B41SPR_+L>-N,?Q9Y';KTKIZ*
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M5>GTOQ-XK\,ZCI>O066E-/:M"IM9S-OEX(DY4;5!'W<DG/)&.>THH YC1/\
MA+;V V_B"UTZT$<1C>6UG,IN7(QN"E1L7OC).<=!UY^+PMXB7P%X?T22UL_M
M.EWEK(Q2Y)5XX7#$Y*C!;' Q]37H]&1G&>: .,.B:L/$'BR^%K&8=5LH8+;]
M\,[D1U.[C@$OVSTK DT_5[$>#]*LK.SGUO1M,/G(M[Y,BKM2(%6*,&1BK<%>
MJCICGU($'H<UF:KX=T;7&B?5-,M;MXO]6\L8+)]#U% &;X,9H=/N-.DT<:9+
M:RDR(MT+@.S_ #EC)@$L222" >1V(J/5-%U"#QQ9^)].C2Y'V)K"[M6<(QCW
M[U=">,AL@@D<&NBL[*UT^U2ULK:*W@3[L<2!5'X"IZ //-5\%ZG/X,\1V=LD
M#:GKMZ;IU:7$<(W)A=V,G"H.<=2>U>@1,[Q*TD9C<CE"0<?B*?10!R::1JUE
MXVUK5((+>>RU*S@3)F*NCQ"0;=N,'.\<Y&,'K6+8^$];M?#?@G3GMX#-HEVD
MUR1/\K*J.GR<<GY\\XZ5Z-10!PNB:5XLT"YN=&MXM/FT:2ZEGM[]YB);>.1R
M[(8]IWL"S8.0.F?2NY;.P[?O8X^M5;S4K:PGLX9S('NY?)BVQLP+;2W) ^48
M!Y.!536/$NEZ$LC7T[J(HQ-+Y4+R&*,G&]MH.U<@\GT/H: .9T'PE=V7B.#5
M8K./2#+;2+JEO;3[H+J8@;71!P,'<=V%/.,')-4-.\&^(++P]X7&RS&I>')S
MY<:SDI=1%61_FVC8Q4\<'!'/7COM*U6TUK3TOK%W>W=F56>-D)VL5/# '&0:
MNT >?ZYX(O?$IUS4'D2PO[RWMX;)2V_RC#)YJLY''+X&!G '<G TGC\5ZSX;
MU*WU.PL;2XFLI+:.""Y,@ED=<;RQ4;%'8<GD^@K>BUJPFUR;1DF8W\$(GDB,
M;#"$X!!(P>01P>QJ?4+^#2].N+ZZ+B"W0R2%$+D =<* 2?PH XGPGX:USPC<
MVL=I!$^F7%I']OM?/_U-TJA3)%QR'QD@XYY]155O"6O'P5-I'V:W^U/K7V\'
MS_D\O[3YV,XSG''3K7H\;K)&KKG:P!&1@X/L:=0!QEIHNLZ'J_B![&VAN[/6
M)/M48DFV&WG*!6#\'*'"G*Y(Y&.]5[/P;>:->>"H;()/9Z%#-'<2L^UG,D>W
M*K]<G&>A[UW9(&,GKTK/TK6[#6UNVL)FD%I<-;3;HV0K(H!*X8 \;A0!YY-X
M/\46_@;4?!UM;65Q;?:/,LKU[HH3&9Q+M==I.X'//3'Y';.F^*]&\4ZC?:3:
M:=>V.KF.6:*>Z:,VLZHJ%@=AWH0J\8!X[5W%% '*VVCZK%\05UB98I;3^R$L
M7F#A6:02%RVSLISZUFKX3O)/%EIK<-E'IE^EX[7EU;3_ +N]MOFVJZ#JY!3)
M(XP3D\"N\HH Q?#FIZEJ4-]_:=G!;2V]V\*&"4R)(@ (8' YYP?<'Z"CK^F:
MS=^)=-N+>"UO=)2&1)K2XF,:K*2I64@*0^ ",'IG(KIP%10  JC@ <"JHU*V
M.KMI8,GVI8!<$>6VW86*_>QMSD'C.: //]'\(^(+#2/!]G/;VA;1;V2:8QW&
M=R%9%&,J.?WF<>@Z^CM3\%ZWJ!\030_9[>YFU6VU33B\FY2T*H L@ XSL/3/
M6O2:* ..L-.\07/CV#Q!?:=:6EO_ &4UG)&+LR.KF0/D80 ]/4=?PK2\;:+<
M^(O!FJ:39M&MS<P[8S(<+N!! )[=*WZ* .1?3-:NO&>BZW/901Q6ME/#.D=Q
MN*M(4(VY R!LY/'7BL&+PAXDL]-M[RR6T75K#6+J_AAEE)BGAG+[HRP'RMM;
MKC&17::MXHTG1#(+ZX=!$$:9DA>00JY(5G*@[02#R:V* ,W1GU>:W:?6+>WM
M)G(VVL$OFB(#U? W$_3 X]R<G7=$OSXLTCQ)IBI/):12VMS:N^PRPO@Y0G@,
MK*#@X!'<5U%% 'G>L>#-4O=.UNXAB@_M'6-1M;IHC+A(HH#'M4MCEB$.<#&6
MQVR=G^RM4'CR]UL6J&UETF.S1?.&_P Q7=^1T ^?&<]JZN@D $DX H \]30(
M[#X/Q^'-?GAM;BWLB%DCDW$/'\RR)T)(;:<8SGBNK\,V%U8:#;KJ#A]1F'GW
MC@8S,_+8]A]T>RBFZC;Z'>>(=,AU"QBN-2B62>SDDMB_E;2NXA\84\KWSQ6S
M0!S7B?2=0U+6/#ES9PQO%IU\;F<M)M.WRW3"CN?GSVZ5DW'AS6)5\=A;:'_B
M>Q[+3,PX_P!'$/S\<<C/&>*[NB@#S2[\*>)KRRNK">VL;BWET1+*V\ZY(6SF
M$;([!0I#%B00W! &.*T[7P_KUOJ_A;4?L]D6LM-DL+N/[0<1[O+PZG;\WW#Q
MQUZ]Z[BJD^I6UMJ-I82&07%V',0$;%3L +98#"]1U(SVH X63P9KTFD:]812
M6EO,^LMJ^FW)D+ R>:LJJZ[> ,$'D]<]N=&^M?%?B#PAK%EJ&GV%E<W5C+:1
M00W)D5G=2OF,Q4;0.RC)Y.>U=I10!RFHZ+-J'AC2]+U#1K74+=46.]MGD&1M
M3 :-N/F#8QRO!/(-7?!^D7NAZ MA>W,DY2:0PB60R-%"6)2,N?O%5P,_AT%;
MU% ',7VD:FOQ!LM=LXK>:U_L][*</*4:/,BN& P=WW2,9'/>N=;PEKS>"KG2
M/LUO]JEUHZ@#Y_R>7]I$V,XSG QTZUW,>MV$VNS:*DS?;X8!</$8V $9. P8
MC!YR.#V-:% 'FGB7PIXFUN'Q#;M;6-R;J6*73[F>X(:"-2A,(3:0IRK98'G=
MSG%=#;Z3J\'CZ763#:&TO-/AMYR)CNA>-G8A1M^8'?C/'3IVKJJ* ,3QAIMU
MK/@_5M+LD1KF\M9((][;5!92,D^@S64^C:K)XF\+ZA]EC$&FV<T%P/.&[=(J
M ;1CD#9[=:["B@#S:+PSXGMO,V6]K+:S:[<7]Q9-=%%N()0=JLP4_=;!*X(.
M.]:.@^'VTS1O$&F>(DT^&PU*^N)$6.;Y6CE'*X(&, <?3/&*[BJ.J:/IFLQ0
MQ:I8VUY'%()8TGC#A7 ." >^,T 8?P^TVZL?"\$U]=-=75PJGSV7!:)0%BX[
M?(%8_P"TS>M6/&6C7NLZ59K8")KBTU"WO1'*Y02"*0,5W8."<=<5T72L_5=;
MT_18H);^9HTGG2WC*QLX,C-M4' ..3WH Y;6O!UWXJFU6]NV&GS7&F?V?:(&
M#M'\_F%W(X^\J<#/ //.!K^'I?%<Y0>(+/3[00IM9[2<R_:7Z;@"HV+U.,DY
MQT YZ*B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ KB_B4)#I&C"$JLO]N6.PN,J#YPQD#J*
M[2LO7M"M_$%A':W$LT)BGCN8982 T<B-N5AD$'!'0@B@#C;[7O$VA:AK^E7.
MH6UY)%HTFK65V;4)LV$JT;(#@C."#^>:EBU[7K2ST WFIP33>(GMXX0MJ$%H
M/*+RD'/SDX &0 "<XQQ70S^$[>\M]2%W>W,MWJ%K]CFN\('6'!^1!MVJ/F8]
M"<GV&$NO"%E>>'M/TF6YNB=.:)[2[!431/&,(P(7:3C@Y&""<B@#F];\3ZUH
M<_B?2VN_.FL=(.KV-VT2;BHW*8Y  %/S+P0!P?QK7_MS4%\5^%[/SE-MJ>GS
MSSQE!PZ+&05/4??/'L*T&\*6=S%J8U"6:\GU*U^QW$S[5;R<, BA0 H^=CZY
M/TQ1MO!:V-YI>I/JVJ7UWI,$L-N)'B D1@HV$! /X!SP3GDG P <_'XLU^^L
M-'N;6[BBU&^U=[&YTUX%?[+&&<$[00^5558DG!W'@9%5KRXU>PU;XD:EI5_%
M:O8M#<X: 2>:4M$;:<GA3C''//48YBT6UU06Z_V?JGBFSU=MTCV-WIJM;I(S
M%BK3-%ADW$\[R2.1SQ7:3>"K6<>(0^HWV->4)= >7\HV>7\GR<?*,<Y_.@#'
M@NK[4?B=I$HOYXK>;P^UU]F4*44F6+<.1GGCGKQQBNUU'_D%W?\ UQ?_ -!-
M8T?A"VBU/2M0CO[Y+C3[3[%E60>?#E3M?Y?50<KMK?EC6:%XG&4=2K#V- 'D
M_AW4O$'A[P;X(U$7UO<:5=?9+&6Q^S[6190%5U?.2P.,CH<UNQ:]XFUJT35M
M#MY'C6_>+[-)Y @>!)6C;+%O,#X4MGIGC!ZG9TSP9:Z?;:;9R7MW=V6F,'LK
M>?9MC(!"DE5!8J"<9^O) -00> K.TUBZN[75-3@LKN8W%QIB2C[/)(>6.,;@
M">2 0#WXXH R8FFLOBAXEO9KZ9H+;2;>9XQ&AW(&F.SIT'/OSR:27Q3K%IX2
MT/Q<]PDMM?2VYNK$1KMCBF8*/+8#=N7<N<D@\\#C'40^&H(O$M[KAO+F26\@
M2WE@<(8MBYV@#;G^)N_>J=CX(LK&TM=/%Y=S:5:7 N+:QE*E(V#;E&[;N*JW
M(!/8=<4 9%KK'B&?6_$;S:I;QZ?H=V"T*68+3Q>0)"F2WRGGKS_2I]'U3Q3J
M$VA:G'"TFG7T0DO8Y?)6.)70,C0E6+G!(&&SD>AK=TSPW;Z;J.KW@NKBX.JR
M"2XBF"% 0H3@!0<;0!R36?H'@6V\/S(MOJVJ3:?"Q:VT^>8-# 3Z<;B!G@$D
M#KUP: .BOY98-/N98#")DB9D,[;8PP!(W'LN>I]*XWP_XBU*?Q;8Z9<79O+:
M[TAKMI6@"+YRNBDQ$!28SO."0<X!!-=?JFG6^L:3>:;=!C;W<+P2[3@[6!!P
M?7!K"T[P3#8:KINI/K&IW5S8VK6BF9X\21$J0K!4'0J.1@GN30!L:[<7]KH-
M_<:7;BXOXX':"$_QN!P/_K5P5YXWN6\&>(]6T;6#)<Z?;HQMM0M EQ:R9;>K
MH HY^7!P1P>M>AZE8C4M/FM#/-;^8,"6$@.ASD%201GCTKA_'GAPQ^#_ !)>
M1B[U'5K^Q2T!C@W.RJ254+&OJQ)/\@ * )+O7]?\->*M/CU6[@O],U.VN)!'
M%;^6UK)#'YA .3N4J".><^G2I=*U;Q1?'0]62%WTV\B$M]'+Y(2)'3<K0E6+
MG!(&&SD>AK;L=!@GGM-2O;FXOI(;9H8!<QJGEJX&\E0H^8@ $GL. ,G-/0?
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MMA;01!XE@=HU(E<C(ERY.%;@;>,'-26@U&;X@^,476+F-(+*T\I0D9$899B
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MIH]K//-;VJ;(VG*EMOH2H _2@#DM3MM2N_BU=0Z7J*:?,?#\69VMQ,1_I$G
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M/#WA,: 5WZSJFI+"GEVZWTJL(%]!A1DXXR<G' QDY .BHHHH **** "BBB@
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M(MK&0Z^C9'4<]JT;V\M-5\47&E>(KZR@AGTBWDL_MT2LCA@_FLA8@!\[<]\
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M6>9%,CF&/][^\(5BI)!R<_/D9YH ]5JD^I0M?3Z=;O')?PP"9H6?: &)"[B
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MI7D!P 2/PW 'WR*\[M=-U+P!XDT.QTK59-2\.:K<&W73[IO,DM1L9M\3]3&
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MFL55B%AD<QF9$QT +#@<#<: /9\CGGI52_DOXUMS80P2EIT6;SI"FV(GYF7
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MIDLOI>,HD3\, +]6;TKH]9\2:9H,MI%J$LL;WDAC@"0.^]@"=HV@\X!P.I[
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M)*_>_P"ES6L-)TW2ED73M/M+,2MND%O"L>\^IV@9-,M]#TBS%P+;2K& 7/\
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MFV;V<9!2W:!3&A'3"XP*P_$WB;^S]5L-$MKA(+J[5II;AEW>1"O5@O\ $Q/
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M[-CIQUPPX/U%</X&\>V$_ASPY::K?7+:E?0*HN)H)/+FF/.P2D;2_MGVZ\4
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M(/(R#R/H:L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=HH \HO+2]AG\9WS:7J<5E>^'<)<7CAFW(DV[=\Q(/S#Y1T]!6E8V4OB+3_
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M<W&FV\UY'''<.@,BQ/N0'_9/<>]<E!XVO[TZ9?6&E37>FWMR(2L=K-YD41)
MF+[=A7@$@= >IQ70^&=#3PWX<LM(CF:9+9"H<C'4DX R< 9P!DX %86@^$=:
MT"7^SK?7T;P[',98;8VW^D1J6W>4)-V-F>^,XXXZT  \5:ROBBY\.36%LE_N
MCELW^;RI[8Y\R0GL5QC;ZD=CD.OO$?B*3Q1J6@Z3IFGO-:VD5S'-<W+*K!RX
MP0%R#E< =.Y/:C5?!M[J9CU :E!#KT%Z+BWOE@)$40R/)V[N5*D@C."23UK/
MMY+YOBYJZ6ES9?:!H]JLBR D;M\O( .>,].^1R* $M?B%J6JVWAI].TBW676
M&N(9$N+@CR)H5?<IPO*Y7KUQVJW=>+M92*^M[?3HIM4TV&,W4$4,\R2SL@<Q
M(ZK\O!7#-GENG&:DM_ TEA/X::ROXQ'HTD\TGFPDM<R3!@YR& 7EV/>I+WPM
MK,'BFZUGP_K4%DNH*BWUO<VOG*60;5D3#+AMN!CH<<T 077CB;^T(M/CB@L+
M^:PBN[>TU,-&UR[[LQ*<@!E( /4Y;H,9JS=^+9%\4W6A6[V<5Y 83';71*O=
MHX!9XFR =H+#&"25/2D\0>#[C7M.N=*NKFVN;":!(XVNH2\UO(!@RJV>6/!Q
MQR.O.*9KO@R?7H9;&\NK>6T\V*2UGDB)N;38$!V/GDL5)SQC<<[NE %2T^U0
M?$3QK)IL,,EX+"Q>..0[5D?$W!(Z9Z9K1T?Q5/K6D>'[FUC@^T:BS?:8B&_T
M<(#YOOE6 3GJ6'2GFQ7P]XAUWQ7J.HP1Z?<VT*R*8B#"L6[!+9.<[SV]*K>#
M=*L?[5UKQ!I[N]CJ-QOM ?N8*J970'H'D&??:".#0!H>+_$%WX<T^SN;6RCN
MC/>P6K*\NPCS'"Y'&">>Y%8K^,];T[4-:TO5=*L1?6FFMJEH;>Y<Q31*<,I8
MKD,#CMSGM4GQ1DV>'],"SQ0R'6++8\G(!$RG)&1D#J>:NWOA:YU2;4[^YNK=
M;Z\TUM-@*1EHX(F)+'J"Q)(/;[H'J2 4K;QAK"Z=I=U?:?8QG6FMH].CCG8G
M?(A=S)QP% SP3GIGO5IO$NK1ZOJN@&TMI=7MK(7]F5++%=1Y*X(Y*,&&WJ>H
M/M1=^#9KOPMHFG&_2/4=%>"6TNTA.W?$NT;DW<JRY!&>]:6GZ'*GB"?7M0DB
MDOY+5+1%A4A(H@Q8@9.22QR3QT QP20"GHWB:;7-,\/W=HL!?48FFN$.[]TJ
MCYP/=7*ISZY[8K,L?&7D:1?S-I=K!>MKSZ5!;P/A)IRX7>S;1UY8G&<#UK:\
M/>%H?#U]JUQ#,SI>W)FBB(^6W5OF9%]B[.WX@=JPY?A[<SZ-?6KZJD=X^LMK
M-G<Q0'$$Q;< 5+'<!R.HZT 49=1DT'XE:YJFK" QVGAQ)V>V0KYBK*Y^Z2<-
MD$=3VZ=!M1^+=0MM31=2TV0:8]I+<RW<=M,BVA1=Q1RZ@,",X88Y&,<U%+X*
MO]6U>]O=<U"TEBOM)_LR>"UMF3@LS;E9G.#\W<&IM*\+ZY_9TFE>(=>CU'3Q
M;O;(L-MY,DJ,I3,K;CDA2> !SR<F@#!U^^U#5_\ A!-5GM[6*UO-8MYHD&3+
M$&BD*!FZ-E3DX P1CYNM=AXSU)M(\':KJ"V5O>BWMWD>WN&PCJ!R#P<\=N]<
M]#X'UX:=H.FS:[9R6VAWL4]M(;)O,DCC5E57_>8SAL9&.F?KT_BC1Y?$/AC4
M='BN$MVO8&A,K(7"!A@G&1G\Z ,>Y\2:L/$EAHEAI]D?M>F->)++,P"%608*
MA>@W]LYXZ5I^$==E\1^'HK^XMTM[D2RP31HVY0\<C(=I/8E<_C52/PW?)XGT
MW63>VY^QZ<]B8A"PW[BI+9W<<H.,'OS5KPEH,_AS2)+&>ZCN2US-<!TC*8\Q
MRY&"3T+$4 8_Q">TU.Q3PQ<:K!IPU"*226:298]J(/E )/4R%..ZJ]2^#?%,
M^N?#R+5 (I]1M8GAN4:3"F>/ALL >N W /#"MK3=,O+;5]2O[RYAG-V4$0CB
M*F*-!\J9+'/)=L\<L:Q[/PGJ&GZ[XCO;;4;9;/6</]E-NW[J79M+YW<ENI&!
MGCI0!SFJ>+?%EW\.U\00V^G6-O=PVK1LDKO*/-D5&&, #A@0<DCZ].HGU>>V
M\;Z5IEY8V1::QN)OMBD[TV%-R@$<*=P[G.*K/X)N)?AG#X3?48_.MXH8XKI8
M#MS$ZLI*;O\ 9 /-79?#E_<^*-*UJYOK9_L=K-;RQ+;E1+YA4L1\QV@;1@'/
MN: (M-\0ZQJUOI.JV6FPS:3J$F"H?;+!"0=LK$G!S@94#(W=3BL+1-7A\/?\
M)E<^3O9O$2P0Q(#\TDD<"J. 3C+9. 3C. 3Q6KX:\):QX=6+2UUU)= MI"]M
M#]G(N N[<(VDW8*@_P"SDCC@<5%-X!FO-/\ $-K<:F$;5+]=0MYX(BKVLJA-
MA&6.[!C4]LY- &IH>N:G>:Y>:=?:=(L$<2S07ZVTL,<F3@H1(,AAUX)R#VJ7
M6)/#/VB5M9GT]Y8XMIBN70E%ZG"GD$Y'3DX%/T&PUVW!EU[5H+V<+Y:"VMS#
M&!W9@6.6.!Z =AR:;K&D:E?W\,UI>64,40SY<]H9=S_WB=XZ=A^/IB*E[:*Y
MTX1P53WY<J[[?DF4/">IZ5IGABRM+G6;$2(K':]VA**6)53SV! _"J^LZMHD
MGBSPY=1ZCI[&.6<22K.AVJ8FQDYX&:VX],U%;6W5[RT>X%P'G?[( K1=T5<_
M*<8YR>])J.A&\U?3+V)K>-+)W<QM#GS-RE<9R,8SGO63C/D45TM_6YW1K8?Z
MQ*K)_%S[/NG_ '>M]/Q.>UKQ'9ZAXE@T^*\L)M/@M_M,H>\6.*>3=A49N<@8
M)Q@Y.,UL:;<Z-XTTZ&[FMXIDMG97M9MLB1R#C)'(.!G!]#5NYT-3K,>JV@A2
M80F"6.1,I(F<CIT(.>?0D5C:EH=W:Z:FGZ=?I;F:9[F\9M.DG6<L22N$8;5S
M_#D\ #IG.^%A4=?XK>>OZ:F6)JX66&C&"?,K6U];WZ=M?3M8G\#Z6FG0ZM+:
M)Y.F7=\\UE O"K'M4%E'968,P XP0>]1?$:"*3P]:RO$C21:E:&-B,E<SH#@
M]N*DA?74TV]2;5]]](H6VD31Y4CAQU)4Y+$_7L./5_B6W;7M)ALHYYH&2>&=
MY&T^9@3&ZN !@8R5]:]:,I?7(UI/2ZUUV5O+7]7<\G[-BUXMTS4]6T86FF?8
M&8RJTL5\K-%,@YV';S@G&?88[U5\#SVKZ7=6L6B0:-=VER8;RT@50@EVJ=P(
M R&4J0:M:C>ZC(;5M-G$)0GSTGTV=UD!'8C!&#3$L[LZ9J"Z5>&#5[MQ,]Y<
M6+A-^%7A&QP$4*!D^IR<YQYG'"NG+U6^]^O1Z?/;S*^U<Z&BD&<#)R:6N H*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D90RE6 ((P0
M>]+10 R.*.($1QH@/4*H%/HHH **** "BBB@ J,00K)Y@B02'^(*,_G4E% !
M1110 4444 (RAE*L 01@@]Z4# P.E%% #)(8IL>;&CXZ;E!Q3P   !@#H***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J">QM
M+IP]Q:P2L!@&2,,0/QJ>BFFUJ@*?]DZ;_P! ^T_[\K_A1_9.F_\ 0/M/^_*_
MX5<HJO:3[L5BG_9.F_\ 0/M/^_*_X5+!96MJQ:WMH821@F.,+G\JGHI.<GHV
M.P4445(!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !116+JFNM9ZWI^C6L,<M]>I+*
MOFR>6BQQ[=QR 23EA@ >O(Q0!M45DZ%K?]L"_BD@\BYL+IK6=%?>NX*K JV!
MD%77L".16M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>literacompareredline-pro003.jpg
<TEXT>
begin 644 literacompareredline-pro003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"!54!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXVX#;7P2N/6KVNZGJCW_ (XTX:G<1V]IHT=U;>6J*T+LLI;#!<X.P=<D=B*
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M-E\]F8;-X4?P@/@=/H0* .RHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;2;RX,1_@(8D_CSD<5T7VF#S4B\Z/S'7<J;AEAZ@=Q0US;I<) \\:S.,K&7
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MK"ZS9OJ46Q=.9F%O(3S(JD@R>@4D''M@]\"_#=6]Q#YT,\4D7/SHX*\=>10
MMO;Q6EM%;0((X8D$<:#HJ@8 _*LN^\.6]WK2:Q%=7=G?BW^RM+;NOSQ;BP4A
ME8<$DY !YZUIP7,%TF^WGCE7^]&X8?I3I9HH(FEFD2.->6=V  ^I- &%+X/T
MQUTE(6N+9-*E,]LL3C_6$$%F+ EB=S9R><D]:GO/#=K<ZT-8@N+FRU P_9Y)
MK9E'FQYR%8,K X/0XR,]:J^%O$%SK;ZX+I+9%T_46M8V@8E601HX8D]3\Y]!
M6M<ZM96VE7&I&XCDM8(V=GC<,"%&2 ?7B@#+N_!FEW%AIEI ;FR_LR3S;2:U
MEVR(Q!#<D'.X,<YSG-8>O^$HM+T&_CTNUU2\74;^*XO1!=GSD"E29(\D9;Y%
M[Y/OC%7=-UGQ-JL>E:C;?V&-*OHX9I?,:198-^"8A@D.VUN#\O(Z<UU4MU;P
M[O-N(H]I .YP,9Z?G0!Q.B:-=W4LJIJ'B==/F@>*X75W0D[A@>6"NX-UY/&/
M4]-J'P;801Z&B75YMT08L@77Y1LV8;Y>?E./_K\UNSW$%K'YEQ-'"F<;I&"C
M/U-++/#!"9I98XX@,EW8!1^- &;I/AZST6[O[BT>X_TV=[B2)Y2R*[G+E5[9
M/-&JZ!;:K?6-^9[BVO;'?]GN+=@&4. '!# J0<#J#TXJGX2UZZUZ/6#=1VZ&
MRU*6SC,!)5D55(;)ZD[CZ47_ (@N;'QOIVCNELMC=6<]PTS,=ZF,I^ 'S^_2
M@!;WP7HVHZ'-I5S%*T<T_P!J><2$3>?G/FAQR&';' '&,<41^#[-=!O=)EOM
M2N5OHS%<W-Q<>9-(A!&W<1P,$\ #J3U)-;HGB:#SQ*AAV[O,##;CUSZ5S_C'
MQ'/H?@N^UW2A:W36Z!EWL2C#< ?N]>OJ* )I_"5C<6FEQ-/=+/I1!LKM'431
M?+M(SMP05X(((/>H[[P9INH:/>:=<2W16^F6>[G#@2SNNW:2<<8V+@   *!6
M[/<P6J![B:.%2<!I'"@GTYI6GB1U1I45F^ZI8 GZ4 8NO^$K#Q'#9?;)KN*[
MLFWVU[;2^5/&Q&&(8#'(ZC&*TM+TR'2;);:%YI.2SRSR&221CU9F/)/^  X
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M7.=YC]<\XZ9'2AO 6D_V[<ZI%-?P"[D\VZLX;IDM[A_[SH.I/?L>X/-=&US
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ML=Q.0'9>A(!/)&>:]"EABG4+-$DB@Y =0?YU']CM=V[[-#NQC/ECIC&/RXH
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M,I'U!%>-ZAHEY%;:QX4TVR3S=%O?[=TV1HLJ(CF1(E]S)YB?[H->R*H50J@
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MKOMW$R-EL 9; &<X7IS0!U47B^QE&!:WZ223B"VCDMRC73%-^8]V 5V@DL2
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M+"9U?"@,P+ %\<#H,^U7X+R:T^+'B(Q6%Q=[M,L^("F00TN =S#KSST&.<4
M;\'BW2[VQTVZT]WO?[31I+2*$#?(JCYC\Q 4+T.XC!P.I JK/X]T2VT674Y3
M<K'!="SN(O()D@F+!=KCH.6'.<'(P3FN9T7P?JWA.X\-:A%;_;!;6]S;W]M
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MVD<4H:S=4D=@-I8J&P#GT8'\16?K'BO3]$U.TTZXBO);N[21X([>W9S)L )
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M^'[[1M?BDT^VOM-T66U<W6F74RR103Y4KY&&; ^_G!V]/H #O:*** "BBB@
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M))CSL!BS';SG)ST':KL'BO4[G4-8TN*YLI)(-*6_MKV*V<)DEU(VLY#C*Y#
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M!C@]:Z<$,H92"",@BNBI0J4XJ4EH_P"OO\MSF33*VG6CV-DD,MU)=3<M)/(
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M.<;%_7UKLZ* .5;PA<ZIH-[IGB36I=4:ZA\GS8X%MQ&,@AE49^?<%.23]T8
MYS:\/Z'J^FD-K'B*75VC3RX<VZPA1QRV"=[< 9/OQR:Z"B@# UWP[/JNLZ1J
MEIJ365QIQE !A$J2+(H##!(PW'![<\'-8\?P^DAT*/3DUN4R6^J_VG;3/;J=
MC^8S[64$;LECDY'; %=O10 R)62)$>0R,J@%R "Q]>.*XF#X?7%MX<TK14UO
M=!IE]'=6[/:@G$;EU0X89Y/)[X& .<]HMU ]W):K*IGB19'C'558L%)^I5OR
MK+\5:^/"_AJ]UEK22[2U3>T4;!21ZY/;\_I0!E7W@6+5;WQ#)?WOF6^M6\,$
MD4<6QHO*SL96W'D%L].H%7_#^AZOII#:QXAEU=HT\N'-NL(4<<M@G>W &3[\
M<FMX'(!]:6@##\1>'WUQ]+F@O39W.G78NHI/*$@/RLA4@D=0QY[53E\)W$FK
M:W?C4TSJMDEF5:VSY80, V0PR?G;/ [5U%8NJ>(!IGB#1=*:SDD_M222-9PX
M"QE(V?D=3D+_ /7H S(O!D\4/A:,:I&1X? $9-L?WV(C%S\_'RGMW_*J]W\/
MA?Q:VMQJCK)J-Y'?0S01;'M9HPH1E)8YQL'Z_AVM8%CXDDU&Z\06L&F2_:=(
M<1B)I5!G8QAU /1<Y Y/?F@"&VT#7$T]Q=^)GN=2W1F.Y^R+'&BJX8KY:MSN
MQACNZ=,5:T+PY%HM[JEZ&B-QJ4JRS""+RHP57:,+D\GDDYY)K6M9)9K2&6>
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M%6?#V@:OI93^UO$<VK+ FRW#6ZQ;1TRY!)=L<9..IXR<UT5% !1110 4444
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MONO84,<<V]MRJ>H'/0]_6JA\):$VGS6#:>AM)YO/EA+L5>3.=Q&>3GG/J :
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MW(BW$C%CQ]T!A\W3GK6MK6GW^J>(/'EK8PSK->Z-!!;2-&RI*ZB7<H<C&?F
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M8\S.H^NU2?QI/&CW6G^)O"VM-;W%QI5E/.MX((VD:(R1[$D*J"2!\P) X#4
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M%9N@:Q%X@T*SU6&&:!+F/?Y4R[70YP01[$&N/N]5U+6'\>:7J%I:&PL+?RD
ME+$9@\P'!3DG<,\C& !G&2 >@JRNH96#*1D$'((I:X#P?XEGM=.\':-=:6T5
MOJ&F1K:W7G EGCA5B&0#Y00"0<GIR!6E'XU<:II5K=Z6]K'JEQ-;P"67$ZE-
MV&>(J,*VPX()ZCUH ZVBN#N?B+<6^G:MJ)\/R_8])OVM+QVND#*HV9=0 =Q&
M_....YZ#O* "BN/N/'D<&B#Q$+#?X?$YB:[6;]XJ;_+\WR]O*;O]K..<=J2^
M\:WL.HZ]966@/<OH\,<[NUTL:R(RLV1P<'"\#OWQW .QHKEI/&UI)!IYLA;F
M>^L5OT2\N1;JL3 ;<MAOF))X _A.2.,Z?AO78_$F@VVJ1V\UMYVX-#,,,C*2
MI'N,C@]Q@T :H92Q4,-P )&>0#_^HTM>:+?W&@^//'5WIND+>,EM97$J"981
M@)*6.<'+'MQSW(KIK3Q>E[JNBVD-H3#J^GM?6\QDP5"A#M9<<?ZP<@GO0!TM
M0SVD-R\33*7\IMZJ2=NX="1T..HST//6N0?X@%-)@O?[&ED:363I#QQSJ=KB
M7R]P) R"0<# ]R*L1^.8[8>(!K5@UA)HL<<TJI*)A)'("4VD ?,2I7;ZXY-
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MC[AP!OR/4^F.67?C@0:3>ZY!IQN-%LIWAGG2;$A"-MD=$VX95.?X@2%) Z9
M.NI&944L[!5')). *9',L]NLT#+(CH'0YX8$9'->2>(-5U'Q#\*?$5WJ]I:@
MV^HM'"8I"Y0QW*I@ J.@'7.3D\#I0!Z_17+IXQ^SZSJ-AK&GG3UM+ ZBLOG"
M4/ "0Q8 ?*P(Z GKUJ/3_&R7>O:?IKV<834(GD@FM[D3>65&XI, H"$CIRP)
M!&: .LHK-US6K?0M.%W.K2,\L<$,28W2RNP5%&?4D<]ADUEOXKEM-8N-(O\
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MW9&1D#.  =(Z[XV4,RY!&Y>H]Q63H>AIH-M*9=0N[^X<#S;R]D#2%5SM7(
M49/;N3WK$E^(5JLMK+#;QW%A/>?9-\-P&G3YBGF&(+]S(Z[LX(.*R/B'K)UO
MX>^*19Z=%<V-F)+=YY)<-YJ8#,B[3D*3C)(.0V,X&0#TC>FX+N7<1D#/)'K^
MM5K'3X=.66.VW)"[EQ%_"A));;Z DYQT],5SRZC:IXVT^Q;2-]]_9$DT-[O7
M.P,@:,#W)')QTJC9_$2>YL-*U*309(=/OK_^SVE-RI:*0RM&IV@?,NY1DY&,
M\9ZT =U0>E<GJOC86":_-;:>;J#0@IO#YVQCE Y"#!#84@\D>E='8737NG07
M1A,1E0.(V8' /3D4 )96$-BLOEY:2:0R32ORTCX R3]  .P  ' JU7*6GC*6
M?2]<GFTT0WNE7)MFL_M&6E?"[,';P'W+MXYSVJ+5_'::8M^8K6WN9--VK=PB
M["REBJNRQ+M_>$*PZ[<G@<YH ["J.KZ?)JFF2V<6H75@[E2+BU8"1,$'@D$<
MXP>.AKG]9\<-I=A>ZC'I<CV%G:Q73S7$A@\T."=L0*D.P Y!(Y(%.U+QC>0:
M['I&F:#+J%Q-IYOX3]I2)7 95VY/3[W4]\>N0 =#IMA#IEC':0,[*F69Y&W.
M[,269CW)))/UJW6!%H5M9^)KSQ/Y;13S68BG5)&;S<;2"5SMRH7 VC^)L]:3
MP[XE?Q%%:W<%K ;"ZMS,EQ#<^;L8%?W;C:-KX;ID_=(H Z"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "N=\9:+?Z[IEI;6!M@\5];W3&>1E&(Y ^!A3R<8KHJ* .%UGP1=^(-
M5\1&\>WBL=6TV*S1HY&:2-XV9@Q!4 C+#C/;WJZN@ZQJESH4^N"R#Z0QF!MY
M6;[1-L**QR@V+\Q;'/.!VYZVB@#G/!>BW^@://9ZA]F+M>3W"M;R,PQ)(SX.
M5'(W8H\6:+J&LOHAL?LV+#4HKV7SY&7<J!AM&%/)W=_2NCHH X\^'-7&L>+;
MP"Q,>L6T4-N#.X*%(V3+_)QG=GC/2J.B>$-9\/7FD:A;&QFGATB+2KZW:9U1
MQ%]R5'V$YZY!'0]>.>^K-;7;)?$<>@DR_;I+9KD Q$)L5E4_-T)RPX% ')S>
M"-1CM=/^RO9O<C7SK=Z9)&12Q+91,*<X! R<?=SCGB_K&A^(K;Q9_P )!X<F
MT]S<VR6M[:7S.J,$9BCJR@D,-S#&,8KKZ* *]C'<Q6<:7DRS7.,R.B[5+$Y(
M4=@.@SDX SFN4F\-:PFK>+);9[%[76X4\OS)'5T<0B+!PI&WC=GD]L=QV=%
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M8TD,K1$1L&)&%?H2,<CMD5!?:[9:=JVFZ9<&47.HNR0;8B5)52QRW0<*>.M
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MW-DDD<*HR[ KXW9!'.=H_+BLR7P)ILVBZEI,EU?-:ZE=-=W(WJ&:1F#'!V\
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M>.O)R ;-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.\U 2LLLXW)$L:@DE0P)R64 9'4GM@R>&M=.KV\]O=/:?VG92F"\2TDWQB0
M'Y2><89<^A)':N9U9M+O_B-X*F_T2X%Q:7K;\*WF?)'M.>_0X_&L"XDCL=-^
M(T6GQHNIIJ'F>3 JB?[-Y<!D*CK@KO\ ;- 'KD-U;W&_R9XI-AVOL<':?0XZ
M4L5Q#,2(IHY" &(5@< ]#^->9K#X2U:+4]6TO6?[1>319(IX8Q"(5B W+YJJ
M@VL#]W//7C@UT'PWTK2[;P7HNH6=K EU<Z9;+/.BC?)A!PQ[X)/TZ=J .LFN
M(+90T\T<2L=H+L%!/IS0+B!CA9HR=N[ 8=/7Z5QWC&"]DURQGTB\L#J4%I/_
M ,2[45_<W<+%-^#U5AM7GISSQ6#IVJ:9'XH\&ZK-#'I-G<^'IHHUN7"A<&$A
M-QQG"@X]1S0!Z>)XC"9A*GE $E]PP!]:Y_Q5XBGT;1K34=-6UN8Y;R"W9G8D
M;9)%0E=O4\^M>;Z5K%II^C:)-<R(-"A\27RWXQ\D19Y?(,@_A4,5// (4]A6
MSXK7P]_PB5U+HLJ/:7FNV<LTT4V87E,T>_RR#CH,G;QG/<' !Z?'/%,7$4J/
ML;:VU@=I]#Z&EEECAC:2618XU&69S@#ZFN(T&WLM-^*^O6>GQ06T+Z7:2M#
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M9L$YP,=-/::3JOQ=N(;R&UNK<>'HB(Y0KICSY.<'CH>OO0!WSS110F:25$B
MR79@% ]<U@^,M?N- \%ZAKFFI;7$EM%YJB5B489_V>OYBO._"=^RZ?\ #8W\
M@;2&M[F$/(<QBY'$08GC.T.%SWS3O$$)M/"?Q.6V95T0R)]D53\@E**9@G;&
M\C@?Q;N^: /7)[J.WMA+)+#$6&%,K[5+'H,UB^$/$,VN^$8-8U%;>VD>2=9
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MUO\ XF0Z0L4>ME(WM$B $VTVR;F0#GUY'?WK2E^PW=]X!OO#)A$K/M?R,?\
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M;PQPQCHD:A0/P%5M1S-HMT0986:!B"K;70[<]0>"/:N)\%>.;1?#OA>QU/\
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MN]9GNOB3X4CCCU.TM[FWNW:*9ML<RA%*-M#$9&3PP##(R* .\50JA5 "@8
MX J-[6WD=G>")G9/+9F0$E?0^WM6?X@\06/AG3#J&H^<+<2)&6BC+X+,%&<=
M!DCDU7@\4V]P@6/3]2%TTDB1VDEOY4LBIC<X#D#9\R_,2.2!UXH UVL[5W#O
M;0LPP 2@)&.E/$4:R-(J*)& #,!R<=,FL.S\8Z5J&GVMS9F::2YF>".U"8F\
MU,[T*D@*5P<DD#ISR,K:>+=-OK+SX%N#-]K>R^R% )?/3):/&<9 !.<XP,YH
M UH[&TBB>*.U@2.1MSJL8 8^I'<U+%%'"FR*-(U_NJN!7'ZQXMT.\\,:G)=R
MZI:)9W*6UW';ADN()-RE1E3@ Y7Y@<$'K6ZGB"U?Q._A\PW"WBV_VH%E 1H\
M[=P.>>>,=: +]Q96MV +FVAF Y'FQAL?G3I;:"?R_.ACD\M@R;U!VGU&>AK+
M3Q';RP0M%:W4D\[R+#;J%\R01G#,,MM"@_Q$@'(QU&8+7QEI-[IL-W;M,\DU
MRUFEKLQ-YZYW1E2>",$DDX &<XH VS;0&!H#!&86SNC*#:<]<BFFSM3"D)MH
M3%&,(FP87Z#M7(^#+^XO/%WC".5[U8H+FW6."[<L8<Q L!R0 6)/!QSQ7:,P
M1"QS@#/ R?R% $26MO')YB01*_\ >5 #^=/EABN$V31)(F0=KJ",CZURUO\
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M-YM[D(9#R6('N.,9KHXM4?3O&PT&>1G@OK5KNT9SDHR,!)'GN,,K#T^8=,
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MV[MB%0S?,0, LHZY.>!UJK;^*+*XU#3[)8;E9M0LS>VX= -R *2#SPPWKP:
M-NH;>TMK3?\ 9[>*'>=S>6@7<?4XZUCVWB[3+K3/MJ>>,WCV*0LG[QYU8J4
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M7R72VQNHEEAV"XC!"DH6(S@D#G'4=JC@\::5<:9HVHQK<&UU>=;>V<Q])#G
M89R/NMS[4 7=4L+XV+#09K.PO2ZDRRVWF*5SR" 5_G5G2[!=,T^.V$C2N"SR
M2L,&1V)9F([98DX[5DS>,]+ANFB*7!@6_73GNE0>6EPV,(>=W5@,XQD]:I:9
M-<#XI:]:M<W#VZZ=:RI"\K,B,S2@E03@9VCI0!U]%%% !1110 4444 %%%%
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MMQ/%N3=#Y8?.[&W<.<$G';/%>A76J6%E=6MK=7D,5Q=/L@B=P&D/7"CJ:MT
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M@O(9+RW4--"C@M&#TW#MG%6Z .5T2PU"#Q]XFOY[&6*SO8[5;>9G0AS&KAN
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M12R=P#Y>><]:VK+PG=V>N:=JC:LLTEEIK:?M>UQO!96+<,,<HN!Z>IYJC;^
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M,AXADOHV/V 630+ 0"-^_<&W'G/MT_.@#>HHHH **** "BBB@ HHHH ****
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M/>&8GTS0/AKJ%M=W@EO)%M9T-PYC>)H9#M\O.T8*@@XSQU- 'L-%>7Z=]O\
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M5+;4[2.YB21945Q]UQT8$<@]>1ZU?JM>W]KIT FNYEB0N$7/)9B<!5 Y))Z
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M3U"/XG6FE?:<Z?-I4UP8/+7B19(U!W=>C'B@#H;VSM]0LYK.ZC\RWF4I(A)
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MQ]G:/Y_.R,C8%R6XR>,\#-<WX.\2OJ%KXBNM1U*.:VL]6DMH)B@C"QA(\+@
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MZ42M_8?;VDN)O+A@7"D*T@4C<=XP,= 3VK US5K3Q-I?@'7X+<Q_:=:MV0.
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M>(DVG?M##.2O(('2H-;\<PZ6VI"VMX;LZ;@7,1NA'*Q*ARL28.]@K X)7).
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M&CZSJMG;FX_MRW:$PON;_C\*[0"HVX "CDY'7%>O5YS'X*\01>#;/0 ^F/\
M8M32ZBD\Z1=\:SF;YOD.&.0N!D#&<GH #;C\;);S:[#K-@U@^DP1W+!9A*)8
MGW;2#@8;*D8]<<FI-,\7B]\1KHTUK$&EMS/%/:W/VB/@X*.0HVOSG'(([UFZ
MMX+OM;U?Q')<RV\%IJNG0VD;Q2,TD3QEF#D%0",L._;WK7\/1>+<H/$<VEXA
M3:#8;R;ANFYMP&W_ '1GD]1C! .BHHHH **** "BBB@ HHHH **** "BBB@
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M/>!K"]_URH,,/*R1M4=>..V.*W_$MY<6TFEPV]^+83W)22.--\\ZA&.R($$
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO(:4F&,+G!5.@)SR?85>HH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHZ44 %%%% !1110 44@(89!!'J*6@ HHI 0PRI!'J* %HHHH ****
M "BBB@ HHHH **0D*"20 .I- (8 @@@\@B@!:*** "BBB@ HI RL2%8$@X.#
MTI: "BBB@ HHHH **** "BBB@ HHHH **** "BD5E<95@P]0<T$A022 !R2:
M %HHI 0PRI!'J* %HHHH **** "BD) (!(R>@]:6@ HI,C)&1D=12T %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1103@9/2@ HH!!&1R*0$$9!!'3B
M@!:**3(! )&3T% "T4A(49) 'J:6@ HHHH **** "BBB@ HI"0N,D#)P,TM
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MK9.4.5XZ]:H6G@SQ%;:!H%@W]F/)INMMJ,C^>ZAT+RMM V'#?O?IQUH U?\
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MIJ "BBB@"I?Z5I^JI&FH6-O=K&X=!/$'"L.A&>A]ZM !5  P!P!2T4 %%%%
M!1110 4444 %%%% !1110 53M=)TZQN9[FTL;:">X.9I8H@K2'U8CK^-7**
M"BBB@"F=)TXZF-3-C;?;PFS[3Y0\S;Z;NN/:KE%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 13VZ7"A7:0 '/[N5D/YJ
M14']F6__ #TN_P#P+E_^*JY15*<EHF!3_LRW_P">EW_X%R__ !5']F6__/2[
M_P# N7_XJKE%/VD^[%8K16,,,@=7N"1V>XD<?D6(JS114N3>XPHHHI %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5F:]H5KXBTLV%V\T:>9',DD+;7C=&#*P.#R"!VK3HH PXO
M"\$.N/K"7]]]K>S6R)9T8>6"6'53SN8G)]?3BLM_AQI!T/2],CN]1@;2F9K&
M\AG"7$&[[P#!<$'N"#7844 4M+TR+2K(6T4L\QR6>:XD+R2L>K,QZGI[   8
M K/_ .$9\N:\DL]8U.S%Y*TLR1/&RECP2N]&V<#^''KUYK=HH Y>_P# .BWF
MG:7:6YNM.;2LBRN;&8QS0@C##<<Y#=\YS3M0\#:7J.EVEI+<7Z7%I-]HAU".
MX(NEE/!;><YR."",8P,8 QTU% '.7/@RRNM/L[22^U FVNTO?/,JM++,F-K.
MS*<XP.!@8 &,"EU[P=8Z]?VFHM>7]AJ-JAC2\L9O*D*'DHW!!7/.,5T5% &!
M<^$-.N#I+B:\AETQG:&6.<[VWC$F]CDG=U)ZYYR*SW^'6DNCQB]U-(3J U&*
M%+G"03;]Y*#'0MS@YQDXQ77T4 8ECH,&BZEJVKPS7MQ/?!7FB9E8,43:NW@'
M.T <GGOZU0\/VJZMX@G\63:/<Z;/+:)9Q1W:!9BH8LS,H) R2H'?Y3V(KJJ*
M *>IZ>FJ6#6CSSP NCB6!@KJR,&!!((ZJ.U8M_X'T_4[/48+NZO'DU%HC=7
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!TO[&\4=TTCJWF;\CY ".W;^E '84444 %%%% !1110 4444 %%%% !1110
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M_B5Y+^XF4:Y=H4D5 "05^?A0<_CCVH [FBLGQ-=:E9>'KJYTFV>XO(]A6*,
MN5W#?L!X+!-Q /4@=:XJ[\8SOX/U#5](UN:>2WO[:(PW5LD<T >2-'BE38.?
MF8@C\SB@#TNF2RK#"\KABJ DA$+'\ ,D_A7$Z[XKO?#_ (EUU7<W%C9: -2C
MMRJ@^9YCKC<!G!VCKGJ:V--AUW[;I]W)J\-UI]Q:DW$3QJI$I *F':H^7[V0
MQ)QCGK0!IZ-J]GKVD6^J:?(9+2X4M$Y4J6&2,X/(Z5>KR#P=?ZOHW@WP'<Q:
M@&LKZ[6QELO(7;M?S"'W_>W KZ@8[=SZ_0!SDGCKP[#->12WLL9LF"73/:3!
M(">1O8IA>/4UT$4L<\*30R+)%(H9'0Y# \@@]Q7F%E;ZG>^(_B18:;;6DKW4
MT,.^YF**FZW R0%.1@YQWZ>]3V]AKWAZ^\.>"]-UU8(3I,^ZX-JLC"2,IA@&
M[9<\'C% 'I=%<+;:MK6MVOB-[+5/LT^C3M9PKY"%9Y8XU9GD!!.UF8C"D8 Z
MYJA8>)M>\4:MH<5C?IIEMJFAM?.HMED:*0/&I*ENOWCC(QCL: /2:*\RTCQG
MK4S66@7\\8U1]:N-+EOXX@H9(8_,,BJ<J&8%5Q@@$DX[5>N=?\16&I>(]#@5
M]3N[2UAO;*4(BRM&[%70@ *7&UBO'/ (/< [74;^'2].N+ZX65HH$+N(HS(Q
M ]%')JPC!T5QG##(R,'\J\XN_&%Q-X#\2ZOHVM2R7-A'N$5[:*EQ:.%Y21-J
MC)/0X(Z]<5J7>H:Y<^.;+1K;51:VESH[W3%;=&=762-<@MD9^8]1CV/& #M:
M*\XL_%^KMX,T.\NIT5Y]5:PO]06-0(HUED3S,$;5+%$&2, M]*W/"6H:KJ&J
M:XMU>B[TZUNO(LYQ$J^:-JL3N7 ;:25R!CCU!H W=6U>QT+3I=0U&5H;2(9D
MD$;.$'J=H) ]ZJZ?XHT?4[U+*WNRMU)'YT<$\+PO(G]Y5=06'N,UE_$[_DF7
MB+_KR>LP>']2UC5_"NM7BVUK9:';-*OE2M)+.SQA<?= 50!GJ<]/>@#OZ*X'
M1]8\4:W:Z#KED&^QWK+)=P3F 0I"XZQE3YF]3C@GGG@<"H=)OO%^I66NWT&J
MPSRZ;>W]K;V/V5%6Y9 1%E\Y7#8^O<\\ 'HE,CBCA4K$BHI);"C R3DG\Z\V
M;XA"S\.:[J<=[<S7=C# ATW4[=89[69W*9<*JY0ED.1G[IYYK<O=1U;0O%NA
MZ;)?O?6FL+-"6EA0-!,B;PR[ ,J0""#G''- '6QQ1PILB147).%&!D\DT^O+
M-/\ $GB8^'/#VNW.K)+]IUD6$]L+5%62-KAXLD]0PP,8(''(/6O4Z (&O(%O
M4L]^9V7?L49*KZGT&>!GK^!J/3=1@U6R6[MUF6-F9 )HFC;*L5/RL >H-<OX
M%N9=4D\5:A(^+A]9GM49AG9'" B+CT&"<>K'UK#@\4>(IO!?AR_74(1>7FN?
M8;AVME(>,W$B#@8QPHZ<^^>: /3ZBN;F.SM9;F;<(HE+ML0N<#K@ $G\*\]N
M?%NK>'?^$N@O+Q;]M,-F;6::)4VFY.S#A, JK<^N.,]ZZ8VFLVEU>_:=42\T
MQ[$[%FC59DF&<XV* 4*XZY(/M0!JZ5J=KK6E6NI63E[6ZC$L3%2I*GH<'D5<
MKS#PIJE]8:%\-+2WN-MKJ%NT5Q$44A@MNS@@XR#E1WJR_C'4[.+6;=[A9;C_
M (2*+1[*62-0(A*L9W,% W;=S'WP!0!VJ:Y8OX@DT-7D^WQV_P!I9#$P'E[M
MH(8C!YXX)Z&IM,U&#5M.AOK99EAF!*B:)HWZD<JP!'3O7&6UI=P?%^XC?49+
MAF\/ QRS1IN3]_CHH4$9YZ=ZSK/Q1XBO/"7@F_74(4NM6U#[-=,ULI# B4Y
MXQC8.F/K0!Z?17G4GB3Q!I6E^-H1*=5O=%>,VLK0*K,DD:N=RH #LRQX R!6
MEI.JZC>>.!9VFKC4=$73ENGG\J-L2LQ4)O0 #(^?&,\'L10!V=5+S48+&:TB
MF68M=S>3'Y<3. V"?F('RC /)XJW7,>*=4U#3=9\,QVEPJ6][J0MKB,Q@EU,
M;MU/3E1TH T-8\2Z;H8D^UO,QAB\^98(6D,46<;V"@X7(/Y'T-:L4B31)+&V
MY'4,I'<'I7#:5:S_ /"W?$#'4+DJEC:-L*QX*EIL(?ES@=L'/J37:WDCPV5Q
M+&T22)&S*TQP@('!8]AZ^U $%SI&G7E];WUS9PRW5MGR9G0%H\]=I[9]JNUY
M_HOB#6)?$VE:=+J#74-_I,EPT[VZK'YR%,M#@*QC^<XW#D8()YK%@\3>+H?
M^D^,9M6AN(1<K'=V M%42QM.8LAAR'&1C''J#R2 >M5G3:Y8P:[;:+(\@OKF
M)Y8D\IMK*F-QW8V\9'&<\UQ$^H>+M0E\7+8Z[!;-HUQ_HR?8T82#R5DV,3G
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MC.>15Z**.&,1Q(J(.BJ, ?A7G^L6MW_PFG@BWBU&03FTO_\ 29(T9U!2+H
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M5C+0K<.5C+=MQ&2!5CS D2M,R(2!D[N,^Q- #+**:"PMH;F;SYXXE627&-[
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MZ'9ZU\1DMO$%E#/<2^&K:6ZA;HTPE(9B!W!&,]JQ[_4M+>XT[4+.XMK?;XM
MD:XD!NB?,9)"S9&R/' 4Y^7;DCI7L'V"S%W]K%I!]I_Y[>6-_I][K3#I>GEY
M'-A:EI7$DC>2N78=&/')'8T >?Z5:Z/_ ,)5X_AD@LA,[QE%**&*-:JS$=\$
MY)]ZS= N<6'PQM;X*VD7%@ZD/S&UR(U\L-GC.-^T'O[@5ZJ]C9RR2226L#R2
MILD9HP2Z^A/<>U-;3-/>R-DUC;-:GDP&)2A_X#C% 'D'B:R6W\/^/;:-5&C6
M^HV360'"PS,T9G"?W1EN@Z$L/6NNTZQLM)^+]S;:?!%;1W&AK/-'$,"203D!
MV]6P2-QY-=BVFV#VB6C65L;9/N0F)=B_1<8%*FG6,=PMQ'9VZ3*-HD6)0P&,
M8SC/2@"S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !6!XM\2?\(SIMO<BTEN'N+N&V4(N0N]PN
M3^!X'<XK?KEO'VGWNH>'H/L%J]U-;7]K=&&,@,Z1RJS;<D#. >] &5/XADTW
MXD7BS2:G/:/HD5REC'$TC*YE<$B-1QPHR3^?-=$OBW2I[72Y[222Z.J1M+9Q
M0I\\JJNYC@X P",Y(Y..M9,$-^?B3<ZQ+I=U'9OHL5N&(5OWJRNY3@GG##GI
MG/-<_H%CXBTO0/".G7&C7IM8(9XKZ.V=%F23(,8+[AB,C))4]0,\<$ Z34/'
MMG%I^A7NG6]Q>0:M>+;(ZQ'Y.6W @X.[Y&&/4>U=+=W]MI^FS:A>2>1:P1&:
M5W'W% R21]*\QT_0M=L_!OAJ!]$N?/TG7FN9H$DC+-$7F^9,M@C]XO4@]>W-
M=_XC.J-X4U Z3;12:FULWD03892Y'0YX/X\&@!EKXJT^YN9K8I=0W$5JMYY4
MD#%GA8D!U"YSR",=1W%5=-\=Z)JMM]JMFN_LI@69)WM9%CD#-L"JV,,^X@;1
MDY..N:Y[2K/4XO&PU<Z)JB6LVB?9WDNI4>3S1)N.X!SC/8#CV J"#PYK4GP<
MTG3$T\+J^FM!,;&Y*A9FBD#%"<D88#KT^E '<:;XALM2U&[TU!-!?VJJ\MM.
MFUPC?=8=BIP>0?KBM6N,TJZDBL[W6;7P,^GW$5OM$!2%+FY;.=BE3]P?[77/
M XYZ2PO!K6@V]Y&LEN+RW615?&Z/<N>W&1GM0!QOC/Q.);'2Y-*N+Z.-]9MK
M;[5 "L4W[X*Z;AR1PPS]TX(R:W4UG2X/$>N,;W46FLK6)[JV:.1HHD^<AHTV
M\DX.2N<X'I7#Q:=XBB\!Z1X9D\.WCWNDZA;%Y8FC\F:*.8-O1BPZJ.A P>N*
MZ-[+4!XP\47O]FW/V>[TN&"!P%/F2*),J.?]L<GCKS0!JZ?XXT;4[;[3;_;!
M 8HI8Y7M759?,.%5#CYFSQ@=_P :GA\7:3(-2$\LEI+INTW<-PA5XPPRA &=
MP;MMSD\=>*Y.;0-9D^%7ARUATT2:GHYM99=.N"H$_E+M>//*\@G!Z<"EU/1[
MW7_"][<:/X6BT6_5[>>&*X2*.6Z>&02;6*$@+\N!D\D] !R =%>>-M/L[;5B
MUM>?;-,M/MDMFT6V1HB#AAVQP<\\8YQ6-JNN7M[:^!]1BENK,WVI01W$*Y19
M%:%W((ZE<J,5H3W&K>*?#&L0G0+C3))].FMT2\9/,DE9" !M8X0$GDXSGH,5
ME7-GJUWHG@9/[&O(Y-.OK>2ZC;86C1(71F.&/\3# '..U '66?B6POKG5+>$
M3B;2SMNEDC*%21N&,]<CD$<5H6-[%J&GP7L0=8IXQ(GF*5;:1D9!Y''K7&^)
M]#N9?&6GRZ?(BQ:Q"UCJL9/+P)\^\>^-T>?^FHKL-1M/MVE7=DLAB\^!X@Z_
MP;E(R/IF@#+C\7Z3)+9#?*EO?2>3:7;QD0SOSA5;WP<$X#=B:C3QKI$NLRZ5
M"M]+=0W*6TP2SD(B=EW N<?*I'\1X/;C-<M#H>K:GX&T+PI>:=-;7>G7%JD]
MQQY2QP,#YB-GDLJ@ =06Y Q6_P"&;2]M_%_BRYN+*:&WO;F&6VE<#$BK"B'H
M<CE3UQ0!?\47UC96MB+Z\OK19KZ".)[,,"\A<;48@$!&/!SC(R*@OO'&CV%Y
MJ5FRWTMQIR))<QPV<CE58$[AQRH"DYZ=.<U!X^LKV_TK3HK&TEN9(]4M;AUC
MQ\L<<@9CR1V%439:@/%/C&[_ +.N3;WVGP0VS@#]ZZ+(& &<CEQUQWH Z-_$
M6GF"P>W=[IM1B\VTC@7+RI@,6&<   CDX'('4@5P^D:_"_@S7KK6-6UB*V77
M98([B/>)XE$B!$SCY!G"G.!R1WIFBZ9KGAZ[\*:K)I%U<PP:$NDWMM%M,MO(
M"K;P"<,I*X.#Z&H;K1M=N/ GBFQ&B7:W5]KK7=O$6C)>,SH^>&P,!#U]L9H
M[74_&ND:5JLVF3+?2WL42SM#!9R2'8S;0PP.1G.2.!CUXJ6]\7:582K]H:9;
M8W(M&NQ$3"DQ.W86[?-\N>@/!(-9\%M>-\4YM3-C<+82:/';+<, %\P2NY7&
M<]&'.,5S^DZ1>Z=<WF@ZAX-AU'=>RS6NJR1Q/"T;R&0-+N.X,I8\ $G QZT
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MZN&N[:39'CA4F1V))('136QJ6JO9?90-)OKR*X)#M;QJWD\<;U+ X/L#TYH
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MT =C2$A5+,0 !DD]JX_3?%&L7FHZ0W]F-+IVHQEI6CM9HS9$KN7<[_+(#TR
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M5:"_B+1A:0W0M;F*XBNH)C'O59(W#KE<C(XQU'6MNB@#BY?!>IW-WKMU<:W
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M+:\M;$BYMHS%#++/)*R(<?*"['CC@=NU:E_86NJ:?/87T"3VLZ&.6)^C*>U
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M,9[YJ\GAW2X[R]NTMW2>^C$=PZS./,4#"C ; P"0,=,G% 'G5D;O3?A3X/\
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M<[#\V,<].E:-<#X7U?1]:\<7>J)J4?\ :,]C';)9K#+&"L;,Q?,B*6.7Z <
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M+A=N[ QG&37 2:UH(^&]U>MX<F.F'47CFLO,7(E^T[2['=_STP>,_E6[XBU
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M5-X*@Y7A@1GMZ'BI6\=01Z=9:S)92+H=Y.L,=[O&5W-M21TQPC'&#DGD9 [
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M=J%G-<.B-Y6=DB2;,Y^9L@KT/>O0:* *U@EVEE&+Z2.2Z.3(8QA02<X7O@=
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M+D\\D <^W-=/"_B*V\):_P"%HFM)].FMY;?2I9KEO,AC="/+D^0Y"DG!!)P
M*[^B@#BG\,ZI<:OX8GFBM1;:=83VEV!.VXF1$7*?+R!L[XZU2M_!FK2>"K?P
M7??9GT^WFC7[<LAW26\<HD4;,<.0H4\X')R>E>A44 <'JO@J_P!:O_&*7#P0
MV>MV<$$$J2%GC:(-@LNT#!+#H>@I8](\67^M>%[[4K33(VTDS"Y:.[=O.WQ>
M7N4>7QZX/TR*[NB@#A_"VC>+?#T,.@,^G2:-:/BWOO,;SS &R(S'MQNQ\N[.
M .<$UI^$='U'1WUO[>ENHOM3FO83#*7PK[>&RHP1M[9ZUTM% !1110 4444
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MC)P&; W$# )QSC- &E1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX,#WRL/EP_EF39U\O=QG.>^,<T =717(7WCB:#4M8T^Q\.ZC?7&EK'),(WB
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M0 4444 %%(2 0"1STJK9ZE;WUQ>00>9OM)?)EWQ,HW;0W!(PPP1R* +=%%%
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MZ-D*R*!N7# 'C(H YO7M)\1Z]H=FLUO9QW:ZE;7;6Z3DI#'$ZL5W[068X/.
M.<=LF]IVDZA!X^U?6)H8EL[RTMX(R),N&C+DY&.AW^O:MO4-2M]+@CFN?,V2
M3)"OEQ,YW.P4<*#@9/7H*MT -<LJ,57<P'"YQFN6\ :)J7A_0[BQU.*%97O)
M[A3#+O4K(Y8#D#D9Q75T4 <SIVDZC;>/M:U:6&(6-[;6\,;"7+@Q;\DKCH=_
MKVKGX/!>K1>"+KP.X@;3GE9(;_S?F6V:3>0R8SY@!(';H<]J[;5-;L-&>R6^
ME>,WMPEK!B-F#2,<*I(&!^.*EM]2M[G4;RQC\SS[/9YNZ)E7YQD;6(PW YP3
MCO0!Q6ER7UK\2/&,>GV4=Q_H]@J[IM@1A&^W/'W?4C)&.ASPW2? ]]X3O=!O
MM+:.]-GIS:=>PLWEF16?S=\>> 0Y/!['KQ7:6^CZ?::C<:A!:I'>7.!/,,[I
M,=-WKCMZ5>H X4^$)OL-_P#;-,LM2&KZFUW?V<C\)%Y950C$<N"J'/');!'%
M5#X.UJ#PUIFFP.)UM-;COXH[FY+&"V23<L6\@EF X]!G&<#)]%) &3P*S[K6
M["SU>PTJ>5EO+_?]F3RV(?8I9OFQM& .YH YJ30-7.K>,KI;> QZQ:10VO[[
MD,D;(=_' RV>,\"L2:QU>TN?"NF6%K93:UH^DXG07ODR*I"1@JQ1@R,4?@KU
M /&.?4*S-5\.:+KCQ/JFEVEX\7^K>:(,R^P/4"@#.\&,T6ES:<^D+ICV4Q1X
MDN?M"LS?.6\S )8EB3D9R?>CQ[H]]XA\%:EH^G)$;F\C\M6E?8J\@Y)P3V]*
MWK2TMK"V2VL[>*W@C&$BB0*J_0#BIJ *4%N\^CI:W<?EL\/E2*KYQQ@X-<MX
M4T_Q?H]I::%?1Z<^GV"B./4(Y299HEX1/+*X5L  G=ZXYYKMJJ6NI6]Y=WEK
M#YGFV;K'+NB91DJ&&"1AN".F: .8T'1-:TOPWK5I):V3W5U?7-U#')+OBD66
M0ML?Y>."0>#6)+\-II],URQTXG1[*\2"6ULC*98X;J-RY< <*A(08'H3@<"O
M3:S]4UNPT8V8OI7C^V7"6L&(V8-(YPH) (&??% &(=)U/5_$&C:UJ5G%:R:3
M#.4ACFW^;-(H4X.!A  <9Y)(X&.<*T\(Z];^#?#.DM;VIN=+U5+R<BX^5D61
MWPIVY)(;'('3K7>P:E;W.HW=A'YGGV@0R[HF5?G!*X8C#=#G!..]6Z ,72-2
MU.[UK5[.^M+>*WM73[--!*7\Q6SP_'RN, D>C#\3Q?HS^(?!^K:1&P66ZM7C
MC)Z;\?+GVSBMD *,  <YXI20 23@#O0!R3M?Z[X'L(+*W0M<I'#?)++Y;1("
M!/'T/S\.G;![U4\7^"4N=.LI_#&EZ=::S97<5S;S!%A4;3\RL57)4KD8^E=+
M-JNF6&N6NF.?+O\ 4M[Q!86Q+L7+$L!C( '4YZ5IT <=XPM+C7AX=THQ!)WU
M&&\N45MPBBA.]CGW;8H]VKL:8L,:2O*L:B1\;F Y;'3)JIK&KV6A:5/J6H2-
M':0+ND=8V?:/7"@F@#A/%'A+Q)K:>)+;RM/NEO&C;3[F>=@T"+L)B";2%R58
ME@>=W.<8&Y!I6L)XVOM;EM;?R9]+BM%1)\GS$9V/51\OSXSUXZ5U<<BRQ)(A
MRKJ&!]C3J /-IM!.F_""#P_JEQ!;ZM96X>U:&4,WGQMF)H\X));:,8[X[UW.
MAV$FFZ/;VT[B2YP9+B0# >5B6=A[%B33[C1]-N]2MM1N;"VFO;4$03R1AGCS
MUVD]*NT <[XVT"Z\1>'3:V$\<-]!/%=6S2YV>9&X8!L<X.,5AW'A[7O$'B)K
MW4[*TLK2XT2?3)UCNS(Z&1@=R_( >G3CZ]J[ZB@#D/#$/C&TMK;3]8@TWR;&
M/9]KMYBSW@5<*-A4!,\$G)Z<#G(JZ3X;UBS^%E[X=FAM_P"T)(;J*/;-F,^:
MSD$G&1C?SQVKJ;76["\UB]TJ"5S>62H\Z-&R[0^=N"1@YVGIFM"@#CM3\,7^
MH> --T^(PP:UIJ6\MK(6W(D\(&.>ZD CZ-4NNZ%JHTC1[323%<Q6MRKWUO/*
M8A>)AMVY@#U<AB,8/.?0ZVI>)=*TB_M[&]N)([JY#&");>1S+M&6V[5.<#KC
MI5G3-7T_6K9KC3;N*YB5S&QC/*,.JL.H(]#S0!P,G@K7F\,^)=-6'38WO-5C
MU&T6.9@A"M$VP_)\H'ED ]\]!70R:5J]QXZTG6I;>V2"WL)K><).6*O(R,-N
M5&0-F,\9STKJJ* .5MO"TUKX\O-7291IERJ7!MN_VL*8R_T,9Y]3@]JHV^E>
M*]"U_58]*BTZZTG4[IKM9KF9DDLY' WY4*?,7(R "/0D=:[BB@#$L]1U0^*K
MO3+BV@:PCMTDANDES(6X!$BXPN23C'936I>BX:PN!:[/M)B81>9]W?CC/MG%
M3  $D  DY/O573]2M]3CF>V\S;#.\#^9$R?.AP<;@,C/<<&@#EO#/A231_$T
MNI6MFFDV4]J5NM/AGWPR7!8$2(O10 &&< G/08YRI?AU?QZ-?06MW$MU9WWV
MG068?+:J)/-VGZEF0_[*K7I-% '):WH6J"#0;;2EAN["RD(O+.YF,0N5V$*6
M8*<X;YB",$UQ^J:-J_A_0[:&Y@LM\WB^&[M5AE.UA)-N /R_*.@[UZV[!$9S
MDA1D[02?R')KDKKQ'X+UY8/MMS%+%%=;(I+B*2.-)P> &8!0X/3G(H NV&CW
M$WC&X\27D2V[&Q2Q@@#AFV!R[,Q'&22  ,\#/? T];TN/6]"U#2IG9([RWDM
MV=>JAE(R/SJ\!@ #H*6@#AH?#>LZEI7AW2M8BMXUT:YAGEN8I=PN#""(]JX!
M&3@MGI@@9SD:?A#2=1TE]<^WQ1(+W5)KV$QR[_D?;@-P,$;?>NFHH BNK=+N
MTFMI<^7-&T;8/.",&N"M_"&L3^#;'P=J*VYL[2>$-?))_K;>*0.H"8R'(55/
M8<D$]*]"HH X:Y\.:VMWXT2WBM)+;6XLP2-.597, BVLNW@9&<Y/';T6#P[J
MZWW@F5X( FBVTD-WB;DEH1'E..1D9YQQ7<5G:MKFGZ)#!+?3-&D\Z6\96-G!
MD9MJ@[0<<G&3B@#E_"FD^+?#\$'AZ5-/DTFS?$&HB4^<T .5C,6W&['R[LX
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ML;B J@%CM7)(/3W.<Z'P!8V^B:/I,>I:D+?2;M;NW8M%N+@D@,?+Y'S'L.M
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M*OD+)@C/)R<9.?I7HE<O<>![.YB\0Q2:CJ&W7L?:\&+Y0$"83Y./E '.?SH
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M6613") 5PT:@97@-NSU+#TJ]J^EVVMZ1=Z7>!C;7<30R!6P=I&#@T <;'?\
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MWO(MN\;AAU(*E2K#J,?3%<OX[T 6O@R]ALX[^[OK_4+:>>:*$RS.5ECRV$7
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MY0J#* 3D'CCO0!VX(/0YI:\DUGP_:Z3K?B^RT>V$>F3>&9+BYMD&8UNLN(V
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MS&$@^8@;MOE^^"<=:R]6T;2K?PYX'MA.NJP1Z[#;Q7=TBNTL1,OR@]TZ =B
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M\NH(81.RW#ND,WE'RY"F=V&Z?PGKC..,BK>H:E:Z7;K-=2%0\BQ1JJEFD=N
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M=WD-Y<V%K-=0?ZJ>2%6>/_=8C(_"LG4/&VAZ<]FDEQ-,U[;M<VHMK>27ST4
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MM/$-W/X;O+W0-0%]9:N\EVJ-&L"(5E \I=P&WYE);&3GDDUIVNCW]KXLAO\
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MF))5DA2XCD=561%89S\V"">".IJS)XVNM'N_$,&OVMNHTNRCOXVLW9O,C<L
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M!9KF24.'/##;]]B.N./2M&Z\,R7?C+^VI;J)K5M-?3WM3"<LK,&)W[O;&,4
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M"WN);:2VDEC5V@EQNC)&2IP2,CIQ7G/ANVU"\\&ZAK4_B#5WNH#J$,8^T_(
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M/):SM)J9E$4R[?+4QH7(/.<X'ICGK5S4[N:PTZ:Z@LIKV6, K;P%0[\XP-Q
M]^O:N"U33;D>(? =M=75TES-+>O,XF+.A:!B45FR0!G:".<#(YYK,O\ 4=4M
M/AKXT6'5[\2Z3JLL%K<&<M,(QY1"ES\Q^^1G.>G- 'K=9$WB"*#Q7:Z UK/Y
MUS;27*3_ "^60A4$=<Y^8=JQ)KB37O&NN:!-?7-FMG80/:K;3-$S-)OW2Y4@
MMM(0 '@<^M95W8R77COPM9SZM/<.-'NTEO(#Y3SD-""05^[DC/RGZ&@#T>@]
M.F:Y3X>7EU=>&)$O+J6ZDM;ZZM5FF;<[I',RKN/<X &?:FZGJ,EY\1;'PW)/
M-!9_V;)?-Y,K1M.XD5 NY2#A068@'GC/ H UO#^OQ>((+V2*VGMS:7DMG(DV
MW=OC(#'Y21C)]:UZ\ATG4)]%L9M/AN&$=[XPNK.2>:=D8KM9@#( 2&9E5<]>
M3T)S5[Q/!K^@^%M>?^WI4Q<VDMG'%<O++;*\JHZM(XW,I^8@=N10!Z+>7DUM
M/9QQ6,]RL\WEN\97$(VD[VR1QQCC/6K=<'K5I=Z!J_AB*WUK59X[S6F$RW%Q
MO#*T+MLZ#Y04! Z#FH)KV\T3Q7K>ARWEU*VJP)/H[2W#ML8GRY$!SD;&*OQS
MM)]* /0ZC:>))HX6D42R E$)Y8#&2/ID?G7GGBN6>WBUZ"PU74)I]+T82JB7
M+Q"T<+(PED<-F1WVC"D$?+S@-26\?]I?$7PM>W,MP9IO#\D[[+AT4ONA/W00
M,')R,8/&<X% '>V-Y-=O="6QGM1!.T2&4K^^4 '>N"?E.<<X/'2K=>;V=OK.
MM^'/&MG:ZO?C4;;5YTL)_M#*R%8XRJ9&/E))&.G)/6K,'BA]6\-7'BG3O.V:
M=H[R?9S*Y5KK9N*.,_,4V@<Y^_ZB@#OZ*X?0[?5)K[0M:BUA#87,!%Q$]Y).
M+PLFY616 6-@03\N!C(QQ7<=: "F"*,/O$:!_P"]M&:XGQM>ZGIVH"[^SWUW
MHJ69%RNF7)CN+1B3^^V CS%P,8[;3QUJIJ&J)I>MZ/JDNIWL^@ZQIC0AEGD4
M"<()$=1GAG0, !SD#N>0#T2BO./!=[J&HPVF@ZE<W8U;2+N4ZDQN7+2*O^KR
M<\AQ(A'8[&XJK!JMZ-2\,7MIJEY=VU_JT]O+=R2E8[I"LI 2#)5578 &X)VY
MP0<T >HT5Y%<1ZO<^%_&6K)XFU:&ZT74;QK/$^$"Q*K!'7&&!'&#QZ#KGU+2
M[B6\TFRNIX_+FF@221/[K%02/S- %NBO-O[0O=<\-^,-6&HW=GJ&EWEW%:B*
M9E2 0#*!DSM;=C)W YW>PQ';/J7BCQ586]SJVJ:=#?>&HKZ6"SG\KRIFD7.W
MCC^?;ID$ ]-HJ*XD:"UEE5&D:-"P4=6('2O+VUG4S\,])\:VNH7,NJ/-!)-"
M)F,,PDF$;0^7G: -V 0,@KUSG(!Z-J>K0:987UT4>X:RA,\L,)7?MP3W('13
MW[4_2=035M'L=2B1DCN[>.=4;JH=0P!]^:\\BLHH]5^)\@DN"4C7:&N)&7YK
M,,<@M@\DXSTZ# I/#_VK2[SX=^5J-[)%J>G-%<P23$Q$);!TVIT4@C&0,D=2
M: /4**\UT*?6O$FD:/XD@U6.TD-WNN@UY(R.F\JUN8<;%/10>N0#DDG-WP?:
M7FHZQK=W=ZWJDHTW7+B&& W'[MD\M/E=<?,!NR!V(R.IR =U-+'!#)-,ZI%&
MI9W8X"@<DFG AE# Y!&0:Y#XIQ++\,=?W-(-EJS#9(R\CUP1D>QX-9NLV5Q_
MPEOA?1K;6-5M;*]LKSSEBNVW$JL94AFR<@N><G';% 'H5%>4^*;Z]T[2]>NM
M,UC4;N72IK6(3M.8TMROE!HV .)G;<68E<?/C.1BMB\M[O4_B)K6EOK&IPV0
MTF&=(K>X,>QV>094KR/NCIU[Y'% '?45Y;9ZUX@N_!OA;6&@N]6@-@S:C;V5
MR8;IC\H690I!?&&!7(R7SVXM_P!I1ZO;:;'INM:A? Z&9EB65K=NH47$L@(;
M.59=N&YR<<9H ]'J.6>*#9YLBIO<(N3]YCT ]Z\Y\/>(+O6W\':9J5Y,BW^B
M->RR1R&)[F9=@V[E((P"[$ C/'84S7M(,%WX-L[K6+S49(M:>$S^>\;A3%*P
M4E6Y91M&[[W7U- 'H45Y-)JEQ:-8SQPQ1HZ7+%=DI;.57G.1@9R.]6B P(8
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MK6L&Y+6=U+)=6\C1-=2QR*JIN7!RJEBV,9*\]Q0!W\L\4 0RR*F]PBY/5CT
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MZ@A@-Q^Z:/:H"NN/F SD>A''?(!WM%%% !1110 4444 %%%% !1110 4444
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MBMS;QZ/(SVS"XD+1@XRB@G!!P <YP,@#G(Z<@$8/(K%'BK2CXJ;PZ+J+[<D
ME92X'4X51ZL>3@= />H/&?B:+PMH#WAD@6X>2.*!96 !+NJ%L9&0N[<?8=J
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MZI9O';R^3,RS*0DG]P\_>]NM.77-)?3DU!-2M6LW;8DRR@JS9QM![G/&.N:
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M 1ECU]:FGT?3KFVM+:6SB:"SDCEMX]N%B9/N%0.F.U<U<>+EM/'*07&J6*:
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MT]*=!K>E7-^;&#4;62[ +>2DH+$ X) [X/!]*6WUG3;N[^RV]_;RW&UF\M)
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MV]].)9+BXWC[1)C!95?!QC S@9(]JQYY8(_BCK<DC(L9T"-&8_=+"20E<]R
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M#^%2QR>V<UROBJU-S:_$'5+(A].OM.@AB*?,MS<JK9*8^]@%!D=3QV->NT4
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M;E!M5)?,)501P"!@X].:]#HH \O\(SZ'K(T"&6UU4:]HZ;'MIEE063!-CDG
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(QK"5>5X]X\SS#G9RH^4 _>YZ  ':UFR2Z;K4FI:-<0?:%A54NHIH3Y;!UR
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MHY+Z<6]N!&S!Y#D@9 P. 3SCH:P]4URZC\56>D27@TVRFTZ2Y%X0G[R964;
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M@@XZT +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:/-X<CFTVUO%#*6W8DR#PSA=@^F2.":Q3:N^D:-;7+R/9P>,S:Z>YD;)M07
M4-G) (8 ^BBO7KO3+"_ACBO+&VN8HSE$FB5PI]0".*2;2]/N8X8Y["UE2#_5
M*\*L(_\ =!''X4 <7X:?3/#?BOQO"'MM.TFU>TFV%A'#"7B^8^BY('U-=['(
MDT22Q.KQNH974Y# ]"#W%9]UH6G7$-TJV%DLETNV5VM4?>,Y^8$?-^.><5:L
M;.'3M/MK&V4K!;1+#&I.<*H 'Z"@#B?AW8PZK\/;JQU2(2M<7UZEZC]2YG?.
M??I5/PA;R74UIX5O[4,WA:=O-D:, 2C&+9AV^9&+'ON09ZUUSZ1>:?\ VI+H
M4EM'+>DSB.Y5C&EQ@#?\I!PV!D>O/<YL:+I]U96\TU_+#/J5T_FW#PH4CR%"
MA5!)(4 #J>N3WH YZU\P?&K4A%GR#H4!GQT\SSI-F??;NJ'X@VNGRZ[X.EOX
M+9X_[4,;O.BD;3#(=I)[9 X]0*ZK3-*6QN;V]D827MZZO/(!@8481%_V5'YD
MD]ZM75G:WL:QW=M#<1JP<+*@<!AT.#W'K0!Y9JNE:;JFI?$Q[FWBG6WLK>2#
M/*QL+4E74= 1@8/4=J>-2@OM6T:Q\0WMI':7?AVWEMFU"-7BEE.?.Y8@;\;/
M?'U->E-HVEL\[MIMF6N.)B8%S)_O<<_C39]$TFZLXK.XTNRFM8CF.&2W1D0^
MH4C H I^$+2&P\*V-I;:C-J-O"K)%=3$%I$#'!R.HQ@ ]P :\VU:>PU?P7\1
M'U@0-K%I<W4:B?'F0QJO[@)GD*1@C'!);U->QJJHH50%4#  & !5&YT/2;VZ
M-U=:793W!0QF66W1G*'@KDC./:@#SB:[TW4_$,VDZYJ%C!9S:/;-8&[16C=2
M'$IC9B '!VYQSP/2@>']+OO%WAC3+N:75+.30[F-I;EB#<HKQA"V,9XY!^AK
MTF[T?2[^.&.\TVSN8X#F)9H%<1G_ &01Q^%/?3;&2\2\>RMFND&$F:)2Z_1L
M9% '$:3HVGW'CWQII,ENK6<MA81O$3D8*S#O^%1>"(6NX[3P_?VRF7PK,\4K
MM'@2..(''KF-BY[YVFN]CT^RANY+N*SMTN9/OS+$H=OJV,FIDBCC>1TC56D.
MYV P6. ,GUX 'X4 >-V.H:8=1\&ZI87$$,%QJER#)/*&NY4992QF?C + #:0
M<87G/%6;:RTF+PC\2XTM[2*ZCNM0VA%575%B1AC'.T-@^F:]031=*C8LFF6:
ML9O/RL"@^;_?Z?>Y//7FGR:5ITK7#26%J[7.//+0J3+CINX^;'O0!Y]K$$.D
M:-X0\:+"K?V9%!'>L$R3;2H$9O4E"58>VZE\0NNC6&B7EZ(K*SU353-JDDD0
M*)OC?REE' VJ?+!)XRN37HBV=JEG]C6VA%KMV^2(QLV^FWIBG7%M!>6[V]S#
M'/!(,/'*@96'H0>#0!R'APZ!X;35;B+Q!:M83W*,<.D=K!*PQLC(. 6X)7/<
M'O777;*EE.S2-&HC8EUZJ,=1[BLZ_P##>F7NA'1A96D5@W'DI;KM4=]HQA6]
M#CBM4HIC,94%",%2,@CTH \R\-6/E:K;^']<TRPNTN]*E6UU6QX2]MP8]WFK
MU#\H=V2,L<5@*TVG:9IES)9H\_@:[,%_*8N98"VT%?7]TWFGT(![U['9Z7I^
MGLS65A:VQ888PPJF1[X%3-:V[I.C01,D_P#KE* B3@+\WKP .>PH X#5$TZV
MM-%:]MPEYK.JFZ$<C"*%G*.RK/D'(5-OR]2ZCW-<C(]K+X.U& W<+):^+T6,
MVTFQ(HFGCY0!CM7EL<\=J]JO+"SU&$0WMI!<Q!@P2:,.H(Z'![USOBWPN^L:
M7':Z9;6$3-?07=P91L$OENK8.U3N)"XR: ,O1M%M]!^*]U;Z+%Y&G3Z2)KV"
M,DH)_-Q&^.S,H?ZX)JWXPN63Q7X1M+L Z-=7,Z7(?_5O,(_W*OV(+;B >X'I
M7565C:V$)2UM+>V#'<Z0(%!./8#-/NK2VOK=[>[MXKB!_O1S('5OJ#Q0!X]X
MML_LFC?$>RMUV:- EK+;QJ<)!<, 9%3TX*,1TRWO7JVDZ+IVC1S_ -G6RPBY
MD\Z8AB?,<@ L23U( SZ]:E.DZ:UB+(Z?:&T!R(#"OE@^NW&*LQ11P1+%%&L<
M:#"H@P /0"@#S^VBLM<\1>-;'Q&D1>W,?D>=C]S:F($/&3]WYMY+#O\ 05@Z
M,OVG5?AU>^)8;<WLVDW1EEND7<Y7RC&6+=6 .>><DUZK=Z5IU_-'->6%K<2Q
M<1O-"KLGT)'%2SV=K=20R7%M#*\#;XFD0,8V]5)Z'W% 'C.K6-F?!GCG5S$I
MO[+Q#+);7!/S0,)(N4/\)]<=>];NM/INK>+_ !+HGB+4K.Q7R(?L1O$7(@,?
MS/$S$ ,)-V2.<@>G'H']A:1Y,D/]E6/E2-O=/LZ89O4C')IUSHVEWAMS=:;9
MSFV_U!E@5O*_W<CY?PH \\3P_I>K?$"QT_4?-U&WD\,*7-RQ5I\3( [@8^;&
M#]?<5V_BVWBG\%ZU#)"DD?V&;".NX9"$C@^A -:)TZQ-\+TV5N;L# G,2^9C
M_>QFK! (((R#U!H \B73]'NM,^&<445L8Y75+A82 ')LV+!MO4GC.>N>>M,\
M76VA65GXKTRPC@@?2]%1%%W)N$/RR/&MLIY#$G)?=U"\'%>I#0]("0H-*L0L
M!S$HMTQ&<Y^7CCGGBI)]+T^YN3<SV%K+.8S$99(59MAZKDC.#D\=.: //(;3
M3M=^(&AF[6.]BN?#<C3*S;TE(DB'S#.&YSP>X]JH:':WMYX)T2WTRYLGNK/4
M+X6]AJ +0W,:2R)Y9/4%5(*GG&.F*]071],65)5TZS$D:>6C"!<JN,;0<<#'
M:F?V#HQA$/\ 9-AY0;>$^S)M#>N,=?>@#SNTU31]03PW:OIZZ?/F_(L[V53:
M0,C[9<C&)"I)" $<%N165H&MV\'ASP1!J=W$^BM?7L%VSM^Z5U:06ZODG"^@
M/'"^E>O2:5ITJ6Z26%JZ6Q#0*T*D1$="O'R_A2/I&FR64MD^GVC6DK%Y(#"I
M1V)R25Q@DGF@#S;Q/IGAR#0;/^S_ ";BQ'B>UD=G*R0PEY4\Q(ST5/4#C)(]
M16C<!;;XF32:-'$9?^$6D:V2+&QF$H"8 XQP!Q7='3+!M/&GFQMC9 !1;&)?
M+ '(&W&*!IMBMX+M;*V%RJ[1,(EW@=,;L9Q0!Y9&L<_P^\(ZWI6/^$@:\M4>
M<?ZV:5FVW"2'J1_K"P/3;GM575]'TZ;1OB=<20*\UE<M+;.S$F"06\;!DY^5
MMW<<]J];BTK3K>]>]AT^UCNI"2\Z0J';/7+ 9--.B:41,#IED1.<R@VZ_O#_
M +7'/XT >=^*Q<[;K6/(LM:L8]*B&I6$QV7$$>&;SH'.0"06)'<H,'(KTE[N
M+^S&O6$BQ>3YI^7Y@NW/3UQ4+:'I#O&[:79%XP%1C;IE0.@'' %7Z /'=!N=
M.3Q)X&GLY[:&WO;2Z4@S!KB5&12IN'& SEN<8X;/)INGZ9#:?#WQ'KNG6S-J
M]E=:C';SQLQDBB\Y@P7GC"@D>_->JQ:)I, 00Z791A':1-EN@VL1@L,#@D=3
M4UII]E8*ZV=G;VRN<L(8E0,?4X'- '%^&;;0+CQ'::QHNMVLSS691K6PC1$D
MCX(>5020RG@$X.3BI?B5;0W$7AD39&=>M(\ABIPQ.1D>N*ZVQTK3M,,IL+"U
MM#,VZ0P0K'O/J<#DTZ[T^ROP@O+.WN?+.4\Z)7VGU&1Q0!YSJ%KHND>,HO#=
MT;#3]%?33)8PW<0>!I6E<S ;S@-@I^'3%1Z?)IVGZ[X;T'4=4-]H0TVX:RN+
M\KLN9UE &2?E;;'G;['([&O2+[2]/U.%(=0L+6[B0[E2XA615/J 0<47FEZ?
MJ%ND%[86MS%&0R1SQ*ZJ1T(!'% 'CQ2RB\):E<6XA6TM?&:&*1<;(HO.B'RG
MH%QQQQCVKIHI-/N?B)XN@CE@=)='MRZQN/F8&7<>.IZ9K>\-^&Y["VURUU:"
MQGM]1U":[$2DR+L?'R,&4 XQ6W'H^EQ(4CTVS16B$)"P* 8QT7I]T9Z=* /*
M+&RM;_0?A3'=+O24&.0%B-Z_9G)4^H)X([]*NW=IHB^)-8\*ZG=66F6$-C F
MFQW: @0%3O:)G;A@^<D<\+_=X](&AZ2!"!I=EB$YB'V=/W9Z_+QQ^%/O=)T[
M4FB:_P!/M;IH3NB,\*N4/JN1P?I0!P&ERVDOC6VT76;G[;91:'$^G-J"C%SE
MB))"#P7VA/?&?4UJ?"9K<> 8(K:1&2*[NU 5MV!]HDQ^F*ZR]TO3]3\K[?86
MMUY3;H_/A5]A]1D<&I;:TMK.+RK6WB@CR6V1(%&3U.!WH \YFB@L_B%XSN+*
MUM/[7&E02V ,:[WFV3\KW)) !QU[U31()/"/@76=$V_VQ+=VL<LR?ZR?</\
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MS6,<6MQWTMK;Q+F&(*X+/MXW$L"0,]>^,U7OM-U&6V^)$::==%M53;9#R_\
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M0Q\S*\:*I'IRIZXQ6WXETO4KG1=#U?1[8MK.DRQR10R_(71@$EC;T!4Y_P"
MB@#H/^$@L/*9P9B1<-:H@A;=+*N<J@Q\V,-DC@8.3P:SG\>>'XK WDUS+&BW
M@L9%>W<-%.2!L<8^7J.3P1T)K(\4Z'?6-OX=O;+3CK*:5*_VRT&WS+A9$(>1
M0>"X;YL=\FJ6LZ?+>>'[:;3/"LNGF75[2Z:V6%%F9(Y%9Y) I(!P, 9)X]\
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M2.1D! W892P'///.: .SC\4:3)!J$WVAD73YQ;7(>)E*R$+A0,98G<N,9SD
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MRR.Q5>_1ASTK T_2=4@\)?#ZSDTR[%QIE]')>)Y?^I58Y%)/KRZ],T =K?\
MC'1M.6ZEN)I?L]I.MM<7$<+.D4IQA"5!.?F4< X) .#6RCK=VBNAD1)4# E2
MC@$>A (/L1D5Y1=QAY_$6ER:)KL^B7VJFXE^PVR3K(RE"^V0." SI\R[21R
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?X@:A:>&UU*[@LH9[?5SINH1'<1  ^-ZG/S87#XX^4]L<@'HE%<[?ZUJD/\
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MCP]XA\0:[JEVIT[3X;&QU&>RN&^T.TA"*"I0;<'DC.<=?;D Z^BBB@ HHHH
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M9=^2,Y'!%=S10!S,FB7EMXK3Q//>I,EOI;VDEO%:G>_S"0LN&/.5P%P?J37
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M_-=?10!QN@>#]6\/RG3[;74/AY)VGAM?L_[^,%MWE>9NQLR3_#G!QD5V5%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI"KR$(H4,[%F/N2>I^M<]IUKJ6JZ]'JNLZ1#8&P66&S43K,[[R,R9 &T;5
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M/:1^%;#2$;0I[;R9KR:\W&%,X:,(V68[/NG. 2/2NJ1%C1410J* %4#  ]*
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M$6UM'"'D<1J%W2.69L=R3R37/6-KJ6K>((]2UC2(;%=-\Z.S'GK,\A<@&3(
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MW_X25M,&HR/^]:#RO,"%^N\DA=W7&<8-=#?^%W/C;P\]IID\>D:=9SP>;;W
MB\MG*;<8<.?NMGUSWKHY?#.CSZ0=*ELE:T,GF[2S;O,W;O,WYW;]W.[.<]Z
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MF@Z='K2ZPL4IOU@^SB9IY&_=YSMP6P1GGIUYH TJ*** "BBB@ HHHH ****
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MP\+Z1)J.H2A(PP1%S@NY. H_'OV'-3SZWI5M;17,VHVJ02@M'(95PX'4@YY
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M.A]C7GWB.YL[K1?[?T#3KJ2R&JV]YJ$MM"Z272("&=%(!;9\ASC!*GT)K?\
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M!U'44 ;E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(TDFC,;+M5L[2"1@YP>F:T* .6ATO4XO'FI:W]EC-K/IT5K&OG#?O1G;D8P
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MPPRD,""K#@@C\JH:AX(L=2TB_L)[R\#ZC.D]W=(4$LK(5V#E2 !L4  =O<Y
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M2[>)["*UN_#K*8() =_[R+9YC# =\%N<#J>O6LK0;"TM?!GP\U>&,+J#ZO'
MUUN)=HV,H9,G^$_W>E 'M>1D#(R>U!('4@?6O(M:MTU67Q?H[W=E+J4^H1FT
MOI+J-#:+MC.S#,'&SYON@@[CW+8OZJ-,G\8:IX=UJ\LK*S_LZ$:>MY&I0QD.
M)&C9B &#8R1SPOI0!Z?D#J:3(XY'/3WKS"VT?3Y_&_AJSGFDU.V;0;A3+=<F
MY19(@I<=&!'/(YZU@MIME;?#>ZU"*("[TOQ 8;&<L2UM&M\%"(2?E7:2,#@T
M >VD@8R0,]*"0.I KRO4VTS6]?\ %>D>(M6M-/GBE0VS7"*)([?RD*O"[$8(
M?>>.AZU9AT/3=4^(=_::C$;V%_#]J\BW0/[QM\@WNO3=P.W!Z8H ]"N=2M+2
M\LK2:95GO9&C@3NY5&<_@ IY^GK5JO%](6RO-/\ A7=ZNEM,IAN(Y9KI58%5
M@?:&+=@1QGO7KUKJ5C?37,-I>03RVS^7.D4@8Q-Z,!T/UH M45PMPUE:?%^<
MW36\,-QX?R_FD*LA$YSG/!XQ^%<;HD-I?>%_APKL'!U.XA<+(0=NV<[3@^PX
MH ]L!!&0<U@+K\Y\>?\ "/&VB%N=.:]6X60EB1(J;2N,#J>Y_"O.+^X'AW3_
M !=96 -KI$.OVB7"0?*MO;2)$9MN/N@Y(./[QK2U7[)IOC_4)?#B6D=X_A.=
M[=+7: \HD!CPHX).!]0!0!ZGD$D C(ZT9'J*\R\+VWA_6+K0-6L=;MWN6MGC
MDM;5%62=63YQ<<ECM(SEOXCUYYSO#'AS3[CX56VH0SQ6>J3[K5+Z8LZD&\^6
M)QG!1F"J1Z,?4Y /5-1U.TTJPDOKR98X(\98GJ2< #U)) 'UJT2!C) STKQG
M7VCF\$^([35-!L]/U&QU"QDN?(P]NY:2("2,D?+E <@\C//6M'Q=)H5Q-XAM
M+3[&KV>A<>>R^3$#YA46Z#'SEARP/!"<$T >K9 [T9&,YXKRNTM['7?%'@MK
MO9>+<^'Y3<!GWK*0(>'&<-R6R#^-9FGWRV&CZ#IMRXC\/_\ "2WEG/O;Y%C5
MY/)B8G^#=MX/' '2@#T.R\07]]K_ (CTF*SMA+ID4+6S&8D3&178;CM^494#
MC/?K6]:/.UE UVD:7+1J94C;<H?'(4G&1G/->7/;Z7#J_P 3[6U%O'&=-@D\
MJ%@H#"&4D@#IS@G'<^].BL+.^U/X91W,8DCGT>99$+'$BBWB(!'<<GCH<F@#
MU4$$9!XI 01D$$>U>/IBR\$:O;6]Q%!96/BMHEM7D")) )U)MP3PH.3P<#UP
M,UU?A'3;9O%6O:U;?9DMKD0I;V\,R.8R%_>,0C%5W''?G;GO0!VI( R3@>]+
MFN)U65;GXJ:=I>J1I)IDNE2R6L<R@QR7(D&_@\%A'C'H"WK7&W5HPT=;25W.
MFVWC2&WT]O,(V0&1=R*<_=5MZCTQ[4 >T YZ4F1G&15+3=&T[1]._L_3[5+>
MTW.WE(3@%B2V/Q)KR73M/M]/^%%_XAL8'.IVTUW#]HC9FDCMS=GS O/0("?;
MDCK0![#=S20V4\L")++&A949]H) Z$@''Y&L[PMK3>(/"FFZS+$L#7D"S-&K
M9"9[9KF-$M-#.L3ZKHVM6L_VC3662UT^-$A9 <K(ZJ3AQG:"<'&1V.,+0;C3
MF\+?#VQNO+:XDL)9(ENG M0%0!F=2/G8!OE&1U;D4 >HWVI6FG"W-U,J&XF2
M"('J[L< #U]?H#0DE^=6EC>&W&GB%3'*)#YADR=P*XP!C'.:\;LAI]YX&\%_
M:S:7(M_$K0,T@5@D1EG 7G.%("X'3 'I71:@\UEXR\5S:"JFZ'AB*:U6+D&3
M=+M*CIV7 'M0!Z9D$D9&1UHR/4>E>7>5;'2/ &K^']HO[F[MXII8_OW$+(3<
M"0]6Q@L2<X8>M86HZ98Q>!O&FI+$OVS3_$$K6DY8EK<B6+[AS\OH<=1P: /;
MB0#@D9K!T?7[C4/$NOZ5<6T4*Z6\"HZ2%O,$B%LG(&.PQ^IKD?%IFT[6M4UA
M[6TUG28Y+=;V#[MW8, I5HB>&7Y@VWCDG'4U4UG2M/U/5OB<][;I.UO9P21;
M^1&XM6(<#LP(X/44 >FW$E^NI6:00V[63!_M,CR$.A &S8N,-DYSDC%6LC.,
MC->;1-]I\2_#6ZF<O/<Z7<&5RQR_^CQG)_$G\S7+RZ%I\_PZ\0ZG '&LZ?K%
MTNGSI(QDAE%QB-$YXW9 QWR/:@#W*JEU)?K>V2VL-N]JSL+IY)"KHNT[=@ P
MQW8SDCBFVFI6L]P]A]KMWU"WC1KFW20%X]PR"5Z@'M7+^*HXQ\0O \O20W-T
MN<]1]F>@#M,CU'I02!U(&:\1U32[%/!'CS45A7[78:[*]I,6):W8&$@H<_*?
MIU'!KI[RYT74O&?BK1O%4]O%']E@^PFY=4"P-'\[Q%N PDW98<\+Z"@#JKG7
MKBW\;V&@FUB^SW5G-<B?S#N!0H-NW&!]_KDUO5P3I ?B)X5B5I)83HETJFXY
M=US#C?GJ2.N?>N0BN;&#X<:'#)- ES;>)PNPL \0%\V1CJ!M(S[$4 >MZ_J,
MND:!J&HP0QSRVMO).(I)"@?:I8C(![#TJOIVHZCJ-KHEY';6PM;RU$UT6D(>
M-F164(,?,,DYR1C%<!>7%AK%A\1TUO[.^H6AF2W6<C=%;" &%H\] 6W-D=2?
MI5FP$$FO?#.6-E8R:3<(Q5LA@((N/PR?S- 'IV1G&102!C) STKQ&;3;&#P+
MK6JQQ*+ZP\3N+6XW$M !>JN$/\(*G!QU[UO^)3#-XF\56%W):7<EUIL,=DLM
MS'&;)RKC'SL",MA]R9/ ]%H ]0I,C.,C([5F^'K!=*\.:?9^:DQAMT#RH<B1
ML?,P^IR?QKRS3;_3#JW@G4K"X@AM[F^N@9)I0UU*C)*29W&.K ?*0<8'.: /
M9<CU'I2UXAJ&F6,7@;QIJ2Q*+S3_ !#*UI.6):W(EB^X<_+Z''4<&NM\2@>#
M_&<'B6UL?.BU6$V%Q'&G)N>6@;_@9!0GIRN: /0J3(SC(S6?H>DQ:+HEMIZ!
M,HG[QD7:'<\LV/<DFO+['2HK?PCXQUK3K9GUG3M0U-+*9'8O"N2"$&?[O0>N
M* /8 0<X(..M&1G&1FO--/L_#NHSQ:KI.M6TIGTV6-[2P14$L>W.Z8 D@J<#
M)P03CO6#IFBVL7A'X>:YI8(UR6YM(7F60LTT1!\Z-N>5"ACCMMH ]JI"0.I%
M>*:Q+8VWP[\?6KO!'+%KLK0Q$@,G,1!4=N,GCMFNFET32-=^+&I0WD*75NVC
MVMP$\P[2XFDP_!ZC YH ]%R,XR,^E8/A[7[C6+_7+6YMHK<Z;>_95\N0OO'E
MJX.2!S\W3%<9X=GT+6]-636[D1>);/6)&E"R!+KSEF81QC^(H4*K@<8SZ&LO
M7=-LKK1OB=>S0J]S9W9EMI"3F%UMXB&3^ZV1U'/:@#V4D#&2!GI02!U(&:\G
M\87>G7\?B-7>$WUOH"-))>N"J%DD9/LZ<'>3U?/!"<$T[5FNKS3+35[4:?KL
M,6A1'4--N7Q)Y9W$RPR<@.2K Y_N#N!0!ZL2!C) S2UY1<7VEZ]X@O\ 3M:O
M;:QM+G2K:73EU&)<^2Z$NR%B KACSCG@?W>.]TU9K7P= ME<S7\T5GBWGN!\
M\Y"_(S?7C\Z -G(SC(SZ49&<9&:\AC"W/PV\,ZYIO/B3[9;*TX&)I9VD"SI(
M>I&-^0> %]JV_#.@Z7>>.?%<]Q;"66QU6&6V+.W[IC;H20,]R3GU_"@#T2BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "@@$8/(HJI?ZC;Z='$TY8M-((H8T7<TCD$[0/H"?H":
M (K30='L+HW-GI-C;W#9S+#;HC'/7D#-276DZ=?3QSWFGVMQ-&,))-"KLOT)
M'%8FK:]I<]CI\DU]J5BLNIQVT9AA=&>82;?*?*G"D\'. 1T-2WGC?1;*YU*V
M=KR2?351KJ.&SE=D5@2&X7E<*3N''3GF@#9DTZQFO([N6RMWN8_N3-$I=?HV
M,BN;T[PHP\7:]J^J6>FW$-^\+V^1YCQ>7&$YW(!S@'@_GUJ]:^,]$O=1L;."
M>5C?H7M)C;N(9\+N(60C:3MYQGL>XQ6#K.JQOX.\:WFCZSJ1NK/SF8R@J;:5
M(@VR,,H(7H?J3@T =I>Z=8ZE&L=]9V]TBMN59XE< ^H!'6F3:3IUS##%/I]K
M+%!_JDDA5A'_ +H(X_"LE/$UEI]A9174D\UX=/6\DCBC:1Q$  TAQVR?J><
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M7-MEXV"Y5ID5@3Z88],5?TSQAHVJZC=V$4TT-U:Q^<\5W;O QBZ>8 X&4]Z
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M>ZA-=6<TX>T295!B'.Y5V_P?= SSP?6@"W%H>DP)&D.EV4:Q*RQA+= $#?>
MP. >_K2?V%I BCB_LJQ\N-M\:?9TPC>H&.#5+4O%^CZ3-=QW4TF++RS=R)$S
M+;A_N[R!QGKWP.3@59O]?L=.N6MI#++<);FY>*",NR1 XWD#MG.!U.#@'!H
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MYQVH VET;2T>)TTVS5X4V1,(%!1?1>.!["@:+I0LY;,:99?99CF6'R%V.?\
M:7&#^-5-1\4:7I<EXL\DC?88EFO&BB9Q;HV<,^/8$X&3@9QCFG'Q+I[6L$\
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M;68<DX/KZ4 =I1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M61[13@S*>"H.1@D9[BO.KSPKX@NO#^N:1I=W?76FB.VGT]=4!642QR[V@W,
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MO ]I)*A5)BD 0\]OF'?MR*[&H)KRUM[BW@FN88YKABL,;N TA R0H/7 &>*
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M6/..,9SC Q0!QVCZ5<V,MSX>U3P:-0D%[++;:F\<;V[QO(9%>0DY#+NZ $G
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MW'%-:3P(#Y;+%L,<@)!3H"">.3WK-TG2]6@T?X<PSZ3=QR:9(3>*4!\I?)=
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8V.< !@"3W Q@=: -^Y\77\NE:WK&EVMO/9://+$\,A(DN/*_P!:58<+CY@
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MXI4#QNI5E(X(/!%<1%\-+2/0M)TYKZ9Y-/N_.^T$?-)#M,9A/^R8MJ'_ ':
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M-GYB#Q(!V&(WFUKQ0/$#V&III]WINHO!%,;R1%MUC((WP@;75ADDMG[W; P
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MW<W)M"#=2"6XB69Q%,XQAGC!V,>!DD<X&<U8FT#3KC6X=9DBD-_#&8HY1/(
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M#S1S1A"KPC8#SN9CCON]ZJWUW9^'O%:C68+_ $[1;W2;>VLS KLD!C+[H'V
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M$0O'_P M#GCF%G ]2JU8\!0ZB+,KK2,KZ(CZ7'+)P)55N9?HR+#R>ZM7<44
M>-V9$7PQT"78XCLO$RSW 5"3%']L=MQ &0-K _0BNB2:QG^)>N74H3RFT*!%
M>5,?Q2%EYZ'#+D=>1FO0J* .3^&C'_A6V@I)D/%9I&ZMP5(&"".V*Y?2M..H
M^#_'D6EPQG5)=1U VK!0'.\$*5/HPR 1QS7JE% 'F6E7OAKQ#Y&H1VVKRZA8
M6,T<\,JRQFT1H\/&<@*22  .?4=#56R>]M[+4M+^WP:[I":%<-:WYB"SVJ@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 445F:CK<-A?6VGQP2W5_<JTD=O
M#MW;%QN<EB %!*CD]2,9H TZ*S-$URTUVVFEMA)');S-;W$$P DAD7JK $CT
M.02"""#6G0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<=K6DZO
M:^/]/\3Z;:_;H!8OI]W:K*J.JEPZNFXA3R,$$CBNQJCJ6FG4X3 ]Y<P0,-LB
M0,$,@[C=C</^ D'WH XWX<-/J&M^,-=,0BM+[45C@4-N5O)38S ]"">,CC(/
M6O0*@L[.VT^SAL[."."VA4)'%&N%51T %3T %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?%FO>)&\(-I]Y#IJ:Y8W3S#[.)3%)$%^9=QY&2<#Z9S0!Z5(ZQ1/(V=J@L<
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M.TL5O%Y@RJO(X0,WL-V??&*SKK4M6T?QEIFBO?&[MM7MIS#+-"F^WFB 8GY
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MMDW 8P0OK0!T]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUPFM6>G6]I&K".:"=F:4AN&VD?*NWL22"/2M+3=1M=6L(KZRE$MM+GRY!T8
MD9'L<4 1ZOI-MKFBW>E7N]K:ZA:&0J<-@C&0?6L:S\%06FJV^J'6-6FO8;,V
M7FRRH=\9((R @&00.@&>^:OZUK3:??:5IL"H;S4YGBA:3.Q D;2,S <GA<8X
MY(JSI,^H3:?&=7MH+:^W,KQPR[T."0&!X."!G!Y&<4 8<'@*QM]&T;2X]1U
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M3W4=_>17\]RES+=Q^6'9D38JXV[=NTD8QSGK5[2-%M]'^V-"SR37EP;FXE?
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M?X?V%KHNCZ5'J.HB#2;L7EN2\98R L1N)3D?,W'O76Y QD]>E("&&5((/<4
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M*6*@C<.HS7-ZAK^I2ZMJ6EZ%:6UQ>:=;PSRI<N4$ID+8C4C[IPA.XY'(&.I
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M/7.*[.UL;.Q1DL[6"W5N2(8P@/Y4LUC:7,\,\]K!+- 28I'C#-&3UVD\C\*
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M,GE_?=3(2N.H^^.H%8>D:/K.G:;\/)GTBZDDTF.:"\@4H'C9X2@/+ %<]P:
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MWGCM88FFV$O(&*HHX&%&2?SY%=$?%6EM#ISVTDEVVHP&XM8[="SR1@ EL'&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *;)&DL;1R(KHX*LK#((/4$4ZL;Q#KHT6.PBCC62[U"[2SMU<X4,V26;
MV"JQ]\ <9S0!J6UO':VZ01;A&@PH9B<#TR:EKCI_$VL6VJZMH7V6UGU:WL/[
M1LF0,L=U'DJ5*Y)1@PQU/4'VJ"U\=27&H^$U!M#9:];,_F!6W12A-VSK@9^8
M#/=2.: .XHKBK[Q7K%HNBO#964\>JZD]K"QD9/W>'*/T/W@F[/H1P:;#XWN[
M2#68-5M8#J&GZA!8QBUWF.8S!#&<8+#&_D#)XXSTH [>JS:A9I?I8-=P"\D4
MNEN9!YC*.I"]<>]<C/XVOM'BUB;5=,EDM;2&.6UNX[:2W2X=V""(K)RK;BO.
M2,'/&*KW*ZDOQ8\-'4/LC%M.O"K6Z,N#^ZRIR3D#C!XSD\"@#MKS4+/3T1[V
M[@MED<1H9I FYB<!1GJ3Z59KB_B@"/"4+K&'D74K(H"<9/VA._:H9O&^HZ!J
MFI67B:QM46'3I-2MI;&1F61$(#1G< =X)'/0Y[4 =U17)6WB'76UF.T;2Q/;
MSVSR+<+;S0);RJ,B.1G7Y@>S #D?=YK+TGQUK-Y9>%=4N]/L8[#7)A;%8Y&,
ML;LKLK<\;?D(QU[Y[  ]!JGJ&K:=I,8DU&_MK1&Z-/*J ]/4^X_.N3N/&FI2
MQ/?:3IDE]:Q7K6K6T=K,9)$20QO(L@&P8(8[><@=03@1>7?7GQ8U2TN/L<]I
M_8T*M!+&2K1-++E>N,G')Q@C'% ':V5_9ZE"TUC=0W,2NT9>&0. RG!&1W!I
MUW=V]A:2W5W/'!;Q*7DEE8*J =R3TKB=%\5^3H$,<6EV5I<S:S+I-M;6_P L
M*LKL"YX' 5&;H,X XS5K7M:UW2?#'B2YU'2+&Y2PCWP.S8BNX]N6RF6*D'((
M)Y]: .Q1U=%=&#*PR&!R"*KS:A9V]W!:37<$=S<$B&%Y 'DP"3M'4X )X]*Y
MS6_$6HZ="KP0V<$ T\W*S7&6$THY$"(K!LX&=W. 1Q63?ZDNMZM\-=7$/E&]
MD>XV9R4#VCMMSWQF@#L_-TS66EMUN(+K[+*/.BCE#!''(#@'KWP?8U;:")YT
MF:-6DC!",1DKGKCTKS^QGU"QUOXB7.CVT-Q>0W,$D=O)D"4BUC)48Z$]O>N@
MTSQ))K*:#)8-;RQ7]JUU<-M/R( HXYX.YMN#Z-Z8H V[K4+.Q:!+N[@@:>01
M0K+(%,CDX"J#U//04Z"S@MIII84V&9M\@!X+?WL=,GN>]<C\2=XL_#KQ1)),
MNOV9C5FV@G<<#.#@>^*8GB?Q+'J.L:'<:;I[:S;60O[+R'<PW,62I4YP5;<,
M>G- '<5 ;2%KQ;MDW3(I1&8YV ]<#MGN:Y_2?$TNM6OAZ:Q,#_VC"UQ<94_N
MD4 -CGA@[*F#ZD]L5:\5^(5\-:9!>2[8X9+E();F1&>.W5L_.X7!VY '4<L.
M: -VBN0N/%-_:0Z%,?[/NH=3U060EMF)1HV#%94.3V7D<\GKQS'<^-I=/NO$
ML-U;12?V7/:P6_EDKYSSA=@;.<89@"?3)QVH ZZYNK>RMGN;J>*"",9>65PJ
MJ/4D\"LNWT+2I];'B.)I9YYHU,;&X=X@-N R)G:"5.,@="?4YQ?$DVMGP]XG
ML]3L[:2R&CS20WD'R@N4<-&4+$Y'!W=#GL:K>&]>U2RF\*:3>6MH++4],S;O
M$[&2-HHD;Y\C!!![=#W/6@#MKJ\M;*+S;NYAMX\XWRN$&?J:9::A97X8V=Y;
MW 7[QAE#X_(US?Q/ /PQ\1 @'_0G/-8,>CWVH^*_"6J:3ICV46GV;B^NY L0
MG5HP$BP,EQN&<XP.HYH [_5=*LM;TV;3]0A\ZUFQO3<5/!!!!!!!! (([BJ>
MF^&[/39DE^T:A=R)_JVO;R2?R^,94,2 <$C/7!//-<I:>/=87PS<^)M1TZPC
MTNV^T1/'%,YE>5)C%&%R,;2>"3SGG':MJ?Q#J>D^(M+TO4X;21=521;:6#<@
MCF1=WEOG.01G##'3[M '4T5YHGQ"\0)X8LO%-SI%@NCFY,%XL<[F9%\XQ>8O
M&" <<'D^U;LWB?4;R#7KK1K>UEAT69X'BFW;KF2- TBJP.$QG:"0V2#T% '7
M5 ;VU6_6P-S$+QHS*L&\;R@(!;;UQD@9KBY_B%%</IZV4MI:?VCIRWMBVH J
MES(V?W(8$!6&!GK]X8%:C:Q<CX@1:0=/M-S:1)=)<%CYFX2(NPG'RKEL\9Z"
M@#IZ*\[T[QWK=QI.@:Q<Z=81V6I:C_9\L<<KF16:5XU=<C& 5&0>O7CI5S6?
M&U[9VOB>\LK6W:+P^Z))#.6#W&45V(8?<&&P.&R0>E ';LP52S$!0,DGH*I0
MZUI5Q,(8-3LI92<!$G5F)^@-3V4LTUE#+<1I',Z!F1&+ $]LD _H*\<ATYM7
M\,^/]*M-%DOKZY\0W:VSJJJL4GR;7+DC;M/S?RZT >U45Q!U_5=/MGT6UQ>:
MII5A ;F5[::87$Q0_*"@^7.W.XY^\..M,E\6^([K5=-TVPT6UMKJ^TM[T1W\
MKJ89%9 4<!>F6QQUX/% '=45QUGXNN+WQ%/HXDL(;ZUN4BEL)MRS/%@%IHV)
M 9>20 .@Y.>*BN?&=^WA_5/$>G6MO-IFFSRHT+9$L\<3;9'5LX7HQ (.0.HS
MP =M17&-XIUG4?$<NE:-:Z>8VTN+4;>XN)'PRNS ;E _V>GOG/:MKPIKG_"2
M^%=-UDP^2UW")&C!R%;H0#Z9!H U+FY@L[=[BZGC@@C&7DE<*JCU)/ I8)XK
MFWCN()%EAE4/&Z'*LI&00>X(KSN:^U:_3XBV]_<6\MK9PO#%&L9&U3;;QC)(
M_B.?4^@XJQX7U[5+%?!VE7=K:?8=3TP"!XW8RHT<*M\V1@@C/ Z'N: /0**X
MF'QEJ":]H]A?6UK&VHW$UN]JC;I;0JK,A=P2I+*N<8!&[OBI_ ^H:OJ,_B%]
M2N8)5@U::W01QE=H0( !DG"X[>I)[T =?16!KVKZAI]W%#;I:PV[022&[N3N
M5I01MA5%8,6;).1GA>AK C\=:K?V?A&;3]-M-WB"-R1/,W[EUB9^PY7*]>N.
M,=Z .^HKB;GQ7K2I>V<%G;R:MIMO&US%%;SSQS3LF_RT91\@QMPS9^]TXS76
M:9=R7^EVMW-:RVDLT2R/;RC#Q,1DJ?<=* +5%<9H/C;^V/,N#-9+%;+,U]9X
M9;FR*= ZD_-T/( 'IFDL/%NL7MUI$T6DO/8:DFYMMM-&;3*[D+R,-KJ>A( Q
MGC(H [2BO,V^(7B&'PPGBB;2-/\ [)@NW@O42=S,$68Q;TXP0,#KR>>E:WB7
MQEJ'A\WMP]M:K;VL\"1P.VZ:ZB<H&E4J?D +D#<IR5ZC(H [:BN/N?$'B&;Q
MC?Z#IMAII%K!!<B6XF<;D=V##A>&PIQV]34,OC+4+36=-MKRVM8Q>ZD]BUHK
M;IH%PYCD9@2OS! =N <-U.#0!VU%>>Z?XHU/3SXQU'598;BWT_4/L\,,4;*<
ME(@B@Y. 2_/!.23[5>?QC?:5<:A)J]A(VEVU@UX+Z*TEA 93S"5DZL>""#@^
M@H ZN;4+.WO(+.:[@CN;C/DPM( \F 2=J]3@ GCTJS7G6IR:I<>-O 5U?QVB
M+-+<.$A#;H2;9SL+$_/P>H"\CIS77>)==3P]I(NS%YLTLT=M!$6VAY9&"J">
MPR<D^@- &O17*R^(]2T[Q(NA7T%K--=6<ES8SQ;HD=H\;XW!W$$ @[AG(["C
MP5KNN>)-+L]7OK.PM["[M%EC6*1VE$A/(((QMQTYS_0 ZJLFR\.:?8:Q=ZK$
ML[W=R26:6=Y F<9"*20@.!G&.@]!63XA\6MI.O1Z0LUG:336OG6LE\&$=U)N
M(\I7R K# ZY/SC INJ>*;Y;R_L-,ME>\L+>.216M9IA)(ZEA&#']S@#YCG[P
MXX- '745P_\ PEOB&]UJQTJRT:UM;B[TDWVV_E<&!PZJ5<!<\%B..O!XHTOQ
MIJ6IZ+'*]C;65W!J,NGZG++*#!:-&"2XR5+ACM &1RWMR =Q17GS>/\ 4CX8
MCU*'3[:6X76?[*E4NR*W[X1[U!&1G(.">/>M2YUGQ)8B.*_ATJV=HYG^U!VD
MB9@P\N)4RKEV!).,XV\ YX .DEU"SAO8+*6[@2[GR8H&D >3 ).U>IP :6^U
M"STRT>ZO[N"UMT^]+/($4?B>*\WNM:NO$.I?#G6[&T@2\O([J18II"$0FWYR
MP&2!R>G/M4/BO7[W5_ASXVTK6;."#5-*14F^SL6BD5P&1USR,CL>F* /5J*Y
M;5O$MU'J=WI>EQJUU9VJ3NSVLLRLS[MB?N_NYV$ECTR, \XV=#O[C5-$L[Z[
ML)K"XFC#2VLP^:)NX/X_I0 ^]UC3--DCCOM0M;9Y2 BS3*A8DX&,GN>*NUYM
M:+?7/B?QXM[#IU_!"+8-;3QML<"#>J\[L#)R>#SGI5NQ\;:R?#VEZQ?6&GI%
MK M8;"**9]YGF/._(P$ ^;C)P,=: .^HKD9_%&HZ;KEYHEY;VLUV-/:_LYHR
MT4<RJ<.C [BK X.03D'M6;:^-=?EMO"MX^G:<;?7XU1$69P\4IB,@)."-ORD
M8P2/4]* /0*0D*"20 .237/>&-=OM3O-9T[4X;=+S2[I86>V+>7(K1JZD!N0
M<-@CVJC<W^KGXK6VF1W$ T[^R9+@Q-&22?.C4DG/7'3CC)ZYH ZBSO[/48#/
M8W4-S"&*>9"X==P.",CN#5BO)_#^NZGX<\/3WD-K:/I@\17%O.&=A+B2Z*90
M 8&"PX/7GIWZ35?%^HAM5_L2P-X^F3"!K?[-,[7+A59E5U&U" V!G.2#P!@D
M [2BH$DDN+))8U,,DD88+,G*$C.&&1T[C-<99^.+VZ\->%-8-I;K_;-\EI-%
MEOW>XO\ ,I]MG0CO0!W5-=UC1G=@J*,LS'  ]37GU_XW\06]EXGO(=-T[RM
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M'Q6_B<1SQ7%A+"8"UQ#$&6:SFRO[IU8Y/5N<#.WIS0!UE%%% !1110 4444
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MW\)1MJ\#GP^, _9"!,/*,0'W_E^4]>>?0<5U$][+'>6,,-E-/#<EM]PA4+
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MG:X&Y2& )'7!J=?#-TGBO3M:_M,2+:63VCQRPEGEWLK,Y<, #E1P%QUKI:*
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M:NFS$IW'( )./7D8Z4OASPOK/A^.&QN?$GVK1+(?Z-$;<)*$'W5DDW<JHQT
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M2U\V&=5)*MMW JPW''/0X^O3V5N]K9QPR3R7$BCYY9.KL>2>.!SV' Z"IZ*
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M-(NYK>8J7C/H2I(H YS0O#/B#3;5;*_\3?;+2VB,=ILMO*E^Z54R,&.[:#V
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M/MW/F2L^"8EZ;B<#V' ]*Y[4]4O=+\4,VKK?#2[C485L]3LKEC##RB^1-$"
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MAH&"RK&X)0GD;AU&17E]]+XBET/5DD9=<CTZZL;@:AI\>R2^@23>\>%.#(@
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M!''6@#N:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?NY=4\>Z+I+V,=]I$]A<3^4\BF.;_5 .0?[H9L?[U '>T55TW3K?2=-M]/M
MXM[= D8>1G(4=!EB2:\WUS6]0\0> O'RW]DL,=A)<P0E)<[?+C0@'&,G)+9Z
M<X[4 >I45RFD^*@-2M-'O=.GLA)I_P!JM[B5T*RHFT/D Y4C<#@]O0\5%:_$
M+3KG4]*MQ&IM]5)6UFCG5V!QN42(.4W#IU]#@T =A117G_@+R_&^BR^*-9C6
M[^VW,HM+>8;H[:%'**JH>-WRDEL9.?04 >@45S6ZW\())%YMQ=/J>H!;*W>4
MNP9HU&P,QX0"-F]AP.PJ&Y\<16$6N1WFG3K?Z/;_ &N:VC=6\V'!(DC8D97@
M@Y ((Z=,@'5T5QDWCZ6UM[*YN?#6I1V]]<006L@>)O-,JE@=N[<.A&"/3..S
M[?X@6D1UF+6M/N=)NM*B6>6"5ED,D3<*R%20V3\N/4@4 =A17/#Q.UOK=II.
MI:=):W%]"\MGMD5Q*4&6C)XVN!SCIUPW%9EA\0'O]'?5T\-ZI]@2.8F1=CL9
M(Y#'Y80-DDXZ]!SSP30!VE%<I<>,9H5\06O]G+_:>D6BW9B$X:.165B/GP""
M-AR"/IG-9PUV.[T'P9=:]I,D]Q?7-L8)4D4+'.T182$ @]"_&"/7M0!WE%<U
M>^+E@BU6YL]/EO;32'*7LD;@,&50SB-3]\JI!/(]!D\5%)XVCEU:TT_3-,N;
M]KS3CJ%M-&Z+'*F5 Y)R/O#)('MF@#JJ*RO#>NP^)-"@U2&&2 2%T>&3&Z-T
M8HRG'!PRGFM6@ HKFKWQ>L$&JW=II\M[9Z3(8[V2-P&#*H9Q&I^_M!YY'<#)
M%5KOQT!J4-CI6C7FJ27&G?VC;/"\:I-'N4<%FX^]WQV SF@#KJ*126125*DC
M)4]1[5R^H>,TTZ9WFTZ=;&/48].:=SL8R/M 9$(^9 7 SG/!P#B@#J:1@61E
M#%21@,.H]ZY*^\;RVU_KME;:#>W,NCQ1S3$21JKHRLV02WHO ZGT%68_&$$V
MJ:%;)9R_9M;MC<6ETS *<('V$=0VTYQWYYXH NZ#H<ND1R/>:G<ZG?2A5>ZN
M%56*+G:H"@  ;F/J23S6Q5#3-2.HM>8@,<5O<- LFX$2E>&(]@<K]0?QP?B$
M-570;:?3;.:^A@O(Y;ZSMVVR7%N =RKCKSM.WN 1WH ZVBN$\*ZEX?U22ZUG
MPI(TGEVQCFTC>8C%(#D8C;A&.""1@' YXS6MIWB^/5/#^E:K:V3L=1G$$=N9
M '1LMNW>ZA&)';:>M '2T5P]Q\1E@L=3OVT&^^QZ7?&SO)3)&/+P5!8 ,=WW
MQP.W?M5T:W?W?Q!O/#TEDAT^*PCF+B49;>S+N/\ WP1@?7Z '5T5Y?\ #_Q,
MVD>#?"]I<Z;<FTO9WM%O2ZX$K22%1MSN(."-WK6_J_Q%TS2?M$S*DUG:W(M;
METG3S5;<%9EBZLJL<'H>#@$#- '8T5R.G^(]2O/%?B33I=-WVFFK"L:Q2J6?
M<C/GG'+9 QG Q3/#OB+3%\+^'8M&TYXAJ,3&QLFD^XBC+%F.< 9&3R<L!S0!
MV-%9NB:J^KV<LLMA<V,T,[P213KC+*<;E/\ $AZAAUKE_B\?*^'5]<H62:&6
MWV2(2'7,T8.".>02* .ZHKD[&/09?$EE%8V=[;74,<ER&>WF@5E $94[P W^
MLSCG!4&DOO'*6ND'6H=-EN=(^T+;+<+*H9V,@C#A3U3><9SGN 1S0!UM%<\?
M%*B]\06?V)S-HL,<[_O!B575F&T]CA#P>_YUGOK^F:GJ?@NYETJ=Y=31[BQG
M9P!;DP%V# -DDKQT(YZT =C17"6/C751IWBC4KO1GFATF^EB$5O,I<1QHA(&
M<9/+-^.!G KI(==6YETA+>$3+J,#7 =) 1'& IW=.1\ZCCN10!KT4CHLB,CJ
M&5A@J1D$5Y9X6UZ+PMX/U[5Y[2XNUBUVXMOD8,R)YP1!ECG:,@8&?I0!ZI17
M+#Q?/]OU33I-&G@O[2R%]!%-,F)XB67.Y2=IRN".?QJIHWC5V\(Z%?:JD,=_
MJD*M$KSK&C_('9BQ^ZH_$\C@YH [2BN('Q*LSIBW:Z;=2R+JBZ7-'"Z.$D9@
M P;/SJ<@@CKWQ5V3QD8!';W6G+9:FZ/*;2[O(HPL:L5!W@D?-C@#T.<=: .J
MHKDM.\>V.LVVDMIT)-QJ44TL4%S((B/*8*ZYYRV6X X(!.0*9-XHU1O%?A_3
MHM,,4&H64EW*LD@$BE0F5([;=_/J?IR =A16!I?B<:Q/&UG:>;927,ML9TE!
M:)H]V?,3'RY*<<GJ,XSBM^@ K$\/Z!)H<^JRM>"X_M&\:\<>5LV.RJI Y/&%
M'O[UG2^.K6'3(-;:TD_L&:<0"^#CY<OL$A3M&6XSG/(.,5(OC">?Q)>Z-::!
M?3O8SP1W$OF1JJ)*,B3EN0!S@<]>!W .HHHKQV*]T]9;_P .>,1<:3XDN99O
MLNL.[(ER&8^68Y0?E4 JOEG P,=210![%17 7\\]A\7I);*PEO;B30,B%) @
M)\_J2QP. !^5;%CXUL]3TO1;FSMY&NM8WBWM7(4J4!\PN><!<8)&>HP#F@#I
MZ*XZ^^(-MIVCZU=7&FW7VO1I4CO+1&4E0^-CAB1E&!!!'/7BH-3\7:Y!J^C6
M:>'Y;5+S4'@S<3Q[I8UB9P5"DXSCG/(VX[\ '<44#.!D8/I7 1(L7QIU$)"\
MBIH<=PL"D8,IE8%@"0H8@ 9X^M '?T5Q6F_$2/4+?0[UM%O(-/U>?[-%<R.G
MRRG=M4J#G!V$9Z9]>M+IWC*X%SXIGU>V6WT_2+GRE99 Q $:,!CC+,6^@R![
MT =I17(1^/K4ZC=V#VADN(;)KZ,6EQ',LJ*<,N[("N/0\8Z$TEGX]2?2+?5+
MK2;FRLKN*!K.6>:,"=Y1]S[WRXZDG P,^F0#L**XV/XBZ:(M4%PB1SZ=+!$^
MR=7A?SF"QL)1QMR?F) *X/%)XG\5:MI7ARXNX-+6.X2^@M-QF#(5D,8\Q#CY
MA^\P,@<@YZ<@'9T5SEUXI>&^NK"'3_/OK2U2ZGMA.!)M;=@1C'SD;3GH.1U)
MQ71T %%17+F*UE<0O-M0GRTQN;V&2!^9%>:ZGK2+\*=$G\/:>]KI][/:PK$9
MOFCB:=04).<[@2#SW- 'I]%96B:+9:0EQ)9V0LFO)!-- CY17Q@[0/E&<<X
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MC(K8)"C)( ]30!Q^N>'[S7K.UMM<TNRU.(QN\GE2^7);3$@H86(!P!D%L@G
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MREATXS7=T4 <J\/B35-$G&JZ7I1>5HT;33,98GCW?O"SE.I'08P,#)YXP)/
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M8L2C!>GS'@@]:M7'@FVN])BL;G5=3F=+F.Z>Z>1&EDDC(*9)3 4$#@ #\SD
MPK_4]<@?QGI$^KO(UGI2WUK=10I')$663*=",9C&#U&>N>:6#4=4T;PWX"6W
MOS)%?SVMM.)8D+%&@+;00!@#;Z9YZUTDGA.SFU74]0GNKN5M2LQ97$3% AC
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M+9!4G.5'?M0!RVE>(]8O/#6GO=:E!%<#5)[&YG2+]].L;2*/)C"L"YVJ2,8
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MDE@0=WR<C#,,#'6@#'\1:QXAT+3-5SK:7-WINF+<)]FM4W2. Y=YU(*QH=H
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M[X7UKJ\OV2=6A5?*E9"ZO'M .W*D$,3QCGUU3X0L;F>6;4YI]2DDLFL&:Y"
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M'R^F\ XQ^E7+SPE!J'VF*[U"]FL[F>.XEM7\O863;C!V;E!* D ]<XQDT =
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MK;9%# $(2#SZ'FO/K'[/9:+\,K=K>"+1KZ)#?;4 26<VP\GS,?>RV>O4@>E
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M6+;G(YQSCTYK"=8-5\'^.I]5"KK=C>7124\36Y09MO+/4#&W;CKD^IH ]8+
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M#1+<IH>BZU90 6^B1>+X[>[2/Y4@M&6)G''W4+'! XPQ'>@#TB#Q!/+XZN-
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M*\JZ;9K))*)G<0*"T@SAR<<MR>>O-9EKXSTJ](6V6\=W=4A0VSIYY9"X,98
M,-JDY!QQUY&;0\1Z>;.VG'G[KJ5X((#$PE=T+!EV'D8VMDG  &<T 7/[+T_S
M)Y/L%KOG!69O)7,@/4,<<CZTMOIMA:-&UM96T+1Q^4ACB52J9SM&!P,\XK'G
M\;Z':Z->:I//-'#93>1=(8'\R&3( 5U R,Y')X.1S4UKXMTBZOKVS\V:"6T@
M^U2?:8'B#0\CS%+ ;ER#R* +QT;2C#'"=,L_*C8LB>0NU2>I QP:?<:7I]W<
M17%S86LT\7$<DL*LR<YX)&1S4%AK=OJ%SY$<5S&YA$Z^=$5#1DX!!Z?AU'<"
MM*@"M)IUC-<BYEL[=[@# E:)2P'IG&:=:V-I8HR6EK!;HQR5AC" GUXK#?Q.
M)/&LGAE;6Z0K9"X:X6(D99MJX/0 8;D\9QZ5S_@;QE GAO2;?5[N]GO+N\GM
MA=2Q.R&3SY B-)C:&(  'TZ<4 =[=6=K?6[6]Y;0W$+?>CF0.I^H/%1G3; V
M0LC96QM!T@\I=@_X#C%9NI^+-*TCS7NY)1;P2K%<7*Q,T4#-C =AT^\,^F1G
M%;@.1D4 1P6\%K"(;>&.&)>B1J% _ 4R:QM+F>&>>U@EF@),4CQAFC)_ND\C
M\*Y)M0\8)IS.=!DDN$U4I)&EY&/.MN</&>B@'8,'G ;N<UGO>W#?$'Q%877B
M.[L-.M+&"XB/FQJL3/NW'+J<CY0<'B@#MUT;2U$(73;,>1_JL0+^[YS\O''/
M/%.32M.C2=$L+54G&)E6%0)!_M<<_C7,^!O$E]?^ 8=9\1,(W5G'GF(IY\88
MA)-G8L,8 '/8<BM1?%^D+-?07,DUI/90"YFBN(F1O*/ =1_$"1CC)SQUH T;
M/2=-T\J;+3[2V*IY8,,*IA<D[>!TR2<>]6R P((!!X(-8-]XPTO2[&^N]16[
MM8[)4></;.2H?(4C:#D$@C/0=\4NG>,=&U/6Y=(AEGCO$B\Y%GMWB$T8."\9
M8 .ON/KTH T+71-)L71[33+*W9"Q5HK=$*EL;B,#C.!GUP*?%I>GP7TE]%8V
MT=Y*,27"0J)''NV,FLV+Q=I,L]DGFRI#?OY=G<O$1%<-R<*W3) .,XW=LU3N
M?B%X?M5O7DDO#'8W'V>[<6<N(#@<O\ORK\PY/7G&<4 ;ZZ98)J#:@MC;+>NN
MUK@1*)"/0MC.*8=(TPB<'3K0^?\ Z[]PO[SG/S<<\\\U6O\ Q'8Z?)<(XGE^
MS1+-<&"(N(D;.TMCUVGIG &3@<UG7E[:3>(M4LX-3U&+48M,WM;@%8HTW-B1
M=RX+$Y&03P,=J -M=(TU;1K1=.M!;,VYH1"NPGU*XQFB?2=-NK:.VN-/M)H(
MCF.*2%65#[ C KB_!/CNPET#PU8ZG=79U"^M8U6ZG@D\N>;;DH)2-K/[9Z\=
M>*N^']5DMM<\9_VEJ$TEI8WL0C,S9$:F%&*J /5C@ 9- '4S:987*1)/96TJ
MP_ZI7B5@G^[D<?A3H;"SM[B2X@M((IY/OR)&%9OJ0,FJ-AXBL=0U6?2U\Z"_
MAB6=K>XB*,T1. ZYZC(QQT/!Q53QU<W-CX&UJ^L[F2WNK6TDGBEC/(95)'7@
MCV- &[-!%<PO#/$DL3C:Z.H96'H0>M5[C2M.O+>*WN=/M9X(L>7'+"K*F!@8
M!&!7 1ZWJ^E:WX*@BU6?45UN'_3+2<(S(/+#><I505 ).<Y!KKW\6Z3%>6L$
MDDJ1W<YMK>Y,3>3)*,_('Z9.#CL<<$T ;2(L:*B*%11A548 'H*YKQ#X<N-:
M\2Z#?&*RELM.:9IHK@DF3S$V<#:1QUYZ^W6EB\?:#-<S0I+=8@EEAGE:TE5(
M6B3>^]BN%X!Z]<&M"+Q%8N+AIA-:I;VXNI'N8RBB(Y^;)X['(ZCN!0!:?2M.
MDM$M'T^U:VC.4A,*E%/LN,"GW&GV5Y:"UN;.WGMAC$,L2L@QTX(QQ6?;^*-.
MGOX;%OM$%Q<0M/;I/ R&=%Y)3(Y(!!*_>YZ5GP?$'P_<BU>*6Z,-S=&T6=K2
M18UEW% CL5PI+# !YZ9QD4 /\6^&YM9\/V^E:9%9PQQW4$Q23*(%CD#[0%4]
M<8_&MVRL;6PAV6MI;VH;YG2! JDX]@,_6N8O]&\12CQ"MOKFH(ER8GL=HBWP
MN"2RIGC81M'S<_>^IM3ZG<Z'K^C6E]/YT&J@P%CTCN53<"O^RX#<=B!CJ: -
MNUTO3[&:2:TL+6WEEYD>*%49^_) YHMM*TZSF::UL+6"5@0SQ0JK'/J0/:K=
M<_XD\3KX?N](MOLD\[:C=BW#1QE@@VECTZG"G 'U[4 :L.EZ?;WTM]#8VT=W
M,,23I"HD?ZL!DU;KSV#Q6NB>+_%_]IW.H7%E;+:2QQ)"\OV=&C9G.U1\JCJ2
M?3O777&OV4,4+Q>==M-#]HCCM8S(S1<?/@=N1CU[9H G?1M+D1D?3;-E:0RL
MI@4@N>K'CK[U)'IUC#<FYBL[=)V&#*L2AB/3.,TS2M5LM;TNWU+3IUGM+A=\
M<B@C(Z=#R"#D$'H16??>*],L-8?29!=R7Z6WVGR(;61V=,A?EP/FY/;I@YQ0
M!HV6F:?IQE-C8VUJ96W2>1"J;SZG Y-6B 001D'J#7,V_C_0+J/3I89KEK>_
MD6&*?[+((UE8D"-VQA6R,8/?ZU9E\8:1#=F!I92BWJV#3K&3&MP<8C+>O(&>
MF3C.: -.RTO3].W_ &&QM;7S#E_(A5-WUP.>M,.C:69I9CIMF99G$DK^0NYV
M'1F..2.Q-8]]X\T2PGU."0WKRZ9M-VL5G*QB4@MN.%^Z ,[NGUJQ=>,='M+V
MVLS)<37%U;&ZMT@MI)/.C&.5P/F/S#@=.IP* -/^RM.%[]L%A:_:LY\_R5WY
M]=V,TUM'TQC,6TZT)G_UI,"_O.<_-QS^-4K/Q3I5_H]MJ=M+(\5S(88H_*82
MM("0R;",AAM;/H 2>!FJDGCS0(-/EO)[B:%8;L64Z/;ONAF) "N,?*#D<G@]
MC0!LKI.FI)#(NGVJR0C$3"%08Q_LG''X4L6EZ?#?R7T5C;1WDHQ)<)"HD<>[
M8R:9I6JV^L6C7-O'<QHLC1%;F!X6RIP?E8 XK/N-0L%\9V]HU]?K>K8RRBT5
M&\B2/<N7/RX9P< 8.>3Q0!I6^DZ;:3--;:?:PRN"&>.%58@]<D"EM-+T_3W9
M[*PM;9F&&,,*H2/? K"MOB#X?NQ9O#+=&&[N3:1SM:2+&)=Q4(S$84DC@'GI
MTR*Z@G )H " 1@C(-4SI6G-8?8#I]J;/_GW,*^7US]W&.O-8[>.=$329=39[
MD6L-W]BE8VSYCFW!=K#&1\Q STR:J>/-9>#PIK\-E<7=KJ%IIK7BRQ*5V##;
M?FQ@$E3QUX- '56]M!:0+!;0QPPK]V.-0JCZ 4L]O#=0/!<0QS0N,/'(H96'
MH0>M8.C>*]/O;B#2]]S]M^QBX4RV[J)T& S(Q'SX)'3UXS4>BZ[I$>@R7T6I
M7MU;O>RPJ]VK&5I3(1Y2J0&P#D 8X ]J -^TLK2P@$%G:PVT(.1'#&$7\AQ4
M=EIFGZ:938V-M:F5MTGD0JF\^IP.37%>-O%*7'@G6IM*OKJQO],N(([A/]7)
M$6D3@^Q5LY!_&NITWQ+IVJ:K<Z9 ;A+NWC64QSV[Q;XV) ==P&Y<@C(H UZ*
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *Y?QWI][?Z18-8VKW+VFJ6MW)%&1N,<<@9MN2,G Z=
MZZBB@#S[7-(O-8OM>UR"QN$63P_+I=M$Z;9;B1R6SM/*J#M W8ZL>F"5U#2=
M5?PUX-O;6RF>YT26"2YL3A791$8WVY."RY)'//.#7H%% 'GFM^'+[Q%>^)]4
MM;>2 7F@'2[:*8>6TTA+L6(/*@;E49QW[8)2R75KWQ1X/OFT&_MK:RL;FWN6
MGV*8V98ADC=TRI]SSQBN^NKJWLK9[F[GB@@C&7EE<*JCW)X%*#!>V@92DUO/
M'D$<JZL/U!!H \CTJ:*TTS3X-0T/7UT33=0?4;9X;>.6%!O=D8RJY9XP&W#"
M@].2.NS>Z9J4R?$A4TVZ)U6$)8_)_KC]F$7'I\P[XXYKI++P;I&E1A8Y]0^P
MPC*6DU_*]O&H[;&;&T>AR/:M:'6M*N)1%!J=E+(QP$2=6)/T!H Y"PL=3M/%
MWAW4#IER]O\ V$;"8C:/(EWQM\^2.,*W(SG'&:[N0%HV4=2"*=10!Y?I>@:E
M>^ _#GA:YTZXM;K3[FW>[FE4!(EB?>2C D,6Q@;<_>YQ3K#2;JPO=2T+4O!<
M>JBXOIKBTU)XHI(&220R#SBQW J6/ !)P,=J].HH XPV-Y-\2M3N3:W,5E<:
M/'9I=A/E\P22,<=^ XYZ<5@PZ!JU]\-['P5=:?-!?6LT$+W0'[D112JWG*_?
M*KPOWLGD <UZC10!QNC:?>-XJ\9M-;7%O;ZBT/V:X9<!PL C8CTP1WQFLCP=
MI]S;V^F:-JG@B*+4-+V(=4>*)H"J# EC;.\NP'3'!.2>U>DUGR:[I$4,TLFJ
M6:1PS?9Y6:=0$EX^0\\-R..O- &A7D]II&M0_#SP[H\NBWBW6FZM;R3 ;2"D
M<Y=G7#<C;C'<YX%>K.Z11M)(RHBC+,QP /4FHK2\M=0M4NK.XBN+=\[)8G#*
MV#@X(X/(- 'G>O>'M6UG5O&:6EJ\?V^QLULY9EQ'+)"SL4/H#D#GCDUM^%B+
M^]2\?P4-#N88C'+//#$'+'&4B9"25ZDDX'3@]NPJO=W]G8*K7EW!;AN%,T@3
M/TR: ,;QW:7-_P"!=;L;.WDN+JYM)(8HD'+,RD#Z5DRVM[)XQ\(WBV%S]GL[
M"YBN9#'Q$[K&%![]4;IFNPMKRUO8S):7,,Z X+1.&'YBIZ /(CH>M0!]5709
M+T6OB&\O'T^55#7%M." Z9X+#J%.#6GK&CW5]HUKJVD>$(;5K748[Q]+ECBC
MFO$".C;PI*[L/\H))^7U.!Z510!YOK6E3:WX%UUM)\)'2[BZ6 K \445Q<&.
M0,=VTD8 &%!.>O3(K5OTOK[QUX6U0:9=QVUO;7@N"Z@F(R",(&P3R=AZ9QWK
MLZ* /*9]'U=_A]J^GKI5W]LGU]KN*+8,M$;M9=V<X^X#QG.>*GUUIE\4^(EL
M])UF>UU.SAMKR2PABFRVQ@>&=3&X1P,$-P02.F?3ZY^;P?ILFIW%_#-J-I+<
MOON$M+Z6%)FP!N958#. !D8/% %SP[-9S>'K+[!#/!:Q1^0D,Z%9(_+.PJP/
M<%2/PK!TRUDT_P"+&O/*/DU6PMIH&['R2R.OU&]#_P "%=;;V\-I;I!!&$B0
M851_GD^]-N+."Z:)I4R\+[XG!PR-TR#]"0?4'!H X*RT:_M/%=O?Z-#J%@L]
M_*=4L)_FM'C._P#?H3D*[':<*<_-R  :R+G2]=C\*:AH,>@WLMQ'KWVQ95*"
M.6(W8E!0EN3MZ@XQ@Y([^MT4 <!:-K?A[Q+KULWAZZU.QUBY%Y;31-'M1VC5
M&CFW-\H&P<C=QTSTJW#;7T/Q#U/4)K*8VSZ/#;":./Y'E5Y&95'7HPQG\Z[2
MJU]J%GIEJUU?W<%K;K]Z6>0(H_$T 8/P\LKO3/ &C6%_;R6]W;6XBEBD'*L/
MIP?PK-U.[%G\8=/D:">53H4ZMY,9<K^_CYP.2. . >OIFNYK*?0;63Q)'KQE
MG%[' ;9<.-GEDABN,=R <]>* //)O"VK:;%!KL>C#4 =:N]0N-(.POY,Z[1@
M'Y2ZA5;&>K$9K0UG3IKWP];RZ9X4?3C+JUI=-:I#&DS)'(K-))M.T' ( R3Q
M[X'I%% '$>,=)_M348KB"+5;._@M2UEJFG@EE<DYAD7NIPIPPQUY%5]+M->T
M;Q5;ZSJUF]RM_H]O;79LTW_9KF/)(VCG8VYN1D ^@YKNKFZM[.W>XNIXH((Q
MEY)7"JH]23P*=#-%<01SPR+)%(H='0Y#*1D$'N* /,4\-:G86^B-]AG9W\3R
MZO/%& WV6%_,P#@X) 9<@9Y)QG%=+X<M+N#QKXMNIK2:*WO)K=[>5UP) D*H
MV/3YAWZUUE% '*^.M+U"^M-(O=-A-Q-I>IPWSVRL 9D4,K*N<#=AB1GTK)UC
M2;O5]7UG7K>RN4C;P_)ID$3Q[9)Y78M]T\@#@9./O'L,UZ!10!C^%(IK?PCH
M]O<0203P64,4L<@P594 (_,5@^/9C;ZUX-E$4DNW6.4C&6QY$N2!WQUQUXXK
MMJPO$6GZ5-)8:EJM\;1=/F\Z!S,L:K)M(R<]?E+<'MF@#C==\*ZKJ]SXBUW3
M[(>;/+826MG<C9]K%LV]MX/0-G:-V/N\X!JS>VKZSX1U]['P5)I-Y<Z9+9J)
M((EGFD92 H*$_NP>[$9STXKNK#5M.U42'3[^UNQ'MWF"57V[AN&<'N""*>VH
M6:7Z6#7< O'0NMN9!YC*.I"]<>] ')ZOI46J>&M"M+_3M27RU4FXLR4N+"58
M\!QMYZY7@'KT(K(MM+\3VEUX8UO4$FU$Z;->6\ZJBB=[>4XCF*#@N JE@.<'
MIG->F44 >6^(_#FIWVF>--0M+"X:76GLTM;7: [+#MR[ GY<_-P<'"CN<5LZ
MI:WDWCNYU%-(GNK-O#TMJ%=,++*7WB(YY&0,9Z<XS79+>VKWSV*W,1NXXQ*\
M <;U0D@,5ZX)!Y]JGH \]\/V.I>&[N]?38=6NM!BT\R0Z=>C,T-P",0Q,W)7
M:#W(!Q@FNTT?4AJ^D6NH+!+!Y\8<Q2XW(>X...O<5<DC66-HW&488(]10B)%
M&L<:JB* JJHP !T % ')SVU_:?%$ZH-/GFL9](2V\^+:1&Z2NY##.?NL,8!S
M7+VNCZO%X \/6#Z5=B[M->6[FBV#*1"Z>0MG.#\K#@'/:O5JK2ZA9P7D%G+=
MP1W5QGR86D >3 ).U>IP 3^% 'G<6F76GZUK6F:AX,76H=0O9+JSOC'$\6V0
M[MDV\Y4*<]CD=!Z^EQKLC5<*-H PHP/P%.HH *\VO/":>(O'?B1=5TN<:;?6
M$$%O>% "LB;B60]5()!!P <?GZ%9WMKJ-HEU97,5S;OG9+"X=6P2#@CCJ"/P
MJ>@#SB]M/%6L^!+O0[^Q\S6K"6)X;A\>1J(AE5U.<_*7"X(;')].EB&"#5M*
MOKA_A\;/?:_9KB&:*))[@,R[HXV1L[0,G)*\[<=#7?T4 >.^(].U/2OA[XPM
MS=7]UH8M(38G4@?/C;?\\>2-S(/EP6]2!G&:ZC7-$N/%WB#3[F*"XL8K.PO(
MGGF38WF3QB,(!WV\L2..!@GMU&O:):>(]'GTJ^,OV2< 2K$VTL <XSU'('2K
M\2&.)4+M(5&-SXR?KB@#SB+1]5U;P;X<\-76FSVE[IES:_:9B!Y2);D?.C]&
MW!0 !R-W(&*AU#2-5G\-?$*TCTRZ,^J73O9+L_URF*- 1SQRIZXKU"B@#S7Q
M%I%[>3R:CI%MJFG:_%:1):W$*YAO,#_4SJ?EP"2,MC /!.,5K&PU"7XBWMV]
MG(()="2T$X'[LS"1V*COC##GI766=_9Z@DCV5W!<I'(8W:&0.%<8RI([C(XI
M+C4+.SF@AN;N"&6X?9"DD@5I&]%!ZGZ4 >>:;H6HZAX.\)^'9].N+6XTJYMI
MKN690%C\@Y^1@2'+$ #;G@DG'0MU+P]K&I1>.([6R9)KN^M;NQ%P ([GR5B)
M4^@)C(YQU]*].HH Y/PMLO;TWX\&_P!A2I 8I);B&)96)(.Q"A)*#!))QDXP
M.N+?CJVN;WP-K5C9V\EQ=75G)!%%&,EF92![ >YKH:* ,+PKI=K8Z%8,NFQV
M=X+6..?]RJ/N"@$$CKS]:X[PGI-UI\%EX>U3P7'->:?,-FKO%$T#HK964,3O
M$F.@QG/4CG'IU(2 "2< =2: .&T"RO+?2/&:76CS2_:[^[N8+:50!=1N@"KU
MXW8(P<'FL*?P=K%WH>NZ#I-UJ"Z-<Z<!:PZIG?;7 <'R48_,8]HP>H&1@GFO
M3[._L]1A,UE=0W,08H7AD#KN'49'<58H XB>WO?$NK^%[Z73;JP;2I'N;OSD
MP5<Q%/*0C[^2V<C(PO7) K 71]7'P^AT_P#LJ[^V+K_VLP[!GROM?F[LYQ]S
MMG.>*]'?7-)CF,+ZI9+*#@H;A 0?3&:O A@"""#R"*  '<H//(SR,5QWC*U?
M4_$G@^QA!+PZD;^0C^&**-@2?JSHOXUV501VD,=U+=!,SR@*TC')VCHH]!R>
M!ZD]30!0T/6WUAK])=.N;&6SN6@9)\9<8!#C!/!!!K*\:V=]-<^'+VRLIKP6
M&JK/-'"5WA#'(F1N(!P6'>NGA@BMU98HU0,Q9L?Q$]2?4U)0!Y[+8:BVI^/I
M3IMR%U*RACM,+D2NL+(P'_ F R<#OTK-BTW4M'N=!U.Z\,3:O9G1+?3KJV2.
M-Y[6:+)W!7(!4[B#@]L^F?5** ,[0K5;/1X(DTRWTQ?F86<"JJQ L3@A?EW<
M\XXSGKUK#EMKI/BHNI?8YS8KHS6QG5,KYGFA]OK]T=<8[=:Z*75-/@N)K>6^
MMHYH8A-*CRJ"D9) 8@GA<@\U-;7,%Y;17-K-'-!*H>.6-@RNIZ$$=10!Y=#H
M^KI\.-*TTZ5=_;8-<6ZDAV#*Q"[:7=G./N$=\YXHUNR\0ZDMUYVA7\D]MKT-
MS"(61(6MEE4AE7<-SE1DEAD'/(&!7IMKJ%G>O.EI=P3M _ERB*0-Y;8SM;'0
M^U6: //9;'47U'Q_*=-N@NI6<4=I\@/FNL#(0.>S$#)P._3FFZ/8:A!KW@^>
M;3KI(K'0WM+ERG$<I$6%/K]QN1D=*[^XN;>TA,US/%#$.KR.% _$U%:ZE8WQ
M86=[;7!7DB&57Q^1H \M30M:MM(M+\:%)>/8:Y>74NFS!0T]O,SX9,\%@&!
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MW,%8%<L0RDC@D=>HZ5JVFC>)AI\HO_$<,VH858)8K/RXD 8,2R;_ )RVW!Y
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M>VD0($()8[L&-3V[UKZ!IFNVG[S7=:CU&54\N/R+;R%QQEF&XY8X'H!S@<T
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MD@')Y& 1N'I69I][J=]H7PV=]8OT?4"4NV2;F8>1(V6)ZG('/;ZT >K$ C!
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MDQEE01O-)<222E1G"[V8L ,G@'J2>]+::YI>I3M;V.HVL\_E^8%20,2F<;@
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MX]?:@#:HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+-^X7@JH'WCD9^8=,9KOZ* /(]">&:;X6^;$V;73YDE\Z(KY;^0BC.X<992
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MU[3O[$F^QWPBVW$!("K;RXX9B.1P&^4Y%,@>*]\*^#I+369]%U2ST_RX;J>
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MD! VK)@_*, D#!SCG%9?Q1,<D'AF%BYVZ]:2R",D,D8+;G)7E0,_>XQ7?44
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M[I,B1S6<>V5W\P QE2IP00P^F#GI6''X,UFUTK1;*!EE@L-<&H1Q7%R6:"V
M8+"&(.XC=GG@=,G&:FU+PUXEDN_%USIKV]O)JCVC6S?:&5BL0571B%RFY00"
M,XSVH UW\:);KXACN=.E-UH<"7%Q%;RJX>-E9@58[>0$;(('3C-1P^.%-C#=
MWFE3V,-WY(L7N9HU6Y,B%SSGY H4D[L''0$\5C?\(GKHG\4/#I^EVT.LZ5':
MQ0PW!Q#(JR+@_(,C]YDG';&#UK0U+PWKDOA?PXVGO:PZYH;12(DKEH9=L9C=
M"P&0&5C@XH GM/B#IT]MJ!DA<7=E=1VAMX9%D$\DN/+\MP0&#9ZG&,'.,51T
MI[AOC)J'VFT^S2?V)$2%E\Q7_?-\P/'H!T'W?3!J77-#\3>)-#M[B<6%EJUE
M?07UG:+*TD0:(GY7DV@G<&/08&![FK.F:9KTOCUO$%_96=K;2:6EFT271D=7
M$C/_ ' ".?4?CTH ZB]O(-/L+B]N7V6]O$TLK8SM5023^0KG(?&F_4-$M9-)
MN0-;A,]FZ21G:@ 9O,R1M(5@<+N[XSBM?Q'=V]AX:U*YNF@$$=M(6\\$QGY2
M,,!U!Z8]ZX70;35]'DT,:OX?MY888UL+:YBU;SC LFU24C*+D<#)R2%!P<"@
M#;7XBZ8UYIBJBR6>I7 MK>>*='<.<[2\8Y56QP?<9 S44OQ&6*RO;]M"OULK
M#4#8WDS/'^Z(=4W8#'=RPZ9X[]J3PII7B[0+>V\/SC3I-)LF"PZ@LK><\ .5
MC,6W&['REMV /4UGW?A#7KCP=XGTE8;07.J:J]Y 3<':J-(CX8[<@@+V!Z]:
M -_7O&]GHLE_&D:7#Z=&)+J/[0D;X*[MJ*WWVVX..!R.<\5!-X]$FH16>E:'
M?ZC+/IJ:E 8VC021,P'\3<'GH<'/'/6H9-,\5:1XKU#4M%M]/N[+5Q$]Q!=7
M#1-;3*@3<"%.Y2JC(ZY':KD&BZM'\0(=9F\B6U7218R2[]KM)Y@<L$Q@+^-
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MZUVZ(L:*B*%10 J@8 'I0!EWVMB#5XM(M(/M.HR0-<F,OL5(@0NYFP<9)P
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M'3)[ZQUC[9+>O<OONHOW@'\'R!0X 7)''&*ZC0M(U"Q\6^)=1N8X5MM2E@>
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MC.Y&P,CMR!R*X_3_  ?=Z2NL?V7I]M#IUZD(&BW,^^ N'/G$<$(&0X  ZC)
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M=QBV>9\J%CC&>@&3]*@TC5;/7-*M]3T^4RVEPN^)RI7<,XS@\BG67_((M_\
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M2)$&6)G^9B%4':#C)(&3Q6C7G'CF'6;?P/J<.I7D%V!J=F;.4+MD\HW$6!(
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M9/G7)X^X#CU]N* /4:*XO3;[6-2US4_#S:RT=QH]K;^=>16T8:XFE#-N*,&
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M4U74+(PO;PV]Y<!E@C92I"8 .=I(!)) X&.:ZL,"< C- 8-G!!QP<4 <I8>
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M/;NS%FVMMZ$L<@@YS5R?P5;76FVMI<:IJ4DD%Y'>M<O(C2RRQD%"Q*$8&!P
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M! )W*2>"1BK>MZ1%KNAW>DW$\T<%W$T,KPE0Y4C! R"!D>U6;6\@O+.WNX9
MT-PBR1L>-RL,C]#4Q8#J0/K0!AW_ (5L]1TG3[*:YNA-ISI+:WBE1-&Z# ;[
MNT\<$%<$=JPO&N@>1X'\320)>:CJNHVGDEUA\R23 (1 L:\*,GMW))KN=RYQ
MD9],T;AN"Y&3VH P-+T*&1M/U*\N+N\FM[8Q6ZW<83R@P 8[0JG<0 "3V],G
M,%EX'T^QM8+!;J[DTJVN!<P6$C*8XV#;E&=NXJK<@%CR!U Q73%E7J0._)I:
M ,"7PI;W,R?:KZ[N+9+X7\=M)L*I*&WC!"[MH8YQG].*JW/@6QNK77[>34-0
M\O7&#7>&CR/E"X7Y./E '?I6[:/?M=7JW<5ND"R 6S12%F9-HR7! P<YZ9XJ
MV&##*D$>QH P)_#BQ:G:ZW'<WMS>Z?9R6\$!:)5E!P2&^0<DJO.1BN(T"QU.
M.VMX].U/Q;:ZD &>TOK)?LRN3E@TCQ_,F2>0Y8CIDUZL65<;B!DX&32T 9^N
M:3%KNBW>E3SSPP7430RM 5#%&!! + @9!]*DTK3DTG2K73XYYIH[:)8D>;;N
MVJ !G: .@]*M[ESC(R>.M!900"0">@SUH Y6P\!6.F:I+<6FHZG'8R3FY.EB
M<?9A(3N)"XW 9YVYQGMCBKEEX4MK&+6HTOKV1=7D>6?>R91W4(2F%&. .N>E
M:@U*T.K'2UF4WBP^>T8/*IG )],G./H:MT <_P#\(A8W$\LVIS3:E))9-8%K
MD("86(+ [%7)) Y]N,<Y-/\ "=O9?V>)K^\O4TT$62W)0^3\NT'(4%F"DJ"V
M>#Z\UO[@#C(SZ4!E)(!!(ZC/2@#E'\ 6,F@W>CMJ6H_9[J]-](VZ+?YAD$AP
M?+QC> <8KI;FTCO+":SN-SQ31-%)V+ C!Z5D>%]>N==_M@75M%;O8:E)9!8Y
M"X8(JG=D@==WI6Z6"C)( ]Z .73P+91Z7I-HNH:@;C26#6-ZSH9H0%V;?N[2
MI4!2"O/?GFMC3-'@TR6[N!))/=WCA[BXEQND(4*HX    P !Z]R2= D $D@
M=S1D8!R,'O0!PTME>7/Q<NKB%]1M(/[&C@%S':DQ,XE=BNYT*Y ((_KR*UCX
M)T]1HRV]S>6ZZ3,T\ C9#OD8,'9RRDDMN;/3J:Z/>O'S#GISUH+*HR2 /<T
M8EWX9@FUXZU:7EU87TD MYGM]A$R Y7<KJPR,G!Z\XY'%<SKNAK8:]X)L=+A
MOX;6RN+AY+BWMVE\K=$XW.VUERSGG/\ >/3K7H60.II 0PR""/:@#GKGP7I=
M]IFH6EZ9YY-0E6>>Z+!9?,7 1E( "[=JXP.W.<G,G_"+0S?:9;V_O+J[GLVL
MA=.45XHF^]LVJ "3@DXZ@=ABMTD $D@ =2:Y?6/%XMM+TC4M+BAO+2_U*&R,
MK2$85Y?+WJ #N[XY':@"Q)X.L+R6YEU66;49+BR-@[SA%/DDY(^15Y)P<^PQ
MBCP]X2C\/E<ZMJFHB)/+MUOIPX@3T7 &3@ 9.3C@8YST (/0@XXXH#*V<$'!
MP<'I0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %<SXVM+B]T^PALKRT@O?MJM;Q7J%H+EU1S
MY3@=B 3[%0:Z:H+NRM+^(17EK#<1AMP2:,. ?7![\T >4R7=O)8^&KB72H](
MFL_%7V>ZC#@QQN5D+;'X^0L1^/':H-7U:.RG^(<^FS*85N]/>?[*WS" K&)V
M7;[;\D>]>LR:5ITUA]@EL+5[+_GW:%3'US]W&.O-/BL+. R&&T@C,H"R;(P-
MX V@' YP !]!0!P>KQ>&#H'BF_T"X@=[C09A,EE(I@"B-MC,J\!CD@$\D*?2
MJ>EV%GIGBCX?W%G"D,]_I<Z74B_>G"PQ,N\]6P>F>E>A0Z-I5M9O9P:99Q6L
MAW/ D"JC'U*@8-.72--1X773[17@&(F$*@Q_[O''X4 <O\4PA\$.)&VI]NL]
MS!MN!]HCR<]OK6%J/AZSTWQ=JMMHEHJ65SH$[ZA;1C,9ER/)8CIO/S\]2 37
MITT,5Q"\,\:2Q.,,CJ&5AZ$'K45G86>G0^38VD%M%G.R",(N?H!0!Y9IM_I[
MO\)W6ZMFG6U*2,'!8?Z&1M8]OFXP>]7=$$NF^)=)CO+:SU.QO[FX.GZQ;?+.
MK,LCM'.O\7&X9!ZJ,@5Z!!HNE6I4V^F6<)1S(IC@5<.>K# ZGUIT&DZ;:S--
M;Z?:0RN"&>.%58@]<D"@#R&XMK8_#G4T  6'Q:R1E6(*#[8J\$=/EK3UF&3P
M]K_C2'PY!]FD;P]%="*V&"9=\JF0 ?Q[1UZDXKTC^P])\HQ?V79>66WE/LZ8
M+>N,=?>IH].L8;K[5'96Z7!&WS5B4/CTSC- 'G5A#X:NY%UK2?$D41?2YDD3
M3XT0B+9GS)57G<AZ$X.3CO5:TBFM(]3T+5X['3[E]%;R==TT8BE@W! [I_"P
M+ ]<$%L&O2K;2-,LQ<"UTZT@%Q_KQ% J^;_O8'/4]:(='TRWAEA@TZTBBE&)
M$2!55QZ$ <T <KX+EN;;Q!JFEZII%E9ZI';02/<:=_Q[W469 C!<91L[@0?3
MT%0Z];Z:OQ;\/SWL-H-^G76'F1?F=7BV\GJ1DX],UVMI86>GHR65I!;(QR5A
MC" G\!3IK2VN)899K>*62%MT3N@8QGU4GH?I0!Y,^S4_AOXGO[T;?$UE>W)\
MX#$\,ZR'R%0]0-OEJH'!![YKTN<W#>%I3=@"Z-D?. Z!]GS?KFK+Z7I\E\M\
M]A:M>+@"X:%3(,=/FQFK= 'C.E:)90^&/AUJ^D1A-<EEM(WFB<EY8-G[Y7YY
M0*#Q_#@ 8J>W_LO7DU&+6-;CL->LM7E.%C07:LLQ,(B)^9E*;%  P02*]4M=
M*TZQGDGM+"UMYI?]9)%"J,_U('-#Z7I[Z@NH/86K7J#:MR85,BCT#8S0!S_Q
M-_Y)EXB_Z\I/Y5A'0=/L/'OAF?1(51KVVN/[4$;EA/!Y?RO)R<GS"H#'DY/7
M%>CLJNA1U#*PP01D$54M=)TZQADAM-/M;>*7_6)#"J!_J .>M 'CMCI\.G?!
M5_$&G6[?VFJS02W43,95MC=GS0"#QA 3[<GUKL+JQM(/B!X:;0H;=;*^L[D7
M\5NH\J6W"*8W8#@X=@ ?]HBNVMK"SLH6AM;2"")CDI%&%!_ 4VRTS3]-#BQL
M;:U#G+"")4W?7 YH \=T^\L(_ '@%)+BW6Y@UV-6#.-\8$T@8'N!TS^%7]?B
MAU*[\9:1+>6$M]=7$(L[N:ZCC-G^[0A2&8. G+?("#N/?(KT]=%TI)7E73+-
M9))1,["!06D&<.3CEN3SUYKE)?"&HS:G>O=VOAS5(;FX:5;F_LB\\:GHA'1@
MHP!RO H JSZ-IMU\4;'3;FVAN+-/#DG[EQF-QYZ=5Z$=\'(SSVKE[*&QF\%_
M#^2^CMY(HM>EMM]P P6(-<JJ$M_#A5&/85ZMI_AW2]/M+:%+*W=[>$0+*T*[
MBH&,9QP,=NF.*L#1],%K]E&G6@M]X?RA NS<.AQC&?>@#*\:>6?AUX@\G:8S
MI5QLV=,>4V,>U<=;Z)9V&K^!=1T&,1ZE=)B]:-R?/MO()9I.?F ;8 3T) ]*
M]2(!!! (/:JMEI>GZ<7-C86MJ9#E_(A5-WUP.: /+/#']EZ]9:)>WNMQV_B.
MTOP;B&*-%NVGW$/$^?F9#DY'3:.P7B_%9I:>)?B1<Z/8VW]J6MM"]GY<*[DE
M:V8_+QP2?SKT1-+T^/4'U!+"U6]<;6N1"HD8>A;&32PZ;86]R]S!96T4[_>E
M2)59OJ0,F@#S41VSZ'X U?0-@U&>[MHY98_]9/$R$W D/5L89CG.&&>M,T?1
M;;['XXU.QLUEUC3M4OCIS DM%)Y"@!1[D]._'H,>F6^EZ?:7,ES;6%K#<2Y,
MDL<*JSYZY(&33K;3[*R9VM+.W@:0Y<Q1*I;ZX'- 'GGA*/P_J=]X=UG3=<B:
M^6W9'MK5$624%/G%P!ECM89RW\1Z_-SI_$NWLY8_#$MY# Z+KMLK-,H("-NR
M"3V.!G\*ZZVTO3[*XFN+2PM8)YSF66*%5:0_[1 R?QJ6YM+:]@,%U;Q3PD@F
M.5 RG'(X- 'G-QI6D:SX[\2PW-M;W-FNAVIBC.#&!^^P0.G Q@]NU96G:NK:
M;X"AUR^AATVZT9@LUX@DB>Y CP'W<;MF[!/J?6O56TG3GFDF;3[4RRC;(YA7
M+CT)QR*231M+FL/L$NFV;V><_9V@4QY]=N,4 97@JPLM,T VNG:C)?V27$AA
ME)!103DI&1P44Y ],$=JX?4-%TN]OOB@+FTBF$$,<L0?D1/]DW;U'9L\Y'/6
MO5XHHX(DBAC6.- %5$& H'0 #I54Z1IC-,QTZT)G_P!<3 O[SO\ -QS^- 'F
MUM:Q6>L?#W4K.)1J6H6,PN9R<O<G[*' D8\M\P!&>G:HO"0T?7+3PWJ4NN)%
MK]M,!<011HMU)-@B:.7^)E)R3D=!GC%>G#2-,5H6&G6@,'^I(@7]WSGY>..?
M2G1:7I\%_)?Q6%K'>2C$EPD*B1Q[MC)H \K\/_V7KUIIUSJ.MQVOB.SU,M-#
M'&BWAG$C QG/S,C XQTVCL%XDM++28_#OQ,A6"TCNDN;XJJJJNL8@C88QR%W
M8/IFO4!I>GKJ)U%;"U%\R[3<B%?,(]-V,XI9-,L)6G:2QMG:X $Q:)290.F[
MCG'O0!YLNGV5_KWPYCN84ECGT6<2HQ^611%#@,.XY/!XY-4(REEX'OK>*YA@
ML;'Q:\2VLD@2.6!;C/V<$\ '/0X''/%>JKI&F*\3KIUH&A&(F$"Y0>B\<?A6
M-K_AA[JS@CT:+3+<)<">>UN+4&"[ 4@+(%P>"0P//*CB@#)\-0:79:YXE\3&
MXL+;3Y1$45;B-A;JJ?O'8HQ5=S '&?X<]37;PW,-Q:I<P2I+!(@D22,[E=2,
M@@CJ"*Y?3/!\44D]S<Z;H=K/+;O;&&QLQY;JQ4GS,X\S[HP"!C)ZYKI-.L(-
M+TZWL+9=L%O&(T!] /:@#R'2M0TLZQX'U&QN+>&WN;N[RTLH:ZD1HY"3._'5
M@/E(."!R35?4]+T^/P-X[U%8$^UV&O2M:39RUNP:$@H?X3].O0U[%'H^F1$&
M/3K-")?/!6!1^\_O]/O<]>M-_L32?*DB_LNR\N1MSK]G3#'U(QR: ./%Q8:A
M\2/$>G>(1;M'#96YT^.ZQM,+*QE=<\9WX!/7Y1Z5<^$\D<GPPT(1R*^R$JVT
MYP0QX/O73SZ1IMRUNT^G6DK6W,!DA5C%_NY'R_A4]M;6]G;I;VL$4$*#"QQ(
M%5?H!P* .+^'D"W6E>)8+Z-97DUV]6X209#98<$'MMV_ABLKP]I_E7I\ 7-H
M'MM*O/MRRNF5EM,[X03W;S#M/J(V]:[<Z1-9WNH7FE2112WR;I(Y5)3SPNU9
M.,'H%##N%&""#E-"T[4+99KS6)[:?5+D(LK6T92)%4':BAB3@$L<D]6/L* ,
M*[\P?&C3/)S@Z)/Y^/[GFIMS_P "S^M'Q#CC,GA25@-Z^(+15;/8ELC]!^5=
M'9:4L&IW>J3D27MRJQE@.(XER51?;+,2>Y/88 M75A9WVS[7:07'EG*>;&'V
MGU&>E '%G3M.?XV%FL[5I1H:SY,2EO,%Q@/T^]TYZUK>-K2YO;#3X;*\M(+W
M[:KV\5ZA:"Z=4<^4X'8@%L]BH-;G]FV'VS[9]BMOM7_/;REW_P#?6,T^[LK2
M_B$5Y:PW$8;<$FC#@'UP>_- 'E4]W;R:5X;N)-*CTB:R\5B"ZC#@QQN1(7V.
M,?(68?CQVJ#5]56SF^)$^DS [9+!Y/LK?-Y6U1.RX[[=^2.ASWKUB32]/ET_
M[!)86KV73[.T*F/KG[N,=>:?#86=L9#!:01&10KE(PNX 8 ..H   ]J .*GC
M\+26>M:CX?N8&DGT219$LI%\D1@$JS*O ?D@$\X!'8UAZ)86>GW_ ,+[RUA2
M*YO;!H[F9?OS+]D#!6/5@"!@'ICC%>F0:-I=K:2VEOIMG%;2G,D,<"JCGU*@
M8- T?3%,)73K0&#_ %1$"_N^_P O''X4 8'Q.('PR\19./\ 0GI-*\*6=Z=$
MUF_N[J_FM+0"UCF*".'>@#,H15R2.,G-=/=6=K?1>5=VT-Q'G.R5 XS]#2Q6
MMO!;BWA@BC@ P(T0!<>F!Q0!XS::;'9?"76->TFV)UFWDOH8[B)B9(X3<L'"
M\\80$CT//>NJN[.RC\7^$;CPY'"EO?0SK=+;@!)[3RLJSXZX8K@^K8[UW-K8
M6=BC):6D%NC'++#&$!/OBH[;3++35E;3M/M+>1QDB*-8PY]RH]?K0!XO;:'9
MM\*-/UG3TQXCMM3*6,ZR$R!S>LOECG[I4DE>G4GN:Z>-+/6$\?Q>(%C%[:7,
MGE/+P]O;")3"\9ZJ,AFR/XLFNC\%>$QX=T:""^M;![^&25A=0+EB'D9_O%01
M@-C\/PK?N-+T^[N8[FYL+6:XBXCEDA5F3G/!(R.: /++R/6Y=!LM3O8++5KB
M+0(CJVDWOR2B,[R98G.0LAPP;(_@'<"MZV-K>_%'2[B.)ECO/#,CE)!ABIEB
MP&'K@XKM;G2M.O9UGN["UGE4;5DEA5F SG )%+)IMC-<_:9+*V>XV[?-:)2V
M.F,XSB@#QO2-/L;;P-X,U:&)%OQXA2%;G.7$;74BL@;LI!.5Z=^M:7B&.'4-
M0\9Z1-=V,U[=20+9W,UU'&;,^6I"D,P8!3\^4!!W'OD5Z;_8>D^2L/\ 9=EY
M2-O5/LZ;0WJ!CK7+3>$-1EU6]>YM?#FIV]S.TJ3W]D6FB4X 3'1@H  Y7@4
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MMI! 9#ES%&%W'WP.:YV;PL][X]FUJ^M=/N+!M/2S6*7YW!5V??@KCG>1C/\
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MMIK98H;D;3#F++*!T SW'48Y-=-?ZK:Z=);PREWN+@D001+N>3 R<#T ZDX
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M,NC+JLK&R79_K@8$0$>GS*>N*V$M+U_'?AV^^PW(MH-)FMYI63 CD8QD*?\
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M=0TC3K&YM;/6[B>XCFE9)'411EA& , @#.3U]*Z&?QM/?I/_ &#;^:\-E#=
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MGIL- &Y1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ^Y<XYS(L; >B-7;3SQ6T$D\\BQQ1J6=V.  .]/  S@ 9ZT ##<I&2,C&17
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M9=0NK:5;34%O;:=8"+B)0^X1!]W0]"?3C'0UT.HW<UE:B:"QFO',B)Y4)4,
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MK6MZM;K9ZI>)+DP,HB8HL87.YLY"CG [U)X"T&#1-%F>!9ECN[B2:".;.Z*
ML3%& >0 ISM/3<16EXGU^'PUH<NJ7%I-<PQNBLL6W(W,%!.XCC)'3)]JV* "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "N7\9ZM)IS:%:B=K>#4M3CM)YU;:54JS;0W\)8J%R
M.>3C!P:ZBJ.KZ-IVOZ;+IVJ6D=U:2XW1OGJ.A!'((]1S0!Q/C?3GTSX?^,X3
MJMQ=Q26WG16\[EVME(P0'8EB"5)&>G05)XGN9I;B_@M-0O&FM=$,WV:WF:W2
MV8[B)FD4Y8G;@)@_=.< UTB>#]"309M$%B?[/G.9HS-(6EZ?><MN;H!R>@ H
MN?!V@WMVEU<V'FS+;_92S3.=\7]UQNPX&>-V<4 <A=ZOK3:#H&L2P7NI6#Z/
M%+J$>G7)AN8I'56\X*I&\<,,=N?>H]=U>\BL(-3CEU'4/#DNDQ9O=.N&CN+-
MB&)N'B# N""IYSC8>.3GLH?!VAVT,$-O;30)!!]F00W4J'RO[I(8%A]<U)-X
M5T:8G-JT:&V6T:.&>2-&A7.U"BL%*C<1@CH2* -6WGBNK:*XA</%*@=&'\2D
M9!KEM6U"6Y^(6F>'9)9H+&73YKLF*5HVGD5U4)N4@X +,0#SQGI75HBQHJ(H
M5%&%51@ >@JCJ>B:?K#6SWL!:6V<O!+'(T<D1(P=KJ0PR.",\]Z /,]2U/6H
M-*U>P35;U1IGB*UM+:[63YVBE:,F-V/+[0^,GKQG->G:5I@TFT:W%Y>78,C2
M>9>3&5QN.=H)[#L.U5+GPKHUWIJZ?-:,ULLWVC:)I 6ESNWLP;+-GG)).:V%
M4*H49P!CDY/YT <YXR;5TL;.32(3=/'<AY[)+DV\ES$$;*HX(PP)5L9&=N._
M/+6WB87P\.Z98W%ZL-]<WJ3KJ$\D,Z2QG<+=G&6!&\XP<D(.>H/H&H:5::I]
MG-TDA:WD\V)XYGC9&P5R"I!Z,1^-4+[P=H&I:1_95YIR36GG&?#.V_S222^_
M.[<23\V<\T <9K$&NZ/I>GVLGB*=G;Q);PH8)F9XH)6!\IW;E\ ]6Z@C.:U;
MBVN="\:^$-.AU?4[BUG-\94NKDR>9A-R[C_%M+8&>@ ]*W3X.T(Z;:Z?]B86
MUK,+B)5GD!$H.0Y8-EF![DDU<NM#T^]U.RU&XA=[NQW?9Y/.<>7N&&X!P<C@
MYZT <+I,^L^)=*MM?M]62RGAU!S<%KN0H$65E,#08V#Y<#/WNASDU.NJ7NG^
M+X;?7!?I!<ZFZV&HVMRSVLP.X+;RQ@X1ATZ<LN<]:Z5/!/AR/7WUQ-+C74'?
MS7<.P5G_ +Y3.PMWW8SGFK,7AK2H;D7"V\A87#701YY&C65B27"%MH.6)X'4
MT :U<+;37'B?6/%MI-?W=G)ILR6UHMO.T7D@Q!A*0I 8EB3\V1A0,=<]U63>
M>&=)O[^2^FMG%S+$(97AGDB\U!T5PC ..3][/6@#SMKF?Q/IOPUU75//2\N[
MK$WE3R1!OW$OS *0%)QG(YP<=*]950B*HS@# R23^9ZUF7GAW2K^6PDGMCFP
M(:U$<KQB$@8!4*0.G'TXK4 P,4 <-J5E%+\9-(=GN ?[(N'PMQ(HRLL6. V,
M<\CH>^<5R;?:M/\ "GB'7+34;V"YL_%$WEQQ3%8F#7:(P=!PX(8_>SCMBO5+
M[0=,U+4+2_N[4275IN$,@=E*AL9!P1D<#@Y'%4F\&:"^FW.G-9R&TNKC[3-$
M;F7#R[MVX_-G.X _4 T <W=2:KXHUCQ1IMI?FRNM.FCAM66\DB, ,2.LA11B
M0%BWWN"%QQW[G3GDDTRT>::.>5H4+RQ#"2-M&64>AZBLC4_!'AS6=2AU&_TU
M9KN)!'YOFNI=!_"^"-X]FS6^ %    '  H \_P#$Y:#XO^"Y[HXLFBNX86;[
MJW#)P/J1P/6N\G, 5!/LVEUV[_[V?EQ[YJOJFD:?K=BUEJ5K'<V[$-L<=&'0
M@]01V(YJ*QT*QTZ19(OM,CH,(UU=RW!3M\OF,V...* /.7UO4[SX4S>-8;ZZ
MBUF&:2?R?.;RAMG*>08L[2-HV],YYSFMBUM+W6OB#X@M)]:U:VMK6*PN8H(+
MG8$=O,)7I]T[<$=^_08Z=?"NBI=RW"V94S3BXDB$KB%Y00=YBSL+9 .<9R >
MHJ>'1+"SU:[U>""3[=<H%F<3.?,"YVC:6V\9./3)H \KF?6D^'FI>)H?$6JG
M4=*U"X\A&G)BD1+@KY;IT?(XYZ<8Q75V4]SXIU?Q7:7%[>6,NG21V]JEO<-$
M808@XD(4@,2Q/WLC"@8ZY=X,\)_9]-N5UK3IHIFU.>\6*2YWQ-NE+HQ17*$C
MY>HZ@>@-='>>&M)O[^2^FMW%S+%Y,LD,\D7FIV5]C ..3][/6@#SS3M2U?Q3
M)X'-YJE_9?VMIEVUVMI+Y6\H$"NN.A.[=GWXI_BF^O=.TK7KK3-8U&ZETJ:U
MB$[7#1I;%?*#1D XF=MVYB5Q\^,Y&*]#D\/:7+J-C?FV*W%@ACM2DKHL2D %
M0H(7!  QCL*HWW@?PWJ4]_-=Z8LC7^/M(\UPLA&,-M#8#<#Y@ ?>@#%M;&)_
MC'J[^;<JW]D6T@Q</@$R2C[N<8X'&,9YQDUB:9X@U%/#7AZUGOKE_P"T?$%Q
M8SW;R'S/+667:@;J"VQ5!&,#.,<5Z"?#6D'4X-1%F%NX8!;I(KL,1@D@$ X.
M"203D@\BH4\(:$FC2:0+'-B\IF,32NV)"V[>K$Y5MW.00<\T <;KUWJ>D:AX
MNTFTU"]^QQ^'VU2WE:9GDM9AO7:';+8;9NP3Q@XQ5C3)+VP\4>#6_M2_N%U?
M39C=QW$Y=&9(XV5E7HIR3R!D]\GFNO/AK2GL;RSDMY)(KU/+N6DGD:25<8VL
MY;<1@D8SCD^II$\,Z2ESIUPMO)YNFH8[1C<2'RE( ('S<Y  YSP!0!KUY=K^
MJ7L+7>HZ?J=Y<&WU^WMVF\YHH8E,D<;VXB!(DQEMS$#D\$D5ZC7.W/@3PU=R
M7CSZ8K&\F%Q,!+( 900=X ;"MD#)7!/?- '+7\5[?>(/'=NVM:I%#96=O/;)
M!=-&(G,4C9&W!QD#CH>^<#$VB:Y=^(=9\/:5?W,T<<OAR+5)3#*T37$SE5/S
M*0<+R< ]6&>@KK1X6T=9K^5;5U>_B6&Y*SR 2(HPJX#8  ) QC@FH)O!>@3V
M^G0M9.HTU=MG)'<RI)"N,;5D5@VW'&,XH R?AE%]GT35H?,>3R];ODWR-N9L
M2GDGN?>K'Q.B67X:>(-Q<;;*1QL=EY [X(R/8\'O6YI&@Z9H,,\6F6JVZ3RM
M-( S-N=CDGDFK5[96VI6,]E>0K-;7$;1RQMT92,$4 <#JVG(WB_P+9QW%U'&
MUK?9=9V,F#'&2 [$L/P.1VQ5;3=2N1H<FG7&L7[-!XEFL+=0Y>XNXT8D0F0L
M"..2Y/1<=Z[2'PGHL$^GSQ6LBRZ>K):O]HD)C#<-_%SD  YSG ]*AD\$>'I;
M9[=[%RCW?VXG[3+N$_>0-NRK')R01F@#SK69;N]^'OBRWOY[ACI^OQPP W<C
ME$+P'87X+@>8V-V<<>@KV&"%+>!(4,A51@&21G;\68DG\36(/!7AP6FHVHTN
M(0:B0UT@9L2$8P>ORGY5.1CD ]:V;6VAL[:.W@7;%&,*"23^)/)/N>30!R/C
M+[6_BCPG:0:E>VD-Y=3PSK;R[-ZB!V_/(X/;J.>:S1#J&HZQK/A>VU2Z#Z7:
M01VT\VH21S?.A/G,4'[P[L [N/EQCDY[6_T/3]3O;.\NX7>XLG+V[K,Z>6Q&
M"0%('3(Y[<53UKP;X?\ $-]!?:GIRS74"[$F61XVV]=I*D;E]CD<F@#DM6NK
M^6TN8/[;GOM0L]!\V7[%*UM%%)\Y^T%U.6+;?E3!'RGH#27VKZU_8>AZQ-!>
MZCI[Z/%+?IIUR8KF"1U#>>$4C>.&&.V#QUKL+SPAH%_>B[N--C:46_V4[695
M:+LC*"%8#/&0<=J;%X.T.WAABM[66!(;?[,@ANI4_=<G:<-\PY/7- '/:3JJ
M^)?$YTHZA=MIT.BVUU;/%,\#W/FYS*2I#< *,9X)/?IA0ZKKEY8>'8;C5KU)
M$\23Z5)<1,%-U#&)0&;C!/R ?4$UZ+<>&=(N)+.7[(89;.+R;>2VE>!HX^/D
M!0@[>!\O3BDF\,://%I\;6>U-/D\VU6.5T$;\_-\I&3R>3GJ?6@#B%OI]-B\
M8:5)KM_%!:ZC:Q6DSNUQ./.2-C$C,<Y8DJ"3\N[.>*IZO=7W]B_$S3;EYQ;V
MVGQR0037+3F+S(7+#<V3SM!QD@'.#7>7/@S0+Q=16YL3*-1='NMT\AWLF-K?
M>^4C P1@C%+#X-\/PR7DBZ9&SWL M[DR,S^<@!&&W$Y.">>I[F@#F(X-0T'Q
M7X4>UU;4+J#5DDAO+2YFWQ@+"7$B+T3! !Q@'(JAI]AJ5[X$\1/H]S<PZC;:
M[?W$"PS,GG%9V)C;:>0P!'L2#7H&G^']-TQUDMHI3(D?DQO-<23-&G'RJ78E
M1P.!CH/050EL)O#%CM\,:(+Q[FZ,D\4M\T84MDM+E]V><9 Y.<T 0>&M6B\5
M7O\ ;EC//_9R6L<4<?FMM:5AO?<N<$J"BY]=P[5OZG=/9:5>7<4?F200/(J?
MWBJD@?CBH-!TI-%T:WL4$>Y,O*8UVJTC$LY [ L2<5HT <1X=634='\-^)5U
MZZ:2>W$EU#YI>.[=TY0(3M0J^<;1QM(/>N>?6]3F^%-MXXMKZZ.KB99FA$S&
M%\S^6T!BSMQ@[1QNR <YS7=:5X+\/:'J,E]INFI;SN6;Y78HA;J40G:F?]D"
MI8O"NBP73SQ697?/]I,0E?R?-SG?Y6=F[/.<=>>M '*7-[>+<_$B$7UVJ6-M
M%+:_Z0^8&-L7)4YR/F&<=*1)Y;K7_AE<3R-)-+8W#N[')9C;(23[YKJ=0\'Z
M%JE_<7UY8^9/<P^1.1,ZK*F"!N4,%8C)P2,CL14D?A;1HIM,ECM&1]+0I9[9
MI (5(P0!NP<C@YSQ0!YIK5T_B;X0W_B&ZN[H7<E\,P+.PCB5;L(L9CSMX4 D
MD9R<YZ5['7-W7@'PS>/>M-II*WL@EN8EN)5BD<$'>8PP7=D#G&3711HL4:QH
M,*H  ]!0!P_B"S%_\4M#MVN)X4;2KS<T$AC<C?%P&'*_4$'WK*T75+JX\/:1
M8W.K7TMR-8N[5(D<^?>QQ-* K2[@5"@*S-GD+CG//?3Z'I]SK$.K2Q2&^AC:
M*.43.NU&Z@ ''.!V["L]O _AUK:*W^P.$BN6NXR+F4,DK9W,&W;AG)SS@]Z
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ML9"'BBDFC_<LV2S *_4G)!&:3Q/JE[H^OW=SJ8OSH;20+%J&GW+8L& 7*S1
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MUIK0?:+0*P2>,NK NJXX(/>NGKB/B[E_ACK%N@9YIDC6.- 2SGS%. !R>.:
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MBTK4[*"*SFM4D:,A ZO"PC!(/S9 QW- ';7OB70M.)%[K%A 1%YY$EPH/EY
MW=>F2.?<5(=<TH7$=O\ VC:^;(RJB^:/F9AE5'J2""!UQSTKA;73M-MO'OAF
MS2Q,5G#HEQ!'#<Y<Q[GCV(Q;.&*AN"?44R=KC3O$S2:+=K=VUSJR)>Z'=1?/
M&V\ SP,.0H"A^<KP>1TH [ZXUS2K6[%I<:C:Q3EE3RWE .YONJ?0GL._:HKW
MQ)H>FR3QWNKV-O) H>5))U4Q@]"1GC/;UKSK#?\ "#^,?#6J0N^MSW-VT$++
M\]V9"6ADC_O#)49'W=O.,5JZ7"EK\2O^)D\4DT'AN"":X<<-*KN7&X]\')'7
M!H ] M[B&ZMX[BWE2:"50\<D;!E=3R"".HK)LO%.E7_B2_T*"YC-W9+'O7>
M69MQ*J.Y4*"<=,^QK)^%FY?AKHL3AEDBA*.C##(0QX(/3C%8U]%>MXH\?6%F
MLT6H:EIL'V!Q&P5F$,BY#XP,,0,D]2* .ZM]<TJ[O/LEOJ-K+<$%A&DH+, <
M$@=\'@XZ58O+VUT^U>ZO;F&VMXQEY9G"*H]R>!7FX9->T?P+;Z9&T6I:;>VS
MW,.PK)9QQQE9E<=5!QMP?O9&,UU?Q" /PY\29 /_ !+;@\_]<S0!H6OB31+V
M]FLK75[&:Z@3S)84G4LB^I&>!1:>)="OKA8+36+&>5HVE5(KA6)16*LPP>@(
M(S[&N(BM;#4M8\#7>D+"'TZ%Y+R6)0HA@,."DGH2Q'RGGACV-95GI4]]\$M5
M@TJT#:IY]T3&L>)'0W)9DZ9^>, #U&* /4+77=)O7E2VU*UE:)/-<+*"53^_
M_N^_2J\/BOP]<7=M:0ZYITEQ= F"-+E"TH!(^4 \\@CCT-<W<2P>)?&?A/4]
M%;>EI'<->.JX\N)XP!%(.S%]ORGD;2<<5QVEV=EK'PCTS2M.CB.N'4A) $7$
MD3K=$F4]PHC!^;ICCT% 'KUYKFE:?.(;S4;6WD^7*R2A<;CA<YZ9/ SUI;[6
M--TO_C^OK>VPA<^;(%PO]XYZ#W/%<!#(EI;^.]&UV-C=7UU//;(R$F\ADB58
MUC_OD;=N!R,"L^^LM2T?2[0QZL(M?M=!MX;RQO(_-M]210_[H=S(#O&5.3N'
M'- 'IVH:UI>E!3J&H6UJ"-P,L@7CIDYZ#WZ5>5E=0RD%2,@@\$5Y;>:A;6GB
MG58?%EMJ5K9ZS9V_V;R%ED1AY6V2W/E@G<&+''?<?7GT31+6*QT.QM+>WDMX
M88$2.&5RS1J!@*2<\@<=:  :WI9N_LG]H6WGY91'Y@R2H)8#UQ@Y].]-77]&
M:U@NEU:Q-O<2>3#*+A-DKYV[5.<%L\8'.:X31)+JP\2Z=#I=X-2TBYO9V>PN
M8\7.F.1(6<,.?+)+#YA_&,$YK!^UK;^"+?1GANC?V7B59+B%;=V,:?;2X;@<
M@J01CKVZ&@#UN]UO2].F6&]U"VMY#M^664*1N.%SGID\#/4USG_"6#3/&NN6
M>MZG9VVEVMK;2P-+B+:TADR"Q/S'Y/\ ZU8D&HV%IJ_BGP_XFTZZN&U2]^TV
MJ?97D6]A9$"(I P"NS&"1CVYJR/LW_"?>*I+B.)0=%MX@6&1D>;O0'OC*Y'T
MH ]"BECFB26)UDC=0R.IR&!Z$'N*XS3?&<-IKGB"S\1:QI]LEM?I;V?F,L.Y
M3$CXY/)!;DY_*KWPZ+?\*Z\/H^1)'8Q1NK#!5E4 @CL1BN89-.AU7Q_::I:!
MYK^1#;P/#E[M/LZ*!'Q\_P P(XZ'TH ]#_M33_MKV7VZV^U)%Y[P>:N]8_[Y
M7.=O(YZ5&NN:4]C%?1ZC:R6LS%(IHY0ZR,,Y"D=2-K9QZ'TKS[2HYO"GBCPN
M-;,H(\-?8#*L;2!KA9(R8\J#DX!QZXK.T.)9O!>A*-3NM"U2WO+Z2VNY8/W2
ML9G.R0,-I5E<<YZC@YXH ]&N]6MKB327LM?L88[BX^525D-X@# I&<]<X.1G
MI3Y_%GAVU+"?7-.C*R^0VZY08DX^4\]>1Q[UPL]Y=7FG>!KC4;.&UNUUQGF$
M"D1E0)E\X9Y5')5AG^^*JZE';R:3\4P(D:6X8B'"?-+_ *.@&W^]\X(X[T >
MGZAJ^G:2@?4+Z"V4@L#*X7@=3]!D9/04ESK6EV<4<MSJ%M%'(GF([2@ I_>S
M_=Y'/3D5YS/J5KIGB3SM>;4%TK5-)MHK:ZMED=-R;P\3A 3D[\]/6EU*QBT>
M&T;P_>R:-=V>EXALM20RP7EOO<K"X;Y@_'0'<-V,'L >AW6N:58JK76H6T*L
M@D!DD &P]&/H#V/>KSND4;22,%1069F.  .I->5ZY+>1QR:II\PL=6.E0"\T
M"\B\R&]382(4_B\P%F3Y<]LCFO4X7>2"-Y(S&[*"R$YVG'(H Q=#\7:/KVDS
M:G:WD*VT+R+(SR!=BJ[*&;/W0VTD9QQ6E8ZI8:EYOV*[AG,3;9%C<$H>H##J
M..>:\FM3>1> =-CCM;ICH_B(W.IVX@?=Y(N96X&/FQE'P,\#-=A8QKJ7Q0;6
M],E633AI M[B>(YCEE,NY!GH65=V?3<!WH N>,-:O=$N?#[P7$$5K=ZFEK=>
M8G_+,H[$[B<+]ST_$5L:=KVD:O9RWFG:G:75M$2))89E94(Y.2#QQS7.?$2)
M6B\-3S0F2TMM<@FN6,998XQ'(-S<<*"1R>.:YGQ#I5W>77BO6O#UJ\MG+;V.
MY+;C[<\4V^4IC[W[O"Y'4DCGF@#TRQUC3=3DFCL;ZWN)(<>8D<@)3/3([ ]C
MWK$\6:Y=Z)JOAWR[F"&QN[XP79E0<((G?.XG"@;.>/QJGX5N/#^MZZVN:2FH
MS77V/[--<W0E0(NX,(B'P"V<GC.,=>1D\?QH+SPK=7$6ZRMM762XD9-R1+Y4
M@#-QP-Q7D\#(H W8O%/A^;2GU6/6M/;3XVV/<BX7RU;T)S@'VJ6/Q#HTL5Q+
M'JEF\=O-Y$K+,I"2?W#S][VZUYAXKTY9=+^(&J6$(_L_4;2WA@\M>+J=<[G0
M#[W!49'4@^E=)KXCT_Q%X0UJ"%!H<+S+=20I\L;O$$BD;'8 %=QZ;J .K_X2
M#1AI_P!O;5;);/?Y?GM.H0/G&TDG .>,=:LKJ%D^H/IZWD#7J1^:UN)!YBIG
M&XKUQGO7E?B/3+FZTOX@ZEI\3S:=>&SD@$2DB9XMIFD0#J, #(ZE3Z5LQZC:
M:S\33<6OVI[*?PZ\2W,<#@$F;/RG'7&<'U&.M '8?\)'HGG)"=6LED<D1JTZ
MC>0<';D_-@\''?BN?\.>,8VEU2V\0:M817,>LS6-HK%8?,50FT!2<DY;U/)K
MD/"NJZ)>'P9:WFK002:.I2W1X)8Y)V=/+16W(%4X(R S98#!J/4EB?X?^/\
MRXPUQ/K<CQ!4R\HWQE&7NPX8@CT- 'IL7BG2IO%,_AY+F/[;!"LCJ7 Y8G"C
MU.%)..G%4_'&KZAHFB6]YI\T4;&^MH9/,CW92254..>#ANN#6?:7"0_%J_=E
MD,=]I-M]FD2-F23:\N[Y@,# 8=3W%3?$RW:X\'$"!YT2]M))46,O^[6="Y(
M.0%!)]J .@TS7M(UDSC3-3L[PV[;9?L\ROL/O@\=Z2WU_1[J6:*#4[21X8_-
MD59E)6/^_P!?N^_2O/O$>DS:_K&L:CX65&5O#LUF\]O@)<2LP*1JPX9@H;GM
MN K2\,WWAW7]5T_4[:WU0:G8P.DPNQ-&+)67YD;=A3R  .>F>U %C1/$MSXC
MFEU*SUNQ@L[.^GBN+238P-M&Q42;L[E8D;LD[<'IQD]1;ZYI5TEPT&HVKK;@
M-,1*/W8/(+>@/J>*\NC2\N/AK?\ V&&6=K?Q!)>7%JBGS)K<79D("]2"N#[@
M5TER]OJWCW3]<TR='L+;2KB._N5^XP8J8XR?[P.]L=1WQD9 .HMO$VA7K2+;
M:Q83&*$7#[+A3MC/1SSPOO5FPU;3]4\[[#>07!A;;*(W!*'J PZCCUKRRPLY
M8?@IH-Q96$LL]B]M+>P6Z;9VCCE#R*!UW#[V/:NP\)OH&J:M=ZWHJWTTD\"1
M7%Y<^:H;:<J@#@9(R<D#C(&>: -76?%.E:%J6FV%]<QQ37\C*F]PH551F+,3
MP!\N/<GZUBZ?XQCL_$'B.T\0:M86UO9WD,%HTA6$$/$KXY/)RW7/Y4OC.3[)
MXG\'7\D<IMH+Z82O'$S[2\#JN0H)Y) KFM1$$T7Q5;RU:2Y@58<K\TN+15 7
M^]\XQQWH ]+U#5].TJ,27][!;(06!E<+P.I^@R,GM5J*6.>%)H9%DB=0R.AR
M&!Z$$=17EAU.WTK7;:XUUM072M1T:UAM[JW61D61-^^)P@)!.\'D=L5Z!X:L
M;33?#EE9V%K-:VD2$0PSLQ=$R2,[N0<'H>1T[4 -E\6>'8/];KNG(/.^SY-R
MG^LXRO7J-P^F15FUUS2KW49].M=2M9[VW&9H(Y59T&<<@'(YXKR^_C@D\(_$
M]%C5I;F]E,("?-*/*C"[?[WS!L8[@UHZW&;CQ'H,6DND<[Z!>P121_*$D9(_
M+!(X'(.![&@#O[?7-*N[XV-OJ-M+=!2WDI*"Q ."0.X!X..E(NNZ2]_]@74K
M4W?S8B\T;CM^]@=\=_3O7GOAF71]=AT:&.UU6/Q%I4#1^3<"9%L'\O8Q)(VE
M3@ #G.1QP<1^#WTC4K30-*U&SU;_ (2+1G3?:R^<JP2(-K2[ON;",GK\V0.]
M '5?\)EI6LZ!JMQIVNV>GFWDD@6[N"I6-E.-Y5B.,YQGKBMBY\0Z/I[&&^U>
MQBFCA\Z19)E0A,@;R"> 2P_,5YG<MCX8>.M,>&87@OK\B)H6&[?*2FWC#9!!
M&,UT*26DGQ3TFZ8QM&F@2 3$#:KF2,@;NQVACCKC- '9+J^FOIL6HK?6[64N
MWRYUD!1\G P>Y)X '>BRUC3-2D>.RU"UN)(\[XXI59DP<'< <CGCFO)K2>'3
M_ 7AV[DDDA;3_$$\BQF%V0*9)SAPH+*"C$JP4\E>,'-='X;\0^'=/@\2Z^-3
M6X:>Y6ZN8+:"0M I"QJ I4,V=N2V ,GVH ]#KG(?%$$EGJ^LRRB+1M-:6/>!
MDRF+_6/] P*@#J03W%;UM<PWEI#=6[B2&9%DC<=&4C(/Y&O-?#/A^?6O@C>>
M&G?RK_=>VLA;^&83R$9]B<'Z&@#J=%N?$&NZ1!J[W%OIRW2":WM/L_F[$897
MS&W LQ&"0NW&<<XS1=ZQJNC^&DUG58H@UJS&_AA4[?*#D&1#UX7#8/49'6J'
MAWQ#8'PE;:;X@V:=J%M;K;W5I=_(2RC;E,_?4XR"N>H[UAZ-#<6'[/5X=5BN
M$NWTN[,PN0WFLS;PN[=SD@J!GVH ]/1UDC5T8,C %6!R"/6J,>N:5-?BQCU&
MV>Z9F58A*"S,OW@/4CN!R.]1>&;:>R\*:/:70/VB"QACESUWJ@!_45Y?;ZBE
MQ)X2N$M+JS6VUR42Z=%9R%;3<LW#-M)9V)R><?-P!0!Z:_BSP[&ZJVN:<&>?
M[.H^TIS(,93KU^8<>XJY%JVG3:C+IT5_:O?1#=);+,ID0>I7.0*\EU2.%_ ?
MQ(6.)6N+C59&A"I\\HQ%M*]V&0V"/0UU?BX7>F:KI7BS0X5NII5&FSQ*>)DE
M/[EB?]F4K^#-0!VEI>VE_"9K.YAN(@Q0O"X<!@<$9'<'@BH'UG3([T6;W]NM
MRSB,1&0;B^,[1_M8YQUQS3]+L$TO2[:R1BXA0*7;J[=V/N3DGW->?>9=6'BH
M-I%X+VSNM8*WFC74?[VV?>0UQ"PY"<;^<K@GG)Q0!VNF7\<LVK2MK=G>6\,_
MW8@H%HH091V!.3U;)QC-/3Q)HDDOE+J]EYNW?L:=0VW&=V"<XQSGIBO.KR&W
MN]#^)T,CSQQ2W)D5H(RS,HAC&Y1_$NY2#CWK2T#7-$UCQLFK3ZM9I?KIGV-;
M5$E0. WF.^9$7ICA0.!N.?0 [&W\4:#=W=O:6VLV$UQ<J6@CCN%9I ,Y*@'G
MH?R-10:M;Q7FLSSZ[93VELT>84VJ;/Y<%7;=R6/(SC'2O,])2&W^'O@!/+$4
MT.MQ/,NS:T8W2!F8=0,%<D]B*ZO1YX(?&7CZ9W5(F^S,KG@-M@"M@]\-P<=^
M* *NF^)=1US2=*UR'Q7I>G6]X4^T6D\:.8V9P5C0[@=Q7*G=DY.0!TKN+_6M
M+TM@+_4+:V)&[][(%P,XR<]!GC)XKRXLO_"D/#4!!^T0SV(>+:=Z%)D+9'48
M )/M6L^J66F>+_$^G>)+2XFM-9$+V3I;/,EU%Y00Q#8#R&W<?[6>] '<WVNZ
M5IC!;[4;6W)0/B24+A2<;CZ+GC)XIMYX@T;3YGAO-5LK>5(O.9))U5ECR!N(
M)Z9(&?>O.?%5PFWQ-I4>G3:=.V@(D2P6[2O> 1R8C#8*A(R=IP 3G.0!5W2I
MK:?QSX6NG7"1^'9%\R:,KL?=%@'<."0'(]1D]* .KU+QGH>FV>F737]O)#J4
MZ0VTB2 H^3RV[IM R2?;%;R.LB*Z,&1@"K*<@CU%>.V9$'@OP]*8Y!!9>*WF
ME"QL?*B,LVUB ,A?G7\Q7JVI+<7FA7B63-'<S6SB!F!4JY4[<YZ<D4 )!KFE
M7-^;&#4;:2[P6\E906(!P2!WP>#CI4<WB+1;:[%K-JMG'.9!$$:902Y. G7[
MW(XZUY_X6ETC6;?1+86FJIXCTB+9Y%P)D2RD$>QB21LVG& ,G.1QUQD+J\$O
MP^\/:+/!<PZQ8:O8QWT,T#@I*+@;G+$8.XDG.>=WUH ];;7-(6.[D;5+()9G
M%TQG7$!QGYSGY>/6JT^HQ/K6EQP:Y91QRQ22&S^5GNE*@JZ'.0JX)R 0<UP>
MM726&I_$JSGCG$^HV*26B+"S><HM-A((&,!@0?2K5O*C>(?ANY1T,>GW"2;X
MV4H3#&H#9'&2"!GKCB@#IK#QYX<OK>\N3JUE;V]K<M;F2>=8P2,#/)& 3D#U
MQ6VVH62W%O;M=P":X4M!&9!NE &25'4@>U<+X:TRUUG1_%_AO489E^T:K>F1
M6B8821\HX)&,\AACTS5_P*VJZDAO=<C*WFG(VEJQ.1*R/B68>SE8_P 4- ':
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 445SGCJ]T^P\*SS:KITM_8^;"LD4;!<$R*%).0<!
MMO3/TH Z.BN9O_%LUOXBNM"M-$O+N]ALUO%VR1HDB%BO!+<<J1SS[8YK+F\<
MW-ZW@^?1[$R6FMNY?S7"N L3MLQV.5Y.?X<<YX .WE$C1,(G5)"/E9EW 'Z9
M&?SK)\*Z#_PC'ANST871N8[52D<A3:2N<\\GGFLC6?B'INCB[F9%FMK*<071
M2=!*K9 8I'U<*3STZ'&<5-_PF4LWB*]T>RT*^NI+-K?S95>,)Y<N<2#+= !G
M'4\\<4 =517''XBZ7]KT\*J265_="TAGCG1G#DD*S1@Y",1PWN,@9K1T_P 3
M_P!J7 ^Q61GM3=36C2I*"T3Q[\[T_A!*8'/\0R!F@#H**X71O'-P^@7.J:Q:
M1VX_M-[&$><NP-YQC52V. ,<L?? Z"NMTZ\GO$G%Q9M;20R^7@N&5QM!W*>X
M.[]#0!C6GA?4-/EFCM/$MZEA+-)-Y#0Q.Z%V+,%D*YQDGJ"1ZUT-K;0V=I#:
MVZ;(84$<:CLH& /RJ4D $DX [URC^.K6/3[36'LY1H=U.(([[>/EW-M61DZB
M-CC!SGD9 H ZNBN7B\837/B.]T>UT"^E>QN88;F;?&%C61=PD^]R,$' R?4#
MH>HH **Y_7/$S:1+=I'ITUP+.R-]/(6\M-@)&U6(PS_*3CCZ\U6G\:Q_;M(M
M;/2KRZ?5K-KRU92BAE 4X.6X.'&<\>F3Q0!U-%<:?B!$N@0:L^E7"1F_.G7:
M-(H^R2B3RR7.<%-W<>HXKHX]2,FN3Z:L!(A@29YMPP"Q8!<=<_*3],>M %^B
MBO*]1U:PT?Q?JMKXXMKB&"]N =+UC<PABBV "-74YA8$,21C))).,4 >J5F>
M(=).O>'[[2?M'D)>0M \FS<0K @X&1S@UDPZR/#[>&=#F22[CO85MXM1\T&-
MG2//S'J2P4D>M&K^-$T>"[N)-,N9K>WOHK'S(64AG<J,X)S@%P#@$Y!';- '
M0:?;/9:=;6LDHE:&-8]X7;NP,9QDU9KD9O&D\:Z_;MHLT&HZ79B\2">9,31$
M-AMRD@<H<C\LUSE[J5Y>R?#C6+NTD>]FD+%(G!,NZT9L@9"C)/?I0!Z?(',;
M"-E5\?*67(!]QD9_.L?PKH!\,Z!!I(NOM*0LY20Q[#\SESGD]V-9]MXYM&TN
M^NKZUDLKBROA82VTDB$F4[=H#9VX(<')(P,YZ5D:Q\1VAT+Q(;"TC;5-)MQ,
M MPLD+(P.)%<?>P>JX!SQWS0!Z#17)W6I6S>)?"T&I:1-_:%QYYM;@2J4@(B
M)?.#R2H],<]>*G/B[S!#<VNEW5WILM[]B^TP#<0P8H7V#GRPP(+9[9P1S0!T
MM%%<%\4RD6FZ#.?,7.MVD4ABW;FC9CN3"\D$=N] '>T5RNF?V$=>=[&"ZM);
M.W\R5I8I849')'(D SC9G(Z?C22>-@D&DWHTN=M.U:ZBMK6X\Q0Q\P_*[(>0
MI&2.2>F0,T =717*S^-HK?3/$5X^GS'^P9"ES&'7+@(')0_1AUQ2SZII\OC3
M1XGTN9M0FT^::UNBX"JGR%TQNZDE>H^AH ZFBO/[#Q]J$7@^]\0ZGI#O#;WL
MT3BWE4^6BRM'GG&0N!D_4XKKQJF[68=.2#S-]L;AYD<%8QG"@^NXYQZ[6].0
M#1HHK@#&J?&Z95C>1%\/BY$"MP9?/(W $A=Q QG]: ._HKBK#XB1WMKHU\=%
MO8-/U.[^QI<2.G[N4LRJ"H.2"5QD<#/>G6/C&X75?%3:K;+;:=HTBKYBR!B%
M\L/DCJ2V[IVX% '9T5R,'CVU?5I-->T+7'V1KN$6UQ',)%7[R$@@*XZX)QZ$
MU'8_$"*ZT>'5[C2+JST^YBA:UGFEC FDD. @&[(QUR<#&3TZ@'945QJ?$734
M75END6.;33#O,<ZR12+*P5&60<8W'#9 VTGBGQ7JND^%K^^@TP)<03PP*YF#
M1E9"@$B''S %\8('(/;J =G17.7GBE[>]GL(M/,VH6UF+R6U$ZARA+ "/^^?
MD.>@&1SS71T %%9VLZS;Z+:Q2S*\DD\Z6T$28W2RN<*HSQZDD] ":R9?&4=G
M<:I97NG3QZAI]G]N^SQ.KB>#D%XV)4'!!!!P0?7- '3T5A^'/$$_B"W6Z;2+
MJRM);>&>":9T(F#KD@ '(Q[@9R*W* "BO'8[ZP$NH>'/&'VC2?$ES+-]EU=Y
M&1+@,Q\LQR@_*H!5=G XQU)%='J$\UA\7GELK":]N)- )$*2!03YXY)8X7@
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M.\D<$CQ1^;(JDJF[;N/89[5Y3?ZY>>(? OA77;^T,<SZ[9R((GSN4W'W0!Z
M <]<4 >E:S87>HV'D6.J3Z9-O5A<0QH[8!Y&'!&#4^GV,6FV$5I"79(P<LYR
MSL3EF8]R222?4FL"#QM;)_;BZI93Z=+HZQR3)(Z/O20'85*G&201C/![T[2?
M&5KJ7B-]#>)$NC;?:HGAG6:-TS@@LO1P<9'Y$T =-1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=P75Q+*Y17=91+(W0\LP;CWKI9]'TVZU.WU*>PMI;ZW4K#</$"\8/4*W4?\
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M:>#]>M/!?ABP$5D^H:-J8NWC-P1'*F9. ^W(.)/3L:]'JO?WL.FZ?<7MQO\
M)MXS(_EH7; &3A1R?PH Y2RT/6]#U?7I;*&VN[;6'%RH>8I]GN-@5]W!RAP"
M".1TQWJMI/@R]T+6/"JV@BFL-'T^:TFE>3:[M)L)8+@\94\9[^U=S%(LT*2I
MG:ZAAN!!P?4'D4^@ KF?%6A7NHWVB:OIC1&_TBY:98I6*K-&ZE)$S@X)4\''
M4>]=-63J?B72M'O;:SOIY8[BZR((UMY)#*0,D+M4Y(')H QSX?OI]0U[6Y((
MDO;^Q2RM[;S>$10W+L!C)9^V<!1US6IX1T^[TCPCI6EWR1K<65K';N8WW*Q1
M0N0<#KCTJYI>L:=K4#S:==QW"1N8Y-AY1QU5@>5/L>:O4 ':O-;7PAXB@\%Z
M#H;P6+2:5J<%QO6Y;$D44I?/*<$C  _6O2J* .!U;P;J>LZGXK9GBM8=5M;6
M.UF63<T<L!9@67'3<1T)X%;WA^3Q3.0?$-MI]H(DVD6<S2^>_P#>Y4;%Z\<D
MYZC'/044 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %>?_%B1SIGAZS<D:?>Z[:07WHT)8DJW
ML2!^5>@51UC1[#7]*GTS4H!/:SC#H3COD$$<@@X((H GN[2WOK*:TN8U>WF0
MHZ'H5(P:Y6/5=5\0W_B2#2[[[$VDRBVMU\I'$LOEAR9-P)VY8* I!P"<\\:M
MIX>G@A6VNM=U*^M5&/*N/*^=?1V5 S#ZGGOG)IDWA2W.KWVI65]>6$NH1JEX
MMN4VS;1A6^93M8#C(QQ0!R5KXLU_Q-+X4_LZ]ATV/6]-N9I,VPE,4D>P9&3R
M,L<#CCKFK"7/C+4=7\2Z3:Z_:PS:4EN8918J?-=HMY!!)P">O4],8QSTB^$+
M"'5-&O;6:YMETB!K:UMHBGE"-@H8'*ECG:O.>U8&FZ9=7WC[QBWGZG8VUT+9
M$D2WV),%BVL5=T(R#D9![_0@ ;X<\9WOB^XTBRCD.G23Z,-2N9(45F+&3RPJ
M;P0%R&)R"?N^]49?&'B)M-B@2XMH[^U\2QZ-<3&#*W"%EPX&?E)5AD#OG!%=
M=)X.TY+G3+G3GFTVXTVW^RP26VWF#C]VP8$,O //(/.:BN?!%A<V-M:B[O(3
M#J U)IHV3?-<!MV]R4(Z]@ ,8'0 4 9FI77B#2S]BFU];B9+*:=&M;1!<22;
M_E+(0R+$JX!;*Y/>LM-2U+7M6^'-\^H36W]HV<UQ-# J;/,$ .X!@?[[#G.
M>.>:ZW4?"-KJ.N_VL;Z^MYGM/L5PD$BJL\620&RI((+'E2#S56#P'8VUGH4$
M6HZDKZ*&6VF$J;RC+L*-\N,;0!P 1C.<\T 8NH>-=2T2/QO/<O#<#29[:*S7
MR]BJ9D3&[!R0&D&>>@[5J7FIZMH?BW1-,EOC>VNL)-$'EA0-;S1IO##8!E"
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M8 5V.EZ9:Z-I-KIEFA2UM8EAC4G)V@8&3WK"T/P\^F>'[KPLSSQ6:&46MQ"
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MC+;+:J%FB^T^3R>H(!!&/3G-;]SX@N]!\97]IK%XS:9/8->:<5B4$&//FQY
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M]P(;-HE,<L<!(82$C=N;:Q&",97@X.>QT325T32+?3DN[FZ2! BR7+*7V@
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M=#;^#(H;S4[V36-2GNM2M4MKB1S$,JH8 @!  <,>V.>G>DA\$6=NGAY8]1U
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M8VN$E,>S*+M7 " C XZT <=::?K_ (6D\*>#-/UJ*-)=/NA)<-:B0K)'M(8
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MS!9D<]2,%\J>,#T H ]@W '&1FC<,XR,^E><Z%X=T?4_'WC WEFDYM-0MI8
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M'FLLT>'<G[S ,WS'GD\UVMAJ%GJEE'>6%U#=6LH)2:%PZM@X."/<&@"P64$
MD GH,]:"P'4@=^:\=^(-WI\UMXTDMY(H[ZS%LKRW3@RK(JJR"W7@H,'.[)RV
M[CO6])I>D:Y\5[J.Z@@O+6?0(I&1COCD/GN-Q'0\ ?3 H ]%HKQ[3[*27X3^
M%_%,,/VK4=!'V@9&YI;=&99(\G_8R1Z%17H/A:.&[BNO$"Q!7U:031L4VMY
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M?6MA:+Y'BN$1P,L>1#=K\K9']THQD(]8V]:]!LK"VT[3H+"UB$=M!&(D0=E
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MGW[T ;18+C) SP,UE:_K2Z+!9XC#SWMY%9P G"[W/4^P )]\8[US$$=IK'Q
M\5Z9X@@BFCBMK<V4=P 0+<H?,=,]/GSEASPOH*Y@6[7W@?X?2ZY%'=73ZU#"
M);E SR09EV9)Y(*!#[]: /5-(FU26WG&KVMO!-',R(T$FY)8QC:^#RN<D;3G
M&.M8VM>,%M-#LM6TJ.&]M;C4([,R-(5 #3>467 .[G/<>M=)]F@^R_9?)C^S
M[/+\K8-FW&-N.F,<8KQ:RATX?![2(H%MXYVUFW6X\DA9/^/T@;B.0< X^G%
M'MH(.<$''% 8'."#C@X[5Y-K"/X=U7QY#X?@^S8T>VN?)M1MPY:0.Z@=&V#J
M.<@&MWPS;>'[CQ'::QHFMV\[S611K6PC1$>/((:55Y#*> 3@\D>M '>T444
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M@C 8V\&2,MSC. "0,G+'KBO4JKQ7]G/>36<5W!)=0 -+"D@+Q@]"PZC.#UH
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M0JX+HK9VDCJ <''TH \P@TS4]&D\.ZE=>&;C5K0:';Z;=VL:(TUK-'D[@K$
MJ=Q!P>P-;#:7<0^)/!T]MH/V&SM&O'GAMHU"6PE3"!MO&XGKMR <\XY/;W5[
M:V0B-U<Q0":588O-<+O=NBC/4GL*GH \JNM%U>7PWXC2/2[IIG\2)J4,6T!I
MH!)$V5R<9PC<'!XKT34);Z7P[=RV5H/M[6SM!;7!&#)M.U7P<=< \X]ZT:*
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M)/)P0 <IX&U_4])\+>!K>:UM3IFHHMFK+(QF5_+9U8C&W!V$8Z]#GM74_$D
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M_P #LH*;\YY_$ 'J=%<KX)U:'4H-3C":E;W<%T!<6.HNSR6K&-?E5B3N0X+
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MV\$>MZ>\MRYC@1;E"9&!P0O/)R"/KQ6O0!@KX+\.K#J4(TN/R]24+=J68B4
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M02+>"+R3-!/)"[1YSM8HPW#/.#G%4[O7]/NY+6/3O$FG0NFH+!,I9)#*1]Z
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MDS/IE[>+=K%&7?<)W).!R>&!^G->@U3ATV&VU&XO("8S<X,\8^[(P  ?V;
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M%(8P#$@8,45BC@A<97D;NE=C\.SI7]AW?]FZE#>M)>S7%QY2E1$\CE]@5@&
M /&1SUK2U?P_=7NKP:II^LW&GW44)@*B-)8G0L&.58<'('((Z<YJ_IVG&R\R
M6:YDN[N;'FSR*JE@,X "@  9.![GK0!4\6P7]UX/UF#2BPOY+.58-IP=Y4X
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MTYKTBB@#RO1M-DM/$W@JQUI$FNK?0)H+CS%#A9#Y8",>F=H8>^#7J:J%4*H
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M.OH:V;=X!\8-UN4\EM 6,-']PL)B0N1QG:<X]/:NWHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *XCXN$Q?#+6+F-FCGA1&CE1BK(?,4<$<CCBNWKE_B%HFH>)/!.H:-IJ0
MFYNPJAII-BKAU8DX!/;TH Y^!Y;;XD:6GAAKNXTK[%,=5B21G@! _=;2YVB0
MMQ@$''6M33_B)#>:+_;<VBW]KI7DNXN9&C.Z02^6(@H;)9CC!Z9[]ZZZ)IOL
M:L\(68)S&'R,^F:X*V\#ZG<?"D>&+J2"UU&&0S0S1N9(]XF,J$\ XS@'CUH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML[PS<Z/>>'K2XT*5)=/D7=&ZDDL2<L6)YW9SG/.<YYK$\.W3P?$7Q9I /^C
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M)'Y?S;HTBP=W_ ^@QTJKI/C.<ZA+!J]U<6>IVD4\UUI5Q;J@D102&MW"_.H
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M:)IR7-TVD1W(N8M.<H8D8/O"@[=VP/\ ,%)Z^W%/E\&6LS>(2VH7P_MU!'=
M&/Y0$\OY/DX^7CG/YUT990 21STYZTM %73;%=,TRUL4EDE2WB6)7EQN(48&
M< #I[5A7'@>RG77HQ?ZA%;ZWN-S#&Z;59D",RY4D$JH')..V*Z>LW7M2ETKP
M[J&IVT,=P]I;R3B-Y"BMM4DC(!]/2@"BOA.V&I:/?-?7CR:5;O;PJWE[71PH
M;>-G)(5>F.E5-$\!V6@W0^R:EJ;:='(98-,DG!MX6)S\HQNP#R 20#SUP:WM
M'OCJ>BV%\ZJDES;1S,BGA2R@X_6G:?J5IJMN]Q93+-"LKP[UY!9&*MCUY!%
M":KI=GK>E7.F:A")K2YC,<J'C(/OV/?-9]AX:BM;JRN;J_N]0FL8VBM6NMF8
MPP )^51EB !N.>,^IRWQ3KUSH$&FRP6L4ZW6H06<A>0J4$CA=P !R>?45N@@
M]"#VH Y+_A7M@-%;2%U/4ULOM@O(XP\9\IA(90JY0_+O.><GMG%7I_!]A=ZM
MJ%_>3W-S_:%D+&X@D*>6T0W8'"@@_,W.>];X8'."#C@X[5S6E>(-3UN6WO=/
ML;>31Y+J>VD=I2LL8C9D\S'0@LA&WJ 0?4  ;HW@J/1K<P#6]7NXTC,5L+J9
M7^S*1CY!MP3CC+9P.!U.=7P]HD/AS0K72+:>>:WM4\N)IRI8+V&5 !_*M($,
M,@@CVH!!Z$&@#)U#P]#J.O:7J[W=S'-IOF>3'&4V'>-K;LJ2>/<5CR?#ZQ>&
M55U34HYFU3^UDG5H]\5P05)7Y,%2#C!!KK@P894@CU%5=2U*TTC3IK^]F6*W
MA&68_D /4DX 'J: .:G^'>GW%CK%H^IZIY6K3I<7'[U"=Z[>1E#C)12?I@8'
M%:-QX3L[S6Y=4N[FYN&FL&TZ6!]GE20L<D$!0<D^AHDU^XC\=P^'VMHA;2Z=
M)>"X\PELJZ+M*XP!\W7)_"M[(QG(QUS0!Q]M\/;>V328CKFKRP:3.)K**1XR
M(@%*A,[,L,,1R2<< UKZ!IE[IT^J-=7UY<PW%TTL"7<BNT0/4*1T3/1>< >I
MP-H$$ @Y![T$XZT <_K&DR#Q%I?B*U0O-9I);W$:_>D@DP3CU*LJMCN-V.<4
M]/#, \7-XF%]>&[>U%IY1V>7Y6[>%QLW=3G.<UN;EQG<,=,YH+!1EB /4T <
MSI7@RT\/ZUJ&JV&HZC$E[*9[BR7RS 6[E4"9!^AR?>K&@:/);ZMK&N72;+K5
M)4Q&>L<,:[8U/N?F8^A;':MXD*,L0 .YJK=ZE:6-Q9P7$RK+>2^3 G=V"ECC
MZ!2: ,_6/#4.KZKIVIB]O+.\L/,6.2V91N1P-RL&5@0=H]QC@T_PYX=MO#.G
MR6-I<74L#323*+B0,4WL6*@X'&6/7)YY)J[ ]^=3NTGBMULE6,V[I(3(Q.=^
MY<8 '&,$YYJT&!. 0>,T 8.J^%8-7&H0W-_=FRU *+FT&PH0 !\I*[ER%&<'
MZ8/-0W_@NUO=5OKZ/4+^T&H6JVUW!;NH295#!2<J6! 8_=(SWKI-PW;<C/7%
M+0!S-CX*M+"[T6XBU&_9M(M&M+97:,@QL%!W?)DG"+Z=*AE\ V,V@:EHSZEJ
M)MM1O&O)FS%O\PN'.#LP!N /2MM-56YUN;3;90YM45KJ0GB,L"50>K$#)]!C
MU%:- &"GA:*/5M3U,:E??:-1MTMYL^5@*@(4J-G!^9O7K52+P-9PZ=H-BFHZ
MAY.B2K+:\QY)52HW?)R-K$=NM:]KJRR:Q<Z3<(([R*,3H <B6$D@./H1@CL<
M=B*M7\\MMI]Q/!$DLL<;.J.Y0,0,X) ./R- '*I\.-/CM[>V35=66VM;_P"W
MVL0F3; Y9F(7Y,E27;[Q)&>".:T[/1X?"R:UJ<,NH7INY&O9H J.S.% Q&%4
M$DA0 ,]JL>%]8;7_  QIFK2QI%)>6R3M$IR%W#.!6MN&[;D9]* .8\,Z?#<:
MQJ?B@Z;/8S:DL4:QW*;)=B+C<RY^5B>,>B+FMS5M*L];TFYTS4(1-:7,9CD0
MG&0??L>X-+;:E:7EY=VMO,LDMFRI.%YV,1N /O@@_B*MT 8=CX:CMKJSN;K4
M+N_GL8FBM7N=F8@P +?*HRQ  W'/&?4Y?H/AV'0&OS!>W<XOKI[N43E"!(^,
MD;5&!P.*V20!DG %)D$9R,=<T 8NK^&H-6U?3]4%[>6=Y8K(B26S*-Z/C<C!
ME(P=HY&".QK+M_A[I]M8:?91:EJ8@L-0;4+<&1&VR%F;!RARN7;W.>2>,=<&
M!7<",>N: 0<X(..M '-3V<'A6[U?Q&JZMJ,NH/#Y]M;1+*PV@(I154' '7D\
M<U-X2T6+2;*\N5L_LDVI7<E[+">J;SPIZX.,$@<!BV*Z"D!!S@@XX.* ,KQ#
MH$'B.PCL[FYN8(XYXYP8"H)9&#+G<IXR :C7PW&GB.XUQ=0O!=SVBVC#]WL"
M*2P(&SKEB>O>MG()QD9I: ..T[X=6&DMIC66JZI$]A;O:*PDCS+"S;RC?)TW
M<@KAO>GV_P /M/M-&TG38-1U*,:5<FXM)Q(AD3(8%>5QMPQ'3/OFNM#!AE2"
M/4&@,"< @\9H Y6?P%9-KESJ=KJ>J62WA!O;2VN L5R0,98$$@D#!*D$UI67
MAR"Q\1WVMQ75R9KR*.&2$[/*"QYV8 4$8W'OWK8!!&001ZB@$,,@@CU% ')S
M> +":QO[8ZCJ(:\U%=3\Y7C#PW"E2&3"8_A7@@BI5\#VBR:U*VJ:F\FL6ZP7
M;-(ASA=FX#9@$J<=,#L!73A@3@$'C-&X;MN1GKB@"II6G)I.DVFG12RRQ6L2
MPH\N-Q51@9P .@]*YZ]\ V=S/K+6^IZC96^LHRWUK;LGER,R[2XW*2K$=<$9
MQS76TFX;MN1GKB@#GX?"-M#J.C7HO[YI-(MWMH%9HR&1@H.[Y,DX5>A'2BU\
M(VL4VG27=Y=7XTU'2U%R$.P.NPY*J"WRY'/KSD\UT!8#J0*6@#E] \#VGAZ9
M%MM2U.6PA8O:V$\P:&W)S]W@,0,G 8D#Z\U5E^'-C+;SVG]JZHEE)?"_CMDD
M0)#+YGF';\F2"W9B0,\<\UV5(2 "20 .YH Y^Z\)07WFQ7=_>3V<MS'=-:R;
M"H="K#!V[@-R@D9]?4TK^%()IXFNKZ[N;>&_.H16\NPK'+N+#!"AMH9B0,^V
M<<5HZWJT&A:%?:M<AF@LX'G95ZL%&<#W/2J^E76M3W<@U"SM4M&A26">"4D[
MC]Y&4C.1Q\W0YZ"@#/;P+I<UGKEI=S75U!K,WVBX21E&R3"@,A5001L7'7I5
MRV\.+%=QWESJ-W>7L-NUO!<3"/=$K8W$!5 W':N20>GUK0EU*UBU.#36E7[9
M/$\L<6>2BX!)]!E@/QK+\+:_/KUMJ$EU;Q6TMIJ,]ELCD+@^6<9R0,YY["@"
ME!X!L;?1M%TJ/4=1%OH]RMU;$M$6+KG 8[.1\S?G5P^%();B!KJ^N[F"WOFO
MX8)=F(Y2S,,,%#;06.!G\2.*WRP&,D#/ SWI: ,_7-(BU[1+S2KB::*"[B:&
M5H2H;:PP0,@CI[5FZOX/LM9T*RTVYN[Q9+%DDM;V*0)/$ZC 8$#&<<'C!JM>
M>*-5C\:R>&K/1[2>1=/^WK-+?-&&3S-FW B;#9]\>]7O"GBBV\5Z.U]#!);2
M0SO;7%O*06BE0X9<C@]1S[T 8/B719M.\-0VJS:[J)FO(GO+^!A)=1JGS!@@
M&& 95&T+@;B<$YS!I^@3:]9WFF7.JZ]>:%=VKQ3#4[5;:1'RI4Q_NT;(^;.0
M5Z=:]!+*%W%ACUS2T <M%X(A34_[2DUK59KUK$V,DLDD?SIDD$@)C(R>@QW(
M)YIS^!M,E\&VWAF:XO)+6U"?9IRZK-"R'*,K*H&5[''US73 @C(((]J 0W0@
M]N* .<L_" MM;.LRZWJ5S?M9"R:27R@"@8L#M5 ,@GT^N:@M? 5C::;H5C%J
M.H>3HLWGVN6B)+888;Y.1AF';K74EL@["I89XSWJMILE[)IL#ZG';Q7I7]ZE
MNY>,-Z*2 3^5 '(>)?#AL-*UZYM#JU[)K,\)O$MBGF1(-JEXP%!)"+]WG/H>
M:7PO#?C5(9+36/$%W8?-]ICUBQ6!0-IQLS&C%MV.F1C.><5W ((R""/:@,&&
M001[4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA 8+VU@N82<F.:,.N?H: /&M=TJ#2="\=VVGQA-$M+NQDM$'*6\V]#.$/\(
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M1)MP>I#9YY49!JOH_@^VANVO+[2-#MY&A: P:?:@(ZL5)WD@;^5&!@8YZYX
M.7TS3K&P\0?#V:V@CCEU'2YX[MQR;A1;QL Y/W@#TST[<5K_  JAT^#PY<QV
MT=K'=+?W:RK&JAPHN) H;'. .F:Z]=(TQ'A==.M%:#B%A H,?^[QQ^%3P6=M
M:O,]O;PQ/,^^5HT"EV]6QU/N: .0^)JQOH>E+*Q6,ZU8AV#%<#SADY'(^M<O
MKVGR^%]8\4?\(G"]O:_V$)KJ&U)VQW'F8#*/X7,0<\<\ ]Z]9N+>"[@>"YAC
MFA<8>.10RL/0@\&F6EC:6$'D6=K!;0YSY<,81<_04 <-X>L?#>H:[;ZEI>KV
METMS8M%+96<2+%+%P=TR#/()QSSR1ZURU@8=+^%=C=VT$4-K-KQBU2:) I^R
M?;) P8CG;C:#_LD]J]<M=(TRQ6=;/3K2W6<YF$,"H)#_ +6!S^-.@TO3[6"2
M"WL;:&&48DCCA55<>X YH X74M/BM?'%W;Z;%''IMUH,LE_!$-L6\-B)\#@,
M1N&>X7VKGX+6QT/X6>&M<BC$(NTL(M6O,%\V_P#MC/*ABH(_N\=.*]9@TC3;
M6T>TM].M(;:3[\,<*JC?4 8-21Z?90V;6D5I ELP(,*Q@(0>ORXQ0!S'A&PT
MFUUC5;G2-7BO([M8I)H+0(+>)@" RA<@,PZ^N 3VJ#XLP02_#G4&GBC<120.
MI=0=G[Y 2,]."?P)KK;+3[+3+<6]A:6]K "2(X(PBY/? &*EG@AN8'@GB26)
MQM>.10RL/0@]: . N]-T?4?B?I=E]GM9M._L*YQ @!A;$\?!4<$9SP>,CU%<
MUIFI)8^&/"EM?74<&B?VG?VLLMPN^)"LD@@5\G&W@@9X!"GM7K@TC31*DHTZ
MT$B)Y:/Y*Y5<8V@XX&.,4G]C:7]BDLO[-L_LDIS)!Y"['^JXP: ,7P7I^GZ;
M;:C'I>I_;K22[:4",+Y,+L 62+;P%[X' )/O6?\ $>WAF/A8R Y.OVR9#%3@
M[LC(^@_*NRMK6WLK9+>U@B@@C&$BB0*JCT ' IEU86=]L^UVD%QY9RGG1A]I
M]1D<4 >9#PYHCZ_X_P!.;3K?[#!:6T\5KMQ%%*T,FZ14Z!OE7Y@,_G5+2]3@
MOI/#UCXCOK6.TNO#5M);/J$:O%+*<B;EB!OQY?OCZFO5CI&F-)-(=.M"\XQ*
MQ@7,@]&..?QIDVAZ1<6D=I/I5C+;1MN2%[=&13ZA2, T >:J]AIFH>'-%OM:
M6?0VT^=+.\U.-9(IY1*!@DX4_N^%)ZKT^]RRYTC1+"3P1";J+4M.BU2XB2ZN
MU1D\LPRG8&/!0-P.W'L*]2O--L-1M1:WME;7-N""(IXE=!CIP1BEET^RGMXK
M>6TMY(8BK1QO&"J%>A Q@8[4 >=7$%L=?^):*J^6VDVLA /&?*F.?;L:K:+8
M6>GZI\,;RTB6*YOK!X[F93\TZ_9 P#'JP! P#TQQBO2VTC37DFD?3K1GG&)6
M,*DR#_:..?QI!H^F*82NG68:#_4D0+^[_P!WCC\* /*EM(-;BFTR2[L)=0C\
M1/,VHM=1AFB64[DV[O,SMS%MQMX&#C!KV!$6-%1!A5  'H*X"'P)>S0R6>K6
M?AJ^5R^_4I+'=<R;B26*GC?SUW8![=J[Z*-884B4DJBA1N.3@>IH XOP$IEN
MO&B7BAI6U^=75QG,?EQ[ ?;;BN?T"TT[1?&=O:S0@^'KVYEN- D=5V+<$#>N
M?0@$QD]1G&?E->AC1HXM9N;^$)LOHUCO877*R[00K?7!VGU&/2IWTC3)8889
M-.M'B@_U2- I6/\ W1CC\* .7USS!\6O"1@SDV=^+C'_ #SQ'MS[;\5UFH_\
M@R[_ .N+_P#H)JM;:4J:S/JUP5>[DB%O'@<11 YVCW).2>^ .U:5 'B^DZ)9
MP^$?A[K&DQ[-=DGM(S-&Y+RPX_?(W/*! >/X<<8JU8_V9K\-R-6UJ*Q\066K
MR%E2-!>*ZS'RU0D[F5DVJ !@CBO4K72=.LKB2>TT^UMYI,[Y(H51FSZD#)I6
MTK3FU%=1:PM3?*-HN3"OF >F[&: //\ 2-!T35/$GC[2KFVLTDN;I(U 11(J
MO;H2R]Q\V6R._-<_!J$UG!X?\1W%@JMX9D_LG5RL.6<DF(LOKM(C?C_GK@=Q
M7LJV=LEV]VMO"MS(H1Y@@#LHZ MU(I3:VYC>,P1%';<ZE!AF]2.YXH \XUP1
MZ#+X8@U)K:QL-0N+B74))8E:$73KN17S@$ EP,_W5/;BA>_V?X=L].BM]96;
MP[<:V_VN8HK6MN7B8K& /E\H2;3C. WTQ7JMW9VM_;/;7EM#<0/]Z*9 ZM]0
M>#4?]FV/]G_V?]BMOL6W9]F\I?+V^FW&,4 >5>(=)TFT\)ZDVG:H+R"36+*7
M;;D+!;R-,@=8MAP"1R0#QG/&:Z71+&TTCXK:Q9:?"EM;S:3;7$D48PK2^;*I
M<C^\0!D]3WKK/[%TH64=E_9EG]DB.8X/(78A]EQ@5)'IMC#=?:H[*W2XV[?-
M6)0^/3.,XH POB)=:C9?#[6KG2O,%Y';DJT7WU7(WLOH0NX@^U8MW:647BWP
MA<^'(X4M[Z.9+I;< )/:>5D,^.N&*X)[MCO7H/6J=KI&FV(E%II]I;B7B3R8
M53?]<#GJ: .(^%FAZ8- @U=;96OX[B]@6<L2RQFY?Y>O3@''N3W-;WCZZLK3
MP;>-J!G^S2-%$PAD$9):10 6((522 QQ]TFMVTL+.PC:.SM(+9&.2L,80$^N
M!4EQ;P7=N]O<PQS0R##QR*&5AZ$'@T >12-:B7XE61FL-ATF*=(+,[8UD$,V
MXJ,\D;5R>.@X%6HM$TM=;^'I6UC#:A831WA!.;I!;JP60_QJ"!P<C''3BO2O
M[&TO85_LVSVM&(B/(7!0<A>GW1V'2@:/I@:!AIUH&@&(2(%S'W^7CC\* /)A
M/_9&F7UC"!#H</C-;:ZC3B.&U948KCHL9D(R.F"1T-:?B2P2SUWQ3:V$:1:5
M+X9EN+N&(;8TN06$;@#A6*ANG7:#7H\>DZ=#'/''I]JB3\3*L*@2?[PQS^-$
M6D:9!9/91:=:1VK_ 'H$A4(WU7&#T% 'G.DV%GIOB'X=7-G$L5Q?:;,ES*I^
M:=1;HP#GJV".,].U9UA96^NVFG:?)=6$U_;Z])-<Z@;J/=<PB5]RXW>9EAA-
MI&/E!!P!7JIT;3@(C'86D<D*X@<0+F+_ '>..>:XNW\ W<]I]@U>R\-W2E2L
MFIBR)NI<]7(/ D/7=N.#SCM0!Z" %  X X%>-:I?Z:]U::C9SP0LOBU$DEN9
M ;IB)=D@SQLB X"G/RXSCI7LP& !Z52;1M+=YG;3;-GG=7E8P*3(RG(+<<D=
MB: /+=4T?2[Z3XHRS6\4WV>!)[<L=PB?[)O#KV#9YR.:T]5V:+#X7\?-$9?*
MM8K?5'5-SM#*B@2>I97V].<,17?G1]+8S$Z;9DS_ .N)@7]YW^;CG\:R[O1M
M2N=1ALTDTZ#PW&(W-M% PF9U;=MSG:$)"YXR1D=\T 6?#>G'3])#RP)%=W;M
M=7*J ,2.=Q7WVY"CV6L+Q!/O^)'A[3]116TFXM;@Q)(,QR70VX# \$A-V ?4
MXKM:@O+&TU"#R+VU@N8<AO+FC#KD=#@T >2:Q9+'X&^(UF8DDTBRG<Z:'4,L
M+F)3(L>>@5V(&.AR!7JNDVMM::7;16D$,,/EJP2) JY(ZX%/?3+"2R6S>QMF
MM5^[ T2E!]%QBIH8(;:%88(DBB7A4C4*!] * .&UJWTU?B_H<]Y#: OI=QAY
MD7YG62+;R>K#)QW&:X^_L;,>"O%.L^4G]H6?BB5K:Y)^>$_:XP=A_AR"<XZ]
MZ]FFL[6YEAEGMH99(26B=T#&,GJ5)Z?A5?\ L/2/)>'^RK'RG;>R?9TVLWJ1
MCDT >=:LVEZSXF\5:-XCU6UT]U\LVC7*(&2W,2D/"['@B3>21T.,UZ5IBE-)
MLU,TTQ$" RSC$C_*/F8=F/4^],N-(TR[EMY;G3K2:2VQY#R0*QB_W21\OX5=
MH \]O()+KXXM##?36DG_  C(^> (6_X^3_?5A^E4_$WA/2-"LO".G6R2&.3Q
M#'YLDLA,DQD20N6;C)8@9^@KT/\ LO3_ +9]L^P6OVK.?/\ )7?_ -]8S3KK
M3[*^*&[L[>X,9RAFB5]I]LCB@#A;+3--M?B')X:N+"!=)BTE7TRTD7=$29&,
MY4-D%LE?<#V-<Q%:F:Q\+V]_)))9+XGN;.RD>5@9+0"8(-V<D'&!ZC%>P7NF
MV&HHB7UE;72H=R">)7"GU&1Q6#XH\-W&M7.A"WAL6M-.O!<2PSD@.NQDV!0I
M'1L\^E 'G^L6\WA7_A-+?05D@T*-[!YXX"=MOO;_ $@)C[O[O:6QT#9XKI=4
MMK?3O'.F2:(Z6=C=:5=MJ)LP @B15\J7"\;@S$ ]2,CM7>065K:VYM[>VAA@
M.?W<<85>>O XYJ*UTG3K"&2&ST^UMXI.'2&%4#?4 <T <#X7@DLM931-8TZP
MEDDTIS;:KIYQ'>6X9 ?,7J'Y4YR0=QQ6#I5K;W?@[X6^>-QDN_+8[R"RF*4D
M<'H2!FO6X-(TRU25+?3K2%)1MD6.!5#CT.!SU-(-$TD)$@TRR"Q'=&!;IA#Z
MCCB@#R^ZMUTW0/B1INF7,.F6MM=Q-"H;RXX]T43.@Q]T.<KQ_>KHO#UA8W_C
MN;7;)+.WMET^.%;6&>)V\[<<R8C8J $(3/4_@*W-?\-_;=+GBTE+&SNII$>5
MI+8,EPJL&,<F,$JV,'GI5/1?"?V;5+?4KK2]"L;BWW%/[+M]K.64J=SD [<$
M_+CK@YXH ZRBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "N0^)^H7VD?#[5-3TV[EM;RV5&CDCQ
MW=0<@@@\$UU]<?\ %"PO-6^'NJ:;IUI+=7ERJ+%%&.N'4G)/ X!ZT 4O[6U/
M1_B5HV@QZG+J5CJ%I-+<1SJA>TV#*R;E4':Q^7#9YZ5T">+M)>^M+7S)E^VA
MC9RM"PCN-HR0C8Y..1_>'(S4T>DV3Z1<QV-G%8/=P,C,D C<$J1D@ <BN/\
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MHGMWC>0R!Y"QW!EW= "3@8]: .BA\=VAO/$(N;2\AM=&<+)+]F=L@('9C@'
MPPP.N!FM2/Q1IDNHZ=8J\WGZC ;BUS"VV1  2=V,# (X//(K(T/3[NW\7>+(
M;S3939:C/'-'<':8G3R$0KUSG*D8Q7,+X2\2V>B6<\"B34O#E[Y.D(S\3VN\
MJQ;TW1.J^WE#UH ]"'B&P,.]?/9C</;1QB%M\DB9W!1CD#:<GIP>:BM/%>DW
MM@;J":1L7+6A@\IA*)UZQE,9W  GZ<].:YOQ1H=YIQ\-W]GI9UJWTOS8KRT
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M&$7^]C)8D?+\HP3FLR'1=5U/P%HGA.ZTZ>VOK"XMDGGV_NDC@<'S4?HVY5P
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MV>I6-PUU#>DBW6%"7D(SN&WJ",'.<8QS50^//#ZV-O=O=2K'->?8,&WDW1W
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MW,DS+NB:20R*%SP%X"YSG!(^]0!VU%<+-XWU#3=,U"?5=->V2UO(H!?M;2I
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MN&D50<8.2"0<<=.M5K[Q!KA\97/A[3K*PW)IRWL4]Q,^.79,, /5>@]<Y[4
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MXRO],U2WBN;6UCCGU:/3UM2^Z8Q.VQ;C() !/(4@<=\T =JS*BEF8*H&22<
M"HK6[M[ZUBNK2>*>WE4-'+$X97'J".#7':9JNN3>*_&$,KVD\&GF%(("&08,
M/F 9Y_O<G!S[4:+XN:]TCPK:V=I:VU[K-JTZQJI\FVC106(48)Y90!D=2<\4
M =O17G^I>/\ 4--TGQ 'TZV?5-#N8(IT$C+')',5\N1>,\AOND\$'DUM:;KV
MIMXRNM U2UM$/V);ZWDMI&;"%RA5MP&2" <C H Z:BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-T@59=F[800P.,C/(%4?^$=U.3Q1IVNW&IVSRVEG+;/&MJRAS(RL2/G.T#:
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MKM;\C3R 001D'J#0!Y=X)TB3Q/\ #T:;->VS:5)J-P\R1H3(46Z=_+SG #$
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M-MJ@U$3?9&^8B8S;-OF?WCC.>E61X1UFQU^_NM&\0)9Z?J<OGW=K):B1DE(
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MKY,[1(92I\Y1C$BX)^4Y[X/'2@#C;_P!J5_:^*()=<@_XGXB\PBR/[IE14)
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MR2<_7L:DN=1O='\2)#K+:B=/GU"*.QU:VNF>(8*KY$\8("DL&!;!R6]J[/\
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MMA?6WGW$9EAC\U=TB 9+*,\C'<5YM<31Z_K/Q ;3$DF^U>'H4A_=,IE)2<#
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M%N9G$<0ED"[V)P%7/4^U<M\+I%/@F*+)$B75T61AAE#7$C*2#R,@@BHOB?\
M9QI>A-=HK0+KMF9 R[AMW\Y'<8H Z*V\4:!>6-Q>VVM:?+:6S;9YDN4*1G_:
M.<"GP^(M%N8[EX=6LI$M=HG99U(BW?=W<\9[5YYXBLK>XU+QEJ^F+&=/F\-M
M:2/",I<71W[0N.&8+M'']X#K5O481::#X(U6UM@VG6<]N^H""+E5$1178 9(
M1FR?3KVH [I=>TA[&:^&IVGV6!BLTQF4+$1U#$GY3]:DAUG3+F2&.#4;65YX
MO/B5)E)DC_OK@\K[]*XU);2/QGXA\1@K+H,FEPPW#(N]+J<,_P!WLY"%5X_O
M8['%;P2A\*:]<>'=04;;B%;C3IPYD6*')_T4L?[A)V_W@2?:@#L-)U*)M.NK
MRXUNROK=+F3%S%M2.)-W$9()!*\ GO5B#7-*N;2:[AU&V>WA?9+()1B-O[K>
MAY'!]17EB//!X5N;VW@N9K:S\63W=W%:@^8;8R/AU Y(!97&/[N>U:\T'AC5
M=+U/5-/N=5@COI[3S-7Q(")HV_=L%D'(0A=QQC!Z\' !Z'9:A9ZC&[V=S%.L
M;^6YC8'8V 2I]#@CCWI]S=6]E T]U/'#$N 7D8*!DX')]ZYKP/=ZI/%JL6IM
M:W3PW05-3M$V1WP\M/GQTW 84XXRN!TJ#QP;FUU7POJA1Y-+LM09[T(I;8&C
M9$D8#^%6;)/;.: .A_X2#1_[/EU ZI9BSA8I+,TRA8V'4,2>#['FI;'5M.U-
MYTL+ZWNFMWV3"&0,8VQG#8Z&O,?%-M]JC\?:K8D2:;>Z1% C1\K<W(#\IC[Q
M"E%R._'8X])T.*T32+22SBB1'@CR8U SA0!G'IC% %J[O;6PA$MW<1PQD[0T
MC 9/H/4^U0IK&F2:<NHI?VS63'"SB4%"<XQGIG/&/7BN4\8:@V@^,/#NM7L4
MSZ+%'<03RQQLXMI'";)&"@G!"LN<<;CZUFZD;>UOO#.N:=I\D'AZ+5)Y[O$+
M+EI8RJW#(1D*'9N2.A!Z&@#N#X@T8:;)J+:I9K91,4DG:90B,.JDYX/L>:?:
M:YI5_?7%E9ZE:7%U;C,T,4RL\8]P#D5YAXKM#<V?Q"U.R_>:=?:?!#$8QN6Y
MN54@LF/O8!09'4C'8ULWCV2>/-(DB13;#P_<Q.(!@$%HRJ9'0D!L#ZT =O::
MSIM].8+2_MYI0GF;(Y 24SC=[C)Z]*9!X@T>YFEAAU2S>2*/S743+E4Z;NOW
M??I7F=O!K3:;?:%I&H)K5G)H5PNGW93R[JR.%"P2D8&6XQD!LH<]*U_#=_X<
MUV^TS4$@U,:GIL$B3)=B6-;%2F'5]P"GD  <^HZ&@#L;?Q-H-W=V]I;:S837
M%RI>&*.X5FD49R5 /(X/Y&J^F^+]%U2[U6""^@']FRF.9FD '"JS,,_PC=C/
M3(->:Z0D-O\ #_X>*(UBFAUF)YEV;6C'[T,6'4#E<D^HK846>/'NF:I]N@6X
MU-9O,@B;<D;)"JRJV,<,,]_NGB@#T6SU*RU RBSNHIVB($BHP)0GD CMQZUA
M^-M7O]$TNRNK"6*/?J-M!-YD>[*22JIP<\'!ZX-5/!-UJLE_JUMJ-S:ZFD A
M$.L6T8072D,=K@?+O3OMX^84?$N S^%8<P--%%J-I+,JQE\1+,I<D '@#)/M
M0!MV_BG0+NTNKJWUO3Y;>T.+B5+E"L7^\<X'XU:&KZ:8+6<7]MY-VP6WD\U=
MLQ/0(<_,3[5R5IIMGJ_Q%N-5L(H9=*?1S9W<L8'E7#M("JY'#%4#9/;<!4/@
MNQU"'46T._1VM/#,CQ6D['/GAU'DGZI$S*?]X4 =_6:GB'1G$C+JEF1%'YSG
MSEPL><;SS]W)Z]*LZD8QI=V9D=XO)?>B?>8;3D#WKS?1$U%&GT:VOH]=TMM&
MF%G=M%MN;3A0L$I'!)XQD!OD.1Q0!Z(NL:8\MG$NH6IDO4WVJB9<SKC=E.?F
M&.>.U-?6M+COUL7U"V6[=]BPF4;BV,[<?WL<XZXKS#1]3M[E?AC'#'<NU@&@
MNL6TG[F06C(5;CKNX/IU/45?\)ZA8MIMOX7UW39YO$%CJ+S&&2W<AY/.9UN1
M)C;MPV=Q/J.<@$ V]#\81I>ZW;>(=5L('@U=K*TW%8=Z^7&P !)).7ZY[UVE
M>.:JD,OA#XG!8U>>XOW,("Y:4>7$%V]V&X-C'<&O7;259[.&5'#JZ A@<YXH
M Y*\UGQ _P 1I/#EE=Z?#;_V5_:"236C2,&\WR]IQ(O'?-.\)^/;76-$-QK$
MMGIUY%>2V+H9@$EDC/)CW<E<'/MS67>06M_\;62:298?^$?\C?#.\0\W[03L
MWH1\V#G;FG^,-*TK2+;P?I]G9P06<&NPR&)$R$39)N=O;+#+'N>: .N'B31#
M80WZZK9M:3AFBF692KA3AB#W [^E2RZYI,$=O)-J=G&ER-T#-.H$HQG*G/(Q
MSD=JY0R)X?\ B=//?JEMI5WIB164Y 6&-UD9I(R>BLVX-SUQWQ7)?8$TFP\,
M'4HA%I\GBNXGM8IDP(;9EF,8(/W1_%ST!YQ0!ZOI^N:3JMC)?:?J5I=6D9(>
M:&961,<G)!P,#FGV6KZ;J,DD=E?6\[Q %UCD!*@]"1Z'L>]>6>(-'O+F7QCJ
MN@6S3:?.]@[Q6ZY%X8GW3; .&^7 ./O$,.3FM[56M==\7Z9K.ELUS8VVEWBZ
MC)!D;XW5=D1/]_=N.WJ,'.* .QBUW2KGS%@U.T9DB,K$2@[4Z;SS]WWZ54T[
M6[&VTC3CJ/B'3[J>X0[+I62);G&261=QXP#T)Z5RGA6>YL-473WU&#6=#BTU
MWM[^2,)/9J"@$,Q'!R,8R WR'(K!TA(3X1^&,-Q&-]O>@S)(G,6(I1\P/W?F
M*]>Y% 'JUEK>E:CI\E_9:E:7%G$6$D\<RLB%>N6S@8I+;7=)N[H6L&I6DER>
MD E7S#QG[O7IS]*\SU:*"XTWXF1&66*)[J":-H8B^XK'%E@H^\N]<-CMFMOP
MUK&C:[X]EU4:I:_VB^GK:1V<:R+N"LSL^9$4D_-C ' !]> #T&BBB@ HHHH
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M;X^X^.0.0<'FL=_B%>7&B:CJ6G^&KQHK)+L/+/+&J))!D%6PQ)S@\KD=L]<
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M0=P!/ )')]N: /2Z*X[4?B-I6GOYK!9+)+O['+*DZ>8C[]A;R\[B@;@GKP2
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M3:I,H^;STZLQ"C@=:V;?QUIMUH&EZFJ^4^I,Z0P7$BQ[63<'#,3@!2I&>>V
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MZ;<6UK>R64\B;4N8U5FC/J P(-1Z1I@TJR,37,MU/(YDGN9@ \SG +$* !P
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MQ97C"(DB'*8Z*<'N0.!796FI6][=7EO#YGF6<@BEWQ,HW%0W!(PPP1R,U;H
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M4#)^N,UH4C,%4L<X SP,T >>V7@[5G\%P>#[Z*W2TCNO,FO(YMWF1"?S@%7
M(8\*<\#DY/2KD&E^*]"\0ZJNDQ:==Z5JER;I9+F9D>SD8 /E0I\Q>,@ CTR.
MM=1H^LV.O6'VW3I6EM_,>+<T;(=R,5888 \$&K] %#5;"34- O=.64>;<6LD
M D<=V0KDX^O:N8L_#FJ7FG^&+#4[>&WAT)XIG:.;S#<2Q1E$V\#"Y.XDX/ &
M.]=M10!PEEX.O;OPAXFT+5/+M_[5O+J>*2&3S-JRL67/ Y!QD=_6K*Z'K&LG
MPXFM06\']C3K<RR12[Q<2I&R+L& 0I+%CGG@#!ZUV5% 'F-YX1\3-X?U70K:
MWT]H9=8_M""YDN6&]#<K-M*A?E(P<G)Z< YX=JEOJ>J>*M>?2M,LK^W>"*PU
M!(M3-LS,%+,C_NVW<2 !AM..,]<>F5CWWA3P]J=_]NOM%L+BZP 9I(%+,!T!
M..?QH YZUM+_ %?6O"NMVVF0V=EIL%W;RV_G@E"VV,!,##*/+R#QD$51?P?K
MK:!J$*Q6GVL^(O[8@C,YVNGG"386V_*V 1T(KT9$6-%1%"JHP% P /2EH K2
M1376F20S"-)I8BK!"656(QP<#('K@5Q>F^%-5F\.^&] U*&"&#1IH)99XYM_
MV@P_<"# (!(!.<8 P,YR.\R,D9Y%+0!PVC:3XMT"[NM'M5T^;19KJ6>WOGF8
M36R2.79#'M(<@LV#D#GGTJZ-#OY?'>J:E/!'_9M[IT=B"LW[S*LY)(QP"']>
MU=8"",@Y!HH \\M_!^KS>"[3P9J"P-9VLT2F^23_ %MO'('4!,9#D*%/8<G)
MZ5M:1H=]#XG\4W=[#$MEJS0F(I+EP$B$9W#'&<9&":Z@D#J<50M-;L+[5[_2
M[>5VO+ 1FX1HV7:'W;<$@ YVGIF@#FO">G>+]&M;30+U=.?3; ".+48Y2998
M5^XGE%<!L  G=TZ9/-:GC?1KS7O"\UEI_E&Z$\$\:RL55C'*C[20#C(4C.*Z
M&B@#E$TO6#X^AUZ:UMQ NDM9ND<^6$AD$G&5&5XQGCGM7/6?@_Q-I7A[0)K$
M67]LZ-=73^1),?)N89W9F7=C*M@K@XZBO0K[4+;3H4DN9"H=Q'&JJ69W/15
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M1'$$.X8XSC/!-=/10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA?!M<B6*Y ,>%54*#9\G'RDCG- &/?>(=4N;"SNK>]2V^T:+]M2WM8Q).9B
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M(H;=U# J.F!CKGJ>GLO \-EJ-AJ']M:M-=65JUHDDLD?S1G:0& 0#@J#GO\
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M6&<'YM_RA5.W[N-R@YSVQ0!+X@UB:TU;0]'MI!#+JL\B&<@$QI'&7;:#QN.
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M!%-X=T\R9!&K60#!BI7,R@X(Z<4 =L64#)( ]<UEZ_K2Z):6TGE^9-=W<-G
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M6B=SPRONY'/"^G!XAMI[6SEU"/R/$.G6VCPQZA:WW[N[CB"NPGB8C 9@22"
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M#(* /3Z*;'''#$D42*D: *J*,!0.@ IU !1110 4444 %%%% !1110 4444
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M2"N,]2!GIS0!K3Z?97-Q'<3V=O+/%_JY)(E9D^A(R*;%I6G0QSQQ6%K&D_\
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M/=1C ;T..#S6FB+'&J*,*HP!Z"L>Q\5:5?W5_;++-!+8QB:=;J!X,1G.)!O
MRORGGVI(?%FE2:@+*22:VF>W:YB^TPM$)8E^\REAVXR.H'.* +@T/20D:#2[
M()$Q:-?LZ81B<DCC@YI6T;2V6X5M-LR+D8G!@7][W^;CYOQJI'XHTUHI)I3/
M;PI:F\,L\+(IA&,N#CWZ=1W%6K'5H+^ZFMEBN8IX421DFB*?*Y8*0>A^ZWT[
MXH EBTRP@+&*QMHR\8B8I$HR@Z*>/NCTZ5+;VMO:6R6]M!%# @PL4:!54>@
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M:AHUM/J<%@=0L4LISLN4W;=A+@;6#8&?0YQ2V_C*\;4M6TX)87LUIIBZA%-
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M\2:?:P3Z7IT\J/"Q(EFCB;;)(K9PN,,0I!R%ZC/%K4?"$^L7]I-J%S:R"SU
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ML43.J.Y56(&<$@''Y5QMAXUUA_#VG:SJ&GV<<&J1VRV4<#R/)YTG)W*%/R@
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MG$TMH]VLYV^655E4@<YSEAU K7KRRVMYM=\3>$1<7]Y%)<>%WDFGMY=DKDM
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M'#;F)/S C QZUCZ-<3>(O%7@?5M0\^.[N]#GFE6.=T4L&BP0H( !SG'?(SG
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY+J<45M/ ^G79M)5FVY+!5;(VD\885KUY.--N[F+Q_?VFMW^FSV6IRSP_9Y
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M GCV^N+NYC>QEO+.&"*9D2-(5QAE!PQ;DG<#PPQC H ]1MIUNK2&X4$+*BN
M>H!&:EKSN.[O];U6XT"WG,'V72;66'9>O;/ND#9D&Q27 (48/ [@YJ"2'7+O
MQ)X?T6^\2W0:XTJZ%W+ISB,/)&T:[UXX;).3ZYQB@#TNBH4@9+-8!/*66,)Y
MQ(+GC&X\8SWZ5Y!;W6OP_#C2/&">(-2GOX;M4>VDD!BN(VN3$4*XY/S=>H[8
MXP >RT5YU:?VA/XE\6SRZSJDD6BW<<UO:Q2A5D'V=7,;#;RI)Z<?G51]7U.+
MP'X=\7VVH7$]_<S6INH/-+13B9PCQ"/.U=I; ( (V\YYR >H45Y9-!K&IP^-
MY%\3:I;2:3>.UD8Y555*P(X# #YER<;>G)[U?\.ZY>>+M8CL=2EN+14T.TO/
M*MY6A:268$N^5(.%P !G&2<YXP >B45Y;9ZWXFN?#UK*\%QJRZ=J%W:WD=K/
MY%S=Q1,465-I&X@]5!&3BK5EXA.LW>@Z5I][/<6=W8W%R'N;F2UFE=)0FPNH
M+;D!;(&,XST&" >D45YU<CQ3I&E6$=Q+)KRVD\_VR"PNC'=-%@&,@_*79 V"
M.-V5/6NL\*7]MJ?ABQO+2\GNX)$.V:X!$APQ!#@_Q @@^XH UA-&T[0!U,J*
M'9,\A22 ?QVG\C3Z\U,AT?QG\0-8A^TS3V&G6]S'$UQ(59O*F;:5S@C(X';M
MBGS7^H:?H_@W7K34;JZFU*YM8+V.24O'<).OS,J=$*GD;0. 0<B@#O-3OUTO
M2[J_>&69+:)I6CBQN(49.,D#I[TFDZC'J^C6.IPHR17EO'.BO]Y0ZA@#COS4
M'B3_ )%;5_\ KRF_] ->=Z;%J>AZ/X U.SUB_F6_^R65S8RN&A,;PYRBX^4I
MMSGJ0.<T >K,=JD@%B!G ZFJVFW<E_IT%U+9SV<DJ;FMYP-\?LV"1G\:X?PG
M9ZAJG]L7MUXAU8M8ZI?6L,:RJ$* [5W+MY(ZCICTZYRK#4]7OO#'PYG;6;V.
M749_*NW1QF4&*1LG(.3E1[>U 'J]%>8MJ.NZ=H/CNSTZ^N;J?2[I/LDMS('E
M2-HXW<!FZD!G*Y[XK<TB/4)O'$LMK<ZG_P (^E@C;+HO@W)9@0/,&\X3!(!P
M#COD4 =E1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !117->,M8O]%MM)FLI(46?5+:UG$D>XF.
M20*=IR #CO@T =+15'3M9TO5XY9--U&TO$B;9(UO,L@0^AP>*;!KVCW7G^1J
MEE+]G3?-LG4^6O\ >;G@>_2@#0HKB/#_ (GNO$:IK%KJ^FQ:?%<7"7=G)@M'
M CNB2;@<JQV!N?EP>.F3U,&M:7<P3SP:C:216_\ KG692(^_S'/''K0!>HK.
M@\0:-="4V^K6,HAB6:4I<(=B,,JQYX!'(-3V.I6.IQ/)87D%TB,4=H9 X5AU
M!QT/M0!:HK$F\4Z6OB7_ (1U;V!-2-N9MKL,*20%7&1DG).!S@>XK*\%^+XM
M5T.P&L:E8)K%U+<*D"NL;2!)I$&U"<XPGOTH ["BJ-UK.EV5U':W6HVL$\A"
MI'+,JLQ/0 $]^WK5QW6-&=V"HH)9F. !ZF@!U%4+?7-)NTF>WU.SE6!0\K).
MI"*>A// /K3+;Q#HMY>16EMJUC-<RQ>='#'<(SNF,[@ <D8YS0!I45E-XFT%
M9(XVUK3@\LQ@C7[2F7D&,H.>6Y''N*LG5M-$ES&=0M!):J&N%\Y<P@]"XS\H
MX[T 7**H2ZWI4%I#=RZE:+;3C,,IF7;(,9RISSQSQ6+XFU^ZL4\.W&E7-M):
MZAJD%M(X7S-\4F3E&!P.G7!ZT =314-U=VUC;/<W=Q%;P1C+RRN$51[D\"J(
M\2:$TT\0UG3_ #+>+SID^TIF-/[S#/ Y')]10!J453@U?3;K31J4&H6LMB1D
M7*3*8\9Q][..O%%MJ^FWEG+=VU_:S6T1(DE252J$=0QS@8[YH N45A:AXPT+
M3]"OM8;4K::UL@?-,,H<[\9"<?Q'L/>G'5X;V_TAK+6]/6&?S"UON5WN0%/$
M9#<;2"3@'H>E &W164WB;05DCC;6M.#RS&"-?M*9>08R@YY;D<>XJS>ZKIVG
M$"]OK:V)4M^^E"_*.">3TY'/O0!<HJ*WN;>[A$UM/%-$3@/&X8?F*I:[K$.@
MZ1-?S*9-I5(XE.&ED9@J(/<L0/QH TJ*JI*]IIQGU&:,-&ADF=1A% &3CV'O
M6#X)\5R^)[2_%W:&SOK*[>*6V;AEC/S1$CW0K^(- '445CQ:NT'B5M$O"OF3
M0M<V<@&/,12 Z$?WE++]0P]#6C=WMK80B6\N8K>,L%#2N%!)Z 9[^U %+Q#H
ML6OZ-+82.8G+++#,!DQ2HP9'Q[,!QW&13)]&MM9;3[O5;5EO+*3S8A'<.%23
M!!8;2,@@G&1G!Y Z5H6EY:ZA:I<V=Q%<0/G;+"X=3@X."/>JLWB#1K>Z-M-J
MUC'<"1(3$UP@8.^=JXSG)P<#J<4 0CPQI2W.J7 AF$NJ*%O&^TR?O !M'\7R
MX''&.*I:AX7M[C0;7PS;1&+1U,8F#2%SY2,"(EW$GG: <]%SCFM8:SI9U$:>
M-1M3>G(%OYR[SCJ-N<\4+K6EM?BP74;0WA8J(!,N\L!DC&<Y Y(H O8XQ5'3
M-(L](2=;-95$\K32>9.\F7/4_.3C/M2G5]-6^%D;^U%T6V"$RKO+8SC&<YQS
MCTI)-9TR*^6QDU&T2[9@BPM,H<L1D#&<YQSB@#-7P5H*/J+I;3JVHNLET1=S
M?O&!!#??X((&",&M*QTFTTZ:>>!',\X42S2R-([A<[068DX&3@>Y]345YXCT
M33S.+S6+"W-OM$PEN$7R]V=N[)XS@XSUP:GNM7TVQACFNK^V@BE&Z-Y)54.,
M9R.>1CGZ4 1:OH>G:[';IJ$#2?9IA/"R2O&R. 1D,I!Z$CKWJM<^%-'NKV>[
M:V>.6XB6&X\B=XEG0# #JI ; XY[<=.*S=<\2RZ?XB\,+#>V8T?46G,\K8(V
MI T@82;L!> >GXTOBGQ1Y/P_U/7_  YJ%C<FVA:2.92)HR1U'RMC/^<4 =3'
M&D4:QQHJ1H JJHP% Z "L"_\#^'=2ULZQ<Z?NO6"K*R2NBS =!(JD*^/]H&M
M.'5K![M+ W]K_:!C$AMO.7S<8SG9G./PJ>VO;6\\S[+<PS^4YCD\J0-L8=5.
M.A]J ,34/ WAW5+G4)[RP,C:B@6Z43R*DN!@,4#!=P'1L9'K1J'@;P]JES:W
M-S9/]HMH_)26.XDC=H^NUV5@7&>?FSU/J:S]%\8QIJ6N6OB#5=.MC;ZH;2TW
MLL&]?+C8 !F))R_K70WNOZ-ILDD=]JMC:O&@D=9KA4*J2 "03P,D#/O0!&?#
MFEG5H=36W=+N"W-K$T<SHJ1''RA00H' [=A4NCZ+8:#9&STZ)XH#(TFQI7D^
M9CECEB3R23^-1V%YY^J:H/[6L[J"(Q[((0-]K\OS"1@QSD@D9 P/6I(->T>Z
M6X:#5;*1;<!IBDZD1@]"W/ ]Z $N-#T^ZUJUU>:*1KZT1DAD$S@(K8W#:#M.
M<#.1V%4SX-\/M:ZE:OIRO;ZD[2743R.R,S')(!.$)//RXY /45D^%?$%_P"*
MQ:ZM9:E8_8FEF6ZL-H:2.,,ZQ,&!R&.T$[N""<8Q6[KVLVVDZ?.6U"SM;OR6
M>$7+#!([[=P)&<#KWH IVW@;P_:Z+=:0EG*;.Z4).'NI6>11T4N6W;1D\9QR
M?6KG_"-:6;^QOC%.;FQB:&V<W,IV(<9&-V#G SG/052\.^(XY_!&C:SK-Y;6
M\EW:1RR.["-2[+N.,_CQ6L^L:9':0W;ZA:BVG&8I3,NR08SE3G!XYXH CTG0
M]/T1+E-/BDC6YF:XEWS/)ND;EF^8G!/M3=1T#3]3O;:]N(I%N[8,L5Q#*\4B
MJW5=RD$J?0\5-+J^FPV45[+J%JEK, 8IC*NR0$9&TYP>.>*CEU_1H8H)9=6L
M4CG0R0NUP@$B %BRG/( !.1V% %>\\*Z-?:,FD3VC&Q1Q((DFD3+AMVYBK L
M=WS9)///6M>-!'&J*6( P"S%C^9Y-8\&KV]UK*R6^NZ=+8&Q\[[,C*SGYAB;
M>&^Y@XZ8YSFIX/$>AW-Y#9P:QI\MS.F^*%+E&>1>>5 .2.#T]#0!7E\)Z--=
MW=P]M)_IC![J)9Y!%.P &7C#;6X !R.0.<U)J/AG2M4U*VU"ZMW-U;H8E>.9
MX]T9.2C!2 ZY .ULBJMOXNTC4Y-8M++5+2*?3R8WED==JMM!+8R,JI8 GID$
M9J]:ZE!;:'976H:I:2B2),W:D)'.Q7.Y.3P>H )XH IVG@W1-/MK.WLH)[9+
M/S/(\JZE4IO(+C.[D$@'!XS4Q\*:,?[-Q:NO]FN9+79/(OEN<Y;AOF)R<DYS
MD^M6SK6E"RAO3J5G]EF8+%-YZ['8G "G."<\8%+8:OINJ/.NGZA:W;6[[)A!
M,KF-O1L'@T 9TG@S0I;/4K1[69H-3D,MXANI<3,0 2?FXX '&.@J/5/ _A_6
M;BTN;VSD:XM8_*CG2YD239_=9E8%A[$FMJ[OK2PB$MY<PVZ$[0TKA03Z#/4\
M5C>)/%MAH7@Z[\00W%M<QI"SVVV9=L[X.%4@\\CMZ&@"S<>&-*N9"S0RQAK9
M;1D@GDC1H5SA"JD# W-VSR139_"NCW#3[[>01SHD<T"3NL4B*,*I0';C QTY
M'!R*;HDU_+)<7<VKV.H:9)&K0R0J T;C/F D$J5Z8[CD'/6N>UWQ_%/X-U'5
M_#=]:/+9720L'&\LIF6,L ", Y."<@X]Z .] P,"N>D\#^'I;.\M&LI/LUY/
M]HFB6YE53)NWY #?*-WS8&!GG%:EEJ^FZE/<06.H6MS+;-LG2&97:)O1@#P>
M#U]*2UUG2[Z[>UM-1M)[B-=S113*S 9QG .<9XS0!3N?"FC7E[/=W5J\TUQ:
M&RE,D\C!X#G*%2V,<DYQG/-16'@O0=-O;2]MK23[3:0F"&62YED81G!VDLQW
M 8& <XQQBJ_BC7+S1=9\.I'/;Q6-[>/#=&5.0HB=\AB<*/EYX_&M2/Q)H4VF
M_P!I1ZSI[6(?8;D7*>7N]-V<9]J %T;0=-\/VK6NEVY@@9BVPR,X7))PNXG:
MN2>!@#)XYHO] TW4M2L]1NK<M=V@80R+*Z$!L94A2 P.!P<CBK0U"R:_:P%W
M ;Q4\QK<2#S G]XKG..1S[U7CUO2[I91;:I9.\<9D8K,K;%_O'G[OOTH SV\
M$Z ^F76FM:S&TN[C[5/&;N;YY=V[<3NS]X _44W4_ WA[6-4CU*]L6>[2,1&
M5)Y$,J#HLFUAO'^]FK.G:Q:0:3I_]HZ[IUQ<3QY6XC=8TN" 260;CQ@$\$]*
MN6>L:9J&GM?V>HVEQ9KG=<13*T:XZY8' Q0!<50JA5 "@8  X K)M?#.EVD\
M,L<4K>1*TT*2W$DB12-G+*K$@'YF^F3C&:LV^M:5=V\]Q;ZE:2PVYQ-(DRE8
MN,_,<\<<\T1ZUI<MO-<1ZC:M#"P65Q,N(R<8#'/!Y'!]10!0'@W0!97]F=/5
MK:_D,L\32.R[RVXE03\GS<_+CGFK=KH.GVOGD1/.\\0AEDNI6F9XQG"$N2=O
M)XZ<GUJU9W]IJ$32V=U#<1JQ1FB<, PZ@XZ'GI69XFUZ#1M'O774+*VODMGE
M@6Y8$$@''R[@2">.O4T 1:/X)T'05E73;22$2(8Q_I,K>6A.2L>6.P$_W<=!
MZ4D7@CP_!#ID45G+&NEEC9%;J4-#N^\ =V<'T/%.T?Q# ?!^CZMK%[;6TEW9
M0S2/(XC4LT89L9^I-:4NL:9!;0W,NH6J03+NBD:90KC&<@YP1CG- &;)X+T&
M6QU*RDM9FMM2E,UY&;N7$KG&2?FXZ#IZ"K%QX9TNYO(;QHYX[N*'[.)X;F2.
M1H^NUF5@6&>><X/-$VH)+JVE"VUFQ2">-Y#;':SW2E<JT9W< <DD Y'I4T'B
M#1KF[CM(-6L9;B0N$BCN$9F*_>  .3COZ4 0W'AC1[F+38GM"L6FN)+1(I7C
M6)@" 0%(R<$CG/4^M4[[P-X?U&ZO[B>TE#:@FR\2*YEC2<8QET5@I..Y&:UK
M/6=,U"XDM[/4;6XFC4,\<4RLR@\9(!Z>]<YX@\6?9-<T"RTS4;"7[7J0M+J$
M$/(%VN200W&"H!X/7M0!=U'P)X=U7["UU8OYEC'Y4$L5Q)'(J?W"ZL&*^Q)J
MZ/#6DKJ5EJ"6S)<6,)@MC',ZK'&<94(#MQP.W84OB+Q#8>&-%FU/4952*/A5
M)P7<]%'N?_KU-+K>E06L=U+J5FEO+DQRM,NU\=<'/.* +LC%(V8(SD#(5<9/
ML,\5P_@'PD;#PMIT&LV-Q%>6LTDWD2W/F1JYD9E<*K%,X(/L>>O-=O#-%<P)
M/!*DL4BADD1@RL#T((ZBN0T?QC''JFNVGB#5=.MOLVI_9+3>P@WKY2-@!F.3
ME_6@#H+#0M/TW4;Z_M8I%N;Y@]RS3NXD(& <,2!@ #@=*K6?A+1;"1&MK5DC
MCF-Q%;^<YABD.266,G:IR2>!P3D8J_?ZMIVE1B34+^VM$8$AIY50$#J>3VS5
MG?YL&^"1#O7*/]Y3D<'@\C\: .'T/PL]SK7BF76-/NXK;4;T21J;G$<\7EHN
M&5'.>5;@CD'!]*Z>^\/:;?WMO>R0O'=V\9BCGMYGA<1GJA*$97O@\9YK"\%^
M,8-5T2P76-4T]-9NI;A5MU=8VD"3.@VH3GHOOTKH'\0:-%=BTDU:Q6X,JP"(
MW"!O,;HF,YW''3K0!$WAO2_+LDBADM_L2NMN;>=XRH;&[.TC=G )SG)YZU5U
M#P1X>U33+2PN=/'DV;F2W:.5TDB8G+,'4ALD\DYY/)K3&LZ8U^+ :C:&[)*B
M 3+O)'48SG(]*:=;TE8;F8ZI9"*U;;<.;A,0GT<Y^4_6@"LOA?2HXK*."&:#
M[$KK T-Q(C .07R0V6R0"=V>>>M:%A86VF645G9Q"*",$*@)/4Y))/)))))/
M))IEQJFGVD,<UQ?6\4<HW1N\H <8SD>HQS]*YWQ'XG>U?0)M)O[*:TO-5BL[
MEEQ)\C*S'#!L#[OH>O:@#:/A_2SKCZR;;_3I(A%(_F-M=1G&Y,[20&(!(R 3
M4&G^%-'TMX#:VSJEL[/;PM,[QP,V02B$E5X)' X!(&,U'?>,M L_#EYKJZI:
MW%C:A@\EO,L@+@?<&#]X\<>]:MI>0ZC8I<V5Q#*DB_)(C!US^!YP?>@"::&.
MX@DAF17BD4HZ,,A@1@@UE:=X7TG2S;FVAE(ME*6RRW$DH@4C!"!F.WCCCMQT
MXK&\'>,8=2TFU36=4T]-7N+BXC2 .L;2!)G0;4))Z+[UT=YK.EZ?.D%[J-I;
MRR$!$FF52<G X)[G@4 0:?X=TS2K>\@LXIHX[V5YI_\ 29&+.WWF!+$@GVQ5
M:+P9H4%MIEM%:RK#I;^99H+J7]RV",CYN>"1SG@FJ&N>*$3Q3;>&K75+2RN9
MK66=[B1D8QN"BQIM)ZMOS@\D#CKD:UEJ\,"6MAJVIZ=_;!"I+'#*%#2XSA5)
MSSU ZXH QO$GA.,Z/JG]DZ:+NXU.>)[Z&6\=3.BE=VTL2%?:H /&..>!5?PS
MX=>TU6&]MM.UC2(H]PFAOM4-R)@5("A/,D48)!W9!^7&.3CI[CQ!HUI<-;W.
MK6,,RND;1R7"*P9\[003U.#@=\&GG6=+745T\ZC:"]8D+;F9=Y(&2 N<YQSB
M@"]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7&?$N%9=!TYY83);0ZO9RW.4W*L2R@NS#^Z!U
MKLZ* /*/$6E3:GJ?B34_"D2202Z"+:1K7&RZF\S=M4CAF$89<C/WP*V?#6H>
M&M?UNWUNPFU":^M;5HIGN0T:VL9P3&^0%)W#IST)Z5WU% 'C=E).WPLTR6U1
MYXK'7C=:A;QJ6<VPNY'/R]2,;6QW K=U3[-J7BZ]UK3IX9=,7P_+!>3QL&BD
M<MF)<]"P&X^H!'J*]'HH \D$*67PG\)ZE96;LMF;)]3^R1@S>4BG?D8R2CL&
MQV()KKO"!T*^U#4M:T26[NOMJQ"XO)MZI*R A0H8#)4=2!W ZYQUM% '$W-Q
M'8_&%);G='%<:&(HG*$JSK.2PR!C@$$^@YKB[(VL7PX\/.!$EPOB=9G. ' %
MXYW'OC80<_W2.U>U44 >2S3Z5+J/B3PWXJ.I>=?7[3VUO"C%;Z%MICV,J]1M
M"]1C:/0X[KQ?*EIX$U5YM.?442R8/:!VS*-N""PY^I'/6N@HH \IM-0M9O&]
MS<O>&ZMKCPUL686K1PDK(Q*KD?= /\1)R<9SQ572?LEMX?\ A<4$44L4X\[
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MEY(%6(R,@[D,I/U4U[#10!YC,/"NMZ;J^KV5_J92ZCMX;G5%#KY;+*OE$!E
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M=NM7;(4-M&3ZXQWP*Z>U\<63Z9?W5[:SV,]C>"QFMI60MYK;=@#!MI!#J<Y
M'.< 9K'@T#7S:^"4N+&W1M$D7[0([D-E5@,61D#)).<>G?-07G@_7;O_ (2"
M>V\BVO)=6@U33FE?<C-$B+LD Y&=IZ9ZT =-H7BZSUS5K_2E3R[VR5)'595D
M1T;HRLIYZ8(."#6CK&JKI%K%*;>:X>:>.WCCA7)+NP49/15&<DGH*JZ#-KUT
MK3ZU86NG$*%6V@G\XL>[%MHQ[ 9[Y/I#XPL]8O=+MDT8HS)=Q27,#3&+[1 "
M=\8<#Y<\?4 CO0!0N_']K8Z'K>HSZ==E]&N/L]W!$R,02%(922 5PZ^_7BKD
M'BSS-=N=(FTB^@N8[0WL"N8\W$0;:2OS?*<D<-@\]JY&^\&:_+H?C+3H-/T^
M%=8EBDM4AN,)'A(U((VC &P\]R>G>NDN--U1_'D.N)8YM4TB2S*F50_F-(KC
MC.,?+C.?PH BTWXA6^HKH<_]D7\%CK+>7;74NS;YFUF"%0V[D*><8R/3FIKC
MQY:VWA_6M7?3[OR]'NVM+F(%-Q*[<LO."/G'<&L.Q\*ZW:^%O!6FO:1F?1+V
M.>Z(F7:R*DB_)ZD[P><=#46L>$_$DVC^,-$L[2T>#6+MKR"ZDN=N-XCRA3;U
M!0\YQ@_A0!U.M^+X]%.I,=.NIX=,MTN;N5<* C;N$W8WL I)'';G)Q6;?NDG
MQ3\,3PNY2XTV\;&X[2!Y6TXZ#[Q_.J'B7PWXFUQ]?@EM;&YM[[3A%8F2Z.VS
MDV$. NSDLQSOX...V*THM&UAO$_AG49[2%8K"PFMKG9.&PTFS&W(&0-G/3KQ
MF@#L)7:.%W6-Y64$A$QEO89('YFN,MOB1;W%AH^H_P!BZDNGZK+Y$,Y$9(E.
M[:A4-NYVD9QC/?O7:2,R1LR(78#(4$#)].:\XL_"FN6W@KPGI+6D1NM)U**Z
MN,3C:41F)VGN2&'! Z'\0#H(?'%HJ:NNI65QI]QI;PK+#,T;%O._U6UE8K\Q
MXZ\'KZU'!\0M)^UZG:WA%O-86PNW*2I*DD1.W*LIZ[OE(.#DCKFLC6?!^M:K
MJWB:YM_*M7O/L,VGS2.& FMF+#>HZ*21TSQ^57KW2_$OBSPOJ%AJUM9:-/)"
M%A$$_GYF5E=9"=HVJ"H^7DX)ST% $I^(%L;R]T]+,O?PV+7T$27,;K,B\$;U
M)"L#C(].1FJ4?B*+4/"OA&_U_2;F26_N[,PO%(JHD[@%9#AP=N2W&#TY%:FG
M)XIU73KFVURPT_3B;9X2;><S>>[#&[&T;%')QDDY[8YQ1X<\0-X/\):9+96P
MN-'O;224)<Y#1P#!() ^9NPZ>IH U;_QX+2YUVWBT+4;A]%5)+K88@/+*%]R
MDOS\HZ=3Z"M)O%%M+=:=:6$375UJ%H;V%,A (1M^9B>F2Z@#GD]@":PYM U=
M[_QO,MHA36;:.&T_>KG<L)C._P!!DYXSQ[\5DSVFKVU]X:L].L+>?6-)TC9<
MHE\(945MJ#YBCJR,4<X(SD \=P#MO#/B*'Q1I7]HVUG=6T)D:,"XV!BRDJW"
MLW1@1SCI4FIZRUC?VMA;V,UU=7$<DJ[2%153&=SG@$E@ ._MUJCX,;RM'DTX
MZ0=+>RE,;P?:!."S .6\P=2=^3D Y-1>(-.UF[\1Z;-;V]M?:0D,B3VD\YC4
M2DKMD8;3O  (P>A.>M $*_$"QETW0+ZWTZ_GBUJ0Q0!%3*. Q*L"W7Y",]/4
M@5-;>.+-M-U.YO;.YLKC3;E;2:T?:\C2-M\L(5)#;MZXYZGGUKF](\)^(+'1
MO"%E/:6Q;1M0DGF,5QD-&1(!C('/[S./0=>P=JG@S6]1?Q'- L-O<3ZG;:GI
M[2295FA5!MD Y&=AZ9ZT 7;.>YE^,V+BTFM6.@,VUIMZ-^_3D8. >QX'X]:[
M#5]3BT;2+G49HII8[=-YC@3>[^@4=R37-6%AX@NO'MMK][IMM9VPTMK.2/[7
MYCJYD#Y&%P?N^O?\*V?%=KJU[X8OK?0YU@U%U'E.SE/X@6&X<J2N0#V)S0!3
M/C".&76K>YTZY2[TFV2[EAC='\R)@Q!4D@9&UL@X]LU#IWCB._OM'MVTF]MX
M]8MC/932E-LA"!RF Q*_*>"0,X-8B>&-;CU+7KF'2;"U@U/1UM$ABN<E)1Y@
M^8[1G.\$M[=S5NV\/:O%-X$9K1,:' T5X?.7J8/*^3U&>><<>_% &I9^,X;S
M0M0U(:==1R6-TUG):.R>:90P7:,-C)+#'/.1ZUTRDE 67:Q&2N>GM7$)HT5U
M\2Y+VQO$?3Y+>.[OH$(96N$+)"V>G(W$^\2FNXH XF?XCP0:=J&HMH>I?8]-
MO6L[V0^7^Y*E5+8W_,,M_#GBM%/&,2:Q=:=>Z9>V;Q63W\3.%?SH4(#$!22&
MR1\IYY_"N;O/"FN7/@SQ;I*VD0N=7U*6YMLS#:$=E(W'L1M.0 >H_#2UO1O$
M%[XG_M33$2U<:)<644TDBDQ3NRLK8&<J"O)_0T :=CXM%YJ<>G/IEQ#=SZ?_
M &C;QNZY>/(&UN?E<%ER#QSUXK-\/>.FNO!]CK&K6PMYKZ=HK=/-0+(Q9R%!
M)& JJ<EL?=/4\55T+PYKEIXKTG5Y],LK9$TV2SNR+LR2-(6C;S&;;\Y.P]3]
M3VJE:^$/$]EX0T:WMEL5U70+UI[8-,6CNT/F!@QV_)E)..O(H UI/B9IL.EZ
MI=M97,DFEW,5O=10,DFWS" CA@V&4[ATYZ\5+?Z[;W%_H:ZOX>U&VF?53#9M
M)(@"R"-B)#L<Y!7=Q@\@Y[5!XATWQ-XD\&7=K-IUI:WMQ-;M':)<[UC6.59&
M+2;1DG;C &!Q[UH^)],U'5;[PW/:VH*V&H+>7 >100OENF!ZGY_IQUH 6[\:
M06=P?-T^Z%FNHIIC7!PO[UB "%/)3+ ;OK@$<U3TM?+^+7B!0SE6TRT?#.2
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M'4M.F\ZTGR8Y-I7< 2#P0#U!K*TO_A()+K3+V2_M;C3[JV+W<13:8Y" 4\G
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M[1C^Z:,<E1C.[N#QWXG\!F^EU/Q7)=ZC+<K'K,L(5T4 8BBP1@<8'&.GX\T
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M9QO5I,':^=P R.QYS4L^O:RGB'Q;8I<6P33].ANK/,!.UF$A.[YLM]P=Q]*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<CTKK;:WAL[6&VMT$<,*+'&@Z*H& /RIMY96FH6YM[VUAN82<F.:,.I/T/%
M'GWB.VTWPWK.A6ZFWL]*U2YF>]FNPTL,ESY:B/S-S <@-U.-P!Z\U"=$:#28
M[/P_K5C?.NK27$%E=I_H<I\HEK9<$X5<EQU"L/;CT.XTO3[O3_[/N+&VFLL
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M*RTVYLKNVA@B63]XZ>7OR2&3'S;^Q[=Z .$T:Q?5H_AS!K3S7/VB+4(F,DC
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MXH \ETV[%S\,_ ^ZY$SQ^(;>,G?N( N) HZG^$#'M79::1_PMW7AG_F%6?\
MZ'-71-H.CM"D+:38F))#*J&W3:KGDL!C@GUZU-'IEA%>M>QV5LEVXVM.L2AV
M'H6QF@"U1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !5+4M5L](@BEO)2@EE6")54LTDC?=50.2
M3_0FKM<UXTDU&*STUK"QENH_MT?VHV\:O-#%ALO&#_%G R.0"<>H +D7BG1Y
M-+O-1-T8[>RF,%SYD;*T4@P-A4C.?F7 &<Y&,YJ/_A+]'6[NK.62YCNK6+SI
MXFM)2R)C(;A2,$ _D1U!KS^?2[J'POXQM;K1]3C^TZO%=669$:1R?("%2S'>
MP922N><8SD\:UE?1W>J:K>WNFZU#J][I_P!EB%QIS0QNJ!FV)AGRQ+,3D]!Q
MT- '2V'C?0=2A,UK<S-%Y44JN;:0"02'"!"5^9B>,#)SQU!JS;>*=(N4OC]H
M>*2P=4N89HF22,M]P;2,G=D;<9ST&37&2Z/JY^%GA9+?2Y)K[1FMI;C3I/D:
M81H4=!GC/S$CUQ1JNE3ZWX>N=1T3PI)874=Q:W'V>]189K[R7W&-L$X7' R>
MOH,$@'62^-=#MX=2DN9YX#IJ"2ZBEMI!)&A&0^W;DJ<'D9%,'CC0C>BT\ZY$
M[P^?"OV27_2%XSY7R_O",CA<US&I6PUKP?XAFT[PA>:=>76FR6B_:(%6XF=A
MP@ ).P'N<#GCO6C);W4GB_P;=K97?D6EA<1W$A@8")G6,*#QZHWTH Z"S\4Z
M3?Z2NI07#F!IC;[#"XE\T':8_+(W;@0>,>_2JLOCG0+>PNKRXNY(4M)UMKE)
M+=P\,C8VAUQD Y&&/!SUKAGT?64L+F_AT:XNC9^*+C438NNQKFVD5DW)G +8
M<D \\5?UZQ;4_!FI2Z5X5NK">]N;,^4\ 6XF\J9&9G"DX 4$#)SP>.1D ZT>
M,](==3\HW;S:=#Y\L!M9$D:,YPR!@-RG!&1QQUIFC>+[74]!TJ_DAN([B_@6
M5;=8'+'Y%9BHQRHW#YNAXYR:R+ZQO+WQ[JEQ#9W'V>Y\/?9(YFB*H9=[MMR>
MG##KQVZUE6^DO?\ A#PM9:CIVN:9>:?9^4E_:*?.M9D1%/RIN)1_F'(YV],'
M- 'H]C>P:E8Q7ELS-#*NY"R%#CW! (^AJ+4]5L](@CEO)2@EE6")54LTDC?=
M50.23_0FN=T77-6TVR\/Z?K^GW,M]?>8DMW#$JQ1L"2GF 'Y69<$@#@Y]*M>
M-)-1BL].:PL9;J/[=']J-O&LDT,6&R\8/\6<#(Y )QZ@ EF\:Z%;Z/=:I/=2
M16UI<?9;@M ^Z&7(&UAC(^\O)XY'/-0-X_\ #T<D<;SW:22S201JUC,#(Z+N
M(4;.>,8QUR,9KAKS2-6_X1/QGIZ:'J7F7NK17-JK_O6D3]P3\VXY($;9)..V
M<\5V'B2*XN?%O@^\@L[J6WMKB:6=UA;]TKPLBEN./F(XZB@"Y)XZT&.T:Z:X
MG\F*".XG86TG^CQR9VF08RN<'@\@#/3FK%]XNT?3]3;399;A[T6_VD00VLDC
M/'D#*[5.[D]L]#GI7&^-;36M4;Q;IRZ/>R1S6"KI[V@54G.P[C*V068,<!#D
M8Z YS6II\=Y_PL"RU*;3;V&V70/L[N\).V7S5?8=N>=HS^G7B@#HHO%&D7&D
MV&IP77FV^H,$M=B,6E<Y^4+C.1ALYZ8.<8IEKXLT:\CO7CN9%%D_E7(D@D4Q
MOD#9RO+9(P!DG(QG(KSRVM+S2_!GA42:5J(U6QU6XE2**$-(BEIF)\LLN]2K
M*#@C&[.<C!L3V<NJZ!K"Z7IVH_VXVHP:O/::C;&V%UL=?D3DC;MCQU)SUZT
M=M)XTT2"+4GN)YX&TV,2W44MM('CC(R'V[<E>#R,CCFF#QSH)NTM?/N1-+#Y
M\ -I+_I"\9\KY?WA&1PN3S7-7]N-9\(^(9[#P?=Z=>7.ERV:_:8%6XF=E.$
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M$<&LG3_$"ZA/K.I,\BZ9I<[VJ+$C.TC1@>8Y"@E@"2H _ND\Y&.CC<21JX#
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M4S2)/$6V;?F4$,'*CISG-64\4:TFI7%M)HS2Q?8GN8KD0SPQ+(O6)V=.XY#
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M/4,0.P W=^M '3VMW;7T GM+B*XA)*B2)PZD@D$9''!!'X5-7E'A#7M0\/\
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MXM+BR^V2S#(VJ<"/ _VOFQGLAH VZ*** "BBB@ HHHH **** "BBB@ HHHH
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M,\<Z #:Q(!#*2K=#T)QWH H:UX=N=1U/1]:M;F*#5=,+@;D+131R !T(SD=
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MO#$]^:=I/A+7-$O)[*RUV)?#TMP\ZV[6Y-Q"'8LT:2;L!22>2"0#QSS7:44
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M]=B/AU)C+# ;<_:(U+;O*$F[&S)ZXSC@8ZUO>)=?A\,>'[K6+FWGG@MEW.D
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MPS$;9V ^\3@GN1R?6NP^W2ZQX\NM N+BX@M;72XKE%@F:)I7D9@7W*0<*%
MSC).<\8TI/!7A^6RU&S:R?[-J,C2W40N)0KLQRV &^4$\D+@'O5JZ\-:9=W%
MI<O',EU:QF**XBN)$E"'JI<-EAQT)///6@#SR/6=>NM/T.";5KJ.:+Q/+I$M
MQ%M4W42"7#D8P3\@'ID'BNJ\(374/B+Q3H\U[<W=M8W4)MVNI#(ZB2%7*[CR
M1G./3-:TWA71IX-/@:T98]/F\^V6.>1-DG/S_*PW-\S<G.<GU-6++0]/T[4K
M[4;:*1;J^*M<NTSN'*C X8D# XX XH H>.KVXT[P'KUY:$K<0V,S1LO53M//
MX=?PKG_$TD^C_!B&72KN:S>UL[4120$ [<HN,X[@]N:[JZM8;VSGM+F,203Q
MM'(AZ,K#!'Y&L&W\,0W7A5/#6M1M=65NJ0HZS,GG1I]S=M(.X #/8D9]@ 95
M]%>ZA\3KC2&UC48+!]%6X\JWE$>U_.*Y4@9' '/7WQD5D>&_$E_JMCX)TW4;
MZ4?VE!=O/.KE)+AH#M5-PP02"6.,$[?0FN['AW31JYU7RY_MQMOLIF^U2Y\K
M.=N-V.O.>N>:H2^ O#<VA6VC-8-]CM93-;@7$F^%R2<H^[<O)/0T <[XJLY]
M/\+V=I<:K)J+1^(K/8\H^>)#.C+&QR2Q (^8\G(JT;R[/B/QW9F]N?(MK&VF
MMU\YOW+LDI8J<Y&2HXZ<5T,WA+19]*M],DM7^R6\RSQJMQ(I\P'<'9@VYFSS
MDD\TE_X1T74M1>_N;:1KB2#[/*5N)%66,9P'4, ^,G&X'K0!RGA_7+S6KSPI
MHUY>7"I/X=34[B1)3&]S*=B@%U(/&68X/.1VK$66\TCX>>*9;'4;J*>W\2R(
M)@_SN#<1H0QQGD,>>#7H,G@?0)+/3;86DL2Z8,6<D-S+'+",8*B0,&P1QC.*
M3_A!?#W]F7>G&RE^R7=Q]JGC^U2CS)=V[<3NSU /X"@#&NX+W4_B3J6D-K6H
MP6)TB*X6.WE$>QS*ZY4@9'W1[^^.*S=)U_5[_P +>!+N\GG>UO2R:E+!D2NP
MC;R_N_-@LN6*^G/&:[@>'--&K2ZH(YQ>RVXMGF%U+DQC)"XW8ZDG/7)S7)Z]
MX/BMH]&L-/\ #\]]HEBLI$%KJ+0W$,C8 *N\BY3&[*[QR1Z4 ;'@F'5EM]4E
MU.XO9(6OY5L%N_O"V!^0D$!LGGEN2 #4?Q.C$GPT\0?/(NVSD8&.0H<@=#@\
MCU'0]ZL>$M&ETE;I]E];6TP3RK.]O3=/$1NW-N+-C.1\H8CY<]ZW;^QMM4T^
MXL+V%9K6XC:*6-NC*1@CB@#@M6TX'QAX%LXKJZB5K6^S()BTF#'&2 S9(_IV
MQ5&S\1:E::5#IDE[),&\3SZ0+FYG*N85WLBF0 G<2%7=C//&#@CN(O"6C07.
MG7"03^=IRLEL[7<K% P ;.6^;( 'S9X ]*BD\$^'IM*OM,FL#+9WTYN;B.6>
M1]TI.2X)8E6SW!% '*>(X_$.@^#/%TK:V\?EPK<V*17+336P((93(ZABI8$C
MN.1GBKNJ0W^J?$*VTA=<U*SL[C0Y)V6UE"%7$L:AE..#SUY].A-;Z>"M!30+
MC1#:2O8W/^O5[F4O+_O/NW$<=,XJTGAS3$U>#51%-]M@@^SQRFYE.(\@[2"V
M#R >1U% &FB[$5=Q; QN;J?K7!7D5_J7CSQ!IC:WJ4%G'I<%Q'';RB/RW9I!
ME2!D?='U[Y'%=_64WAS3&U2ZU/RIA>7<(@FD6YD&Y!G P&P,9/0#J: .,T75
M[S7M&\)"XU&ZFO+K2VGFL[9S"TQ^1?.>52"BJ2>!G)?@'%9^F:QK6I:#\/9Y
M=8NXY;^ZEM[IHRH\T+'+@GCD_(/YXKM8_ OAV%=/6*RD0:?&T5MMNI05C;JA
M.[+)Q]ULCVI;;P-X>LXK"*WLI(DL)FGM56ZE C=LY(^;T)&#Q@D4 <5=+J<>
MF>/8$\0:L%T)FFL6^T?.I^SK+AFQEU#9&"<8)]L:J:KJ7B36'TD3>4ZZ/;7:
M".]>U8O+NW2 HI+!2%&#P,\@YXZ=_"6C.NJJUO,1JPQ>C[5+^^^7;S\W'R\<
M8XXJOJ'@3P[JB6"W-E(7L(_*MI8[F5)43^[O5@Q'L2: .7U2]\0Z1864NK27
M.K6=O9-%?W.C3E)H)@[#SS&""XPN".@*MQ5SQA?#^QO!>JV-R;ACJ]EY,X!!
MF252C>_S*YKIY?"^E2,I6&6$+;"TVV]Q)$IA&<(0K 'J>>O/6H;K04O=1TF,
MPI#IFD.)H(5QAY0A5, =%0,?J<=AR ;U<8UQ?-\1]9T[^T;I;;^Q8IXT!&(G
M,DBDJ,8SA1US79UE/X=TR35KC5&BF%[<0?9I)5N9!F/)(4 -@<DG@=Z //-#
MO]6CT?X?:S+K5_<3ZG<+;744LN8I$:*1ONX^\"@.[K^'%>L5@Q^#-"BL],M(
M[698-,D$MF@NY<1, 0"/FYX)'.>IK>H X2&6[\5W'BB%-9N-,N]-OOLUJT3D
M"W541A(R9 ?<2WWLC P,<U)97<WB?Q1XDTR6_NH(]-CMH[8VLK1',D>\S?*?
MFR2  <CY>G)K7O\ P3X?U/6O[7NK#=>,H65DF=%F Z"15(5P/]H&K5YX;TR^
MU+^T9(I8[PQ>0\UO.\+/'G.UMA&X>F>G:@#S[2=;US7SX#>[U.ZMGU 7T-XM
MN519O*5@'Z<$XS[9XQP:9<ZGK%OX-UB.+6;X2:=XE2QAG:0-(T)EB&UV(RV!
M(1^5>B/X9TA[K3+D6ICDTM2EF(I7C6%2-I 52!TXY'2JDG@C0);6ZMGM9S#=
M70O)E^V3?/,""'^_URH_(>E '*:IK.I>$]6\6QP7UU>QV^B1ZC"MV_F>7*6D
M4D<<+\H)4<<<8JY=/K>B0R^(K;4(IK!=,FE-K)>R7/VJ18S(CIN4;3\IR%X(
M/08KJ_\ A&]*.J3ZD]N\EU<6XM96DF=U>+GY"I)4CD]NY]:JZ'X*T#PX\C:9
M8F/>I3;),\JHI.2JAR0H/<#&: ,_1K*6]MM"U=?$-TT5Y:$7432%ENVDC# I
MSB(J0Q^0#CCM7%V#76E? D:C8:A>P70NN7$[-D&]*$?-G&0QSC!)Y->B:)X+
MT#P[=/<:79&%CNVJ9G=(MQR0BL2$S_L@4P^!O#QTJYTO[%(+&XF\Z2%;F4+N
MW;^,-\HW$MM&!GG% &?'=2^(/''B'1;BZNK:#3+>V\A;:9HF9I59FDRI!;&%
M4 Y P>.:YG3=:UW68_!0NM5NH)+F]O;.Z>WVH+@1)* ^,=3L!],\@5Z%=^&]
M-O+^*_>.>.\CA\@7$-Q)'(T?7:S*P+#//.<'D4C^%]'>33'^R%#I>?L8BE>-
M8LC:<!2 <@D<YZT 9'@6XNC)XBT^YO+B[CT_57@MY+A]\@C,<;A2QY."QY-;
MFOV-UJ6@WMK8W<MI>/$WV>>)RI23'RG([9QD>E+INAZ?I%Q>SV44B27LOG7!
M:9WWO@#=AB0#@ <>@K1H \FM?&3?;/#&N37-U'I;0?8M65YV,<%T0P7(SU#1
MLIS_ 'T/4UM:K)JFFV_A&7[?>Q2WVM(+F!I2PV2+(_E$GG"[57&<<>]=2WAG
M1GT^XL6L(C;7%U]LFCQP\N\/N/ON /X8J75-#T_69+.2^BDD:SF%Q!MF=-D@
MR WRD9.">OJ: .#@LTCU;XFR"6Y8QH H>X=E^:T#'@G!Y)QZ=!@4SP\UYI<_
MPZ\O4KR2'4].,5Q;R29BPMJ'3:N,*01C(Y/?-=O<>%-&N;Z_O9+5_/U"(173
M)/(@D4+M' 8 ';\NX#..,XIL?A/1HFTIDMY@=)4K8_Z5+^Y!7;C[W/R\<YXX
MH VZ\D%FD7A;XJ2B6Y=EGO(P)+AW&/LL9Z$D9]^H''2O6ZPI_!^AW,FIO+9O
MG5%VWBK<2*LO 4_*& !( !(P2!S0!RMG/>Z'XA\,K'?WMU!J&CSR36TLF4W1
M)$R%%QA3\Q''7OD\T_P])KFM:?X;\2PZK#%'<;'O@UX\D<ZN,&,1%0L;*QP,
M'.1@D]:ZU/#&DI>Z=>"&;S].C:*U<W,I\M" ",%L'( ZYZ"JNF^!O#ND:L^I
MV.G^3<.[2;1*YB5SU98R=BDYZ@4 =#7E$T>M7^D^-KQ/$^J03Z/?SM9[)%"#
M9"CA7&W#+VQTY)ZUZO7">'O"KSW_ (G;6M.NHH+_ %)IXXVN1Y<\6Q  R(Y!
MY4Y!'(.#D<4 9UK)JOB;Q5:6MQK.IZ?#=^'+>_DAM)!&8YFDYVG!QT[Y/;..
M*1M5U#5O!/B?Q%%J-S:ZCIES=_9T24B.$6Y.(WC^ZVX+D[@3\_&,#'=C0=.7
M7O[;$,@U#R/L_F"=\>7G.W9NVXSSTZU6E\):--=W5PUJX^V,'NHDF=8IV'=X
MP=K'@9R.>^: .1MVU/Q-XOELI]9U/3[:XT*UO3!:RB-H979P0IQD8P/<XZXX
MJGX:\2ZOJDGAC0]5NY3Y[7Z3W<;&-KO[.^Q &7!&?O'!!.WT)KH)-!N[SXG7
M>ISV=Y%8-I<=K'=0W0CRZR.S#".&QAAU'4=NM;UQX8T>YL;*S-F(XK%@]H87
M:-X& QE64@COGGG/.: .,-]XC2;Q-H=A(]\=,OK9K42W'ERSPR()'@$IYW
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]G:10,PZ$J@!/YB@#3HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** # SG'-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK975]-=79=0M"L:+(Y$RX5&Z,>> >QJ2/4+*6U:ZCN[=[=,[I5D!08ZY.<4
M48/#UG;Z[>:S%)<K>W<:QS-YN5*KG: IX&,G&/6L]_ 6A2>'FT.2&=[/SS<Q
MYF;S(I2Q;>C]5.XD]>YK=BU&QGM&NX;RWDMESNF252@QURP.*(=0LKFX>W@O
M+>6=%#M&DJLRJ>A(!R ?6@#'D\&:5/X>N-$G:\GMKD@W$DUT[S38Q]Z0G=V'
M?M27O@K1]0OI[NX%T9;FU%I<A+ET6XC (&\*0&(R>?>M^::*WA:6:1(XD&6=
MV "CU)-0QZC8S6;7D5Y;O:KDF=95*#'7YLXH R8/!^EV\NCRQFZ#Z.C1VA:X
M9MH8;6SG[V1@<] .,5OD @@C(/:H8+RUNFD6WN89C$=L@C<-L.,X..G%<WHO
MBEI=7UZSUBZL+=;*_6UMFSY?F!HT<#YF.6^;M^5 %NQ\':3IXAB@2;[);SFX
MM[-I2889,DY5?8DD D@'D 5HS:/8W&LVNKRP*U[:Q20PR]U5]N[_ -!_4^M3
M?;K3[9]C^U0?:L9\GS!OZ9^[UZ4^"ZM[G?Y$\4NQMK^6X;:WH<=#0!G0>'--
MM=&NM)M83!:73RO*L;8),C%GP>W4CV&,=*K1^$-,B_L;8UR!HR[;$><?W8V[
M,'^]\OR\YXK4FU73K=PDU_:QL9/*VO,H._&=O)ZX(XZ\TZYU*QLBPNKVW@*K
MO(EE5<+D#/)Z9(&?4T 8=IX$T.PUJ74[:.ZB,DWVAK5;EQ;&7.?,\K.W=GGI
MP>>M:.D:!9Z)+?26C3YO9VN9_,D+!I#@%AGID <#CBK<NHV,%U':S7MO'<2_
MZN)Y5#O] 3DT-J-BEPUN]Y;K.JEFC,JA@ ,DD9SC'- "W]A:ZI83V-] D]K<
M(8Y8G'#*>HJAI_ARST^6&82W-Q+;PF"WDN93(T,9QD+GUP,DY)P,FK8U;3B8
M0-0M29O]5^^7Y^<?+SSSQQ4Z75O)<26Z3Q--& 7C5P67/3(ZB@#/T;0+/0C=
M_8VGQ=W#W,PED+[I6^\W/3..@XJQJ6F0ZFEN))9XGMYA-%)#(497"E?Q&&(P
M<@YI]UJ5C921QW=[;6[R?<6654+=N 3S52;Q)I5OXBAT*2\A6_EA:81EP" &
M50#[DMP.^#0!4F\&Z5/%"C_:-T5]_:/F+*0SW':1L=2.F.F.,4R]\$:-J+:L
MUVEQ(=5$8NOWS#)CYC*X^Z5QP1^.:T-;U_3?#UM!/J-S'"L\\=O$&8 L[L%&
M,^F<GT )K'B\4M'XSU#3[RZL(]*AT^&\AN-VW_6.R_,Y;:1\O&,=: )O^$&T
M?SKR<M?-->6HM+B1[R1FE3GKD\G#$9[ \8JQ=^$-'O\ PQ#X>NX9)K"!46$-
M(=\>S[A5QR".QK6GOK2UM?M5Q=00V^ ?-DD"ISTY/%20S17$*30R))$XW*Z,
M"K#U!'6@##M_"&G6VGK:I/?LZS+/]JDNW><NO"Y=B20 3\O3D\<FM'3M*MM,
M^TM#O::ZE\ZXFD.7E?:%R>W10,  8%.EU;3H"1-J%K&1((B'F4?.1D+R>O/3
MK4D=]:37<MI%=0/<Q &2%9 70'IE>HH J:OH5EK1M9+E9$N+.3S;:XA<I)"V
M,$@^A'!!R#W%03>%]-GTB_TV03&+4"QO)/,/F3[EVG<W7[H XQ@  8%:*:C8
MR7KV27ENUV@RT"RJ74>I7.11_:-C]N^P_;;?[9C/V?S5\S'7.W.: %L;./3[
M&&TB>1HH4")YC;B% P!GOQ5*\\/6%[K=MK$@F2]MXC"LD4S(&0D-M8 X8;@#
M@]ZK0>)K#6+?5XM'U&S-U8L\.^5P8UD"*=Q .2@+ $\<@BM"&_AALK9KV^LQ
M,\(D9T<*CX7+,N3]WO\ 2@#(_P"$&T?^R#I6;O[&;K[84\]L^;OW[L]?O<XZ
M9HOO FB:AK;:M(MW%=2JJ7/V>Z>)+I5& )54@/QQ[C@\5O)?6DMD+V.Z@>U*
M[A.L@*8]=W3%%M>VMXNZUN89UY&8I PXZ]* )@ H    X %8MYX6T^ZU=M6A
M>YLM0= DMQ:2F,RJ.@<<JV.Q()%37GB32K#7+31[B\A2]ND9TC9P"%&.3GID
MD >O/H:N/J-C'>K9/>6ZW3<K 95#GZ+G- %*Z\-Z7?:1<:9>P-<V]S@S&61F
M=R,8;=G(((&,8QCC%)#X<M(O.=YKJ>YE@^S&YFEW2"+KM![>YQD\9)P*UG=8
MT9W8*JC)8G  JM#J=A<W'V>"^MI9_+$GEI*K-L/1L YP<CF@#C?&'AG[-\-?
M^$<T6UN[A%EMEAA5RS+&DR.PW$Y&%4XYSZ5T]KH=DLTMY,);N>X@$#27?S-Y
M779C  '//&3WS@5;34K&6X6WCO;9YF+!8UE4L2OWL#.>._I2V^HV-W-)#;7E
MO-+%_K$CE5F3Z@'B@#+T[PEIFF?9$A^T/!8DFS@FF+I;$@CY ?0$@9S@$@8H
MM_".E0:?JM@4FFM=5>22[CEE+!VD&'(_NY]L>U:7]JZ=Y\4/V^U\V5BL:><N
MYR." ,\D=Z==:C8V3QI=WEO \APBRRJI8^V3S0!C:?X*TG3M1L]0B:]DN[2
MV\<LUY(Y,9(.ULG! P,#IWZ\U&O@+1$T,:,BW:V F6=8OM3G85?>H4D\*&Y
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ML(A+>7<%M&3@/-($!/U)JO=7%P-2TU;>[LDMI2_FQRY,DPV$KY1!QP>3P>*
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M@U0EKRV@NG2*5SU<J#C<>_KWKJ:* ,&?PEIUPEQ$\MX;:ZC6*Y@-PS),BC:
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M.#E$\H1CJ"7Z8ZFK\M[;V&NW^D>-M5FL5OM*M8HI65#'<*(]LR!F1OF\PL<
MC.X&NZ\->')M#GU66XNH+HWU_)>J4@*&(N%!7)8Y'RCGBM]D1\;E5MIR,C.#
MZT >7V^HZ5X8\51V>O2S6^CW&APV^FSZCTVJ6\R-CV=@4)!P2% ["I[N/1]/
M\7?#J*RB6TA074=NDS$2"+R&" [CNP>, \\XZUZ2R*^-ZAL'(R,X-.H \_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+!LGOT(Q@@DQS7.N:CXC\3V2Z_<6L%IIUM=0"V2(['=920K%.4RHZC)XY'<
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M3>;&4^8J&XSSC!%:E>27[ZE:?\+(U73M5GLI=/N5N8UB1")&6VC;#[@<KQC
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M(5RH'&2??'>@#T]65T5T8,K#((.012UG:#"T&@V*-/+,?(0[Y,9^Z.. *T:
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M4$D\D<2A0T\ID<_4FKE%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)=0)=V/B:/[1 6&ZW O')+C^ 8/4XZU[6D$,<C2)$BNPPS!0"?J:!!"'+")
MQ;<3M&2?7ZT >80:EH%Q=^+- \6L/MMQJ7FPP,S++=0?*;?R2,%L;< *>#GU
M-/NXM*OO&?CT7Z6DICTFUPLQ5MA\N;=U[C(Y]_>O33%&TJRM&AD485BHR/H:
M#%&228T)/7Y>M '/^ Y5N_AUX>9G6;=IL"N2=V3Y8!!_K7EJZ1I%W\+]26R@
MMO[?BU>>.Q:(#SXYA='RU3N!@YP.,9/J:]SV[8R(PH..!CC-8'A+PW)X=T^2
MWN9;>YE:XFF69(=A DD9RO)/0MZT </?W.CW&M^*M \7ZK-8R7<R- FQ!]HM
M_+0)Y1*%BP8-PISN/ R35VPTG1+WXIWUI>6MO<L-%M&,5VJ.YD5WRSCH7 "Y
M/7\#7I+PQ2.CO&C.G*L5!*_3TI?+0/NV+N]<<T >8:5<W5AKVFPVL]EK6E7=
M[=&SEQMN["=ED9Q)CATR6!/!&1GM64CG4/A%9VL3!?%UM?H C$?:$O?M'SL1
MUY4LQ/3:2>E>Q+!"DK2)$BR,,%@H!(^M*(8A,9A$GFD8+[1N(],T >2ZA9Z)
M-JGQ2,T-B[1VD;+N"G8QMCDCT.[&3US7HOA.<7/@[1)O,$I>P@)?.<G8,\_6
MM7R8R2?+3GK\HYIRJ%&%  ] * /,KRYGT[Q)+/:SV>KZ7<ZU$MS8R#;=V5SN
M5 \9'WE& V"/N^V:V/BW' _PWU)YT4B)X'#$<I^^09!['!/(KLO(A\X3>4GF
M@8W[1G'UK&\8:#/XF\-W&D07,=L9VC)EDC+X"NK] 1UVXZT <C=Z1HT7C^VN
M-&@LDL#HUP-5\D+Y+(2OD[\<$D[B">2%/I7/V=G:6WP8\/ZM8V<#X-H-6FA0
M-*]JLH,J,1R5&!D>@/:O98($BAV>5$I;EQ&N%+=S4JHJC"J /0"@#SG6(+;4
M?&LUUIA@N+&709UU(QD/$_(,&['!;[^.^ >U<_I6EZ9<>%_AQ=Z-';_VVMS:
MM)-!CS3$$_?AR.=H48.>G [@5ZU>6/F:5<V=F(8&FC9 =GR@L,9(&,U3\+Z&
M?#_AZPTV1X9IK6W2W,\<>PR!  "1D]AZT >;M(EY\-/$^G:B0/$T=]<-Y><3
MM<F3=;LG?D>6%([# Z5<UZXOM+NM0OTN;+5=JVB:QH\XVR^8%3:]NPYR2P(!
M&,@XYKU(PQ&83&)#*!@.5&X#TS2-!"TJRM$AD7[KE1D?0T >.>-=6TZ2Q\7Q
MPRPV=S!J5JTT4K%KB9D:'$HR?W<87I@=B<C.*ZZ&^M9OC*6CN(F#^'4*X8<C
MSR?Y<_2NV,4;%B8T)888E1R/>E\M-^_8N[UQS0!6TS5++6=.AU#3KE+FTF!,
M<J=&P2#^H-6Z:B+&@1%"J.@48 IU !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(!)().!DG K3M[JWND+V\\4R X+1N&&?3BH]0U"TTK3Y[^^G2"U@0O)(YP%
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MY7:1D@@J5 !4C!QTSS3[SP9HVH:+=Z9>123)=S?:)IR^)6F&,2;AC##  Q@
M #&.*9JFOW6G>,]&TIEMA87UO<RR2N2'0Q!3US@#Y_TK?2XADMQ<)-&T)7<)
M P*X]<],4 <[)X'TZX\/W6CW5YJ5S'=A1<3W%R9)I%7D*7(X ]!COZG-E?"M
MI%K5QJ\-W>17ES L%PT;J!*%& S+MP6&?O8SVZ<5K)>VLMM]ICN87M_^>JR
MK^?2GQW$$TDD<4T;O$=LBJP)0^A]* .=A\#Z;;Z;H]A'<7@M](F$]FOF+E&
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M%%>-R"5( !&02/R-8GC73;Z_@T:>PMFN6T_58;R6%'57:-0P.W<0"?F'!(H
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M9\N1W#8QNR<#/(&,_G0!K6_C#3KB]TZ 172Q:GO^PW31CRKC:-W&#D9 )!8
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MNF(]G(7ODX[#!Y( .OHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:U.'7R,J!ER !GG(.3GI0!WM%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ^S)=*$>41[R!D'@9'/%;-8NK^(/[*UO1=.:S>0:I.\(F#@+&51GY'4\+_\
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MY2Y!R5'WB2HR2>@P,9.=>\\0?8_%>EZ$UFY_M"*:5+C>-J^6%)&.O\0]*VJ
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M/!?AU+(62Z5 +0#'D GR\>FW.,5H/HVGR?;=]LK?;E"7.2?WJ@8P>>F#CZ4
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MU^P8_P#$^\,1R6C'[QVJ,Q2CU&P@C/7::])L=*LM->X>S@$37$GFS$,3O?\
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MM[9I(_L>Z148!B[$J_)VG@<\<U;U.>[\,>+/$ TN>ZE_XIJ34!#/.\P:X1V
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MJ102&-5=9HG1VX8@X^Z.GK6':W,\$GA:VETR^@C.B"(WD%B[3>: @-N3M/E
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M6@#+M_$FCW5[':0WR--*7$7!"RE/OA&(VN5P<X)Q@U5/C?PR'5/[:M"6G^S
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M-XA\%:MINHRZ9'?W\/D)' S^1".[;BNYB<^@' 'J3V5% ')'P_JMEXJB\0V
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%G%W',@$80@8)7 4C^' [<UW7ARRN=-\,:38WLGF75M9Q13/G.YU0 G/?D4
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M2"[F_M"&-+/!N?./EF$$9!<-@KD=,]:CLO%.A:E?0V5GJEM-<S0B>.-'Y=,
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M=1-<VSQ220LHD"P*I*L1@X8$<4_X8^9!X-AT^XMKF"YLYITF6:%DP3,Y&"0
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M%_KMQB:)6;IM&5(7(/OTJ"'QK"T&HF:S9+BTU0:5'"D@;SYF"%<$@8'S\YZ
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M^*K74*RNH96#*PR"#D$4M '*^&/#%WX=\*SZ:UREY=D/'%)(Q \I1LA4G!(
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MN1D27<H"/PK9*') (QSV(!K:DU"./58-/,5P9)HGE$BQ$Q@*0""_0'G@5;H
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M5'(V]O6NDHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5IK=K+=WQBUIQ)> .@R<!?E^7CA0/PJQ<^'A%J,6N0375SJ-E9O;V\3R(J2
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MO7#@J5.#SD <YQ@'%++X(TEFTIK9[NSDTSS!#);3%699.9 Y.=VXC)/7/.:
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M(%>#SWC,Z2@X8?NU *$$'GD'VI;CP3I-ZVN?;3/<QZT$^UQ2,-N4 "%< %2
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MG]XV-Q&%&,X''3B@#6HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,%4GJ.O2N2UFRTW0]?\ "3P6EO!HE[=R/?2*!LEN##B!I#WR<\G^+!ZUGZM
M;2R^**VA5-'.G[D1?]6MR8'\T+V!/R$^Y]: /3M.N&O-,M+EP \T*2,%Z D
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M%M/&#)=K @98+8JI^[@C8)"I(QCKQ0![+#-%<1B2&5)$/1D8$'\16)KGB/\
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MH>M '923PP@F65$ 7<=S 8'K]*>"&4,I!!Y!'>O/[G2])U#XR7$5Y9VMPCZ
MDDD<J!E<^>PW,IX)QCDUH?"J3S?AGHI\S>%C= <YP%D8 ?@ !0!ULEQ!#_K)
MHTY ^9@.3T_.B:X@ME#3S1Q*3@%V"Y/IS7EQT/PUJ/B[XAPZQ;6C0QI;RGS
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M?09IS.B%0S*I8X&3C/&?Y"O/].N;34_'7B*W\001K!/I]K)8Q7J@#[,8SYH
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MU+Q%::SH6N/>7)L3$T%L(518<@CSD1 5(/ !YZ\8S0!W]%%% !1110 4444
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MUBN(UE42+M8 C(R.Q]JQK/QGI=[=V,,2W'E:A)+%9W+(/+G>/.X#G(^ZV-P
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M%NH+>4A 9OF('5@,9R<\ U0?QSHJPZ-*CW,R:PA>S,5L[;\(7P>.#@=.N>U
M&]'9VL4OFQVT*2?WU0 _G1;V=M:;_LUO##YC;G\M NX^IQU-8UIXQTFZT>\U
M)C/;I9W!MKB&>(K*DN0 FT9R3N7 &<[A6-I^IW5S\6[BU<:A;P#11*;2Y?Y
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MLSVD+/$\3E!F-\94^AP2/R-><Z>]U-=?$/3K;39KJ2ZOFBC(*B,LUM&N&)/
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M=(-Q7S1*3L)& Q7'?&>,F;2O%T^K>(I=+2XL;>ZM[J:*?3[B)EG6)0^R526
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M%'I.I+:76D7$\\4CV_F1$3;O,3R]PPOS_+AN,#K0 R#QK>>1?13PVS7BZ_\
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M#%WI>HZ]YUW=M$9+D6@5%6-PX5(PW'(Y)))R?;&A'X?N!XS'B&2^C8_8!9-
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M Z"JMGK-Q?V&BWMMILDD.HQI+*PE4?9E:/>"<\MSA>/7-'BO_D3];_Z\)_\
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M:Z?J%O<SVV/.2-\E<]#[C@\CB@#1HHHH **** "BBB@ HHHH **** "BBB@
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ML449D9L3HQX )X )_"HBT?\ PMY;SRG\@:#Y8G\EM@;SMVW=C&=N3CTKMJ*
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M'I7:44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %9NL:Q%I$=J#&9;B\N%MK:$'&^0@GD]@
MK$GT!X)P*TJYOQEH%]K=G83Z3<PP:IIMXEY:F<'RW8 J4?'(4JQ&1S0 V7Q:
M]C;WIU32I[:X@NXK2!%;<EV\N!'Y3D+GEL'(&W!]*&\626NK76DW^FF._CLS
M>P)!,)$N(U.&"LP7# XR".A!&:I:OX=U[Q+H"_VA<65IJMO=0WEDD!:2&*2)
MMPW,0&;=D@\# Q@'',\^@:EJ>L?VU>0VD-U!ITMG;6Z3LZ[Y""S,^P$#Y0
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MV%Y;22.;S4EV8+H3M4A@"#C!!'>L;XA 0ZIX/NX[0W%RFLJJ*F [ PR_*"<
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MEEX;\'VT;Z>]]H$X:16F<12IY;H2&V9!^;.,=NM6+CPKK<Q\;?\ (/\ ^)_
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M<BVBE@N0\R$DA7>(#Y4)'7=D9&0.UG1?%M]KFJ3V\'A^>.UM;Z:RN;E[B/\
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M8Z]I,6IV,C&UE=T1I4*$E7*'@\CY@>M:5>,VBW#?#KPF(+ZXM@_B;RW$.W#
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MT9W9^]VQQ5V2^UW4O$WB;3X-<FLK>TL;:YMO+MHB\;.LA()93D?*,Y&?0CN
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M5VAF R,$YX]\YSP =Q1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML!GZ42SPPE!++'&7.U0S ;CZ#UH P;?P5I$/@]O"THFNM*92FR=P64%MW#
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M+%D9"*RKD^F2PQZX/I0!GW/A&PO-(U/3YYKEO[4_X_;C<HEF^4+@G;@#:
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M231HKG"EF W'V]:EH JZE8IJ>FW-C+))''<1M$[1D!MK#!QD'M61=^#=+O\
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M!)(+*=HQE64_CS6[)/#""9940*-QW,!@>M2 @@$'(/>@#%F\,V4FKZ5J*/-
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M]E%##<,L)MV))0D>6K;O^6AST''(JL_B*>/QVFB.ELM@VF/>BXWG=E9%3![
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M62Q@)^6,4+I]DK(RVEN&3[A$8RO.>...: +%>*:Q;V*_#SXEQ". 1Q:T[(H
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M.FQ2R'[ GB^)--9V_P"747/[O!/5< X_V<=JV-6$]OX[\8-HRJNIMX:22(1
M;FFW3;3[M]W]*]%EM+:X55FMXI%7[H= 0/IFA;.V2;SDMX5E_OA &_.@#A?"
M=QX/UI?#UWITD,NI0V31&&&3YXU9!Y@G4'/WAC+?Q'CKFN3$-@/AC;.\=O\
M9K;Q5RS ;(X_MW/L%QC\*]EBLK6!IFBMH8VF.92D8!D/^UZ_C2+8V:PO"MK
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M_+0+N/J<=30!-1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU2UCCLF#Q_OF6 QG^+CYCWQQ0!T]SXFL8<>0D]X?L@O6%LH8K"<[7P2"<X.
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M=/91B6[%M&'\A2"03R,G )VKDXYQR,UI_&VC13Z;#$]Q=-J4#7%H;:!G$RJ
M3@@<GD<=L\X%9ME9ZIX>\6^(KC^SI]0L=6:.Y@>%DRDBQA&C<,1@':"#TQUK
M*T3PGJ?A^^\#6WV62XATJTNTN[B-EV(\VT@ $AB 01P.F* .WT+7;/Q#IQO;
M,2JJRO#)',FR2*1#M96'8@BL3XA:M>:+H=K>0K=?85O(QJ4EH,RQVV#N9<<C
MG:"1R 3C'4/\#V%_I\.N+?V4MJ;G6+FZA#LIWQR-E3\I./H:UM:NM2M#8R:?
M8/>QFXVW44;(K"+8_(W$ D-LXSS0!D^';FRN))-8TOQ"]_H+6Q^66Y,H@<')
M)9OF'R]0QXQVS5N#Q3IU_?6FFE;N!]1@>6RD=-@N$4 L4(.5(!!^8*<'-<BW
M@8W^N:_<:382:)8:GH\ME.C@(L]P_P!V01J3C:,Y/&<\=S6_X6U'Q&]C:66J
M^'I+*2RAV7$[31NDY5<#R0K9Y.#\V .G- &/X"\8PQ>%M MM4DU":XO9I;<7
MLT;.C2^9)M1I#U8@8';C'%=/J?C#3-)66:Y%Q]B@F6"XO$3,4#D@88YSU(!(
M! )P2.:XNRT#78/ WA/3WT>X%WI^LQW5S&)(ODB65V+9WX/##@<U8M=&U+3=
M7U?3;CPA::M!>WLMU::E((BB+*VXK,&^;Y23T!R.E '0>+?$$46B:[;6GVU[
MBSLV>::SX-LQ0LI)R#GH<+D@<D8(R>%_$43:9X=TNY-Q)J-UH\5VKO\ -YH5
M$WG<3][+#KZUAOINNZ1/XQTY-'GO[;6C+<V=U \8"L\(0QN&8%<;1C&<C\J+
M+3=:TJ[\&:@VB7,YLM(?3KN"&2(O%(1%AN7"E<QGD'CB@"QXK\0KJG@^#4])
MNKRV,>KP6S[6,39%PL<B-@\CJ/2NEU;Q19:.EV\L5S/'9()+Q[>/>+=2,Y;D
M$\<X7) YQ@BN%_L#Q ? D^G-HTWVPZ_]L$:31D&+[5YNX$L/X1WP?:K]WIFH
MZ;XQU:XD\)1Z]I^KF.:*3,.^VD$:QLDGF'[IV@Y&<<\&@#T"WN(;NUBN;>19
M()D$D;J<AE(R"/PKE_'%W?6+^'9+.^FMUFUJUMYHTVXEC9CD$XSV[$5TUE";
M>PMX&CAC,<2H4@7;&N!C"CL/3VKF_'%C?WZ:$MA8RW1MM7MKN;8R#9&A)8_,
MPR>>@H V]6OY+2&."T57O[EO+MT;H#W=O]E1R?P'4BL3X;WMYJ'@6RN=0NI+
MJZ:6X#S2'YFQ/(!^@ QVJWJ_A:/6-3CU$:MJUA,L'DA;.=4&W)8\%3R3C/K@
M>E<MX=\/ZYX<^'?]F"+4I[^\G>*1//C;[)$TS;I$.0,[&W8!)+8Z4 7-#\4:
MA+\0)K2_8#2M8MC/HQ]H6*N/<NI$@]B*[VO/O&/A"6#2M-OO#-I>SZMI5U%-
M9P/?.R[ 0'3]X^U5*9''H!77PZC>RZC;0-I%Q%;RVYE>XDD3]TX( C*@G)()
M.1D<4 :5<%XL\4:AH_B?3;F%@-"LKF.UU5O]J<80GT"?NR?^N@KN+F5X+:26
M."2=T4E8HR SGT&2!^9KBSX-AUGP9=Q:O!J"7^H1/+=PK>/@3/SP@?RR%. .
MV%&: .YK&UKQ/IV@75C;7OV@RWKLD"PP/)N8*6QP.N!P.I]*K^"9=:?PI8P^
M(+&6UU."(13;W1_,*\!P5)Z@ GW)K)\<3/;^)O!4J023E=2E_=QXW$?9Y,XR
M1T'/X4 :NF^-M'U.RO;A3<V\EE,MO<6MQ"4FCD8@(NSJ2Q(QCKFH[CQSI-E%
MJIO8[RVFTN)9KFW>'=((V!PXVD@KP>0>,<XKF-;\(ZMJLWB#7+.SC%U<75C/
M:V-T5 N%MN2).H&_<P /8#.,\6-1L+[6?!>O)9^#$TF[N[![6.']R)I78?WE
M. @]SDYZ#'(!TEMXQL;MUCAM-0,LL@CMT>W\O[1E#)NC+D J%!R<_P QFS_P
MDEF;:T<17!N+N22*"TV 2NR$AQ@G  VG)) Z<\BL;7=(76-#T>TU#1[UT10S
M2VTH2XL957"NI#?4?+GJ.,5CVFB^*+&[\,ZW?";4I=/-W;7$9*"<V\K?NY#R
M%+@*FX Y.>Y% '27'CO1;71KO4YVN42RN!;74)A)D@D)  8#@ [AAL[3D8-7
M--\36.IZQ<Z4D5W!=P1+/LN8#'YD1) =<]1D$<X/M7$^(/"^K7VE^+KZUTZ9
MKK6[FS\BTWH&6. IEV);:"<,<9SC;WR!T<=G?O\ %#^U383)8-HXM?/9DP)/
M-W[<;L].^,9H ZRBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBH;JZALK.:[N'$<$$;22.>BJ
M!DG\A0 ])HI)9(DD1I(\!U# E<C(R.W%/KR70M7CTKXB65])J"2IXIA*7<0E
M#?9[E26B4^G[L^7[E<UW%WK-_=:]?:+H_P!E2XL;1+B62Y1G4M(6"( &7^X2
M3GC(X] #HJK6NH6=[-<PVUS%-):R>5.J-DQO@':?0X(KC)]2\22^,_"EK</;
MV'VJQN)[FSV&4+*@0$;@XW??./3GKV@O_&>JZ?X?\9ZA%9:>+G1;LQHN&VR+
MY:-N;N6^;';I0!Z'17*6FOZO%XT&C:G#9M!<:>]] ;4-OCV.JLC$G#??!! 7
MZ5DVOC;6+VQ\,:A;V]BT.O7#0B J^^WP'8$L"=V A#<#!H ZWQ#:Z1=Z'<IK
MJQ'3D7S96E8J$"\AMP(*D$9R#FH](T'3;#9<VLEU<EES'+=7LMR54C^ R,V
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M"] ?M$F<>U9]OXGU#1KKQSJNK7<5Q9:3,H2".$JV/)1E53N(&2V#D').>.E
M'HE5+W5+#36MUO;R"W:XE6&%9'"F1R<!5'<Y/:N>G\0ZKH^LZ';:LEI+:ZNY
M@#VR,IMY]NY5.6.]2 1G"\CISQ7^)1D&E:(845Y1KMB45VV@MYHQDX.![X-
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MPPLRLHNMG'S \XR?7)Z9S5ZY76/^%K72:?)8_;CX=AW2SQOY>?/D_@#9Y/\
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MT5AI_P!IL=9>Q,:[@CCSECW>[$MG/% 'HM5+'4[#4Q.;"\@N1!*893"X8(X
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M0J3@9&2/I4VM>%/[<TN.*YU"1=0ANH[RWNT3B&9/NE4)QMZC:3R"><\UT=%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY&.6&#G'7MCG4G\1ZKI.I:'%JD5HUMK#_9T>!6!MIRA95;+'>IP1D;>1TYX
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M_M([^*P>YB6[E1I(X"XWLJD D#T&17&W/CMXDT5)Y;+37U/34NHI[Q&,$DS
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M$^H?;=2L-)@1KO3X(W='M99A+*ZEA&"F G&/F.?O=..0#K6941G=@JJ,DDX
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MR\[>O-2Z: /BYK_'72K/_P!#FH [*BBB@ HHHH **** "BBB@ HHHH ****
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M!R?E''/2K1\+:,8M2B-HQCU(DWB^=)B8D8.[YO3CZ<=* )M &?#6ECULXO\
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M/C\JR(-KY1,308&!L9""O'H:JMX&\--:3VQTF'RY[@74F&8,91T<-G(;W!H
M\Y\0/=7'@/Q_97LLQ2PU"/R(_M;R>4&6)MN\X++EB<'@9]A767SRW7C23PNE
MU)'!'IBW$"O>S))*S2.KMO#;F*[5QD\9^F-]?!WAU(M0B72;<1Z@@2Z7!Q*
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M.!^)Y-5[3PYI5E/%+!;,&A=I(E:9W2-VSN958E5)W-R /O'U- 'G=OJ>H?\
M"N] NVU*]^U?\)$MNTIN7W/']M9"C'/S#:,8.>*N2:9=ZWKGCBU?Q!J]LEC)
M"UH8;QD$+&W#YXZKN)^7I[=,=6_@7PS)),[Z3$QFN!<NI=MOFYW;@N<+D\G
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M-Q$,L1&YSG:,\#D_*..>E69/"FAR'4BVGH#J61>;79?-R &S@\9 &<=<<YH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MVB[B%TJRY*ABL2$?O"%8'^'K@9.0%D\;2RZM/INF:)<WDR6$=_&QE2-9(W)
MY)X^Z>HSGMCF@#K:*SM UFW\0Z!8ZO:JZ0WD*RJK_>7/8^X/%8^DZ@=>\8ZV
M'YM-'DCM8$[&8IOD<^XW*H],-ZT =317&0J8OC)<(LLQC?0ED*/*S*&\\@D
MG"\ =,=*RX<^)YO'%W=,P?3YWL;!@<&U,<0;>A_A8NV<CG@#H* /1Z*\Z'B:
M>/P9X7\9R?+).;:+40O"R1RD(Q(]5<AAZ<CH37<ZO#'/HU[%*H9&@<%3WX-
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M;T!(7#@$'!XQWJ'PIXLN?%,%O>1Z'<VNG3P-(EU+,ARZOMV;0=WJ<XQP?8D
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MIBLCNC.VY@$P =_8\8Z5U=% '/\ @C1[WP_X-TW2+_R3<VD7ELT+EE;D\@D
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M@X(Y!QD5#J?@K5+G3-2>W%F=1U+5H-0F5YF6.-(F3:@8*23B/K@<L?2O0:*
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M3,MMJ6FXGBGMW DMY222 2"#PQ4@@@UL7'A#3;S3-6LKUI[EM54+=W#L!(X
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M97 *]P1@AB#Q0!ST>K:MKR>)Y-.U%K)]'N7M+:/RD82O'&K%I-RDX9FQA2O
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MEQLI"*3U1F#J.Q!!]* /6\C.,C/I2UQWA[5M.OK*[\=7@CLK:YA1(Y;@!#'
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M[V>&>WC<-&)0Y+E".JDDGVY':N4 M-3TKX@QZ\L8U&VNYRCR<210",&W9#U
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M;.V1?8[6!'8J1SP3R4&AZ+9^-M%U/PB;6%;D2#48;!E\F6W\MBLC*OR@B38
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M:Q2F98+NX^R079C_ ',DV2-@;U)! .,$C@FM74-0MM+LGN[R7RX4(!."222
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M;QK*,2*D2@./? YIUI8VEA#Y-G:P6\6<[(8PBY^@KG;'X@Z#?WNG6T;7<?\
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M'5D R21QE?O#/2J^G>/-%U.?2X[<W834U)M)Y+9UBD8*6V!B,;L G'L1UXH
MW)-,L)1()+&V<2/O?=$IW-TR>.3[T+IMBDPF2RMEE"[0XB4,!C&,XZ8XK'\,
M^*#XBNM7C^PW%NEC>O:J9$QG8J9SSURQX],4[6/&6EZ)J1TZX2]EO/LS7*PV
M]I)(712 =N!\QY[=,'.* -6/2]/B1$CL;5%C#*BK"H"AOO <<9[^M-_L?3/+
M6/\ LZTV*=P7R%P#ZXQ6;J'C'2M,ADN;C[0+2!T2YN5A)2W9L8#]Q]Y<X!QG
MG%6+[Q'96,MQ&$N+EK:,37/V:/?Y*$$@M^ )VC+8YQ0!IS00W$)AFB22(]4=
M05/X&JYTG33$L1T^T,:DLJ&%< ^H&*S[3Q9I=[/I$4)FSJ]LUU9DQD"1 H8\
M]B R\'UK-UGQ1HMWX5U"ZFO-2L[6WN_L<\MJCI-%*LB@J" <#=A<]#GKS0!U
MC11L4+(I,9RF1]TX(R/3@D?C4-W8VFH0B&]M8+F('<$FC#C/K@UBZIXUTK2=
M5ETR:._FO8H%N&AM[.21C&6V[A@<C/4C@8]>*DO_ !?I>FMNN3.+1;@6LEX(
MR88Y2<!6;MR0"<8!X)!H W54*H50 H& !T%9UMI$=GJ5Y<6Y407S>9<P,N09
M-H7>/J  1WP#P<YP_&?B&.W\.>((;*2]^U65F[2SV:_\>SE"R9/KT) R0""<
M YK9\/3R2>%-*N)FDED:QA=V.69SL!)]R: +MI86>GQ&*RM(+:,G)2&,("?7
M JM8:4MM?W>HS,)+V[VJ[@<)&N=L:^PRQ]RQ/' &-H/C:VU3P[<:S>V\UC!%
M<20CS$R6Q*T:J,9W.2 ,#N<#-:MCK]G>ZI-I96:VU"&,3-;7";6,9. ZD$AA
MGC@\'@XH U:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *Y?QUIU[J&DV#6-L]S)::G:WCQ(RAF
M2.0,VW<0"<#IFNHJK>:E8Z>8!>WD%N9Y%BA$L@4R.3@*N>I)(X% '':IX?O?
M$6J:WJL=L]L)]!ETJV2?"O*[DL6(_A4':!GGEN,8)I:=;ZW<ZOX&GD\/WMO#
MI=M-;W;2O$"C&)$R &Y7(Z]3Z5Z110!YWX;T74-+U^RN=-M=0T[3IHY7U32[
MA@\$,A7*F#DX)<GA3C'7!P*SH=$UI/!FEV3:/=?:8/$8OI(\ID0BZ:7=G=C[
MI''7->JT4 >:Z[X<U?6M6\9);6CPKJ%C:)9SS8\N22%G8J><@$E1R.YJ[8I-
MJ6FWDTOP^AL;E+*6*6*98=URQ7!AC93]P\Y9L#IP>2.]I&8*I9B  ,DGM0!Y
MM9>'KRQM=6T^*RU'4O#,UK&J:9J#@RQN7P\<3$YVA.1DX!Q@]:W/!>F:EI-U
MJ5N]S?3Z*!%]@_M$YGC.&WID_,4'RXW>_;D]+8ZA9:G;_:+"ZANH-Q3S(7#K
MN!P1D<<&K- '%ZI;:KI7Q'@U^#3KC4=.N=-%A*EL5\R!UD+AL,1E3G!QTQ6#
MIUGXFT_3(8SH=ZMO)KUW<7:0R1"<P2,Y0QG?\HR0&((.,X.#FO4J* //_#OA
M>:[\/>*M"UC39;.VO]0N)8F>17RDF"K*02<J0#D]QWIVB65_?> +F\UNR35[
M[4(4CE@C; G@7"+M)(^\-T@Y&#(:ZO6] T_Q!!!#J"S-'#*)56*=XLG!&#M(
MR,$\&M&.-(HUCC5410%55&  .@% '(^#-*U+2+[4;?[3?S:%LB-BNHG,T3?-
MO0$_,4'RXW>^/4GB*/6)_%$,*:;<76D26#H&MI$C(N"W25BP;R]N.!D$YR#Q
M7176M:78W<5I=ZA;07$S!(XY)0K,QZ#![G!QZXJ\3@9/2@#RVVTC6X_ G@BP
MDT6Z%UIFH6LEU&&C)2./(9OO8[\ <^U;=YI.HS^.=5E6SF^Q:KHT=HMVK*!
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MQC)&_&W/. 2.OKY (P>E<U;>"M"TQ6\HWD5DF6^R-?S?9E'4_NRVW;[8Q[4
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M5Q@CIR*S[/QUKTNC:1K-Q8Z<MG=:I_9T\<;.9!F=H0ZD\#! R#G//3I5_3?
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M(AD+,BPD0M( H X48_I[UJQ>$9?[8N]9ENK1=2N+ V326]H463)!\QUWG<>
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MV*4.(Q@K@L6Y;IQDUU^'URFB36"ZYF4:Q_:UM,]H"(W\WS-KJ&&_))!(*]L
M59N?"&KQ>(IM8T;Q']ADO8XTU".2S69)F1=HD4;AL;''<=.N* .FL[F>]TF"
MY-NUI<30*YAG&3$Y7.U@,9P>#]*\UT/5)-,\,:EJ.IQ6=_+_ ,)#/%:1M"0?
MM37!C5MQ+;0,]AD =37I\,!M[2.!)&8QH$#RG<3@8RWJ?6N/3X?&7PMJ&B7N
MJ"3[3?/?PW,%OY;P3-)Y@(!9LX;].* +<OB'4].\3Q:%?1VDTM[:27%C<1*T
M2L\>-\;J2Q'!!# ^V*/!.N:[XDTJSUB_MM/@L+NT$D:0LYE$F[G.>-N/?/\
M2RGAZ\N-3AU74;ZVGU"UM9+>U:.V*1QE\;W*ER23M48R,#/KFK'A/0I/#/AB
MQT62[6[^R1^6DRQ>7N7MD;FY_&@#)%]J[_%>73?MD']GQ:2ERL/DG/S2LIYW
M?>^0<XQCC'4GEO!NN:IH7@[PRRV]F^EW>J26+@EO.!DN)0'!^Z #QC!R.XZ5
MW-SX=N6\9+XAM-16$M8BRE@>WW[PKLZD-N&.6(/!R.F#S6-!X NX/#&CZ,-9
MA/\ 9NHK?K,;(_O")6D"D>9QRQ&<],4 .O\ QCJCI?W.B:>;U;&\-J;06LK/
M<;&"R%91\B$'=@$'.WJ,X'1^(-2N-*\-:CJ=K#')-:VLEPL<Q*@[5+8..>U8
M*>#=4L=;OY]*\1/::7J4QN+JS-L'99&^^T4A/R;OH<'D5T6MZ:^K:!?Z7%.M
MN;NW>W\UH]^P,I4G&1G@^M '*1^*_$1O_#L+6FF&/7K5GA 9P8)%C$A+'G<I
M!/  .>,]Z=:>.+M-,NDU"W@_M*'63I"FW1VC=]H<.%Y;&PD[>22N,C.1>3PC
M=K=^%ISJD)_L*)H]OV0_O]T?ED_ZSY>/KS^549_A[+<V.K12:R8[F[U0:K:W
M,%MM:UG 4 X+D,,+C'&<G\ !Y\8ZGIZ:@-3TUB([BW@L;I+:6%+EIF"X\MLL
M"A/.,Y'3TJGKGB7Q+;Z%XGV0+%]CTYKJTU/[%)$C$ [D*.<AQC(.2.<XXQ6I
M=>#[_6O#US8:]KKW%[*8VANK: 0"W>-MR,J9/S;ADDGGIQ4@\+ZKJ'A[4M-U
M_7_MTMY:26BRPVH@6-67!;8"=S=#G.., #G(!5.L:A87/@VTN8;*Z&HN8WN"
MC!XR(&<%02><#!.>YXK-O?'/B&VTCQ)JB6&F>1H6H-!*A=RTT:K&QVGC#8<G
M)XZ#'>MI_">HS2>&Y9]8A>71I#(2+(@39C,> /,^7Y2?7GVXJI<^ [JYT+Q/
MI;:Q"%UVZ:X:069S#N55( \SGA!SQWH T+_Q%>-XBN]&TY+>.6VTT7YDNE9A
M)N9E"@ C &TY;GJ.*N^$M9N?$/A>PU>ZMH[=KR)9EB1BVU2,C)(%<+XHGBD\
M7M;WOB'2M,EM;*.!5U73@\5R6RSM$6=>#\JD;FY&,<<]%:2^)[F#1)([RW18
M[EDN$AL"L=W;@@!QN.8<#<0.=QQCB@#LJ*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *J:G=7%E
M8//:V,M],I4"WB=59LL 3EB!P"3^%6ZY'XF3W-IX&N[JTNKBVGBFM]KP2%#A
MID4@D=B&(H V=5UI=/N[2PA@-SJ%XLC00;P@98P"Q+'H.5'U8>Y%K2[V34=,
MM[N6SN+*25<M;W  >,],'!(KC]>T^&?XL>&F=[D&2RO6.RYD0 KY., ,,#U
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M 5E_B SD9Z$#'?(!WU%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_'RY<X.>]1^'UTZXMX/#?B#3-7EUZROVE6(FX$,CB5G6X5P=@7G<23UR,$D
M^LT4 >.:I$LO@GXE1QP,UQ=:E(T"B([IALCVE>,L-P;!'H:ZN"<1_%<7)BG:
M"]T.&."5(69&99G+ L!@8# \XZUW%% #9'2*-I)&"HHRQ/0"O)-,T^Z;X'6R
MV&GR/?VLHEFM40QS2(ET)'0=&!95_'BO7:* /*-8CT_Q-X<US4_"UAJLVJ2:
M;]FEFN?/1F0.&, 63AF(W_=SC.,_-5\Z]8>(/'O@FYT^*X2)8KX$36SQ;#Y2
M?)\P&2.^,BO2*Q=1T W_ (ETG6?M9C;31*$A$>0_F *V3GT QC]: /,1<-!X
M)M]&:TO6O[+Q(LMQ$EK(VQ/MID#9 P05((QG/X&NDGE0>-?&4I5Q'+HT"(QC
M(#L!+E1QR1N7CKS7HE&1G&>: /*FMYK?X4>$KRTT^XE_LXV<FH6]LA2<QHI#
M@ 8;<K-NQZC-,UR"QU/P[J>M^%]-U*Y\V>SEOWE$^^\BAD!:-4EY;:HY(&#T
MYY ]8HH \_LM5M-6^+%CJ-C'<RVLFA2P^?\ 99%4,9HV"DE1C@-U[\=:[J[1
MI+*=%&6:-@!ZG%344 >0:1)=6_ACX>WS6MW]BT:3RM3B:W<&)S"T8<J1DA&8
MY(SC/L<=?X?M6F\?^(-;M"?[,NK>VB#@?+/,@;<Z^H"E5R.#R.U=A2 AAD$$
M'N* .5^)=I<7WPYUNVM;>2XG> ;8HD+,V&4G ')X!K%UFP'B3Q)IU]X:VJ;7
M2[R&2[C4HH,B!88LX'(;+8_AQSC(SZ+10!YGX0ET;5CH,$VDZO'KVD($>*Y^
MT*EFP38YW$["IQ@ 9SD<#!(]+9E1&=R%51DD] *6B@#QB"&/_A5>A6[VK>:O
MB!)986A.X(+QF+,N,XV$')[&M'Q-<B#Q)XON$TO^THI-)LU$)B9DE997W'Y?
MO;%8,0#G [5ZM10!X[J4>HZGJ/B]-*?4+FYU'0(5MKB2U:(2D&7<J_*H'!P,
M\\]3UK4.LV6L>)O -S8VEVJ6QN$F3['(#;$VY78WR\8; ].AZ<UZ=10!Y-X8
M73KFSTWP[KNF:O)XATR\$GE,;@1>8KDBX#@^7MP2W)YR1@Y&?6:** /&YKYK
ME=#E%A>VAM/$Q>?3X+&0I;@M+\Y;:2[-N#9!Q\W XK8A^UV'BJ-M&NGN[*ZU
MB07FCWD/SVS%VWW$3]0G!;G*G=@')Q7IE% !7D"VUU<?"G4?"-W!*?$JW,J+
M&4(:65K@R).I[KR&+]!@YKU^B@#B _E_%^V\QF8+H+0--M.TRF93MSTW$ G'
M6NWHHH \@5;^'P9?0PV%_+-IOB.2\N[:*)T>2 7+/^[/&XX(<;3V^E3Z_P#V
M'JW@KQ5JFA66HRSWFGBW>XN%GW3./N1JDG+$9/('&<9/./6** .#5H?^%E>'
M9+=<0#19X2Z(0JDM$50G& ?E; ]JZCQ+:3W_ (5UBSM<_:)[*:*+']YD('ZF
MM2B@#GO ]Q$_P]T"4$*BZ; &SQM*Q@,#]"#^5<WX7TUM:^''B'1P6BFO+C48
MU\Q2I EDDV-@]B"#7=6.G0Z<TRVQ*0RR&7R?X49CEBOIDG)'3))[FK= 'F9M
MKC7]&\#:.L$L=WIMW;7.HHR$?9OLZ$$,?5GP%]0<CCFMB6&2?XT6\L0.RUT)
MA.PZ?O)AL4_78Q_"NTJI9:?#927$RDO<7+AYIF^\Y P![ #@#^I)(!;HHHH
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M/F%U;(RG*_+C/'7.*SX=#M]*^&5UX<\475G;F7[5(K13[B=TC2AD!"DLI9>
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M** "BBB@ IB11QERB*I=MS$#&X^I]:?10 4444 %%%% !1110 4444 %%%%
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M%I]W<P'3[*VM9X"$"; XD+%F)Y^Z.>!0!U%%9D/B+1IXYY(]4M&2WC$LS>:
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M?033;/,"(X)*9 W#U7) STJ]0 45FKK%C>2/:6.HVS7A1F1<[^%."V,C< 2
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>5*&+_W1DKDGU%,U2\TA&\4>&]0U,VEM>:R+IYY[:;S(\&-V"D(5(RF%;<,
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MK*'0$=<;AG'(S7:Z#H<ND1R/=ZG<ZG?2A5DNKA55BBYVJ H  &YCZDD\UL4
M>9Z!<Q7?Q(MYO,N+NVNO#XA64V31PY$N2B@KPH!_B)ZXR363)I>MZ?HDD<%O
M,?\ A"KUIK(XR;R$D-L!Z\0.RD#J2/2O8J* .$US3A_8>DM=:C/H^J2WS7<=
M[&H=;>X9'.V0'@H%)CYQT S6QX)N]0N_#Y?4[>WCN$N9D,MLI6.Y <_OE!Y
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MVUBK8_V<]J["B@#S/Q++;:YX<O\ 6?#6FS3HUW9W%[(ENZ/?1Q."R!6 +;5
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MT4 >8>$9Y],U/3;6UOUU+P^UG*\?VF/;<Z2H"D1R-W4\* P!^7T%9.D)';^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5GZOJ\.D16Y=&EGNIUM[>%,9DD;)QD\   DGL
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M9\R-NCKCGL>#QQ5[QAHNJZA_9>I:%+;KJFEW)FBCN21',C(4="1R,@\'U%/
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MB*;4;9(_+NM/E6.=5D$B'<,JR..&4C/H000139?$[QZ]J.CC3I#<VEF+V/\
M>*!<QDD?)[@@@YQSCUS5W17UJ:!Y]:AM;65\!+6VE,JQ@9R2Y49)STQ@8'O6
M7XG\,3:UJ^D7UK.L#0-);WF?^6MI(OSI]253'IDF@";2?%<>LZ7HE_9VC.FJ
M@NJ"0;HD )+-]#A3CHQ ]ZYJZ\5+I?@S6]3T#1VM9DUE[:X2>49$S2JCR=6!
M.YN #C^5;WA?PK)X?U35Y3*KV<EP[Z?"/^7>.3#R*/3,F>/116'-X.UNX\'>
M(],*VB7=]J[:C;#SB4*^>DH5CMX/R8Z$<T /O+FZM?BQ!<0:9+/>2^'Y,VR3
M*!N$Z=6)"@8'6NN\.:Y!XDT"UU:WBDA2<,#')C<C*Q5E...&4BL=-*UEO'EO
MK\UM:B!=*>S=([@EA(TBOQE1D#;C/'KBK/@71[[0/"L&F:BL(GBFG?,,A=2'
ME>0<D#^]C\* .<U+6]0UO1O']E>62Q6^G0S11,DN2N+<."<8.26S[=/>M'PO
MXG:./PYHMUIEQ +S35>TN6=")3'&A8;0<KP01GK[5%<>&M;5O&MO!'9R6^N*
MS6\C3LK*[0+%M9=O !&<Y/';TDA\.ZPNI^"[AH;81Z-:R076)R22T2IE/EY'
MRYYQUH -,\3Z/I^DZK>P:<]A_P 3M[29)Y0-]RS*I=FR0JDGL3P.!VKJ=.O)
M[Q)_M-FUM)#+Y>-^]7&T'<IXR#N_0UR5CX;U:WTK6K6[TW3KR+4=8EO'MI9=
MR26\F,J<KPXP".V<<CK6KX,\/3>'+*]M=\B6,ER9+*T>8RFUBVJ-FX]MP8XY
M SU- $GB_P"TWFD_V)83F"]U3=;I,.L2;29'_!1@'^\RU!X%U^XUKP;!/=QN
MVIV>ZTO801N\^([6') R< ]?XJF;1&U7Q)=76M:;97%E%"L5B)")2O),C%2N
M%+?+T)X05FZ+X<U+P[XSUFYTZRLX]!U!(Y!;I+L:.=5P65 N &&,\]1F@#-O
M?B/J-QX'O?$&E^';F.!+*6:*YN98PBNKE,%02QQUZ8.",]ZVKO4[9O$/A2#4
M](E-_<M.;6X$JE(&$3%LX/)*CTQSUXK-L_!^K'X077A.Y-K%?O;S1(Z2%HR6
M=F7)V@CJ >*O76D:Y?:WX3U&6VLX_P"S'F>ZC2X+8WQ&,!3M&[&<G./3GK0!
M;?Q;N"75II=U>:<;W[$UQ!\S!PY1G" 9,:L""V1T) (YK&TV]M-$\;^/K^Z<
MQVMO#932')./W;DX'OZ>IJ7P_HOBGP]-<:+;BPDT5[J2>WO6E8301R.7:/R]
MN&;+-@Y YR0>E-O_  =J&K:AXR6=HK>UUNW@CMIDD+/&T2D!F7 XR0>#T% &
MIIGC2UO_ !&FB21(D\UN;B!X;A)D8 X96*_=<9SCD>A-;&I:3!JRQQ7;2M;K
MDM"DC('/&"2I!..>.G/L*R_#S^+92B^(8-.MQ NUGLYFD-RW3=@J-B]\<DG'
M0#E/%&BS:H]NUOIEA=,.)7N92C!!R%4A3C)/)_+KD1/X=KG1A5>JO>Y?/M][
M7YC_  A#/;Z==Q--+-:)>2K9-*Q9O)& .3R1D-@^F*;XOW+%I,B2RH1JELI"
M2%0P,@R" <'\:I1^&F&G7#OX=T1;L%1! K$H1QDLVT=L\ =O>GZ[X-LKF*S7
M3M*LE:.ZBEE+?+F-6RR]#G(XK'WO9\J7]?<>BG0^MJK*>[[+M_B_'J[FWJNB
MVVLF);N2X\J+)$<4S1Y)[DJ03C^IK$T30;>ZT>[C2>ZCL;N[9@HN'+-"ORA0
MY.X!BN[@]&Q5O4/"FEOIEPMGI-FMV\96(L@PK$8!_#K^%0ZAIZ>'-'V>'K?3
M;:]D"Q"2ZF$(VCJ<[3EOPQDY/H>BA"<J\7%)/O\ UV.6=:$<,Z:FW=[6TTU[
MO?OY%?PKIC:3XHUVTL)9CHL:P^7%+*T@BG()=4+$G&TH2,]35SQ^&_X0+6Y$
MEFBDBM))$>*5D((4D<J1Q[=*J:+J=_;0R0W(T&VACA8PK#J)E:64G.78J,9.
M23R23GZNUVX?6O MWI[76EIJ=Y:&*11=CRD=EP?FZD#Z5Z[4WBX5)]'&[]+:
MO[KL\S3ELA_B77[C0?"%G+9KOO[QH+.U!4L/-DX!([X&3COBI?#EYIR7]QI/
MEW::O!$LD[7P!FF0G_6!@2"N>P.!TP*J:S;V^K>']-C74=/BU'3YX+N$-<*8
MS)'_  DCG!&1G'&<XJ2&)KSQ'<Z]!)9'4%TTVEK:BY#;CN+DN5Z#<%'&<#)[
MX"<::P[35GK?UTMZK?\ ,>MSK#R*\QUWP[8:9XP\#:;")C!<2W,=SNG<F?;
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M&A*2EF41QA#N&!C.,\$T =/1110 4444 %%%% !1110 4444 %%%% !1110
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M&20JA<A1WVJ"3T/04S3=1MM7TNUU&S<O:W42S1,5()5AD'!Y'%</:+=OXO\
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MY@@=T=C;E0Q*L&7EE/=0:UJIW3WZWUDMM%;M:LS"Z:1R'4;3MV #!.>N2.*
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M?4M3BLM5F^T3VL4B!%ERN74[=W.T<$D=\=,=>2%!)( '4FC(QG(QZT <]?\
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M#*D$>H- 8,,J01[4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:1&6W9?),P&8;3R@5>,G[OS!V)'\7TK$L-.;6[_X>Q^)H//N;S1[P7:3$@S
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M33;I?[+M'BO3L_U+&W$8!]?F';/'- '66/BO2K_2GU"*658X[@VKQ20LLJS
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M4-/<//'M;?Y1C$:CG=DG)(XPHY)-9-OX9UC4?@_J.@K;26>IM<S311SX ?\
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M"< U6M_%L5QXPOM#6TN=EI;13F=868.7W],9^7"\'N>GOS)TVZTSQ'K=E?\
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M0O&L!MEER#&N\!F*X)9AG.<D# KH;.VO8?&?BZ]DL+D6]W9VR6[A,B1HTD#
M?BPZ]: -+P!>7.H?#_0KN\GDGN9K.-Y)9&RSL1R2:O:SXCTW09+--0DEC:\F
M\F#9"[AGP3C(!&< X'4]LU0\ 6=UIW@/1;&]MY+>ZMK5(I8I!RK 8/L?PJOX
MTM+N[O?##6MI-.MIJ\=S.T:Y\N,1R*2?Q8<#F@"_9^+]'N[#4+PS2VR:=)Y=
MVES"T3Q' (RI&>01C YSQS4D7B:QDO)[%H[J*^B@^TBUDA*R21]-R#^+GC Y
M!(SBN&UOPYK6JW7C-K*SD22>\L;RR\WY4NO(6/<F>V2A SCL>E=$UE<>(/&>
MAZVMG<V4&FVMP)/M*;&>24*HCQW"X8D],XP3S@ T_"'B,>*O#MOJHMI;<3@L
M$="/EW'&#WX R1WK-^(5_<:9IVD7<%]-:H-8M$F\ML!XVE 8-W(QGBG_  XM
M+_3?!.GZ7J-A-:7%DAA<2%2'(8\K@GCIR<5)X[T^]O\ 2+!K&U>Y>TU2UNY(
MHR-QCCD#-MR0"<#IWH L:=XST74GU"-9IK673T\VYBO8'MW2/&0^UP#MXZU9
ML_$EA>:N=*Q<07IA^T1Q7$+1F2/.-RYZX/4=1W%<AXC\,:AXLO=9U*SB:T,F
MC?V?:BY78TTGFB4[E/*K\H7G^\W&,$ZGA<_;[V&ZF\$KHEW;QE9KB:*('<>J
M0LA)*GJ2<#@=<\ '94444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 445R?Q!U#4]-T6RDTR>.%Y=
M2M8)&=225>500,$8SW]L_6@#K**XV[\0>)?^$LF\/6%CI<D\6GQ7OG332*C!
MI"C# !(/RG Y]SVJ.\\9:AI^KV4%U;6J)=:J-/\ LH;=,D;$A)BP) #8SM(!
MP>O% ';45Y_J/C3Q!!'XJEMM.T[R_#[AG\R9R9H_*$A P.&P>IX'OU%S5?&S
M6^IQ:?;R6=K<7%@EW9"_!"WCMN_=*X("L,+GJ3O''% ':45QOBWQ;J/AV/4[
ME;>T2WL;99X5G;<][U,BH%.4"@#YB",GL!5V77[W4-3N]-T2.W^T6EE'=2M<
M@D%I-WEQ@ CD["2V>..#G@ Z6BN%FU?Q%-XS\+VLJ06"7=A/<7-D_P"\*2+Y
M8(+JV&QO.,?4YXP[_A-=1NEMK_3-,DO+"6\-NT,=K-Y@B#E#,),;#@C.WT[Y
MXH [&\O;33K5[J]N8;:W09>69PBK]2>*F5E=%=2&5AD$="*\V\:ZU=Z_\/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5!;WMK=R3);W,,SP/Y<JQN&,;8SM;'0X(X-3$
M@@C(/4&N'^'\$5MK?C6*")(HUUDX1%  _<QGH* .R>]M8KN*TDN85N9@3'"S
M@.X'4@=3BIZX;7+>&/XO^$ITB199;2_$CA0&?"QXR>^,FNYH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** #MQ7,>%]#U/2-6\07-Z+3RM3O?M4?D
MRLS)\BKM(*#^[G/O73T4 <QJNAZG>>.M#UJ 6GV33HKB-U>9A(_FA1D (1QM
M]><]JZ>BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&K1:7+J$GA_4T@73WU"-F:$B1%"D@8D.&PP.#C@'TQ4GQ$_Y)OXD_P"P=/\
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MB2<A<@#D\8KA*.BHK@]2EN]?\9:UX?%[]E-M90O;*)Y(F^??NE781N((4<Y
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MIITY-,C2S,PF,*,RKO!W \'L>0.@/2EU3P?X?UN^@O=2TN&YN8$V)*Y.2O\
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M@@CJ*H#7])-\EG]O@\]Y#$B[N'<=4!Z%A@Y4'(QTIV2)=2<KIMZE@VT5K:W
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M^'X+XV,NLV2W0F2W,7G#<)'^ZF/4XZ5,GB#2I)C$E[&SA&D  /S*I 9E./F
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MWV17L3*=K[@-HD[,"<Y&><U@Z1>^;I_PVMTLM0,FFRB&\!LY1Y+BV="#\O\
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M^#GN#@X-=+<0Q7%N\4T:R1L,,CC(/X5SWAR+Q>OE1>(7TP1VR[?-LW=FNCC
M9@R@(.Y SD^@X/0SF40/Y"(\N/E5W*J3[D X_(T >0^!AH-W\,M(CU'3+FXO
M+QOLSW0LY2P,DY0-YVW QD<[NV*[G6O&']@Z[%IMY8,([F!Y+2Y$N5N)5'^I
M "Y$ASP._;)XK/\ ">B>*?"_@FST,66BW-Q:JX65KZ4(6+LP)'DYXR._:K/B
M#POJ?B.SEM;NXB4VL"/IUQ%,R.+P<^<X"X7! P!G@MZC !K3Z[-#<:?IXLE.
MK7D3S"V,_P D2)C<7<*> 64< Y)],FN/\2:E)J,O@W4Y='NK:]CUPP&VE4"3
M(CE!"DX!4E00W (P:T+_ $/Q9)=Z'XA@.EG7;&![6\MS,XM[F-]I)5]F5.Y0
M0-I^IQS:U70_$&J2^'KF5M/:>QU$7MPOFNJ*NQD"1_(2V-V<G&2#P,X !+;>
M,Y9;+5C+HMRNHZ9=1VLEG"PE+-)L*,& ^[AP2<< 'TJ&X\>+:6/B26;36DN-
M "M<16\ZNKJR;P58A>@!!!&01WK/U#PGXEEF\33V<UC$=3O;:XB3[1(/,CC5
M%>*0A,J'"'D9ZXJ"Z\%Z_/!XNBBBT>"/7+**"&*.9PL#+&4(XCY SG( SZ"@
M#HK#Q9)<^(;72KO2I;,7MHUW:3-*K^8JE=P('W3\X(]O0\52_P"%@*]CI.HP
MZ5+/8:M=&TLWCF42%\MM+*V H;8Q'S'MD#/#IM'U*#Q%H6MW/V&*STK3IX;H
M^>Y;Y@A+*-G('E]R.M<IH:ZG8:5I^JMI&CW^F1S->6H@U-U*-*6.8X2A0/AR
M F[J2 <DF@#JM7^(=EI8NITBBN;6SN?LUQLN5\\,&"LR18RP4G!Y!X. 0,GL
M000".AKB;+0_%>B:OJ5KID^FR:-?W<EVDT[.)[1I#ND 4#:XR21DCKS7;C@4
M <CX]AU'5]+;0-&N6M[^YB>X\U3@HL>"HSVW2&-?IN]*L:)XQL[[P!#XHO&\
MF%+8RW8QS&Z9$BXZY# @#Z4ZV\/&^U;4;[Q#INF7+2.J6G_+?RX5'"G>@P2Q
M=CC/W@.U<_!X!U 6OBW0F^PV_A_66:6T6"5C):R,H#?)L"[2P#8!XZ<YH Z,
M:_J@NS;2Z!+&TEFUS!)YI:+(Q^[E8+B-^1TW#K@G%-\"ZQ?Z_P"#]/U348HT
MFNHA+F-\A@>>F!CTQS]:;H$'BMX$A\1/IR"&(QE[-W=KEL8WMN4;!WP,Y/<
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MK%BZR/)$2SL=DF54@;793C/K0!TOAWQ3%KM_J5@8%CN;!DWM#,)H95<95D<
M9Z$$8!!%:VH6$>I6XMYV<0%LR(C%?,']TD<XSCZXQTJGH?\ ;LD3SZZME#*P
M"I;V;LZ)C.6+, 23GIC QWS4?B;2I=6T]8K>QTZYG#?*U\,B-3U*_*W/'I_+
M%3/X7I<VPZO5BN;E\^WY%/PUIXT[6-9@LV<:4KQK#$SEE27:?,"Y[<K^.1VJ
M7QTN?!6JL'D1D@+*4<J<_@>1[51L?"FV*87?A[PVFR$B!8HS)N?MO9D!Q^9Y
MI=5\&6M]X9DMK?1M'M]4FA"F1(@B1OCDJP4GKTK"TO9N*7?^MCU.:C];A5G4
MV<;Z+I;5OF\M7W-^_P!+M]7L8[:Z,A@R&9$D*;\#@$@@XSSQZ"L'2- LUO=:
M%@T]M;G9:!EG=FX&Z0J6)()W;<CH5K1C\+:(+8%] TOS@O*K;H1GZ[1_*J=O
MH<'AW0%FL;+28]96+:)YE\M#(W+995+;<DX [ #BMH0E*K%I*_?^D<WMH0H3
MIJH[/2UM.]_B\K7\RCIN@0:+\0430_,@L38NVH0>:SQERP$1^8G#G#_@/?GK
M[V%;BRGB<NJLA!,;E&'T(((KD]!N]9M;E$U"X\/I;,S27,T%V\DTSXZ_,B@<
MX^@& ,8QK6VKROIDWVVXTP7I9PB17!\LKD[<DC(.,9XKU<5&K*:DW=JRO>[>
M^M_ZLK'EQM8Y_0]>_L#X+V>MS S/;Z>) &/WW/"@GW8BK7AV^AM-2LK#6K>[
M77[V%IENKI%*S$#+I$0QV!0?N87CG&<U6L]%M9OADGA/5-1LDE%MY!EMYMZ@
M@Y5AD*>" <>W6K\,+:OK>BWNHW%@L^FK(56WGW^=*Z["1D#"XR<<G)'ISTU?
M9/VNF\IN_E;W;>3=[_(2OH=+?3S6UA//;VYN9HT++"&VF0CL#ZGM7+VWCR*Y
M3PO*MFJV_B $1R&X_P!2X4ML8;>3P1Q_$,<<$]A7G=S\.KEM,UJ"WO(UE^UF
MZT0D<6;;Q,?IF7(.,_*!7B&AI>(M=M3I?F:EHGVRR75X;2(B48+B55$AS@C:
M_&!GE3VY,L&L:CJ'CW6-!N+*W;3+>SA;F7)82&3+$;><[0,9XQG)S@+XD\,W
MM[X6T_2-,:W9[:ZMIGDNI&3?Y4BNQ^56RS$'\3FI%T;5[7QS?ZU;+926M]8P
MPNLDS*Z21ER  %((._KD8QT- '+?#[Q++I/@SP?9W&F2BROC]DCO/-7B4[V4
M;.NT[2,^O;'->H,2%) +$#H.IKSNR\%Z]:^%/".E-_9K3:+J"74["Y?:Z+O&
M%_=YR=_?'2O1#G:=H!.. 3B@#C+'Q^US97.I3Z'<VVE6C7*7-T\\9\MXF*[0
MN<MN(P".,\5(OC^UAU"YM;RW0"*QDOEEL[@7*E$&61L ;7QSCD'L:K6/@N_F
M\#ZWX>U.6V@DO[FYGBFM9&DV>9(9%)RJ\J2/KCM5[3HO&\NFSQZJVCQ745NZ
M0/;L[K<3;<*[AE&Q<\D#)/MC! '2>,)8- O-:;35N+*"Q^VI+9W2RK*H!++D
MA0" ,GKUXS4%GXY>36M*LM0T2YL+;5HRUC=O*C+(P7<58#E#CD9Z^@/ Y_5O
M";:)H'C#4[>U@TNTNM#G2;3[68O$\^QB90-H"\<< 9SR!CG:T_1+W7;;PK<:
MC%;PVNF0K.!'*7::0P[%_A&U0&)]<X'O0!)%\0[&:[TLQQ1RV.ISBW@FAN%>
M5&.=C21 95&QUR<9&0,U<3Q9+<+;7=EI,]WI<][]C%Q"VYP0Q0R^6!_J@RD;
MMV<<XQ6?X5T7Q;H$%OH,UQILNC6;!8+U6?[0T(.5C*8V@X^4MGIVSS3?#>@>
M*/#N[1(IM/?0DN'EM[HN_P!H2)G+F+9C:3DD;MW .<=J +WA77=5U?6?$,%[
M:P16]C?FVB*3;BH$<9 QM&<[B<]LX[9J7Q]K=_X>\&WVI:=%&]Q'M0&1L;-S
M!=PX.2-PXH\/Z+J6D>(=?EE-J^GZC=_;(G5V\T,8T0J5Q@ ;,YR<YZ"I_&FB
M7/B/PAJ&E6<D4=S.JF-I20FY75@#@$@';CI0 LNOW']III$%E%+JOV8W4L1N
M-L<4>[:N7VDDL0<#;V.<<9G\.^(+?Q'IC7<$<D,D4SV]Q!+C?#*APR'''![C
ML16,VB:U;^+8?$T$=F\]Q8BSO[/SV"C#ED:-]O)&2#D#(YXZ5I^%]!;0K*\\
MYT:ZO[V:^N/+SL#R-G:N>2  HSQG&<#.* )M5U>>QO+:TMK!IY)XY)6ED<QP
M1*@&=[[6P3N&!CG!]*PD^(4,^D^'=0MM)NIDUN8P1JKH#&X#DJ<GGE&YZ=\B
MKFOZ1K%YXDTN]M!97.GP1R)-:7<C(JR$J5F "D.R@$ ''7@C.1S^F>"_$-EH
M_A:QD.F.=&U&2ZD99Y!YB'S ,?(>?WG3VZG/ !IR^/+B#0]=O9="E^UZ)-LO
M+1)PQV; ^]6Q@C:P...A_'?36#-J5A:00QS)=6S7+3)+E8T&T ].=Q;CIG!]
M*R-.TZ31=9\2ZCK<NG0Z?JUQ$T>ZX/01+'M?<JCG;V)ZXJ+X=Z*-*T66073W
M,,DC16,C]5LT=O)7/<89B#W#"@#L:*** "BBB@ HHHH **** "BBB@ HHHH
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M^7&,9(.#CG3O-9\0Z;XAUGP_:R'4K@Z1_:.G22JB.K[S&8VV@*><%20/0YH
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M#*D$<,6/'4UCVFO>*;71_!GB*YU=+RVU:6UMKRQ^RHBCSA@2*P&[<#R1G'/
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M[<\<5T>F_P#)7->_[!5G_P"AS4 =C1110 4444 %%%% !1110 4444 %%%%
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M2!'V*9&5ODW8YP3VSTJ22:*&/S))$1/[S, /SH PI?"5M<23W%Q?7TM[+#'
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MTX;:P.#Z&@#+U3P]!J>IV6IBZNK2^LU=(I[=ESL?&Y2KJRD':.V>.#5*_P#
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MG# [B3@*/4D\ 5>!##(((]10!RS> M-;1Y].-Y?@2W_]I+.)$$D-QOW[T(7
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MPK=6:)XQ(LB,C=&# @_C0!P7B#PT=)T=;6R36KJUNM5-]>364B_:(&.7WHH
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MIT' _,UNI-%*6$<B.4.&"L#@^AH ?1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7)^/+RPM;31
MX[]01/JD*0F27RX5D 9@93W48)V]R%Z=1UE17%M!=Q&*YACFC)!*2(&''L:
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MTGV@$IM;RL!8@>_W &(/0LU<[XXANAJ\][8'3K]K?3#]MTB_^42VY9B7C?\
MA;Y2#D8X7/:N_50BA5 "@8 '0"J]QIUE>2+)=6=O.Z?=:6)6*_0D4 >?6%]I
M<?Q$M+VX6*RMK_PO$RI=;5+?O<[6SU8*0"*YWPQK%E8Z#X!&HS0KH9>]BG:0
MCRH[G<?*$F>!QOQGH2#VKV::TMKB6*6:WBDDA.Z)W0$H?52>GX4U]/LI+/[&
M]I;M:XQY!C!3_OG&* /-=>M-!CTC08-'??IT_BJ%LK*6C9F+%Q&0<;,DC"\
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M9\P3/;SQ2)M>&5?O(P[$<>W-2:CJMMIGV=9M[S7,GE001C+RM@G 'L 22<
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M].^<5B&VN]5\-ZRT/@A=(O)=,FM0I6'SI9'7 5&4_<!ZEB,\<<4^/3-4&I>
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M\Q0&P<,G3.2.W:N@\-Z1<0>(O$>NSQ-;C59H/*@<C<$BC";FQP"QSQZ 9YX
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MEH]VETB<%!MQ@$@_Q@G(X_EEK:ZYX6\6R:A:Z"=0T_4;"WMY(-.:-/LLT6X
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MBU2UN'6,J-J1R!F/S$=ATH EOO'&E6-[J5D8=0GN=.C26XC@M'8A&#'<..0
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M%0:'<P1E9IV6$EF/!6(H2=O<DX[#!SD '84444 %%%% !1110 4444 %%%%
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MGO[;3UL_$$'W8-_F12>290<DX*G!&,9'')H [+4-3L=*MOM&H7D%K#N"AYI
MH)/0#/4^U6J\K\9:U?>)/AE?:M:_95TJ2\CCBC9&,KHERJ>9NW8&67.W;T[Y
MKHM6\5:F;C6(-#M5GGTMEC,+VDLOVF0HLA0.F%CX90"<\DY  Y .RHKAY?$O
MB:\\2?V/INGZ=;R-I<.H 7[29C+.59'V]Q@CC_ZU7/B3?:CIO@6^NM-N4MYE
M:-&<H6.UY%0A>1@_-UY_/D '1#4[$ZF=,%Y ;\1^<;82 R!,@;BO4#)'/O5J
MO/[]=57XJ6*VSV3WYT"<&62-EB'[^/G8&)/TW#ZU-IOCNXU#1-$9[>.+4M1D
MN(G$<,DR1^0S*[!%^9@2!@9&-W)XY .ZK-N/$.BVL[07&L:?#,GWHY+E%9?J
M"<U5\,:IJFI6MV-6T\VL]O<M$D@C:-+B,8*R*K?,N<]"3@CK7,O<36WQNOF@
ML9KMFT"'*Q,BD?OGY.]@* .ZL[^SU&$S6-W!=1!BI>"0.H([9'>K%<I<7>MP
M^%+W5M(TB"+5FEEFDL;@$F4H=F,JV-Q1%Z9!/US4-IXV$OA+4/%SB-]%B@,M
MLJ(5FDVC#;LL0/GRH'MF@#K9IXK:!YYY4BB0;G>1@JJ/4D]*99WEMJ%G%=V<
M\<]O*NZ.6-LJX]0>XK%2;Q%]K,-_:V4NGS63N\T&5,$O_/,AF.\$$_, .G(Y
MKC?!&NZMI'A?P)!+#9MI>I(MF N[SD?RV=7S]W!V$8QQZ]J /0+?0;*UUZ[U
MF,S?;+J-8YB92595SM&WH,9/3UK3KA[SQCJ=AJ]C!<P6:I<ZL-/-JF7ECC;<
M(Y6D5BH+8#;"H.#[54U'QEXC@M_%=Q;VFEB/P_+EA(TC&:,1+(0,8PV&Z]/8
M]: /0Z*YB;Q'=W?B*#1M.6"&272_[1$URA=2"P54 ##IU)SQQQS65I7CN]U/
M1="GDM(K:]UA998E2*2X6.*/&XE5P6)+#&"!@YSV(!WE,FFBMX7FFD2.)%+.
M[MA5 ZDD]!6/X8U/5-3L;DZMIYM+B"Y>%6\MD6X08VRJK?,H(/0\@@UD>/GL
M=3M8O#%YJ$=E#J$<CW$K2!"L2C@ GN7*<=PKT =E17#^"_%Z7'PV?5-2DWW&
MCQ2PWY0[B7A'+ ]]R@-_P*M2ROO$UU+I\IMK V5]:M*[H#FS<J&0-EOWH.<'
M:%Z9XS0!TE%<C\-K[4]3\&6M_JEW'<2SR3-N6(H0?-?.?F((]  ,#CFNNH *
M*** "BBB@ HHHH **** ,O2M!LM&N+Z>T,V^^F,]QYDI8-(0!NP>G  X]*U*
M** "LM-!LD\12:Z#-]N> 6[,93M,8)8+MZ<$D^O-:E% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !63XD\/67B?1I--O?,5699(Y
M8CAX9%.5=3V(-:U% &'::=K_ )"VVHZU;3Q ;6D@LS#-(/=O,(!/<A1[;:J?
M\(M=66M:K?Z/J4=K'JH5KF&6W\P+*%V^9&0RX)&,@@@D UT]% '*6O@E-.U7
MP_<:?=I#9Z+:26D=NT!9I%?;N)?<,'Y >G<UB:3]IO\ X@^.H-.U2UA\TVJG
M,7FL/W 4LN&'(.1R",X^A]&HP* .2A\#Q:3?Z7?:#=+9S6-B-.99HC*D\ .0
M& 93N#<[@>YXYJ.Y\"M)9VD=OJ*17$>KC6+B9[;?Y\V<XP'&U>@QDG '.>3V
M-% '+:KX3NK_ ,0SZI;ZO]G2ZT_[!<0FW$AVY8[HV+?(?FYR"#Q56T\#W=I#
MX6\O6O\ 2-!@>V$AM1B6)D5" N[Y6 1<$EN<\'I79T4 <;<^ 8]0@\2V^H7_
M )D.MS)/^YA\M[=T50A5MQSC8IZ#FM&'P]>S:E8ZGJNH075[I\$D=JT=L8T#
MN &D9=YR<*!@$ 9;UXZ&B@#A[?P#=6WAO0='76(B-(OUO5E-F<RE69@I'F<?
M>//TKLKN%[BSGACE:&22-D65>J$C (^G6IJ* .;T_P +O!XECU^]N+>6_2S-
MHTEM;>3YP+*=TGS-DC:,#MD^V,;Q;.?^%F>#([>\MX+@)>\3#<.40 $9!YP<
M<]1WZ5WM&!0!QNH>!9+[3;N(:E''>WNHQ:A<W)MBP9HRI1%7>,* BCDGOZUH
MZIX;EN]>T_7K*]2UU.TA:W=GA+QSPM@E&7<",, 00>#ZUT-% '-1^%'BM;F)
M;Y-^H7OVK4G,!_T@< QJ-WR+M55ZMQGKDU7M=.@\"G6]5GU-(=!FE^U&T%LQ
M%JYP&*D$G#'DC;C)XQS76T4 <EX,TBSM[G6=;LUE6WU6Z,MND@(VQX&653RH
M=R[^X(-;NJV5[>?9C9WD<'ER$RQS0^:DZ%2I1AN'J#GVK0HH XE?A\MMIFGV
M^GWZ6D]EJCZFA6VS$&?>&C6/<-JX<@<\8J'4/A[>WMMK=HGB$I;:G>1WOSV8
M>1)5*'!;<-R?NQA0!CUQP>\HH YB3P@TVOW]_-J'F6NI6"6=];- ,RA0X!#9
M^4$.<C'XBHO#OA;6=$CAM;GQ-)?Z?9KMLX7M0CJ ,*)'#9D"CM\N< UUE% '
M#Q> ;J+PIINAC6(B+'4%OEF-F?G(F,P4CS/[Q(SGI5O4/ ZZMJFMW&H7JR6N
MK6,=E)!'"5:,(6*L'W'G+$].PKK:* .5TWPWKT.GS6VJ>)SJ)$#06[&S$>W(
MQOD ;,C8XZ@<GOS4%OX)N;>S\*VPU:(KX?(*$VAS,!&8^?G^7Y6/KS^5=C10
M!@^'_#TVA7NK.+_SK6^O)+Q(#"%,;R$%@6R=PR..!C)SGC'.W$TTGQJECL;Z
MTBF&@HC),GF9/GN<8#*00,'Z'\:] HP* ..F\"F+3M)33=1$&H:=?/?BZF@\
MQ9I9-_F[D#+PV\]#QQ56[^'MY=Z7XBLGUX?\3JXCN))&LP3&5" X <9SL'T'
MKUKNZ* ,?4]+O[]K?%Y:&$0R175M/:&2*XW;<';O&,;3USPQK#B\!2:=#X<_
MLC55MY]%CFA5Y[?S4ECEP7&W<"N"!MY..G-=I10!PB?#Z]@MT$&O_P"D1:U+
MJT3RV@9-SELHZAAN^]U!&#R *)_A[=S:3K6GG7@4U/44U!F>S!*.K1L1PPSD
MQ+Z8&>IYKNZ* .;F\+37/B>[U>>_0QW6F?V<\"6Y4A=S-N#%CSECQCI5SPQH
M]QH'AZSTJXOA>?9(EACD$/E?(H"J,9/.!R<\^U;%% ''7/@&*]C\26=U?L^F
MZW+Y[0+$%>&7:@W!\G.#&I P.>N:T+7P[=RZEIE_K.H17L^F1NMN8K<Q9=U"
MM(V6;+;<CC ^8^V.AHH Y[QCX;F\5:,NFQWZ6:B>.9G:#S22C!@!\RXY'-,U
M'PO-<>(+'7[#4$LM3AC,%RXM]\=U$>=CKN!X/(.<CWKI** .)U/P+>WS^)(K
M?6TM[/7HL7$7V3>Z2>4(]RMN^Z0 2N,^A%:">%;D:]HNIOJ4;C3;.2T,9MO]
M:'VY.=_'W!V/>NFHH X[P_X,U+P_(EE#XCEDT"&7S+>Q:W DC&[<(S-G)0'M
MC..,XKKW#F-A&RJ^/E+#(!]QD9_.G44 <_X9\,C0O#2Z)>3PZA"LDCY:WV [
MY&D(*EF!P6X^@IB^#=-C\76VO0P6T7D6CVP@2V4#<SJPDR.A&W'3OUKHZ* .
M"M/AY?VMMI%M_P )%NBTG4&N[<FS&]@V_<');YF_>'#<#U4UV4^FV=Q!/"]O
M&%GC:.0JH5B&&#R/K5NB@#F+7PFZVNB6=[>QW-KHTB26VVWV2,40HFYMQ' /
M. ,D=AD5?\4Z"/$OAVYTK[2;9Y2CQS!-VQT=74X[C*CBMBB@#D/^$0U.76KO
M5KK7(I+FZTO^SW5;+;&OS,VY1OSCYNA)[\]@EOX*N;>W\*0C58B/#PPA^R']
M^/*,7/S_ "_*3Z\_E7844 >?3?#B]'A^_P##EGKZ0Z+<7 G@A>SWRV_[T2%
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M#H$>DV.OA$ANO,B<V:DB$R%VC.6Y)W$;N,<8&>O5T44 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\1"7(498H?H<C.,CD9%8OA#6_LF@ZM<:M?SS"#6[JTB>4F1V FV1HH')/0
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MA_+DX*DC.#Z&N$LO&^MMH^H:[?6&GQZ7I\UU!,D<KF9WC<HFSC&"1@YQZXH
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M6D-H)/)3#2OOD8G+.W3))Z\ #V  Z"N4_P"$B\0V?BJVT34K/3HQJ<$KZ=/
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MV@@L2S  9'<]L'4A\=S![C2[FUB76X=4CTP*K'RG+J9$E]0OEAFV]<C&><T
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ME12H'F?-P@YX[UV]% ''7?A'6(_$#:SHNOQV-Q=01PW\<EGYL4Q085U4N"K
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MSR?O"F-I^]P1@8(QC%.?PQI,D,L<EO(YE>.1Y6N)#*63[A\PMN^7J.>,GUH
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MCM'(R3;MK$Y"DHIVYQVQ@XKLAX'\-K#)"FF)'')="[98I'0>:#D-P1C!Y Z
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M_P ?GC#_ +&";_T5%78]16=IVA:=I+W3V4+QF[D,L^Z9W\QS@%B&)Y( Y]J
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M"_MQ,D<BRQG<5:-QT964@JP]00:A_L#3?[/NK$P,8+O/VC,SEYLC:=SYW-P
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5>\O[/3H?.O;N"
MVBSMWSR!%SZ9-6*X?QC!KNF^(M-\3Z3IHUBWM+>2WN-/#8E57*DR19X+?+@C
MJ1QWX .S@N8+J/S+>:.9/[T;!AT!ZCV(/XU+7 :+XM\.0>';[5]"A<->ZFD<
MMBT1C>*ZDV1[60 D=-QP#GG&35F3QK?Z6NK-J>ERO!:I$UI=);R6\=P\CA!&
M1(,JP9EYR1@Y[8H [:H+F]M;-H%N;F&$SR"*(2.%\QSDA5SU/!X'I7-:KJ?B
MC3[+62UK9;+?3FNK>^0'8)1G,31EMQ( R&X!]!69!KFH6GASP1)?VUG?-J,]
MK"9Y"=\1>$L' (.7X;G(Z]* ._HKD+CQ5J%S9Z]?Z/;6TUOHL\D#Q2E@]RT:
MAI K#A,9P,ALD=A4$7C+4=6UO3[+1;.S:WU#1_[2@GN96!7YD&&4#MOZ \^H
MH [:FM)&CHC.JLY(52<%L#/'KQ6+X0UV7Q)X9MM3G@6"=VDBEC1MRAXY&1L'
MT)4D?6L;5]7T1O&7A^Z34=/)C-PLLHG3Y08\ ,<\<^M1.:BKG3AL/*O)Q5]$
MWHK[)O\ &QV$]U;VJAKB>*$$X!D<+G\Z?O3R_,W+LQG=GC'KFN#\0^*K+2=<
M@UBSOK'48FMFMY;:.X4N@!W;U(SW(!'4X&,XJ\$TRZ^&=[;P75OJ,"64Q9EP
M0&*LV-O\.,\ \@ 4Z,XU*JIW-:^!G1P\:S3U\O6_I;3?>^FQU9N8!;?:3-&(
M"H?S=PV[?7/3%10:G874OE6]];328SMCE5CCZ UCZ#IUKJG@#1+2]A6>V:PM
MB\3\J^$4@$=QD#BJFB:)I4'C/4;O3=,L[2*Q@2S!MX%CW2/B1\X'.%\H?B:[
MO84DJB;=XWZ:;V7XGGW>AUM5KS4;'3D5[Z\M[56.%,\JH"?;)JS7 ?#:4ZY/
MX@\17H\R^DU.:TC+<F""/ 6-?0=2<=2<FN,H[J&Y@N5W031RJ0#E&##!Z'BH
M(M7TR>\-G#J-I)=+G,*3*7&.OR@YK@_B/ OA_1)6TDFR;7]3M;2[D@^4J&)#
MN".A*@*3_6NA\7:+8GP#J-I#"ELEG9O+:&(;3;O&I9&0C[I! Y% '0"]M#=F
MT%S";D#)A\P;\?[O6DGOK.UE2*XNH(I'^XLD@4M] >M>73V>H>.-#\&:K#<_
M8O$ T^6[M[L*!^^41\-_L-DY'HU;>E^)H_$\_A[[5;"TUBQU5X+^S?[T$OV2
MXZ>JG&0>X^E '7G7-)#E#JEEO!QM^T)G/YU:ENK>"#SYIXHX<9\QW 7\SQ7"
M^&;.VG^)OQ 6:WAD!EL1AT!X-N,]?6LBWC&A^,/&7A>R&-&ET8ZA';=4MI&!
M5E0=@V=V.GI0!Z=%?V<]NUQ%=P20+]Z5) 5'U/2G6]Y:W4)FM[F&:(<%XW#*
M/Q%<Y\-E"_#3PX  !]@B/'^[7'7<IN(_AWX7(V:;J;S2W:+PLJPIO$9]58GD
M=\4 >FVVLZ7>,RVNI6<[*0&$4ZL02<#.#Z\4UM=TA'*/JMBK*<$&X0$'\Z;J
M.AV&IQVBSVZ9LYX[BW8* 8V1@PV^@.,'V-<7XVTFPL+[P1;VUI"D?]NQJ0$'
MS9CD)SZY/)H [^VN[:]B,EK<13Q@[2T3AAGTR*9>:A9:=&)+Z\M[9&. T\JH
M"?J326>G6FGM<&T@CA^T2>;($4 ,^T+G ]E'Y5Q?P_G;6]?\6ZU??/=P:M+I
ML ;GR((@,*OIDDDXZF@#MQ>VIM!=BYA-L1N$PD&S'KNZ5677='9@JZK8EB<
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M[HLZ ?PX # ?7GM8\7ZY+I?A+Q)=:3<+$U_J\$"7<)'R)+# #("/]G.#[@T
M>C'6=+%X;,ZE9BZ!P8?/7?GTVYS4ESJ%E96HNKJ\MX+<XQ++*%0YZ<DXK'U:
MUT7P]X)NH)M*\_1[6V8S6T:*Q,:J2Q(8C)P"2<Y)]ZYC4UU=;;POXJ\/:9)J
M=G9611M-N&59VB=4VRI@D>9M7IUP2.YH ]#M[JWNX_,MIXIDX^:-PP]>HJ6N
M)\+:OINK:-KFH^$;=(]1EF,D]A>(8#%<[ N) .F=HR1U.><YKLH#*;>,SJBS
M%1YBH<J&QS@]QF@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *Q[W3]5.M#4=/OX(T^SB&2UGA++(0Q(;<&!4C..AZGCIC8HH
MXFY^'RW]AK37-_Y.JZI=17?VJUCVK;RP@>444DYQMY).6R>G&)KCPCJFO>&[
M[3/$VMK<RW$8CCDL[?R%B*L&63&X[GW*I[#C  R<]A10!S-GH&MW&E7=IX@U
MN.\>:U>T5K:V\E0K#!=@6.Y^GH!S@<U2_P"$-U-]&\-6,VKVS/HEU#.'%H0)
M5C0HJXW\9!))R>>P'%=G10!R(\(7EG-KL6F:C%#8:U(\TT<L)=X)77;(\9W
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=H6$,DHS\@?&TG@XYY(('-<W\1O%*VG@[5VTJ^NX;NU=8C<VT1*))N7*%]I
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MC0%2>J1,"2P)YSP, =SP =G1110 4444 %%%% !1110 4444 %%%% !1110
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M([568B;>!Y+9["0L /0YZT =C4%S>VMDJ-=7,,"NXC0RN%#,3@ 9ZDGM3O\
M2/LG_++[3L]]F['YXS7D=SJ.IZQ\+-(U35/(N+E]:MWC* @Y^V$$<]!P /:@
M#V&BN,/C6YTRY\0V^N6<"/I5M%=Q_9)&<2I)N"K\P'S;EQGH<CI5S3/$&JS^
M(UTV[TN4VLMN9DO8[::-(G!YC?S%&>.0PQG'04 =/1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^)[W01;3QW%I;QW#2/MV.KE@-N"3U4]0* .>NO!%_<Z1XLL#J%LO]OS-+O\
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MUJT;77YKFW\Z_LH[9)-\J00.KR8!PNXN<#=C/!R!CO6O&XDB20# 901^-.H
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MDNJJ21M)&/F% %6\\/WC^-+7Q!9WL,82R:SGADA+;UWAP5(88.1CD'@UB?\
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M3ELXQV%7_#VE^([0H->UR"_6!-D7V>V,)D[;Y3N.3CL,#DGDXQT5% !1110
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MD1AD,I&"#^%8-CX&\/:=/I\]O92"73PRVKO<RN8U./E^9CE1@84\#L!0!?\
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MRQ6<XCM;C[3;1?;)C' _/*+NPH^8\#BM;3]#T_3+Z^O;2*1+B^<27#-,[[V
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M@$8;>QSP2,]>:BL_ WA^QGL9XK25IK%'CMWFNI9"B, "N68Y7  "G@<X')H
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M*Z&%"X(7!4 N"2W ) !!ZC,$]WJ$OA;QI9:G<V.K+'I)6WU>V0+]IW)*%C<
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M&3YANRWIU%;7A34;C5_"&C:E=E3<7=E#-*5&!N9 3@=N37)6]S OB7XCL95
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M9.W!.?E8' (/KP36?H/C@W'A#1]4U2!8;O4Q^XC,J*KD@L3DG"J .IYX'!)
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M9Q!% 642*V6W;N<?+M8D9R IH Z.BJ&L:JFCV(N6MY[AGECACBA7+,[L%7V
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MNQA@F@AM9[6=9)2A0.R,&'!W?<(QQU'-=%;7$5W:PW,+;HID61#C&5(R*EH
M\UN/"FNS>"]=TI;2(75_K37\69QM$;7"RX)['"XQ@\D<UI#3O%.B^*-3NM)L
M;&^TW5Y$N&2YN3$]G,$5&)PK;U(53@<UU-IK5A?:K?:9;SE[RQ"&XC*,-@?.
MWDC!SM/3-%UK5A9:M8Z7/.4O+_?]GCV,=^U2S<@8& #U- %E?-ALU#9N)D0
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M2+SM^UB%WX^7KC/.#T-F7Q!XET:&6#4K4L;K4H+33;A_)\UTD!+;U5MFY=K
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M6<]K;S*4 ENCA$4N Q]VP3@=S@5Q[^.+[2X?%AGWW":6UH+-[J'RG/VC"CS
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MA[NZ7^U':2]N4V>;*2 #U7 & H&!P!^-;]K"UM:QPM,\Q10OF. "WUP /TH
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M3]1M_$FJ7DU_=2V5PL?EV\S*4C<#!\L#E5Z=>I/MDZUU;QW=I-;3 F*9&C<
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MIHX(\]7=V"J!Z\G\LFO(_#FN0_V'X MM7NTDTF<7<5PTSYC,RG$*2$G&,;L
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M?^E00KM,+0N6R 5 Z#DD]2>;T0TC3/'/C>^O52"2+3+6<31QJLX/E3F1X_\
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MG!YQ0!W=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M% %6'3+"WNY+N"QMHKF48DF2)5=_JP&35HC(P:** *5EH^F::SM8Z=:6K/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %<G\0K6YO-"M(;2UGN)5U*UF*Q(6(1)59C^ !KK** ..ACGC^)FIZDU
MG=?8GTB&%)O(;#.LDC%1QG.&%<=I.DZOHFB^$=0N?#UY?Q65E/87]C&G[^$N
MZLLB*2-WW0#@]#7L5% 'F6JZ7<6CZ)KUAX2?[!!-<&ZTJ!5%P4F"?O2H."X*
M9(SG#>N<3:KILLNC:9?Z9X9FLDCUZWOY;1(U%PZ+PTCJ#C=STR3@#/H/1Z*
M.&DBO#X_U346T^\6WET*.W5O*+ RAY&*9&<G##IQ[UCZ?INHP^'OAU;2:;>"
M;3+A#>+Y+?N0(70D_BPZ9KU&B@#R&8(6UO2Y]'UZ31;G67O'^QV0G5RLBLVV
M17SM,B9(VY'(SZ>F66L"_OS##9W/V4VT=Q%>LH$4H?.%4YSD#!.1WK-M?!.F
MV3LMM=ZI%9LS,;);V00@DY( SD DG@''/2NC1%C1410JJ,!0, #TH 6BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LN35S
M)J5SI]A"D\]K&'G+R;%0L"43(!^8XSTX&#W&=2N)^'[2/-XQ>?/G_P#"0W*M
MGKL"QA/PV;: -WPGKC>)?"VGZRUN+<W<?F>4'W;.2,9P,]/2K%IJJ3ZI<Z9,
MGE7D"K+LSD21,2%=3Z9!!'8CT()\AT?1H;?X<>#==TQIDU_[5;Q0NDS$RJTN
M'B*YQLV;B1CC:3ZUW6L&1/B[X7,&<R:?>K<8_P">8,97/_ L4 =K7&7'C'6+
M2\T2TG\/01S:PS+ CWYS&53>?,Q'QP.V>:[.N&\9$#Q]X"Y_Y?;G_P!$-0!>
MG\5:E::II%E>:,D#7]\]FS"ZWA<1F0,OR#<"![8KJZXGQW!'=:]X-@EW;'U5
MPVUBI(^SR\9'-<K/>-X<TSQ9:V;FVTJUU^U23&YEM[>183+@ @A>3D CACC%
M 'L%,D,@C8Q*K28^56;:"?<X./RKD_#&G6%GX@OKG3M7M9XKNW1WLK",+;QD
M' D #,%9AD=MVW/:NOH XC3O'=_J'A!O$ZZ #81^:TD4=YNG"QLRN0I0*<;2
M<;N1^5=;INH6VK:9:ZC9OOMKJ)9HFQC*L,CCMUKR+P[I$M_\#KEV\175A;'[
M8S1_NA"5$TF58[=^UN^'!Y_"M+0=7?6+KP+9ZGIL=EI=YI4SQV6T^2\Z;0B[
M3U C!90<_>SR1F@#U6BO)O.CL#J^D7,EP^E+XCM[;3(A*%C=V19&@=B#B$-G
M(P?[H]*R]5D5? _Q$LUN8E6UOU>".UD*I%E8=P0 _=W,<CIDG@4 >VUA:#K\
MVKZGKEE-:);MIETMN"DN_P P&-7#=!CANE<QJ]EIVB>,?#FD",Q:5JUQ<W%T
M)96=+BY6-1&KEB>O)V]"P!QFK7@*"TM/$GC6ULQ&D2:FA6-#PN8(\@#L,Y&.
MW2@#NJ*YOX@7VHZ;X!UN\TK>+V*U9HV3[R?WF'N%R?PK"N[>VLO$O@V[\.!5
MBU R1W*Q'Y;FV\HOO?\ O$':0QYRV,\T ;A\1ZA>:A=Q:/ID=Y!87R65V7N/
M+?)56=D!&"%#C@D$X..@ST<AD$;&)59\?*K-M!/N<''Y5PWP^TZPM]5\7206
MEO')'K<L2,D8!5/*B.T$=!GM7=T <;HGC+5M=\/?VW:>'%DM]\B>1'? SML8
MJV%*!3RIQ\PK3L/$H\0>'(=6\.PI=F214:&X?R6CPP$@;@X91GCOCWKG_A9>
M6UC\,8KNZGC@MXKB[=Y9&"JH\^3DDUQL%G.OP]U?662:V@U/Q3'?649+(?)D
MN(U!*_[0SP>V#0![C17GCZ'8:Q\5M9MK]9IH4T^SN%B^T.H$@DDPPP1C&T>U
M9&CFV\1645_>ZY;6.N66J/YVR'_2UD$K 0DE\E&7"A=N",<<4 >M56BO[:>_
MN;**57N+94:9!_!OSMS[_*3CZ>M>=:=+H^OP:V==O6MM9L=9D'F)($N(520>
M2L6<G:RA1@#YBS=S5>Y"Z5KOQ+O=*M;==5AMX9+0K&N\.;8LQ7N3P3[XH ]6
MHKS2:*"W7P)JGAYOW]]<10W#QMS=6[PLTC2'JY&W=N/(/UJKH.@V%UH_BJ_E
MO)K6\M-2U."VOVGD/V12"N<;L' .>>>!SP, 'JM%<-X,FGM/$.H:5JFC6^GZ
MJMI#(TM@V;6YB#. ZC *-DD$'G@>E=#XKNKZQ\(ZQ=:8I:^ALY7@ &3O"DC
M[GVH V*YJ[\1ZA)J>HV6BZ9'?2Z8\*7*27'E,QD ;"9&,A2#R1G.*Y>2.&"T
M\!:OX?;_ $J]NH(;B1&RUU \3-*9?[Y&W=ELD$'UK1\(:;80_$#QI)#9VZ/#
M=6PC9(P"@:V0G'IDYS0!WE<SK7BY+'2K#4=/ABOK:ZU".Q,GF[0NZ7RBPX.[
M!SZ?6NCEBCGA>&:-9(G4JZ.,A@>H([BO%K"VLE^#WAQ($BBEDUBU$QAPK_\
M'X0"2.<C! ^E 'ME%>2ZM)+X8O\ Q[%H@DACCTVTNA'&S'8S&19)%YX;:,D^
MH!KHO#MEI1\1V^K:5K=E(EU9E6M-/BV1S*"")7&]OF&<;C@\X- '<5SFG>);
MG7Q/<:%80W&GQ2M"MW<7)B6=E.&,8"-E001N.,D'&1S6UJ$$MSIMU!"^R66%
MT1_[K$$ UQWPCN(A\/K'3&'E7VFE[6\MFX>&0.V0P]\Y]\T =3HVIRZI:S23
MV4EE-%.\+PR,&(*GKD<8(P1[$5HUQ'B?5(Y_%/A2R9@^C7EW<17+$?NY9EC_
M '2,>C MNXZ%D'I7)>*X);+1_B-I]L\D>DVL-M-;(CE5@F=<R(N#POW6V]!N
MZ<T >R45YIXE\.:7I^O>%H[;[1"FH:JYNB+N3]\3;N"3ENIVCIC]:P]3^T^$
MO^$NLM)DGBT"*[T_?MD8_9%E(^T!#G(^7:3Z;\\4 >ST5P5U81V'Q$TZUTE!
M%I^H:9<'4+>W.R/"%/+DPN,,2Q7(Y(^E<SH=CH]I\)]'UB\:\-[J$=O:/+'<
MD&;=."L;%LJJ$C#'&=I;UY /7;JZ@L;2:ZN95B@A0R22,<!5 R2:KR75Y)+I
M[V5M'-:3DF>1Y=C1)M)4A<'<2<#''6O)]32$Z1\4=-D%D8H+6.>*U@YBAD\@
MEBBGH00,D <C.!70WD-G;ZY\/?L.R.,SRJR0MA#FU=N5'&<X.<9H ]%HKR9V
M75O GC#5+YC%K^G7=V8YP<2VSQG,*H>H7 3 '#;CUR:O6VEQZW\0FM]<A>1I
M_#=M+=6S2L$\TR.&^7..,=.G /6@#TNBN3^&-S-=_#;0I;B5Y9/L^TNYR2%8
M@9/T JM\185D7PSF25"VO6L9\N5DRK$Y'!]OPH [6BO+!X=TN3Q#XYTMK<_8
M(+2WN8K;S&$:2O')N<+G&[Y5.?6J=O>6VL:'I<5Y,+F_7PI'<3&^D!AC5ACS
M57JTI*XSD8'?)P0#U^BO*=S1>!O!OC<,;JXTFU@;4.=[20/&%D+>K)NWC//!
M]:[KPQ KVEQJYC"2ZI,;GI@B/ $8]OD"DC^\S4 ;E%<SXZN;2WT"*.\>=4N;
MVW@1(9 @E=I!A'8@@1G&&_V<]>E>?7^L7.AV/C^*RN(H4@N[/*6+$+;1R+&)
MFC Y! )R1CGG H ]*N-?F@\:V6@&T3R;JSEN5N/-.049 5VX_P!OKFMVO,]1
M@L=+^(NF7&@P6PFDT&\>%(<;96!C,9P.I/KU./:J"-YGP_\ "7B+2W+:_+=6
MJRS@_O+F1W"SQR'JP^_D'IMXQB@#UNJQO[8:DFG>:OVMX6G$8Z[ 0I)].6'Z
M^E>3S:#IVI:9\0I[R>X$VGW\TMK*;I\VS+;QLKKSUR/TQ6EH4$<OQ%TF[UBV
MMUU.7PO;S3M*BAC<>:H)Y_BSQZ]J /3SG''6L/PQK\VOP:B\]HEM)9:A-9%$
ME\P-Y9 W9P.OTK<KQ>XT6PNO"/C?5F>:/4['6;Z2QGBF=6BF# H$ .,LV!TR
M<CVH ]HHKS?599_"'B'3?$L]HTHU2S%E>PQC.V\V[HRH[;V!C/;.W-=OH.EK
MH^BVUE\ID1=TK*,!Y#RQ^A)./08% &C17#^/K6*YUOP?'(\H275#%(J2LH9#
M#(2" >^![UC7%EIB^*-0\(W4]E96$&G0_P!FPWRM(-AW^8\;,XPX;'/)&!CI
M0!ZC17E>K6E[;V%M<VTL'BBRL])5+JWNF\NX:+<^+F%CD;F"GGJ=@(-:&D7-
MGXE\9WMCJ4'G6']CV=QIEO=+UB<-YDFW^_DHI/48H Z?Q%K\VA7&C(EHD\>H
MZA'9,YEVF+>"=P&#N^Z>X[5NUY#;SWLWA+P;]NFDG\OQ2L-O/*V6EA5IEC8G
MO\H'/<8-6-3DM[>#XJP2/'&L<220HS !&:T!!4=B7R1CO[T >FO?VT>HPZ>T
MJBZFC>5(^Y12H8_3++^=-L9;Z5KH7MK% J3LMN8Y=_F18&&/ VDG/'/3K7GE
MC;Z=-X_\*W5S%;.TGAQG\V15)9U>':<GJ1DX^IK,FO[C2?#/BEH9IDM1XM$-
MW+YC%HK8F$2?-G(&#C/8&@#V&BO/[VP2P\?P6FE((=.OM(N'O[> [(U*%1'(
M N,,=Q7(Z@>U<WH%I%::'\,]7A:07]U<);S3M*Q,D;0R$H<GIE0<>O/6@#V2
MBBO,[]Y],\3F^O;2WU32;K5XDCOX&VW5C-N5!$ZG[T>X <=FSCI0!Z917C.L
MS06WP]^(L32I$\&L2_9U+8,9*Q%=@[=\8]ZZ*XN-*UGQIXDT7Q#<1)$ME ;#
MS9 H6)D;S)8R> P?^(<C:OI0!TYU^9?'4?AUK1!%)ISWJW(E))VR(FTKCC[V
M<Y-;M>;_ -FV&I?$31K*9YKVR_X1F0!KASNG431 &3&-V1R<]3VK9^&$COX"
MLT>1W\F>YA0NQ8A$GD51D^B@#\* .OHKBOB=$)/#M@?,EC(U6S4-'(4(#3*#
MT/H:IW.D:;X=^(GA6WL(A;6]Q%J#2*9&(=B(VY+$YZL0.V3B@#I/%VOS>&?#
MTNJQ6B70CDB1D:79@.ZID<'."PXX^M;M>,W4\4OPL\6"&5'A3Q&RQ[6RJI]L
MBV@>V.E;FL/;:UXS\0Z%K-_96BK:PFR^V1Y(C9#NDB)=0K!\Y(Y^5?2@#TJB
MO*=?M[N"P^V*T7B;3;?1HX[V*=O+NXX_G/VF%CQN9<D]"=@YKTFRU:QOS''!
M<QF=X$N/LY<"58V'!9>H% %VBBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBL[6=>TWP_;17&J
M7/V>&6585<HQ&]C@ X!QR>IXH T:*Q(?%FDW-HMQ ]S+N:15B6TE\T^6<.?+
MV[L D#.,<CU%21>*-&N-/L;VWO%GAOV*6HB1F:5@"2 H&<C:<Y'&#G% &O17
M/#QQX>-I+=?;9!##.MM*QM91Y<I;:$;Y>#NXYZ'K5]M5L[K4[G1(KN2+48X!
M,RB(@JC$J'4LNT\@^O2@#2HKBO!?B<-X"\.W>L7<D^H:A&0H"%Y)G&YCA5'8
M#)["K>I>.],M-*TS4+19[N'4+Z.S0QP.=C&3:^X8R&&&^7&21C'6@#JJ*PK?
M4K*X\72P1ZG=_:5L%D;3WB*1JA?B7YE!W'.WKVZ9%20>*M'N+JT@2Z8?;"1:
MR/"ZQSD#.$<C:W R,'D<C- &S17,S?$#PU +AI+Z39;7'V:X<6LI6!^/OG;A
M%^8#<<#WX-:5]XAT[3I9HYY)28$5YC% \@B#9P6*@XS@_ASTH U**:[K&C.[
M!4499B< #UK'L?%FC:C<0P6]S(7GMS<P;X'03Q#&60D ,.1T[$'H: -JBN:M
MO'WAN[:S$%](Z7DYMH9?LTHC\T,5V,Y7"L2#@$@GMU%0^-/$D&G^'-<2TO;B
M*_M+-Y/,MH#)Y#["4WG:57/'7L<\#F@#JZRX-)%GKMSJ-J55+X+]KB/=U&%D
M7WQA2.X"],<NT">2X\-:7<3N7EDLXGD=NK$H"2:QY/B/X5A8>9J95!<&V>0V
M\NR*0';AVVX3GCYL=_2@#;M=#TFQNFN;33+."=B29(H%5B3UY []_6H[;20N
MMW&L7)5[N2(6\07I%$#NP/4DG)/LH[9-.\\:Z#8:G-IT]W(+N$QB2)+>1ROF
M'"GA3QGOT'&>HJ6?Q7HUM+LFNF6,3_9C/Y3^2LN<;#)C:#GCD]>.O% &U5*[
MT;2[^YBN;S3;.XGB_P!7+- KLGT)&1575/$VE:-Y_P!LN'46Z"2X,<+R"%#T
M9RH.T<'KV!/2EU#Q+I>FQ-+-/(Z)"+AS;PO-LB.<.VP'"G!Y/7!QT- %NZTO
M3[Z:&:\L;:XE@.Z)YHE=HSZJ2./PID6C:7";DQ:;9H;K(N-L"CSL_P!_CYOQ
MJ"?Q!IJQ6WE7+S->0F: 6D;3,T>!\X"@_+R.2,9('?%<SX&\612^%M-EU?49
MI[C4-0N;:VFDA;]Z1-($4E5PIVKT..E '7:9H^F:+;M;Z7I]K90LVYH[:%8U
M)]2 .M6I8HYHFBE19(V&&5AD$>XK&NO&&AV4.J2W%X\::456]S;R9B+#<.-N
M2".<C(I;?Q;HUVDK07$LGES"$*+>3=(Y7< @VY<;><KD8!.<4 /C\)^'(L>7
MX?TI,'<-MG&,'UZ5>O=-L=2@6"^LX+F)6#JDT88*PZ$ ]"/6J%OXJT>[LQ<P
M7+OFY:T\H0OYHF4$M&8\;@P )((Z#/3FK^GZA;ZG:"YM6<Q[WC^>-HV#*Q5@
M58 C!!'2@".;1=*N=-&G3Z;9RV(.1;/ K1YSG.TC'7FHG\.:'*DR2:-I[I/L
M\U6MD(DV#"[N.<#@9Z5SNLZV][XXB\,+/J%I VGR3--:P2!_-,B(A#!2-J@L
M2?NYP">,5J6_B73=/MK:UOM4>XD1ULY+]K=EBDG'RD%P-BDMD8S@'CKQ0!J7
MFC:9J&GK87FG6EQ9KC;;RPJR#'3"D8&*6QTC3=,:1K#3[6U:3&\P0JA; P,X
M'.  *S+CQKH-KJLNF2W<GVR&2**2);>1BID)"9PN,$C[W09&3R*E\6^(8_"O
MAB^UB2"6?[/&2L<:%LMVSCH,]2>E &T0""",@]JHV.BZ7IC,UAIUI:LPP3#"
MJ9&<XX'3/-<KJOB-[+QWH9-Y>KIMU8W3M:&V8,SH8PN(]GF%OF/&#Z@5T-KX
MFTF]T>#5+:Z,EM.YBCQ$^]G!(*;,;MP*G(QD8/84 6[/2--TZ666QT^TMI)3
MF1X(50N?4D#FK4D4<T;1RHKQL,,K#((]Q5'2=;L-;CG>QF+M;RF&>-XVC>)Q
MU5E8 @\CMS3=2UVPTIBES)(9!$9FCAA>5EC'5B%!('N>O:@"*'PKX=MRI@T'
M2XBIW I9QC!]>!5V^TVQU.%8;^RM[N)6#!)XE=01WP1UJI_PDFE-;6<\-R;E
M;V(S6RV\;2M*@ )8*H)P,C)/0D#J:K2>,_#\6FV>H/J*BUNYQ;12>6^/-)V[
M&X^0@]=V,8.: -*+2--@OFOHM/M([QEVFX2%1(5]-V,XJ/\ L+2/[7_M;^R[
M+^TL8^U^0OFXQC[V,].*KV'BG1]2CU!X;IHQI_\ Q]BYA>!H1C<&8. 0I'(/
M0BN=N?$KS_$30+:TNKY;&>SNIIK:2U9%?:$*,N4#-U;C)[<#N =7)H>DRZLF
MJR:99OJ*#"W30*95'LV,U,-.L1J+:B+.W%ZR>6;GRE\PI_=W8SCVK-C\7:'+
MIVGZ@EXQM=0N!:VTGD28>4N4"GY?E^8$?-BG:CXKT;26F^V71C2!TCGE$3M'
M S8VAW *J3N7J>,@G (H M6>B:5I\SRV6FVEO(^=S10JI.3D]!W/)H@T32;:
MWN;>#2[**&ZSY\<<"JLN>NX 8;/O6=8>*H+_ ,7:IH*6]RKV,<),K0/M9GWD
M\XP!A1@G&23C.*UK_4+73+<37<NQ&=8T 4LSL3@*JC)8GT H ++3+#30PL;*
MWM@P ;R8PN0.@X[#M5JL>/Q-IL]M?R0O,\MA@7%O]GD$T9(R,Q[=V".0<8QS
MVK"\#W-[X@T[2_$4NIWH:>UW7=G)"5@=FY4Q[@,!>F5)!'7)Y(!T]GHNE:?.
MT]GIMI;RMG<\4*J3DY/('<\GUIUMI&FV5U+=6NGVD%Q,<RRQ0JKN?<@9/XU2
MU/Q5H^D2W,=Y<NIM8UEN3'"\@@1B0K.5!"@X/7L,]*;?>+=&T_4CITUS*U[]
MG^TK!#;R2L\>0,J%4[NO09/4]C0!MUF'PWH31-$VC:<8VE,[*;5,&0_QD8^]
M[]:J)XRT&2WTJ=+UGBU5MEFZV\C"1N?ER%^4\'AL'@^E:D6HVTVI7&GQNYN;
M=%>5?*8* V=OS8VG.#P#VH ;'I.FPWDEY%I]JEU(NR2985#NOH6QDBF:;H>D
MZ,9CI>F6=EYQW2_9H%CWGWP!FJ^H>)])TO4HM.NKB07DL32QPI!)(TBKC.T*
MIW'D<#GVJ@GQ \-26UO<K?2&":40^9]EEVPR;MFV4[<1'=QA\4 =-69>>'=%
MU"\%Y>:38W%SC;YTL"LY'H21DCVJ+5/%&DZ/YIO;ATC@*B>5(7=(-V,;V4$+
MU!YZ @G@T[4_$NEZ0DKW4TA2&,33-# \HBC.<,Y0':."<GL">@H NW6G6-[9
M?8[JSMY[7@>3)&&3CIP>.*A?1-*DT\Z>^F6;V9;<;=H%,9/J5(QGWK+'C"S?
MQ=!H<,<\JRV/VP7*0N\; LH3:P!!4@DEN@XYJO9^*=#T[2+W4I];N;BS&HR0
MM-<1-^YD+ >4 $!"J2 "?SH 3Q+X8FU:_P##HM;2P;3],NC-+!,Q4%?+9 JJ
M$(XW9[=*Z.'3K*WM'M(;2".V?.^)8P%;/7(Z'/?UJCIWB?2=4N[RUMKAQ-9J
M'F2>%X2$.<.-X&Y3@_,,CBH8_&.B2W-C MS+OOUWVA-O(!.O'S(=N".0<^A!
MZ'- %ZUT32K&WDM[73;2"&50KQQPJJLHZ @#D<]*0:#HXTM]+&E6(T]^6M1;
MIY1YSRF,=?:K-Y>6VGV<MW=S)#;Q+N>1SP!5&V\1:;=7<]FDDR7<$/GM;RV\
MB2&/^\J%06&>. >>.M $T.B:3;F4PZ991^;$()-D"C?&!@(<#E<<8Z4U?#^C
M(MJJZ18!;3_CV MD_<_[G'R_A7+>%]1N_%D[ZFNI:A:/:ZC<1FW^SLL$L".R
M*AW*!NX#$@[@<CV'57^M66G2^5.TK2^49BD,+RLJ#@L0H) _GSCI0 Z71=*F
MO_M\NFVCWGR_OVA4O\OW><9X[>E*^CZ9)>/>/IUHUU(GEO.8%+LO]TMC)'M6
M0/&%I)XMM-#B@N7^T6)O!.+=RN"R*@! Z?,22>!@#.:M-XKT9)XHVNF"2SFV
MCG,3^2TH)&P28VYR".O4$=>* -*RL+/3;86UA:06L )(B@C"*"?8<4V]TRPU
M+ROMUC;77E-OC\^)7V-ZC(X/O5#4_%.CZ.9_MMTR);E!<2+$[I!NQMWLH(7.
M1U[$'IS6+!K<MEX[\1K?ZC(VE6FG6UTBLH*Q;C)N*A1DYVCU- '2'0](::XF
M.EV1EN5VSN;=-TH]&./F'UJ-?#FAJ]LZZ-IX:U!6W(MDS$#U"\?+^%<WKOB&
M2S\8>%94O;N+3+R.[,ULUNRF0I&"GR%?,+9/W>_'%;]KXIT:\T8ZK%=G[*)3
M =\3JXE#;?+*$;M^[C;C)S0!2U'0[]UAT;2XM*LO#DD)CNHTB990"?F6-5P@
M#*2,GD9)YKI  H    X %8DFN6FIV6JV]A=RP7UI"3(C1%)825)5MKKR#C@X
M(/-4/"OB!1X#\.7FJW,DMY?6L6,(7DGD*;CA5&3P"3Q@ 9- '1WUA9ZG:/:7
M]K!=6SXWPSQAT;'/(/%0PZ+I5N93!IMG$9HQ#*4@4;T P%.!RH'&.E<KX/\
M$9G'BBYU#4)YK:UU<V\!N(BKHOEQXC"!0<[F( QDD]S6O-XWT"VL]1NKB[D@
M732HNTEMY%DBW#*DIMW8(Z'&#0!=LO#.@Z;)')8Z+I]M)%N\MH;9$*9ZX('&
M<#\JF@T72K:]>]@TVTBNG8LTR0J'+'J<@9R>Y[U1@\7:-=.Z6\\TLBRF$(EM
M(6<A0Q*C;\RX(.X<<CGD5J6-];ZE91W=JS-#("5+(4/7'(8 CIW% ',:!X2-
MKK&NWVKV&FS&^O\ [7 ZGS&1=J*%.Y!T*9XSR:Z:;3K&XO8+V:SMY+JW!$,[
MQ*7CSUVL1D9]JH7_ (HTC3&N!=7#A+4J+F1(7=(,@$;V4$+P0>3P""< YK&\
M3^)!;^(= T>-[M;?4&F>>6U@D9F18BRA&13G+$$[>0!V!H [&J']AZ3_ &@;
M_P#LRS^V%@QG\A=Y(Z'=C.?>JT;R>&O#$DVHWMWJ7V.-Y'F,0,LB@D@;5')
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M,4(W8(R00,'!]*;I_B_1-4U&"PM;IVGN(/M$&^"1$F08R4=E"MC(R 21W[T
M6;CPYHEU=SW=QH]A-<W"".:62W1FD48X8D9(X'!]*6\\/Z+J)MC>Z38W)M?]
M1YUNC^5_NY''X5/J6IV>DVGVF]F\J(NL:_*6+.Q"JJ@9)))  %4X?$^DS6MW
M<"X919S"WGC>)UD21MNU=A&XD[EQ@'.1C- %N32=-FOOMTNGVKW>S9Y[0J9-
MOINQG'M3['3K'3(#!86=O:1%BQC@B5%)/4X ZTRPU.VU+[0+?S0UO)Y4J2PM
M&RMM#8PP&>&!R..:S[K4+-/%UI:-J=U'=BTED%@D9,<J@KER=O)7@  _Q=*
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MHPZ?)HD<2RRP;3N661B"OWLX/3&?;D5UNG:9#IJ-LDGGE?'F3W$A>1\=,D]
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MD7V9]RQ"\:7=TZ;"#^G6K,T6JZ;8^/-&GTC4+I]6:ZNK&YMX#(DJRPA0A/\
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MF.G6=VEU-'&SI"\H4JI8#& 05S[=A4'C6UUK5;7Q;8#1+]I&>%K+['$%BN$
M0EW8$&1^"NTYP N!U->KT4 <9$MY#\3I-2?3+S[)>:/#$L@0$1NDLC,KX/!P
MP..<]LUS%IH^LQ>&M*NX].NS)I?B*>_FLVB*O+ \DGS(#C<0L@8#ZCK7JMQ=
M6]I&)+F>*&,L$#2.%&XG &3W)( J6@#SG7=+NM5U'Q+KEI:78@F\.MID,36[
MI)<3,7;(0@-@949('4]AFI(;6[_MKX?2?8+P)964T=TQMW A9H40!N./F4C\
M,].:]"HH YOQM+J$.C6SZ?8O=D7L)G\J%9988MV6DC4Y!<<8X..O:N0@TIY'
M\80:CH.LR:??W=I+&VXF4J%B7>K!BQ9""^!G&W''2O4Z* .5\%0:Q:+J5MJ%
MU<WME',HL;N\A\NXE38,B0$ G:> Q )Q]*CU*"X?XH:'=I:W#6T-A<Q23K$Q
M16=HRH+8QSM-==10!R'P_M[S3],O].O;&YMY(M1NI \B@)(KS,ZE#GD8(YK.
M\::9<7&KW%]I/]JV6M06*BWN;:%I8+SER()5P5P#W;&-^<\5Z!4375NMTEJT
M\0N'4NL1<;V4=2!U(H XRR2^3XB7>HWMC<*C:%! \D4#M&9E=V=%('.-PQZU
M@^'(=8TW0O!NGW6BZ@L,-I-#=26\&+B*7(VQ[C@QHPY+*1DA>0 :]6HH \CL
M=-U2#X?^&-/ET?4([FQU])IHS"7*Q+<.Y?C/&UASW[9KKM.AN%^*.L7;6MPM
MK-IUM%'.T+!&=&D+ '&. PKKJ* "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LC7]<718;-4B
M$UW?726EK$6VAG;)R3@X4*&)X/2M>N>\7>')O$-G9/97:VFHZ?=I>6DSIO3>
MN1M89&5()!Q0!RL&IMX?\>^+]3U."%1;Z5:R'[+G]]\TN.#T8GY>2>@YK:/C
M.[L+VY&JZ7,NGPV,EX;V"&4)&4&6C;>B\XY![^@JM<>!M0UF^UJ?6;^T$6JZ
M='9R1VD+ QLA8AE9F[%L\CGV[W+/PYK]_I%SI?BG6+:]M9+9[4&T@:)Y0R[2
M\A+$;L'@  9.>>, "V?BG5I]9LK-]%=H+V!Y$G2.94MY%&0DK-'C#= P[C&*
MR;3X@ZO/HF@ZTVAVPL]4NQ9F-;LF5)&9E4C*XVY4 \YYSBMGP[HWBG38HK;5
M=:L[VVLTV6QBMVCDGP-JF9MQ' [ <G!SQSEV_@;4[?PEH&BB]M&?2=02],VU
M@)0DA<+CMG=C.3T]^ #<T#7[Z_UW6-&U.SMX+K3A#)NMIC(CQRABO+*#D;"#
MQ715S^FZ'>6?C'6=:EF@:'488(A$N=T?E;L'/0YWGZ8[UT% '&:YXTN]$N)'
MN+&".V2_AM$BEFQ-<1N44S(!QM#/C!Z[3R.E)=^*O$4FMZ]I6D:'9W$VE)#(
M&EO"HF5U9L !.&.W '3KENE4]3\":S>PZW;QZO9^3?ZC%J$<DMLS2J4=&$;-
MN&479@8]>U-THZF?B3XQCL9K-IOLU@LC2AAM?RWPX SD#GY<CJ/F% $MM\0+
MW5V\/KHVD02?VU937$37%T4$3QE0ROA#P"W49)QT'6HA\1=031FEET2)=2M=
M7CTJ\MA<\*SLH5XSM^8$,",XJK)H_P#PC?C/P-H^E/%(;33KY,7#%?-_U18D
MC.TDY/0]^*U+[P/=W&GR"*[MQ?7.KQ:K<RNC;-T;*5C4=< (HR3ZG'.  7X/
M$.KOJL.A3V5E#K#P2W<FR=I(8X%<(C9V@L6)Z<8P3[5ER_$.Z33XG31T:^CU
ME-'O+?[3CRY&8 ,A*_,I!!&=O7VK9U/P]=R>*;'Q+ILT,=]#;-9W$,V?+GA+
M;@-PY4JW(.#U(Q7*^+-$;1-*TZ1;B$ZAJ'BFUNY964A/,+@  9SM"JHZY.">
M,T :4GCG5].EU^QU31K5-2TS3SJ<*PW;-%<0#.<,4!# C'W>3Z4S4_$VJKX5
M75M5\.Z;-8SR61AB>Y+G$KJ-S*4QN5F4@ _CQSHZEX3N]7.MWEQ+;1W^HZ8=
M+A"[FCMXCN).< LQ+9Z#[H'J2NK^%]0U/P-9: MS;1SP&VWS%6*GR75A@=>=
M@[\9[T 1^*O&%YX;BU.Z-C +6PB25/M$VUKW/+K%CIM&.2#R>PYH?6M5?XF0
MZ<C6XTL:0;O:S,&.954L>,9&.![GGFJFN^"-7U>?Q((]4M8[?6[1(2)8&>2W
M*IMV(VX#83\W3J3QSFM)?#.HKXFL-8-_:L4T[[!>1FW;#KO#Y3YN.A'.>* *
MEIXWO+V71[JVT>>XTS4Y50/%#*9($8$I*Y*;2IXS@_+GJ:[6N,\->%_$'A\0
MZ3_;EO-H%J^ZV7[.1=! <K$S[MNT=,XR0,<=NSH YOQ-J@T_5?#L,FF6UVEY
MJ @2:5OFMWV.P=1M/.%89R.M8VH>.-:MHO$\L&BV;1^'Y,S%[QAYL?EB0[<)
M][:>^ /4]MWQ)H=WK-]H<]O-#&NFWPO&$@),F$9=HQTX<G//3I63<^#M1N+7
MQA!]JM1_PD.0IPW[@&(1<_WN!GMS0!I2>)+F^O;BQT2VBFN+>RCNY#<.5'[S
M<8XQCN=C9/0<=<\8FHRRWGCCP#?7%@;*]FAO#)#(0S1GR =A8=<&K#>$M=L-
M8MM7T34[&"Z>RBLKZ&Y@>2&41YV2+AE(89/&<<UH7?AR_G\0>'=1%['*-*$W
MFF4'?.TJ[21CA<=0/PXQ0!G3>.[N'PIJ>LG3H"^GZHVGR1"8X<"98MX.WCEL
MXQ^-7-7UF?5#K^EZ=:VTZ:=;[;DW+$"21D+"-0 <87!+'N0,=<9-_P" M8N-
M*US2+?5;**QU#4?[0B9[=FD1FE61E;YL$ J<8Y/'2M!O"FL6>O:M?:7J-F+?
M68E^V0W$#'9*J;/,CPW0CJI].M &/X7U06?A_P"&UG)IEM<+>VP2.YD;Y[=E
MMV;*C;W QG(ZFK%WX_UBVTO7=3_L6T^RZ)J#6UR/MC%G1=F2GR<GY\\X'0<U
M:L?!6I65KX/@:^M)?^$?SN(B9?.!B,>!R<8!SGN>PJ.[\#ZE=>'/%.DF\M%.
MN7CW(DVL?)#! 5Q_%C8.>.M &OJ'B6Y77+[2=.MXGGL=/6^D,[%1)N+!47'3
M[ARW...#VO>%]9E\1>&['6)+5+87D2S)$LIDPI&1DE5Y_#'N:X3Q'<M=>,[F
M+^U_#]G<6EC';RP:J'C\P/EVV,KH7C(*@@Y&1CCG._8W_B*:#03;+ID< G>*
MYBMHG,<T P%DB)QL4#)&<@\ $@C(!V=8&NZ]<Z+K&B0&VB:QU&Y^RR7#2$&&
M0J2@VXY#$;>HP2*WZQ_%.A?\)'X=NM-6;R)GVO!/C)BE1@R/^# 4 8MAXSNK
MR+7H?LEJ-0TR_6RC@69BLI8@(Q.WY022.AQM;/2B77+F/Q#XDMH-+L(K^QTV
M&X2[+$F<'S,!\*#A2IP,GKU&:LV_@JVM/%-CK$,[A+>S^SRQ'_EM(I.R1CW8
M!Y<^[ ]J>/#5T_BG6=3EN(?LVI6,=GY:@[XPF_YL]#G>>/:@#C;B[U"_\._#
M?5+R&&XU&:_MW5P^#)NMI#\S$?+D\G&>G&:Z-/'<UG9:V-6L8DU#3+V*S6*V
MF+).\P0Q88J",[QGCC!//2H;?P9K$6D>%K&74+*7^P;B.566)D\U$C:-5ZG!
M(8DGU[4M_P" 9]5;Q+]IO8X?[5N(+JVDA4EK:6%55#SPWW 3TZD>] &F_B2^
MLO$<6A:A:VRW%Y:R7%E/$[>7(T>-\; C((!!SSD=ATJE:>.;BZT3PGJG]GQ*
MFNW"6[Q^<<PEE=@0<?-]P^G6M*'0;N]UVQUC6GMFN+&WD@@CM@VW=)MWR$MS
MR% "]LGDYXYZR\!ZY;:7X>TUM7L?L^AWZSP,+9BTD:JX&_YOO8<#C ZGGI0!
MK>#]5UC4]7\2IJ!MS!::DUO$(V;* 1QD  CIR23ZD\5UM<]H>@7FC:YK=S]L
MADL=1NOM:Q>41(CE$4@MG&WY..,\^W/0T <38)Y7Q7\1M;0QF1M*M&VD[ [;
MYNI /YX-5--\9S1>$_"MYI^@VD,.KW?V06T4WEK;DF0C "8(^0Y/'7H:WX-#
MOK?QGJ6NK+;M'=V<5LD)W J8RQ!)]RYXQ6)9^!M3M/#OAC2_MMH[:)?"[,FU
M@)@-^%Q_#_K#SST]Z '/XP\0J/$5N-'T\WNA@2S'[8WE21-'YBA3LSNP".0!
MQUJVWB2.\USP>PTFWD35[:6X@N96S+;?N0Y4#;QD$ D'UXIS^%]0:_\ %ER+
MBUQKD"11J0W[G;&8\G^]D'/;ICWJ.U\):C!<^#Y&NK4KH%N\$@ ;,^Z(1Y']
MW &<<]<>] %70?$7B&72_$-Y-9PWT]MJLMK###(5QM=8^XX11EB>O4XJ/4/&
M]^^@^,18_8FO=$MA-'=1.6BD5HRX(']X;2,9(SCGM3[GP+JKZ7K=A;ZM;)#>
MZF=1A5[=B"3(KM'+\WS(=I&!C(//I4K^"=2NY?%!O-4M=FO6"6SB&V9?)=8V
M0$98Y4!NG4^U $C:Q<V]QX-@U#3;.YEOW*K=&0L\#"!FW*"O4@$$Y'4]:==>
M,[H:-JNNV%A%<Z9I<\L<JF0B698CB5TXP,8; /WMO49I\GAG5YY/#$L]Y9-)
MHTIDDV1LHES&8\+R<<$G)SSV%0IX+O;73]=T6SO8%T?5Y99"70^;;"7_ %JI
MV8')*DXVY_BH D;Q;JE]XA?2M&TZSG5],CU&WN9[ED5T=B!N 0D'CH,]>HK:
M\+:Z/$OAC3]9$!@^UQ!VB+;MC9P1GOR#S6=:^&;G3_%AU6T>V%HFE1Z;#;G=
ME0C%E8G\<8]LYK/TC2/$'A71_#>C6=W9SQV\S1W:^0V9HBV=P.?DV@L><Y(4
M=\4 =Q7/>)/$\.@WNF6DTMO;"_:15NKMBL*,H!"$_P!YL\9(Z'KT/0UC:[IE
MSJ9BB$5C=V!CD2YLKQ25ESMVD'!P5P>QZ]NM %$>)+^'7M TN[L((WU2WGD<
MI,6\EX@I(''S [A@\?2JMIXWDGM9%>RC%\VLRZ1!$LIV.Z9)<G&0-JL<8/3'
M>JT/@:_TNV\,'2]1@-SHBSQ?Z7&S(\<O4##9&W "\]!@U7;X>:DVEW2KK42:
MBNM/K%C<+;G$<C$Y5QN^92"00,8SWH @^(%QJ-UX!U^'5=+2)K.YMOLUQ&P9
M+A3+&=R@\J1DJ0?SKI=-\0:A+XNNM U.QMX'6S6]MY()S(#&7*%6RHPP('3(
MYJEK/AG7_$'A.\T[4-3LOMUV\66AA=8(5C</A5+$DDCDDCJ/2K\>AWO_  G0
M\0R2VXB.G"Q:!=Q8'?OW _7C&/?/:@#HJYS4/$5ROB"[T73[>%[FUT\7SM.Q
M"OEF54&.F=IRW...#GCHZ\Q\5W0NO'5S%#J^A6<MI8I T.KAXS(KDLVQE="Z
M$;00<@$?6@#8T?QS=ZI-X7,FF00P:_%-*FVX9VB")O&<HN<]/;U-5=7\8R/X
M+\2WUUHEG=KI5^]E+;32YCF52GS\H>[@[?;K4D.EZQK=OH&KVKZ5;7FD33)$
M(HW-I/"Z;,H,A@,8QVXX)!!J.X\!:I/X6\2Z.VJ6KOK-\UT)3 R^5N*$\;N?
MN# XQGJ: .ANM9FO-=N]!TV"VFEM;9)KIKDG8/,+!(\ <DA6)/88X.:Y#P'K
MW]E> /#>GQ0#[9>_:V1-CNL:),VXD("3@LHP,=>HKHIO#>K6WBZ3Q!I5Y:1/
M>VT<%_;7$;.C%,[9$((.0"1@\$>E8]M\/M9T[0]#%CK5M'K.CRSM!,UNQADC
MF8L\;KNR1TY&.@X[T 5?$VJW&N^#H9]1TF2QN[37[6 >;&P$@%Q'B2,NH.U@
M?3U':NF;5G7Q[>Z:FDV9NHM*6YCNS)AY5,C*(V.S*@$$_P 77-0ZQX:UK6O#
MT-I=:E:O??;8;R618F6)?+=6"(N20/E'))/)/L++:%J'_":7&OK+:[)-,6Q6
M$[L@AV?<3Z98C&/QH QM*\>ZG>VGAC4KK2+:#3M<F%NI2Y+2QR,KLIV[<;?D
M(ZY[\=*L7?CB["->Z;I$]_917K6KQPPRM*ZK(8WD0A"I 8'C/(&<CI4-IX(U
M*U\.^%=*%Y:,="O$N3)M8><%5U"X_AR'///2K&G^%-?T?4KRVT[6[=- O+E[
MDPR6[&XMR[;G2)PP !))!(.,T 6K?Q:]]XAO-*M!:>?9W:P36DLI6X\LA29E
M'=>>@[#.>U=57'ZGX0N-9U.TN+YK,O9WZW=M?1J5N8XP^[R?<'[I.<8/W2>:
M["@#'UO5+O3YK2.""$0S;S->W#[8K<*!C=W)8D ?C]#S<?Q O+CP[X>U2WTF
M)VU74#I[QFY(\MPTBY!V\J3&>>",C@UM:[H6HW_B#1]5L+VWC^P^:KP7,+2(
MV\ ;P PPZX('LQZ5@VG@35;31]&T_P#M*TE73-7;4E8Q,I=2\C;#R>3YIY[8
M'!ZT 6U\=36-OX@76;&*.\TB>&(1VLQ=)S,%,04L 026 .1QUJJ%O1\8]+>^
M@M$D?1K@^9;DG=^\BRIR,G'8]\]!4FJ^ ;C69O$YN+Z.!=7>VEMWB4E[:2
M(QSPV2H)Z>GO5VT\/:_+XJTW7=4O].+VMG+:R16]N^)-[*<@EN/N#L<=.>M
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M0QO(\A<&3(()"[5 '3+'.>, '37-Z]O?V=LMG<S+<EPTT:@I#M7.7).1GH,
M\U;KA;BXU6Q\3>"+&37)+L3?:H+QHT5$N'CA8[BHS@[ATSC(Z5SEQ)X@F\*>
M+-:C\3ZA'=:)J5V;5<IY;)$0=LBA?F! QC@#TZY /7:898Q,L)=1(REE3/)
MP"<>V1^8KS'Q1KFHMI&O:C9W]T+RSTR"Y6"!O*33Y"A<^8<_O6;CY2#@ 9QG
M)TD@-W\7;*=[BY4MX?,VU)F"AO.3HN<8/<=^] ':6%Z]Z+@O9W-KY,[PCSU
M\P+_ !K@G*GL>#[5;KRU/$VJV6B7L<FH3223>+#I(NY-I:" R 9'&!A00.,
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M W*SY.U@PX.>1QBLW1+[5H1\/=0FUF]N6UB'R[R&9P8V!MC("!CA@R]>IR:
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M1T*WUA+RWCM)D1BSRJ!&6 .UCG ;D#%7[2\MK^W6XL[B*X@;[LD+AU/T(XH
MS#X4T5[S4KE[/>VIKMNXWD=HY?E"D["=H)  R!GBF>'_  CH_AD,-,AF7*[%
M,UQ),43^XN\G:OL/0>E6?$.OV'AG0[K5M1F$=O A;!/+MV5?4GH*Q+[Q6;;Q
MAI-NM_8'1+NRN;B2?(^4Q%!GS-VW;\Q[=NM '75@:OX,T36]4BU.\MY1>1IY
M1FM[B2%GCSG8^PC<OL:U4U.PDTY=02^MFLF7<+E95,9&<9W9QUIUG?6>HVXN
M+&Z@N8"2!)#('7(ZC(H HW?AO3+N[M;OR7M[JUB,,,UM(T3+&?X/E(RO X/
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MI?VMQ);-MG2*96,1]& /RG@]:A&L:?=VUR;'5;%GBC+%Q*KK%D'#, >GY=*
M-&L[5M#L-:6W^V1,9+:43031N4DB?IE64@CC@CH1UIEKJEO:Z+8SZGJU@[2Q
M*3=*ZQQ3-MR63)Z'KU/%5[CQ=HEMK&GZ8VH6QN+Z(S18E7:4XPV<_P 61CUY
MQTH ED\,Z7-I-[ILD,K6]]N-T?.<//D;3N<'<> !UZ #I5^PL8--L8;.V#B"
M% D8>1G(4# &6)-1MJVFIJ"V#ZA:K>MPMN9E$AXSPN<].:BE\0:+;MMFU>PC
M;SO(P]R@/F<'9R?O<CCKS0!>FA2X@DAE&8Y%*,,XR",&LNS\-Z;9R1R*DLS1
M0-;1&XF>7RXFQE1N)X.U<GJ<#FFOXHTF/Q.GA]KR$7Y@\XQF0#;\P"K_ +QR
M2!UP/I6P[K&C.[!549+$X 'K0!S\?@G08M'M]+CM95M[659K9OM,AD@=?NE'
M+;EP.  <8XQR:M/X8TB;3;[3[FT%S!?\W?GL7:8X !9B<\ #'I@8Q4W]OZ-Y
M$4_]KV'DS.4CD^TIM=AU .<$^U1ZOJ4,5A?Q6VK6%G>PP[M]RZE8,_=9UR./
MKB@"E;>"-#MM&N]*6&YDMKN/RIS+=RN[QX(V;RVX+@GY00.3ZU,GA'1XM1M=
M0CBN$N[:V%I'*MU*#Y0.0K?-\P^N:)O%.EVFM66B7&H6W]H7,!E'SA5P-H!P
M3_$6X&<G!]*S?"_BP7BWL&MZAI\-XFK7%C;(&$7G"-@HVJS$D_B>M %Q/ ^@
MII5MIBV]P+2UN?M<,?VN7Y)=V\-G=G[Q)ZXR:GN?">D75[=W30RH]Z@2[6*=
MT2Y &!O4'#<<9ZD<'(K;JG<:KIUI<+;W-_:PSMC;'),JL<G P"<\GI0!7F\/
MZ;/J]EJCPN+NQC:*W*3.JQJV,C8#MP<#J.PK*E^'GAN5+F(VUPEM<3BY>VCO
M)4A$H8-N5 P"G('3%;AUC3!%<2G4;01VQVSL9UQ$?1CGY3]:==:KIUE;)<7=
M_:P02#*22S*JL,9X).#QS0!CZAX$\/ZGK U6XM)/M918Y6CN)$$ZKT$H5@''
M^]G/0Y%:$.@:=;Z[-K44<HOIHEA=_/<J47)"[,[<#)[=S61J_B2;3_%V@6PN
MK,:/?V]S-+*PZ"-%8-OW;=IW>G;K71V=[:ZC:1W5E<PW-O(,I+"X=&[<$<&@
M#.M/#&F6<UM)&D[BU=I;=)9WD6)V!!90Q.#AF'L"<8K8J"YO+6R1'NKF&!7<
M(IE<*&8G  SU)/:JUKKND7TBQVFJV-Q(V["Q7".3M^]P#V[^E $&H^&=+U75
M+;4KJ&3[7;QM$LD4[Q[HR<E&"D;ER,X.15.T\"Z!8Q:;%;6T\::;*TMH!=2_
MNV8$$_>YX)&#QCBJ_C#Q++IWA"XUC0[NRG,,\43-_K5^:548 JPPPW9YS]*W
M[[5M.TP(;^_M;0/]WSYE3=],GW% &9+X*T&>VU2WGLWFAU202W:RSR,'<8PP
MRWRD8&"N,8%.T_PCI6FZI'J<7VR2^2W^S">XO)96,><[3N8Y&?7TK1O-6TW3
M@IO=0M;;<NX>=,J9'KR>E7* "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N&^*:6IT+29+Q(S
M"FLV6\N,@+YHW?ABNYK#\3Z!-XAM;*&*]2U^RWL-YEH3)N:-@RC[PP,CF@#@
M]=L-.;6?%>I:6ML-+;PT\%R\.WR9+DEC&!C@N%].1N7UJ2Y@M['PCX)U:SM8
M?[/AGLY-4D@C&=BQD!Y".2$=LG/0\]J]34$* <9[X&*6@#SX3Z?'XXU[7A/"
M_AUM'BCO9%(>*>?>^ ,<.PCP"!G[RBJO@<KX7\12>'=2PKW$"S:3(TOF>7;$
MD_9BWJA)Q_>'^Z*]+Z4UU9HV57*,00& S@^M 'GFGZ9=:?XKNO"*6Y_L26X7
M6(9 /ECCW;GA]OWP4@?W6:LS4O[/GOOBHTOV:20V:+&6P2<6N,+_ ,# ''?'
M>O0-!T:ZTQ))M2U235-0E54DNGA2+Y%SM4(O  W,?4DGV V* /,=#U);'Q3H
MM]JMPB:;=>'(8;2ZE8"-9@094+'@,1M//7;CM63- VF>#H1*PBL9?%Z7&GH_
MRA;7[2"" >B\,P]B#7LG6B@#RZ75K6RUGQW8:[(D=U?1;['S1Q<VWD;52/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<.K?+;NWS J3C.P*ISW*YK7\&V=]:^&[:;57WZK=J+B\?;C,A4#&/90J_P#
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M.+[1KU_:AV@@*X)5 9')SM"@D=.[#&:6+QK8RV,\HM;L7=O>II\MEL!E29B
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M;Y ?3V XJP_@V2[\/W^F:EKM_?2WT!MI+J58PZ1$8*HH4*,YY."3W/ QU-%
M'/KX64:UI&IMJ$[2Z9;/;1IL0*ZOM#%N,Y^1>F.E3^(/#RZ__9V^\FMOL-XE
MY'Y2J=SIG:#D'CDULT4 8.K>&O[1UNPU>WU*YL+RUB> O J-YD3E25(=2!RH
M((Z5F+\/K9/#B:*FJWPMTO\ [>K$(S!_-\T*"5Z;N><GWKL:* .5O_!7VCQ#
M)K6GZWJ.EW-U&D=ZMKLVW(48!(93M8#C<.<5/J/A*/4+2\L#?3)IMY;K;2VA
M17"HHVY0D95B.YST!QGFNCHH PK/3+ZU\52W$=]<G2OLBPBTD*^6CC;M,?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6M_X4TFZL5F6UDM(C$L_WPNT8W>I]Z<?#>AF&&+^Q[ 1P(4B46R 1J>2J\<
M]P.M:2(D<:QQJJHH 55&  .P% 'FOCF6QN[WQ-$&5[JRT3>YNW CMLB0HT*X
MSYA(&6R,83J>*@U*2_N]*TW5H8K/7H8M$B-_ITTNV90P),\3\C>=K ]_E&#F
MO1;G1-*O;U;RZTRSGNEC,2S2P*SA#G*[B,X.3Q[FHF\-Z&R1*='L-L,?DQC[
M.F$CSG8..%Y/'2@!-&U;3KVQL([6Y7S)K*.YCMY' F$3 89EZ^V>F:T9HEF@
M>)\[74@[6*G'U'(K.;0K-_$,6LF" 7,,!@1TB ?:>Q?J0.PZ#)Z\8TI(TFC:
M.5%>-AAE89!'H10!XWIT7VKP!\-VDGGW2ZJL3LL[*64B8D$@^H'/6NP\%V\6
MG>+/&.E6@,=C;W5N\, 8E8R\"LV,],GFNC'AS0U@@@71M/$5N^^&,6J;8V]5
M&.#[BK%OI>GV=U/=6UC;0W$_^NECB57D_P!X@9/XT <I\68()OASJ+3Q1OY4
MD#J74':?.0$C/3@D?0FJE_I>F7WQ/TJP\B(V(T2Z'D1';&<3Q@J0O!&<\>HK
MO+FUM[VVDMKJ"*>WE7;)%*@97'H0>"*J)H.CQS13)I5BLL4?E1NMN@9$Z;0<
M<#VH \KTO56M/#GA6QO;N*+29-3OK226\4R1?(\@@CDRPRO& "<95?2N_P#!
MVG6^EPZC;VFJ+>VYNC(L<2XBM2P!,4?)PHZ[<\;JT_\ A'M%_LZ73O[(L/L,
MIW26PMD\MCZE<8)]ZM65C::;:1VEC:PVMM&,)#"@1%^@'% '*_$I?^)'ILH=
MU9-7LL;7(!S.@.0.O'K5)VMH/B'XJAN6BCMY-&MYF20@*QW2AFP>.PR?I6UK
MNC:GKU[%:7 LTTB*ZM[M)%D;SRT3!RI7;MP2!SNX&>#6O=Z+I=_>P7MWIUI<
M74 (AFEA5GC!_NL1D4 >7^%-16^;P)I.JR+)IUQHCS(DQW)<72E!M;/#%4+$
M ]SGJ!45L%LO"OB*+3[B**WA\78>W\T+Y\6^+= "3@;AQR0,<' S7I\WAO0K
MC3HM.FT;3Y+*%@T=NULAC0^H7& :R?$'A-9]-CM]$T_1XT^TK/=6=S;@0W@
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M2+L>=85#LOH6QDCVJ/3="TC1FF;2]+L[(S'=*;:!8]Y]\#F@#0HHHH ****
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MCQUX;MHK.5M1#I>P-<6QBA>3S4498KM4Y(].OM6M_:ED-'&K/.L=CY'V@S2
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MK,#("<9P"QQZ]^G-;D9U'0_'OB.2XTR^N[/6(X'M+BUB,BHR1[#$^/N<\@G
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M';FRAA=M40RS)YA_<(J_.>G)5RJ8..6H Z:HFNK=+E+9IXEN)%+)$7 9@.I
MZD5SGQ%U34-%\ ZQJ&F/&EU# 2)'S\@/!*X_B&>/\BL;6_M\?Q)\,S0V=HVI
M2:??*1YA6/@Q8+-MW$ >W4_C0!Z#17%V/CM[G1[1YK(1ZI/?SZ<8(R\B+)"7
MWL"J[BN$)Z9Y XZC6\-:Y>ZN;^&_TR:SELY_+65HI$CN$(R'3>H/L1S@CK0!
M!:^"K&Q9DMM0U6*R9F;["MXWDC<<D#^( DG@-CFM[S[6VD@M#+#$\@*PP[@I
M8*,X5>^ .W85EWVM3_V\-#TZ*%[T6INY'G8A(TW;5&!R2Q#>F "?0'D=6N]0
MO/%'@+49=&6TU:0WJO:S2CY#Y+#!D /R]^ 3@],T >DU'<7$-I;R7%Q-'##&
MI9Y)&"JH'<D\ 5R>G^+=2O-'NY#I41U"SU0Z;<K'-F&/!!:8L0#L"L#C&>WO
M5"[\:_:_!WBFZETRQU :/(\,L7FY@NH]BON&5/4-]WD<=: .^5@RAE(*D9!'
M>EKCK_Q/K$.NVNB:3H]G-+<:8U["TMT8U!5D7:0$.!\W&,YXZ#)JI=>-==BB
M\3-%HMCNT##SA[UL2)Y0E.T[/O8/< ?6@#O**Y*T\67TGB#1;2ZTZ&*QUJWD
MFM)$G+2H417Q(NT 95NQ."*AMO&EW_;NCZ=>V$$$FJ/,GV;SLSVI16=3(!Q\
MRKGMC/>@#LZ*\]E\?ZO%I6H:J^BVBV6FZHUA= 7;%R!(L>Z,;,'EL\X]/>O0
M6944LQ 4#))["@!:K7NHV6G1K)?7EO:QL=H:>54!/IDFN1E\>30^'+7Q2UC&
M= GF5682'SHXF?8LQ&,$9()7J >IZ5#*MYJ'Q8OM/NX+2>P.B(K12.2#$\SA
MN-N-QV@$=.!S0!W$UO#=(@E42(K!U!/!(Y!QW]?J >U#75NEREL\\2SR LD1
M<!F ZD#J<5S7CJ\N_#?PZU*XT40P26EKMBSD")0-OR@=P.G;^58VL_;X_B)X
M3FBM+1]2DL+Y3^\*QG'E8+-MW8 /H>3^- 'H=9^LZ-::]IS65Z)?+WK(KQ2-
M&Z.I#*RL.000#7-V/CM[C2+9I[)8]4FU"?33!&7D021;][ JNXKM0GIGD#CK
M6MX;UR]U=]0@O],FLY;.8(LK12)'<H1D.F]0?8CG!'6@"?3= BL)5FEOK^_E
M3/EO>3[_ "\C!P  ,XR,XS@D9Y-:]<UK/B'4;#Q3IFB6FGV\QU"">6.:2X*!
M3'MR& 4\?..1GZ#K6"_C_6(?#UWK$VBVBQ:7?-9:BHNF))641EHODY'S _-C
MN/>@#T.BN.U?QE>6[:I_9&ER7YTR0121+%*S3OM5V5"B$ @,.O4Y& .2:AXS
MNO\ 3ETC2Y;B>Q@CED@EAFWN[IY@B&Q&VMM*]>Y QU- '8U%!<V]T'-O/%,(
MW,;F-PVUAP5..A'<5QEIXAUG4/'UA:I;K;V$VBB]-K<;HY49I$!WC'WEP0![
MGGFJJ^,YM.\+ZEJEMH%G$]OK;V,\$,VT,YF6,R9V#<Q9L\X^M 'H5%<G#XMN
M[35M:L-:L(86T^P&I(UI,9=\)W@@Y5?F!0^QS4%MXPU*74/#4#:=:M%K]NUQ
M&RW# VZJJNP/R'>=K#!^4$C''!H [.BBN9U7Q#J5KXMM-!L].MI3=V<MQ'/+
M<%0"C*"& 4X'S=LY]NM '351UC2XM:TB[TRXDEC@NHFAE,1 8HPP0"0<9!KB
MQX_U=?#_ /;,VC6J6UI?_8-0471+!Q-Y):(;<$ D'YB#U';)O^(/&EWH#W4T
M]C EK!=0P)'+-B:Z1R@:6,#LI?&#UVGD4 =5I]FNGZ?;V:222)!&(U:3&X@#
M S@ =/:K-<XGB.XB\9W>A7]O!;PK9_;+6Y\TGSD!P^00 I4XSR>"#6GHE[<Z
MCHUK>W5NMO).@D$2L3M4\KG('.,9';I0!;CN;>6>:".>)YH<>;&K@M'D9&X=
M1D<C-2UQ4GB:2RO?&LT6BV8N='ABF=UFVM=KY1<;FV9!"C '/UJ33_%^HR:Q
MH=OJ.FVUO:ZS9O<6\D=P7=&1%=@X*@ $-Q@GI0!V-10W5O<M*L$\4K1/LD".
M&V-C.#CH<$<>]<WI_B35-4ATK4[+25GTG492H99<2PQ$';,P/!!P,J.1N'7I
M7,6>LMX3TSQ_JUI9Q3+::T7,!;RP08H0<$ X/.>E 'J%1375O;M&L\\432L$
MC#N%+L>PSU/M6%>>)_[/\6R:3=0QI9II<FI-=;SE51U5@5Q[DYSVZ5RGB"_O
M=9?P+JTMC;0VMUK$$L/S$S1JT;E0W&/F7D@=",?-UH ]-HKB;SQS=JDEYINC
MW%_90WIM7C@@F>5U63RWD0JA4[6!XSR!G(Z5VU $0MH1<M<[!YS+MWGD@>@]
M!]*EK UW7KG1M9T2W-K$UCJ-S]EDN6D(,,A4E!MQSN*[>HP2*S+#QG=7L6O1
M?9+4:AIE^ME' L[%92Q 1B=OR@DD=#C:V>E '6K<V[W,ELL\37$:AGB#@LJG
M."1U .#^5$UU;V[Q)-/%&\K;(U=P"[>@SU-<E+KES'X@\36T&EV$6H6.FPSI
M=EBQG!\S ?"@X4J<#)Z]1FN9N+O4+_P_\-M4NX8;C49KV!U</@R;K60_,Q'R
MY/)QGVS0!ZQ17%)X[EM+'6AJMC$FH:;>Q62PV\Q9)WE"&+#%01G>,\<8)YZ5
M>?Q)?67B./0K^UMUN+NUDN+*>-V\N0QXWQL",@@$'/.1Z=* .GHKB[3QS/=:
M+X2U/^SXUCUZX2!T\XY@+([ @X^;[A].M3^#M5UC4]6\2KJ!MS#::F]O$(V;
M*!8HB% (Z<DD^I/% '4375O;&,3SQ1&5PD8=PN]CT SU/M0ES;R7,ELD\33Q
M!6DB#@L@.<$CJ,X./I7(?$".,W7A&0HID7Q!;@-CD K)D9I[>()+?7_%B1:-
M9BZTRS@N/.$NUKI2LA =MF5P%.!\W6@#L:CN+B"TMY+BYFCAAC&YY)&"JH]2
M3P!7$6_C;69#X:D;1K3R=?MPUN%NR&CE\GS?G^3 3 /3)XZ9XJ._\87+>#O%
M,NI:)8W-SHLK07-H9BT$Z;%<$$ISPP^4CMUH [X$, 000>0165'X?@B\3S:^
M+FY-U+;K;,A*^7Y:DL!C;G@L3G/>L-]7U<_$?3=+@%LNG/I+W)CW,"3YD2D]
M,9 ) 'N<GT2+QI=IKFD6-[8P6[:G<30"V\[,]MM5F1G'3#A,XXQD=: .PFFB
MMX))IY$BBC4L[NP554<DDGH*6.1)8UDC=71@&5E.00>A!KSRS\1:P_AWQM?Z
MG9V-_!IUU=1_96D8(T<4:Y3E2,%03SU)/ S6[;>(WN+C2]'TVVMTNY],6_=7
M)$5O%\JJ !R<L2 .,!2?0$ ZBBN#D^(5R--AECTA#>IK2:/>VYN,>5(6 W(=
MOSJ001G;UK:T#7[[4-=UG1]2L[>WNM.\F0-;S&1'CE#%>2JG(V,#Q0!T58IT
M33['6KGQ!=7ER6QN"W-TQM[?Y=I9$)VH2."?<^IK:KRS4]1U36/!OQ(35%M9
M(+-KJ&$*2?+V6Z%0 1[DYZY)X% 'J*.LB*Z,&1AE64Y!'J*=7%:/XEO;+4-(
MTG4[&W@M+O3&N+:>.<NZ^4J;A(-H X8'@GICGK3K+QI?7MUHTT6BW$NFZH0!
M)'!-OME9=R.Y*;2IXS@_+GJW6@#LZJPZE8W-W+:07MO+<P\R0I*K.G;E0<BH
M->FNK?0;^:RV?:(X'9"[$ 8!.> >:X?PQ>QV7AWP29=/LY=;O[)+>RFW'(B\
MD22,[8S_  Y(&<DCGDF@#T:::*WA>::1(HD&6=V"JH]23TJ/[;:;[=/M4.^X
M&8%\P9E&,Y7UXYX[5PWB+73J?AGQOH.I6D4=_IVF2R_(=T<T;Q.4D7(R""""
M.Q'4U"\<?_"1_#*78OF?99UWXYQ]EZ9H ]&HKBKGQS<)X=NO$]K8QSZ+:SNC
M@2$3/$CE'E48QP0Q"GJ!G(SBK$OBV[36=4T];2UQ!IJZE8RO.0MS'DAL_+\F
M" #U^\#0!UM107-O=(SV\\4RJ[1L8W# ,#@@X[@\$5SFA^*I]>TS0;NUMH-V
MHPO-/&9&'D*F PSMY(<A#T[GM6+#XSFL/"TFI6N@6D3?VV]A-;PS;1N,_EF0
M'8-S%CGG;UZT >A45R$7C"ZL[WQ#;:U811/I-DNH VDQE$D)#G'*K\P,9'H<
MTEOXMU)]8\/V4FG6C1ZU:M=)(EPP\A5"LRGY3O.'&#\H//2@#L*:[K&C.[!4
M499F. !ZFJFFS:C,MS_:-I#;E;AU@$4N_?$/NN>!@GT[5@:I?-??$72O#Q_X
M]H;*34YU[2$.L<8/L&+-]57TH Z0WUH)9(C=0"2-!(Z&0953G#$=@<'GVJQ7
M-6>I)<^/-7TJ72[6.2&R@D-VIW//&S. K?*, 8/&3UJ#P;J$GV_Q!H$C%AH]
MZ(X"3G$$B"2-?^ Y*CV H ZRHH+JWNO,^SSQ2^6YC?RW#;6'53CH>1Q[URVM
M:KK$/Q"T'2[4V_V&YM[B9U=F#,4V#G Z /P/7KVKE=+UV]\*:9XLU"TTVVET
MVU\13FX!F*.$8QJ?+4*02,YY(H ]8HKDM9\6W5M<ZI;:3I[7L^F(IEC\N5C*
MY3?Y:E$8 [2O)[L!CO72:==F_P!-M;PV\UN9XED,,Z%9(\@':P/0CH10!9HK
MB1XYNYS97EAH]Q>:;<7?V<^3!,TB1[BOG9";"N1DC/0YSGBK>F>+9-7UJXL;
M1;,M:WDMM<VKRE;B%4W 2E<<JQ"XQV8')Y% '5U%<7,%G;O<7,\<$*#+R2N%
M51[D\"N'\/\ B/Q#-HFLWL]G#?7$6K2VD<<,A4(%E$>3D<(H&XGJ<&LKQ=XA
M3Q!X"\<6$T=K*^EQ*%N(&WQRAT#JRYZ$<CJ>G6@#U'((R#QZUG7USIU]HUQO
MU***TE!@>XCF3"DG:0&.1G)Q]?>L&V\2ZG;^)M/T/6M)MX+;5(9#930W!ER4
M7<R2@J #MYXR.V3UKF=(U&/1/A;/<'2[6_MDUJ:-K><X50UZ55@-I!VD@XXZ
M=: /1]%TJ'0]'M-+MI)9+>UC6*(RD%@BC &0!G JU'=6\T\L$<\3S0X\R-7!
M9,],CMG!Z^E<U>^+7C\2W>AVJVGVVW2.1+>YE,;W2MR3%Q@[1GUR01QUKG#?
M:AHGC'Q_>Z3I]K.8(;2YE6:4Q A868@;5.6.#UP/>@#TVBN/;QA?7&JZ)9Z=
MID#IJ^G-?0RS7!79@(<, IX^<<C.?0=:S?\ A/\ 5X_#\NLS:-:+!87YL=04
M71+;A,(BT0V\@$@_,0>H]R >A45R&L^,+NVFU6/2-->^DTO"RQ"*5FF?8',:
M%$8 [67D]SC ZTP^+-9N_$#:1IVC0+*^EQZC&U[.T94.Q79(NPE6!!&.?J*
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M(ANRVYE8L#VY0<?K56;PEJ,J^,%^TVH_X2!-B'#?N/W(BY_O<#/;GCWKLJ*
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MNWOR,9SWIFJ>!-;U&WU^V75;)8M4NHKQ7E@9Y(V0H1$6W#,8V<<9Y/2O0:*
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MO:'J\&O:'9:M:I(D%Y"LT:R !@I&1G!(S6A0!2TB2]ET:RDU)$2^:!#<*@P
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MC@9R?8&K= ' S^!=6.E:G86^K6JQ3ZL=3@1[=B'S*)&BF^;YD)XXQ[^E.N?
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M5'A81IN#1>7'L')^]G /;'O7144 %%%% !1110 4444 %%%% !1110 4444
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M9HDEGJEH\-PT&JN9+U#=2_O6( )^]QD #C' H YZ6]UCQ1JNNZ98W0M)[&"
M6[)=O"8WDB#B4JJ'>-QQACCY.G)--CO=:US5;K0GO81=6FF6TGFVMX]N))9
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MS9!  %2ZEK5YIGBDIK)O[>PN+^%;#4K24O;!<H#!,@/RDL&&X@_>ZC&*WY_
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MY- '':?X@U6^T/P'=7T\HLM0A;^T9X<J[2"+*9*\JI(8DC'(&<"N@\#IJ_\
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M'=N?DTZ!&!!&"$ (Y]Q0!7U+QK9RZ;XC71;ZTDU'1X)'*R'>K.D>\C:&!('
M)'0_2M/P_K]IJNGV,;WUH^IO9Q7$]O'(N]-R@DE,Y R?UKA[B[@M1\4+.=_+
MN)5>6-&!&Y#:*H(]BPP/?CK3;)K&#6?AJ;1K:.1M.N$<I@<F!,!L>K@]>X/>
M@#TA=6TUM0_L]=0M3>\_Z.)E\SCK\N<\5:DDCAB>65U2- 69V. H'4D]J\E\
M)W&DZK9:'HVKSZD?$FDW:R/8%-K1SJ2&E+!!E""S$EL'/<D5Z!XPCLYO"E]%
M?W,UK;2*J/<0_>BRX ?Z X)]@: +\6L:9/!-/%J-I)# ,RR+,I6,?[1SQ^-,
M_MS2C83WR:C:/:VYQ+*DRE4/H3G /(X]Q7FMUK5S#HFMQZ];V&LQV\]B/[6M
M R0S*9,J\JH>L9 9@IP05' -7O#^I6R^*O'$DM]YR36UK,MPT?EHZB)@67C&
MW. #DYXY- &SX9\2WFMV5GK\FIZ6FDSVY>ZMR</:N2"@WYQT.#NQST]*UM3\
M8:'I>CIJDFI6TEK)*L,3Q2JPD<L%P"#CC//H :\ZM=1_L_X>> =2>6<:98%5
MU%[90[6Y,+(KLN#PK'GCC/KBK.NQZ,?!FIZOHLMU<VEQJME=W-W(#LD99H][
MJ,#@ #+ 8./8T >F6^L:9>7/V:VU&SGGV[_*BG5FV^N <X]ZGMKRVO$9[6XA
MG1'*,T3A@&'4''<>E<3XMDETO4=*\:Z/;-=MM^P7,,8P;B&5@(R,^DNS'LQK
MKM'T_P#LO2;>T9Q)*H+32 8\R1B6=OQ8L?QH ==ZMINGRI'>:A:VTCXVK-,J
M%LG P"?7BL7Q1XJM]$O])TW[9:V]QJ$YC:29U_<1A'8N02.I7:,\9/?&#SMO
M=6EIJGCG3?$K(DE[*98!-_R\VIA"*L>?O;2&&T<Y;WJC%]HTN'X86NMSJE_
M[?:!*_S(/LSJ-V?0E5SZT >A:=->V>C--KUY9.\1=FN804C,0)*L03P=N,\X
MSTKF[_QRMWI6@ZGH-U:R6M]JT%G.'7<XC=R,\,-A(&>0>M=LXS&P'.17BUI=
MV,OPN\#V4[INM]8M([F*5<;-LC;U8'T'7T!&>M 'L%EJFGZG%)+87UM=1QL4
M=X)5<*PZ@D'@T6>JZ=J$CQV5_:W+Q@%UAF5RH/3.#Q7E/B*.>>\^)%IH:J]Q
M):V#""#&957/G*H'4[/E./4"N@O+BSU[QAX6U309DEBM[>Y-Z]N?N6[1C;&^
M.AW[<*>003V- ';6^JZ==W+6UM?VLTZ@LT4<RLP ."< YP"<4EOJVFW=W):6
MVH6LUS&,O#',K.HSC) .1SQ7EVEOJL=F='T:_M]:MI=$N5TJ\0!+JP^1=D4V
M..2$ )P<H<]*TO"-[X>\07F@30SZA)K&EPM&;1X_+^PY3:ZR (HQD  $G)P1
MWH ]%N;NVLT5[JXB@1F"!I7"@L> .>YJO;ZUI5W'<26VIV<R6QVSM'.K"(^C
M$'Y?QKE?BLEN?!T4ERB&--1LRQ89POGIG],UBZM8:8WBC6=2TI;0:8OAR6"]
M>#;Y+RELQ+Q\I< 'W V^HH ]#AUO2;A96AU.RD6&-992DZD(C#*LV#P".03U
M%.AU?3+FSDO(-1M);6,E7F292BD=06!P#7F,B6^F_##P?J]E;8AMC8OJLMG"
MK2B)8B&+#!+;)&#$$'!!-7)HO#6I:;JFJZ;K=["+^YM&;6-H\M;B-OW;;2JJ
M0I"[N,<C)R#@ ]$BU33Y[66ZAOK:2WB)$DJRJ40CD@G.!U'YU&FN:2]BU\FJ
M636B-L:<3KL5O0MG /M7F%[JVKIHQO-0BCEATW7HI-0U#24W)=0^3CS@I#<H
M3'N R 4XZ4SQ2/#MYX%\3ZOI5Q->C4'M#)=2C"2R*ZC"#:!N"]2!^H. #U$:
M[I!6\9=4LV%C_P ?6V=3Y'^_@_+T/6JND^*M&U?1[74X+^W6WN76./S)5!WM
M]U",\,?[O6N8/V%/BL\-C]G59?#A15AP Q\W*@8ZG:21[57\(Z[X<LOACX9&
MMO#LB,%LOGV[.([H X'W3M92#SQCU% 'I/2N<MM<EU?P[>ZO:7=K96CK(ME<
M7(RF%)42OR/E)&0..,$GG UM8AFN-$OX+8D3R6TB1X_O%2!^M>?QM;R?LY[7
M5.- :,*X_P"6HB*XQ_>W#'UH [9KJ?[=H\8U;3P)48S1%?GNODR#%\W !RQ^
M]Q^=-AN+^?\ M7[+J.GW<D4^((4&/* 4?NY""<,3GG'&0<'I7'SSVA\3_#64
M2PEOL\X+@C.#;X S[MP/>M+P*]O_ ,)'XSC@:/!U4.JH1R/)C!(QVR"/J#0!
MT^B:O;:]HUMJ=KN$4ZYVM]Y&!(93[@@@^XK+CUJ^'Q%N=$F>#[ FEI>H50JX
M8R,A#,201\OH.M9WPPCD7PY?S'/D7&KWLMO_ -<S,P&/;()IOVBV_P"%RW2R
M2Q;?^$?1&#,,9$SL0?\ @)!QZ&@#?TO4XTTJWDU'6-.N9)IGBCG@8)'(V\A4
M7+'+#A< ]0:D/B;01:279UO3?LT4GE23?:DV(_\ =)S@'VKR:T;3W^''A*.4
MVY$?B895L?*GVJ0G([+M()[8(KHD32?^$\\<&1;/:=,MA\P7&=DH?]-@/X4
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MA>:V,Y0K*$&77*L<,H.2#VZ$U#;^+;>\FTT)I]\;'5"R6MXJ@HV 2"0#N56
M)4D?E0!%9^&=8L&FMX?$C-I\DLDNR6S1YEWL68"3.#R3C*FNBM+6&RLX+2W3
M9!!&L<:_W548 _(5P?@G5_L&FW=FL5U?7,FN7T4<22!W6-96&]B[#Y0 !DGJ
M0.2:BCUJ70?'/C2X6PU"_2*VLYVABD#>4H20N1O8 ?[H.3V% 'H]%80\4VEP
M=/CT^*6\N+^T^VPQ(54B'Y?G8L0 ,LH'<D^Q(Y;QAKUMKW@)[ZR:YMYK75;:
MWGA9BCPRBXC5T<*<'@^X(((H ]&P#VHKGM8UN-VU+2[6TNKR:VMO,NOLT@0Q
M!@=H#%@=Y ) ';J1D9PO!GB**P^'_AB"4M<7]SIXE5&E5257&YF9R!U8#U)/
ML2 #OJ*XV+XD:;<66EW%K8:A.=1N9+1(XU3='.@8F-OFQGY3R,KWR!S5N/QB
M)4F5-'OOM5M;I<75H3&)80^<#;NY/RD\=L=3Q0!T^.<T4UW2*-I)&"HH+,Q.
M  .]<VGC:RV:7=2VEU#INJ2K%:7KA=C,W^KW '<H?^$D=QG&: .FP!17GL@?
MQ3X[U_1=3L;O[';6ULL#I,B&V9C*QE4ALAFVK@C)PH! KJ/$/B&W\+:?;7%S
M;7=Q%+<16P,(#E6=@H)R03R>V30!M45S7_"7HJQQ3:7=6U_()&%G<R11L$1M
MN\MOVX)(Q@G/T!-)IOCC3=9T_3KC38I[B>_\SRK7Y5=/+.)-^3@!3@9R<Y&,
MYH N3:)>77B 7MUJ\LNFQE)(=-$"*JRJ/O%\;F&?F /0@'M6U7.P>,+2XLK2
M06=Y'>75S):164J!93(F=_4[=H"D[LXQ[G%5;OQ]8V&EZU=7-C>+<:+M-Y9@
M(9%5AE7!W;64CH0<]>.* .LQ17.+XM3<D<NDZA#<7%QY%G#*J!KKY-Y=?FX4
M+DDM@C&,9XK)\$3S3>+O&@EBN8=EY;@0SR[RG[E2<')X)R1CL>@Z4 =S167?
MZW%9ZE;Z9#!)=7\\;S+!&5&V-2 78D@ 991ZDGZXY3Q3XU>;X;ZWJ6CQ74-Y
M:F2TG5MJR6<H(5MWS=1D$%<]010!W]&,5BZ'HUI82W%];VEQ927842VSRAD!
M7(W!58J&(/)!YP,\UR&K^(K[7/"7C^*:RN+1=,2YB@E28 J4@5ADJV<DL6],
M<9- 'I.*,5R7A_Q3&TVE:-=6%Y;27&GB>VN)PFR<(J[\88L"-P/S <4Z+Q_I
M4E_I<)206VJ2>59W6]"KMC*@J&W*& X)'UQ0!?\ %6@2^)-+BLH[Q+4)<Q7!
M=H?,R8W#@8W#'*C-;:@A &(+8Y(& 3]*YGX@^))O"G@J_P!5M45[M0L5N&&1
MYCL%!/L,Y_"IH?"<"Z6(9[Z_DU!H\2:@+IQ*7(Y8<X SR% V]L8H Z&C&!BN
M?CUA[#R]&AMYM3U*SLXY+H0LHP""!DN1\S%6P/;G'%4G^(.FO::-<V=G?7D>
MKR/#;B)%!650Q,;AF&ULJ1Z#N0.: .MQ@8HQCI7''Q\QNFL$\,ZT^I+9I>&T
MV1!@C,5Z[\9!4\$Y/8&KECXWTS5=-TJZT])YY=4+BWML!9 8\^9OR<+M(P>>
MI&,Y% '2U7O;**_@\B<L82P+H#PX'\)]O4=^G3(KFKOX@:?9:+J=_/97HDTN
MX6WO;4*ADA9B I^]@J=RD$$Y!Z<&K2>*I'N(;4Z%J45W/+*D,4RHN](U5C(6
MW$!3N &><]N#0!T=4;#3(M->X6V8K;S2-+Y&.$=CEBOH"221ZDGO7+7OCUY=
M*\.:AI.G3RPZO?BU;>45XR"VY,%L;LQL,YQWSTJ_#J^DQ>+]7\^VNK2]M=.B
MFNIYY/W7D9<C #$#!#Y.!^- '45!=P/<VSPI.\!<;3(GW@.^T]C[]JPX_&-M
M]HTI;JRN[6WU8A;*XE"[78KN56 )*,PY (]N#Q6=+\1[2*TO+QM&U06EC?&Q
MO)BL>(&#*NX_/EAEA]W/')QQ0!UUG:6]A9PV=I$L-O @CCC7HJ@8 J:BN:\7
M>(;S06T9+2Q:X-_J,5JS*RC:#EB &(R2%(]!Z]* .EHKSB/69M%\>>+[E=/U
M&^"65E.UO%(K&(;92YR[A1_NJ>>PZUTTGC#3VM=/EM ;B2_M1>01F1(SY1 (
M9BY &=P&.N<]@2 #H:*XA_%N@Z]:>&=0^R7TL=WJ(BMF5MGD7"AP1( XS@!^
M/F!_*M"W\9+=Z]=:3;Z+J<DEI=);7,H6/9%N0,')W\K@CIDCN!QD Z>BJ&KZ
MO;:-9+<W =B\J0Q11@%Y9'.%10<#))[D =3@"N(CUB:P^(_B&]N;*]2.UT.*
M=[<S*^[$DA+1Y;:. !CCE3]2 >C8HKGXO%MI+=>'H5MKD#783-;2$+A,1^80
M_P V0=OH",UR^B:\GA?2/&6I7%O?7MM9Z],'$3B1XX]D?/SL,J,^O H ]((S
MUHK._M=#JEG8);RR-<P-<>8A4I&J[1\QSW+#&,YY]*35-873;BQMEMIKBYO9
M&CA2, #*J6)9CPH !_3 H TL45RT?CNPDTW3[W['>!+S4O[,9<)NAG\PQX;Y
MN1N!Y7/%-UCQH+"V\3K;:=/+>:%:K<.KLBI(K*S*0=V< (<\ ^@- '5T5YMJ
M&J7<GB3P%J,MK>F>>*YWVR.#YI^SY!"AM@Y)Y)&.^*Z.T\;6%QH\E[+;75O/
M'?'36LG"F7[3N $8PVTYR#G.,<DC!H Z:BN;?QC;6\VIVMW8W<-]I]K]L>V^
M1FE@Y^>,[L, 00<D$$?3.-JOC#3]3\(37VI>']9&D/':S+(&6/S1(RE=I60,
M-K;0?KW!H [WITHK UWQ5'H%K?7EUIMXUE9*#)<*T05B0#A0S@L>0.!R3@5#
M<>,H(8(_] N?MAM%NY+.5XHY(D;.T-N;&X[6P 3T.<4 =+@>E%<W9^,].U>U
MTU])CFO9-2MVN8HD(1DB4A69R3\N&(7N<].A(SOAC,\VB:LT@N%(UJ\54N'W
M21J)" K')Y XZGI0!VM&*YO6O&5MHIU-GL+R>'2XHYKR6,* BOG&W<1O( R<
M?SXI;WQ<EOKYT6VTF_O+PV7VV(0B,+(FX+PS. .3_%CIQG(H Z/&:*YNS\::
M?J&D:3?6D-Q)+JK,EM:D!9-RYW[LG "[3DY[<9) .7X$GEF\2>,A+'<P[-0B
M AN)-Y3]RA.#D\$Y(YZ$=.E '<45E7^N):Z@-.MK6:]OO(-PT,14;8\X!)8@
M<G( [X/8$U3M_%UI>P:8;.TNY+K486GBM)$$<B(N S/N/R@$@=\DC&>M '0T
M=.E<E-\0=-@T=]0:SOB8;]=/N;<(IDMYBP4!ANY'S @KNR",5,GC>SC;6DU&
MQO-/DTFW6ZE2<(2\+!L,NQB/X2,$C% '3U@VGA^:V\8:AKS7L;I>6\4!M_((
M*",L5.[=R?G.>/2J.N^+;O3/#6LZC%I$QFL;,7,9:1#'(&#8(8,<XVY(Z\C&
M<YIL^K6DNJ>%%U/3;Y+ZZ>0VL@D4(CB%BQ<*^#E<X&#U[4 ==17#6OCVXCL?
M%&HZCI%TMGH]Y)%B)HF8(B1D@_,,MEBWI@XR<5O2^)(8]<M=)%G<O/=V<EW
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M(XG.ZX6-[69(]F&SG<I !RN2,=*Q--\+^*= TWPQ?6NGV5Y>Z?8-I][I[W(
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MA@I;]S-D GC./7]*Z^\O+>PLYKNZD$<$*%Y'()V@=^*SVL]'\46FFZH4-S"
MEW9RAW3;D95P,C!P>_/- ')>(O">J:U:>*[V*T$=YJUE%86MN\B@HB;B7D()
M&26/ )X ]3C6UW1M3N[[PUKUC #>Z0[^;922 >9'*FQP&Z;A@$9.#ZBNNHH
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M$[\KG9EA\[<G)':@#.'_ "$/BE_USC_](Q75^#/^1%\/_P#8-MO_ $4M5_\
MA$4\[Q%+_:-QG75"SC8G[O">6-G']WUSSS6MHVFC1]%LM,29YH[2%($=P Q5
M0 ,XXS@"@#D_&"7DOC_P<EC/%!<,E\%EEC,@3]VF3MR,G\1_2J=MXSUJR>\T
M/4EAN=7@U:'3H[F",(LJ2Q&57V,P ;8&&-V,XKK=9\/KJNI:;J45Y+:WNG-(
M8'5592'4*P92.00!T(/O5"_\":;J.CW5G//="ZN;I;UK^-PLZW"X".I P-H
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M$\0=DSO^4_-][GZ#H;5GX%M+33X](%Y<2:)%<"XBL'"D*0_F*F[&2@?! Z\
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M>7;+>%,0KT_A4%FQQN;)QG&,G(!T5%%% !1110 4444 %%%% !1110 4444
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M9@<!O4=.G)'<UF^%OLNOZ=X>UJ77;:WUF&Z7[4L,)%U-*25D@ERY)4DGC;P
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MYP?Y5:%U?275AY5I$UG-$SW$QEPT38!4!<?-G)[C&*Q?B5_R33Q'_P!>$O\
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M.EVL<3E$M[DA\A,'@$*&*].AQS0!ZY16+X:T6QTJP$]HCB6\2.6X=Y6<R,$
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MLI)8M(,4#VO[QB+2[96+;#G(_@8C/\6.AK7\&WS>*9K34+JS%O-H\#64T>S
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MZDH;J48)SST')Y':KFJVUEX3U?Q9:07%_:^'WTF">X2UF):"YDE:,!&8D*6
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MYQF@#2.B:4VH'4#IMH;PD,9S"N\D=#G&<CL:>^D:9)J*ZB^G6C7RC N3 ID
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M^T-'Y1E^SKO*8QMSC./;I574/%&D:8]P+JY=5M2HN9$A=T@R 1O900O!!Y/
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M?+'>/$)UBEMY(R8S_'\RCCCKV/%36&OZ?J5Q'!;/,6EA-Q$7@=%DC! W*S
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MS26PA4GD$9XX!.*]2HH \Q-G-I^O:]I6K>%;_5[;4KMKFTN(!O@=751Y<N6
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M:-R]<,N01GO4%]X,U[5;W6;RYUBTM)M2TI;#_1(7S$RLY#!BW3YN>.0>V,D
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5T7N;95>2-HG0[6R R[@-RG!^9<CWH U:*KWM_;:=;&XNY1''N"@X)+,3@*
M.222  .35.W\1:;=+>>3+*TMF0+B#[/()H\\C,97=@]CC!H U**XCP/?W_B>
MPTWQ$^IWD8EC<W5B]N1"^XG9L8J/NX'*DY[UL7?BFWM_&%MX<,%UYTUJ]P9D
MMW95PR*H!"D?Q')Z# R>: -^BN \*^-+>"WNK;7=5DENCK-S912R0D@ 2E(U
M9D78F<8&<9KJ=4\2Z3HWF?;KEHUA"F9UA=TA#="[*"$'^]CUH UJ*:'1HQ(K
M H1N# Y!'K7.GQ]X9"*YU,>4;@VIE\F38DF[;M=MN$YXRQ - '245CV/BC1M
M1N[NUM[P>=:QB:598WCQ&<_."P 9.#\PR/>G6GB32KW4/L$5PZW1A\]8YH7B
M,D><;UW@;A[C- &M16-%XJT>:\CM$N9/.FB:: &WD N$49)B)7$G&#\N>"#6
M$/&FFZWX(EU:2_O=$@:<QK<BW8.H$Q1<;D()8+@@9QNQP: .VHK$O_%VAZ9?
MS6%S>,+R&$3O!'#)(^PG&0%4D]^F>A]*G7Q%I+Z=8W\=XLMO?X%J8U9FF)!.
M%4#). 2>.,'.,4 :E%9NE:_IFMM.NGW/G-;N8YE*,AC8'!5@P!!&.E/O]9L=
M-D$=Q))YGEF4I%"\K*@ZL0H.![F@"_17#W?B?[#\0H!-J,[://HC74=ND._,
MGFH 555WL=I/'..>E= GBC1I=.L+Z&\$T&H'%IY4;.\Q )(5 -W !SQQ@YQ0
M!L45Q/B[Q&9?!<6LZ!J;HOVZWB+H@!8&=8W1@ZY4C)'8@BKB7]\OQ5DTUKR1
M[ Z,+E;<A=J2>=M)! R>!W)[T =51574-1M-*LS=7LPBA#*F2"268@*H Y))
M(  Y.:S9?&&A0:=?W\]Z88-/?R[OS(75X6P" 4*[N001QSF@#<HK&M/%>B7M
M_/96][NN(8?M#*8G4-'G&]"1AUSQE<U6LO'/AS4)K&*UU(2?;F*VS^3($=AG
MY=Y7:&X)VD@D=J .BHK'OO%&CZ=),MU=E%@=8YY1$[1PLV,!W *H>1U(QD>H
MJP-;T\ZI-IHF8WL, N6A$3DF,G 8<?,,C'&: -"BL ^-?#HM=/N3J:>3J)86
MK;'_ 'I7.1TX^Z>M3V7BC1K_ $RYU&"] MK:0PSF6-HVC<8^5D8!@>1@8R<C
M'6@#8HK)M_$ND7)OE6[\M[ *UU'/&T3Q C*DJX!P1T/>I+#7].U*^GL;>9Q=
MP*KR030O$X4]&VN 2O'4<4 :5%4]0U6STM8/M<I5IY/*A149WD?!.%502> 3
MTZ UAZKXZTNQT2WU.V\^[CGO4L@(X')20R!&#C&5(YX(R2,#K0!U%%,CE66!
M9E#A67< R%6Q[J1D'V(S7G7B+QO-J/@'Q+J.C27NGW&FS/$DC6Q4G8RJV=ZX
M!)+<?>''2@#TBBLG3_$NDZGJ,^GVMWONH(Q*Z-&Z90G&]2P =<\;E)%);>)]
M(N]1@L(KIOM%Q&TEN'A=%G4=3&S *X (/RD\'/2@#7HJAK&LZ?H&F2ZEJEP+
M>TB^_(5+8_  FL]O&N@+>SV9O7^TPQ^9Y0MY2TB9QNC&W]Z,]TW4 ;]%9-OX
METB[TFVU.VN_.MKEBD/EQNSR,,Y4(!NR-K9&,C!STHMO$ND7>G?;X+O?")C;
ME1&_F"4'!C\O&[>/[N,T :U%<KJOC[2;#0IM2M_/NC%=)9O$MO('BE9@N)%*
MY3[P/(&>,9R*MG5K&7Q1:Q#5KF*;[%)-_9[0E5=-R_O&W+D$=,9'7I0!OT5S
MEOX[\-7;V:P:D'%Y,;>%Q#)L,H8KL+;<*Q(. 2">V:N:AXGT?2GN5O+O9]E5
M6N66)W6 -]TN5!"YZ\]N>E &O14-I=P7UK'<VS^9#(,JV",C\:QW\9Z#'IMU
MJ#WCK:VEQ]EN)#;2_NY<@;6&W(.2!^(H WJ*YKQ;K/V7PYK"6-W/;:E!IDU[
M$RP$[0JD@DLI4<C&#S1X;\5Z=J4.G:<UZ9-3DL4G8-&P$N%7>5<C:V">=I.*
M .EHK'_X2C1_M\%F;LK)<.T<#M$XCE=<Y59"-C'@\ ]CZ53'CWPR6 &I@@W/
MV0N(9-J2YV[7;;A.3@%L GI0!TE%-DD$43R,&*J"Q"J6/'H!R3["O.=7\;RZ
MIX'MM>TN>ZTX#5(H7\R'8'B-SY1RSKCE1D[3P>": /2**R-/\3Z/J;WR6UX-
MUB UR)HVB\M2"0WS@94@$AAQQUIUEXBTN_U(Z?#.ZW8B\\130/$SQYQO7>!N
M&>XS0!JT5G:MKNF:%';R:G>1VR7$RP1L^<,[' ''3ZG@55TOQ=H6LK?&SU!#
M]@YNA*C1&(8SN8. 0N 3GI0!MT5E6GB+2[^]2QAN'2YDB\Z))87B,B=V3>HW
M 9'3.,BN!OM>UR+X:>+[]-7N!?:=J=S#!<;(]PC20*%QMQT/8 T >IT5F:CX
M@TW2FE6[FD!AB$TWEP/)Y2'.&;:#M'RMU]#Z5I$X!/.!SP,T +17 :=KL_B/
M4-7N!JUYI46DZB57=:LL)MXT0R"4NH +;FZD,HP0.#GJ;;Q+I5W=_9$N'2X,
M)G6.:%XB\8ZLN\#<!WQG&10!K45A:5XQT'7+N*VTV_\ M$LJ2.@6)P"$;8W)
M& 0>V<X(/0YK3O=1MM/6,W#MND;;&D<;2.YQG"JH)/ )X% %JBL6+Q7HD]A!
M>17OF1SSFVC18G,C2C.4\O&X,,'((R ,FI8/$>DW&EG4H[L&V$I@)*,'$H;;
MY>PC=OW<;<9SVH U:*X7QIXJ5O!6K7NA:G+;WFGSPQSKY6QXRTB JRR+D JV
M0>/8UTNF^(]*U:_N;&RNB]S;*KR1M$Z$H<@,NX#<IP?F7(]Z -6BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-HH @LX1;V-O (TB$<2IY<9RJ8&,#V%<!X+EO[#2K'PKJOAR\DO].N"!>2P
MVS*')$ZR'C=M/0?-GTY(]&HH \DU'3[^;P+X]M(],OVN;[5I);6/[+)NE1O*
MPR\=/D;\OI5CQDFIZJGBVQBT74-L^G)]B:TM2HNSY9R97X)922HC)Z?PG->I
MT4 <(HN9/'7AN_;3[Z.WBTB>*5VMFQ&[&,JK8!P2$/'YX/%9FGV5ZOP9U_33
MIUZE],NH*ENULX=S*\ACP,<Y#+SV[UZ5%<0SM(L4L<AB;9($8'8V,X/H<$<>
M]24 <"T-PWB?P).+&\\JTLKA+AS;.!"SQQJH;CC)4BLB'^U+"SU%TT6]>.;Q
M5)<-)]@,DL-NPXGB1EY.1C(!(!)Q7JM% 'CE[IVI'PIXTL$T;5C)=ZQ#<VXD
MA:1I8\P'.<G/",3Z8QP>*[.*.9_BR;X6MT+1M$6 3M;NJ>9YQ?;DC&=IS^G6
MNPHH Y+QW9:A-'H>HV,$ETNF:G'=W%M$,O)$%96*C^)EW9 [X]:BMK9[CQ[>
M^)XX+J.P72$L\/;NCSR>87)$9&X[1@9QSN..E=E4<]Q#:PF:XFCAB7 +R,%4
M9.!R?<T <O\ #6"XL_A[H]E=VT]M=6\'ERQ3Q,C*<GU'/X5'J<5U:_%#2M2%
MC=3VCZ7/:&6"/>(Y#+&PW?W1A3R?2NPHH \CN+"_?X>:[:)I>H&ZG\0M=11?
M9)-S1F\60.!CIL!/Z=:OSQ26/B?7K/5O#FK:K8:Q,MQ:RVBNT;@Q(C12KN 3
M&SJW&#STKTVB@"O90BUT^WA$21"*)4\N/)5,#&!Z@5Y9=Z??R_#;Q+9+I=^;
MJYUR2>&'[))N>-KI9 P&.FT$_P#UZ];JN;^S$$TYNX!#"Q660R#;&1U#'L1[
MT >>>+M(U#7?%&J16%O<J+OPS):13O ZQF8R;PA8C R/7U]>*?:P#Q5I\Z)X
M9U+3-8%A/;M=:B'"V[R1E2(F9CN!8@Y Q@<\X%>B-<0K,D+31B60$HA8;F Z
MD#O1-<0VZAIY8XE9@H+L%!). .>Y- ' >$=M_+I,5]X3U.TU734VRW%Z&,,+
M!-K&%RQ#;N -O8\].<9K#4U^#%[H+:1J/]H0W;+Y8MV/F9O#)E,?>&SG=T]\
MUZY10!QJ"4?%6?439WGV,Z&D(G^RR;2XE9RO3KM(X_#KQ7(6$%UI'@_P-+)I
MNIIJFG7,_P"ZCLVD>-2L@?=%D,P(8#(/&0<]C[#6-K/ANWUB[M;W[9?65[;*
MZ17%G-L8(V"RD$%6!*J>0>@H R? DUB5U981?I?7%VU]=QWMD]L=TG *HW\.
M$QU/(.:J^,]/DN=72[L9M6T[5K:T)MK^RMWFBERQS#*@4@C(!P?7KZ]7IVEQ
MZ<KGS[BYGD $EQ<ON=P,X'8 #)X  Y/J:O4 <!IB:D/'FDW^I:;- R^'/)N3
M!;L88YRZ.8U(!'0-T],5C:&NJ:;X>\,VTNBWZ1+?7OVJ:.R+7%L&>1H]@(RJ
MN&P7'0<9'4>L44 >0?V=J:?#G4--.C:FMR/$'G)&T+.S1_:Q)N!&2P"#.[H>
MQ-=>L<[?%H7HM;K[(VB" 3F!PGF>=OV[L8!V\_IUKKR0JEF(  R2>U-AFBN(
M4FAD26)QE71@RL/4$=: .>\;RWL&A1/9:>UZ1>0&41VXGDAC#@M+&A!W.N,C
M@X/.#BN#U+3]1ETSXB6\.D:NW]I0PM9M-"SM,?)5?<YR#Q_".#MZ5[!10!P\
MHE_X6'HE^+*]^R1://%)*+63".S1LJGY>N%;BN<T[3[^#P#X'M)-+OUN;+6(
MIKF+[))NB17D)8C'3##\Z];J.">&YB$L$L<L9) >-@PR#@C(]""/PH \WALM
M0L?#_C+P[>:;=W-SJ%Q=RV4B0,\=RLX.S+@;4*DX.XC&,]*LV5C?>&?&6DO<
M6=[?1?\ "/0Z;]HMH3(#/&^2&/1<@Y!; ]Z]#J-;B%IW@66,S( S1AAN4'H2
M.H!P: /)] L-1@T/X?0W&DZA%)87\TERK6SGRE*R@,<#@$NO6I-1TS69)/$U
MY8:;=220Z]::G# \31_:XHDC#!"P )RIQ[@>U>L44 >?Z^;WQ9X5U&YT?0+J
MUNA]GE O8OLTUT8I5D\O^\!A2 3QEN.YK1\+/9ZGJ9U6'PYJ6G7"VWD27&IH
MRR\L&\M=S$E0023TSC&<G'7U'//#;1-+<2QQ1KU>1@H'XF@#F?&$]Y!>:&8-
M/GGM3=-]IN;6V\Z>V'EL%*#!*[B=I8#@$],YKBUTS5(_"6IQ?V-J8>W\4B_$
M;QEY)(/M*OE>27(7DD9SZGFO7J8\L<9P\B*3_>.* $@E\Z!)3&\>\ [)!AA]
M1V->4:C8:G_P@/C?1AI&H-=W&IW,T 2W9EF628,A4CKD9/'3'..,^IW5]:6,
M(FN[J"WB) #RR!%)/N:G!#*&4@@C(([T >?Z[I]YJWC67[)!=117/AJYLDNF
MMW5$E=U*@G'!P"?;'K3/"(6^DTF&_P#">IVNJZ8FV6XO0QAA8)M9H7+$-NX
MV]CSTY]$HH Y/XEVMS??#O6;.SMIKFYGA"110QEV8[AV'TJ&X$LGQ0TO4$L[
MLVB:1/$TWV:3:KM)&RJ3C@X5J[*B@#QNUL=5TVUTS57T75+FUL]4U'[5:01R
M1S^5/)NCE1>"V,#@=F-:NJZ?+'9:;KVD>&K]+6#4VNKJP4LEW<(\1C:7;NW;
MP6X4G) YZUZ?10!YGKFGC4/!FHWNC^'+^V>:\L[AXYHV^U7(BF1F8H26X48
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M\CG*L*K>.(KVUUW0M;CTZ]U&PM5G@NX+$MYR"385D55(+8*8(]#7;T4 >=7
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M565'#GLA(;Y.!R.N2.]:#P)>0>&;OPB+J!M!GF8QR'<)XH6?>T6,8/)8!\C
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MN>W6@#8FUYK_ %=]&TRV@N)5LUNK@W+E41'R$0@ Y+8;Z =\XK+^$P(^&^G
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MP.!G&2!CC/&5-\/]=C\*:AX4LM2L/[)EN/.M))HW,L*F82F,@'! .<'\,=P
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MK9[E)-@\LJI4$9SG.6':N#NO$VJ>&[+Q?:_VA-=&QO[6WM+F[VLT(N%CR6.
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M'N-,GM3+!<2^?,SNWF/+D'S-^<A@0,$$8P , 8IU_P")](TW6+'2KF^@2[O
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=Q91E@!G.0""1VS0!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5L#>&SEN3 NV"02>7\PW;B"W'R@]><5?@\9Z>;S4K6^MKS3I+"V%V_VM%&^
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MG6VMW?Q#37;K1GL;-M(^R,);B-G63S=_1"01^/\ A0!V=%%% !1110 4444
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M&=S'=\I&&XY[#L =]17'6&J^*[C4]-)L4?3KR!FGE:)5%H^W<A'[PF12>",
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MI;WMCYFE2VY9KGRUB,,P/W<>8Q92.G<$<DT =/5)-7T^36)-(2[C;4(X?/>
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MAL@8[?SJMIO@B:QU+1;Z77KJXETNV>T13#&JO$=N <#C[@R>I]JZ^B@#B?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !12
M$X!.,^PK!\-^)&U^ZUF![![-M-O#:D/(&+_*K;N.!][IDT ;]%<-K?CS5-"C
M;5;CPS*?#B2!)+X72^<J%MOF^3C.S.,<YP<X%=P"& (.0>0: %HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *XKP-_P C#XV_[#/_ +1CKM>HK,TS
MP_INCW5W<V,,L<MX_F7#-<2/YC]-Q#,1G  S0!G^(+5/$X;P^N&L_,1M1D[!
M 0PB'^TV!GT4D\$KGH4=)(U>-E9& *LIR".Q%<C+\+O!TTDDDNE.[RL6D+7D
MY+$\DGY^2:ZV*)(8DBB0)&BA54#@ < 4 /HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
>*** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>literacompareredline-pro004.jpg
<TEXT>
begin 644 literacompareredline-pro004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"!54!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-:?3[+^QH)+@"\C-Y##*L4KV_.X([$ '.WN#C."*XQ_"/B%K#Q"MGIL-G/\
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MQ$ICS@[_ )&PY.?FR>,#'(!Z717*:IXBOU\0ZEI-D;:W:QTP7PDN8RPF)+#
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MIKVI7]E>V$-L]M!;SB3S9Y5,K[P!L2.($,Y.23C. IXYS0!NT5YU;>.=<O\
M0_"5Y;6VGK/K-S):S+('VHRB3YEYR!F/.#D\XSWJOJ'CGQ)HVF^*+>]@TV75
M=%^SS1RQQNL-Q#,< [2Q*L"#GG% 'IM%<+=>+=9\-^)1:>(X[%].NK*XO+>6
MR1PT1@4.Z-N)W?*>&&W)[#LLGBW5K'3/#NMWD=H^G:O-!%+!$C![;SQ^[8.6
M(?!(#<#.<C'2@#K[;4K.\N[NTM[A))[-E2XC4\QLRA@#]00:M5P-_P"+M8L[
M/QS+'%8>=H)5H,QMB13")/G^;)/..,=*N6FO:\OB?3],O6T\Q:IITMS;F&%]
MUO(FSAB6^<'?V"]* .R(R"*SM)T+3]$^U?8(I(_M4[7$V^=Y-TC?>;YB<$^U
M8'PSN]2U#P7;WNI7:7,DTL[;A$5;/GR9R=Q!]@ ,#CFKUYK=U/XM_P"$<TYX
M89H['[;-/-&9  7V(H4,O.0Q)ST ]<@ Z*BO.3X[UF33[/RK6Q6_37_[$OD<
M/L+?WXSG(!&#SG&>^*M?\)GJ6E?\)+;:LEK<W.ES6J026T31++]HP$!4LQ&&
M/)!Y% '>45S>CZEX@E\0SV>H60?33;B6*]$!@VR;L-$5+L3QA@1[BI_$&NR:
M;?Z/I=J(_MNJW#11/*"4C5$+NQ (SP, 9')% &[17GVK^--8T:'Q3921V4FH
MZ19+?VTWEL(YX6!X9=V0P*D=<'KQTKJ]"?69H))]6>Q*R['MUM48%%*@E7+$
MY.>XQ]!0!IQ11P1B.*-8T&2%48'/)I]<E?:QKTGCJ;P]82:?#$=,%Y'/-"\C
M(WF;,%0XW#CU'7OC!Q++QKXAFT'P]KL\>FK:WNH1Z?<VR1N7):5HC(KEL*-P
MSM*GC^+T /2**X>?Q9JUUH6NZ[I26C6NDSSQBVFC8M<+#_K#O##:3AMORGH,
MYSQ&WBC7]7\006&@_P!F1V]WHT6J6\MY$Y*[G VL%89X],8SWQ0!WE9;>'-)
M?Q NO/9JVIK&(UG9F.U1G&%S@'DC.,\FN8E\6:_>P27^AZ:+R"&^>V^R^0=T
MT<<AC=A*7 4Y5F (/ QU-=R^[8VP@/@[2PR,^] %?3]2L]6LQ=V%PEQ;LS()
M$.02K%6'X$$5:KSF'QIKC^#=#U6.WT[[3>ZS_9\T>QU3:;AX\KR2#A>ISUSC
MM5T>*=>LI/%=G<VUO?WFD0P7$!LX'7S$E#'!0LQ)78>A^8>E '<T5YY?^.KM
M/!6J^(=&U#2M3AMO*\IA$Z$%FVNDB;LJPR",X^E6;KQ;K7ASQ+]D\116,FGW
M-C<7EM)9*X:,P*&>-MQ.[Y3PPQD]AV .ZHKBK/Q)X@:[TV[GT]9-(NK=I;IT
M@,9L\)O4ABY\Q3]T\ ]_:K6D:MXBU>TT35[>*Q;3=13S982")+>)EW1MNW8<
M] PP.O&,9H ZNBO,]&\4:KIGA[4;V_N8+VZGUZ33;8&(H/,,_E*6.X_( ,X
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M#=OH44IE@TUHD_=G=N"^;]XH#R%XZ8)(R#T.MZ/::_HEYI-\K-;7<1CDVG!
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M=SJTK7@N!J-XUXR^5LV,RJI Y.1A1^M1ZMX<FU#Q%IVM6NJ2V<]I%) RB)9
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M=6\,]PAP887D578'L<$C/;.:Z*ST^UT]9!;1;#(V^1RQ9G; &68Y+'  Y/0
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M<6>KQR7,?V.0-"H$H9F&W@?,.?>N[^($4MQ\/]>MX()IYYK*6..*&-G9V*D
M  $]: +4WBC1=.>*UO-6A^TFW$X4_?=.!NV@=R1QCG/ J:'Q%I-SIEKJ-O>+
M/:W1*P-"K.9",Y"J 6)&ULC'&#GI7*PASX^\-W1L[OR(M$FC>4VLFV-V,1"D
M[>#A6X-8>F:;Y_AJVM[D:SI-W%K%[/:WT%K(&MBTCE2RE<&-E;'/'.* /0)?
M%WA^".V>;5;>(7/F>2)#M+>7NW\'GC:W7N,5)I_B?1-5TN74[+4H)K.)RDD@
M.-C#^$@\@\C@C/(]:\^>\OTOO <_B"W7[1'J=Z&>*V9?-7RY-LWEXRN[ASQQ
MG/%-U?1-2>Y\2>(=+L+J6TEU.PNEM(MT4MTD _>L@X())R#P24R,Y&0#T:U\
M0Z3=QWCQWJ)]A_X^EF!B: 8R"ZN 5!'.2,&JESXQT6UL=1N6N)&.GP^?/"('
M$H3!(8(0"0<'GI[UQ6KV<>N^'-4U3PWH>I_;<6SR&_\ -26[$4JR&$+(23@*
M>>F2 ,\XVKR]A\6>'-=N--T&[BNYM)FMO.N[,P3.Q1ML(W#+ $G./E!(QG)P
M =!8^);&ZT2QU&5FB^UHNR'RW+LY7<55<;FP,]!T!-*_BK0HM+&I2:I;I:&7
MR?,9L8DSC81U#9X((R*XNTDNX-0\%ZX]E?\ ]F6VG/87*O:N'MI62/#F/&[;
ME"I;&!UZ'-9WB'2+N31?&%[!8W<EMJVJV,MK:I;.SNL;0^;)L R VUCR.0N>
MXH ]/TK6=.UNWEN--NX[F**5H7=,X#KU'ZC\ZQ/'VJ7NC:';7ME>?92-0MHI
M3M4AHWE56!W XX)Y%:5]X@M--U'3+.6WNS_:+%8YDMV,<9XP)&_A)R ,]ZR?
MB-:3W?A5!;VTMR8KZUGDCBC+MY:3(S$*.3@ G H UM*\4:'K;W2:;J<%P]K_
M *]0<%!V)SCCWZ4ZW\2Z1=7,EM#=YG2'[1Y9C=6>+^^@(^=?=<BN)\2Z'>>*
MM5U?4=%BDC#>'YK!99(VB^T2NP94&X D *03TR^.QQ?\-76FZUJ-EJ!\/ZS;
M:E90NLTFHB?%ME<,B%R0Y) X7/ R<' ( FA^(KG7Q-K1UQK"TLKZ=)[:6V'D
MO;HS(,LP!#G ;.XX)(Q74P^(M)G-THO%C>U023I.K1/&AZ,5< [3@\XQ7F\5
MAJMQ\.IUM=/O3<6FOOJ#V<EN\;W$*W1EPH8#=E<$#OC'6NANX_[7\:6FOV,5
MRMG::3<17$C6\B&4R%2D84@,Q&&) '!QW- &_9>,O#NH>9]DU:WE\N!;AL$\
M1L<*>G<\8Z\CUJ[IVM:?JLEQ%9W&^:V8+/"Z-')&2,C<C ,,CIQS7G,&GZE'
M\&O#HM=,O&NM,DMI[JP5'AGD6-LNJC@[OXACJ1Q75>%3I=_?W6KZ=I.HVSS1
M)%+=:B)5DEP>$"R$DA>>>G. 3S@ W-2UK3])7-Y.4PAD(2-I"J#JQ"@D*.Y/
M%59_%OA^W>!9-6M=UQ!]HA"ON,D?'S#&<YR,>N>*Y77I'T?Q[<WFIZ?J]UI.
MHV,,,4VG><WE21M)E'6(YPP?()'7/O26^GQV'C+P@MIHUU9V%I87BA!"\BV_
MF%"BL^" Q ;C/'(H WM0\=:-9Z1INI6\S7=OJ%Y':PM#&S#<SA6S@<;>>#SD
M8ZUHWWB32=,B$MY=^4GEK*[&-SY:'HSX'R#KRV!P?2O-A:WB>&#+_9M_MMO&
M/VYXQ:2;_L_VDMO5-NYA@YX!K0O9$M/%NN1ZYHVN76FZTD4EJUFLS*P\E8WA
MD2,@*<@GYNS')% '8ZCXS\.:3*\5[K%K%(D2S,N[<0A( ;C/7/Y<]*BA\0:7
M:W&N7ESXCAFM+5T\V-@H2R^3E=P&6)QGG)YQ6)IEE]D^)=DJZ7/;VL/AU+1#
MY3O%$PESY7F8P2%]^U96K6]U+%\45CL+YC?0(EKBTD/GG[,(_D^7YOFXXH [
MRP\3Z+J>HMI]EJ$4UTL7G>6N>4SC()&#@D XZ'K4<_BW0;9E%QJ<,2-(T22R
M96-W7AE5R-I8$'(!SP?0US2)(?&7@F6.SNQ#!IEQ%,_V60+$S+%M5CMPOW6X
M/I7,:1>Z7!I^CZ9J4NI6FG:3JCWL#RZ7-D@/)L#S %-HWY+#@CCCDD ];U+4
M[/2+"2^OYA!:Q#,DI!(0>IQT'O4<FMZ;#?+92W<<=PT!N%5\KF,8RP)XP,C/
MUK+\?6-SJ?@#7;.SB::YELI%CC49+G'0>]<_9W[:I\0/#E_;Z?J2VBZ5<0M-
M+921JLA:([3N (^Z>3P>Q- '16WCGPO=WEI:6^M6LD]Y_P >ZACB0^@/3)[#
MJ>W6KM[XCTC3I9([N]6+RBJRN58I"6^Z)' VIG(^\1U%>6:':)X@^$7A[1K&
MVE_M 7T<JOY#*(-EP6:7=C&-@89SR3CK6W#%<V.E^-]"U*QNI[G4+JZGLRD#
M.EU',F$ 8# *_=()&T 'IS0!VE]XIT/3;U[.[U*&.Z2'SVA!+/LR!G R3U''
M6K^GZA::K807UC<)<6LZ[XY4.0PK@]#TZ[TCQOHL5[#<RFR\,+:378@=HS,'
M0D!\8)P">M:WPRAFMO MI;W%M<6TT<UQNBGA:-@#.[+PP'!4@_C0!6U?QJMY
MH'B[^QYI[:]T6&8I,UN<,Z1!SPRXQD@<]>HXP:V/#_BC3=42TL!J,<VJ?8TF
MEC'!;@;B.,'!.#CH:X^]BNX=/^)FGG3K]I[X326WEVKLLP>U5%VL!@DL",#D
M=ZM&"XD\0>!3#:WD2P:7<PRR_99 L#-'$%#';A>5/!]* .R7Q'I#ZC%8"]7[
M1,S+""K!967[RHY&UB,'(!)&#5V\O+>PM7NKN9(8$^\[G &3@?B3@ =Z\S\(
M0V\UGHNAZOX=UC^VM'DC!:=IC;1M'QYZ.6V$$9P!U)QC'-='\0XK_P"P:/?V
M=K-=PZ=JL%W=V\"[G>%=P)51]XJ2K8]O:@""Q\3O<>.==M'U1DTRTTV&<+/"
M(C;.S.&)W*&Z!3\WK[UMZ9K-G#H.F22ZJ^I&XA#1W*0$O<@#EPB#@<C.!@9'
MK7,6UX+SQ]K>I0V6H?8Y]#A2.9[&5 [*\I(P5!S@CCJ:R]/TR1_!G@Z)YM7T
M75[.PD6*]CM'(@<",-%,A7!5N" <9V<&@#T5M>TQ;.UNQ<^9%=+OMQ$C.\JX
MSE44%B,<].*YO6?%2IK7A*\L-7B.B:A+.LY4*4D5878'<1D$,.@(Y&*Q+74=
M;T;6- \0ZYH]R;>?27LKA;"U=S;2^;O#F, LH=0O&.#@'I5^_@4Z]X(DM=#G
ML[.&\N9FABM#M@5XI K.%&$+,P.#R">><T =7;^*-%NM)?5(=0B:S27R6?!!
M$F0NS:1NW9( 7&3D>M-D\5Z%#IMWJ$VHQ0VUG)Y5PTP*-$^ =K*P# X(.,<Y
MK@7EO+&'Q'*NC74T<OB:*<.]@\ABAVQ W$:%?G*E#C .#S@CK1U2VO)=%^(]
MO%IVL3/?B![5I;.0M/\ N47(PO7(/&!MQ@A>E 'IL/BK0[F.9X-1BE$-P+5@
M@))E(R$4 98D<\9I]KXFT6\2Z:#4K=OLF?M"LVUH<'!#J<%3GL17,^-98H+/
MPQJ4$%YYMM?K)$L-H\F!Y3A@\0&_&W(X&0<'H#6!,J:CX=UR;1#>7FJOJ=OJ
MUU8-;2VCNB.GR1AP"?EC^\.2P[<"@#TK3];T_5)[BWM+C=<6V/.A=&CDCSR"
M58 @'L<8-27VJV>G-&ES*1)("4BCC:1V ZD*H)(&1DXP,BN=\*OI6IZG-K%A
MI&J6\S6X@ENM2$R2'G(C D)) Y)(X!Z$Y.(;[[3I/Q/35KJ&>32KO2Q:)-%$
MT@@E60N0P4$J&!Z^JX]* +/BKQE;:7X*DUO3)X[D3;$MI8U,B99U3)QZ;LX/
M<8K4T2&\1KJXFU>:_LYRK6RW%NL<D. 0P) 7<">1E01[UYYJ6CWUI\-_$"+9
M7CMJ6N&]M+2.W=Y$A-Q&W* $KD(SX.,9]>*]4>19+-Y C.I0G85*EN.F#S0!
M0C\2:3*2([EF_<M<*?)?#Q*0"ZG&&7YEY7(YIR>(=)D&G,E[&RZD,V; ';-Q
MN^4XQG )Q7#>&;+4;.]@T_3IKR[T*;3I0D.I6S)/IC87;%YC %E/3:>0$!Z"
MLS29;AM&^'EG_96J+-I5VL=]NL9 (6$$B'.1R,GJ,CU(R* /2Y_$>D6UXMI-
M>HDC3"W!*ML$IY$9?&T.?[I.>>E<QIWC*#3-;\36_B'6$6"TOTAMC(@&Q&B1
MN=HZ O\ >/MS5'PU<R65M/X5UGP_=W>H0ZC-/#+):%[></,TJ3^:1M7&[G)W
M#' )XJIJ-M<2Z7\3T33[UI+XD6H%I)F?_1U0;/E^;Y@1Q0!ZDSHD9D9@$ R6
M)X ]:YS3?$ND6>AVMU>>)8;R*ZNGA@NY L8D8R$! % !V_=S[9-:^DO_ ,2.
MR=UD4BW3<KH0P(49!4C.?:O+;:UNAX#T&VDTR_\ -B\3BXDB-E+N6+[4[[R-
MN=NT@Y]Z /2K/Q/HNH6][<6VHPO'9'%R3E?+XR,@@'!'0]^U-G\5:):VUQ<7
M5\MM';%5E^T(T14M]T;6 .3VXKC;ZUBN/$OC<7VG:G)87EK81A[>WD#/M+AV
MC(7EDW*>,]*QO$7]KP^ /%MKJ%T^J6,,=K]DU&:V\J:8&4%HWX&\KQ\V/XCW
MS@ ],TSQ1H>L:A<V&GZG!<75L-TL2'D+G&X>HSW&13[;Q'I-WJ$=C#>*;B5#
M)"I5E$RCJT;$8<#U4FN0\0:3-XG\2VUUHL<D!MM'O;:2Y>)HANE4+%'R <J=
MS$?P]\9%5?#JV^M6^FVTF@:S::]IT#1F6],PBLW\LH61F8JP/  7/!SP!0!W
M"^)-'>^CLUO4\Z4NL7RL%E9/O*C8VL1@Y )(P:I:+XRTO6K&_OE=[>VLYY(G
MDN$:,80[2QW 8Y!XZ],\USW@F^\S1]$T#4?#=VFKZ.JPN]Q:$10E%VF5)2-I
MW#IM.26],FL5[#5SX6U*UM]-OFN=/\3/J4MN8&47, N?, 0D8?*X8 9^[ZD9
M /28?$6DS?:A]L6-K1!)<).K1/&AZ,5< A3@X.,&LZ3Q+8>(-.O+;PYKD0U
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MI"K*VW"R(<#M\H7 &,5'X1:SU)]%AN_#FL0:SI2;9&O3-Y5JP3:S(S,48-C
M"YX/H* .^OM2M--CC>[F">:XCC4*6:1SD[54 EC@$X Z U0;Q7H*:?%?R:I
MEM+/]G1G)4^;NVE"#R&!X((X[UF^,[J:UNM"9;&:2 WC>;>P6AN9;/\ =L R
M*%8@L3MW8. 3QR*X5K6\'A74[)M*U0R?\)8MR%DM)'9H?M"/OR =PV@DGI0!
MZEIOB+2-8>[6POXIFM"!.!D;,C()SC@@'!Z'%<Y>>*C<>//"]CINHNUE?+<M
M-$8,+,JQ%D=69<LN>ZG!XK"\5:9JFKZUXS@TNVNEEO="@A@E,+HDKJTA9 Y
M&2K =>]6VU8:UXK\$7MMI6IPQVWVE;E9+"5/LS-"%"L2N,;N,CCWH ](HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ4FF?V.(-1M;EXKV![@G[/& "LN=GS!\C:._/H< '42VL,\\,TJ[FA):/).
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MR)&5#NJESM4$XR?0?E3JX9]9<:?X,?6=(@NY[ZYA6*?SMWDRF)F$G*@[B W
MZ9ZU-JWC^+3Q>36MFE[;V5S]GG2.?_2&((#F.,*=VTGN03M;VR =A+$L\+Q/
MG8ZE6P2#@\=1R*YS3_!WV"VCL6UW5KG2XT$:6,[1%-@& A81B0KCC!;D<'-
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MWRHC#?L*[F7Z\D<\<#J(HO$VF:;J7B^ZN-*%G)IK0&ZFC(9[LM&#'T YP54
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MK*WAM;.>V>!9V.2[* R'9@I^[!!XR&'2M/P?HM[H6GWMO?-;L\]_<7:F!V8
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M.7RKDC3YL0M@'#?+QP0?85J:7KUGJ][J5I:B82Z=,(9Q)&4^8J&&,\D8(YH
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MN^>5E\MOLXP<!3N'MD=.O/'H-5+?3-/M+J6ZMK&VAN)O];+'"JN_^\0,G\:
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ML3WDA4R;%SM484* "Q/ ZDGK2Z!H=KX<TB#2[%YC:0#;$LK;B@R3C.,GKWH
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M$G/Z8H Y#4M5OM6^$MU)J,C2W%OK<=MO<*&*QWR*N[;QG  )'I74'_DLZ?\
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MP1*NW:Z$ %2-B]..* ,;3;W7-1U?Q7HD%]>6KP6MO-827*Q-)"\BR=>""I*
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M,E:2S#7CD0A@04'/W<,??MG'% '*^%=7D?Q)JOAV.[ETYY]=OKD7(13]H"N
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9%UR4#R]N0GE1#C';(/X@TOCQK*W\1^#;N_\B.V349$DEFP%&8), D\<G]:
M-32?$LL_B'Q#I^I/9P0Z=/!%!(&*[_,C#C)8\GG'%=!<W=M91B2ZN(H$)VAI
M7"@GTR:\GU>#2;^?XJRW,=K,\5HAB,H!,9%H,%<_=.X#ISD#TJ3^V;&/6].'
MB+5C9Z??^'[=;2YD$9AD?YO.0M(K ,04)Z9 'M0!ZT"" 0<@]Z@2]M75V2YA
M98QER) 0OU]*S/"5E9Z=X6T^ST^:ZFLH8RL$EV<R-'D[3T'&,8X'&*Y2]LIM
M'\<ZAI-I PL_%4(D#QK@0S)A9SD=,Q$,">K#WH [V74+*"*.6:[@CCD.$9Y
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M#'@A201D?G2_\)9IB/K"7!F@.DO&ESYB9R7 *;=I.[<", <Y('6@#<50BA5
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M@ I"H+!B 2.AQTI:* (YK>&XV^=#')M.Y=Z@X/J,TYD1\;U#8.1D9P?6G44
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M<;L\GIWS4.H^&/$FK2^+IX[!;.>\N+&]T\RSHRN\"QG8VT\<KCTSW(Y/J%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH) I@L;1;O[6+6 7)&/.$8WX_P![K5BB@ HHHH **** "BBB@ HHHH ****
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MS[H)(PDB_>7YE'(R.*AF\5Z1;VVHW$TMPD.FG;=N;.;$1VAN?EY^4@\9X(-
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MUBVX C9RN V6''3FO9HM!=;PW<VKZC<3B%HHVD,0$08@DJJH%W<#D@\50M?
M>CVW@U_"KFXN-+*L$69P7CRQ;*L #D,<@G.* .F P !VK$\5WTEIHQ@MO-^U
MWKBUA\E2SKNSN=0.I5 [?\!K2T^S:PLH[9KNXNO+&!+<E6<CW( S]3S4$^D)
M<:W:ZHUW<A[:-XTA!7R\-C<2"N<_*.<\=NIR <1X'EA\/>--8\+PV\]KIUVH
MU+38YHC'MZ+,@![!L$ =B:36_#M]<^(M8\2>'R$\0Z;=((U8X6[A^SQ%H']C
MU!['TZUUNL>%[76=:TS5I+N[@NM-+FW,#( -XPV<J<@@ 8Z5<L=)6QO[Z[6[
MN96O'$DB2;-H8*%!&%!'"@=: .9\*^([/Q3?ZMJ5F&3.GVT<T$@P\$JM<;HV
M'8@_T/>F_"J.*;X2:'%,BO$]JRNKC*E2S9!]JZ&/PY86UYJMY9A[2XU0)]ID
MAQRR@@, 01N(;!..P[UF6?@.QLM CT%=3U1])C4H+4S*@*DY*ET57(.3QNH
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ME*NK*0=H[9XXJK=^#=,O-#?3"US'NN1>&ZCDQ/\ : P82[B,;L@=L8X P *
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MA:6&N1:R;_4KF^2U%HTEQ<;A(@8D;@ !D$GI@=\9YH Z"BBB@ HHHH ****
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M-E0,XQR,X%=?X8NH;[PII-U;6TEM!+9Q-'#(<M&NT8!/? [T :K.JD!F +'
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MM]=ZA*PDO;O:LD@& J+G:B^PRQ]RQ/L*5EXNTN[?5$<W%F^F(LMRMW"8BL;
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MK@+C.3S@<U/K7AC5M:U#QY;1VTEO'JUC;0V=R[+L=XU?<#@D@$L!R/6O2**
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MD,3O"X<*XQE<CN,BG7]_::792WM]<Q6UK$,R2RL%51G')_&@#F/%VFZIXO\
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M";._@BV-%)$,(^TD@\<$9YR>E %=_&&K:='J"ZCIH;;<V]OIUR(7MX[IYF"
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M3:2MC)/);ND\4\4\7#Q,C Y4]B1D9]ZAL_"=C8^+)M>MR8S+:1VWV=1A 4R
M_P!=NU?8#WH Y[5O$FK+9>/TMEL[2ZT6 20SI&7+Y@\S+9(^;& .P]#TJG>G
M4CK/PZ?S+:>]:.Y*NRLBC-KU;EB2.O49]JZ%_!KW$_BPW&HJT7B&$0NB0;3
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M<OY<N<H&/L<9.,'FG?\ "&W]IK^H7FD>()+'3]3E\Z\L_LZN?,P SQN3\A8
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MA($Y4$9'/3(]<\8-_P ':[-XD\*V6JW,*0SR[TE2,DJ'1V1L9YP2I(^M1_\
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M(/Y5Y)X9TS6+_P"#=\ECK4=G&[WV5: 'Y?-DW+OS\N1GYL<9]JO>'-?358/
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M_P"&8=7G@DTN""&TEENI1,BF(,)\JPWMO)R3G[N.YS#X@O-6L+87][+<ZMI
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MC#NK>8@/$@VG@'K@\BK=>31ZYJ%AX?N8C?731S^,'TR6YDF9GAMC+C <G*\
M+GMNR.:U]2-YI?B_4-*L[N\_LZZT*:[93<.S6TR,%#HQ.5W ] <9&?6@#T*B
MO*]#>[M3\-]0_M/4)I]4M_*O!-=.Z2K]E+C*$[00R@Y R>Y.:[+QC<I!IUE$
MUY<V[7-_#"D=MP]R2<^5NR-H8 Y;(P ?I0!T58W_  D"?\)BOATVDJR-8M>B
MX++L90ZIM !SG+=\=.]>>S>(=3T;2/$\#7,D*1:[;V:R?:&E^QPRB+>5=AG
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M(_A"/$=W<7#7\VHPM(@G8)'B\5!%LSC"KCC'4;NO->E>,_\ D1O$'_8-N?\
MT6U &CIMZ-2TJSOE0HMS DP0G)4,H./UJU7EMK976BOX%OK#4]1E?4O*M+RT
MEN6>.2(VY8LJ=$*;1@J![^\]M->6&IZKX)GO]0DN[NZ2>PNI+N1I/LC\OARV
M08PDBYSU*>M 'I=%8OBFZBTSPAJ4\FHRZ?'%;,/M:+YCQ<8# '[S9(Q[USOA
MZ:]M?B-=:;)]HAM'T:&Y%M-=M.0_FNNXYR%8@<A21QG)H [RBBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "J>H:79ZHD*7<3/Y$HFB99&1D< C<&4@@X8C\:N53U#5=/TI(GU"\
M@MEED6*/S7"[W)P%'J: *=YX5T/4-(?2KS389[.20RNDF6+2$Y+EB=V[_:SF
MF#PAH*Z7;Z:FG(EG;RB>.-788D!R')!R6![G)II\:>&A#<S?VW9;+5@DQ$H.
MTD$CCJ<@$C'H?2KDNO:5#;6UPU]$T5TF^W,9WF5<9+*%R2 .21TH :/#VE_;
M;N\-KOGO(O(N&=V;S8\$;6!.".3^9JG<^"/#5WHL.CSZ1 ]C P>*,YRC#C(;
M.X'''7IQ3K[6+.==&EM/$-I;1W=RC18V2?;4(/[M,GOD'<.1BKE_KVE:9(R7
MM]# R@,^\\1@G +GHH)Z$X% $!\+:)]FL+=;!4AT]_,M4C=D$3\_,,'[W)Y/
M/)]:=_PC6C[M19K%)/[2&+P2LSB? P-P)(.!P/04:EXGT+2)#'J&K6=M((C,
M4DE (08&['IR/K52/7]/2_U2\/B&WN;*VM8I7M(45C;@[CO++ECO&,#VXZT
M6=*\*Z%HEA/8Z?ID$5M<+MFC(+^8N,;6+9)&"1CIR:30O">A>&?-_L?38K0R
M_?*DDD=<9).![#BJ^E>--%U+3=*NS>102:DBF""1OF9BH;8/4C(Z5LI?6LM]
M-9),K74*J\D0ZJK="?8X/Y'TH @O=%L=0NH[J>.3[1&C1K+%,\;!3@E<J1P<
M#CV%0KX;TA+RUNX[,1S6D/D6YC=D$4?]U0#@#@<>PJ[>7MM80B6ZF2)"P1=Q
MY9CT4#J2?0<UF7WBC3;;PW?:U!<Q7$-JDA(5O^6B G8>ZMD8P>10 QO!?AY[
M1;5M-1H4N#=*#(^5E.<N#G()R<XZYYI3X+\.&RO+,:3 EM>R"6YB3*K(PZ9
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M>F>?KSUYJK<^,O#5H91/KE@GE2^3)F8?(_'!],9&?3/-$_BO38/%<'AYY/\
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M^TB4O"'*&*,.-O3KWSFM2&ZN-,DOY]5U:WEL($3=(8A&8&Y+;B"1C:4/;'-
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M[X&<D]0!@@'14444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(_X5_P"P[;_^EQKL8M2U/Q%JWB2SL-1?3SI4B6UN$C1M\AC#EWW*<KE@,#'
M/.3P =C17G&G>+]4O[?P;KL]PUKIFL![2\@5$VQW!#>6P8@L%+*PQGNOOEWA
MSQ)JNK6]SI4NI3C54U-4CF,,2L;-AYJ2;=N &B!'(X8CITH [JWU&*YU"\LD
MCG62TV;V>)E1MPR-K'AO?'2K=>?WVO:W#-\08X]0 _LBTCGLCY"?NR8&D(/'
MS<@#G-.TW5M<M_$7A1+S53=V^MV$LDT#0(BQ.D:.&0@;N=Q!R2/3'2@#OJ*\
MQ'B7Q!?6E@UO?M!K$VM-9W6FB&-O(@$C#=@C=\J!7W$X.?<8],96:(IYC*Q7
M&]0,@^HSQ0!G:SKUAH-@+V^>00&58=T<;/AV8* <#CD@9.*TZ\89;IO@I=3S
M:A<7,LFL  W&T[2-2QG@ G/4Y/TQ72:AXFU;PMJ_B2&[O3J<-IHRZI )(DC\
MMR\B%/D RF5!YR1ZF@#T.BN4TW_A)EU^SEEN#/I$\#"<7)A#+)C*M%Y8Y!YR
M"3V.>M:GB>[N+'P[=7%K>VUE,NT+<7 )5,L <  Y;!(48.6P,4 :]%>;R>)-
M;BM_'<,=Y<*VD6$=Y92W4$?FKNBD8@A0!C,8QD9&3FK5AJFNP>(O#$-UJQNH
M-;TZ:22)K=%6&1$C8,A SSN.021Z8Z  [ZBO*K/Q%XE'AK2-=GUKS2VM_8)K
M86T:I+$;IHN3C(8#&""!QR#UK6NM>U>*+X@HFH/NT:,2V3^5'E/]&$N#\N&&
M[U&<=Z ._K-O=<L;#6-.TJ=I!=:BSK;@1,58HI9LMC X!XSFN3U'6]7>QMY(
M=4*2MH8NQ!:1(TQF(R9'WJ46/CCD9.0,XJN^HS:OJ'PNU.X"B>[62>3:,#<]
MDS''MDT >C44R57>%UCD\MR"%?&=I]<5Y98>(?%$OA7PCKCZV&FU*_2SG@:U
MC\IED9UW< -N& >& XQCO0!ZM17FUQXIU?0+SQ)IUQ?M?FUGT]+6XFBC1H_M
M3;#NVA5(7!(R/8FK>IZSXE\+VVLZC>,)]-2U1K4W;1>;'.7"$$1A08_F#<\\
M$9H [ZJ=[J4%BEL[I-*MQ.D"&"(R8+="<=%]6/ KE+I?%,,FHF2^G33'TZ0K
M+*T N(;A02#'L7!4C.<@D'I61I^H:KI'P^\!36VIRM]MN=/@G$L<;$Q2*N4!
MVC XZ\MR>: /3J*\YU'4O$<NI>-X;?76M8]'@BN+4):Q,03"TFTE@<KD<]^F
M".]UO$][<7/AA;JY&FV&J::US+=J% ,^Q&$0+@A>&=N>3M]C0!W-%<UX$O-8
MU'PS%>ZU,9+B62383"(\QARJ-@?WE ;\:K>*-1U&WU&2"SU)H0NG23);VD:/
M.9 >'?>I58P!W(R<CF@#K2R@@$@%C@9/4TM>8I?ZCKNK_#>^EU&XMVU"QFN)
MHX FSS/(4E@&4]=[#G. >,<FO2YD:2%T25HF92!(@!*GU&01^8H ?6;K6NV.
M@6D=U?M*L4DJ0J4B9_G=@J@X'')')P*\ZE\9:U8Z!I\]YJ4QO=.U5[76UC@B
MP8$<*TOW?E $D)X[-^(O^.9KJ\\(ZC=?:B]N^KVD=HC(NU EQ&K'@ G+A^IZ
M 8H ]'9@B,Q!( SP,G\JK:=?Q:GIUO?0QS1QSH'59XS&X!]5/(-<K97VLV_B
M_7-"GU5KI%TZ*]MII((U:!F:164!0 5^4$9R?<U0T#Q5J6K:;X,LY[PQWFLV
M<MU<72H@8^6%^5 1M!)<'H<!3ZY !V.JZ[8Z-+81WC2JU]<I:P;8F8&1N@)
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M?%'1DN]5E\Q="DDFCM@ODF02Q!]H92=K$>N[@8(I-)UCQ/K]AH^OZ<^+6YN
MUS;SM$(1;EB"%(&_S%XZG!(/'0  Z[7=<L?#FCSZIJ+2+:P@%VCB9R,\#@#]
M3Q6E7D?BS4[WQ/\ "?Q)K(OY(+<32PQ6BQH5\J.79\Y(W;FP6X(QD>ASZY0
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M36(HXKJ)V4)B/.PKA005R2#FBR\$Z=;Z7=:??7>H:O%<PFW=M2N#*PB/\*D
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M1NKJ>ZG(H YNS\%6]MJ=AJ,NKZM>7=C"\$,EQ.I^1L9!VJ-WW1R>3WSQ40\
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MDD-%N0'81W'I^% 'C/A_6[6S\.>!QJ-S$=$COKV"\9S^ZBE#R?9Q)V4#G /
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M<;R"GO@5W8TO3UB:(6-L(V(+*(5P2.F1BG3:=8W$,<,UG;R11$&-'B4JA'<
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M@NT3^6-X'INZXH \SM+OP_J4GB;2_%,R1ZM'K#-'&9-ER\:LK6_D_P 1& H
M7N3_ 'N2Y"VGB[XA'38K=-;;3X)-/4*HE:3R)22G<G/7'?K7ICV5I)=I=O:P
MM<H-J3&,%U'H&ZBG^1#]H\_RD\[;L\S:-VWKC/7% 'F.RTN-*^'VH>'_ "Q?
M/=P)(T6-[P&,_:5D[G&,G/\ $!W-7OA_H>CR:EX@OA96[7=EX@NUMY !F$%5
M!"^@()XKO(;"SMIY9X+2"*:7_62)&%9_J0.:6WL[6U+&WMH82WWC'&%S]<4
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M&<X(Z<XLW^E:K;:AX<\1:?X=2&*QGN#<:3:^6LHCF15W\$(T@*Y(!Z'&3C-
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M:]5XIX8W;:LC1R+)L)[9VX_&@">/Q3:OJ\6E/9WT-[- ]Q#'+$%\R-<9(.<
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MN+[^< YQA !QDG/'3/,ZMJ<4GPYT[4=#U753"VJQ(L]Q,PE<&[V.K$\[?O
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MDVG217]Q=BU^UB*UM'E+Q[@,K@?-U[=,&LG3M1>'Q+XZ%[>WS6-LELZ*"[M
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MW:-*FT3P\?,IR<?>4X;!Y'%4/AW<W-SX=NFNKJ>YDCU.\B$DTA=MJS,JC)]
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M&Y9=I "<')R_MSWE !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% $8AB$[3B-?-9=I?'./3/I4E%% !1110 5SY\%Z-]OGO(A>V[7$A
MEGCMK^:&*5SU9D5PI)[\<]ZZ"B@!D44<$*0Q(L<:*%1%& H'0 >E/HHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "L/Q3H$OB+3[:UBO$M?)NX;K<T/F;C&X<#
M&X8R0,UN44 <E?\ @A=6U36[C4+U9+75K%+*2". HR!"Q5E;<><L3T["ET_P
MGJ;Z9/IWB/Q ^L6CV[VRH+80$HR[27()+MCC/'4G!/(ZRB@#D=%\(ZG9V?\
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M[21Q@98GTQTM% ''^'?!NH^'A'81^(9)M"MY"]K9-;@2(,[E1I<Y9 ><8!X
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO]IEB%JPEABR1N=3@C[K8'4X. <5.WBC3&M[:6T>2^^TV_VJ)+5-[-#Q\_;
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M+93J"!CG':H].\=OJ^EZ"UO (+W5+)[M_P!Q)<+"J%5/RIAFRS #D< Y/0$
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MJ.K;>N.1S7._$G4-0TOP!JMYIDZ07$<8'F,I)"L0IV\C#<\'M67K U-/B9H
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MI86%F%U^Q>ZS/*W[EA&KXX'(&_\ '';K0!T^C:+8Z#8"RL$=8\[F:21I'=L
M99F)). !SV '05H5P*^/KFV\-RWNIPV]O+:ZO)I=Y<QH\D$.TG]\5SNVGY1R
M>"W6M5M>U+^RK*ZC?3)(;BY9'U%)0;>.'#%),;\L6(5=H;@MWQR =317$:=X
MZGO=*M@UO$-2N-6ETJ/AEC+1EB9"I^8#8A.WKG R.M5O&.K^*M/\'ZU)(MK:
MR07,,4%Y$"1<0R.BDJN\F-@6(Y)Z<>H .XDOK2*^ALI+F)+J=6>*%G =U7&X
M@=3C(_.K%<O<:O>6GC;1=)NK:RD%U:7,INE4AU*;,A0<[0=P[G.*RY_'=Y'X
M1C\9);V[Z&9?G@PWGB R>7YH;.">C;-O3C=D4 =Y17#7WBKQ#_:?BBTL+/3
MNC017"232.?-5D9\$#')VX]![]NKT;41K&A:?J:QF-;RVCN A.=H=0V/UH O
M45C>)-=&@V5JRQB2YO;N*RMD8X4R2-@$GT R3]*H0Z]J,7BN7PU>BU^U2V1O
M+*[CC81N VUE9"Q(()!X;D'M0!M#6=,.IKIHU"U^W,#BW\U=YQUP.O'>K<LT
M5O"\TTB1Q(-S.[ !1ZDGI7#?#&VDO?!MA>:BMK<R)<W,L$AA_>1NT\H=MQ)Y
M.3TQP>]=Q. UO(" 05.0?I0 VTO+:_M([JSGCGMY1NCEB8,KCU!'45-7DGA#
MQ%K?AWP%X1NI[*RDT&<0VDC)(WVB,R-M60\;=NXC(Z^_IT%WXUU*U\+^*]3^
MSVC3Z%>R6ZKA@LRJB-D\Y4_/[]* .[JN+ZT;4&L!<Q&\6(3-!O&\(20&QUQD
M$9KEM6\82VGB!]&BELK6[-LDUHEZK 7K-G*(^X $8 QR26JP^M7:^.M0TE+&
MSW0Z4EW#.6(=\R,H5CC@ J3@9ZT =317GVD>.-:N[3PIJ5Y96"6&NR"W*1.Y
MEC=D=U;GC;\A&.O?/:K,WC/4YXOM^D::][:+>M;-;):3&1XUD,;R++]S@@G;
MCH.H/  .XHKD+?Q=+>^*+K1XIK*&ZMKL1-87"LD\D&!F9"6 8<DX / Z]J-&
M\72ZQK\FGQS64<MO=S0W6GRJR7,4:[PD@RV'#$(>%P _7B@#KZ**9*9!$YB5
M6DP=H<X!/N<&@""VU*QO-.&H6UY!-9%2PN$D!CP,Y.[I@8/Y4VPU73]464V%
M[;W(A?9)Y,@;8WH<=#7FVM:S?:U\&;'4X(K2Q%S<0++!$AV@&Z50%P1QZ^N3
MTKTJSLDMVDN'AMA>S[?M$T$6SS2HPN>23@<#)- %NBLK7]0O-.LH9;2* [YT
M2::=PL=O&<[I&R1N QC ())%4O"/B&;Q!!J@G2,26%_)9^9$K*LH"JP<*V2N
M0XXR>G6@#HJ*@O;N'3["XO;AML%O$TLC>BJ"2?R%<C-XJUF"#PWJ#V]D+36[
MN& 08;S(%D4NI+YPQVK@C P3U..0#M:*X.\\;:E:^%O%>I_9[1I]"O9(%7#!
M9E54;)YRI^?WZ5LOKM[J.OZAHVD?94FTZWBEGEN49U+RABB *01PN2V3U'!H
M Z.J.L:3:ZYILEA>&802%23#,T39!!&&4@CD5QD7Q U+4K;PZ^G:;;)-JES/
M9SQW$K?N)HE<L.!RN4SGJ1V!K5TS7=;D\0W6A:E'IZ7<.F17ADMP[('=W4K@
MD$CY,]NM '2V5G;Z?9Q6EK$(X(EVHH)./Q/)/N>34]<!9>.=6U"Q\'3P:?9!
MM?$@D#RL!$RQNXQQT^7K^G>HI_&?B:#1O$=R;+2FG\/3.+D[I MPBHLGR#JI
MVMU)(R.GH >B57N[ZTL!";NYB@$TJPQF1PN^1N%49ZD]A3[:=;JTAN%!"RHK
M@'J 1FL'Q=J\VD#13'9VUQ'=:K;VKF?.8][8#*,?>'/.1CWH Z.BN0;Q=+)X
MLN=#BFLK>[M[B)%M+I662Y@8*7EC;< < O\ * ?N<]:Z^@ HKD]7U_7(O&,/
MA_2[.P8SZ?)=I/<R/A2KHOS #I\W0=>.16+%\0=9DTJR;^RK1=2_MS^Q;V)I
MFV))_>0XY4C!R>F>AH ]&HKC6\2:U'</I$J62ZQ;VHN9W@MI[B'YW=8U 7##
M(0DDGCL&[5I/'=S#%HR:G;Q:!<:A;.Y.I(QC6=6"^3N!4*3RP)[8XH [NBN2
MN_$]^;HZ9;11QZE#8Q75P3:RW$8>3<%C'E]!E&^8GIC /.*:>+O$%Q?>'+(:
M+!97&K6MQ))%>.P:WDBVY! '(^;([GVZT =S17F>I>+-=O?"]K+&]K9WT7B*
M/2[LQHS(^VX"DIR"%/&0<G!(XZUZ3$)!"@F96DVC>4& 3WP"3@?C0 ^BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "L/Q5H$WB/38+.*]2T\J[AN2[0&7)C<.!C<N,D"MRJFIW<
M]E8/<6UC+?2J5 @B959LL 2"Q X!)_"@#)3P]>1^+KS7UU&#-Q8I9B$VI^78
MS,&SOYY<\8':L"#X=7VG:1H*:9KXM]6T9)(8KO[)F.:%R"R21E^>@Y!XQ7H%
M% ''ZKX.U'4+?3KN/7WAU^PF>:._^S@QMO4*Z&+. A  QG/&<DY)EU'PIJ.J
M:-:Q7.MJ^J6]_#?K<FV_=!XSPHB# A,?[6<DG-=710!S7_"-7O\ PE4VN_VI
M"7DTU;#RVM#V8MO)#CNQXP.*SK;P'=VVA^&-,76(6&@W*W"R&S.9MJLH!'F?
M+PYYY[5VU8_B7Q!'X9T@ZC-:S7$0ECB81%1M+N$!.2.,L.F30!YNEZMSK^I7
MD'B/1+>^>^9ET[5-++W2E#M0 !U9N%RN%) /4G->L6$EQ-IUM+=PB&Y>)6FB
M4Y".0-P!]CD4Q+J=M7EM382K D*R+=EEV.Q)!0#.<C /3'-6Z ,'Q7X?N/$>
MGVUK!?1VGDW<-T6> R[C&X<#&Y<<CFH9O#=W#XH;Q!IM]##=7%LMM>12P%XY
M@I)1P P*L,D=2"#CWKH(+B*YB\R"19$W,NY3D94E2/P((_"LOQ1X@C\+Z!<:
MO-:S7,4&W<D)4$98*#R1QDCID^U &+_P@C0+H8L]12,Z;?27\K26V\W,L@?>
M3AQM!\QL=<<>E=E110!A^*- E\065FEO>+:7-G>PWL,CQ>8NZ,YPR[ER#D]"
M*J1^%[Y-?U35?[5A9[^QCM"C6A^39NPV0_.2YXP.U=/5+5]5M=$TFYU*]8K;
MVZ;WVC)/8 #U)P!]: ./C^'VH:?8:"VDZ^MMJND6ILQ<FTW1W$!Q\CQ[_4 Y
M#=?T['3;2>SLECNKQKNY)+2SLNT,Q]%'"@= /;DDY)J:?K4MQJ5QI]]ITUC.
MF#"SLK)<*1DE".I7HPQQD=<BM>@#DOB=+'%\,_$/F.J;K*15W'&21P![U-IN
MC2:C<Z+K%]?6]T+"W;[(+>/:I=T"F0G<<G;D #@9/7C'3D ]1FC&.E ' 0_#
MW4H=,T[2TUZ$66F:FM]:+]BR^ [/LD._YN6QD;>.N>V]I.ARZ)K&O:K=:C!)
M#J4J3LGD>7Y)5 GWBYR,*.PYKH:.M 'EWP^T>3Q%\-- MKF^MY--AE$[PQ1_
M.YCE+JC-N(P& )XR0 ..IZ+_ (0RYMO[=M-/U-(--UJ22:>)X-[PO(,2&-MP
M'S=<$'!YYZ5TU_=#3]/N+L023"&-I#'%MW, ,X&2!GZFH=#U6/7-!T_5HHVB
MCO;=)U1SDJ&4$ _G0!@:QX*.IZ1/H@GM/[&DM8[:&WFMC(UJ57:'C;</FQC'
M'!&?45'-X-U2S\03:GX?\0&P6\BCCO8;BV%P)#&H59%)8;7V@ ]0>XKLJCFN
M(K=5::14#NL:[CU8G  ]\T %O"+>VBA#NXC0)OD.6; QDGN:QO$OAP:\EA-#
M=?9-0TZY6ZM)]F\*P!!5ER,JP)!&1]:W:ADNHTE:%3YEP(S((5(W,HX[D#KQ
MR10!B1^')S>:GJ<]W"VJWMJMHLJP'RX8EW$ +NR>78DY&>.F*M>%]&E\.^&[
M#1Y;M+K['"L*2K%Y>Y5&!D;FY_&E\-:]%XF\/VNL00201W&_;'+C<NURO../
MX:UJ *6KZ5:ZYH]YI=ZI:VNX6AD"G!P1C(]ZP[3PK>.FC1:MJ45['H[B2V*V
MY1I)%0HCR'<<D!CP,9//'2NIHH XQ--NO!O@_P 12O>/=O-+<WJ-:VA#QM*2
M3A=S;@"<_0<@US_A"22TO+&+1]>\.:S& D$L=E8&.=(L_,2XD;9CEL, ">.I
M%>IT  =!0!P-A\/M2LH-"A/B%'31KMYX&^Q?-(KAPWF'><O\Y^;@>JFI;GP#
M=W/AK7]';681_;%^UX919']UN96*@>9S]T<Y'>NYHH YN7PYJ#>+)-?CU2W2
M9M,-@L9LR0K;MXDSYG/S?P^G&>]5M!\):CH>FBQ768)/-F,]Y<BS9;BY=CEF
M+^:0">!T. ,"NMHH X/2_ .I:>?#F_7XI%T)Y!"%L=IEC="AW'>?GP?O=/53
M4\O@2[?0/$>BIK,:VNKSSS(3:9:#SFW."=XW8/3ICOGMNWGB".S\3Z9H;VLQ
MDU".62.<%=@\L L.N<_,.V.:V* .7;PM=0:]::Y8:A#'?I9"QNA);DQ7$8.5
M.T-E6!SSD\'%59? C?9]-2WU&..6VU<ZO<RO;%OM$S;L\!QM'SD#K@ =>_94
M4 86DZ!/IOB77-7DO8YEU1HF\E8"AB\M-@^;<<Y'L*W",J1DC(ZBEHH X'3O
MA]J5C%H$1\0QR+HES)+ ?L.&D1U=6WG><O\ .?FX'JIJ6X\ W=QX9UW1SK,(
M_M;4&O3,+(_NMSJY4#S.>5'.17<T4 <B_A+4;?Q%J&JZ9J\%NNJQ(E_!+:F1
M6=%VB2/YQL..,'</K6MX5T23PYX8T_1Y;I;HV<(B$HC\O<!TXR?YUIO<Q).L
M&X&=HVD2($;F52 2,^[*/Q%9OAO7XO$FE-?Q6TMNJSRP&.4@L#&Y0YP2.H]3
M0 >*="7Q-X9O]&:X-O\ :H]@E"[MA!!!QQGD#BJ/_"-ZC)XFTS7+C5K>2:SM
M);=T6S*B0R%22/WGR@;1@<^Y-=+10!P1^'=TFD110:[Y&J6NI3:C9WL5K@1M
M*6+HR%SN4AB.H[5U>C66H6ELS:IJ(OKR0@O(D7E1J!T54R<#KR222?3 &E10
M CJ'1D/1A@UPMOX!U"#PYH6C_P!NPLFCWL5S"YL3\ZQD[5(\SKSR?I@#G/=T
M4 <MJWA2]O\ Q%-JEOJZV\=UIQL)XGMO,(7).Z-MPV$[N<A@<"JNF^";ZPF\
M*R/K,,O]@6KVP7[&1YRLBIUW_+@(/7G/T'9T'ITS0!R6G^%-4TN*\6#6+9S=
M:K+J$BO9G8ZR*0T3#S.1D@@^J]#5*'X>R6'V"72M2@M)K349[\0FU+VV95V%
M%C#@K@=#G@D^N!T7A[7X_$,%]+':S6QM+V6S=)BI;=&0"?E)&,^];% ' O\
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M(<JV#U'4$=P34=MH-R=;.MW]U;RZBMH;2#RH"L<:EMS'!8DDD+W' QZD[U%
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M+JLUK-<Q1NBLL14$;F"@G)'&2.F3[5L4 %%%% !1110 4444 %%%% !1110
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MC/#9U77=+\.>)X]<2'S71KT?:))$GW_*\/E$[$(8X&.F.^36'J=R_B7X1?\
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M3T/3-9DM9-0M$G>U<R0L204)&#T/((X(/![T >7:I#/%I?Q'U6VU"^M;FPU
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M6VO:3>/*EOJ%O(T4?G.H<9$?]_W7_:Z5YKXEL[[4;[XB6^DQ/)<7%I8&-%!
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MKC-<U:ZO;:G\1?#]]:I<O9_V/<1F<VTBH&+1'!)''0\GC/&<USH5&^'MG!)
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M4$JRQ-&5=5 888#.#QD<55\6.;7QQX/OWAG:VB>[C=XHFDVL\0"@[0>I! H
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MUR@Q\WS*1QZ5TGB&TLIK30Y;+4GT6[4&2TOXH08E8(%*2J1C:5XYQ]T#.>*
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M<>'8+VVBM%TQ;]&:VWN&,I3:3N (XS72Z/:QV6BV-K#;O;10P)&D#N7:-0H
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M.>U8<:G6_"?@K3+*"2#5],O+0SPM&5>T$(Q*6]%(! SPVX8SFM_P[,A^)7C
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MM9SB\70==N[.TGN4M/%W]H3VT:'?/;*Z,2H_B&1N'8[: .R\6>*!#X)US4=
MU&W-[IT)=LKO,9QD J<8R.1G]:VM,U_3-2N'LK;4;:>^@C5IX8Y 63MD@>_'
MUKB?%5_I.O>!?%.HZ-82M)>6(A:Z-J\;W#@$*BJRAFV@GG&.<<\XNHT(^)/A
MV2W4"$:+-"61<*I+1%4)Z _*V![4 =U++'!"\TTBQQ1J6=W.%4#DDD]!52PU
MG3=3DDCLKR&:2)59T5OF56^ZV.N#@X/0UG^-93!X+U>0:9_:>+9LV>"?-'0@
M@<X[\<\5RWAZZ$_Q/^U++>74%SH4:1W#V311EEF<E5^4;5 (QDD\XR: /1Z*
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH ***SM8U>'1X(&D1Y9KF=;>WA3&Z61LX SP. 22>@!H
M T:*Y.;QG+:3:[;W6E%+C1[);Z4)<!EEC(<_(< YPAZ@<_G5Q/%43:GH%H;1
MPNM6SSPR;Q^[VH'(8?1AT]Z .@HKDI?'=O#I4.NM9N= EG$/VX2#*@OL$I3'
M^K+=\YP0<4\^+[N;Q%J&C6/AZ[N);"6!)Y#-&B*DH)#]>0!S@9/7@=P#JJ*Y
M&+QW#)X=T[6?[/E$-YJ T\QF0;HW,QAW>A&X9^E-O?'$T%SK]O;:!=W#Z(J/
M/F:- R,A?*\G^$<#KZXH LV7A6^T]Y(;7Q+J":>\KR_9VCB9U+L68"0KNQDG
MKD\]:Z.WMXK2VBMH$"0Q((T0=%4# 'Y5S-GXU6[U71K=M+N8;/68FDL;IW7Y
MR(_,PR Y7*Y()].@K5US78-$6R67R_,O;D6L/FR>6F\JS?,V#CA"!P<D@=Z
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M:=GXSAU6PTZ?3+"XFEO9I(&CE&P6SQ@EQ,P#;<%<#KDD8]: .GHKC#\0[?\
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M'R]<=\]JZ#1M'U&R\:>(M4N([<6>HBW$.R4EQY2%3N7: ,YSP372T4 >9?\
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MOSNP/3!ZU$GA/6X_#'@S31'9&?0[J"6Y/VAMKK'&R?(=G).[/..E=^2 "2<
M=36=-KEA;ZY::-)(XO;N-Y85\IMK*F-QW8V\9'&<\B@"+Q1I,NO>%=5TF&1(
MY;RUD@1WSM4LI )QVK(BT'4-4OM"GU:""VBTA681Q3&4S2F/R\YVC"@%CZDD
M<#'/6T4 <1X4TCQ;H$%OH$[Z=)I%DVV"_61O/> '*QF/;C=CY2V>G8FG_%,N
M/ \AB"F3[=9[0QP"?M,>,GTKM*PO%,^@PV%N/$%NL]M+<1Q1J\#2KYK, F<
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M(X& OI79DA022 !R2>U8"^-=#:4HUS)&IMQ=12O X2:(L%#1MC#<LH ')W#
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MW;:;:O;W5I)<.(C)D;)A\AWD $;2!C/![CT7(W!<C)YQ2T >;6G@WQ#;^#M
MTAET]I],U=+QV$[!7B65GX^3[QW8QT&.M=)9:/J,/C_4]:E2W%E=64%NFV4F
M0-&SDDKMQ@[_ %[5TM% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7+>.M5U32-/TR72KB*&
M2?4[:U?S(MX99) I'7CK]?3%=37&?$FVGO-'TN"VAO)'&K6DK-:0M(T:)("S
M\ XP.>?UH RKS6_$VAZMX@TBYU6.]*:+)JUE=M:JAB*$JT;*O!&<$$\_6I(M
M<UZSTWP]+>:ND\WB*2UACQ:H@M,Q%Y&!_B+  #(P#SC'%=++X5M;R+46N;R[
MEN-1M?LDERVP2+#S\BC:%4?,Q/&<GV&"Y\(6%WX<L=%GFNF2P,36MSN430O'
M]QP0N,@<=.>^: .9UOQEJ7A'4==L;N0:@EOIB:C9SS(J%2TGE%)-@ (#$'(
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M\\$8Y[S7/#UMKK6$DUQ<V\UC<"X@FMG"LK;2I'((P0Q!XJD_@RSD?7F-_?\
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MN00H+$*2H+9X)[\UFZEX=30O 7B6RL9+Z]>^ANI5C9!(YFE5LA0B@\L?P]J
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MB!E'!4JPX!Z<$9&* .1E\7>(CIT<"W4$=]9^)H]'N)S;@K<1LRX;;GY2589
M[YP172>&M0U3_A*_$.B:C??;H[);::"9HEC8"57RIV@ @%.#UYYS4]SX*T^X
ML;:U%S=Q>3?C4FE1DWS7 ;=O<E2#SV  Z#H *E;PI"=0UB_34M0BN-5MUMY7
MC=%,84,%:,A<JPW'!R: -^O,M=U#4=*^+.IWVF::-1G@\,(_V;SO+9P+AS\O
MRG)]N*](MH/LUI#!YLDOE(J>9*VYWP,98]R>]9*>&;=/%LGB07MX;Q[86AC)
M3R_*#;@N-N>I)SG- ''^'[J#PC\*KSQ!97D6H/?SM?F14V1++.ZIM"D\*I(R
M"1T/3MMI<>++"^OIC#+>Z>+!Y(8[HPB;[2N2$7RN"C#UY![U:3P-I*1:O:AK
M@Z;JK,]SIY9?(#,/F9!C<A)YX/7FJG_"+S>'?#NHM8W>KZW>+:/#:17EV"R
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MO$5H="\9:D/#ENMO>S^%[N4+ ,--,LB['/\ >?DX)R3FGZ(OAC4)=,UO3/$
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M(B4R1V8NOFRHYV $<=,$CI5W7OL&E^'O$FL>&-:-V]Q;P?:TT[9Y44?F*K2
M1_=D,9?G.<+GL* .]N/$$\/C?3M#6"!K:[M9YC,)"7#1E 5VXP/O^I_"K?B/
M6X_#VA7&IR1F7RRB)&#C<[N$49[#<PR?2N,W>'XOBIX9ETE[!(Y]*N54VS*
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M[-PW@9VYYQ7 S):P_%/3I-)CMLMX?N1"(L!&Q+'M QQBN<0"\^%.CZM9 ?\
M"51WT*^;C$[79G"S(_<Y4OE3QM'H* /82Z+]YE'3J?7I3J\@U;1M*NIOBHT]
MG!*;:%)H=XR(I/L8;>H_A;=SD<UZ-IMQ=R^"[.Y@/FWCZ<DB%CG?(8P1GZF@
M#7#J7*!AN R5SSBN=U/7=1?6+W2-#M[::^LK2.Z=;EBJR;V8+&"/NDA&.XY
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MQ27! \T$O\NXKMZ]B1WY[[P;96FG>%K.SL+^>_LXMZP7$Q!+IN.,$=5'13Z
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M#2$O!#%( !*960G)!.,#ITI]IKFIZ#X_3PSJMX^H65]:/=6%R\2B9&3[\3!
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MQC/% &U:Z1IEBRM::=:6Y3=M,4"IC=C.,#O@9^E375E:WJ!+NVAG53D"6,,
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M/P)*_A^^MXM*MYK>[:5HP48PJF0-W*Y'7J>PID5KXBL-&ULVFDW.^X\1M=E
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNNF^-X/#>KV:6HNXE>UO$F+QN[%@(VRHVL=C8Y.<52^)# 77@L$@?\5);?\
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M .]0<ACD#TH ]4) QD@9Z4$A1DD#ZUYU;Q66MZUXXL_$21F:V=?),V,P6GE
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M >N1^I]36-X7_LS7K+0[^\UN*W\16M\#<PQ1JMVT^XK)$^3N*'G(Q@* > *
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M !1110 4444 %%%% !116#XL\2KX8TZWN3:S7#3W<-LHC0L%WN%R<>QX'4G
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MR_.A1E925964\@@@C!J#4/$5AITT\+^?-);1":X6WA:0PH<X9L#O@\=3@\4
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M(P<2!E_AP2!D'.*H2?$>*/0_$NI_V9>[=(GEA1# PW[%7ECT7YF/N%P<9XH
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M/_K=Q4JW'RD$$<XZ&D7QMHS6&J7C-=QII9'VR.2TD66)2-P8H5W;2.<XZ9H
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M>02I/W1Z5%8>/=!U.734MI[@QZED6L[6TBQ2, 3LWD8W8!.,YX]>* .D
M  '0"JK:7I[ZBNHM86IOE7:MR85\T#T#8SBI+R\M]/M7N;J3RXDP"<$DDG
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M>.H[@4VS\2:?>:N=*'GP7OD_:$BN(6C,D><;ER.<'J.H[@4 :]%%% !1110
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MD673]&EDL]+8')\M]LA#>Z@I&#_LM72>'];;7+2XEDTZZT^:WN&@D@N0-P(
M8'@D8*LIJYIVGVVE6,=G:(5ACSC<Q9B2<DLQR22222>234T%O%;1>7#&$3).
M!W).23ZDGG- ')QP74/Q,U74FLKDV;Z3# DRQDAY$>1BH[]&'M7-:=I&JV_@
MOP!8RZ9=BYTS48I;R/R\^4BI(I8^OWUZ9_2O5:.E ',>/=+O]5\,[=,@CN;N
MVN8+M+61@%N/+<,8R3QR ?QQ6%/]MNO#NJZCH7@H:=J)MA$J7EO")ICN!95
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MNWB*37%Q%&#N/5(F4DLI/))P, =<\=E10 4444 %%%% !1110 4444 %%%%
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MAV2I(J@[5WY4C8,$EN<\=J *<GC74)DCO]+TN6]LOMK6S0QVLQD:-9#&TJR
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MN+B4,N&51,S'(]0*M_\ "(ZW8:_>WFB^(4M;+4G66\MYK02E9=H5I(CD!68
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M/<P+;WL-Q;&:.55)V. &4AADCKC^H FH^(]9M+2WEET^VTYFL#<R?:Y1(/M
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M9,YP=H/7(Q575?!^IZE9Z?=_VX(_$%A<FYAO!;_N@678T?E[N(RO&,Y[YYH
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MQ)*K!SD,-N=['H>WI72K!J UJ2=KR,Z<8%1+7R?G67<27WYY&,#&* +M%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %4-7U>VT6R6YN0[;Y4ABBC&7ED<X5%' R2>Y [D@5?K!\
M7:-I_B#2(]+O[F6U::=3:W$+;9(IU!964]B-IH GL]>^TZN-+N-,OK*Y:!KA
M?/"%&1653AD9AG+CCK^F=>O/=#O_ !%I?BJW\+>*C#J'VJVF:PU>V!BD=4V[
MTD ^ZV-IR#Z=3TR].U?4I/ G@2^DU&[:ZN=8BMYY#,V9D,D@*OS\WW1U]* /
M5JR-,\01:GKNKZ4MK/#-I;1+(TFW#^8I8%<$\8'?!YZ5R]A-<>*++7+UM<N=
M-O-.U:6%6CD.RWCA<?*T>0K!E!)+ _?]@*R]2M)9]?\ B1<1:A>VDEK:VTT3
M6LQB.];9BI)') (Z9P<\@\8 /4Z*S?#UY-J'AG2KVX;=-<6<,LA QEF0$_J:
MX;4([Z]U[QY VMZI%#8VD$]JD%R8Q$YBD;(VX.,@<=#WSQ@ ]+J.:>*W0/-(
MJ*75 6.,LQ"J/J20/QKS_1=<N_$.M:!I=_<3QQ3^&XM3D,$K0M/,Y53\R$'"
MC)P#_%ST%8-_+>:CIEM8ZE<W4XTSQE!807'G.CRP[U(W%2-S#=C=UR,]<T >
MK_;)O[7^Q?89_(\CS?M>5\O=NQY?7.['/3&.]6ZX._U&]T?QYJ$<%Q<W%M;>
M&FNX[224LID60@'GDDA0,G)Z^M3Z DMYI?AWQ(FO73M/;;[J R%X[QWCSM"$
M[8RK D;1P 0: .UHKS?P[+K6OZ5X=\30ZO';^;*CWH:\DDCF5SM:'RB B,&(
M (Y!'?)->D4 %%<GKNI3/XYT'P^TLL%G=V]Q<2-%(8VF:,+M0,I! &XL<'G
M[9SQ^MZIK5EI'BS3HM4O572=3LDL[OS"9/+F:(M&S'EMH<C).<$9)H ]<I H
M!)  )ZGUJCI6F?V5;RP_;KV\\R9I=]Y-YC+G'R@X&%'8=LUP_C>_NE'BF2PU
M*\>XTW3%F6."9H([%PKN&8@_O&? .TJ0 O)&[D ]'HKSYFO=6\>:992ZK?PV
MEWX?>YFAMYC&"XDB&01RI^8\@Y]\$UE07>LR?#*PU]=0O[BYT:]F:Y19V#7=
MM%.Z.KX/S,$4'/4E?<T >K45@>'KI=8O+[6[>YDEL)BL-H!*QC94'S2!<X!+
MEE^B ]S5#Q[-<Z78V&OP7-S'!IMY')>Q1RLJRVQ;:^5!P=N0W_ 3V- '745Y
M?9ZO='7];T7[9>E=8V3:+,UT[,(BQCE9#G@+M,HQU4BF>-M1O++3_%%UI6J7
MTLVE1P;"L[1QV3!5.T_,?.9L[CN!&#@F@#TAKN8:NEF+&<PM 93=@KY:L& V
M'G.3G/3'%6ZX^XFN6^*T-@;RY^Q3Z'-(UNLI5 XEC7<,8PV">>HSQ65H%U>2
M/=>#[R_O)-3LM2+27+7#^:]GGS4DW YP05B('<T >BT5YJ9]:\30:[<6.J)I
M]WINIRP),UY(J6Z1/P'A VLK*"26S][KP +FG6EYJWQ!\103ZWJB6UA+8SPP
M0W&Q,E"S*1CE#T*]\\]!@ [[I6)?>)K6SU'1+5899TUARD%Q&5,8PA?GG/('
M&!1XPB6;P7K:,TBC[#,V8Y&0Y"$CE2#V_&N%:Q4:9\,8(I[F/S9%8R>:SLN;
M-L[2V=H]AP.V* /5:*\J.O7^AV&N6'V^>6"#Q#!8QW-W<,SPP2K&S R') ^8
M@,<D;O859\36VNZ%X;\572ZW)#$;#[1:6\=W)-+;N@PS"1QNVMQQV(XH ],H
MKSZ^:[T?4M"T]=4O;@:Y*[S-=WC( R1 B.-E&8PQ^; ZE<="15>ZN=:\/OIV
MC7FK&6'4M;6 2K,SRVT#(7$)E;YB25P&/S8/7H: /1A%&'WB- _][ S6'IGB
MA=6NK3[+IMX^GWB.\%^H4Q':<?-@Y7=U7/7V/%8]N;JW\<ZMX<:YNY]*ETN.
M_C+W#F2WD,C(4$F=^&V[L$\8...*?\*;9(/AKH<B-*6EM59@\K. >?N@DA1[
M#% ':45P_B".\O/B+I&EIJU_:V5UIUR\L5M+LR4:/!! R#\QYZ^F*YJWU+6K
M.V@LIM5O9_[/\7Q:;'=/*=\]NVTE)".'(W8)/I0!Z[17FFM:AJ$,_P 2D@U*
M\B%CIL-S;;9B?)<PRL=N<[02HX%6+BQUNQT+3M0T^[U'6);@Q7%Y8RWYB>5!
M"01 W&WYF5BN>=O7GD ]#HKS2UUP75SX,FTZ_P!3$-QJ=U;W,-Y(XD&$E;RI
M5).2A &3D_*.:7^U)XT\66TNLWD"QZW!:VI4F64AUB/DQY8$%RS*#D;=V>,4
M >E45Y/J&I:O;:-\1K=;V]M3IL,4]H/M32R0%H-Y D;)Y(SC/&2 <5LVRW=G
MXYTBS;5-0N+?5=(G>YCFN&(#H8\,F,;#AR/EQ^?- '=PSQ7"%X9%= S(2IR-
MRDJP_ @C\*))XHI(HWD57E8K&I/+$ D@?@"?PKC/A-;)#\/K"17F9I6FW>9,
M[CB:0<!B0/?'7O3/$UE%/\4/"!>2X7?!>Y$=Q(@^58R,!6&.ISZ]\XH [JBO
M,7U2_P!6\#^)O$::C=6FIZ;<W9@1)F6.$0$[8VCSM;(7G<"3N^F/0]+NI;[2
M+*[GB\J:>!)7C_N,R@D?@30!6U_Q!IWAG3/[0U.;RK?S8X=WN[!1^ SD^P-:
ME<3XFM/^$GU&\TN339[[3[:U>!S$\8VW$J=?G8?,D9&,?\]#Z5E:7KFH7?P<
MUA+BXFM=<T.UN+2Y>-L.LT*':V?<!3GODT >CS3Q6Z!YI%12RH"QQ\S$*H^I
M) _&H/MDW]KBR^PS^1Y'F_:\KY>[=CR^N=V.>F,=Z\SUW1F_X1SPO?76K:K=
MS7NJZ4TBRWCA$)902@4C;G.>YR 1@\UNWM_>:3\0;N*&XNI[6#PV]U':22EE
M,B2  \\EB!C)R>3ZT =T>E9'A_7XO$$-])%;3VYL[R6SD2;;NWQX!/RDC&3Z
MU@^&HY=3TOPUXC'B"YWW$ >[B:0O%=/(G*!"=J%6SC:,C:0>]<[:ZQ-H^BZR
M89%B%WXPEM9)F<H(T>09.X [<XV[NV[/6@#U>L_5-032X?.CL+F\N)#A8+2-
M3(^/<D  >I('0=2!67X?T_5--UK45N]166SN$22WLVN)+AX".&(=_FVMQP>A
M!Q703K,]O(MO(D<Q&$=TWA3ZD9&?S% &;X=\0VGB73#>VD<\.R5X)H+A-DD,
MB'#(PYP1]:L:QJEIHND76HW[;;:",L^!DMZ #N2> .Y-<Y\/VO[>#6M*U-8'
MNK#4G5[N!-BW1D59=Y&3AOWG(Z#@=JS?&^J70?5H;C0-7N+2ULI!;36\2-"9
M'B.Z5B7!^4,5'''S'G(P =MI%W;ZCI-GJ-K$8H;R!)T4J P5E# ''?!JJGB"
M)_%LGAXVLZ3I9B\\YMNQD+[,#!SG.>H'2J/P_NVO/ 6ALUK<6^RRACVSJ 6V
MQJ-PP3\IZC^58^HZ>-3^+DELUU=6Z-X>&YK64Q.?](/\0Y'KP1T],B@#O:*\
MJT'Q'JFI:3X,TZZNC))J-O=F662Y:!IWA8*J^8@W9()8XP3MZ]09]4@U[2K#
M1K*?Q%.TC^(X[;=!,6=+>0%A%(S#+L!CD]01D&@#TZBO/?+N_P#A)IO",>H7
MDT=MIRW,,ESJ4D4\ADDD#/YB#+[,(H!X&><]DTV\U27Q+HWA;6=5-SY>E37$
M]U:.T/VJ9)A&!N4@_*N20",DY/2@#N-4U*UT;2KK4KV3R[6UB:65L9PH&>!W
M-5M-U:XO;ZZM;G2;RR,*HZ2R[6CE5L_=921N&.1VXZ@UYGXAGO+OX:^.=/O[
MBXN$TB\>"UN&E8,\>$8*Y!&\KOQSG/&>>:]9M+:.TMDAC:5E'(,LK2-_WTQ)
M/YT 3UE>)-=B\->'[S6)[:>XAM4,CI#MW8]?F(%.\0K?/X>ODTR>."_>$K;R
M2MM4.>%Y[9)QGWKS76]7%[X$\:6=S;ZGI^I0:<IGTZ^G:=8_O8DBD).Y6Z9'
M=: /6XW$D2.!@, <4X\#IFN CFN-$\=VT#:O=M9W>B37,XNI2\<;QM'B15Z+
MPQR%P*IZ%J%_%XG\)*M]?7%IJ>GW#RS74S'[656-EE$1)$0.XD $'#8(&* -
MV?Q_:6_A;5]>;3+[R=+NI+6:']WYFY&"D_>QC)[$UUU>.ZG_ ,DG^(?_ &&+
MW_T<M>Q4 %1QSQ3/*D<BLT3[) #]UL X/O@@_C7G[ZK>Z?XNC@UL7Z6UUJ92
MPU*TN6>V<$E5MY8P<(W\.<<D9SUK-TA(=,\.>,)UU6\L7.O3VR3B22=^9(P%
M56;EVSM#=1G.>* /520 22 !U)IL,T=Q!'-"X>*10Z,IX8$9!%>77TUY+:?$
M;3+J2[CMK;2H[FWADO'D>)FAE)^?.>2BDKDKU'(-7+6ZF@?PEX>@ED6"]TI[
MD^;?2QM+(JQ (L@RP #,VT8' ],$ ](J)[B-)EAW S,C2)&"-S!< D?BRC\1
M61X5M-1L-+EL]4U)+^>&X=4D#%F2,X94=CRS $<GJ,5A3644GQKAD:2X!&AM
M)A;B15R)T'W0V,>HZ'N#0!T?AS7X?$>F/?0V\UNJW$L!CFV[@T;E#G:2.H/>
MM:O&K/[5IOA!=9M-1O8IH?$TD8A28K$R/>E'5D'#9#'DY([8KH)I=8\4W?B6
MWL=1%A=Z=>^1;R"\DC^SJJ(RLT2C:X8EC\V<CCC% 'HM5+J_$5G>S6T37DUJ
MK9MX2-[.%#!!D@9((Z^M2VK-+90O(Z.[1J6>/A6)')'M7ENG6[Z?X#^(%Y97
MM]!<VU]J)BE%T[%=@RI^8GG@?-U/K0!ZI!(TMO'(\31,ZAC&^,H2.AQQD5)7
MGFZ]OO%OAFR?5=02UO-#EEGCBG*;V7ROFR.0?F/.<^A%8+W.J6W@2\U<:YJD
MEWI&MM:6Y>Y.'B6[$>)!_P M,J<9;/;&* /8:*\\N)-7\4:CXGLK+4/L-WIU
MTL%LZWDD1MQY:.KM&HVR!F+?>X(&.,5WEB[R:?;/++'+(T2EI(QA7.!DCV-
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M,9SZPKK.FZC)\//L4$RO8W/E3P"V??:D6[H48;?E^;'Y9Z5ZQ10!QGQ45)/
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MC[P[G%)+JVH6T?AO7-<LY;;3X9;ZWO)]-5]BN[C9<A1EMC[7.?\ ;]Z];HH
MY[P?:Z7!IMU/H\-REI>7;W/F7&\&9V W2!7Y4$Y[#.,C@US%O/%87?CG2_$"
M'S;^=Y[;>I/VNW:%41(_[Y7:5VCG)Z<UZ110!Y5IFG26?B#X?V.M*DMW;Z/<
M0W'F .$=EB"JQZ9P& ]<&NR\=1HOPY\1HJ*$72KD*H' Q$V,5T=9NOZ6VN>'
M[_2A.(%O8'MWDV;BJNI4X&1S@T <);6=CJFH> 9]%2+[18(9+J2%<>3"8"&1
M\="SE1M//4]C6$UXEOX(71WBN#J%GXE$D\*V[DHGVTN&X'0J01CKV[U[!IEH
M]AI=K9O*)6@B6+S FW<%& <9/85:H X30(K&Z^)OBYY((I"RV31-)'U*H=VW
M(ZJ=N?0XS7&6UE8ZO\)[G1[&.%M<EU6;[,B*!*L@NVQ)ZA57JW0 $9[5[:X8
MHP0@-C@D9 /TK%\+: WAK1_[.-V+I!-+,K^5L(,CL[ \GNQQ[4 <K:W$.G:O
MXVT_Q"ISJ$OG6Q=21=6YA""./^\RE2-HYR>G-8R6&IZ+H6C?\3D6'B.RT5$E
MM[Y/,MKR/+'R&[[U(QE3GGO7KU% 'E4NJ1Z=XA2?Q/:ZAIMAJNCVJ0B!9'2%
MU#^9;ML!.<OQQS3M2L8M'ALV\/W[Z-=V>E[8;+4T,D-Y;EW(A?=\P?CH#N&[
M&#V]3HH R;0WEYX1@:.W^P7TUBI6%C_Q[R&/A3_NGC\*\YA1M5^&_AS0K:-X
M?$=A=VJO P(EMI(I!YDK#J%*ASNZ'=U)->N44 <593Q?\+@U7YQAM)MXE/8N
MLDA*@]R P./>K7C>"*=-+QJ\ND7L=PTEI?! \<<FQ@1(&X*LI8<XYQS75T4
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MQ,:@CAF W>XW =ZQH;FUN_#'PSA921:W5NLZRQ%=A2V=6)##H&(&>F:]<HH
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MQ1-;Z;<2RSEY-K$/$T8"C')^;/;I0!FW7Q&2VL]6O3H6H&UTF\-M>R%XQY8
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M<N8S'MPS98@-N [X.,5F:IX3\47[79D@TZYG368KZVNYKE@[6Z2JZP@;#Y8
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MI:=*9;24L$<H5SM8J>" 1RIKF]/OM7N_$%QX;EU@F;3+..:YO8K9$>>25FV
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M/ !+'-'- 0'C=&#*PR".H'4&M2L'Q3KUQH$.F206L4Z7>HV]G(7D*F,2.%W
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MM=6!!P>0>"/IQ6W7)ZAXW31?&EIH.K6BV]O?)_HM\LQ9"Y)"HX*C83@XY.:
M)[WP3I]YH$.CK=7EO!'<B[>2%D\R642>9O<LIR2_)P!^7%=&BE452[.0,%FQ
MD_EQ6;<:E=1>([/3$M(6AN()9S.9R&41M&"-NWG/F#OV-:>1G&1GTH Y2Z\
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MZ=J A^SRO:E")XLY"NKJPX/0@9%6?#7AZW\,:,FF6MQ<3P([NIN&!8%F+$9
M'&2>M:V1G&12T 8,_A>$ZY=:O8WUW875Y$L5U]GV%9@O"L0RG# $@$=NN:BN
MO!>GS6FBVEO<75E;:/,D]K%;E,;U! +%E8GAFSSSG/6NB!##(((]JP=5U^?3
M_%6@Z2EM$\&IO,CS&0[HS'&7P%QCG YS^% &Z5)C*[V!QC<,9^OI7,:;X)72
M8;Z&SU_6(X[VYDNI@#!DR2'+D'RLC/L>.V*W;&2_=[L7T-O&JSE;?R9"Q:+
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M((/J3GO75 @YP0<=:-R\\CCKSTH Y8>!X#?7E])K.K/=WEHEK-+YB G:25<
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MZ,8C,:;SD!&ZCI3[#Q.\GBJ7PWJ5B+34!:_;(6BF\V*:+=M)#;5((/4$?G0
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M.-?^#8+357U".!+Z:=]/N(/*4D7#.F=RABI^5L9Y/MQ7HH(/0B@$$9!!'J*
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MFFQ+;1R,C%$ZA?*#DC'0,/:NI\&:?I^G)J::7J8O;66Y\W;"%\B!V W)'MR
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M5+^074_V^V$(D"JL8\L!F&% 4=2><GK5+Q9!K-]J^K62Z5=SV4^DF.TEM&5
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6UKQAX=7Q#"TMS<^%C)>0R,=KOYD6=RYQW.1C&?I7H]QH^F7=VEW<Z=:37*
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MH>H&-@ '!W'KDU!XLNH;W2O$S71C76+/1;=KIKMQBWF,;.HMEX*L6.2V>H7
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MMI+:[@BG@D&UXI4#*P]"#P: /*M7^R>'=/E^PZPDVD7VM6:ZBMJ EM9POGS
MI!.T-A-PST?MNK;TJVTRQ^,E_%IZ6T*RZ'"YCAP 6\Y^@'MM_G790Z/IEOII
MTV'3K2.P(*FU2%1$0>HVXQ3;'0](TQU>PTNRM75/+5H+=4(7).T$#IDDX]Z
M+]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(RV. <88@<Y8^AKU0'(S0!AS>+M&@NS;O</\MVMD\HB8QI.V,1EP, \@>@)
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M@]*X/QAI5W/JU[J&BIJ=EKL5NBVTT$9DMK\<D13*05P"2,MC ;.3C% '7?\
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M<OVMK:-7GACVM\T8/0YP"1R 3CU%+P!9WNGR>(X;O3KRT2;5I+F%KAP^]&1
M/FW$D_*<GGZF@#H;K7=/L]9M-(GDE6]NT=X$$#D.$&6PP&W(';.>15:W\6:/
M=Z;<:A!-.UO;W'V60_990PEW!-FTKN)W$#@=:I>.--OKFPL=3TF#SM5TJ\CN
M;>/.WS5/R21Y[!D9OR%96B^%M3TKQA<1.YFT>Y\O4YY2>&O0"C@#T8[9/8H!
M0!MCQOH3ZH^G)-<O=1W MI$6SE/EN5W -\O (Z$\'MT-9)\8Z?H_ABWO[2YU
M'5XKK5/LJ2S0L61FGVL"-H("Y(48R< #-6?"\-Q;^*_%UQ/:7,4-U=Q302/$
MP$JK"B$CC^\IX_*N732-5'P^6(:7=FYMO$(OVM_+Q(T/VOS,J#U^4YQ0!VXU
M6PD\6I"-0U!;I=-:<Z>8'6,Q[U_>8*9+@D+@'/)&*AL_'WAV_:P^SW<S1W\I
M@MYC:RK&T@)&PN5PK':<*2#^8JF5NF^)]KJCZ?=QV@T.2!Y#$6"2&5'"';GG
M:IZ9&>,YKF;/3-3B^'_A:R?2[T75GKJ7,\7D-F.(7#N6/MM8'CU]C0!WNH^+
M-'THWANKAQ'8[/M<B1,ZP;N5WE0<<$'V!!. :UK:YCN[:.XAW^7(-R[T9#CW
M# $?B*\LUA2VK^+-.72]<ETO5)8UN7L;1;@,1$@<HV\%"1A2"K8VY'7 ]-TN
MZMKW2[:XLPXMWC!C5U*LHZ8(/((Z$&@"K%XAT^:]BM8VF8S3R6\<@@<QM(@8
MNN_&,C8P^H('-9^EZ]I$.G:SJ)UBZGM;>^D2=[M&'V=\*#$B[0< D #!))QS
M7/6.E7]EXKM[S1(]1LXKC4)3J>G749:UV'?F>)B,*S'!PIYW\@8-9]WI\Y\&
M^,H;K3KX/=ZX;FS1%"22;GB\MTW8#$,N=IY.,<9% '<_\)?I"WES9R27,=U;
M1>=-"UI*62/&0W"D8(!_(CJ*CT_QOH.J7>GV]K<S,VH1F2TD:VD6.;"[BJN5
M"E@.2,Y&#WKFK&_CN]7U.^OM-UJ'5[S3_LD/VC3C#&ZH&;8F&?+DLQY/0<=#
M5>PT[4(=(^&\+Z=>"33&7[:/(;]SBW:,YX_O$=,^M ':3^*](MKN&":>15FN
M/LJ3F%_),V2/+\S&W.01UZ@CKQ6!\1/%"6/@[7CIM[=PWMG'M-Q:PEEBDP"$
M9]I /(SW&1DC(K(\/Z;<68_X1S5O!\MY<P7;O#J3HCVLB&0NLK,3D, ?NXSD
M>_%.]L=;M/!GC'PO)HM_=7=W/=3VES!&'CN$E;<"6SPPR00>>.,T >KP$O:Q
M$D[B@)/X5Y[X?\=66D1ZO%XAU2ZD,6MW-LMQ) SI"@<*@=T78@],XKO[%G:P
MMS)$\+^6NZ-\;E..AP2/UKSLZ7J)\.>,?#KZ7<&\U6_NWM6:/,)CF/RR&0?*
M O4@G=QP": .YM_$&G76N7.C12R&_MHUEDC,#J C=&#$;2#ST)Z&K&G:C;:K
M9K=VC.T+,RAGC9"2#@\, <9!YKC?%&BZAILGA^_T.91J42C29&<X\V&1<;CZ
ME&428] U=M9VD-A8P6=NNV&"-8HU]%48'\J *,WB'3X+MK=FF8I/';.\<#LB
M2OMVJS 8!.]?89&:@D\7Z+%8:G>R7,JP:7(8KT_9I,PL%#'*[<D8(.0".:Y;
M5=*OT\33ZGH$>HV6I-?0K<6[1E[*_B!0&1LC:C*F>00V4X!R#5#6[#5HK+X@
MZ5#HU]<2:L6GM)HD!B=6@1,;L_>!4C;UZ=N: ._O_$>FZ<N99)9&$'VEDAA:
M1EB_OL%!P.#UZX.,X-<Q?^)TB\<:%<P:E<3Z/?:7<3I!!&9!*P,>TJJKN8X8
M\<X]N:KQ2:QX=\5RZC+H&H7VGZMI]M"5ME1Y+:6(,-CKNP%(<G.<9JZ]M>#Q
M]X?O'TV2&WM]-N(I?(B+1P,[1E4R!@\*1D<<=LT =3H^L6.O:9%J.GRF6VEW
M %D*D%258%2 00000?2F:AJ]I93+:.\S74L;2)%;Q&20(."^ #@ D=>IXYZ5
MB?#ZUN;/1+Z&[M9[>1M3NYE65"I*/*S*1GU!%5;M=1T7XES:LVG7=]INH:?'
M;+):IYC6\D;L=K+U"MNSGIGK0!F^&?$$=WX&T.ZU;7-12:ZU=XH;B-#NN&%R
MZI&_RD*K  $';P.U=1-XUT.#5Y=*:>X-[#-%#)&EI*VQI/N$D+C:?[W3D<\U
MPMKIFK1^!M"M)=&OH[BW\1B[DC,88K"+EY"_RD\!6'N>V:ZO0[>Y3XA>*KF2
MUN8K>[BM%@G:(A7,:.'P3Z%AUZ]LT :K>*](6^M;5YY%^U3&WMYFA<12RC/R
M+)C:3P<<\X.,TEQXLT>UN8X9KEU5[H68F\IC%YYX\O?C;G/'7 /'7BN+\):=
M/:VVG^'M7\'RR7^F3+MU*1%:U94;Y9E<G._;T &<GL,XN>%6UC1K=_"U]X>N
M;B2"]ED@U JK6SQO*T@D9B<AAN/R@9R!]0 ;VE^,;34-2UVWDBFM8=)EV233
MQ,BX"!V8L1A1\W )S@9J[;>)],N;Z.R$DT5Q-"9X$FMWC,R#J4W ;L9&0.1G
MI7$:KX<UC4K?Q_HT%G-%)JDJ7%I<M@12 11C9NSG)*%3QQFM>XBNO$VM>%K\
MZ?=V)TN22YO//A*&,F(IY2_W\D]5R,+UY% &SI/C/1-<O([73YYYGD\W#?99
M%0&-MK*6*@!@>QYQ@]Q6_7%>"1=Z-X-OS<:9>?:(;N\N%MO*Q)*K2NZ!<X!)
M!'?K77VD[7-G!.T,D#2QJYBE #QDC.UL=QT- &%XVU#5+/P_+!H(#:S=!DM
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M6<TZ:3;.JH3&DPS*<MD,5/4?Q=/?B>V\87ZZ1X-&F:+8JNN0X2+SC&EN1"9
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MSTW 'C\:?-?V=M)Y<]W!$^,[7D"G\B:RO#6GQIIEA?3VMHM]]BC@$T*_-Y0
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MX1@]@6PJY]<9-;=>9^.-3.M?"S7KGS;"]LQ'$]M=6;;ED^=<\$G:P/&,_P"
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MNM@-@^^"#^(I] 'G&J6-AIO@.T\!WFHQ2ZU]D1-/6%2LCR(0(Y .<88 DYX
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M=NSZMC&.E<];?#[5=-T;0AIVM00ZQHQF6*X:W)AGBE;<R.F[/7'(/;\O0Z*
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M88')/)QCHJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKB24Q1G&50L3M' Z=<#T%.TG0-.T,W1T^*6/[5,UQ-ON))-\C?>;YF/)QVH
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MU'3K35]-N-/OH5FM;A#'+&W1E- 'G>C:O>7&H:MX>EO+WS[Z[BN=,F>X8O\
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M>/S$_NN%(#CV;-;ZJJ*%50J@8  P * /%I[18?@[XJ=9;AF.K3Q_O9WDX6\
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MH_+R-I&5(R"."#D'OFF3^$]&N+N[N7M7!O"#=1),ZQ7!' +H#M;C@Y'(X.:
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M.[?S LZ2!0RC VKAN5&!Q76/X)T!]*O-,>TF-G>7!N;B,WDW[R0MN+$[\\D
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M+O1,;74;2<0@-+Y<RML!Z$X/ ]ZB@\1:)<W5O:P:Q82W%PI>&)+E&:11G)4
MY(X/3T-<M<36>M^/M UG2;F&6SMK&Z&HSH1L\I@OEQN>QW9;:>1M-<CI L[;
MX>^ "JQ13QZY$TN %91ND#%NX&"N2>Q'M0![55*WUG3+N[:TMM1M)KA028HY
ME9L X)P#G@\55\4P7]WX2U>WTMBM_+9RI;D'!WE"!@]CGO7#^9!KVF^ X]&
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MHHH **** "BBB@ HHHH **** "BBB@ HHKF_&NOWGA[2K6>RM?/DGOK>V)+
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MB!2ZKM!QWQDX_.IJYB[\8M#XBNM$MM"U&[NK9(97,7EA3'(Q7>"6Z#!XZ^V
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MI,VHSZ7#)JMK#:WS9\V&&7S%7DXPV!GC!Z=ZIZK!>S:WH\UO:^9!;2O),_F
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MSK>UMF\R*>VB)9G\S )?((P5&!ZUV>J^%5U3Q'8:Y_:M[;7-A')' L(B* .
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M2CS-2UB:Y5Y+=$!58BY.Q7(7.%4<D\9/-6'\0^)-+@@T_4X8X[N_U9;*PNI
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M2RO)P;BWE\E8TMF)&Y6W;]Z\$YX// K3T#P/!X>D2.#5M2FTV!R]KI\TBF*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU4G5[.[ABE4+#" #:C:,J[ G))R><8S6)_PE1NOB#IFE6&H6=SI]Q93S2+$
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MMBSPRD,K(3PW<$#D$5U&B^&;/PZ9(M(>6VL7<R?8L[HD8]2@/*Y/. <>U;5
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MIWZUZ;10!Y3X1FT?5K;0+"XAU0>(]&"J;299%%I(J;'<G&W81G')SD#K6/\
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M&^0%+;NPST)^O=T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#!*FXQ)&NY<[EYP6;.>^!G K5LM'U.#X@W&KS)&]G)I<5GYN\!VD1V8L4 P
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M-$I52,\%"N,]P1T-94G@O4K#PUX<TRR2&XEL=634KMS)L4_O&=PF1SR^!G'
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXQ;6P/FN Q=YU((C4X 4!@3\V,]* .WBT;3X-5EU2.V5;Z90DD^3N=1T!YY
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M;]^T(E*CSX^BD@9Z=<]^*I67B_7C!I<5W-#]LB\1G1+UHX@([A K-YB@\J2
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M <#-20M(8(S,J+*5&]5;(#8Y /<4 <VO@:P2"]L4NKI=)O9S<3Z<"GEEB06
M.W<$8C)4'N<8!(J'5?A]8:K+K9?4=1@M]911=VT+H$+*H4.,J6!P!QG!QR#7
M749H P;7PM%:^(X]<_M*_FN4LA9%)3&4= V[)P@.=Q)X(';&.*RKSX<V5S#K
M-I#JNHVFG:NS275E"T?E^8WWF4LA9<]2 <9_*NSS1F@"*VA^SVT</FO+L4+O
MDQN;'<X &?PK)O?#4-QKZ:Y:W=Q8Z@(/LTDD(4B:+.0&5@02#R",$9[CBMO-
M&: .:O/!&GW6A6ND)=7EM!;W2W9>%DWRS!_,W.64Y)?YC@#\N*Z-%*HJERY
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MK(2S[I"F",#&-I[GM1K&O7&F>)- TQ+6.2#5)I8FF,A#1E(V?A<8.=O7/X4
M-D\*1_VO#J]MJ-Y;ZDMO]FFN%V,;B/.1O4KMR#D@@#&<=.*AD\$6#0Z1%#=W
MENNF71O(_**$RS-NW.Y9#DG>V<8Z_2NFZT9STH PM6\,)J_]H1S:A=+::A"(
M;FU 0H5P02N5)5B#@G/8=",UM11)!"D4:[8T4*H] .!5>34;9-3CTP2J;V2!
M[A(L\[%*J2?09<#\_2LWPGKTWB+2I[NXMH[:6*\GMC''(7'[MRF<D#.<>@H
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M5A OH,*,G'&3DXX&,G/144 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^TK=QH[%QO"^3*"#WQN _$59?R]4\ ^+]0U ;/$5A>796;I-;R(<P*AZ@8V
M <')ZY->F1:#H\#EXM)L8V,WGY2W0'S,$;^GWL$\]>34DFDZ;-?K?2:?:/>+
MC%PT*F08Z?-C/% 'GD.A6NN_$62VU^U$TDGAZTGN("[!?.\ULG /4$"L/5Y;
M*V^'7CNV>2".6+7I3#$2 R?/$1M';C/3MFO81IM@M\;X65L+PC!N!$OF$>F[
M&:BFT/2+BYGN9M*L9)YU"32O;H6D4$$!B1D@8'7T% '%OI&E:S\5M5M[R".[
MM)M$MY&C=MT;DRRC.,X/ &/3BN9T>U@C\&?#O6P"=3?5+>V:[9R9#$?,0Q[C
MSMP -O3BO73I&F&=YSIUIYSIL:3R%W,N,8)QDC':H_[!T?R8X?[)L?*B;?&G
MV=-J-Z@8X/O0!D_$.-)/AUXBWY^33IW4@XPP0D'\ZY?7;>\:VLKZTM[#5X;;
M18_MFDW1VOY1!/FPOR%8[2#_ +H[XKTBYM;>\@:"Z@BGA;[T<J!E/U!XJK)H
M6CS"/S=*L7\I/+CW6Z'8O]T<<#VH BM)+;4_"=O+&DHM;BR5T23Y7",@(!QT
M..M>3:5HULG@7P'K^F[QK[W=K$)UD)>5"Q$L;<_<"AB1VVGWKVBZ65K.5(%1
MI2A"*[%5S[D X_*N>\$^%8_#7AW3[2ZM+#^T;6'R7NK=,F0>NXJ#SZ>U '(Z
M5HUNP\<ZG:6IFU;3=3NI-..]F,<OV5,;1GN3CWP/05+X930M1DT'7+'7X%O!
M;.LD-G&JRS QY<3\EF*D9RW\7UY]&M=-L+&222TLK:W>4YD:*)4+GW('-,MM
M'TNSN9[BUTVS@GN/]=+% JM+_O$#)_&@#R^QEU308)+46-I<ZD^A73Z1K.G_
M /+XJJC9E3KYF?+.<D$L?6M'PQ:Z!J]YH.KV&MVSSR6SQRVUH@5[A63YA<?,
M6.TC.3_$>O->@6>DZ=IS,UCI]K;,PP3!"J$CKC@4VWT72K26XEMM,LH9+G/G
MO' JF7/]X@?-^- 'D&BV%I;>"O >KPIC4#KB0?:=Q+F-YI59,D_=(ZCIGGK7
M8>"[73;;QMXR"06D5T-138%15?:8(V..^"<D^]=;_8.C>1'!_9-AY4;;TC^S
M)M5O4#'!]ZLI96D=Y)>):PK=2*$>98P'91T!;J0* .(\;VUZVK&]LK>PU9+6
MP/VO2+P[6,3,?WD+\A7^4@Y]![51M;72_$?CW2A-:F;3Y_"B2K;W(ZJ95P'7
MH< ]#QGGM7H%WI.FW\JRWFGVES(J[5>:%7('IDCI2OI6G271NGL+5K@IL,S0
MJ7*XQC.,XQVH \K\/7=E+X7\$V-Z_G3O)>BW2ZE'V;9$SIF0$'>54C:O'/<8
MS5:WNHY/A/;0K<Q2_9_$4<:A&X5!??* ,G"X' ]*]8_L'1O(C@_LFP\F*3S8
MX_LR;4?^\!C@^].?1-*EB:*33+)XVE,S(UNI!D/5R,?>/KUH YN,C_A<]R,\
M_P#"/1?^E$E0>.;6WO?%?@NVNQN@EO;A77<5W V[\$CL>F._2NO33+".\^V)
M8VRW6W;YXB4/CIC=C.*=>6%GJ,'D7UI!=0Y!\N>,.N1T.#Q0!Y%?!O"J^)[?
M36>#PQ#JE@L@4%X[=6P;E5&?N\IN4?WB*[3PII^E6VO:A=Z3J]O=)=PQO+;6
M*J+>,CA7PI(#,,_7&>U=5'96L5G]CCMH4M=I7R5C 3!ZC;TQ3+#3+#2K<V^G
M6-M9PEBWEV\2QKGUPH S0!QFH6NFCXTZ?-=P6@=]%D9'E1<F43Q!2"?X@.G>
MN0-C:1^"I]:6,#4;;Q2WD7.3NC!OMI"GL""<@<'/->R3V-G=3PSW%K!++#GR
MI)(PS1YX.TGIGVJM_8&C>08/[(L/)+;S']F3:6]<8Z^] 'G.H'3==UKQ7I7B
M#5[33KJ"X4V[SHHFBM_+0I)"[,,?-N/RCJ>>M=YK%U#8>"+VYO9[SR8=/=I9
MHAMGP(^6'H_?V-7KC1M+N[JWN;G3;.:XM\>1+) K/%C^Z2,C\*MNB21M'(JL
MC AE89!![$4 >16%U_9OBH?V0UC%-+X5D>"VMG#;Y59/*WD8$C\GG:.IZ]:V
MO"2^%=9L/#6I0722:J;9HY4CD!DN&:/$PN%ZL 03\W?'J,]Q;:-I=DT+6NFV
M<!@#+$8H%7RPWW@N!QGOCK2VNDZ;974]U::?:6]S.<S310JCR?[Q R?QH Y#
MX3P:?!X0*VT5M'<_:KD3")5#X%Q*%#8YP!P,U';16>N^-/%^F^(88I!;QP?9
M4G Q';&/EXR>GS[LL.00.>!7<6]E:6C3-;6L,+3.9)3'&%,C'JS8ZGW-17FD
MZ;J,L<E[I]I<R1Y"-/"KE<^A(XH \I$,FI>#OAM<:]!%<WTNJQ1O+<1AGDAV
M3[-Q/)!4(3GJ>:]&\66EO)X(UFV:WB:%;"4+$4!4;4)7 Z<$#'TK2NM,L+YX
MWN[&VN&B.8S-$KE/ID<59VKLV;1MQC&.,4 >316FF7%A\,K:!+?R9'_?I 0H
M9S9,6W;>YXSGJ#SUJK+=+X>TCQ):VI%KH]KXGACG5$)2WMG6)G^4=$W'D#C!
M([UZHNA:0BP*FE6*K;DF$"W0>62<G;QQSZ5)'I.FPB<1:?:H+@$3!85'FYZ[
MN.?QH YOPGI^EVFMZE<Z3J]O=1W4<;RVUDJBWB89 <!20&8=?7&:S_%\1N/B
MGX'B6YEMV,6H'S(BNX?NT_O C]*[:PTVPTJW^SZ=96UG!DMY=O$L:Y/?"@#-
M17>B:3J$WG7NEV5S+C&^:W1VQ]2* /.(6O=%^)^O6NF3-K5W<:,UPUS/AYK6
M1<B.$E<*%8\A< \YYJ*-8I? W@S7-((.NR7=HDDZ_P"MN'8XN$D/5A]\L#TV
MYXQ7J=G86>GQF.RM(+:,G)6&,("?H!4<.DZ;;7DEY!I]I%=2$EYTA578GKE@
M,F@#R;5[[3GN8=2LIHHW3Q9%%)/<R W3$2A)%!XV1 9 4YRO7%;>FZ+IVH>/
M/&-R;5;N:RGL[JS4R-A9?(W!A@]S_.N[?0])DDGD?2[)GN&5YF:W0F1E.06.
M.2#TS4L&FV%M=2W4%E;17$O^LECB57?ZD#)H \>,VE:A\/\ PCK,SV[ZLVMV
M;7=Q(0)O.\X>:K'KQ_=/  '8"O0/B/?7MC\/M4N].:02JB%GA)W+$742,I'<
M(6.1TZULGP]HC74MT='T\W$K!Y)3;)O=@<@DXR3GO6B0&4J0"",$&@#@KFRM
M;3Q]X7?0(H$L[^UN1?1VZCRYK<1@QNP'!P[* W^UBG_#:PL+<^)9;:TMHY%U
MV\A#QQJ"$#+A,@=!Z5U]EI.FZ<KK8Z?:6HD^^((53=]<#GJ:=::98:>7-E8V
MUL7.7,,2IN/O@<T <?XG8#XK^! 2 =FH?^BEJKXT9?$'CCPGH^FL)KK3M074
M;UX^1;1(.CGL7/ '4XKMKO1=*U"837NF65S*!@/- KMCZD5/:V5K8P^39VT-
MO%G.R&,(/R% 'D&MP0KX,^**#.V*_+)\QX/DQ?U)K;\16NE^&]7T&$?9[+2=
M4GF>]GN09(9+GRU$1DW-CD!^O&0#UYKNVT+2&296TJQ*S-NE!MTQ(?5N.3]:
MFGTRPN;#[!/8VTMG@+]GDB5H\#H-I&* /,+@Z=X<32;8:JMUX9N-<D^V, !;
M0EHB4A&"0(A)@D9P#P>XJ3QAIGAR'PC?-IIBN+7^V;.>095X+=VFC#K'V4%>
M2!_>]Z]*.EZ>=-_LTV%J;#;L^RF%?*V^FS&,?A0NE:<NF_V:MA:BPV[?LHA7
MRL=<;,8Q^% '%6::?J?Q#U?1]1MK6;3XM-MVTNW**8C$2XF9!TSNVJ2.0 *Y
MBQM9-0LO L6J/+<1'5[NVADDD.Z:U"3"/<<\@@ >XQZUZU=:/IE['#'=Z=:7
M"0#$2RP*XCXQ\H(XX]*=/I>GW3PO<6%K,T'^J:2%6,?^[D<?A0!YIXDTV/PX
MU]<66GV6IZ!8VL4-U8%MMU8(H+!X&;.1AMV#U(X/6O3H;^TN+J2UBN8FN8D5
MY8 XWQAONEEZC.#UJ.;2-,N+L7<^G6DMR,8F>%6?CI\Q&>*F2TMH[J6ZCMXE
MN)@JR3*@#N%Z GJ0,G'UH FHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9KIK[%FHR;LPN+?'J)=NPC\:\C:ZEM_@AIT =DM+W7FM;UU.,6[7,F_)[ X
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MJYDFU'3)V=F2Z"Y^=BQY4#^(Y!ZCM1<^#Y;S0)=!N==OIM,EC\EA(D9F,?\
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MMPUG]B$0"&,)NW ],YW'/6MJB@#D(_ %M%X>T[15U2^\BPO5OHG(CWF19#(
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M8W,%&!G  S@>E8FG>)[R[\4P:-=:8MIYNDKJ!)FW.C%PIC(V@<$GG)S[5TU
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M1MC'I%@AM1BW*VR#R><_)Q\O/I3KW0])U*ZBNK[3+.YN(1B.6:!79![$C(H
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M=*FLDLI=-LY+1#N2!X%**>N0I& :?'I6G0WOVV*PM4N]FSSUA4/M]-V,X]J
M+=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4DP/EE!&T8RR[B00.Y[22VMY_;OCZ4V%V8[ZQ@BMF$#$3.L3JP7C^\P'Z]*
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MT;2FWF1R_P!U06*'<1D _=&<5!+X?U&SL[6<6-RQN_%PU<P)&6-O!GJP'0X
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M;"&%[NV>)C':KAR&0!<G< 22">@Z5)IWC/0]4OK.SM;F4RWL'GVS/;R(DR@
MG8Y4*Q (R <COT-<[=6EY_PD7CR86%VT5[ID$-LZP,1,ZI*K*O'JZ_Y%0VEE
M>I-\-MVGW@_LVV:.\)@;]P3;>7AN/[W''UZ<T >CT444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(.3C&",<]: /2J**XFZ\;7MMH/BN_P#L-NTN@7#1;/,(6=5C1\YQ\I^?WZ4
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M:[MKV(RVMQ%/&&*%HG# ,.",CN*FKRCPYKU_X:\/3W,6GVSZ4/$5Q;3$RE9
M)+HH"BA<84L.IYYZ=3TVK^,;V%M5_L?3'OCIDHBDA6&5FN'VJS*C(I52 PZY
MR<\ 8) .QHKC)/%6O77B2?1],T:U+1V4%Z&N[EHSLD8@JRA"5<;3QR..O:J5
M_P"/]0T[P_KM_<6%HMUHU^+:XM_-;F([2LJG&>5?=C'0'F@#OI)$BC:21U2-
M 69F. H'4DUD:/HUE;:C?:W9WLMR=6\N61MZ-&X50J,N!TVX'!Y]ZK:AK5R(
M=5:WM;2]M+2P$[;I"JRNRLWEYPPQM /?[Z^N:R8O&D%KI?A>,I8:6NK:>L\+
M3Y6W1@J$0*1@ G><>@7H>E '<45RMSXGO5GM]-CM$35#8)>7"F.69(BV0$_=
MJ2<LKC/& O0YK6\.ZK<:WH%IJ%UIUQIUQ*I\RTN%(>-@2".0#CC(..010!J4
M5SWB7Q/#H%YIEM--;VJW[N@N[K(A1E (0D8P6SQDCH>O0Y][XHURVU/0]+CT
MBR>[U2WFDW-=D)&\84D$A#E?F!R,D^@ZT =C17"V/Q F>SGMM0TY;?6X-2&F
M/;Q,TD;.4,@D4A=Q78"V,9XQWS4R>-;VW2]AU#2)4N([R"TLI?+DAAO6F.%*
MEURNTYW=<8XSF@#L9IHK>&2::1(XHU+N[L JJ!DDD] *CDNK?[";K[5&ENR;
MA<!UVA2.&!/&.?I7.:CJ^LV>E^(3J.BVMQ!96AGBD\W;#=IL8NA4AB",$<@@
MY'2L/Q%?W]S8^ I;*&U@@N[ZV?R,D*&\AW"8 ^X,#'N!0!TOA.#0].L3I^C:
MO'?1%GN0HN(Y6 =V+-\O8MN_'(KH:XBWU33_  _XJUZ&31;"R6VTT:I<WEJ,
MO,"S[MWRCNC'&3UJ>U\7:@=4L5N]*E&G7<#RO<QP3 695=V)&90"",@,,<C&
M.] '57%W;6GE_:;B*'S7$<?F.%WN3@*,]2?2IJ\O\1ZG>:]IW@[6#:6T=C=:
MY9R0 DF:-&?*,3T^88R!TR.37J% #)98X8FEE=8XT&6=C@ >I-)!/%<P1SP2
MI+#*H>.2-@RNI&001P01WK@GU#5=2U/QW87WV62PLK=8XXQGY0T!<<'@G+<G
MV'I4?@[Q!J-AIG@;2[FQMQ8:GIL<4$J3$RJ\=N'RRXQ@A3C!)'&?2@#T6BN)
M3QO>W)L;VPTF:\TVZN_LY$5O,9$CW%1-NV["N1DC/ /7/%%IXQU>>XUB:;2[
M*'3-&O)H;V;[4S/Y:1"3<@V#)YY!QU'7DT =M4-O=6]Y&TEM<13HKM&S1.&
M93@@D=P>"*Y:P\5ZK<ZMIL+:-*UGJ$3/YT<,RBT8+N59&9 I#=-P[]CUK,A\
M:7%EX4_M.UT&SB9M::PEMX9MH#&?RRX.T;F)Y.=O7- 'H5%<YHFOZA=^)=4T
M/5+.V@N+2*&XC>VE:17CD+#!W*#D%#VYS71T %0P7=M=-*MO<12M"^R41N&*
M-C.&QT.".#7+^)-4UBU\:^%].L7MUM;QKAI5<L"Y2(D D?P_-GZ@>E<O!K.H
M>&'\>:EIVG6LUK9:IY]PLDIC)001%@@"GYL9.3@=.N> #U:BN4U3Q9<+=WEG
MI%K]HN+2V2=P\,KAV<$K&-BG:2!G)Z9'!YQO:/?R:IH]I?2V<]E)/$KO;3J5
M>)CU4@^AH NT5@:_K5]IMRL4$%O'!]G>4W=T^(S(" L( .2S9)SV Z&J.F>,
MGURVT)+"V2.]U6Q-\5F8E+>-=H.<8+'<X ''<\8P0#K:*Y:+Q+J?_$KT^[TM
M+/6;^6=!$\N^-4B^]+D<D$%<+P?F[8S37\4:C96\$&I:7]GU*YOI+2W5"TJ2
MHBE_. 0%MI53\N,YX.!S0!U=%<%=>.]8L-+N9[CP^WFV^HPV89_,A2X25E59
M(PZ@D\X*DC![FG3^,-=M+_6-'O\ 3;&VU*'37U&QEBF:6&1%."&RJG<IQ]?:
M@#NZ*XK1]=UE/"/AN>Y6V9KRTCDN-0FD_=PKY2L&?)!+,QQ@''OV->/X@7L_
MAS0M3@TJ!WU'4_[-DC-P0$<.Z;E^7D'83SC&1P: .]HKBE\<7%BGB"+6+&%;
MO298$5;64LD_GX\H L 0=QP>/>KUYXAU/0UU*XUG3HS86MF+E+JU?(=\D&':
M>=V<8;H<]J .GHKF--\0ZI/XC33;O2I/LLUN94O(H)E2)P>8W+J.W(88SCH*
MZ"]NX=/L;B]N7V06\32R-Z*HR3^0H GJK>:GI^G&,7U];6QE.V,3RJF\^@R>
M:Y=O&5Y:V6A:M>V,*:5K$L42[')EMC*,Q%^S \ XQM)_BZU1TZWN-8^(?B^P
MU2WLKJP,%G%)%)EAY965E !&.IR??I0!Z!14<KB"W=UC9A&A(1!R<#H!7(:/
MXQN-;T>34[$Z=<0K9O.Z1R-OMYEP?)D'4'&[YL#[O3U .SHKD+7QE<7$7@Z;
M[%$(_$* N/,.8&\DR\<?,.,=JEM?$NJ:G;6NIZ5ID=UIDUZ;8J)-LHB#E#/S
MQ@%2=O4CG(/% '207=M=-*MO<13-"_ERB-PQ1L9PV.AP1P?6IJ\IM]9O_"Y\
M=ZGI^G6LUI9:J9[A9)3&2GDQ;@@"GG&3DX'U[>J1N)8DD7[K ,/H: '45R6L
M>(]<@\6?V!I.EV5Q*^G->Q2SW3("5=5(8!3CKQC.>.G-5;_QO?QPW=UIFD2W
M\=E=&VEMX89GDE*L%D,;!-ORG/!Z[3TH [>H8[NVFN)K>*XB>>#;YL:N"T>1
MD;AU&1R,US*^+GN?$UWHUK]D6ZM;B*-K2X<I-+"P0M,F>" &;C!^Z<D=*A'B
MF+3]0\:3W.E0Q?V-%%-+);G=)=+Y1<;CM'(   .<>N* .RHKD(?%.K?V_I&F
M/864HU.R:\25;AD$07;N3[C;OOKAOE!YX%9EIX^U>;2M-U>?2+2.QN-3_LZ8
M+<LTBDS-$&7Y0" 0,YP3SP.X!Z%17%Z_XSO-!EN)I[*WCMH;R&W2&27]]<QN
MR*9D Z*"^,$<[3R*DL-5UNX^(VOZ>3:O96EI;-#$69<;_-.<X/)(&3C@ =>X
M!U5K=6][;K<6EQ%/"V0LD3AE.#@X(XX((_"IJX70O&"3>&_#XM=+M;2]UBYG
M@M[.(XBB\MI"[D@#( 0G@#)/;.0NI^.KW2+7Q)!/I]O)J>BVRW843%8KB!@<
M.O!((((*GN.O- '<T5RMAXEU)O%5II.HV%M#%?V3W=L\,Q=EV%0RN" ,X<'@
MGTYZUU1. 30 C,J(7=@JJ,DDX %5)!;:SI4BP70>WN8RHFMW5LJ>#M/(]:YW
MPUXI_P"$MA61%L9;22%S<P!CYUI(" (I4/4\MDX'*]#UKF/ 7B#4='\'>"()
MK&W.F:@19+*)CYRR%796VXQM.PCKGH?:@#T;1M)@T/1[72[:25[>UC$47FD%
M@@& ,@#.!4XOK,RSQ"Z@,ENH:9!(,Q YP6'8'!Z^AKE+_P 9WFFZI:PW5E;Q
M1W&JKIZ6[2_OS&QVK<<<;2W8CIWSQ5:PMX3X^\=QF)"CV5D77:,,=DW)H [B
MWN(;NW2XMIHYH9!N22-@RL/4$<&I*Y7X:?\ )-/#G_7A'_*K'BCQ#>Z%<:-%
M:V$-T-1OEL\O.4*,59@?NGCY3D]O0T =%17$CQW/86NNIJ]C"M_I=U#;+';2
MDI.TP0Q89@"/O@'CC!/M5Z3Q%J-EXC@T&^M[47%_:R36%Q&S>6SQXWQN#R,
M@Y!Y&>E '45#<7=M:",W-Q%")'$:>8X7<Y. HSU)/05S?P[U/4M9\$Z?J6IO
M&\URAEW(3DY8]0>GH .U4_B8N-*T2585EFCURQ,8. 2?.7@$],]* .VHKAV\
M=7FCW^K6'B3388)[2R_M"!K*8RI/%NV;0652&#%1TYSGBM+3/$.J3^(UTV[T
MJ3[-+;F9+R*"9(XW!YC?>HYQR&'7'04 =-1110 4444 %%%% !1110 4444
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MQ]N@,D5S$IW*2 P*E23CGH<9]>TT^WGM;*.*YN3<SC)DE*[=S$Y.!V'. ,G
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MYTCQ;8&^M5_M^9I _EM^X!14(QGYN%'IUKL[2.2&SABF*F1$"L4Z$@=JFHH
MY^70KMO'D/B!;B 6\=@UD8"IW$,ZONW9QU4#&*S(?"FNZ9K6HG2-<@@T?4KA
MKJ>"6W+S02/]\Q.& &X\\@X)Z'OV=% '(:WX0N->N4%[):,D%['<VEV$(N;5
M596**W?)!&<C ;H<"JFLV%SX>A\9^()[N(1:E;QB,) 7,!5/*5F!R&'(8\8
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MD+;Q[M^03RS%\')P/E QU)M^'M,\2VI0:_K5M?+ FR+[-;F)I3TWRDL<G'8
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M2-CN0"ZY!QNS[YQ5KQ=I42_\(2@N+T@ZQ"F3=2$X,4ISG/7WZXXKIQX-T/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=1R)(E;YOM##/(ZXXS4<<2^%/B[INEZ4/)TO6[.:2:R3B**6/GS$7HN1P0,
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MF<A<  @^F:L6WC#5(O$>DV&K:/#;6>LQL;*XAN?,975-Y21=H )&2,$CMDT
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MR21PQM)*ZI&HRS,< #U)KS#Q5JUQXB\/^'=8CLK==.GUNS:W9V/G*GG@*_3
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M1MF3A6S@CL:Z.#6'N]7M+6T2&>UDL_M<MPLA^0,<1X&.0WSD'(X0T :]%%%
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M3.TE<@MP,D*"0.: -VBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%Q)$)T'19 I <>Q^G2KLWA[39M<M]8:%UO8(?(1TE=%,>=P5E!VL >1D'!H
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MRH7&=WS9W9)Z^V/::PM/\(:/IH@2WAF^SVTAEM[:2=WBA<YY522!U./3/&*
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M2S1#)=8V[-QGJ. >:T]*TNUT73+?3K%72UMT"1(\C.54=!EB3@4FI:7;ZI'
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M[%)P."0/0$@8!J>Q\/Z?IVJWVIVRS"[OBK7+-.["0J-J_*3@8'' H U****
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M*)"<9QMSG..:;)K.EQ7/V:34K-)_,6+RFG4-O;[JXSG)P<#J<5Y+K>KV,JW
MBQ8FS\5P2W%H$9I,B90T\C'.U6 RN,#'&3TKH]#M=,OOB)XS>.WLY;E39RVW
MFQJ2KB+[P!'!#8R>H(&>: -CQ?XK_L<6,6G7VGM=R:C;VT]O(0\FR215; #
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M5"/X0NT9S@!><"JUS<Z5-J?B;PUXKN]0AGO+\S06L<0/VR$A?*\M@A)8;0N
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MVE%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %&,]:*RM=UZ#0(K.6Y@GDCN;J*T#1!3L>1@JDY(
MXR>V: -6C /4=*YV\\86EE=:Y;R65XTFCVJ7<VP(?,C8,<I\W/"-P<5#8>-K
M>^U'3;1M+U"W&IVK7%E+,J!9MJAF4 -D$!A]X 'G% '4$ ]117G4GC"/4_AY
MK>J>(-&O180SSPRQVLJ!MB2E,!E<'(VC)XZ\9%:6H9C^+&@!))0DFF7>Z,R,
M5.UHL';G&>3S0!V=%<WXQ\0W?AZUTU[2R:Y:\U&WM&(91L#N >"1DD9 [#.2
M1CGGCJUQI7Q'UV:/3]1O"=(M9S9QR*QC.Z7=]YP@Z#@'GL#0!Z+@#H.M%<ZO
MC+39]/TRZM T[:E;?:K>(ND9\L!<EBQ &"RC&<Y/L2+GASQ#9>)](74;'S%3
M>T3QR !XW4X93@D9!]"10!J@ = !2X [=:XRZ^(UI:VVJ7+:-JC6^E71MKZ0
M)'B' 4E_O_,/F'"Y.!D@<9TM9\76>D/<QK#)=26L N)TBDC4JAR1C>PW,0I.
M!^F1D Z&@  8 P*Y63Q_I,4FD.\=PMCJT)FMK]MBP<)O*L2V5; Z$?R-1:YX
MNOK&S\/SV^BW:G5;Z*W:.8QK)$K M@C=C<0I'7CO@\4 =?@'M156]U"WTW2Y
MM0O6,$$$1EE+<E0!DCC.3]*Q+3Q98:GKA\/SPSVUU/;&>+]\A$B X8!HV.UA
MGIQZ@F@#I:*\^\":_%IWPU\-F[D>>[NT=8U:0;I"&8DEF(   Y)/H.20*V;#
MQWI>H69DABG^UB^;3_L7RF0S@;BH(;:1M!;=G&!^% '4  =!28 [5Q6O>.KB
MQT"^N;72+M+RTOHK*6.<*H0NR@.ISAP0XQCOUQ6B=1L9/'-A;7%A>P:HVGRR
MQR/(/*6/>FY2%<@MDKSC\: .EH(!&",BN8;QQ8):VFH/;7*Z1=SBWBU#"^7N
M+;58C.X(QX#$=QG .:KW_C^"REUN-=%U2<Z+M:\,:QX5"F_>"7&1MYP/F]J
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M;^:KR374P@MX8\;Y7()P,D#@ DDG  - &A6#KOA^?5]7T6^CO8X%TRX:<1M
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M;:&4EQW!]#Z9J[8^)HM1NHDM;.XEMI+J:T^TJ4*I)'OW;ANW 90@''/'3(H
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MM[;WB0N^P2^5(K%=QX!(!Y-=)10!Y[<Z)XBO=2\57KZ9#&NK:.EI!&+H%ED
MD&&XQ_RT!)SQVW59@T/5EU'P-,UB0FCVLD-X?-3Y6:$1C;SR,C/T]^*[FB@#
MS.X\*^(&^'?B3PVME"TUU<W#6LHN!B199C("01\H ..YS^==%=:;J-SX\T35
MULF6TMK*>"8F1-RM(4(XSR!L.?KWKJJ* .:\;:3?ZKI=@=.B2:XLM2MKSRGD
MV>8L;@E03P#CUJG#IFKKXRU?5I=/_<W6EPVR".9#^\0N2.2./GP#[=!78T4
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MQRB0$+G<)"%"X(P#SFK=UH&KRS>/BMCQK<"QV9\U.2+?ROFYXYY^GOQ7>T4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZX&?<@'I=17-Q#9VLUS<.(X84:21ST50,D_E4.F:G9ZSIMOJ.GSB>TN$WQ2
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M /5000"#D'O6-+XFTM?$/_"/K?6ZZD8#+L9Q\O("@C())SG'7 ^E0>!IA<>
M?#\@D$A_LZW#,#GYA&H(/OFL>XNK:Q^,JM=2)$+C0ECA+\;V$[$@>I ()]!S
MTH O>#?%7]LZ%:2ZK=6,6IW$]Q&L$;!/,$<SIE4))/"CUKH)]3L+6ZBM;B^M
MH;B4@1Q22JKOGI@$Y->,V;Z9%\/-!O%:U6Z7Q0KF7*[P/MKY.>N-A_(UJ7%U
MH]UJ/B;PYXJU"]MY[N_,T%M'&N;R$A3"8FV%BPVA< \$?6@#URN/M-<UV_\
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M'9D@'/)QTKI+[Q-#:W%_!;65W?OIZ+)=BV"'RLC<!\S#<VWG R<8]1D VP
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MMX86<91!O*C#9Z#CG!QBM6T\6VUW>Z9"+&^2#5%9[.Z:,>7(%7=S@EERO(W
M9]CQ0!T%&*Y?_A.]+%WIR-'.+74I_LUK>90QR2'.T8#;@&P<$K@_B*ZB@ I%
M54&%4 =>!7-3>.-.@M(]0>"Z_LA[C[,-1 7R0V_9N/S;@F[Y=V,=^AS0WC.
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M/#"-$+;B1D<D 9I)= N;+Q=X9ET^Q<Z5I-A/:%A(F1N$80 $@G CY^HKL:*
M//K+PEJEY\/==T"ZC^PW=W=7,]O(SJZ_/*9$SM)[X!_K4L>DZ[XE\/:AI>KZ
M%8:&\]E);O/!*LIE=EVAE"CY4[X)ST'J:[RB@#E_"\_BIX+6TUO2[>R%I&$E
MN$N1*+H@8!10,J#]XYYXQCG(Y?3_  CXBM/"OAR+[)"NH>';XRI%]H!6[C)<
M/@]%)5QC/?(..M>H44 <#K?AO4M9E\1ZLMB\-S?:(=)M+5Y$W\[R7<ABH&7
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MGL+9KI%LWL;NT#JL@1F#JR;B%)##!&1QTS6%J?A'59=,U*>"SWWNIZW;Z@\
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MG;7,<[&2,%6E"8P-W.-AS]>,UAZEX1UC5U\;1)&+1M3N+:YL)I'5E+PK'@,
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M_=XW!\8')P.N3C!] 8;E(/0C%+5$ZQIXUI='^U)_:#0F<0#.[8" 6]!R1^=
M'!0>$-8/P]D\!7%KF 2>2FI"1/+:W\W?N*YWB0+QC&,XYQ71:)IE_:>.?$E_
M/9M'97R6RV\OF(<^4C*V0#D9SQ^N*ZFJ.JZQI^AV?VO4KI+>#<J;VR<L3@#
MYZF@"Q=VZWEG/;.2JS1M&2O4 C'%>?0>%M9N_ VG^#-0M B6DT*/J"2(8Y((
MI ZE1G>'(4+@@ $DY/?N1K&GG6CHPND.HB W!@&=PC! W'L.2*-3UC3]&BBE
MU"Z2W2:588RV3N=C@  >Y% '(7.A:W'=^.(X;!)H-9BW6THG4'<;<1;2IZ88
M9STQZGBE@T/5UO\ P+(^GN$TBUDAO#YL?R,T(C&/FY&1GZ>_%=Y10!Y[X2T;
MQ%H4-MH%SH>GR6ME)MBUD2H3)"&RH\O&[S,?+G..^3CG:\&:;J&FOKWV^T:
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MC&5!Z=1GK5_4K/4-97Q1I\,C2ZR=606-_%.%%O%^[.S<"&3:NX,HZECC))P
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M=R-Y;>0Y!!+9R",CTH ]4HKRO3$:&Z^&VK">X:^U.'9>RO.S&=3:%\,"<8#
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M)&XKGJ5#QM%C_IHM:6L7MMXC^&GB7Q1!%Y<-UH[0VZD8PJQDOQZ[V9/^V8H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK&QM[9IW\R4PQA/,;^\V.I]S5#3_ !?H6J7\%C9WPDGN(?/A!B=5E3 )VL0
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M.7.Q!QC@;3UZ]JV/^$GT?^T(+(W966XD:*!FB<1RNN<JLA&QFX/ .>#Z5KT
M5K[3[/4[4VU]:PW,!(;9*@89'(//<>M1#1M,_L^33_L%N;.7/F0F,%7SUW#O
MGOFL\:M81>)=15]:D+6MFCS6)3Y(5W-^\SMR2>F,GITI+#QKX>U.ZLK:SU$2
M27R%[8^4X67 R0&*[=V.=N<^U &Q9V5KI]JEM9V\5O @PD42A54>@ Z56DT+
M2I;Y[V33[9KF1E=Y#&,NRXVEO4C P3TQQ6A7.IXG@OO%.H^&X4O(9[:WC<W"
MV[8#/OZ$J5P O4\$G SB@#6&E:<NIOJ8L;87[QB-[D1+YC)_=+8SBH[#0M)T
MN4R6.G6UL^" 8HPNT$Y(&.@)Y(%<IX"\;6NH>&M @U74C+K%_$?F:)@LC@L2
MNX#8&P,[<YQVKI+OQ/H]C<K!<W9C+3"W\PQ.8ED/1&D V*W(X)[T 21>'=%A
MUE]8BTFR34I 0UTL*B0YZ_-C--;PQH+VUQ;-HU@T%S)YL\9MU*ROUW,,<GW-
M:M8U_P"*]$TS47T^ZO=MZD/GF!(GD<IG&0%!)Z]!D]3V- %A= T=+A[A=+M%
MG>/R6D$*[F3^Z3C./:FGP[HITZ+3AI5F+.)Q)% L*A(V'\2@#Y3[BHH/%.BW
M,>ER0WP>/5.+-UC;;*<$D9Q@' /!P>#4=SXPT&SM+^ZN;\11:?*(;HO$X,;D
M @$8R<@CIZT 79=#TF?33ILVFVDEB3N-N\*F,G.<E2,$YY^M1WOAS1=1:V:]
MTJSN#:\0&6%6\L>@R.![53/C7P^+JXM?MS&X@02&(6\A>12<!HQMS(.#RF:P
M_$/BR(?\(GJ^F:QMTB]U#RIR% 21/+D)SE=P(9,8XYXQF@#I7\+Z!)I+:4^C
M6!T]FWFV^SKL+?WL8Z^_6G-X;T-K*ULVTBQ-K:-NMX3 NV)O51C /N*ATWQ;
MH6K6%U>V>H(T-H^RXWHT;1-Z,K ,">W'/:F/XQT&*&_EGOC!]@4/=)/!)&\:
MGHVQE#$'!Y QQ0!=N]#TJ_N/M%WI]O-,8_*+O&"6CR3L)[KDG@\<UH    #
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M61=.L+:T61B[B"((&8]2<=3[UAV_CG39;[7(9H[N"#2&"S3/:2XX0.S'"\
MCKU'/3FM7_A(=+^U6-M]I)EOX6GM5$3GS4"[B5.,9 (..O(H L7VE:?J9@-_
M8V]T;>3S83-$'\M_[RYZ&JS>&]#:*ZB;2+$QW;;KA3 N)CZN,?,?K7.GQMIN
ML>$=5U![Z\T6W@EE@^V&V<-'M<KN&Y2"25/R\D9YP:W+SQ5HNF7W]G75\?MJ
MV_VCR5B=W9,@9 53DY(X'/7C - $E_X7T'58[:._T:QNDM>(%F@5A&/09' ]
MJU0 JA5   P .U9<7B32)](M-5BO4DL[Q@ENZ*Q,K$D!57&XMP>,9&#GH:=I
MGB#2]8GN(+&Z\R:W8I-&49&C8=0P8 @^U  ?#NBMK0UEM*LCJ8&!=F%?,Z8^
M]C.<<9]*>V@Z0TUY,VF69EO5V73F%29UZ8<X^8?6K%_>1:=83WDRR-% AD81
M1EV('HHY-<'J'C.6\TGP=K=K<SV%K?ZA#'=0R1;5:-XG?&67) P.5.#SUH Z
MV'PMX?M@HAT33XPL+6Z[;9!B-OO)TZ')R.^:EC\/:/%;36RZ9:^1,@BDC,0*
ML@Z(0?X1D_+TYJ*Q\3Z/J-E=WEO>#R;-S'<>;&T31, #AE<!AP1CCG/%2Z?K
MVG:I>7%G;3/]JM@IE@FA>*10W1MK@'!]>E %BRTVRTX/]DMHX2^-Y5>6QTR?
M;MZ4E_I6GZHL2ZA8V]VL,@EC$\0?8XZ,,]#5EU+(RARA(P&7&1[\\5YKHNM:
MS>>#-8UB[\4-!<6-U=1(TT$ AVQ,0N\! ><<X8'TH [RXT'2;N^^VW&G6LMR
M0 TKQ LP'*@^N#TSTK0KG="\4+>>$M'U;58C9W.H1*1;*C,S.03A% +'@%L<
MX'7I5M/$^C/ID^HB^46\$OD2[D97CDR!L*$;@V2 %QDY'K0!I?9H?M7VKRD\
M_9Y?F;?FVYSC/IGFH)=(TZ?33ILMC;R6)&#;O&#&1UQMZ50?Q=H<5A?WDU[Y
M,.GMMNQ+$Z/"2 PRA&[D$$<<BB#Q?H5S%/+#?;U@E2%L1/EG<954&,N2.FW-
M %L:#I"W$%P-,M!-;IY<,@A7=&O]U3C@>PIJ^'=%33I].72;);*X)::W$"B.
M0GJ2N,$^]8'A/6[C5?%_BNW:\GGM+22V6WCFA\MH=T9++MVJ>OJ,XQUKL"0
M22 !U)H RT\,:"FD+I*Z/8C3@VX6OD+Y>[KG;C!/O5B/1]-BU!=0CL+9;Q8_
M*%P(AY@3^[NZX]JJVWB?1[N[MK6*[/F72EK8O$Z)< <GRW("OQS\I/'/2N:&
MKWOB;Q1K>D66I7^F-I[6ZVTB6;%2Q7>YD#KC!X4 D9 R.N: .\HHHH ****
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M:B@ KC(5N=.^)NLW4MA>/:WFGVPBGBA+IF,R[@2.A^8<=3G@5UIN[93,#<1
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M9"6?53J EW/M ,XFVXQZC;G\?:NQU?3SJ^@7^FLXB:\M9("X^8)O4KGMG&:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !4<-O#;[_)ACCWL7?8H&YCU)QU/O4E% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$W*KC)/'&,CKCJ* +=%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&QGAO-;M3!:V$:&65(DB9$#!,_,Q.2!G'K5+5K2YN/AAX)T\Z5J$LUK<Z?\
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MGIG-96MZ+9ZAKNEZYX8T[4--\2&[B-R1:R0(T)8>:)\@(1MSR"23C&:]1HH
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M])T=KI]$L&OK>.VNS;QF>"/[L;[1N4>P.15J26.$*9)$0,P5=QQDGH![FGT
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M9&?E8[SM;V&/>JM]X?\ $5EXLN]9\.7VGB+44C6]MK]'8*Z#:LB%#G.W (.
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M]J$CE]V"I7:,#'(.?P%/71-0N]=BUW4$LUO+6SDMK:"&5F3<Y!=V<J#_  @
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M$#C&4R#SZ8'43Z[X-U[5KCQ#B_T]HM6T];9'FC<O:D(594&>$9CN)SG/8XH
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M6.D7OV*?=/LD9@4#,HVD8!<=3D@$^F>HN]1CTW19M2U$"".W@,\X#;M@5<L
M>,]#]:\P$LU_J6LZC9W7A::SDU!G>"_N98&#1$(/,C4E204R"RY/RGT ]&N;
M-?$WA.2SU"![9=1L]DT6?FBWIR,XZC/IVH RCXON+671)-2TU;>RUEUAMY4G
MWM%*Z[D21=H W $9!.#QTYI-"\4ZMKFJ7,":%'%9VE_-97-P;P$H44$,J[1N
M!)QVQD=><0VWA;5+JST"PUJ:TD@T6>.=9H&;?<M$I6,LI "=0QP6R1VK0\*:
M)?Z*^L_;&MF%_J,M]'Y+L=@?'RG('3;U[YZ4 =%1110 4444 %%%% !1110
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M'.Y#Y:_*5ZCH.V* .GHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+USP_8^((+:.\\Y6M9UN(
M)8)3&\<@!&0P]B1^-:E1SW$-K"TUQ-'#$OWGD8*H^I- '/'P'H1L=6LS%<M!
MJKB2Y5KJ1LN-OS D\-E%.>I(K?M;9+2UCMT:1U08W2N78^Y8\DUSWB'Q)/82
M:!)ILMG<6NH:G'93/R^%8,<J0<9^7'.>M;\%_9W5N]Q;W<$L"$AI(Y RJ1UR
M1P,4 <]=?#[0KLWXD%XL=[<B[DBCNY%19@P;S%4' 8E1D_RKIXT6.-8USM4
M#)).![GK4$&HV-U;O<6][;S0QYWR1RJRKCKD@X%(FI6,B2NE[;,L*AI6$JD(
M",@MSP".>: ,RU\-V&F&TGWW=PNG*WV1)7,GD[AM.WC<3C(&2< X&*Y[X?\
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MB&VOA;J--O\ [-$T2E<IY:/ELD\_-[5MVE_9WZ,]G=P7*H=K-#('"GT.#UH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV"B=)E!)=7 &%(P",<'IBL>"[U+2/"GP^^S:G<;+RXL[>='2,AHV@+;<[<@
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M*Z:YAB$SA8&(V$D @]#DJW'7BLNV\>:+>:.-7MUU"73R&/VA;"8J I(8_=Z
M@Y],5G>"_$T/BG7M0NUA>VNX;&W@O+23[]O,LD^Y#_,'N"*Q_A9'K;^ -"$#
MV1TXW$_G1F-O-,?FRY&2<?>QVZ4 =E+XLTV/6Y]'V7KW\$8E>*.TD?"$X#9
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M@"A)X3M'\03ZXE[?Q7\\0@=XY0!Y8.0N,8P"?K4=]X+T[4]&OM+O;B^G@OI
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M?1K?6;ZQ_M'4!L'V9\1.P0LS+N.=GR]3ZCUJY8Z_INI:E?6%I=1RSV3A)@K
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MT-G:Q6UO&L<,*".-%& J@8 %9-AH^HKK,U_JNII>*C2"RACMQ$($8C[QR=S
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M89S&P#KOBS;N"K]P2X&<]37K$4$4.[RHDCWG<VQ0,GU-(EM!&Y=((U8L6)5
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MEK(_F1965I$8#&_)X0C/3)% &A;^,M*NM#T_58?/*:A/]FMX"@$K2Y8%""<
M@HV<G VGFK&C^)+36;Z^LH8+J&YL)/+N4FCQL; (&X$@Y!!&#T-< =)U33_"
M6BZ?+I$IUB+6YKRWACNHEE"[Y9"Z$DH?E8*0W'S'OBNI\'R&/4M2CO-&U'3]
M2O&%W-)>212>>  @P8B0 H"C&!Z\\F@#>O\ 68+*]@L4AFNKZ=&E2V@V[MBX
M#,2Q  RP')Y)XKEO%/C7/PYU76-#6X^T0[[9\JJO:2A@K!U8\,,]L]CTYJ[J
MFF:E9^/[+Q+9VKWMLU@VGW4$;JKQC?YBR+N(!YR",YZ=:P=7\):M)X)\5Q6M
MBTFHZ[?&Y2U$J#RER@ 9BP7.$R<$\G'.,T =EHFDQV4US>QG48?M87=9W=QY
MJQ,N1N7YFP6XSACG Z'-<CK/B>]UKPAXZ M+W3SI0N(H)XY@C!HX589*/G)+
M$\<8P"<\5Z)"[21*[Q/$Q'*.02OUP2/UKSNZT'75T?Q[I<6E-+_:\L\UG,L\
M863S(40+@L"""ISG'MF@#?T'Q5:W-Q8:/-!>PW,EB+B&:XBVI<*H4.5.<Y!8
M=0.N1D5,GC+3FO=-A>*YC@U-BEC=NJ^5.V,@##;AD#(W  ]JQKC1-4O-?\,R
MOI\T5M:Z9<6EU)YL68FD2-1P&R<;#TSVJOX.TK6=-AL-'U'PII\3Z>%C_MA6
MB99D3A651\X<@ <XQR<]J .F\:O)%X(UNX@GF@G@L9IHI(9&1E=48@Y!]1TK
MSV]\1K:>#/#]UH/B":[\4W*VNVQ^W-<_:G;;YJNC,VT8+$D;<8ZBO1?%UK=7
M_@_6+&QMFN+JZLY8(HU95^9T*C)8@ 9-<;K.@ZUKOPSL?"BZ \-XMO;PF[NI
MX?+MVC"YD4H[,3\IQ@#K0!VU[K\-K?2V,%K<WUW#")YH;4*3&A)"D[F49.UL
M <G!XJK'XQTNZMM*FT_SKXZHKM:QP* S!!E\[RH7;T()!SQ659Z3JWASQG?Z
MC';3ZK9:G9V\<CQN@ECFA4J"0[*"K YR#P>W>LRQ\.>(-"M=$LDLVO;"2:ZN
M-2M[:X6,I)*^^,$L1NC7)! Z]<'I0!T#^/M'72-+U(1WKP:E<_9852 EEERR
ME6'8Y1AQG..,U8C\4P7D<$$>FZG]MN(7F-BT:Q3Q1ABFYMS +DCCYLGJ.AQQ
M=AX;\0VGAGPYISZ(1)INOM>2B*XB*^3YDK97+#M(N!UX.0.,]#=V.L:3\0Y-
M=M--DU+3[^QCM9DAEC62W>-F*G#LH*D,<X.<T .^%]W->^!+:XGFN)G:YNAO
MN79I,"XD #%N<@ #GTK7O_$MM9W%Y!%:W=[)91K+="U56\E2"1G+#)(!.U<G
M&..1FA\/M-U'2?"PLM4M/LUPMU<2;?,5\J\SN#D>S"JUI8:MX?\ %WB"\BTZ
M74;'5C%<1-#)&K12J@1D<.PX. 01G'(H @\4^*#-:>&7TA;BZL-7OXE::V=5
M\V(H[[ 2P()V#/3C()[5TVD:1'IFG/:I/?/%*[2!;F<N\(;G8K9R .W)QZUQ
M4?A'5-&\/^"-*MK1KTZ3J"W=W)%(BJH*R[@N]@3AI...@KT9F(C+!&8@9V#&
M3[=<?K0!YWX%L)]=\/ZC-=:SK NDU*ZMXIUOY"8T20JN%)*G ]0<U6M/%WG>
M$=?LO%DMV\^C:@+*XNM.!C>8;U,<@VD;,\ \@?GBM#P;!K_AW0[ZUF\.73W4
MU_<7,0^TP"/;(Y9=S!R1UYPI_&J%]X'U:W^'^NVRQKJ&OZU>K>7/DNJ1JWF*
MVU2Y'RJJX&>2: .JU3QI9:9K,VD?8-4N[V*W6Y,5I:F0M&6VY'/.#G/T]>*=
MJ'C/3=-'G3Q7/V!;D6DE\JJ88Y=VS#?-NP&^4D*0#QG@U6BL=1/Q.?5VTZ5-
M/?2$M?.:2/B02LY!4,3C!QG'7\ZPM)T+6-(O[W2)?"UA?VTMY+/:ZO(T6$21
MR^)%/SEE+'IUX&1UH Z?4_&.G:4EY/)#=36EC*L-W<P(&2!VV\'G<<;ESM!Q
MGGO4-GXJEN/&6M:/-82PVFFP02-<LZ;1O$A+-\V0N$ '&>#G%96F6WBCPYK>
MM6-KI"7UCJ-])>VU^;A$6 R8W+(I.XA2,C:#D>G9U[X<U.Z\3>*86MS]@UW2
MXK5;U9%'DLJ2J<KG<3^\!&!CKS0!LP^,-/DFTT2P7=O;ZH=MC=3(!'.Q&Y0,
M$E2PY 8#/UXJM#X^TR>YNHTL]3\JSGE@NK@VI\JW,:;R7/8$=..OID9R(]#U
MG6-!\,:-J6G-:2Z1=V\US<^:C1N(!P8\'<=Y"]0, G/09NZ!IVK6-IXO\_2?
MGO;^XNK2*:2-DG5HU55;#'&2N#GL: .@T[6DU&=8A97<&^!;B-Y0FUT)XP58
M\^WN*U*X#0=$U3PS>7]QHVGWR:3]A+Q:-=7:,!=9R%B;<VQ2,@Y.,D8]NPT7
M47U;1;2_DMFMGGC#M"S!MA[C<.&'H1U'- &;?>,=/L(KVY:&ZEL;"7R;R[A0
M-' PQNR,[B%R,E0<<^AQ%J'CC3['57TV.RU*^NEM5NPEE;&7?$S;0R\\C_/7
M K!AT#6]/T+Q3X;73VNHM3FNI+.\$J"-5N <B4$[@5+'. <CIS5[1] OM)\<
M6DBVDKZ9;:##IJW9=/F=')R5W;L$=\=: .KU34[71]*NM2O9#':VT32RL%)(
M4#)X'6LN/Q;9FXOK:XM+VVN;.U6\>&2-69X6R R[&8'E2,9SQ5CQ0FKOX8U!
M=!*?VH82+?>0!N_'C.,XSQG&:X^VT764\37^I1^'YX;:\T(6N);R.2;S@[G#
MG<<L=PYR1@=1TH W].\>:9J5SI,4=IJ$4>K1&2SGF@"QR$)O*9SG=MR>F#@X
M)J>U\86-WI&J:BMM>(FF2O#<1.BB0.@!90N[D\C'KD8S7-66@ZW!IWP^@?2I
M0^C8%[^^B^3$#1<?/\W)SQV_*KUWH,I^)2O:S(-/OH$O-2M\<F6!@(6]MQ(S
MZ^30!VGG*MOYTH\E0F]Q(0-@QDY.<<?6L2U\76-UJ&G6OV>\B74XWDL;B2,"
M.=57<<8)*_+R-P7(K2UBP_M71+_3O,,?VNVD@WC^'<I7/ZUS'A?_ (2A]'M=
M"UC1ULEM;?[--?+<HZSJJ[5,:CY@3P3N QS^ !HGQKIBI:7+1W*Z==S_ &>#
M4"J^0[DE1_%N )! 8J%/'/(S7O?'VG6;ZPHL-4G.D,/MGE6W^K4KOW\D9 4Y
M]?0&N>A\+ZU=?#VU\$7MBR&WFAB;4%D3RF@CE5PZC=OW%5 P1P3UQS5V?1=8
M>7X@E=+E(UB)4LCYL7[PBV$7/S_+\PSSCC\J -VV\9:=<ZM:6"V]Z@OH7FL[
MB2#$5R% 9@G.[.#GD#(Z9JB/B/I'V*.^-GJ:V+79LY+DVV$AD#^7\_.<%N.
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M($>0<*,8SC:.IFA\):OJ/PS\0>'Y[<V%Y>75S- 9)$96#S&1,E"< \ _CUH
MM7NL3W?Q(\(A(-3LX+B&[=HYWVQS*(P5.P,0&&?X@",_EV6IZG:Z18/>WDA2
M)"J\#)9F(55 '4DD #U-<=L\1:OXI\*:G=>'9K(6"W*WN^YA8*SQJH*;6)9<
MCV/M6QXYT2^US08ETPH;ZRO(+Z".1MJRM$X;83VSS^.* +=OXEMYM4GTJ2SN
M[?4HK?[2MK,$W31YQN0ABIYXZC!(SBN;\%F?Q1%'KMZVIVUW!?W6&6X AEC$
MCH(B@8@JH"]AR,@G)SI+IUYJOC*P\0SZ?/91Z?8RPI#*\9DEDD*DCY6(P O<
M\EO09IWP_P!/U#2O#;66I6+VLXN[B4!I$<%9)G<8*L>S#- &?XQ,Y\<>#[..
M]O8+>^GN([F.WNI(A(JPEESM(Q@CM4?B"]O_  1K^AW45_<W6BZG>II]Q:W4
MAE,+N#LD1V^;J#D$D5;\5Z?JESXQ\*ZC9:7/=VVF33R7#1RQ*</$4  =UR<F
MDU71-3\7:_I$E_:?V?HVE7(O1%+(KS7$Z@A.$)54&2>I)]!0!(GBC1M*7Q3J
M>-486$ZF]1U9]I$:G]VI/RKMP>PYK0M_%UK<K\MAJ2.\JQVR2P!#=93?F,L0
M"H4$DDC&/I7+:EX?URYT_P"(,$>E2E]9(%EF:+Y_W*QY/S_+RI//;\JO^)]&
MU:ZLO#FJ66DQ7MUI;'S]+N70><CQ[& 8DKN'!'./Y4 ;%KXTTNZM)I0MQ'<0
MWGV![-T'G"?L@ )!R.<@[<9.< XS==\?+I_A_5[NTTV[-]ITT=M-;S!%,32;
M0CD[L,OS _*3^')%'5=&UR[TS3M7TS0;2PO]/U!+R/2Q)&IF0(R.K.ORAR'.
M.H&!SSQ;\2VGB#Q3X$U. Z2+.ZE\EK>RDG1I#LD5VW,#M!., 9/3D\X !OS>
M((XKF.S6PNYM0: W#6<?E^9'&#MW,2X49/ ^;)YQT.,^3Q]HB:;IM^GVN:'4
M+G[)$(H"66;G*..S J1CKQ5-;+6++QP?$:Z9--:ZAIZ6UQ;)+&9;:1'9D/+!
M2"&(."<'U'-9#>$]7L[72GAL'GF?Q,^M74<<L8$"-O\ E!9AD@,O3C.?;(!T
MP\:6S6LLHTK5/-@M?M=Q:M"J30Q[G4%D9ADGRWP%SP/<9Z6N$\9^'KG6-1EN
MK+3KR#5+>U T[5K&X2-A)EB8I 6&4SM/((P6[]=ZSU;4D\01:+?:=\OV$3C4
M$E4I+(I4.NS[RC+#!/6@#=HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKF_&FMZAH&DVMWIZ
M6SO)?6]NZSAL%9)%3@@\'GKS]* .DHKB$U;Q5)XGU3P\MSI GAM(KV"[-K)M
M579UV-'YG)RGWMPX['H&Z=XNU35_#_A[446SLDU&V=YY&4RL)1@*D<0(9LG<
M>,X"^^: .YHKSRW\<:O+X9\,>(I8K&+3[V=;?4\Q.3 6<HKJ=PPN\ '(.-PZ
MUU^EWUU?:AJ98PFQ@F\BW*H0S,H'F$G<00&)7@#E30!875M/;5VTE;N)M06'
MSVMPV76/(&XCL,D5<K@-874W^+4*Z1):173>'Y!YMTC.BC[0G\*D$GMU'7/.
M,%-,\>:C>VUII]Q:11:VU]<V-QY*-)&I@&7=%R"0=R8!/&2><8(!Z!16'X8O
M]:O;:[76[$6\T%PT<,JKL6XBX*OMW,5/8@GM63]JU9OBV]D+V+[#'I"SK 83
MQNE*MSN'S'8.2#QQCN0#L20H))  Y)-5=.U2QU>W:XTZZBN85D:(R1-E=RG!
M&>^*X_3O%VJMXBT+3[X63'4_M"3Q6Z,PM9(U+!1*&*N< A@.0?3I69X'UF:2
MZU/0M+FMDO5UB^NKDW,98+ 9W4;0&4LQ88XX'.>P(!W5CX<TG3=6O-4M+-8[
MZ\.Z>8LS%LXSC).T' R!C.!6I7$ZCXGUVX;6%\/V:7$NF3BW$36Y87,@178;
M]XV??P.#R,G@XIDGB#Q->>(M4TJS73K,V^G07L9N87D9&??E&"N >4QD$8]#
M0!W-%9'A767\0^%-+U>2)8I+RV29T4\*Q'('MFN8U+Q;KU@OBNUQIQU#2UBG
ML$-O)BYBD&%& ^2Q<%..,@<<T =Z2%4L3@ 9)-5].U&TU;3X;^PG2XM9UW1R
MIT85AZ=KUWK:VD^F3VCVTFFK=R.\+??D_P!6!A^!\KY')&!SS7*'Q%KFLZ'X
M!OX;FULVU2\ N(D@+(3Y<C ??!VC:.,]<<\8H ]$M-6T^_N[NTM+N&>>S95N
M$C;)B)&0#[\=*N5Y?/=ZSIWB;XA7^E26*R6<-K</]IB9Q)LMMVP ,-N<'YLG
M'H>M=':^*+G6]5LM,T[R;:672H]3FEFC,FP2'"( "N>=Q)ST XYR #:UCP_I
M>O) -1M?-:!B\,B2-')$3P2KJ0PS[&I=-TBRTF-DLXG!?&^265I9'QTR[DL<
M9/4]ZXN'QWJ<MMIX:WM$NE\0?V'J";&*D\G?&=W (VD YZ^U)XD\2ZT-.\?6
MMO/;V[Z-:1RVT\<)WX>)G(.6QN&, CZXH ]#HJAH@N!HEG]JECEE,*DM'&4&
M,#'!8_SKD]9\7ZMI.H#S!9>7_:T-E]E1&D?R)&51(TBMA')8D*P' []: .[H
MJ&Z:9;29K<H)@A*&0$KG'<#'%>=V7C+Q--HOA/6'32FAUN9+5[<1R*8W='97
M#[CP"GW=OX]P >E45P(\::IIL^M:=J2VMS?6=]:6MM+;0M&DGV@ KE"S'*Y/
M ;G Z5-<>*M=T:+5I]4TWS+.%8?L5T(O)\R21Q'Y;*68\,RG([>XH [BJM[J
M5GIS6RWEPD)NIEMX Y^_(02%'N<&N0OM9\5PPZTA@2.VBTR2YMM1-KY?ES+G
M,9C,AW<<AN@[@U7M-;UC2_"O@9Y)+2Y&I36EM*SPL'57AW9!WG+?*<GOGH*
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MK@Z-X?T^366D_L:YBN(I&MA\_EH412 1@8)SW)[CI77T4 <I/X-EG_X2G.I
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M'80P/-);W%K<)=6MS& 6AF0Y5L'@CJ"#U!--M="FCU2XUBYNXIM5DMEM4E6
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MZ19VU[/GS)HH@&.>OTSWQUJ[?:79:EY/VN 2- _F1/DJT;8QE6!!!P2,CUH
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MUM[&UBM;6&."WB4)'%&H554=  .E5K;1=-L[^XOK>T2.ZN2#/*N=TN!@;O7
MX&>E '"3-)967@;6-(NIY9]0NK>WNB9F<7<4L9:1G!/++MW ]L$=.*S[6*XM
M/#_C'Q!!=ZA/J.CZAJ(LA)=R.B )@ J3AP.OS9Z"O1['P[I&F2B6RL(8&7=L
M"#B/=][8.B9[[<9J6PT;3M+%P+*TC@%RYDF"C_6.>K-ZD]SWH Y-8[.TTNW\
M1:-J=S-</I4K16_G&1;YQ'O#N#DE@1UX^]CVJKX:M6O_ /A&O$5OXDB*S1;9
MXXT=C?,R9*OF0C<I!.0ORX(X'%=;I'A;0M GGFTG2;2SEG_UC0QA21G./8>P
MXI--\)^']'U*?4=.TBSM;R?/F311!2<\G'IGOCK0!L4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 56OM0M--@6:\F$2,ZQIP27=C@*H'+$^@YJS7+>.+F>UM-+DBT^2YC_ +0C
M\V>*U-Q):+AOWJ( 3N!P,X.-V<'I0!H/XLT*+3)-1EU*&*UBF^SR-)E2DN0-
MA4C<&Y'!&>:FT[Q%I&KW=S:V%]%//; &5%R" <X89ZJ<'D9%>67UI>MX0\;V
M*Z5J\DMUK4-Q")+.1VFC)MSNX'/",3CIC!QP*W?$MCJ&J>+]933+>Z1[KPL]
MK!<&W=(_.+L0F\C .#Z\9H TM8\5[_%'A:VTK4F-M?7<D<R"'Y)XQ$[;D=E^
M8!@O*G'(]:[9W6-&=V"JHR6)P /6O+5U%M1/@(1Z/JD,NG702\B>PE7[.1;N
MA&=N",XY&1C'2NW\9Z=>:OX+UG3]//\ I=Q:21Q#.-S$?=S[]/QH GM_$ND7
M5S);0W>9TA^T>68W5GB_OH"/G7W7(KB8O&%[>Z+?^)H=3GACTZXN]VGFSW13
M0QEU1=VW<K$J"6W<9((Q6AX:NM.UK4K34?\ A']:MM2LX76:341/_HV1AD0N
M2')./NYX&3@X!S=*2Y7X2^);1M/U!+J4ZEY<#6<HD?S7D*;5*Y.0PZ>M &[H
M&J7!M;36;[7)Y[6\M44V3V7S"XP&)BVJ&*[<_+ANF<\&MV'Q#I-QIB:C#?1R
M6LC^6C)DEGSC8%QNW9!&W&?:N$U%KJP@\&ZQ+IVJSZ=:V#6E[%:I*D]NSI%A
MRBX<@&,@^F:;>P?V3)H?B32- U :7#J4]S>6VQWN7\Z+8;@QL2V0<Y'7!SCD
MT =5JGCK1]/TF._BE>Y5[U+'9'$^Y)2X4JXQE",YP0#T'4BNCBE6>%)4SL<!
MAN4J<?0\BO/O$P&H^%1J.F:'<PP_VQ:7DBK9LL\ZI*A>4Q ;SP.XW$+G&,5Z
M!!*)X$E".@=0P612K >X/(/L>: ,Y?$NCM?I9B]7SI)FMT.UMCRKDL@?&TL,
M'Y0<\'TJ0Z[IHO5M/M!\UI3 I$;%#(!DIOQMW  \9SP:\PGEO;H:/*^BZG;S
M6?B7S9[*WL'6&!-TOS@A?WA;<K%@2/F/W0>=>*WO[+Q6EQHC7WV>ZU9QJ&DW
MMLQC3YVW7,4A'R@XW<$@EL=>* /1+FY@L[66YN94A@B0O))(V%10,DD]A5/3
M]<T[4[B6WM;@M/$BR/%)&T;A&SM;:P!*G!YZ<54\9/<1^#M6:UTQ-4F%NVVS
M=-ZR^Q7^+CG'?&*Y?P^TS_$LWH@U:6UN=$CC6[NK-HE+K*Y(P5 3 (P,#/7G
M.2 =Q?ZK9:7]G^VSB$7$RP1,P.&D8X5<@8!)Z9JO/XCT>V>_2XOXH6T]%DNA
M)E?*5LX)SV.#C'I6+\18)Y/#UI<06\TXL]3M+N5(8R[^6DJEB%')P.<#TKF]
M0EGOM5\<W,.F:F8+[08XK5C8RCSF"S#:!MR#EUX(!]L4 =U8>*M#U/4$L;+4
M8IKEXO.1!D;TXR02,'&1D#D=Z=;^)M'N[R*UAOD:6;?Y)VL$FV??V.1M?'.=
MI.,5QL,5PFK?#ITTZ]Q:6$T<_P#HDBB%C BA7.W"992.<=*R-,EO)]1\%7LF
MC:G;&TN[E+FTBT]XH+(O%(JHHVC(R1\^2/4CI0!WX\<>&3)&BZS;,9)_LRE2
M2/,SC:3C YX!/!-2'5;.+Q+>))KT>+>R5YK A0L(W']Z6QD9&!@GM7GEY:7;
M_#OQ9;II>HFXN?$,EQ#$+&7?(AN4<.!MR1M4G/M73NTG_"T-0O?L=Z;5M CB
M$PM)-K.)9&*@[>6PPXZ\T ;$7C?PS-);(FL6W^DQF2%B2%< 9/S$8SCG&<XY
MJW8^)-&U*SN[NUU")H+1BMR[Y3R2!D[@V"..<GM7G-C9W47@;X<VTFEWXGLM
M1@>YC-E+NA"I(&9AMX&6')]:7Q#I>K:C>^/!IUC=L\DVGW$*O Z+=K"%,B*Q
M #'Y<<'F@#T>W\0Z9=33017#>?#&)GA>%TD\L]'"$!F7W (IL?B31Y;?3[B.
M^C:#47$=I( =LS'.%!QC/!X]C7/R1GQ%X[\.:S80W,5O86US]JDF@>$GS%4)
M$0P!)!!8CMMYZC/'Z7]KB\(^!M*;2M4^U:3K$0O1]BDQ%M$H)SCYAR#E<C'7
M&1D ]4&NZ:;Y+,7!,KRM"A$;;&D4$L@?&TL K9&<C!]*L:AJ%KI5C+>WLODV
MT*[I)""0@]3CH/>O/[6WO[#Q7%-HCWS6ESJTPOM*OK9BD.6?=<PR$#:#][&2
M#OP.>*]%N((KJVEMYT$D,J%'1NC*1@@_A0!575[%DL768E;XXMB(V_>?+N].
M/E!//8$U GB32'O(K5;U/,FD:*%BK!)77.51R-K,,'@$G@^E<MX2T;68M.N]
M+OB\1T>.;3=.N7ZRHW*2_@GE*#ZAZQH;"]U3X;Z'X7^P75KK=C<VL<F^!@L!
MAD!:8/C:044D$'G=CK0!W&F^+=/U/6-7T^/S(_[,8)+)+&R*3MW,<D8  (Y/
M7J..:NV6OZ9J-\]E;76;I8Q-Y3HR,T9. ZA@-RY_B&17 ZGIFJ74WQ$TNTL[
MH76H&*:T<Q,L4RB! 5$GW<DJ5QG//IDUL^&+C3=<U:VU*+0-8MM0MX6CEFU/
MS@8,]8U,A(<D^G&!DD' (!UU]J%IIL FO)A$C.L:\$EW8X"J!RQ)Z <UAZOX
MWTG3/#5WK4<CW,=O+]G:-(VW+-D#8XQE.2,Y QGW%1^.+F>ULM+DBT^2YC_M
M&+S9XK4W$EHN&_>H@!)8' !P<;LX/2N&NK#4)?"'CRTBTS5'EEU2.\A$MN^^
M:/\ <'*\?,<(QP.1C! X% 'KT$\=S DT6[8PR-RE3^1 (K.;Q+HZWRV;7JB5
MI_LH.UMAFQGR]^-N_P#V<Y]JOVMRMY:QW")*B2#*K+&4;';*GD?0@'UKR;5)
M+V[*,VC:E!+9^*(KB2UM;!Q$(A-GS]P7]ZS#YB03UZ#J0#UR66."%Y9G6.-
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MXMT5(KYS<OOLH/M$T)@<2^7V=4(!93Z@$5GQ>)[/5](\/7RZLVE/?SPLL#1
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MA*ML:7_GF'QMW_[.<^U:,TL=O#)--(L<4:EW=S@*!R23V%>6:!;1>2GAK7M
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<<FI=,\7B]\1KH\UK"&EMS/%<6ES]HCX."CD*-K\YQR",\T =/1110 4444
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M?T2\\/Z))/:ZA9I9>7>7#E_M/F*IQ)Z;"0%YY);V-6_%_AZ?7["R:RGCAO\
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MF+]UP_4%>V,#KQR<@'.>/[76;'P)XG$^NR2V_P"Z>U"JJS)&Q"NDA P5)SC
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MG3=0@6>TN4*2QGN/Z'OGM0!@ZA'K.C1:K=?\)%;_ &3^SV>%M1108)USF0E
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MUC8+"&3>!PVX8(]ZSKG2=$_X6OI<"V=F8KC1IWECVJ5F(EC*EQ_&>6()SZT
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M, $# /?IQFL&PM+#3?@YX?URWM47(M5U6[@C#RFV$@+AL@[E! RIR,#&,<4
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MS<FV$\?G@;C%O&['KCKBO/DCM[+QIX#M(+B>6./3+Q(FO&'FNNV+:6X') ]
M?QK%\,/HFN66C0ZIK-S'XFL-0WS6*");C[2&(?(V;VC8$ECG&WJ>* /6FNK=
M)%C:XB#LVQ5+C);T ]?:L&W\1SCQKJNCW@M8;*TLX+F.;<0QWLZ_,3P/N_KU
MKS270]"NO!/CEOLMO_:=KK%XMDT8'G0R[P85CQRN6P,+C.:Z%+&SU#QYK4&M
MQ6UU-'X>M?-68!E#YEW'!XSSU[9]Z /2I9X8(3--*D<0Y+NP"C\31Y\7E"7S
M4\ML8?<,'/3FO)/">H,6^'AU.0/I<FCR10O(<H+L;0 Q/&[RPP7/JP%4]9LH
M8M#UY<1C1T\36ATXYP$)DB\[RSV7<7'' (;WH ]GCGAF+B*5'*-M<*P.T^A]
M#217-O.TBPSQR-&=KA'!*GT..E>5:Y"=+\0>-;7PW"EO,_A^"4068"%G#R@E
M0O\ %MZ'KTK9\+GPMJWB"PUG0]:DN[I;(PFW@$2+'"<$"940$8.  ><].,T
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MY\\(BO+V1KNY7'(=SG:?7:,+_P !H T9;NVAW>;<11[2 =[@8)Z?G3A/"9S
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MLU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %1RP0S@":)) .@=0<?G4E9.O>(K#PW;V\^H&81W
M%PENACB9\.YP,XZ#G_#- %_[':[BWV:'<1@GRQR*46=J @%M" C;U^0?*WJ/
M0U@Z?XXTB^FU*"475A/IT7GW$5] 8F$7:0 ]5X^OM4A\86$6H2V-W;7MI=+:
MF[CBEARTT0."4"DY(XRIPPSTH EUG2M4O/L]OI>HP:=9MYBWBBWW2.K=XVR
MC?>YP>3GMSL0PQV\$<$*!(HU"(BCA0!@ 5S-CX^TO4;6&Y@M=1$-PD)MI)+8
MHD[2'"HC$X+9Z\@#UK0;Q+:16K2W$-S!*+H6:V\B#S))B 0J@$@Y!SG.,9.<
M#- &G/:6UUL^T6\4VP[E\Q VT^HSTITT$5Q$T4\22QM]Y'4,#]0:P9/&FEV]
MMJTEU'=6\VDQB6[MGBW2HA!(<!20RD \@D<'.*73_&.FZCJMMIZPWD$EW;&Y
MMI+B HDZ#&[:>Y&X?S&10!I7^DVNH6\%O-&GV>&19!&$&/EY 'H/IVXJ^1D8
M/2L?3/$=MJLML+>WN1!=P-<6UPRKY<J KR""2,[@0& ./H:UV8(C,<D 9. 2
M?R'6@"L;);>RGBTY(+21U8HRQ#:'(X8J,9YQ]:I:%I=[8QRW&JWL=[J=P%$L
MT47E(%4':JKDX RQZ]6/3H,1/B;H+0VMR8]12RGN#;&\>T988I Y0*['[N2/
MPR,XK0OO&>F6$]VLJ7+06=Q%:W5RB QP22;=H;G<?OID@$#</>@#?EABF7;+
M&DBYSAU!%1_8[7<&^S0Y P#Y8X%85[XUTZSUJXTE;34[F\MQ$TD=O:,^%D8J
M&]U!')Z?6LE/&,.J^&O$USJ=GJ5A8V4UQ;/);_ZU%0!6(*$D,#N.>@XYH [0
M6=J(GB%M"(W&'38,-]1WH^R6QMA;?9XO(7&(M@VC'3CI66=<M;:&SMK>*[O+
MB6U$\<$>&E\H #>Q9@.X')R3G&<&LR3Q-H>KOX7NXKK4-NH3LUEY(>-'8(^5
MEZ# PWRGN* .G>TMI-V^WB;<=S90')QC)_"D^QVH;=]FAW8VYV#IC&/RXKEK
MOXDZ)9I?2-;ZI)#I]R;>\ECLG*P$!26?T7YA[\'C%7]1\9:98&XVK/=K;6:W
MUPULJL(H&SASDC.0K'"Y.!TZ4 ;=O:6]HK+;6\4(8[F$:!<GU.*6XMK>[B\J
MY@CFCSG9(@89^AKG+CQ<1XMTG2+6QGN+>^LWNQ<IMP5!0# )!Q\^3QZ8SSBK
M%XLT/2-,\1:N9=5DM[._9+H3([F.3:G"*?NIR.N!DF@#K7MH)45)(8W1?NJR
M@@?2GHB1H$1551T"C %8UAXIL+_6YM)$5W;W,<'VE/M,)C66+.TNI/8' YP>
M151?'6DM_9KB*]-OJ;LEC.L!=9R,G@+EAP"1N R!F@#H$M+:/;LMXEVL7&U
M,,>I^IJ1XTEC:.1%=&&&5AD$>A%.KETUW2;36_$T_FZFTVGP0/>1NKM&B[7*
MF)/< DD#!XYH Z2."&& 011(D0&!&J@*!Z8ID5E:00&"*VACA)R8TC 4GZ=*
MPM-\;Z7J=_IMK'#>Q?VG;F>SEF@*1S *&90?[P!SZ<'!-=)0!!]BM!M_T6'Y
M?N_NQQ]*=':V\3[XX(D<_P 2H :X#5_%-WK'A;QRL=K>Z>VDI<1P7"2!&#)"
MK@Y5L@DMG'3&,\\5N>'O%5I=2:;I$L=Y'=RV"SQ2W$15+@*%#E6/)(+#KC.<
MC(H Z%+*UC$HCMH5$IS)MC WGU/K3T@ABC,<<2(AZJJ@ _A6&OC#33>:?"Z7
M$<&I.8[*[=!Y-PV,@*0<C(!() #=B:Z"@"NEC:1VXMTM8%A!R(UC 7/KCI3E
MM+975UMX@R_=8(,CZ5S-U\0M(M8=3F-MJ4D6F3^3>.EHV(< $N<X^4!A[]3C
M%7K;Q=IUSK2:84NH9)8&N+>:>$I%.BXW%&/7&X'D#@Y&10!LQVUO#-)-'!$D
MLO,CJ@!?ZGO0MK;I<O<+!$L[C#2A &8>A/4UBP^+M.DU'3[-X[F$:DK-8SRH
M!'<X&["D'(..0& R.E(?&.FI=6$<B7*6^H2F"SO"@\F>3!(4'.1G!P2 &QP3
MQ0!O21I+&T<B*Z,,%6&0?PJ.:TMKCR_.MXI/+.Y-Z [3ZC/2N+7QC#JOAGQ-
M<ZI9:E86-E-<6SR6_P#K45 %8@H20P.XYZ#CFM:7Q;INGW-AI@BU"XN;FS^T
M0(D#2-(BA?XNA;YAGGZD4 = UO \HE>&-I%Z.5!(_&F_98%N&N4MXA<,NTR[
M0&(]">N*Q;?QEI-SH5MJJ&8)<W/V2*!X]LIGW%/+VGHV0>^  3G'-6-+\26>
MK:I?:9%%=17EB0+F.:$@1D@%?F&5.001@GCZ4 4O"_AE]&EU*:]6TGGNM0FO
M8I43YHA(<E,D9X]1U]!6^UG;,[.UO"6;[S%!D_6BZNH+&TFN[J58;>%#))(Y
MP%4#))_"L:+Q=IYOS:7,5U92&T:^C-S& )(5^\PP3C&1E6PW/2@#8>RM9+<V
M[VT+0'DQF,%3^'2E:UMWC2-H(FC3A5* A?H.U8VG^+[#4+N&V6"[A>YLOM]M
MYD0/GP\?,H4DY^9?E(#<CBJ5E\0M&OUTR6*&_6VU&<VT-S);%8Q+E@$)/0DJ
M<=?0X/% '3I:V\<GF)!$K_W@@!_.B&UM[8N8((HC(VYRB!=Q]3CJ:EKSX>(&
MT+Q[XM-Q_:=[;0VEG,EO"&F\H$2EV4$X4< GIGMF@#O9H(;F)HIXDEC;[R.H
M8'Z@TTVELT*0FWB,2?=0H,+]!VK./B.SDMK.6QCGOVO+?[5!%;@;FBP#O^8J
M /F'4@G/%4[;QMI-_:Z;+IXGO)-1$IMX(T"R'R_]9NWD!=IP#D]3QF@#HE54
M4*H"J!@ #  J&.RM(97ECM84D<89UC +#T)[US[^/=%72])U$?:W@U2;R+?9
M;L3YGS90CLV588ZDCC-;FEZ@NJ:;#>K;75L)03Y-U$8Y$P2,,IZ=* '_ &&S
MV[?LD&W.<>6*7[':[BWV:'<1C/EC..E5K_5H[&>.V2">ZNY$:1;>W"[RBX!;
MYB !D@<GG/&:S+;QMI-_:Z;+8">[DU'S1;V\:!9,Q_ZP-O("E3P<GJ1C- &W
M]AM, ?98, Y \L<4X6MN'=Q!%N<$,=@RV>N?6LBV\6:9>Z18:A:F:47[M%;0
M!,2R.N[<N#@ KM;)) &.M<QXK\31:AHUA>V%Q?6CV?B&VL[N(%D92)5#QL%)
M#@@CID'/% '?"SM0H46T(4+L V# 7KCZ>U/CBCA39%&B+UPHP*RM&\26FM7M
M_910W5O=6)3SH;J+8VUP2C#U!P??CD"M666.")Y975(T4LSL<!0.22: &RVU
MO/)')+!%(\1S&SH"4/J#VI+BTMKM56YMXIE4[E$B!L'U&:QH/%^GRW.GQR17
M5O%J7_'C<31A8[@XW #G*DCD!@I/:N0\1>*[W6O /C.:&WOM,DTR6:&&9)0C
M QA 061LY)+''3&.: /29+:"9E:2&-V7H64$BF_8K3YO]%A^;[W[L<_6L?3?
M%5C>:J=):.[@N5M?M*-<1%$FB!"LZD]0"1G..N>E(GC'36OK"VDBNHDU%6:Q
MN'C_ '=SM&["X)8$KR P&>V: -D65H""+6$$# (C%)]AL]NW[+!MSG'EC&:Q
M=$\9Z?X@N4BL+343&QE4SO:LL2-&VUE9CT;N!_\ JKHJ (7L[61P[VT+.$,8
M9D!(4]5^GM0;2V9PYMXBP& 2@R!5+4M;M]-O;2Q,4UQ>W@D:"WA"[F5 "QRQ
M"@#(ZGN*S#X\T4:;I%^#=O!JLOD6^RV9CY@W95@!P<JPQU..,T ;WV"SV[?L
MD&W.<>6,4Y[6WEDBDDMXG>+_ %;,@)3Z'M6+:>,M*N+#4[N;[19C3)/+NXKJ
M+;)&Q *_*,YW!AC&<YQUK%M]4N;GXN6ULR:C:PMHLLK6UP_[LMYL8#A58KG&
M1ZCOUH [5[:"20R/#&SE2FYE!.T]1GT]J7R(<QGRDS&,)\H^7C''I3V8(C,<
MD 9. 2?R'6N.3XFZ"T-K<F/44LI[@VQO'M&6&*0.4"NQ^[DC\,C.* .MCMK>
M(,(X(T#<,%0#/UIL5E:00&"*VACA)R8TC 4GZ=*Q+[QGIEA/=K*ERT%G<16M
MU<H@,<$DFW:&YW'[Z9(! W?6FWOC73K/6KC25M-3N;RW$321V]HSX61BH;W4
M$<GI]: -W[%:#;_HL/R_=_=CCZ416=K!,TT5M#'*XPSI& Q'N:XQ/&,.J^&O
M$USJ=EJ5A8V4UQ;/);_ZU%0!6(*$D,#N.>@XYKH#KEK:PV=M;Q7=Y<2VHG2"
M/#2^4 /G8LP'<#DY)SC/- &Q)%'-&T<J*\;##*PR"/<4P6MN+;[,((A;[=OE
M;!MQZ8Z8KEY/$NAZN_A>[BNM0VZA.S67DAXT=@CY67H,##?*>XIEW\2=$LTO
MI6M]4DAT^Y-O>2QV3E8" I+-Z+\P]^#QB@"]8>'[BR\9W^LAK9;2YM(;5($!
M!C$98@^G.\\=L5MQ6=K!M\FVACVYV[(P,9ZXQZXYK%U'QEIFGFXVK/=K;6:W
MUPULJL(H&SASDC.0K'"Y.!TZ5!<>+2OBW2=(M;&>XM[ZS>[%RFW!4% , D''
MSY/'IC/. "3Q7X:?7-$&GZ?]EM2UQ#.[LG!\N17 P.N2N/;-;D%E;0VWDK:P
M1HW+QQH I/?C'-<]I?B#1;>V\0:@+N^$-K?M'<_:]YV2[4^2-3R%.Y0% Y)X
MZU>B\3V;:C-IUQ;W=I?1V_VE;>6,,TL6<%DV%@V#P0#D9'% &I]BM/E_T6'Y
M>G[L<4Y+:WC9BD$:EN&*H!GZUS6G_$#1]2;26AAODM]58QVMS+;E8FDP3L+?
MWB%/MQC.>*ZJ@"NEC:1P>1':P+#G/EK& N?7'2G+9VRNKK;PAE^Z0@R/I7/K
MK6EV_B/7F\W4FN+&TADNHF5VB5/G*F-.Y.#D@<X%&F^.M*U.[TJ"*&^C7583
M+9S36Y6.0A-Y0'^\%Y].#@F@#I$BCBW>6BIN8LVT8R3U)]ZCEM+:::.:6WBD
MECY1W0%E^A[5-6-%XDMI[I(H+:ZEB>YDM%N$53'YJ;MRGYLC!1AD@#(Z\B@!
MFJ:3J>IZK$K:C"FB;5,UH+?,DKJV['F9X4\ C'(!'>MRN;;QMI::)+JS1W0M
M8;PV,W[L;HY1((\$9Y&\@9&:GU;Q78:0+UI(KF>/3T62]>W0,+=2,@MD@DXY
MPN2!@XY&0#6-E:DL3;0DO]X^6/FYSS0+*U!4BVARGW?W8X[\5P\VO&P^)5V\
M;:C?6DFAPW,5I;[I<L97!94)PORJ/3\S79:3JMIK>D6NJ6,ADM;J,2QL1@X/
MJ.QH L"UMQ<FY$$0G8;3*$&XCTSUQ2?9+;<S?9XLLP=CL'+#H3[^]5-3UJVT
MN:RMY$EFNKV0Q6T$0&Z1@I=N20  JDY)%&BZU::]I_VRS\P()'A=)%VO'(C%
M64CU!!H M?8K3YO]%A^;K^['-(VGV3/&[6EN6C.4)C&4^G'%4]?U^R\-:8=0
MU 3>0)$C)BC+X+,%&<=!DCDUFGQO8_VC=:<-/U4W\$2S);?9#OFC)(WH,_=R
M"/FQSQU- '35##:6UO)))#;Q1O(<R,B %S[D=:R+3Q9I^HZ987NGI/=F_C:2
MWMXU D8*</D,0%VD@')') [BDLO%^F:EI\%U9">:2:9[=+4(%F$J9WH02 I7
M!R20.G/(R ;,=K;PN7B@B1C_ !*@!J1E5QAE##T(S7%ZC\0K>/3;:XTZQN9Y
MGU:/2[B%E57MY"X#*P+=<'C!()(YQ6BNJZ>WC)X6.IIJ*:6)GMB&,0BWCD*,
MAI,G&5ST(S0!T>U=Y?:-Q&,XYQ4/V&T.[_18?FZ_NQS7-V'Q!T;4?[*DAAOU
MMM4D,-M<R6Y6(R?-A"?4[3CMVSGBK.I>--*TR+4)Y5N)+33I5AO+B&/<D#D
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M,9@6#,2=I7A@/;DUW>E:#8:-/>S622J][,9[@O.\F^0@ MAB<'  X]*TZ .
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M#9#SH?W@:!(P?O\ R\J3SCBK&JZ#JNJZMX<']G3PVT.E7=I=3&2+]PTL:*.
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MG';FO6W4.C*20",9!P?SK/T70[#P_8FRTZ.2.W+M)L>9Y,,Q+,<L2>22?QH
M\_\ %6C^)]8M?$-H^C37<GVR&73I4N8TA\A'C; 4L#YORODL.AP&Q@'I-+LM
M47XBZIJEQIDL-G=:?;PI,98V&]"Y88#;OXQSCL:ZVB@#S=M#UU/"?CG1ETB5
MY=1N;V6SD6:(+,)_N8RPQC)SNQ[9[3/9^(=$\0Z9KMIHLVH0RZ3%IUY9QS1K
M- Z,65P2VUA\Q!P?>O0J* .,URQUO4-1\)W1TPNUI?M<W8AECVP(8W4#+,"Q
M&]<X'.#6'IWVR[M_B'I5IILMQ)>:G/#')N01AGMXU^8DY &03P<CID\5Z?69
MI6@V&C3WLUDDJO>S&>X+SN^^0@ MAB<'  X]* .$U/P[X@2PO?#RZ?+J&GIH
M,=EITL<Z1QB98V1C,"P9B3M*\$#VY-7[/2];M];\(ZBVD2%;;2I+&ZC$\>;=
MSY6&;YN1\A^[N/M7?U6L-1L]4MOM-C<QW$.]H]\9R-RDJP_ @B@#SFZ\*:]?
MZ3XHCCLFMKJ77$U2P$TL>R<((L*=K';DQGKCJ*WY;"]UGQ9I6OR:9<VD>F6=
MPHAE:/S)I90HV##$84*>20"2,=ZZ?4-0M-*L)KZ_N([>UA&Z260X51TYJP""
M 0<@]#0!YA8>'M?M_!O@;3Y-&G^U:5J4<]V@FA^1%60$@[\'[XX'/6O4***
M.(FTS5AXM\57JZ7,]M>Z9#;VT@EB_>.@DR,%\C[XY('>L^RT/6X;'X=Q/I$X
M?1P%OOWT/[K%NT7]_P";YCGC/'Y5Z/10 5Y[%X?U&'Q;%JNE65YI4TNH2'4H
M_.5K2[@RV)=FXXD8;>@!R3D=Z]"JM8ZC9ZG T]C<QW$22-$S1G(#J<,/J"*
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M$FM$DD,DZ1WTT4$CL>2T:N$))/3')/>@#<TZ\BU'3;:]@5UBGB61%==K $9
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M:E:Q02RVEI+.(YP2C!5+$$#U K#G\1ZVVL^'=-LHM.1=5T^2X,DJ.?*=%C/
M!&1\_3/;J*Z+Q!I;:YX>U#25G$ O;=[=I2F_:KJ5) R.<$UE1^%;A-7T+4#J
M49;2;1[54^S$"4.%!)._@_(OZT 3^#M;O-=T>>74(X4O+6\GLYC "(W:)RNY
M022 < X)-9VI:YXC?QI<>'M)CTM,::M['/=+(V"9"F"%(S]WMCKG/&#K>&=
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MWN!$&+CRR%"$Y)SNXZ<Z_P#;FHZGK^IZ-I3VD$VFV\+SRW,32!I90S*H"LN
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M\F&T@>>3;UVJI8X_ 5S&GZ_XBN]3TP?8$DL+Z%FEE6UDC^QOMW)EF;$JG[O
M4]^]=5>6D-_8W%G<IO@N(VBD3^\K#!'Y&N:\/>$]5T..*VF\33WUA:*5LH);
M95,8P0OF.#F0*#P/E_08 *FA^)M>U#Q#<^'[V*Q@U"PG9[MEB;8]J0/+>/+Y
MW,3SU"X.><9L_P!O:[JL.I76@6]E,EA?FS%M/D/<;&"RG?N 3JV,AON^^ 2>
M"YOM>DZE!JBPZM922/<7GV;)NU?[R.N[[IP.,\;1MQBFQ^"KNSUO4+C3=?GL
M],U*8W%Y8K K$R$8=HY"<INQSP?8CC !%J?BK6)7U@:!9I<2:9.+<0/;2/\
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M)+B_T&XN+^)X]*MI;8Q?9B!.LB!&R=_'"CU[U%X<\':AH'DV;^)+F[T:U/\
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M"#Q=9: UG)FZMI;A;C>-OR%01CKGYAZ4GAE'EL9M3D>8G49C<HDDC,(XCQ&
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MF'F"1?L; &9\$M$V<C.#[9Z=L4 =W1110 4444 %%%% !1110 4444 %%%%
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M6T33GUA=7:W_ .)@J>4)][;@F<[>OW<\XZ4_2]7T_6[5KK3;N*Z@61HB\9R
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MDG-3T4 9]_HFG:G<0W-U;;KB %8YD=HY%!Z@,I!P>XS@TR;P]I,ZV*O8QA;
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO(CO-"\NR=NA*2AG0>^/FQZ4OC^*2\\5^!K6SR;Q-5^TG;U6!%_>$^@P0/Q
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M@Q+(7* @&0$*2#@D#CFJ7B__ )*!X!_Z^KK_ -)S1\3_ /D'>'?^QAL?_0Z
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MGPUI5Y<V=S<6\DL]EG[-(T\A:(G@E3NX)'!-2ZKH6FZXL"ZE;>>L$@EB4R,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8]PP I 7YLC'4GFJT_P]OIM(UC3O[>0IJ6IIJ)=[+)1@R.1PXSDQCTP,]>M
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M!$7W8*A@!G;G;Q[T 5[OQ1XJFO\ Q+:Z5INELVBNAQ/*Y,ZM$)-HP!AB#U/
M..N<B'3_ !/J7B#Q?X:FLKB*#3+_ $>2]-M)$68-OB# D,,D9(!Q@<\'/$.C
MK<ZEXX\>VVG:G:1":6W1B8_,=?\ 1U4LN&'3D<@C(_ [T?@M;#5-!NM)O1:P
MZ59-8&)X?,,D)*'@Y&ULH.<'J>* *,'C/5+\:=J&FZ:]WIUW=>4\26DHDCA+
M%1-YI^0XP"5QT/4XK%\<ZU>^(?AGXGO+(6JZ9"TELJR*QDE$;A7<,#A?F!P,
M'(7J,\=!HO@S5-"N6L[7Q"__  CPG::.Q-L/-C!;<8Q+G[F2>V<'&>]4;OX=
MWS:1KFA66N10:-JDCS"&2T\R2W9VW,$?>!M)YP1GGKWH [Z/_5I]!7"^*OMP
M^)7A@Z8ELUVUC?A3<$A!_J>3M&3]/U%=Q;I)';QI+())%4!G"[0Q]<9.*Q=9
MT"YOM?TK6K*\B@NM/2:()-"9$D23;NZ,I!&P8/Z4 <Q)XZUR#P]J-Y<:?9QW
MFBWXM=51-[IY)VDS1<@X"MNVGL#R*["VU&>\UZ>V@:![&"WC9Y%!),CY(4'.
M.% ;I_$OK6/.-#\(:;=?VY=>:^M7+F=C S?:)&3&Q44$@;%"@<].I)YN>"="
M_P"$=\*65BYE,VP/*9FW."0 %)[[5"I]%% &],[QP2/'&97525C! +'' R>F
M:X[1_%U_<^)--TF^CLRU]927#K;9/V65"FZ)GW%7(WX)&,$=.175ZC:?VAIE
MW9>;)#]HA>+S8SADW C(]QG-<GI7@C4;'4/#UW/KD,O]CVKV8CBL1&LD3! /
MXSAOD&3R#V ZT =K7GE[XU\10Z9XHOX;'3 F@73HZ.[DS1K&CD C&&PQYZ=!
MCO7H=<9/X'NI]*\4V!U:$#7Y7D9Q:']SN14( \SYN%'IS0!+%XEU>+Q/9:?=
MV=HUOJ5E-=6BP.WF(T>P['+<'(<<@#!]>M0:3XOU"?Q'I>E7L5F9+^SEG=+?
M)-I+'LW1,^65R-^"1C!'3D58U#P==ZC?Z9<OJR1?8K">R/E6Y5F\U54NK;_E
M(V@C@UE+X<?PP?#VJZQXFM8[;1(6LMPLO*1XY-BKD[SM;*C+=/9>M $UGXTE
MAT>YEEL+6*]DU]](@BA)$;RF3;O8XR>C,>,G%79_$^I:;KM[HEY!:370TYM0
MLIXPT4<JJ<.C*2Q4@X.03D'M63I/A3^WO#.II+,]K))XAN=3TZZ1=Q1A,3'(
M!_$IP?J#QU!KH'\-7-W>W&I7UY;OJ+V+6,+QVY$<*,<L=I<DDG'<< #U) .<
MNO%WB/\ X5M<>*;K3-&DM)-.AN8K=G<DLWW@X(P1R"!GZFM:YOM9;XJ6VFPW
MENEC_8\EP(FA9N?.C4DD,,GT/8$\'-/N/!4]Q\,U\''5(QBU2T^UBV/W%P =
MF_K@>OX5=N/#UT_BJP\0)J21206;6=S']GR)4+J_R_-\ARO?=P?QH S;'Q9J
M<^EZK%<0VD>N66H"Q%LJML8L5\MNN2K*V[/8 ^E=FNX*-Q!;') P":XC1H]'
M\4>-O^$KTF626UAM!"T@5DCFFRP4X(&61&<9_P"F@':NXH YV;6[R^\27^AZ
M2;:.:PMHYIYKE&==TF[8@564]%))SQD<'MR&O^([SQ+X*T>]MUCLI#KEM:7E
MO(I?;*ERH(R",KN7/3D8Z5U]QX;N(O%4GB#2KV*WN+FW6WNX9X3)'*%)*.,,
MI##)'<$'MUJA=>!2WAZPTJRU!8#;Z@NHS3RV_F&>82^:3@,N 6^N!Q0!T]G9
MQVPDE\FW6ZG(>XDABV>:X &3U)X ')/ KF?$E]J\/CKPM865W!%:W1N6D1X2
MVYDBXR0PR,-P/49YKKTW!%#D%L<D# )^E86N^'I]4UG1M4M;\6EQIKRD;H?,
M#I(FUAU&#T(/(]0: .'36=5\.CQ[JVG6]G+!9:L9YTG9@TBB&+<JXZ''.3GZ
M5U&J>*KQKV_LM&A5[BRMXYB)+2682.X++'^[^YP!\QS][IP:@N? MU<Z3XIL
M&U:$+K\S2LXM#F'**A _>?-PH].<T^Z\'ZM%KB:QHNOI874UM';WR/9^;%<!
M,[7"E@58 D=3_B =+I%[/J.CVEY<V<ME<31*\EM+]Z)B.5/T-8_B;7M2TC5M
M"L[&UM9EU*Y:W9II&4J1&SCH.GR__6K?M(#:VD4!EDF9%PTDARSGN3[D\\<5
MD:[H$^KZMHE[%>QP#3+DW&QH"_F$HR8SN&.&/8T <W<^.-8L/#^OW-S;6+7^
MBZA':R",/Y<R.8\,,G*G$GOT]^-J\\17]MXMO-&B@MI$CTDZA$S%E.X/LVL>
M>.,Y JC>> I;ZQ\3VTVJ(!K<Z7"LEM@V[H$"]7.X?NU)Z=ZF3PIJ\FOOK5WK
M=O)=2:8;!T2R*QC+EMRC?D=N"3GGD<  &7:>-O$,UAX5U%[#33;Z]MA$2R.K
MQRM&SJV[D;?E((P3[GI6;XPUN_U'P-XSTO5(;7[9I4]LGF6VX1R*YBD4X8D@
M\X//:NA@\#W<&C^%M/75H2- F257-H?WVU&0 CS/EX8^O-&H> Y-3'BE)]45
M4UUH6_=VV# T2J%Y+'</D&>G?I0 RY\8:KX?U]K3Q)9V:64]E<7EM/9.S%?)
M7=)&X8#)VG((P#Z>DUCXEUVYU/3D&EB>SOH7=I%MIHA9N%W*'=QAU/W=R@<]
MN:NR^%CJUW]J\03PW;K9RV<<=O"8D590!(W+,2S  =>!]<U7\.^&-=T6.&TN
MO$IOK&S0I9QM:!'QC"^:P;YPH[#;G )H ;X)U[7_ !-I]KJU[:Z=;Z?/%)\L
M3N91(LA4=1C;@'OG('K@='JFHP:/I-YJ5T2+>T@>>3 R=J@DX]^*SO".@2^&
M/#EOI$MXEV("Y658?+R&8MR-S=V-:>H6%OJFFW6GW:;[:ZB:&5<XRK @_H:
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M.9ONLQ) R,]>]9UK/J&H:3\,UDU?48SJ,3)=M'<LK3#[,[$L>I.1UZCJ.>:
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M=RLG690?ND<^A[=1BJEUI$5_\5+JQ:ZO881X=A7=!<NDAQ/*!F0'?[]>>^:
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MGY0V5'S8W>^:;K=S?Z9X;^(EC:ZKJ*II<L,EG*UV[RQ;XD9E\QB6(R3P3WH
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M3Z>G%==I&G7UMXAM=0CUE'TVZM2OV3[3)<"=OO+*C.3MXX..""/:@#KJ***
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MVDM8D4O9X#9#$$EBQ&0"!C% &G:Z+866IW>I6\++=W@47$AE=O,V\+D$XX'
M]*+K1;"]U2SU*XA9[NSW?9Y/,8>7NX; !QR.#ZUB+X_T3.A(]Q&LFK*65=^1
M$!&7.X].H"^Y/L:VKG7=*L[U+.XU"WBG=Q&J.X'SGE5] Q[#J: *;^#]"DL+
MVQ>R9K6^F,]U$9Y")9#U9OFY)P/R'I6RL2)"(L%D"[<.2Q(]R>3^-4KW7=*T
MZX6"\U"W@D9E7$C@8+<*">V>V>O:EN-:TVTNA;3WL,<Q=(]K-T9B JD]B<C
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M<!8B43&,2OEG&"&9MV6(P,$DXP/2KEWH5A>W$=Q,DWGQQ&%9([F2-MAZJ2K
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M-OO2IKFGZ@9K73M3MGO!"9$ ._Y>F\#(W+GN.* &6WA70[71)M&BTV$Z?/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6)9AC( 0CD]B*VKJ*2ZUCXFQ6\3R276F1) %0_OF%O(I"G^(@D XZ$BO2Z*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MERH<#[1)DD]<;"/P(J?Q)K&GR6^L)"Z6+VGB6WEGMB&>5RLL0-P['.Q" -N
M!P.3G%>T48% 'G>A6NBZA\4O%9DM[.=_+L98A)&I(8*Y+ $<,#MR>H.*YZ._
M:U\#WB1&=CIWB26?4X8$W21P?:6;)4@@XRK8(Y STKV6B@#Q[Q,?#6I>"?%^
MM:5?RZD]Y9(DMS(%$32+P@4!5!D )Z#(XSUKU#1;/3;:PCETRWM8XYT5V>W1
M0)/E !)'WC@8R:T  HP  /04M '#3WRZ9\5KE]9ECALKK2DCL)IV"QAE=C*F
M3QN.5..X4>E<:MC;6>F^%HK]85LV\53/8I/@%;(^=L'/\!)4CMAEKVHJ&&"
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M02"0"1T/I2T %>)1WEBWP@TBPFFC$UOK4,=S"_!0_;"2K9[A>2.PYZ&O;:*
M/)->1AKWCFTT!8_M$NB6I6"VP#(5:3<% ZML./Q%;OA>]\->(O$%KK.DZC>W
MU]#:-!(&18Q;Q$@[) J*,[N@Y/!(X!KOJ0 #. !GDXH 6BBB@ HHHH ****
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MEV%A;EDWY_NYW;<_CBO,-0\2W>O^"O#.NSV]W9O)KEJ=L4F5DC,Y&T*C9?
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJ
MAK6KV^AZ3/J%R&9(@ J+]Z1V(547W+$ ?6H9IM2C;3 ]UIT+RS$7,;@Y==I.
MR(Y&6!QR1R 3@=* -6BLFTU<G7KC1;L(MTD0N863@30D[<X[,IX(]U/? SO&
M^OZAX<T^QN;!+61KB^ALV6=6('F-M# @CIZ=Z .GHKD-<\3ZIX1^S7FMVUK<
M:/)*L,]Y:;D:U+'"LR-G*9(!(;(STKI;G4K&R>)+J]MX&E.(UEE52Y]LGF@"
MU15:[U"RT]4:]O+>V5SA3-*J!CZ#)K%U#6[ZT\<Z'I""W:QU"WN9')4^8&C"
MD8.<8._T[4 ='155-2L9;QK..]MGNESN@652XQURN<T#4K%KA;=;VV,[.R+&
M)5W%E&6&,YR 02.V: +5%5H-1L;JXEM[>]MYIX?]9''*K,GU .14L\\-M"TU
MQ*D42#+/(P51]2: )**X[3/$M_JMUXKMX;O2PNG&-;*ZP3%\\0<-(=W(!.#@
MCI72P:A;9@MYKZT:\>-6*1R ;R1G*KG.#VH N45EZE?L;1CINHZ='-'<1QR-
M<-N11N&Y3@C#$9 ]Z?K.J0Z982N;RTM[@HQ@%RX =@.F,@GMT]: -&BN?\.>
M(EOO!.DZYJT]K:M=VL<LK,PCC#,,X&X\?G6P;ZT"0N;J +/S$QD&).,_+Z\<
M\=J +%%06]]:7EM]IMKJ">WY_>Q2!EXZ\CBN=L_$[WWC^31K:YL;G31IGVM9
M(#N<2>8$*E@Q&,<]!UH ZFBJUKJ-C?,RVEY;W#)]X12JY7ZX-.NKRUL8?.O+
MF&WBSC?,X1<_4T 3T5 ;VU6&*8W,(BE*K&YD&URW0 ]\]J=;75O>0":UGBGB
M)($D3AE)!P>1[T 2T5ROB_Q2VB1V:6%U8/=/?V]O-;RMND$<DBJ2%# @@-U(
M(K:@GN3K5[')=636J11M'"F?.C)W;B_.,' QP.AH T**RKOQ+HMGI=WJ,NJ6
MAM;1-\SI,K;1V'!ZG& .YJ2WUS3)[&"\^W6R131F12TRC@#+<Y[#KZ4 :-%8
MEU?WOVB[DLK[39+86 F@B(+2;\D[SAN8R,8QW[U#X2\21Z[X>TFXNKFT74KN
MRCN9+:-P"-PR2%))Q0!T-%5/[5T[[.;C[?:^0'V>9YR[=WIG.,^U51XDTH^(
MFT(7D)OTB$KQ[QE<G '^\>3CT&>XH U:*S=,NIO[-DGU"]L92DLF9K8[8U0,
M< DD\@8!YZ@U9AU&RN;5KJ"\MY;=<[I4E5D&.N2#B@"S15:'4;&YN&MX+RWE
MG5!(8TE5F"GHV <X.1S1%J-C<7+VT-[;R7"9W1)*I9<<'(!R* +-%1SW$-K"
MTUQ-'#$OWGD8*H^I-1#4;%K'[:+RW-IC/GB5?+Q_O9Q0!9HJ"&]M+F>:""ZA
MEF@.)8TD#-&?1@.GXT75Y:V,0EN[F&WC)VAI7" GTR: )Z*Q[OQ3HUGJ6GV$
MNH6_GWX9H0)5P4 )W9STS@#U)^M7Y-1L8;M+26\MTN9/N0M*H=OHN<F@"S15
M:[U"RL AO+RWM@YPGG2JFX^@R>:Q'UR\C^(::(_V;^SWTJ2]#[2'#K(B<MG&
M,,3TH Z2BJJZGI[Q1RI?6S1R2")'$JD,YZ*#GD^U6J "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#BOB4LG]G:!,,_9X-?L9+@]A'YF,
MGVW%:C\<26</BSP3),\"3_VFP#.0&VF&0=?3)'XXKL+^PMM3L)[&\B$MO.A1
MT/&0??L??M3[6*6"V2*:<SN@QYC+@L.Q..,^N,?0=* .0U=))/B]X9\C.8M.
MO7N,?\\R8PN?^!55^+-W;6VAZ.)[B*+_ (G5F_SN%^429)Y[ =378VNF1P:A
M<ZA(WFWDZK&9",!8UR511V&22?4D^P%Z@#SKXBW]OXK\,R>%M FBU&_U.2.,
MFV821V\8=6:21APH 7C)R2>,UF7]QI-OXB\2^'O%6J7%E!>QPK:;D0K=6_DJ
MFU&*,=P</P#G+9 S7K%-9$8J6525.5)'2@#S"+4M)T3Q3J6E^*9)(+&^TFU@
ML'OR<R0A&66(L/X]S9(')R/:KUQ)86?CWP':6X^S11Z?=QPV\S_O$39$$4AC
MG.!WYX->@LBN5+*&VG(R,X-.H \5LM;TN>X\&75K-%:V\6LW"FR!+RVQ=9LB
M9R2=[-SMXZX ;&:T-#TZQO-&\?2Z-;V<FL0:C??8'B53)$QA 4QG^')+ 8[Y
MKUG:H_A'7/3O2T >:^$KOPUX@U+0;ZQU*\GU33[9XOL@1(S:H4PZ2JJ+P"
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M/)X/U'K[(KE2R@E3D9'0TZ@#CH/$O@B^\.Z'>-+8#3Y+B)+".2,8AN #L7:
M=C+R.V/6NQJK?6$6HPI#.6,0<.R#&'QR ?;Z8STZ9%6J "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@!DLL<$+S32+'%&I9W<X"@<DD]A5$ZQ'BP9
M;.]D2]DV(Z0$A!M+!W_N*<=^Y'%<[\2;B1-(T>Q!(AU+6K.SN,=XFDRP^AVX
M_&K/BG4+^Q\1>%8[6\>*WO-0:"XA"J5D7RG89)&1RHZ&@#9.KHLVH1M9WH6R
MV;Y/(.V0,,DQG^/ ZXYSQ@FKL$\5U;QW$$B2PRJ'21#E64C((/<5S/A[4+^?
MQIXLL+J\>>VLY+;[,KJH\L/%O(^4#/)[Y-5OAU<2&V\0V!)\C3]<NK>W']V/
M(<*/8%R* -Q?$E@WB5O#X%Q_:*P_:"GDMM\K=MW[NF,\=:UZX:/_ )+I<?\
M8N)_Z4-5/0/$6I2ZD--U2>[LM?6TF8VMVJFUNW&")89%&-@_NY!PW()&: /1
M:*\SL/$E[/9:I:W5YJFFZ]9Z5+--97<:',B@?OX6"[63((P..1P*O6FN:K)=
M?#MGOG*ZM:LUZFQ=LS"U\P-TR#NYXQ0!WU%>=Z3J'B?Q#INE^(=/O;>&*2Z+
M7$,\X\HVX=E:/:(\AP .=W4'/!P.I\5SZK;:$\NCP//<K+&6AC95DDB# R!"
MW&[;NQ^G- &R[I&NYV55Z98X%.KR;6=637?"D$UGJ^I@)XALXI+>X013VV9(
M@8I 1S@Y89SU&<XKJ+:\O-:\5Z[H2ZE=6L>D6]LJ21;/,DDE1F,C$K@XP !C
M&=V0>, '8UEZKKUGH]WIMM=+,7U"X%M 4C)7>03\QZ#A3^5<5X;\7ZGXC?P_
MI=[-]EGN8+Q[J: !3.T$HB 3/0')8XYXP.*B\82:CHFE^&7U"Y?6;JS\0!Q]
MGC"RR((9V1".A?;@=LT >G45A>%+IM3T:+5_[4-\E]F9 H CA!/^K7@'Y>A+
M<Y!Z=!0.HW.L^.-5T%;R>RM]/LX908-H>624M\V2#PH4<=,DYSQ0!U3.B8WL
MJY(49.,D]!6;IVO6>J:KJ>G6ZS"?371)_,C*C+KN&,]1CO[UYO\ VIJFOIX1
M-_?3Q7<&OW%A/);[428Q)*/,VD$9.T>P.<"K%_'J$>M_$B\L-6N+&:R@M[A&
MA1"7=+7<-VY3\O'(&/K0!ZI17!1:[JGB'4K?3+>7[.YT6WOW,4PB9GE+#(RC
M9"[1QZMSFJDTWBPZIX3T>_U]8+N]M[R.^DL$1D+Q ;70LF0W/(Q@'.!Q0!Z1
M65>>(;&RU72M/<RO+JC,ML\:;HSM0N<MTZ U4\20W%OX U.+[?<&YATZ3-VA
M"2.RQD[N!@$D=L=>,5Q9M9_L_P ,(H[Z99),D3,JLT8-DW"C&.!TR#[YZ4 >
MJ45YS9ZSJ<.E:Y97&NN)+'74LH;J:(//)$WEMY:A5P9"'90=OOVS5#4_$6NV
MOAOQZ(KZ[MIM'>-[1YA$\L:O$CE&."",L<'D\]: /5:*XRSNM4L/B+;Z;<:K
M->6M]I<ETT<J(!%(DB+\FT A<.>"3T')K2\27<T5]I%M%?/$MQ+('M;=<SW(
M"$@(3PH!P68D#&!D9Y .AHKS2Q\0^(I_!=I>^3>:@UOJ=S!?):[!=/;QO(@*
M@8#,"$SMY.#CK77^$=3@U?P[#>6VHR7\;22CSI8]D@^=L(ZX&&484\=L]Z -
MRBO*YKKQ1=Z)XPU&W\37$,VAZA<?98_(BVR)'$C[)/EY&"0,8Y))SVNP7VN^
M(_%4%G#KEUIEM=:!;ZD(X8HF:*5Y"" 64\8'.<GW% 'H]%>;R:_J^I^"M?\
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M$T_6[>W@O[=98[>XCN8@?X70Y4_T^A-:%% &7J^@VNM3V$US).K6%P+F#RW
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHIAEC!4%U!9MH!/4]<?6@!]%-$D99U#KE/O#/W?KZ4)(DBAD=6! 8%3G(/0T
M .HHHH **** "BBB@ HHHH **** "BBB@ HHII=595+ ,WW03R?I0 ZBBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .:\<:Q/I.B01V;F.\U*
M]@T^"0?\LVE<*6'N%W$>X%1ZU-I^DZKX8T]]'2X2:\,5M.S#_1I!&YW<Y))
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M<XMY9'\[S%0;E!0;?N].<>I[ ':USGCW5[_0? ^K:GIJQ&YMX&93*Q 3MN&
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M8*SHX9<#D_)C!QUSSTH X[PQX@E\+:'?R)I ?2D\17-O+,LP0PA[G8I1,'<
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MA>P:30KQ)YG\Y\2*JNN%^3J=^>?3WH UK;QC));^(OM6G+;W>BR;&M_M&XS
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MV5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"[/D$G<6([8 &.>: .W@UJ"XDTQ8K>Z9-0@,\<HA)1%"JV';HI(;@=\&M*N
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M#PSX>UV?7)II)]:%C-;F")8Y8FN7BR<+G< !@@@<#CJ2 >K!U+E P+  D9Y
M/3^1I:XCPE%<?\)UXR,FH74R17D*K'(5*X,"-_=R,9. "!]3S6CXEUFXM=>\
M.Z);RFW.K3RK)<* 2B1QERJY!&6.!GTSWQ0!NVUG9:='+]EMK>V1V,LGE1A
MS'JQQU/O6=IWB>RU2^AMH(;L+<6_VJVN'A(BGBR!N5A]1P<'!!Q7,7%_J;7'
MC'PW<WT\D=I8+=VMV%02!'1\QM\N#RAP<9P>N1FMSX?0O#X T#?<RS;]/MV'
MF!?D'E+\HV@<#WR?>@#I:*XBXEUG4/'^KZ+%KMS:6::9#<Q>3%$7C=GD4X+*
M>/E'7)]"*Q-,\0^()=!\$^(+C5Y)'U2\BL[JT$,:PNKJX+?=W!\H#G=CV H
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MO]!,=]+KUJUQ=:O!826T$<DJHDH/S!6P!C+!?F[?2MV6:*WB:6:1(XU&6=V
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M3AC$X;!]#B@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBXP=C0YV^@&.U;%[?>$=3TK6]7T*XMYISH4L,LMM)^[CB"DHKJ#A7R3@$;L
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MSE=X56Z*AA&_FIL+ \%=VT$'C!->>Z]=7DW@OQ3!JVGV4=_8WUC+<WECDP7
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MT/3IR"=.35;9M3P,@6H;YBW^SG;GVSGBNP1$C4*BJJCLHP*4@,"" 0>"#WH
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MW LC1,\39 =>HJPEI;13--';Q)*PPSJ@#$>YJ'3M-@TU)Q"/GGE,TK;0-SD
M9P.!PJC\.YR: ,SQQ=6MEX'UFXOH)Y[5;5Q+% Y1V4C! 8=.O)[#-<GX;O[1
MOBI(L.H6$RW&@PA!9<1L5E?A3D[RJ]_T'2O2F4,I5@"",$'O3$@ABV^7$B;5
MVKM4# ]![4 24444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6175D>5G!7'08(ZX/L*9I&E7X\6>+YKJREM[/4S!]GGWH=P6$1MP&)'/(R*
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M9;%&+>:RK'M.Q6*Y^8\]@>2,5T=CXNT[4-(COX4N SW+68M7CVS>>I(:,KG
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M226\$L0BDAC>,=$900/PH X+6XM)U?XE^$9MEK=0W5A>-D@,LR8B*Y_O#DD
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M!'G!I-SX]>G/7!QT->B&RM6NQ=FVA-RHP)C&-X'INZTOV6!)6GCMX1.<_/M
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M9E&2OR \YJM8:[J[>([_ $K[=<R0_P!BK?037=LB.)-[*650%.TX'#@'(]*
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M,UM8SW.^"V)SG8N,]SC<3C/%)_P@6CG2]0TV1[N2TO+AKH1M-_Q[R%]^Z(@
MJ=W.3G\N*ZCK2%E!P2,^F: ,5/#4.^XGGOKRYO)K;[)]KE\OS$BSDJH5 HR>
M2=N3QZ##+;PM!9Z!IVD6VH7T46GLIMIE=/,4*" I.W!&"1R.:W-ZXSN&/K5
MWEQ:W6HS:A)90Z9!&DD,HD(=1@[S)G@#(XQVSF@ TK1K;2/M;PM))->3FXN)
MI,;I'VA<G: !PJC@#IZYJ!O#L)\2RZ\MY=I=R6HM-JE-BQABPP"O4,2<Y_3B
ML^]\5R+J'A864,4ECK<A!E=B'0>2TBX7IV'4_A73)(DJ!XW5U/0J<B@#D[3X
M>:98PZ0EK?ZG"^E+)'!*DRAFCD(+1L=O*Y&>Q'8U8TWP3::/;6T&G:EJ=NMO
M+-)&?.5\"5MS(0RD%<\],YYS72DA5+,0 .23VI(Y$E0/&ZNAZ,IR#0!3TC2;
M71-/6RM PC#O(S,>7=V+,QQQDL2> !Z8%<#>6=U-XIU:6=O&&FSSW $/]E[9
M+>:-454;<595)P<@[<?F3Z93(Y8YEW12*ZYQE3D9H YZP\-S27FDZQJE]=2:
MG8V[PCF,*RN1G> O+$*N2"!D<8%:(T'3QXE.OB(_V@;46A?/&S=NZ>N>_I6@
MLL;NZ)(K,G# ')7ZT"6,L%$B%CG W#)QUH YF[\!Z=<Z]<:M#>ZG9/=[?MEO
M:7)CBNL# +KC.<<94@U;_P"$4M5U34[^.\NXY=1MTMI54Q[51 0H4;.,;F]>
MM;9EC618VD4.W*J3R?H*4RQJVUG4,2!@GGGI_(T 4M$TF'0M&M-*MI99+>UC
M$41E(+!0, $@#.!7GL=C>RZKJ+R/XSTR_N+R23R+'8]LW.$97=67E54G)&#D
M8 %>G+-$TC1K(A=?O*&&1]16%X8UVZUN76X[NWAA;3]2>S41,6#*J(P)) Y^
M;T% %&7P+%?7EMJ]SJ>HV6L-;1PW\NFW'DK=E1_&,>N<$8('>M)/"]I#KR:O
M;W-S#-'9"PCC0IY:1 Y  *DY!YR3^G%:6I7\.EZ7=ZA<9\FUA>9\==JJ2<?@
M*R=$U/6+[R;V\AL4TNYLDN4DC<AX7;!\M@>&&#]X8Z=* ,]_AQI#:#8Z4MWJ
M,9T^9Y[.\BF5+B!F)+;6"XP<G((/Z"K<_@NSN+&QMI-0U%FM+Q+[[0TJM++,
MOW6<LISC &  ,#&*Z,2(8_,#KLQG=GC'KFD$L9Z.I^;;U[^GUH PM1\(6.I:
MTVJ/=7T,TMI]CN$@FV)/%DD!N,Y!8\J1U]*@MO ]A:PZ#%%?:AC1,_92TBL3
M\FSYLKS\IQ@8_/FNC$\)17$L>UCM5MPP3Z"G[ER1D<=>: ,[7M$M/$>B7.DW
MWF"WN -S1-M=2&#*0>Q! /X5FV_@NPAU.XU":[U"[GNK,6=Q]HGRLR#=RP '
M.&(XP.^,\U)XFUZZT2;1!;P0RQ:AJ45E(SN<H'R<J!U^Z>_YUNF:-95B,B"1
MAD(6&3^% '+6/@"PL9M'E.I:K<-H^Y;/SKA<(A79LP%&0%X]?4G PMQX TRX
MTW5=.-YJ*6FI7)NI8DF7".SAVVY4X!8 ]_; )%=73'ECC95>15+G"ACC)]J
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M:[W)AD+%0>3TY(_&L33=2TNQ\,_#X275M:Z/);;+Z=$1HTN_)3R_-R" ?O\
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M([&O0XK2V@??%;Q1ML$>40 [1T'T'I26MC:6*,EI:P6ZNVYA#&$#'U..] '
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MP,CH>_6N_.G6+6J6IL[<V\?W(C$NQ?H,8%#:=9.8B]G;L8@!&3$IV = ..*
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MHG,8W@>F[KB@"Q7D-QHV@ZE;?$:758(9+FWOY&@=C^\A8V\>QH^X8L !C[Q
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M;44 9)R3Q[TES:V]Y T%U!%/"WWHY4#*?J#0!YG:^"=/U6[\<:!:P1Q:%/Y
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ME10^==SI)()%D<D/\[')W# &1CTZ4 =);^);&ZTS2M0@6>2#5&5;;:G+;E+
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M.[=N4]L8[],]90!RFA^-[?4M%O=5OK::QM[>[DMU\Q,EBLAC51@G+EAC [D
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M505*=LY(SGL>V.;/B;7M6TO7-"T[3;:SD_M.66$O<,PV,L3.#@=N.?7IQUH
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M=PPD*ISGJ3VQ5KQ;XD7PU:V4\K)!;3W(AFO)8FDCM@58AF"D'!8!<Y &[)H
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M&[G&SMCK0!TM%<-IGCBXU72M V11PW^J6#7SE;>2X2)5*K]Q/F.2X[@#!YZ
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MAV#,J;B=H) .!Z#T%<\_B3Q+>^)YM'TVPTZ$I86]\/MKON4.[*R-M'##:>G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ K!\5^&O^$ETZWCBO9+&]L[E+NSNXU#&*5<@$J?O @D$=
M\UO44 <IJ/A34]9\)ZEI.I:XLMWJ$0ADN5M=L<:>B1ANO)Y+$\^@ $=[X-OK
MO5I[U-;6(7>F#3[E/LF[@;L-&2WR9W'(.[/ZCKZ* .0@\'W\7A^VT6;5+2\L
MX]/2QEANK'<C[!A7 #C!QC/7..HXPVZ\#R3Z!_8'V^&;2?[/BLA%>6WFNC("
M/-5MP ;!';@J"*[&L?Q3X@3POX?N-7EM)KF.#;N2(J",D#)R1QDCID^U %.W
M\+2VOBJTUB+4%,5MIG]G+!)"68KN5MQ?=R<J.WK52U\&WD'A_P 1:4VK0O\
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M7<4*HS>=%-#YJ3H5(VD;ACL<^U)X?UB/Q!X?L-7BB:*.\A698W.2H(S@UI4
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MF42D8##)+ <\#'85MMX?N7\9VOB%K^+]S8M9M;BW/S!F5BP;?QRHXP>*WZ*
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MI&6(880<<=3^&AIWAK5(O%D?B#4=7M[B86'V)XH+,Q*PW[]PR[$'/^17444
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M\HEBW9!1L$9!'L2,=#5>Y\,:->7LUW-9#S9T$<^R1D6=1T$BJ0K@#CY@>.*
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M/M#[23YP.5S@CT!&!VQ7=UF3^']*N=5.J2VB_;C#Y/GJS*VSGC@]1DX/49-
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M\OR0RPJ9'=80>HC5B0@/HH%26&A:=IEY=7=G T<]VV^=C*[>8V,9()(SCC-
M#?$G_(K:O_UY3?\ H!K"\'W=G8?"/1;O4'1+.+2(GF:3[NP1C.:ZB]LH-1LY
M;2Z0O!*I21 Y7<IX()!!P:RH?!OA^&""W&G+);P8\F":1Y8H\=-J,2HQVXH
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M\S!Y9'=G=R  "S,23@  9/% '.^.[BXM/^$<EMKFX@9]<M89/*E9 \;,0RL
M<,#Z&N=UR]O8YOB9'#J5[&++38+BW"7+_N)#%*Q*<_+D@9 QTKT+5M(L-<L&
ML=2MEN+=F5MI)!# Y!!!!!!'4&LX>"_#H2\4:9&/MD0AN2';,J#LQSD]3GUR
M<YS0!RL,MUHOBCPY-%>ZA=#4=(N9;J&>Y:197C2)E*J3M4_,1\H'6LBX?^V?
M O@[Q#/>3S7MWK-C-,PG;R]S3#*;,[0%/ P.-ON<^E+X<TI+NQNQ;OY]A&8[
M9S,Y,2G@@9;H<#/K@>E43X"\+EW8Z1%M><7)CWOY8E!SN"9VJ<^@&: .8=M3
M\4_\)&8-:&F7FFZB\4<OGR#[*D>"I,8(5E902=V<[CZ#%FPL9]7^(?B"WN-7
MU1;>T33[F**&Z=$#D.S#&?NG'*]#GGH,='>>"_#E_K2:Q=:1;R7Z!1YO(W;?
MN[@#AL8&,@]!5ZWT33[75KG5(8&6]N@%FE\UCO ^Z""<<9...,\4 798UFB>
M)MVUU*G:Q4X/H1R/J*\8L[1(_@QH9BEF5Y=8MP296?;B](!4,2!^ Y[YKVJL
M'_A"_#PM6M5TU$@:X%R421U'F [@W!XP22!T!)(H XO5=4OO"=]XUCL;R\EB
MMM,MKR$7,SSF&1VD5W7>2<8 ;'3CI72:1IMW;^(+748M;1].N[4K]D\^2<3M
MPRRJSL<$#@D<'(]JVU\/Z6NH7-\;7?<W,0@G>21G$D8SA6!)!')XQW/K4&A>
M$=!\-/*^CZ;%:M*,,5+,<9S@9)P,]A@4 ;5%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<O\0]
M:O\ PYX)U#6=-DC6YM%5E65-Z-EU4@C@]#ZUU%<3\6U>;X9ZQ;0QR2W$R(L4
M4:%V<^8IX Y/'- $OB+5/$GA?17UL2VFJV=JHDO+?[.89?+_ (FC8,1D#G!'
M('6MQ_$NCQ:9;:C+?1QVUS +B)FZF,@'=CJ  1D]!FN=\7:M)K/A.\T30;2Y
MO;_4K=K53Y#I%"KC:SR.P 4 $G'4GH*P3;0>"M>M['68]3ET>71[6QM[RS69
ME5X=X9'6+GYM^1Q0!U>J:W=Q^,?"EM97D+Z9J8N#($4-Y@6(NI#^G0\?G6PN
MOZ2]^MBNH0&X:1HE3=]YU&60'H6'=1R*XIK.UTSQ%X MK&PGL[*V^V;89-[F
M!'B(3>3G:23T)X/':L.6]>Y&A2C3KZT:T\2F2?3X+&39;@F7YRVTEV;<&R#C
MYN * /3&\4Z"EI<W;ZM:+;6LODSRF0!8I/[K'L?8^HJV^JV$<R0R7<22/";A
M5=L?NQU;GL,C)[9KA=:\.7=UXJU?1(H7&D>);59[F=1Q;R1823';+J8AZ\$]
MJ+!]7E^'NK:EK.CM>ZE%8O8&R8$_:!$&5S@<_.^X\=0%QVH [.W\1:/="8Q:
MC;_N8A-)N?;MC/1^<?*<'#=/>HK3Q7X?OFD6UUFRE,4 N'VS [8ST8^W^(]:
MX;2;Q3X[AOV:^FM9O#K1"=[%XHE82ABBC:-J@=,D^F2:JV5E=1?!;P]+::=<
M23Z?);37EI"A2=TCDW.H'!W9^;ZC- 'IVGZOI^J-.ME=QS/ P69 <-&2,@,I
MY&1R,]:QM7\073>*K3POI'E+?26YO+JXE7<MO &V@A<C<S-P.<#J<]#!X4;0
M]2U.[UK1[34-\T*13W=YYRE]IX0++UV\Y(&!G&3SC.U:SNO#WQ/A\5"WFN-*
MO;#[!>-#&9&MF5MRR%1R4/0D#CJ: .D$&N6NIV*K>I>6#NPN?-A594^1BI!7
M QN &-N>1SUJS+KVDPZA'8RW\"7,DGE(C-C+XSLSTW8YV]?:N/U@V^N?$CPC
M<:8/M=M!]J:^EA4M&H\H>7YA'&=W0'G-8^BK831-X9\0Z7J\VLV^H231Q@SB
M&<F9I$G5U.Q5^;))QR#P3Q0!WT_C'PU;%A-KE@NV;R&S.O$G'RGTQN&?3(S5
MS4=:TW2%W7]Y%;C:7.\]%'5CZ*.Y/ KS'4HED\.?$]%MW::[N&\@"$[IAY**
MNWCYAN#=.^:N7-];:=XHN)==@U232M6TZVCMKFT6=EW(&#PNL?.26R,CN: .
MYOO%?A_3?^/S6;&$^3]HPTZY\O@!^O0Y&#WS4C>)-&2X2!M2M][ND:_/E=SC
M**6Z!F!! )R<C%<7:6%E9^//#-M#ILEO90:-<01Q3*TGD[GCV(S'.&*AN"?4
M<UB^*+E[BR\06T>GWEI);ZU;RFUMK)V$Z++#_I#/M.[(7@*1@+T/6@#O+75=
M0;XDZAH\LZ-8QZ9#=11B, JS2.IR>IX3]:=XG\1S:5?:1H^G1QR:MJ\S1V_F
MY*1(B[I)& ()"CMD9)ZBLZQE$OQ<OIPDJQ2:);QJSQLHWB61BN2/O ,"1UYJ
M+QMI]W:^*O#7BVUM9KN'2GFBO(($+R"*5-N]5'+;3R0.<4 ;L\'B"S:T>WU"
M.]C:XC6Z2:W"L(RP#&,KC&/1L\9Y];D^OZ3;7@M9M0@CF,@BPS8 <]$)Z!CD
M8!Y.:BM/$-AJ31KIKM=LQ&[8C 1CN6)'RG'8\G^7G0@N&^'/B/PG?VTTFO27
M-R(HS&2;IY)2\4RG&"N67+?P[><8H ]#O?%?A_3;B2WO-9L8)HF19$>904+'
M"@CL3@_E43>-/#"SP0'7].\R>0Q1 7"G>X."!SZ\?7BN>T>V"_$^^2\7SY!H
MMK 9WC)621'<N Q&,_=./IZ5S*PV>J>!O&^BQVXFU.[UJ]2" 1_.\AE^1AQT
M4\ENBX.<4 >JZAK>F:6Q6^O88"$\Q@Q^ZG3<W]U?<\5%?>)-$TPQB]U:S@,D
M1F0/,H+(!DL.>1CO7):0\GA_Q=XB@\0;WAOX+9[6Y:-G2=4BV/&, _,&R=O4
M[\@<UB:%I5SI%S\-['5(9#+:Q7ID#H6^SB1?W:L>0I (7GN,4 >BMXIT)$B<
MZK:^7(D;JX?*A9/N$MT4-VSC/:HF\5Z8OBI_#YF NH[?SY"W &3@+[GJ?;%>
M=^.9'N++QKIMOIUU:S".$Q16MFS?;55$_>,^TC:N-H (QMYSG Z>*Z$?Q56]
M>"Z6VO-#BCAD-NX!99G9@QQ\I 8'YL=: -[2-5MO[%FOI]>M=0MEGD_TQ J1
MJ-Y 3(."5X7/<BK"^(=':SNKLZE;)!:'%PTD@3R3C.'!P5X]:\PM(KV/PSI]
M[%;7$EMI_BF:\O(%B;?Y!EDVR!<98#<K<#MGM6KK]N;_ %;Q5K=@&?3I?#3V
M3.B'%S<$N5"C^(A2!D?W@/44 =S9>)-$U&_^PV>J6L]WY0F\F.0%MG'./Q'T
MS63\1=;U#PWX*OM9TR2);FU,>%ECWHP:14.1D'^+UKGK4(FL_#8QQ,JP6,\<
MI$9 B+0(H#<?*2P(P>XK2^+P>7X::I;0QR37$QA$<42%W?$R$X YX )H [6!
M)(X4664RR ?,^T+D_0=*HIK^DR7ZV*:A ;AW:-$W?>=?O*#T+#G('(Q53_A*
M].FGMK>S%Q<3W$JHJBVD4*/XF9BN  ,GGTQWKSDWKW(\.S#3KZT-IXC9I]/@
ML7\NU!\X9+;<NS%@20<?-T% 'IC>*=!2SN+QM6M%MK>7R)I3( L<G]UCV/L?
M6KPU"T:[CM!<)]HEB\Y(L_,R?WL>G(_.N!UKPW=W7B?6=!BB=='\26ZW,]PH
MXMY8\))CW<>3_P"/'M6MX/N=1_X1^76_$-O+'>P0?9I$"EF*P;@[A1R2S[SQ
MU&V@#L:*KV-Y%J.GV][")!%<1K*@D0HP##(R#R#STJQ0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (<X."
M>V:QO#F@?\(_#?1B[:X%W>2WC%D"E7D;<P&.V>G\S6U10 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-7 /;(S0!+16/?>(([#Q+I6BO:S,^I+*T<X*[%\M=Q!YSGIVQSUK8H ****
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MKP,T#L<.>1DJ"0#@'.#7I&K:18:[ITFGZG;+<6LA!9&)'(.001@@@CJ*S/\
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M7P=I$<@W(]A"&'J/+%<!X(\7-X>\"Z"+W2+S^RI)FMWU(.A2-WF<*2N=VW)
M+8Z^M 'J]%<[:^*TEO=?M+FT-I+HR"27S91B1"I977'\) //8@C'%:]M>M)I
M4=]<V[VQ:'S7A8[FCXS@X[CVH MT5S%IXLGU#2/[2L]-6:VEL7O+>1+D%6QM
M_=N0/D;YN1SC!ZXJKH'BK4KWPQX>N;C36FO]5B5E9&Q$/W>\N[ '8.H P3G%
M '8T5P6H>/+F?P_I.H:38C==ZQ'ITZRRC]V1-L< C(;=M(!]#GVK<B\3L^IZ
MMIK6#+=:;:Q73#S05=7#8 ..HV'M0!T-%<,WC6^OM0\'G3=/'V/6X9+EO,E
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MX!Y8J?Q-2C2-7MO'EUK=O#:R6EWI\4$BO,5>-XV=L ;2"#O SD8P>#T/4T4
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M.3@X'X5Q,'@_6;;0?![Q?91J_AO">7YI\JXC,?ER -MRI(Y!(X(_&O0:* .
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MF.1 !N)7"\Y'?/:NZHH I:>^I/)>#48+:)%N&%J89"Q>' P6R!ALYX%7:**
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6[F6)T8^8[ #ORV>^3[U=,FF37?B#PSXHAU5[J[U&2XMK:)9=M[$S!HBC*,
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M3:SIBV$%\=0MOLEQCR9A*"LF1D;3_%T/2L'Q=XDFL_"4>LZ%>VLL;75O'Y@
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ME^,.;<QB)M 6,&/&TD3$A<CC.TYQZ>U ';T444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445GZM
MJ\&D16YD1Y)KF=;>WA3&Z21LD#G@  $D]@#0!H45YOX_U5]1\":Y'<:?=V5U
MIUU;*2<E)-TL9W1L,;P58@\<'(Q71P^+T_M34M/OM+O+.:RL_MZJVV0S0989
M4(3\V5(V]>10!TM%<YIWBL7FL)I<^G36]U-IXU"%"ZL6CR%*MTVN"PXZ<]>*
MQ=,\7Z5I7A+2KS3]$OH[._U)[..!65GCE:9U);+'JP8\9].* .]HKDD\:77]
MIVNES>&M1AU"YMYIXX7DA((C<+C<'('4')QQTR>*K)\1HVTF+5'T2_CLUN_L
M=[(S1_Z++YOE$$;LN Q&2O&#ZY  .VHKE];\:1:)_:,TNG7+V6FO"EU/PO,F
M,>6#]_ 89Y'MDTM]XNDM]?O-%M=#O;N\MK1;L!'C59$9F&02W'*D<\^V.: .
MGHK/T+6+;Q!H5EJ]H'$%W"LJ*XPRY['W'2K=S<1VEI-<S$B*%&D<@9P ,F@"
M6BN1N]:.N^%KUOL;I:76ERW,-S'.&4C;PI*]&Y!(Z>YYK/\ !?B<P:1X/T>Z
MTZZB2_TR-;:[=E*R/'"K,-N=PX!()'.* .^HKEX_&D37NFQRZ=<P6VI7<MG;
M2R8#&1-W+(>0IV-@\]L@9KFC @_X6E"#)L4!E_>-E3]D5N#G/4YH ]-JG_9L
M*ZJ=1B)CGDC$<P'251G;D>HR<'W(^E+P@<^"M!)Z_P!G6_\ Z+6N:NKV'2/B
MOJ-RY<@Z#$RQ!B3)(9W 51_>.  !0!WU4[73HK:\N;TDR75QM5Y6ZA%SM0>B
MC)./4D]ZR[WQ2FGBT@N[>.WU"ZC:5+:>Y1 BKC)9\X'+ 8&<D^@)%"R^(>DW
M^DVEW#A)[J:6!8+B5(]CQ_?W/G;M''(SG<,#F@#KZ*XB/XEZ?+I]O<QZ=>2O
M)J9TJ2.$H_ES]<9#?,I'((R#WQ6KX?\ %:ZSJFH:3=:;<Z9J=B$>2VN&1MT;
M9VNK*2".,'T- '145B^)O$<7AFQM[J:SN;E)KF*V_<;259V"@D$@GD]@:H2>
M,A ([>[TXV.HR"1UM;NZBCQ&C;=Q<,1\V1@#/?L,T 7].T*>VU>XU&^U:YU!
MV9Q:QRHB+:QN02J[0-W0#+9.![G.U7*:=X]T[5['1Y;"&5[G59)8H+>0A2C1
M F3>PR %QU&<Y&.M0'XA0+I=[?OI%ZD=C?KIUSN>/B4N$.W#$D LIR0.",9Y
MP =E16')K,-WK]_X;EMI5DCLENC('^5XV9EP,'(.5-<WX#UB2S^'OA*VCM)K
MNZO;=@IR0B[06+.^#M]!U))^M 'H%%<<?B%:'0]*U./3+V5=0OO[/$:;"8Y@
M[(0?FY&4.",CIG%=+I5Y<7^G1W%WI\UA.Q8-;3,K,F&(ZJ2#G&>O>@"Y17*W
MGC.2'4]9TZUT*^NKC2HHYI 'C571PQRI+>B].I/;O3;/QW!>7.AD:9>16&M+
MBTO)"@!?RRX4J#N' (SCJ/3!H ZRBN$B\6Z7HF@^)-9M]$O8TM-5>*\B#JSO
M,1&#)]\@+\RC"YZ=*UH?%K/K%[I4VD75M=06?VZ%973]_%NVDC:3M.>Q]10!
MTM%<Q;^-;:XL_#5VMG.(->8) 25S$Q1G 89]%/3-4=(\:SM!XCO=8M/LMGIN
MH/:QE9%;H(U5.V69FSGI\V,\9H [6BN-'Q&TN*YU.VO$$<MA9?;R8)DF22'.
MTX93@,#@$''4'..:Z'3=2FOII8Y;/RE2..1)DE$D<JON^ZPZXV\\=Q]: -&B
MLW5M9@TG[)&R-+=7LP@MH$(!D?!8\GH JDD^@[G .6/%;2KK5FMB\6KZ9&)'
MMF=2'1@2LB-T9>#Z'(((H Z:L_7-*37-&N=->XGMEG 'FP, ZD$$8R"#TY!&
M",BN6^'NFPWNA:+XCN;1X]5DL$$ESYO-T' 8LX!^8YZ;N1FM;5[W3XO&GAVT
MN=.GEO9A<&SN@X"18CRX(W9)(P.1CGK0!/9:)?B6)]7UJ345A</&GV=(5W#H
MS;>21VY ]NF-RN'TOQS<?V=KVHZQ9"WMK'4VLH\2J0I#)&JD]OF;)8\#)]*Z
MK3KZ>\-PMQ9M;-#($!WATE!4-N0CJ.<<@<@T 7J*P=>\3KH6IZ98?V;>7<VH
MM(D/D;,;E0MM.6&"<=>@ZDC%8K_$JVM]$U:]N]'OX+O2;B."]LB4+Q%R C9#
M893D<C)]J .XHKG$\4RFYALI='N;?4;F:5+:VFD3]Y&B@F4LI(5?F [G)QBF
M0^-[![6Z\V">&_M;Q+"2Q.TR&9\; IS@JP((;(&,DXP: .FK#U/0)=0\2Z/K
M"WJQ?V9YNV$P[O,\Q=K9.X8X'''YU _BZ*RCU,ZK87%DU@\2%FP8YS+@)Y;G
M /)VG.,'KQS5.#XAZ4+G5+:\VPRZ?;K=,8IEF26-CM&U@?O;L*0<<D=N: .O
MHKDK?X@Z4=3O+&],=LUM9-?F5)TFC,*G#?,IX8=U]^":Q]3O[B_^('@6YETZ
M>UCG:Z>,O*#E?L[$*Z@X5N<]_KVH ]%HKA(?%VEZ)H/B+6+?1+V-+75GAO(M
MZL[3'RU,GWR I+*,+GZ5LVGBR.37+W2[_3[C3Y;>T^W*\S(PD@W%2WRDX((Z
M'GF@#HJ*Y.'QS'++H6-)NVAUU2UBZ/'G 7?F0,PV_)\V 6Z$=>*NZ;XF75KB
M,VEFTMF]S-:FX2128WCW9WKU4$H0/J,XS0!OT55U*^CTS3+J_E262.VB:5DB
M3<[!1G"CN>*Q;?Q;OU*YTVXTR>.]AL%U!8DD5B\9)&,D@!P1R#QSU- '245Q
MVF>/XM1;096TB]M[+6AMMKF1DQYFPN%*@[AD*><=1Z<UB?$G7!JWP\UY[&SE
MFL[>3[.;M90O[Q9 K%5_B4'*D^H. 0,T >F445R5GXY%Y>7L8T6^BM-/NY;:
M]NY&C"6^R,.7.&)(.>V<<9ZXH ZVBN0M?B!87.L6&G_9R6U&)Y+,Q3QR%BJ[
MBC@-\C$<C)QVR#5.W^)UO-8Z9J<NAZE;Z1?S"W^W2>7MBD+E5#*&W8R/O8P"
M>IH [NBN:OO%\=M!JEU;6$]Y9Z3(8[V6)E!4JH9PBG[^T'GIW R1BJ]YXZ1-
M3AL-,T>]U22XT[^T;=[=HPDT6Y1P688^]GG'8#.: .MHKEO#7B+4M9\0:_:7
M6G_9X+"Y6"/]XK%?W:M\V.I.[/' Z5)XWUZ]\/:%%=6%L)I9;N"W)9@-@>15
MSSU/.!]<]J .EHKSRXN[JS^*\D]OIEQ<W4OA]7-JDRC#>>0<LQ"C@ <>U;4/
MCO3+K1=)OX<(^J(SP0W$JQ;=G#[F)P,' XSR1@4 =316+X8\36GBG39KNU1H
MVM[A[6>-B&V2)U 8$AAR"".H(I-2\1+9ZL=*MK8W5\+4W9@$JHS1@D83/WFR
M#QP/4C(H VZ*YG5?%_\ 9D5W*NEW,L=E8K?W+$A J'=\JD\,^%;CCMSS23>,
MD.L6FF66E7EW-=Z>;^W9615=,J,9+<??&<X]LT =/17$Q?$6*32[34VT6_CL
M9+L6=U*[1_Z-*9/*P1NRP#8R1QS]0+&N?$'3=$^W.4$\6GR*EWLG19%) )V(
M3E\!@3T]!D@@ '744R&:.X@CFB8/'(H=&'<$9!KC-)\;S&R\1ZCK-H;:TTW4
M)+9-CJY^4(JH .K,S?3+8S0!VU%84'B0+X@@T34;*2RN[J%IK4EPZ3!<;U!'
M1U!!(Z8/!-.\7ZQ<^'_".J:M:6ZSSVMN\JHS;0,#.3[#KCO0!MT5YQJMY=?\
M)AX&OY+*=[N6"\!@CD4F0^4N#U"CJ3GC&:W;;QU8RZ*U[<P/:7"WSZ<UK-(@
M(N%)RN_.W& 6SGH/7B@#JJ*P/#GBNT\17>I642".[TZ1$G59%D0AQE&1UX8$
M ^A!!!%8/Q598=&T>?=*G_$XM8W:$L&:-GPR_+R01V[T =[17FIU*"/XGZ'I
M_AVYNH4>*9]2M;@R1Q-$%^0JDF,ON[H.G7BNBO?&UO:V-]JD=E/<:383M!<W
M4;#*E3M=E3JRJ<@GKP< XH ZBBN8UCQG%I<6H7,=A/<VFGVL=W<3J0JM&^2/
M+)X<X4DC([<Y.*9J7C0VFL)I=EHE_J%S+8&^A\EHU61 RC +,,'YN^/09S0!
MU5%>?>.M=_M+P/XIBLK&::*RMI89YEE">7,$R0H!^;9D;N<=0-Q!%=IHW_(#
MT_\ Z]H__010!=HKF[[Q=';Q:K<6EA/>VFDN4O9(F4%650SA%/WRJD$]/09.
M16+XDUF34M?\(VUI:B_TC4O.N"F]=ETH@+*"&[#<&P>X'<4 =]15#2M'L]&T
MJ/3;-'6TCW;(Y'+[0Q)VY)/ S@#L.*X7P-HUIJR>*A>-=,T.OW=O"ZW<J-%&
MNW:JE6&T#)QB@#TFBO*(?$36.A>-]"\2QW6MVNA.JLX<++-;2KN4.V5RR@8+
M#D^E==J7B]M-UB/1K30KZ^NFL&O(5A:,*ZJRJ5!9N"-W?'3C.: .IHKC=7^(
MVF:1'<SRQ[[>SF6&ZQ/'YL;' ;;'G+!2V#CT.,XJ_J'BU+==1DL=.N=2BTW;
M]K-M@L"5#;47^-@K*Q''!'.>* .CHKDXO$]]+X]N-(:R\O3X=.CNS*SA3AV8
M;F!Y &PC'7J33AXWMEMM-U&:RFCTC4IEAM[TL.K\1LZ]55NQYZC(&: .JHKE
M(O&K7&LWVGPZ%J#+I]RL%W.6C"PJ4WA_O9(P1P,GU X!OZ'XB.N+:3PV3"RN
M[8W,%RLJNN,J-C8^Z_S=.1P>>* -RBBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N9\::'J.K6F
MG7>C20KJ>EWJ7D"3DB.7"LK(Q'3*L>:Z:B@#B/$6E^)O$W@R]LY[2RMKVYD@
M\NU6Y+I$J2*[%I-HR3MQ@# X]Z75M#U^[\4ZAJNG&*T:;0FL+>9Y,M%/O9PQ
M !^49 SSSVKMJSQK=@=?.AB5O[0%N;KRS&P'EA@N[=C!Y('!H X_1/#FN67B
MG3=8ETVPMXX]+DM+E([II)&D+HV\L5&\L5[GW)/2JMOX2U^'PGHFFFVMC<V.
MN?VC+BX^4QB=Y< X^]A\=,<=:]*HH YB]TK49?'^F:S' ALK:QFMY,R /ND9
M",#T&SU[USLWA'7I? NK:,+:V%W=ZNU]&3/\@C-R)L$XSG QTZUZ310!YIXH
M\*>)=>B\26[6]C<+>K&VGSSW!#6R@+NB";2 2P;+ \YYS@"MZ#2]87QQ>:Y-
M:0>3-I45H$CGR1(KNYZ@?+\^,]>.E=;10!PGAZ/7_"6@^%=#DL;28 FVO&6X
M)91U5HQCYA@DG.,!:[2\$[6-P+79]H,;"+?]W?CC/MFIMHW;L#<!C/>EH \\
ML_!MW97.IW.EV":7!>Z=)#/IT=SN@DNFQB1!T0 ;@3@$Y^[QS-:>&M9@7P(K
MV\'_ !(HBEV1-][]P8LIQSR<\XXKO:"0 23@"@#S*+PIXJ=]&GN[;39[^PU9
MKF>]>Z;?=1D2 '[GR!0XPF2..,5JGP]J_F>.&^SPXUM0+3]]T(@$7S\<<C/&
M>*[BB@#,\.6EQI_AG2[&[14N+6UB@D"MN&Y5"D@^G%<AXH\%:AKWB^XU:(+;
MF'3DCT^Z24>9#=1R.ZMC&-IW;2,\@GBNRTG6[#6UNVL)6D%I<-:S;HV0K(H!
M*X8 \;A6A0!PE[IWC WVC^([:TT]M7MK9[._L6N"(IXV*MNC?;\I#+GD=\?6
M76=(\4SS:-X@LQ8-K%BTHDL&E(A>&4*&C$FW.X;%.XCDYXQ@5V5Q/':V\D\I
M81QJ68JI8X'L,D_A5?2M4M-:TNVU*PE,MI<H)(G*E=RGH<'D4 <-XPDUDV'A
MB>_M[9;U_$5LR6D4I9(QM?">85&X\$YP!DXZ#-='IFC7#>+K_P 1WD0@DFM(
MK*" ,&98T9G+.1QDLW0$X"CGG U-0T?3]5: WULLYMY!+#N)_=N.C#T8>O6J
MZ>)-+:YU2V6>0RZ4J->+Y#YC# D8X^;A2>,T 4/&VDZAK6E6=OIT43RQ7]O=
M-YLFP;8Y Y&<'DXQ57Q!I?B"#Q/9>)- AM;J06IL[NQN9C$'CW;U97 (# YZ
MCH:Z73=1M=7TRVU&RD,EK<QK+$Y4KN4C(.#R*KZKKMAHR_Z6\A?RGF\N&)I7
M\M<;FVJ"<#(Y]Q0!R/B4:O<7WAV%(;"XU^*2:]\A+HP&*,+L(CD*'(^=0=R_
M-Z 9Q5ETC4=8\)ZSH,6C0Z;JD=S!J!WWHG2YD,PD):0*"&/ED8*\ KCCIT\0
M\,>/M/6Z:S@U*VAE*Q27%L1@X!RA8 X((Y'!K:L=/LM+M5M;"UAMH%.1'"@5
M<^N!WH Y6STSQ WC6ZU^ZL;.*&?24M1 ET6=761V SM /WN3QC/?%96F^%_$
MNG>'_"FG-;V=S;Z<DD5_9/<E8YB1^[?.T[@O)VD=3T.!7>ZEJ5MI-F;N[,@B
M#HG[N-I#EF"CA03U(JWD9QGGTH \RM?!_B*VT/2M/-M8LUCX@.I$QW! :'S7
M?@%>#\^ /;DUZ:.GI110!R"Z+JL?BCQ1J(MHF@U*SA@M_P!\ VZ-7!W#' ._
MWZ5FVWA?6H-%\#V;6\!DT*5'NB)^&"Q-'\G'/WL\XZ5Z#10!YM?>$==N?"GB
MS3$M[87&KZH;RW+3_*J$QGYCC@_NSTSU%;TNC:C<^/?[7>!([%]':P8^:"ZN
MT@?..XXQUZ]JZNB@#S/3O"_BF'3?"%C-::>BZ!= NXNV/GHL;IO'R?+PPXYY
M/;'-JX\&:U<Z?XITU);6!;_4O[3L;L2%F64&)D5DV\ -'R<GKTKT*B@#E+=O
M%^H:3<C4],TF"<0^6MJ)S+'<L2,EB4^12 1CYC\QST%,\(^%W\/ZIJ4MI"]A
MI-RD9BTTS>8L4H+;W7DA5.5X!['@<"MZZUNPL]8L-*GE9;R_W_9T\MB'V*6;
MYL8& .YK0H YGQ9H5[J-UHNJZ8T9OM(NC.D,K;5FC92DB9P<$J>#CJ/>H!H-
M]-JNMZ]);HEY>6"6-M:^:/E5=QR[#C)9^V<!1U)P.MHH P_!VG7FC^$-*TN_
MC1+FRMH[=S&^Y6*J!D'TX]*K:WI.H7GC/PWJ=O%&UIIQN#.6DPW[Q-@VC'..
MIZ5TM% '#6GA_6K&T\1V;:?IM[:W^IO=QI-*2)HI'0NC*5PI"AN><G%:'@SP
MY+X<_M**/S;?2YIE>RL))O--L-N' .3@%N0H) _' ZFB@#B/&DDT7C+P2]O"
M)I!>W'[LOMW#[.^<$]\9Q_,=:I:]X.U75-,\37$$,"ZCK<UKLA>7"Q10%2NY
M@#ECACQD#(&3C-=M>:/I]_>VUY=6RRW%J28)"3F(GJ5YX)'%7J .5UO1=1F\
M2:)XDT^-'N+*.6"YLY)-OF12 9VMTW*R@\\'U%8NJ^!]4OO[3UJUEM[?7)]2
MMM1MHG8M$OD)L2-R!_$"^2.A;'.,GT2B@#B]6TCQ+XH\-3K="STK4HY8;BQB
MCF,Z)+$X<,[[1D$@# ' YYZ!+[2O$_BSPO?V&KQV6D7#QJ(!;3&<&975UD8E
M1A=RCY1G@G)Z5TMQK=A:ZU9Z1-*RWMXKM GEMAP@RWS8QP,<9SR*T* .)N=*
M\4>+?"^HZ1X@AL--\^T: -:3&;S9#C#X*C:H(^[DDYZC'->/2O%E_JOA2[U#
M3]/B;2'E%RZ7A82[HC'N0;..N<'Z<=:[ZB@#S:]\(Z]<^%?%6FI;6PN-5U;[
M;;EI_E6,M&<,<<']V>!GJ.:UM3M;FS\777B>]BMXM)AT-[:9II,E6#^825 Y
M7'''/M79TV2-)HGBE17C<%61AD,#U!'<4 >7>';?6-&AT"74_#D,MM:!(;:>
M'5A*+?S<*3'&4&>N,%F(7(!]=>V\)WG_  E=EK<5G%I=\L[G49[6?]U?0X8*
M&C'5R2I)(&,'D\5TFF^%/#^CW/VC3M&LK6;G#Q0JI7/7'I^%;% &7XCM=2O?
M#FH6VCW2VNHRP,MO,W 1R.#GM]>W6N2T_P .:Y:^)1JRZ5IUM#)HYLY(8KLN
MXEW[MQ8H-Q.>2?KDFO0:S[#6[#4M0O[&UE9KBP=4N4:-EV,PR.H&<CG(XYH
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MV;2Q4J=V5)QM)'!'6ET?P_#HU_JEY%=W,SZE.+B99=FU7VA?EVJ"!A0.<]*
M,7Q+J&NKXQT;1M+U&"SAU&UNF:1K82-&T83#<GG[_3C\>E58=:UJ*?QE8SZB
M)9=(LH)K><0(IWM"SMD8Q@LO3L.,]ZZ.]\/17WB33=;>\NHY]/21(HDV>6PD
MQNW94DYVCN.E4=1\&6]_JNHWR:E?VHU*V%O>00,@28*&"L25+ @,?ND9XS0!
M@&^FU/6OAAJ%R09[J"::0J, LUGDX';DU-;Z]XFUNS@UC18)'A-\\;6\GD"!
MK=)61OF+>8),+G/3/&,<UM0^"[6!_#S)J-^?[!C,=J&,9W*4\L[_ ).?EXXQ
M^=06W@*SLM7N;JUU/4X;&YG-Q-I:3#[,\A.2<8W $\E0<'OQQ0!1B\4W(\8G
M1]1O)M,NFO66VMYX%\B\MQT,4F/O]"06ZY&/3>\8Z^?"_A+4=96)97MHQL1C
MP79@JY]LL,^U1R>%()YXC=7UU<V\-^=0B@EV8CEW%AA@H;:&8D#/MG'%:FJZ
M99ZUI5SIM_")K2YC,<J'C(/OV/O0!S=[J>KZ#XHT.PGO1?6NK^; 6DA53!.J
M%U9=N,H<$$')''S5'X#O?$.N:?!J^I:K ]N7NH&M8[0+N*3LBONSD8"D8],=
M^:UK+PNEM-937.HWE]+81-%:/<;,Q;AM+?*HW-@8R<\9]3F?PYX?A\,Z5_9U
MM=7-Q")9)5-QL+ NQ=ONJ.-S$_C0!E>*]4UFS\0>'+#3+JW@CU*XEAE,L&\C
M;"[@CD=,=._KBN6U'Q9XIT;2/%ME-?6T^HZ)):O#>FV"B:*<\ J#@,,$9Y^E
M;WC6"XN?%/A#R!>H(+V626XMK=I!"#"Z@L=I4 L0.?7\:T-0\#V6IZ3J=E<W
MMYYFIRI+=W2%!(^S&Q1E2 HVC  ]>Y)(!3EU#6;+Q)IWAVYU9)I]2:XNOM,=
MJL9@AC5<1J"6!.YOO'/ /&>:SG\::GI][J>@W31RW]OJEI8V]ZT8"M'<C<KL
MHP-R@,., D#@9KJM6\-P:M+IUT]U<0ZAISE[:\BVAQN&'!!&TJPZC'TQ52]\
M#Z5J6DZA97K7$LM_,MQ/=A@LWFH $92  NT*  !CCG.3D IZOJ>N>%K+4KFZ
MNH;ZVDEMH=/9U43*\CK&WF !4*@L".G<$CK5+5/$7B+PK::UJ>H6\EQI-O9"
M6V>Z,*RBXW!?+(B."AW*<XR.>O%;'_"%6=UH5[I>KWU]JPO(Q'+/=R#>%4Y7
M;M "X/.<9)ZYIMMX'M/[(N].U;4M1UF*Y@-N6OY0S)&<<+M YR =QR<@<\4
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M(JD)SR"''WL]*S]'\8ZM?V6C:=,7DU&ZGOHIKBU2-69;:39E5<[0S94GKT;
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M<5Z#X@\.P^($LB]W=6EQ8W*W-O<6Q7<C@%>C!E((8C!%93_#[3I-,UNPDO\
M47AU>=;F4M*I,<HV'>AV]<QJ><CC  '% '4P1O% B23-,ZCF1P 6^H  _2N(
MTOQ/=77BD:-J-[/INI?:)Q]AGMU$=Q  _EO!)M^8XV,<D_Q<"NUM8&MK:.%I
MY9V48,LI&YSW)P /R 'H*Q8_"D'VBQDN;ZZNX["X:YM8YMG[MV##[P4$@!S@
M9],YP* .63Q7K1\#66K&[4W7]M_89#Y2XDB^U&'D8X.WN,<UKC4M<\0MK_\
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M-K$\_9F@4Q_]\XQ3Y-*TZ73AITEA:O8A0OV9H5,>!T&W&,5SEQ\0--,WA_\
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MU<V-M-<09\F62)6>//7:2,C\*CDT32IM.73I=,LGL5QMMF@4QC'3"XQ6)/\
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M)&DT<ENXCE2:,H58J&[]1@CD9%9 \3)=^+[WPTD%W"T%JDAN5A/WG+ $'!
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MW]GIUN;B^NH+:$=9)I B^O4_2J\VO:/;Q6\LVJV,<=R 8'>X0"4'IM.><^U
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MYN?E(/.,UZO10!YO>V]Y8^,-2O+_ ,(W.L:=K,4+1^2D4CVTBH$:.0,P 4@
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M<0^428XUN&D+>A^4@\'V]:MZ_H&JZSK'C)+.UD3[=86BVDLJ%8Y9(6=F0D]
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MX:,@.%@$;$?1AWQGJ*R/!]C<1VVEZ-JG@KR=1TO8C:D\<;6^$&!+&^=Q=@.
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M6MLEO!>0P);N^9KB)V13,N#\H#.1@CG:>1D5"G@._3PC9Z$-5MB;;4A?^?\
M9F^;$YFV[=_J<9STIFI> =5OK?7;5-<MT@U.]COE,EH7D1T9"$+;QE!Y8P,
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M.F:E*J$1VLP>WC8$I*SD;&7ID#&,\%L5VU<;X<\):UX?,6FIX@67P_;2;[:
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M% !1110 4444 %%%% !2,BNI5U#*>H(R*6B@!J1I&NV-%1?11BG444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6?JVBV&
MN6\4&HPO+%%*LR*LKIAU.5/RD=#R*T** ,H>&]*_M&[OVM3)<7< M[@R2NZR
M1C.%*DE2.3V[GUJMHG@OP_X=$PTS3Q$)4,;!Y'E 0\E5#D[5/<# -;U% &%H
M?@W0/#D[S:58"!F! !E=P@)R0@8D(">H7%,TGP1X=T+4GO\ 3=-6WG9F8 2.
M40MU*(3M0G_9 XXKH** ,2V\):-:PQPQVTC110-;Q)+<22"*-AAE3<QVY QQ
MVXI1X3T4V\D$MHUQ');&T(N)Y)<0G&4!9B0#@=/0>@K:HH Y^V\$>'[.XAN8
M;*1;B& VR3&YE9_+/\)8MDXP,9Z=L4YK.3PIX>AL_#.BF\2)U1+0WFS8A/)#
M29X'I^5;U% &7X?TK^R-,\ITB6XGFDN;GRA\IED8LV/4 G /H!3]6T+3M<6W
M74(7E%M,L\069X]LB\JWRD<CM6C10!E7?AS3+V^COI(IDNTB\CSX;B2)VCZ[
M696!89YYSSS39?#&CRS:;+]D*-I@Q9B*5XUAXP<*I Z<<CI6O10 UT62-D=0
MR,"&4C@CTK!A\$>'[>VL;>&RD2*PE\ZV474O[I\8!'S=@2 #P <"N@HH QF\
M*:(_]J>99>:-5Q]M665W6; P,AB0,  #&,8%+H/A?1_#,+Q:5:F$/@,SRO(Q
M Z#<Y)P,G Z#-;%% &/J'A;1=5U1=2O++S+H0FW+B1U#QDYV.H(#C))PP-56
M\#>'6L=.M%L7B33CFTDBN)$EAR,$"16#X(P,9Z >@KHJ* ,&/P7X>CTZ\L%T
MY3;7DWVB=6D=BTN<[P2<JV0#D$'BJVO>'U3PGKUMI=I-<W]_8R6X:2??)(2C
M*@+R-]T%CQGC)XYKIZ* .=\,^'K>PTO2I;BTFCOK6T6$+<7!E\@[0&"?,RKG
M'\/;CIQ3Y/!7A^6RU"S:P/V;4)#+<Q">0*[$[C@!OE!/) P":WZ* ,JZ\.:9
M>7-K=2Q3+=6T9BBN(KB2.4(>JEU8,PXS@D\\]:9-X7T>:/3XVM"J:=)YMJL<
MSH(WY^;Y2,GD\G/4^IK8HH S['0]/TW4+V^M8G2YOF#W#M,[^80, X8D#  '
M':H[[P]INH:BFHS1S)>+%Y/GP7$D+F/.=A*,,C)S@]#6I10!SFL0:C;65OHF
MA:+;M8SPO!).TRI'9KC /ED$N.3P/3GKFMNQLH--T^VL;5 EO;1+%&H[*HP!
M^0JQ10!GOH>GOKJ:TT3_ -H)"8%E\YP!&3DKMSMQD ].HI-(T'3="CFCTVV\
MA)I#(RAV89)). 2=HR2<# R3QS6C10!D7GAG2K[4)+Z6"1;F:(0S/#/)%YR#
MHKA& 8#)ZYZTZ]\-Z5?O8//;,/[/8-:"*9XEA(& 0%('3CZ<5JT4 5-2TRRU
MC3)]-U"!;BTG39+$Y.&'UZ_CUK*B\$>'XIS<+9/Y[6QM&F:YE+M'SP6+9)Y(
MR><<9Q7044 8D?A+18DTM$MI0NE?\>0^TR_N>-O'S<\<<YXXJKI%KJ.J:TNM
M:UI$.G3VL,EM;1"=9VP[ NY8   A$P.H^;/6NEHH @O;.#4+*:SN59H)D*2*
MKE25/49!!%9TWA;1;CPV/#T]BLVE*@C6WE=GVJ/N@,3N&,#&#QVK8HH P;;P
M;H=GI8T^"UD2#S5FW"YE\S>OW6\S=OX[<\5/+X7T>XT^YLI[,3174@FF,DC,
M[R# #[R=VX!5P0>,#&*UZ* ,R+0-.A@NHA'*YNT$<\LD\C2NH! !<MNP,G@'
MN?4U4E\&Z'-I5AIIM95MM/8/:>7<RJ\! Q\KAMP&#C&<8K>HH P!X*\.C3]0
ML!IJBUU&02W,8D?#N,88<_*?E7D8Z"K*>&]*CU&TU!8)/M5I$T,,AN)#M5N6
M!&[!R0"2<DGDUK44 8L'A31;>X::*T*AI_M/DB9_)\W.=XCSL#9YSCKSUYI7
M\*Z/)+JDK6\I?55"7I^TRCSE V@'YN...,<<5LT4 95MX;TJSNK"Y@MV66PM
MVM;9C,[;(CC*\DY^Z.N<8K5HHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\%F;B(71C,HAWC>4!P6V]<9(&: )J*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **AN+RVLQ&;FXA@$CB-#(X7<Q. HSU)/:A+NVDNI;5+B
M)KB)5:2)7!= V<$CJ <''TH FHHHH **** "BBB@ HHHH **** "BHKFYM[.
MW>XNIXH(4&7DE<*JCW)X%2*RN@=&#*PR"#D$4 +1110 4444 %%%% !1110
M4444 %%%0I>6TEW):I<0M<QJ&>%7!=0>A(Z@&@":BBB@ HHHH ***J7>J:?8
M211WE];6\DQVQK-*J%SZ $\T 6Z*** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ KCO#FKKJ.I>*M;O'Q!IUY)I\0//E10J
MID(]V<L3Z[5]!78UR&BZ.FEZKXDTBZ7-GK%T]] QZ/YJ 2IG^\"I./1@>QP
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MH41WR3MP&)(&<G!X P;GA;0KO0O[5%S<0SB^U"6^7RT*[/,()4Y)SC'7CZ4
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M, 3DYV]!G-7_ !7H5WKMG8K97D5O-9WL=V%FC+Q3;,_(Z@@D<@_510!RFO\
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M;OJEMIXTRVVW-UID6HL)(I95C63(1#Y:D\E6YXQCH<XJ*'QKK%S/X;MQX?\
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M[M9FWR"1001E_F&#QT^EV_\ #.KW[Z'<3ZI;RW6GWWVV9C"RI(VQDV(N[Y%
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MAOP#JQU_4C=:I<16EUND#(R/%(Q.TC&X%00QR?PXJ36+_5=*T7XB65MK-_\
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M\0>'MMU?7=K?:3<S2M<2'_3'C$;+*L9)\H'<< 8X;! Q6IX8:ZUS0O#OB?\
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M4H8+&SMY[9()0GENT<K<$#.,J.._?- 'I-%9'A6^GU/PAHNH73;KBZL()I6
MQEFC4D_F:UZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH*C?NBM4B<,I7# 8(YZXZ51U_68O#?Q*M-0UGS(]'N-+-K!<^6SI%/YNYE.
M=NY=G/?;7>44 >;9M-"\2^%;R*S:P\,+;74$/F*42VE=@RN^[[F]00-W3=@X
MSBL+7K-$T3Q1=*$.EWNOV<UBI'#X>'SY$]5)#<C@[2>E>S44 <#'_9@^,%U(
M?L@B&@Q#>=NT$2OGGIG81_P$^E<EX?-F^B?#2.?RBT-]<+(K@9C79*%# ]!D
MIC/J*]KHH \BO4L&TSXK;5MR\N_RL 9<FV4?+Z_O >G\7O6M;7%O)X[\&2K+
M&S-HLZNX(R6(BP"?4X; ]C7H]% 'C32A?A/?VA247%AKGFW2>4V8E^W[\GC^
M[\WTYK6U36=.M?&>IC7KF]M])UBQA2QN(XF,<R .'B/RD@DL2!W#?2O3Z* /
M*'N;#PIXAM8=3;4M.T&YTB&UL975G$91GW12?*Q#%60X/ICM76Z!J.@Z!;:)
MX:MFN;5KF*1K""Y5R[1J2>6(^4XY"M@@<8XQ7557FLXI[J">4LQ@):-<_*K$
M$;OK@D?C0!8KQ2VN+5OA1X6T^XXEMM9M8[J&5"-FVY)<,".PY/H",]:]KHH
M\EU])Y]9^($&CH);B73K%EAAQF;87\Q5]3L^7'N!70^%[WP[XB\01:WI4VH7
M=]%:&WEDF5D$"$@^6XV@%MW;G&"?KW-% '.>/O+/P^\0K(%.[3YU0'NQC(4#
MWSC%<IMTUO$OPXVK;%5LKC. N%)B3;GT.X''N#WKTZB@#Q5;W^SQ>:@AG.E6
M7BVYGN_LB[FCA>+:LH4 Y0.V<@'U'(JYXCC\/W'A'4=2TIIKB+4-3L99+F<'
M;.ZRIO**P' 0?,0,'GT->O44 <#'_9@^,-U(?L@B&@1#>=NT$2R9&>F=A'_
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MP\G3M5DTRXWJWVA(4E. >5VL,<U-IUA%IMA%:1,[JF27<Y9V))9F]R22?<T
M6J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&^]00,=<#/3TK U_2];M_&&G>)-%MX+TI:R6-U:33>43&S*X=6P1D%>1W%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1RVM_+;_ &JQ$8Q%%.0%,;#YMR[ESDD-SPM9\S7\NG?%$W.HRSQPQSQ)&Z*
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M.!G@>U1VT4D,*K-,9Y>C2E0I;GC@<5R"-?O\8;F ZC+]ECT>*9(-B[5W2LK
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M_(4 G<@4$CGD^F:ZRXUW5M(\4W.AR3PW:S:7+?6-Q<@1[)(SADE*@#9RIW
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M8QCU[]6/%5P/&#Z-?7CZ9=&\"VMO<0 0WEOQS')CF0\\9]L=Z .YHK@H=?\
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MW#:6.T#<^WC)[$\<FI-!\.IH$NHO'?7-P+^[>\E68)A9& !V[5'&%''-;5%
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MEMY9=.M'DM@%@=H%)B Z!3CY?PJ9;*U2]DO4MH5NI$$;SA '91G +=2!D\4
M3T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !5+4-7L=+,2W<^V28D11HC.[XZ[54$G'? XJ[7%^+=*U]->L_$?AB
M2VGU"SMFMY].N6VK<0NP;Y6_@;*\$\''M@@'4:;JUAJ\,DVGW<5S''(8G,9S
ML< $J?0@$9':KE>=V/CNU?1;Z[LM+GLM:FU2"TN[&Y4;HKB39&&/(##:H(Y&
M<=LU8OO$?B3P[;:M=:C8^98HL(L+BX,2MYLCB,I(L;'*@L&R,<9'6@#O*J7N
MIVFG/:)=2E&NYQ;PX1FW.02!P#C@'D\5S>M_\)-I^F:[(-2@:T33'F@N1&%G
MBG4,6 7&TI@#!/(/K69:ZMJ^C^&_ @2[AFCU&:UMI_,A^?8T);@YZ_+U(.<]
MJ /0J*X=_$6KZIIOB34])GAA&C7,UO#;R1;EG:%07WGJ-QR!MQC@G.<5!:>)
M]:\0>(=-M=-N;:SLM1T$:DADMS))"Q=!C[P#?>]A]: ._JE+JVGP:G;Z9+>P
M+?7 8Q6Y<;W &2=O7&!UK+\$:U=Z_P"$;/4+\1_:V:6*4Q#"LT<C1[@.V=N<
M>]9_B,#_ (63X)..<WW/_;$4 =)J.K:?I*1/J%[!;"6011^:X!=R<!5'<\]J
MNUQWQ, /A6 D#(U.QQ_X$1UV-  2 ,G@5C'Q9H0B>8ZC&+9,AKHJWD#'_37&
MSVZUSOQ@O+BS^'=V()&B2XFAMYY5."D3N W/;(X_&NS%A:#3AIXMX_L?E>3Y
M.WY/+QC;CTQQ0!3;Q%I2ZG!IIO%^VSIYD4.QMSI_>''(]^@IQU[3%UD:.;H#
M42GF"WV-O*9QNQC[N>_2N-U=)[+XL^&XK"W2=HM'N$5)92GRAD'WL'G\*=;2
M7DOQQB-Y;16[CPZX"QS>8"/M"\YVB@#N[F\MK/R?M,Z1>=*L,>\XWN>BCW.*
M2^OK;3;.2\O)?*MXE+22$$A .I..@]Z\\^(<1\1-?6=N;P7.CQ+/9/;VLL@^
MW9$BY**0"JA1S_SV/I6U/KL/B;X17VL0@ 76D3LR#^!_+8,OX,"/PH UYO%N
MA0:?;7\VH(EG=,%@G96"2D] IQSGMZ]JMZ?K>F:K+-#8WT$\T./-B5OGCSTW
M+U&?<5YIK19?A+\/F1-["YT@A<XR=J\9K6\.!_$/Q/U/7KE%T^YTJV_LQM/+
M9E8%MXE<]-I_AQGUSVH [2QUS3-2O;NRM+R.6ZM"!<0C(>+/3<IY&<4NI:UI
MND-;+?WD<#W4GE0(Q^:5_P"ZH')->;ZP3X:\?7?C-/EM1J::;JGIY$EO;[)#
M_N28_!J7Q<?[3\6>&-7)S!%XABL;3TVJLGFN/]YQM^D0/>@#U"YN[>SLIKRY
ME6*WAC,LDC\!% R2?H*62XBCMS<%LQ!=VY 6R/48ZUS/C.2UOQ:^'KM;AK6]
MW27@MX9)&\E.WR D;G*CGJ U4_A?JLMUX9?1[QW-_HDQL93(C(SHO^J?:P!
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M8.=IZ5Y[<:W<>(_"?P^U:\2-+FXURW,@C&%W!95) [=*W] _Y*?XR_ZX:?\
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M+Q2(Y Z ",I@879M&.OOG)H'@B*\T*\TS7M6OM8%U%Y)EN-B-&@((V!% !R
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M75KQY["\%\9W"%IYMI7+_+@#:2,*!@8]*L:SX9.LKJ%O-J$HL=0A$-Q;&-6
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MD1=S*25PO&>N,X.,XKC?"5A+!:Z=X>UCPG>RZCIDZ[;Z4%K0A&^6=7+?>V]
M!G)[#..B\"03V\GB07%I<6_VC6I[F(S0LGF1L%VL,CV/O0!U]%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%<_P"+O$%SX;TVVN[>Q2[\V\AMF0S;"/,<*"."">>A(^M '045
MR4GB?5;>Y32[JPM8M5:.2X(B>6>)8@^U#E4W9;GL,8/L*J1^/V-KHOV^R&BW
M6I><I&IEHXTDC*C9D@<ONRI.. >">* .SDN8(IX89)XTEF)$4;. SX&3M'?
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MSNIM?TC2[^Q@@EU2.9OLZS;IK1D7<%E'3)7Z8/'/6F_#J-(8?$T<:*B+X@O
MJJ, #*]!0!V;,J(7=@JJ,DDX %06=_9ZA$9;*[@N8U8J7AD#@$=1D=ZY/XG3
MWL/A6-;01;);ZUBEWN5)!GC&W@'(/0^WK4-QJNJ:;XNN=*TKP[IC:E>6']H2
MS"[*+*RNL>&.S/0X!YSQTYH [JBN/N?&%XVF:SJNG:?#<66D3213H9B))C$
M92G&!MY S]XJ>G% \87VH:_;Z;H^GVLT5WI*ZG;7,]RR JS* &4(2.O;.>.E
M '845P%KX_U.?1='UJ71K>*PN[U;"X'VHF1)#*8BRC;@J&'<@D=O7O7W!&V
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M]WGH>:Z&WUMK[4=.ALE@GMKFS^URSJY^13@)@8YW9;&<<(: -FBBB@ HHHH
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MCBDE>9E>9Y/G8Y8Y8GJ230!YU/J$_AJ[^)>M6TEQ/<6+PM#'+*SIEK=#DCN
M6SCL!BMV]N;[0M<\*R6NH7-[;:K,;6[CFDWB0F,N)E_N$;3D+A<'I71'PQI#
M:I?ZBUJ6GOXQ'=*TC&.4!=F3&3MSM^7.,XXINF^&-,TI[9K=)G^R(8[59YWD
M%NI&"$W$XXXSUQQG'% &+\2E9]'T94<HQURQ <#.T^<.<51AN=2LM5\:Z4NK
MWLL=I8PW=M-,RO)"[I)NP2N,90'&..<8KL-8T.PUV*WBU".1TMYTN(PDSQXD
M4Y5OE(S@\\U7?PMI4E[J-VT<_GZC"+>Z87,@WH 0!C=@8R>F.IH XVVU#5KP
M?#A#K%Y$NJ6+F\V%<RL+;?N)()SD_3OC-9UW=:U;^$/&5TGB'4O-\/W\RV3%
MU)*JD<@$AQEQ\Y&#VKOXO"&C0-I#1PSJ=(0I8_Z5)^Z4KM(^]\WR\<YXIC^"
M]$DL=4LG@N&M]5D,MXANI?WK$ $YW9&0 .,=* +FKZI)IOA:^U9(O-DMK*2Y
M$8_B*H6Q^E<;-J>I:?HG@_7[?4;BZEU.YM(;Z)WW1S+..2J]$*D@C;C@<YKT
M&&VBAM4ME!:)4V 2,7)&,<D\G\:R-/\ "6D:8;<6T,ODVKF2V@>9WB@8Y!**
M3@=3CTR<8H P/",.IZGK&LW-YK^HR1Z;K4\$4&4"/'Y:85P%Y W9&,8(]S4G
MC*%[CQKX)BCGD@9KF['F1XW*/LSYQD$9KI-*T&PT62\DL4E1KV<W$^^=Y \A
MP"V&)P>!T]*6_P!"L-2U.PU&Y25KFP9FMF69T"%AM)P" <@D<YXH X"#Q%J>
MFZ=?:<U_).4\3#2HKJYEPZ0LBN 7VGG)*AL$C</2G^*1XF\/^%/%%R-:\F-8
MHY[&..Y,\T'(5P7= 2A/([CG!KKI/!.@36.IV4]DTUOJ<OGW:2SN^^3CYAD_
M*>!RN.@J-? F@C0KG1I(;F:TN=OGF6[E:20+]U2Y;=M'89Q^9H T])TV;3DN
M/.U*\OFGE\W-R5/EY !5, 87(SCMFN-TK3R/B'XV:*^O(I(X+1E99<X+1R=B
M"#CMD<5Z!#$L,*1*7*H, NQ8_B3R:RH_#.F0ZEJ&H1K<+=:@JI<N+J3YPH(7
MC=@8!.,8H \]L-6UBR\ ^']>GUV_FNM9:SLI6E*&*W$DF&E4;?O;<C))&2..
MU;]]<ZCI'C(Z-:W]TUC?Z5/<J9'\V2UEB*C<K/D[6# 8.1D<8KH8O">BQ>&?
M^$<^QF32=FP6\LKOM&<C#$EA@\CGCM4D'ARPA68L;F:6:'[.\\UP[R>7_=#$
MY Y[8SU.30!Y[8WFM-HO@'4SK]^9]7>.VNE8J4*O"[;@I7&X%00QSU].*ZGP
MA<7D?B#Q1H\]]<7D&GW4/V=[EM\BK)"KE2W< DX^M:">#-$CL]*M$@G$&E.)
M+)!=2_NF (!^]S@$CG/!J[8Z%8:;J=_J-LDJW5^RM<LTSN'*C"G!) P.. *
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MLKNLJJ,*-I.!@=, 5!IG@G1-(TZZL;6*Y,5S";=VENI)'6,C&Q&9B4'/\.*
M.AHJ"SM(K"QM[. ,(8(UB3<Q8[5&!DGDG ZFIZ "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *C
MFGBMXS)-*D:#JSL /S-25P?CA-4T[Q!IGB&+1FUS2K6"2&YLHP&EA+%3YT:'
MAFP"OK@GU- '=JZN,JP8>QS2UP6A>)/"]AX8O-9\/LLEK>Z@@%HB&,Q7#B./
MRRN"5Y&XX'0D@'C-D^.Y++^U?[3TN5$LXXY()X5?R[DR,$6,%U7#[RHQSP<T
M =I4<MQ# 8Q-+'&9'")O8#<QZ 9ZG@\5S.IZYXAL+75]VD6ZM;:<UY;W8F+0
M%QG,;?*&W#&>!@CTK+BUVY7P[X)GU?2K.^EU"XM8UG>;<T4C1%A, 4^]PW0\
M9ZF@#OJ*Y2Z\6W3VVMWFE:?%=VNC2O#.'F*/,Z*&D"#:1\H.!GJ01QU,"^-;
MO4-9L+#1=-@N8M0THZE;7$]R8QC<@PX"$C[_ &R<XZ<D '94C,J*69@J@9))
MP!6-X4UX^)?#MOJ;VWV:5VDCEAW[@CH[(P!P,C*G!K$^*\$4WP]OWD3<T4D#
M(?[I\Y!G\L_G0!V;ND2,\C*B*,EF. !0CI(BO&RNC#(93D&J.JZ)8:XD4.IP
M+=6T;;_L\HS&[=BR_P 6.< \9.>H&.=\ :0FEMKQL 8M$GU MIT /RJH10[)
MZ(9 ^,<8&1P: .RIDLT4$9DFD2-!U9V  _$T^O/_  PZ^*?&_BB^U)%G32KP
M:?8P2#<D 5<NX!XW,3][K@8Z4 =\DD<JAHW5P1D%3G(]:9]IM_M'V?SX_.QG
MR]XW8^G6N"^(6WP3X4\0>)-#1;6^N((;<^6H"JWF%1)CH& D;GN0*Z!O!ND'
MPR=(%NF?*P+K'[WS<?ZW?][?GYMV<YH Z R(K!2ZACT!/)IU>*.-0^(7PO\
M".H%MNOBXE:WN@ &,T$<Q0Y_VFC7/;)KL9/$H\6>!+ V1,5QK$31S*IPUNJ
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MV*ZVB@!D0D$2"4J9-HWE1@$]\>U<K-H&LKX_F\2VSV!C?3UL%@D9P<"0OO)
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MIQR/O"NII&)"D@$D#H.] '#V7@:]T2[T(Z3?V[VNG6<EL\=Y$S?.[!FG0*0
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M.>+FC:)>:?XIU_59W@:'5&A9$0G='Y:;.<C!SU]NG/6NAHH YKQ3X=O-5O\
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M<*#V R3QCDD]: .;^$MOY7PYTJ3SIG\Q&.UVR%Q(_0=J;\1?^/WP7_V,=O\
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MFM+E"DJ9(R/J.0?>LZP\(:5IVK1:I$+M[Z.W^S>=/=R2%TR2-VYCNQDXSTH
MW:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*M)57L[Q?#\2G[23+<7JB*0J%'( 0D[F )R2<C&: /6+R_L].B$M[=P6T9.
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MZ=;S&&>_M8I0R(4>958,V=HP3U.#CUQ7CSZ1+HW@2"]UF&.TO=3\4Q:F()2
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4A
M88(!![&EKF/'MG<7?A>7[%?W5A>B6%(+BWF="C-*BY(4@,.>AH Z8    # [
M48!["O.E\3W6K>"?$6FZJ9+#Q/H]G*;E()6C+%4)2>,J02C<'V/![5UMQK,-
MC>_V39VMU?7D5N)WAB=2R1DD*6:1AR2"!SDX- &S2!0&+ #)ZG'6J&B:U9>(
M=)AU*P=F@DR,.NUD8$AE8=B"""*CO];BLM2@TZ.WEN;V>%YTAB9 =B%03\S
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M<YM IV1L"R_>898J"0HR<?49Q[J]%Q\2/#-W:R7+6]WI5U,(B[*&QY14[&.
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MM(.!\WM0!UI56 ! ('/(I:Q9O$MH+VVLK.*:]NKFT-ZD4.T?N00-Q+$ 9+
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MV28!W$<'U&<8Z5WU8,Z>'_#VM#4)I/L^H:O+';;FED8SOT1=N2.,G'&!D]*
M.9T?P?J.@W_@J&*#[1;:1;74=W.CJH#S[3\H)R0&![=,=:F;2?$&C>*]6DLM
M"L=7TW59EN4EFG6-K638J,'R"63Y01MY%=]10!P@T[Q-X=\7:A?:;IUOJUEJ
MT4'FC[0MN;>:-!'G!!RA !P,D>GK?N=+U63QUH&I/;B:"TL9X+F=&51YDGE\
MA2<X^0_F.M=92,RHC.[!549))P * /+9/#/B9/#;Z%%I43BWUL7T=RUTH6:+
M[3YW Z@@'!SZ<9K0?1?$6F7'BRSM=-2^LM<\RY@G6Y5#!*\01D<-@D?*,$ ^
M^.W7Z?XATK5+Z2RM+K?<QQ+,8VC9"T;='7<!N4_WAD5J4 >90^'O$FC2:#J<
M&BV>IO%H\.EWU@]PJE#'DK(CL-IY9@1].M>@Z5'<1Z=$+N&""<Y9H8.4CR<A
M0<#.!@9P,G)P*N44 <3XGTK7M3UNZA6SBO=(GTTQ0*]P(T@N#NR[K@[\@K@X
M.,=LDU3TC0M=M[SP+)<Z8$71M-EM+HI.C89HXT&.1G_5DG'J.M>A44 <1HWA
MMY/#OB;2]>MOL]MJFH7<ZEI$/[J4[@<@G##K[$5H> K2^A\,6]YJLXN-1O$2
M268 C<H4+'P>1E5#$?WF:M76/#^DZ^ENFK6$-XEO+YL2RC(5L8SCOUZ'BM(#
M P.E ',>.=$U#6M&M6THQF_T^^@OX(I6VI,T;9V$]L@GGUQ5&SM==G\>G7[C
M13:VK:.+4QM=1M()!*7Q@''ZX_D.UHH \RT_PSKMIX5\%:>^FDW&CZ@+BZ"S
M1XV 2#Y3NY/[P<>QK4UG2M;T_P :3:UIFC6NM6=_;10W%O+,L3P/&6VNI8$%
M2&((Z\5W-% '!WFE^)=)\3V7B'3=.M=0,MA]AO;&*<0B/$C2*T;,,$ LRG."
M>N.>+>KZ9KUQJ_A;5UM+>>XL9K@W,"3[502QE1AB/F"Y )QD]0.U=C10!Y_!
MX>UK3-,\4:##9BZM]6GN)K2[\U0L7GCYEE!.[Y6).5#9'I5O2?#E[H_C/3I(
MK9Y-+L]!32Q<%TR75U(.W.<8'Y^W-=K10 5PEOH^L(GC</IK@ZN[/:?OH_FS
M L0W?-QRN?I[\5W=% '!7?AK5Y_!?A5((535M!DMIS;22#;,8TV.@89 R"<'
MZ9Q4FIZ!J&KZEJ^N?8)()Y=$?2[6UDDCWLSL69F(8J!G:!R?XO:NYHH X*'0
M]727P$6T]\:-$R7G[V/Y2;<Q?+\W///T]^*U?">FW^GZIXDFO+1H8[_43=0,
M75LIY:)S@G!RA/XBNHHH YKQ=HT6NQVEI=Z,=1LLLSM%*L<UO(,;'C8LN#][
M.#_@>8/AOQ5IL>@ZJ(8M=O;**XM+JTO)E$DD#R!HSYA&WS%"J">_//>O3**
M.&U32M:OG\-W TB&)K35!>SV]O*F(8_+=-NX[=[?,"<#'49X&='QEH%_JO\
M9=_HTR0:K870,<K=!%(-DH]_E.['J@KJ** .2\4:'=36_AJVTJS,L.FZE;W#
M@2*NV*-6&!N(R>1^1K-N]!UB9O'^W3VQK<*QV1\V/YB+<1?-\W'(S]/?BN_H
MH \RN8-7M]8T3^S-*>;4].T<07@M[V*.6,,0%5MX9&4F-B.^1VZ'J_!?E0Z"
M-.CTF;2S82&![::592&(#EMZDAL[\Y]2:M:GX6T36+U+V^L$>Z1=@G1FCDV_
MW2RD$CV/%:-I9VUA;);6D"0PI]U$& /6@#GO$&EZG-XO\.:O86T=Q%9"YBG5
MI0A42JH#<]0"O..>:YN_\,:Y=>$O&^FIIQ%QK%_)/: S1X*,L:C<=W!^0_F*
M],HH X"ZTO7]-\77FJV6@6NK66JQ0F6&>X2*2TE1=F<D$%2 ,XR<C\^XLHY8
M;*&.;RO-5 '\I<(#WVCT]*GHH XR?0]3T+QQ>^)-(M1?VNJ0QQZA9B18Y0\8
MPDB%B%/RD@J2/7-7-?TJ_P#%_AC5-+FA;38[NV:*,3,KR;S@@ML) 4$= 23G
MMCGIZ* .*;2M7UZ7PVVJZ>;-]'G%U<,)4<32K&R*(\$G:2V[+!> !CGB@FFZ
MAI7PR\90:A:FW>4:E=1_O%;*2!W'W2<$ \_UKT2JVH6%MJEA-8WB&2VG0I(@
M=EW*>""00<$4 <5IVE7GB+3O!C3V36EMI:17<DKR(3*PA**J;23@EMQ+ = ,
M<\4H/"&L?\*]D\!7%MF 2>2FI"1-AM_-W[BN=PD"Y&,8SCG%>B65G!I]E#9V
MRLD$*!(U+EMJCH,DDU/0!RNC:9J%IXY\27\MH8[.^CMEMY3(IR8E93D Y&=P
MQ^N*YFR\/>*I+_PUJ&HZ7!+J.GWLK7UT]XI,RO&ZAEX^5!N'R\8_N]Z]0HH
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MN1C!P3G'2N;T/PQX@L-,\#VUSIJAM%N96N3'<(WR&-T!&2.<OG'H/7BO3J*
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M+I8"&,R,<MAB-RH3R5! //8XH J2^)=7U'2?$6K:3);(FCW,\$5M+$6^T>2
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M>&//.3V&.>AL/!$5G8V.ERW\USI.GSK/:VTB#<I4Y16?^)5."!@'@9)Q3)_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MKE/%G_)3/ '_ %VOO_2<UU>H:='?7%C*]W=0&UG\U5AF*+*=I&UQ_$O.<>U
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MZI:R);3""4I(#MD/1..K'/ '6@"76-$T[7[(V>J6PN;8D,8F=@K$'(R 1G!
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M[MD>[_6;?O!3T8CN!G'>@Z_I*Z@EB;^ 7+R&)$+?><#)0'H6 _ASGVH 34=
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M7I+E+Z]B@81^:P8_<3.-[8^ZN?XC@5)>:M86$4<MS=1JLH+1X^8N ,D@#)(
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M"=J$Y/*@=3ZUK$9&*0G )/05F'Q)HHL&OCJ=L+5)O(>8O\JR9QL)[')Q@]Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW^F1-;236C(9\0.IQ\JC.< # )]*]=HH S/#UW'>^'[&:))53R$7][$T;<*
M?E8 _I6/X]L[C^R;76K"!YK_ $6Z2]CCC&6D0?+*@_WHV;\0*ZNB@#SC2]&U
MBS\836-Q$S:=K!CU>Z8?<@G0_/$/7+>1]0K5!>(K:G\3F,$A-S8QQPMY+?OB
M+8J50X^;YB!@9YKTT$, 000>A%&021D9'44 >;6K,VM?#5S'-^YT^9)F,3?N
MF:!% <X^4E@1@]Q3?"-[#'IMMX6UO1;J?6["_>4"6T=HV;S6=;D2XV@8;.<Y
MSD $D5Z7D @9&3T%+0!X_JD)E\(?$R-+65I[N_<VZB%MTP\N,*5XRPW!L8]#
M7K5I(LUG#(IR&0')^E34F1G&1D\XH \W\8W$DNL>(=/6QNH))M$*0SVUHTCW
MQQ)^[+[2%52>G!.[KBJ>F:L^@:MX?U;4K*__ +)N?#\-B)EM)'-O.C9960*6
M 88YQSM';FO5 0PR""/44M 'G=_'#I^M>![RUT>XLM-@EO%$$-LQ,0DC(3**
M,J6/."."<&LO7-/U'57^)EKI<4IN;I;0P H5$X2)1(JD\-G#)QW.*]8HH X.
MZEC\2>*/"6J:8DL:V'GS7C/$R&"-HMOE/D##%MOR]?E)[5R]O$8_AOI<0M9E
MN$\2K<-'Y#!PHO"^\C&<;,'/I7LE% " A@"#D'D5Y_9R_P!D^(/&-GKL$KQZ
MC(+BU?RF=;F$Q!/*7 .67:1MZ_-G'->@ @D@$$CK[4M 'E7A_2[O2-:\ VFJ
M([7%CI%S'.Y0LL+MY>Q"W0$ %1SVKI/AR"FE:NC1R1_\3F\D170IE&E9E(!'
M0@Y!KL:* .5\=7ALK329#9&:/^T8M]R(&F-F,-^]" ')'W0<8!;)!Z'S^_25
MO!OCFR:UU&66XUJ&>(36CAID)MSNQM /"L2 . .0*]JHH XF,1R_%QI$B+6T
MF@+#O$9\MF\XMLSC&=ISCTJKX2TN^LM=G\/SH3I6@3M-8RDYWK*O[I/^V:M*
MO/JAKN+^VDO-/N+:*ZEM9)8RBSPXWQDC[PR",BJ^C:2ND61A-S/=SR-YD]S<
M$&29\ ;C@ =   !P * -"O,_#%[##9-X5US1;JYUBVU*6=!):,T4Q,S2)<"7
M!4 ;LY)SQC!/%>F4@((R""/:@#R^-9+;0/''A_5K6:34+VZNY;5/*9OMB2K^
MZ*'&"1PI_N[1G JUHUA):?$#2+74D-Q+;^&$M)IVC+(TP==R[L8R0"<>E>C9
M&[;D9ZXI: /)HCI\^G_$G39;?S[N[U":.*%8BSS,8(P@7CDAN?\ 9SDXZUH^
M'XKSPGXJ*:\SM!<:+96\-YM+(LD*L)(R1T+%MPSU]S76Z#X?.AW6JS?;&G_M
M&[-W(K1A=CE54A<=L*.OYUM$@8R0,\4 >0V6E3Z7:>#8;JVE6)=>N+M(6A8_
M9;=Q+Y>X8^3[RGG&"?:K_C*1GNO%FEPZ=<VSR:+M@>TLV<WYV2?*7"D*J$XQ
MP3NZ]J]0HH \XL)GB\6^$;][2]%O+H4EH&^RR<2[HB%88^7A2<M@8&:S?#<=
MC/:V7AS7M)UB77M/O?-",;@0,ZR%EN%<'8%P=WUR,$GGUFB@ KRF\C#Z1\45
M%O(9+MG%N/);,W^C*HV<?-\X(X[UZKD9 R,GG%+0!YI>OY>N>"9K>RDG6WTJ
M\1XDC(&3%&%C8XPI8J0 >]9^AW+3^(? EVMK?)%':7,$D"V$D<-F[)&!$N5S
M@8(+$G[N<CI7K=% 'C\L-R?A5KVFBQO3=VNKO-)']F?.S[:),KQ\_P GS?+G
MBM;5=2M['QK-J&KVNKMHVJZ?#%;7%M'.-C(TF8W2/YAN#@C(_K7I5% 'FT6G
MV5CXQ\%6UKIDUK8VUE>HD4JM)Y DV;%=CG:2 W!/'(KTA5"J%4  #  [4M%
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MQMJHFTMX[RTTE;F2]!!,L =L(H![$-UP:?'XQ4:'/K<]FATV.Q:]6XM9Q,&
MY*=!AOT]^#B*71-</C&_UN'[!&LVCK90YF9F696=PQ&S&W+8ZYXZ=JS[#P=?
MZ9J>HZEI5GI^F-=61CDL$F9[6>XW ^85V *, KPN2&/ QR ;;>*EM=-N]1O[
M>)+*&**2*XMK@2QS^8Q4*K$*,[@HYX^8<UGGQ_%%/JEM)8K--96!U!397*S1
MRQKPPWD*%<=U/8Y&:RG^'$LEIKD%@8M$@OXX)(+2"4RQ174<GF>: 0 H)"#
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MDN-.M=0_LZ21)0LGF;Q&2%(QMWD+DL#WQBJEIX3UNWL_ \##3R= P+DBX?\
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M5Y9BIP,8X.2.,X.I>"M9U'3O&EL7L8VUN:.:U83.VTHJ* _R#&=G49ZU<O\
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M7>VSR"99Q)MQM'ERK@;7(8\9.-I%<K\/O$TNE^#O!UE<Z9*+*_'V2.\\U?\
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MLQQC[H X]R=&/1M3/Q#&O2+9K9G2Q9%5F8R!_,WYQL QVZT =+1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !117.^+-;GTH:19VKB*XU6_CLUF*@^4I!9F /!.%(&>,D<'&* +
MT?B"PFU>_P!+C,QN[&%9IT\EA\K9QMX^;.T],U;L+V/4=/M[V))4CGC$BK-&
M4< C/*GD&N#M8KVR^(/BTKJ,DLZZ/;/#-+&FY,&; (4 'D'MWI@\5ZO#X/\
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ML=:DODLFD8V-P;:<21,A$@4,1A@#T8<UHLRJ,L0!D#D]STKC_ __ "&?&?\
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M*-%&6D=NBJ.Y/]"3P*YCQ7J>I6M[=166I-%Y6F/<1V]I$CS>8"?GDWJ56,
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MWD@8<_=S[>M 'K=%<5'JNJ^()?$_]G:BU@VDW#6EM&L2,'=8U<M)N4D@LV,
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M&MKVL:OH7B?6=.U VKZ3=7,-O;&)&C<0#D29&[YR#T(P"/0YJ7=Q/KWB_P
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M]*Z=W2)"\CJB#DLQP!6!XB\07.D7F@I;0P30:CJ"6<CLYR@96;*@<'[OK^%
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M>@G\1P:X;NZ6[@MVMD52FS8Q!;@KURH/7M6H\T4>=\J+C&=S 8STI] '*Q^
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M03U?T[UZ(=,L"9";&V)D^_\ NE^;G//'-/6RM4\G;;0CR<^5B,?N\]=OI^%
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MK]X2%#D+MVC&P8'OVJ3Q5X=GUJTTJULEM(X;*_ANV27(5EC.=@ !X/3/;T-
M'*G2+71/%?BV+18([72&T 274,("Q)<_/MP!P#Y8R0/4'O44E@L'PY\&^+K2
MV2:]T&QMIVVJ"TEN8@LR#W"DL/0K[UZ7%I]G%:&UCL[>.!N6A2,!"?IC%9&J
MZ+J%Y+#8V5U9VFAR1LEY;K;'S9 3R$8$!01D'@]3WZ #_#%NCVEQK!A$=QJT
MOVIODVMY> (@>^0@7(]2U<?=K%:?$+Q@UE#;+K+Z/!)IX*+YCS;9^4[DYQG'
MXUZ:    , 5&8(3<"X,2&8+M$FT;@OIGKB@#RM%MKKPGX"U#1-@U?[9;([I_
MK7!'^E+(>IZ.6SW&>M=?X_N[&T\-Q_VBC/#->V\0'F^7'N,BE?,;!Q'D?-P>
M..]=#%86<%S)<PVD$=Q+_K)4C 9_J0,FI)X(;F%H9XDEB889)%#*?J#0!P?@
M2Z@/C7QC:QWEG+F>VF5;4!8SF%0S*N3WP"<\FI+N_M/^%K3V6O- MK_92-IR
MW./+8EV\XC=P6QL![[1Z9KMX[:"%V>*&-'8!2RH 2!T'T%-N;*TO/+^U6L,_
MEMN3S8PVT^HST- 'C&F?V>?ASX1$+0-]F\5HB%6!,8-Y(<>V5P?IBNHTS0])
MU#XF^,#-8VT\ULUA<0*X_P!7+Y;$.!V.0.?\:[QM-L7B2)K*V:-"2J&)2%)Z
MD#'%/CLK2&9IHK6%)6^\ZQ@,?J: /*/"9T37++P]->:W)%XDL;L&>TC$271N
M,D2JXV[RA^8MVP.O%6_"]WX?U?2[6'7)D7Q19ZN\DL(DVW1N1*VW ^\4V$#^
M[M'H./2TL;2.\>[2U@6Y<;7F$8#L/0MU-*+*T%X;P6L(NBNTSB,;R/3=UQ0!
MX_>,FG:%\1QI,44>JIJ3$) H6=;4I!YA7'(7;O.1W]ZZ>[MK&3QQX3N/#Z6_
MV6ZM;A;Q;=1Y<MIY8V%P." Y4#/J?>N\6"%)GF6*-99  [A0&8#ID]ZB@TVQ
MM4E2WLK>%9?]8(XE4/\ 7 YH X;X3:-I*>$K'58;2#[<&NH/M &6"?:'^3/I
MP./\34OC*&+0O%.D>*5L1<+,KZ7>QI&&:59!F+_R(H7_ ('7<6]K;VB%;:"*
M%2<D1H%!/X4]T20 .JL 0<$9Y!R#^= 'F7@O2I+:[;P;?6D31:'=F^$BQ?NW
M20;H0,]P[2<]?W(K U:SL&\$^.]4:*%KZT\02M!<'!>%A)%@H?X3],9KVP(@
M=G"+O8 %L<D#.!^I_.JW]E:=L9/L%KM8Y*^2N"?7I[T <9;FTU#X@^*]/\0Q
MP21?9+<V:W(&TVI0^85SVWYW$?[/H*T_AO\ ;S\/M)&I/))-Y;!6EY9HM[>6
M3G_8VUT,^FV%RL2SV5M*L/\ JA)$K!/]W(X_"K5 'F<&EII?BK6?!T=DO]G:
MY(NHQ%8QL6(\7*'\54#T\T>E6[-+"^\9>,-,\0Q6_E)!!]E2< *+/R^2F>@#
M[LD=#CT%=^40R"0JI=05#8Y .,C/X#\A4-S86=X\;W5I!.T1S&98PQ0^HR.*
M /(M)3$OPUN?$JPF=K2]5YKQ1N90JF'<6ZMMP>><Y[U+:-HVMQWUGKFMR67B
M"TUB1_(01+=%Q,3#Y19=S IL48R,<=*]<E@AF*&6*.0QMO0NH.UO4>AJ,V-H
MUXMXUK ;I5VK.8QO ] W7% 'DVIWFGWWAOXEP:XUM_:\,MTL27! <0K'_HQ3
M/;N,?Q$GJ:]-\/R0W7A;3&1DEA>SC&00RL-@!JU/IMC<S^=<65M++L,>^2)6
M;:>JY(Z')XJQL3R_+VKLQMVXXQZ8H \4AMK)_AUH2%8PD?BT)&5."BF]8$*1
MR/E]*[3PO:V>F?$KQ78V$,-M;?9K*7R(5"('(D!8*. 2 N?PKK?[*T[8$_L^
MUV YV^2N,^O2I8[*TAG,\=K"DK=9%C 8_C0!Q?C>TL)_&/@K[5;VTC27\J-Y
MJ*2RB"0@'/49(X]37)>+]0TMK/Q++:2VUM<6NL6H?[0^;@NCPC=&,CRXPO3K
MGYNE>P3V-I=2+)<6L$KJ,!I(PQ'YTCZ?92/*\EG;NTJA9&:($N!T!XY H X3
M7MOAWQM9^(M,M8YX]>MCI[F-,JUQ@O Y([-\RD],8/:G26D&C>/?#>C74<?]
MC_V;,EKO0!)+S<N21TWE-Q'^\V.]>@-&C[=R*VTY7(S@^HJ.ZM+:]A,-W;Q3
MQ$Y*2H&4GZ&@#QK5+*./0=3A8+_9$/BNV73CG C4R1^:(SV4,7''3!]*]>T[
M2K#1K-K72[.&U@+M((HEVKN;DG J62PLY88X9+2!XHQA$:,%5^@QQ4ZJ%4*H
M 4#  Z"@#QH;K_X0?:U 7Q?;W^"^ +A;[[1C;Z\J<8Z;#Z"NJ6SL&^-;[[:U
M,PT))O\ 5KGS/M!^?Z].>M=H+"S%Z;T6D'VHC!G\L;\>F[&:/L-G]H^T?98/
M/SGS?+&[/UZT <_XUM;B[ATI+&_M;744O?,M8[Q-\%RXC?,;@<\J6((Y!4$5
MQ?VVV:+P=>W&FP:0;3Q#<6UP X,22%9MVQ^/D9R<>_':O5KFTMKV/R[JWBGC
MSG;*@89^AILEA9RV8LY+2![8  0M&"@QT^7&* /'K_5;>V7QM/8R(]BNMV4M
MZMMR6M"D/FL .JD;@2.H)K>\2'PQ-X2\8ZAH%Q!-)<Z.PN&M)0T PC!,A3M#
MD$^^!],^C);6\?F;((E\W_6;4 W\8Y]>.*BCTRPBM/LL=C;);9W>2L2A,^N,
M8H X&QLK'3/B!X1>QAA@DO='N/M#1X#3X$+*7/5CDDY.36SXUO=/M]2\.6]Y
ML66:\=K>2YDVVR,L39:0?Q<'Y5XRV.173+IUBDB2+9VZO'PC")05^AQQ4D]M
M;W2*EQ!%,JL& D0, 1T//>@#Q>QUFWL=!B6>YADT6W\6W"7XB_U<<#/)Y99<
MG;%OVG!XX'6MCQG:^&G\#^(;S1S!<0R7MI//+&XD@23S8PVPCY5.T9;'][FO
M3S9VQBFC-O"8YB3*NP8<GJ6'?\:1+*TCL_L:6T*VNW;Y*Q@)CTV],4 <-=+8
M)\4?#DNEK:@/I5ZJ&':%8!H]HX[9W?K7,KNO_A#;7L( \707ZC>1BX%]]HPR
MGORI.1TV>PKU[[#9^:DOV6#S(P C^6,J!T /:@6%FMZ;T6D NB,&<1C>1Z;L
M9H \MU'1](N]6^*'VFSMI?)M(I5#J"(W-JQW@=FSSNZUW7AG5[5] \/6L][$
MU_=:;%,D;2#?* B[F [\FM8Z;8,TC&RMBTGWR8ERW.>>.>:?'96D+1M':PHT
M2E8RL8!0'D@>@.* )Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 5=2LO[2TZXLOM,]L)T*-+;D!U!X."00#[XJO-
MHT,_AU]$>:7[.]N;9G 3=L*[>FW;TXZ5I44 <E)X LY?#^EZ*^JZHUKIDT<U
ML2\1<&/[@)\OD#TK1O\ PO:WVM6.LK=7=KJ5I&81<6[(#+&>2D@*D,N><8X/
M3%;E% &)KGAFWUZ\TRYN+V\A;3IQ<P+ 4 \P C)W*<\$C'2E\2>&K?Q/I\5E
M=W=W##',DW^CE 69#E22RGH1GBMJB@##U;PM::K=6=\;FZMM3LP5AO[9E64*
M>JL"I5E/H5(^E6K;27B)DGU&[NKC:52:41@Q@]=JJH7/N036E10!RFE^!QHN
MF-IVG>(M:@M2[OM!MR0SDEB&,1(R23UJ:Y\%VL^HZ3?1ZGJ-O-I,+06OEM&0
MJLH5B=R'<2 .372T4 9ECHYM+^2]GU&]OIGC$2FY,8$:YR=H1% R<9/).T>E
M5M5\,0:MKVEZQ+>WD5QIAD:W6(IL!==K9!4DY''6MRB@#-U_0[+Q)H=UI&HH
M7M;E=KA3@C!!!!]00#5^*)(8DBB0)&BA551@ #H!3Z* "BBB@#(O?#MM=:NF
MKV\\]EJ*Q>2UQ;[<R1YSM=6!5@#R.,CL1FEL?#]O97EU?FXGN-2N4$;WDQ4R
M!!T50%"JH)S@#D\G)K6HH Q?#?AJW\,6<]K:7=U/%-.]P1<%"0[G+$%5'4TT
M^&(#XN'B7[;>?;!:_9/+RGE^5NW[<;<]><YS6Y10!C>)O#=MXJTK^S;RZNH;
M<R+(PMRH+%6#+DLIZ$ \4S5O"]IJ\ME=27-U!J5EG[/?V[*DRY^\#\NUE/=2
MI'M6Y10!FVVDO$?,N-2N[R<*5CEF$8\O/4JJJ%S[D$]NA(K*TKP8-$LIK33]
M?U:&&::2=A_H['>YRQ!,1(YKIZ* .;E\&6<FH:)>B_OTET9'6VPZ$'>NUV?*
M$L6 Y)/4DU97PO:0^)9]=M;BZM;BZC5+J*%E\JXV]&=2I^8#C((.*VZ* .7'
M@BW.BPZ)/JVI7&D1JB&TE>,AT7&$9]F\KP.-WMTXKJ  !@# HHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK<VFGS7MII+E+V2)U#!E4,X13]\J"">1Z#)XJ*3QM%)J]KIVF:9=:@]YI_\
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M1[/7?&HU2WO;B.UO_P!PD4,TBQKY2G:&4%4&2>I '7I787.A7GB#Q)I>IZI
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MI#WEA-:V6L.L=G<,P/SL-R+(H^X6'3KZ'!K7UG2TUK0;_2IY&5+RVDMW=1R
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ME@08UV=N3GJ,<TIQK+_$#PK!?ZF8YFTVY>YBM IA\U#$&*[ES@[B.>1VQSD
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M<0QP9DFD#$%Q(0 GRCA1GD\C% ';56OM0M-,M&NKVXC@A4@;W.,DG  ]23P
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M<A#T&U6!YZG(XQR =-1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMP71PN]!;KP4ZY+9^]GCO7I^JZ2FI&TG5_*O+*7SK:;&=C8*D$=U9201[]B
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M =]IB7< V0RDL1G);)[5N^(M#NG\;6;V+(MMK=N;75HB>L41#!P.Y*EHB?\
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M.&>]\EB2K[20!@_+DYR#TXJ_X@74_&'@77X;;0KFPFN+,QPQ7@1)IG'.,!B
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\\L3@\@'8!G!ZYH ZNBO.]/\7:CI=EXPU;6)(;B#3]3:VAAB!4EML*QH"20
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M99 \H)2*.,#<Q (+'+* ,CJ3GCD VZSX==TBX:X6'5+*0VP#3A)U/E ]"W/
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M_=DS+*4V[^>5 SGI7=UD#Q!%_P )=_PCIM9UG^Q&]$YV^6R!PF!@YSD]P.E
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M-XVCPZKT7 8Y P*IZ'J%_%XF\(A;Z]N+34[&Y:6:YE;_ $PJJ,LHB)(B!W9
M!!P<$#%=HWAG29+V"\DMGDG@@:VC:2>1@(F^\I!;!!P,YSG%5+/P+X;L);&6
MWT[;)8%C:LT\CF('JHRQ^7T7H.P% ' :E_R2OXB_]AB]_P#1BU[ GW%^E8;>
M#="?3+[36LY&L[^8SW41N92)7)R23NSR>OK6U%$L,21)NVH,#<Q8_B3R?QH
M\B-A=?\ ".^.M9L];U"PNM-U>^N8!!+MB+(JMAUQ\X;&,'(].^=B*_UCQ;J&
MK::)C8W=M96K1*EY);M"\L0<R;5'SX<[<,<?)C')SUQ\*:*;JXN/LC?Z3*)Y
MXA,XAEDX^9H]VPG@<D<X'I4>L^#/#_B#4(;_ %+3Q+=PKL69)'C8IUVL5(W+
M['(H T='-P=%LOM=U%=7/DJ);B(825L<L!Z$\UY5XBNI/$WPG\5:S<W=TMQ'
M<SQ+ D[*D*1R[!&4!VG*C))!.6]ACV".-(8DCC14C0!551@*!T %<[>> _#=
M_/?2W&GL1?G-W$EQ(D<S?WF16"EN.N,T 4(9[AOB)K>G-=W/V/\ L>"=8O.8
M!'9Y 67GY>%'3'2N;M+VYU'PG\,;R]GDGN9M2B:260Y9CY,W)-=[=>$]$O+Z
MWO9K,F>"'[.K+,ZAH\YV. <.N><-FHXO!F@P66G6<5DR6^FR>;:(MQ(/*?D;
MOO<G!/7/4T <S>:C>>&_$VL:3-=74_\ :\"RZ,9IW8+*2(WB!SQAG1\CD*3_
M ':[VRMOL=E!;>=+,8D"F65RSN0.I)ZDUA06NI:QXBBN]6TB"SM]+EE^Q/\
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M2,<LWS$\D\F@#E=?L_M_Q3T2W-Q/ C:3=[F@DV.1YD7 8<CZC!]ZP4U75?\
MA7VG2G5;PSVWB);$S&7YYHA>>7AVZM\O!]>]>CSZ%I]SK$6K2Q2&^AC:*.43
MNNU&ZC ..<#MV%4?^$+T'^SQ8?8Y/LHN?M8C^U2_Z[=NWYW9SNY^O- '->(]
M5O=(\1W,^J"_&B/<6X@U&PN&*V9&S,<\0(^5FS\V#PX'I79^(-1DT?PWJFIQ
M1>;)9VDLZQ_WBB%@/TJ&;PSI5Q<SSRP2N;ATDF0W$GERL@4*63=M. J]N<#.
M:UF571D=0RL,%2,@B@#RZ\@\Z/X=:L]_=74]W?Q23.\[-'(SV\C%@F=JX.0
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M:"-MNX;E!!Y'TKF(O%&L/H?@*^,T&=9E@CO1Y/+;X6<E3G"\KZ=ZS=-O(_\
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M5F2/'4;D+#'^V*T/$2W\O@N+74L[MWFU"WU*[M81^^%LK+A0!_$J!&(_O!J
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M&N+^<P0+)((T+!2W+<XX4@8!))'%57\0W 6PB&D7(O+R29!%(<)$(B<L[@$
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M ^00V05!P" 1Q[UW.E^&XM)N]6N8+^\:34YO/E\SRR$?:%RN$'91USTK-A\
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M!!!XYX J6S\0:PL>M:'>7N[7X+Z."T<1( \4N#'(%Q@@*'+?[C=.*V8O!EK
MWAYEU"_/]@H4M03'\P,?E_/\G/R\<8_.JND00^(_%47BA]'O;!K2U:TB^W0^
M5*[,V2=N>B@$ ]_,:@#KD!5%4L6(&"QQD^_%<EX@U'68O&VAZ187T-O:ZA;W
M32$VX=E,83!!)_V_IZYZ5IVFFWT/BR_U W]X]C/"BBUFD5HD<8YB4#*C .<G
MDM[4^^\/0WWB+3M:>[NHY[!)(XHXRGED28W9!4D_='?M0!R%CXQU7^SK/3KF
M>.349]>GT?[9Y04;(RQ,FWIN*K@#IDYP>E;NEZOJ%OXZOO#-],;N,6*:A:W+
M(JN$+E&1]H"DAAD$ <'FD_X0#33IUQ:/>7SM)J)U2*X+()+>X+;MZ$(!U)X(
M(P2*V-/T2*RO[C499Y;N_GC2)[B8*"(UR510H  RS'W)^F #,O=7N;OQNGAF
MUN7M FG&_FGC56=LR;%5=P( X8DX/;IS7%^)=8U'6OACXD@O9_+N])U$6,TD
M* +<A98RK8(.W*N"0#U![<5Z#J?AR"_UFTUB&YGL]2M8VA6>#:=\3')1PP(9
M<@$=P>AJG?>"=/O_  W<Z&UU>10W<YN+F:)D\V:0N'+,2I') Z <  8% &+X
MJLKP>+O!,?\ :UR6-W.-_EQ9R()3NQMQG!QTQCWYI;_Q?J&AZEXT:Z:.YM='
ML+>YM8ECV?,XDR&/?)5<G]*Z+4?#4>IZCI-_-J5\D^F.TD/E^4 S,I4E@4.?
ME)'&*C?PAI\^IZS>W,UQ<+J]NEM=6\A3RS&H8 #"AAPS<Y[T 5+NZUO08+C6
M+K4(+_2X--EN)XF0(_G(NX>5M7[A ;AB2..3S5?3;OQ7<W^EW*!GTZ[MV:[-
MPL 6%RFZ-H0C;F7/!#$G&.:NZ+X+MM)MC:W&IZCJELL)MX8;^576*(C!4 *,
M\<9;)QP,9.6:#X'@\/E$@UC5KBU@!%G;7,RNEKD$?+\N3@$@;B0!0!SVBZQX
MQOO X\2"[2^E,<B?V?;V:AV*W&TR(Q/+",/A<8)V]3G/3>#]=@UZVO)[;57O
MHDE"".>$13VYVC<DBA5P<Y[=/7&:=I_A"#3/"ZZ#:ZGJ"PQRB:*<M'YL;"7S
M>#LVD;NQ!X)%7M+T.#3;Z_O_ #'FO+\H;B9PHW!%VJ,* .!GWY^F #G;R^\0
MWGC?5M$M-6AL[>'38KJ%UM5=T9G=<?,<'[@Z]NPZU2TCQEJ6NZ?X;MT29+S4
M=+>^N)+01;P5*)A!*=H!+$GK@ #'.1U!\-1?\)%>:VE_>)<W5JMJRCR]BHI)
M&T%,Y!8GDGK6.WPWTY='T>RM=2U.UN-'#+97T,B+.B-]Y"=NUE/'!':@"M%K
MWB2W.D:+JL#)J=Y)<DS6ODEWABVE6 9MBN0ZY'(&&P.1A%U[Q)9'3=&U0)#?
MZEJ<EO;71"%OLJH9-[*I*B3 VXZ9.<=JU-2\"V.I:;9P/?ZC'?6<QGAU..8"
MY$A&&8MC!!& 1C&    !2WG@:ROM*M[:?4-0:]M[D7<6I>:OVA9@,;L[=N,<
M;=N,=J ,[PI#/;_$CQG'<737+".P*R.JJV-DG!V@#(]@*BUJWO[KXL6D.G7R
MV,[:#-^_,(E*CSX^BDXSG'7/?BN@T?PO'I.M7^K'4KZ[N[Z.))S.8PK>6"%(
M"J,'D].*DU#P['>ZY;ZS!>W-G?00-;;X=C!XF8,5*NI'50<C!XH Y#2_&>LW
M"6NBWB^9JW]J76G37-HB*9%@3?O17.T,0R\'('S<=JZSPR^O&*]BUV,9CN#]
MDE8H))(3T\Q4)4,#D<8!]*J:AX#TJ_T>"P66[MIK>Y-Y%?02[;A9V)+2;L8)
M;)R,8[8&!C7T?21I-JT;7EU>SN=TMS=.&D<]!T   [  #\220#CO%_B;5]%3
M6KRUO8V^P26YAM8(@Z"-BF_[0Q7Y6.XX"L#C:<'FNQU_5H]!\/:CJTJ&1+.W
M><H#@MM4G'X]*P=2^'FGZG_;4;ZEJ<-MJ[K-<6T,B!!* HWKE2<_*O!)''3I
MCI9M/@N]*DTZ[#7-O-"891*<F12,'./7GI0!P&I+J,VN_#Z^O=0\\W-VTDD(
MB541VMI#\A SM&2/F+$\<^K-4\5^(+3PIXXO8[RW%UH]\8K9_LXP(_+C;&,]
M<N>3FMRU^'\%M_9"OKNKSQ:1-YEE'(\7[L;2NPD)EA@XY)..XJ2Z\ V-WINN
MV$NHZCY.MS^?=8:($-A1A3LX&%4=^E %>\U'7-,UBQTB>^:\GU1YYXVM;>*-
MX(HU3,:^8VUCN?.YLG /'<00:YXCM9M,T75MD%[J.HS007>$+FV2,R!BJDH)
M3C;CIWQVK;U_PE;>(+2Q6>^O8+VP?S+;4+=U2>-L8)R%VX(X(Q@U6OO MCJ.
MC0V5S?ZBUW#<"ZCU+S@+E9@,!P<;>G&,8QVH PO&2>(;3PTT=YK (_MFU2"6
MW51));O,@"RC;C<"3]T ' SW%;,.I7^K>)M7T"VU*2U_LFV@+W BC9YI90S
MD%=NT!1P "23R,59N?!EK?>'Y-+N]1U">626.=KYY%\_S$8,A'R[0 5'&W'7
MC))J1_"D0U==6M-1O;6_:W%M<3(4;[0@.07#*1N!)P0!C..G% '(VOC'Q#K$
M'A40SVUE/?WEU87H$&\;XDDRZ9/3*9 ]>"2*]%TZ&[M].MX;Z[6[ND0"6X6(
M1B1NYV@D#Z5B'P5IZ-HGV:YN[9='D>6!8V0AW<,'9RRDDG<V>1R2:UUT]EUM
M]1^W791K<0_9"X\E2&)WA<9W'.,YZ4 7:*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MSQV&" :=%<?X"M;JQ_MVS^UW%SI-OJ#1:<]Q(9'"!5WJ&/)57W*,_P!TUV%
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M%7*YX)!!QD'T(H MT5F:GJYL+RRLH;.:YN;POY87Y44(N27;HO8#U)^N,/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@8XHRAP2!EB3D#ICO7H%% '#6_A_6=';Q/86=O#=6>LSRW5O,\H7R))5PZR
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M G@"T3PO:Z NJ7_V:VNQ=I)^[W[Q(90"=F,;SGI[4 :GC'_D2-?_ .P;<?\
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M397OA73]"EO+O&FF)K.\5E6:%XQA&!"XR!QTYR: ,O08+BW^+'B!+B[:Z/\
M9EH4D=%5MN^7@[0 3G/( XQ]:UK_ %BXN/&L'AFUG-J?[/>_FG559\;PBJNX
M$=<DD@] .^:DTOPM_9WB"?6YM6O;R\N+9+>7S5C5&"%B#A4&#\QZ?K4VJ>'(
M=0UBRUB&YFL]2M$:))X@IWQM]Y'4@AER ?4$9!H \_\ %.M:EK'PR\6VE[,(
M[S2+LV<TD* +<IN0JV#G;E6&0#U'H:]4M89(856:<SRC[TK*%+<\< 8KG[_P
M18W_ (:OM$:[NXX]0F,]W<(4\V9RP)))4@?= X'   KHHXW2 1M,TC@8\Q@
M3[X Q^E '%?#?_7>,_\ L9KK_P! BKE[*_O?#<WQ2&A/%%9Z8R7=JKQ[XTF:
M(O*JC( Y XZ#TKN--\&-I)U+['X@U2(:C=O>3X6 GS' #%28C@8 _*IF\%:4
MOA2]\.VIGMK:^#BYF1PTTK/]]F9P<L?4T 8]_JOB.Z\2Z3I&GZC:VB7^D27)
ME>U\QDD4QC.-P!^_TX_&HY=<\4:G;ZF^A1--=:=>&T2,K"L$[1[?,\PL^]<D
MMC;C QUK?C\*QQZYINJ_VC=M-86C6B(1'M=&VYW?+G)VKT(Z54G\"6[:]=ZG
M9ZOJ=A'?,'OK.VE417# 8W<@E20,$J03[4 0#5=;\02Z]%HUS#97.ERI;PQ3
M*'667RUD;S#@G9\P4;<'@G)Z"D;R_MOB7J$UWJ$GV6TT*.[:WC560?.^]5R,
M\[ <]3].*U;KP/;R:_/JUAJNHZ8UVB)>P6;JJ7 484G*DJ<<94@X].M77\*V
MA\11ZQ%/<0E;-;*2V3;Y4L2L64,"I/!)Z$9Z'B@#F9?%6L6GA/0_%TDT<MK?
M2VYNK$1C;'%,P"^6P^;>NY<Y)!YX':UIVH>*-3\0Z]!'J%FMOI-\L:P"UYN$
M,*OLW%OEY8?-S^ XK1L? ]G96=KIWVRZFTFTN!<6UE+M*QL&W*I;&YE5N0">
MPR2!BK5CX7AL;K6YUOKJ0ZNV^=7V (VP)E,*"/E ZYZ4 9'@WQ1)KE_]FN;^
M6._AMLWVEW=N(9H)<K\R<#=']X9R>J\\UVM8$'A9%OHKZYU&ZN;V"S>S@N65
M%D1'P2Q*J S94<D8]N3G5TZT>PTVVM)+N>[>&,(UQ.09)"!]YB.] %JBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT(]:K7FO+#J<NFV=G-?7L, N)HHF5?+1B0N2Q W-M; ]CG% &O17G_BCQ?\
M;_!6G:AHD=R\&H7]O;2,I5'C!G5'B8%@0Q^9./?D<&J=_;)IWC'1M(M]&O/[
M-U0W-U<V#31F-G6-  JE]H W%B.F<$9QP >F45PV@7GA[PS_ ,))#%%J%LNE
M-$+R6\G:8OE,Q[/F;C:5  P3P,9K:'BJ&"\NK?4["[T\6]D;]IIE#1^4#AOF
M4D!AW7\LT ;]%<M;^.+*;6H=*:TG2ZNK=[BU421/YP3EDX?Y7 .<' ]ZE\,>
M+D\5107-KI.H06,]OY\5U<*@1CNVE.&)W=^F.O- '245D7FO+#JCZ99VDU]?
M1P"XEBB95V(20N2Q RQ#8'L<XK)?X@Z:=.TB]MK.^N8]4N3:1+&BAHY@&S&X
M+##91AZ<=<<T =;15&PU![O2([^YLKBQ8H7>WG ,D>,\$*2#TSQ63IGC"WU#
M4=-M'L;JU.IVK7=F\P7YT7;D, 25;#*<'M[\4 =)17)2^/K)+.SOXM/O+BQO
M;TV-M-#Y?[R4,R#AF&%+*P!/IVR*=K/C[3-%2\FEBDEM[&18[N2-X\Q$XSA2
MP9MNX9P/7&2"  =717)W7CJ**^U2SM=&U&]ETZ".YD,/EA7B<,0RDN!T7IU.
M>!UQ%/XTEFUOPO!IMA+/8ZS;278E#(&*! 0N&(QC>I/TP,\T =C15+5M5M=&
ML&O+MB$#K&H&,N[,%51D@9)(') [D@5R>J>*K/6]$\4Z2JS6U_9:=).0DP.Y
M"C%71XV]1@C@_A0!W-%<AI'B&#3?"OARU8>?>SZ7%*L9E1/E6- 6+.0!RP'J
M2?0$BQIOCG3=8T^PN-/BGFN+YY8X[0[0ZM'_ *S<<X 7C)R>HQG(H Z>BN(U
M3QS<QV&ES66CW:R7.KIIL\<X5&C8-\P&3AMP4@,#CG.1TJ_K/CBQT9+UWMI9
MOL$:R7B))&&B!4,0 6&Y@I!('8\$GB@#J**Y^3Q+:7["TTRWGU%I+-+M_L[A
M-L4@.SYB1AFP<#VYQQ6?\+)7F^&NC22/([LDA+2$EC^\?J3WH ["BN9O?&MG
M9VE]?K9W4^F6$Y@NKN(*1&5(#D+G<RJ3AB!V.,X-,O\ QM%:ZR^E6FCZCJ-R
M+-+U/LHC*R1,VW<I+CWZX]LT =315#6-5BT737O9H9I@'2-8X5W.[.P50.W4
MCD\"L2Z\=6EC8Z]/=:?>++H>TW<$>QCM9-ZLIW $8^AX/% '545RMMXX@FUZ
M#2;C2=2M);R%YK%YT0+=A1E@OS9#8YPV#CKBJ$'Q.L)K33=0?2-5@TJ^G^SB
M^EC01Q2%R@#@,3@D?> (&<9ZX .YHKG;[Q?;VD>ISP6-U>6NEL4O9H-O[LA0
MS!02"Q52"<?09.14$VLZ1=>*] V6]S/<75G//87<<F(6CVH6XW#)(*8RO?K0
M!U-%<6GQ&M'M5O#H^II8B_.GSW#K&%@D\SRQN&_)&['*@@9_"K-KXKG;QAX@
MTZ[LV@T[2K>"0W)=,*&61F=N<X(4   XQDXS0!U=%<M:>.M.N-:L=-EBD@;4
M(GEM)&DC97"#<RL%8E&V\X/;/<8KG_%6N_VO'X3O;.UO$L9]=M1#="0*DJ;S
MR4#9VMC*DC\LC(!Z317'?%4$?#+79%DDC>.WWJT<A0@Y'H>1[5:M_&<;Z\-&
MN='U&TNIH7FLO/5 +Q4^\$.[Y6Z':VTX/.* .GHKF[#QE:ZCX;AUF"PO<2W7
MV06K>6)A)YGED$;L#!R3SP 33_'&O77AKP;J.K6=MY\\$?R@L $)X#'/4 GH
M.OZT =#17G^KWUQ;_$CP]<K8WSS3:;>9LEE4DLK1X_C\M>"3G(Z^O%;5IXWT
MZZT.VU$Q30R7%R]FMK*4603(6#H3G:,;&.<XP/7B@#IJ*P_#OBBS\1/?PP(\
M5UI\PAN(796VDC*L&4D%2.A_E7*ZU/;P?%^VMKV\O(["717F:&.XE5#*)@ V
MU#UVY&: /1J*\[\&>(%.H>+;D:G+/X7T]T-O/=RL[Q$(3,,M\^P$<;OPS71Q
M>+8!?Z9;7EC=62ZH#]BEFVE7;;NV-@DJQ'(!ZX(SGB@#H:*YF+QI:R7>GHUC
M=Q6VH7<MG;7#A0&E3=G*YW '8V#CMSC-1V?C>*]U&ZMH]'U%(K*[>UN[F01B
M.W*QA]S'?]T@]LX[XR,@'545YQXAUI]5U/P1>6]G>P6EUJJ-%.T@5)8S%(1N
M0-QN^5AD9P#G!XKN=7U:UT73GO;LML#*BH@RTCLP554=R6( ^M %ZBL*#Q,C
MZU+HUS8W%MJ(MC=0PNR$7$8.#L8-C(. 0<8R#TYKF_!</_"3&36M2M;N*^M=
M4NC%<B95RJR,@A.UB2H4 ;2,9&>>I /0:*X'Q!!]H^*_A^S:XO$M;BQN7FAB
MNI(T=DV[20K#D9--U"ZO/!WCS0;>"]NKG1M;=[:2VNIFF,$P&5=&8EL'H5)Q
M0!Z!17#0^+=(T70O$6LPZ7J2Q6FJ/%>QEE=S-A 6 +D!?F48!_"M4^+HXR(K
MG3;NTNI9GCMX+IHXS,B!29 =V OS*.><G&* .DHKE].\=Z9JEC%+:Q3M=R7D
ME@+/Y?,$Z EQD';M"C=NSC&.Y JAK7CFZM=%-Q::1=I=)JL6G31SA5V%I%!9
M23AP0WRD<<\XQ0!V]%8<WB/%Y+8VNG7-U>V]NEQ<6\;1@PAL[5)+8+G:V #V
MY(R,YS_$'37MM$N+*SOKV/6"Z6WDHH(D16)1@S#:V5(] >I YH ZVBN9B\8"
M83*FD7IN;:".>[M28Q+"'R0"N[G &3C\,GBMS4KY=,TRYOGAEF2WC:5HXL;B
M ,G&2!T]Z +5%<?#\0()7T<G1=36+6(/,LI-L9$K[-_EXWY4XSRV%X/..:GM
MO&]O/97#OIM]%>V]^FG26156<3/MV_,K%=I# [LXQF@#J:*Y.Y\>6UGHNL:C
M+I=^YT>?R+V"((SI\H;>,L 5VL#USUXXK:_MB,ZE8V4=O+(UW UP)$*%(T7;
MRQW=RX QG//I0!I4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4450U/6=/T?[+]ON!#]JG2VA^
M4G?(Y 5> <9)[\4 7Z*** "BBB@ HHHH *QK^76+?6-\%BM[I;VX62)95642
M;CRH;"D8/.6';&>:V:* /,O^%?7ZZ5KDNEQVVEW%UJ4&I6%@QW10O%M.'V\#
M>0<A<@9')Q6GJ>C^(_%OA._L[VQL]#NV2,VR1SB?,R.L@9F"C"Y0# R>23VK
MNJ* .5B3Q-KVAW]KJ^GVFF/-926ZQQW/G>9(RXWY"C:H].2<\XQSD/H6OS>'
M?!MI+IT2SZ/>6TMPJ7*L/+BB*$@G&6).0/3O791ZSI\NMRZ.EP#?Q0B=X=IX
M0G .<8Z^]7Z .%M]!UG1SXHT^UM4N[36;B6[MIS*JB&25<.L@/.T$9!4,<'I
M2Z3X7O-"\3Z*]O T^G:;H9TTS;U#.^Y&SM)Z?(?Q/IS7<U4CU.TEU6?3$D)N
MX(DED38P 5B0IW8P?NG@&@#%\":5?:+X:%CJ, BG6YN)?E<,"LDK..1[-@^X
MJ+7K75O$>F:MX?N-'B@M;I6@CO6N5=/+/\>S 8..H7&,@?-WK;OM:T_3;JRM
MKNX$<U[+Y-NNTG>^"<<#C@'KZ5?H S@;ZVU&RL[>SC?31 PEN6FPZ,N JA<<
MY&><]JQOB+H^H>(? ^HZ/ID"RW5V$52[A%7#JQ))]@>@-=510!QM[HFJ6?B2
MT\3:':JL]PBP:M822A1/&!\KAAD>8G0>H..*C;3]:C^)4OB*/26>S?24L0AN
M(Q)O$I?.,XQ@XZUVU% '*ZA%K=_I%[$-*CAWSQ&WMUF3. X=W9N@).1@9Z9[
M\5W\'RMX_P#^$@CD,=A<0)+>67&9;F+B)CVX#'OU1:Z>PU.TU-;AK24N+>=[
M>7*,NV1#AAR!GZCBHQK.GG7?[%%P/[1\@W/D[3_JP0N[.,=6'?- '%6/@FZU
M/2/&6CZU;&WMM;U"6[@E217* A-F0#]X% <=/>MV";Q1#H2:>=.B?54B$(OO
M/7[,2!CS"/O^^W;UXSWKIZ* ,7PQX:M/#/A6ST&$^=!!$4=G'^M9B2Y(]R3Q
M[UD^ _"5SX6M[R"ZN//1)6@L.<F.T#,Z*??+MGV"^E=A10!S?]CMJWB6\NM8
MTT&VBB6&Q+2*PVYR[8!R"QV_@B]#Q6;X=T/4O#7BW7OLFG8\/W[+<0HDJ[HY
MPN'(4GH^ >N<CIZ=M534M3M-(LS=WLAC@#HA8(S?,S!5X4$]2* .-\'V?B3P
MSH=S93:$D\KWD]PA2]0+B1RP!R..N.]=/;3:VL^FQ7%G;O') SWLZS8\F7@A
M%7'S+DD9]!6G+*D,322'"*"Q.,\"JVE:K9:WID.HZ=.)[2<$QR!2-P!(Z$ ]
M0: *7B>&_N]':RL+9IC<LL4Y$@0I"2/,P2?O%=P'N<USOC#P7YVE65QX9TZ&
M+6;&[BN+5MX15VGYE8Y^Z5R,#VKNZ* .2-AJDOC^RUU].9+6/2I+61?.0L)&
MD1^.>1\F,^]9ECX<$/PRU#0O$1CLM[74WF^:&V!I7E5P0>JY!^JUZ!6=J6@Z
M5K%Q9SZCI]O=2V;F2W:9 WEL<<C\A^0H I^$+.^M?#EM+JK!]5NU%Q>MC&9&
M4<8_V5"K_P !K/;2=2TCQW?:[96WVVSU.UBBN(4D59(I(LA&&X@%2&(/.0?6
MNMHH \ZNO!VIVO@^STZU@CN+UM935+G;*%1/W_FLJDX)XPHXYQGBMO5M/U*[
M\<>'=5AL6-I8PW*SDR(&!E5 ,#/.-O//?C-=510!YYJ?@[5-9D\;PD+:+J[6
MTEC.7#8>%$ W <@%D![\>_%:,ECXD\6>&M1TK7;*UTG[19O;DPW'GF21A@..
M!M0=<9).>V.>RHH Y/P])XK\N--:T:QMGM8R'FMK@2&\;&!M4@; >IR<]L=:
MG\ :5?:%X(TS2M1A6*ZM(S&X5PRMR3D$=N:UI=9T^'6;?2)+@"_N(VEBAVGY
ME7&XYQCC([]ZOT <G)I.I:5X\N]?LK8WMGJ-I'!<P)(JR1R1D[&7<0"I#$$9
MR#SS6*/!VJ6-MH0@MTGFAUV35[W9* J>9YF43.,X\P#MG:>F:]&HH @ODN9-
M/N4LY%CNFB80NXR%?!VDCT!Q7GNE>'O$%OKGAK5[[3;2*2QMIX=2N'O=\DK,
MJ9E+;>1\I(&>,XX%=UIVLZ?JTEY'8W F:SF\B<!2-CX!QR.>".E7R 001D'J
M#0!Y'IBZA:Z7!J$GADWF@V]W)JMM]FU./RE!9G61(V4-T;<%+8R>@. .@M]+
M\3Z'K^JQ:?IMAJ&F:G=-=Q7,\_EO:.X&\.NTEUR,@#'ID=N@L_!OAS3[L7-I
MH]I#(&WKL3"JW7*KT!]P*W* .+71M5B\2^)KW[(9(+_3X+:W<2("SQK("2,\
M EQ^1JAIWAK7;"/P+*MI \NBV<MG=QO.% W1HH=2 <C*=.O->AT4 <]XTT2]
MUS0!%IDL4>H6MQ%=VWG#]VTD;!@K8['D?C5%XO$6K^&=6BO=&M=/N)[*2WAM
M8;E92[LI&YGP JC(P.3U]A77T4 >='0/$>E?\(YJNG:?;7ES9:8NFWVGSSA-
MZC:0\;X(R&4]>H-6]7TCQ,;[0_$EC:64FI67G)<:8)MB-#*%^59"OWE**<D
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MC21L&"MCL>1[5T,DBQ1M(YPJ@DGVJII.K6.N:9#J.G3B>TFW>7(%(W88J>"
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M+:'B$\<>,$DC(8YY]JU;^WU%_BK9P6U]''='P_,&N7@W8'GQ\A,@9Z>U:;>
MK63P_K&CRZA=M'J=XU\\N$#Q2EQ)E>,8W*."#5V/PPR>(H-<;5+J6ZBLFLOW
MB)M968.6.%'.X \8';% ">!]9N]?\)6>H7_E_:RTL4IC7:K-'(T>X#MG;G'O
M5-=7U/7=6\066DW4=H=)9((M\0<33% YWY_@Y P,'@G/2M;PUH$?AG1UTR&Z
MFN(EDDD5I@NX%W+D?* .K&JTOA94UR]U;3M0N+";4(U2\6-599"HPKC<#M<#
MC/3ID&@#E;7QEKWB,^$SI<MI8+KEG=/)YMN9##+"%!(^8;AN)P./4D]*[_RK
MXZ0(3=1B_P#)"FX$7R&3'+;,],]L].]8L?@RRMM0T&YLKB:VBT6%X+:W0*49
M7 #;B1DD[1SGK72T >8Q>.M333?#%W=W"1M->/9:S$(1^X=7\LL#_"HD*+SG
MA@?4UK>(?$&LZ=X;O-9L[F Q?VE%! DD&3Y)F2)CD$<EBQ!Y^7;QWK2N? ND
M7,'B*)ED UTYN"#_ *LA  4'8Y&[ZU8UKPM;:QX<AT,7$UK:1&$J8@I;$3*R
MCY@>ZB@#)M'U"3XN:G"^H.;6'3+>1(#&-JAGD! _%0<]?P KEO!VJ:QHO@WP
M5.ES;MI][??8)+7R?FP[28??GJ"O3&,'\:] D\- ^)CKL.HW,-R]HMK-&@0I
M*%+,K$$$@@L>A&>,^^9!X @M]"T724U2[\C2+Q;R!RJ;F=2Q ;Y<$?,W0"@"
MI+XEU?4="\0ZYI<\,:Z1<W$4-K)&&6<0??WGJ"Q#8QC'&<U9T?Q-=ZSXI@M8
MI/+T^]T&+4X@4'F1.[XQGH0!ZCK5I_!5N'U>.VO[FVL-7=I+VT0*0SL,.R,1
ME"XZ]?48/-37?A*&37+/5+&_N=.DM[3[$T=NJ%9( P8)\RG;@C@CGF@#C%US
M6M>TGP%?2:@+>6^U*2.=88AL<JLVTD'TV#C.,\]A7H7B#5U\/>&M0U>5#,+*
MV>8H.-Y49Q[9-85O\/K6UT+2-,@U6_1M*NS=6UQ^[+JQW;EP5(*G>W4$^]=/
M>V%MJ&FSZ?=Q^=;3Q-#*C'[RD8()^E &+:_\)(ES;7+W=C=64UFSS(P\LQS8
M!7RR <H>0=Q)&,Y[5B:/XFU6?Q%HVG7%Y'<)J>GS32RQ0XCBF39GR7Q\Z?.1
MD[LX!SU%:6E^!TL=.DTZ\UO4]1LA ]M;PW#(/(C92IP54%FVD@%B<#IBFZ=X
M$6PO=$NGUS4;B32(7MX0XB :)@HV$!!TV+SU/K0!D6OB_69?!7A[5WE@^TW>
MLK8W $7RO&;EHL@9X.U1WZYJZ_BNX3QA)HUY=G3+DWB+:07$'[F]M_ER4DQS
M)RW&?08[T_\ X5S +2.Q76]12QM]0&H6L"B,"!_,,F =N6&XG[V>OXUIW/A-
M+YUCO=0GN+-+Y;Y(9$7*2*V\!6 R%W<XZ\D9P<4 8@\0^)M6M6U30;)IXX[^
M2 6S^2L<D,<IC<ERX</\I8<8Z#!ZGO:Y*'P)%:ZQ=W-GK&HV^G7LQN+K3$9?
M)DD/WB"5W*&/4 C/TXK2TJPU&VU_5[F>_N9[&X,9MX9]N(F&0VS'(7[O7DD'
MZD Y_P 5QWLWQ(\*QZ?<16UPUG?@32Q>8$'[GG;D9/X_GT.=)XH\4P>'=:>2
M2WDU#P[?B.]>&WXNK7"N752?E<(Q..1Q[UV6K^'QJ6K:=JL-Y+:WVGB5(F55
M=663;N5E(Y^Z.A!XJI.;#P?8,&LM1U&34;EC.T%L9GFE8<EPHPHPH4=   *
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M:6.6+SG5/,59"Q;&!C^(XXH P)[[5=0\1^ )/[1:)+ZQFN)HUC4J9!"AW?\
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MM=VV\1D[CN^4_+RN';WYZ], "Z=J.LWVN7?AY]3B%SI=I%)=WD5L!YTLI8H
MA) 4*N3W)/!&*;\*=W_"M=)WXWYFW;>F?.?I6C?>%%F\2C7[#4KK3KQX1;W/
MDJC+<1@Y7<KJ0&&>&%6O#'A^+POH4.DP74]S%"S,KS[=PW,6(^4#C)/7)]Z
M,/\ MW5M9A\2W.D7$5O_ &-<R6L$,D0<3R1HK-YAZA26VC;@C&><X&->:G<^
M)=9^'.K6MPUHE_Y\RQ&,/Y3_ &5R>O7J1^M=3+X0B74-4N;'4+FRCU8#[;#&
M%*LVW:73(^1B.">0< XSS3KGPC;27NA3VMS+9QZ(&6T@B52F"GEX;()(VG'4
M4 ;^T)&0 !U)P,9/<UPWPGMX;OX0:-;7$22P2PRI)&ZY5E,K@@CTKN)XWE@=
M(Y3$[# < $K[X/%<KI?@3^R?#<7A^W\0:HNG1JR!4\I)"K$DC>$R.IY&#[T
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M/A!)$[OO)7"X^]SR#5S3=!CL=7O-7EF\^_NXHX9) @0;$W;>!W^8Y)]N@&*
M*'B+4M0MM2AMK>\CMX7M)9%$4?FW$DH*[0$P1Y8!.YN.2!D5RRZWJWB"X^'-
M\+W[)_:232SQ11@H9!;N<\\XY.!GC/>NPU+PLE_XCBUJ/4;RTG%J;.9(=FV:
M(MNP=RDJ<YY&#6?:_#^WL],T&TAU?4%DT5V-M<?N]^UD*%"-N,;3C.,]\T =
M#K5S<V>AWUS9FV%S% [Q&Z?9$& R"[=E]:YSP_XAO;GQC<:--<-=6O\ 9L5[
M'/);^4VXNR, ,#*' (./Q-;^OZ);>(M O-'NWE2"ZC\MFB;#+W!!]<@5G:?X
M3-GXCCUV?6;^[O!9BSD\T1A95#%@2%48P2>F/?- '1T444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 445S7C6UO+S3K*+3Y[-;O[8K1VUZ"8;S:CDQ-CV!8>Z"@#I:*\@N9K?4M/
M\-1_8KK2)$\3-9WEFMR0J.4D9U1E(!4DK@CIT&,5'JJS^#KGQA;Z+)-#HL26
M$TJ*S.+4R2XGV<Y&8_F(!!&0>.* /8Z#TXKRG6E31=(U_6_#>LV\DLNE;C::
M5$%B4!QFX #-A]K, >,X_P!DUU&DV/A>XU6&^T:\!^UV!C,%I-B.6+(/FN!S
MO&<;B<_,10!T>F2WTVG0R:E;16UXP_>PQ2^8J'/9L#/&.U9OBS7YO#>CKJ$5
MHEROVB&!U:79M$DBIN'!S@L..*X#PU<VL_@OP%973/<75R9WB@GE MYMH?<T
MV0=VT-D#J6QZ9%07(E^$5W#]ICF%OX@6*/8V56,7Z[0HR<+@<<]* /9Z*;)&
MLL;1OG:P(."0<?4=*\4T[3X!X \%:FKSB_?6HK<W(G<2>4]PZ.@;.0"#V[\]
M>: /;:*\@UF9O"U]XWATK?;6446FSR)&681*\C+.X .02@Y((/&<YYJYJJ1:
M/IFNZWX=UFVDDETDN;32X@L0 8?Z1@.</M+ 'C./:@#U(D*I9B  ,DGM6:=3
MFO=-LK[18H;R&YDC.YY?+'DL?F<<') Y [UQ=MI>BWD\FH6&K6%S!>:7*DEC
M90 17"8R))%+-\P.!N//.#6+;0V<7PQ\ 26NR.0ZCI9E\EMNYF90=X'4\=_2
M@#V&BO+-0T>RU'Q'\1$NUDF2&QMI8T:9]J.893N SP01D>G:I([YYH_ 5QJ<
MT=[:W&CE[BTED3+R&*(^<0Y ?&2OJ"^0.N #T^BN6\ Z//H_AH)=2%YI9I9
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M.#GEO:H+[Q3/HE_IL&M:<L$&HW"VD-S;7'G(LS9VJX*J1G! (!'KBLOXQ?\
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M8L--L]/0FUL;:U>0#S!"@&<=!D 9 [57;Q#IJW8MO,E9C/\ 9MZP.8_-[KO
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M,D9SAO7./3:* /.-6TYY-"TZ_P!,\-W-I&FO6VH36RQ#[0Z*0'D= 3\WMG.
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M#&-D;*P+9Z@X&/?/3FNPHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y3Q]JNIZ3HUE)IC1
M(\VHVMO(SD@[7E52!CUS@GTS75UA>+="F\0Z*EK;7$=O<0W,-U$\B%DW1R!P
M& (.#C% ',3G4[?XKWK:;963W\GAZ!I!)*4BW>?+DDA2QZ =/Q%:-EX\75-(
MT*:UM2EYJMJ]SY;*\BPJA57SL4EOF8 =,\G(Q@W(=!U2/QC-K\EQ:2F33$L?
M+"LGS*[/O[X&6(QSP.IK"M? &L:7HOA_^S-7MH=8T1)84E>%FAN89""R.N<C
MD \'M[\ '5>&-9N];TMY[[3)]/N8IW@>.5& ?:>'3< 2C#!!QZCM5+4?$6J1
M>,4\/6.G6LC2Z>]Y'/-<LHRKJA# *<#YNV<\=.M;.E6]];V?_$RNTN;R1M\C
M1(4C4X VHI)(48[DDG)[UF3Z'>OXZ@\01RP>3%I[V7DMD,VYU?=GH.5 QB@#
MGX/'^JOH5AK4VC6T=F;X6%XHNB9%<S>26C&W!4-@\D$\^F3=U/QO>0K?7&E:
M3+J$-A=?9I(8HI6EF*D"0H50KE23P3SM/3BJO_"#:G_PAW]A?;;3?_:?V_SM
MC8QY_G;=OUXSGI5J#PMXATS6M0?2-:M8-)U.<W-Q!-;F26WE;_6&%L@?,>?F
M! /8]P!VJ^,[N+^TSH^F27QTUPDD/E2EYWV*[(A5"%(5QUZG(P.I;9:YK-[\
M0Y;)8XDL%TF&[2"4LDBF1V!WC!^;Y,8[?G3G\+Z_IWB2^OO#^L6MO9:FRR7=
MO=V[2F.0*%,D9##DA1D-D9'>KP\.7MOXR77+6^C,+:='9313H6D;8[,K!\\$
M[B#D&@#!MO&<UEX2MM2M- M(O.UEK"6VAFVA6:X,9<'8 Q)R3G;R<UIQ>,;J
MSN/$D&M6$43Z-:+??Z)*91+$RN<?,J_,/+(Z8Y%4%\#:HOAJ'2OMMGOCUC^T
M_-V-@_OO.V8^IQG/3M4NNV5UH=QXG\43W$*PW.F);JB1&5HF3>%<@\,,R<@X
M  Y[T 6K?Q7J;:WH-A+I]HR:S:-=I(EPP\E5"EEQM.\X=<'Y0>>E2?$N..7X
M:^(1(BOML96&X9P0IP?K7-^%)+K3]0TV*UOO"NJQ>6ML!ISRM/'#QDKEW"H,
M D?*#CUP*[SQ'HX\0>&]1T<S& 7MN\'FA=VS<,9QD9H YRS\3ZO8ZSI&D:GI
M5M!;ZI PL+B*X,A$B)NV2C:,$J"?E)'&,GK26WCNYN/#'A_63IT2_P!IZDMA
M+%YQ/E;I6CW*=O/W<X('6M.V\/WMSJ.DWNL2VQ;2486\=L&VO(R[#(Q;I\N0
M%[9)R>,<_%X!UJ+2-/TA-6L5L]-U5;^U8VS%V42M)M?Y@#@MCC&>N>Q -;PW
MJNL7_C'Q/:WAMS:V-Q%#$J,V4!B5Q@8Y)W<FM+Q1XBB\-:?;W4YCCBFN4MVG
MFSY<&[/SN1_#QCMR1R.M1:7H%YIOBO6M3%Y"]GJ;Q2M#Y1$BND8C^]G&W"@]
M,U?UFTO+RW@2T-LRB7-Q!=(6CGB*L"A].2#G!Z=#0!C77BF^L8]%DFM+25-2
MU,6(>"<LNQ@S+*IQR"%Z=L]3BH[CQN;&Z\1PW=FI_LF6VAA\N3FX:<#8.1\O
M+ 'KW-41\/IK30;>UTRYMK:XM=9_M:VA96:WB/(\D#(.S#'D8Y).!THNOA_>
MZK_PDO\ :.K1 ZS]FD1[> JUO+"J[6&6Z!E''4CO0!9\37&JS^'?$]AJNEP?
M95TB6:*[B?=&S;&S&5;G<N <]#GM4'AKQ#J%H_A71[VP@2TU'3 ;6:.<M(&B
MB0D.NT 9!XP3TJ^VB>)M1\/:C9:QJMA+=7-G):1FV@:.-0XP9'!8EF]A@#GU
MID/A;4$U#PG<-<6NW0[=X)  V9MT8CR/[N N<<]<>] &YXAU.;1?#NHZI!;I
M</9V\EQY3R% P12Q&0#V'I7/P^+]4CL[*>_TNWA.J&)=/6*9Y6;=$TCF153(
MVA>BYSD#(ZUT/B'3IM7\.:EID$B1R7EM);B1P2$WJ5)P.N,]*PM3\)7]]X9T
M6VM]1CL]8T=HY+:Z2,M&61"A#*>=K*2",\9[T 4;SQWJVGZ3J%S<: WF65[!
M;;W\R&.XCE9562/>@)(+8*GH1UJX/$GB)O$E[X?&DZ<+U+1+VWD-X_E>6S,F
M'.S=N#+V&#GJ,<IJWAKQ!KOAM[+4=3L3?2W$$K&&%UAC6*0.%52Q))(Y)/?I
MQ5]=#U!?&\OB'S+;8^FK9"#+9!5V?=NQTRV,8Z<^U %#2O')UJP\/BUM$CU#
M6(I9?*D?*0+%Q(20,M\V !QG/;%5KWQW?VFD:_(-*BDU+0)5%[;B8[6A8!A*
MAVYQLRV".-I&?6/2_ -_I%CX>EM[ZV.J:*TZ*Y1A%<PRDED8=5/(P1G!'0YK
MHM*\.I;7.L7M]Y<UUJ[J;E5'R!%0(L8SU &<D]2QX'2@ N=<N5EE-A:)?Q1:
M>;PB%\/(QSY:)G@[MK<YXP/6J&D>*)-3\2R^'[V"S=SIXNV-O)O5#OV/$X/<
M$CGOZ"H['P1+I_@*^\.0ZK,L]Q')"E[_ !1IC9&/HJ!5Z]B>]-TOPMK-EXBL
M]8FO=-S!I9T]K:WMFC3 8,NT[CCD<\=. .] !\*@%^&FC@#  E  _P"NKU9U
MSQ8VG:__ &+!]D2]>S^TVR7DAC%VQ9E\I&Z;AM&>OWAQUQ;\&Z%<>&O"]IH]
MS/%.]N7Q+&"H8,Y;H>GWL?A53Q5X9N/$L=W93I87&GW%L(XTN4.^VFRV9D(Z
MG#+Q\OW>O- &+='4(/BU?-I%E:O>2>'X783R&-,^?)RQ4$D\ =/QK4LO&-SJ
MOA_0]5MK**WAU&%I9[BYEQ%:%0/E)X+%FX'3H3[5+9^&K^P\5?VNEU%/&NDQ
M::JREM[%&9A(S=R2QR/UK)TKP+K.D6OAF.#5+-WT:.:%EF@9HY!(1B15###K
MR.O0GD9H HZUK:>*?!GA36GM4AE?7[1=N=^QEN=C;6P."5_*MO3HTC^,&ME$
M52^D6K-@8R?-EY/O5.#P'JMOX6TW1O[2M)#8ZL-020PLNY5F,H4C)Y);&>@]
M#UK?M=#O(?'%YKSS0&"YLHK7R5SN78S-NST.2Y&* ,OXK(C> ;J0Q"1X[FT9
M.!D'[1'T)Z>E(_C:]T;6;NQ\3:;!:1+8RZA;SVDYF5XXOOH<JI#@$'T.:V_%
MFA/XE\-W.EQW*V\DC1R)*R;P&217&1D9!*XZ]ZH7?A-M?N9KG7WB+/I\MA'#
M;$[8TEQYC[FY+'"XXXQWS0 W3_%&I7&O6%E/H\OV2^A=Q<10R[;5U&[9(60#
M!'1@>HQCO6GXHU2]T3PW?:I8V:7DMI$9C TA3>B\M@@'G&3TYQ6=X:T;Q-IH
MM[;6-;M;RSLUV0&&W:.688V@RDL0<#L!R<$GCGJ'19$9'4,K#!!&010!RL7C
M#S/%VG:05M?LFH:<;ZWNEE.7QCY=N..,L#GH#Z57F\03R7OA-KW1[)_[3N7$
M,QD+/;_NG964%>"RCGD8R1S5-?AE"OAVSTS^T)3-:7PFCN/XEM\E/)![#R6*
M_4DUO:]H-UJ>L:!>6TL$46EW+3LC@YDRC)M&.G#$]Z .-U34-4UCPA\2(]46
MUD@LVN880I)\O;;H5 !'N3GKDGBM[1_$M[9ZCI&DZG96\%I=Z8UQ;3QSEF7R
ME3<)!M '#@\$XQCGK277@O4I+3Q;90:A:BTUYI)%#PMOB=XUC;)!P0 N0,#K
MUXYLOX6O+C6= O+B6U:'3;*:SFB ;]\)%120>WW!QSU/- %:3QU/!H.G^)I;
M&,:%>3(A(D/G0QR-M25AC!!)7*CD;NIQ4MQXQN[>T\7R?88&D\/?,!YI G7R
M1+Z?*<''>H+3P-=IX;M_"MW>PSZ);3HZ/M(F>))!(D3#IP0 6'4#H"<T:MX,
MU:ZNO%*66HVD5GX@@VR"6%FDBD$/E<$'&T@ GC/7ZT .CU_6+OQ]H]I$MNEA
M<Z,]ZT1=LY+Q DG') 8@#W.3Z=%XCU670_#>HZM#;I<-96[W!B>0H&"*6(S@
M\X'I6/#X5U&VUS0]3CU&V,EEI[:?<@V[8D0LC;D&[Y3\F.<CG\*M^/"%^'GB
M0D@#^S+GK_US:@#)M_&>KQ:QHL&IZ-;P66MQD6<T5T79)0F\)*-N!N&<;2V/
M>HM/\=ZI-HD^O7NCVT&EV[7$4GEW1>4RI*8T51L (8\9.#GMC&;6D:+=ZK9>
M&+Z_DMFBTRW6>W2$G]]*8MBNV?N@!FX&>3G/&"EEX'D/@;4?#.I7:,MW+-*L
M]N"I0R2&0'![JQ'UQ0!:L?$>K7&N2Z;-H[-&UJ9X;I8YHX=X.#$[.@P>X(!R
M,\"LO1?&&/#_ (/GMM'M;2TUF<VWV>%]HMOED8;0%P1\A].M:.FRZMHIM_\
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MR)%<*P_AWJ"&4C!'/8YJEXMU75['7O#%IIQMQ#>WKQS"1F!?$3L%R!PO&??
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MG"#MQ]X9SBJ<A\1V>H>#M+O_ !"\D\UU=6]W):%<2JL,C)NROWP  >V1G&:
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ML:RRI&L>-C9VL"7 .<'WKH*\\@COY/C+KPL+FV@8:7:[C/;M*"-S] '7'ZT
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M6*-75S&R1L&94<@_,RC;ACSWH ]+JIJ5Z^G6+W*6=S>,K*/)ME#.<L!D D#
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MP=KX]Q]:Z.B@#+3P_I\>LW>K(LZWMW$L,T@N),,BYV@+G QDXP.].T30M/\
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M,]3P>* )**** "BBFNZQHSNP5%&69C@ >IH =10"",@Y%->1(UR[JHZ98XH
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M4;0VB':TXG78I]"V<5+;7MI>;OLMU#/L"EO*D#8R,C./4<B@">BBB@ HHHH
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M@FCE0,5+1L&&0<$<=P: )***C^T0_:?L_G1^?MW^5N&[;G&<=<9[T 24444
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M92Q+J^\#G'*XQD^N>U6-!T2^TK6=?O9GMY$U.Y6XC1"P*$1JFTDCG(4'/Z4
M<_9>,WLO".FZC9>'K:%;S6&L'M8)@HC9KAHRX^4!B2"3G;R:TH_&D]F?$R:U
MI\<$NAVZ7;"TF,JRQ.K,,$JIW?(0>,50B\#ZK%X9T_2OM5F9+36!J9D^;# 3
M&;9C''+8S[=*?KUE<Z$WB[Q)<W%M';WVGQ6Z#RS+Y+('568$8929,G/  YXS
M0!H6_BK46\0Z1I<VFVV-3M#=I*ERW[M5V[EQL^8C>N#P#ST[V/'FIIH_@S4+
M^;2[?4X(E4RVMPV$=2P'.5(."0<8[5S'A9[S3M4TZ**?PQJ431K; Z=<2O/'
M".<KN9P$! )&0.G? KK?&>AW'B7PG?:-:RQ0R72A/-ER0@# YP.O3]: *M_X
MCU6+Q>WAW3]*MII#IYO8IYKHHOWPF& 0D=^F<\=.:O\ A77?^$E\-6>K&W-N
MTX8/#NW;'5BC#/<94\U4_L34?^$W3Q"6M=BZ8;(P;VSN+A]V[;TR,8Q[^U2^
M#=#N?#?AF#2KJ6&9X9)6$D60&#R,_0],;L?A0!F^)?&ESX<%_<S:?$MG9R1(
MOG3[)+L-MWM$,<A=WXD'I4M[XFU@>*+_ $'3M(M9IK>R2\CEFNRBN&9EP0$)
M!RIX&?J*R]=\"ZSJH\301:G9"#5VCDCDGA9I8M@7$60<;,KD<?Q'CG-;,&A:
MK%XNN]=DELY#/IT=GL7<GS(S-N[X!+D8YQCJ: *-OX\EN;/PKJ*Z;&FFZZ5B
M>=[@@VTK*2JD;?F!(*@Y'./6NCTW49K^]U%#!&MM:S^1%,LA)E(4%N,#&"=O
M4\J:XB\TRPT7X:0>"-5U&W?5#:F.Q2%\2S2JV8V13SD/M_+/3..[T?3_ .RM
M(MK(R&5XT_>2GK+(>7<^[,2?QH S[G7;B;7[G1-*@@ENK6V2XG>>0HB;R0B<
M G)VL2>PQUS7(>)/%-QX@\"V-W8VRP&75K>SO;>:8AHY%N$5H\A2&4D$$\<'
MH<XKI[CP_>VOC"7Q%I,MNS7=JMM>6MP657V$E)%8 X(R1C&"/2LV[\#7(\,V
M^EV5S;_:/[375+J>52!)+YWFL HS@$\#G@ =: *.K6UW9_$CPX+;3=.B>^%W
M<W"K.P6:58D3<WR=0K$ XYR<XJQINM:1X6/BN*'0;73H-'DA#?8\%KHR*&3/
MRC!RX4 Y SUQ6UJ6B:C?>+=#UE&M4BTV.='B+,2YE50<''&-H[<^U9E]X%FU
M:3Q='>W4<=OKODF-H<E[=HD55//!Y4-V]/>@#2N/$6H:0]]-K6EK%I]K8->F
M\MI=Z@J?FB((!W8Y!Z'VJ/3O%-_<>(;73KG29!!=P-(MS"LI6%UY*2%D4#(Z
M$'DC&*CB\/:[K&AWFF>*M2M)XY[5[7_0(FCW;A@R/N)^;T   R>O&)_#>F>*
M;/R8==U>RN[>U79$UM R23\8#2DL1T[*.O.>* +^O:XFC)8QK$)KN_NEM;:(
MMM!<@DDG!P JL3P>F.]4+;Q)>/KFHZ!<6<$>JVULMW 1,?*N(6.W=G;E2&!!
M&#VYYXG\5>'9->M["6UN5MM0TZ[2\M9'7<A9<@JP'.U@2#CGO3+?0[LZY=^(
M+D6W]I2V2V4,2.QCBC#%CEB 6)8YZ# 4#U- &+\,[,:AX,\/ZMJ-I;/>Q6[-
M!=!BTI\PDR$Y P2>O)J\^J:M-\3I=$:.U?3%TI;@H7.3OD*DD;2"?DP!TP3S
MS6AX-T2Y\-^%-/T:ZEAF>SB\H2Q9 <9/.#T_6HKG0;\>.4\06ES;B)M/%E-#
M*AW';(7!4@\9W$'(./>@#C/!>OWOA[PAH:C38&TJXU::Q:43XD1I+J1594"X
MV@X!RP/MZ]%JOCF>V%_-INE2:A%87/V>6*)9#+*00'\L*A7Y<G@GG:>G!-2'
MP/JL7A/3-&^U69DLM5&H&7YL.!.9MF,<<MC/MFK</ACQ'I>N:B^C:O9Q:3J=
MP;F>*X@9Y;>1@-YB((!SC/S# /8\Y .FU34/[/T*]U)8R_V>V>X"$8)VJ6Q^
ME<M\.].@U#P79ZQJ445[J.JQ_:;NXF0.S[B2$YZ*HP HX&*[1X8Y(&AD7?&R
M[&5^=PQ@Y]:Y30/#VM^$[7^R=-N+*\TB-V-J+IG2:W4DG9D B0 DX^Z>U $J
M2V_A6;3O#>E0J\]_-<301R,52&/)D<D\G +@ #U X S6;J/Q!N--T?7Y)-*C
M;4M#GBCN;87!"NDI'ER(VWD$'."!C!&?73U;PS>W.I:/K5K>QMJVFO)GSE*Q
M3QR##QX&2@X&T\XQSG)-9VL^![O5=)\0 7%M'J>N2P-*YW&.%(=NQ1QEONGD
MXY8],8H FO/%?B'3]5TW3KCP]:&;4KF:*WV:AD;4BWJ6^3C/(.,XP< \9AM?
MB%)'#J5KJVF+;:U8WL%C]EBGWQS//CRF5RHPIY)R,@ \=J3Q>UV/&7@4Q"W%
MU]JN3L=SL/\ H[9&<9_''IQ3]1\!/JT&J7<UVEOK%Y>6][#-$I9+=X !$N#@
ML/O9/&=QZ<4 7I/%-Y9:Y/HM]80?;#9->V;QS'RYU4X="2N589'8@@Y]JIZ5
MXOU_4] M=97PY%]FO(8'@"7>YE,C ,9!M^5%!W9&>!T&2!=D\/W]_JIUB_\
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M3VY;:)8V3=C.,C&: /-O"?BC4M$\+^"XK[2(AH]];VME'=QW.Z1)60!"\>W
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MI,R^'G\P[1\_^D(.?7BLOP?K,'A_P;'&D(:2YUN\M;:)00N?.E;G:"0 J,>
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"<!U)^M&]"<!ESZ9H =1110 44WS(_[Z_G36GA62.-I4#R$A%+#+X&3CUXH
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M8-P^3C//IQ0!)138Y$EC62-U>-P&5E.0P/0@TDTT5O"TL\J11+]YW8*!]2:
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M' T$$%LS.J*S*SDNP!8DHG\(QCOFL_5M U&^\<Z'KD+VHMM,CGC,;NP>3S5
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:M:1K^G:V;E+*9C-:R>7<02QM')"V,@,K $9'0]#VKD-06\;XX6PL98(Y?\
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M:6HDV*22\LC2.['JS,Q)8GU)JC?>%M/O=6&K1M<V>H[!&]S:2F-I$'17'W7
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M/($*I'#']^61CA47W)/]:I7=QXLM=$GOTATN>[2%I%T]$D'S8SM$N[YC_P
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M#2;G1X--D6Y,<$ZW23?:7\[SE.1(9,[BWN3TJ'2[G77UL)>:GH=QILBN]O\
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M6]NX+:-C@/-($!/U)H%]:&?R!=0>;L\SR_,&[;_>QZ>] $.KZ18Z[IDNG:C
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M"IZ%PNS..<E:]>VC;MP,8QBA45%"JH51T & * /,98-#/CKP.$CL"LVFW7F
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M*%##.X22DCZX(S]17<;%+A]HW@8#8YQ3L#TH P_&DT4'@C77FD2-383J"[
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MZKD$$Y&*BU+6+?39[2V9))[N\9EM[>+&]]HW,>2  !U)([#J0*H^#]/U/2]
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MZ?J,GQ'L=8-A(EDFDR6KNTD>5D:1'' ;.,*1D=Z .ENYS:VDLZP2SF-"WE1
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MG._]X"&/'R]J6P\4:U/I-PMQ+8+<66M/IMS=E2@,:C(=(\DF0Y50H)Y.>>E
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M+/:SKOBD7.&'J,U9KROP_K6I>'_AAX,U&%[<:5MAAU$R1%FBC<[1("&  #$
MY!X.>U=_IE[=7VJ:F2\1T^"400;4(9G"@R'=G! )V]!RK4 6CJ=F-672C.OV
MYH#<"'!SY88*6].I JW7,R:QJ0^(9T)6M1:/I+WD;&(EUD$JI\QW<KR3@8^M
M<UIGC'Q)-HOAG6[M].-OJ6HBPGMHH&#?-(Z!U<MQ@J/EP>,\^@!Z76=<7&FZ
MG<W>@RS;Y_(#SP*S(WEN2 =PQUP1P:P$UK7M;@U*[T'[%_H.H-9I;7"G]\(V
M"REG!^4_>VX'89SGA+OQ9<:3XE\10WXA;3M+TJ/4$\J,B0Y,F5))(/W..!UH
M VH9M%\-)INAQSK;>;^YLK=I&=B%&=HR2< #Z<5KUYMJLNJW>K^ +^^GMRES
M?>:T$41'E,UO(0%;/( )!R.2 >.E78_$_B35+>#5-%TW[3:->M"UN41=T"R-
M&SB0R A_EW8VX[8/6@#NR-RD'.",<'%4-)T33]$CGCT^%XDGE:>0-*[[G8Y9
MOF)Y)Y/K7#ZEXJ\40VGC"ZMYM,5/#\V45K9R9T$2R%3\_P IP3\W/T'>^E]J
M=Y\4[&..]5+%]#-T+=HLXW2QAN=P^8X'/;TZT =S17'_ !&N-0MM%TXV%X+8
MR:K9Q2?N]V]6F48ZC ]?7ID5.FKZEJ?B'4]"L;JW@FTJV@:>X> MYDTH8J N
M[A %R>23NQD8Y .IHK!\'>()/$WAN'4)[=;>Z$DD%Q$IRJR1N4;:?3(R/K6-
MIGBVXU#Q0^CS7<%C?Q74R2:=<VY5W@ ?RY(G)P^<(QQG@G@8R0#MZ:8XS*)2
MB^8!M#XY ],UY\WC/65\%2:P?L9N8-9-@X\EMCQ_:1#D#=D-@YZGGM6M+K.M
MZO/KT>@-:)+I,PMHX[E"1<2[%=@Q!&U<.%&.<@GIQ0!T$6KZ?-J\VE174;WT
M,8EDA7DHI. 3^-7:\]N4U:?XJ7BZ?-:VEVWAZ M)-&9E0^=)P "N>>^?PKIO
M!NN3>)/!VEZQ/&D<]U 'D5,[0W0XSVR* -RBO/K3Q3XA\CQ!JUY-IW]FZ%>7
M<4\45NXDGCBB#+M)<A3DCKG.3TQ6C9:MXK;5+%GTP7.G7-N[SL%2+[/(%W)M
M/F,65C\O3(.#TXH ["BN T3QG>:Q97<D-]:+?VMC)+=Z=<VK1S6MP-I *E@6
MC^\,_3GG%5;3Q=XG@L_".M:A_9TNF:X]M;36\$+K)"\R_*X<L01NZC' ..>M
M 'I-%<!/XQU6?P?J'B[3Q;-96<TQ6S>,[I8(G*.2^?E<[68<8' (/6IFU_7]
M3\2W^F:7<V%O;+I<%_;S36S.P\PN-K#> ?N]>,>AH [FJESJEE9WUI97%PL=
MS>;Q A!^?8NYO;@<\UPW_"P9AX=\-:M?XTZRU.U,ES?+;M+%!-\NU&P?E5LO
MR?0#(ZUJOK^J1:YX.LVFL)X-5@E-U) A(+I#OW1MN(V$^QX[T =%IFK6&L02
MS:==)<Q12M"[IT#KU'X4K:K8IJATU[E%O%M_M1B.1B+=MW9Z8SQ7E]EJ/B+1
M- \5ZUI+Z>UII^MW\\]K/$Q>=%DR^'# (0,XX.3^5=G9>(;R[\=QZ8!#_9TV
MC+J$7[LB4,9 N&.2",>@'6@#27Q1HKZ*-874(VTXR^2+@ E2^_R\=/[W%:]>
M5:1K-]H'PH74+#[/O76)8G6:,L"LE\R'&",$;L]^G2N@@FU:7XKZE:C4(_LD
M.EP21PM!D+N>0'&&'.5!)[].* .JT[4[/5K4W-C.LT(D>/>H(^96*L.?0@BF
MZMI-EKFFRZ?J,)FM)1B2,2,@8>A*D''M7&Z9XUU*X\/:8\T4+ZGJ&J7-BGD1
MX11$TI+!6;D[8NA;J?PJ6X\1^)])TK4I]3TJ3R;:[B6*[BA#NULWWY#$CL=R
M<@]CP<<$4 =M!"EO D,>[8@VC<Y8X]R22?QI+BXAM+>2XN)5BAC4L[N<!0.Y
MKG=,U/4=>T!KS1=8TN[W72^3=")BAA&W<K*&R)/O#MSC@=M^^_Y!]S_UR;^1
MH 33[^UU33X+^RF$UK.@DBD4'#*>AYJS7E?@W5]8TCP]X!C>2T?3-2B6T,"Q
M-YD9\IG5]^[!^YR-HQGOUK87Q/XDU.W34]#TW[5;"^> VQ1 'A24QLWF&0$/
M\I8?+CM@]: .\HK$\7ZG>:+X0U;5+ P_:;.UDG03(64[5)P0"/3UKGSKGB9/
M$.BV!N=-,>M64LL9^S/FU>,(Q/W_ -X"'Z?+S^1 .[HK@]/\4:U<:0PN);".
M>UUF73;J[VE0R)G#1QY)+M\H"@GDDX-5CXO\0R^"]6U>T2V>XT?49H)U>U<&
M:WC8;F";@5<(<X/<$8&: /1:*Q+#59=4ULBRG@ETN.TCD:0(27DD^90&S@#9
MAB,?QK53Q'JNHV-^D%M/;V\#6DLJMY9FFDF4C"B,<[ "2S?3D4 =-17#V?C*
M]U*Q\&$1Q6KZ_$SS3[=RQ,L6_8H/=CTSG@'K6;/XR\30^$]2U7_B6O)::N-.
MC_T=U69!.(BX.\]=WI@$$<T >E45QLNL:_:ZM%H,\L%Q?2Q37AGM+7&R$,JH
MNQY.N6.3D\ <<Y$$'B?Q"$TK2]2TW[+K-W]H9S$JN#%$5&]5WX!;>O!8XYZT
M =S16)X8N];NM/G&O6*VUU%<O'&RX GB'W)-H9MI(/*YZ@U@W7BG5X+;QUM:
MT,F@*)+5C"V''V<2X<;N>3C(Q0!W-%<(WB#Q)?\ B+3M)L)M-MUO=$^WF:6W
M=S$^Z,'@.-P^8X'&,YR<8-;2/'>IWR6&CW4-M#KLVJW.F32HI,(\A#(\BJ3D
MY7: ">K9[8H ]$ILD:RQ-&Q8*PP=K%3^!'(KS[6/&.M:/!XKL6^R27^CV:W]
MK<-"VR:%@>&4-PP*D9!P>#CM6G8:YK47C'3],U&2SEM=2T^2ZC$$+(T#H4RI
M8L=X(?K@<CH* .BTC1['0=.CT_383#:1YV1F1G"Y.3C<20,]JO5B^(=0O+#[
M +:6W@AFN/+GFD^9U7:Q C3J[E@!@9[G!KD3XWUQ_"L-_"MF;I->&E2^;"Z"
M1//\L,!G*-C&<YQSQ0!Z15*?5]/MM5M=,FNHTOKL,8(/XG"C+'Z "N.N/&FH
M>')O%2:VUM>+I-G#>P/;0F'>)-X$9!9OXE SGO3-1BU1/B+X(?4;JWF+K>%E
MBA*!'\GD Y.5^O/'7G@ ]!HK"\2:W+I+:;:VL7F76HW7V>/Y0VT!&=FP2,G"
M$ 9')'TK)6]\<2:5K21V=K'>VK!].FNHQMNT*Y*LJR?(P.1G.#D''6@#LZ*X
MG2/&TE]X/U'Q=)Y9TRWM6DCME3$V^-/W@8[B!\P( QTP<\TY->\26-Y%=WUA
MYVC&SEGNYEC2,VS(F\;?WC%U;!'3(.#G% ':45RVE7OB34HM%U)6L&L-0MS-
M<Q;2&M@R;H]AS\_)PV<9ZC'2L6'QGK+^"]*UAOL?VB?6183J(6VM&;HPY4;L
M@X&>IYH ]#HKSM==U#2/$WCO4;V[6XLM)MX)%MQ%M.WRG<*ISQR3DD'.>U;.
MFZCXH;7[*.YL1+I=S QGGV)']FD !7&)&+JW(Z9!P<T =75+4]7T_1K=)]1N
MH[>-Y%B0O_$S'  '<Y-4?$&H7EC+IZ6\MO!;SS,D\SC?(!L)58HQR[%@.!G
MSQZ</K6NW7B'X4->7J(MQ'K$-LY1"@;R[U$#;225) &1ZT >C+J^GOK+:0MU
M&VH)#Y[0#EECR!N/IR11J.KZ?I/V87]U' ;F98(0W621C@*!]37-G_DLZ?\
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MM-TZ*2.TLXH5D4(^U>64= 3UP,G [9IVG:3IVD0-!IME!:1,=QC@C"+GUP*
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M&R!@R#HF#_".R]* .>\%WCG6-5TZ_P!'_LG58(H&F@ADWVTB$N%EB/;)#9!
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M(&XG4-V,>UBO^^M>A7BI;Z1<+',+5(X&"R@9\H!?O8]NOX5E:/8ZQ/J1U/Q
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN <\=/7H.:)O%^AP6$=\]Z3:O EQYJ02.$B;[KOA3L!YY;'0^AKA=#M[Q?\
MA68GTK48_P"S[66*Y+V;_N6, 0;N/ERP(YQZ].:MZBCZ;XSUV'5]#UG4=,U@
M1/;R:?YCQG$2QO%(JL /NYRW!!.30!VUYXCTJP5FFNB42$3NT43RJD9SAV*
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MW%:'B+3+K4KCQAK-E:79M[OP_P#V=#%]F</<SGS#D(1NP RKDCN?2@#M-/\
M%6B:IJ0T^SOEEN6A\]$V,H=.,E6( ;&1G!..]7M0U.STN*.2\F\L2R"*-0I9
MI'/154 DG@G '0&N*2&X/BGP+,MC>B*VTZXBG<VL@6%F2,*K';\O*GKZ5K^-
M+BZMVT9H=/FN(/MP\^YM[7[1-:KL8!T3!())VEL' 8^M %Z3Q?H,6E'4Y=1C
MCM%G-LSNC*4E#;2C*1N#9XP14^F^(])U>[NK6QO%EGM0IE0HR$*<X8;@-RG!
MPPR/>O,+BPU#_A"O%&GC1]6\Z;Q"ES"CV[R-)$9H7W9&=WRJQ)YZ8ZUN>(M-
MU'5_%NOII]O=1F\\,?8X+EH'2,S;Y#MWD8!PP^F?6@"]K'BH3>*?"D&E:C-]
MFOKN1)4$!$5Q&(G;<KLOS $+RK8Y'K78WE];Z?!YUS)L0L$&%+%F)P  ,DDG
ML*\V6]N=2;P($T+5H)=-N@M[&]C(H@Q;NGWB,%<D<@D8QG%=?XRL[:_T:*VN
MHM0,;7*$3Z>&,ULPR5E7:">"!VZ&@#+\7>)&BTFPOM*U&6V1-9MK2Z#Q;,JT
MBAU82+E>#U&.M;UIXJT2]AU":&_0)IPS=F56C\D8R&(8#Y2 2#T/:N"OH=?F
M\-06^HQ76HO!XBM7ANH[!EEN+:-XV,DB*.",,N2!D*,>]K6%U&/7_&UW9Z'-
M?^?I5LEO%/:.8KAT\S<O(PV X^7//04 =O9ZYI^KS3V5G=2I=)$LA1X6CD5&
MSM<+(HR.#S@C(K@[;Q%K<OPT\,:LVIR_;;G5((;F01I^^1KDH01MXX_NXJWH
M1N%^(IU(V6LO:3Z(D?VJZM63YUE9B-F!LX( 4 9Z@'.3D6ME?Q_"CPU9/IFH
M"[M]6@DF@^R2;T1;DNS$;<XV\YH ])\12W%OX:U.>UN&M[B*UDDCE55)5E4D
M<,"#T]*Q_"7B[3]3TO1+*?4!+J]SIT4[AD8>:WEJ7PV-I()Y .1Z5K>(]TGA
M;55CBED>2SE5(XXV9V)0@ *!G.37$V5M=QR_#/.GWR_8;9TN\VD@$!-MY>'^
M7CYN.?KTYH [2#Q1HUQ?0VD5YNEGDDBA;RW$<KIG>JN1M8C!X!['T-+;>)=)
MO+;4+B"Y9HM.=DNR87!B91E@05SD#D@5YO!_:=U+X7NIM!U.WGL]9D:YM(+,
MQP6RLLH&P  ,"6!,G(R3DKG%=+?:%?Q>/95M("VCZ[ CZBPZ1R0D?^C$(0CV
M)[4 ='?>)-*TZ#SKJ>1$$(G?;;R.8XST=PJDH.#RV.A]#6E#/%<6\=Q#*DD,
MBATD0Y5E(R"#W&*\\U<2Z5XXU9]3T;6-0TK5H81!)IWFNJ,JE&BD5&& >H)X
MY/O7;:=:QV/A^"VBL%MHXH JV:MN$8QPF>^.E $4/B72KAL13RMF!KE"+:3$
MD2E070[<./F7[N>H-$?B;1Y8M,ECO0T6J$"S<(VV8D$@ XP#@$X..E<;X5T_
M4;#4[:STU]0DT&:QDS:ZI;,LFFO\NV-)& +*>FWG 0'/2LC2EOQX>\ Z>VBZ
MJL^D:@BWNZT<"/;%*N<D?,O(.X9'OD@4 >DW?B;1[&Y\BYO C><MN7\MC&DK
M8PC.!M5CD<$@\CU%<S;^,(M&\5^*X-=U5_L5G+;?9PT.[RD>(,V1&N=H)^\>
MG&35309KS3&U+PQJOAR\O9VU*:YMKAK;S+6=))3(LCR'Y5*D\@\C:,9/%,O+
M:Z>\^)9&GWS"^M(X[4BTD(G(MBA"?+\WS'''UZ4 >D(Z2QK)&P9& 964Y!![
MBLH>)]'-W#;_ &P!IIC!%(8W$4D@R"BR8V%L@C .<@CM3- BF?P7IL!$MO<?
M8(XCYB%'C<( <@X((-<#%I6HW_POL/!TNGW=OK5K/!"TA@?RX_+F5C,LN-I!
M0$C!R2<=: .KN/%L=_<>)-*L?M=M=:9!Q<&V; D*,_\ $I7& N,]<G&>#3?!
MOC"QU/1M L[O41+K%WI\<S!D(\U_+!?#8VEAG)4'(]*SC'=V?B?QT)-.OF2_
MMX9+:6.W9T<+;[" 0/O;AC;UYSC&35#3[6[BM?ABC:=?*VGH5NQ]DD'D'[,T
M?S?+Q\Q _7I0!W,WB;2+>^BM);O9)+-]GC<QOY;2_P#//S,;-W!&W.<C'6J\
M?C/P]+J8TZ/4XWNS<?9?+5&.)=N[:3C X[]*XG0;,QQCPUKGAO5KN_MKUY(K
MAC*UE*/-+I-NW;%(!R1C.1P,FNC\'12Q>(_%SRVES"MSJ*RPR2V[HLJ")%RI
M( /S*U &_JOB#2=$DMTU*^BMFN"5B#Y^8@$G] :@TWQ9H6K:==7]GJ436UHQ
M6Y=P8S"1R=P8 K^(K!\?S);ZOX-EDC=T3602(XR[?ZF7D*,DXZ\>E8'B'PWJ
MFK3>*]9TFTE"W#V#16[H8FO#;MO?Y6P>1A1GJ5],&@#T&'Q'I<\UQ D\BW$$
M/GO!);R))Y?]X(RAF';(!YXJ&/Q=H<L&FSQWI>+4VV6;K!(1,W/ ^7V)Y[#-
M8[0OX@\=Z!K5G;W=O;:?:7(N7N+=X2QE"!(\, 200S'L,#UKFKSPIKB:=K.F
M6<3QV^B7C:IH;+_RUD8B58P/1294QW\P>E 'I#ZUI\;7:O.5-HZQS9C889@"
MJCCYB<K@+D\CU%49?&?A^"POKV?41!%8N$NA-$Z/$Q&0&0@-R.1QSVKG?$>G
M:L?".G:C#83W%]%J,>J7UE!(5E=2&#1J002R*R@=,^6*R_$5K#J_@/Q+=:/X
M<U:*ZO[>.'-U!*;FY8'@;&);:H[GCGCI0!W4'BW1+HR+;7AG>.8P%(H9'8N%
M#'"A<L,$'<,CD<UI65[;ZC9Q7=K)YD$HRC;2,CIT/-<MXMLH-5.D/&^K:?<(
MLDEKJ-E;N6MFPHVR)M/RL#R&'\.*UO",FJ2^%[-]:A2+4"'\T)'Y8;YSARO\
M)888CL2: )$\4:,]]'9K>9DEG:VC;RW\MY5SN028VEA@\9SP?2JEUX[\,V9N
M1/JL8^RRB&XVQNPB;C[Q .!R/F/'/6N#G_M.[_L::70=3AN++Q'YT]I;V92"
M&/=+AUP )-VY6+\\D\J#S<O[2[ETOXF1IIM^9-0)%H/LDF9_]'5!M^7GY@1^
MO2@#T*_U>RLBD,L\@FF1GC2")I9-HZL%4,<#(YQC)'K6+\.=6NM;\%VU_>W;
M7<TD]ROGLH4NJSNJ\  ?= [5B6,U[HGC2WU*\T_49M.O]'M[:.6&TDD:WEC+
M%D=%!9<[LY(QD5K?#2&YM?!R6]W97-I,EW=,8YXRAPT[NI /;#"@ \=^)XM*
M\+:X;'4)8-1L[5G$D,!D$4FW**YVLJYXX.#R/45K:;KUG+]GL);AFU$6*7;Q
M>4VYDP 6'&&Y..,\UY_>+J5CX<\?>'[K2M2GO;^6\N;*:"U>6.XCE3Y!O4$!
MEP!M)!X&,UK0O<Z;XST35)M,U%K>;0?L7[JU9S',)$;:X ^3(!Y; XZT ;5_
MX[TFVM-(N;8SW<.J7?V:&2&WD8 @D-G"YR-K<=21TP#5ZTU&TN/$]]%'K#R2
M16L326#(%6 $M\^<9R>A!/&.E>>Z=9:E;>"?"#S:3J"OIVO//<PBV9I$C9I\
M-M R1^\7D>M:^J:9J&K^*?%D-M;74!O_  ^EI!/)"RQ^;^]RN_&W(WKT/TH
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MN=@!DG &3[G%/KS*U\4WMS\*[37-=TBRU)+BYCW1M+\OSW&U6VE"!M8K@9/
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MZ;MCEMS/'=6[/)&K X,;ED7#=P>_/2@#IZ*** "BBB@ HHHH **** "BBB@
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N(^+__ "2K7O\
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MXCU:\^&MYXWM;^6*\MYIIDM#CR1%',R>2RXY)5>6^]D\$#BM%[=KKXP:?/\
M:;N+S-"DF\O<!M_?1?)TZ>M= /!ND++<[4F6UNI_M,]F)3Y$DN0=Q7W(!('!
M[@U:D\/V<GB./7B]P+Z. VZD2';Y9(8KMZ<D ^M &!\6_P#DE7B#_KW'_H:U
M/\0/L?\ PJW7/M^SR?[.?&[_ )Z;?DQ[[]N/?%;6O:%9>)-)FTO4?-:SFP)8
MXY"F\ @X)'/4"JK>$M*G>W:]%S?"V8/#'=W+R1JPZ-L)VDCL2"10!RVB7FMV
MVH^ M/O+VX07FC2F[MV5?]9''%AB<9W?.<Y.,]JH6NL:Y9>$=;\3W&NW5S)I
MEU>V\=O)'&(G"RE$9P%!RO7C P,8ZY]!N]!L[W6[/5Y6G%W9HZ0%9"%4/C=\
MO0YP.OI46G^%]+T[3+W34CDFL[UY))XKAS(':3)?KZY.10!S6HW7B3PU%?ZZ
MUW;W.F1:9+*;::Z,KR3HI=70B-< @'(!QCD 5JZ=8ZA/_9E^OB.5[6\LR+B-
M@I\Z1E#*\1_@(&XX (Q],U/HG@G1M!BDBMUNIXFB,*Q7ER\Z11'K&BL2%4\9
MQUP,TN@>#-(\-R;K#[640%8(I[J26.W4]1&K$A?PY]Z .%\+:K=Z=X%\&VL=
M[<;];OF@EN)&#&-09&8*2/O,5 R<]2>M:6N:OK.C7GBO2(-1N#';:&=5LKE@
MKR0,-ZF,E@=P)3(SSUYZ8Z6/P)H,6C'25@G^RK.+B$&X<M;N&+*8CG*8))&/
M4U9E\+:?<66H6UPUQ,VHQ"&[G>3]Y+& 0$R,87!/ QU)ZDF@#F)O^$BT_P /
MZ?JL=WJ6M)=&&:]LX6C258O*.[R, '[Q0D9R0.O)KI?"&IV^K^'8KNVOYKU#
M+*/,N$V2H=[?NW7 PRC"_AGO4[>'K4V6GVR7%W%_9^/LTB3'>N%*X)/##:<8
M8'\Z9'X7TZ);01_:$-M=O>Y2=E,LK9W-)C[V2Q.#Q^'% &S1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2
M,ZHI9V"J.Y.!2UP/CO[=IVO:9KDNBOKFAVT$D5S9QJ'>!V*D3K&>'( *^P)Z
M9- '? @]#17"Z#K_ (7TWPQ=ZSH,\<UA>WR>7;I\@BF<1QB,@_<&0&/' )P,
M8JP/'J6S:JNHZ>R"QCCDBEM9#+%<[V"*BLRKA]Q P?4'.* .RICRQQ%!)(J;
MVVKN.-Q]!ZFN8U+Q!KMC;ZL'T2))+73VO(+D7#/;N1G,;'8"&&,X Y'<5EIK
MDK>'_!5QK6D6U[-?W-JL<QFW>5*T1838*#YOO<#IGK0!WU%<M=^+I_L^LW>F
M::M[::/*T5R3<;'=D4-((UVD':#CDC)!'O4/_";37NLV5AHVEK>)?Z7_ &C;
M7$ESY2%=R###:2OW^H!.>W4@ Z^BL?PMKP\2^'K?5/LQMGD:2.2 ON\MT=D8
M9XR,J>:PO'&KWHU;0_#6G+<>9JCR27+VSA)%MX@"RJQ(VEB0-V<@9QSB@#M
MRDD @D=0#TI:Y[PGJVF7]O>65CI[:;/IT_V>YLW15:-L9!^4D,"#D-GFNAH
M**\LO[+0S\7M9&IZ4MU"VBPR;([)IVWF1P6 120Q  SP?>L.^TV_M_AOX37Q
M+;223KXAMU6.Z3S9EMFD;;&_4L=O&WGL/:@#V^BO-_":1WWQ$U#4_#<1M/#<
M5J;2ZB"^4DEXK\D0G!4JO!) S[]:IZ5:Z1'\2/'"76@B]1);0QK'8B8)F#+8
M&.,GGWH ]3)"@DD #J30K*P!5@01D$&O.M<T^Z_X0W0+[0-$^U:?#.-0N=$.
M%\V.16<H!C!*,^X+C&0/05=\%7?A/Q!<ZG>Z+"D+S11PWVF2P>6T+*7/SQ]
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MUOYGW,8R!G+=?PJ*S\<FYU+2XFT\?8]21F2>&8R-;_+N'G+M 7(XR&(!X]Z
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M9!&ZKNV3?( A(Z$$C((^H!UM%<#9_$6[G\,IXCNM"6TTF2-<3O> [9#,(L,
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M:'XRG0JP/3KQ[UL_\))):>(]&T9M.BBM-2MF>WN!/P&103'LV]<'(YZ ^F*
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MTM#+$%;>& '#!L$= <8QTK0_X0O1&AU>"6"66VU61I+FWDF8Q[FP695S\I)
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MXSS0!P>F7NJ:5\$K/5;35KM;DW2;B^Q\A[O8PR5SR&)SG.>]=7JNL77AWQW
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MQ)*BXB,J#KM R S9YYP.M==-X7LKF6;SYKJ6VFN$NI+5Y 8FD4AE.,9 RJG
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MG1 8I/-*$+M4?*1C@YZ=:T+SP=I=_I%WIMP;AH[R99[J428DG=2I!9L=MJX
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MZW9.YR/+"D=A@=*U+#2]+U#XIWMKJ]M875W_ &):/-&Z*P:<.^YMO]X?+SU
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MOJ!W%-@O[.YEEB@NX)9(3B18Y Q0^X'2O.K2?6]>^'^JZK]FEBUNVTR7385
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MTM4M4U6VTBT6>Y+'S)%ABC09>61CA44=R3^ Y)P 30!:2&**+RHXD2,?P*H
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MMPJ@%E0ENHW#K@=P2.: .C**R[64%?0CBFF*,DDQH2>IQUK \%^([CQ1H?\
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MWI.GZ'?VL.MI)JUS9V=W&]VC+("P+,,R':[C*Y!'&<X/- 'J!AB,PF,2&4#
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6?HF@:7X<L!8Z19I:V^[<54EB3TR222> !R>@% %^:&.X@DAF0/%(I1U89#
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MQ 9>G&0?:NYU37]*T5=VHWL=NH 9BP)"*3@,Q ^5<\9.!6B"&4,I!!&01WH
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M;&]N4=X'Y\P!RYQ']W +$Y!X]>@O[#7)O&\&K66GM&J:)/:I+-)&52=V1D#
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M.R*1HMR^?P#M(./:L2QO;RX\!^ +J6^NFG.MQ6[OY[?O4$DBX<9PW"+USTH
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M!I45AJEW,J^*+<,&F/\ HZ2,"8 1_!R/E.>OTH ]%EEC@A>:5U2.-2SNQP%
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M%::VD(.4;[KHPX9#Z]0>" :RSXU;[(=7CTQI= 0W(EODF&^(0;PS&,@?*2C
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MVL?Q2\8RA<2C[&RG>>2T3YXSS0!W=%%% !1110 4444 %%%% !1110 4444
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M":X60%?+C.<-R.0<'D>E4X_&_AN66")=7@W7$/GPE@P$B8#?*2,$X(.WK[4
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M1+6U6/S%".P)+%1T&XG.!DX&>,\5>HH R#X6T%M%?1CI-H=-<[C:F,&/.<Y
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%(3@$XS["L'PWXD;7[K68'L'LVTV\-J0\@8O\
M*K;N.!][IDT ;]%8<WB'S==DT;2K87EW;JKW;M)LBM@WW0S8)+D<A0.G)QQG
M;7=L7?C=CG'3- "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<5X
M&_Y&'QM_V&?_ &C'7:]169IGA_3='NKNYL89(Y;Q_,N&:>1_,?IN(9B,X &:
M /+="TZ\;X?>*];BU6^LM<AU"^NI&CF*JDL9)VNG1@551ALX!XQ7JGA^]N-2
M\-Z7?7<7E7-S:132Q@8VNR D?F:AG\,:1<W-S/):G-T5:YC65UCG(X!= =K<
M #D<@ '-:] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
-%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>literacompareredline-pro005.jpg
<TEXT>
begin 644 literacompareredline-pro005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"!54!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV=>?NXZ]\UBVPGUSQEX6TW6UCT^+3;6/4-.$3&3[>X0!OG(7:4X)3!)SG.*
M/5:ANKF&RLY[NX;9#!&TDC8)PJC).!ST%0"TO!K;7AU%S9&W$8LO*7:)-V?,
MW]<XXQTJXZ+(C(ZAD8896&01Z&@#G?\ A.=%%]#9$:D+N:(S1PG3+D.R#&6
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MG4]6OM7^%%S)J,C27%OKD=J7=5#,L=\BKNV_+NP #CCBNH_YK/\ ]R]_[<4
M=C13)BZP2&/;Y@4E=QP,XXS[5YWHOB6_O/M5C?W^HZ=KMOILDEQ8W4$8S(-N
M)H6"[63(8=3P1QWH ]'HKSRR\1:Q/8_#NY>_;=JZA;Y?*3$I-LTF?NY4[@.F
M!65<:KXM;PMXDUV#Q$1)H>HW2QV[6L6R>*%N5D.,_=!QMQSZ]@#UBBO/WUK7
MO$L^LV^B2O97%C'"( 'C $CPK*#(&4DKEMN!CA3WZ->X\3ZEXPCT;^W?[/\
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MXCFU>+41J/V6">VU2>QC6-B XC(&1N.23S0!KZMI-CK>GO8ZA )H'(;&2"K
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M6X\3V_B!KFZ%Y;Q-!&%9=@C8Y9<;><D=>M/O- M[W7['67GN$NK*.2.$(R[
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M9F3O@8XQ_%GN:]*@L+.UE>6WM((9'^^T<84M]2!S3I+2VFGCGEMXGFC^Y(R
MLOT/:@#RS3](M]3\;>'[3Q-:6]S?3>%?]-CG4$R2AX_OCNP^;Z$9'2JQT+PS
M<Q_$>&^M+,&VN&:$%1N@S;H5:,?PDL.W)( YKUTVT!F\XPQF7^^5&[\ZY[0_
M#,FGZWK.H7RV<YOKL74)5,M =BI@$CT0'(Q0!R_AN2[C\5V-EXL"F63PY;BV
M^U8*M(/^/@<\%\[=W? ':L%+&#^R/"D-^L<EE_PE,T6GF8Y+61$P1<GDH<#
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MH\,RO(SXYY&-V.O:MZ2TMIIHYI;>*26/[CL@++]#VH \YLGO4\2?#:/6)/\
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M51%VL#P >>O& :[=+:".0R)#&KGJRH 3^-$%K;VH86\$40=MS"- NX^IQWH
MX3XL/ --\.)/.(5;Q!99;S-A"[CD@]L#G/:LS5!;V/Q1\,SZ'?OJUU.9(;JW
MFG^T_9K<CF56))B/;K\W2O3I;:"<@S01R$="Z X_.EB@A@!$,21@]0B@?RH
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M@76O2:/Y#VZQV%^EZZS GS=JLNSCID.>>>G2MM;.U2W%NMM"L(Z1A %'X=*
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MMAB""*(8"_(@7@=!Q1!:V]MO\B"*+>VY_+0+N/J<=30!+1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !7->/]:N_#_@?5=1L8W-S' WER* 1$Q& YR>@_'MQ72US'Q"T^_U?P)J
MNFZ9:/=7EU#Y<<:NB<DCDEB!B@"*PDMM'U -&=9FO-1AW+I<UP)2HCX:4;V(
M3.Y0?F )QQFI9?'NAPZ3#J+-<^5)>"P=! Q>&?<%*2#^$@G\>V:IWEAJEMXV
MTWQ/!I\\]N^G-I]W:JZ>;!\X=7 W;6Y&" <]#S6)?^%=8%C<75OILLMS?^)(
M-4>V26(&&&-DZEF +$)G@GDX[9H [_3-475-/-VEG>V^&=?)NH3')E21]T]C
MC@]Z\\UWQ9>:W\.+_5DBO=+>WU)(D=)=F5%T(BI*-S\N<CISQFO45)*@D$$C
MH>U>63^'_$/_  K_ %30$T2:2Y_M8SQ.L\(6:,W8FW+EQ@;?7!SV] #M[/Q;
MIMU?:A:2K<V4MC +F7[9$8@83G]X,_P_*>N",<BEMO%-E/K-OI4T%U:7-U"T
M]K]HC"BX1<;MN"<$ @E6PV#TKFO$'AK5-?\ $VM;;.6VL[_P[_9Z73R1X6;>
M[8*ABV/F'./6KGA.+499[8ZCX-L](NK5")[M?)82MMQ^ZV?, >I)Q@<<YX -
MS6_$^GZ!=6-M>+<M+?.T< A@:3<P4MC@=2!P.IK*_P"%CZ&NB:EJ<T=_!_9D
MHBO+:6V(FA8_=W+V!SP<X]ZK>.97@\2^"I(X))V74Y/W<9&XC[/)G&2!P.?P
MK(\2>%]7U33O&5]::;(UUK2VL%M:F2-7V0_QN2P49R>,YP!ZX !V$?BRSE(C
M%GJ"7$EPUO;V\MN8WN"J[RZ;B!LV\[B0.W7BJ]QX\T6TTB]U"Y-S$+&X6VNX
M&A)D@D8@ ,!D '<,-G:<\&JWB'3M3?Q)X<\265G).+$30W5EO02>7*H&Y<MM
M)4J,C/(Z5RWC32+FV\.>,_$$UNT+:I<:>(K9F7<%BDC4%L$@%B3QG@ 9YR
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M=2T^=8[BUE)^Y]\9!&/5>.?6@#9D\26PMX)+:UN[N66U6[^SP(OF)$>A8,0
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M91U4_-N&#QG&,\9KC_#WBV'0HM?_ +4?4KFWAU^:W^TL&F2VC)14#.3PN3C
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MX8?+\O3CG'/&#A37>L:=XK\?WVDFQ$MK;VEQ(;J-V#[(&.T!6&,X/.3CT/8
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M10!RMCX/EBM=(L=0U/[=9:1*LMHA@V2,44K'YC;B&V@]E7) )][FF>'Y]/\
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M1HU).,'U))R<GIBWH'B*S\0PW36R30SVD[6]S;3J%DAD'8X)!X((()!]:UZ
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MY^/E/;O^51Z7X)O-'OIH;/Q%<)H,D[7']F>0I*%FW,BR]0A)/RX[GGDUV-%
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M$!<+B4<8 ZYKJZ* ,%/#]S(+./4-16]@B=Y;B.2WP+B0DE2?FP%7(PN#T'<
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MM'(3E-V.>#[8XQU]% '(W'@V^B\1W>JZ)XAGTN*_VF]M1;)*KLH"AT+?<;:
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M9>6D9W1Q&1VCC/8JA)5?P J1O#NE/<7UPUH/-OT"73AV!F4< -SR "1CT)%
M'$17TFMV6AI-=W%S?R^&UNYK8S&&)-X7]^SKR7R&"@ XY/'6H++4KZ[T/X97
MLU_=-/=3QQW)\Y@)@;>0_.,X8Y4')KMSX0\/,UFS:3;,;*+R;?<N[9'_ '.>
MJCL#P.U+#X2T&W@LH(-,ABBL7\RV5"5$3_WA@]>V?3B@#E_#NCC5O$GB5KO4
MM59;#5]MNBW\JA 8$)'#<CYNAZ8XQSGF],6[;P3X$U<ZMJ?]H7>HQ6L\QO'.
M^*0R!E*D[3T!SC.1UKU6UT+3;*6\EMK?RI+T[KAED;,C=,DYZX[]:K+X3T-+
M&TLDT]%M;.7SK:)78+"XZ,HSP1SC'3)]: .(GN$T2?QYI[:OJ-II]O'9/#(L
MS32PO,"K"-G8D%F"CKP3G(I6EO;?4_&UAYD]G%'HL5U###>NQ@DVR_,K<%6.
MU<@<<=Z[BX\+:)=O?M<:?%,=00)=^82WG ?=#9/;MZ=L5&G@WP[&9&32+96D
MM_LSLH(9H^<J3U.<G/KG!H XS1UGLM7^'MRE_?22:K8.MZ)KEW64"V#K\I.T
M$$=0!U.<YKJ_&%Q''!I=LUS<QR7-_'''! VTW1 9O+9LC:F!DGT7&#G!OIX:
MTA'T]ULP&TY=MF=[?N!C&%YX&./IQTJ;5=%TW7+9+?4[..YBCD$J!Q]QQT8$
M<@\GIZT >67MYJ"> ?%J_;KF";3_ !"D%N8+MV\J-GM\H&."R_O'&",<]*U=
M6O;OPCXE\2G39KJ=$\.'41#<3O,//61UWC<3C@#(&!Q78-X,\.-#<P_V/:K%
M=.LDZ(NT2,N-I('I@'ZC/6KBZ'IJZF=2^S!KPP_9S,[LS&/^X<GD9YQZ\]:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD1"5.0%/S9R<YZ8&,D ](HKC]7\4:D;O6+31($EN=+"J8I+267[1*4$FP,A
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M9(Z"G6-_=:IXJ^'NH7T?EW=SHUU+,H&,,R0$\=NO2NQNO#6CWM[->3V2F:=
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MV-+ORP&!C(ZGN/6N1TJ%X/A_\/X3:SQSVVLQR3Q^0P:)09=S,,94?,,D^HH
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M:_A2XDD$*JQP#(1D)GINQ_#G/M6D3@9/2O)])CL9(Y_#'B+2-7N-6BU&6:)
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MZD')!X7 ]1!H;WNDZ-X+OKJPOQI^E7]^FH(ULY:%I&D$<A7&6 W'+#(&[UH
M[?PSXFDU#7?%:W6H0R:=ITT(AD*",1*8@SAL\Y#9!STQVKH[#6=.U26>&SNT
MEFMR!+%R'3/()4\@'L>]>6ZBM[J%UXWNM*T^^G4WVFWJ1K!)$;J.)8FD5&('
MS':>!R>W6NHT34?#\UQ>^)[#3M6+PV)2YN;E+CS"JG<(E23[Y'S'*YQTSS0!
MW%<EH&KZG>^//$^DW-TKV>E?9O( B"LWFQECN/?&.,8KJ+6X2[M(;F,.J3(L
MBAU*L 1D9!Y!]J\^T/3['4?BAXRFO;+S8IA9_9I)H6"OMB(?:Q&#@X!Q0!K^
M&=:U&]\3>*+._NT:UTFXCBA/EJA*M&')<^HSVQ6_8Z[I>I7<EK:7L4MPB"0Q
M@X;8>C@'JI_O#BO+X],N+BW^)-AH]K(CW3QM9Q^6T:SJL0#*A( (.&7CUKJ/
M#-UHFOZS;:K9Z7JZ:C;V[132W_VA?LP;&8OWAVL2>PSC&<CC(!W%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+$  9))].<9H ],HKDK7QU;R:1/=7EK]CNX=1;3'MY)UV^>.?]9P-NT[LXZ
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M.,!F# !!W(&<GT'!Z6B@ KA=.\(W\'B:RU\VMC8W\<4BZ@UG.PCU E<+N78
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MRM3TZ.T@4W#AE9 _+?N^ ?,[9Z>]=E6)+XLTB+6)])+W;W\$8EDABL9W(0G
M;Y4(()[B@#G[?PGKEI:^"7B.GM=:# UM<*TS['5H1'O4[,DC .T@9Z9'6N[J
MCI>L:?K5JUQIUTD\:.8WVY#(XZJRGE6'H0#5Z@#C[OPK>W7B?7IG:V;2=;TZ
M.TG.]A-&5613M7&"").N1C'0U6MO"NL7>B:#H>KFS-MI%Q#*;F&1BUPL/^K&
MPJ-I.%W<GH<9SD=S10 5R1T#6+?Q5X@U"U^PR6FK6T*#S971TDC1EQ@*1M.X
M'.<C&,'K6W>:[8V.LZ=I,[2B[U N+<")BIV*6;+8P.!TSFM%F5%+,0 .I)H
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M\D%TS/\ :8HF8L8]F-I/) ;/ YP>E=Q65JWB&RT<LLPGFE2%KAXK>(R.L2D
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MV$!<G'7/?':L.S\&:]:^$_"6E'^S6GT;4$NIV%S)M=%W\+^[SD[^^.E>BT4
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M+1X:9V*D@ LQ3'S9Y;\*Z[3_  /8:?J&FWXO]4GN-/@:VB::YSNC.WY6  !
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M_M-S%-I\;QV\<101JK@!@05.<A1WXQQB@#'^*K3I\,]<D@NIK=U@Y:(@%@2
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MXY>WNYK=AXDE#&(@;U:6)2IR#P0W;'Y9![FQ\!V%E=:1<G4=4N9=)5TM3/<
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M>^TFRNY%57G@25@O0%E!./SKRI+RW_LKXJVJ7MG+FV>95ML(AW6@#,JY/!.
M3GDUZ;X=(;PQI)4@@V<."/\ <% &?'XBN-6US4-,T2&%UTYA'=7<['8LI&?+
M51RQ ZG(QD#GM)I'B3[7K-_H>H0I:ZK9(LK(K[HY86^[(A(!QG@@C@\<]:Y[
MP%$=!\1^+-$OSY=S<ZK+J=L7X\^"4#E?7:1@XZ&DM;./7OB[J&LQI'-I-EI
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M>WTP_;=(O^!+;EF)>-_X6^4@Y&.%SVH [X2(<X=>!D\]J&EC6,R,ZA ,EB>
M/K7F]C?Z9'\1+.]N%CL;:^\+Q,J71"EOWN=C9ZL 0"*YWPSK-E8Z#X!_M&:%
M=#WWL4[R$>5%<[CY0DSP.-^,]"<]J /2_$OB"YT=M#:TBMYX=0U*&SD=G.55
M\_,N.#T]?SK?CDCE!,;JX!()4YP1VKR_7[704TC08='</IL_BJ%\K*6B=G+%
MQ&<XV9)&%XR#6UX0M[73_'WC/3[&*&WM8VLI%MX5"HC-$=Q"C@9P,T =L\B1
M(7D=411DLQP!5/4]8L=(TM]1O+A$MEQALCYB3A0/4DD 5S'B>X,7C_PK#?A?
M[(F%PHW_ .K-UM'EAL\9QOVY[D]ZXSQ'9)!H'CJ-(XSH<&JV3V@(!2*0O$;C
M9V"Y)SC@'</6@#T9O$-PGCP:')';K8G2WOA<;SNRLBI@]@/F/K6^98UB\UG4
M1XSO)XQZYKS^6ST;5/BK96Q@L[FP_P"$>E*0A5:)O](3^'H1U_+/:N7TC4X;
M#PIX*^WWGV?0Q>7T$L[!6CB=9'$ ?<" N P&>!P>,9H ]H$L;1K()$*-C:P8
M8.>F#2HZ2+N1E93W4Y%>0ZSI.@6^A:=_9U^;ZRE\4VT@F+)Y4;.X\Q860 !?
M7' .>X./5=-TNPT>R%GIMI#:VP9F$4*[5!8Y.!]30!F>,=>E\.>%]0U*U6WE
MNK:!IDAFD*A@HR>!R?\ /-;%O<+-;1R,RAF0,P!Z9%>-ZQ>Z??> _B#%K+6W
M]MQ7=R#'.0)%5?\ 4;,\[=N-N.#SZFNCM;S2K?XEK<7$]HEM>>&XMKNRA9R)
MFR ?XC@B@#N;W6+'3Y[*"XN$66]E\FW3(R[ %CCV !R:= ]\=5NDF^R?8A'&
M;?8S&7)SNW@\ <#&/>O&]%.E/X1^&L]W]C-O%?S0S/-MVI\DQ"L3TYQP?:MO
M4C/;:[\27T-=MZ=(M9(Q ,.6V2Y( _BQT[YQ0!ZDDT4K.L<B.R'#!6!*GT/I
M21SQ2DB.5'*D@A6!P1UKS33O^$1U*2+6M*\0R&1=+FCDCLA$IB@*9)E5%!!4
MXVY_BJ[X,-WI_B2/2=1M=/N)5TL/::OIPVK<6ZNH D3^%LD$$$@Y;% 'H$DB
M11F21U1!U9C@"D$L9C$@D78V,-G@YZ<UR?C6]T^WU+PY!>>6LLMX[6\ES)MM
MXV6)LM(/XC@_*O&6QR,5YX&L+GP8]NT]O*;;QD%C\H[?+1KH?< .44C<1@]*
M /<$DCDW;'5MIVMM.<'T-<]J'B.:U\9:)HT"6TEM?BX$L@D)>-HT#8P.!U'7
M\JX/7UDT#4/B!#X:@6UD&CVLRPVBA=K9D#NJCHVSG(]!6A)=>&F\>> KG1IK
M 126]TB-"R@E#$-BG'.<YP#SG/O0!V'C77+OPUX1U#6+*"&>:U0/LF8A2,@=
MNO7IQ]:W(Y4D)574NN-R@Y*Y]:Y'XJD+\,-?+$ ?9\<G_:%8UY'IF@_$2:6W
M@\B"3PS<3W*VG$DQ21"&XY9\%L,>>>M 'HR7$,C.J31L8^' 8';]?2G>;'MW
M;UV],YXKR+P]=Z6?%_A 6\^G+:W.BSP"")PYV_NBD<KY_>/R2>!SGCO6IX>T
MQ;/5K[P&]FO]GV=Z-3B)C&QK5VWHGU$P*^ZJ: /2&FB658FE02/]U"PRWT%/
MKR!VT769/$.E^(M:DL-7AU9WCB01+<LH<&W,!92QRNT +[CO7J&L^4- U#[1
M<26\0M9/,F3[T:[3EA[@<T 6EN8'!*31MM.#A@<&G[UR!N&2,@9ZUY.L5W%I
MVN:'J6GZ==W'_".2O::GIZ@)=0J-J!T_A?)R,$@\XZ4ZSU/2Y]<^&3V]W:23
M+831LRNI()ME 4GL<YXH ]5\Z+SO)\Q/-QNV;AG'KBL#POXAGUE=5%_';V\M
MGJDUC&L;DAP@4@Y.,DY/:N.\'7GA[6-%T5=5F7_A*;._9YX1)MN_M6Y@Y8 [
MBF"2?X=H]L5B:O:6#>"/'FJ-%"U[:>()6@N#@O"PDBP4/\)^F,T >W4P31&8
MPB1#*!DIN&X#UQ4=VTXL9VM K7'E,8@>A;''ZXKR6,)>_"_P[?:?@>)XK^!=
M_2<W7FA9U?OR/,+ ]AD\"@#T+5/$T,&FZ])IK07-YI$+22QN^%#!"^TD9.<
M?F*O:'J7]J:+I]W(8UN+FTBN'C0_=WJ#TZXR:\Z9=-M;WXH1E;6*[\IFC7"A
M]ALU)([X)SGMFETJSL=/UWX;7%G###<7FFS+/(F TX^S(P#'JV"!C.<4 >I>
M=$9C#YB>:!N*;ANQZXH\Z+>$\Q-Y)&W<,Y S7D?A=M$URQT1M1UJ6'Q-8W^Z
M>SC$271N0Q$BL-N]HR"2W.-HZ\<;?P_T/1I-2\07PLK9KNR\07:V\@49A!50
M0O\ =!!/% 'HE%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %,FABN(FBFC22-AAD=00?J#3ZRM=
M\1:?X<M[>?47E2.>=+=&2)G&]C@9(& /K0!<;3K)I&D:SMS(PP6,2Y(QC&<>
ME(VFV+6C6K65N;9CEH3$NPGW&,5CZ?XVT:_EU*%WN+&;3H_.N8[Z!H&6+!/F
M8;JO!Y_.IX/%-E+J%O8R0W5O<7<336BSQ[?M*J,G9SPP!!VMAL=J -F.-(HU
MCC1411A548 'H!4-S86=Z8S=VD$_EG<GFQAMI]1GI6"OCK26TFUU,1WGV:YO
M/L*$PX*S;]FU@3\OS C)P/S&=.XUZSM)[N*<2H+58VD?9E27.$5<<EB>-H&>
M1ZC(!FZ[X<GU?Q/H>HE;1[/3A.)89@29?,4+TP0,8SSG/M70+;0);?9DAC6
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M$4LW,CI&%9_J0.:S9O$MK%++']GNY/(:)+@QH#Y#2 %589SG#*3@$ 'DUM4
M5DTZQCCDC2SMU23AU6)0&^HQS2?V9I^$'V&VPGW/W2_+]..*CU;5K31=/:]O
M7*Q!TC 5<LSLP55 ]22!6#K6OQ:CX6\416DEW9:AIEK)YJ$[)(7\HNA#*2""
M,'()H Z:&SM;>1I(;:&-W^\R( 6^I%,N-/LKN19+FSMYG3[K21!BOT)%<,;V
M]%S\-G^W76+M"MRGFG;-_HC-EQ_$<C/->A4 0RVEM<2Q2S6\4DD)W1.Z E#Z
M@GI^%->PLWL_L;VD#6N,>28P4Q_N]*Y:#Q9H>DZ1KVL-=:I+:VNHO%<^?'(Y
MBEPF412,J@R,9P,DUL:?XGL-2UJ?28TNH;N*$7"K<0-&)8B=N],]1GCM0!HR
M:?92QQQR6D#I$,1JT8(0>@&.*6.SM89FFBMH8Y6^\ZH Q^II+^^MM+T^YO[R
M416MM&TLLA&=JJ,D\>U9MCXHL+R]ELY%FM+B*U6\*W*A<P,2 X()&,@YR01W
M% &K<6T%W T%S#'-$WWHY$#*?J#2"UMQ:_91!$+?;M\H(-F/3'3%9%KXMTVY
MU*RLBMQ"]_"\]D\T>U;A% +%>XP"#A@#@YI(/%^ESWVGVR^>J:EO%C<-'^ZN
M"HR=ISGID@D $=,T :ITZR,GF&SMR^W;N,2YQC&,XZ8XH_LZQ^S/;?8[?[/)
M]^+REVM]1C!K(D\8Z5$(IG,PL);C[*E_L_<&7=MQNSD#<-N[&W/>F/XUTM=<
MGTB.#4)KNWFAAF$5G(PC,GW6)QPO^UTY[\T ;3:=8O#'"UG;M%$,1H8E*H/8
M8XJP %    '  KS[QKXF$^EZ?+I4NH1Q'6+:W%Y 2L4O[X*Z9!R5X89QM.,9
M-=%>^,M*L9[E)?/:&TN([6ZN43,<$LFW:K<Y_C7D @;AG% &M-IMC<3F>>RM
MI9BFPR/$K,5],D=/:I)+.VFEAEEMX7DA.8F9 3&?]D]OPK!OO&VEV.H:A8&#
M4)[JPB6::*"T=CL;/(XY'RGGI]3Q5P>)=/FMM/FLS)>-J$/VBUB@4;Y(\ EN
M2 H&Y>21R0.IQ0!H_8K7R$@^S0^3&04C\L;5(Z$#H*5+.VCG:=+:%9F^](J
M,?J>M9%GXLTS4=,M+VP,US]L+K# B8E9D)#@AL!=I!!)('3GD9MZ)KECX@L7
MNK%W(CE>":.12KQ2(<,C ]"* +4-A9V_G>1:01>><R[(POF'_:P.?QI;:QM+
M+?\ 9;6"#><OY487<??'6J5_KUIINKZ=IMPDWG:@S);LJ90LJEB"W8X!//7M
MFJMOXML+FRU.Z2&[VZ;.;:X0Q8<2#&5 SS]Y>G7(QF@#9GMH+I%2XACE56#
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MFM=2N8Y( I@/F*L00Y!D&,D=Z/"7@F>+P?KND:W"L%IJUW<2Q6".'%G#)]U
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M4'.<[?X<9W>W-=)H^GW\?CGQ7<S6<\%I?I;+;W)9<,8XV5L '(Y(QD"NNHH
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M). 0WW>>O$L7B#Q)J'B[5-(L;73(X+#[)*SW!DWM%+N+# _CPO'8$=\Y#O\
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M@5UZ[@BAR"V.2!@$_2@#Q^XO=5U+X/P7^I7,-U/)K$93$90Y&H$8)W'C@ 8
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M%(\S@;F/.>F*LR>#M2MO$5[J.B^(I-/M=1<27MI]E67,@4*7C8GY&( SD,*
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M;'EM*S%T9"Q#*=Q&,CC%=5HUA>V5LQU+4CJ%Y(<O*(A$@ Z!4!.!U[DDD\]
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M-RDS)CMC."#S[56M4FL?$WC#2(K^_-HNFP747F7<DCQ2,)0Q1V)89V*< XH
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M #O[XKHXO^2SW7_8O0_^E$M '1:QK-EH.G/?7\I2)6"*%4LTCL<*BJ.2Q/
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M9N2;+L0I7&20.1P>U-\'7]U%X@&CZU:7MEK$=B6(-TUQ;7BAE!FC8GALD9!
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MF/R]J@*RD_,!GC/3 QWR =]1110 4444 %%%% !1110 4444 %%%% !1110
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M /!/(]:GB\-:/!=65S%9B.:QC,5LR.P\M#U &<<]_7O4NHZ]I6DOMO[^&W(
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MHF\QU5&EEE:5RHSA=SDG R<#.!D^M)+HFF3P:A!)90M%J))NU(_UV4"<_P#
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MRAU# .I!&?4'H:\TDM;S5)?B79Z=YD=U?!%LW92@E(ME0[6/!^8%<CI7IU%
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M2<XZ9SVKRG6KJ6Y6<#3KZU>T\40S2VEO8N5,:SKFX9PIWLPY^4]^AQFO8J*
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MUR+^R[LJ<;&PS17 '<HHDS[8KO:QK70##KL^J7.IWMYN8M;V\Q7R[;< #L
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1E5U*LH9
M2,$$9!%9EAX;T+2KEKG3M&T^SN'R&EM[9(V/X@9K4HH **** "BBB@ HHHH
M**** "BBB@ JG_96GG4_[3^PV_V_9Y?VGRAYFW^[NZX]JN44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@Y],&J=SJ]K<WFC&SU^SBCN9&98?E<WJ;6X0YR,'YMPST]Z -RBN/^('BM=
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M^\M(+^RGL[F,26\\;12(>C*PP1^1J:B@#S_X>:;J]N7L=81O+\/F33K*5_\
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MYCD0@$$8P/;:!Q6M>WUG8^+-1_X2&WU8:7J]E;K:3017&U@J%7A=8QN#98D
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M:2>RD9WN2R%-V&4!!@YQR2<=!U +]KXEN[FYT]1H=T+?48'FMIPVX+A0P6;
MQ&6!XY/IUK)\.^-KFY\(VNJZM:*MQ>WSVMK%#("97,\B*@R!@*%Y)[*3[5<\
M*6GBVRMK/3=:_LX6UA&(A<VTC,]V%7:N5*@)Q@GDY(["L.#P/KD?A:PT_P R
MQ2\T753J%@XE8I<?O9'*R?+\F5D*\;L$9H Z"7QDMG<:K8WNG2IJ.GV?V[R(
MI%<7$'(+1L=O0@@@@$>]5H/'C/IUG?76CR6-MJ'V=;*:YN$5)6E4MAB,E -O
M4CG(P.:;?^&]1U:_U/6)8+>"\FTA],M;<S$@;R69G8+Z[<  \ ^N!,NA7_\
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M@'CGJ2 >H5!>W<=A8W%Y,)#%!&TCB-"[$ 9.%')/L*Y"6?QG9-J[6\+W=O\
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MSVYU*X\4W?PXUA;JXLC?22.8HPA$;_9I"2NY3GN.<C';/->H 84 DD@=3WH
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MP*@<%CP>H'K6?JL6O#6_ UKJ>M$7C75REPUBJB-V6"0J^UE/S;<9!XY.!T-
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ME>5$(YZ<-5&:^UNSUVW\.R:E<7MQ/!/?&YMX((I%C#HJQJ'.P@;CDX)Z>YH
M[:D) (!(!)P/>O/[O7/%&BZ+I\VNPW'E)/,E_=:;$DLJ1C_52,F& !!^;:#@
M@8X-5Y[NYU7Q%X#FM_$4MS;W2W;^=;+&$E*Q'#[2G#88J0>G.,')H ])JIIN
MHP:K8K=VZS+&S,H$T31ME6*GY6 /4&N1T&Y\2:QK^MH^N1Q6NF:HT"Q+9H?-
MC,*,%)SD8+ Y'/7/;%+1/%VJ7N@^&H+FZ47^L:A=6TEV(U&Q(FE/RKC&XA%4
M9!ZYYH ]%)"@EB !U)JJ^HP1ZK#II6;SY8FF5A$Q3:I .7Q@'D<9K@_&L.O6
M?A.Z2\UHN/[5M1;R0*BR- \T:[9?EQD$M]T ' SGD5LW&K:CIWCZRTR6]:;3
MVTF>YD5HEWL\;H-Q( [,>  * .NHKS:;Q9K,7@"P\<K=;XI)(Y)].\M#'Y$D
M@3:K8W[U# Y+$$@\<@!=3U?Q*UUXX2VUI;9-$B2>U"6B,3F#S=C%L_*3P>_3
M!'< ](HKSS6O&%]9VVFWMY+=:;I=[IL<HU"VMUFB@N7YQ,"K%4P5P1CJ<GT[
MZUD$MI#()4E#QJWF(<J^1U!]#0!+5+4-4MM-$0F+M+,Q6&&)"[R$ L0H'H 3
M7'/K^L:MH7B;6=-OOLS:1=7$-O:F)&CE$ ^;S,C=\Q#?=*X!'OFI=W,VO>+_
M  #JD5Y=6BW]C<W"Q*L9\K,,;8&Y#G.<'.?;% '>:3JMIK>F0ZC8NSV\P.TL
MA0@@D$%2 0001SZ5%JVNZ?HD,$U](ZI/<);1E(V<&1FV@$@$#D]3BK\J-)$Z
M+(T;,I =<94^HR",_4&O'(OMDOP>T:XFOYKF>?6H&#7 4A6^W')X )R>3D_3
M% 'LU%>=WGBK5?#-YXKAOKP:BFGV,%Y:M)$L>QI"Z%3MQE0R@\\XSSWK<TP^
M)8_$:"Y:671Y;<[S=^0LD<P.1L\KJI&<@Y(QUH ZBBBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"LCQ+X=MO%.ASZ1>SW$5K/@2^05#, 00,E3CD#I6O7/^-?$4_A/PM>:W#9QW
M8M0I>)Y3'D%@O!VGUH VHX'CM!#]HE=@NWSF"[_KP,9_"L&V\$Z5!X/E\+3-
M<7>F2!P5G9=PW,7X*@=&.0>U11>++FU\66'A[6=.BMI]1A>6SGMK@S1R%!ET
M.44J0.>A!]:Z<.A. P)] : .:LO!<-IITUK+K6LWDCH(X[FYN0\L"@A@$.T
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MF1:+H]GID$LLD%I$L,;2D%MJC !( !X [5<9U09=@HSC).*&D1$WLZJO]XG
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MO-=VS:5)+)!)#(%9C+GS W&,-N). ,=L5LW^JV6FI;-<SJGVF=+>$9YD=S@
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M<'!P>AI%='SL=6VG!P<X- #J*** "BBB@ HHHH **** "BBB@ HHHH ****
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M!W)N. I'5!T!] ,<8K3ETC39[-;.;3[22U4[A"\*E ?7:1BK:JJ(J(H55&
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M=N,UZU!;06L0BMX8X8QT2-0H_(5'+IUC/,\TUG;R2O&8F=XE+,AZJ21R/:@
MT^XCN].MYXI5E1XP1(K;@W'K7B^L7>G:G\*/$\^K&V_X2"+4)1<B8@2QN)\1
MJN>0HCV@8XQGWKV]$6-%1%"HHPJJ, #T%5)M(TRXN7N9M.M))W4*TKP*68#H
M"2,D<"@#SC5KG1M7\5^)-)\1:O:V<$UO";&2X$>UK=HQEHG?@$2;SD<YQZ<1
M^(;>:RM+B_@:#7K"VTB"/4;'4?DNUA56831OCAR"200,E?6O3KG3;&\>%[JR
MMIW@.8FEB5C&?5<CC\*)],L+FX6XGL;:6=<;9)(E9ACI@D9H XZ#RI/B_<2P
MCR'N/#<<C$KA@3,W+#U Q^5<OX:M=/UZW\(0M=:7)<Z?-))=7'VJ-VO5(8#"
MYWDNQ5R' ((]:]5O-+AN([F2W6*VOY8FC2]6)3)&2N P)ZX]/:N3L?!%R\<%
MMJMGX=*0;/\ 2K6Q(N)-I!!!8_(QQR<D]<>H .,U;2=,/A#XDW?V6'[19:I*
M]K)CFW<1PD%/[ASW&"<8[5I>.;S3+L>+X]]NM];Z+&7>]<-DE)'06Z<8.3DM
MGKMX.*]._LC3-KK_ &=:;9#EQY"X8^IXYIQTO3RZN;"U++&80QA7(0]5Z?=]
MNE 'GEJ^E7/Q%\-WUT;.4W'A]BD\FUO,F$L(&&/5QR!WZUD23MIOA?Q%]G&S
M3D\8E-0$? 2TWQ^8..BXP#[$]J]>^PVF8#]E@S;C$/[L?NAC'R^G''%-AT^R
MMUE6"SMXEE_U@2)5#_7 YH X/4[""'QU-'IL4*Z==:%,^HPQ@"(D$"%R!QN/
MS@'N%/I6#H-A966G?"W4;>&..^N"L,UP/OR(;9\JS=2,@8'08&,5ZQ!I>G6M
MJ]K;V%K%;O\ ?BCA54;Z@#!I!I&F@1@:?: 1',8\E?D/MQQ0!F^.!GP!XD Z
M_P!EW/\ Z*:N)M]"TZWU+P)?:)!&M_=1XOFB.?M%KY!WF7^\ VP GN0*]4(R
M,&JEMIME8"4V%G:VKR<L8H57<?4XQF@#SJQTI--UN_\   L5.FWETNIP,(QL
M%J6W2QGMQ(H0=]L@]*]+E@AEMGMY(D>%EVF-E!4CTQZ5D:#IFJP227VO7=K<
MZBZ"$&TB:.*.,$G #$G))R3[*,<5N4 >(Z7'IS_"GP5%#Y"R/K-BMSY)"ON\
MUA\Q7G. ?>M#50= N/B)!H< MH8;?3YS!:(%V*VX3,JCH3&"21Z9KU)M)TUT
MV-I]H4#F3:85(W'JW3J?6I(["SAG>>*T@29QAI%C 9OJ<9- '&^%[;P]/XF&
MK:'K<5U)/8B.2WLEC6'8&!5Y%0<.,D#.#C(['"?&(J/AAJ89MN9;8 YQ_P O
M$==E9Z=9:<KK96=O;*[;G$,2H&/J<#DTZYLK2]55N[6&=5.0)8PP'YT >9^-
MXETOQ#X5U"RU&75K_P#M!(8M-N91*K(P(:55&-K*/XSD#-2(MGJMM\08?$"Q
MB^M;F4QO+@/#;")3 Z'JHR"P(_BR>M>BVVFV-DY>ULK:!B,$Q1*I/Y"B?3;"
MZN8[FXLK::>+_5RR1*S)WX)&10!Y1=7:7>GI:ZX85UQ/"R-=-J+ K\^[B.,X
MS*6'S-GC"C![.M+73/$%[\-%O1#>BYT6XCN=S;O-(@ARK^N"6X/?->L2V5I/
M<1W$MK#)/&"J2/&"R@]0#U&:B72M.1H673[56A $1$*@Q@= O''X4 >;#^R6
MN?'&E:O':QR6-NL-C!<8 CLQ -GE[NV[))'?'H*[+X?RQS?#OPV8I%<+IENI
M*G."(U!'U!K9N=,L+R>.>ZL;:>:,$))+$K,H/4 D<5/%%'!$L44:QQH,*B#
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M>WD:+4,/'M+#]VG0,".WI5#QUX6TO0_ 6IRH99;JZU&UN+B\N'!E=S/&I.X
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MSPFVG2W-]:2_9ECB2=UBE5V>3:=HX! &2>/? 7Q)X=U+Q!X@\1QP6TL,&H:
MEE!<R !#,'D;:><@88#./6@#K+7Q7IESJ26#&:WGEMC=P_:(C&)81U8$],9&
M0<'GI1;^*],N-4L[ ^?%+?1M+9M-$52Y51EMA]0#G!P<<]*Q;>?7/%7AZZTN
M^T&?1[B2QEMI[BX9"OF,A7]UM8DKDYR<< #GM6\(073MI]OJ/@B'3K_3UVSZ
M@\<)0D+MW0LIW$M]  ,Y)XR =EJ.J6NEQQ-<,V^>00PQHNYY7()"J.YP"?0
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M;.0UG=0;B#-@DA9"H4C&#GJ,<UFSV'B6];2+B\T&]>^L=?\ M$_ERQK!Y.9
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M9+ZYT73FODLKPVK6BVLS27&Q@LA64?(I!W8!SG;U&<#J]3P^C7F1P;=^"/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%8?B[0)?$_AV?28KQ+3SGC8RM#YN-CJ^ -R]2H[UN5C^)_$5OX5T*?6+RVN9
M[6WP9?LX4LH)"@X9AGDB@#,\1>$;GQ+:WMA?WMK)8W6PJ'M29+9@ &:)M_!.
M,CC@GOTJUXZDC@^'OB'S)%5?[,N%!=L9)B8 <]S3K3Q9:3:]%HEY9WFG:A/"
M9K>*Z"8F4?>VLC,I([C.?:M\@'J,T <7X?T:75])\,7]Y?6UQ#I]LDULL,1
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M28J6W1X!/RDC&3ZT 1^$M E\,Z!'I<MXEWY<LL@E6$Q??D9R,;FZ%CWK+N?
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MH<7AOP]9Z1#*TL=LI 8C'5BQP,G &< 9.!@5S\'@%H-!N?#0U!#X>FG,@MS
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M(,?D^6@0?,7.1@<\"N-\ :0_B3X:Z59W%_;R:6MTTTD44?[QMD[.L;-NP!N
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M'FNRHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MAEA^SN;B5YB8O[F7)(7GITJE9>"/#NG364UMIJB6QW?9G>5W,0( (!9CQ@#
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M-*O[F:.+_A'X-19896A,\LAVLQ*D'"XZ9QEO88ZD^%=&W:BWV1@=101W>)I
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M>0>6V,9'S>G'/0<=* .'EUR]\/6?B6Q74+AK6VUVUM4N+NX9VMX)A$7S(V6
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M]NL9,9A8=&1E(93UY!SR?6K5CIUKIL;I:Q;/,<R2,S%WD; &YF8DL< #)/0
M=J /-(_&2CQ'I_B"*2\DT+4[ VZ1&Y<HM\$$H15)QN*G9_O C@@YU93>Q^(]
M-\*37LC_ /$J:Y9Y+V:-KB;?M?#J=QVC)"YX#>PQUR:!I4=E;6:6$*V]K/\
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MUA"T1NI3/-F5WWR'JQW$\GN?:@#0HHHH **** "BBB@ HHHH **** "BBB@
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MA1K2$0LLD;Y^Z2=JX/7KT&:Y^\BC?X7^*(5MRTTWB"25(Q$2TBF[5@P&,D;
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M0+&BY9CCH!WK%U&]@OO%G@*[@64PJUR6=X67:&@*@G(!4%N!G&>U '3-XO\
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M /5 01D<BBLC2[ZTMIK;0(X)X)X+".41.K.J1_<"^8>&8$8ZY/6M>@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZC8R^9;3KN1L8/H01V(.01V(H MT51U34O[,AB<6=S=R32B)(;8*6)()_B(
M  )))K 3Q[%(^J(F@ZPS:6P6\"K 3$2N[H)?FX.?ES0!UM%<W)XQC77K[1H=
M&U2XN[*)9I?*$.-C9VD9D!.<'@#/'2I[7Q9IM_X5D\16'G75E'&\CK&H61=F
M=P*L1@C!XH W:*YRT\7"]TFUU6+0]4^P7*)*DW[@X1\88J)=V,')XR!6IK6K
MVF@:+>:M?,5MK2(RR;>I [#W)X'N: +]%0VUW!=V4-Y!*KV\T8E20'@J1D'\
MJY]?&EO)80ZE'I>I/ID[JD-XJ(4<,P56V[]X4DCDJ..>* .FHK#_ .$GM_\
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M:YB?SHE9$EBE>)PK8W+N0@X.!QTX'I3)?#^E3)IJ-9HJ:9()+-(R46)@I48
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M!T+3CK4FL>5(+^2#[.TPG<?N\YVXW8 R2>!UYH \STZYNK/X1Z!/:7D]L_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<UQ;QRJ73(&25'(Y/ZU;36]*DU$:>FHVK7AW8@$HW';]X =R.X[5P7[L>(_
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M, ,,-A!!_A..E 'L%M<P7EM'<VTT<T$JAXY(V#*ZGH01U%1WFH6>G(CWES%
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MM4G(! )X&>O:L'1CIMU"?#/B&WU9]=M=2DG2V E"3/YS.DZNHVA?FR23Z_B
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M@$$L3T[=*HR2 ? N]TQXIEO;:\9)(6A8,&^VE\#(Y.WYN,X'- 'K-_J^G:6
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MX5M$>&PU$KK%O=@?+#-SE >Q,R(_^Z7Z4 >D'4;(7+VQO(!.D7G-&9!N6/\
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MVC6.[6V%U&T4ZS1O'NVGYEZ,#C*GUR":;XMU_4-%O-!M[&S68:A?K;R.9 I
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MC@%=VU%8Y=@I!QQU !)XH ZJBJ]G>PW^G07]J3)!<1+-$0,%E89'7V/>N/\
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M6C)A?S?*!VAB6^;&=N>O&>:VM*\2M?Z_>:+=:;<6%Y! ERBRNCB2)B5#94D
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M*\]O[JZNOB=X-EN-.EL_-AO&7=,&R/*&%8#A6&?<<]3S79:SK%MH>G&\NM[
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M9C<%N#E3TX[Y YH [&BN4'C&<F2W_L69-3@L_MLVGR3H)=FYU 3&0Y/ED]0
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M:2>5 2 0"57:,[AW[UJ:?KNGZI<RVUK+(9XD5WCE@DB8*20#AU&1P: ,&_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"U32'U/4C;ZE>&]G;=%O$A<.=I\O &5'&.U #9=2U?7=3\16.CWR6,^DF.&
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M3]4==H*N,>W7..>-NS\$V^GFY:SU;5(GGOS?EC*C;9"NUARIRK#J#GV(HN?
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MRJ[ QD2-7;: < 8X! P,#%>J5R[^ ]*FM=:LYY;N:RU:9KB6V>0!(I&()="
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MUG>3*US;S>0L*6[$C*,&\S>O'7@G/ X%2>%K:X7XC^,C)J$\BQRV@9&1,/F
M$9PN1C/&,>^:T-*\!66C7[26FI:FNG><;A-+,P^S1R$[LJ,;L;N=N<9[5I:;
MX<BTS7=4U:.^O)9M29&GCE,>P%%VKMP@(X]Z -FBBB@ HHHH **** "BBB@
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MJSL+<PR%MT6!@MD##=<@9'3FK>X $Y&!UKQ?5K>W7X<?$)  JP^('*8;[AS
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M<"-BO3<07'N%/I0!J:3X@U/7)+6^L+&WDT::XGMW=I2LL8C9D$F.C LA&WJ
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MZQHT@&U20  /ITR*ZC5/%>E:.)WNY)A!;,J7,Z0L\=N6QC>P''# GT!!. :
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MS+;R'=)D@H0%X;*L,'DD'&:EA\6Z;<PV[0)=O-/"\ZVWV9UF$:-M9F0@$#/
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MH4QGY3@%AM.>""1FK5]XUT:PU:;2Y6NWO(!&9(HK.5R%=MJMPO*YZL.!ZY-
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M5<[0P!P<9.#C/- '"G3Q!I'ARZT30;^^M-"EFMK[2[R-4N2)55BX4_*6!(;
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[1"BL%,<AZ-GG!/7!_  W+3Q3JEWI6FZO'HT+Z=J$D 0QWFZ6*.5U57==F.
MP) 8X]^2+"^);EO'K^&#I\0"V(OOM/VD\H7V8V;/O9'KCWKB+S3)? MI:^(_
M!>J&?0;JXAWZ+*WF12"5PH-N>JMELX_PQ701D?\ "]IAD9_X1M./^WDT 6HO
M&-_>Z!-K^FZ/#=:8ADV 7>V=U1BI;9LP.5)QNSCWXJ7Q/XJU3PYI^K:G_8D,
MVGZ<%)D>\,;S9522J^61@%L<GL:X[5--&AZ+=>// NK"UMW4W5YI4QWVMP?X
MU"_P29R.._ Q72_$V9I_A#K4\D;0M)9*QC;JA)7@^XZ4 =!IFHZK<W:QW^E0
M6\,D'FQSP71F!.1\K HN#@Y[YY]*KKXLLF\<-X6VL+D6GV@2G[I8$9C'^T%9
M6^C"KSZA;Z9X=_M"Y?;;V]L)7(] N>/>O.?$^F:]I6@67BB2TLQ?Z/=MJD[1
M3LTCH_$T>"H&-AQUZ1B@#K_%WC$>#FL+F^L?,TNYG$$MU'(2\!*D[BFWE0%.
M2#QZ5I:IJ\MI#8365O!=Q7D\<0<W&P /T8$*VX50U:6RUB7PQ(IBN;*]N7*A
M@"LL;6D_;N"#7'I:ZAX,\0Z5X7=);G0+K4$ETJX)W&V(RS6[GT R5/ID?0 Z
M/6_%^L:)%!/-H%N8+G4ET^#=?E78LY17*^40%.,]2<$5T.F7FI7$US#J.G16
MC1;3&\-P9DE4YZ$HI!!&",>GK7+?%$@:9X?R0/\ BH+'K_UTKNJ .5\3>*-4
M\/6&K:D-%AFT_3E#&1[PQO-\JD[5\MA@;L<D<@U,-=UJ.TFN+C1+98ULFNXW
MCOF=6*X.QB8AM.#D<'H:J?%,X^%_B'/_ #Z'^8K5NB/^$)F.1C^SF.?^V= '
M/1?$2:+1-$US4M'6WTO5GCC2:"Z\UH#)]S>I1>/4@G%:^N^);S2O$FBZ-;Z;
M!</JQF$4LET8PAC3>=P"-U'3%>:Z5";'PWX$U379Y+WPLD$.^)]JI8W/_+.5
MMH&Y,_+\V=I.:Z[QG&+GXC> 8TN9(=\E\5EA(W#_ $?MD$?IWH Z^QN]3DO9
M8-0TZ"W18U>.:"Y,JN22"IRBX(P#WSGVJC<^++*U\;6/AAU;[1=VSS+)_"&7
M!"?4J';Z*/6ELS:Z!<Z@EWJ\MP\H:^<W+ F&)$13G  "Y&1QW/H:XCQ'I6OW
M7A-_$,5I:)J%M=#7(F,S>: HXB*[<?ZH!",X)&: .\UW7AI%QIME#"D]]J4Y
M@MTDD\M,A2[%FP<  =@220/>H8M:U42ZI;W6D0QSV5O'/&RW1:*<-OX#; 01
MLYRO?TYK+UD^&/'6A:-!?N1#J@^T:?/')LDCE"[AL;LX!/'L0:H>&W\0Z?KV
MK^$-4U :Q#%IZW-K?LNV50Y9!%+CJW!(/4@$]^ #IO"NOS>)O"UIK0LDMOM<
M?F10F<O@9.,MM&.G8&L?4?&]]IWABUUE]&@;[1>+:>2+T_*6D,8;=Y?3(].E
M-^%MW!'\+M(,LJ1?8X6BN?,8+Y+HQ#!L_=(QWK \6JW_  JO1R6:+SM4M95)
M&& >XW*<'O@@\B@#L+7Q5(OBU/#>JZ>+2]GMC<VTD,_G12JIPPR54AAZ$?C4
M5MXGU.^\4ZQH5KI-H9-,6%WEEOF4.)5)7 $1Z;3FL71X_P"ROBA=P^(Y6NM2
MNH3_ &-J$V%#VXY> * %$BGDD#+ YI-*LVO/BWXT5+^YM2MO89^SLH+?NWZ[
ME/3^M &SK_BW4?#WALZK=:+$94NEMW@%V<?,X175O+^8'<#T&*GA\5RP^++;
MPYJVGK:W=W T]K+!/YT4H3[RY*J0P'/3'O7+>/\ R8/A<VG17S7+V-[9VTMP
M2"Q<2QDDGH6P03[U9TZ/^R?BG*GB29[N[NH2-$U";"J(_P#EI!M4!1(#SD#+
M _A0!T*>([W4-0U2WT?3K>Z33)OL\QFNS$[R;0Q"+L;@!@,L1DY[#-;&DWS:
MGH]E?O UNUS DIA8Y,990=I]QG%</J_AFVUG5M1U_P *ZT^B^(K20P7;*P,,
MQ0<">,\$%<8;T/?%:?A^_L?%'AWPMK6O0P6NIN3+:1&8Q@R[64E%S\P*Y8#G
M@_C0!T^I74MCIES=PPK,\,;2"-GV!L#.,X./RKGM)\3:UK'AJTUVVT*T-O<P
MK.L(OV,NT]@/*P6QVSS6[K9QH.HD]/LLO_H)KA/!-@D?PT\.:E<ZY=06UK;Q
M7,D;N@AVKR0?ESC\>H% 'I-%>-^/+ZQN+#Q?>VDBQWEF]L&FO''FPR (RK;K
MP4&#DG)R=W'>MVYO-%UCQIXETGQ'<VRVYLH#I[3R*JB%D;S)(B> P?.6'/RK
MZ4 =2=?G7QVGAYK6,0/ISWJW E)8E9$3:5QQ]XG.36]7G!TS3M2^(FCV4XDO
M++_A&9 !=,2TRB:( R#^+(Y.1UYQFM?X7NS> ;)"[.(9[F%-S9(1)Y%49]E
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M$7[1I%ZV//0JF7C;D"0%=O(_B[9YN:1>Z;-XN\)WL"&VL;SPY*$6Y(#,%,.
MQZ,0N?PH ].K!\8Z_/X8\+7>L6]K'=-;[28WE*#!8+G(!SC(XX^M>>Z'>Z;)
MX9T>QED$S3>(+Q;>$S!8&VO,0)<@Y0+@A1U8+BJEQ<1M\(O&]JES!(EOJTR1
MK"<(D?G1D!%R=JY)P,XH ]KHJ*YB2>UEB<$HZ$$ D<8]17BFEZ/ OP]\%>(-
M.:3_ (2 WEM$DXE9FE5I"LD9YQMV[B1VVD^M 'N%%>4L(=7\+>.KK5<)K.GW
MEUY<Q.);4(N;<QGJHP%(QU)/7)J?4/.T;4/#GB+5+ 3RZKIPTW4H!&#NN6C#
MQ\>K,K1Y_P!I?2@#T^COBO,O ]E()(_">H6\;R^'+MYI)?+^64,,P')ZY#L?
M7,0SUJAHAL?$%G:WE_K5O9>(+/5&,RQQ 7@E$K#R22V61@0-N,;<>E 'KE%>
M9:#H>EW&J>,;VZ,B2Z?JTKV]QYCDVV;9,NHSUY/UP/05:\&_:-,\20Z1JFFV
M:WG]G,]OJ>G']S>PJR EUZJ^2ISR#N.#0!Z'1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !115+
M4]5L](@BEO)2@FE6")54LTDC?=50.23_ $)Z4 7:*Y^;QKH5OI%SJD]S)';6
MMQ]EN"T#[H9<@;6&,C[R\GCD<\U8T_Q/I6IZA=V,$TJ7%K&)72>!XLQDD!UW
M@;ER#\PXXH V**X+6/$_VKQ1X033+R\2TO;MPP\DI%<QB)SN#%>1D*1S@@@@
M$<UWM !17 ^+_%*L-".DWUW&DNMVULTL41$,Z^:%=-Y7!'!Z$ X/7%=')XLT
M>*UU6X>>41Z2VV]_T>3,/RALXVY(VD'(R,4 ;=4[S2=.U$@WMA:W)  !FA5\
M8Z=1[G\ZQV\7VW_"766AQV]RZW-BUX)U@<KC?&J@8'3YR23P..:71]:TL6>K
M7D>JW=S!%J#Q2FZ1@89?E'DHNT-@$@ 8))..: -J#3K*VLC906=O%:$$&!(P
MJ$'J-H&.:98Z1INEVKVNGZ?:6ENY):*"%45B>N0!@U0B\6:/)]N5YY(9K$H+
MB&:%DD7?PF%(RVXD 8SD\=:O6&IV^HO<)$LR26[A)4FB9"I(!'4<\$<C(H +
M#2-,TJ&2'3M.M+2*0[G2WA6-6/J0!S48T#1A!! -)L/)@8O#']F3;&QYRHQP
M?I3-9\0Z9X?2V?4[@P)<S"")O+9@7/0$@$#OUQT-5=,\9:'JL6H/!=O$=._X
M^X[F%X'B!&02K@'!'0XH T;C1],N[M+NYTZTFN4 "S20JSJ <C!(SUYITFEZ
M?->?;);"U>ZV[/.:%2^WTW8SBLW_ (2_1UFO(9I;B":TM_M4L4UM(K^3G'F*
MNW++G@XZ=\5CZA\3-'ATH7EA'>7>]K8(1:2A")V 5MQ7!QSP,G(QUH ZRST^
MRTZ(Q6-I;VL9.XI!&$!/K@"FW>EZ??R1R7EC;7+Q',;30JY0^Q(XK-OO%^D:
M<)OM$DX^SVZW5P%MI"8(CG#.,97[IX//!.*2[U/3SXGT> ZG=QW$L$TL%M$I
M\FY3:"68[<$J,$8(/S>] &M>6%GJ$'D7MI!<PYSY<T8=<_0\4DFFV,UO#;R6
M5N\,+J\4;1*5C93E2HQ@$=B.E8*_$#PX^PK=3F,W7V-I3:2A(I=VW:[%<)\W
M'S8J<ZKI\7BN^C;4;XW-M8K)+8^4QB1-QQ(HVY9CR."?N]* -RXMX+N!X+F&
M.:%QAXY%#*P]"#P:C2PLXK+[%':0):;=OD+& F/3;TQ6)I_CK0-3N-.BM;J9
MAJ()M96MI%BE(!.T.5V[L G;G/'K4U_XOT731<O<W$@@M9EM[B=(7=(I3C"$
MJ#S\R_0D X)H N)H&C1VIM4TBP6W+;S$ML@0MC&<8QG!(J2TT?3+"&:*ST^U
MMXYO]:L4*J'XQ\V!SQZU:AF2X@CFCW;)%#+N4J<'U!P1]#7/Z=XNMK_7M;T]
MX9K>/2BJR331,JGY-[,6(PHP1C.,\GI0!I1:!H\%XMW#I5C'<J21,EN@<$]2
M"!FI1I&F"_\ MXTZT%X?^7CR%\S_ +ZQFJ=KXGTN[OK:S666.:[C,MJ)H7C%
MPH&24+  X!!QUQSC%:LJ&2)T61HRP(#IC*^XR"/TH H#P[HBW"7 T>P$T9!2
M06R;E(Z$''45:O+"SU&#R+ZT@NHLY\N>,.N?H17#^ ?&MM<>&/#]OJU[<S:E
M?;XQ<20N4DEW.=ADQLW8'W<]JW;36M*AU'Q#.VJW<@LWB^U03HP2U.S@1C:"
M=PP>,Y)&.M &Q+I6G36*V,MA:R6:XVV[0J8QCT7&*?-86=Q9_8Y[2"6UP%\E
MXPR8'0;3Q45CJMO?SSP1I/'- %,B30LA ;.",CD<'D9I]_J%KIEK]HNY?+CW
M*@X+%F8X55 Y))(  YH A30M'C$(32K%1 <P@6Z#RS_L\<?A5V2*.7;YD:OM
M8,NX9P1T(]ZS+;Q'IUT][%&9Q<V04SVS0.)5#?=(3&6![$9'!]*\X?Q7J)^'
MA\;17^I1WXMIB]L;=VMG9RPCX*[0$X^9>N,,3F@#U*]TO3]2V?;["UNMARGG
MPJ^T^V1Q5I55$5$4*JC  & !7%V_V6T\5:67\1:ZIOBYMM-N(W$<CI&V\L73
M(&!N"Y&" 1P:VKKQ9H]G<+%/<.J&Y%H9Q$QB68\!"^, YX] >#@T :=Y86>H
MP>1?6D%S#G/ESQAUS]#2'3K$V/V$V=N;3&WR#$OEX]-N,5G:CXKTC2FD^V3R
M)#%*L,UP(6:*%VQ@.X&%^\.O3(SC-;5 %./2=-AL'L(]/M4LW!#6ZPJ(VSUR
MN,&J[^&M!D6-9-$TUQ&,1AK5#L'H..*@\7>(D\*^&+W6'MY)S GR1HI.6/ W
M8Z+GJ?ZXJ>;7[*'R%(N6GG1I([=;=_-*J<,Q3&0 2.3CJ/44 .3P]HD44T4>
MCZ>D<X E1;9 ) .FX8YQ[U:-A9M9?8C:0&TV[?(,8\O;Z;>F*SX_%&CRZ1!J
M<5X)+:>401;4;>\I.WR]F-V[((((R,'.,4RV\6:/<R7\8N)(Y-/!^UK+ Z>2
M>."2,9((( )R#D9H M#0-&6U%J-)L!;@DB$6R; 3UXQCL/RJ>QTVQTR-H["S
MM[5';<RP1! Q]3@<FL:Z\:Z5:PZF66[^TZ?:F[DM&MG25HN<,H8#*Y&,]N^*
MYZ]\53S:CX&U+[3=6MI?F7[5:B)@LA^S,X 7;N?YB,8SGC&30!V,WAS0[B]-
MY-HVGR73,&,SVR%R1T))&<U8O=+T_4U1;^QMKM4.5$\*R!3[9%4;'Q5I&H:7
M-J$,\BPPSFVE22%TD27('EF,C=NR1@8R<BJL_CG0;2RU*ZNKB: ::5%Y&]M)
MYD.X94E<9P>S=/>@#8N=+T^\ABANK"UGBA(:))858(1T(!''X56D\-:#+*TL
MFB::\C?>=K2,D_4XJ32M:LM9%R;-I6%O+Y3F2%XP3@'*[@-RD$$$<&FW.O:?
M::U;:1-)*M[=1O+"@A<AU3[V& VY''&<\CUH 5O#^BO:):/I%@UM&Q9(3;(4
M4GJ0N, U-<:7IUY;QV]S86L\,1#1QRPJRH1T(!& :S[;Q9I%WI<NHP2SO;17
M/V5S]EE#"7>$V[=N[.X@=.M9\OB33=-E\4WZWFHWCZ='')<V1B;;;X0D",%1
MPP&XG)'?(% &S<>'=$NWWW&CV$S>LELC']15N6QM)WMWEM89'MFW0,\8)B.,
M97T.#CBN$O\ Q3.^I^!]1^TW5M:7S2_:K41,%D/V9G "[=S?-C&,YXQDUV&B
MZ[8:_:27-@\A6*9H)4EB:-XY%ZJRL 0>1U]: +MQ;07<#07,$<T+C#1R(&5O
MJ#6<OA;P\A4KH6F+M.1BTC&#^56[[4K?3_(68N9)W\N&.-"S.P!8@ >@!/X5
M1C\4Z5)-I\/FS))J$DD5LKV\B[GCW;U.5^4C8W!QTH M3Z)I-U<37%QI=E-/
M/'Y4LDENC-(G]UB1DCV-%WHFDWYMS>:997!MO]098%?RO]W(XZ#I5>/Q/I$D
M&H3?:BJ:?-]GN=\3J4D(!"@$98G<N,9SD 5SWB_Q1'/X.\3#2;ZYL]5TRU\U
MU,9CECRI*G##H<=1^8- '6R:5ITUY]LEL+5[K;L\]H5+[?3=C./:GV=A9Z="
M8;&T@M8B=Q2",(I/K@"LG1_%&FZC>1Z7'-,;X6RS@2P.@E3@%T9@ XR1R">M
M;<TT5M!)//(L<,:EW=S@*H&22>PH AM].L;2XFGMK*WAFF.99(XE5I#_ +1
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M>6 01,[,B$!SM R-I(!SSDXZUIV5Y#J%C;WMLQ:"XC66,LI4E6&1P>1P>AH
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MM-DM%^T6ZK<3.PX0!23L![G YX[UJZWIL&JZ'H4-U::K T:ADO+%76XL90F
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MAD9&1E10!0O-5N;;QEH.FW.FV,LUW;W3I=ACNC*!<JN5R =RY.3G'2L0^/\
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MW,4CIO4-'(K@, 02#C'6J2^&]1LO$LVO:?>VQN+ZVC@OXIHF$<CIG9(N#E2
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MJ\[1J5C+Y) P#DXSD@'CH;>D:#J&F:_K^IO<VTHU22.18Q&R^44C" $Y.[(
M/:@#@K"[DMOA WB#4]'TS5WM+BYGC6ZR3N:XD5V.5///3C([UW]YKE[/J^H:
M5HT$$EU86J3S&<G:S/NV1C&.3L)+'@9'!SQB#P)J!^&=QX0;4K8O*SXNA V
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MA#:3Z"+D"XG\R3S1(%\S#%@A(/W02.G - 'H=,2:.1Y$216:)MK@'E3@'!_
M@_C7E&AW^K)H7P_UN76K^XN-3NDM;J.67,4B/'(>5_O H#NZ_AQ70_#^S2'5
M/%THEN79=;EC DN'<8\N(]"2,]L]<<=* .PU&^33=/FO)(Y95B7/EPKN=ST
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MKF-3CY1N8Y7@84\#L!71T4 9&G^&=+TM[5K:*4_9(S%;":XDE$*G (7>QQP
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !67J.N0V%]!8);W%
MY?3HTJ6UN%W>6I +DLRJ!D@<GDGC-:E<=XL\.7&KZQ;:CH.L'3/$=A =C,N^
M.:%V^Y(O=2R]1T].E '0:1K,&LI=&&&XA>UG-O-'<1[&5PJMC'<8<<C@]LCF
MM&O+QXYU2/0]1M]0L(-,UVVU2ULK^2.3]SB8H!,K$' *=,@XX//2K6NWFO\
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MXQO-)N[243M#K4\CQ%##<,,9VN6Q&VP#(' YK?\ 'GGGQ?X&^RM&)OM\^PR
ME<^0W7!!H Z;2O$UAK%Q?VEL)DO[ @7%G-'LE3(RO!X((Z$''O4?A[Q59>))
M;^*T@NH9+"8V]PMP@1ED';&2?QZ'L:YKX>H+W7O$.JZJQ3Q.95M;ZU VI;QH
M/W?ECJRL/FW'K[8J'QG:7.A>,M(UG1KD6LVNSKI%\-N0VY6,<P'3>FT@9Z\"
M@#M-(UJ/6?M)AM+J%+>9X&>95"LZDJP7!.0"",]*TZS;C1D;P^VD65S<:>GE
M>5'-;-B2/W!.>?<UH1J4C52S.5 &YNI]S0!RS>/;-9=-C;2=6#ZGG[&&@4&7
M"[C@%^/EYYQ4Y\96BW>GVLFGZA#+>WC62B6)5\N0(7^;YNA49!&<UD^, !X_
M\ @# %W=8 _ZX&I/'D+2ZSX/CCE:%GU@CS$ W#_1Y>1D$9QZT =M17ES>(=2
MT*W\0:?_ &A-.EOKEK90W5W+EH8IEC+9?!X&Y@"0<9'7%=9H5CK.GZ]>B\OH
MFTZ>)7M[1KI[B2)U.'(=U!*G(X.<'IUH T]3UN#3+FUM/)GN;V[W>1;0!2[A
M0"S98A0!D<DCJ!U-&E:U!JTMW"EO<V\]HZQSQ7$>TJQ&0!R0W!'()'/6L3QA
MX<?7+W3Y]+U=]+\06*2RV<RKN5D.T.KJ>&4G9]*YM_'&LV.B:_!K%A;6/B#3
M7M(I[F!LP2132!%F4D'& 6."#C XZ@ 'J-%>=:Y=>(?"%CK>LK>0M9#3B\%G
M+=/=.DX8 R@NH.S##*],@=,UN2:;<VLCWEKXDNC;3V#*(G82F24#<)D9LA>,
MY4#;R.!0!U--DD2&)Y)'5(T!9F8X  ZDUY78:EJMAX$\/ZY/K=Y<7.L_8[67
M[1*JQ0[SDN#M)5B/EW<]<XI_C/3M9LO!?B];W4O]!DLO.M;9;R266%APX+L
MS(V1P<^G0T >I A@"#D'D&EKB=3$D=_::7;ZE?2D:;)*+.&9DD#%E G>;=D*
M.5"\Y)Z''&#9ZKK6M67PY9]9N[=M6AE6\,&U?,(MW;=T^]D?0'G% 'JE%>?W
M=W/X&\2V4FIZM?WFBW=BT DN9=QCN8UW9.  3(@;'^TO'6NNT&VNK71;9+Z6
M22[9?,F\QR^UFY*@GLN=H^E &B3@$X)QV%9>@:_;^(;2YN+>">$6]U+:.DX
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MV_Y%_4/^PQ??^CWKGO&&MOH/Q*EN=KI#)H<4$UVHR+1'N6!F8 @D#CIZ@]*
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M-4;5;625["\L9(I6A>&[C"ME>X()#*>S D&K['"DX)P.@[U5O9%LM)N)#<K
ML,#-]HE^81@+]YO7&,FN%T#4M1C\7:!;&[O9K2_TB6:5[I_^/B1#'B94)/E
M[S\O'!Y48H VI/'NGQ^%;KQ ;*^^S6UTUK)'L3S%=9/+)(W8QN]ZZNO';O\
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M$NUBG=$N !@;U! ;CC/<<'(XJ=O#VFMK,>K"*1+V*W-K&Z3.JK$2"5"@[<9
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M U:>SN+JVG%S:1>3'/%=2QR&/^XSJP+#ZDUOP6\5M;1V\$:QPQH$1$& J@8
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M[@2>WFCFA<922-@RL/4$=:KW>KZ;I[.M[J%I;,D9E833*A" @%CD],D#/N*
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M *S%CGH/EQGU(%9&F^+1%X@\16>N:CI]M;V5U#!:N["$/OB#XRS'+?-V].E
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MC#W 4*6$L>,D\9QG&:]!K"G\/S3>-+;Q +V-4@M'M/LQ@)+*[*Q.[=URH[4
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M #Z&O6J* /*H[?PS%XM^(%GJD%BD9CMDCA=%!*&V7(C'KG'"\YV^U-\+"_\
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M[5VNF3PM\7M="RH2VEVJC!ZD/*2/J P_,5VM% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6
M?J^K1Z1#;NT$T\ES<);11Q+DEVZ9)X &"23Z?A6A7.^+[36;NSL1I"B5$O$>
M\MO.\DSP8.4#]N=I([@$=\$ R=;\>26_A#6-2T_3Y?MFG7GV":*5D_=2$H-V
M<X8?O%(QUSSCG%UO$^H?\)W8Z'_9$T<$MA)<R,TD98$2(H/#=%!.<$DYX'%<
MW+X,UU_#'B[3([&PMSJ%^E[9I%/\AQY)V?=&W_5D9]3TQ70RZ9K3^.-*UX65
MOY9T^6SN8_M',&Z1'# [?FX4C [^W- "O\0=)CN[!2KFTOKK['!=+(A!D)(7
M*AMP5B" V/3H"#4$_P 1[6"TU"\;1M4%IIUZ;.]F(CQ 05&[[_S#+#[N3@9.
M.*J^%-)\4:!%!X>FT_3Y-.M),0ZMYPWM &R%,6W._'RYR .O..:5]X6URY\'
M>,-+2Q47.KZE)<VVZ9=H1MF-QSP1L/ SU% '7:GK<37-[I5K9W-[/!;B6Y6W
MD"&-6SM&XL/G.TD >G)&1G/^&$KS?#309)79W:U!9F.23D]2:KQ:9KVD^--5
MU6SL([RQUJ*$R(]PL;VLL:;.>H92,=,D$=*T? .DZAH7@?2]+U.**.ZM8O+9
M8Y-XZGO@<\^_UH H:1XW>6U\1W^KV<EG9Z7?26X;<K\(J )A3DN68GICY@,F
MM>#Q+'_;UOHU]97%C=W4+36HE*,LP7&Y05)^9002/3H37*7?@K6+_1O%NC-]
MG@34-1;4;*[\TG+YC=59<< &/!/OP#6X-+U'7/$F@ZOJ5B+ Z2DS%/-60R32
M($^4J?N ;CDX)XXH F\7>(;S06T9+2Q:X-_J,5JS!E&T'+$ ,1DD*1Z#UZ5S
MJ:Q-HOCWQ=<IIVH7P6QLYVMXI%8Q#$I<Y=@H_P!U3SV'6NA\9Z3J&IP:/-IL
M,<TVGZI#>-$\FS>BA@0#@\_-G\*H+H^KCQ%XHOWL5,>I:?!;P;)E.9$60'.2
M,#+\'T'0=* -23QAIYM-.FM<SOJ%J+R"-I$B_=84[F+$ ?> QUS[ D6_#GB&
MR\4:+%JEAO$3LR,D@ :-U)#*<$C(([$BN*M?#?B70[;PSJ%AI]K>W5CI:Z7?
M6$TX0.J[2'C?!&00>O8UWVEK>"Q1K^."&X<EFA@.Y(L]%#8&[ ZG R<]J ,+
M4?'=C86>H7PL[JXL-/NQ97,\6SY9<J#@,PR S!2>.?4#-.74[)_' @.EWZZN
M-(,ZEY%"&+S%_=@!]N_<>I';KBN0%KJ%Y-K,UIX>34]!N]3:Y*V^J1Q13-&P
M!8JZYSOCR<,%)'H>>IL[:]O_ !Y9^)8[1TTV;11 #(ZAU=W6097/0#@^_MS0
M!;T[QA;ZIX>M]7M["[Q/<_95MFV"97#E""-V!@@D\Y !-4/^$DTK2[WQ??KI
MFH"XTT12:A\ZMY@$6Y6C4OM "#V)],U-I7A>XT[QGJ=Z)4_LB>07L$'=+IUV
M2M_WR,_61JR]0\.ZS<OX^\NR&-<MDALR9EZB#RB6YX&3GOQ[\4 ;FG>,(;[6
M;+3I=-O;0W]JUS9S3A-LRKM+  ,64@,#\P%5I/'UDMG8WT6GWMQ8W]X;*UFB
M\O\ >2AF4<,PPI*L 3Z=LC-8Z3J2:]X3U"6U$=MI-C/#=NTR?(71!D<\@;"2
M?0BN9TI=0L]*M+^;PR;O0K:ZDU.U^S:E'Y2!F9ED2-E#<!R0A;J>@.  #T[6
M-5AT729]1GBFD2(#]W"FYV)(4 #U)(]JQW\9P01Z\+C3[M+C1(5N+F%"C%HV
M4L&0[@#PK<'!X^E6_%MMK%WX:N8="D"7[%"N9/++H'!=0_\ "2NX ]L]NM<C
M_P (OK:3^+6@T>SMH=9TJ.WACBN02DH21<-\HSRX)/\ Z$: .BT[QI!?ZKIM
ME)IE]:+J=LUQ9SS!-LNU59EP&+ @,#R!GFN<\<:^-6\-VEU86UV;(ZM;11WJ
M2A4?%PJL=H;)0X902.3VP0:T4T'56U+P5*]GMBTFTE@O#YJY#/$L8V\\C*D]
MN"._%8:>%O%=OX&M_"2Z?:SC3[R%X+TW019H4G$@RN"5; P1TXX)Z4 >D:OJ
MEMHFDW.I7A(M[=-[XQGZ<\=?7BJ$OB6*SMKN?4;2:U2W$6UBR,LQD.U A!P2
M6P.<<GTYJWK,5Q<:)<1165O=RR(%:UF8>7*I(W*21T(R,X_"N#/@#4ETG5K3
M1WDTZU,MM=:78WLWFI!<1/O;H6VQMA1C)[G Z4 ;LGQ$TZ#^V(YK2X^T:7:?
M;9(87CD\R#G+HP;!Q@@@D'ZT2^/DMK.&]N= U6&RFF@ACN'$00^=C:YR^0N2
M <C(R.*@O+7Q-KOA'6;2[T2STZYN;&6UBMXKE9=\CKC>6P JCTY/)]!6O+H(
MUGP)_86I1>4TUD+>09#;'"@!@1UP0"/H* 'ZUK%O#;ZO;7%A=W%O:V)FN&@9
M1N1@P*J=P.["L>W&.>16;;^+;'3[3PU86>E:C*FJ6(DL40JQ"I&&V,S/G=@K
MR>.Y-/M-&U>/X?WEI?%+G7;VT<7#(P"M*T>P<GL %!/L36?9Z!J\-YX%D>R
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M=W3V\ESMCPJJB$ Y9B!DE@ /Y"L^PTS4(_B%J>KR6NRRN;&"WC8R*6W(SDY
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M7I<:@\T-M/;QQQM& %5H0X ] "Y^O>@#M*H'6=/&N+HIN!_:#0&X$.T_ZL$
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M2Z@9'1>#F@#N**X.Z\0>)M334[GPY9M,]A?O:QV[^2(IA&P60.S.&4GYL$
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M:,!E>#C]VX/WAD @Y!SSFH[GP/:3V-M;)>W,3Q:D-4DG4(7FN V[<V5QC/8
M< #M7037]M!>VUG)*HN+G<8H^[!1EC]!Q^8JS0!SNI>$H]0U\ZNNI7MK)+9?
M8;B.'9MFBW%A]Y25.6/*X/-5+;P'!:V?A^&+5M0671 R03_N]S1LFPH1MQC:
M ,@9XSG/-=;63XGUB7P_X9U'5X;9+EK.!IS$TGEA@HR><'^5 &=+X'T^[?Q"
M+Z>>Z@UW9]IB?: A10JE"!D$!1USR,U9M/#1CNK.[O=2GO[FQB>*TDE104W
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MT65VLU;ROEC92A0X3GAL9//H175W=_;6)MUN)51KB40Q*>KN>@'X GZ U9H
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M03IIEDLUNNR&00*&B7T4XR!]*;;:%I%GJ4VI6VEV4-]-GS;F.!5D?/7+ 9-
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MBP-IYOG>0;9-GF9SOVXQNSWZTMWH.D7]_!?7FEV5Q=V^/)GE@5GCQR-K$9%
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MI>EV=D9CNE-M L>\^^ ,T 7Z*** "BBB@ HHHH **** "BBB@ HHHH ****
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MMJ MEEMA;,(KBY<HP5=R':AR5^7Y2._!)MV%O=PKX^9[&\'VRX=[8?9WS,#
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M[2B@#@[GP%>W=KK2G4H[:ZN]435;*XA0L;:9555!!X883GIU-6=3\->(]?\
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M5HR$););ACLR3TYZ5V%A>O>BX+V=S:^3.\($Z@>8%_C7!.5/8\?2K?6@#A]
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MV\DDJG) 8NV&Y/5NF!C&* .2M+K7K'1_ GB+^W;Z[DU.6SM;VTF*F)TF3E@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9X]5OM,MS8  @NRPRC*GMAL#/8D4 =_;ZMIMU=O:6^H6LUR@):&.96< '!R
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M W#TK;HH 9$'6-1(RM)CYF5=H)]ADX_.GT44 %%%% !1110 4444 %'6BB@
MHQ110 4444 %%%% !1110 4444 &**** "F31^=!)%O=-ZE=Z'#+D=0>QI]%
M '*6/A34H-.32+W7A>:2D0A\HV2)*\8&-K29(/'!(4'W!YKJZ** "BBB@ [T
M8HHH **** "BBB@ HHHH **** "BBB@#%U?1+S5K^#.KRPZ4$VW-@D*$7'.>
M7(W =B!U&>E;5%% !1110 4444 %%%% !1BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8&&.,>O&?3%,T3QKJNOVFB6;120W]U:W,MT]F(]VZ&40_)YIVX));H2,8]P
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M 4444 %%%% !1110 5D^(- @\164-I<W-S!'%/'< P%02Z,&7.Y3QD UK44
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M7C#,3SD\X.1Q6O8:)%9ZA+J,US->7\D2P&XG"@B-22% 50 ,DD\9)^@QJ44
M9%_X?AU#7],UA[NZCGTX2"&.,IL/F !MP*DG( [BLJ;P#83Z)JNDOJ.HFWU.
M\-[<,&CW>86#':=G RHXQVKJRP4$L0 .I-*"#TH Q?\ A'(AXD.N_;[S[6;/
M[%C]WLV;MV<;.N[GK^&.*S8_ -C'H%AHRZCJ(MK&\%["VZ+?Y@D,@R=F"-Q)
MQBKOC/7KGPSX8N=6M;:*X>!D!260J,,X7/ .<;NG'UK># D@$$C@^U %#6]&
MM/$&B76DWWF&VN4V.4;:W4$$'UR :J)H\>G3-J]U/>ZK>VMLZ1,ZH7"<%E14
M51N;:O/4X X%7],DOWT]'U2.VBN\MO6WD+Q@!CC!(!Z8SQUS5L,&4,I!!Z$4
M <MX<LHM0U^^\6-I5QI\UY;Q6T<=W'LF*+DEF7)VDDJN#SB,>M;.O:+:^(M#
MN])O3(MO<IM9HFVLN"""#SR" :EU'5;+2M,FU&\G2.UA7<SYZ]@!ZDG@#UJY
M0!@IX6B76[+5WU/4);NTMGME:1HR'5R"Q;Y.I(!XP!C  '%9TGPZTN70AI;7
MNH#R[UKZWNEE5)[>9F+%D95 ZL>"#UKI--U*TU>Q6]LI1+;L[HLB]&V.4)'J
M,J>:M*RLH92"#W!H SM&T==(MFC-Y=WL[G,ES=N&D?'0<   =@ !U[DFJ%SX
M3CG\4'Q#'JVH6]]]E^QCRO)*"+=OVX:,_P 7.>M:T^IVEOJ-KI\DRBZN@YBB
MSR0HRQ^@X_,5E^%]?N-<75OM=O#;R6.I2V*K'(7#! ISD@<G)[4 ,M?!>D0G
M57NA-J%QJR>5>SW;AGDCQ@)\H 50#T4"GZ=X4M[%M.,U]>7RZ:"+);HH?)RN
MW.54%B%)4%L\$]^:WBRKC<P&3@9/4TM '&VGPXTZSATV"/5-6\G3+HW%G&9U
MQ""&!087)7#'DY8=B*U=.\*66GP:O \]Q=P:M-)-=17.PJ6=0K8VJ, @ 8K<
M#*6*@C(ZC/2C<N[;D;L9QGF@#D+;X>VMM'I4)UK5Y;?29Q-91221D1 *5"9V
M;F7#8Y)(' -;VNZ'9>(M)ETZ_5S"Y5@T;;7C=3E64]F! (K1+*.K ?4U5DU.
MTBU6#3&F7[9/$\R1#KL4@%OIE@* *=GH"6]\VH3WMS=W_P!G^S)<S! T<><D
M*%4+R0"3CG [#%'AWP]!X:TYK&VN[J>$RO*/M!0D,[%FP54=2Q-:VY<XR,^F
M: RDD @D=1GI0!@7_A2*^\2V^O#5+^VO+>!K>,0^445&(+##1G.2!^53Z=X9
ML;#59M6>2>\U.6/RFN[IPSJF<[%  5%SSA0,]ZA\+Z]<ZZ-7%U;16[V&I2V0
M6*0N&"*IW9('7=Z5O,RKC<0,G')H Y2;P!8SZ+JFE/J6H^1J5[]NG(:+=YFY
M6^4[.!E5X]JN>(/"5KXA6PEEO;VUO[!BUM?VD@29,C##IM(; R,8JUX@UI=#
MLK>7R_,ENKN&SA4G WR.%!)]!DD_2I-,N-3\F[.M06L!AE81S0R926+ (<@\
MIW!!)Z=: ,G4/ NGZCI=K:RWNH+>6L_VF'4EF'VD2XP6W8P<CC&,8 &!@5+=
M>#;2\T-=-N+_ %!Y1<QW?VYI5,_G(05?)7;QM QMQCM46I>+O)C\-W6G0Q7-
MCK-[';"9G(*JZLP8+CG(4]QU'%=."&&001[4 8+^%(%U<ZK9ZA>V=[);K;W$
ML3(WVA5^Z7#J1N&3AACKCIQ4?_"&:='-H;VL]U:KHI<VL<3*5)=2K%]RDL2"
M<G/<GK71*RL,JP(SC@T,RJNYB /4F@#!U/PI;ZM_:$5U?7C66H,AN+/*&-MH
M4<$KN7(49P?I@U);:7>0^+KS4?MUX;&:W6/[++*&A5QMPT:@97@-G/4M[5'J
MNO7.G^+=!TA;:)[?4S.&F,AW(8XR^ N,<\<Y_"M/4I;Y=,FDTI+:6[ !B6XD
M*QGD9RP!(XSVH H:MX9M]5UFPU47M[9WEFCQ*]LZCS(WQN1@RGCY1R,$=C69
M;?#W3[33]-LH=1U,0:=?&^MP9$;:Y+'!RARHWM[\\D\5UI95 W$#)QR>]9&M
M:T=.O-+T^!%:\U.=H82^=B;8VD9FQR<!<8XR2.E %"[\"Z7J#:]]MFNKB/6_
M+^TQNR@*8P C)A001@=STI;'P<EKK-CJUQK6J7UW90/;QM</'AHV()#;4&?N
MCGJ>Y-;&D3:E-IZMJUK#;7@9E=()-Z$ D!@<9P1@X/(SBKJLK9VL#@X.#WH
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M5GC1NJ$[=K*>."*OS>#;68:46U'4/-TZY^U)*9$9YI2I4M(64YX)&!@ < #
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M"N=F.AQG&:72-?N+_P 3:_I5S;PPIICP+&Z2%O,$B%LG(&#T&/U-;[,J#+,
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MDTS3YK^._EL;9[R,82X:)3(H] V,BK5 'GUU:V47B_P==>&XX4@O(IEN5MP
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MOV=<,?4C')H \\UJ32]4\8>)=%\2:G:V*-;P_8C=J@_<&/YFB9^ PDW$D<Y
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M[FO89=.L9YHII;.WDEB&(W>)2R?0XXJ+^Q=*\MX_[,LO+D;<Z^0N&/J1CDT
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MM#^T/L5M]MV[?M/E+YF/3=C.*;-I.FW-P]Q/I]I+/)'Y3R/"K,R?W22,D>U
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M-N\,2:%!XE%E/=Q*5CN[0,<2OD_=:0@,>A[]36[XA-MH'B+Q.T2W$.A-X?\
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MG;'$@51DY. ..I)H EHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU-H\5PS:A"H>2'R7!13T))&,'L<\UP5KJVM^$Y]+T#QG8QWNF?:(8+#6[08
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M2/H,*:?I]C8W5U8064Z2@6[X,H7)*.2"65B<MW/K6MFJBR7_ /:[QM! -/$
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MC1;Z>X2WN%59'BV!S@@]U(!R >E:^<T4 8R>'V6XTR=]7U"5]/1D4R>4?-R
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4+75P-(-Q<2_.6 >,<YX PS#Z<=*]5M]!T>TM9[:VTJQAMYSF:*.W15D/^T
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M10!XKH-A:6G@WX=ZO!&$U"35X[=KD$[S$YF#1Y_NG'W>E;_V5)-7^(]FE^+
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M/E$HE=RF1QP&'/3WJ'PSX>O]*\1:A9RQ@:':7+WFF\_Q3CYE [!"90/:7VH
MVKOQ9I%E<)'<32+$]P+7[3Y+&$3$XV%\8!SQZ \$YXK9=TBC:21E1%!9F8X
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M^*K6XG^(?A:^72[J[L;".[%R\<.]5,B*$X/7D'IG% $OAW7;V;QUJNBIJ/\
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M]*GKS*]?47U?X<W+I;SZ@ZW&UBQ4-FU/+,<GW-:]IXYN!I5S]OLXEU*#5SI
M2WWO&\F X<  MC8<XP3QB@#MJ*Y_P]K6I:CJ&I66H:=+"MJ4,%X+>2*.Y5AG
MA7&0RD8(R>U6O$^F7.M>%M4TRSN?LUS=6SQ1RY(VDC'..<=J +=MJNG7DC1V
MM_:SNK;66*96(/H0#UX/Y5;KS+1=>LKGQ!HFC>*-"_L+Q%8,?L3",&"X'ELA
M$,@[$-G;[#J:UI_&U_)&+[2]*FOK);UK5H8K69I719#&\JN%V<$$[>X'4'@
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M.K1^7EOWF V#VXSZU4N? &JRZ5?Z1#K5M%83:G_:,&;0M(A,PF*L=^" 0<8
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MS=2O.3%_<RY/RG/([]ZI:5X&\.Z+;7-OI]B\4=Q&8G'VB5BJ'JJDL2B^RXH
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M;S[:DMC9ZM!97FD1)JD:O,J&6X5LQ1X)Y&%DR/5DH ]&FGBMTWS2I&F<;G8
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M8C*@QLW42-D'';KVD\;>&HO%OA'4-(D5?-EC)@=A]R4<H?;D#/L30!MM<P)
M)VGC6(XQ(7 4_C3XY$E0/&ZNC<AE.0:X.QUI/&O@;2;*:)1<ZDWV2_@*_P"J
M\K_CX!';[I4>AD6NXDDMK"TWR/%;VT2@;F(1$'0>P% $U1S3PVZ;YY8XE)QN
M=@HS^-9__"2Z#_T&]-_\"T_QK-^(:I)\-_$>0&']FSD9YZ(2#0!O1W]G-(L<
M5W [MT59 2?PI\UU;VVWSYXHMW3S'"Y_.O.=:\.)KOA#P1:6TWV&]!B-K=Q*
M-\+K:2.N/;<BY'?%36GB-M?L;73=9MH[?Q!I>J6J7ML1D;MXVRIZHPY![9Q]
M0#NSJ5@&*F]M@P."#*N?YU.TL:1&5I%6,#)<G Q]:X&SL;.Y^-.O>?:P2_\
M$IMC^\C#<EG'?V J*PB7PQ\8!H>FCR])U736NWLE_P!7#,KX+HO10PX('!-
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)]. '^"?#]QX5\*66B7%Q%<FT4HLT:%=P+$\@DXZ^M6K;7DGU)M-DL+VWO!
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M,3>='&/NJP4X? XS\O2NIHH R]4TVXO/#=WID-P#-<6[PF><9Y<$%B!CUZ#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ J*>Y@M8C+<31PQ@XWR,%'YFI:X3QM'J^F^
M(=,\1VVD'6]-M()(;FQ3!EBW%3YT:GAFP-N.N#[D@ [E)$D7<CJP]5.>V?ZT
MZN"T+Q-X8LO#-[K/AX!X+W447[&L9C:.YD$<>PJ 2O(W' /4D ][)\<W%A_:
MO]J:3.L=I'$]O<1Q2)'<F1@@C!D4;7WE1WX.: .TJ*:Y@MS$)YHXC*XCC#N%
MWL>BC/4\'CVKFM3UKQ'86NK[M+M5-MIS7=O>+*6A+C.8V& V0!G/0CTK+BUV
M[C\.^"9M5TVSOI-0N+6,3O(6:)VB+"4 I][ANA&,]30!WU%<G<^++R2VUR]T
MFPANK;1I7AF624J\[QJ&D"8! QG SU((X')@3QI>:EK5A8Z+IUO/#J&E'4K:
MXGN2@ W(,.H4D?>[9YQTY- '9T5B^$]>;Q)X<M]3DMA;2NTD<L(?<%>-V1L'
M R,J<4_Q5;Q77A+5XIXUDC-G*2K=/N&@#61UD171@RL,A@<@CUI:P?!'_(@^
M'/\ L%VW_HI:WJ (7N[:-RCW$2L.JLX!I\<L<R[HI$=<XRK9%<+KMO _QE\*
MNT,;,;"\)8J,\;,?S/YUB7"7G@KQ1KOBG38VDT3[<L6K6$2_ZM/)B;[1&!W!
M9MWJ#^( /4C>6H+ W,(*]07'%+'<03'$4T;GT5@:XR0:=J%KXOO;5;>>"ZL4
M=944$2*8"0<]ZJ>$_".BZY\*M#AN+&".:33XF6ZBC"312%1\ZN.0V><YH [Z
M2X@A($LT:$\@,P%(MW;/G;<1-M&3AP<#UKQ1M8N?$?PW\!ZCJD/VV\3Q%!!(
MVT%IPCR+WP#N &<\$UZ;I<5A<>(+C;X>;3YK6U4"62*-?-65FW+\A(('E+U]
M: .BCD25-\;JZ^JG(ILEQ!"0)9HT)Y 9@*\M^'<A\+:\VARMMT[6H6U&P)X5
M)5.V:,?@%?'89I=+!U/XT6FK7(WI>Z+-+;(XR(X1*BQD ]-PR_\ VT([4 >I
MQR1RKNC=77U4Y%1?;;7G_28>.O[P<5Y9;O<^ -7U'Q!;JS^&+O49HM2M8UXL
MF#[5G0#^'H&'X\]MO4H;*?PM\0YX(X)(YED=7100X^P0D$'OUS^- '<?;;0
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M]SJBR(&CY4$+DYZ\X' JJ_CB>#1M*\0W%A&NB:C+&@82'S8$D.(Y&&,$'*Y
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M-GRD9R3CG&?EIU]X]U+3-#\3W%UI-JVH: Z"6*.Z;RI$=%=65BF<X;D$=NM
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MY./X5 &>?3'544 <-!X,U*#0_"6G"YM&.@3I,S_,//"(R  8^7(<GOTJ/6/
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MU6TK1NR?W6P<./9@<4VU\,:5:MJ$AMS/+J*".\DN7,K3J 0%;<<8P2,# YH
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M\<<N3\X )!Z\=@>0 :WY_".CW%W>W#0RH+['VR&.9EBN,#&70'!XX/J.#D4
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M7;R2)$NZ1@JDA<D]R< ?B2!6=KWA_3O$NEOINJQ236<A!>))7C#8((R5(/4
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M/CS8N 2#CZ]:Z_2=,M]&TBSTRT7;;VL*PQCV48Y]Z@GT"PN-<BUEUF^WQ0M
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MZ>)_M A6ZE #[]XP0V0 W( X!YQ5^X\.Z;=:M9ZI-'*;VTC,<<HG=24)!VL
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MXU)64AYONGHW7J*T?!OBK1+#P+X2MKF^6.6XM[>QC!1B#.(U!3(& 0>.>_%
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M#VRVTCD0Y\U"V&+-RW&.,=.E<UI^IZ.TWB+PSXGMY)=3GU:2XBM61]]XA<-
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MJ $CYF&#\PZX].O%5I_B)%$VI1Q^'=;FFTU8WNXDBCW1JZ;\_?P<#L.?;@T
M=I00#U&:P(O%MC?"P72DDOYKZT^VQ1Q%5Q#P-S%B .2!CKG/H<49/B#IB:79
MWR6E](+C4!IKPK&OF6]QNVE)%W=0?3/;U% '6T5R[>,BL9#Z#J<=TEK)=S6T
MBQJT<:.5Z[MI)P2 ">.>.*K7'C2676?"T.FV$UQ8ZU!)="4,BL4$88* S#!^
M=2?I@9YH [$ #H*  .@KDK/Q#HEA<^*KUX;NT:QN$%^T[%M[^6NWRU#'J"H
M&,D]*OIXHC768M)O-/NK2]N('GM8Y"A%P%^\JD,1O&1D$CKG)H W< =A4-[9
M6VHV,]E=Q++;SH4D1NA!KE;#XB65_!I%T-*U*&QU.Y^R174J(%27<RJK#=NY
M*GD CD#/7&EXUUVX\-^#]3U>UMOM$UM"S*NX *?[QSU ZX')H V+6!X+5(99
MFN"@V^8X&YAVW>I]3Q]*GK#/B+;-:6(L+A]3G@:?[(&CW)&I +LV[: 20!R2
M<].#BQH.O6GB&QDN;421M#,]O/!,H$D,J'#(P!(R/8D<B@#4P!5:[LHKWREF
M+&..19-@Z,RD%<]^" ?PYS7,:A\0(;*YU>WBT+5[N322OVOR(XR%0KOWC+C(
MVX.!S[<&GW'C^R$UC%8:;J&I-?V+7UI]E1")47;D#<PPWS#@X].N!0!UM%<W
M<>,8(;>_N(=.O;F'3@/MIB"9A.P.RX+?,RJ02!GT&3Q4L?BZQFUO2]-AAGD3
M5+9KJTNUV>3*@ ) .[=G# XQWH WZ*Y'7=>TV6PM7U#3=0:W.KQ6D3QR*H\Y
M90JN2K@[-X(]\=*D\2Z[')I^NZ?9VMW=26=H3<O:R!#"60LH!W EL8; [$>H
M! .JHP,YQS7$>&O$<-AX*\,VS*US?S:1#/Y?FHA*A%!8L[ <DX'.2<]@2.B\
M/:]8^*-#@U73S)]GFW#:XVNC E64XZ$$$<&@#5H  & .*\LT#Q<GA?3M=DO-
M/U6ZT^WUV[2:]3]ZMLGF;5W%FWL!WP#@=:ZNY\:Q1:Y/I%MH^IWMQ#'#,QMT
M0J8I&(#@EQP,?7T& 2 #J*  .@Q7,77CBPM+&74VMKE]'AN#;RWZ!3&A#[&;
M&=Q0-\I8#MGD<TNL>-;/1_[1DDLKN:VTQ8FO)XU7:@DY&W)!? ()QV/<\4 =
M, !T%! (P1D5BW^MQ?;IM*MK2YOKE+<33I;.$,:-D+\Q889L-@ YX/3BN6\!
M>(HK'X=>'5N&DGO;N.9HT>4!F"R-N9F<@8&5!R<Y(H ]#HKC4^)&ER:?:7<5
ME?R&XU$Z6T4:HS0W(S\C8;!X&01D=.172Z;?RW^EQWDNGW5G(P;-K<!1(I!(
MP<$CG&1ST(H NT5PVG>+]&TGPQ:WUIINIK9W6J/9[&/FR),TY0ELN3C=G 7/
MTK5MO&EBQUI=1MKG2WT>-9KE;K8?W3 E7!1F!SM(QG.1B@"T-$O)?$+:A>ZO
M)<64;B2TL/(1%@?9M+%Q\S]6(!Z9]AC:KS^]U"YN?B=X2,EE?622VUXY2:4;
M' 1<956(##)SQW')[:H^(&E&\TV/9+]EU*;[/:70>,J[G)4%0VX!L'!(^N,T
M =7@9SCDTF!Z5QDOQ'LX=/NM0?1]4%E97S65Y-LCQ RN$)(WY8;C_#GBM*W\
M6QRZQ=:7-I6H6]U#:F\B201YN(@VTE<.<'..&VGD4 =%@9SCFBN0TWX@V>I'
M1)!IFHP6>LG9:W4RH$\S:6"$!BP)"GG&/>BUUFTB?Q;<:;IU[]OLYA]J260$
M22")2K("^T+MVGC'TS0!U]%>3Z:-,;P[X2\0ZUI^K&]O&LX6FBN0JSS2,C++
M(%D^8!B<9&<<8QBNWU/Q;;Z>-1>*QO+Z+32HO'ME5O+) ;: 2"S!6#$#H#Z\
M4 =#17,ZMXUM-*74)38WL\&G01W%W*B!0B/DC 8@L0 20.GUXIK^)[L^/X="
MBT^22S;3C=F963YLR*H;!8$*/F]R3TXR0#J, =NM%<?H_B/1;32-0O+>VO8
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MP74J(%67YMJ,-V[G:>0",\9H [$@$8(S17/>.->N?#/@[4M6M+;SY[>(E 6
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M4=#\%V.FZI#%%=0&3*QR[QAG9AS@<\^]8%[X9U[^QO'.E0V4,B:S/-/:3"X
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M,EB23GG'8 4V_P#"$>H>#;?PU)J%PMO"L*>>JKYC")E9<\8ZHN>* (_[7O\
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MVBJ\=L&2)1Y90)M8!>?E')ZGU% ":)JVO>(=,TC7]/EM/L=Y.6FM)5QLMLL
M589)D&%)!XY(XQFN4CU76- T;QEK6GW%LL%EXAF>2WDA+F<$Q!ANR-O!XP#S
M77Z/X%CT2[*6NL7_ /8XG-Q%I1V>5&Y;=PVW?M#<A<XSUS3)_ ,-SH6MZ3)J
MESY.L7;7<[A$W(S%20O& /E7KGO0!V%<!KGBK5M*O))1/;N(]7@M/LL,9D06
M\C(N9),?)+EB0N>F.#G-=[&&6-5=M[ 8+8QD^N*XVZ^'<-S%?P+K>HPVUWJ
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M0QPGM\V-S!>P)P..X!JSIOA+^S- N]*@U6[ GN'N5N J"2)W?S#MXQC=Z@T
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MA5W8+?+D'YVSM(!JIH'@IM ,<*:]J5UI]MG[%97!0I!Q@?, &<*#P"<#Z@$
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MRK;SS-*S&2-H)"4.3C&5!QZ\]:];M[RUO#+]FN89_)D,4OE.&V..JG'0CT-
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M0@<9WLJ[NI#8S2>$O[#U72/#&NPZBYUCR2)?*E'F7<S1_O4F'5@&!;!^[CC
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M77-1F\^6ZL->NTMF>XD/EJ54$8S@\'OGMZ"@#T*BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J
M][8VFI6DEI?6L-U;28WPSQAT;!SR#P>:L5B^*KZTL-"DDO-5N-+B:2-?M5NF
MYU.\8 ^5NOW>G>@"TNA:0MP;A=*L1.8O),@MTW&/&-N<9VX[=*C3PWH48MQ'
MHNG*+8EH MJ@\HGJ5X^4_2JU_P",=#TV_N+&XNI/M=O$)I((K>21]A)&0%4[
MAP>F<8.:D7Q7HKOI2)>%_P"UEW6+)"[+,,;N&"X!QR02"* +&I:!H^L2PRZG
MI5E>R0',37$"R%/H2.*==:'I-[>I>W>F6<]U&AC2:6!6=5/502,XY/'N:236
M]/B:[629E-HZ1RYB?[[8VJO'S,=RX"Y/(]:K0^*M'GCO&6Z='LY$BN(9(725
M'<@(-A 8[LC;@<]LT 61H.CB*RB&E6/EV)W6B_9TQ ?5!CY3]*0Z!HYU@:N=
M*LO[2 Q]K\A?-Z8^]C/3BLG6_&]AI.D2WJ0W<S1W<=FT?V612DCE<;@5R!AU
M.>^0!DFK*:G97/BVWMDU2[2Y-@\HTYH61&3>O[QMR@A@2!C(ZGB@"XWA[1&2
MY1M'T\K='=<*;9,3'U?CYOQIM[X;T+4H+>&^T:PN8K;_ %"2VR,L7^Z".!]*
MJS>,M!@\HR7K".:9H(I1!(8Y)%)!56"X8\'H>Q]#4D_BS1;>[:VDNR&6Y6T>
M00N8TF;&V-G VACN'!/<>M %O4=#TG5XX8]2TVTNT@;=$L\*N$/MD<50OO"&
MBWEDEFNFV,, N1<L$MESOSDLI_A8Y/S=<$XYY$=KXNM+GQ-J^C>1=1_V;'$S
MS&VDP68.3SMP  HP3]XDXS4.D^)M&M-#T7?K-U?IJ#^3:7DUNY:X?)P"50 '
M@XR!P* .G.=IP 3V!.*Y'PGX1.EG4)M6L=.>ZGU.>]AEB)D(#N67)9%PRYQG
MG\*Z";6K"WFNHIIBC6J+),6C8*H;A<-C!)(Q@$FF:=K^G:I>7-G;2R"[M@IF
M@FA>*15;[K;7 )!]1Q0 M_H&CZK=076H:597=Q;\Q2SP*[)WX)''/-2/H^F2
M7SWKZ=:-=NGEO.8%,C)_=+8R1[51\2:TVE16-M;[3?:E=):6VX9"DY+.1W"J
MK''<@#O5FYU6RTHQ6L\T\UP8RX2.)YI648RY5%)QDCG &3@>E #9/#6A2Z8-
M,?1M/-@K[UMOLR>6&]0N, ^]"^&=!6WFMUT73A#/CS8_LJ;9,# W#&#C Q67
MJ?CG3+.ST:ZM?-O8-5NDMX9;>%W49SNS@9R K?+UR.G!QDP^+H](\8^*5UC4
M;I]/MH;26"/[,SF!61V<[8TW!1QDL..,F@#KQH>DK<I<C2[(3I'Y22BW3<J?
MW0<9 ]NE<_XA\(^?;V,&CZ5H3V,$SRSZ9=P"."=BN V55L,,MU4YS["MVXUW
M3[>"";S7F%Q%YT2VT3S,\> =P5 3MY'..X]:H2>.?#<5O83G4U:/4$=[5HXG
M?S0H)8# /(P1MZYXQGB@"+POX7AT2YGO4TS3=+DGC$;6NFY\LX.=S$JNX^GR
MC'/7-;]Y9VNH6LEK>VT5Q;R##Q3('5OJ#Q3;*_M]0TV#4+5V>VGC$L;;&!*D
M9'RD9_#&:\_\0>-YM3^'NL:MI$M[ITUE=B%7: IN59UC.2ZXY^;@'(XSB@#N
MAHFE"PDL?[-M#:2G,D#0J4<^K C!/ ZU:M[:"TMTM[:&.&",;4CC4*JCT '
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M+>&*+3SB[62%UDAXR-R%=PR.0<8(Z59TG7]-UPW TZ=I?L[*LA,3H/F&006
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MTFTNQ]@AOXIY;PQK)%(Y7IL.#P<#D>XZ'.N?B!KL6E:OJL7ARWDLM&O9;>\
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MEO)""7MI( -C<\-R >WI[UMZ!:>(XOWGB'4;*XD1/+C2RA:-6Z9=]Q.6X[8
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M9$4+,'!(P>6Z>PK1\/:?XGMR@\0ZM97:P)LC^R0-&TQZ;Y26(SCL !DYYXP
M=%1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.D$I .&&=V!N7+ $#/)X.,B^FO="\9^';.VOKJZL=7$\%S'/(7*ND>]94/\
M">""!\O(P!4/PYLQ!/XHD%Q<.5URZCVR2E@?N<D?WO>@#NJ*YWQ/<O'>:/:I
M>S1FXN'#6=L,3786-CM5\C8%.&+9' QGG!XD:WKLGA&R?^U;F&YB\4#3F<%7
M9X?M.P*Q(^; XSQG'.: /6**\NU3Q%JOA(^.%COKB_73[.UN;4W9#F)Y2ZL>
M ,J"H;'3@UM:A->Z'XH\-P6NH75W9ZNTMK=)+)O)81EUF0_P'Y3D#"X/08H
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MXR:WIH(KFVDMYT$D,B%'1N0RD8(/X57N-5TZSNHK6YO[6&XE($<4DRJ[D],
MG)I)]9TNVG,$^I6<4P9$,<DZJP9\[1@GJ<' [X- &/8^ ] T^?39H(+DR::&
M6T:2\E?RU( V<M]T8&%Z#'2KFG>&--TQ[-H1/)]BC,5H)YVD\A2 "%W$]@!D
MY(' P*UIIHK>%YII$CB099W8 */4D]*J)K>E26+WR:G9-:(VUIQ.IC4^A;.
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M!QUZFI(+F"ZC\RWFCF3.-T;!AGZB@#$'@K0AX87PZ+:7^S$8/'']HD+1L&W
MJ^=P(/(P:(O!6A12ZA)]FED;4;<6UV9;F1_.0 K\V6.6P2-W7WK4.K::+X6)
MU"U^V$X%OYR^9G&<;<YZ<UE?\)OX>%UJL+ZI;(-+ ^TLTHP#C) [G' ..YQU
MH >O@_1U32UV7+?V8^^U9KN5F1L;<DELM\O'.>..E+-X1T>:ZO)C#*JWS!KR
M!)F6*X8#&70'!)  /]X=<U8T_P 1:7J&A6^L)>6\=I,B,7>50$+ ':QS@-R.
M*L_VMIWV 7_]H6OV-NEQYR^6><?>SCK0!7;P]IYUQ]9"S+?/;_93(L[@"+.=
MH7.!R<YQFLEO ^GV\6B6VFB>VATNY\^$_:Y#L!8%EP2=X;D?,> QQZ5MKKFD
M.<+JEDQWO'@7"'YT&67KU Y(["I;;4["\L3?6M];3V@!)GBE5H^.OS XXH B
MUQ)9-!U".&%YI9+=T2-,99BI '.!WKG_  7X92R\->'QJ-O<K?:?:H@AN)BZ
MP2[-KE1DC^\ >< D# .*WUU[1VM&NUU:Q-LC^6TPN$V*W]TMG&?:K!O[,/ A
MNX ]P,PKY@S*,9^7UX]* .?7X>^'$6-%M;@1Q7?VR&,7<H6&3))V#=A02QR!
M@'-:NF:!8:1=WUS9I*LM]+YUP7F=P[X SAB0. !QCI4]OJNGWLKPV=_:SS*I
M8I',K$#ID@'.,U1\+WFL7ND&36X[-;M9G0/9[_*E4'AEW\X[<]<9'!% %2+P
M'H$-A;6,=O<+;6MRMU!&+N7$<BDE=OS< $DA>G)XJX?"ND/>:G<RVS3/JD2P
MWBRRLZ2HH(4%2<# )Z =:S==\4I!XFM/#EIJ-E:7<]O+,\\Q5O**[ B;=PY8
MOGGLO'7(UK#54C6UT_5M0TT:TR 2P038W/C)V*QW8[T 4-,\"Z'I-A<V5M%=
M&&XB,!\V[E=DB/5$);*+[+CMZ5<7PSIT>DV&FQ?:8K?3V5K4I<N'BVJ57#9R
M0%)&#D8JY-JNG6UY'9SW]K%=2D".%YE5W)Z84G)I9=5TZ"[6TFO[6.Y8A5A>
M90Y)Z  G//:@#,F\'Z/<10I+#,QBO/MX<7#JS7':1B",GMSP!QC%/D\)Z3+/
MJTSQSF35HQ%>G[3(/,4 J!U^7@D<8ZU);:NR^(9]$N]HN/)^U6[KP)8MVT\=
MF4X!['<I[D#7H X/4_#4B>+O"<=C:7RZ9I=M<0FXCGYAW*@C&2VYAA2.A]ZU
MM8\'6=]H!TNV$L):Y^T^>MPZN)<D^:6!R[ \X)QP!P!5^/4EM[_5'O=7T[['
M"T8CC#!'M\KR)6+8Y()' X]:OB_LVN4MA=P&X=/,2(2#<R^H'4CWH CU.\N+
M&S\^VT^>_?>JF&!D5MI/+#<0#@<XS7/Z+X2A;PQ?Z9K=LLL>H7UQ>20%N4\R
M4NHW*>& V\@\$<'O2>+?%?\ 9$FFP:=?:>US+J=M:W%NY#R".215; # J0#W
M!ZUT5SJFGV<PANK^U@E;&$EF52<G X)[F@"O::#9VCRRJUQ+<RQ"%KB:=GEV
M#.%#$Y Y)X[\GFJ,/@C0[>QTNSB@N%M]+E\ZS074G[I^>?O<]3USU-:DVLZ7
M;@F;4K.,"(S'?.HQ&" 6Y/W<D#/3FFKKFD,]HBZI8E[P9ME%PF9QZIS\WX4
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ME7Z77AKQ'=ZBNMPZK+<)8H@5IW\YGBEC8)G;@KSNP #G KU[ SG'-&!G..:
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M87+6]Q*'87+()&$C9.\@\'D].!VX% 'G>I69EE^+-O:P;I)+*+;'&O+,;0]
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M]M@&.^#D>WM7J%% 'EWA^_\ #6OMI5Y%=:E-J6EV<L;VOEB)K)3'MD1P$7N
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M6[O'O,F=&6105^4[4 9?E[8Z=ZL:IX-UC5[7QG J):R:G=V]W8R2.&4M"L>
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MG8H#+\O^SG!))H W;OXBVEI!JTYT;57@TBX\B^D5(\1#"DOR_P PPPX7)XY
MXSV*LKH&4Y5AD'U%>=7OAK6[C0?'5DEAB76KAWM,S)C#1(GS<\<H3WZUWUB)
M%L+=98S'((U#(2#@@>HXH YM-<TRSUWQ5.EAJ'VS3K>"6]^<,)4VN4,:E\#
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M)/-W] 3QCC/K[<T =31110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD?:6VCZ $G\*L@AE##H1D5SOCS5[_0/!.J:MIKPK=6L7F+YT9=3SSP".>?\
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MSF50C2*7\KRY,<9WE>0!P>G%&H6^I0_$OP8;^]CN2T-Z2$A"!'\M=VWG[O3
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MO/?6UO=VMK+*JSW3,L*=VVJ6/X #K[CUH S_  UH">&M'738KJ6XB66256E
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M3,T*ER5^Z2<<D=O2L ^%9+OQ_?:SJ%E83Z?/8Q6L8=RTBE&<DE2N,'?C&>U
M'"Z+!<:B/A_;:I>7<T<TNHV^\W#J;B!%<1DX/.5 YZD=^:=/+=>&6UG2K2>=
M?#47B&QMV<RL1;P2JK3H')R%W%%// <^M=UXA\,SZKXD\.7,=I8R:;IAF,L4
MKE20\>Q=BA2/E.#U'2NA73+!+![!;*W%FX(>#RQL8'KE>ASGGUH X/5;1]-\
M8:GI^EW?]EZ;=^'YIKEHQB.TE#;4F"CA3@MTQG9GJ,UD7FK:CH&C^(K:XTB/
M3-:M[""1Y].8M;SVXE*M,@&&1@&?(// .>*]/@T32K:SFM(=.M4MIUV2Q")=
MLBXQAACD8XP>U/M-)TZQ21+2QMX5D4(X2,#<HZ*?89.!TYH \XU/;HNG:OXB
M\.:S9RSOHTCQV>G0XB;;@BX(WM\RYZ]^AS4LEKH\7BGX=7VG&-OM'V@^>'RT
MX-LQW.?XFR>IYR3ZUWNF:#H^BI,FEZ79V2S',HMX%C#GWP.:@MO"?AVRE26U
MT+389$<R(T=J@*MZCC@T 97Q/@BN/AGX@$L:R!+-W4,,X8#(/U%92M:/XWT'
M09H8/[%DTF6:&  &*:Z#)D$=&*H2P!_O$UW\T,5S!)!/$DL,BE'C=0RLIX((
M/451?0-'>P@L&TNS^R6YW0PB!0D1]5&/E/)Y'K0!@> OM4+^(;!I))-/LM5D
MAL6=BVV/:K% 3U56)4>F,=JIW5E8'XUVT\\$'F'0V<.ZC)<7"!3GU&<"NWM[
M:"TMT@MH8X84&%CC4*J_0"H;G2]/O+N"ZNK&VGN+?/DRRQ*SQYZ[21D9]J /
M'ULX8/!CZU$9%U"V\4N(91(PV*U]M90,XP0QSZ]ZV+SR/$>J^*].U76;/3;N
MSNAY$DT9$]M (T9)(7\Q=H)W$D#J3G(P*[__ (1K0?LIM?[$TW[.9/-,7V1-
MA?\ O8QC/O3KOP]HM_?6][=Z38SW5M@0S2P*SQXZ8)&1CM0!<L]QLK??(TC>
M6N79-I8XZD=B?2O%K;1XH_A99:_I[W">((-1=;*1)WRS&\9?*"YP58$Y&/4^
MM>WUGP:%I%K>M>6^F6D5RS%S*D*ABQX+9 ZGN>IH \ZN?(\27GBBTU/6[33+
MZQOR(I9(R+BUA4*8WB;>,*1SP.23G.:FUZ6ZTS6+G5KVVBUC1Q<VHFGB/EWF
MFR*(\ *>J$E6*C!_>-UKOKKP_HU]J4.I7>E64]]!CRKB6!6D3'3#$9&*<^B:
M5)?->OIUJUT[*[3&)=S,N-I)QR1@8)Z8XH Y+PI96%O\1/&C)!!',+NWV$*
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M864%LK8#"*,+G'3./3MZ4 6Z*** "BBB@ HHHH **** "BBB@ HHHH ****
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M+A,@@_-C ()IVH>+-%TN2=+J\(^S(CW#I$\BPJ_W2[*"%!]^W/2N,FM9=/\
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MMM#8PP!Z,#GIS7G$&EM))XP@U'0];>POKNTEC?YC,5"Q+YBL"6+(P+X'3;C
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MK:SQW1=DF*;U61=N &YQ@GIS5WP'JVK:QI^H7&J?9R4U"YA4Q.W&R0IM (X
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M1MSM%O?*GY00 58XR>M '3RW,$#QI--'&TK;(P[ %V]!GJ:EKS37;V]U74O
M6J3V%M!!<ZFDD1#[I8U:&0JK<8Y')P< C'/6M6X\=W&%O+#29KVP%Z;5UACE
M:4J',;2KA"I 8$XST&<@\4 =G--%;PO--(D42#+.[!54>I)Z4Y'61%=&#*PR
M&!R"/6O._&NLS:[X(\8+8V=M-96$4]K(\SD,\B)\[(,$#83QGJ0>G!/;:06'
MA^P* %OLL> 3@$[!WH M07,%U%YMO-'-'N*[XV##(.",CN""*EKSVS\9R6?A
M+3-1LO#UK"MYK#6#VL$P01LUPT9<?( Q)!)SMY-=!H'B"]U#7=8T?4K*"VNM
M.$,@:WF,B/'*&*\E5.1L(/% '14BLKKN4@CU!K)\2ZI_9&AS3I+'%<2E8+=I
M2 HE<[5)SV!.X^P-<K\-+U+&;6?"+7PO#I5QYMK/Y@<RVTOSJ21U*L6!_"@#
MT&HI[F"U17N)HXE9@@:1@H+$X Y[D\ 5R%EXI\0ZI>ZI!9:+8K'IU[):32RW
MK8XC#*P 3)Y89''48SR1DV/B:^E^'7AW5M8TRRU$W]W:JQDD)V-)* ) I0C*
MD\ 'C YH ]*J+[3!]I%MYT?V@H9!%N&[:#C=CKC)'/O7.WGB34)9-870]-CO
MFTEECEC>78T\FT.8TX(!"LO)[G&.]9DDD,'Q=BOI8A;Y\-R23%@-P GC/S8Z
MX% '=4$X&3TKC;'QI>7M]H[)H\SZ?J@XDBCE+6P*[D:3*!<$<$@\'U'-;/BJ
MRU34?#EU9Z.UH+J8!#]J9A&4S\ZDJ,\KD<>M &K'/%-GRI4?'7:P.*)[B&VC
M\R>:.),XW2,%&?3)KBOAVNGVIU734\-VV@ZO:/&+Z"VPT<H()CD5NZD;L9Y'
M(K8\6Z=IMSI-Q=W^@MK;10LL=J(A(QR.=@/ )XY'/2@#H>M%<Q\.Y;67X?:)
M]CNY;N&.V$7FRJ5?<ORLI!Z8((Q[54O?&5_92^)X&TRW^T:- EU#&;DC[5"R
ML=P.SY3E2N.>10!V516]S!=PK-;31S1-D!XV#*<'!Y'N"*P]-\13ZNFER6-O
M;RQWEA]LD;SB!'G&Q?NG.XDCMC8W':N37Q1?OX/\*W>BZ=8Z;%J&L"UEMD8A
M4'G/E5*J!ABAW''<\<T >D)<P27$ENDT;31 &2-6!9 <X)'49P?RJ6O-!=:E
MI7CSQE=:7IUG-<)864\RR3&-,A92<$*26/;('N1T/>:-JBZUH%AJL$91;RVC
MN$C8_=W*& )_&@"_17"67CS4I=,O=8O-&@@TNQEN8)V2[+R&2)]BA%V@$,>,
MDCD],#FU_P )E?VU[=Q7>BSRP16$EXD]K%+MW(,F$[T7YB.A[^@H [&BN+_X
M36X;PMJ.OVD.G:C9VME]K1[:[.&(!+QM\I*LH ZCG/04EOXTU*'7-'MM8T>&
MTL-8C)M+F*Y\QD<)OVR+M &1G&">GY ':T5Q5IXYNKV?1[BWTB:?3-3E"*\4
M4ID@1AE)7^3;M/&<'Y<CDU<M?$^I:E!9:EINDK=:5<WAM\K+B58@S(9R",;<
MKG;G."#UXH ZFBN2\'ZMK&J:KXD34!;^3::F]O%Y;L2@6.(A0".1R23GJ3Q1
M?:MK"?$W3M)@%O\ V>^G37#*SL&8B2-2QX/(!.![G)H ZVBN)N/'DL7AK_A*
MH[&.30%G*.PD/G>2)/+,P7&",\[<YV\YSQ71Z]JCZ/X<U#5H($N3:6SW'EM)
ML#JJEC\V#V'I0!IT5P]MXVU5-3T--3T6&WL-;0"TGCNB[)+LWA9%VX&X9Q@G
MIS45KX_U Z->Z]?Z/;V^D6+7,5PZ79>3S(G**$7: 0Q&,DCGMCJ =[17,2>)
MKO2]<TNPUJS@ABU17$,T$I<12JNXQOD#J,X8=2.@I-/\2ZGJD6DZC9Z0)M)U
M&0@.LN)88B"5E8$8P<#(!R,CKTH ZBBN)/CNXE-I=V.DS7FG3WGV8F&.5I53
M<5\[A-I7(SC/0YSG@%[X[N(TEN].TF:_LX+PVLB0QRM,X5_+=TPA4A6!XSR!
MG(Z4 =G++'!$TLLBQQH,L[G  ]2:C%Y:F2!!<PE[A2\*B09D48)*^HY'(]:X
MCQ=K,VM^$_&$%A9VT]GIUO/;3/.Y!>41;GV#!QL##D]6!'&,U+INIK;W_@O3
MGTNVEDNM*=X+UF_>0[(H]R@;> VY>0>W2@#N:*\^'Q U4:6VK2Z);)8V^JG3
MKK%X6<?OA#N0;,, 2#SCZ=ZU=4\77%M=>(8K&SBF.@VJ7-P)9"AEW(S[4P#C
MY5ZG/)QCO0!UE%<8?'#E](MWBL;.[U.R-Y MS<L(Y<D;8E<H/G(()XX[!JZJ
M.2ZETU)?)2.[:(-Y3L=JN1T)'8&@"S17GWACQEJ,G@[0[O48X)]2UBY:&V59
M" S%G9BW'RJJJ>!GH!WKH=*\12W'B2_\/:A;)#?VL*7,;Q.62>%B1N&1D$,"
M"#[<F@#H**YW6/$CV>K'2;*%)+Q;87+F19"BJ6*H/D5CDE6^F._2LF'QSJEU
M)X<AC\.M!/K,<^8;R9HG@DB'(8%,[3P0W4CM0!W%5K74+*^,HL[RWN#$VV00
MRJ^P^AP>#7GWB+Q1J>I_"OQ3.MM#:7]@US8W7ESL5!48+1MMR<AAC('4^E;4
M%TEIK]I86NF6":]=V'F32JYV);1D*N3M!8[GP!@=^>!D ["BN#N/B%<PZ5+,
M-(1K^TU:/2[RV^T8"L[*%=#M^92&!&=OZ5JP:_K$FHQZ--I]E#JYADN7"W+/
M#'"'V(<[026/; Q@GT! .GHKDQXNO!!IEM<Z4UEJ]Y#+-);2EI1 L;!228U)
M8$LN.!P><8P=/PQK5SKNDFYO--GT^YCF>&2&56 )4XWH6 )0C!!P/TH V:BM
M[F"[B$MM-'-&25WQL&&0<$9'H017*Z?XGUW5-<U&QMM%LQ#IU]]FGE>](RIC
M#AE&SD_,,CMD8SSBGI/C"&'P=I=[!H]O9R:CJCZ?#:0MB))#.ZEBP4<?*S'C
MDG'?- '<3316\+S32)%$@RSNP55'J2>E.1UD171@R,,JRG((]17G'BC6[G5_
M#GCS1K[3K9?[)T^0M.LI;S&>$NA"%>..OS$@COG-:>C>(M2@O]&T6ZTZWCCO
MM,::RE6X+,6B5,K(-N%R'!X+?C0!VM%><Z)XWO[7P-::SKAM5^U:A);?:2["
M.',THR_'RHNT*.3U&2.M=OI%W<WMD9KF.!278(T$OF)(G\+@XZ$<^W3GK0!?
MJ);:%+F2X"?OI %9R<G Z >@]AZUP\'BZ^T_5?&=WK/D?V9HS1[1$[%@OE!P
M ",%F+<G(YP.@K5?Q->Z=K&CV>KV,,,.KDQPRP2E_)F"[A&^0,Y .&'<8QWH
M ZBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "N)^)Q<:)I'E/&DIUNQV-)RH;S1C/M7;5FZV;>
M+3S<SZ4^I&)E"P10K))\S 94-CIG)YZ T 8FH^%KS5I]7U"XDMH[Z\TQM,@1
M&9HX8V)+,6P"Q)(.,#[H'J:;>>$+J[\,Z#:K=PPZKHCPRVTX4M&[1KM(8<':
MRY!&<C/?%=< %4   #@ =J6@#"T_1)AXCN/$&H&'[=):I9QQP$LD42L7/S$
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MESJ/ES7&ML!=(@.P1K&(UC&>2 N<GC))X'2N@JE?ZBMGIUU=PV\]\UN#F"T
M>1B/X0,CGVS0!R$'PW5-+T"WFU%Y;O39]T]R1S<PE/+:(^Q18U^B>M:.O^'=
M8D\26WB'P[J%K;7RV_V2XAO(F>&>+<67[I!#*2<$>OY]4IRH.",CH>U+0!SN
MM>&Y]<\'7&D7=]OOI%\Q+L)M$<X;>C*N3A58# R3@=3UJ'7?",FH^&[&PL=0
M:UO].FCNK6[9-W[Y<Y9U[[MS9_WC7444 <7J_AKQ'XA\(:AIFJ:EI_VV\$:
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MCC@CJ;B^:WO[.U%G<RBY+@S1H#'#M7/SG/&>@P#S5A)8Y&D5'5FC;:X!SM.
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M,'JJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY9LDDDYR2<UCZAH]W>?%"TO_ +/>QV,.E26WVN&0*!*TBL ><D;0>H(SCOT
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M&C7%]<7EO87$#6[W+!I%$D(<KD 9 .<?6K7B.X<ZSI-E'>SCSA,S6-J=DMP
MHPWF;AL52<GGDD#GH=.QT*PT[5;_ %.W2475^5-RS3,P<J,+P3@8'' %1ZKX
M;TW6;ZROKM)A=6>X0RP3O$P5L;E)0C*G X/I0!F_#S4KW5O!%E=:C,TUUYD\
M3R-C+!)G09P!DX4<]ZR[Z+4]6^(NHZ*NOZA9V/\ 94-RJVI161VD=?E8J>/E
M!]??'%=5HF@:=X=LFL],A:&W:1I-AD9PI8EB!DG R3P..3ZUS<FBW=Y\4;K4
M7@OH+)M*CM4NH90@9Q([,N <XPPYQUZ$4 <UINL^(M4MO"%O<ZS<PS3ZA>Z?
M=S0*BBX6)90).5.&^0>V><5T.E&ZU+Q'K7AN?5M0\O1K6VCBG$NR:5Y%9C,Q
M4#<1@ #&W@Y!S6^_A+1V.E%;>2(:42UF(IW01D@@G /S$@G).<Y/K4M[X<T^
M]U1=3(G@OA%Y#3VTS1,\><[6P>1GD=QV(H XCPUXKU+Q!)X<TK5)VA>YAO6N
M)H3Y9NG@D$8"D<KD9<[<=/3(K1N[O5=*O-$\-R:L+^2]N+D-</(;=RB*'2$N
MH8[MKCYA@D+VS6[J?@O0M5TVQL9K,Q1V!!M'MI6BD@.,?*ZD$9[\\]Z+_P %
MZ%J6APZ1<VC-;02>;$XF<2I)G.\29W;LDY.<G/- ',S7OB'0SI^C7^H6\YU'
M5FAAD^TL'B@,3.L32[,[BR[0VW)!Z@\A-0OO$'AJ%;&[U*)DU/6+:TM'68S3
M6<,N=^YF4;ON,%)!Y/.<5TT_@K0;KP\=$N;1Y[1I!*6EF=I3(.DGF$[MWOGI
MQTXI/^$)T)] FT6>VEN+69@\CSSO)*SC&&\PG=D8&,'CM0!@6M@UK\6=4ABO
M;K]YX?A9'DD\QXOWT@^4OG/()YSU/; K)L-8UN^\+?#RX.LW4<VIW'E7;J$)
MD!CD;)RIYRHQV]C7;VG@[2K/4&U!&OI+UK46C7$M[*[F/)."2WJ>O;M38?!.
MAV]II5K%#<+!I4GFV2BZD_=-@C/WN>"1SGJ: .4?5=?TW0_'5K8WMQ>W&DW*
M?9);@J\J1O'&[\D88J&<KGV'-;6D'4)_',IL[Z_D\/)8)(1-RIN2S KN==_W
M<$@$8.,]<4>)/"D:Z1JS:5ITE[<:I/$]]"UXRM*BE<E"S85PJ@#D#@>E0^&=
M#GM]6AO+:#Q#I]NFX30ZKJ7VA905( 5/,DQ@X.[(Z8YR< '<4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5G:YK$.AZ6]Y*ID8ND4,2G!EE=@J(/JQ ]NM:-<5\14DQX6G&?(@
M\0VC3'L 2RJ3[;F6@#J6O(].L4EU6\M86/#2,PC3=UP-Q_SBG'4K!;:&Y-[;
M""=E6*4RKMD+' "G."3VQUKD]9O#I?Q1TF]U-UBTB339K>">0XCBN3(K')/"
MED7 )ZX(%<7JEG;P:%=R3B(:5<>+H)K!7QM\DR1^:R>B%@YXXQD]#0![':7M
MIJ%N+BRNH;F$DKYD,@=<@X(R..#5;^W=(,\,']JV/G3L4BC^T)ND8'!"C.20
M>.*L6MG9VML8K2V@B@<ERD2!58MR3@<'/ZUXJ-/TC4/AKKEA:PVK:\=7N5LT
MC $ZRBY/E[?X@ .XX W>] 'LUQJVFV=REM<ZA:P3OC9%+,JLV3@8!.3DTEWK
M&F6#LEYJ5G;NBAF6:=4(!. 3D]"2!7DOCO4;:2P\<6*XM;V-+=IHPC/+>;50
MB49R%C4<?*.HR2,XKHA%HFL?%]_.AL[J*;0$(66-6#MYS'H1R=N#ZX/I0!UN
MD>*-(UR_O[.PO89IK*8Q2*L@))"J20.X!8#/J"*+WQ/I-AKUIHMQ>PQWUTC2
M+&S@;5& ,Y/<D #OSZ5@^"[B*+Q/XQL';;='5C<"(@Y\LPQ -]"0<?2C7[F*
MQ^*/AFXN6\N*2RO($<@D-(3$0HQW(!P/:@"SX9\5_:SJ,.MWUA#<Q:O/86RA
MA%YP3:!M5F)+<]B>M=%>ZKIVFE!?7]K:F0X03S*F[MQD\]17CFHMI[^ /'5R
MIMFN?^$@=HY!@OQ-&5*GKC[Q&/?WK;U;4]+A\7^(M-\3:A<VMAJ\$/V)T0-'
M=0>4%:-6V,=P<N< _P >10!Z-=ZQIE@S+>:C:6S*GF,)IU0A<@;CD],D#/J1
M2S:MIMO=Q6DVH6L5S+@1PO,JN^>F%)R:\]M=,T5OB9INGW%K%)$OAH0B"]"R
M.2)%PKYZOLSUYQFLXSZ3=3Z_X7\376H17TNIR3P642 -=(7#0-$P3/ "K][C
M;S@4 >J7>JZ=82)'>7]K;/)]Q9IE0MSC@$\\UB^*?%5OH-SI=A]KM8+G4+D1
M;YW $,>UF,A!(X^3:.V3[8KG;:ZL[76/&^F^)GC1[QQ)!YY ^T6IA"JL>?O;
M2&! [M[UGJ;G3-+^&-KK<X2_AN5,XE?YD'D2*-V?3*KGUH [+2-7U*VU2+1]
M>ELY;BZ22:QNK0%4GC0C(93T<*RG@D$$XZ<ZFN3S6VEO);W]G8S;T"SW@S&/
MF&01D<D9 YZFN;\6(\WCSP,L'^L6ZN96([1"$AOP^91^(I/BN8!X!N3-Y>\7
M-L8]V,Y$\9./P!_#- '4W>L:78&47FI6=N8E#R":=4V*3@$Y/ SWJ'4+Q_\
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M%I&W3HN[8T1<D;N>02<^IH [*+38UU634I6\VY,?DQL1@11YR57ZD D]\#T
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M*89@-V5ZYQ@'D\4 =M17*VVMZ-;>(O$TTL5U:3V%O!+?SW#YC,>URI10Q P
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M?0O$<6N3ZC:FRNK&\T^58KBWN=A9=RAE8%&92"#V-:\TR6\$DTK;8XU+L?0
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M3UJ;PEXCO/$$FK_:=.EM5M-0EM4)9& ";1@X8DMG)Z8YQDT =-1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7-^.-)OM8T&*/3HDEN;>]MKI8G?9Y@CE5RN3P"0#7244 <C!8:
MLOC^YUR;3B+>32([0".9&/FK([D<D<?.!GCD=,5S.G>%/$NAZ-X6N[73;6[O
M]*MIK*\T^:=56:-V#;HWY (*@\^]>J44 9^C+>_8=]_;06DTC%_LT#;EB&
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M3[9Q7GFG^%]>EUG0+Z]TJ&%H[&XM-1G:]$DLCR! 9"<?-]UL#/&<?**],HH
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MOH!;2S1E9(DDW[ >,;L<G'^35RJFI:G9Z19&\OIO*@#HA?:6Y9@JC !/)(%
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MD [3[CI4]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&+':0#D=>G).<#TTYP<'![&N0?P#$_AZYT8ZI<^3<7YOWD\M-XD,HEP.,8W
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M!@<]!B@#VRBO+[T6>N^(?$NA7NIV%BMM%"+ S1_-# 85(E@;>H4A]V2!V /
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M0^3'NQ@]-Q;(Z9S70W6AV"_%"SLPLWV:_P!)GDO(C.^VX9)(]I?GG[Q_ETH
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M/GPZCI<7('F2,)E578D#+8Q^=:?Q-!7PM!*LDB.FI6>"DA7.9T!! /(P3UH
M[.BO-KS2+35/'WBVVO?.EMQI5M((C.^T.?.Y SVP,=AUKIO %U/>_#[P_<W,
MK2S26$1>1SDL=HY)[F@#HZ*\E^P7>N0W5DLHDU9/$+,=2CN0O^CK+\R9#!P
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MCF(V[6B:50P8D<#!/0BM+2_%VA:P][':7X\RQ&ZY2:-X6C7&=Q#@';@?>Z4
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M#^(/2@"E_8FE?:Q=_P!F6?VD1^2)O(7>$_NYQG;[=*C/AS1#IG]F_P!CZ?\
M8-_F?9?LR>5NSG.W&,Y[U%!XIT:XNK6WCNSNNR1;2-$ZQSD<D(Y&UN.>#R.1
MFL^X^(OA2U,GG:J%6*X-M*_DR%8I!CAR%PHY R<#KSP: -:]\/:+J-Y;W=[I
M-E<W-MCR998%9H\<C!(XQ2ZEX?T;69H)M3TJRO)(#F)[B!7*?0D<50U+QMX>
MTFZN+6[OR+B"-99(HX9)&"'." JG(X/3ICFK:>)-(ETZROX+Q9[>^_X]3"K2
M--P2=JJ"3@ YXXP<XH U:QAX2\.+.\XT'3?->7SF?[*F2_\ >Z=>>M/A\2Z1
M<:>U[%=[HDG^S,OEMYBRYQY9CQN#9(XQGOTIZ:_ISVLEQYLBK'-]G9'@=9/,
MP#M"$;B<$'@4 31:/ID$]S/#IUI'-=#%Q(D*AIA_MG'S?C56S\*^'M/EAEL]
M#TZ"2$LT3QVR*4+8R5('&<#\J2#Q3HUQ8W=XMYLBLY/*N%EC9'B?C"E& ;)R
M,#'.1C-8>E:[/??$_4-/2[NFL8M+BF%M/ 8O*D,C X!4$Y4+R<]30!U-[I>G
MZEY7V^QMKKR7WQ>?$K[&]1D<'W%-CTC3(;JXN8M.M$N+D;9Y5A4-*/1CC+?C
M6=XD\3P>''TR.6WN)7O[M+9#%"[A<Y))V@\X!P.I], U/?>)M*T[S?M$TH\F
M(33[+>1_)0]&DVJ=G0GYL< GM0!9T_1M,TK/]GZ?;6N0%/DQ!>!T'';VZ5)9
M:98:;YWV&RM[7SY#++Y,2IYCGJS8')]ZF@FBN8(YX)$EAD4.CH<JRD9!![BN
M%U?QFVI>&/&+:6U[8W6C).L4YMBN6CB5R<NI4<MC'WL#/% '57/AO0[RYN+F
MYT>PFGN4$<\LELC-(OHQ(R1P.OH*6\\.:)J,EK)>Z18W#V@ MVEMU8Q = N1
MP/:J&@>*M-U(VFFB[9]1-FDY#Q.HE& &9'("O@GG:3BK2>*-'DU"VLA=,);H
MLMNS0NL<Q7J$D(VL>#T//:@"]/IEA=7MO>W%E;RW5MGR)WB5GBSUVL1D?A1?
M:;8:I"L.H65O=Q*P8)<1+(H(Z'!'6N>^(]_>Z5X)O+^PO9+2>&2'YT"\JTJ*
MP.0<##'I@UH:9XNT/6-0N;"RO@UU;IYDD4D;QG9TWKN W+_M#(H N'0](,\T
MYTNR,TZ>7+)Y"[I%_NL<9(]C5BSLK33K5+6RM8;:W3[L4,815^@' K.MO%&D
M76H0V,=TRSSQ-- )87C6=!U:-F #@ @\$\'/2FKXITN2)I(VN9!]F:[3;:2_
MO8EQED^7YOO+T]0>E '(1?#^YN!+!J^@>%[R:5W9]8VL)W+,3O,?E_>Y[28'
M:NWF\/Z5=F!KRPM[N6&(1++<1AW*^A)'(/4CI4/A?7X_$WA^TU6*&6$7$:R;
M)(V7&1D8) W<'J,BH?[5L(_%%_&VKSF6VLD>:Q,9\N)=Q_> [<DGIP3TZ4 :
M=]I=AJ44<5[9P7"1,'C$L8;8P[KZ'Z4V72--GTPZ9+86KV!7:;9HE,>,Y^[C
M'7FLNP\<>'M3N;""TOS(U^I-J_D2*DN!DJ'*[=V 3MSGVIFC>,K'5I-:+)/:
MPZ9<O"\MQ \:D(B%F)(P#EC\N<X ..: -.PT#1]*E\W3]*LK678(]\,"HVT=
ML@9Q4MYI&FZA/#/>Z?:7,T!S%)-"KM&?]DD<?A6?_P )=HBF]66ZD@DLH1<3
MQSV\D;K$?XPK*"5X/(!IMEXST'48Y9+6]:18UB8GR)!N\W[@7*_.3@C"Y.1C
MK0!:N/#6A7<]S/<:-I\TUTH2>22V1FE48P&)'(X'7T%6(](TV*_%]'I]HEX(
MQ$+A85$@0?P[L9Q[52@\4Z/<6]S*ETP-M,MO-$\+K*DC8VJ8R-V3D8XY[51U
MGQOI^EZ<EU'#=S%K^*Q*"UD!1W9<[@5R,*X(]> ,YH TAX8T!8EB&B:<(UF,
MZI]E3 D/5P,?>]^M6H-+T^UO9KVWL;:&ZGP)9XXE5Y,=-S 9/XU4N/$NF6N[
MS9)QL1'DQ:RGR@WW=^%^0GT.".]:I(4$D@ <DF@"E=:)I5]>Q7MWIMG<74*E
M(YI859T4]0"1D#K44/AW1+=K5H='L(VM%*V[);(#"#U"G'R_A45MXIT>ZN[6
MVBNFWW8)M6>%T2X &3Y;D!7XYX)R.1Q7-_VM=^)O%6N:/::CJ.F-IYMUM98K
M1]NXJ7<R!EP0>% 8@$#(ZYH ZK_A'=$^Q7-D-(L!:W3;IX1;H$E;U88P3[FE
ML- T?2I?-T_2[*UEV"/?# J-M';(&<52\2>)X/#C:8DL%Q*]_=I;(8H7<+GD
MD[0>< X'4^G!Q@1>+4TCQIXF35M1N6T^WMK2:"+[.SF%6$A<[43<%&!DL..,
MF@#LKC2]/N[R"\N;&VFNK?/DS21*SQYZ[6(R/PJL?#6A&VFMCHNG&WGD\V6(
MVJ;9'_O,,8)]S3I]>TZ"VMYQ,\RW,7G0K;1/,TD> =P5 3CD<X[CU%3Z9J=E
MK&G0ZAI]PEQ:3KNCE3H><?@0000>A% $SVT$EJUJ\,;6[)Y;1,H*%<8VD=,8
MXQ5*S\.Z)ITD$EEI%C;R6ZLD+16Z*8PWW@I XSWK TW6+WQ7XDUFVM+R2RTK
M2)Q9EX%4R7$X&7R6!VJN0, 9)YSVK5@:]T:YU*YU;51+I,<$3PRSJB-&07\P
M,5 !_@P<>W7D@&C=Z7I]_-!->6-M<2P'="\T2NT9]5)'!^E0GP_HI%T#I%@?
MM?\ Q\YMD_??[_'S?C44'B32[BYGM1/)'<P1>>\,\$D4GE]-X5E!89XR,\\=
M:RU^)'A-K5KH:KFW$(G\W[/+M*%M@(.W!.X@8Z\T :[>&]#>6WE;1M/,EM'Y
M4#&V3,2?W5XX')X'K2P^'=$MVMFAT>PC:U4I;LML@,2GJ%./E'TJMIGBW0]8
MU2XTVQOA)>0)YC1-&Z;DSC>I8 .N?XER*?!XIT:YNK6WCNSNNR1;.T3K'.1R
M0CD;6XYX)R.1F@!__",Z!Y7E?V)IOE^;Y^W[*F/,_OXQ][WZU8CTC38;R:[C
MT^T2YF79+,L*AY%]&;&2/K67'XX\.2WYLDU',ZSO;N/)D"HZIO8,VW"_+SDG
M!P<=#4]EXJT?4)EAMKB5I'MOM<2FWD4S0\?.F5^<<C[N>H]10!+9^&=!T^WN
M;>ST;3[>"Z_U\<=LBK+_ +P Y'UJ]9V5KI]JEM96T-M;IPL4*!%7Z <"N/'C
M33=<\$/JTM]?:+ \_EK<+;L'4"8JH&4();: <9QNQP:Z74-=T_39FAN))6E6
M+SGC@@>9DCSC<0@) X/7K@XZ4 7I+>&:2*26)'>%M\;,N2C8*Y'H<,1]"::M
MK;IY^V",?:&W384?O#M"Y;UX 'T K*N/%^@6RZ<TFI1E=14M:,BLXF 4MP5!
M[#IU)XZU:T;7-/U^TDN=.F:1(I6AD5XVC>.1>JLK ,IY'!'>@!@\-:"+6*U&
MBZ<+>*3S8XA:IM1_[P&, ^]6(=)TVWNY[N'3[6.YN!B:9(5#R#T9@,G\:MDA
M022 !R2:QK+Q9HNH7,$%M=LSW$3S6Y:%U6=%QN9&( 8#(Z$\$'I0!-9>&M"T
MZ"Y@LM'L+>&Z_P!?'%;HJR_[P Y_&G+X>T1%ME71[ +:G-N!;)B$^J<?+^%9
ML/CWPU</;"+42RW%P;5'^SR;!+N*[&;;A22, ,1GM3?%OB*WT[1-7C@O9X;Z
MVLVE\RW@,OD':2A<[65<X_B[9/O0!NWNGV>I0K#?6L-S&K!U25 P##H1GH1Z
MU!+H>DSZ9)ILVFVLEC(=SV[Q HQSG)!ZG/.?6H?"]S->>$M&NKB0R3S6,$DC
MMU9C&I)/XFIM6UNPT.WBGU&9H8I95A5A$[C>QPH.T'&3QS0 6VA:19.[VNF6
M<+21B)S' JED P%.!]W';I4=GX:T+3[*XL[/1K""UN3F>&.W14E_WAC!_&G0
MZ]IT^K7>EQRR->VD8DGB\B0;5.<'.W!S@XP3G!K.&N:9?:YHS0:O=(UQ;2S0
MV8@95NDP#O;<F1MZCD?>[YH TET#1D:U9=)L5:S&+8BW0>3_ +G'R_A5B_TZ
MQU2W^SZA9V]W!D-Y=Q$LBY'0X(Q7G_B+QO-J7P^\0:GH\M[IT^GW!A21K<J2
M%D5&R77 )^;@?,.,XKL].\2:5JNI7&G6ERS74""1HWB=-R$X#H6 #KD8W+D4
M 3_V)I/VI[K^S+/[0\?E-+Y"[V3^Z3C)'M4,OAG09M,339-&T]K%'WI;?9D\
MM6]0N, ^]/U?Q!I>@BV.IW0MQ<RB&(E&.YST' ./QJK'XNT:;3HKZ&:>6*1'
M=5CM)6D"HQ5B8PNX $$9(H MP^']&M[>XMX=)L8X;D8GC6W0+*,8PPQR,<<U
M'#X9T&WTMM+BT;3TT]VWM;"V3RV;U*XP331XGTA[6VN8+HW,5S";B(VT3REH
MQC+84$@<@<]^*K77C?P]9R)%-?GS9+47:1)!([O$<8(55)/4<#GJ<<&@#1_L
M32OM45U_9EG]HB3RXY?(7>B_W0<9 ]JA'AG0!&L8T331&DOG*OV5,"3^^!C[
MWOUIMKXGT>^T>VU6TO1<6ETVV!HD9FD;G*A -V1@Y&,C!STHM_%&CW6G/?17
MF8HY_LSJ8V$BS9QY9C(W;\D?+C/- $[:#H[R74C:38L]VNVY8VZ$S#T<X^8?
M6AM"TAX;2%M+LFBLV#VR&!=L##H4&/E/TK$U?Q]I6G:%>ZC;^?<O:W"VLD @
MD#Q2L0%#J1E1\P.3U[9)%=-%<)-;"=5D"%=P#Q,K?]\D Y]L4 4G\/Z-)K"Z
MN^E63:DHPMV8%,HXQ][&>G%%QX?T:[U6+5+G2K*;4(<>7<R0*TBXZ88C/':L
MS0_&NGZOI-[J4BS6=M:W$D1:XA=.%<H.2,%B1]T9(R!C-:EAKNGZC>SV4$KK
M=P*'D@FB>*0*>C;7 )7C&1QGB@#1HHHH **** "BBB@ HHHH **** "BBB@
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M.D2!UP9&R26;VX Y]:-7\,:AJ?@S3]$6>UCGMGMF>4[BK>2RMP.O.P?3/>@
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MA^,$]*IOX^NWTK3M7L],@FL]1U(Z="DEPT;JWF-&KL0K8!9#D 9 (Y/.+?\
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MC..P &3GTP =%1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9>EZ_8ZO?:C9VGG>;I\BQ3B6)H\,R[A@, 3QCG&.:U*X[PM_R/GCC_K[M?\
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M6L6LSZJOF_:IX4A?,K%-JDD87. >3SBH=/T"PTS4K[4+99A<WS*URSS.X<J
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M%O\ 9?,:=R#'G.W;G'7G.,YK4HH **** "BBB@ HHHH **** "BBB@ HHHH
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M/;^=&LGDW";9(\C.UAV([BN T>"YBU7X@SQ:G>I-#<_NW+J^T_9D8'# C@\
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M-P'(_&FQZE97%U+:07MM)=1@EX5E5G3MRH.1S0!%-I%O/K-OJKO/]IMXVCC
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M /:O9::R*XPZAAZ$9H \EB\10V>H^';_ %GSO#^D7>BB"W(1'BAF#_-&6=&
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M]<U.6Q=+&\MK:&*;S$/,?F9)4-D [QCCMVH ZB-/+C5-S-M &YCDGW-<!?\
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M7&U@Y=1G>3\NUAG&.V2:F.CZX;?P*'TH[](96O%2XC.T"!HL DC)R<\<>YH
ME\-:RNE:OXAT>6UO;?2M("3&>[N$E\E75Y&R=Q(3& H&< <XK7B\:63ZO!ID
MMG>07-U \]H'"'SP@!95VL<, 0<-C^=8U_X6U/4-9\8VQA1+#7[.*..[\T?N
MF6)DP4ZDY(/IC/.>*M>&E\0JD2ZKX9L;&6TC(DN+>:-S=,%P/+  V ]3N(QT
M[Y !H^&O&%OXI2&:RTS4HK2: S1W4\(6-L-M*9#$[N_3&.];.HW]OI6FW6H7
M3%;>VB::4JI8A5&3@#KP*POA_IE]HO@C3=+U*W\B[M4*.N]7!^8D$$$\<UI^
M(H]5F\.:A'HDJ1:HT#"V=^@?''7C\Z *-MXMMY[V:RDT^^M[J.R6_6)U0F2(
MDC*[6(R",$'%4]-^(&GZD^C,FGZC#:ZP,6EU-$JQE]I;8?F+ X4\XP<<&LC3
M=$UJW\6#6/[!$$$NC&TE5KU9)C-OW9=C]XGIG)XZD=*BL?#>MV_AOP)8OIK>
M=HUTDEWB:/ 58W3*G=SRX/X&@#TFN.OH/&)@UY;:&S>0W$3V#&Z=/.BW M&<
M#]W\HQD=22>.M=C10!S&I>-+71X[XW=E=2#3(HI-0DMPI2#>,\;B"^!R< \>
M_%7K_6X!>2:9;VUU?7(M_/ECM&56CC;(4EBRX+8; !SP>E<?XR\/^)=>'B>Q
M_L^.\MKJV1=+D>Y5$A.SY@4/_+0MG#>AQD5?L]/\0Z-XRNM8BTI;NUU>TMTN
M(H[E ]I+$"HR6P&0AN=N2#G@]P"EX%\4II_@CPI%?17]Q)JDLD$=RQ5@)#(Y
M =F8') /8YQZUU=]XHM=/-V);6[;[/<0VH**I$LLNW:B_-U^=<EL 9ZUR^G>
M#]5E^$4>@WD*6FKVVZ:U9)0_ESK(9(VW#@<X!]LUJ:IIOB&'PC:QZ<!)J3W4
M<^HQQ3>4TRLVZ9(W)^7KM!SPHQF@":[\>:?8:5K5]<V5\C:-(([RW"(SKE0R
ML,-M((8<YJU:^+;.?6YM*N+2\LI4M3>1R72*J2P@@,XPQ(P2,A@IYZ5Q6H>$
MM?FTKQO9VVBP0IK*PFT2.Y3 (C52&Z8Y!)/J>-W6MW6/#^H:WXI29[.6"QFT
M.YTZ64R1EHWE*G. V3@*>G?% &Q:^+;6ZOM.MS97T46I1O+9W,D:^7(JKNYP
M24RIR-P&?KQ4"^.M,-YIL30W"V^IL4LKH[#',V,J,!BPW 97*C-4O#,/BIM(
MM]!UK3(+6*UM_LTM]'<K(+E0NU2B 94G@G=C&#@<\5/"&F>(M*M[+1=0\/Z<
MJ:>%C&KQRH?/C3A=L>-P<@ ') ')R>E %UOB/IRV!U!M,U5;&.]-E<7!A3;!
M()/+^8;LD;N/E#>^*T;;QA92:E?V-[:W>FR65K]M8WBJ%>#)!D&UC@ J<@X(
M]*Y*;PSKLG@#5])&F-]LNM8:\C4S1X\LW0FY.[@[1C'K^=:6O>&=0\0>)]38
MVSV]C?>'WTT7#.A*2LY;)4-G SCZ^W- &O'XULFU:WTV6SO(;B[@>>T#A#YX
M0991M8D, 0<-CC\:K:=\0M.U(:-,FGZE%9ZN_E6UW-$JQ^9AB$/S;LD*<$ C
MWJ'PTGB)8XDU7PS8V4UI&1)<V\T;F[8*0/+  V ]3N(QTYSD8]CX9UVV\'^"
MM-?36^TZ1J,=Q= 31X"*) 2IW<_?''L: .F\+^)+O7M1UV"?39K:.POVM8W9
MHR,+'&<'#$[B6)X&,8&<UT4\\5M;R3SR+'#$I=W8X"J!DD_A7->%],U/2=<\
M1I<VJ"SO=0:]@N1*#N#1QKMV]004.2?;&:V=>TL:WX>U+2FD,0O;:2W\P?P[
ME*Y_6@#-B\8V33Z6L]I>6MOJIVV5S,JB.5B-RKPQ*EEY 8#/3KQ7/0^;XL\9
M>(],U"VU*"&R:V6VFAN$C:U/E^86!5R<L3U /& <=*FCT+6=8TGPSI6J6'V5
M]'NX+BXN1*C1S& $+Y8!W?,=I^8+@9Z\5IZ!I^HVOC3Q/?W-B\5IJ$ENUO(9
M$.1'$$.0&R.1Q_2@#JJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***P_$NMRZ0FG06T7F76H7
M8M8N =OR,Y."0#\J$ 9')% &Y17&I=^-Y=.UN*.UMHKJV*OIMQ=1KMNE*Y*.
MB2':P(QNR <@XZTS0/%.H^(?"][X@M9+:.!;<B""6(LRS(O[SS,/TW @#@XY
MSR* .UHKS:T\6^)X++PCK>H-ITVF:V]O;36\$++) \R_*X<L01NZC P#CGK5
MV'Q-XDU6WMM5T73OM-F]ZT36[*BAK=9&1G$AD!W_ "[L;<=L'J0#O**\UU'Q
M5XHAL/%][!/IBIX?N3M0VSGSXQ&DFT_/\IPQYYSZ#'.AK_C*?3]56TDN8M*C
MN;2.33[FZ@+03S-NW1O)D!,87TZYYZ4 =U2,JNI5@&4C!!&017&:IXAUV[O=
M;M?#UMOGTLK&BM&K+/*8UDVL2ZE5(91D=\G/:JNJ^,[ZPU"&RU!HM"GN+.*2
MT:[B\R"6X8'?$TH.U2IP!R.N>>!0!9AM/ &AW-_)&]A;-I962ZB,[>7;%CE3
MY9.U3DC&!UKK+:_M+QBMO<1RD(LGRG.4895AZJ>Q''!]*J3:#9SW=[=,J^?=
MQ+"[^6APH^HY.?[V>@]*YSQ7Y?AF7P?<:>GE)#J4.E[!WMY5*;3Z@%8V^JT
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M#]IBVN5#-M/4$9[>] 'IM%<'XR\5:MH$6M74$EH%T^WCGM[<1F5IASO,N/\
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MFU%UIMW%=6YZ2Q-N4_0]#4UY_P >4_\ US;^5<E\)O\ DEGA_P#Z]O\ V9J
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MI?B;7O[2\)-J,ME)::]9L[110,K0.L(EW;BQW \C&!CCK5[1M8U_7].TC7;
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M"$)S_=4=<U-J'A*74M.NM-N=3,EC=VR6\\+VZM@*,;T.?E8C')R 0"!73T4
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M,9;/[0E[J$%DQ\W9Y?F,%#=#G'IQ0 FM^'#JVK:5J<&HSV-UIQD"-&BN'20
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M\L[^>NWTQSS[5%HG@<Z%<>3:ZW>G1$F,\.EE4V1L6W8#XW[ W(7/USSGK:*
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M(TY-4;4UL;<7[+L:Y$8\PKZ%NN/:GZAIECJUJ;74;."[MR0QBGC#J2.AP>*
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M>$='U??<27UYIL GDEN'<, N1\I.!C/85TEOH6E6MK-;0V%NL,RA)4V [U'
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M6Q(<F>&5E&W+?P@G/F'IS@ [(^)]'6_@LFO-LL\C10LT3B.1USE5D(V%A@\
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MC*L >0<@XP>U<?XA$E_9:#<VF@W=M&?$$%X\26;>9Y8SOEE50=I)/?G&,\Y
MT_#\4Z?$3Q;.]K<QP7"V?DRR0.J2%(V5MK$8."10!JWM_:1^*=.M'UAX+@P3
M/]@"@K.H RS''&WZCK5>/QWX9FD@2/5$;S[@VR,(GV^;NV[6;;A22,#)&>V:
MHZY'.WQ*\,7*6MT]O;VUZLTR0.R(7$>P%@,<[6KDI+&^/PZO[1=+U#[4_B$W
M*1?8Y-YC^V"3?C;TV#/Z=: .[\5>(+;3=(U2.*^E@OH+1I@\$!E,'!VL_P K
M*H)!^]V!]*9H?B&*/P;H-WJ<\LMW=:;#<.(X7ED<^6I=]B G&6Y.,<CUKF6>
M_P!*OO&MC=Z7J-Q_:^ZYL+F"U>5)5: ((F('R%2N,-CK6?9QZAHA\,ZA?:)K
M5Q8'0;?3YX[))/.M9X^<M&A#%3DC/^R* .^/C+P\%T]AJL+#4$:2TV MYH4$
MG&!UX(QUSQUXJN?B!X7%G]K.J 0B4PR$P2 PL#@B0;<Q\GJ^!7/_ -FK:>(/
M!!L="NK*QMY;R5XDA9Q;K)&P4N1D*S$Y(SP3^-9U]97LOA#XC6T>F7YGO[V5
M[5/LDF9@T4:@K\O(RK4 =W?^+M"TV^EL;J_ NXH1.\"1/(^PG&0%!)[\#)X/
MI4%[KNEW<.@W-OKQMX;ZZC:V,*AA> @_NSE3@'OT(QU%9%CYH^)2Z@UE?+:_
M\(_'!YS6D@'F"4N4^[UP1Q^'6N<TVQOX? W@2UDTS4%GLM:6:YB-G)NAC!ER
MS#;P/G7\_8T =WIWB^RU#6]8T_R[B!=+*K+-- Z)G;N8EB,* ",9(SR1D8-7
M+3Q'I5[?O8Q7++=)#Y_E30O$6CSC>N\#<N>XR*X;5-(U:\NOB#IMK97*SZFL
M,UG,4(AE"P(I7?TR64KC.><].:>+5?%^D7RVOAO5=-U=M-GMOM.J>8ODNZ%=
MD;.3N!;N.,#/7 H [6T\2Z3>ZC'80W1^TRQ&:%9(GC$R#JT98 ..1RI/4&M:
MO/O"\T.I7&G3W7A35[75--B82RWPD*0$IM80LS$/N.!\O;KCC/7:!K<7B#24
MOXK6[M,LR-;WD7ERQLIP0R]J ,Z/Q!I5E>>(+NXUYI8+)H_M$+I\EE\G0$+D
M[L;CR?PJWI_BO1-4U(:?9WPDN6A\]%\MU#IQDJQ #8R,X)QWKBM4M;R5OB<J
M:=?-]OM8X[3%K(1.PMO+(7CGYN/UZ5:FM;JXU_P68;2]B6'2[F":;[+(! [Q
MQJH8XX.5/7TH ZU/$^CR7\%DMX/-N'>.!C&XCE=?O*DA&UB,'@'L?2N?\/>)
MOL5IXDN=?U*1[>SUN2TCGDB^XFV,(IV+@#+8R1U-5/!%U=)H^C^'=2\,WD>I
M:2%A>XGMO]'0(-OFQRGABR]-O.6YXR:R;W2]2N_!7CNVATV]-Q/K37EO$UNZ
MM-$&A.4R!NSY;8 YX]Z /2EU>Q;6)-)$^+Z.'[0T3(P_=YQN!(P1GC@UR>N>
M*Q+XA\*PZ3J,_D7M^8Y5$!$5Q&(W.5=E^8 A>5;'-9>JQ:CXC\4ZG+IVGZC;
M1WOAB6SM[FXMFA F9V(!W8*GZ@'OTP3$MW=W]IX$A&@:M!<:7>QK>QO9.JP[
M8'0D,1M9<D8()&,9QP* .LA\2Z-I\6NZC=>(&FM+6Y"S"2/Y;0[%_=KA<MZ]
M^M:-AXFT?5-3ETVSO!)=Q1^<8]C+N3.-RD@!USQE217GNL6-]/X?^),$6F7[
MRW]P#:*+23,P\J-,KQR,J:Z%XY)?B1HUVMG=BT71IX))C;2*B,SQD*Q(X.%;
MKTH VV\8:"CP*VH!1<.R02&-]DS*<$(^-K=^A/0UN5XYX=NK*+3_  U:ZG!K
M=M8:3<&>U>3290@R&6/S)URA4*_W@ #P<XZ^G:7KL.J:EJ5@MG>VTUA($;[3
M#L$JG(#QG^)2589]J '/XATR/4[G36GD^V6T'VB6(02$B/IN&%Y&>.,]#Z4V
MV\2:5>6-C>V]P\MM?2>7;2+"^)&P3Q\O P"<GC@UB>+=-U1-?T;6]#BWW?[S
M3[GCA891D2-ZA'56Q[FJO@WP]?:+JUYI<\;_ -CZ5.\FER.2=XF 8CZQYD7/
M?>?2@">Y\8:?HGAW7-934;K5XX+YHMBPDB"0A0(<JH^0$CYCGKC)/%17GB=K
M'X@VB3WURFDS:1-/]E>V(;S5EC4$)L\PG!/'/<@5SU[IFHW7@?QY;0Z;>F>X
MUEKJ")K=U::/="=R @;ON-P.>/>NB\V6Y^)VG:H-/OTM!HT\1DDM) %=I495
M/'!*J3@\]C@\4 =%#XCTBXT>VU6&]62SNB%@=%8F5B2-JJ!N+<'C&>#Z5"_B
M[0XM,N]1DO2EM9R>7<EH7#0-Z.FW<O4=0.HKSW1]/U:PL/"^IMIU\8=+U:_:
M[M?LSB01SM($E5,98*'!X!.&/'6K?B/P]J&LVWCO4K"TGV:CI\$%O"\;1O</
M$"6;8P!Z$*,CG![8R >@S:[I\&I-ISRR&\6W:Z$*PNS-&" 2N!\W) P,GFJO
MA7Q)!XJT.+5+>&>*.4L566)E^7<0.2,'@#.,@'BN=M+NXU3XDZ5JD6DZG%9'
M1YH#+<6C1!7,D;88-@K]T]>N.,BKOPRBN;/P-8:;>65U:W-D&BE6>(IEM['Y
M<_>&,'(X.>#UP /L]5NX_B#X@LKJ_=M/MM/MKB-&50(2S2!L8&3]T=<U-IOB
M?1;#0-(>Y\0&\6]REO>3IM:X//. H Z'L.E5+(30?$[7KR2TNQ:OIUM&DPMG
M*.R-(6"D#!(##IUS7*Z387\'@OX=VLNF:@L]AJ2R749M),PJ$E!+?+P,NOY^
MU ';MX_\,I:7%RVHL$MY#'.IMI?,B( )+IMW*N"/F(QSUJS=ZG9-XBT>%=:>
M.2:.62*SB4,MVNT'<3@X"CD8(SGO7*36]R;_ .)##3[TK?6T:VQ%I)B<BV\L
MA?E^;YN/UZ46=O=C5?APS6%\%L]/FCNF:UD @9H40!SCCYE(Y]/2@#H-*\<Z
M7J-GJ=[*)[2VL;I[8O<6\B;BI"=U^\7. @^;IQGBI=0\::38Z)JVI*T\W]EJ
M3<VZV\BRH=NX H5! (P=Q&,<YQ7'+_:NF:!XCM5T"[N)?^$ADN26L_-'D/.&
M$L2D8D8+\P S@CGT,,^F:C=Q_$2"WTS56_M/3HC:2749!G(A92,GHQ)^[QCT
M'2@#M#KMG>WGAXG5+BQGNV9DLS R_:OW9)4AUR .6!XSCO5Z[\4:-8RR)<WF
MP12K#++Y;F*)SC"O(!M4\C@D=1ZBN5O'N+W4O 5RFFZBL=M,[3[[1P8@;=D!
M<8^7YB!SCUZ<UGQV&H0>#/%?A2\TV[GU"[GN_LDJP,T5P)R61S(!M7!;G<1C
M;]* .UO_ !?H6FWL]E=7X%U!$)I(4B>1PA[@*"3T/3/0UJ6-];:E807UE,D]
MM.@DBD0\,I&0:XK2K*XTSX@EKB"[EA@\/6]FUV+:1DDE1W+ ,!R<$'\?6H_!
M&JOX;\%>%=*U'2M4CGGS;.WV5@EL^["^:3C:&+  \Y_"@#N;V^M]/@$US)L0
MLJ+A2Q9B<   $DD]@*JIK^FO:27(G<)'-Y#*T+J_F<?($(W$\C@"J'C*RMM0
MT:*VNH=0:-KE")M/#&:V89*RKM!/! [=ZXFZMO%$>F6=_>6]YK$>DZPSY@A:
MWNKRU,!C\S8,$NI<CMN"^G) .Y?QIX>CL);V74DBABN!;2^;&Z/'*2 %9" R
MGD=1WI+3QKX?OKVWL[:^9Y[B62&%?L\HWNG+@$KC@<GVYZ5QGB"SAO\ P=J%
MQI7AS4X7OKVS=UFMY&N+CRYD9F9#E@ H(!;!.#QTSU'CG3[J^T"'4]+A>35-
M*F2_M$"D-(5^_'CK\R%EQZD4 6/$.NZ;%I&HK+K,VE&VECBENTA):)R58*-R
MD,2"!P#PP]JT-3U_3=(WB]G93'$9I!'$\ICC'\;! =J\'DX'!]#7*>,]-O6^
M%]];+:3W&I7;QS2Q6\;2L9&E5V P#PH& ?113)KR[T+QUJ]S=:+J.HZ5K=M;
M^1):VIE\MD5E:*1>J@[L\X')SWP =9<^(M*M;6*Y:Y,L4L/VA#;Q/.3%C._"
M G;R.>E7+2^M;^PBOK29)[65!)')%\P=3SD8ZUY[J*76B>+(K^[T#4IM*O=-
M@MECT@.YLY(V<^64C(^3$G7ID5V_AZR@T_0K6VMM/&G0("8[0'/E*6) /)YY
MY )P<\F@#.T3QIIVL:;?:@PFM+:TN)(F>YA>,81MF<L ,DC[HY&0",UJ6.N:
M?J-W/:6\S"Z@4-)!-$\4BJ>C;7 .#@\XQQ7FATK6O^$5O+6#2[TW6F^)&U-H
M&CVB[A%R9 (R>'RI##'=<=<5U4-K)K'Q$L=?M8+F"TM=-DMY7G@>%I6=U*IM
M< D+M))Q@$CWP =C1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !116;K.HW.G6T+VMDUU)+.D1^
M;:D*G.9'.#A5 ]/3ZT :59?B+0H/$NA7.D74\\-O<KLE,!4,5],L#C\JY>;X
MB21^%=8UB+3H;E]+U 64J0W64DR4 =&V\C]XO!]#S6SIOB*]G\676@ZCIT5K
M*MHM[ \5QYH>,N4(;Y1M8$#@9'/6@#?@C,,"1M*\I50-[XRWN< #\A4E(S!%
M+,0% R2>PKC+;QY+=SZ1-;Z6\^G:G((TDB+M)"&!*/(NS 4\9.[Y<CK0!VE%
M>?S_ !"U.#1=1UAM!A^QZ9J+V5V!>_.0L@C+1C9AN3G!*_C6H/%>I0:[?:3>
MZ1#'-'IS:C;>7=[A(BMM*N=@VMDCIN'/7B@#5O?#UO?ZY;ZG<7E^5@50+(7!
M%LS*VY7:/NP..?8>E:D<T4K2+'*CM&VUPK E3C.#Z'!%<)9_$+4'B\.ZA?:
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M0PW]YYX>VG8XMS"P20,54DX9E P.<]JA_P"$_OAI^FS-X?D6>ZU7^RY(WF*
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MPR1D'/(X-<%9_$'4;C3=)U6;0HH=/O=1_L^1A>;I(W,K1*P79AERHSD@\GC
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MG8.+GR;2X6ZC;[0Y=IE.0[N3N8YYY)I[>%=.:ZU:Y+7/FZK&L5V1,?G505
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MHQDA^TE-KG')  &1C/?-:21:O+XE\3Z&?$FI"VM;2"[AD'E^:CN),C=L^[E
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M@LWEM'D ?=D9#GD[6]JTH_ASX?BBAMXQ?+:6]T+NWM5O95B@D!)!10?E&3G
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MK<=<'MTI(_#^GP^()M;C69;V>-(Y2)F"2;00I*9VD@$C..] &I1110 4444
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M0?Q6X%XYRX_A&#U.,T >B6WBB2#Q-XGM=6GM(--TF&VF2;!0A9 Y.\DG)^4
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M6\TTL,4\3RQ8$B*X+)GID=JY[6=?NM*\8Z'I[R6J:;?0W,DSR AD,2J<[LX
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M1N(#)NR!\YVQC8< 9Y+=!BM2+QQISZAIUJ]O=1KJ:LUE.P0I.0N[& Q925Y
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M!T^VT/5=3NM/U&!M*G$%Y:M&AEC8A2IX8J5(93D-WH ZO8H<N%&XC!;'.*7
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MM\PVG'S >N*[+6?%UGHPOBUM<W2V$8ENS;[/W*D;N0S D[?FPN3C'J,@'08
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M::Q<27EK.)44122H%9)0Q!"@@$%0W&>,\4W2/"]]H/B/P\(;=[BPTS17L'N
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MPVG.(M*L)8+L^;'\CO&B#'S<C*'IV(^E9#>%?$26\E_;V*B]M/$LNKP6LLZ
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M:X3SH\;8&4L0=V#G'']*[FVU?3[S4KO3K:ZCEN[,(;B)>3'NSMSVYVG\JNT
M>?MI&O:1XJU:6U\/66L:=JLRW*2S3I&]I)L5&5]P)9?E!&W..:GM=*U[0/&.
MJWEO8)J5CJ\$&YXI4B-M-%'Y?*L?N$8/RY(]#7<T4 <U\/\ 3+_1? NDZ9J<
M"P7=K"(W19 _0^HX_G3?B!IE_K/@^YT[3+4W%S-)"57>J !)4<Y+$=E-=/10
M!R%SINJ6?CR+Q+:V,EU;7.GBRNK59(UEB*N71QN8*1R01N]#S6+-X1U6WM;.
M6"S,UQ/XG_MNZB25 (4)(V@DC<VW;TXSGGIGTFB@ '3TKE?&&A1Z]+9P7.CS
M7D$:R.EU:3K%<6DOR[61BR]1NSSV&0:ZJB@#SY-&\3V-YX1U.XA_M:\L+2XM
M;[;,B/F39M?+8#8V8;')Z@&LZ/PKXIM=/2_@LK;^T[#Q!<ZE#;&Y&VYAE+AE
M#8PI*OP3^(%>I44 <-XFM/$?B3P?- VD+!=2W-L\=F+A&,:QRJ[%WR%R=I
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MIBIX?NB%0VSGSXQ&C[3\_P IPQYYR>PQSH:]XRFT[6!927,6E)<6L<FGW%W
M6@N)FW;HVDR I&%P..N>>E7+CP/]HT[Q)9/J;B/7I#).1",QY0(0G/\ =4=<
MU/J/A*74]/N]-NM3\RPO+=()X7MP<;1C?&<_*Q&.3D @$ 4 4M4\0Z]>7>MV
MWAVU$D^ELL2*T:LL\IC63:Q,BE5(<+D#KDY[56U3QG?6.IQ6-^T6ASW%I%):
M&\BWP33L#OB:4':"IP!R/7D<5?N? [KKTFJZ-KM]I+7,<<5Y%"B2+.$&U6^<
M':X7C</2K&J^$!JEC>Z9)?-_95Y$D,EM)$)#&%4+F-R?E8@#DAN0".: .E.<
M'!P?6O/+GQEK4'@O7=6!LS=:9K#V*YA;9)&LRQY(W9!PV<Y_"O0D18XU11A5
M  ^E<5?_  [%[::S8+K=W!I^IW?VUH$C0F.4NKL0Q&2"5R!VSWH +W6?$D_B
MG7M(L;K3H([*QANH)9+9G;+>9\I&\ _<Z\8]#G(32/&-WXA_X1VRMA%:W>HZ
M7_:=U)MW"-!M7:@)ZEVZG. IZYK67PQ*FN:EJJZDS2W]I':.'A!"JF[##!'/
MSMGM["LV#X?+96^A-8:O/;7^C0&UANA$K>; <921#P>@.1C!YH P?#FLWFB6
M>K0%4GU"_P#%=Q:*\<>%W; Y;:6'\*' W=2.:O:SXD\8:)X<UZ]GLK=/L4L!
MLKBXC7_2(Y&"L&1)#M92>O0\<5>?X<6\VE7]I-K%\T]SJ1U2&Z4(CVUQV9,+
M^!!XY/2K%[X+N=4\-7>E:EX@NKNXNS&)KQH8U(5&W*J(H"KSU."3D^V #?TJ
M/58HIQJUS:SR-,6B-M"T86/ PI!8Y(.>>_%<W)/JC_%];1;]19)H_GK 8<@9
MF"MSGJ=HY[>E=C&'6-1(P9P/F8# )^G:L6[\.>?XJ@\007\UO/':FTDB5%9)
M4W[QG(R/F].HXXH X#P[J^L:%X4L+ZWEM#I[Z_+:2V[0L9'66[="P?< I!/
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M);*6UUZR>0Q0PLK0.L2R9W%CN!R>,#'%=AJD]S:Z3>7%G'%)<Q0N\23/L0L
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MM(F1K*[(1&F4CYE9%=L%3WX!!Z5FS_#VWN]/U2UGU&X#WNH_VG'/"H1[6X
M#(>>!M'!]^>:W-#TB[TV-WU#5[C5;QP%,\T:1@*,X"H@ '4DGJ?7@8 (O$.H
M7EB^GK;RV\$$\Y2XFD&^11L8J(H^KN6 &!G R<&N:T[QS?W>CZ?$Z0#5+W5Y
MM+20Q,J 1,^Z0H3D'8GW<_>/I71Z[X<.L:CI6HP:C/8W>FR2-&\:*X977:P*
ML".G0]JQ3\-[?^S'MDUB]6X34VU.SNMJ;[:5F+'C&&!W'(/4>E &=91ZY#XW
M\;BSN;:;4DL+)K5I82%<@3%5<!AR3QD$=CBMW0/$=UXAL- N+66+-Q;-<7RF
M(_)CY2@Y^5O,R.<\(U6M'\,3:;XAOM:N-6GN[F]ABAE0Q(B?N]V" !D?>/?\
MZETGPK8:.=7^S&3;J<[S2#=CR]PY5?0;B[?5S0!SNG>+-7?Q!H-A=26DIU-;
ME9U@B8QV\D:[@$ESB3&"K=>?3I5!?&'B9- ;7)I=-,%KK)T^>W2W<&:/[0(=
MP8O\A&0<8;IU[5L:?\/FT\Z"1K][)_8F]+4-%$!Y;)LV-A>>,#/7CC!YI[>
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M831'S%VG>6R<=@"<8%1>(9+VPBEU6Y5=?T>.P@2[FB;R;NR(3<T\:GC#!@Q
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M)SAXRA.W:$!;@<;2?4UI(#XEAUR6YU^WTS5-.U64>=Y+&XMDCD_=A?W@RC(
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M9UI=)LAJ9&#=B%?,Z8SNQG..,^E%IXCTF\DO(X[ORY+)0]S'<1M"T2$9#$.
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M('7&",* 2,@9'6@#NZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y'XF6]Q=^!+RVM;6XN9Y);
M?9%!$TC';,C'A0>@4G\*ZZB@#BX_,'Q2O]0:SO/LC:)#"LWV23:7$LCE0=O7
M#+Q^'6N2\.6^JZ#9^!M2N]*U%[2RLKBRO(4M7:6UD=E(?RP-Q!VXR <"O7O.
MB,Y@\U/."[C'N&['KCTI] 'D,UEK$MGKU[::/J+B'Q*FIK;E&ADNK<1HI$?0
M[N"0.N5]>*M>(K6'6/ GB6YTCPWJT-W?6J09NH)3<W# \+L8EMJCN>.>.E>J
M5&D\4DLD22HTD>-Z!@2N>1D=LT <?<B23XGZ1?I9WAM$TF>)IOLL@5'9XV52
M=O!PK<5RL%G?+H.E1-I>H[XO%S7CH;*7*P&:1A(1MZ88'\:]>IDLT4"!YI4C
M4D*"[ #). .>Y- 'G=Y;W3:I\1F6POBM[I\4=L1:R$3N('0A?EY.6 _^M1%!
M>VU[\/+TZ;?O%::?-;7"I;MNAD:*(*'!&5&489.![UZ/10!Y7I-FT1N?#.N>
M&M5O;I;^6:"XS(UG,KRM(DC-NV*1NR1C.1P"3BECM&@U#7/#^N>&M5U(7E_+
M<VDL9D:TGCD?>HD(;:A4\'([ C/%>IT4 (HPH'H,5Y1>>%-<CTS5].LXG2#0
MKUM3T,K_ ,MG)$JQ@>BYECQW\P>E>J>?$)Q 94\XKO$>X;BN<9QUQGO4E 'G
MWBBPO9/!-D&L;B6_N=3M;VYBAA:4I^^5V!V@\(HVY]%%4/$^BZGKNM^,+;3[
M>YC-_H<$%O,\+I')(K2%DWD <A@/Q^M>H4C,%4LQ  &23VH X2=)_%&I^$;F
M"PO+*73IVN;LW%N\7DCRBIB!8 ,2Q ^7(P">F,Z7Q)M[B\^'>MVEI;SW%S/;
MF.**"-G9F)'8"NI5@RAE(*D9!'0TM ' ZD+MO'=I?6FEW-Q&GA^YA426SK&T
MK,C)&Q(P,[3UZ5D:*M_+XD\'W[Z/JRK'87%O<J]F88K9V6/$:IP$0;2 <<@#
MEB*]2BFBFW^5*DFQBC;6!VL.H/H:?0!YQX/LM0TS6M.ATW^T3H,MM(TMCJ=L
MROIC?*0D<C $J3QMYX7-;'CR+48ET/5["RFOUTO45N+BT@&Z1XBCH2B_Q,N_
M(%=69XA.L!E03,I<1[AN*C@G'IR/SJ2@#SSQ)]LUK01K&D>'[M/(U"WO);=H
MS;W5ZB9#\<-D C;G!.W@8QF"^D2?0-2UC1O"5^9Y?L\<QU&V=[B15D!)6)R2
MQC&6&>,XQG!KTJB@#RR*S,NK^,/MVC:Y=:=J5I9;9)(7$DJKO#LO<,-P(0 $
M8Z 5'=Z7XHDT/5K6"6\UFVLIK*ZL9;N(V]U<+')O>!FPI8@ $-@<MCKT]7HH
M \LUG3CXJ\*:U<:%X>U.TU*6S2(R:H'CFF"R*Y@ =B2,!@3TRPP3DXTFU*77
M/'?A/4H-'U:&"&VO$N#<64D7D.XCPK%@.X/(R#V)YKT&B@#E/B19W5]X$OH;
M.VEN9Q);RB*%=SL$GC=L =3A3Q5&.6ZL/B'-K=Q97S:7J>FQ0Q2+;.[V[QNQ
MV.B@LH8/D9'7@X-=S10!R_@/2+G2-$NQ<1M"+O4;F\BMVX,,<DA**1V.,$CL
M3BL^(OI/CWQ1<WFG7LMOJ%M:_9C#:O*LVQ'#IE00IRPX;'7TKN** /(;#1-3
M\%#P[)J&FZE?V*:8UG<+I;2/):RF4R#Y4(++AMN1G[H]J]'\-6=M9:+&EIIC
M:; [M(EL_P!]0QSEADX8]2,\9]:UZ* /)/%2:IJ%GXCM?[#U))H]4MYH(K.T
M(BGB62(F9G4?O7(4@C)(P/EX)KT[4(I[_0[J*V9K>XGMG6,OP8W92!G'<$U=
MHH \CBFOI?"?@O27T#58K_1M2LUO(_L3[46)65I ^-K*>N5)Z\UH:A;7<DWQ
M,V:??-]OLXX[3%I(1.PMC&0G'/S''Z]*],ID<T4K2+'*CM&VUPK [3C.#Z'!
M'YT >>ZW;:A'X6\(:E:Z9?74>E-&UW80*\5QL,#1,57AMRENG?GM575;*2?2
MHM?T#PY?HT&J6U]<07"LMU>I&&5OD<DY 8;<\G;TZ9]/HH \]\4>=XI\ >))
M-+T"[@GNK90OGVOE7%RRG.-A^8@#@9ZY./>P\]W!\0;/Q')8WYTF\THV?_'L
M[26THE+@O& 64,#UQP0,XKMX9HKB,20R)(A) 9&!&0<'D>X(I] 'DUQHE]::
M=%-]@O'2\\8)JBV\=L[M#;[QEF4 [<X+8//S=,Y%>AW.O0VOB"PTB2SO2UZC
M-'<K ?(# %MC/V8A6.,=JTFGB2:.%Y4663)1"P#-CK@=\4UK:%[E+ATW2Q@A
M"22%SU('0'WZT <U\0+#4+S0[*?387N9-/U&VOI+9/O3QQON91ZGN!ZK4$<#
M:G\0;;Q%;P74-E::7);RO+;21M*SNK*@1@&.T*2>.I ZYQUPGB,Y@$J&8*',
M>X;@I. <=<<&I* /+;&VO5^!NJZ8VFZ@M_)%?1I;-:2"1C++*4P,<Y##GMGF
MM76DGN%\"O%8WSBVOHY9\6LF85$#H2PV\?,P'-=[10!YQI,UYI5WKGAW4_#E
MY?M=:G-=VD_V;S+69)'WJ7<_*I0]<\C QDXJ":!K'Q%X@TO6O#NL:I:ZI<_:
M+66T\QX)59$4QR88*A!7&6XQ[ 5Z=10!Q.CVLMM\3+Z0V$\5O_9%M;1RB!_*
MWHSED5R,' 9?K70Z-KT.M27\:6E[:R65P8'2[A\LOCHZ^JGL:U:A@MH;;S/*
M3!D?>[$DEFZ9)/)X 'T ':@#A/$'VG2/'LFI7>E:MJ&DW]C%;B33?,9X)8WD
M.&2,@[6$G7UI$TT67BOP4+/1+BRL;2WO@T4<+.EL)=FQ689 )P<C) .><8KT
M*B@#R._L;Z7X>^.;2/2]0-S>:Q--;Q"SDW2HSH591MY'RGGVK;M-1MK;XI>(
M9)K>ZD672K,CR[220XS+\I 4D$^A':O0:Q[7P]#:>);W75O+I[B\B2&2)BGE
MA4SMP N>-Q[]Z ."TS0-0T/3_A_9S65R6L[ZXN+A8H6D6V219=JL5! P9%7\
M^U21V&H6_@WQ9X5O-.NY]0NY[LVDBP,T=R)R61S(!M7!;G)&-OTKU&B@#S_Q
M'I&J:+%X=U72'2;5K6)-)G+G GCD 4,?79(%?Z;J9XBT^;P[K/A^^AT[4M0T
M>ULI+"=+ N9XBQC99-J$,P.S#?G76+X>@_X2)]9EO+^:0X,5M+<$V\#!=NY$
MZ!B"<GGJ?6M>@#R[4K%],ET37=/\-ZFNDI-=?:[*V+B[ F"8F*!MQ.Y#E<YP
MW/.0-^QU;3O#FF+>Q>'M4M;;4]0^;$#-(&< &><$Y0$C'//3CG%=E4,]M#<^
M7YR;Q&X=5).-PY!(Z'!Y&>A - &9XMTVZUGPAK&FV4@2ZNK22*(DX&XJ0 3V
M!Z?C7*R0W/B2V\&QQZ?>65WI=Y%<WGG6[QB!8XF5T#$8;<Q &TG(YZ5Z'10!
MQ_P_AF@MM>6>TN;=I=:N[A//@:/?&[Y5AN R"*E\7W%U!J>@F+3[B:U-Q()[
MRUM?/GM?W9"[!@E0Q)4L!P,],Y'5T4 >/+:7-IX,N$GTO5H+NU\3M=VH,)E<
MDSEU;;G,PVYSM)SG@\$BU<Q?V_IWBL:<FH+XBU.*&<6UW8RV:ND!4!$W]<]"
M=W\8Z"O0M<T"WUU+4RW%W:SVDOFV]Q:2['C8J5.."#D$C!!'-/TW1UT]_.EO
M;R_N=I03W;J6"D@D *%49(&<#G SG H XI)+76=+U+4+?POK5K?KIDUNTFH1
M2F4%EXBC#$EP6YR!CCWIEE;722_#/.GWR_8+9DN\VD@\@FU\O#_+Q\W'Z].:
M]*HH X_X?Q7-E9ZM87=E=02QZI=R[Y8BJ.KRLRE&/W@0>V<=ZK^)WO7\5&U&
MEWC6LVEND=W96^YY92Q_<O*/]6@&&ZJ"3UXP>XHH \JT"VOD;X:";2M1B_L^
MTFBNC):./)8P!!NX^7+ CG'KTYJM-8ZO':WM];Z7?RI9^+SJDEM]G=7N+;:!
MNC# ;R#\P _N_2O7J* .'T6>6^^)VH:E'I^H1V-QI-O''/<6CPJ6620D?. 0
M?F'!&?PP:M^--/BU"?3!YFJ65U$97MM2T^)I#;/A1M=0""K G((P=M=;10!Y
MI:KK=QJ_@.ZU>PF-S;O>F[E@M'"*&1EC=@!A"_!(/0L<XJJAU*QLM9DCT6\D
M6;Q5]H+G3VDDBMRJ?Z1$C+\S KP0#C.<5ZK10!Y++97_ /PCWQ'M$TG5BU_E
M[0RP.[3[K=%&#R220>/X>AV]*W[F.XD\6^!;A+*],-O:W*SO]EDQ$7C15#G'
MRY*GK7=T4 8GC&.2;P5KD$,,LTTUA/%''%&79V9"   ,]2*Y:""Y_P"$@^'\
MIL+T1V>FSQW#FUD A=HXE 8[>"2K#\/>O1** /))+#4!X;U"==+OR;;Q<-2,
M0M7$DEN)PV]%(RW&3@<U;OOME]J/CNYCTC4Q#J.AQ0VC-:.#*X28;0N,@Y=>
M",C/(%>H44 ><:O:ZA'X/\'ZA:Z9?7*Z2T3W=A"KQ3[/(:)MJ\-N4MT[\UTG
MA6.RE-[J5EH]WIXNV0O)?*ZSSLH(W,KDL !@#/)YXQ@GHZ* ./U**ZMOBCI.
MH"RNIK233)[3S88BZI(98V&\]%&%/)XXKE8](U.7X5WG@>YL+LZP)GA28P.8
M9-T_F+.)<;<8.XY.<@C&<"O6J* &*A6%4+%B%QN/4^]>265KJ"?#KPCIDNCZ
MFMUIVKVIN4-FYVK'*6=N <J!@YZ'/&><>O44 >7:]I.JZEJOCM-/L[GS;JUL
M&M6>)XTN&A9F= Y &2,+U[UO^%Y;+5M535(O#FJV%W%;F&6XU19%=,D'RDWD
MEAG))'' [FNRHH Y'QO;SM>>&;Z.UGG@L=56>X\B(R,B>5(N[:H)(RPZ US>
MO^']5U*X\2:_I5E-B5K!X;5MT,EY]FDWN<'#+D85<X)V^F#7J5% 'FEZMKK/
MACQ#?:?X:UBWO9](FL_,OH9?M$C,IVQ*K%F(!)R>@)&"><6#;74OB#P,T=G>
MQI;Z;<PSR_99 (&>.-5#'''*GKZ5Z'10!Y=X0M<VFD:#K'A?53JND21C[1.9
M&M%,? F1RVTDKT &<G&,9-;7A\RP>)O&MQ-97L<-Q<120.UI(!*JP*AV_+S\
MRD<5V]% 'D^FV.HV7@SX>22Z7?E],NU^V0K;.98AY4B9*8SC+#GIS7H?B*QN
M=7\*ZI86KF&ZN[.6&-F.-CLA R1[GM6K10!YO]EN_$&B>#=/73KRSO\ 2[VV
MGN_.MV18!"I#@.1M8-]T;2<AL] <:_AM9E\>^+YI+2[BANI;4P2R6[HD@2$*
MV&(QP1BNQHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *Y;QYJ^IZ-H]G+I8AWS:A;6\C2.5
M(5Y54@8!ZYP3V!/!KJ:P?%^A7/B#1$MK.:*&YANH+J)I@2A:.17PV.<'&.*
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MX. C'YB?4G@U8A\,:[IOB1=;T^[T]Y;NSBM=1@F1U0F/.R2,C)R 2,'KZCL
M<_X*\0W.@^ O"=M#I:S?VC?7%H%\\)Y3>9,P'0@CY2/\:V9?&^N1VWB!?[ M
M#=Z"=]TOV\^6\7EB0&-O+R6*D\%0..O:H-.\#ZS8Z1X;LGN["5M(U*2^=E#H
M'#>9\HZ_\]3S[#CO5^7PMJDDWC)Q)9@:_$L<7SM^YQ#Y66^7GCYN/I[T 33:
M];7/B;PL!I,,IU*TGN+6\D8>9 !&K,H&WC<&4$@]JS3\0M133)]4DT&%+&SU
M0Z==M]MRZXF$6]!L^89()R5_'K5Z#POJD6H^$KEI+,KHEI);2J';,I=%3*_+
MQC8#SZX[9JA-X(U>;PEJVC>?8B6^U5M0$F]]J SB;;C;R?EQGWS[4 :DVN06
MGC/5X9-'C^T6>D+=F[B(:::+<^(\;01RK8&3UJ >+[Z^\*WVLZ9#IL\4>GO=
M0S171D0.!DQN-H(('Y]/EJS-H.KOXLU#6X)[6$W&E"QB&YF:.169@Y^7!&7Z
M>WX52A\"L^H:M?&.STV34M,>RN(K$L8YI&_Y;,I"@,.0.I^8Y- $5MXNUJST
MKPE#+I<%Y=ZS"%607A7YA!YFYLIQG'.,XYQGI4VK^--5T32KN]U#1(+;[%:Q
MSS++>8$SD$M'"VW#E0OMR0,=Z;!X5UQ5\)&>XT]VT(G?LWJ)%\DQ #(/."6S
M^&.]-\0>#=9U:^\1F"_LOLNKV(MHS<1LTEMA"I5,'&UB=Q]^QH LMKVJR_$>
MSTZ".V_LN326O"'E96.9(P6/RD9 R /<Y/:F3>/6A\/0>)S8(WA^28(TPF/F
MI$7V"8IMQMS@XSD Y]JFB\,ZK'XCTK5C=V3&'33I]XAB;!4NKY3GK\N.?K[5
M0M_ E['X3/@Z:YMY="$P*3Y;S_($GF>45QC/\._=T_AS0!H1^*=7NO%6I:-9
MZ'#(FG36ZSSM>;?W4H)+@;>6 _A]CSTJ;PSXL;Q.(+BUAM6LY$<R&.XW2VS@
MC$<J;1ACSWXQWZU+I.B7UCXNU[5I7MS;ZF(!&B,V^/RE*\Y&#G.?;WK.TSPA
M=1>);#7KM;&WU""W>&[GLBP^WLP !D7  P1NZL<XYXH [.BJ6DKJ2:7 NL26
MLE^ ?.:U5EC)R<;0Q)Z8J[0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (<X..#VS7*>
M#=5U/4-2\3VVI727'V'4C;P%(A&%3RT8#')_B/4FNLZ#)KA/ -W;S>(O&BQ3
MQN7U;S%"L#N7RHQN'J,@C- &?<>,+V6#Q+Y>I26^NZ;>/#::2(T/G '$/RE=
MSB3@D@\9XQBO28R[1(9%"N5!90<X/<9KR'6K%-6AUK6KF];3O&>F7DPT[RVQ
M)Y:9\F)4_P"6B2+[')<^F*]9LGN)+"W>[C6.Y:)3*BGA7QR!^.: )Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!,#.<<^M+110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M,DECA0O*ZH@ZLQP* 'T4@8-T(/TI: "BBF2310E!+*B&1MB!F W-Z#U/!H ?
M1110 444TR1B01EU#L,A2>2/I0 ZBBD+*O5@/J: %HH!!&0<BD#J3@,"?3-
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M0 4444 %%%% !1110 5P7CE=1T[7],U\:*VN:-:P217-E&H>2%F*GSD0\,0
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MO:C21;8,>UO.\[=P<YQLV]NN:Q_&GA^_\16>GV]E);1_9;^&]9IF;YO+;=M
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M!X2NO#][)I@:ZB\F2_C=P2.,MY.W&>.F_'O75V\'V>SBMPV[RXPF[&,X&,T
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M-GKLDNB^8VEVHO$DCE<0SISN =HQAQCI@^M='H>H:GJ,4LVH:9'91-L:V*W
MD,B,H/S# VD'C'/UK"OM"\5:YX3U33M7O=+%W>6K6L8M%D6) PP9&W9);T'
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M5HQPRKM&X$\=L9[\TOCW2]8U?28+73;"PU"W$OF7EG=SM$+A /E0$ _Q8/)
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M"_?:.PSTSSCK7*Z=X9UC3[#4H#_9MP+W5IKZ2"4LT<D,N=T397J..<'IT[$
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M;;4&:Z>3:LOV8 2(2 , ,KQH0.Y)[5:\*QZSK&HZS/<^)+_R]/UBYM8XECA
M>,(H7=\G4%@1C'3D'- '8:?J27VFPWLEO<60E.!%>)Y<BG=M (SP2<8]<BK8
MD0R&,.ID4!BN>0#G!Q^!_*O(Q=ZAK?@OX?WU[J=VUU<ZTB32(P7?S-R0!C(V
M#'8>E:BSSZ+XQ\>:H+J[N3IVF6]PD,DF5?$4S;2,=,CMCDDT >E45Q&E1>);
MB\T?4EU6#^S;NV/VL-<^8969-T;PKY0"D'MG!'8XKG=+UC7QX9\*:[/KMU//
M=:RMC/"R1B.2)YWC.0%SNP 000!C@4 >LT45PN@7>I^)]#L/$<.M&S<WSM/
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M2:1/;E7AENO-=INH>,^6H (SD X[@"@#JJ*** "BBB@ HHHH **** "BBB@
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MYR 1GTH KZ'H=GX>TQ=/L/-%LKNZK)(7(+,6;D\\DD_C3=9T"SUUK)KQI_\
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M 2J7'U7.:YC4/$]U>>(K_0=!O-,COK.VCE!N\NLTK,X\K"L",!.2,D;AQQR
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MS7,:N;H'#H6PRK@CYST'OVJ2XU33[3S/M-_:P^45$GF3*NS=G;G)XS@X]<4
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M^LWT4EU9O;(D1BAC!\Z,D'<9.>AP,<#H:FMM1LKR66*UO+>>2(XD2*56*?4
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MJ /*O#FI6-S\1=*:&^M)X;CPXT,2VJDQ K+&1&I.2Q49SDY'.0O2L6*[TL_
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M4N]HLP@D#YF !))&#CFLE?!NMZ-/I.NV-O'=WUOJ=[?76GK,%REUP51FPNY
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MX/7)'XUS^L>#-7OUU37+:&W759]2MKZ&PN&!1D@C\L1R,,C<P+DXR 2!GC-
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MG'4XZY[4 9OC&^TZQT:)]3CO6MGNH$!LV*L',B[,D$87=C/-17WC2VL]6O\
M2X]+U2[O+*W6Y=+>%<,C%N5+,!_">N,]LTWQ[IE_J_AM;/3K4W$YN[>4J'50
M%CE5SRQ'93^-5TT_4T\=:SJO]G2FTN=,AMHF$D>6=&<D8W<?? S[&@#1B\6:
M?=6>DSV23W;ZK%YUK!$%#L@ +,=Q 4#(!R>I Y-<WX*UQ+2P\0SWAO<GQ#-;
M06]Q)OFW%8\1@LQ''/\ %@ $YQS5#1/#?B/P\OA/4H],-U-I^FOIE]9+/&'"
MEE821L6VGE>02#BFR^%/$DVGZE<IIUJMY'XB.L6MK/.K)<QE-AC8CA25+<GO
MCZT =)<_$72K.QU>XN;6^CETF2-+NV"(TB"3[C JQ4J<]<_7%66\:0KK$^D_
MV-JQOU@^TP0^4@-S'NVEE)?"X.,[RIY'K6%KNE:YKO@75;6+PW;Z;=W8B2*S
MCGB+?*X9F=QA<<8 &?UXV'L=1;XD6VM#3I?L*:1):,WF1Y$C2(X&-WHI&?7V
MYH !\0-*.DZ1J*VU^T6J7)M(D6#+QR@L"CC/!!1AQGI4=WXMTS4/#GB(WMCJ
MEL--1H[^VP%G1#'NW*4<C!4Y!#5S]EX;UZ'0_#UH^E2"6Q\0R:C.!-%@0LTQ
M&/FY/[T<>Q]LW;_0=9N&^((CTUR-:MDBLB98QN(M_*.?F^49YY[>_% &G_PE
M$MOX@\/:-9:9=2V=[8M<"9I$+;5"  [GSQO!8GD\8SS5FY\<:9:2VQEBN/L5
MQ=_8TOAL,7F[BH!&[>!N!&[;CWQS6:-'UF'7/"6HQ:>'6ST^6SNXVG53"S"/
M#=3N'R'ID].*I>&]$U[1)#H4WA[3[BTBN':#6FE3/E,Y8;H\;C( <#MTY]0#
M?U+QQIFEAIYXK@V$=T+26]388XI-VPY&[=@-\I(4@'Z&NFKSK2]$U[1M1O\
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MIFBP8V=&!)W<'"'CW% '9ZCXGM;"\O+1+:YNY[*V%U<I;A28HSG&=S#).UB
M,GCW&;FC:M;Z[I-OJ=HLJVUP@DB,J[2RGD''H17"ZVFI7/C'4Y](T>YN0]A%
M:7IL[Z")PQW-LD$@(W!6&"ISAN2<C'8^%I8'\.VL5MI\NG1VP-J+24JQB\L[
M-NY20W3J"<_6@"?4M8ATVYL[4QR375XS+!#&5#-M7<QRQ X'O5)/%5L=0TFR
MELKV";5#,L/F(@"-$"75\,2#A3TR/>H/%^C1:Y':6EUHSZA:;F=G@F6*:VD
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MM(RQP!QQSTZU?\6>*6\/:E917,XT_3[B-\ZC);F6))@5"(Y!&P$$G)QG'44
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MBDB7$B,P9B2,<D@=!C'&*Q8OAQ)#IEEI*>(;P:987L=W9Q&&,O%L;<J%R#N
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M?RK74!J"2& ;BXE,N#SC&XG\*[.B@#)\2:%'XE\.W6D3W$D G"_OHL;E96#
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M-G[W''/:K5I9VUA:1VMI!'!;Q#:D4:[54>@'84 <-<*Q\=^+H/M%R(SHD$H
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M)F?;G;UVD''X=:Y;2['4+/P#X :72]0\S3-25KN 6KF6)=DJ[MF,D9=>0.]
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M#>VD=Q:S)+!,@>.6-@RLI'!!Z&N#\->/+&TCO;3Q%KBF[76+FTA>5, (LA5
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M7[^0/0BN8AM;VQT3QIX?OM.O+BYU"YNYK-X[=GCN4G7Y!O VJ0?E.XC& >E
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M2MM?8[HNW!56SU89 )X[U];\:SZ)++)<:8L=I'?16:^=/LFG#E 98TVX907
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M@*Q[(U8D*., $X/%<3I_@O5K+2?!]D9K)SH$QDD;>X\X;&08^7CA\_A7?44
M>?ZAX"U'4AK[F\M[:XO-1@U*QE3<_DRQ*JJ'! R#LYQZ^U6)?"6LZSKLU_K<
MVG1P7.C2Z7<06F]B0[9+*S8Q^(_/K7<4V21(HVDD=41 69F.  .I)H Y7PWI
M7BW388+/5M3TZZM+)-D#P1NDMSA=J^:3D+CJ=H.2![YRX/!.KP>#M#T7SK%I
MM-U-+YI-[A9 DQE"@;>"<X_#/M7H%% '%:GX4U6^U'Q3<1R6:IK6F+81AI&S
M$0KKN/R\_P"L/'M[U,GAK5!JOA2[9[/;HMM)!,HD;,I=%3*_+QC;GGUQ[UT.
MI:K;Z8+=90\D]S+Y-O!'C?*^TM@9('W58Y) XHTC5(]8T];N.VNK;YV1H;J+
MRY$92001TZCJ"0?6@#DCX.U9O!WB;13-9";6+JYF20.^V)9CD@_+DD?K[5HZ
MCX?U2^N?#$X-FATB?SIAYC'S/W;1X7Y?]HGGTQ[UU5% '%:7X8\0Z)J-_::?
MJ=D-!O+I[H>9&YN;<R'<Z(0=N"<X)Z9Z&J.K>!]>OXM=@34-/9+_ %"*]AGG
MC<RA4=&$+$' 1=G&,]3P,YKT.B@#F;70M4LO&.H:U'<6<D%_:01S1LK*WF1!
MP-O4!3O[Y(QWZUB6'@+4K'0?#J1W=J-7T&YEF@D^;RIDD+;T;C*Y5L9&<8S[
M5Z#10!P^M>"[W6;'Q'*\EK%J6LVL=F '9H[>),_Q;06)+,>@[#MDZ/\ 86I/
MXPTK67-JL5I826DD:R,68N4)8?+T&S]:Z>B@#GO$^B7NL7FA36K6ZKIVH+>.
M)68%\(R[1@'^^3GVK$U#P+?ZG-XF=[V&U?4[FVN[.:$EFMY8%4(2" #R@/XD
M>]=E>W\&GB)[DE(I'$?FX^5&)PNX]LDXSTS5J@#CKG1?%>L^%M5T_6+S2_M5
MW9R6D:VBR+$N\8,C%LDGT   YY.>':OX7U6]T;0I+"]M[37-&97AD8,\,GR%
M'1AP=K*?J*Z2._\ ,U2>Q^RW2^3&DGVAH\1/N)^56[L,<CMD59CD26-9(W5T
M89#*<@T <CJ_AW7]=\,M#?7UBNK+<P74(B1Q;1M$X<+R=QS@Y;W'''-:;PIK
MUUJ6O7\]UIV_5=*6Q\I%?$;#?SN/4#?Z<X_AKN:R[?7[2X\1W6A(DXN[:!+A
MV=,(48D#![\J>W:@# A\*ZFEQX/=WLRFA0/#,!(V9=T/E97Y>.!GGZ>]9'_"
M!>(8/"7_  BMO?Z<VFVUW'-9W$JOYHC682A'4<9&"-P//3 ZCTJLO6=?M-";
M3UNDG;[==QV<1B3< [G W'L* .?'ASQ-I7B+4+K0]3TY=/U219[F*[A=F@FV
MA6>+:><A0<,>HJ_8Z#?VOC>[UEY87M9K&&S +DRYC9FWGY<'.\\>U:-IKUI>
M>(+_ $6-)UNK**.64NF$*N6 VGO]T]J->U^T\.V"7EXD[1/-'"/)3=AG8*N>
MP&2* ,WQUH]QJNA02V<9EN]-O8-1AB'60Q.&*CW*[@/<BDU73;C5]7T#Q%I$
M]M+]@$V(9V9%E255!^8 E2-O3:?3BNGI%55SM4#)R<#J: .)U/P/=7VCZJZ7
M4"ZS?W\&H&1E)A5H2GEQ^I4*@!/4DDX[4]?"NL7>N:QJ&H7EBBZGI2V+1P(Q
M\MAOY!)&0-_7OZ"NTHH Q_"^G7^D^&[#3M1EMY)K2!( UN&"E44*#SSDXSVZ
MX[9KF+OP3JUUX9\5Z5YUDKZW?/=))O<B(,$&"-O)&P?G[<]_678:]::CK>IZ
M3"DZW.FB(S&1-JGS Q7:>_W30!D1>']4TWQ3>Z[IQLW.IV\27MK/(RA98QM5
MT<*<C:<%2!G .:HIX%NM-M_#7]EWEN;C2;F>>5KB,[9C,KB1@ <CER0,^V:[
MFL.T\4VE[J%M;V]K>R0732I!>K$&@=HR0PW Y7[K8+  XX)H G\2Z;<:SX7U
M32K9XUFO;62V#R$A5WJ5W< ],YQ6-#X;U2/7O#NH,UGLTO3Y+21!(V7+A!N'
MR]!Y8_/VKKJ* .>\(Z)>:%97\%X\#M<7\]XIA8D 2N7VG('3.,]_:N=UGP/K
MVHQ>(+>/4-/:/4;N*ZAFGC<RH$9&$)(X" H<8SU/'.:]#HH 9$)!$@E96DVC
M>5& 3WP,G _&GT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9)%MF=54'& S  DCGY3C!.1UUIX2TZQO[6^MY+M;BUM#9Q.TY?$1()!W9SR
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M Y/1]>U#7- \)2W&H2FYO;%Y;BTLU"S7+ *!)NX"*I))Y )('/2LTZI>ZUX
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M4X(8 @@@\@BO*)-;L;;Q!%_PD.K26>FZEH=NEI=%8VAD(W>=&6=& 8[E/;(
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M80DR@'&/FR.#5+5[/PU!IFARV%S]IL[KQ5#.)[DILD+_ .L,> !Y>>N!C.:
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MYO+>&:8XCCDE56<^P)YKQ.+2M(O?A7=PV$-K_P )"FK2I8F(#SXYA=ML"]P
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M#;7\QO[B2UCCCA!=)D#%HW&<!OE(X)'?..:33_&=WJ'BZ+2CH5_:0'3A>/\
M:1&LB[GV@LN_( VL.Y)/3&"0#KP !@ #Z4C1H^W>BMM.1D9P:YW3O&>GZK=:
M;;I;7D,>JQ22V,\BJ%F5 "<88LIP01N X]^*Q/!.M&ST>6VD6]U"YEUF]AB1
M9!)($29AN8NP^50 ,D]P.I% '?$ ]0*1XTDV[T5MIR,C.#7,#6M,M_%&MM]G
MU+[=9V$4MPI),;1Y?;L7=C=PV3@?6C3?'FGZG<Z/&MCJ,$6L1&2SN)XE6-R$
MWE/O$AMN>V#C@F@#IV17 #J& .<$9YK(\0:-=:M:VRV&H_8)[:X%PK&$2QR$
M C:Z9&X<YZ@Y /:J%[XZTVRMY[LVUY-907OV%[F)%*";=MQ@L&QN.W.,9]N:
MZ:-_,B1]K+N4':PP1['WH Q=,T2YBO5O]4N+.XO$C:.,VEGY"*K$$\%G8GY1
MWQ[5M[1Z"LOQ+J\F@^&M2U:.U:Z:SMWG\I6"Y"J2<DD<#&3W] 3Q7&ZCK%W)
MKW@/498;^-[A;CS;6-\B8_9R0=BL5ZG@G&.^ * /1@ ,X YZTCQI(NV1%=?1
MAD5S]EXRT^]TJ6],%U!)#>&P>TF51*+@$#9PQ4GD'.[&.20 :LZ-XEM-9O\
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MN9#\A>-PX5O8[<?C6O<ZG9VE]9V5Q.J7-ZS+;QD',A5=S8^@&:MT <D=-O\
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MT#6H-/\ A_ ^FOOT7 O,31X7$#19'S<\G/T]^*]$HH \EB@O9%U&1/#5W?\
MA^;59+]19ZA;B&79)D/M?#\LF\KNVD].#SWNGZ]=7OB%[%M+:*Q>S2ZMKPS
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MP)*'8#\H)'/!JSXG\.:CXAM!;"(VTNE1)<Z=<PB,"2\4<$*3\J#&-IP#N/\
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M'SC!QV[5U5% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>)_$>KPZ7JVE:;]HT^ZN=LL!15V6Y8CS!(9.6& 2-O.2.V39^*W_ "3+6_\
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MV7,MUY#GF%78E(_;:N!CL<U-JWAM]1\0:?K-MJ<]E<VD4D!\M$<21N5)&&!
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M9%"LH(/3 'O[UF6_@&YBAT6WF\27DUOHUR)K,&",.%",@5FP=V V,X'';/(
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MT!602; Y'*Y'&1Q[]*O3^"9T\076J:7XAO\ 34O]IO[>)(V69E 7>I8?NV(
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MN[@]3O;/U[5%8>#OL]OI5G>:E)>V.D2+)91R1!7!52J>8P/S[0>,!>0"<XH
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M5M/^TM:3V;B62)X)\;T*.5YP2.<9&">"*Y[X:7D%_P##?2(;=C#-:VRVDZ
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M'FD9V"_;0GWB<GY>,FNEN-&L-2^*LUA,KFS'AV)?+CF9 0+B08)4@G'IG^5
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MX >A(P<$\Y.:[KPYI2:;X@OI8-9@G@NX$D^P6L16*(@X\Q?G;;N'88SC/8T
M=7163XHO;S3O">KWNGIOO+>SEEA7&?G"$CCOSVKBI?\ 1+'P)K.B3R/<W]W;
MP73^86-W#)&6D:3^\R[2V3R,&@#J+WQ+=C4;^ST?2O[1ETYH1=)]H$3_ +P;
ML(",,0N&.2O7&:Z.N$\):=9P_$/QI)'"%>*YM@AR?EW6ZD_S-=S(BRQM&XRK
M J1Z@T <_KWBR+2=#75;2 7T'VQ+1RLNP*QE$1.<'.&X_"NBKQ."SM8/@D@@
M4122:NBL4/("ZCA>.V!6QK,]UX6UKQBFBO< +H$=\J-*TNV;?*ID&XGG: 3Z
MXYH ]4HKA]!T^V_MW3=9T_Q!;26]U:LAM;6)MMV,9$CDR-\R]V(SS@GFNW8$
MJ0#@XX- &!;^))-6O;R#1+);N*SE,$]U-/Y41D'WD0A6+$=S@#W/-7M'U5]4
M6\$EC/9RVMP;=XYBI)(16W J2"I#C!_ETKD/@X?LW@C^Q[@[=4TV[GAOHV/S
M!S(S GV((P>]7?&&K"/4?#]DDI6PO-6%M?R(2 3Y9*1DCLS!0?7&#U(H [2B
MO*?$:7.FS^.M-L9IX]+CT'[?&L4K(+6XQ(-J$'Y0P0,5Z>W-.UG1(+#2O"ES
M;7NHQ3:EJMBEU(+Z7]YF-@>-V!G Z 8P,8H ]4HKQS7Y=0\%3^,;?0;B[_L]
M-.MKK#2O*;2224I(4+$D'RPS]>P-=1?6RZ9XX\,)HK.MGJ<5Q'>Q12MMEC6,
M,LN<_>#$#?U._K0!W=([K&C.[!549+$X 'K7D.BVMA;?"V3Q!J&I:M'<G[1:
M&YANW:3:UV555#-MR2 -QY&XG-6)XR+WQ]I4\<$-M_8L4PLH92T<<A2;..!R
M0JDX S@=>M 'HSZC-/;:==:7:K>VUVZ%Y/-$?EPLI/F $?-_#\O!Y]JT:\N>
M&*S\+_#=[.22+S+^R658YF"ONMV8AES@\A3S4R,-?T[QU-J,TD.HZ;>7$=M(
M)"CVD4<8:)TQ]T'EB?XLG.10!Z717ENEQW.O^+?#XUI[H/>>%C/=VZSNB-)Y
MD.<J"-O7D#'O72?#.::;P+:"::28PW%S KR,6;8D\BJ"3R<* /PH Z6_O[;3
M+">^O)1%;P(7=SS@#V[GV[U7-YJ1%@R:6"L\F+@-. UO'M)#$8^8YP"HZ9ZG
M%<W\2GD&FZ!%S]GFU^QCN?0Q^9GGVW!:D\8EX_$_@UTFF3?J;1NBRL$=?)D/
M*YP>0.2* .QHKQO5K(-H'Q&O#=WQGTV^>6S?[7)^Y988F!'S>OKG X&.:Z1;
MFWU_QEJ^B:W.41=+MY+*,OLX</YLR?[8;:-W\...IH Z6_\ $#V/BO1]$-GO
M34DG=;CS,;#$H)&W'.=P[UMUY_<I$/&/P_BCNY;Z);2]1;F<[FG BC&\G SG
MKGOG-<[=W30_#;7&-TZ36WB9X8&,I#1J+Q1L4YSC9D8]* /6=0N7LM.N;J.'
MSFAC9Q'NV[L#.,]JRM(UV\UG1]!U.VTP>1J42S7!-P ;963<.WS\X7C'7-<R
M\L/B#7?&]GJA)?3HDCM82Y7RHC#N\U?1BQ/S#G@#-9FBLZ:?\)VCFF420E'1
M96",!:,>5S@D'OC- 'J]%>+ZI:E?"/C[4A=WWVO3-8E>SD-W(3"56$@CYN>N
M.<\<5U>N-)/XRNK:\1[RTDT8&WMX&&Z"8NP+$9&UFX"OVV'D=P#O:J:A/>6\
M$;6-DMW(945D,PCVH6 9\D'.!DX[XK/\(:;?:5X4TZTU.XDGU!85-S)).TQ:
M3'S?,Q/Z<>E9/Q'+QZ/I<L<TT;KK%DO[N5E#!IE!# '##'8T =4MY;O?262R
MJ;F*-97C'558L%)^I5ORJ>O.H;.SB^)7C&X\Q;29=.M9%N2?]6Q68%\=\ #\
MJE\'37-EXC71]8TP6FJ+8%DNK68R6U_&K(#+SRLF2,YY.[J>* ._8L$8H 6Q
MP"< GZUR.F^-+S5-/U&^M_#\TD6GW4UK-''<(9&>(X;8#@'VY&:Z^O*O"FDW
MVI^'?%R6GB&YTO?K>H+N2.(HGS\DEEW#ZAACMB@#T;1-9LO$&BVFK:=(9+2Z
M3?&Q&#Z$$=B""#]*OUXYX5UPWNA?#[3VL5T_1[N6Z@GCB9O*F>)6\M<DY*NV
MYL$\D8Y[Z%]=?V1>>+M)DO+V'1EFL!:K;OAHY9B-T",W"JV%R,@*'.,9H ]3
MHKR2[DG@M?B;9"46BVNGQW$%O9W#A()#!(QV$;<9**2  #Z5<NH8-%C\)Q">
MZ2VUZYA74IY;EV$A6 E$Y.%#M@$+@$#'3B@#M-,U]]0\3ZWHSV?DG3%@82^9
MN\T2AB.,<8V^IZUMUPOA.SMK#XE>-(+5!''Y5@PC!X3*2< =A[#UKIO$MY=Z
M?X6U:]L(_,O+>SEE@7&<NJ$KQWY'2@#4KG+_ ,2W:ZAJ%EH^E?VE-IWD_:H_
MM B;]YR F00Q"_-R5'(YKE7)MM(\"ZWHT\CWE]=VL-T_F%C=Q2H3*9/[Q&"V
M3]W:<8K2\*Z=9Q?$CQG)'" \4UIL.3\NZW&?SR: .[HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ JGJ6E:?K%J;74K."[MR<F*= ZGZ@\5<KE/B1JNH:#X$U+5M+NC;W=JJ,AV
M*X.752"&![$T ;-KX>T:RN$N+72K.*=!M25(5#*/0'&0*;K'AS1?$ A&KZ7:
M7WDG,?GQ!]OKC/\ *L#Q+<^(O"^@RZ[9ZD=4BLT\Z[M+R&-3)$.7*/&J[2!D
M\AAQ5^#7].U'5M&FM];:(75B]U'8[!B:-@K!V.,KM'N.M &M-HVF3W-I<RV%
MN\]F,6TAC&81TPG]WCCBJ?\ PB'AS?(YT+3BTDXN')MU^:0<ANG7D_F:BM/&
MWAN_N1;VVK0NY65LX8*!&<.2Q&!CW/O5NS\1:7?7TEE#<E;J.(3F*:)XF,><
M;P' W+GN,B@"^UK ]W'=-"AN(T:-)"OS*K$%@#Z$JOY"HO[-LOL,UE]DA-K,
M7,D)0%'WDE\CH<EB3ZYJA#XJT:>X$$5T[RM UQ$@@DS-&.K1?+^\'3[F>H]:
MJZ%XST[6?#D>M-YMM;R.502Q."V7*H%X^=C@<+GDXH M0>$_#UJ8C;Z+81&*
M-HD*0*"J-]X XZ&K4&B:7;:4VE0Z=:II[*5-J(AY9!ZC;TQ5;_A*M$%E?7;W
MRQ16'_'T)D:-X>,C<C ,,CD<<]JBM?&.@7ID6UO_ #W1T0I'$[,S.I90H"Y;
MY58\9P%.>AH NZ1H6E:!:M;:1I]M90LV]D@C"ACZG'6M"JUA?VVIVBW5HY>%
MF9,E"I#*Q5@0P!!!!'([59H S+CP[I%S=R74EA"+B48EE0;&D'HQ7&[\<T^3
M0=(ET@Z0^F6ATXC!M?)7R^N?NXQUY^M9T6N:9;:GK\\VO>9#9+$;BW=0$LOE
M;H0,G=@D\G&.U3V'BW0M4OX;&SU!);B>'SXEV,!(G!)5B,$C(R <CN!0 ]/"
MN@1Z2FE)H]D-/1_,6V\D;-V<[L>N>]68]&TV+4#J"6, O&C\HS[!O*?W2>N/
M:N4\<^*UL],A_LG4I8KE=2M[9FC@+1OF55DCWE2N0"W ((P?0UTFI>)=)TAG
M%]=^4L942R>6[)#NZ>8P!5,\?>(ZT ,T_P *>']):Z;3]&LK5KH8G,,*KO'H
M<=O;I4G_  C>B?V,VC_V59_V:W)M/*'E]<_=Z#GGZU3U'QOX;TJ:ZAO-5B26
MU"M,BJSL@;.#A0?0Y].^*O-KVF"QMKQ+GSX;I-\!MT:9I5QG*J@)(QCH.* (
MT\+Z#&)Q'H]B@N(1!-M@4>9&.B'CD>U:%I:6]A:QVMI"D%O$NV..,851Z =A
M60?&?AP6]C<'5K?RKXL+9LGYRN=PZ<$8/!QR,=:GLO$VC7^EW.I6]^GV2U=H
M[AY%:,Q,O4,& (/(ZCN* -.:&*XA>&:-)(G4JZ.H*L#U!!ZBL[3_  WHNE2*
M]CIMO R?<V+Q'_NCHOX8KG[+Q%+>?%&33HKVX.GKHYN6MI[<P^7)YJKN^958
M@KZY'6MR'Q3HT]XMJMZ%E>)IX_,C=%EC'5HV8 .!P<J3P<T 3W.@:1>7IO+G
M3K>6X90KR,@RX'0-_> [9SBI'TC3I-434WLH&OT38MR4'F*OH&ZX]JS+3QQX
M;OYK**UU2.1KUBENP1]KL,_+NQ@-P< D$]13M&\56NM:UJNG007*-I\PA9Y+
M=U#-M#'DC ^\,9Y/4<8- &5HGA(KKWB&]U?3K9X]0O%GA._?E BJ%<8 /*D@
M<@9KI;_1].U.2&2]LXII(,^5(P^9,]<-U /<=ZGO!(UE.(I6ADV';(H!*G'4
M @C\Q7->#_$+3_#_ $+4]7N6EN[RW4L5C+/*Y!)VH@R3@$X Z ^E &W/H.D7
M4=I'/IMJZ69#6RF(8A(Z%!_"1[4EYX>T;4+X7UYI=G<70C,0FEA5FV'^')'3
MD_F:CA\3:/<:8NH17R-;M-]G!VMO\W.WR]F-V_/&W&?:HT\7:"Z7K?VE$GV$
M$W*R*R-#@@?,K $'D8&.<C'6@"8>'-$$=A&-)LMFGG-F/(7$!_V../PJ2'0]
M*MQ=B'3K9!>$FY B&)B>#O\ [V1ZU1N]=MK_ $G6$TR]DAOK* LX:$I)"Q0L
MA*2+T..,C!YI_@Z]N-1\$Z%?7<IEN;C3X)99" "SM&"3Q[F@"W9Z%I>GPO%:
MV,,2.@C8*O5!T7/]T9.!T&:A7PQH26UM;+I%FL%K)YMO&(@%B?\ O*/X3[BK
ME[J-KIR1M<R%3(VR-%4N\C8)PJJ"6. 3P.@)JI#XDTBXTP:A%>J]N93 ,*V_
MS0<>7LQNWY_AQGVH U:R;SPQH6H7WVV\TBSN+K;M\Z6$,^/3)YQ[4QO%>B)I
MUY?O>[(+)MEUNB</ <9^="-R\<Y(Z59?7--BU%+"2Y"7+P-<JC*P#1C&6!Q@
MXR,\]Z (/^$5\/\ V"XL/[&L?LERP>:'R%VR,.A(QR1@<U/8Z'I.FW,ES8Z;
M:6T\B+&\D,*JS*O0$@=!6?:>./#=]-916VJQR&]<QV[!'VNXS\N[& W!P"03
MVS5YM?TU;P6AG<R&;R 1"Y3S,9V;P-N?;- %C^S+'[/]G^R0^3YWVC9L&/,W
M^9OQZ[_FSZT7&G65W>6MW<6L4MQ:,S6\KJ"T188)4]LCBJ<_B;2+6]CM9KO8
M\DWV=',;^69?^>?F8V;NVW.<\5F>']0OY_&OBNPN;MY[:S>U^S(RJ/+#Q%F'
MR@9Y]<F@#J:J1:98P7\M]%:Q)=S "28+\S@9P">^,G\ZMU3OM4M-.,2W,C"2
M8D1Q1QM)(^!DX106..^!Q0!/]F@^U&Z\I//*>69-OS%<YQGTS6=I_A?0=)OK
MB]T_2+*UNK@$2RPPJK,#R1D>IJ.3Q=H$6FV^HR:I MI/,((Y#D9DW;=I&,@@
M\$'&.^*N:5J]AK=E]LTZ?SH [1EMC+AE.",, >#0! /#6AC39].&DV?V*X??
M-;^2-CMG.XCH3GG/K3T\/Z1'=?:H]-M4G\D0>8D8#>6.B9'\/MTJ#5[ZV@U?
M1[:36&LIIK@^7;*@;[5A&^0Y!P.^>.E5-.\9Z=?WFM1,L]O%I4IBDEF@D13A
M%9CDK@?>P!U/4#!% %R7PIX?GT8:/)HUDVG*V];4PKY:MZ@=CR>GK4C>&M$:
MSM+0Z39FVLV#6T7DC;"PZ%1V/N.:GLM5M-0EGAMVE\V#:9$EA>)EW9QPP!YP
M:GN[N"QM9+FYD$<,8RS'\@/<D\ #K0!-5/4-)T[5EA74+&WNA!()8A-&'V..
MXST-8NN>-M-T;0;_ %()<S-:%8VA^S2*P=L;0P*@J#D<GCGU(%:DVO:?;I"9
M'G#S(TB0BVE:4JIP6\L+O !(Y([CU% #6\-Z(ZWBMI=H5O3FZ!B&)_\ ?_O?
MC4>H>%/#^JV]K!J&C65S%:\0)+"&$8]!GH.G'2IEU_2I-,M]1BO8Y;2Y(6!X
MLN96.?E51DD\'@#/!]#7-^)O$_G:5IE[H.ILJ_VW;6-TJQ@'F55>-U==R'GV
M/- ':(BQHJ(H5% "JHP /054U'2-.U=(TU&R@NDB<21K,@8*PZ,,]_>L;Q/K
MH7PUXC.EWLL.H:99RRF1(,B.18]X&64J>W'7!I_ASQ5INIPV&GF_$NJ/9).Z
ME&&_Y5W%6QM;!/."<=Z +USX9T.]N_M5UI-E/<&$P&66%68QD8VDGM@D?B:?
M'X>T:&6SEBTRT22R79:LL0!A7N$_N@]\=:C_ .$GT<7<5N;P!I9C;QR&-A$\
MHR"@DQL+9!& <Y!'45EZ3J5ZWQ \2V%S>M)96MM:2P1NJ@1;_-W<@#(^4=<]
M* -B/P_H\5O>0)IEJL-Z2;I!$,3D]2X_B)]34-OX4\/VA0V^C649CB,*,L(R
MJ'D@'KSGGUKG]0\4_:/&_A.UTS49OL=\]QYT1MRL<Z+"S*ZNR_,,XY4XZ>HK
MHG\3:1%?PV<EYMEFF,$3-&XC>49R@DQL+<$;<YR".U $\&BZ7:Z4VEP:?;1Z
M>RE3:K$/+(/4;>F#3='T'2?#]L]OI&G6UE"[;V6",+N/J<=:H1^./#4M[]D3
M5H3-YTD!&&PKHN]@6Q@87)R3C@^AJW%JMKJWFVEC=3PW/E"56:W="%)X8!U
M8$C^= &K6=9:!I.FS^=9:=;P/\VTQH!MW'+;1T7)ZXQFH/#6M_V[ICRR(L=W
M;7$EI=QJ>$FC;:V/8\$>Q%,\3^);?PQ807,\,\IGN8K9%BB9_F=PN3M!QC.?
M?H.30!=M=&TVQO)[RUL8(;FX.9I8T :0]BQ[_C5ZLNZ\0Z;9JIGEE#-#YYC6
MWD>1(_[S(%+*/<@=#Z5>M+NWOK2*[M)XY[>90\<L;;E=3T((H SF\*^'WBGB
M;1K$QSS>?*OD+AY,YW$8Y.><U9CT;38M0:_2Q@%X\?E-/L&]D_ND]2/:N?\
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M-903L+I8Q+Y,T3Q.4)QN < LN>,C(H -/\/:/I,[W&GZ9:6TSJ$:6*(!F4=
M3UK2IDLBPQ/*P8JBEB%4L<#T Y)]A7GFJ^.)-3\&V&NZ5<7-@C:K!#)YL&T/
M"UQY9R77'*C)VGC.": .ULM TC3I_/L].MX),L08T VEOO;1T7/?&,T^UT;3
M;*^GO;6Q@ANK@@S3(@#2$=-Q[_C5?3_$NCZH;T6M\C&QP;GS%:/R@02&.X#Y
M2 2&Z''6GV7B'3-0U![""X87:Q";R987B9HR<;U#@;ESQD9% &G1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+FU?=*RK*",8&#EE^0 'G[H'-=;X&CE@\!Z#;SPS03P6$$,L4T;(R.J $$$
M]16[+-%!'YDTB1ID#<[ #). ,GU)Q3Z .+\8/?Z7XG\/>((;"ZO]/M!<07<5
MI&9)8Q*$VR!!RV"F#CH#5'5XKJ2Z\/>(K'1+B"QM-3DN+FT2WVSNDL1C,[1
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MLNW&&QVQFF1&\T;5-,O]0T76[C3KO1;6T;["DOFVTT6[*O&A!P=_7U%>K44
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M#_+\OS C]>E>FT4 >4HVHV-GK$B:)>R+-XK-P9#ISR20P,J_Z1$C*=S K@$
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M9++S=;N;F:-P[;8A,NT@_+R5Q^/M0!0CCL=-D\&WM[X9TZ2^O&AL8KM)=S0
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MRVTJ"1B7,@097Y>VP=>N?:NKH Y*[\93IIVKZK8::MWIVDS217#>?MDD\O\
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M5"> Q0-C_&N1C\8F;3K:+3;RZ\V^UI;%XM1'DSV.8MQB8E6Y)3 .&^_UR,T
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MM7@<#K@9Z"KFN:'8^(=,?3[]',)=9 T;E'1U(965AR""!4.I>)]'TI; W-_
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MU!'K/]J66D7VE7MBEO=2H95N#EF1D)V)@\29*^O>M.;4+*VN8[:>\MXIY?\
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M;F[3SCF20XR<]1G:O P.*W?MMKNA7[3#NG&8AY@_>?[OK^%2R2)#$TLKJD:
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M>A"\D=AST-:6MCR-:\?6F@)&)GTFS<6]IM!?:9 X51_%LXZ=Q7KFQ?[H]>E
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M1XA%A%XS\+WOA:_;5-4-X(9K=KMKU([5@?,DR[-Y1&!\P(SD]:]5*@]0#]:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MUG 9<\_3-6[/2-;T2X\3VD6G?;K;6)WO+>5)D"Q22(%=)-Q!V@@$%0>.V>*
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MCE?P.1^%<AJ?B6]UC1?'5JUE=V2Z7#-'#<1S*I#+ '!)1]V23D8XQUYR*W_
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MJ#U Y[>]7KWQ7%92FW?3+][M;1[V6W01EHXE;;DG?M))S@ D_2N0N/!6L?\
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MJESK_BO[;?I/%!J9A1/)VE0(HB,'=P #TQR><T =G3)IH[>%YIG6.- 69F.
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M2[V%FN7$:Q_96V[D*G>2ZG[IXST/'2HOB+YO_%*^0$\W_A(+?9OSMSLDZXH
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M058>;]..G- 'I-%<)-XA\2Z1XGDTC4FTV9;RPFN[":&!U$3Q8+1N"_S#!'S
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MNXY)R2#GVH [.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHKJD4\485[6X4*%9.3D *.#ZGFNSJ"6\MX+FWMI)56:X+").[;1D_@!_3UH
MYVV\'S'79=7U+69KR:;3_P"SY8U@2)&3<QS@ D?>]>OMP*=AX FM/^$?$OB"
M[F30F(M%$,:_N_+,85N.3M."?;C')K:\.>(&U_\ M4/9FU;3]0DLBOF;]^U5
M.[H,9W=/:MN@#D=+\#OI%],EIKEXFB2W#7/]E[$V*[-N(#XW!"W.T?R)S+)X
M7GL9/$%UI^L7EL=4;S@D4*.89MBH67(R>%'!.!S^'4T4 4M)CO8]&LX]1E$M
M\L"+/( !N? W'CCKZ5BVOA.6.^TZ_N]16ZO=-MGM[:X:W"NP8 $R$-\_ Z#:
M.2:Z>B@#C;;P%]ET+0-)35&,6B7:W4+M -TA7=@-SC'SMTQV_&*7X=EXIH$U
MZ\CMSJHU6",11GRI?,\P@DC+#.<9Z9YS7;T4 8%OX<EMO$.J:Q'J&9;^WB@9
M'A!""/=M/!&3\QSZ^U6/#&ACPUX=L]&2Y:XCM$\N.1DVL5SQG'>M>N<_X26[
MNK^XBTK2OMUM9WZV-W(+@(Z-M5F95(PRKO&?F!X. <<@%2+P.]IK-_<6.N7E
MKIFH3FXN].1$*O(WWRKD;D#=P/?!%:>G>'VL/$FKZP;SS?[3$0D@,6 GEJ57
M!SZ'G/7VK;HH Y#0_ \N@W @MM?OFT..4S0:6R)MC.[<%\S&\H#R%SVYSSFM
M'\.C%:V=HGB"]6VL=2.H6B>5&3&2SL5)(RW,C<GUZ&NXK$\4>('\-Z=!>"S-
MRLEU#;L/,V;/,<(&Z'."W2@"A-X&L[J;Q ES>3R6&MX:>TPH"OL5-ZMC.<*"
M!T!JSX>\.W^D%3J/B&\U?R4\NW$\:)Y:^IVC+M@8W$^OJ:Z&B@#!UCPV^I:]
MINL6VISV5S9)+#\B*X>.3;N&&! .5&#_ #I_A;PZOA?1AID=[-=1++))&954
M%0[E\<#GECR:VZ* /-] L)M8U?QQ:1:EY%K>:@5=5B!=HS"BEHVSQGYESAAQ
MQ@UT]MX5CL_$UKJ]K<"*&VT\:=':"+Y1$&##G.<@@?AV[UT-5)I[Q-3M88K(
M26DBN9KGS@IB(QM&S&6W9//;% '-IX&DM=9OKBPUZ]M-,U"8W%WIR(C*\C??
M*N1N0-WQSR<$=K5_X3.JN(KZ_P#/LEODOHXF@'F1,K!PJ29X7(YXS@D9 /&]
M;7EO>><;>59!#*T3E>@=>H_#I66?$#KXV3PZUF0KV#WJW/F==KJFW;C_ &NN
M>U &+J?P^_M"/7[5-:N;?3]:?SI[9(D.V4JJE@QYP0HX]1UQQ6I#X:F@\3#7
M!J323#3Q8;)(1@J&+AC@CYMQ[8&.,=ZZ&B@#C(O 1A\-Z7HJZJWE:=?K?1RF
M ;F99#(%;G&-Q/3MBLO0[*XU7Q)XXMH=3%O;W=TB/MB#,R>0BL\;9X.<KDA@
M"!^/H]% '.?\(C;P:WI6HZ?=2V2Z?9&P$$:JRO!E2%R1D<H.1SC\ZI'P!;S:
M1JEA=7\KF]U$ZG'/&@1[:X)#!DZC (&,^^<YKK+B1XK:22./S75253=C<?3/
M:LSPOK@\2^&=/UD6YMQ>1"41%]VSGIG S^5 %4^&I;BXGOKZ^6?47LVLHYE@
MV)%&QRQ";C\Q(&3G'RC '.:=OX):WM?#-NNI$IH!!@)@&9<1F/YN?[I/3'-=
M-;WEO=2W,<$JN]M)Y4P'\#[5;!_!E/XUEWOB![/Q;I6AFS++J$,TBW'F8V^6
M%)&W'/WASF@"7Q+H4?B70+C2I;B2W$K1NLL8!*,CJZG!X/*CBJD?ANXC\3Q:
MZVIF6XCL#9;9(!A@6#EC@CG<!TP,<>]=#10!Q-I\/FL+714M=;N(I])FN)(9
MA"AW+,275E.1GDX/;WIR_#U$T273EUF[W?VH-4MYFC0F&42^9TQAN2<Y_2NM
MGO+>VGMH)I526Y<QPJ>KL%+$#\%)_"LO0O$#ZSJ&M6CV9MFTRZ%L29-_F917
M#=..&''- &H;826)M9I'E#1^6[M@,V1@G@8S]!7*6_@22WTK0+#^VII8]$N4
MGMS) N3L0HJ'&.-K'/<GOVKLJ* .1O/ 5MJ1\0B^O97CUIXI'\I=C0/$%",C
M9/(VJ>>X_"M/0=$O],S)JFNW.KW 3RXY)8DB")_NH.2<#).3P.G.="RGO)IK
MM;NR%LD<VR!Q,'\Z/ ._ 'R\DC!]*MT 8FI: VH>)-(U@7GE-I@E"1>7N#^8
MH5LG/H!C'ZUCR^ C-X=U31FU5O+U'4#?R2" ;E<RB4J.<8W*.O;-;&O^(&T.
MZT>+[&9TU&^2R\SS-OE%@Q!Q@YX4^E;= ')S^#)?[:U'4;#6);+^U(52_A2%
M721E7:)$W?<;''<'Z\U3_P"%=M;66B?V9K][9:EI-M]DBO5BC;S(>/W;H1M(
MX!'<>]=Q10!S4WA-Y;W1+MM4FDFTN:2<R2QAFN)'4HQ;& !AC@  #CL,57F\
M%--9>);5M3.S7V+3D0#,64$9V\_W0.N>:ZVJ:7%X=4GADLU2R2)7CNO.!+N2
M=R[,9&  <YYS[4 8]IX6FM=?M]7&HAYH--&G!#!\I0,&W'YL[L@>V/SJA#X!
M,&@Z1I*:JQCTS4/[0CD, W.X=G"MSC&7;I@XQ^/6V=W!?V<-Y:R"6WG021R+
MT92,@BIJ .9G\&6MUJVMW,]W,]IK4"Q7=GM7:Q5#&"&QD?+V]1FH]'\'3V5H
MUCJNO7FL6*PM;PV]Q&BA$92IW,H!<[21DGN>,UU55[ZX>TL9[B.+SGBC+B/=
MMW8&<9[4 <]X<\(76@&&"7Q%?7^G6@Q9VDZ(/*&,#<X&Y\ X&>!Z<#%_Q#H#
M:Z^EL+O[/_9]ZEZ@$>[>Z@@ \CCYCGO[U-X<UC_A(/#>G:P(/(%[;I/Y6[=L
MW#.,X&?RK4H X[4_ 2ZI)KTDFJ2QMJ[V\I,<0'DO 1Y9&2<CY1D'K[5+'X,N
M8]3U'4AXAO!=W\$,<CB*, /$258 #IR1C\\UUE% &+I?A]+#6K_6)I(Y+^]C
MBBE:&+RD*Q[L';DDM\QR2>@ XQ39/#\C>+_^$A2]"R"Q-DL+197:6W[B<@YW
M#\N/>MRL32?$#:GX@US27LS VEO"OF>9N\T2)O!QCCC'K0!CVOP^CLM+TB"'
M4I%O=(N)9[.\\H9'FDF1'7.&5MQ!Q@\#GBK5]X)MM4TG7+:\NG-WK(07-U&@
M7;L "!5YPJXS@D]3SS74USFC>);O7)+&ZM=)W:->I(\5ZMP-R;3A=\9 P&QQ
M@M[XH V[6">"Q2*6Z-Q<!3F>1 -S>NU<#'M^O>N4C\!&+PQ8Z&NJMY5G?B^2
M4P#<S"4R@'G&-Q/X?G79T4 <M?>";?5=3U>YU"Y,T&JV264T"Q[=JH6*LK9)
M# L3^5.TKPG=VMG+:ZMXAO=6B,#6\(F1$\M&&"25&7?'&YO?U-=/10!E>'-&
M?0-"M=+:^EO%MHUBCDD15(10%484=@!SU-8]UX($T?B2&+59XK;70QFA\I6$
M;-&(V93UR548!X'O733WEO;3VT,TJI)<R&.%3U=@K,0/^ JQ_"IZ .:_X11F
MU70[Z6^#G2;:2V6/R,"57"JQ;GKA%Z>]5M \$3:!*EM#K]]-HD$GF6VFR(F(
MCG(4R8WLH/(7/89S7744 8GB3P\?$$%CY=]+97%C=I=P2H@<;U!&&4\$88UQ
M'C?PT=$\%^))%U2ZN9-5O+:?RW1-PD$D09EVKSPF>F !TKU*B@#E[S2D"7.O
MZA?1W4\>GR06[HFR-$<98@9.68A><]@ !SG&\#:$^I>"?"AU"\\Z#3XHITMA
M%L99E7 $ASSL).!@<@9SBNFTCQ VIZ_KFE/9F!M+>)-_F;O-$B;P<8XXQZUM
MT <L?!S-!XFB.I'&O[O./DC]UF,1G;S_ '0.O?GVJ"[\#2.VCW>GZU/I^JZ9
M:_8Q=Q0JPFAX^1T;(/0'V.3].PHH Y>?P>[:EI>HV^M7D-Y91RQ23,B2&=92
M&<D$85LJ""!@=,8P*J6OP^6RT;3+&#6+DRZ7?/>VDLD2,%+%\JR@#<,2-W!]
MQTKIH[NY%W?B[M4MK*WVF&Y,X/FKMRY*X^3:>.3SUJQ;7$5W:PW,#;X9D61&
MQC*D9!_*@#G[KPBEYIFN0S7A-[K4/D75T(P,1[2H5%SP "V,D\L2<U5O_!$T
MTVEW^GZY<:=JUA;"S^UPPJRSP_W7C;(/(R/0D_AT&M:BVD:+>:DL'GBTA>=X
M]^TLJ@L<''7 IN@ZHVMZ%9:J;?R$O(4GCC+[B$90PSQUP: )]/L_L%E';F>6
MX=<EYI2-\C$Y+'  Y)Z  #H !6)%X3+W^E76H7_VMM*D>2U<PA9<LI7:SYY4
M!N@ S@9SBNEHH XK_A7OEZ7%8V^MW<2VNI_VC9'RD(@<N[%2,?."9&Z^WIRV
M[^'GVNQU^T?7+IDUJ2.6<M$A*LH4$C ')V#V SQWKMZ* .<N_"BZAX@;5+VZ
M65)--?39K8185XG(+'.[()(_+\ZRX/A_<16NC6<GB2\EM-'NEGLU,$>\*JLJ
MHS8.[ ;&<#CMT([>B@#AS\.CY"VR:_>);0ZK_:EM&(HR8I-Y<@DC+#+'&>F>
M<ULZ;X9%CJFMWDUW]I35V5IH6B "[4$8 .>A4<Y[^E;]5+V>\ADM!:60N4DF
M"3L9@GDQX.7P1\W( P/6@#D(OAU+#INGZ4OB*\_L[3;V.[LXC#&7C",65"Y!
MW 9XR.GK73Z_H5GXDT*YTF_W^1.H!=#AT8$%64]B" ?PJY%>6\UW/:QRJTUN
M%\U!_!N&1GWP,_EZUEWOB![/Q=I>A&S++J$,\JW'F?=\H+D;<?[8YS0 VU\/
MS?VE:ZEJ5^+V]LX'@MG\@1JF_&YRH)RQV@$Y QG &33O#7A]_#T%Y#]M-RMU
M=RW;%H@I5Y&W,!@],GC^=;=% '+ZMX0EN_$:Z]I6M7.DWSPBWN3%$DBSQ@Y7
M*N" PR<-4DWA)$U>QU?3;U[;4+:V-H\DJ>:MQ$3N(D&02=WS9!')/7-=)10!
MR=QX'ADM+*&&^>.2#5!JTTS1AFGN,D_-R %YQ@=@!GBFW_@.UU:;Q";^[>2'
M6XX4ECC3883%_JV1LGD'GG/('TKK6)"D@9(' ]:QO"^OMXDTE[YK3[*R7,UN
M8O,W\QN4)S@=<4 9]IX1O5US2M7U#Q!<7EQI\,L"XMXXQ(K[<[N#S\HR1^&.
M]"+X<M%8V.GKK]V+'3]0%]9Q+#&#'AV?:6(.[ECR>W;N.R2\MY;V:S256N($
M1Y$'50V[;GZ[6_*LO5/$#Z;XDT/2?L9D35'E3S_,QY92-G^[CG.W';K0!F)X
M'>VUJ_N;#7+RTT[493/>Z>B(5DD(PQ5R-R;L<XY]".,:=MX=%IXLOM<AOIE6
M^CB6>UVKM9HU*JV<9'!Z>H'TK;HH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y'QYJ,UC'H
M, =XK.]U:"VO)%8KB-MQVDCH&8*I/H2.]==4%[96NHV<EI>V\5Q;2C#Q2H&5
MA[@T ><ZY%/IFN>*=,L)9X=+?PX]\8X9606UP"ZJ4P1LW!22!@':?>NA\&V-
MAI/AS3M2DNI1<:C9VHFDN;IF$C^6-NT,< G.,*!GBMM-"TI+*>S%A";>X&)D
M9=WFC&,-GEN..>W%4]6\*:7JFA0Z,;.V2RB=3&GE9$. 1F,?PL 2 >V: -J6
M-98GC8L%8$$JQ4_@1R/J*\?L#/<_#[X?.]]>B2;65AED6Y<-(I:;(8YY/RCD
M\CL17L,B++&T;C*L,$>HK*7PMH*6MM:KI%FMO:R>;;Q"(!8G_O*/X3[B@#!\
M'1"P\7>+]*@>7[%;3VTD,4DK/Y9DA!?!8D\D9J'Q+8V<OQ4\*2SQJ2UI?;F+
M$?=$9'Y9)KK[;2=/L[ZXO;:SABNKG'GS(@#2XZ;CWQ[T7NDZ=J4UM-?6-O<R
M6K^9 \L88QMZKGI_]:@#R/5+58_"GC[5XYKB.]L-=EEMGCG9!&X$/( ."3TY
MSQ70ZD3XC\6^(]"O-2M[-K>WA-F)4;>B-'DS1$2+A@Y(+<D;0,XKL6\+Z$UM
M<VS:39F"ZD\VXC,0*S/_ 'F'\1]S3=1\*Z!J[VSZCH]E=M:@"$S0AB@]!GM[
M=* +&C>8N@66Z].H2+;I_I1789SM^_CMNZ_C7$>$7L/$'AS0M?N]3G@UA;O-
MRT<F'DF+,K6[J<_)R,+Q@ $8ZUZ.    , =JRH/#.AVNLRZQ!I-G%J4N=]TD
M*ASGJ<^I[GO0!YS)?(;KP_JVGW,C177B1X#>SS8GN$)E5XRHX$2[0 ">P.!6
MD;FYTSQ9#)J=J+W3[S5F2SU>TE^>)RS(+>9#R4!RH(R. <9KKSX0\-EY'.A:
M<6EG%PY-NOS2 Y#'CKDG\ZLQ:#I4-X;N*P@28RM.6"\>8<Y?'3<<GYNO- 'G
M>D"3Q)IL6KS>((+#5+/5'^T%86,Z,LK*+=OWG*E<*%V\Y'&>:Z_XA:G?:/X!
MUF_TW<+N&#*.@R4!(#./=5)/X5H?\(QH7]N?VW_9%E_:G_/UY*^9G&,Y]<<9
MZUJNBR(R.H9&&&4C((]* .$O8$TSQ=X3DT)V^S:D)HKN-9"R7$(BWK*V3RP.
M/GZG=@GFE^'>GVEO?>*Y88@KIKD\2G<3A=D1Q75Z?H6E:4<V%A!;G;L'EKC:
MN<[5_NKGL.*=8:-INER326%E!;/.Y>4Q(%\QCU9L=3[F@#F_&<>J'4;*YTZS
MM]6BMX)3<:3++Y;R*2N)8STWK@@9_O'!!-9&BWUK>>+?"<UC)<"PN] F^2X8
M[I-AB WC.&8#.3SWKN[W1]/U&>.>[M(Y)HU*)*>&53U (YP<#([XJ*]\.:+J
M,5I%>:59SQV?_'LCP@B+C&%'88 &.G% 'F>DZWY.EZ#;7=XPTB\\0WUM<3-*
M2"JM*88RV?NE@HQT(&.A-:7C#3;+3O"M[:6-_/+&^MV4AB+AEM"TT?[N/CY1
M_%M[;O>NW;PQH3Z=<:>VD61M+ES)/"85VR.3DLW')SSGK0/#&A#2X=+&D68L
M(6WQV_DC8K9SNQZYYSUH Y_08%TOXF:YIMK),+.33[:Z,4DSR 2EY%9AN).2
M%&?7%6_%$EO/XAT+3G+SW$PGD2R=PMO*JJ 6EX.=NX8 !Y.>V1O1:1IT&HOJ
M$5E"EZZ"-IPOSLHZ*3U(]J;J6B:7K#6[:EI]M=M;L7A,\0?83UQGUH Y[X87
M4MUX%M#/<F>2.>YC#LY8[%GD5>22<   >PK&\1W%UI/B*[U*^M!J.B?;+;-U
M:RXN=,<>7\A4_>C8X8A3_&<@UWUAI=AI4<D>GV<%JDLC2R+#&%#.>K''4U"^
M@Z5)>R7CV$!N)'621]OWV7&UF'1B,#!/3 Q0!YYJ4WD:=\4XS.T:VJA[<>81
MY+&U5@4Y^7+G(QWK3#R-XR\#G[1.5N=*N3*AF8JY$<6#MSC/S'GKS75WGAC0
MM0OI;V\TFTGNIHC!)*\0+,A!&"?H2/H<5*F@:1'<6EQ'IEJDMFNRV=(@#"IZ
MA,?='L* .6^&%G:6FE:KY$:H_P#:]['@'^%9F &/;BH];TNUUCXL6=G>>:;=
MM!G+I',T>_\ ?Q\$J0<>V>U=E9Z3IVGW-U<V=C;V\]V_F7$D485I6]6(ZFF7
M^BZ;J<L,U[90S30Y\N5E^= >H##D ]QWH \I2.\&D:592:C?O:V_C Z?:S?:
M7#2VHW?*6!^;# J#U&W@BNDL;&TC\>3>%)TE;2[72EGLK>>9Y Y>5O,?+$EB
MIV@9/RCIC-=A<:#I%W!:P3Z;:R16C!K>,Q#;"1T*C^$CL13[_1].U-X7O;.*
M:2 DQ2,/F3/!PPY&>_K0!YA87>H!/#0N;J>1;?Q3<:?#<O(=T]LJS! [?Q<K
MCGKMJS?75ZMI\2TTO4!!);SP^0WG;1'F&,NJG^$D[@,8^8^M>B7F@Z3J&F)I
MMWIUM+8QE2D#1C8A7IM';'M6-KWA&WET:[AT/3=*AN;IHA.LT 5+B)"O[IBH
M) *KM!P<=A0!1TO2I9?&4NJVD5U9Z,FFJGV4S-&C7))RWE!MIPF 21@G!&<9
MKD/#=LNG>%OAKJEM-<+=7-XEI*WG,5:)HI24VYVXRJGIU&>O-=9H7@BUM]1C
MO7\-Z5HOEAU=+"X:0SAE*E7^1!MYSC!Y Z8YZ1?#&AI;VL"Z3:+#:/YEM&(@
M%A;^\@_A/N* .:^'=C9VNH^+&AC5)1KD\8^8YV[(C_,YS1XML(=3^(OA.TN3
M+Y,EM?AQ'*T98;8N-RD''T//TKK[?2=.M=0N=0M[&WBO+G'GSI& \F.FX]3T
M'Y4FH:1I^J^2;ZSBG:%MT3NOS1GN5;JOX4 >:0Z!J%WH'BG2M.N;F5='U+?H
M[RS,Q)5$=H"V<LFXE,'/7VKK/"FHP>*KAO$UNCI:M;QV]NC9&&QNE./4,P3V
M,;>M:>HP:I86%M;^&;/35Q)M=+EFC1$.<E0@.3G!QWYJYI.G1Z3I5O8QMN$2
MX9\8WL>68CU+$G\: .1\86-G<_$/P6]S&K;GO%8EB.! 6_GS7,:S8QS6'Q-U
M#S;A+BRN?/MGBG=/+D6VC8, I&3D#KG]37JVH:3IVJB :A8V]UY$@EB\Z,/L
M;U&>AJLWAK1'2\1M+M"EZ<W2F,8G/J_][\: .+N+A_$7BF]T34;^VM\Z5;S6
MJ3QL=V\/YDL>'7# [1GDC QCG/:^'(WA\.V,4FI-J;1Q!/MK+M,^.-W4YSZY
M.>O>H]0\)^']6AM8=0T:RNH[48@66$-Y8]!GM[=*UT18T5$4*JC 4#  ]* /
M']9::/P+\2]MY>!K;4G,+_:9-R#RH3C=G..3QTK:U R^&_'-U)IC7$KR^'+J
M[>&29Y!-/&Z;&P2>?F(XQP<5V+^&-"D@NX'TFT:*\?S+E#$")F]7'\1^M3KH
MFF)?17RV, NX8_*CFV?.B?W0>H'M0!YG+%97>@_#C6DF,]Y=:I:M/<F3+3.T
M4A?=ZD," /X>@P.*FMA)XFL]3O)_$$&F:IIVK2AY!"S3VP24A(Q^\ *,@4;=
MN&W'J>:[A/!?AA)?,70=.#>=Y_\ Q[K@2<_,!C //]:GE\,:%/K::U+I%D^I
MIC;=-"ID!'0Y]1Z]: //]2TZ.[N?B6)[B]86*1S6H^UR#R7^R"3<OS=FY Z#
MM5JSB:W\1^ [U;FZ:XU>SF%^[W#GS_\ 1PXR,X&&Y& ,5W+>'='9KUFTVV)O
MAB[/EC]^/]O^]Z<T?\([HP:S8:;;;K)2MJ?+&8 >,)_=XXXH \J2!H/!7]LK
M>7K7]GXD,4,KW4C;4^V^65()P05)!SDG\!72WD(G\:>,K29Y9;9]#A<PR2LR
M@DS9P"> <#@<5UG_  BV@_8S9_V19_93+YQA\H;#)G.['3.><U9BT;38;^2_
MCL8%NY4$<DX0;W4=%)ZD>U 'F.E74-CX<^'NF?:+>UL=2L]UPTX+QR3"%-B.
M-R_>R^ 3@E1Q5J[,GAO^S=)E\013Z9=ZS)'+)+$WE6P:(O';$^9DINQP6] >
M.*[IO"?AY]';2#HMA_9S/O-L(%";O[V,=?>I3X<T5M$&BG2K,Z6!@6GDKY?7
M/W>F<\Y]>: ,GPU:0^'FU.&;78;BW>Y5XX<;([1G'^J4L[=3@A<\9Z<BN@U'
M_D&7?_7%_P#T$UCW_@O1+OPV- ATVS@T_?N$:PC$9YRRCL_)PWX\UT! (P1D
M=,&@#QO2=+.G>#O &MZ9<WBZK--9V[K]H=DGA<?.A0G:%"@MP.-N?>M"Q$GB
M6PN=0F\00:=JMAJLHE<0LT\&R9@L/^L *,FT;=N#GH3DUZ'8^'](TR82V.G6
MUNXW;?+C "9Z[1T7/?&,U&_AC0I-<76GTBR;4UZ71A7S,XQG/KCC/6@"/Q=>
M6^G^$-6NKJ\N+.%+9]UQ;#]['D8!3_:R>/Z5S'AQI++XE3Z>%CM;>31(9C:Q
M3;UW^:RAVZ#>5ZD#GU/6N\NK6"]M9;6ZACGMY5*212*&5U/4$'J*S[+PUH>F
MW$%Q9:196\T$9BBDCA561#R0#C- &)XQU%H?$/A72IY#%INHWDB7+;MH<K&6
MCB)]&;''?&.A-<?J%R/#-]\0)-.<VT*76F"5TR?(B<*)" "" %+=",=L8KU3
M4]*T_6;)K/4K.&[MF()CF0,,CH?8^]5[7PUH=C]H-MI%E$;E/+G*P+F5,8VM
MQR,=C0!S^E:';1ZU=2IK-M<65]8ACIUK&RQ$JPQ,#YC8)!QQC=UYP:X[0KI-
M(^&W@51-%9V>I3I%?7$H9D/R2%%?##"EPH/('8\$@^GZ;X8T+1[.XM--TFTM
M(+@YF2&(*)/KCK3AX<T4:.^D#2K3^S7&#:>4/*ZY^[T'//UH \\\3:7)HWA3
M6EM]?DE!U"REB@M2\26>^9%9%^=LJPR=AX&<XY%:$]H=-\8^)-,L-2GL(;GP
M^MR9I9WD$,Y>1/.RQ)!  SCTKKT\*Z!%I":2FCV0T]'\P6WDC9NSG=CN<]ZF
ME\/:/-<37$NFVTDTT!MY7>,$O$1@H2>J^W2@#S6ZUR_T'1_$,-QI3:3K=O8P
M.[VDADMI8/-*-/%C!5@&8D'#<#DXKJ]!TR&W\21ZC9Z];2VUY9?\>-I$PCEP
MP(GR9&^;G!/?//-=':Z-IUFDJP6<2B5!&^1NW(,X4Y_A&3@=!DU#H_AS1?#X
MF&D:7:6/G',GD1!-WIG';VH YCQE8VESX_\ !+7,:L&FNT8EB/E%NQQ^8S5"
M)AX@LO',FHS20W^G7DT5K(LA1K2)(E:)TP?ESRQ/\7.<@8KOM0TG3M66%=1L
M;>[6&02Q":,/L<=QGH:ANM TB]O#>7.G6\MPRA'D9!EU'(#?W@.P.<4 5_#-
M[>WW@O2KW4OW5[-8QRSG;C#E 2<=O7%<7X>:XM-3M]'US3U:\GTV86VIVDI>
M#4D&QC(XZB7A3DY^\<'I7IK*&4JP!4C!'M5"PT/2]+96L;&& HGEIL7 C3J5
M4?PC@<# X% 'FNF7TC^%_A?.UV[75Q=QI(YE.Z5?)DW!N?F&X+U[XK1TA[+Q
M'I^J7FJ:E/9ZM8:S*KR12[9;<1RXCB4'/RL@4;0/F+'J3771>#O#<!!BT+3U
MQ/\ :!B!<"3G#=.HW-CTR:F?PSH<NMKK3Z39MJ:XQ=&%?,&. <^N.,]: //-
M8TZ"]U3XG3RO.LEK;030F*9H]DBVFY6^4C)! QG/ZFO1=!N9;OPQIEU/(6EE
MLXI'<]V* D_G0WAW1G>]=M,MBU\-MT3&/WX]'_O>G-7;:TM[*TCM+:%(K>-=
MB1(,*J^@'84 ><>&GGM=9L=*UVQ66XNK&86NJVLI>'4D^1B\BGD28 .3GJ<&
ML[2[Z1_!7PSG>[D-U-J44<CF4[Y$VR[E8YRPR%SGOBO3K#0M*TMD:QL(8"B&
M./8N!&IY*J/X0<#(&,X%5$\'>&XV+)H6G@F<7)_<+_K!G#=.HW-^9H XC5(1
M,/BK:S/+-#'9QO&DLK.$/V4OQD\#=SCI7:>%/L5GX6T:&-XHS+:Q%4+\LQC#
M'&3R<<X]*OQZ+I<-Q>7$=A;K->C;=/Y8S,,8P_\ >XXYJ*#PYHMJEDD&E6D2
MV+L]J$B $+$8)7T)% $/C#_D2=?_ .P=<?\ HMJX.U@^T6WPJ@-Q=1Q3V1CE
M2&X= ZBSSR >OOU]Z]/O+*UU&TDM;R".>WD&'BD&58>A'<52C\-:)$;,QZ7:
MK]BS]EQ&!Y&>#L_N_A0!@_#X&#_A)=/621K:RUJ6&W21R_EQ^7&VT$DG&6;\
MZY[Q[<QRQ>,I;2>5[O3;&(M)+-L%B^UG3R .=[9!)R.PR>0/1['2=/TV2>2R
MLX;=[A_,F:- #(W]YO4^]5KSPSH>H7LMY>:193W,L1ADEDA5F9",;22/0D?2
M@#D9;6/6/B586]U<7,EM<>'9))H4N75'831#H#@=><8SCFLFRM+Z^^%%CJ=M
M)/<ZAHEY/-$C2L3<10W#@POS\P,:X&<\@5Z-%X>T:"XBN(=,M8YH8?(CD2,*
M4C_N CHOM5"\TO4-*MH++PG9:5:6\KO]H:3<GE9'WT11ACG)(.,^O.: &^%[
MF#7I[KQ-;EC;7BI%:$Y&8D'+8[$N6&>X1:Y[QR;VTU"_U%K1=5T>.Q5+N&&;
MR[K3\;R9XL\'(/."#\@["N\T^Q@TS3;:PMEVP6T2Q1C_ &5&!5>[T'2KZZ>Y
MN;"&69T$<CLO,B#HK?WEY/!R.: .3M[B";Q_KP,I%C/H=O=!'8JO+2Y?!Z'
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M,^GW+N[XZJ!L0!3T.<\9&.XZC_A%M!^QFS_LBS^RF7SC#Y0V>9G.['3.><T
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M@>P% &A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFER7/AG5[75=.C999=0\WR[8E-K")G8AMQP/E[<G&!77>(6N$\-ZFUK8I?W
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M%%% !1110 4444 %%%% !1110 4R26.%0TLB(&8*"S 9). /J33ZXCXFHO\
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MVY9]F3T !V^G05IV?CV#4-&T6ZAMECNM5ADE6&:0A8A&0KY95).&( P.<]J
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MSIOB.\G\5W.@ZCIL=I*MHM[ \=QYH>,N4(;Y1M8$#@9'/6@#HJ*** "BBB@
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M^"KG7-7UZ6\FABL]5TV.R'E.QDB9&9@_( /+=,]O>NS>1(U#.ZJ"0H+'').
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M[=1H=-NG\M'&T%7B[8[YY[]*Z;0+2[LM%@M[ZXFGF4M\\[AY I8E59APS!2
M3W([]:9J'AZPU/5;'4IQ,MU9!UB>*9DRK8W*V#\RG:.#Z4 >9&XU+2?#?BK7
M+#5)[=[+Q+,5MT5/+E#3HK!\@DY#'H1BMGQOKFIZ?;^);S3]3G>;3889(8[=
M5$=H<!F$Q;AR^?NC) QP,Y/22>!M(ETG4-+D:[:TU"Z-W<KYYR\I8,3GJ,L
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M?@-#4]-L]8TVXT[4+=+BTN$*2Q-T8?T^O:@#E[NYU'1_'.D:1'J%U/8ZQ;7
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ J.>>&VA::XE2*)>6>1@JCZDU)7)>/=0LM.M-&>^2,*VJ0B*XG
M<K#;2 ,1))@C(&. 2 21R.M '3P7EM=6WVFWN(98.3YL;AEXZ\CBN9M_%HG\
M=3Z6MYI\FE)I@O!/&^2K^;L*LV[;COT'6O/)-2\G1O$@2<W-G'XJAN=2$<?W
MK(B$NVT?P,1^(W=1DUU5G?:)JOQ?E:SN+*ZAN_#PC9HF5UE_?'*DC@G;V]*
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MP)'F.%R ,D\^@!)KB+>[M8/B#XLM?$;P1P75M;FS-T0$DM@A$BJ3QPY8L/\
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M0MG$D3AU./<<5-7G?A/6-&T*3QK-/=V]KI]OK1/RGY4WQQ+P!T!<D?7->B4
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MC12J1JJDY( QDT^B@   & ,"D*J3D@9QCI2T4 )L7^Z/RI-BD$;1@]>*=10
MU(TC0)&BHHZ*HP!2[0#G SZTM% ";5)R5&?I0% Z "EHH 38N -HXZ<=*3RT
M\SS-B[\8W8YQZ9IU% "!0#D 9]:1(TCW;$5=QR<#&3ZTZB@!KQI)C>BM@Y&1
MG!IU%% #7CCDV[T5MIRNX9P?6E*@G) )^E+10 4U8XT9F1%5F.6(&"?K3J*
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M&G%03D@&EHH :8T((**0>H(IU%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !3)IHK>)I9I$CC499W8*
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M4N[6XM[2&/Q%-NM6<M/"7$X8S.3D%FZ+@=<?-C- 'L3W]G&X1[N!6,GE -(
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M\[B.^!Z5:\)3^%]=U'P_J&G:M<S:G96SQ?8T$:&!"F'6950':&  R?O8QG-
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M#+0K("ZCW7K4L8C6)1$%$>/E"=,>V*\8LM:TJ:Y\%W=I<6]K;IK%P/LI<O-
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M"Q0L2"" %.0<\9)K1TS2=$OOBIK=O>6EM<2+IUC)Y=PJ._F R99AT+C"Y/\
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M,%QJ$\MLMT(K<*&6)ONLV]E SS@$Y.#QP: -:.&*'=Y42)O.YMJ@9/J::MM
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M2ISP=U '4O%'(1O16QZC-"Q1HVY8T4^H&*I:5JHU:*>1;*]M1#,8@+N$QF3
M!WJ#U4YZ_7TJCJ_BRRT>XO('M[NY>RM/MMU]G53Y,)+88[F&?N,<#)^7ITR
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MK(M-$UK2=:U:P/A>QU.TOKV6[MM3D>+$(E8LRRJWSG:Q.-N<C XKT>B@! ,
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MZM-,U*8W%YIZQ(P:1OOE)#RF['..?0CC !AKK1T[XG^*-/M'A75-1^Q1V8N
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M7BLX6E*+U8CHOXG _&N/U)=6/Q!\"R:C-:/YGVQBD,3+Y;_9SD ECN'Y=/?
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MFXAM#>S1VZJ3'""1N.XC/(/ R>#Q0!MT5REUXR UWP]96%C/=6NKP/=)<)M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ-++.!)%O:>256#LQ!&,[V/ ZGTXK0T'0)-%O=8N'O%G_M*[-VRB'9Y;%57
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MT[5K6ZCO8#.[KB-%*R@DY#9;:6!YW#/-<;I]I$GPA\)B)Y$>;6;3<PD+%?\
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ML-)DD%[(H: S*IAC+E6<D\' &<#D]JZ*O'M*DFA^$_@26"XGA;^U;2-O*E9
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M!:Z!?&+>"=4O4VM*S *L[@8!.!]>_>@#N:P-<\56^D:=:WT,#7L,]\ED6C<
M(S2^42<]<-D<#M6Y+&LT3Q/G:ZE3AB#@^XY%>+V=I%%\&-#\IY$>76+<$^86
MVXO2 0#D#\OK0![717E>K7]YX4O_ !O'IES=M%!I=M>1K-,\YAD9I%=UWDGH
M V.GRUT>BZ9);^(+35+;7XI;&\M"OV.(R2+<8PPF!:1L$#@MWR,\XH [&BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?/6 JP8Q_P![IT[9]>.M)_;VF?95N1= QO*T* (Q9Y%R&55QN8C#9 '8^AH
M=>:+INH7UK>W=E#-=6F?(E9?FCSC.#^ /U -%AHFFZ7#<0V=HD45R[23("2)
M&;[S$'J3W/?O4!\3:*-.74#J$/V0R^09><+)G;L;^ZV3C!P<\58;4;6XO;C2
MH+Q8]0CA\PIM^9%/ ?!X(S^'% %"S\%^&[![9[;1[5&M7+P';DQD\<9Z>WIV
MQ5JR\/:5ITL<EK:",Q;O*!=F6+=][8I)"Y[X S6+X,\1O=_#W2-8UN[4W%RG
MSR; #(Y8@*JJ.2>P S2>$M>N=8\1^*;=[PW-I97,,=MF(1F,-$&92, Y#$CG
MGB@"QJ?@70K[2)]-BTVUABN)_/D94(*OS\ZX_B&XX[ DG!Z'IJXR_P#$SZ/\
M1);/4=22+2/[(^U"-D'$OF[>"!N;@'CZUT!\0:5]AM+Q+V.6"]&;8P@R&;C/
MR*H);@$G XQ0!/J6E6.KPI%?VR3+&XDC)R&C<=&5ARI]P0:K3^&]'NM,;39[
M&.2S=_,DB<DB1\YW-SECD Y.>0*:?%&B"TL;K^T8C!?2>5;2+DB5\XV# ^]D
M$8Z\'TJY)JEE#<SV\MPL<EO")Y=^5"1G.&)/ '![]CZ&@"S&BQQJBYVJ,#))
M/YFFSP0W5O);W$22PRJ4>-U#*RG@@@]15.PUO3M3N9[:UN0UQ  TD+JR.JGH
MVU@#@]CT-4]4\56&E>(-,T:;S#<7PD<$(Q554=<@<G) Q[Y^H!;T[0]-TD@V
M5J(V"")6+,Y5!T12Q.U?]D<55'@_P\MO]G32K=(1/]I"("H$N<AN#U!)(],G
M%8&A>,X;6ZUVW\1:S"K0:R]I:F153$>R/:#M' RQ^8]SUKJM2US3=(4F^NA$
M%3S'PK-L3^^V =J_[1P/>@!$T+3$O;J\%HAN+J,17#N2WFH. K9/(Y/!]:IZ
M;X,\.:/;W4&G:1;VL=V-LXB!!=?[N<Y Y/ XK8%S ;470GC-N4\P2[AL*XSN
MSTQCG-8MOXW\,75Y:6D&N6<D]WG[.JR?ZPY(P#TR<<#OVH UM/T^TTJQBLK&
M$06T0VQQ*3A!Z#/0>U6:S+[Q#I.FRO'>7L<1C*B5B"5BW?=WL!A,]MQ&:>^N
M::FI2:<;H?;(X?M#0A6+"/\ OX Y&>,^O% %33_!_AW2M2GU'3](M;:\G!#R
MQ+M//7']W/MBE'A+0A8)8C3HQ:)-YZP[FVB3.=X&>N><^O-3V_B+2;K3[>_M
M[Q);2YD$4,R*Q61B<  XYYX^M$OB'28+^.REO8TFDE\A-P.TR?\ //?C;O\
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M5M2@:YBE1&*>7@8.<<YW#Z#DXXSMW=Y;V,'G7,@1-P4<$EF)P  .22> !R:
M*UUH>F7OV,3V<;"R8/; 940L!@%0.A XIO\ 8&EBZOKD6H$]\H2Z<.P,P P
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M5CB4@%F]2< #U))  [DUEMXLT)-/N+^348X[:UD\JX:164P/Z.",IU'4#J*
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M:O;7<"30/C=&XR#@@CCZ@4?8[87QOO)3[48A"9<?-L!SMSZ9.:S+;4[4Z[K
M.NPS1VD41FM,(!9\,2S/U^;&<'IM]Z4:]8ZG;W4&FWX6[2W\]0T9#!#G;(%8
M#<I(ZC(H <_A?17COHWL49+\YNU+-B<]/GYYXXY[5%J?@WP[K,5I%J6DV]TM
MH-L!D!)1?0'.<>W2L7P3XYT[5M$T.UU#6+:37;NT25XB0K.Y&2  ,9QSM'..
MU7+W57.G^*I].\0)<3V<1>.)(D863K%G:3CYLD9YZ9Q0!LW.@Z3>2V,MQI]N
M[V/_ !ZDH/W/ &%]!P./8>E5F\)Z$]C<V3:=&UK<S>?/$68K+)G.YAGDYP<^
MH'I6;INLM=:9X0>[UU+:^OK>.:2W,:%KTF'+#&/E /S9&.F*EM?'>BW$FL&6
M=K>#2Y_)EFEC95X526SC@9?'/IGI0!<U3P?X>UJ[M[K4](MKNXMU"QRS+N;:
M.Q/\0]CFK@T73QJ_]K"V47_E^3Y^X[O+Z[>OW<\XZ9YIQU:Q LB9_P#C^.+;
MY3^\.-W''H"?H">U2WE];:?");J98T+!%SR68]%4#DD^@YH L50U#1M/U22"
M6\M@\UN289E8I)'D8.UU((SWP>:KOXIT.+2KC4Y=3MXK2W<QS/(VPQN/X&4\
MAO\ 9(S5C3=:TW6#<C3KR*Y^S2^3-Y9SL? ./R- $4_AS2+FVM+:6PB,%G()
M;>,941N.0PP?O<GGKR?6M0<#%<KH>K7LGB[Q997UXKV>GO;F#<JH(E>+>V2.
MO/<^E;%EKVEZA=_9;:[5IS'YJQLI4O'TWKD#<O\ M#(H EU+2;#6($@U"W6X
MB1Q(J,3@,#D'CN#TIB:'IL>HRZ@+53=S1"&65F+%T'13D\CKQ26^O:9=7(MX
M;H,[1M*A*L%=%(#,K$891D<@D<BELM:T_4+CR+6XWR&/SE4HR[H\X#KD#<IS
MP1P: &:=X>TG271K&R2(QJ4C&21$I.2J DA <#A<#@5+8:-INEW%U/8V4-O+
M=R&6=HUP9&/4G\>:=+JEE!J4&G2W"I=W"LT,3 @R!1EMOKCO5-_%6@QVIN9-
M4MTB%S]D)=MI$V0/+P>=V2..U &Q6)_PA_AX6[VZZ5;K"\_VAD0%09,Y#<=P
M22/0DXJSIOB'2-8>Z33]0@N&M2!.$;[F1D$^Q .#T.*YR]\5F?QWX7L-,U'=
M97PN#/%Y.!*JQ%D=7(Y7/=3C@4 =*FAZ:E_/?"T4W-Q&(9I&)8R(.BMD\CD\
M'UJOHGA30?#DDSZ/I5M9O/\ ZQHEP2.N/8>PXJ4^(M)74([%KZ-9Y7:.,$$*
M[K]Y%;&TL,'*@Y&.E06WB_P]>:C%I]MJ]K-=2R/$D<;[BSH,L!CT'\CZ4 ;5
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %<=\1M#OM6TG3;W2X?/OM'U&'48[?.#.(R<H">Y!X
M^E=C10!AVGBFSU"!?L=O>O=,/^/:6UDB9&]'++A<=R?PSQGG;)WT;Q'XOMM:
MM;B6'4I%N;61(&D6XC,00Q#:#\R[<;3USFN]W+OV;ANQG;GG%+0!Y7H.C7VC
MZM\/;+4;>>6:QTRZBN)!"SI"[B/8A< J. R]>U7;6YT^W\=>/H;RV>4316B>
M6D#.95^SX,8P#DG^[7H]8VF^'ETWQ!JVKB\FEDU,QF6)U4*OEKM7;@9Z=<DT
M <'X7TO5/!VK>')=9CF>T_L 6#RHID%K.)/,*MMS@%<+NZ90#TJM=:1=6NFI
M*UE=-;7GC&/48H%MG8QV^\;G90"5!P6P0/O>M>O44 <%XFGD_P"$IDM$TZZC
MCGTEQ'>6EF9'N'+G]P7"D1J.&.<9+=1CG%T?[3;6GPSNY=.U 1V5I-:W ^R2
M%HY# J@%<9 +*1D@#OG'->K*RN,JP89(R#GD<&EH \GUO2]4U5/B1;Z;:W'G
MW4UI);AXF1;E8XX_,56( ;.QEX]:WKEAXC\7^%M8L(;F*+3H[F6\>6!XS&KQ
MA1$00,MNP=O.-N?3/=44 >/65M<1?#KPO =.O5N(/$<=Q+%]CD#H@NG<N1MR
M!L(.?0UZMJ>GV^L:3=Z==+NM[N%H9!_LL,'^=6Z* /(XK/Q9%8Z)KYM'?5])
ME_L@P'I<0DF)ICWP7\M_HF>]=#JMC/H'BGPK?".>?2+.VGLYY$0N87<+ME8#
M)^8J06[9YZUW=&: /)M=T:^FT;QMJ=I:7#6E]J%E<VUNL3;Y%A:(RR*F,\[6
M[9.W/<5N6&H+>?%"XU..TOQ82:%&B7$EG*JL1,[$<KD''0$ GMGC/>T4 >.:
M(FH:/X=^'NI7.GWWV+2VN(]0A%LYD@:12J2&/&X@9.2!P&KK?!\IF\:^,;E;
M6[BM[F>UDADFMGB60"W1206 YSVZUVU% '%R I\7_M3V\_D)H1B\_P AR@?S
MMVT-C&=O.,URWAV:YTWP]X.MKC2KZW"R7J2W:Z>\D]H2[%45=I*[P?O8(P,=
M\CUVD) !). .I- 'E^AZ!=:O\++_ $@6]U9ZG;7US/:-<QE&2=;AY(F!/7^'
M)&1R>>M7M4M=:UOX;WFJ+I\J:O?&WNS8[BKB.-T;R0>H)56..N7(KT)6#*&4
M@@C(([TM '&^%I='UC63K-AI.JPW2VOV>6ZU(3JR#<&\H"0G=SDDC(&.O-'B
M<2V_CWPEJ'V6YEMHEO(9'@A:38[I'L!V@X!VGD\<<D5V5% 'D&J6MQ-X)^(\
M,>GWC7%YJ4CVR"TDW3*4B"E1M^895N1Z5IZE<1:?XRU&36=/UBYTK5[2 6LU
MDD[*"JE6AD2,Y!.<C([FO3** *&B6D-AHEE:V]F;.&*)5CMF<L8E[*3D\@>Y
M^IKR;1K2/7OA#HNBV,#G4SJ"21L(6'DE;HLTI;& -@89SR3CKQ7LTBLT;*C[
M&(P&QG'O65X9T"/PQH,&D07,UQ# 6V/,%W89BQ!P .I/:@#BX$GL+'QQHFJV
M5S-<:A=7-Q:;(&=;N.6,*BJP&,KC:0>F >G-2W>B:UH.G>#]0LHC>:OI]NFF
M7:@Y#I(@7+'^ZLJHV?3)KT:FLZH5#, 6.%R>I]!0!P7A#0=0T?7+K1)UDDTC
M3)VO+&X?_EH9E^[_ ,!8SY_WUK'T2"V:-O#.OZ'K%SJMO?R2Q'=/]EFS*TB3
MAP=B@;LG/.0>">*]7HH XSP;%M\2^+Y)+6:/SM366*26W9!(@A1<JQ R,AAQ
M_6G^/DE!\,W:6]Q-%9ZW#-/Y$+2LB>7*N[:H)(RR]!WKL** . T^9])\2^*X
M]9L[IX-4:.YM7%NT@FC\H(8?E!^92,;>^<BMSP'I5[H?@31M-U$G[7;VP60$
MYV=PN?\ 9! _"NCHH \>O[>XF\ ^+[8:?>O+<>(S-%%]CD+2QFXB;<!MY7:K
M'/3BM7Q-9:AJ?BW7H]*AN%ENO"YMH)_)94:7S'(3>1@-AAWXS7IE% 'EJZHN
MIW7@%H-+U*%["X*7<36$J_9C]G=,$[<8W8Y'&,&HM!@MFA3PUK^AZQ<:O:7S
M2QDM/]EE/FEUG#@[%'.3WSG@DXKU>B@#RB]MYI/#7Q-B6PNVEO;B4VR_9),S
M@P(JE/E^8;@>E;$A(\:>#+A+6Y$$&F723.+9PL998MJL=O!^5N#Z5W]% 'CU
ME;3Q?#GPS =.O5N(?$27$L7V.0.B"Z=RY&W(&P@Y]*ZW17,'Q%\7W4L%REO)
M!9^7*;=]LFQ'#;3CYB,CI7:44 ><^%= .N?!BUT*[BN+.[$#!?.B:-X)A(61
M\$ \,%-;G@>74-4TO^W=7@$-_>(D1C!R%2,%>,=F<R./9AZ5K:WH[ZS#!$FJ
M7^GB.3>QLI AD&""K$@\<]L&M"WMXK2VBMH(Q'#$@CC1>BJ!@ ?A0!PGC6VF
M_MI[[2[Z\T_5X+ >6WV9I[:^3<Y\AUP06R.,'=\_ -,BN;K3_'^FZEJ6FW,/
MVSP_';;+:!Y52X$FYHLJ#MP&X)P..M>A44 >-:#)J&A:%X(U>XTO46LM/^V0
M7T*VKF6$RM\DNS&64 $9&>&K>\1B"\TW1+BPT2X@MY?$=O>.JV3!Y$!R\TB!
M<KD]V&< 'O7H]% ''>'UD'Q)\72M!.D,\=EY4KPLJ2%$<-M8C!QD#BJNJ75M
M9_&+39KH$+_8<X5_++!#YT?)(''&1GWQWKNZQI/#RR>+H?$/VR8316K6@@"K
ML*,P8YXSG*CG- 'FRZ3?Z#;VNM?V;J$FD?V]>7CV=H'2>&WF78D@12&&""Q4
M<@/TZU>UVTT^?PVMUI&BZBL-YK5G<RF:&>26X"2*7D9&RP4*,9.,XZ8P3ZI1
M0!PGC"V9]7BO=+O[W2M6@LRT%PELTMO<J6),,BX()R 1T;YCC.*JZ1/J.E^+
M[?5-<L)+6WU'1+:)?)B9X[29"2\)P#MSNR,]<8SD5Z+10!Y'%HUWI]EX=66R
MN?)?Q5-J$< MW;[+;-YNS< /D^\IP<8W>QKJ_"ZR+XZ\9R-;SQQ3W%L\+O"R
M)(%@56*DC!PP(XKL:* /-?&4MS<:EXFT]=-O(VGT79;S6EFSM?-MDRCR!2%5
M"1\N03N/)X%5)-371K[PEJWV?4$F&B/;3(]A-( H\K@JBET;<,Y(P0,=Q7JM
M8.I>&GN]9_M:RUG4--NVA6"7[/Y;I(BDD K(C $%FY&.M '$6-U8:=H'ANUT
ML7-[;0:A,+K4%TZ1IK*1U=R5A*EDW&3:"00%/?K6?/;W?_"N/%5B-.U,W#Z\
MTL:/:R,\B&Y1PPP/F^4$DBO6M/T]-/A=1-+/+(V^6>8@O(V ,G  '  P !QT
MJW0!Q$;#_A:NH7S6UQ]F.AQ1+.;9]I82R,RAL<G!4XKEM%TZ;_A#/":?:M4T
M+6K*RF6*[-HYC0[EW0S(RX(;"D XSMXKV"B@#S:UEU0:]X&U/4])F@D.G7-O
M-':V[LD,C>5L4@ [ 0I/S8 Z$\5TWC2TMKW1X(+E[^$&Z1H[JQ!,EJXR5DP
M> 1@Y&,'FNCHH \IO3KC^&[:YU2)KX:9XCMIVO;:T97NK9"N9C&HR2,X.!R%
MR..:AUFWU+7+KQZ=+T^]WWEI8/:^=;O&MP(BS.F6 P2#C:<'YNE>N44 <.^M
M6/B/2=2U&TT*]BNAIDL$D]S8O',A(X@7*[G^;DA<@$>]8^GPS1+\+A]BNT-G
M R7/^BN/()M2F'^7Y<OQS7J%% ''_$.*]73M+O[6TNKR+3]1CN;JWM&82O#L
M="4VD$D%PV >U5+230Y--UC4K+0=1FCU18K:4WD<Y>\;!0!E?+*B@X+XQC/7
M%=W10!YOX:ANO#FG:[X3OX9YFM[=I;;4O)?R[B(QX",YR-R !<9^Z%QT-9FD
M6D>O>"?AW::? _VNQGM+J5_)9!#&B9D)8C&&Z#^]N!Y&37J=_:F]L+BU$K1>
M=&8RZ@$J",'&>*K:#I":#H5EI,4\D\5G$L,;R !BJC S@ =!0!YSH\%L4E\,
M>(-#UBYU.'4))HCNG^RSYF:1)@X.Q0-V3GG(/!/%)J-M-+H7Q.C2PNVEO96^
MS 6DF9_W"*-GR_-\P/2O6** /+M>BN@9-2T6>^MM633H4>SGM'DMM30*<1%2
M.'R67@@C=SP:6[D6R\4Z[:^)=(UB>TUE8I+=K'SY(G'DK&\#",X!RIZ\$$G(
MKU"B@# TS5K*RO[+PPME<VD\=BDD:E&:)54;?+$IX9AC\A6;X^61Y/#'E03S
M>5KEO-)Y,+2;(U#Y9MH. ,CD^M=7]DA-X+LJ3,$**Q).U3@D =!G SZX'I4U
M 'F^H&YA\2>/KB+1IK\2Z5;I#!);OY=TR++N0'&&^\,@')SBH-'::X\=6]VD
M&IS07'AYK=9IK%X4602*=@4J @ Z9Z^I->GT4 >3:7IDFI^!/!VA165Q%JFG
M7=M+<>9;M&;3RFW2,20!DC(&/O;N,C)K2"3?;?B6WV2[VW*)]G/V9_WV+54.
MSCYOF&.,UZ/10!YFL<PLOAD#9W>ZT*?:!]FDS#BU9#OX^7YB!S6KX:M0VM^,
M])U"QN/+O;]IOWD#"*6%X8UX?&TYPPP#G@UV]4M6L'U32YK.*^NK%Y,8N;5@
MLB8(/!((YQCIT)H Y'P+8ZE'<2V6J9DC\/E].LYBV3.IPP<^XC\I?KOJUXQC
MO+;Q'X6UI(9I].L+F87B0H79!)$467:.2%).<= QKIM,TZ'2[!+2%I'"DLTD
MK;GD9B2S,>Y))-6Z /)/%>F75YI_C_4[&UN9+;4[.VM[>..!RUS*@.YU7&2,
M%1G'.#Z5ZI9F)K2)X4V(R @%"A QW! (J>B@#RG7=*U35Y?B59Z=;W"W%Y':
M?9B\3(EP$C =58@ YP5Z]ZV[ECXH\2^$M1T^WN8?L!FFNS+ T9A1HMIB;<!\
MQ8CCT4GTKNZ* /*]!AN]/>"ULA>ZCX=ET^=GL+VW9;C3?D!$(D(!(;[H4\\9
M&0*U?!L6HV&NQV$-Y<:GH*V):":]MS'<63;E @9B!NR.<$9&SGMGOZ* .+\6
MNUCXS\)ZM+!<O96[7<4TD$#RF-I(U"95 3@E2,XKD+B*YG\+ZW"^EZ@'E\6K
M<K$UG(2T7GQL6& 00 K9QZ5['10!Y9XJT_4M5UWQC!I4%R);S0(88)/*94E=
M7D+('(QN*L!U[U9;5H]:\4>!KNUTW48DMOM*7"O82K]F+0;0K$KC[V!D<=*]
M*HH \H\*P6TEGIGA[7-#UB77-+NE?,C3_9MR,2+A7SY>,$G'4DD8YKI/ $12
M7Q,9+6:%Y=<N)XVF@:/>C!0K*6 R#@\BNSHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YC
MQUK.I:)I%I-ID<#23W]M;.TLA7:KRJIQA3USCVSGGI73US_C'1+O7M#CM["2
M!+J"[@NHQ.2$8QR*^TD D9QUP: .:EEOK'XK:A-8:1#<7TN@0220I.(T+^=*
M"3(5R>  #MYXZ#IL6_CRRO=)T:[MDB2?5;9KF**[G$2QJN VY\'HS # .?H#
M3X=%UE/&UQKTJV#1RZ7'9>6LS@[U=WS]P\?/CUXS[5@6'@CQ+HFC^&YM+NM-
M_MC1X9;66.9G-O=0NP8@L%W*05!'!YH [#PQX@7Q)I37GV62UDCF>"6)SN =
M3@E6P-RG@AAU!KD=(T72[[XL>,(KO3K6>..WLF19(E8(61]Q (X)P,D>E=UI
M4>HI9[M4E@>[=MSK;@^7'V"KGDCCJ>I)X'0<W::)K^G^-M>UV&#3)H=2CMXT
MC>[D1D\I6&3B(@YW?ACO0!BVNKCP1X_U?19[N=]!_L@ZQ$DKF0VNURKHI/.T
MXR!G@\"N@LO%R7^O6^C7-C"4O;=Y(Y;>X%P@VCYHY0% 0X/J0<'FJC> 3J?]
MOWFN7JS:EK%F;'? A$=I!V1 3D\_,2>I'05?\/6WC&%(X=>N=+D2V0JDEH7W
MW1Q@&3<,)ZD#//H!@@&#X!U"72_ASHD-GI[W+3WEU"N"5CA43S,6D8 [5 7'
M3J0.]7S\01_PC<FLKIR/%;:D=/O-MUE(B) GFJP7YD^8'. <'I5"S\&^(K+P
MYH6GK)IDQT^^FN+FUDFD\BZ21I& )V9RI<$ @@E0:T]&\'W<>C>)-)UJ2TFM
MM6N[B93;A@0LO7(;H1VQGIUH NCQ:J^(]9T>XMX86TVS6\$IN,^;&<\X"_+C
M'/7&1C.:BU+Q9?Z=9O/+HFPPZ?\ ;K@SW/EQ*23B%9-A#2<'CCMSS69#X NB
M/#MS=:@LFH6I*ZK.!_Q^1LJY3IR-T<0YQ\H/>K>O^&M;U+Q!=W-O-82V-SII
MM(UNB^ZTD.[<Z*!@[@P!.0>!U Q0 Z[\<3^?HD&F:)->OK-@]Y:[ITB'RJK;
M6SG'#CG^=1ZCX_%C;7<J:?%+)8;%O+7[6!,'*JS)$H4B0J&'=02"!4.E^%=<
MM+_P?/<-IS)HEA)9S^7*^7W)&N5RG./+SSC.>V.9AH/BG2/$FISZ%=:8^EZI
M,+B5+T/YEM+M"LR!1AP0H."1SWH V]>UY=)\'7^O0QF006;7,:,"-WRY4$=1
MVS6+X5T.PN?"%CJVLVT>J:C?6R7=S<SPB9V+J&VJ,'"C. J\<=*ZFZT^"^TJ
M;3KP&>">$P3;^KJ1@YQZBN=\/:3XA\+Z1'HT7V+4[.U&RSGFN&AE$?\ "C@(
MP.T<;AU '% %/1?%.@Z?X9L!I%T]U;W5W-%:/=EX03N>1@SR#.U0"N<$Y '4
MTV3XC>3I=S=-HTCS6NH16,J0SAHV\QE59(Y"!O4[O0'((.*IVW@#6-*\):%;
MZ9J-H-<T>ZENHGE5O(E\TOOC;'."'QG&>.@[:6M:%XFU_P .QP7DFF+?&\M[
M@Q1R.(8TBD5\!BI9F..I '3CCD L)XV6UNM;M]:T]K!M+M4O"5F$HEA;< 1@
M##94C;SSCDTV'QLSZLVGOIR2.]H]S#)9W0F0E>L;G: C8Y'4'GFJVK^#+W7=
M:UV6ZDMX;+4]*CL5:*1FDC=&=@^"H!&7Z9[>]7=*M?&;63PZY/I#M%"T<;6K
M2#[2Q& TA9?D'?"@\^@&" 5M,\;:GJFBVVK1>%[G[+>10-;%+A7+/(X4A@!E
M47.XO@\=NU4M>UZ#Q'X'\<V,]K")]+M)XY/+E$T;'R"Z,K8'(SZ#!%2KX3UZ
M'X<:1H$-Q8B\L'@$J&5_(NXHS\T;,%W ,.HP?3D&HV\'ZZ\'C*,OI:KKUJL4
M*1LZB%O($6#\OW0!V'/HO2@#J]!<1^%M,<]%LHB?^^!7(_#R"W\8>&QXIURV
MAO;O49I7C2X02+;1*[(L: \*,+DXY)/.:[31[:>RT2QM+D1^=! D3^6Q9254
M#@D ]O2N;T'P]K7@[[1IVD)8WNB/,\UM%<3O#):[SED!".'3))'0C/>@"V3:
M>#@+6V5YY=6U#;9VS2'"L8QD;CG"*(V;H<#@#H*K7GCHZ;#K\5YI;+J.CVOV
MQ[>.<,DT!!(='(''RD$%<@CO4NO^'-3U9=+U"*ZMUU?3;T7<*-D0E2NUHB0"
M<%2?FP3GG&.!3UCPCJ.LQ^(;V06<6I:GI?\ 9<,8F8QPQ_.2Q;9DDL^<;?X1
MS0 ZX\<ZC90V$]SX8N%AU"ZAM[1DNXV,GF(6!(_A(P1@_F*(OB%':_VW#KVE
MRZ;>Z5'',T"RB83QR':AC8  DMA<'&"1S5/QC#>VFC^"8"EN;V'6K1-OF'RV
M98Y!][;G!QUQQZ&I];\"3>)QKESJ$\5K>7UK#;6WD,9! (G,JL20-Q+G)&.@
M S0!KGQ-<6FOVFC:GIRP7%]#))9-#<>:LK1C+QDE5VL <]P1GGBLO2_'>I:I
MH?\ ;,/A6[:R,4A3RIUDD>59?+"! ,X/)+=L'@\$WAHNJZGK.CZMJ\=C'/I,
M<IBCMIF=99I$"%B2@VJ!NXP3\WMSEVOA'7[;X8-X<BN[.#45D9DECE<QR*9C
M(48[0R@J2AQGK^% %F[\:W2V?BF&"RM/[2T.U%P0+HR0N&1F^\$!R-C94@=N
M><B+^V2UCX+DUK2(;JYOIXA#<"8,(93"6$G*@[B W &!GK4<?@[5Y;SQ$\S:
M7:VVL:4ED(K;>?L[*LB@#( *_O,YXZ8VCK4K^&M?GT[PE#-_9HET:YCFFV32
M;65(FCPI*<D[BW(&.G/6@"]>>,7BLM7U&QTW[9I^DRO%=.)]LA,8!D\M-I#;
M<]V7)4X[98_C.:YUR+3-(TDWQN-,74;>=KE8HY$+ #/!('/7!/3CN*L7A35]
M/M_$>EV$EF^G:S--.DLTC"2U:88D&T*0X!RP^9>N#ZU8T_PK=Z1XKL[VS%L=
M-L]%72XD>9A(2K!@Q^0C'&.OO[4 ;/AG78_$OAVSU>*!X!<*=T3D$HRL589'
M7!4\UROABRM5^+?C5EMX@88K QX0?(6C?=M],X&<=:W_  1HE[X=\*VVE7[6
M[30O*VZ!V92'D9QU4'^+'X5FV>B>(M-\:^(-<@M]+G@U1;=5B>\DC:/RE*Y)
M$3 YW'CM0!T.KZG/I_V1+:PDNI+F;RLY*QPC:S%Y& .U<+C..I [US9^((_X
M1QM973D:&WU(Z?>%;G*0D2"/S0P7YDR0<X!P>E/U71/%&I_V?<RR:8[07S33
MZ<\LGV>2+9M52VS+%3\_*X+?04NC^#[M-#\2:1K4EI+;:M=W$RFW# A9NN0W
M0@],9Z=: +J^+0OB'6](N+:*%M,M%O!(;C/FQD'G 7Y<8YZXR,9S6[8S3W%C
M!-<V_P!FGD0,\._=Y9(^[G R17%0^ +HGP[=76H+)J%KE=5F _X_(V524Z<C
M='$.<?*#WKL'_M3^VHP@M/[*\AO,)+>?YN1C'\.W&<]\T 7:*** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@"I>Z7I^I-$U]86MT86WQF>%7V-ZC(X/TJW110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !117(^(O$IL?%NE:%)J":5!
M>P22K>.BDR2*R@1*6^4'!).0<\ <F@#KJ*Q],GU&SM]1;7KJV,<$Y\FY5/*5
MH?+0AF!)YW%@3TX[=*L6FNZ7?"Z,%[$3:?\ 'PKG8T(QG+!L%1CG)XH T**Q
M9?%FB16E[<&_0K90^?,@4[Q&>C!<9(..".#5&/Q+::OIV@7EOK46FM>S1/\
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MN:XO/*MS;N)'WR$IA<9.0:]"\.Z-I,5E8:LEKF\6T2/SYRS21C:-RC?R@SU
MQ7144 >;^"-7MM*N_%@OH[V'[1KMQ<0DV4Q$D95 &4A3D$J:EU..ZF\6>'?'
M-O8W364<4UG=0^2WG)"Q.R7R\;L9Y(QD CC@UZ'10!P7C*)?'$>F:'I>Z:#[
M=%<WMT$(CABC.XC<>"Y. %'/4G J3XNVQNOASJ$<$$LU\K1R6:P(S2+*KKAD
MV\@@9Y';-=S2!@20""0<'!Z4 5+-[.WTF!K<+'9Q1 (H4@*H& ,=1CIBO+_
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M)/:EH C@A6WMXX4SMC4(,]< 8KB/&S'_ (3/P6ZQS.EO>RR3.D3,L2F(J"Q
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MM[2$D#G<$P/0'GG E3P_K&J?\(^NN+9K_8THN"]O,S?:951D0X*C8/F+'KR
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M^(;[Q#:Z%$MW+%>Q+(VL(4CR'C_=M&PV_*3(<C&/E4T =O16%XNUJ70M#%S
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M6VEW0NK;YT+!P21D[.0"S<>_TKJ%974,C!E(R"#D$5SNK:_=+KPT'2FM%O\
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M1@;P/0<9!!Q72F12,(Z%R,J">M9$>MC3['2TURXLTU&]<0A+5R8WDP2=F[G
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M@&3_ 'N.?QH;3[)XTC>T@9(\[%,8(7/H,<4 >47C1V#?$I=-CB355F1XHX%
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MWDA$ PQDQ-@@#^+&,?A7IK6MNT*PM!$8E(*H4&T$=,"D6TMDG,ZV\2S-UD"
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MOC&P\2) R>3";<7.-OV,Q_,4)[!]VXCOCVKF]&L6O+GX:)X@B6>[EM+Y9/M
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#,UC0;'7/LGVT3'[).MS#Y<K)MD7[K<'G'OQ6F.!BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR2E)HI0X1D&%8,P)&.F010!VU%<[)XK@N_!$GB;11%>0+;M<*DDACR%!+*2
M<,,$8QUK>C=MJ+-L$Q&2JMD?AGM0!)15+5+B^M[53IUI'=7+R*@264QH 3RQ
M8*V !D].>E<O;>+/$5YK&OZ7;:'ISW.CB+>#J#@3&2/> O[KTXY[T =K17.:
M1XBN+[Q1KNE7=O#;PZ=':O&X<DOYH<_-D#!&T#'ZFM>Z>_6_L5MEM3:,SBZ,
MKD2 ;3M\L 8)SUSVH N44T2(9#&'7>.JYY'X4Z@ HKG6\76B^/$\+&-A*]JT
MRSG[ID7!,0_V@C!_H170LRKC<P&?4T +15*/5K*75GTR.=7NXX5G=%.=J,2%
M)^N#CZ4NFR7SV;-J2VJ3B1QBV<LFP,=O) .=N,^^: +E%<_XPU^?P_X/O];L
M(8+I[6/S LDA"D9QU .?IQ]:W#,B1*\CJ@..6.!DT 2445RVL^)M2AULZ1H&
MFV>I7<40DN4GOQ 8PWW0!M8MP"3TQD>M '4T4U"YC4R !\#<%.0#[&@R1J<%
MU!SMY/?T^M #J*:'1F90P++U /(I%EC<L%D5BAPP!SCZT /HI-PQG(Q575+J
M:RTF[NK>-)9886D5)'*JQ S@D X_*@"W163X:U=M<\-:5J4JQQSWEG%<O$AX
M7>H/'?&36IYB"01EUWD9"YYQZXH =114?FATD\AHY'7(QOXW>A(SB@"2BN5\
M/>,8[_PII^KZJ(;2:]NVM$BC;(,GGM$H7/)Z9/XFNH:2-"H=U7<<+DXR?:@!
MU%-:1$^^ZKWY.*#(@D$9=0[<A2>3^% #J*R_$6J2:-X?O]0@2&6>VMY)DBED
MV!]BEB,@$]!4^CWKZEH>GWTBJCW-M',RKT!902!^= %VBFF1!($+J';D*3R:
M&D1/O.J_4X]J '444U)(Y03&ZN <$J<X- #J*:)(V8*'4L1N !ZCUH1TD7<C
M!E]0<B@!U%,66-T+I(K*.I!R!2K(C,55U+#!(!Y&: '45SWB;Q#/HDVD);PV
M\PO=2@LYM\A#1K(<;@H'/0]2/QK?,B+(J%U#MT4GDT .HK+\1:I)HWA^_P!0
M@2&6>VMY)TBEDV!]BEB,@$]!4^CWKZEHEA?2*JO<VT<S*O0%E!('YT 7:*;Y
ML?F>7O7S,9VYYQ]*JVNJV=[?7EG;S+)-9LJ3A3G8Q&=OUQ@_C0!<HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *X[Q;HWA_Q3JMMHVHS26FK10_:K
M"Z@E\N>/G#&,]\8&1[CTKL:K76GV5\A2\M+>X1@ 5FC#@XZ=1[F@#RBXUO7[
M/PKK=CJ]\=1M='U6U@GU2&+F:U+(T@91D$J#A_8D'N:EUL:;8Z%XBUKPQK#W
MSSVT!O(].,?E)$)%#/\ NQ\LAC+]\X'L*]5AM+:WM1:P6\45N!M$2(%0#TP.
M*;:6%G80&"SM(+>$DDQPQA%)/4X% '"7T'A'4M,UN]T)[6YEFT.1)([1@T(1
M06C+H. ^3QD9P#Z5D%-+/A7X:S62VF]=2LE=X0N=YMV+ D=R0N?PKU*TL+.P
MB:*SM(+>-F+,D,80$GN0!UJ,Z3IQBCB.GVICBR8T,*X3/)P,<4 >=*MGJEA\
M08M?6,:A;74Q1Y?OPVXC!MV0]5'!(Q_%D]34>DZ:-3\:^'$\16D4]]-X6+7L
M<Z@^9()(O]8IX8]>#W'L*],GTZQN;F.YGLK>6XB_U<LD2LR?0D9%$FGV4MQ]
MHDL[=YL8\QH@6QTQG&: .6^%I'_"!VT2-F.&ZNHHQG.U%N) H^@  'M6KXON
M)8_#TMI;.4NM0=;&!AU5I3M+#_=4LW_ :U[:SMK-"EK;PP(3DK$@4$_A3WAB
ME:-I(T=HVWQEE!*-@C(]#@D?0F@"I]HT[218:<T\%N9!Y%I"S@%]J_=4=\ 5
M9N;B&TMI;FXD6*&)"\CL<!5 R2:62W@FDBDEAC>2(EHV902A(P2#V.#BB>"&
MYA:&>*.6)NJ2*&!_ T >8^(-$US5O!ESK<!LTO1.NN6Q*MYJ,@!C3.<9\L!#
MVSD]ZZ*;6K'Q+X>\-ZG$T;6U_=PG8Q!&2K;D/N#D$>U=5]CM1:_91;0_9\8\
MG8-F/3'2J_\ 8VEA @TVSVJ=P'D+@'UZ4 >?>%+.^M=4G\"7$4AT[1KL7L<[
M<K):D[X(\]R),Y]HB*P[:1#^S?KA#J1NO!G/K<-C^8KVAX8I%97B1E==K!E!
M!'H?;DU5&C:6(C$--LQ&2"4\A<$^N,4 <]:PZ;IZ:1J+ZS<.518H[>2Z\Q96
MD4*H52?O9(P?0GZU3U'PU:^*V\2VOGFWOK;5(YK.[B/SVTPM8-K#^H[BNMBT
M?3()5EATZTCD4Y5T@4$'V(%2P6-I:R/);VL$3O\ >:.,*6^I'6@#A?">JZGJ
M!\2_V[:"TU.RMXK:ZQ]QV59#YB'^ZP((^M'@#7]+T3X0:)>7][#%'%:<C<"S
M')^55ZECT '-=[+:V\ZNLT$4BR !PZ A@.@.>M0P:5IUK*)+>PM8I!T:.%5/
MY@4 >;>$-%GTSP9H%OJ]N('U#6))VM)?X%E24A"/7'4>^*F\(VM_!J$O@B[C
ME:PT"[^TI</]V:W/SVR9[D-DGT\D#O7H]Q8VEVR-<VL$Q3[IDC#;?IFGR012
MJZR1(ZN-K!E!##T/K0!XI%(A_9=OB'4C%P.O<W;8_F*]&B@TW3KK3=0;6;B1
MMHMX[>2Z\P2M)M VJ3UXZ]@3VK<_L;2Q$8O[-L_+)R4\A<9]<8HATC3+>598
M=.M(Y%Y5T@4$?0@4 <CJ'AFW\5CQ##'<?9M1M-56:RO8_OVTPMH,'Z=B.X_"
MI/ &J:EJE[K9UFR-IJEL\-M=1C[C.J'YT_V6!!'UKKX+&TM7=[>U@A9_O-'&
M%+?7'6I@B!V<*H9L L!R<=* .'T!U/QA\8J&&[['8\9Y^Z_^(_.NY(RI&<9'
M457CTZQAN#<165NDYSF18E#<]><9JS0!P'PF0Z/X3D\-WI$6HZ1<S1W$;'!*
ML[.L@]58-P>G!K"F@:[A^*?B:(XTR^L/L]K)_#.8;=E=QZKN. >AP:]1O-+T
M_4&1KVPM;DI]TS0J^WZ9'%2S6EM<0"":WBEA&,1N@91CIP: /);*,:-)X+UO
M7IWO] >PMX[>28@)IET8QM<A0 58?*&8$J<<C->O@AE#*00>01WJ 6%FMJ;4
M6D MSUA$8V'\,8J6*&*"%888DCB48"(H  ^@H \N\11/8)-XQL%\RYT'6)FN
M$CY,EJX59D^H&&YZ;33M3A>/Q5X&OKQ?+O=1U.>YE1^"@,!")_P% BGWR>]>
ME0Z?96RR+!:01"3[XCC"[OK@<TD^G6-U*);BRMYI!P'DB5B/Q(H XGP7$VB>
M./%VE7WR3W][_:-HS<>?$XP=OKL(P1VR*6. ZQ\9QJEH0UEI6EM:W$ZGY3.[
MY\O/<A>3Z9&:[:[L+/4(A%>VD%S&#D)-&' /K@TJ6=K':"T2VA6V VB$( F/
M3;TH \_^%^M:9I?PHLKJ^O[>"&*2Y+L\@&/W\A_$GL.]<E?V%S9?!7Q/J-["
M]H-8UL:C#;RC:T<;W,6T$=CA<X]*]HATC3;>020Z=:1R#HR0JI'X@5+<V5K>
MJJW5M#.%Y EC#8_.@#A?&,,=W\4/ MNUQ)%N34#NADV/_JDZ$?2IO&^G+H_P
MD\1VWVJ:<&WGD\R=]SG>Q;!)ZXW8'X5UYTC32Z.=/M"R !6\E<KCICCBIKBT
MMKR/R[FWBG0'.V5 PS]#0!YI?LNC^-?!?B2\<+I#Z8;![@GY()&4,A8]@WW<
M]*](;4+59H85F5Y9N41#N)'=OH/7IT[D4Y;.U6U-JMM"+<@@Q!!L(/;'2HK3
M2M.L(I(K/3[6VCD^^D,*H&^H YH X^^TFX\;PZY)%)9/IUY$VFP-*&8A48AG
M7!P#YF?KY:&K_P .==EUKPG%%>.#JFFNUA?+NR1+&=I)^H /XUTUO9VMI&8[
M:VAAC8Y*QH%!/T%-MM.LK-F:UL[>!F&&,42J2/? H X[P.ZMXT\>!6!(U*+.
M#_TQ4?T-4)+0ZI\2/'&G0RJDUSH<$*G/W2RR#/X;A7H%OIUC:2F6VLK>&1N"
MT<2J3^(%(FFV,5R;F.RMDG))\U8E#<]><9H Y;X;7T,/P^L+2Z*VMSI47V6]
MAE(4P.G!W9Z @;L]"#FN<T*UDCT+Q'KDH,5IJ_B*&YM-_P NZ'[1$%DP>F[!
M(]L'O7I5SI.FWEPL]UI]I/,GW9)859A]"1FIKBSMKQ ES;0SJ#D+*@8 _C0!
MY=XVTN\\&1ZQJ6CP--H6LPR1:C9I_P NT[J56X0=E)(##\?IZ%-%HI\46TLI
MM_[;%JZP@O\ O/)W#=A<],XYQ6D88C#Y)C0Q;=NS:-N.F,>E(;>!KE;@PQF=
M5*+*5&X*>2 >N.!Q[4 25POA-U;XH_$ !@2)+#@'_IWKNJK0Z;8VTQF@LK>*
M4]72)58_B!0!YQJ.EZ;JGBOXAKJ%M#<B+3+5D64!@C>5-\P!X##L>HSQUIED
MZW%Y\)KR5E>ZELY TK'+-_H>3D]^3^M>D-I>GN\KM86K/+_K&,*DO]>.:!I6
MG*8B+"U!B_U9$*_)SGCCCF@#SS33-I?BC3'FALM6TR]U.Y^Q:C"-MU;3.)2\
M<H_C4#>N0>-HR.!7HFI:A;:3IESJ%Y(([>VC:61CV &?SHATVPM[EKF&RMHI
MVSNE2)58YZY(&:EN+:"[B\JY@CFCSG9(@89^AH \O\4:-KUCX5A\1L++^T=)
MNCK+A-V]L\RQ;LX*^6=ON$6KWB/^Q_$OBKP#=E(;FSO_ +406QB6,VS$*?49
M/(]R*]!>SMI+46SVT+6X  B* I@=..E0+H^F*4*Z=9@H<H1 ORGVXXH X;3-
M*T+2OBQ>6*6=E BZ-:K:Q,BY.'E4[<\DX !/I7/:=?PZ5X(T!K@JFA#Q'<QW
MY_@6/S9O+W]MF_83GC@5["]K;RS":2WB>4*4#L@+!3U&?0^E1IIMA';26R65
MLL$O^LB6)0K_ %&,&@#SKQ=%H,7PY\:3:%,DD-P@EG:"4/ )2%!"8^4' !('
MJ*EUR\TZ3QU<:9XBO[>TL;C2HOL+721F%_F<3 ,XP&Y3WP!7H TVP%FMF+*V
M^RI]V#REV#Z+C%)/I>GW4$4%Q86LT,1S'')"K*A]@1Q0!2\*VL%EX7T^UM;R
MYO+:*+9#<7)!>1 3M.0!D8Q@]QBN6\;:1X8UFPU*]LI+-/$UF3]GNK-U%TMT
MH^1"5Y))PNT]C7H/2JRZ=8I>M>I9VZW;C#3B)0[#W;&: );?S?LT7G[?.V#S
M-O3=CG'XUXQJ>DZ6W@KXDW!M(#-9ZI.]L^!F!A'$04_NG/<8SCVKVNJ?]D:9
ML=/[.M-KG+CR%PQ]3QS0!YYJD6F:!XUL;R&$P)<>'[V6]:UXEG">6VXGJS_>
M(8\Y[U1\/3Z8/&/A9()=.6UN]#FA\B)PY9<Q%$E;I(YR3]T<D]>M>I#3-/61
M)%L;821C",(5RH] <<4T:9:P0@65I:02Q*_D,(1B-F') &.O&<8S0!Y[H^E+
M9:K<_#U[)3IT-X-3A<Q_(UF6+A">["8!.>J_2O0=9'_$AU  ?\NL@ '^Z:IZ
M#IFI6WFWNMW=O=:G,B1N]M$8XT1<X5023U9B3WSZ 5M4 >.:7HMA'X>^'&J:
M-%&FN226BRS0MF26 1_OPY[J%&.?NG &.E2:4='UVW":OK1M/$=EJ[N\$:QK
M=^<)6V*I(W,I4J..-O' ''JUMIMC9S2S6ME;P2RG,CQ1*K/]2!S1_9]D;[[=
M]CM_M@7;]H\I?,QZ;L9Q0!1\5W=M8^$=7N;S[1]FCLY3+]F.)=NTYV'L?0]J
MX7PO<V4/Q+LHK>YTU(I_#P58;-P5RLJ[5+9_>.%)YP.#TKU!E5U*LH96&"",
M@BJT>F6$*HL5C;(J(R(%B4!5/4#C@'N* /'H(K*7X9^#YKN.W>)/$F'>4 JJ
M&ZEW9)Z \9K3U"70=3\0^)-&U_5;73[>2"'^SS*(E4VIA7#0LPP"'WGY>^/2
MO31IFGK;-;+8VPMW.6B$*[6/J1C%.N-/LKN6&6YL[>:2$YB:2)6,9]5)''X4
M ><)X?T?5/B/;V&HP&^B?PQ$SB\'[R8B; >0<?/C'/8U0C.CZV-8LM<UHV&N
M6NKR,L:+&MT"LN8/)+#<P*;%&,Y!([UZO]@L_M?VO[)!]I_Y[>6-_3'WNM(^
MGV4EZEZ]G;M=H-JSF)2ZCT#8R* /+KZ[T^_T_P"),&O&W_M2!IE@2YP&6V$(
M\@IGH"V3Q_$?6O0?",L<_@S1)(I%D0V,(W*<CA #5ZXTS3[N<3W-C;33!"@D
MDA5F"GJ,D=#D\591$C1410J*,!5& !0!Y&XBU+X?>,9M14+XBL[VY82=)XIE
M;-L$/W@,>6%QUSQU-:%KH5CK'Q*FM]=LK>>X;P_:37$3#@SB5]S8'<$ 9]/K
M7HKZ=8RWJ7LEE;O=(,+.T2EU'LV,BE%A9K=F[%I +D]9A&-_IUZT 8_CB[M+
M'P1K%Q?BY-J+9ED%L^R0@\<-VZ]>U</:26!\:ZU9^?I;07/AR,F"S(\HLK2<
M=?G95_BP.,<"O5I(TEC:.1%='!5E89!![$56&EZ>J!%L;4*(_*"B%<!,YV].
MF><4 >2:?I&F#P_\,+H6T0N;IXH)YAP\L;6SY1FZLO &T\=NE.U"1- 3QM;Z
M?&+;2;75[![F&VC&V*!TB,Q"#C!YR,<C->L?V1INV-?[.M,1G*#R5^7Z<<4^
M/3[*%Y'BL[='E!$C+& 7!ZYXYH \J\0Z?X=D\*^+]1TG5HK_ .T:26FBMO+^
MSHR@^6Y"# D/('? ]JORVD6C>,]%FT2VBCO;O0+MGV#FY=1$R%SU8Y)Y.37H
M<>D:;#:&TBT^T2V+;C"L*A"?7;C&:<NF6"2QRI8VRR1C".(E!4>QQQ0!X^+S
M0[GP9X"U SVIU(:Q:-=S2,HF$V3YV\GG[W7/M[5;W:/KK:]8Z]K1L-9M]6=D
M5%C6ZPLF;<P%@6.4V !>N2.]>IC2--6X>X&GV@F=Q(T@A7<S#HQ.,D\GFGOI
M]E)>I>R6=N]U&,).T2EU'H&QD4 >6WUUI]_IOQ)@UXV_]J0-,L"7. RVPA'D
M%,] 6W'C^(UZ%X1ECG\&Z))%(LB&QA&Y3D<( :O7&EZ?=SB>YL;::8(4$DD*
MLP4]1DCH<GBK*(L:*B*%11@*HP * /&;W4]*>XTO4+2XMK<#Q9^\-Q(#=9WN
MDC.V1L3' 4@_+MR>U=5X0BTR#X@>,D6.TCNS>0M$ JA]AMXR2.^"<D^]=I_9
ME@7D<V-MND<2.?*7+..C'CDCUJ5;:!;AKA88Q.ZA6D"C<P'0$]<4 2T444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 51U75[31X(9+IFS/,EO#&@RTLC?=4>_!Z\#!S5ZN;\8G5E
ML]/.EVDUS']M3[8MN5$P@P<F,L1@YVC((."<8Z@ )_'&BVNC7FJ7#W$4-E=?
M9+E3 Q:&7*C:V,@?>7YLXY'-2P^,--GN;^V6*^6XLH!<O"]JZO)$21O12,L,
M@CCFN"N] US_ (1;Q?IT6@W8DO\ 5HKNU4S(Y=,P$Y;>>0(VR2>O0FNOCM;Q
M_BE_:?V&=;!M&%MY[  "3S2^TC.>AZXQ0!J6_B?3[O2--U.W$\EMJ3JEL5C^
M9BV2"1V& 3[8YQ5W5M172=(N]0>&69;:)I3'$,LP S@5R/A70KC3_%&J6>]&
MT;3+AY=/0?\ +.2=0[I[; 6Q[35UFM6LM]H6H6D(!EGMI(D!.!N92!_.@#FE
M\2VFIZ%X7OM1DU'3YM0N+9HDME=5EE9-VQB 08SD\$C./:KEYX]T6R;5%9;^
M0Z6P6\\JSD/D@KNW'C[N.<]QTS7./8:Q-X/\$6K:)>1W&F7MFUS&3&2B0Q[7
M?AL8ST'4^E3SZ9JCO\1=NF7)_M6(+9?=_?'[,(N.>/F'?''- '36GB[2KS6+
M;38FN!)=Q-+:RO RQ7"J 6V,1AL @_3IF@^+M+6\LH':9(KZ4P6ETT9$,T@S
M\JMZG!P3@-C@FN;_ ++U)]0\!,=.NE33[66*\?Y?W#- (QGGGYAVSZU6\'Z7
M?6%OI^@:GX,MS=::ZJNKLD30NB'Y95.=_F%>@QP>210!Z%?7UMIFGW%]>2B&
MVMXVEED;HJJ,D_E67;>*]-GGN()?.M)8+07S+<)MS;G/[P$9&.#D=1W%3>)_
M[3/AC4AHT,4VI&W<6\<H!5FQT(/!_'CUKB;;3M5_X2B?4_\ A'+^6VN/#[VS
M+?3QLTDP<ML?YS@-T ''/0"@#NK#6H=0N/(6WN87,(G0S1X#QDX!!!(_#J.X
M%,USQ%IOAV.UDU*22-+J=;>)DA9QO;H"0,#\?PS7.>#]%OM&UN6*R;48_#AM
M 4M-1;<UK/N'R1,23LVYSR1G&"></^),C0V?AR1(GE9=?LR(TQN;YCP,X&:
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MMEV Y<@=.I/:NDU'=_9MT$C>1S$P5$'+'' %>=:9H^KVVD_#N"72KD2:2_\
MIH^4^4/)>//7GEATSQ0!W6AZ_9>((+B2T$R/;3M;SPSQ&.2)P <%3[$'\:HZ
M[XH.C^(=#TI;&XG.HO+NDC3(54C9L#GELA?PS[56\)V=[:Z_XIFNK.:"*\U!
M9[=WQB1!$B9X/'*GKBD\4V6H-XG\+:K9V$MY%8SSB=(F0,HDA**WS$#&2,T
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MU"O* S $'YB@&20,MD^E=GHUU/>Z5%<7#VTCN7(DM6W1R)N(1E.3P5VGJ>M
M%^BN(N?&6H/X>U7Q)IUO;3:;IL\J- X;S9XX6Q(ZOG"GAB 5.0!R,\#^*M=U
M'Q*VEZ':Z:T3Z;!J,,]W)(-R2.5P0HX.%./Y]J .WHK!\8ZO?Z!X:N=6L(89
MC:8DFCD4G]T#\Y&".5&6]\5G?\)@8?&5SI-Q/9BQ&F?VA!<(C$L!]Y2=V,JI
M5L#J&'2@#H-9T>TUW3FL;WSO)9E<^3,\394Y'S*0:LVEI!8VD5K:Q+%!$H1$
M7H *Y:]U[7K*TM3<0V%K))8M.\DJEPT_!$"1APY.,DL,].E4V^(*G3?#=W</
M;:5%K-F9_M-VC/"DN$(B+ J 3N8Y)'"].> #NZ*K:?+<3:;:RW:1K<O"C2K$
MV5#D D*>XSG%<A8^,=3;Q!HNFWUO9K)J8N%DMXB6:SDC4N$>0,RL2!R  10!
MW%%><GQUK\>C7.LRV.FK9V.KMI]S&KN7=1.(=R'@ @D'GKZ#OV?B'6[?PYX>
MO]8NE9H;.%I65>K8Z*/<G _&@"^L$23/,L:B5P SXY('09]/\:JW>M:78745
MK=ZA;03S,%CCDE"EB>@P>YP<>N*PIO$6IZ1K.B6NK16C6^KL84DMU93;S[=P
M1LD[P0"-PV\CISQC>&K74-1U+QDEY)IUP%U4#$]HSKO2&$H0"_ &!@=<\YH
MZZY\4:!9W)MKG6;"&<'!CDG53G<%QR?[Q ]C6M7D>BWUSIGPBT#6[FRTW498
MWA6)KB$[XA+,$9LDG+98'C;T[UVMWKNJWE]K=GH$%K)/I*(&2X!/VB9DWB-2
M& 0;2OS'/+=..0#IZ*Y"^\4ZB]S=6%A:K%J%I:13S126TMR/-D#$19CX&-OW
MB3U& >:IR>+/$USJ>E:=9Z/9VEWJ&F2W?EW\CY@E0H"K;1TRV..3P>.E '=T
M5C>(->'AKPO/JUY$LDD*(#%&V \K$*J@D< LP&<=*SYM?U/2O$VFZ/J4=I,-
M5BE^RS0*T82:-=Q1P2V01DAACITH ZFD9E1&=V"JHR23@ 5R7@K7M?\ $MC;
M:I>6NG0:?*DRE8G<R^8DI0$9&-N%/OD9[X%ZYUJYN?$\N@Z8;=)K>U6YN)IT
M+JN]BJ(%#+DG:Q)SP .#G@ T$U[2)+*"]34[1K6XF%O#,LRE))"Q4*IS@G<"
M,#TK0KRCPQJ]UH_P[\.M]BM)OM6OO:S"0DB(O>2#<@QR1S@G&.*Z9/$/B&\\
M7:OI-I:Z8EMIDELTLLTC[FAD!9L8'WL#CMQWSP =C17$6/C#5=1.C7]EIK7.
MFZE*JO&EI*LEM$X.V4R'Y&'3< .,\$XS5NQ\0:UK-I9:OI-E:W&FW%X86A8[
M95@#LAFWEL9RN[9MS@]<T =917G-GXKU'2+;QIJVK3PW5OIVI&WA@CC*$L4A
M$:@EB "7&>#R2?:MV?7]4TGQ+IFD:E':3+JL<HMIH%:,1S1KN*."6R",X88Z
M=* .IHKD?!>O>(/$ME;ZG>6NFP:?()T98G<R^8DI0$9&-N%.>^1GO@2^*/$&
MI:/+<?9X[.*"*R>XCEN,N;B49_=*BL&& ,EL$#<..#0!U-%</<^/0D>A-)+:
M:6FK:>MW#/?*S0M*P4B'>"H4X.<G\!77Q-=RZ9&S"**\>$$@C>B.1Z \@'W_
M !H LT5YQX7\6:FO@SP_+>S076I:W=O# 2A4(2TC.S?-R %. ,=AQU'2:5K]
MT_BN_P##>IQP_:X+=+R">!2J30L2IRI)*L&!'4YZ\4 ='17-^(];U+2[DI;I
M:0VXM))EGN,R&68'B%8U8-G&22,X':LE/&FJWS^$186%FHU^S><F:5OW++$'
MQP.1S^.,<=: .ZHKS^3QIKL?A'4]4-G9/<Z-J,EI?JBN4:)&&Z6,9SPK;MI/
M8\UU-MJ<U[KK6]L\$EA':I+)*JDDNY.T*<XQM&X\=U]: ->BL#7M6U"PO((;
M86L%N\,CFZN07W2C&V)8U8,Q(+'(SPO3FLO2/&D^O6?AZ.T@A@OM6LGO7\W+
MI B;0W (+$LP &1QD]L$ [.BO/\ 7-6\51Q>&H[A;73KBYUH6DZ*#(LR .R.
M"&R%.P$J>><9ZYO_ /"73R>*KC0EGL8+VWN(4%I<HR27,+!"\L3%@#C+X4 G
MY.>M '8T5C^)M>3P[HKWS1>;(TD<$,1;:'DD8(H)[#)R3Z UFR>(-3T[Q3;:
M%?QVDSZA:RS6-Q$K1*9(\%XW!+'H00P/J,4 =517)^"->U[Q-I=GK%];:?;Z
M?=VN]$A=S*)-Q'.>-N!ZY_/BU+K=[?\ B+4M%T@VL<VG6\4L\MRC.I>7<40!
M6&.%R6R>HX- '145Y_;^/]0U&W\.26>G6T<FI7<UE<Q3RMF":-7+ $#D93KZ
M'I3)_&'B>'3?$S_9=):Y\/.S3MF0)<1B(2@*N<JVT]22,]O0 [N2_M(KZ&QD
MN8DNIU9XH6<!W5<;B!WQD58KE6\0RR^+O#UHME;_ &?4K":Y29LF6/:(R5'8
M [QZYQ5;P[XRFUZ9S$UHTD*R_:]-"LEW:LOW5(9OFSTW  9QCV .S) &2<"J
M]E?6FI6<5Y8W,5S;2C,<L3!E8=."*Y?POXLN/$T'GVEQIT^+9FFM@&BEM)\K
MB*0$DXY8;MH^[TYJIH7C.6_T+PK%!:6MM?ZXLK)&JGR8$C!9CM!!/\( R,EL
MY&* .[HKSW5_'NJ:1IGBB-[.TDU70A%)G++%/#)]UP.2#U!7/4=:U4\2:Q:^
M*KK2+^QMI0=,?4+5;1F+_(P4QMG[Q.X8( ^E '6T5ROA'Q0WB95N(;RPN;?R
M<S) K)+;39&8Y$9B?7G S@U#XBOM7B\>^&+"SNX(K2Z6ZDDC>(L69$'4AAD8
M?@>O//& #L*JVNI6-]+<16EW!/);MLF6*0,8V]&QT/M7)7WC'4M.U:TAN;>T
M5+C5UT_[*I+S)$Y(29G5BJ[L A2H.#UXK,TW6#9?$'Q?I=@UN=6O+VW:WBFX
M78MM$7=L$' !Z#DDCMD@ ]*HKE=2\17T>IW.D6'E-?6EJD\LALIID9G+!4"H
M<K]PDDD]1@'G%!/%OB&YU+0+!='M[&XU2RFGDCO';=;R1[000!R/FX[GVH [
MFBL#PAKESKVC2S7T,45Y;7<]G.(2?++Q.5)7/.#C/-4I?$FIW_\ ;TFB16CI
MHTK0,EP&+7,JH'=001L'S!02&YSQCJ =917 CQOJVL7FC0^'[.Q,>K:7)?0O
M>.X\ME*#:X4=,MCC-=+X@UX>&O"]QJ][$LDD$:@Q1M@/*Q"A03T!9@,XZ<T
M;-%<M-K^IZ5XFTS1]2CM)AJL4OV6:!6C"31KN*."6R",X88Z=*P+?QWXAD\.
MZ/KKZ?IIM[S4/L,L"R.'RTS1*RMT ! R"#GD\=* /1I)$BC:21U1$!9F8X
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M^9UR ,Y_"K-UX1U2+Q/<ZUHNO+8'4(XUOX7M!,LC(-JR)EAL;''.1Z@UUU%
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M<-&9/+R,9 R.1VYK/UGPVFK^"KCPYN@B2:U^S*PB)2/ P"%W9XP".>PK>HH
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M:7<0!>"5?NL >".Q!Z@TZUM-=D5(]2U&S9%QO:SMWC>3'N7.T'OC)]"*V:*
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M:5(#Y<2*A10%W98@,223S[ 5UE% &/X>TBYT+PO8Z0;J*>6SMT@CF\DJ&"@
M$KN//'K5;P5X;G\)^'8](FO8[P122.LJ0F,_.[.01N;NU=#10!QUQX4UB]\*
MMX:O=7M9[&2$02SFT(F\OT'SE=V. V..#@FNM@@CMK>*"(;8XD"*,] !@5)1
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!;WMK=R3);W,,
MSP/Y<JQN&,;8SM;'0X(X-3$ @@C(/4&N'^'\$5MK?C6*")(HUUDX1%  _<QG
MH* .KEUG2X+Y;&;4;2.[9@JPM,H<D]!C.<GL.]7J\8;5+2W^%WB[1]?8PZY%
M)>2R1R*0\LA8O%*OJOW,,.!M'2O5/#<]U<^%](GOL_:Y;*%Y\]=Y0%OUS0!I
MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 ';BN8\+Z'J>D:MX@N;T
M6GE:G>_:H_)E9F3Y%7:04']W.?>NGHH YS6M!NO$\D5GJ9ABT:.599;:-R[7
M94Y57) "H" 2!G.!R!UZ/I110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %9&HZZEGJEOI5O:RWFH31-.(8V50D:D NS,0
M,L .I)[<$C7KC_%GAJ/Q!JUO-INKS:3XCL(3);W,0W QL<%70\.F5Z=N/7%
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M.$)($A.T,>H!]:M>!KV#4O"L5_:N7M[FZNIHF(QE&N)"#CZ&LCX6?\B_JO\
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M5$!CSM*E  01R3GKS6S)91W/Q?TR:;[3'+)H4LSHMS(H5A-#Q@-C'JO0]P:
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M!;L"W./05YJ^JW]_\+-0\7)?74&NVUQ/*%69MD1CF*B QYVE=@ ((Y)SUYH
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MY8+2[CDFB4,\71U4]&VGG!['H:GO+VVT^V:XNYTAA! +N<#). !ZDD@ =R:
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M3<:@MA%?P-=.&*1AN9 OWMIZ-COC..]7IIHK:"2>>5(HHU+/([!54#J23T%
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M1P#U4_WAQ0!H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDG2)"@DD #DDT <"VHVWC/1+PZ+I-S;:U_9<UL)[FU:!K1F3 B#LHR=V/NY
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M#%?Z9:_9Y5A8QOL:7=EP,#&X=2.H]:D^*2/-\.M5ABBDEED$:I'&A=F/F*>
M.3P"?PKL** .(,D+?%X7I0F :#L$YC.P-YV[;NQC.WG'7%3_  N1X?A[IL$D
M4D4D33*T<B%&7]ZY (/(X(/T-=A10!P]O*=.^)?B1[F"X6.\T^T:"40.R,(Q
M+O\ F P,9'!.>17+Z3$UOX*^&T7V::.>UU*-KA/)8-"/+E#%QCY1EER3ZU[!
M10!Y-I\=C(+[POXCTG6+C4QJ4T\**;@070:9I8Y0ZG8H&1DG&,=SQ7INJLJ:
M1>LW3R'Z#.>#V[U<HH \ETN(P:!\,(_LTL<EK,/M"^2P,/[AU;?Q\OS$ Y[F
MJTUY)<KHDO\ 9M_:-:>)C)/I\%@_EVZEI?G+;<NS;@V0<?-P!7L=% 'D=]%Y
MGA+XFQK;2F:[O)3 ODMNF!AC52O'S#<&QCWK4U2*2Y\5>&UT\/&QT6\@698V
M"Q.ZQ^6&./EY4X!]*](HH \P\'MI6I1Z#97>C:Q'KVCA5>*Y,ZQ6K*FQG#$[
M"I X SG(XQDCI/B-9ZA>>#IAIT#W$D-Q!<26T8RT\:2*S(!W) Z=\8[UU=%
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MQGN:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ .[U2_&EZ5=7YMY[@6\32>3;IODDP,[5'<FL&/Q?)_:.I:;/I\:7]E8+?\
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MGRI$"C<2N%Y) '.>Q ([GXDS06&HZBOAF^>PTN\DM;Z431[H@A 9@N?FQG)
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M%9%$;87&6)).1UQS6WX>\1Z?_P (SX<AT;3! =2@9[.Q,F%BC098LV#@#('
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MJ-E;W<2L&"3QAU!'0X/>K2JJ(J* %48 '84M% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %6#3+"UO;B]M[*VBNK
MG'GSQQ*KRXZ;F R?QJU110 4444 ,EBCGA>&:-9(I%*NCC(8'@@@]145E8VF
MFVD=I8VL-K;1C"0P1A$7Z <"K%% !1110 54U#2]/U>V^S:E8VUY!G/E7$2R
M+GUP0:MT4 5=/TRPTFV%MIUE;6< .?*MXEC7/K@#%6J** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "@@$$'H:** *=AI.G:7YW]GV-M
M:^<YDE\B()O8]6..I]ZN444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445R?B#Q(]EXN
MTOP_]NATU+V"25;N9 WF.K*!$F?E#'))SGH !DT =9161I=QJ5M!J+:]/:A+
M><B*X1#$C0^6AW,"3@Y+ \XXJQ9ZUIE^MPUK?02?9O\ 7@. 8N,_,#TXYYH
MOT5CR>*M#CL[VZ_M*!H[*+SI]C994/1L=2#V(Z]JHQ^)+35]/T*\M-;M; WL
ML3F"3:[S@IDPC)&&^8<C.,4 =-16?>:[I6G3>3>:A;P.-NX22 ;=QPNX_P .
M3TSC-,O?$6BZ;<26][JMG!-'%YSQR3*&5,@;B,YQD@>^: -.BH+*]M=1LXKR
MRN([BVF7='+$P96'J"*YGQ3-XMMK>_U'2+G3;>VL(C*MO<P-(UT%7<V7##8.
MH'!Z9)YH ZVBJ.C:@=6T/3]2,+0F[MHYS$W5-ZAMI^F<57\3WMUIOA;5-0LG
M1+BTM9;A/,3<I*(6P1D<''K0!K45D>%KR[U+PMI>HWTD;W%Y:Q7#^6FQ5+H&
MP!D\#/K67;:]>>(?$NJZ7I<J6MEI3+#<71C#O),1DH@/ "C&20<DX '6@#JZ
M*Y?3/$-U#XPN/"NK&)[H6HO;2YB78)X=VU@RY.'4^AP1S@=*@\0^,7T3Q;HV
MG>0&L+B407MR>D+RAA /Q9&SZ CU% '7T5S7C?4=;TC03J&A+!-=1S0H+6:/
M(GWR*FT-D;3\W7FJW_"7+K7@277M#F6&:,8>*>/<89 0&C=<@@C_  /2@#KJ
M*X^^\13_ /";Q^%_[3AT^3[$MQ%++$"UVY9@53)QA=N2.ISQC!K5L]4N--T>
M2Y\3W-G;.ERT7G*#%$RE]L9 8G&05XR>30!MT4V0,T;!'V,1PV,X/TKA_"OC
M6[N?$-YX>\0)%%>>=/\ V?<QH4CO8HY&1L DX=2IR,].: .ZHK#TO4+@2:R^
MIWD M[*Z,2N4$85!&CY8D]?G// XJ_8ZMI^I/+'9W<4TD./-16^9,],CJ,]O
M6@"[17,^.-6U#1M)L[K3YHXV?4+:"3='NW))*J$#/3@]<&M>_P!:TS2VQ?7T
M%N=N\B1P-J]-Q]%]SQ0!?HJC>:QIUA'$]U>0QK*I:/+9+J!DD =0!R3VJ*7Q
M%HL"6KRZM8HMVADMRTZ@2H%+%EYY& 3GI0!IT5FVOB#2+W36U&UU*VFLU?RS
M,D@*A\XV_7) QUY'K5FRU"TU&-Y+.XCF6-S&Y0YVL,$J?0C(XH LT51OM:TW
M37*7M[# 0H=M[8VJ3@$^@)! )ZD5S1\6#2_&NNV>MZG:6^EVMK;2P&0"/:TA
MDR"2<L?D'Y=* .SHJA<ZUIEG##-/?0+'.I>$A\^8H&2RXZ@ @Y'&*P_$NOW-
MM_PC-SI-Y ]GJ.J0V\C*HD$L3JQRK9P/N]?>@#JZ*YG1M6U"Y\=>)-+N9HWM
M+**TDME6/:5\P2%LGJ?NC_"F>+=<N]$U3PZ4NX(+&ZOC!=^:H^X(G?.XG"@;
M/_KT =316=I_B#1]5T^2_L-3M+FTB)$DT<H*ICD[CVXYYJ2PUC3M4>:.RO(9
MY("!*B-\R9Y&1U&>WK0!=HJO>7UK81"2[G2%6;:NX\LWH!W/!X%0)K6ER::N
MHI?V[6;G:LRR JS9QM!]<\8ZYXH OT5F'Q'HJZ9+J3ZK9I9PL4EF>4*J,.JM
MGHWL>:2#Q'HMS<W=O!JEI+-:)ON(TE!:->Y(% &I17.:5XYT#5=)M]1&HVUO
M%<S&&%9I0K,V\JHP><M@''O5M?%>@/9I=QZO9R6\@<J\<H8$(<.>.R]ST&:
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M,BG6FM:;?W'V>UO89I2AD"(V2R9 W#U7)'(XH O4444 %%%% !1110 4444
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M633Y##;@JU\8)-\K1XQGY< $?>(.,UU'A670-7UF;7-'M]1>=K46\]W=^>N
M&R(\2<,0<DD9QTSS78T4 <1XOOY-"\8^']<NX)Y=&BBN+>>2&)I/LTC["LC*
MH)P=I7..,^]9VI>5;:AX8UW3],EM] AU*XFNE$#*298RJW#1D94;F;DC@$'B
MO2** /(O%5D]S9?$'5+)6>PU"P@@@\M21<SJI!9 /O8!49'7!]*Z%7MQ\3M
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M^PW]O+(85QO,BO&=K="Q&".GO0!@^$O$@\.>%R\FEW3B\\27%FL,;(3"SSD
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M0J5ZDD$8]:M#Q.]MK=GI.I:<]K<7\3R69259%E9!EHR>-K@<XY!Y^;BL#6?
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MM;?VY<:O%?7T-Q<VR6TPCD7;($W;6(*GYAN;V]16[10!RT'@2QM]-T.PCO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X#Q[?2Z1KFFZEJFG7&H
M>%HX)$ND@4N()B5VRR(/O*%!'MDGKC/?UC7S:W!K0GM+>"ZTYK<))"TVR02;
MCRF1M/!P<D=O2@#'T;5]!TCPW>:S8ZK]MTJZNU:W_?E]C.L<8B!<_+\PZ$@*
M#S@"G0?$/2_.U6"\412Z=$DS>1*LZ3(YVKL9>K;L+@XY(['-8I^'U\=.UR>P
M-KI=_>:C!J-E:H2T,$D.TC=@#ER"6P,#(ZXK2U/1O$WB_P *7UAJR66DW+HA
MMEMYC./-1U=79BHP,J!M&>"<D\8 +]_XJOK&+5$DT*X6YL[ WT1+YAE49RID
M P'&.5YXY&:S!KL=WH?@RZU[299KB^N;8P2I(H2.=HBPD(!!P1OXP1Z]JTH;
M?Q/K>B7]KK=O86#S6<ELJ6\YF$DC+CS"2HVJ.R\GDY/ K*;P[X@F\/>#[.6U
MLUGT:\MY9PER2&CBC*<$J,L<YQT'K0!M7OBY+>+5;FTT^:]M-)<I>R1.H8,J
MAG"*?OE003R/09/%12>-HI-7M=.TS3+K4'O-/_M"VEC=%CECRH'+-Q][DD#V
MSFJ$'AW6=(;Q-8V,5O<V6LSRW4$LDNTV\DJX<.,<KD9&.>W'6G:7X4O-#\3:
M/-:QI+INFZ(=-#M)B1WW(V[;C&/D]>] '0^&]=A\2:%;ZI!#)"LI=6BEQNC=
M&*,IQQPRFD\0Z?87^G,=4^U/91 O)# 9/G^HC^9L<\#CG..!BCX'TB_T+PX+
M#44B69;F>4&*3>I625G'.!R-V/PK3U.YU:WGMO[/TV&\A8L)R]SY31]-I4;2
M&[YY'XT 8'PRN(KGP5 T&I/?0K/,L9E9C)"F\[8G+<[E4J#G\,C!KL*YBSTC
M4M"TC5[G3;>SFU;4+UKTP/*4A#-M4C=C/"KG..6STS73T <):W3^+/B-KNFW
M;.=)T*.",6H8A)YI5+%W ^\% P%/'?%;<GAJTM[N>Y@+I:/9O"]F'/E!LJP9
M%SA3P<XQGCTK/N/#^IZ/XTN_$FAQP7,>I11QZA92R>6S-&,))&V",X."IQGU
MK;#ZM/;3RR6L4),16*V$H8LQ[LV,#'H,]^O0 'GO@_5[!_@S"ETUU)=R6,KR
M2FWF<L_S8;?M/(XYSQBJ.H8B^"'AB]W2_:'ELFEF1F,C[W4/DCYFR.,=Z['P
MUX?U;1OA?'X>N((&U"&UDMUV39C8MNP=V,@<C/%95WX1U^7X9Z'X=CM[3[=8
M26S2,UP1&1"P;@[<\X]* -VR.A#78S96]];3VL#W#F2&:%63&W!$@ ;KGC.-
MOO6;X"C3QEX=7Q/KD8NIM0EE>""4[H[6)7**B+T!PN2V,DGK72;]:N;ZU5].
MM+>V!/GS&X\Q]F/NJNP=2%R<]!ZXQB>&M%UKP5;RZ-96D.HZ*LSR63_:/+E@
M5V+&-P1A@"3A@<^U &/\0]*_L/P'?/'=W3YU."2&1IG:6)'DC5D#YW$?>&/0
M@=JV=$73?&TMOKD17^R[-GAL[>-RI8@X+3*/I\J'H#D\D!7>-=#USQ%X3;3X
M$M6NY;J&8AI2L<2HZMM#;<L?EZX')/3I5;4/#6M:7XIA\0>$X+:)KS_D+V-Q
M.4AG]'&%.).OS <]^^0"EXPU2/0_&*WOB?3[BZ\,2VJ10W,:F2*SFW-O:1!T
M+ KA\9&,#O77>%8K2+08S8:B=0LY9))8+@SF8E&<L!O)).W.WD]JAD?7TU"Y
M=].M[O3IXD M_M \Q'P0XPPVLIX[@\'@YK T[3-5\!^%YCIUE92RW6JO<O8B
M8JD$4A_U4)Q\S<* , 98]J ._KSNQTRUOOBUXDMKA9'MXK*UDCB$KJJ,V_<0
M 0 3@<UZ)7&6^DZ[9>/]:UV*QM9;6]MH((E:ZV.#'NY(V$8.[U[4 4=-FN-&
M^)-SX/N+F>^TB^T[[=:K=2&5[=@^UH]S98J>HR3CI7":3>/<?#31X="O;V3Q
MM-.SV_ESR%F5;A@QER=IC"<'=QTKU#2_#E_%XEOO%6K-!/JLMN+2VMK=CY5O
M"#NVAV +,6Y+8'L*Y_2_ &JP?#_3+!WM[3Q'HTLEQ87D4A=-[.S%6. =C!MK
M#'OSB@#O]4U :5I$][(GF-$F5C7K(YX5![LQ 'UKDO 5[J5EJFM^%]=NOM&H
M6DHO8IN@EAF^8[?97WK[<"M*[LM7UN328-5TNS%E&_FWT0N/,5W"X0 %1N4,
M=W.#E5K/U7PG<67C#1-<\,Z=8P?9UDAOT#"$3POCY<!3DJ1N&<4 8\DFFV_Q
M4\11:C#=RVB6-M*D4$,TRHQW;FVQ@[2<#TS72V/AC2;K3;:\Q=/;M TD$,MP
M_P"[$A\P_P 7/4 9S@# INF:-JEO\1M7UR:"%;&]M88(\39=3'NY*XQ@[NQK
MIKA7CLG6VA5G";4CSM'H!GL* //_ (8:/#?>!?#NM/+.=25))#,T[MYA)=,.
M"<$8/Z"L;0[[3IQ'X=\2_:M&\9+*&-U-*RB^8/G*2@X=&Z;#QS@#BNX\ Z)J
M'AWP-8:+J"Q"ZM(V0M#)N5LLQ!!P#W]*Q]=\.:YXK\'P:!K&G6/V[$8?4EGW
M+$RD;I$!4-OP#QP.?O8H ] JKJ<4<^EW4<JAD,39!^E9UOJ.I_\ "6SZ7+:P
M'3EM1+%<I*6DW J")%Q@9R<>NP_AIWXF;3[A;>,22M&512VT$D8Y/:@#RSP8
M^C7WP[T-=0BU)]0O%2 W8BN ?,=]H;S<;>,YZ\XQ[5I_%/2(-/\  VO:S!)<
M+J#R0NLRSN#'F2-,* < ;?3U-7_#&F>)?#O@:PT3^R]/N+NTAV+(]X?++!B5
M8C9G@X/X5=\?:#J?B+P+=:)8&*6\N!$#+._EK\CJQ)P#UVG@#O0!F>-73P)X
M9O\ 5]$#QWMR(K.)'D9XUD9\*^&) (#,?? S6ZO@W3?[*:U9[@WC1%&U(3,+
MHL1R_F9SUYQT[8QQ4GBCP['XO\*7.D7A:V>=0RNIW&&12&5AZX('U%,TZY\4
M_94MK_3;(7:KM:\CN287/]\)M#>^W\-W>@#:LX7M[&WAD??)'$J,P_B(&":A
MTF]N-1TR*ZNM/GL)GW;K:<J73#$#)4D<@9_&FQOJBZN('B@?35M0?M)DQ*T^
M[!!0#&W;SGU[4[2)-2ETR%]7M[>WOCN\R.WD+HOS'&&(!/&#TH FO+N&PL9[
MRX?9!!&TLC>BJ,G^5<-X.U+5K+QAJFBZ](3-J,2:O9AO^6:L LD(/^P0H^G/
M>ND\1V-YJBV=C':PS:>]PKWPDDVEHU^8*!@YRP7(. 5R.]8?B3P=(FIZ%JWA
M;3=/M[_3[O?*<B%9(&4J\9VJ<D@C'IB@!\,*?\+BU&/YMDN@0LXW'DF>12?;
M@#IZ5)\+./AY8#).)KD9)R?^/B2K,6E:FOQ#N->:WB%G)I4=F%$WS^8LCOTQ
MC'SXSGM4G@31[_0/"EOIFHI$MQ%+,Q,4F]2'E9Q@X'9L=.U &EJFL1Z=<6=H
ML9GO;UV2WA! W;5W,Q)Z* .3SU  )-<1XOU8ZGI&DW4NG7EI<67B6UMWA<'+
ME91DIT#JPQ@_RK?\7:+JUUJ&C:YH1MY-0TJ23_1KARB3Q2*%==P!VG@$'':J
MNNZ3XBUS2],,T%FEU#JMO?/ DY*11Q,&V!]H+L<'G '/MD@%R#QM;)_;BZI9
M3Z=+I"QO-'(Z/N20'RRI4D9)!&,]:@B^(6EIJ-Y9WYCMS;637_FQ3K/&T2G#
M#*]'''R^_!-9^K^#=4UG4O%;%XK6+5;6T2TF$FYHY8&9@67'0L1T)X!JU-I7
MB?Q7X9U'2/$45AIPGM6@WV<S3>;(>DF"HVJ"/NY).>HQR :3:S-?3MI=[HUY
M;)=63SQS9W( ."CLOW'Y'&2/>L3X<ZNY\%^&K"WMWNI38H]Q(' 6 =MY/=NP
M'/&>G-:FCGQA+8>3K5KI\3P0F/=;7!<W;XP&Y4>6O?')SZ 8//\ @[P=K_@W
M^RFLX[8Q26P@U>V\\['D0 )-$=OWL<$' ( [\T =7IOB8:K<I]CM#+:-=36C
M3I*"T3Q[\ETZJ"4P.<\C(&:WZX2#PG>-XLLM<CLX=,OTN'-_<VL_[N^@PP56
MC &7)*$DCC!P3Q70^&M2U/4[*Y;5;2WMYX;EX5^S2F2.10 0P8@>I4^ZF@"Q
MJVLQ:4UG!Y;3W=[-Y-M I +M@L22>BA023Z#N2 >!L=?;PYK7Q"UB[TVX(M&
MM9)+>*57./*)+*S$?*<Y]>>F>*Z;Q;HFIWNI:'K>C^3)?:1.[_9IW*)/'(FQ
MUW8.&QT.,5S^I^%?$FJ6_C7=:6,3:]!!' OVLMY92/8=QV=/IW_.@#I4\47C
MR0PGP_?12W4_E6IE9=CKY9<R,RYV# (P1G.!CKC"\4>,9[WX6:OJ^DPS03QF
M6UD/F*&@=7\MB"#SST(]0:UM>TW7;T:"UM!;36]N[?VAI\UP42;*84[@IW!6
MYP1@\<<5@2^#?$#?#[Q#X?6"P%Q?WTTUNR3D($>7S,M\ORX'  S0!:CD?0?'
MNFV>G:$MFNKP2RW2)<#:QAP 0H^4'#@DCDX [<]%IOB8:M<I]CM#+9M=36C3
MI*"8GCWYWIU4$I@<YY&0,U4U;2=6NO%7A[6[2"VQ:17$%S%-,5*"79AE(4[L
M;.G&<CI6=;^$[P^*[+7([.'3+Y+AS?W%K/\ N[Z##!5:, 9<DH22.,'!/% '
M=UFZMK,.E/9P%&FN[Z;R+:!2 78*6))/10JDD^W<X%5_#6I:GJ5I=MJMI;V\
M\%T\*_9I3)'(@ (8,0/4J?=3]*I^*M"O=0U#1-8TPQF^TBY:5896VK-&Z%)%
MS@X;:>#C&10!7O/'MOIUAKLEUIUR+W1462ZM$9"6C8961&) 93@^XP>*V]&U
M2YU1)WGTJYL8U9?):=D/G(5!W *21UQ@X-<GKWA#4]:M?$]ZL,,5_J]@EA;P
MO+Q$B[CN=@.I+'@9X YY..WL5E2PMUGC$<JQJKJK;@"!V/>@"GJ>M1V%]9:=
M'$9[^]WF&$-M&U!EF8]E&0.A.2.*Y?7?'TUOX8U6YL+%H]4TZZCL[JWF=<P&
M1E57'4,"'!7U[XP16IX@T._E\3Z+XBTP1RSV"RP3VTC[/.AD SM;H&!4$9X/
M/(K'UCP5J.IZ3XGN8_(CU36;BUF2%I#L1;<IL5F ^\=C9(& 6QSC) &W=U=6
MOQ8AN(=-GGNY?#\F;5)E^\)TZL3M P.O\ZV+?QWIUUH6EZBJ^5)J3.D4%S*L
M>UD)#[F)P I4C(SG(P.:;'I>LMX]M]?GM;98%TE[-TCN-S"1I%DXRHR %QGC
MGM7/67@_Q/I.AZ%<6(LCK&CW-VQMY)CY-S#.Y9EWXRK#*X..HH UE^)=B^F)
M=)IUW*_]J+I<T<+(_ERD@ @[OF4YR".O?%=5I5Y<W]@L]YITVGS%F4V\SJS#
M!(!RI(P0,_C7+ZYI7B77-+TQI[:R2[AU6WO7MTN"4BCB8':'VY=CSS@#G';)
M[0$D D8/I0!D7>NE-6ETK3[0WE]#;BXF3S BHC$A06/\3%6P/8Y(XSC-\0[*
M2QT>ZL].OKD:I</:)&H16BF4-F-P6X;*$>G?.*FET;4M,\<W7B#3HH[NVU"T
MC@NK=I-CH\9.QU)&",,01P>XSTK(3P7J=BN@FW2WFEM]8FU6^/FE5W2B0%8^
M.<;P!G&=O;- &['XCFU _P!GIHTW]H?91<7=G).B_9U8D*I<$@LVUL =AR1Q
M7-^ _$5MI'PX\/13,OVJ\^T>2EQ,(QA97+%F;H!D#N<D<5LRZ/K>E>/+W6]+
M@MKRSU2WBBN89IS$T,D60K@[3E2&.1UK T[PAXJT70_#EU9+I[ZMH[7,<EJ\
M[>5<P3/N(W[?E8$+C@CCKVH V4^)5C+IEM=Q:;>2O+JG]E21Q,C>7/\ 7=AE
M(Y!'!SSBKJ^,)VD-HVBS1:HEHUY)82W$8D\L.Z#9@D.3L)Z@ $9/-5-:TKQ'
MK-EHLLUO9+=6VK0W\L"3G9%&G\"OMR['.<X YQVH\9>&9O$DKH^F0RE+8?8+
MZ.X\FXM+G+9.X#.S[AX)Z'Y30!V4;;XU?!&X X/:N$UEY=7^)4.@WVFB[TLZ
M3+(87D7:2TJ*9<>JC('<9..M=K80SV^G6T-S/Y]Q'$B2S8QYC  %L>YYK DT
MK4O^%DQZVL$1T]=,:R)\WY]QE5]VW&,8&.N: *</BZPT;PY!?0VER_ARVD%G
M]O:;>RJK>5YA!^9DW#&[.>^,<U:?QC*_B.]T6TT&^N9K-K?SI%>,*(Y2?W@R
MW08SCKUXXK"M_!>K1>"+KP,XA;3GE9(;_P WYEMFDWD,F,^8 2!VZ'(Z5OZ/
MHU_8^-]<U*2&);"]@MHH"LN7'E!P<KCH=W')Z4 =)*SI$[1IYCA253.-Q],U
MY/JFNWOB+X;:7K6H6AAE_MJW9!$^[*_:]NT =< !>1SUKUNO-(_"'B*+P-9^
M'S!8M)9:FEPD@N#B2-;@S9/R\$C  Y[\T ='#XUMXYM:AU6RGTU]*A2YD$K(
M^^)]VUAM)&<J1CUQUI=,\:VE_P"(UT1XECN);<W$+Q7"3(R@X925/RN,@XY'
MH363K/@_4==UGQ&\ACMK74],AM(95DW/'+&SL&*XZ98=^U;?AZ3Q9,47Q#;:
M=:B!-K/:3&0W+]-V"HV+WQDDG'0#D TM=U9-"T*]U62WEGBLX6F>.';N*J,G
M&X@=!6#9>.DGUK3+"\T>]L8=5C+V%U,4*3,%W%2 24..1N S[5>\=_\ )/?$
MG_8+N?\ T4U8]AI%_KMMX3N+J".U@TJ);G<) YEE\G8FT=E&XL<X.0!CO0!?
MM/&B7&H:5;R:;<6Z:L9ELVE(5R8P2=Z'E 0I(Z^^*=9^,DN]&U:^.G3Q3:;<
MM:R6CNOF-("  ,<?-N7;SSD5S6G>%/%$=[X;O;VVTV2]TVZE:\NC=,TET'C=
M/,SLXQN&$_ ;0*U/[)M[_P")0O\ 3[V.2R>V2XU&&(AE>:-BMNQ([\N?^V2T
M 7+CQI-'?ZQ86^@7L]UI4,4TJB6-597#'*DM_LGW)["BS\=0WEUH9&EW<5AK
M2_Z)>2% "_EF0*4!W#@'GU'I@TQ=$U6/Q/XIU 6\+0:G:006W[[#;HU<'<,<
M [_?I6=;>%M:@T?P/:-!;&30I$:Z(GX8+$T?R<<_>SSCI0!?N?B-I5M/;MA9
M+*:\^Q><DZ%U?<5W&/.[9N&-W7OC'-0W7Q%6VL]6O#H.H&UTB\-M>R%XQY8
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M@<\GK6GKNM3P>)=#T"VE\B34O/D><*"R)$H)"@@C<2R\D' !XZ4 =$2 "2<
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M-.T_5H;&S_LZUOXMUF)'4.[90Y/.0O7MV%0R^)M8M=6TDM?1W*7>M/83QP1
MVR1GS-@60J&,@V#=@D [@<<4 =]<7$=M;33R$[(4+OM4L< 9. .2?84VSNXK
M^Q@O(-_DSQK(F]"IVL,C(/(//0UP&D3ZK;_\)_>)JTLDUI>2B$3QHR#;;QLO
M  /'3&<=R":N:7XFO]7F\+Z3]I,%S?Z*NIW=TB+N/RH-J @J,LY)X. ,#KD
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MU/3Y3+:7"[XI"I7<,XS@\CI7-:=_R5CQ%_V"[/\ ]"FIWPK_ .28:!_U[?\
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M%(.[/K[4[2O$&L3V-SHMW>X\1P:H+-W6) #$?W@D"XQM,(8\_P 0(S0!WU%
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M1[&]=51[BWCF9%/"EE!Q^M &!I'A6'PG:O.NHZSJD%E$QM;2>02^4H4_+&H
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M+F^N[N.PN&N;6.;9^[<AAU"@D ,0 3Z=<"LV3X<V,EM+:#5M42R-\+^*V21
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M@O+JX%Y=27<GV@H<2.<L1M4<9[4EYX<@N_$=MKJW=W;W<$#6Q$+*%EC+!MK
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M&@@)_NC&2!G@,2!UZX-=3D$D C(ZU5U+4K32;)[R]F6*%2%R>[$@*![DD 4
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MKU.ZTK3K^:.:\L+6XEB_U;S0J[)]"1Q2W.FV%[)')=V5M.\?W&EB5BOT)'%
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M&AW!U&:S-F\R[&N-Q++$>-P)/ 'T[5TKZ1ILMG':2:?:/;1G<D+0J44^H7&
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MU[F+4;.:&)X_%L4<DMS(#=%A*J2 'C9$!D!3G*]<5['%%'!$L4,:QQH,*B#
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MIXYH X#5KFPU/QCJ6D>(K^SM8)M-@:R^VQJ4=&#^:T98@!PV,XYX7TKM=%M
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M"#P: .&:WL!\6-*6S2$6\FAW*;8<!"!+$, #CUZ5QEKI=@OPVT#4DB"WT?B
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MW!(.W;G& <GH.G7BLEM,G@\2^#9K;0?L-G:?;&FAM8E$=J)5P@.WC<3][;D
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@!LB"2-HVSM8$'!(//N.E9NA
MZ!8^'K,VUEY[;CEY;B9I9'[#+,2< < =!6I10 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<J313^;'*'+CC*J01LY!'>M>@ HK.U[5XM!T*\U25&D%O&66)?O2-T5![LQ
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M%-?G/CJ3P\]K&L(TX7J7 E)9OWFS:5P,=^Y[4 ;U%%% !1110 4444 %%%%
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MH,>IBWL;J>W2." W(8R@(""O R2HR0!Q6SJA TF\)X'D/_Z":<^GV3M;,]I
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M$-E_R-2WD(,^,327+3A)8G[D8+ J>  ., 5N:/X>TO5/B)XN^VP--]CO+.:
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M ';6&IP:BUPD2S));N(Y4FB9"K$!AU'/!'(R*EOKQ-/L)[R1)72%"[+$A9B
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MN[[)(\+K'<;1D['(P>.1SR.1D5@7EC=ZA\0$N([>ZBM9?#\MG]I,+ 1RO(K
M'T. 3^G6J'@^TF\G2M*U/P7)!J>EA$>_E1&MQL&WS(GSDLP'  XSSP* .SL_
M$.GW]S!#;M,WVA6>"0PL(Y57J5;&.X^O49'-6K_4K73(XFN9"#-((HD52SR.
M03M51R3@$^P!)X%<+X6TJ_TW7]/;2H]1M=(GCE>_TN^0F.RD(R/(=O5B1M4D
M8)/%:_BZQOQKWAK7;.WDNH=+N9?M-O$,N8Y8RF]1_$5ZX'."<4 7Y?&6AP:7
MJ&H37,D<6G-LO$:!_,@.,_,F-P!'(.,$=ZNZ3KMCK?VC["TS"W<(S20O&#D
M@J6 W @]1D5P7B/0K_4;7QQJEI97)_M:PALK2W\HK),R*V7*GE1\P4;L?=/;
M&?1M/;?IULVQXSY2Y1U*LIQT(- &?J'BK2=--S]HFD\NT(%U+'"[I;D@$;V
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#"\77]_9Z!+%HX5M7N\V]D&Z>85)W?
M\!4,W_ :7PKKJ^*?"5AJJ$Q27$.)57K%*/E=>?1@1S5.2VDUSQ9,TO\ :-I!
MIT/EVTBHT:RNY_>,&(P0 $4?\"[&LCPI;77A?Q;XATG[+J$FBW,HOK6Z:!F5
M9F'[U,@<Y(W# QU'6@#GAXH\06OPYO\ Q(WB*5]0M;^6""VF@A,=QMFV+'M5
M Q)']TYS7HTUKJFIBTN1J5UI<?V;=);P)$S&1L'#%T;A>1QC.?:O-]$\'WY\
M.'5;'3GLO%&FZG<WEK]H@,?VF-W)\IB1R&4XZY4XZ5Z?I^K_ &_11?2V%[:2
M;,R6TT#>8C8Y7 'S?49% ')^ )=?\0^$M$UV[\0W4DLYD-S T, C=0SH,8C#
M C"GKV]ZS['QM?Z-X+\4:YJEU+J,MAJUQ8VD3HB;MKA(U^11W/)],UN?"ZVN
MM+^'&F6.H6EQ:W5JL@EAEB8,,R,PQQSP1TS7+V_A*_\ $/@/Q5H[6\]C>W&M
M7%_9-<PLBL/,#QG)'0XQZC/2@#NH]'UQM*WR^(9UU9H\EEBC\A)".@3;G8#Z
MG=CO6+<7^MP^/O#.E2:G-%#=Z?+-=P*D1!EC"]&*DXRQS@UM:;XFGNK2-+K1
M-4MM3V@26S6S; _?$W^K*YZ'=T[=JPM<-Y%\2_#^I-IM[/;6EC<17,MM;/(B
M.^W ''/0]* .I\2S7%MX8U2YM+A[>X@M)98Y$"DAE0D<,"#R/2N8\/WUUJ?A
MC0;R3Q=,-3OH()#"5MRKR%0[IM$>X @-T.16CK&JW&K:%KEM;Z5J"1_8)(XS
M+;,K32NK *B]<#')( ^8>]9/A[[/IO@W0H7\-WLFLV-K"BI]@="LXCV',A7
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M]ZA\90SZG\-->TK1]#O8D<B*T@^S,K2L7#NP7'RIR<9QT/M0!;GUC5M'\?\
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MV[_.\F+'^O\ +QMV8QMKN["]M8=0N/L&C7=O;M'YUQ,;-XP[C"JJI@%FQG)
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MIXFMI(X H/#RNY1<\8RQ !P,5U>F)9W'B%\>'GTZ:UMP4FDCC4R"0D,H*$Y
MV G/M0!NQWEK,^R*YA=CV5P32RW$%OCSIHX]W3>P&?SKP>)=/N/!VIZ#!I8;
M6M2UR\ATZX,8B2*19<@B8XVE0. #D] *]FBT"UGAT^35H8;^]M;80F::,,"2
M%WL 1QDJ* +ZW]FYPMW 3Z"04"_LR"1=P8'4^8./UKS_ .$^B:9=?#K0[N6Q
M@-U#//)'.(P'!$\@^]C/3CZ5GZ);0#P)\35$,8']J:J,;1T"<?E0!Z@M]:.X
M1+J!F)P ) 2:='=VTS[(KB)V_NJX)K@?!T5E>^'_  I:3^&GC(L;>X2^DBC
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M ,(;#<>"([6]M);IGCB=S"L:O*6D7&"5*[CA<>E '7U&\\,<JQ/+&LC?=4L
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MMQ;.\]U(',8)(3?DL!DD\<GOFM+3M.%EHEKILLAN5AMT@=Y.3( H4DYSU]Z
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MF>*2-\$9#(01D$CK6>W@/PZ^G:AIYLI!:ZA,)[F-;J50[Y!SPV1R 3C&2.:
M*5U_R6/3/^P'<_\ HZ*K7B?59;;7/#FD"9K>#5+F2.:9&VMA(V8(&_A+-@9'
M. <<G-:9\/:<=;@U@I,;^" V\<IN9#B,D$@KNP<D \CM2Z[X?TSQ+IXLM5MO
M.A5Q*A#E&C<=&5E(*D>H- '%^.+&XT[X>:];3ZJ]^OVVWD@649>WC:>+$98D
ME\$'!/.#3O&VI7L">)YK#4[I[C3=.2:..W;RDLG"N^Z0YQ(7 &%(. .<;LGI
MY?!NB3Z VB36\TED\@ED#74N^5P00SR;MS'*KU/8>@IE]X(T#4;J\N;JUE=[
MVW%O= 7,JK.@!5=ZAL,P!X8C(]: .9\4:SJ=FJWUVFH?V-+IL9:\TR0^9I\Y
MW%I9(@073!4YY V'CFE\2:_<:?JDU[>O?+H$R0_9=4T^4LEH2 3Y\8/W6R#N
M(/##IUKJ#X/TCRC$J72Q/;+:2(MW+B6(;L*WS<_>;GKR>:DN/"FDW+W'F0R^
M3<A!/;K,XAD" *H*9VXPH' &0,'(H Y>:?7/%%SXC@TN^6RN].O!;VK_ &MT
M$.$1@SQ!") Q+?>[<#&,F'7-<O\ 2]3:XUA[M-)E%OY&J:9,6AM7PI=9HP<[
M6)^\0?E8=*Z;4O WA_5=:_M>YLW^V,H25HIWC6=1T$BJ0''L0>..E6KKPOI=
MY/=231S,EVR-<0^>_E2E  N4SCHJ@X SCG- !XKNS8^%M1N%U(::RQ86[,7F
M>420 0O\1R< >I%<>NHZI!J_BK3TN+^TAAT:.]MEGF$TL,G[T$Y;=C.P<9('
M;&:[O5M)L=<TJXTS48!/:7"[9(R2,\Y'(Y!! .1Z5E+X'T%9YIS!<M//:_9)
MI7O)F>2/G[S%LD_,1NZ@' .* .5T:\U2WO\ X?7,NL7MS_;5FRWD4S@QMBU\
MT$#'#;AUZG)S65K%Y-XF^$@\2W%Y<">XU"%C LI$2(+Q46/9TX !)QNR.N.*
M]%C\(Z-$=(*03C^R%VV/^ER_N1MVX^]S\O'.>.*I3_#SPW<+>1M:W"V]Y,+B
M:VCNY4A,@8-O"*P )*CD"@#8U_[>?#]^-*ECBU PLML\I 42$87D^^*\^D\9
MO8:/K,BKJ.FZG ;.*>QU.4R"U$DOEM,DAW!D(;KR,H..U>D7FG6VH:;)I]RK
MO;2)L8"1@Q'^\#NS[YS5$^&-)EBO([JW:[^V0K;SM=2-(SQ#.$R3P 6)X[G/
M7F@#E]6MO$.D6/B"[35_L]F=(EGMX!=M<31SQ@DNK2)]P@@$<X.,8S5'51JV
ME_#VWUR/Q%J<EW=G3F=7=-B[G17"_+D!@YSSG@<]<]58^!- T_2KO38;>X-M
M=1&"427<KMY73RU8ME5YZ BK=UX5TB]T&#1+B&9]/@V>7%]JE!&P@IE@VXX(
M&,GL* .<OKC5_$6O>)=(T^[^RSZ:(H[9UO'A,;/$'$I54/F#<<88XPG09)JA
MK^L:OI<:W6KRW4NF-I\2OJ>C2DK9W&#OE>($%D.5(." !TYS75:MX(T'6M3A
MU&[MI?MD<8B,T-S)$TB?W7*L-P^N:L77A;2KMYS)',L=Q"MO/#'.Z1R1J" I
M0'&,$C@#@XZ4 -\4ZV^B^#-4UJS19Y+>T>>$=58[<@GV[_2N<O+N_P!%N?"%
M]:ZA<WD>JW,=I>1RR%UE\R)G$JCHA4J3A<#!Z=*[IX(9+9K=XD:!D*-&5!4K
MC&,>F.U96F^%M*TIK8VT4Q6T!6U26=Y%MP1@A Q.../8<#CB@#G?!=BD/C+Q
MDXGN6,>H1J \S,#FWC/()Y/N:L>,]0U+3;ZWNEM+Z\T:.W?[6NFS;;BW<D;9
M=H(+J &&/J<'%;^G>'].TF_O;VSCF6XOG$EPSW$CAV P#AF('  X]*=>Z':7
M]X+R1KF.<1&$O#</'E"<D$ X/UZCL10!P\:IK?CO0#;:M</#/X:D;[9 =DDR
MF6'G)&5)Z^HI-#UF^OO#/AV*\U6ZEN9+Z[MWAAXGODA:50/,!79M"JS-D9QC
MO@]C#X4T>VU"UOK>V>&>UM?L<'E3R*L</'R!0VW' [9X%5%\!>'DMK2".VN(
MULYWN+=TO9E>-WSOPX?< V3D9P<T <7_ &SKLGA&S(U:Y@N8O%(TTR!E=FB^
MT[ K,1EL#C/&<<YK<<7T/BA?"::C=W4:V#7PDN;YH9I"\K+@/&F2$ &!Q]X9
MS@5L?\(#X<%LUNMG*D+7@OMB7<J@3 [@PPW&#R .,]JLZ[X1T;Q&UK)J-O(9
M[0DP7$,[Q2QYZ@.I!P?K0!REW<^)]'TO2FU-IM<AM8YX]1;2)BDX;<!'+M&T
MOM4,K*,<G.#CCL-$U"&Y\)V-_;74FH1&S5UG(P\^%ZD=F)'(]:3_ (1G34^R
MF!;BV-K$T,1@N'3Y&(+ X/S$D Y.3GG.:T+&QMM-L8+*SA6&V@01QQKT51T%
M 'FCZ]JG_"L]-\<6]]/)J#RPRS6XD)AE2281F$)T& V 0-V5Y)R:V+6Q3_A<
M^HOY]SD:/;RX\YL9,TO&,_=]NE;]MX1T:TES#;NL(N/M2VWG.85ESG>(\[0<
M\XQ@'D#/-6(_#^G1:_+KB1S#4)8A"\AN)""@)(79NVX!)/3N: .<^(MN)Y/"
MN9IXPVNV\9$4K(""&/.#UX&#VK)NK&:?QEXV$&I7MF8-,LW5[>3:Y94F*DL0
M3QC\>]=[K&B6&O6L=MJ$3ND4R3QF.5HW21?NLK*001[&JB^$]'2ZO[E89UEO
MX5@N"+J4;XU!"KC=@8!/3'4T <GIGB#4O$#^'M-ED'F7>@1ZC*5NFMFFD;:"
M0R*3\O)P,#YN<XKK_"\.J6VA16VLW\-]?0LT;W$1SN )V[N!\P& >.HJC>>
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MK)L29X\LI#*<J0>" ?PH Y(6=^WQ"OM .OZK]@GTN.];$RB19/-9#L;;\BD
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M4E#;MRH&PISSQB@#J:*10%4*,X QR<TM !1110 4444 %%%% !1110 4444
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M#,<[8]HP-N!\O4[L5TNE0Z1J/Q7\0-)!:S[["S>,21@DL#(S'!'WA\A/<<4
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MU'?O&\UW)D1RR*I'R# ' QD@8/U!H T]=\2:9X<2T;4;F.$W=PEO"K, 6+,
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M!0!+JEM=WFF3V]A?M873KB.Y6)9#&<]=K<'TIFDZ;_9=EY3W#W-Q(YEGN)
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M23(B \L" H+9[DG@<9KFO!_BA="T(1W=E?S6DFMW-HUZ6#)$S7#(@;<V]AR
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M,I7/ZUR_A>U\5PZ7:Z%K5E9PVUG#]G>^AN=YND5=J[4V_(2,$DGMP.>.SHH
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MM[KSAY<0>)8SYBGYLC:3A0<],CK3/$WA[[)X>\/6>C7RP:OI,MO;6,K#+%6
MB<$>ACW,?]S/:N]K.70=*77'UL:?;_VF\8B-UL&_:.V?TH M65I#I]C;V=NN
MV&"-8D'HH&!7'ZAHVN0>*]>N["R@N;76-/B@\UYPGD/&)!RN,L"'&,=Q@XZU
MV]% 'GND>'-<LKCP*;FRCVZ+82VUT8YU;EHT12N<9^YD^F>,U7E\*:[)X=U:
M%;.,73^(AJ]O$\Z@21^<K[2PSM;"GVZ<UZ-<3PVMO+<7$J10Q*7DD<X55 R2
M3V&*HZ=K^FZK>75G:3.;FU"F:&6%XG4-RIPX!(.#R..* ,;^SM5?XAVFMRV2
MBU327M)"DRG$C2(_&<$@!<9XY[8J7P/I=_H^DWEOJ%N(9)=0N;E,.&!221G'
M3N <&NFHH Y?5]*U-O'.BZU900SV\%K/:SAY=A3>48,.#N^X1CZ5S=WX6UVX
M\%^)=+6P476I:P][ #.FWRVF23YCG@X4C'/)'X>F5G:KKFGZ-&7O9G7$;2E8
MXGE8(N-S[4!.T9&3C R* .5?3O$NC^*]2O=,TJRU+3]8:.9DN;D0O:3+&J')
MVMN4A5/'/]>WMTDCMHDE=7D5 '95VACCD@=OI3;6Z@OK.&[M95EMYXUDBD4Y
M#J1D$?4&IJ .%\+:9XJ\.QGP[]DM)-+AN'>WU0W'SB%G+[#%MR7&2,YQWYQ@
MLTO2?%&A:A?Z7;Z?876EW5Y+<VVHR3[7MEE<NRM'M)<AF;&" >,D=N]HH YC
M0M,U"T\9^)M0N;7R[347MVMW\Q2?W<80Y /&3R/;KBN:E\*>(?\ A6.J^%Q9
MV[7#W$IMI%N!B17N#+N.0-H .,<G/I7IE% '*:MI^IWGC;PWJL-BQM+"*Y6X
MS*@8&54  &><%>>?IFL?4_!VJ:S+XWA*BT75S;/93EPV'A50-P'(!91Z\>_%
M=Y>7D&GV-Q>7+E(+>-I96"EMJJ,DX')X]*AEU6RAL(;V28B"?;Y7R,6<M]T!
M<;B3Z8S0!SJR>-M4T"^CFM++2-1%H\<#)<><))R.'^[\BCL#D\\].<_0O#VL
MVWC&QUB;2;6TA.E-9W7^F>;+YF]6WLVWYR=I[GW/:NFT;Q7HWB"YGM],NVFF
MMUS,AA=#'\Q7#;@,-E2".HK9H \PM/"7B>Q\(>'XH+:R_M7P]<,T4,D^8[R,
MAU<9Q\A*OQG.".:[K0VU2:W>XU2QM]/D<@):0RB78!W9P "3GH!@ #GK6K10
M!S&NZ7?W?C3PSJ-O;>9::>UP;A_,4$>9'L& 3S@\GVZ9K(L_"UZGBRSUJUL3
MI%T;B0ZH\$X-O>Q88*3&#_K"2AR0,?-R>*[ZJ!UG3QKBZ,;@?V@T!N!#M/\
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M;A]D,2EG;!. /I46G:A:ZMIMOJ%C+YMK<QB2*3:1N4\@X/- ')VNBZY;^)M
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M,5W#-#M+))&V5.&!!^A%5_\ A&<>)#KBZE<_:?L L-K*A79NW;CQ][=SZ>U
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MQK%O%!,L>U1&(B2A7C.02>N<TJ^"2=3GU*;7=0FN[C3_ +!,[K$ ZY8AMH0
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MBBAMS"8,0>N2  :Y7P[906/A?X::K;ATOI[U+:2;S&):)HY<IUQMX''KSUH
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MD@XB)#$@#V YQ69JX@D\"_$.QE-I)'::BDD$,0!CA^6$ML!S@ L>F.2>F<4
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MH.2!@8/&16EK/D^&M*O6L-9233;W5;);Y+-?+@L(';$NPACLW@#(SQNSQD4
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MHQ[8LG 5U(5L%0" -N,,:UK?Q/I%S!>2I=%392B&XCDB9)(W;&U2A&XELC&
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MA4-*/1CC+?C7)^#1KVM^%M#UFX\1WCO=VV^YB,-N%^9#@IB,$$-M/)(QFH?
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MI4M=-_LG4+J-FUBWM7DB@/E2@RA9$\PKCU'!'(([$4 =K9V5IIULMM96L-M
MOW8H8PBCZ <5!+HNE3WAO)M-M)+EBI:9H5+DK]W)QDXQQZ5)J5_%I>F7-_,D
MKQ6\9D98D+L0!G@#K7":AXOFN['P3K4-S<V-MJ%W&MW;M$55@T#28&Y=S#(
M!4X/O0!W4FE:=+>M>R6%J]TT1A:=H5+F,]4+8SM]NE06GA[1;![=[/2+"W:W
MW>28K9$,>[[VW XSCG'6H;'Q3I&H6%U>PW+K%:2F&X6:%XI(WX^4HP#9.X8&
M.<C%2Z=K^GZI>75G;RR"[M=IF@FA>)U#?=;:P!(/J.* )%T/25M+FT72[(6U
MTQ>XB$"A)F/4L,88GWHM]$TJTTMM,MM-LXK!@0UJD*B-@>N5Q@YJMK'BG1]!
MNH+74;EXI[A'>*-87<N$&6QM!R?;KR*JZ=K6FZGXES::M=/(^FQSBQ>(I&(V
M;*R_,H.XYQU[=.* -"P\.Z)I<J2V&D6-K(B;$>&W1"J]< @=.:LWNGV>I6_D
M7UI!<P[@P2:,. PZ'![CUK*'C/0C)9H+MR+TL+5Q;R%)RO78P7!]?IR..:YS
M0O&=OI<WB*/7]4N)5M];>VBE>!G$,>R+:'*+M1=S$ M@$Y]Z .RDT32IK 6$
MNF6<EF&W"W>!3&#G.=I&,YYIZ:1IL5\M]'I]HEVJ>6)UA42!?[N[&<>U97_"
M5VW_  F<OAXP7"O#:+</,8'V?,Q YQ@#Y6RQXSQG@U>L-?T_4KB*"V>8M+";
MB(O Z+)&"HW*S  CYE_,4 :=%%% !1110 4444 %%%% !1110 4444 %%%%
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MMQ=BT\^+[24,@AWC>5! +;>N,D#/O1;W5O=HSVT\4R*[(6C<, P."..X/!%
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M*K--+OC=7>O/<P1?9GW21FX1PPXZ;5)KU:WN(+N!)[::.:%^5DC8,K?0BI*
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MK<PSJC;',4@8*V <''0X(/XU/0!YEX/LY4M-)T+5O"%T-2TEHU^VS+NM1Y?
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M6#*&4@@C(([T <:T<\OQ+TB^2SNA:+H\T#S&W<*KL\;*I)'!PIKD[+3-;LO
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M<;1ZU)HVAWVG>*-=U6>:W>'5'A81IN#1>7'L')^]G /;'O0!T5%%% !1110
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MYW--&#EE(*'/. .@SFIX[^ZE\4>,;1;Z<VD.G6UQ; 2G]VSK*2R'J,[5]N*
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MDD+99HXC.[10EOO%$)*H3D]!T)'2I+6[UBWU5%O[C3[C2GM'F^V0QM%M<,F
M<NPP59B#GM[<Z2ZOIK);.NHVA2Z;;;L)EQ,?1.?F/TH EO;*VU&RFL[V".XM
MIE*212+N5@>Q%9=CX6T[3TCBCDOI+>+'EV\]Y++&F.@VLQR!V!SC Q5^?5M.
MM;N.TN+^UAN9" D,DRJ[$], G)S7.V?BS[/XI\1V.MZAI]K96#VRVTDA$.?-
M1FPQ9N6X[8Z=* -6[\+Z7>:C<7[1S17%U$(;EH)WB$Z#@!PI&< D9ZXXSBGO
MX;TM]5L-2$#I<6$1AMO+F=$C0@ J$!VXX';L*U@00"#D&H+J\M;&'SKNYAMX
MLXWRN%&?3)H XS3_  W-=^-?%=UJ%I>P66H?9UB=+C8LZ+$$8$(V1SZ@'%=)
M>>&M+O);&;R&@GL5*6LMLYB:)",% 5Q\N /E/' JW_:FG_V>M_\ ;K;[$P!6
MX\U?+(/'#9Q3%UG2WM8+I=2LS;W#B.&43KLD8G 53G!.>,"@"E<^$=&NK*TL
MY+>00VMR+N()<2(?.W;O,9@V6;))R2>32ZAX4T?4]534KJWD:Z$'V9F2>1!+
M%G.QPI =<DG#9ZU"?&WATZK8Z=%JUG-->*[QM'.K+A3CJ#C);@#N0?2G'6XM
M/M-9O[_5;">UM9246$A3" @/EN=QRY/TZCB@!D?@C08K/2[5+658]+)-H1<R
MAD!&TJ6W9*D<;22, #&*LIX6T=)M5E:U:4ZL +U9I7D68!=HRK$@<<< <5S>
MEZ]K.KV^C:K#X@T*&POA 9[>1<R1RL5)@0AN6*MCGD$#CG ["[U;3K"5(KS4
M+6WDDQL2:94+9.!@$\\\4 5+#PUIVG-$T(N'>&$P0/-</(T,9QE4+$XZ#GKP
M.>!51? ^@II5MIBV]P+.UN?M<,?VN7Y)=V\-G=G[Q)ZXR:U;O5],L)EAO-0M
M+>5\;4FF5"<G P">YXJG+XHTF'Q/'X?>\A6_> S>69 ,?,JJO/\ $V[('7 /
MM0!;U;2+'7-)GTO48//M)U"R(6(S@@@Y'(((!S[5F1^"=#CN9KD0W+7$]M]E
MEE>\F9Y(^?O$MDGYB-W4 X!Q6JNK::VH?V>NH6IO>?\ 1Q,OF<=?ESGBA=5T
MY[W[$E_:M=Y*^0)E+Y')&W.>* *+^%-%E\,#PY-9^=I(C$2P2R,^U1]T!B=P
MQ@8YXQQ4NA^'=.\.V[PV"3?/C?)/.\SL!T!9R3@9.!T&3ZUJU2_M73WO#8QZ
MA:?;22JP^:I?(&3\N<\#DB@"*?0K"YURVUF6.4WUM&T43B9P%5L;AM!VG.!U
M'856M?">DVBP(L<\D=M$\5NDUP\@A5AM8+N)QQQGL.!@5F>$O%JZC8[-9O["
M+47O[FVAB5A$91'*R#8A8D\#WKH9]7TRUNTM+C4+2&Y<@+%),JN2>@ )SSV]
M: *UEX;TVQEAE1)I7@@-O";B9I?*C.,JNXGKM7)ZG YK.M/A_P"'K,V/E6]S
MBPE,MH&O)6\@X(PF6^5<$_*./7-._MC4?^%BR:%OM_L1TDWD?[H[UD\T)\QW
M<CZ8ZT_P/K-[KWAE;[4#";G[3<1,84*KA)G08!)[*.YH 1? OA]-?DUE+-TN
MI9!-*B3N(I)!T=HP=I;/.2.O/7FDOO N@ZA=ZA<2V\Z'48_+O$@NI(HY^,9=
M%8 G'?%'CK6+_0/"TVI:<T EBFA1A-&6!5Y50XP1@_-GOTZ5L6>K:=J,L\5C
M?VMU);MLF6"97,9]& /!^M &5%X5M;;Q%I^I6OFQ+96AM5S<R/OCYPA5B1@9
MSDY.0.PJ[KWAW2_$VGBRU6V\^%7$B$,4:-QT964@J1ZBK%MJVFWEW):VNH6L
M]Q&,O%%,K.HSC) .1SQ5R@#GI/!.A2:5!ISV\YC@N!=1S?:I1.)@,;_-W;]V
M.,YZ<=A0/ WAW[)J=JVG^9;ZF0UW')*[AV  W<GAOE!+#!) .<BM6/5M-ENS
M:1ZA:O<@D&%9E+C'7C.>.]5M+OO^)9/=7NJV%S&DTG^D0$)&B!CA6.XC*C )
MSUH IP>"=#@T2[TGR;F2UNT\NX,MW*\DB<@*7+;MH!/ ..3ZFK*^&=+34-/O
MQ'.;G3XFAMG:YD.Q#C(P6P<X'7/05936])DCDD35+)DB!,C"=<(!USSQBG6V
ML:7>7;6EKJ-I/<K&)6ABG5G"'&&V@YP<CGWH M2Q)/$\4J!XW4JRD9!!X(K-
MA\-Z3;Q:3%%9HJZ0,67_ $R^0I^/RGO]>M65U;37U#^SUU"U:]Y_T<3*9..O
MRYSQ7.^._%?_  C^ASRZ??V U**6%3;S$,Y5W53A0P(.&ST/3I0!N2Z#83:]
M#K3I+]OAA:!)!.X 0D$C:#MY(!Z=A5!O!&A/HU]I+6\[6-].UQ<QF[E_>2,V
MXG.[(R>2 <5T-<G<>*'TWQY=:;J=[8VVDQZ6EXLLO[HJ[2E,,[-@_=XZ=: .
MJCC$42QJ6(48!9BQ_$GDUBV'A'1]-\A;:"406\AFM[=YW>*%SGYE0D@=3CTS
MQBK[:QIB-;*VI6:M= &W!G4&8'H4Y^;\*G2\MI;J2UCN(7N(@#)$K@N@/0D=
M1F@#"O? OA^_UU]8FLW%W(%$_ESNB3[>GF(I"OCW!]\UOSP)<V\D$FX)(I5M
MC%3@^A'(JCK^NV'AK1+K5M1F6*WMT+')Y<]E7U)Z 5AWOBLV_BW188[ZP.B7
MMI=3R39'RF+9SYF[;CYCVXQUH O1>"]#AM-*M8X)UATI_,LE%U+^Z;!&?O<\
M$CG/!J]I^A6&EW]]?6J2K<7[B2Y9YG<.P  .&) X '&.!5B/4]/ETX:C'?6S
MV+#<+E95,9&<9W9QUIUE?V>HV_VBQNH+J')7S(9 ZY'49'>@"A?>&M-U&>ZE
MN%G(O(Q%<QK<.(YD P%90<="0<=1P<BHK_PCH^HZF=0G@E$[0?9I!%.\:2QC
M.%=%(5@,G&0>M:UU=VUC;M/=W$5O"OWI)7"*/Q-00:QI=U+<Q6^HVDTEJ<7"
M1SJQA_WP#\OXT 8USX!\.W.E:=I[6LR1:;_QYR1W4JRP#&"%D#;@".V<5<D\
M)Z/(--'V>11ILAEM=EQ(NQSG+'#?,3DY+9)R?6K<&N:3=,ZV^J64S)%YS".X
M5ML?]\X/"^_2G6^L:9=V\UQ;:C:3009$LD<RLL>!D[B#@<>M $6G:%8:5>WU
MY:)*L]]();AGF=P[   X8D#@ <8Z4VZ\/Z?>ZW:ZQ,DQOK162!UN'4(K8W#:
M#M.<#.1V%1ZAJ]M/HE]/INM:=#)$A'VJ617BA;'&_##^=6[K4;6PM$DO+^UM
M]ZX669PB,V,Y&3R.^,]* *$WA'1IKJ\G:WD5;U@]W DSK%<,.,N@.TD@ 'CY
MN^:LC0-/'B#^W1'*-0\C[/YGGOM\O.=NS.W&>>E9/@[Q+)JOA$:OJ]S:1D7,
M\33)^[BPDS(I&2>H [FMM-:TN2UANDU*S:WF<1Q2B=2CN3@*IS@G/&!0!G/X
M-T22TU6U>"<PZJYDO5^U2_O6( /\7&0 .,<"K \,Z8-1T_4"DYN=/B:&V=KF
M0[$;&01NP<X'7/04Z7Q-H<6F7NI?VM9O:66?M$L4RN(R/X3@]?;K4^D:K:ZW
MI5OJ%G*DD4T:O\KAMI(!VG'<9YH @U?P[INN3V5Q>QR^?9.SV\T,[PNFX88!
MD(.".".]5+?P5HEE$([.">V"W;7B&*YD4I*P8$CYN!AV^7[O)XK;N+F"T@:>
MYGCAB7[SR,%4?B:KC6=+.GMJ U*S^Q)D-<>>OEC'7+9Q0 [3]-M=+MVAM(RJ
MO(TKDL69W8Y9F)Y))JDOAC3%N!*4G=1=&\$+SNT:S$EMX4G .23CH#SC/-:%
MK?V=\9A:7<%P8)#'*(I _EN.JMCH?8TV\U*QT_R_MM[;6WFMMC\Z54WGT&3R
M: ,>3P/H,NF:AISV]PUIJ%P;FZC-W+^\D)!+9W9'(' P.!27O@70-1N+V>ZM
M9G:^@6"Z'VJ4+,%7:I=0V&8#HQ&16GJ.H016]W!'J5G;7J0-(IG<$1<8#LN0
M=H./3ZT)J5M9Z3:W.HZC9@/&F;G>$BD8KG*Y/0\D<GB@"M'X7TJ+4+&_2*<7
M-C"8+=S<R':AQN!!;#9P,DY)Q4^D:%8:&+L6$<J"[G:YFWS/)ND;[S?,3C/M
M4[ZII\5BE])?6RVC@%9VE41L#TPV<&I;6ZM[VVCN;2>*>"0926)PRL/4$<&@
M#/O/#>G7NJ'4F%Q#>-"('EM[AXB\8)(5MI&<$G!ZC/!J#5?!V@ZQI=IIUS8J
ML%D0UKY#M$T! P"C*016O<7EM:"/[3<0P^8XC3S'"[F)P%&>I)[56M]=TB[M
M9[JVU6RFMX"5FECN$9(R.S$' _&@"33-,M-(L4L[*,I"F3\SEV8GJ69B2Q/J
M3FL:^\"Z#J%WJ%Q+;SH=1C\N\2"ZDBCGXQET5@"<=\5JQZWI,R3O%J=DZ6X4
MS,LZD1;AE=W/&1TSUIT6KZ9-8F^BU&T>S4[3.LRF,'.,;LXSGB@#(U#P'X?U
M/[ T]M.DMC'Y-O/#=2QRK'_<+JVXK[$FKEQX7T>YFTV5K4H^FJ4M?*E>/8I
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M/%#ZA\0Y='M;VQNM-73!=*UO\S+)Y@7#,&(/'/0=: .LHHHH **** "BBB@
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MC9DY]*G\;:I9W%AXSMX!]DN([JVDDA5&DDNPOE8G).0L8 P-N.5R3SBO9J*
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MRI;OY]@&."X7 X_O+W-=]XFT";Q!%IR17J6OV.^AO<M"9-[1MN5?O# SUK<
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M-X4\C."0..>M0ZGK,.FW-G:>6\]Y>NRV\$> 6VC<S$D@!0.I]P.20*T0 H
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MY[.Z@T_5I%BL[R0+L=F&4# '<N\?=R/K@\53U;PW<^+-8MKF_MWL+>UL+JV
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MX7$4*3FRU&XO[YDD 53,L@VIG!.#(/3A??%;OA?3+_3]:\27%W;>5%J%\+F
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M[NCJ:S2V=VXA$T&4&V"-AP"#@<C&?<Y- ':+K-@VD0:J+C%G.B/$Y1@7WXV
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MSE2^25(!QSUK<'@^,WFA7#ZA<,=&@>WB7:H$BNH1MW&<X4=,<UTM% '%Z?\
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M3GH** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=:>FGW&G6DMDF"MO)"K1KCIA2,#% TC3!>/>#3K074B>6\PA7>R_W2V,D>U
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M 5>_X1[1?L\%N-(L1# 2T,8MU B)ZE1CY<^U7H((;6!(+>)(H4&U(XU"JH]
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M<@&NP.B:4=0.H'3;0WA(8S^2N\D< YQG(]:?)I&FRZ@NH2:?:/>H,+<M"ID
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M^&/#$I6X:]UA[)65KDB.[D6$LJREMP"8R< 9)"C%>@IHFE1V,MDFFV@M9?\
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M*/\ >SZU!J6G2>)_#>IW&C>%[O3M1,$05M27RI9S'*DODC+$[3L(R<#+#'?
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MJ<XEU43P0PVQWS(R11[D#8!P0Q//09H [NO/]+U34+OQGXJTV^\3W%M:Z;+
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MHJK(R*PPS+R0#U('6J[V>H?;/&TD>DZPT6J:+%';2W"%VDD"3*01DD$EU^7
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MQ+#JVHP7S>$K[2[VWB9)9[],%">J1$DE@3SD8&!ZF@#LZ*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *BN;FWLX&GNIXH(5(!DE<*HR<#D^I(%2US?CK5%T?PK/>R:9;:C"DL*R
M07#87#2*H;&T@D$@XXZ=: .C)"J68@ #))[4RWN(+N!9[::.:%ONR1L&4]N"
M*P;K69[_ %G4=$TVUMIWL8$DNC<L0A:0$I&  >2%))Z#(X.>.4\":_\ V;X
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ME=GRD]3@G@'BMK0M3EU6"6<O9SVN5^SW5G+O292.3[$'(QD]/>@#6I"0H))
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M\2SC:)00COTW9(P.#TSTH Y>]\ 7^MMXD.JZE;(NM6]O'MM86S#)"248$MR
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M89$,D$J. '1AP<':I!ZC'XU+)I.MSV,27USI]^\C,;VVEA*V\J%0 B [BH!
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M&E:G/J1\1Z/.K/8,FQHIER'D+!1E""S$EB&SCDD4V>ZMV\$_%)%FC+27UUL
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M2#SWZU R:4WQ>U=KI;0J-$A#&0+@-YDN[.>^TC/L: .XEU"R@M%NYKN".V<
MK,\@"-GI@]#FGVMU;WMNEQ:7$4\#\K)$X96^A'!KR#PE>O8V/P[O[^3&DQ6,
M]K)*Y^2VN3@)O/\ #E0R@GIDCO7:>"[5X]>\5WEL?^)/=WZ26>W[COY2^<Z^
MH+]QU(- '17>N:38&87FJ65N80IE$UPJ; >A;)XSVS4UQJ-C:6BW=S>6\-LP
M!6:2550Y&1@DXZ5PCII3?%/Q$URMH0-&A#&0+C.Z7?U[X*Y]B*YG1-871M&\
M#:CJ=Y<VVD+I,EF]U"H<6UP2F!)E6VY52N<<?3- 'KHUG2V-J!J5F3=C-N!.
MO[X?['/S?A2)K6E217$L>IV;QVW$[K.I$7^\<_+^-<#J&D6-GX#36/#D5RZZ
M3?G5K4RY!F7.9@H(!",IDP, '@C@BFV5GJ<?BVXL9;9QI_BE!J$R[0!;>6P$
MD;#U>,PH?]HL: /3$=)(UDC961@&5E.00>X-5;75=.OIY(+2_M;B:,9>.*96
M91G&2 >.:S/&\&H7/@?6X-*#F^>SD6$1_>)QT'N1D#WKFH-5T3Q7I+W'AFW8
MZ[!I,UM"51HS9$IQ&V< '>% '7@D<9H [>'6-,N;J6U@U&TEN(@6DB296= #
M@D@'(&:S]1\9^'=,TZ>]GUBQ:.&%IRL<ZLS*I*G: <GYAM^O%<;X5O?#>O2:
M%*9[Y]5TF!HY+2:/RQ8@Q[9!)\@&WC !)SQ[XR]*TZRG^ NK26=I ]^+6_0M
M'&#* 97.W/7!4*<>@% 'I(U9+ZXT>6PU;3UM[AG+PLP=[@;"=L9#=5(R>#P#
M6'<^*KG5=?U;2-!U72K>YTY(3']I(=;EV#,ZG!R%55 )&2#G/3%9VHZCIUYX
MD^'EY;SQ.IDF EZ?*;9E')[;B!Z9XJ[X?N[)OB+XV62> HPL\[F&"%A8-]<=
M_3O0!TFE7^SP_#=ZEJMA<D9\R\@(2!OF(&,L0.PZ]15I=7TU[#[>NH6AL\[?
MM F7R\YQC=G&<\5Y#H6I)H_@[P%JEP&.BV-U=+?%%+"W=O,6)W4= -QY[;@?
M2NAU?4_#MK8V6HZ?8HMG>ZXL_P#:,HD$"3E#FX(R-PXVCHI8Y[<@'7:KXMT3
M2-";6)M0MY+3=Y:/%*K"1\X"@@]<_ESGI5R?6])M;6.ZN-3LHK>49CEDG54?
MZ$G!KR*YF5O WCN)7GF>/7X[EF>$JWE[[=BY 4 # 8].@)K?U?7M/L_&US-K
M-_<VNC:KIL4=C=I$&ADVM)YD9)0X+;@1T!&.O% 'H5SJNG621O=7]K D@W(T
MLRJ&'J,GD<C\ZLHZR(KHP9&&58'((]:\LU"UAT6WLCX>U1;"XL]**II^LC=%
M>VI=R$.<,K<?4!@"/3O;:=)O!D5Q<V<UHCZ>'EM0?GB!CR4SZCI^% !>ZY;2
M:9?MI6HV,UY!;O,J[Q*!M'5E5@<9XZBJOA/Q+;ZUH>D&YOK,ZO=6$-U-;)(H
M<;D!)V9R!DUQFDWEQ8I<Z=)J-EK.E1Z),;35$ 2:WC&T"&8#Y<GC!X)*'CK5
M;1S86UK\*7B-O'*J%92N 03:LK!OJ^ <]_>@#U)=7TU[_P"PIJ%HUYDCR!,I
MDR.2-N<\5RP\1ZQYOC:+?9^9HH5K0^0VT@P>;AQNR3SC((^G:N+&L6,__",S
MP V<=OXED\W3TB=VMBWGY,K$$[V8Y &!\V #C-;HN[?^T/BA^_CYB3'S#G%J
M%./^!<?7B@#N?#E]-J?AC2=0N-OGW5G#-)M&!N9 QP/J:TZP?!,B2>!- *,&
M TZW4X.<$1J"/J#Q6]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !117%_$F0V^FZ)<JTX,>MV65A9
MLN#*,C:/O?0YH [2BN5M?'=BUQJEMJEE>:1<Z=;_ &J2*\527@Z!T*,P89XP
M#G/%3Z?XQLKWQ"NB2026]Y);FYAW21NLB X891CAAD9!_#- '1T4CDJC,%+$
M#(4=3[<UQV@^)-'M_#=C-I]I=0QWVH36MO;W,H+F;?(6RS,0!E'(Y/8#L* .
MRQFBL%O$\:?8HGL;B*]O9IH8K65D5B8\[CG=C&!D8))R/?")XJA_M/2+";3[
MV";5/.$7F!/W;1 EE?#'!P.,9'O0!OT5S</C33Y+*^N)(9X&M-0.FF*38&DF
M&WA3NQ@[NI(P 2<8J&#Q_I+IJZW*R6]QI9C$T.5D+^9_J_+*DAMQX X.>#B@
M#JJ,<UP5K=7,WQDB6>UNK3.A2.8Y9@Z-^^C ( 8@$=#T_'K7=NQ6-F5"Y R%
M!&3[<T .HKEH/'5A/HFCZLME>BWU2]6RC!";HI#(8QO&[IE3TS4%]\08+(ZW
MC1-4F&BN!>E%C 1-@?>,O\PVG.!S["@#L,8HQBN5?Q3<OXZL-&MK%Y;&XTYK
MSSU9/F^>-0V"00H#'/<YX'%<WXAO;"]^&?C>;38+^REM[FX$_FSL&-PH7<00
MYPO(X!Q[4 >G8S14-KS9P?\ 7-?Y5S^M>([W3_&.AZ-!I\DT-\D\CRJZ GRU
M'R@$CH6!)]N,\T =-17F&C>)E\+IXMN+FSU&[L;?7I!-<*X<6\92( DNVY@"
M>BY('IQGK=;\866C/>((7NGLH1/<I%)&I12"0 &8;FP"<#MCU&0#HL<YHJKI
MNH6VK:9:ZC9R>9;742S1/C&589'':N6\<:G=V^I^'-.BLYI[6]O]MPJ,@$RB
M.1O+^9AW52<\$#&>U '9XHP,8[5R%GJ=CX<M-1LM*T_4+R#36,MTB2J_V<N-
MYC3<W.U2#M' ! '/%/NO'UDD]A#I^G7^IMJ%D][:&U5,3(NW(&YA@_,.N/3K
MQ0!UE&,]:XZ;Q_'&-7":!JTDFD(DEW'B(%$9/,SR^#A>P.?:KEIXSM;O5],L
MO[/O8H-5B:2QNY54)/M3>1C=N7Y>1N S@T =+C/6BN3?X@:5'=6"E)#:7]U]
MD@NE="ID)(7*AMP5B" V/3H"#4VD>,EUK4Y+.VT74U2&[FL[BX=8_+ADC7)W
M$.>#T!&>V<9H Z:C%-DD2&)Y9'"1HI9F8X  ZDU@6GBR*[O-,C&G7R6VJ(SV
MET4!1@J[LM@Y3<O(W 9[X/% '0T5R8^(&E&\TV/9)]EU.;[/:72O&5=SG;E0
MVY0V."1Z9QFH4\?FZBOGLO#NJS"REN8)G;RD1)(1DJQW]#C&1G^E '945P:>
M(X-1\+>$M0UW3+SS;^ZM#"T,BJJSNH*N=KYV9+<$'IR.E,U:636_B+/X>O\
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MX?UGPI'!%]HLM)TV:TGN-Z@L\A0[@I.<94_F.M=_10!PTFAZL;[QS*+'*:Q
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MDH"J91("J9P3C>/3.WWQ7HU4-5UG3]$MXY]1N!!')*L2$J6R[$!1P#U)%7Z
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M@3:W=/):9F3&UHT3YN>/N$]^HKN-8UG3] TV34=3N!;VD>-\A4MC/3@ FK]
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M &V[RH/(4G XZU3E^&L!TF\T:WUO4+?1[BX%REFBQD0-Y@D(1BI(7<,X[>]
M'<UR#:KKFN2:\-!N+:";2KH6D$5PF5GD5$=_,/4*=^T;<'C.3G ZU%*HJERY
M  +-C)]SCBN7N?!*-XAN]6L-9U'3A?[?M]M;%-EP5& V64E&QP2I!^AYH J:
MAKNO7]]K5AH<)%WI:1JH58G22=HQ)AR[J0F&4?* >ISVJO-J_BZ]\3V^BP36
M&F33Z*+YUDM_.,$PD567(?##)(R,<>M:5_X(277CJ^E:Q?Z//+$D%TEIL*3H
M@PN0ZD!@. PZ"KL/A>&V\36^M0W<ZF"Q^P);D IY6X-R2-Q;('.: .;T2ZUJ
M.]\=7!U-)I;.Y*PB6#*#$",!@$' R1C/N235+7+W4=:\'> =2DNUBFO;_3I)
M0L0P9'&[=] >U=:/"4<=]KEQ!J-W&FKC,T "%$?8(RZ_+G.T#@DC/.*KR>"8
MWT+0=)&IW*PZ+-#- X1-SF(80-QC&.N,9H AGU^]TKQK<Z?=20RZ?#H;ZBYC
MAVR-(CA22<D'@'' _2I]%N_$.IPZ%K"W%F]A?P>==VQ7'DJZ!H_*8#+$$@'=
MUZC'2KDGAJ.;Q0=<FNI)':Q-@]N47RVC+;CGC.2??IQ5+P_X(30#';IK6HW.
MF6Y)M+"=D*09SQN"AF SP"<#Z@$ &3:>*M77Q!H%M<7$$XU*YN;>Y2"/,$)1
M'9!%+@;B-F&Y/.?N]*I:1KVIZ/I/B;4+B\-]-_PD#6$*21J!O9XHD/4< $<9
M'3J.M;%C\.8;"/1HDUS4VBT>=I+-3Y7R(RLI0G9SPQ&3SZ8JU+X!TZXM-=LK
MB[NY+'5YVN7M]R@0RL5)=&"YSN52,D@8H L:+/XD&OW5OJ-J[:28%D@NIO*6
M19<X:,K&QR,8(.!W!S71URUOX8O;+2+R.;Q'JU]>O;M!!=-Y8E@4_P!P  %B
M0,LV3P.16WHT%Y;:+90:A.9[R.%5FE.,LP').."?>@#"\3ZMJ5C>O%;7<4$2
MV$D\2Q1^=/),IXRF#B(#JW') R.^MX9U276_"NDZK,BI+>6<4[JGW0S("0/;
M)JEJ?A*/4=??5DU*\M7FLOL-S%#LVRQ9+#[RDJ<L>1@\U?\ #VC+X>T&STF.
MZFN8[2)8DDFV[MJC 'R@#@ #_&@#%UO5-;C\;Z7HMA=6D%M?6=Q*7DMR[HT9
M3G[P!^_TX]\]*RM-\9:I/IFGV4RK-JMQJEUIS30(J[E@\PEU5F #$(."< DG
MG&#U%YX?%WXGL==^V2QS64,D,<052A63;NSQG/RKW[5C2?#JSET>2Q.IWJ3C
M4'U*WO(RJ2V\[L2Q7 P5^8\$=#0!2U/6/&6D^&M5U"Z@2,:=<K*DC)&SW-GQ
MYA*HQ"NHW'/0XZ5,?&,MOXPU2QGNQ+IXT_[78M%$ 7< %XPQ^\P#Q$8_O\YK
MI-,T/[)I\]O?WUQJDURNVXGN@H+KC&W:H"A<$\ =R>IK,MO 6D6VG^'K0>:X
MT.;SH'9LL[;2#N/<9(./]D=J .@TY+M-.MUOY4EO!&/.>-=JE\<X'IGI6"VK
MWNK^*]6T+3[I;(:9;0R23>4'9Y)=Q48/&T!>>YW=1CGIZPKOPTK^(CKMA>RV
M5]) +>XVHKI,@.5W*?XER<$>N#D4 <E:^-M>U2'PSY LK6>]O[C3[Y&A9U$D
M2R99#N'RY3..O;/>K$'C#5K*TU.RO&BN]0M]:BTNWF2(('$BHP8J6 R S<9
M) Z9K;_X0FSB.B?9;J>%=(G>XC&%8S2.&#LY(Y)WL>,<FH+GX?V-];:W!=WM
MTZZK<I=LZ%4>WF4*%>,@<$;5ZYZ>] %W09_$7]K:A;ZK;-_9P5'L[F3REE)/
MWT98V(XX(.!UJ/Q]K&H:!X+U#5=,>%;FV56'G1EP06 /&1@\]>?I5W0M#GTI
M&>]U>\U6Z90@GN@@VH/X550 /<]3QD\#"^)M!C\3^'[G1Y[F6WAN0!(\0&[
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M+6V73Y_+C+-Y2R9$[J,Y!V DX(Z9KJ/#EAIT?B;^TM,UFRECN['#66G1!(7
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M1[&K]% &7_PC6A>5%$-&T\)""L2K;( @/4# X![CO6E'&D4:QQHJ1J JJHP
M!T %.HH RH/#.@VQ0P:)IT1CE,R;+5%VR$8+# X;'>E_X1K03:O;?V)IOV=W
M\QXOLJ;&?^\1C!/O6I10!F7?AW1-0N8KF\TBQN)X4V1R2VZLR+Z D<"KMK9V
MUC:I;6EO%;VZ#"11($51[ <"IJ* ,L^&M!-O+;G1--,,LGFR1FU3:[_WB,8)
M]ZL)I&F17POH].M$NPGEB=8%$FS^[NQG'M5RB@#(M_"GAVUF$UOH6FQ2"3S0
MZ6J A_[PXZ\GGW-3C0='&K_VN-+LAJ6,?:_(7S>F/O8STXK0HH S3X>T0QW$
M9T?3RERVZ=?LR8E/JPQ\Q^M..@Z.9893I-CYD">7$_V=,QK_ '5..!["M"B@
M#+'AK01;1VPT331;Q2>9'%]E3:C_ -X#& ?>K$6D:9#=3W46G6D=Q<#;-*L"
MAY1Z,<9(^M7** .;U'1-02&#2-!ATK3]$EC>.["Q,DJ!O^>2KA<D%N3T)!YZ
M5T4<:0Q)%&H2-%"JJC  '0"G44 57TVQEU"+4)+*W>]B0I'<M$ID13U ;&0/
M:HK?1-*M;Q[RWTVTBN78LTJ0JK%CU.0.I[GO5^B@".XMX+NWDM[F&.:"52DD
M<BAE=3U!!X(JE'H&C12P2QZ18)) GEPNML@,:?W5..!["M&B@#-_X1[11I\U
M@-(L!9SG=+;BV01R'U*XP35FQT^STNS2TL+2"UMH_N0P1A%7Z <59HH IZCI
M&G:O$D6I6%M=HC;D6>(/M/J,]#[BGV>GV>GVY@L[6&WA)R4BC"@GU('4U9HH
M H66AZ3IQ<V6FVEL7!5O)A5<@G)' Z9YQ69KGAJ*7P?K&CZ%8Z?9RZA;2PX"
M"&/<ZE=S;%.>OI7144 8^@:';:1IUJOV"S@O$@6*5[=00<#G#;0<$\]!5E-$
MTJ*_:_CTVT6[9M[3K"H<MC&[.,YQQGK5^B@"G;Z5IUI>37EM86L-U/\ ZZ:.
M%5>3_>8#)_&J]OX:T&U:-K?1=.A,<IG0QVJ+MD/&\8'#>_6M2B@#.?0-&E%V
M)-(L'%XP>Y#6R'SV'0OQ\Q^M.N-$TJ[AMX;C3;26*W_U"/"I$7&/EXXXXXJ_
M10!1GT72KF.VCGTRSE2U(-NLD"L(B.FT$?+^%/M]+T^TNY[NVL+6&YG_ -=-
M'"JO)_O,!D_C5NB@"C=:+I5[>I>W>F6<]TB&-9I8%9U0YRH8C..3Q[FH3X;T
M-DB0Z/8;88_)C'V=,)'G.P<<+DGCI6I10 @ 50J@  8 ':LS_A&M!\H1?V)I
MOEK,9PGV5,"0]7QC[WOUK4HH IQZ1ID-U/=1:=:)<7 VS2K H>4>C'&2/K3-
M,T/2=$25-*TRSL5E;=(+:%8PQ]3@#-7Z* *%_H>DZK)')J.EV5X\?W&N+=)"
MOT+ XI]EI&FZ8SM8:=:6C2??,$*QEOK@<U<HH H+HFE+J#7ZZ;:"\9MYG$*[
MRV,9SC.<<9ZU'<>'=$N[BXN+G1]/FGN4$<\DELC-*HQ@,2,D<#@^@K3HH I0
MZ/I=O>F]@TVSBNR@0SI JOM]-P&<>U5KCPOX?N[N:[N=$TZ:XF $LLELC-)C
MD;B1ST'Y5K44 -1$C14155%& H& !Z52LM$TK396EL=-M+:1LY:&%4/)R>@[
MGFK]% %.TTC3+"XEN+/3K2WGF.99(8%1G/\ M$#)_&F7^AZ3JLD<FHZ797CQ
M_<:XMTD*_0L#BK]% %2RTO3]-#BPL;:U#G+>1"J;OK@<U"^@:-))=2/I-@SW
M8Q<LULA,P]'./F_&M&B@"FVD::^EG3&T^T.GE=GV4PKY6WTV8QC\*9!HFE6V
ME'2X--LX]/8%6M5@41$'KE<8.:OT4 4+;0])L]+?3+;3+.&P<$/;) HC8'KE
M<8.>])+H6D3VEO:RZ79M;VW^HB,"[8NWRC'R\>E:%% %"?1-)NH+>"XTNRFA
MMB#!');HRQ$=-H(^7\*+K1-*OK@7%WIMI/,$\OS)(59MF<[<D?=R3QTJ_10!
M'+!%/ \,T221.-K(Z@JP]"#VJA_PCNAB&WA_L;3_ "K9MT"?94VQ-ZJ,?*?I
M6G10!FR>']%E^U^9I%@WVP8N<VR'SQ_M\?-^-5[K1AI]E-/X:TS2+?51"L,#
MS0[(]@;.QB@W;<9P!WK:HH S=%T^:QM97O'BDOKJ4SW+Q*0I<@* N><*JJHS
MV7-97C/P_>>(8M(AMHK*6&TU&*[G2[D(#HFX%0 C9SN[UT]% %#^Q-*-C+9-
MIMF;68[I86A4HY]6!&">!U]*=+I&F3Z9_9DNGVKV&W;]E:%3%CL-N,5=HH S
MAX?T9=.AT\:59"R@;?% (%V1MS\RC& >3R.>:?-HFE7&F-ILVFVDEBQRUL\*
MF,G.<[<8SGG/K5ZB@#-;P_HKV$%B^D6#6=N<PP-;(4C/JJXP/PJ:;2M.N;JW
MN9]/M9;BV_U$KPJSQ?[I(ROX5<HH H#0])&H&_&F68O&8.9_(7>6'0YQG/OU
MI-0T'1]6N(+C4=+LKN: YBDN(%=D^A(XK0HH K_8;3^T/[0^RP_;?*\G[1L'
MF>7G.W=UVYYQZU8HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6NV(B3[,Q4,A0B0EU)X((ST/'2M+Q5KSZ%9V @5#=:A?PV$!D!*HTA^\0,9
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M/5-?DTWQ-H>D_8Q)'JCRIY_FX,92,O\ =QSG'J*X3PUK4^L7_AJP\7,I2[T
M7$<=SPEQ/YF&)!X9_+",!VW,:3Q"EQI+>"H_#<TFKW%K)?K:/>3;FF*P2<;@
M!NQR!ZX'/>@#UBBN?\&2Z1=^'8;W2&=TN"6F>;_6^;D[UD'9@V1M& .P Q6]
M(BRQM&ZAD8%6![@T 0V=[;:A 9[6598A(\>Y>FY&*,/P92/PJQ7B5O9VMO\
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M6:UCBD+^8'CE#EQE#P2!L[@'VZ$ZM<=\1-9?3?"]T]I,T;)-;I>2Q$AH('D
M<[AT.TGW&<^]5;JR&G_$32K/2E,6GZEI]R;^W@<H@";/+E&T_*Q+E=PY/X4
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M=1RWWPZT\:H3=_9?$<=I:W$YW/);K=A 23UR!C/<"O8(((K:%(84"1H,*J]
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M)L;IKJUTVUAG9F8O'$%.6^\1Z$]_7O3K;1M+LS<FUTZTA-T2;CRX57S2>N[
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MVM+B2$M<0NG"MLZD8W$C[HY&0",UJ6&N:?J-Y/9V\SB[@4/)!-$\4@4]&VN
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M5KKKVUS<:5<:6;%F@A:1K>42;P6106VL.,@<$#.*Y/4M.FT>PM;ZYMYEBO\
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M-JW<0N3(%C)X;*G(QW&.N*ZJ&UDUGXAV.OVT%S!:6FFR6\CSP/"TKNZE4VN
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MAW4KJVGTS3)XI$F0,)9XXCF)&7&%QA<D$Y"]!G@ 9?\ CR^T_2_$UQ+I-O\
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M7$3F(*TF#M#' )[9/.*\\B\$>)(]$T;1&U33GM-&OX+BVN&A<R211$E5=00
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M,F_<,>8Y8GYN.   "3UXP .?Q7>6-WH@U33HH;766$,$D4Y8PS,NY(W!4?>
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MF3<WF6>H)@D-$PX4JN#MXXZY/-=-XKDU6+09'T:/SKP21GR1*(WEC#@NB,>
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M]UT\L;R<)["HM'\#:+H4,L5B+P(\9A02W<DGDQGJL>XG8.G3G@>E+X[UF_\
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M]M?6TT\?+QQRJS+SCD Y'- &=+X6TZXM[Z.X:YEDOH%MYKAIV$IC7)50PQ@
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M1C@-/*J _B36/XK\4VWAS1HKOSK<RW,T4-N)) %.]U7?UY50VXX[#J,YH Z
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M1LKZ!YK2\M[B)"0SQ2JZJ1U!(/%):ZG87PD-I>VUP(P"_DRJ^W/3.#QT/Y4
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M(Y24*BCA@  >XR. 35WQU/#9:_X.O;IUBMHM3<22O]U2T$@4$^Y( KM0 ,X
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M7,*N3]TE=H /TJGJEUIUSX-\7>:T>3XJCD02+M;:9(,D9P1\H;\ :]O(!&"
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MX8>U=^%"] !WXH"J%*A1@]1B@!L4B31)+&VY'4,I]0>E/HHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQR)*NZ-U=<D94Y&0<$?G0 ZBBB@ HJ![ZTCE>)[J!9$ +(T@!4$X&1[DBIZ
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M\XM=9O=-TQ;VST>5XKEOM&R1V10T@C7:0VT'')&2"/>N5\&:+>^)/A=I&EW
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M2L68R!,E?EZ#9WQG/:K/BW0[G7=/LELY84N+*_@OHQ-G9(8FW;21R ?7!^E
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M@"O9V%GIT'D65I!;19SY<$81<^N!5BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0@,"" 0>"#45K:6UE
M;K;VEO%;PK]V.) BCZ <5-10 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 455
MU*].GV$MRMO)<.N D,6-TC$@*HSP,D@9/ ZFN9TOQAJ1\4P>'_$&@_V7<WD+
MS64L5T+B.8)RRDA1A@#G_(R =A17(W'C<I::MJ=M8"?2-)G:"ZN!-B1BF/-:
M--I#!,]R,[6QT&>KAFCN((YH7#Q2*'1U.0P(R"* 'T444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 ([K&C.[!549+$X 'K7.6UJFK>(H/$5QA+:UB:W
MTY7X+>81OEY_O;551Z9/\7&OJVE66MZ;-IVH1-+:3#$D8D9-P]"5(./:L;3/
MA_X7T?4H=0L=,\NZ@),<C7$K[2002 S$=": .)\/G[!\#?%-O=\7%M_:<-P&
MZ^82_!^NY?SKT+P=;3V7@G0K6Z!6XAT^".16ZAA&H(/TJ2X\,Z1=7DMS-:;F
MF=))D$CB.5UQM9XP=K$8')!Z#T%:U !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
; %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>literacompareredline-pro006.jpg
<TEXT>
begin 644 literacompareredline-pro006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" __!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBD+!<9(&3@9[T +1110 4444 %%%% !112 @D@$9'4>E "T444 %%%
M% !1110 444F1N"Y&2,XH 6BBB@ HIH=69E# LO4 \BG4 %%%(K!AE2"/44
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M%@"/91GJ<GIC,;PQXAFT#PE92KI@GT6[MYIMMP^UTBC*?*?+Y)SGD #ISUH
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M*\B+^?-$O"*R$;5.  3D\#CDY&QX9O\ 5=0L;E]7ALTGBN7CC>S=FBEC !#
ML,]RI]U- %?5-9^UW.IZ/9:>E^]I;A[Q9)=BC>"50<'<Q )P<#!&3S7->"?$
M4&E?#[PK8AK8WEQI_FHMS<"&,(I )+8/=@  "3SV!-:QT'7-+\8ZOJFE"RN;
M+68XOM$=S,T;P2QIL#+A6W*5QD<<CK6+IO@SQ3H.E^&[K39M,?5M+LWL;FWE
MD?R;B%B&X<+E6!4'I0!OZ;XY@U:SL/LME(-1O)IH5M97VA#%_K&+@'*#Y<,
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M99!<O<PR2M'8R/U6S1V\E<]QAF8'N&% '84444 %%%% !1110 4444 %%%%
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M\8Z[-H>F6?V8JL]_J%O8)*PR(O-< N1WP,D=LXH Z*BN'O\ 5M8TCQ5+HO\
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MNI1ZR.<G\.P'M6C10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M06LEU=CRWE#W"J\<A_?OGEF?'RXZ\9;&:F$&D#P#\2;;R;,745WJ3"/:H=%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=I)=3RL3&HGW$A O)XX^85N^$HFC^+/BR"Z=W>RLK&WLC(<GR-A+8^KC)]Z
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MNVY&[&<9YQ0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-(N;NY\JYA:":5-@D=&!##[N!D'L*TJ* .=B\)"+2[;2_P"V]4>P@1(A 3"
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU.NE0Z;J%E+<LB-Y62DB2;.OS-D%>A[UW5@MVME&+]XWNCEI#$/D!)SM7/)
MZ9/)QF@#G[SQHEC<KYVG7"69U--,\]SM8RL0 RH?O1Y(&X'/4XQ71W=U!8V<
M]W<R".""-I)';HJJ,D_D*\ZU/PEXGOFNS)#IMS.FLQ7UM=S7+!VMTE5UAQL/
MEA0,<$@D9P2<UW>L:8-:\/WVE7#[!>VKV[NG.W>I4D?G0!G6OB>2:]L4GTFZ
M@M+ZW>XANC\RQJH#8EQQ&2#D<GN.M5O^$XMTM--U*:RECT?4IEAM[PL#@N<1
MLZ=51N,')ZC(%0:#I_BF728]%\01V$=I!;FV>YM9V=[M=A0':5'E\')Y/(Z
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M0TCK)&J^7*2-XRW0;>G4\\<5SNO^$O$VJQZY"T6G7+SWT-S97<]PP=(4>-A
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M&VLIK9R9<.6D9&R%QC V>O>@"E#XGL- \-M<65C<S>'M,D-H]UYWF.H1MC.
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MW&I:A(\=K;J7D=8V?:!WPH)JU#*D\$<T9RDBAE/L1D5SGQ%_Y)OXD_[!T_\
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M6HIDD@CER )%!&3ZBGD@=2!0!S$_@6PN(@&O+R.4ZDFJ22Q^6#).N I(*$8
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MX=N](OM7U2Y^V;!/=R2(9F53E5'R;5 /HHZGUK0\/:M?ZK'?C4=-6QFM;MH
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M%NB!VXQ*V1L4YQGZU##X,TO_ (06'PG=1F6Q6W6%\$@LPY+@]FW?-GUKHJ*
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M]EQZ1?7]MY-^]Y<E)56.XWOND\U0/FR"P 4  GVKJZ* "BBB@ HHHH ****
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M)N&N196OVDIL\XPJ6QC&,]<8[9J/1])MM%T];.TC1(P[.0B!%W,Q8X4< 9/
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MQS7<W&BZ5=S&:YTRRFE/5Y(%9C^)%6H+>&UA$5O#'%&O1(U"@?@* /)_"?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\8VB%KC0KCS)U4<R6K_+,OX##>VTT =9=ZQ8V-_:V5Q*ZW-UGR$$3MOQR<$
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M ,237_CB*5 \;Z],K*1D$&./(K->ZN;+QC\3KNR!-W!I5K)#@9.]8)2OZ@4
M=Q)XDTM+J:W6>2:2!MLWV>WDF6)O1V12%/L2*AF\7:#!9VEXVH(UM>2^3;RQ
MHTBRR9*[5*@Y.5.!WQQ6=\,X8(OAMH!@(;S;19I&SDM(_P SDGN=Q-9'Q%M$
ML+'PK%801@_\)1;2K&S;5+NTCG) . 68]CUZ4 =C::[I][>BSADE%PT;2+'+
M;R1%E! )&Y1G!8?G6E618/JTVKW!U.RLX(8X8_LSP3&4EB7\P$E%(X"<8K7H
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\HB >9&F!L9A&#@@8.""1GFMC4K.2_L);:*^N;)I!CS[;;YBCV+*0/KBK=%
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MCM6)4(('0Y7/XT 9WQ!E-I?^$KI%N)'7640Q0L<R Q2';MR 3D#D]/4"I?\
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MS HR!L9!7@Y^N: /2Z*X7^V]=L[C1+.[U"VEGU^51 T=MM%I&L)DDY).]C@
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M!8IY 4C<DX #L I.>.M;M>(6#ZU+^SK!;PZ7;36+V+B:83EY8X=[%W$14!F
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MVKP3^3,8E5X)HE#'I@%"#P",@CJ:I_#>"X\C7GN+LSJ-;O5VM&!\PE^]G^E
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MP#TVD$<$8P15W3=%CL+Z[U"29[F_NPBRSN /E3.U5 Z*,L?7)/-2:1<:C<V
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M.%4 98@$GV&,5KT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME6-NUNK+"T-NB&,-]X+@< ]\=:4:'I L9[$:79"TN&+S0"W39(QZEEQ@GW-
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M_L;3_(#^8(OLJ;0W][&,9]Z2ST*SLM:O=4BA@CN+I$1S%$$RJ]-Q'+'MD]@
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MP6MA<>5#DB,.S"9U .0=@))&#QFO2_\ A'=$%M%;?V/I_D1/YD<7V5-J-_>
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M$/P$U5=31)-4TM3:7BN Q2XB<*6^I&&S[UM7UAH<7Q1\.O':Z>L']FW>UE1
MNY9(B,=L@EOIDUVD.@:-;I<)#I-A$MR"LX2V11*#U#8'S#ZT_P#L;2]MFO\
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MF:.615N;O*Q(7;FW89"CDXZ\5A:QX;U:XGUWQ%I^G22B;5+.[BT]_P!T]S%
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MNM#2#?M,0E*B4NH=AA3AQR>.?:J7AR[5M5\.R:W8ZY#<Z?:_8;66XTPPQ!Y
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M1SMVIOR#&C<Y8$<J,D"F_#2TO-/\%6]A?V-Q:3V\TX*3XR09G8$<G(PPY[T
M;EQKNGVNM0:1-+(M]<1/+%&('(=5^\0P&WC(XSGD>M5[;Q7H]WI;ZE!/,]JE
MQ]E9A:R[O-W[-NW;NSN('3K6?XWTV_F@TS5]'MQ/JNEWB2PQ9QYL;_NY4)[
MJV?^ BLS0?"^I:1XNNK:1FFT:0IJAF8_?O"I208]"1YOL<8H Z*3Q;HT=Z+9
MKILF[%CY@A<QBX/2,OC;NYQUZ\=>*KKK>F6VN:[(^J7LK6-O"]U:&%V2V7Y\
M,@"98M@DX)^Z*XG6;?6[_P WS=!U'S[3Q%#<+';1JL#6ZS*1(N"/,9E&23D@
MY^Z*ZK1[>Y'Q'\17<UE<1VMU9VD<<DD1V.R>9O&>G&\>Q[9H W(/$&FW-CIM
M[#+(]OJ146K+ _[S*EAQC(&T$Y..!4,GBK1XKVWM9+AU-Q.;:&8PN(I)1GY!
M)C:6R",9Y((ZC%87@W0-0TB]N]/NX\:9I4\B:4Q.=\<N'_\ ' 2@/NPK$\+:
M=-:P6GAS6/"-S<7UA< IJ,BAK5U5R5F#EN&Q_"!G/IDX .QL_&FA:AJ8TZUN
M9I+DW#VQ46TH"R(NYE8E<+QTSC.#C.*VKJZM[&TFN[J9(;>%"\DCG"JHY))K
ME_ T%Q;3^)?M%I<6_P!HUF:YA,L1021LJ ,,_P"Z>.M6?'^CW^N^"=0L-,P;
MQO+DB1FP)"DBOL)]]N/QH OVWB/3;J^:Q5YH[L0^>L,UO)&[Q_WE# %O<#D<
M9ZUS/A_4;KQ9J5]<IJ.HV3Z?JTD21K ZPR6\>U3&X9<;FY)_C&>P&*L30S>(
M_%WAK6(K*\M(M+CN)+C[3 T;!I(P@B (^;G))&1\HYY%2^ X;BVCUY;FTN;<
MSZS=7,7G1,F^)V!5AGU].OM0!NZSKVF^'[6.YU.X\B&2585<HS#<QP 2 <<G
MJ<"H=/\ %.D:E)?QPW+QO8*'N5N87@*(02'^<#Y2 ?FZ<5E_$.VN;S0+6&TM
M9[B4:C:RE(8RQ"),K,3CT -<]XFT#4O$&M^+;>S@GB74-$AMK>=XV1'E5Y&*
M$D<9# ?B?2@#M;;Q/I5U>PVB32I/<1&:W66WDC\]!R2FX#=@$' YP<XK /C7
M3M8\(:S?W%QJ.CVMO++ UU';.)(@C%=P.TC=D'CG&><4R:"[\4:AX3G_ +/N
M[&73)S=7AGA,?E$1,AC4GA]S,.5R, \],XD^F:J/AIXOT/\ LB]-Y+=WA@ C
MRLPEE+(4(/(P<YZ"@#T&]UVPTQ42>6:23R3-LBA:5_+'5R%!P/?UZ4W_ (27
M2GL;6[MYWNHKN(S0"UB:5I$&,L%4$X&0.>Y ZG%<K//J>@^-?[9&C:AJ.F:E
MIL-L?LL.Z6WEC9R R$@A2'//KUJ'6+:_TWQ%IFM2^&[B\TR2P-G-9:> TEFW
MF;T.T$!A@[3CC(^F0#NM+U2RUK38-1TZX6XM)AF.1<C/.#P>00000>013+[6
M;/3YTMY6EDN'0R+!!"TK[!@%MJ@D#) SZ\=:A\.VL-IH\:0:6NEQ.S2+:  %
M 3GYL$C<>IQT)QSUK"N8+W1_B5+K,MM<7.EWVG):^9;Q-*UO+&[, 54%MK!C
MR >1SB@ \5>,X+7P4FKZ-.TXNY8HH9XH6<+NE5&)X.U@&. W\0Q@GBMS1+*2
MV%S,-1OKFUN7$D$-XI#VXQ@KE@'P3SANE<#?>'M2L_ -_ EC<R7&HZ^-1CM(
MHR[0Q&Y23!QP#L7)'J<5ZDCB1%=0P!&1N4J?R/(H S;CQ#IUM=/;N\S-'-'!
M(T<#NL<C[=JLP! )WKUZ;AG&14,GBO1HK75+E[F01Z4VV]_T>3,/RAN1MR1M
M(.1D8KD]<TR_3Q-=ZGX?34K35#=P++ T3/9:C& @+MD;4*KD;L@_)WR*J:W9
MZI!_PL33XM'O[E]8@,EG+#%NC<?9A&1NSPP93\O4\8H [R[\1:;91H[RR2%X
M/M(2&%Y&$7]\JH) ^OTKF=2\41Q^,?#-U:ZI--HVH6-U-Y4*;Q*5$>PJJKO9
MOF/'/T'-4K:35_#GB6'4YM!U&]L-1TFVM72VC626UFBW?*R[N%(<G.>O6M">
MVN_^$X\*W7]ERV]O;6=VDRPQ%H[<R>7L0E1C.%(..,CTQ0!U.CZS8Z]IJ7^G
M3&6W=F7+(4964D,K*P!!!!&"*AU/Q'I>CWUG9WUPT=Q>;A;H(G;S"JEB 0#S
M@=.IX ZUC^ ;:YM+#6$NK6>W:75[NXC$T93=&\A96&?4&CQ/;W$OC+PA<16M
MQ+!:7,[W$D<198U:!T4DC_:84 2-\0_#:V,MXUU<"*"4Q7(-E-NMF&,^:NW,
M8Y'+8%:>I^)-,TE)6N9966&(3S&"!Y?*C.?G;8#@<'KZ'T-<->:??RZ!\1[=
M-.O#+J4TALU^SM^^#0(@(X_O*>OUIHM[G2]?N9M1\,:CJVFZK:6PC-M%N:"1
M(Q&\4B,5P#C.3QR?P .[NO$NEVMLD_G//&\ N1]EA>8^4>CX0'Y3V/?!QG%9
MLGC?3VUW1M/M%FN8=3MWN8[F&%W0H-N,$#GEAGT[XS7-7-A<>'O$J74WA:XO
M=(O=.@MQ#IB^8;*2,O\ )MR,H0_WNF1VJ^VF7.F^*/"5W::#)!8P6MW;M;VB
MJ5M3(8V0-S@?=.2.,Y]J -.'Q1HFF6FO:I<:S>36EK>%+CSH7(M7V+^[4! =
MO(.>>6ZUJ:?XGTG4]5FTRVGD-W%$)MDD+QAX\XWH6 #KGC*Y%>?ZMIFI7'A;
MXA6L6F7K3ZC?^9:)Y#9F4I$N1QTRC=?ZUT=Q#)-\2K2_:SN?L']AS6\DS0LJ
MAVDC8*20,?*K?2@#5_X330M]HOVJ0K>LRVL@MY"DY7KL(7!]?<<C(YK?KR#P
MW<PPV?AF+5=-UZ"RTES):L^G$QQE@53S)E8AE57QN"J#P37I.DZXNJ:AJ5D;
M"\M);&4(?M"!1,I)"R(03E3M;'TH NWM_;Z?$DEPY&]Q'&J*79V.3A5&23@$
M\=@3T%8TOCGP_;Z3<ZG-=RQVUK-]GN2UM+N@DXX=0N5ZCDC'(YK/\>V=^7T7
M5K/3I=3BTVZ9[FRA.))(WC9"R#(RRYSCOS3(H[>70[XVGA66T75W6W:*YM_G
M?(VM+,JDX4 ]"<G';(- '2Q:UI\LMZ@G*BR :X=XV1(P5#\N0%^Z03@\ \U7
MM/%&DWFH?84N'CN#;_:D2>%XM\6<%UW 9'\JX:'P_K"^"?$G@-(9V\J)UTW4
M)(RJ72-\P1VQC>#\I/0C\:V3<ZCXS\/7UDWA^[TF^ETZ:VDN+V-4"2.FW;&0
M267=SNZ8 [G@ W8O%FCRWL=H)Y4FFA:> 26\BB=%Y8QDK\^ 0<#)P0>E4K7X
MB>%[VXL(8-19OM[;+:4V\BQN_9-Y7:&./NDYZ>HK)\)@WUQIHO?!MU8:GIZ%
M9KNZ0>7&VS:WDON);=QT&,9R>F><\/64GB3X1^'-$MK2X$XNHI6G:%E2%(YR
M[2!\;22H( !SENG7 !Z#HGBF#6];U?3H[:YB.GSB#=) ZASL5B<D8'WA@'DC
MGI6AK.MV&@6'VW4I7BMMZH9%B>0 L<#.T'&20,GCD5@^&K>]L/&'BJ.XL+A8
M;R\2YAN=H\ID\E%P#GKE2,8K>UW2(->T&^TFY_U5W T1/]W(X(]P<'\* &QZ
M_I\NMS:.DDOV^&$3O$8)!B,G 8,5P>01P>HKE+[Q2J>-= N(;^[;2+W3[J7[
M.+=LR,ACVE4"[V)#' YXY%9*:%XLN!H6NS*T>M2H=*OT#G]W:LNWS?J)%\T?
M[^.U=#?V4D/Q%\.S6]E/]@L["Y@:2.%BD9;R]BY ]$/TH V[3Q/I-]H\&J6U
MRTEM.YBC B?S&D!(*;,;MP*MD8XP3T%5'\<>'XK"6\FO6BBAN1:3"2!U:*4D
M *ZD97J.3QSUK@TTG6+;2H-131;NZ%AXAO+N6PV%))K>8R .@.,L X('U%:6
MN6/V_P *S3:7X8N[%[K4+.5HG@Q<2B.569W4$X 4$#)SP>.10!V^E>(],UF\
MN[.SEE^TVFTRQ30/$P5L[6 <#*G!P1QQ4/BWQ%'X5\,WFKR02S^0GRQQH6RQ
MX&<=%SU/]<"LRRAN#\4]0OOLMPMI+I4$"3M"RHTBR2,5R1Z,*G^(FG7>J^ -
M8LK"!I[J2$>7$G5R&!P/? - &;J?B-[+Q]HY:[O5TVYTZYD-G]F;<TB-& 1&
M%\PMR>,'U%=%:^)])O='M]4MKEI+:X<QQ!8F\QW!(*!,;MPVMD8XP3T%8$S7
M-Y\0]!U7^S;Z*UCTZYCD:2 _NV=HRH;&<$A"?;O@UR\6E:Q::19:BNB7EVNG
MZ[>W,^G["DLMO,T@#H#C<0&!Q]10!Z=I.MV&MQ3O8S,QMY3#-&Z,CQ2#JK*P
M!!Y%1:OXDTG0I[6'4KHPR7198!Y3MO(!8@8!YP.!U/055\+Q6QANKVVT*324
MNG#%;B,)/*0,;G )QZ#)SQ]*Q_',XMO$W@J9HY)%74I,K$A=L?9Y.0!R<=>.
M>* -O3?&&AZMIUU?6MX?*M9/)G62)XY(WR %*, V22 !CDG J.3QIH4%OJ,M
MQ<RP?V:H>[CEMI%DC4C(;;MR5..H&*XS6_#6JW]SXC\0:;8.YFN[">"RES$U
MVMMR^0<%=V2!G!^0>HJQJENNM>#O$,^F^$KZPN[K3GM5^U0;;B9R.$ !)V@]
MS@<\=Z .MMO&.C7C,MM-/(XD$:H+:3,A*;P4ROS#:"=PX]^E6?\ A(M--G;7
M(ED(N9&BAC\E_-=U)# )C=QM;.1QCFN?UW3H-5T70X;BVU:W>-0T5Y8HZSV4
MH3 )4 G!R5(P1^'(R+6S\36M_P"%]=U6&6]%DUY:W7DP8E\J1OW<YB7G<0JE
ME R-W3J* .MF\::#;Z//JLMZ4M;>;[/.6A?=#)D#:ZXRIR1U ZCUJSIOB72]
M6U*YT^TFD^U6Z+(\<L#QED8D!UW ;E)!&X9%<!XBT#4+K2O&>H6MC=.=9NK+
M[+:B(^8RPF/=(5_ASANN#A1ZXKIHX9W^*_\ : M+D6;:*+<3M"P3S/.+[22.
M#M.?TZ\4 =?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1169KFH76G6D,EI:K,TDZQN[N%2!#
MG=*Y_NJ!T[\=.M &G17FNL^-]3N? >OWNG?98KO3M0%@T\;EDD5FC'F1^A(E
M'<XP>3Q6P^JZ\/B58:4YLUM#I<EQ)&C-R?-C4MG') Z#W/- '945Q-OXXO+Q
M]+O++2)[K3+^X$.8K>8O%&Q(68MLV%> 2 > >IJE<^/]9M])UG53HUF+31]2
M:TN1]K8LZ*4!*?)R?GSSCT]Z .LU30K6_P!6T[5I[J>*73"[P[&4("RE6+94
MYRI(ZUI6]Q!=P)/;31S0N,K)&P96'L1P:Y^]UFXU'4]5T;3;:VF.GP(UT;DG
M:SR*66, #^Z,ECG&1P><<GX/\41:'X%\&:?+-:VOVZR<QW-X2L6]"N(\CHS;
MB1D_PGKTH ]1HJOI\MQ/IUK-=PK#<R1(TL2MN".0"5![@'(S7*1>,[Q-<TBQ
MOK*" ZE<30?9O-S/;;59D9\<$,$SCC&1R: .SHK!\9:_<>&/"UYK%M:1W36^
MTF-Y"G!8+G(!SUZ<?6LY_$>OKXJDT#^R[#SYK,WEK(;IMBJKA&$GR9S\P/R^
MN,]Z .OHKB-/\>OJ&EZ6?L8BU*]>Y1XU5YDB\A]DC?(NYANVXX'WN3Q3[;QO
M=O9P17FD7%IJ<]]+9QQO!+L=44N9E&W>R%<8&,Y."1R: .TJ$W5NMVMH9XA<
MLAD6$N-Y4'!8+UQD@9]Z\]UKQ?XA/AV9H]/.GW,.K6]FTTL<B)<1/(@#Q;E!
M&<X.<XYZ\5T!U6=?'MMI4VEV)N6TF6X2\60[^)$4QY*Y522#U/0<4 =117GU
MCX^U:XTK1=7N-(M(K"_U'^SY0MRS2(QE:)64;0"H*C.2"<G@5=UCQM<V4/B6
MYL[*&6+P]L\^.60HT^4#MM.#M 4C!(.3GIUH [2JKZG817T=C)?6R7D@RENT
MJB1OHN<FBSN+BZTN*XDABBN)(P_EK(64$C(&XJ#Z=A7FNCZFMGH&NZOKME:W
MOV;Q#.;9<DO]I\X11A21P!P W4 =* /5**YEO$5_8^)K70M1M;8S:A;R2V,T
M4C!'>, O&V02, @AAG(SP*A\&>(]9\46-KJEQI=I::=<0NRE+DO()%D*XV[0
M-N ><YXZ#- '65#;7=M>1F2UN(IT#%"T3A@&'49'<5RUWJ>KGXH6ND1FV.FM
MI<EPT;%LL?-C4D]B0,@#W.3SQR_AW7K[PSH%W=0Z?;/I2^(KBWG)E*R*)+HH
M"BA<84L.I&>>G4@'I>J:9::SIEQIU]&9+:==LBABIQUX(Y!R <BJ.G^&H+&5
M))=0U*^,9S&+VZ,@0^N.,GW.2*R-8\8WD$FJKH^FO?/I;B.2)896:=]BNR(R
M*0I"L.O4\8 Y/17&KP6GA^36;I)8;>*U-U(DB8=%"[B"O9@.WK0!?HKD;+Q3
MJUSK%A:OH\IMK^!W6X2"8+:N%W!969 "&Z!ACD8QWIFA>+=4U?5IM(FTR&VU
M"RN&2_C,C%8H< QR(V!NWYX''0YZ<@'8T5P-WXT\1[?$,EAH%E,FAW!2</>L
M&E01JYV?)][#'K@#@#=VE;QMJNHZI9V>@:5:7"WVD#5+:2YN3'P64;6 4X^]
MVSSCIS0!W-%<1?\ CB^CBNKK3='FOX;.[-M+!!!,\DI5@DAC94V_*=W!/.T]
M*MKXN>Y\37>C6OV1;FUN(HVM+ARDTL3!"TR \$ ,W'/W3R.E '645RECXM?4
M]?NM-M?L?FVEXUO<6DDA6X2,?\M@#]Y3QC'8YSVJYXP\07'AG0QJ-O9)=XN(
M86C:780))%0$<$$Y8<$CZT ;]%<0?&&LV6M7^D:KI5I!=+I[ZA9/#<-)'*B'
M#(Q*@AAQR!CG\[-OXQN)U\'R?8HA'XABWL/,.8&\@RX''S#C':@#KJ*X2U\8
M^(;RWU:]BT.P^R:7<W=O/NOF#,85R"O[OD$C'..O3CEMIXYU=9/#5UJ>C6\&
MDZ\(HH9H;DO)%-(FY0Z[0-K<@8)]_2@#O:*XFY\=7">&9O%5O913:'!.Z, Y
M\YXDD,;2KQC@@D*>H&<@\59D\8F;Q'<:/9-9_:8# R6]Q(4DNHG"LTD78A03
MQSDJ>E '6T5Q>J^-;V$:C+I&E2Z@FG7'V>2&."9I)R,;]C*I4%<]">2#TX)Z
M35-8MM'T&ZUB[WI;6T!G<%<-@#.,'OVQZT :%5;G4["RGA@NKZV@EF(6*.65
M59SZ*">?PKGG\4WVG7VAKJUE!':ZRXAB>&0L;>8KN5'R/F! (W#'(Z=ZR=!M
MI]:\7^,;36+6RNK1;JV1XW)<+MA1D"@CH"<_4F@#T&H;B[MK-%>YN(H5=@BF
M1PH+$X &>Y/:LK4M<>'7[+0K)(WO[F&2Y+2D[(HD(!8@<DEF  X[G/'/#^*]
M?.M>'98;BQ2/5=(U^SMYHE;<"3,A5D8@<,I'7&.0: /4B0H))  Y)-1VUS!>
M6T=S:SQSP2#<DL3AE8>H(X-<K9^)]7'B&]\/ZOI-G%>_8FO;-H+EGAGC#;65
MF* JP)'\)SFJNC^,(G\,^&_L>G16L^J6SS16T,3O';QIC=\L:Y(!91@ =>HH
M [FBN-L?&=[<Q6EI<:1)::M=7\ME%'.KQQR+&I<SJ64,4VC@8SGCWJGXGU_Q
M-9>')7-E!97*:K!:";S"5GA>1 '3'*YW8(/3!QGL =P;JW6[6T,\0N60R+"7
M&\J" 6"]<9(Y]ZFKEFU6=?'EKI4VEV)N7TJ6X2\60E_E=%,>2N54E@>IZ#BL
M>Q\?:M<:7HVKSZ/:16%]J7]G2A;EFD1C,T2LHV@%00,YP3D\#N >@T5QFL>-
M;FSC\2W%E90RQ>'@AGCED*-/E!(VT@': I&"0<G/3K75:?<37>G6]Q/$D4DJ
M!RB.7"YY')52>/84 6:*R=<U*ZTY;06T$92:4I-<S.%BM4"D[WY&>0% XY/6
MN,U'QKJNH>%;6]T]+:WG&OQZ9<,'9E8"X"$H<<!O?H"1SUH ])J&>[MK9HEG
MN(HFE<)&)'"EV/89ZGVJ&[EO(=(FEC6#[8D)8!B3'O _,BO+Y[[4=3\'?#W5
MKZ.&XOYM6M9$8-@ONBD/)(^7GTST[T >N45Q<?C>XLXM>BU>QB2]TJY@MU2U
MD9TF,X7RL$KN'+@'@],C/2M#1=?U&]U^YTR]TR9(4MUGAODMY8XGR<&,^8HP
MXX/!.0<\8H WC=VRW:VAN(A<LI=82XWE1U(7KCD<U-7 ^(?MD/Q4T>32K6VE
MOI-)NE'GR&-.'BY9@"<#T /7MUJ6P^($ES9+!=:=]GUH:C)ILMLA:5%D1/,9
MP57<R;,$8&<D#CK0!W-(S!5+,0 !DD]JXH^.;VTTJ]FU#1IH;B"^ALH':.2*
M&Y\U@J2 NH(49^88.,=3D5:A\1ZI)K^M:+)IMG*VG6R7'G?:&03"0-M79L;;
MRK _,>QP>P!T]O<P7EO'<6TT<T$B[DDC8,K#U!'!%2UP%AXQNET7P:=.T.SC
MBUM"B0I-Y:6Y$3.% "XV_+U_(&EN?'NIV/AK7+V?2K9[[1[];.>*.X;8X8Q[
M74E<GB0<''0\T =]45M=6][;)<6L\4\#C*21.&5OH1P:YVR\0ZJ_BF]T&]T^
MTCG6Q%]:F*X9E92Y0JY*<'('(!'-8FG>-+B/PKX4N]/T&SBBUBZ-J+:.;RU@
M)\PC "X(^0Y/'7H: /0J*XAO'=QIND^)Y]7T^(7>@R(CQVLI9)1(JM&0S $?
M? /'&,UHV_B#4QXU7PY<V=HX-B+XW4<S+A-VS:$*G)W8YW#(.>V* .FHK%U7
M7&M-:T[1;1(WO[Y9)%,A.R*.,#<Q Y/+* .,Y//%<OKOBF_O/!OC.T6&.TU?
M1X)8[C;(2NQHBR2QG&>1R >A!Y[T =Q:ZG87TLT5I?6UQ)"0)4AE5RA_V@#Q
M^-2W-U;V5N]Q=3Q00(,O)*X55'N3P*QO#6G1IIMC?S6=HE_]BC@$T(Y,0 *J
M20#C/:N US4-4UCX<?$!M6%K(EK=7$$03)\ORP@ 4$=.^>N2: /7000"#D&H
M;NT@O[*>SN8Q);SQM%*A.-RL,$<>QKE[?Q5>67B Z9J]G;V]L=,?4(9HIB[*
MD94.KC:!G# \9'4<]:9I_B_4;S4M(']C3OI^IH6,L=O,#:?+N7S&*A2#TR#P
M?4<T :.G^$;33_+3[?JEU;Q8\JWNKMI(TQTXZMC QN)Z"MN&WB@:1HT"M*V]
MVZECZD_3 ]@ *Q/%7B"Z\/QZ6]M91W0O=0ALFWRE"GF-@$#!S^8_&LC_ (2G
MQ&U_KNEII.F_;M,BCN-YNG\IXW5B!]S=NRA'0#O[$ [>BN.A\<?VC9Z3]@MB
MMSJ&G+J!5XI)5A0X !$:DDEB1G@?*3Z LM/&]U=VFG0RZ1<6.JW:3/);SP2N
M(5B8*6VJNY@Q9<<#@GGC! .TJ%;JW>ZDM4GB:XB4-)$'!= <X)'4 X./I7G]
M[XM\174'AXIIW]F2W&LFQN8KA9$\W:KL&0E0?+;:#G&>WK6J_B">V\0>)XET
M>R^UZ;I\-SYRRD-<J1(0K-LR -IP.>OO0!U\B&2)D61HR1@.N,K[C((_2L[P
M_H5MX;T6#2;.69[:#(C\Y@S*"<XR ,\D]:YS2O&>J75YX7^VZ9;0V>OVQDA:
M*<M)'((?-^8%0-I&0,$GIGTJ*Z\>7BZ4=7L]/@FM/[6_LL0RS-')GS/*\PD*
MV/G_ (=I..<YXH [NBFH7,:EU"O@;@IR ?8X&:Y/6]4UB#X@^'],M6MQ97,%
MS*ZL6!9D"#DCL _ ]>O:@#KJ*XJZ\;W*^'K[Q+9V,5QH]E/)&Z[R)I8XW*22
MKQ@8(8A3U ZC.*Z34+Z0>'KC4-.,3O\ 9C- TN=A^7()QSB@"W-=VUO)%'/<
M11/,VR)7<*7;T4'J?I4U>33W>HW_ (<^&VJ7<<-QJ$U];NK[\%]UM(?F8CC)
MY.,^V:Z6'QQ/;6VLQZK8Q+J&G7T-DL=M(SI,TP0QD';N'WQG@G@XSTH [2BN
M<T/7]1OM<O--O=,FCBBB6:&]6WECBE!."A\Q1AP?<Y!SQ535-4UF/XD:3I=L
MUO\ 89;&>=D9F!9E:,9) [!N![G/:@#KJ*XG2_%GB'4UU&YBT"V>VT^YN[65
M([LF61X@=HC!4 [F&,G'7IQS-IOBZ\NM?GT9X+*6Z73?MRF"<[48-M:%S@\@
MD?,/R% '85DZIX?M]6U+3;Z:XN8Y=.E,L B*A=Q4J2<J<_*2/QKE]*\>:I>V
MOAC4;K2K6'3M<E%N-EP6ECD*NRG&W&WY".N>_M6GI7BU]8UR:QMOL>;:\EMK
MJU>0K<0(FX++M/WE8A<8&,..3R* .KHKC%\9WD.M:39WME!!_:-W+:_9O-S/
M;A0Y1W X(<)G'&-PY-68_$NJ:A;C4='TN.\T\7QM"GF[9719#&\HSP &!^4]
M0,Y'2@#J6944LQ"J!DDG  IEO<07=O'<6TT<T$BADDC8,K ]""."*XS3-9UN
M?7O&,5Q'9W$&G.D<,!D91M,(<#.T]=QR<?ABGZ-XK6YT?PM:Z?86UM=ZO9FX
MC@7B&VB106. !D LH &,Y[8H [2BN"U'X@7FG:1KKOI<+:GHES##<P"<A'24
MKY<B';SD-G:<8P>?79TWQ!J,GB^ZT#4[&WA<6:WMO);S&0%"Y0JV5'S @=..
M: .DHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ K \5:%>ZW!I_V&\B@ELKV.ZV3QEXI@H(VN 0
M>X(]"HK?HH X*?P#J-SHOB?3YM7MR=8NUO(W6V(\N0>6>1N.5S$!CK@]36O)
MX>U-_%6F:]_:%J)H;-[2[3[.VUU9U?,?S?*<KCG/%=-6#I_BF'4[RU2UT^^D
MLKL2>1?K&&A;82#D@Y7.#@L!F@#)\/>%->\/LFEPZY _AV&4R01&W/VE$W;A
M%YF[&W/&<9QQQVKW7@74;KPQXET@W]JK:U?O=B7RV(A#%25QGYL;!SD=:[RB
M@#D?^$9U>S\4WVM:7?VD:ZK#&E_;W$3.!)&NU9(R".W!!_.JNF>#-0L/"NFZ
M!=RZ9JEE;VK6\]O<0,J2$D%6!RV"OS#ISGMBNXHH R_#NC_V!X<L-(%P]Q]D
MA$7FMU;'YX'H.<#%<C8^ M;M(M#B?6K.3^R+Z2Y20VC;YPX<,TAW\O\ /UZ=
MSFO0JR="U^#7TOV@MYX#97DEG*LX4'>@&2,$C'S4 0>,="G\3>%KS1[>XCMW
MN0H,LBE@H#!N@QGICKWJ%]#OW\:V_B S6P6+3WLC!ALDLZN6W?50,8KHZ* /
M.XOA_J]E8:?+I^L6T&L:==W,\$S0%HI(YW+/$ZYSC..0>U:>J^%-9U2PL;LZ
MW%%XAL;DW4-RD!\A25V-%Y98G85X/.<Y/M737-Z]O?6=LME<S+<LX:>, I!M
M7.7R<C/08!YJW0!R.J>&-9UOPR]KJ&JVQU0W$%RCQ0,+>,Q.KJH0L6(.#DYS
MSZ "K)T'4F\86FO/=6KF#3WLVC$;+O9V5RPY.!E0,<\=ZZ6B@#@H? NI0^%-
M*T7[?:%[#5!J'G>6V'Q,9=F,\<MC.3TZ5@ZA="]\5:[-%K7AB'%PEO)9ZQ&Z
M2$1*,9 D4.F[<5+*>O!Q@#UNHFMH'F69X8VE7[KE06'T- %;2;F[O-&MKB[@
M2&ZDC#/&I.T'VR,@'K@C(SSS7*+X!FN?"VLZ+?WT>;^_EU"&XMT(:"1I!(O!
M/.UAZC(]*Z/3M?@U+7=6TE+>XBGTSRO-:0+M?S 2I7!.1@=\=:UJ .;CT+4+
MO6+#5]6EM'N].@ECMD@5@ADD #2-GD<+@*.F3R>,3>#="N/#/A>UT>YN(KAK
M;>!+&I4,&8MT)..N.M;U% '/7V@7DOC.R\06=Y#&(K-[.>&6(MN1G5\J01@Y
M7'(/7I6&_@74G\*7FBF_M ]QJIU'SO+;"YG$VS&?48SGIVKO:* .-D\,:_8^
M)+[4="UFTMK75"DEY;7-L9?+E"A3)$0PY( X;CC\*Z6]TN#4-#N-)N6DDM[B
MW:VD9FR[*R[2<^N#UJ[10!R?AW0_%&EPPVFI:[:WMK9(4M2ELT<DN%VKYS;B
M" .P') )/K"?!^H0ZOI>MVM];QZO%O74IF1BM[&V,H1G@ @;>NW '-=ETK&O
M/$EI::MHUAY4TO\ :Y<6\\>TQ_+&7Y.<\@<8!ZT <?HMO?ZGK/CZQLKFUCBN
M=0\EY&!9XLV\:E@!PW'0'&"._2M^Q\)2:9XHTZ_LYH5T^QTH:7';LI+[ RL&
MW=,_*!C%=)#:6UN[/#;Q1LW4H@!/Y5-0!Q=OX4U[2]9U :3KD$.BZC<-=30R
MVY>:!WYD\IPP W'GD'!/0]Y=;\(7&O72?;'M"L%['<VEXJ$7-LJLK%%/?.",
MY& W0X%=?10!R%[X0N-5UBQO;][,RV&H&ZM[V)"MP(MQ(@)[K@@$YP0/NYYJ
M'XK,5\"R;9$C<WMGL9^0#]HCYQD9]:[6HIK:"Y $\$<H'($B!L?G0!@MX<DU
M+6)=4U22(2FP>QACM\E41SEWR>I.%QQP!WS6+I_@K7;<>%DN-7L63P^Q2(1V
MK?O8_*,0W9?[VT]N![]NYD>&UMFD=DB@B0EB>%10/T %03WKPZE:6@LKF1+A
M7+7" >7#M P'.<C.>, ]#0!RR:)<^'_"7BW[7<P2K>O>7P,:E?+\Q22IR><8
MZ\?2JOA;1;G6_"?@R2_FMS9Z=;V]W$L(.Z618<)NSPH7<2<9R0.G2N[EBCGC
M,<L:R(>JN,@_A1%#%!&(X8TC0=%10!^0H XF+P)<P>'[_P +1WL/]@74SNN4
M/G0Q.^]XAV.26PW;/0XJQX@\&S>(#+;7#67V59XI;*<1D7%B$"9$9'7)4D'(
MQNYSTKL:J75Z]M>6=NME<SK<NRM+$ 4API.7R<@'&!C/)H YA?"VO:;K^HSZ
M)K=O;Z7J<WVBX@GMC))#(0 [1,& RV ?F! /8UT6KZ/;:WH-WH]WO-M=0- Y
M#98 C&<GN.M:%% ')VOA?4+A-#AUJ\M[F+1I!-$\*%6N)%0HCN"?EP&)(&<G
M!R ,&WH>A7NE^(-=U&>>WDCU2=)@B*08MD80#)^]D*#VKH:* .=UGP[<77B+
M3?$&FW$<5_91O \<P)CN(7P2A(Y4@@$$9]P:S;[P+)>:9J!^VQ)JE]J,.HR3
M>43&'B*;(]N0=H" 9SGDGVKL7ECC>-'=5:1MJ GEC@G _ $_A3Z .3GBM=.U
MP:WX@U&RM[Z:U:RM(@^U%7[[X+<LQ(![8"@>I//Z)X1U:?P+X-O+"\&FZYI5
MKE!<1%XW211OCD7(/.%]P179V6LV>KZYJFD-9RB?2FA:1IT4JQD#%2F">P[X
MZULT <;JWA/6-4L=/O#K,,?B&PNC=0W"P'[.I*[&BV%B=A7@\YSD^U2ZMX9U
M?7/#,EK?:I;G5&N(;E)(X&$$9B=75 A;.#M.23DY]  .MJIJ>I6NCZ7<ZC>R
M>7:VT9DD?&< >W<^U &*= U)O&%GKSW5JY@T^2S>,1LN]G97+#DX *@8YX[U
MCP^!=2A\*:7HOV^T+V.J+J/G>6V'Q.9MF,\<MC.>@Z5U6FZO)?WMW:3:7?63
MVX1@UPB[)5;.-C*2"1@@CJ/QIGB'7X/#FGI>W-O/-$T\<!\D*=I=@BDY(XR1
MTS0!YWJ-T+[Q7KLT>M>&(,3I;RV>L1NDA$:C&0)%#IN+%2RGKQQ@5V5C>^([
MK5M'ED%M'936K&]MEA;<C_-B17., D* A&<$YZ'%T:O8S>,6T1[%_MT5F+Q;
MAT4J4+[?E.<YSGL.E;= '/>)-"O]5O\ 1KVPO8(7TZX:4PW,1DBEW(5R0"#N
M7.5/K6%_P@.I?V)?67]K6S3R:T-7MY#;$*K^:)2KC=R">.,8]Z[ZB@"#R9)+
M$P7$@>1X]LCHNT$D<D#)P/;)KBK;P/JT&@>&M+?4[.0:'>17".(&7S$C5E53
M\QP2&Y/3@<5WE8X\0P-XGN-!%K<_:H;,7F["[)$+%0%.[KD'KCI0!@:AX$GU
M6?Q.UQ?K"NL-;RP/ IWVLD 4(W)^;E0>WI[UMZ!9>(8<R>(-4M+N54\N-;.
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MZ567PY?IXAU_5%N+;;JEK%;I&5;,7EAP"3WSO/''2MC4]7ATS3A?F&:Y@+(
M;?:Q.\A5/)&021TJ^C%D5BI0D9*MC(]N.* . @\"ZUI5IH-QH^KVL.JZ59?V
M?(TT#/!=0<$!E!!4@C/!J]JOA36KB72]7L=;BCU^Q\Q7EF@)MYTDQNC*!LJH
MVKC!R,<DDYKIWO7358;(65RR21-(;E0/*0@@;2<YR<Y''8U1UWQ+::#I8U"6
M*:Y@^T);L;?:=CLXCYR1T8X/>@#,U/PQJ^IV6DRR:K;G5+'4%OS(UNWDDA&0
MHJ;LA<-Q\V<C)ZTDWA;49-9U^_%Y;$:II\=DJE&S&4#C>>><[R<<=!S76T4
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M"#RX3"85"_PKMQQ^%6:R?$&OP>';2"YN;>XECFN8K8&$*=K2,%4G)'&2.F:
M.;MO!>KQ:1X6L9=2LY/[!N(Y598&7S42-HU7[QP2&))]<<4Z^\!W&IOXD,VH
MI ^J7$%W;2P(=]K+"JA&Y.&Y0'MW'O7<44 8F@V>OP@R^(-2M+J8+Y:)9P-%
M'CNS98Y8X'H!S@<U#JN@7EUXLTK7+*\AA-I!-;31RQ%]Z2%#E2",,"G?(YZ<
M5T-5-/O7OH)))+*YM"DSQ!+@ %@K$!A@GY3U'M0!S-KX/OX_#7B/27U-(I-7
MN+FXCN+="# 9CG')YQZY&?:F6'A/6K77;35I-0T[=#I9TYK>"U9$QN#*5^8X
MY'/MP!WKM** .$M? ^H6OA[PKI8OK5CH5VER9/+8><%5U QGY>'///2KDWA"
MXU#7=.U*_>S^T:?>/<17L"%9WB.[;"W^R P!.3G;T&<UU]% 'GMIX"UNVM]'
M@;6K-QI>I/>)*UHQDG#!P3(=_+_/U'ISFK^E>$];T2_N[2PUJ!/#]S<O=>2U
MN3<0EVW/'&X; 4DGD@D9..>:[%W2*-I)&"HH+,S'  '<TJLKH&4@JPR".XH
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MG[7+']KF^:7=OW9W9^\ >N,BN9U;PY/<^*+^YO?#VJW*RF-+:\TK5O(S$J@
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M29UGG:2360N996DQC4< X8]?4]^]>KMX?TUM9MM6\AUO+6$P0LDKJJ1G&5"
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M:D?:<S&2*2-PO3&T9W#:%YP*]>H S[W7=(TXRB^U2RMC$H:037")L!. 3D\
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MH.>6Y''7D5/:ZMIM]=7%K::A:W%Q;'$\44RN\1]& .1^->/ZBE@WPV^('EI
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M&)Y975(T4LSL<!0.I)["N+\#74$OB'QDL<R,7U;>H#?>7R8UR/49!&?:NVH
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ME-P)<="#P<'C@'K4&H?$/2=/D$D@9K(7?V-[E)$.R3=L)V;MVT-\I./?!'-
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M;LCD;.T/E@1G!Q@'GCN*IQ>,;>0Z^AL+M)M$($\3&/=)E=R[ &YW \9QD\4
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MVU9EP5=,]B58X/K7344 <I%H]Y-XFU#Q--9M%,^G+86]H9%+D!F=F8@E1DL
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MM*^R.ANQ(ZOYN_H%P?S_ ,*[*B@ HHHH **** "BBB@ HHHH **** "BBB@
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M5WSJ#ZY-;R%NJ1QA1&GT )Q]:W?$E]'X>A.H6ENK7^HW-M8@X'+,Y5202 2
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M]N)Y/L']GO#*$*21EMQ+?+G)/X=L4 <[+XIUBR\.>'O%$TL4UIJ4MNMU9K&
M(8Y\!3&W4LI9<YR&YQMJEJ/B;Q3#I?C"_BO[%!H%VPCC^R$^<BQH^PY;CACS
MR<^F,5TMAX)M;*TLM.:^N;C2["<3VEI+M(0J<HI;&653RH/H,DXID_@6WN-/
M\0V3ZE>>5KLADN2!'E"5"D)\O VJ!SF@#<O]4BT_0+G5Y48Q6]JURZCKM52Q
M'Z5R,OB;6-.TCPUK]Q-%<6NK36\5U:K& (1.!L:-AR=I(!W9W<XQ7:)91_V:
M+&X/VB(Q>2_F ?O%Q@Y XY%8.G^"[>RM=/L9+^YNM.TV836=M,%_=E<[ 6 R
MP3/RY]!G.!0!1\.:AXDUG6]5\[4;)+/3-6DM7B2T.Z:,1J0,EOE(+ YYSS]*
M7QB]_P#\);X/@M=0>VAGO)@Z*BD,1!(03GK].G.?3&WH?AY-#N=3FCO)Y_[1
MNC=RK*%PKD!3MP!QA1P<]*-=\.Q:Y/IMS]LN;2YT^X,\,MOMSRI1@0RD8*L>
MU '!75WK&F:C\2-4TJ\@MVL)8KIEE@\SSMEHC;>HV@@'D<\]L<]%/XCU35]0
MFT_2(YHI8=/@NV>)8G/F3;BJD2,/E&SG')SU&.;<O@F":+Q'&VI7FW7EVW/"
M90>6(_D^7CY1CG/K45YX#26[L+^QUO4=.U&UM5LVN;?R\SPCHKJRE21V..]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0[8"MC:<\*><@<4 >ET5R4NC2Z?X1UFXN;R[:^GMYIW9;R4K"VTD+%EOE"\
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M) 4D(783TYSUXJ+P'X<E\,:%/9R*L*S7DUS%:H^];6-VRL0/? _#)/UKJ**
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KFM8\130>*]/\ #EI-:6US=V\EP)[M"ZL%(&Q%
M#+N8Y)Z\ =#72UQOC&V\+Z[>QZ#XD6.)O)%Q:W32>4T;;B#L?^%N <9Y]#B@
M#=T>[U)X[]=8BMH7MK@QI+"2$DC\M&W_ #=.68$=L=3UJY9ZC9:A$\EE>6]S
M&AVLT,JN%/H2#P:\D-UKMMX0UFW?4+K6M'TG5;4QZ@BAY;BT5D>5<X(DV=">
M0<,#P,59UM],U3P_X@UWPM>WNL7,]M MZ\0 22))%+)A54%_+\P$<D#@XR*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7-C>07UG:_;#:OY9:6'H70AMIP1@C((/U% '0!550J@!1P !Q0JJJA54!1V
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MN"C@DLQ. H Y))Z <T <KJ.FZSIOQ!7Q#I]C_:-G=6"V5S LRQR0LKEE<;R
M5^8@C.>_-<W!X3\3VFCV%Y'IEG-J&G:K=W7V"6X4I<PSL^1NQA6 8$$^G/I7
MI&EZO8:U:&ZT^X$\2NT;'!4HZG#*RD J1Z$9I-/UC3]5ENX[&Z2=K27R9]F?
MD? .,_0CI0!Q^MZ7KFK^'K8)H,-I<?VE:W/V.&:,F..*178L_ +'!P!D=.>M
M:NO:=J%YXN\*ZA;V3O;6$L\ERWF("@DA9 ,$\D$Y..WK74T4 <C=^&+IO'R:
MI;.BZ9=P(=1B/5YH&!A(_/GV0#O6-XPT#Q)KK^)K+[!%>VEU9JFEN]RJ) VS
MYP4/\9;D-CI@9%>CT4 <9!I>M0^-=,UDZ?&86TC[#<*+@9@82!\]/FX!''?V
MYI?#?AR=M#\1:9K5D8H-3U"[F"EU;=%,21]TG! /YUTBZQI[ZT^CK=(VH)#Y
M[0#.Y8\@;CVZD5>H X6R\'ZI=?#O4-%UB[0ZK=VIM/M"\@(BE(C[@@;S[NU7
M?"X\0220KK'AVPTQ[=,2W,,R2?:&QC*!1E%/4Y.>V#G(ZVFR21PQ/+*ZI&BE
MF=C@*!U)/84 <UXFMM:N-7T@V=J+W25,HO;83B(LQ \MFS]Y!\V5]QP<8KD;
M#PIXHTC1]$NK73K5K_1-0NY%LA<@+<P3N^=K8PI 9<9]#G'2O0].U_3-5NY[
M2SN=]Q JO)$\;(P5ONL P&5/8CBM*@#BO$5AXAU[PW!*VG117L&HVUY'8"X4
MG9%(K%3)]W<<$^@X&>]+>:)J6I^-FO+BR:&QN-"DT^65)D;9([AN!D$@#(SC
MK[<UVE5KV_MM/B62YD*AVV(JJ79VP3A54$L< G !X!]* .#@\,ZU?>#='\)Z
ME9B(:?/;B6^65#')# P*E #O#,%48*C&3R<#*7OA[6[C2/'MJFFMYFM2,;/,
MT>"#"L>6^;CE2?I77Z+XGT7Q$TZZ1?QW1@"F4("-F[.,Y Y^4\=1CFK-QK&G
MVNJVFF372)>W@8P0G.YPH)8_0 'K0! ^G-J/A1],N0]NUQ9&VD&063<FT]#C
MOZUR4'AS6M1\+Z!X;U.R$']EW%NTUXLJ-'+' ?E,8!W;FVJ.5&,MZ#/H5% '
M+>$M.U#3]3\227MFT$5]J37<#&1&W(8T3! )P<H3^-4?&LLL/B_P3)#;M<.+
MZ?\ =HP!8?9WS@D@9QD\D5UAU.S&KC2C./MQ@-R(<'/EAMN[/3J0*BOM$T_4
MKZSO;J%WN+-BUNXF=?+)&"0 0,D$CZ<4 <+XA\)ZMJ>F^++RWL2+[6Y+1(;8
MRH"D<!7YG;.,GYN 3QM]\;NNZ5J4GB;0?$MA;-,UDDL%S9&15=HY0.5).W<K
M*.,X([UUM% 'F^K>#-8O9-6U^R6.#5YM2M+^UM)G&TBV38$=ER 6!?H2!E>>
M]:.M:?XD\6^%;F.:PM])O4>&>TMI9Q.&EBD$G[QE&-IV@ #/<GT';U1O=8T_
M3KJSM;NZ2*>\D\JWC.<R-C.!CZ&@#C[O1M<\4^%M2LKG1;+P_<RP!8@LJ3%Y
M597!)08"94#').>@QR/H^N^*/#.I:7J6A6.@RSV<D!EBF64RR,, C:/E3N03
MGD#MSWU% 'GB67BG4-0\(3WFA);OI$S_ &MS=QE'S"T>Y,9.,G." >V.]5-1
M\,Z]=>%/&>GQZ8WVC5M3-S:@S1@&,^5RQW<']V>/<>^/3J* .-OK:ZB\<MX@
MN[,1:3%H<MM/+/+& C%Q(=P#$[0%()Y_$<US7AV'4M+MO#\NK>%[XV=A@6TB
MW\$D5L9?D!5.)" &V@,6(![FO4YX(KF"2">))89%*/&Z@JRD8((/45D:;X0T
M'2)DELM/6-H^8P9'=8_]Q6)"_@!0!!XZT>\UWPC=6&GJCW3202HKOM#>7,DA
M&>Q(4@>]4;S2K_5]=77)=/EMOLFG3VUO:O)&99))=NXDJQ4* H ^;DD],#/8
M44 >=_\ "*:S-\-/#FGI"D.L:'+:W*0R2#9,\/5=RYP&&<'UQFM.XT"\U_Q"
M^L7-J^GA-*EL(HIG1G9Y2"S'86&T  #G)R>!@9Z/4]8T_1XHI-0NDMUFE6&/
M=GYG8X  'N15Z@#S32]$\3!? T=QHT<"Z"3%<,UVAWCR#%O7&>#D''7V'4T(
MH+V5-0FC\-7&H>'YM4DU!1::C ()=DF0^U\/RR!R-VTGIP:],TW6-/U<7)T^
MZ2X%K.;>8IG"R  E<]^&'3UK.A\%>'+>Z:XATJ*-F<NT:LPB+9SGR\[,Y]J
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MB!'(S\QSQGCWXKOZ* /,;GPGK\]EK,UO9Q)>#Q"-8LHKF1#'<((U0QM@G:2
MWYC\.Q\._P!HRI)<:AHEMHY8!5MHY4E<GG+,R@#'3 'N3UP+$WB32+?4HM/E
MO52XEE,*95MAD SLWXV[L<[<Y]JJ_P#";>'1J%O8'4T6YN2@MT:-QYP<X5D)
M&&4D?>&1[T 9NJ:%J6F^.%\5Z-;K>"XM1:7]D9!&[J#E)(V;Y=PZ$$@$=ZU+
MVWO?$FD7VGW%I+IMM=6LMNWG,C2Y=2N0$9E &<]<GV[[M% 'G\/A_6=4\/\
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MTNXO=*AN-1L-<^U27;WBXE@S(%$8P=BA67*\'*YP22:]0HH X:'1=9M)?&D
ML%EAU5WGM95G4%BT"1[-IZ8*G).!CIFJNG>'=:TB?PEJT=D9IM/TH:5?V8E0
M/MPGSQDMM.&3H2,@^O%=W?7UKIEC->WLZ06T*EY)'/"@=Z=:W4-[9PW=NXD@
MGC62-P"-RL,@\^QH \\U7PCJL^GZO=069:]U76+6]-N)4'DQ0M'@$DX+$(3P
M2,L!GC-;#VFLVWC?6-=M])::.328X+='GC3S)D:1]I.3M!W@9QZUV--DC26-
MHY$5T8896&01[B@"CH>HRZMHEI?SVOV66>,,\.\.%/LP^\.X/<8-:%&,# HH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8N;>1U57PCG8W)!Z^H%+<-XEA\?>&K&^UBUD$L-[*P@M"B-L*!207)SM?'7
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M@GW)K.\1:IJ-EJ$<%M<06\#6DLBL(S--),I&U1&.=@!)9OIR.M=(    , =
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MUY]Z -NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@#UZWE\^VBEQC>@;'ID9J2N"@E75/'RZ)JD8DL8]$BGM;>3E)&+D2/CH6&%
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MQ$UU;EY0QWW$KS".2%_5>6&WHNT8QBNBT_3K+_A<6M2>0F]=-M90?1S)+DT
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M 'O69>>(-6L-'FU6Y\/M]GCB,I@CN@UPH S\R;0HQWP[$=LUA_%N*4>'])U
M(SV>FZQ:WEZJC/[A6.XX[@9!_7M7;O>6GV#[89HVM60.) =RLIZ8QUS^M %B
MBO/[18?$NO\ C*RUAF22RDCCM<L5-M"8@RRQG^%BVX[ASP!VKG]-2[\2W'@
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MW+*3G[P./GZG=C/-<G86_D>"?#^LK<W;7\?B,0+,]R['RVO71DY.""IYSUH
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M/271)F:PAR6ZD;1@_EBH?%,EK-X@T'3I-T]Q-Y\D=G(X6WE"H-S2Y!SMW J
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M:VIIJ36%L;Y$V+<F(>8J^@;J![5C1?$'PK//9Q1ZQ$QO)#% VQPC.&*[2V,
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M%XL0F\F:%XF:,G&]0ZC<N>,C(H U**** "BBB@ HHHH **** "BBB@ HHHH
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M>$+O3KN;4KB>Z6VE\AFBN!,Y=)3(!M7!;G)!&WZ5ZI39)$AC:21U1%&69C@
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MQX*$$$;CD]23P!6[9Z!?6WCB;6FFADM9-.BL<,Y,IV,S;SQ@D[B"/Q]JS_\
MA$=5BTWQ;IT5W9M;ZW)<2PEE8-&TR!3N/(PN#@ <YZB@"AXBO[V6'P(+"SM8
MK2[O('\@S%%R('=8R A&T8!!]5''>K5C?:/X;\3>((3H5EIPM-/74KJ\MSN:
M569RPQM!X*L<9[]JLW?AG59[;PI&CV8;1)8Y9=SMB4K&T>%^7C(;.3]/>GWO
MA*?5/$6M75X\/]GZII:Z<R1L?,4 N=W3'\9_(4 7;/6]7FO+$3Z&5LKRV:<3
M0S;S 0 0D@('+ \8)Y!'O5"P\9W,^N:7I=YIT-O<:E;2SI#]HS+;,@5MDR[?
ME)#=1T((P>M.T+1/%5MIR:;JNM6;06L#06\]I"RS2?*55Y-QP" <X'4@'/'.
M=I'@O7;*[\+SW%]IG_$F2:&010OF=9%4&0DG[YVY/N2>>E !H'C+4%\-3ZCK
M$5N\TNJ2V5NL4K89_.9 N-ORJH7.>20"<9XK>T#Q%<ZKJFHZ?=Z<\#6NQH[E
M YAG5A_"65<,",$?2L$^ M3/A^[TQ-5@@DBU-]3TRYCB):.0RF0>8"<$?,5P
M.QS[5T^A0:\J/-X@NK*2X("K%8HZQ*.[?,22Q_(8^I( FI:X;;6K+1;.))M0
MNXI)P)'*I'$F 6) )/+* ._/(Q7)^)/%M[??#_Q:D%NMGJNEI+;W:>>?W8*9
M$D;!<ME2",A>_3'/1:WX?NKCQ)I?B'3)85OK*.2"2&<D)/"^"5+ $J00"#@^
MXK-U'P7=WGA[Q- DULNI^(&_?R$MY<*[ BJO&6VJO7C))/'2@#;T'2H((HM0
M?3[2VOY+:.!WMV+;HU'R@DJO3/I7+V]K%'\;M7F@M(&N!H<+KD!<N96&2V#C
M. ,^U=U8I-%8P1W C$J(%;RV)7(&.,@5SL>@:I#X_O?$:FS:&>P6S2$R,&&U
MBP8G;CG.,=O4T 9FE_$"_OK+PYJ4^B16^FZU.+57%WOECD8.5^79@K\F,Y!Y
MZ5J-XHO[F*:\TG2/M]C!?&S?9-B5]K[)'1<8PK9ZD9"D\<9R+/P1JUIX7\+:
M1Y]DSZ)?)=/)N<"8+O\ E V\$[_?I[\6]-\+^(-%U*_M=.U2S70KVZ>[(DB8
MW-N9#ETC(.W!.<$],]#0!<N?%5U)'K4^DZ='>0:/(T4^^<HTLBH'=4&TC(#
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M4,+,=HE;=M.0.GKW]!4?CGP_?>)_#_\ 9=E+;PEIXI6DF+<;'#@  <YQCVH
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ML>#\O. N>WI[U)>^$;R\\-Z!;K<P0ZMH;PRV\H!:)VC7858<':RYSW&>^.0
MN_&EQITFNV5WIL?]I:78G44C2X/EW,'.65BN5(*D$$=<<\\11^,]7-_HENVA
M0;=;M6ELR+WE75 Y$@V?*N">5+'CIDXJ74?"E[JK:UJ%PUK'J6H:6=+A1'9H
MX(SN)8MM!8EFST'W0/4T)X8U,7_A&X+VFW0X7BE =LR[HA'E?EXP!GGZ>] &
MGX6U^?7K6_%W:):WFGWLEE/''+YB%U"G<K$ D$,#R!6>^L:P?B>='2.V.GII
M8N0#*RL2TNTL?E()&W 'H2<\X%SPOHE[HUQKDET]NRZCJ+WJ>4Q)3<JKM.0,
MXV Y]^E)<:%??\)W#X@M;BW$)L/L4\4J,6P)-X*D''.2.>G7GI0!@0>,O[-\
M.76HVOAVWAVZZ]A/!#.%S(9A&TN=@W$L<\X^M:*^*-?DU[4-"30[+^T(+>.[
MA8WY\EXF++\S>7N#97& I'N.^<_@C5W\/7>G>?8B2XUO^U0^Y\*/.$NS[O7(
MQG\<5N1Z+J4?C>[U\?9#'-I\=FL/F-D,CL^XG;T)?'X9]J *5EX]BU/2M&GM
M+94NM3M'NA%,S;850JK9*J2?F8 <#/)XQBMGPSK<VOZ1]KN-/FL+A)7ADAE!
MQE3C<I(!93P0<#K7(V/@/7]%TKP_)I6I6,>L:1#+:L9D=H+J!V#%6 PRD$ C
M&>E=UI<-]#9C^TKF.>\<[Y#"A6-3_=0$D@#'<Y)R>^* .8M_$FHP^-?$\6H?
M9DT?2K2"8L)&W1H5E8OC;\S':,C(P ,9J8^,KBVCT*]U#34ATW698X89$FW2
M0/(,QB1=H'S="03@\<]:=<^$I[KQ'KMQ)<0-I>MV,=K=1%3YJ[5=?E.<8(?.
M3Z?C4%IX2U*;2]#TC5[FUFL]'GBF2>+=YESY0Q$&4C"8^4G!;.WMF@#8\8:E
M>Z/X.U?4M/6(W5I:23)YI.T;5)SP.3QTK%DUB6+_ (0U-4TFTN9KZ8)'<&;>
MT#^2S;QE!R0"#TQGO72>(-+.N>'-3TD2^4;VUEMQ)C.S>I7..^,US\WAK6KF
M/PL9Y[ RZ/.)I=F]0X$;1[5X/9B<GZ8H J7OCS5;>P\17L6@V[Q:#<M'<!KT
M@R1JBN2GR<MANAP..I[:4/BVYC\1VNGZCIT5K:7UG+=VLZW&]@L>TL)%V@*<
M.#P6'O6?<>#M5GT?QA8^=9@Z_,\D;[V_<AHUCY^7G 7/XU<N/#%]>:YH5[.;
M3[/864]I/&)&)D\U44E3MXQL_'/:@".R\<3WEYH[1Z3))I^J'"2Q;V>W!7<C
M2#9M (ZD-P3WZU-H]\UAX^U?PW_R[-:Q:E:KVC#,R2*/;<H8#_:-0^%_#WB?
M0XK;2+K5[*XT6RPMO(D+"Z>-?N1N<[0!P"0,D#'&:B-E>W/B7Q#XFL9;>%UL
M$T[3YKA28V*EG=R!R5WL%&.NT]>* .WKCKOQM-'HVHZ]9Z<ESI.G3R13,)L2
MR+&VV1T7;@A2&P"1D*>G%='HTU[<:+93:E&D=Z\*M.B @!\<X!Y'T/2N5C\%
MZA:Z1K?AZUNK;^QM4EF=9'W>=:K-_K$5<8?JVTDC&>0<4 3S^,-3G\0R:3HV
MC07N+&&_BF>\\M9(I'*_W#@_*2!W]16IXTUUO#/@W5=8C4-+;0$Q!NA<_*N?
M;<156P\-W.G^-&U2(VZZ>-,BTZ.$,V]1&S,&Z8_BQCVSGM5OQEH1\3>#M4T9
M&"R74!6-CT#CYES[;@* ,G7GA\,^$-/2ZTV'55-U;1SFX89,KR*/..5.YMYW
M=JT(_$LR>,+S0KRSAMTBLA>V]R;@GSH]VUN-HV[3C/)ZBJ6L65YXR\(64-L8
MK>Y$]O-<)<$@Q/$ZNT9 !YRN/UYJWXE\*CQ#=Z1=>?\ 9YK*9O.V\^; Z[98
MOHWR_E0!E>*=9NK#P;:>,'MA:W5F\,TD2N6W6[NJO&Q('\+;L8X91Z5VTLGE
M0O($:3:I8*G); Z#WKF/'M@VOZ$OAR'F34IHED(_Y9P*ZO(Y]L+@>[ 5T5_;
MR7>FW5M#<-;2S0O&DR=8V((##W'6@#F-.\97-SKMAI-WI\$%S?63W2PK<[I+
M=EVGRI5V_*<..?4$8[U0L_B#J-QINE:K-H<,.GWFH_V=(PO-TD;F9HE95V89
M<@9R0>3QQDKI/@[7K&_\-W<MWI?_ !*+6:V>.*)QYH<)\^2?O,4R3C@DGYJ9
M%X(U>/PCIVC>?8F6TU8:@9=S[6 G,VW&W@Y.W/MGVH V8/%DJZQK^GZC9PV;
M:5 MTC_:"PN(2&.\#8, %2#UP?PSO:=/<W.FVT]Y;+:W,D8>2!9-_EDC.W=@
M9Q]*XW5[;2?%/C/218:A')>:=))'J<=O(&Q ,$Q2XZ9E6/ /4!_0UW= ''IX
MUN(]8TFSO=-CMAJ=S+;I"T_^D1;0Y1W3'W6"$\'C(ZU.GBB_O(5O]*TC[;IO
MVXVA9)L2E5<QO*JXQM5@>,Y(&>*P[/P-X@MXM&CDU/3I'TS4WO#.T+F2Y#!P
M6D.[[^'Z=..O:M#1_"_B#0KRZL++5;,>'Y[I[E \3?:8 [;GC0@[<9)PQY&3
MP: $T[7=9NM;\7P75I9SVVG.L<4(G897R0^#E"#G=R?PP<5)HOBF"31?"]KI
MFF06]QJUIY\%HK[8K:)5!8DA>@W*  .2>W-6(?#FIV>N>)+N"XM'M=7".L;J
MP=)!$(\$CC;P#TSV]ZS;+P1J.G6/A6>VN;4ZIH$#6I#%A%=0LH5@3C*G@$'!
MP1WH =?_ !"FT_1];FDTE6U'1;F*"ZM1<?*5E*B.1&V\@A@<$#H1]=?3?$5[
M/XLN=!U'3HK65;1;V!XKCS0\9<H0WRC:P(' R.>M9&L^![S5-)U_;-:QZGK<
M]O),Q+&.%(2NQ!QEN%/.!RQ],5KQZ+?GQZ/$$AMEMSIHLFB5V+ []^[.T#&>
M,?C[4 ='1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !116#XKNY+:SL4COVM6GO8XBD:;I;A>28
MH_[K''WNP!.1U !O45YO8ZOXCGT'Q#%:K/=7.GZWY$=N\RB=K8+&[1J_0OM9
M@#DGWS@TZ/Q!>7_AR2[T,:G?>3J86]TZ<^3>PQ"/YH5)ZL#AASDC(SGF@#T:
MBO.+;Q4=0BT*PTN_GF74;RZCD:\8P3Q>6"WD,=I*L,@9QDA>O.:CUF3Q7HFC
M0Q7&N(LK:[;10-"PE<6TLBKLE+("2.>1@D=2: /26D1&16=59SA03RQQGC\
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M&&[TYK;3X('L[E 2@,BR$F0[B" 5'3'0UOP7\=MHUK=ZE?V0W1(9+E'"0NQ
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M3VTW@L>1+$[+>W>[802 ;B0C/U!!%=M@>@I0 .@H Y#XIQM)\,]="H6(@#8
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M[/X4F%LMN57=-YF8^G?G(]JB26UU?P]X!3161=5LKRV$D2<2V\:H1<K(.JC
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M1$@[)0J* =PX!YZD< UWF!Z4*BKG:H&3DX'4T +1110 4444 %%%% !1110
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M0:U/#IW]DPM<0+=J;ZWCG$,DL.T\*Y(Q\VTD9&0,=S7&R^$_$"^%_$6E1:-
MAO=;COK98+E-HC#PN1SC&!&1]3TQS0!V,7C&&2[U.S;2=3CO+"W6Z^SM&F^>
M$D@/&-^#RIX)!]L\5/:>*K2^TG1M1MK:YDBU9E6W0;-RY5FRWS8&%4DX)(QT
MS5*#3]0_X65/K,ED\=A)I,=J)6D3(D61G.0&SC#8SZC\:I>$=!?3_$FLA)UD
MTFRN7&GQ ?ZEI@LDR^F V ,=-S"@#MG8(C.QPJC)/M7.Z;XSLM2O=,MUM+R!
M=4@>XL99E4+,B8)X#$J<,#A@.#Z\5O70G:TF%JR+<&-A$SC*AL<$^V:\XTSP
M_P")'UKPMJ5_I"+<VD5Q#J5S)>J\DC2(H\P$9^7()"CIG&%'- '5)XQLI);
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M*RO(HVAF#MC&0,#GDXL^(;#Q%XJ\":O:RZ;%8W=Q&@M[-KA7.58,=SCY1G&
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M=WEPMHMY+! $WQ1MG;NW,!DX8  DG::2+Q797:6 L(+F[N+VU^V16Z*J.L7
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MJ$1]@@(5CE<#D8P3DYR<UJG3;_6_%.B:Y>Z=)8#28)_W3RQNTDLJJN%*L1M
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M:X*%AGC@9XS6QX>EO8?$[3:SH%_;7]]"($O9[J"8%8\L$Q%C:.6.=O)ZGH*
M.WHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.BR  E<]^&'2N3TOQ%XGU9-#U:STWSM-U!U:XB81KY$#C*R*_F98KQD;><G
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M,JAP&R">5&&/8=.M06WC?44TB3[2MJVH3>(GT2W9(V6(8D*ARNXDX56.,\G
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MG6MWMV^?$DFW.<;@#C]:L4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZV:J:K>/IVDW=['#Y[6\+2B/?MW;1G&<''2@"C-X:L9_%4/B!PQN8[5K;9_
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MF/ROM=M'/Y>[.W>H;&>^,U=H XV;X>V]UINJ6D^HW >]U'^U(KB%1'):W&
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MZ$CFNPHH YV3PNUT][=WE]YNHW-D; 3K"%6*(DEMJ9/))R22>@XP,57@\&&
M>&0NI,1X?0I!F$?O08S%\_/]T]L<\^U=510 5SEOI;W_ (W?Q!*K+!:V?V*T
M##!<LVZ23'IPBCUPQZ$$]'10!BZ_H!UV72Y/M9M_[/O%O$ C#;W4$ 'GIACT
MY]ZSY_!AG3Q,K:DP7Q NV?$(_=#RQ'\G/]T=\\\^U=56'9>('NO%^I:"]GY?
MV.WAN%G\W=Y@D+#[N.,;#W- &EIMH;#3+6S:7S?(B6(/MV[@HP"1ZX%6J**
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M@\'>!]96YNFU"36TMGF>X=BT3S2JR$$XP1^O->L66A:5IL;I9Z?;P*Z>60B
M?)_=]E]NE0CPOH*VD%HNC6(MK>3S88A NR-^NY1C /N* /.==O(V>;4]/N'9
MXO$\%NUY/+B4,)$1X(P!Q$!D8)Y^8XYS75:6P;XM:\RD$'2K,@@]?GFK:F\)
M^';B6ZEGT/3I)+HAIV>V0F4@@@MQSR ?PJW%I&FP:B^H0V-O'>2*$>=8P'91
MT!/4CVH NT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5B^*;VVL-"DDNM7DTE"\:BZC0,RG>.
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MS*IC@@D=BT2[G'"]0 ?K@^AJ;2/%MCJ>@:;J;I<0O?1*Z0?9Y&<DH&.T!<L
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M5(7M('F2WDA#!HL("0#OR#@ _6@#H)_%N@6T=A))JD'EZ@";5U)82@ MP1[
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MZO6<1*Y(4!5RS$@$X' X'4CH,D &S17"2>/[Z'38IY/#\@G.KQZ8Z&4HK[V
M66(L@WJ<]]N#Q[UIZ=XDU.\O]<TJ?3;6#4M-2*5 MTSQ2)(&*G=L!!&U@1MH
M Z%+VUDNGM8[F%KB,9>%9 74>I'45/7EOA"^BM_"/A#4+W3K:XUN\'D6$WG'
M>YD#/*SMM^48!)^]S[FM^^\<7&F+X@MKK3(_[2T>S^WB)+@^7<P8)W*Q7((*
MD$$=>YH [.BN1M_%FIL+%+K1X89M4=%TY!=[O,!C,CM)\OR;0IZ;LD@>]32^
M*[NPM9/[4THVUV;\65L/,+1W)*[A(K;<A=H8GY21M(YH ZBBN?\ #OB&YU>^
MU*RNM/>WDLG3;.H<PW",,@HS*IR,$$=CW.:J^.-7U328=%&F+!F[U6VMI3(Y
M4[6?.T8!X.,$]@>ASP =.)HFG:$2H954,T88;@#T)'IQ3Z\W,^H:=\2/$D^F
M:7:S79TFTFE1I_*C+!I<_,%)).,#Y>W)%;4/CF&_L=(DLH%%SJ5C]N"3LP6)
M/E&"54DG<V!QV)] 0#KJ*Q_#.MRZ_HL=]/I\]A/O:.2WF!RK*<9!(&Y3U!P,
M@UGZOXFU*S\4PZ!I^D174]Q92744LEUY:C8RJ0WRD@?-U&3TX[@ ZBBN C^(
MUU+I-G<#0B+UM8&C7=JUR 8)\]FVX9<8.>.M:+^+-2B?^SYM-M8=82W-Q-";
MEWB12[+& ZQDDML)Y Q[T ==17*:;XQFUE--@L]+DM]1N[1[N6VOB8OLR*P0
M[OER26.!P,@$\< @\7W"VVFPW6EFQU:]29VM;B0E8EC8*S%E4D@EEQP,ANU
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M&!5G2/"4UKXJC\03Q6-I=&T:"[^P%@MZY*D2.I  QM..I^;KQSUU% !1110
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M.0HP*L&!##D$$#I6;-X3TN[L]2M[U)+O^THEANI)7^=T7.T9&,8R2,8Y.>M
M&%KNOWVB^--1*2R36EOX<GU'[(<;6EC< $=QD<=>]7M#AU"Y30=9&OM)!=6N
M^[@D4%+AG0,IC_N;3G@=1UYYJW9^#-)L]2CU$_:[B\2V-J9;FZ>0O&3DJV3A
MATX/''2F:+X(T;P_(S:?]K1 &$$4ET\D=MNZ^4C$A.IY S^!H X#P[/J.D^#
M?"NHVNJ7"I-KALY+0!?*:*2YD5LC&2W<'/%>Q5S:>!M&CTFSTM/M0M+*Z%Y
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M-;:G<?:KM/M#?O)."3GJ/NKP,#@5?3P_9KK\>ME[AKY+;[*':4X,>02"O3J
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M!1@8(P,&EHH 145%"JH"CH .*1D5UVLH*^A'%.HH 0* " !@TBHJJ%50%'0
M<"G44 (5!QD#CI[4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !115/5=4M-$TJZU._E$5
MI;1F25\9P![=S[4 7**C\]#;">/,J%=R^7SN';%<Q!\1?#LVG)J3374.GO*8
M1=S6DBQ!]VW#-MPOS<9.!GO0!U=%96HZ_::;=+;20WDTAB\X_9K9Y0J9QDE1
M@=_R-4=,\;:5K$=E)917[PWV[[-*UFZI(55F(#$8!PK8SUQ0!T=%8ND>*=+U
MK3KK4+:22.SM7>.::X0Q*C)]_.['3N>E0OXPTZ/37U1X+\:8L9D^V?97V%0,
M[@/O;<?Q;<8YSB@#H**Q7\4Z>FOV^B;;DWUQ#]HB5825:/."V[H #ZFKNK:I
M;Z+I=QJ-V)/LUNADE:-"Q5 ,DX'. !VH NT5A0>*[&>"TN%MM0%O=-&(IFM'
M"'S" A)QP"6')]:U+Z\33[.2ZDBGE2,998(S(^/91R?PH LT5@67C+2-1\+2
M>)+5YGTR,.QD\HAL*2&(4\\$'MGBG7WBW3]-336NX;V+^TI5@ME:V;<TC9PI
M'53@9YQ0!NT5C?\ "36/_"1C0/+N?[1-O]I\OR3CRMVW=NZ8SQUS3M&\26.N
MW-];V2W&^QF,%QYD10)(,97)ZGD'CB@#7HHHH **HZOK%CH6FR:AJ5PL%K&R
MJTC= 68*/U(JS<SBVMI)V21UC7<5C7<Q'L.] $M%9?A_Q#IGBC1XM5TFX\^T
MD+*&*E2"#@@@\@U"GBG3)O$EUX?MWDGU*TB$T\<<9(C4C(RW3)R.,]Z -JBN
M=LO&>G:E%<265MJ,Z6\SP2F.S<[9$.&7IU%2/XQT>&\TJVGEF@.K*#922PLJ
M2DJ&"[L8#8/0X.: -ZBJ%_JT&G7%G!-%.SW<OE0^7&6!?:S8/I\JL<GCBLU?
M&6FOJU]I<<&H27=AL-S''9N_EAAE>0#G(Y&,T =#1638^)=+U33KB]T^=KI+
M9BLT:1L)8V'56C8!@WL1FG^'_$&F^*-'BU72;CS[24L%8J5((.""#R#Q0!IT
M5BQ^*=,G\1W>@6[RSZC:1"6>..,D1J1D9;IDY'&>]5['QGIVI0SRV5MJ4Z6\
MSP2F.S<[9$.&7IU!H Z*BL%_&.CPWFE6T\LL#:JH:RDEA94E)4,%W8P&P1P<
M'-7[_5H-.N;."6*=GO)/*A\N/<"^UFP3V^56.3QQ0!?HKF+GQYI%H;?SHM15
M;FX^RP-]ADQ+)DX"G'.=IP>^*M?\)9IHM9)I%NXG2Y6T$$ELZRO*RA@JH1DY
M!SGI@$YP#0!NT5EZ?K]IJ&H2Z>L5U!>0QB62&XA9"JDX!!^ZP)!^Z3T-:E !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !7)^*PFKW]OH4MA<7UD(S<7T4.WE3E8E;<PX+;F^L0]:Z
MRL^RTB&QU"]O8YIWEO&#2B1]PR!@8'8 =A_.@#E_A?J%P?#\_A_4!(NH:%,;
M-UEQO,6,PL<$]4('7^$UYY9275S\-M/T6_,=IX<U/5+BWN]13+R0_P"D,54@
MX"!F&W?R!W'->P1^%K*#Q%>:[#/=QW]Y&(IF67Y651A1M(QQV.,U%8^#-'L/
M#ESX?6*6;2[G?YD$\F_[Y);!//).>O!Z8H U98(K?39(XE 5(-@]=H!P,URW
MPH56^%OATD E;?(R.AW-716FC16>B_V7%=7;0!/+5Y)=\BKC& QYZ=SS3=$T
M&T\/:+%I.G/,EI"I6$.^XQ@DG@D>I[YH \;OWE7X.:H,L+1O$LJWI':#[3\V
M?;.*]U*120&,JC1,N-N/E*XZ?3%8VE^$M*TK2KS2XHY)[&\=WF@N6\Q69_O]
M?7TZ4RQ\)V=A MI'>ZB]@@VI9RW)>-5[+D_,5[;2Q&.,8H PIEC7XSZ,L./*
M&@3!,'(QYJ8YK9\>.G_" ^(X]PWG2KEMN><>6W-2WWA*PO\ 7H]:DN+V*^BA
M,$;P3F,+&3DK@<8SZTDGA&PGL=1M)[F_F348Q#<O+<LS-& PV G[J_,W3'4T
M 9GAI-;7P]X8DDN; Z8EI$UPHA9'"" [3N+D<-MSP/6NRK C\(V4=C;V/VS4
M6L[<(J0-=-M*IC"MW*\ $'J.M:FIZ>FJ6$MG+-<0QRC:[6\AC<CTW#D?A0!Y
M<3;>'_'27>V0>#-5O^.0(8]0'23'_/-F'';>N>@4GH_B+_R$/!7_ &,,'_H$
ME;^I>%M-U?PP/#UXLCZ=L2,HK;253&T9 XQ@=/2H+KP?87L&EQ7-S?2+I<JS
M6I:?+*ZC"L3C+$ X^;- &.?^2[+_ -BT?_2FCX>_\A;QM_V'Y?\ T7'70?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %(2%&20!ZFEK@/'AO-.UW3=;N-%?7- MX)([JTC0
M2/ [%2)Q&>'P 5]@3TS0!W]%<-H6O>%],\,7>M:'=1S:=>7R>5"AV"*5UCC$
M>#]P9 )&. 3@8Q4Z^/X8&U5-0LMGV&..6.6TE\Z*X#ML55<JN'W$+M/J#G%
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MV0=OWL9]>/< ':45PMQX[U=7UJ*T\*23S:.4-TAO47Y6C$AV_*=S8/3OCJ.
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MN_\ B=#%Y\XY^79\O'R_*-O'\^:U-,L(M*TRVT^!Y&AMHUBC,A!8*HP 3CG
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MP(?+3Y<#)8<D$X!YR<CT6XMXKJVEMYEWQ2H4=?52,$?E7/)X'TJ/2M/L4DO
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M8Y"<EEBZ YY'8'IC J&+X=:'!%:PQR:BL-G=F[M8A>.%@8[LJH!X4[F]^>M
M$?A7_D>O'/\ U^6O_I-'5[Q_YH^'OB!X;B:WDCT^>17B;#95"<9]\=N:OZ=H
M-MIFJZEJ,,L[3ZBZR7 D8%2RJ%4@8XPH JWJ%C;ZIIMUI]VF^VNHFAE3.-RL
M"",_0T >>7EI<?VQ\.H$U"<2O'<XN&1"Z VW8;0O Z9!]\TMIXHU>TTV;3Y;
MUKFY'B5M&BNY0BOY>WS 3A=N['R@[>I!Q750^#K"&?2)ENKYI-)#"V:2;>?F
M78V[(YRO'MVP>:AF\!Z+<Z9J>GW0N)X-1NOMDV^3#+/Q^\0@ J?E'3CCIUR
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M[.D%M A>25S@*!WKBM/AT[3_ (Q36VGI;6Z3:"CO' %4.PG;#$#J<'KZ5O\
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M8^VP9]1UK=FO;6V\L7%S#"93A!(X4L?09ZUGVWBG1+VPCO+34K>XCE'[M8I
MSN?[H7KN]NM<G:S64OB[QG8^)_)198H6A%T0%:S\O!"D]@^_..A/TH [Z:Y@
MMQF>>.($$_.X7@#)//H*CDU"RB3?)>6Z)A3N:0 ?-]WOWQQZUY%I6G)<7OPV
MM?$L,,UY+I]ZDT=T 7D3:IC5P>N%QP>^>]:5KH7A/_A-_&EAJ=EIT=E%9V96
M*1558T\IPS*.Q Q\PY''/- 'I\]S!:PF:XGCAB'5Y'"J/Q-*;B$1)*9HQ&^
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M6--GLYCIFIPC;<0Q#:S).HX/\(W#^(<C)KL_&&E3ZYX.UC2[5@+BZM)(HLG
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MC!XZ@C.W;V>C:/\ %S[$MO9VD+Z%$EM"$50Q$\F0H[D C..U '0:CXAE\/\
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M8/H<4D-[:W,LD4%S#+)&<.B2!BOU Z5P.KRVH\;6&JZ.1/9C1KI]3^PL#YD
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M'KZ4 =[1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW #M%@'>=Q4*/F4<D<D"L7X:W<U[HNJ232W3[=8NT073LTB('PJDL2>!QC-
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M35)()%NMS.;@LJ^7&I.0"Q 5>* .G$$(G,XB3SB-IDVC=CTSZ4X(@=G"J&;
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !15;4+Z#3;&6\N"_E1#)"*69CT 4#DDD@ #J2*Y_1_'-IJFO'1+K3-3
MTK4&B,T,5_"J>>@ZE"K$''<=: .IHK'N/$MG;>*++P^\5S]KO(Y)8W\HB/"
M%OF/4\CIGKS6Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (RJX
MPRAAD'!&>0<BN92Q37O&=IK@ ^QZ3#-!:R?\]I9,"1A_LJ%V@]R6]!G9UC3!
MK&E3Z>UW=6B3KM:6U<)(!W )!QGIZUAZ5X'ATN]M9_[?UZ[CMO\ 5VMU>!H>
M!@94*,XZCT('I0!4U_\ Y*QX._Z]=0_]!BKM:Q;[PW!?^)-/UQ[V[2XL$D2"
M-"GE@. '!!4DYVCO],5M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %74A>FPE7
M3C&MVV%C>495,D L1QG R<9&<8KC;*X\2Z!X^TW1]0UDZUI^J6\\@>2V2*2V
M>+:2?D !4[@.>Y_/KM8UBRT'2I]2U&816T"[F;&2?0 =R>@%<?X<\8^'-7U]
M;A+_ .TZU>KY,4$<+D6\(RVW<5 [%F;/)  SA: (/&$WC'P_I-QXHAUN-EMI
M%=M&^RH8FB+A=GF??WX(YS@GH,5Z(IRH)&"1T/:O.=1^(7A#4M5\F_U=%L+"
M8.(Q#(_VF93D-\JD%%/(_O, >@&[T.WF%Q;13A'02('"N,,,C.".QH DHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH IZMJEMHNDW6I7K,MM;1F20J
MI8@#T ZUB?\ "<6G_0$\1_\ @GG_ /B:/B+_ ,DZU[_KS>NG[4 <Q_PG%I_T
M!/$?_@GG_P#B:/\ A.+3_H">(_\ P3S_ /Q-=/10!S'_  G%I_T!/$?_ ()Y
M_P#XFC_A.+3_ * GB/\ \$\__P 373T4 <Q_PG%I_P! 3Q'_ .">?_XFC_A.
M+3_H">(__!//_P#$UT]% ',?\)Q:?] 3Q'_X)Y__ (FC_A.+3_H">(__  3S
M_P#Q-=/10!S'_"<6G_0$\1_^">?_ .)H_P"$XM/^@)XC_P#!//\ _$UT]% '
M,?\ "<6G_0$\1_\ @GG_ /B:/^$XM/\ H">(_P#P3S__ !-=/10!S'_"<6G_
M $!/$?\ X)Y__B:/^$XM/^@)XC_\$\__ ,373T4 <Q_PG%I_T!/$?_@GG_\
MB:/^$XM/^@)XC_\ !//_ /$UT]% ',?\)Q:?] 3Q'_X)Y_\ XFC_ (3BT_Z
MGB/_ ,$\_P#\373T4 <Q_P )Q:?] 3Q'_P"">?\ ^)H_X3BT_P"@)XC_ /!/
M/_\ $UT]% ',?\)Q:?\ 0$\1_P#@GG_^)H_X3BT_Z GB/_P3S_\ Q-=/10!S
M'_"<6G_0$\1_^">?_P")H_X3BT_Z GB/_P $\_\ \373T4 <Q_PG%I_T!/$?
M_@GG_P#B:/\ A.+3_H">(_\ P3S_ /Q-=/10!S'_  G%I_T!/$?_ ()Y_P#X
MFC_A.+3_ * GB/\ \$\__P 373T4 <Q_PG%I_P! 3Q'_ .">?_XFC_A.+3_H
M">(__!//_P#$UT]% ',?\)Q:?] 3Q'_X)Y__ (FC_A.+3_H">(__  3S_P#Q
M-=/10!S'_"<6G_0$\1_^">?_ .)H_P"$XM/^@)XC_P#!//\ _$U9U3Q,EGX@
MM- L[?[7JMS"UP(FD$:1Q*<;F;!/)X  )X-3Z3K;ZC?WUC/IUQ97-D(S()2I
M5]^[!1@?F7Y>O'I@$4 9_P#PG%I_T!/$?_@GG_\ B:/^$XM/^@)XC_\ !//_
M /$UT]% ',?\)Q:?] 3Q'_X)Y_\ XFC_ (3BT_Z GB/_ ,$\_P#\373T4 <Q
M_P )Q:?] 3Q'_P"">?\ ^)H_X3BT_P"@)XC_ /!//_\ $UT]% ',?\)Q:?\
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M_P )Q:?] 3Q'_P"">?\ ^)H_X3BT_P"@)XC_ /!//_\ $UT]% ',?\)Q:?\
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M39?]<$_]!% %NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M #\* -RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(!ZCCT% 'ME<IHGC9-7\;:QX7:P:"YTQ%=Y1*'1P<8QP#T85P/BBQD\/>(?
M_@B'4=1ET>\O));E[BX)>X^<$1LPQ\HST]Q5CP':16/QW\:6T)?RH[:(+O<N
M0,1G&3S@=![4 >H:YK,&@:1<:E<PW,L,"-(ZV\1D; !).!TX!Y.!5'PCXJ@\
M7>%8-?@MI;>"8R;8V^9\([+T'<[<X&>O>I?&'_(DZ_\ ]@ZX_P#1;5ROP._Y
M))I'^_/_ .CGH U_#OCVR\2^*M6T*UL;N%],4&62Y7868G& O7'N<?2NEOKM
M+"REN7CED$8R(XEW.YZ!5'<DX%>4_#__ )+?X^^J?SKU2'4K"XFN(8;VVDEM
MF"3HDJEHF/0, ?E)]#0!QV@?$A]3\:2>%M5\/7FCW_E&: 32+()$'.?EX'&>
MA(X(SFNI\0:Y9>&M!O-8U%V6UM4WOM&2>< #W)( ^M>:S0>(/#_Q[TRYNYX-
M2M=<MY+>-_("O;1Q@N57K@ D$G/S9.>0*L_&VZAU/X6ZG_9UW#<BTNXENA!(
M'\O#@%6P>""5X- '3Z/XXBO_ !!:Z)?V7V&^O+!-0M5$OF+)$V?E)P,.,'(Y
M'H3765XE<12S?'#X?F#.$T-7<CLFR4'^>/QKNO&'BI8-#B?1X+[5H9[DVUS)
MHB"XE@4 E\;3PW 7)(V[L]0 0"WHGCG3_$'C#5] L$,@TM$,MR&^5G)(*@>V
M.N>N?K4L7BR/4==NM)T2U-_+9,%O+@R>7! W]PO@EG]E!QW(KQ_P+KK+\1/&
MKZ9HFI6CSV.;:"6VV&U,<>5609^7.  .<UC:'J6K>%/A#IGBO1=4N1<MK#I=
MVC$-%/NS]X8SN.U><YY^E 'TQ*TJPL841Y0/E5GV@GZX./RKSSP]\4Y_$ND:
MCJ>G^&;F6#3GVSQI<H93@9.U2 &X[9S7HR$LBL05)&<'M7BO[/+K'HGB1W8*
MBWP+,3@ ;: /4O"_BG2O&&BQZKI$YD@8E&5AAXV'56'8\C\ZV:^7?"&J:OX>
M^&'CO7-),D,$UU!#:RJ,>7ER'9?0A749[$CTKN[:^NO#OC_P%9Z=+,T&K:6H
MOH3(6$S;,^:<G[^>=W7 Q0![/17B?@:"\^(VD7>L3:Y<Z?KMGKAF>1"6,< 4
M8@VY "')_$'(/-/DN;G_ (6_\0+'[5<?9(]"::.'SFV(YCA;<HSP<DG(]: /
M::*^>)M3U!OV8[?43?W?VY+LXN?/;S/]>5^]G/3BM0VDEO\ %SPEIL6HZD+;
M5M&#WX^V2$SD)(W)SQG8OW<8 XQ0![G17SYHOB75] ^''Q#-C=SLVFZD8+-I
M'+F!7D"$@G)X'/UYKMO"&DZN]YH^K136J:#?:0D5U";UY7N92I82X*@;ST)S
MG&>N* /3:HWVKV6GWMA9W$P6XOY3%;Q_Q.0I8\>@ Y/T]:^8X[S4!\$QXB.K
M:DVJ6VNB*&9KR0[%V X SCKZ^E>A>,]/MK_X[^#4N%D9;JT<RA9G7HKXP0?E
MZ=L4 >T45@^+]1N- \$:OJ%@N;BSLY'AS\V"%X)SUQU_"N)\!:1)J6C^&O&5
MIK=T9DLY5U"W+%_MTIW#YR6X(?..#T &,4 >J45\W+K^JR_"*[\;-?3KX@&M
M@I<"0_(GRCR@,XV8)^7I76:S)<:I\<O"]E-<7EM:ZAH_G75M#</&K-MFR#@C
M^Z!ZX% 'LM%?,\'VF7X6>-IGU'4&;1M3"6 ^UR 0 RJ#CGG@]\X[8).>F\57
MU]>77PDD.H7D4FJ)$+QX)VC,V1 3G!_VVY]S0![E17C>@W=SHGQ4\;>&K34Y
M;;2(]-^V1R3R&5;*39&2XW'H-[$C/.!Z5S]EJM[:^)OAU<6=]<S+?3S6]QJ#
M,R?VDHD4%FC))P-Q +<G&<#B@#Z$K!NO$-U;^-;+0%T2\EM;FW:9]24?N8B,
M_(W'7@=_XAQ7F;:=<>(/CKXJ\/OJVHVFFMIBR-':W!3!(A^[U"\MDX'/0\$U
M:DBFT7X]>%=%M[Z\>S71BKK+.S><RI,H=QT+85><=J /8**\,\'ZKJ.B^/;'
M0_%<%P;Z>YFN++5H)F:*_5T<!7YVLN&!4C[N%&!S6*FNZI?_  J\2^-)[RXB
MUZWUI5MY5D(-N@,0\M1T"X=@5Z'OF@#Z-HKQ76+N[U?XL>!8I[B[M8M4TKSK
MRWM[AX@S&.0D':1],]<=ZUO@E=W,EGXEL);F::"RU62.W$LA<HGH"><<?SH
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M+);]-DWFQO$>OS%5(93U&/<4 :NE^'+#2GCEC-S<7$47DQSW<[3.B<94%B<
MX&<=<#.<"JFF>!O#ND6VK6UKIR>1JSE[R.1BZR9SQ@G@<G@>M<K+\6Y;#Q7I
M^EZOX5U#3=/U&416E].X!<D@ F/'R\D9&<@'D5VGBCQ)8^$_#]UK&H,?*@7*
MHOWI&[*ON?TY/04 ,TGPGI.BW?VNVAD>Y%NMHDT\K2-' OW8U+'A1^O?-+X9
M\)Z-X0L9K/1;4V\$TQF=2[/EB .I)XP ,5-X;UC_ (2#PUINKF#R/MMND_E;
MMVS<,XS@9_*N0\:?$V[\)S231>%;Z^TFWD$5SJ D$:*Q."%&#NP3C)P,\9H
MZO3_  QI.F:]J.MVEL4U#4=OVF4R,=^.G!.!^ JA%\/_  W#<;X[$B 7?VX6
MGFMY N,8\P1YQGVZ>U;FF:C;ZOI5IJ5HQ:WNX4FB)&#M8 C(]>:YCQKXWOO"
M\<C:;X:O-8%O'YUW)&_EQP)[M@Y.!G ' P3UH Z^:(30M&6=0PQE&*L/H1TK
MDK#X8>%M,L[FSL[6[BM;HYN(%U"<)+_O#?S_ %JWH/C2R\0>"XO$MI:W3Q.C
M%K:--\@920R^AZ'GCM3? GC.#QUH4VK6UG):PK<O B2,"S!0IW'' ^]TY^M
M&M_8.D_V&VB#3[==,:,Q&U5 $VGJ,#^?KS5'2_!NC:1?P7T,,LMU;6XM;:2X
MF:0P0C^!,G@>_7WK?KD_^$[L9/B-'X.MHO.N!;//<3A\+$1C"8QR?7GCCWP
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MTU"=)([^T#""Z@D,<B!AAER.H/H<U1E\ ^&YO"P\-&P*Z47$CPI,ZF1LYRS
M[F.<'D]AZ5TM% '-)X#T"/6-,U46\_VW3(5M[20W4A\N, @+C=@C!(YSG-=+
M110 4444 %%%% '.?$#_ ))UXD_[!EQ_Z+:MC2_^039?]<$_]!%8_P 0/^2=
M>)/^P9<?^BVK8TO_ )!-E_UP3_T$4 6Z*** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** .8^(O_).M>_Z\WKI^U<O\1R%^'.OD]!9
MO3O^%@>&O^?Z;_P"G_\ B* .FHKF?^%@>&O^?Z;_ , I_P#XBC_A8'AK_G^F
M_P# *?\ ^(H Z:BN9_X6!X:_Y_IO_ *?_P"(H_X6!X:_Y_IO_ *?_P"(H Z:
MBN9_X6!X:_Y_IO\ P"G_ /B*/^%@>&O^?Z;_ , I_P#XB@#IJ*YG_A8'AK_G
M^F_\ I__ (BC_A8'AK_G^F_\ I__ (B@#IJ*YG_A8'AK_G^F_P# *?\ ^(H_
MX6!X:_Y_IO\ P"G_ /B* .FHKF?^%@>&O^?Z;_P"G_\ B*/^%@>&O^?Z;_P"
MG_\ B* .FHKF?^%@>&O^?Z;_ , I_P#XBC_A8'AK_G^F_P# *?\ ^(H Z:BN
M9_X6!X:_Y_IO_ *?_P"(H_X6!X:_Y_IO_ *?_P"(H Z:BN9_X6!X:_Y_IO\
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M^%@>&O\ G^F_\ I__B*/^%@>&O\ G^F_\ I__B* .FHKF?\ A8'AK_G^F_\
M *?_ .(H_P"%@>&O^?Z;_P  I_\ XB@#IJ*YG_A8'AK_ )_IO_ *?_XBC_A8
M'AK_ )_IO_ *?_XB@#IJ*YG_ (6!X:_Y_IO_  "G_P#B*/\ A8'AK_G^F_\
M *?_ .(H Z:BN9_X6!X:_P"?Z;_P"G_^(H_X6!X:_P"?Z;_P"G_^(H Z:BN9
M_P"%@>&O^?Z;_P  I_\ XBC_ (6!X:_Y_IO_  "G_P#B* .FHKF?^%@>&O\
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M1Z0;I8X)!E7VI]TD';R<\?2J_A_Q5XCU'X&1ZJVNVMM?0W1BEOK]B-T0?D9
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML:]/X/\ #%M%<:S:V%I!,_EI(UGN4MC.,JIP< ]?0UJ_V#HW_0)L/_ 9/\*
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MUK?V!HW_ $";#_P&3_"@#BGT3P>-/T2&V\7I;7>BKY=E?1WT'G(F,%&XVLI
M'!7^M1S^'O!MU!K4=SXP\Y]6>*6:4ZA &22/;L=<  '*@],=L8KN?[ T;_H$
MV'_@,G^%']@:-_T";#_P&3_"@#D8+'PQ#K9UD^-FDOWL_L<DKZA!\Z@DABNW
M:",G@ +WQGFGVNG^"8/!!\(S^(+2\TLQF("XO8=ZKG(P5QT/(.,UU?\ 8&C?
M] FP_P# 9/\ "C^P-&_Z!-A_X#)_A0!QEOI?AQ+[1[RZ\>R7LVD%_LK37]N,
M!EVD-M4;N.,GGWKK?^$H\/\ _0=TS_P+C_QITVC:%;P233:9IZ11J7=VMT 4
M 9)/%,L],\/ZA8P7MIIVGRV]Q&LL4BVR896&0>GH: %_X2CP_P#]!W3/_ N/
M_&C_ (2CP_\ ]!W3/_ N/_&IO[ T;_H$V'_@,G^%)_8.C9Q_9-AGT^SI_A0!
M%_PE'A__ *#NF?\ @7'_ (T?\)1X?_Z#NF?^!<?^-5],M?#NK0336ND6P6*=
MX&\VQ$9W(<' 91D>]7O[ T;_ *!-A_X#)_A0!#_PE'A__H.Z9_X%Q_XT?\)1
MX?\ ^@[IG_@7'_C4W]@:-_T";#_P&3_"C^P-&_Z!-A_X#)_A0!#_ ,)1X?\
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M?^!<?^-'_"4>'_\ H.Z9_P"!<?\ C4W]@:-_T";#_P !D_PH_L#1O^@38?\
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MX?\ ^@[IG_@7'_C4W]@:-_T";#_P&3_"C^P-&_Z!-A_X#)_A0!#_ ,)1X?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'2$6_OM6U&10\<TOV.($9!BBRIR/^NAE^HQ6#\,X(K>T\3P01K%$GB*]5$0
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MTQH]/74#TM3>D2G_ (!OS^E9NCVLMM\9C->3+)>W/A\RSE6RJL;@ (O^RH
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MT.GSO&XD<[6"$@\M7=:7_P @FR_ZX)_Z"*Q_B!_R3KQ)_P!@RX_]%M6QI?\
MR";+_K@G_H(H MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9E6RDM@E[;$<3R1MF$GZ;F/_  %:=X)\*/X4L;JVDN//!G=;7_IE;!F:*/\
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MHZOH<=A<Z?JT<0N;:XF:%H)(UV*R%4;*[>HXYJ]_PA:_]#'XB_\ !@?\*/\
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M'K.DZFUXMI--&RSH<\ ABO<<$CH: /3&^(FFV4'B+^UHFM+G0-ANX4;S P<
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M;3G$:QP,I:X;:K$(,]@PSGOD<XI==<WMO8:9L9#J$RB5&ZK$HWR X[$+L/\
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MR$E9!&L8'!)SC+' Y)Z5NV&NQZIK.H^'[ZP,-W;P1S21LPDCEBDR 0?JI!!
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M]I:6*]^P7%Y*8I60B=@TC#*D9 8D8/& *T)%U75B;.31I-/T^2[CW+*\;.R
MM+([;&8;68*F,Y^9B:N>-K2\U'P5K.GV%J]S=7=G+!%&C(OS,I )+$ #GUH
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M;?\ 9Z>U=*N@>)T4*OC JH& !ID( %=310!S']A>*?\ H<F_\%D5']A>*?\
MH<F_\%D5=/10!S']A>*?^AR;_P %D5']A>*?^AR;_P %D5=/10!S']A>*?\
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MA>*?^AR;_P %D5']A>*?^AR;_P %D5=/10!S']A>*?\ H<F_\%D5']A>*?\
MH<F_\%D5=/10!S']A>*?^AR;_P %D5']A>*?^AR;_P %D5=/10!S']A>*?\
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M\CT =/17,?\ %=?]2[_Y'H_XKK_J7?\ R/0!T]%<Q_Q77_4N_P#D>C_BNO\
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MQ_Q77_4N_P#D>C_BNO\ J7?_ "/0!T]%<Q_Q77_4N_\ D>C_ (KK_J7?_(]
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MH_XKK_J7?_(] '3T5S'_ !77_4N_^1Z/^*Z_ZEW_ ,CT =/17,?\5U_U+O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*?\ H3__ "IQ?X5T]% ',?VYXI_Z$_\ \J<7^%']N>*?^A/_ /*G%_A73T4
M<Q_;GBG_ *$__P J<7^%']N>*?\ H3__ "IQ?X5T]% ',?VYXI_Z$_\ \J<7
M^%']N>*?^A/_ /*G%_A73T4 <Q_;GBG_ *$__P J<7^%']N>*?\ H3__ "IQ
M?X5T]% ',?VYXI_Z$_\ \J<7^%']N>*?^A/_ /*G%_A73T4 <Q_;GBG_ *$_
M_P J<7^%']N>*?\ H3__ "IQ?X5T]% ',?VYXI_Z$_\ \J<7^%']N>*?^A/_
M /*G%_A73T4 <Q_;GBG_ *$__P J<7^%']N>*?\ H3__ "IQ?X5T]% ',?VY
MXI_Z$_\ \J<7^%']N>*?^A/_ /*G%_A73T4 <Q_;GBG_ *$__P J<7^%']N>
M*?\ H3__ "IQ?X5T]% ',?VYXI_Z$_\ \J<7^%']N>*?^A/_ /*G%_A73T4
M<Q_;GBG_ *$__P J<7^%']N>*?\ H3__ "IQ?X5T]% ',?VYXI_Z$_\ \J<7
M^%']N>*?^A/_ /*G%_A73T4 <Q_;GBG_ *$__P J<7^%']N>*?\ H3__ "IQ
M?X5T]% ',?VYXI_Z$_\ \J<7^%']N>*?^A/_ /*G%_A73T4 <Q_;GBG_ *$_
M_P J<7^%']N>*?\ H3__ "IQ?X5T]% ',?VYXI_Z$_\ \J<7^%']N>*?^A/_
M /*G%_A73T4 <Q_;GBG_ *$__P J<7^%']N>*?\ H3__ "IQ?X5T]% ',?VY
MXI_Z$_\ \J<7^%']N>*?^A/_ /*G%_A73T4 <Q_;GBG_ *$__P J<7^%']N>
M*?\ H3__ "IQ?X5T]% ',?VYXI_Z$_\ \J<7^%']N>*?^A/_ /*G%_A73T4
M<Q_;GBG_ *$__P J<7^%']N>*?\ H3__ "IQ?X5T]% ',?VYXI_Z$_\ \J<7
M^%']N>*?^A/_ /*G%_A73T4 <Q_;GBG_ *$__P J<7^%']N>*?\ H3__ "IQ
M?X5T]% ',?VYXI_Z$_\ \J<7^%']N>*?^A/_ /*G%_A73T4 <Q_;GBG_ *$_
M_P J<7^%']N>*?\ H3__ "IQ?X5T]% ',?VYXI_Z$_\ \J<7^%<]J^K^(F\9
M>&W?PMLE3[5Y<?\ :$9\S,8SSCC%>D5S&N?\CWX4^EY_Z+% !_;GBG_H3_\
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M3,?]"YXB_P#  _XT?\)F/^A<\1?^ !_QH Z:BN9_X3,?]"YXB_\   _XT?\
M"9C_ *%SQ%_X '_&@#IJ*YG_ (3,?]"YXB_\ #_C1_PF8_Z%SQ%_X '_ !H
MZ:BN9_X3,?\ 0N>(O_  _P"-'_"9C_H7/$7_ ( '_&@#IJ*YG_A,Q_T+GB+_
M , #_C1_PF8_Z%SQ%_X '_&@#IJ*YG_A,Q_T+GB+_P  #_C1_P )F/\ H7/$
M7_@ ?\: .FHKF?\ A,Q_T+GB+_P /^-'_"9C_H7/$7_@ ?\ &@#IJ*YG_A,Q
M_P!"YXB_\ #_ (T?\)F/^A<\1?\ @ ?\: .FHKF?^$S'_0N>(O\ P /^-'_"
M9C_H7/$7_@ ?\: .FHKF?^$S'_0N>(O_   /^-'_  F8_P"A<\1?^ !_QH Z
M:BN9_P"$S'_0N>(O_  _XT?\)F/^A<\1?^ !_P : .FHKF?^$S'_ $+GB+_P
M /\ C1_PF8_Z%SQ%_P" !_QH Z:BN9_X3,?]"YXB_P#  _XT?\)F/^A<\1?^
M !_QH Z:BN9_X3,?]"YXB_\   _XT?\ "9C_ *%SQ%_X '_&@#IJ*YG_ (3,
M?]"YXB_\ #_C1_PF8_Z%SQ%_X '_ !H Z:BN9_X3,?\ 0N>(O_  _P"-'_"9
MC_H7/$7_ ( '_&@#IJ*YG_A,Q_T+GB+_ , #_C1_PF8_Z%SQ%_X '_&@#IJY
MC7/^1[\*?2\_]%BE_P"$S'_0N>(O_  _XUSNK^*Q)XR\-S?V#KJ^5]J^1K(A
MGS&!\HSSCO0!WFK/?II%VVEQ12WXB;[.DK;5+XXR?3->3ZE-XFL/$_@J!O#%
MM'-#<W31 ZJ'-R[0MO9V\L;3R6S@Y/'%=]_PF8_Z%SQ%_P" !_QJ";Q+9W%S
M;W,WA/79)[8EH)'TW+1$C!*G/&0<<4 +XJ\+^%/$ME?OJ,5DEU;IE[^,JL]J
MP7*L7'(P,'!XK3\)/J,GA#1WU?=_:#6D9N"XPQ?:,[O?U]ZYU[W09-7;5G\"
MZJVH,06N#I(+DCH2<]1Z]:U?^$S'_0N>(O\ P /^- '345S/_"9C_H7/$7_@
M ?\ &C_A,Q_T+GB+_P  #_C0!TU%<S_PF8_Z%SQ%_P" !_QH_P"$S'_0N>(O
M_  _XT =-17,_P#"9C_H7/$7_@ ?\:/^$S'_ $+GB+_P /\ C0!TU%<S_P )
MF/\ H7/$7_@ ?\:/^$S'_0N>(O\ P /^- '345S/_"9C_H7/$7_@ ?\ &C_A
M,Q_T+GB+_P  #_C0!TU%<S_PF8_Z%SQ%_P" !_QH_P"$S'_0N>(O_  _XT =
M-17,_P#"9C_H7/$7_@ ?\:/^$S'_ $+GB+_P /\ C0 _X@?\DZ\2?]@RX_\
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MHHM2U+5_#6IZD;&]6\CDG9+F.Z11;%"=J[=PX  R,<\]<T_;^7?\!_6?+O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT :-%9W]OZ-_T%[#_P "4_QH_M_1O^@O8?\ @2G^- &C16=_;^C?]!>P_P#
ME/\ &C^W]&_Z"]A_X$I_C0!HT5G?V_HW_07L/_ E/\:/[?T;_H+V'_@2G^-
M&C16=_;^C?\ 07L/_ E/\:/[?T;_ *"]A_X$I_C0!HT5G?V_HW_07L/_  )3
M_&C^W]&_Z"]A_P"!*?XT :-%9W]OZ-_T%[#_ ,"4_P :/[?T;_H+V'_@2G^-
M &C16=_;^C?]!>P_\"4_QH_M_1O^@O8?^!*?XT :-%9W]OZ-_P!!>P_\"4_Q
MH_M_1O\ H+V'_@2G^- &C16=_;^C?]!>P_\  E/\:/[?T;_H+V'_ ($I_C0!
MHT5G?V_HW_07L/\ P)3_ !H_M_1O^@O8?^!*?XT :-%9W]OZ-_T%[#_P)3_&
MC^W]&_Z"]A_X$I_C0!HT5G?V_HW_ $%[#_P)3_&C^W]&_P"@O8?^!*?XT :-
M%9W]OZ-_T%[#_P "4_QH_M_1O^@O8?\ @2G^- &C16=_;^C?]!>P_P# E/\
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M /H!Z9_X"1_X4?\ ",>'_P#H!Z9_X"1_X5JT4 97_",>'_\ H!Z9_P" D?\
MA1_PC'A__H!Z9_X"1_X5JT4 97_",>'_ /H!Z9_X"1_X4?\ ",>'_P#H!Z9_
MX"1_X5JT4 97_",>'_\ H!Z9_P" D?\ A1_PC'A__H!Z9_X"1_X5JT4 97_"
M,>'_ /H!Z9_X"1_X4?\ ",>'_P#H!Z9_X"1_X5JT4 97_",>'_\ H!Z9_P"
MD?\ A1_PC'A__H!Z9_X"1_X5JT4 97_",>'_ /H!Z9_X"1_X4?\ ",>'_P#H
M!Z9_X"1_X5JT4 97_",>'_\ H!Z9_P" D?\ A1_PC'A__H!Z9_X"1_X5JT4
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M"YEM_M<9C:5[&9]H/7  '/XUG?92VI^&[Q[\?\2:*2,J-.G_ 'V^,(3_ +/
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MF_&]G_\ BZ7_ (5_X:_Y\9O_  ,G_P#BZXIRYI-E'345S/\ PK_PU_SXS?\
M@9/_ /%T?\*_\-?\^,W_ (&3_P#Q=2!TU%<S_P *_P##7_/C-_X&3_\ Q='_
M  K_ ,-?\^,W_@9/_P#%T =-17,_\*_\-?\ /C-_X&3_ /Q='_"O_#7_ #XS
M?^!D_P#\70!TU%<S_P *_P##7_/C-_X&3_\ Q='_  K_ ,-?\^,W_@9/_P#%
MT =-17,_\*_\-?\ /C-_X&3_ /Q='_"O_#7_ #XS?^!D_P#\70!TU%<S_P *
M_P##7_/C-_X&3_\ Q='_  K_ ,-?\^,W_@9/_P#%T =-17,_\*_\-?\ /C-_
MX&3_ /Q='_"O_#7_ #XS?^!D_P#\70!TU%<S_P *_P##7_/C-_X&3_\ Q='_
M  K_ ,-?\^,W_@9/_P#%T =-17,_\*_\-?\ /C-_X&3_ /Q='_"O_#7_ #XS
M?^!D_P#\70!TU%<S_P *_P##7_/C-_X&3_\ Q='_  K_ ,-?\^,W_@9/_P#%
MT =-17,_\*_\-?\ /C-_X&3_ /Q='_"O_#7_ #XS?^!D_P#\70!TU%<S_P *
M_P##7_/C-_X&3_\ Q='_  K_ ,-?\^,W_@9/_P#%T =-17,_\*_\-?\ /C-_
MX&3_ /Q='_"O_#7_ #XS?^!D_P#\70!TU%<S_P *_P##7_/C-_X&3_\ Q='_
M  K_ ,-?\^,W_@9/_P#%T =-17,_\*_\-?\ /C-_X&3_ /Q='_"O_#7_ #XS
M?^!D_P#\70!TU%<S_P *_P##7_/C-_X&3_\ Q='_  K_ ,-?\^,W_@9/_P#%
MT =-17,_\*_\-?\ /C-_X&3_ /Q='_"O_#7_ #XS?^!D_P#\70!TU%<S_P *
M_P##7_/C-_X&3_\ Q='_  K_ ,-?\^,W_@9/_P#%T =-17,_\*_\-?\ /C-_
MX&3_ /Q='_"O_#7_ #XS?^!D_P#\70!TU%<S_P *_P##7_/C-_X&3_\ Q='_
M  K_ ,-?\^,W_@9/_P#%T =-17,_\*_\-?\ /C-_X&3_ /Q='_"O_#7_ #XS
M?^!D_P#\70!TU%<S_P *_P##7_/C-_X&3_\ Q='_  K_ ,-?\^,W_@9/_P#%
MT =-17,_\*_\-?\ /C-_X&3_ /Q='_"O_#7_ #XS?^!D_P#\70!TU%<S_P *
M_P##7_/C-_X&3_\ Q='_  K_ ,-?\^,W_@9/_P#%T =-17,_\*_\-?\ /C-_
MX&3_ /Q='_"O_#7_ #XS?^!D_P#\70!TU<QKG_(]^%/I>?\ HL4O_"O_  U_
MSXS?^!D__P 77/:OX)T"+QEX;MTLY1%-]J\P?:I3G;&".=V1^% 'HDL4<\+Q
M2H'C=2K*>A!X(KD(/ \@TO3=#N;U)M$TVX6>&/RSYLBHQ:.-SG&U3CD#YMHZ
M<YN?\*_\-?\ /C-_X&3_ /Q=5T\'>#I+Q[-$5KI!N> :C*74>I7?D=: .NHK
MF?\ A7_AK_GQF_\  R?_ .+H_P"%?^&O^?&;_P #)_\ XN@#IJ*YG_A7_AK_
M )\9O_ R?_XNC_A7_AK_ )\9O_ R?_XN@#IJ*YG_ (5_X:_Y\9O_  ,G_P#B
MZ/\ A7_AK_GQF_\  R?_ .+H Z:BN9_X5_X:_P"?&;_P,G_^+H_X5_X:_P"?
M&;_P,G_^+H Z:BN9_P"%?^&O^?&;_P #)_\ XNC_ (5_X:_Y\9O_  ,G_P#B
MZ .FHKF?^%?^&O\ GQF_\#)__BZ/^%?^&O\ GQF_\#)__BZ .FHKF?\ A7_A
MK_GQF_\  R?_ .+H_P"%?^&O^?&;_P #)_\ XN@#IJ*YG_A7_AK_ )\9O_ R
M?_XNC_A7_AK_ )\9O_ R?_XN@!_Q _Y)UXD_[!EQ_P"BVK8TO_D$V7_7!/\
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MY[5_"\D?C+PW#_PD>N.9?M6)&N$+)B,'Y3LXSWKT>N8US_D>_"GTO/\ T6*
M%_X1"7_H:O$7_@3'_P#&Z/\ A$)?^AJ\1?\ @3'_ /&ZV-:U$:1H.HZD5WBT
MMI)]OKL4MC]*\RNKJ?1/A=HOC8RL^K[[:\NYR?FN$F=0\;>J;9,!>B[1C&*
M.U_X1"7_ *&KQ%_X$Q__ !NC_A$)?^AJ\1?^!,?_ ,;KIJ* .9_X1"7_ *&K
MQ%_X$Q__ !NC_A$)?^AJ\1?^!,?_ ,;KIJ* .9_X1"7_ *&KQ%_X$Q__ !NC
M_A$)?^AJ\1?^!,?_ ,;KIJ* .9_X1"7_ *&KQ%_X$Q__ !NC_A$)?^AJ\1?^
M!,?_ ,;KIJ* .9_X1"7_ *&KQ%_X$Q__ !NC_A$)?^AJ\1?^!,?_ ,;KIJ*
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M .FHKF?['\6?]#9;_P#@J7_XNC^Q_%G_ $-EO_X*E_\ BZ .FHKF?['\6?\
M0V6__@J7_P"+H_L?Q9_T-EO_ ."I?_BZ .FHKF?['\6?]#9;_P#@J7_XNC^Q
M_%G_ $-EO_X*E_\ BZ .FHKF?['\6?\ 0V6__@J7_P"+H_L?Q9_T-EO_ ."I
M?_BZ .FHKF?['\6?]#9;_P#@J7_XNC^Q_%G_ $-EO_X*E_\ BZ .FHKF?['\
M6?\ 0V6__@J7_P"+H_L?Q9_T-EO_ ."I?_BZ .FHKF?['\6?]#9;_P#@J7_X
MNC^Q_%G_ $-EO_X*E_\ BZ .FHKF?['\6?\ 0V6__@J7_P"+H_L?Q9_T-EO_
M ."I?_BZ .FHKF?['\6?]#9;_P#@J7_XNC^Q_%G_ $-EO_X*E_\ BZ .FHKF
M?['\6?\ 0V6__@J7_P"+H_L?Q9_T-EO_ ."I?_BZ .FHKF?['\6?]#9;_P#@
MJ7_XNC^Q_%G_ $-EO_X*E_\ BZ .FHKF?['\6?\ 0V6__@J7_P"+H_L?Q9_T
M-EO_ ."I?_BZ .FHKF?['\6?]#9;_P#@J7_XNC^Q_%G_ $-EO_X*E_\ BZ .
MFKF-<_Y'OPI]+S_T6*7^Q_%G_0V6_P#X*E_^+KGM7TOQ*OC+PVDGB6!YF^U>
M7(--4!,1C/&_G/Z4 =[J5C%J>EW>GSY\FZA>%\==K*0?T->?/X;U;5/ ^C^"
MKRS=/LLT$5Y=9'E-;PL""ASDEPJ@#'&3G&.>E_L?Q9_T-EO_ ."I?_BZ/['\
M6?\ 0V6__@J7_P"+H Z:BN9_L?Q9_P!#9;_^"I?_ (NC^Q_%G_0V6_\ X*E_
M^+H Z:BN9_L?Q9_T-EO_ ."I?_BZ/['\6?\ 0V6__@J7_P"+H Z:BN9_L?Q9
M_P!#9;_^"I?_ (NC^Q_%G_0V6_\ X*E_^+H Z:BN9_L?Q9_T-EO_ ."I?_BZ
M/['\6?\ 0V6__@J7_P"+H Z:BN9_L?Q9_P!#9;_^"I?_ (NC^Q_%G_0V6_\
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MTZXU-=/CE?SW4O$6B94E Z[&(PV/8FM.N!GL9QXB\*R#4]2F15E+NT28AS&
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M=>TA=173CJ5H+QV*+"95W,PZJ!Z^W6@#)\SQS_SZ^'?_  )G_P#C='F>.?\
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M*&[\/V2Z_K5I_:UU=7$422.D3RA9G10J#'90/?ZT :?F>.?^?7P[_P"!,_\
M\;H\SQS_ ,^OAW_P)G_^-U?%P'\6^0FN0D)9DOI(5"^=X_?$_> P0N.G-3_V
M[I/]H+I_]I6OVMF*+#YHW%@,E0/7'..M &3YGCG_ )]?#O\ X$S_ /QNCS/'
M/_/KX=_\"9__ (W6O)KFE17HLY-1MEN3((A$90&+GHO^]STZU+J6H6VDZ9=:
MC>2>7;6L32RMZ*HR: ,/S/'/_/KX=_\  F?_ .-T>9XY_P"?7P[_ .!,_P#\
M;JGK%[XG?P%<:YIDJ0ZI]G^UQV;Q!T5,;O+/<MM[Y^]VQ5_3O$$-Y\/H=?\
MMK,CV/VAIU1=P.W) 7&,@Y&/;% #/,\<_P#/KX=_\"9__C='F>.?^?7P[_X$
MS_\ QNFK+J5OI&AQZQXCMK'59KB)IU\J,"X)^];HI/<D#<,GCWK9NM<TJQN/
M(NM0MH9<J"DDH!!;[H/N>P[]J ,CS/'/_/KX=_\  F?_ .-T>9XY_P"?7P[_
M .!,_P#\;J_#<"3Q5/$FN0R*EJH;2U5"\3;O]:2/FY! P>.*G77M(:_6Q&I6
MANF8HL7FKN+#JH'<CN.HH R?,\<_\^OAW_P)G_\ C='F>.?^?7P[_P"!,_\
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MYX&>.:S/$7B)6\!:GK_A[4K>;[+;2SQ31%98W* DJ?R]C0 [S/'/_/KX=_\
M F?_ .-T>9XY_P"?7P[_ .!,_P#\;JC;2^+Y_"-EK-AJ-E=WLUI'<FSN+7:D
MA9 Q165@5/. 3FKOAWQUHVO>'-.U=[J&Q-ZWE""XE56$H.UD&<9.?TP: %\S
MQS_SZ^'?_ F?_P"-T>9XY_Y]?#O_ ($S_P#QNM!?%&@O917B:Q8O;2EA'(DZ
ML'V_>Q@\X[^E2OK^CQI9N^JV*K>X^RDW"@3YZ;.?FZ]J ,KS/'/_ #Z^'?\
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MC2_^039?]<$_]!% %NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#F/B+_ ,DZU[_KS>NG[5R_Q')'PYU\@9/V-^*7_A(/$?\
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MEOI]G+<SS/!J,GR0VY6':20" S,I"KN./RP>!O;FRD^&?CF)KI9VB\2>:S,
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M@O1&I8QQ2J%,F!R0N.?K5Y+O7!K3ZJW@FZ-QY1A0B\M1M0E2V3ORQ)5>O0
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MM5MX'VNUP&]?O]?>@#SV.>SF^&_B^(ZJB/;>(Y9P\HP&_P!(0IY@ &U7(ZX
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M\71_PD'B/_H2KS_P.MO_ (N@#IZ*YC_A(/$?_0E7G_@=;?\ Q='_  D'B/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S'Q%_Y)UKW_7F]=/V
MKF/B+_R3K7O^O-ZZ?M0!QUMXCUN]\:ZQX>@AT\#3HH9A/)O_ '@D!.-HZ$8]
M:Z#2Y]1=+L:K%;1-%-MC>!B4DCVJ=W/0Y+ CVKA]/LFO?C-XL5;VZM=ME9\V
M[*"WRMUR#47Q!L;>R^$NO:5)=O>W-H/M!DE.7'F3EE+$<9P2/_K&@#TP.I8J
M&&Y>HSR*YOQUXAO?#G@V\UK3$M9I(-AQ-DJ0SA?X2,_>]>U<WK'A[28/BAX:
MBBLHT34;.]6^49_TH((V7S?[_)/WLY[US6K0167PY^(^G6J"&SMM858(4X6)
M28&(4=ADDX'K0![<'5F90P)7J >E)YB>9Y>]=^,[<\X^E><ZIX?M/#_Q&\,W
M7AZW\BZO/M*7R(YQ<1+'NWR9/)#E?F/)+#-8_AZRM/%'A#2=9NM:M;74K6Z6
M:>>*VQ=K<AB&C9BV3N)QMQR" !C% 'I^O7\VFZ'>W=MY#7,,#RQI,2%8JI..
M.>U1>&]5DU;PEI.K78BCEN[*&XE"<(K.@8XR>!D^M<#:?8_$6D?$.36(8I]0
MMKNZMPLP!:"!(_W.W/W1P6!'4Y-0>';Q+G4?A[HVHA&TY_#BW$$<G*3705!@
M@\$JFX@=LYH [;PQK]]K&K>(;.\CME73;Q8(C!GYE,:ODDGD_-VQ71I(DF=C
MJV#@X.<&O%[J=/#UAX^.GA;:TCURT6?RE)$4#B+S> 1Q@L,#'!/2M[4K"/0E
MU+Q-HFJ6C7SZ+-Y-IIUN$BF"+N64J&;)4D 'W [T =-XL\17FAS:(MFMK(M[
MJEO8W E)+(LAZJ 1S@'K70W)F%M(;<QB8+E?,!*Y]\&O)]2LM(?PI\.M3M(X
M7FDU?3V-T,&21GYDW-U)+#)SW%>MR?ZMOH: .,\*>)/$7BOPC::];VVEP"Y1
MV2&1Y."K,O+#_=]*ZZSEEFLK>6XB\F=XU:2+.=C$<C\#Q7E_PQT"75/A!I 3
M5[^WWK(1&CJ(^)GX(VYVG'//<UJ>/+&/58-*UWPXD<WB2VE,^G,J BX1?OAL
MXS&1T;U*X/S<@'H>0>E-1TD!*.K '!(.>:\LU'5M)M/A?I%]I&Z'2;K4;==5
MDP%D"-)^_P#-QC!+?*WL2!QBM/Q3:6&@Z7XBUCPY(8=4FT<MY-HP$81.DH51
M@, QPW<#CH: ._\ ,5BZHRLZ]1GH??TKGO!NO7NOVNJM?QV\<MEJEQ8@0 [2
ML9 SR>IYK"TC1])N-7\/>(=/UBR0&-XH8["V$?VM&3)63YV+;<;N>ASFK?PW
M_P!1XH_[&2__ /0Q0!VU%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5S&N?\CWX4^EY_Z+%=/7,:Y_R/?A3Z7G_HL4 =
M)--';P23S.$BC4N['HH R37&0^-[@:/IOB*ZM8HM$U&X2%!SYL*.VV.5ST()
MVY4 ;0W4XKHO$UG-J/A36+*V&9[BRFBC _O,A _4UYGK _M/]G_P_IMH";F\
M6PLHD'7S5= P^HV-GTP: /8**** "BBB@ HHHH **** "BBB@ HHHH ****
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M#%8?]_:/^%B^#O\ H8K#_O[0!T]%<Q_PL7P=_P!#%8?]_:/^%B^#O^ABL/\
MO[0!T]%<Q_PL7P=_T,5A_P!_:/\ A8O@[_H8K#_O[0!)\0/^2=>)/^P9<?\
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M]7@?PX]LJ06 C^=).,L3CV8YSWQCBNCH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KE]<_P"1[\*_2\_]%BNHKF-<
M_P"1[\*?2\_]%B@#IC@ DX %84/BS39DM)PEPMC>2B&VO70"*5R<*!SN 8\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YCXC<?#
MK7_^O-ZW?[2L/^?VV_[^K_C4MS:V][;26UU!'/!*NV2*5 RL/0@\$5C_ /"$
M^%/^A8T;_P  (O\ XF@#)\=>'-*\=Z3%I=YKB6MJDHF/DLA9F (')/3YCVK6
MC@TI_#O]B7]_:W=LUO\ 9I-SJN]-NWG!ZX]*/^$)\*?]"QHW_@!%_P#$T?\
M"$^%/^A8T;_P B_^)H YBQ\":%;OH4=WKJWEEH+O)I]N[(I#$Y!D8'Y]N!C
M'3G-7[;PQH]GXZO?%-KKK0RWR*MS;++'LD*XP<D;@/E' /Z<5L?\(3X4_P"A
M8T;_ , (O_B:/^$)\*?]"QHW_@!%_P#$T < ?A%X<.@MI'_"5WIMQ??;H0UQ
M$1&^,'C')(/4^GUSTLWAC3)_'MCXM?Q"&O+.W%LL;-'M=,,#NQCD[V.1@=.*
MVO\ A"?"G_0L:-_X 1?_ !-'_"$^%/\ H6-&_P# "+_XF@"?5!H>M:7<:;J,
MUI<6EPA26-I1@C\^#W![5S>A^'O^$;L!I>E^,V33$)\F*=(99(03G"N>W/&X
M'%;O_"$^%/\ H6-&_P# "+_XFC_A"?"G_0L:-_X 1?\ Q- &#XK\(:+XKT&Q
MTB?7FA@M+C[3Y@F22223YN69L_WF/X]@,4^#POI<7CRZ\6MKZO=W5K]EDA#(
MJ;,*..<@Y4'.:V_^$)\*?]"QHW_@!%_\31_PA/A3_H6-&_\  "+_ .)H X&/
MX2>'8]$MM,7Q9>F*UO?MEN3/$1&W< 8P<\<G/3W.>CG\,:;-X\M_%W_"0J+V
MWMOLJ1DQE"N&&3T).6)[5M_\(3X4_P"A8T;_ , (O_B:/^$)\*?]"QHW_@!%
M_P#$T ><:OX=M? WPOU;2=%\0S.U[>1R>?\ (QB+,BN7V_\ +/:HW<' SP<X
MIOAG7/$^G>)-,M&\1^%M9TVZD*W4>F*BF!-I/F,54 <@#D\YP!Z>D_\ "$^%
M/^A8T;_P B_^)H_X0GPI_P!"QHW_ ( 1?_$T <QX?\#Z7X9U*[.E^*IX-'N9
MO/?2UDBV;O0/C<%Z# P2  2:LZCX2TK6+JV_M'7H[FSMM1;48H7\O>CEBVP2
M=1'D\CJ<=0.*WO\ A"?"G_0L:-_X 1?_ !-'_"$^%/\ H6-&_P# "+_XF@#/
MM]$TVW\>7?BD>()'>YMEMS9M<+Y*XQR!G_9SCU)/>NC_ +3L/^?VV_[^K_C6
M9_PA/A3_ *%C1O\ P B_^)H_X0GPI_T+&C?^ $7_ ,30!I_VG8?\_MM_W]7_
M !H_M.P_Y_;;_OZO^-9G_"$^%/\ H6-&_P# "+_XFC_A"?"G_0L:-_X 1?\
MQ- &G_:=A_S^VW_?U?\ &C^T[#_G]MO^_J_XUF?\(3X4_P"A8T;_ , (O_B:
M/^$)\*?]"QHW_@!%_P#$T :?]IV'_/[;?]_5_P :/[3L/^?VV_[^K_C69_PA
M/A3_ *%C1O\ P B_^)H_X0GPI_T+&C?^ $7_ ,30!I_VG8?\_MM_W]7_ !H_
MM.P_Y_;;_OZO^-9G_"$^%/\ H6-&_P# "+_XFC_A"?"G_0L:-_X 1?\ Q- &
MG_:=A_S^VW_?U?\ &C^T[#_G]MO^_J_XUF?\(3X4_P"A8T;_ , (O_B:/^$)
M\*?]"QHW_@!%_P#$T :?]IV'_/[;?]_5_P :/[3L/^?VV_[^K_C69_PA/A3_
M *%C1O\ P B_^)H_X0GPI_T+&C?^ $7_ ,30!I_VG8?\_MM_W]7_ !H_M.P_
MY_;;_OZO^-9G_"$^%/\ H6-&_P# "+_XFC_A"?"G_0L:-_X 1?\ Q- &G_:=
MA_S^VW_?U?\ &C^T[#_G]MO^_J_XUF?\(3X4_P"A8T;_ , (O_B:/^$)\*?]
M"QHW_@!%_P#$T :?]IV'_/[;?]_5_P :/[3L/^?VV_[^K_C69_PA/A3_ *%C
M1O\ P B_^)H_X0GPI_T+&C?^ $7_ ,30!I_VG8?\_MM_W]7_ !H_M.P_Y_;;
M_OZO^-9G_"$^%/\ H6-&_P# "+_XFC_A"?"G_0L:-_X 1?\ Q- &G_:=A_S^
MVW_?U?\ &C^T[#_G]MO^_J_XUF?\(3X4_P"A8T;_ , (O_B:/^$)\*?]"QHW
M_@!%_P#$T :?]IV'_/[;?]_5_P :/[3L/^?VV_[^K_C69_PA/A3_ *%C1O\
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M_"$^%/\ H6-&_P# "+_XFC_A"?"G_0L:-_X 1?\ Q- &G_:=A_S^VW_?U?\
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MI_T+&C?^ $7_ ,30!I_VG8?\_MM_W]7_ !H_M.P_Y_;;_OZO^-9G_"$^%/\
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MRS[UT.E_\@FR_P"N"?\ H(K,_P"$(\)G_F6-&_\  "+_ .)K=551%1%"JHP
M!@ 4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
2444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272710299984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 15, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-21617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ProPhase Labs, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">23-2577138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">711 Stewart Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Garden City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">345-0919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0005 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRPH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,240,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,045,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the Registrant&#8217;s definitive proxy statement relating to its 2024 annual meeting of stockholders (the &#8220;2024 Proxy Statement&#8221;) are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. The 2024 Proxy Statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000868278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272802456256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Morison Cogen LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Blue Bell, Pennsylvania<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272802480928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,609<span></span>
</td>
<td class="nump">$ 9,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">540<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities, available for sale</a></td>
<td class="nump">3,127<span></span>
</td>
<td class="nump">8,328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">36,313<span></span>
</td>
<td class="nump">37,054<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">3,841<span></span>
</td>
<td class="nump">3,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">2,155<span></span>
</td>
<td class="nump">2,366<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">47,585<span></span>
</td>
<td class="nump">60,833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property, plant and equipment, net</a></td>
<td class="nump">12,898<span></span>
</td>
<td class="nump">7,288<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseNoncurrent', window );">Prepaid expenses, net of current portion</a></td>
<td class="nump">832<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset, net</a></td>
<td class="nump">4,572<span></span>
</td>
<td class="nump">4,059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">12,333<span></span>
</td>
<td class="nump">8,475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">5,231<span></span>
</td>
<td class="nump">5,709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax asset</a></td>
<td class="nump">7,313<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">1,163<span></span>
</td>
<td class="nump">1,163<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">91,927<span></span>
</td>
<td class="nump">87,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">9,383<span></span>
</td>
<td class="nump">5,905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued diagnostic services</a></td>
<td class="nump">314<span></span>
</td>
<td class="nump">1,009<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedMarketingCostsCurrent', window );">Accrued advertising and other allowances</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities</a></td>
<td class="nump">1,840<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">953<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">2,382<span></span>
</td>
<td class="nump">2,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Income tax payable</a></td>
<td class="nump">3,278<span></span>
</td>
<td class="nump">4,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">2,683<span></span>
</td>
<td class="nump">2,072<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">20,857<span></span>
</td>
<td class="nump">16,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of discount of $341</a></td>
<td class="nump">2,924<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent', window );">Due to sellers (see Note 3)</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">1,059<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities, net of current portion</a></td>
<td class="nump">4,092<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">4,237<span></span>
</td>
<td class="nump">4,259<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="nump">21,687<span></span>
</td>
<td class="nump">7,942<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">42,544<span></span>
</td>
<td class="nump">24,017<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">91,927<span></span>
</td>
<td class="nump">87,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock authorized 1,000,000, $0.0005 par value, no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock authorized 50,000,000, $0.0005 par value, 18,045,029 and 16,210,776 shares outstanding, respectively</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">118,694<span></span>
</td>
<td class="nump">109,138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings (accumulated deficit)</a></td>
<td class="num">(5,029)<span></span>
</td>
<td class="nump">11,753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost, 18,940,967 and 18,126,790 shares, respectively</a></td>
<td class="num">(64,000)<span></span>
</td>
<td class="num">(58,033)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(300)<span></span>
</td>
<td class="nump">757<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">49,383<span></span>
</td>
<td class="nump">63,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prph_A2023NoteMember', window );">2023 Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured convertible promissory notes, net</a></td>
<td class="nump">7,334<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prph_SeptemberTwoThousandAndTwentyNoteMember', window );">September 2020 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Unsecured convertible promissory notes, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedMarketingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedMarketingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized from contingent consideration in asset acquisition, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of uncollateralized debt obligation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prph_A2023NoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prph_A2023NoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prph_SeptemberTwoThousandAndTwentyNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prph_SeptemberTwoThousandAndTwentyNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272802640528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent', window );">Discount</a></td>
<td class="nump">$ 341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par or stated value (in dollars per share)</a></td>
<td class="nump">$ 0.0005<span></span>
</td>
<td class="nump">$ 0.0005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par or stated value (in dollars per share)</a></td>
<td class="nump">$ 0.0005<span></span>
</td>
<td class="nump">$ 0.0005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">18,045,029<span></span>
</td>
<td class="nump">16,210,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">18,940,967<span></span>
</td>
<td class="nump">18,126,790<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prph_A2023NoteMember', window );">2023 Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent', window );">Discount</a></td>
<td class="nump">$ 266<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prph_A2023NoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prph_A2023NoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272705753712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Other Comprehensive Income - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues, net</a></td>
<td class="nump">$ 44,384<span></span>
</td>
<td class="nump">$ 122,647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenues</a></td>
<td class="nump">28,145<span></span>
</td>
<td class="nump">51,993<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">16,239<span></span>
</td>
<td class="nump">70,654<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Diagnostic expenses</a></td>
<td class="nump">1,932<span></span>
</td>
<td class="nump">12,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administration</a></td>
<td class="nump">34,502<span></span>
</td>
<td class="nump">34,385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,418<span></span>
</td>
<td class="nump">652<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">37,852<span></span>
</td>
<td class="nump">47,059<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">(Loss) income from operations</a></td>
<td class="num">(21,613)<span></span>
</td>
<td class="nump">23,595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Interest income, net</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,275)<span></span>
</td>
<td class="num">(764)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Change in fair value of investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(76)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">(Loss) income from operations before income taxes</a></td>
<td class="num">(22,800)<span></span>
</td>
<td class="nump">22,908<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="nump">6,018<span></span>
</td>
<td class="num">(4,445)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Loss (income) from operations after income taxes</a></td>
<td class="num">(16,782)<span></span>
</td>
<td class="nump">18,463<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTaxAbstract', window );"><strong>Other comprehensive (loss) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain on marketable debt securities, net of taxes</a></td>
<td class="num">(1,057)<span></span>
</td>
<td class="nump">932<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive (loss) income</a></td>
<td class="num">$ (17,839)<span></span>
</td>
<td class="nump">$ 19,395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Earnings (loss) per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.98)<span></span>
</td>
<td class="nump">$ 1.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.98)<span></span>
</td>
<td class="nump">$ 1.02<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">17,207<span></span>
</td>
<td class="nump">15,845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">17,207<span></span>
</td>
<td class="nump">18,651<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272705154976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid in Capital</div></th>
<th class="th"><div>Accumulated (Deficit) Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,485,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 58,628<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 104,552<span></span>
</td>
<td class="nump">$ 2,642<span></span>
</td>
<td class="num">$ (175)<span></span>
</td>
<td class="num">$ (48,407)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock for debt conversion (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock for debt conversion</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchases of common share (in shares)</a></td>
<td class="num">(303,145)<span></span>
</td>
<td class="num">(303,145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common shares</a></td>
<td class="num">$ (2,152)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,152)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends</a></td>
<td class="num">$ (9,352)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,352)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon stock options cashless exercise (in shares)</a></td>
<td class="nump">1,833,000<span></span>
</td>
<td class="nump">828,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Treasury shares repurchased to satisfy tax withholding obligations</a></td>
<td class="num">$ (7,474)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,474)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain on marketable debt securities, net of taxes</a></td>
<td class="nump">932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">3,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 18,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">16,210,776<span></span>
</td>
<td class="nump">16,210,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">$ 63,631<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">109,138<span></span>
</td>
<td class="nump">11,753<span></span>
</td>
<td class="nump">757<span></span>
</td>
<td class="num">(58,033)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock for debt conversion (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock for debt conversion</a></td>
<td class="nump">2,400<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">2,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common shares related to business acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock in asset acquisition</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchases of common share (in shares)</a></td>
<td class="num">(69,628)<span></span>
</td>
<td class="num">(69,628)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common shares</a></td>
<td class="num">$ (588)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(588)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_IssuanceOfCommonStockSharesExerciseOfWarrant', window );">Issuance of common stock upon exercise of warrant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount', window );">Issuance of common stock upon exercise of warrants</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon stock options cashless exercise (in shares)</a></td>
<td class="nump">1,348,000<span></span>
</td>
<td class="nump">603,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of warrants with unsecured promissory note</a></td>
<td class="nump">$ 398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Treasury shares repurchased to satisfy tax withholding obligations</a></td>
<td class="num">(5,379)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,379)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain on marketable debt securities, net of taxes</a></td>
<td class="num">(1,057)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,057)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">4,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="num">$ (16,782)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,782)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2023</a></td>
<td class="nump">18,045,029<span></span>
</td>
<td class="nump">18,045,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2023</a></td>
<td class="nump">$ 49,383<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 118,694<span></span>
</td>
<td class="num">$ (5,029)<span></span>
</td>
<td class="num">$ (300)<span></span>
</td>
<td class="num">$ (64,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_IssuanceOfCommonStockSharesExerciseOfWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Common Stock, Shares, Exercise of Warrant</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_IssuanceOfCommonStockSharesExerciseOfWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Common Stock Upon Exercise of Warrant, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481284/470-20-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272702583584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Parenthetical)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_PrepaidShareBasedCompensationExpense', window );">Prepaid expense</a></td>
<td class="nump">$ 1,024<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_PrepaidShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid Share-Based Compensation Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_PrepaidShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272706790336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (16,782)<span></span>
</td>
<td class="nump">$ 18,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss', window );">Realized loss on marketable debt securities</a></td>
<td class="num">(22)<span></span>
</td>
<td class="nump">354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">6,277<span></span>
</td>
<td class="nump">4,718<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization on right-of-use assets</a></td>
<td class="nump">421<span></span>
</td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfProperties', window );">Gain on sales of assets</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(127)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">3,536<span></span>
</td>
<td class="nump">3,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_ChangeInFairValueOfInvestmentSecurities', window );">Change in fair value of investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(174)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Accounts receivable allowances</a></td>
<td class="nump">718<span></span>
</td>
<td class="num">(761)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_InventoryValuationReserve', window );">Inventory valuation reserve</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(78)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLeaseAndOtherLosses', window );">Credit loss expense, direct write-offs</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">6,163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(68)<span></span>
</td>
<td class="num">(4,498)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(376)<span></span>
</td>
<td class="num">(617)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_IncreaseDecreaseInDeferredIncomeTaxAssets', window );">Deferred tax asset</a></td>
<td class="num">(7,313)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(555)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">3,478<span></span>
</td>
<td class="num">(1,121)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_IncreaseDecreaseInAccruedDiagnosticServices', window );">Accrued diagnostic services</a></td>
<td class="num">(695)<span></span>
</td>
<td class="num">(881)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances', window );">Accrued advertising and other allowances</a></td>
<td class="num">(75)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(76)<span></span>
</td>
<td class="nump">619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="num">(224)<span></span>
</td>
<td class="num">(138)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="num">(181)<span></span>
</td>
<td class="num">(301)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="num">(912)<span></span>
</td>
<td class="nump">2,878<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other liabilities</a></td>
<td class="nump">611<span></span>
</td>
<td class="num">(423)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in) provided by operating activities</a></td>
<td class="num">(11,348)<span></span>
</td>
<td class="nump">28,551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EscrowDepositsRelatedToPropertySales', window );">Business acquisitions, escrow received</a></td>
<td class="nump">478<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="num">(2,904)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_IssuanceOfSecuredPromissoryNoteReceivable', window );">Issuance of secured promissory note receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities</a></td>
<td class="num">(3,819)<span></span>
</td>
<td class="num">(6,777)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sales of marketable securities</a></td>
<td class="nump">3,817<span></span>
</td>
<td class="nump">1,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from maturities of marketable securities</a></td>
<td class="nump">4,168<span></span>
</td>
<td class="nump">7,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment', window );">Proceeds from dispositions of property and other assets, net</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable', window );">Proceeds from promissory note</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="num">(3,155)<span></span>
</td>
<td class="num">(3,919)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,369)<span></span>
</td>
<td class="num">(2,077)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from issuance of note payable</a></td>
<td class="nump">10,524<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of warrants</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Repayment of common stock for payment of statutory taxes on cashless exercise of stock options</a></td>
<td class="num">(5,379)<span></span>
</td>
<td class="num">(7,474)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of note payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7,044)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchases of common shares</a></td>
<td class="num">(588)<span></span>
</td>
<td class="num">(2,152)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payment of dividends</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,353)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">5,757<span></span>
</td>
<td class="num">(26,023)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">(Decrease) increase in cash, cash equivalents and restricted cash</a></td>
<td class="num">(6,960)<span></span>
</td>
<td class="nump">451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, at the beginning of the year</a></td>
<td class="nump">9,109<span></span>
</td>
<td class="nump">8,658<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, at the end of the year</a></td>
<td class="nump">2,149<span></span>
</td>
<td class="nump">9,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">1,696<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest payment on the promissory notes</a></td>
<td class="nump">932<span></span>
</td>
<td class="nump">763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation', window );">Stock-based compensation included in the prepaid expense</a></td>
<td class="nump">1,024<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_IssuanceOfCommonSharesForDebtConversion', window );">Issuance of common shares for debt conversion</a></td>
<td class="nump">2,400<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities', window );">Net unrealized loss, investments in marketable securities</a></td>
<td class="nump">1,520<span></span>
</td>
<td class="nump">1,294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Assets obtained in exchange for new finance lease obligations</a></td>
<td class="nump">5,809<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_IssuanceOfWarrantsWithUnsecuredPromissoryNote', window );">Issuance of warrants with unsecured promissory note</a></td>
<td class="nump">398<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Common stock issued in asset acquisition</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_ChangeInFairValueOfInvestmentSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of investment securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_ChangeInFairValueOfInvestmentSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease In Accrued Advertising And Other Allowances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_IncreaseDecreaseInAccruedDiagnosticServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in accrued diagnostic services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_IncreaseDecreaseInAccruedDiagnosticServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_IncreaseDecreaseInDeferredIncomeTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Deferred Income Tax Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_IncreaseDecreaseInDeferredIncomeTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Deferred Income Tax Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_InventoryValuationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory valuation reserve.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_InventoryValuationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_IssuanceOfCommonSharesForDebtConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance Of Common Shares For Debt Conversion</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_IssuanceOfCommonSharesForDebtConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_IssuanceOfSecuredPromissoryNoteReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of secured promissory note receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_IssuanceOfSecuredPromissoryNoteReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_IssuanceOfWarrantsWithUnsecuredPromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance Of Warrants With Unsecured Promissory Note</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_IssuanceOfWarrantsWithUnsecuredPromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non cash investing and financing unrealized loss investments in marketable debt securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for employee benefit and equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeBenefitsAndShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDepositsRelatedToPropertySales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Escrow deposits related to property sales in noncash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDepositsRelatedToPropertySales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of real estate or properties that were intended to be sold or held for capital appreciation or rental income. This element refers to the gain (loss) included in earnings and not to the cash proceeds of the sale. This element is a noncash adjustment to net income when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the proceeds from sale of notes receivable, as well as principal collections from a borrowing supported by a written promise to pay an obligation (note receivable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow for the sale of long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForLoanLeaseAndOtherLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(2)<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-11B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.11)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForLoanLeaseAndOtherLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272703212608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Business</a></td>
<td class="text">Organization and Business<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ProPhase Labs, Inc. (&#8220;ProPhase&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221;) is a diversified company that offers a range of services including genomics testing, diagnostic testing and contract manufacturing. We are also focused on licensing, developing and commercializing novel drugs, dietary supplements, compounds and diagnostics.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until late fiscal year 2020, the Company was engaged primarily in the research, development, manufacture, distribution, marketing and sale of over-the-counter ("OTC") consumer healthcare products and dietary supplements in the United States. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In October 2020, the Company completed the acquisition of all of the issued and outstanding shares of capital stock of Confucius Plaza Medical Laboratory Corp. (&#8220;CPM&#8221;), which owned a 4,000 square foot </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Clinical Laboratory Improvement Amendments (&#8220;CLIA&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> accredited laboratory located in Old Bridge, New Jersey for approximately $2.5 million, and began offering COVID-19 diagnostic tests through our wholly-owned subsidiary, ProPhase Diagnostics, Inc. ("ProPhase Diagnostics") in December 2020. Also in December 2020, we expanded our diagnostic service business with the build-out of a second, larger CLIA accredited laboratory in Garden City, New York. Operations at this second facility commenced in January 2021. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We offered a broad array of COVID-19 related clinical diagnostic and testing services including polymerase chain reaction (&#8220;PCR&#8221;) testing for COVID-19 and Influenza A and B through ProPhase Diagnostics, as well as rapid antigen and antibody/immunity testing for COVID-19. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Due to the significant decrease in demand and reimbursement rate for our diagnostic testing service, we have reduced the amount of diagnostic testing services that we provide since the second half of 2023. Nonetheless we are prepared to provide an increased volume of our diagnostic testing service if diagnostic testing is required due to a new COVID-19 outbreak. We have continued to ship COVID-19 antigen kits under an existing contract to our customer. In addition, in order to maintain licenses in certain states in which we operate, we currently perform several diagnostic tests each quarter to maintain our certified lab status, and we currently plan to do so for the foreseeable future.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2021, the Company acquired Nebula Genomics, Inc. (&#8220;Nebula&#8221;), a privately owned personal genomics company, through our wholly-owned subsidiary, ProPhase Precision Medicine Inc. Nebula focuses on genomics sequencing technologies, a comprehensive method for analyzing entire genomes, including the genes and chromosomes in deoxyribonucleic acidDNA. The data obtained from genomic sequencing can be used to help identify inherited disorders and tendencies, help predict disease risk, help identify expected drug response, and characterize genetic mutations, including those that drive cancer progression. </span></div><div style="text-align:justify;text-indent:29.15pt"><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's wholly owned subsidiary, ProPhase BioPharma, Inc. (&#8220;PBIO&#8221;), was formed in June 2022, for the licensing, development and commercialization of novel drugs, dietary supplements and compounds. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Licensed compounds currently include Equivir (a OTC, dietary supplement candidate) and Equivir G (prescription drug (&#8220;Rx&#8221;) candidate), two broad-based anti-virals, and Linebacker LB-1 and LB-2, two small molecule proviral integration site for moloney murine leukemia virus (&#8220;PIM&#8221;) kinase inhibitors. The Company also own the exclusive rights to the BE-Smart Esophageal Pre-Cancer Diagnostic Screening test and related intellectual property (&#8220;IP&#8221;) assets. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the activities of PBIO, in January 2023, the Company acquired exclusive rights to BE-Smart Esophageal Pre-Cancer Diagnostic Screening test and related IP assets. The BE-Smart test is focused on the early detection of esophageal cancer, and is intended to provide health care providers and patients with data to help determine treatment options. The development of these novel drugs and compounds is highly dependent on how each performs during the testing and development stage, the demand for these product and services once entered into the marketplace, our marketing and service capabilities and our ability to comply with applicable regulatory requirements. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's wholly-owned subsidiary, Pharmaloz Manufacturing, Inc. (&#8220;PMI&#8221;), is a full-service contract manufacturer and private label developer of a broad range of non-GMO, organic and natural-based cough drops and lozenges and OTC drug and dietary supplement products. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also develops and markets dietary supplements under the TK Supplements&#174; brand. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The TK Supplements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">product line includes Legendz XL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a male sexual enhancement and Triple Edge XL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an energy and stamina booster. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:29.15pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's wholly owned subsidiary, Pharmaloz Real Estate Holdings, Inc. (&#8220;PREH&#8221;), was formed in November 2023, for the purpose to receive additional investment to expand its current facility. There was no operation for PREH as of December 31, 2023. </span></div><div style="text-align:justify;text-indent:29.15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company continues to actively pursue acquisition opportunities for other companies, technologies and products within and outside the consumer products industry.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272704663680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no effect on the reported results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification ("ASC") 280, &#8220;Segment Reporting&#8221; (&#8220;ASC 280&#8221;), the Company discloses financial and descriptive information about its reportable operating segments. Operating segments are components of an enterprise about which separate financial information is available and regularly evaluated by the chief operating decision maker in deciding how to allocate resources and in assessing performance.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows ASC 280, which establishes standards for reporting information about operating segments in annual and interim financial statements, and requires that companies report financial and descriptive information about their reportable segments based on a management approach. ASC 280 also establishes standards for related disclosures about products and services, geographic areas and major customers.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are defined as components of an enterprise that engage in business activities for which separate financial information is available and is evaluated by the Chief Operating Decision Maker (&#8220;CODM&#8221;), which for the Company is its Chief Executive Officer, in deciding how to allocate resources and assess performance. We maintain two operating segments: diagnostic services (which includes our COVID-19 and other diagnostic testing services) and consumer products (which includes our contract manufacturing, retail customers, biopharma and personal genomics products and services). See Note 15 Segment Information.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business and Liquidity Risks and Uncertainties</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our diagnostic service business continued to be impacted by the level of demand for COVID-19 and other diagnostic testing, the prices we are able to receive for performing our testing services, our ability to collect payment or reimbursement for our testing services in December 31, 2023 and ultimately led to our revenues decreasing significantly for the year ended December 31, 2023. On March 22, 2022, the Health Resources &amp; Services Administration ("HRSA") program stopped accepting claims for COVID-19 testing and treatment provided to uninsured individuals due to lack of sufficient funds. We recognized approximately 1,000,000 tests for the year ended December 31, 2022 and approximately 480,000  tests for the year ended December 31, 2023, of which 28%  were reimbursed by the HRSA uninsured program for the year ended December 31, 2022, and none were reimbursed from the HRSA uninsured program for the year ended December 31, 2023. As a result, we have reduced the amount of diagnostic testing services that we provide since the second half of 2023. Nonetheless we are prepared to provide an increased volume of our diagnostic testing service if diagnostic testing is required due to a new COVID-19 outbreak. We have continued to ship COVID-19 antigen kits under an existing contract to our customer. In addition, in order to maintain licenses in certain states in which we operate, we currently perform several diagnostic tests each quarter to maintain our certified lab status, and we currently plan to do so for the foreseeable future. There is no guarantee that the demand of our diagnostic testing services will increase or meet the level of demand that we experienced during the COVID-19 pandemic, and there is no guarantee that we will be able to substitute the revenues previously generated from this line of business from our other business lines.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our personal genomics business is and will continue to be influenced by demand for our genetic sequencing products and services, our marketing and service capabilities, and our ability to comply with applicable regulatory requirements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our contracting manufacturing business is and will continue to be impacted by demand for our services, which is largely a function of the timing, length and severity of each cold season. Generally, a cold season is defined as the period from September to March when the incidence of the common cold rises as a result of the change in weather and other factors. We generally experience in the first, third and fourth quarter higher levels of net revenues from our contract manufacturing business. Revenues are generally at their lowest levels in the second quarter when customer demand generally declines. This line of business is also impacted by our ability to meet such demands. The building of our manufacturing facilities and manufacturing of products necessitates compliance with applicable regulatory requirements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consumer sales are and will continue to be impacted by (i) the timing of acceptance of our TK Supplements</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consumer products in the marketplace, and (ii) fluctuations in the timing of purchase and the ultimate level of demand for these products. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2023, $11.3&#160;million was used by operating activities.  The Company had cash, cash equivalents, restricted cash and marketable securities of $5.3 million as of December&#160;31, 2023. Based on management&#8217;s current business plans, the Company estimates that it will have enough cash and liquidity to finance its operating requirements for at least one year from the date of filing these financial statements. However, due to the nature of the diagnostic business and the Company's focus thus far on COVID-19, there are inherent uncertainties associated with managements&#8217; business plan and cash flow projections if the Company is unable to grow its diagnostic testing business beyond COVID-19 testing services and to grow its other businesses.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As such, the Company&#8217;s future capital needs and the adequacy of its available funds will depend on many factors. These include, but not necessarily limited to, the actual cost and time necessary to achieve sustained profitability from diagnostic services, the ability to successfully diversify the diagnostic services revenue streams and the ability to market and grow the personal genomics, biopharma, manufacturing and supplement businesses. The Company may be required to raise additional funds through equity or debt securities offerings or strategic collaboration and/or licensing agreements in order to fund operations until it is able to generate enough revenues. Such financing may not be available on acceptable terms, or at all, and the Company&#8217;s failure to raise capital when needed could have a material adverse effect on its strategic objectives, results of operations and financial condition. </span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements and the accompanying notes thereto, in conformity with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;), requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the respective reporting periods. Examples include revenue recognition and the impact of the variable consideration around diagnostic test reimbursement rates, the provision for uncollectible receivables and billing errors, sales returns and allowances, rates, slow moving, dated inventory and associated provisions, the estimated useful lives and potential impairment of long-lived assets, stock based compensation valuation, income tax asset valuations and assumptions related to accrued advertising.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimates and assumptions are based on historical experience, current trends and other factors that management believes to be relevant at the time the financial statements are prepared. Management reviews the accounting policies, assumptions, estimates and judgments on a quarterly basis. Actual results could differ from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all highly liquid investments with a maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents include cash on hand and monies invested in money market funds. The carrying amount approximates the fair market value due to the short-term maturity of these securities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash as of December&#160;31, 2023 includes approximately $540,000 held in escrow related to the Company's mortgage loan. There was no restricted cash as of December 31, 2022. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have classified our investments in marketable debt and equity securities as available-for-sale and as a current asset. Our investments in marketable securities are carried at fair value, with unrealized gains and as a separate component of stockholders&#8217; equity. Realized gains and losses from our marketable securities are recorded as interest income (expense). Marketable debt securities carry maturity dates between <span style="-sec-ix-hidden:f-378">one</span> and three years from date of purchase and interest rates of 1.40% to 4.90% during fiscal 2022. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the components of our marketable securities and the underlying fair value input level tier hierarchy (see fair value of financial instruments) (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Unrealized <br/>Losses </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate stock</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(401)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,528&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(401)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrealized <br/>Losses </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">U.S. government obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,186&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,234&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(92)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,328&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the unrealized gains or losses generally are the result of a change in the risk premiums required by market participants rather than an adverse change in cash flows or a fundamental weakness in the credit quality of the issuer or underlying assets.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable, net</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable consists primarily of amounts due from government agencies and healthcare insurers. Unbilled accounts receivable relates to the delivery of our diagnostic testing services for which the related billings will occur in a future period, after a patient&#8217;s insurance information has been validated, and represent amounts we have an unconditional right to receive payment. Unbilled accounts receivable is classified as accounts receivable on the consolidated balance sheet. We carry our accounts receivable at the amount of consideration for which we expect to be entitled less allowances. When estimating the allowances for our diagnostics business, the Company pools its trade receivables based on the following payer types: healthcare insurers and government payers. The Company principally estimates the allowance for credit losses by pool based on historical collection experience, current economic conditions, expectations of future economic conditions, other credits and the period of time that the receivables have been outstanding. To the extent that any individual payers are identified that have deteriorated in credit quality, the Company removes the payers from their respective pools and establishes allowances based on the individual risk characteristics of such payers. On a periodic basis, we evaluate our receivables and establish an allowance, based on a history of past write-offs, government and healthcare insurer payment trends, collections, current credit conditions or generally accepted future trends. Accounts receivable are stated at the net amount expected to be collected, using an expected loss methodology that is referred to as the current expected credit loss ("CECL") model.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts are written off as uncollectible at the time we determine that collections are unlikely. Accounts receivable, net is comprised of the following (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40,177&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">37,568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unbilled accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40,177&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(3,864)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(3,140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total accounts receivable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">36,313&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">37,054&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The table below presents a roll forward of the Company's allowance for credit losses (amount in thousands).</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.212%"><tr><td style="width:1.0%"></td><td style="width:83.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.190%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance as of January 1, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period provision for expected credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,864&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For Fiscal 2023, we recorded  $0.3&#160;million to credit losses in operating expenses representing a write-off of trade receivables we have determined to be uncollectible and increased the allowance for credit losses as a reduction of revenue by $0.4&#160;million. The results of these adjustments and our current year allowances, resulted in an allowance of $3.9&#160;million at December&#160;31, 2023. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At December 31, 2023, within the diagnostic services business, insurers had significantly aged balances that we are continuing to work to collect.  The specific facts and circumstances related to each of these individual payors have been considered by our management, which informed the determination of the year-end reserve balance. We continue to pursue collection of amounts due. However, there will inevitably be billings that are rejected by the insurance carriers and associated receivables that will not be collected. We believe that the reserve established at December 31, 2023 is adequate to capture this collectability risk. While past history is helpful informing the determination of an appropriate reserve, its utility is somewhat limited by the circumstances underlying a significant portion of these aged balances; specifically, an unprecedented volume of activity related COVID 19 diagnostic testing.  Accordingly, the determination of an appropriate reserve required significant management judgment and was informed by the unique facts and circumstances related to each of the three significant insurers. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For Fiscal 2022, we recorded $5.9&#160;million to credit loss expense in operating expenses representing a write-off of trade receivables we have determined to be uncollectible. Additionally, we wrote off $2.9&#160;million of trade receivables and related allowances at December 31, 2022, that were fully reserved for in 2021 and did not impact the result of operations for the year ended December 31, 2022. The Company also increased its allowance for credit losses in Fiscal 2022 by $5.5&#160;million. The results of these adjustments and our current year allowances, resulted in an allowance of $3.1&#160;million at December 31, 2022. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory, net</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is valued at the lower of cost, determined on a first-in, first-out basis (&#8220;FIFO&#8221;), or net realizable value. Inventory items are analyzed to determine cost and the net realizable value and appropriate valuation adjustments are established.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2023 and 2022, the components of inventory are as follows (in thousands): </span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services testing material</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">623&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,739&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Finished goods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventory</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,099&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,488&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventory valuation reserve</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(258)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(512)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventory, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,841&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,976&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are recorded at cost. We use the straight-line method in computing depreciation for financial reporting purposes. Depreciation expense is computed in accordance with the following ranges of estimated asset lives: building and improvements - <span style="-sec-ix-hidden:f-443">ten</span> to thirty-nine years; leasehold improvements - lesser of lease term or estimated useful life; machinery and equipment including lab equipment - <span style="-sec-ix-hidden:f-445">three</span> to seven years; computer equipment and software - <span style="-sec-ix-hidden:f-447">three</span> to five years; and furniture and fixtures - five years.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Financial Risks</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash investments, marketable debt securities, and trade accounts receivable. Our marketable securities are fixed income investments, which are highly liquid and can be readily purchased or sold through established markets.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain cash and cash equivalents with certain major financial institutions. As of December&#160;31, 2023, our cash and cash equivalents and restricted cash balance was $2.1 million. Of the total bank balance, $1.0 million was covered by federal depository insurance and $1.1 million was uninsured at December&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable subject us to credit risk concentrations from time-to-time. We extend credit to our consumer healthcare product customers based upon an evaluation of the customer&#8217;s financial condition and credit history and generally do not require collateral. Our diagnostic services receivable credit risk is based on payer reimbursement experience, which includes government agencies and healthcare insurers, the period the receivables have been outstanding and the historical collection rates. The collectability of the diagnostic services receivables is also directly linked to the quality of our billing processes, which depend on information provided and billing services of third parties. These credit concentrations impact our overall exposure to credit risk, which could be further affected by changes in economic, regulatory or other conditions that may impact the timing and collectability of trade receivables and diagnostic test receivables. Additionally, the reimbursement receivables from the diagnostic service business are subject to billing errors and related disputes.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, see Note 13 - Significant Customers Concentrations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the inception of an arrangement, we determine whether the arrangement is or contains a lease based on the unique facts and circumstances present in the arrangement. Most leases with a term greater than one year are recognized on the balance sheet as right-of-use assets and short-term and long-term lease liabilities, as applicable. We have elected not to recognize on the balance sheet leases with terms of 12 months or less. We typically only include an initial lease term in its assessment of a lease arrangement. Options to renew a lease are not included in our assessment unless there is reasonable certainty that we will renew.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected remaining lease term. Certain adjustments to the right-of-use asset may be required for items such as incentives received. The interest rate implicit in our leases is typically not readily determinable. As a result, we utilize our incremental borrowing rate, which reflects the fixed rate at which we could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term and in a similar economic environment (see Note 12, Leases).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of a lease should be allocated between lease components (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., land, building, etc.) and non-lease components (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., common area maintenance, consumables, etc.). The fixed and in-substance fixed contract consideration (including any consideration related to non-components) must be allocated based on the respective relative fair values to the lease components and non-lease components.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the fair value of the consideration transferred over the fair value of the underlying identifiable assets and liabilities acquired in a business combination. Goodwill and intangible assets deemed to have an indefinite life are not amortized, but instead are assessed for impairment annually. Additionally, if an event or change in circumstances occurs that would more likely than not reduce the fair value of the reporting unit below its carrying value, we would evaluate goodwill and other intangibles at that time.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In testing for goodwill impairment, we have the option to first assess qualitative factors to determine whether the existence of events or circumstances lead to a determination that it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If, after assessing the totality of events and circumstances, we conclude that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is not required. If we conclude otherwise, we are required to perform the two-step impairment test. The goodwill impairment test is performed at the reporting unit level by comparing the estimated fair value of a reporting unit with its respective carrying value. If the estimated fair value exceeds the carrying value, goodwill at the reporting unit level is not impaired. If the estimated fair value is less than the carrying value, an impairment charge will be recorded to </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reduce the reporting unit to fair value. Management completed a qualitative assessment of Goodwill and it was not deemed impaired at December 31, 2023. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets deemed to have finite lives are amortized on a straight-line basis over their estimated useful lives, where the useful life is the period over which the asset is expected to contribute directly, or indirectly, to our future cash flows.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews long-lived assets, including property and equipment and finite-lived intangible assets, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. An impairment loss is recognized when the asset&#8217;s carrying value exceeds the total undiscounted cash flows expected from its use and eventual disposition. The amount of the impairment loss is determined as the excess of the carrying value of the asset over its fair value. For the fiscal years ended December&#160;31, 2023 and 2022, the Company did not have an impairment of the long-lived assets.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure assets and liabilities at fair value based on expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale date of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the hierarchical levels of inputs to measure fair value:</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Level 1: Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Level 2: Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Level 3: Unobservable inputs reflecting the Company&#8217;s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of our financial assets and liabilities, such as cash, accounts receivable, accounts payable, and unsecured note payable, approximate their fair values because of the short-term nature of these instruments.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for our marketable securities at fair value, with the net unrealized gains or losses of marketable debt securities reported as a component of accumulated other comprehensive income or loss and marketable equity securities change in fair value reported on the condensed consolidated statement of operations. The components of marketable securities are as follows (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">U.S. government obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,496&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,832&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,328&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers of marketable debt securities between Levels 1, 2 or 3 for the years ended December&#160;31, 2023 and 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue that represents the transfer of promised goods or services to customers at an amount that reflects the consideration that is expected to be received in exchange for those goods or services. We recognize revenue when performance obligations with our customers have been satisfied. At contract inception, we evaluate the contract to determine if revenue should be recognized using the following five steps: (1) identify the contract with the customer; (2) identify the performance obligations; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations; and (5) recognize revenue when (or as) the entity satisfies a performance obligation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract with Customers and Performance Obligations</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account. A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Sales from product shipments to contract manufacturing and retailer customers are recognized at the time ownership is transferred to the customer. Revenue from diagnostic services is recognized when the results are made available to the customer. Revenue from our personal genomics business is recognized when the genetic testing results are provided to the customer. For subscription services associated with our genomic testing, we recognize revenue ratably over the term of the subscription.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s performance obligation for contract manufacturing and retail customers is to provide the goods ordered by the customer. The Company has one performance obligation for its diagnostic services, which is to provide the results of the laboratory test to the customer. Our personal genomics business has separate performance obligations to provide initial testing and genome results and subscriptions services to our customers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction Price </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our diagnostic services business, a revenue transaction is initiated when we receive a requisition order to perform a diagnostic test. The information provided on the requisition form is used to determine the party that will be billed for the testing performed and the expected reimbursement. We provide diagnostic services to a range of customers. In many cases, the customer that orders our services is not responsible for paying for these services. Depending on the billing arrangement and applicable law, the payer may be the patient or a third party, such as a health plan, Medicare or Medicaid program and other government reimbursement programs. We bill the providers at standard price and take into consideration negotiated discounts and anticipated reimbursement remittance adjustments based on the payer portfolio, when revenue is recorded. We use the most expected value method to estimate the transaction price for reimbursements that vary from the listed contract price.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our personal genomics business, a revenue transaction is initiated by a DNA test kit sale direct to the consumer sales via our website or through online retailers. The kit sales and subscriptions are billed at a standard price and take into consideration any discounts when revenue is recorded. We also contract with third party B2B partners and universities and sell DNA test kits directly to them.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contract manufacturing and retail customers, the transaction price is fixed based upon either (i) the terms of a combined master agreement and each related purchase order, or (ii) if there is no master agreement, the price per individual purchase order received from each customer. The customers are invoiced at an agreed upon contractual price for each unit ordered and delivered by the Company.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from retail customers is reduced for trade promotions, estimated sales returns and other allowances in the same period as the related sales are recorded. No such allowance is applicable to our contract manufacturing customers. We estimate potential future product returns and other allowances related to current period revenue. We analyze historical returns, current trends, and changes in customer and consumer demand when evaluating the adequacy of the sales returns and other allowances.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not accept returns from our contract manufacturing customers. Our return policy for retail customers accommodates returns for (i) discontinued products, (ii) store closings and (iii) products that have reached or exceeded their designated expiration date. We do not impose a period of time during which product may be returned. All requests for product returns must be submitted to us for pre-approval. We will not accept return requests pertaining to customer inventory &#8220;Overstocking&#8221; or &#8220;Resets&#8221;. We will accept return requests only for products in their intended package </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">configuration. We reserve the right to terminate shipment of product to customers who have made unauthorized deductions contrary to our return policy or pursue other methods of reimbursement. We compensate the customer for authorized returns by means of a credit applied to amounts owed.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our diagnostic services business, a revenue transaction is initiated when we receive a requisition order to perform a diagnostic test. The information provided on the requisition form is used to determine the party that will be billed for the testing performed and the expected reimbursement. We provide diagnostic services to a range of customers. In many cases, the customer that orders our services is not responsible for paying for these services. Depending on the billing arrangement and applicable law, the payer may be the patient or a third party, such as a health plan, Medicare or Medicaid program and other government reimbursement programs. We bill the providers at standard price and take into consideration negotiated discounts and anticipated reimbursement remittance adjustments based on the payer portfolio, when revenue is recorded. We use the most expected value method to estimate the transaction price for reimbursements that vary from the listed contract price.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our personal genomics business, a revenue transaction is initiated by a DNA test kit sale direct to the consumer sales via our website or through online retailers. The kit sales and subscriptions are billed at a standard price and take into consideration any discounts when revenue is recorded. We also contract with third party B2B partners and universities and sell DNA test kits directly to them.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recognize Revenue When the Company Satisfies a Performance Obligation </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For diagnostic services, the Company satisfies its performance obligation at the point in time that the results are made available to the customer, which is when the customer benefits from the information contained in the results and obtains control.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For genomic services, we satisfy our product performance obligation at a point in time when the genetic testing results are provided to the customer. For subscriptions services associated with its genomic testing, we satisfy our performance obligation ratably over the subscription period. If the customer does not return the test kit, services cannot be completed by us, potentially resulting in unexercised rights (&#8220;breakage&#8221;) revenue, including lifetime subscription services. We estimate breakage for the portion of test kits not expected to be returned using an analysis of historical data and consider other factors that could influence customer test kit return behavior. When breakage revenue is recognized on a kit, we recognize breakage on any associated subscription services ratably over the term of the subscription</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance obligations related to contract manufacturing and retail customers are satisfied at a point in time when the goods are shipped to the customer as (i) we have transferred control of the assets to the customers upon shipping, and (ii) the customer obtains title and assumes the risks and rewards of ownership after the goods are shipped.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and December&#160;31, 2022, we have deferred revenue of $3.5 million and $3.6 million, respectively. Our new personal genomics business comprised $3.4 million of the deferred revenue as of December&#160;31, 2023. The remainder of deferred revenue relates to research and development (&#8220;R&amp;D&#8221;) stability and release testing programs recognized as contract manufacturing revenue. Deferred revenues primarily consist of amounts that have been billed to or received from customers in advance of revenue recognition and prepayments received from customers in advance of services performed for the R&amp;D work. We recognize deferred revenues as revenues when the services are performed and the corresponding revenue recognition criteria are met. Customer prepayments are generally applied against invoices issued to customers when services are performed and billed.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates our deferred revenue by recognition period (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Recognition Period</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0-12 Months</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13-24 Months</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Over 24 Months</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,482&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,558&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We disaggregate revenue from contracts with customers into four categories: contract manufacturing, retail and others, diagnostic services and genomic products and services. We determined that disaggregating revenue into these categories achieves the disclosure objective to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company&#8217;s revenue by revenue source for Fiscal 2023 and 2022 (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue by Customer Type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">108,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Contract manufacturing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Retail and others</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Genomic products and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">44,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">122,647&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer Consideration</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes payments to certain diagnostic services customers for distinct services that approximate fair value for those services. Such services include specimen collection, the collection and delivery of insurance and patient information necessary for billing and collection, and logistics services. Consideration associated with specimen collection services is classified in cost of revenues and the remaining costs are classified as diagnostic expenses within operating expenses in the accompanying statement of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales Tax Exclusion from the Transaction Price</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from the customer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shipping and Handling Activities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for shipping and handling activities that we perform as activities to fulfill the promise to transfer the good.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising and Incentive Promotions</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising and incentive promotion costs are expensed within the period in which they are utilized. Advertising and incentive promotion expense is comprised of (i) media advertising, presented as part of general and administrative expense, (ii) cooperative incentive </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">promotions and coupon program expenses, which are accounted for as part of net revenue, and (iii) free product, which is accounted for as part of cost of revenues. Advertising and incentive promotion expenses incurred from continuing operations for Fiscal 2023 and 2022 were $1.8 million and $0.4 million, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for stock-based compensation in accordance with FASB ASC 718, &#8220;Compensation &#8211; Stock Compensation.&#8221; Under the fair value recognition provision of the ASC, stock-based compensation cost is estimated at the grant date based on the fair value of the award. The Company estimates the fair value of stock options and warrants granted using the Black-Scholes-Merton option pricing model and stock grants at their closing reported market value. We recognize all stock-based payments to employees and directors, including grants of stock options, as compensation expense in the financial statements based on their grant date fair values. The grant date fair values of stock options are determined through the use of the Black-Scholes option pricing model. The compensation cost is recognized as an expense over the requisite service period of the award, which usually coincides with the vesting period. We account for forfeitures as they occur.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock and stock options to purchase our common stock have been granted to employees pursuant to the terms of certain agreements and stock option plans (see Note 7, Stockholders' Equity). Stock options are exercisable during a period determined by us, but in no event later than seven years from the date granted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D costs are charged to operations in the period incurred, R&amp;D costs incurred for the years ended December&#160;31, 2023 and 2022 were $1.4 million and $0.7 million, respectively. R&amp;D costs are principally related to personnel expenses and new product development initiatives and costs associated with the OTC health care products, dietary supplements and validation costs associated with the diagnostic services business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes in accordance with accounting guidance now codified as FASB ASC 740, &#8220;Income Taxes,&#8221; which requires that the Company recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for, or benefit from, income taxes includes deferred taxes resulting from the temporary differences in income for financial and tax purposes using the liability method. Such temporary differences result primarily from the differences in the carrying value of assets and liabilities. Future realization of deferred income tax assets requires sufficient taxable income within the carry-back, carryforward period available under tax law. We evaluate, on a quarterly basis whether, based on all available evidence, it is probable that the deferred income tax assets are realizable. Valuation allowances are established when it is more likely than not that the tax benefit of the deferred tax asset will not be realized. The evaluation, as prescribed by ASC 740- 10, &#8220;Income Taxes,&#8221; includes the consideration of all available evidence, both positive and negative, regarding historical operating results including recent years with reported losses, the estimated timing of future reversals of existing taxable temporary differences, estimated future taxable income exclusive of reversing temporary differences and carryforwards, and potential tax planning strategies which may be employed to prevent an operating loss or tax credit carryforward from expiring unused.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under ASU No. 2019-12, &#8220;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (&#8220;ASU 2019-12&#8221;), which simplifies various aspects related to accounting for income taxes. This standard became effective for the Company January 1, 2021. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for uncertainties in income taxes under the provisions of FASB ASC 740-10-05 (the &#8220;Subtopic&#8221;). The Subtopic clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements. The Subtopic prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The Subtopic provides guidance on the de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards, Adopted</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2023, the Company adopted Accounting Standards Update ("ASU") 2016-13, &#8220;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&#8221; (&#8220;ASU 2016-13&#8221;) ASU 2016-13 requires an impairment model (known as the CECL model) that is based on expected losses rather than incurred losses. Under the new guidance, each reporting entity should estimate an allowance for expected credit losses, which is intended to result in more timely recognition of losses. This model replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost, accounts receivable and available for sale debt securities and applies to some off-balance sheet credit exposures. In February 2020, the FASB issued ASU 2020-02, Financial Instruments - Credit Losses (Topic 326), which amends the effective date of the original pronouncement for smaller reporting companies. ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022. The adoption of ASU 2016-13 did not have a material impact on the Company's consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2023, the FASB issued ASU 2023-05, "Business Combinations - Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement." The new guidance applies to the formation of a joint venture and requires a joint venture to initially measure all contributions received upon its formation at fair value. The guidance is intended to reduce diversity in practice and is applicable to joint venture entities with a formation date on or after January 1, 2025 on a </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prospective basis. The Company currently does not have any transactions that fall under the scope of ASU 2023-05; therefore, the adoption of ASU 2023-05 is not expected to have an impact on the Company's consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards, Not Yet Adopted</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), which requires an enhanced disclosure of significant segment expenses on an annual and interim basis. This guidance will be effective for the annual periods beginning the year ended December 31, 2024, and for interim periods beginning January 1, 2025. Early adoption is permitted. Upon adoption, the guidance should be applied retrospectively to all prior periods presented in the financial statements. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which improves the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the effective tax rate reconciliation and income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. This guidance will be effective for the annual periods beginning the year ended December 31, 2025. Early adoption is permitted. Upon adoption, the guidance can be applied prospectively or retrospectively. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272706402832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Acquisition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Asset Acquisition</a></td>
<td class="text">Asset Acquisition<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stella Diagnostics - Asset Purchase Agreement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 15, 2022, the Company entered into an Asset Purchase Agreement (the &#8220;Stella Purchase Agreement&#8221;), with Stella Diagnostics Inc. (&#8220;Stella&#8221;) and Stella DX, LLC (&#8220;Stella DX&#8221; and, together with Stella, the &#8220;Stella Sellers&#8221;), pursuant to which, on January 3, 2023, the Company purchased all of the assets, rights and interests of the Stella Sellers and their affiliates pertaining to the Stella Sellers&#8217; BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test and certain clinical assets, including all intellectual property rights (the &#8220;Stella Purchased Assets&#8221;). All capitalized terms used in this section to describe this transaction but not defined herein shall have the meanings set forth in the Stella Purchase Agreement, </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As consideration for the Stella Purchased Assets, at closing, the Company (i) paid to the Stella Sellers $3.5 million in cash, minus (a) the Secured Note Amount of $0.5 million, (b) the Liability Payoff Amount of $1.6 million and (c) the Promissory Note Payoff Amount of $400,000, and (ii) issued to Stella DX 100,000 shares of common stock, par value $0.0005 per share, of the Company at a value of $10.00 per share. Total consideration paid was $4.6 million. The Secured Note Amount of $0.5 million and the Promissory Note Payoff of $400,000 were paid in 2022. The balance of the consideration was paid at closing during the year ended December&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition to the consideration paid at closing, the Company will issue shares of common stock valued at $2.0 million (the &#8220;Milestone Stock&#8221;) to the Stella Sellers upon a Commercialization Event (as defined in the Stella Purchase Agreement). The Milestone Stock was recorded at closing as a non-current liability at its fair value of $2.0 million. Also, the Company is required to pay to the Stella Sellers for each of the seven calendar years during the seven years period commencing on the first day of the calendar year following the date of the Commercialization Event, a non-refundable, non-creditable royalty of 5% of the Adjusted Gross Margin for such Annual Period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The asset purchase does not qualify as a business combination under FASB ASC 805, Business Combinations, and has therefore been accounted for as an asset acquisition. In connection with the Stella Purchased Assets, the Company incurred $0.2 million in transaction costs, which were capitalized into the purchase price of the Stella Purchased Assets. The total purchase price for the Stella Purchased Assets was $6.8&#160;million, which was allocated to the proprietary technology intangible asset acquired. The Company is amortizing the acquired intangible asset on a straight-line basis over its estimated useful life of five years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272823851328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets, Net</a></td>
<td class="text">Intangible Assets, Net<div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, the Company acquired intangible assets of $6.8 million included with proprietary intellectual property, in connection with the acquisition of the Stella Purchased Assets. See Note 3.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets as of December&#160;31, 2023 and 2022 consisted of the following (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Estimated Useful<br/>Life (in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Trade names</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Proprietary intellectual property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">CLIA license</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">19,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(3,822)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,475&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for acquired intangible assets was $2.9 million and $2.4 million during the years ended December&#160;31, 2023 and 2022, respectively. The estimated future amortization expense of acquired intangible assets as of December&#160;31, 2023 is as follows (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year ended December 31, 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year ended December 31, 2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,583&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year ended December 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year ended December 31, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,731&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year ended December 31, 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,815&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-30/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272796549696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">Property, Plant and Equipment<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of property, plant and equipment are as follows (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lesser of lease term or estimated useful life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Building improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10-39 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Machinery</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3-7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lab equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3-7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3-5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,432&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,728&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(11,534)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(8,440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,898&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,288&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for Fiscal 2023 and 2022 were $3.1 million and $2.3 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272796123856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Outstanding Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Outstanding Debt</a></td>
<td class="text">Outstanding Debt<div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Secured Mortgage Loan</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On December 20, 2023, the Company's wholly-owned subsidiary PREH entered into an Open-End Mortgage Agreement (the "Mortgage Agreement"). The Mortgage provided for a loan of $3.3 million (the "Mortgage Loan") with stated maturity date on January 6, 2034, bore a fixed interest rate of 8.25% per annum and required monthly mortgage payments of principal and interest of $25,000. The obligations under the Mortgage Agreement were secured by PREH's  certain real property in Pennsylvania. The Company incurred $341,000 issuance cost, which was recognized as a debt discount and will be amortized using the effective interest method over the term of the Mortgage Loan. The Company retains $540,000 cash in an escrow account which was recognized as a restricted cash on the Company's consolidated balance sheet as of December 31, 2023. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Unsecured Promissory Note Payable</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 26, 2023, the Company issued an unsecured promissory note (the &#8220;2023 Note&#8221;) and guaranty for an aggregate principal amount of $7.6 million. The 2023 Note is due and payable on January 27, 2026, the third anniversary of the date on which the 2023 Note was funded (the &#8220;Closing Date&#8221;), and accrues interest at a rate of 10% per year from the Closing Date, payable on a quarterly basis, until the 2023 Note is repaid in full. The Company has the right to prepay the 2023 Note at any time after the Closing Date and prior to the maturity date without premium or penalty upon providing seven days&#8217; written notice to the note holder. Repayment of the 2023 Note has been guaranteed by the Company&#8217;s wholly-owned subsidiary, Pharmaloz Manufacturing, Inc. In addition to the 2023 Note, the Company issued warrants to purchase 76,000 shares of the Company's common stock at an exercise price of $9.00 for a term of 5 years, vesting immediately. The warrants were valued at $0.4 million fair value, using the Black-Scholes option pricing model to calculate the grant date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of 81.5%, risk free interest rate of 3.62% and expected warrant life of 5 years. The relative fair value of the warrant was $0.4 million and was recorded as a discount to the note payable in accordance with FASB ASC 835-30-25, Recognition, and is being accreted over the term of the note payable for financial statement purposes. As of December&#160;31, 2023, the unpaid principal balance of the 2023 Note was $7.3 million, net of debt discount of $0.3 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Unsecured Convertible Notes Payable</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;15, 2020, the Company issued two unsecured, partially convertible, promissory notes (the &#8220;September 2020 Notes&#8221;) for an aggregate principal amount of $10.0 million to two investors (collectively, the &#8220;Lenders&#8221;).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;28, 2022, the Company entered into a letter agreement (the &#8220;Letter Agreement&#8221;) with one of the Lenders providing for the payoff of its September 2020 Note in the principal amount of $2.0 million.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the Letter Agreement, (i) the Lender converted $0.6 million of the principal amount due to him under his September 2020 Note into 200,000 shares of Company common stock (the &#8220;Conversion Shares&#8221;) at a price of $3.00 per share as provided for under the terms of the September 2020 Note (the &#8220;Conversion&#8221;), (ii) the Company paid to the Lender $1.4 million in cash, representing $1.4 million of the remaining principal under the September 2020 Note following the Conversion plus $41,000 in accrued and outstanding interest under the September 2020 Note, and (iii) the Company repurchased the Conversion Shares at a price of $5.75 per share for an aggregate amount of $1.2 million (for a total aggregate payment to the Lender of $2.6 million).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, the Company paid the remaining Lender </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$5.6 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in principal on the remaining September 2020 Note. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 10, 2023, the Lender converted the remaining </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2.4 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> principal into 800,000 shares of the Company's common stock. The September 2020 Note was settled in full as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2023 and 2022, the Company incurred $0.8 million and $0.8 million, respectively, in interest expense under the September 2020 Notes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272703406112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders&#8217; Equity</a></td>
<td class="text">Stockholders&#8217; Equity<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our authorized capital stock consists of 50 million shares of common stock, $0.0005 par value, and one million shares of preferred stock, $0.0005 par value.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preferred stock authorized under the Company's certificate of incorporation may be issued from time to time in one or more series. As of December&#160;31, 2023, no shares of preferred stock have been issued. The Company's board of directors have the full authority permitted by law to establish, without further stockholder approval, one or more series of preferred stock and the number of shares constituting each such series and to fix by resolution voting powers, preferences and relative, participating, optional and other special rights of each series of preferred stock, and the qualifications, limitations or restrictions thereof, if any. Subject to the limitation on the total number of shares of preferred stock that the Company has authority to issue under its certificate of incorporation, the board of directors is also authorized to increase or decrease the number of shares of any series, subsequent to the issue of that series, but not below the number of shares of such series then-outstanding. In case the number of shares of any series is so decreased, the shares constituting such decrease will resume the status that they had prior to the adoption of the resolution originally fixing the number of shares of such series. The Company may, subject to any required stockholder approval, amend from time to time its certificate of incorporation to increase the number of authorized shares of preferred stock or common stock or to make other changes or additions to our capital structure or the terms of our capital stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Dividends </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No dividends have been declared during the year ended December&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 9, 2022, the board of directors of the Company declared a special cash dividend of $0.30 per share on the Company&#8217;s common stock, paid on June 4, 2022, in the amount of $4.7 million to holders of record of the Company&#8217;s common stock as of May 25, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2022, the board of directors of the Company declared a special cash dividend of $0.30 per share on the Company&#8217;s common stock, paid on March 10, 2022, in the amount of $4.6 million to holders of record of the Company&#8217;s common stock on March 1, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Repurchase Program</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 15, 2023, the Company announced that its board of directors had approved a new stock repurchase program. Under the stock repurchase program, the Company is authorized to repurchase up to $6.0 million of its outstanding shares of common stock from time to time, over a nine-month period. The number of shares to be repurchased and the timing of the repurchases, if any, will depend on a number of factors, including, but not limited to, price, trading volume and general market conditions, along with the Company&#8217;s working capital requirements and general business conditions. The board of directors will re-evaluate the program from time to time and may authorize adjustments to its terms.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Commencement Date (as defined in the stock repurchase agreement), and for a period of nine months thereafter, repurchases may be made through open market transactions (based on prevailing market prices), privately negotiated transactions, block trades, or any combination thereof, in accordance with applicable federal securities laws, including Rule 10b-18 of the Securities Exchange Act of 1934, as amended.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 26, 2022, the Company announced that its board of directors had approved new stock repurchase programs. Under each of the stock repurchase programs, the Company was authorized to repurchase up to $6.0 million of its outstanding shares of common stock from time to time, over a six-month period. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company repurchased 69,628 and 303,145 shares during the years ended December&#160;31, 2023 and 2022, respectively, pursuant to the stock repurchase programs for an aggregate amount of $0.6 million and $2.2 million respectively, including commissions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The 2022 Directors' Equity Compensation Plan</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On May 19, 2022, the stockholders of the Company approved the 2022 Directors&#8217; Equity Compensation Plan (the &#8220;2022 Directors&#8217; Plan&#8221;) at the 2022 Annual Meeting of Stockholders of the Company (the &#8220;2022 Annual Meeting&#8221;). The 2022 Directors&#8217; Plan amended and restated the Company&#8217;s Amended and Restated 2010 Directors&#8217; Equity Compensation Plan and provided for an increase in the number of shares reserved for issuance under the plan by 300,000 shares and for the adjustment of the per share exercise price of stock options granted under the 2022 Plan in the event of any change in the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">outstanding shares of common stock of the Company as a result of, among other things, any distribution or special dividend to stockholders of shares, cash or other property (other than regular cash dividends).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 16, 2023, the stockholders of the Company approved the Amended and Restated 2022 Directors&#8217; Equity Compensation Plan (the &#8220;Amended 2022 Directors&#8217; Plan&#8221;) at the 2023 Annual Meeting of Stockholders of the Company. The Amended 2022 Directors&#8217; Plan provides for an increase in the number of shares reserved for issuance under such plan by 150,000 shares.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company issued 120,000 and 120,000 options issued under this plan during the year ended December&#160;31, 2023 and 2022, respectively. As of December&#160;31, 2023, there were 210,000 shares of common stock available to be issued under the 2022 Directors&#8217; Plan. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The 2010 Directors&#8217; Equity Compensation Plan</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 20, 2021, the stockholders of the Company approved the Amended and Restated 2010 Directors&#8217; Equity Compensation Plan (the &#8220;Amended 2010 Directors&#8217; Plan&#8221;) at the 2021 annual meeting of stockholders of the Company (the "2021 Annual Meeting"). The Amended 2010 Directors&#8217; Plan authorizes the issuance of up to 775,000 shares of common stock. This plan was amended and restated on April 11, 2022 (to become the 2022 Directors' Plan), subject to stockholder approval, which was obtained at the 2022 Annual Meeting.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The 2022 Equity Compensation Plan</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 19, 2022, the stockholders of the Company approved the 2022 Equity Compensation Plan (the &#8220;2022 Plan&#8221;) at the 2022 Annual Meeting. The 2022 Plan amended and restated the Company&#8217;s Amended and Restated 2010 Equity Compensation Plan and provides for an increase in the number of shares reserved for issuance under the plan by 1,000,000 shares and provides for the adjustment of the per share exercise price of stock options granted under the 2022 Plan in the event of any change in the outstanding shares of common stock of the Company as a result of, among other things, any distribution or special dividend to stockholders of shares, cash or other property (other than regular cash dividends).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 16, 2023, the stockholders of the Company approved the Amended and Restated 2022 Equity Compensation Plan (the &#8220;Amended 2022 Plan&#8221;) at the 2023 Annual Meeting of Stockholders of the Company. The Amended 2022 Plan provides for an increase in the number of shares reserved for issuance under such plan by 700,000 shares.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, there were 1,093,285 shares of common stock available to be issued under the 2022 Plan. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The 2010 Equity Compensation Plan</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 20, 2021, the stockholders of the Company approved the Amended and Restated 2010 Equity Compensation Plan (the &#8220;Amended 2010 Plan&#8221;) at the 2021 Annual Meeting. The Amended 2010 Plan authorized the issuance of up to 4,900,000 shares of common stock. This plan was amended and restated on April 11, 2022 (to become the 2022 Plan), subject to stockholder approval, which was obtained at the 2022 Annual Meeting.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The 2018 Stock Incentive Plan</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2018, the Company's stockholders approved the 2018 Stock Incentive Plan (the &#8220;2018 Stock Plan&#8221;). The 2018 Stock Plan provides for the grant of incentive stock options to eligible employees of the Company, and for the grant of non-statutory stock options to eligible employees, directors and consultants. The purpose of the 2018 Stock Plan is to advance the interests of the Company and its stockholders by providing an incentive to attract, retain, and reward persons performing services for the Company and by motivating such persons to contribute to the growth and profitability of the Company. The 2018 Stock Plan provides that the total number of shares that may be issued pursuant to the 2018 Stock Plan is 2,300,000 shares. At April 12, 2018, all 2,300,000 shares had been granted in the form of stock options to Ted Karkus (the &#8220;CEO Option&#8221;), the Company's Chief Executive Officer.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Stock Plan required certain proportionate adjustments to be made to the stock options granted under the 2018 Stock Plan upon the occurrence of certain events, including a special distribution (whether in the form of cash, shares, other securities, or other property) in order to maintain parity. Accordingly, the Compensation Committee of the board of directors, as required by the terms of the 2018 Stock Plan, adjusted the exercise price of the CEO Option in connection </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with each special cash dividend paid by the Company proportionately to the amount of the dividend paid. The final exercise price of the CEO Option was $0.60 per share after the latest special cash dividend paid on June 3, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023 and 2022, 1,100,000 and 1,200,000 stock options were exercised under the 2018 Stock Plan. No share based compensation expense will be recognized in forward periods related to the 2018 Stock Plan.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inducement Option Awards</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no issuances of inducements awards during the year ended December&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 9, 2022, the Company issued a non-qualified stock option to the prospective Chief Financial Officer of the Company (the &#8220;CFO&#8221;), as an inducement to his employment with the Company, effective May 23, 2022 (the &#8220;CFO Award&#8221;). The CFO Award entitled the CFO to purchase up to 400,000 shares of the Company&#8217;s common stock at an exercise price of $6.74 per share, the closing price of the Company&#8217;s common stock on May 9, 2022. The CFO Award provided for certain proportionate adjustments to be made in the event of any change in the outstanding shares of common stock of the Company as a result of, among other things, any distribution or special dividend to stockholders of shares, cash or other property (other than regular cash dividends) in order to maintain parity. The exercise price of the CFO Award was reduced from $6.74 to $6.44 per share, effective as of June 3, 2022, the date $0.30 special cash dividend was paid to Company&#8217;s stockholders. The grant date fair value of the CFO Award was approximately $1.6 million. In connection with CFO&#8217;s separation from service on October 4, 2022, these options were forfeited on October 4, 2022.  The Company reversed $149,000 of stock based compensation expense previously recognized for the unvested options at the time of forfeiture.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year ended December 31, 2022, the Company issued an inducement award to a prospective employee to purchase up to 250,000 shares of the Company&#8217;s common stock at an exercise price of $13.00, the closing price of the common stock on the date of grant. The award vested 50% on the date of grant and the remaining portion will vest 25% per year for the next two years. The award expires on the <span style="-sec-ix-hidden:f-688">seven</span>th anniversary of the grant date.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All inducement awards have been granted outside of the Company&#8217;s equity compensation plans pursuant to Nasdaq Listing Rule 5635(c)(4).</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of all option grants  </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock options activity during Fiscal 2023 and 2022 (in thousands, except per share data).</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Number of Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Weighted Average Remaining Contractual Life (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,110</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.27&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,820&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,095</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,833)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(420)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,952</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.35&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,379&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,135</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,348)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(788)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,951</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.30&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">693&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Options vested and exercisable</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,880</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.69&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">693&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the closing stock price of $4.52 and $9.63 for the Company&#8217;s common stock on December&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2023, certain holders of stock options elected to exercise their stock options pursuant to a cashless exercise provision resulting in the net issuance of 603,881 shares of common stock and the return of 744,369 shares to the Company. The Company also made a cash payment of approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$5.4 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to repurchase 603,881 shares of treasury stock to satisfy tax withholding obligations related to the cashless exercise of these stock options.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December 31, 2022, we issued 828,021 shares of common stock through a cashless exercise of 1,833,000 options.  In connection with the cashless exercise, the company repurchased 1,103,000 common stock at a cost of $7.5 million to satisfy tax withholding.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023 and 2022, the Company granted options to purchase 1,135,000 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,095,000 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares of the Company&#8217;s common stock to various employees and consultants, respectively. The options grant date fair value was valued at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$4.2 million and $6.1 million during the year ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2023 and 2022, using the Black-Scholes option pricing model to calculate the grant-date fair value of the options. The fair value of stock options for employees are expensed over the vesting term in accordance with the terms of the related stock option agreements and are expensed over the terms of the consulting agreement for consultants.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes weighted average assumptions used in determining the fair value of the stock options at the date of grant during Fiscal 2023 and 2022:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercise price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8.65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.03&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Risk-free rate of interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected dividend yield (per share)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected stock price volatility is based on the Company&#8217;s historical common stock trading prices and the expected term is based on the period that the Company&#8217;s stock-based awards are expected to be outstanding based on the simplified method.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on Stock Warrants </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2023, the Company issued warrants to an advisory firm to purchase 50,000 shares of the Company's common stock at an exercise price of $10.00 for a term of 5 years, vesting immediately. The warrants were valued at $0.3&#160;million fair value, using the Black-Scholes option pricing model to calculate the grant date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of 80.9%, risk free interest rate of 3.5% and expected warrant life of 5 years. These warrants were expensed over the 1 year term of the engagement which ended on December 31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 27, 2023, the Company issued five-year warrants to purchase 76,000 shares of the Company's common stock with the unsecured promissory note (see Note 6).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2023, the Company issued warrants to a consultant to purchase 250,000 shares of the Company's common stock at an exercise price of $9.00 for a term of 5 years, vesting immediately.  The warrants were valued at $1.4&#160;million, using the Black-Scholes option pricing model to calculate the grant date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of 80.4%, risk free interest rate of 3.6% and expected warrant life of 5 years, which was initially recognized as a prepaid expense and to be expensed over the term of the consulting agreement. As of December 31, 2023, $5.1&#160;million was remained in the prepaid expense and other current assets on the consolidated balance sheet.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between August and September 2023, the Company received $1.2&#160;million from the exercise of outstanding warrants with an exercise price at $3.00 per share. The Company issued approximately 400,000 shares of common stock upon these warrant exercises.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, there were no stock warrants issued.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes warrant activities during Fiscal 2023 and 2022 (in thousands, except per share data):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Number of Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average<br/>Remaining Contractual<br/>Life <br/>(in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">855</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8.23&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">855</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8.23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">831</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11.16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants vested and exercisable</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">831</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11.16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.9</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized $3.5&#160;million of share-based compensation expense during the year ended December&#160;31, 2023. The Company will recognize an aggregate of approximately $5.1&#160;million of remaining share-based compensation expense related to outstanding stock options and warrants over a weighted average period of 4.3 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272703384768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Defined Contribution Plans</a></td>
<td class="text">Defined Contribution Plans<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains the ProPhase Labs, Inc. 401(k) Savings and Retirement Plan, a defined contribution plan for its employees. The Company's contributions to the plan are based on the amount of the employee plan contributions and compensation. The Company's contributions to the plan for the years ended December&#160;31, 2023 and 2022 were $0.2 million and $0.2 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//715/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480126/715-20-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272710185712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the provision (benefit) for income taxes, in the consolidated statements of operations are as follows (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.818%"><tr><td style="width:1.0%"></td><td style="width:65.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.018%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.334%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Continuing Operations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,056&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,583&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(5,459)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,615)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(210)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(7,074)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(138)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income taxes from continuing operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,018)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,445&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the statutory federal income tax expense (benefit) to the effective tax is as follows (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.507%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Statutory Rate - federal</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4,788)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,811&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">State taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research &amp; development tax credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(350)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Permanent differences and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(601)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income taxes from continuing operations before valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(5,761)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,799&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(257)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,354)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income tax expense (benefit)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,018)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,445&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,018)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,445&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of the primary &#8220;temporary differences&#8221; between values recorded for assets and liabilities for financial reporting purposes and values utilized for measurement in accordance with tax laws giving rise to our deferred tax assets are as follows (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net operating loss and capital loss carryforward</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,649&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,324&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Right of use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,464)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,466)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Capital lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(479)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(705)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,612)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2,703)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Tax credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(567)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,313&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(224)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes tax assets and liabilities for the future tax consequences related to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and for net operating loss carryforwards. Management evaluated the deferred tax assets for recoverability using a consistent approach that considers the relative impact of negative and positive evidence, including historical profitability and projections of future reversals of temporary differences and future taxable income. The Company is required to establish a valuation allowance for deferred tax assets if management determines, based on available evidence at the time the determination is made, that it is not more likely than not that some portion or all of the deferred tax assets will be realized.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As of December&#160;31, 2023, the Company is in a net deferred tax asset position for federal and state jurisdictions. Based on a three-year cumulative income position and anticipated future taxable income, the Company concluded that the federal and combined state deferred tax assets will be realized and there is no need for a valuation allowance at this time. The Company will continue to monitor the need for any valuation allowance changes on a quarterly basis.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company continues to maintain a valuation allowance against some of the separate company state net operating loss ("NOL") carryforwards. As of December 31, 2023 there is a valuation allowance of $0.6&#160;million compared to $0.8&#160;million as of December 31, 2022. As of December 31, 2023, the Company has state NOL carryforwards of $1.5&#160;million, which begin to expire in 2024 and federal NOL carryforwards of $3.1&#160;million as well as an R&amp;D tax credit carryforward of $0.3&#160;million which can be carried forward indefinitely. A portion of the federal NOL is attributable to 2021 Nebula acquisition, and it is Section 382 limited with an annual limitation of $0.3&#160;million.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files a consolidated federal income tax return and separate company state returns as well as combined state returns where applicable.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272796556448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Current Liabilities</a></td>
<td class="text">Other Current Liabilities<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of other current liabilities at December&#160;31, 2023 and 2022, respectively (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued diagnostic services commissions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,093&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued payroll</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued bonus</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued benefits and vacation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total other current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,072&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272703341600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Manufacturing Agreement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its wholly owned subsidiary, PMI, entered into a manufacturing agreement (the &#8220;Manufacturing Agreement&#8221;) with Mylan Consumer Healthcare Inc. (&#8220;MCH&#8221;) and Mylan Inc. (together with MCH, &#8220;Mylan&#8221; in connection with the asset purchase agreement we entered into with Mylan in 2017. Pursuant to the terms of the Manufacturing Agreement, Mylan (or an affiliate or designee) purchased the inventory of the Company&#8217;s Cold-EEZE&#174; brand and product line, and PMI agreed to manufacture certain products for Mylan, as described in the Manufacturing Agreement, at prices that reflect current market conditions for such products and include an agreed upon mark-up on our costs. On May 1, 2021, the Manufacturing Agreement was assigned by Mylan to Nurya Brands, Inc. (&#8220;Nurya&#8221;) in connection with Nurya&#8217;s acquisitions of certain assets from Mylan, including the Cold-EEZE&#174; brand and product line. Unless terminated sooner by the parties, the Manufacturing Agreement was to remain in effect until March 29, 2023. Thereafter, the Manufacturing Agreement could be renewed by Nurya for up to four successive one-year periods by providing notice of its intent to renew not less than 90 days prior to the expiration of the then-current term.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On November 15, 2022, the Company was notified by Nurya of its election to renew the Manufacturing agreement for one year. As a result, the Manufacturing Agreement will remain in effect until March 29, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">License Agreements</span></div><div style="text-align:justify;text-indent:32.39pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Linebacker LB1 and LB2</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:32.39pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In July 19, 2022, the Company through its wholly-owned subsidiary ProPhase BioPharma entered into a License Agreement (the &#8220;Linebacker License Agreement&#8221;) with Global BioLife, Inc. (the &#8220;Licensor&#8221;), with an effective date of July 18, 2022 (the &#8220;Linebacker Effective Date&#8221;), pursuant to which it acquired from Licensor a worldwide exclusive right and license under certain patents identified in the Linebacker License Agreement (the &#8220;Licensed Patents&#8221;) and know-how (collectively, the &#8220;Licensed IP&#8221;) to exploit any compound covered by the Licensed Patents (the &#8220;Licensed Compound&#8221;), including Linebacker LB1 and LB2, and any product comprising or containing a Licensed Compound (&#8220;Licensed Products&#8221;) in the treatment of cancer, inflammatory diseases or symptoms, memory-related syndromes, diseases or symptoms including dementia and Alzheimer&#8217;s Disease (the &#8220;Field&#8221;). Under the terms of the Linebacker License Agreement, the Licensor reserves the right, solely for itself and for GRDG Sciences, LLC (&#8220;GRDG&#8221;) to use the Licensed Compound and Licensed IP solely for research purposes inside the Field and for any purpose outside the Field.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:32.39pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Subject to certain conditions set forth in the Linebacker License Agreement, the Company may grant sublicenses (including the right to grant further sublicenses) to its rights under the Linebacker License Agreement to any of its affiliates or any third party with the prior written consent of Licensor, which consent may not be unreasonably withheld. Either party to the Linebacker License Agreement may assign its rights under the Linebacker License Agreement (i) in connection with the sale or transfer of all or substantially all of its assets to a third party, (b) in the event of a merger or consolidation with a third party or (iii) to an affiliate; in each case contingent upon the assignee assuming in writing all of the obligations of its assignor under the Linebacker License Agreement.</span></div><div style="text-align:justify;text-indent:32.39pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the terms of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Linebacker </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">License Agreement, the Company is required to pay to Licensor a one-time upfront license fee of $50,000 within ten days of the Linebacker Effective Date and must pay an additional $900,000 following the achievement of a first Phase 3 study which may be required by FDA for the first Licensed Product and an additional </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$1.0&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> upon the receipt of regulatory approval of a New Drug Application for the first Licensed Product.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:32.39pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the term of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Linebacker </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">License Agreement, the Company is also required to pay to Licensor 3% royalties on Net Revenue (as defined in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Linebacker</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> License Agreement) of each Licensed Product, but no less than the minimum royalty of $250,000 of Net Revenue per year minus any royalty payments for any required third party licenses.</span></div><div><span><br/></span></div><div style="text-indent:32.39pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In connection with the Linebacker License Agreement, the Company has incurred approximately $0.6&#160;million and  $0.5&#160;million  in general and administrative expenses that are included in the Consolidated Statements of Operations and Comprehensive Income (Loss) for the year ended December 31, 2023 and 2022, respectively. No clinical studies have begun under this agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Equivir</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In March 2023, we commenced patient enrollment in a randomized, placebo-controlled clinical trial of Equivir to evaluate its effect on upper respiratory tract infections. Vedic Lifesciences, a leading clinical research organization, is contracted to conduct the combination prophylactic and therapeutic study, which will be conducted at 8 sites. We currently anticipate trial completion in the third quarter of 2024 and anticipate launching Equivir (dietary supplement) in the United States toward the end of 2024.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the license agreement relating to Equivir, for the year ended December 31, 2023, the Company has incurred approximately and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$0.4 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in general and administrative expenses that are included in the Consolidated Statements of Operations and Comprehensive Income (Loss) for the year ended ended December 31, 2023. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">BE-Smart Esophageal Pre-Cancer Diagnostics Screening Test</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In March 2023, and in connection with the Asset acquisition of Stella,, we announced a collaboration for the continued development of its BE-Smart Esophageal Pre-Cancer diagnostic screening test. We are pursuing initial commercialization of the BE-Smart test as an LDT (Laboratory Developed Test) and RUO (Research Use Only) for the third quarter of 2025 with full commercialization backed by insurance expected by the third quarter of 2025.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the license agreement relating to BE-Smart License Agreement, for the year ended December 31, 2023, the Company has incurred approximately and $0.3&#160;million in general and administrative expenses that are included in the Consolidated Statements of Operations and Comprehensive Income (Loss) for the year ended ended December 31, 2023. No clinical studies have begun under this agreement.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of our business, we may be named as a defendant in legal proceedings. It is our policy to vigorously defend litigation or to enter into a reasonable settlement where management deems it appropriate.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272705216592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Jersey Laboratory Lease</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;23, 2020, the Company completed the acquisition of CPM, which included the acquisition of a 4,000 square foot CLIA accredited laboratory located in Old Bridge, New Jersey, which was owned by CPM (which is now known as ProPhase Diagnostics NJ, Inc.). The lease was renewed in February 2023, for an additional 36 months until February 2026. The monthly base rent remains the same at $5,500 per month. The lease renewal resulted in the recognition of an additional right-of-use asset and operating lease liability of $170,000 during the year ended December&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New York Second Floor Lease</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 8, 2020, the Company entered into a Lease Agreement (the &#8220;NY Second Floor Lease&#8221;) with BRG Office L.L.C. and Unit 2 Associates L.L.C. (the &#8220;Landlord&#8221;), pursuant to which the Company leases certain premises located on the second floor (the &#8220;Second Floor Leased Premises&#8221;) of 711 Stewart Avenue, Garden City, New York (the &#8220;Building&#8221;). The Second Floor Leased Premises serve as the Company&#8217;s second location and corporate headquarters, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">offering a wide range of laboratory testing services for diagnosis, screening and evaluation of diseases, including COVID-19 and Respiratory Pathogen Panel Molecular tests.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NY Second Floor Lease was effective as of December&#160;8, 2020, and commenced in January 2021 (the &#8220;Commencement Date&#8221;) when the facility was made available to us by the landlord. The initial term of the NY Lease is 10 years and 7 months (the &#8220;Initial Term&#8221;), unless sooner terminated as provided in the NY Lease. The Company may extend the term of the NY Lease for one additional option period of five years. The Company has the option to terminate the NY Lease on the sixth anniversary of the Commencement Date, provided that it gives the landlord written notice not less than nine months and not more than 12 months in advance and that we pay the landlord a termination fee.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2022, the Company entered into a First Amendment to the NY Second Floor Lease (the &#8220;Second Floor Lease Amendment&#8221;). The Second Floor Lease Amendment amends the NY Second Floor Lease to provide that any uncured default by the Company or any of its affiliate under the NY First Floor Lease (defined below) will constitute a default by the Company under the NY Second Floor Lease.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New York First Floor Lease</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;10, 2022, the Company entered into a second Lease Agreement (the &#8220;NY First Floor Lease&#8221;) with Landlord, pursuant to which the Company leases approximately 4,516 sq. feet located on the first floor (the &#8220;NY First Floor Leased Premises&#8221;) of the building. As described above, the Company currently leases space on the second floor of the building. The First Floor Leased Premises will be used to expand the Company&#8217;s in-house lab capabilities to include traditional clinical testing across multiple specialty areas and Next Generation Sequencing (NGS) to perform Whole Genome Sequencing (WGS) and an array of genetic diagnostic test offerings for both clinical and research purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The NY First Floor Lease became effective as of June 10, 2022 and will commence upon the date of the Landlord&#8217;s substantial completion of certain improvements to the NY First Floor Leased Premises (the &#8220;First Floor Commencement Date&#8221;), as set forth in the NY First Floor Lease, targeted to be approximately five months from the execution of the NY First Floor Lease. The initial term of the NY First Floor Lease will expire on July 15, 2031, unless</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">sooner terminated as provided in the NY First Floor Lease. The Company may extend the term of the NY First Floor Lease for one additional option period of five years pursuant to the terms described in the NY First Floor Lease. The Company has the option to terminate the NY First Floor Lease effective July 31, 2027 (the &#8220;Early Termination Date&#8221;), provided the Company gives the Landlord written notice not less than nine months and not more than 12 months prior to the Early Termination Date and pays the Landlord a termination fee as more particularly described in the Lease.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the first year of the NY First Floor Lease, the Company will pay a base rent of $11,290 per month (subject to an eight month abatement period), with a gradual rental rate increase of approximately 2.75% for each twelve month period thereafter, culminating in a monthly base rent of $14,026 during the final months of the initial term of the NY First Floor Lease. In addition to the monthly base rent, the Company is responsible for its proportionate share of real estate tax escalations in accordance with the terms of the NY First Floor Lease. The Landlord will provide a construction allowance to the Company in an aggregate amount not to exceed $203,000, to reimburse the Company for the cost of certain improvements to be made by the Company to the First Floor Leased Premises. During the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">December&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, the Company recognized additional </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$0.8 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> right-of-use asset and operating lease liability for the NY First Floor Lease.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2023 and 2022, the Company had operating lease liabilities for the New York and New Jersey leases of approximately $5.2 million and $4.6 million, respectively, and right of use assets of approximately $4.6 million and $4.1 million, respectively, which were included in the consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finance Leases</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 19, 2023, the Company entered into a master lease agreement for a laboratory equipment (the "First Equipment Lease") with a vendor. The First Equipment Lease has a 5-year term and is recognized as a finance lease under ASC 842.  The present value of the minimum future obligations of $1.5 million was calculated based on an interest rate of 8.0%, which was recognized in finance lease liabilities in the consolidated balance sheet. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 21, 2023, the Company entered into a master lease agreement for a laboratory equipment (the "Second Equipment Lease") with a vendor. The Second Equipment Lease has a 4-year term and is recognized as a finance lease </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">under ASC 842.  The present value of the minimum future obligations of $5.1 million was calculated based on an interest rate of 7.4%, which was recognized in finance lease liabilities in the condensed consolidated balance sheet. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 26, 2023, the Company entered into a master lease agreement for a laboratory equipment (the "Third Equipment Lease") with a vendor. The Third Equipment Lease has a 3-year term starting on the commencement date. The commencement date is when the equipment is shipped and installed, then the Company will provide Final Acceptance Certificate to the vendor. As of December&#160;31, 2023, the commencement date was not established, therefore, there was no fixed assets or finance lease liability recognized in the condensed consolidated balance sheet. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Depreciation and interest expense related to the Equipment Lease was $760,000 for the year ended December 31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes quantitative information about the Company's operating and finance leases (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Variable lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">956&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Finance leases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest lease cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total finance lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other information related to the Company&#8217;s leases is shown below (dollar amounts in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the Years Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating cash flows used in operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(839)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(774)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"></td><td style="width:67.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.729%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted-average remaining lease term &#8211; operating leases (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8.5</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term &#8211; finance leases (in years)</span></td><td colspan="3" style="padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;NA </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted-average discount rate &#8211; operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate &#8211; finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease asset (1)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">NA</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) As of December&#160;31, 2023, the Company had recorded accumulated depreciation of approximately $760,000 for the finance lease asset. Finance lease assets are recorded within <span style="-sec-ix-hidden:f-939">property and equipment, net</span> on the Company&#8217;s condensed consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Minimum lease payments over the remaining lease periods as of December&#160;31, 2023 are as follows (amounts in thousands):</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Jersey Laboratory Lease</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;23, 2020, the Company completed the acquisition of CPM, which included the acquisition of a 4,000 square foot CLIA accredited laboratory located in Old Bridge, New Jersey, which was owned by CPM (which is now known as ProPhase Diagnostics NJ, Inc.). The lease was renewed in February 2023, for an additional 36 months until February 2026. The monthly base rent remains the same at $5,500 per month. The lease renewal resulted in the recognition of an additional right-of-use asset and operating lease liability of $170,000 during the year ended December&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New York Second Floor Lease</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 8, 2020, the Company entered into a Lease Agreement (the &#8220;NY Second Floor Lease&#8221;) with BRG Office L.L.C. and Unit 2 Associates L.L.C. (the &#8220;Landlord&#8221;), pursuant to which the Company leases certain premises located on the second floor (the &#8220;Second Floor Leased Premises&#8221;) of 711 Stewart Avenue, Garden City, New York (the &#8220;Building&#8221;). The Second Floor Leased Premises serve as the Company&#8217;s second location and corporate headquarters, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">offering a wide range of laboratory testing services for diagnosis, screening and evaluation of diseases, including COVID-19 and Respiratory Pathogen Panel Molecular tests.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NY Second Floor Lease was effective as of December&#160;8, 2020, and commenced in January 2021 (the &#8220;Commencement Date&#8221;) when the facility was made available to us by the landlord. The initial term of the NY Lease is 10 years and 7 months (the &#8220;Initial Term&#8221;), unless sooner terminated as provided in the NY Lease. The Company may extend the term of the NY Lease for one additional option period of five years. The Company has the option to terminate the NY Lease on the sixth anniversary of the Commencement Date, provided that it gives the landlord written notice not less than nine months and not more than 12 months in advance and that we pay the landlord a termination fee.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2022, the Company entered into a First Amendment to the NY Second Floor Lease (the &#8220;Second Floor Lease Amendment&#8221;). The Second Floor Lease Amendment amends the NY Second Floor Lease to provide that any uncured default by the Company or any of its affiliate under the NY First Floor Lease (defined below) will constitute a default by the Company under the NY Second Floor Lease.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New York First Floor Lease</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;10, 2022, the Company entered into a second Lease Agreement (the &#8220;NY First Floor Lease&#8221;) with Landlord, pursuant to which the Company leases approximately 4,516 sq. feet located on the first floor (the &#8220;NY First Floor Leased Premises&#8221;) of the building. As described above, the Company currently leases space on the second floor of the building. The First Floor Leased Premises will be used to expand the Company&#8217;s in-house lab capabilities to include traditional clinical testing across multiple specialty areas and Next Generation Sequencing (NGS) to perform Whole Genome Sequencing (WGS) and an array of genetic diagnostic test offerings for both clinical and research purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The NY First Floor Lease became effective as of June 10, 2022 and will commence upon the date of the Landlord&#8217;s substantial completion of certain improvements to the NY First Floor Leased Premises (the &#8220;First Floor Commencement Date&#8221;), as set forth in the NY First Floor Lease, targeted to be approximately five months from the execution of the NY First Floor Lease. The initial term of the NY First Floor Lease will expire on July 15, 2031, unless</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">sooner terminated as provided in the NY First Floor Lease. The Company may extend the term of the NY First Floor Lease for one additional option period of five years pursuant to the terms described in the NY First Floor Lease. The Company has the option to terminate the NY First Floor Lease effective July 31, 2027 (the &#8220;Early Termination Date&#8221;), provided the Company gives the Landlord written notice not less than nine months and not more than 12 months prior to the Early Termination Date and pays the Landlord a termination fee as more particularly described in the Lease.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the first year of the NY First Floor Lease, the Company will pay a base rent of $11,290 per month (subject to an eight month abatement period), with a gradual rental rate increase of approximately 2.75% for each twelve month period thereafter, culminating in a monthly base rent of $14,026 during the final months of the initial term of the NY First Floor Lease. In addition to the monthly base rent, the Company is responsible for its proportionate share of real estate tax escalations in accordance with the terms of the NY First Floor Lease. The Landlord will provide a construction allowance to the Company in an aggregate amount not to exceed $203,000, to reimburse the Company for the cost of certain improvements to be made by the Company to the First Floor Leased Premises. During the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">December&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, the Company recognized additional </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$0.8 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> right-of-use asset and operating lease liability for the NY First Floor Lease.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2023 and 2022, the Company had operating lease liabilities for the New York and New Jersey leases of approximately $5.2 million and $4.6 million, respectively, and right of use assets of approximately $4.6 million and $4.1 million, respectively, which were included in the consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finance Leases</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 19, 2023, the Company entered into a master lease agreement for a laboratory equipment (the "First Equipment Lease") with a vendor. The First Equipment Lease has a 5-year term and is recognized as a finance lease under ASC 842.  The present value of the minimum future obligations of $1.5 million was calculated based on an interest rate of 8.0%, which was recognized in finance lease liabilities in the consolidated balance sheet. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 21, 2023, the Company entered into a master lease agreement for a laboratory equipment (the "Second Equipment Lease") with a vendor. The Second Equipment Lease has a 4-year term and is recognized as a finance lease </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">under ASC 842.  The present value of the minimum future obligations of $5.1 million was calculated based on an interest rate of 7.4%, which was recognized in finance lease liabilities in the condensed consolidated balance sheet. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 26, 2023, the Company entered into a master lease agreement for a laboratory equipment (the "Third Equipment Lease") with a vendor. The Third Equipment Lease has a 3-year term starting on the commencement date. The commencement date is when the equipment is shipped and installed, then the Company will provide Final Acceptance Certificate to the vendor. As of December&#160;31, 2023, the commencement date was not established, therefore, there was no fixed assets or finance lease liability recognized in the condensed consolidated balance sheet. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Depreciation and interest expense related to the Equipment Lease was $760,000 for the year ended December 31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes quantitative information about the Company's operating and finance leases (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Variable lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">956&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Finance leases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest lease cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total finance lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other information related to the Company&#8217;s leases is shown below (dollar amounts in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the Years Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating cash flows used in operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(839)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(774)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"></td><td style="width:67.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.729%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted-average remaining lease term &#8211; operating leases (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8.5</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term &#8211; finance leases (in years)</span></td><td colspan="3" style="padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;NA </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted-average discount rate &#8211; operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate &#8211; finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease asset (1)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">NA</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) As of December&#160;31, 2023, the Company had recorded accumulated depreciation of approximately $760,000 for the finance lease asset. Finance lease assets are recorded within <span style="-sec-ix-hidden:f-939">property and equipment, net</span> on the Company&#8217;s condensed consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Minimum lease payments over the remaining lease periods as of December&#160;31, 2023 are as follows (amounts in thousands):</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272802559952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Customers Concentrations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Significant Customers Concentrations</a></td>
<td class="text">Significant Customers Concentrations<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue for years ended December 31, 2023 and 2022 was $44.4 million and $122.6 million, respectively. Diagnostic Services accounted for 54.9%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 88.3%, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our net revenue for the year ended December&#160;31, 2023 and 2022. The company decreased its diagnostic services business in the second half of 2023 due to the significant decrease in demand for our diagnostic testing services. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2023 &amp; 2022, there were no consumer products customers that accounted for 10% or more of our total revenues.. Collections of diagnostic services revenues are driven by payers, which are government agencies (primarily HRSA), insurance providers, and client payers. For the year ended December 31, 2022, requisitions from each payer group were approximately 29%, 66%, and 5%, respectively. For the year ended December 31, 2023, requisitions from government agencies including Medicaid and Medicare were approximately 17% and insurance providers were 83%.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to account receivable credit concentrations from time-to-time as a result of the timing, payment pattern and ultimate purchase volumes or shipping schedules with our customers. These concentrations may impact its overall exposure to credit risk, either positively or negatively, in that our customers may be similarly affected by changes in economic, regulatory or other conditions that may impact the timing and collectability of amounts due to the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Three diagnostic services payers generated 32.6%, 18.7% and 12.6% of our total reimbursement receivable balances from government agencies and healthcare issuers at December 31 2023. Two diagnostic services payers generated 68.8% and 16.0% of our total reimbursement receivable balances from government agencies and healthcare issuers at December 31, 2022. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, the Company relies on a sole supplier to manufacture its saliva collection kits used by customers who purchase its personal genomics services. Change in the supplier or design of certain of the materials that the Company relies on, in particular the saliva collection kit, could result in a requirement for additional premarket review from the FDA before making such a change.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272796607424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has identified two operating segments, diagnostic services and consumer products, based on the manner in which the Company&#8217;s CEO as CODM assesses performance and allocates resources across the organization. The operating segments are organized in a manner that depicts the difference in revenue generating synergies that include the separate processes, profit generation and growth of each segment. The diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third party payers and government organizations. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provides personal genomics products and services. The unallocated corporate expenses mainly included professional fees associated with the public company.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of segment information for Fiscal 2023, 2022 and 2021 (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.939%"><tr><td style="width:1.0%"></td><td style="width:65.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.981%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">108,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consumer products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">19,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consolidated net revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">44,384&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">122,647&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cost of revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">39,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consumer products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">16,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consolidated cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">28,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">51,993&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Depreciation and amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consumer products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total Depreciation and amortization expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,049&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,542&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Operating and other expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">43,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Income (loss) from operations, before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,804)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">56,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consumer products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(7,493)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(10,824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unallocated corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(13,503)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(22,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total income from operations, before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(22,800)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22,908&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4,445)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Net Income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16,782)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18,463&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of segment information for Fiscal 2023 and Fiscal 2022 (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">44,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">50,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consumer products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unallocated corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">91,927&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">87,648&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272796518288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share (&#8220;EPS&#8221;) excludes dilution and is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or otherwise result in the issuance of common stock that shared in the earnings of the entity. Diluted EPS also utilizes the treasury stock method which prescribes a theoretical buy back of shares from the theoretical proceeds of all options outstanding during the period, and the if-converted method for convertible debt.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the weighted average number of common shares outstanding used in calculating basic and diluted net loss per share (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net (loss) income - basic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16,782)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18,463&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest on unsecured convertible promissory note</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net (loss) income - diluted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16,782)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">19,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average shares outstanding - basic</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,207</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,845</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diluted shares- Stock Options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,493</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diluted shares- Stock Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,073</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unsecured convertible promissory note</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">240</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average shares outstanding - diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,207&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18,651&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the number of securities excluded from the income per share computation as a result of their anti-dilutive effect (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Anti-dilutive securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Common stock purchase warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Stock Options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Anti-dilutive securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,782&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,225&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272703346688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Parties</a></td>
<td class="text">Related Parties<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Executive Vice President and Co-Chief Operations Officer of ProPhase Diagnostics, is a related party to the Company's Chairman and Chief Executive Officer. For the years ended December 31, 2023 and 2022, there were no payments made to the Executive Vice President outside compensation for the position held at the Company.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272703097312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> February&#160;14, 2024, the Company entered into an agreement of sale of future receipts (&#8220;Future Receipts Financing Agreement&#8221;) with Libertas Funding, LLC (&#8220;Libertas&#8221;) by which Libertas purchases from the Company, its future accounts and contract rights arising from the sale of goods or rendition of services to the Company&#8217;s customers. The purchase price was approximate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2.5 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which was paid to the Company on February 16, 2024, net of $50,000 origination fee. The Future Receipts Financing Agreement requires twelve equal payments of $247,000 to be paid monthly for a total repayment of approximate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3.0 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> over the term of the agreement. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated subsequent events through March 28, 2024, which is the date the consolidated financial statements were available to be issued. There were no additional subsequent events that required adjustment to or disclosure in the consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272710468400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no effect on the reported results of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification ("ASC") 280, &#8220;Segment Reporting&#8221; (&#8220;ASC 280&#8221;), the Company discloses financial and descriptive information about its reportable operating segments. Operating segments are components of an enterprise about which separate financial information is available and regularly evaluated by the chief operating decision maker in deciding how to allocate resources and in assessing performance.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows ASC 280, which establishes standards for reporting information about operating segments in annual and interim financial statements, and requires that companies report financial and descriptive information about their reportable segments based on a management approach. ASC 280 also establishes standards for related disclosures about products and services, geographic areas and major customers.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are defined as components of an enterprise that engage in business activities for which separate financial information is available and is evaluated by the Chief Operating Decision Maker (&#8220;CODM&#8221;), which for the Company is its Chief Executive Officer, in deciding how to allocate resources and assess performance. We maintain two operating segments: diagnostic services (which includes our COVID-19 and other diagnostic testing services) and consumer products (which includes our contract manufacturing, retail customers, biopharma and personal genomics products and services). See Note 15 Segment Information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Business and Liquidity Risks and Uncertainties and Concentration of Financial Risks</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business and Liquidity Risks and Uncertainties</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our diagnostic service business continued to be impacted by the level of demand for COVID-19 and other diagnostic testing, the prices we are able to receive for performing our testing services, our ability to collect payment or reimbursement for our testing services in December 31, 2023 and ultimately led to our revenues decreasing significantly for the year ended December 31, 2023. On March 22, 2022, the Health Resources &amp; Services Administration ("HRSA") program stopped accepting claims for COVID-19 testing and treatment provided to uninsured individuals due to lack of sufficient funds. We recognized approximately 1,000,000 tests for the year ended December 31, 2022 and approximately 480,000  tests for the year ended December 31, 2023, of which 28%  were reimbursed by the HRSA uninsured program for the year ended December 31, 2022, and none were reimbursed from the HRSA uninsured program for the year ended December 31, 2023. As a result, we have reduced the amount of diagnostic testing services that we provide since the second half of 2023. Nonetheless we are prepared to provide an increased volume of our diagnostic testing service if diagnostic testing is required due to a new COVID-19 outbreak. We have continued to ship COVID-19 antigen kits under an existing contract to our customer. In addition, in order to maintain licenses in certain states in which we operate, we currently perform several diagnostic tests each quarter to maintain our certified lab status, and we currently plan to do so for the foreseeable future. There is no guarantee that the demand of our diagnostic testing services will increase or meet the level of demand that we experienced during the COVID-19 pandemic, and there is no guarantee that we will be able to substitute the revenues previously generated from this line of business from our other business lines.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our personal genomics business is and will continue to be influenced by demand for our genetic sequencing products and services, our marketing and service capabilities, and our ability to comply with applicable regulatory requirements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our contracting manufacturing business is and will continue to be impacted by demand for our services, which is largely a function of the timing, length and severity of each cold season. Generally, a cold season is defined as the period from September to March when the incidence of the common cold rises as a result of the change in weather and other factors. We generally experience in the first, third and fourth quarter higher levels of net revenues from our contract manufacturing business. Revenues are generally at their lowest levels in the second quarter when customer demand generally declines. This line of business is also impacted by our ability to meet such demands. The building of our manufacturing facilities and manufacturing of products necessitates compliance with applicable regulatory requirements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consumer sales are and will continue to be impacted by (i) the timing of acceptance of our TK Supplements</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consumer products in the marketplace, and (ii) fluctuations in the timing of purchase and the ultimate level of demand for these products. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2023, $11.3&#160;million was used by operating activities.  The Company had cash, cash equivalents, restricted cash and marketable securities of $5.3 million as of December&#160;31, 2023. Based on management&#8217;s current business plans, the Company estimates that it will have enough cash and liquidity to finance its operating requirements for at least one year from the date of filing these financial statements. However, due to the nature of the diagnostic business and the Company's focus thus far on COVID-19, there are inherent uncertainties associated with managements&#8217; business plan and cash flow projections if the Company is unable to grow its diagnostic testing business beyond COVID-19 testing services and to grow its other businesses.</span></div>As such, the Company&#8217;s future capital needs and the adequacy of its available funds will depend on many factors. These include, but not necessarily limited to, the actual cost and time necessary to achieve sustained profitability from diagnostic services, the ability to successfully diversify the diagnostic services revenue streams and the ability to market and grow the personal genomics, biopharma, manufacturing and supplement businesses. The Company may be required to raise additional funds through equity or debt securities offerings or strategic collaboration and/or licensing agreements in order to fund operations until it is able to generate enough revenues. Such financing may not be available on acceptable terms, or at all, and the Company&#8217;s failure to raise capital when needed could have a material adverse effect on its strategic objectives, results of operations and financial condition.<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Financial Risks</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash investments, marketable debt securities, and trade accounts receivable. Our marketable securities are fixed income investments, which are highly liquid and can be readily purchased or sold through established markets.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain cash and cash equivalents with certain major financial institutions. As of December&#160;31, 2023, our cash and cash equivalents and restricted cash balance was $2.1 million. Of the total bank balance, $1.0 million was covered by federal depository insurance and $1.1 million was uninsured at December&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable subject us to credit risk concentrations from time-to-time. We extend credit to our consumer healthcare product customers based upon an evaluation of the customer&#8217;s financial condition and credit history and generally do not require collateral. Our diagnostic services receivable credit risk is based on payer reimbursement experience, which includes government agencies and healthcare insurers, the period the receivables have been outstanding and the historical collection rates. The collectability of the diagnostic services receivables is also directly linked to the quality of our billing processes, which depend on information provided and billing services of third parties. These credit concentrations impact our overall exposure to credit risk, which could be further affected by changes in economic, regulatory or other conditions that may impact the timing and collectability of trade receivables and diagnostic test receivables. Additionally, the reimbursement receivables from the diagnostic service business are subject to billing errors and related disputes.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, see Note 13 - Significant Customers Concentrations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements and the accompanying notes thereto, in conformity with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;), requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the respective reporting periods. Examples include revenue recognition and the impact of the variable consideration around diagnostic test reimbursement rates, the provision for uncollectible receivables and billing errors, sales returns and allowances, rates, slow moving, dated inventory and associated provisions, the estimated useful lives and potential impairment of long-lived assets, stock based compensation valuation, income tax asset valuations and assumptions related to accrued advertising.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimates and assumptions are based on historical experience, current trends and other factors that management believes to be relevant at the time the financial statements are prepared. Management reviews the accounting policies, assumptions, estimates and judgments on a quarterly basis. Actual results could differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all highly liquid investments with a maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents include cash on hand and monies invested in money market funds. The carrying amount approximates the fair market value due to the short-term maturity of these securities.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div>Restricted cash as of December&#160;31, 2023 includes approximately $540,000 held in escrow related to the Company's mortgage loan. There was no restricted cash as of December 31, 2022.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have classified our investments in marketable debt and equity securities as available-for-sale and as a current asset. Our investments in marketable securities are carried at fair value, with unrealized gains and as a separate component of stockholders&#8217; equity. Realized gains and losses from our marketable securities are recorded as interest income (expense). Marketable debt securities carry maturity dates between <span style="-sec-ix-hidden:f-378">one</span> and three years from date of purchase and interest rates of 1.40% to 4.90% during fiscal 2022. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the components of our marketable securities and the underlying fair value input level tier hierarchy (see fair value of financial instruments) (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Unrealized <br/>Losses </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate stock</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(401)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,528&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(401)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrealized <br/>Losses </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">U.S. government obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,186&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,234&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(92)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,328&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the unrealized gains or losses generally are the result of a change in the risk premiums required by market participants rather than an adverse change in cash flows or a fundamental weakness in the credit quality of the issuer or underlying assets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable, net</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable, net</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable consists primarily of amounts due from government agencies and healthcare insurers. Unbilled accounts receivable relates to the delivery of our diagnostic testing services for which the related billings will occur in a future period, after a patient&#8217;s insurance information has been validated, and represent amounts we have an unconditional right to receive payment. Unbilled accounts receivable is classified as accounts receivable on the consolidated balance sheet. We carry our accounts receivable at the amount of consideration for which we expect to be entitled less allowances. When estimating the allowances for our diagnostics business, the Company pools its trade receivables based on the following payer types: healthcare insurers and government payers. The Company principally estimates the allowance for credit losses by pool based on historical collection experience, current economic conditions, expectations of future economic conditions, other credits and the period of time that the receivables have been outstanding. To the extent that any individual payers are identified that have deteriorated in credit quality, the Company removes the payers from their respective pools and establishes allowances based on the individual risk characteristics of such payers. On a periodic basis, we evaluate our receivables and establish an allowance, based on a history of past write-offs, government and healthcare insurer payment trends, collections, current credit conditions or generally accepted future trends. Accounts receivable are stated at the net amount expected to be collected, using an expected loss methodology that is referred to as the current expected credit loss ("CECL") model.</span></div>At December 31, 2023, within the diagnostic services business, insurers had significantly aged balances that we are continuing to work to collect.  The specific facts and circumstances related to each of these individual payors have been considered by our management, which informed the determination of the year-end reserve balance. We continue to pursue collection of amounts due. However, there will inevitably be billings that are rejected by the insurance carriers and associated receivables that will not be collected. We believe that the reserve established at December 31, 2023 is adequate to capture this collectability risk. While past history is helpful informing the determination of an appropriate reserve, its utility is somewhat limited by the circumstances underlying a significant portion of these aged balances; specifically, an unprecedented volume of activity related COVID 19 diagnostic testing.  Accordingly, the determination of an appropriate reserve required significant management judgment and was informed by the unique facts and circumstances related to each of the three significant insurers.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory, net</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory, net</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is valued at the lower of cost, determined on a first-in, first-out basis (&#8220;FIFO&#8221;), or net realizable value. Inventory items are analyzed to determine cost and the net realizable value and appropriate valuation adjustments are established.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2023 and 2022, the components of inventory are as follows (in thousands): </span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services testing material</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">623&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,739&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Finished goods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventory</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,099&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,488&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventory valuation reserve</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(258)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(512)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventory, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,841&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,976&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are recorded at cost. We use the straight-line method in computing depreciation for financial reporting purposes. Depreciation expense is computed in accordance with the following ranges of estimated asset lives: building and improvements - <span style="-sec-ix-hidden:f-443">ten</span> to thirty-nine years; leasehold improvements - lesser of lease term or estimated useful life; machinery and equipment including lab equipment - <span style="-sec-ix-hidden:f-445">three</span> to seven years; computer equipment and software - <span style="-sec-ix-hidden:f-447">three</span> to five years; and furniture and fixtures - five years.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the inception of an arrangement, we determine whether the arrangement is or contains a lease based on the unique facts and circumstances present in the arrangement. Most leases with a term greater than one year are recognized on the balance sheet as right-of-use assets and short-term and long-term lease liabilities, as applicable. We have elected not to recognize on the balance sheet leases with terms of 12 months or less. We typically only include an initial lease term in its assessment of a lease arrangement. Options to renew a lease are not included in our assessment unless there is reasonable certainty that we will renew.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected remaining lease term. Certain adjustments to the right-of-use asset may be required for items such as incentives received. The interest rate implicit in our leases is typically not readily determinable. As a result, we utilize our incremental borrowing rate, which reflects the fixed rate at which we could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term and in a similar economic environment (see Note 12, Leases).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of a lease should be allocated between lease components (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., land, building, etc.) and non-lease components (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., common area maintenance, consumables, etc.). The fixed and in-substance fixed contract consideration (including any consideration related to non-components) must be allocated based on the respective relative fair values to the lease components and non-lease components.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the fair value of the consideration transferred over the fair value of the underlying identifiable assets and liabilities acquired in a business combination. Goodwill and intangible assets deemed to have an indefinite life are not amortized, but instead are assessed for impairment annually. Additionally, if an event or change in circumstances occurs that would more likely than not reduce the fair value of the reporting unit below its carrying value, we would evaluate goodwill and other intangibles at that time.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In testing for goodwill impairment, we have the option to first assess qualitative factors to determine whether the existence of events or circumstances lead to a determination that it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If, after assessing the totality of events and circumstances, we conclude that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is not required. If we conclude otherwise, we are required to perform the two-step impairment test. The goodwill impairment test is performed at the reporting unit level by comparing the estimated fair value of a reporting unit with its respective carrying value. If the estimated fair value exceeds the carrying value, goodwill at the reporting unit level is not impaired. If the estimated fair value is less than the carrying value, an impairment charge will be recorded to </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reduce the reporting unit to fair value. Management completed a qualitative assessment of Goodwill and it was not deemed impaired at December 31, 2023. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets deemed to have finite lives are amortized on a straight-line basis over their estimated useful lives, where the useful life is the period over which the asset is expected to contribute directly, or indirectly, to our future cash flows.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews long-lived assets, including property and equipment and finite-lived intangible assets, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. An impairment loss is recognized when the asset&#8217;s carrying value exceeds the total undiscounted cash flows expected from its use and eventual disposition. The amount of the impairment loss is determined as the excess of the carrying value of the asset over its fair value. For the fiscal years ended December&#160;31, 2023 and 2022, the Company did not have an impairment of the long-lived assets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure assets and liabilities at fair value based on expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale date of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the hierarchical levels of inputs to measure fair value:</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Level 1: Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Level 2: Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Level 3: Unobservable inputs reflecting the Company&#8217;s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of our financial assets and liabilities, such as cash, accounts receivable, accounts payable, and unsecured note payable, approximate their fair values because of the short-term nature of these instruments.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for our marketable securities at fair value, with the net unrealized gains or losses of marketable debt securities reported as a component of accumulated other comprehensive income or loss and marketable equity securities change in fair value reported on the condensed consolidated statement of operations. The components of marketable securities are as follows (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">U.S. government obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,496&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,832&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,328&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers of marketable debt securities between Levels 1, 2 or 3 for the years ended December&#160;31, 2023 and 2022.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue that represents the transfer of promised goods or services to customers at an amount that reflects the consideration that is expected to be received in exchange for those goods or services. We recognize revenue when performance obligations with our customers have been satisfied. At contract inception, we evaluate the contract to determine if revenue should be recognized using the following five steps: (1) identify the contract with the customer; (2) identify the performance obligations; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations; and (5) recognize revenue when (or as) the entity satisfies a performance obligation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract with Customers and Performance Obligations</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account. A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Sales from product shipments to contract manufacturing and retailer customers are recognized at the time ownership is transferred to the customer. Revenue from diagnostic services is recognized when the results are made available to the customer. Revenue from our personal genomics business is recognized when the genetic testing results are provided to the customer. For subscription services associated with our genomic testing, we recognize revenue ratably over the term of the subscription.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s performance obligation for contract manufacturing and retail customers is to provide the goods ordered by the customer. The Company has one performance obligation for its diagnostic services, which is to provide the results of the laboratory test to the customer. Our personal genomics business has separate performance obligations to provide initial testing and genome results and subscriptions services to our customers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction Price </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our diagnostic services business, a revenue transaction is initiated when we receive a requisition order to perform a diagnostic test. The information provided on the requisition form is used to determine the party that will be billed for the testing performed and the expected reimbursement. We provide diagnostic services to a range of customers. In many cases, the customer that orders our services is not responsible for paying for these services. Depending on the billing arrangement and applicable law, the payer may be the patient or a third party, such as a health plan, Medicare or Medicaid program and other government reimbursement programs. We bill the providers at standard price and take into consideration negotiated discounts and anticipated reimbursement remittance adjustments based on the payer portfolio, when revenue is recorded. We use the most expected value method to estimate the transaction price for reimbursements that vary from the listed contract price.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our personal genomics business, a revenue transaction is initiated by a DNA test kit sale direct to the consumer sales via our website or through online retailers. The kit sales and subscriptions are billed at a standard price and take into consideration any discounts when revenue is recorded. We also contract with third party B2B partners and universities and sell DNA test kits directly to them.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contract manufacturing and retail customers, the transaction price is fixed based upon either (i) the terms of a combined master agreement and each related purchase order, or (ii) if there is no master agreement, the price per individual purchase order received from each customer. The customers are invoiced at an agreed upon contractual price for each unit ordered and delivered by the Company.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from retail customers is reduced for trade promotions, estimated sales returns and other allowances in the same period as the related sales are recorded. No such allowance is applicable to our contract manufacturing customers. We estimate potential future product returns and other allowances related to current period revenue. We analyze historical returns, current trends, and changes in customer and consumer demand when evaluating the adequacy of the sales returns and other allowances.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not accept returns from our contract manufacturing customers. Our return policy for retail customers accommodates returns for (i) discontinued products, (ii) store closings and (iii) products that have reached or exceeded their designated expiration date. We do not impose a period of time during which product may be returned. All requests for product returns must be submitted to us for pre-approval. We will not accept return requests pertaining to customer inventory &#8220;Overstocking&#8221; or &#8220;Resets&#8221;. We will accept return requests only for products in their intended package </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">configuration. We reserve the right to terminate shipment of product to customers who have made unauthorized deductions contrary to our return policy or pursue other methods of reimbursement. We compensate the customer for authorized returns by means of a credit applied to amounts owed.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our diagnostic services business, a revenue transaction is initiated when we receive a requisition order to perform a diagnostic test. The information provided on the requisition form is used to determine the party that will be billed for the testing performed and the expected reimbursement. We provide diagnostic services to a range of customers. In many cases, the customer that orders our services is not responsible for paying for these services. Depending on the billing arrangement and applicable law, the payer may be the patient or a third party, such as a health plan, Medicare or Medicaid program and other government reimbursement programs. We bill the providers at standard price and take into consideration negotiated discounts and anticipated reimbursement remittance adjustments based on the payer portfolio, when revenue is recorded. We use the most expected value method to estimate the transaction price for reimbursements that vary from the listed contract price.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our personal genomics business, a revenue transaction is initiated by a DNA test kit sale direct to the consumer sales via our website or through online retailers. The kit sales and subscriptions are billed at a standard price and take into consideration any discounts when revenue is recorded. We also contract with third party B2B partners and universities and sell DNA test kits directly to them.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recognize Revenue When the Company Satisfies a Performance Obligation </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For diagnostic services, the Company satisfies its performance obligation at the point in time that the results are made available to the customer, which is when the customer benefits from the information contained in the results and obtains control.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For genomic services, we satisfy our product performance obligation at a point in time when the genetic testing results are provided to the customer. For subscriptions services associated with its genomic testing, we satisfy our performance obligation ratably over the subscription period. If the customer does not return the test kit, services cannot be completed by us, potentially resulting in unexercised rights (&#8220;breakage&#8221;) revenue, including lifetime subscription services. We estimate breakage for the portion of test kits not expected to be returned using an analysis of historical data and consider other factors that could influence customer test kit return behavior. When breakage revenue is recognized on a kit, we recognize breakage on any associated subscription services ratably over the term of the subscription</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance obligations related to contract manufacturing and retail customers are satisfied at a point in time when the goods are shipped to the customer as (i) we have transferred control of the assets to the customers upon shipping, and (ii) the customer obtains title and assumes the risks and rewards of ownership after the goods are shipped.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and December&#160;31, 2022, we have deferred revenue of $3.5 million and $3.6 million, respectively. Our new personal genomics business comprised $3.4 million of the deferred revenue as of December&#160;31, 2023. The remainder of deferred revenue relates to research and development (&#8220;R&amp;D&#8221;) stability and release testing programs recognized as contract manufacturing revenue. Deferred revenues primarily consist of amounts that have been billed to or received from customers in advance of revenue recognition and prepayments received from customers in advance of services performed for the R&amp;D work. We recognize deferred revenues as revenues when the services are performed and the corresponding revenue recognition criteria are met. Customer prepayments are generally applied against invoices issued to customers when services are performed and billed.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates our deferred revenue by recognition period (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Recognition Period</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0-12 Months</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13-24 Months</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Over 24 Months</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,482&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,558&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We disaggregate revenue from contracts with customers into four categories: contract manufacturing, retail and others, diagnostic services and genomic products and services. We determined that disaggregating revenue into these categories achieves the disclosure objective to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company&#8217;s revenue by revenue source for Fiscal 2023 and 2022 (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue by Customer Type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">108,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Contract manufacturing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Retail and others</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Genomic products and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">44,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">122,647&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer Consideration</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes payments to certain diagnostic services customers for distinct services that approximate fair value for those services. Such services include specimen collection, the collection and delivery of insurance and patient information necessary for billing and collection, and logistics services. Consideration associated with specimen collection services is classified in cost of revenues and the remaining costs are classified as diagnostic expenses within operating expenses in the accompanying statement of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales Tax Exclusion from the Transaction Price</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from the customer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shipping and Handling Activities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for shipping and handling activities that we perform as activities to fulfill the promise to transfer the good.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising and Incentive Promotions</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising and Incentive Promotions</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising and incentive promotion costs are expensed within the period in which they are utilized. Advertising and incentive promotion expense is comprised of (i) media advertising, presented as part of general and administrative expense, (ii) cooperative incentive </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">promotions and coupon program expenses, which are accounted for as part of net revenue, and (iii) free product, which is accounted for as part of cost of revenues. Advertising and incentive promotion expenses incurred from continuing operations for Fiscal 2023 and 2022 were $1.8 million and $0.4 million, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for stock-based compensation in accordance with FASB ASC 718, &#8220;Compensation &#8211; Stock Compensation.&#8221; Under the fair value recognition provision of the ASC, stock-based compensation cost is estimated at the grant date based on the fair value of the award. The Company estimates the fair value of stock options and warrants granted using the Black-Scholes-Merton option pricing model and stock grants at their closing reported market value. We recognize all stock-based payments to employees and directors, including grants of stock options, as compensation expense in the financial statements based on their grant date fair values. The grant date fair values of stock options are determined through the use of the Black-Scholes option pricing model. The compensation cost is recognized as an expense over the requisite service period of the award, which usually coincides with the vesting period. We account for forfeitures as they occur.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock and stock options to purchase our common stock have been granted to employees pursuant to the terms of certain agreements and stock option plans (see Note 7, Stockholders' Equity). Stock options are exercisable during a period determined by us, but in no event later than seven years from the date granted.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D costs are charged to operations in the period incurred, R&amp;D costs incurred for the years ended December&#160;31, 2023 and 2022 were $1.4 million and $0.7 million, respectively. R&amp;D costs are principally related to personnel expenses and new product development initiatives and costs associated with the OTC health care products, dietary supplements and validation costs associated with the diagnostic services business.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes in accordance with accounting guidance now codified as FASB ASC 740, &#8220;Income Taxes,&#8221; which requires that the Company recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for, or benefit from, income taxes includes deferred taxes resulting from the temporary differences in income for financial and tax purposes using the liability method. Such temporary differences result primarily from the differences in the carrying value of assets and liabilities. Future realization of deferred income tax assets requires sufficient taxable income within the carry-back, carryforward period available under tax law. We evaluate, on a quarterly basis whether, based on all available evidence, it is probable that the deferred income tax assets are realizable. Valuation allowances are established when it is more likely than not that the tax benefit of the deferred tax asset will not be realized. The evaluation, as prescribed by ASC 740- 10, &#8220;Income Taxes,&#8221; includes the consideration of all available evidence, both positive and negative, regarding historical operating results including recent years with reported losses, the estimated timing of future reversals of existing taxable temporary differences, estimated future taxable income exclusive of reversing temporary differences and carryforwards, and potential tax planning strategies which may be employed to prevent an operating loss or tax credit carryforward from expiring unused.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under ASU No. 2019-12, &#8220;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (&#8220;ASU 2019-12&#8221;), which simplifies various aspects related to accounting for income taxes. This standard became effective for the Company January 1, 2021. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for uncertainties in income taxes under the provisions of FASB ASC 740-10-05 (the &#8220;Subtopic&#8221;). The Subtopic clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements. The Subtopic prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The Subtopic provides guidance on the de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Standards, Adopted and Not Yet Adopted</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards, Adopted</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2023, the Company adopted Accounting Standards Update ("ASU") 2016-13, &#8220;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&#8221; (&#8220;ASU 2016-13&#8221;) ASU 2016-13 requires an impairment model (known as the CECL model) that is based on expected losses rather than incurred losses. Under the new guidance, each reporting entity should estimate an allowance for expected credit losses, which is intended to result in more timely recognition of losses. This model replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost, accounts receivable and available for sale debt securities and applies to some off-balance sheet credit exposures. In February 2020, the FASB issued ASU 2020-02, Financial Instruments - Credit Losses (Topic 326), which amends the effective date of the original pronouncement for smaller reporting companies. ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022. The adoption of ASU 2016-13 did not have a material impact on the Company's consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2023, the FASB issued ASU 2023-05, "Business Combinations - Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement." The new guidance applies to the formation of a joint venture and requires a joint venture to initially measure all contributions received upon its formation at fair value. The guidance is intended to reduce diversity in practice and is applicable to joint venture entities with a formation date on or after January 1, 2025 on a </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prospective basis. The Company currently does not have any transactions that fall under the scope of ASU 2023-05; therefore, the adoption of ASU 2023-05 is not expected to have an impact on the Company's consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards, Not Yet Adopted</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), which requires an enhanced disclosure of significant segment expenses on an annual and interim basis. This guidance will be effective for the annual periods beginning the year ended December 31, 2024, and for interim periods beginning January 1, 2025. Early adoption is permitted. Upon adoption, the guidance should be applied retrospectively to all prior periods presented in the financial statements. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which improves the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the effective tax rate reconciliation and income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. This guidance will be effective for the annual periods beginning the year ended December 31, 2025. Early adoption is permitted. Upon adoption, the guidance can be applied prospectively or retrospectively. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482105/912-330-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272704898176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Summary of Components of Marketable Securities</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the components of our marketable securities and the underlying fair value input level tier hierarchy (see fair value of financial instruments) (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Unrealized <br/>Losses </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate stock</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(401)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,528&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(401)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrealized <br/>Losses </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">U.S. government obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,186&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,234&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(92)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,328&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts Receivable Net</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts are written off as uncollectible at the time we determine that collections are unlikely. Accounts receivable, net is comprised of the following (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Trade accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40,177&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">37,568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unbilled accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40,177&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(3,864)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(3,140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total accounts receivable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">36,313&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">37,054&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The table below presents a roll forward of the Company's allowance for credit losses (amount in thousands).</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.212%"><tr><td style="width:1.0%"></td><td style="width:83.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.190%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance as of January 1, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period provision for expected credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,864&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Components of Inventory</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2023 and 2022, the components of inventory are as follows (in thousands): </span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services testing material</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">623&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,739&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Finished goods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventory</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,099&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,488&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventory valuation reserve</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(258)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(512)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventory, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,841&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,976&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">U.S. government obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,496&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,832&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,328&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Deferred Revenue</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates our deferred revenue by recognition period (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Recognition Period</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0-12 Months</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13-24 Months</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Over 24 Months</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,482&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,558&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company&#8217;s revenue by revenue source for Fiscal 2023 and 2022 (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue by Customer Type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">108,329&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Contract manufacturing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Retail and others</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Genomic products and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">44,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">122,647&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272706490352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets as of December&#160;31, 2023 and 2022 consisted of the following (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Estimated Useful<br/>Life (in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Trade names</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Proprietary intellectual property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">CLIA license</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">19,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(3,822)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,475&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule Estimated Future Amortization Expense of Acquired Intangible Assets</a></td>
<td class="text">The estimated future amortization expense of acquired intangible assets as of December&#160;31, 2023 is as follows (in thousands):<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year ended December 31, 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year ended December 31, 2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,583&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year ended December 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year ended December 31, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,731&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year ended December 31, 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,815&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272705451472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of property, plant and equipment are as follows (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lesser of lease term or estimated useful life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Building improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10-39 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Machinery</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3-7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lab equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3-7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3-5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,432&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,728&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(11,534)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(8,440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,898&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,288&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272706716416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Options Activity</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock options activity during Fiscal 2023 and 2022 (in thousands, except per share data).</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Number of Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Weighted Average Remaining Contractual Life (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,110</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.27&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,820&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,095</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,833)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(420)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,952</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.35&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,379&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,135</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,348)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(788)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,951</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.30&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">693&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Options vested and exercisable</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,880</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.69&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">693&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Weighted Average Assumptions Used in Determining Fair Value of Options</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes weighted average assumptions used in determining the fair value of the stock options at the date of grant during Fiscal 2023 and 2022:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercise price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8.65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.03&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Risk-free rate of interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected dividend yield (per share)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_ScheduleOfWarrantActivityTableTextBlock', window );">Schedule of Warrant Activity</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes warrant activities during Fiscal 2023 and 2022 (in thousands, except per share data):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Number of Shares </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average<br/>Remaining Contractual<br/>Life <br/>(in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">855</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8.23&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">855</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8.23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">831</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11.16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants vested and exercisable</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">831</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11.16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.9</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_ScheduleOfWarrantActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Warrant Activity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_ScheduleOfWarrantActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272703228240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit)</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the provision (benefit) for income taxes, in the consolidated statements of operations are as follows (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.818%"><tr><td style="width:1.0%"></td><td style="width:65.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.018%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.334%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Continuing Operations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,056&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,583&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Deferred</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(5,459)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,615)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(210)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(7,074)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(138)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income taxes from continuing operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,018)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,445&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the statutory federal income tax expense (benefit) to the effective tax is as follows (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.507%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Statutory Rate - federal</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4,788)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,811&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">State taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research &amp; development tax credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(350)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Permanent differences and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(601)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income taxes from continuing operations before valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(5,761)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,799&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(257)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,354)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income tax expense (benefit)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,018)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,445&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,018)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,445&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of the primary &#8220;temporary differences&#8221; between values recorded for assets and liabilities for financial reporting purposes and values utilized for measurement in accordance with tax laws giving rise to our deferred tax assets are as follows (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net operating loss and capital loss carryforward</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,649&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,324&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Right of use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,464)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,466)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Capital lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(479)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(705)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,612)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2,703)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Tax credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(567)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,313&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(224)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272796110736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Schedule of Other Current Liabilities</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of other current liabilities at December&#160;31, 2023 and 2022, respectively (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued diagnostic services commissions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,093&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued payroll</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued bonus</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued benefits and vacation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total other current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,072&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272704663680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Quantitative Information About Operating and Finance Leases</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes quantitative information about the Company's operating and finance leases (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Variable lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">956&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Finance leases:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest lease cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total finance lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other information related to the Company&#8217;s leases is shown below (dollar amounts in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the Years Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating cash flows used in operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(839)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(774)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"></td><td style="width:67.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.729%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted-average remaining lease term &#8211; operating leases (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8.5</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term &#8211; finance leases (in years)</span></td><td colspan="3" style="padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;NA </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted-average discount rate &#8211; operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate &#8211; finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease asset (1)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">NA</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) As of December&#160;31, 2023, the Company had recorded accumulated depreciation of approximately $760,000 for the finance lease asset. Finance lease assets are recorded within <span style="-sec-ix-hidden:f-939">property and equipment, net</span> on the Company&#8217;s condensed consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Operating Leases</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Minimum lease payments over the remaining lease periods as of December&#160;31, 2023 are as follows (amounts in thousands):</span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.121%"><tr><td style="width:1.0%"></td><td style="width:39.421%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.986%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.017%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Operating Lease</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Finance Lease</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year Ended December 31, 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">952&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,840&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,792&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year Ended December 31, 2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">977&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,840&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,817&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year Ended December 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year Ended December 31, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">955&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,188&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Year Ended December 31, 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,667&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,667&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,830&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less present value discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2,284)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(898)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(3,182)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total   </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,190&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,932&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,122&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272796483584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Information</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of segment information for Fiscal 2023, 2022 and 2021 (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.939%"><tr><td style="width:1.0%"></td><td style="width:65.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.981%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">108,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consumer products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">19,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consolidated net revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">44,384&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">122,647&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cost of revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">39,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consumer products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">16,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consolidated cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">28,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">51,993&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Depreciation and amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consumer products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total Depreciation and amortization expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,049&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,542&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Operating and other expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">43,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Income (loss) from operations, before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,804)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">56,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consumer products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(7,493)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(10,824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unallocated corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(13,503)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(22,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total income from operations, before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(22,800)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22,908&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4,445)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Net Income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16,782)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18,463&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of segment information for Fiscal 2023 and Fiscal 2022 (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diagnostic services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">44,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">50,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Consumer products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unallocated corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">91,927&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">87,648&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272820989856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the weighted average number of common shares outstanding used in calculating basic and diluted net loss per share (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net (loss) income - basic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16,782)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18,463&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest on unsecured convertible promissory note</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net (loss) income - diluted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16,782)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">19,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average shares outstanding - basic</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,207</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,845</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diluted shares- Stock Options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,493</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diluted shares- Stock Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,073</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unsecured convertible promissory note</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">240</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average shares outstanding - diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,207&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">18,651&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Anti-dilutive Securities Excluded from the Income Per Share Computation</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the number of securities excluded from the income per share computation as a result of their anti-dilutive effect (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">For the years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Anti-dilutive securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Common stock purchase warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">831&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Stock Options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Anti-dilutive securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,782&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,225&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272705092704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Business - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>inhibitor </div>
<div>numberOfLicensedCompound</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_NumberOfLicensedCompounds', window );">Number of licensed compounds | numberOfLicensedCompound</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_NumberOfInhibitors', window );">Number of inhibitors | inhibitor</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prph_CPMMember', window );">CPM Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_NumberOfInhibitors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Inhibitors</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_NumberOfInhibitors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_NumberOfLicensedCompounds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Licensed Compounds</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_NumberOfLicensedCompounds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prph_CPMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prph_CPMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272708362832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>test </div>
<div>Segment</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>test</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | Segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_NumberOfTestsRecognized', window );">Number of tests recognized | test</a></td>
<td class="nump">480,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage', window );">Number of tests recognized reimbursed by HRSA uninsured program (as a percent)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash used by operating activities</a></td>
<td class="nump">$ 11,348,000<span></span>
</td>
<td class="num">$ (28,551,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash, cash equivalents, restricted cash and marketable securities</a></td>
<td class="nump">5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EscrowDeposit', window );">Escrow amount</a></td>
<td class="nump">540,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts receivable, allowance for credit loss</a></td>
<td class="nump">3,864,000<span></span>
</td>
<td class="nump">3,140,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease', window );">Allowance for doubtful accounts period increase</a></td>
<td class="nump">724,000<span></span>
</td>
<td class="nump">5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Accounts receivable allowances</a></td>
<td class="nump">718,000<span></span>
</td>
<td class="num">(761,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">2,149,000<span></span>
</td>
<td class="nump">9,109,000<span></span>
</td>
<td class="nump">$ 8,658,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Federal depository insurance</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashUninsuredAmount', window );">Bank balance uninsured</a></td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract balance, deferred revenue</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,418,000<span></span>
</td>
<td class="nump">652,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=prph_PersonalGenomicsBusinessMember', window );">Personal Genomics Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract balance, deferred revenue</a></td>
<td class="nump">$ 3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=prph_UncollectibleTradeReceivablesMember', window );">Uncollectible Trade Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Bad debt expense</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">5,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease', window );">Allowance for doubtful accounts period increase</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=prph_FullyReservedTradeReceivablesMember', window );">Fully Reserved Trade Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Bad debt expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=prph_CooperativeIncentivePromotionCostsMember', window );">Cooperative Incentive Promotion Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expense</a></td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Building and Building Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Machinery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Computer equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_DebtSecuritiesAvailableForSaleMaturityPeriod', window );">Debt securities maturity (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rates (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration period (in years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Building and Building Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">39 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Machinery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Computer equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_DebtSecuritiesAvailableForSaleMaturityPeriod', window );">Debt securities maturity (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rates (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_DebtSecuritiesAvailableForSaleMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-Sale, Maturity Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_DebtSecuritiesAvailableForSaleMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_NumberOfTestsRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of tests recognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_NumberOfTestsRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of tests recognized reimbursed by HRSA uninsured program, percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashUninsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashUninsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=prph_PersonalGenomicsBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=prph_PersonalGenomicsBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=prph_UncollectibleTradeReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=prph_UncollectibleTradeReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=prph_FullyReservedTradeReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=prph_FullyReservedTradeReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=prph_CooperativeIncentivePromotionCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=prph_CooperativeIncentivePromotionCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prph_MarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prph_MarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272802481840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Components of Marketable Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 3,528<span></span>
</td>
<td class="nump">$ 7,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(401)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Fair Value</a></td>
<td class="nump">3,127<span></span>
</td>
<td class="nump">8,328<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=prph_CorporateStockMember', window );">Corporate stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">3,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(401)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Fair Value</a></td>
<td class="nump">$ 3,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=prph_USGovernmentObligationsMember', window );">U.S. government obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=prph_CorporateObligationsMember', window );">Corporate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,850<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=prph_CorporateStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=prph_CorporateStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=prph_USGovernmentObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=prph_USGovernmentObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=prph_CorporateObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=prph_CorporateObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272796124256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Accounts Receivable Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrentAndNoncurrent', window );">Trade accounts receivable</a></td>
<td class="nump">$ 40,177<span></span>
</td>
<td class="nump">$ 37,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled accounts receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Accounts Receivable, before Allowance for Credit Loss</a></td>
<td class="nump">40,177<span></span>
</td>
<td class="nump">40,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Less allowances</a></td>
<td class="num">(3,864)<span></span>
</td>
<td class="num">(3,140)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Total accounts receivable</a></td>
<td class="nump">$ 36,313<span></span>
</td>
<td class="nump">$ 37,054<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480833/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481058/954-310-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272796264080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Accounts Receivable, Allowance for Credit Loss (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning balance</a></td>
<td class="nump">$ 3,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease', window );">Current period provision for expected credit losses</a></td>
<td class="nump">724<span></span>
</td>
<td class="nump">$ 5,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending balance</a></td>
<td class="nump">$ 3,864<span></span>
</td>
<td class="nump">$ 3,140<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272796367664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Components of Inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_InventoryLabMaterial', window );">Diagnostic services testing material</a></td>
<td class="nump">$ 623<span></span>
</td>
<td class="nump">$ 1,739<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">1,619<span></span>
</td>
<td class="nump">1,639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">306<span></span>
</td>
<td class="nump">754<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">1,551<span></span>
</td>
<td class="nump">356<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventory</a></td>
<td class="nump">4,099<span></span>
</td>
<td class="nump">4,488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory valuation reserve</a></td>
<td class="num">(258)<span></span>
</td>
<td class="num">(512)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">$ 3,841<span></span>
</td>
<td class="nump">$ 3,976<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_InventoryLabMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory lab material.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_InventoryLabMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272706768608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Fair Value of Financial Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="nump">$ 3,127<span></span>
</td>
<td class="nump">$ 8,328<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="nump">3,127<span></span>
</td>
<td class="nump">5,496<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,832<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=prph_CorporateStockMember', window );">Corporate stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="nump">3,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=prph_CorporateStockMember', window );">Corporate stock | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="nump">3,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=prph_CorporateStockMember', window );">Corporate stock | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=prph_CorporateStockMember', window );">Corporate stock | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=prph_USGovernmentObligationsMember', window );">U.S. government obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=prph_USGovernmentObligationsMember', window );">U.S. government obligations | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=prph_USGovernmentObligationsMember', window );">U.S. government obligations | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=prph_USGovernmentObligationsMember', window );">U.S. government obligations | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=prph_CorporateObligationsMember', window );">Corporate obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=prph_CorporateObligationsMember', window );">Corporate obligations | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,496<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=prph_CorporateObligationsMember', window );">Corporate obligations | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,354<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=prph_CorporateObligationsMember', window );">Corporate obligations | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=prph_CorporateStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=prph_CorporateStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=prph_USGovernmentObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=prph_USGovernmentObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=prph_CorporateObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=prph_CorporateObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272802540432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Deferred Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueArrangementLineItems', window );"><strong>Deferred Revenue Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Deferred revenue</a></td>
<td class="nump">$ 3,482<span></span>
</td>
<td class="nump">$ 3,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueArrangementLineItems', window );"><strong>Deferred Revenue Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueArrangementLineItems', window );"><strong>Deferred Revenue Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Deferred revenue</a></td>
<td class="nump">2,382<span></span>
</td>
<td class="nump">683<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueArrangementLineItems', window );"><strong>Deferred Revenue Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Deferred revenue</a></td>
<td class="nump">750<span></span>
</td>
<td class="nump">$ 376<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueArrangementLineItems', window );"><strong>Deferred Revenue Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Deferred revenue</a></td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272796478336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Performance Obligation (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueArrangementLineItems', window );"><strong>Deferred Revenue Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Expected timing of satisfaction, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueArrangementLineItems', window );"><strong>Deferred Revenue Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Expected timing of satisfaction, period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueArrangementLineItems', window );"><strong>Deferred Revenue Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Expected timing of satisfaction, period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueArrangementLineItems', window );"><strong>Deferred Revenue Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Expected timing of satisfaction, period</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272802425936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Disaggregation by Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">$ 44,384<span></span>
</td>
<td class="nump">$ 122,647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=prph_DiagnosticServicesMember', window );">Diagnostic services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">24,849<span></span>
</td>
<td class="nump">108,329<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=prph_ContractManufacturingMember', window );">Contract manufacturing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">9,400<span></span>
</td>
<td class="nump">8,740<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=prph_RetailAndOtherMember', window );">Retail and others</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">2,378<span></span>
</td>
<td class="nump">1,281<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=prph_GenomicProductsAndServicesMember', window );">Genomic products and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue, net</a></td>
<td class="nump">$ 7,757<span></span>
</td>
<td class="nump">$ 4,297<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=prph_DiagnosticServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=prph_DiagnosticServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=prph_ContractManufacturingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=prph_ContractManufacturingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=prph_RetailAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=prph_RetailAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=prph_GenomicProductsAndServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=prph_GenomicProductsAndServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272699196560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Acquisition (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 03, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionContingentConsiderationLiability', window );">Secured note amount</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff', window );">Liability payoff amount</a></td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff', window );">Promissory note payoff amount</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par or stated value (in dollars per share)</a></td>
<td class="nump">$ 0.0005<span></span>
</td>
<td class="nump">$ 0.0005<span></span>
</td>
<td class="nump">$ 0.0005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare', window );">Shares issued (in value per share)</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Consideration transferred</a></td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent', window );">Due to sellers (see Note 3)</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Life (in years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_AssetAcquisitionTransactionCosts', window );">Transaction costs</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Purchase price</a></td>
<td class="nump">6,800<span></span>
</td>
<td class="nump">$ 6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=prph_StellaPurchaseAgreementMember', window );">Stella Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_PaymentsForAssetAcquisition', window );">Cash paid</a></td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Stock issued during period (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_PurchaseAgreementRoyaltyPercent', window );">Royalty percent</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Consideration Transferred, Liability Payoff</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Consideration Transferred, Promissory Note Payoff</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Shares Issued and Issuable, Value Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_AssetAcquisitionTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_AssetAcquisitionTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_PaymentsForAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for Asset Acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_PaymentsForAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_PurchaseAgreementRoyaltyPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase Agreement, Royalty Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_PurchaseAgreementRoyaltyPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479908/805-50-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized from contingent consideration in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized from contingent consideration in asset acquisition, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=prph_StellaPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=prph_StellaPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272802546752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 03, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.9<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Purchase price</a></td>
<td class="nump">$ 6.8<span></span>
</td>
<td class="nump">$ 6.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272699201120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, Net - Schedule of Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 03, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total intangible assets, gross</a></td>
<td class="nump">$ 19,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(6,768)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,822)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total intangible assets, net</a></td>
<td class="nump">12,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,475<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total intangible assets, gross</a></td>
<td class="nump">$ 5,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Life (in years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Proprietary intellectual property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total intangible assets, gross</a></td>
<td class="nump">$ 11,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Life (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total intangible assets, gross</a></td>
<td class="nump">$ 1,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Life (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicenseMember', window );">CLIA license</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total intangible assets, gross</a></td>
<td class="nump">$ 1,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272824336704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, Net - Schedule Estimated Future Amortization Expense of Acquired Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Year ended December 31, 2024</a></td>
<td class="nump">$ 2,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Year ended December 31, 2025</a></td>
<td class="nump">2,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Year ended December 31, 2026</a></td>
<td class="nump">2,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Year ended December 31, 2027</a></td>
<td class="nump">1,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Year ended December 31, 2028</a></td>
<td class="nump">370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">2,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total intangible assets, net</a></td>
<td class="nump">$ 12,333<span></span>
</td>
<td class="nump">$ 8,475<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272704706272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property, Plant, and Equipment - Schedule of Property, Plant and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 24,432<span></span>
</td>
<td class="nump">$ 15,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Less: accumulated depreciation</a></td>
<td class="num">(11,534)<span></span>
</td>
<td class="num">(8,440)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Total property, plant and equipment, net</a></td>
<td class="nump">12,898<span></span>
</td>
<td class="nump">7,288<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property, plant and equipment, gross</a></td>
<td class="nump">352<span></span>
</td>
<td class="nump">352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property, plant and equipment, gross</a></td>
<td class="nump">374<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 1,746<span></span>
</td>
<td class="nump">1,729<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">39 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 6,103<span></span>
</td>
<td class="nump">5,048<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Lab equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 12,667<span></span>
</td>
<td class="nump">5,788<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Lab equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Lab equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 2,744<span></span>
</td>
<td class="nump">2,350<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment and software | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment and software | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 446<span></span>
</td>
<td class="nump">$ 461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272710011856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272697727296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Outstanding Debt (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 20, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 10, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 26, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 27, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 12, 2023 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 15, 2020 </div>
<div>USD ($) </div>
<div>debt </div>
<div>investor</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EscrowDeposit', window );">Escrow amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 540,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Warrant fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">79.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate of interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants outstanding, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalancePrincipalAmount', window );">Remaining principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Interest payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion, principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=prph_A2023NotesWarrantsMember', window );">2023 Notes Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual life, options vested and exercisable (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate of interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.62%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants outstanding, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=prph_A2023NotesWarrantsMember', window );">2023 Notes Warrants | Black-Scholes Option Pricing Model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Warrant fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt conversion, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion, common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Letter Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prph_A2023SecuredMortgageLoanMember', window );">2023 Secured Mortgage Loan | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="nump">8.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Periodic payment</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="nump">$ 341,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EscrowDeposit', window );">Escrow amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 540,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prph_A2023NoteMember', window );">2023 Note | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prph_A2023NoteMember', window );">2023 Note | Unsecured Debt | 2023 Notes Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=prph_SeptemberTwoThousandAndTwentyNoteMember', window );">September 2020 Notes | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_NumberOfDebtInstruments', window );">Number of debt instruments | debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_NumberOfInvestors', window );">Number of investors | investor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseOther', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_NumberOfDebtInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Debt Instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_NumberOfDebtInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_NumberOfInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Investors</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_NumberOfInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalancePrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of investment owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalancePrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=prph_A2023NotesWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=prph_A2023NotesWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=prph_BlackScholesOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=prph_BlackScholesOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=prph_LetterAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=prph_LetterAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prph_A2023SecuredMortgageLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prph_A2023SecuredMortgageLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prph_A2023NoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prph_A2023NoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=prph_SeptemberTwoThousandAndTwentyNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=prph_SeptemberTwoThousandAndTwentyNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272688278496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 06, 2023</div></th>
<th class="th"><div>Mar. 15, 2023</div></th>
<th class="th"><div>Jan. 26, 2023</div></th>
<th class="th"><div>Jan. 12, 2023</div></th>
<th class="th"><div>Oct. 04, 2022</div></th>
<th class="th"><div>Jul. 26, 2022</div></th>
<th class="th"><div>Jun. 03, 2022</div></th>
<th class="th"><div>May 09, 2022</div></th>
<th class="th"><div>Feb. 14, 2022</div></th>
<th class="th"><div>May 20, 2021</div></th>
<th class="th"><div>Dec. 12, 2019</div></th>
<th class="th"><div>Apr. 12, 2018</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 16, 2023</div></th>
<th class="th"><div>Jan. 27, 2023</div></th>
<th class="th"><div>Jan. 03, 2023</div></th>
<th class="th"><div>May 19, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par or stated value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0005<span></span>
</td>
<td class="nump">$ 0.0005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par or stated value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0005<span></span>
</td>
<td class="nump">$ 0.0005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Special cash dividend (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Payment to stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700,000<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Stock repurchase program, term (in months)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,628<span></span>
</td>
<td class="nump">303,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 588,000<span></span>
</td>
<td class="nump">$ 2,152,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,135,000<span></span>
</td>
<td class="nump">1,095,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of shares, exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,348,000<span></span>
</td>
<td class="nump">1,833,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Closing stock price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.52<span></span>
</td>
<td class="nump">$ 9.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of shares, forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">788,000<span></span>
</td>
<td class="nump">420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Cash payment for repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,379,000<span></span>
</td>
<td class="nump">$ 7,474,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">603,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue', window );">Fair value of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="nump">$ 6,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Estimated fair value of options at date of grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">79.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate of interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants outstanding, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Warrant fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based compensation, nonvested award, cost not yet recognized, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GranteeStatusAxis=prph_CertainHoldersMember', window );">Certain Holders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of shares, forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">744,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=prph_A2023NotesWarrantsMember', window );">2023 Notes Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate of interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.62%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants outstanding, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,628<span></span>
</td>
<td class="nump">303,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of shares, exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">603,881<span></span>
</td>
<td class="nump">828,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">828,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld for tax withholding obligation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,103,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_IssuanceOfCommonStockSharesExerciseOfWarrant', window );">Issuance of common stock upon exercise of warrant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants (in shares)</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Exercise price (in dollars per share)</a></td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">80.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate of interest</a></td>
<td class="nump">3.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants outstanding, term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant, fair value</a></td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_IssuanceOfCommonStockSharesExerciseOfWarrant', window );">Issuance of common stock upon exercise of warrant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prph_InducementOptionAwardMember', window );">Inducement Option Award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=prph_InducementOptionAwardMember', window );">Inducement Option Award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber', window );">Inducement award (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=prph_InducementOptionAwardMember', window );">Inducement Option Award | First Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=prph_InducementOptionAwardMember', window );">Inducement Option Award | Second Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=prph_InducementOptionAwardMember', window );">Inducement Option Award | Third Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=prph_InducementOptionAwardMember', window );">Inducement Option Award | Fourth Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=prph_InducementOptionAwardMember', window );">Inducement Option Award | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=prph_CFOAwardMember', window );">CFO Award | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=prph_CFOAwardMember', window );">CFO Award | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=prph_MrKamalObbadMember', window );">Mr. Kamal Obbad | Inducement Option Award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=prph_A2022DirectorsPlanMember', window );">2022 Directors Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=prph_Amended2022DirectorsPlanMember', window );">Amended 2022 Directors' Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance', window );">Increase in shares for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=prph_Amended2010DirectorsPlanMember', window );">Amended 2010 Directors' Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">775,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=prph_Amended2022PlanMember', window );">Amended 2022 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance', window );">Increase in shares for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=prph_A2022PlanMember', window );">2022 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,093,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance', window );">Increase in shares for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=prph_AmendedTwoThousandTenPlanMember', window );">Amended 2010 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=prph_TwoThousandEighteenStockIncentivePlanMember', window );">2018 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of shares, exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=prph_TwoThousandEighteenStockIncentivePlanMember', window );">2018 Stock Incentive Plan | CEO Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=prph_TwoThousandEighteenStockIncentivePlanMember', window );">2018 Stock Incentive Plan | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=prph_TwoThousandEighteenStockIncentivePlanMember', window );">2018 Stock Incentive Plan | Chief Financial Officer | CFO Award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Special cash dividend (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Inducement award amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_ShareBasedPaymentArrangementExpenseReversal', window );">Reversal of stock based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 149,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Increase (Decrease) In Capital Shares Reserved For Future Issuance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_IssuanceOfCommonStockSharesExerciseOfWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Common Stock, Shares, Exercise of Warrant</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_IssuanceOfCommonStockSharesExerciseOfWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_ShareBasedPaymentArrangementExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Payment Arrangement, Expense, Reversal</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_ShareBasedPaymentArrangementExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481071/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An excess of the fair value of the modified award over the fair value of the award immediately before the modification.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 25<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480637/718-40-25-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramPeriodInForce1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramPeriodInForce1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=prph_CertainHoldersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=prph_CertainHoldersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=prph_A2023NotesWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=prph_A2023NotesWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prph_InducementOptionAwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prph_InducementOptionAwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=prph_InducementOptionAwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=prph_InducementOptionAwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=prph_ShareBasedCompensationAwardTrancheFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=prph_ShareBasedCompensationAwardTrancheFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=prph_CFOAwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=prph_CFOAwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=prph_MrKamalObbadMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=prph_MrKamalObbadMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=prph_A2022DirectorsPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=prph_A2022DirectorsPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=prph_Amended2022DirectorsPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=prph_Amended2022DirectorsPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=prph_Amended2010DirectorsPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=prph_Amended2010DirectorsPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=prph_Amended2022PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=prph_Amended2022PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=prph_A2022PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=prph_A2022PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=prph_AmendedTwoThousandTenPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=prph_AmendedTwoThousandTenPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=prph_TwoThousandEighteenStockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=prph_TwoThousandEighteenStockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=prph_CEOOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=prph_CEOOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272706645824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Stock Options Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of shares, outstanding, beginning (in shares)</a></td>
<td class="nump">3,952,000<span></span>
</td>
<td class="nump">5,110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares options granted (in shares)</a></td>
<td class="nump">1,135,000<span></span>
</td>
<td class="nump">1,095,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of shares options exercised (in shares)</a></td>
<td class="num">(1,348,000)<span></span>
</td>
<td class="num">(1,833,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of shares options forfeited (in shares)</a></td>
<td class="num">(788,000)<span></span>
</td>
<td class="num">(420,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of shares, outstanding, ending (in shares)</a></td>
<td class="nump">2,951,000<span></span>
</td>
<td class="nump">3,952,000<span></span>
</td>
<td class="nump">5,110,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Number of shares, options vested and exercisable (in shares)</a></td>
<td class="nump">1,880,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, outstanding, beginning (in dollars per share)</a></td>
<td class="nump">$ 5.35<span></span>
</td>
<td class="nump">$ 3.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, granted (in dollars per share)</a></td>
<td class="nump">8.65<span></span>
</td>
<td class="nump">9.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, exercised (in dollars per share)</a></td>
<td class="nump">0.98<span></span>
</td>
<td class="nump">1.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, forfeited (in dollars per share)</a></td>
<td class="nump">0.64<span></span>
</td>
<td class="nump">1.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, outstanding, ending (in dollars per share)</a></td>
<td class="nump">7.30<span></span>
</td>
<td class="nump">$ 5.35<span></span>
</td>
<td class="nump">$ 3.27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, options vested and exercisable (in dollars per share)</a></td>
<td class="nump">$ 6.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Remaining Contractual Life (in years) and Total Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life, outstanding shares (in years)</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">3 years 9 months 18 days<span></span>
</td>
<td class="text">3 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm', window );">Weighted average remaining contractual life, granted shares (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual life, options vested and exercisable (in years)</a></td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Total intrinsic value, outstanding, beginning</a></td>
<td class="nump">$ 20,379<span></span>
</td>
<td class="nump">$ 20,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Total intrinsic value, outstanding, ending</a></td>
<td class="nump">693<span></span>
</td>
<td class="nump">$ 20,379<span></span>
</td>
<td class="nump">$ 20,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Total intrinsic value, options vested and exercisable</a></td>
<td class="nump">$ 693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272796398784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Weighted Average Assumptions Used in Determining Fair Value of Options (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price (in dollars per share)</a></td>
<td class="nump">$ 8.65<span></span>
</td>
<td class="nump">$ 10.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">79.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate of interest</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield (per share)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272710439472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Warrant Activity (Details) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life, outstanding shares (in years)</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">3 years 9 months 18 days<span></span>
</td>
<td class="text">3 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of shares, warrants outstanding, beginning (in shares)</a></td>
<td class="nump">855<span></span>
</td>
<td class="nump">855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Number of shares, warrants granted (in shares)</a></td>
<td class="nump">376<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Number of shares, warrants exercise (in shares)</a></td>
<td class="num">(400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of shares, warrants outstanding, ending (in shares)</a></td>
<td class="nump">831<span></span>
</td>
<td class="nump">855<span></span>
</td>
<td class="nump">855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber', window );">Number of shares, warrants vested and exercisable (in shares)</a></td>
<td class="nump">831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1', window );">Weighted average exercise price, warrants outstanding, beginning (in dollars per share)</a></td>
<td class="nump">$ 8.23<span></span>
</td>
<td class="nump">$ 8.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1', window );">Weighted average exercise price, warrants granted (in dollars per share)</a></td>
<td class="nump">9.13<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_WeightedAverageExercisePriceWarrantsExercised', window );">Weighted average exercise price warrants, exercised (in dollars per share)</a></td>
<td class="nump">3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1', window );">Weighted average exercise price, warrants outstanding, ending (in dollars per share)</a></td>
<td class="nump">11.16<span></span>
</td>
<td class="nump">$ 8.23<span></span>
</td>
<td class="nump">$ 8.23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1', window );">Weighted average exercise price, warrants vested and exercisable (in dollars per share)</a></td>
<td class="nump">$ 11.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life, outstanding shares (in years)</a></td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life, warrants granted (in years)</a></td>
<td class="text">4 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable', window );">Weighted average remaining contractual life, warrants vested and exercisable (in years)</a></td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non options outstanding granted weighted average exercise price 1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non options outstanding weighted average exercise price 1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non options vested and exercisable weighted average exercise price 1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non options vested and expected to vest exercisable number.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation, Shares Authorized, Under Stock Option Plans, Exercise Price Range, Granted, Warrants, Weighted Average, Remaining Contractual Term 2</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_WeightedAverageExercisePriceWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price Warrants, Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_WeightedAverageExercisePriceWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non options vested and exercisable weighted average remaining contractual term 2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272796551792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Plans (Details Narrative) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Contribution amount</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272706686480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 772<span></span>
</td>
<td class="nump">$ 1,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">284<span></span>
</td>
<td class="nump">3,543<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current Total</a></td>
<td class="nump">1,056<span></span>
</td>
<td class="nump">4,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(5,459)<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(1,615)<span></span>
</td>
<td class="num">(210)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred Total</a></td>
<td class="num">(7,074)<span></span>
</td>
<td class="num">(138)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes from continuing operations</a></td>
<td class="num">$ (6,018)<span></span>
</td>
<td class="nump">$ 4,445<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272710124976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Statutory Rate - federal</a></td>
<td class="num">$ (4,788)<span></span>
</td>
<td class="nump">$ 4,811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal benefit</a></td>
<td class="num">(1,133)<span></span>
</td>
<td class="nump">2,789<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research &amp; development tax credit</a></td>
<td class="num">(350)<span></span>
</td>
<td class="num">(1,200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Permanent differences and other</a></td>
<td class="nump">510<span></span>
</td>
<td class="num">(601)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance', window );">Income taxes from continuing operations before valuation allowance</a></td>
<td class="num">(5,761)<span></span>
</td>
<td class="nump">5,799<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(257)<span></span>
</td>
<td class="num">(1,354)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes from continuing operations</a></td>
<td class="num">$ (6,018)<span></span>
</td>
<td class="nump">$ 4,445<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income taxes from continuing operations before valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272706681152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss and capital loss carryforward</a></td>
<td class="nump">$ 4,649<span></span>
</td>
<td class="nump">$ 1,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Right of use asset</a></td>
<td class="num">(1,464)<span></span>
</td>
<td class="num">(1,466)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">4,972<span></span>
</td>
<td class="nump">2,684<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_DeferredTaxAssetsCapitalLeaseObligations', window );">Capital lease obligations</a></td>
<td class="nump">1,464<span></span>
</td>
<td class="nump">1,466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_DeferredTaxLiabilitiesDepreciation', window );">Depreciation</a></td>
<td class="num">(479)<span></span>
</td>
<td class="num">(705)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_DeferredTaxLiabilitiesAmortization', window );">Amortization</a></td>
<td class="num">(1,612)<span></span>
</td>
<td class="num">(2,703)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credit</a></td>
<td class="nump">350<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(567)<span></span>
</td>
<td class="num">(824)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Total</a></td>
<td class="nump">$ 7,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (224)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_DeferredTaxAssetsCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets, capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_DeferredTaxAssetsCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_DeferredTaxLiabilitiesAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities, amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_DeferredTaxLiabilitiesAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_DeferredTaxLiabilitiesDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities, depreciation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_DeferredTaxLiabilitiesDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272705761744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax assets, valuation allowance</a></td>
<td class="nump">$ 567<span></span>
</td>
<td class="nump">$ 824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">Operating loss carryforwards, state and local</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Operating loss carryforwards, federal</a></td>
<td class="nump">3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Tax credit carryforwards, research</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_TaxCreditCarryforwardLimitationAmount', window );">Annual limitation amount</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_TaxCreditCarryforwardLimitationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax credit carryforward limitation amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_TaxCreditCarryforwardLimitationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272710109920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Current Liabilities - Schedule of Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesForCommissionsExpenseAndTaxes', window );">Accrued diagnostic services commissions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedPayrollTaxesCurrent', window );">Accrued payroll</a></td>
<td class="nump">181<span></span>
</td>
<td class="nump">202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrent', window );">Accrued bonus</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">1,445<span></span>
</td>
<td class="nump">714<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_AccruedReturns', window );">Accrued returns</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrent', window );">Accrued benefits and vacation</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Total other current liabilities</a></td>
<td class="nump">$ 2,683<span></span>
</td>
<td class="nump">$ 2,072<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_AccruedReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_AccruedReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesForCommissionsExpenseAndTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount for commissions, taxes and other expenses that were incurred but unpaid as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesForCommissionsExpenseAndTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedPayrollTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedPayrollTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272704914256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 19, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>site</div>
</th>
<th class="th"><div>Nov. 15, 2022</div></th>
<th class="th">
<div>May 01, 2021 </div>
<div>period</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_ManufacturingAgreementRenewalOptions', window );">Number of successive periods | period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_ManufacturingAgreementRenewalPeriod', window );">Agreement term, successive periods (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_AgreementTerm', window );">Agreement term (in days)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,502<span></span>
</td>
<td class="nump">$ 34,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_NumberOfSites', window );">Number of sites | site</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=prph_LinebackerLicenseAgreementsMember', window );">Linebacker License Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_UpfrontLicenseFee', window );">Upfront license fee</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LicenseAgreementTerm', window );">License agreement term (in days)</a></td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LicenseOrRoyaltyNetRevenuePercentage', window );">License or royalty net revenue percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Minimum royalty</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=prph_EquivirLicenseAgreementMember', window );">Equivir License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=prph_BESmartLicenseAgreementMember', window );">BE-Smart License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=prph_PhaseThreeMember', window );">Phase Three | Linebacker License Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_AdditionalPaymentOfFee', window );">Additional payment of fee</a></td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=prph_NewDrugApplicationMember', window );">New Drug Application | Linebacker License Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_AdditionalPaymentOfFee', window );">Additional payment of fee</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_AdditionalPaymentOfFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional Payment Of Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_AdditionalPaymentOfFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_AgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreement Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_AgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_LicenseAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License Agreement Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_LicenseAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_LicenseOrRoyaltyNetRevenuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License Or royalty net revenue percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_LicenseOrRoyaltyNetRevenuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_ManufacturingAgreementRenewalOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Manufacturing Agreement, Renewal Options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_ManufacturingAgreementRenewalOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_ManufacturingAgreementRenewalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Manufacturing Agreement, Renewal Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_ManufacturingAgreementRenewalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_NumberOfSites">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Sites</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_NumberOfSites</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_UpfrontLicenseFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront License Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_UpfrontLicenseFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=prph_LinebackerLicenseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=prph_LinebackerLicenseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=prph_EquivirLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=prph_EquivirLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=prph_BESmartLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=prph_BESmartLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=prph_PhaseThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=prph_PhaseThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=prph_NewDrugApplicationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=prph_NewDrugApplicationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272709734800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 10, 2022 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>option</div>
</th>
<th class="th">
<div>Dec. 08, 2020 </div>
<div>option</div>
</th>
<th class="th">
<div>Oct. 23, 2020 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Sep. 26, 2023</div></th>
<th class="th">
<div>Jul. 21, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 19, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,190,000<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,572,000<span></span>
</td>
<td class="nump">4,059,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseTermOfContract1', window );">Equipment lease, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Present value of minimum future obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,830,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,100,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate &#8211; finance leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.56%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.40%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Depreciation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 760,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=prph_NewYorkSecondFloorLeaseMember', window );">New York Second Floor Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LesseeOperatingLeaseNumberOfRenewalOptions', window );">Number of renewal options | option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years 7 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=prph_NewYorkSecondFloorLeaseMember', window );">New York Second Floor Lease | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod', window );">Option to terminate, notice period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=prph_NewYorkSecondFloorLeaseMember', window );">New York Second Floor Lease | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod', window );">Option to terminate, notice period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=prph_NewYorkFirstFloorLeaseMember', window );">New York First Floor Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of CLIA accredited laboratory (sq. ft.) | ft&#178;</a></td>
<td class="nump">4,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LesseeOperatingLeaseNumberOfRenewalOptions', window );">Number of renewal options | option</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Base rent</a></td>
<td class="nump">$ 11,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LesseeOperatingLeaseAbatementPeriod', window );">Lessee, operating lease, abatement period</a></td>
<td class="text">8 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_GradualRentalRateIncreasePercentage', window );">Gradual rental rate increase percentage</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidRent', window );">Rent total</a></td>
<td class="nump">$ 14,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_ConstructionAllowance', window );">Construction allowance</a></td>
<td class="nump">$ 203,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=prph_NewYorkFirstFloorLeaseMember', window );">New York First Floor Lease | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod', window );">Option to terminate, notice period</a></td>
<td class="text">9 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=prph_NewYorkFirstFloorLeaseMember', window );">New York First Floor Lease | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod', window );">Option to terminate, notice period</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=prph_CPMMember', window );">CPM Acquisition | Old Bridge New Jersey</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of CLIA accredited laboratory (sq. ft.) | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LesseeOperatingLeaseMonthlyBaseRent', window );">Monthly base rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 170,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_ConstructionAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Construction Allowance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_ConstructionAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_GradualRentalRateIncreasePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gradual rental rate increase percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_GradualRentalRateIncreasePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_LesseeOperatingLeaseAbatementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, operating lease, abatement period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_LesseeOperatingLeaseAbatementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_LesseeOperatingLeaseMonthlyBaseRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Monthly Base Rent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_LesseeOperatingLeaseMonthlyBaseRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_LesseeOperatingLeaseNumberOfRenewalOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, operating lease, number of renewal options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_LesseeOperatingLeaseNumberOfRenewalOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Option To Terminate, Notice Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for rent that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=prph_NewYorkSecondFloorLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=prph_NewYorkSecondFloorLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=prph_NewYorkFirstFloorLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=prph_NewYorkFirstFloorLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=prph_CPMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=prph_CPMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=prph_OldBridgeNewJerseyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=prph_OldBridgeNewJerseyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272796261856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Quantitative Information About Operating and Finance Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jul. 21, 2023</div></th>
<th class="th"><div>Apr. 19, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Operating leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 956<span></span>
</td>
<td class="nump">$ 816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">956<span></span>
</td>
<td class="nump">816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Finance leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest lease cost</a></td>
<td class="nump">259<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Depreciation expense</a></td>
<td class="nump">760<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_FinanceLeaseCost', window );">Total finance lease expense</a></td>
<td class="nump">1,019<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows used in operating leases</a></td>
<td class="num">$ (839)<span></span>
</td>
<td class="num">$ (774)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term &#8211; operating leases (in years)</a></td>
<td class="text">7 years 4 months 24 days<span></span>
</td>
<td class="text">8 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term &#8211; finance leases (in years)</a></td>
<td class="text">3 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate &#8211; operating leases</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate &#8211; finance leases</a></td>
<td class="nump">7.56%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.40%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease asset</a></td>
<td class="nump">$ 5,809<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Property, plant and equipment, net<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization', window );">Finance lease, right-of-use asset, accumulated amortization</a></td>
<td class="nump">$ 760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated amortization of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272705332688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Maturity of Operating and Finance Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jul. 21, 2023</div></th>
<th class="th"><div>Apr. 19, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityAbstract', window );"><strong>Operating Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Year Ended December 31, 2024</a></td>
<td class="nump">$ 952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Year Ended December 31, 2025</a></td>
<td class="nump">977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Year Ended December 31, 2026</a></td>
<td class="nump">941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Year Ended December 31, 2027</a></td>
<td class="nump">955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">Year Ended December 31, 2028</a></td>
<td class="nump">982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">2,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">7,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less present value discount</a></td>
<td class="num">(2,284)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">5,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityAbstract', window );"><strong>Finance Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Year Ended December 31, 2024</a></td>
<td class="nump">1,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">Year Ended December 31, 2025</a></td>
<td class="nump">1,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">Year Ended December 31, 2026</a></td>
<td class="nump">1,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">Year Ended December 31, 2027</a></td>
<td class="nump">1,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">Year Ended December 31, 2028</a></td>
<td class="nump">122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">6,830<span></span>
</td>
<td class="nump">$ 5,100<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less present value discount</a></td>
<td class="num">(898)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total</a></td>
<td class="nump">5,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LeasesLiabilityAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LeaseLiabilityToBePaidYearOne', window );">Year Ended December 31, 2024</a></td>
<td class="nump">2,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LeaseLiabilityToBePaidYearTwo', window );">Year Ended December 31, 2025</a></td>
<td class="nump">2,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LeaseLiabilityToBePaidYearThree', window );">Year Ended December 31, 2026</a></td>
<td class="nump">2,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LeaseLiabilityToBePaidYearFour', window );">Year Ended December 31, 2027</a></td>
<td class="nump">2,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LeaseLiabilityToBePaidYearFive', window );">Year Ended December 31, 2028</a></td>
<td class="nump">1,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LeaseLiabilityToBePaidAfterYearFive', window );">Thereafter</a></td>
<td class="nump">2,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LeaseLiabilityToBePaid', window );">Total lease payments</a></td>
<td class="nump">14,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LeaseLiabilityUndiscountedExcessAmount', window );">Less present value discount</a></td>
<td class="num">(3,182)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_LeaseLiability', window );">Total</a></td>
<td class="nump">$ 11,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_LeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_LeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_LeaseLiabilityToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, To Be Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_LeaseLiabilityToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_LeaseLiabilityToBePaidAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, To Be Paid, After Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_LeaseLiabilityToBePaidAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_LeaseLiabilityToBePaidYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, To Be Paid, Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_LeaseLiabilityToBePaidYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_LeaseLiabilityToBePaidYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, To Be Paid, Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_LeaseLiabilityToBePaidYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_LeaseLiabilityToBePaidYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, To Be Paid, Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_LeaseLiabilityToBePaidYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_LeaseLiabilityToBePaidYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, To Be Paid, Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_LeaseLiabilityToBePaidYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_LeaseLiabilityToBePaidYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, To Be Paid, Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_LeaseLiabilityToBePaidYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_LeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_LeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_LeasesLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Leases Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_LeasesLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272705085344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Customers Concentrations - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues, net</a></td>
<td class="nump">$ 44,384<span></span>
</td>
<td class="nump">$ 122,647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prph_DiagnosticServicesMember', window );">Diagnostic Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues, net</a></td>
<td class="nump">$ 24,849<span></span>
</td>
<td class="nump">$ 108,329<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Segment Concentration Risk | Diagnostic Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">54.90%<span></span>
</td>
<td class="nump">88.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=prph_GovernmentAgenciesMember', window );">Government Agencies | Revenue Benchmark | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=prph_InsuranceProvidersMember', window );">Insurance Providers | Revenue Benchmark | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">83.00%<span></span>
</td>
<td class="nump">66.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=prph_ClientPayersMember', window );">Client Payers | Revenue Benchmark | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=prph_DiagnosticServicesClientsOneMember', window );">Diagnostic Services Clients One | Reimbursement Receivable | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">32.60%<span></span>
</td>
<td class="nump">68.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=prph_DiagnosticServicesClientsTwoMember', window );">Diagnostic Services Clients Two | Reimbursement Receivable | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">18.70%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=prph_DiagnosticServicesClientsThreeMember', window );">Diagnostic Services Clients Three | Reimbursement Receivable | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">12.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481027/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prph_DiagnosticServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prph_DiagnosticServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=prph_SegmentConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=prph_SegmentConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=prph_GovernmentAgenciesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=prph_GovernmentAgenciesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=prph_InsuranceProvidersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=prph_InsuranceProvidersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=prph_ClientPayersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=prph_ClientPayersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=prph_DiagnosticServicesClientsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=prph_DiagnosticServicesClientsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=prph_ReimbursementReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=prph_ReimbursementReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=prph_DiagnosticServicesClientsTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=prph_DiagnosticServicesClientsTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=prph_DiagnosticServicesClientsThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=prph_DiagnosticServicesClientsThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272796405696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272706582016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Segment Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues, net</a></td>
<td class="nump">$ 44,384<span></span>
</td>
<td class="nump">$ 122,647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">28,145<span></span>
</td>
<td class="nump">51,993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">6,049<span></span>
</td>
<td class="nump">4,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_OperatingAndOtherExpenses', window );">Operating and other expenses</a></td>
<td class="nump">32,990<span></span>
</td>
<td class="nump">43,203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total income from operations, before income taxes</a></td>
<td class="num">(22,800)<span></span>
</td>
<td class="nump">22,908<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="nump">6,018<span></span>
</td>
<td class="num">(4,445)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="num">(16,782)<span></span>
</td>
<td class="nump">18,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">91,927<span></span>
</td>
<td class="nump">87,648<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prph_DiagnosticServicesMember', window );">Diagnostic services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues, net</a></td>
<td class="nump">24,849<span></span>
</td>
<td class="nump">108,329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">11,790<span></span>
</td>
<td class="nump">39,896<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">3,979<span></span>
</td>
<td class="nump">2,336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total income from operations, before income taxes</a></td>
<td class="num">(1,804)<span></span>
</td>
<td class="nump">56,389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">44,221<span></span>
</td>
<td class="nump">50,832<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prph_ConsumerProductsMember', window );">Consumer products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues, net</a></td>
<td class="nump">19,535<span></span>
</td>
<td class="nump">14,318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">16,355<span></span>
</td>
<td class="nump">12,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">2,070<span></span>
</td>
<td class="nump">2,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total income from operations, before income taxes</a></td>
<td class="num">(7,493)<span></span>
</td>
<td class="num">(10,824)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">38,358<span></span>
</td>
<td class="nump">22,080<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=prph_UnallocatedCorporateMember', window );">Unallocated corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total income from operations, before income taxes</a></td>
<td class="num">(13,503)<span></span>
</td>
<td class="num">(22,657)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 9,348<span></span>
</td>
<td class="nump">$ 14,736<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_OperatingAndOtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_OperatingAndOtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prph_DiagnosticServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prph_DiagnosticServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prph_ConsumerProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prph_ConsumerProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=prph_UnallocatedCorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=prph_UnallocatedCorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272796628752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net (loss) income - basic</a></td>
<td class="num">$ (16,782)<span></span>
</td>
<td class="nump">$ 18,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_InterestOnUnsecuredConvertiblePromissoryNote', window );">Interest on unsecured convertible promissory note</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">632<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net (loss) income - diluted</a></td>
<td class="num">$ (16,782)<span></span>
</td>
<td class="nump">$ 19,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding - basic</a></td>
<td class="nump">17,207<span></span>
</td>
<td class="nump">15,845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Unsecured convertible promissory note</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">240<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding - diluted</a></td>
<td class="nump">17,207<span></span>
</td>
<td class="nump">18,651<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Diluted shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember', window );">Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Diluted shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,073<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_InterestOnUnsecuredConvertiblePromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest on unsecured convertible promissory note</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_InterestOnUnsecuredConvertiblePromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480454/718-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272705545792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Schedule of Anti-dilutive Securities Excluded from the Income Per Share Computation (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount</a></td>
<td class="nump">3,782<span></span>
</td>
<td class="nump">1,225<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=prph_CommonStockPurchaseWarrantsMember', window );">Common stock purchase warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount</a></td>
<td class="nump">831<span></span>
</td>
<td class="nump">455<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount</a></td>
<td class="nump">2,951<span></span>
</td>
<td class="nump">770<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=prph_CommonStockPurchaseWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=prph_CommonStockPurchaseWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140272796473664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - Subsequent Event - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Feb. 16, 2024</div></th>
<th class="th"><div>Feb. 14, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_ProceedsFromFinancingAgreement', window );">Proceeds from financing agreement</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_FinancingAgreementOriginationFee', window );">Origination fee</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_FinancingAgreementPeriodicPayment', window );">Periodic payment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_prph_FinancingArrangementAggregateRepaymentAmount', window );">Aggregate repayment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_FinancingAgreementOriginationFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Agreement, Origination Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_FinancingAgreementOriginationFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_FinancingAgreementPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Agreement, Periodic Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_FinancingAgreementPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_FinancingArrangementAggregateRepaymentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Arrangement, Aggregate Repayment Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_FinancingArrangementAggregateRepaymentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_prph_ProceedsFromFinancingAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Financing Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">prph_ProceedsFromFinancingAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>prph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>102
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MUA\$7[2OLCUR(?B\/9PQ*K._,I"_/W$I?/-!O1VW?1MR^%]02P,$%     @
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M"+U3582B5X!%.B)/SI3"(G*[NT4FS'#6/0<B^X%*G[9U4BH4NMH,A'2']QH
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M;P 9%NT&S+B'K\L^)\!B Z;)_NAR< [2:8E,F(Y]$[#R-&DG2"R=!'PC?+<
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M^)*OA;V<J%25(K$K/6L,\@F.*9GWH"U)Y!%? ?C7@PG'F_B06(]>"!(%U6D
MM+[GB#O::S!Y'+ZTC",Q#(J32)(3X0B0;YJFQA@R(TB0K:X1F<: ^I82H2.=
MQ*'U6\,DZ",5D@Z%11(\E9U7P^J)$>)41 I$8*"58>ONA98-B#9L+N8<@"VV
MX5CK OR :GF*CQ6RY2.,1,[O)&V#AP/VB'G%R0B)K, WH SR+_Q:^&Y?/#5S
M0Y9GWF"\AS1":U$3,LH^+-P(,7P*"?P,X .<GS)RK48>NH%=J<3R)EX9GY#H
M3,U,B1;0"7 '"LT])M=%O,ED'I;M*)PV!L_2CXK1";-U<?:<I%?2]*-X7:/>
MDG_O"DD_4:9,7##0,S/,[0/^8*NNZI$5;6'1]BA&K%VD),;9K0)1^LL/ 5FC
MBZJ' "60?$X"$@A82=I<R[2PIX2:O%/_' RB 5^$JTC0I!%VC/@6>QW,WCZT
M%]JB3_QYID=QHTD,$/#7E)%DHK@T #XR.T4*$KY&M3_/FX;4N,14H^@S[PF8
M,(VWD+R:&""[%2B;4[2'O>4B  OF'CUK[Y;0,C[VW91AYR,DGM*H^)/+"PZ+
MKTQ)R\,T*U:AA%.3HO(UT$D)Q[+.*PT!HM=5U?LNTR M4Y1:[T=]"E#&!V9#
M$07ZJ;%$(/_#NX2%2)4S/(I@41XAW5/0E:>H_>1T8QQ'CBQI#]8!AZ>)AVUX
MHY$VD#K:4MK+$0MK5P&V+"F)L01LZ\*,/OWJ$[J4"4%EMZI+. O>+^'%X$[O
MC02VTL5QF,-$HD5J"@Y-428>S8JHS6.Q?"?)1O2!)<ES$,:"Y'AFVBU6NJ"#
M^)FBPFA") *?:R5?%-:*<M</$*S1 8RTESN.LBAG@>I-)Z$B..(4I +S"4=\
MEQT[8^)'$[@%3&N;CC;T)#LF1%1W#L,\)R_0H1H\)C<HW\3U7\-61G]]AY/=
MULVFILUD8_4D.Q]=3J_A3]K#Z4OXV_'%V>2$OIE,GSWBB6&"IH\CZ-?QIW&V
MK,&J56Q99Z5=BCU\DDU&%]<7\.<53CJ9GO!'SZZC=<0O7(Z>G4WAB2G0>WQ]
M=I)=C:XOS^"E9Z/)]16]/#W'\8Z?TUC7HW-X\C>C9BTD /9. RIL%N$(R38:
M9M=@9QZ%.ND;Z^[0Y*UMMX[R/#.OA>%D 72RH*&P^H=CHT $8C&/_L.0WLLG
M>BA"7.3(-O0F3'['T4.>>@X3@?L#]K ,&AEDW74P!2$P+[&,7\9:*^7@_"H>
M&U$8U7\1@!H;0DS< '9?LT.-#!#$BO:!SGJTM:!ZJ[D>FA5E?><<!T$8C4[[
MKQ4BO^ :)!.R7G>JUPN#X(M/[->2-*&4A+>+#82@3 DDU/,YJ5)B*T4E&#P#
M^%A@3#>'O6IM'/<BNCDX%56C@/GFDCHXUUPQJ"5#4C7G>:193=AJA,.5=Z ;
M++^-RP,DQ?\5!H$>B^P/JNZ!AZ0,+ZEHE)K"C$IO*1#/&I1BS@-CR!D)&=C4
M,PC<EFP7IQMGZ'>WMD7R&?MX# ]SHB\L&$P]FO"]SY>$30[IIC30N*GKDNMS
MP$LN4M?"H^$VT?_ 73QUNXUQ+X;DDH,J08[I^5Y<1!Q8SEU$L<YH%;0(.96B
M2F9,[R!,5_^HK@81.R8<,*83?'I$QL1L489H45B0!Y]EG,_T!#LF>2#4%@SE
M9:]C-H:JT;IKJ=:,O)'/?"[-EY8\"G*M,>CHBRF$<1S[+% 6N-H4GZ0Q"X-Q
MC[KQI:R)"DOW&71J?2\LEG$UXDOE=-X99H$@J!65R$6RE4A%1"WI;M"]F"T"
MLECHJ 0$)%MEX#WJ"V8:AH31Y:#$M]:?20%-ZMYZ0DC+*R6CN."/!8&4VP;#
MVEO &^:T7BRP/B]2J8.:U)<$L5LWBF3)!0D2[@:90*LP$*81(>*QQH.V .<F
M/Z]0W8!60_0#"Z6OJQ):4"UV'-"KPB-X+K*U ;A3U&6]W$FV "<#?TT"CI*R
M]"=!7X[.5G9\=/O#[<]')P#ZP5!$5".IR,P6Q7>!(9Y>+"+VR+8BDVO,T$FI
MI^<D#=55I;T#;V20+VP\+:?0,#E:^-"/5SY]=+>/Z_:!U6?2;$.:^4D&/M'D
M&:&V9Z/+J^N'+88BNNGH:GJEK^(?SR^RGU,5G1V?CZZO+D[PS\D%0*O/-:*.
M82+.KT;GDW,FXNSR@C0E0^>9X1P%64)*% ,G4#-N\\9S)[AL#RG/8Y&OA('C
M[(U9VJJB+(:8-?;E_BNO.@3XRE9"KQ=GV6V_M#T.4PW)%DS];'J1O4E&W]\V
M'!\81JG =]:A2N>LWS9R<9Z<1<DW+$Y(IL'XMD]Y^9B?!Q)T>()F(.[MV3P%
M&5Z.]1SVI)[*GK6DZ6MV2U+\F.R44+&&$\&BP9HN=$UL)*/0-$<%\N+W3AU6
M+='0XTS)NR2\1V^S18CU)24OS\?/0_*R'2PD&_B475X!RD,)EX M/ C A&M:
M]0AX-NK'T)(<+LBG]#8!F9IZN:*"3>8)VB<<BB)MS(6Y;>;@)K0\7A3&H,H.
MS[S4H-9-;) 5B(6:@1"[\S4F!%9EEU4L\KC0!+?@U!!FI;X?7>18 F ^=;_I
M&G G8JB2N@!11I73GE(M9>XQ9U92*LFC<$8,% #XW<25MP%G<_RB<?UP;BSP
MO \XCV1PO,$9#WIZNL: #HI!2:(P 64D6UK[/-^P75R1@J<Y-!^'T $QK2T-
MFV\UY_#HRI0;C##S-BC6W=L'E'0,=X'=D+IQI')$R+9K>1H8S=5KL\6E:#)3
M^S,268I]O5B(,\H3^(W'DQG+]$LOI5)$A([*!IF-Z"TI?90RA9T76TH99Y/G
M WX9V\H&46,IJ.Z1RP\>=+R(*#RMP6"N-*$ D@B[\*6K[!_HFG[3H9/0;3QG
M\%E3_3[MZ??+2#^E^ET5^K]1RP/C?986.8\%A$U-"2E0I=.(U,%)V(ME!D7
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M"CF FA;]GV405_\>>U%]%5YIZ8XFKVGIW;$_VX<5TJ-.]@QODW[[MQM6>7<
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M+W-H965T,3$N>&ULE5=I;]LX$/TKA-LM$L#QE:-!<P!.FG:[:'>-NGL B_U
M4Y3%K42J)!77_?7[AI1D.;'3[H>FEC3GFS<SY.7*V,\ND]*SKT6NW54O\[Y\
M-1PZD<F"NX$II<:7U-B">SS:Y="55O(D*!7Y<#(:G0T+KG3O^C*\F]GK2U/Y
M7&DYL\Q51<'M^D;F9G75&_>:%Q_5,O/T8GA]6?*EG$O_>SFS>!JV5A)52.V4
MT<S*]*HW';^Z.2'Y(/"'DBO7^<THDX4QG^GA77+5&U% ,I?"DP6._^[EK<QS
M,H0POM0V>ZU+4NS^;JR_";DCEP5W\M;D?ZK$9U>]\QY+9,JKW'\TJY]EG<\I
MV1,F=^$O6T79TY,>$Y7SIJB5$4&A=/R??ZUQZ"B<C_8H3&J%28@[.@I1ON:>
M7U]:LV*6I&&-?H14@S:"4YJ*,O<67Q7T_/74.51^*KY4RBG"Z7+H898^#D5M
MXB::F.PQ,9ZP#T;[S+$[G<ADV\ 0\;1!39J@;B9/6GPMQ8 =C_ML,IH</V'O
MN$WR.-@[WF/OIG)XXQR[-<5":1[YH!/V*'OV]W3AO 57_MD%1'1SLML-]<\K
M5W(AKWIH$"?MO>Q=OW@V/AM=/)'$29O$R5/6?ZQ2_],$FWOT V>O%5]JX[P2
MCAW5J,PJ*S+PG4V75DKTH6>_:8;2R&(A+1N?AO),^LQGDH MN5XS2$DK$Z:T
M-T!XOZD#TGKQ['PR&5W403R6"M_'%X=]-(7/=@7[3H,I!UMV&J50X$;EKSY[
M__[V@21>U\(DBT3,4B(LV_46T]M6F^.OM&X375E95W%DA:17F1)9GP';7[BN
M,.?8<>3Q-E!EG6S">)XSDX:/G-!R?69IE+B0@ J .CS5,MLQ!!F\5I;Q-%6Y
MXEXZ5DKK,8^57E)$C[4H\O'+"W9S=S3'*/;LSIDRPPSF.9M9>73+M0 ,&Z#9
M7* DP> G!!.\BNB$";!,"6@VT2LM\BHA64J-$LAI!E<0*:VAV-9-AD^PH&[.
M%N4!F\*:X*7R/%??\!W %(Y5+M -62K'7#WKD74BG;!J(>,'M+1V/'Y<5)YI
MXVEVHS\2AHI+&' 9A9OQ>QD0*R2G?,FF9UA^8$3PTF+YF*Y]A,R$P<)*I(U#
M!HJ[=)KD^HQ[ &@PGI;;_#A0AZSD*ME=0/;\>'"*=9#GY(2*P!U(A_U0 51^
M&%6DJ*@7?S4>01:F D%!HN>CC6J?'2RB\'O%%Z /2C/C:Y.F787QX*SU194_
M$%%G9DVAG#/@>/#Q6/-D-.J/\"^J*>0$^4J&K-H>9.,H114 U4E1F** ,VP_
M\1GMQ2V[YWDE*78(GA+!HW2_:8L&-^#):^$0.BELQ ?LDP%]'A0IX+SB0/5D
MDRE$?PS#I@7WP='!@:U M>@.-:/I&;TL>$X=U^2R'1T%%E0V5&%)94-S0W@M
M@8ZDQ;N9S<WJ'& ^,IXDJFF*Q]8?6-XFX4I1 U/%]M0F(AT,/)\,1BTDW;[^
MH'*,#*.)PU!IQ_-N8E<E(4H1%-(*1:T> [V[#VL#8#1]^[UV/(S@/O ?\+12
M&)O(+4SQFF,NZ"-4W)*OO&T)2"E,JY0KV^%6)V$:3LYL@Z?(#3:MC70O^7I/
MRC0C)!=94WXGD2HZ.D=545LJL.M6/'Z/K\%L99)0$ZD%29B(2JHLYG0"IPVI
MNO;@,\=QO+&88&MT&FD7\OT:')R9*YA9Y&B] !;2PT3&,[-FS7,?')[^U)B;
M)O_B$ L(WEJ# ]@';I<JCD57(>6IUK079B&-6*^P1MK]R!(#VM&X_@)!E:YC
MG1;-B4YT3G0(#.1_,YW?L.G\EIV/<$39=?1S<1[!/(6(C RZ<H']ACN"H!9'
MN!0A>=)U/'QS: I=A2[2];()IX4GA_P6+73@5T(S9-(=X=T5);!UH1?.$G%H
M=!=?.%R1S1:DTJK-^-@31D37A_GW0/$[6RK.QK/!^69MU)$10B"2X%ZVFXIV
MO%72T]''2Y%IDYLEY>VY7BHB2@=1 !'CZG0-+[!MU;>&G(W<8PMA4M!IG0X3
M1W38I0L:+)A[\( Z%HVOBA <C@EIE:.GTX!3BJM@;*'!KJ/YL'.A0C<LP[61
MR 9RQ+M5^[:]F4[CA6PC'J^UD?&.Y3*%ZFCP\K073S_-@S=EN)XMC,=E+_S,
M<+N6E@3P/358)O4#.6COZ]?_ 5!+ P04    " !DFWQ8NBR?*,4#   ="0
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MJ!V ]DNE[,%P 8:W=/4/4$L#!!0    ( &2;?%B<&;>S9@@  )$5   9
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M"_!\;0"SN: #NJ^PU_\'4$L#!!0    ( &2;?%B(.9.;V1,  .)(   9
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M8&!B*=2(W=("P"/%=@D36J\,6%X<7B#;\#L!LXG<S#>BY322+@M>IM@QE24
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M3B'N\;6Y]$ ';$FQSHD2@*W 42V$RB)5^C*.+M0/SO0^3VMS(&3T>8O]%5K
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M72URG$4T$@[M%J/YJQ>CT^3]$;:3CNWD&/H_WLW_8L&7$LFM:J%WP&/LZ>/
MDW=IS;*D)P^?1>8&<*WI-B;)Z,W]6[@3VTJO'0A=0.]4&7$ @N<BE,O[Y6K:
M!-(1X&-'54NS0W3#/H'7[E$*T3"!24@5%L,$%D!@[!7*;*BH607K@-@&/X9A
MFCF5(#41[/G[HLR7C1T*2ZSY80,]2U09VNYI!GQ:I- @D7R9#%,:5BF#[M!6
MWS$@+7,U!C62N^%3[R3NS;-"NPZJQ22IVW:T.V\GC!>M'OP);U7U1M@U7Z?$
M%:4FPW<G$=A6J5K#FSJH0V8\:4U8EB3N:#F ]E?&^(/!!;J_B_EO4$L#!!0
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MLBFB(. ,^0G\F=0L2>RU)Y4HE(\H!2U-$*@;25I0!I*N\'K*!KE?0PF+>ET
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MAJ6UZ/TIAJ6@V5-.G=\L<*DG:K"B1#HWKFZ+-L7E=W0H.QU$Z%0 PB*#GMS
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M&@TVJ6H,_$H#B1K5A-9*]A)D0H505:9:^DF,53G;)^*1 7@JSHD&-3C2 C8
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M^,Y^&?#N #5CZZ7PTE!.AE(,GS(P.=J0?CA$+.!'0\9!/,^B;X@N;B_%Z='
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M#P/0]8NMGEBU\J^DA;+TYO+#@AZYJ)T![>>*=-1,W '=LWG^'U!+ P04
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M:#M/"U'L@%PS.R&5**@4HE[I7(]5($:[P413BU2Q,AC@!5YB"FQ%IG]3:83
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MY&JD ?PDPZ]6@#J PFE15'.<')"NZFHD'R)&V'X#H&KP41B.E@,G3BCM(;H
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M"_']R(VLS0MM(Q^MK%9#KX7_LV;7AZ-,W=/4S!6Y0]"PF0\K!.4%L=[S>W<
MMXWS?9S\%$9%7Z9[:&RZ$F&O)'Z-[+Y&O2W_UF42<Z?T ''8 )^983(5*GXM
M)C-H?@^+O2P'HO<69=48)G&(/5][]GQ]D+G>JO9,OWP?M.<A/OT'AT(-5"D2
MR:%G<!BK1)P\<(SH&%+EIP;!M>8<P J=;$T3':)UF/!9]RV!,2_)V@;*7.A1
MQ#K"2?155)03PHOBQ##XR&W%O-'(&REJ:5V33)%PD F<,8(L@ CU/20>9VW[
M9@6<[Q008-W;+JI.P8H[=,C/_"$_.W@R'X(1A( 8.MH_,4"TI,E92!\].SCF
M3\%FO?.['<P/_0/CA&A52,Y#C=/B&IF=L=E-$@NP!(["VM$F5>441,(I,GEA
M8NC<%LY$3))9W?YI>N8YHE#.EB A"V')B,F@*\'^+BBRNP0;N0DS^M0:GZQ#
MX6'DZ2NPSD&14V<-;P8=RSLC@4K06.?T_D6BX*TS]M=3EA5*3Y$.QR+@3Y!+
M[O-A,*4$-,^(0F:N?2 CJ71$3IPN)F')5+.]C:_?Y"4=6+"Z3#'\6&S9]:R0
MA56#9BQ>5'@</?>@)0#SV";'J!^;1R.MTGB'3I)C4ORJKD'?]\GS?>X)T -1
MMT&H_QR.TOSZ!B>[K6I0@? P629_DYR/+J?7\)/.</H"?CN^.)N<T#>3Z=4C
MGAA>T/1Q"_IY?#>VIG U*_*EB/UODLGHXOH"?C[%22?3$_[HZMKLP[YP.;HZ
MF\(34UCO\?792?)T='UY!B]=C2;73^GEZ3F.=_R,QKH>G<.3OSJ5WB$JND,-
M* H8A8W"7FOL42- J8G_T#?H(P#)OLZ[M0E^SSQ_)QL6?77D@>& $2R"O!^D
MTC0VI.1=G[0>"IME*8(-<.;!I9\XI,)3BV5K+''28$%?@"E(T?08RVK:(=8_
M,6GZDX/\T;N3/GC5=83QJ4%6^\>&&G19B>\3X[\@$NN<79]J)Z @)-;S%4Z7
M,> JZMO!((LF9!VT4?F:.51Y:^_R.!1(#UF+C#VLS(IN+W'V:CXGSDZG3&YY
M-EE Y5M@W"T%U&ES&YL(?D#K2P$]A9U#P&8X,5ZS4R4YW,-(,T\ \] (*=6A
M $B\7+4VA4O2L+X (&"K1ARB)!EX2++-H\1]=9I2L0@Y%)FA4UQP8 PAV9 E
M$]MC =J2D2 >#8S&M'F+RV<ESUM.,"=&-47S53LR?.]CVN&00TI ' S:5%7!
MJ:"[3AUO@[21.&(W8KO=N.;Y$%ZR+S/@,3W?"YG9"("-1YE=T":$20AGF_%Z
M!XTCXSP<LI/4&6;\7B,!=HA5""(//BM>,UI/$*OB\D3FQ0:4G/47_9\ #J9+
M\D6WXM# P)!/>!/ <7PJ0US@H@I\DL;,'*9X5[6OV(@X:GS.P.*K>P&QC*MN
M-LK<]BX(1@C2_$PVML&M""O,:MG]ODHQH@_+8J2C-#W ;,6!=\@O&&@8MD-#
MCY*3--59DAQCIX)?" D=7<G(YI:K&QV-'PP]/H#ZXTZKQ0)3P0U+'>2D/FV3
MC>F1P:4F8%!PWZK?M*J'G&."1#S6</B"?)<M'9O@"TH-X0^,E#[W5=:";+%K
MV"4;'D&Z2-8.M*^L*JKE5B*Z.!E8R9(I)VDEGA+T94-;R?'1[?>W/QZ=@'$'
M@N*@I)T&23L]*![?J@]GOWP].,!PY5<\:N+_Q%V3INIABMDA-;-;S%8A:EE3
MH@VA#"6QG.;E2'[#8@)"2.^H?//VS;O@J(33YC065+OH&&FZL5U"Z]::79$6
MV_]F^/N):2&>=0P-%A).@4$B.83X4IK]UJD-A3.84",@V4#DC,8*J;VQP6#\
M:[C:QA>G])7Y:-CXCX$(C&H2R,YK-!1 ,X:5H%Y[=?XL^9 ^^*\:^.SIY!G^
M#]_\6M6?$JHNHP!,<G[V-+FZO," -$=3EU65X2N7EY/D_/*I ?HWR<7H[-DS
M^GEQ?6V^"< 3[$F.IY?78+!<HJ;>0R0T%JXO)O3SV=73Y! )A%+(R<':Q9?O
M:\R30%[\ODB%_Z G:(/G.$@1?V*\)'R[\=\Z_VULNK:$C*2\=(UDX8(&@)K4
M*25!,5?A@, :K$0ND (Z1$>LJBW!(C2>ZPXL'THW>&T?%\.8M"X:D&764'E<
M4#5J#F9A1IWW\[+SE=R\ST.2%97,K-$[+"[+4T#&4KQE]/^A PW5HI/#=9X_
M8FKIL%OF,2\BH4KJGMMHL :%6DT[Q963. PLXV'EQ.9R]BD$8\49=.S!H)0;
M%POGKLQ_1[LBU:3->5[/P<YK69"K?BWVF!E]G/Q4-9S%X[P3DEQS2TS75Q/0
MY_<H:DGBO4P?J<G(8TA/!Z%\BAAGHBW&]<>>F'+)?_&>3#!F1&JZ3WH+6=B.
M921%S=D0X,4,K\5N#"<B#)M,>UY5&AW47%0OT5HKBZWWDU+6>4[!!5XDK1<@
M2<HA541IN$&/)H+O.XUCX5HQPSP\Y6@3,A'1"-D58<RN)'/ 9R/7E$C*1J;D
M+FWCK&2:PE:[[0!6I5*..%6C.EAQF'[PS"PGB3!.4<J[C'@BT:\:BG"+UBM*
M".BEL."P)H1C*#:V0D_LV-T%4>B:0AKBO4#.Q**8=$]RTV$8ER)#8B-F;(]X
M_QVY:G+,KISGK0)=\ 1@'-" \S(X$4C)E'&Q7R8!/+,@%"0[><XI<IA, P!6
M]M;ZM O0V!"'Q5-.:4JTIK0-QJ%$_NE]5F)"9@A1'NLOL;')^>_1,6BF;+I6
MM7 .0H-R]Y(F7^=%6B>>',G$UT^]:>3*^[RN6*L^#J%T4#:8TYUH\D94/BD+
M 8*7% :M*<R\^Y.?,.\=)VZ\3,:C!"@8E&#E^&"]M?/QB=:^G.Y_3]*BL0R4
M$[%<R?8#9_R0G2&C\:(9^KSW4TKC9WN4/O9)R[$1?\P$RZ)HV_O2A -QJ6&1
MH&\#?O< 80DJB@W#(%2@YIVRGBAV-K\/*@<U^U 8/SE<W_Y/4,:(L> T;P&I
MRR5%@V^(/PQ*QS\S8.*_]DZA1K@(*8L:E8^<U>JU":= +1#$+/*,:/<EXW=4
MJYN-MCWI 7/A.D0GIH1Q/<->"I1+%VTO#]N3(3,'K(&P0_U;8%9C34".*<[Y
M(DB%5#W62 <MN>&!%8D.CP)"N5\(>'-)>+'MI^#D7,U\+^6*QH<;*0GDYM/:
M+:):6 *NZA,61I :P!P1J\'V0#3HAJ"14"1:,E1]Q%#C/$[F\.Z I84<NV "
M_"3NB?]19M_;TAL@" 3_;H!&*%_#=56L@E%F<]VT6LG,_A.E-8FF5WMT,JKF
MTB(,@B8K9A$0"SPD*B;S$H-GEOQKX-F#4/7NI"_"%$L76"E(RQBT+ @ . OO
MF?6M"GR"IY:MW'OF$6V Z\<JWYK$KQH7^34K3[]VW62[EK8>E];\4)T"U#<6
MSRF'19:DF@#N.EHZ8=!#WC"NL1XCY(LEA5(7=V@*EA #J.47(*,$/T1ORQQM
MPU0]=,WY+*!@X'P!9*2U<I\-+QMB0J)M[QT3F:;+Q"?4(\! ;@>6+D#FK0N0
M]\X6'?#0E'CN 8CH/UR&6CJO99*>[%E,;UE(P'[&*#V%ZF4<68T16<<:>LR>
M6\I*QAT*7]:-[LE/?OLE?NX9^;V6WOBX(^EPL=W-*IS*I[S>D^&$:J.3\)[_
M?$'PMG[I>V<C.:PN8V<)XV,DA2:?89VB)LN2LPM=N_JGI$B+:S-$^0ZJ$Z&#
MP>1P]X"W47K6CVC^_4CI60?TB3\U8A2*T!2F@;2PH--MQ+72]ZF4F1ROO+DC
MW$=]>8SU:%C88H5%R-D-^D,D0/ LJ/6&YZO]9!L1"X*!:!$A!E.2,%HM2$B8
M7<R&2D1RY/\E,](;\+[$D(8+Q441Z4:,A,L$0'7*&W)WN\S&@CVZ4<B!JJ&E
MFHN T%$-<D,% ]H(JK>O@?4:?VXZI [V5FL!Q'2!Z[!\0PO%%K '6!%Z-II]
M!6,]YVIHFL0N"*_'17C(3ND>EATDH9!5/#F<%$RI"K_H1D,9S]N0J#%(1G]Z
M5*IN 2.CJ_=KR#:9)Y@W'BE A6JY)P<>I!;#2E^$M&M75:U\>]GE["M$_V,8
M4Q805?+T3 5!)Z/'SISW!:BU18E,FNB;EHHL&"#*N71 3 BT9&6'VY$/L*"I
MQ;Z($3=CXL+](NJ^Y@W=@00+\B&@SV(4[8[=&R':U<^#'DK5X#TBF7'/MKF$
MCOR6_/J%W+X6SG%X4-,;J!E'G:X=MI DUL?O]/*.\/ASTJ%1O4$7!)5ZUFBS
MAK]9%)*<FVTY5ZD9<5UF;E)S0?.:K\C5B?Y!QL-\27S!YS-1B)C4EW$ON4IS
M9':?E$ )SLIEOHSE81O/N=/:TQ?)CZ0839XG[V88:.#T GD33TB<.Z"#5)S$
MS-V.NI(=7"X[83%!]B8N0$C)G!-G84KSS5!<%J]@^AQHDZ8=GO&1D\CH$I16
MVY-F?C$PHCJ''KGH%PJ:*F03Q8/Z>:L 3NT@,3C)"U98 L"YBU=-Q&US#3B]
MCYV<U4Q"YUCD&R82:@(VD+*67K/G!9WU6CP#N%#N /_\>?)S6>T@@)R$[RW!
MHL(+54O-F$0H:6-[49SQ/[)'K1#[2/FR_6QR:^7,G"56*6OM,Y"!8@L:1CS-
MVY !.IC[ZY,231.Y0>$P\BY:+J >2)\Q'V[2K7R"#9)*2G-DI[\SWX6T8]&@
MK<-LYN9IUWAUP(0>HN)BXIM>R%$D0%;A<VOVY%L.9*YJM/= SA[,NK_FU925
M,*LU6:ZPJF[=L7M1"[O6(/E6V.^7>O517JK,U"\_WTWN#7X@PZ[]_"$;*L-@
M7A;G1?F"@5XOS@%/\/[LV@.QZ'V)I<)]E0<J.28?22GM9Y1R3FC('>6?(7<T
M_'8X>_3PK(?31L,<G"VZ^\F^_-&+9T_AB?/+"_^&II#R=]\DT]'U^30:D;-(
M/Y*]2!VBRJ#)? GU5%OYD24B;AZ1Z3QJ'?5E-?F@EAN*,R:'2RJD'PCF6VKI
MTZ!6^]6C1)W#?(65B.Y(C_0:(/?H6.>-3TZH:I,(49F:8<KLBC30*-C3\U)+
M!D\O#<BKJEC8^5FHE,\ BV!V5C >WM*#\::Q@F>PBYB5[41E<]>P(*K!!#3*
M-O%1$!_)CM.X9%^^OU405KFOB#-A(&-[=MXS&72T!7(R],8USY/CR8GZY;?Q
M-)[7ZO)?),?3WL-[M@Y/GI^81?J3%IV=]!)XZ.(D=,$<?$8#,GOGH98GER?[
MCN888W -=UVA[,^M!WS#F7,#PU)C!P.#4+^*L[TW[[PSIWVS9S0N-Q#<YJB&
M/4EC F74R P^1NPSR!>:/4O7G93[F4I.@LHM]DO?^-&]2K0+U;PQ 3(8G?HK
M^>GW[(.SB$,[P"8"-?FXTE"YO@<2!NWO4E^<K'T!L-^;CT[O:6?$R\".HLY2
M5B]G(JK@>BCA"6PEES=1U*H'5]\@B1<U5!*_QZ^C-76XB#6UTO"]9P_/47VQ
MV]C0=-I,3*,S=GK;]C&>&/TQ&'WEOL-P'*'32:\MBS0LH\"T[_3Y,,3_@,F2
M^NKC?Z3ZJ3)H)HO2E3UF[L&31;6WF54X?7/V>6,[&+:KP+\S[:,1@\+Z*S%A
M'C-O#JREUTIFH+-9;WK30YV<5"F91IA#1U&-G:/Y0M,Y7*(ORMHG;<P2-)7&
M-@:E40VFEEET/DTD:R.A!> R#.0],9 W.PGQX?V0&)\&T6]&P%;)M,!6<?K!
MRV-Z!91H]ER&1HT:2DK[=1::=C+03,*'_,-X-$8^9/,1UTIKG^DC 1,I=U#E
M3 %J8E*2?6H2<$S9-VD->BI#L*(@)N4Q46)M /E;:D>U)2>8,%7/_FF%!)HF
MZK07PG68;M3D:N:#*:<QW%;*/U6I>4W].,A9)(E=4G!N<^,DB58[HQ7I@W!Y
M*EP0=QI_0!4J7*L4>G9L@U6:2KHX952.DI\<^N%KLJ?X]SPT4PTA:J/WQU7U
M\BAK9[ATR9HB@+.FJ'W/U2.*YX6]$/*218Q1%4NWK 0MU>\N59$EV_$[YXOI
M5GG+Z2PVMRI.XB(PH<4'&EA>C1CGE3*$Q6-4+LH>76/&H,<J]1=2#FE;^2#6
M'JUIT6^8+$Z'>ZQX].U BIQ*D#VGI7?'GK;W,Z1'4?8,^SR^_M<-L[Q/H*:P
M.YB"8)X%QHWT[O.4IGYPLP9C?(2QW JJ(KO#2WZQ@G78(89&9?]2KM127/#1
MF* 7-DBAU*'SHJXX?9W98W[R:OJ*?BM5?02%#:O\0I9@XP!M+9R:T&2'H;3F
M,_D*B3C:@Q=Y(UE7INV2.(Y];T+-WTPEY\:AAZ.A1(=E[0)'()U1,[%\A3RQ
M)=(%J1$A=VGS75[[ YG^X8AN4;%.-&*PUPA[N1]H),YC33 O[ZM\+B=?\H2R
M7P4C3>*IA49D95J4!NIMPD5^0840I:&GQ0TI)-K/F;@NE8*A"5#U.C=D QT]
MF.>9"B&;7J@7Q30BVPHSB,TCQ7[/PG5] 5AN<WU-FZXAK#*BZ->0BF!Z@&B1
MHFCN!S=@\O5Z%]8(53$E<8V'+4*34?OM.=AA:<*\D67D>8HTL23RU<YB6MN7
M@5:0SGV9[)=/@98H?<2X-LD__J4&K/:"#"K'PM>XI\=66'4/?ZBET+KB0G8_
M3<542HQ)FV1K7\X1TQM"#KL25 U5EDI#T/PD] T-Y6XUXKPC0Y-#STY3EC.'
M 9^4@XF;7)@BKL9"(5]C78*O/_-%>]**AW5CQ0^?4XQ[(:<'I1^B!U[:7/8Q
M23,Y@:FCC&7TZ?19=TI^Z7MLX?:K)+CL'$V88,,)T'3\P95DRG:D1.D=\F9T
M:YKK?6 ^^?:#0Y^[?![FW3,G);B;G2DAYY1SQQZ^33K_A->=8).H?-G5XG\@
M7Q.7V+2:HTW"0)+=G+>436_;V$GVL))T&;)'NU("DFA'9LB:6$8RQM;;<!^"
MQ4U<.V@0G?-A&M0_I M37\WU?7Y<K*U2&G287(\72^(QZB.BAFOGB#U)E9T&
M/AX06_ZR-_ZR-_ZR-_ZR-_ZR-_[?V!L?O*=/%=U?U?FH?K,[XT<?]HG3R0[Z
MS>PXP1^?MWL]@N+.W52Y%-CUN@,\UOUJ7';>F^KYW,R5;D%9;(JQEL]+;2"'
MC*)9D6_,N&Z0#J8J&*G5A6K\A4ZVR\TM5'#OWW3:V_*_V07<[/<!(QR&?,#1
M^H?7O>,4CKS.K"WZ+.=PE4#E5)R0#J+R#U%T%-8Y3TO)Q S)R$#Z>&>*;:G-
M\."[_H &W&=7SRFV2+I4J$FGVV=  ].Z=*4[FZR*B< $_4'O>6P@Z7A>A%-F
MM?0S]@2'.]@)2+)F'+H2D#TDUZ :FX@2:=3.H9YW XT*N;+-WTAB9+DR1X'R
MS(&2F%>UM$#QR^^QGU")FO)Y1-$ _Y:P,H-+PP&'1X<-DG'$6ZR_VQJ57Q$K
MH%X1&H0Z3&(40Z#G0=G>[-(3*AAHD/D:&!-:$D;0RR/N#="P1X*&)_I*]0*'
M:!IE+M2\)G2WE.XCM;\4KG8/=,$C9HOXD!?7J SNQ\0Y7^GMM?MR0G#\@9NR
M=.N9]L=0O,';%\['E^'V!6Q5?CY^JA^,3+D%%E.A88QUNP>B()2(0S0, UWX
MD;6!=7\%>^][^$B\&RL7,\X[V'G5M'I",XRNB6%W$"RV8KM+&<@'NM+MM><?
MC6_L+#V3I0Q7%'E1('N!U#T([+TCKWLKM%VO]!( T_TJV/B4:B!*"9IX?4>:
M<5E1_S&]B61?4UQJ6BI5KX\;R=-\L&&4-0KHZ'KT7GY%_T@:$VXVHCM(K]H-
M&$F]TNN!/<VQKTT-6B"I#MA]2H/]T59[]^6(E9I2UEFKSL:&FZUE?3O<E8?6
MR8?3SZ*5Y*&\29?+VBVY]3/:OWU4G6VC_8@KYM$M!/?D8ME4GO<\Y-EIN"H=
MDZ+.KZ?T\^+9LV1R?CJ]T"^O+L^2I]?G";I2DO#Q.7Q\?O54TKDP&>R"1C@?
M75Y>)Z_#3H6FO=X9@\%OG)%.Z$:O>S XB$5,?']#"V86WN+]_$L7E'H#$'2)
M(>/9AU'AP\'+N]@[%NHHB [-ZBT6T@K9/ Y+3%*\0UG[2MG.VM28'1T6Y$78
MY+ )ND9VI;>XC$*%7V@U'VY?V5JJ)NTAE)-0FJ#I>>^+TOW]55]&3J/1^^A^
MA*.2HD3W8!('>,-E(5%:VP[BVLN&-"ON0QC6$^O'[<8-X/<N9@]UV0$TOAA=
M7V#+F\D9)O<]"X(Q9LC/1A=G9\GUZ.KB#);10QHDBJMK;#EY/<'[R?;C27(U
MNKJ\2BY&TV=70A!>[>3>.1<70&#8N'("4O;IQ578Z6UD.-I$!FSQWH2F!,B%
MI.W#$#('6EF0E2:Y/_'MDC;WU^2OACRY@/EW'5W*[*]AY0)1%/&@5)6F!9BV
M3_+MY4R@9<LE O9^$_7Q6%.,[_ BWT(5+IM(P]T*- WW/EE*Y[2PTAB"?;MG
M8,61P\NT.*1>/BQYHZ;TK5<P^%K*1B1(W!W1'(KO8H\KP%X9OK&(_T:;RMB[
M!O;F!W-FU<?T<_+]9S@'[C6O-NUN,@?=X,+GY9\RI2G^CKX=MP\VVV[3STY;
MM*@7)OC/,%%=*F'$TTE>D@H-3 H?L$W!UHP&>:1!#IW$ L CP#UE6B(.9)9B
MCGTG3A?V$VS@.]&VZ<4?X#]"GIMPQW@O-[VQSZ_T>7,GN;^'57W&3?1MA26#
M"^,KI#Q F_FGROG!I-[0C'MRN)GV36B,+^T?I%<+]K.2 .1@EN^?'S;I/^3[
MQ(3@IZ$'0>Y,T5XR!W-ND^7+;+FGFG1_P<C1(R;I=<=BLP'P&,TUT+Q0X0NC
MC+3/#A,FNL_P65'XV. R%S7?^Y5+T&U>"?%Q?4!_,=( H");3YW-2MCVHBS!
M.M&0S4K,=8_>1L1;_K 7EP@8X]C:.TR?67T5*(FG=Z1[>M4K+SMRY7O6LU^P
M4Y[\-Y/Q=6P1G@5#KF<1'J"%:6@"/SW<O/T.0WFG?,'?K;F'8@C__^!0D0CV
ME37$..B-@4LP!MJTO;FY>Y7<W-TF5Y/KD88;HVE(JYJ\2&@=T0K&&JC\F0Q:
MI**HUL18!_[F$6'I,.-H_SH)7_+&]HIC?^L2K^KEPLZXI^U.6XT4/1)QOF7<
MGC9^A2M*JDT@FP<*#*$ODJX'MOGLK_#B\M.[^:H":7?Z$R R;FSCY1,U3L3V
MFZQ[T=!+'LS?>"J1\L17Y-CK%'HV*4H["RNK:;GUIJBVSNF5..A/IPM;@A=1
MIN[O<L3VOP&[YUUZ.>S !2(6[+ -<R"F.$MZ:PQ^-P#MNF>[<!P$EV *O"*@
M#T([E"?M(%+L]$C#5KT?4(.G7K.TR06*3\KKNH8Z\<#P?'5O$TH6[D/@E)S-
M/9D._Q8N1[.ID52:+7?F&0M]!8RI0F>YD))$N1[4!8L?"KX61=,()RB(GI8^
M"N5SK%1!]PE1S<[,?..HZ0EV->(URE4,_Z"&E>WV1)=NSU/<WFROB5-4(6K.
M6OSGW ()\[2XC5$16A/B9<RE6&'Q[:.RX8/\.C23GQ[N /_!>MM>!V_;(+_^
M8T-YKY/1RZE)"CO(@BCK*R0L_$:]]X-0_*KZ+2\/+_KR\&J?AW1WW;80UWC#
MV85:NB*(;FI?YAY\P,DZ,B6"ZJ]YDO%[9A%N[=W'6PVGV]L<R5L"QG"-%YF&
MFXMQ+.E!;]2^@6$/Y70<1*O0.7GZI<[)5+3Y$4V5051Z_.O[Q7VXSTJ+M&,1
M;ZYS\NT 2MC)O,J\31C4@(LSKP;8Z4<JZ[4I@USVYD.AH0O+CBL5;]KJMZB4
MN$0DQ?E**,?-R:5<<8\@VJU35OL7)YNE4HJ[KU:99;DK^8)L?(5N,*.:/+Z+
M3HB0B:J_.+4A-(J&>FW=2 5U=,L:):1*>)?XUZA_7')'IP46I=YI%-$S/=@X
M%I+6VV@IV*F4!XS;^'+0_[-OXFO4%]\P0M(LQ(4R/+[<.!*\_N9.QV@59.ON
M=&H9/H!Q\H:3.*5MMKI>/1#Z5[0U >&:;K' *\E0J*6?I3Z?GC;&'"T$M*7Y
MIQ'_#L!YH(P(R6+U8?J.55?$T/2!(ZI2^C@:O,U,>\;9IO68B><'=!@!IZZ4
MW!4-T&'&"0%**0=VF0:84$7^+Z%K>$AJ[34-9T?_8YK/$6D(+O:#5^$V/)_1
M.-.U:)0@7))+NB/:KO,ZG[$<%^9QFDR^P$ \RFM:3'")(<+L 29Y;KBQT+T3
ML;(DX4&WHL+9(MZ9:+6]UYPS%()&C $DP!\F;N*17@WG,O[^E83A"ON%(BY2
M?,JM1:AU(/NG&2$'2<GF7NO5 C$"._:9W?M 6,TT.TB8[$H/J"VYR2%/FJ@?
M5+B2/7;(X)8YQ;"0@4LRFZB*++YKUKY2ZP>D9@,54XA>G& )BK/B,5>7N[AA
MPN'XD;**:>_F[F?0+\>@G4R>G6+?V0'D28X_5AL0TX!@)\^3.VKON]@J0[L)
M @[GB%^4T7 6F2'<!,"@:'@XA U>M%EUJ"ULJ*H[OO[13F(W@OO%"E--N\+6
M%'B<)$FH^:2H: J2_TS+#L^3E;/).#&K2_2"#U71,44ZF *:@E-S$8&YLM5#
MB.4K96L5L)^%%[EKNF'28ZM7!F!8Z;AN&XI((N1.#65\H"'0DT?2R)YP:Z4B
M48Q5-TXG9Z=GE\DQ/B6'==?-6MR-GA3/KY^:;:EGVAR,C3SUEV/,0&[KA*ZW
MFIQT ]=\!ZNW-[]G?-PG.K@YL#U]@^81M^<PGNRTU=9\B@M#2DT_Z-WSA:=,
MT])=C7+Z2DZBCQ)Z^'.J]R;-AO)M=K9 F5I-U""*!<*I6<7(AP[F_O)4Z;--
MS 8TJ$+:N8=3(*AC<'NME]^.;$21-!/T0'./N$-Z=KB>87KX.H4/Q-!!Z+WE
M0+CA"'="E;"(FZSB6X]A!6#1)O\+;_CBSP:5\W_GG._*'M6?Q\F(J3PW-$KR
M\X8LWN,CX!-')\@IGIY.SCVG'.[G=IK<,K_^D3O3" L]GSX%%OI3C%GQDYA
M.32D2O >3\6U^"P4\UG0V>(&>NP:._X$-DBI]41X:0U_<9)HXXS=!G/28\?>
M7N?-8/YN;'R1:'<J>H^T:DS[C6I/!NY<X;/H[+U$7)XU<,E.5(#M*RHX9P>5
M9;I:M>8> $6<)D&W%O-"268P+&!913IWVOQ0^'.T->-0W*FF&@B;Q==MH2W2
M[]\D+W FFN]CRC?L#-Y]5EJUF=S,Z4";&9]"SQ&HAGH6+1:G\;T-LCP +O$$
M+@-XXV8U$0A0QQE3!\D)26YAS)J"L  =X:M1WH<[6 @2H+U\ME>"@_JXS$N2
MKE59H30AF-*&UX ;5!*H6,0Q4;)H+.+3*:$ZCY/I!<!<9[%?*6"M@ODFY^*7
M5"G(+)0:.=E^EC/0YEBWXT0[[_*97'+&@;0#S"I_/XE=8MS@,MSSHQ>/1RG7
M_VCB_E##,A*.\*9;8O%48&\#!W@.TGZ4'+W2[+K;T& =3_ _*2?R%^PF6E.Y
M_UJ^.O;"Z_KL\O0I*H(?>O+RK;0?,-QM?$1@L+S XB=)8A_>)QG[&RW@7A;
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M5^2A_U1D1U(789N&2!ZPWT ':K)\SA;SVY9M<._N4GM>ZKN#:F#,[V@]I?3
M'H;%_WVB^S,4!&S$DL\F(AXN/+<?_7\FBB$;] EIJJ_3-GWY[=K52W?KB@('
M QGPW1$&%OVGL)L%ID<]OYD>/8$WP^,OO]VD2_=36B^QC*)P"WCU;'QU><35
M0/H'J#4X)#HYVVI-OZY<"K(1'X#O%U75ZA\X >:MT_)>_@]02P,$%     @
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M<FMS:&5E=',O<VAE970R."YX;6R-5FUOVS80_BL'K1@20(C>+-O-; /.2[<
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M<VAE971S+W-H965T,CDN>&ULG57;;MLX$/V5@5H4":!&$B5?XMH&XC1%%T@
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M:'#K[HC:/5C5N&/A4EDZ9+K;-9WJ4?,&>E\H9;</[&#XG[#X%U!+ P04
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MVM%-W(I;^O5!XQ7H?*VU.RZ\@]//U/Q?4$L#!!0    ( &2;?%A/Y*"HO0,
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M<VAE970S-BYX;6RMEEEOVD 0Q[_*RD55(K6Q,6=3L!1(JZ;*@7*T#U4?%GO
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M#\6ED"ROC%4$.:'VBQ^K?5@S:'_881!6!N$S@S#<8="J#%H&U$9FL$ZQQ-&
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MP5%/A<1M86 [DA4FMTZ95)G:-%-52P'7"]3\C#&YZF@'KCJ+_@!02P,$%
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MIX CX-I /8\9D\\3?9(NOIP,_P-02P,$%     @ 9)M\6*(4MZH< P  ;1
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MUVO 6\ #T V<H 5H"QCZM9Q/T,==IBH10O2=I'J=%E"]$A$.\@5+B;E$ZE
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MM1)TVJ7:>W=!?1'_BGE,J$ )1 K>.3M7[0W/[[;Y1++,7 ]73*K+IAFN 8?
M]0+U/F),/DWTC;/\AV'R!U!+ P04    " !DFWQ851X=<ZX#  !!$   &0
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M0)IAH7I\X-I /=\Q)I\G^@>Z?PV2_P%02P,$%     @ 9)M\6,Y%N?;4!
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M3^]^450P14?QW/[3IUSI"L$V4UWT@3 !^ON,<[7NF FJ,C+\"U!+ P04
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M;+6;;6_;-A#'OPKA%4,*I+'X(-O)$@-KTJ(%6B!HVNW%L!>,3<="]>!*5)P
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MCVH!JH6H%J&:H#0U+VUQP-0>-KW[).N&7MT3JMZ+TFFRBA>:HS9ZK'>*T.8
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M9PEM7J":BVH>JOFH%J!:B&H1J@E*4Q/7-B_&;/-BC#8O4,U!-1?5/%3S42U
MM1#5(E03E*:&K6U>C/7-BYX[W-$&!JHYJ.:.#S^J8K-W\&#W(%K!0+4 U4)4
MBU!-4)J:HK:",=97,-:MW8=F/?%#]?8UKT]%_B6+TVJ%\>%$.T-O]PX5VLY
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M5=UPYF?.Z:?H'2RT(8%J+JIYJ.:C6H!J(:I%J"8H30F@W38D[!&ZX66C5[!
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M]\<L*W]\4T_P-<N_K!?[[G]02P,$%     @ 9)M\6'Y3,8!@)P  ?2(# !D
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MU2Q4LU'-0347U3Q4\U$M0+40U2)4BT>GMTENN^AE@LZ:HII M8S2&DW@IHY
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M$J!SAJ@6H5J,:@FJI:@F4"VCM&9CT.K&($]6-]:9\A_GUIGD2N?*CP:H4<U
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M?P4  '<=   9    >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;+69;6_;-A"
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M@FU$ %V"3 3\MTG?$P<WZ8M*A=Y[1. PXA=2_.G1 ^_?78!WP !\C1GA($S
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M.X[2:.>X%:L:G2,N1BU?P1W@?3LW9,4]2R4:4%9HQ0PLQ]%U>C4=NG@?\%7
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M@Y*FDZ6<%2A6[2.C94:72(T]G.BYH;\1X<YWYC)T\+ -WC7S?3]H@=M[S;@
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M[6;743H:3=S=H9O3J&CD^WW0"\JXIXQ_2PE$FZWQEG LJ;@I.E"R!@X%TT/
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M<V\.@QP:^6$0]4;WX*,>/AJ%;VJ2V<FU D+-!K;AM3Z2@Y6?^0AXQ&>W2NR
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MT<OFKFTZ6I3U=;42VEQ^=3,WGR<@;8!YOQ9"/W?L#=A]\*1_ 5!+ P04
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MIV7:8F?6NN8.JGE0S8=J 52C4(U!-8[2]#SOG%"W7^K$8BVCLHW4/*CF0[4
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MCXMNNX=NW[A:Q"7QNM!#'7 =M]<0T.+M[FZ#^U+O_GL2=L$]W_I*[WZ]B[N
M)DWN)3)Z10[T4KS>&;RCGF&JX5630AE$OQE"36=7?(<],K/D?,5)_$2L^8=W
M:.A\:F+7)-C2)-C*$%A)AWZA0U^'7M4!/,9%DQ09RB!%40O!TWPR&$[MIU.&
MZS9C5+%9:J-I2YPAL!)Q@X*X@9:X[S@.\*.<N_2\92!#+6]UFSIOVF#:\F8(
MK,3;L.!MJ!WXAZE;,^R')H>]2;"E2;"5(;"2"J-"A9$V>V^I(!)5O)*]HUIF
MNH-))7OK-DXE=[6AM&7-$%B)M7'!VEC+VI)(4"_(]B7D66Z<.6FB;5RC9#2L
MD+*HVU1IT\;2EC9#8"7:)@5M$RUMWYC (:Q/![Z.O4F-&>2@:M;5C:KT:6-J
M2Y\AL!)]R#GNEYTW+M(>YEM8RTJ+0\*)K_:XK+*3:MSJ.K6E^7+<JW+:9#4:
M]2N\ZF-M2ZPIM#*S)Y4(TC+[(RWJB'^)GR2+&R+K4%7I'O=#<IJ,X,.[L8O0
MIQK5<"'Y?R$XYA\;6=>W/<I<H0]15FBX??#Q2Y. BU>@QCG4,(=J6KOT$*UU
M,X16ULT]ZN8:U*TT];RJFK[E7D[UY* :&I]730O5=O-A%&UE"JTLX+'\0]JJ
MIBZ@'W"/)52 '&'D[(AK%"QK":'3Q:"+JI/;6ZR6^JA;<_Q_5';H6-HA?6WW
M1H[+HZ.1X:P=-5>?<.>,:I6,/J#6"7^FV<J*M#K8E:5UQH59F;]CA8?T)5ZI
M5 ',.6G<).<HI\OF8.S4%E>3%=S2*-K*%%J9YV-%B+2ESKQTFM>!].#XDJTO
M'R3KUXKU#MP+F;$1D:G+UOGI7R#WE'>,!^EF_._5LU GR:H@7]$D2F<-1O]I
MU$L?S5VL)AWQTH%=B&6#ZKR1_$J"G6J^ [0Q"19ZT-;R&BTT3:&5Y3V6FDA?
M:Y:&40?B@[S)85!U 'M>$B6AU-@''+%8!/^F^C7*-ZH-MWIUI0^IM1Q&*UA3
M:)D<]LDYO$S[37H!PB&=Y[.SZ>)K<<ERG5XM5+[?H*M%=E5RA,EN;K[@>!-0
M+@5<2TBG.Y+<Q]EE2/8BV"X][7]D0K H?=P2[)-8&<C?UXR)PXMJH+B2FO\'
M4$L#!!0    ( &2;?%BKQZ-1704  *XN   9    >&PO=V]R:W-H965T<R]S
M:&5E=#8V+GAM;+6:76_;-AA&_PJA%4,+K)%(?3JS#;0UBVYHL:!I-^R2L>A8
MJ#X\B8Z;?S]*5B13E+G(?7>32+;>A]2A0.B8G!^*\ENUY5R@[UF:5PMK*\3N
MVK:K]99GK+HJ=CR7WVR*,F-"GI;W=K4K.8N;HBRUB>,$=L:2W%K.F\]NRN6\
MV(LTR?E-B:I]EK'R\2U/B\/"PM;3!Y^3^ZVH/["7\QV[Y[=<?-W=E/+,[E+B
M).-YE10Y*OEF8;W!U]1M"IHK_DSXH3HY1O6MW!7%M_KDMWAA.76/>,K7HHY@
M\M\#?\?3M$Z2_?BG#;6Z-NO"T^.G]/?-S<N;N6,5?U>D?R6QV"ZLR$(QW[!]
M*CX7AP^\O2&_SEL7:=7\18?V6L="ZWTEBJPMECW(DOSXGWUO09P48.], 6D+
MR',+W+; ?6Z!UQ9XSRWPVX+FUNWCO3?@5DRPY;PL#JBLKY9I]4%#OZF6O)*\
M?E!N12F_362=6'[DDG*%7J-;^0C&^Y2C8H,^,;$O$_%8'_^QXR4327Z/6!ZC
M]TG.\C5';=G+%1<L2:M7,N#K[0J]?/$*O4!)CKYLBWTE"ZJY+60OZ[;L==NC
MM\<>D3,]6O'U%7+Q+X@XQ!TI?V<N_WV?7B%ROGQE+G^S*Z\0GITMI\_O/%'+
M;3DRW?"0;GA(D^>>R>OI-\3':!X#O/& >IZYKG9LS1>6G$@J7CYP:_GS3SAP
M?AUC"QFV@@RC0&'**+C=*+BF].7?G)6(YC&/D1Q@GMWQ\FF0O;$A.:;Y35H]
M4S\L9[Y\&AY.21M;G$H:,HP"A2FDO8ZT=REI?XST,2TX)1V& ]+&%J>2A@RC
M0&$*:;\C[5]*.A@C[>ND/3P@;6QQ*FG(, H4II ..M+!I:3#,=*!3MKW!Z2-
M+4XE#1E&@<(4TF%'.KR4=#1&.M1)1\-YVMCB5-*0810H3"$==:0C(^DO6RZU
M9"-X.<8UTKB2(!A.R\8&IH*%#*- 80K860=V9@9;"):BM'[90SOV*)5,C+Y#
MSS3$H1=Z \3&IJ8BA@RC0&$*8NSTSN,8(7_D586:Y%R@!Y;N.8J3:EWL<S'J
M*XX&^S4AT9"VN=&IN$'3*%2:"OQ$,O%_/]6C:+&&UL<S9TC6F#Z9+&0:;=-.
M7_:]P.GO0"76>Q\VBY\BVJ/D0+T/-&T%FD:ATM21Z-T/P\I?&W?Z2./(TQYI
M4/\#3:-0:2KP7@$QK -B70+'@(-J(&@:A4I3@?<FB&%5$.LN. 8<U 9!TRA4
MF@J\%T(,:X185T*,HV@('%0*0=,H5)H*O/="#"N&6#=#3(9F:&YS,F]0-X1*
M4WGW=HA_1 ^Q[H?:Y %JAZ!I%"I-9=L+(H8Q1*PK8A"Y&NB9]OKJ8V=PU6KD
M*NP/KZ+FCE\(AO161T"MCHQ8730;3JKF-B>OB(!*'52:RKN7.G*AU)$1J9NY
MP^G3G#Z9+*C40:6I9$\6_<SR=YXL[&(?[&H?['+?_R%]I)<^ BM]1)<^$LZT
M1QY4^D#3*%2:"KR7/@(K?427/A+AX6_,YD8G P>5/J@T%7@O?016^H@N?22,
MABN YD8G P>5/J@T%7@O?016^H@N?01[[A XJ/2!IE&H-!5X+WT$5OK(B/1A
M9_@KO[G1R<!!K0\J307>6Q_Y$>LCSUH5-#<Q&2^H^$&EJ7A[\2,PXD=T\9/S
MAOX@@ZX.@J91J#1UMU=ODBZH2;HC)NEB;2>!N=')6[Y 51(J307>JZ1[H4JZ
M^NH:QOI/<>;XR6A!71(J[8C6/MGJ6^_D_L3*^R2OY+2PD?'.52A1E<?-T<<3
M4>R:W;]WA1!%UAQN.8MY65\@O]\4A7@ZJ3<4=UO4E_\"4$L#!!0    ( &2;
M?%CD /W;IP0  &(<   9    >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;*U9
M76_;-A3]*X16#"W012(ERW)F&TB<?018VR!IMX=A#XQ,VT0DTB-INP7ZXT=*
MLF0Z,F%CS$/TQ7MXS^4A=2R.=UR\R!4A"GPM"R8GP4JI]748RGQ%2BRO^)HP
M_63!18F5OA3+4*X%P?,JJ"Q"%$5I6&+*@NFXNO<@IF.^405EY$$ N2E+++[=
MDH+O)@$,]C<>Z7*ES(UP.E[C)7DBZLOZ0>BKL$69TY(P23D#@BPFP0V\GJ',
M!%0M_J1D)P_.@:'RS/F+N;B?3X+(9$0*DBL#@?5A2V:D* R2SN/?!C1H^S2!
MA^=[]%\K\IK,,Y9DQHN_Z%RM)D$6@#E9X$VA'OGN=](0&AB\G!>R^@]V3=LH
M /E&*EXVP3J#DK+ZB+\VA3@(@.F) -0$H.. Y$1 W 3$%=$ZLXK6'59X.A9\
M!X1IK=',256;*EJSH<P,XY,2^BG5<6KZ1)>,+FB.F0*SJCLB))AQEA.F!#:E
MEN G\!$+<[$EX.T=49@6\IV^^^7I#KQ]\PZ\ 92!SRN^D9C-Y3A4.C$#'^9-
M$K=U$NA$$A"!#YRIE02_L#F9VP"A9M320GM:M\B)>$?R*Q##]P!%*.Y):'9^
M.'*D$[=5CBN\^ 2>54_P2.4+^/L/W0;<*U+*?_HJ5@,F_8!F<E_+-<[))-"S
M5Q*Q)<'TQQ]@&OW<Q]83F,4]:;DG+O3I(]D2MB'R/6!$]3&MPP=5N%EUMM,D
MB;-D'&X/*;QN!1%*DV';S$INT"8W<"9W1_&2<:EH#IXT;YJ37ODZ02X=#$]@
M%M^TY9OZ%F+JD[LG,(O[L.4^_']"'+Z2&$JR9'0DQ->M8)3%:-0OQ*Q-+CLG
M.7!+6+[2+]07\%TK<JE?F KT#-IW<*9RG;U>.GJ>P*P"C=H"C7PK=^23NR<P
MBSN,NK=TY)2'S5YH]KUOV1K$'%IQ1E>#5Q+N;Y=E<;^&X8&9@,XT?^-;(E@E
MVINE5C(E4DNU3]M[K]$C[EYFSGXO'4M?:':54%<EY%O*#:(O_I[0;/Z=&8).
MOW&NF&L0""V1PN&QEGN;G5J.8>=:H-NVW#.Y$5@G"AX$W]*YL<5^I.SL]^*A
M](1F5ZFS3W#@7<I>S90O-)M_9Z>@T[&<*^6T3Z,'RVW#I;=9FIZ0<N=[H-OX
MS IJ5N0'_,V?B)T]7CR(GM#L^G36"V;>1>S55_E"L_EWS@HZS<NY(O9JIQJT
M(ZU'@WZMH\XH(;=1ZK'%H-:_!)_TD!KUT_)Y(R2I;,HCR0G=XN>"7#X)W*E<
M6A%?:';A.NN&H.])@+R:,E]H-O_.E"&GZ3ES$C0@1\XY1NG14M[?+LV&H\._
M$V+OC!1R&RF7V#_ON%^Q>_T@Y0O-+EQG[E#B7>Q>;9LO-)M_9]N0^[/7F6(?
M](D89L<6?-_NR*F?\"VH,U?(;:Z<\EX)XGDU]_JARQ>:7;K.\J&A=X%[M72^
MT&S^G:5#[L]I9PH\ZQ7XZ]7<JS\+#W9KM#R7U2:6!#G?,%7O<+1WVXVRFVI[
MZ.C^+;R>U=M='4R]^_8!BR5E$A1DH2&CJZ&>H:+>T*HO%%]7>T+/7.DY4IVN
M"-8_<DT#_7S!N=I?F [:;<7I?U!+ P04    " !DFWQ8U-B\-B0"  "F!
M&0   'AL+W=O<FMS:&5E=',O<VAE970V."YX;6R%5$V/TS 0_2N6D1!(J$[=
M;D%+$JG=@MC#KJI6P %Q<)-)8JUC!]MMEG^//])0I&ZY)!Y[WILWXQFGO=)/
MI@&PZ+D5TF2XL;:[)<04#;3,3%0'TIU42K?,.E/7Q'0:6!E K2 T21:D95SB
M/ U[&YVGZF %E[#1R!S:ENG?*Q"JS_ 4GS:VO&ZLWR!YVK$:=F"_=AOM+#*R
ME+P%:;B22$.5X>7T=C7W_L'A&X?>G*V1SV2OU),W[LL,)UX0""BL9V#N=X0[
M$,(3.1F_!DX\AO3 \_6)_7/(W>6R9P;NE/C.2]MD^ -&)53L(.Q6]5]@R.?&
M\Q5*F/!%??2=)Q@5!V-5.X"=@I;+^&?/0QW. )2^ * #@ ;=,5!0N6:6Y:E6
M/=+>V['Y14@UH)TX+OVE[*QVI]SA;+Z#VI78HGL9+]A7ZLT:+./"H$>F-?-5
M>YL2ZX)Y""D&XE4DIB\03REZ4-(V!GV2)93_$A"G<I1*3U)7]"KC&HH)FDW?
M(9K0&1J$7^&=C268!=[9?TJPA4YIRV6-?BSWQFK7,#\OY1W9YI?9_!#=FHX5
MD&$W)0;T$7#^^M5TD7R\HG4^:IU?8\\?#^T>-%(5<F/I[\:I-5&_N:0ULBT"
MFY_/8TY3<CP70,YZIP5=APDQJ% ':6,;C;OC$"YC[_UUCQ/\P'3-I4$"*@=-
M)N]O,-)Q*J)A51<Z<:^LZ^NP;-Q# MH[N/-**7LR?(#Q:<K_ %!+ P04
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ME8%\OV1,[&_4 .U_&F;_ E!+ P04    " !DFWQ8YF"8,ZL#  "-#@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6RM5VV/FS@0_BL65U6[4KM@0DBR
M39 VFU97Z7I=-=W;#U4_.. $M&!SMDG:?W]C(.3-8;,GOB38S#P\SWCL\8PW
M7#S+F%*%?F4IDQ,K5BJ_M6T9QC0C\H;GE,&;)1<943 4*UOF@I*H=,I2VW4<
MW\Y(PJQ@7,X]B&#,"Y4FC#X()(LL(^+WE*9\,[&PM9WXEJQBI2?L8)R3%9U3
M]9@_"!C9#4J49)3)A#,DZ')BW>';>]S7#J7%/PG=R+UGI*4L.'_6@\_1Q'(T
M(YK24&D( G]K>D_35",!CW]K4*OYIG;<?]ZB?RK%@Y@%D?2>IT])I.*)-;10
M1)>D2-4WOOF3UH)*@B%/9?F+-K6M8Z&PD(IGM3,PR!)6_9-?=2#V'+!_QL&M
M'=QC!^^,0Z]VZ)5"*V:EK!E1)!@+OD%"6P.:?BAC4WJ#FH3I99PK 6\3\%/!
M1R)8PE82/5"!YC$1%+U'<TB6J$@IXDLT)3()$6$1FB5IH6B$_H;D^HO+?9>K
M&54D2>4U.#_.9^CJS362^HU$"4/?8UY(0)#OT)N#\=A6($$3L<.:[K2BZYZA
MBUWTA3,52_21130Z!+!!>Q, =QN J=N*.*/A#>KA=\AUW)Z!T/WE[FX+G5ZS
M'KT2KW?Y>ORX6T@E(-]_FN)5P7EF.'T(W,J<A'1BP2Z75*RI%;S] _O.!Y/6
MCL .E'N-<J\-/=!I=95"7EU#CH0\TXFXT,EG4EU!]4LH?5*M@_?8'PQA!=;[
M>D[-\-#S>XW5 =%^0[3?2O0S4Q3D*P2G4,$D#0L!NR+D;$V%2A:P;7+!LT1*
M+GXCQA4U":@^X>\Q<XZXGUKX/=?,W&^8^Z\.<53M:A-'_[(@GYKAD3/JFZD.
M&JJ#5JI/Y?D+<2405:@GV^,$*I%4<'; 'FG+C\%)\/# =09'S U6_:%WAOFP
M83YL9?[X?U-B^&)*G%JXGF-F.VK8CCJ(<TN2C"Z*M,%JZ/>QF3MV=L7+:64_
M5SQ\1E]S?2,P5Y-6_]<>CUVA':K=*]6XV]I0XW6EOB.T0_7N3KW;NM;;ZT>5
MH$:Y[HL[R&""O=&9@H!W11NW5L8Z#Y^($(0I,[=.ZW17:(=R=Y4:>QTG8FOI
M?[7ZCM .U>_*/VZO_Q<DXLO5W6""G<%Q(MI[%_N,BE79[T@H+ 53U16WF6UZ
MJKNRDSB:G^I>JVP8=C!5H_:%B%7")$KI$B"=FP$0$U7O4PT4S\OV8<$5-"/E
M8PS](A7: -XO.=2S>J _T'2@P7]02P,$%     @ 9)M\6#XN(>4N P  ;PP
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MY-Q#^!L,4TMVN^FTP 2!3/8&.;<J Y I IGN$?(^!)!C!'*\-\@I-VL >8Q
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M   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/-VLUJHU 8QO%;"5Y
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M.X'>CGH[@=Z!>@>!WH%Z!X'>@7H'@=Z!>@>!WH%Z!X'>@7H'@=XQ^=F$0.]
MO8- [T"]@T#O0+V#0.\&]6X(]&Y0[X9 [P;U;GY2[S)^'7*Y]GRO\?H_2?5X
M/C=?+W]9?N^<W)<+SO5M17GZ"U!+ P04    " !DFWQ80&L7N@ "  #&*0
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M<F]P<R]A<' N>&UL4$L! A0#%     @ 9)M\6#U*J#'O    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 9)M\
M6)E<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " !DFWQ8VB:<0D4(  !C,@  &
M@($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 9)M\
M6/.:204Y @  O 4  !@              ("!B1   'AL+W=O<FMS:&5E=',O
M<VAE970R+GAM;%!+ 0(4 Q0    ( &2;?%B^;(9VNP@  !DI   8
M      " @?@2  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M" !DFWQ8G&:I\2P#  !["P  &               @('I&P  >&PO=V]R:W-H
M965T<R]S:&5E=#0N>&UL4$L! A0#%     @ 9)M\6"5\OJ*Q!0  4A<  !@
M             ("!2Q\  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4
M Q0    ( &2;?%AE?9V@C@@  %=#   8              " @3(E  !X;"]W
M;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " !DFWQ85Q,&;$$"  #3
M!   &               @('V+0  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL
M4$L! A0#%     @ 9)M\6'<1V8=""@  X#   !@              ("!;3
M 'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( &2;?%CNA0Y$
MP H  + 9   8              " @>4Z  !X;"]W;W)K<VAE971S+W-H965T
M.2YX;6Q02P$"% ,4    " !DFWQ85)QEBS4I  ##A0  &0
M@(';10  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( &2;
M?%B3ZA&H6P8  +L/   9              " @4=O  !X;"]W;W)K<VAE971S
M+W-H965T,3$N>&UL4$L! A0#%     @ 9)M\6+HLGRC% P  '0D  !D
M         ("!V74  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
M    " !DFWQ8XQ=]IE@#  !7!P  &0              @('5>0  >&PO=V]R
M:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( &2;?%B<&;>S9@@  )$5
M   9              " @61]  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL
M4$L! A0#%     @ 9)M\6(@YDYO9$P  XD@  !D              ("! 88
M 'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " !DFWQ88.=0
M/ZL"   Z!@  &0              @($1F@  >&PO=V]R:W-H965T<R]S:&5E
M=#$V+GAM;%!+ 0(4 Q0    ( &2;?%A7G[PYG0<  -,2   9
M  " @?.<  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @
M9)M\6/H[']W. @  = 8  !D              ("!QZ0  'AL+W=O<FMS:&5E
M=',O<VAE970Q."YX;6Q02P$"% ,4    " !DFWQ8>:P&7V@+  !@'P  &0
M            @(',IP  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4
M Q0    ( &2;?%@RTQ&TU0P  %U&   9              " @6NS  !X;"]W
M;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ 9)M\6 B[@5V#!0
M<@T  !D              ("!=\   'AL+W=O<FMS:&5E=',O<VAE970R,2YX
M;6Q02P$"% ,4    " !DFWQ8)$QH0)H%   Q#0  &0              @($Q
MQ@  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( &2;?%BQ
M\!,;DP0  $(+   9              " @0+,  !X;"]W;W)K<VAE971S+W-H
M965T,C,N>&UL4$L! A0#%     @ 9)M\6#B_&!R> @  \@4  !D
M     ("!S-   'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &2;?%A<4'IK. ,   0'   9              "
M@>,4 0!X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ 9)M\
M6&/'T324!   %0P  !D              ("!4A@! 'AL+W=O<FMS:&5E=',O
M<VAE970S,"YX;6Q02P$"% ,4    " !DFWQ8%+0:;P@%   S#   &0
M        @($='0$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0
M   ( &2;?%B;2Q4TW (  &\&   9              " @5PB 0!X;"]W;W)K
M<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ 9)M\6 !2&UB;!   %PP
M !D              ("!;R4! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q0
M2P$"% ,4    " !DFWQ8>G;X4?@#  !8"0  &0              @(%!*@$
M>&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( &2;?%A/Y*"H
MO0,  '\)   9              " @7 N 0!X;"]W;W)K<VAE971S+W-H965T
M,S4N>&UL4$L! A0#%     @ 9)M\6)E0/#'K @  J0D  !D
M ("!9#(! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " !D
MFWQ8 (<D\*T)   B3P  &0              @(&&-0$ >&PO=V]R:W-H965T
M<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( &2;?%A&VH0C1@0  -X6   9
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M970T,BYX;6Q02P$"% ,4    " !DFWQ8 Q9K,G,#  !%$0  &0
M    @($#4P$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    (
M &2;?%BB%+>J' ,  &T0   9              " @:U6 0!X;"]W;W)K<VAE
M971S+W-H965T-#0N>&UL4$L! A0#%     @ 9)M\6%4>'7.N P  01   !D
M             ("! %H! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"
M% ,4    " !DFWQ8SD6Y]M0$  #+&   &0              @('E70$ >&PO
M=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( &2;?%@%%R9KX@(
M %(*   9              " @?!B 0!X;"]W;W)K<VAE971S+W-H965T-#<N
M>&UL4$L! A0#%     @ 9)M\6)QH],2#!   L1P  !D              ("!
M"68! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " !DFWQ8
MQ(EV+/<"  !#"@  &0              @('#:@$ >&PO=V]R:W-H965T<R]S
M:&5E=#0Y+GAM;%!+ 0(4 Q0    ( &2;?%@=9.O')P8  !XR   9
M      " @?%M 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%
M  @ 9)M\6)6&/9-: @  NP4  !D              ("!3W0! 'AL+W=O<FMS
M:&5E=',O<VAE970U,2YX;6Q02P$"% ,4    " !DFWQ8<?X1O,X-   6Q0
M&0              @('@=@$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+
M 0(4 Q0    ( &2;?%A^4S& 8"<  'TB P 9              " @>6$ 0!X
M;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ 9)M\6)U$G&!_
M!0  =QT  !D              ("!?*P! 'AL+W=O<FMS:&5E=',O<VAE970U
M-"YX;6Q02P$"% ,4    " !DFWQ8:P8S[28#  #:"   &0
M@($RL@$ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( &2;
M?%@<Z2'ATP0  "X;   9              " @8^U 0!X;"]W;W)K<VAE971S
M+W-H965T-38N>&UL4$L! A0#%     @ 9)M\6%'CR4A: @  LP4  !D
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M=#8Q+GAM;%!+ 0(4 Q0    ( &2;?%A9M*"_[P(  /P(   9
M  " @<;* 0!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @
M9)M\6 71@ 9=!@  M#H  !D              ("![,T! 'AL+W=O<FMS:&5E
M=',O<VAE970V,RYX;6Q02P$"% ,4    " !DFWQ8(7T!*& *  "9>P  &0
M            @(& U $ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4
M Q0    ( &2;?%BH2(*S)@4  )X:   9              " @1?? 0!X;"]W
M;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ 9)M\6*O'HU%=!0
MKBX  !D              ("!=.0! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX
M;6Q02P$"% ,4    " !DFWQ8Y #]VZ<$  !B'   &0              @($(
MZ@$ >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( &2;?%C4
MV+PV) (  *8$   9              " @>;N 0!X;"]W;W)K<VAE971S+W-H
M965T-C@N>&UL4$L! A0#%     @ 9)M\6 <3>-TG!0  =1@  !D
M     ("!0?$! 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"% ,4
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M  #N$P  #0              @ &F  ( >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( &2;?%B7BKL<P    !,"   +              "  0P$ @!?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( &2;?%A7&JOH7P4  '4O   /              "
M ?4$ @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !DFWQ8K&U05SP"  "O
M*@  &@              @ &!"@( >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    " !DFWQ80&L7N@ "  #&*0  $P              @ 'U
L# ( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     4 !0 .<5   F#P(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>244</ContextCount>
  <ElementCount>481</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>92</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>14</UnitCount>
  <MyReports>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Statements of Operations and Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Operations and Other Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Organization and Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/OrganizationandBusiness</Role>
      <ShortName>Organization and Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Asset Acquisition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/AssetAcquisition</Role>
      <ShortName>Asset Acquisition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/IntangibleAssetsNet</Role>
      <ShortName>Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Property, Plant and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/PropertyPlantandEquipment</Role>
      <ShortName>Property, Plant and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Outstanding Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/OutstandingDebt</Role>
      <ShortName>Outstanding Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Stockholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders??? Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Defined Contribution Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/DefinedContributionPlans</Role>
      <ShortName>Defined Contribution Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/OtherCurrentLiabilities</Role>
      <ShortName>Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Significant Customers Concentrations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/SignificantCustomersConcentrations</Role>
      <ShortName>Significant Customers Concentrations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/RelatedParties</Role>
      <ShortName>Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://prophaselabs.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://prophaselabs.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/IntangibleAssetsNetTables</Role>
      <ShortName>Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://prophaselabs.com/role/IntangibleAssetsNet</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - Property, Plant and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/PropertyPlantandEquipmentTables</Role>
      <ShortName>Property, Plant and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://prophaselabs.com/role/PropertyPlantandEquipment</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - Stockholders??? Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders??? Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://prophaselabs.com/role/StockholdersEquity</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://prophaselabs.com/role/IncomeTaxes</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://prophaselabs.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://prophaselabs.com/role/Leases</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://prophaselabs.com/role/SegmentInformation</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://prophaselabs.com/role/EarningsPerShare</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - Organization and Business - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/OrganizationandBusinessNarrativeDetails</Role>
      <ShortName>Organization and Business - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - Summary of Significant Accounting Policies - Summary of Components of Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Components of Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - Summary of Significant Accounting Policies - Schedule of Accounts Receivable Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofAccountsReceivableNetDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Accounts Receivable Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable, Allowance for Credit Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableAllowanceforCreditLossDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Accounts Receivable, Allowance for Credit Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - Summary of Significant Accounting Policies - Schedule of Components of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Components of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Fair Value of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - Summary of Significant Accounting Policies - Schedule of Deferred Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Deferred Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - Summary of Significant Accounting Policies - Performance Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPerformanceObligationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Performance Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - Summary of Significant Accounting Policies - Schedule of Disaggregation by Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDisaggregationbyRevenueDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Disaggregation by Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - Asset Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/AssetAcquisitionDetails</Role>
      <ShortName>Asset Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://prophaselabs.com/role/AssetAcquisition</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954492 - Disclosure - Intangible Assets, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/IntangibleAssetsNetNarrativeDetails</Role>
      <ShortName>Intangible Assets, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets, Net - Schedule of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - Intangible Assets, Net - Schedule Estimated Future Amortization Expense of Acquired Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets, Net - Schedule Estimated Future Amortization Expense of Acquired Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - Property, Plant, and Equipment - Schedule of Property, Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails</Role>
      <ShortName>Property, Plant, and Equipment - Schedule of Property, Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - Property, Plant and Equipment - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/PropertyPlantandEquipmentNarrativeDetails</Role>
      <ShortName>Property, Plant and Equipment - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954497 - Disclosure - Outstanding Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/OutstandingDebtDetails</Role>
      <ShortName>Outstanding Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://prophaselabs.com/role/OutstandingDebt</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954498 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954499 - Disclosure - Stockholders' Equity - Schedule of Stock Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Stock Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954500 - Disclosure - Stockholders' Equity - Summary of Weighted Average Assumptions Used in Determining Fair Value of Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/StockholdersEquitySummaryofWeightedAverageAssumptionsUsedinDeterminingFairValueofOptionsDetails</Role>
      <ShortName>Stockholders' Equity - Summary of Weighted Average Assumptions Used in Determining Fair Value of Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954501 - Disclosure - Stockholders' Equity - Schedule of Warrant Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Warrant Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954502 - Disclosure - Defined Contribution Plans (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/DefinedContributionPlansDetailsNarrative</Role>
      <ShortName>Defined Contribution Plans (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://prophaselabs.com/role/DefinedContributionPlans</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954503 - Disclosure - Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails</Role>
      <ShortName>Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9954504 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9954505 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9954506 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9954507 - Disclosure - Other Current Liabilities - Schedule of Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Other Current Liabilities - Schedule of Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9954508 - Disclosure - Commitments and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9954509 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9954510 - Disclosure - Leases - Schedule of Quantitative Information About Operating and Finance Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails</Role>
      <ShortName>Leases - Schedule of Quantitative Information About Operating and Finance Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9954511 - Disclosure - Leases - Schedule of Maturity of Operating and Finance Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails</Role>
      <ShortName>Leases - Schedule of Maturity of Operating and Finance Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9954512 - Disclosure - Significant Customers Concentrations - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails</Role>
      <ShortName>Significant Customers Concentrations - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9954513 - Disclosure - Segment Information (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/SegmentInformationDetailsNarrative</Role>
      <ShortName>Segment Information (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://prophaselabs.com/role/SegmentInformationTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9954514 - Disclosure - Schedule of Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/ScheduleofSegmentInformationDetails</Role>
      <ShortName>Schedule of Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9954515 - Disclosure - Earnings Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails</Role>
      <ShortName>Earnings Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9954516 - Disclosure - Earnings Per Share - Schedule of Anti-dilutive Securities Excluded from the Income Per Share Computation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromtheIncomePerShareComputationDetails</Role>
      <ShortName>Earnings Per Share - Schedule of Anti-dilutive Securities Excluded from the Income Per Share Computation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="prph-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9954517 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://prophaselabs.com/role/SubsequentEvents</ParentRole>
      <Position>72</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 10 fact(s) appearing in ix:hidden were eligible for transformation: prph:DebtSecuritiesAvailableForSaleMaturityPeriod, us-gaap:LesseeOperatingLeaseTermOfContract, us-gaap:PropertyPlantAndEquipmentUsefulLife, us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod -  prph-20231231.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Not-Referenced] WARN: 2 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 -  prph-20231231.htm 4</Log>
    <Log type="Warning">[DQC.US.0076.7653] The filer has reported a value for us-gaap:RevenueRemainingPerformanceObligation with a value of 350000.000000 using the dimension member (none) The filer has not reported a duration value for the corresponding elements of RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1.

The properties of this us-gaap:RevenueRemainingPerformanceObligation fact are:
Context: c-76
Unit: usd. - prph-20231231.htm 4 - prph-20231231.htm 4</Log>
    <Log type="Warning">[DQC.US.0076.7653] The filer has reported a value for us-gaap:RevenueRemainingPerformanceObligation with a value of 750000.000000 using the dimension member (none) The filer has not reported a duration value for the corresponding elements of RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1.

The properties of this us-gaap:RevenueRemainingPerformanceObligation fact are:
Context: c-74
Unit: usd. - prph-20231231.htm 4 - prph-20231231.htm 4</Log>
    <Log type="Warning">[DQC.US.0076.7653] The filer has reported a value for us-gaap:RevenueRemainingPerformanceObligation with a value of 2382000.000000 using the dimension member (none) The filer has not reported a duration value for the corresponding elements of RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1.

The properties of this us-gaap:RevenueRemainingPerformanceObligation fact are:
Context: c-72
Unit: usd. - prph-20231231.htm 4 - prph-20231231.htm 4</Log>
    <Log type="Warning">[DQC.US.0076.7653] The filer has reported a value for us-gaap:RevenueRemainingPerformanceObligation with a value of 376000.000000 using the dimension member (none) The filer has not reported a duration value for the corresponding elements of RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1.

The properties of this us-gaap:RevenueRemainingPerformanceObligation fact are:
Context: c-77
Unit: usd. - prph-20231231.htm 4 - prph-20231231.htm 4</Log>
    <Log type="Warning">[DQC.US.0076.7653] The filer has reported a value for us-gaap:RevenueRemainingPerformanceObligation with a value of 2499000.000000 using the dimension member (none) The filer has not reported a duration value for the corresponding elements of RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1.

The properties of this us-gaap:RevenueRemainingPerformanceObligation fact are:
Context: c-73
Unit: usd. - prph-20231231.htm 4 - prph-20231231.htm 4</Log>
    <Log type="Warning">[DQC.US.0076.7653] The filer has reported a value for us-gaap:RevenueRemainingPerformanceObligation with a value of 683000.000000 using the dimension member (none) The filer has not reported a duration value for the corresponding elements of RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1.

The properties of this us-gaap:RevenueRemainingPerformanceObligation fact are:
Context: c-75
Unit: usd. - prph-20231231.htm 4 - prph-20231231.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="prph-20231231.htm">prph-20231231.htm</File>
    <File>prph-20231231.xsd</File>
    <File>prph-20231231_cal.xml</File>
    <File>prph-20231231_def.xml</File>
    <File>prph-20231231_lab.xml</File>
    <File>prph-20231231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="905">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="39">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>109
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "prph-20231231.htm": {
   "nsprefix": "prph",
   "nsuri": "http://prophaselabs.com/20231231",
   "dts": {
    "inline": {
     "local": [
      "prph-20231231.htm"
     ]
    },
    "schema": {
     "local": [
      "prph-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "prph-20231231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "prph-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "prph-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "prph-20231231_pre.xml"
     ]
    }
   },
   "keyStandard": 406,
   "keyCustom": 75,
   "axisStandard": 29,
   "axisCustom": 0,
   "memberStandard": 36,
   "memberCustom": 52,
   "hidden": {
    "total": 17,
    "http://fasb.org/us-gaap/2023": 12,
    "http://prophaselabs.com/20231231": 1,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 244,
   "entityCount": 1,
   "segmentCount": 92,
   "elementCount": 716,
   "unitCount": 14,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 905,
    "http://xbrl.sec.gov/dei/2023": 39
   },
   "report": {
    "R1": {
     "role": "http://prophaselabs.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://prophaselabs.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://prophaselabs.com/role/ConsolidatedBalanceSheets",
     "longName": "0000003 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "0000004 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome",
     "longName": "0000005 - Statement - Consolidated Statements of Operations and Other Comprehensive Income",
     "shortName": "Consolidated Statements of Operations and Other Comprehensive Income",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GrossProfit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity",
     "longName": "0000006 - Statement - Consolidated Statements of Stockholders' Equity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical",
     "longName": "0000007 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "shortName": "Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "prph:PrepaidShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "prph:PrepaidShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows",
     "longName": "0000008 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://prophaselabs.com/role/OrganizationandBusiness",
     "longName": "0000009 - Disclosure - Organization and Business",
     "shortName": "Organization and Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://prophaselabs.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "0000010 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://prophaselabs.com/role/AssetAcquisition",
     "longName": "0000011 - Disclosure - Asset Acquisition",
     "shortName": "Asset Acquisition",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://prophaselabs.com/role/IntangibleAssetsNet",
     "longName": "0000012 - Disclosure - Intangible Assets, Net",
     "shortName": "Intangible Assets, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://prophaselabs.com/role/PropertyPlantandEquipment",
     "longName": "0000013 - Disclosure - Property, Plant and Equipment",
     "shortName": "Property, Plant and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://prophaselabs.com/role/OutstandingDebt",
     "longName": "0000014 - Disclosure - Outstanding Debt",
     "shortName": "Outstanding Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://prophaselabs.com/role/StockholdersEquity",
     "longName": "0000015 - Disclosure - Stockholders\u2019 Equity",
     "shortName": "Stockholders\u2019 Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://prophaselabs.com/role/DefinedContributionPlans",
     "longName": "0000016 - Disclosure - Defined Contribution Plans",
     "shortName": "Defined Contribution Plans",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://prophaselabs.com/role/IncomeTaxes",
     "longName": "0000017 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://prophaselabs.com/role/OtherCurrentLiabilities",
     "longName": "0000018 - Disclosure - Other Current Liabilities",
     "shortName": "Other Current Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://prophaselabs.com/role/CommitmentsandContingencies",
     "longName": "0000019 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://prophaselabs.com/role/Leases",
     "longName": "0000020 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://prophaselabs.com/role/SignificantCustomersConcentrations",
     "longName": "0000021 - Disclosure - Significant Customers Concentrations",
     "shortName": "Significant Customers Concentrations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://prophaselabs.com/role/SegmentInformation",
     "longName": "0000022 - Disclosure - Segment Information",
     "shortName": "Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://prophaselabs.com/role/EarningsPerShare",
     "longName": "0000023 - Disclosure - Earnings Per Share",
     "shortName": "Earnings Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://prophaselabs.com/role/RelatedParties",
     "longName": "0000024 - Disclosure - Related Parties",
     "shortName": "Related Parties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://prophaselabs.com/role/SubsequentEvents",
     "longName": "0000025 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesTables",
     "longName": "9954472 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://prophaselabs.com/role/IntangibleAssetsNetTables",
     "longName": "9954473 - Disclosure - Intangible Assets, Net (Tables)",
     "shortName": "Intangible Assets, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://prophaselabs.com/role/PropertyPlantandEquipmentTables",
     "longName": "9954474 - Disclosure - Property, Plant and Equipment (Tables)",
     "shortName": "Property, Plant and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://prophaselabs.com/role/StockholdersEquityTables",
     "longName": "9954475 - Disclosure - Stockholders\u2019 Equity (Tables)",
     "shortName": "Stockholders\u2019 Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://prophaselabs.com/role/IncomeTaxesTables",
     "longName": "9954476 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://prophaselabs.com/role/OtherCurrentLiabilitiesTables",
     "longName": "9954477 - Disclosure - Other Current Liabilities (Tables)",
     "shortName": "Other Current Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://prophaselabs.com/role/LeasesTables",
     "longName": "9954478 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://prophaselabs.com/role/SegmentInformationTables",
     "longName": "9954479 - Disclosure - Segment Information (Tables)",
     "shortName": "Segment Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://prophaselabs.com/role/EarningsPerShareTables",
     "longName": "9954480 - Disclosure - Earnings Per Share (Tables)",
     "shortName": "Earnings Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://prophaselabs.com/role/OrganizationandBusinessNarrativeDetails",
     "longName": "9954481 - Disclosure - Organization and Business - Narrative (Details)",
     "shortName": "Organization and Business - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-39",
      "name": "prph:NumberOfLicensedCompounds",
      "unitRef": "numberoflicensedcompound",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-39",
      "name": "prph:NumberOfLicensedCompounds",
      "unitRef": "numberoflicensedcompound",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "longName": "9954482 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "prph:NumberOfTestsRecognized",
      "unitRef": "test",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConcentrationRiskCreditRisk",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "unique": true
     }
    },
    "R38": {
     "role": "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails",
     "longName": "9954483 - Disclosure - Summary of Significant Accounting Policies - Summary of Components of Marketable Securities (Details)",
     "shortName": "Summary of Significant Accounting Policies - Summary of Components of Marketable Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofAccountsReceivableNetDetails",
     "longName": "9954484 - Disclosure - Summary of Significant Accounting Policies - Schedule of Accounts Receivable Net (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Accounts Receivable Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccountsPayableTradeCurrentAndNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableAllowanceforCreditLossDetails",
     "longName": "9954485 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable, Allowance for Credit Loss (Details)",
     "shortName": "Summary of Significant Accounting Policies - Accounts Receivable, Allowance for Credit Loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R41": {
     "role": "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails",
     "longName": "9954486 - Disclosure - Summary of Significant Accounting Policies - Schedule of Components of Inventory (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Components of Inventory (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "prph:InventoryLabMaterial",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "prph:InventoryLabMaterial",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails",
     "longName": "9954487 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value of Financial Instruments (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Fair Value of Financial Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:MarketableSecurities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:MarketableSecurities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails",
     "longName": "9954488 - Disclosure - Summary of Significant Accounting Policies - Schedule of Deferred Revenue (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Deferred Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPerformanceObligationDetails",
     "longName": "9954489 - Disclosure - Summary of Significant Accounting Policies - Performance Obligation (Details)",
     "shortName": "Summary of Significant Accounting Policies - Performance Obligation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R45": {
     "role": "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDisaggregationbyRevenueDetails",
     "longName": "9954490 - Disclosure - Summary of Significant Accounting Policies - Schedule of Disaggregation by Revenue (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Disaggregation by Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-78",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://prophaselabs.com/role/AssetAcquisitionDetails",
     "longName": "9954491 - Disclosure - Asset Acquisition (Details)",
     "shortName": "Asset Acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-90",
      "name": "us-gaap:AssetAcquisitionContingentConsiderationLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-90",
      "name": "us-gaap:AssetAcquisitionContingentConsiderationLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://prophaselabs.com/role/IntangibleAssetsNetNarrativeDetails",
     "longName": "9954492 - Disclosure - Intangible Assets, Net - Narrative (Details)",
     "shortName": "Intangible Assets, Net - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails",
     "longName": "9954493 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets (Details)",
     "shortName": "Intangible Assets, Net - Schedule of Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails",
     "longName": "9954494 - Disclosure - Intangible Assets, Net - Schedule Estimated Future Amortization Expense of Acquired Intangible Assets (Details)",
     "shortName": "Intangible Assets, Net - Schedule Estimated Future Amortization Expense of Acquired Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails",
     "longName": "9954495 - Disclosure - Property, Plant, and Equipment - Schedule of Property, Plant and Equipment (Details)",
     "shortName": "Property, Plant, and Equipment - Schedule of Property, Plant and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://prophaselabs.com/role/PropertyPlantandEquipmentNarrativeDetails",
     "longName": "9954496 - Disclosure - Property, Plant and Equipment - Narrative (Details)",
     "shortName": "Property, Plant and Equipment - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://prophaselabs.com/role/OutstandingDebtDetails",
     "longName": "9954497 - Disclosure - Outstanding Debt (Details)",
     "shortName": "Outstanding Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-132",
      "name": "us-gaap:DebtInstrumentPeriodicPayment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-132",
      "name": "us-gaap:DebtInstrumentPeriodicPayment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails",
     "longName": "9954498 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DividendsCommonStock",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails",
     "longName": "9954499 - Disclosure - Stockholders' Equity - Schedule of Stock Options Activity (Details)",
     "shortName": "Stockholders' Equity - Schedule of Stock Options Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://prophaselabs.com/role/StockholdersEquitySummaryofWeightedAverageAssumptionsUsedinDeterminingFairValueofOptionsDetails",
     "longName": "9954500 - Disclosure - Stockholders' Equity - Summary of Weighted Average Assumptions Used in Determining Fair Value of Options (Details)",
     "shortName": "Stockholders' Equity - Summary of Weighted Average Assumptions Used in Determining Fair Value of Options (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails",
     "longName": "9954501 - Disclosure - Stockholders' Equity - Schedule of Warrant Activity (Details)",
     "shortName": "Stockholders' Equity - Schedule of Warrant Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-186",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "prph:ScheduleOfWarrantActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://prophaselabs.com/role/DefinedContributionPlansDetailsNarrative",
     "longName": "9954502 - Disclosure - Defined Contribution Plans (Details Narrative)",
     "shortName": "Defined Contribution Plans (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails",
     "longName": "9954503 - Disclosure - Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details)",
     "shortName": "Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails",
     "longName": "9954504 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)",
     "shortName": "Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails",
     "longName": "9954505 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://prophaselabs.com/role/IncomeTaxesNarrativeDetails",
     "longName": "9954506 - Disclosure - Income Taxes - Narrative (Details)",
     "shortName": "Income Taxes - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails",
     "longName": "9954507 - Disclosure - Other Current Liabilities - Schedule of Other Current Liabilities (Details)",
     "shortName": "Other Current Liabilities - Schedule of Other Current Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccruedLiabilitiesForCommissionsExpenseAndTaxes",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccruedLiabilitiesForCommissionsExpenseAndTaxes",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails",
     "longName": "9954508 - Disclosure - Commitments and Contingencies - Narrative (Details)",
     "shortName": "Commitments and Contingencies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-188",
      "name": "prph:ManufacturingAgreementRenewalOptions",
      "unitRef": "period",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-188",
      "name": "prph:ManufacturingAgreementRenewalOptions",
      "unitRef": "period",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://prophaselabs.com/role/LeasesNarrativeDetails",
     "longName": "9954509 - Disclosure - Leases - Narrative (Details)",
     "shortName": "Leases - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:OperatingLeaseLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-209",
      "name": "us-gaap:LesseeFinanceLeaseTermOfContract1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails",
     "longName": "9954510 - Disclosure - Leases - Schedule of Quantitative Information About Operating and Finance Leases (Details)",
     "shortName": "Leases - Schedule of Quantitative Information About Operating and Finance Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails",
     "longName": "9954511 - Disclosure - Leases - Schedule of Maturity of Operating and Finance Leases (Details)",
     "shortName": "Leases - Schedule of Maturity of Operating and Finance Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails",
     "longName": "9954512 - Disclosure - Significant Customers Concentrations - Narrative (Details)",
     "shortName": "Significant Customers Concentrations - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-210",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://prophaselabs.com/role/SegmentInformationDetailsNarrative",
     "longName": "9954513 - Disclosure - Segment Information (Details Narrative)",
     "shortName": "Segment Information (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R69": {
     "role": "http://prophaselabs.com/role/ScheduleofSegmentInformationDetails",
     "longName": "9954514 - Disclosure - Schedule of Segment Information (Details)",
     "shortName": "Schedule of Segment Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails",
     "longName": "9954515 - Disclosure - Earnings Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details)",
     "shortName": "Earnings Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://prophaselabs.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromtheIncomePerShareComputationDetails",
     "longName": "9954516 - Disclosure - Earnings Per Share - Schedule of Anti-dilutive Securities Excluded from the Income Per Share Computation (Details)",
     "shortName": "Earnings Per Share - Schedule of Anti-dilutive Securities Excluded from the Income Per Share Computation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://prophaselabs.com/role/SubsequentEventsDetails",
     "longName": "9954517 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-242",
      "name": "prph:ProceedsFromFinancingAgreement",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-242",
      "name": "prph:ProceedsFromFinancingAgreement",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "prph-20231231.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "prph_A2022DirectorsPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "A2022DirectorsPlanMember",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022 Directors Plan",
        "label": "2022 Directors Plan [Member]",
        "documentation": "2022 Directors Plan"
       }
      }
     },
     "auth_ref": []
    },
    "prph_A2022PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "A2022PlanMember",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022 Plan",
        "label": "2022 Plan [Member]",
        "documentation": "2022 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "prph_A2023NoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "A2023NoteMember",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets",
      "http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 Note",
        "label": "2023 Note [Member]",
        "documentation": "2023 Note"
       }
      }
     },
     "auth_ref": []
    },
    "prph_A2023NotesWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "A2023NotesWarrantsMember",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 Notes Warrants",
        "label": "2023 Notes Warrants [Member]",
        "documentation": "2023 Notes Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "prph_A2023SecuredMortgageLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "A2023SecuredMortgageLoanMember",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 Secured Mortgage Loan",
        "label": "2023 Secured Mortgage Loan [Member]",
        "documentation": "2023 Secured Mortgage Loan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable Type [Axis]",
        "label": "Receivable Type [Axis]",
        "documentation": "Information by type of receivable."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r839"
     ]
    },
    "us-gaap_AccountsPayableTradeCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableTradeCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofAccountsReceivableNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade accounts receivable",
        "label": "Accounts Payable, Trade",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r916"
     ]
    },
    "us-gaap_AccountsReceivableGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableGross",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofAccountsReceivableNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, before Allowance for Credit Loss",
        "label": "Accounts Receivable, before Allowance for Credit Loss",
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r230",
      "r347",
      "r989"
     ]
    },
    "us-gaap_AccountsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofAccountsReceivableNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total accounts receivable",
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r746",
      "r798",
      "r845",
      "r989"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, net",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r348"
     ]
    },
    "us-gaap_AccruedBonusesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedBonusesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued bonus",
        "label": "Accrued Bonuses, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_AccruedEmployeeBenefitsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedEmployeeBenefitsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued benefits and vacation",
        "label": "Accrued Employee Benefits, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_AccruedLiabilitiesForCommissionsExpenseAndTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesForCommissionsExpenseAndTaxes",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued diagnostic services commissions",
        "label": "Accrued Liabilities for Commissions, Expense and Taxes",
        "documentation": "The carrying amount for commissions, taxes and other expenses that were incurred but unpaid as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r987"
     ]
    },
    "us-gaap_AccruedMarketingCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedMarketingCostsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued advertising and other allowances",
        "label": "Accrued Marketing Costs, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedPayrollTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedPayrollTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued payroll",
        "label": "Accrued Payroll Taxes, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued diagnostic services",
        "label": "Accrued Professional Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "prph_AccruedReturns": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "AccruedReturns",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued returns",
        "label": "Accrued Returns",
        "documentation": "Accrued return."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r244",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45",
      "r137",
      "r231",
      "r676",
      "r708",
      "r709"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r244",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r15",
      "r45",
      "r582",
      "r585",
      "r619",
      "r704",
      "r705",
      "r890",
      "r891",
      "r892",
      "r900",
      "r901",
      "r902"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r839",
      "r993"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r543",
      "r544",
      "r545",
      "r722",
      "r900",
      "r901",
      "r902",
      "r970",
      "r997"
     ]
    },
    "prph_AdditionalPaymentOfFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "AdditionalPaymentOfFee",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional payment of fee",
        "label": "Additional Payment Of Fee",
        "documentation": "Additional Payment Of Fee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Treasury shares repurchased to satisfy tax withholding obligations",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r94",
      "r511"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of warrants with unsecured promissory note",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r83",
      "r163"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdvertisingCostsPolicyTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advertising and Incentive Promotions",
        "label": "Advertising Cost [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for advertising cost."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "us-gaap_AdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advertising expense",
        "label": "Advertising Expense",
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line."
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "prph_AgreementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "AgreementTerm",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agreement term (in days)",
        "label": "Agreement Term",
        "documentation": "Agreement Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r540",
      "r546"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableAllowanceforCreditLossDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofAccountsReceivableNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, allowance for credit loss",
        "negatedLabel": "Less allowances",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r349",
      "r384",
      "r387",
      "r390",
      "r989"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableAllowanceforCreditLossDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for doubtful accounts period increase",
        "verboseLabel": "Current period provision for expected credit losses",
        "label": "Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "documentation": "Amount of increase (decrease) in allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r916"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableAllowanceforCreditLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bad debt expense",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance."
       }
      }
     },
     "auth_ref": [
      "r389"
     ]
    },
    "prph_Amended2010DirectorsPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "Amended2010DirectorsPlanMember",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amended 2010 Directors' Plan",
        "label": "Amended 2010 Directors' Plan [Member]",
        "documentation": "Amended 2010 Directors' Plan"
       }
      }
     },
     "auth_ref": []
    },
    "prph_Amended2022DirectorsPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "Amended2022DirectorsPlanMember",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amended 2022 Directors' Plan",
        "label": "Amended 2022 Directors' Plan [Member]",
        "documentation": "Amended 2022 Directors' Plan"
       }
      }
     },
     "auth_ref": []
    },
    "prph_Amended2022PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "Amended2022PlanMember",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amended 2022 Plan",
        "label": "Amended 2022 Plan [Member]",
        "documentation": "Amended 2022 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "prph_AmendedTwoThousandTenPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "AmendedTwoThousandTenPlanMember",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amended 2010 Plan",
        "label": "Amended 2010 Plan [Member]",
        "documentation": "Amended 2010 Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfDebtDiscountPremium",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of debt discount",
        "label": "Amortization of Debt Discount (Premium)",
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r106",
      "r145",
      "r457"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/IntangibleAssetsNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization expense",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r75",
      "r79"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://prophaselabs.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromtheIncomePerShareComputationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r303"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://prophaselabs.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromtheIncomePerShareComputationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://prophaselabs.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromtheIncomePerShareComputationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://prophaselabs.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromtheIncomePerShareComputationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "us-gaap_AreaOfRealEstateProperty": {
     "xbrltype": "areaItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AreaOfRealEstateProperty",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails",
      "http://prophaselabs.com/role/OrganizationandBusinessNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Area of CLIA accredited laboratory (sq. ft.)",
        "label": "Area of Real Estate Property",
        "documentation": "Area of a real estate property."
       }
      }
     },
     "auth_ref": []
    },
    "prph_ArrangementTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ArrangementTypeAxis",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type Of Arrangement [Axis]",
        "label": "Arrangement Type [Axis]",
        "documentation": "Arrangement Type"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r576"
     ]
    },
    "us-gaap_AssetAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionAxis",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Axis]",
        "label": "Asset Acquisition [Axis]",
        "documentation": "Information by asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "us-gaap_AssetAcquisitionConsiderationTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionConsiderationTransferred",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consideration transferred",
        "label": "Asset Acquisition, Consideration Transferred",
        "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer."
       }
      }
     },
     "auth_ref": [
      "r837",
      "r967",
      "r968",
      "r969"
     ]
    },
    "prph_AssetAcquisitionConsiderationTransferredLiabilityPayoff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "AssetAcquisitionConsiderationTransferredLiabilityPayoff",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability payoff amount",
        "label": "Asset Acquisition, Consideration Transferred, Liability Payoff",
        "documentation": "Asset Acquisition, Consideration Transferred, Liability Payoff"
       }
      }
     },
     "auth_ref": []
    },
    "prph_AssetAcquisitionConsiderationTransferredPromissoryNotePayoff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "AssetAcquisitionConsiderationTransferredPromissoryNotePayoff",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Promissory note payoff amount",
        "label": "Asset Acquisition, Consideration Transferred, Promissory Note Payoff",
        "documentation": "Asset Acquisition, Consideration Transferred, Promissory Note Payoff"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionContingentConsiderationLiability",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured note amount",
        "label": "Asset Acquisition, Contingent Consideration, Liability",
        "documentation": "Amount of liability recognized from contingent consideration in asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionContingentConsiderationLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails",
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due to sellers (see Note 3)",
        "label": "Asset Acquisition, Contingent Consideration, Liability, Noncurrent",
        "documentation": "Amount of liability recognized from contingent consideration in asset acquisition, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "us-gaap_AssetAcquisitionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionDomain",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Domain]",
        "label": "Asset Acquisition [Domain]",
        "documentation": "Asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "us-gaap_AssetAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionLineItems",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Line Items]",
        "label": "Asset Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "prph_AssetAcquisitionSharesIssuedAndIssuableValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "AssetAcquisitionSharesIssuedAndIssuableValuePerShare",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued (in value per share)",
        "label": "Asset Acquisition, Shares Issued and Issuable, Value Per Share",
        "documentation": "Asset Acquisition, Shares Issued and Issuable, Value Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionTable",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Table]",
        "label": "Asset Acquisition [Table]",
        "documentation": "Disclosure of information about asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "prph_AssetAcquisitionTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "AssetAcquisitionTransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction costs",
        "label": "Asset Acquisition, Transaction Costs",
        "documentation": "Asset Acquisition, Transaction Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetImpairmentCharges",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment charges",
        "label": "Asset Impairment Charges",
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r80"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets",
      "http://prophaselabs.com/role/ScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL ASSETS",
        "terseLabel": "Total assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r228",
      "r262",
      "r312",
      "r333",
      "r339",
      "r381",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r577",
      "r579",
      "r593",
      "r670",
      "r751",
      "r839",
      "r852",
      "r929",
      "r930",
      "r977"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets [Abstract]",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r235",
      "r262",
      "r381",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r577",
      "r579",
      "r593",
      "r839",
      "r929",
      "r930",
      "r977"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets, Current [Abstract]",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "prph_AuditInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "AuditInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit Information [Abstract]",
        "documentation": "Audit Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://prophaselabs.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r857",
      "r858",
      "r859"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://prophaselabs.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r857",
      "r858",
      "r859"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://prophaselabs.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r857",
      "r858",
      "r859"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized Gains",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r354"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unrealized Losses",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r355"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized Cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r394",
      "r669"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539"
     ]
    },
    "prph_BESmartLicenseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "BESmartLicenseAgreementMember",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BE-Smart License Agreement",
        "label": "BE-Smart License Agreement [Member]",
        "documentation": "BE-Smart License Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "prph_BlackScholesOptionPricingModelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "BlackScholesOptionPricingModelMember",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Black-Scholes Option Pricing Model",
        "label": "Black-Scholes Option Pricing Model [Member]",
        "documentation": "Black-Scholes Option Pricing Model"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BuildingAndBuildingImprovementsMember",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Building and Building Improvements",
        "label": "Building and Building Improvements [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BuildingImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BuildingImprovementsMember",
     "presentation": [
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Building improvements",
        "label": "Building Improvements [Member]",
        "documentation": "Addition, improvement, or renovation to a facility held for productive use including, but not limited to, office, production, storage and distribution facilities."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails",
      "http://prophaselabs.com/role/OrganizationandBusinessNarrativeDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r574",
      "r831",
      "r832"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails",
      "http://prophaselabs.com/role/OrganizationandBusinessNarrativeDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Axis]",
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r574",
      "r831",
      "r832"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://prophaselabs.com/role/OrganizationandBusinessNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Line Items]",
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination and Asset Acquisition [Abstract]",
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/OrganizationandBusinessNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total consideration",
        "label": "Business Combination, Consideration Transferred",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3",
      "r13"
     ]
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition",
        "label": "Business Combination Disclosure [Text Block]",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r575"
     ]
    },
    "prph_CEOOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "CEOOptionsMember",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CEO Options",
        "label": "CEO Options [Member]",
        "documentation": "CEO Options [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "prph_CFOAwardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "CFOAwardMember",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CFO Award",
        "label": "CFO Award [Member]",
        "documentation": "CFO Award"
       }
      }
     },
     "auth_ref": []
    },
    "prph_CPMMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "CPMMember",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails",
      "http://prophaselabs.com/role/OrganizationandBusinessNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CPM Acquisition",
        "label": "CPM [Member]",
        "documentation": "CPM acquisition [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash",
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r673",
      "r723",
      "r745",
      "r839",
      "r852",
      "r880"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r224",
      "r807"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Cash",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r173"
     ]
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash, cash equivalents, restricted cash and marketable securities",
        "label": "Cash, Cash Equivalents, and Short-Term Investments",
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable."
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash, at the beginning of the year",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, at the end of the year",
        "terseLabel": "Cash, cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r148",
      "r258"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "(Decrease) increase in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r148"
     ]
    },
    "us-gaap_CashFDICInsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFDICInsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal depository insurance",
        "label": "Cash, FDIC Insured Amount",
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashUninsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashUninsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank balance uninsured",
        "label": "Cash, Uninsured Amount",
        "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "prph_CertainHoldersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "CertainHoldersMember",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Certain Holders",
        "label": "Certain Holders [Member]",
        "documentation": "Certain Holders"
       }
      }
     },
     "auth_ref": []
    },
    "prph_ChangeInFairValueOfInvestmentSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ChangeInFairValueOfInvestmentSecurities",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of investment securities",
        "label": "Change in fair value of investment securities",
        "documentation": "Change in fair value of investment securities."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ChiefExecutiveOfficerMember",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chief Executive Officer",
        "label": "Chief Executive Officer [Member]"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "srt_ChiefFinancialOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ChiefFinancialOfficerMember",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chief Financial Officer",
        "label": "Chief Financial Officer [Member]"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Axis]",
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Domain]",
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price (in dollars per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r476"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants (in shares)",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r476"
     ]
    },
    "prph_ClientPayersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ClientPayersMember",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Client Payers",
        "label": "Client Payers [Member]",
        "documentation": "Client Payers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COMMITMENTS AND CONTINGENCIES",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r112",
      "r672",
      "r736"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r420",
      "r421",
      "r800",
      "r926"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future issuance (in shares)",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockDividendsPerShareCashPaid",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Special cash dividend (in dollars per share)",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "prph_CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in shares for issuance (in shares)",
        "label": "Common Stock, Increase (Decrease) In Capital Shares Reserved For Future Issuance",
        "documentation": "Common Stock, Increase (Decrease) In Capital Shares Reserved For Future Issuance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r842",
      "r843",
      "r844",
      "r846",
      "r847",
      "r848",
      "r849",
      "r900",
      "r901",
      "r970",
      "r992",
      "r997"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails",
      "http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par or stated value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "prph_CommonStockPurchaseWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "CommonStockPurchaseWarrantsMember",
     "presentation": [
      "http://prophaselabs.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromtheIncomePerShareComputationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock purchase warrants",
        "label": "Common Stock Purchase Warrants [Member]",
        "documentation": "Common Stock Purchase Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r737"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, outstanding (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r126",
      "r737",
      "r757",
      "r997",
      "r998"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock authorized 50,000,000, $0.0005 par value, 18,045,029 and 16,210,776 shares outstanding, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r675",
      "r839"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Benefits [Abstract]",
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total comprehensive (loss) income",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r239",
      "r241",
      "r247",
      "r665",
      "r683"
     ]
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer equipment and software",
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDisaggregationbyRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r64",
      "r104",
      "r105",
      "r346",
      "r799"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDisaggregationbyRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r64",
      "r104",
      "r105",
      "r346",
      "r710",
      "r799"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r64",
      "r104",
      "r105",
      "r346",
      "r799",
      "r868"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business and Liquidity Risks and Uncertainties and Concentration of Financial Risks",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r189"
     ]
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Customers Concentrations",
        "label": "Concentration Risk Disclosure [Text Block]",
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Line Items]",
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration risk",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r64",
      "r104",
      "r105",
      "r346"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Table]",
        "label": "Concentration Risk [Table]",
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r62",
      "r64",
      "r65",
      "r104",
      "r172",
      "r799"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r64",
      "r104",
      "r105",
      "r346",
      "r799"
     ]
    },
    "prph_ConstructionAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ConstructionAllowance",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction allowance",
        "label": "Construction Allowance",
        "documentation": "Construction Allowance"
       }
      }
     },
     "auth_ref": []
    },
    "prph_ConsumerProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ConsumerProductsMember",
     "presentation": [
      "http://prophaselabs.com/role/ScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consumer products",
        "label": "Consumer Products [Member]",
        "documentation": "Consumer Products [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "prph_ContractManufacturingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ContractManufacturingMember",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDisaggregationbyRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract manufacturing",
        "label": "Contract Manufacturing [Member]",
        "documentation": "Contract Manufacturing [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Contract balance, deferred revenue",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r479",
      "r490"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue, net of current portion",
        "label": "Contract with Customer, Liability, Noncurrent",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r479",
      "r490"
     ]
    },
    "prph_CooperativeIncentivePromotionCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "CooperativeIncentivePromotionCostsMember",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cooperative Incentive Promotion Costs",
        "label": "Cooperative Incentive Promotion Costs [Member]",
        "documentation": "Cooperative Incentive Promotion Costs [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "prph_CorporateObligationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "CorporateObligationsMember",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate obligations",
        "label": "Corporate Obligations [Member]",
        "documentation": "Corporate Obligations [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "prph_CorporateStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "CorporateStockMember",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate stock",
        "label": "Corporate Stock [Member]",
        "documentation": "Corporate Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome",
      "http://prophaselabs.com/role/ScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenues",
        "verboseLabel": "Cost of revenue",
        "label": "Cost of Goods and Services Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r661"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Current Federal Tax Expense (Benefit)",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r872",
      "r899",
      "r965"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Current Total",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r564",
      "r570",
      "r899"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current",
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State",
        "label": "Current State and Local Tax Expense (Benefit)",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r872",
      "r899",
      "r965"
     ]
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Concentration Risk",
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r346"
     ]
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer relationships",
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt conversion, principal amount",
        "label": "Debt Conversion, Converted Instrument, Amount",
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r57"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt conversion, common stock (in shares)",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r57"
     ]
    },
    "us-gaap_DebtConversionOriginalDebtAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtConversionOriginalDebtAmount1",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt conversion, amount",
        "label": "Debt Conversion, Original Debt, Amount",
        "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r57"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Debt",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r260",
      "r435",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r451",
      "r458",
      "r459",
      "r461"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets",
      "http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://prophaselabs.com/role/OutstandingDebtDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r122",
      "r123",
      "r175",
      "r176",
      "r264",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r442",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r602",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r897"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion price (in dollars per share)",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r438"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate principal amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r109",
      "r436",
      "r602",
      "r821",
      "r822"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rates (as a percent)",
        "label": "Debt Instrument, Interest Rate During Period",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r107",
      "r454"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate (as a percent)",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r437"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets",
      "http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://prophaselabs.com/role/OutstandingDebtDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r264",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r442",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r602",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r897"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentPeriodicPayment",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Periodic payment",
        "label": "Debt Instrument, Periodic Payment",
        "documentation": "Amount of the required periodic payments including both interest and principal payments."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r115"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnamortizedDiscount",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt discount",
        "label": "Debt Instrument, Unamortized Discount",
        "documentation": "Amount, after accumulated amortization, of debt discount."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r109",
      "r932"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnamortizedDiscountNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount",
        "label": "Debt Instrument, Unamortized Discount, Noncurrent",
        "documentation": "Amount of debt discount to be amortized after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r109"
     ]
    },
    "prph_DebtSecuritiesAvailableForSaleMaturityPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "DebtSecuritiesAvailableForSaleMaturityPeriod",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt securities maturity (in years)",
        "label": "Debt Securities, Available-for-Sale, Maturity Period",
        "documentation": "Debt Securities, Available-for-Sale, Maturity Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleRealizedGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Realized loss on marketable debt securities",
        "label": "Debt Securities, Available-for-Sale, Realized Gain (Loss)",
        "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r911"
     ]
    },
    "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Held-to-maturity, Allowance for Credit Loss [Table]",
        "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]",
        "documentation": "Disclosure of information about allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r916"
     ]
    },
    "us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]",
        "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r916"
     ]
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Federal",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r899",
      "r964",
      "r965"
     ]
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFinanceCostsGross",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt issuance costs",
        "label": "Debt Issuance Costs, Gross",
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax asset",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r554"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Total",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r169",
      "r197",
      "r569",
      "r570",
      "r899"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred",
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liability, net",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r554",
      "r671"
     ]
    },
    "us-gaap_DeferredRevenueArrangementByTypeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenueArrangementByTypeTable",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPerformanceObligationDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Revenue",
        "label": "Deferred Revenue Arrangement, by Type [Table]",
        "documentation": "Schedule of deferred revenue disclosure which includes the type of arrangements and the corresponding amount that comprise the current and noncurrent balance of deferred revenue as of the balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueArrangementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenueArrangementLineItems",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPerformanceObligationDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Revenue Arrangement [Line Items]",
        "label": "Deferred Revenue Arrangement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Deferred Revenue, Current",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "State",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r899",
      "r964",
      "r965"
     ]
    },
    "prph_DeferredTaxAssetsCapitalLeaseObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "DeferredTaxAssetsCapitalLeaseObligations",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital lease obligations",
        "label": "Deferred Tax Assets, Capital Lease Obligations",
        "documentation": "Deferred tax assets, capital lease obligations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss and capital loss carryforward",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r963"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating loss carryforwards, federal",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r963"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating loss carryforwards, state and local",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r963"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r963"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credit",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r98",
      "r963"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credit carryforwards, research",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r98",
      "r963"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesNarrativeDetails",
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "verboseLabel": "Deferred tax assets, valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total",
        "label": "Deferred Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r962"
     ]
    },
    "prph_DeferredTaxLiabilitiesAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "DeferredTaxLiabilitiesAmortization",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Amortization",
        "label": "Deferred Tax Liabilities, Amortization",
        "documentation": "Deferred tax liabilities, amortization"
       }
      }
     },
     "auth_ref": []
    },
    "prph_DeferredTaxLiabilitiesDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "DeferredTaxLiabilitiesDepreciation",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Depreciation",
        "label": "Deferred Tax Liabilities, Depreciation",
        "documentation": "Deferred tax liabilities, depreciation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Right of use asset",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r963"
     ]
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/DefinedContributionPlansDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contribution amount",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/PropertyPlantandEquipmentNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r81"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/ScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization expense",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r81"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r317"
     ]
    },
    "prph_DiagnosticServicesClientsOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "DiagnosticServicesClientsOneMember",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diagnostic Services Clients One",
        "label": "Diagnostic Services Clients One [Member]",
        "documentation": "Diagnostic Services Clients One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "prph_DiagnosticServicesClientsThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "DiagnosticServicesClientsThreeMember",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diagnostic Services Clients Three",
        "label": "Diagnostic Services Clients Three [Member]",
        "documentation": "Diagnostic Services Clients Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "prph_DiagnosticServicesClientsTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "DiagnosticServicesClientsTwoMember",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diagnostic Services Clients Two",
        "label": "Diagnostic Services Clients Two [Member]",
        "documentation": "Diagnostic Services Clients Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "prph_DiagnosticServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "DiagnosticServicesMember",
     "presentation": [
      "http://prophaselabs.com/role/ScheduleofSegmentInformationDetails",
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDisaggregationbyRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diagnostic services",
        "verboseLabel": "Diagnostic Services",
        "label": "Diagnostic Services [Member]",
        "documentation": "Diagnostic Services [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Disaggregation of Deferred Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "us-gaap_DividendsCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends declared",
        "label": "Dividends, Common Stock",
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r163"
     ]
    },
    "us-gaap_DividendsCommonStockCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsCommonStockCash",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash dividends",
        "label": "Dividends, Common Stock, Cash",
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r857",
      "r858",
      "r859"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r857",
      "r858",
      "r859",
      "r861"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated by Reference",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share [Abstract]",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r284",
      "r287",
      "r300",
      "r301",
      "r302",
      "r306",
      "r590",
      "r591",
      "r666",
      "r684",
      "r811"
     ]
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasicAbstract",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings (loss) per share:",
        "label": "Earnings Per Share, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasicLineItems",
     "presentation": [
      "http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share [Abstract]",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r287",
      "r291",
      "r300"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r287",
      "r300",
      "r301",
      "r302",
      "r306",
      "r590",
      "r591",
      "r666",
      "r684",
      "r811"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/EarningsPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r283",
      "r303",
      "r304",
      "r305"
     ]
    },
    "us-gaap_EmployeeBenefitsAndShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeBenefitsAndShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation included in the prepaid expense",
        "label": "Employee Benefits and Share-Based Compensation",
        "documentation": "Amount of expense for employee benefit and equity-based compensation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation, nonvested award, cost not yet recognized, amount",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average period (in years)",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://prophaselabs.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromtheIncomePerShareComputationDetails",
      "http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options",
        "label": "Employee Stock Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquipmentMember",
     "presentation": [
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lab equipment",
        "label": "Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails",
      "http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r218",
      "r243",
      "r244",
      "r245",
      "r270",
      "r271",
      "r272",
      "r274",
      "r280",
      "r282",
      "r307",
      "r382",
      "r383",
      "r477",
      "r543",
      "r544",
      "r545",
      "r565",
      "r566",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r589",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r619",
      "r704",
      "r705",
      "r706",
      "r722",
      "r780"
     ]
    },
    "prph_EquivirLicenseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "EquivirLicenseAgreementMember",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equivir License Agreement",
        "label": "Equivir License Agreement [Member]",
        "documentation": "Equivir License Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EscrowDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EscrowDeposit",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Escrow amount",
        "label": "Escrow Deposit",
        "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r801"
     ]
    },
    "us-gaap_EscrowDepositsRelatedToPropertySales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EscrowDepositsRelatedToPropertySales",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business acquisitions, escrow received",
        "label": "Escrow Deposits Related to Property Sales",
        "documentation": "Escrow deposits related to property sales in noncash investing and financing activities."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r56",
      "r57"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r449",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r592",
      "r631",
      "r632",
      "r633",
      "r821",
      "r822",
      "r828",
      "r829",
      "r830"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r449",
      "r494",
      "r499",
      "r592",
      "r631",
      "r828",
      "r829",
      "r830"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r449",
      "r494",
      "r499",
      "r592",
      "r632",
      "r821",
      "r822",
      "r828",
      "r829",
      "r830"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r449",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r592",
      "r633",
      "r821",
      "r822",
      "r828",
      "r829",
      "r830"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r449",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r631",
      "r632",
      "r633",
      "r821",
      "r822",
      "r828",
      "r829",
      "r830"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value of Financial Instruments",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r26"
     ]
    },
    "prph_FinanceLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "FinanceLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total finance lease expense",
        "label": "Finance Lease, Cost",
        "documentation": "Finance Lease, Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseInterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_FinanceLeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest lease cost",
        "label": "Finance Lease, Interest Expense",
        "documentation": "Amount of interest expense on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r607",
      "r611",
      "r838"
     ]
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiability",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Finance Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r605",
      "r618"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityAbstract",
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease",
        "label": "Finance Lease, Liability [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease liabilities",
        "label": "Finance Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease liabilities, net of current portion",
        "label": "Finance Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails",
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Present value of minimum future obligations",
        "totalLabel": "Total lease payments",
        "label": "Finance Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiabilityToBePaidAfterYearFive",
       "weight": 1.0,
       "order": 1.0
      },
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiabilityToBePaidYearOne",
       "weight": 1.0,
       "order": 2.0
      },
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year Ended December 31, 2024",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiabilityToBePaidYearFive",
       "weight": 1.0,
       "order": 1.0
      },
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year Ended December 31, 2028",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiabilityToBePaidYearFour",
       "weight": 1.0,
       "order": 2.0
      },
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year Ended December 31, 2027",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiabilityToBePaidYearThree",
       "weight": 1.0,
       "order": 1.0
      },
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year Ended December 31, 2026",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiabilityToBePaidYearTwo",
       "weight": 1.0,
       "order": 2.0
      },
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year Ended December 31, 2025",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less present value discount",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease asset",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r604"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAssetAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease, right-of-use asset, accumulated amortization",
        "label": "Finance Lease, Right-of-Use Asset, Accumulated Amortization",
        "documentation": "Amount of accumulated amortization of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r866",
      "r869"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_FinanceLeaseCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails",
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation expense",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r607",
      "r611",
      "r838"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r606"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails",
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average discount rate \u2013 finance leases",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for finance lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r617",
      "r838"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining lease term \u2013 finance leases (in years)",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r616",
      "r838"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r385",
      "r386",
      "r391",
      "r392",
      "r393",
      "r395",
      "r396",
      "r397",
      "r460",
      "r474",
      "r587",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r682",
      "r817",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r911",
      "r912",
      "r913",
      "r914"
     ]
    },
    "prph_FinancingAgreementOriginationFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "FinancingAgreementOriginationFee",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Origination fee",
        "label": "Financing Agreement, Origination Fee",
        "documentation": "Financing Agreement, Origination Fee"
       }
      }
     },
     "auth_ref": []
    },
    "prph_FinancingAgreementPeriodicPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "FinancingAgreementPeriodicPayment",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Periodic payment amount",
        "label": "Financing Agreement, Periodic Payment",
        "documentation": "Financing Agreement, Periodic Payment"
       }
      }
     },
     "auth_ref": []
    },
    "prph_FinancingArrangementAggregateRepaymentAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "FinancingArrangementAggregateRepaymentAmount",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate repayment amount",
        "label": "Financing Arrangement, Aggregate Repayment Amount",
        "documentation": "Financing Arrangement, Aggregate Repayment Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails",
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated Useful Life (in years)",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: accumulated amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r415"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year ended December 31, 2024",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year ended December 31, 2028",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year ended December 31, 2027",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year ended December 31, 2026",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year ended December 31, 2025",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails",
      "http://prophaselabs.com/role/IntangibleAssetsNetNarrativeDetails",
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r412",
      "r414",
      "r415",
      "r416",
      "r662",
      "r663"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total intangible assets, gross",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r663"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://prophaselabs.com/role/IntangibleAssetsNetNarrativeDetails",
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r662"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails",
      "http://prophaselabs.com/role/IntangibleAssetsNetNarrativeDetails",
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r78"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleEstimatedFutureAmortizationExpenseofAcquiredIntangibleAssetsDetails",
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total intangible assets, net",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r662"
     ]
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails",
      "http://prophaselabs.com/role/IntangibleAssetsNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase price",
        "label": "Finite-Lived Intangible Assets Acquired",
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "prph_FullyReservedTradeReceivablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "FullyReservedTradeReceivablesMember",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fully Reserved Trade Receivables",
        "label": "Fully Reserved Trade Receivables [Member]",
        "documentation": "Fully Reserved Trade Receivables"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and fixtures",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnInvestments",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value of investment securities",
        "label": "Gain (Loss) on Investments",
        "documentation": "Amount of realized and unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r864"
     ]
    },
    "us-gaap_GainLossOnSaleOfProperties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnSaleOfProperties",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gain on sales of assets",
        "label": "Gain (Loss) on Sale of Properties",
        "documentation": "The difference between the carrying value and the sale price of real estate or properties that were intended to be sold or held for capital appreciation or rental income. This element refers to the gain (loss) included in earnings and not to the cash proceeds of the sale. This element is a noncash adjustment to net income when calculating net cash generated by operating activities using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r895",
      "r920",
      "r924"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administration",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r761"
     ]
    },
    "prph_GenomicProductsAndServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "GenomicProductsAndServicesMember",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDisaggregationbyRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Genomic products and services",
        "label": "Genomic Products and Services [Member]",
        "documentation": "Genomic Products and Services [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeographicDistributionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeographicDistributionAxis",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographic Distribution [Axis]",
        "label": "Geographic Distribution [Axis]",
        "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r667",
      "r668",
      "r816"
     ]
    },
    "us-gaap_GeographicDistributionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeographicDistributionDomain",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographic Distribution [Domain]",
        "label": "Geographic Distribution [Domain]",
        "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r667",
      "r668"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r401",
      "r664",
      "r819",
      "r839",
      "r918",
      "r919"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r73"
     ]
    },
    "prph_GovernmentAgenciesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "GovernmentAgenciesMember",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government Agencies",
        "label": "Government Agencies [Member]",
        "documentation": "Government Agencies [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "prph_GradualRentalRateIncreasePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "GradualRentalRateIncreasePercentage",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gradual rental rate increase percentage",
        "label": "Gradual Rental Rate Increase Percentage",
        "documentation": "Gradual rental rate increase percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GranteeStatusAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GranteeStatusAxis",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grantee Status [Axis]",
        "label": "Grantee Status [Axis]",
        "documentation": "Information by status of recipient to whom award is granted."
       }
      }
     },
     "auth_ref": [
      "r510",
      "r512",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539"
     ]
    },
    "us-gaap_GranteeStatusDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GranteeStatusDomain",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grantee Status [Domain]",
        "label": "Grantee Status [Domain]",
        "documentation": "Status of recipient to whom award is granted."
       }
      }
     },
     "auth_ref": [
      "r510",
      "r512",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r262",
      "r312",
      "r332",
      "r338",
      "r341",
      "r381",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r593",
      "r813",
      "r929"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r857",
      "r858",
      "r859"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of Long-Lived Assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r158"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome",
      "http://prophaselabs.com/role/ScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "(Loss) income from operations before income taxes",
        "terseLabel": "Total income from operations, before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r138",
      "r178",
      "r312",
      "r332",
      "r338",
      "r341",
      "r668",
      "r680",
      "r813"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r550",
      "r557",
      "r558",
      "r562",
      "r567",
      "r571",
      "r572",
      "r573",
      "r718"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      },
      "http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome",
      "http://prophaselabs.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails",
      "http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails",
      "http://prophaselabs.com/role/ScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income tax benefit (expense)",
        "totalLabel": "Income taxes from continuing operations",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r198",
      "r281",
      "r282",
      "r320",
      "r555",
      "r568",
      "r685"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r551",
      "r552",
      "r558",
      "r559",
      "r561",
      "r563",
      "r714"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Change in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Permanent differences and other",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statutory Rate - federal",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State taxes, net of federal benefit",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Research &amp; development tax credit",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "prph_IncomeTaxesFromContinuingOperationsBeforeValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "IncomeTaxesFromContinuingOperationsBeforeValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income taxes from continuing operations before valuation allowance",
        "label": "IncomeTaxesFromContinuingOperationsBeforeValuationAllowance",
        "documentation": "Income taxes from continuing operations before valuation allowance."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for income taxes",
        "label": "Income Taxes Paid, Net",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued expenses",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "prph_IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 24.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued advertising and other allowances",
        "label": "Increase Decrease In Accrued Advertising And Other Allowances",
        "documentation": "Increase Decrease In Accrued Advertising And Other Allowances"
       }
      }
     },
     "auth_ref": []
    },
    "prph_IncreaseDecreaseInAccruedDiagnosticServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "IncreaseDecreaseInAccruedDiagnosticServices",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued diagnostic services",
        "label": "Increase Decrease In Accrued Diagnostic Services",
        "documentation": "Increase decrease in accrued diagnostic services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes payable",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "prph_IncreaseDecreaseInDeferredIncomeTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "IncreaseDecreaseInDeferredIncomeTaxAssets",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred tax asset",
        "label": "Increase (Decrease) in Deferred Income Tax Assets",
        "documentation": "Increase (Decrease) in Deferred Income Tax Assets"
       }
      }
     },
     "auth_ref": []
    },
    "prph_IncreaseDecreaseInDeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "IncreaseDecreaseInDeferredIncomeTaxLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liability",
        "label": "Increase (Decrease) in Deferred Income Tax Liabilities",
        "documentation": "Increase (Decrease) in Deferred Income Tax Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred revenue",
        "label": "Increase (Decrease) in Deferred Revenue",
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventory",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r870",
      "r894"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "documentation": "Amount of increase (decrease) in current liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other assets",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "calculation": {
      "http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsecured convertible promissory note",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method."
       }
      }
     },
     "auth_ref": [
      "r296",
      "r297",
      "r302"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "calculation": {
      "http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted shares",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r289",
      "r290",
      "r302",
      "r513"
     ]
    },
    "prph_InducementOptionAwardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "InducementOptionAwardMember",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inducement Option Award",
        "label": "Inducement Option Award [Member]",
        "documentation": "Inducement Option Award [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "prph_InsuranceProvidersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "InsuranceProvidersMember",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance Providers",
        "label": "Insurance Providers [Member]",
        "documentation": "Insurance Providers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/IntangibleAssetsNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets, Net",
        "label": "Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77"
     ]
    },
    "us-gaap_IntellectualPropertyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntellectualPropertyMember",
     "presentation": [
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proprietary intellectual property",
        "label": "Intellectual Property [Member]",
        "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "label": "Interest Expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r181",
      "r246",
      "r316",
      "r601",
      "r765",
      "r850",
      "r994"
     ]
    },
    "us-gaap_InterestExpenseOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpenseOther",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense",
        "label": "Interest Expense, Other",
        "documentation": "Amount of interest expense classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestIncomeOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeOther",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income, net",
        "label": "Interest Income, Other",
        "documentation": "Amount of interest income earned from interest bearing assets classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "prph_InterestOnUnsecuredConvertiblePromissoryNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "InterestOnUnsecuredConvertiblePromissoryNote",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest on unsecured convertible promissory note",
        "label": "Interest on unsecured convertible promissory note",
        "documentation": "Interest on unsecured convertible promissory note"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest payment on the promissory notes",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r256",
      "r257"
     ]
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest payable",
        "label": "Interest Payable",
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r987"
     ]
    },
    "us-gaap_InventoryFinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryFinishedGoods",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails": {
       "parentTag": "us-gaap_InventoryGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished goods",
        "label": "Inventory, Finished Goods, Gross",
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "us-gaap_InventoryGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryGross",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Inventory",
        "label": "Inventory, Gross",
        "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "prph_InventoryLabMaterial": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "InventoryLabMaterial",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails": {
       "parentTag": "us-gaap_InventoryGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diagnostic services testing material",
        "label": "Diagnostic services testing material",
        "documentation": "Inventory lab material."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      },
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory, net",
        "totalLabel": "Inventory, net",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r808",
      "r839"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventory, net",
        "label": "Inventory, Policy [Policy Text Block]",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r223",
      "r233",
      "r398",
      "r399",
      "r400",
      "r660",
      "r810"
     ]
    },
    "us-gaap_InventoryRawMaterials": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryRawMaterials",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails": {
       "parentTag": "us-gaap_InventoryGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Raw materials",
        "label": "Inventory, Raw Materials, Gross",
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "prph_InventoryValuationReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "InventoryValuationReserve",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory valuation reserve",
        "label": "Inventory Valuation Reserve",
        "documentation": "Inventory valuation reserve."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryValuationReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryValuationReserves",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventory valuation reserve",
        "label": "Inventory Valuation Reserves",
        "documentation": "Amount of valuation reserve for inventory."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r888"
     ]
    },
    "us-gaap_InventoryWorkInProcess": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryWorkInProcess",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails": {
       "parentTag": "us-gaap_InventoryGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofComponentsofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Work in process",
        "label": "Inventory, Work in Process, Gross",
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "us-gaap_InvestmentOwnedBalancePrincipalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentOwnedBalancePrincipalAmount",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining principal amount",
        "label": "Investment Owned, Balance, Principal Amount",
        "documentation": "Amount of principal of investment owned."
       }
      }
     },
     "auth_ref": [
      "r725",
      "r726",
      "r788",
      "r792",
      "r794",
      "r844"
     ]
    },
    "prph_IssuanceOfCommonSharesForDebtConversion": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "IssuanceOfCommonSharesForDebtConversion",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common shares for debt conversion",
        "label": "Issuance Of Common Shares For Debt Conversion",
        "documentation": "Issuance Of Common Shares For Debt Conversion"
       }
      }
     },
     "auth_ref": []
    },
    "prph_IssuanceOfCommonStockSharesExerciseOfWarrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "IssuanceOfCommonStockSharesExerciseOfWarrant",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon exercise of warrant (in shares)",
        "label": "Issuance of Common Stock, Shares, Exercise of Warrant",
        "documentation": "Issuance of Common Stock, Shares, Exercise of Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "prph_IssuanceOfCommonStockUponExerciseOfWarrantAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "IssuanceOfCommonStockUponExerciseOfWarrantAmount",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon exercise of warrants",
        "label": "Issuance of Common Stock Upon Exercise of Warrant, Amount",
        "documentation": "Issuance of Common Stock Upon Exercise of Warrant, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "prph_IssuanceOfSecuredPromissoryNoteReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "IssuanceOfSecuredPromissoryNoteReceivable",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Issuance of secured promissory note receivable",
        "label": "Issuance Of Secured Promissory Note Receivable",
        "documentation": "Issuance of secured promissory note receivable."
       }
      }
     },
     "auth_ref": []
    },
    "prph_IssuanceOfWarrantsWithUnsecuredPromissoryNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "IssuanceOfWarrantsWithUnsecuredPromissoryNote",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of warrants with unsecured promissory note",
        "label": "Issuance Of Warrants With Unsecured Promissory Note",
        "documentation": "Issuance Of Warrants With Unsecured Promissory Note"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LandMember",
     "presentation": [
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land",
        "label": "Land [Member]",
        "documentation": "Part of earth's surface not covered by water."
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "us-gaap_LeaseCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostAbstract",
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance leases:",
        "label": "Lease, Cost [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Quantitative Information About Operating and Finance Leases",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "prph_LeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "LeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1": {
       "parentTag": "prph_LeaseLiabilityToBePaid",
       "weight": 1.0,
       "order": 1.0
      },
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Lease, Liability",
        "documentation": "Lease, Liability"
       }
      }
     },
     "auth_ref": []
    },
    "prph_LeaseLiabilityToBePaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "LeaseLiabilityToBePaid",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease payments",
        "label": "Lease, Liability, To Be Paid",
        "documentation": "Lease, Liability, To Be Paid"
       }
      }
     },
     "auth_ref": []
    },
    "prph_LeaseLiabilityToBePaidAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "LeaseLiabilityToBePaidAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiabilityToBePaid",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Thereafter",
        "label": "Lease, Liability, To Be Paid, After Year Five",
        "documentation": "Lease, Liability, To Be Paid, After Year Five"
       }
      }
     },
     "auth_ref": []
    },
    "prph_LeaseLiabilityToBePaidYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "LeaseLiabilityToBePaidYearFive",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiabilityToBePaid",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Year Ended December 31, 2028",
        "label": "Lease, Liability, To Be Paid, Year Five",
        "documentation": "Lease, Liability, To Be Paid, Year Five"
       }
      }
     },
     "auth_ref": []
    },
    "prph_LeaseLiabilityToBePaidYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "LeaseLiabilityToBePaidYearFour",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiabilityToBePaid",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Year Ended December 31, 2027",
        "label": "Lease, Liability, To Be Paid, Year Four",
        "documentation": "Lease, Liability, To Be Paid, Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "prph_LeaseLiabilityToBePaidYearOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "LeaseLiabilityToBePaidYearOne",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiabilityToBePaid",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Year Ended December 31, 2024",
        "label": "Lease, Liability, To Be Paid, Year One",
        "documentation": "Lease, Liability, To Be Paid, Year One"
       }
      }
     },
     "auth_ref": []
    },
    "prph_LeaseLiabilityToBePaidYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "LeaseLiabilityToBePaidYearThree",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiabilityToBePaid",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Year Ended December 31, 2026",
        "label": "Lease, Liability, To Be Paid, Year Three",
        "documentation": "Lease, Liability, To Be Paid, Year Three"
       }
      }
     },
     "auth_ref": []
    },
    "prph_LeaseLiabilityToBePaidYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "LeaseLiabilityToBePaidYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiabilityToBePaid",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Year Ended December 31, 2025",
        "label": "Lease, Liability, To Be Paid, Year Two",
        "documentation": "Lease, Liability, To Be Paid, Year Two"
       }
      }
     },
     "auth_ref": []
    },
    "prph_LeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "LeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1": {
       "parentTag": "prph_LeaseLiabilityToBePaid",
       "weight": 1.0,
       "order": 2.0
      },
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Less present value discount",
        "label": "Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Lease, Liability, Undiscounted Excess Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "prph_LeasesLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "LeasesLiabilityAbstract",
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Leases Liability [Abstract]",
        "documentation": "Leases Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeasesOperatingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesOperatingAbstract",
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating leases:",
        "label": "Leases, Operating [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeFinanceLeaseTermOfContract1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeFinanceLeaseTermOfContract1",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equipment lease, term (in years)",
        "label": "Lessee, Finance Lease, Term of Contract",
        "documentation": "Term of lessee's finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r973"
     ]
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeFinanceLeasesTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Finance Leases [Text Block]",
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r603"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "prph_LesseeOperatingLeaseAbatementPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "LesseeOperatingLeaseAbatementPeriod",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, operating lease, abatement period",
        "label": "Lessee, Operating Lease, Abatement Period",
        "documentation": "Lessee, operating lease, abatement period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturity of Operating Leases",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r975"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiabilityToBePaidAfterYearFive",
       "weight": 1.0,
       "order": 2.0
      },
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiabilityToBePaidYearOne",
       "weight": 1.0,
       "order": 1.0
      },
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year Ended December 31, 2024",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiabilityToBePaidYearFive",
       "weight": 1.0,
       "order": 2.0
      },
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year Ended December 31, 2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiabilityToBePaidYearFour",
       "weight": 1.0,
       "order": 1.0
      },
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year Ended December 31, 2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiabilityToBePaidYearThree",
       "weight": 1.0,
       "order": 2.0
      },
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year Ended December 31, 2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiabilityToBePaidYearTwo",
       "weight": 1.0,
       "order": 1.0
      },
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year Ended December 31, 2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "prph_LeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less present value discount",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "prph_LesseeOperatingLeaseMonthlyBaseRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "LesseeOperatingLeaseMonthlyBaseRent",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monthly base rent",
        "label": "Lessee, Operating Lease, Monthly Base Rent",
        "documentation": "Lessee, Operating Lease, Monthly Base Rent"
       }
      }
     },
     "auth_ref": []
    },
    "prph_LesseeOperatingLeaseNumberOfRenewalOptions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "LesseeOperatingLeaseNumberOfRenewalOptions",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of renewal options",
        "label": "Lessee, Operating Lease, Number Of Renewal Options",
        "documentation": "Lessee, operating lease, number of renewal options"
       }
      }
     },
     "auth_ref": []
    },
    "prph_LesseeOperatingLeaseOptionToTerminateNoticePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "LesseeOperatingLeaseOptionToTerminateNoticePeriod",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option to terminate, notice period",
        "label": "Lessee, Operating Lease, Option To Terminate, Notice Period",
        "documentation": "Lessee, Operating Lease, Option To Terminate, Notice Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Renewal term (in years)",
        "label": "Lessee, Operating Lease, Renewal Term",
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r973"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease term (in years)",
        "label": "Lessee, Operating Lease, Term of Contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r973"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r603"
     ]
    },
    "prph_LetterAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "LetterAgreementMember",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Letter Agreement",
        "label": "Letter Agreement [Member]",
        "documentation": "Letter agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r262",
      "r381",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r578",
      "r579",
      "r580",
      "r593",
      "r735",
      "r812",
      "r852",
      "r929",
      "r977",
      "r978"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r177",
      "r678",
      "r839",
      "r898",
      "r915",
      "r972"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r222",
      "r262",
      "r381",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r578",
      "r579",
      "r580",
      "r593",
      "r839",
      "r929",
      "r977",
      "r978"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current liabilities",
        "label": "Liabilities, Noncurrent",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r119",
      "r120",
      "r121",
      "r124",
      "r262",
      "r381",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r578",
      "r579",
      "r580",
      "r593",
      "r929",
      "r977",
      "r978"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current liabilities:",
        "label": "Liabilities, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "prph_LicenseAgreementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "LicenseAgreementTerm",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License agreement term (in days)",
        "label": "License Agreement Term",
        "documentation": "License Agreement Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LicenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LicenseMember",
     "presentation": [
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CLIA license",
        "label": "License [Member]",
        "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark."
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "prph_LicenseOrRoyaltyNetRevenuePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "LicenseOrRoyaltyNetRevenuePercentage",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License or royalty net revenue percentage",
        "label": "License or royalty net revenue percentage",
        "documentation": "License Or royalty net revenue percentage."
       }
      }
     },
     "auth_ref": []
    },
    "prph_LinebackerLicenseAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "LinebackerLicenseAgreementsMember",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Linebacker License Agreements",
        "label": "Linebacker License Agreements [Member]",
        "documentation": "Linebacker License Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt, net of discount of $341",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r82"
     ]
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery",
        "label": "Machinery and Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Axis]",
        "label": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r827",
      "r933",
      "r990",
      "r991"
     ]
    },
    "prph_ManufacturingAgreementRenewalOptions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ManufacturingAgreementRenewalOptions",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of successive periods",
        "label": "Manufacturing Agreement, Renewal Options",
        "documentation": "Manufacturing Agreement, Renewal Options"
       }
      }
     },
     "auth_ref": []
    },
    "prph_ManufacturingAgreementRenewalPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ManufacturingAgreementRenewalPeriod",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agreement term, successive periods (in years)",
        "label": "Manufacturing Agreement, Renewal Period",
        "documentation": "Manufacturing Agreement, Renewal Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecurities",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable Securities",
        "label": "Marketable Securities",
        "documentation": "Amount of investment in marketable security."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r883"
     ]
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable securities, available for sale",
        "verboseLabel": "Fair Value",
        "label": "Marketable Securities, Current",
        "documentation": "Amount of investment in marketable security, classified as current."
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "prph_MarketableSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "MarketableSecuritiesMember",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable Securities",
        "label": "Marketable Securities [Member]",
        "documentation": "Marketable Securities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesPolicy",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable Securities",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment classified as marketable security."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Components of Marketable Securities",
        "label": "Marketable Securities [Table Text Block]",
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails",
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r422",
      "r423",
      "r424",
      "r425",
      "r509",
      "r658",
      "r703",
      "r727",
      "r728",
      "r787",
      "r789",
      "r790",
      "r791",
      "r793",
      "r802",
      "r803",
      "r815",
      "r825",
      "r833",
      "r841",
      "r931",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails",
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r422",
      "r423",
      "r424",
      "r425",
      "r509",
      "r658",
      "r703",
      "r727",
      "r728",
      "r787",
      "r789",
      "r790",
      "r791",
      "r793",
      "r802",
      "r803",
      "r815",
      "r825",
      "r833",
      "r841",
      "r931",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984"
     ]
    },
    "prph_MrKamalObbadMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "MrKamalObbadMember",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mr. Kamal Obbad",
        "label": "Mr. Kamal Obbad [Member]",
        "documentation": "Mr. Kamal Obbad [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Domain]",
        "label": "Customer [Domain]"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r827",
      "r933",
      "r990",
      "r991"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r255"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r255"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (used in) provided by operating activities",
        "negatedTerseLabel": "Cash used by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r149",
      "r150"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows",
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome",
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://prophaselabs.com/role/ScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss (income) from operations after income taxes",
        "terseLabel": "Net Income",
        "verboseLabel": "Net (loss) income",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r150",
      "r179",
      "r220",
      "r238",
      "r240",
      "r245",
      "r262",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r281",
      "r282",
      "r298",
      "r312",
      "r332",
      "r338",
      "r341",
      "r381",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r591",
      "r593",
      "r681",
      "r759",
      "r778",
      "r779",
      "r813",
      "r850",
      "r929"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net (loss) income - basic",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r275",
      "r276",
      "r277",
      "r278",
      "r284",
      "r285",
      "r299",
      "r302",
      "r312",
      "r332",
      "r338",
      "r341",
      "r813"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net (loss) income - diluted",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r286",
      "r292",
      "r293",
      "r294",
      "r295",
      "r299",
      "r302"
     ]
    },
    "prph_NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net unrealized loss, investments in marketable securities",
        "label": "Net Unrealized Loss (Gain), Investments In Marketable Debt Securities",
        "documentation": "Non cash investing and financing unrealized loss investments in marketable debt securities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Issued Accounting Standards, Adopted and Not Yet Adopted",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "prph_NewDrugApplicationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "NewDrugApplicationMember",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Drug Application",
        "label": "New Drug Application [Member]",
        "documentation": "New Drug Application"
       }
      }
     },
     "auth_ref": []
    },
    "prph_NewYorkFirstFloorLeaseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "NewYorkFirstFloorLeaseMember",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New York First Floor Lease",
        "label": "New York First Floor Lease [Member]",
        "documentation": "New York First Floor Lease"
       }
      }
     },
     "auth_ref": []
    },
    "prph_NewYorkSecondFloorLeaseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "NewYorkSecondFloorLeaseMember",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New York Second Floor Lease",
        "label": "New York Second Floor Lease [Member]",
        "documentation": "New York Second Floor Lease"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of non-cash investing and financing activities:",
        "label": "Noncash Investing and Financing Items [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "prph_NumberOfDebtInstruments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "NumberOfDebtInstruments",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of debt instruments",
        "label": "Number Of Debt Instruments",
        "documentation": "Number Of Debt Instruments"
       }
      }
     },
     "auth_ref": []
    },
    "prph_NumberOfInhibitors": {
     "xbrltype": "integerItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "NumberOfInhibitors",
     "presentation": [
      "http://prophaselabs.com/role/OrganizationandBusinessNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of inhibitors",
        "label": "Number Of Inhibitors",
        "documentation": "Number Of Inhibitors"
       }
      }
     },
     "auth_ref": []
    },
    "prph_NumberOfInvestors": {
     "xbrltype": "integerItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "NumberOfInvestors",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of investors",
        "label": "Number Of Investors",
        "documentation": "Number Of Investors"
       }
      }
     },
     "auth_ref": []
    },
    "prph_NumberOfLicensedCompounds": {
     "xbrltype": "integerItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "NumberOfLicensedCompounds",
     "presentation": [
      "http://prophaselabs.com/role/OrganizationandBusinessNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of licensed compounds",
        "label": "Number Of Licensed Compounds",
        "documentation": "Number Of Licensed Compounds"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://prophaselabs.com/role/SegmentInformationDetailsNarrative",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r904"
     ]
    },
    "prph_NumberOfSites": {
     "xbrltype": "integerItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "NumberOfSites",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of sites",
        "label": "Number Of Sites",
        "documentation": "Number Of Sites"
       }
      }
     },
     "auth_ref": []
    },
    "prph_NumberOfTestsRecognized": {
     "xbrltype": "integerItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "NumberOfTestsRecognized",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of tests recognized",
        "label": "Number Of Tests Recognized",
        "documentation": "Number of tests recognized"
       }
      }
     },
     "auth_ref": []
    },
    "prph_NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage": {
     "xbrltype": "pureItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of tests recognized reimbursed by HRSA uninsured program (as a percent)",
        "label": "Number Of Tests Recognized Reimbursed By HRSA Uninsured Program, Percentage",
        "documentation": "Number of tests recognized reimbursed by HRSA uninsured program, percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OffsettingAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingAssetsLineItems",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offsetting Assets [Line Items]",
        "label": "Offsetting Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OffsettingAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OffsettingAssetsTable",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offsetting Assets [Table]",
        "label": "Offsetting Assets [Table]",
        "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r136"
     ]
    },
    "prph_OldBridgeNewJerseyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "OldBridgeNewJerseyMember",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Old Bridge New Jersey",
        "label": "Old Bridge New Jersey [Member]",
        "documentation": "Old Bridge New Jersey [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "prph_OperatingAndOtherExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "OperatingAndOtherExpenses",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/ScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating and other expenses",
        "label": "Operating and other expenses",
        "documentation": "Operating and other expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "(Loss) income from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r332",
      "r338",
      "r341",
      "r813"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails": {
       "parentTag": "us-gaap_VariableLeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease cost",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r612",
      "r838"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails",
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease liability",
        "terseLabel": "Total",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityAbstract",
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofMaturityofOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating Lease",
        "label": "Operating Lease, Liability [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities, net of current portion",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Operating cash flows used in operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r608",
      "r614"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets",
      "http://prophaselabs.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use asset, net",
        "verboseLabel": "Right-of-use asset",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r604"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization on right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r895"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average discount rate \u2013 operating leases",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r617",
      "r838"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining lease term \u2013 operating leases (in years)",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r616",
      "r838"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/OrganizationandBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization and Business",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r171",
      "r711",
      "r712"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsLineItems",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Line Items]",
        "label": "Other Commitments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsTable",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Table]",
        "label": "Other Commitments [Table]",
        "documentation": "Disclosure of information about obligations resulting from other commitments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTaxAbstract",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive (loss) income:",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome",
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gain on marketable debt securities, net of taxes",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r236",
      "r237",
      "r380"
     ]
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/OtherCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Current Liabilities",
        "label": "Other Current Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of other current liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets",
      "http://prophaselabs.com/role/OtherCurrentLiabilitiesScheduleofOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current liabilities",
        "totalLabel": "Total other current liabilities",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r839"
     ]
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Liabilities Disclosure [Abstract]",
        "label": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/OtherCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Current Liabilities",
        "label": "Other Liabilities Disclosure [Text Block]",
        "documentation": "The entire disclosure for other liabilities."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other income",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "prph_PaymentsForAssetAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "PaymentsForAssetAcquisition",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid",
        "label": "Payments for Asset Acquisition",
        "documentation": "Payments for Asset Acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRent",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Base rent",
        "label": "Payments for Rent",
        "documentation": "Cash payments to lessor's for use of assets under operating leases."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchases of common shares",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_PaymentsOfDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDividends",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of dividends",
        "label": "Payments of Dividends",
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDividendsCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment to stockholders",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of common stock for payment of statutory taxes on cashless exercise of stock options",
        "terseLabel": "Cash payment for repurchase",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r253"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Business acquisitions, net of cash acquired",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireMarketableSecurities",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of marketable securities",
        "label": "Payments to Acquire Marketable Securities",
        "documentation": "Amount of cash outflow for purchase of marketable security."
       }
      }
     },
     "auth_ref": [
      "r910"
     ]
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireProductiveAssets",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Capital expenditures",
        "label": "Payments to Acquire Productive Assets",
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r967",
      "r968",
      "r969"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/DefinedContributionPlans"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Contribution Plans",
        "label": "Retirement Benefits [Text Block]",
        "documentation": "The entire disclosure for retirement benefits."
       }
      }
     },
     "auth_ref": [
      "r491",
      "r492",
      "r493",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r830"
     ]
    },
    "prph_PersonalGenomicsBusinessMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "PersonalGenomicsBusinessMember",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Personal Genomics Business",
        "label": "Personal Genomics Business [Member]",
        "documentation": "Personal Genomics Business"
       }
      }
     },
     "auth_ref": []
    },
    "prph_PhaseThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "PhaseThreeMember",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Phase Three",
        "label": "Phase Three [Member]",
        "documentation": "Phase Three"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par or stated value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r463"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r737"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r463"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r737",
      "r757",
      "r997",
      "r998"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock authorized 1,000,000, $0.0005 par value, no shares issued and outstanding",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r674",
      "r839"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "us-gaap_PrepaidExpenseNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses, net of current portion",
        "label": "Prepaid Expense, Noncurrent",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "us-gaap_PrepaidRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidRent",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rent total",
        "label": "Prepaid Rent",
        "documentation": "Amount of asset related to consideration paid in advance for rent that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r809",
      "r818",
      "r917"
     ]
    },
    "prph_PrepaidShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "PrepaidShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expense",
        "label": "Prepaid Share-Based Compensation Expense",
        "documentation": "Prepaid Share-Based Compensation Expense"
       }
      }
     },
     "auth_ref": []
    },
    "prph_ProceedsFromFinancingAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ProceedsFromFinancingAgreement",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from financing agreement",
        "label": "Proceeds From Financing Agreement",
        "documentation": "Proceeds From Financing Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from maturities of marketable securities",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r252",
      "r910"
     ]
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromNotesPayable",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of note payable",
        "label": "Proceeds from Notes Payable",
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleAndCollectionOfNotesReceivable",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from promissory note",
        "label": "Proceeds from Sale and Collection of Notes Receivable",
        "documentation": "The cash inflow associated with the proceeds from sale of notes receivable, as well as principal collections from a borrowing supported by a written promise to pay an obligation (note receivable)."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sales of marketable securities",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfOtherPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from dispositions of property and other assets, net",
        "label": "Proceeds from Sale of Other Property, Plant, and Equipment",
        "documentation": "Amount of cash inflow for the sale of long-lived, physical assets used to produce goods and services and not intended for resale, classified as other."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromWarrantExercises",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of warrants",
        "label": "Proceeds from Warrant Exercises",
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants."
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "us-gaap_ProductInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProductInformationLineItems",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDisaggregationbyRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product Information [Line Items]",
        "label": "Product Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r343",
      "r661",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r806",
      "r826",
      "r840",
      "r871",
      "r927",
      "r928",
      "r933",
      "r990"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r343",
      "r661",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r806",
      "r826",
      "r840",
      "r871",
      "r927",
      "r928",
      "r933",
      "r990"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diagnostic expenses",
        "label": "Professional Fees",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r850",
      "r995",
      "r996"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Abstract]",
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: accumulated depreciation",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r866",
      "r869",
      "r923"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets",
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Total property, plant and equipment, net",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r869",
      "r921"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment, gross",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r865",
      "r882",
      "r922"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/PropertyPlantandEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r190",
      "r195",
      "r196"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property, Plant and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r190",
      "r195",
      "r679"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/PropertyPlantandEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property, Plant and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated useful life (in years)",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable allowances",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r388"
     ]
    },
    "us-gaap_ProvisionForLoanLeaseAndOtherLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProvisionForLoanLeaseAndOtherLosses",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit loss expense, direct write-offs",
        "label": "Provision for Loan, Lease, and Other Losses",
        "documentation": "Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r14",
      "r180"
     ]
    },
    "prph_PurchaseAgreementRoyaltyPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "PurchaseAgreementRoyaltyPercent",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty percent",
        "label": "Purchase Agreement, Royalty Percent",
        "documentation": "Purchase Agreement, Royalty Percent"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails",
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r422",
      "r423",
      "r424",
      "r425",
      "r492",
      "r509",
      "r536",
      "r537",
      "r538",
      "r634",
      "r658",
      "r703",
      "r727",
      "r728",
      "r787",
      "r789",
      "r790",
      "r791",
      "r793",
      "r802",
      "r803",
      "r815",
      "r825",
      "r833",
      "r841",
      "r844",
      "r925",
      "r931",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://prophaselabs.com/role/LeasesNarrativeDetails",
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r422",
      "r423",
      "r424",
      "r425",
      "r492",
      "r509",
      "r536",
      "r537",
      "r538",
      "r634",
      "r658",
      "r703",
      "r727",
      "r728",
      "r787",
      "r789",
      "r790",
      "r791",
      "r793",
      "r802",
      "r803",
      "r815",
      "r825",
      "r833",
      "r841",
      "r844",
      "r925",
      "r931",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984"
     ]
    },
    "us-gaap_ReceivableTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivableTypeDomain",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable [Domain]",
        "label": "Receivable [Domain]",
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivablesPolicyTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, net",
        "label": "Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable."
       }
      }
     },
     "auth_ref": [
      "r906",
      "r907",
      "r908",
      "r909"
     ]
    },
    "prph_ReimbursementReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ReimbursementReceivableMember",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reimbursement Receivable",
        "label": "Reimbursement Receivable [Member]",
        "documentation": "Reimbursement Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions [Abstract]",
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/RelatedParties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Parties",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r719",
      "r720",
      "r721",
      "r762",
      "r763",
      "r764",
      "r784",
      "r786"
     ]
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfLongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repayments of long-term debt",
        "label": "Repayments of Long-Term Debt",
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r716"
     ]
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of note payable",
        "label": "Repayments of Notes Payable",
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r549",
      "r985"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "us-gaap_RestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCash",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r880",
      "r896",
      "r986",
      "r988"
     ]
    },
    "prph_RetailAndOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "RetailAndOtherMember",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDisaggregationbyRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retail and others",
        "label": "Retail and Other [Member]",
        "documentation": "Retail and Other [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings (accumulated deficit)",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r163",
      "r677",
      "r707",
      "r709",
      "r717",
      "r738",
      "r839"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated (Deficit) Earnings",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r270",
      "r271",
      "r272",
      "r274",
      "r280",
      "r282",
      "r382",
      "r383",
      "r543",
      "r544",
      "r545",
      "r565",
      "r566",
      "r581",
      "r583",
      "r584",
      "r586",
      "r589",
      "r704",
      "r706",
      "r722",
      "r997"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome",
      "http://prophaselabs.com/role/ScheduleofSegmentInformationDetails",
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDisaggregationbyRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues, net",
        "verboseLabel": "Total revenue, net",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r313",
      "r314",
      "r331",
      "r336",
      "r337",
      "r343",
      "r345",
      "r346",
      "r488",
      "r489",
      "r661"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r805"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligation",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPerformanceObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected timing of satisfaction, period",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r194"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPerformanceObligationDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDeferredRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r194"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets obtained in exchange for new finance lease obligations",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r615",
      "r838"
     ]
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RisksAndUncertaintiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risks and Uncertainties [Abstract]",
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RoyaltyExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RoyaltyExpense",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum royalty",
        "label": "Royalty Expense",
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Closing stock price (in dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Benchmark",
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r346",
      "r867"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts Receivable Net",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/IntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Intangible Assets",
        "label": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]",
        "documentation": "Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://prophaselabs.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromtheIncomePerShareComputationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/EarningsPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Anti-dilutive Securities Excluded from the Income Per Share Computation",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://prophaselabs.com/role/OrganizationandBusinessNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r574"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value of Financial Instruments",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/EarningsPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Basic and Diluted Net Loss Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r60",
      "r287",
      "r291",
      "r300"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://prophaselabs.com/role/IntangibleAssetsNetNarrativeDetails",
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r78",
      "r662"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Inventory",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r132",
      "r133",
      "r134"
     ]
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfProductInformationTable",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofDisaggregationbyRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Product Information [Table]",
        "label": "Schedule of Product Information [Table]",
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://prophaselabs.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantandEquipmentDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://prophaselabs.com/role/ScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r70",
      "r71",
      "r73"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Information",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r70",
      "r71",
      "r73"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Options Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r90"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Weighted Average Assumptions Used in Determining Fair Value of Options",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShortTermDebtTable",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Short-term Debt [Table]",
        "label": "Schedule of Short-Term Debt [Table]",
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "prph_ScheduleOfWarrantActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ScheduleOfWarrantActivityTableTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Warrant Activity",
        "label": "Schedule of Warrant Activity [Table Text Block]",
        "documentation": "Schedule of Warrant Activity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/IntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Estimated Future Amortization Expense of Acquired Intangible Assets",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_SecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuredDebtMember",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Debt",
        "label": "Secured Debt [Member]",
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "prph_SegmentConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "SegmentConcentrationRiskMember",
     "presentation": [
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Concentration Risk",
        "label": "Segment Concentration Risk [Member]",
        "documentation": "Segment Concentration Risk"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentDomain",
     "presentation": [
      "http://prophaselabs.com/role/ScheduleofSegmentInformationDetails",
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r341",
      "r346",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r418",
      "r419",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r819",
      "r871",
      "r990"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Information",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r324",
      "r335",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r346"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://prophaselabs.com/role/ScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r345",
      "r814"
     ]
    },
    "prph_SeptemberTwoThousandAndTwentyNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "SeptemberTwoThousandAndTwentyNoteMember",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets",
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "September 2020 Notes",
        "label": "September 2020 Notes [Member]",
        "documentation": "September 2020 Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated fair value of options at date of grant",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquitySummaryofWeightedAverageAssumptionsUsedinDeterminingFairValueofOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price",
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquitySummaryofWeightedAverageAssumptionsUsedinDeterminingFairValueofOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield (per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails",
      "http://prophaselabs.com/role/StockholdersEquitySummaryofWeightedAverageAssumptionsUsedinDeterminingFairValueofOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected stock price volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails",
      "http://prophaselabs.com/role/StockholdersEquitySummaryofWeightedAverageAssumptionsUsedinDeterminingFairValueofOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free rate of interest",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r538"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Number of shares, warrants exercise (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised",
        "documentation": "Number of non-option equity instruments exercised by participants."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares, warrants granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of shares, warrants outstanding, beginning (in shares)",
        "periodEndLabel": "Number of shares, warrants outstanding, ending (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails",
      "http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, warrants granted (in dollars per share)",
        "label": "Weighted Average Exercise Price, Warrants Granted",
        "documentation": "Share based compensation arrangement by share based payment award non options outstanding granted weighted average exercise price 1."
       }
      }
     },
     "auth_ref": []
    },
    "prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted average exercise price, warrants outstanding, beginning (in dollars per share)",
        "periodEndLabel": "Weighted average exercise price, warrants outstanding, ending (in dollars per share)",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1",
        "documentation": "Share based compensation arrangement by share based payment award non options outstanding weighted average exercise price 1."
       }
      }
     },
     "auth_ref": []
    },
    "prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, warrants vested and exercisable (in dollars per share)",
        "label": "Weighted Average Exercise Price, Warrants Vested and Exercisable",
        "documentation": "Share based compensation arrangement by share based payment award non options vested and exercisable weighted average exercise price 1."
       }
      }
     },
     "auth_ref": []
    },
    "prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares, warrants vested and exercisable (in shares)",
        "label": "Number of Shares Warrants Vested and Exercisable",
        "documentation": "Share based compensation arrangement by share based payment award non options vested and expected to vest exercisable number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares authorized (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Remaining Contractual Life (in years) and Total Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails",
      "http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares, forfeited (in shares)",
        "negatedLabel": "Number of shares options forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual life, granted shares (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Granted, Weighted Average Remaining Contractual Term",
        "documentation": ""
       }
      }
     },
     "auth_ref": []
    },
    "prph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of stock options granted",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Fair Value",
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails",
      "http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Number of shares options granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Total intrinsic value, outstanding, beginning",
        "periodEndLabel": "Total intrinsic value, outstanding, ending",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of shares, outstanding, beginning (in shares)",
        "periodEndLabel": "Number of shares, outstanding, ending (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r517",
      "r518"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted average exercise price, outstanding, beginning (in dollars per share)",
        "periodEndLabel": "Weighted average exercise price, outstanding, ending (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r517",
      "r518"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total intrinsic value, options vested and exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r534"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number of shares, options vested and exercisable (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r534"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, options vested and exercisable (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r534"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inducement award amount",
        "label": "Share-Based Payment Arrangement, Plan Modification, Incremental Cost",
        "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average exercise price, granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "prph_ShareBasedCompensationAwardTrancheFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ShareBasedCompensationAwardTrancheFourMember",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fourth Installment",
        "label": "Share Based Compensation Award Tranche Four [Member]",
        "documentation": "Share based compensation award tranche four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First Installment",
        "label": "Share-Based Payment Arrangement, Tranche One [Member]",
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationAwardTrancheThreeMember",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Third Installment",
        "label": "Share-Based Payment Arrangement, Tranche Three [Member]",
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Second Installment",
        "label": "Share-Based Payment Arrangement, Tranche Two [Member]",
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "prph_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual life, warrants granted (in years)",
        "label": "Share-based Compensation, Shares Authorized, Under Stock Option Plans, Exercise Price Range, Granted, Warrants, Weighted Average, Remaining Contractual Term 2",
        "documentation": "Share-based Compensation, Shares Authorized, Under Stock Option Plans, Exercise Price Range, Granted, Warrants, Weighted Average, Remaining Contractual Term 2"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price, lower range (in dollars per share)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price, upper range (in dollars per share)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "prph_ShareBasedPaymentArrangementExpenseReversal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "ShareBasedPaymentArrangementExpenseReversal",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reversal of stock based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense, Reversal",
        "documentation": "Share-Based Payment Arrangement, Expense, Reversal"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inducement award (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number",
        "documentation": "Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award vesting rights (as a percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award expiration period (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r835"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails",
      "http://prophaselabs.com/role/StockholdersEquitySummaryofWeightedAverageAssumptionsUsedinDeterminingFairValueofOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r535"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual life, options vested and exercisable (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails",
      "http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average remaining contractual life, outstanding shares (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual life, options vested and exercisable (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r534"
     ]
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price (in dollars per share)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued (in dollars per share)",
        "label": "Shares Issued, Price Per Share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares withheld for tax withholding obligation (in shares)",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermDebtLineItems",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term Debt [Line Items]",
        "label": "Short-Term Debt [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r259"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://prophaselabs.com/role/ScheduleofSegmentInformationDetails",
      "http://prophaselabs.com/role/SignificantCustomersConcentrationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r309",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r341",
      "r346",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r417",
      "r418",
      "r419",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r819",
      "r871",
      "r990"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails",
      "http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r41",
      "r218",
      "r243",
      "r244",
      "r245",
      "r270",
      "r271",
      "r272",
      "r274",
      "r280",
      "r282",
      "r307",
      "r382",
      "r383",
      "r477",
      "r543",
      "r544",
      "r545",
      "r565",
      "r566",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r589",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r619",
      "r704",
      "r705",
      "r706",
      "r722",
      "r780"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets",
      "http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r271",
      "r272",
      "r307",
      "r661",
      "r713",
      "r724",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r737",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r747",
      "r748",
      "r749",
      "r750",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r758",
      "r760",
      "r761",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r780",
      "r845"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets",
      "http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r271",
      "r272",
      "r307",
      "r661",
      "r713",
      "r724",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r737",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r747",
      "r748",
      "r749",
      "r750",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r758",
      "r760",
      "r761",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r780",
      "r845"
     ]
    },
    "prph_StellaPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "StellaPurchaseAgreementMember",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stella Purchase Agreement",
        "label": "Stella Purchase Agreement [Member]",
        "documentation": "Stella Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant fair value",
        "label": "Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants",
        "documentation": "Value of preferred stock and warrants for common stock issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued in asset acquisition",
        "label": "Stock Issued",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r56",
      "r57"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common shares related to business acquisition (in shares)",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r126",
      "r163"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock for debt conversion (in shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r40",
      "r84",
      "r163",
      "r452"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued (in shares)",
        "label": "Stock Issued During Period, Shares, Employee Stock Ownership Plan",
        "documentation": "Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r95",
      "r125",
      "r126",
      "r163"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r125",
      "r126",
      "r163",
      "r715",
      "r780",
      "r795"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock issued during period (in shares)",
        "label": "Stock Issued During Period, Shares, Purchase of Assets",
        "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails",
      "http://prophaselabs.com/role/StockholdersEquityScheduleofStockOptionsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon stock options cashless exercise (in shares)",
        "verboseLabel": "Number of shares, exercised (in shares)",
        "negatedLabel": "Number of shares options exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r125",
      "r126",
      "r163",
      "r522"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock in asset acquisition",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "documentation": "Value of stock issued pursuant to acquisitions during the period."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r41",
      "r163"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock for debt conversion",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r41",
      "r163"
     ]
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Authorized amount",
        "label": "Stock Repurchase Program, Authorized Amount",
        "documentation": "Amount of stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramPeriodInForce1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramPeriodInForce1",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program, term (in months)",
        "label": "Stock Repurchase Program, Period in Force",
        "documentation": "Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchases of common share (in shares)",
        "terseLabel": "Stock repurchased (in shares)",
        "label": "Stock Repurchased During Period, Shares",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r125",
      "r126",
      "r163",
      "r716",
      "r780",
      "r796"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchase of common shares",
        "terseLabel": "Stock repurchased",
        "label": "Stock Repurchased During Period, Value",
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r125",
      "r126",
      "r163",
      "r722",
      "r780",
      "r796",
      "r851"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets",
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r129",
      "r130",
      "r153",
      "r739",
      "r757",
      "r781",
      "r782",
      "r839",
      "r852",
      "r898",
      "r915",
      "r972",
      "r997"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 equity",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 Equity",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r261",
      "r462",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r475",
      "r477",
      "r588",
      "r783",
      "r785",
      "r797"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://prophaselabs.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r600",
      "r626"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://prophaselabs.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r600",
      "r626"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://prophaselabs.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r600",
      "r626"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://prophaselabs.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r600",
      "r626"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://prophaselabs.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r600",
      "r626"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events [Abstract]",
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r625",
      "r627"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosures:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "prph_TaxCreditCarryforwardLimitationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "TaxCreditCarryforwardLimitationAmount",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual limitation amount",
        "label": "Tax Credit Carryforward, Limitation Amount",
        "documentation": "Tax credit carryforward limitation amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax payable",
        "label": "Taxes Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "presentation": [
      "http://prophaselabs.com/role/AssetAcquisitionDetails",
      "http://prophaselabs.com/role/IntangibleAssetsNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Technology-Based Intangible Assets",
        "label": "Technology-Based Intangible Assets [Member]",
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Axis]",
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r905",
      "r976"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Domain]",
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TradeNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TradeNamesMember",
     "presentation": [
      "http://prophaselabs.com/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade names",
        "label": "Trade Names [Member]",
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r460",
      "r474",
      "r587",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r682",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r911",
      "r912",
      "r913",
      "r914"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock, at cost, 18,940,967 and 18,126,790 shares, respectively",
        "label": "Treasury Stock, Common, Value",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r85",
      "r86"
     ]
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock repurchased (in shares)",
        "label": "Treasury Stock, Shares, Acquired",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r126",
      "r163"
     ]
    },
    "prph_TwoThousandEighteenStockIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "TwoThousandEighteenStockIncentivePlanMember",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2018 Stock Incentive Plan",
        "label": "2018 Stock Incentive Plan [Member]",
        "documentation": "Two Thousand Eighteen Stock Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r576"
     ]
    },
    "prph_TypeOfArrangementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "TypeOfArrangementDomain",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type Of Arrangement [Domain]",
        "label": "Type Of Arrangement [Domain]",
        "documentation": "Type Of Arrangement [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "prph_USGovernmentObligationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "USGovernmentObligationsMember",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofFairValueofFinancialInstrumentsDetails",
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesSummaryofComponentsofMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. government obligations",
        "label": "U.S. Government Obligations [Member]",
        "documentation": "U.S. Government Obligations [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "prph_UnallocatedCorporateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "UnallocatedCorporateMember",
     "presentation": [
      "http://prophaselabs.com/role/ScheduleofSegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unallocated corporate",
        "label": "Unallocated Corporate [Member]",
        "documentation": "Unallocated Corporate [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnbilledContractsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnbilledContractsReceivable",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesScheduleofAccountsReceivableNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unbilled accounts receivable",
        "label": "Unbilled Contracts Receivable",
        "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet."
       }
      }
     },
     "auth_ref": [
      "r659"
     ]
    },
    "prph_UncollectibleTradeReceivablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "UncollectibleTradeReceivablesMember",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Uncollectible Trade Receivables",
        "label": "Uncollectible Trade Receivables [Member]",
        "documentation": "Uncollectible Trade Receivables"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnsecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnsecuredDebtMember",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsecured Debt",
        "label": "Unsecured Debt [Member]",
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnsecuredLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnsecuredLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsecured convertible promissory notes, net",
        "label": "Unsecured Long-Term Debt, Noncurrent",
        "documentation": "Carrying value as of the balance sheet date of uncollateralized debt obligation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "prph_UpfrontLicenseFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "UpfrontLicenseFee",
     "crdr": "debit",
     "presentation": [
      "http://prophaselabs.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upfront license fee",
        "label": "Upfront License Fee",
        "documentation": "Upfront License Fee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r67",
      "r68",
      "r187",
      "r188",
      "r191",
      "r192"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesDomain",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "documentation": "Valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r266",
      "r267",
      "r268",
      "r269"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "presentation": [
      "http://prophaselabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "documentation": "Information by valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r266",
      "r267",
      "r268",
      "r269"
     ]
    },
    "us-gaap_ValuationTechniqueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationTechniqueAxis",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Approach and Technique [Axis]",
        "label": "Valuation Approach and Technique [Axis]",
        "documentation": "Information by valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_ValuationTechniqueDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationTechniqueDomain",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Approach and Technique [Domain]",
        "label": "Valuation Approach and Technique [Domain]",
        "documentation": "Valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/LeasesScheduleofQuantitativeInformationAboutOperatingandFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Variable lease cost",
        "label": "Variable Lease, Cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r613",
      "r838"
     ]
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingAxis",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Axis]",
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingDomain",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Domain]",
        "label": "Vesting [Domain]",
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantMember",
     "presentation": [
      "http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails",
      "http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant",
        "verboseLabel": "Stock Warrants",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r842",
      "r843",
      "r846",
      "r847",
      "r848",
      "r849"
     ]
    },
    "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsNoteDisclosureAbstract",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants and Rights Note Disclosure [Abstract]",
        "label": "Warrants and Rights Note Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant, fair value",
        "label": "Warrants and Rights Outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://prophaselabs.com/role/OutstandingDebtDetails",
      "http://prophaselabs.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants outstanding, term (in years)",
        "label": "Warrants and Rights Outstanding, Term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r971"
     ]
    },
    "prph_WeightedAverageExercisePriceWarrantsExercised": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "WeightedAverageExercisePriceWarrantsExercised",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average exercise price warrants, exercised (in dollars per share)",
        "label": "Weighted Average Exercise Price Warrants, Exercised",
        "documentation": "Weighted Average Exercise Price Warrants, Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome",
      "http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average shares outstanding - diluted",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r286",
      "r302"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average common shares outstanding:",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://prophaselabs.com/role/ConsolidatedStatementsofOperationsandOtherComprehensiveIncome",
      "http://prophaselabs.com/role/EarningsPerShareScheduleofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares outstanding - basic",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r302"
     ]
    },
    "prph_WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable": {
     "xbrltype": "durationItemType",
     "nsuri": "http://prophaselabs.com/20231231",
     "localname": "WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable",
     "presentation": [
      "http://prophaselabs.com/role/StockholdersEquityScheduleofWarrantActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual life, warrants vested and exercisable (in years)",
        "label": "Weighted Average Remaining Contractual Life Warrants, Vested And Exercisable",
        "documentation": "Share based compensation arrangement by share based payment award non options vested and exercisable weighted average remaining contractual term 2."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(c)(2)",
   "SubTopic": "10",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(1)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(2)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13",
   "SubTopic": "20",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-13"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "44",
   "SubTopic": "20",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-44"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "60",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "330",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "((a)(1),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-2"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b),(f(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "40",
   "Section": "25",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480637/718-40-25-10"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-5"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-5"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//805/tableOfContent"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.11)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "35",
   "Topic": "720",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(1)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(4)",
   "Publisher": "SEC"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(5)",
   "Publisher": "SEC"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(1)(i)",
   "Publisher": "SEC"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(1)(ii)",
   "Publisher": "SEC"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Subsection": "Instruction 5",
   "Publisher": "SEC"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "(a)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "(a)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "(a)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "(a)",
   "Subparagraph": "(4)",
   "Publisher": "SEC"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "(a)",
   "Subparagraph": "(5)",
   "Publisher": "SEC"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "(c)",
   "Publisher": "SEC"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-11"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-42"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//280/tableOfContent"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//330/tableOfContent"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-30/tableOfContent"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//715/tableOfContent"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//850/tableOfContent"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481058/954-310-45-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479908/805-50-55-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-2"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-4"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480123/805-50-15-3"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>110
<FILENAME>0000868278-24-000004-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000868278-24-000004-xbrl.zip
M4$L#!!0    ( &:;?%@:>R.[GE0  (U7 0 <    ;&ET97)A8V]M<&%R97)E
M9&QI;F4M<')O+FAT;>U]6W/;2++F^_D5V-[8#2D"5EORI;OEGHE@2W2;9VS)
M*\G=,T\;$ E*:), #P!*UOSZS6M5%E @*5]F9G?GH<,MDBC4)2NO7V;^_.;J
MW=L__\?/;\:CTS___-^>/$E.J^EZF9=M<I.7>9VU^2RY?DA^K^J/Q5V63,II
M\N0)/' UN7H[_O.B:.$WTVJYRNJ\SF>+HLR?K.KJY^_Y^__X^7L:^3]^_N7\
M]&_)]<VT6E3UG[Z[OX4'OX./3R>_)=FBN"G_]-T47IK7^F'3/BSR/WVWS.J;
MHGRRR.?M\6&^?'5?S-K;X\.G+UZ\^H[G.S2%IT\/#_Y8W?!LS8BK;#8KRILG
M;;4Z/H(1\863=[\F33W]TW=;!OLN:8L6!VD6Q2P__"ZAZ?SI.YS/=\EM7MS<
MMG_Z[L7SET]E&7_^^?7YV572%'^'A^#W,H=Y5;9/\,/CPU7[BO;D6+;DE[^]
M'?U^F9R_3MY?G+]_,[H<)V]'OURFR>3LY"#9&S5)!J<S@U/)REE2YTU+1_2?
MZS)/#E^^R^KI;7+T,DV.GAX]@_^>[R>CBZO)R=MQ,DG^YW__\>CP\!4,_GIR
M,KY,+O-I6U1E<GB07-WF,-A-T;2X[*2:SXMI#O\D[^MJ=9LU>?(VNVY2/'^8
M10N_QL&.GKXZJ>I5!60"X] GAZ_VDZ),\!>7.#4<XS1?9/>PH4G1)#_^\#SY
M/5M\S.ODHLIF:7*YAG4G)RD0WEU>PS_CY/"GGYX^YSF5L%H<HF@;.[_L!BDT
M:Y-F#>N%$X6-:'#X#V6!VZ&S@DGD]1TL1:>N2S[BX<WLDV7VD-QF=SF/R3O0
MP FWM[">JJ;_J];MP-*RAK[XI<KJ&7U1U/"JJFYHW%G> (W3,[7^]'K= '7!
MM.'7;60N=?Y?:Q@DF=?5$N@.]J&MZ-\#?Z3^3"^OSD_^\N;\[>GX(CC8T=G9
MA]';Y-UX?#4Y^_685IV5Y3I;),L\;^$FX/N;MII^O*T6LQPFW-QFBT5RG0-!
M+V9)GL%N/.19G<" 63+#12#I93PGMS)B$_$M@%FT/$[GS3.W2>Z=^0(^$>K.
MRH>D@B'K!*[@"OYQ6X;[ S]NZZQL,OQ]<+*7[\<G$[_HRV,X>R22@GZ NXC4
MCI?5;;ZN'?[$MS9Y7>0-TW\^SVNDN4O<HS1I5OFT\&MP(P1;*/.;PJ)P+2T-
M2OL%F[27[?.!WV9%O<R(N/:N]X?H9[6NFW4&Y X3S_#&5XLU+21;P;;<\<9G
M\,H_JKIH'W0^]S"7^&'\HKOHMT^GV%G<,&DLBB5=--E,F..J:F#'A!T)!RBK
M%MD(_,B.XL_JV4'R_NWH9(SL+J#0K=<()[M:9-,\3?*"2&3'BYKJ]:.G\1M=
MZQRO)@S;O1VU^Z:[.W*\&^A^>"TI[A%RM0:/:58TTSK'/4EAD<#CEG!",&K&
MJ] 7\O;#KKK;*><F6W$-J\9]*DK@D]G,_0K?L7C B2YS.'*<3)TO*]@9$'7+
M=5E,F>W UB!)%2A>UB!D:GJ[XW&_DD:P"#C5V^S>GR<P[;-S8$WA@?Y^"\\!
M;P])"0<4%C?#35[AHENEJ>PCGW'& ^,R=1?@!)/[&G]:*H'IK47&'>X5[,!-
M<0>_!/$*7\KO^3NB54\+J>=M0#ZUWB/_UG*6*F%/42+B6[LTD=KK0,O2FX%$
MQ).P)PHBBZE(Q)V97PI'L"#Y@/1]7\!X*[C]T[JX9J+#^:];/'9DPPM8)FXE
M4@<]!M0#DX6E[QT^W8>/ZV19U3E_W!2?@%/LO80O9ME# R/,^;N<-Z&[=KEC
M<$9-5<+<'G!I2$Y9 ?.\IC^%5IFGXZ&I7!,VE^+!DA0P=,"D.*W@AH!$1^6*
MSO\.:5/%N\SB()G,Z84YG -]$9PF;4*^Y.>#';D'^H,_X1@*PYM$4R &T<A"
M1)'P?,W.%*9S"\>ER@;<E:)%'@RBL4'9Z'[/?'6.\JJJ/L;D>TH\*H$9M:#)
MX+=U#B/ \:ZR DCA+"!KPXQ[@B;@".XZ\0XPX:/4P+MA5@*B01[,\!;-PHL#
M^\/G+&<,'.'3@V.J\!?L%U/%JB[@)_ "?_K(3_)RFI,%T:4B_ -NVD?\0B2Z
MD1#KD#)28N5NIO<9K,;]G#9L'O KF/:HAF^!F_YU(J^&*_/+ S"O)MC2V1]P
MO4N=8;9Q?\M<KI3;SV+NKDG*(ATYAG"0@DZ,*)WO.I (T0R]$@E7]9K-C!B9
MA:BV\J3A0W!1]XI]E%/5&K9ZEG2D!/SI&8U=+<P$&2N0WUX! X#0@6D_P "S
M=8T/XN]I1<WT-I^M\2ZZB;A-$D)'O9QTM;J"6<,^M?=@(B9KN3QYF5TO.GM)
M^T3$I)_ #\'0@H,I5LAUX B#=VV55Z@X%;B4)F]QJG"G0LT#]1<[HAPA")0I
M\IP,MH^O(G%M)*4&QI4K"]NE%'5T\/R5([44YG^?D[%"$EHHHK/3\X#A/GO*
MC+:"A[(Y"/CDT#Z ,JW,[Y45$@_&,8I/<@;F!9866F1MF5EM]'==6?AX/FS(
MRTO[%T[:__*W9/QV?')U<7XV.4FN+D9GE^\FEY>3\[/C)!D!M4<509F-J$]6
MJ0A4WO+!GTSW7C-/&7^:PAX#(QU-6]"N&V#V\Z(,><+1P>%+^.\%*MK7^:*Z
MWT]D6T]R^,D<28IV$,Q$,Q-OE\SGN&S@07#<;N(9'LX2'S-W@=C_LFAHPE,@
M)W1L,%-^Z$D5XA1HX'FBA8.G%[!*( /@IW5^5TWI7D4&@H\Z6I'(,+.QT1$_
MXD;-C\DLZ=K$\),UWV083"0JOFEHM< $>/CINO7\NAD^Z8&K*%-\13P#CPPG
M5L!,B@6:.+M-YAKH>0DO_UA6]\[L@ZF!HIW5#V@(- 4(8-@)\Z&3W>QB !IA
M"U3^[)OJH RL8+8%;I+>5%BN"!3>@(/DC><8M) 9_-'BB'-0/-8U'U:=RU6+
MKE1.=<."@?(S(1*:VJR"U:/P*LJ[;%',U' RIHTL;LK4(4*23\M>PH 9'AZ\
MZ.E<*AN9C'YY@'5-&[ 1X>=+8#5P&U/1PT@]Y.L C&N]O&;5RDLL2]2WL*3@
M!L'#N2>L5T0;OP0[PII<_UUE]T=>D_O\MT_I[:C'B6P,7Z-2L:UN<F>D K6!
MT,.S".]IAQO31VA< &O2-X!)L!(!O,A:^AUL^.%^<HE"3GXDE^:(+XTG1:;^
MX-7RTQFMPGM;MO"TR.YVYG^0C!I6!4@<A[23JNMP8'AQ(XKHQUGI?$+ACX3-
M<UB@Q7M7+>Y4B5G=/C3PLT5X/5#KS%9DU&8M$^H)7KF<KPT)/Q+HXKU!EE"0
MT@;_5Q?YG7.ZWA7YO3?\X=%B51CV$,S3\[!W/*R;,VC[=35;3WF;>&JTU-ZX
M[6U=K6_0?99DZ[9:DH\%'@;6:KPI+P^2D[?GEV!SH_E-4OCU^"+YY?S\+Y?)
M^47R>O)7^>YB?')^<9J<CJ[&Q\EK85K.:)T[%P3I#E:%L[J!5SK8"%!=H6.R
M!,^KB\6H2J++D[H_^"Z]>*OLP>GM,,ZL0(4,[7)XF)P_(E*7Y#]PZ\C4'@U>
MH&Z=P,4HNY .>>,&G+6B&WJ73=02=%QSNJ@:T>PR]9G!VXMJ1CX<)&U4TCY-
M\YR=#CA/=#JD7=/] 'V;BR)?TP6!8?4.Q"8PN"I< BB;]*;9'<EB=?4V2HM.
M,77N,&0Z&[=8[/29*/>Z"+%/<96#+@GO;_&^E@&J2H=\'J1Q.R/5.S=*P^_9
M_E@O,I6"J9C11/L[K+!H9#ED6I&3XFB8 M!XP]D* 2!K**O-:O]F(M[I1@[O
MW&,OG;ER_?T,S1#CXF*OC2K<_4,P3FUY^%IIU(<(9OD43LD?BTR$[>MJU9)U
MW7CW''/QU%^Z&!UO/V'TE[=^#X!,%HNJU0W16? 5$D?!,@-.T*5L(D8V_;9N
M@E_2 7E/M[*RF,VVB0^C9G.=YR5/M>-&Z5B^+]/8+HG_:+5:/*B5%N'J&+.#
M@UQ(F O]W8N\O $E"'G;"A6O7/V.P?#A!%7^T=D*C[/>FMXM*V?RI>6LAD'B
M\/FG%3K+O/S\X4!DY>CL-!F=G)Q_.+NZQ'@$;,=)SR;\F.<K>A$0=XF* NXY
M+A 83HD.C85&475+R=7(>L<HF;+5";.;5JL'W9Q-MJCXCG#7,0*,V]SP/K?5
M 2D80Z.JK;SQ^2D^S[L)A'2#RB4*I]EZM>#YV.]24H*8@V&T9 &6$VC*N TJ
M?S!RB^]<K&ZS:Z#"*;F-L[I&2QTE]ISFPJ[&ACQ]R!Q#=2'B.6UNJWMY1U&S
MWTT<1 W>1/'"D<V7.D(0.P.OP2V\I>&P".M92S+AV+A?/+PBIQ)HQ$:L>CKS
M.Z/[0@1AOQ.=796Z.KNIL]4M[F^JLIYN2).W?#4E4J61;J+Q-0PY*[)RV]N[
MIZ+KQ4 !1<A+I(3E:@&7B^P#I4FQ?5# 3A?K&2MZ-7 +%DFT7=Z=R;?4>VBW
MSB3<A8X%\ /RMX]P^_W5^_$@^5\?SB\^O#L&(NQ&,F&'T$R?B2>KSJ-:6)<%
MIJ1?YV*\19W:*AO0QH.'U\@WD_]:5_5ZN5%L;G %=L)#P!6)'1L- =\.@JS!
MF! *((HTLS2U0>C>+N X(:.G #,<:=\9)$,8W8;>:-^G%/+HC5&7:F=$?Y8_
M@?5W^I_G'R[.WHV!@;Y*WI]?7KT_/QO3GQ2+)R_E=8.WE6?*8Z=V!YB<W!F2
M8SNV*?C%"@ZA5HXB)!)=H"4)%]H(_9NIJBE3%Y[OA#%0THNLVRAD]_S=0L/-
M2L?*.Q] 79W>EF2M&E\0[/Q=7N; ,WKPCU1T,_Z%SIX<\G@:%?[+%@W')%C'
M),VL'\VPD=.^WU@\VV&4PT=?ZOP+@A 'R>MUC4.AHI0:S4A'<"K ;$WQQINL
M+/Z>B^(Y<#B[GLV_Q+9N"2&I7?S(B-&_XT2]S4F_::#(Q(@(Z#0<JNEY#12
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M9H"(NNZ\ ZW4I'PW&@M2MGN Q7Q;%_3LC!O9([@I1$1<+TTITBTM\"'3 LE
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M@I=!ZOZ&J51.EP,SK+]+':KW@)[\3NXG>GY@>5Q,@8,/\S66&54!WZWJMQ-
MKT.A74T@F!35Z,!@;T-O]#8XJRH2XI3#JK@Y*U49<Y2EOPE+-G5>%">B3H7
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M->_SY6F-^OYD":0,<J:='NPGSU_ P^?2MC0Y?7=YG!3WQ]]_OVZ>S.##%G0
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MNI2@XC3LS(T%.#Y[3Y!AO43]Z?*1W^QW/G+=EO_2&^X@OSF,.KN.TPFWUYE
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MB4J/%TN0$J0KM@BQ3SK2&.F1-"[#$I=CD5>1%U-0[93983=(=%=O[--1:C[
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M5+(\V_H#0(Q.-/S6%GET[7PS<X":\Y+6?87K]\!4,_.^G+!Q!.$@19QSH\%
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ML81]YXV3,.BH3>;X 2$VSJ ,3L=0[DOMTTX^>H()<G?(;')>N0=!)E'/ YN
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MSIHK.X'BMB)$=V^Y;\EK(,Y%$:]55')=%IA^#Q>.+2Z-[] Y8+ZBXB>HYOO
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MZ@F\/;4.EPH'.X)6?2Q]0[X_S>O-M01MVXVJ[5 X(C:0<&UTG>4WQ-HN:5+
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M[5,Y\RD>KPS_C(M)^N:_4$L#!!0    ( &:;?%CI,_\DKT<  "@S!  7
M<')O<&AA<V4M97AH:6)I=#$Y,2YH=&WM?>MS&S>R[_?[5^ Z>[)2%<D59<F2
MI:RK%#_.^IQ-XFM[R[6?3H$S((EX.)@ ,Z1X_OK;W< \^+*I1/*,TMS:BFW.
M"PTT&OW\]0_3?):\^&&J9/SB__SP?_M]\<I$Q4REN8BLDKF*1>%T.A&?8N4^
MBWX_W/729$NK)]-<G)Z<GHE/QG[6<^FOYSI/U(OR/3_\S?_[A[_11WX8F7CY
MXH=8SX6.__Y$J[$\/3NY5/'ET\NSX<501F<7H_A,79P,Q\].GEW^S]/S)_ L
MW.\?<ODR47]_,M-I?ZIP %<7IUE^O=!Q/KT:GIS\QY.5^W)UF_=EHB?I%0T7
MKHX-$!<N1R8Q]NJ[$_K?-5[IC^5,)\NKOW[4,^7$SVHAWIN93/_:<S)U?:>L
M'OL;G?Y?=37$C],_%WXT9_">1*>J'-WP%(?T^G:J1SH7P^>#X0]_P_M+FC8H
M:XPX@NE3]L&'?+$^Y//A?US3,&(5&2MS;=*K(HV5Q;N>O'CW_I=W_[CY\%K\
M\^;'#SWQ]N>7@Y*F;S_0)R_$ZH0^JJE\^_.'MZ]>OQ<?W]^\>OOS?XIWO_SS
M[<M_WYD@V%7VQ3Y/_5JX7(^7WWX>AJ>P4A^G"EX%(N6-L>)&O#.)CI;B0PYB
MQDN*O0GP<ZIA(M/\ZCS+NS(/PZ]) YJ'-PH80";"J:BP.M?PYD0NG)C)STJ
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M)7_#)&(W [EA2[J<&QVSI5[-U0/9!H^ >%#PV-(.5@GHQC*-^$Z!&;,E7<_
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MYU-M8X%81DNAQF-X&W8-RV'D3D9850/C2F&I8<7'.$)\IFP 6Z%DXP?+QIC
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M(H_<,8KLR.J1+EN?-I^X2Q^PO?J?["J#Z<P&.^O<!JLY$I/*\["Y+.6?^KZ
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ML/$+U]>Y*3-?:%2&V8C;MV]:1R=+BSH[M;P?BXF>?:7!AA50-^:9$>W)EY-
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M'80!R?LREG:,>=*J:3$$$3X)<RYZ+'2=JU@0<[TI%I3E.@/H&\KK?!\(&"E
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MDZCUJU-#460O9*1:Q^QU+>&IM63:?O>5FZO>#:=JV75L^X>:X3OK1UFJT)A
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MU&SIRI3&;0WN$JQB">[!;OS4<BZ*-K--#.NJVS?U?2>F9:Y4@:B\/;"#Y_&
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MFF3"0T'(O37?'];Y>A05Q)R,0>6? T(#'J02"RJ3 /5,D>\<U#"1BV!?J.=
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MB!N@%1C5L1')@ AGY5:F2AB5B4&29B.AX_*U7U'RQ?$P58J"J$F:W&GD!7
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M&#6&<2NS<X/)T"UL+QFX12E3V1*K>"B'2.DV^PN3&&N#_>\<_ 7/AS98 (F
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MV_H/GK5/I0.ZI3J ^@(F(AXJ=F%5Z6<C ;I&>[@P^H&L.4B9$'YSF(7UQBH
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M+E$1L(12J4F9!IO 2G&V"U-$S$TA"3K&8N74F5ZT1!%]Q0++5V!SW5,608"
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MSJR9L=;<C+A M40HA]+-B#*L[7ZN9G,S0@ROBX"%ZJG-B"^\^AZMA>*@M%&
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M5Y4".TMW_Y_!@JV#Q;!@:?W7,HQS7!;02^L7KIK=BP#?K3<64_M]4%IO:]4
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M#OJ%4GUIO>VQT7;VX]/!,(Q'N,8M]F_T6L'-] MV2NMCEP8S*_($=DKK6<_
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MKQK;3?K\ ]U/VB\-HG>&R1;]!MX$ ?#+UL[6V,N:X\.57A"G" RDO)^&+ C
MMOK8\)IP#_N #_3FT[A-PR*)AYKZZ-4U%+ \E,NMF?P&#WL.C1^.T?C!.(VW
M$,R__CB[/CWQKJ[;UZ=7$Q1B3U.6TUZ='O]Z>79]=GKEM7^<>*?_<_R/]H^O
MI][Q^??O9U=79^<_5O@*K;E>X??VU3_.?GR]/O]1\TZVC[>]5F-O]VCFL<M*
M-U_.+[][/X-.BN+H!V8[A>\9U76)LM&O-[>\B*'J#[CX>!+[Z<!HXBW26EVX
MX%.S4?\7:;;L+I-B:@Y0_)$J,!E&"X?%HWJ"8/'N.Y,WWGG$W\][]JTUD:NM
M[:.CA\7JW!)Z=_NP.9>$GB6.K<!M#>]1Y$YRP@04XN'\!/$[W!IOK^8EA0FV
M:.XB=)_,$>TH2EEXR8>Q3+:\;BP'+ &;[C[YV!7W/*@G,G4< _[J_4QV28)G
M0,XPSHM ]TQ>F@[ ]H\?O[:_>9>G%^>7U][%KY=7O[9_7'O7YQ[(_FL0\%YS
MQSN_])I[[X+WWOD7[_H?IUY.+3B5T#Z^QJ^;1SN[!1"534W/)V*^Q-)+^MSK
M"@58\D:<20]\-QX\0P9?D,-QJCV_(LD%\$E] +?HX\_J 1O5\5%U'ED2W'D*
MC1^G4L(#O]"A_PTWFO>AV?/ Q3SAOG;T,.Q3)/Z:AZ&_16B05\+N=&5Z?EDI
MCDIQ/-64DO X6L\S6WET6:B<]MC;^A1ON/:XOFS_N#HC-5%ID.D:)'%DX^G(
MD]>5\<#[/_0_+XG-O]9.AF(V4B@, X*2! $9I:0S['N\_I$>C&7-S>VG%&/\
M F_T@U[(,O,^A4YQ\%+SH,3Z;SYG\JG@N.0]G,[.HN0'?&-!<K#UZ4+&M C8
M^\8ZJN:=1?[VW, I"Z.^.[UG?D+OC%%#Z=[58\I30^YC;#SP1.2)1'E^GTDX
MZ\9YGKN/1_06>*M%6Q : BN2A$_E)N 24[0KL)P#K/'C.(T2.3J.@Z*I#B?R
M,;N4\*&,;_$^F:%^B(9ZR.Z8Y(LU,LH%X<9S('S-[L],5DNOHR[*\J.M3ZV=
M>FOOX*"Y<_@@\%9JZ2Y*RA$(WQ&A>6"4Q&"52.^/5 H5")\,$Q![(D^4=)GL
ML4C\17^_7P9%K1 69]N7VU?;GBF\D%Z16+P?\?;[YUN@E<1?K,0/>7<""$X:
MK=2>6(RP:@>!Q/6O^O_A%O"FB]@WMCX=-)O>5<)!SB=>FZ943@9E7O[(EGMD
M<^O352I 5+0:C8=MN3F$03%95Z%_-BZ.X9_G\CJ^<PH>EPI\92 [(@^_7!C6
M21&<2QI!&OGS&QPX1AYAA.N87DP8;Q?1%S' -_S?8JBM/0/;W:U/S>;>SCP<
MMZ:V\PQ5;*"")LA0 CV*(0L]?L]]*IF$C[O8P+P4 V2U+PX4X"$)O,#2*$TL
MZ D9"F0$R5F!^/< '*WFWOMQXG^"A/L6 UXO^G$T%K;!.=D[NWOUQA$N/5NW
MR$06=_GO_SQL-0]^4E["0S[$]S0!MQI:[F&*E.^!*\@ 2,'\>?'21$NSVF@3
M@.&2!]XPE2K%2$P2>W %&>?-UKO.>Q07&%QM^\G'38O$[!QM[^SM/LDNG_WY
M;F-_(19^\V"[<?C4AR_[4 "IQM[.)@::)NLC*=LB$EW9R)G?]_R0*?4$O>AL
M\8T A60D\JY&@TX<OE4H_# Q:Z('?N_W<?6P!T+RKB_@DTR2/B6H9>0BB<UA
MXJDX%(%GWZ6449Z79GB-\ADU6QUB,6<\'.@T%P"4>G-JWG^11-_SADQZMRQ,
M.>;T/-5_61#V$9I\>P@QW*V9VV'C<.O3Q>7%/\H'Z&F>JP9SN=S69[+%J1$L
M.O<W'BU L3,6*#A"R:0"]N>$07_,A@*\7P\+.'DRR[E]CO^SVHK4)YFOO8+Y
MZOT 8W[]:G#/H@##Y=SKC#R_S_T;#X=1>T*_6"Z)*I3'O#L>AO6;*+Z#<W*F
MX(T#^$*EZ+\PY06\*R*=8[U,P<39!1%K0)2#+$!KV_LW5__]G\W]QD]/+#1X
M<MG0]->.7Z>^8?K#GQSQ^QW _B^$^I4!^AG!W)6W-H!1)TJ45@G>^\UFA"A.
MX),_4X'2 80"%<Y(JB93TZ7%#J;BW%]4097)CHH;GL0-O\5A&B5,4G6/5(X+
MFA47+(L+[OJ<LLUCK/"N^=[K@]Q'^@\\%H:."?+<T>'F KAGD2$*C)#3$-92
M0>; K[&4T O@6_ 4\=*AY#XGO['9\J@"6GGOX'Y@TW@J!8])]6.L[K&5>DF?
M)>-GOV-JDH?IQ^8=WH-*BP+O74N_8P<L(_B^\P>\ 5Y/E\*/\!3F/C3>C0Y!
MAV0J\8X:7L!&:OO)1&Y*P'6)*MK0"4O2C-9;6Y] 9I22V%<B0W[$I9"?F\KH
MR ! ^P.1), M/ 0>D'&$;E(X\CBX3"/O#'TAYE.VYX0ES/NBE6)!#F3WR&O)
MO*UXR7MIJ,LWKNK7WCM$Z\%/K=;1MC,F!57O#;%Z;QZA\%R!H,_J^)RK]T_G
MXAQ0$":&J1T7[U1<7''QZW$QN7 AO OWF.\#%^.\T8"(&_VW:.JG8.Q&]:E?
MJ &P/SQ%6AT%_#  ((QJJ-OA=J 0$6X]KR?CNZ1OO]X&5<^UKRALV1KFQ5KP
MAM,/1]\V?ZK9RQZ]8.;1W(6HVLW%,XYI+G7.;+/5J;>LL9*W4+9?1C=KD<QJ
M'FXW=UL+R?8LKL5I]V"[M?-PWFCN0^TL]/V6E<R:T3BTT@J(;]-Y=BD=4D]]
MT9=KAD91,RPS,27QB:5"[7/:;>0QT$ OEJ,I(6:ZB*C#-Q=ET69<WM2>)*+Q
M2I(74=5"(+P@FKI_2BYOS43"CVDF0R40UE\@7,VRJS:(,9\J] @F=LC_HY,H
M]AX;13&G))B3JA9[V5K0Z.ET<_X-4ZB%R%<"R+&&QZ-M[[@%[N&^]S5-\IYU
M'W!.L0YSSD00!L4H% 8:#C-"2>REBM-5\*IZRLB4KG'PC?%9X0@??B?@T4B=
M$;Q;C(+U5BC2F!&+?,%"-*RQJQ OQOF' 9.!\K"J7P2S4M,[[]C[J8[J4[NZ
MJ\#*_.%1DP,QJA&+MS#$P)*$*SU6&%&$G<=P-M:C7($K!F9*@>[ CRS:>+?+
M*6P8F:)Z_*7 :&($-($<+^/0BT$>Y4@ET\K4,N\(8K>QFZNUO6*RP^"V]?/[
MD(\HQ?*NN>?]NGV%4]4.6OM8F/L>7SQ[2U,&T0E!W.0(LBOD0,=2A_!LAA<!
M#5-!0$ G9FD@$G.N55'?_-+RS._*-IXXENT,;U]"UGM4K1\\I-;7A^J[GLJR
M<(#/IQ9QSY2>><;)"%;9'4G*WB,?K8ST=&X,P.F?F5Q;-Z04''SDQU)RU_J*
M0EU*S+[%2(^W(DY5.++D..VIVU[I:=).K?DBHJMDD)SB"QZ[UYY%FT5%?OB0
M(E\?XGR8LE")$A'%H(,U'63D88DY1W DMER^!^6V'U,B"\1S.%)"F6YJ#%K<
M\GJ'H5I&Q<TCI>4YYIO@*\IKNZ?G2?CO:J(#2JI\RDJ"^7"+M.X>;HR$/*^9
M#-AN8[O9.*DW@>%61K8;K\@I0Z+Z/ R=V_!N2EU;(14 8N]]5<'S-)<9(3RW
M'W)4U?6\&$770*BLUP-21UX84-FNJ7R?$%O.++V-R<I#.Q:3@.9/7U?2*ZRD
M]P"1)/\H2=A%%0WW5Y1+_R]#%5\H 0Z_2".A:2)5P=88D;2V@,E\,0#$_[+5
MF*28"[(]OX0Q&YO7%J6#>A#3O"C\-;CRX)YSNH<9O-C <;F-&@C0VD[#34*T
MI_J$=:L @G^F$?=V&GHP8LW3XC[6EH<?Q@K?? B$Y^!5  /\ R&LJZ7'JJ/Q
M2RHBP'F-F1'\<MKI,/\&G%>P]>N&C+KTOY]>BZC:!#EX2[^OV;&Y1_#;K2&$
M0.'>X7^\F71 _19JG!1V\J1P]N/+E-JH;($2K6=1YVE"OC$@Z:G4@<.4#VN-
MW;U:JW$T21SZB%Z</> !?LF31"W76^*Z36R/R;,RQBOM##XY/_[U^^F/ZROO
M[,?Q^>7%^64;QY]__K=W>?KE]/+TQ_'I^@G%IUOA*IOYQ(//([@4*!QLQ&OX
MW><0T.[H"@0:!V(;8L<(.HJ?+M U1TO4T,^4GF!;$G&+Q4SQ_2CS5-!29"1]
M31 !N0P$,XY ]@:<)X8PB?3Z<1B@H?D.'V-J'.CZ"[JI6TQK"AS>DVTL<B^&
M EW:5\.H0^Q=X-B2L[,S5X&EQR][ER[:\078SL.YY&A;T0VUX15LDVB<=@#O
M3H"AY<I#*1:&9\901+X<%!60BV/EYA7B#P0ZH;K(TF/=Q)AT''YAX)R?_ LO
MHCOJZ!5,I(9 .UF%-3>/KDL)1_EW/>2WJ@QC'3;]J"G_ED_L6<F.0,]N9#]A
M'16':3+[)[.DZNR5'D_=''/@-L?T'3B'K =^I.3LIDZ4^I&%=T"V")=JO4RU
M7N8IZV7*;BY<MS]_.\4AP,?G/Z[1;-@X8;K=V'O:N(19=SHXW-X[6LP<A1>/
M49CT*'R?<V#FYS;-OKJP:CPR/_@UA=7#9YE?6.' KHOVY;5W-BFB'DAF/XK,
MQ[JHY_[]DZG*^*D+IZKE%L--HYTE/G&"=L X?1+9[&]].@-#VVMNOY!NGH>N
M_,RW2@XL0@X 0FV=T<HQ^I@I77'GX\C<GX'%TFCI"F-YC!U9>=I^J4!]'KXJ
M@;IH@0H8O13JQOO"_"26+Q6J+\=J)51?SJ*MYJ*D:F6EO@+*L)-=2]7/E9FZ
M$5(5,?IKA!NX0RR.N4I8MTM1^^E!MLIN73M^W6M4ANN:H4R+6$+;&I[^>%T/
M7CD*&Z'2FON[1ZW]@]W=5G,7R7'4X=(42H]6CN%*HY5)HU5.PVN@;,]HM%;E
M,VR$@$6$7LAXB&#FE9.P"?RYM[ X3.4DO ;*#HU(W:ELULT0J8#0;[S'0JRZ
M!)10W\/*45M)UI>SZ>(D:V6LO@+*L,6 ).MN9:QNA&1%A'Z'GWA7K,N3D7<B
M%'8(I;*R7#>"6<MON5;<^@2,[MKJR:I\LE+;3Z"; Z.V]]Z@VFZ52! \?):G
M(=1TY.(,IBG]=V9'V.F?J4A&-;@BI&ZXJZRISON. WVD;DG32UB\BU3Z?:8X
M=?;IW^::UU9..Y5%\'(YL-<JNT50H2R'LMV&$=W[52QK(VPX1.C_>\GA +<\
M^/]6CM-*I+Z</Q<G4BMK^#50MF-$ZL$;M(8W4J3NH#4\,8D28UFIGJZ )FX[
M-POMBQN@=QQ'@9YIBM> 7$Y#/<'O?,CUD2JS=Q,8OC)[UPIE!TY&5PU*FR&D
M$:/_#\Z!% G-0"%Y"Q^$]N]<ZL%K=^(TL3/'L*UIY310R>"7,_1^59FX5BBS
M3?>'E9V\&2(8$)I9OE?9_& 4Q5?I<!C2WTR.:.OERI%>R=R7,_!^9?>N$\J:
M^S;>>U39O1LA= FCQS3O$;=>D*P%4Y?U)#?2EV9%MO4F"D;[ R+[IQU9G$GM
MS$I>.7E4XGD!O'YT6-G$:X4S&Y@X>G%@HK**2R*@ :4X.%,"TDC:4I%Y4-5
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M3PV-U+?NS*)EV><S!]F^@N%.\R&F9^%DVO-.<M+IW(4'UI1L2SD+8XI*R$^
M0G6=B)#2^$/)ZVX644YO:(H6B8<S[G30)AIY(\XDVN>@//@C]KB,P20' ?99
MQ-HV'S?%/Y^=9S,5P>RS:8Z\LL* T\0;P-5=G$[X@*A[<^V_NU7[;PG.\O;:
M?ROA_%SA;&P*/9O&%JUG(VZ&J50I]X8,Q\JG.-YSBB2_ZXN0DUE"TRUB6VN*
M@A/3M116R5U/1?:!B[RXF2LHWE&BPR.Z(M%T*4T>V.N!P !AX87BAH>B'\<!
M!7&<E+;9NW4U/,M,)#KS@C0B!65!*7M/B.21!-5+1A1.%D$B(6L3=/K$;,&Q
M23$T:,X4-$RAJJ0O:8#LN!>IBW><B6OK#EQ:A\ZF?9<A50FL<3:GS$1Q7$2O
M'>2K8RXU*OSPQ@H_<M&9;!#3:&WC,&7&SIBO"/XAH(+*8O4,(];EB<YX<^1:
MELT\FV3%BGN6(E)GR#T=<,%'Q:G*JI]N[6BBV:&8;,*4B/Y(I49O &JS3X,_
MA<RKRVS@IU&]MNT;A?H]EF.E0O4KT;D,Y)\",M%[O..F5LYP9<11E3'2:MRI
M3Y4 4NTLP7&=>C>ETM5,RQY3E-G<WNPQMAQP,C([4Q@@?6C)XNR BD2697*A
M3LWPFI6DZ:B?38LH%I+<R$U])<L,S650L&!I@?%L!K11+6_2%S+01KTV\TT4
MD6[&PW#FU-_I%:$]FK*2</>3F<69%5TL,)B6A71[R.X6AQ3>=8,Q=2Z<OK&M
MF ,6AG:)QQV.<:0]%16REBKGD9.GAQ9G\1HM&BF@NMA'F^8&#6"+NAZU89.;
M-.L;N+R.7(XE4V+0 5]>)TV'F%_%DM,:.=@<EW7@K"RX#,L=06B %*$@I9MI
M-5:5-;LT86WJ>F:G!\Y <E)-.L[YNI!8.YA4$Z06G\_ZDHV9 3I/;-D+SBCC
M*+/R WI%'B=#@Q-#E6(P9)O2#5MF<?:[H/$_9DIVXIU=>!)_HF;8!7KFC'50
M0)J$U/&A!]"C2JHLQZ7$9:B)!@QXP(^(NE@]H\6^"?1B 76J7$N<F>.5C6/0
M P3)X2QF]TVU1H6TQ2/MJL],*I.D'XX$D%S[^WX<=?4^,A869Q>[:9-F7@TU
MIL1*"1MCQ<#ZU'N:D/R,.V?)5J'(:P3S@IG00""4CR7X4^(":Z/YIU?T?LU7
MB5TZ0VI-B;W,>O\;NRML%:(L4-:.$PB)I@ ZHO@G2BV@P3Y0=:('@*L$S-UD
M/)TP[KA2#H*VSQEEHW],D[N-_!O@T'&]]M"-@\IJF>* A^/W6%?9-R<YM)JM
MO=;1ZY<UZ=Y53!9FH8F1ZPC!N!7.\U76J  [@N(8X11"6EO+K\P<B]D$@$\!
M^+;+EY!@[/?Q;CHWV08WA)*;6= S9&G8OA)P>]DFEJ'-[O,]UB-0KW $:HV\
M3EKF1&TE<:@I6VLE"N=\9PE<L;H*M;?0<N^&&F<+8&V;(#@Y[,:4FALOQNW?
M\BW*$%NYH=V2AH13_E,;:ZC,)GH]1'3+<7NN,\ATGW$Z5EU;<VL\,#A?7'TY
M=4ZXC?\].O2[]&,<UGJB[A6%YZ?-6I_1^R-P4\LXSNQVL/Q "(;+2'#J\J;;
M)2N1!6<(=!:.%%7*1V;Q4Z*7TM!*V2$U+[ .3@)+R;X$=AO1B.O"Z(IX*"(]
MN9\6IB+J-5XU 9AY^Q4.E]..<GQZ3MQSW&<"EV-AF3!N!2I,,1_@/)5RR<8-
MQXIKOR3Q=A;YL1R:6E8])<8LJ3>;@A.RG#HC,C??;7VF?VR])]6+Z2]33J2=
M!3516-AA4@KC0C /MTW%#Y9N5\A]"7(U=JSC9C"!IL@)6,!W&.HZ!CXC?@.N
MQ%*PD;-6NCS G1T8:=)^OH^7ZOHR:E*Z]\.4^OK D4@'>@UQCI=1CX;T\V%*
MU:EV&AVQ<S\.@VI*P%)M9ZHV("<'(32( &!Z@P,F#DP;M0GRX/([FK_FHL]5
M,X5KIMB;W4R!IQ7!+UN/5_@W=[:J#HQ7/\O;Z\!X? %;V4(R%^W+:^]L4MS,
MR5?[6W- H2 GB8D>4R:[>RO;(*<WCV[_]W\V]QL_3?[WT?DE:_WRY[<8;.9W
M3X@Q/G.CX/PW>NWXR>^F3,F.48ZQVR,Q)GB LR&5#HE%<%Y;]8?F>D=@]+=?
MRV8#Z5]DLVXQ6(R=FV0(FHX.-3$4 %XE K,<C#>9]E1MRKP'N] .;H>BP_TY
M;63$PH+)C^'G%4793,3%M# :4.5U9,QP(;9D%'8_/O_M[*3>/'*;Y[,VVVP&
M*-G>7*\Z=^,(LW+R81R. $DT]X[6I."<>L*\:Z,]OG03;>R-T"YW3\<GG$7=
M,.717\QKT]^?M6_'A@))+!% /=-_;%N!LE;?^@.MOKD9R^/-OE,N<<=.AUX*
MAPB]=MK#7$>KT=K9]B:S29M.1 1AKED9BP;^!)3YMM38$I$CDKE0\X-WTI"Y
M<:9C6-'?6CQ,R=\M N*MH^WF:VB7Z54GWM0ISJM$.1WK_,'6^<]GY]@0WXW]
ME-;&ZXZ"$- >*4II/#[?!3=N/TV@+PG]962X\P>EV?<S/8[ PW&T]6PXXH2F
MPR7G5+$E;C&6%K(.=R,4<#E]U^D$B84.&B=1_>OW<ZS^[;'(R/^(P<U86.\P
MQ+:O>R^E5=-A_!>G,@G*0X I4 =BJ-,4:GB(9>7SZV,G3Q'ELZ8VV1*-U\/V
M:]I0H8HM LS,2CVC99+X<SN(K_^5&Q8(6JEYL/L3X U^OXE)<1(_T]1QQ?VS
M;1DSE9U1R', /P%+[-Q/X@Z0$%@KC=IRK4"P\9YDVYE$YEWLN5;A;ZR#P1)L
M1SL;8'18BX,VAOHU0UA)<OSMK)W-2-2Y CAV:&]@1CGZ]#((AQ">*470XS7"
MT#\Q\::#RE^9!"KPCD4RTM_].Y8WVY[E5 NSQ^W0!TJ+%NL=KE2,$6N>1=YW
M)H':-%VA@#IN7YY>>6W0/4B!/&(X)KEF8OP65,4^DR3.-Y=D95Q%XY[V#Y@O
M ]W9(B+<3QK0F CX.*56QUSO"ZI!$:5(Z793F=T^O.V=N[.W:GC^EC[_/W3]
MT:4;;_'?;##\R;NRA-X.!D"EU"--V2-+B?^XO,HH,3L:'+@GV0"S"L,A#TS?
M56Z+P<1+6ALZP4D6>F)"2G7R9%8Q7(/<S9?7Z\2^=\+54"2<2A<)5!0PQ]^T
M=<'5B0FET[1Y^/B<XNSXUW=:WNOLL\\IL$<V1.'W/M[V'S&V&Q_',19?(F<5
M#P[@&@(T*-F2W_4,=Y7 )_[(;7VVO:03(*I-N1B$F^D6 %YCH65D PP$^>1]
MMKUK2O\,1;;R,9\PNL"\O&_Q?.J>&2,]C+QFDZAAQQ1\%N:D]5*!VR\B&DN%
M2F$2<YD<[ A=F.K' ;?EAWFJE[I-MDL#JJEJ@Q)=$0=1*&\*(FQVMF.MI<=)
M1M>%>=]V>#X QHS-GPX]-TU_;$U)3C%1+RJEF_1:%$W261I_]B]--O+."20X
M(U9<T6EQ52^VN85=O(D. ?R( 75]'F)1L.GD&TH^9%(3K+T+BUPI?N#=QF$Z
M<+56LP^#W8%3OA7*5BH'5D@PVL#CR!*(BA(XI,<(#IE,Q&+HOACF%;16:C?"
MF9P,5Z<)_33G5)@2:#OP>!NTNN/Y&A6]23)7L7):Z+2[=@?-P!>3@J=</7WB
M]LCH<C6--=P,#Y@.:6L>]1LJ'*-6M$6T5L!UB-Z?*9/)V&/IF'FK@!Z:&F^R
M^) 0WM7LK8F=E,+1<8ISHSG0C=I8,WLL^O)F+&SSWCI^07N17'C:\AE&K2,X
M3H_,249A",G[9F[P -@^UJL]J!#L+_P)UH5*&QXK#-U LL*@N(EK]T%-Q]@[
MH+2\B^]'4G3B*/5#CL:V#]:FM3%.?K2S^!=J.2R&-G,<@+Y)XV?K8EQ$#FM;
M0# -*=>N*U:QPZX/\$)M&@A%#*N,98^H\NE-Z4?PI@'65\!E))6E4#?F*W<S
M'.CCT[W0FY?&&# QFSY#J0$/^XN[A2D#LZQA##+8<Z9C_Q(AZU/-AU;L(%9I
M&//O>:;5D4B#P9D1R6R0+9E ]22NV[TLB&\D"5W^@3) N2810$<WCL%V=2&*
M 5.9P??EY+NS]R2X[ )'<*"XT&#,)'[>1P!KA?(C-%$!E4BJC3.+-90V:)2^
MG:2$09ZK <HPPVA0&RDU["@,2 B[=@$^"]V@CA+MLF7W=*/Y"<W9C:D.>Z?1
M<.T%</# 56SJ$)<.: KI<$1SYT).'(C\8.L[X4@^39\+O#01<"O+[>A*J\13
M9*^CE>/0;$)RFDXR+\:Q"85*(PH'8;G;>( .U#&JZB*7411@VSMV[PQ<--LC
M?7/E,OO5[-$2G.7M5;Z4R0"<+HFM6"1A9Z7:K6!>EGEK'ORDK/@UBA,O8^&V
MUU;D>>2$'/8 HX 59HKS@ 5@$F2R6"^EY/0S\[@:KHF\0^7+E'&\06<.S:3'
MV)S->23N5S:].'[2M*-\*?3N*&K4+/@JUOF<)OQ=-O)Q)8(EXD*7)X,=%-KB
MY"3&3I_,NF$DU5&$WRF3C#$?Z?8!H>@G5JWHGV/,XR[W:'B<OH$!!1J N!F>
ME D:&%9SW#(IF,N;:;N49XIL@:/<U\3"R(@"]12UKS-E1MA@9G,8WU%\MS,B
MFA!1%-_:G3]=\(IB"3KWN)]*+&"YZ&^?;%/\O0M$H&-J7^V*1S!?_\$D("#P
MOJ/I#/K\RN\#.L?:"[KCY'J5\4X[N$6K?.1]CN$^V]X)>-GZX103&\*Y.!V7
MMK3F$JQPUP'.5AV"Q 1WH> &D)]2L+@'8$'I>;WV1_=$JMC-#SZU#8)P/5ML
MO)XGG_3/V#9B43S$^;PYD^RMTMHLCP0Q0S8A*D<*#R+$[VD;*-#B_O:N#A]B
MT13Z7$.@&64#F?T4R4??M.;P@<&B7!!-A[CH-UI&Z!@+O_<Y#U0^"H9$^2<8
MG:;_EES*.XQSCES. W@"?-3$3&K)!\FVIQ4LO!:PRU<N0<>Z-LJ(HMQZ3V@N
M(DYR7:<:"-3$8"#[[72\@.SUHGLMF9SB.A><AYQ#2T,[;EF8$M.*2.GA.S3B
M+Z< 7(H>VR!,U[6.BH6AGHUD-."8+^4>1&KPCO,;7(,+CBPS;^AK*PUU53>5
M=!K]V)LHO@MYT..F%RX'H.Q<^(HO[?$NIX"@*-MGZU,6&H.M/^BLCCNS+KL+
M?)]D99&H_:U7Z2-'8BHH)X4+L@%']H'Q\%_HWR)B.]QG&&R.+,3!,06EAE)H
M(BXR4W+IHV!.@GK3>S'.A"&[)) ,^_5]TJ8VQ#UAD5&3:\=MR'6]J[7\)TD*
M4-$)EH2 3]L](O>][OGII-:( W>T7UCQI8L]-9WF]=T#X1<B/!=^P3"3C0CC
M%O7!D'HYD[Z@TR/B>D;J%MYP6OB-&(\607X[:]<+X>BW5,=D*!L7O[OX'8;H
MHUZ,4(IX+Z9I@BC92+1$B#X<;IS#+"UL&U(K.P8[S0P8G>K5A(OD8&>SY/]M
MPW:?6Y]=V"[KCJ_TV.S(G V*ZJ 6IW(-RMU8,<(D;=GM4XK858Q@M@6[SXV7
M9Y25<3'A4OB S!- "(@%'!*B:$^.WMNCX]O'1O 5B ;3HT@QNF./] NR$DB0
MF%K%+"OJ1C(*8Y-RTR>C>I"HQV_1WG$?Z>@N/,DL]W13KQW].'GR=HQ96^B/
M^I_9R7SP<).:=CCXNMLRZ70LX, $2<CU6()V)_5.^JPC3+D@T\V\>I 83FK$
M?*//'7.VLX6G&FEU3+U8_5<S[!_&-K-2%+39&,@,?_$0W?DTTNO+%B9M2Y2\
MTUU*$PNLW@*5DD7U.[=U;KH4.?+^F8*)@Q4]+HV[Z&KD\6+D;SJ]G?O,Y,_S
M3\NK/31(N'?Z9RINP>Y]QZ95O[HIO^_I<?;BK]Z[(=@I+JY%V2G+0)?W636<
M^WF-JNLH=V#Y$)BC#C=#:STW2Q@?\PT C#B%PW_[7&_JSS[76_HF-!7:A@U,
M:80TW-RS80%A2C/@,C VP7?$/AM  D]O^$ P#WZ29@KYXBS+HX%<UX4?-,8-
MVWZGK)G(2O+NHK%6;S-GU,3U/I_6KP:HG$Y5/.RS'J<YO;Q^K-.*6=&D=P6F
M)8]TJE<E;F2B2<F.K9FSM9'39\W:USJ[<&_%P'199!'S"CB0'O61MC7Y<]02
M.,)^$EE?WN>^?$ORBPIS,BH& R<,, 23H^=\H7AQ,/ASA0CS"O#6.[R8]MN9
M+=C)=@(851_&':!VT#+?1)>/=>@4O\S6);)9%<PH:D^NKLQM-JC&O\ $U)[1
M"6ER89>:Y(9],%Y"6ZI=-N-?MR*9-=F*=@1@F6I*/KBVDJ,4,PNWO,=I_YHR
M\04I"T;6*H!^K=>4V+QT-I>>"L)4'ORNP,^L-O!LE$U2" ,<E[@744Z(*=J$
M1)TV(.C_T+4N>LHDE2GZ;*A0'U*9FH8%#8\!<.%X?EQ&!S1 ,7;P.^"](^W?
MY$Z*]S8'H5M3$6A'%^Z8?7E"U\(;70-_#M#0Z::1G]C2&!NS, OYIAHWEBX9
MTN6DR #_B.KL>OA479:8B[:@QXY%$[N-&B"R=(XKT<"7D^_%BIQ5$J3V2G2N
M=#)<L3RKX/5Z%@O_*R5!Y-L4=FIFG]( /4^<(9M0&7UN0R$69&.130 .YE_4
MO! RGW<H.HKS&T,^OF$ISU;HHU+T/=&A$CW6'D.^P&*<!A-3:3IF]W0]K8AH
M\#U-I?T-,X8>ZD_*I/NZX-#ZT^ZIKH!(M^;]94=],^7*=+48D:FVD4GVU'$O
M!QUX5?&N,K>Y:M!KA\.8]U(,W#1-H(HOO"-38[< *>T:Y:+Z\1W\ )0*-4-2
M5B=K/C&S-07E?NPB+Y37%0JF:F\-*M"&KJ@4P[C9"C27HC<&5:X@WY: (V[>
M1F2]8&A^G6UJ@E,.#V8DG1YPSM[;Q5\\*Y+!T@8PB$PMLO:^)5D]5#MC0KIP
M%1H_-%X;<QZ)*A@W9EG$D,F"&#,[Z]Q-R6RQ":ZQLH;L+<EP*<1 LJB&#D=D
MO5.NAI/84F:3E?46! N@[/#:QC$/JWAT"K7=FMG#*NWUJ/W"C>V;2GD9-*ET
M1</=AF>1M4,<=*H9.M&RU8:(*'/6I\H#'IJLN>2=D=T[HK-K1GF:V,PP-!NC
M-85B17EV![2ZLT$4LPBL5G *JMI95SM[4-7.EN L5>ULJ6IG22A:]3I#HV!)
M3\=I-!ZXQ$2FJ*@1U(HR6NY+A@[6<6(.',X5)Z.A[1BU7?0H\R[[(HI)8)K>
M)!Q*;,/R^HZX(;BG)VIP]&HB1GD(IE3LZYT]3N^;WP/@*-Q#!24K2X^760_^
MGND(*@O)XYOF]V.*@B*[\ZB\TTX<SE1[^=V*=N66_L%O](,3W9I5(6GB6!3S
M)DC]@P]B*?NL!X9L%P-<MM#:]+7I&G5)">Q.FNAF4UVV$(,:B[PN2XBC#$O4
M]&)<JI[5E2PJ[=2O&/;A1%Z[*\$,V3;/[I/%>M3XFUZS[>D>5ZPKTJN,C#GZ
M.\;];6/Z><ZQWRY84$18Z'.2B0-Z]%8D,K:VM'$R.V"27;4OK^K'Y[^U*O:=
MRKZNP&N(VVIT_Z9W1ELV1,]6,^+C3C#%VAYFIJ5+\OTX<5D^_/T#/DI]IH^R
M[5W 0:+"ERQ[F'+I8H?/6FZ.BJ/P&A;T8L@6C>0WE6W,I:S?%7+651)QWB1B
M 6S3K1/=C%LCXX,-!CJ Z80G#E<?#8;@V>ADT #%[:CN!@&.HD#J3NAI/\G7
M: 84B1":LMOA7_"><%!706I^7GM.OO)-E&YIEBC@$SM;<JTNF1D*!F810JA1
M4*]%($)P-D0>B)?YIM63G._\%=YTJ+M7,%7HTL&7)U^S=G7\2\]9*C[0MLQF
M3%RSJ3( C4\!/Y1H;,A3+-4 H9U0FBW!XN7$-+8PD(#"KWD13R4UZL._+<'J
MXF%G"%OZHVJR@9#2$/L%B^!Q#)MZ,,&'I_AU^PH'ZW2)LMK!+:.,@8.#N5)Y
M;3U!QL[ZH7B(*YBG6J*:>2-]Z/P+*=,7#B_A#?LC)?3Q 4(1=FILYPMR*+PW
MB -=/YSY&H6+LA(D:KJS5W\?89DUP"M7W>*\!=2$Z&UBUSTX)R&[C:,8@WWN
M5R!9J"8'?Z2EBFU"ILI 75&M>QF,ME)@E%!1'H#]7@1,E\]@@;A%2X)5 !UN
M9XI145)!NF2WIJ9NW-40LI&:>*3>25X([6&<1!(0Y2WY3R.5\,&VUXZX'\1H
MR?'I<2R1[0+A$3?%BKG5TZR'>>0D$V.T@!W4_07#LE3E-@"IZ0+LC<D@RFIK
ML6Z%CC:-G#_DQW7-#B,]?N4NJIN12\"39]^QVNW916:VHLS2O"$?[P9^(+'!
M <^"->A^3)V80.?6X=9DFF_@'(S@!0:LYIY!4\UT)33E_+$](;$_I$Y3, #S
M]=!VJ)TQU6M:[9IJ-RQ@//L^YNQ9*('45MC,0<-#S-AMG?HP,S*(@:A9%($"
M3(5Y$(X5T+ADT5Z;@9JJ!E'R99%R0A/&'5YD.Y:8((_[8)3D 8"^%!!/31=H
M7+?_Y_S;4CRE?=SP]N@!I\20<4A^?8=^?8M](T!'1@B@-Z$CDWH&:"E]+.!=
M!O2?L'L>O@<Z_T.'MVK E:[G;*2#'(2)GJ)Y*2F8CLB",;8I>[/$"+:7X<P>
M4U41CNSH810:_'YH)L:H A-)G&Z3M5!IWL$#8"H^RA)*X[F$7&LEW"4T:\[U
MNOH:#HPBW>%/$IC5#AD@*!B8WW5/P-!UK*:OG2!@,Q;T_BZ@5(@BCDE2K-4*
MB*)QO[>U,DBL<IJ1EW]A7%9'L_5 V)K6PS>4,CVG[CLRB T5H=BTI#9;0V5S
MP5#6ZJD^F$E"7']\'O3*O4F*H/7 )JF5A@.F2]%I2Z<N'/N54E!^Q$H\U,BK
M#-11R@'-9S0)C#53\V(]20)T9(KM$YT0P(OFNS5]P+,!;1618<1=G7UAD(?N
MR7'9"P6N6F!EG#&6*NY8)7><Q/>Q3#O@ZT3E9H\BB1;_LH8[!@=4,6#E1K+F
M+71'R^[O?S&TP/Z.Q;[2UY;^:##LT[_(OO93G)Q/G_DC=%NM)U#1[TKI]SI&
M90UH7"?J-8+54%]%02NEH&,*+27K)?]HL"0E('-JVBEH<*_TX.2(^S=:?>O
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MN!'UY_979_DU&M3B#T0VP*JTNSY+:I[H>K@YPW8SYOJ$[ZC#L#-!5:;!M;B
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M@$(6!:C=NI<M<W>]W'087#_DY)D3XT#COIX)'T=_F-'LQHRA':ZXH!VP!@
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MQQPOJ/0QAJ6E=YD7Z[Q:Z:%)YU(0MO5E4UW*AJ&F6J6\@OIKYC.JF6FP;R*
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M*2*Z8:2=-=:H7[LV:'1T<B@ 5+S!::4Z>QJ>275%V2+5[%0 85I3/PW>;J4
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MPC-LW=D+E%=OZ>E8E<RD4P8;O!"#R(T.K$;#%:%?A2YA8WRR7)/V>MYFID4
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MRM3T,ZN=ZO*0T:#E2^>V+<+4HG6^&*WD@8V'.D'M\2Q[E1YZ0L%UBG"XV?I
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M,LK3K@:>X7Z?F5^"G=N"V9%\:F5]Z821G5D.H&(X]"#6,T^GJ=3GUW?&H>F
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M-;\X\UP:R?NIWU]41=YJ1NI:UNSCV:G^,]+/^KU)AFU3%X#2K9M$^BI5SU5
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M("@Y86G\]U6XI$"7//Y'K<)E8%^)NP6@DG NN2(G+6^2*_^UV/7,YQS& K&
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M#/;#1K$5S:+4DZ)H)#7ALBG#O0?:S7T^5=X>%BHF!HJ[%B5<UAE8S)P%^IP
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M14$4__0FO/+@2"<"\ZJX@3+"=:_P\'*[O'WH^+8E^.F$O%\$^6@CP*9QYP6
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M?T3\W2TSB7CJPF"3ZCW]:\SCL\4$M)KR'C(TWJO5=4-\&EY%K"P;,]QBQRD
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MMB66$W65/JW8*I)&6X!=+7;*+)Q]:'ZXVYCQZ_CA;F=^/8C37/Z#?E.?1$%
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M_I$OAK2^NU(G)\YG*JFT]K.*3A%V"%B<C)_!*7$@R82]E(TB$IR2,R2CT
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M8CX3HBZ3WJJZ:SD[#\I!5&ZG/1   <19E724M,L7@IGG^Z9M#?B0J_]ZGH=
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M,NHSN?UK?Y25D?YT?.RRJ?9;O=/#54]O]^"LYBMWT<BI4]*)Q#9::]ZZVA>
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M27B>>J4$1^< [:*'9^*?5A*;)*?8SPL<ORU4+"/@=KEIQ+-BL^V\,29E%=C
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M"OU>\9V#\ O FW\Y(:@Y_D?53%BL)JV.QF$!Q-HDX/ISN1VAVX*))"AMX)^
MV6Z-7_:!T+H)K51+RF_VB[,=2BA,EZO)5U\N3WHC@#FX#/WQ(W<I<80$.SFG
M'8K-4:/'%2I#^KB',=KZS"K'X_H $B<3FK5 0WM@'%_6#++=V]GY+/R]:R*
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M@%&2*NS"'V'@#8T39J'U'-O1HN8+;:H'N6 ,+04./D@"H#M!&)DTA]V@;9]
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M<@D:<YJE?4"H$J-*0$IQC1B?,9VI9%-<++_#B'_@(QY>!#&"+UC9Q2F*@(:
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M56%/1R2U(UF(AR$&S+_!.V"M)A$"I##C)R@=(XP0K/'DJN7$'YZ,.<6"/4<
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M'A6RK&6EK[*=<.#Z!% =CX> 3R<H#!2F9 ?F&0CTUHBI5,D7'R8^PM0;D1N
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MP9Y#Q<Q31K;V7FF+.]9>6:V8):BU@6"?G.=-#C'I$QGB]D-M'_/9_[.BMI
M3'<I9NW(D5QW\4BN/?!J_V"J3$S)*=7H[&IS?,!UBE[&3)>0?+'<'1B%G^8.
M\$NBSJNOP;&LM3]G!XA,/4*D>(OX%N/,H<!H$.(3Y[-I4AN+LERB2VW^'*U=
M'ZGVY+O DPGNUUGCH N>[I;IX<$J=34;_?F1"> TJT^@/@Y-OG59Q.*I<*GZ
M&UD6Y"0+73$5JLK0IU:C#8B<OY9X@*30URL^:" G:"A*GO6@1U)3:F;=W- G
MT^*: IM$W5+7"M#5'6 M/TR>#_B!<@D<9*V<<S,H]5CQ8SDQOQ=V'$-\A-(Q
M> Q@KV%MRS3\D<<>_(B,#3 .2/!)*$ 5_9VJ!F,0D<'<GH5P(+052I/BJJP7
MV$>81<A5E&_2WDEY(K8UL$'+_<%PHATVXG-2$;.IH*V"ZWW(8G/U@WL@%1#M
M&.R/1=Q.+SM5=ZUT\PL86R]:NC:Q2_N0 _H#X&,",-9HT&-ZJB3-O0K%@ <X
M76GJX;:)678T-XP;!,H.G/Y6,YH0#0$>**6HAAHH9+%H,,>B8TN8SEP6" P(
M*+XBXX[&[NDB6WCA-%-RP8K-F/8L8<=A ^08QJ<") ,[@:')9G)"J;3LQ*V2
M3K68< :]KUCX#,75-.).&((B$\"/GE-"\")'\D&I+S<@L7O@I11;$[!K$AP"
MP*@LR+;)Y8@#4H( ,G2,1I*(U(NV<+S5Q,.0@ACF#<TMP1.3N4\<["$DGF7;
M 1PYF?ER$#2-%7/"\01>K&^Y=-@TJ5,,UE0B2T2-^<W#1Y57H=M2\-M2"]!.
M!NI0Q!TMOOR 1A 2;3QROF)4CX#R8"\,RM^%BT.XKWP73\!'DFAR^R%CR LA
MI:Q>5\XIMA#-R25$'<W]T^J34(N!G,*.;13OFG,H2HN!B=3NR4$_R5N",H%\
MB +U"%0)-$0SG& P&841$37TS@Q4#C.Q@KA..*+L!3T,IXKZX,DA!LT+ZBKH
M6>-\RM45*#('30O%I/;<FT^_CJ_M'\P\Q3>#+B+M'?GG8I G9B\Q?A/( DZX
MC<K82+W(112_6.PK=,N#,Y?8;=G%+L<=R=!1?)FCZ?%_3WRXJ2@"$*.H'"%$
MU$Q.FK0IVX],@0K"8'HZGOYX#),.+3?\G*@4D:8'B+3/-/<0!SK'@E;->@Z5
M<4(&D\ BTG:__Y(*4O690%SC^R<Q?9*9W, )?R;B ]-[,8&!K_^1D1/Q?&@E
MY"O#0=OQ E6EH)XYC/WN6"_J#DCL8)G:('"<X(I;J[HQ/F,=L/QRQL#-SS%>
M$X:%/L\(K:B.%1D8B^38\<\",E1H-* X_B6U@\J)GTSVQ6%@26YFK#N3H#,B
M1K(7\KU+ :E[Z]=>! 2T5#X*5Q5N8ZH;6?D^DC=L)AT2Z]=4]%:3U!CPE%:\
M-)OX)>" D(M&X04AO5%VQJE@E1*7Q199@3)X"K^CB%["'#<J74*I"0Z#F5SM
MK!!RD)0CN@LC,RH#6%?TS-C,Y0@_ZQ=>/R?*+;/D^LK$(G11#QFD%PVKB.*Z
M5&\'&V^AP)$E*D+O""..VV@P-MV66$[:2#Q'537!?W$Z-LXG8HU_\_LA-;B*
MPH'[\[]U5'>#Z'%-U&]2[R!,;P01"C_G0LOFRPA\ 5*B2T*IG(4C^Z/4*PF"
ML&5M$;Y,N*#AL=+47DJ"K\,H/^Z0HKT+Y8OT,$4]HO.*J@K! ZR=_AD64JW\
M66O9D@U?])C6;(EU>$4#[:)H( =K*8H&\JM+_]!">@:./B1E"FJ0A#1B,VF"
M"507]51Z2^DI(<P$X"!*S$1S"@I@E-/4>,WO38$U-&%%N3]"Z.MW%J,[ ':#
MBO>5XJ?LYVSE/V.9"F]C59VO140%WL=26K_KZ9F!&4_%.%,<SY%14"Q43ULI
MTI^,%(Z:VE2:/QM[F1BM(76,&(.8&>-V","::IWN_"?(C)(F? C_P$%0)]UH
MS%D]0-!2O8H#Z]TC:NG R^&ZN(!6AM?A^38TOHJ/IZX@X_V9.X&6,%.H%U#$
M@:0)!%X)^I]6G&S5 F[8#*"FM/B1P)63 32X+6)'B_^>IA1T*QGU&5(T?D]<
M LJ1.WOA$715QI^?%GK *CW!"8$%5)2!"*"QQ8PA5X0RYV]@BK^@/1Q#O,J>
M_-K]>A.WF&#F :+%"&$.Q"JB$RA(H84]P*@+!IOB0H1_0Y^((P?Z/,J!SI1)
M@/!RH@0".ME"D;#'"H9(GP!.EGZ,< B%X!HYZ\D/&0@5;>BFS [)C+'J?E=E
MM0LRBCM$X9 $1URECNUC$%QS&WLBB[(<[5?S2OMIR(<$;H,<K6S)U^_] /^@
M<5+A/Y"TK315UPNC8$+*XL0XIT#X%:5-CN_]L3,P:M7&AT_&=_+V9'5,\I><
MK#)O*6?,2)[2UJ)<-7V!L38'L+(XL#CB3I=K'/_T_&=/!64%[2M]J.57U //
M+\^OU)/P+A^$*:(%#=4=1+J(<X8&HHO/L56B*1[6!G!G %EA8=$-(H'%)5<,
MV/Y%IA]4&G J*92U>M3_:-PX82(S(E/1'G^5@!(O(M2K&3URH0BX01O'E^5:
M V$C*52UQ*N)7PHH:0TU6N*-)X\_F5\#\:6.7T:D973 PC)1OBO_$:TP9G:V
MSTL@0L&\!>A0Q8HP E>.PS:P.G+-0Q]![(8GR5B"6![?7*K:1[/K*^L'!%.O
M\+2^=GI?)/P^D6&U?%*NFMG4/(]!XC9L3+7%=C1XZGJY'U>]7,#09"#"8E'3
MR\.1!2,^-"JB"DB"*-&X!$\);%EX&"U-#OJ,'RH-6RD/*&0&1;PCH2]PDH6H
M#43T>B>$3" UY?497R;./R)<^JF95R4#XR@H9@3IZ6M,]NO%74HRI./IB_L_
M-.A(]9UD6=)SAFWLCM#F9-B9/,"\A5A@Q[26I:E$\\@QD.J'%*W63LJG^L \
MOIM]D2,!8OV;S\_;^ =_9? 3OD+G''UUW)OT(R3=5OGTI%'FXCU=4]:%O_F2
M-+%?.L(#U\6>SHKH1,EGD/?X+US DU@ &3Y2OJ>^1*1D?"27:$)VH+NCMXE+
M@2$3^0X%;\4CK4C+A%"03ZUS2I "\@Y"J <AR&F >X>"&%F!,B4#DZMETJ@3
MR>)X$7*V!<!S(=\D=?0I69^<]U69KJAHO-=8-<:&M'T6)MM>M2(2X9(.89OB
M/MAPP+VNF!N12#Y3Z30D@HCFIKD6?R?3\4HK 0P@/7D#QMT'JU)O(]0%=PB=
M<\8_N<X1YN9^"*EK_TD$S6,QE=*5UWY)D$W3-'J,JFGNE.H2NK': NG2'8&C
M(RN<?/$SY"UYY8768W<<DV13:5;=-&3>HX4H9LGZ>SU^'XK[QH 0!!U"6D\-
M&N3*4#$@)WXE,&;KTY3>C/7D_#Q M4XEAKH:GKY'2EJ4C$OT*Q6[.F$\EH+;
MHB $Y7=T2NH%M,(7E-&8-HW%CHMP"R Y: 2$7,H8ZF(P:SPGE85>K^UKHF)*
MJ$2)W51B),L.D&6,6Q BN>>K.!FU!%^U34//X$J6:M:S6"K^Y2Q6:BM6<NC:
M,*Y*A.I]0+>C20FRBT'O>^W+4($ 9.8\$V$I&C^A!XPG(7D_X$P6K-22&#2"
M(APOUI*"MF+FDM%E=&:\ 8[UE*9((L^+J"S:S2G]^"_N'H2V@UJ1V_H1@<BH
M<+/L0*88J68U@]5!>Y%<CQS<DKT7KR\K-F%\+OUTKA\G>![K31-B(!>\/+\8
M?4F @MHR  5C*"6!VB8V% F]!?+B!'[T7J >T%K?[)3^\J=*H_QY^I]_I^@B
M%=4 J_P=@M[BOW4IT.E#?%, )-XYX<\]B/U>.3^9\>0$$57PD:\@QTP20B)7
M;:%(IHAI51@1B,O3H:)*Q8I$T1A\ID)&6HV<*IR235+"$P'E"4*)$NHT@%@*
MG)CZ'2V,0-U*(K66&OFB96L2M5$F!(?I"M%!AT")-C@O5.9F8KV4^D^M[4N\
MF+CU/M2. ^"%GEL2:(T:3@R<(HIP):3 ^>&O(IPK0#QV)]!%)FK /"@O]H%4
M)ECN$CA/Q$?99RA2?C2D"PU-Z3^2=80!-_P)[;Y(J,E?BP..[T=E_Q"[ C +
M&<#")%;T4N!!J-*.1KDH[<C!6HK2CMS@0<C.H"RO3 D_$:C'<)5H$9= 4;H(
MD[U/ADI&BG)=<K&QE5XIR6D4T&0UKYB=EK -9<,N -YX6!P"TH1S*W^VHZKN
M0#AR_S6(3B!IF[JM )N8'UO&<@Q1'V$%'LV1C*.#F,_55+K6DYV2T?@C4*Q/
M,.J:ZCGD>D[$K741'Z<J]D'/GLL<FRRAUCJ.P*(:6* L82#I "Z&#5,%U@+C
MD[H3P[' 32<'E"P@;'L/P2T1X N):G<,EBC=*X8%4# W42.:;*'-2"WA!-%X
M\CBZ=3*G+I/QV"I!]46J%#8U76C)Q<FQJ*EW$QT16KY>DN?TUNI5L!;%JG6O
M663)U&K)5C"U]0@F??+!#J"B*7I/AG!3KT&9"QJ)#\].J<RV4U;P:1M'A7%3
M&#=O;MSL7I2D-3-(DHEA"/*P-QF/7?QOB+A?6)&UCEQ\(RDSX]6O+R[_Q[B_
M,;YVKSO7Y]W.E=&[[]Q??K^\ON]MEG83YHP4Q#!7#X"C7&L<LD_RC\_0D.M:
M+Y\<#Q>'%WT6]Q?2&Z@'X6T&EBN>@@^DKV.Y5"J3;(H"_C];/EE\7>)??9S^
MO-4J->NMS*_*I4KFY[-NU2Z53ZMS[_015T:KXQL F_M?1[6C6"PCSWPJ&Q7.
M"A\7_:PZ_@4_G":E]&;1/KT]@57J,+F9ZQI%1Y&]<!.F4<8& \:X&)_SVB!D
M9K[TNVBJ^EQ-1<G+D+"6XZ[1._8 *1$H>1*S@[2<\5<G&*FBP[>V1^ @C>/;
M\\[-%Z-[\<GXJ_/KD^=[UQ,<MHP5%OQM[T#G#4XJ1X9GC?C*;.9\0CQ3/X#5
M=^TC-%J&)S6N]4YKC;]^3-SF[$-*QP"UK$@D0LR@8!I'!F81#-B;>>3SKER3
MO=F-ZF8\(Y#YUN69]WCE+"W[*;$+:[Z\$J>%Y'EC&WGN6I:WD5NG1V<)4.DO
MHE2S!Z6:&>;R.I)CQ^1#\UWE0T'96Z+L5HJR-0>#&P<WR>:G&\S%0=U<P!Z9
MAY%54;1Q#/7$'S;DA,5$D4=.:!?6Y1YP0KLREQ-ZT,#WZ+L ^28@8 R:.OCJ
MTG_1\><I;@@,D7G\K_C$J>/G%OVJ)]\LSSC&0K'M*#O7Y[+S.>3$OD+B[-55
M5L&^K\R^_*2;E6VQ;Z&-\\&^S:.SY>?Y%"IXUWF8'W>S.H^'/V)<?HWT8ULO
MJ5T_$_5V)UQ=&-5&\.C+VYN[>^/FJP$)E-M+_H_K>^/N\O=N[_[R[O+"N/WQ
MY:I[;G3.SV]^7-]WKW\WOG;OOF\]-_=Z[YW=@'!/5:_3XZC00?V.)>BHX6\#
M__81)ME?6?T0NQ!*(F76#QW;L3+A(]9$%'\G&K@9.QZ6@WBI)DQ=,N[(&V:?
M]A],%$A!$)]E#%5)%.HG&JB7)@*:&"^: 3] ,3.0U9Q)GA(&1E9<)=80)LS,
M%'C,(!$YH<X,D[!A4JXEU4'3L[0B+VRWARY]T8D=/?NBUSD)531C'.GTVFDH
MS;$L0'JB9OP8 %T"%2SJA_B E48^UC0C49K+72>;M;"P#8;I.H@N$-?#B4H_
M,6Y%JU<2Y31R)Q1D1.+XYIR=*N*##MS4.1&$Z_9V/6/6CSY-A 9" $AK!OZU
M>,0/SU%>#"Z[@RDK:]5&E+S)L"\(6 ,[+*39SKS/#/V$4).+Z1[J_>6P(^A$
MBVOA-&I66,,QS&[)N*$:5/TJ)Z0A\N- X,S[2<V0OMWBY2E@$42V!^DK)IM#
M2[LQIN2P1L-#)Q@!B)!,'ZLA2B*/+-E3RR??8.,ZWSD)#Y @\0\BV_N!@!YP
M? ,VS]JB>45'.T[7!.L"04SM#&2?FU@7@F%*E$H-G -A/M7\KKA_/IA(>'R"
M2E)8PO"[7A+<XU*VN9S'$^[E+?&E=H=I9ZIE*/6<$#ZIHI!9>ZW*N^5^T288
M]SC@*/Y6CD?%1I)G;$"AC1/%J70F.)\4"K_[V)\$ XI]C_!7 $^-,!VP6>SY
MD0D4G&4Y<BAFKRKU \<G?V*J&]J$],VU),QAAG%-?%5)_ .!0J 3+5@RU*3S
MS (<-\"\!\[6^*5X11,;O/$5A6K"2FT 6T$4"=\UH-!7>P.%M%(R.M!;&D1R
M%"L="K:.I?E'[!U_%CKG> 3 DUA8O.3S8B!8V2HZG@30FH9X@R2+!'!Z2AQ-
M]:AFR:A5WAMICO\)!L0S4X+0\XUP FJ;'K_K7'>C,YH :Q9D(S#^!LS&7DDT
MW$+8 MDA&,ZD:KG_"QED ?F;.J>FUP,,+491D'P&,L%UE;@MSH](^[%Z-_;+
M LAUH#1$',%11F*&"0,X0^#T&.,=7J(HWE;%V]54)*5H,BOJL-^B#CLWXE*.
M'$U//Q<.U1)@79K U<$8;#D^24J=;%]N A9T&I(]'A%)N.WZ! U3G]F2>@1V
M]R#2";K+B9&F2[P)3"ZC 9DDBS6;34##8I>.LJ3ZRBO37/H5]6=>E6NV'WHN
MY]9CO:CQW8JX.-SU\!D8I /Y8F15CNC%L/5^XN&('D#8<?UG&H@@OK8"'.4:
M#V^3;5\BU*%,U.5L:V'1!RSY7(3R2'AUB:^%)T?/@F\ .D2,U^,W_&0<5SZ(
M2)8812N&# <)AJ=)!_1R9/_(R7Z+?0+^J./J!SG)DIP=]#,)Y8W[>:[+K7@T
M4D3KOO,D>C-Q+.,O;=@E.@CQ&PH6GG% "C;-<@&,!JWU%X-K9YTEI46]A/$&
M PD]@FIX?O1=,2U2^ ;\.:88=R07)UL3LU>'%&,*X0&_#6DJ-I,K"]72LF\
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MHK7U,;+XTV2"0TN0:?<9,'[8@2##L[_V@X^ID7BYNVQK1X]!@,7] 3W&#&L
MD4W+>P$85)S("(.O.*/@D6$ =(APMPZZ[?P#Q#%X%8J=6O84C^.RC9D;*WY6
M/^7W&?LT >A3P%P+TF*?GQT[>N0/@7OH5PDJ+L>76'W^]I-H]B4Y.,'**5]3
MHY5*]6G_A.6"Z'':]?)@T*JTRXW!H#ZPA_U^95CK-^N-9J/5&K3L_VU!0R1=
M]*B0)L;6 SOI!\SZ>6(-^1M^LMQGZR4$%M0V8N1X)_JNIS=LYK8,AZ^V+21,
MN"#V:=C3)RZ_6 "_XFNR<K,6XS$ /?2GQ>?3Y X8R#O (P;T$&) :UK S)4^
M;_YE#N1>M@"YO;NY_=;I71I7G2\]T^A>GQM_L4;CST;OQY=>]Z+;N=,1?O+Z
M%N<WU[V;J^Y%Y_X27''^+\(JNOEJW-Q>WG7NN_P'X*?G_DUN[K]=WAGG-]]O
M[RZ_75[WNO^XA$.Y^7YI'%_=]'H?<O\&QXYG1(_^A-_##DV#_1HP;MJ,64#E
M&88U@AF^X>P7&5G! Q>E:"^5"=P'.5ZI*#2G^.NXUCADG^0?GVTG'+O6RR?'
MPT7A19_%S81> [&<LJ9PV^CK6&)#-Q9(;1')$D\67Y?X5Q^G/V\T2ZU:._.K
M<JF2^?FL6U7JI59YM5O-_KQ>;FQG4;52O3[_5@NB?W,#S.VIGV4XGD38;^-D
M+29WFEKB!YS<F?'"K" T&%=IMI%P(3;9%"TVL*P3D?/MNF #-NIS85"KF$:U
M7*TM@V:T,4K@GFY>]5W!C=[:R*<J>!QT&69.5ULE[5$Z31!"SL)>2^[&\G&O
M-7;@G6);2[[Z*L&MRJ(R;:2IKX$_RIK.>/EKX$Y@6V">+O]_&\LH5HQWP8".
MNEEK;:O]:H6#?*?,<<&,!3-F,F/Y_;D1RLBK5;-1?XW1#:_ CCN=55^2AL[]
M$(=,B5'6>U-2^O;Z#';R9OB[[]N8K&'!DS-@8<]WEP1YT1@%1IRT3*Z^<E(=
M>,"5I>\@BK=(2%"[7S';[4/M6WL/4O@]\,/0& ?^T%EO$/66++4=9Y+Y/(*;
M?(M[O#)3M EEJ+:MH>WY=PH*LMN6;-Z [DZAX+]L-DYWQ!G=!NS_,@;!$M<O
M^::;HJN_U?(.00O&@VW9KS'SN-/X:2T _3T?_/#.#3-+'N:%8SUXW"IU!NHT
M"S]Q7=,%M <+0P0&^LI6'WEU"J!29KNV\2C"PCG,(_$L,$ VIAY DZJ:F,3*
M!?GL1^?ALKXA\[A:=!'MP[)'CN>$$55E[0M4WSNX@K2G'<_N:#OZQ"Y)4ZW,
M(+6CLUK=/"UO:]3KCOE_^TY,BQR\+5-3':FIUMHXE%M :*Q3MA R*Q@\HKRU
MV1-S_3'4CA?&Z_I)>]I1SA\7\7ZNRQR B676"T#I_:2DA1GGN:0T32V-H[/&
MZ9Z9K;D6GP24X4]%<HJLQBM)5Q4T$URPNG?7Y.9&TVQMSB9%;F/_B&^!0-Z<
M^EI'9_6F63[=D<S:(=3W' ,,U0?#04@J8QCX(RG0?6^C(.[^\=)*^')3DGP&
MOIQBJA@4;&6V:A^=52MFH[() N/JI[8#%O3^T>"KR//U2:]1YJ17,T_;VZI$
MVX&<]98RAJ^5LWZGY1V"KNQ"YQ$+(Z$M,YM="@=_66=&[B9)'T3)S)(PE:.S
M9A$ VDOZ6*"?EB002%@>[."%=Q6#(MYS8*G)S=R ;!)?,T#>J$& O-J<MKX*
M[/X=IYLE9>/L<'BCSA5G8[J6=%=!^7,M$L\?+>^!<;O0&%J.F 0,75..]\0/
M"?(61L@&DP"AV@J3<>U2#LOQP$V]\;IJ8U,^Z]P!\(W3K0V +RS*W1";,\)N
M,RAIFF(:($7??W;#(=B5:.$+W_K ;,IMY@AA%Z]]ST]&]^88"C 4?GH\25',
MM@>DLB@"O(!6EE>LK:TIUL+JW$[NSN@S?GQ,?AM9OS:S/'=CC,1[IO+B-(I$
MR7"\"=^8&W4F7_!(Z'?W<""7OZ+ XAOK>%;PTHW8*.3<"$\/?-=%?B0W;^7
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M>)[IP5<W3#1\HLZGLYOE57<V,:H-FWCI^)?KW;\*/E%!S,F8@EZ.9EI;;[S
M\5.*>/VCJA*W;Q&;VYY;;LQ_^H5_95OCS!GA3*=7P!D<%3?G7[08?WF&1@1O
M$[<SOBWCW=ZKTWGI;$;B5>-E7O6=\5$O[(9%]Y[#N-C[SISP+J"WB ;#V[&R
M7JMQWFOV!W7IS620T; *<SKF=,SI'-WIO'!NY(M*V7:]I.QA1P()F[ZRA$*
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M&I?IDU78;YB$&,-+/H?1QS =)Y/4E[ N0_YAX[P^T5:CJ3XSPUR1+K4MTHP
M:09%G_J^-OS>#XZ)XBQ(PFA!"BFW^",&+[M_FL6_OUI#53JH@NB_)$"_<WAN
MHW6>&:USW_"G6B;Z&"H54&;8 O99%+E&WWQ6FSYBKB>*-H2?M&FY'FB?B?4
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MY.+>]GR$_.<P0M+;@<8P MALETRO,KW^#@#CMF#A+X=R'>R:WNZT:H)R1Z^
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M8[\*+,M5#2O07>.G+N]]S9591JX<FFD0%YLV&J/U8$7I>DGZ:3;WPP5C'UC
M)AX-BJVF!TJO3T._=^]):3P[ADA>6]]\(I6LK3WMU75PW('H2^ODYI76S#C7
MSH)B'2X;)X@@L.X83L,X?HS)^F0Y.X_FTW<2W52_!L*USV'T$3#M4B':UB)V
MB$E.O=V#)\999"BO7CNO0GAO1WI%ZAHUS@=[0EO'8_%B^7\:1 P6]#>8MWX8
MQTWAX*!&#FCPSNSH)TMH.$',G#0J[0%0C:_I$'G)]@ X(%ZRAI4 ZOU0F/<%
M$.]WVQ/C@@CUKH(_%.(A=[E1N+>U8*?95OU.55D1]1#L.UC6AAB/DAC7"?:7
MH\9^BYK^GU7ER:J9*K"W1CR?T6F%XP1.GKNZF:@H)C,^@(_Q8 >S?&IJ$(YA
M[>2G*0[4,+:%L2VV[XZ,K[V>_(CYP-AK@8I7@2QM!T.#]YYA7Q #OWCVV/.]
M9+$U#VIC3Z31[D6ZQM0WY%BOG5?::;H:>ESKM^]7/BNK9@K!WOH&=*^^&ISU
MX"53P"ER!("2L)35N74@_'CYSE%;(AMY&,5,J!A'BOR0&/=-(1RVOB_C)]W&
M>?>LJI8(]1#LQM0W!/8</OR-*&QS25[Y(+::2?*]->TO];%L.'F8F_<V*G66
M[?R5>K%'.&6L>&,V[&S%4Q;E%6%9>VO#G*>Y[4F<T!CFAL)>Q3!?36+K)71U
M.7(O9VO_1C$'^-/U[L__!_XC%S6SHSLOX&T[6E3=P=<^CGY334@>>TA?C,.P
M#.;EL:/3PL(#QD 28]*Y'2RPFH"*)*TD1,R@?B0X8E%6&]B^A>-4J5!AY5;%
M^WM]6, \Y!+^782S&KU[]O[!<Y,IK X_KC_%H?^NE3UBC^'[:;+ZD1K L-V'
M-0W;>5CH_\7E(A5X9[V6XXS:9ZV!X_0<=S(>MR?=\; W& Y&(V?D_M^S84,^
M-%5%1'/[CIV,(V;_/+$GL,-WMO]@+V)$4AVY +-TJ"\#;"58)I-G PO'<& F
M842AFG= Q"S"NV!-=FW68DTC9'W_\?CYP/'<4C)*.+$ND6N" ?,_O]E%DE_+
M#U[\XF;/;XBC@%*-[9C;O],X\2:+ER^K(NZ&EJ35MDCVM-];0A1^36?P.J>H
M7>:%W75T9P?>WX0QEXH9PC\N C!668S%6OC/Z\EGR1UO)'.,/ZH:KEOXQ >?
M)GM)<3CD<M<+0(Y>).(W7  #T3E'SA:E0";Z JCFZT,:PQ;C6 I1L9&EXX1K
MXNVBB,C5OE#RW4YCR\/D/WE 0T'RKCM0(O"E9=>W*/R&\].L+R JFM95X)Q:
M;_"L.ZWW\AK]L_V^:8G?'PJ_I/'R+V$:B9^L,**Z*W'ADHM)<?$MF+26C=._
M,/EPXHGB+;@!GK%Q,M@$+L =$<6R<<0XB^X]A\6BK@O%[1T+PIGG@,3EM7U-
M>)]]%X3P#T?^1F>/!X<ZDP5@2R?PES2"2Z?6GR"_(_B_'X>@D#DT0 <.W8?O
M!#%_(;MG?CC/7C2;X=1S3+G@ A\N6VZ4WL7X<9;8T<**53TB_(B[0AV,MQO-
MUA>?/D7=J1D2_0!Z\"T<) U*#FJNU"S5ZK0ZK2:=O3ATZ\&.+1;<@4#&\ .H
MR!$L1A;F(3NP(V>JH(V@:VIGQ1"VV -OG")1-D5VHSR4V.:"!<X"M-HI W4W
M18W&>M.XOKULO"5M#*G=FC+;3Z8.GOD\"MW42>2Q%$Y.+NX':/RP:&).\:FU
MG60I4;;*3K!S=BK&D[RT!M:AYA_6M9.$8U9V<(B^/D,(X*^ZVPD ;ON^;)(K
M'%0(S#!-0,\-B$)%10F6F-AS+R$5&/U97 V8I(Z7QM8WW_[;MOY@+MH3R(]0
MT\#HU&48S3.N=/GM#\D\FM;#U'.F5OB 22^VM=),B_^:),MV6G>HVVFM9<EU
M 0KC]>0[8,HG4M>!&<[!UMDP7:&5":I1X[Q7ZA6QXK]21,%)&"8*H?237^E;
M?2F4N(2?E@_C:H;#QH@XK OXK\O)1)W.EZL+>3ROU4T2EXX&602HA"CK9ZL'
M'8)L,:#J:Q^4@<AS[X"MX$?_%P0-6U"ZE#V'/?Z" TT8L*=_;&/]=T?KK7^I
M?@!AC4'CD7J1![HT_>,6!%T,,B_:V $WR% -._V>]HN(!O#UB6$B78X9:$1<
ML")I7E[_Z^KC2?ML66:"-)T"[MT!=:41T%GH^XL33FAQ.H8%>\ IFY;2'SYF
M(DVJ$8VRBPV<K&-]9 Z;259S:EV@Y%W^&:B;894V+!KE,:Q"6Z)0 ZRQ@"</
M;M, AM3SW1/@/L2:,.T]#-PF($%T!R]&_%R!&_#]W^T(.+%UZ24+CA3_)XQ^
MGEK7<W$Z,>\+#CH+?ZT%@HF2)KA&$#@<M?X71!;*$=A%^[2>I/TGXRA ?',<
MA3;\&47V@EBR1 ER.*!*)OF =@"(2E*W*M')YJ&_ %&+A^],;8 )L%-./4J[
MO/RNE$#Y(B0^]77\PE4P\5,6@%RXX-J[PLIRQ /]XH&!.((_(Y T*(D2#_1#
M>AC_/@[=Q6_>;(8TO"C];OF!O=2Y?$P9.HX0D7$Z$JC$#BP;68H:1N6R&=\-
MMJWW9N,4^!:QXX@4,-C*$JTL'1/1U=2^1XT+=!\ITV>H+?%1O*N>C+E2_L#D
MP$E8(R:9T&HY04QM?X(O =3OGEI?PX#!19\(E"O9U'X!T0YV*=]B!VK:EFO=
MASXH::3(K=V&Y94N%6@SPN[^^ F7 ].F_%>%5\ :R!M$>C_!01ET>'<\]>8Z
M$G+\^>D!1R27!ZZ6_?+XUY1% 0_B<L%V2$+ ^U/ 7 L]J%Q1A5,C9RO>-@-J
MP%PL85X0U5@.J!;X&ZD:] O7; !H(3$??FI."H(A2$ HP8\H'  8H.WF*9-S
M;R"WJ84*1K+T65HF>FW)V@+^1Q]-8RX=\A_Q8:_PK M0"0FS\*3A3]#4&?EQ
M)BGJY44;YB#4X8OT#I9%7#RO#9/^BPCVE8U3W[9^%P;HDOW,KV;*JHTVSSU7
M*K@DA5.,PP".3YFPPOIM;BE]OT6@%6#U'M>?83=\*6*!W*B-T:A57XJ!2ACO
M?I,P9QH 7.\\AFA BXC8%(U?H(X9D'#(6]_:L-8%6;QP0  !_C9&=6>2\R.@
MX&?&32H'MC$+8[R)\Z[PUP(,N#!('9^A&'$\]^/7BU/K%AYS[<3.DM@G\*1<
MKKY:8(B@Q%ADI0-R GN96SBO&!$(OC&%\T:A!:8BT5PL1!4BE4,;I"?FJ $
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M-$#4/$"M8'?</ )U4&B@<!NH?@M@B!'*(I^E/]G,LRUX),V<!=^NE"L'%*R
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MW":I[Y^H0RJ&Q<C,=:6]@E8BHB9'([A&GC7N-5*!.>RQ^?L?P"%""KER#U$
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MY4&_47QBF4I+QLP-2\;,[2F59A"P,A <AJ3DJ:U9A3X&7'41B0(IVSUYNLA
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ME>$E'QF>X3'=OS3U6XSE)3&1S:S,[8(V(;BT$"UCOM[2T9V.F/H*OY9-\60
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M8MYLG$8Q[Y.'[I/(8T3FLBTDVNOPQCNDGX#;LK TQQ,=MC3XR.9WO#6(&![
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MU,\:Y^UF;S@RY&7(Z\C(:V=7WUK1-6P9T65HZTAIJ_<";O1A>U]$UZ[I8/M
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M1,*8%5=P:I5NZ4$;.<QGK60) [R+,_9\SI9.(YW&2)\QW!1//!R*>Y'P,8!
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MO0/MC-KW*!U83"N2KRT3C$@9@@.A V,;7.:3M242K\4XVX_#@@FO:-?ZT/E
M?PND*0BF"Y!C+ 8IX:(9$)X.IUC ""?@$I1FAX)56^B&S16T">"GV+=@$ND\
M&XK[QGNKE'%2X6@$UYCF(L]L(%;@JW<1R[@RV7\41<(IBVGD3'$6,8D&LNO>
M>/!&CU3!B''Q4'B1X.6TMCG.>0=Y .P3I\SGWY@YP(B#T+?SBFW>JO."^Q!>
MZDKG&WY0[%>"D3ZB.!:]D1O&0GW&/;H,IY9KRK10GP\!I7(V99EQ =M.':F
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M@+5FZ'L0"=E;K;[_DJOOX.J+76[DZIOD?@'Y"4:2O^"1O #09$T2*:H+$:D
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MIM3L3.K)>ZZ?,2FVU+RX($F[&-VBWBJE\<C"95@"KC?I :\J>U]]P-&J4C@
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MV9U%%R1?B=OO5A0(PY*9?:/J.EM^>!'?L\47J_M#4U @XW3KS;?@G4W8 &_
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M%I5\F))SJ"6+-T.(!GR3;VO+J.*8FMQH\7P967OI^IOYRP5A)!;&FOFNI&M
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MN0+A>O"G]B:\[LPS]T%I,G!LZ/,HSE.\[#:%XI4M0%$=6*X%^"1XA0_Y?C:
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MG>V@_,8/)IHZ76D_V?+JW\PR4S3Q1.[,J0-)>=^$/N[=4<9:Z( "=V!X/'=
ML&&!5U">1Y5SYM']C$3SN+/?Z[=!?O*.I:XPOS1(>O,XH[(!'34RPI\,FA?A
MMY#-EP+9'),*I4%1_61XL*B^<7CJEZN^LV+Y^KK@#AK+C]I8OHWEJ[LBX]>+
MY9,.R+@S'TR2->^G'PN=';/U<\>_YIKY\;',?+EH/6GM)]B3)>]M[1O(AN<6
MDA=8[G$)YMJQ]<_C+6%M:K3CT\B@UXO%OO?MN%>WNILE/UTXNC<G8,H]N4@U
MYC,J6TYHT02.YD&!Z&H.BLZ3U6JWXWDFUQ/L).\$)GC:SZCP?P4HP^.'U2=E
M@O?.BI]@C%F<%2\U8C2+%.>55BEOOR:-S(I/Y<Y\.D@VRM8-"U\/5YQ;5KS:
MYD]4('+-;#J>20.RXE-$MY)[<EWYFM=/B]<40I^7_BX,KAN=%I\.#I 6/^5P
MF@-+"! 1'[ZHO<2OS5VI2S-S --K8^FCJICXIQ#F5+;+,JS192E]RNT5?WO%
M_[JY_Y#(^$)2V:L9U>35-.VROYH 7ZX!*'>94,)#P2Y!S^RF<68)YV5<TGDY
MTRD7(6@6#_>K&CA+/C3+M:Z;"T2E2E<]GSB^5560%O +4J&8HR MYHKC HBQ
M&(O0>WU@K64NR 5_G@\,' $\>8:W!%2C$0>/CQ9[%/AX42"4LX0WFT[+P)L!
M+2R_R[?P/ AMC,\K"</I<#0.C@/)1Z;XR!R$/J=*SUY[L<JUA3<QI1"O[VCD
MY9 EMZ8E_H3?*X'@-\4[G@ 8/X;*70;=#1]4#*TE*^#1-G+<2WH_.2$=3R6J
M[9??5SSD>S@H]'R,)<TTN(?CLIBC6=P)8@9;:8[]4;,7NFF[5@I RZS/I18H
M#4S@B+_ABZ*P+1_A28CK1S9+>W")V>F^.]/BY&"%\5><@;5!?># _]FD>>\M
M\YZ FK^H#W97^FPL>M*P+[_Y\ZWT77T"^><B_\T_(:)@%Z1^*<B[")-W"Q\2
MMJ^&5]M"G.V(]B9\Y. G!!]-N(OX4X22B4Q'4C?@D3D^E+QX(O]R]#&XS+!>
M*_]27*]GA>Q<,Q3@X1#D4IW66G!KF%F1TD(E6B@0*":FH5HOX2]=$X%23,1,
MQMNK))J:Y%D'W$NU'?2/O04E?PM=L%DV9@^T)X1HKE,A3VI1R)DYU*-JZMF.
MFAJ4@;EA/]2?N=IXD**-!TEMS!\FP=-8L?XMO\8 W0LEW33HVFOEKUPXN<*L
M9"!^S88)Q*\L&T ;2]FN<LJ68>%3SM.SX#\_:6BEI3</G'1ON5;GA^C@(78]
MP-P( "ZXC0[9"7J6"9Z@*M0SZ$O5%HAD=A1/[+2 PV;CWE2>5L4-&X]Z$V50
M#QK6J-?'!=0#T:6,ZEK48' XB*[9Z4$O4=;E-NE;5+F<*9N[VB5%U4!J[51G
MLG?B[TR)IUS<+> --\R8M;CS+4][]Y>1VF];Z>H@Y"44!-[PP0=UE(2=ZC&W
M;2J'E8J<4N:XW]\X\;AEH-M4?9^R[3,M!3B3"__\5%ZBDE>H2\$6B2Q$2D7+
M;-293R99DP].L!^@Y?VSY?W^GLQ?YJ(S)!E8(]#M#YO2*U.3NW<:ANT[)O-:
MA($][0!1\=I8?C$7):W!I#-7IEDC&T^Y0;MEF9+JLXAG*BK1:6<^Z(Z&3>GY
MWS<Z:$MQVU+<?31RQO5@9;&:D6\R.KM:VE;.6CFKQ8S5(VC3?K\S'W9'T^8C
MU%U"-OBCF/G6IH/;='";#BZ=#BX5!)TNR$HVGD\9-\V&]<._I504DJH1)*W+
MG.!@]NYP-&O!>YK/5W5Z)679*<DQ2F?>F/1\FX(\\WS2055I)+-4ET)%%(+N
M6$YVA957J&VVLI'<E="HM;!7DH.&G;DB[X.FUZ8FVY1)PV6IHBC5I9RQMJ#;
MGR3ODRI[NVV"LB%\UTI;_9:K@K'"FH3!M,GR= EYR,^A9B1I99D;KS$+Z[_-
MS/KO(A*(0Q$=00,@_M)TL;^(#N8RM4B=I#DG'5-2Q=1ER2>=^;C;E_?1/#6>
MY"N%9ZW\MO)[G'1A76*+(P^ZPV$69LZIR&X&%%.TQSX'G$F<TQ";;+>F32 L
M[PAT1GMBHK=6#%X)_4ILLQ_\1'V 3;E.]D\2;7JOP(LC6-,L@ [GU K]<VT%
M+9Z/[.K!8NJ?5^H*%OM.U9_5%QLI'NZ#UHRK, 'C>\_<X6IUL!URW@'&-[FK
M]<[%X2+X+5B3VIBU2&L+Y?T_BF$?P+X21 "VKF,O(;:Q_]>O:@R?P*?V_+\>
MK%\;\&$^; T')]@15.'3:L7A-7Q=^$UU&*(H&0M-U^A-Z:@*T_XL@:IPD@@)
MUX0T%FS7PTA I /7,:T7:<6ODT+H"#ZF5@"?( !GF$=0^IIFGPDF BBB7I\K
MHTJ@"./>;)#^467\@6%O/)K4!8K0']>UJ%$_?U$E 0!.P1\M72=S6GWU)7$(
M2M;XG-S>+P]&X+NOV='825>>@M\GO=<;19SQ<P\X=Z! L^/*P^:%H@Y51MQY
M[375^?P9<<JJAJ4R%=5.IC7GL0N.^00NAUI1/6U1/4@*Z%4D5$8)A?\Y0-G[
M <3T$NZ<J+S%P[\S& &3>N&?"/7:8K6#&<;TXB(<7E)1L'"T4U<>)/M)VGJU
MQC'8$=1Y;7PU@(@)7*ID8?EI]MDV7"-3OND;LYEJ+=;2_U(WV_=P^D],-[>$
M5(T9MH7%ECOJY-.MF=]/)Y<2&?C##9'6]@X@31Z&G?E@U,Y(/CN6V4W-IO%,
M106+TXNZ2A/&;E^"MWO/X' 0&%I::JL5LYBQ8!QHW\31#1?FZ1Y>J=Z:%KS0
MB 2-'P7E'2U=(L:=^2BE<+[%BFDF$QVFAK5&?L(:LWXRXW!RC1BGH%]+5K!*
M#PS,)).>5%W<[:MX8:R"-M['L=TWYWGJPE4@6S0'+Q0,WL+Y! #3 ;[T!SJ<
M?WAG<^T=367?!D=Z=2?C?63O9/+QE\VG=?C:1V?/&;'G;._<1IN,K@V6>XVS
M8W$,2UV6X5+\JOW<*D[WSX;7.01?N+9MYMAI4I80)*7?F2NCR>M[6*VSWBAG
MO1)75=/=BHQID\%HGQ;0UJW?P:U/UH&V-4276YC0Y-XR1=F_M^QDHH]6Z"Y'
MZ!K8$*8,:FH(:T.INKB$IHC7VHC7C_7B79@>.02)FJUH&FW=A\?I'*]XHJ?8
M0=[*]87)=1,=B-$1.\J/(-,9G>7A/O(=^U<3R12L\M/4!TW7'(W9&:VKRO@\
M6E=QN#=E(:CI-#3=&_C*>J&I\ J>TV9K6OB'4)4'?2:_EQZ8\\P8SS##PK 5
M%EAA2=/ 5:(HU8/H 4WIHY5FJ,9"4W7X!3S<P0O-K6MM35L4D(CGN0[\ZM_B
M>1NFXHQYJMW3#$E=X+LPWR4]:\Z:=J*KS[;TJ#WA\RS-9MA6:[H6"!T_9_J2
MMZZSF3B^:W?MI#<=S.IJ9)WVJSWJ"-VU@]YPF/^HR^FN/:,!Z=(N$]+/X C/
M?R1Y.\^]G>=>05Z^8H,5KV0 >Z^;-O<=P#'3'' MZ \+U;)>P'MX5JW$1)(V
MS]OF>=/"M&&Y,0%^T'#G\> 7X+B;$,-5[A!2)ABYC8<G4D73WK6T,G@@&1R]
MG@Q.J1I"V7O :GO]4A?C?,-_Q_2$:S,>OK?E:W68KU"JZPM3;2#*M65AF1'F
M6*H+#LV['(X;4$;4UJ[5RE'EE7&]'#7H<XY*3E!M"],.P!-W.W?MG6YCZT'C
M J1G99XG5)=98\:)M;W1K^K6[L1""N),C*=U>;"MBUJBV<)+.H'58Y+Y "M*
MGR]QYGY%#?J46I<2DB (C%X%NPO(6UDV!EE.:ML2??H<E:%>#\M1PRPGM47U
M.11/?&1;"PZ$#NS"'-8Z4@%Q>0A%;6'*IC$[EA9-VLG(Y\8H)15G!489=^:3
M_CX37UOGL_117V^PANK?NZO#T_4.#JP.PY2M[!A,^-CC9"3?YD-/FX^J:\N]
M^&A*L)']!L"17H)O^>-282$/F0KUL?UB5[-)9I^E8T*VR<_39YJJR<\LI@FK
MSY7VDRVO_LTL,X69AGTLJIPJLO*^(0QU"=[H/UJTF4.JTE(H,D.Y,Q^-6Q29
M<V.6JBJT'+,HG?DTI=ZI=2^/U4I>Q4DX>/MI\T3DD.HT%*1]995;+8>#SGS2
M'<C)V&RO8L'&MT_7B]UX2;Q\^,*K-#8==N;*7AJ^(?Q9HA7X9%MQ;\P-O/F%
MFF@?#?BQ'6E736FCQ<:XE>NX%N_C!=ZQV5\NAV&GR=G8\6I&T-F]AEWZJ=^%
MB\-J>6,M]<M@.XVZ@>/G3<'LIV93BTW&4O"_X7F:!2^UMZ'YM0^JC8.0\'-<
MKI'LUPFWY]@]Z7?54'FMH,0X:"6C1Z<V\.(CD5; +'PM+Y)KTS*)$K!F?(ZZ
MW5JFNEC#8U2'?P ,:M-3O>GBD@:47U"%L<$>^9]PT7RF./P'>X(? ?VZ.,17
M=Y&%I36\P+202R5XPTISO$70+RWS7VS!X9EQ!A0_)(O!6FT09FJU3NNKYK3R
MCY3:B/G<X)X4YA$-#_@O5[/X"3,;14*SU[#W%+!/(E4:";65M E(OF0.LS;
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M+>*6F"X$@J;MV#WISH#UO$B\]4#NYBU0>L9V>9MHO90>7L2) #6^NM:+*GU
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MI-Z-B#=N3CP)E:V3[=/9FL.2FFF4Y]%])3?P;O4=?FJG&-YIOS-/SL"2\$U
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MQ5.-J[(!73JP2.Q\XM;R-_[N;_3J;_"&S^+%N;@BL[[<F2N]2;(/_A>RZ 2
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M'+$K E/=VNR=]R_OEYJ]U=67=YI!.Z8?O1?/%Q$?1CE/J.B [<1;Z(7\XR
MZO5Y$.18\']+[\WBXQY\]&OR[Y-^;S0>IW[4[\FI?\]ZE*ST9K/TC[(>E?WW
M8;^V18T&T]Q'_4KTXC2#8\$C)S_.CTJ7V*#PKB_)P/J_1K\V2WQ-V?[$+[Y/
MA-[Q(^2G=WR4/WD8JH#['^KF_81*R6=V9[D?38*O":8G,=DZ$EDZ"3?W_K2H
ME5#7$5KMNO<+)9Y2A=&2]0/@^['5*H\&.ELE].6K4N N>GMNORO#/ED;WY^O
MBDBZZ^\KK*SRJ8NJD=BI2_2__<8<?]()3CE^JF&+<T"5C?>E9C%]^J[_<Z\M
MAK=&E0J-VEN- 4FTK@"]>#^\& 0>_*PSGXVRYH#M0VA/B$H3O():B+TNK%9:
M=C];=B\8K%B*WQ4<XY32Y_PZ_%Z3BW(:QNH?$%-3W+J#K2KM!YRC6%?;_!D)
M?+Z\>_R4*^YR+>:MT@D<TO#E^-.M[+2R4]Y8EA(>I19;>7#AJ2GD:PC'9V35
M(MGDW<+\'*_Y57]_45[09^^::G<OZ*3T-=T;5-;7IZ&5^9W(8:X0/3[QIWLE
MU3/V.XYF-:GG$_!@CL+WN>-$3Y+;:]A1G9Y'+I.'[\:I".+JW\PR4Z[%E6%G
M3DA)RON&"$#)>ZV3,E:1(@M15Y'I>BBI>TT5U(O1XKF%($F-/J):CVH,?1C%
MG>OD'?ND&ZS!2E?ZY&NS\8[:K$D)2$5IN#;[82*<2[26+D.IM<F4-IE2J/ )
MNB2L#'@>I4Q]7TCG3SISN=N7Z_+CVQQE0QBL%:M=[6P)N4JQIB&1FM8=&QP\
M=QEKWY-'5 I;5X7< !:V-%V\>ZM2SG. %]%V?Z5*U).N/K_#<OU(07"LVCR.
M&RVJ@*D[ >=M$E:]]&:)M;J6P-<2+3275",\GO0&TV$]Y;C#WG@T:5J-\+#7
M'PW:&N'B&F&I+1)NBX3;(N'#5HDN5'N-0Q*>;3[K .Q-#'_+;B/A2W/9WQRL
MYM3KNT[ST6>=^720#'K?-L<U;^/=5GAJ%IY*%:PYTC/H=^:32;)OOT'24S[2
M:T@$,YOU1L/1#@',>%8MZLB)%2;*K+8 )K\SL?2B!KUQ01/GON57^]81G:8;
M6LJ';TG7>O!( 0_=Y4KE\"Z2Q3:J9@2-7X2D0<DF^7W"I:?><YI"D[ /]3;A
M>34-C;_R#Z>JTZ$0AOFV.0:W\\T[#A\E)1T;!0\A,.)R!'S'0T79YX@.WV=Y
M1D=< ,1;RQ$3S.0H]XBKU0TU54U1ZK>:FDH!R"BMI,Z0'1,:)P?>:S=F''3F
M@P!UOX*^J7A?U/2S(%[E%X%?KROEG<_3F5@*L#B.4Y?E192H^]N]<K=1_)%_
MD9V.U1=!J*_F/)3$ZAL,.W,9+]F:4._Z.F?RR\%\HY:'XW,*#L/#HY:'+\;Y
M2S<K4:_OPHK)=[$=^Z.\#L88:%;M@CXMV2*ZE[$/Y^C+?KV^)">V'Q[>(K!T
M:?C6&[GR_<<%7+.=T&7:[B.AJO1H5*W0'DPZ\U%WVC^C3LN:M$+S."A-$^YW
M"7GD71 <+2BR$AC3X2EZ" 1M816=NEBX&X%%OPQW[]4Y@*U21U2PH'U@D ?3
M$C#(JZ11Z$DIEL*6</ZN3S.$4=<,*7+4F$&[TGY>K;7EDAGO< 6SSAS'^ *W
MOQ# KX\YWI4,YC7Q>RCF\?K?,KC<\;%JB41=.PHF?Q3,J!T%TX"U7,XHF"I
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MW:;(LL3^B"%:;&RC>P_7LVRP48#UF\1BI<]6*"*TZ 1^?$6F2=_E/@LF_*S
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MY3M\N3V2NR_<O):NB!?OAC2DYY0?@M3,_$[,7@&EG;ENL=S1A8K^CI;^=E:
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MCM =:)WK,/3M?A1RK4+FUS#KR9C@P]>^;[BO]+T@EP.I4Y@#J81%U-NY#TX
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M&W%J9T(6<T A';2%?7IGS T3&Z)V J+Z#Q LAN^C/$+9 1L09E]J5B.OO0,
MNR#SY!^Y!.&B6X; \#.\&VNUU+HT4 C!U7!!.(47WT@*:@WC2FM=LG?T5:UE
M\=_>8;4@O&<NVH5VHAVDMX\.OO3A$C0,HC$ZAP,Y!9H4 @IG8>@3T29]G.)0
MK:90SR-%#G#VV0^;O:GTEOV@.L[BY*69M($U;XM/B99H(,-\.(\9['!DIP:8
MZCZ-?W; $G<6WM'Q*>R_Q=<2:VG?B+GA)=+T"?1$"%U>>43_46*T\B?Q DZ
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M*A4'W:LB7A4GV$WQ+XYR@,..I0P-5,D5C$S[B/FB58K',7>-F-91Z@6?F6D
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MO&X>3S%]NX^ 9X[WMF:B2"61BY'(?V!TRJ);E"X&XMJ(F8HI+ ^!2J15 A*
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MLKH$G6]2+8(K5K: E4E2RZ29:4Z30)9WS^(D.05F288;(VQ7.U&$U1<BK.!
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MW7KG/?O9E%;1E^EVLE.4MRZUQ4;05/E6; -1B_FUO!-<$-9/GOZT>B7QSHL
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M>45K)B4J_6_?LR;POV$X<C[]?U!+ P04    " !FFWQ8*O K#_<6  #L"P$
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MT;A5@/45P/R8\EIU;)5@\TJ@S]>]\FYJ>\Y:P,MI)PPR@W?>0R@G05HU)F[
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M^GU3+:&ETU(\OL!Y>)S24%X=?\1!];!<;K".S@IU_DK!\0Z4JQ[?5=<TJY[
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M DV>'"35=&A%[VWOM,*AQC(F\V@H*HZ"!_V*6BX88;L_,UU-*)/22!J48@>
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M,<YP$]*IA\[50];-L"8^"B%=8&-)JU:SRTE(HD2P0E3G*U4M^M\WNHZ@3\^
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M/6SR[W!.0L'\2YB.R?B8W6CZ4H9I.!\PYUE(B9.O(CPHB[1J(P24*'RTVHC
M6QM]VU&=#"\:*Z 'A^##%,/L8OIU(8#E#K;<O+3+7"5#UJG+DLZG.M4NZ@(R
MR4!'6!)1M$Z";L)R,G1H(NP><@W7:+FH\2-HGZ9X5F=<?,9E?N3U9%:S(F_*
MA_!EX)WG3 0%3%@+BAE-[@M]6[*A_8X9)V+S!/E^$$^&,GVJIH?$Q)J(![->
M>9EB/?2(X,IX\$X%X%J)Q RJV/R$>0SAII[XT%' &Q,-__'S+<F0 _S/YF,
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M1QS4X#@H7YM5ZB( F2'9*&-2<X=W-V0G1H\F"NBG\_\=$K^:S2Z(P#Y$[VU
M0!4\J%)*[5IF #7/@>RE3(?M 7:,)9H3H\.#!=U[B<H2V9N+^6P>QK4+.<$+
M*N0LP(C*4$-?1:4T%!:D#=EJIUI/ =@"Z23)\%"1]U2]>%EA<>=8\]$A*]Z
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M9L(^PN[W.M4J0RNU1"4-P8@&%)G5X"SM?]H&Q11GQJ0>'<QC9;X;*&>S8_D
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M,)V&\7S@'1-)J0C&U5E;F3'R+(T#;7@=]BI#"K=Z1&^XLK_/4T^3%/T*?TV
M\<%QZ,U(__@T&=_!^>R\WD(?H CDULD"S#('2G"2B?,67,0B$8.SN%MWAWV?
M_+W1I942UE"F35!ZDT^W^.&;3PM+?+6 3'NAL=+EN@V&>L6L5):'4+NB<I.S
MX,JVK[O>%^5I<NQ 6EM#M 8=K__OQ6PY<N'#9$/]T.6K<7G%N7"#.B8.97%'
MB5L)053_SZ2H9<(42NN[Y'N#/&V:]:NS-2SK',^^AO@=+LI//DP^A"]UV&25
M$+TI))?%:_*\N@"UO@''L\7DTH&E-\1R<AFM]1Y4O3_KE?; BW4L2F=T:5WP
MT0'N=\.\7O6XAH.=0]F;"I[^&)/81O66]G\OE_ WDGIM$/QF?!6'?S8=SNA'
MUW?UJ_[!9%QBG4V1F<^TC\L(H<XY+,Y&(H#1,;=.M_2UEM-F[Z-@P!IJ=V]&
MOL.!L'@KX^VW\ATN@[KX'J>?APF7"WN':?)QJ?EE!,8FPSSZ"!D%G1\LI)J:
M3X#.DO\=T?CFR9V^UW3:5']4C%A#^<X9 'KWKEJY#X+F9.&P EX7"\I'#BY@
M@:*3R-IA-KEUP<X- *=-IH?+>HWF.\?P[ZTE(R)&0B=!1PR@#"&,1%6@]1':
MF(+,K;,^NU?U-:E-<]PP\A<3%(YD1KG%T$7#0<@BN&9)B]2Z2^3&V_@M&PV\
MF7X,X^&_%GL0">_Y!9VV.)O]7OV8.1W5+^O5AM'L)K-VZS*PZT<W:#'PH%4T
MZB^P>MBU1.WK;V6_02AEDF>@"@MU@ *#4+("4>^&A9("UZV'%-Z'I_.+D<XP
M7XSP35GSE-GSK]>^6]ZRCM+H;,CO98RS6D>3P:GD@'EB"5?!1=T\K[<GQD/U
M+6C&DSOAKSZ5\EAZ'*Q9VN*F+L],N,7<ZA!KQV*7P!O:H2/]20=/Y@%;=\C9
M .5H?0UZ5?^DO1IZ*"9?!ZM^.<559^M= /;4_V KN./T0FBBRAWHT5T/1R&,
MLYIAE&2O<T4&G[ !Z/T($(6-//&@6&F=USD24;9T2C@.3_81?^O&_R_>_G9Y
M%Z]$1V>Q(:M?*%HC9O)K5!ULP)01+A@5LMUF!M_\R,.[K(UE/>DLJ#YZ'I S
M_J:\PS#Z95;OWKTE+P&GY+;)8%DTY'\[;6N>CQPXKZ4 X92(PMNH>.O;B9NP
M/ K-M[$XFXB[!QJL%OQB<AZ'XX4W6)O/#>G3%]]\F(;Q;-DVF ]\U*D4J4#*
M6M[&F810NT 5R0M37J%JWIQ['WPG1)?>U-)ZX__]HDKH37D]3'0X+@.TDXMQ
MG@V\8#9Q;X%A'5;IR#1W3!<P9$(7=*F@W:V0;.,C3D#?#678\*+A#52OQF?#
M.*1?G-59-Z2;R,")Q;"1VN/))-JP@K=*)!.="7NI].JS3TV7#Y3:QAMZ32.8
M[R_.S\/TZZ2\'WX<#\LPU7*RM!@M4U.&D]$P#;%)0/.!3VH0WVRQQD;ASM59
M_W94,8QSC4Q_NMGK('J>C< (EGD#BD4%T20'@I<2(TK.?>M8^794[4*?&Y]U
M&5Y!>J6,$Y!-TN07:0>N,$N8:U,0,HE,^X+ ';$=*M39F".; YX-57'L0.=L
M.A^\"^./N'"N&9DZP6.&7%(MA,WDC5F&4*PCOUHP9>-.F57ZU&L$HN^NR'/C
M@<</7K94Y:2K2!L:EM] K-K![0!CGT#D+AIN'WK8'F;L(/S;ZNL@N1X5F4+P
M/GH%3-:<MQ,%(D\9?'(9D_%9IYTR#\=6X(;P7WO][2.PQGK[C21U?G&^ZLO'
M4RC,D %LDJBS@>KU)9E!*Z>+Y8++T&)SO?'0P[D$G<0^:2&SAI&=!9#PY1H0
M98EPGKR7PEPBPX%%<,%FB)K<RJ*-%KA3PY=MRKO^T">HO ?+K(=D2RU=6P1Z
MGHU&DS_KA: 9'?#O<(;3SSC[0)^R3"@4I;6* 7(N"+2C9 @&.;"\: OCO72M
M6_GLANPDC:,>E=-#EZC[4:YRBSM@["G'NPN^XZ1Y^]#O7A3JH)R#[T676$N6
M3.3B(:(AYS3[1%_94!OW.LF2*K9Y3\OC$6A+^O>Q\&<?G31/"$_J]KL(K;TB
M=./Z!6W)YY-E*F,V7W5\5H(Q[1('K\A65DD'VHBY@IPD5\GK0/OT;OGB'9]X
M^$AS>V5-^I9T[P/F%V^ %58A*[5;+QEH"KDA;-F!U&2QU689(K5NHGT7Q4F;
M*AV%WD/#P)N(?@_GJY**77#U9(ILPG0<\Z.KSNZE0$>!]V!>;,3'>?*>*]J@
M<IU'S(2!X .'XI)$&9V6K+5)<5@B;#$C#L6#?>3<VDSX+4S_B?-PHY/DY7%E
MBJNI5C**!%;SR!0(T47@41BFZ2C#V[[M!L-@\S,.;PJT4<*DO03[J#!;9EMG
MOT_F.'L]">-J]?PZ'),!-!Q_?(<)AY\K[N=?K[[^9AS7PTU$6:.GC)C.E"9Y
MH .O34;T7@37NNEY%[PG;40<3)$]M(6]B>CR9=L%4T^FQCH\QS$S#J?5.Z-_
M&JFDE]%/:["1]Z4$MPY*JHGW.O(RTC$,LF[:67O+76LWY7 TV6*$/"Z6[*.)
MUJ;*'^,T&8TP+?I>?YB&C%<05R>NURSS&"*@E!X45P%BD $"SR(F;Q5/:B>;
M98>''=YXZ:Z228_R;&C!+/#]>C$:?;T,TN0-^'BPCKMH06?&R<)R 5S6&:RQ
MO*!2Q?+=@E<[/.RIZ[NU/'O8_3?:4,^_?MO3O'2>R22@J#K!RAHRU).S$'70
M23E'AE9KPW0'6"=M?[962P\-XS>O_NK-V05B3U;G#O".8X0V5^VNU.FHET-N
M/M<W7\6X42C!,44&E0F6#"K!0)-O7X3E,;G6$XB/1ITMANEC8,X^ZNCE1NYP
MT03L66W?L?SRU?FGZ>3SHKQV=:;:+%*)44,6Y7)8E6=DA ?DF46CG-7M;^7N
M .SP]DQSE=ZYM-5:'SU$Y7X+Z6PXQNG7ZP)890B5*]X)349V1E"QD*OFF 1O
M!.9"/[.\]?9R#YS3(T@KV?>PE]0[9Q=SG-Z&5:+B05@!VM4B!49_A&0YI*")
MKDZB-:UC'QN@G!X=6LB\A\*Q7R^F)-F+*2XB/5_J5ZN]*Z'+)3O"$U/M3\\]
M."XC"(M>&Z59*JTWB,UH3H\0C23?,&M?"V-IU?DBS=],+_LL+DPK)P/+6",S
MIHY<KDTMO) &DBQ%2\Z"W"T_LZ6F>-VS3]+7;2+HNXI_</?*:WAJQ/<2T:I8
M:1=0#6_D; 1R^/LYW75T5^&-!-SX LAF<)(+9A$5Z*PCN56,=J42/)#*1$""
M*?-.-L'CTOH]EWH.I/1]Y-HZN_$6I[/:=_=O.)Z<#]-L=3M^99W&S%*R"KBJ
MC0AJLPF7:7-C11H? Z$SM^XG;PATW_^<P]X:::2)23]B[*,BHS;8_18=*8:'
M>IV%<)0$RJLZ.2;4ZTJ*<^>]1=Z\Q.(Z@),\Q[N+^J[>NP\37#OGX%F=N_%Q
M&9MX_O7J=]Z&KXN"L[J"JV6,<Y72M8JE7=;44SB[C_4<J0CCX32Y?</_L>BX
MA^!$+VM3B$PB"V "+[1 \M$<&E;[<%DEBTV*M^XS_'1XNZTJY''3=A_5]D#7
M7\X_C29?$:_-T5I="<Y>,U[SYA'KC'0R+IPAI]X91*.L3EZT;O.R$<SAPR?'
MU_6D#T7U8*BMNDB]6=[L&7]\O^R4,AMDE51@6H,N6I'74<-+)7,PRH3$G8O:
M-I\?L0G,(PK O6[2):>-V%L7(JU0?<!9'6:U&&_R+\R$R>A<? TMQ@!*"T_.
MA"1GPF5Z(Y36*-U./MF&!YR,>IM)L:_FB;<PO</A>;R8TA[X_.M_OWO_[(_Q
M<#R[F-*6.)U\G(9S<C+K/;_P$0>TQ2'Z%" R+^O :4*?DJG7!E*]*J)II^K"
M@=VA?!=LZ4DS/21Q?L=YG3M-N.I :H+[!X%^-?ZVLSU+\^'GQ661 <M*.NTU
M\)!H;S-60XA<U@VN2(L)Q>TBQA8CB79$=S*TZEDQ/=S4K##K_ZL /H=1/0=K
MI.QL,IU_P.GYJ_%GO!S<-9 8?4E$\;2HVV1%@Q-!@^)1)%DDSZ[U8,'=T9T<
MA7I23 ^W;WZ9D=S^?(F?)K/A?!"<CD4I"5+6ING69O#UO$7,,4=O+8;6\U%O
M #@Y(CQ<O U+8!?G9;W7>&T"Y><P'-40:IVQ2@3]+<SK3[XN)_0-I$PQ%!\A
M2$Y+UHJ3RZ8MR&@=9]PP,L=V,EKV>>K)*+]?>3=,(:^_\_IJ/,<I[4_OPARO
MCR@=F!2]CE*"YJAKWV5/IE,09##Q%&2,))U^FT%L0G8RS.E1(3TD+;XU2R%2
MOYQ<Q'FY&*UNHUW='!E$)[DM,8-Q]9)S=AF<-0Z,1*>3<=+LUO9UGRS63LA.
MCC8]*.0N;=QA:/,/VA[Q32FS@8H\.4UVD9*L@!(E0Y2Q)O0]ZIRU=K+YP.#]
M('ZG1'J8BNXRRA^&4<M-\_:PVP'CV?J2!5@9,BAG. 1O,C!1ZWR%U@5;1_R[
MX/U.N=9 >6MB@YW3 (L@04W(K0$_\"F%7!-NV01&#IUVX&4FJTX9S;3&HF^'
M?UO<!=J(Y^28TTSX:YC1WV6Q/V9(.%\/"PZ<KNZ](HPU *"*8D!N@%V0.417
MO+2M@S([P#I%GC15Q1JZ=(X&KXD8O2.3?SI,<\SU!\M^A-?^XMIO#FQR(DNT
MH*VK7:<L.0*UG;GG*!QCQD7;NA%7)\ G1['#J6\-^9K$D7]]^>K%JV6JY-EY
MW4('!74)S"<RZFHI9$(%OG9ZR(5I(TH4D;<VC-8".4FR=!/W&A)TC@175-^R
M99>8I$>>8K!05+WG)+(&EYV 6"0YB9G\1-W:]5H#XR0)T$74:]3?N3_"L]D,
MYZ_./X7AM"[TQ5F8?D1:)@O(F*PS4%D=D< CA,4LU:1E'9%@9&E=@[<>R<F1
MH(' U_"@<RSXQ60\GX8T_\=P?O;B8C:?G./T]3#$X6@X_SJPSGAK. >#)=;0
MD0'OR58J2L@2,)-IW3R->!^@DV-%._&O(4?WB&_^3&LGGVO\\9<OM3X0!Y;\
M;$RF *\)"^63)S\K(4A'=C.+SDK3^L+I710G1X..@EZC^\YAVT7=9[RG-O2R
M-#3>+@VE!0R7,W$OTQ:6<7*I3 16W2S%2$11,@?99YM\5BR(UI1I!O[DF'8<
MM:XA:.<H<.U<1I]87:V7^!E'DX645J^/5UPJ+ E8TKSFRI#.5:Y U$!1J@WV
M96MOYEY )T>D=N)?4VS'CC9C]]MO+68^CZN_/BGK6CKW/H-W;R0'F]';34:-
M9OC>++CX;QQE,IXNRRRNYQA>D,\UG+^>S&97O.<^%9]9!&-=[6IH @19N[9G
M;;D1W.7;74&;5#8\$&Z+<H^;C_XP^>W>1R]O6V8I7/1* =(.7PO42AV DH'I
M9 SSBO;Y_J6T$]1#S00^%.?6U8?TK<%UI?2'G!V\6NME*^,PNC5I07D9E$('
MD0ORA;C34*]G@R53N!0T.IK6EZ,W0#G6->F#L.!V YP&VNCA0M\',E=G!:=7
MG0+H>'I3UJ!=3/>:K?_1ZL+:#FOIZ=YTRW4<Y[YT$X),'IEV'SMC4XA&9&,!
M4R372W@'=+H$*#[)+"0FDUJ'Y1X_4[?<D'[T1-U'J:WOO;V83#]-R+M?7KR]
MO'(;'49I;:AU@XO&X@R<\QI*B*%.JQ%LQ][YZS[]\/[P\90U:2GIUI=9_WC_
MM\EGG([KZM[$T?#C(L;SK?][M-FDF(!K4R/0@=Z3$B,$JXQDP3D6=^NG?^]C
MOE<RM)-];QO"75@L>.N]9\!MJ3-$4H+ =0+CA5/)BA)N&^+;MH4??&@K]1YN
MK]Z^T'+KNLOY9#JOUW'K=-/G84;'*C,IV3HS57*4H#0+M*5E"5E*.E"=8KYY
MB&5?C,<9-G>,^$&OVNNC+=K]>%.Z.+\8T6N2_S8E&?TQGF(8U07\C93P',MD
MBA_"ET%PQ2B6-?#ZHJBB#6V=5@ Z>J+1OG"K#TO!W8#_X&5_>N[!LWOH(JH8
MKQ:AO93&$73M6$WW.ED'[=!RN&0E:,8U;ST4H GP'V3M3\\]G./KLC0O+J93
MLEX&!"@)E@-(;TTM14+P6,M2M9'<:)8=8XTI> ^<[X=8K72RL>/$,=*HERT]
M)^77,)S^/8PNZI?K3.;>TZC[(CE<&K63C!Y!&M4);TPQ&I+*1'H?)3FH0D&(
MS".1-J84?J1153;DL4<!D;MP.2B@H !A(M/..!YEZ_*G$TZC[L.Y5FG4?33X
MV-.HPI84G$9 7NT/9DE^=(H VAJQ8-8XU;K$_T32J'NQ8,<TZC[:>.Q)J5W6
M\B.-NF=V:B^"])F=>HAV'SMC>4A,<!V!_N.6C3&\JM,(+683,2 9]-\=4Q^8
M1GTT1-U'J0=)HVIK@Q9>$"!?9UXF Q$%HST!<V'!.XQEFZMSJFG4O92U-8VZ
MCZ0/FT8M&!RWS@.:6,NA.2-D!)3)I(TRN60==N+ *:=1'TR&=K(_8!HU*^>*
M9Q*T4AH4.@U>\PC.2^DLLL#SU@C(::=1NV\.W:3>0_CU6Z#G^==O7_[W$*?U
M(L77U_4:Q>(PC2;)F,BW\+F.24Y8P$GR/*QB06J7Z>>MDZ>[(?NN?+;VNNJ3
M4;]AJ/?+%R_07;R7K]0N8'ORT?8">B0GK >-;R)5;^KJP>G:#[0Q26>7-)A"
M>)7V"9S.M4.<\EYR^MJV]JH> ;>VN4V/C5K[:*E/2KT:?[J8SQ82X)=GM.-<
MRR(=Q)CIC!:)4#'-@&EA7!UKE)SLBT!WX1S>B.I1D9LHTU$+/90 K8,FOLT"
MLMPR4R"I8,F(DV08FLS UZ89&45*JG5ASSUPOC>"/$0+!]I!Y&HV=\XR.!O(
M<U"1EEPR.!4C%%IK0N90L];%-/? ^=X(\A M'*C499"$)>^/6_ .R:?4R4+0
MEM!ASHS1GYA;WYQ9A^-I%;=TR;EVUL+&L^6H52TOL>!T6N</?<;Q!1ZPBF7#
MDX]0M;*+#)I5J=QXU+5V)5<L)1=?Q6 YV)0]V<XI@)=&0C9,&96L=Z*U5; #
MK.Y5)YL>\?QK#:$MXQS<R5 "&DB>CF&538; 2KWGZT0VPB6,K2]'[P3L<!4E
M;?EQMW*DM18>2YW(Y8K>83U%EJ,FRF1Z7D^#J^AI[>I2&YE^&)XOXKGOZ6]G
M):3ZL_?S,)V_#//EY-GH<\Z1?-=4ZI"U5.\L\5" &;(*G?+"Y=8UI&U7<+P(
M9W.&W6G8<S1-]V#^[[2:@8XB*9\$&,5JCRJ>:OFL!!VEJX9NXMBZ)?M.P(YA
M__6[0[;7QU,R_ ;\>*;?@#\>X^^V''Z8?S_,OQ_FWU,W_WX<HS^.T2;'Q]K5
M]!X[N?>I!SLZ=U_[ 0]-*6SV/$7@H5*5HX>HK(;LG$PI<N55^[LIC^30##H9
MA4:#"]+12Q0,.%\\"!5S,KH$J=JW-WQBA^8^_'C8H;F/%I[4H;F[)QV422+1
M]JULK4E3V9*0R8(0NG"-M,]'WGJ:S_<4,]F+8?W&3/;1]+%B)O>M9MGYFP]\
MK02H8_C*8HAYEI:$RR,4@=+YX$0T[9MKM\'^.$W&+OOL4;3Z5*S*/@,S6Y[[
M*"S+(P9D?MB6/VS+'[;ECS/ZQQG]XXR^GC@8SL+'CU-<KCE^/4(%S?T(CI%,
MV4,FC4[PM]-)ODCS5^,%#R^7N*KW0JZMDPRLQ4!,%Q*"S0XB([]%^>B\YXVW
MCGO@=!YD=2GF-^7N0Y;G!#K),1IRRT2M9'6U'"W3'SS9Z'(66=G6Y:);01WJ
MI&[%@SMSIII*_;&<SB\FM&/7B7UU&>^&LW\^__H<Q^F,WO9_+CS\)!W7TA;(
MDM,A810#SP0'],F8$!VC_;PQE;9A.E9TIC$#[@Y.;*>)'F(M=_&MT*V:!.^
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M-3Y05JU?SO?X:;Y \>'/R8>SR<6,G"9R03_\26O]>@UC"(5)92)X])QVI9C
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MM,0T'S(H(Q74_0FD(ON%]K!LF[MXUQY_.O;<0V7:PQBZ2RBK .<.8'JRVFX
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M-!D2UH!3126;#..A]?3.>^ <7OG]3,II)?%^R? V3-],%V78^>]A=(%O<;I
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M;&Q%=:(<Z2K_->&O!FU]-D-<.-D#C(ISVO! U)9#*I*;35 3:)-#D%*A*.J
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MV\+7SK?<RS.B>6AYZLF\@S^:'\T&,@235:!$R8Q""V"(#4X04?H<\!1<K&X
M[H?L:IA57P\M=.E\V?TLS#=?OXTF/THL&O[2[1]CF):>9J7F_H 9'YB*0"B4
MZKFQR8X/C"0?K0(=*175"X\<!_4O0:A*FFIA6/>+\]8M=G/?_&V,PRW1-[9
M@3Y[\R=,X[#<VPTC-+D*OTS^@.GRJ^'7X7Q@-3AKC<#M-7,BLPG$EYH-,40A
MC.2ED/-)SM(Z\[D:KEZ*SEL(7>=B?]M"?#"=NZFD@:/6:,44,:;I+B2*.9L"
M@>1UY):G)'NYYC\(Y=60KU_]M%"J^QM S?7RV[=OC]:+2=J7T KB*.[]TG+
MKZ@B-C'M(G4HV(O>(S?F<S4TO12=MX1F]E7#;K=?5>;WZR0-\S V?Z6Y[2H_
M]:.'G_339#8?\ 3*>I6(I\V%EL;Y925(8DF#Y Z8K!VK<XIY73?!S\B!%J)W
M2T=Z"O]^<F_^+$#A WQ'6]R/T-'C@(M.$V-#:4U64F2-2"0%&;RA3"FSL0OO
MK*&V<]"7SJ1>A=S"ALXAZ0W6L)ORX4E/NQAA!-,F:GI9A6YYP30(+#OK98F:
M+E7H*/?(=*M)B+J\.5J5H789MNJ3>.DTO SMMO"USI/,*BR[,2;NHO4=!\E
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M#;4V,H_6=MG3T(PGCG*/5GVRRE!F0]PO/^I2KT4.DOI>UR*'B*QV+%0I0;=
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M4]56RV++YK+Z=ODC((#_\]_^/U!+ P04    " !FFWQ8#$* ZMI$ 0 ;APP
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M^M.TK,$]I4^3:\ZKI390)67EM%R4LGZ]K"KM<4X$(5(0)$&,*0<H5@206,5
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M<PB0H 04,D: 8!YSF',EW3:>)^@,GOW04HUD1[993>JY6FC4';W:4U#9V?@
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M<7T5M7Q_!S75YR#]UA73)_G[UZB'/@=OL&KGLX0\<AVNS6LTAPRKT^I<)+R
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M=P]TPE^?.N#:JYZH;V;M,=??9#/12UP_RTKO2;J_?ZST!F9"4ISEE!# "88
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MZ.I]N:-PQB%S>."8/IJ[G'MNF\<#?/K*[YCW299FF2HR @J8ZATD(4S[:40
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M#YUDLWQZFC:=D>@T$NL)"L:!G,UGP/"X?2@WT[YFQ^;6$9WC<%Y[V"V/YH8
MT_%$KF5AZ^AMDXED?FK8&.8,SE7X4$=OUG3'/7%SA>/@H,WY ;XI/EI=-8E5
M3Z,)Y")+4D6 0*8O(\\E** V,Z)(*,,99BA.7)-Z=BB,D,;3TG-KLW@*#SO5
M]Y'1,U*[$N[M&>$\\G..BA L(V?WZ2/GX!P5[3#KYOAEG@.$2W-"/A/UZF3'
M- .=Y ICF:(4$!1C@)@D@,:4 :)0@7*90(&M"O_[B Q]C-*1C(3D4^K<TNLH
M+G9:=JFT;JJVIG:U/B@U! -.!^X1)]1DX&,DQIT*W"/DP43@OFO]M/ =+:N_
MTNE2_MH,5FAG7ZQ_^5^EK/0C'UY6VS=:9(11I8!61*(7OY@#BO5W68(APW&<
MX]PIT<V)^L!Z:\A&#=UH3;CQ#C]<_]5S\^L&KIV.#P:9F_)?AI:S*?"2.I"-
M<*,]JO'P@F7?JO@]Q,W<"%E.;KBJKI?"= VZ7BRT']&$LM]-Z?TDS5.()"Q
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M3C*1P2R#>L.19XD9+2< 31,$N$H831#B%%OM\X\]?&"5;,E%AMXJ%=F^ .X
MAW[MNU0Z-YUS$,RIPNV4!%YU;0</&ZV:[908VS5L)Z^YU-N_=&ZR66\G)NH?
M<R$ $Z:_-R0,4"7T5E]F2A0LB2%V.E<,R]Z(>X*PX\]=Q[R&?:FN>XFQ7Y7_
M]F*LM_0-)]-O@_G=3:5OF/L7G4B_#>QPT^AWJ'B:>-/HY'HF_D9-[MVB-E,A
MI'BC69G=:SKE7#2M"CY6J^[D^]=/*$OCF"D$%"MB@&AB!M?KO4Z,("RR/,YC
M5#@9]0L9&MB,K\A$RC3I:,YT':WOI7A;VML1472TL(92T\ZDHQ6US$4M=U'+
MWE7; >4J6K,8'=X9T*0&PBN4$;V4G7'-9B#P#@QEJ.=Z=E'3N\^;6;VHFH+W
MWV;T<5XM3 G>F]5!]"1/,H)4E@)1* R04 4H2)$!A@E6VMDER*UGTUF* QNW
M9@237XK*>;#L#%=0"-PL4R/]AK;),UE3C]Z<0\6]!9NMI*'ZL9VE-VYS-EOQ
M#SJU6=\X0$[;JA2A?K.4UTIKV+H91XHI)(E (!%2NT$9X8"Q+ &RR&*>Q7D>
M4Z>]K1<7 YN'NP=926H(!DQ?.XFHR[GW@#CY'8CWI:\MYA'K6I\T:(9L@!($
MES'RUT[R\/WDKYV#R2E_[>S#_*S5"6JOE]HA,JFV!!4Q40Q@&B< X2(%+*8(
MH)S@+$XDT;]V,4O]Y :V/QNEFC9CSKI!>LZ9_&= L[,\X:!P,S%]IF5%/)P9
ML1,RD+TX0VQ4PV G^+X%L+S+TS$IN3G"_K7IK39!+.=9(A/ )&, %2:=7F9F
M.H,2$-,<2NRDV3M/'UB17[^_N=;:R]U;I.]B8.DB^$KFN/2W9*+?6T(A3XF/
M"1!JC=YY]KAK[S&Q#M;4HQ=Y][Y99\3M]]K'62YH#!40<9$#!)OI)A@"SA1#
M>8'2#+JVO#E%:V#E6K?I;Q=)/J\=M_)],-EI7"#AW?1O)P?U*AIN6H&%=.%Z
MV9RD-'8+FW,B'^E<<_86]T2.58/6=V7U>",FA=#:JA=!D""MKTA*"0B$#.2I
M4*E4$"?,:M-]\.2!5;3KZ&N(13=O[/,W=L7O5\:+A')3/5MYG-(VCO+NE;.Q
M^Z31$C:."K"=K7'\ L_V%&T4;'52N-\K:I(+)F!*]#X0QF;@)-=^(TE-H"I5
M.<>\8#%VZD712VYH]=DB[C=IYPQ:=JM<. P<M6U;_";Q>:^16\!N$%8BAFK]
MT$]LW#X/5H(?-'6PN\LW?_'S@YQ.348 G;U,M-ZF B<"8,8Y0"1A@&0H TG&
M5!'GG&*NW#(8MQ\_L :O4OT:BM&*I&L6XPX:YY?"RV1TTU G\3QR&8])<4$V
MX\[C1LYG/";*84;CT:N&/=XQ\=D[#:J<B$Q!H60.8JB5#.4< 5;D"<@)CJ52
M*:/,+9'?E8.!E;&G<S\>YJ!G@VW80QXOQ(8]X&G ;7@:_VSG (Z1SW4V]+_+
M,YT#>'S/<PX?Y&>:7BWK<F8:&YC.KG79=,1KF[QVQ3)%@=*\T-M<% MMBE!*
M .52+_HD5E+"3";<*>A[EN+ IJ>C'VTQ<-7U(?8M-#H/HYW5"0J.FY6Y%!=G
MDV(M:R 3<I[>J";#6OQ]$V%_H\?LH-?SZFFN;8^\9=/ROME5U*N3CR21D"#!
M0:&P\?X)UX: )8 PA1(LB$+4RB<Y0V?H<Z".<#3?4'88D-,#4+^*!Q3;3;$W
M$F\1/7]DY"2ZPUR@,!#XS03RA,)M%-!Y 7O' /7</MX(H/,R[(S_L;C\DM$1
M[X_UHO\@%Q.*%<<I9T 1J$PPGFCCI#=,VEV)"Y)SHBV5S2@S.W).ELE]FMF=
MN24J-Y$UVA"^BF;2_32M#S4[5R0<%F[FJG]@Q%7TH0<-SV$1YX0,.B;B)+%O
M,"#BG.#'1T.<O<M/US]6<[WMT;L<_7%87,_$6^W3/!D;_UZ[.S<+^5A/$(IC
MR0@%"4O3-@&ER"G27Q3-TXS$L2 N>Y'S) ?V1CH&KJ*&A:;29,U$]+MA(VKX
M<-R/6&!I9P7"(N1F"0* XVP0[.4-9!0L"(YJ&.P!V#<.#G?Z&8@/\LNJ7;4I
MQJGF,_TM;^<;MQWYVJ^;GD-Y',<090+$,I/:7 @&&-7F@O-,0IP@KHA3%-65
M@8&-A^G9/5M,7[IBM@UOT6<SJ(!60J^7UV+^U QT,=.\YXOH[W+1_<[-ICC#
M;V=AA@35S=YH3K8QW.5EG.Z/OF $,D;.Y$<U3;[@[!LJ[^=XQ5,>'^>SIDKP
M9L8K$\Y](]M_;V:OZ5.I??YVW-XG6<M*.U;OYM6[Y6)92:/5)IUI@H6D,!$"
M())J,\:8-$,]4H"AS& LDQRGT"'P<C%# YNUCJUH/9*TF411KJB[CRH-]B*L
M CRCPNL:"3+,M47-)EMQA?./'8=_TK^+5DQV@T8[-LW<CZAE-.HX'1E^IR#3
MJ*_!-QHUTNMPC5\%P^Y,H.MR.F-&Q(*ALA<Z"_?<@6K./VAX5F5*689AGB@,
MBD1Q@&(6 R(+D[=.&8<D(Z)P2EEWH#WPJG.VV/IB[.S<X8$0<5LHK,K2KZ(-
M*R.6J!_*/U:Q^A;E[ZML_1 2YP+V(X_PLR:'1DS[VM72! Q7;5%E_9&^-'V\
MM.M*N,((9-BT*\US!8H\Y: @*I-"R)@3Y&)-'&@/[\.:QL +0S%Z:DFZ6187
M'.TLRT#HN%F68UZ.]N<WC90U7A_/X.5L4SPD#V137"B/:E,\(-FW*3Z/\+,I
MKVG]8/XW$<5G.I7-O#IMS$J^D,+\X7HF=G^Q=>5$,!*+%&) LJ9-1I: @J49
MB%6>0B$2BKGV\9K>/I\7M%K8V9J+>'+1KWW.[+<7FN95Q/772&Y(-W' :LU8
M\_>KB"ZBQ8.,F+PO9\W0WKEJ?F%&.;O9K<O>%:5*$HKT$L!C") @&2C2F(,D
M+U*F/4^!8+%Z5V]GEH.Z1GY3'5]#OB>I__:-WI Y4B=<,) 2E)FF,Q04DE.@
M"@X+E64"2Z>F,Z.]'9]<H:-OYNK8JQGS%=@M]Z,!ZQB#:C U7Z.WVYAN6(G:
M2PS(>[_<OB.<=Q $J$#^PF6\C.I!!(%MWZ<(\U"/./V6S]+V0#6' TN]$JY2
ML>>S^I54\TJ:]G_MX/!NFNY$94D1\TP[&)12@+! @)H-31%+O9/)9<85LLE"
MNI21@?.3=O8T31]BOF8NFJ^YTTZ$8:]I5-K6"]*.08=X\27OPR),/Q+*SGLC
M7Z9&0M8A C\2PGZ1]\L_RC\%"K8'@*DWR'[)\\<+K@= 82>H'N)YP1-6]>YX
M^;ALQB1O%^U.9 Q9(2$%,<5(>]0%!01J!ULBD1.L4"P9<QM-[,Z$E<I=.I?X
MSQ'=4(_H%OE@Z:VG,+9SF0?";9 TV"V&HFL;*$/FQIY!8_A\V5,,?"\YM&<
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MNBU0J!^Z_+O&4%"J&,E3:RA<6QZ%4\0QR5%%"E*D:8G+HO V%)>HC6PW>L2
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M-4M%D:7N -7>9Q!AUIG@6%!4EH2RLK!?4J^CU(N4IO$C'''T+T<]V9)ORV3
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M@"Z 4!"']79$:*#N[ID,Y@ZN.Y-TK"1W8\)U94;S];!%3FQ>@#]MUV<X#X,
M3G0^L]SKYCL/RW@Q[?G"[8'-$^17K9[G^LZ\U4:O5EI]X7^U<8/;A=JF%-5Z
M_<7UB]\GJA@NB2+4()81:V>+7"#![<:E-!6G.F-<*= DF$ ^1K:[6ZZ<+FSY
M2BQC75.A)M.WQQNP74,@]'Y>U02 PJPU$,OD]X:Q<?*&K@0G5G>)0"ZF[4-Q
M'51''2NN7"[T*/%6*?O97#>G%'>K^]7R6VW%MQ>8/!6FM-NV7"*B"V7=154@
MA4DJI2"88P,[0SQ-:)K#PXYV[WAL2Q]Z9'@&KF'3$Q,$F&T)ES_@:'!8N"O.
M!,\L//%AX+!XQZ> %ZX/V.[=6FRRM_5*2_LHUO?V27=S!NS.C@F*-=+<-7<D
M*D>"*C=>EDF:IMBHO/+>W)VC,K*J.JK)CFSBZ )V)6>A\=BRQ1 8II8G9 T9
M/G%6:,#&*X;P8=LLR .'[:,NR32X:SI[\W1[I$O\'^R(+EY\S:1+W6RP=@44
MV^[5;Y_UC"K)J$@KI*4H$,FS%+%2"42RS%3$Z%+DH /.2P1'-C_W]F_N"/Y;
MT\[)NN*/]:)^?'Y,S//&E2<NQ;Q^X $3)BX":9$J\JJJD#+6RVH:\]E?I$@J
M0PS-+9XIGFW<B>PK +DC"SL[;B,FR5-'-3)B?AN]F#C S'M'>1MUVQ&_23;+
M1.CDGM<1BN*A<D:=,#I [A5&C5X6_O3,48_[PJSG)[UQW8L:IT]I]?/W?ZRU
M^K#8Q:UNW<RR9CNWRYA0E2$I41P92:7K'R@0RPJ&RDP:+@J2807*MX:S,+*%
M==PD9K[\<]W61>W#JWS'"LQ0!*#L9SK&Q0YF3"PO20/=EIM$?$]^<@PE]>)O
MO1C_GJE1$EW",8ED> (8F-04A0/TTCA=L5+@N;W=L*IZ_NQ&:>U'G[[[2\Z?
M+?VVS.WQZ;EU\._,M@73O5XU$PT^[C)/)",2F]3Z@Y4QB(B2(599S]#D)K=>
MMLI+#LK3B<78V#D"/3;[(WFWC&X+07>L.@=SUW/,<MO.Z+@B&2C:$_0SD*_Q
M7&!F<])' L^(B(Q?K#R*6&Q-FWT1&<RCG(W8ZP?V8YKS]?K._).O5GRQN5M]
MKA^^;GN::V'WWGDAD*QRNX<T+KLC)0+I7!8E)D5J'4A0]Z7SM,;V$AUEIXL=
M;1>L;J@']GX?0LW/UD7" F:^KH !WB7ILH"Q>B(-4)JV ])ED8_Z'7G<$AQJ
MJS?63'S31Y-<;A^7JTW][\:R=/EBG_1?FR]_ZODW_<MRL?FZGO%*%UHJC2I6
M6,<K507B1J5(<Y&5.6%E)D 9EM>Q,[)Y^!_-5XE>J*8[JVP"G4F.;Q+[42/@
M*-,UJ'O'H";"$ARALGRAAK&CF5 W30:HW+1MKG=,WB0-^'>+B)FA<?")%]FZ
MAIFIXUX1@#L1%8NQ:F#UQT%2US86-U-86\.F4Y13:^-(2CEB3*9(<4J%R7"6
MJ6H[P?8+H +D)#4OC3L<7?LEH ID%[.1^YC8<QO1>9EU" R)G0'1SUI=@4E8
M.<C+_-3[2^<%\$J009%BE8&<)C)M#<B@H$<%(,-7AS>,/3]XEK),TK)$64D%
M(A2GB!(ND<QR4W)2DBH%C<=YQ;&SW735=3M==;FGF_Q4;\=0 [OI#T)'6%X2
M;"@RBC)$F"NAP9(A+31A0E"A2S%K6RW_NN&KS;0 OB3L#>//^J%>N)UR(OB\
M.2\;!SZMB@P7M$2"&/L"X:5]@>@\11F6I>"R2+76'7SO%IY#T.."MR4+2.M2
MX^/FN3M^E3G'IP8<W\2=< P1,&++X->==0P1^E1#X,ASCIL$EUX^;"\-]JU^
M6FE9MQE.IJB*0AKE!K40J^(Y1J(J*:H43M.J* M29@ ?T9/L-,YBGR(@-\P#
MM6$%CPE"8 .K7BY\C_I-,AXD@,2YN-"$I=#M(-I8B.9]B)0/1+"L.G^!!_/K
M/):9+M/.7Z:#G#O ;3&Z\KU9+IJJ4;L9;[]=6PKWJUIJ/-,Z5YA;QT:GI4($
M$Y>H;TT?$]A4/$UUFJGP-GT#E$=WLK?D7..^SLE1R_F<K]9NKDCK\ #]'7]8
M_9R?4<""6LD7;?YZ7&Q_:%!L&!FK\9^'Z*-T ARB^XJM 3W@&.X5Z+- F&6Y
M7RVEUFKMCBU_X9ON,/-^I;>YFFZ8 Y_/UW?F]ANOYZ[:Z/UR]2N?]\X^9VG&
MLA*7J=U)N62/PA2(J9PCG N)BZID&:RK0Q2N1K9(6Q[;S('''9=-LC!?_4MO
MFKJ\]8X?F&V*\V#\[-;D<,-LVB'2>P9ODAZ+[309QV1;.&G-X)ZWFV3'-S++
M%7*<Q[-]4>&+9!?C\#2IS8P*XTM[&G?QP&*MO!O4\LMRM7G@#_KC<E>B0T66
MIRDE*.=&(L)2C@3+&3)I1;@R999IKP)+#UHCVT5'.]E.I-E23QQY8"G3 %H>
M6]5X&,",U7GQ0TNZ!G  %G;%P2.XO OZL8!7>5T6\&*MU\ 2TU9\79;EJ.[+
MXY8P+_%E#MO/?%W+?;?9O,BT:V9I=%$A(F2%..%VSYEFAO*,$%)XS9_PHC:R
M]=I/_ITOU^N_[;>6_P5SWX81\W/+HN$ LV#'6:\W24-ZE#H"+R$C.47#M"9U
M=KS$?NG$^-T4X)S<S=7/JUH]Z$_ZS__'*<WW[@4C4IQ755&XIC76+:$%0Y23
M%&5%EN)"\$P6_C..SU$96:4MV:2EFUC"24L9\ X^"XZ'%Q)#9)CVGI0VQ/4X
M*S; Z8@A?IB[$0@#S.6X)-Z@LW'VYNG<C$O\'S@8%R\.S1*Q?+J96>[Q?J[7
M_WIC'9AZX[Z;96ZVC.MC(3-)$9&J0@)C-SPOET(+G67"R_IXT!K9!OW\O*X7
M>KWMWO3'<ZU<(Q9'N?W=/RQG*S?1O@DA=9-Q]\RZF$9;HUKS>7L;]&C_/,Q^
MWD@D\&#6[! $1^LF:>EV/W13\T:=GN<A>;03__.4)C[PORCR\7G_Y5O@7:EN
MG^T:R]5']Y#<ZX97A4FY5JC456Y-0JH1*VF%*FL7RJHBAAJOBL(3:X]L CIJ
MR9:<?ZNIEQ@,Z^N5DL'TTULH4/^H,^P'M8QZN=9D7:+."-%O#'7NDL"C'+UP
MQT*W"]7T\[Y?VGV!WM0K[;RGG_5"FWK3F\6];Y189B)-BT(@S;%U\LM"(2%9
MB9C$%2YEH4KI%7N\EI&1%?"MI;O0[<CY52V>FU>*:Y #/9D)Q=GS,&8"]&!*
M_GE'/MG23WX?Y4U[K>RQ#D]"V9CVO.1*L(Z.2*Y=+[#9@+3[N^>Y2X?;SB%X
M6NFOCIEOVHW.>M0?E^O>.(M<L2K-\Q1I)3)$[#X ">I.G$VF:,F+C'%02UTH
M V/["7MVDMV C#U#2<M1\M/')CYY18L *.Y^YFM,-(&^27P@X87]@6C$*N"'
MDI^V4#\0G*."_-!UP@Q6N^(7_I<;=F\WY/-Z/]C/]>:U'XKY[AJ]GNF<E:(D
M'!GL4O+RJD2493DJ**\HS7-.4Y![!:0_LKEJ6\AN'*6;9*$W+E)AM$63SQ/1
MOC1@=@D*KY]9&A$TX.F*,5IN>O;'I3-_=A@><K9MSML$C!QWO>N;A);(DWL#
M 8IDJ*#4)[53@="\-%.ARUQ=?7?/5W>KAHSZS;6SW!X?S7C%&2\(056664]*
MTAPQS PJ#$_SBDE9:%#/3@^:(UNCPUJ\)[YRC3+6#1M=*\\8><,^V/H&5:,B
M!@VN]JNF[ENP6@Z2AH7]"? H]5.7)(Y?1G66XFM54UV"8*"HZN*M$1O][A(7
M1)55M" &5:(2B B.$5<F1=9:D(I((S():BPT2&UD6W'0EC5"2UI@=D<TT6%*
M?ZX9[2C)'5XRCMF(]G62.[S$]FI!&ZFAXYD.DA\6W_3ZL(/DK- %%54JD>25
M1,1*CVB5,J1$(6F6:<VS$M)^VI\T2-WAC:A=X]2FO\:VLT:]92%VP]E3L/K9
MA'' @AF("PUF=[ST&LR.WE5V (!QN\F>(OPC=)$= ,2S>^S0"C CLUYM9I_X
MH[XSO_#_=[EZ\VR][T>]ZIKJ*<E-GE&%J"$%(M@:%9'J#'%=$<RX3#'VFD4R
M2&7L745'#-AS<!B888L035S@EL!;4F_5]I)D2(OM CT-MC_MM7=X[4D4U4N\
MK4[Z71S\CM_'.G<U+%^6O2W#U^7<KK=NTD9GA/&2I+GKCR";L*2R.BFP5=&<
M*4-D)0DHN0I(?V25=6^Q+H6[;N-F*!&.+O@-#P+5^S4_%E3P=_WA,<B.&S>;
MHA\@Z!CJ4L&COO%#L(CWV@=1G_K='P+-"0<@:)EK!Z4Z#V-A'_[W-\^KE?WN
MQ7A.55",.2N0R-,4$4,X$IH3I(CFKH45SU,=-AEUF/#8YR&]\9WN(&JY:*I3
M[4\[MD+'GUX U,_VC $3S.CT$=KQ<)-T7$PTS]1/^.@#3"^0?:6)I7Y@G!]1
MZGE_<(<"H]<N,X7/WVN[E29"\32M4E0(-U2B<GN+@FF49R2MJEQK0QFPV< !
M@;'3T&K^L%C:K9=,=-LX%=X9X! 0/\6_1DR8@O<I)8Y4U%+[DT+$JYH_7'[J
M OB3PIVH93]]78SF0K=_U>N9+K!].]O].B_=P2!-*>*YS!%/\]2494EQ#NKG
M<4QB;"4[;(.3_.YH A.D3N#BIVG720O3-:"@5_;UZ<LR2@.?AL K=NKI"SC<
MDN?@RH"2RVT!IU;.2[2O@389H.F4>/N\^;I<U?_6ZA\+NUSCHM\]N;\WZ<KO
M_M(K6:]UTP#HL_TTZ/]V,PBTZH81K/^IW3 "K6Z_Z15_T)^U"R_4BX<F\YG+
MS3.??]&KQVS&*DT(MIO^JN*YZ]N3(T&(0%5.%,YE993TJJ;X820:V:QLV4AX
MRT>RVC*2R#TGR;PV^B;YL^,]>6AE:5(/OFN^\FW+^L.@ZE/I^B/P.>*>Q<F!
MA!,OZ<NW;3:;[$6\21HAVZA)THK9EAFX00JMI&WWM:21]2;II+W9#G>Q%^X^
M:)W(-\E.Z*0G=>+$3K+_M(\3H(+X1^ 7\K$*JU;^#_UXP:JE?Z1'.5B9_4,P
M.ET5^ \A[@N?Z\=C+,80DUU:QRPWN"@REP2N4X4(4R42N%#(F#3-"B$)9WAF
M61/+L $F.TH0V]6GYVVZ&G*[9L/ V.8Y> J=I4)F$I6<67@*11#3"KL>_23/
M"E.E!)0R'P&< &^Q&7T>!Q"_C6<$,6%NT='$EH\7/P=7CFPY$FJ4F2U[*J\X
MM.5(U.&I+<>7!^Q*WRQ73TN[J&X,:M?P)155BH4TB%%AM3%3&E&..9)5E=.,
MEBS%7K-:SE(8.WUC2[+-"P=XRR?A\-@,72LD3 OW\K5.84"SGY." MST:P4.
M<YM?"![)3QV29=!O/'GC='[<$-\'?M7@A0%&P[I6ROI+G]WSF[M2I@\+N6H&
M25DGS/WR0<^DL'X-J1A*,U&XB'**&+%?)--%2E):"L&];8@'P9%-2L=!LFI8
M2)K/8-TQX<I*.BX &N@#HH?EB0P-S!!M46FIMU5M6_K)_5BH ,Q49'3"K);G
M9^?OD<P90.9!Z^:SSG3&#B#5@>V#W!>8 '-RUWKKMIT/;2N%[_M+NE%[MW_R
ME6JWK^O?]-KM2Q=J.W7UR]+]JMO1NI/UVX>'53,_Z(-K9+)8U[(I )K)LBQ2
MNSE"F<IS1')N$*=4(R*RROIJ5.<8U!CAU2298E]F5:XCV18&WB3+ENOD6\-V
M4WBK]ZP"DW9>[4/@MU/\CWBT(2'ZGX]BJ$E/*E?*T+^NDRQI1+OIHJGKF^2W
M_4=@-_MXLVQ^O8NR\F:BRD[,9"=G6SL9,6GIM9]5K"RH5Y-CVK2JUWY<1WE:
MK\Y0V(NT-TIK9I1KZU/8=UD3+Q6J0"Q3&=*52@O[9BMRD4&JTGIK@UXV\+*S
M]F73&\8&>Y'T0? S[8&BP8SM1P]YP(;N!.>13$]_Y4F-P0F17JKGJ4L"-N']
M\M$WR_5FEA5YIIA)44HK@XAD$O&BM'K#"J-T5J:$8A^5.;GZ)$ICNE+E9O#Y
M-ED2L'D\@L1C_WR-H# 5>E&([8A=(QM@%WR-C&%;7HBLL-WM.5D&M[)'-TVW
M;SW'[\$F]>Q% 7;A8RV=VMS:-W3SLG>GFC-1R924N$2%$MS:ABQ#K.0ERJL\
ME90SPK#7E,BS%$;>P74D$[ZEF6Q<ID+3VX5_!^57G<3'PU!<*S7T?=L*O"/7
MI&9<*R; 9EPK;IC= (H-,QU#(@V:CY,W3F="AO@^,".#%P9VE6H+/'9MJMZU
M+^6N.^B,9[ED%<?(L%RU$2C!#$5YKG,F,19EYN5S^)$;V0G9%B0%'.-?@,G/
MD8\G// XL9.[UY^N(YW\U!$_;V#A_:"\I(S5"FJ8V+1=H+P$/VH Y7?7Q*'K
M][Q>-5O^V_7Z^;$-&VRC!;\MYW89EYC@PNTSKFFNC-V66#]#N.JM%#%:9*C$
MBE=&6ON1@WK.3<#SR,[,+L+89"=TXZV_[3B8*/ ,>(0CAYC'>3"3!Y.=&%T;
MO9X@-_N \EZ6YJ3T!P@8PY%_[= P@./_C" P_!%$"_<&D [L^+Y>Z\VM_..Y
M7M<-;ZZTCI5IQKE*D<F-W9)2ZT0RH9C]DG%9IA4O"E [@%-$1C;D#<FD1S.H
M[/ D.GXF]UJ98382+"Z\>_J /+$ZI)\B,6T7] $ACSJ=#UT;F*&^>N"+^M^-
MD7AC-7XYKU5K,1;JWC[][9[]SNSFCS5-1YNAV:>FG!2FT)I+C@IL[!Y0:=?Z
M*U-(FHSJJM+6[_-J^#46@R,;@3Z[S0'R=O0;,!$\]F/QLR"O"3;,^O0Y=1'E
M'J\-['UN#Z?G[1E.]AR/--!F+#QC9;W'9F_:=/F1P#W*LQ^+3D X_ZTV>K72
MRF[]>P>'MX_+U:;C<,9E4>45LSML+B4B&7'-&[A&Q"C&6$%<G_?9HCFO5U\\
M8_R7R7II.FLU_8BXO\_1HPB(?GN@YA'RCP1"8)^'EG83CNM1;P9!C 0)X'@@
M+C1AAP4[B#86HGD?(NX#$>SPP%_@P:,$CV6F.UCPE^G@F %PVX^:4?NB&O2@
M>G3&""V$<LE&NBA=!UN%>%&E2!4:Y](HGE=>AZ4_AC@CN[]''3+TMB:]B6M>
MRK*-,I[CE3\O(X=')_\43!XY#4C#?=G0X$4KA!\@MAKUL;UVV#6.,/\9$=FH
M#V[ZW%POKL+>R[^U#>2[?N:X- 87RC6)LV](^YJDB+DOF=:L,%@:BD$'>P>K
MC_S6ZF@!^[N?QL'/_ =+![/&WH*!#>%) 2+9I<.U)S43)\5ZJ;6G+PJ>)MG4
MG[W5[;\?%O<K_<1KM76KNQ/^[5C>)@2\GN52\#R3'*G42#>(22,AB4:5*555
M8HIU6FPW^7[Z%L9(P+8?IIH=$[M>J8TWL&S&N<HN484WG("G3(; [J?<(T(9
M9 5V-;@_;3ER7?&3+;3;[!Z';#LH]W88T9#ADE< $F_&9 @34X^:O *H$Q,G
MKUEMM'G>77\)G0NBL*P0*=W<B0)+Q'BJD&DZ.5L#EA)0(V=ORF.? T,&3T<?
MVNW5I614R(#'R'=O/B2WF\VJ%L^;[>2)>][V@K_4R62,@=RG.GY,,8E[RH8A
MP7 $S-Z^JL'(ELYG_4TOGO=]VN[URBQ7CZY,XD[,ZX=FW[3;!-6/]I([\ZO]
M[=JXZ6[-F-W5YJT;M>OR*611IGE)<U3E)D>DPA6B1EC30Q7..#?*,-!F)2Y[
M(]NGCME^T\<>O\F>X5ZR6LNS.TCM<]T,J5YM$L=X4+)+Y,?J9_1>[V'!+./K
M/">P21T'SDAV-S)SDQKG<8!]:<%'HA)87\+77]U_[_YXKK_QN3M M\[IKU^7
MJZ9ZI1U:V)RKS]QI=E84):*4"$1(GB)!RA0ID;,L9\Q@+D'#R[U)CVR>'1,W
M[:A2O>?E)K&W6">IT?+FCVZ[]LA7_]*MU[36=C\<4&$.@-S/O(X#),QTMA@V
M8TS?]3%TF#6<H*:U<8^7B!4M8/EC5;?X$YZVT@4,R%'5"WR%D-R:W62>7_7J
M6RWU^LV\=HM^^7.Y;8E8*JY9*9#U$ M$,E8@EN<"X4J93&>\S(V7T?&D-[*E
MZ8TBVG*0="PDE@=(-LEEZ(:-QPB P"S&!2Q"FFKZ?)X *391P0E,L;D6)&"2
MC;?(PTDVEY>9,,G&6Z;#)!O_VP(]K_TTR#?\J=[P>=MH_;->6X):O5^NWC]O
MGE?ZPWK][)S#69YQAE.6(\9XB0@S#+&2<*0P+0I,"E5BKY:>P1R,;!U;8DG=
M46M24YIT%&C0#@ZMIZ,U)F! ?ZLW*=;Y70TWV^$56WX2NZ](.E2W+$5TNT+1
MB.5]@>E/ZX2%PG/DBP4O%#S_\4FO-M_=7(>-RW2P/N"3>W6=JG*0>5FR/,L1
MUD+;32%.$:T(0UF9:\X%R[0";0HAQ$<V1UM6;III+YLV*VK+#GB"I#^D?K9H
M+*!@9F@0H_&K/4) B#>YTI_TU%,MP:"<F'@)7R/4#VH'P/RSWGQ]\[S>+!_U
M:C=:X9,5N4TZF'%2I3S#&N549(C@@B$NE$#6]\E57N58&J#WXT5W[!WA-H=^
MM8T]+_3&19.WN19/+JO;M]  BJFOVQ,=*:BSTS*0_&DY2+8L](:?W"1[-F(Z
M.""YH[DU?E0G=F9 4!R[,+#;K^Y?NE_S5JP;TK/28$9RG2'!\@J1/->(:L51
MQ<NTS#C.[)\A]F.0VLA6PQ)$6P/1*[SYK^!6IR?P\K,-T5" 682#@JP]X>3W
M+>F(3H:7B/'[IIZ@]5J=5,^+/=!;=> FF'JO5YO9EWK3SKU7];?:S1-H3I\)
M+F6:YQ(9ZCH5"S?4+<\-RBLEI-&\J JO0J&S%$96XX:F>]GOJ8(.]<\C,ZR\
M4>2%*6R J-Z*>E&<(>6T-_<4T_ZT5\KSZTZBB!?%VBK?Y0N#$PM7SUK]O%P\
MK_7ZS=8/5YABDPIDWY@I(F6>V_=HII'2NB2E%HK!VDV<I#)^PJ"CF0A'%)P0
M> (4OY?EU:+"=&XK94?O)GD3VT,>%"A>(M\)&E,G[9T7\T2"WL#%HZ7XNMS6
M+RXO859J;2K.-)(\4XBDE"&ABAP93(R1!6%Y22-G^>Z(CZ^W_HF^R>\-2]!N
M4!"HO=5^% #!UB B=F/D 1^!,%TJ\)[TCY8-? 1*0$+P\1J!)P/V _6)/[:I
MGSBGF&AK9DI"*")5:A!-"482IR0M2Z'2#!;Y[RT^=F3?_I0X6D$IM <H> ;K
M V4#!N-]Q8+'V4_P'RN.WE]ZVCCY":&.XN"GK@E3GK=:]*+GNS!+FDII*,D1
MT5@@4A02"9$3E/&,5Y71J1$@=_HTF=&CV.+PM.=R& :"D9^272\Y3-T"A 8K
MWK!,D53P#)%)E7%8T)=J>>'JR.?>7^QZVYK[HF*%=+M=ZB8^JDHB6@J.,I8*
M47%9%,)$.>[>TQQ9=3\N%P_H8_VMZ72U>*A=9G/;:#2L-M\'1<^79EQL@ 'F
M<%CBG6(?"SKVX76/XH]Q9GT,@?=1]8E;PPS#.[YR=1KK>[UJ,F]V[R6K]#P5
MDJ$\Q04B&&LD2EJA7&J6"9$1S0N(-3A':&03L"7KBIW:%++@%_A9J/Q4/@8
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M\/77F<Z-+%65H:(HK5O**HU8I@Q2&DO-<IUQ!AK\<+C\R#JZ)Y9(2PVFF2^
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M=C+/[:.;>_5OWA8U-U;(9;2_M]?.6"D+([,<%=((1"I)$&6*H4K+/*>YYJP
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MUIM:KV<BPXI7A?4X<H&M)9$%$B1G2%1,4&D$3G$%F>SM3QID2^!CORTCS=B
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MM[T/2B'0"1RPU\AQ?*AGTPCV#+;B#,4:I*QM(/8\B]F"L@@L8O-@HKMT#?+
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M85KHF""<I"7"U&Q5&./F7W-9E$DI99DZQ2ZN/']@.VT HP81T+3L A'=%AI
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MZ1#X8./CU0-GR#?FYLE>R7L GHGZO0)X^]SAR0G5:G= 2<=MRSL\Y6<M?$>
M''8C:W<9'XRQ3!E1/,X9030M2H0SSA"5:8D4R;G.&=6I -7:0P5XN8UK,<S&
M=<=LV VK#U\C;%2M2./O5$_)&'F'NH-_E3O34W)\=Z1GS[EA8N6;_@%J;TX'
MJ/UJ7&==0-,<47Y<5.M5?492_6SN-5N\:9%**K(X0\K.K<4%MDD.L4*4$QT7
M7*6E@$^L'$34@;W<KYO:L2UUVR9I$AFI+'(5/38"W-!#:;CWY^8A7\=;@?G2
M *,LC?2HK?IK4S .%+#YO[4*@6=9#DISR%F6PP@Z_BS+00F_.,MR6,21OQ&-
M5-7]9EVMV<*63_Q-S1Z_&HGNOIGOVZ-Z_Z=:B5FE/J]F0DUCH<M4$8DHQ3'"
M:9*@,L]25*8R$;QD7&=XVI1Z_[9FJ_7 GPV8]!!O=:J#L^/:"A"Q1H)(M2)$
MSU:&2;3<"VNGL#W.%G9K4W]>Y'(^9ZO*ULHWGYJQOC3 7T%*,]MA/454"YO7
M$*=FV9 4B,LD);@4%,ND_168G<,_^6]@J\% OP!5__.?ZO4/O.H8[H6.O@2Y
MWX[/OC]\Y;L?2*M/M%4HJC5Z!2L2OU?PTLL3H-3_'&L5OU<1;.'B"1]R%3-E
MNDB%$!II*BG")"T12VF)2,Y3D1%*92EOWZ4.O,.L4X91/>3<]NO=>Q.O(1Y7
MF+K%,X_C2'<.<O_3:Z::LNKK=BK?T YP%'_U&MP+S!MX&F]=V/-YM11*R7J<
MZ(?9@BV$\11WCRM5O^%IC),\Y<KN&$2.L$HR1'.JD3(+1:TR+@OLU)G; 6M@
M,]Z"-Y-[]18^8EM\0-U?#VG=QAR8"IA%[UBPP-$..;H+SP*@OC$<&WX5C/ZL
MP,H3W?3L+$#L><1X)89NNAP5$3K>XK<$>5NWTJ\_UFVO5AUG+*NGARB<(5Q0
M;$L"*8IS+;)8&[^&&63U<88PL,=J\)J:--@BXYP+M_7%31K"'-&A<@/TR+ZJ
M2:"EP_GS1UTU7%7O=,%P_4*OIIF'YV4/RS?*'H?:P[('0ZN:ZD)A6B0Y8G&N
MS(HA,XL%FB:HY*G.:9$+99O;+M=L[K!8Z $#V=X.,L3A>0YJXMC-F,-*(2 /
MT$/QTR/PAV7TYN@(O)8@(!V@#I;!:/'M5WDC/=#FE$[Z]K2B['[&F(TGG;0Y
M:3/I=L\-$XR^J&?SMK\R&Q2QTT^?FFK$CXL/2_,C2*9"\@*G3*$T411A;:>&
M*X$1(Z2P \5ISD K"A?0,:(;T6HG0_3<"#&I.P'7T>VG.BO?9_Y0'Y^.48_
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MJ]5LZ5J1[\Z=RXE 8$: 9P2'Z-$.?A*U FSG3H4F!G**$)@@SW.%6XD"GC,
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M6W3WZ[OHMX?[M__Y?^\_O7O_Y;=__9<R38K_B-[_?[]_?/AO8"BCCTW'6$9
MCH#!C#URO2]I\ +&+APU"Q6\Z(,;-WKAJ/Q9^,+U/L_V3+;ZBI_-J[?_M;K;
MK+\N5[/_5?+WA7GBP1![FZQ9O6]K3S^O9D)]L75[[7^Q36W: .O?U.SQJUG
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MQM\7E<TM5M(66+2%\#K."[/S2E&A!$4XC7/$25[8/1C#7'.B= D)F%S &-@
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M+J7IN&'0VGWE&[50>K:>ZI1*EA.,F+"#_W(B$24I1AF5,5.<)3*6+CW='/%
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M M-<(TX$1D(SE>)4EI*7(/]P#6E@IU#CVE.#%MG0TW1.C?ZPZ,"UPW6^'+U
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M8(IC.ZTM"[!&%.%P!1S^IP8!9E9V\M_,"+G7G2\2&,!-06J XBX.!@,%NT>
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M_=C-(U: 37\"P MS+A-# K.&+1I'U+,#^9$B8("\J=H#!5"<ME%0. 07+8,
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M .KB5L,+5,I<%[2F1BE03>T=>B-K8$<I<Z]^B>Z&> ^R,-5," 1,46]FS.[
M2=N[+U#.$?-CCZD]>UKL%=%#LF&OO1:G\+^(]1]FZ^MB&E/2[-BS4A#&:5WY
M C>GY;YHGADBD!:YKK&Q7&'0R?<U(B.K]H%D=J )4^RKT(1I\U"!82H,DQ6L
MLGW")-+3JR0F5<X^(<\ULO?9^';GV^^^@=!J:9;;5RN?T3HK-<XM=;NMS(U
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M/2S_B>OJT%VT!YGBI70F*+*M!49@ \/ZB)N#MPE!:\,0'9?1M4ZK/$#..'=
MP^&FE>0[ -&SE&K'\]5[3$A6DUCZ'=>7O!@K#>>A@*[) U7JX"6!!GR4Y 9J
M11'A0X5?1SD^#] SSO2:X6#43/8=X.CU_"M1O5A^)Q8FRB995#0@!866*B7R
M#0UYB:GV0Y<Q9Q$?ZLYQ#&YVUQ]GGLUP.#E:MAW@XMT2OX1I?OGM"\Y72![:
MV_5G7-Z0T20K;XQ+!4I4!'7/"P2M#&@C<PK&618?>G=]#%P.(&N<>3C#H:BU
M)CH UTWB1<K.1Y' 2R5 :3*;+D<)J1B4V8B$\J%&42>'Z>.,SAGP>#I:NL=#
M8[$.LT9V9_$%E^OO[V:A3I/,-2C\LITLF;=W^/@&PPK?UV'';\L?M",JN\\*
MH9/.Y?.S\UFM,GF!Q$":;K4XS\_.:JND_]A6_P2A5,$ZD52P6D7D#81$)W1"
M--I*VBNL=3@V/%<]A'A-<DR= : #:WGS /A],4\76SLF5DR6&:RO#Y<X6@BH
M+.3DA0J*,RM;YZCVT=)#I-@(?@V$W0%HWM(F"K4[W'V;98+HA9.<HMN@:QUL
M0(A:.RC6UA'O,GCG&R/G08)ZB!";P*>=V#O T&O2P?S3E.+;K80HC'GY+<W.
MZVOLORT6^<_I;#9)A6?N.2?_1$;:%[4<E]=I2<ZB1ZPM85H74AY"5P^Q9!-$
M-5="!\#:H5N&9"-%*\XF4#'326PMAY(B"N93M@^.RCP&/(\"R,!A8A. '"7,
M#D#PXF+9^EK_##^&;U?XGCBI'2:!8(RH@^,9@V"8H:.WOMC3(ECW4)^=XXH+
M]U'30WC8!"B-!-X!='8R(#L>FJFMI5B6$$HMY&;:;]]H*AUMMDQ:$5OG$>XE
M9)P1JT,X,R>+N0.L;.F?).>$([<+O,D!E)$"0F:^=@#) IF2,;6.E;8KCS-%
M=;#BCT<)LH-\TIMIB-/9YJ;OV3QO.@M]7LQ(Z*N:6%A_OQ*-S-R%VE,H,"WJ
MN_X(CHY,*.2@2\EX+;9M#)!#:>ND!O%-DT*S0132@9W9X>MV,C=$5F_],K 4
M#&T98B)X$I=V,0=52S<?[&A^(K2Z*D8;1OO[(7:**CH U>5-\[OPO5XS7^;T
M$QID3"6(@>2BZDM6KTA,*0MAD$M7TD//P4^YW[])23=@.DG/>Z[W3Q!Z']!9
MGF-^MUP47*U((V'V"J_+78J55HEB 8VF8QP]!Z^QGN69F1"$B,U#K(<I&O>0
M&PY*K930#Z2V5533^:?GB]7U/2,+R0@N CBE:_T4(D3G)?BH1$I6..9:IW(>
MHF?<"XEAX72Z CH T^Y=WJ6X+D?;3)PQ)9C:5MS7$9F&MDBHHRI*,>04V.)T
M:EW ]A ]XUY/# 2F9@KH $PWKUWN<(-<I%!K.W7VQ)(J#F+B%A)GR>82A6:M
M7Y(]3-&XMQ,# :JA$CJ U&6V]#U^Q?GYE1?HK.>\\ "9EXNQ?"'7FQ;NDPQ:
M2I2MC[G[*1GW_F(@"#40>@?0^1B^X>WH06X>:V<.O-3WOLEQDDJL4W^E8%P9
MIAZ<AG@,;NXA8]R[C(% <ZJX.T#,)M-^5SP4(& QQC% "C O7HG[VBR?\5P<
MEHS8.G.TAY1Q+S6&.K$:B+T#]-S#@4LVE-I]1.A2+_1X#0M2'?SG1=+2)H^M
M2[./Q,Q@5Q\#8>9$8?=U)7)]K7<E&Y111V_)+V/UK-5%@Q-90(ZB]AI(AKG6
M!]6#!'63%WJ2?/6)"NG!&"WFGS[B\JQV/MFY-;8Y9BXL[39OZETQ[1%O3  Z
MJ(N1/,CB6G=KN)^2;E+6IZKZ-HA.EWL'Z/ECOJHO,VG='78F$5EBKCZ;DI4)
M= 9<Y E*G4&GK:/CN'4ZZ%Y"NK%%C;%SNM0[@,[V&4 BL[QM\/A\,:_)"))1
M;3\ZS9OD1.U<>I&7V-DDFB6A)1/ BJCM!51M#^\3<)L8CX$C_6^(XI"CJ.TF
ML]T8A$^DOPZ06CFKXOK'=/WY^?EJO3B[CD)VV<+D0K!HP<K:KCQ%K&.*$C"7
M2F02'39_CGL@:=TDQ!MC< C-= "X.Y6?NQ+$]82"6V39./!!;=XEU.D6+@)G
M G5@+ICTT/B@)O6V-TGJ)D'>&& M-=$!L.Z]0]KU/FV0GG8*6,\L!=HIUNH)
M#D$F#"46GDSK=B8_(*F;M'EC8+741 ? VG.7M,-0+MP+A@XBKT]>6,GDG18.
MT40O4G"^-'\U_D.BNDFO-P976VUT *][1341+$OAZKRWY,B-9+11HA;UKLG8
M)+/R3#7/4=Q'2#>Y]M8IBI.EWE?V=)(I/$Y>$LS9IL<N+^"+2B"S=$D'82A^
M'@XPW02"3Y(9?92P^\+)O?*9N-K(PSH#MM0W5[HV:,[U'TPFQ9Q1O'GWG!_1
MU$U8]R2(.ETM'<"L3LR>KC=CCVL;S<N<2:H[AB0AD <!/A62$_<,',\!BBH8
M9#'H?6N$/4#.N.:J\2N65F+OP!=Z8*-%MPD./+!8)ZX76<#1Y@!G@A><Z8+-
M&XR<^ IJ,./4&#^-A-X!?-Y=KKMA:=NNE]DZW,!RX*AJG_J@(01-O^(BAJ(Y
M<ZSUXX)[R!B[/WL;#=_M3W.2N#M 3+6=B_D._<4FH5 $4,X0U<&09R>4!RLP
M*\$TD[JU&WV;AK&?6 Z"E9,$W0%0GN6\N0D*LW=AFE_/GX<O4_*;)HBLY&0E
M,%5?,2=+WEG("K*,*D1R_D)L_G;I?E+&]FD&@4T+L7> GO>X#G16YY=A.2?G
M;'6C.5R9INEZPIQG(25.,:3PH"R2E(P04*+PT6HC F_M(/^8JK']G$$PU5@9
M'<#KXQ+#ZGSY?2.PK:7=&EGM,E?)D.?OLJ0SV$AR"W4!F62@8SJ)*%H7$^RC
M9=Q;M(&@U$3PCP>0WP)HCI\J:%N]I[S<!)M*9&*&B/F,\]7T*VYO"-\L5O5>
M\&WY&+Y-O/.<B:" "6M!,:,IL*3_+-F096;&B=B\3.5Q)(Y[NS;4>3B@FCHP
M9/?DP)CURLL4Z]%.VTD9#]ZI %PKD9A!%9N?BT<F(P>[3!L(2R<*NUG"\:F&
MD;_;"/LSKJ>)O.4;7)PXF?SFEX<=4_X %T\YLQR5BDE).M9T(@><_A\XX1Q8
MRRW!1#GE!AN(^'0SRST=U"Q91O8RUG&5,H.WN8"5W%N;HRQEL,GL/\O,\L<@
MX0<SRQ\C[@Y.JWO&+4?GF,(8P2!J<O[HJ/66:\"H$;.OG9F''47=W<SR1^GT
MQS/+'R/@[B"R,W/7<.WH9.40I4R@ B8(A@M(SB<ILF<8_G\[L_Q1.CYT9OEC
M!#[V_.K;L[<=1V6L*"#J7!7Z)8/ 1:QE*3RSY*31Y4?.RT\TL_Q1JGIH9OEC
MY-:!L;CG7D_44]2)6KQ6IZXC\>*-<!!$,EP*5D=$#.6 O.ER[O0IY\F) NX
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M!/"8:_Z]B@JE !E\#B5:8T/KEV('D#7VC>E0B&JBAKZ0==?.\J0Y%A7!2^E
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M(_A<) @4J6B2C7"M [O'T#>NK6J+GWNZH RCIUX-U=OS]:IN>@IF:ZW 4?<
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M$M[YV6[2A9&+ZJ(%INI4C,)2;0EOP!N>K/:Q*-ZZ8^U!A!V&NY_M&J"]3CH
MVGND".@<7Y$0-UT<24AU+NSE \<[QAUU,)@E,$>.JG),@ ^!+'QF5GJ-%%NW
MSVH\AL+#H/>S71@,J*4.,/@LDR.YGJY(:L\7JWLN0F1T1O  1'ZIK30,!%$*
MI,(T!J5RC*WOIGY TF$H^]DN %KJH0-8[?;PO*C7OI>M["1Z)]VV6[!*(D'4
M,4-!SYA1-NG2NIW!@:0=!K.?+?T_A%XZ@-M[T@X14*_(7I"YGBTV29Z7WRJO
M>.$<U"X@R#9U2JS6PW$RS"(A1!L+DR8[W;P^XP"R#H/9SW<]T%8?'4#LJJGG
M[:T2I.:H. ?FW>9U?Z8#GV?@)N=D5/&L><^T?;0<!J:?[Z*@@>2[R+/]CG_N
MR&BYF-,O$^Y$,'?2TL4[;Y.$K&M2Q_/:J]$A8/$IB\)(;KXQMAY+XV&5KS_;
MQ<&@FOJYGXM\W-SZ#O=8Y.+[3_A4Y#Z.AG\H(D/2T@N]K<I7$3D$;@2@*"EY
M;:2WK<^-X1Z*W%=6<KTY7/$F"Y_ J&CJ!&H-CG8@9"N38I$0(EH/^7R0H&Z?
MA3P&$X=4]ARG@@Z\K0_I,^;S&5X]<UG5H3.K-XLPKWV6+G* \T_7=2@[@ZU"
M[9J,%I"G7#L82'!!6LC&%XIA(K/8NBW7">1V^W+D%"P^E?HZ0.HE@]>L/)O-
M%G_6-H*O%LOMZX8WB]7VD-GM2DD@4M4YT2I7Z1:(T3)0@H)MQ8)BI;5G=QRE
MW;Y".06?3Z"T#J!YO0NO:JTNAB'<XDNC-EX& \E* 2IG!H'59JFNH"J60BS=
M.C5R*&W=/FII8QX;*J8KP+W )>VK]?0K[MS2O9Y_(-5MHJB=:[QWB]6TZO/J
MBF_':4DV!UL0BL8 Q'!MZ,HR1"D-!B&MB*VSPXU9Z/8)31OX/KV:.T#YB^DJ
M?/JTQ$\;/;XM%Q>$M[:NB70\\/ID2",).# 2L B!Y,V<=XF3_)N/[#V$L&Z?
MSYR"R/8JZ35'<[L"['=<'Y^0V?^Q1C/=#J*U4:KE@3*Y>Z91%.&%2UD!1D8G
MJU>J3L')X'W&:)/1);4.$A]%8,L ^M_/IX1>LL33-6[*M&XO_]OWOX?_37[O
M+*QV.^!HITP)'C3AGYP/55,&,8$KM!N5(#$U;YMX.M7CIG:&P^!#$?83Z+>#
M8_>2XT5Y@--7Y^LJX;/:L.(_-FJ_N'2\<Q1D"OT,0I9,@ZIC8H(AQ]HY%Q-7
MT7#5O)]R0_K'31H]/<J?7.>]'O\W'K2$G0<MQSL!/_ID$U?@470W<@CV/OZY
M[AR7C+-8"CB&]=6/#N"%\,"*9;IDE>A_3_4>J]E\ZGT+[!3WR%!?9'K()I/A
MYY9"+5_;0Y&_[950/J76QN_'5(U[<+?%RL'/T([32:_&Z<.:./F\F)&J5I7%
M]?<3[HKW?:O-O?!!E+9JOKY9X/H\9-G6!])T'H8"JA"D?(D>1*80M(C$/&O>
M<OT&!>U"BTV[[]](NGFWKG CW+=?M@U_TWKZ]5*\UVB7UG+!B'/)',D "QW%
M468HS-;VFJ($V[RKZ<E4C]RZ_7@4[8\=GD2!'<4.NQR_"]\W!O[/L,R['-?D
MY%:KJ]7YV?;W;G$?+!,83('"&0,E0X*:6@*75)(!(_V[M=_0EH-QXX>!H?Q$
MBAT1UO6XW&']'V&YW!0VW;M5E35"%E7'P\AZ:2G"MDK2,>^$EK1M0_S1:?R8
M!<>],&Z K<&DVZO?=E5@>TIQW]V/-,HA/TA;(Q?M:I7[\A<J.B^9!!NY!N6=
M)@W; ,F*((PJ2>C6:= 'R&EW$M83?S&O%W;U&OIBP8O,R6\XQS*]?1O-'$^N
M& O9N@"*Y?JRDEGPT@FF.>TT-9S7]FARQW776B%J_X$WK/ZZ<MI>EH)I>\M\
MP>?[L"8#EQ;S-)U--TJ]Q:LK-M)?XA"TJLW,9 +'HP*6N;.9"Y3-6Y*?0N^X
M#MGP8!U8@UVA]<4% <3D-D'];)[?3$,D/M>7U>8[B9^D<C)&0$ IR>6D<"H*
MDB^Z>AD33<IBN-JK1Y$ZKF,W/$:'TUNOCM_;]6=<7E2>W>;T*"?PX0\V<0@?
M07,CYW"SXLY2]P!04QC I(Y0#*NOLT4=ELD29*<P!8$^NM8M='],U:D6[2%)
M[S1W\8FQ.FS8F^AH[U6#[2D4LD$4RQ-MP=RZ#\I!A(WK_C7&S&VCU5XUO9JH
M;8>UXRW2C;_?Q #MIZB1O=DN<(43%3(+ABLP2=/A5@>'1T4>458AH%'2NMSZ
M\=1-"DYO54A?JUT&;A<W2Y11:@LL1@$JZ@"QS@DEY LO(^>J>=7Y'E+&M14G
MZ/MN5\+31=V!+[UMKOCV"]8Q(?-/&ZXNS=SWOX=U?=UV.Q''#"^210]6;/RQ
MC=ESM8C8,$5.(.;F(\./('/<.*\ITH954:_GT<5,I-?SLEB>78>MQ]UQ[_M6
MFSON@RAM-:1SWW!ZEJ,LR<K:O3G7;C(*HD,#W(<<R?_0/@X]L&N >^];*^S(
M^+?O%W^X4W>F<C"5\2P,P5X(!K[>&#@?7"F""\N&JC5\)*DC#_AL@:$'+@@'
M4UJOMNK.8/:C+=6>+S6Q4X=0V:H2Y]92.[%8-K)609=@"&&EGH0..:1"QZ#7
M,AG3^D)_'RT-L^:W5JAS(U/MR#2=G:]KFNOF16:Q&8NB764%4K#(D,)1$H:(
MUA>91 G-RY*.)'7D.IP6&'H@43Z8TCKPZW<>+<S7TUQ9FG[=:5?Q\EN:G=,V
MW_;://MROKYXSW7'1EQ)(/J4@M61/,EZ2^ #V6E3'!#U7A>> O+6T7%[+D8N
MQQD6T:.HNM<C^>WR4YA?O%((\_S;^6HZITCJ]UIC4@7T M=A.CLN]W[@I]MD
MX8_AHU4^?F?MYXOY:C&;YNUFF>=W.QSM/#Z^>I"\,S4^2(:$X#J<J&P[7/I"
MX&8,BXLZ^JQ;>^5-"&]G@R^5MGE MGV<O?KM^\Y_;0Z;"47G.AOROAGCM29.
M97 JT;;SA#RN @EKN$?XA]$X<J[_R?&XW]@.H-,._(9[N'KV;;J:\,R$2XXX
M"#'1/QS)S*"OTU;0QI1YP-8^ZQY21HZ<!]7_[?'S#931*::V+VGQQ>(L3.<3
M9S7#N"D[H<!?U<M]$D^HU_R1)UZ[_;0>=?-#HL;%61/5'P"GX_4P=E'V\W=_
M_SN>15Q.2G2J2).@"$4RP6PAJJ# ,V6$"T:%;'_DTMW\9'^Z/T%/BY.%UJ<-
M(3<:7]/9OIH$H91)GM4Y)+6KC6002E84FZMH0DF!Z]8U(0_1,VZ,.?8)=9Q:
M.H#8LR6&VL\FS%ZNJM-X^91T(H-ET=27!IJDI%*==:.E .&4B,+;J'CS!H)[
M:.G.,!VI[=M- EN(O@,(70KH^>(L4@!R&:9,\^;NEC;<,LQ76\KXQ$>=2I$*
MI,P"%&<20C :BN2%*:]0N=:9\,?0-ZX5&PQJ@ZEH;'_H]_-ZKK\M;Z:IODO8
M/#-=G,_S:N(%LXE["PRM!>4B@F.Z@"%[7]"E@C8?Y!_M76+<>N7F6&DHSUY0
M\7K^>1JG](.KB>&:]!H9.&$X>7[.4@B1R+#6K@@BF>AN3V?Y 1RNOSUN"]%A
M<7"D!'M-CQ_6K[]%MOS(E9YP*L&3Y-(?ZL<HM#;<,)!8$Y(EU2?^Q4)05IE"
M0;UN_C!EN/D$U_''_EXLV[@#:=L9)R";5%\=:0>N,$NT9MI6Y.H9VSKI<RAM
M_4XM> 12]J>N&RIFQ/-MM5Q/WH?Y)]PDQACY8\%CAEPH=E4B!XB6(13K>$#!
MU($M%.FK.TBB_[I&T8T%>TE#M]3EXE3!]H"&B_Q6"L'[Z!4P63L=.U$@UBD'
M/KF,R?BL#QOA>@@>QDP:GJ"LV^H^0G(C*_SOT_GT[/SL@G#)4RBU9[LPB:(U
MDW5M[)5!*Z>+Y8++T,($W%AT9*4?H[)%"_F-K?CP;8=P90G<GISYPEP"Q5@$
M%VI;-TT16M%&"SRH\OE'BM]==)ST2#/%'RV_#K)LU]V%+B>)U/?#=1#F\BNN
M/M)7ME=E16FM8H"<:]-=&S,$4Z_YLY9:1^^E:UT/?QAEO=P/#. Z#*BB[H%W
M<3=7LF0B%P\1C0&5?:)?V0#,!2=94L4V'S=T"%WC^JM#X.%1D#M".6.G[IXO
M%MLW7YM6'B1D^@5MV;/%-F>]6J\NS3<MK5WBX!5Y?BKI0!N5*\A)<I6\#K2/
M#[O_/G#%GK%TC*(70TN] ]OU N/Z>G+,9K=9816R(L&).OX-N2%>L@.IR8<H
M):)(K9M,W:5BW*N#)SD,3Q1]=^#Y/9Q=%J)PGKSGBE"?4_4<12VJ#!R*2_4=
MM-.2M3[L]M$RKE$Z5<</0N9(@8]]@-TW)O7">)KBZJT+'>^BS@>RID"(+@*/
MPC!-AA5O^^9[CJS]:_2$AV,5N&@OS0ZLR:&#2G_[OC.T]-)%K 97U/['N3#:
M54QIDA\Z\-ID1.]%< /-<CZ*WG%O1)_D>'LR=78 W9L<7&QI<B>5X-9!2;[Z
MFK9 ),L/LN[UK+WEKK4?=1\=75Q:/0$*%HU5,O8Q^<<\+6:SVK.Q\K ,&:]9
MNK3P7K/,8XB 4GI07 6(008(/(N8O%4\J8/.RP,6&Q='IZMS,:!LQ\;*J_/9
M[/M%J)OW\,.#==Q%"SHS3MZ H\ TZPS66%Y0J=J0[""L'+#8N*G,MEAI+=L.
MCJN]I_YOWZ]LKY?.,YD$%.54=1[)(4W.0M1!)^4<N09/-J+HFJQQI_D^B=_4
M6CD]XVUW?RK&C4(*BUF=[&Z"I;->,- 4MA1A>4RN=1?+ \CJ=";6L5 X>"K6
M<7KI &J_G9-$:^NB^B1^^\O79U^6BZ_;Q[X7]MIFD4J,&K(HO/9A+^ 9.98!
M>6;1*&=U^X>%!Q#6*=R.A<.=&OO6NND <'\/)-4Y+K_O"NSR+D"Y4H>0D.-8
M1\K%0J&+8Q*\$9@+_9GEK6W: ^2,ZY0-#:Y6>N@ 4MMN++B\S4:)B@=A!6A7
MKT$9_2,DRR$%35O#2;2F=4)A#RGCWLX,#:46\N\ 1J_.E_/I9C!OS;A\J[^Z
MM+$)72[9$?TQ,0J&N ?'901AL4Z>UBR5UH9I/S7CYD*'!E,C+8Q<6$=2RN=I
M_7;Y@<+@:=JZGDX&EK%F2&H3*%7;#W@A#219BI:<!7E8SOT']77WK7T09LQ0
MF!F\S/ID<?<!EYKKO>#@L@!#<L$LH@*==:1PA1'Z2_! "A<!B1V9#SK##L/,
M70+&*\P]7:=W 7*B@,=.6[ZCSRSF8?8WG"_.IFEU^5+OTFV+F:5D%7!5'U36
M![<NTSYB11H? W%C#IN;^/ ZHT/B5"TNAA%I!R[,9H+H5:JC&!YJ[7&=(IE
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M'VLDMGZ>%YPY77,VBEBJ61U5% .*L>S6;D)TQ4O;.NLV@*QA&#NW0L18>ND
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M5&F\BQ?SCUL%WDR\CS:;%!-P;6I&-)!-4M 'P2HC67".Q6';!)[]S+2OI_L
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M+G#U];:4KE@Q4B:EE8?:%PS*2@,^UL0?SY'^?Q;8/ I^AIQI*V!C(ZJ5'CJ
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M0515#4('[;WPJA_G]S[QPV!];@6^253; Z;#!;XKNY?X=QPNDRT*BD(A2YE
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M.%D7SZ4WD5P*&Q$)-S%"C,E""H&[Z%6PIO6:F+99EU<I77Z^O*A#R+8]W]7
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MM(9HBP8FBU0I*L'9L)ER>WUVVJS3Z @=3P5G///P@(N*14GW5"E@HB/)",'
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M-M%3OS"DWWA-Q,PWZ_>D1J+PTZQ83#D3.TX61IXVC^1I!P<">49NI2.GYC0
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M#IA!1U.?_. .7"D<9& V"6OJ==U#K,.SJW70;#J(M6@GX@[R&1M6-E<5)XJ
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M1/L$QX\)2(LF9(T<N*\1&W%1$Y"&@BPF!?V%%.H4A'20\CTG3(Z7;9]8F:1
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MX\WJ=L\]CM4>A'(35E(T5F8*SQTY%K0&>&TM'0O18:E=^:7U*('3J1ZWZV1
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MFY1"+Y)0S1/G3Y/2%7".T/$+H#E&X'WB9A.1!>VLDYG1L:ERO;FAP8=@P;%
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M,#(R<&QA;F\N:'1M4$L! A0#%     @ 9IM\6.DS_R2O1P  *#,$ !<
M         ( !*L8  '!R;W!H87-E+65X:&EB:70Q.3$N:'1M4$L! A0#%
M  @ 9IM\6/S5"S<, @  . 4  !<              ( !#@X! '!R;W!H87-E
M+65X:&EB:70R,3$N:'1M4$L! A0#%     @ 9IM\6!$O_LV0"   [3D  !@
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M+FAT;5!+ 0(4 Q0    ( &:;?%C9H<5[^Q@  #:O   >              "
M 95" 0!P<F]P:&%S92UF;W)M;V8R,#(R<&QA;FEN8RYH=&U02P$"% ,4
M" !FFWQ8HETD6G(7   :J@  '@              @ ',6P$ <')O<&AA<V4M
M9F]R;6]F,C R,G!L86YN<6\N:'1M4$L! A0#%     @ 9IM\6*PS\XLUZ@(
MV'H: !$              ( !>G,! '!R<&@M,C R,S$R,S$N:'1M4$L! A0#
M%     @ 9IM\6"KP*P_W%@  [ L! !$              ( !WET$ '!R<&@M
M,C R,S$R,S$N>'-D4$L! A0#%     @ 9IM\6#R QQVS,   'O4! !4
M         ( !!'4$ '!R<&@M,C R,S$R,S%?8V%L+GAM;%!+ 0(4 Q0    (
M &:;?%B  G(F('8  &0,!0 5              "  >JE! !P<G!H+3(P,C,Q
M,C,Q7V1E9BYX;6Q02P$"% ,4    " !FFWQ8#$* ZMI$ 0 ;APP %0
M        @ $]' 4 <')P:"TR,#(S,3(S,5]L86(N>&UL4$L! A0#%     @
M9IM\6&<'Q\Z?PP  >KP( !4              ( !2F$& '!R<&@M,C R,S$R
M,S%?<')E+GAM;%!+ 0(4 Q0    ( &:;?%A'/*8DZ0(  $H)   :
M      "  1PE!P!P<G!H+65X:&EB:70R,S%C;VYS96YT+FAT;5!+!08
..$P 3 "P%   ]* <    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>prph-20231231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:prph="http://prophaselabs.com/20231231"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="prph-20231231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2024-03-15</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:SeptemberTwoThousandAndTwentyNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:SeptemberTwoThousandAndTwentyNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:A2023NoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:A2023NoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prph:CPMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:OldBridgeNewJerseyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-23</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prph:CPMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:MarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:MarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:CorporateStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:USGovernmentObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:CorporateObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">prph:UncollectibleTradeReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">prph:UncollectibleTradeReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">prph:FullyReservedTradeReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:CorporateStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:CorporateStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:CorporateStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:USGovernmentObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:USGovernmentObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:USGovernmentObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:CorporateObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:CorporateObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">prph:CorporateObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">prph:PersonalGenomicsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:DiagnosticServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:DiagnosticServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:RetailAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:RetailAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:GenomicProductsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:GenomicProductsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">prph:CooperativeIncentivePromotionCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">prph:CooperativeIncentivePromotionCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">prph:StellaPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-03</startDate>
            <endDate>2023-01-03</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2023-01-03</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <startDate>2023-01-03</startDate>
            <endDate>2023-01-03</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-03</startDate>
            <endDate>2023-01-03</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:A2023SecuredMortgageLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-20</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:A2023SecuredMortgageLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-20</startDate>
            <endDate>2023-12-20</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:A2023SecuredMortgageLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:A2023NoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-26</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">prph:A2023NotesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-26</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">prph:A2023NotesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-26</startDate>
            <endDate>2023-01-26</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">prph:A2023NotesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">prph:BlackScholesOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-26</startDate>
            <endDate>2023-01-26</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">prph:A2023NotesWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:A2023NoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:SeptemberTwoThousandAndTwentyNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-15</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">prph:LetterAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-28</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <startDate>2022-02-28</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:SeptemberTwoThousandAndTwentyNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-10</startDate>
            <endDate>2023-09-10</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:SeptemberTwoThousandAndTwentyNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">prph:SeptemberTwoThousandAndTwentyNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <startDate>2022-05-09</startDate>
            <endDate>2022-05-09</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <startDate>2022-02-14</startDate>
            <endDate>2022-02-14</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2023-03-15</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-15</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2022-07-26</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <startDate>2022-07-26</startDate>
            <endDate>2022-07-26</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:A2022DirectorsPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-19</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:Amended2022DirectorsPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-16</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:A2022DirectorsPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:A2022DirectorsPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:A2022DirectorsPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:Amended2010DirectorsPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-20</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:A2022PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-19</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:Amended2022PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-16</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:A2022PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:AmendedTwoThousandTenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-20</startDate>
            <endDate>2021-05-20</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-12</startDate>
            <endDate>2018-04-12</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:CEOOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-03</startDate>
            <endDate>2022-06-03</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">prph:MrKamalObbadMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:InducementOptionAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-09</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prph:InducementOptionAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-09</startDate>
            <endDate>2022-05-09</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:CFOAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-12</startDate>
            <endDate>2019-12-12</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:CFOAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-12</startDate>
            <endDate>2019-12-12</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:CFOAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-03</startDate>
            <endDate>2022-06-03</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:CFOAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">prph:TwoThousandEighteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-04</startDate>
            <endDate>2022-10-04</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:InducementOptionAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:InducementOptionAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:InducementOptionAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:InducementOptionAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:InducementOptionAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:InducementOptionAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">prph:ShareBasedCompensationAwardTrancheFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">prph:CertainHoldersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-12</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2023-01-12</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <startDate>2023-01-12</startDate>
            <endDate>2023-01-12</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-12</startDate>
            <endDate>2023-01-12</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">prph:A2023NotesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-06</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-06</startDate>
            <endDate>2023-04-06</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2021-05-01</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2022-11-15</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">prph:LinebackerLicenseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-19</startDate>
            <endDate>2022-07-19</endDate>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:PhaseThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">prph:LinebackerLicenseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-19</startDate>
            <endDate>2022-07-19</endDate>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">prph:NewDrugApplicationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">prph:LinebackerLicenseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-19</startDate>
            <endDate>2022-07-19</endDate>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">prph:LinebackerLicenseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">prph:LinebackerLicenseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">prph:EquivirLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">prph:BESmartLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">prph:CPMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:OldBridgeNewJerseyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-23</startDate>
            <endDate>2020-10-23</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:NewYorkSecondFloorLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-08</instant>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:NewYorkSecondFloorLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-08</startDate>
            <endDate>2020-12-08</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:NewYorkSecondFloorLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-08</startDate>
            <endDate>2020-12-08</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:NewYorkFirstFloorLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-10</instant>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:NewYorkFirstFloorLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-10</startDate>
            <endDate>2022-06-10</endDate>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:NewYorkFirstFloorLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-10</startDate>
            <endDate>2022-06-10</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:NewYorkFirstFloorLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-10</startDate>
            <endDate>2022-06-10</endDate>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">prph:NewYorkFirstFloorLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2023-04-19</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2023-07-21</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2023-09-26</instant>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">prph:SegmentConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:DiagnosticServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">prph:SegmentConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:DiagnosticServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:GovernmentAgenciesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:InsuranceProvidersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:ClientPayersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:GovernmentAgenciesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:InsuranceProvidersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:DiagnosticServicesClientsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:ReimbursementReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:DiagnosticServicesClientsTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:ReimbursementReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:DiagnosticServicesClientsThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:ReimbursementReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:DiagnosticServicesClientsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:ReimbursementReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">prph:DiagnosticServicesClientsTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">prph:ReimbursementReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:DiagnosticServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:DiagnosticServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:ConsumerProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:ConsumerProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:UnallocatedCorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:UnallocatedCorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:DiagnosticServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:DiagnosticServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:ConsumerProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:ConsumerProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:UnallocatedCorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">prph:UnallocatedCorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">prph:CommonStockPurchaseWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">prph:CommonStockPurchaseWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-16</startDate>
            <endDate>2024-02-16</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-14</startDate>
            <endDate>2024-02-14</endDate>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-14</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="numberoflicensedcompound">
        <measure>prph:numberOfLicensedCompound</measure>
    </unit>
    <unit id="inhibitor">
        <measure>prph:inhibitor</measure>
    </unit>
    <unit id="segment">
        <measure>prph:Segment</measure>
    </unit>
    <unit id="test">
        <measure>prph:test</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="debt">
        <measure>prph:debt</measure>
    </unit>
    <unit id="investor">
        <measure>prph:investor</measure>
    </unit>
    <unit id="period">
        <measure>prph:period</measure>
    </unit>
    <unit id="site">
        <measure>prph:site</measure>
    </unit>
    <unit id="option">
        <measure>prph:option</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-33">0000868278</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-34">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-35">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-36">false</dei:AmendmentFlag>
    <prph:DebtSecuritiesAvailableForSaleMaturityPeriod contextRef="c-41" id="f-378">P1Y</prph:DebtSecuritiesAvailableForSaleMaturityPeriod>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-49" id="f-443">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-51" id="f-445">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-53" id="f-447">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-72" id="f-513">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-74" id="f-514">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-76" id="f-515" xsi:nil="true"/>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-73" id="f-516">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-75" id="f-517">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-77" id="f-518" xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-163" id="f-688">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="c-4" id="f-939">http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-199" id="f-968">P10Y7M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2023-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-4">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">000-21617</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">ProPhase Labs, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">23-2577138</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">711 Stewart Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-11">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-12">Garden City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-13">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-14">11530</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-15">(215)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-16">345-0919</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, $0.0005 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">PRPH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-20">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-21">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-22">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-23">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-24">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-25">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-26">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-27">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-28">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-29">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c-2" decimals="0" id="f-30" unitRef="usd">100240301</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-31" unitRef="shares">18045209</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c-1" id="f-32">Portions of the Registrant&#x2019;s definitive proxy statement relating to its 2024 annual meeting of stockholders (the &#x201c;2024 Proxy Statement&#x201d;) are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. The 2024 Proxy Statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId contextRef="c-1" id="f-37">536</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c-1" id="f-38">Morison Cogen LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-39">Blue Bell, Pennsylvania</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-40" unitRef="usd">1609000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-41" unitRef="usd">9109000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash contextRef="c-4" decimals="-3" id="f-42" unitRef="usd">540000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash contextRef="c-5" decimals="-3" id="f-43" unitRef="usd">0</us-gaap:RestrictedCash>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-4" decimals="-3" id="f-44" unitRef="usd">3127000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-5" decimals="-3" id="f-45" unitRef="usd">8328000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-3" id="f-46" unitRef="usd">36313000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-5" decimals="-3" id="f-47" unitRef="usd">37054000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-3" id="f-48" unitRef="usd">3841000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-5" decimals="-3" id="f-49" unitRef="usd">3976000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-50" unitRef="usd">2155000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-5" decimals="-3" id="f-51" unitRef="usd">2366000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-52" unitRef="usd">47585000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-5" decimals="-3" id="f-53" unitRef="usd">60833000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-3" id="f-54" unitRef="usd">12898000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-5" decimals="-3" id="f-55" unitRef="usd">7288000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PrepaidExpenseNoncurrent contextRef="c-4" decimals="-3" id="f-56" unitRef="usd">832000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:PrepaidExpenseNoncurrent contextRef="c-5" decimals="-3" id="f-57" unitRef="usd">121000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-58" unitRef="usd">4572000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-59" unitRef="usd">4059000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-3" id="f-60" unitRef="usd">12333000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-5" decimals="-3" id="f-61" unitRef="usd">8475000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-62" unitRef="usd">5231000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-5" decimals="-3" id="f-63" unitRef="usd">5709000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-4" decimals="-3" id="f-64" unitRef="usd">7313000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-5" decimals="-3" id="f-65" unitRef="usd">0</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-66" unitRef="usd">1163000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-5" decimals="-3" id="f-67" unitRef="usd">1163000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-68" unitRef="usd">91927000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-5" decimals="-3" id="f-69" unitRef="usd">87648000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-70" unitRef="usd">9383000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-5" decimals="-3" id="f-71" unitRef="usd">5905000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-4" decimals="-3" id="f-72" unitRef="usd">314000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-5" decimals="-3" id="f-73" unitRef="usd">1009000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedMarketingCostsCurrent contextRef="c-4" decimals="-3" id="f-74" unitRef="usd">24000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:AccruedMarketingCostsCurrent contextRef="c-5" decimals="-3" id="f-75" unitRef="usd">99000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-76" unitRef="usd">1840000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-77" unitRef="usd">0</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-78" unitRef="usd">953000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-79" unitRef="usd">301000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="c-4" decimals="-3" id="f-80" unitRef="usd">2382000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="c-5" decimals="-3" id="f-81" unitRef="usd">2499000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="c-4" decimals="-3" id="f-82" unitRef="usd">3278000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="c-5" decimals="-3" id="f-83" unitRef="usd">4190000</us-gaap:TaxesPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-84" unitRef="usd">2683000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-85" unitRef="usd">2072000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-86" unitRef="usd">20857000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-87" unitRef="usd">16075000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent contextRef="c-4" decimals="-3" id="f-88" unitRef="usd">341000</us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-3" id="f-89" unitRef="usd">2924000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-5" decimals="-3" id="f-90" unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:UnsecuredLongTermDebt contextRef="c-6" decimals="-3" id="f-91" unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt contextRef="c-7" decimals="-3" id="f-92" unitRef="usd">2400000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent contextRef="c-8" decimals="-3" id="f-93" unitRef="usd">266000</us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent contextRef="c-9" decimals="-3" id="f-94" unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent>
    <us-gaap:UnsecuredLongTermDebt contextRef="c-8" decimals="-3" id="f-95" unitRef="usd">7334000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt contextRef="c-9" decimals="-3" id="f-96" unitRef="usd">0</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:AssetAcquisitionContingentConsiderationLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-97" unitRef="usd">2000000</us-gaap:AssetAcquisitionContingentConsiderationLiabilityNoncurrent>
    <us-gaap:AssetAcquisitionContingentConsiderationLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-98" unitRef="usd">0</us-gaap:AssetAcquisitionContingentConsiderationLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-99" unitRef="usd">1100000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-100" unitRef="usd">1059000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-4" decimals="-3" id="f-101" unitRef="usd">0</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-5" decimals="-3" id="f-102" unitRef="usd">224000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-103" unitRef="usd">4092000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-104" unitRef="usd">0</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-105" unitRef="usd">4237000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-106" unitRef="usd">4259000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-107" unitRef="usd">21687000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c-5" decimals="-3" id="f-108" unitRef="usd">7942000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-109" unitRef="usd">42544000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-5" decimals="-3" id="f-110" unitRef="usd">24017000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-111" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-5" id="f-112" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-113" unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-114" unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="4"
      id="f-115"
      unitRef="usdPerShare">0.0005</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-116"
      unitRef="usdPerShare">0.0005</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued contextRef="c-5" decimals="INF" id="f-117" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-118" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-119" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-4" decimals="INF" id="f-120" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue contextRef="c-4" decimals="-3" id="f-121" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-5" decimals="-3" id="f-122" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-123" unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-124" unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-125"
      unitRef="usdPerShare">0.0005</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-126"
      unitRef="usdPerShare">0.0005</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-127" unitRef="shares">18045029</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-128" unitRef="shares">16210776</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-129" unitRef="usd">18000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-5" decimals="-3" id="f-130" unitRef="usd">16000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-3" id="f-131" unitRef="usd">118694000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-5" decimals="-3" id="f-132" unitRef="usd">109138000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-133" unitRef="usd">-5029000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-3" id="f-134" unitRef="usd">11753000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockCommonShares contextRef="c-4" decimals="INF" id="f-135" unitRef="shares">18940967</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-5" decimals="INF" id="f-136" unitRef="shares">18126790</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue contextRef="c-4" decimals="-3" id="f-137" unitRef="usd">64000000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-5" decimals="-3" id="f-138" unitRef="usd">58033000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-139" unitRef="usd">-300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="-3" id="f-140" unitRef="usd">757000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-141" unitRef="usd">49383000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-142" unitRef="usd">63631000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-143" unitRef="usd">91927000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-5" decimals="-3" id="f-144" unitRef="usd">87648000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-145" unitRef="usd">44384000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-10" decimals="-3" id="f-146" unitRef="usd">122647000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-3" id="f-147" unitRef="usd">28145000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-10" decimals="-3" id="f-148" unitRef="usd">51993000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c-1" decimals="-3" id="f-149" unitRef="usd">16239000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-10" decimals="-3" id="f-150" unitRef="usd">70654000</us-gaap:GrossProfit>
    <us-gaap:ProfessionalFees contextRef="c-1" decimals="-3" id="f-151" unitRef="usd">1932000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c-10" decimals="-3" id="f-152" unitRef="usd">12022000</us-gaap:ProfessionalFees>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-153" unitRef="usd">34502000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-10" decimals="-3" id="f-154" unitRef="usd">34385000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-155" unitRef="usd">1418000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-10" decimals="-3" id="f-156" unitRef="usd">652000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-3" id="f-157" unitRef="usd">37852000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-10" decimals="-3" id="f-158" unitRef="usd">47059000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-159" unitRef="usd">-21613000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-10" decimals="-3" id="f-160" unitRef="usd">23595000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeOther contextRef="c-1" decimals="-3" id="f-161" unitRef="usd">78000</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther contextRef="c-10" decimals="-3" id="f-162" unitRef="usd">153000</us-gaap:InterestIncomeOther>
    <us-gaap:InterestExpense contextRef="c-1" decimals="-3" id="f-163" unitRef="usd">1275000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-10" decimals="-3" id="f-164" unitRef="usd">764000</us-gaap:InterestExpense>
    <us-gaap:GainLossOnInvestments contextRef="c-1" decimals="-3" id="f-165" unitRef="usd">0</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments contextRef="c-10" decimals="-3" id="f-166" unitRef="usd">-76000</us-gaap:GainLossOnInvestments>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-167" unitRef="usd">10000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-10" decimals="-3" id="f-168" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-169" unitRef="usd">-22800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-10" decimals="-3" id="f-170" unitRef="usd">22908000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-171" unitRef="usd">-6018000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-10" decimals="-3" id="f-172" unitRef="usd">4445000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-173" unitRef="usd">-16782000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-10" decimals="-3" id="f-174" unitRef="usd">18463000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-3" id="f-175" unitRef="usd">-1057000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-10" decimals="-3" id="f-176" unitRef="usd">932000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-177" unitRef="usd">-17839000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-10" decimals="-3" id="f-178" unitRef="usd">19395000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-179"
      unitRef="usdPerShare">-0.98</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-10"
      decimals="2"
      id="f-180"
      unitRef="usdPerShare">1.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-181"
      unitRef="usdPerShare">-0.98</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-10"
      decimals="2"
      id="f-182"
      unitRef="usdPerShare">1.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-3" id="f-183" unitRef="shares">17207000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-10" decimals="-3" id="f-184" unitRef="shares">15845000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-3" id="f-185" unitRef="shares">17207000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-10" decimals="-3" id="f-186" unitRef="shares">18651000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-11"
      decimals="INF"
      id="f-187"
      unitRef="shares">15485900</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-3" id="f-188" unitRef="usd">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="-3" id="f-189" unitRef="usd">104552000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-13" decimals="-3" id="f-190" unitRef="usd">2642000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-14" decimals="-3" id="f-191" unitRef="usd">-175000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-15" decimals="-3" id="f-192" unitRef="usd">-48407000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-16" decimals="-3" id="f-193" unitRef="usd">58628000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-17"
      decimals="INF"
      id="f-194"
      unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-18" decimals="-3" id="f-195" unitRef="usd">600000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-10" decimals="-3" id="f-196" unitRef="usd">600000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-17"
      decimals="INF"
      id="f-197"
      unitRef="shares">828021</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-17"
      decimals="INF"
      id="f-198"
      unitRef="shares">303145</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-19" decimals="-3" id="f-199" unitRef="usd">2152000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-10" decimals="-3" id="f-200" unitRef="usd">2152000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:DividendsCommonStockCash contextRef="c-20" decimals="-3" id="f-201" unitRef="usd">9352000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-10" decimals="-3" id="f-202" unitRef="usd">9352000</us-gaap:DividendsCommonStockCash>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-19" decimals="-3" id="f-203" unitRef="usd">7474000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-10" decimals="-3" id="f-204" unitRef="usd">7474000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-21" decimals="-3" id="f-205" unitRef="usd">932000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-10" decimals="-3" id="f-206" unitRef="usd">932000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-18" decimals="-3" id="f-207" unitRef="usd">3986000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-10" decimals="-3" id="f-208" unitRef="usd">3986000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-20" decimals="-3" id="f-209" unitRef="usd">18463000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-10" decimals="-3" id="f-210" unitRef="usd">18463000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-22"
      decimals="INF"
      id="f-211"
      unitRef="shares">16210776</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-3" id="f-212" unitRef="usd">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-3" id="f-213" unitRef="usd">109138000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="-3" id="f-214" unitRef="usd">11753000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-3" id="f-215" unitRef="usd">757000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-3" id="f-216" unitRef="usd">-58033000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-217" unitRef="usd">63631000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c-27"
      decimals="INF"
      id="f-218"
      unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-27" decimals="-3" id="f-219" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-28" decimals="-3" id="f-220" unitRef="usd">999000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-1" decimals="-3" id="f-221" unitRef="usd">1000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-27"
      decimals="INF"
      id="f-222"
      unitRef="shares">69628</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-29" decimals="-3" id="f-223" unitRef="usd">588000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-1" decimals="-3" id="f-224" unitRef="usd">588000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-27"
      decimals="INF"
      id="f-225"
      unitRef="shares">800000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-27" decimals="-3" id="f-226" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-28" decimals="-3" id="f-227" unitRef="usd">2399000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-1" decimals="-3" id="f-228" unitRef="usd">2400000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <prph:IssuanceOfCommonStockSharesExerciseOfWarrant
      contextRef="c-27"
      decimals="INF"
      id="f-229"
      unitRef="shares">400000</prph:IssuanceOfCommonStockSharesExerciseOfWarrant>
    <prph:IssuanceOfCommonStockUponExerciseOfWarrantAmount contextRef="c-28" decimals="-3" id="f-230" unitRef="usd">1200000</prph:IssuanceOfCommonStockUponExerciseOfWarrantAmount>
    <prph:IssuanceOfCommonStockUponExerciseOfWarrantAmount contextRef="c-1" decimals="-3" id="f-231" unitRef="usd">1200000</prph:IssuanceOfCommonStockUponExerciseOfWarrantAmount>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-27"
      decimals="INF"
      id="f-232"
      unitRef="shares">603881</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c-28" decimals="-3" id="f-233" unitRef="usd">398000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c-1" decimals="-3" id="f-234" unitRef="usd">398000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-29" decimals="-3" id="f-235" unitRef="usd">5379000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-3" id="f-236" unitRef="usd">5379000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-30" decimals="-3" id="f-237" unitRef="usd">-1057000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-3" id="f-238" unitRef="usd">-1057000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <prph:PrepaidShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-239" unitRef="usd">1024000</prph:PrepaidShareBasedCompensationExpense>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-28" decimals="-3" id="f-240" unitRef="usd">4560000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-241" unitRef="usd">4560000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-31" decimals="-3" id="f-242" unitRef="usd">-16782000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-243" unitRef="usd">-16782000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-32"
      decimals="INF"
      id="f-244"
      unitRef="shares">18045029</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-32" decimals="-3" id="f-245" unitRef="usd">18000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-33" decimals="-3" id="f-246" unitRef="usd">118694000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-34" decimals="-3" id="f-247" unitRef="usd">-5029000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-35" decimals="-3" id="f-248" unitRef="usd">-300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-36" decimals="-3" id="f-249" unitRef="usd">-64000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-250" unitRef="usd">49383000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-251" unitRef="usd">-16782000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-10" decimals="-3" id="f-252" unitRef="usd">18463000</us-gaap:NetIncomeLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss contextRef="c-1" decimals="-3" id="f-253" unitRef="usd">22000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss contextRef="c-10" decimals="-3" id="f-254" unitRef="usd">-354000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-255" unitRef="usd">6277000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-10" decimals="-3" id="f-256" unitRef="usd">4718000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-1" decimals="-3" id="f-257" unitRef="usd">132000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-10" decimals="-3" id="f-258" unitRef="usd">4000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-3" id="f-259" unitRef="usd">421000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-10" decimals="-3" id="f-260" unitRef="usd">343000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:GainLossOnSaleOfProperties contextRef="c-1" decimals="-3" id="f-261" unitRef="usd">23000</us-gaap:GainLossOnSaleOfProperties>
    <us-gaap:GainLossOnSaleOfProperties contextRef="c-10" decimals="-3" id="f-262" unitRef="usd">127000</us-gaap:GainLossOnSaleOfProperties>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-263" unitRef="usd">3536000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-10" decimals="-3" id="f-264" unitRef="usd">3986000</us-gaap:ShareBasedCompensation>
    <prph:ChangeInFairValueOfInvestmentSecurities contextRef="c-1" decimals="-3" id="f-265" unitRef="usd">0</prph:ChangeInFairValueOfInvestmentSecurities>
    <prph:ChangeInFairValueOfInvestmentSecurities contextRef="c-10" decimals="-3" id="f-266" unitRef="usd">174000</prph:ChangeInFairValueOfInvestmentSecurities>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-1" decimals="-3" id="f-267" unitRef="usd">718000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-10" decimals="-3" id="f-268" unitRef="usd">-761000</us-gaap:ProvisionForDoubtfulAccounts>
    <prph:InventoryValuationReserve contextRef="c-1" decimals="-3" id="f-269" unitRef="usd">0</prph:InventoryValuationReserve>
    <prph:InventoryValuationReserve contextRef="c-10" decimals="-3" id="f-270" unitRef="usd">-78000</prph:InventoryValuationReserve>
    <us-gaap:ProvisionForLoanLeaseAndOtherLosses contextRef="c-1" decimals="-3" id="f-271" unitRef="usd">91000</us-gaap:ProvisionForLoanLeaseAndOtherLosses>
    <us-gaap:ProvisionForLoanLeaseAndOtherLosses contextRef="c-10" decimals="-3" id="f-272" unitRef="usd">6163000</us-gaap:ProvisionForLoanLeaseAndOtherLosses>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-3" id="f-273" unitRef="usd">68000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-10" decimals="-3" id="f-274" unitRef="usd">4498000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-1" decimals="-3" id="f-275" unitRef="usd">-135000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-10" decimals="-3" id="f-276" unitRef="usd">-702000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-277" unitRef="usd">376000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-10" decimals="-3" id="f-278" unitRef="usd">617000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <prph:IncreaseDecreaseInDeferredIncomeTaxAssets contextRef="c-1" decimals="-3" id="f-279" unitRef="usd">7313000</prph:IncreaseDecreaseInDeferredIncomeTaxAssets>
    <prph:IncreaseDecreaseInDeferredIncomeTaxAssets contextRef="c-10" decimals="-3" id="f-280" unitRef="usd">0</prph:IncreaseDecreaseInDeferredIncomeTaxAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-1" decimals="-3" id="f-281" unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-10" decimals="-3" id="f-282" unitRef="usd">555000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-1" decimals="-3" id="f-283" unitRef="usd">3478000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-10" decimals="-3" id="f-284" unitRef="usd">-1121000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <prph:IncreaseDecreaseInAccruedDiagnosticServices contextRef="c-1" decimals="-3" id="f-285" unitRef="usd">-695000</prph:IncreaseDecreaseInAccruedDiagnosticServices>
    <prph:IncreaseDecreaseInAccruedDiagnosticServices contextRef="c-10" decimals="-3" id="f-286" unitRef="usd">-881000</prph:IncreaseDecreaseInAccruedDiagnosticServices>
    <prph:IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances contextRef="c-1" decimals="-3" id="f-287" unitRef="usd">-75000</prph:IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances>
    <prph:IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances contextRef="c-10" decimals="-3" id="f-288" unitRef="usd">-5000</prph:IncreaseDecreaseInAccruedAdvertisingAndOtherAllowances>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c-1" decimals="-3" id="f-289" unitRef="usd">-76000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c-10" decimals="-3" id="f-290" unitRef="usd">619000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <prph:IncreaseDecreaseInDeferredIncomeTaxLiabilities contextRef="c-1" decimals="-3" id="f-291" unitRef="usd">-224000</prph:IncreaseDecreaseInDeferredIncomeTaxLiabilities>
    <prph:IncreaseDecreaseInDeferredIncomeTaxLiabilities contextRef="c-10" decimals="-3" id="f-292" unitRef="usd">-138000</prph:IncreaseDecreaseInDeferredIncomeTaxLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-293" unitRef="usd">-181000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-10" decimals="-3" id="f-294" unitRef="usd">-301000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c-1" decimals="-3" id="f-295" unitRef="usd">-912000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c-10" decimals="-3" id="f-296" unitRef="usd">2878000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="c-1" decimals="-3" id="f-297" unitRef="usd">611000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="c-10" decimals="-3" id="f-298" unitRef="usd">-423000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-299" unitRef="usd">-11348000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-10" decimals="-3" id="f-300" unitRef="usd">28551000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:EscrowDepositsRelatedToPropertySales contextRef="c-1" decimals="-3" id="f-301" unitRef="usd">478000</us-gaap:EscrowDepositsRelatedToPropertySales>
    <us-gaap:EscrowDepositsRelatedToPropertySales contextRef="c-10" decimals="-3" id="f-302" unitRef="usd">0</us-gaap:EscrowDepositsRelatedToPropertySales>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-1" decimals="-3" id="f-303" unitRef="usd">2904000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-10" decimals="-3" id="f-304" unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <prph:IssuanceOfSecuredPromissoryNoteReceivable contextRef="c-1" decimals="-3" id="f-305" unitRef="usd">0</prph:IssuanceOfSecuredPromissoryNoteReceivable>
    <prph:IssuanceOfSecuredPromissoryNoteReceivable contextRef="c-10" decimals="-3" id="f-306" unitRef="usd">0</prph:IssuanceOfSecuredPromissoryNoteReceivable>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-1" decimals="-3" id="f-307" unitRef="usd">3819000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-10" decimals="-3" id="f-308" unitRef="usd">6777000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-1" decimals="-3" id="f-309" unitRef="usd">3817000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-10" decimals="-3" id="f-310" unitRef="usd">1047000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities contextRef="c-1" decimals="-3" id="f-311" unitRef="usd">4168000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities contextRef="c-10" decimals="-3" id="f-312" unitRef="usd">7120000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleOfOtherPropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-313" unitRef="usd">46000</us-gaap:ProceedsFromSaleOfOtherPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfOtherPropertyPlantAndEquipment contextRef="c-10" decimals="-3" id="f-314" unitRef="usd">452000</us-gaap:ProceedsFromSaleOfOtherPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable contextRef="c-1" decimals="-3" id="f-315" unitRef="usd">0</us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable>
    <us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable contextRef="c-10" decimals="-3" id="f-316" unitRef="usd">0</us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="c-1" decimals="-3" id="f-317" unitRef="usd">3155000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="c-10" decimals="-3" id="f-318" unitRef="usd">3919000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-319" unitRef="usd">-1369000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-10" decimals="-3" id="f-320" unitRef="usd">-2077000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromNotesPayable contextRef="c-1" decimals="-3" id="f-321" unitRef="usd">10524000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="c-10" decimals="-3" id="f-322" unitRef="usd">0</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-1" decimals="-3" id="f-323" unitRef="usd">1200000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-10" decimals="-3" id="f-324" unitRef="usd">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-3" id="f-325" unitRef="usd">5379000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-10" decimals="-3" id="f-326" unitRef="usd">7474000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:RepaymentsOfNotesPayable contextRef="c-1" decimals="-3" id="f-327" unitRef="usd">0</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="c-10" decimals="-3" id="f-328" unitRef="usd">7044000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-3" id="f-329" unitRef="usd">588000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-10" decimals="-3" id="f-330" unitRef="usd">2152000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividends contextRef="c-1" decimals="-3" id="f-331" unitRef="usd">0</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends contextRef="c-10" decimals="-3" id="f-332" unitRef="usd">9353000</us-gaap:PaymentsOfDividends>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-333" unitRef="usd">5757000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-10" decimals="-3" id="f-334" unitRef="usd">-26023000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-335" unitRef="usd">-6960000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-10" decimals="-3" id="f-336" unitRef="usd">451000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-337" unitRef="usd">9109000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-16" decimals="-3" id="f-338" unitRef="usd">8658000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-339" unitRef="usd">2149000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-340" unitRef="usd">9109000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-1" decimals="-3" id="f-341" unitRef="usd">3000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-10" decimals="-3" id="f-342" unitRef="usd">1696000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-3" id="f-343" unitRef="usd">932000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-10" decimals="-3" id="f-344" unitRef="usd">763000</us-gaap:InterestPaidNet>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="c-1" decimals="-3" id="f-345" unitRef="usd">1024000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="c-10" decimals="-3" id="f-346" unitRef="usd">0</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <prph:IssuanceOfCommonSharesForDebtConversion contextRef="c-1" decimals="-3" id="f-347" unitRef="usd">2400000</prph:IssuanceOfCommonSharesForDebtConversion>
    <prph:IssuanceOfCommonSharesForDebtConversion contextRef="c-10" decimals="-3" id="f-348" unitRef="usd">600000</prph:IssuanceOfCommonSharesForDebtConversion>
    <prph:NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities contextRef="c-1" decimals="-3" id="f-349" unitRef="usd">1520000</prph:NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities>
    <prph:NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities contextRef="c-10" decimals="-3" id="f-350" unitRef="usd">1294000</prph:NetUnrealizedLossGainInvestmentsInMarketableDebtSecurities>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-1" decimals="-3" id="f-351" unitRef="usd">5809000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-10" decimals="-3" id="f-352" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <prph:IssuanceOfWarrantsWithUnsecuredPromissoryNote contextRef="c-1" decimals="-3" id="f-353" unitRef="usd">398000</prph:IssuanceOfWarrantsWithUnsecuredPromissoryNote>
    <prph:IssuanceOfWarrantsWithUnsecuredPromissoryNote contextRef="c-10" decimals="-3" id="f-354" unitRef="usd">0</prph:IssuanceOfWarrantsWithUnsecuredPromissoryNote>
    <us-gaap:StockIssued1 contextRef="c-1" decimals="-3" id="f-355" unitRef="usd">1000000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-10" decimals="-3" id="f-356" unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-357">Organization and Business&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ProPhase Labs, Inc. (&#x201c;ProPhase&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, &#x201c;our&#x201d; or the &#x201c;Company&#x201d;) is a diversified company that offers a range of services including genomics testing, diagnostic testing and contract manufacturing. We are also focused on licensing, developing and commercializing novel drugs, dietary supplements, compounds and diagnostics.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Until late fiscal year 2020, the Company was engaged primarily in the research, development, manufacture, distribution, marketing and sale of over-the-counter ("OTC") consumer healthcare products and dietary supplements in the United States. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:29.15pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In October 2020, the Company completed the acquisition of all of the issued and outstanding shares of capital stock of Confucius Plaza Medical Laboratory Corp. (&#x201c;CPM&#x201d;), which owned a 4,000 square foot &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Clinical Laboratory Improvement Amendments (&#x201c;CLIA&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; accredited laboratory located in Old Bridge, New Jersey for approximately $2.5 million, and began offering COVID-19 diagnostic tests through our wholly-owned subsidiary, ProPhase Diagnostics, Inc. ("ProPhase Diagnostics") in December 2020. Also in December 2020, we expanded our diagnostic service business with the build-out of a second, larger CLIA accredited laboratory in Garden City, New York. Operations at this second facility commenced in January 2021. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;We offered a broad array of COVID-19 related clinical diagnostic and testing services including polymerase chain reaction (&#x201c;PCR&#x201d;) testing for COVID-19 and Influenza A and B through ProPhase Diagnostics, as well as rapid antigen and antibody/immunity testing for COVID-19. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Due to the significant decrease in demand and reimbursement rate for our diagnostic testing service, we have reduced the amount of diagnostic testing services that we provide since the second half of 2023. Nonetheless we are prepared to provide an increased volume of our diagnostic testing service if diagnostic testing is required due to a new COVID-19 outbreak. We have continued to ship COVID-19 antigen kits under an existing contract to our customer. In addition, in order to maintain licenses in certain states in which we operate, we currently perform several diagnostic tests each quarter to maintain our certified lab status, and we currently plan to do so for the foreseeable future.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:29.15pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In August 2021, the Company acquired Nebula Genomics, Inc. (&#x201c;Nebula&#x201d;), a privately owned personal genomics company, through our wholly-owned subsidiary, ProPhase Precision Medicine Inc. Nebula focuses on genomics sequencing technologies, a comprehensive method for analyzing entire genomes, including the genes and chromosomes in deoxyribonucleic acidDNA. The data obtained from genomic sequencing can be used to help identify inherited disorders and tendencies, help predict disease risk, help identify expected drug response, and characterize genetic mutations, including those that drive cancer progression. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:29.15pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:29.15pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company's wholly owned subsidiary, ProPhase BioPharma, Inc. (&#x201c;PBIO&#x201d;), was formed in June 2022, for the licensing, development and commercialization of novel drugs, dietary supplements and compounds. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Licensed compounds currently include Equivir (a OTC, dietary supplement candidate) and Equivir G (prescription drug (&#x201c;Rx&#x201d;) candidate), two broad-based anti-virals, and Linebacker LB-1 and LB-2, two small molecule proviral integration site for moloney murine leukemia virus (&#x201c;PIM&#x201d;) kinase inhibitors. The Company also own the exclusive rights to the BE-Smart Esophageal Pre-Cancer Diagnostic Screening test and related intellectual property (&#x201c;IP&#x201d;) assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the activities of PBIO, in January 2023, the Company acquired exclusive rights to BE-Smart Esophageal Pre-Cancer Diagnostic Screening test and related IP assets. The BE-Smart test is focused on the early detection of esophageal cancer, and is intended to provide health care providers and patients with data to help determine treatment options. The development of these novel drugs and compounds is highly dependent on how each performs during the testing and development stage, the demand for these product and services once entered into the marketplace, our marketing and service capabilities and our ability to comply with applicable regulatory requirements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's wholly-owned subsidiary, Pharmaloz Manufacturing, Inc. (&#x201c;PMI&#x201d;), is a full-service contract manufacturer and private label developer of a broad range of non-GMO, organic and natural-based cough drops and lozenges and OTC drug and dietary supplement products. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also develops and markets dietary supplements under the TK Supplements&#xae; brand. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The TK Supplements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;product line includes Legendz XL&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, a male sexual enhancement and Triple Edge XL&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, an energy and stamina booster. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:29.15pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company's wholly owned subsidiary, Pharmaloz Real Estate Holdings, Inc. (&#x201c;PREH&#x201d;), was formed in November 2023, for the purpose to receive additional investment to expand its current facility. There was no operation for PREH as of December 31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:29.15pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company continues to actively pursue acquisition opportunities for other companies, technologies and products within and outside the consumer products industry.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:AreaOfRealEstateProperty contextRef="c-37" decimals="0" id="f-358" unitRef="sqft">4000</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-38" decimals="-3" id="f-359" unitRef="usd">2500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <prph:NumberOfLicensedCompounds
      contextRef="c-39"
      decimals="INF"
      id="f-360"
      unitRef="numberoflicensedcompound">2</prph:NumberOfLicensedCompounds>
    <prph:NumberOfInhibitors
      contextRef="c-40"
      decimals="INF"
      id="f-361"
      unitRef="inhibitor">2</prph:NumberOfInhibitors>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-362">Summary of Significant Accounting Policies&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no effect on the reported results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification ("ASC") 280, &#x201c;Segment Reporting&#x201d; (&#x201c;ASC 280&#x201d;), the Company discloses financial and descriptive information about its reportable operating segments. Operating segments are components of an enterprise about which separate financial information is available and regularly evaluated by the chief operating decision maker in deciding how to allocate resources and in assessing performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows ASC 280, which establishes standards for reporting information about operating segments in annual and interim financial statements, and requires that companies report financial and descriptive information about their reportable segments based on a management approach. ASC 280 also establishes standards for related disclosures about products and services, geographic areas and major customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating segments are defined as components of an enterprise that engage in business activities for which separate financial information is available and is evaluated by the Chief Operating Decision Maker (&#x201c;CODM&#x201d;), which for the Company is its Chief Executive Officer, in deciding how to allocate resources and assess performance. We maintain two operating segments: diagnostic services (which includes our COVID-19 and other diagnostic testing services) and consumer products (which includes our contract manufacturing, retail customers, biopharma and personal genomics products and services). See Note 15 Segment Information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business and Liquidity Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Our diagnostic service business continued to be impacted by the level of demand for COVID-19 and other diagnostic testing, the prices we are able to receive for performing our testing services, our ability to collect payment or reimbursement for our testing services in December 31, 2023 and ultimately led to our revenues decreasing significantly for the year ended December 31, 2023. On March 22, 2022, the Health Resources &amp;amp; Services Administration ("HRSA") program stopped accepting claims for COVID-19 testing and treatment provided to uninsured individuals due to lack of sufficient funds. We recognized approximately 1,000,000 tests for the year ended December 31, 2022 and approximately 480,000  tests for the year ended December 31, 2023, of which 28%  were reimbursed by the HRSA uninsured program for the year ended December 31, 2022, and none were reimbursed from the HRSA uninsured program for the year ended December 31, 2023. As a result, we have reduced the amount of diagnostic testing services that we provide since the second half of 2023. Nonetheless we are prepared to provide an increased volume of our diagnostic testing service if diagnostic testing is required due to a new COVID-19 outbreak. We have continued to ship COVID-19 antigen kits under an existing contract to our customer. In addition, in order to maintain licenses in certain states in which we operate, we currently perform several diagnostic tests each quarter to maintain our certified lab status, and we currently plan to do so for the foreseeable future. There is no guarantee that the demand of our diagnostic testing services will increase or meet the level of demand that we experienced during the COVID-19 pandemic, and there is no guarantee that we will be able to substitute the revenues previously generated from this line of business from our other business lines.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Our personal genomics business is and will continue to be influenced by demand for our genetic sequencing products and services, our marketing and service capabilities, and our ability to comply with applicable regulatory requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Our contracting manufacturing business is and will continue to be impacted by demand for our services, which is largely a function of the timing, length and severity of each cold season. Generally, a cold season is defined as the period from September to March when the incidence of the common cold rises as a result of the change in weather and other factors. We generally experience in the first, third and fourth quarter higher levels of net revenues from our contract manufacturing business. Revenues are generally at their lowest levels in the second quarter when customer demand generally declines. This line of business is also impacted by our ability to meet such demands. The building of our manufacturing facilities and manufacturing of products necessitates compliance with applicable regulatory requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consumer sales are and will continue to be impacted by (i) the timing of acceptance of our TK Supplements&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; consumer products in the marketplace, and (ii) fluctuations in the timing of purchase and the ultimate level of demand for these products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December&#160;31, 2023, $11.3&#160;million was used by operating activities.  The Company had cash, cash equivalents, restricted cash and marketable securities of $5.3 million as of December&#160;31, 2023. Based on management&#x2019;s current business plans, the Company estimates that it will have enough cash and liquidity to finance its operating requirements for at least one year from the date of filing these financial statements. However, due to the nature of the diagnostic business and the Company's focus thus far on COVID-19, there are inherent uncertainties associated with managements&#x2019; business plan and cash flow projections if the Company is unable to grow its diagnostic testing business beyond COVID-19 testing services and to grow its other businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As such, the Company&#x2019;s future capital needs and the adequacy of its available funds will depend on many factors. These include, but not necessarily limited to, the actual cost and time necessary to achieve sustained profitability from diagnostic services, the ability to successfully diversify the diagnostic services revenue streams and the ability to market and grow the personal genomics, biopharma, manufacturing and supplement businesses. The Company may be required to raise additional funds through equity or debt securities offerings or strategic collaboration and/or licensing agreements in order to fund operations until it is able to generate enough revenues. Such financing may not be available on acceptable terms, or at all, and the Company&#x2019;s failure to raise capital when needed could have a material adverse effect on its strategic objectives, results of operations and financial condition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements and the accompanying notes thereto, in conformity with generally accepted accounting principles in the United States of America (&#x201c;GAAP&#x201d;), requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the respective reporting periods. Examples include revenue recognition and the impact of the variable consideration around diagnostic test reimbursement rates, the provision for uncollectible receivables and billing errors, sales returns and allowances, rates, slow moving, dated inventory and associated provisions, the estimated useful lives and potential impairment of long-lived assets, stock based compensation valuation, income tax asset valuations and assumptions related to accrued advertising.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our estimates and assumptions are based on historical experience, current trends and other factors that management believes to be relevant at the time the financial statements are prepared. Management reviews the accounting policies, assumptions, estimates and judgments on a quarterly basis. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider all highly liquid investments with a maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents include cash on hand and monies invested in money market funds. The carrying amount approximates the fair market value due to the short-term maturity of these securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash as of December&#160;31, 2023 includes approximately $540,000 held in escrow related to the Company's mortgage loan. There was no restricted cash as of December 31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have classified our investments in marketable debt and equity securities as available-for-sale and as a current asset. Our investments in marketable securities are carried at fair value, with unrealized gains and as a separate component of stockholders&#x2019; equity. Realized gains and losses from our marketable securities are recorded as interest income (expense). Marketable debt securities carry maturity dates between &lt;span style="-sec-ix-hidden:f-378"&gt;one&lt;/span&gt; and three years from date of purchase and interest rates of 1.40% to 4.90% during fiscal 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the components of our marketable securities and the underlying fair value input level tier hierarchy (see fair value of financial instruments) (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Unrealized &lt;br/&gt;Losses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Corporate stock&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(401)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(401)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unrealized &lt;br/&gt;Losses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;U.S. government obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We believe that the unrealized gains or losses generally are the result of a change in the risk premiums required by market participants rather than an adverse change in cash flows or a fundamental weakness in the credit quality of the issuer or underlying assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable consists primarily of amounts due from government agencies and healthcare insurers. Unbilled accounts receivable relates to the delivery of our diagnostic testing services for which the related billings will occur in a future period, after a patient&#x2019;s insurance information has been validated, and represent amounts we have an unconditional right to receive payment. Unbilled accounts receivable is classified as accounts receivable on the consolidated balance sheet. We carry our accounts receivable at the amount of consideration for which we expect to be entitled less allowances. When estimating the allowances for our diagnostics business, the Company pools its trade receivables based on the following payer types: healthcare insurers and government payers. The Company principally estimates the allowance for credit losses by pool based on historical collection experience, current economic conditions, expectations of future economic conditions, other credits and the period of time that the receivables have been outstanding. To the extent that any individual payers are identified that have deteriorated in credit quality, the Company removes the payers from their respective pools and establishes allowances based on the individual risk characteristics of such payers. On a periodic basis, we evaluate our receivables and establish an allowance, based on a history of past write-offs, government and healthcare insurer payment trends, collections, current credit conditions or generally accepted future trends. Accounts receivable are stated at the net amount expected to be collected, using an expected loss methodology that is referred to as the current expected credit loss ("CECL") model.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts are written off as uncollectible at the time we determine that collections are unlikely. Accounts receivable, net is comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Trade accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;37,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unbilled accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(3,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(3,140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;36,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;37,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The table below presents a roll forward of the Company's allowance for credit losses (amount in thousands).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.212%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.610%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.190%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period provision for expected credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;For Fiscal 2023, we recorded  $0.3&#160;million to credit losses in operating expenses representing a write-off of trade receivables we have determined to be uncollectible and increased the allowance for credit losses as a reduction of revenue by $0.4&#160;million. The results of these adjustments and our current year allowances, resulted in an allowance of $3.9&#160;million at December&#160;31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;At December 31, 2023, within the diagnostic services business, insurers had significantly aged balances that we are continuing to work to collect.  The specific facts and circumstances related to each of these individual payors have been considered by our management, which informed the determination of the year-end reserve balance. We continue to pursue collection of amounts due. However, there will inevitably be billings that are rejected by the insurance carriers and associated receivables that will not be collected. We believe that the reserve established at December 31, 2023 is adequate to capture this collectability risk. While past history is helpful informing the determination of an appropriate reserve, its utility is somewhat limited by the circumstances underlying a significant portion of these aged balances; specifically, an unprecedented volume of activity related COVID 19 diagnostic testing.  Accordingly, the determination of an appropriate reserve required significant management judgment and was informed by the unique facts and circumstances related to each of the three significant insurers. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;For Fiscal 2022, we recorded $5.9&#160;million to credit loss expense in operating expenses representing a write-off of trade receivables we have determined to be uncollectible. Additionally, we wrote off $2.9&#160;million of trade receivables and related allowances at December 31, 2022, that were fully reserved for in 2021 and did not impact the result of operations for the year ended December 31, 2022. The Company also increased its allowance for credit losses in Fiscal 2022 by $5.5&#160;million. The results of these adjustments and our current year allowances, resulted in an allowance of $3.1&#160;million at December 31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is valued at the lower of cost, determined on a first-in, first-out basis (&#x201c;FIFO&#x201d;), or net realizable value. Inventory items are analyzed to determine cost and the net realizable value and appropriate valuation adjustments are established.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2023 and 2022, the components of inventory are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diagnostic services testing material&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Inventory valuation reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Inventory, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are recorded at cost. We use the straight-line method in computing depreciation for financial reporting purposes. Depreciation expense is computed in accordance with the following ranges of estimated asset lives: building and improvements - &lt;span style="-sec-ix-hidden:f-443"&gt;ten&lt;/span&gt; to thirty-nine years; leasehold improvements - lesser of lease term or estimated useful life; machinery and equipment including lab equipment - &lt;span style="-sec-ix-hidden:f-445"&gt;three&lt;/span&gt; to seven years; computer equipment and software - &lt;span style="-sec-ix-hidden:f-447"&gt;three&lt;/span&gt; to five years; and furniture and fixtures - five years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Financial Risks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash investments, marketable debt securities, and trade accounts receivable. Our marketable securities are fixed income investments, which are highly liquid and can be readily purchased or sold through established markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We maintain cash and cash equivalents with certain major financial institutions. As of December&#160;31, 2023, our cash and cash equivalents and restricted cash balance was $2.1 million. Of the total bank balance, $1.0 million was covered by federal depository insurance and $1.1 million was uninsured at December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable subject us to credit risk concentrations from time-to-time. We extend credit to our consumer healthcare product customers based upon an evaluation of the customer&#x2019;s financial condition and credit history and generally do not require collateral. Our diagnostic services receivable credit risk is based on payer reimbursement experience, which includes government agencies and healthcare insurers, the period the receivables have been outstanding and the historical collection rates. The collectability of the diagnostic services receivables is also directly linked to the quality of our billing processes, which depend on information provided and billing services of third parties. These credit concentrations impact our overall exposure to credit risk, which could be further affected by changes in economic, regulatory or other conditions that may impact the timing and collectability of trade receivables and diagnostic test receivables. Additionally, the reimbursement receivables from the diagnostic service business are subject to billing errors and related disputes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, see Note 13 - Significant Customers Concentrations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the inception of an arrangement, we determine whether the arrangement is or contains a lease based on the unique facts and circumstances present in the arrangement. Most leases with a term greater than one year are recognized on the balance sheet as right-of-use assets and short-term and long-term lease liabilities, as applicable. We have elected not to recognize on the balance sheet leases with terms of 12 months or less. We typically only include an initial lease term in its assessment of a lease arrangement. Options to renew a lease are not included in our assessment unless there is reasonable certainty that we will renew.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected remaining lease term. Certain adjustments to the right-of-use asset may be required for items such as incentives received. The interest rate implicit in our leases is typically not readily determinable. As a result, we utilize our incremental borrowing rate, which reflects the fixed rate at which we could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term and in a similar economic environment (see Note 12, Leases).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of a lease should be allocated between lease components (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;e.g&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;., land, building, etc.) and non-lease components (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;e.g&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;., common area maintenance, consumables, etc.). The fixed and in-substance fixed contract consideration (including any consideration related to non-components) must be allocated based on the respective relative fair values to the lease components and non-lease components.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the fair value of the consideration transferred over the fair value of the underlying identifiable assets and liabilities acquired in a business combination. Goodwill and intangible assets deemed to have an indefinite life are not amortized, but instead are assessed for impairment annually. Additionally, if an event or change in circumstances occurs that would more likely than not reduce the fair value of the reporting unit below its carrying value, we would evaluate goodwill and other intangibles at that time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In testing for goodwill impairment, we have the option to first assess qualitative factors to determine whether the existence of events or circumstances lead to a determination that it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If, after assessing the totality of events and circumstances, we conclude that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is not required. If we conclude otherwise, we are required to perform the two-step impairment test. The goodwill impairment test is performed at the reporting unit level by comparing the estimated fair value of a reporting unit with its respective carrying value. If the estimated fair value exceeds the carrying value, goodwill at the reporting unit level is not impaired. If the estimated fair value is less than the carrying value, an impairment charge will be recorded to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reduce the reporting unit to fair value. Management completed a qualitative assessment of Goodwill and it was not deemed impaired at December 31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets deemed to have finite lives are amortized on a straight-line basis over their estimated useful lives, where the useful life is the period over which the asset is expected to contribute directly, or indirectly, to our future cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews long-lived assets, including property and equipment and finite-lived intangible assets, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. An impairment loss is recognized when the asset&#x2019;s carrying value exceeds the total undiscounted cash flows expected from its use and eventual disposition. The amount of the impairment loss is determined as the excess of the carrying value of the asset over its fair value. For the fiscal years ended December&#160;31, 2023 and 2022, the Company did not have an impairment of the long-lived assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We measure assets and liabilities at fair value based on expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale date of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are the hierarchical levels of inputs to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Level 1: Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Level 2: Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Level 3: Unobservable inputs reflecting the Company&#x2019;s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of our financial assets and liabilities, such as cash, accounts receivable, accounts payable, and unsecured note payable, approximate their fair values because of the short-term nature of these instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for our marketable securities at fair value, with the net unrealized gains or losses of marketable debt securities reported as a component of accumulated other comprehensive income or loss and marketable equity securities change in fair value reported on the condensed consolidated statement of operations. The components of marketable securities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Corporate stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;U.S. government obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers of marketable debt securities between Levels 1, 2 or 3 for the years ended December&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue that represents the transfer of promised goods or services to customers at an amount that reflects the consideration that is expected to be received in exchange for those goods or services. We recognize revenue when performance obligations with our customers have been satisfied. At contract inception, we evaluate the contract to determine if revenue should be recognized using the following five steps: (1) identify the contract with the customer; (2) identify the performance obligations; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations; and (5) recognize revenue when (or as) the entity satisfies a performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract with Customers and Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account. A contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Sales from product shipments to contract manufacturing and retailer customers are recognized at the time ownership is transferred to the customer. Revenue from diagnostic services is recognized when the results are made available to the customer. Revenue from our personal genomics business is recognized when the genetic testing results are provided to the customer. For subscription services associated with our genomic testing, we recognize revenue ratably over the term of the subscription.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s performance obligation for contract manufacturing and retail customers is to provide the goods ordered by the customer. The Company has one performance obligation for its diagnostic services, which is to provide the results of the laboratory test to the customer. Our personal genomics business has separate performance obligations to provide initial testing and genome results and subscriptions services to our customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transaction Price &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our diagnostic services business, a revenue transaction is initiated when we receive a requisition order to perform a diagnostic test. The information provided on the requisition form is used to determine the party that will be billed for the testing performed and the expected reimbursement. We provide diagnostic services to a range of customers. In many cases, the customer that orders our services is not responsible for paying for these services. Depending on the billing arrangement and applicable law, the payer may be the patient or a third party, such as a health plan, Medicare or Medicaid program and other government reimbursement programs. We bill the providers at standard price and take into consideration negotiated discounts and anticipated reimbursement remittance adjustments based on the payer portfolio, when revenue is recorded. We use the most expected value method to estimate the transaction price for reimbursements that vary from the listed contract price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our personal genomics business, a revenue transaction is initiated by a DNA test kit sale direct to the consumer sales via our website or through online retailers. The kit sales and subscriptions are billed at a standard price and take into consideration any discounts when revenue is recorded. We also contract with third party B2B partners and universities and sell DNA test kits directly to them.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For contract manufacturing and retail customers, the transaction price is fixed based upon either (i) the terms of a combined master agreement and each related purchase order, or (ii) if there is no master agreement, the price per individual purchase order received from each customer. The customers are invoiced at an agreed upon contractual price for each unit ordered and delivered by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from retail customers is reduced for trade promotions, estimated sales returns and other allowances in the same period as the related sales are recorded. No such allowance is applicable to our contract manufacturing customers. We estimate potential future product returns and other allowances related to current period revenue. We analyze historical returns, current trends, and changes in customer and consumer demand when evaluating the adequacy of the sales returns and other allowances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not accept returns from our contract manufacturing customers. Our return policy for retail customers accommodates returns for (i) discontinued products, (ii) store closings and (iii) products that have reached or exceeded their designated expiration date. We do not impose a period of time during which product may be returned. All requests for product returns must be submitted to us for pre-approval. We will not accept return requests pertaining to customer inventory &#x201c;Overstocking&#x201d; or &#x201c;Resets&#x201d;. We will accept return requests only for products in their intended package &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;configuration. We reserve the right to terminate shipment of product to customers who have made unauthorized deductions contrary to our return policy or pursue other methods of reimbursement. We compensate the customer for authorized returns by means of a credit applied to amounts owed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our diagnostic services business, a revenue transaction is initiated when we receive a requisition order to perform a diagnostic test. The information provided on the requisition form is used to determine the party that will be billed for the testing performed and the expected reimbursement. We provide diagnostic services to a range of customers. In many cases, the customer that orders our services is not responsible for paying for these services. Depending on the billing arrangement and applicable law, the payer may be the patient or a third party, such as a health plan, Medicare or Medicaid program and other government reimbursement programs. We bill the providers at standard price and take into consideration negotiated discounts and anticipated reimbursement remittance adjustments based on the payer portfolio, when revenue is recorded. We use the most expected value method to estimate the transaction price for reimbursements that vary from the listed contract price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our personal genomics business, a revenue transaction is initiated by a DNA test kit sale direct to the consumer sales via our website or through online retailers. The kit sales and subscriptions are billed at a standard price and take into consideration any discounts when revenue is recorded. We also contract with third party B2B partners and universities and sell DNA test kits directly to them.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recognize Revenue When the Company Satisfies a Performance Obligation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For diagnostic services, the Company satisfies its performance obligation at the point in time that the results are made available to the customer, which is when the customer benefits from the information contained in the results and obtains control.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For genomic services, we satisfy our product performance obligation at a point in time when the genetic testing results are provided to the customer. For subscriptions services associated with its genomic testing, we satisfy our performance obligation ratably over the subscription period. If the customer does not return the test kit, services cannot be completed by us, potentially resulting in unexercised rights (&#x201c;breakage&#x201d;) revenue, including lifetime subscription services. We estimate breakage for the portion of test kits not expected to be returned using an analysis of historical data and consider other factors that could influence customer test kit return behavior. When breakage revenue is recognized on a kit, we recognize breakage on any associated subscription services ratably over the term of the subscription&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Performance obligations related to contract manufacturing and retail customers are satisfied at a point in time when the goods are shipped to the customer as (i) we have transferred control of the assets to the customers upon shipping, and (ii) the customer obtains title and assumes the risks and rewards of ownership after the goods are shipped.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and December&#160;31, 2022, we have deferred revenue of $3.5 million and $3.6 million, respectively. Our new personal genomics business comprised $3.4 million of the deferred revenue as of December&#160;31, 2023. The remainder of deferred revenue relates to research and development (&#x201c;R&amp;amp;D&#x201d;) stability and release testing programs recognized as contract manufacturing revenue. Deferred revenues primarily consist of amounts that have been billed to or received from customers in advance of revenue recognition and prepayments received from customers in advance of services performed for the R&amp;amp;D work. We recognize deferred revenues as revenues when the services are performed and the corresponding revenue recognition criteria are met. Customer prepayments are generally applied against invoices issued to customers when services are performed and billed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table disaggregates our deferred revenue by recognition period (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Recognition Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0-12 Months&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13-24 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Over 24 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We disaggregate revenue from contracts with customers into four categories: contract manufacturing, retail and others, diagnostic services and genomic products and services. We determined that disaggregating revenue into these categories achieves the disclosure objective to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table disaggregates the Company&#x2019;s revenue by revenue source for Fiscal 2023 and 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.263%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Revenue by Customer Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diagnostic services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;108,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Contract manufacturing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Retail and others&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Genomic products and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;44,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;122,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Customer Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company makes payments to certain diagnostic services customers for distinct services that approximate fair value for those services. Such services include specimen collection, the collection and delivery of insurance and patient information necessary for billing and collection, and logistics services. Consideration associated with specimen collection services is classified in cost of revenues and the remaining costs are classified as diagnostic expenses within operating expenses in the accompanying statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sales Tax Exclusion from the Transaction Price&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shipping and Handling Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for shipping and handling activities that we perform as activities to fulfill the promise to transfer the good.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising and Incentive Promotions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising and incentive promotion costs are expensed within the period in which they are utilized. Advertising and incentive promotion expense is comprised of (i) media advertising, presented as part of general and administrative expense, (ii) cooperative incentive &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;promotions and coupon program expenses, which are accounted for as part of net revenue, and (iii) free product, which is accounted for as part of cost of revenues. Advertising and incentive promotion expenses incurred from continuing operations for Fiscal 2023 and 2022 were $1.8 million and $0.4 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for stock-based compensation in accordance with FASB ASC 718, &#x201c;Compensation &#x2013; Stock Compensation.&#x201d; Under the fair value recognition provision of the ASC, stock-based compensation cost is estimated at the grant date based on the fair value of the award. The Company estimates the fair value of stock options and warrants granted using the Black-Scholes-Merton option pricing model and stock grants at their closing reported market value. We recognize all stock-based payments to employees and directors, including grants of stock options, as compensation expense in the financial statements based on their grant date fair values. The grant date fair values of stock options are determined through the use of the Black-Scholes option pricing model. The compensation cost is recognized as an expense over the requisite service period of the award, which usually coincides with the vesting period. We account for forfeitures as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock and stock options to purchase our common stock have been granted to employees pursuant to the terms of certain agreements and stock option plans (see Note 7, Stockholders' Equity). Stock options are exercisable during a period determined by us, but in no event later than seven years from the date granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;R&amp;amp;D costs are charged to operations in the period incurred, R&amp;amp;D costs incurred for the years ended December&#160;31, 2023 and 2022 were $1.4 million and $0.7 million, respectively. R&amp;amp;D costs are principally related to personnel expenses and new product development initiatives and costs associated with the OTC health care products, dietary supplements and validation costs associated with the diagnostic services business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes in accordance with accounting guidance now codified as FASB ASC 740, &#x201c;Income Taxes,&#x201d; which requires that the Company recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for, or benefit from, income taxes includes deferred taxes resulting from the temporary differences in income for financial and tax purposes using the liability method. Such temporary differences result primarily from the differences in the carrying value of assets and liabilities. Future realization of deferred income tax assets requires sufficient taxable income within the carry-back, carryforward period available under tax law. We evaluate, on a quarterly basis whether, based on all available evidence, it is probable that the deferred income tax assets are realizable. Valuation allowances are established when it is more likely than not that the tax benefit of the deferred tax asset will not be realized. The evaluation, as prescribed by ASC 740- 10, &#x201c;Income Taxes,&#x201d; includes the consideration of all available evidence, both positive and negative, regarding historical operating results including recent years with reported losses, the estimated timing of future reversals of existing taxable temporary differences, estimated future taxable income exclusive of reversing temporary differences and carryforwards, and potential tax planning strategies which may be employed to prevent an operating loss or tax credit carryforward from expiring unused.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes under ASU No. 2019-12, &#x201c;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (&#x201c;ASU 2019-12&#x201d;), which simplifies various aspects related to accounting for income taxes. This standard became effective for the Company January 1, 2021. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for uncertainties in income taxes under the provisions of FASB ASC 740-10-05 (the &#x201c;Subtopic&#x201d;). The Subtopic clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s financial statements. The Subtopic prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The Subtopic provides guidance on the de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards, Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2023, the Company adopted Accounting Standards Update ("ASU") 2016-13, &#x201c;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&#x201d; (&#x201c;ASU 2016-13&#x201d;) ASU 2016-13 requires an impairment model (known as the CECL model) that is based on expected losses rather than incurred losses. Under the new guidance, each reporting entity should estimate an allowance for expected credit losses, which is intended to result in more timely recognition of losses. This model replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost, accounts receivable and available for sale debt securities and applies to some off-balance sheet credit exposures. In February 2020, the FASB issued ASU 2020-02, Financial Instruments - Credit Losses (Topic 326), which amends the effective date of the original pronouncement for smaller reporting companies. ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022. The adoption of ASU 2016-13 did not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2023, the FASB issued ASU 2023-05, "Business Combinations - Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement." The new guidance applies to the formation of a joint venture and requires a joint venture to initially measure all contributions received upon its formation at fair value. The guidance is intended to reduce diversity in practice and is applicable to joint venture entities with a formation date on or after January 1, 2025 on a &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;prospective basis. The Company currently does not have any transactions that fall under the scope of ASU 2023-05; therefore, the adoption of ASU 2023-05 is not expected to have an impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards, Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), which requires an enhanced disclosure of significant segment expenses on an annual and interim basis. This guidance will be effective for the annual periods beginning the year ended December 31, 2024, and for interim periods beginning January 1, 2025. Early adoption is permitted. Upon adoption, the guidance should be applied retrospectively to all prior periods presented in the financial statements. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which improves the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the effective tax rate reconciliation and income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. This guidance will be effective for the annual periods beginning the year ended December 31, 2025. Early adoption is permitted. Upon adoption, the guidance can be applied prospectively or retrospectively. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-363">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no effect on the reported results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c-1" id="f-364">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification ("ASC") 280, &#x201c;Segment Reporting&#x201d; (&#x201c;ASC 280&#x201d;), the Company discloses financial and descriptive information about its reportable operating segments. Operating segments are components of an enterprise about which separate financial information is available and regularly evaluated by the chief operating decision maker in deciding how to allocate resources and in assessing performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows ASC 280, which establishes standards for reporting information about operating segments in annual and interim financial statements, and requires that companies report financial and descriptive information about their reportable segments based on a management approach. ASC 280 also establishes standards for related disclosures about products and services, geographic areas and major customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating segments are defined as components of an enterprise that engage in business activities for which separate financial information is available and is evaluated by the Chief Operating Decision Maker (&#x201c;CODM&#x201d;), which for the Company is its Chief Executive Officer, in deciding how to allocate resources and assess performance. We maintain two operating segments: diagnostic services (which includes our COVID-19 and other diagnostic testing services) and consumer products (which includes our contract manufacturing, retail customers, biopharma and personal genomics products and services). See Note 15 Segment Information.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-365"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-366">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business and Liquidity Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Our diagnostic service business continued to be impacted by the level of demand for COVID-19 and other diagnostic testing, the prices we are able to receive for performing our testing services, our ability to collect payment or reimbursement for our testing services in December 31, 2023 and ultimately led to our revenues decreasing significantly for the year ended December 31, 2023. On March 22, 2022, the Health Resources &amp;amp; Services Administration ("HRSA") program stopped accepting claims for COVID-19 testing and treatment provided to uninsured individuals due to lack of sufficient funds. We recognized approximately 1,000,000 tests for the year ended December 31, 2022 and approximately 480,000  tests for the year ended December 31, 2023, of which 28%  were reimbursed by the HRSA uninsured program for the year ended December 31, 2022, and none were reimbursed from the HRSA uninsured program for the year ended December 31, 2023. As a result, we have reduced the amount of diagnostic testing services that we provide since the second half of 2023. Nonetheless we are prepared to provide an increased volume of our diagnostic testing service if diagnostic testing is required due to a new COVID-19 outbreak. We have continued to ship COVID-19 antigen kits under an existing contract to our customer. In addition, in order to maintain licenses in certain states in which we operate, we currently perform several diagnostic tests each quarter to maintain our certified lab status, and we currently plan to do so for the foreseeable future. There is no guarantee that the demand of our diagnostic testing services will increase or meet the level of demand that we experienced during the COVID-19 pandemic, and there is no guarantee that we will be able to substitute the revenues previously generated from this line of business from our other business lines.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Our personal genomics business is and will continue to be influenced by demand for our genetic sequencing products and services, our marketing and service capabilities, and our ability to comply with applicable regulatory requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Our contracting manufacturing business is and will continue to be impacted by demand for our services, which is largely a function of the timing, length and severity of each cold season. Generally, a cold season is defined as the period from September to March when the incidence of the common cold rises as a result of the change in weather and other factors. We generally experience in the first, third and fourth quarter higher levels of net revenues from our contract manufacturing business. Revenues are generally at their lowest levels in the second quarter when customer demand generally declines. This line of business is also impacted by our ability to meet such demands. The building of our manufacturing facilities and manufacturing of products necessitates compliance with applicable regulatory requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consumer sales are and will continue to be impacted by (i) the timing of acceptance of our TK Supplements&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; consumer products in the marketplace, and (ii) fluctuations in the timing of purchase and the ultimate level of demand for these products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December&#160;31, 2023, $11.3&#160;million was used by operating activities.  The Company had cash, cash equivalents, restricted cash and marketable securities of $5.3 million as of December&#160;31, 2023. Based on management&#x2019;s current business plans, the Company estimates that it will have enough cash and liquidity to finance its operating requirements for at least one year from the date of filing these financial statements. However, due to the nature of the diagnostic business and the Company's focus thus far on COVID-19, there are inherent uncertainties associated with managements&#x2019; business plan and cash flow projections if the Company is unable to grow its diagnostic testing business beyond COVID-19 testing services and to grow its other businesses.&lt;/span&gt;&lt;/div&gt;As such, the Company&#x2019;s future capital needs and the adequacy of its available funds will depend on many factors. These include, but not necessarily limited to, the actual cost and time necessary to achieve sustained profitability from diagnostic services, the ability to successfully diversify the diagnostic services revenue streams and the ability to market and grow the personal genomics, biopharma, manufacturing and supplement businesses. The Company may be required to raise additional funds through equity or debt securities offerings or strategic collaboration and/or licensing agreements in order to fund operations until it is able to generate enough revenues. Such financing may not be available on acceptable terms, or at all, and the Company&#x2019;s failure to raise capital when needed could have a material adverse effect on its strategic objectives, results of operations and financial condition.&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Financial Risks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash investments, marketable debt securities, and trade accounts receivable. Our marketable securities are fixed income investments, which are highly liquid and can be readily purchased or sold through established markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We maintain cash and cash equivalents with certain major financial institutions. As of December&#160;31, 2023, our cash and cash equivalents and restricted cash balance was $2.1 million. Of the total bank balance, $1.0 million was covered by federal depository insurance and $1.1 million was uninsured at December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable subject us to credit risk concentrations from time-to-time. We extend credit to our consumer healthcare product customers based upon an evaluation of the customer&#x2019;s financial condition and credit history and generally do not require collateral. Our diagnostic services receivable credit risk is based on payer reimbursement experience, which includes government agencies and healthcare insurers, the period the receivables have been outstanding and the historical collection rates. The collectability of the diagnostic services receivables is also directly linked to the quality of our billing processes, which depend on information provided and billing services of third parties. These credit concentrations impact our overall exposure to credit risk, which could be further affected by changes in economic, regulatory or other conditions that may impact the timing and collectability of trade receivables and diagnostic test receivables. Additionally, the reimbursement receivables from the diagnostic service business are subject to billing errors and related disputes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, see Note 13 - Significant Customers Concentrations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <prph:NumberOfTestsRecognized contextRef="c-10" decimals="INF" id="f-367" unitRef="test">1000000</prph:NumberOfTestsRecognized>
    <prph:NumberOfTestsRecognized contextRef="c-1" decimals="INF" id="f-368" unitRef="test">480000</prph:NumberOfTestsRecognized>
    <prph:NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage contextRef="c-10" decimals="2" id="f-369" unitRef="number">0.28</prph:NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage>
    <prph:NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage contextRef="c-1" decimals="2" id="f-370" unitRef="number">0</prph:NumberOfTestsRecognizedReimbursedByHRSAUninsuredProgramPercentage>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-5" id="f-371" unitRef="usd">-11300000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments contextRef="c-4" decimals="-5" id="f-372" unitRef="usd">5300000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-373">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements and the accompanying notes thereto, in conformity with generally accepted accounting principles in the United States of America (&#x201c;GAAP&#x201d;), requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the respective reporting periods. Examples include revenue recognition and the impact of the variable consideration around diagnostic test reimbursement rates, the provision for uncollectible receivables and billing errors, sales returns and allowances, rates, slow moving, dated inventory and associated provisions, the estimated useful lives and potential impairment of long-lived assets, stock based compensation valuation, income tax asset valuations and assumptions related to accrued advertising.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our estimates and assumptions are based on historical experience, current trends and other factors that management believes to be relevant at the time the financial statements are prepared. Management reviews the accounting policies, assumptions, estimates and judgments on a quarterly basis. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-374">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider all highly liquid investments with a maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents include cash on hand and monies invested in money market funds. The carrying amount approximates the fair market value due to the short-term maturity of these securities.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="c-1" id="f-375">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;Restricted cash as of December&#160;31, 2023 includes approximately $540,000 held in escrow related to the Company's mortgage loan. There was no restricted cash as of December 31, 2022.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:EscrowDeposit contextRef="c-4" decimals="-3" id="f-376" unitRef="usd">540000</us-gaap:EscrowDeposit>
    <us-gaap:MarketableSecuritiesPolicy contextRef="c-1" id="f-377">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have classified our investments in marketable debt and equity securities as available-for-sale and as a current asset. Our investments in marketable securities are carried at fair value, with unrealized gains and as a separate component of stockholders&#x2019; equity. Realized gains and losses from our marketable securities are recorded as interest income (expense). Marketable debt securities carry maturity dates between &lt;span style="-sec-ix-hidden:f-378"&gt;one&lt;/span&gt; and three years from date of purchase and interest rates of 1.40% to 4.90% during fiscal 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the components of our marketable securities and the underlying fair value input level tier hierarchy (see fair value of financial instruments) (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Unrealized &lt;br/&gt;Losses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Corporate stock&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(401)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(401)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unrealized &lt;br/&gt;Losses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;U.S. government obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We believe that the unrealized gains or losses generally are the result of a change in the risk premiums required by market participants rather than an adverse change in cash flows or a fundamental weakness in the credit quality of the issuer or underlying assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesPolicy>
    <prph:DebtSecuritiesAvailableForSaleMaturityPeriod contextRef="c-42" id="f-379">P3Y</prph:DebtSecuritiesAvailableForSaleMaturityPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod contextRef="c-41" decimals="4" id="f-380" unitRef="number">0.0140</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod contextRef="c-42" decimals="4" id="f-381" unitRef="number">0.0490</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:MarketableSecuritiesTextBlock contextRef="c-1" id="f-382">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the components of our marketable securities and the underlying fair value input level tier hierarchy (see fair value of financial instruments) (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Unrealized &lt;br/&gt;Losses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Corporate stock&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(401)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(401)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unrealized &lt;br/&gt;Losses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;U.S. government obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-43" decimals="-3" id="f-383" unitRef="usd">3528000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-43" decimals="-3" id="f-384" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-43" decimals="-3" id="f-385" unitRef="usd">401000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-43" decimals="-3" id="f-386" unitRef="usd">3127000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-4" decimals="-3" id="f-387" unitRef="usd">3528000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-4" decimals="-3" id="f-388" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-4" decimals="-3" id="f-389" unitRef="usd">401000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-4" decimals="-3" id="f-390" unitRef="usd">3127000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-44" decimals="-3" id="f-391" unitRef="usd">1484000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-44" decimals="-3" id="f-392" unitRef="usd">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-44" decimals="-3" id="f-393" unitRef="usd">12000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-44" decimals="-3" id="f-394" unitRef="usd">1478000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-45" decimals="-3" id="f-395" unitRef="usd">5702000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-45" decimals="-3" id="f-396" unitRef="usd">1228000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-45" decimals="-3" id="f-397" unitRef="usd">80000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-45" decimals="-3" id="f-398" unitRef="usd">6850000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-5" decimals="-3" id="f-399" unitRef="usd">7186000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-5" decimals="-3" id="f-400" unitRef="usd">1234000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-5" decimals="-3" id="f-401" unitRef="usd">92000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-5" decimals="-3" id="f-402" unitRef="usd">8328000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="c-1" id="f-403">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable consists primarily of amounts due from government agencies and healthcare insurers. Unbilled accounts receivable relates to the delivery of our diagnostic testing services for which the related billings will occur in a future period, after a patient&#x2019;s insurance information has been validated, and represent amounts we have an unconditional right to receive payment. Unbilled accounts receivable is classified as accounts receivable on the consolidated balance sheet. We carry our accounts receivable at the amount of consideration for which we expect to be entitled less allowances. When estimating the allowances for our diagnostics business, the Company pools its trade receivables based on the following payer types: healthcare insurers and government payers. The Company principally estimates the allowance for credit losses by pool based on historical collection experience, current economic conditions, expectations of future economic conditions, other credits and the period of time that the receivables have been outstanding. To the extent that any individual payers are identified that have deteriorated in credit quality, the Company removes the payers from their respective pools and establishes allowances based on the individual risk characteristics of such payers. On a periodic basis, we evaluate our receivables and establish an allowance, based on a history of past write-offs, government and healthcare insurer payment trends, collections, current credit conditions or generally accepted future trends. Accounts receivable are stated at the net amount expected to be collected, using an expected loss methodology that is referred to as the current expected credit loss ("CECL") model.&lt;/span&gt;&lt;/div&gt;At December 31, 2023, within the diagnostic services business, insurers had significantly aged balances that we are continuing to work to collect.  The specific facts and circumstances related to each of these individual payors have been considered by our management, which informed the determination of the year-end reserve balance. We continue to pursue collection of amounts due. However, there will inevitably be billings that are rejected by the insurance carriers and associated receivables that will not be collected. We believe that the reserve established at December 31, 2023 is adequate to capture this collectability risk. While past history is helpful informing the determination of an appropriate reserve, its utility is somewhat limited by the circumstances underlying a significant portion of these aged balances; specifically, an unprecedented volume of activity related COVID 19 diagnostic testing.  Accordingly, the determination of an appropriate reserve required significant management judgment and was informed by the unique facts and circumstances related to each of the three significant insurers.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="c-1" id="f-404">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts are written off as uncollectible at the time we determine that collections are unlikely. Accounts receivable, net is comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Trade accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;37,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unbilled accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(3,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(3,140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;36,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;37,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsPayableTradeCurrentAndNoncurrent contextRef="c-4" decimals="-3" id="f-405" unitRef="usd">40177000</us-gaap:AccountsPayableTradeCurrentAndNoncurrent>
    <us-gaap:AccountsPayableTradeCurrentAndNoncurrent contextRef="c-5" decimals="-3" id="f-406" unitRef="usd">37568000</us-gaap:AccountsPayableTradeCurrentAndNoncurrent>
    <us-gaap:UnbilledContractsReceivable contextRef="c-4" decimals="-3" id="f-407" unitRef="usd">0</us-gaap:UnbilledContractsReceivable>
    <us-gaap:UnbilledContractsReceivable contextRef="c-5" decimals="-3" id="f-408" unitRef="usd">2626000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:AccountsReceivableGross contextRef="c-4" decimals="-3" id="f-409" unitRef="usd">40177000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross contextRef="c-5" decimals="-3" id="f-410" unitRef="usd">40194000</us-gaap:AccountsReceivableGross>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-4" decimals="-3" id="f-411" unitRef="usd">3864000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-5" decimals="-3" id="f-412" unitRef="usd">3140000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNet contextRef="c-4" decimals="-3" id="f-413" unitRef="usd">36313000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet contextRef="c-5" decimals="-3" id="f-414" unitRef="usd">37054000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock contextRef="c-1" id="f-415">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The table below presents a roll forward of the Company's allowance for credit losses (amount in thousands).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.212%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.610%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.190%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period provision for expected credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-5" decimals="-3" id="f-416" unitRef="usd">3140000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease contextRef="c-1" decimals="-3" id="f-417" unitRef="usd">724000</us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-4" decimals="-3" id="f-418" unitRef="usd">3864000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="c-46" decimals="-5" id="f-419" unitRef="usd">300000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease contextRef="c-46" decimals="-5" id="f-420" unitRef="usd">400000</us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-4" decimals="-5" id="f-421" unitRef="usd">3900000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="c-47" decimals="-5" id="f-422" unitRef="usd">5900000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="c-48" decimals="-5" id="f-423" unitRef="usd">2900000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease contextRef="c-10" decimals="-5" id="f-424" unitRef="usd">5500000</us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-5" decimals="-5" id="f-425" unitRef="usd">3100000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:InventoryPolicyTextBlock contextRef="c-1" id="f-426">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is valued at the lower of cost, determined on a first-in, first-out basis (&#x201c;FIFO&#x201d;), or net realizable value. Inventory items are analyzed to determine cost and the net realizable value and appropriate valuation adjustments are established.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2023 and 2022, the components of inventory are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diagnostic services testing material&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Inventory valuation reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Inventory, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c-1" id="f-427">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2023 and 2022, the components of inventory are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diagnostic services testing material&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Inventory valuation reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Inventory, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <prph:InventoryLabMaterial contextRef="c-4" decimals="-3" id="f-428" unitRef="usd">623000</prph:InventoryLabMaterial>
    <prph:InventoryLabMaterial contextRef="c-5" decimals="-3" id="f-429" unitRef="usd">1739000</prph:InventoryLabMaterial>
    <us-gaap:InventoryRawMaterials contextRef="c-4" decimals="-3" id="f-430" unitRef="usd">1619000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="c-5" decimals="-3" id="f-431" unitRef="usd">1639000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess contextRef="c-4" decimals="-3" id="f-432" unitRef="usd">306000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="c-5" decimals="-3" id="f-433" unitRef="usd">754000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods contextRef="c-4" decimals="-3" id="f-434" unitRef="usd">1551000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="c-5" decimals="-3" id="f-435" unitRef="usd">356000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryGross contextRef="c-4" decimals="-3" id="f-436" unitRef="usd">4099000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross contextRef="c-5" decimals="-3" id="f-437" unitRef="usd">4488000</us-gaap:InventoryGross>
    <us-gaap:InventoryValuationReserves contextRef="c-4" decimals="-3" id="f-438" unitRef="usd">258000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves contextRef="c-5" decimals="-3" id="f-439" unitRef="usd">512000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-3" id="f-440" unitRef="usd">3841000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-5" decimals="-3" id="f-441" unitRef="usd">3976000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-442">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are recorded at cost. We use the straight-line method in computing depreciation for financial reporting purposes. Depreciation expense is computed in accordance with the following ranges of estimated asset lives: building and improvements - &lt;span style="-sec-ix-hidden:f-443"&gt;ten&lt;/span&gt; to thirty-nine years; leasehold improvements - lesser of lease term or estimated useful life; machinery and equipment including lab equipment - &lt;span style="-sec-ix-hidden:f-445"&gt;three&lt;/span&gt; to seven years; computer equipment and software - &lt;span style="-sec-ix-hidden:f-447"&gt;three&lt;/span&gt; to five years; and furniture and fixtures - five years.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-50" id="f-444">P39Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-52" id="f-446">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-54" id="f-448">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-55" id="f-449">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-5" id="f-450" unitRef="usd">2100000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashFDICInsuredAmount contextRef="c-4" decimals="-5" id="f-451" unitRef="usd">1000000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:CashUninsuredAmount contextRef="c-4" decimals="-5" id="f-452" unitRef="usd">1100000</us-gaap:CashUninsuredAmount>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-453">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the inception of an arrangement, we determine whether the arrangement is or contains a lease based on the unique facts and circumstances present in the arrangement. Most leases with a term greater than one year are recognized on the balance sheet as right-of-use assets and short-term and long-term lease liabilities, as applicable. We have elected not to recognize on the balance sheet leases with terms of 12 months or less. We typically only include an initial lease term in its assessment of a lease arrangement. Options to renew a lease are not included in our assessment unless there is reasonable certainty that we will renew.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of lease payments over the expected remaining lease term. Certain adjustments to the right-of-use asset may be required for items such as incentives received. The interest rate implicit in our leases is typically not readily determinable. As a result, we utilize our incremental borrowing rate, which reflects the fixed rate at which we could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term and in a similar economic environment (see Note 12, Leases).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of a lease should be allocated between lease components (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;e.g&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;., land, building, etc.) and non-lease components (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;e.g&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;., common area maintenance, consumables, etc.). The fixed and in-substance fixed contract consideration (including any consideration related to non-components) must be allocated based on the respective relative fair values to the lease components and non-lease components.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="c-1" id="f-454">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the fair value of the consideration transferred over the fair value of the underlying identifiable assets and liabilities acquired in a business combination. Goodwill and intangible assets deemed to have an indefinite life are not amortized, but instead are assessed for impairment annually. Additionally, if an event or change in circumstances occurs that would more likely than not reduce the fair value of the reporting unit below its carrying value, we would evaluate goodwill and other intangibles at that time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In testing for goodwill impairment, we have the option to first assess qualitative factors to determine whether the existence of events or circumstances lead to a determination that it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If, after assessing the totality of events and circumstances, we conclude that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is not required. If we conclude otherwise, we are required to perform the two-step impairment test. The goodwill impairment test is performed at the reporting unit level by comparing the estimated fair value of a reporting unit with its respective carrying value. If the estimated fair value exceeds the carrying value, goodwill at the reporting unit level is not impaired. If the estimated fair value is less than the carrying value, an impairment charge will be recorded to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reduce the reporting unit to fair value. Management completed a qualitative assessment of Goodwill and it was not deemed impaired at December 31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets deemed to have finite lives are amortized on a straight-line basis over their estimated useful lives, where the useful life is the period over which the asset is expected to contribute directly, or indirectly, to our future cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c-1" id="f-455">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews long-lived assets, including property and equipment and finite-lived intangible assets, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. An impairment loss is recognized when the asset&#x2019;s carrying value exceeds the total undiscounted cash flows expected from its use and eventual disposition. The amount of the impairment loss is determined as the excess of the carrying value of the asset over its fair value. For the fiscal years ended December&#160;31, 2023 and 2022, the Company did not have an impairment of the long-lived assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:AssetImpairmentCharges contextRef="c-1" decimals="INF" id="f-456" unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-10" decimals="INF" id="f-457" unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c-1" id="f-458">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We measure assets and liabilities at fair value based on expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale date of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are the hierarchical levels of inputs to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Level 1: Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Level 2: Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Level 3: Unobservable inputs reflecting the Company&#x2019;s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of our financial assets and liabilities, such as cash, accounts receivable, accounts payable, and unsecured note payable, approximate their fair values because of the short-term nature of these instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for our marketable securities at fair value, with the net unrealized gains or losses of marketable debt securities reported as a component of accumulated other comprehensive income or loss and marketable equity securities change in fair value reported on the condensed consolidated statement of operations. The components of marketable securities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Corporate stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;U.S. government obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers of marketable debt securities between Levels 1, 2 or 3 for the years ended December&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock contextRef="c-1" id="f-459">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Corporate stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;U.S. government obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Corporate obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:MarketableSecurities contextRef="c-56" decimals="-3" id="f-460" unitRef="usd">3127000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-57" id="f-461" unitRef="usd" xsi:nil="true"/>
    <us-gaap:MarketableSecurities contextRef="c-58" id="f-462" unitRef="usd" xsi:nil="true"/>
    <us-gaap:MarketableSecurities contextRef="c-43" decimals="-3" id="f-463" unitRef="usd">3127000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-59" decimals="-3" id="f-464" unitRef="usd">3127000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-60" decimals="-3" id="f-465" unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-61" decimals="-3" id="f-466" unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-4" decimals="-3" id="f-467" unitRef="usd">3127000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-62" decimals="-3" id="f-468" unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-63" decimals="-3" id="f-469" unitRef="usd">1478000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-64" decimals="-3" id="f-470" unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-44" decimals="-3" id="f-471" unitRef="usd">1478000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-65" decimals="-3" id="f-472" unitRef="usd">5496000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-66" decimals="-3" id="f-473" unitRef="usd">1354000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-67" decimals="-3" id="f-474" unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-45" decimals="-3" id="f-475" unitRef="usd">6850000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-68" decimals="-3" id="f-476" unitRef="usd">5496000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-69" decimals="-3" id="f-477" unitRef="usd">2832000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-70" decimals="-3" id="f-478" unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-5" decimals="-3" id="f-479" unitRef="usd">8328000</us-gaap:MarketableSecurities>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-480">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue that represents the transfer of promised goods or services to customers at an amount that reflects the consideration that is expected to be received in exchange for those goods or services. We recognize revenue when performance obligations with our customers have been satisfied. At contract inception, we evaluate the contract to determine if revenue should be recognized using the following five steps: (1) identify the contract with the customer; (2) identify the performance obligations; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations; and (5) recognize revenue when (or as) the entity satisfies a performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract with Customers and Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account. A contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Sales from product shipments to contract manufacturing and retailer customers are recognized at the time ownership is transferred to the customer. Revenue from diagnostic services is recognized when the results are made available to the customer. Revenue from our personal genomics business is recognized when the genetic testing results are provided to the customer. For subscription services associated with our genomic testing, we recognize revenue ratably over the term of the subscription.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s performance obligation for contract manufacturing and retail customers is to provide the goods ordered by the customer. The Company has one performance obligation for its diagnostic services, which is to provide the results of the laboratory test to the customer. Our personal genomics business has separate performance obligations to provide initial testing and genome results and subscriptions services to our customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transaction Price &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our diagnostic services business, a revenue transaction is initiated when we receive a requisition order to perform a diagnostic test. The information provided on the requisition form is used to determine the party that will be billed for the testing performed and the expected reimbursement. We provide diagnostic services to a range of customers. In many cases, the customer that orders our services is not responsible for paying for these services. Depending on the billing arrangement and applicable law, the payer may be the patient or a third party, such as a health plan, Medicare or Medicaid program and other government reimbursement programs. We bill the providers at standard price and take into consideration negotiated discounts and anticipated reimbursement remittance adjustments based on the payer portfolio, when revenue is recorded. We use the most expected value method to estimate the transaction price for reimbursements that vary from the listed contract price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our personal genomics business, a revenue transaction is initiated by a DNA test kit sale direct to the consumer sales via our website or through online retailers. The kit sales and subscriptions are billed at a standard price and take into consideration any discounts when revenue is recorded. We also contract with third party B2B partners and universities and sell DNA test kits directly to them.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For contract manufacturing and retail customers, the transaction price is fixed based upon either (i) the terms of a combined master agreement and each related purchase order, or (ii) if there is no master agreement, the price per individual purchase order received from each customer. The customers are invoiced at an agreed upon contractual price for each unit ordered and delivered by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from retail customers is reduced for trade promotions, estimated sales returns and other allowances in the same period as the related sales are recorded. No such allowance is applicable to our contract manufacturing customers. We estimate potential future product returns and other allowances related to current period revenue. We analyze historical returns, current trends, and changes in customer and consumer demand when evaluating the adequacy of the sales returns and other allowances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not accept returns from our contract manufacturing customers. Our return policy for retail customers accommodates returns for (i) discontinued products, (ii) store closings and (iii) products that have reached or exceeded their designated expiration date. We do not impose a period of time during which product may be returned. All requests for product returns must be submitted to us for pre-approval. We will not accept return requests pertaining to customer inventory &#x201c;Overstocking&#x201d; or &#x201c;Resets&#x201d;. We will accept return requests only for products in their intended package &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;configuration. We reserve the right to terminate shipment of product to customers who have made unauthorized deductions contrary to our return policy or pursue other methods of reimbursement. We compensate the customer for authorized returns by means of a credit applied to amounts owed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our diagnostic services business, a revenue transaction is initiated when we receive a requisition order to perform a diagnostic test. The information provided on the requisition form is used to determine the party that will be billed for the testing performed and the expected reimbursement. We provide diagnostic services to a range of customers. In many cases, the customer that orders our services is not responsible for paying for these services. Depending on the billing arrangement and applicable law, the payer may be the patient or a third party, such as a health plan, Medicare or Medicaid program and other government reimbursement programs. We bill the providers at standard price and take into consideration negotiated discounts and anticipated reimbursement remittance adjustments based on the payer portfolio, when revenue is recorded. We use the most expected value method to estimate the transaction price for reimbursements that vary from the listed contract price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our personal genomics business, a revenue transaction is initiated by a DNA test kit sale direct to the consumer sales via our website or through online retailers. The kit sales and subscriptions are billed at a standard price and take into consideration any discounts when revenue is recorded. We also contract with third party B2B partners and universities and sell DNA test kits directly to them.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recognize Revenue When the Company Satisfies a Performance Obligation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For diagnostic services, the Company satisfies its performance obligation at the point in time that the results are made available to the customer, which is when the customer benefits from the information contained in the results and obtains control.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For genomic services, we satisfy our product performance obligation at a point in time when the genetic testing results are provided to the customer. For subscriptions services associated with its genomic testing, we satisfy our performance obligation ratably over the subscription period. If the customer does not return the test kit, services cannot be completed by us, potentially resulting in unexercised rights (&#x201c;breakage&#x201d;) revenue, including lifetime subscription services. We estimate breakage for the portion of test kits not expected to be returned using an analysis of historical data and consider other factors that could influence customer test kit return behavior. When breakage revenue is recognized on a kit, we recognize breakage on any associated subscription services ratably over the term of the subscription&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Performance obligations related to contract manufacturing and retail customers are satisfied at a point in time when the goods are shipped to the customer as (i) we have transferred control of the assets to the customers upon shipping, and (ii) the customer obtains title and assumes the risks and rewards of ownership after the goods are shipped.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and December&#160;31, 2022, we have deferred revenue of $3.5 million and $3.6 million, respectively. Our new personal genomics business comprised $3.4 million of the deferred revenue as of December&#160;31, 2023. The remainder of deferred revenue relates to research and development (&#x201c;R&amp;amp;D&#x201d;) stability and release testing programs recognized as contract manufacturing revenue. Deferred revenues primarily consist of amounts that have been billed to or received from customers in advance of revenue recognition and prepayments received from customers in advance of services performed for the R&amp;amp;D work. We recognize deferred revenues as revenues when the services are performed and the corresponding revenue recognition criteria are met. Customer prepayments are generally applied against invoices issued to customers when services are performed and billed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table disaggregates our deferred revenue by recognition period (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Recognition Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0-12 Months&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13-24 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Over 24 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We disaggregate revenue from contracts with customers into four categories: contract manufacturing, retail and others, diagnostic services and genomic products and services. We determined that disaggregating revenue into these categories achieves the disclosure objective to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table disaggregates the Company&#x2019;s revenue by revenue source for Fiscal 2023 and 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.263%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Revenue by Customer Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diagnostic services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;108,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Contract manufacturing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Retail and others&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Genomic products and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;44,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;122,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Customer Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company makes payments to certain diagnostic services customers for distinct services that approximate fair value for those services. Such services include specimen collection, the collection and delivery of insurance and patient information necessary for billing and collection, and logistics services. Consideration associated with specimen collection services is classified in cost of revenues and the remaining costs are classified as diagnostic expenses within operating expenses in the accompanying statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sales Tax Exclusion from the Transaction Price&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shipping and Handling Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for shipping and handling activities that we perform as activities to fulfill the promise to transfer the good.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerLiability contextRef="c-4" decimals="-5" id="f-481" unitRef="usd">3500000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-5" decimals="-5" id="f-482" unitRef="usd">3600000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-71" decimals="-5" id="f-483" unitRef="usd">3400000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-484">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table disaggregates our deferred revenue by recognition period (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Recognition Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0-12 Months&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13-24 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Over 24 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table disaggregates the Company&#x2019;s revenue by revenue source for Fiscal 2023 and 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.263%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Revenue by Customer Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diagnostic services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;108,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Contract manufacturing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Retail and others&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Genomic products and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;44,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;122,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-72" decimals="-3" id="f-485" unitRef="usd">2382000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-73" decimals="-3" id="f-486" unitRef="usd">2499000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-74" decimals="-3" id="f-487" unitRef="usd">750000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-75" decimals="-3" id="f-488" unitRef="usd">683000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-76" decimals="-3" id="f-489" unitRef="usd">350000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-77" decimals="-3" id="f-490" unitRef="usd">376000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-4" decimals="-3" id="f-491" unitRef="usd">3482000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-5" decimals="-3" id="f-492" unitRef="usd">3558000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-78" decimals="-3" id="f-493" unitRef="usd">24849000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-79" decimals="-3" id="f-494" unitRef="usd">108329000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-80" decimals="-3" id="f-495" unitRef="usd">9400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-81" decimals="-3" id="f-496" unitRef="usd">8740000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-82" decimals="-3" id="f-497" unitRef="usd">2378000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-83" decimals="-3" id="f-498" unitRef="usd">1281000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-84" decimals="-3" id="f-499" unitRef="usd">7757000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-85" decimals="-3" id="f-500" unitRef="usd">4297000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-501" unitRef="usd">44384000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-10" decimals="-3" id="f-502" unitRef="usd">122647000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="c-1" id="f-503">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising and Incentive Promotions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising and incentive promotion costs are expensed within the period in which they are utilized. Advertising and incentive promotion expense is comprised of (i) media advertising, presented as part of general and administrative expense, (ii) cooperative incentive &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;promotions and coupon program expenses, which are accounted for as part of net revenue, and (iii) free product, which is accounted for as part of cost of revenues. Advertising and incentive promotion expenses incurred from continuing operations for Fiscal 2023 and 2022 were $1.8 million and $0.4 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense contextRef="c-86" decimals="-5" id="f-504" unitRef="usd">1800000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="c-87" decimals="-5" id="f-505" unitRef="usd">400000</us-gaap:AdvertisingExpense>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="c-1" id="f-506">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for stock-based compensation in accordance with FASB ASC 718, &#x201c;Compensation &#x2013; Stock Compensation.&#x201d; Under the fair value recognition provision of the ASC, stock-based compensation cost is estimated at the grant date based on the fair value of the award. The Company estimates the fair value of stock options and warrants granted using the Black-Scholes-Merton option pricing model and stock grants at their closing reported market value. We recognize all stock-based payments to employees and directors, including grants of stock options, as compensation expense in the financial statements based on their grant date fair values. The grant date fair values of stock options are determined through the use of the Black-Scholes option pricing model. The compensation cost is recognized as an expense over the requisite service period of the award, which usually coincides with the vesting period. We account for forfeitures as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock and stock options to purchase our common stock have been granted to employees pursuant to the terms of certain agreements and stock option plans (see Note 7, Stockholders' Equity). Stock options are exercisable during a period determined by us, but in no event later than seven years from the date granted.&lt;/span&gt;&lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-88" id="f-507">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c-1" id="f-508">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;R&amp;amp;D costs are charged to operations in the period incurred, R&amp;amp;D costs incurred for the years ended December&#160;31, 2023 and 2022 were $1.4 million and $0.7 million, respectively. R&amp;amp;D costs are principally related to personnel expenses and new product development initiatives and costs associated with the OTC health care products, dietary supplements and validation costs associated with the diagnostic services business.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-5" id="f-509" unitRef="usd">1400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-10" decimals="-5" id="f-510" unitRef="usd">700000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-511">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes in accordance with accounting guidance now codified as FASB ASC 740, &#x201c;Income Taxes,&#x201d; which requires that the Company recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for, or benefit from, income taxes includes deferred taxes resulting from the temporary differences in income for financial and tax purposes using the liability method. Such temporary differences result primarily from the differences in the carrying value of assets and liabilities. Future realization of deferred income tax assets requires sufficient taxable income within the carry-back, carryforward period available under tax law. We evaluate, on a quarterly basis whether, based on all available evidence, it is probable that the deferred income tax assets are realizable. Valuation allowances are established when it is more likely than not that the tax benefit of the deferred tax asset will not be realized. The evaluation, as prescribed by ASC 740- 10, &#x201c;Income Taxes,&#x201d; includes the consideration of all available evidence, both positive and negative, regarding historical operating results including recent years with reported losses, the estimated timing of future reversals of existing taxable temporary differences, estimated future taxable income exclusive of reversing temporary differences and carryforwards, and potential tax planning strategies which may be employed to prevent an operating loss or tax credit carryforward from expiring unused.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes under ASU No. 2019-12, &#x201c;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (&#x201c;ASU 2019-12&#x201d;), which simplifies various aspects related to accounting for income taxes. This standard became effective for the Company January 1, 2021. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for uncertainties in income taxes under the provisions of FASB ASC 740-10-05 (the &#x201c;Subtopic&#x201d;). The Subtopic clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s financial statements. The Subtopic prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The Subtopic provides guidance on the de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-512">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards, Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2023, the Company adopted Accounting Standards Update ("ASU") 2016-13, &#x201c;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&#x201d; (&#x201c;ASU 2016-13&#x201d;) ASU 2016-13 requires an impairment model (known as the CECL model) that is based on expected losses rather than incurred losses. Under the new guidance, each reporting entity should estimate an allowance for expected credit losses, which is intended to result in more timely recognition of losses. This model replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost, accounts receivable and available for sale debt securities and applies to some off-balance sheet credit exposures. In February 2020, the FASB issued ASU 2020-02, Financial Instruments - Credit Losses (Topic 326), which amends the effective date of the original pronouncement for smaller reporting companies. ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022. The adoption of ASU 2016-13 did not have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2023, the FASB issued ASU 2023-05, "Business Combinations - Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement." The new guidance applies to the formation of a joint venture and requires a joint venture to initially measure all contributions received upon its formation at fair value. The guidance is intended to reduce diversity in practice and is applicable to joint venture entities with a formation date on or after January 1, 2025 on a &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;prospective basis. The Company currently does not have any transactions that fall under the scope of ASU 2023-05; therefore, the adoption of ASU 2023-05 is not expected to have an impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards, Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), which requires an enhanced disclosure of significant segment expenses on an annual and interim basis. This guidance will be effective for the annual periods beginning the year ended December 31, 2024, and for interim periods beginning January 1, 2025. Early adoption is permitted. Upon adoption, the guidance should be applied retrospectively to all prior periods presented in the financial statements. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which improves the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the effective tax rate reconciliation and income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. This guidance will be effective for the annual periods beginning the year ended December 31, 2025. Early adoption is permitted. Upon adoption, the guidance can be applied prospectively or retrospectively. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="c-1" id="f-519">Asset Acquisition&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stella Diagnostics - Asset Purchase Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On December 15, 2022, the Company entered into an Asset Purchase Agreement (the &#x201c;Stella Purchase Agreement&#x201d;), with Stella Diagnostics Inc. (&#x201c;Stella&#x201d;) and Stella DX, LLC (&#x201c;Stella DX&#x201d; and, together with Stella, the &#x201c;Stella Sellers&#x201d;), pursuant to which, on January 3, 2023, the Company purchased all of the assets, rights and interests of the Stella Sellers and their affiliates pertaining to the Stella Sellers&#x2019; BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test and certain clinical assets, including all intellectual property rights (the &#x201c;Stella Purchased Assets&#x201d;). All capitalized terms used in this section to describe this transaction but not defined herein shall have the meanings set forth in the Stella Purchase Agreement, &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As consideration for the Stella Purchased Assets, at closing, the Company (i) paid to the Stella Sellers $3.5 million in cash, minus (a) the Secured Note Amount of $0.5 million, (b) the Liability Payoff Amount of $1.6 million and (c) the Promissory Note Payoff Amount of $400,000, and (ii) issued to Stella DX 100,000 shares of common stock, par value $0.0005 per share, of the Company at a value of $10.00 per share. Total consideration paid was $4.6 million. The Secured Note Amount of $0.5 million and the Promissory Note Payoff of $400,000 were paid in 2022. The balance of the consideration was paid at closing during the year ended December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In addition to the consideration paid at closing, the Company will issue shares of common stock valued at $2.0 million (the &#x201c;Milestone Stock&#x201d;) to the Stella Sellers upon a Commercialization Event (as defined in the Stella Purchase Agreement). The Milestone Stock was recorded at closing as a non-current liability at its fair value of $2.0 million. Also, the Company is required to pay to the Stella Sellers for each of the seven calendar years during the seven years period commencing on the first day of the calendar year following the date of the Commercialization Event, a non-refundable, non-creditable royalty of 5% of the Adjusted Gross Margin for such Annual Period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The asset purchase does not qualify as a business combination under FASB ASC 805, Business Combinations, and has therefore been accounted for as an asset acquisition. In connection with the Stella Purchased Assets, the Company incurred $0.2 million in transaction costs, which were capitalized into the purchase price of the Stella Purchased Assets. The total purchase price for the Stella Purchased Assets was $6.8&#160;million, which was allocated to the proprietary technology intangible asset acquired. The Company is amortizing the acquired intangible asset on a straight-line basis over its estimated useful life of five years.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <prph:PaymentsForAssetAcquisition contextRef="c-89" decimals="-5" id="f-520" unitRef="usd">3500000</prph:PaymentsForAssetAcquisition>
    <us-gaap:AssetAcquisitionContingentConsiderationLiability contextRef="c-90" decimals="-5" id="f-521" unitRef="usd">500000</us-gaap:AssetAcquisitionContingentConsiderationLiability>
    <prph:AssetAcquisitionConsiderationTransferredLiabilityPayoff contextRef="c-90" decimals="-5" id="f-522" unitRef="usd">1600000</prph:AssetAcquisitionConsiderationTransferredLiabilityPayoff>
    <prph:AssetAcquisitionConsiderationTransferredPromissoryNotePayoff contextRef="c-90" decimals="-3" id="f-523" unitRef="usd">400000</prph:AssetAcquisitionConsiderationTransferredPromissoryNotePayoff>
    <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets
      contextRef="c-89"
      decimals="INF"
      id="f-524"
      unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-90"
      decimals="INF"
      id="f-525"
      unitRef="usdPerShare">0.0005</us-gaap:CommonStockParOrStatedValuePerShare>
    <prph:AssetAcquisitionSharesIssuedAndIssuableValuePerShare
      contextRef="c-90"
      decimals="2"
      id="f-526"
      unitRef="usdPerShare">10.00</prph:AssetAcquisitionSharesIssuedAndIssuableValuePerShare>
    <us-gaap:AssetAcquisitionConsiderationTransferred contextRef="c-91" decimals="-5" id="f-527" unitRef="usd">4600000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:AssetAcquisitionContingentConsiderationLiability contextRef="c-90" decimals="-5" id="f-528" unitRef="usd">500000</us-gaap:AssetAcquisitionContingentConsiderationLiability>
    <prph:AssetAcquisitionConsiderationTransferredPromissoryNotePayoff contextRef="c-90" decimals="-3" id="f-529" unitRef="usd">400000</prph:AssetAcquisitionConsiderationTransferredPromissoryNotePayoff>
    <us-gaap:AssetAcquisitionContingentConsiderationLiabilityNoncurrent contextRef="c-90" decimals="-5" id="f-530" unitRef="usd">2000000</us-gaap:AssetAcquisitionContingentConsiderationLiabilityNoncurrent>
    <us-gaap:AssetAcquisitionContingentConsiderationLiabilityNoncurrent contextRef="c-90" decimals="-5" id="f-531" unitRef="usd">2000000</us-gaap:AssetAcquisitionContingentConsiderationLiabilityNoncurrent>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-90" id="f-532">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <prph:PurchaseAgreementRoyaltyPercent
      contextRef="c-89"
      decimals="INF"
      id="f-533"
      unitRef="number">0.05</prph:PurchaseAgreementRoyaltyPercent>
    <prph:AssetAcquisitionTransactionCosts contextRef="c-90" decimals="-5" id="f-534" unitRef="usd">200000</prph:AssetAcquisitionTransactionCosts>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="c-92" decimals="-5" id="f-535" unitRef="usd">6800000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-536">Intangible Assets, Net&lt;div style="margin-top:10pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2023, the Company acquired intangible assets of $6.8 million included with proprietary intellectual property, in connection with the acquisition of the Stella Purchased Assets. See Note 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets as of December&#160;31, 2023 and 2022 consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Estimated Useful&lt;br/&gt;Life (in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Proprietary intellectual property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;CLIA license&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;19,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(3,822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense for acquired intangible assets was $2.9 million and $2.4 million during the years ended December&#160;31, 2023 and 2022, respectively. The estimated future amortization expense of acquired intangible assets as of December&#160;31, 2023 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Year ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Year ended December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Year ended December 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Year ended December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Year ended December 31, 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="c-93" decimals="-5" id="f-537" unitRef="usd">6800000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock contextRef="c-1" id="f-538">&lt;div style="margin-top:10pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets as of December&#160;31, 2023 and 2022 consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Estimated Useful&lt;br/&gt;Life (in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Proprietary intellectual property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;CLIA license&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;19,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(3,822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-94" decimals="-3" id="f-539" unitRef="usd">5550000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-95" decimals="-3" id="f-540" unitRef="usd">5550000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-94" id="f-541">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-96" decimals="-3" id="f-542" unitRef="usd">11064000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-97" decimals="-3" id="f-543" unitRef="usd">4260000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-96" id="f-544">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-98" decimals="-3" id="f-545" unitRef="usd">1180000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-99" decimals="-3" id="f-546" unitRef="usd">1180000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-98" id="f-547">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-100" decimals="-3" id="f-548" unitRef="usd">1307000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-101" decimals="-3" id="f-549" unitRef="usd">1307000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-100" id="f-550">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-4" decimals="-3" id="f-551" unitRef="usd">19101000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-5" decimals="-3" id="f-552" unitRef="usd">12297000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-4" decimals="-3" id="f-553" unitRef="usd">6768000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-5" decimals="-3" id="f-554" unitRef="usd">3822000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-3" id="f-555" unitRef="usd">12333000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-5" decimals="-3" id="f-556" unitRef="usd">8475000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-5" id="f-557" unitRef="usd">2900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-10" decimals="-5" id="f-558" unitRef="usd">2400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c-1" id="f-559">The estimated future amortization expense of acquired intangible assets as of December&#160;31, 2023 is as follows (in thousands):&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Year ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Year ended December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Year ended December 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Year ended December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Year ended December 31, 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-4" decimals="-3" id="f-560" unitRef="usd">2583000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-4" decimals="-3" id="f-561" unitRef="usd">2583000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-4" decimals="-3" id="f-562" unitRef="usd">2251000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-4" decimals="-3" id="f-563" unitRef="usd">1731000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-4" decimals="-3" id="f-564" unitRef="usd">370000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="c-4" decimals="-3" id="f-565" unitRef="usd">2815000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-3" id="f-566" unitRef="usd">12333000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-567">Property, Plant and Equipment&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of property, plant and equipment are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Lesser of lease term or estimated useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10-39 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Machinery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3-7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Lab equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3-7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3-5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(11,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(8,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense for Fiscal 2023 and 2022 were $3.1 million and $2.3 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-568">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of property, plant and equipment are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Lesser of lease term or estimated useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10-39 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Machinery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3-7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Lab equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3-7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3-5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(11,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(8,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-102" decimals="-3" id="f-569" unitRef="usd">352000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-103" decimals="-3" id="f-570" unitRef="usd">352000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-104" decimals="-3" id="f-571" unitRef="usd">374000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-105" decimals="-3" id="f-572" unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-106" decimals="-3" id="f-573" unitRef="usd">1746000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-107" decimals="-3" id="f-574" unitRef="usd">1729000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-108" id="f-575">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-109" id="f-576">P39Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-110" decimals="-3" id="f-577" unitRef="usd">6103000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-111" decimals="-3" id="f-578" unitRef="usd">5048000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-51" id="f-579">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-52" id="f-580">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-112" decimals="-3" id="f-581" unitRef="usd">12667000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-113" decimals="-3" id="f-582" unitRef="usd">5788000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-114" id="f-583">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-115" id="f-584">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-116" decimals="-3" id="f-585" unitRef="usd">2744000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-117" decimals="-3" id="f-586" unitRef="usd">2350000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-53" id="f-587">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-54" id="f-588">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-55" decimals="-3" id="f-589" unitRef="usd">446000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-118" decimals="-3" id="f-590" unitRef="usd">461000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-55" id="f-591">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-3" id="f-592" unitRef="usd">24432000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-5" decimals="-3" id="f-593" unitRef="usd">15728000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-3" id="f-594" unitRef="usd">11534000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization contextRef="c-5" decimals="-3" id="f-595" unitRef="usd">8440000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-3" id="f-596" unitRef="usd">12898000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-5" decimals="-3" id="f-597" unitRef="usd">7288000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:Depreciation contextRef="c-1" decimals="-5" id="f-598" unitRef="usd">3100000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-10" decimals="-5" id="f-599" unitRef="usd">2300000</us-gaap:Depreciation>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-600">Outstanding Debt&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2023 Secured Mortgage Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On December 20, 2023, the Company's wholly-owned subsidiary PREH entered into an Open-End Mortgage Agreement (the "Mortgage Agreement"). The Mortgage provided for a loan of $3.3 million (the "Mortgage Loan") with stated maturity date on January 6, 2034, bore a fixed interest rate of 8.25% per annum and required monthly mortgage payments of principal and interest of $25,000. The obligations under the Mortgage Agreement were secured by PREH's  certain real property in Pennsylvania. The Company incurred $341,000 issuance cost, which was recognized as a debt discount and will be amortized using the effective interest method over the term of the Mortgage Loan. The Company retains $540,000 cash in an escrow account which was recognized as a restricted cash on the Company's consolidated balance sheet as of December 31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2023 Unsecured Promissory Note Payable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 26, 2023, the Company issued an unsecured promissory note (the &#x201c;2023 Note&#x201d;) and guaranty for an aggregate principal amount of $7.6 million. The 2023 Note is due and payable on January 27, 2026, the third anniversary of the date on which the 2023 Note was funded (the &#x201c;Closing Date&#x201d;), and accrues interest at a rate of 10% per year from the Closing Date, payable on a quarterly basis, until the 2023 Note is repaid in full. The Company has the right to prepay the 2023 Note at any time after the Closing Date and prior to the maturity date without premium or penalty upon providing seven days&#x2019; written notice to the note holder. Repayment of the 2023 Note has been guaranteed by the Company&#x2019;s wholly-owned subsidiary, Pharmaloz Manufacturing, Inc. In addition to the 2023 Note, the Company issued warrants to purchase 76,000 shares of the Company's common stock at an exercise price of $9.00 for a term of 5 years, vesting immediately. The warrants were valued at $0.4 million fair value, using the Black-Scholes option pricing model to calculate the grant date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of 81.5%, risk free interest rate of 3.62% and expected warrant life of 5 years. The relative fair value of the warrant was $0.4 million and was recorded as a discount to the note payable in accordance with FASB ASC 835-30-25, Recognition, and is being accreted over the term of the note payable for financial statement purposes. As of December&#160;31, 2023, the unpaid principal balance of the 2023 Note was $7.3 million, net of debt discount of $0.3 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2020 Unsecured Convertible Notes Payable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September&#160;15, 2020, the Company issued two unsecured, partially convertible, promissory notes (the &#x201c;September 2020 Notes&#x201d;) for an aggregate principal amount of $10.0 million to two investors (collectively, the &#x201c;Lenders&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February&#160;28, 2022, the Company entered into a letter agreement (the &#x201c;Letter Agreement&#x201d;) with one of the Lenders providing for the payoff of its September 2020 Note in the principal amount of $2.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the terms of the Letter Agreement, (i) the Lender converted $0.6 million of the principal amount due to him under his September 2020 Note into 200,000 shares of Company common stock (the &#x201c;Conversion Shares&#x201d;) at a price of $3.00 per share as provided for under the terms of the September 2020 Note (the &#x201c;Conversion&#x201d;), (ii) the Company paid to the Lender $1.4 million in cash, representing $1.4 million of the remaining principal under the September 2020 Note following the Conversion plus $41,000 in accrued and outstanding interest under the September 2020 Note, and (iii) the Company repurchased the Conversion Shares at a price of $5.75 per share for an aggregate amount of $1.2 million (for a total aggregate payment to the Lender of $2.6 million).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2022, the Company paid the remaining Lender &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$5.6 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in principal on the remaining September 2020 Note. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 10, 2023, the Lender converted the remaining &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$2.4 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; principal into 800,000 shares of the Company's common stock. The September 2020 Note was settled in full as of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2023&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December&#160;31, 2023 and 2022, the Company incurred $0.8 million and $0.8 million, respectively, in interest expense under the September 2020 Notes.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-119" decimals="-5" id="f-601" unitRef="usd">3300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-119" decimals="4" id="f-602" unitRef="number">0.0825</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment contextRef="c-120" decimals="-3" id="f-603" unitRef="usd">25000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DeferredFinanceCostsGross contextRef="c-119" decimals="-3" id="f-604" unitRef="usd">341000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:EscrowDeposit contextRef="c-121" decimals="-3" id="f-605" unitRef="usd">540000</us-gaap:EscrowDeposit>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-122" decimals="-5" id="f-606" unitRef="usd">7600000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-122" decimals="2" id="f-607" unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-123"
      decimals="INF"
      id="f-608"
      unitRef="shares">76000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="c-123"
      decimals="2"
      id="f-609"
      unitRef="usdPerShare">9.00</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-124" id="f-610">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="c-125" decimals="-5" id="f-611" unitRef="usd">400000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-124"
      decimals="INF"
      id="f-612"
      unitRef="number">0.815</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-124"
      decimals="INF"
      id="f-613"
      unitRef="number">0.0362</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-123" id="f-614">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-123" decimals="-5" id="f-615" unitRef="usd">400000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-126" decimals="-5" id="f-616" unitRef="usd">7300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-126" decimals="-5" id="f-617" unitRef="usd">300000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <prph:NumberOfDebtInstruments contextRef="c-127" decimals="INF" id="f-618" unitRef="debt">2</prph:NumberOfDebtInstruments>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-127" decimals="-5" id="f-619" unitRef="usd">10000000</us-gaap:DebtInstrumentFaceAmount>
    <prph:NumberOfInvestors
      contextRef="c-127"
      decimals="INF"
      id="f-620"
      unitRef="investor">2</prph:NumberOfInvestors>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-128" decimals="-5" id="f-621" unitRef="usd">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-129" decimals="-5" id="f-622" unitRef="usd">600000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-130"
      decimals="INF"
      id="f-623"
      unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-129"
      decimals="2"
      id="f-624"
      unitRef="usdPerShare">3.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:Cash contextRef="c-131" decimals="-5" id="f-625" unitRef="usd">1400000</us-gaap:Cash>
    <us-gaap:InvestmentOwnedBalancePrincipalAmount contextRef="c-131" decimals="-5" id="f-626" unitRef="usd">1400000</us-gaap:InvestmentOwnedBalancePrincipalAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="c-131" decimals="-3" id="f-627" unitRef="usd">41000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-131"
      decimals="2"
      id="f-628"
      unitRef="usdPerShare">5.75</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="c-132" decimals="-5" id="f-629" unitRef="usd">1200000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtInstrumentPeriodicPayment contextRef="c-132" decimals="-5" id="f-630" unitRef="usd">2600000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-133" decimals="-5" id="f-631" unitRef="usd">5600000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:DebtConversionOriginalDebtAmount1 contextRef="c-134" decimals="-5" id="f-632" unitRef="usd">2400000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c-134"
      decimals="INF"
      id="f-633"
      unitRef="shares">800000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:InterestExpenseOther contextRef="c-135" decimals="-5" id="f-634" unitRef="usd">800000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther contextRef="c-136" decimals="-5" id="f-635" unitRef="usd">800000</us-gaap:InterestExpenseOther>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-636">Stockholders&#x2019; Equity&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our authorized capital stock consists of 50 million shares of common stock, $0.0005 par value, and one million shares of preferred stock, $0.0005 par value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preferred stock authorized under the Company's certificate of incorporation may be issued from time to time in one or more series. As of December&#160;31, 2023, no shares of preferred stock have been issued. The Company's board of directors have the full authority permitted by law to establish, without further stockholder approval, one or more series of preferred stock and the number of shares constituting each such series and to fix by resolution voting powers, preferences and relative, participating, optional and other special rights of each series of preferred stock, and the qualifications, limitations or restrictions thereof, if any. Subject to the limitation on the total number of shares of preferred stock that the Company has authority to issue under its certificate of incorporation, the board of directors is also authorized to increase or decrease the number of shares of any series, subsequent to the issue of that series, but not below the number of shares of such series then-outstanding. In case the number of shares of any series is so decreased, the shares constituting such decrease will resume the status that they had prior to the adoption of the resolution originally fixing the number of shares of such series. The Company may, subject to any required stockholder approval, amend from time to time its certificate of incorporation to increase the number of authorized shares of preferred stock or common stock or to make other changes or additions to our capital structure or the terms of our capital stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Stock Dividends &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No dividends have been declared during the year ended December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 9, 2022, the board of directors of the Company declared a special cash dividend of $0.30 per share on the Company&#x2019;s common stock, paid on June 4, 2022, in the amount of $4.7 million to holders of record of the Company&#x2019;s common stock as of May 25, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 14, 2022, the board of directors of the Company declared a special cash dividend of $0.30 per share on the Company&#x2019;s common stock, paid on March 10, 2022, in the amount of $4.6 million to holders of record of the Company&#x2019;s common stock on March 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 15, 2023, the Company announced that its board of directors had approved a new stock repurchase program. Under the stock repurchase program, the Company is authorized to repurchase up to $6.0 million of its outstanding shares of common stock from time to time, over a nine-month period. The number of shares to be repurchased and the timing of the repurchases, if any, will depend on a number of factors, including, but not limited to, price, trading volume and general market conditions, along with the Company&#x2019;s working capital requirements and general business conditions. The board of directors will re-evaluate the program from time to time and may authorize adjustments to its terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the Commencement Date (as defined in the stock repurchase agreement), and for a period of nine months thereafter, repurchases may be made through open market transactions (based on prevailing market prices), privately negotiated transactions, block trades, or any combination thereof, in accordance with applicable federal securities laws, including Rule 10b-18 of the Securities Exchange Act of 1934, as amended.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 26, 2022, the Company announced that its board of directors had approved new stock repurchase programs. Under each of the stock repurchase programs, the Company was authorized to repurchase up to $6.0 million of its outstanding shares of common stock from time to time, over a six-month period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company repurchased 69,628 and 303,145 shares during the years ended December&#160;31, 2023 and 2022, respectively, pursuant to the stock repurchase programs for an aggregate amount of $0.6 million and $2.2 million respectively, including commissions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;The 2022 Directors' Equity Compensation Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On May 19, 2022, the stockholders of the Company approved the 2022 Directors&#x2019; Equity Compensation Plan (the &#x201c;2022 Directors&#x2019; Plan&#x201d;) at the 2022 Annual Meeting of Stockholders of the Company (the &#x201c;2022 Annual Meeting&#x201d;). The 2022 Directors&#x2019; Plan amended and restated the Company&#x2019;s Amended and Restated 2010 Directors&#x2019; Equity Compensation Plan and provided for an increase in the number of shares reserved for issuance under the plan by 300,000 shares and for the adjustment of the per share exercise price of stock options granted under the 2022 Plan in the event of any change in the &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;outstanding shares of common stock of the Company as a result of, among other things, any distribution or special dividend to stockholders of shares, cash or other property (other than regular cash dividends).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On June 16, 2023, the stockholders of the Company approved the Amended and Restated 2022 Directors&#x2019; Equity Compensation Plan (the &#x201c;Amended 2022 Directors&#x2019; Plan&#x201d;) at the 2023 Annual Meeting of Stockholders of the Company. The Amended 2022 Directors&#x2019; Plan provides for an increase in the number of shares reserved for issuance under such plan by 150,000 shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company issued 120,000 and 120,000 options issued under this plan during the year ended December&#160;31, 2023 and 2022, respectively. As of December&#160;31, 2023, there were 210,000 shares of common stock available to be issued under the 2022 Directors&#x2019; Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;The 2010 Directors&#x2019; Equity Compensation Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 20, 2021, the stockholders of the Company approved the Amended and Restated 2010 Directors&#x2019; Equity Compensation Plan (the &#x201c;Amended 2010 Directors&#x2019; Plan&#x201d;) at the 2021 annual meeting of stockholders of the Company (the "2021 Annual Meeting"). The Amended 2010 Directors&#x2019; Plan authorizes the issuance of up to 775,000 shares of common stock. This plan was amended and restated on April 11, 2022 (to become the 2022 Directors' Plan), subject to stockholder approval, which was obtained at the 2022 Annual Meeting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;The 2022 Equity Compensation Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 19, 2022, the stockholders of the Company approved the 2022 Equity Compensation Plan (the &#x201c;2022 Plan&#x201d;) at the 2022 Annual Meeting. The 2022 Plan amended and restated the Company&#x2019;s Amended and Restated 2010 Equity Compensation Plan and provides for an increase in the number of shares reserved for issuance under the plan by 1,000,000 shares and provides for the adjustment of the per share exercise price of stock options granted under the 2022 Plan in the event of any change in the outstanding shares of common stock of the Company as a result of, among other things, any distribution or special dividend to stockholders of shares, cash or other property (other than regular cash dividends).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 16, 2023, the stockholders of the Company approved the Amended and Restated 2022 Equity Compensation Plan (the &#x201c;Amended 2022 Plan&#x201d;) at the 2023 Annual Meeting of Stockholders of the Company. The Amended 2022 Plan provides for an increase in the number of shares reserved for issuance under such plan by 700,000 shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, there were 1,093,285 shares of common stock available to be issued under the 2022 Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;The 2010 Equity Compensation Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 20, 2021, the stockholders of the Company approved the Amended and Restated 2010 Equity Compensation Plan (the &#x201c;Amended 2010 Plan&#x201d;) at the 2021 Annual Meeting. The Amended 2010 Plan authorized the issuance of up to 4,900,000 shares of common stock. This plan was amended and restated on April 11, 2022 (to become the 2022 Plan), subject to stockholder approval, which was obtained at the 2022 Annual Meeting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;The 2018 Stock Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 12, 2018, the Company's stockholders approved the 2018 Stock Incentive Plan (the &#x201c;2018 Stock Plan&#x201d;). The 2018 Stock Plan provides for the grant of incentive stock options to eligible employees of the Company, and for the grant of non-statutory stock options to eligible employees, directors and consultants. The purpose of the 2018 Stock Plan is to advance the interests of the Company and its stockholders by providing an incentive to attract, retain, and reward persons performing services for the Company and by motivating such persons to contribute to the growth and profitability of the Company. The 2018 Stock Plan provides that the total number of shares that may be issued pursuant to the 2018 Stock Plan is 2,300,000 shares. At April 12, 2018, all 2,300,000 shares had been granted in the form of stock options to Ted Karkus (the &#x201c;CEO Option&#x201d;), the Company's Chief Executive Officer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2018 Stock Plan required certain proportionate adjustments to be made to the stock options granted under the 2018 Stock Plan upon the occurrence of certain events, including a special distribution (whether in the form of cash, shares, other securities, or other property) in order to maintain parity. Accordingly, the Compensation Committee of the board of directors, as required by the terms of the 2018 Stock Plan, adjusted the exercise price of the CEO Option in connection &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;with each special cash dividend paid by the Company proportionately to the amount of the dividend paid. The final exercise price of the CEO Option was $0.60 per share after the latest special cash dividend paid on June 3, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2023 and 2022, 1,100,000 and 1,200,000 stock options were exercised under the 2018 Stock Plan. No share based compensation expense will be recognized in forward periods related to the 2018 Stock Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Inducement Option Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no issuances of inducements awards during the year ended December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 9, 2022, the Company issued a non-qualified stock option to the prospective Chief Financial Officer of the Company (the &#x201c;CFO&#x201d;), as an inducement to his employment with the Company, effective May 23, 2022 (the &#x201c;CFO Award&#x201d;). The CFO Award entitled the CFO to purchase up to 400,000 shares of the Company&#x2019;s common stock at an exercise price of $6.74 per share, the closing price of the Company&#x2019;s common stock on May 9, 2022. The CFO Award provided for certain proportionate adjustments to be made in the event of any change in the outstanding shares of common stock of the Company as a result of, among other things, any distribution or special dividend to stockholders of shares, cash or other property (other than regular cash dividends) in order to maintain parity. The exercise price of the CFO Award was reduced from $6.74 to $6.44 per share, effective as of June 3, 2022, the date $0.30 special cash dividend was paid to Company&#x2019;s stockholders. The grant date fair value of the CFO Award was approximately $1.6 million. In connection with CFO&#x2019;s separation from service on October 4, 2022, these options were forfeited on October 4, 2022.  The Company reversed $149,000 of stock based compensation expense previously recognized for the unvested options at the time of forfeiture.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the year ended December 31, 2022, the Company issued an inducement award to a prospective employee to purchase up to 250,000 shares of the Company&#x2019;s common stock at an exercise price of $13.00, the closing price of the common stock on the date of grant. The award vested 50% on the date of grant and the remaining portion will vest 25% per year for the next two years. The award expires on the &lt;span style="-sec-ix-hidden:f-688"&gt;seven&lt;/span&gt;th anniversary of the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All inducement awards have been granted outside of the Company&#x2019;s equity compensation plans pursuant to Nasdaq Listing Rule 5635(c)(4).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of all option grants  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock options activity during Fiscal 2023 and 2022 (in thousands, except per share data).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Number of Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Weighted Average Remaining Contractual Life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,110&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,095&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(420)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,952&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,135&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(788)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,951&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Options vested and exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,880&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the closing stock price of $4.52 and $9.63 for the Company&#x2019;s common stock on December&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2023, certain holders of stock options elected to exercise their stock options pursuant to a cashless exercise provision resulting in the net issuance of 603,881 shares of common stock and the return of 744,369 shares to the Company. The Company also made a cash payment of approximately &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$5.4 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to repurchase 603,881 shares of treasury stock to satisfy tax withholding obligations related to the cashless exercise of these stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the year ended December 31, 2022, we issued 828,021 shares of common stock through a cashless exercise of 1,833,000 options.  In connection with the cashless exercise, the company repurchased 1,103,000 common stock at a cost of $7.5 million to satisfy tax withholding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2023 and 2022, the Company granted options to purchase 1,135,000 and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,095,000 &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;shares of the Company&#x2019;s common stock to various employees and consultants, respectively. The options grant date fair value was valued at &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$4.2 million and $6.1 million during the year ended &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2023 and 2022, using the Black-Scholes option pricing model to calculate the grant-date fair value of the options. The fair value of stock options for employees are expensed over the vesting term in accordance with the terms of the related stock option agreements and are expensed over the terms of the consulting agreement for consultants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes weighted average assumptions used in determining the fair value of the stock options at the date of grant during Fiscal 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the years ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Risk-free rate of interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Expected dividend yield (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The expected stock price volatility is based on the Company&#x2019;s historical common stock trading prices and the expected term is based on the period that the Company&#x2019;s stock-based awards are expected to be outstanding based on the simplified method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comm&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;on Stock Warrants &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 12, 2023, the Company issued warrants to an advisory firm to purchase 50,000 shares of the Company's common stock at an exercise price of $10.00 for a term of 5 years, vesting immediately. The warrants were valued at $0.3&#160;million fair value, using the Black-Scholes option pricing model to calculate the grant date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of 80.9%, risk free interest rate of 3.5% and expected warrant life of 5 years. These warrants were expensed over the 1 year term of the engagement which ended on December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 27, 2023, the Company issued five-year warrants to purchase 76,000 shares of the Company's common stock with the unsecured promissory note (see Note 6).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 6, 2023, the Company issued warrants to a consultant to purchase 250,000 shares of the Company's common stock at an exercise price of $9.00 for a term of 5 years, vesting immediately.  The warrants were valued at $1.4&#160;million, using the Black-Scholes option pricing model to calculate the grant date fair value of the warrants, with the following assumptions: no dividend yield, expected volatility of 80.4%, risk free interest rate of 3.6% and expected warrant life of 5 years, which was initially recognized as a prepaid expense and to be expensed over the term of the consulting agreement. As of December 31, 2023, $5.1&#160;million was remained in the prepaid expense and other current assets on the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Between August and September 2023, the Company received $1.2&#160;million from the exercise of outstanding warrants with an exercise price at $3.00 per share. The Company issued approximately 400,000 shares of common stock upon these warrant exercises.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2022, there were no stock warrants issued.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes warrant activities during Fiscal 2023 and 2022 (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Number of Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted Average&lt;br/&gt;Remaining Contractual&lt;br/&gt;Life &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;855&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Warrants granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;855&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Warrants granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Warrants exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;831&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Warrants vested and exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;831&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized $3.5&#160;million of share-based compensation expense during the year ended December&#160;31, 2023. The Company will recognize an aggregate of approximately $5.1&#160;million of remaining share-based compensation expense related to outstanding stock options and warrants over a weighted average period of 4.3 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="-6" id="f-637" unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-638"
      unitRef="usdPerShare">0.0005</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-639" unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-640" unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-641"
      unitRef="usdPerShare">0.0005</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued contextRef="c-4" decimals="INF" id="f-642" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:DividendsCommonStock contextRef="c-1" decimals="INF" id="f-643" unitRef="usd">0</us-gaap:DividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-137"
      decimals="2"
      id="f-644"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-137" decimals="-5" id="f-645" unitRef="usd">4700000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-138"
      decimals="2"
      id="f-646"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-138" decimals="-5" id="f-647" unitRef="usd">4600000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-139" decimals="-5" id="f-648" unitRef="usd">6000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramPeriodInForce1 contextRef="c-140" id="f-649">P9M</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:StockRepurchaseProgramPeriodInForce1 contextRef="c-140" id="f-650">P9M</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-141" decimals="-5" id="f-651" unitRef="usd">6000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramPeriodInForce1 contextRef="c-142" id="f-652">P6M</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="c-1" decimals="INF" id="f-653" unitRef="shares">69628</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-10"
      decimals="INF"
      id="f-654"
      unitRef="shares">303145</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-1" decimals="-5" id="f-655" unitRef="usd">600000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-10" decimals="-5" id="f-656" unitRef="usd">2200000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-143"
      decimals="INF"
      id="f-657"
      unitRef="shares">300000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <prph:CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance
      contextRef="c-144"
      decimals="INF"
      id="f-658"
      unitRef="shares">150000</prph:CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-145"
      decimals="INF"
      id="f-659"
      unitRef="shares">120000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-146"
      decimals="INF"
      id="f-660"
      unitRef="shares">120000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-147"
      decimals="INF"
      id="f-661"
      unitRef="shares">210000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-148"
      decimals="INF"
      id="f-662"
      unitRef="shares">775000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <prph:CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance
      contextRef="c-149"
      decimals="INF"
      id="f-663"
      unitRef="shares">1000000</prph:CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance>
    <prph:CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance
      contextRef="c-150"
      decimals="INF"
      id="f-664"
      unitRef="shares">700000</prph:CommonStockIncreaseDecreaseInCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-151"
      decimals="INF"
      id="f-665"
      unitRef="shares">1093285</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-152"
      decimals="INF"
      id="f-666"
      unitRef="shares">4900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="c-153"
      decimals="INF"
      id="f-667"
      unitRef="shares">2300000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-153"
      decimals="INF"
      id="f-668"
      unitRef="shares">2300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-154"
      decimals="2"
      id="f-669"
      unitRef="usdPerShare">0.60</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-155"
      decimals="INF"
      id="f-670"
      unitRef="shares">1100000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-156"
      decimals="INF"
      id="f-671"
      unitRef="shares">1200000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-157"
      decimals="INF"
      id="f-672"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-158"
      decimals="2"
      id="f-673"
      unitRef="usdPerShare">6.74</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-159"
      decimals="2"
      id="f-674"
      unitRef="usdPerShare">6.74</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-160"
      decimals="2"
      id="f-675"
      unitRef="usdPerShare">6.44</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-161"
      decimals="2"
      id="f-676"
      unitRef="usdPerShare">0.30</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost contextRef="c-161" decimals="-5" id="f-677" unitRef="usd">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <prph:ShareBasedPaymentArrangementExpenseReversal contextRef="c-162" decimals="-3" id="f-678" unitRef="usd">149000</prph:ShareBasedPaymentArrangementExpenseReversal>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="c-163"
      decimals="INF"
      id="f-679"
      unitRef="shares">250000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c-164"
      decimals="2"
      id="f-680"
      unitRef="usdPerShare">13.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-165" decimals="2" id="f-681" unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-166" decimals="2" id="f-682" unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-167" decimals="2" id="f-683" unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-168" decimals="2" id="f-684" unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-167" id="f-685">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-166" id="f-686">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-168" id="f-687">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-689">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock options activity during Fiscal 2023 and 2022 (in thousands, except per share data).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Number of Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Weighted Average Remaining Contractual Life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,110&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,095&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(420)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,952&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,135&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(788)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,951&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Options vested and exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,880&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-16" decimals="-3" id="f-690" unitRef="shares">5110000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-16"
      decimals="2"
      id="f-691"
      unitRef="usdPerShare">3.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-169" id="f-692">P3Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-16" decimals="-3" id="f-693" unitRef="usd">20820000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-10" decimals="-3" id="f-694" unitRef="shares">1095000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-10"
      decimals="2"
      id="f-695"
      unitRef="usdPerShare">9.92</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm contextRef="c-10" id="f-696">P7Y</prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-10" decimals="-3" id="f-697" unitRef="shares">1833000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-10"
      decimals="2"
      id="f-698"
      unitRef="usdPerShare">1.29</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-10" decimals="-3" id="f-699" unitRef="shares">420000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-10"
      decimals="2"
      id="f-700"
      unitRef="usdPerShare">1.56</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-5" decimals="-3" id="f-701" unitRef="shares">3952000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-5"
      decimals="2"
      id="f-702"
      unitRef="usdPerShare">5.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-10" id="f-703">P3Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-5" decimals="-3" id="f-704" unitRef="usd">20379000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="-3" id="f-705" unitRef="shares">1135000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-706"
      unitRef="usdPerShare">8.65</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm contextRef="c-1" id="f-707">P5Y</prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-1" decimals="-3" id="f-708" unitRef="shares">1348000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-709"
      unitRef="usdPerShare">0.98</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-1" decimals="-3" id="f-710" unitRef="shares">788000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-711"
      unitRef="usdPerShare">0.64</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-4" decimals="-3" id="f-712" unitRef="shares">2951000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-713"
      unitRef="usdPerShare">7.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-714">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-4" decimals="-3" id="f-715" unitRef="usd">693000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber contextRef="c-4" decimals="-3" id="f-716" unitRef="shares">1880000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-717"
      unitRef="usdPerShare">6.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-718">P4Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue contextRef="c-4" decimals="-3" id="f-719" unitRef="usd">693000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-4"
      decimals="2"
      id="f-720"
      unitRef="usdPerShare">4.52</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-5"
      decimals="2"
      id="f-721"
      unitRef="usdPerShare">9.63</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-27"
      decimals="INF"
      id="f-722"
      unitRef="shares">603881</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-170"
      decimals="INF"
      id="f-723"
      unitRef="shares">744369</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-5" id="f-724" unitRef="usd">5400000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-1" decimals="INF" id="f-725" unitRef="shares">603881</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c-17"
      decimals="INF"
      id="f-726"
      unitRef="shares">828021</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-10"
      decimals="INF"
      id="f-727"
      unitRef="shares">1833000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="c-17"
      decimals="INF"
      id="f-728"
      unitRef="shares">1103000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-10" decimals="-5" id="f-729" unitRef="usd">7500000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="-3" id="f-730" unitRef="shares">1135000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-10" decimals="-3" id="f-731" unitRef="shares">1095000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue contextRef="c-1" decimals="-5" id="f-732" unitRef="usd">4200000</prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue>
    <prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue contextRef="c-10" decimals="-5" id="f-733" unitRef="usd">6100000</prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-734">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes weighted average assumptions used in determining the fair value of the stock options at the date of grant during Fiscal 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the years ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Risk-free rate of interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Expected dividend yield (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-735"
      unitRef="usdPerShare">8.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="c-5"
      decimals="2"
      id="f-736"
      unitRef="usdPerShare">10.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-1" id="f-737">P4Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-10" id="f-738">P4Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-1" decimals="2" id="f-739" unitRef="number">0.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-10" decimals="2" id="f-740" unitRef="number">0.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-1" decimals="3" id="f-741" unitRef="number">0.037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-10" decimals="3" id="f-742" unitRef="number">0.025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-1" decimals="2" id="f-743" unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-10" decimals="2" id="f-744" unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-171"
      decimals="INF"
      id="f-745"
      unitRef="shares">50000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="c-172"
      decimals="2"
      id="f-746"
      unitRef="usdPerShare">10.00</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-173" id="f-747">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-173" decimals="-5" id="f-748" unitRef="usd">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-174" decimals="3" id="f-749" unitRef="number">0.809</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-174" decimals="3" id="f-750" unitRef="number">0.035</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-174" id="f-751">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-4" id="f-752">P1Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-175" id="f-753">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-176"
      decimals="INF"
      id="f-754"
      unitRef="shares">76000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-177"
      decimals="INF"
      id="f-755"
      unitRef="shares">250000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="c-177"
      decimals="2"
      id="f-756"
      unitRef="usdPerShare">9.00</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-177" id="f-757">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-177" decimals="-5" id="f-758" unitRef="usd">1400000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-178" decimals="4" id="f-759" unitRef="number">0.804</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-178" decimals="3" id="f-760" unitRef="number">0.036</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-178" id="f-761">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-4" decimals="-5" id="f-762" unitRef="usd">5100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-179" decimals="-5" id="f-763" unitRef="usd">1200000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-180"
      decimals="2"
      id="f-764"
      unitRef="usdPerShare">3.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <prph:IssuanceOfCommonStockSharesExerciseOfWarrant
      contextRef="c-181"
      decimals="-3"
      id="f-765"
      unitRef="shares">400000</prph:IssuanceOfCommonStockSharesExerciseOfWarrant>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="c-10" decimals="INF" id="f-766" unitRef="usd">0</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <prph:ScheduleOfWarrantActivityTableTextBlock contextRef="c-1" id="f-767">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes warrant activities during Fiscal 2023 and 2022 (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Number of Shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted Average&lt;br/&gt;Remaining Contractual&lt;br/&gt;Life &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;855&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Warrants granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;855&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Warrants granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Warrants exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;831&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Warrants vested and exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;831&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</prph:ScheduleOfWarrantActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="c-182"
      decimals="-3"
      id="f-768"
      unitRef="shares">855000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1
      contextRef="c-182"
      decimals="INF"
      id="f-769"
      unitRef="usdPerShare">8.23</prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-183" id="f-770">P1Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c-184"
      decimals="-3"
      id="f-771"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1
      contextRef="c-184"
      decimals="INF"
      id="f-772"
      unitRef="usdPerShare">0</prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="c-185"
      decimals="-3"
      id="f-773"
      unitRef="shares">855000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1
      contextRef="c-185"
      decimals="2"
      id="f-774"
      unitRef="usdPerShare">8.23</prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-184" id="f-775">P1Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c-186"
      decimals="-3"
      id="f-776"
      unitRef="shares">376000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1
      contextRef="c-186"
      decimals="2"
      id="f-777"
      unitRef="usdPerShare">9.13</prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingGrantedWeightedAverageExercisePrice1>
    <prph:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2 contextRef="c-186" id="f-778">P4Y2M12D</prph:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedWarrantsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="c-186"
      decimals="-3"
      id="f-779"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <prph:WeightedAverageExercisePriceWarrantsExercised
      contextRef="c-186"
      decimals="2"
      id="f-780"
      unitRef="usdPerShare">3.00</prph:WeightedAverageExercisePriceWarrantsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="c-187"
      decimals="-3"
      id="f-781"
      unitRef="shares">831000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1
      contextRef="c-187"
      decimals="2"
      id="f-782"
      unitRef="usdPerShare">11.16</prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-186" id="f-783">P1Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="c-187"
      decimals="-3"
      id="f-784"
      unitRef="shares">831000</prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableNumber>
    <prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1
      contextRef="c-186"
      decimals="2"
      id="f-785"
      unitRef="usdPerShare">11.16</prph:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExercisableWeightedAverageExercisePrice1>
    <prph:WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable contextRef="c-186" id="f-786">P1Y10M24D</prph:WeightedAverageRemainingContractualLifeWarrantsVestedAndExercisable>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-5" id="f-787" unitRef="usd">3500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-4" decimals="-5" id="f-788" unitRef="usd">5100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-1" id="f-789">P4Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="c-1" id="f-790">Defined Contribution Plans&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains the ProPhase Labs, Inc. 401(k) Savings and Retirement Plan, a defined contribution plan for its employees. The Company's contributions to the plan are based on the amount of the employee plan contributions and compensation. The Company's contributions to the plan for the years ended December&#160;31, 2023 and 2022 were $0.2 million and $0.2 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c-1" decimals="-5" id="f-791" unitRef="usd">200000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c-10" decimals="-5" id="f-792" unitRef="usd">200000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-793">Income Taxes&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the provision (benefit) for income taxes, in the consolidated statements of operations are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.818%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.018%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.425%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.334%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Continuing Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(5,459)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(7,074)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Income taxes from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,018)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the statutory federal income tax expense (benefit) to the effective tax is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.657%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.507%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Statutory Rate - federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(4,788)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;State taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research &amp;amp; development tax credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Permanent differences and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Income taxes from continuing operations before valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(5,761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(257)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,018)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,018)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax effects of the primary &#x201c;temporary differences&#x201d; between values recorded for assets and liabilities for financial reporting purposes and values utilized for measurement in accordance with tax laws giving rise to our deferred tax assets are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.839%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.809%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the years ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net operating loss and capital loss carryforward&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Capital lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(705)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(2,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Tax credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes tax assets and liabilities for the future tax consequences related to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and for net operating loss carryforwards. Management evaluated the deferred tax assets for recoverability using a consistent approach that considers the relative impact of negative and positive evidence, including historical profitability and projections of future reversals of temporary differences and future taxable income. The Company is required to establish a valuation allowance for deferred tax assets if management determines, based on available evidence at the time the determination is made, that it is not more likely than not that some portion or all of the deferred tax assets will be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;As of December&#160;31, 2023, the Company is in a net deferred tax asset position for federal and state jurisdictions. Based on a three-year cumulative income position and anticipated future taxable income, the Company concluded that the federal and combined state deferred tax assets will be realized and there is no need for a valuation allowance at this time. The Company will continue to monitor the need for any valuation allowance changes on a quarterly basis.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company continues to maintain a valuation allowance against some of the separate company state net operating loss ("NOL") carryforwards. As of December 31, 2023 there is a valuation allowance of $0.6&#160;million compared to $0.8&#160;million as of December 31, 2022. As of December 31, 2023, the Company has state NOL carryforwards of $1.5&#160;million, which begin to expire in 2024 and federal NOL carryforwards of $3.1&#160;million as well as an R&amp;amp;D tax credit carryforward of $0.3&#160;million which can be carried forward indefinitely. A portion of the federal NOL is attributable to 2021 Nebula acquisition, and it is Section 382 limited with an annual limitation of $0.3&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files a consolidated federal income tax return and separate company state returns as well as combined state returns where applicable.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-794">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the provision (benefit) for income taxes, in the consolidated statements of operations are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.818%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.018%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.425%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.334%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Continuing Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(5,459)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(7,074)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Income taxes from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,018)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-795" unitRef="usd">772000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-10" decimals="-3" id="f-796" unitRef="usd">1040000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-797" unitRef="usd">284000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-10" decimals="-3" id="f-798" unitRef="usd">3543000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-799" unitRef="usd">1056000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-10" decimals="-3" id="f-800" unitRef="usd">4583000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-801" unitRef="usd">-5459000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-10" decimals="-3" id="f-802" unitRef="usd">72000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-803" unitRef="usd">-1615000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-10" decimals="-3" id="f-804" unitRef="usd">-210000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-805" unitRef="usd">-7074000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-10" decimals="-3" id="f-806" unitRef="usd">-138000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-807" unitRef="usd">-6018000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-10" decimals="-3" id="f-808" unitRef="usd">4445000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-809">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the statutory federal income tax expense (benefit) to the effective tax is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.657%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.507%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Statutory Rate - federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(4,788)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;State taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research &amp;amp; development tax credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Permanent differences and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Income taxes from continuing operations before valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(5,761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(257)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,018)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,018)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="-3" id="f-810" unitRef="usd">-4788000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-10" decimals="-3" id="f-811" unitRef="usd">4811000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="-3" id="f-812" unitRef="usd">-1133000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-10" decimals="-3" id="f-813" unitRef="usd">2789000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-1" decimals="-3" id="f-814" unitRef="usd">350000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-10" decimals="-3" id="f-815" unitRef="usd">1200000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-1" decimals="-3" id="f-816" unitRef="usd">510000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-10" decimals="-3" id="f-817" unitRef="usd">-601000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <prph:IncomeTaxesFromContinuingOperationsBeforeValuationAllowance contextRef="c-1" decimals="-3" id="f-818" unitRef="usd">-5761000</prph:IncomeTaxesFromContinuingOperationsBeforeValuationAllowance>
    <prph:IncomeTaxesFromContinuingOperationsBeforeValuationAllowance contextRef="c-10" decimals="-3" id="f-819" unitRef="usd">5799000</prph:IncomeTaxesFromContinuingOperationsBeforeValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="-3" id="f-820" unitRef="usd">-257000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-10" decimals="-3" id="f-821" unitRef="usd">-1354000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-822" unitRef="usd">-6018000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-10" decimals="-3" id="f-823" unitRef="usd">4445000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-824" unitRef="usd">-6018000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-10" decimals="-3" id="f-825" unitRef="usd">4445000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-826">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax effects of the primary &#x201c;temporary differences&#x201d; between values recorded for assets and liabilities for financial reporting purposes and values utilized for measurement in accordance with tax laws giving rise to our deferred tax assets are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.839%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.809%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the years ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net operating loss and capital loss carryforward&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Capital lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(705)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(2,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Tax credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-4" decimals="-3" id="f-827" unitRef="usd">4649000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-5" decimals="-3" id="f-828" unitRef="usd">1324000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-4" decimals="-3" id="f-829" unitRef="usd">1464000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-5" decimals="-3" id="f-830" unitRef="usd">1466000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-4" decimals="-3" id="f-831" unitRef="usd">4972000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-5" decimals="-3" id="f-832" unitRef="usd">2684000</us-gaap:DeferredTaxAssetsOther>
    <prph:DeferredTaxAssetsCapitalLeaseObligations contextRef="c-4" decimals="-3" id="f-833" unitRef="usd">1464000</prph:DeferredTaxAssetsCapitalLeaseObligations>
    <prph:DeferredTaxAssetsCapitalLeaseObligations contextRef="c-5" decimals="-3" id="f-834" unitRef="usd">1466000</prph:DeferredTaxAssetsCapitalLeaseObligations>
    <prph:DeferredTaxLiabilitiesDepreciation contextRef="c-4" decimals="-3" id="f-835" unitRef="usd">479000</prph:DeferredTaxLiabilitiesDepreciation>
    <prph:DeferredTaxLiabilitiesDepreciation contextRef="c-5" decimals="-3" id="f-836" unitRef="usd">705000</prph:DeferredTaxLiabilitiesDepreciation>
    <prph:DeferredTaxLiabilitiesAmortization contextRef="c-4" decimals="-3" id="f-837" unitRef="usd">1612000</prph:DeferredTaxLiabilitiesAmortization>
    <prph:DeferredTaxLiabilitiesAmortization contextRef="c-5" decimals="-3" id="f-838" unitRef="usd">2703000</prph:DeferredTaxLiabilitiesAmortization>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-4" decimals="-3" id="f-839" unitRef="usd">350000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-5" decimals="-3" id="f-840" unitRef="usd">0</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-3" id="f-841" unitRef="usd">567000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="-3" id="f-842" unitRef="usd">824000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-4" decimals="-3" id="f-843" unitRef="usd">7313000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilities contextRef="c-5" decimals="-3" id="f-844" unitRef="usd">224000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-5" id="f-845" unitRef="usd">600000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="-5" id="f-846" unitRef="usd">800000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal contextRef="c-4" decimals="-5" id="f-847" unitRef="usd">1500000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic contextRef="c-4" decimals="-5" id="f-848" unitRef="usd">3100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="c-4" decimals="-5" id="f-849" unitRef="usd">300000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <prph:TaxCreditCarryforwardLimitationAmount contextRef="c-4" decimals="-5" id="f-850" unitRef="usd">300000</prph:TaxCreditCarryforwardLimitationAmount>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock contextRef="c-1" id="f-851">Other Current Liabilities&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the components of other current liabilities at December&#160;31, 2023 and 2022, respectively (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued diagnostic services commissions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued payroll&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued bonus&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued benefits and vacation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock contextRef="c-1" id="f-852">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the components of other current liabilities at December&#160;31, 2023 and 2022, respectively (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued diagnostic services commissions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued payroll&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued bonus&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued benefits and vacation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:AccruedLiabilitiesForCommissionsExpenseAndTaxes contextRef="c-4" decimals="-3" id="f-853" unitRef="usd">0</us-gaap:AccruedLiabilitiesForCommissionsExpenseAndTaxes>
    <us-gaap:AccruedLiabilitiesForCommissionsExpenseAndTaxes contextRef="c-5" decimals="-3" id="f-854" unitRef="usd">1093000</us-gaap:AccruedLiabilitiesForCommissionsExpenseAndTaxes>
    <us-gaap:AccruedPayrollTaxesCurrent contextRef="c-4" decimals="-3" id="f-855" unitRef="usd">181000</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedPayrollTaxesCurrent contextRef="c-5" decimals="-3" id="f-856" unitRef="usd">202000</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedBonusesCurrent contextRef="c-4" decimals="-3" id="f-857" unitRef="usd">1000000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedBonusesCurrent contextRef="c-5" decimals="-3" id="f-858" unitRef="usd">0</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-859" unitRef="usd">1445000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-860" unitRef="usd">714000</us-gaap:AccruedLiabilitiesCurrent>
    <prph:AccruedReturns contextRef="c-4" decimals="-3" id="f-861" unitRef="usd">3000</prph:AccruedReturns>
    <prph:AccruedReturns contextRef="c-5" decimals="-3" id="f-862" unitRef="usd">13000</prph:AccruedReturns>
    <us-gaap:AccruedEmployeeBenefitsCurrent contextRef="c-4" decimals="-3" id="f-863" unitRef="usd">54000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent contextRef="c-5" decimals="-3" id="f-864" unitRef="usd">50000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-865" unitRef="usd">2683000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-866" unitRef="usd">2072000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-867">Commitments and Contingencies&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Manufacturing Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and its wholly owned subsidiary, PMI, entered into a manufacturing agreement (the &#x201c;Manufacturing Agreement&#x201d;) with Mylan Consumer Healthcare Inc. (&#x201c;MCH&#x201d;) and Mylan Inc. (together with MCH, &#x201c;Mylan&#x201d; in connection with the asset purchase agreement we entered into with Mylan in 2017. Pursuant to the terms of the Manufacturing Agreement, Mylan (or an affiliate or designee) purchased the inventory of the Company&#x2019;s Cold-EEZE&#xae; brand and product line, and PMI agreed to manufacture certain products for Mylan, as described in the Manufacturing Agreement, at prices that reflect current market conditions for such products and include an agreed upon mark-up on our costs. On May 1, 2021, the Manufacturing Agreement was assigned by Mylan to Nurya Brands, Inc. (&#x201c;Nurya&#x201d;) in connection with Nurya&#x2019;s acquisitions of certain assets from Mylan, including the Cold-EEZE&#xae; brand and product line. Unless terminated sooner by the parties, the Manufacturing Agreement was to remain in effect until March 29, 2023. Thereafter, the Manufacturing Agreement could be renewed by Nurya for up to four successive one-year periods by providing notice of its intent to renew not less than 90 days prior to the expiration of the then-current term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On November 15, 2022, the Company was notified by Nurya of its election to renew the Manufacturing agreement for one year. As a result, the Manufacturing Agreement will remain in effect until March 29, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;License Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:32.39pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Linebacker LB1 and LB2&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:32.39pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In July 19, 2022, the Company through its wholly-owned subsidiary ProPhase BioPharma entered into a License Agreement (the &#x201c;Linebacker License Agreement&#x201d;) with Global BioLife, Inc. (the &#x201c;Licensor&#x201d;), with an effective date of July 18, 2022 (the &#x201c;Linebacker Effective Date&#x201d;), pursuant to which it acquired from Licensor a worldwide exclusive right and license under certain patents identified in the Linebacker License Agreement (the &#x201c;Licensed Patents&#x201d;) and know-how (collectively, the &#x201c;Licensed IP&#x201d;) to exploit any compound covered by the Licensed Patents (the &#x201c;Licensed Compound&#x201d;), including Linebacker LB1 and LB2, and any product comprising or containing a Licensed Compound (&#x201c;Licensed Products&#x201d;) in the treatment of cancer, inflammatory diseases or symptoms, memory-related syndromes, diseases or symptoms including dementia and Alzheimer&#x2019;s Disease (the &#x201c;Field&#x201d;). Under the terms of the Linebacker License Agreement, the Licensor reserves the right, solely for itself and for GRDG Sciences, LLC (&#x201c;GRDG&#x201d;) to use the Licensed Compound and Licensed IP solely for research purposes inside the Field and for any purpose outside the Field.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:32.39pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Subject to certain conditions set forth in the Linebacker License Agreement, the Company may grant sublicenses (including the right to grant further sublicenses) to its rights under the Linebacker License Agreement to any of its affiliates or any third party with the prior written consent of Licensor, which consent may not be unreasonably withheld. Either party to the Linebacker License Agreement may assign its rights under the Linebacker License Agreement (i) in connection with the sale or transfer of all or substantially all of its assets to a third party, (b) in the event of a merger or consolidation with a third party or (iii) to an affiliate; in each case contingent upon the assignee assuming in writing all of the obligations of its assignor under the Linebacker License Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:32.39pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Under the terms of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Linebacker &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;License Agreement, the Company is required to pay to Licensor a one-time upfront license fee of $50,000 within ten days of the Linebacker Effective Date and must pay an additional $900,000 following the achievement of a first Phase 3 study which may be required by FDA for the first Licensed Product and an additional &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$1.0&#160;million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; upon the receipt of regulatory approval of a New Drug Application for the first Licensed Product.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:32.39pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;During the term of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Linebacker &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;License Agreement, the Company is also required to pay to Licensor 3% royalties on Net Revenue (as defined in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Linebacker&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; License Agreement) of each Licensed Product, but no less than the minimum royalty of $250,000 of Net Revenue per year minus any royalty payments for any required third party licenses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:32.39pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In connection with the Linebacker License Agreement, the Company has incurred approximately $0.6&#160;million and  $0.5&#160;million  in general and administrative expenses that are included in the Consolidated Statements of Operations and Comprehensive Income (Loss) for the year ended December 31, 2023 and 2022, respectively. No clinical studies have begun under this agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Equivir&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In March 2023, we commenced patient enrollment in a randomized, placebo-controlled clinical trial of Equivir to evaluate its effect on upper respiratory tract infections. Vedic Lifesciences, a leading clinical research organization, is contracted to conduct the combination prophylactic and therapeutic study, which will be conducted at 8 sites. We currently anticipate trial completion in the third quarter of 2024 and anticipate launching Equivir (dietary supplement) in the United States toward the end of 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In connection with the license agreement relating to Equivir, for the year ended December 31, 2023, the Company has incurred approximately and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$0.4 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;in general and administrative expenses that are included in the Consolidated Statements of Operations and Comprehensive Income (Loss) for the year ended ended December 31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;BE-Smart Esophageal Pre-Cancer Diagnostics Screening Test&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In March 2023, and in connection with the Asset acquisition of Stella,, we announced a collaboration for the continued development of its BE-Smart Esophageal Pre-Cancer diagnostic screening test. We are pursuing initial commercialization of the BE-Smart test as an LDT (Laboratory Developed Test) and RUO (Research Use Only) for the third quarter of 2025 with full commercialization backed by insurance expected by the third quarter of 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In connection with the license agreement relating to BE-Smart License Agreement, for the year ended December 31, 2023, the Company has incurred approximately and $0.3&#160;million in general and administrative expenses that are included in the Consolidated Statements of Operations and Comprehensive Income (Loss) for the year ended ended December 31, 2023. No clinical studies have begun under this agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of our business, we may be named as a defendant in legal proceedings. It is our policy to vigorously defend litigation or to enter into a reasonable settlement where management deems it appropriate.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <prph:ManufacturingAgreementRenewalOptions
      contextRef="c-188"
      decimals="INF"
      id="f-868"
      unitRef="period">4</prph:ManufacturingAgreementRenewalOptions>
    <prph:ManufacturingAgreementRenewalPeriod contextRef="c-188" id="f-869">P1Y</prph:ManufacturingAgreementRenewalPeriod>
    <prph:AgreementTerm contextRef="c-188" id="f-870">P90D</prph:AgreementTerm>
    <prph:ManufacturingAgreementRenewalPeriod contextRef="c-189" id="f-871">P1Y</prph:ManufacturingAgreementRenewalPeriod>
    <prph:UpfrontLicenseFee contextRef="c-190" decimals="-3" id="f-872" unitRef="usd">50000</prph:UpfrontLicenseFee>
    <prph:LicenseAgreementTerm contextRef="c-190" id="f-873">P10D</prph:LicenseAgreementTerm>
    <prph:AdditionalPaymentOfFee contextRef="c-191" decimals="-3" id="f-874" unitRef="usd">900000</prph:AdditionalPaymentOfFee>
    <prph:AdditionalPaymentOfFee contextRef="c-192" decimals="-5" id="f-875" unitRef="usd">1000000</prph:AdditionalPaymentOfFee>
    <prph:LicenseOrRoyaltyNetRevenuePercentage
      contextRef="c-190"
      decimals="INF"
      id="f-876"
      unitRef="number">0.03</prph:LicenseOrRoyaltyNetRevenuePercentage>
    <us-gaap:RoyaltyExpense contextRef="c-190" decimals="-3" id="f-877" unitRef="usd">250000</us-gaap:RoyaltyExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-193" decimals="-5" id="f-878" unitRef="usd">600000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-194" decimals="-5" id="f-879" unitRef="usd">500000</us-gaap:GeneralAndAdministrativeExpense>
    <prph:NumberOfSites contextRef="c-195" decimals="INF" id="f-880" unitRef="site">8</prph:NumberOfSites>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-196" decimals="-5" id="f-881" unitRef="usd">400000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-197" decimals="-5" id="f-882" unitRef="usd">300000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:LesseeFinanceLeasesTextBlock contextRef="c-1" id="f-884">Leases&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New Jersey Laboratory Lease&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October&#160;23, 2020, the Company completed the acquisition of CPM, which included the acquisition of a 4,000 square foot CLIA accredited laboratory located in Old Bridge, New Jersey, which was owned by CPM (which is now known as ProPhase Diagnostics NJ, Inc.). The lease was renewed in February 2023, for an additional 36 months until February 2026. The monthly base rent remains the same at $5,500 per month. The lease renewal resulted in the recognition of an additional right-of-use asset and operating lease liability of $170,000 during the year ended December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New York Second Floor Lease&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On December 8, 2020, the Company entered into a Lease Agreement (the &#x201c;NY Second Floor Lease&#x201d;) with BRG Office L.L.C. and Unit 2 Associates L.L.C. (the &#x201c;Landlord&#x201d;), pursuant to which the Company leases certain premises located on the second floor (the &#x201c;Second Floor Leased Premises&#x201d;) of 711 Stewart Avenue, Garden City, New York (the &#x201c;Building&#x201d;). The Second Floor Leased Premises serve as the Company&#x2019;s second location and corporate headquarters, &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;offering a wide range of laboratory testing services for diagnosis, screening and evaluation of diseases, including COVID-19 and Respiratory Pathogen Panel Molecular tests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The NY Second Floor Lease was effective as of December&#160;8, 2020, and commenced in January 2021 (the &#x201c;Commencement Date&#x201d;) when the facility was made available to us by the landlord. The initial term of the NY Lease is 10 years and 7 months (the &#x201c;Initial Term&#x201d;), unless sooner terminated as provided in the NY Lease. The Company may extend the term of the NY Lease for one additional option period of five years. The Company has the option to terminate the NY Lease on the sixth anniversary of the Commencement Date, provided that it gives the landlord written notice not less than nine months and not more than 12 months in advance and that we pay the landlord a termination fee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 10, 2022, the Company entered into a First Amendment to the NY Second Floor Lease (the &#x201c;Second Floor Lease Amendment&#x201d;). The Second Floor Lease Amendment amends the NY Second Floor Lease to provide that any uncured default by the Company or any of its affiliate under the NY First Floor Lease (defined below) will constitute a default by the Company under the NY Second Floor Lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New York First Floor Lease&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;10, 2022, the Company entered into a second Lease Agreement (the &#x201c;NY First Floor Lease&#x201d;) with Landlord, pursuant to which the Company leases approximately 4,516 sq. feet located on the first floor (the &#x201c;NY First Floor Leased Premises&#x201d;) of the building. As described above, the Company currently leases space on the second floor of the building. The First Floor Leased Premises will be used to expand the Company&#x2019;s in-house lab capabilities to include traditional clinical testing across multiple specialty areas and Next Generation Sequencing (NGS) to perform Whole Genome Sequencing (WGS) and an array of genetic diagnostic test offerings for both clinical and research purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The NY First Floor Lease became effective as of June 10, 2022 and will commence upon the date of the Landlord&#x2019;s substantial completion of certain improvements to the NY First Floor Leased Premises (the &#x201c;First Floor Commencement Date&#x201d;), as set forth in the NY First Floor Lease, targeted to be approximately five months from the execution of the NY First Floor Lease. The initial term of the NY First Floor Lease will expire on July 15, 2031, unless&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;sooner terminated as provided in the NY First Floor Lease. The Company may extend the term of the NY First Floor Lease for one additional option period of five years pursuant to the terms described in the NY First Floor Lease. The Company has the option to terminate the NY First Floor Lease effective July 31, 2027 (the &#x201c;Early Termination Date&#x201d;), provided the Company gives the Landlord written notice not less than nine months and not more than 12 months prior to the Early Termination Date and pays the Landlord a termination fee as more particularly described in the Lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the first year of the NY First Floor Lease, the Company will pay a base rent of $11,290 per month (subject to an eight month abatement period), with a gradual rental rate increase of approximately 2.75% for each twelve month period thereafter, culminating in a monthly base rent of $14,026 during the final months of the initial term of the NY First Floor Lease. In addition to the monthly base rent, the Company is responsible for its proportionate share of real estate tax escalations in accordance with the terms of the NY First Floor Lease. The Landlord will provide a construction allowance to the Company in an aggregate amount not to exceed $203,000, to reimburse the Company for the cost of certain improvements to be made by the Company to the First Floor Leased Premises. During the year ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;December&#160;31, 2023&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, the Company recognized additional &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$0.8 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; right-of-use asset and operating lease liability for the NY First Floor Lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2023 and 2022, the Company had operating lease liabilities for the New York and New Jersey leases of approximately $5.2 million and $4.6 million, respectively, and right of use assets of approximately $4.6 million and $4.1 million, respectively, which were included in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On April 19, 2023, the Company entered into a master lease agreement for a laboratory equipment (the "First Equipment Lease") with a vendor. The First Equipment Lease has a 5-year term and is recognized as a finance lease under ASC 842.  The present value of the minimum future obligations of $1.5 million was calculated based on an interest rate of 8.0%, which was recognized in finance lease liabilities in the consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On July 21, 2023, the Company entered into a master lease agreement for a laboratory equipment (the "Second Equipment Lease") with a vendor. The Second Equipment Lease has a 4-year term and is recognized as a finance lease &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;under ASC 842.  The present value of the minimum future obligations of $5.1 million was calculated based on an interest rate of 7.4%, which was recognized in finance lease liabilities in the condensed consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On September 26, 2023, the Company entered into a master lease agreement for a laboratory equipment (the "Third Equipment Lease") with a vendor. The Third Equipment Lease has a 3-year term starting on the commencement date. The commencement date is when the equipment is shipped and installed, then the Company will provide Final Acceptance Certificate to the vendor. As of December&#160;31, 2023, the commencement date was not established, therefore, there was no fixed assets or finance lease liability recognized in the condensed consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Depreciation and interest expense related to the Equipment Lease was $760,000 for the year ended December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes quantitative information about the Company's operating and finance leases (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Finance leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Interest lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total finance lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other information related to the Company&#x2019;s leases is shown below (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.657%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the Years Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating cash flows used in operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.697%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.729%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted-average remaining lease term &#x2013; operating leases (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term &#x2013; finance leases (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;NA &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted-average discount rate &#x2013; operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate &#x2013; finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease asset (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) As of December&#160;31, 2023, the Company had recorded accumulated depreciation of approximately $760,000 for the finance lease asset. Finance lease assets are recorded within &lt;span style="-sec-ix-hidden:f-939"&gt;property and equipment, net&lt;/span&gt; on the Company&#x2019;s condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Minimum lease payments over the remaining lease periods as of December&#160;31, 2023 are as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-883">Leases&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New Jersey Laboratory Lease&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October&#160;23, 2020, the Company completed the acquisition of CPM, which included the acquisition of a 4,000 square foot CLIA accredited laboratory located in Old Bridge, New Jersey, which was owned by CPM (which is now known as ProPhase Diagnostics NJ, Inc.). The lease was renewed in February 2023, for an additional 36 months until February 2026. The monthly base rent remains the same at $5,500 per month. The lease renewal resulted in the recognition of an additional right-of-use asset and operating lease liability of $170,000 during the year ended December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New York Second Floor Lease&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On December 8, 2020, the Company entered into a Lease Agreement (the &#x201c;NY Second Floor Lease&#x201d;) with BRG Office L.L.C. and Unit 2 Associates L.L.C. (the &#x201c;Landlord&#x201d;), pursuant to which the Company leases certain premises located on the second floor (the &#x201c;Second Floor Leased Premises&#x201d;) of 711 Stewart Avenue, Garden City, New York (the &#x201c;Building&#x201d;). The Second Floor Leased Premises serve as the Company&#x2019;s second location and corporate headquarters, &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;offering a wide range of laboratory testing services for diagnosis, screening and evaluation of diseases, including COVID-19 and Respiratory Pathogen Panel Molecular tests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The NY Second Floor Lease was effective as of December&#160;8, 2020, and commenced in January 2021 (the &#x201c;Commencement Date&#x201d;) when the facility was made available to us by the landlord. The initial term of the NY Lease is 10 years and 7 months (the &#x201c;Initial Term&#x201d;), unless sooner terminated as provided in the NY Lease. The Company may extend the term of the NY Lease for one additional option period of five years. The Company has the option to terminate the NY Lease on the sixth anniversary of the Commencement Date, provided that it gives the landlord written notice not less than nine months and not more than 12 months in advance and that we pay the landlord a termination fee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 10, 2022, the Company entered into a First Amendment to the NY Second Floor Lease (the &#x201c;Second Floor Lease Amendment&#x201d;). The Second Floor Lease Amendment amends the NY Second Floor Lease to provide that any uncured default by the Company or any of its affiliate under the NY First Floor Lease (defined below) will constitute a default by the Company under the NY Second Floor Lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New York First Floor Lease&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;10, 2022, the Company entered into a second Lease Agreement (the &#x201c;NY First Floor Lease&#x201d;) with Landlord, pursuant to which the Company leases approximately 4,516 sq. feet located on the first floor (the &#x201c;NY First Floor Leased Premises&#x201d;) of the building. As described above, the Company currently leases space on the second floor of the building. The First Floor Leased Premises will be used to expand the Company&#x2019;s in-house lab capabilities to include traditional clinical testing across multiple specialty areas and Next Generation Sequencing (NGS) to perform Whole Genome Sequencing (WGS) and an array of genetic diagnostic test offerings for both clinical and research purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The NY First Floor Lease became effective as of June 10, 2022 and will commence upon the date of the Landlord&#x2019;s substantial completion of certain improvements to the NY First Floor Leased Premises (the &#x201c;First Floor Commencement Date&#x201d;), as set forth in the NY First Floor Lease, targeted to be approximately five months from the execution of the NY First Floor Lease. The initial term of the NY First Floor Lease will expire on July 15, 2031, unless&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;sooner terminated as provided in the NY First Floor Lease. The Company may extend the term of the NY First Floor Lease for one additional option period of five years pursuant to the terms described in the NY First Floor Lease. The Company has the option to terminate the NY First Floor Lease effective July 31, 2027 (the &#x201c;Early Termination Date&#x201d;), provided the Company gives the Landlord written notice not less than nine months and not more than 12 months prior to the Early Termination Date and pays the Landlord a termination fee as more particularly described in the Lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the first year of the NY First Floor Lease, the Company will pay a base rent of $11,290 per month (subject to an eight month abatement period), with a gradual rental rate increase of approximately 2.75% for each twelve month period thereafter, culminating in a monthly base rent of $14,026 during the final months of the initial term of the NY First Floor Lease. In addition to the monthly base rent, the Company is responsible for its proportionate share of real estate tax escalations in accordance with the terms of the NY First Floor Lease. The Landlord will provide a construction allowance to the Company in an aggregate amount not to exceed $203,000, to reimburse the Company for the cost of certain improvements to be made by the Company to the First Floor Leased Premises. During the year ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;December&#160;31, 2023&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, the Company recognized additional &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$0.8 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; right-of-use asset and operating lease liability for the NY First Floor Lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2023 and 2022, the Company had operating lease liabilities for the New York and New Jersey leases of approximately $5.2 million and $4.6 million, respectively, and right of use assets of approximately $4.6 million and $4.1 million, respectively, which were included in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On April 19, 2023, the Company entered into a master lease agreement for a laboratory equipment (the "First Equipment Lease") with a vendor. The First Equipment Lease has a 5-year term and is recognized as a finance lease under ASC 842.  The present value of the minimum future obligations of $1.5 million was calculated based on an interest rate of 8.0%, which was recognized in finance lease liabilities in the consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On July 21, 2023, the Company entered into a master lease agreement for a laboratory equipment (the "Second Equipment Lease") with a vendor. The Second Equipment Lease has a 4-year term and is recognized as a finance lease &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;under ASC 842.  The present value of the minimum future obligations of $5.1 million was calculated based on an interest rate of 7.4%, which was recognized in finance lease liabilities in the condensed consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On September 26, 2023, the Company entered into a master lease agreement for a laboratory equipment (the "Third Equipment Lease") with a vendor. The Third Equipment Lease has a 3-year term starting on the commencement date. The commencement date is when the equipment is shipped and installed, then the Company will provide Final Acceptance Certificate to the vendor. As of December&#160;31, 2023, the commencement date was not established, therefore, there was no fixed assets or finance lease liability recognized in the condensed consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Depreciation and interest expense related to the Equipment Lease was $760,000 for the year ended December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes quantitative information about the Company's operating and finance leases (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Finance leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Interest lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total finance lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other information related to the Company&#x2019;s leases is shown below (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.657%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the Years Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating cash flows used in operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.697%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.729%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted-average remaining lease term &#x2013; operating leases (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term &#x2013; finance leases (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;NA &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted-average discount rate &#x2013; operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate &#x2013; finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease asset (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) As of December&#160;31, 2023, the Company had recorded accumulated depreciation of approximately $760,000 for the finance lease asset. Finance lease assets are recorded within &lt;span style="-sec-ix-hidden:f-939"&gt;property and equipment, net&lt;/span&gt; on the Company&#x2019;s condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Minimum lease payments over the remaining lease periods as of December&#160;31, 2023 are as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:AreaOfRealEstateProperty contextRef="c-37" decimals="0" id="f-885" unitRef="sqft">4000</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-37" id="f-886">P36M</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <prph:LesseeOperatingLeaseMonthlyBaseRent contextRef="c-198" decimals="-2" id="f-887" unitRef="usd">5500</prph:LesseeOperatingLeaseMonthlyBaseRent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-37" decimals="-3" id="f-888" unitRef="usd">170000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability contextRef="c-37" decimals="-3" id="f-889" unitRef="usd">170000</us-gaap:OperatingLeaseLiability>
    <prph:LesseeOperatingLeaseNumberOfRenewalOptions
      contextRef="c-199"
      decimals="INF"
      id="f-890"
      unitRef="option">1</prph:LesseeOperatingLeaseNumberOfRenewalOptions>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-199" id="f-891">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <prph:LesseeOperatingLeaseOptionToTerminateNoticePeriod contextRef="c-200" id="f-892">P9M</prph:LesseeOperatingLeaseOptionToTerminateNoticePeriod>
    <prph:LesseeOperatingLeaseOptionToTerminateNoticePeriod contextRef="c-201" id="f-893">P12M</prph:LesseeOperatingLeaseOptionToTerminateNoticePeriod>
    <us-gaap:AreaOfRealEstateProperty contextRef="c-202" decimals="0" id="f-894" unitRef="sqft">4516</us-gaap:AreaOfRealEstateProperty>
    <prph:LesseeOperatingLeaseNumberOfRenewalOptions
      contextRef="c-202"
      decimals="INF"
      id="f-895"
      unitRef="option">1</prph:LesseeOperatingLeaseNumberOfRenewalOptions>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-202" id="f-896">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <prph:LesseeOperatingLeaseOptionToTerminateNoticePeriod contextRef="c-203" id="f-897">P9M</prph:LesseeOperatingLeaseOptionToTerminateNoticePeriod>
    <prph:LesseeOperatingLeaseOptionToTerminateNoticePeriod contextRef="c-204" id="f-898">P12M</prph:LesseeOperatingLeaseOptionToTerminateNoticePeriod>
    <us-gaap:PaymentsForRent contextRef="c-205" decimals="0" id="f-899" unitRef="usd">11290</us-gaap:PaymentsForRent>
    <prph:LesseeOperatingLeaseAbatementPeriod contextRef="c-205" id="f-900">P8M</prph:LesseeOperatingLeaseAbatementPeriod>
    <prph:GradualRentalRateIncreasePercentage
      contextRef="c-205"
      decimals="INF"
      id="f-901"
      unitRef="number">0.0275</prph:GradualRentalRateIncreasePercentage>
    <us-gaap:PrepaidRent contextRef="c-202" decimals="0" id="f-902" unitRef="usd">14026</us-gaap:PrepaidRent>
    <prph:ConstructionAllowance contextRef="c-205" decimals="-3" id="f-903" unitRef="usd">203000</prph:ConstructionAllowance>
    <us-gaap:OperatingLeaseLiability contextRef="c-206" decimals="-5" id="f-904" unitRef="usd">800000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-206" decimals="-5" id="f-905" unitRef="usd">800000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="-5" id="f-906" unitRef="usd">5200000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="c-5" decimals="-5" id="f-907" unitRef="usd">4600000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-5" id="f-908" unitRef="usd">4600000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-5" id="f-909" unitRef="usd">4100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:LesseeFinanceLeaseTermOfContract1 contextRef="c-207" id="f-910">P5Y</us-gaap:LesseeFinanceLeaseTermOfContract1>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue contextRef="c-207" decimals="-5" id="f-911" unitRef="usd">1500000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-207" decimals="3" id="f-912" unitRef="number">0.080</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeFinanceLeaseTermOfContract1 contextRef="c-208" id="f-913">P4Y</us-gaap:LesseeFinanceLeaseTermOfContract1>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue contextRef="c-208" decimals="-5" id="f-914" unitRef="usd">5100000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-208" decimals="3" id="f-915" unitRef="number">0.074</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeFinanceLeaseTermOfContract1 contextRef="c-209" id="f-916">P3Y</us-gaap:LesseeFinanceLeaseTermOfContract1>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-1" decimals="-3" id="f-917" unitRef="usd">760000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-918">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes quantitative information about the Company's operating and finance leases (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Finance leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Interest lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total finance lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other information related to the Company&#x2019;s leases is shown below (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.657%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the Years Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating cash flows used in operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.697%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.729%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted-average remaining lease term &#x2013; operating leases (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term &#x2013; finance leases (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 10pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;NA &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted-average discount rate &#x2013; operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate &#x2013; finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease asset (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) As of December&#160;31, 2023, the Company had recorded accumulated depreciation of approximately $760,000 for the finance lease asset. Finance lease assets are recorded within &lt;span style="-sec-ix-hidden:f-939"&gt;property and equipment, net&lt;/span&gt; on the Company&#x2019;s condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-3" id="f-919" unitRef="usd">956000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-10" decimals="-3" id="f-920" unitRef="usd">816000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-1" decimals="-3" id="f-921" unitRef="usd">956000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-10" decimals="-3" id="f-922" unitRef="usd">816000</us-gaap:VariableLeaseCost>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-1" decimals="-3" id="f-923" unitRef="usd">259000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-10" decimals="-3" id="f-924" unitRef="usd">0</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-1" decimals="-3" id="f-925" unitRef="usd">760000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-10" decimals="-3" id="f-926" unitRef="usd">0</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <prph:FinanceLeaseCost contextRef="c-1" decimals="-3" id="f-927" unitRef="usd">1019000</prph:FinanceLeaseCost>
    <prph:FinanceLeaseCost contextRef="c-10" decimals="-3" id="f-928" unitRef="usd">0</prph:FinanceLeaseCost>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-3" id="f-929" unitRef="usd">839000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-10" decimals="-3" id="f-930" unitRef="usd">774000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-4" id="f-931">P7Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-5" id="f-932">P8Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-4" id="f-933">P3Y9M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-4" decimals="4" id="f-934" unitRef="number">0.1000</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-5" decimals="4" id="f-935" unitRef="number">0.1000</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-4" decimals="4" id="f-936" unitRef="number">0.0756</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-937" unitRef="usd">5809000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization contextRef="c-4" decimals="-3" id="f-938" unitRef="usd">760000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-940">&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Minimum lease payments over the remaining lease periods as of December&#160;31, 2023 are as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.121%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:39.421%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.986%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.017%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.291%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.191%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.294%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Operating Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Year Ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Year Ended December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Year Ended December 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Year Ended December 31, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Year Ended December 31, 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;14,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less present value discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(2,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(898)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(3,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total   &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-4" decimals="-3" id="f-941" unitRef="usd">952000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-4" decimals="-3" id="f-942" unitRef="usd">1840000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <prph:LeaseLiabilityToBePaidYearOne contextRef="c-4" decimals="-3" id="f-943" unitRef="usd">2792000</prph:LeaseLiabilityToBePaidYearOne>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-4" decimals="-3" id="f-944" unitRef="usd">977000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo contextRef="c-4" decimals="-3" id="f-945" unitRef="usd">1840000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <prph:LeaseLiabilityToBePaidYearTwo contextRef="c-4" decimals="-3" id="f-946" unitRef="usd">2817000</prph:LeaseLiabilityToBePaidYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-4" decimals="-3" id="f-947" unitRef="usd">941000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree contextRef="c-4" decimals="-3" id="f-948" unitRef="usd">1840000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <prph:LeaseLiabilityToBePaidYearThree contextRef="c-4" decimals="-3" id="f-949" unitRef="usd">2781000</prph:LeaseLiabilityToBePaidYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-4" decimals="-3" id="f-950" unitRef="usd">955000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour contextRef="c-4" decimals="-3" id="f-951" unitRef="usd">1188000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <prph:LeaseLiabilityToBePaidYearFour contextRef="c-4" decimals="-3" id="f-952" unitRef="usd">2143000</prph:LeaseLiabilityToBePaidYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-4" decimals="-3" id="f-953" unitRef="usd">982000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive contextRef="c-4" decimals="-3" id="f-954" unitRef="usd">122000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <prph:LeaseLiabilityToBePaidYearFive contextRef="c-4" decimals="-3" id="f-955" unitRef="usd">1104000</prph:LeaseLiabilityToBePaidYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-4" decimals="-3" id="f-956" unitRef="usd">2667000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-4" decimals="-3" id="f-957" unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <prph:LeaseLiabilityToBePaidAfterYearFive contextRef="c-4" decimals="-3" id="f-958" unitRef="usd">2667000</prph:LeaseLiabilityToBePaidAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-4" decimals="-3" id="f-959" unitRef="usd">7474000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue contextRef="c-4" decimals="-3" id="f-960" unitRef="usd">6830000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <prph:LeaseLiabilityToBePaid contextRef="c-4" decimals="-3" id="f-961" unitRef="usd">14304000</prph:LeaseLiabilityToBePaid>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-4" decimals="-3" id="f-962" unitRef="usd">2284000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount contextRef="c-4" decimals="-3" id="f-963" unitRef="usd">898000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <prph:LeaseLiabilityUndiscountedExcessAmount contextRef="c-4" decimals="-3" id="f-964" unitRef="usd">3182000</prph:LeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="-3" id="f-965" unitRef="usd">5190000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability contextRef="c-4" decimals="-3" id="f-966" unitRef="usd">5932000</us-gaap:FinanceLeaseLiability>
    <prph:LeaseLiability contextRef="c-4" decimals="-3" id="f-967" unitRef="usd">11122000</prph:LeaseLiability>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="c-1" id="f-969">Significant Customers Concentrations&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue for years ended December 31, 2023 and 2022 was $44.4 million and $122.6 million, respectively. Diagnostic Services accounted for 54.9%&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and 88.3%, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of our net revenue for the year ended December&#160;31, 2023 and 2022. The company decreased its diagnostic services business in the second half of 2023 due to the significant decrease in demand for our diagnostic testing services. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December 31, 2023 &amp;amp; 2022, there were no consumer products customers that accounted for 10% or more of our total revenues.. Collections of diagnostic services revenues are driven by payers, which are government agencies (primarily HRSA), insurance providers, and client payers. For the year ended December 31, 2022, requisitions from each payer group were approximately 29%, 66%, and 5%, respectively. For the year ended December 31, 2023, requisitions from government agencies including Medicaid and Medicare were approximately 17% and insurance providers were 83%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to account receivable credit concentrations from time-to-time as a result of the timing, payment pattern and ultimate purchase volumes or shipping schedules with our customers. These concentrations may impact its overall exposure to credit risk, either positively or negatively, in that our customers may be similarly affected by changes in economic, regulatory or other conditions that may impact the timing and collectability of amounts due to the Company&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Three diagnostic services payers generated 32.6%, 18.7% and 12.6% of our total reimbursement receivable balances from government agencies and healthcare issuers at December 31 2023. Two diagnostic services payers generated 68.8% and 16.0% of our total reimbursement receivable balances from government agencies and healthcare issuers at December 31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Currently, the Company relies on a sole supplier to manufacture its saliva collection kits used by customers who purchase its personal genomics services. Change in the supplier or design of certain of the materials that the Company relies on, in particular the saliva collection kit, could result in a requirement for additional premarket review from the FDA before making such a change.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-970" unitRef="usd">44400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-10" decimals="-5" id="f-971" unitRef="usd">122600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-210" decimals="3" id="f-972" unitRef="number">0.549</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-211" decimals="3" id="f-973" unitRef="number">0.883</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-212" decimals="2" id="f-974" unitRef="number">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-213" decimals="2" id="f-975" unitRef="number">0.66</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-214" decimals="2" id="f-976" unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-215" decimals="2" id="f-977" unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-216" decimals="2" id="f-978" unitRef="number">0.83</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-217" decimals="3" id="f-979" unitRef="number">0.326</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-218" decimals="3" id="f-980" unitRef="number">0.187</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-219" decimals="3" id="f-981" unitRef="number">0.126</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-220" decimals="3" id="f-982" unitRef="number">0.688</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-221" decimals="3" id="f-983" unitRef="number">0.160</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-984">Segment Information&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has identified two operating segments, diagnostic services and consumer products, based on the manner in which the Company&#x2019;s CEO as CODM assesses performance and allocates resources across the organization. The operating segments are organized in a manner that depicts the difference in revenue generating synergies that include the separate processes, profit generation and growth of each segment. The diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third party payers and government organizations. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provides personal genomics products and services. The unallocated corporate expenses mainly included professional fees associated with the public company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of segment information for Fiscal 2023, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.939%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.515%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.412%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.981%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the years ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diagnostic services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;108,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Consumer products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;19,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;14,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Consolidated net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;44,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;122,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diagnostic services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;39,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Consumer products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;16,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Consolidated cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;28,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;51,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diagnostic services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Consumer products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Operating and other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;32,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;43,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Income (loss) from operations, before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diagnostic services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,804)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;56,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Consumer products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(7,493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(10,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unallocated corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(13,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(22,657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total income from operations, before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(22,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;22,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(4,445)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Net Income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(16,782)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;18,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of segment information for Fiscal 2023 and Fiscal 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diagnostic services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;44,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;50,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Consumer products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;38,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;22,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unallocated corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;14,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;91,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;87,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-985"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-986">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of segment information for Fiscal 2023, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.939%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.515%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.412%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.981%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the years ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diagnostic services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;108,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Consumer products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;19,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;14,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Consolidated net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;44,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;122,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diagnostic services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;39,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Consumer products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;16,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Consolidated cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;28,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;51,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diagnostic services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Consumer products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Operating and other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;32,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;43,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Income (loss) from operations, before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diagnostic services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,804)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;56,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Consumer products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(7,493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(10,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unallocated corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(13,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(22,657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total income from operations, before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(22,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;22,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(4,445)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Net Income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(16,782)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;18,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of segment information for Fiscal 2023 and Fiscal 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diagnostic services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;44,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;50,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Consumer products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;38,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;22,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unallocated corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;14,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;91,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;87,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-222" decimals="-3" id="f-987" unitRef="usd">24849000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-223" decimals="-3" id="f-988" unitRef="usd">108329000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-224" decimals="-3" id="f-989" unitRef="usd">19535000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-225" decimals="-3" id="f-990" unitRef="usd">14318000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-991" unitRef="usd">44384000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-10" decimals="-3" id="f-992" unitRef="usd">122647000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-222" decimals="-3" id="f-993" unitRef="usd">11790000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-223" decimals="-3" id="f-994" unitRef="usd">39896000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-224" decimals="-3" id="f-995" unitRef="usd">16355000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-225" decimals="-3" id="f-996" unitRef="usd">12097000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-3" id="f-997" unitRef="usd">28145000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-10" decimals="-3" id="f-998" unitRef="usd">51993000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:DepreciationAndAmortization contextRef="c-222" decimals="-3" id="f-999" unitRef="usd">3979000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-223" decimals="-3" id="f-1000" unitRef="usd">2336000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-224" decimals="-3" id="f-1001" unitRef="usd">2070000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-225" decimals="-3" id="f-1002" unitRef="usd">2206000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="-3" id="f-1003" unitRef="usd">6049000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-10" decimals="-3" id="f-1004" unitRef="usd">4542000</us-gaap:DepreciationAndAmortization>
    <prph:OperatingAndOtherExpenses contextRef="c-1" decimals="-3" id="f-1005" unitRef="usd">32990000</prph:OperatingAndOtherExpenses>
    <prph:OperatingAndOtherExpenses contextRef="c-10" decimals="-3" id="f-1006" unitRef="usd">43203000</prph:OperatingAndOtherExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-222" decimals="-3" id="f-1007" unitRef="usd">-1804000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-223" decimals="-3" id="f-1008" unitRef="usd">56389000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-224" decimals="-3" id="f-1009" unitRef="usd">-7493000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-225" decimals="-3" id="f-1010" unitRef="usd">-10824000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-226" decimals="-3" id="f-1011" unitRef="usd">-13503000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-227" decimals="-3" id="f-1012" unitRef="usd">-22657000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-1013" unitRef="usd">-22800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-10" decimals="-3" id="f-1014" unitRef="usd">22908000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1015" unitRef="usd">-6018000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-10" decimals="-3" id="f-1016" unitRef="usd">4445000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-1017" unitRef="usd">-16782000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-10" decimals="-3" id="f-1018" unitRef="usd">18463000</us-gaap:NetIncomeLoss>
    <us-gaap:Assets contextRef="c-228" decimals="-3" id="f-1019" unitRef="usd">44221000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-229" decimals="-3" id="f-1020" unitRef="usd">50832000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-230" decimals="-3" id="f-1021" unitRef="usd">38358000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-231" decimals="-3" id="f-1022" unitRef="usd">22080000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-232" decimals="-3" id="f-1023" unitRef="usd">9348000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-233" decimals="-3" id="f-1024" unitRef="usd">14736000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-1025" unitRef="usd">91927000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-5" decimals="-3" id="f-1026" unitRef="usd">87648000</us-gaap:Assets>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-1027">Earnings Per Share&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share (&#x201c;EPS&#x201d;) excludes dilution and is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or otherwise result in the issuance of common stock that shared in the earnings of the entity. Diluted EPS also utilizes the treasury stock method which prescribes a theoretical buy back of shares from the theoretical proceeds of all options outstanding during the period, and the if-converted method for convertible debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of the weighted average number of common shares outstanding used in calculating basic and diluted net loss per share (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the years ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net (loss) income - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(16,782)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;18,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Interest on unsecured convertible promissory note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net (loss) income - diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(16,782)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;19,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted average shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;17,207&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,845&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diluted shares- Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,493&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diluted shares- Stock Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,073&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unsecured convertible promissory note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;240&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted average shares outstanding - diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;17,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;18,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the number of securities excluded from the income per share computation as a result of their anti-dilutive effect (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.263%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Anti-dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Common stock purchase warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Anti-dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-1028">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of the weighted average number of common shares outstanding used in calculating basic and diluted net loss per share (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the years ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net (loss) income - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(16,782)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;18,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Interest on unsecured convertible promissory note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net (loss) income - diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(16,782)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;19,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted average shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;17,207&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,845&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diluted shares- Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,493&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Diluted shares- Stock Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,073&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unsecured convertible promissory note&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;240&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted average shares outstanding - diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;17,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;18,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-1" decimals="-3" id="f-1029" unitRef="usd">-16782000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-10" decimals="-3" id="f-1030" unitRef="usd">18463000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <prph:InterestOnUnsecuredConvertiblePromissoryNote contextRef="c-1" decimals="-3" id="f-1031" unitRef="usd">0</prph:InterestOnUnsecuredConvertiblePromissoryNote>
    <prph:InterestOnUnsecuredConvertiblePromissoryNote contextRef="c-10" decimals="-3" id="f-1032" unitRef="usd">632000</prph:InterestOnUnsecuredConvertiblePromissoryNote>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-1" decimals="-3" id="f-1033" unitRef="usd">-16782000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-10" decimals="-3" id="f-1034" unitRef="usd">19095000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-3" id="f-1035" unitRef="shares">17207000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c-10"
      decimals="-3"
      id="f-1036"
      unitRef="shares">15845000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="c-234"
      decimals="-3"
      id="f-1037"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="c-235"
      decimals="-3"
      id="f-1038"
      unitRef="shares">1493000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="c-236"
      decimals="-3"
      id="f-1039"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="c-237"
      decimals="-3"
      id="f-1040"
      unitRef="shares">1073000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities contextRef="c-1" decimals="-3" id="f-1041" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="c-10"
      decimals="-3"
      id="f-1042"
      unitRef="shares">240000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-3" id="f-1043" unitRef="shares">17207000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c-10"
      decimals="-3"
      id="f-1044"
      unitRef="shares">18651000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-1045">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the number of securities excluded from the income per share computation as a result of their anti-dilutive effect (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.263%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;For the years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Anti-dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Common stock purchase warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Anti-dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-238"
      decimals="-3"
      id="f-1046"
      unitRef="shares">831000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-239"
      decimals="-3"
      id="f-1047"
      unitRef="shares">455000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-240"
      decimals="-3"
      id="f-1048"
      unitRef="shares">2951000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-241"
      decimals="-3"
      id="f-1049"
      unitRef="shares">770000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="-3" id="f-1050" unitRef="shares">3782000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-10"
      decimals="-3"
      id="f-1051"
      unitRef="shares">1225000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c-1" id="f-1052">Related Parties&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's Executive Vice President and Co-Chief Operations Officer of ProPhase Diagnostics, is a related party to the Company's Chairman and Chief Executive Officer. For the years ended December 31, 2023 and 2022, there were no payments made to the Executive Vice President outside compensation for the position held at the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-1053">Subsequent Events&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; February&#160;14, 2024, the Company entered into an agreement of sale of future receipts (&#x201c;Future Receipts Financing Agreement&#x201d;) with Libertas Funding, LLC (&#x201c;Libertas&#x201d;) by which Libertas purchases from the Company, its future accounts and contract rights arising from the sale of goods or rendition of services to the Company&#x2019;s customers. The purchase price was approximate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$2.5 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which was paid to the Company on February 16, 2024, net of $50,000 origination fee. The Future Receipts Financing Agreement requires twelve equal payments of $247,000 to be paid monthly for a total repayment of approximate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$3.0 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; over the term of the agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has evaluated subsequent events through March 28, 2024, which is the date the consolidated financial statements were available to be issued. There were no additional subsequent events that required adjustment to or disclosure in the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <prph:ProceedsFromFinancingAgreement contextRef="c-242" decimals="-5" id="f-1054" unitRef="usd">2500000</prph:ProceedsFromFinancingAgreement>
    <prph:FinancingAgreementOriginationFee contextRef="c-242" decimals="-3" id="f-1055" unitRef="usd">50000</prph:FinancingAgreementOriginationFee>
    <prph:FinancingAgreementPeriodicPayment contextRef="c-243" decimals="-3" id="f-1056" unitRef="usd">247000</prph:FinancingAgreementPeriodicPayment>
    <prph:FinancingArrangementAggregateRepaymentAmount contextRef="c-244" decimals="-5" id="f-1057" unitRef="usd">3000000</prph:FinancingArrangementAggregateRepaymentAmount>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
